PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Baker, K; O'Donnell, C; Bendix, M; Keogh, S; Byrne, J; O'Riordain, M; Neary, P; Houston, A; Brint, E				Baker, Kevin; O'Donnell, Charlotte; Bendix, Maura; Keogh, Samuel; Byrne, James; O'Riordain, Michael; Neary, Peter; Houston, Aileen; Brint, Elizabeth			IL-36 signalling enhances a pro-tumorigenic phenotype in colon cancer cells with cancer cell growth restricted by administration of the IL-36R antagonist	ONCOGENE			English	Article							ULCERATIVE-COLITIS; EXPRESSION; INTERLEUKIN-36; RECEPTOR; FAMILY; ROLES	The IL-36 cytokines are a recently described subset of the IL-1 family of cytokines, shown to play a role in the pathogenesis of intestinal diseases such as Inflammatory Bowel Disease (IBD). Given the link between IBD and colitis -associated cancer, as well as the involvement of other IL-1 family members in intestinal tumorigenesis, the aim of this work was to investigate whether IL-36 cytokines play a role in the pathogenesis of colon cancer. Whilst research to date has focused on the role of IL-36 family members in augmenting the immune response to induce tumour rejection, very little remains known about IL-36R signalling in tumour cells in this context. In this study we demonstrate that expression of IL-36 family member mRNA and protein are significantly increased in colorectal cancer tissue compared to adjacent non-tumour. In vitro assays showed stimulation of colon cancer cell lines with IL-36R agonists resulted in the activation of the pro-tumorigenic phenotypes of increased cellular migration, invasion and proliferation in both 2D and 3D models. In addition, the IL-36 cytokines induced strong expression of pro-inflammatory chemokines in both human and murine cell lines. Intraperitoneal injection of IL-36Ra significantly reduced tumour burden using the subcutaneous CT26 tumour model in syngeneic Balb/mice, and this was associated with a decrease in Ki-67 expression by tumour cells in the IL-36Ra- treated group relative to untreated, suggesting the inhibition of the pro-proliferative signalling of IL-36 agonists resulted in the decreased tumour size. Moreover, colon cancer cells lacking the IL-36R also showed reduced tumour growth and reduced Ki-67 expression in vivo. Taken together, this data suggests that targeting IL-36R signalling may be a useful targeted therapy for colorectal cancer patients with IL-36R(+) tumour cells.	[Baker, Kevin; Bendix, Maura; Keogh, Samuel; Byrne, James; Brint, Elizabeth] Univ Coll Cork, Dept Pathol, Cork, Ireland; [Baker, Kevin; Houston, Aileen; Brint, Elizabeth] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [O'Donnell, Charlotte; Houston, Aileen] Univ Coll Cork, Dept Med, Cork, Ireland; [Bendix, Maura] Univ Coll Cork, Canc Res UCC, Cork, Ireland; [O'Riordain, Michael] Mercy Univ Hosp, Cork, Ireland; [Neary, Peter] Waterford Univ Hosp, Waterford, Ireland	University College Cork; University College Cork; University College Cork; University College Cork; University College Cork	Brint, E (corresponding author), Univ Coll Cork, Dept Pathol, Cork, Ireland.; Brint, E (corresponding author), Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland.	e.brint@ucc.ie		Houston, Aileen/0000-0003-1362-5256; Bendix, Maura/0000-0001-8883-2677; Brint, Elizabeth/0000-0001-9214-149X	Government of Ireland [GOIPG/2018/2974]; IReL Consortium	Government of Ireland; IReL Consortium	This work was funded by a grant from the Government of Ireland postgraduate scholarship scheme GOIPG/2018/2974. Open Access funding provided by the IReL Consortium.	Aldinucci D, 2020, CANCERS, V12, DOI 10.3390/cancers12071765; Baker KJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01197; Bassoy EY, 2018, IMMUNOL REV, V281, P169, DOI 10.1111/imr.12610; Byrne J, 2021, CELL MOL LIFE SCI, V78, P6215, DOI 10.1007/s00018-021-03909-4; Chun E, 2015, CELL REP, V12, P244, DOI 10.1016/j.celrep.2015.06.024; Diaz-Maroto NG, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22094960; Ding LP, 2018, ONCOTARGET, V9, P2895, DOI 10.18632/oncotarget.22814; Dunn E, 2001, TRENDS IMMUNOL, V22, P533, DOI 10.1016/S1471-4906(01)02034-8; Duronio Robert J, 2013, Cold Spring Harb Perspect Biol, V5, pa008904, DOI 10.1101/cshperspect.a008904; Fernandes P, 2014, J IMMUNOL, V193, P6103, DOI 10.4049/jimmunol.1303083; Fonseca-Camarillo G, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5140691; Frick VO, 2016, WORLD J GASTROENTERO, V22, P833, DOI 10.3748/wjg.v22.i2.833; Gabay C, 2015, J LEUKOCYTE BIOL, V97, P645, DOI 10.1189/jlb.3RI1014-495R; Gelfo V, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176009; Holen I, 2016, ONCOTARGET, V7, P75571, DOI 10.18632/oncotarget.12289; Ko HBM, 2015, MODERN PATHOL, V28, P1584, DOI 10.1038/modpathol.2015.111; Kobelt D, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00980; Le Rolle AF, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0555-4; Leon G, 2021, INFLAMM BOWEL DIS, V27, P440, DOI 10.1093/ibd/izaa232; Liu Q, 2020, INT J BIOL SCI, V16, P1023, DOI 10.7150/ijbs.40535; Mao DL, 2019, TECHNOL CANCER RES T, V18, DOI 10.1177/1533033819883633; McCombs JE, 2021, AM J RESP CELL MOL, V64, P153, DOI 10.1165/rcmb.2020-0461ED; Medina-Contreras O, 2016, J IMMUNOL, V196, P34, DOI 10.4049/jimmunol.1501312; Najdaghi S, 2020, CYTOKINE, V135, DOI 10.1016/j.cyto.2020.155205; Nishida A, 2016, INFLAMM BOWEL DIS, V22, P303, DOI 10.1097/MIB.0000000000000654; O'Donnell C, 2016, BRIT J CANCER, V114, P37, DOI 10.1038/bjc.2015.433; Pijuan J, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00107; Qu QX, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00634; Queen D, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00317; Ridker PM, 2017, LANCET, V390, P1833, DOI 10.1016/S0140-6736(17)32247-X; Russell SE, 2016, MUCOSAL IMMUNOL, V9, P1193, DOI 10.1038/mi.2015.134; Swindell WR, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00080; Uppala R, 2021, CELL MOL IMMUNOL, V18, P307, DOI 10.1038/s41423-020-0519-3; Wang D, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0701-2; Wang XF, 2015, CANCER CELL, V28, P296, DOI 10.1016/j.ccell.2015.07.014; Weinstein AM, 2019, CANCER IMMUNOL IMMUN, V68, P109, DOI 10.1007/s00262-018-2259-0; Weinstein AM, 2017, ONCOIMMUNOLOGY, V6, DOI 10.1080/2162402X.2017.1322238; Xie YH, 2020, SIGNAL TRANSDUCT TAR, V5, DOI 10.1038/s41392-020-0116-z; Yang W, ADV SCI, V2022; Yashiro M, 2014, WORLD J GASTROENTERO, V20, P16389, DOI 10.3748/wjg.v20.i44.16389; Zhao X, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01803	41	1	1	1	1	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2022	41	19					2672	2684		10.1038/s41388-022-02281-2	http://dx.doi.org/10.1038/s41388-022-02281-2		APR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1A5QI	35365751	Green Published, hybrid			2022-12-26	WOS:000777275200001
J	Atnafu, A; Desta, K; Girma, S; Hailu, D; Assefa, G; Araya, S; Bekele, D; Wassie, L; Bobosha, K				Atnafu, Abay; Desta, Kassu; Girma, Selfu; Hailu, Dawit; Assefa, Gebeyehu; Araya, Shambel; Bekele, Dinksira; Wassie, Liya; Bobosha, Kidist			Integration of cytopathology with molecular tests to improve the lab diagnosis for TBLN suspected patients	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; EXTRAPULMONARY TUBERCULOSIS; LYMPHADENITIS	Background Tuberculosis lymphadenitis (TBLN) diagnosis is often challenging in most resource poor settings. Often cytopathologic diagnosis of TBLN suspected patients is inconclusive impeding timely clinical management of TBLN suspected patients, further exposing suspected patients either for unnecessary use of antibiotics or empirical treatment. This may lead to inappropriate treatment outcome or more suffering of suspected patients from the disease. In this study, an integrated diagnostic approach has been evaluated to elucidate its utility in the identification of TBLN suspected patients. Methods A cross-sectional study was conducted on 96 clinically diagnosed TBLN suspected patients, where fine needle aspirate (FNA) samples were collected at the time of diagnosis. FNA cytology, Ziehl-Neelsen (ZN), Auramine O (AO) staining, GeneXpert MTB/RIF and Real time PCR (RT-PCR) were performed on concentrated FNA samples. Considering culture as a gold standard, the sensitivity, specificity, positive and negative predictive values were calculated. Cohen's Kappa value was used to measure interrater variability and level of agreement and a P-value of <0.05 was considered as statistically significant. Result Out of the 96 FNA sample, 12 (12.5%) were identified to have Mycobacterium tuberculosis (Mtb) using ZN staining, 27 (28.1%) using AO staining, 51 (53.2%) using FNAC, 43 (44.7%) using GeneXpert MTB/RIF, 51 (53.1%) using Real time PCR (RT-PCR) and 36 (37.5%) using Lowenstein-Jensen (LJ) culture. Compared to LJ culture, the sensitivities of GeneXpert MTB/RIF, RT-PCR, and FNAC were 91.7%, 97.2%, and 97.2%, respectively and the specificities were 83.3%, 73.3%, and 68.3%, respectively. GeneXpert MTB/RIF and RT-PCR when combined with FNAC detected 61 (63.5%) cases as having Mtb, and the sensitivity and specificity was 100% and 58.3%, respectively. Conclusion FNA cytology and RT-PCR detected more TBLN cases compared to other Mtb detection tools and the detection sensitivity even improved when FNA cytology was combined with GeneXpert MTB/RIF, performed on concentrated FNA sample, suggesting the combined tests as an alternative approach for improved diagnosis of TBLN.	[Atnafu, Abay; Girma, Selfu; Hailu, Dawit; Assefa, Gebeyehu; Bekele, Dinksira; Wassie, Liya; Bobosha, Kidist] Armauer Hansen Res Inst, Addis Ababa, Ethiopia; [Atnafu, Abay; Desta, Kassu; Araya, Shambel] Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia	Addis Ababa University	Atnafu, A (corresponding author), Armauer Hansen Res Inst, Addis Ababa, Ethiopia.; Atnafu, A (corresponding author), Addis Ababa Univ, Dept Med Lab Sci, Addis Ababa, Ethiopia.	ayatab.ayele7@gamil.com		Mitku, Gebeyehu Assefa/0000-0003-1308-7566; Ayele, Abay/0000-0001-7594-4004; Girma, Selfu/0000-0002-1866-0950	AHRI's NORAD/SIDA core budget	AHRI's NORAD/SIDA core budget	This study was supported by AHRI's NORAD/SIDA core budget. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No author has received a salary from the funder.	Abebe G, 2016, GENEXPERT MTB RIF AS; Addise Desalegn, 2016, Ethiop J Public Health Nutr, V1, P57; Aljafari AS, 2004, CYTOPATHOLOGY, V15, P44, DOI 10.1111/j.1365-2303.2003.00119.x; Babafemi EO, 2017, SYST REV-LONDON, V6, DOI 10.1186/s13643-017-0608-2; Biadglegne F, 2014, TUBERCULOSIS, V94, P502, DOI 10.1016/j.tube.2014.05.002; Boyle DS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103091; Fantahun M, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222402; Global Laboratory Initiative, 2014, MYC LAB MAN; Gouda Kalyani, 2021, Indian J Tuberc, V68, P437, DOI 10.1016/j.ijtb.2021.01.005; Hemalatha A, 2014, ANN MED HEALTH SCI R, V4, P393, DOI 10.4103/2141-9248.133466; Kant K, 2019, J FAM MED PRIM CARE, V8, P828, DOI 10.4103/jfmpc.jfmpc_20_19; Linasmita P, 2012, CLIN INFECT DIS, V55, P313, DOI 10.1093/cid/cis401; Manitchotpisit Boonchu, 1999, Journal of the Medical Association of Thailand, V82, P363; Mehta PK, 2012, FEMS IMMUNOL MED MIC, V66, P20, DOI 10.1111/j.1574-695X.2012.00987.x; Mekonnen D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215647; NationalCancerControlprogram, 2005, MAN CYT; Nur T-E., 2019, J ENAM MED COLL, V9, P30; Nur T-E., 2019, CLIN INFECT IMMUNITY, V4, P6; Pang Y, 2019, EMERG INFECT DIS, V25, P457, DOI 10.3201/eid2503.180572; Sarfaraz S, 2018, INT J INFECT DIS, V76, P73, DOI 10.1016/j.ijid.2018.08.020; Shruti V., 2016, INT J MED RES REV, V4; Smith I, 2003, CLIN MICROBIOL REV, V16, P463, DOI 10.1128/CMR.16.3.463-496.2003; Tadesse M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137471; Upadhyay G., 2016, INT J RES MED SCI, V4, P5103; VANSOOLINGEN D, 1992, J CLIN MICROBIOL, V30, P1772, DOI 10.1128/JCM.30.7.1772-1777.1992; Yu GC, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/4878240; Zewdie O, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2194-2	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265499	10.1371/journal.pone.0265499	http://dx.doi.org/10.1371/journal.pone.0265499			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358212	Green Published, gold			2022-12-26	WOS:000799828800034
J	Rajaraman, S; Cohen, G; Spear, L; Folio, L; Antani, S				Rajaraman, Sivaramakrishnan; Cohen, Gregg; Spear, Lillian; Folio, Les; Antani, Sameer			DeBoNet: A deep bone suppression model ensemble to improve disease detection in chest radiographs	PLOS ONE			English	Article							LUNG NODULES; RIB	Automatic detection of some pulmonary abnormalities using chest X-rays may be impacted adversely due to obscuring by bony structures like the ribs and the clavicles. Automated bone suppression methods would increase soft tissue visibility and enhance automated disease detection. We evaluate this hypothesis using a custom ensemble of convolutional neural network models, which we call DeBoNet, that suppresses bones in frontal CXRs. First, we train and evaluate variants of U-Nets, Feature Pyramid Networks, and other proposed custom models using a private collection of CXR images and their bone-suppressed counterparts. The DeBoNet, constructed using the top-3 performing models, outperformed the individual models in terms of peak signal-to-noise ratio (PSNR) (36.7977 +/- 1.6207), multi-scale structural similarity index measure (MS-SSIM) (0.9848 +/- 0.0073), and other metrics. Next, the best-performing bone-suppression model is applied to CXR images that are pooled from several sources, showing no abnormality and other findings consistent with COVID-19. The impact of bone suppression is demonstrated by evaluating the gain in performance in detecting pulmonary abnormality consistent with COVID-19 disease. We observe that the model trained on bone-suppressed CXRs (MCC: 0.9645, 95% confidence interval (0.9510, 0.9780)) significantly outperformed (p < 0.05) the model trained on non-bone-suppressed images (MCC: 0.7961, 95% confidence interval (0.7667, 0.8255)) in detecting findings consistent with COVID-19 indicating benefits derived from automatic bone suppression on disease classification.	[Rajaraman, Sivaramakrishnan; Antani, Sameer] NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA; [Cohen, Gregg; Spear, Lillian; Folio, Les] NIH, Ctr Clin, Dept Radiol & Imaging Sci, Bethesda, MD 20892 USA; [Folio, Les] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA	National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); H Lee Moffitt Cancer Center & Research Institute	Rajaraman, S (corresponding author), NIH, Natl Lib Med, Bldg 10, Bethesda, MD 20892 USA.	sivaramakrishnan.rajaraman@nih.gov	Antani, Sameer/GVS-8371-2022	Antani, Sameer/0000-0002-0040-1387	Intramural Research Program of the National Library of Medicine part of the National Institutes of Health; Intramural Research Program of the National Library of the Clinical Center part of the National Institutes of Health	Intramural Research Program of the National Library of Medicine part of the National Institutes of Health; Intramural Research Program of the National Library of the Clinical Center part of the National Institutes of Health	This research was supported by the Intramural Research Program of the National Library of Medicine, and the Clinical Center, both parts of the National Institutes of Health. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Bhattacharya S, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102589; Budapest University of Technology and Economics (BME), 2013, BON SHAD EL IM JSRT; Chollet F., 2016, ARXIV PREPRINT ARXIV, P1; Cohen J.P., 2020, COVID 19 IMAGE DATA; Dietterich TG, 2000, LECT NOTES COMPUT SC, V1857, P1, DOI 10.1007/3-540-45014-9_1; Freedman MT, 2011, RADIOLOGY, V260, P265, DOI 10.1148/radiol.11100153; He K., 2016, CVPR, P770; Nguyen HX, 2015, IFMBE PROC, V46, P194, DOI 10.1007/978-3-319-11776-8_47; Hu J, 2018, PROC CVPR IEEE, P7132, DOI [10.1109/CVPR.2018.00745, 10.1109/TPAMI.2019.2913372]; Huang G, 2017, PROC CVPR IEEE, P2261, DOI 10.1109/CVPR.2017.243; Imaging C, 2020, THIS IS THREAD COVID; Institute for Diagnostic and Interventional Radiology HMS, 2020, COVID 19 IM REP; Islam M.T., 2017, ARXIV; Kim I, 2019, DIAGNOSTICS, V9, DOI 10.3390/diagnostics9020038; Kodama N, 2018, CLIN IMAG, V51, P196, DOI 10.1016/j.clinimag.2018.05.021; Kuhlman JE, 2006, RADIOGRAPHICS, V26, P79, DOI 10.1148/rg.261055034; Li F, 2012, EUR RADIOL, V22, P2729, DOI 10.1007/s00330-012-2550-y; Li F, 2011, RADIOLOGY, V261, P937, DOI 10.1148/radiol.11110192; Li F, 2011, AM J ROENTGENOL, V196, pW535, DOI 10.2214/AJR.10.4816; Lim B, 2017, IEEE COMPUT SOC CONF, P1132, DOI 10.1109/CVPRW.2017.151; Manji F, 2016, QUANT IMAG MED SURG, V6, P1, DOI 10.3978/j.issn.2223-4292.2015.10.09; Matsubara N, 2020, PHYS ENG SCI MED, V43, P97, DOI 10.1007/s13246-019-00822-w; Oda S, 2009, AM J ROENTGENOL, V193, pW397, DOI 10.2214/AJR.09.2431; Open Source Computer Vision, 2020, HIST COMP; Rajaraman S, 2019, IEEE ENG MED BIO, P3689, DOI 10.1109/EMBC.2019.8856715; Rajaraman S, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11050840; Rajaraman S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242301; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Sandler M, 2018, PROC CVPR IEEE, P4510, DOI 10.1109/CVPR.2018.00474; Santosh KC, 2018, IEEE T MED IMAGING, V37, P1168, DOI 10.1109/TMI.2017.2775636; Shah PK, 2003, RADIOLOGY, V226, P235, DOI 10.1148/radiol.2261011924; Shih G, 2019, RADIOL-ARTIF INTELL, V1, DOI 10.1148/ryai.2019180041; Suzuki K, 2006, IEEE T MED IMAGING, V25, P406, DOI 10.1109/TMI.2006.871549; Szegedy C., 2016, P IEEE C COMPUTER VI, P2818, DOI DOI 10.1109/CVPR.2016.308; Tan MX, 2019, PR MACH LEARN RES, V97; Vaya M.I., 2020, ABS200601174; Xie XM, 2018, LECT NOTES COMPUT SC, V11259, P199, DOI 10.1007/978-3-030-03341-5_17; Yakubovskiy P., 2020, GITHUB REPOS; Yang W, 2017, MED IMAGE ANAL, V35, P421, DOI 10.1016/j.media.2016.08.004	39	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265691	10.1371/journal.pone.0265691	http://dx.doi.org/10.1371/journal.pone.0265691			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358235	Green Submitted, gold, Green Published			2022-12-26	WOS:000799828800044
J	Kawakami, E; Ataka, M; Kume, T; Shimono, K; Harada, M; Hishi, T; Katayama, A				Kawakami, Erika; Ataka, Mioko; Kume, Tomonori; Shimono, Kohei; Harada, Masayoshi; Hishi, Takuo; Katayama, Ayumi			Root exudation in a sloping Moso bamboo forest in relation to fine root biomass and traits	PLOS ONE			English	Article							NET PRIMARY PRODUCTION; TEMPERATE FOREST; RESPIRATION; CARBON	Exudation by fine roots generally varies with their morphological traits, but the effect of belowground resource availability on the root exudation via root morphological traits and biomass remains unknown. We aimed to determine the effects of morphological and physiological traits on root exudation rates and to estimate stand-scale exudation (E-stand) by measuring the mass, length, and surface area of fine roots in a Moso bamboo forest. We measured root exudation as well as morphological and physiological traits in upper and lower plots on a slope with different belowground resource availability. The mean (+/- S.D.) root exudation rates per mass in the upper and lower slope were 0.049 +/- 0.047 and 0.040 +/- 0.059 mg C g(-1) h(-1), respectively, which were in the range of exudation found in woody forest ecosystems. We observed significant relationships between root exudation per mass and root respiration, as well as specific root length and surface area. In contrast, exudation per length and area did not correlate with morphological traits. The morphological traits did not differ between slope positions, resulting in no significant difference in root exudation per mass. Fine root biomass, length, and surface area on a unit ground basis were much higher in the lower than those in the upper slope positions. E-stand was higher when estimated by mass than by length and area because the morphological effect on exudation was ignored when scaled using mass. E-stand was 1.4-2.0-fold higher in the lower than that in upper slope positions, suggesting that the scaling parameters of mass, length, and area determined the E-stand estimate more than the exudation rate per mass, length, and area. Regardless of scaling, E-stand was much higher in the Moso bamboo forest than in other forest ecosystems because of a large fine-root biomass.	[Kawakami, Erika; Shimono, Kohei] Kyushu Univ, Grad Sch Bioresource & Bioenvironm Sci, Nishi Ku, Fukuoka, Japan; [Ataka, Mioko] Res Inst Sustainable Humanosphere, Uji, Kyoto, Japan; [Kume, Tomonori; Katayama, Ayumi] Kyushu Univ, Shiiba Res Forest, Shiiba, Miyazaki, Japan; [Harada, Masayoshi] Kyushu Univ, Fac Agr, Nishi Ku, Fukuoka, Japan; [Hishi, Takuo] Kyushu Univ, Kasuya Res Forest, Sasaguri, Fukuoka, Japan	Kyushu University; Kyushu University; Kyushu University; Kyushu University	Katayama, A (corresponding author), Kyushu Univ, Shiiba Res Forest, Shiiba, Miyazaki, Japan.	ayumi.katayama0920@gmail.com			JSPS KAKENHI [19H02996, 15K07467]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The major funding for this research came from JSPS KAKENHI Grants (No. 19H02996, Tomonori Kume and No. 15K07467, Ayumi Katayama) to Kyushu University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akatsuki M, 2020, TREE PHYSIOL, V40, P1071, DOI 10.1093/treephys/tpaa051; Aoki M, 2012, ECOSYSTEMS, V15, P1194, DOI 10.1007/s10021-012-9575-6; Ataka M, 2020, TREE PHYSIOL, V40, P367, DOI 10.1093/treephys/tpz143; DEIMS, 2019, DATABASE DEIMS SDR; EISSENSTAT DM, 1992, J PLANT NUTR, V15, P763, DOI 10.1080/01904169209364361; Erktan A, 2018, J ECOL, V106, P2031, DOI 10.1111/1365-2745.12953; Finer L, 2011, FOREST ECOL MANAG, V261, P265, DOI 10.1016/j.foreco.2010.10.016; Finzi AC, 2015, GLOBAL CHANGE BIOL, V21, P2082, DOI 10.1111/gcb.12816; Hill P, 2007, PLANT SOIL, V291, P131, DOI 10.1007/s11104-006-9180-6; Ichihashi R, 2015, ECOHYDROLOGY, V8, P450, DOI 10.1002/eco.1515; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Lin GG, 2017, NEW PHYTOL, V213, P1440, DOI 10.1111/nph.14206; Maeda Y, 2018, FOREST ECOL MANAG, V422, P214, DOI 10.1016/j.foreco.2018.03.046; Makita N, 2015, OECOLOGIA, V179, P959, DOI 10.1007/s00442-015-3413-4; Meier IC, 2020, NEW PHYTOL, V226, P583, DOI 10.1111/nph.16389; Nakayama M, 2018, TREES-STRUCT FUNCT, V32, P871, DOI 10.1007/s00468-018-1685-0; Phillips RP, 2008, FUNCT ECOL, V22, P990, DOI 10.1111/j.1365-2435.2008.01495.x; Phillips RP, 2009, TREE PHYSIOL, V29, P1513, DOI 10.1093/treephys/tpp083; Preece C, 2018, TREE PHYSIOL, V38, P690, DOI 10.1093/treephys/tpx163; Pregitzer KS, 1998, TREE PHYSIOL, V18, P665; Shimono K, 2021, B KYUSHU U FOR, P9, DOI [10.15017/ 4377826, DOI 10.15017/4377826]; Shimono K, 2022, J FOREST RES-JPN, V27, P28, DOI 10.1080/13416979.2021.1965280; Shinohara Y, 2019, CATENA, V172, P451, DOI 10.1016/j.catena.2018.09.011; Song QN, 2017, SCI REP-UK, V7, DOI 10.1038/srep40383; Sun LJ, 2021, NEW PHYTOL, V229, P259, DOI 10.1111/nph.16865; Sun LJ, 2017, TREE PHYSIOL, V37, P1011, DOI 10.1093/treephys/tpx026; Sun LJ, 2017, ECOL RES, V32, P331, DOI 10.1007/s11284-017-1440-9; Tateno R, 2004, FOREST ECOL MANAG, V193, P297, DOI 10.1016/j.foreco.2003.11.011; Thorsos E., 2011, THESIS DUKE U; Wang QT, 2021, PLANT SOIL, V458, P277, DOI [10.1007/s11104-019-04156-0, 10.1145/3361242.3361254]; Xiong DC, 2020, FOREST ECOL MANAG, V458, DOI 10.1016/j.foreco.2019.117793	31	0	0	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266131	10.1371/journal.pone.0266131	http://dx.doi.org/10.1371/journal.pone.0266131			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324979	Green Published, gold			2022-12-26	WOS:000780951300102
J	Jovanovic, P; Wang, YD; Vit, JP; Novinbakht, E; Morones, N; Hogg, E; Tagliati, M; Riera, CE				Jovanovic, Predrag; Wang, Yidan; Vit, Jean-Philippe; Novinbakht, Edward; Morones, Nancy; Hogg, Elliot; Tagliati, Michele; Riera, Celine E.			Sustained chemogenetic activation of locus coeruleus norepinephrine neurons promotes dopaminergic neuron survival in synucleinopathy	PLOS ONE			English	Article							PARKINSONS-DISEASE; ALPHA-SYNUCLEIN; INSULIN-RESISTANCE; SUBSTANTIA-NIGRA; NONMOTOR SYMPTOMS; MOUSE MODELS; BRAIN; NORADRENALINE; DEGENERATION; ONSET	Dopaminergic neuron degeneration in the midbrain plays a pivotal role in motor symptoms associated with Parkinson's disease. However, non-motor symptoms of Parkinson's disease and post-mortem histopathology confirm dysfunction in other brain areas, including the locus coeruleus and its associated neurotransmitter norepinephrine. Here, we investigate the role of central norepinephrine-producing neurons in Parkinson's disease by chronically stimulating catecholaminergic neurons in the locus coeruleus using chemogenetic manipulation. We show that norepinephrine neurons send complex axonal projections to the dopaminergic neurons in the substantia nigra, confirming physical communication between these regions. Furthermore, we demonstrate that increased activity of norepinephrine neurons is protective against dopaminergic neuronal depletion in human alpha-syn A53T missense mutation over-expressing mice and prevents motor dysfunction in these mice. Remarkably, elevated norepinephrine neurons action fails to alleviate alpha-synuclein aggregation and microgliosis in the substantia nigra suggesting the presence of an alternate neuroprotective mechanism. The beneficial effects of high norepinephrine neuron activity might be attributed to the action of norepinephrine on dopaminergic neurons, as recombinant norepinephrine treatment increased primary dopaminergic neuron cultures survival and neurite sprouting. Collectively, our results suggest a neuroprotective mechanism where noradrenergic neurons activity preserves the integrity of dopaminergic neurons, which prevents synucleinopathy-dependent loss of these cells.	[Jovanovic, Predrag; Wang, Yidan; Novinbakht, Edward; Morones, Nancy; Riera, Celine E.] Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Biomed Sci Dept, Los Angeles, CA 90048 USA; [Jovanovic, Predrag; Wang, Yidan; Novinbakht, Edward; Morones, Nancy; Riera, Celine E.] Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA; [Vit, Jean-Philippe] Cedars Sinai Med Ctr, Movement Disorder Program, Dept Neurosurg, Los Angeles, CA 90048 USA; [Hogg, Elliot; Tagliati, Michele; Riera, Celine E.] Cedars Sinai Med Ctr, Movement Disorder Program, Dept Neurol, Los Angeles, CA 90048 USA; [Riera, Celine E.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA	Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Riera, CE (corresponding author), Cedars Sinai Med Ctr, Ctr Neural Sci & Med, Biomed Sci Dept, Los Angeles, CA 90048 USA.; Riera, CE (corresponding author), Cedars Sinai Med Ctr, Board Governors Regenerat Med Inst, Los Angeles, CA 90048 USA.; Riera, CE (corresponding author), Cedars Sinai Med Ctr, Movement Disorder Program, Dept Neurol, Los Angeles, CA 90048 USA.; Riera, CE (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA.	Celine.riera@cshs.org	Jovanovic, Predrag/G-5989-2015	Jovanovic, Predrag/0000-0002-1273-5341; Riera, Celine/0000-0003-3535-3407	Leon Fine Award in Translational Science (Cedars Sinai Medical Center)	Leon Fine Award in Translational Science (Cedars Sinai Medical Center)	This study was funded by the Leon Fine Award in Translational Science (Cedars Sinai Medical Center). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGNATI LF, 1995, NEUROSCIENCE, V69, P711, DOI 10.1016/0306-4522(95)00308-6; Alsharif I, 2021, REDOX BIOL, V40, DOI 10.1016/j.redox.2020.101839; [Anonymous], NEUROPATHOLOGY IMMUN, DOI [10.1002/ana.410270405, DOI 10.1002/ANA.410270405]; Armbruster BN, 2007, P NATL ACAD SCI USA, V104, P5163, DOI 10.1073/pnas.0700293104; Arodin L, 2014, FREE RADICAL BIO MED, V73, P328, DOI 10.1016/j.freeradbiomed.2014.05.011; Athauda D, 2017, LANCET, V390, P1664, DOI 10.1016/S0140-6736(17)31585-4; Bassil F, 2014, PROG NEUROBIOL, V118, P1, DOI 10.1016/j.pneurobio.2014.02.005; Bellinger FP, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-8; Bosco D, 2012, J NEUROL SCI, V315, P39, DOI 10.1016/j.jns.2011.12.008; Boukhzar L, 2016, ANTIOXID REDOX SIGN, V24, P557, DOI 10.1089/ars.2015.6478; Braak H, 2004, CELL TISSUE RES, V318, P121, DOI 10.1007/s00441-004-0956-9; Bridi JC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00080; Bucci D, 2017, FRONT NEUROANAT, V11, DOI 10.3389/fnana.2017.00098; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Butkovich LM, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00626; Cereda E, 2012, NEUROLOGY, V78, P1507, DOI 10.1212/WNL.0b013e3182553cc9; Chen JJ, 2014, THER ADV NEUROL DISO, V7, P52, DOI 10.1177/1756285613495723; Dias V, 2013, J PARKINSON DIS, V3, P461, DOI 10.3233/JPD-130230; FREEDMAN R, 1975, J COMP NEUROL, V164, P209, DOI 10.1002/cne.901640205; Garcia-Serrano AM, 2020, FRONT NEUROSCI-SWITZ, V14, DOI 10.3389/fnins.2020.00229; Gesi M, 2000, NEUROSCI BIOBEHAV R, V24, P655, DOI 10.1016/S0149-7634(00)00028-2; Giasson BI, 2002, NEURON, V34, P521, DOI 10.1016/S0896-6273(02)00682-7; Gonera EG, 1997, MOVEMENT DISORD, V12, P871, DOI 10.1002/mds.870120607; GRZANNA R, 1980, NEUROSCIENCE, V5, P21, DOI 10.1016/0306-4522(80)90068-8; HIRSCH E, 1988, NATURE, V334, P345, DOI 10.1038/334345a0; Hogg E, 2018, J PARKINSON DIS, V8, P259, DOI 10.3233/JPD-181305; Ip CW, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0416-x; Isaias IU, 2012, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00179; JAGER WAD, 1960, J NEUROL NEUROSUR PS, V23, P283, DOI 10.1136/jnnp.23.4.283; Khoury N, 2011, DIABETES-METAB RES, V27, P604, DOI 10.1002/dmrr.1212; Kilbourn MR, 1998, SYNAPSE, V30, P205, DOI 10.1002/(SICI)1098-2396(199810)30:2<205::AID-SYN10>3.0.CO;2-0; Klein C, 2006, NAT CLIN PRACT NEURO, V2, P136, DOI 10.1038/ncpneuro0126; Kleinridders A, 2015, P NATL ACAD SCI USA, V112, P3463, DOI 10.1073/pnas.1500877112; Kodl CT, 2008, ENDOCR REV, V29, P494, DOI 10.1210/er.2007-0034; Koprich JB, 2017, NAT REV NEUROSCI, V18, P515, DOI 10.1038/nrn.2017.75; Kreiner G, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-41756-3; Lee MK, 2002, P NATL ACAD SCI USA, V99, P8968, DOI 10.1073/pnas.132197599; Lima MMS, 2014, CNS NEUROL DISORD-DR, V13, P418, DOI 10.2174/18715273113126660155; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; MAVRIDIS M, 1991, NEUROSCIENCE, V41, P507, DOI 10.1016/0306-4522(91)90345-O; MOUTON PR, 1994, J CHEM NEUROANAT, V7, P185, DOI 10.1016/0891-0618(94)90028-0; Papapetropoulos S, 2004, EUR J NEUROL, V11, P231, DOI 10.1046/j.1468-1331.2003.00748.x; Poewe W, 2008, EUR J NEUROL, V15, P14, DOI 10.1111/j.1468-1331.2008.02056.x; Pont-Sunyer C, 2015, MOVEMENT DISORD, V30, P229, DOI 10.1002/mds.26077; Puchades MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216796; Robertson SD, 2013, NAT NEUROSCI, V16, P1016, DOI 10.1038/nn.3458; Rommelfanger KS, 2007, P NATL ACAD SCI USA, V104, P13804, DOI 10.1073/pnas.0702753104; Rommelfanger KS, 2004, J NEUROCHEM, V91, P1116, DOI 10.1111/j.1471-4159.2004.02785.x; ROTH BL, 1994, J PHARMACOL EXP THER, V268, P1403; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Schwarz LA, 2015, CURR BIOL, V25, pR1051, DOI 10.1016/j.cub.2015.09.039; Song S, 2019, MOL NEUROBIOL, V56, P2653, DOI 10.1007/s12035-018-1235-1; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Srinivasan J, 2003, EUR J NEUROSCI, V17, P2586, DOI 10.1046/j.1460-9568.2003.02684.x; Stefanis L, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009399; STROSBERG AD, 1993, PROTEIN SCI, V2, P1198, DOI 10.1002/pro.5560020802; Stutz B, 2019, MOL METAB, V24, P120, DOI 10.1016/j.molmet.2019.02.005; Surmeier DJ, 2011, ANTIOXID REDOX SIGN, V14, P1289, DOI 10.1089/ars.2010.3521; SVENSSON TH, 1987, PSYCHOPHARMACOLOGY, V92, P1, DOI 10.1007/BF00215471; Tanaka KF, 2002, J NEUROSCI RES, V70, P232, DOI 10.1002/jnr.10399; Thau-Zuchman O, 2012, J NEUROTRAUM, V29, P375, DOI 10.1089/neu.2010.1673; Tong J, 2006, ARCH NEUROL-CHICAGO, V63, P1724, DOI 10.1001/archneur.63.12.1724; Trist BG, 2019, AGING CELL, V18, DOI 10.1111/acel.13031; Troadec JD, 2001, J NEUROCHEM, V79, P200, DOI 10.1046/j.1471-4159.2001.00556.x; Walters JM, 1997, METABOLISM, V46, P1448, DOI 10.1016/S0026-0495(97)90146-3; Xu Q, 2011, DIABETES CARE, V34, P910, DOI 10.2337/dc10-1922; Yao N, 2015, BRAIN RES, V1625, P255, DOI 10.1016/j.brainres.2015.08.032; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648	68	2	2	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0263074	10.1371/journal.pone.0263074	http://dx.doi.org/10.1371/journal.pone.0263074			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316276	Green Published, gold			2022-12-26	WOS:000834238000004
J	Nourani, L; Mehrizi, AA; Zakeri, S; Djadid, ND				Nourani, Leila; Abouie Mehrizi, Akram; Zakeri, Sedigheh; Djadid, Navid Dinparast			Untangling population structure and genetic diversity of reticulocyte binding protein 2b (PvRBP2b) erythrocytic stage vaccine candidate in worldwide Plasmodium vivax isolates	PLOS ONE			English	Article							MEMBRANE ANTIGEN-1 AMA-1; NATURAL-SELECTION; MALARIA PARASITE; POLYMORPHISM; FALCIPARUM	BackgroundsPlasmodium vivax is the predominant Plasmodium species distributed extensively in the Americas and Asia-Pacific areas. Encoded protein by Plasmodium vivax Reticulocyte Binding Proteins (PvRBPs) family member are of critical prominence to parasite invasion and have been considered the significant targets in development of malaria vaccine for the blood stage. As high genetic polymorphism of parasites may impede the effectiveness of vaccine development, more research to unraveling genetic polymorphism of pvrbp2b from various geographical regions seems indispensable to map the exact pattern of field isolates. Methodology/Principal findingsThe aim of this study was to determine the sequences of Iranian pvrbp2b (nt: 502-1896) gene and then, to ascertain polymorphism of pvrbp2b gene, recombination, the level of genetic distances, evaluation of natural selection, and the prediction of B-cell epitopes of Iranian and global P. vivax isolates. Pvrbp2b partial gene was amplified and sequenced from 60 Iranian P. vivax isolates. Iranian pvrbp2b sequences as well as 95 published sequences from five countries were used to evaluate the genetic diversity and neutral evolution signature in worldwide scale. A total of 38 SNPs were identified among 60 Iranian pvrbp2b sequences (32 non-synonymous and 6 synonymous mutations), and 32 amino acid substitutions were observed in 29 positions as compared to Sal-1 sequence. Worldwide sequence analysis showed that 44 amino acid changes had occurred in 37 positions of which seven polymorphic sites had trimorphic mutations while the rest was dimorphic. The overall nucleotide diversity for Iranian isolates was 0.00431 +/- 0.00091 while the level of nucleotide diversity was ranged from 0.00337 +/- 0.00076 (Peru) to 0.00452 +/- 0.00092 (Thailand) in global scale. Conclusions/SignificanceOf amino acid substitutions, 12 replacements were located in the B-cell epitopes in which nine polymorphic sites were positioned in N-terminal and three polymorphic sites in predicted B-cell epitopes of C-terminal, signifying both variable and conserved epitopes for vaccine designing. Using the achieved outcome of the current investigation interrogate questions to the selection of conserved regions of pvrbp2b and understanding polymorphism and immune system pressure to pave a way for developing a vaccine based on PvRBP2b candidate antigen.	[Nourani, Leila; Abouie Mehrizi, Akram; Zakeri, Sedigheh; Djadid, Navid Dinparast] Pasteur Inst Iran, Tehran, Iran	Le Reseau International des Instituts Pasteur (RIIP); Pasteur Institute of Iran	Mehrizi, AA (corresponding author), Pasteur Inst Iran, Tehran, Iran.	abouei@pasteur.ac.ir			Iran National Science Foundation: INSF [99001732]	Iran National Science Foundation: INSF(Iran National Science Foundation (INSF))	We are grateful for the hospitality and generous collaboration of Zahedan University of Medical Sciences, and the staff of the Public Health Department, Sistan and Baluchistan province, Chabahar district, for their support in collecting blood samples from the field. We also appreciate the patients in Chabahar district for their contribution in this investigation. We express our sincere gratitude to S. Yaghoubi and M.R. Nourani for their support during our investigation.	Arnott A, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002506; Battle KE, 2019, LANCET, V394, P332, DOI 10.1016/S0140-6736(19)31096-7; Chan LJ, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21811-2; Chenet SM, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-68; de Souza-Neiras WC, 2007, MEM I OSWALDO CRUZ, V102, P245, DOI 10.1590/S0074-02762007000300002; Cowman AF, 2006, CELL, V124, P755, DOI 10.1016/j.cell.2006.02.006; Delgado-Ratto C, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004376; Fola AA, 2017, AM J TROP MED HYG, V96, P630, DOI 10.4269/ajtmh.16-0716; Franca CT, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0005014; Franca CT, 2017, ELIFE, V6, DOI 10.7554/eLife.28673; FU YX, 1993, GENETICS, V133, P693; Gruszczyk J, 2018, NATURE, V559, P135, DOI 10.1038/s41586-018-0249-1; Gruszczyk J, 2018, SCIENCE, V359, P48, DOI 10.1126/science.aan1078; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; He WQ, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007596; Hietanen J, 2016, INFECT IMMUN, V84, P677, DOI 10.1128/IAI.01117-15; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kosaisavee V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032105; Lee S., 2021, MALARIA J, V20, P1, DOI [10.1186/s12936-020-03550-9, DOI 10.1186/S12936-020-03550-9]; Lee WC, 2014, BLOOD, V123, pE100, DOI 10.1182/blood-2013-12-541698; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; malERA Consultative Group on Vaccines, 2011, PLoS Med, V8, pe1000398, DOI 10.1371/journal.pmed.1000398; Martin DP, 2015, VIRUS EVOL, V1, DOI 10.1093/ve/vev003; Moon SU, 2010, ACTA TROP, V114, P71, DOI 10.1016/j.actatropica.2010.01.006; Mueller I, 2009, LANCET INFECT DIS, V9, P555, DOI 10.1016/S1473-3099(09)70177-X; Rayner JC, 2005, AM J TROP MED HYG, V72, P666, DOI 10.4269/ajtmh.2005.72.666; Roobsoong W, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0815-z; Rosado J, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009165; Sharma J, 2015, INDIAN J MED MICROBI, V33, P401, DOI 10.4103/0255-0857.158565; SNOUNOU G, 1993, MOL BIOCHEM PARASIT, V61, P315, DOI 10.1016/0166-6851(93)90077-B; Stanisic DI, 2013, TRENDS PARASITOL, V29, P612, DOI 10.1016/j.pt.2013.10.001; Stumpf MPH, 2004, EUR J HUM GENET, V12, P469, DOI 10.1038/sj.ejhg.5201179; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor JE, 2013, MOL BIOL EVOL, V30, P2050, DOI 10.1093/molbev/mst104; Valizadeh V, 2014, INFECT GENET EVOL, V21, P424, DOI 10.1016/j.meegid.2013.12.012; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; Zakeri S, 2013, ACTA TROP, V126, P269, DOI 10.1016/j.actatropica.2013.02.017	40	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266067	10.1371/journal.pone.0266067	http://dx.doi.org/10.1371/journal.pone.0266067			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349608	Green Published, gold			2022-12-26	WOS:000783906500001
J	Rojas, TR; Poizot-Martin, I; Rey, D; Duvivier, C; Bani-Sadr, F; Cabie, A; Delobel, P; Jacomet, C; Allavena, C; Ferry, T; Pugliese, P; Valantin, MA; Lamaury, I; Hustache-Matthieu, L; Fresard, A; Houyou, T; Huleux, T; Cheret, A; Makinson, A; Obry-Roguet, V; Lions, C; Carrieri, MP; Protopopescu, C				Rojas Rojas, Teresa; Poizot-Martin, Isabelle; Rey, David; Duvivier, Claudine; Bani-Sadr, Firouze; Cabie, Andre; Delobel, Pierre; Jacomet, Christine; Allavena, Clotilde; Ferry, Tristan; Pugliese, Pascal; Valantin, Marc-Antoine; Lamaury, Isabelle; Hustache-Matthieu, Laurent; Fresard, Anne; Houyou, Tamazighth; Huleux, Thomas; Cheret, Antoine; Makinson, Alain; Obry-Roguet, Veronique; Lions, Caroline; Carrieri, Maria Patrizia; Protopopescu, Camelia		Dat'AIDS Study Grp	Incidence of cervical, breast and colorectal cancers between 2010 and 2015 in people living with HIV in France	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HUMAN-PAPILLOMAVIRUS; INFECTED WOMEN; RISK; AIDS; MALIGNANCIES; POPULATION; TRENDS	BackgroundWe aimed to evaluate the incidence rates between 2010 and 2015 for invasive cervical cancer (ICC), breast cancer (BC), and colorectal cancer (CRC) in people living with HIV (PLWH) in France, and to compare them with those in the French general population. These cancers are targeted by the national cancer-screening program. SettingThis is a retrospective study based on the longitudinal data of the French Dat'AIDS cohort. MethodsStandardized incidence ratios (SIR) for ICC and BC, and incidence rates for all three cancers were calculated overall and for specific sub-populations according to nadir CD4 cell count, HIV transmission category, HIV diagnosis period, and HCV coinfection. ResultsThe 2010-2015 CRC incidence rate was 25.0 [95% confidence interval (CI): 18.6-33.4] per 100,000 person-years, in 44,642 PLWH (both men and women). Compared with the general population, the ICC incidence rate was significantly higher in HIV-infected women both overall (SIR = 1.93, 95% CI: 1.18-3.14) and in the following sub-populations: nadir CD4 <= 200 cells/mm(3) (SIR = 2.62, 95% CI: 1.45-4.74), HIV transmission through intravenous drug use (SIR = 5.14, 95% CI: 1.93-13.70), HCV coinfection (SIR = 3.52, 95% CI: 1.47-8.47) and HIV diagnosis before 2000 (SIR = 2.06, 95% CI: 1.07-3.97). Conversely, the BC incidence rate was significantly lower in the study sample than in the general population (SIR = 0.56, 95% CI: 0.42-0.73). ConclusionThe present study showed no significant linear trend between 2010 and 2015 in the incidence rates of the three cancers explored in the PLWH study sample. Specific recommendations for ICC screening are still required for HIV-infected women and should focus on sub-populations at greatest risk.	[Rojas Rojas, Teresa; Poizot-Martin, Isabelle; Obry-Roguet, Veronique; Lions, Caroline] Aix Marseille Univ, APHM St Marguerite, Clin Immunohematol Unit Marseille, Marseille, France; [Poizot-Martin, Isabelle; Houyou, Tamazighth; Carrieri, Maria Patrizia; Protopopescu, Camelia] Aix Marseille Univ, INSERM, IRD, SESSTIM,ISSPAM, Marseille, France; [Rey, David] Hop Univ Strasbourg, Trait Union, HIV Infect Care Ctr, Strasbourg, France; [Duvivier, Claudine] Hop Necker Enfants Malad, APHP, Serv Malad Infect & Trop, Ctr Infectiol Necker Pasteur,IHU Imagine, Paris, France; [Duvivier, Claudine] Univ Paris, Inst Cochin, RIL Team:Retrovirus Infect & Latency, CNRS 8104,INSERM,U1016, Paris, France; [Duvivier, Claudine] Inst Pasteur, Ctr Med, Paris, France; [Bani-Sadr, Firouze] Univ Hosp, Robert Debre Hosp, Dept Internal Med Clin Immunol & Infect Dis, Reims, France; [Cabie, Andre] Univ Antilles, CHU Martinique, Fort De France, Martinique, France; [Delobel, Pierre] Univ Toulouse III Paul Sabatier, CHU Toulouse, Serv Malad Infect & Trop, INSERM,UMR 1043, Toulouse, France; [Jacomet, Christine] Clermont Ferrand Univ Hosp, Infect & Trop Dis Dept, Clermont Ferrand, France; [Allavena, Clotilde] CHU Nantes, CHU Hot Dieu, Dept Infect Dis, INSERM,UIC 1413, Nantes, France; [Ferry, Tristan] Univ Claude Bernard Lyon 1, Hosp Civils Lyon, Serv Malad Infect, Villeurbanne, France; [Pugliese, Pascal] Univ Cote Azur, CHU Nice, Nice, France; [Valantin, Marc-Antoine] GHPS Pitie Salpetriere, APHP, Infect Dis, Paris, France; [Valantin, Marc-Antoine] Univ Paris 06, UPMC, Sorbonne Univ, INSERM,IPLESP, Paris, France; [Lamaury, Isabelle] Univ Hosp Pointe A Pitre, Dept Infect & Trop Dis, Pointe A Pitre, Guadeloupe, France; [Hustache-Matthieu, Laurent] Jean Minjoz Univ Hosp, Dept Infect & Trop Dis, Besancon, France; [Fresard, Anne] Univ Hosp St Etienne, Dept Infect & Trop Dis, St Etienne, France; [Houyou, Tamazighth; Carrieri, Maria Patrizia; Protopopescu, Camelia] ORS PACA, Marseille, France; [Huleux, Thomas] Ctr Hosp G DRON Tourcoing, Serv Univ Malad Infect & Voyageur, Tourcoing, France; [Cheret, Antoine] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Cheret, Antoine] Bicetre Hosp, AP HP, Dept Internal Med, Le Kremlin Bicetre, France; [Makinson, Alain] Montpellier Univ Hosp, Dept Infect Dis, INSERM, U1175,IRD,UMI 233, Montpellier, France	UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; CHU Strasbourg; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; CHU de Reims; Universite de Reims Champagne-Ardenne; CHU Martinique; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; CHU Clermont Ferrand; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Nice; UDICE-French Research Universities; Universite Cote d'Azur; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; CHU Guadeloupe; Universite de Franche-Comte; CHU Besancon; CHU de St Etienne; UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bicetre - APHP; Institut de Recherche pour le Developpement (IRD); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier	Carrieri, MP (corresponding author), Aix Marseille Univ, INSERM, IRD, SESSTIM,ISSPAM, Marseille, France.; Carrieri, MP (corresponding author), ORS PACA, Marseille, France.	pmcarrieri@aol.com	Delobel, Pierre/K-3166-2014	Delobel, Pierre/0000-0002-2874-3581; lions, caroline/0000-0003-0712-2572; Cabie, Andre/0000-0003-0117-3061; Rojas, Teresa/0000-0003-1536-3675				Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V63, pE163, DOI 10.1097/QAI.0b013e31829cb7c3; Abraham AG, 2013, JAIDS-J ACQ IMM DEF, V62, P405, DOI 10.1097/QAI.0b013e31828177d7; Al-Naggar RA, 2012, ASIAN PAC J CANCER P, V13, P243, DOI 10.7314/APJCP.2012.13.1.243; Binder F., 2013, SANTE PUBLIQUE FRANC; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chabeda A, 2018, PAPILLOMAVIRUS RES, V5, P46, DOI 10.1016/j.pvr.2017.12.006; Coghill AE, 2018, JNCI-J NATL CANCER I, V110, P959, DOI 10.1093/jnci/djy010; Defossez G., 2019, SANTE PUBLIQUE FRANC; Elbachiri M, 2017, PAN AFR MED J, V28, DOI 10.11604/pamj.2017.28.287.13527; Engels EA, 2006, AIDS, V20, P1645, DOI 10.1097/01.aids.0000238411.75324.59; Engels EA, 2009, AIDS, V23, P875, DOI 10.1097/QAD.0b013e328329216a; Fiorino S, 2015, WORLD J GASTROENTERO, V21, P12896, DOI 10.3748/wjg.v21.i45.12896; Grabar S, 2019, HIV MED, V20, P222, DOI 10.1111/hiv.12703; Harris TG, 2005, JAMA-J AM MED ASSOC, V293, P1471, DOI 10.1001/jama.293.12.1471; Haute Autorite de Sante HAS, 2019, EV RECH PAP HUM HPV; Hessol NA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014349; Horn J, 2019, BRIT J CANCER, V120, P1015, DOI 10.1038/s41416-019-0453-2; Jacobson LP, 1999, J ACQ IMMUN DEF SYND, V21, pS34; Keller SC, 2014, AIDS CARE, V26, P716, DOI 10.1080/09540121.2013.855700; Mahale P, 2017, CANCER-AM CANCER SOC, V123, P1202, DOI 10.1002/cncr.30559; McMullen KM, 2017, AM J INFECT CONTROL, V45, P1050, DOI 10.1016/j.ajic.2017.05.022; Mitsuyasu RT., 2016, TOP ANTIVIR MED, V22, P660; Morlat P., 2018, CONSEIL NATL SIDA HE; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Poizot-Martin I, 2021, CANCER EPIDEM BIOMAR, V30, P554, DOI 10.1158/1055-9965.EPI-20-1045; Pugliese P, 2009, HIV MED, V10, P504, DOI 10.1111/j.1468-1293.2009.00719.x; Robbins HA, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/dju503; Robbins HA, 2014, AIDS, V28, P881, DOI 10.1097/QAD.0000000000000163; Rohner E, 2020, INT J CANCER, V146, P601, DOI 10.1002/ijc.32260; Serraino D, 1999, INT J CANCER, V82, P334, DOI 10.1002/(SICI)1097-0215(19990730)82:3<334::AID-IJC5>3.3.CO;2-3; Shepherd L, 2016, HIV MED, V17, P590, DOI 10.1111/hiv.12359; Shiels MS, 2008, JAIDS-J ACQ IMM DEF, V48, P485, DOI 10.1097/QAI.0b013e31817dc42b; Shiels MS, 2017, CURR OPIN HIV AIDS, V12, P6, DOI 10.1097/COH.0000000000000327; Shiels MS, 2011, J NATL CANCER I, V103, P753, DOI 10.1093/jnci/djr076; Shiels MS, 2009, JAIDS-J ACQ IMM DEF, V52, P611, DOI 10.1097/QAI.0b013e3181b327ca; Spano JP, 2012, EUR J CANCER, V48, P3335, DOI 10.1016/j.ejca.2012.05.019; Strickler HD, 2003, JNCI-J NATL CANCER I, V95, P1062, DOI 10.1093/jnci/95.14.1062; Tron L, 2017, HIV MED, V18, P181, DOI 10.1111/hiv.12412; Vandenhende MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129550; Wang CCJ, 2014, CURR INFECT DIS REP, V16, DOI 10.1007/s11908-014-0406-0; WHO, 2014, COMPR CERV CANC CONT; World Health Organization, 2010, INT STAT CLASS DIS R, V2, DOI [10.1016/j.biopsych.2010.10.023, DOI 10.1016/J.BIOPSYCH.2010.10.023]; Worm SW, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-471; Yanik EL, 2016, AIDS, V30, P1663, DOI 10.1097/QAD.0000000000001077; Zongo N, 2018, WORLD J SURG ONCOL, V16, DOI 10.1186/s12957-017-1297-y	46	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0261069	10.1371/journal.pone.0261069	http://dx.doi.org/10.1371/journal.pone.0261069			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333883	Green Published, gold			2022-12-26	WOS:000784335700035
J	Sicilia, P; Castro, G; Fantilli, AC; Gierotto, R; Lopez, L; Barbas, MG; Pisano, MB; Re, VE				Sicilia, Paola; Castro, Gonzalo; Clara Fantilli, Anabella; Gierotto, Robertino; Lopez, Laura; Gabriela Barbas, Maria; Belen Pisano, Maria; Elizabeth Re, Viviana			Rapid screening of SARS-CoV-2 infection: Good performance of nasopharyngeal and Nasal Mid-Turbinate swab for antigen detection among symptomatic and asymptomatic individuals	PLOS ONE			English	Article							AG	Although the nasopharyngeal swab (NPS) is considered the gold standard for the diagnosis of the SARS-CoV-2 infection, the Nasal Mid-Turbinate swab (NMTS) is often used due to its higher tolerance among patients. We compared the diagnostic performance of the NPS and the NMTS for the Panbio (TM) COVID-19 antigen-detecting rapid diagnostic test (Ag-RDT). Two hundred and forty-three individuals were swabbed three times by healthcare professionals: a NMTS and a NPS specimen for the Ag-RDT and an oropharyngeal swab for real time RT-PCR. Forty-nine participants were RNA-SARS-CoV-2 positive by real time RT-PCR: 45 and 40 were positive by the Ag-RDT with NPS and NMTS, respectively. The overall sensitivity and specificity were 91.8% (95% CI: 83.2-100.0) and 99.5% (95% CI: 98.2-100.0) for Ag-RDT with NPS, and 81.6% (95% CI: 69.8-93.5) and 100.0% (95% CI: 99.7-100.0) for the Ag-RDT with NMTS. The Cohen's kappa index was 0.92 (95% CI: 0.85-0.98). Among asymptomatic individuals, the Ag-RDT with both sampling techniques showed a high sensitivity [100.0% (95% CI: 95.5-100.0) with NPS; 90.9% (95% CI: 69.4-100.0) with NMTS], while the performance of the test decreased in samples with Ct >= 30 and in patients tested after the first 7 days from symptom onset. Although the NMTS yielded a lower sensitivity compared to NPS, it might be considered a reliable alternative, as it presents greater adherence among patients, enabling scaling of antigen testing strategies, particularly in countries with under-resourced health systems.	[Sicilia, Paola; Castro, Gonzalo; Gierotto, Robertino] Minist Salud Prov Cordoba, Lab Cent, Area Biol Mol, Cordoba, Argentina; [Clara Fantilli, Anabella; Belen Pisano, Maria; Elizabeth Re, Viviana] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Cordoba, Argentina; [Clara Fantilli, Anabella; Belen Pisano, Maria; Elizabeth Re, Viviana] Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina; [Lopez, Laura] Minist Salud Prov Cordoba, Area Epidemiol, Cordoba, Argentina; [Gabriela Barbas, Maria] Minist Salud Prov Cordoba, Secretaria Prevenc & Promoc Salud, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Fantilli, AC (corresponding author), Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Dr JM Vanella, Cordoba, Argentina.; Fantilli, AC (corresponding author), Consejo Nacl Invest Cient & Tecn CONICET, Buenos Aires, DF, Argentina.	anabellafantilli@gmail.com		Castro, Gonzalo Manuel/0000-0002-0984-3835; Re, Viviana/0000-0002-4106-6642				Abbot, 2021, GLOB POINT CAR; Albert E, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.11.004; Alemany A, 2021, J INFECTION, V82, P188, DOI 10.1016/j.jinf.2020.12.033; Alqahtani M, 2022, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.728969; Ap-Biotech, 2019, DISCOVERY SARS COV 2; Baro B, 2021, J INFECTION, V82, P269, DOI 10.1016/j.jinf.2021.04.009; Berger A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248921; Brummer LE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003735; Bulilete O, 2021, J INFECTION, V82, P391, DOI 10.1016/j.jinf.2021.02.014; Callesen RE, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11071257; Centers for Disease Control and Prevention, 2020, DISC TRANSM BAS PREC; Corman VM, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.3.2000045; Dinnes J, 2020, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD013705, 10.1002/14651858.CD013705.pub2]; Favresse J, 2021, J CLIN MED, V10, DOI 10.3390/jcm10020265; Fenollar F, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02589-20; Gremmels H, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100677; Guglielmi G, 2020, NATURE, V583, P506, DOI 10.1038/d41586-020-02140-8; Jones TC, 2021, SCIENCE, V373, P180, DOI 10.1126/science.abi5273; Kiyasu Y, 2021, J INFECT CHEMOTHER, V27, P1489, DOI 10.1016/j.jiac.2021.07.005; Klein JAF, 2021, MED MICROBIOL IMMUN, V210, P181, DOI 10.1007/s00430-021-00710-9; Kruger LJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247918; Kruttgen A, 2021, J VIROL METHODS, V288, DOI 10.1016/j.jviromet.2020.114024; Lambert-Niclot S, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00977-20; Lee RA, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02881-20; Lee S, 2020, JAMA INTERN MED, V180, P1447, DOI 10.1001/jamainternmed.2020.3862; Linares M, 2020, J CLIN VIROL, V133, DOI 10.1016/j.jcv.2020.104659; Lindner AK, 2021, EUR RESPIR J, V57, DOI 10.1183/13993003.03961-2020; Masia M., 2021, OPEN FORUM INFECT DI, V8, P1; Nagura-Ikeda M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01438-20; Nikolai O, 2021, INFECT DIS-NOR, V53, P947, DOI 10.1080/23744235.2021.1969426; Schildgen V, 2021, PATHOGENS, V10, DOI 10.3390/pathogens10010038; Schuit E, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1676; Torres I, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2020.12.022; Wachinger J, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.07.020; Wang H, 2020, FRONT MED-LAUSANNE, V7, DOI 10.3389/fmed.2020.00334; Winkel B, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-048206; World Health Organization, 2020, EM US LIST PROC, P1; World Health Organization, 2021, ANTIGEN DETECTION DI; Xunta de Galicia (Consellera de SanidadeServizo Galego de Sade), 2006, EP 3 1	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266375	10.1371/journal.pone.0266375	http://dx.doi.org/10.1371/journal.pone.0266375			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363814	Green Published, gold			2022-12-26	WOS:000804748600015
J	Turimumahoro, P; Tucker, A; Gupta, AJ; Tampi, RP; Babirye, D; Ochom, E; Ggita, JM; Ayakaka, I; Sohn, H; Katamba, A; Dowdy, D; Davis, JL				Turimumahoro, Patricia; Tucker, Austin; Gupta, Amanda J.; Tampi, Radhika P.; Babirye, Diana; Ochom, Emmanuel; Ggita, Joseph M.; Ayakaka, Irene; Sohn, Hojoon; Katamba, Achilles; Dowdy, David; Davis, J. Lucian			A cost analysis of implementing mobile health facilitated tuberculosis contact investigation in a low-income setting	PLOS ONE			English	Article							CARE	IntroductionMobile health (mHealth) applications may improve timely access to health services and improve patient-provider communication, but the upfront costs of implementation may be prohibitive, especially in resource-limited settings. MethodsWe measured the costs of developing and implementing an mHealth-facilitated, home-based strategy for tuberculosis (TB) contact investigation in Kampala, Uganda, between February 2014 and July 2017. We compared routine implementation involving community health workers (CHWs) screening and referring household contacts to clinics for TB evaluation to home-based HIV testing and sputum collection and transport with test results delivered by automated short messaging services (SMS). We carried out key informant interviews with CHWs and asked them to complete time-and-motion surveys. We estimated program costs from the perspective of the Ugandan health system, using top-down and bottom-up (components-based) approaches. We estimated total costs per contact investigated and per TB-positive contact identified in 2018 US dollars, one and five years after program implementation. ResultsThe total top-down cost was $472,327, including $358,504 (76%) for program development and $108,584 (24%) for program implementation. This corresponded to $320-$348 per household contact investigated and $8,873-$9,652 per contact diagnosed with active TB over a 5-year period. CHW time was spent primarily evaluating household contacts who returned to the clinic for evaluation (median 30 minutes per contact investigated, interquartile range [IQR]: 30-70), collecting sputum samples (median 29 minutes, IQR: 25-30) and offering HIV testing services (median 28 minutes, IQR: 17-43). Cost estimates were sensitive to infrastructural capacity needs, program reach, and the epidemiological yield of contact investigation. ConclusionOver 75% of all costs of the mHealth-facilitated TB contact investigation strategy were dedicated to establishing mHealth infrastructure and capacity. Implementing the mHealth strategy at scale and maintaining it over a longer time horizon could help decrease development costs as a proportion of total costs.	[Turimumahoro, Patricia; Gupta, Amanda J.; Babirye, Diana; Ochom, Emmanuel; Ggita, Joseph M.; Ayakaka, Irene; Katamba, Achilles; Dowdy, David; Davis, J. Lucian] Uganda TB Implementat Res Consortium, Kampala, Uganda; [Tucker, Austin; Tampi, Radhika P.; Dowdy, David; Davis, J. Lucian] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Gupta, Amanda J.] Yale Sch Publ Hlth, Dept Epidemiol Microbial Dis, New Haven, CT USA; [Gupta, Amanda J.] Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; [Sohn, Hojoon] Seoul Natl Univ, Dept Preventat Med, Coll Med, Seoul, South Korea; [Katamba, Achilles] Makerere Univ, Coll Hlth Sci Kampala, Clin Epidemiol Unit, Kampala, Uganda; [Davis, J. Lucian] Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT 06510 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Yale University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Seoul National University (SNU); Makerere University; Yale University	Davis, JL (corresponding author), Uganda TB Implementat Res Consortium, Kampala, Uganda.; Davis, JL (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.; Davis, JL (corresponding author), Yale Sch Med, Pulm Crit Care & Sleep Med Sect, New Haven, CT 06510 USA.	lucian.davis@yale.edu		Gupta, Amanda J/0000-0003-2318-1783; Tampi, Radhika/0000-0002-6953-7768	National Institutes of Health [R01AI104824, D43TW009607]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank all of the community health workers on the mHealth Contact Investigation Study; AIDS Information Centre staff; all administrative, TB unit, and laboratory staff at the participating Kampala City Council Authority clinics; staff at the Department of Health at the Kampala City Council Authority; National TB and Leprosy Program staff at the Uganda Ministry of Health, and all participants of the mHealth Contact Investigation Study.	[Anonymous], 2021, INT J INFECT DIS; Armstrong-Hough M, 2018, INT J TUBERC LUNG D, V22, P1152, DOI 10.5588/ijtld.18.0129; Armstrong-Hough M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187145; Ayakaka I, 2017, IMPLEMENT SCI, V12, DOI 10.1186/s13012-017-0561-4; Braun R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065772; Catalani C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103205; Chang LW, 2013, AIDS CARE, V25, P652, DOI 10.1080/09540121.2012.722600; Chapko MK, 2009, HEALTH ECON, V18, P1188, DOI 10.1002/hec.1422; Davis JL, 2019, ERJ OPEN RES, V5, DOI 10.1183/23120541.00112-2019; Fox GJ, 2018, NEW ENGL J MED, V378, P221, DOI 10.1056/NEJMoa1700209; Fukuda H, 2009, J EVAL CLIN PRACT, V15, P451, DOI 10.1111/j.1365-2753.2008.01033.x; Ggita JM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8427-0; IDEO, 2020, IDEO DES THINK; Iribarren SJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170581; Jo Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228216; Kakinda M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234418; Larsen-Cooper E, 2016, TELEMED E-HEALTH, V22, P317, DOI 10.1089/tmj.2015.0060; Meyer AJ, 2018, JMIR MHEALTH UHEALTH, V6, DOI 10.2196/10239; Ngamvithayapong-Yanai J, 2019, PUBLIC HEALTH ACTION, V9, P15, DOI 10.5588/pha.18.0055; Nsengiyumva NP, 2018, EUR RESPIR J, V52, DOI 10.1183/13993003.01363-2018; Prinja S, 2018, COST EFFECT RESOUR A, V16, DOI 10.1186/s12962-018-0110-2; Sacks JA, 2015, GLOB HEALTH-SCI PRAC, V3, P646, DOI 10.9745/GHSP-D-15-00207; Sohn H, 2020, IMPLEMENT SCI, V15, DOI 10.1186/s13012-020-01047-2; Subbaraman R, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002754; The World Bank, 2016, GDP CURR US; Velen K, 2021, EUR RESPIR J, V58, DOI 10.1183/13993003.00266-2021; WHO, 2019, GLOB TUB REP; WHO, 2020, WHO CONS GUID TUB; World Bank, 2015, WORLD BANK WORLD DEV; World Health Organization, 2011, MHEALTH NEW HORIZONS, V3; Yasaka TM, 2020, JMIR MHEALTH UHEALTH, V8, DOI 10.2196/18936	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265033	10.1371/journal.pone.0265033	http://dx.doi.org/10.1371/journal.pone.0265033			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363783	Green Published, gold			2022-12-26	WOS:000804748600029
J	Ucar, I; Torre, M; Elias, A				Ucar, Inaki; Torre, Margarita; Elias, Antonio B.			Mind the gender gap: COVID-19 lockdown effects on gender differences in preprint submissions	PLOS ONE			English	Article							INEQUALITY	The gender gap is a well-known problem in academia and, despite its gradual narrowing, recent estimations indicate that it will persist for decades. Short-term descriptive studies suggest that this gap may have actually worsened during the months of confinement following the start of the COVID-19 pandemic in 2020. In this work, we evaluate the impact of the COVID-19 lockdown on female and male academics' research productivity using preprint drop-off data. We examine a total of 307,902 unique research articles deposited in 5 major preprint repositories during the period between January and May each year from 2017 to 2020. We find that the proportion of female authors in online repositories steadily increased over time; however, the trend reversed during the confinement and gender parity worsened in two respects. First, the proportion of male authors in preprints increased significantly during lockdown. Second, the proportion of male authors in COVID-19-related articles was significantly higher than that of women. Overall, our results imply that the gender gap in academia suffered an approximately 1-year setback during the strict lockdown months of 2020, and COVID-related research areas suffered an additional 1.5-year setback.	[Ucar, Inaki] Univ Carlos III Madrid, UC3M Santander Big Data Inst, Getafe, Spain; [Torre, Margarita] Univ Carlos III Madrid, Dept Social Sci, Getafe, Spain; [Elias, Antonio B.] Univ Malaga, OASYS Grp, Malaga, Spain	Universidad Carlos III de Madrid; Universidad Carlos III de Madrid; Universidad de Malaga	Ucar, I (corresponding author), Univ Carlos III Madrid, UC3M Santander Big Data Inst, Getafe, Spain.	inaki.ucar@uc3m.es	Ucar, Iñaki/L-6174-2014; TORRE, MARGARITA/L-3150-2014	Ucar, Iñaki/0000-0001-6403-5550; TORRE, MARGARITA/0000-0002-1051-9717	Madrid Government (Comunidad de Madrid); Spanish Ministry of Science and Innovation [RTI2018-098182-A-I00]	Madrid Government (Comunidad de Madrid); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government)	This work has been supported by the Madrid Government (Comunidad de Madrid) under the Multiannual Agreement with UC3M in the line of "Fostering Young Doctors Research" (CONCIERGE-CM-UC3M), and in the context of the V PRICIT (Regional Programme of Research and Technological Innovation. M.T. and I.U. also acknowledge support from the Spanish Ministry of Science and Innovation through the research grant RTI2018-098182-A-I00.	Andersen JP, 2020, ELIFE, V9, DOI 10.7554/eLife.58807; Antecol H, 2018, AM ECON REV, V108, P2420, DOI 10.1257/aer.20160613; Barber BM, 2021, J FINANC, V76, P1655, DOI 10.1111/jofi.13028; Bendels MHK, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189136; Catalyst, 2020, QUICK TAK WOM AC; Collins C, 2021, GENDER WORK ORGAN, V28, P101, DOI 10.1111/gwao.12506; Cooke SJ, 2021, CONSERV PHYSIOL, V9, DOI 10.1093/conphys/coaa139; Gayet-Ageron A, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2288; Harrop C, 2021, AUTISM RES, V14, P1078, DOI 10.1002/aur.2503; Hechtman LA, 2018, P NATL ACAD SCI USA, V115, P7943, DOI 10.1073/pnas.1800615115; Holman L, 2018, PLOS BIOL, V16, DOI 10.1371/journal.pbio.2004956; Huang JM, 2020, P NATL ACAD SCI USA, V117, P4609, DOI 10.1073/pnas.1914221117; Klebel T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239518; Landivar Liana Christin, 2020, Socius, V6, p2378023120947997, DOI 10.1177/2378023120947997; Macaluso B, 2016, ACAD MED, V91, P1136, DOI 10.1097/ACM.0000000000001261; Matthews D., 2020, TIMES HIGHER ED; McGuinness L, 2020, MEDRXIVR ACCESSING M; Myers KR, 2020, NAT HUM BEHAV, V4, P880, DOI 10.1038/s41562-020-0921-y; Ram K, 2019, ARXIV INTERFACE ARXI; RCore Team, 2020, R LANG ENV STAT COMP; Ribarovska AK, 2021, BRAIN BEHAV IMMUN, V91, P1, DOI 10.1016/j.bbi.2020.11.022; Rosen S, 1990, NATL BUREAU EC RES, P3542; Ruggieri R, 2021, SCIENTOMETRICS, V126, P1647, DOI 10.1007/s11192-020-03802-0; Ruppanner L, 2021, MEN MASC, V24, P181, DOI 10.1177/1097184X21990737; Santamaria L, 2018, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.156; Staniscuaski F, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.663252; Sugimoto CR, 2013, NATURE, V504, P211, DOI 10.1038/504211a; Teele DL, 2017, PS-POLIT SCI POLIT, V50, P433, DOI 10.1017/S1049096516002985; Terrell J, 2017, PEERJ COMPUT SCI, DOI 10.7717/peerj-cs.111; Tscharntke T, 2007, PLOS BIOL, V5, P13, DOI 10.1371/journal.pbio.0050018; Ucar I, 2021, CONCIERGE-CM-UC3M/COVID19-gender-gap, DOI 10.5281/zenodo.5142676; van den Besselaar P, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183301; Viglione G, 2020, NATURE, V581, P365, DOI 10.1038/d41586-020-01294-9; Wais K, 2016, R J, V8, P17; West JD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066212; Wolen A., 2020, J OPEN SOURCE SOFTW, V5, P2071, DOI [10.21105/joss.02071, DOI 10.21105/JOSS.02071]; Zhu YM, 2017, SCIENTOMETRICS, V111, P557, DOI 10.1007/s11192-017-2316-z	37	1	1	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264265	10.1371/journal.pone.0264265	http://dx.doi.org/10.1371/journal.pone.0264265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P6KD	35333874	Green Published, gold			2022-12-26	WOS:000784335700007
J	He, JX; Zou, LN; Pareek, V; Benkovic, SJ				He, Jingxuan; Zou, Ling-Nan; Pareek, Vidhi; Benkovic, Stephen J.			Multienzyme interactions of the de novo purine biosynthetic protein PAICS facilitate purinosome formation and metabolic channeling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FLUORESCENT PROTEINS; AMPK ACTIVATION; SUBSTRATE; MECHANISM; ENZYMES; PHOSPHORIBOSYLAMINE; COPURIFICATION; ACCUMULATION; MITOCHONDRIA; BINDING	There is growing evidence that mammalian cells deploy a mitochondria-associated metabolon called the purinosome to perform channeled de novo purine biosynthesis (DNPB). However, the molecular mechanisms of this substrate channeling pathway are not well defined. Here, we present molecular evidence of protein-protein interactions (PPIs) between the human bifunctional phosphoribosylaminoimidazole carboxylase/succinocarboxamide synthetase (PAICS) and other known DNPB enzymes. We employed two orthogonal approaches: bimolecular fluorescence complementation, to probe PPIs inside live, intact cells, and co-immunoprecipitation using StrepTag-labeled PAICS that was reintegrated into the genome of PAICS-knockout HeLa cells (crPAICS). With the exception of amidophosphoribosyltransferase, the first enzyme of the DNPB pathway, we discovered PAICS interacts with all other known DNPB enzymes and with MTHFD1, an enzyme which supplies the 10-formyltetrahydrofolate cofactor essential for DNPB. We show these interactions are present in cells grown in both purine-depleted and purine-rich conditions, suggesting at least a partial assembly of these enzymes may be present regardless of the activity of the DNPB pathway. We also demonstrate that tagging of PAICS on its C terminus disrupts these interactions and that this disruption is correlated with disturbed DNPB activity. Finally, we show that crPAICS cells with reintegrated N-terminally tagged PAICS regained effective DNPB with metabolic signatures of channeled synthesis, whereas crPAICS cells that reintegrated C-terminally tagged PAICS exhibit reduced DNPB intermediate pools and a perturbed partitioning of inosine monophosphate into AMP and GMP. Our results provide molecular evidence in support of purinosomes and suggest perturbing PPIs between DNPB enzymes negatively impact metabolite flux through this important pathway.	[He, Jingxuan; Benkovic, Stephen J.] Penn State Univ, Dept Chem, University Pk, PA 16802 USA; [Zou, Ling-Nan; Pareek, Vidhi] Penn State Univ, Huck Inst Life Sci, University Pk, PA 16802 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park	Benkovic, SJ (corresponding author), Penn State Univ, Dept Chem, University Pk, PA 16802 USA.	sjb1@psu.edu		Pareek, Vidhi/0000-0003-1329-8021; He, Jingxuan/0000-0002-2130-3196	National Institutes of Health Grant [R01GM024129]; Huck Institutes ofthe Life Sciences, Penn State	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Huck Institutes ofthe Life Sciences, Penn State	This work was supported by National Institutes of Health Grant R01GM024129 (S. J. B.). L. Z.and V. P. acknowledgefinancial support from the Huck Institutes ofthe Life Sciences, Penn State. The content is solely the responsibilityof the authors and does not necessarily represent the official viewsof the National Institutes of Health.	Agarwal S, 2020, CANCERS, V12, DOI 10.3390/cancers12040772; An SG, 2008, SCIENCE, V320, P103, DOI 10.1126/science.1152241; An S, 2010, P NATL ACAD SCI USA, V107, P12872, DOI 10.1073/pnas.1008451107; Asby DJ, 2015, CHEM BIOL, V22, P838, DOI 10.1016/j.chembiol.2015.06.008; Balleza E, 2018, NAT METHODS, V15, P47, DOI [10.1038/NMETH.4509, 10.1038/nmeth.4509]; Baresova V, 2016, MOL GENET METAB, V119, P270, DOI 10.1016/j.ymgme.2016.08.004; Bulock KG, 2002, J BIOL CHEM, V277, P22168, DOI 10.1074/jbc.M111964200; Caetano-Anolles G, 2007, P NATL ACAD SCI USA, V104, P9358, DOI 10.1073/pnas.0701214104; Caetano-Anolles G, 2009, INT J BIOCHEM CELL B, V41, P285, DOI 10.1016/j.biocel.2008.08.022; Chakravarthi BVSK, 2017, PROSTATE, V77, P10, DOI 10.1002/pros.23243; Chan CY, 2018, P NATL ACAD SCI USA, V115, P13009, DOI 10.1073/pnas.1814042115; Cho KF, 2020, NAT PROTOC, V15, P3971, DOI 10.1038/s41596-020-0399-0; Cho KF, 2020, P NATL ACAD SCI USA, V117, P12143, DOI [10.1073/pnas.1919528117/-/DCSupplemental, 10.1073/pnas.1919528117]; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; Ducker GS, 2016, CELL METAB, V23, P1140, DOI 10.1016/j.cmet.2016.04.016; French JB, 2016, SCIENCE, V351, P733, DOI 10.1126/science.aac6054; French JB, 2013, P NATL ACAD SCI USA, V110, P2528, DOI 10.1073/pnas.1300173110; Gallenne T, 2017, ONCOTARGET, V8, P20572, DOI 10.18632/oncotarget.16244; Gaude E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13041; Gookin TE, 2014, PLANT J, V80, P553, DOI 10.1111/tpj.12639; Graham JWA, 2007, PLANT CELL, V19, P3723, DOI 10.1105/tpc.107.053371; Han YS, 2019, ACS CHEM BIOL, V14, P619, DOI 10.1021/acschembio.8b00919; Islam MM, 2007, J BIOL CHEM, V282, P11893, DOI 10.1074/jbc.M700198200; Kim JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018556; Kremers GJ, 2006, BIOCHEMISTRY-US, V45, P6570, DOI 10.1021/bi0516273; Laursen T, 2016, SCIENCE, V354, P890, DOI 10.1126/science.aag2347; Lewis CA, 2014, MOL CELL, V55, P253, DOI 10.1016/j.molcel.2014.05.008; Li SX, 2007, J MOL BIOL, V366, P1603, DOI 10.1016/j.jmb.2006.12.027; Liu XN, 2014, P NATL ACAD SCI USA, V111, pE435, DOI 10.1073/pnas.1311121111; Madrova L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208947; MCCAIRNS E, 1983, J BIOL CHEM, V258, P1851; Ohashi K, 2014, METHODS MOL BIOL, V1174, P247, DOI 10.1007/978-1-4939-0944-5_17; Ohashi K, 2012, BIOTECHNIQUES, V52, P45, DOI 10.2144/000113777; Pareek V, 2021, MOL CELL, V81, P3775, DOI 10.1016/j.molcel.2021.08.030; Pareek V, 2020, SCIENCE, V368, P283, DOI 10.1126/science.aaz6465; Pihur V, 2008, GENOMICS, V92, P400, DOI 10.1016/j.ygeno.2008.05.003; Racanelli AC, 2009, CANCER RES, V69, P5467, DOI 10.1158/0008-5472.CAN-08-4979; Romei MG, 2019, ANNU REV BIOPHYS, V48, P19, DOI 10.1146/annurev-biophys-051013-022846; ROWE PB, 1978, J BIOL CHEM, V253, P7711; RUDOLPH J, 1995, BIOCHEMISTRY-US, V34, P2241, DOI 10.1021/bi00007a019; SCHENDEL FJ, 1988, BIOCHEMISTRY-US, V27, P2614, DOI 10.1021/bi00407a052; Schopp IM, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15690; Shcherbakova DM, 2012, J AM CHEM SOC, V134, P7913, DOI 10.1021/ja3018972; Skerlova J, 2020, J BIOL CHEM, V295, P11656, DOI 10.1074/jbc.RA120.013695; SRERE PA, 1985, TRENDS BIOCHEM SCI, V10, P109, DOI 10.1016/0968-0004(85)90266-X; Szecowka M, 2013, PLANT CELL, V25, P694, DOI 10.1105/tpc.112.106989; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Velot C, 1997, BIOCHEMISTRY-US, V36, P14271, DOI 10.1021/bi972011j; Wall M, 2000, BIOCHEMISTRY-US, V39, P11303, DOI 10.1021/bi0007268; Wan CH, 2015, NATURE, V525, P339, DOI 10.1038/nature14877; Wu F, 2015, ANGEW CHEM INT EDIT, V54, P1851, DOI 10.1002/anie.201409336; Zhang Y, 2008, CELL MOL LIFE SCI, V65, P3699, DOI 10.1007/s00018-008-8295-8; Zhang YJ, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15212; Zhou SY, 2019, GENE, V692, P1, DOI 10.1016/j.gene.2018.12.064	54	1	1	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101853	10.1016/j.jbc.2022.101853	http://dx.doi.org/10.1016/j.jbc.2022.101853			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35331738	Green Published, gold			2022-12-26	WOS:000793483000004
J	Teegala, LR; Elshoweikh, Y; Gudneppanavar, R; Thodeti, S; Pokhrel, S; Southard, E; Thodeti, CK; Paruchuri, S				Teegala, Lakshminarayan Reddy; Elshoweikh, Yasmine; Gudneppanavar, Ravindra; Thodeti, Sathwika; Pokhrel, Sabita; Southard, Erik; Thodeti, Charles K.; Paruchuri, Sailaja			Protein Kinase C alpha and beta compensate for each other to promote stem cell factor-mediated KIT phosphorylation, mast cell viability and proliferation	FASEB JOURNAL			English	Article						asthma; KIT; MC; P38 MAPK; PKC; proliferation; SCF; viability	PKC-EPSILON; RECEPTOR; EFFECTOR; ACTIVATION; MIGRATION; SURVIVAL; ISOFORMS; INNATE; IGE; INHIBITION	Mast cells (MCs) develop from hematopoietic progenitors and differentiate into mature MCs that reside within connective or mucosal tissues. Though the number of MCs in tissues usually remains constant, inflammation and asthma disturb this homeostasis, leading to proliferation of MCs. Understanding the signaling events behind this proliferative response could lead to the development of novel strategies for better management of allergic diseases. MC survival, proliferation, differentiation, and migration are all maintained by a MC growth factor, stem cell factor (SCF) via its receptor, KIT. Here, we explored how protein kinase C (PKC) redundancy influences MC proliferation in bone marrow-derived MC (BMMC). We found that SCF activates PKC alpha and PKC beta isoforms, which in turn modulates KIT phosphorylation and internalization. Further, PKC alpha and PKC beta activate p38 mitogen activated protein kinase (MAPK), and this axis subsequently regulates SCF-induced MC cell proliferation. To ascertain the individual roles of PKC alpha and PKC beta, we knocked down either PKC alpha or PKC beta or both via short hairpin RNA (shRNA) and analyzed KIT phosphorylation, p38 MAPK phosphorylation, and MC viability and proliferation. To our surprise, downregulation of neither PKC alpha nor PKC beta affected MC viability and proliferation. In contrast, blocking both PKC alpha and PKC beta significantly attenuated SCF-induced cell viability and proliferation, suggesting that PKC alpha and PKC beta compensate for each other downstream of SCF signaling to enhance MC viability and proliferation. Our results not only suggest that PKC classical isoforms are novel therapeutic targets for SCF/MC-mediated inflammatory and allergic diseases, but they also emphasize the importance of inhibiting both PKC alpha and beta isoforms simultaneously to prevent MC proliferation.	[Teegala, Lakshminarayan Reddy; Elshoweikh, Yasmine; Gudneppanavar, Ravindra; Thodeti, Sathwika; Pokhrel, Sabita; Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Teegala, Lakshminarayan Reddy; Southard, Erik; Thodeti, Charles K.; Paruchuri, Sailaja] Univ Toledo, Dept Physiol & Pharmacol, Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA; [Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; University System of Ohio; University of Toledo; Northeast Ohio Medical University (NEOMED)	Paruchuri, S (corresponding author), Univ Toledo, Dept Physiol & Pharmacol, Block Hlth Sci Bldg,3000 Arlington Ave, Toledo, OH 43614 USA.	Sailaja.Paruchuri@UToledo.edu	Teegala, Lakshminarayan/ABB-5531-2021	Teegala, Lakshminarayan/0000-0001-7725-8294	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R01AI144115]; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI) [R01HL148585]	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI)	HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R01AI144115; HHS | NIH | National Heart, Lung, and Blood Institute (NHLBI), Grant/Award Number: R01HL148585; James Foght support	Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bell KS, 2015, IMMUNOL LETT, V168, P31, DOI 10.1016/j.imlet.2015.09.001; BLUMEJENSEN P, 1993, EMBO J, V12, P4199, DOI 10.1002/j.1460-2075.1993.tb06104.x; Chang EY, 1997, J IMMUNOL, V159, P2624; Da Silva CA, 2006, FUND CLIN PHARMACOL, V20, P21, DOI 10.1111/j.1472-8206.2005.00390.x; Fehrenbach K, 2009, J IMMUNOL, V182, P7897, DOI 10.4049/jimmunol.0801773; Feuser K, 2011, MOL IMMUNOL, V48, P546, DOI 10.1016/j.molimm.2010.10.010; Galli SJ, 2005, ANNU REV IMMUNOL, V23, P749, DOI 10.1146/annurev.immunol.21.120601.141025; Garrington TP, 1999, CURR OPIN CELL BIOL, V11, P211, DOI 10.1016/S0955-0674(99)80028-3; Gombedza F, 2017, FASEB J, V31, P1556, DOI 10.1096/fj.201601045R; Grimbaldeston MA, 2006, CURR OPIN IMMUNOL, V18, P751, DOI 10.1016/j.coi.2006.09.011; Gurish MF, 2006, J ALLERGY CLIN IMMUN, V117, P1285, DOI 10.1016/j.jaci.2006.04.017; Hart PH, 2001, IMMUNOL CELL BIOL, V79, P149, DOI 10.1046/j.1440-1711.2001.00983.x; Jaken S, 2000, BIOESSAYS, V22, P245, DOI 10.1002/(SICI)1521-1878(200003)22:3<245::AID-BIES6>3.0.CO;2-X; Jensen Bettina M., 2007, Inflammation & Allergy Drug Targets, V6, P57, DOI 10.2174/187152807780077255; Kondeti V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071536; Leitges M, 2002, MOL CELL BIOL, V22, P3970, DOI 10.1128/MCB.22.12.3970-3980.2002; Lennartsson J, 2012, PHYSIOL REV, V92, P1619, DOI 10.1152/physrev.00046.2011; Lessmann E, 2006, INT IMMUNOL, V18, P767, DOI 10.1093/intimm/dxl012; Li GM, 2005, CELL IMMUNOL, V238, P10, DOI 10.1016/j.cellimm.2005.12.001; Mani M, 2009, BLOOD, V114, P2900, DOI 10.1182/blood-2009-01-200733; Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Metz M, 2007, IMMUNOL REV, V217, P304, DOI 10.1111/j.1600-065X.2007.00520.x; Nechushtan H, 2000, BLOOD, V95, P1752, DOI 10.1182/blood.V95.5.1752.005k18_1752_1757; Newton AC, 1997, CURR OPIN CELL BIOL, V9, P161, DOI 10.1016/S0955-0674(97)80058-0; NISHIZUKA Y, 1995, FASEB J, V9, P484, DOI 10.1096/fasebj.9.7.7737456; Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97; OZAWA K, 1993, J BIOL CHEM, V268, P1749; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2003, J BIOL CHEM, V278, P45577, DOI 10.1074/jbc.M302881200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2008, J BIOL CHEM, V283, P16477, DOI 10.1074/jbc.M705822200; Prussin C, 2006, J ALLERGY CLIN IMMUN, V117, pS450, DOI 10.1016/j.jaci.2005.11.016; RAZIN E, 1994, P NATL ACAD SCI USA, V91, P7722, DOI 10.1073/pnas.91.16.7722; Reyland ME, 2009, FRONT BIOSCI-LANDMRK, V14, P2386, DOI 10.2741/3385; SHEFFER AL, 1995, INT ARCH ALLERGY IMM, V107, P11, DOI 10.1159/000236917; Sundstrom M, 2001, EXP CELL RES, V267, P144, DOI 10.1006/excr.2001.5239; Tkaczyk C, 2006, IMMUNOL ALLERGY CLIN, V26, P427, DOI 10.1016/j.iac.2006.05.011; Wedemeyer J, 2000, CURR OPIN IMMUNOL, V12, P624, DOI 10.1016/S0952-7915(00)00154-0; Zeidman R, 1999, INT J CANCER, V81, P494, DOI 10.1002/(SICI)1097-0215(19990505)81:3<494::AID-IJC26>3.0.CO;2-L	41	2	2	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22273	10.1096/fj.202101838RRR	http://dx.doi.org/10.1096/fj.202101838RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0K2TQ	35349200	Green Published			2022-12-26	WOS:000780645900001
J	Ali, Y; Khalid, O; Khan, IA; Hussain, SS; Rehman, F; Siraj, S; Nawaz, R				Ali, Yasher; Khalid, Osman; Khan, Imran Ali; Hussain, Syed Sajid; Rehman, Faisal; Siraj, Sajid; Nawaz, Raheel			A hybrid group-based movie recommendation framework with overlapping memberships	PLOS ONE			English	Article							SYSTEM; IDENTIFICATION; ALGORITHMS	Recommender Systems (RS) are widely used to help people or group of people in finding their required information amid the issue of ever-growing information overload. The existing group recommender approaches consider users to be part of a single group only, but in real life a user may be associated with multiple groups having conflicting preferences. For instance, a person may have different preferences in watching movies with friends than with family. In this paper, we address this problem by proposing a Hybrid Two-phase Group Recommender Framework (HTGF) that takes into consideration the possibility of users having simultaneous membership of multiple groups. Unlike the existing group recommender systems that use traditional methods like K-Means, Pearson correlation, and cosine similarity to form groups, we use Fuzzy C-means clustering which assigns a degree of membership to each user for each group, and then Pearson similarity is used to form groups. We demonstrate the usefulness of our proposed framework using a movies data set. The experiments were conducted on MovieLens 1M dataset where we used Neural Collaborative Filtering to recommend Top-k movies to each group. The results demonstrate that our proposed framework outperforms the traditional approaches when compared in terms of group satisfaction parameters, as well as the conventional metrics of precision, recall, and F-measure.	[Ali, Yasher; Khalid, Osman; Khan, Imran Ali; Hussain, Syed Sajid; Rehman, Faisal] COMSATS Univ Islamabad, Dept Comp Sci, Abbottabad Campus, Abbottabad, Pakistan; [Siraj, Sajid] Univ Leeds, Leeds Univ Business Sch, Leeds, W Yorkshire, England; [Nawaz, Raheel] Manchester Metropolitan Univ, Manchester, Lancs, England	COMSATS University Islamabad (CUI); University of Leeds; Manchester Metropolitan University	Nawaz, R (corresponding author), Manchester Metropolitan Univ, Manchester, Lancs, England.	r.nawaz@mmu.ac.uk	Rehman, Faisal/AAO-2685-2021; Khan, Imran Ali/GVT-0232-2022	Rehman, Faisal/0000-0002-6804-3467; Khan, Imran Ali/0000-0002-8774-2896; Hussain, Syed Sajid/0000-0002-4212-8817				Abdollahpouri H, 2020, RECSYS 2020: 14TH ACM CONFERENCE ON RECOMMENDER SYSTEMS, P726, DOI 10.1145/3383313.3418487; Agarwal A, 2017, EXPERT SYST APPL, V82, P115, DOI 10.1016/j.eswa.2017.03.069; Ahmed M, 2018, 2018 IEEE 8TH ANNUAL COMPUTING AND COMMUNICATION WORKSHOP AND CONFERENCE (CCWC), P143; Aipe A, 2019, ARXIV PREPRINT ARXIV; Amer-Yahia S, 2009, PROC VLDB ENDOW, V2; Baltrunas L., 2010, P 4 ACM C REC SYST, P119; Baral R, 2019, IEEE T COMPUT SOC SY, V6, P1020, DOI 10.1109/TCSS.2019.2938239; Baskin JP, 2009, P 3 ACM C RECOMMENDE; Berkovsky S., 2010, P 4 ACM C REC SYST, P111, DOI DOI 10.1145/1864708.1864732; Boley D, 1999, DECIS SUPPORT SYST, V27, P329, DOI 10.1016/S0167-9236(99)00055-X; Boratto L, 2010, STUD COMPUT INTELL, V324, P1; Burke R, 2002, USER MODEL USER-ADAP, V12, P331, DOI 10.1023/A:1021240730564; Carvalho LAMC, 2013, PROCEEDINGS OF THE 22ND INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'13 COMPANION), P951; Castro J, 2018, EXPERT SYST APPL, V94, P237, DOI 10.1016/j.eswa.2017.10.060; Chu-Hsing Lin, 2020, Advanced Information Networking and Applications. Proceedings of the 33rd International Conference on Advanced Information Networking and Applications (AINA-2019). Advances in Intelligent Systems and Computing (AISC 926), P895, DOI 10.1007/978-3-030-15032-7_75; Cui Y, 2015, ARXIV PREPRINT ARXIV; Dara S, 2020, J INTELL INF SYST, V54, P271, DOI 10.1007/s10844-018-0542-3; Dara S, 2019, APPL INTELL, V49, P3293, DOI 10.1007/s10489-019-01455-y; del CarmenRodrguez-Hernndez M, 2020, 2020 IEEEACS 17 INT, P18; Deldjoo Y, 2018, INT J MULTIMED INF R, V7, P207, DOI 10.1007/s13735-018-0155-1; Feng SS, 2019, KNOWL-BASED SYST, V171, P56, DOI 10.1016/j.knosys.2019.02.002; Fu MS, 2019, IEEE T CYBERNETICS, V49, P1084, DOI 10.1109/TCYB.2018.2795041; Ghosh S, 2022, IEEE T COMPUT SOC SY, V9, P1484, DOI 10.1109/TCSS.2021.3116242; Ghosh S, 2020, PROCEEDINGS OF THE 12TH INTERNATIONAL CONFERENCE ON LANGUAGE RESOURCES AND EVALUATION (LREC 2020), P1618; Grabusts P, 2002, PAR ELEC 2002: INTERNATIONAL CONFERENCE ON PARALLEL COMPUTING IN ELECTRICAL ENGINEERING, P425, DOI 10.1109/PCEE.2002.1115319; Gunjal S, 2020, 2020 INT C SMART INN, P3945; Handy MJ, 2002, 2002 4TH INTERNATIONAL WORKSHOP ON MOBILE AND WIRELESS COMMUNICATION NETWORK, P368, DOI 10.1109/MWCN.2002.1045790; Hassan SU, 2021, J INF SCI, V47, P712, DOI 10.1177/0165551520930917; He XN, 2017, PROCEEDINGS OF THE 26TH INTERNATIONAL CONFERENCE ON WORLD WIDE WEB (WWW'17), P173, DOI 10.1145/3038912.3052569; Herlocker JL, 2004, ACM T INFORM SYST, V22, P5, DOI 10.1145/963770.963772; HTGF, COD FIL; Huang ZH, 2020, IEEE T NEUR NET LEAR, V31, P4461, DOI 10.1109/TNNLS.2019.2955567; Iqbal S, 2021, SCIENTOMETRICS, V126, P6551, DOI 10.1007/s11192-021-04055-1; Jogunola O, 2022, ENERGIES, V15, DOI 10.3390/en15030810; Junaid M, 2020, IEEE ACCESS, V8, P173208, DOI 10.1109/ACCESS.2020.3024113; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kassak O, 2016, INFORM PROCESS MANAG, V52, P459, DOI 10.1016/j.ipm.2015.10.001; Khan MUS, 2021, IEEE INTERNET COMPUT, V25, P40, DOI 10.1109/MIC.2020.3037034; Koohi H, 2016, MEASUREMENT, V91, P134, DOI 10.1016/j.measurement.2016.05.058; Koren Y, 2009, COMPUTER, V42, P30, DOI 10.1109/MC.2009.263; Lang F, 2021, MOBILE NETW APPL, V26, P2199, DOI 10.1007/s11036-021-01775-9; Le T, 2018, SYMMETRY-BASEL, V10, DOI 10.3390/sym10070250; Lian M, 2020, PROCEEDINGS OF 2020 IEEE 4TH INFORMATION TECHNOLOGY, NETWORKING, ELECTRONIC AND AUTOMATION CONTROL CONFERENCE (ITNEC 2020), P2547, DOI 10.1109/ITNEC48623.2020.9084812; Mahmood Z, 2020, INFORM PROCESS MANAG, V57, DOI 10.1016/j.ipm.2020.102233; Majdi A, 2019, INT J ROCK MECH MIN, V113, P172, DOI 10.1016/j.ijrmms.2018.10.030; Mann A.K., 2013, INT J SCI ENG TECHNO, V2, P803; Mirzaei A, 2010, IEEE T FUZZY SYST, V18, P27, DOI 10.1109/TFUZZ.2009.2034531; MIT, SINGULAR VALUE DECOM; MovieLens, 1M DAT; Mullner D, 2013, J STAT SOFTW, V53, P1; Nallamala SH, 2020, IOP C SERIES MAT SCI, V981; Nawi RM., 2020, INT J MACH LEARN COM, V10, DOI [10.18178/ijmlc.2020.10.2.939, DOI 10.18178/IJMLC.2020.10.2.939]; Nozari RB, 2020, KNOWL-BASED SYST, V205, DOI 10.1016/j.knosys.2020.106296; Pongpaichet S, 2020, 2020 17 INT C ELECT; Portugal I, 2018, EXPERT SYST APPL, V97, P205, DOI 10.1016/j.eswa.2017.12.020; Ricci F, 2011, RECOMMENDER SYSTEMS HANDBOOK, P1, DOI 10.1007/978-0-387-85820-3_1; Said A, 2011, P 2011 ACM C REC SYS; Souri A, 2018, HUM-CENT COMPUT INFO, V8, DOI 10.1186/s13673-018-0147-4; Su X., 2009, ADV ARTIF INTELL, V2009, P19, DOI [10.1155/2009/421425, DOI 10.1155/2009/421425]; Suman C, 2021, IEEE T COMPUT SOC SY, V8, P1407, DOI 10.1109/TCSS.2021.3082942; Takahashi T., 2018, WORKING NOTES PAPERS; Vilakone P, 2020, J INF PROCESS SYST, V16, P494, DOI 10.3745/JIPS.04.0169; Wang H., 2011, P 17 ACM SIGKDD INT, P618, DOI DOI 10.1145/2020408.2020505; Wang ZB, 2015, IEEE T MOBILE COMPUT, V14, P538, DOI 10.1109/TMC.2014.2322373; Yadav V, 2021, J SCI IND RES INDIA, V80, P159; Yuan NJ, 2013, IEEE T KNOWL DATA EN, V25, P2390, DOI 10.1109/TKDE.2012.153; Zhang F, 2016, KNOWL-BASED SYST, V96, P96, DOI 10.1016/j.knosys.2015.12.025; Zhang Q, 2019, IEEE T NEUR NET LEAR, V30, P1998, DOI 10.1109/TNNLS.2018.2875144; Zhang Y, 2006, WCICA 2006: SIXTH WORLD CONGRESS ON INTELLIGENT CONTROL AND AUTOMATION, VOLS 1-12, CONFERENCE PROCEEDINGS, P5868	71	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266103	10.1371/journal.pone.0266103	http://dx.doi.org/10.1371/journal.pone.0266103			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358269	Green Published, Green Accepted, gold			2022-12-26	WOS:000799828800069
J	Cesaro, E; Falanga, AP; Catapano, R; Greco, F; Romano, S; Borbone, N; Pastore, A; Marzano, M; Chiurazzi, F; D'Errico, S; Piccialli, G; Oliviero, G; Costanzo, P; Grosso, M				Cesaro, Elena; Falanga, Andrea Patrizia; Catapano, Rosa; Greco, Francesca; Romano, Simona; Borbone, Nicola; Pastore, Arianna; Marzano, Maria; Chiurazzi, Federico; D'Errico, Stefano; Piccialli, Gennaro; Oliviero, Giorgia; Costanzo, Paola; Grosso, Michela			Exploring a peptide nucleic acid-based antisense approach for CD5 targeting in chronic lymphocytic leukemia	PLOS ONE			English	Article							CELL-LINE; T-CELLS; B-CELLS; PNA; DIFFERENTIATION; PROLIFERATION; ACTIVATION	We herein report an innovative antisense approach based on Peptide Nucleic Acids (PNAs) to down-modulate CD5 expression levels in chronic lymphocytic leukemia (CLL). Using bioinformatics tools, we selected a 12-mer tract of the CD5 mRNA as the molecular target and synthesized the complementary and control PNA strands bearing a serine phosphate dipeptide tail to enhance their water solubility and bioavailability. The specific recognition of the 12-mer DNA strand, corresponding to the target mRNA sequence by the complementary PNA strand, was confirmed by non-denaturing polyacrylamide gel electrophoresis, thermal difference spectroscopy, circular dichroism (CD), and CD melting studies. Cytofluorimetric assays and real-time PCR analysis demonstrated the downregulation of CD5 expression due to incubation with the anti-CD5 PNA at RNA and protein levels in Jurkat cell line and peripheral blood mononuclear cells from B-CLL patients. Interestingly, we also observed that transfection with the anti-CD5 PNA increases apoptotic response induced by fludarabine in B-CLL cells. The herein reported results suggest that PNAs could represent a potential candidate for the development of antisense therapeutic agents in CLL.	[Cesaro, Elena; Catapano, Rosa; Romano, Simona; Pastore, Arianna; Oliviero, Giorgia; Costanzo, Paola; Grosso, Michela] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Falanga, Andrea Patrizia; Greco, Francesca; Borbone, Nicola; Marzano, Maria; D'Errico, Stefano; Piccialli, Gennaro] Univ Naples Federico II, Dept Pharm, Naples, Italy; [Borbone, Nicola; Piccialli, Gennaro; Oliviero, Giorgia] Univ Naples Federico II, ISBE IT, Naples, Italy; [Chiurazzi, Federico] Univ Naples Federico II, Dept Clin & Expt Med, Div Hematol, Naples, Italy	University of Naples Federico II; University of Naples Federico II; University of Naples Federico II; University of Naples Federico II	Oliviero, G (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.; Oliviero, G (corresponding author), Univ Naples Federico II, ISBE IT, Naples, Italy.	golivier@unina.it		greco, francesca/0000-0003-4217-7990; CESARO, Elena/0000-0003-3931-7956	Ministero dell'Universita e della Ricerca FOE 2017 - ISBE-IT Joint Research Unit; Regione Campania POR FESR [B63D18000250007, B61G18000470007]; Regione Campania "SATIN"	Ministero dell'Universita e della Ricerca FOE 2017 - ISBE-IT Joint Research Unit; Regione Campania POR FESR; Regione Campania "SATIN"	NB, GP, and GO acknowledges funding support from Ministero dell'Universita e della Ricerca FOE 2017 - ISBE-IT Joint Research Unit. GO received funds from Regione Campania POR FESR 2014/2020 within the project "Biochip per la diagnosi rapida ed il follow-up della leucemia linfatica cronica nella popolazione in territorio a rischio" (project N. B63D18000250007). NB and GP received funds from Regione Campania POR FESR 2014/2020 within the project "Combattere la resistenza tumorale: piattaforma integrata multidisciplinare per un approccio tecnologico innovativo alle oncoterapie-Campania Oncoterapie" (Project N. B61G18000470007). MG received funds from Regione Campania "SATIN" grant 2018-2020.	Amato F, 2014, MEDCHEMCOMM, V5, P68, DOI 10.1039/c3md00257h; Amato J, 2011, BIOCONJUGATE CHEM, V22, P654, DOI 10.1021/bc100444v; Bosch F, 2019, NAT REV CLIN ONCOL, V16, P684, DOI 10.1038/s41571-019-0239-8; Cesaro E, 2021, HUM MOL GENET, V30, P2100, DOI 10.1093/hmg/ddab173; Comegna M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85549-z; Crisci T, 2021, NANOMATERIALS-BASEL, V11, DOI 10.3390/nano11020523; DEMIDOV VV, 1994, BIOCHEM PHARMACOL, V48, P1310, DOI 10.1016/0006-2952(94)90171-6; di Caprio Roberta, 2015, Biology-Basel, V4, P41, DOI 10.3390/biology4010041; EGHOLM M, 1993, NATURE, V365, P566, DOI 10.1038/365566a0; Fabbri E, 2021, EUR J MED CHEM, V209, DOI 10.1016/j.ejmech.2020.112876; Falanga AP, 2019, BIOCONJUGATE CHEM, V30, P572, DOI 10.1021/acs.bioconjchem.8b00674; Friedman DR, 2018, BRIT J HAEMATOL, V183, P747, DOI 10.1111/bjh.15632; Ganesh KN, 2000, CURR ORG CHEM, V4, P931, DOI 10.2174/1385272003375969; Gary-Gouy H, 2002, BLOOD, V100, P4537, DOI 10.1182/blood-2002-05-1525; Gary-Gouy H, 2002, J IMMUNOL, V168, P232, DOI 10.4049/jimmunol.168.1.232; Gary-Gouy H, 2007, J IMMUNOL, V179, P4335, DOI 10.4049/jimmunol.179.7.4335; Gasparello J, 2020, NUCLEIC ACID THER, V30, P164, DOI 10.1089/nat.2019.0825; Ghavami M, 2019, BIOMOLECULES, V9, DOI 10.3390/biom9100554; Goltermann L, 2020, METHODS MOL BIOL, V2105, P231, DOI 10.1007/978-1-0716-0243-0_14; Hertlein E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076607; HIROHATA S, 1988, J IMMUNOL, V140, P3726; Jaseb K, 2019, ONCOL REV, V13, P77, DOI 10.4081/oncol.2019.400; Jensen KK, 1997, BIOCHEMISTRY-US, V36, P5072, DOI 10.1021/bi9627525; Klitgaard JL, 2013, BRIT J HAEMATOL, V163, P182, DOI 10.1111/bjh.12503; LIPSKY PE, 1990, RES IMMUNOL, V141, P424, DOI 10.1016/0923-2494(90)90034-V; Loisel S, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-42; Lu XH, 2002, J IMMUNOL, V168, P5612, DOI 10.4049/jimmunol.168.11.5612; Mergny JL, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni134; Mologni L, 2001, CANCER RES, V61, P5468; Montano G, 2015, ONCOTARGET, V6, P28223, DOI 10.18632/oncotarget.4950; Montazersaheb S, 2018, ADV PHARM BULL, V8, P551, DOI 10.15171/apb.2018.064; Nabhan C, 2014, JAMA-J AM MED ASSOC, V312, P2265, DOI 10.1001/jama.2014.14553; Pellestor F, 2004, EUR J HUM GENET, V12, P694, DOI 10.1038/sj.ejhg.5201226; Perez-Chacon G, 2007, LEUKEMIA RES, V31, P183, DOI 10.1016/j.leukres.2006.03.021; Pers JO, 2002, LEUKEMIA, V16, P44, DOI 10.1038/sj.leu.2402327; Ricci Francesca, 2009, Ther Clin Risk Manag, V5, P187; Rosen A, 2012, ONCOIMMUNOLOGY, V1, P18, DOI 10.4161/onci.1.1.18400; Sarnelli G, 2017, UNITED EUR GASTROENT, V5, P200, DOI 10.1177/2050640616648870; Sodaro G, 2018, BIOCHIMIE, V154, P127, DOI 10.1016/j.biochi.2018.08.011; Sodaro G, 2018, ONCOTARGET, V9, P3417, DOI 10.18632/oncotarget.23283; Starostka D, 2018, CYTOM PART B-CLIN CY, V94, P576, DOI 10.1002/cyto.b.21607	41	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266090	10.1371/journal.pone.0266090	http://dx.doi.org/10.1371/journal.pone.0266090			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358273	Green Published, gold			2022-12-26	WOS:000799828800065
J	Bertolini, I; Perego, M; Ghosh, JC; Kossenkov, AV; Altieri, DC				Bertolini, Irene; Perego, Michela; Ghosh, Jagadish C.; Kossenkov, Andrew, V; Altieri, Dario C.			NF kappa B activation by hypoxic small extracellular vesicles drives oncogenic reprogramming in a breast cancer microenvironment	ONCOGENE			English	Article							INTEGRIN	Small extracellular vesicles (sEV) contribute to the crosstalk between tumor cells and stroma, but the underlying signals are elusive. Here, we show that sEV generated by breast cancer cells in hypoxic (sEV(HYP)), but not normoxic (sEV(NORM)) conditions activate NF kappa B in recipient normal mammary epithelial cells. This increases the production and release of inflammatory cytokines, promotes mitochondrial dynamics leading to heightened cell motility and disrupts 3D mammary acini architecture with aberrant cell proliferation, reduced apoptosis and EMT. Mechanistically, Integrin-Linked Kinase packaged in sEV(HYP) via HIF1 alpha is sufficient to activate NF kappa B in the normal mammary epithelium, in vivo. Therefore, sEV(HYP) activation of NF kappa B drives multiple oncogenic steps of inflammation, mitochondrial dynamics, and mammary gland morphogenesis in a breast cancer microenvironment.	[Bertolini, Irene; Perego, Michela; Ghosh, Jagadish C.; Altieri, Dario C.] Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA; [Kossenkov, Andrew, V] Wistar Inst Anat & Biol, Bioinformat Shared Resource, Philadelphia, PA 19104 USA; [Kossenkov, Andrew, V] Wistar Inst Anat & Biol, Gene Express & Regulat Program, Philadelphia, PA 19104 USA	The Wistar Institute; The Wistar Institute; The Wistar Institute	Altieri, DC (corresponding author), Wistar Inst Anat & Biol, Immunol Microenvironm & Metastasis Program, Philadelphia, PA 19104 USA.	daltieri@wistar.org		ALTIERI, DARIO C/0000-0002-0617-3469	National Institutes of Health (NIH) [P01 CA140043, R35 CA220446, R50 CA211199]; Mary Kay Foundation	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mary Kay Foundation	We thank James Hayden and Frederick Keeney of the Wistar Imaging Core Shared Resource for assistance with time-lapse videomicroscopy and Sudheer Mulugu of the Electron Microscopy Resource Lab, Perelman School of Medicine, University of Pennsylvania for cryo-electron microscopy. This work was supported by National Institutes of Health (NIH) grants P01 CA140043, R35 CA220446 (D.C.A.), R50 CA211199 (A.V.K.) and an award from the Mary Kay Foundation (D.C.A.).	Baram T, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.614468; Bertolini I, 2020, DEV CELL, V55, P163, DOI 10.1016/j.devcel.2020.07.014; Caino MC, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13730; Chen F, 2019, NAT CELL BIOL, V21, P498, DOI 10.1038/s41556-019-0299-0; Curtius K, 2018, NAT REV CANCER, V18, P19, DOI 10.1038/nrc.2017.102; Hannigan G, 2005, NAT REV CANCER, V5, P51, DOI 10.1038/nrc1524; Jaiswal R, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00125; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Lucien F, 2019, BIOCHEM SOC T, V47, P273, DOI 10.1042/BST20180253; Ma YF, 2021, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.606906; Marar C, 2021, NAT IMMUNOL, V22, P560, DOI 10.1038/s41590-021-00899-0; Sansone P, 2017, P NATL ACAD SCI USA, V114, pE9066, DOI 10.1073/pnas.1704862114; Singh A, 2016, MOL CANCER RES, V14, P1136, DOI 10.1158/1541-7786.MCR-16-0058; Sung BH, 2021, DEV CELL, V56, P1861, DOI 10.1016/j.devcel.2021.03.020; Sung BH, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15747-2; Vaynberg J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06906-7; You SX, 2019, P NATL ACAD SCI USA, V116, P24012, DOI 10.1073/pnas.1909243116; Zhao LJ, 2021, EMBO REP, V22, DOI 10.15252/embr.202050922	18	4	4	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2022	41	17					2520	2525		10.1038/s41388-022-02280-3	http://dx.doi.org/10.1038/s41388-022-02280-3		MAR 2022	6	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0R6YF	35354906	Green Accepted			2022-12-26	WOS:000775854600002
J	Canchola, A; Meletz, R; Khandakar, RA; Woods, M; Lin, YH				Canchola, Alexa; Meletz, Ruth; Khandakar, Riste Ara; Woods, Megan; Lin, Ying-Hsuan			Temperature dependence of emission product distribution from vaping of vitamin E acetate	PLOS ONE			English	Article							PUFF TOPOGRAPHY; COIL TEMPERATURE; HEATING COIL; PARAMETERS; CIGARETTES; CHEMISTRY; IMPACT	Nearly two years after vitamin E acetate (VEA) was identified as the potential cause of the 2019-2020 outbreak of e-cigarette, or vaping product-associated lung injuries (EVALI), the toxicity mechanisms of VEA vaping are still yet to be fully understood. Studies since the outbreak have found that e-liquids such as VEA undergo thermal degradation during the vaping process to produce various degradation products, which may pose a greater risk of toxicity than exposure to unvaped VEA. Additionally, a wide range of customizable parametersincluding the model of e-cigarette used, puffing topography, or the applied power/temperature used to generate aerosols-have been found to influence the physical properties and chemical compositions of vaping emissions. However, the impact of heating coil temperature on the chemical composition of VEA vaping emissions has not been fully assessed. In this study, we investigated the emission product distribution of VEA vaping emissions produced at temperatures ranging from 176 to 356 degrees C, corresponding to a variable voltage vape pen set at 3.3 to 4.8V. VEA degradation was found to be greatly enhanced with increasing temperature, resulting in a shift towards the production of lower molecular weight compounds, such as the redox active duroquinone (DQ) and short-chain alkenes. Low temperature vaping of VEA resulted in the production of long-chain molecules, such as phytol, exposure to which has been suggested to induce lung damage in previous studies. Furthermore, differential product distribution was observed in VEA degradation products generated from vaping and from pyrolysis using a tube furnace in the absence of the heating coil at equivalent temperatures, suggesting the presence of external factors such as metals or oxidation that may enhance VEA degradation during vaping. Overall, our findings indicate that vaping behavior may significantly impact the risk of exposure to toxic vaping products and potential for vaping-related health concerns.	[Canchola, Alexa; Lin, Ying-Hsuan] Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA; [Meletz, Ruth; Khandakar, Riste Ara; Lin, Ying-Hsuan] Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA; [Woods, Megan] Univ Calif Riverside, Dept Chem, Riverside, CA 92521 USA	University of California System; University of California Riverside; University of California System; University of California Riverside; University of California System; University of California Riverside	Lin, YH (corresponding author), Univ Calif Riverside, Environm Toxicol Grad Program, Riverside, CA 92521 USA.; Lin, YH (corresponding author), Univ Calif Riverside, Dept Environm Sci, Riverside, CA 92521 USA.	ying-hsuan.lin@ur.edu	; Lin, Ying-Hsuan/J-4023-2014	Meletz, Ruth/0000-0003-1038-248X; Lin, Ying-Hsuan/0000-0001-8904-1287; Canchola, Alexa/0000-0001-8285-4795	UCR Regents' Faculty Development Award; NRSA T32 training grant [T32 ES18827]; National Institutes of Health [T34GM062756]	UCR Regents' Faculty Development Award; NRSA T32 training grant; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	YHL gratefully acknowledges support from the UCR Regents' Faculty Development Award for this research. AC was supported by an NRSA T32 training grant (T32 ES18827). RM was supported by a grant from the National Institutes of Health (T34GM062756). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker RC, 1999, ANNU REV PHARMACOL, V39, P127, DOI 10.1146/annurev.pharmtox.39.1.127; Behar RZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117222; Blount BC, 2020, NEW ENGL J MED, V382, P697, DOI 10.1056/NEJMoa1916433; Bonner E, 2021, PHARMACOL THERAPEUT, V225, DOI 10.1016/j.pharmthera.2021.107837; Braymiller JL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.30189; Byju K., 2013, MAPANA J SCI, V12, P57, DOI [DOI 10.12723/MJS.25.6, 10.12723/mjs.25.6, DOI 10.12723/mjs.25.6]; Canchola A, 2022, CHEM RES TOXICOL, V35, P254, DOI 10.1021/acs.chemrestox.1c00309; Chen JY, 2021, TOXICS, V9, DOI 10.3390/toxics9120345; Chen JY, 2019, ENVIRON SCI-PROC IMP, V21, P856, DOI 10.1039/c9em00033j; Chen WH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195925; Cunningham A, 2016, SCI REP-UK, V6, DOI 10.1038/srep35071; Dibaji SAR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206937; Duffy B, 2020, TOXICS, V8, DOI 10.3390/toxics8010008; EFSA Panel on Food Contact Materials Enzymes Flavourings and Processing Aids, 2016, EFSA Journal, V14, P4412; Geiss O, 2016, INT J HYG ENVIR HEAL, V219, P268, DOI 10.1016/j.ijheh.2016.01.004; Gerasimov PA, 1985, PHARM CHEM J+, V19, P730; Gonzalez-Jimenez N, 2021, TOXICS, V9, DOI 10.3390/toxics9100240; Grimme S, 2013, ANGEW CHEM INT EDIT, V52, P6306, DOI 10.1002/anie.201300158; Jaegers NR, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87044-x; Jiang HH, 2020, CHEM RES TOXICOL, V33, P2157, DOI 10.1021/acs.chemrestox.0c00174; Kim S, 2021, NUCLEIC ACIDS RES, V49, pD1388, DOI 10.1093/nar/gkaa971; KUMAR CT, 1992, MOL CELL BIOCHEM, V111, P109; LeBouf RF, 2022, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.765168; Lechasseur A, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14093; Li YC, 2021, CHEM RES TOXICOL, V34, P1640, DOI 10.1021/acs.chemrestox.1c00070; Lynch J, 2021, FRONT CHEM, V9, DOI 10.3389/fchem.2021.734793; Mikheev VB, 2020, AEROSOL SCI TECH, V54, P993, DOI 10.1080/02786826.2020.1783431; Narimani M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238140; Ojo O. O., 2020, Journal of Herbs, Spices & Medicinal Plants, V26, P155, DOI 10.1080/10496475.2019.1689541; Omaiye EE, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248127; Patocka J, 2016, MMSL, V85, P171; Prevention CfDCa, OUTBR LUNG INJ ASS U; Russo EB, 2011, BRIT J PHARMACOL, V163, P1344, DOI 10.1111/j.1476-5381.2011.01238.x; Saliba NA, 2018, J ANAL APPL PYROL, V134, P520, DOI 10.1016/j.jaap.2018.07.019; Schwotzer D, 2021, INHAL TOXICOL, V33, P33, DOI 10.1080/08958378.2020.1867260; Shapiro SS, 2001, NUTRITION, V17, P839, DOI 10.1016/S0899-9007(01)00660-8; Sleiman M, 2016, ENVIRON SCI TECHNOL, V50, P9644, DOI 10.1021/acs.est.6b01741; Son Y, 2019, CHEM RES TOXICOL, V32, P1087, DOI 10.1021/acs.chemrestox.8b00400; STEIN SE, 1995, J AM SOC MASS SPECTR, V6, P644, DOI 10.1016/1044-0305(95)00291-K; Stein S, 2012, ANAL CHEM, V84, P7274, DOI 10.1021/ac301205z; Su WC, 2021, J EXPO SCI ENV EPID, V31, P1008, DOI 10.1038/s41370-021-00362-0; Talih S, 2015, NICOTINE TOB RES, V17, P150, DOI 10.1093/ntr/ntu174; USHIKUSA T, 1991, Journal of the Japan Oil Chemists' Society, V40, P1073; Vas G., 2021, EVALUATION VITAMIN A; vom Dorp K, 2015, PLANT CELL, V27, P2846, DOI 10.1105/tpc.15.00395; Wagner J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240613; Wang SY, 2020, J CHEMINFORMATICS, V12, DOI 10.1186/s13321-020-00470-3; Williams M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-50441-4; Williams M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057987; Wu D, 2020, P NATL ACAD SCI USA, V117, P6349, DOI 10.1073/pnas.1920925117; Zhao TK, 2016, ATMOS ENVIRON, V134, P61, DOI 10.1016/j.atmosenv.2016.03.027	51	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265365	10.1371/journal.pone.0265365	http://dx.doi.org/10.1371/journal.pone.0265365			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324938	Green Published, gold			2022-12-26	WOS:000780951300039
J	Fiseha, T; Ebrahim, H; Ebrahim, E; Gebreweld, A				Fiseha, Temesgen; Ebrahim, Hussen; Ebrahim, Endris; Gebreweld, Angesom			CD4+cell count recovery after initiation of antiretroviral therapy in HIV-infected Ethiopian adults	PLOS ONE			English	Article							THAN 500 CELLS/MM(3); CELL RECOVERY; VIROLOGICAL SUPPRESSION; IMMUNOLOGICAL RECOVERY; AIDS; RISK; DISEASE; AGE; NORMALIZATION; INDIVIDUALS	Background CD4+ cell count recovery after effective antiretroviral therapy (ART) is an important determinant of both AIDS and non-AIDS morbidity and mortality. Data on CD4+ cell count recovery after initiation of ART are still limited in Sub-Saharan Africa. The aim of this study was to assess CD4+ cell count recovery among HIV-infected adults initiating ART in an Ethiopian setting. Methods A retrospective cohort study of HIV-infected adults initiating ART between September 2008 and June 2019 was carried out. CD4+ cell count recovery was defined as an increase in CD4+ cell count of > 100 cells/mm(3) from baseline or achievement of a CD4+ cell count > 500 cells/mm(3) at 12 months after ART initiation. Factors associated with CD4+ cell count recovery were evaluated using logistic regression analysis. Results Of the 566 patients included in this study, the median baseline CD4+ cell count was 264 cells/mm(3) (IQR: 192-500). At 12 months after ART initiation, the median CD4+ cell count increased to 472 cells/mm(3), and the proportion of patients with CD4+ cell count < 200 cells/mm(3) declined from 28.3 to 15.0%. A total of 58.0% of patients had an increase in CD4+ cell count of > 100 cells/mm(3) from baseline and 48.6% achieved a CD4+ cell count > 500 cells/mm(3) at 12 months. Among patients with CD4+ cell counts < 200, 200-350 and > 350 cells/mm(3) at baseline, respectively, 30%, 43.9% and 61.7% achieved a CD4+ cell count > 500 cells/mm(3) at 12 months. In multivariable analysis, poor CD4+ cell count recovery (an increase of.100 cells/mm(3) from baseline) was associated with older age, male sex, higher baseline CD4+ cell count and zidovudine-containing initial regimen. Factors associated with poor CD4+ cell count recovery to reach the level > 500 cells/mm(3) included older age, male sex and lower baseline CD4+ cell count. Conclusions CD4+ cell count failed to recover in a substantial proportion of adults initiating ART in this resource-limited setting. Older age, male sex and baseline CD4+ cell count are the dominant factors for poor CD4+ cell count recovery. Novel therapeutic approaches are needed focusing on high risk patients to maximize CD4+ cell count recovery and improve outcomes during therapy.	[Fiseha, Temesgen; Ebrahim, Hussen; Ebrahim, Endris] Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia; [Gebreweld, Angesom] Mekelle Univ, Coll Hlth Sci, Dept Med Lab Sci, Mekelle, Ethiopia	Mekelle University	Fiseha, T (corresponding author), Wollo Univ, Coll Med & Hlth Sci, Dept Clin Lab Sci, Dessie, Ethiopia.	temafiseha@gmail.com	Ebrahim, Endris/AFB-5334-2022; Ebrahim, Hussen/AAE-6426-2022	Ebrahim, Endris/0000-0002-0808-0303; Ebrahim, Hussen/0000-0002-4360-7422				Anude CJ, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-113; Asfaw A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122583; Baker JV, 2008, JAIDS-J ACQ IMM DEF, V48, P541, DOI 10.1097/QAI.0b013e31817bebb3; Baker JV, 2008, AIDS, V22, P841, DOI 10.1097/QAD.0b013e3282f7cb76; Battegay M, 2006, LANCET INFECT DIS, V6, P280, DOI 10.1016/S1473-3099(06)70463-7; Bayarsaikhan S, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247929; Belay GM, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4156-3; Boatman JA, 2019, JAIDS-J ACQ IMM DEF, V81, P10, DOI 10.1097/QAI.0000000000001967; Collaboration of Observational HIV Epidemiological Research Europe (COHERE) Study Group, 2008, AIDS, V22, P1463, DOI 10.1097/QAD.0b013e3282f88d02; Desta AA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226293; Dronda F, 2002, CLIN INFECT DIS, V35, P1005, DOI 10.1086/342695; Enawgaw B, 2018, TROP MED INT HEALTH, V23, P765, DOI 10.1111/tmi.13071; Gandhi RT, 2006, JAIDS-J ACQ IMM DEF, V42, P426, DOI 10.1097/01.qai.0000226789.51992.3f; Garcia F, 2004, JAIDS-J ACQ IMM DEF, V36, P702, DOI 10.1097/00126334-200406010-00007; Gazzola L, 2009, CLIN INFECT DIS, V48, P328, DOI 10.1086/595851; Gelba SB, 2020, HIV AIDS-RES PALLIAT, V12, P69, DOI 10.2147/HIV.S229036; Geng EH, 2015, INT J EPIDEMIOL, V44, P251, DOI 10.1093/ije/dyu271; Gezie Lemma Derseh, 2016, BMC Res Notes, V9, P377, DOI 10.1186/s13104-016-2182-4; Grabar S, 2000, ANN INTERN MED, V133, P401, DOI 10.7326/0003-4819-133-6-200009190-00007; Gutierrez F, 2008, CURR HIV RES, V6, P100, DOI 10.2174/157016208783885038; Haas DW, 2006, J INFECT DIS, V194, P1098, DOI 10.1086/507313; He L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148915; Joint United Nations Programme on HIV/AIDS (UNAIDS), 2014, AMB TREATM TARG HELP; Kaufmann GR, 2003, ARCH INTERN MED, V163, P2187, DOI 10.1001/archinte.163.18.2187; Kaufmann GR, 2005, CLIN INFECT DIS, V41, P361, DOI 10.1086/431484; Kayigamba FR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159446; Kelley CF, 2009, CLIN INFECT DIS, V48, P787, DOI 10.1086/597093; Kesselring A, 2008, 15 C RETR OPP INF BO; Kigozi IM, 2009, JAIDS-J ACQ IMM DEF, V52, P280, DOI 10.1097/QAI.0b013e3181ab6eab; Kroeze S, 2018, AIDS, V32, P1043, DOI [10.1097/QAD.0000000000001801, 10.1097/qad.0000000000001801]; Lawn SD, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-59; Lewden C, 2007, JAIDS-J ACQ IMM DEF, V46, P72; Loutfy MR, 2005, J INFECT DIS, V192, P1407, DOI 10.1086/466537; Lundgren D, 2015, NEW ENGL J MED, V373, P795, DOI 10.1056/NEJMoa1506816; Maman D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031078; May MT, 2014, AIDS, V28, P1193, DOI 10.1097/QAD.0000000000000243; Mocroft A, 2007, LANCET, V370, P407, DOI 10.1016/S0140-6736(07)60948-9; Moore DM, 2006, AIDS, V20, P371, DOI 10.1097/01.aids.0000196180.11293.9a; Moore RD, 2007, CLIN INFECT DIS, V44, P441, DOI 10.1086/510746; Mulu A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-28; Mutoh Y, 2018, CLIN INFECT DIS, V67, P927, DOI 10.1093/cid/ciy176; Nakanjako D, 2016, AIDS, V30, P1913, DOI 10.1097/QAD.0000000000001085; Nakanjako Damalie, 2008, AIDS Res Ther, V5, P23, DOI 10.1186/1742-6405-5-23; Obiri-Yeboah D, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3142-5; Olsen NJ, 2011, J INVEST MED, V59, P32; Robbins GK, 2009, CLIN INFECT DIS, V48, P350, DOI 10.1086/595888; Roul H, 2018, AIDS, V32, P2605, DOI [10.1097/QAD.0000000000002010, 10.1097/qad.0000000000002010]; Stafford KA, 2018, AIDS, V32, P25, DOI [10.1097/QAD.0000000000001663, 10.1097/qad.0000000000001663]; Takuva S, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.18651; Torti C, 2012, CLIN MICROBIOL INFEC, V18, P449, DOI 10.1111/j.1469-0691.2011.03650.x; Tsegaye A, 1999, CLIN DIAGN LAB IMMUN, V6, P410, DOI 10.1128/CDLI.6.3.410-414.1999; Viard JP, 2001, J INFECT DIS, V183, P1290, DOI 10.1086/319678; Wandeler G, 2013, AIDS, V27, P2225, DOI 10.1097/QAD.0b013e328362d887; Yamashita TE, 2001, AIDS, V15, P735, DOI 10.1097/00002030-200104130-00009; Yang XD, 2020, J LEUKOCYTE BIOL, V107, P597, DOI 10.1002/JLB.4MR1019-189R; Young J, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001194	56	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265740	10.1371/journal.pone.0265740	http://dx.doi.org/10.1371/journal.pone.0265740			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324948	Green Published, gold			2022-12-26	WOS:000780951300064
J	Guimaraes, RA; Policena, GM; de Paula, HDC; Pedroso, CF; Pinheiro, RS; Itria, A; Neto, ODB; Teixeira, AM; Silva, IA; de Oliveira, GA; Batista, KD				Guimaraes, Rafael Alves; Policena, Gabriela Moreira; Cintra de Paula, Hellen da Silva; Pedroso, Charlise Fortunato; Pinheiro, Raquel Silva; Itria, Alexander; Braga Neto, Olavo de Oliveira; Teixeira, Adriana Melo; Silva, Irisleia Aires; de Oliveira, Geraldo Andrade; Batista, Karla de Aleluia			Analysis of the impact of coronavirus disease 19 on hospitalization rates for chronic non-communicable diseases in Brazil	PLOS ONE			English	Article							COVID-19; REGRESSION; REDUCTION; MORTALITY; INCREASE	Background The coronavirus disease (COVID-19) pandemic has impacted health services and healthcare systems worldwide. Studies have shown that hospital admissions for causes related to chronic non-communicable diseases (NCDs) have decreased significantly during peak pandemic periods. An analysis of the impact of the COVID-19 pandemic on hospital admissions for NCDs is essential to implement disability and mortality mitigation strategies for these groups. Therefore, this study aimed to analyze the impact of the COVID-19 pandemic on hospital admissions for NCDs in Brazil according to the type of NCD, sex, age group, and region of Brazil. Methods This is an ecological study conducted in Brazil. Data on hospital admissions from January 1, 2017 to May 31, 2021 were extracted from the Unified Health System's Hospital Admissions Information System. The hospital admission rates per 100,000 thousand inhabitants were calculated monthly according to the type of NCD, sex, age group, and region of Brazil. Poisson regression models were used to analyze the impact of the COVID-19 pandemic on the number of hospital admissions. In this study, the pre-pandemic period was set from January 1, 2017 to February 29, 2020 and the during-pandemic from March 1, 2020 to May 31, 2021. Results There was a 27.0% (95.0%CI: -29.0; -25.0%) decrease in hospital admissions for NCDs after the onset of the pandemic compared to that during the pre-pandemic period. Decreases were found for all types of NCDs-cancer (-23.0%; 95.0%CI: -26.0; -21.0%), diabetes mellitus (-24.0%; 95.0%CI: -25.0%; -22.0%), cardiovascular diseases (-30.0%; 95.0% CI: -31.0%; -28.0%), and chronic respiratory diseases (-29.0%; 95.0%CI: -30.0%; -27.0%). In addition, there was a decrease in the number of admissions, regardless of the age group, sex, and region of Brazil. The Northern and Southern regions demonstrated the largest decrease in the percentage of hospital admissions during the pandemic period. Conclusions There was a decrease in the hospitalization rate for NCDs in Brazil during the COVID-19 pandemic in a scenario of social distancing measures and overload of health services.	[Guimaraes, Rafael Alves] Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil; [Guimaraes, Rafael Alves; Policena, Gabriela Moreira; Pinheiro, Raquel Silva] Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil; [Cintra de Paula, Hellen da Silva; Pedroso, Charlise Fortunato; Batista, Karla de Aleluia] Fed Inst Educ Sci & Technol Goias, Goiania Oeste Campus, Goiania, Go, Brazil; [Itria, Alexander] Univ Fed Sao Carlos, Sorocaba Campus, Sorocaba, SP, Brazil; [Braga Neto, Olavo de Oliveira; Teixeira, Adriana Melo; Silva, Irisleia Aires] Minist Hlth, Dept Hosp & Emergency Care, Brasilia, DF, Brazil; [de Oliveira, Geraldo Andrade] Fed Inst Educ Sci & Technol Goias, Valparaiso Campus, Valparaiso, Go, Brazil; [Batista, Karla de Aleluia] Univ Fed Goias, Inst Biol Sci 2, Goiania, Go, Brazil	Universidade Federal de Goias; Universidade Federal de Goias; Instituto Federal de Goias (IFG); Universidade Federal de Sao Carlos; Instituto Federal de Goias (IFG); Universidade Federal de Goias	Guimaraes, RA (corresponding author), Univ Fed Goias, Fac Nursing, Goiania, Go, Brazil.; Guimaraes, RA (corresponding author), Univ Fed Goias, Inst Trop Pathol & Publ Hlth, Goiania, Go, Brazil.	rafaelalves@ufg.br	; Batista, Karla A/J-3919-2014	Cintra de Paula, Hellen/0000-0003-2083-3651; Batista, Karla A/0000-0003-4396-032X	Brazilian Health Ministry [25000.038957/2020-10]	Brazilian Health Ministry	Brazilian Health Ministry, process grant number 25000.038957/2020-10. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3; [Anonymous], 2011, ICD 10 INT STAT CLAS; Aquino EML, 2020, CIENC SAUDE COLETIVA, V25, P2423, DOI 10.1590/1413-81232020256.1.10502020; Basu Saurav, 2020, Indian J Med Ethics, VV, P103, DOI 10.20529/IJME.2020.041; Belon AP, 2012, CIENC SAUDE COLETIVA, V17, P2279, DOI 10.1590/S1413-81232012000900010; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Birkmeyer JD, 2020, HEALTH AFFAIR, V39, P2010, DOI 10.1377/hlthaff.2020.00980; Blecker S, 2021, JAMA INTERN MED, V181, P269, DOI 10.1001/jamainternmed.2020.3978; Caristia S, 2020, EPIDEMIOL PREV, V44, P60, DOI 10.19191/EP20.5-6.S2.104; Chan KPF, 2020, RESP MED, V171, DOI 10.1016/j.rmed.2020.106085; Conti S, 2020, ERJ OPEN RES, V6, DOI 10.1183/23120541.00458-2020; da Costa AM, 2021, CANCER CONTROL, V28, DOI 10.1177/10732748211038736; da Fonseca EM, 2021, SOC SCI MED, V281, DOI 10.1016/j.socscimed.2021.114093; Danhieux K, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01326-3; Cardoso CRD, 2021, REV SOC BRAS MED TRO, V54, DOI 10.1590/0037-8682-0713-2020; De Filippo O, 2020, NEW ENGL J MED, V383, P88, DOI 10.1056/NEJMc2009166; De Negreiros RV, BRAZILIAN J DEV, V7, P77218, DOI [10.34117/bjdv7n8-100, DOI 10.34117/BJDV7N8-100]; Dorjee K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243191; Drumond Ede F, 2006, CAD SAUDE COLET RIO, P251; Du Pengqiang, 2021, Can J Infect Dis Med Microbiol, V2021, P6660930, DOI 10.1155/2021/6660930; Fonseca GA, 2021, JCO GLOB ONCOL, V7, P4, DOI 10.1200/GO.20.00471; GARDNER W, 1995, PSYCHOL BULL, V118, P392, DOI 10.1037/0033-2909.118.3.392; Hasan ATMH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0240385; Horton R, 2020, LANCET, V396, P874, DOI 10.1016/S0140-6736(20)32000-6; Instituto Brasileiro de Geografia e Estatistica, 2021, SIST IBGE REC AUT SI; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Leite JS, 2021, CIENC SAUDE COLETIVA, V26, P987, DOI 10.1590/1413-81232021263.39232020; Libruder C, 2021, NEUROEPIDEMIOLOGY, V55, P354, DOI 10.1159/000516753; Malta Deborah Carvalho, 2019, Rev. bras. epidemiol., V22, pe190030, DOI 10.1590/1980-549720190030; Maselli-Schoueri JH, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.0799; Ministry of Agriculture of the People's Republic of China, 2021, CHINA FISHERY STAT Y, P2; Nakvasina M.A., 2016, Vestn. Voronezh. Gos. Univ., Ser.: Khim., Biol., Farm., P67, DOI [DOI 10.1093/cid/ciaa344, DOI 10.1093/CID/CIAA344]; Nogueira PJ, 2020, ACTA MEDICA PORT, V33, P376, DOI 10.20344/amp.13928; Normando PG, 2021, ARQ BRAS CARDIOL, V116, P371, DOI 10.36660/abc.20200821; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; Rennert-May E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252441; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; da Silva LLS, 2020, CAD SAUDE PUBLICA, V36, DOI [10.1590/0102-311X00185020, 10.1590/0102-311x00185020]; Tomimatsu Maria Fátima Akemi Iwakura, 2009, Rev. Saúde Pública, V43, P413, DOI 10.1590/S0034-89102009005000019; Wambua S., 2021, PLoS Global Public Health, V2, DOI 10.1371/journal.pgph.0000029; Wright A, 2020, J GEN INTERN MED, V35, P2816, DOI 10.1007/s11606-020-06025-4	42	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265458	10.1371/journal.pone.0265458	http://dx.doi.org/10.1371/journal.pone.0265458			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324951	Green Published, gold			2022-12-26	WOS:000780951300044
J	Kelley, MB; Geddes, TJ; Ochiai, M; Lampl, NM; Kothmann, WW; Fierstein, SR; Kent, V; DeCicco-Skinner, K				Kelley, Mary B.; Geddes, Taylor J.; Ochiai, Maria; Lampl, Noah M.; Kothmann, W. Wade; Fierstein, Sara R.; Kent, Victoria; DeCicco-Skinner, Kathleen			Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes	PLOS ONE			English	Article							RANDOMIZED PHASE-II; CANCER-CELLS; LUNG-CANCER; KINASE; HER3; COMBINATION; MUTATIONS; BRAF; MET; CARCINOGENESIS	Cutaneous squamous cell carcinoma (cSCC) is the second most common form of skin cancer in the United States, affecting one million people per year. Patients with aggressive disease have limited treatment options and high mortality, highlighting the need to identify new biomarkers linked to poor clinical outcome. HRAS mutations are found in skin papillomas and cSCCs and increase in frequency when MAP3K family members are inhibited, suggesting a link between blockade of mitogen-activated protein kinase (MAPK) signaling and initiation of RAS-primed cells. Tpl2, a MAP3K gene, can serve as a tumor suppressor gene in cSCC. We have previously shown that upon Tpl2 ablation, mice have heightened sensitivity to aberrant RAS signaling. Tpl2(-/-) mice display significantly higher numbers of papillomas and cSCCs in two-stage chemical carcinogenesis studies and increased tumorigenicity of keratinocytes expressing oncogenic v-rasHa in nude mouse skin grafts. In part, this is mediated through increased mesenchymal-epithelial transition factor (MET) receptor activity. Epidermal Growth Factor Receptor (EGFR) is reported to be an essential factor for METdriven carcinogenesis and MET activation may confer resistance to EGFR therapies, suggesting that the concurrent use of both an EGFR inhibitor and a MET inhibitor may show promise in advanced cSCCs. In this study we assessed whether normal or Ras-transformed Tpl2(-/-) keratinocytes have aberrant EGFR signaling and whether concomitant treatment with EGFR/MET tyrosine kinase inhibitors was more effective than single agents in reducing growth and angiogenic potential of Ras-transformed keratinocytes. Tpl2(-/-) keratinocytes exhibited increased HER-2 and STAT-3 under basal conditions and elevated p-MET and pEGFR when transduced with oncogenic RAS. Inhibition of MET by Capmatinib increased pEGFR in Tpl2(-/-) keratinocytes and papillomas, and inhibition of EGFR by Gefitinib increased HER2 and HER3 signaling in both genotypes. Treatment of keratinocytes with EGFR and MET inhibitors, in combination, significantly enhanced endothelial tube formation, MMP-9 activity and activation of other RTKs, with more pronounced effects when Tpl2 was ablated. These data indicate that Tpl2 cross-talks with both EGFR and MET signaling pathways. Upon inhibition of EGFR/MET signaling, a myriad of escape mechanisms exists in keratinocytes to overcome targeted drug effects.	[Kelley, Mary B.; Geddes, Taylor J.; Ochiai, Maria; Lampl, Noah M.; Kothmann, W. Wade; Fierstein, Sara R.; Kent, Victoria; DeCicco-Skinner, Kathleen] American Univ, Dept Biol, Washington, DC 20016 USA	American University	DeCicco-Skinner, K (corresponding author), American Univ, Dept Biol, Washington, DC 20016 USA.	decicco@american.edu			U.S. Department of Health & Human Services, National Institutes of Health (NIH) [2R15CA152907-02]	U.S. Department of Health & Human Services, National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grant #2R15CA152907-02. U.S. Department of Health & Human Services, National Institutes of Health (NIH). The award was received by Kathleen DeCicco-Skinner. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abel EL, 2009, NAT PROTOC, V4, P1350, DOI 10.1038/nprot.2009.120; Abel EV, 2013, J CLIN INVEST, V123, P2155, DOI 10.1172/JCI65780; Balmain Allan, 2014, J Invest Dermatol, V134, pE2, DOI 10.1038/skinbio.2014.2; Belich MP, 1999, NATURE, V397, P363, DOI 10.1038/16946; Bonan NF, 2019, ONCOGENESIS, V8, DOI 10.1038/s41389-018-0109-8; Braicu C, 2019, CANCERS, V11, DOI 10.3390/cancers11101618; Canueto J, 2017, BRIT J DERMATOL, V176, P1279, DOI 10.1111/bjd.14936; Cataisson C, 2016, SCI SIGNAL, V9, DOI 10.1126/scisignal.aaf5106; Ceci JD, 1997, GENE DEV, V11, P688, DOI 10.1101/gad.11.6.688; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Corchado-Cobos R, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082956; Corso S, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-121; Cruickshanks N, 2019, CLIN CANCER RES, V25, P663, DOI 10.1158/1078-0432.CCR-18-0926; Cuevas BD, 2007, ONCOGENE, V26, P3159, DOI 10.1038/sj.onc.1210409; Dahlhoff M, 2017, J INVEST DERMATOL, V137, P921, DOI 10.1016/j.jid.2016.11.023; Dahlhoff M, 2015, MOL ONCOL, V9, P1825, DOI 10.1016/j.molonc.2015.06.007; DeCicco-Skinner KL, 2011, ONCOGENE, V30, P389, DOI 10.1038/onc.2010.447; DeCicco-Skinner KL, 2013, CARCINOGENESIS, V34, P2789, DOI 10.1093/carcin/bgt319; DeCicco-Skinner KL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056212; DeCicco-Skinner KL, 2014, JOVE-J VIS EXP, DOI 10.3791/51312; Dempke WCM, 2010, ANTICANCER RES, V30, P4673; Dey N, 2015, AM J TRANSL RES, V7, P733; DIGIOVANNI J, 1992, PHARMACOL THERAPEUT, V54, P63, DOI 10.1016/0163-7258(92)90051-Z; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Fania L, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9020171; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; FUJIKI H, 1989, MOL CARCINOGEN, V2, P184, DOI 10.1002/mc.2940020403; Gantke T, 2011, CELL RES, V21, P131, DOI 10.1038/cr.2010.173; Gellrich FF, 2019, J EUR ACAD DERMATOL, V33, P38, DOI 10.1111/jdv.16024; Guix M, 2008, J CLIN INVEST, V118, P2609, DOI 10.1172/JCI34588; Gusenbauer S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0319-z; Huang XP, 2010, CANCER RES, V70, P1204, DOI 10.1158/0008-5472.CAN-09-3321; Inman GJ, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06027-1; Kennedy SP, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00088; Krahn G, 2001, EUR J CANCER, V37, P251, DOI 10.1016/S0959-8049(00)00364-6; Lee S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21031102; Li YY, 2015, CLIN CANCER RES, V21, P1447, DOI 10.1158/1078-0432.CCR-14-1773; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Lomas A, 2012, BRIT J DERMATOL, V166, P1069, DOI 10.1111/j.1365-2133.2012.10830.x; Lyu H, 2018, ACTA PHARM SIN B, V8, P503, DOI [10.1016/j.apsh.2018.05.010, 10.1016/j.apsb.2018.05.010]; Matsumoto K, 2017, CANCER SCI, V108, P296, DOI 10.1111/cas.13156; Mishra R, 2018, ONCOL REV, V12, P45, DOI 10.4081/oncol.2018.355; Montero-Conde C, 2013, CANCER DISCOV, V3, P520, DOI 10.1158/2159-8290.CD-12-0531; Munoz-Maldonado C, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01088; Niederst MJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004652; Oberholzer PA, 2012, J CLIN ONCOL, V30, P316, DOI 10.1200/JCO.2011.36.7680; Ou SHI, 2017, J THORAC ONCOL, V12, P145, DOI 10.1016/j.jtho.2016.09.131; Pickering CR, 2014, CLIN CANCER RES, V20, P6582, DOI 10.1158/1078-0432.CCR-14-1768; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; ROOP DR, 1986, NATURE, V323, P822, DOI 10.1038/323822a0; Santini FC, 2017, TRANSL LUNG CANCER R, V6, P393, DOI 10.21037/tlcr.2017.04.06; Sequist LV, 2011, J CLIN ONCOL, V29, P3307, DOI 10.1200/JCO.2010.34.0570; Sergina NV, 2007, NATURE, V445, P437, DOI 10.1038/nature05474; Solomon B, 2017, J THORAC ONCOL, V12, P9, DOI 10.1016/j.jtho.2016.11.2214; South AP, 2014, J INVEST DERMATOL, V134, P2630, DOI 10.1038/jid.2014.154; Spigel DR, 2013, J CLIN ONCOL, V31, P4105, DOI 10.1200/JCO.2012.47.4189; Su F, 2012, NEW ENGL J MED, V366, P207, DOI 10.1056/NEJMoa1105358; Tanizaki J, 2011, BRIT J CANCER, V105, P807, DOI 10.1038/bjc.2011.322; Wee P, 2017, CANCERS, V9, DOI 10.3390/cancers9050052; Xu HY, 2019, CANCER MANAG RES, V11, P6343, DOI 10.2147/CMAR.S197337; YUSPA SH, 1994, CANCER RES, V54, P1178; Zhu GA, 2015, J AM ACAD DERMATOL, V73, P165, DOI 10.1016/j.jaad.2015.03.028	63	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266017	10.1371/journal.pone.0266017	http://dx.doi.org/10.1371/journal.pone.0266017			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325006	Green Published, gold			2022-12-26	WOS:000780951300093
J	Pradhan, MM; Pradhan, S; Dutta, A; Shah, NK; Valecha, N; Joshi, PL; Pradhan, K; Daumerie, PG; Banerji, J; Duparc, S; Mendis, K; Sharma, SK; Murugasampillay, S; Anvikar, AR				Pradhan, Madan M.; Pradhan, Sreya; Dutta, Ambarish; Shah, Naman K.; Valecha, Neena; Joshi, Pyare L.; Pradhan, Khageshwar; Daumerie, Penny Grewal; Banerji, Jaya; Duparc, Stephan; Mendis, Kamini; Sharma, Surya K.; Murugasampillay, Shiva; Anvikar, Anupkumar R.			Impact of the malaria comprehensive case management programme in Odisha, India	PLOS ONE			English	Article							ELIMINATION; PREVALENCE	Background The Comprehensive Case Management Project (CCMP), was a collaborative implementation research initiative to strengthen malaria early detection and complete treatment in Odisha State, India. Methods A two-arm quasi-experimental design was deployed across four districts in Odisha, representing a range of malaria endemicity: Bolangir (low), Dhenkanal (moderate), Angul (high), and Kandhamal (hyper). In each district, a control block received routine malaria control measures, whereas a CCMP block received a range of interventions to intensify surveillance, diagnosis, and case management. Impact was evaluated by difference-in-difference (DID) analysis and interrupted time-series (ITS) analysis of monthly blood examination rate (MBER) and monthly parasite index (MPI) over three phases: phase 1 pre-CCMP (20092012) phase 2 CCMP intervention (2013-2015), and phase 3 post-CCMP (2016-2017). Results During CCMP implementation, adjusting for control blocks, DID and ITS analysis indicated a 25% increase in MBER and a 96% increase in MPI, followed by a -47% decline in MPI postCCMP, though MBER was maintained. Level changes in MPI between phases 1 and 2 were most marked in Dhenkanal and Angul with increases of 976% and 287%, respectively, but declines in Bolangir (- 57%) and Kandhamal (- 22%). Between phase 2 and phase 3, despite the MBER remaining relatively constant, substantial decreases in MPI were observed in Dhenkanal (- 78%), and Angul (- 59%), with a more modest decline in Bolangir (- 13%), and an increase in Kandhamal (14%). Conclusions Overall, CCMP improved malaria early detection and treatment through the enhancement of the existing network of malaria services which positively impacted case incidence in three districts. In Kandhamal, which is hyperendemic, the impact was not evident. However, in Dhenkanal and Angul, areas of moderate-to-high malaria endemicity, CCMP interventions precipitated a dramatic increase in case detection and a subsequent decline in malaria incidence, particularly in previously difficult-to-reach communities.	[Pradhan, Madan M.; Pradhan, Sreya] Govt Odisha, Natl Vector Borne Dis Control Programme, Bhubaneswar, India; [Dutta, Ambarish] Indian Inst Publ Hlth, Bhubaneswar, India; [Dutta, Ambarish] Kalinga Inst Ind Technol, Bhubaneswar, India; [Shah, Naman K.] Univ N Carolina, Chapel Hill, NC 27515 USA; [Valecha, Neena; Sharma, Surya K.; Anvikar, Anupkumar R.] Natl Inst Malaria Res, New Delhi, India; [Joshi, Pyare L.] Gallup, Washington, DC USA; [Pradhan, Khageshwar] Natl Inst Malaria Res, Field Unit, Rourkela, India; [Daumerie, Penny Grewal; Banerji, Jaya; Duparc, Stephan] Med Malaria Venture, Geneva, Switzerland; [Murugasampillay, Shiva] Global Publ Hlth, Geneva, Switzerland	Indian Council of Medical Research (ICMR); ICMR - Vector Control Research Center (VCRC); Kalinga Institute of Industrial Technology (KIIT); University of North Carolina; University of North Carolina Chapel Hill; Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR)	Pradhan, MM (corresponding author), Govt Odisha, Natl Vector Borne Dis Control Programme, Bhubaneswar, India.	anvikar@gmail.com		Duparc, Stephan/0000-0002-9649-4847	Medicines for Malaria Venture	Medicines for Malaria Venture	The study was funded by Medicines for Malaria Venture with financial and scientific assistance provided to the National Vector Borne Disease Control Programme, Delhi, and National Vector Borne Disease Control Programme, Odisha. Authors from these institutions contributed to the study design, conduct, oversight, analysis and reporting as detailed in the author contributions. Naomi Richardson of Magenta Communications Ltd. developed a first draft of this article from an outline by AD, PGD and SP and a report developed by the authors and provided editorial and graphic services, and was funded by Medicines for Malaria Venture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], NATL VECTOR BORNE DI; Anuse SS, 2015, INDIAN J MED RES, V142, P71, DOI 10.4103/0971-5916.176628; Anvikar AR, 2016, AM J TROP MED HYG, V95, P108, DOI 10.4269/ajtmh.16-0163; Anvikar AR, 2014, INDIAN J MED RES, V139, P205; Aung PP, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-0632-7; Bal M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238323; Baliga BS, 2021, MALARIA J, V20, DOI 10.1186/s12936-021-03656-8; Bharti PK, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03402-6; Bousema T, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1001993; Brady O, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002453; Crowell V, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-4; Drakeley C, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002452; Galatas B, 2020, PLOS MED, V17, DOI 10.1371/journal.pmed.1003227; Gueye CS, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1518-9; Prat JGI, 2020, REV SOC BRAS MED TRO, V53, DOI 10.1590/0037-8682-0048-2020; Kumari P, 2020, AM J TROP MED HYG, V103, P1510, DOI 10.4269/ajtmh.20-0018; Landier J, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1399-y; Lek D, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03197-6; Linn AM, 2015, TROP MED INT HEALTH, V20, P1438, DOI 10.1111/tmi.12564; Mendis K, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2907-7; Mlacha YP, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03363-w; Napier HG, 2021, GLOB HEALTH-SCI PRAC, V9, pS98, DOI 10.9745/GHSP-D-20-00379; Panda B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221223; Pradhan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149126; Pradhan MM, 2019, J VECTOR DIS, V56, P56, DOI 10.4103/0972-9062.257776; Pradhan MM, 2019, J VECTOR DIS, V56, P53, DOI 10.4103/0972-9062.257775; Pradhan S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0208943; Rabinovich RN, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002456; Rae JD, 2019, MALARIA J, V18, DOI 10.1186/s12936-019-2677-2; Rahi M, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-004198; Rajvanshi H, 2021, T ROY SOC TROP MED H, V115, P1229, DOI 10.1093/trstmh/trab148; Rajvanshi H, 2020, MALARIA J, V19, DOI 10.1186/s12936-020-03458-4; Ramsay CR, 2003, INT J TECHNOL ASSESS, V19, P613, DOI 10.1017/S0266462303000576; Shretta R, 2017, MAJOR INFECT DIS, DOI 10.1596/978-1-4648-0524-0_ch12; Silumbe K, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0722-3; van Eijk AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53386-w; WHO, 2011, WORLD MALARIA REPORT 2011, P1; WHO, 2015, GLOB TECHN STRAT MAL	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265352	10.1371/journal.pone.0265352	http://dx.doi.org/10.1371/journal.pone.0265352			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324920	gold, Green Published			2022-12-26	WOS:000780951300037
J	Bizuayehu, H; Bitew, A; Abdeta, A; Ebrahim, S				Bizuayehu, Hiwot; Bitew, Adane; Abdeta, Abera; Ebrahim, Semira			Catheter-associated urinary tract infections in adult intensive care units at a selected tertiary hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							RISK-FACTORS; NOSOCOMIAL INFECTIONS; SURVEILLANCE; ENTEROBACTERIACEAE; EPIDEMIOLOGY; RESISTANCE; MORBIDITY; RATES	Background Catheter-associated urinary tract infection is the leading cause of hospital-acquired infections. They remain the second most common healthcare-associated infection in critically sick patients. Objective To determine the prevalence of catheter-associated urinary tract infection, the spectrum of etiological agents, antibiotic sensitivity profile of bacterial pathogens among adult patients admitted to intensive care units. Materials and methods Patients admitted to the intensive care unit of hospitals in Addis Ababa who were on urethral indwelling catheters for >48 hours from October 2020 to September 2021 were included in the study. Urine specimens were aseptically collected and processed as per standard protocols. Microorganisms were isolated, identified, and subjected to antibiotic susceptibility testing. Results In all 220 pateints included in the study development of significant bacteriuria/candiduria was not affected by sex, age, and prior antibiotic therapy. However, the length of stay in the intensive care unit was significantly associated with bacteriuria /candiduria (P-value < 0.001). The overall prevalence of bacteriuria/candiduria was 51.4% among which 21.0%, 19.1%, and 11.4% were bacteriuria, candiduria, and polymicrobial infections, respectively. About 138 organisms were recovered of which 79 (57.25%) were bacteria and 59 (42.75%) were yeast isolates. Acinetobacter species, Pseudomonas species, Klebsiella species E. coli, and Enterococcus species were the dominant bacterial isolates. Candida. albicans, Candida. krusei and Candida. tropicalis were the commonest yeasts. Many gram-negative bacterial isolates were resistant to ceftriaxone 36(94.7%), ampicillin 21(91.3%) followed by cefotaxime34(89.5%), amikacin (16.0%), nitrofurantoin (17.4%), meropenem (20.0%) and imipenem (20.0%). Out of 79 bacterial pathogens, 52(65.8%) were multiple antibiotic resistant of which 37(71.0%) were Gram-negative bacteria and 15(29%%) were Gram-positive bacteria. About 13(86.7%) isolates of Acinetobacter, all isolates of Klebsiella species (100%) and E. coli (100%) were multiple antibiotic-resistant. Out Of 18,10(55.56%), isolates of Enterococcus were multiple antibiotic-resistant. Conclusions A very high prevalence of bacteriuria/ candiduria was demonstrated in this study. This warrants the establishment of multidimensional infection control approach on catheter associated urinary tract infection in ICU. In addition to high prevalence of candiduria, recovery of non-albicans candida species almost in equal proportion with candida albicans in the present study was an important finding as non-albicans candida species distinct to C. albicans are intrinsically resistant to the commonly used azole antifungal drugs in Ethiopia. The prevalence of rate MDR bacteria in our ICU particularly of E. coli, Klebsiella spp, Pseudomonas and Acetobacter spp was very high. In order to combat this problem, proper antibiotic policies should be formulated.	[Bizuayehu, Hiwot] Addis Ababa Burn Emergency & Trauma Hosp, Dept Microbiol, Addis Ababa, Ethiopia; [Bitew, Adane] Addis Ababa Univ, Coll Hlth Sci, Dept Med Lab Sci, Addis Ababa, Ethiopia; [Abdeta, Abera; Ebrahim, Semira] Ethiopian Publ Hlth Inst, Natl Clin Bacteriol & Mycol Reference Lab, Addis Ababa, Ethiopia	Addis Ababa University	Bizuayehu, H (corresponding author), Addis Ababa Burn Emergency & Trauma Hosp, Dept Microbiol, Addis Ababa, Ethiopia.	hiwimd2@gmail.com						Alkilani A., 2016, BJMMR, V15, P1; Alvarez-Lerma F, 2003, INTENS CARE MED, V29, P1069, DOI 10.1007/s00134-003-1807-y; Aubron C, 2015, EPIDEMIOL INFECT, V143, P653, DOI 10.1017/S0950268814000934; Bagchi I., 2015, PEOPLES J SCIEN, V8, P23; Barchitta M, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16132253; Bearman GML, 2006, SEMIN RESP CRIT CARE, V27, P310, DOI 10.1055/s-2006-945534; Ben-Ami R, 2009, CLIN INFECT DIS, V49, P682, DOI 10.1086/604713; Bitew A, 2018, BMC WOMENS HEALTH, V18, DOI 10.1186/s12905-018-0607-z; Bradford PA, 2001, CLIN MICROBIOL REV, V14, P933, DOI 10.1128/CMR.14.4.933-951.2001; Brolund Alma, 2014, Infection Ecology & Epidemiology, V4, P24555, DOI 10.3402/iee.v4.24555; Burton DC, 2011, INFECT CONT HOSP EP, V32, P748, DOI 10.1086/660872; Cassini A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002150; CLSI, 2020, M100ED30 CLSI, DOI DOI 10.1016/S0196-4399(01)88009-0; Duszynska W, 2016, ANAESTH INTENSIVE TH, V48, P1, DOI 10.5603/AIT.2016.0001; European Centre for Disease Prevention and Control, 2016, SURV REP ANN EP REP, P11; Fahim NAE, 2021, J EGYPT PUBLIC HEAL, V96, DOI 10.1186/s42506-020-00065-8; Foxman B, 2002, AM J MED, V113, p5S; Galiczewski JM, 2017, INTENS CRIT CARE NUR, V40, P26, DOI 10.1016/j.iccn.2016.12.003; Hanumantha S, 2016, INDIAN J MICROBIOL R, V3, P454; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Kang CI, 2011, AM J INFECT CONTROL, V39, P135, DOI 10.1016/j.ajic.2010.03.022; Kauffman CA, 2005, CLIN INFECT DIS, V41, pS371, DOI 10.1086/430918; Kauffman CA, 2000, CLIN INFECT DIS, V30, P14, DOI 10.1086/313583; Kumar Neeraj, 2018, Int J Crit Illn Inj Sci, V8, P17, DOI 10.4103/IJCIIS.IJCIIS_24_17; Laupland KB, 2005, CRIT CARE, V9, pR60, DOI 10.1186/cc3023; Leblebicioglu H, 2013, AM J INFECT CONTROL, V41, P885, DOI 10.1016/j.ajic.2013.01.028; LujuYn CEM., 2016, THESIS U LA LAGUNA S; Malt Greg, 2007, Int J Nurs Pract, V13, P348, DOI 10.1111/j.1440-172X.2007.00649.x; Merle V, 2002, EUR UROL, V41, P483, DOI 10.1016/S0302-2838(02)00069-6; Negromote GR, 2015, REV SOC BRAS CLIN ME, V13, P90; Ozer B, 2011, MED SCI MONITOR, V17, pPH17, DOI 10.12659/MSM.881434; Passos XS, 2005, MEM I OSWALDO CRUZ, V100, P925, DOI 10.1590/S0074-02762005000800016; Perez F, 2013, CLEV CLIN J MED, V80, P225, DOI 10.3949/ccjm.80a.12182; Resende JCP, 2002, MYCOSES, V45, P306, DOI 10.1046/j.1439-0507.2002.00763.x; Rosser CJ, 1999, AM J SURG, V177, P287, DOI 10.1016/S0002-9610(99)00048-3; Salgado CD, 2003, PREVENTION CONTROL N, P297; Shah L. J., 2015, National Journal of Medical Research, V5, P71; Simpson C, 2004, J INFECTION, V49, P248, DOI 10.1016/j.jinf.2003.08.008; Tissot E, 2001, EUR J CLIN MICROBIOL, V20, P260, DOI 10.1007/s100960100480; Tutuncu EE, 2011, SAUDI MED J, V32, P489; Vinoth M, 2017, INT J RES MED SCI, V5, P2367; World Health Organization, 2016, HEALTHC ASS INF FACT; World Health Organization, 2021, 10 THREATS GLOB HLTH	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265102	10.1371/journal.pone.0265102	http://dx.doi.org/10.1371/journal.pone.0265102			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316286	gold, Green Published			2022-12-26	WOS:000834238000016
J	Almulla, L; Al-Naib, I; Ateeq, IS; Althobaiti, M				Almulla, Latifah; Al-Naib, Ibraheem; Ateeq, Ijlal Shahrukh; Althobaiti, Murad			Observation and motor imagery balance tasks evaluation: An fNIRS feasibility study	PLOS ONE			English	Article							NEAR-INFRARED SPECTROSCOPY; FALSE DISCOVERY RATE; PREFRONTAL CORTEX; CORTICAL ACTIVATION; PRECISION GAIT; BRAIN ACTIVITY; CHRONIC STROKE; WALKING; MIRROR	In this study, we aimed at exploring the feasibility of functional near-infrared spectroscopy (fNIRS) for studying the observation and/or motor imagination of various postural tasks. Thirteen healthy adult subjects followed five trials of static and dynamic standing balance tasks, throughout three different experimental setups of action observation (AO), a combination of action observation and motor imagery (AO+MI), and motor imagery (MI). During static and dynamic standing tasks, both the AO+MI and MI experiments revealed that many channels in prefrontal or motor regions are significantly activated while the AO experiment showed almost no significant increase in activations in most of the channels. The contrast between static and dynamic standing tasks showed that with more demanding balance tasks, relative higher activation patterns were observed, particularly during AO and in AO+MI experiments in the frontopolar area. Moreover, the AO+MI experiment revealed a significant difference in premotor and supplementary motor cortices that are related to balance control. Furthermore, it has been observed that the AO+MI experiment induced relatively higher activation patterns in comparison to AO or MI alone. Remarkably, the results of this work match its counterpart from previous functional magnetic resonance imaging studies. Therefore, they may pave the way for using the fNIRS as a diagnostic tool for evaluating the performance of the non-physical balance training during the rehabilitation period of temporally immobilized patients.	[Almulla, Latifah; Al-Naib, Ibraheem; Ateeq, Ijlal Shahrukh; Althobaiti, Murad] Imam Abdulrahman Bin Faisal Univ, Coll Engn, Biomed Engn Dept, Dammam, Saudi Arabia; [Almulla, Latifah] King Abdullah Univ Sci & Technol, Biol & Environm Sci & Engn Div, Organ Bioelect Lab, Thuwal, Saudi Arabia	Imam Abdulrahman Bin Faisal University; King Abdullah University of Science & Technology	Althobaiti, M (corresponding author), Imam Abdulrahman Bin Faisal Univ, Coll Engn, Biomed Engn Dept, Dammam, Saudi Arabia.	mmalthobaiti@iau.edu.sa	; Althobaiti, Murad/K-4708-2018	Al-Naib, Ibraheem/0000-0002-7499-0655; Almulla, Latifah/0000-0003-3165-8561; Ateeq, Ijlal Shahrukh/0000-0002-3404-0508; Althobaiti, Murad/0000-0002-8084-6916	Deanship of Scientific Research at Imam Abdulrahman Bin Faisal University, Saudi Arabia [2019-013-Eng]	Deanship of Scientific Research at Imam Abdulrahman Bin Faisal University, Saudi Arabia	This work was supported by the Deanship of Scientific Research at Imam Abdulrahman Bin Faisal University, Saudi Arabia under project number 2019-013-Eng. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalmalak A, 2020, NEUROSCI LETT, V714, DOI 10.1016/j.neulet.2019.134607; Al-Shargie F, 2016, BIOMED OPT EXPRESS, V7, P3882, DOI 10.1364/BOE.7.003882; Almulla L, 2020, BIOMED PHYS ENG EXPR, V6, DOI 10.1088/2057-1976/aba102; Arenth PM, 2007, CLIN NEUROPSYCHOL, V21, P38, DOI 10.1080/13854040600878785; Babiloni C, 2009, INT REV NEUROBIOL, V86, P67, DOI 10.1016/S0074-7742(09)86005-4; Bang DH, 2013, CLIN REHABIL, V27, P1118, DOI 10.1177/0269215513501528; Barker JW, 2013, BIOMED OPT EXPRESS, V4, P1366, DOI 10.1364/BOE.4.001366; Batula AM, 2017, COMPUT INTEL NEUROSC, V2017, DOI 10.1155/2017/5491296; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brassard P, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00204; Chiarelli AM, 2017, NEUROPHOTONICS, V4, DOI [10.1117/1.NPh.4.4.041411, 10.1117/1.NPh.4.4.041411]]; Cho HY, 2013, CLIN REHABIL, V27, P675, DOI 10.1177/0269215512464702; Chul J, 2009, NEUROIMAGE, V44, P428, DOI 10.1016/j.neuroimage.2008.08.036; Condy EE, 2021, FRONT HUM NEUROSCI, V15, DOI 10.3389/fnhum.2021.627983; Crosson B, 2010, J REHABIL RES DEV, V47, pVII, DOI 10.1682/JRRD.2010.02.0017; Ferrari M, 2014, BRAIN TOPOGR, V27, P353, DOI 10.1007/s10548-013-0320-z; Ferrari M, 2012, NEUROIMAGE, V63, P921, DOI 10.1016/j.neuroimage.2012.03.049; Fujimoto H, 2014, NEUROIMAGE, V85, P547, DOI 10.1016/j.neuroimage.2013.05.014; Gatti Roberto, 2019, Arch Physiother, V9, P1, DOI 10.1186/s40945-018-0053-0; Granacher U, 2011, GERONTOLOGY, V57, P304, DOI 10.1159/000320250; Grezes J, 2003, NEUROIMAGE, V18, P928, DOI 10.1016/S1053-8119(03)00042-9; Hamel MF, 2005, AGING CLIN EXP RES, V17, P223; HE B., 2013, NEURAL ENG; He B, 2011, IEEE T BIO-MED ENG, V58, P1918, DOI 10.1109/TBME.2011.2139210; Herold F, 2018, J CLIN MED, V7, DOI 10.3390/jcm7120466; Herold F, 2017, HUM MOVEMENT SCI, V51, P51, DOI 10.1016/j.humov.2016.11.002; Higuchi S, 2012, NEUROIMAGE, V59, P1668, DOI 10.1016/j.neuroimage.2011.09.021; Holper L, 2011, EUR J NEUROSCI, V33, P2318, DOI 10.1111/j.1460-9568.2011.07720.x; Hoppes CW, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193710; Huppert TJ, 2016, NEUROPHOTONICS, V3, DOI 10.1117/1.NPh.3.1.010401; Ihme K, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00327; Irani F, 2007, CLIN NEUROPSYCHOL, V21, P9, DOI 10.1080/13854040600910018; Jacques SL, 2013, PHYS MED BIOL, V58, pR37, DOI 10.1088/0031-9155/58/11/R37; Jeannerod M, 2001, NEUROIMAGE, V14, pS103, DOI 10.1006/nimg.2001.0832; JOBSIS FF, 1977, SCIENCE, V198, P1264, DOI 10.1126/science.929199; Karim H, 2012, GAIT POSTURE, V35, P367, DOI 10.1016/j.gaitpost.2011.10.007; Kempny AM, 2016, NEUROIMAGE-CLIN, V12, P312, DOI 10.1016/j.nicl.2016.07.013; Kim JC, 2018, J MOTOR BEHAV, V50, P373, DOI 10.1080/00222895.2017.1363697; Koenraadt KLM, 2014, NEUROIMAGE, V85, P415, DOI 10.1016/j.neuroimage.2013.04.070; Kotegawa K, 2021, BEHAV BRAIN RES, V399, DOI 10.1016/j.bbr.2020.113046; Kotegawa K, 2020, EXP BRAIN RES, V238, P221, DOI 10.1007/s00221-019-05706-9; Lin CC, 2017, EXP BRAIN RES, V235, P1247, DOI 10.1007/s00221-017-4893-8; Mahoney JR, 2016, BRAIN RES, V1633, P126, DOI 10.1016/j.brainres.2015.10.053; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; Menant JC, 2020, GAIT POSTURE, V82, P254, DOI 10.1016/j.gaitpost.2020.09.012; Mihara M, 2008, NEUROIMAGE, V43, P329, DOI 10.1016/j.neuroimage.2008.07.029; Miyai I, 2001, NEUROIMAGE, V14, P1186, DOI 10.1006/nimg.2001.0905; Moro SB, 2014, NEUROIMAGE, V85, P451, DOI 10.1016/j.neuroimage.2013.05.031; Mouthon A, 2018, NEURAL PLAST, V2018, DOI 10.1155/2018/1598178; Mouthon A, 2015, NEUROSCIENCE, V303, P535, DOI 10.1016/j.neuroscience.2015.07.031; Nicholson V, 2019, J PHYSIOTHER, V65, P200, DOI 10.1016/j.jphys.2019.08.007; Obrig H, 2003, J CEREBR BLOOD F MET, V23, P1, DOI 10.1097/01.WCB.0000043472.45775.29; Olsson CJ, 2008, SCAND J PSYCHOL, V49, P133, DOI 10.1111/j.1467-9450.2008.00625.x; Peirce JW, 2007, J NEUROSCI METH, V162, P8, DOI 10.1016/j.jneumeth.2006.11.017; Rahimpour A, 2020, J NEUROSCI METH, V341, DOI 10.1016/j.jneumeth.2020.108790; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Rosso AL, 2017, GAIT POSTURE, V57, P193, DOI 10.1016/j.gaitpost.2017.06.013; Santosa H, 2018, ALGORITHMS, V11, DOI 10.3390/a11050073; Sherrington C, 2008, J AM GERIATR SOC, V56, P2234, DOI 10.1111/j.1532-5415.2008.02014.x; Singh AK, 2006, NEUROIMAGE, V33, P542, DOI 10.1016/j.neuroimage.2006.06.047; St George RJ, 2021, NEUROSCIENCE, V452, P208, DOI 10.1016/j.neuroscience.2020.10.027; Suzuki M, 2004, NEUROIMAGE, V23, P1020, DOI 10.1016/j.neuroimage.2004.07.002; Taroni P, 2003, PHOTOCH PHOTOBIO SCI, V2, P124, DOI 10.1039/b209651j; Taube W, 2015, CORTEX, V64, P102, DOI 10.1016/j.cortex.2014.09.022; Taube W, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00972; Tia B, 2010, NEUROSCI LETT, V480, P138, DOI 10.1016/j.neulet.2010.06.026; Vanzella P, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00164; Visschedijk J, 2010, J AM GERIATR SOC, V58, P1739, DOI 10.1111/j.1532-5415.2010.03036.x; Morais GAZ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21716-z	69	0	0	7	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265898	10.1371/journal.pone.0265898	http://dx.doi.org/10.1371/journal.pone.0265898			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320324	Green Published, gold			2022-12-26	WOS:000784240600008
J	Gillespie, JM; Stephens, MJ; Chang, W; Warden, JG				Gillespie, Janice M.; Stephens, Michael J.; Chang, Will; Warden, John G.			Mapping aquifer salinity gradients and effects of oil field produced water disposal using geophysical logs: Elk Hills, Buena Vista and Coles Levee Oil Fields, San Joaquin Valley, California	PLOS ONE			English	Article								The effects of oil and gas production on adjacent groundwater quality are becoming a concern in many areas of the United States. As a result, it has become increasingly important to identify which aquifers require monitoring and protection. In this study, we map the extent of groundwater with less than 10,000 mg/L TDS both laterally and vertically near the Elk Hills, Buena Vista and Coles Levee Oil Fields in the San Joaquin Valley, California and note evidence of effects of produced water disposal on salinity within the Tulare aquifer. Subsurface maps showing the depth at which groundwater salinity is less than 10,000 mg/L (or Base 10K) in the Tulare aquifer are generated using geophysical logs and verified by comparison to water sample analyses. The depth to Base 10K ranges from 240 m (800 ft) in Elk Hills to 800 m (2650 ft) in the adjacent Buena Vista syncline and is 670 m (2,200 ft) deep in the Coles Levee area to the east. Log-calculated salinities show a relatively smooth increase with depth prior to disposal activities whereas salinities calculated from logs collected near and after disposal activities show a more variable salinity profile with depth. The effect of produced water injection is represented by log resistivity profiles that change from low resistivity at the base of the sand to higher resistivity near the top due to density differences between the saline produced water and the brackish groundwater within each sand. Continued post-disposal logging in new wells in the 18G disposal area on the south flank of Elk Hills shows that injected water has migrated approximately 1,200 m (4,000 ft) downdip (south) over a period of 20 years since the inception of disposal activity.	[Gillespie, Janice M.; Warden, John G.] US Geol Survey, San Diego, CA 92101 USA; [Stephens, Michael J.] US Geol Survey, Calif Water Sci Ctr, Sacramento, CA USA; [Chang, Will] Hypergradient LLC, Berkeley, CA USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Gillespie, JM (corresponding author), US Geol Survey, San Diego, CA 92101 USA.	jmgillespie@usgs.gov		Gillespie, Janice/0000-0003-1667-3472; Stephens, Michael J/0000-0001-8995-9928; Warden, John/0000-0003-1384-458X				Abadi M., 2016, TENSORFLOW LARGE SCA; Archie GE, 1942, T AM I MIN MET ENG, V146, P54, DOI 10.2118/942054-G; Asquith G.B., 2004, BASIC WELL LOG ANAL, V2; Atwater T., 1970, GEOL SOC AM BULL, V81, P3513, DOI [DOI 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2, 10.1130/0016-7606(1970)81[3513:IOPTFT]2.0.CO;2]; Bartow JA, 1991, 1501 US GEOL SOC; Bateman RM., 1977, LOG ANAL, V18, P3; Borkovich G.J, 1958, SUMMARY OPERATIONS D, V44, P5; California Department of Water Resources (DWR), 2020, PER GROUNDW LEV MEAS; California Geologic Energy Management Division, 2020, WELL SEARCH; California Geologic Energy Management Division (CalGEM), 1998, CAL OIL GAS FIELDS, V1; California Geologic Energy Management Division (CalGEM), 2019, 2018 REP CAL OIL GAS; California Resources Corporation, 2016, ELK HILLS OILF PHAS; California State Water Resources Control Board, 2018, WAT QUAL AR OIL GAS; Croft M.G, 1972, US GEOLOGICAL SURVEY; Dale RH, 1966, US GEOLOGICAL SURVEY; Domenico P.A., 1998, PHYS CHEM HYDROGEOLO, P506; Eastern Municipal Water District (EMWD), 2013, EMWD DES PROGR; Faunt C.C., 2009, US GEOLOGICAL SURVEY, DOI DOI 10.3133/PP1766; Fiore PE, 2007, AAPG BULL, V91, P321, DOI 10.1306/11010606030; Fram MS., 2007, US GEOLOGICAL SURVEY, V301; FRINK JW, 1954, AAPG BULL, V38, P2357; Gillespie J. M., 2019, ENV GEOSCI, V26, P73, DOI DOI 10.1306/EG.02271918009; Gillespie J, 2017, AAPG BULL, V101, P1239, DOI 10.1306/09021616043; GRAHAM SA, 1985, AAPG BULL, V69, P385; Hamlin HS., 2015, GULF COAST ASS GEOL, V4, P109; Hardoin JL., 1962, SUMM OPER CALIF OIL, V48, P53; Howells L., 1987, SALT LAKE CITY UTAH, V92, P59; ICF, 2018, 0014512 ICF; Jones CL, 1997, GEOLOGY W CORDILLERA, V82, P4956; King DB, 2015, ACS SYM SER, V1214, P1; Kiser SC, 1988, CALIFORNIA SELECTED, V7, P14; Leitz F, 2011, 65 US BUR RECL DES W; Lettis WR, 1982, US GEOLOGICAL SURVEY; Magoon LB, 2007, PETROLEUM SYSTEMS GE; Maher JC., 1975, GEOL SURV PROF PAPER, V912, P109, DOI [10.3133/pp912, DOI 10.3133/PP912]; McCann H., 2018, ALTERNATIVE WATER SU; McJannett GS, 1996, 35670 SOC PETR ENG; McMahon PB, 2018, APPL GEOCHEM, V98, P127, DOI 10.1016/j.apgeochem.2018.09.015; Mendenhall WC, 1916, US GEOLOGICAL SURVEY; Meyerholtz K, 2016, FINDING NEW OILFIELD; Mickley M., 2012, IDA J DESALINATION W, V4, P44, DOI [10.1179/ida.2012.4.1.44, DOI 10.1179/IDA.2012.4.1.44]; Miller DD, 1999, THESIS STANFORD U CA; Milliken M, 1992, GEOLOGY GEOHYDROLOGY; Mitchell DC, 1989, CALIFORNIA DEP CONSE; Morris AP, 2012, AAPG BULL, V96, P1001, DOI 10.1306/10241111030; OBryan PL, 1992, 24084 SOC PETR ENG, P555; Page RW, 2015, BASE FRESH GROUND WA, V489, P1973; Page RW, 1986, US GEOLOGICAL SURVEY; Rasmussen CE, 2005, ADAPT COMPUT MACH LE, P1; Reid SA, 2018, PAC SECT AM ASS GEOL; Reid SA, 1995, CENOZOIC PALEOGEOGRA, P131; Scheirer AH, 2007, PETROLEUM SYSTEMS GE; SCHINCARIOL RA, 1990, WATER RESOUR RES, V26, P2317, DOI 10.1029/WR026i010p02317; Schlumberger, 1989, LOG INTERPRETATION P; Shelton JL., 2008, DATA SERIES, V337; Stephens MJ., GEOPHYSICAL GEOLOGIC; Swartz R. J., 1996, ENV GEOSCI, V3, P143; U.S. Environmental Protection Agency, 2018, AQ EX UND INJ CONTR; Williamson A. K., 1989, US GEOLOGICAL SURVEY; WINSAUER WO, 1952, AAPG BULL, V36, P253; Wood Environment and Infrastructure Solutions Inc, 2020, 1 SEM 2020 INT SB4 G; Wood PR, 1959, 1457 USGS; Wood PR, 1964, 1656 CAL WAT; Woodring WP, 1932, USGS BULL, V835; WYLLIE MRJ, 1950, T AM I MIN MET ENG, V189, P105	65	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263477	10.1371/journal.pone.0263477	http://dx.doi.org/10.1371/journal.pone.0263477			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344541	gold, Green Published			2022-12-26	WOS:000788055200019
J	Hintschich, CA; Fischer, R; Hummel, T; Wenzel, JJ; Bohr, C; Vielsmeier, V				Hintschich, Constantin A.; Fischer, Rene; Hummel, Thomas; Wenzel, Juergen J.; Bohr, Christopher; Vielsmeier, Veronika			Persisting olfactory dysfunction in post-COVID-19 is associated with gustatory impairment: Results from chemosensitive testing eight months after the acute infection	PLOS ONE			English	Article							CHEMICAL SENSES; TASTE; COVID-19; SMELL	Olfactory and gustatory disorders are prominent symptoms of acute COVID-19. Although both senses recover in many patients within weeks to months, persistency has been described in up to 60%. However up to now most reports on the course of chemosensitive disorders after COVID-19 are not based on psychophysical testing but only on subjective patients' ratings. In this study we assessed both olfaction and gustation using psychophysical tests eight months after COVID-19. Validated psychophysical testing revealed hyposmia in 18% and hypogeusia in even 32% of 303 included patients. This shows that olfactory and especially gustatory disorders have to be seen as important chronic symptoms post-COVID-19. The high prevalence of gustatory dysfunction indicates that gustatory function does not recover or might even deteriorate in the months following the acute infection.	[Hintschich, Constantin A.; Fischer, Rene; Bohr, Christopher; Vielsmeier, Veronika] Regensburg Univ Hosp, Dept Otorhinolaryngol, Regensburg, Germany; [Hummel, Thomas] Tech Univ Dresden, Smell & Taste Clin, Dept Otorhinolaryngol, Dresden, Germany; [Wenzel, Juergen J.] Regensburg Univ Hosp, Inst Clin Microbiol & Hyg, Regensburg, Germany	University of Regensburg; Technische Universitat Dresden; University of Regensburg	Hintschich, CA (corresponding author), Regensburg Univ Hosp, Dept Otorhinolaryngol, Regensburg, Germany.	constantin.hintschich@klinik.uni-regensburg.de		Wenzel, Jurgen/0000-0001-8422-6581	Bavarian State Ministry for Science and Art	Bavarian State Ministry for Science and Art	: Constantin A. Hintschich and Veronika Vielsmeier received funding by a grant for COVID-19 related research of the Bavarian State Ministry for Science and Art (https://www.stmwk.bayern.de/ englisch.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. months tial to ratings COVID-19 results	Amanat M, 2021, BMC NEUROL, V21, DOI 10.1186/s12883-021-02152-5; Besser G, 2019, RHINOLOGY, V57, P385, DOI 10.4193/Rhin19.021; Biadsee A, 2021, AM J OTOLARYNG, V42, DOI 10.1016/j.amjoto.2021.103065; Boesveldt S, 2011, RHINOLOGY, V49, P324, DOI 10.4193/Rhino10.155; Boscolo-Rizzo P, 2021, CHEM SENSES, V46, DOI 10.1093/chemse/bjab006; Cooper KW, 2020, NEURON, V107, P219, DOI 10.1016/j.neuron.2020.06.032; D'Ascanio L, 2021, OTOLARYNG HEAD NECK, V164, P82, DOI 10.1177/0194599820943530; Doty RL, 2004, OTOLARYNG CLIN N AM, V37, P1229, DOI 10.1016/j.otc.2004.05.002; Gudziol H, 2007, LARYNGO RHINO OTOL, V86, P640, DOI 10.1055/s-2007-966228; Haehner A, 2020, ORL J OTO-RHINO-LARY, V82, P175, DOI 10.1159/000509143; Han PF, 2018, RHINOLOGY, V56, P158, DOI 10.4193/Rhin17.186; Herridge MS, 2016, INTENS CARE MED, V42, P725, DOI 10.1007/s00134-016-4321-8; Hintschich CA, 2022, INT FORUM ALLERGY RH, V12, P210, DOI 10.1002/alr.22902; Hintschich CA, 2020, INT FORUM ALLERGY RH, V10, P1105, DOI 10.1002/alr.22655; Hopkins C, 2021, RHINOLOGY, V59, DOI 10.4193/Rhin20.544; Huart C, 2020, RHINOLOGY, V58, P623, DOI 10.4193/Rhin20.251; Iannuzzi L, 2020, CHEM SENSES, V45, P875, DOI 10.1093/chemse/bjaa066; Klein H, 2021, CLIN MICROBIOL INFEC, V27, P769, DOI 10.1016/j.cmi.2021.02.008; Landis BN, 2010, J NEUROL, V257, P1303, DOI 10.1007/s00415-010-5513-8; Le Bon SD, 2021, INT FORUM ALLERGY RH, V11, P1504, DOI 10.1002/alr.22815; Lechien JR, 2021, EUR ARCH OTO-RHINO-L, V278, P2851, DOI 10.1007/s00405-020-06548-w; Leedman SR, 2021, J LARYNGOL OTOL, V135, P839, DOI 10.1017/S0022215121002085; Liu G, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-013246; Lundstrom JN, 2011, ACS CHEM NEUROSCI, V2, P5, DOI 10.1021/cn1000843; Migneault-Bouchard C, 2020, J NEUROL, V267, P138, DOI 10.1007/s00415-019-09564-x; Monti G, 2021, ACTA ANAESTH SCAND, V65, P912, DOI 10.1111/aas.13812; Mueller C, 2003, RHINOLOGY, V41, P2; Niklassen AS, 2021, LARYNGOSCOPE, V131, P1095, DOI 10.1002/lary.29383; Paderno A, 2020, OTOLARYNG HEAD NECK, V163, P1144, DOI 10.1177/0194599820939538; Parma V, 2020, CHEM SENSES, V45, P609, DOI 10.1093/chemse/bjaa041; Petrocelli M, 2021, J LARYNGOL OTOL, V135, P436, DOI 10.1017/S002221512100116X; Rawal S, 2015, CHEMOSENS PERCEPT, V8, P138, DOI 10.1007/s12078-015-9194-7; Sayin P, 2021, ENT-EAR NOSE THROAT, V100, p174S, DOI 10.1177/0145561320977464; Singer-Cornelius T, 2021, EUR ARCH OTO-RHINO-L, V278, P3325, DOI 10.1007/s00405-020-06590-8; Soriano JB, 2022, LANCET INFECT DIS, V22, pE102, DOI 10.1016/S1473-3099(21)00703-9; Spence C, 2020, FOODS, V9, DOI 10.3390/foods9040407; Taylor AJ, 2020, COMPR REV FOOD SCI F, V19, P3439, DOI 10.1111/1541-4337.12633; Tomita H, 2002, ACTA OTO-LARYNGOL, V122, P116, DOI 10.1080/00016480260046490; Vennemann MM, 2008, J NEUROL, V255, P1121, DOI 10.1007/s00415-008-0807-9; von Bartheld CS, 2020, ACS CHEM NEUROSCI, V11, P2944, DOI 10.1021/acschemneuro.0c00460; Welge-Lussen A, 2011, J NEUROL, V258, P386, DOI 10.1007/s00415-010-5763-5; Wolf A, 2016, INT FORUM ALLERGY RH, V6, P362, DOI 10.1002/alr.21681	42	3	3	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265686	10.1371/journal.pone.0265686	http://dx.doi.org/10.1371/journal.pone.0265686			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320821	Green Published, gold			2022-12-26	WOS:000784240600024
J	Riiser, K; Richardsen, KR; Haraldstad, K; Helseth, S; Torbjornsen, A				Riiser, Kirsti; Richardsen, Kare Ronn; Haraldstad, Kristin; Helseth, Solvi; Torbjornsen, Astrid			"It's hard to keep a distance when you're with someone you really care about"-A qualitative study of adolescents' pandemic-related health literacy and how Covid-19 affects their lives	PLOS ONE			English	Article							OF-LIFE; US	PurposeThe aim of this study was to explore how adolescents accessed, understood, appraised, and applied information on pandemic preventive measures, how their lives were impacted by long-lasting regulations and how they described their quality of life. MethodsA qualitative design with focus group interviews was used to elaborate on the quantitative survey results obtained and analyzed in a previous survey study from the first phase of the Covid-19 pandemic. Five focus groups with seventeen adolescents were conducted digitally during the second pandemic phase in November and December 2020. The interview data were analyzed with directed content analysis. ResultsThe adolescents reported using traditional media and official websites as sources for Covid-19 information. They engaged in preventive behavior, and washing hands and keeping a distance from strangers had become a habit. However, not being physically close to friends felt strange and unpleasant. The measure most frequently discussed was limiting social contact, which was a constant struggle. No one disputed the authorities' guidelines and rules, but the social restrictions caused boredom and despair, particularly due to interrupted schooling and missed opportunities to engage in life events, and freely socialize with friends. ConclusionThe adolescents gave an overall impression of being health literate, which corresponds well with the results from our previous survey study. Their descriptions of how they translated protective measures into their everyday lives demonstrate that they took responsibility and accepted personal costs for the collective good. However, life with social restrictions decreased their quality of life.	[Riiser, Kirsti; Richardsen, Kare Ronn] OsloMet Oslo Metropolitan Univ, Fac Hlth, Dept Physiotherapy, Oslo, Norway; [Haraldstad, Kristin] Univ Agder, Fac Hlth & Sports Sci, Dept Hlth & Nursing Sci, Kristiansand, Norway; [Helseth, Solvi; Torbjornsen, Astrid] OsloMet Oslo Metropolitan Univ, Fac Hlth, Dept Nursing & Hlth Promot, Oslo, Norway	Oslo Metropolitan University (OsloMet); University of Agder; Oslo Metropolitan University (OsloMet)	Riiser, K (corresponding author), OsloMet Oslo Metropolitan Univ, Fac Hlth, Dept Physiotherapy, Oslo, Norway.	kiri@oslomet.no	Richardsen, Kåre Rønn/P-3406-2017	Richardsen, Kåre Rønn/0000-0002-5911-4876; Riiser, Kirsti/0000-0002-0801-1121; Torbjornsen, Astrid/0000-0003-2385-2452				Abel T., 2020, CRITICAL HLTH LITERA; [Anonymous], 2020, NORWEGIAN CITIZEN PA; Branquinho C, 2020, J COMMUNITY PSYCHOL, V48, P2740, DOI 10.1002/jcop.22453; Bukowski W.M., 2018, HDB PEER INTERACTION; Bullinger M, 2002, INT J REHABIL RES, V25, P197, DOI 10.1097/00004356-200209000-00005; Burke M, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1909; Christensen T, 2020, PUBLIC ADMIN REV, V80, P774, DOI 10.1111/puar.13241; Creswell J, 2003, HDB MIXED METHODS DE, P209; Dyregrov A, 2021, J LOSS TRAUMA, V26, P597, DOI 10.1080/15325024.2020.1853974; Hafstad G. S., 2020, SCAND J WORK ENV HEA, DOI [10.2139/ssrn.3727297, DOI 10.2139/SSRN.3727297]; Helseth S, 2010, J CLIN NURS, V19, P1454, DOI 10.1111/j.1365-2702.2009.03069.x; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Jones EAK, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052470; Krok D, 2018, J ADULT DEV, V25, P96, DOI 10.1007/s10804-017-9280-y; Lee K, 2009, GLOB INST, P1; Leigh-Hunt N, 2017, PUBLIC HEALTH, V152, P157, DOI 10.1016/j.puhe.2017.07.035; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Nearchou F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17228479; Norwegian Institute of Public Health`, COR FACTS ADV MEAS; O'Sullivan K, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18031062; OECD, YOUTH INT JUST; Oosterhoff B, 2020, JAMA PEDIATR, V174, P1184, DOI 10.1001/jamapediatrics.2020.1876; Oosterhoff B, 2020, J ADOLESCENT HEALTH, V67, P179, DOI 10.1016/j.jadohealth.2020.05.004; Orben A, 2020, LANCET CHILD ADOLESC, V4, P634, DOI 10.1016/S2352-4642(20)30186-3; Paakkari L, 2020, LANCET PUBLIC HEALTH, V5, pE249, DOI 10.1016/S2468-2667(20)30086-4; Ravens-Sieberer U, 2022, EUR CHILD ADOLES PSY, V31, P879, DOI 10.1007/s00787-021-01726-5; Riiser K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0238161; Rogers AA, 2021, J ADOLESCENT HEALTH, V68, P43, DOI 10.1016/j.jadohealth.2020.09.039; Sawyer SM, 2018, LANCET CHILD ADOLESC, V2, P223, DOI 10.1016/S2352-4642(18)30022-1; Scott SR, 2021, J ADOLESCENT HEALTH, V68, P262, DOI 10.1016/j.jadohealth.2020.11.010; Sheldon KM, 1999, J PERS SOC PSYCHOL, V76, P482, DOI 10.1037/0022-3514.76.3.482; Sorensen K., 2019, INT HDB HLTH LITERAC; The Kidscreen Group Europe, 2006, KIDSCREEN QUESTIONNA; Tsao SF, 2021, LANCET DIGIT HEALTH, V3, pE175, DOI 10.1016/S2589-7500(20)30315-0; University of Oslo, SERV SENS DAT TSD; Verduyn P, 2017, SOC ISS POLICY REV, V11, P274, DOI 10.1111/sipr.12033; von Soest T., 2020, TIDSSKR LAEGEFOREN; World Health Organization, WHOQOL MEAS QUAL LIF; Yang XY, 2020, CHILDREN-BASEL, V7, DOI 10.3390/children7120311; Zarocostas J, 2020, LANCET, V395, P676, DOI 10.1016/S0140-6736(20)30461-X	40	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266510	10.1371/journal.pone.0266510	http://dx.doi.org/10.1371/journal.pone.0266510			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363837	Green Submitted, Green Published, gold			2022-12-26	WOS:000804748600054
J	Sinn, CLJ; Sultan, H; Turcotte, LA; McArthur, C; Hirdes, JP				Sinn, Chi-Ling Joanna; Sultan, Heebah; Turcotte, Luke Andrew; McArthur, Caitlin; Hirdes, John P.			Patterns of home care assessment and service provision before and during the COVID-19 pandemic in Ontario, Canada	PLOS ONE			English	Article							MINIMUM DATA SET; HEALTH; PEOPLE; SCALE	ObjectiveThe objective was to compare home care episode, standardised assessment, and service patterns in Ontario's publicly funded home care system during the first wave of the COVID-19 pandemic (i.e., March to September 2020) using the previous year as reference. Study design and settingWe plotted monthly time series data from March 2019 to September 2020 for home care recipients in Ontario, Canada. Home care episodes were linked to interRAI Home Care assessments, interRAI Contact Assessments, and home care services. Health status measures from the patient's most recent interRAI assessment were used to stratify the receipt of personal support, nursing, and occupational or physical therapy services. Significant level and slope changes were detected using Poisson, beta, and linear regression models. ResultsThe March to September 2020 period was associated with significantly fewer home care admissions, discharges, and standardised assessments. Among those assessed with the interRAI Home Care assessment, significantly fewer patients received any personal support services. Among those assessed with either interRAI assessment and identified to have rehabilitation needs, significantly fewer patients received any therapy services. Among patients receiving services, patients received significantly fewer hours of personal support and fewer therapy visits per month. By September 2020, the rate of admissions and services had mostly returned to pre-pandemic levels, but completion of standardised assessments lagged behind. ConclusionThe first wave of the COVID-19 pandemic was associated with substantial changes in Ontario's publicly funded home care system. Although it may have been necessary to prioritise service delivery during a crisis situation, standardised assessments are needed to support individualised patient care and system-level monitoring. Given the potential disruptions to home care services, future studies should examine the impact of the pandemic on the health and well-being of home care recipients and their caregiving networks.	[Sinn, Chi-Ling Joanna; Turcotte, Luke Andrew; Hirdes, John P.] Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada; [Sultan, Heebah] Univ Toronto, Inst Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Sultan, Heebah] Ontario Hlth, Toronto, ON, Canada; [McArthur, Caitlin] Dalhousie Univ, Sch Physiotherapy, Halifax, NS, Canada	University of Waterloo; University of Toronto; Dalhousie University	Sinn, CLJ (corresponding author), Univ Waterloo, Sch Publ Hlth Sci, Waterloo, ON, Canada.	cjsinn@uwaterloo.ca		Turcotte, Luke/0000-0001-5678-7234; Sinn, Chi-Ling/0000-0002-7878-2060				Anderson S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910010; [Anonymous], 2014, MAK WAY CHANG TRANSF; Bandini J, 2021, NEW SOLUT, V31, P20, DOI 10.1177/1048291120987845; Burrows AB, 2000, AGE AGEING, V29, P165, DOI 10.1093/ageing/29.2.165; Canadian Foundation for Healthcare Improvement Canadian Patient Safety Institute, 2020, REIM CAR OLD ADU NEX; Canadian Institute for Health Information, 2020, COVID 19 S IMP HOM C; Canadian Institute for Health Information, 2020, 1 3 UNP CAR CAN DIST; Canadian Institute for Health Information, 2020, COVID 19 S EFF HOSP; Carpenter I, 2004, AGING CLIN EXP RES, V16, P259; Carpenter I., 2013, GOOD LIFE OLD AGE, V17, P93; Cheng L, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0203-1; Estabrooks C.A., 2020, RESTORING TRUST COVI; Expert Group on Home and Community Care, 2015, BRI CAR HOM REP EXP; Falvey JR, 2020, PHYS THER, V100, P1058, DOI 10.1093/ptj/pzaa069; Frankfurter C, 2020, CAN J CARDIOL, V36, P1680, DOI 10.1016/j.cjca.2020.07.006; Giebel C, 2020, BMC GERIATR, V20, DOI 10.1186/s12877-020-01719-0; Health Quality Ontario, 2018, MEAS UP 2018; Heckman G., 2013, CAN GERIATR J, V3; Hirdes JP, 2006, AGE AGEING, V35, P329, DOI 10.1093/ageing/afl036; Hirdes JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099066; Hirdes JP, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-277; Hirdes JP, 2003, J AM GERIATR SOC, V51, P96, DOI 10.1034/j.1601-5215.2002.51017.x; Hogeveen SE, 2017, BMC MED INFORM DECIS, V17, DOI 10.1186/s12911-017-0547-9; Home Care Ontario, 2018, MORE HOM CAR FOR ME; interRAI, 2020, GUID COMP COMM BAS I; Jones A, 2021, J AM MED DIR ASSOC, V22, P2258, DOI 10.1016/j.jamda.2021.08.031; Kim H, 2015, GERIATR GERONTOL INT, V15, P220, DOI 10.1111/ggi.12330; Landi F, 2000, MED CARE, V38, P1184, DOI 10.1097/00005650-200012000-00005; McArthur C, 2021, J AM MED DIR ASSOC, V22, P187, DOI 10.1016/j.jamda.2020.10.028; Morris JN, 2000, CAN J AGING, V19, P87, DOI 10.1017/S071498080001391X; Morris JN, 1997, J AM GERIATR SOC, V45, P1017, DOI 10.1111/j.1532-5415.1997.tb02975.x; Morris JN, 1999, J GERONTOL A-BIOL, V54, pM546, DOI 10.1093/gerona/54.11.M546; Morris JN, 2018, INTERRAI CHECK UP CU; Morris JN, 2016, J GERIATR PSYCH NEUR, V29, P47, DOI 10.1177/0891988715598231; National Institute on Ageing, 2020, NIA LONG TERM CARE C; Penfold RB, 2013, ACAD PEDIATR, V13, pS38, DOI 10.1016/j.acap.2013.08.002; Primary and Integrated Health Care Innovations Network, 2020, PROV PRIM CAR PAND S; Public Health Agency of Canada, 2020, EPID SUMM COVID 19 C; Rowe TA, 2020, ARCH GERONTOL GERIAT, V91, DOI 10.1016/j.archger.2020.104214; Sinha, 2020, IMPACT COVID 19 RESI; Sinn Chi-Ling Joanna, 2020, CMAJ Open, V8, pE796, DOI 10.9778/cmajo.20200083; Sinn CLJ, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2737-7; Sinn CJ., 2019, LESS INVISIBLE MORE; Tenforde AS, 2020, AM J PHYS MED REHAB, V99, P977, DOI 10.1097/PHM.0000000000001571; The Ontario Caregiver Organization, 2020, SPOTL ONT CAR COVID; Vogel L., 2020, COVID 19 TIMELINE CA; Wang JN, 2020, CAN MED ASSOC J, V192, pE1347, DOI 10.1503/cmaj.201521; Weeks LE, 2021, BMC RES NOTES, V14, DOI 10.1186/s13104-021-05686-6; Zagrodney Katherine, 2017, Healthc Policy, V13, P31	49	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266160	10.1371/journal.pone.0266160	http://dx.doi.org/10.1371/journal.pone.0266160			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353856	Green Published, gold			2022-12-26	WOS:000786647900042
J	Tariq, M; Israr, M; Raza, M; Ahmad, B; Azizullah, A; Rehman, SU; Faheem, M; Sun, XX; Yuan, QP				Tariq, Muhammad; Israr, Muhammad; Raza, Muslim; Ahmad, Bashir; Azizullah, Azizullah; Rehman, Shafiq Ur; Faheem, Muhammad; Sun, Xinxiao; Yuan, Qipeng			Engineering of phenylalanine dehydrogenase from Thermoactinomyces intermedius for the production of a novel homoglutamate	PLOS ONE			English	Article							L-LYSINE; 2-AMINOADIPIC ACID; PENICILLIN BIOSYNTHESIS; CATABOLISM; AMINOTRANSFERASE; STREPTOMYCES; RECOGNITION; CHRYSOGENUM; EXPRESSION; TREHALOSE	The dramatic increase in healthcare costs has become a significant burden to this era. Many patients are unable to access medication because of the high price of drugs. Genetic engineering has made advances to increase the yield, titer, and productivity in the bio-based production of chemicals, materials of interest, and identification of innovative targets for drug discovery. Currently, the production of homoglutamate (alpha-Aminoadipic acid) involves petrochemical routes that are costly with low yield and often not suitable for industrial production. Here, we established the development of NADH-dependent homoglutamate by engineering NADH-dependent phenylalanine dehydrogenase (PDH) from Thermoactinomyces intermedius, which provides a novel tool for in-vivo metabolic engineering and in-vitro catalysis. Based on computational insight into the structure, we proposed the site-specific directed mutagenesis of the two important residues of PDH through docking simulations by AutoDock Vina which elucidated the binding mode of PDH with alpha-Ketoadipic acid and ligands. Our results demonstrated that the catalytic efficiency K-m/K-cat of the final mutant Ala135Arg showed a 3-fold increase amination activity towards the ketoadipic acid as compared to the other mutant Gly114Arg, a double mutant Gly114Arg/Ala135Arg, and wild type TiPDH. Furthermore, we have introduced formate dehydrogenase as a cofactor regenerative system in this study which further made this study economically viable. Our study unfolds the possibility of biosynthesis of other non-proteinogenic amino acids that might be valuable pharmaceutical intermediaries.	[Tariq, Muhammad; Israr, Muhammad; Ahmad, Bashir; Azizullah, Azizullah; Rehman, Shafiq Ur] Univ Haripur, Dept Biol, Haripur, Khyber Pakhtunk, Pakistan; [Tariq, Muhammad; Sun, Xinxiao; Yuan, Qipeng] Beijing Univ Chem Technol, Sch Life Sci, Beijing, Peoples R China; [Raza, Muslim] Bacha Khan Univ, Dept Chem, Charsadda, Khyber Pakhtunk, Pakistan; [Faheem, Muhammad] Natl Univ Med Sci, Dept Biol Sci, The Mall, Rawalpindi, Pakistan	Beijing University of Chemical Technology	Israr, M (corresponding author), Univ Haripur, Dept Biol, Haripur, Khyber Pakhtunk, Pakistan.; Yuan, QP (corresponding author), Beijing Univ Chem Technol, Sch Life Sci, Beijing, Peoples R China.; Raza, M (corresponding author), Bacha Khan Univ, Dept Chem, Charsadda, Khyber Pakhtunk, Pakistan.	m.israr@uoh.edu.pk; dr.raza@bkuc.edu.pk; m.israr88@hebut.edu.cn		Faheem, Muhammad/0000-0002-3635-1246				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Azizi A, 2011, INT J BIOL MACROMOL, V49, P652, DOI 10.1016/j.ijbiomac.2011.06.025; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; BRAKHAGE AA, 1992, FEMS MICROBIOL LETT, V98, P123; COQUE JJR, 1991, J BACTERIOL, V173, P6258, DOI 10.1128/jb.173.19.6258-6264.1991; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; ESMAHAN C, 1994, APPL ENVIRON MICROB, V60, P1705, DOI 10.1128/AEM.60.6.1705-1710.1994; FYKSE EM, 1992, NEUROSCI LETT, V135, P125, DOI 10.1016/0304-3940(92)90151-V; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hanwell MD, 2012, J CHEMINFORMATICS, V4, DOI 10.1186/1758-2946-4-17; Jung K, 2013, INT J CANCER, V133, P2914, DOI 10.1002/ijc.28303; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; KATAOKA K, 1993, J BIOCHEM-TOKYO, V114, P69, DOI 10.1093/oxfordjournals.jbchem.a124142; KERN BA, 1980, ANTIMICROB AGENTS CH, V17, P679, DOI 10.1128/AAC.17.4.679; KINZEL JJ, 1983, J BACTERIOL, V155, P417, DOI 10.1128/JB.155.1.417-419.1983; Laskowski RA., 2002, PROCHECK VALIDATION; Laskowski RA, 2011, J CHEM INF MODEL, V51, P2778, DOI 10.1021/ci200227u; LESLIE SB, 1995, APPL ENVIRON MICROB, V61, P3592, DOI 10.1128/AEM.61.10.3592-3597.1995; Li ZJ, 2004, J CHEM INF COMP SCI, V44, P1886, DOI 10.1021/ci049794h; Liu XZ, 2019, 3 BIOTECH, V9, DOI 10.1007/s13205-019-1619-6; LUENGO JM, 1979, J GEN MICROBIOL, V115, P207, DOI 10.1099/00221287-115-1-207; MADDURI K, 1991, APPL MICROBIOL BIOT, V35, P358, DOI 10.1007/BF00172726; MADDURI K, 1989, J BACTERIOL, V171, P299, DOI 10.1128/jb.171.1.299-302.1989; Mehrabi M, 2008, INT J BIOL MACROMOL, V43, P187, DOI 10.1016/j.ijbiomac.2008.05.001; OHSHIMA T, 1991, J BACTERIOL, V173, P3943, DOI 10.1128/jb.173.13.3943-3948.1991; Politino M, 2005, WO Patent, Patent No. 2005106011; Pymol T, 2010, PYMOL MOL GRAPHICS S; SCHMIDT H, 1988, FEMS MICROBIOL LETT, V49, P203; Seah SYK, 2003, EUR J BIOCHEM, V270, P4628, DOI 10.1046/j.1432-1033.2003.03852.x; SHAKED Z, 1980, J AM CHEM SOC, V102, P7104, DOI 10.1021/ja00543a038; Sun J, 2018, J CHEM TECHNOL BIOT, V93, P1677, DOI 10.1002/jctb.5540; TAKADA H, 1991, J BIOCHEM-TOKYO, V109, P371, DOI 10.1093/oxfordjournals.jbchem.a123388; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Umamaheswari M., 2011, PHARM CHEM, V3, P240; Valmaseda EMMD, 2005, MOL GENET GENOMICS, V274, P272, DOI 10.1007/s00438-005-0018-3; Wang HH, 2009, NATURE, V460, P894, DOI 10.1038/nature08187; Wang TJ, 2013, J CLIN INVEST, V123, P4309, DOI 10.1172/JCI64801; Wargasetia TL, 2018, EXP THER MED, V16, P2985, DOI 10.3892/etm.2018.6588; Webb B, 2014, METHODS MOL BIOL, V1137, P1, DOI 10.1007/978-1-4939-0366-5_1; Wiederstein M, 2007, NUCLEIC ACIDS RES, V35, pW407, DOI 10.1093/nar/gkm290; Xu HY, 2006, CELL BIOCHEM BIOPHYS, V46, P43, DOI 10.1385/CBB:46:1:43; YONAHA K, 1992, J BIOL CHEM, V267, P12506; Yousefi F, 2017, ARCH BIOCHEM BIOPHYS, V635, P44, DOI 10.1016/j.abb.2017.10.009; Zhang XL, 2016, METAB ENG, V35, P64, DOI 10.1016/j.ymben.2016.01.007	46	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263784	10.1371/journal.pone.0263784	http://dx.doi.org/10.1371/journal.pone.0263784			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353822	Green Published, gold			2022-12-26	WOS:000786647900026
J	Yang, JX; Xiong, JB; Cen, J; He, W				Yang, Jianxiang; Xiong, Jianbin; Cen, Jian; He, Wei			Finite-time generalized synchronization of non-identical fractional order chaotic systems and its application in speech secure communication	PLOS ONE			English	Article							SLIDING MODE SYNCHRONIZATION; NEURAL-NETWORKS; STABILIZATION; DELAY	This paper focuses on the finite-time generalized synchronization problem of non-identical fractional order chaotic (or hyper-chaotic) systems by a designing adaptive sliding mode controller and its . The effects of both disturbances and model uncertainties are taken into account. A novel fractional order integral sliding mode surface is designed and its stability to the origin is proved in a given finite time. By the aid of the fractional Lyapunov stability theory, a robust controller with adaptive update laws is proposed and its finite-time stability for generalized synchronization between two non-identical fractional-order chaotic systems in the presence of model uncertainties and external disturbances is derived. Numerical simulations are provided to demonstrate the effectiveness and robustness of the presented approach. All simulation results obtained are in good agreement with the theoretical analysis. According to the proposed generalized finite-time synchronization criterion, a novel speech cryptosystem is proposed to send or share voice messages privately via secure channel. Security and performance analyses are given to show the practical effect of the proposed theories.	[Yang, Jianxiang; Xiong, Jianbin; Cen, Jian; He, Wei] Guangdong Polytech Normal Univ, Sch Automat, Guangzhou, Peoples R China; [Cen, Jian] Guangzhou Key Lab Intelligent Bldg Equipment, Guangzhou, Peoples R China	Guangdong Polytechnic Normal University	Cen, J (corresponding author), Guangdong Polytech Normal Univ, Sch Automat, Guangzhou, Peoples R China.; Cen, J (corresponding author), Guangzhou Key Lab Intelligent Bldg Equipment, Guangzhou, Peoples R China.	986412676@qq.com		Yang, Jianxiang/0000-0003-2337-215X	National Natural Science Foundation of China [62073090, 61473331]; Guangzhou Key Laboratory of Intelligent Building Equipment Information Integration and Control [202002010003]; Natural Science Foundation of Guangdong Province of China [2019A1515010700]; Key (natural) Project of Guangdong Provincial [2019KZDXM020,2019KZDZX1004, 2019KZDZX1042]; Introduction of Talents Project of Guangdong Polytechnic Normal University of China [991641277, 991512203]; Guangdong Climbing Project; Special projects in key areas of ordinary colleges and universities in Guangdong Province [2020ZDZX2014]; Intelligent Agricultural Engineering Technology Research Centre of Guangdong University Grant [ZHNY1905]; Innovation Team Project of Ordinary University of Guangdong Province [2020KCXTD017]; Guangdong Special Project in Key Field of Artificial Intelligence for Ordinary University [2019KZDZX1004]; Guangzhou Yuexiu District Science and Technology Plan Major Project [2019-GX-010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangzhou Key Laboratory of Intelligent Building Equipment Information Integration and Control; Natural Science Foundation of Guangdong Province of China(National Natural Science Foundation of Guangdong Province); Key (natural) Project of Guangdong Provincial; Introduction of Talents Project of Guangdong Polytechnic Normal University of China; Guangdong Climbing Project; Special projects in key areas of ordinary colleges and universities in Guangdong Province; Intelligent Agricultural Engineering Technology Research Centre of Guangdong University Grant; Innovation Team Project of Ordinary University of Guangdong Province; Guangdong Special Project in Key Field of Artificial Intelligence for Ordinary University; Guangzhou Yuexiu District Science and Technology Plan Major Project	This study was supported in part by the National Natural Science Foundation of China under Grant no. 62073090, 61473331, in part by the Guangzhou Key Laboratory of Intelligent Building Equipment Information Integration and Control under Grant no. 202002010003, in part by the Natural Science Foundation of Guangdong Province of China under Grant no.2019A1515010700, in part by the Key (natural) Project of Guangdong Provincial under Grant no. 2019KZDXM020,2019KZDZX1004, 2019KZDZX1042, in part by the Introduction of Talents Project of Guangdong Polytechnic Normal University of China under Grant no. 991641277, 991512203, in part by Guangdong Climbing Project no. pdjh2020b0345, in part by Special projects in key areas of ordinary colleges and universities in Guangdong Province no. 2020ZDZX2014,Intelligent Agricultural Engineering Technology Research Centre of Guangdong University Grant no.ZHNY1905, in part by the Innovation Team Project of Ordinary University of Guangdong Province under Grant no.2020KCXTD017, in part by the Guangdong Special Project in Key Field of Artificial Intelligence for Ordinary University under Grant no. 2019KZDZX1004, in part by the Guangzhou Yuexiu District Science and Technology Plan Major Project under Grant no. 2019-GX-010. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd El-Maksoud AJ, 2019, MICROELECTRON J, V90, P323, DOI 10.1016/j.mejo.2019.05.005; Aguila-Camacho N, 2014, COMMUN NONLINEAR SCI, V19, P2951, DOI 10.1016/j.cnsns.2014.01.022; Ahmad I, 2016, OPTIK, V127, P8172, DOI 10.1016/j.ijleo.2016.05.065; Behinfaraz R, 2018, ISA T, V80, P399, DOI 10.1016/j.isatra.2018.07.014; Cai N, 2011, NONLINEAR DYNAM, V64, P385, DOI 10.1007/s11071-010-9869-1; Chen XY, 2019, IET CONTROL THEORY A, V13, P1246, DOI 10.1049/iet-cta.2018.5661; Chen XY, 2018, NEUROCOMPUTING, V273, P9, DOI 10.1016/j.neucom.2017.07.063; Chen XY, 2017, APPL MATH COMPUT, V308, P161, DOI 10.1016/j.amc.2017.03.032; Deepika D, 2018, CHAOS SOLITON FRACT, V115, P196, DOI 10.1016/j.chaos.2018.07.028; Ding ZX, 2016, NEURAL NETWORKS, V76, P97, DOI 10.1016/j.neunet.2016.01.006; Ding ZX, 2016, NEURAL NETWORKS, V73, P77, DOI 10.1016/j.neunet.2015.10.010; Golmankhaneh AK, 2015, J VIB CONTROL, V21, P1154, DOI 10.1177/1077546313494953; Huang XQ, 2005, AUTOMATICA, V41, P881, DOI 10.1016/j.automatica.2004.11.036; Kilbas A. A., 2006, THEORY APPL FRACTION, V204, DOI 10.1016S0304-ff////0208(06)80001-0; Leung AYT, 2015, APPL MATH COMPUT, V253, P172, DOI 10.1016/j.amc.2014.12.076; Li D, 2016, NEUROCOMPUTING, V216, P39, DOI 10.1016/j.neucom.2016.07.013; Li HL, 2017, ASIAN J CONTROL, V19, P202, DOI 10.1002/asjc.1346; Li RG, 2019, ISA T, V92, P35, DOI 10.1016/j.isatra.2019.02.027; Liu H, 2017, COMPLEXITY, DOI 10.1155/2017/6853826; Luo RZ, 2017, CHINESE J PHYS, V55, P342, DOI 10.1016/j.cjph.2016.10.024; Matouk AE, 2016, COMPLEXITY, V21, P116, DOI 10.1002/cplx.21719; Muthukumar P, 2018, ISA T, V82, P51, DOI 10.1016/j.isatra.2017.07.007; Ouannas A, 2018, DIFFER EQUAT DYN SYS, V26, P125, DOI 10.1007/s12591-016-0317-7; Ouannas A, 2018, ADV DIFFER EQU-NY, DOI 10.1186/s13662-018-1485-2; Pang SQ, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/7693547; PECORA LM, 1990, PHYS REV LETT, V64, P821, DOI 10.1103/PhysRevLett.64.821; Shao SY, 2016, NONLINEAR DYNAM, V83, P1855, DOI 10.1007/s11071-015-2450-1; Shukla MK, 2017, CHAOS SOLITON FRACT, V102, P274, DOI 10.1016/j.chaos.2017.05.015; Sun ZW, 2018, CHINESE J PHYS, V56, P2553, DOI 10.1016/j.cjph.2018.08.007; Wang SQ, 2020, IEEE T NEUR NET LEAR, V31, P4157, DOI 10.1109/TNNLS.2019.2952410; Wang Z, 2013, T I MEAS CONTROL, V35, P713, DOI 10.1177/0142331212468374; Wu HQ, 2017, NEUROCOMPUTING, V235, P264, DOI 10.1016/j.neucom.2017.01.022; Xi XJ, 2018, J VIB CONTROL, V24, P3842, DOI 10.1177/1077546317713532; Zhang DY, 2017, APPL MATH MODEL, V48, P303, DOI 10.1016/j.apm.2017.04.009; Zhang D, 2019, IEEE ACCESS, V7, P8519, DOI 10.1109/ACCESS.2018.2890311; Zhang LZ, 2018, J FRANKLIN I, V355, P1217, DOI 10.1016/j.jfranklin.2017.12.017; Zhao JK, 2013, NONLINEAR DYNAM, V74, P479, DOI 10.1007/s11071-013-0970-0	37	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263007	10.1371/journal.pone.0263007	http://dx.doi.org/10.1371/journal.pone.0263007			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320280	Green Published, gold			2022-12-26	WOS:000784240600056
J	Cohen, R; Mukai, C; Nelson, JL; Zenilman, SS; Sosnicki, DM; Travis, AJ				Cohen, Roy; Mukai, Chinatsu; Nelson, Jacquelyn L.; Zenilman, Shoshana S.; Sosnicki, Danielle M.; Travis, Alexander J.			A genetically targeted sensor reveals spatial and temporal dynamics of acrosomal calcium and sperm acrosome exocytosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							STORE-OPERATED CHANNELS; MOUSE SPERM; ZONA-PELLUCIDA; HUMAN SPERMATOZOA; PROGESTERONE; CAPACITATION; MOTILITY; MURINE; FERTILIZATION; CHOLESTEROL	Secretion of the acrosome, a single vesicle located rostrally in the head of a mammalian sperm, through a process known as "acrosome exocytosis" (AE), is essential for fertilization. However, the mechanisms leading to and regulating this complex process are controversial. In particular, poor understanding of Ca2+ dynamics between sperm subcellular compartments and regulation of membrane fusion mechanisms have led to competing models of AE. Here, we developed a transgenic mouse expressing an Acrosome-targeted Sensor for Exocytosis (AcroSensE) to investigate the spatial and temporal Ca2+ dynamics in AE in live sperm. AcroSensE combines a genetically encoded Ca2+ indicator (GCaMP) fused with an mCherry indicator to spatiotemporally resolve acrosomal Ca2+ rise (ACR) and membrane fusion events, enabling real-time study of AE. We found that ACR is dependent on extracellular Ca2+ and that ACR precedes AE. In addition, we show that there are intermediate steps in ACR and that AE correlates better with the ACR rate rather than absolute Ca2+ amount. Finally, we demonstrate that ACR and membrane fusion progression kinetics and spatial patterns differ with different stimuli and that sites of initiation of ACR and sites of membrane fusion do not always correspond. These findings support a model involving functionally redundant pathways that enable a highly regulated, multistep AE in heterogeneous sperm populations, unlike the previously proposed "acrosome reaction" model.	[Cohen, Roy; Mukai, Chinatsu; Nelson, Jacquelyn L.; Zenilman, Shoshana S.; Sosnicki, Danielle M.; Travis, Alexander J.] Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA; [Travis, Alexander J.] Cornell Univ, Coll Vet Med, Dept Publ & Ecosyst Hlth, Ithaca, NY 14853 USA	Cornell University; Cornell University	Cohen, R (corresponding author), Cornell Univ, Coll Vet Med, Baker Inst Anim Hlth, Ithaca, NY 14853 USA.	roy.cohen@cornell.edu		Sosnicki, Danielle/0000-0001-8480-0950	National Institutes of Health [R01-HD093827, R03HD090304]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by National Institutes of Health grants R01-HD093827 and R03HD090304 (A. J. T). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Amatore C, 2009, BIOPHYS CHEM, V143, P124, DOI 10.1016/j.bpc.2009.04.007; Arndt L, 2014, MOL BIOL CELL, V25, P948, DOI 10.1091/mbc.E13-09-0523; Asano Atsushi, 2013, Commun Integr Biol, V6, pe27362, DOI 10.4161/cib.27362; Asano A, 2013, J BIOL CHEM, V288, P28104, DOI 10.1074/jbc.M113.450981; Baibakov B, 2007, DEVELOPMENT, V134, P933, DOI 10.1242/dev.02752; Bhakta HH, 2019, DEVELOPMENT, V146, DOI 10.1242/dev.176966; Blackmore PF, 1999, STEROIDS, V64, P149, DOI 10.1016/S0039-128X(98)00109-3; Calogero AE, 2000, HUM REPROD, V15, P28, DOI 10.1093/humrep/15.suppl_1.28; Cardona C, 2017, MOL REPROD DEV, V84, P423, DOI 10.1002/mrd.22803; Chavez JC, 2018, J CELL PHYSIOL, V233, P4735, DOI 10.1002/jcp.26262; Cohen R, 2016, ADV ANAT EMBRYOL CEL, V220, P107, DOI 10.1007/978-3-319-30567-7_6; Cohen R, 2014, DEV CELL, V28, P310, DOI 10.1016/j.devcel.2014.01.005; Correia J, 2015, REPRODUCTION, V150, pR65, DOI 10.1530/REP-15-0102; Costello S, 2009, REPRODUCTION, V138, P425, DOI 10.1530/REP-09-0134; Darszon A, 2012, CELL TISSUE RES, V349, P749, DOI 10.1007/s00441-012-1397-5; de Lamirande E, 1998, J ANDROL, V19, P215; Francavilla F, 2002, INT J ANDROL, V25, P106, DOI 10.1046/j.1365-2605.2002.00333.x; Grafen A, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00218; Harper CV, 2004, J BIOL CHEM, V279, P46315, DOI 10.1074/jbc.M401194200; Hasuwa H, 2010, EXP ANIM TOKYO, V59, P105, DOI 10.1538/expanim.59.105; Helassa N, 2015, SCI REP-UK, V5, DOI 10.1038/srep15978; Henderson MJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139273; Herrick SB, 2005, J CELL PHYSIOL, V202, P663, DOI 10.1002/jcp.20172; Hino T, 2016, BIOL REPROD, V95, DOI 10.1095/biolreprod.116.140400; Hino T, 2011, ZYGOTE, V19, P315, DOI 10.1017/S0967199410000481; HOLT WV, 1984, J EXP ZOOL, V230, P473, DOI 10.1002/jez.1402300316; Ikawa M, 1998, FEBS LETT, V430, P83, DOI 10.1016/S0014-5793(98)00593-6; Jin M, 2011, P NATL ACAD SCI USA, V108, P4892, DOI 10.1073/pnas.1018202108; Kim KS, 2003, DEV BIOL, V264, P141, DOI 10.1016/j.ydbio.2003.08.006; Kim KS, 2001, BIOL REPROD, V64, P36, DOI 10.1095/biolreprod64.1.36; Kirkman-Brown JC, 2000, DEV BIOL, V222, P326, DOI 10.1006/dbio.2000.9729; La Spina FA, 2016, DEV BIOL, V411, P172, DOI 10.1016/j.ydbio.2016.02.006; Lawson C, 2007, MOL HUM REPROD, V13, P307, DOI 10.1093/molehr/gam012; Li S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031905; Lishko PV, 2010, J PHYSIOL-LONDON, V588, P4667, DOI 10.1113/jphysiol.2010.194142; De La Vega-Beltran JL, 2012, J BIOL CHEM, V287, P44384, DOI 10.1074/jbc.M112.393488; Luque GM, 2018, J CELL PHYSIOL, V233, P9685, DOI 10.1002/jcp.26883; Mills TT, 2009, GEN PHYSIOL BIOPHYS, V28, P126, DOI 10.4149/gpb_2009_02_126; Molina LCP, 2020, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00387; Moody MA, 2017, MOL REPROD DEV, V84, P408, DOI 10.1002/mrd.22801; Morris J, 2015, MOL HUM REPROD, V21, P563, DOI 10.1093/molehr/gav019; Naaby-Hansen S, 2001, MOL HUM REPROD, V7, P923, DOI 10.1093/molehr/7.10.923; Nahecr RA, 2016, J BIOL CHEM, V291, P3076, DOI 10.1074/jbc.M115.677799; Nakanishi T, 1999, FEBS LETT, V449, P277, DOI 10.1016/S0014-5793(99)00433-0; Nakanishi T, 2001, DEV BIOL, V237, P222, DOI 10.1006/dbio.2001.0353; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Nishigaki T, 2014, BIOCHEM BIOPH RES CO, V450, P1149, DOI 10.1016/j.bbrc.2014.05.100; O'Toole CMB, 2000, MOL BIOL CELL, V11, P1571, DOI 10.1091/mbc.11.5.1571; PITELKA DR, 1983, J CELL BIOL, V96, P613, DOI 10.1083/jcb.96.3.613; Molina LCP, 2018, FRONT CELL DEV BIOL, V6, DOI 10.3389/fcell.2018.00072; Sagare-Patil V, 2012, INT J ANDROL, V35, P633, DOI 10.1111/j.1365-2605.2012.01291.x; Santi CM, 2010, FEBS LETT, V584, P1041, DOI 10.1016/j.febslet.2010.02.005; Schinfeld J, 2018, MOL REPROD DEV, V85, P654, DOI 10.1002/mrd.23057; Selvaraj V, 2007, J ANDROL, V28, P588, DOI 10.2164/jandrol.106.002279; Sharara F, 2020, REPROD BIOMED ONLINE, V41, P69, DOI 10.1016/j.rbmo.2020.03.011; Shui B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00428; Sun XH, 2017, REPROD BIOL ENDOCRIN, V15, DOI 10.1186/s12958-017-0281-2; Teves ME, 2006, FERTIL STERIL, V86, P745, DOI 10.1016/j.fertnstert.2006.02.080; Travis AJ, 2004, BIOL REPROD, V71, P139, DOI 10.1095/biolreprod.103.025809; Travis AJ, 2002, J CLIN INVEST, V110, P731, DOI [10.1172/JCI200216392, 10.1172/JCI0216392]; Travis AJ, 2001, J BIOL CHEM, V276, P7630, DOI 10.1074/jbc.M006217200; UHLER ML, 1992, FERTIL STERIL, V58, P1191; Vasudevan SR, 2010, J BIOL CHEM, V285, P18262, DOI 10.1074/jbc.M109.087858; WALENSKY LD, 1995, J CELL BIOL, V130, P857, DOI 10.1083/jcb.130.4.857; Wang D, 2003, NAT CELL BIOL, V5, P1117, DOI 10.1038/ncb1072; Wennemuth G, 2003, J GEN PHYSIOL, V122, P115, DOI 10.1085/jgp.200308839; Williams KM, 2003, INT J ANDROL, V26, P366, DOI 10.1111/j.1365-2605.2003.00438.x; WOLF DE, 1990, P NATL ACAD SCI USA, V87, P6893, DOI 10.1073/pnas.87.17.6893	68	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101868	10.1016/j.jbc.2022.101868	http://dx.doi.org/10.1016/j.jbc.2022.101868			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35346690	gold, Green Published			2022-12-26	WOS:000860390500008
J	Collins, GA; Sha, Z; Kuo, CL; Erbil, B; Goldberg, AL				Collins, Galen Andrew; Sha, Zhe; Kuo, Chueh-Ling; Erbil, Beyza; Goldberg, Alfred L.			Mammalian Ddi2 is a shuttling factor containing a retroviral protease domain that influences binding of ubiquitylated proteins and proteasomal degradation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							UBIQUITIN-ASSOCIATED DOMAINS; 26S PROTEASOME; UBA DOMAINS; NELFINAVIR; INHIBITION; BREAKDOWN; PROMOTE; CHAINS; DSK2P	Although several proteasome subunits have been shown to bind ubiquitin (Ub) chains, many ubiquitylated substrates also associate with 26S proteasomes via "shuttling factors." Unlike the well-studied yeast shuttling factors Rad23 and Dsk2, vertebrate homologs Ddi2 and Ddi1 lack a Ub-associated domain; therefore, it is unclear how they bind Ub. Here, we show that deletion of Ddi2 leads to the accumulation of Ub conjugates with K11/K48 branched chains. We found using affinity copurifications that Ddi2 binds Ub conjugates through its Ub-like domain, which is also required for Ddi2 binding to proteasomes. Furthermore, in cell extracts, adding Ub conjugates increased the amount of Ddi2 associated with proteasomes, and adding Ddi2 increased the binding of Ub conjugates to purified proteasomes. In addition, Ddi2 also contains a retroviral protease domain with undefined cellular roles. We show that blocking the endoprotease activity of Ddi2 either genetically or with the HIV protease inhibitor nelfinavir increased its binding to Ub conjugates but decreased its binding to proteasomes and reduced subsequent protein degradation by proteasomes leading to further accumulation of Ub conjugates. Finally, nelfinavir treatment required Ddi2 to induce the unfolded protein response. Thus, Ddi2 appears to function as a shuttling factor in endoplasmic reticulum- associated protein degradation and delivers K11/K48ubiquitylated proteins to the proteasome. We conclude that the protease activity of Ddi2 influences this shuttling factor activity, promotes protein turnover, and helps prevent endoplasmic reticulum stress, which may explain nelfinavir's ability to enhance cell killing by proteasome inhibitors.	[Collins, Galen Andrew; Sha, Zhe; Kuo, Chueh-Ling; Erbil, Beyza; Goldberg, Alfred L.] Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA USA; [Sha, Zhe] UCB, Cambridge, MA USA; [Kuo, Chueh-Ling] Totus Med, Cambridge, MA USA; [Erbil, Beyza] Labcorp Drug Dev, Munich, Germany	Harvard University; Harvard Medical School	Goldberg, AL (corresponding author), Harvard Med Sch, Blavatnik Inst, Dept Cell Biol, Boston, MA USA.	alfred_goldberg@hms.harvard.edu		Collins, Galen/0000-0002-3926-9483				Bertolaet BL, 2001, J MOL BIOL, V313, P955, DOI 10.1006/jmbi.2001.5105; Besche HC, 2014, EMBO J, V33, P1159, DOI 10.1002/embj.201386906; Besche HC, 2012, METHODS MOL BIOL, V832, P423, DOI 10.1007/978-1-61779-474-2_29; Bodnar NO, 2017, CELL, V169, P722, DOI 10.1016/j.cell.2017.04.020; Chen L, 2001, EMBO REP, V2, P933, DOI 10.1093/embo-reports/kve203; Chen PC, 2011, J NEUROSCI, V31, P17505, DOI 10.1523/JNEUROSCI.2922-11.2011; Chowdhury AMMA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12675-y; Clarke DJ, 2001, MOL CELL BIOL, V21, P1997, DOI 10.1128/MCB.21.6.1997-2007.2001; Collins GA, 2020, P NATL ACAD SCI USA, V117, P4664, DOI 10.1073/pnas.1915534117; Diaz-Martinez LA, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-28; Dirac-Svejstrup AB, 2020, MOL CELL, V79, P332, DOI 10.1016/j.molcel.2020.05.035; Driessen C, 2018, BLOOD, V132, P2097, DOI 10.1182/blood-2018-05-851170; Driessen C, 2016, HAEMATOLOGICA, V101, P346, DOI 10.3324/haematol.2015.135780; Elsasser S, 2002, NAT CELL BIOL, V4, P725, DOI 10.1038/ncb845; Fassmannova D, 2020, CANCERS, V12, DOI 10.3390/cancers12051065; Finley D, 2020, CSH PERSPECT BIOL, V12, DOI 10.1101/cshperspect.a033985; Funakoshi M, 2002, P NATL ACAD SCI USA, V99, P745, DOI 10.1073/pnas.012585199; Gomez TA, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-33; Grice GL, 2016, CELL MOL LIFE SCI, V73, P3497, DOI 10.1007/s00018-016-2255-5; Gu Y, 2020, CELL SIGNAL, V75, DOI 10.1016/j.cellsig.2020.109775; Guan M, 2011, CLIN CANCER RES, V17, P1796, DOI 10.1158/1078-0432.CCR-10-3216; Gupta AK, 2007, NEOPLASIA, V9, P271, DOI 10.1593/neo.07124; Hamel FG, 2006, DIABETES OBES METAB, V8, P661, DOI 10.1111/j.1463-1326.2005.00546.x; Hartmann-Petersen R, 2003, FEBS LETT, V535, P77, DOI 10.1016/S0014-5793(02)03874-7; Hitz F, 2019, BLOOD CANCER J, V9, DOI 10.1038/s41408-019-0228-2; Kaplun L, 2005, MOL CELL BIOL, V25, P5355, DOI 10.1128/MCB.25.13.5355-5362.2005; Kim HT, 2007, J BIOL CHEM, V282, P17375, DOI 10.1074/jbc.M609659200; Kim HT, 2018, P NATL ACAD SCI USA, V115, pE11642, DOI 10.1073/pnas.1808731115; Kleijnen MF, 2000, MOL CELL, V6, P409, DOI 10.1016/S1097-2765(00)00040-X; Kleijnen MF, 2003, MOL BIOL CELL, V14, P3868, DOI 10.1091/mbc.E02-11-0766; Koizumi S, 2016, ELIFE, V5, DOI 10.7554/eLife.18357; Koltai Tomas, 2015, F1000Res, V4, P9, DOI 10.12688/f1000research.5827.1; Kottemann MC, 2018, MOL CELL, V69, P24, DOI 10.1016/j.molcel.2017.11.035; Krylov DM, 2001, CURR BIOL, V11, pR584, DOI 10.1016/S0960-9822(01)00357-8; Kuo CL, 2018, METHODS MOL BIOL, V1844, P277, DOI 10.1007/978-1-4939-8706-1_18; Kuo CL, 2017, P NATL ACAD SCI USA, V114, pE3404, DOI 10.1073/pnas.1701734114; Lehrbach NJ, 2016, ELIFE, V5, DOI 10.7554/eLife.17721; Leto DE, 2019, MOL CELL, V73, P377, DOI 10.1016/j.molcel.2018.11.015; Li JM, 2021, MOL CELL, V81, P4722, DOI 10.1016/j.molcel.2021.09.015; Medicherla B, 2004, EMBO REP, V5, P692, DOI 10.1038/sj.embor.7400164; Mendez-Lopez M, 2019, CLIN ADV HEMATOL ONC, V17, P615; Meyer HJ, 2014, CELL, V157, P910, DOI 10.1016/j.cell.2014.03.037; Motosugi R, 2019, FRONT MOL BIOSCI, V6, DOI 10.3389/fmolb.2019.00030; Nathan JA, 2013, EMBO J, V32, P552, DOI 10.1038/emboj.2012.354; Newton K, 2012, METHODS MOL BIOL, V832, P185, DOI 10.1007/978-1-61779-474-2_13; Northrop A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010327; Nowicka U, 2015, STRUCTURE, V23, P542, DOI 10.1016/j.str.2015.01.010; Peth A, 2010, MOL CELL, V40, P671, DOI 10.1016/j.molcel.2010.11.002; Piccinini M, 2005, ANTIVIR THER, V10, P215; Raasi S, 2003, J BIOL CHEM, V278, P8951, DOI 10.1074/jbc.M212841200; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Sha Z, 2018, METHODS MOL BIOL, V1844, P261, DOI 10.1007/978-1-4939-8706-1_17; Sha Z, 2016, CURR BIOL, V26, pR836, DOI 10.1016/j.cub.2016.08.030; Sirkis R, 2006, J MOL BIOL, V364, P376, DOI 10.1016/j.jmb.2006.08.086; Siva M, 2016, SCI REP-UK, V6, DOI 10.1038/srep30443; Tsuchiya H, 2017, MOL CELL, V66, P488, DOI 10.1016/j.molcel.2017.04.024; Wang XR, 2007, BIOCHEMISTRY-US, V46, P3553, DOI 10.1021/bi061994u; Wilkinson CRM, 2001, NAT CELL BIOL, V3, P939, DOI 10.1038/ncb1001-939; Wu YL, 2007, NAT PROTOC, V2, P3278, DOI 10.1038/nprot.2007.459; Yau RG, 2017, CELL, V171, P918, DOI 10.1016/j.cell.2017.09.040; Yip MCJ, 2020, P NATL ACAD SCI USA, V117, P7776, DOI 10.1073/pnas.1902298117; Zhao JH, 2016, NATURE, V529, pE1, DOI 10.1038/nature16472; Zhao JH, 2015, P NATL ACAD SCI USA, V112, P15790, DOI 10.1073/pnas.1521919112	64	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29a, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101875	10.1016/j.jbc.2022.101875	http://dx.doi.org/10.1016/j.jbc.2022.101875			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35358511	Green Published, gold			2022-12-26	WOS:000798082100013
J	Tuplin, EWN; Alukic, E; Lowry, DE; Chleilat, F; Wang, WL; Cho, NA; Sampsell, K; Sales, KM; Mayengbam, S; McCoy, KD; Reimer, RA				Tuplin, Erin W. Noye; Alukic, Erna; Lowry, Dana E.; Chleilat, Faye; Wang, Weilan; Cho, Nicole A.; Sampsell, Kara; Sales, Kate M.; Mayengbam, Shyamchand; McCoy, Kathy D.; Reimer, Raylene A.			Dietary fiber combinations to mitigate the metabolic, microbial, and cognitive imbalances resulting from diet-induced obesity in rats	FASEB JOURNAL			English	Article						dietary fiber; fecal microbiota transplantation; gastrointestinal microbiota; hippocampus; obesity	HIGH-FAT-DIET; GUT MICROBIOTA; SATIETY HORMONES; WEIGHT-LOSS; OLIGOFRUCTOSE; PREBIOTICS; HEALTH; MICE; IMPROVEMENT; PHYSIOLOGY	Dietary fiber promotes a healthy gut microbiome and shows promise in attenuating the unfavorable microbial changes resulting from a high-fat/sucrose (HFS) diet. High-fiber diets consisting of oligofructose alone (HFS/O) or in combination with beta-glucan (HFS/OB), resistant starch (HFS/OR), or beta-glucan and resistant starch (HFS/OBR) were fed to diet-induced obese rats for 8 weeks to determine if these fibers could attenuate the obese phenotype. Only the HFS/O group displayed a decrease in body weight and body fat, but all fiber interventions improved insulin sensitivity and cognitive function. The HFS/O diet was the least effective at improving cognitive function and only the HFS/OB group showed improvements in glucose tolerance, thus highlighting the differential effects of fiber types. Hippocampal cytokines (IL-6, IL-10) were more pronounced in the HFS/OB group which coincided with the most time spend in the open arms of the elevated plus maze. All fiber groups showed an increase in beneficial Bifidobacterium and Lactobacillus abundance while the HFS group showed higher abundance of Clostridium. Fecal microbiota transplant from fiber-treated rats into germ-free mice did not alter body composition in the mice but did result in a higher abundance of Bacteroides in the HFS/O and HFS/OB groups compared to HFS. The HFS/OB recipient mice also had higher insulin sensitivity compared to the other groups. This study highlights the influence of dietary fiber type on metabolic and cognitive outcomes suggesting that the type of supplementation (single or combined fibers) could be tailored to specific targeted outcomes.	[Tuplin, Erin W. Noye; Alukic, Erna; Lowry, Dana E.; Chleilat, Faye; Wang, Weilan; Cho, Nicole A.; Sampsell, Kara; Sales, Kate M.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Mayengbam, Shyamchand] Mem Univ Newfoundland, Dept Biochem, St John, NL, Canada; [McCoy, Kathy D.] Univ Calgary, Cumming Sch Med, Snyder Inst Chron Dis, Dept Physiol & Pharmacol, Calgary, AB, Canada; [Reimer, Raylene A.] Univ Calgary, Cumming Sch Med, Dept Biochem & Mol Biol, Calgary, AB, Canada	University of Calgary; Memorial University Newfoundland; University of Calgary; University of Calgary	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca	Cho, Nicole/GZL-2564-2022; Wang, Weilan/ABH-1501-2020	Cho, Nicole/0000-0002-0553-1754; Wang, Weilan/0000-0002-8469-8797; Reimer, Raylene/0000-0001-5088-7947	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Snyder Institute for Chronic Diseases; Alberta Innovates | Alberta Innovates --Health Solutions (AIHS); U of C | Alberta Children's Hospital Research Institute (ACHRI); Gouvernement du Canada | Natural Sciences and Engineering Research Council of Canada (NSERC); Faculty of Kinesiology Dean's Doctoral Scholarship; University of Calgary Eyes High Postdoctoral Fellowship	Araujo JR, 2017, BIOCHIMIE, V141, P97, DOI 10.1016/j.biochi.2017.05.019; Aslani S, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.178; Bannerman DM, 2014, NAT REV NEUROSCI, V15, P181, DOI 10.1038/nrn3677; Biessels GJ, 2015, NAT REV NEUROSCI, V16, P660, DOI 10.1038/nrn4019; Bomhof MR, 2016, FASEB J, V30, P2720, DOI 10.1096/fj.201600151R; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Braniste V, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009759; Bruce-Keller AJ, 2015, BIOL PSYCHIAT, V77, P607, DOI 10.1016/j.biopsych.2014.07.012; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Carlson JL, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121361; Chen KT, 2020, INT J FOOD SCI NUTR, V71, P965, DOI 10.1080/09637486.2020.1754351; Clapp M, 2017, CLINICS PRACT, V7, P131, DOI 10.4081/cp.2017.987; Cluny NL, 2015, OBESITY, V23, P769, DOI 10.1002/oby.21017; Cohen SJ, 2015, BEHAV BRAIN RES, V285, P105, DOI 10.1016/j.bbr.2014.08.002; Cominski TP, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00273; Cordner ZA, 2015, PHYSIOL BEHAV, V152, P363, DOI 10.1016/j.physbeh.2015.06.008; de Cossio LF, 2017, BRAIN BEHAV IMMUN, V64, P33, DOI 10.1016/j.bbi.2016.12.022; de la Cuesta-Zuluaga J, 2019, NUTRIENTS, V11, DOI 10.3390/nu11010051; Dinel AL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024325; Dotson S, 2008, DIABETES CARE, V31, P1222, DOI 10.2337/dc07-2243; Duan YH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02649; Ellacott KLJ, 2010, CELL METAB, V12, P10, DOI 10.1016/j.cmet.2010.06.001; Engin A, 2017, ADV EXP MED BIOL, V960, P111, DOI 10.1007/978-3-319-48382-5_5; Fuller S, 2016, PLANT FOOD HUM NUTR, V71, P1, DOI 10.1007/s11130-016-0529-6; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Gomes AC, 2018, GUT MICROBES, V9, P308, DOI 10.1080/19490976.2018.1465157; Hariri N, 2010, NUTR RES REV, V23, P270, DOI 10.1017/S0954422410000168; Hildebrandt MA, 2009, GASTROENTEROLOGY, V137, P1716, DOI 10.1053/j.gastro.2009.08.042; Holscher HD, 2017, GUT MICROBES, V8, P172, DOI 10.1080/19490976.2017.1290756; Jakobsdottir G, 2013, BRIT J NUTR, V110, P1565, DOI 10.1017/S0007114513000809; Janssen I, 2013, CAN J DIABETES, V37, P90, DOI 10.1016/j.jcjd.2013.02.059; Johansson MEV, 2011, P NATL ACAD SCI USA, V108, P4659, DOI 10.1073/pnas.1006451107; Klingbeil EA, 2019, NUTRIENTS, V11, DOI 10.3390/nu11112710; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Lai ZL, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33893-y; Lang UE, 2015, CELL PHYSIOL BIOCHEM, V37, P1029, DOI 10.1159/000430229; Li JM, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0713-7; Maciejewska D, 2018, J PHYSIOL PHARMACOL, V69, DOI 10.26402/jpp.2018.2.05; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Mayengbam S, 2019, J NUTR BIOCHEM, V64, P228, DOI 10.1016/j.jnutbio.2018.11.003; Mulders RJ, 2018, OBES REV, V19, P435, DOI 10.1111/obr.12661; Nicolucci AC, 2017, GASTROENTEROLOGY, V153, P711, DOI 10.1053/j.gastro.2017.05.055; Ong ZY, 2012, J DEV ORIG HLTH DIS, V3, P299, DOI 10.1017/S204017441200030X; Ong ZY, 2011, FASEB J, V25, P2167, DOI 10.1096/fj.10-178392; Parker A, 2020, GUT MICROBES, V11, P135, DOI 10.1080/19490976.2019.1638722; Parnell JA, 2008, OBESITY, V16, P736, DOI 10.1038/oby.2007.128; Parnell JA, 2017, OBESITY, V25, P510, DOI 10.1002/oby.21763; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Paul HA, 2016, SCI REP-UK, V6, DOI 10.1038/srep20683; Proctor C, 2017, METAB BRAIN DIS, V32, P1, DOI 10.1007/s11011-016-9917-8; Rodenburg W, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-144; Schwiertz A, 2010, OBESITY, V18, P190, DOI 10.1038/oby.2009.167; Shi HL, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00920-y; So D, 2018, AM J CLIN NUTR, V107, P965, DOI 10.1093/ajcn/nqy041; Tang T, 2021, INT J BIOL MACROMOL, V174, P289, DOI 10.1016/j.ijbiomac.2021.01.164; Tran DMD, 2018, J EXP PSYCHOL-ANIM L, V44, P217, DOI 10.1037/xan0000170; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Villanueva-Millan MJ, 2015, J PHYSIOL BIOCHEM, V71, P509, DOI 10.1007/s13105-015-0390-3; Vitaglione P, 2009, APPETITE, V53, P338, DOI 10.1016/j.appet.2009.07.013; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wang SM, 2020, J FUNCT FOODS, V66, DOI 10.1016/j.jff.2020.103838; Wang YA, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00129; Wing RR, 2001, ANNU REV NUTR, V21, P323, DOI 10.1146/annurev.nutr.21.1.323; Zhang ZX, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102291; Zheng J, 2013, FOOD NUTR RES, V57, DOI 10.3402/fnr.v57i0.22754; Zoll J, 2020, AM J PHYSIOL-ENDOC M, V319, pE203, DOI 10.1152/ajpendo.00037.2020	70	1	1	8	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22269	10.1096/fj.202101750R	http://dx.doi.org/10.1096/fj.202101750R			25	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SH	35344215				2022-12-26	WOS:000773602700001
J	Edwards, RJ; Mohammed, A; Lavia, LO; Edwards, J; Verma, S; Reddy, S; Boyce, G				Edwards, R. Jeffrey; Mohammed, Abigail; Lavia, Leon-Omari; Edwards, Jonathan; Verma, Shiva; Reddy, Saketh; Boyce, Gregory			Correlates of prevalent syphilis infection among men who have sex with men (MSM) living with HIV attending the HIV clinic in Trinidad	PLOS ONE			English	Article							ASYMPTOMATIC SYPHILIS; SEROSTATUS DISCLOSURE; RISK BEHAVIOR; GAY	Background Syphilis among men who have sex with men (MSM) living with HIV is of public health concern, thus the objective of the study is to determine the correlates of prevalent syphilis infection in this population so that urgent interventions could be instituted. Methods A cross-sectional study was conducted during the period September 2020-June 2021 among MSM who attended a large HIV Clinic in Trinidad. A questionnaire was administered to obtain socio-demographic data and correlates of prevalent syphilis and patients were screened for syphilis using the traditional algorithm. Descriptive and bivariate analyses were conducted and multivariable logistic regression factors was used to assess factors significantly associated with a syphilis diagnosis. Results Two hundred and sixty four MSM were enrolled; age range 18-64 years, median age 33 years and 89 (34.4%) were actively bisexual. The prevalence of syphilis was 28% (74/264) and 89.2% (66/74) of these infections were asymptomatic. Multivariable logistic regression analysis showed that those patients who participated in sex with anonymous partners (OR 2.09; 95% CI, 1.03-4.26), those with a previous diagnosis of syphilis (OR 5.16; 95% CI, 1.03-25.83) and those who used marijuana in the last 12 months (OR 2.13; 95% CI, 1.14-3.96) were more likely to be diagnosed with syphilis. Conclusion There is a high prevalence of asymptomatic syphilis among MSM living with HIV in Trinidad. Repeat episodes of syphilis and anonymous sex may play a role in the transmission dynamics of T pallidum infection in this population, thus urgent public health prevention interventions are warranted.	[Edwards, R. Jeffrey; Mohammed, Abigail; Lavia, Leon-Omari; Edwards, Jonathan; Verma, Shiva; Reddy, Saketh; Boyce, Gregory] Med Res Fdn Trinidad & Tobago, Port Of Spain, Trinidad Tobago; [Edwards, R. Jeffrey] Univ West Indies, Dept Paraclin Sci, St Augustine, Trinidad Tobago	University West Indies Mona Jamaica; University West Indies Saint Augustine	Edwards, RJ (corresponding author), Med Res Fdn Trinidad & Tobago, Port Of Spain, Trinidad Tobago.; Edwards, RJ (corresponding author), Univ West Indies, Dept Paraclin Sci, St Augustine, Trinidad Tobago.	jeffreye2000@gmail.com		Edwards, R. Jeffrey/0000-0002-4392-8998; Iswaravaka, Saketh/0000-0002-4884-1402; Boyce, Gregory/0000-0002-2434-4612				[Anonymous], HIGH COURT RULES DEC; BARTHOLOMEW C, 1983, W INDIAN MED J, V32, P177; Bellis MA, 2002, J EPIDEMIOL COMMUN H, V56, P235, DOI 10.1136/jech.56.3.235; Van der Meer JTM, 2009, SEX TRANSM DIS, V36, P84, DOI 10.1097/OLQ.0b013e318186debb; Cleghorn FR, 2000, P NATL ACAD SCI USA, V97, P10532, DOI 10.1073/pnas.97.19.10532; Cook CL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207838; Crepaz N, 2003, AIDS CARE, V15, P379, DOI 10.1080/0954012031000105432; Edwards Jeffrey, 2019, J Int Assoc Provid AIDS Care, V18, p2325958219888463, DOI 10.1177/2325958219888463; Edwards RJ, 2021, AIDS RES THER, V18, DOI 10.1186/s12981-021-00341-3; Edwards RJ, 2019, INT J STD AIDS, V30, P1201, DOI 10.1177/0956462419863536; Edwards RJ, 2021, INT J STD AIDS, V32, P830, DOI 10.1177/0956462421997193; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gorbach PM, 2019, SEX TRANSM DIS, V46, P105, DOI 10.1097/OLQ.0000000000000919; Henao-Martinez Andres F, 2014, Neurol Clin Pract, V4, P114; Henry E, 2012, ARCH SEX BEHAV, V41, P525, DOI 10.1007/s10508-012-9916-8; Kenyon C, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy096; Marra CM, 2020, CLIN INFECT DIS, V71, P1243, DOI 10.1093/cid/ciz943; Oneworld Accuracy, 2015, STAND EXT QUAL ASS P; Pathela P, 2006, ANN INTERN MED, V145, P416, DOI 10.7326/0003-4819-145-6-200609190-00005; Phipps W, 2009, SEX TRANSM DIS, V36, P331, DOI 10.1097/OLQ.0b013e3181990c85; Przybyla S, 2014, AIDS PATIENT CARE ST, V28, P677, DOI 10.1089/apc.2014.0203; Rosser BRS, 2008, AIDS CARE, V20, P925, DOI 10.1080/09540120701767265; Roth JA, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa019; Rutledge SE, 2009, AIDS PATIENT CARE ST, V23, P531, DOI 10.1089/apc.2008.0179; Solomon MM, 2015, SEX HEALTH, V12, P96, DOI 10.1071/SH14173; Tomkins A, 2019, PERSPECT PUBLIC HEAL, V139, P23, DOI 10.1177/1757913918778872; Tsuboi M, 2021, LANCET GLOB HEALTH, V9, pE1110, DOI 10.1016/S2214-109X(21)00221-7; UNAIDS/AIDSinfo, COUNTR FACTSH TRIN T; UNAIDSKEY POPULATIONS ATLAS, TRIN TOB; Williams LA, 1999, AM J PUBLIC HEALTH, V89, P1093, DOI 10.2105/AJPH.89.7.1093; Winston A, 2003, SEX TRANSM INFECT, V79, P257, DOI 10.1136/sti.79.3.257; Zea MC, 2005, AIDS BEHAV, V9, P15, DOI 10.1007/s10461-005-1678-z	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265909	10.1371/journal.pone.0265909	http://dx.doi.org/10.1371/journal.pone.0265909			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358217	gold, Green Published			2022-12-26	WOS:000799828800052
J	Rojas, LJ; Yasmin, M; Benjamino, J; Marshall, SM; DeRonde, KJ; Krishnan, NP; Perez, F; Colin, AA; Cardenas, M; Martinez, O; Perez-Cardona, A; Rhoads, DD; Jacobs, MR; LiPuma, JJ; Konstan, MW; Vila, AJ; Smania, A; Mack, AR; Scott, JG; Adams, MD; Abbo, LM; Bonomo, RA				Rojas, Laura J.; Yasmin, Mohamad; Benjamino, Jacquelynn; Marshall, Steven M.; DeRonde, Kailynn J.; Krishnan, Nikhil P.; Perez, Federico; Colin, Andrew A.; Cardenas, Monica; Martinez, Octavio; Perez-Cardona, Armando; Rhoads, Daniel D.; Jacobs, Michael R.; LiPuma, John J.; Konstan, Michael W.; Vila, Alejandro J.; Smania, Andrea; Mack, Andrew R.; Scott, Jacob G.; Adams, Mark D.; Abbo, Lilian M.; Bonomo, Robert A.			Genomic heterogeneity underlies multidrug resistance in Pseudomonas aeruginosa: A population-level analysis beyond susceptibility testing	PLOS ONE			English	Article							CYSTIC-FIBROSIS; INFECTIONS; ADAPTATION; SEQUENCE; DIVERSIFICATION; PROGRAM	Background Pseudomonas aeruginosa is a persistent and difficult-to-treat pathogen in many patients, especially those with Cystic Fibrosis (CF). Herein, we describe a longitudinal analysis of a series of multidrug resistant (MDR) P. aeruginosa isolates recovered in a 17-month period, from a young female CF patient who underwent double lung transplantation. Our goal was to understand the genetic basis of the observed resistance phenotypes, establish the genomic population diversity, and define the nature of sequence evolution over time. Methods Twenty-two sequential P. aeruginosa isolates were obtained within a 17-month period, before and after a double-lung transplant. At the end of the study period, antimicrobial susceptibility testing, whole genome sequencing (WGS), phylogenetic analyses and RNAseq were performed in order to understand the genetic basis of the observed resistance phenotypes, establish the genomic population diversity, and define the nature of sequence changes over time. Results The majority of isolates were resistant to almost all tested antibiotics. A phylogenetic reconstruction revealed 3 major clades representing a genotypically and phenotypically heterogeneous population. The pattern of mutation accumulation and variation of gene expression suggested that a group of closely related strains was present in the patient prior to transplantation and continued to change throughout the course of treatment. A trend toward accumulation of mutations over time was observed. Different mutations in the DNA mismatch repair gene mutL consistent with a hypermutator phenotype were observed in two clades. RNAseq performed on 12 representative isolates revealed substantial differences in the expression of genes associated with antibiotic resistance and virulence traits. Conclusions The overwhelming current practice in the clinical laboratories setting relies on obtaining a pure culture and reporting the antibiogram from a few isolated colonies to inform therapy decisions. Our analyses revealed significant underlying genomic heterogeneity and unpredictable evolutionary patterns that were independent of prior antibiotic treatment, highlighting the need for comprehensive sampling and population-level analysis when gathering microbiological data in the context of CF P. aeruginosa chronic infection. Our findings challenge the applicability of antimicrobial stewardship programs based on single-isolate resistance profiles for the selection of antibiotic regimens in chronic infections such as CF.	[Rojas, Laura J.; Mack, Andrew R.; Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA; [Rojas, Laura J.; Yasmin, Mohamad; Marshall, Steven M.; Mack, Andrew R.; Bonomo, Robert A.] Louis Stokes Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA; [Rojas, Laura J.; Bonomo, Robert A.] CWRU Cleveland VAMC Ctr Antimicrobial Resistance, Cleveland, OH 44106 USA; [Benjamino, Jacquelynn; Adams, Mark D.] Jackson Lab Genom Med, Farmington, CT USA; [DeRonde, Kailynn J.; Martinez, Octavio; Perez-Cardona, Armando; Abbo, Lilian M.] Jackson Mem Hosp, Jackson Hlth Syst, Miami, FL 33136 USA; [Krishnan, Nikhil P.; Scott, Jacob G.; Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA; [Krishnan, Nikhil P.; Scott, Jacob G.] Cleveland Clin, Dept Translat Hematol & Oncol Res, Cleveland, OH 44106 USA; [Krishnan, Nikhil P.; Scott, Jacob G.] Cleveland Clin, Dept Radiat Oncol, Cleveland, OH 44106 USA; [Perez, Federico; Bonomo, Robert A.] Louis Stokes Cleveland VA Med Ctr, Med Serv, Cleveland, OH 44106 USA; [Perez, Federico; Smania, Andrea] Ctr Invest Quim Biol Cordoba CIQUIBIC, CONICET, Cordoba, Argentina; [Perez, Federico; Bonomo, Robert A.] Div Infect Dis & HIV Med, Cleveland, OH 44106 USA; [Perez, Federico; Bonomo, Robert A.] GRECC Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA; [Colin, Andrew A.; Cardenas, Monica] Univ Miami, Miller Sch Med, Dept Pediat, Miami, FL 33136 USA; [Martinez, Octavio] Univ Miami, Div Pulmonol, Dept Pathol, Miller Sch Med, Miami, FL 33136 USA; [Rhoads, Daniel D.] Cleveland Clin, Dept Lab Med, Cleveland, OH 44106 USA; [Rhoads, Daniel D.] Cleveland Clin, Infect Biol Program, Cleveland, OH 44106 USA; [Rhoads, Daniel D.; Jacobs, Michael R.] Case Western Reserve Univ, Cleveland Clin, Dept Pathol, Lerner Coll Med, Cleveland, OH 44106 USA; [LiPuma, John J.] Univ Michigan, Div Pediat Infect Dis, Dept Pediat, Med Sch, Ann Arbor, MI USA; [Konstan, Michael W.] Case Western Reserve Univ, Sch Med, Dept Pediat, Cleveland, OH 44106 USA; [Konstan, Michael W.] Rainbow Babies & Childrens Hosp, 2101 Adelbert Rd, Cleveland, OH 44106 USA; [Vila, Alejandro J.] CONICET UNR, Inst Biol Mol & Celular Rosario IBR, Rosario, Argentina; [Smania, Andrea] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Quim Biol, Cordoba, Argentina; [Abbo, Lilian M.] Univ Miami, Miller Sch Med, Dept Med, Div Infect Dis, Miami, FL 33136 USA; [Bonomo, Robert A.] Dept Pharmacol, Cleveland, OH 44106 USA; [Bonomo, Robert A.] Case Western Reserve Univ, Sch Med, Dept Biochem, Cleveland, OH 44106 USA	Case Western Reserve University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Case Western Reserve University; Jackson Laboratory; Case Western Reserve University; Cleveland Clinic Foundation; Cleveland Clinic Foundation; US Department of Veterans Affairs; Veterans Health Administration (VHA); Case Western Reserve University; Louis Stokes Cleveland Veterans Affairs Medical Center; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Miami; University of Miami; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; University of Michigan System; University of Michigan; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University Hospital; University Hospitals of Cleveland; Rainbow Babies & Children's Hospital; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario; National University of Cordoba; University of Miami; Case Western Reserve University	Bonomo, RA (corresponding author), Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Louis Stokes Vet Affairs Med Ctr, Res Serv, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), CWRU Cleveland VAMC Ctr Antimicrobial Resistance, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Case Western Reserve Univ, Sch Med, Ctr Prote & Bioinformat, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Louis Stokes Cleveland VA Med Ctr, Med Serv, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Div Infect Dis & HIV Med, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), GRECC Louis Stokes Cleveland Vet Affairs Med Ctr, Cleveland, OH 44106 USA.; Bonomo, RA (corresponding author), Dept Pharmacol, Cleveland, OH 44106 USA.	Robert.bonomo@va.gov		Konstan, Michael/0000-0002-0557-7277; , Octavio/0000-0002-0254-6854	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) [R01AI100560, R01AI063517, R01AI072219]; Cleveland Department of Veterans Affairs from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development [1I01BX001974]; Geriatric Research Education and Clinical Center VISN 10	National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Cleveland Department of Veterans Affairs from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development; Geriatric Research Education and Clinical Center VISN 10	This work was supported by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (NIH) to R.A.B. under Award Numbers R01AI100560, R01AI063517, and R01AI072219. This study was also supported in part by funds and/or facilities provided by the Cleveland Department of Veterans Affairs, Award Number 1I01BX001974 to R.A.B. from the Biomedical Laboratory Research & Development Service of the VA Office of Research and Development, and the Geriatric Research Education and Clinical Center VISN 10. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH or the Department of Veterans Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Band VI, 2019, NAT MICROBIOL, V4, P1627, DOI 10.1038/s41564-019-0480-z; Band VI, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.53, 10.1038/NMICROBIOL.2016.53]; Behzadi P, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10010042; Blount ZD, 2018, SCIENCE, V362, DOI 10.1126/science.aam5979; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bonvillain RW, 2007, J HEART LUNG TRANSPL, V26, P890, DOI 10.1016/j.healun.2007.07.002; Brinda K., 2019, BIORXIV; Cansizoglu MF, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000291; Carbon S, 2019, NUCLEIC ACIDS RES, V47, pD330, DOI 10.1093/nar/gky1055; Card KJ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2016886118; Card KJ, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000397; Centers for Disease Control and Prevention, ANTIBIOTIC RESISTANC; Cingolani P, 2012, FLY, V6, P80, DOI 10.4161/fly.19695; Ciofu O, 2010, MICROBIOL-SGM, V156, P1108, DOI 10.1099/mic.0.033993-0; ClinicalLaboratory Standards Institute, 2009, PERFORMANCE STANDARD; Datar R, 2021, FRONT MICROBIOL, V12, DOI 10.3389/fmicb.2021.604555; Dopfer D, 2008, APPL ENVIRON MICROB, V74, P3490, DOI 10.1128/AEM.02789-07; Foundation CF, CYSTIC FIBROSIS FDN; Gu ZG, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4625-x; Hasman H, 2014, J CLIN MICROBIOL, V52, P139, DOI 10.1128/JCM.02452-13; Imamovic L, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006609; Jia BF, 2017, NUCLEIC ACIDS RES, V45, pD566, DOI 10.1093/nar/gkw1004; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; La Manno G, 2018, NATURE, V560, P494, DOI 10.1038/s41586-018-0414-6; La Rosa R, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23451-y; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liao Y, 2014, BIOINFORMATICS, V30, P923, DOI 10.1093/bioinformatics/btt656; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; MAHENTHIRALINGAM E, 1994, INFECT IMMUN, V62, P596, DOI 10.1128/IAI.62.2.596-605.1994; Maltas J., 2019, BIORXIV; Martinez J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53847-2; Marvig RL, 2015, NAT GENET, V47, P57, DOI 10.1038/ng.3148; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; McCaslin CA, 2015, J CYST FIBROS, V14, P70, DOI 10.1016/j.jcf.2014.06.009; Mi HY, 2019, NUCLEIC ACIDS RES, V47, pD419, DOI 10.1093/nar/gky1038; Montanari S, 2007, MICROBIOL-SGM, V153, P1445, DOI 10.1099/mic.0.2006/003400-0; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nichol D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08098-6; Page AJ, 2015, BIOINFORMATICS, V31, P3691, DOI 10.1093/bioinformatics/btv421; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Poplin R., 2018, BIORXIV, DOI DOI 10.1101/201178; RAIVIO TL, 1994, INFECT IMMUN, V62, P3506, DOI 10.1128/IAI.62.8.3506-3514.1994; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Rees VE, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.02538-18; Ronkainen S, 2014, TRANSPL INFECT DIS, V16, P666, DOI 10.1111/tid.12253; Rutter WC, 2017, MICROB DRUG RESIST, V23, P51, DOI 10.1089/mdr.2016.0048; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schiessl KT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08733-w; Seemann T, 2014, BIOINFORMATICS, V30, P2068, DOI 10.1093/bioinformatics/btu153; Stefani S, 2017, INT J MED MICROBIOL, V307, P353, DOI 10.1016/j.ijmm.2017.07.004; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Tlachac M, 2018, PREDICTING FUTURE AN; Treangen TJ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0524-x; VISHWANATH S, 1984, INFECT IMMUN, V45, P197, DOI 10.1128/IAI.45.1.197-202.1984; WHO, 2017, GLOB PRIOR LIST ANT, DOI DOI 10.1016/S1473-3099(17)30753-3; Williams D, 2015, AM J RESP CRIT CARE, V191, P775, DOI 10.1164/rccm.201409-1646OC; Winstanley C, 2016, TRENDS MICROBIOL, V24, P327, DOI 10.1016/j.tim.2016.01.008; Yang L, 2011, P NATL ACAD SCI USA, V108, P7481, DOI 10.1073/pnas.1018249108; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265129	10.1371/journal.pone.0265129	http://dx.doi.org/10.1371/journal.pone.0265129			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358221	Green Published, gold			2022-12-26	WOS:000799828800025
J	Goren-Inbar, N; Belfer-Cohen, A; Grosman, L; Herzlinger, G; Agam, A				Goren-Inbar, Naama; Belfer-Cohen, Anna; Grosman, Leore; Herzlinger, Gadi; Agam, Aviad			Kaizer Hill (Modi'in), a pre-pottery neolithic a quarry site - the terraced slopes	PLOS ONE			English	Article							LANDSCAPES; EXTRACTION; COMPLEXES; ROCKS	The research of the Kaizer Hill site (the Hilltop and its Terraces), recognized as a Pre Pottery Neolithic A (PPNA) quarry site, involved studies of the rock damage associated with the quarrying activities as well as of the recovered material remains, mostly chipped stone artifacts. We present here the results of our on-site explorations (excavations, surveys and surface-collections), focusing on the findings deriving from the Terraces. Diverse rock damage patterns were identified and described, portraying systematic rock mass-exploitation through quarrying fronts, natural rock joints and fissures enlargement, drilling and chiseling. There are multiple indications that the local bedrock (Bi'na Formation, Turonian) comprising flint and limestone was quarried under a systematic quality evaluation, leaving residual flint unsuitable for exploitation. Of interest to note that nearly all of the flint artifacts excavated and collected on the Terraces were made on raw material transported from the Hilltop (Mishash Formation, Campanian), knapped in-situ, on the quarried rock surfaces of the slopes. The flint tools bear witness to intensive use involving mainly boring and drilling. The dominant tool type is the flint axe for which a variety of waste products related to its production were found in-situ, enabling the reconstruction of axe reduction sequence. Similar axes and waste products were found in many PPN sites indicating that there was a common, widely-used scheme of making flint axes during the PPN. Interestingly, besides the flint waste, there were also limestone waste products typical of the last shaping and thinning stages of axe production, indicating that limestone axes were shaped technologically similar to the flint ones, contrary to what has been assumed before. Rare findings, such as obsidian pieces, originating from much further a-field indicate ties with other PPN communities, near and/or far. Overall, this study provides unique and novel insights on Levantine PPN lifeways.	[Goren-Inbar, Naama; Belfer-Cohen, Anna; Grosman, Leore; Herzlinger, Gadi] Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel; [Agam, Aviad] Friedrich Alexander Univ Erlangen Nurnberg, Inst Prehist & Protohist, Dept Class World & Asian Cultures, Erlangen, Germany	Hebrew University of Jerusalem; University of Erlangen Nuremberg	Goren-Inbar, N (corresponding author), Hebrew Univ Jerusalem, Inst Archaeol, Jerusalem, Israel.	goren@cc.huji.ac.il	Grosman, Leore/GRJ-0792-2022	Grosman, Leore/0000-0002-6976-6202; Herzlinger, Gadi/0000-0002-6437-607X	Institute of Archaeology, Hebrew University; Care Archaeological Foundation; Stekelis Foundation	Institute of Archaeology, Hebrew University; Care Archaeological Foundation; Stekelis Foundation	Institute of Archaeology, Hebrew University (NG-I, LG) Care Archaeological Foundation (AA, NG-I) Stekelis Foundation (NG-I, AA) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agam A., 2019, FLINT PROCUREMENT EX; Agam A, 2020, J ARCHAEOL SCI-REP, V33, DOI 10.1016/j.jasrep.2020.102447; Agam A, 2016, J FIELD ARCHAEOL, V41, P713, DOI 10.1080/00934690.2016.1240598; [Anonymous], 2006, AXE AGE ACHEULIAN TO; [Anonymous], 1988, NATUFIAN SETTLEMENT; Aston M., 2002, INTERPRETING LANDSCA; Balkan-Atli N., 2011, ANATOLIA ANTIQUA, VXIX, P259; Bar-Yosef O., 2010, GILGAL EARLY NEOLITH; Barkai R, 2007, TECHNICAL SYSTEMS NE, P25; Barkai R, 2005, FLINT STONE AXES CUL, V11; Barkai R., 2011, STONE AXE STUDIES 3, P39; Bender B, 2007, STONE WORLDS NARRATI; Chew SC, 2001, WORLD ECOLOGICAL DEGRADATION, P1; Crowfoot J., 1937, LIVERPOOL ANN ARCHAE, V24, P35; Crowfoot-Payne J., 1983, EXCAVATIONS JERICHO, VV, P622; David B., 2016, HDB LANDSCAPE ARCHAE; Ekshtain R, 2021, QUATERN INT; Finkel M, 2018, ARCHAEOL RES ASIA, V16, P14, DOI 10.1016/j.ara.2018.01.004; Finkel M, 2016, J WORLD PREHIST, V29, P217, DOI 10.1007/s10963-016-9097-9; Finlayson B, 2016, P INT C SAN 2012 AQ; Garfinkel Yossi, 1989, PALEORIENT, V15, P139; Golani A., 2005, ATIQUOT, V50, P73; Gopher A, 2011, WORLD ARCHAEOL, V43, P211, DOI 10.1080/00438243.2011.579484; Goren-Inbar N., 2021, OPEN SCI FRAMEWORK O, DOI [10.17605/OSF.IO/54327, DOI 10.17605/OSF.IO/54327]; Goring-Morris AN, 2014, OXFORD HDB ARCHAEOLO, P147; Grosman L., 2013, ARCHAEOLOGICAL SERIE, P622, DOI DOI 10.2307/J.CTV8BT33H.41; Grosman L, 2007, CURR ANTHROPOL, V48, P732, DOI 10.1086/520966; Grosman L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150395; Herzlinger G., 2021, PALEOANTHROPOLOGY, V2021, DOI [10.48738/2021.iss1.70, DOI 10.48738/2021.ISS1.70]; Herzlinger G., 2013, STONE TOOLS TRANSITI, P395; Herzlinger G, 2019, J HUM EVOL, V128, P45, DOI 10.1016/j.jhevol.2018.11.008; Herzlinger G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207890; Hofmann Daniela, 2013, TRACKING NEOLITHIC H, P19, DOI DOI 10.1007/978-1-4614-5289-8_2; Karul N., 2021, TURK ARKEOLOJI ETNOG, P21; KOLODNY Y, 1969, J SEDIMENT PETROL, V39, P166; Liphschitz N, 2001, ISRAEL EXPLOR J, V51, P36; Malinsky-Buller A, 2013, PALEORIENT, V39, P155; Malinsky-Buller A, 2009, NEOLITHICS, V2, P2; Marder O, 2007, PALEORIENT, V32, P79; Milic M, 2013, SUBSTANTIVE TECHNOLO, V9; Mithen SB, 2018, STRATIGRAPHY CHRONOL; Mithen SJ, 2011, ANTIQUITY, V85, P350, DOI 10.1017/S0003598X00067806; Modiin Spivak P., 2016, HADASHOT ARKHEOLOGIY, P128; Nadel D., 1997, EARLY NEOLITHIC VI 1, P71; Naveh D, 2003, CAMB ARCHAEOL J, V13, P83, DOI 10.1017/S0959774303000052; NEWCOMER MH, 1971, WORLD ARCHAEOL, V3, P85, DOI 10.1080/00438243.1971.9979493; Novoselsky I, 2020, LITHIC TECHNOL, V45, P68, DOI 10.1080/01977261.2020.1716165; Richter T., 2017, QUATERNARY LEVANT EN, P94; Schmidt K., 2012, GOBEKLI TEPE STONE A; Singh BP, 2011, CURR SCI INDIA, V101, P1402; Taute W., 1994, NEOLITHIC CHIPPED ST, P495; van den Brink ECM, 2004, A40690401 ISR ANT AU; Zbinovich V., 2006, ATIQOT, V51, P1; Zbinovich V., 1999, MODIIN PROJECT FLINT, P1; Zbinovich V., 1999, MODIIN PROJECT FLINT; Zbinovich V., 1999, MODIIN PROJECT SALVA	56	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265727	10.1371/journal.pone.0265727	http://dx.doi.org/10.1371/journal.pone.0265727			62	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324993	Green Published, gold			2022-12-26	WOS:000780951300062
J	Li, AD; Zhang, XY; Singla, J; White, K; Loconte, V; Hu, CY; Zhang, CY; Li, SL; Li, WM; Francis, JP; Wang, CX; Sali, A; Sun, LP; He, XM; Stevens, RC				Li, Angdi; Zhang, Xiangyi; Singla, Jitin; White, Kate; Loconte, Valentina; Hu, Chuanyang; Zhang, Chuyu; Li, Shuailin; Li, Weimin; Francis, John Paul; Wang, Chenxi; Sali, Andrej; Sun, Liping; He, Xuming; Stevens, Raymond C.			Auto-segmentation and time-dependent systematic analysis of mesoscale cellular structure in beta-cells during insulin secretion	PLOS ONE			English	Article							X-RAY TOMOGRAPHY; MIXTURE-MODELS; NEURAL-NETWORK; GRANULE MOTION; GLUCOSE; MICROSCOPY; FLUORESCENCE; MECHANISMS; EXOCYTOSIS; 1ST-PHASE	The mesoscale description of the subcellular organization informs about cellular mechanisms in disease state. However, applications of soft X-ray tomography (SXT), an important approach for characterizing organelle organization, are limited by labor-intensive manual segmentation. Here we report a pipeline for automated segmentation and systematic analysis of SXT tomograms. Our approach combines semantic and first-applied instance segmentation to produce separate organelle masks with high Dice and Recall indexes, followed by analysis of organelle localization based on the radial distribution function. We demonstrated this technique by investigating the organization of INS-1E pancreatic beta-cell organization under different treatments at multiple time points. Consistent with a previous analysis of a similar dataset, our results revealed the impact of glucose stimulation on the localization and molecular density of insulin vesicles and mitochondria. This pipeline can be extended to SXT tomograms of any cell type to shed light on the subcellular rearrangements under different drug treatments.	[Li, Angdi; Loconte, Valentina; Li, Weimin; Wang, Chenxi; Sun, Liping; Stevens, Raymond C.] ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China; [Li, Angdi; Loconte, Valentina; Li, Weimin; Wang, Chenxi; Sun, Liping; Stevens, Raymond C.] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China; [Li, Angdi; Li, Weimin; Wang, Chenxi] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Xiangyi; Hu, Chuanyang; Zhang, Chuyu; Li, Shuailin; He, Xuming] ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai, Peoples R China; [He, Xuming] Shanghai Engn Res Ctr Intelligent Vis & Imaging, Shanghai, Peoples R China; [Singla, Jitin; White, Kate; Stevens, Raymond C.] Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90007 USA; [Francis, John Paul] Univ Southern Calif, USC Michelson Ctr Convergent Biosci, Bridge Inst, Dept Comp Sci, Los Angeles, CA 90007 USA; [Sali, Andrej] Univ Calif San Francisco, Dept Pharmaceut Chem, Dept Bioengn & Therapeut Sci, Calif Inst Quantitat Biosci, San Francisco, CA USA	ShanghaiTech University; ShanghaiTech University; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; ShanghaiTech University; University of Southern California; University of Southern California; University of California System; University of California San Francisco	Sun, LP; Stevens, RC (corresponding author), ShanghaiTech Univ, iHuman Inst, Shanghai, Peoples R China.; Sun, LP; Stevens, RC (corresponding author), ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China.; He, XM (corresponding author), ShanghaiTech Univ, Sch Informat Sci & Technol, Shanghai, Peoples R China.; He, XM (corresponding author), Shanghai Engn Res Ctr Intelligent Vis & Imaging, Shanghai, Peoples R China.; Stevens, RC (corresponding author), Univ Southern Calif, Bridge Inst, Dept Biol Sci, Los Angeles, CA 90007 USA.	sunlp@shanghaitech.edu.cn; hexm@shanghaitech.edu.cn; stevens@shanghaitech.edu.cn	Singla, Jitin/AAD-6768-2021	Singla, Jitin/0000-0001-6225-0783; Li, Angdi/0000-0001-6143-6295	NIH [P41GM103445, R01GM083960, P41GM109824]; DOE's Office of Biological and Environmental Research [DE-AC02-5CH11231]; National Natural Science Foundation of China [31950410543]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE's Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The National Center for X-ray Tomography is supported by the NIH (P41GM103445) and DOE's Office of Biological and Environmental Research (DE-AC025CH11231). VL was supported by the National Natural Science Foundation of China (31950410543). AS was supported by NIH grants R01GM083960 and P41GM109824. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait Skourt B, 2018, PROCEDIA COMPUT SCI, V127, P109, DOI 10.1016/j.procs.2018.01.104; Akkus Z, 2017, J DIGIT IMAGING, V30, P449, DOI 10.1007/s10278-017-9983-4; Arganda-Carreras I, 2017, BIOINFORMATICS, V33, P2424, DOI 10.1093/bioinformatics/btx180; Aydin AS, 2017, IEEE COMPUT SOC CONF, P753, DOI 10.1109/CVPRW.2017.105; Bratanova-Tochkova TK, 2002, DIABETES, V51, pS83, DOI 10.2337/diabetes.51.2007.S83; Carr RD, 2003, DIABETES, V52, P2513, DOI 10.2337/diabetes.52.10.2513; Chen CG, 2017, MOL METAB, V6, P943, DOI 10.1016/j.molmet.2017.06.019; Chen W, 2017, ACS NANO, V11, P5062, DOI 10.1021/acsnano.7b01809; Dalca AV, 2019, LECT NOTES COMPUT SC, V11766, P356, DOI 10.1007/978-3-030-32248-9_40; Daniel S, 1999, DIABETES, V48, P1686, DOI 10.2337/diabetes.48.9.1686; Darrow MC, 2016, J CELL SCI, V129, P3511, DOI 10.1242/jcs.189225; Dehghany J, 2015, TRAFFIC, V16, P797, DOI 10.1111/tra.12286; Dima AA, 2011, CYTOM PART A, V79A, P545, DOI 10.1002/cyto.a.21079; Dong X, 2019, MED PHYS, V46, P2157, DOI 10.1002/mp.13458; Durisic N, 2014, CURR OPIN CHEM BIOL, V20, P22, DOI 10.1016/j.cbpa.2014.04.005; Fehse F, 2005, J CLIN ENDOCR METAB, V90, P5991, DOI 10.1210/jc.2005-1093; Francis JP, 2020, I S BIOMED IMAGING, P1183, DOI 10.1109/ISBI45749.2020.9098739; Gao G, P IEEE CVF INT C COM, V2021, P14677; Gibson E, 2018, IEEE T MED IMAGING, V37, P1822, DOI 10.1109/TMI.2018.2806309; Girshick R, 2015, IEEE I CONF COMP VIS, P1440, DOI 10.1109/ICCV.2015.169; Haythorne E, 2016, NEUROPHARMACOLOGY, V111, P212, DOI 10.1016/j.neuropharm.2016.09.008; He KM, 2020, IEEE T PATTERN ANAL, V42, P386, DOI 10.1109/TPAMI.2018.2844175; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Hou JCQ, 2009, VITAM HORM, V80, P473, DOI 10.1016/S0083-6729(08)00616-X; Johnson GR, 2017, BUILDING 3D INTEGRAT; Krizhevsky A., 2012, ADV NEURAL INF PROCE; Krull A, 2019, PROC CVPR IEEE, P2124, DOI 10.1109/CVPR.2019.00223; Le Gros MA, 2005, CURR OPIN STRUC BIOL, V15, P593, DOI 10.1016/j.sbi.2005.08.008; Le Gros MA, 2016, CELL REP, V17, P2125, DOI 10.1016/j.celrep.2016.10.060; Levine BG, 2011, J COMPUT PHYS, V230, P3556, DOI 10.1016/j.jcp.2011.01.048; Li XM, 2018, IEEE T MED IMAGING, V37, P2663, DOI 10.1109/TMI.2018.2845918; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Long J, 2015, PROC CVPR IEEE, P3431, DOI 10.1109/CVPR.2015.7298965; Ma JW, 2020, PLOS COMPUT BIOL, V16, DOI 10.1371/journal.pcbi.1008356; Maechler P, 2001, NATURE, V414, P807, DOI 10.1038/414807a; McDermott G, 2009, TRENDS CELL BIOL, V19, P587, DOI 10.1016/j.tcb.2009.08.005; Mica OI, 2004, BIOCHEM J, V381, P13, DOI 10.1042/BJ20040434; Ohara-Imaizumi M, 2002, J BIOL CHEM, V277, P3805, DOI 10.1074/jbc.C100712200; Ohara-Imaizumi M, 2007, J CELL BIOL, V177, P695, DOI 10.1083/jcb.200608132; Pelt DM, 2018, P NATL ACAD SCI USA, V115, P254, DOI 10.1073/pnas.1715832114; Poudel RPK, 2017, LECT NOTES COMPUT SC, V10129, P83, DOI 10.1007/978-3-319-52280-7_8; Qi Dou, 2016, Medical Image Computing and Computer-Assisted Intervention - MICCAI 2016. 19th International Conference. Proceedings: LNCS 9901, P149, DOI 10.1007/978-3-319-46723-8_18; Quinault A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193882; Ren SQ, 2015, ADV NEUR IN, V28, DOI 10.1109/TPAMI.2016.2577031; Ronneberger O, 2015, LECT NOTES COMPUT SC, V9351, P234, DOI 10.1007/978-3-319-24574-4_28; Schisler JC, 2005, P NATL ACAD SCI USA, V102, P7297, DOI 10.1073/pnas.0502168102; Schwarz TL, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011304; Singla J, 2018, CELL, V173, P11, DOI 10.1016/j.cell.2018.03.014; Smith EA, 2014, BIOPHYS J, V107, P1988, DOI 10.1016/j.bpj.2014.09.011; Uchida M, 2011, YEAST, V28, P227, DOI 10.1002/yea.1834; Uchida M, 2009, P NATL ACAD SCI USA, V106, P19375, DOI 10.1073/pnas.0906145106; Van Valen DA, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1005177; Wang YR, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/9471583; Wang ZX, 2009, J CELL SCI, V122, P893, DOI 10.1242/jcs.034355; Weinhardt V, 2019, BIOCHEM SOC T, V47, P489, DOI 10.1042/BST20180036; Weiss D, 2000, ULTRAMICROSCOPY, V84, P185, DOI 10.1016/S0304-3991(00)00034-6; White KL, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc8262; Wollheim CB, 2000, DIABETOLOGIA, V43, P265, DOI 10.1007/s001250050044; Woolrich MW, 2006, IEEE T MED IMAGING, V25, P1380, DOI 10.1109/TMI.2006.880682; Woolrich MW, 2005, IEEE T MED IMAGING, V24, P1, DOI 10.1109/TMI.2004.836545	60	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265567	10.1371/journal.pone.0265567	http://dx.doi.org/10.1371/journal.pone.0265567			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324950	Green Published, gold			2022-12-26	WOS:000780951300047
J	Sun, JC; Zhang, WS				Sun, Jingchi; Zhang, Weishe			Supplementation with dietary omega-3 PUFA mitigates fetal brain inflammation and mitochondrial damage caused by high doses of sodium nitrite in maternal rats	PLOS ONE			English	Article							OMEGA-3-FATTY-ACIDS; PROLIFERATION; EXPOSURE	Objective Food safety and nutrition during pregnancy are important concerns related to fetal brain development. In the present study, we aimed to explore the effects of omega-3 polyunsaturated fatty acids (PUFA omega-3) on exogenous sodium nitrite intervention-induced fetal brain injury in pregnant rats. Methods During pregnancy, rats were exposed to water containing sodium nitrite (0.05%, 0.15%, and 0.25%) to establish a fetal rat brain injury model. Inflammatory factors and oxidative stress levels were detected using enzyme-linked immunosorbent assay (ELISA) or flow cytometry. Subsequently, animals were divided into three groups: control, model, and 4% PUFA omega-3. Pregnancy outcomes were measured and recorded. Hematoxylin-eosin (H&E) staining and immunohistochemistry (IHC) were utilized to observe brain injury. ELISA, quantitative realtime PCR (qRT-PCR), western blot, flow cytometry, and transmission electron microscopy (TEM) were adopted to measure the levels of inflammatory factors, the NRF1/HMOX1 signaling pathway, and mitochondrial and oxidative stress damage. Results With the increase of sodium nitrite concentration, the inflammatory factors and oxidative stress levels increased. Therefore, the high dose group was set as the model group for the following experiments. After PUFA omega-3 treatment, the fetal survival ratio, average body weight, and brain weight were elevated. The cells in the PUFA omega-3 group were more closely arranged and more round than the model. PUFA omega-3 treatment relieved inflammatory factors, oxidative stress levels, and mitochondria damage while increasing the indicators related to brain injury and NRF1/HMOX1 levels. Conclusions Sodium nitrite exposure during pregnancy could cause brain damage in fetal rats. PUFA omega-3 might help alleviate brain inflammation, oxidative stress, and mitochondrial damage, possibly through the NRF1/HMOX1 signaling pathway. In conclusion, appropriately reducing sodium nitrite exposure and increasing PUFA omega-3 intake during pregnancy may benefit fetal brain development. These findings could further our understanding of nutrition and health during pregnancy.	[Sun, Jingchi; Zhang, Weishe] Cent South Univ, Xiangya Hosp, Dept Obstet, Changsha, Hunan, Peoples R China; [Zhang, Weishe] Hunan Engn Res Ctr Early Life Dev & Dis Prevent, Changsha, Hunan, Peoples R China	Central South University	Zhang, WS (corresponding author), Cent South Univ, Xiangya Hosp, Dept Obstet, Changsha, Hunan, Peoples R China.; Zhang, WS (corresponding author), Hunan Engn Res Ctr Early Life Dev & Dis Prevent, Changsha, Hunan, Peoples R China.	zhangweishe@yeah.net			National Key Research and Development Program of China [2016YFC1000206]; Science and Technology Innovation Program of Hunan Province [2019SK1010, 2020SK2072]	National Key Research and Development Program of China; Science and Technology Innovation Program of Hunan Province	The research was supported by the National Key Research and Development Program of China (NO.2016YFC1000206) and The Science and Technology Innovation Program of Hunan Province grants (NO.2019SK1010 and 2020SK2072).	Adamo AM, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00062; Ahmad Rizwan, 2019, J Immunoassay Immunochem, V40, P343, DOI [10.1080/15321819.2019.1583109, 10.1080/15321819.2019.1616555]; Bennet L, 2018, J REPROD IMMUNOL, V125, P45, DOI 10.1016/j.jri.2017.11.003; Chen XM, 2018, FREE RADICAL BIO MED, V117, P158, DOI 10.1016/j.freeradbiomed.2018.02.011; Czystowska-Kuzmicz M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10979-3; Devarshi PP, 2019, NUTRIENTS, V11, DOI 10.3390/nu11051107; DiNicolantonio JJ, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082333; Djuricic I, 2021, NUTRIENTS, V13, DOI 10.3390/nu13072421; Dumont U, 2020, BRAIN RES, V1738, DOI 10.1016/j.brainres.2020.146798; Feltham BA, 2020, ADV NUTR, V11, P724, DOI 10.1093/advances/nmz135; Franco PN, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22020680; Gassowska M, 2016, TOXICOLOGY, V373, P13, DOI 10.1016/j.tox.2016.10.014; Ge L, 2019, TOXICOLOGY, V427, DOI 10.1016/j.tox.2019.152284; Giambrone AB, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20164051; Healy-Stoffel M, 2018, CNS NEUROL DISORD-DR, V17, P216, DOI 10.2174/1871527317666180412153612; Kasture V, 2019, MOL CELL BIOCHEM, V461, P159, DOI 10.1007/s11010-019-03599-4; Larque E, 2012, BRIT J NUTR, V107, pS77, DOI 10.1017/S0007114512001481; Lindsay KL, 2019, BIOL PSYCHIAT, V85, P135, DOI 10.1016/j.biopsych.2018.06.021; Madore C, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19861-z; MAEKAWA A, 1982, FOOD CHEM TOXICOL, V20, P25, DOI 10.1016/S0278-6915(82)80005-7; Manassaram DM, 2006, ENVIRON HEALTH PERSP, V114, P320, DOI 10.1289/ehp.8407; McDougle DR, 2017, P NATL ACAD SCI USA, V114, pE6034, DOI 10.1073/pnas.1610325114; Monthe-Dreze C, 2021, NUTRIENTS, V13, DOI 10.3390/nu13020578; Neth MR, 2021, PREHOSP EMERG CARE, V25, P844, DOI 10.1080/10903127.2020.1838009; Novak D, 2020, SEMIN CANCER BIOL, V67, P74, DOI 10.1016/j.semcancer.2019.08.007; Nuttall JR, 2015, J NUTR BIOCHEM, V26, P1116, DOI 10.1016/j.jnutbio.2015.05.007; NYAKAS C, 1990, BEHAV BRAIN RES, V38, P69, DOI 10.1016/0166-4328(90)90025-A; NYAKAS C, 1994, EUR J NEUROSCI, V6, P746, DOI 10.1111/j.1460-9568.1994.tb00986.x; Patrick RP, 2019, FASEB J, V33, P1554, DOI 10.1096/fj.201801412R; Pu HJ, 2017, CELL TRANSPLANT, V26, P555, DOI [10.3727/096368916X693842, 10.3727/096368916x693842]; Raza C, 2019, LIFE SCI, V226, P77, DOI 10.1016/j.lfs.2019.03.057; ROTH AC, 1987, FUND APPL TOXICOL, V9, P668, DOI 10.1016/0272-0590(87)90173-4; Tang MM, 2018, PROSTAG LEUKOTR ESS, V128, P11, DOI 10.1016/j.plefa.2017.11.001; TARBURTON JP, 1985, TOXICOLOGY, V36, P15, DOI 10.1016/0300-483X(85)90003-4; Tenorio-Lopes L, 2017, J PHYSIOL-LONDON, V595, P1637, DOI 10.1113/JP273471; Tsai CM, 2020, J BIOPHOTONICS, V13, DOI 10.1002/jbio.202000095; Vlachou C, 2020, FOOD CHEM TOXICOL, V143, DOI 10.1016/j.fct.2020.111480; Wang RH, 2021, FRONT GENET, V11, DOI 10.3389/fgene.2020.616947; Weinberg RL, 2021, J AM COLL CARDIOL, V77, P593, DOI 10.1016/j.jacc.2020.11.060; Wufuer R, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10101610; Xie YN, 2020, CHIN MED-UK, V15, DOI 10.1186/s13020-020-00314-0; Yang L, 2020, NEUROBIOL DIS, V140, DOI 10.1016/j.nbd.2020.104814; Zhong Y, 2018, AM J PHYSIOL-LUNG C, V315, pL116, DOI 10.1152/ajplung.00527.2017; Zhou FK, 2020, J HAZARD MATER, V388, DOI 10.1016/j.jhazmat.2020.122081; Zhou FK, 2019, ENVIRON INT, V133, DOI 10.1016/j.envint.2019.105192	45	0	0	5	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266084	10.1371/journal.pone.0266084	http://dx.doi.org/10.1371/journal.pone.0266084			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324981	Green Published, gold			2022-12-26	WOS:000780951300100
J	Vazquez-Cornejo, E; Morales-Rios, O; Hernandez-Pliego, G; Cicero-Oneto, C; Garduno-Espinosa, J				Vazquez-Cornejo, Edmundo; Morales-Rios, Olga; Hernandez-Pliego, Gabriela; Cicero-Oneto, Carlo; Garduno-Espinosa, Juan			Incidence, severity, and preventability of adverse events during the induction of patients with acute lymphoblastic leukemia in a tertiary care pediatric hospital in Mexico	PLOS ONE			English	Article							MEDICATION ERRORS; DRUG EVENTS; CHILDREN; CANCER; MALNUTRITION; DEFINITIONS; MORTALITY; INCOME; HARM	Healthcare-associated adverse events represent a heavy burden of symptoms for pediatric oncology patients. Their description allows knowing the safety and quality of the care processes in countries with limited resources. This study aimed to describe the incidence, types, severity, and preventability of adverse events occurring in pediatric patients with acute lymphoblastic leukemia during the induction phase in a tertiary care pediatric hospital in Mexico. This study analyzed a cohort based on medical records of between 2015 and 2017. Initially, information on patients and adverse events was collected; subsequently, two pediatric oncologist reviewers independently classified adverse events, severity and preventability. Agreement between reviewers was evaluated. Adverse events incidence rates were estimated by type, severity, and preventability. One-hundred and eighty-one pediatric patients pediatric patients with acute lymphoblastic leukemia were studied. An overall adverse events rate of 51.8 per 1000 patient-days was estimated, involving 81.2% of patients during induction. Most adverse events were severe or higher (52.6%). Infectious processes were the most common severe or higher adverse event (30.5%). The presence of adverse events caused 80.2% of hospital readmissions. Of the adverse events, 10.5% were considered preventable and 53.6% could be ameliorable in severity. Improving the safety and quality of the care processes of children with acute lymphoblastic leukemia is possible, and this should contribute to the mitigation and prevention of adverse events associated morbidity and mortality during the remission induction phase.	[Vazquez-Cornejo, Edmundo; Morales-Rios, Olga] Federico Gomez Childrens Hosp Mexico, Dept Drug Assessment & Pharmacovigilance, Mexico City, DF, Mexico; [Hernandez-Pliego, Gabriela; Cicero-Oneto, Carlo] Federico Gomez Childrens Hosp Mexico, Dept Hematooncol, Mexico City, DF, Mexico; [Garduno-Espinosa, Juan] Federico Gomez Childrens Hosp Mexico, Dept Res, Mexico City, DF, Mexico	Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez; Hospital Infantil de Mexico Federico Gomez	Vazquez-Cornejo, E (corresponding author), Federico Gomez Childrens Hosp Mexico, Dept Drug Assessment & Pharmacovigilance, Mexico City, DF, Mexico.	edmundoepiclin.qfb@outlook.com		Vazquez-Cornejo, Edmundo/0000-0001-8118-4734				Aguilar-Hernandez Maximo, 2017, Rev Med Inst Mex Seguro Soc, V55, P286; Martin-Trejo JA, 2017, LEUKEMIA LYMPHOMA, V58, P898, DOI 10.1080/10428194.2016.1219904; [Anonymous], 2021, PROT MAN PAC PED CON; [Anonymous], 2012, NORM OF MEX NOM 004; [Anonymous], 2018, MEAS PAT SAF OP BLAC; [Anonymous], 2021, AN EST; Barajas-Nava LA, 2016, B MED HOSP INFANT M, V73, P467, DOI 10.1016/j.bmhimx.2016.11.005; BRENNAN TA, 1991, NEW ENGL J MED, V324, P370, DOI 10.1056/NEJM199102073240604; Call RJ, 2014, J PEDIATR-US, V165, P447, DOI 10.1016/j.jpeds.2014.03.033; Cancer Therapy Evaluation Program (CTEP), 2017, COMMON TERMINOLOGY C; Nunez-Enriqueiz JC, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5878-8; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Rendon-Macias ME, 2012, B MED HOSP INFANT M, V69, P153; Ferner RE, 2006, DRUG SAFETY, V29, P1011, DOI 10.2165/00002018-200629110-00001; Gandhi TK, 2003, NEW ENGL J MED, V348, P1556, DOI 10.1056/NEJMsa020703; Gates PJ, 2018, PEDIATRICS, V142, DOI 10.1542/peds.2018-0805; Gerber A, 2020, HEALTH SCI REP-US, V3, DOI 10.1002/hsr2.160; Hakkarainen KM, 2012, DRUG SAFETY, V35, P105, DOI 10.2165/11596570-000000000-00000; Haukland EC, 2017, ACTA ONCOL, V56, P1218, DOI 10.1080/0284186X.2017.1309063; HIATT HH, 1989, NEW ENGL J MED, V321, P480, DOI 10.1056/NEJM198908173210725; Houweling TAJ, 2010, BRIT MED BULL, V93, P7, DOI 10.1093/bmb/ldp048; Howard SC, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26879; Inaba H, 2017, ANN ONCOL, V28, P386, DOI 10.1093/annonc/mdw557; Klein DO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208087; Leape L, 2005, WHOEIPSPOQPS053; Leape L L, 1993, QRB Qual Rev Bull, V19, P144; LEAPE LL, 1991, NEW ENGL J MED, V324, P377, DOI 10.1056/NEJM199102073240605; Li MJ, 2017, PEDIATR BLOOD CANCER, V64, DOI 10.1002/pbc.26535; Lipitz-Snyderman A, 2017, CANCER-AM CANCER SOC, V123, P4728, DOI 10.1002/cncr.30916; Logan C, 2020, HEMATOL-AM SOC HEMAT, P135, DOI 10.1182/hematology.2020000098; Maaskant JM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006208.pub3; Magrath I, 2013, LANCET ONCOL, V14, pE104, DOI 10.1016/S1470-2045(13)70008-1; Manias E, 2019, J PAEDIATR CHILD H, V55, P320, DOI 10.1111/jpc.14193; Matlow AG, 2011, BMJ QUAL SAF, V20, P416, DOI 10.1136/bmjqs.2010.041152; McFatrich M, 2020, CANCER-AM CANCER SOC, V126, P140, DOI 10.1002/cncr.32525; Morales-Rios O, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230576; Pui CH, 2010, LEUKEMIA, V24, P371, DOI 10.1038/leu.2009.252; Rivera-Luna R, 2008, PEDIATR HEMAT ONCOL, V25, P17, DOI 10.1080/08880010701774132; Rocha-Garcia A, 2003, PSYCHO-ONCOLOGY, V12, P78, DOI 10.1002/pon.679; Rodziewicz TL, STATPEARLS INTERNET; Sherief LM, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002280; Soop M, 2009, INT J QUAL HEALTH C, V21, P285, DOI 10.1093/intqhc/mzp025; Vazquez-Cornejo E, 2019, CANCER MED-US, V8, P5979, DOI 10.1002/cam4.2438; Walsh KE, 2009, J CLIN ONCOL, V27, P891, DOI 10.1200/JCO.2008.18.6072; West Z, 2019, BLOOD, V134, DOI 10.1182/blood-2019-131873; Woo SA, 2020, BRIT J CLIN PHARMACO, V86, P291, DOI 10.1111/bcp.14139	46	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265450	10.1371/journal.pone.0265450	http://dx.doi.org/10.1371/journal.pone.0265450			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324939	gold, Green Published			2022-12-26	WOS:000780951300043
J	Zein, HF; Alam, I; Asanithi, P; Sutthibutpong, T				Zein, Husnul Fuad; Alam, Ibrar; Asanithi, Piyapong; Sutthibutpong, Thana			Molecular dynamics study on the effects of charged amino acid distribution under low pH condition to the unfolding of hen egg white lysozyme and formation of beta strands	PLOS ONE			English	Article							ELECTROCHEMICAL IMPEDANCE SPECTROSCOPY; LONG-RANGE INTERACTIONS; AMYLOID FIBRILS; BUILDING-BLOCKS; FORCE-FIELD; AGGREGATION; HYDROGELS; PROTEINS	Aggregation of unfolded or misfolded proteins into amyloid fibrils can cause various diseases in humans. However, the fibrils synthesized in vitro can be developed toward useful biomaterials under some physicochemical conditions. In this study, atomistic molecular dynamics simulations were performed to address the mechanism of beta-sheet formation of the unfolded hen egg-white lysozyme (HEWL) under a high temperature and low pH. Simulations of the protonated HEWL at pH 2 and the non-protonated HEWL at pH 7 were performed at the highly elevated temperature of 450 K to accelerate the unfolding, followed by the 333 K temperature to emulate some previous in vitro studies. The simulations showed that HEWL unfolded faster, and higher beta-strand contents were observed at pH 2. In addition, one of the simulation replicas at pH 2 showed that the beta-strand forming sequence was consistent with the 'K-peptide', proposed as the core region for amyloidosis in previous experimental studies. Beta-strand formation mechanisms at the earlier stage of amyloidosis were explained in terms of the radial distribution of the amino acids. The separation between groups of positively charged sidechains from the hydrophobic core corresponded to the clustering of the hydrophobic residues and beta-strand formation.	[Zein, Husnul Fuad; Alam, Ibrar; Asanithi, Piyapong; Sutthibutpong, Thana] King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Nanosci & Nanotechnol Program, Bangkok, Thailand; [Zein, Husnul Fuad; Sutthibutpong, Thana] KMUTT, Dept Phys, Theoret & Computat Phys Grp, Bangkok, Thailand; [Zein, Husnul Fuad; Sutthibutpong, Thana] King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Bangkok, Thailand; [Sutthibutpong, Thana] King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Ctr Excellence Theoret & Computat Sci TaCS CoE, Bangkok, Thailand	King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi; King Mongkuts University of Technology Thonburi	Sutthibutpong, T (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Nanosci & Nanotechnol Program, Bangkok, Thailand.	thana.sut@mail.kmutt.ac.th		Alam, Ibrar/0000-0001-9408-6762; Zein, Husnul Fuad/0000-0002-7130-6870; Sutthibutpong, Thana/0000-0002-4468-8885	Thailand Science Research and Innovation (TSRI) Basic Research Fund; Petchra Pra Jom Klao Doctoral Scholarship, KMUTT	Thailand Science Research and Innovation (TSRI) Basic Research Fund; Petchra Pra Jom Klao Doctoral Scholarship, KMUTT	This research project was supported by the Thailand Science Research and Innovation (TSRI) Basic Research Fund through a grant awarded to TS. The Petchra Pra Jom Klao Doctoral Scholarship, KMUTT, also provided support to HFZ.	Altunbas A, 2012, TOP CURR CHEM, V310, P135, DOI 10.1007/128_2011_206; Bleem A, 2017, BIOTECHNOL BIOENG, V114, P7, DOI 10.1002/bit.26059; Bogomolova A, 2009, ANAL CHEM, V81, P3944, DOI 10.1021/ac9002358; Chen ZB, 2011, TALANTA, V83, P1501, DOI 10.1016/j.talanta.2010.11.042; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Das S, 2018, BIOMACROMOLECULES, V19, P1826, DOI 10.1021/acs.biomac.8b00279; Defelice FG, 2002, AN ACAD BRAS CIENC, V74, P265, DOI 10.1590/S0001-37652002000200006; Deidda G, 2017, ACS BIOMATER SCI ENG, V3, P1404, DOI 10.1021/acsbiomaterials.6b00570; English NJ, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2515315; Erimban S, 2019, J CHEM PHYS, V151, DOI 10.1063/1.5108830; Guvench Olgun, 2008, V443, P63, DOI 10.1007/978-1-59745-177-2_4; Hauser CAE, 2014, CHEM SOC REV, V43, P5326, DOI 10.1039/c4cs00082j; Humenik M, 2014, ACS NANO, V8, P1342, DOI 10.1021/nn404916f; Jacob RS, 2015, BIOMATERIALS, V54, P97, DOI 10.1016/j.biomaterials.2015.03.002; Jafari M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165213; Jiang ZT, 2019, POLYMERS-BASEL, V11, DOI 10.3390/polym11020282; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kamenik AS, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0022135; Kim JY, 2016, J AM CHEM SOC, V138, P402, DOI 10.1021/jacs.5b11357; Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680; Knowles TPJ, 2016, ADV MATER, V28, P6546, DOI 10.1002/adma.201505961; Li C, 2018, BIOMATER SCI-UK, V6, P462, DOI 10.1039/c7bm01124e; Liu HL, 2006, J BIOMOL STRUCT DYN, V24, P229, DOI 10.1080/07391102.2006.10507115; Mankar S, 2011, NANO REV EXP, V2, DOI 10.3402/nano.v2i0.6032; Mishima T, 2007, BIOCHEM BIOPH RES CO, V356, P769, DOI 10.1016/j.bbrc.2007.03.043; Mishra R, 2007, J MOL BIOL, V366, P1029, DOI 10.1016/j.jmb.2006.11.084; Moraitakis G, 2003, BIOPHYS J, V84, P2149, DOI 10.1016/S0006-3495(03)75021-8; Ohkuri T, 2005, J MOL BIOL, V347, P159, DOI 10.1016/j.jmb.2005.01.022; Olsson MHM, 2011, J CHEM THEORY COMPUT, V7, P525, DOI 10.1021/ct100578z; Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090; Patel D, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176886; Peralta MDR, 2015, ACS NANO, V9, P449, DOI 10.1021/nn5056089; Randviir EP, 2013, ANAL METHODS-UK, V5, P1098, DOI 10.1039/c3ay26476a; Robustelli P, 2018, P NATL ACAD SCI USA, V115, pE4758, DOI 10.1073/pnas.1800690115; Sabate R, 2014, PRION, V8, P233, DOI 10.4161/19336896.2014.968464; Sedov IA, 2017, J MOL GRAPH MODEL, V76, P466, DOI 10.1016/j.jmgm.2017.07.032; Seker UOS, 2017, ACS SYNTH BIOL, V6, P266, DOI 10.1021/acssynbio.6b00166; Sondergaard CR, 2011, J CHEM THEORY COMPUT, V7, P2284, DOI 10.1021/ct200133y; Sugimoto Y, 2011, BIOCHEM CELL BIOL, V89, P533, DOI [10.1139/o11-041, 10.1139/O11-041]; Sutthibutpong T, 2018, J BIOMOL STRUCT DYN, V36, P3978, DOI 10.1080/07391102.2017.1404934; Tokunaga Y, 2013, INT J BIOL SCI, V9, P219, DOI 10.7150/ijbs.5380; Walker AR, 2019, J PHYS CHEM B, V123, P3267, DOI 10.1021/acs.jpcb.9b01694; Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014; Wirmer J, 2004, ANGEW CHEM INT EDIT, V43, P5780, DOI 10.1002/anie.200460907; Xing L, 2019, J RAMAN SPECTROSC, V50, P629, DOI 10.1002/jrs.5567; Yoshimura Y, 2012, P NATL ACAD SCI USA, V109, P14446, DOI 10.1073/pnas.1208228109	46	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0249742	10.1371/journal.pone.0249742	http://dx.doi.org/10.1371/journal.pone.0249742			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324907	Green Published, gold, Green Submitted			2022-12-26	WOS:000780951300002
J	Dhaouadi, S; Kharroubi, G; Cherif, A; Cherif, I; Bouguerra, H; Bouabid, L; Najar, N; Gharbi, A; Ben Salah, A; Ben Alaya, NBE; Bettaieb, J				Dhaouadi, Sonia; Kharroubi, Ghassen; Cherif, Amal; Cherif, Ines; Bouguerra, Hind; Bouabid, Leila; Najar, Nourhene; Gharbi, Adel; Ben Salah, Afif; Ben Alaya, Nissaf Bouafif ep; Bettaieb, Jihene			Knowledge attitudes and practices toward seasonal influenza vaccine among pregnant women during the 2018/2019 influenza season in Tunisia	PLOS ONE			English	Article							IMMUNIZATION; COUNTRIES; SAFETY	Background The uptake and acceptance of the influenza vaccine (IV) among pregnant women remain unknown in Tunisia despite the increased influenza-related complications and death. The present study aimed to assess the IV uptake and acceptability and to describe related knowledge and attitudes among pregnant women in Tunisia. Methods A cross-sectional study was conducted in 84 Tunisian healthcare facilities over a period of three months (from March to May 2019). All pregnant women aged >= 18 years who sought antenatal care in related health structures were included in this study based on a multistage self-weighted sampling. We measured knowledge and attitudes towards the IV and assessed factors related to willingness for its uptake. Results The questionnaire was completed by 1157 pregnant women. More than half of the participants (60.2%; 95% confidence interval [CI] [57.3%-63.0%]) reported awareness about the IV. Among included PW, only 4.6%; 95% CI [3.5%-6.1%] received it during their current pregnancy. However, (36.8%; 95% CI [34.0%-39.6%]) declared their willingness to receive the vaccine in the next pregnancy. Recommendation by healthcare providers, identified to be the most trustful source of information, was the main reason for acceptance. However, the intention to accept the IV by pregnant women was significantly associated with such recommendation and perceived safety and effectiveness of this vaccine. Conclusion Antenatal care visits are a precious opportunity that should not be missed by health care providers and especially gynecologists to promote the IV uptake by pregnant women in Tunisia.	[Dhaouadi, Sonia; Cherif, Amal; Bouguerra, Hind; Bouabid, Leila; Najar, Nourhene; Ben Alaya, Nissaf Bouafif ep] Natl Observ New & Emerging Dis, Tunis, Tunisia; [Kharroubi, Ghassen; Cherif, Ines; Gharbi, Adel; Ben Salah, Afif; Bettaieb, Jihene] Pasteur Inst Tunis, Lab Med Epidemiol, Tunis, Tunisia; [Kharroubi, Ghassen; Cherif, Ines; Gharbi, Adel; Ben Salah, Afif; Bettaieb, Jihene] Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia; [Ben Salah, Afif] Arabian Gulf Univ, Manama, Bahrain	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Arabian Gulf University	Bettaieb, J (corresponding author), Pasteur Inst Tunis, Lab Med Epidemiol, Tunis, Tunisia.; Bettaieb, J (corresponding author), Pasteur Inst Tunis, Lab Transmiss Control & Immunobiol Infect LR11IPT, Tunis, Tunisia.	bettaiebjihene@yahoo.fr		Ben Salah, Afif/0000-0002-6696-4713	Task Force for Global Health [F821E23E52C0-4C51-8FC9-C356C34499B2]	Task Force for Global Health	This project was funded by the Task Force for Global Health [grant numbers: F821E23E52C0-4C51-8FC9-C356C34499B2].	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Anselem O, 2013, PRESSE MED, V42, P1453, DOI 10.1016/j.lpm.2013.01.064; Bednarczyk RA, 2012, AM J OBSTET GYNECOL, V207, pS38, DOI 10.1016/j.ajog.2012.07.002; Bodeker B, 2014, VACCINE, V32, P4131, DOI 10.1016/j.vaccine.2014.06.007; Buchy P, 2020, INT J INFECT DIS, V92, P1, DOI 10.1016/j.ijid.2019.12.019; Centers for Disease Control and Prevention, 2017, PREGN WOM FLU VACC; Centers for Disease Control and Prevention, 2021, FLU PREGN WOM; Centers for Disease Control and Prevention, 2020, BURD INFL; Chang YW, 2019, PUBLIC HEALTH NURS, V36, P284, DOI 10.1111/phn.12600; D'Alessandro A, 2018, HUM VACC IMMUNOTHER, V14, P1573, DOI 10.1080/21645515.2018.1483809; D'Angiolella LS, 2018, ANN I SUPER SANITA, V54, P49, DOI 10.4415/ANN_18_01_10; Ditsungnoen D, 2016, VACCINE, V34, P2141, DOI 10.1016/j.vaccine.2016.01.056; Eppes C, 2013, VACCINE, V31, P2874, DOI 10.1016/j.vaccine.2013.04.031; European Centre for Disease Prevention and Control, 2017, SEASONAL INFLUENZA V; Fedson DS, 2005, VACCINE, V23, P5133, DOI 10.1016/j.vaccine.2005.06.010; Glanz K, 2010, ANNU REV PUBL HEALTH, V31, P399, DOI 10.1146/annurev.publhealth.012809.103604; Hanslik T., 2010, PLOS CURR-TREE LIFE, V2, DOI [10.1371/currents.RRN1150, DOI 10.1371/CURRENTS.RRN1150]; Healy CM, 2015, VACCINE, V33, P5445, DOI 10.1016/j.vaccine.2015.08.028; Hu Y, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14121551; Jung EJ, 2016, HUM VACC IMMUNOTHER, V12, P1997, DOI 10.1080/21645515.2015.1119347; Khan AA, 2015, VACCINE, V33, P5103, DOI 10.1016/j.vaccine.2015.08.014; Li RC, 2018, VACCINE, V36, P3315, DOI 10.1016/j.vaccine.2018.04.060; Lutz CS, 2018, VACCINE, V36, P7445, DOI 10.1016/j.vaccine.2018.10.046; Mantel C, 2020, VACCINE, V38, P212, DOI 10.1016/j.vaccine.2019.10.028; Marie JE, 2013, HLTH SCI DIS, V14; Memoli MJ, 2013, INFLUENZA OTHER RESP, V7, P1033, DOI 10.1111/irv.12055; Munoz FM, 2012, AM J OBSTET GYNECOL, V207, pS33, DOI 10.1016/j.ajog.2012.06.072; Napolitano F, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-016-2138-2; Offeddu V, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7172-8; Office of Disease Prevention and Health Promotion, IMM INF DIS; Ortiz JR, 2019, J INFECT DIS, V219, pS97, DOI 10.1093/infdis/jiz024; Oxford vaccine group, 2021, FLU VACC PREGN VACC; Polyzos KA, 2015, OBSTET GYNECOL, V126, P1075, DOI 10.1097/AOG.0000000000001068; Primary Health care directorate,Ministry of Health, 2005, SITUATION ANAL CHILD; Sebghati M, 2021, BEST PRACT RES CL OB, V76, P53, DOI 10.1016/j.bpobgyn.2021.03.007; WHO European health information at your fingertips, 2020, INFL VACC COV PREGN; World Health Organization (WHO) Global Influenza Programme, 2015, SEASONAL INFLUENZA V; Xu J, 2016, VACCINE, V34, P3149, DOI 10.1016/j.vaccine.2016.04.057; Zaraket H, 2019, J INFECT PUBLIC HEAL, V12, P472, DOI 10.1016/j.jiph.2018.10.009	40	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265390	10.1371/journal.pone.0265390	http://dx.doi.org/10.1371/journal.pone.0265390			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316299	gold, Green Published			2022-12-26	WOS:000834238000024
J	Barden, P; Sosiak, CE; Grajales, J; Hawkins, J; Rizzo, L; Clark, A; Gatley, S; Gatley, I; Federici, J				Barden, Phillip; Sosiak, Christine E.; Grajales, Jonpierre; Hawkins, John; Rizzo, Louis; Clark, Alexander; Gatley, Samuel; Gatley, Ian; Federici, John			Non-destructive comparative evaluation of fossil amber using terahertz time-domain spectroscopy	PLOS ONE			English	Article							MICRO-CT; RESINS; IDENTIFICATION; EOCENE; COPAL; GENUS	Fossilized plant resins, or ambers, offer a unique paleontological window into the history of life. A natural polymer, amber can preserve aspects of ancient environments, including whole organisms, for tens or even hundreds of millions of years. While most amber research involves imaging with visual light, other spectra are increasingly used to characterize both organismal inclusions as well as amber matrix. Terahertz (THz) radiation, which occupies the electromagnetic band between microwave and infrared light wavelengths, is non-ionizing and frequently used in polymer spectroscopy. Here, we evaluate the utility of amber terahertz spectroscopy in a comparative setting for the first time by analyzing the terahertz optical properties of samples from 10 fossil deposits ranging in age from the Miocene to the Early Cretaceous. We recover no clear relationships between amber age or botanical source and terahertz permittivity; however, we do find apparent deposit-specific permittivity among transparent amber samples. By comparing the suitability of multiple permittivity models across sample data we find that models with a distribution of dielectric relaxation times best describe the spectral permittivity of amber. We also demonstrate a process for imaging amber inclusions using terahertz transmission and find that terahertz spectroscopy can be used to identify some synthetic amber forgeries.	[Barden, Phillip; Sosiak, Christine E.] New Jersey Inst Technol, Federated Dept Biol Sci, Newark, NJ 07102 USA; [Barden, Phillip] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA; [Grajales, Jonpierre; Hawkins, John; Rizzo, Louis; Clark, Alexander; Gatley, Samuel; Gatley, Ian; Federici, John] New Jersey Inst Technol, Dept Phys, Newark, NJ 07102 USA	New Jersey Institute of Technology; American Museum of Natural History (AMNH); New Jersey Institute of Technology	Barden, P (corresponding author), New Jersey Inst Technol, Federated Dept Biol Sci, Newark, NJ 07102 USA.; Barden, P (corresponding author), Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.	barden@njit.edu	Barden, Phillip/GLS-1283-2022	Barden, Phillip/0000-0001-6277-320X; Clark, Alexander/0000-0002-1703-3672	Faculty Seed Grant from the New Jersey Institute of Technology	Faculty Seed Grant from the New Jersey Institute of Technology	This project was partially funded by a Faculty Seed Grant from the New Jersey Institute of Technology to PB and JF.	ANDERSON KB, 1992, ORG GEOCHEM, V18, P829, DOI 10.1016/0146-6380(92)90051-X; Azar Dany, 2010, P271; Barden P, 2017, SYST ENTOMOL, V42, P837, DOI 10.1111/syen.12253; Barden P, 2012, AM MUS NOVIT, P1; Beimforde C, 2017, ARTHROPOD-PLANT INTE, V11, P495, DOI 10.1007/s11829-016-9475-3; Bray PS, 2009, SCIENCE, V326, P132, DOI 10.1126/science.1177539; Brody RH, 2001, SPECTROCHIM ACTA A, V57, P1325, DOI 10.1016/S1386-1425(01)00387-0; Cunningham A., 1987, PHYTOCHEMISTRY, V16, P1142; Serrano-Sanchez MD, 2015, J S AM EARTH SCI, V62, P243, DOI 10.1016/j.jsames.2015.06.007; Dierick M, 2007, NUCL INSTRUM METH A, V580, P641, DOI 10.1016/j.nima.2007.05.030; Fabre M, 2017, J INFRARED MILLIM TE, V38, P483, DOI 10.1007/s10762-017-0356-3; Fukunaga K., 2012, CHARACTERISATION WOR, P521; Fukunaga K, 2016, CULT HERIT SCI, P85, DOI 10.1007/978-4-431-55885-9_6; Garnier S., 2021, VIRIDIS COLORBLIND F, VVolume 2, DOI [10.5281/zenodo.4679424, DOI 10.5281/ZENODO.4679424]; Grimaldi D.A., 2000, ROCKY MT GEOL, V35, P163, DOI [10.2113/35.2.163, DOI 10.2113/35.2.163]; Grimaldi David, 2005, pi; Grimaldi David A., 2010, P167; Grimaldi David A., 1994, Curator, V37, P251; Henderickx H, 2006, ZOOTAXA, P41, DOI 10.11646/zootaxa.1305.1.4; Jackson JB, 2015, FRONT OPTOELECTRON, V8, P81, DOI 10.1007/s12200-014-0446-y; Jansen C, 2010, APPL OPTICS, V49, pE48, DOI 10.1364/AO.49.000E48; Kalmykov YP, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.041103; Kraemer MMS, 2007, PALAEONTOGR ABT A, V282, P1; Lambert J.B., 1990, GEOARCHAEOLOGY, V5, P43, DOI DOI 10.1002/GEA.3340050105; Langenheim J.H., 2003, PLANT RESINS CHEM EV; LANGENHEIM JH, 1990, AM SCI, V78, P16; Langenheim JH, 1995, ACS SYM SER, V617, P1; Leiss-Holzinger E, 2015, PALAEONTOL ELECTRON, V18; Maksoud S, 2017, PALAEOWORLD, V26, P331, DOI 10.1016/j.palwor.2016.03.003; McCoy VE, 2017, ORG GEOCHEM, V113, P43, DOI 10.1016/j.orggeochem.2017.08.005; McKellar RC, 2011, P ROY SOC B-BIOL SCI, V278, P3219, DOI 10.1098/rspb.2011.0276; McKellar RC, 2011, SCIENCE, V333, P1619, DOI 10.1126/science.1203344; Mittleman D., 2003, SENSING TERAHERTZ RA; Penalver Enrique, 2010, P236; Pichersky E, 2018, NEW PHYTOL, V220, P692, DOI 10.1111/nph.14178; Prabhu SS, 2018, MOLECULAR AND LASER SPECTROSCOPY: ADVANCES AND APPLICATIONS, P65, DOI 10.1016/B978-0-12-849883-5.00004-8; RCore Team, 2020, R LANG ENV STAT COMP; Rissanen K, 2021, ENVIRON EXP BOT, V185, DOI 10.1016/j.envexpbot.2021.104410; Ross Andrew, 2010, P208; Rust J, 2010, P NATL ACAD SCI USA, V107, P18360, DOI 10.1073/pnas.1007407107; Sasaki T., 2015, INT LETT CHEM PHYS A, V62, P29; SAUNDERS WB, 1974, GEOL SOC AM BULL, V85, P979, DOI 10.1130/0016-7606(1974)85<979:FAFTEC>2.0.CO;2; Schmidt AR, 2012, P NATL ACAD SCI USA, V109, P14796, DOI 10.1073/pnas.1208464109; Seyfullah LJ, 2018, BIOL REV, V93, P1684, DOI 10.1111/brv.12414; Sherratt E, 2015, P NATL ACAD SCI USA, V112, P9961, DOI 10.1073/pnas.1506516112; Shi GH, 2012, CRETACEOUS RES, V37, P155, DOI 10.1016/j.cretres.2012.03.014; Solorzano Kraemer Monica M., 2010, P42; Stubling E, 2019, J INFRARED MILLIM TE, V40, P763, DOI 10.1007/s10762-019-00604-1; Stubling EM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40211-7; White J.S., 2016, VERY HIGH SPEED THZ, DOI [10.1109/irmmw-thz.2016.7758567, DOI 10.1109/IRMMW-THZ.2016.7758567]; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolfe AP, 2016, REV PALAEOBOT PALYNO, V225, P21, DOI 10.1016/j.revpalbo.2015.11.002; Wolfe AP, 2009, P R SOC B, V276, P3403, DOI 10.1098/rspb.2009.0806	53	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0262983	10.1371/journal.pone.0262983	http://dx.doi.org/10.1371/journal.pone.0262983			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353830	Green Published, gold			2022-12-26	WOS:000786647900007
J	Davies, T; Watts, S; McClure, K; Migicovsky, Z; Myles, S				Davies, Thomas; Watts, Sophie; McClure, Kendra; Migicovsky, Zoe; Myles, Sean			Phenotypic divergence between the cultivated apple (Malus domestica) and its primary wild progenitor (Malus sieversii)	PLOS ONE			English	Article							GENE	An understanding of the relationship between the cultivated apple (Malus domestica) and its primary wild progenitor species (M. sieversii) not only provides an understanding of how apples have been improved in the past, but may be useful for apple improvement in the future. We measured 10 phenotypes in over 1000 unique apple accessions belonging to M. domestica and M. sieversii from Canada's Apple Biodiversity Collection. Using principal components analysis (PCA), we determined that M. domestica and M. sieversii differ significantly in phenotypic space and are nearly completely distinguishable as two separate groups. We found that M. domestica had a shorter juvenile phase than M. sieversii and that cultivated trees produced flowers and ripe fruit later than their wild progenitors. Cultivated apples were also 3.6 times heavier, 43% less acidic, and had 68% less phenolic content than wild apples. Using historical records, we found that apple breeding over the past 200 years has resulted in a trend towards apples that have higher soluble solids, are less bitter, and soften less during storage. Our results quantify the significant changes in phenotype that have taken place since apple domestication, and provide evidence that apple breeding has led to continued phenotypic divergence of the cultivated apple from its wild progenitor species.	[Davies, Thomas; Watts, Sophie; McClure, Kendra; Migicovsky, Zoe; Myles, Sean] Dalhousie Univ, Fac Agr, Dept Plant Food & Environm Sci, Truro, NS, Canada	Dalhousie University	Myles, S (corresponding author), Dalhousie Univ, Fac Agr, Dept Plant Food & Environm Sci, Truro, NS, Canada.	sean.myles@dal.ca		Migicovsky, Zoe/0000-0002-3931-1258; Myles, Sean/0000-0001-9754-5987				Aprea E, 2017, SCI REP-UK, V7, DOI 10.1038/srep44950; Busatto N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219354; Carew R, 2004, CAN J PLANT SCI, V84, P829, DOI 10.4141/P03-164; Cliff MA, 2016, J SCI FOOD AGR, V96, P2170, DOI 10.1002/jsfa.7334; Cornille A, 2014, TRENDS GENET, V30, P57, DOI 10.1016/j.tig.2013.10.002; Cornille A, 2013, EVOL APPL, V6, P737, DOI 10.1111/eva.12059; Duan NB, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00336-7; Eccel E, 2009, INT J BIOMETEOROL, V53, P273, DOI 10.1007/s00484-009-0213-8; FAOSTAT, 2020, FOOD AGR ASS US; Ferree DC., 2003, CAB INT 2003 APPLES; Furbank RT, 2011, TRENDS PLANT SCI, V16, P635, DOI 10.1016/j.tplants.2011.09.005; Gottschalk C, 2013, J AM SOC HORTIC SCI, V138, P367, DOI 10.21273/JASHS.138.5.367; Hampson CR, 2000, EUPHYTICA, V111, P79, DOI 10.1023/A:1003769304778; Harker FR, 2008, POSTHARVEST BIOL TEC, V50, P70, DOI 10.1016/j.postharvbio.2008.03.020; Holderbaum DF, 2010, HORTSCIENCE, V45, P1150, DOI 10.21273/HORTSCI.45.8.1150; Iezzoni AF, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00398-7; Jung M, 2020, HORTIC RES-ENGLAND, V7, DOI 10.1038/s41438-020-00408-8; Khan MA, 2014, PLANT GENOME-US, V7, DOI 10.3835/plantgenome2014.04.0018; KRAMER MG, 1994, EUPHYTICA, V79, P293, DOI 10.1007/BF00022530; Kumar S, 2014, PLANT GENET RESOUR-C, V12, P330, DOI 10.1017/S1479262114000136; Lin DR, 2016, MOLECULES, V21, DOI 10.3390/molecules21101374; Lutes H, 2019, FACTS CONVENTIONAL N; Mabberley, 2006, STORY APPLE; Mattila P, 2006, J AGR FOOD CHEM, V54, P7193, DOI 10.1021/jf0615247; McClure KA, 2019, HORTIC RES-ENGLAND, V6, DOI 10.1038/s41438-019-0190-y; McClure KA, 2018, PLANT GENOME-US, V11, DOI 10.3835/plantgenome2017.08.0075; McCouch S, 2013, NATURE, V499, P23, DOI 10.1038/499023a; Migicovsky Z, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.671300; Migicovsky Z, 2021, HORTIC RES-ENGLAND, V8, DOI 10.1038/s41438-020-00441-7; Migicovsky Z, 2016, PLANT GENOME-US, V9, DOI 10.3835/plantgenome2015.11.0113; Nybom H, 2013, TREE GENET GENOMES, V9, P279, DOI 10.1007/s11295-012-0554-z; Pimentel D, 1997, BIOSCIENCE, V47, P747, DOI 10.2307/1313097; RCore Team, 2020, R LANG ENV STAT COMP; Skreli E, 2012, INT FOOD AGRIBUS MAN, V15, P137; Soares S, 2013, J AGR FOOD CHEM, V61, P1525, DOI 10.1021/jf304198k; Spengler RN, 2019, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.00617; Stowe E., 2020, PLANT BREED REV, V44, P273; Sun XP, 2020, NAT GENET, V52, P1423, DOI 10.1038/s41588-020-00723-9; Toivonen PMA, 2006, CAN J PLANT SCI, V86, P1361, DOI 10.4141/P06-147; Urrestarazu J, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.01923; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; WAPA. U.S. Apple and Pear Forecast, 2018, WAPA WORLD APPL PEAR; Watts S., 2021, QUANTIFYING APPLE DI; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wu B, 2021, PLANT BIOTECHNOL J, V19, P1022, DOI 10.1111/pbi.13527; Zohary D., 2000, Domestication of plants in the Old World: the origin and spread of cultivated plants in West Asia, Europe and the Nile Valley	46	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0250751	10.1371/journal.pone.0250751	http://dx.doi.org/10.1371/journal.pone.0250751			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320270	gold, Green Submitted, Green Published			2022-12-26	WOS:000784240600039
J	Enany, S; Zakeer, S; Diab, AA; Bakry, U; Sayed, AA				Enany, Shymaa; Zakeer, Samira; Diab, Aya A.; Bakry, Usama; Sayed, Ahmed A.			Whole genome sequencing of Klebsiella pneumoniae clinical isolates sequence type 627 isolated from Egyptian patients	PLOS ONE			English	Article							ANTIBIOTIC-RESISTANCE; PLASMIDS; VIRULENCE; TOOL; EVOLUTION; EXPANSION; CLONE	Klebsiella pneumoniae is considered a threat to public health especially due to multidrug resistance emergence. It is largely oligoclonal based on multi-locus sequence typing (MLST); in Egypt, ST 627 was recently detected. Despites the global dissemination of this ST, there is still paucity of information about it. Herein, we used 4 K. pneumoniae ST627 for whole genome sequencing utilizing an Illumina MiSeq platform. Genome sequences were examined for resistance and virulence determinants, capsular types, plasmids, insertion sequences, phage regions, and Clustered Regularly Interspaced Palindromic Repeats (CRISPR) regions using bioinformatic analysis. The molecular characterization revealed 15 and 65 antimicrobial resistance and virulence genes, respectively. Resistance genes such as tet(D), aph(3'')-Ib, aph(6)-Id, blaTEM-234, fosA, and fosA6; were mainly responsible for tetracycline, aminoglycoside, and fosfomycin resistance; respectively. The capsular typing revealed that the four strains are KL-24 and O1v1. One plasmid was found in all samples known as pC17KP0052-1 and another plasmid with accession no. NZ_CP032191.1 was found only in K90. IncFIB(K) and IncFII(K) are two replicons found in all samples, while ColRNAI replicon was found only in K90. Entero P88, Salmon SEN5, and Klebsi phiKO2 intact phage regions were identified. All samples harbored CRISPR arrays including CRISPR1 and CRISPR2. Our results shed light on critical tasks of mobile genetic elements in ST 627 in antibiotic resistance spreading.	[Enany, Shymaa; Zakeer, Samira] Suez Canal Univ, Dept Microbiol & Immunol, Fac Pharm, Ismailia, Egypt; [Enany, Shymaa] Armed Force Coll Med, Biomed Res Dept, Cairo, Egypt; [Diab, Aya A.; Bakry, Usama; Sayed, Ahmed A.] Childrens Canc Hosp Egypt, Genom Res Program, Basic Res Dept, Cairo, Egypt; [Sayed, Ahmed A.] Ain Shams Univ, Fac Sci, Dept Biochem, Egypt, Egypt	Egyptian Knowledge Bank (EKB); Suez Canal University; Children's Cancer Hospital 57357; Egyptian Knowledge Bank (EKB); Ain Shams University	Enany, S (corresponding author), Suez Canal Univ, Dept Microbiol & Immunol, Fac Pharm, Ismailia, Egypt.; Enany, S (corresponding author), Armed Force Coll Med, Biomed Res Dept, Cairo, Egypt.; Sayed, AA (corresponding author), Childrens Canc Hosp Egypt, Genom Res Program, Basic Res Dept, Cairo, Egypt.; Sayed, AA (corresponding author), Ain Shams Univ, Fac Sci, Dept Biochem, Egypt, Egypt.	shymaa21@yahoo.com; ahmad.sayed@57357.org	Enany, Shymaa/F-2053-2010	Enany, Shymaa/0000-0002-7827-6504; A. Diab, Aya/0000-0002-7143-862X				Andersgs, 2020, SNIPPY; Andrews S., 2010, FASTQC QUALITY CONTR; Arndt D, 2016, NUCLEIC ACIDS RES, V44, pW16, DOI 10.1093/nar/gkw387; Balloux F, 2018, TRENDS MICROBIOL, V26, P1035, DOI 10.1016/j.tim.2018.08.004; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Carattoli A, 2014, ANTIMICROB AGENTS CH, V58, P3895, DOI 10.1128/AAC.02412-14; Caza M, 2015, MOL MICROBIOL, V97, P717, DOI 10.1111/mmi.13059; Chen LH, 2005, NUCLEIC ACIDS RES, V33, pD325, DOI 10.1093/nar/gki008; Chen L, 2014, TRENDS MICROBIOL, V22, P686, DOI 10.1016/j.tim.2014.09.003; Dafne diaz-jimenez jf, 2019, AVIAN MEAT TRANSMISS; Dagher TN, 2019, BMC MICROBIOL, V19, DOI 10.1186/s12866-019-1401-2; DebRoy C, 2010, PLASMID, V63, P53, DOI 10.1016/j.plasmid.2009.10.003; Deleo FR, 2014, P NATL ACAD SCI USA, V111, P4988, DOI 10.1073/pnas.1321364111; Dolejska M, 2013, ANTIMICROB AGENTS CH, V57, P1073, DOI 10.1128/AAC.01886-12; Dolejska M, 2012, INT J ANTIMICROB AG, V40, P510, DOI 10.1016/j.ijantimicag.2012.07.016; Alcantar-Curiel MD, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/7012958; Effah CY, 2020, ANN CLIN MICROB ANTI, V19, DOI 10.1186/s12941-019-0343-8; Enany S, 2020, MICROBIOL RES, V234, DOI 10.1016/j.micres.2020.126423; Enright MC, 1999, TRENDS MICROBIOL, V7, P482, DOI 10.1016/S0966-842X(99)01609-1; Feil EJ, 2004, J BACTERIOL, V186, P1518, DOI 10.1128/JB.186.5.1518-1530.2004; Founou RC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42672-2; Galata V, 2019, NUCLEIC ACIDS RES, V47, pD195, DOI 10.1093/nar/gky1050; Gorrie CL., 2018, POPULATION STRUCTURE; Grant JR, 2008, NUCLEIC ACIDS RES, V36, pW181, DOI 10.1093/nar/gkn179; Greenfield LK, 2012, CARBOHYD RES, V356, P12, DOI 10.1016/j.carres.2012.02.027; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Guo QL, 2016, J ANTIMICROB CHEMOTH, V71, P2460, DOI 10.1093/jac/dkw177; Gurevich A, 2013, BIOINFORMATICS, V29, P1072, DOI 10.1093/bioinformatics/btt086; Hasan CM, 2014, CLIN MICROBIOL INFEC, V20, P34, DOI 10.1111/1469-0691.12187; Hassan R, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61159-z; Hastak P, 2020, MICROB GENOMICS, V6, DOI 10.1099/mgen.0.000371; Hojati Z, 2015, JUNDISHAPUR J MICROB, V8, DOI 10.5812/jjm.17520; Hua MG, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4254530; Jackson RN, 2014, CURR OPIN STRUC BIOL, V24, P106, DOI 10.1016/j.sbi.2014.01.001; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kumar V, 2011, ANTIMICROB AGENTS CH, V55, P4267, DOI 10.1128/AAC.00052-11; Lam MMC, 2018, MICROB GENOMICS, V4, DOI 10.1099/mgen.0.000196; Lin TL, 2016, SCI REP-UK, V6, DOI 10.1038/srep31644; Mahmoud MAM, 2019, ENVIRON POLLUT, V255, DOI 10.1016/j.envpol.2019.113039; Martin RM, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00004; Mohamed SS, 2018, EGYPT J CHEST DIS TU, V67, P318, DOI 10.4103/ejcdt.ejcdt_25_17; Mosbahi K, 2018, P NATL ACAD SCI USA, V115, P6840, DOI 10.1073/pnas.1800672115; Munoz-Price LS, 2013, LANCET INFECT DIS, V13, P785, DOI 10.1016/S1473-3099(13)70190-7; Navon-Venezia S, 2017, FEMS MICROBIOL REV, V41, P252, DOI 10.1093/femsre/fux013; OHTSUBO H, 1978, P NATL ACAD SCI USA, V75, P615, DOI 10.1073/pnas.75.2.615; Ong CLY, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-183; Peyclit L, 2020, J ANTIMICROB CHEMOTH, V75, P1410, DOI 10.1093/jac/dkaa057; Potter RF, 2018, MBIO, V9, DOI 10.1128/mBio.02481-18; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Qi Y, 2011, J ANTIMICROB CHEMOTH, V66, P307, DOI 10.1093/jac/dkq431; Racine JS, 2012, J APPL ECONOMET, V27, P167, DOI 10.1002/jae.1278; Rafiq Z, 2016, MEM I OSWALDO CRUZ, V111, P144, DOI 10.1590/0074-02760150423; Ringel PD, 2017, CELL REP, V21, P3927, DOI 10.1016/j.celrep.2017.12.020; Rodrigues C, 2014, INT J MED MICROBIOL, V304, P1100, DOI 10.1016/j.ijmm.2014.08.003; Shelenkov A, 2020, ANTIBIOTICS-BASEL, V9, DOI 10.3390/antibiotics9050261; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Silverman JM, 2012, ANNU REV MICROBIOL, V66, P453, DOI 10.1146/annurev-micro-121809-151619; Struve C, 2008, INFECT IMMUN, V76, P4055, DOI 10.1128/IAI.00494-08; Taitt CR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178880; Villa L, 2013, J ANTIMICROB CHEMOTH, V68, P2482, DOI 10.1093/jac/dkt235; Vuotto C, 2017, J APPL MICROBIOL, V123, P1003, DOI 10.1111/jam.13533; Warnes G.R., 2009, GPLOTS VARIOUS R PRO; Wick RR, 2018, J CLIN MICROBIOL, V56, DOI [10.1128/JCM.00197-18, 10.1128/jcm.00197-18]; Wilde C, 2003, NUCLEIC ACIDS RES, V31, P4345, DOI 10.1093/nar/gkg494; Wyres KL, 2016, MICROB GENOMICS, V2, DOI 10.1099/mgen.0.000102; Yang TY, 2020, INT J ANTIMICROB AG, V55, DOI 10.1016/j.ijantimicag.2020.105894; Yao H, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01610; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Yoon EJ, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00056; Zaman TU, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-3114-9; Zankari E, 2012, J ANTIMICROB CHEMOTH, V67, P2640, DOI 10.1093/jac/dks261; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593; Zhou K, 2016, SCI REP-UK, V6, DOI 10.1038/srep20840	73	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265884	10.1371/journal.pone.0265884	http://dx.doi.org/10.1371/journal.pone.0265884			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320327	gold, Green Published			2022-12-26	WOS:000784240600023
J	Jensen, VFH; Molck, AM; Nowak, J; Wohlfarth, M; Nusken, E; Demozay, D; Nusken, KD; Bogh, IB				Jensen, Vivi F. H.; Molck, Anne-Marie; Nowak, Jette; Wohlfarth, Maria; Nuesken, Eva; Demozay, Damien; Nuesken, Kai-Dietrich; Bogh, Ingrid B.			Placental nutrient transporters adapt during persistent maternal hypoglycaemia in rats	PLOS ONE			English	Article							AMINO-ACID-TRANSPORT; FETAL-GROWTH; INSULIN-RECEPTORS; GLUCOSE-TRANSPORT; DOWN-REGULATION; EXPRESSION; TROPHOBLAST; PREGNANCY; RESTRICTION; METABOLISM	Maternal malnutrition is associated with decreased nutrient transfer to the foetus, which may lead to foetal growth restriction, predisposing children to a variety of diseases. However, regulation of placental nutrient transfer during decreased nutrient availability is not fully understood. In the present study, the aim was to investigate changes in levels of placental nutrient transporters accompanying maternal hypoglycaemia following different durations and stages of gestation in rats. Maternal hypoglycaemia was induced by insulin-infusion throughout gestation until gestation day (GD)20 or until end of organogenesis (GD17), with sacrifice on GD17 or GD20. Protein levels of placental glucose transporters GLUT1 (45/55 kDa isotypes) and GLUT3, amino acid transporters SNAT1 and SNAT2, and insulin receptor (InsR) were assessed. On GD17, GLUT1-45, GLUT3, and SNAT1 levels were increased and InsR levels decreased versus controls. On GD20, following hypoglycaemia throughout gestation, GLUT3 levels were increased, GLUT1-55 showed the same trend. After cessation of hypoglycaemia at end of organogenesis, GLUT1-55, GLUT3, and InsR levels were increased versus controls, whereas SNAT1 levels were decreased. The increases in levels of placental nutrient transporters seen during maternal hypoglycaemia and hyperinsulinemia likely reflect an adaptive response to optimise foetal nutrient supply and development during limited availability of glucose.	[Jensen, Vivi F. H.; Molck, Anne-Marie; Nowak, Jette; Bogh, Ingrid B.] Novo Nordisk AS, Dept Safety Sci Imaging & Data Management, Malov, Denmark; [Wohlfarth, Maria; Nuesken, Eva; Nuesken, Kai-Dietrich] Univ Cologne, Med Fac, Dept Pediat, Cologne, Germany; [Demozay, Damien] Novo Nordisk AS, Dept Diabet Pharmacol 1, Malov, Denmark; [Jensen, Vivi F. H.] Lund Univ, Dept Orthoped, Lund, Sweden; [Bogh, Ingrid B.] IBB Consulting ApS, Solrod Strand, Denmark	Novo Nordisk; University of Cologne; Novo Nordisk; Lund University	Jensen, VFH (corresponding author), Novo Nordisk AS, Dept Safety Sci Imaging & Data Management, Malov, Denmark.; Jensen, VFH (corresponding author), Lund Univ, Dept Orthoped, Lund, Sweden.	vfhj@novonordisk.com		Nusken, Eva/0000-0002-0674-804X; Jensen, Vivi/0000-0001-7661-9262; Nusken, Kai/0000-0001-5749-7183				ASSIMACOPOULOSJEANNET F, 1995, METABOLISM, V44, P228, DOI 10.1016/0026-0495(95)90270-8; Belkacemi L, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-105; CHOI YS, 1988, BIOCHIM BIOPHYS ACTA, V963, P237, DOI 10.1016/0005-2760(88)90286-X; DESOYE G, 1994, HISTOCHEMISTRY, V101, P277, DOI 10.1007/BF00315915; FOWDEN AL, 1992, EARLY HUM DEV, V29, P177, DOI 10.1016/0378-3782(92)90135-4; FRANKEL BJ, 1979, ENDOCRINOLOGY, V104, P1532, DOI 10.1210/endo-104-5-1532; Furukawa S, 2019, J TOXICOL PATHOL, V32, P1, DOI 10.1293/tox.2018-0042; Furukawa S, 2011, J TOXICOL PATHOL, V24, P95, DOI 10.1293/tox.24.95; Ganguly A, 2007, AM J PHYSIOL-ENDOC M, V292, pE1241, DOI 10.1152/ajpendo.00344.2006; Ganguly A, 2016, ENDOCRINOLOGY, V157, P4041, DOI 10.1210/en.2016-1259; GAVIN JR, 1974, P NATL ACAD SCI USA, V71, P84, DOI 10.1073/pnas.71.1.84; Girard J, 2006, DIABETES, V55, pS65, DOI 10.2337/db06-S009; Hahn T, 1998, FASEB J, V12, P1221, DOI 10.1096/fasebj.12.12.1221; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; Illsley NP, 1998, PLACENTA, V19, P517, DOI 10.1016/S0143-4004(98)91045-1; Iozzo P, 2003, J NUCL MED, V44, P682; Jansson T, 2006, PLACENTA, V27, pS91, DOI 10.1016/j.placenta.2005.11.010; Jensen VFH., 2017, J PREGNANCY CHILD HL, V04, P321, DOI [10.4172/2376-127x.1000321, DOI 10.4172/2376-127X.1000321]; Jensen VFH, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-62554-2; Jensen VFH, 2018, REPROD TOXICOL, V77, P1, DOI 10.1016/j.reprotox.2018.01.007; Jensen VFH, 2020, REPROD TOXICOL, V91, P14, DOI 10.1016/j.reprotox.2019.10.003; Jones HN, 2010, DIABETES, V59, P1161, DOI 10.2337/db09-0824; KARL PI, 1992, AM J PHYSIOL, V262, pC834, DOI 10.1152/ajpcell.1992.262.4.C834; KASUGA M, 1981, P NATL ACAD SCI-BIOL, V78, P6917, DOI 10.1073/pnas.78.11.6917; Khayat ZA, 1998, BIOCHEM J, V333, P713, DOI 10.1042/bj3330713; KOITER TR, 1995, PHYSIOL BEHAV, V57, P717, DOI 10.1016/0031-9384(94)00290-8; LAKSHMANAN M R, 1973, Biochemical and Biophysical Research Communications, V50, P704, DOI 10.1016/0006-291X(73)91301-6; Langdown ML, 2001, MOL CELL ENDOCRINOL, V185, P109, DOI 10.1016/S0303-7207(01)00629-3; Lee ACC, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3677; Lesage J, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740037; LETURQUE A, 1984, AM J PHYSIOL, V246, pE25, DOI 10.1152/ajpendo.1984.246.1.E25; Malhotra A, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00055; Mikines Kj Fau-Sonne B, GLUCOSE TURNOVER INS, P0002; Miller SL, 2016, J PHYSIOL-LONDON, V594, P807, DOI 10.1113/JP271402; NOLAN CJ, 1994, DIABETOLOGIA, V37, P976, DOI 10.1007/s001250050207; NORMAN NA, 1979, J REPROD FERTIL, V57, P345, DOI 10.1530/jrf.0.0570345; Novak D, 2006, PLACENTA, V27, P510, DOI 10.1016/j.placenta.2005.05.002; OKABAYASHI Y, 1989, DIABETES, V38, P182, DOI 10.2337/diabetes.38.2.182; RAHIMA A, 1987, EXP GERONTOL, V22, P257, DOI 10.1016/0531-5565(87)90004-0; RONNETT GV, 1982, J BIOL CHEM, V257, P4285; Roos S, 2009, AM J PHYSIOL-CELL PH, V297, pC723, DOI 10.1152/ajpcell.00191.2009; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Simpson IA, 2008, AM J PHYSIOL-ENDOC M, V295, pE242, DOI 10.1152/ajpendo.90388.2008; Su HS, 2000, J NUTR, V130, p315S, DOI 10.1093/jn/130.2.315S; Takata K, 1997, MICROSC RES TECHNIQ, V38, P145; Varvarigou AA, 2010, J PEDIATR ENDOCR MET, V23, P215, DOI 10.1515/JPEM.2010.23.3.215; von Versen-Hoynck F, 2009, PLACENTA, V30, P361, DOI 10.1016/j.placenta.2009.01.004; ZHOU J, 1993, J CLIN INVEST, V91, P845, DOI 10.1172/JCI116305	48	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265988	10.1371/journal.pone.0265988	http://dx.doi.org/10.1371/journal.pone.0265988			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344549	Green Published, gold			2022-12-26	WOS:000788055200013
J	Lange, A; Cajander, S; Magnuson, A; Stralin, K; Hultgren, O				Lange, Anna; Cajander, Sara; Magnuson, Anders; Stralin, Kristoffer; Hultgren, Olof			Sustained elevation of soluble B- and T- lymphocyte attenuator predicts long-term mortality in patients with bacteremia and sepsis	PLOS ONE			English	Article							BTLA; IMMUNOSUPPRESSION; INFLAMMATION; LYMPHOPENIA; EXPRESSION	Soluble B and T lymphocyte attenuator (sBTLA) has been shown to be associated with severity and outcome, in critically ill septic patients. We aimed to assess the dynamic expression of sBTLA, as a prognostic biomarker of long-term mortality in patients with bloodstream infection (BSI) and sepsis, and to evaluate its association with biomarkers indicative of inflammation and immune dysregulation. Secondarily, sBTLA was evaluated in association with severity and bacterial etiology. Patients with BSI (n = 108) were prospectively included, and serially sampled from admission to day 28. Blood and plasma donors (n = 31), sampled twice 28 days apart, served as controls. sBTLA concentration in plasma was determined with enzyme-linked immunosorbent assay. Associations between sBTLA on day 1-2 and 7, and mortality at 90 days and 1 year, were determined with unadjusted, and adjusted Cox regression. Differences related to severity was assessed with linear regression. Mixed model was used to assess sBTLA dynamics over time, and sBTLA associations with bacterial etiology and other biomarkers. sBTLA on day 1-2 and 7 was associated with mortality, in particular failure to normalize sBTLA by day 7 was associated with an increased risk of death before day 90, adjusted HR 17 (95% CI 1.8-160), and one year, adjusted HR 15 (95% CI 2.8-76). sBTLA was positively associated with CRP, and negatively with lymphocyte count. sBTLA on day 1-2 was not linearly associated with baseline SOFA score increase. High SOFA (>= 4) was however associated with higher mean sBTLA than SOFA <= 3. sBTLA was not associated with bacterial etiology. We show that sustained elevation of sBTLA one week after hospital admission is associated with late mortality in patients with BSI and sepsis, and that sBTLA concentration is associated with CRP and decreased lymphocyte count. This suggests that sBTLA might be an indicator of sustained immune-dysregulation, and a prognostic tool in sepsis.	[Lange, Anna; Cajander, Sara] Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden; [Cajander, Sara] Orebro Univ, Fac Med & Hlth, Sch Med Sci, Orebro, Sweden; [Magnuson, Anders] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, Orebro, Sweden; [Stralin, Kristoffer] Karolinska Univ Hosp, Dept Infect Dis, Stockholm, Sweden; [Stralin, Kristoffer] Karolinska Inst, Dept Med Huddinge, Stockholm, Sweden; [Hultgren, Olof] Orebro Univ, Fac Med & Hlth, Dept Clin Immunol & Transfus Med, Orebro, Sweden	Orebro University; Orebro University; Orebro University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Orebro University	Lange, A (corresponding author), Orebro Univ, Fac Med & Hlth, Dept Infect Dis, Orebro, Sweden.	anna.lange@regionorebrolan.se		Cajander, Sara/0000-0003-3921-4244	Region Orebro Lan; Stiftelsen Olle Engkvist Byggmastare; Signe och Olof Wallenius stiftelse	Region Orebro Lan; Stiftelsen Olle Engkvist Byggmastare(Swedish Research Council); Signe och Olof Wallenius stiftelse	The study was supported by grants from Region Orebro Lan https://nyckelfonden. regionorebrolan.se/sv and https://www. researchweb.org/is/oll, (AL, SC, KS), Stiftelsen Olle Engkvist Byggmastare https://engkviststiftelserna. se (OH), and Signe och Olof Wallenius stiftelse https://www.signeolofwalleniusstiftelse.se (OH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhavani SV, 2019, AM J RESP CRIT CARE, V200, P327, DOI 10.1164/rccm.201806-1197OC; Bian B, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2018.1561120; Boomer JS, 2012, CRIT CARE, V16, DOI 10.1186/cc11404; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Cai GF, 2009, IMMUNOL REV, V229, P244, DOI 10.1111/j.1600-065X.2009.00783.x; Cajander S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192883; Chen YL, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0744-4; Cheng TT, 2016, SHOCK, V45, P40, DOI 10.1097/SHK.0000000000000479; Dong MP, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60440-5; Drewry AM, 2014, SHOCK, V42, P383, DOI 10.1097/SHK.0000000000000234; Farrah K, 2021, CRIT CARE MED, V49, P215, DOI 10.1097/CCM.0000000000004777; Gong J, 2018, J IMMUNOTHER CANCER, V6, DOI 10.1186/s40425-018-0316-z; Gorgulho J, 2021, INT J CANCER, V149, P1189, DOI 10.1002/ijc.33610; Han LF, 2009, J IMMUNOL, V183, P7842, DOI 10.4049/jimmunol.0804379; Han P, 2004, J IMMUNOL, V172, P5931, DOI 10.4049/jimmunol.172.10.5931; Hotchkiss RS, 2019, INTENS CARE MED, V45, P1360, DOI 10.1007/s00134-019-05704-z; Hotchkiss RS, 2019, CRIT CARE MED, V47, P632, DOI 10.1097/CCM.0000000000003685; Inoue S, 2013, CRIT CARE MED, V41, P810, DOI 10.1097/CCM.0b013e318274645f; Khan M, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.651634; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Lange A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169176; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Mira JC, 2017, CRIT CARE CLIN, V33, P245, DOI 10.1016/j.ccc.2016.12.001; Monaghan SF, 2018, MOL MED, V24, P1, DOI 10.1186/s10020-018-0036-3; Oster C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184505; Prescott HC, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i2375; Riche F, 2018, CRIT CARE, V22, DOI 10.1186/s13054-017-1934-4; Seymour CW, 2019, JAMA-J AM MED ASSOC, V321, P2003, DOI 10.1001/jama.2019.5791; Shao R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1024-4; Shubin NJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13131; Shubin NJ, 2012, J LEUKOCYTE BIOL, V92, P593, DOI 10.1189/jlb.1211641; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stortz JA, 2018, SHOCK, V49, P249, DOI 10.1097/SHK.0000000000000981; Venet F, 2013, CURR OPIN IMMUNOL, V25, P477, DOI 10.1016/j.coi.2013.05.006; Wang QC, 2019, J IMMUNOTHER CANCER, V7, DOI 10.1186/s40425-019-0810-y; Wang XF, 2007, TISSUE ANTIGENS, V69, P145, DOI 10.1111/j.1399-0039.2006.00710.x; Wang XF, 2012, HYBRIDOMA, V31, P417, DOI 10.1089/hyb.2012.0052; Watanabe E, 2019, SHOCK; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Yende S, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.8686; Zhang Y, 2011, CRIT CARE, V15, DOI 10.1186/cc10059	41	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265818	10.1371/journal.pone.0265818	http://dx.doi.org/10.1371/journal.pone.0265818			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312715	Green Published, gold			2022-12-26	WOS:000803647900051
J	Nagano, S; Mori, N; Tomari, Y; Mitsugi, N; Deguchi, A; Kashima, M; Tezuka, A; Nagano, AJ; Usami, H; Tanabata, T; Watanabe, H				Nagano, Soichiro; Mori, Naoya; Tomari, Yukiko; Mitsugi, Noriko; Deguchi, Ayumi; Kashima, Makoto; Tezuka, Ayumi; Nagano, Atsushi J.; Usami, Hitohide; Tanabata, Takanari; Watanabe, Hiroyuki			Effect of differences in light source environment on transcriptome of leaf lettuce (Lactuca sativa L.) to optimize cultivation conditions	PLOS ONE			English	Article							SENESCENCE-ASSOCIATED GENES; EMITTING-DIODES LEDS; BLUE-LIGHT; RED-LIGHT; SUPPLEMENTAL BLUE; PHYTOCHROME-B; EXPRESSION; GROWTH; PLANTS; PHOTOMORPHOGENESIS	When used in closed-type plant factories, light-emitting diode (LED) illumination systems have the particular advantages of low heat emission and high luminous efficiency. The effects of illumination quality and intensity on the growth and morphogenesis of many plant species have been examined, but improvements are needed to optimize the illumination systems for better plant products with lower resource investments. In particular, new strategies are needed to reduce the wastage of plant products related to leaf senescence, and to better control the ingredients and appearance of leafy vegetables. Although the quality of light is often altered to change the characteristics of plant products, the transcriptional status underlying the physiological responses of plants to light has not been established. Herein, we performed a comprehensive gene expression analysis using RNA-sequencing to determine how red, blue, and red/blue LEDs and fluorescent light sources affect transcriptome involved in the leaf aging of leaf lettuce. The RNA-sequencing profiling revealed clear differences in the transcriptome between young and old leaves. Red LED light caused large variation between the two age classes, while a pure or mixed blue LED light spectrum induced fewer transcriptome differences between young and old leaves. Collectively, the expression levels of genes that showed homology with those of other model organisms provide a detailed physiological overview, incorporating such characteristics as the senescence, nutrient deficiency, and anthocyanin synthesis of the leaf lettuce plants. Our findings suggest that transcriptome profiles of leaf lettuce grown under different light sources provide helpful information to achieve better growth conditions for marketable and efficient green-vegetable production, with improved wastage control and efficient nutrient inputs.	[Nagano, Soichiro; Mitsugi, Noriko; Tanabata, Takanari; Watanabe, Hiroyuki] Tamagawa Univ, Fac Agr, Dept Adv Food Sci, Machida, Tokyo, Japan; [Nagano, Soichiro; Tanabata, Takanari] Kazusa DNA Res Inst, Dept Frontier Res & Dev, Kisarazu, Chiba, Japan; [Mori, Naoya; Tomari, Yukiko; Usami, Hitohide] Tamagawa Univ, Res Inst, Machida, Tokyo, Japan; [Deguchi, Ayumi; Kashima, Makoto; Tezuka, Ayumi; Nagano, Atsushi J.] Ryukoku Univ, Res Inst Food & Agr, Otsu, Shiga, Japan; [Nagano, Atsushi J.] Ryukoku Univ, Fac Agr, Otsu, Shiga, Japan; [Nagano, Atsushi J.] Keio Univ, Inst Adv Biosci, Tsuruoka, Yamagata, Japan; [Nagano, Soichiro] Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki, Japan; [Deguchi, Ayumi] Chiba Univ, Grad Sch Hort, Matsudo, Chiba, Japan; [Kashima, Makoto] Aoyama Gakuin Univ, Coll Sci & Engn, Sagamihara, Kanagawa, Japan	Kazusa DNA Research Institute; Ryukoku University; Ryukoku University; Keio University; Forestry & Forest Products Research Institute - Japan; Chiba University; Aoyama Gakuin University	Nagano, S (corresponding author), Forestry & Forest Prod Res Inst, Forest Tree Breeding Ctr, Hitachi, Ibaraki, Japan.	snagano@ffpri.affrc.go.jp	Nagano, Atsushi J./A-2957-2019	Nagano, Atsushi J./0000-0001-7891-5049	JST CREST [JPMJCR15O2]	JST CREST(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST))	This study was supported by JST CREST GrantNumberJPMJCR15O2, Japan	Ahmad M, 1998, MOL CELL, V1, P939, DOI 10.1016/S1097-2765(00)80094-5; Argyris J, 2008, PLANT PHYSIOL, V148, P926, DOI 10.1104/pp.108.125807; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Briggs WR, 1999, ANNU REV CELL DEV BI, V15, P33, DOI 10.1146/annurev.cellbio.15.1.33; BROWN CS, 1995, J AM SOC HORTIC SCI, V120, P808, DOI 10.21273/JASHS.120.5.808; Buchanan-Wollaston V, 2005, PLANT J, V42, P567, DOI 10.1111/j.1365-313X.2005.02399.x; Cashmore AR, 1999, SCIENCE, V284, P760, DOI 10.1126/science.284.5415.760; CAUSIN HF, 2007, INT J PLANT DEV BIOL, V1, P239; De Cremer K, 2013, PLANT CELL ENVIRON, V36, P1992, DOI 10.1111/pce.12106; Devaiah BN, 2007, PLANT PHYSIOL, V143, P1789, DOI 10.1104/pp.106.093971; Dewitte W, 2007, P NATL ACAD SCI USA, V104, P14537, DOI 10.1073/pnas.0704166104; Duek PD, 2003, PLANT J, V34, P827, DOI 10.1046/j.1365-313X.2003.01770.x; Franklin KA, 2005, ANN BOT-LONDON, V96, P169, DOI 10.1093/aob/mci165; GAN SS, 1995, SCIENCE, V270, P1986, DOI 10.1126/science.270.5244.1986; Goins GD, 1997, J EXP BOT, V48, P1407, DOI 10.1093/jxb/48.7.1407; Guo Y., 2021, MOL HORTIC, V1, P5, DOI [10.1186/s43897-021-00006-9, DOI 10.1186/S43897-021-00006-9]; He YH, 2001, PLANT PHYSIOL, V126, P707, DOI 10.1104/pp.126.2.707; Higashi T, 2016, FRONT PLANT SCI, V7, DOI [10.3389/fpls.2015.01114, 10.3389/fpls.2016.01114]; Ishikawa T, 2017, ELIFE, V6, DOI [10.7554/eLife.26845, 10.7554/eLife.26845.001]; Johkan M, 2010, HORTSCIENCE, V45, P1809, DOI 10.21273/HORTSCI.45.12.1809; Kim HJ, 2006, P NATL ACAD SCI USA, V103, P814, DOI 10.1073/pnas.0505150103; Kitazaki K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25686-0; Kozai T., 2013, CHRON HORTICULT, V53, P8, DOI DOI 10.2115/FIBER.70.P_94; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li ZH, 2012, J INTEGR PLANT BIOL, V54, P526, DOI 10.1111/j.1744-7909.2012.01136.x; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma LG, 2001, PLANT CELL, V13, P2589, DOI 10.1105/tpc.13.12.2589; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Mas P, 2000, NATURE, V408, P207, DOI 10.1038/35041583; Moore B, 2003, SCIENCE, V300, P332, DOI 10.1126/science.1080585; Oikawa S, 2006, NEW PHYTOL, V172, P104, DOI 10.1111/j.1469-8137.2006.01813.x; OKADA K, 1992, PLANT CELL PHYSIOL, V33, P1183; Ono Kiyomi, 2013, Japanese Journal of Ecology (Otsu), V63, P49; OuYang FQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127896; R Core Team, 2021, R LANGUAGE ENV STAT; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Sakuraba Y, 2018, NAT PLANTS, V4, P1089, DOI 10.1038/s41477-018-0294-7; Sellaro R, 2009, CURR BIOL, V19, P1216, DOI 10.1016/j.cub.2009.05.062; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Solfanelli C, 2006, PLANT PHYSIOL, V140, P637, DOI 10.1104/pp.105.072579; Terashima I, 2009, PLANT CELL PHYSIOL, V50, P684, DOI 10.1093/pcp/pcp034; Wang WJ, 2013, PLANTA, V237, P1123, DOI 10.1007/s00425-012-1831-7; Wang YJ, 2017, PLANT GROWTH REGUL, V83, P13, DOI 10.1007/s10725-017-0280-5; Weaver LM, 1998, PLANT MOL BIOL, V37, P455, DOI 10.1023/A:1005934428906; Woo HR, 2016, PLANT PHYSIOL, V171, P452, DOI 10.1104/pp.15.01929; Xie Y, 2014, DEVELOPMENT, V141, P4772, DOI 10.1242/dev.117689; Xu CX, 2015, SCI REP-UK, V5, DOI 10.1038/srep17706; Yanagi T, 1996, Acta Hortic, V440, P117; Yeh CM, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01803; Yorio NC, 2001, HORTSCIENCE, V36, P380, DOI 10.21273/HORTSCI.36.2.380; Zhang G, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.01110; Zhang HS, 2013, PLANT MOL BIOL, V82, P539, DOI 10.1007/s11103-012-9980-4; Zhang YZ, 2018, PEERJ, V6, DOI 10.7717/peerj.4607	55	0	0	7	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265994	10.1371/journal.pone.0265994	http://dx.doi.org/10.1371/journal.pone.0265994			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349601				2022-12-26	WOS:000783906500010
J	Howlader, MA; Demina, EP; Samarani, S; Guo, TL; Caillon, A; Ahmad, A; Pshezhetsky, AV; Cairo, CW				Howlader, Md Amran; Demina, Ekaterina P.; Samarani, Suzanne; Guo, Tianlin; Caillon, Antoine; Ahmad, Ali; Pshezhetsky, Alexey, V; Cairo, Christopher W.			The Janus-like role of neuraminidase isoenzymes in inflammation	FASEB JOURNAL			English	Article						inflammation; leukocytes; neuraminidase; sialic acid; sialidase	INDUCED CYTOKINE PRODUCTION; AIR POUCH MODEL; IN-VIVO; SELECTIVE INHIBITORS; HUMAN MONOCYTES; CELL-MIGRATION; SIALIDASE; EXPRESSION; LIPOPOLYSACCHARIDE; DIFFERENTIATION	The processes of activation, extravasation, and migration of immune cells to a site are early and essential steps in the induction of an acute inflammatory response. These events are an essential part of the inflammatory cascade, which involves multiple regulatory steps. Using a murine air pouch model of inflammation with LPS as an inflammation inducer, we demonstrate that isoenzymes of the neuraminidase family (NEU1, 3, and 4) play essential roles in these processes by acting as positive or negative regulators of leukocyte infiltration. In genetically knocked-out (KO) mice for different NEU genes (Neu1 KO, Neu3 KO, Neu4 KO, and Neu3/4 double KO mice) with LPS-induced air pouch inflammation, leukocytes at the site of inflammation were counted, and the inflamed tissue was analyzed using immunohistochemistry. Our data show that leukocyte recruitment was decreased in NEU1- and NEU3-deficient mice, while it was increased in NEU4-deficient animals. Consistent with these results, systemic as well as pouch exudate levels of pro-inflammatory cytokines were reduced in Neu1 and increased in Neu4 KO mice. Pharmacological inhibitors specific for NEU1, NEU3, and NEU4 isoforms also affected leukocyte recruitment. Together our data demonstrate that NEU isoenzymes have distinct-and even opposing-effects on leukocyte recruitment, and therefore warrant further investigation to determine their mechanisms and importance as regulators of the inflammatory cascade.	[Howlader, Md Amran; Guo, Tianlin; Cairo, Christopher W.] Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada; [Demina, Ekaterina P.; Caillon, Antoine; Pshezhetsky, Alexey, V] Univ Montreal, Div Med Genet, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Samarani, Suzanne; Ahmad, Ali] Univ Montreal, Dept Microbiol Infect Dis & Immunol, St Justine Hosp Res Ctr, Montreal, PQ, Canada; [Pshezhetsky, Alexey, V] McGill Univ, Dept Anat & Cell Biol, Montreal, PQ, Canada	University of Alberta; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; Universite de Montreal; Centre Hospitalier Universitaire Sainte-Justine; McGill University	Cairo, CW (corresponding author), Univ Alberta, Dept Chem, Edmonton, AB T6G 2G2, Canada.; Pshezhetsky, AV (corresponding author), Univ Montreal, Div Med Genet, St Justine Hosp Res Ctr, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca; ccairo@ualberta.ca	; Cairo, Christopher/B-5355-2009	Caillon, Antoine/0000-0003-0803-569X; Cairo, Christopher/0000-0003-3363-8708; Howlader, Md Amran/0000-0002-1872-3480; A, Pshezhetsky/0000-0002-6612-1062	GlycoNet student travel grant; GlycoNet collaborative team grant (CD-2); GlycoNet collaborative team grant (ID-01); Canadian Institutes of Health Research [PJT-148863]	GlycoNet student travel grant; GlycoNet collaborative team grant (CD-2); GlycoNet collaborative team grant (ID-01); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a GlycoNet student travel grant (MAH), GlycoNet collaborative team grants (CD-2: CWC and AVP; ID-01: CWC, AVP, and AA), and the Canadian Institutes of Health Research (Grant PJT-148863, CWC and AVP)	Albohy A, 2013, ACS MED CHEM LETT, V4, P532, DOI 10.1021/ml400080t; Amith SR, 2010, CELL SIGNAL, V22, P314, DOI 10.1016/j.cellsig.2009.09.038; Armstrong L, 1996, THORAX, V51, P143, DOI 10.1136/thx.51.2.143; Choi YS, 2009, BLOOD, V114, P3117, DOI 10.1182/blood-2009-02-203372; CRONSTEIN BN, 1993, J CLIN INVEST, V92, P2675, DOI 10.1172/JCI116884; Cross AS, 2003, J BIOL CHEM, V278, P4112, DOI 10.1074/jbc.M207591200; Diab A, 1999, INFECT IMMUN, V67, P2590, DOI 10.1128/IAI.67.5.2590-2601.1999; Feng CG, 2013, J IMMUNOL, V191, P4828, DOI 10.4049/jimmunol.1202673; Feng CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032359; Feng CG, 2011, J LEUKOCYTE BIOL, V90, P313, DOI 10.1189/jlb.1210708; Gadhoum SZ, 2008, NAT CHEM BIOL, V4, P751, DOI 10.1038/nchembio.116; Gomez-Cambronero J, 2003, J IMMUNOL, V171, P6846, DOI 10.4049/jimmunol.171.12.6846; Guo TL, 2018, J MED CHEM, V61, P11261, DOI 10.1021/acs.jmedchem.8b04111; Guo TL, 2018, J MED CHEM, V61, P1990, DOI 10.1021/acs.jmedchem.7b01574; Howlader MA, 2019, FRONT CHEM, V7, DOI 10.3389/fchem.2019.00791; Jia F, 2016, BBA-MOL CELL BIOL L, V1861, P1170, DOI 10.1016/j.bbalip.2016.06.013; Kawasaki T, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00461; Kho I, 2020, MOL GENET METAB, V129, pS88, DOI 10.1016/j.ymgme.2019.11.220; Ley K, 2007, NAT REV IMMUNOL, V7, P678, DOI 10.1038/nri2156; Liang F, 2006, J BIOL CHEM, V281, P27526, DOI 10.1074/jbc.M605633200; LINDBERG B, 1981, CARBOHYD RES, V97, P105, DOI 10.1016/S0008-6215(00)80528-5; Lotfi N, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01265; Matsubara K, 2015, J NEUROSCI, V35, P2452, DOI 10.1523/JNEUROSCI.4088-14.2015; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Miyake K, 2004, TRENDS MICROBIOL, V12, P186, DOI 10.1016/j.tim.2004.02.009; Muller WA, 2013, VET PATHOL, V50, P7, DOI 10.1177/0300985812469883; Nan XL, 2007, J LEUKOCYTE BIOL, V81, P284, DOI 10.1189/jlb.1105692; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XF, 2017, FASEB J, V31, P3467, DOI 10.1096/fj.201601299R; Pearce OMT, 2016, GLYCOBIOLOGY, V26, P111, DOI 10.1093/glycob/cwv097; Pelletier M, 2004, J IMMUNOL, V173, P7521, DOI 10.4049/jimmunol.173.12.7521; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Pshezhetsky AV, 2011, GLYCOCONJUGATE J, V28, P441, DOI 10.1007/s10719-011-9350-5; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Quinn MT, 2001, IMMUNOLOGY, V104, P185, DOI 10.1046/j.1365-2567.2001.01300.x; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sakarya S, 2004, GLYCOBIOLOGY, V14, P481, DOI 10.1093/glycob/cwh065; Schauer R, 2009, CURR OPIN STRUC BIOL, V19, P507, DOI 10.1016/j.sbi.2009.06.003; Senger DR, 2002, AM J PATHOL, V160, P195, DOI 10.1016/S0002-9440(10)64363-5; Seyrantepe V, 2010, J BIOL CHEM, V285, P206, DOI 10.1074/jbc.M109.055475; Sherry B, 1998, MOL MED, V4, P648, DOI 10.1007/BF03401925; Shiozaki K, 2011, J BIOL CHEM, V286, P21052, DOI 10.1074/jbc.M111.231191; Sieve I, 2018, VASC PHARMACOL, V103, P16, DOI 10.1016/j.vph.2018.01.005; SIN YM, 1986, ANN RHEUM DIS, V45, P873, DOI 10.1136/ard.45.10.873; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Stamatos NM, 2010, J LEUKOCYTE BIOL, V88, P1227, DOI 10.1189/jlb.1209776; Stamatos NM, 2005, FEBS J, V272, P2545, DOI 10.1111/j.1742-4658.2005.04679.x; Stamatos NM, 2004, J LEUKOCYTE BIOL, V75, P307, DOI 10.1189/jlb.0503241; Sutterwala FS, 2014, ANN NY ACAD SCI, V1319, P82, DOI 10.1111/nyas.12458; Terkeltaub R, 1998, ARTHRITIS RHEUM, V41, P900, DOI 10.1002/1529-0131(199805)41:5<900::AID-ART18>3.0.CO;2-K; Tessier PA, 1997, J IMMUNOL, V159, P3595; Wright RD, 2014, GLYCOBIOLOGY, V24, P1242, DOI 10.1093/glycob/cwu101; Wu XD, 2010, BBA-MOL BASIS DIS, V1802, P259, DOI 10.1016/j.bbadis.2009.10.008; Zen K, 2007, J MOL BIOL, V374, P54, DOI 10.1016/j.jmb.2007.09.014; Zhang Y, 2013, J MED CHEM, V56, P2948, DOI 10.1021/jm301892f	55	1	1	1	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22285	10.1096/fj.202101218R	http://dx.doi.org/10.1096/fj.202101218R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E4ZB	35363389	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000776689300001
J	Kim, SH; Kim, M; Park, D; Byun, S; Rhee, S				Kim, Sang-Hoon; Kim, Minjeong; Park, Daechan; Byun, Sujeong; Rhee, Sangkee			Substrate-binding loop interactions with pseudouridine trigger conformational changes that promote catalytic efficiency of pseudouridine kinase PUKI	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RNA MODIFICATIONS; CRYSTAL-STRUCTURE; ESCHERICHIA-COLI; STRUCTURAL BASIS; GENE-EXPRESSION; RIBOKINASE; ACTIVATION; REVEALS; FEATURES; FAMILY	Pseudouridine, one major RNA modification, is catabolized into uracil , ribose-50-phosphate by two sequential enzy-matic reactions. In the first step, pseudouridine kinase (PUKI) phosphorylates pseudouridine to pseudouridine 50-mono -phosphate. High-fidelity catalysis of pseudouridine by PUKI prevents possible disturbance of in vivo pyrimidine homeo-stasis. However, the molecular basis of how PUKI selectively phosphorylates pseudouridine over uridine with > 100-fold greater efficiency despite minor differences in their Km values has not been elucidated. To investigate this selectivity, in this study we determined the structures of PUKI from Escherichia coli strain B (EcPUKI) in various ligation states. The structure of EcPUKI was determined to be similar to PUKI from Arabidopsis thaliana, including an alpha/beta core domain and beta-stranded small domain, with dimerization occurring via the beta-stranded small domain. In a binary complex, we show that Ser30 in the substrate-binding loop of the small domain mediates interactions with the hallmark N1 atom of pseu-douridine nucleobase, causing conformational changes in its quaternary structure. Kinetic and fluorescence spectroscopic analyses also showed that the Ser30-mediated interaction is a prerequisite for conformational changes and subsequent catalysis by EcPUKI. Furthermore, S30A mutation or EcPUKI complexed with other nucleosides homologous to pseudour-idine but lacking the pseudouridine-specific N1 atom did not induce such conformational changes, demonstrating the catalytic significance of the proposed Ser30-mediated interac-tion. These analyses provide structural and functional evidence for a pseudouridine-dependent conformational change of EcPUKI and its functional linkage to catalysis.	[Kim, Sang-Hoon; Byun, Sujeong; Rhee, Sangkee] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea; [Kim, Minjeong; Park, Daechan] Ajou Univ, Dept Mol Sci & Technol, Suwon, South Korea; [Park, Daechan] Ajou Univ, Dept Biol Sci, Suwon, South Korea; [Rhee, Sangkee] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea	Seoul National University (SNU); Ajou University; Ajou University; Seoul National University (SNU)	Rhee, S (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea.; Rhee, S (corresponding author), Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea.	srheesnu@snu.ac.kr		Rhee, Sangkee/0000-0002-8779-9737	National Research Foundation of Korea - Korea government (Ministry of Science and ICT) [2020R1A4A1018890, 2021R1A2C2092118]; Basic Science Research Program - Ministry of Education [2021R1A6A1A10044950]	National Research Foundation of Korea - Korea government (Ministry of Science and ICT)(National Research Foundation of Korea); Basic Science Research Program - Ministry of Education	We thank Jeongyun Lee for her assistance in the purification of enzyme for CD measurements. This work was sup-ported by the National Research Foundation of Korea grant funded by the Korea government (Ministry of Science and ICT) (grant nos.: 2020R1A4A1018890 and 2021R1A2C2092118 [to S. R.] ) and Basic Science Research Program funded by the Ministry of Education (grant no.: 2021R1A6A1A10044950 [to D. P.] ) .	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; Bodenhofer U, 2015, BIOINFORMATICS, V31, P3997, DOI 10.1093/bioinformatics/btv494; Boutet E, 2016, METHODS MOL BIOL, V1374, P23, DOI 10.1007/978-1-4939-3167-5_2; BREITMAN TR, 1970, J BACTERIOL, V103, P263, DOI 10.1128/JB.103.1.263-264.1970; Carlile TM, 2014, NATURE, V515, P143, DOI 10.1038/nature13802; Charette M, 2000, IUBMB LIFE, V49, P341; Chen MJ, 2020, PLANT CELL, V32, P722, DOI 10.1105/tpc.19.00639; Chen MJ, 2018, PLANT CELL, V30, P1511, DOI 10.1105/tpc.18.00236; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Diederichs K, 2013, ACTA CRYSTALLOGR D, V69, P1215, DOI 10.1107/S0907444913001121; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Eyler DE, 2019, P NATL ACAD SCI USA, V116, P23068, DOI 10.1073/pnas.1821754116; Frye M, 2018, SCIENCE, V361, P1346, DOI 10.1126/science.aau1646; Gilbert WV, 2016, SCIENCE, V352, P1408, DOI 10.1126/science.aad8711; Helm M, 2006, NUCLEIC ACIDS RES, V34, P721, DOI 10.1093/nar/gkj471; Holm L, 2016, NUCLEIC ACIDS RES, V44, pW351, DOI 10.1093/nar/gkw357; Kang PA, 2019, J STRUCT BIOL, V206, P110, DOI 10.1016/j.jsb.2019.02.007; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim SH, 2021, NUCLEIC ACIDS RES, V49, P491, DOI 10.1093/nar/gkaa1144; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Li J, 2012, J STRUCT BIOL, V177, P578, DOI 10.1016/j.jsb.2011.12.010; Liebschner D, 2019, ACTA CRYSTALLOGR D, V75, P861, DOI 10.1107/S2059798319011471; Mallette E, 2018, J BIOL CHEM, V293, P19909, DOI 10.1074/jbc.RA118.005485; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Paradis E, 2019, BIOINFORMATICS, V35, P526, DOI 10.1093/bioinformatics/bty633; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Paul R, 2015, ADV EXP MED BIOL, V842, P293, DOI 10.1007/978-3-319-11280-0_19; Preumont A, 2008, J BIOL CHEM, V283, P25238, DOI 10.1074/jbc.M804122200; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schwartz S, 2014, CELL, V159, P148, DOI 10.1016/j.cell.2014.08.028; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Sigrell JA, 1999, J MOL BIOL, V290, P1009, DOI 10.1006/jmbi.1999.2938; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Spenkuch F, 2014, RNA BIOL, V11, P1540, DOI 10.4161/15476286.2014.992278; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5	39	1	1	4	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101869	10.1016/j.jbc.2022.101869	http://dx.doi.org/10.1016/j.jbc.2022.101869			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35346685	Green Published, gold			2022-12-26	WOS:000798082100001
J	Yu, JH; Zhang, J; Shi, ML; Ding, H; Ma, LY; Zhang, HL; Liu, J				Yu, Jianghong; Zhang, Jun; Shi, Menglin; Ding, Hao; Ma, Liyun; Zhang, Huilu; Liu, Jie			Maintenance of glutamine synthetase expression alleviates endotoxin-induced sepsis via alpha-ketoglutarate-mediated demethylation	FASEB JOURNAL			English	Article						alpha-ketoglutarate; demethylation; glutamine synthetase; macrophages; sepsis	INHIBITION; TLR4	Glutamine synthetase (Glul) is the enzyme that synthesizes endogenous glutamine, which is responsible for critical metabolic pathways and the immune system. However, the role of Glul in regulating endotoxin (lipopolysaccharide, LPS)-induced sepsis remains unclear. Here, we found that Glul expression in macrophages was significantly inhibited in endotoxemia, and that Glul deletion induced macrophages to differentiate into the pro-inflammatory type and aggravated sepsis in mice. Mechanistically, TLR4/NF-kappa B-induced alpha-ketoglutarate (alpha-KG) depletion inhibits Glul expression through H3K27me3-mediated methylation in septic mice. Both Glul overexpression with adeno-associated virus (AAV) and restoration by replenishing alpha-KG can alleviate the severity of sepsis. In conclusion, the study demonstrated that Glul can regulate LPS-induced sepsis and provides a novel strategy for the treatment of this disease.	[Zhang, Huilu; Liu, Jie] Fudan Univ, Huashan Hosp, Dept Digest Dis, 130 Dongan Rd, Shanghai, Peoples R China; [Zhang, Huilu; Liu, Jie] Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China	Fudan University; Fudan University	Zhang, HL; Liu, J (corresponding author), Fudan Univ, Huashan Hosp, Dept Digest Dis, 130 Dongan Rd, Shanghai, Peoples R China.; Zhang, HL; Liu, J (corresponding author), Fudan Univ, Inst Biomed Sci, 130 Dongan Rd, Shanghai, Peoples R China.	zhanghuilu003@163.com; jieliu@fudan.edu.cn		Ding, Hao/0000-0003-0774-4670; Yu, Jianghong/0000-0002-1441-1500	National Natural Science Foundation of China [81630016, 81802964]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	National Natural Science Foundation of China, Grant/Award Number: 81630016 and 81802964	Angurana SK, 2018, CRIT CARE MED, V46, P1656, DOI 10.1097/CCM.0000000000003279; Balic JJ, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17669-5; Bott AJ, 2015, CELL METAB, V22, P1068, DOI 10.1016/j.cmet.2015.09.025; Chung C, 2020, CANCER CELL, V38, P334, DOI 10.1016/j.ccell.2020.07.008; Cruzat V, 2018, NUTRIENTS, V10, DOI 10.3390/nu10111564; Eid T, 2008, BRAIN, V131, P2061, DOI 10.1093/brain/awn133; Freemerman AJ, 2019, J IMMUNOL, V202, P1265, DOI 10.4049/jimmunol.1800002; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hakvoort TBM, 2017, HEPATOLOGY, V65, P281, DOI 10.1002/hep.28852; Haniuda K, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108333; Hou YC, 2019, BRIT J NUTR, V122, P657, DOI 10.1017/S0007114519000990; Hu YM, 2014, SHOCK, V41, P115, DOI 10.1097/SHK.0000000000000086; Kim SM, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15545-w; Kuzmich NN, 2017, VACCINES-BASEL, V5, DOI 10.3390/vaccines5040034; Lancaster GI, 2018, CELL METAB, V27, P1096, DOI 10.1016/j.cmet.2018.03.014; Lee JB, 2018, METHODS MOL BIOL, V1767, P257, DOI 10.1007/978-1-4939-7774-1_14; Li CW, 2021, J CELL MOL MED, V25, P2013, DOI 10.1111/jcmm.16082; Liu MY, 2020, SHOCK, V53, P103, DOI 10.1097/SHK.0000000000001333; Liu MX, 2018, ONCOGENE, V37, P1637, DOI 10.1038/s41388-017-0070-6; Liu PS, 2017, NAT IMMUNOL, V18, P985, DOI 10.1038/ni.3796; Luan HH, 2019, CELL, V178, P1231, DOI 10.1016/j.cell.2019.07.033; Lugin ML, 2020, ACS NANO, V14, P14262, DOI 10.1021/acsnano.0c03850; Miller SI, 2005, NAT REV MICROBIOL, V3, P36, DOI 10.1038/nrmicro1068; Muhling J, 2010, AMINO ACIDS, V38, P167, DOI 10.1007/s00726-008-0224-5; Oliveira GP, 2009, CRIT CARE, V13, DOI 10.1186/cc7888; Pai MH, 2020, NUTRIENTS, V12, DOI 10.3390/nu12041086; Ren WK, 2019, ADV NUTR, V10, P321, DOI 10.1093/advances/nmy084; Sacramento LA, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008435; Shahmirzadi AA, 2020, CELL METAB, V32, P447, DOI 10.1016/j.cmet.2020.08.004; Shakespear MR, 2018, TRENDS IMMUNOL, V39, P473, DOI 10.1016/j.it.2018.02.009; Skirecki T, 2019, FEMS MICROBIOL REV, V43, P239, DOI 10.1093/femsre/fuz004; Slotwinski R, 2011, ARCH IMMUNOL THER EX, V59, P139, DOI 10.1007/s00005-011-0117-2; van der Poll T, 2017, NAT REV IMMUNOL, V17, P407, DOI 10.1038/nri.2017.36; Williams NC, 2020, TRENDS IMMUNOL, V41, P93, DOI 10.1016/j.it.2019.12.009; Wu TY, 2019, EUR REV MED PHARMACO, V23, P184, DOI 10.26355/eurrev_201908_18646; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhu KY, 2021, EXP NEUROL, V345, DOI 10.1016/j.expneurol.2021.113828	37	1	1	6	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22281	10.1096/fj.202200059R	http://dx.doi.org/10.1096/fj.202200059R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0J9NC	35344214				2022-12-26	WOS:000780424000001
J	Geng, WL; Li, YY; Sun, DQ; Li, B; Zhang, PY; Chang, H; Rong, TQ; Liu, Y; Shao, JW; Liu, ZY; Zhu, HR; Lou, YY; Wang, QQ; Zhang, JB				Geng, Wenliang; Li, Yanyan; Sun, Dongqi; Li, Bin; Zhang, Pengyan; Chang, Hao; Rong, Tianqi; Liu, Ying; Shao, Jingwen; Liu, Zhenyue; Zhu, Huiru; Lou, Yuanyuan; Wang, Qianqian; Zhang, Jinbing			Prediction of the potential geographical distribution of Betula platyphylla Suk. in China under climate change scenarios	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; GENETIC-STRUCTURE; MEDICINAL-PLANT; FUTURE; FOREST; IMPACTS; MAXIMUM; CARBON; L.	Climate is a dominant factor affecting the potential geographical distribution of species. Understanding the impact of climate change on the potential geographic distribution of species, which is of great significance to the exploitation, utilization, and protection of resources, as well as ecologically sustainable development. Betula platyphylla Suk. is one of the most widely distributed temperate deciduous tree species in East Asia and has important economic and ecological value. Based on 231 species distribution data points of Betula platyphylla Suk. in China and 37 bioclimatic, soil, and topography variables (with correlation coefficients < 0.75), the potential geographical distribution pattern of Betula platyphylla Suk. under Representative Concentration Pathway (RCP) climate change scenarios at present and in the 2050s and 2070s was predicted using the MaxEnt model. We analyzed the main environmental variables affecting the distribution and change of suitable areas and compared the scope and change of suitable areas under different climate scenarios. This study found: (1) At present, the main suitable area for Betula platyphylla Suk. extends from northeastern to southwestern China, with the periphery area showing fragmented distribution. (2) Annual precipitation, precipitation of the warmest quarter, mean temperature of the warmest quarter, annual mean temperature, and precipitation of the driest month are the dominant environmental variables that affect the potential geographical distribution of Betula platyphylla Suk. (3) The suitable area for Betula platyphylla Suk. is expected to expand under global warming scenarios. In recent years, due to the impact of diseases and insect infestation, and environmental damage, the natural Betula platyphylla Suk. forest in China has gradually narrowed. This study accurately predicted the potential geographical distribution of Betula platyphylla Suk. under current and future climate change scenarios, which can provide the scientific basis for the cultivation, management, and sustainable utilization of Betula platyphylla Suk. resources.	[Geng, Wenliang; Li, Yanyan; Li, Bin; Zhang, Pengyan; Chang, Hao; Rong, Tianqi; Liu, Ying; Shao, Jingwen; Liu, Zhenyue; Zhu, Huiru; Lou, Yuanyuan; Wang, Qianqian; Zhang, Jinbing] Henan Univ, Coll Environm & Planning, Res Ctr Reg Dev & Planning, Inst Agr & Rural Sustainable Dev,Key Lab Geospati, Kaifeng, Peoples R China; [Sun, Dongqi] Chinese Acad Sci, Inst Geog Sci & Nat Resources Res, Beijing, Peoples R China	Henan University; Chinese Academy of Sciences; Institute of Geographic Sciences & Natural Resources Research, CAS	Li, B; Zhang, PY (corresponding author), Henan Univ, Coll Environm & Planning, Res Ctr Reg Dev & Planning, Inst Agr & Rural Sustainable Dev,Key Lab Geospati, Kaifeng, Peoples R China.	libin@henu.edu.cn; pengyanzh@126.com			National Natural Science Foundation of China [41601175, 41801362]; 2018 Young Backbone Teachers Foundation from Henan Province [2018GGJS019]; Program for Innovative Research Talent in University of Henan Province [20HASTIT017]; Key R&D and extension projects in Henan Province in 2021 (agriculture and social development field) [202102310339]; Innovation Team Cultivation Project of The First-class Discipline in Henan University [2018YLTD16]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 2018 Young Backbone Teachers Foundation from Henan Province; Program for Innovative Research Talent in University of Henan Province; Key R&D and extension projects in Henan Province in 2021 (agriculture and social development field); Innovation Team Cultivation Project of The First-class Discipline in Henan University	This research was funded by the National Natural Science Foundation of China (grant number 41601175, 41801362), the 2018 Young Backbone Teachers Foundation from Henan Province (grant number 2018GGJS019), the Program for Innovative Research Talent in University of Henan Province (grant number 20HASTIT017), Key R&D and extension projects in Henan Province in 2021 (agriculture and social development field) (grant number 202102310339), the Innovation Team Cultivation Project of The First-class Discipline in Henan University (grant number 2018YLTD16) all awarded to PZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelaal M, 2019, ECOL INFORM, V50, P68, DOI 10.1016/j.ecoinf.2019.01.003; Adams DM, 1999, LAND ECON, V75, P360, DOI 10.2307/3147183; Ahmadi M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42792-9; Alberto FJ, 2013, GLOBAL CHANGE BIOL, V19, P1645, DOI 10.1111/gcb.12181; Austin KG, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19578-z; Austin M, 2007, ECOL MODEL, V200, P1, DOI 10.1016/j.ecolmodel.2006.07.005; Bellard C, 2012, ECOL LETT, V15, P365, DOI 10.1111/j.1461-0248.2011.01736.x; Bosso L, 2017, FOREST ECOL MANAG, V400, P655, DOI 10.1016/j.foreco.2017.06.044; Burrows MT, 2014, NATURE, V507, P492, DOI 10.1038/nature12976; Busby JR, 1991, NATURE CONSERVATION, P64, DOI DOI 10.1046/J.1365-294X.2001.01244.X; Cao B, 2016, J PLANT ECOL, V9, P742, DOI 10.1093/jpe/rtw009; Chakraborty A, 2016, ECOL ENG, V97, P593, DOI 10.1016/j.ecoleng.2016.10.006; Chambers D, 2013, FOREST ECOL MANAG, V291, P20, DOI 10.1016/j.foreco.2012.10.046; Chen TY, 2019, ECOL EVOL, V9, P7792, DOI 10.1002/ece3.5365; Chen WZ, 2019, QUATERNARY SCI REV, V218, P293, DOI 10.1016/j.quascirev.2019.06.003; Espindola A, 2012, ECOL LETT, V15, P649, DOI 10.1111/j.1461-0248.2012.01779.x; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Fischer G., 2008, GLOBAL AGROECOLOGICA; Ge Q.S., 2014, CHINA POPUL RESOUR E, V24, P1; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Huang JH, 2018, FORESTS, V9, DOI 10.3390/f9010009; Isidorov V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201949; Jimenez-Valverde A, 2007, ACTA OECOL, V31, P361, DOI 10.1016/j.actao.2007.02.001; Jing GH, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12010339; Khan D, 2019, ADV METEOROL, V2019, DOI 10.1155/2019/5692574; Li YC, 2020, FORESTS, V11, DOI 10.3390/f11030302; [刘宇 Liu Yu], 2016, [林业科学, Scientia Silvae Sinicae], V52, P48; Lyu Zhao-yang, 2020, Yingyong Shengtai Xuebao, V31, P1889, DOI 10.13287/j.1001-9332.202006.011; Mantyka-Pringle CS, 2012, GLOBAL CHANGE BIOL, V18, P1239, DOI 10.1111/j.1365-2486.2011.02593.x; Merow C, 2013, ECOGRAPHY, V36, P1058, DOI 10.1111/j.1600-0587.2013.07872.x; Moreno-Amat E, 2015, ECOL MODEL, V312, P308, DOI 10.1016/j.ecolmodel.2015.05.035; Pacifici M, 2015, NAT CLIM CHANGE, V5, P215, DOI 10.1038/NCLIMATE2448; Pearson RG, 2007, J BIOGEOGR, V34, P102, DOI 10.1111/j.1365-2699.2006.01594.x; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2017, ECOGRAPHY, V40, P887, DOI 10.1111/ecog.03049; Porfirio LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113749; Pravalie R, 2018, EARTH-SCI REV, V185, P544, DOI 10.1016/j.earscirev.2018.06.010; Rong TQ, 2020, ENERGIES, V13, DOI 10.3390/en13102600; Rong ZL, 2019, FORESTS, V10, DOI 10.3390/f10010062; Shi H, 2020, SCI TOTAL ENVIRON, V706, DOI 10.1016/j.scitotenv.2019.135718; Shikov AN, 2014, J ETHNOPHARMACOL, V154, P481, DOI 10.1016/j.jep.2014.04.007; Smith P, 2014, CLIMATE CHANGE 2014: MITIGATION OF CLIMATE CHANGE, P811; Stanton JC, 2012, METHODS ECOL EVOL, V3, P349, DOI 10.1111/j.2041-210X.2011.00157.x; Stocker T.F., 2013, PHYS SCI BASIS CONTR, DOI DOI 10.1016/S0925-7721(01)00003-7; Stockwell D, 1999, INT J GEOGR INF SCI, V13, P143, DOI 10.1080/136588199241391; SWETS JA, 1988, SCIENCE, V240, P1285, DOI 10.1126/science.3287615; Thapa A, 2018, ECOL EVOL, V8, P10542, DOI 10.1002/ece3.4526; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Tognelli MF, 2009, REV CHIL HIST NAT, V82, P347, DOI 10.4067/S0716-078X2009000300003; Tolmacheva AA, 2014, ACTA PHARMACEUT, V64, P173, DOI 10.2478/acph-2014-0019; Tsuda Y, 2017, MOL ECOL, V26, P589, DOI 10.1111/mec.13885; Vieira KS, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202813; Wang RL, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192153; Wang WJ, 2019, J ECOL, V107, P1901, DOI 10.1111/1365-2745.13144; Weber TC, 2011, FOREST ECOL MANAG, V261, P779, DOI 10.1016/j.foreco.2010.12.009; Wei B, 2018, GLOB ECOL CONSERV, V16, DOI 10.1016/j.gecco.2018.e00477; Wei Hong, 2019, Chinese Journal of Plant Ecology, V43, P843, DOI 10.17521/cjpe.2019.0127; West AM, 2016, ECOL INFORM, V36, P126, DOI 10.1016/j.ecoinf.2016.11.001; Wieczynski DJ, 2019, P NATL ACAD SCI USA, V116, P587, DOI 10.1073/pnas.1813723116; Wiens JA, 2009, P NATL ACAD SCI USA, V106, P19729, DOI 10.1073/pnas.0901639106; Xie GY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160746; Xing BY, 2021, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.617635; Xu DP, 2019, GLOB ECOL CONSERV, V19, DOI 10.1016/j.gecco.2019.e00691; Xu N, 2020, BIOCHEM SYST ECOL, V90, DOI 10.1016/j.bse.2020.104052; Xu X, 2018, FORESTS, V9, DOI 10.3390/f9030103; Yang XQ, 2013, ECOL ENG, V51, P83, DOI 10.1016/j.ecoleng.2012.12.004; Yi YJ, 2016, ECOL ENG, V92, P260, DOI 10.1016/j.ecoleng.2016.04.010; Zarzo-Arias A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209972; Zhang JJ, 2019, ECOL EVOL, V9, P6643, DOI 10.1002/ece3.5243; Zhang KL, 2020, ECOL EVOL, V10, P4828, DOI 10.1002/ece3.6236; Zhang KL, 2019, ECOL INFORM, V50, P62, DOI 10.1016/j.ecoinf.2019.01.004; Zhang KL, 2019, FORESTS, V10, DOI 10.3390/f10020190; Zhang KL, 2018, SCI TOTAL ENVIRON, V634, P1326, DOI 10.1016/j.scitotenv.2018.04.112; Zhang PY, 2020, LAND USE POLICY, V99, DOI 10.1016/j.landusepol.2020.104958; Zhang XQ, 2018, ECOL ENG, V113, P27, DOI 10.1016/j.ecoleng.2018.01.009; [郑瞳 Zheng Tong], 2016, [生态学报, Acta Ecologica Sinica], V36, P6284; Zurell D, 2020, ECOGRAPHY, V43, P1261, DOI 10.1111/ecog.04960	79	1	1	15	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0262540	10.1371/journal.pone.0262540	http://dx.doi.org/10.1371/journal.pone.0262540			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358194	Green Published, gold			2022-12-26	WOS:000799828800007
J	Liu, J; Ho, PJ; Tan, THL; Yeoh, YS; Chew, YJ; Riza, NKM; Khng, AJ; Goh, SA; Wang, Y; Oh, HB; Chin, CH; Kwek, SC; Zhang, ZP; Ong, DLS; Quek, ST; Tan, CC; Wee, HL; Li, JM; Iau, PTC; Hartman, M				Liu, Jenny; Ho, Peh Joo; Tan, Tricia Hui Ling; Yeoh, Yen Shing; Chew, Ying Jia; Riza, Nur Khaliesah Mohamed; Khng, Alexis Jiaying; Goh, Su-Ann; Wang, Yi; Oh, Han Boon; Chin, Chi Hui; Kwek, Sing Cheer; Zhang, Zhi Peng; Ong, Desmond Luan Seng; Quek, Swee Tian; Tan, Chuan Chien; Wee, Hwee Lin; Li, Jingmei; Iau, Philip Tsau Choong; Hartman, Mikael			BREAst screening Tailored for HEr (BREATHE)-A study protocol on personalised risk-based breast cancer screening programme	PLOS ONE			English	Article							HEREDITARY BREAST; PERFORMANCE; BOADICEA; PROBABILITIES; MAMMOGRAPHY; VALIDATION; MUTATION; BEHAVIOR; DECADES; BRCAPRO	Routine mammography screening is currently the standard tool for finding cancers at an early stage, when treatment is most successful. Current breast screening programmes are one-size-fits-all which all women above a certain age threshold are encouraged to participate. However, breast cancer risk varies by individual. The BREAst screening Tailored for HEr (BREATHE) study aims to assess acceptability of a comprehensive risk-based personalised breast screening in Singapore. Advancing beyond the current age-based screening paradigm, BREATHE integrates both genetic and non-genetic breast cancer risk prediction tools to personalise screening recommendations. BREATHE is a cohort study targeting to recruit similar to 3,500 women. The first recruitment visit will include questionnaires and a buccal cheek swab. After receiving a tailored breast cancer risk report, participants will attend an in-person risk review, followed by a final session assessing the acceptability of our risk stratification programme. Risk prediction is based on: a) Gail model (non-genetic), b) mammographic density and recall, c) BOADICEA predictions (breast cancer predisposition genes), and d) breast cancer polygenic risk score. For national implementation of personalised risk-based breast screening, exploration of the acceptability within the target populace is critical, in addition to validated predication tools. To our knowledge, this is the first study to implement a comprehensive risk-based mammography screening programme in Asia. The BREATHE study will provide essential data for policy implementation which will transform the health system to deliver a better health and healthcare outcomes.	[Liu, Jenny; Chew, Ying Jia; Oh, Han Boon; Tan, Chuan Chien; Iau, Philip Tsau Choong] Ng Teng Fong Gen Hosp, Dept Gen Surg, Singapore, Singapore; [Liu, Jenny; Ho, Peh Joo; Riza, Nur Khaliesah Mohamed; Goh, Su-Ann; Wang, Yi; Wee, Hwee Lin; Hartman, Mikael] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Liu, Jenny; Ho, Peh Joo; Tan, Tricia Hui Ling; Yeoh, Yen Shing; Chew, Ying Jia; Riza, Nur Khaliesah Mohamed; Goh, Su-Ann; Wang, Yi; Chin, Chi Hui; Kwek, Sing Cheer; Zhang, Zhi Peng; Ong, Desmond Luan Seng; Quek, Swee Tian; Wee, Hwee Lin; Li, Jingmei; Iau, Philip Tsau Choong; Hartman, Mikael] Natl Univ Hlth Syst, Singapore, Singapore; [Ho, Peh Joo; Tan, Tricia Hui Ling; Yeoh, Yen Shing; Li, Jingmei; Hartman, Mikael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore; [Ho, Peh Joo; Khng, Alexis Jiaying; Li, Jingmei] Genome Inst Singapore, Lab Womens Hlth & Genet, Singapore, Singapore; [Chew, Ying Jia; Iau, Philip Tsau Choong; Hartman, Mikael] Natl Univ Singapore Hosp, Dept Surg, Singapore, Singapore; [Chin, Chi Hui; Ong, Desmond Luan Seng] Natl Univ Polyclin, Jurong Polyclin, Singapore, Singapore; [Kwek, Sing Cheer] Natl Univ Polyclin, Bukit Batok Polyclin, Singapore, Singapore; [Zhang, Zhi Peng] Natl Univ Polyclin, Choa Chu Kang Polyclin, Singapore, Singapore; [Quek, Swee Tian] Natl Univ Singapore Hosp, Dept Diagnost Imaging, Singapore, Singapore	National University of Singapore; National University of Singapore; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; National University of Singapore	Li, JM (corresponding author), Natl Univ Hlth Syst, Singapore, Singapore.; Li, JM (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Surg, Singapore, Singapore.; Li, JM (corresponding author), Genome Inst Singapore, Lab Womens Hlth & Genet, Singapore, Singapore.	lijim1@gis.a-star.edu.sg	Li, Jingmei/I-2904-2012	Li, Jingmei/0000-0001-8587-7511; Ho, Peh Joo/0000-0002-3017-4023	JurongHealth Fund [JHF-20-RE-003]; Precision Health Research Singapore Clinical Implementation Pilot (PRECISE CIP) Fund; PRECISE CIP Fund; Breast Cancer Prevention Programme under Saw Swee Hock School of Public Health Programme of Research Seed Funding (SSHSPHRes-Prog-BCPP); Breast Cancer Screening Prevention Programme under Yong Loo Lin School of Medicine [NUHSRO/2020/121/BCSPP/LOA]; National Medical Research Council Clinician Scientist Award [NMRC/CSA-SI/0015/2017]; National University Cancer Institute Singapore (NCIS) Centre Grant Programme [CGAug16M005]; NCIS Ng Teng Fong General Hospital Collaborative grant [CGAug16C002]; Asian Breast Cancer Research Fund; National Research Foundation Singapore [NRF-NRFF201702]; BMRC Central Research Fund (Applied Translational Research)	JurongHealth Fund; Precision Health Research Singapore Clinical Implementation Pilot (PRECISE CIP) Fund; PRECISE CIP Fund; Breast Cancer Prevention Programme under Saw Swee Hock School of Public Health Programme of Research Seed Funding (SSHSPHRes-Prog-BCPP); Breast Cancer Screening Prevention Programme under Yong Loo Lin School of Medicine; National Medical Research Council Clinician Scientist Award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National University Cancer Institute Singapore (NCIS) Centre Grant Programme; NCIS Ng Teng Fong General Hospital Collaborative grant; Asian Breast Cancer Research Fund; National Research Foundation Singapore(National Research Foundation, Singapore); BMRC Central Research Fund (Applied Translational Research)	This study is funded by the JurongHealth Fund (reference number JHF-20-RE-003) and the Precision Health Research Singapore Clinical Implementation Pilot (PRECISE CIP) Fund. M.H. is supported by the JurongHealth Fund, PRECISE CIP Fund, the Breast Cancer Prevention Programme under Saw Swee Hock School of Public Health Programme of Research Seed Funding (SSHSPHRes-Prog-BCPP), Breast Cancer Screening Prevention Programme under Yong Loo Lin School of Medicine (NUHSRO/2020/121/BCSPP/LOA), National Medical Research Council Clinician Scientist Award (Senior Investigator Category, NMRC/CSA-SI/0015/2017), the National University Cancer Institute Singapore (NCIS) Centre Grant Programme (CGAug16M005), NCIS Ng Teng Fong General Hospital Collaborative grant (CGAug16C002) and Asian Breast Cancer Research Fund. J.Li is supported by the National Research Foundation Singapore (NRF-NRFF201702) and BMRC Central Research Fund (Applied Translational Research). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright FS, 2019, CANCER CAUSE CONTROL, V30, P581, DOI 10.1007/s10552-019-01171-5; Antoniou AC, 2008, J MED GENET, V45, P425, DOI 10.1136/jmg.2007.056556; Antoniou AC, 2004, BRIT J CANCER, V91, P1580, DOI 10.1038/sj.bjc.6602175; Bhatt AA, 2021, J BREAST IMAGING, V3, P144, DOI 10.1093/jbi/wbab001; Bleyer A, 2012, NEW ENGL J MED, V367, P1998, DOI 10.1056/NEJMoa1206809; Canelo-Aybar C, 2021, J MED SCREEN, V28, P389, DOI 10.1177/0969141321993866; Chan Claire Hian Tzer, 2018, Oncotarget, V9, P12796, DOI 10.18632/oncotarget.24374; Chikarmane SA, 2021, AM J ROENTGENOL, V217, P587, DOI 10.2214/AJR.20.23976; Chootipongchaivat S, 2021, CANCER EPIDEM BIOMAR, V30, P653, DOI 10.1158/1055-9965.EPI-20-1230; Costantino JP, 1999, J NATL CANCER I, V91, P1541, DOI 10.1093/jnci/91.18.1541; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Delaloge S, 2016, B CANCER, V103, P753, DOI 10.1016/j.bulcan.2016.06.005; Esserman LJ, 2017, NPJ BREAST CANCER, V3, DOI 10.1038/s41523-017-0035-5; Evans DGR, 2019, BREAST CANCER RES TR, V176, P141, DOI 10.1007/s10549-019-05210-2; Fischer C, 2013, J MED GENET, V50, P360, DOI 10.1136/jmedgenet-2012-101415; Gagnon J, 2016, CURR ONCOL, V23, pE615, DOI 10.3747/co.23.2961; GAIL MH, 1989, J NATL CANCER I, V81, P1879, DOI 10.1093/jnci/81.24.1879; Gail MH, 2020, JNCI-J NATL CANCER I, V112, P433, DOI 10.1093/jnci/djz180; Gotzsche PC, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub5; Hall P, 2013, BRIT J CANCER, V108, P2202, DOI 10.1038/bjc.2013.257; Ho PJ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-019-57341-7; Ho WK, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-17680-w; Keane H, 2021, NPJ BREAST CANCER, V7, DOI 10.1038/s41523-021-00288-8; Lee JY, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-31859-8; Leong SPL, 2010, WORLD J SURG, V34, P2308, DOI 10.1007/s00268-010-0683-1; Lim GH, 2017, GLAND SURG, V6, P35, DOI 10.21037/gs.2016.11.05; Lim SK, 2015, ANN ACAD MED SINGAP, V44, P317; Loy EY, 2015, J MED SCREEN, V22, P194, DOI 10.1177/0969141315589644; Mahdi KM, 2013, ASIAN PAC J CANCER P, V14, P3403, DOI 10.7314/APJCP.2013.14.6.3403; Malhotra Chetna, 2016, Asian Pac J Cancer Prev, V17, P3887; Marmot MG, 2012, LANCET, V380, P1778, DOI 10.1016/S0140-6736(12)61611-0; Mavaddat N., 2019, AM J HUM GENET, V104, P21, DOI 10.1016/j.ajhg.2018.11.002; Mavaddat N, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv036; McWilliams L, 2020, BMC CANCER, V20, DOI 10.1186/s12885-020-07158-9; Miller AB, 2014, BMJ-BRIT MED J, V348, DOI 10.1136/bmj.g366; Narod SA, 2018, HUM GENET, V137, P769, DOI 10.1007/s00439-018-1944-6; Nazari SS, 2018, BREAST CANCER-TOKYO, V25, P259, DOI 10.1007/s12282-018-0857-5; Pashayan N, 2018, JAMA ONCOL, V4, P1504, DOI 10.1001/jamaoncol.2018.1901; Pederson HJ, 2020, SEMIN ONCOL, V47, P182, DOI 10.1053/j.seminoncol.2020.05.008; Pons-Rodriguez A, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2020-044597; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raat HPJ., 2021, NED TIJDSCHR GENEES, P165; Rudolph A, 2018, INT J EPIDEMIOL, V47, P526, DOI 10.1093/ije/dyx242; Shieh Y, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw290; Tehranifar P, 2021, CANCER EPIDEM BIOMAR, V30, P587, DOI 10.1158/1055-9965.EPI-20-1627; Teo CT, 2013, AM J HEALTH BEHAV, V37, P667, DOI 10.5993/AJHB.37.5.11; Vilaprinyo E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086858; Wang X, 2018, BREAST CANCER RES, V20, DOI 10.1186/s13058-018-0947-5; Weigel S, 2020, ROFO-FORTSCHR RONTG, V192, P678, DOI 10.1055/a-1100-0016; Wong ESY, 2016, NPJ GENOM MED, V1, DOI 10.1038/npjgenmed.2015.3; Wong HZ, 2015, ANN ACAD MED SINGAP, V44, P326; Wong XY, 2018, PATIENT PREFER ADHER, V12, P1837, DOI 10.2147/PPA.S171348; Wong XY, 2017, BMC CANCER, V17, DOI 10.1186/s12885-017-3781-8; Yanes T, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01260-3	54	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265965	10.1371/journal.pone.0265965	http://dx.doi.org/10.1371/journal.pone.0265965			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358246	Green Submitted, gold, Green Published			2022-12-26	WOS:000799828800058
J	Thomas, R; Mantero, J; Canovas, CR; Holm, E; Garcia-Tenorio, R; Forssell-Aronsson, E; Isaksson, M				Thomas, Rimon; Mantero, Juan; Ruiz Canovas, Carlos; Holm, Elis; Garcia-Tenorio, Rafael; Forssell-Aronsson, Eva; Isaksson, Mats			Natural radioactivity and element characterization in pit lakes in Northern Sweden	PLOS ONE			English	Article							WATER; URANIUM; SEDIMENTS	Northern Sweden has been the object of intense metal mining in the last decades producing several water-filled open-pits, or pit lakes. Most of these pit lakes have been limed to maintain a good water quality and to prevent generation of acidic water that could leach the exposed rocks and release metals into water. The aim of this work was to examine the concentration of stable elements and naturally occurring radionuclides in water and sediment samples from pit lakes originating from non-uranium mining activities in Northern Sweden. Surface water and surface sediments were collected from 27 pit lakes in Northern Sweden. Water quality parameters, concentration of stable elements and radionuclides were measured by a water probe, ICP-MS and XRF, and alpha and gamma spectrometry, respectively. Furthermore, a multivariate statistical analysis (PCA) was performed on the water samples and sediments. In general, the quality of the surface water was good, but some lakes had low pH values (2.5-5.7), and high concentrations of Fe (up to 200 mg/L) and other metals (e.g. Zn, Cu). When relating the metal concentrations in sediments in pit lakes with the concentration found in natural lakes, some sites had relatively high levels of Cu, As, Cr and Pb. The activity concentration of Po-210, and U and Th isotopes in water and sediment samples were at environmental levels, as was the ambient dose equivalent rate at these sites (range 0.08-0.14 mu Sv/h).	[Thomas, Rimon; Mantero, Juan; Holm, Elis; Forssell-Aronsson, Eva; Isaksson, Mats] Univ Gothenburg, Inst Clin Sci, Dept Med Radiat Sci, Sahlgrenska Acad, Gothenburg, Sweden; [Mantero, Juan; Garcia-Tenorio, Rafael] Univ Seville, Dept Appl Phys 2, ETSA, Seville, Spain; [Ruiz Canovas, Carlos] Univ Huelva, Dept Earth Sci, Huelva, Spain; [Ruiz Canovas, Carlos] Univ Huelva, Res Ctr Nat Resources Hlth & Environm, Huelva, Spain; [Garcia-Tenorio, Rafael] Univ Seville, Spanish Natl Accelerator Ctr CNA, Seville, Spain; [Forssell-Aronsson, Eva] Sahlgrens Univ Hosp, Dept Med Phys & Biomed Engn, Gothenburg, Region Vastra G, Sweden	University of Gothenburg; University of Sevilla; Universidad de Huelva; Universidad de Huelva; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC - Centro Nacional de Aceleradores (CNA); Sahlgrenska University Hospital	Thomas, R (corresponding author), Univ Gothenburg, Inst Clin Sci, Dept Med Radiat Sci, Sahlgrenska Acad, Gothenburg, Sweden.	rimon.thomas@gu.se	; RUIZ CANOVAS, CARLOS/M-1923-2014	Forssell-Aronsson, Eva/0000-0002-7558-4368; RUIZ CANOVAS, CARLOS/0000-0002-2860-5154; Mantero Cabrera, Juan/0000-0002-1906-8625	Swedish Radiation Safety Authority [SSM20143485]	Swedish Radiation Safety Authority	Financial support was granted by the Swedish Radiation Safety Authority (SSM20143485). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelouas A, 1998, J CONTAM HYDROL, V34, P343, DOI 10.1016/S0169-7722(98)00097-7; Acero P, 2006, GEOCHIM COSMOCHIM AC, V70, P4130, DOI 10.1016/j.gca.2006.06.1367; BORG H, 1987, WATER RES, V21, P65, DOI 10.1016/0043-1354(87)90100-X; Canovas CR, 2016, SCI TOTAL ENVIRON, V541, P400, DOI 10.1016/j.scitotenv.2015.09.070; COWART JB, 1981, J HYDROL, V54, P185, DOI 10.1016/0022-1694(81)90159-1; Dill HG, 2010, EARTH-SCI REV, V100, P1, DOI 10.1016/j.earscirev.2009.10.011; Elless MP, 1998, WATER AIR SOIL POLL, V107, P147, DOI 10.1023/A:1004982515941; EPA, 1999, 402R99004B EPA; Evans S., 1983, KBS TECHNICAL REPORT, P83; Geological Survey of Sweden, 2003, 112 GEOL SURV SWED; Gonzlez-Roldn M.J., 2010, THESIS U HUELVA N SW; HAKANSON L, 1980, WATER RES, V14, P975, DOI 10.1016/0043-1354(80)90143-8; Ivanovich M., 1992, URANIUM SERIES DISEQ; LANGMUIR D, 1980, GEOCHIM COSMOCHIM AC, V44, P1753, DOI 10.1016/0016-7037(80)90226-4; Lu M., 2004, THESIS LULE U TECHNO; Manjon Guillermo, 2019, Journal of Sustainable Mining, V18, P45, DOI 10.1016/j.jsm.2019.02.003; Manjon G., 2015, Naturally Occurring Radioactive Material (NORM VII). Seventh International Symposium on Naturally Occurring Radioactive Material Organized by the China Institute of Atomic Energy and the Nuclear and Radiation Safety Centre, Ministry of Environmental Protection, China, in Cooperation with the International Atomic Energy Agency Hosted by the China Atomic Energy Authority and the National Nuclear Safety Administration, China. Proceedings, P277; Mantero J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70521-0; Mantero J, 2019, J RADIOANAL NUCL CH, V322, P891, DOI 10.1007/s10967-019-06769-2; Mantero J, 2015, RADIAT PHYS CHEM, V116, P78, DOI 10.1016/j.radphyschem.2015.02.018; MARTINEZAGUIRRE A, 1992, RADIAT PROT DOSIM, V45, P249; Naturvrdsverket, 2017, NV0319516 NAT; PERSSON C, 1987, AMBIO, V16, P20; Ramstedt M, 2003, APPL GEOCHEM, V18, P97, DOI 10.1016/S0883-2927(02)00068-9; Salminen R, 2006, GEOCHEMICAL ATLAS EU; SCHINDLER DW, 1988, SCIENCE, V239, P149, DOI 10.1126/science.239.4836.149; SGU, 2019, AIRB GEOPH SURV SWED; SGU, 2015, GEOL SURV SWED; Suksi J, 2006, URANIUM IN THE ENVIRONMENT: MINING IMPACT AND CONSEQUENCES, P683, DOI 10.1007/3-540-28367-6_69; United Nations Scientific Committee on the Effects of Atomic Radiation, 2000, COSMIC RAYS, V9, P11; Wallstedt T, 2005, SCI TOTAL ENVIRON, V336, P135, DOI 10.1016/j.scitotenv.2004.05.024; Wallstedt T, 2008, SCI TOTAL ENVIRON, V407, P405, DOI 10.1016/j.scitotenv.2008.07.062; Wanhainen C, 2012, ORE GEOL REV, V48, P306, DOI 10.1016/j.oregeorev.2012.05.002; Wanty R.B., 1999, ENV GEOCHEMISTRY MIN, V6, P201; Younger PL, 2002, ENVIRON POLLUT, V5	36	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266002	10.1371/journal.pone.0266002	http://dx.doi.org/10.1371/journal.pone.0266002			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358244	Green Published, gold			2022-12-26	WOS:000799828800059
J	Ali, A; Rumbold, AR; Kapellas, K; Lassi, ZS; Hedges, J; Jamieson, L				Ali, Anna; Rumbold, Alice R.; Kapellas, Kostas; Lassi, Zohra S.; Hedges, Joanne; Jamieson, Lisa			Association between self-reported periodontitis and high-risk oral human papillomavirus infection among Indigenous South Australians: A cross-sectional study	PLOS ONE			English	Article							DISEASE; PREVALENCE; CANCER; HEAD	Introduction The incidence of oropharyngeal squamous cell carcinoma (OPSCC) is increasing globally, reflecting an increase in human papillomavirus (HPV)-related lesions. Indigenous populations are disproportionately affected by OPSCCs. Currently, testing for oral HPV is not recommended as a screening tool to permit early detection of OPSCCs due to the high population prevalence of HPV infection. Periodontitis may be a marker of oral HPV infection, but previous research evaluating this association has been inconclusive. Here we report a large population-based study examining the association between high-risk oral HPV infection and periodontitis among Indigenous South Australians. Methods We utilised a large convenience sample of Indigenous South Australians aged 18+ years recruited between February 2018 and February 2020. Of the original cohort (n = 1011), 748 (73.9%) participants participated in the 12 month follow-up. Detailed information on socio-demographic characteristics, health-related behaviours, and sexual history were collected at enrolment. Saliva samples were collected at 12 months and tested for the presence of oral HPV DNA using the optimized general primer (GP) + PCR system. The primary outcomes were the prevalence of any high-risk oral HPV DNA, and separately, HPV 16 and/or 18. Periodontitis was assessed at follow-up by using validated self-reported periodontitis screening questions. Logistic regression analyses were undertaken to assess the association between self-reported periodontitis and oral HPV infection with adjustment for potential sociodemographic and behavioural confounders, with estimates presented as odds ratios (OR) and 95% confidence interval (CI). Results Data on 673 participants (89.9% of the follow-up cohort) were available. Participants ranged in age from 18 to 80 (mean age 42.2, SD 14.7) and 31.5% were male. Overall, 115 (17.1%) participants had self-reported periodontitis, 40 (5.9%) had any high-risk oral HPV and 14 (2.1%) had HPV 16 and/or 18. Any high-risk HPV was detected among seven (17.5%) participants and HPV 16 and/or 18 was detected in three (21.4%) who self-reported periodontitis. In the regression analyses no significant association was found between self-reported periodontitis and high-risk oral HPV (adjusted OR: 1.10; 95% CI: 0.45-2.70) or HPV 16 and/or 18 (adjusted OR: 1.27; 95% CI: 0.32-5.03). Conclusion This study did not find any association between self-reported periodontitis and high-risk oral HPV among Indigenous South Australians. Further targeted studies with standardized clinical measures of periodontal disease are needed to clarify the link between high-risk oral HPV and periodontal disease. If confirmed this would add further weight to the importance of recommendations about the utility of periodontitis screening to identify individuals at risk of carrying high-risk oral HPV, who may benefit from more intensive screening and ongoing monitoring.	[Ali, Anna; Rumbold, Alice R.; Lassi, Zohra S.] Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia; [Ali, Anna; Kapellas, Kostas; Hedges, Joanne; Jamieson, Lisa] Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia; [Rumbold, Alice R.] South Australian Hlth & Med Res Inst, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Ali, A (corresponding author), Univ Adelaide, Sch Med, Robinson Res Inst, Adelaide, SA, Australia.; Ali, A (corresponding author), Univ Adelaide, Australian Res Ctr Populat Oral Hlth, Adelaide, SA, Australia.	anna.ali@adelaide.edu.au	; Ali, Anna/E-6480-2018	Lassi, Zohra/0000-0002-5350-6334; Ali, Anna/0000-0002-7832-1694	NHMRC [APP1120215]	NHMRC(National Health and Medical Research Council (NHMRC) of Australia)	This paper is a part of a larger study investigating Human Papillomavirus and Oropharyngeal Squamous Cell Carcinoma (OPSCC) among Indigenous Australians which is funded by a NHMRC project grant (APP1120215).	Ali A, 2021, J PUBLIC HEALTH-UK, V43, pE610, DOI 10.1093/pubmed/fdaa156; [Anonymous], 2018, ABORIGINAL AUSTR C T; Association AD, 2017, POLICY STATEMENT 610; Australian Research Centre for Population Oral Health, 2019, AUSTRALIAS ORAL HLTH; Castellsague X, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv403; Cook RL, 2014, SEX TRANSM DIS, V41, P486, DOI 10.1097/OLQ.0000000000000159; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dalla Torre D, 2019, CLIN ORAL INVEST, V23, P179, DOI 10.1007/s00784-018-2425-y; de Silva AM, 2017, AUST HEALTH REV, V41, P469, DOI 10.1071/AH15229; Gipson BJ, 2018, ORAL ONCOL, V77, P52, DOI 10.1016/j.oraloncology.2017.12.008; Hong A, 2016, HEAD NECK-J SCI SPEC, V38, P743, DOI 10.1002/hed.23942; Horewicz VV, 2010, J PERIODONTOL, V81, P562, DOI 10.1902/jop.2009.090571; Hormia M, 2005, J PERIODONTOL, V76, P358, DOI 10.1902/jop.2005.76.3.358; Jacob Anila, 2014, J Indian Soc Periodontol, V18, P447, DOI 10.4103/0972-124X.138682; Jamieson L, 2018, JMIR RES PROTOC, V7, DOI 10.2196/10503; Jamieson LM, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.4951; Jamieson LM, 2019, HIGH PREVALENCE ORAL, DOI [http%3A//dx.doi.org/10.2139/ssrn.3471347, DOI 10.2139/SSRN.3471347]; Joseph BK, 2002, MED PRIN PRACT, V11, P32, DOI 10.1159/000057776; Kapellas K, 2014, AUST DENT J, V59, P93, DOI 10.1111/adj.12135; Kapellas K, 2021, INT DENT J, V71, P407, DOI 10.1016/j.identj.2020.12.013; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Lechner M, 2019, LANCET, V393, P2123, DOI 10.1016/S0140-6736(19)30227-2; Marino R, 2017, BMC ORAL HEALTH, V17, DOI 10.1186/s12903-017-0439-5; Mello FW, 2019, CLIN ORAL INVEST, V23, P2849, DOI 10.1007/s00784-019-02958-1; Ortiz Ana P, 2019, Curr Oral Health Rep, V6, P22, DOI 10.1007/s40496-019-0206-6; Ortiz AP, 2018, PAPILLOMAVIRUS RES, V5, P128, DOI 10.1016/j.pvr.2018.03.003; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Papillomaviruses H., 2011, IARC MONOGRAPHS EVAL; Plummer M, 2016, LANCET GLOB HEALTH, V4, pE609, DOI 10.1016/S2214-109X(16)30143-7; Speight PM, 2020, TXB ORAL CANC, P201; Sun CXH, 2017, DIAGNOSTICS, V7, DOI 10.3390/diagnostics7010011; Tezal Mine, 2012, Int J Otolaryngol, V2012, P575242, DOI 10.1155/2012/575242; Tezal M, 2012, ARCH OTOLARYNGOL, V138, P669, DOI 10.1001/archoto.2012.873; Tezal M, 2009, ARCH OTOLARYNGOL, V135, P391, DOI 10.1001/archoto.2009.6; Wiener RC, 2015, J AM DENT ASSOC, V146, P382, DOI 10.1016/j.adaj.2015.01.019; Wierzbicka M, 2019, CURR OPIN OTOLARYNGO, V27, P85, DOI 10.1097/MOO.0000000000000525	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265840	10.1371/journal.pone.0265840	http://dx.doi.org/10.1371/journal.pone.0265840			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324953	Green Published, gold			2022-12-26	WOS:000780951300078
J	McBride, O; Bunting, E; Harkin, O; Butter, S; Shevlin, M; Murphy, J; Mason, L; Hartman, TK; McKay, R; Hyland, P; Levita, L; Bennett, KM; Stocks, TVA; Gibson-Miller, J; Martinez, AP; Vallieres, F; Bentall, RP				McBride, Orla; Bunting, Eimhear; Harkin, Oisin; Butter, Sarah; Shevlin, Mark; Murphy, Jamie; Mason, Liam; Hartman, Todd K.; McKay, Ryan; Hyland, Philip; Levita, Liat; Bennett, Kate M.; Stocks, Thomas V. A.; Gibson-Miller, Jilly; Martinez, Anton P.; Vallieres, Frederique; Bentall, Richard P.			Testing both affordability-availability and psychological-coping mechanisms underlying changes in alcohol use during the COVID-19 pandemic	PLOS ONE			English	Article							BRIEF RESILIENCE SCALE; DRINKING; PTSD; PERSONALITY; RELIABILITY; LONELINESS; INVENTORY; ANXIETY; STRESS	Two theoretical perspectives have been proffered to explain changes in alcohol use during the pandemic: the `affordability-availability' mechanism (i.e., drinking decreases due to changes in physical availability and/or reduced disposable income) and the 'psychologicalcoping' mechanism (i.e., drinking increases as adults attempt to cope with pandemic-related distress). We tested these alternative perspectives via longitudinal analyses of the COVID19 Psychological Consortium (C19PRC) Study data (spanning three timepoints during March to July 2020). Respondents provided data on psychological measures (e.g., anxiety, depression, posttraumatic stress, paranoia, extraversion, neuroticism, death anxiety, COVID-19 anxiety, intolerance of uncertainty, resilience), changes in socio-economic circumstances (e.g., income loss, reduced working hours), drinking motives, solitary drinking, and 'at-risk' drinking (assessed using a modified version of the AUDIT-C). Structural equation modelling was used to determine (i) whether 'at-risk' drinking during the pandemic differed from that recalled before the pandemic, (ii) dimensions of drinking motives and the psychosocial correlates of these dimensions, (iii) if increased alcohol consumption was predicted by drinking motives, solitary drinking, and socio-economic changes. The proportion of adults who recalled engaging in 'at-risk' drinking decreased significantly from 35.9% prepandemic to 32.0% during the pandemic. Drinking to cope was uniquely predicted by experiences of anxiety and/or depression and low resilience levels. Income loss or reduced working hours were not associated with coping, social enhancement, or conformity drinking motives, nor changes in drinking during lockdown. In the earliest stage of the pandemic, psychological-coping mechanisms may have been a stronger driver to changes in adults' alcohol use than 'affordability-availability' alone.	[McBride, Orla; Bunting, Eimhear; Harkin, Oisin; Butter, Sarah; Shevlin, Mark; Murphy, Jamie] Ulster Univ, Coleraine, Londonderry, North Ireland; [Butter, Sarah; Levita, Liat; Stocks, Thomas V. A.; Gibson-Miller, Jilly; Martinez, Anton P.; Bentall, Richard P.] Univ Sheffield, Sheffield, S Yorkshire, England; [Mason, Liam] UCL, London, England; [Hartman, Todd K.] Univ Manchester, Manchester, Lancs, England; [McKay, Ryan] Royal Holloway Univ London, Egham, Surrey, England; [Hyland, Philip] Maynooth Univ, Maynooth, Kildare, Ireland; [Bennett, Kate M.] Univ Liverpool, Liverpool, Merseyside, England; [Vallieres, Frederique] Trinity Coll Dublin, Dublin, Ireland	Ulster University; University of Sheffield; University of London; University College London; University of Manchester; University of London; Royal Holloway University London; Maynooth University; University of Liverpool; Trinity College Dublin	McBride, O (corresponding author), Ulster Univ, Coleraine, Londonderry, North Ireland.	o.mcbride@ulster.ac.uk	McKay, Ryan/C-2160-2008	McKay, Ryan/0000-0001-7781-1539; McBride, Orla/0000-0003-3399-9466; Butter, Sarah/0000-0001-9735-9156; Levita, Liat/0000-0001-6002-6817; Hartman, Todd/0000-0001-9136-2784	UK Research and Innovation Economic and Social Research Council (UKRI ESRC) [ES/V004379/1]	UK Research and Innovation Economic and Social Research Council (UKRI ESRC)(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The COVID-19 Psychological Research Consortium (C19PRC) Study (authors OMB, MS, JM, LM, TKH, LL, KMB, JGM, RPB) is funded by the UK Research and Innovation Economic and Social Research Council (UKRI ESRC) grant number ES/V004379/1. https://gtr.ukri.org/projects?ref=ES%2FV004379%2F1 The sponsor or funder played no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036371; Bell S, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-91; Ben-Ezra M, 2018, DEPRESS ANXIETY, V35, P264, DOI 10.1002/da.22723; Bhattacharjee B, 2020, PSYCHIAT QUART, V91, P1135, DOI 10.1007/s11126-020-09836-0; Bollen Z, 2021, ADDICT BEHAV, V115, DOI 10.1016/j.addbeh.2020.106772; Boschuetz Nicole, 2020, WMJ, V119, P171; Callinan S, 2021, ADDICTION, V116, P1381, DOI 10.1111/add.15275; Clay JM, 2020, LANCET PUBLIC HEALTH, V5, pE259, DOI 10.1016/S2468-2667(20)30088-8; Cloitre M, 2018, ACTA PSYCHIAT SCAND, V138, P536, DOI 10.1111/acps.12956; Cooper M.L., 1992, PSYCHOL ASSESS J CON, V4, P123, DOI DOI 10.1037/1040-3590.4.2.123; Cooper M.L., 2016, SHER KJ EDITOR OXFOR, P375, DOI DOI 10.1093/OXFORDHB/9780199381678.013.017; Creswell KG, 2020, ALCOHOL CLIN EXP RES, V44, P2150, DOI 10.1111/acer.14468; Dawson DA, 2005, ALCOHOL CLIN EXP RES, V29, P844, DOI 10.1097/01.ALC.0000164374.32229.A2; Economic and Social Research Institute, SIGN DISP EC IMP GLO; Elahi A, 2017, SCHIZOPHR RES, V190, P77, DOI 10.1016/j.schres.2017.03.022; Enders CK, 2011, REHABIL PSYCHOL, V56, P267, DOI 10.1037/a0025579; Garnett C, 2021, DRUG ALCOHOL DEPEN, V219, DOI 10.1016/j.drugalcdep.2020.108461; Goncalves PD, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.581113; Hacker J, 2020, EUR J INFORM SYST, V29, P563, DOI 10.1080/0960085X.2020.1814680; Horesh D, 2020, PSYCHOL TRAUMA-US, V12, P331, DOI 10.1037/tra0000592; Hughes ME, 2004, RES AGING, V26, P655, DOI 10.1177/0164027504268574; Hyland P, 2017, ACTA PSYCHIAT SCAND, V136, P313, DOI 10.1111/acps.12771; Inman P., 2020, GURADIAN; Irizar P, 2021, DRUG ALCOHOL DEPEN, V226, DOI 10.1016/j.drugalcdep.2021.108913; Jacob L, 2021, DRUG ALCOHOL DEPEN, V219, DOI 10.1016/j.drugalcdep.2020.108488; Karatzias T, 2016, J ANXIETY DISORD, V44, P73, DOI 10.1016/j.janxdis.2016.10.009; Kilian C, 2021, ADDICTION, V116, P3369, DOI 10.1111/add.15530; Koopmann A, 2020, ALCOHOL ALCOHOLISM, V55, P698, DOI 10.1093/alcalc/agaa058; Kroenke K, 2019, J AFFECT DISORDERS, V246, P437, DOI 10.1016/j.jad.2018.12.098; Kroenke K, 2016, PSYCHOSOM MED, V78, P716, DOI 10.1097/PSY.0000000000000322; Kuntsche E, 2008, PERS INDIV DIFFER, V45, P796, DOI 10.1016/j.paid.2008.08.009; Kyriazos TA., 2018, PSYCHOLOGY, V9, P1828, DOI [10.4236/psych.2018.97107, DOI 10.4236/PSYCH.2018.97107]; Lehavot K, 2014, PSYCHOL ADDICT BEHAV, V28, P42, DOI 10.1037/a0032266; McBride O, 2021, INT J METH PSYCH RES, V30, DOI 10.1002/mpr.1880; McBride O, 2021, INT J METH PSYCH RES, V30, DOI 10.1002/mpr.1861; McIntyre JC, 2018, SCHIZOPHRENIA BULL, V44, P681, DOI 10.1093/schbul/sbx110; McPhee MD, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.574676; Melo S, 2009, PSYCHOL PSYCHOTHER-T, V82, P247, DOI 10.1348/147608308X398337; Miles DK, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13674; Neill E, 2020, PSYCHIAT CLIN NEUROS, V74, P542, DOI 10.1111/pcn.13099; Nicholls E, 2021, INT J DRUG POLICY, V88, DOI 10.1016/j.drugpo.2020.103025; Office for national statistics, 2018, ADULT DRINKING HABIT; Ramalho R, 2020, AUSTRALAS PSYCHIATRY, V28, P524, DOI 10.1177/1039856220943024; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Rehm J, 2020, DRUG ALCOHOL REV, V39, P301, DOI 10.1111/dar.13074; Rodriguez-Rey R, 2016, PSYCHOL ASSESSMENT, V28, pE101, DOI 10.1037/pas0000191; Schmits E, 2022, INT J MENT HEALTH AD, V20, P1147, DOI 10.1007/s11469-020-00432-8; Sharma M, 2020, J ALCOHOL DRUG EDUC, V64, P8; Shevlin M, 2020, J TRAUMA STRESS, V33, P866, DOI 10.1002/jts.22592; Skrzynski CJ, 2020, ADDICTION, V115, P1989, DOI 10.1111/add.15055; Smith BW, 2008, INT J BEHAV MED, V15, P194, DOI 10.1080/10705500802222972; STEIGER JH, 1990, MULTIVAR BEHAV RES, V25, P173, DOI 10.1207/s15327906mbr2502_4; Steptoe A, 2013, P NATL ACAD SCI USA, V110, P5797, DOI 10.1073/pnas.1219686110; Stevely AK, 2021, ALCOHOL CLIN EXP RES, V45, P630, DOI 10.1111/acer.14560; Tomas-Sabado J, 2005, PSYCHOL REP, V97, P793, DOI 10.2466/PR0.97.7.793-796; Tran TD, 2020, J AFFECT DISORDERS, V277, P810, DOI 10.1016/j.jad.2020.09.012; TUCKER LR, 1973, PSYCHOMETRIKA, V38, P1, DOI 10.1007/bf02291170; Vallieres F, 2018, ACTA PSYCHIAT SCAND, V138, P547, DOI [10.1111/acps.12973, 10.]; Van Overmeire R, 2020, J TRAUMA STRESS, V33, P864, DOI 10.1002/jts.22594; Villadsen A, 2021, MENTAL HLTH RELATION, DOI [10.1101/2021.03.26.21254424, DOI 10.1101/2021.03.26.21254424]; Wardell JD, 2020, ALCOHOL CLIN EXP RES, V44, P2073, DOI 10.1111/acer.14425; Wilder-Smith A, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa020; Wilkins P, 2021, AUST J PUBL ADMIN, V80, P12, DOI 10.1111/1467-8500.12437	63	0	0	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265145	10.1371/journal.pone.0265145	http://dx.doi.org/10.1371/journal.pone.0265145			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324964	Green Published, Green Accepted, gold			2022-12-26	WOS:000780951300030
J	Xie, L; Shang, ZJ				Xie, Long; Shang, Zhengjun			Burden of oral cancer in Asia from 1990 to 2019: Estimates from the Global Burden of Disease 2019 study	PLOS ONE			English	Article							RISK; EPIDEMIOLOGY; MORTALITY; SMOKING; INCOME	Background Oral cancer (OC) poses a threat to human health and imposes a heavy burden on countries. We assessed the burden imposed by OC on Asian nations from 1990 to 2019 based on gender and age. Methods We collected oral cancer data from the 2019 Global Burden of Disease study from 1990 to 2019 in 45 Asian countries and territories. Annual case data and age-standardised rates (ASRs) were used to investigate the incidence, mortality, and disability-adjusted life-years (DALYs) of OC based on age and gender from 1990 to 2019 in 45 Asian countries and territories. Estimated annual percentage changes (EAPCs) were used to assess incidence rate, mortality, and trends in DALYs. Results The age-standardised incidence rate (ASIR) of OC increased from 1990 to 2019 with an EAPC of 0.32 (95% CI, 0.19-0.46), and the age-standardised death rate of OC remained stable at an EAPC of 0.08 (95%CI, from -0.06 to 0.21). The age-standardised DALYs of OC decreased at an EAPC of -0.16 (95%CI, from -0.30 to -0.02). The proportion of patients older than 70 years increased yearly in terms of incidence, mortality, and DALYs from 1990 to 2019. Of the DALYs, smoking was the main contributor in the Asian regions, and the largest contributor to DALYs in most Asian regions. Other contributors were alcohol use and chewing tobacco. Conclusion Although the burden of OC was declining in Asia, South Asia remained the region with the highest burden. OC caused the greatest burden in Pakistan, Taiwan China, and India. Therefore, measures should be taken to reduce the burden of oral cancer in high-risk regions and countries with attributable risk factors.	[Xie, Long; Shang, Zhengjun] Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China; [Xie, Long; Shang, Zhengjun] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China; [Xie, Long; Shang, Zhengjun] Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan, Peoples R China	Wuhan University; Wuhan University; Wuhan University	Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan, Peoples R China.; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan, Peoples R China.; Shang, ZJ (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Dept Oral & Maxillofacial Head & Neck Oncol, Wuhan, Peoples R China.	shangzhengjun@whu.edu.cn		shang, zhengjun/0000-0002-4884-8129				Al-Jaber A, 2016, SAUDI MED J, V37, P249, DOI 10.15537/smj.2016.3.11388; Albar M A, 1994, J Family Community Med, V1, P79; Allemani C, 2015, LANCET, V385, P977, DOI 10.1016/S0140-6736(14)62038-9; Alshehri BM, 2020, WORLD J SURG ONCOL, V18, DOI 10.1186/s12957-020-01989-3; Amarasinghe H, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027661; Anwar N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236359; Bai XX, 2020, BMC ORAL HEALTH, V20, DOI 10.1186/s12903-020-01192-6; Bayarsaikhan D, 2015, INT SOC SECUR REV, V68, P93, DOI 10.1111/issr.12089; Chen DT, 2009, J OTOLARYNGOL-HEAD N, V38, P208, DOI 10.2310/7070.2009.070242; Chuang SL, 2017, CANCER-AM CANCER SOC, V123, P1597, DOI 10.1002/cncr.30517; Conway DI, 2008, INT J CANCER, V122, P2811, DOI 10.1002/ijc.23430; Csikar J, 2013, BRIT J ORAL MAX SURG, V51, P25, DOI 10.1016/j.bjoms.2012.03.008; Dantas TS, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002314; Fanaras Nikolaos, 2016, Prim Dent J, V5, P64; Fitzmaurice C, 2017, JAMA ONCOL, V3, P524, DOI 10.1001/jamaoncol.2016.5688; Fitzmaurice C, 2018, JAMA ONCOL, V4, P1553, DOI 10.1001/jamaoncol.2018.2706; Fu JY, 2014, CHINA J ORAL MAXILLO, V12, P261; Fu QY, 2020, ECLINICALMEDICINE, V27, DOI 10.1016/j.eclinm.2020.100558; Hankey BF, 2000, CANCER CAUSE CONTROL, V11, P31, DOI 10.1023/A:1008953201688; He BC, 2016, ACTA OTO-LARYNGOL, V136, P1074, DOI 10.1080/00016489.2016.1185539; Huang YT, 2020, SUBST USE MISUSE, V55, P1472, DOI 10.1080/10826084.2020.1732421; Jayakar R, 2017, NEW ZEAL MED J, V130, P111; Kadashetti V, 2015, J CANCER RES THER, V11, P280, DOI 10.4103/0973-1482.151417; Li-Ting C, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-380; Manthey J, 2019, LANCET, V393, P2493, DOI 10.1016/S0140-6736(18)32744-2; Mills A, 2014, NEW ENGL J MED, V370, P552, DOI 10.1056/NEJMra1110897; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pignon JP, 2009, RADIOTHER ONCOL, V92, P4, DOI 10.1016/j.radonc.2009.04.014; Ren ZH, 2020, CANCER COMMUN, V40, P81, DOI 10.1002/cac2.12009; Rezapour A, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203059; Rimal Jyotsna, 2019, Asian Pac J Cancer Prev, V20, P411, DOI 10.31557/APJCP.2019.20.2.411; Thavarool SB, 2019, WORLD J SURG ONCOL, V17, DOI 10.1186/s12957-018-1550-z; United Nations department of Economic and Social Affairs Population dynamics., INT MIGR STOCK PERC; United Nations. Department of Economic and Social Affairs Population Dynamics, WORLD POPULATION PRO; Warnakulasuriya S, 2009, ORAL ONCOL, V45, P309, DOI 10.1016/j.oraloncology.2008.06.002; Ye LL, 2016, J CANCER RES THER, V12, P237, DOI 10.4103/0973-1482.200746; 代晓明, 2002, [中国肿瘤临床, Chinese Journal of Clinical Oncology], V29, P674	38	3	3	14	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265950	10.1371/journal.pone.0265950	http://dx.doi.org/10.1371/journal.pone.0265950			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324990	Green Published, gold			2022-12-26	WOS:000780951300088
J	Hu, YY; Cai, YJ; Jiang, X; Mao, FY; Zhang, J; Liu, L; Wu, Q; Wang, XH				Hu, Yao-yao; Cai, Ya-jing; Jiang, Xin; Mao, Fang-ying; Zhang, Jing; Liu, Lin; Wu, Qing; Wang, Xiao-hua			Relationship between dynamic changes of peri-procedure anxiety and short-term prognosis in patients undergoing elective percutaneous coronary intervention for coronary heart disease: A single-center, prospective study	PLOS ONE			English	Article							QUALITY-OF-LIFE; ARTERY-DISEASE; RISK-FACTOR; PCI	BackgroundPatients with coronary heart disease (CHD) often experience anxiety, but the current studies on anxiety mostly focused on a certain point in time. Therefore, this study aimed to investigate the dynamic changes of peri-procedure anxiety, status of post-procedure quality of life, and cardiovascular readmission rates in patients with CHD who undergoing elective percutaneous coronary intervention (PCI), and to analyze the influence of peri-procedure anxiety on quality of life and readmission rate after PCI. MethodsThis prospective study was conducted at Changshu NO.1 People's Hospital. A total of 220 patients with CHD undergoing elective PCI were selected as study subjects. The general information, clinical data, anxiety, quality of life and readmission of patients were collected. Multivariate linear regression was used to examine the effect of peri-procedure anxiety on quality of life, and multivariate logistic regression was used to analyze the influence of peri-procedure anxiety on readmission rate. ResultsThis study showed the anxiety scores at hospitalization appointment(T1), 3 days before procedure(T2), 1 day before procedure(T3), 1 day after procedure(T4) were 57(55,61),64(61,68),54(51.58), and 54(50,60), respectively. And, at 3 months and 6 months after PCI, the scores of Seattle Angina Questionnaire (SAQ) were 346.61(319.06,366.52) and 353.34(334.18,372.84) respectively. During 6 months follow-up, 54 cases were readmitted, with a readmission rate of 25.5%. Statistical analysis showed that T1 with anxiety (P = 0.002) and T2 with anxiety (P = 0.024) were independent risk factors for treatment satisfaction at 3 months after PCI. Anxiety in T4 (P = 0.005) was an independent risk factor on the angina frequency at 6 months after PCI. T2 with anxiety (B = 1.445, P = 0.010, 95%CI:1.409-12.773) and T4 without anxiety (B = -1.587, P = 0.042, 95%CI:-0.044-0.941) were risk factors affecting readmission for cardiovascular reasons within 6 months. ConclusionPatient anxiety at T1 and T2 affects the treatment satisfaction dimension of the SAQ at 3 months after PCI, and anxiety at T4 affects the angina frequency dimension of the SAQ at 6 months after PCI. Anxiety at T2 and no anxiety at T4 increase short-term readmission rates. In the future, interventions should be strengthened at various time points in the peri-procedure period to improve post-procedure rehabilitation effect.	[Hu, Yao-yao; Liu, Lin; Wu, Qing; Wang, Xiao-hua] Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China; [Cai, Ya-jing] Changshu 1 Peoples Hosp, Dept Cardiol, Suzhou, Jiangsu, Peoples R China; [Jiang, Xin] Nanjing Med Univ, Nursing Dept, Affiliated Wuxi Peoples Hosp, Wuxi, Jiangsu, Peoples R China; [Mao, Fang-ying; Zhang, Jing] Soochow Univ, Sch Nursing, Suzhou, Jiangsu, Peoples R China	Soochow University - China; Nanjing Medical University; Soochow University - China	Wu, Q; Wang, XH (corresponding author), Soochow Univ, Dept Cardiol, Affiliated Hosp 1, Suzhou, Jiangsu, Peoples R China.	2870786811@qq.com; 378195372@qq.com			Suzhou science and Technology Bureau [sys2018018]	Suzhou science and Technology Bureau	We thank all patients with CHD who participated in the study.	Abdallah MS, 2013, JAMA-J AM MED ASSOC, V310, P1581, DOI 10.1001/jama.2013.279208; Acikel MET, 2019, BRAZ J CARDIOVA SURG, V34, P389, DOI 10.21470/1678-9741-2018-0426; Bavishi C, 2018, CLIN CARDIOL, V41, P450, DOI 10.1002/clc.22893; Celano CM, 2015, AM HEART J, V170, P1105, DOI 10.1016/j.ahj.2015.09.013; Chang ZX, 2020, AUST J RURAL HEALTH, V28, P124, DOI 10.1111/ajr.12587; Chen J, 2018, 2018 INTERNATIONAL CONFERENCE ON MANIPULATION, AUTOMATION AND ROBOTICS AT SMALL SCALES (MARSS); Chen YY, 2019, MEDICINE, V98, DOI 10.1097/MD.0000000000016973; Coatsworth-Puspoky R, 2021, J ADV NURS, V77, P4291, DOI 10.1111/jan.14893; Cohen David J, 2011, N Engl J Med, V364, P1016, DOI 10.1056/NEJMoa1001508; Committee of experts on rational drug use of national health commission of the P.R China Chinese pharmacists association, 2016, CHINESE J FRONTIERS, V8, P19; Dai GL., 2020, J MEDICAL INTELLIGEN, V41, P67, DOI [10.3969/j.issn.1673-6036.2020.01.014, DOI 10.3969/J.ISSN.1673-6036.2020.01.014]; De Hert M, 2018, DIALOGUES CLIN NEURO, V20, P31; Delewi R, 2017, INT J CARDIOL, V228, P926, DOI 10.1016/j.ijcard.2016.11.043; Ding F., 2019, CHINESE COMMUNITY DO, V35, P41, DOI [10.3969/j.issn.1007-614x.2019.07.025, DOI 10.3969/J.ISSN.1007-614X.2019.07.025]; Du JL, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003364; Feng Y., 2021, SHAANXI MED J, V50, P58; Gu GQ, 2016, BMC PSYCHIATRY, V16, DOI 10.1186/s12888-016-0972-9; Han, 2018, ASSESSMENT ANXIETY D; Han, 2016, CHINESE J HLTH CARE, V18, P349; He HY., 2018, PRACTICAL J CARDIAC, V26, P121, DOI [10.3969/j.issn.1008-5971.2018.04.030, DOI 10.3969/J.ISSN.1008-5971.2018.04.030]; [胡盛寿 Hu Shengshou], 2019, [中国循环杂志, Chinese Circulation Journal], V34, P209; Iles-Smith H, 2015, EUR J CARDIOVASC NUR, V14, P506, DOI 10.1177/1474515114543227; Kwok CS, 2021, CATHETER CARDIO INTE, V97, P395, DOI 10.1002/ccd.28797; Li Xi-ming, 2012, Zhonghua Xin Xue Guan Bing Za Zhi, V40, P99; Liang QL., 2019, CHINESE J PRACTICAL, V35, P1041, DOI [10.3760/cma.j.issn.1672-7088.2019.14.001, DOI 10.3760/CMA.J.ISSN.1672-7088.2019.14.001]; Lichtman JH, 2014, CIRCULATION, V129, P1350, DOI 10.1161/CIR.0000000000000019; Liu SH, 2003, EVALUATION RELIABILI; Mosleh SM, 2015, J CARDIOVASC NURS, V30, P471, DOI 10.1097/JCN.0000000000000189; Rao SV, 2011, JAMA-J AM MED ASSOC, V306, P1461, DOI 10.1001/jama.2011.1409; Roth GA, 2018, LANCET, V392, P1736, DOI [10.1016/S0140-6736(18)32203-7, 10.1016/s0140-6736(18)32203-7]; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Wang X., 1999, MANUAL MENTAL HLTH R; Wei, 2001, STAT STAT ANAL APPL; Wei JK, 2014, AM J CARDIOL, V114, P187, DOI 10.1016/j.amjcard.2014.04.022; Wijeysundera HC, 2014, EUROINTERVENTION, V9, P1165, DOI 10.4244/EIJV9I10A197; Wu, 2019, EFFECT DELAYED PCI D; Xiao C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195024; Yan BP, 2018, VALUE HEALTH, V21, P423, DOI 10.1016/j.jval.2017.10.004; [杨吉羚 Yang Jiling], 2021, [解放军护理杂志, Nursing Journal of Chinese People's Liberation Army], V38, P20; Zhang S, 2022, HIGH VOLT, V7, P718, DOI 10.1049/hve2.12201; Zhang XC., 2019, CHINESE J EMERGENCY, V39, P301; Zhang XL., 2018, CHINESE J EVIDENCE B, V10, P199, DOI [10.3969/j.issn.1674-4055.2018.02.20, DOI 10.3969/J.ISSN.1674-4055.2018.02.20]; Zhao J., 2014, W J TRADITIONAL CHIN, V27, P46; Zhou, 2015, STUDY ANXIETY DEPRES; Zhou HD., 2019, J CARDIOVASCULAR PUL, V38, P356, DOI [10.3969/j.issn.1007-5062.2019.04.008, DOI 10.3969/J.ISSN.1007-5062.2019.04.008]; ZUNG WWK, 1971, PSYCHOSOMATICS, V12, P371	46	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266006	10.1371/journal.pone.0266006	http://dx.doi.org/10.1371/journal.pone.0266006			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363813	Green Published, gold			2022-12-26	WOS:000804748600045
J	Janssen, LMA; Reijnen, ICGM; Milito, C; Edgar, D; Chapel, H; de Vries, E				Janssen, Lisanne M. A.; Reijnen, Ineke C. G. M.; Milito, Cinzia; Edgar, David; Chapel, Helen; de Vries, Esther			Protocol for the unclassified primary antibody deficiency (unPAD) study: Characterization and classification of patients using the ESID online Registry	PLOS ONE			English	Article							COMMON VARIABLE IMMUNODEFICIENCY; QUALITY-OF-LIFE; INTERNET-BASED PATIENT; RESEARCH DATABASE; DISORDERS; SUBGROUPS	BackgroundPrimary antibody deficiencies (PADs) without an identified monogenetic origin form the largest and most heterogeneous group of primary immunodeficiencies. These patients often remain undiagnosed for years and many present to medical attention in adulthood after several infections risking structural complications. Not much is known about their treatment, comorbidities, or prognosis, nor whether the various immunological forms (decreased total IgG, IgG subclass(es), IgM, IgA, specific antibody responses, alone or in combination(s)) should be considered as separate, clearly definable subgroups. The unclassified primary antibody deficiency (unPAD) study aims to describe in detail all PAD patients without an identified specific monogenetic defect regarding their demographical, clinical, and immunological characteristics at presentation and during follow-up. In constructing these patterns, the unPAD study aims to reduce the number of missed and unidentified PAD patients in the future. In addition, this study will focus on subclassifying unPAD to support the identification of patients at higher risk for infection or immune dysregulation related complications, enabling the development of personalized follow-up and treatment plans. Methods and analysisWe present a protocol for a multicenter observational cohort study using the ESID online Registry. Patients of all ages who have given informed consent for participation in the ESID online Registry and fulfill the ESID Clinical Working Definitions for 'unclassified antibody deficiency', 'deficiency of specific IgG', 'IgA with IgG subclass deficiency', 'isolated IgG subclass deficiency', 'selective IgM deficiency', 'selective IgA deficiency' or 'common variable immunodeficiency' will be included. For all patients, basic characteristics can be registered at first registration and yearly thereafter in level 1 forms. Detailed characteristics of the patients can be registered in level 2 forms. Consecutive follow-up forms can be added indefinitely. To ensure the quality of the collected data, all data will be fully monitored before they are exported from the ESID online Registry for analysis. Outcomes will be the clinical and immunological characteristics of unPAD at presentation and during follow-up. Subgroup analyses will be made based on demographical, clinical and immunological characteristics.	[Janssen, Lisanne M. A.; de Vries, Esther] Tilburg Univ, Dept Tranzo, TSB, Tilburg, Netherlands; [Janssen, Lisanne M. A.] Amalia Childrens Hosp, Dept Pediat, Nijmegen, Netherlands; [Reijnen, Ineke C. G. M.] Elisabeth Tweesteden Hosp, Dept Pediat, Tilburg, Netherlands; [Milito, Cinzia] Sapienza Univ Rome, Dept Mol Med, Rome, Italy; [Edgar, David] Trin Coll, Dublun, Ireland; [Edgar, David] St James Hosp, Dept Immunol, Dublun, Ireland; [Edgar, David; Chapel, Helen] Univ Oxford, Nuffield Dept Med, Primary Immunodeficiency Unit, Oxford, Oxfordshire, England; [de Vries, Esther] Elisabeth Tweesteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands	Tilburg University; Elisabeth-TweeSteden Ziekenhuis (ETZ); Sapienza University Rome; Trinity College Dublin; Trinity College Dublin; University of Oxford; Elisabeth-TweeSteden Ziekenhuis (ETZ)	de Vries, E (corresponding author), Tilburg Univ, Dept Tranzo, TSB, Tilburg, Netherlands.; de Vries, E (corresponding author), Elisabeth Tweesteden Hosp, Lab Med Microbiol & Immunol, Tilburg, Netherlands.	e.devries@tilburguniversity.edu		de Vries, Esther/0000-0003-4311-3550; Edgar, John David Moore/0000-0003-2969-4475				Aghamohammadi A, 2011, IRAN J ALLERGY ASTHM, V10, P47, DOI 010.01/ijaai.4751; Ameratunga R, 2020, CLIN REV ALLERG IMMU, V59, P109, DOI 10.1007/s12016-019-08765-6; Bonilla FA, 2016, J ALLER CL IMM-PRACT, V4, P38, DOI 10.1016/j.jaip.2015.07.025; Bousfiha A, 2020, J CLIN IMMUNOL, V40, P66, DOI 10.1007/s10875-020-00758-x; Chapel H, 2008, BLOOD, V112, P277, DOI 10.1182/blood-2007-11-124545; Chapel H, 2009, BRIT J HAEMATOL, V145, P709, DOI 10.1111/j.1365-2141.2009.07669.x; de Vries E, 2006, CLIN EXP IMMUNOL, V145, P204, DOI 10.1111/j.1365-2249.2006.03138.x; de Vries E, 2012, CLIN EXP IMMUNOL, V167, P108, DOI 10.1111/j.1365-2249.2011.04461.x; Driessen GJ, 2013, HAEMATOLOGICA, V98, P1617, DOI 10.3324/haematol.2013.085076; Eades-Perner AM, 2007, CLIN EXP IMMUNOL, V147, P306, DOI 10.1111/j.1365-2249.2006.03292.x; Filion CA, 2019, J ALLER CL IMM-PRACT, V7, P1277, DOI 10.1016/j.jaip.2018.12.004; Gathmann B, 2009, CLIN EXP IMMUNOL, V157, P3, DOI 10.1111/j.1365-2249.2009.03954.x; Guzman D, 2007, BIOINFORMATICS, V23, P654, DOI 10.1093/bioinformatics/btl675; Janssen LMA, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02384; Jorgensen GH, 2014, QUAL LIFE RES, V23, P647, DOI 10.1007/s11136-013-0491-9; Kutukculer N, 2009, PEDIAT ALLERG IMM-UK, V20, P693, DOI 10.1111/j.1399-3038.2008.00845.x; Picard C, 2018, J CLIN IMMUNOL, V38, P96, DOI 10.1007/s10875-017-0464-9; Picat MQ, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-13; Piqueras B, 2003, J CLIN IMMUNOL, V23, P385, DOI 10.1023/A:1025373601374; Quinti I, 2012, YONSEI MED J, V53, P603, DOI 10.3349/ymj.2012.53.3.603; Rider NL, 2017, J CLIN IMMUNOL, V37, P461, DOI 10.1007/s10875-017-0404-8; Rosel AL, 2015, J ALLERGY CLIN IMMUN, V135, P198, DOI 10.1016/j.jaci.2014.06.022; Seidel MG, 2019, J ALLER CL IMM-PRACT, V7, P1763, DOI 10.1016/j.jaip.2019.02.004; Sigstad Hanne Marie Hoybraten, 2005, Health Qual Life Outcomes, V3, P31, DOI 10.1186/1477-7525-3-31; Tangye SG, 2020, J CLIN IMMUNOL, V40, P24, DOI 10.1007/s10875-019-00737-x; Titman P, 2014, J CLIN IMMUNOL, V34, P844, DOI 10.1007/s10875-014-0072-x; van de Ven AAJM, 2011, PEDIAT ALLERG IMM-UK, V22, P347, DOI 10.1111/j.1399-3038.2010.01085.x; Warnatz K, 2002, BLOOD, V99, P1544, DOI 10.1182/blood.V99.5.1544; Wehr C, 2008, BLOOD, V111, P77, DOI 10.1182/blood-2007-06-091744	29	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266083	10.1371/journal.pone.0266083	http://dx.doi.org/10.1371/journal.pone.0266083			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333892	gold, Green Published			2022-12-26	WOS:000784335700022
J	Jeganathan, V; Knight, S; Bricknell, M; Ridgers, A; Wong, RY; Brazzale, DJ; Ruehland, WR; Rahman, MA; Leong, TL; McDonald, CF				Jeganathan, Vishnu; Knight, Simon; Bricknell, Matthew; Ridgers, Anna; Wong, Raymond; Brazzale, Danny J.; Ruehland, Warren R.; Rahman, Muhammad Aziz; Leong, Tracy L.; McDonald, Christine F.			Impact of smoking status and chronic obstructive pulmonary disease on pulmonary complications post lung cancer surgery	PLOS ONE			English	Article							INHALED TIOTROPIUM; COPD; PREVALENCE; RESECTION; OUTCOMES; RISK; REHABILITATION; MORTALITY; CESSATION; RELAPSE	IntroductionSmoking and chronic obstructive pulmonary disease (COPD) are associated with an increased risk of post-operative pulmonary complications (PPCs) following lung cancer resection. It remains unclear whether smoking cessation reduces this risk. MethodsRetrospective review of a large, prospectively collected database of over 1000 consecutive resections for lung cancer in a quaternary lung cancer centre over a 23-year period. ResultsOne thousand and thirteen patients underwent curative-intent lobectomy or pneumonectomy between 1995 and 2018. Three hundred and sixty-two patients (36%) were ex-smokers, 314 (31%) were current smokers and 111 (11%) were never smokers. A pre-operative diagnosis of COPD was present in 57% of current smokers, 57% of ex-smokers and 20% of never smokers. Just over 25% of patients experienced a PPC. PPCs were more frequent in current smokers compared to never smokers (27% vs 17%, p = 0.036), however, no difference was seen between current and ex-smokers (p = 0.412) or between never and ex-smokers (p = 0.113). Those with a diagnosis of COPD, independent of smoking status, had a higher frequency of both PPCs (65% vs 35%, p<0.01) and overall complications (60% vs 40%, p<0.01) as well as a longer length of hospital stay (10 vs 9 days, p<0.01). ConclusionSmoking and COPD are both associated with a higher rate of PPCs post lung cancer resection. COPD, independent of smoking status, is also associated with an increased overall post-operative complication rate and length of hospital stay. An emphasis on COPD treatment optimisation, rather than smoking cessation in isolation, may help improve post-operative outcomes.	[Jeganathan, Vishnu; Ridgers, Anna; Wong, Raymond; Brazzale, Danny J.; Ruehland, Warren R.; Leong, Tracy L.; McDonald, Christine F.] Austin Hlth, Dept Resp & Sleep Med, Heidelberg, Vic, Australia; [Jeganathan, Vishnu; Bricknell, Matthew; Ridgers, Anna; Wong, Raymond; Brazzale, Danny J.; Ruehland, Warren R.; Rahman, Muhammad Aziz; Leong, Tracy L.; McDonald, Christine F.] Inst Breathing & Sleep, Heidelberg, Vic, Australia; [Knight, Simon] Austin Hlth, Dept Thorac Surg, Heidelberg, Vic, Australia; [Bricknell, Matthew; Ridgers, Anna; Leong, Tracy L.; McDonald, Christine F.] Univ Melbourne, Fac Med, Parkville, Vic, Australia; [Rahman, Muhammad Aziz] Federat Univ Australia, Sch Hlth, Berwick, Vic, Australia	Austin Research Institute; Florey Institute of Neuroscience & Mental Health; Institute for Breathing & Sleep (IBAS); Austin Research Institute; Florey Institute of Neuroscience & Mental Health; University of Melbourne; Federation University Australia	Jeganathan, V (corresponding author), Austin Hlth, Dept Resp & Sleep Med, Heidelberg, Vic, Australia.; Jeganathan, V (corresponding author), Inst Breathing & Sleep, Heidelberg, Vic, Australia.	vishnu.jega@gmail.com	Ruehland, Warren R/R-1118-2019; Rahman, Muhammad Aziz/B-3380-2009	Ruehland, Warren R/0000-0001-9626-7460; Rahman, Muhammad Aziz/0000-0003-1665-7966				Australian Bureau of Statistics, 2018, NAT HLTH SURV 1 RES; Australian Institute of Health and Welfare, 2019, CANC IN AUSTR; Bolukbas S, 2011, EUR J CARDIO-THORAC, V39, P995, DOI 10.1016/j.ejcts.2010.09.025; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brenner DR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017479; Chaiton M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2016-011045; CONGLETON J, 1995, RESP MED, V89, P291, DOI 10.1016/0954-6111(95)90090-X; Cooley ME, 2009, LUNG CANCER, V66, P218, DOI 10.1016/j.lungcan.2009.01.021; Cox LS, 2003, CANCER-AM CANCER SOC, V98, P632, DOI 10.1002/cncr.11538; Eapen MS, 2018, DRUGS, V78, P1717, DOI 10.1007/s40265-018-1001-8; Fernandez-Bustamante A, 2017, JAMA SURG, V152, P157, DOI 10.1001/jamasurg.2016.4065; Fukui M, 2019, ANN THORAC SURG, V107, P1005, DOI 10.1016/j.athoracsur.2018.12.002; GOLD G, 2017, MAN PREV COPD GLOB I; Hillas G, 2016, INT J CHRONIC OBSTR, V11, DOI 10.2147/COPD.S106160; Hughes JR, 2008, ADDICT BEHAV, V33, P1516, DOI 10.1016/j.addbeh.2008.05.012; Janssens JP, 2005, CLIN CHEST MED, V26, P469, DOI 10.1016/j.ccm.2005.05.004; Karner C, 2012, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD009285.pub2, 10.1002/14651858.CD009285.pub3]; Kendall F, 2018, DISABIL REHABIL, V40, P864, DOI 10.1080/09638288.2016.1277396; Kim ES, 2016, INT J CHRONIC OBSTR, V11, P1317, DOI 10.2147/COPD.S105206; Lai YT, 2017, INTERACT CARDIOV TH, V25, P476, DOI 10.1093/icvts/ivx141; Laisaar T, 2018, ERJ OPEN RES, V4, DOI 10.1183/23120541.00001-2018; Laurent H, 2020, EUR J PHYS REHAB MED, V56, P73, DOI 10.23736/S1973-9087.19.05781-2; Leo F, 2008, EUR J CARDIO-THORAC, V33, P424, DOI 10.1016/j.ejcts.2007.11.024; Li X, 2019, CANCER MANAG RES, V11, P1765, DOI 10.2147/CMAR.S186432; Licker MJ, 2006, ANN THORAC SURG, V81, P1830, DOI 10.1016/j.athoracsur.2005.11.048; Loganathan RS, 2006, CHEST, V129, P1305, DOI 10.1378/chest.129.5.1305; Lugg ST, 2017, J CARDIOTHORAC SURG, V12, DOI 10.1186/s13019-017-0614-4; Lugg ST, 2016, THORAX, V71, P171, DOI 10.1136/thoraxjnl-2015-207697; Makino T, 2018, MOL CLIN ONCOL, V8, P647, DOI 10.3892/mco.2018.1595; Mammen MJ, 2020, ANN AM THORAC SOC, V17, P1133, DOI 10.1513/AnnalsATS.201912-915OC; Marrufo AS, 2019, ANN THORAC SURG, V107, P1494, DOI 10.1016/j.athoracsur.2018.11.055; Mason DP, 2009, ANN THORAC SURG, V88, P362, DOI 10.1016/j.athoracsur.2009.04.035; McCarthy B, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003793.pub3; Miskovic A, 2017, BRIT J ANAESTH, V118, P317, DOI 10.1093/bja/aex002; Moore E, 2016, CHEST, V150, P837, DOI 10.1016/j.chest.2016.05.038; Mujovic N, 2014, ARCH MED SCI, V10, P68, DOI 10.5114/aoms.2013.32806; Nayan Smriti, 2011, ISRN Oncol, V2011, P849023, DOI 10.5402/2011/849023; Nia PS, 2005, LUNG CANCER-J IASLC, V47, P351, DOI 10.1016/j.lungcan.2004.08.011; Nojiri T, 2014, SURG TODAY, V44, P285, DOI 10.1007/s00595-012-0481-5; Parsons A, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.b5569; Phillips JD, 2020, J SURG RES, V254, P110, DOI 10.1016/j.jss.2020.04.005; Rami-Porta R, 2009, ANN THORAC CARDIOVAS, V15, P4; Rodriguez M, 2017, EUR J CARDIO-THORAC, V51, P498, DOI 10.1093/ejcts/ezw359; Roy E, 2020, CHRON RESP DIS, V17, DOI 10.1177/1479973120925430; Sekine Y, 2002, LUNG CANCER-J IASLC, V37, P95, DOI 10.1016/S0169-5002(02)00014-4; Shiono S, 2015, GEN THORAC CARDIOVAS, V63, P93, DOI 10.1007/s11748-014-0461-3; Simmons VN, 2013, CANCER-AM CANCER SOC, V119, P1420, DOI 10.1002/cncr.27880; Takegahara K, 2017, GEN THORAC CARDIOVAS, V65, P388, DOI 10.1007/s11748-017-0761-5; Ueda K, 2010, THORAC CARDIOV SURG, V58, P38, DOI 10.1055/s-0029-1186269; Win T, 2005, EUR RESPIR J, V25, P594, DOI 10.1183/09031936.05.00077504; Young RP, 2009, EUR RESPIR J, V34, P380, DOI 10.1183/09031936.00144208	51	1	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266052	10.1371/journal.pone.0266052	http://dx.doi.org/10.1371/journal.pone.0266052			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349598	Green Published, gold			2022-12-26	WOS:000783906500022
J	Kelley, M; Paulines, MJ; Yoshida, G; Myers, R; Jora, M; Levoy, JP; Addepalli, B; Benoit, JB; Limbach, PA				Kelley, Melissa; Paulines, Mellie June; Yoshida, George; Myers, Ryan; Jora, Manasses; Levoy, Joel P.; Addepalli, Balasubrahmanyam; Benoit, Joshua B.; Limbach, Patrick A.			Ionizing radiation and chemical oxidant exposure impacts on Cryptococcus neoformans transfer RNAs	PLOS ONE			English	Article							CODON USAGE; OXIDATIVE STRESS; POSTTRANSCRIPTIONAL MODIFICATION; NUCLEOSIDE MODIFICATIONS; BINDING-PROTEIN; GENE-EXPRESSION; ANTICODON LOOP; YEAST; TRANSLATION; SELECTION	Cryptococcus neoformans is a fungus that is able to survive abnormally high levels of ionizing radiation (IR). The radiolysis of water by IR generates reactive oxygen species (ROS) such as H2O2 and OH-. C. neoformans withstands the damage caused by IR and ROS through antioxidant production and enzyme-catalyzed breakdown of ROS. Given these particular cellular protein needs, questions arise whether transfer ribonucleic acids molecules (tRNAs) undergo unique chemical modifications to maintain their structure, stability, and/or function under such environmental conditions. Here, we investigated the effects of IR and H2O2 exposure on tRNAs in C. neoformans. We experimentally identified the modified nucleosides present in C. neoformans tRNAs and quantified changes in those modifications upon exposure to oxidative conditions. To better understand these modified nucleoside results, we also evaluated tRNA pool composition in response to the oxidative conditions. We found that regardless of environmental conditions, tRNA modifications and transcripts were minimally affected. A rationale for the stability of the tRNA pool and its concomitant profile of modified nucleosides is proposed based on the lack of codon bias throughout the C. neoformans genome and in particular for oxidative response transcripts. Our findings suggest that C. neoformans can rapidly adapt to oxidative environments as mRNA translation/protein synthesis are minimally impacted by codon bias.	[Kelley, Melissa; Paulines, Mellie June; Yoshida, George; Jora, Manasses; Levoy, Joel P.; Addepalli, Balasubrahmanyam; Limbach, Patrick A.] Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA; [Myers, Ryan; Benoit, Joshua B.] Univ Cincinnati, Dept Biol Sci, Cincinnati, OH USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati	Limbach, PA (corresponding author), Univ Cincinnati, Dept Chem, Cincinnati, OH 45221 USA.	Pat.Limbach@uc.edu		Myers, Ryan/0000-0001-7488-1937	Defense Threat Reduction Agency [HDTRA1-15-1-0033]; National Science Foundation [NSF CHE1507357]	Defense Threat Reduction Agency(United States Department of DefenseDefense Threat Reduction Agency); National Science Foundation(National Science Foundation (NSF))	Financial support of this research was provided by the Defense Threat Reduction Agency (HDTRA1-15-1-0033) https://www.dtra.mil/and National Science Foundation (NSFCHE1507357)http://www.nsf.govto P.A.L.The fundershad norole in studydesign,data collectionand analysis,decisionto publish,or preparationof themanuscrip	Agris PF, 2007, J MOL BIOL, V366, P1, DOI 10.1016/j.jmb.2006.11.046; Arimbasseri AG, 2016, RNA, V22, P1400, DOI 10.1261/rna.056259.116; Auten RL, 2009, PEDIATR RES, V66, P121, DOI 10.1203/PDR.0b013e3181a9eafb; Azzam EI, 2012, CANCER LETT, V327, P48, DOI 10.1016/j.canlet.2011.12.012; Badet T, 2017, ELIFE, V6, DOI 10.7554/eLife.22472; Begley U, 2007, MOL CELL, V28, P860, DOI 10.1016/j.molcel.2007.09.021; Boccaletto P, 2018, NUCLEIC ACIDS RES, V46, pD303, DOI 10.1093/nar/gkx1030; Bouzyk E, 2000, ACTA BIOCHIM POL, V47, P881, DOI 10.18388/abp.2000_3943; Brigelius-Flohe R, 2013, BBA-GEN SUBJECTS, V1830, P3289, DOI 10.1016/j.bbagen.2012.11.020; Burgio E, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091971; Hurtado JC, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43941-w; Chan C, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1611-1; Chan CTY, 2015, CHEM RES TOXICOL, V28, P978, DOI 10.1021/acs.chemrestox.5b00004; Chan CTY, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1938; Chan CTY, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001247; Chan PP, 2016, NUCLEIC ACIDS RES, V44, pD184, DOI 10.1093/nar/gkv1309; Charette M, 2000, IUBMB LIFE, V49, P341; Chionh YH, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13302; Cozen AE, 2015, NAT METHODS, V12, P879, DOI [10.1038/NMETH.3508, 10.1038/nmeth.3508]; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; De Zoysa T, 2020, PLOS GENET, V16, DOI 10.1371/journal.pgen.1008893; Deutsch C, 2012, J BIOL CHEM, V287, P13666, DOI 10.1074/jbc.M112.344028; Dimitrova DG, 2019, GENES-BASEL, V10, DOI 10.3390/genes10020117; Endres L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229103; Fernandez-Vazquez J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003647; Fu Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2822; Torres AG, 2019, P NATL ACAD SCI USA, V116, P8451, DOI 10.1073/pnas.1821120116; Torres AG, 2014, FEBS LETT, V588, P4279, DOI 10.1016/j.febslet.2014.09.025; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Ghosh T, 2004, MOL CELL, V13, P817, DOI 10.1016/S1097-2765(04)00127-3; Giles SS, 2006, EUKARYOT CELL, V5, P1447, DOI 10.1128/EC.00098-06; Gupta S, 2021, GENOMICS, V113, P821, DOI 10.1016/j.ygeno.2020.10.013; Guy MP, 2015, RNA, V21, P61, DOI 10.1261/rna.047639.114; Guy MP, 2012, RNA, V18, P1921, DOI 10.1261/rna.035287.112; HEYER WD, 1984, J BIOL CHEM, V259, P2856; HOLLEY RW, 1965, J BIOL CHEM, V240, P2122; Hori H, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00144; Horn D, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-2; Jora M, 2018, J AM SOC MASS SPECTR, V29, P1745, DOI 10.1007/s13361-018-1999-6; Jung KW, 2016, MBIO, V7, DOI [10.1128/mBio.01483-16, 10.1128/mbio.01483-16]; Kellner S, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku733; Klassen R, 2016, NUCLEIC ACIDS RES, V44, P10946, DOI 10.1093/nar/gkw705; Klassen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119261; Knoll AH, 2006, PHILOS T R SOC B, V361, P1023, DOI 10.1098/rstb.2006.1843; Lee JH, 2001, BBA-GEN SUBJECTS, V1526, P191, DOI 10.1016/S0304-4165(01)00126-X; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loftus BJ, 2005, SCIENCE, V307, P1321, DOI 10.1126/science.1103773; Novoa EM, 2012, TRENDS GENET, V28, P574, DOI 10.1016/j.tig.2012.07.006; McCloskey JA, 2001, NUCLEIC ACIDS RES, V29, P4699, DOI 10.1093/nar/29.22.4699; McCown PJ, 2020, WIRES RNA, V11, DOI 10.1002/wrna.1595; Mettler FA, 2012, J RADIOL PROT, V32, pN9, DOI 10.1088/0952-4746/32/1/N9; Meyer S, 2008, J MOL BIOL, V380, P532, DOI 10.1016/j.jmb.2008.04.072; MICHAELS HB, 1978, RADIAT RES, V74, P23, DOI 10.2307/3574754; Missall TA, 2004, EUKARYOT CELL, V3, P835, DOI 10.1128/EC.3.4.835-846.2004; Mueller S, 1997, BLOOD, V90, P4973, DOI 10.1182/blood.V90.12.4973.4973_4973_4978; Nakamura Y, 2000, NUCLEIC ACIDS RES, V28, P292, DOI 10.1093/nar/28.1.292; NAU F, 1976, BIOCHIMIE, V58, P629, DOI 10.1016/S0300-9084(76)80387-2; Ng CS, 2018, MOL SYST BIOL, V14, DOI 10.15252/msb.20178009; Noon KR, 2003, J BACTERIOL, V185, P5483, DOI 10.1128/JB.185.18.5483-5490.2003; Novoa EM, 2019, MOL BIOL EVOL, V36, P2328, DOI 10.1093/molbev/msz124; Novoa EM, 2012, CELL, V149, P202, DOI 10.1016/j.cell.2012.01.050; Och LM, 2012, EARTH-SCI REV, V110, P26, DOI 10.1016/j.earscirev.2011.09.004; Pang YLJ, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku945; Pereira M, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19123738; Podobed MY., 2018, KNE ENERGY, V3, DOI [10.18502/ken.v3i2.1842, DOI 10.18502/KEN.V3I2.1842]; Rafels-Ybern A, 2018, RNA BIOL, V15, P500, DOI 10.1080/15476286.2017.1358348; Rocha EPC, 2004, GENOME RES, V14, P2279, DOI 10.1101/gr.2896904; Rojas-Benitez D, 2015, J BIOL CHEM, V290, P18699, DOI 10.1074/jbc.M115.665406; Rosendale AJ, 2019, MOL ECOL, V28, P49, DOI 10.1111/mec.14949; Ross RL, 2017, BIOMOLECULES, V7, DOI 10.3390/biom7010021; Schweizer U, 2017, RNA BIOL, V14, P1197, DOI 10.1080/15476286.2017.1294309; Scrima A, 2005, EMBO J, V24, P23, DOI 10.1038/sj.emboj.7600507; SHARP PM, 1986, NUCLEIC ACIDS RES, V14, P5125, DOI 10.1093/nar/14.13.5125; Shuryak I, 2015, NUCL MED BIOL, V42, P515, DOI 10.1016/j.nucmedbio.2015.02.006; Sun CL, 2018, ACS CHEM BIOL, V13, P567, DOI 10.1021/acschembio.7b00898; SUZUKI T, 1994, NUCLEIC ACIDS RES, V22, P115, DOI 10.1093/nar/22.2.115; Taymaz-Nikerel H, 2016, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00017; Thomas C, 2009, REDOX REP, V14, P102, DOI 10.1179/135100009X392566; Torrent M, 2018, SCI SIGNAL, V11, DOI 10.1126/scisignal.aat6409; Tubiana M., 1990, INTRO RADIOBIOLOGY; Upadhya R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055110; Wang M, 2012, MOL CELL PROTEOMICS, V11, P492, DOI 10.1074/mcp.O111.014704; Wardman P, 1996, RADIAT RES, V145, P523, DOI 10.2307/3579270; Wei YL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39369-x; WEISSENBACH J, 1981, EUR J BIOCHEM, V116, P207, DOI 10.1111/j.1432-1033.1981.tb05320.x; Whipple JM, 2011, GENE DEV, V25, P1173, DOI [10.1101/gad.2050711, 10.1101/gad.2050711.]; Whittle CA, 2015, G3-GENES GENOM GENET, V5, P2307, DOI 10.1534/g3.115.021402; Wilkinson ML, 2007, RNA, V13, P404, DOI 10.1261/rna.399607; Wu JJ, 2015, CHEM SCI, V6, P3013, DOI 10.1039/c5sc00484e; Yang EC, 2012, P NATL ACAD SCI USA, V109, P10960, DOI 10.1073/pnas.1120915109; Ye J, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-134; Yi SK, 2018, GENOMICS, V110, P134, DOI 10.1016/j.ygeno.2017.09.004	93	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266239	10.1371/journal.pone.0266239	http://dx.doi.org/10.1371/journal.pone.0266239			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349591	gold, Green Published			2022-12-26	WOS:000783906500027
J	Lee, KY; Lee, J; Park, YY; Oh, ST				Lee, Kil-Yong; Lee, Jaeim; Park, Youn Young; Oh, Seong Taek			Use of gentamicin-collagen sponge (Collatamp (R) G) in minimally invasive colorectal cancer surgery: A propensity score-matched study	PLOS ONE			English	Article							SURGICAL SITE INFECTION; SHORT-TERM OUTCOMES; RISK-FACTORS; LAPAROSCOPIC SURGERY; WOUND-INFECTION; COLON-CANCER; PROPHYLAXIS; TRIAL; IMPLANTS; POINTS	Background Minimally invasive surgery is commonly used to treat patients with colorectal cancer, although it can cause surgical site infections (SSIs) that can affect the oncologic outcome. Use of a gentamicin-collagen sponge may help reduce the occurrence of SSIs. We aimed to determine the effectiveness of a gentamicin-collagen sponge in reducing SSIs in minimally invasive surgery for colorectal cancer. Methods We retrospectively reviewed the records of 310 patients who were diagnosed with colorectal cancer at our hospital and underwent minimally invasive surgery between December 1, 2018, and February 28, 2021. Propensity score matching was conducted with a 1:1 ratio using logistic regression. The primary outcome was the incidence of SSIs in the mini-laparotomy wound. The secondary endpoints were factors affecting the incidence of SSIs. Results After propensity score matching, 130 patients were assigned to each group. There were no differences in clinical characteristics between the two groups. SSIs occurred in 2 (1.5%) and 3 (2.3%) patients in the gentamicin-collagen sponge and control groups, respectively (p<0.999). The following factors showed a statistically significant association with SSIs: body mass index >25 kg/m(2) (odds ratio, 39.0; 95% confidence interval, 1.90-802.21; p = 0.018), liver disease (odds ratio, 254.8; 95% confidence interval, 10.43-6222.61; p = 0.001), and right hemicolectomy (odds ratio, 36.22; 95% confidence interval, 2.37-554.63; p = 0.010). Conclusion Applying a gentamicin-collagen sponge to the mini-laparotomy wound did not reduce the frequency of SSIs. Further studies should be conducted on whether the selective use of gentamicin-collagen sponges may help reduce SSIs in high-risk patients.	[Lee, Kil-Yong; Lee, Jaeim; Park, Youn Young; Oh, Seong Taek] Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Div Coloproctol,Dept Surg, Uijeongbu Si, South Korea	Catholic University of Korea	Lee, J (corresponding author), Catholic Univ Korea, Uijeongbu St Marys Hosp, Coll Med, Div Coloproctol,Dept Surg, Uijeongbu Si, South Korea.	lji96@catholic.ac.kr	Park, Youn Young/GYU-4948-2022	Lee, Jaeim/0000-0002-4074-3904				Badia JM, 2017, J HOSP INFECT, V96, P1, DOI 10.1016/j.jhin.2017.03.004; Bennett-Guerrero E, 2010, NEW ENGL J MED, V363, P1038, DOI 10.1056/NEJMoa1000837; Bonjer HJ, 2005, LANCET ONCOL, V6, P477, DOI 10.1016/S1470-2045(05)70221-7; Brehant O, 2013, INT J COLORECTAL DIS, V28, P119, DOI 10.1007/s00384-012-1557-9; Chang WK, 2013, ANN SURG, V258, P59, DOI 10.1097/SLA.0b013e3182895b8c; Chen CF, 2019, J SURG RES, V244, P136, DOI 10.1016/j.jss.2019.06.014; Degrate L, 2011, INT J COLORECTAL DIS, V26, P61, DOI 10.1007/s00384-010-1057-8; GRANDIS JR, 1992, CANCER, V70, P2166, DOI 10.1002/1097-0142(19921015)70:8<2166::AID-CNCR2820700826>3.0.CO;2-H; Guillou PJ, 2005, LANCET, V365, P1718, DOI 10.1016/S0140-6736(05)66545-2; He YZ, 2017, DIS COLON RECTUM, V60, P433, DOI [10.1097/DCR.0000000000000760, 10.1097/dcr.0000000000000760]; Hewett PJ, 2008, ANN SURG, V248, P728, DOI 10.1097/SLA.0b013e31818b7595; Ho DE, 2011, J STAT SOFTW, V42; Hou TY, 2020, INT J INFECT DIS, V96, P676, DOI 10.1016/j.ijid.2020.05.124; Huh JW, 2019, INT J COLORECTAL DIS, V34, P277, DOI 10.1007/s00384-018-3194-4; Konishi T, 2006, ANN SURG, V244, P758, DOI 10.1097/01.sla.0000219017.78611.49; Kowalewski M, 2015, J THORAC CARDIOV SUR, V149, P1631, DOI 10.1016/j.jtcvs.2015.01.034; Kulkarni N, 2020, TECH COLOPROCTOL, V24, P1017, DOI 10.1007/s10151-020-02293-8; Mangram AJ, 1999, INFECT CONT HOSP EP, V20, P250, DOI 10.1086/501620; Murthy BL, 2007, BRIT J CANCER, V97, P1211, DOI 10.1038/sj.bjc.6604004; Nakamura T, 2016, SURG INFECT, V17, P454, DOI 10.1089/sur.2015.205; Nasser H, 2020, J SURG RES, V249, P25, DOI 10.1016/j.jss.2019.12.021; Nelson RL, 2018, TECH COLOPROCTOL, V22, P573, DOI 10.1007/s10151-018-1814-1; Nespoli Angelo, 2006, Surg Infect (Larchmt), V7 Suppl 2, pS41; Neudecker J, 2009, BRIT J SURG, V96, P1458, DOI 10.1002/bjs.6782; Pan WH, 2008, ASIA PAC J CLIN NUTR, V17, P370; Pinkney TD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4305; Pochhammer J, 2015, LANGENBECK ARCH SURG, V400, P1, DOI 10.1007/s00423-014-1232-4; Tsujimoto H, 2009, ANN SURG ONCOL, V16, P311, DOI 10.1245/s10434-008-0249-8; van der Pas MHGM, 2013, LANCET ONCOL, V14, P210, DOI 10.1016/S1470-2045(13)70016-0; Vlug MS, 2011, ANN SURG, V254, P868, DOI 10.1097/SLA.0b013e31821fd1ce; Wahl TS, 2018, DIS COLON RECTUM, V61, P938, DOI 10.1097/DCR.0000000000001085	31	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							0264513	10.1371/journal.pone.0264513	http://dx.doi.org/10.1371/journal.pone.0264513			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344540	Green Published, gold			2022-12-26	WOS:000788055200009
J	Colli, SL; Cardoso, N; Massone, CA; Cores, M; Lombardi, MG; De Matteo, EN; Lorenzetti, MA; Preciado, MV				Lorena Colli, Sandra; Cardoso, Nazarena; Antonella Massone, Carla; Cores, Maria; Garcia Lombardi, Mercedes; Noemi De Matteo, Elena; Alejandro Lorenzetti, Mario; Victoria Preciado, Maria			Molecular alterations in the integrated diagnosis of pediatric glial and glioneuronal tumors: A single center experience	PLOS ONE			English	Article							X-LINKED AGAMMAGLOBULINEMIA; TYROSINE KINASE; BRAF(V600E) MUTATION; LARGE COHORT; EXPRESSION; PROTEIN; FAMILY; BRAIN	Objectives: Tumors of the central nervous system (CNS) are the most common pediatric solid tumors, where low grade (LGG) and high grade gliomas (HGG) represent up to 55% of CNS tumors. Current molecular classification of these tumors results in a more accurate diagnosis and risk stratification, which ultimately enables individualized treatment strategies. Identifying known alterations is a suitable approach, particularly in developing countries, where NGS approaches are not easily accessible. We sought to assess molecular alterations in BRAF and histone 3 genes. Study design: FISH, IHC and Sanger sequencing were performed in a series of 102 pediatric glial and glioneuronal tumors. We also correlated these results with clinical and histological findings to evaluate their usefulness as diagnostic and/or prognostic tools. Results: We found that the KIAA1549-BRAF gene fusion was a relevant diagnostic tool for pilocytic astrocytoma, but not related to progression free survival (PFS) and overall survival (OS). BRAFV600E mutation was associated with a decreased OS in LGG, and with decreased PFS and OS among pilocytic astrocytomas. All HGG of the midline were H3K27M mutants, while H3G34R mutant cases were located in brain hemispheres. HGG harboring the H3K27M variant were associated with a decreased PFS and OS. Conclusions: Assessing druggable molecular markers with prognostic value is particularly important in those cases where complete resection or further radiation therapy is not possible. These potential diagnostic/prognostic markers may be suitable as further screening tests to reduce the requirement on NGS, which is not available in all laboratories. Furthermore, these results broaden data on BRAF and Histone 3 alterations in children from geographic regions, other than USA and Europe.	[Lorena Colli, Sandra; Cardoso, Nazarena; Noemi De Matteo, Elena] Hosp Ninos Dr Ricardo Gutierrez, Div Patol, Buenos Aires, DF, Argentina; [Cardoso, Nazarena; Antonella Massone, Carla; Noemi De Matteo, Elena; Alejandro Lorenzetti, Mario; Victoria Preciado, Maria] Hosp Ninos Dr Ricardo Gutierrez, Inst Multidisciplinario Invest Patol Pediat IMIPP, Lab Biol Mol, CONICET GCBA,Div Patol, Buenos Aires, DF, Argentina; [Cores, Maria; Garcia Lombardi, Mercedes] Hosp Ninos Dr Ricardo Gutierrez, Unidad Oncol, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires; Hospital de Ninos Doctor Ricardo Gutierrez; University of Buenos Aires	Preciado, MV (corresponding author), Hosp Ninos Dr Ricardo Gutierrez, Inst Multidisciplinario Invest Patol Pediat IMIPP, Lab Biol Mol, CONICET GCBA,Div Patol, Buenos Aires, DF, Argentina.	preciado@conicet.gov.ar	Lorenzetti, Mario Alejandro/O-8976-2019	Lorenzetti, Mario Alejandro/0000-0002-9434-399X	National Institute of Cancer (INC) of the National Ministry of Health [Res 83/2020]; National Research Council (CONICET) [0058]; INC; Buenos Aires City Ministry of Health	National Institute of Cancer (INC) of the National Ministry of Health; National Research Council (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); INC; Buenos Aires City Ministry of Health	This study was supported in part by a grant from the National Institute of Cancer (INC) of the National Ministry of Health (Res 83/2020) and National Research Council (CONICET) PUE 2018 no0058. E.N.D.M, M.A.L, and M.V.P are members of the CONICET Research Career Program. C.A.M. was supported by a fellowship from INC and N.C. by a fellowship from Buenos Aires City Ministry of Health. There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aadam Z, 2016, J CLIN IMMUNOL, V36, P187, DOI 10.1007/s10875-016-0251-z; Basile N, 2009, J CLIN IMMUNOL, V29, P123, DOI 10.1007/s10875-008-9227-y; BRUTON OC, 1952, PEDIATRICS, V9, P722; Castel D, 2015, ACTA NEUROPATHOL, V130, P815, DOI 10.1007/s00401-015-1478-0; Chear CT, 2013, ASIAN PAC J ALLERGY, V31, P320, DOI 10.12932/AP0304.31.4.2013; Conley ME, 2003, J CLIN INVEST, V112, P1636, DOI 10.1172/JCI20408; Conley ME, 2002, J PEDIATR-US, V141, P566, DOI 10.1067/mpd.2002.127711; Cruz GR, 2014, J NEURO-ONCOL, V117, P235, DOI 10.1007/s11060-014-1398-1; Dahiya S, 2013, ACTA NEUROPATHOL, V125, P901, DOI 10.1007/s00401-013-1120-y; Donson AM, 2014, BRAIN PATHOL, V24, P173, DOI 10.1111/bpa.12103; Dufour C, 2020, BRAIN PATHOL, V30, P179, DOI 10.1111/bpa.12768; Guidi M, 2021, MOL CLIN ONCOL, V14, DOI 10.3892/mco.2021.2232; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; ICLGG SIOP, 2010, COOP MULT STUD CHILD; Jones DTW, 2019, ANNU REV GENET, V53, P483, DOI 10.1146/annurev-genet-120417-031642; Koelsche C, 2013, ACTA NEUROPATHOL, V125, P891, DOI 10.1007/s00401-013-1100-2; Kristufek D, 2007, MOL IMMUNOL, V44, P1639, DOI 10.1016/j.molimm.2006.08.003; Lee Jeongeun, 2016, Korean J Pediatr, V59, pS49, DOI 10.3345/kjp.2016.59.11.S49; Lee WI, 2005, BLOOD, V105, P1881, DOI 10.1182/blood-2003-12-4420; Lopez-Herrera G, 2008, MOL IMMUNOL, V45, P1094, DOI 10.1016/j.molimm.2007.07.022; Martinez Anthony P, 2019, Surg Pathol Clin, V12, P1, DOI 10.1016/j.path.2018.10.001; Moreno F., 2013, SUPERVIVENCIA 2000 2, V3, P1; Mosaab A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65272-x; Ochs HD, 1996, MEDICINE, V75, P287, DOI 10.1097/00005792-199611000-00001; Orlandi P, 2000, Hum Mutat, V15, P117, DOI 10.1002/(SICI)1098-1004(200001)15:1<117::AID-HUMU26>3.0.CO;2-H; Ostrom QT, 2015, NEURO-ONCOLOGY, V17, P1, DOI [10.1093/neuonc/noab200, 10.1093/neuonc/nov189, 10.1093/neuonc/noaa200]; Plebani A, 2002, CLIN IMMUNOL, V104, P221, DOI 10.1006/clim.2002.5241; Tejada ARQ, 2021, CHILD NERV SYST, V37, P831, DOI 10.1007/s00381-020-04900-3; Ryall S, 2020, CANCER CELL, V37, P569, DOI 10.1016/j.ccell.2020.03.011; Schindler G, 2011, ACTA NEUROPATHOL, V121, P397, DOI 10.1007/s00401-011-0802-6; SIDERAS P, 1995, ADV IMMUNOL, V59, P135, DOI 10.1016/S0065-2776(08)60631-8; Singh S, 2016, ANN ALLERG ASTHMA IM, V117, P405, DOI 10.1016/j.anai.2016.07.044; TSUKADA S, 1993, CELL, V72, P279, DOI 10.1016/0092-8674(93)90667-F; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; VETRIE D, 1993, NATURE, V361, P226, DOI 10.1038/361226a0; Vihinen M, 2016, HUM MUTAT, V37, P549, DOI 10.1002/humu.22976; Xu YD, 2016, J THORAC DIS, V8, pE1207, DOI 10.21037/jtd.2016.10.12; ZHU QL, 1994, J EXP MED, V180, P461, DOI 10.1084/jem.180.2.461	38	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266466	10.1371/journal.pone.0266466	http://dx.doi.org/10.1371/journal.pone.0266466			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363819	gold, Green Published			2022-12-26	WOS:000804748600009
J	Thayer, KL; Lane, K; Simon, MC; Brugge, D; Fuller, CH				Thayer, Katherine L.; Lane, Kevin; Simon, Matthew C.; Brugge, Doug; Fuller, Christina H.			An exploratory analysis of sociodemographic characteristics with ultrafine particle concentrations in Boston, MA	PLOS ONE			English	Article							USE REGRESSION-MODEL; AIR-POLLUTION; ENVIRONMENTAL JUSTICE; SOCIOECONOMIC-STATUS; URBAN NEIGHBORHOODS; EXPOSURE; POLLUTANTS; INEQUITIES; TOXICS; CANADA	Little is known of the relationship between exposure to the smallest particles of air pollution and socio-demographic characteristics. This paper explores linkages between ultrafine particle (UFP) concentrations and indicators of both race/ethnicity and socioeconomic status in Boston, Massachusetts, USA. We used estimates of UFP based on a highly-resolved land-use regression model of concentrations. In multivariate linear regression models census block groups with high proportions of Asians were associated with higher levels of UFP in comparison to block groups with majority White or other minority groups. Lower UFP concentrations were associated with higher homeownership (indicating higher SES) and with higher female head of household (indicating lower socioeconomic status). One explanation for the results include the proximity of specific groups to traffic corridors that are the main sources of UFP in Boston. Additional studies, especially at higher geographic resolution, are needed in Boston and other major cities to better characterize UFP concentrations by sociodemographic factors.	[Thayer, Katherine L.] Tufts Med Ctr, Boston, MA 02111 USA; [Thayer, Katherine L.; Brugge, Doug] Tufts Univ, Sch Med, Boston, MA 02111 USA; [Lane, Kevin; Simon, Matthew C.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Simon, Matthew C.] US Dept Transportat, Volpe Natl Transportat Syst Ctr, Cambridge, MA USA; [Brugge, Doug] Univ Connecticut, Dept Publ Hlth Sci, Farmington, CT USA; [Fuller, Christina H.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA	Tufts Medical Center; Tufts University; Boston University; University of Connecticut; University System of Georgia; Georgia State University	Fuller, CH (corresponding author), Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA.	cfuller@gsu.edu		Simon, Matthew/0000-0002-0924-8630	NIH [P01 AG023394, P50 HL105185]; NIH-NIEHS [ES026980, ES030289, ES015462]; JPB Environmental Health Fellows Program	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); JPB Environmental Health Fellows Program	We acknowledge funding for this analysis and UFP model development from NIH Grants P01AG023394and P50 HL105185 to the University of Massachusetts Lowell; NIH-NIEHS Grant ES015462 to Tufts University; NIH-NIEHS Grants ES026980 and ES030289 to the University of Connecticut School of Medicine; and the JPB Environmental Health Fellows Program. The contents of this article do not necessarily reflect the views of the Volpe Center or its sponsors. The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abernethy RC, 2013, ENVIRON SCI TECHNOL, V47, P5217, DOI 10.1021/es304495s; Acolin A, 2018, URBAN STUD, V55, P1690, DOI 10.1177/0042098017699366; [Anonymous], 1989, RAC REL COD PRACT EM; Boston Public Health Commission Office RaE, 2019, HLTH BOST 2016 2017; Brugge D., 2021, AMBIENT COMBUSTION U, VFirst; Bullard R., 2004, HIGHWAY ROBBERY TRAN; Bullard R.D., 2000, DUMPING DIXIE RACE C, VThird edition; Calderon-Garciduenas L, 2019, ENVIRON RES, V176, DOI 10.1016/j.envres.2019.108574; Chakraborty J, 2011, AM J PUBLIC HEALTH, V101, pS27, DOI 10.2105/AJPH.2010.300109; Chakraborty J, 2009, ANN ASSOC AM GEOGR, V99, P674, DOI 10.1080/00045600903066490; Clougherty JE, 2013, J EXPO SCI ENV EPID, V23, P232, DOI 10.1038/jes.2012.125; Cohen AJ, 2017, LANCET, V389, P1907, DOI [10.1016/s0140-6736(17)30505-6, 10.1016/S0140-6736(17)30505-6]; Gray SC, 2013, ENVIRON RES, V126, P152, DOI 10.1016/j.envres.2013.06.005; Grineski SE, 2017, SOC SCI MED, V185, P71, DOI 10.1016/j.socscimed.2017.05.042; Hajat Anjum, 2015, Curr Environ Health Rep, V2, P440, DOI 10.1007/s40572-015-0069-5; Health Effects Institute. (HEI), 2010, SPECIAL REPORT, V17, DOI DOI 10.1016/J.ENVINT.2019.104909; Jimenez MP, 2015, HEALTH PLACE, V33, P1, DOI 10.1016/j.healthplace.2015.02.001; Karner AA, 2010, ENVIRON SCI TECHNOL, V44, P5334, DOI 10.1021/es100008x; Kumar P, 2014, ENVIRON INT, V66, P1, DOI 10.1016/j.envint.2014.01.013; Maantay J, 2007, HEALTH PLACE, V13, P32, DOI 10.1016/j.healthplace.2005.09.009; Mannocci A, 2019, J ENVIRON PUBLIC HEA, V2019, DOI 10.1155/2019/2058467; Oberdorster G, 2001, INT ARCH OCC ENV HEA, V74, P1; Ohlwein S, 2019, INT J PUBLIC HEALTH, V64, P547, DOI 10.1007/s00038-019-01202-7; Pastor M, 2006, POLICY STUD J, V34, P337, DOI 10.1111/j.1541-0072.2006.00176.x; Patton AP, 2015, ENVIRON SCI TECHNOL, V49, P6051, DOI 10.1021/es5061676; Patton AP, 2014, ATMOS ENVIRON, V99, P309, DOI 10.1016/j.atmosenv.2014.09.072; Patton AP, 2014, ENVIRON SCI TECHNOL, V48, P3272, DOI 10.1021/es404838k; Pratt GC, 2015, INT J ENV RES PUB HE, V12, P5355, DOI 10.3390/ijerph120505355; Shmool JLC, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-91; Simon MC, 2018, ENVIRON SCI TECHNOL, V52, P6985, DOI 10.1021/acs.est.8b00292; USEPA, 2020, REV AIR QUAL STAND P; Verbeek T, 2019, SSM-POPUL HLTH, V7, DOI 10.1016/j.ssmph.2018.100340; Weichenthal S, 2016, ENVIRON RES, V146, P65, DOI 10.1016/j.envres.2015.12.016; Weichenthal S, 2016, ENVIRON POLLUT, V208, P241, DOI 10.1016/j.envpol.2015.04.011	34	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263434	10.1371/journal.pone.0263434	http://dx.doi.org/10.1371/journal.pone.0263434			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353820	gold, Green Published			2022-12-26	WOS:000786647900008
J	Vega, D; Huang, HJ; Arellano, CJ				Vega, Daisey; Huang, Helen J.; Arellano, Christopher J.			Step-to-step variability indicates disruption to balance control when linking the arms and legs during treadmill walking	PLOS ONE			English	Article							SPINAL-CORD-INJURY; GAIT VARIABILITY; INDIVIDUALS; FALLS; FEAR	We recently discovered that a rope-pulley system that mechanically coupling the arms, legs and treadmill during walking can assist with forward propulsion in healthy subjects, leading to significant reductions in metabolic cost. However, walking balance may have been compromised, which could hinder the potential use of this device for gait rehabilitation. We performed a secondary analysis by quantifying average step width, step length, and step time, and used their variability to reflect simple metrics of walking balance (n = 8). We predicted an increased variability in at least one of these metrics when using the device, which would indicate disruptions to walking balance. When walking with the device, subjects increased their average step width (p < 0.05), but variability in step width and step length remained similar (p's > 0.05). However, the effect size for step length variability when compared to that of mechanical perturbation experiments suggest a minimal to moderate disruption in balance (Rosenthal ES = 0.385). The most notable decrement in walking balance was an increase in step time variability (p < 0.05; Cohen's d = 1.286). Its effect size reveals a moderate disruption when compared to the effect sizes observed in those with balance deficits (effect sizes ranged between 0.486 to 1.509). Overall, we conclude that healthy subjects experienced minimal to moderate disruptions in walking balance when using with this device. These data indicate that in future clinical experiments, it will be important to not only consider the mechanical and metabolic effects of using such a device but also its potential to disrupt walking balance, which may be exacerbated in patients with poor balance control.	[Vega, Daisey; Arellano, Christopher J.] Univ Houston, Ctr Neuromotor, Dept Hlth & Human Performance, Houston, TX USA; [Vega, Daisey; Arellano, Christopher J.] Univ Houston, Biomech Res Lab, Dept Hlth & Human Performance, Houston, TX USA; [Huang, Helen J.] Univ Cent Florida, Dept Mech & Aerosp Engn, Orlando, FL USA; [Huang, Helen J.] Univ Cent Florida, Disabil Aging & Technol DAT Cluster, Orlando, FL USA	University of Houston System; University of Houston; University of Houston System; University of Houston; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Arellano, CJ (corresponding author), Univ Houston, Ctr Neuromotor, Dept Hlth & Human Performance, Houston, TX USA.; Arellano, CJ (corresponding author), Univ Houston, Biomech Res Lab, Dept Hlth & Human Performance, Houston, TX USA.	carellano@uh.edu						Barbeau H, 1999, ARCH PHYS MED REHAB, V80, P225, DOI 10.1016/S0003-9993(99)90126-0; Barbeau H, 2003, NEUROREHAB NEURAL RE, V17, P3, DOI 10.1177/0888439002250442; Bauby CE, 2000, J BIOMECH, V33, P1433, DOI 10.1016/S0021-9290(00)00101-9; Behmran AL, 2000, PHYS THER, V80, P688, DOI 10.1093/ptj/80.7.688; Blight AR, 2019, SPINAL CORD, V57, P348, DOI 10.1038/s41393-019-0276-2; Brotherton SS, 2007, SPINAL CORD, V45, P37, DOI 10.1038/sj.sc.3101909; Bruijn SM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2012.0999; Callisaya ML, 2011, AGE AGEING, V40, P481, DOI 10.1093/ageing/afr055; Chamberlin ME, 2005, J GERONTOL A-BIOL, V60, P1163, DOI 10.1093/gerona/60.9.1163; Collins SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073597; Day KV, 2012, CLIN BIOMECH, V27, P145, DOI 10.1016/j.clinbiomech.2011.09.001; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hausdorff JM, 1998, MOVEMENT DISORD, V13, P428, DOI 10.1002/mds.870130310; Hausdorff JM, 2005, J NEUROENG REHABIL, V2, P19, DOI [DOI 10.1186/1743-0003-2-19, 10.1186/1743-0003-2-19]; HOF AL, 1996, GAIT POSTURE, V4, P222; Huang HJ, 2004, J APPL PHYSIOL, V97, P1299, DOI 10.1152/japplphysiol.01350.2003; John LT, 2010, J REHABIL RES DEV, V47, P497, DOI 10.1682/JRRD.2009.09.0150; Klarner T, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/1517968; Kuo AD, 2010, PHYS THER, V90, P157, DOI 10.2522/ptj.20090125; Madehkhaksar F, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0195902; Ochs WL, 2021, J NEUROENG REHABIL, V18, DOI 10.1186/s12984-021-00840-4; Richardson JK, 2005, ARCH PHYS MED REHAB, V86, P1539, DOI 10.1016/j.apmr.2004.12.032; Richardson JK, 2004, J AM GERIATR SOC, V52, P1532, DOI 10.1111/j.1532-5415.2004.52418.x; Rosenthal R., 1991, METAANALYTIC PROCEDU, DOI DOI 10.4135/9781412984997; Siragy T, 2020, J BIOMECH, V99, DOI 10.1016/j.jbiomech.2019.109529; Vega D, 2021, J NEUROENG REHABIL, V18, DOI 10.1186/s12984-021-00887-3; Zhou R, 2018, J NEUROPHYSIOL, V119, P2194, DOI 10.1152/jn.00569.2017	27	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265750	10.1371/journal.pone.0265750	http://dx.doi.org/10.1371/journal.pone.0265750			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320305	gold, Green Published			2022-12-26	WOS:000784240600041
J	Wen, PJ; Tan, FY; Lei, ML; Khan, MSA; Chen, WH; Hu, XD				Wen, Peijun; Tan, Fuyun; Lei, Menglai; Khan, Muhammad Saddique Akbar; Chen, Weihua; Hu, Xiaodong			Wavelengths and irradiances modulate the circadian rhythm of Neurospora crassa	PLOS ONE			English	Article							BLUE-LIGHT; CLOCK; TRANSCRIPTION; CONIDIATION; NOP-1; MODEL	The circadian rhythm affects the biological evolution and operating mechanisms of organisms. The impact of light on the circadian rhythm is a significant concern for both biology and human well-being. However, the relation between different wavelengths, irradiances, and circadian rhythm is unknown. In this study, we compared the effects of four different monochromatic light-emitting diode (LED) light and two different irradiances on the circadian rhythm of a wild-type Neurospora crassa. The results demonstrated that the circadian rhythm of Neurospora crassa can be modulated by violet (lambda p = 393 nm), blue (lambda p = 462 nm), and green (lambda p = 521 nm) light, regardless of the irradiances, in the visible region. Unexpectedly, for the yellow light (lambda p = 591 nm), the 2 W/m(2) light had a more significant impact on circadian rhythm modulation than the 0.04 W/m(2) light had. Considering the highest energy of yellow light (2.25 eV) is lower than the High Occupied Molecular Orbital (HOMO)-Lowest Unoccupied Molecular Orbital (LUMO) gap of WC-1 (2.43 eV). We speculate that there may be other potential photoreceptors that are involved in circadian rhythm modulation. The HOMO-LOMO gaps of these proteins are greater than 1.98 eV and less than 2.25 eV. These results provide a strong foundation for a deeper understanding of the impact of different light on the circadian rhythm and also shed light on the identification of new circadian rhythm modulation photoreceptors.	[Wen, Peijun; Tan, Fuyun; Lei, Menglai; Khan, Muhammad Saddique Akbar; Chen, Weihua; Hu, Xiaodong] Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China	Peking University	Hu, XD (corresponding author), Peking Univ, Sch Phys, State Key Lab Artificial Microstruct & Mesoscop P, Beijing, Peoples R China.	huxd@pku.edu.cn	Hu, Xiao/GQI-0007-2022	Hu, Xiao/0000-0003-1128-4099; Wen, Peijun/0000-0002-0276-0113	National Natural Science Foundation of China (NSFC) [61874004]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	The authors thank Professor Qun He and Dr. Chengcheng Zhang for experiment assistance.	ARONSON BD, 1994, SCIENCE, V263, P1578, DOI 10.1126/science.8128244; Baker CL, 2012, FEMS MICROBIOL REV, V36, P95, DOI 10.1111/j.1574-6976.2011.00288.x; BARGIELLO TA, 1984, NATURE, V312, P752, DOI 10.1038/312752a0; Belden WJ, 2007, GENE DEV, V21, P1494, DOI 10.1101/gad.1551707; Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Berson DM, 2002, SCIENCE, V295, P1070, DOI 10.1126/science.1067262; Bhadra U, 2017, SLEEP MED, V35, P49, DOI 10.1016/j.sleep.2017.04.008; Bieszke JA, 2007, CURR GENET, V52, P149, DOI 10.1007/s00294-007-0148-8; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Brunner M, 2008, MOL MICROBIOL, V68, P255, DOI 10.1111/j.1365-2958.2008.06148.x; CROSTHWAITE SK, 1995, CELL, V81, P1003, DOI 10.1016/S0092-8674(05)80005-4; Davis RH, 2002, NAT REV GENET, V3, P397, DOI 10.1038/nrg797; Dunlap JC, 2017, MICROBIOL SPECTR, V5, DOI 10.1128/microbiolspec.FUNK-0039-2016; Dunlap JC, 2004, J BIOL RHYTHM, V19, P414, DOI 10.1177/0748730404269116; Froehlich AC, 2002, SCIENCE, V297, P815, DOI 10.1126/science.1073681; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; He QY, 2005, GENE DEV, V19, P2888, DOI 10.1101/gad.1369605; Heintzen C, 2007, ADV GENET, V58, P25, DOI 10.1016/S0065-2660(06)58002-2; Hofstra WA, 2008, EPILEPSY BEHAV, V13, P438, DOI 10.1016/j.yebeh.2008.06.002; Koritala BSC, 2017, ADV GENET, V99, P1, DOI 10.1016/bs.adgen.2017.09.001; Lewis JA, 2006, J BACTERIOL, V188, P5479, DOI 10.1128/JB.00514-06; Linden H, 1997, FUNGAL GENET BIOL, V22, P141, DOI 10.1006/fgbi.1997.1013; Liu Y, 1998, SCIENCE, V281, P825, DOI 10.1126/science.281.5378.825; Liu Y, 2006, EUKARYOT CELL, V5, P1184, DOI 10.1128/EC.00133-06; LORENZ MR, 1968, SCIENCE, V159, P1419, DOI 10.1126/science.159.3822.1419; Loros JJ, 2001, ANNU REV PHYSIOL, V63, P757, DOI 10.1146/annurev.physiol.63.1.757; Michael TP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000795; Navarro-Sampedro L, 2008, GENETICS, V178, P171, DOI 10.1534/genetics.107.079582; Oakenfull RJ, 2017, PLANT CELL ENVIRON, V40, P2571, DOI 10.1111/pce.13033; Olmedo M, 2013, FUNGAL BIOL REV, V27, P10, DOI 10.1016/j.fbr.2013.02.004; Olmedo M, 2010, GENETICS, V184, P651, DOI 10.1534/genetics.109.109975; Pan JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135330; PITTENDRIGH CS, 1959, NATURE, V184, P169, DOI 10.1038/184169a0; Prairie MW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0226761; Ryan FJ, 1943, AM J BOT, V30, P784, DOI 10.2307/2437554; Schubert EF, 2005, SCIENCE, V308, P1274, DOI 10.1126/science.1108712; Tsumoto K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020880; Wang Z, 2018, MOL ECOL, V27, P216, DOI 10.1111/mec.14425; Zoltowski BD, 2007, SCIENCE, V316, P1054, DOI 10.1126/science.1137128	40	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266266	10.1371/journal.pone.0266266	http://dx.doi.org/10.1371/journal.pone.0266266			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353854	gold, Green Published			2022-12-26	WOS:000786647900005
J	Ma, XL; Wang, C; Zhou, B; Cheng, ZN; Mao, ZY; Tang, TS; Guo, CX				Ma, Xiaolu; Wang, Chen; Zhou, Bo; Cheng, Zina; Mao, Zhiyong; Tang, Tie-Shan; Guo, Caixia			DNA polymerase eta promotes nonhomologous end joining upon etoposide exposure dependent on the scaffolding protein Kap1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DOUBLE-STRAND BREAKS; HOMOLOGOUS RECOMBINATION; TOPOISOMERASE-II; CELL-CYCLE; REPAIR; PCNA; SWITCH; REV1	DNA polymerase eta (Pol eta) is a eukaryotic member of the Y-family of DNA polymerase involved in translesion DNA synthesis and genome mutagenesis. Recently, several trans lesion DNA synthesis polymerases have been found to function in repair of DNA double-strand breaks (DSBs). However, the role of Pol eta in promoting DSB repair remains to be well defined. Here, we demonstrated that Pol eta could be targeted to etoposide (ETO)-induced DSBs and that depletion of Pol eta in cells causes increased sensitivity to ETO. Intriguingly, depletion of Pol eta also led to a nonhomologous end joining repair defect in a catalytic activity-independent manner. We further identified the scaffold protein Kap1 as a novel interacting partner of Pol eta, the depletion of which resulted in impaired formation of Pol eta and Rad18 foci after ETO treatment. Additionally, overexpression of Kap1 failed to restore Pol eta focus formation in Rad18-deficient cells after ETO treatment. Interestingly, we also found that Kap1 bound to Rad18 in a Pol eta-dependent manner, and moreover, depletion of Kap1 led to a significant reduction in Rad18-Pol eta association, indicating that Kap1 forms a ternary complex with Rad18 and Pol eta to stabilize Rad18-Pol eta association. Our findings demonstrate that Kap1 could regulate the role of Pol eta in ETO-induced DSB repair via facilitating Rad18 recruitment and stabilizing Rad18-Pol eta association.	[Ma, Xiaolu] Taiyuan Univ Technol, Coll Biomed Engn, Taiyuan, Peoples R China; [Ma, Xiaolu; Tang, Tie-Shan] Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China; [Wang, Chen; Mao, Zhiyong] Tongji Univ, Sch Life Sci & Technol, Shanghai Key Lab Signaling & Dis Res, Shanghai Matern & Infant Hosp 1,Clin & Translat R, Shanghai, Peoples R China; [Zhou, Bo; Cheng, Zina; Guo, Caixia] Chinese Acad Sci, Univ Chinese Acad Sci, China Natl Ctr Bioinformat, CAS Key Lab Genom & Precis Med,Beijing Inst Genom, Beijing, Peoples R China; [Tang, Tie-Shan] Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China; [Tang, Tie-Shan] Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China	Taiyuan University of Technology; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Tongji University; Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences	Tang, TS (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, Inst Zool, State Key Lab Membrane Biol, Beijing, Peoples R China.; Guo, CX (corresponding author), Chinese Acad Sci, Univ Chinese Acad Sci, China Natl Ctr Bioinformat, CAS Key Lab Genom & Precis Med,Beijing Inst Genom, Beijing, Peoples R China.; Tang, TS (corresponding author), Chinese Acad Sci, Inst Stem Cell & Regenerat, Beijing, Peoples R China.; Tang, TS (corresponding author), Beijing Inst Stem Cell & Regenerat Med, Beijing, Peoples R China.	tangtsh@ioz.ac.cn; guocx@big.ac	Chen, Wang/GQH-6831-2022	Chen, Wang/0000-0003-2931-7856	National Key Research and Development Program of China [2018YFA0108500]; National Natural Science Foundation of China [31800684, 81921006, 82030033, 31970740]; Postdoctoral Research Foundation of China [2021M703206]; CAS Strategic Priority Research Program [XDPB2004]; Natural Science Foundation of Shanxi Province [201801D221281]; State Key Laboratory of Membrane Biology; CAS Key Laboratory of Genomic and Precision Medicine	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Postdoctoral Research Foundation of China(China Postdoctoral Science Foundation); CAS Strategic Priority Research Program; Natural Science Foundation of Shanxi Province(Natural Science Foundation of Shanxi Province); State Key Laboratory of Membrane Biology; CAS Key Laboratory of Genomic and Precision Medicine	This research was supported by the National Key Research and Development Program of China (2018YFA0108500) , National Natural Science Foundation of China (31800684, 81921006, 82030033, 31970740) , Postdoctoral Research Foundation of China (2021M703206) , CAS Strategic Priority Research Program XDPB2004, Natural Science Foundation of Shanxi Province (201801D221281) , the State Key Laboratory of Membrane Biology, and CAS Key Laboratory of Genomic and Precision Medicine.	Albertella MR, 2005, CANCER RES, V65, P9799, DOI 10.1158/0008-5472.CAN-05-1095; Arlett CF, 2008, BRIT J RADIOL, V81, P51, DOI 10.1259/bjr/27072321; Bergoglio V, 2013, J CELL BIOL, V201, P395, DOI 10.1083/jcb.201207066; Bohgaki Toshiyuki, 2010, Genome Integr, V1, P15, DOI 10.1186/2041-9414-1-15; Busuttil RA, 2008, CANCER RES, V68, P2081, DOI 10.1158/0008-5472.CAN-07-6274; Chang HHY, 2017, NAT REV MOL CELL BIO, V18, P495, DOI 10.1038/nrm.2017.48; Chen CY, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010355; Chen LX, 2015, AM J PHYSIOL-CELL PH, V308, pC372, DOI 10.1152/ajpcell.00321.2014; Chen YW, 2008, P NATL ACAD SCI USA, V105, P16578, DOI 10.1073/pnas.0808589105; Despras E, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13326; Durando M, 2013, NUCLEIC ACIDS RES, V41, P3079, DOI 10.1093/nar/gkt016; Goodarzi AA, 2008, MOL CELL, V31, P167, DOI 10.1016/j.molcel.2008.05.017; Guerillon C, 2020, J BIOL CHEM, V295, P8350, DOI 10.1074/jbc.RA120.013780; Hedglin M, 2015, ANNU REV BIOPHYS, V44, P207, DOI 10.1146/annurev-biophys-060414-033841; Hendel A, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002262; Inui H, 2008, J INVEST DERMATOL, V128, P2055, DOI 10.1038/jid.2008.48; Johnson RE, 1999, SCIENCE, V283, P1001, DOI 10.1126/science.283.5404.1001; Kannouche P, 2001, GENE DEV, V15, P158, DOI 10.1101/gad.187501; Kannouche PL, 2004, CELL CYCLE, V3, P1011; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kantidze OL, 2007, GENE, V391, P76, DOI 10.1016/j.gene.2006.12.006; Kuo CY, 2016, CELL CYCLE, V15, P787, DOI 10.1080/15384101.2016.1138184; Ma XL, 2020, ENVIRON MOL MUTAGEN, V61, P680, DOI 10.1002/em.22359; Ma XL, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02164-1; Mao ZY, 2008, CELL CYCLE, V7, P2902, DOI 10.4161/cc.7.18.6679; Mao ZY, 2007, P NATL ACAD SCI USA, V104, P13068, DOI 10.1073/pnas.0702410104; McIlwraith MJ, 2005, MOL CELL, V20, P783, DOI 10.1016/j.molcel.2005.10.001; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Ogi T, 2010, MOL CELL, V37, P714, DOI 10.1016/j.molcel.2010.02.009; Pommier Y, 2010, CHEM BIOL, V17, P421, DOI 10.1016/j.chembiol.2010.04.012; Rattray AJ, 2005, MOL CELL, V20, P658, DOI 10.1016/j.molcel.2005.11.018; Sebesta M, 2013, DNA REPAIR, V12, P691, DOI 10.1016/j.dnarep.2013.05.001; Sekimoto T, 2015, MOL CELL BIOL, V35, P699, DOI 10.1128/MCB.01153-14; Sharma S, 2012, NUCLEIC ACIDS RES, V40, P682, DOI 10.1093/nar/gkr769; Srivastava AK, 2015, P NATL ACAD SCI USA, V112, P4411, DOI 10.1073/pnas.1421365112; Stoll GA, 2019, P NATL ACAD SCI USA, V116, P15042, DOI 10.1073/pnas.1901318116; Tubbs AT, 2014, MOL CELL BIOL, V34, P2811, DOI 10.1128/MCB.00441-14; Uematsu N, 2007, J CELL BIOL, V177, P219, DOI 10.1083/jcb.200608077; Ulrich HD, 2009, DNA REPAIR, V8, P461, DOI 10.1016/j.dnarep.2009.01.006; Wang ZF, 2016, J CELL SCI, V129, P1223, DOI 10.1242/jcs.179408; Yang W, 2014, BIOCHEMISTRY-US, V53, P2793, DOI 10.1021/bi500019s; Zhang C., 2022, MOL CELL, DOI [10.1016/j.molcel.2022.1001.1020, DOI 10.1016/J.MOLCEL.2022.1001.1020]; Zhang XL, 2013, DNA REPAIR, V12, P377, DOI 10.1016/j.dnarep.2013.02.008; Zhao Y, 2012, P NATL ACAD SCI USA, V109, P7269, DOI 10.1073/pnas.1202681109	44	0	0	5	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101861	10.1016/j.jbc.2022.101861	http://dx.doi.org/10.1016/j.jbc.2022.101861			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35339488	gold, Green Published			2022-12-26	WOS:000798142000012
J	Sanchez, AM; Jacewicz, A; Shuman, S				Sanchez, Ana M.; Jacewicz, Agata; Shuman, Stewart			Fission yeast Duf89 and Duf8901 are cobalt/nickel-dependent phosphatase-pyrophosphatases that act via a covalent aspartyl-phosphate intermediate	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN; COMPLEX; REVEAL; GENE	Domain of Unknown Function 89 (DUF89) proteins are metal-dependent phosphohydrolases. Exemplary DUF89 enzymes differ in their metal and phosphosubstrate preferences. Here, we interrogated the activities and structures of two DUF89 paralogs from fission yeast-Duf89 and Duf8901. We find that Duf89 and Duf8901 are cobalt/nickel-dependent phosphohydrolases adept at hydrolyzing p-nitro-phenylphosphate and PPi. Crystal structures of metal-free Duf89 and Co2+-bound Duf8901 disclosed two enzyme con -formations that differed with respect to the position of a three-helix module, which is either oriented away from the active site in Duf89 or forms a lid over the active site in Duf8901. Lid closure results in a 16 movement of Duf8901 Asp195, vis-a -vis Asp199 in Duf89, that brings Asp195 into contact with an octahedrally coordinated cobalt. Reaction of Duf8901 with BeCl2 and NaF in the presence of divalent cations Co2+, Ni2+, or Zn2+ generated covalent Duf8901-(Asp248)-beryllium tri -fluoride (BeF3)center dot Co2+, Duf8901-(Asp248)-BeF3 center dot Ni2+, or Duf8901-(Asp248)-BeF3 center dot Zn2+ adducts, the structures of which suggest a two-step catalytic mechanism via formation and hydrolysis of an enzyme-(aspartyl)-phosphate intermediate. Alanine mutations of Duf8901 Asp248, Asn249, Lys401, Asp286, and Asp195 that interact with BeF3 center dot Co2+ squelched p- nitrophenylphosphatase activity. A 1.8 structure of a Duf8901-(Asp248)-AlF4-OH2 center dot Co2+ transition-state mimetic suggests an associative mechanism in which Asp195 and Asp363 orient and activate the water nucleophile. Whereas deletion of the duf89 gene elicited a phenotype in which expression of phosphate homeostasis gene pho1 was derepressed, deleting duf8901 did not, thereby hinting that the DUF89 paralogs have distinct functional repertoires in vivo.	[Sanchez, Ana M.; Jacewicz, Agata; Shuman, Stewart] Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA; [Sanchez, Ana M.] Gerstner Sloan Kettering Grad Sch Biomed Sci, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Shuman, S (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Biol Program, 1275 York Ave, New York, NY 10021 USA.	shumans@mskcc.org		Sanchez, Ana/0000-0002-9119-7624	National Institutes of Health [R35-GM126945]; National Science Foundation graduate research fellowship [1746057]; NIH [P30 GM124165]; Department of Energy [DE-AC02-06CH11357]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation graduate research fellowship(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy(United States Department of Energy (DOE))	This work was supported by the National Institutes of Health grant R35-GM126945 (to S. S.) . A. M. S. is supported by the National Science Foundation graduate research fellowship (grant no.: 1746057) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The NE-CAT beamline and the Advanced Photon Source at Argonne National Laboratory are sup-ported by NIH grant P30 GM124165 and Department of Energy Contract No. DE-AC02-06CH11357, respectively.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Baxter NJ, 2008, J AM CHEM SOC, V130, P3952, DOI 10.1021/ja078000n; Bitto E, 2005, ACTA CRYSTALLOGR F, V61, P630, DOI 10.1107/S1744309105017690; Cho H, 2001, P NATL ACAD SCI USA, V98, P8525, DOI 10.1073/pnas.131213698; Dennis TN, 2020, J STRUCT BIOL, V212, DOI 10.1016/j.jsb.2020.107576; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; FANKHAUSER H, 1995, J BIOL CHEM, V270, P28457; Ghosh A, 2008, MOL CELL, V32, P478, DOI 10.1016/j.molcel.2008.09.021; Guhaniyogi J, 2006, J MOL BIOL, V359, P624, DOI 10.1016/j.jmb.2006.03.050; Henry TC, 2011, EUKARYOT CELL, V10, P198, DOI 10.1128/EC.00216-10; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Huang LL, 2016, NAT CHEM BIOL, V12, P621, DOI [10.1038/NCHEMBIO.2108, 10.1038/nchembio.2108]; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kamenski T, 2004, MOL CELL, V15, P399, DOI 10.1016/j.molcel.2004.06.035; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Miao Y, 2016, P NATL ACAD SCI USA, V113, P7148, DOI 10.1073/pnas.1601774113; Nahas JV, 2018, G3-GENES GENOM GENET, V8, P2333, DOI 10.1534/g3.118.200303; Perry JJP, 2015, CELL REP, V10, P1288, DOI 10.1016/j.celrep.2015.01.054; Sanchez AM, 2019, NUCLEIC ACIDS RES, V47, P8452, DOI 10.1093/nar/gkz567; Sanchez AM, 2018, P NATL ACAD SCI USA, V115, pE10652, DOI 10.1073/pnas.1810711115; Schwer B, 2022, MBIO, V13, DOI 10.1128/mbio.03476-21; Shuman S, 2020, NUCLEIC ACIDS RES, V48, P8243, DOI 10.1093/nar/gkaa630	23	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101851	10.1016/j.jbc.2022.101851	http://dx.doi.org/10.1016/j.jbc.2022.101851			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35314193	Green Published, gold			2022-12-26	WOS:000798142000004
J	Chowdhury, SR; Das, SK; Banerjee, B; Chowdhuri, SP; Majumder, HK; Das, BB				Chowdhury, Somenath Roy; Das, Subhendu K.; Banerjee, Bijoylaxmi; Chowdhuri, Srijita Paul; Majumder, Hemanta K.; Das, Benu Brata			TDP1 knockout Leishmania donovani accumulate topoisomerase 1-linked DNA damage and are hypersensitive to clinically used antileishmanial drugs	FASEB JOURNAL			English	Article						camptothecin; DNA repair; Leishmania donovani; oxidative stress; phosphodiesterase; TDP1; topoisomerase 1	PROGRAMMED CELL-DEATH; PHOSPHODIESTERASE TDP1; ANTIMONY-RESISTANT; BREAK REPAIR; I TOP1; CAMPTOTHECIN; ANTICANCER; APOPTOSIS; PARASITE; NUCLEAR	Leishmania donovani, a unicellular protozoan parasite, causes a wide range of human diseases including fatal visceral leishmaniasis. Tyrosyl DNA-phosphodiesterase 1 (TDP1) hydrolyzes the phosphodiester bond between DNA 3 '-end and a tyrosyl moiety of trapped topoisomerase I-DNA covalent complexes (Top1cc). We have previously shown Leishmania harbors a TDP1 gene (LdTDP1), however, the biological role of TDP1 remains largely unknown. In the present study, we have generated TDP1 knockout L. donovani (LdTDP1(-/-)) promastigotes and have shown that LdTDP1(-/-) parasites are deficient in 3 '-phosphodiesterase activities and were hypersensitive to Top1-poison like camptothecin (CPT), DNA alkylation agent like methyl methanesulfonate, and oxidative DNA lesions generated by hydrogen peroxide but were not sensitive to etoposide. We also detected elevated levels of CPT-induced reactive oxygen species triggering cell cycle arrest and cell death in LdTDP1(-/-) promastigotes. LdTDP1(-/-) promastigotes accumulate a significant change in the membrane morphology with the accumulation of membrane pores, which is associated with oxidative stress and lipid peroxidation. To our surprise, we detected that LdTDP1(-/-) parasites were hypersensitive to antileishmanial drugs like amphotericin B and miltefosine, which could be rescued by complementation of wild-type TDP1 gene in the LdTDP1(-/-) parasites. Notably, multidrug-resistant L. donovani clinical isolates showed a marked reduction in TDP1 expression and were sensitive to Top1 poisons. Taken together, our study provides a new role of LdTDP1 in protecting L. donovani parasites from oxidative stress-induced DNA damage and resistance to amphotericin B and miltefosine.	[Chowdhury, Somenath Roy; Banerjee, Bijoylaxmi; Majumder, Hemanta K.] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata, India; [Das, Subhendu K.; Chowdhuri, Srijita Paul; Das, Benu Brata] Indian Assoc Cultivat Sci, Sch Biol Sci, Lab Mol Biol, 2A&B,Raja SC Mullick Rd, Kolkata 700032, India; [Chowdhury, Somenath Roy] Westfalische Wilhelms Univ Munster, Inst Phys Chem, D-48149 Munster, Germany; [Das, Subhendu K.] NCI, Lab Pathol, NIH, Bethesda, MD 20892 USA	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur; University of Munster; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Das, BB (corresponding author), Indian Assoc Cultivat Sci, Sch Biol Sci, Lab Mol Biol, 2A&B,Raja SC Mullick Rd, Kolkata 700032, India.	pcbbd@iacs.res.in			DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant [102/IFD/SAN/3574/2019-20]; DST-SERB core research grant [EMR/2017/001652]; Wellcome Trust/DBT India alliance intermediate fellowship grant [IA/I/13/1/500888]; CSIR [31/002(1128)/2019-EMR-I]; IACS senior Research Fellowship, India	DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant; DST-SERB core research grant; Wellcome Trust/DBT India alliance intermediate fellowship grant(Wellcome Trust DBT India Alliance); CSIR(Council of Scientific & Industrial Research (CSIR) - India); IACS senior Research Fellowship, India	BBD team is supported by DBT-S Ramachandran National Bioscience Award for Career Development (NBACD)-2019 grant (102/IFD/SAN/3574/2019-20); DST-SERB core research grant (EMR/2017/001652), and Wellcome Trust/DBT India alliance intermediate fellowship grant (Award#IA/I/13/1/500888). SRC was supported by the CSIR-Research Associateship (31/002(1128)/2019-EMR-I). SKD and SPC are the recipients of the IACS senior Research Fellowship, India	Ashour ME, 2015, NAT REV CANCER, V15, P137, DOI 10.1038/nrc3892; Banerjee B, 2010, MOL MICROBIOL, V78, P119, DOI 10.1111/j.1365-2958.2010.07318.x; Barthelmes HU, 2004, J BIOL CHEM, V279, P55618, DOI 10.1074/jbc.M405042200; Basu JM, 2006, ANTIMICROB AGENTS CH, V50, P1788, DOI [10.1128/AAC.50.5.1788-1797.2006, 10.1128/AAC.50.5.1768-1797.2006]; Bhattacharjee S., 2022, POST TRANSLATIONAL R, V111; Boonnoy P, 2015, J PHYS CHEM LETT, V6, P4884, DOI 10.1021/acs.jpclett.5b02405; Capranico G, 2017, J MED CHEM, V60, P2169, DOI 10.1021/acs.jmedchem.6b00966; Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369; Chiang SC, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1602506; Chowdhuri Srijita Paul, 2021, NAR Cancer, V3, pzcab003, DOI 10.1093/narcan/zcab003; Chowdhury S, 2012, EMBO MOL MED, V4, P1126, DOI 10.1002/emmm.201201316; Chowdhury SR, 2019, TRENDS BIOCHEM SCI, V44, P415, DOI 10.1016/j.tibs.2018.12.001; Chowdhury SR, 2017, BIOCHEM PHARMACOL, V138, P19, DOI 10.1016/j.bcp.2017.05.002; Croft SL, 2006, CLIN MICROBIOL REV, V19, P111, DOI 10.1128/CMR.19.1.111-126.2006; CRUZ A, 1991, P NATL ACAD SCI USA, V88, P7170, DOI 10.1073/pnas.88.16.7170; D'Annessa I, 2015, MINI-REV MED CHEM, V15, P203, DOI 10.2174/138955751503150312120912; Das BB, 2006, NUCLEIC ACIDS RES, V34, P1121, DOI 10.1093/nar/gkj502; Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078; Das BB, 2021, MITOCHONDRION, V60, P234, DOI 10.1016/j.mito.2021.08.017; Das BB, 2014, NUCLEIC ACIDS RES, V42, P4435, DOI 10.1093/nar/gku088; Das BB, 2010, P NATL ACAD SCI USA, V107, P19790, DOI 10.1073/pnas.1009814107; Das BB, 2009, EMBO J, V28, P3667, DOI 10.1038/emboj.2009.302; Das SK, 2018, J MED CHEM, V61, P804, DOI 10.1021/acs.jmedchem.7b01297; Das SK, 2016, NUCLEIC ACIDS RES, V44, P8363, DOI 10.1093/nar/gkw665; Ghosh A, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aax9778; Huang SYN, 2013, NUCLEIC ACIDS RES, V41, P7793, DOI 10.1093/nar/gkt483; Interthal H, 2005, J BIOL CHEM, V280, P36518, DOI 10.1074/jbc.M508898200; Katyal S, 2007, EMBO J, V26, P4720, DOI 10.1038/sj.emboj.7601869; Kawale AS, 2018, NUCLEIC ACIDS RES, V46, P520, DOI 10.1093/nar/gkx1219; Laffitte MCN, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006117; Ledesma FC, 2009, NATURE, V461, P674, DOI 10.1038/nature08444; Mandal SM, 2015, MOL BIOSYST, V11, P2551, DOI 10.1039/c5mb00366k; Mukherjee B, 2013, P NATL ACAD SCI USA, V110, pE575, DOI [10.1073/pnas.1213839110, 10.]; Mukhopadhyay R, 2011, INT J PARASITOL, V41, P1311, DOI 10.1016/j.ijpara.2011.07.013; Murai J, 2012, J BIOL CHEM, V287, P12848, DOI 10.1074/jbc.M111.333963; Nitiss KC, 2006, P NATL ACAD SCI USA, V103, P8953, DOI 10.1073/pnas.0603455103; Pal DS, 2015, ANTIMICROB AGENTS CH, V59, P2144, DOI 10.1128/AAC.05146-14; Paris C, 2004, ANTIMICROB AGENTS CH, V48, P852, DOI 10.1128/AAC.48.3.852-859.2004; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Pommier Y, 2016, NAT REV MOL CELL BIO, V17, P703, DOI 10.1038/nrm.2016.111; Pommier Y, 2014, DNA REPAIR, V19, P114, DOI 10.1016/j.dnarep.2014.03.020; Rehman I, 2018, NUCLEIC ACIDS RES, V46, P5601, DOI 10.1093/nar/gky291; Sen N, 2004, J BIOL CHEM, V279, P52366, DOI 10.1074/jbc.M406705200; Sen N, 2004, CELL DEATH DIFFER, V11, P924, DOI 10.1038/sj.cdd.4401435; Sen N, 2007, EXP PARASITOL, V115, P215, DOI 10.1016/j.exppara.2006.08.005; Sundar S, 2015, EXPERT OPIN PHARMACO, V16, P237, DOI 10.1517/14656566.2015.973850; Vermeersch M, 2009, ANTIMICROB AGENTS CH, V53, P3855, DOI 10.1128/AAC.00548-09; Villa H, 2003, J BIOL CHEM, V278, P3521, DOI 10.1074/jbc.M203991200; Zagnoli-Vieira G, 2020, DNA REPAIR, V94, DOI 10.1016/j.dnarep.2020.102900	49	0	0	3	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22265	10.1096/fj.202101668RR	http://dx.doi.org/10.1096/fj.202101668RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319800				2022-12-26	WOS:000772957100004
J	Huang, J; Chai, XJ; Wu, YJ; Hou, Y; Li, CX; Xue, YH; Pan, JR; Zhao, YK; Su, AM; Zhu, XY; Zhao, ST				Huang, Jian; Chai, Xuejun; Wu, Yongji; Hou, Yan; Li, Cixia; Xue, Yuhuan; Pan, Jiarong; Zhao, Yongkang; Su, Aimin; Zhu, Xiaoyan; Zhao, Shanting			beta-Hydroxybutyric acid attenuates heat stress-induced neuroinflammation via inhibiting TLR4/p38 MAPK and NF-kappa B pathways in the hippocampus	FASEB JOURNAL			English	Article						cognitive dysfunctions; heat stress; MAPKs; neuroinflammation; beta-hydroxybutyric acid	ANXIETY-LIKE BEHAVIOR; OXIDATIVE STRESS; DOPAMINERGIC-NEURONS; CELLS; HSP70; PERFORMANCE; EXPRESSION; MICROGLIA; CONTRIBUTES; ALZHEIMERS	Heat stress causes many pathophysiological responses in the brain, including neuroinflammation and cognitive deficits. p-Hydroxybutyric acid (BHBA) has been shown to have neuroprotective effects against inflammation induced by lipopolysaccharide. The aim of the present study was to evaluate the effects of BHBA on neuroinflammation induced by heat stress, as well as the underlying mechanisms. Mice were pretreated with vehicle. BHBA or minocycline (positive control group) and followed by heat exposure (43 degrees C) for 15 min for 14 days. In mice subjected to heat stress, we found that treatment with BHBA or minocycline significantly decreased the level of serum cortisol, the expressions of heat shock protein 70 (HSP70), and the density of c-Fos(+) cells in the hippocampus. Surprisingly, the ethological tests revealed that heat stress led to cognitive dysfunctions and could be alleviated by BHBA and minocycline administration. Further investigation showed that BHBA and minocycline significantly attenuated the activation of microglia and astrocyte induced by heat stress. Pro-inflammatory cytokines were attenuated in the hippocampus by BHBA and minocycline treatment. Importantly, compared with the heat stress group, mice in the BHBA treatment group and positive control group experienced a decrease in the expressions of toll-like receptor 4 (TLR4), phospho-p38 (p-p38), and nuclear factor kappa B (NF-kappa B). Our results elucidated that BHBA inhibits neuroinflammation induced by heat stress by suppressing the activation of microglia and astrocyte, and modulating TLR4/p38 MAPK and NF-kappa B pathways. This study provides new evidence that BHBA is a potential strategy for protecting animals from heat stress.	[Huang, Jian; Wu, Yongji; Hou, Yan; Li, Cixia; Xue, Yuhuan; Pan, Jiarong; Zhao, Yongkang; Zhu, Xiaoyan; Zhao, Shanting] Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China; [Chai, Xuejun] Xian Med Univ, Dept Basic Med, Xian, Peoples R China; [Su, Aimin] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Xi'an Medical University; Northwest A&F University - China	Zhu, XY; Zhao, ST (corresponding author), Northwest A&F Univ, Coll Vet Med, Yangling 712100, Shaanxi, Peoples R China.	xyzhu0922@163.com; zhaoshanting@nwsuaf.edu.cn			National Natural Science Foundation of China (NSFC) [31802154]; Shaanxi Provincial Regional Inovation Capability Guiding Plan Project [2020QFY10--04]; National Key Research and Develpoment Program of China [2018YFE0127000]; Key Research and Development Projects of Shaanxi Province [2021NY--021]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Shaanxi Provincial Regional Inovation Capability Guiding Plan Project; National Key Research and Develpoment Program of China; Key Research and Development Projects of Shaanxi Province	National Natural Science Foundation of China (NSFC), Grant/Award Number: 31802154; Shaanxi Provincial Regional Inovation Capability Guiding Plan Project, Grant/Award Number: 2020QFY10--04; National Key Research and Develpoment Program of China, Grant/Award Number: 2018YFE0127000; Key Research and Development Projects of Shaanxi Province, Grant/Award Number: 2021NY--021	Ari C, 2016, FRONT MOL NEUROSCI, V9, DOI [10.3389/fnmal.2016.00137, 10.3389/fnmol.2016.00137]; Bianchi A, 2014, FREE RADICAL BIO MED, V76, P114, DOI 10.1016/j.freeradbiomed.2014.07.028; Binley KE, 2014, J NEUROSCI METH, V225, P65, DOI 10.1016/j.jneumeth.2014.01.017; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; Briggs GD, 2013, NEUROCHEM INT, V63, P726, DOI 10.1016/j.neuint.2013.09.016; Brusa D, 2009, PROSTATE, V69, P1343, DOI 10.1002/pros.20981; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cai M, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1665-3; Camargos QM, 2020, BRAIN RES BULL, V155, P1, DOI 10.1016/j.brainresbull.2019.11.009; Cheng BH, 2007, AUTON NEUROSCI-BASIC, V134, P38, DOI 10.1016/j.autneu.2007.02.002; Cheng BH, 2013, NEUROCHEM INT, V62, P620, DOI 10.1016/j.neuint.2012.09.011; Cheng BH, 2010, NEUROCHEM RES, V35, P444, DOI 10.1007/s11064-009-0078-6; Cheng K, 2019, J THERM BIOL, V82, P70, DOI 10.1016/j.jtherbio.2019.03.012; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; Conti P, 2020, EUR J PHARMACOL, V875, DOI 10.1016/j.ejphar.2020.173035; Cunnane SC, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00053; Cwynar P, 2014, BERL MUNCH TIERARZTL, V127, P177, DOI 10.2376/0005-9366-127-177; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Davis BM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01747-8; DAVIS EJ, 1994, BRAIN RES BULL, V34, P73, DOI 10.1016/0361-9230(94)90189-9; DRAGUNOW M, 1987, NATURE, V329, P441, DOI 10.1038/329441a0; Dunkley PR, 2019, J NEUROCHEM, V149, P706, DOI 10.1111/jnc.14675; Erfani M, 2019, EXP PHYSIOL, V104, P1544, DOI 10.1113/EP087535; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Ferreira TA, 2014, NAT METHODS, V11, P982, DOI 10.1038/nmeth.3125; Fu SP, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-014-0230-3; Fu SP, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/983401; Garaschuk O, 2019, METHODS MOL BIOL, V2034, P27, DOI 10.1007/978-1-4939-9658-2_3; Grace AA, 2016, NAT REV NEUROSCI, V17, P524, DOI 10.1038/nrn.2016.57; Guettouche Toumy, 2005, BMC Biochemistry, V6, DOI 10.1186/1471-2091-6-4; Hancock PA, 2007, HUM FACTORS, V49, P851, DOI 10.1518/001872007X230226; Hancock PA, 2003, INT J HYPERTHER, V19, P355, DOI 10.1080/0265673021000054630; HANCOCK PA, 1986, PSYCHOL BULL, V99, P263, DOI 10.1037/0033-2909.99.2.263; Harikai N, 2003, BIOL PHARM BULL, V26, P701, DOI 10.1248/bpb.26.701; Hei MF, 2019, BEHAV BRAIN RES, V365, P26, DOI 10.1016/j.bbr.2019.02.044; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kim HG, 2013, BIOL PHARM BULL, V36, P1556, DOI 10.1248/bpb.b13-00268; Kim YH, 2005, LIFE SCI, V77, P2783, DOI 10.1016/j.lfs.2005.04.024; King AM, 2015, ANNU REV ENTOMOL, V60, P59, DOI 10.1146/annurev-ento-011613-162107; Klein MO, 2019, CELL MOL NEUROBIOL, V39, P31, DOI 10.1007/s10571-018-0632-3; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kuniishi H, 2017, NEUROSCI RES, V123, P27, DOI 10.1016/j.neures.2017.04.012; Lawrence T, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001651; Lee W, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0324-6; Leon LR, 2010, J APPL PHYSIOL, V109, P1980, DOI 10.1152/japplphysiol.00301.2010; Li HB, 2018, ONCOL LETT, V15, P775, DOI 10.3892/ol.2017.7360; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mahmoudi J, 2021, NEUROCHEM RES, V46, P2307, DOI 10.1007/s11064-021-03370-6; Marongiu L, 2019, J LEUKOCYTE BIOL, V106, P147, DOI 10.1002/JLB.3MIR1218-483RR; Moon M, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101057; Nakagawa H, 2020, J THERM BIOL, V87, DOI 10.1016/j.jtherbio.2019.102458; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orr AG, 2009, NAT NEUROSCI, V12, P872, DOI 10.1038/nn.2341; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Qu J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0997-0; RAMSEY JD, 1995, ERGONOMICS, V38, P154, DOI 10.1080/00140139508925092; Ransohoff RM, 2012, J CLIN INVEST, V122, P1164, DOI 10.1172/JCI58644; Ren BQ, 2018, ONCOL REP, V40, P895, DOI 10.3892/or.2018.6485; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Soncin F, 2003, BIOCHEM BIOPH RES CO, V303, P700, DOI 10.1016/S0006-291X(03)00398-X; Taylor L, 2016, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00372; Tsigos C, 2002, J PSYCHOSOM RES, V53, P865, DOI 10.1016/S0022-3999(02)00429-4; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Wang L, 2015, BIOMED REP, V3, P425, DOI 10.3892/br.2015.445; Wang YL, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1054-3; White MG, 2003, J NEUROCHEM, V87, P958, DOI 10.1046/j.1471-4159.2003.02077.x; Wu YC, 2020, FASEB J, V34, P1412, DOI 10.1096/fj.201901984R; Xu L, 2016, MOL NEUROBIOL, V53, P6709, DOI 10.1007/s12035-015-9593-4; Yong VW, 2004, LANCET NEUROL, V3, P744, DOI 10.1016/S1474-4422(04)00937-8; Yoshima T, 1998, J BIOL CHEM, V273, P25466, DOI 10.1074/jbc.273.39.25466; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Young K, 2018, JOVE-J VIS EXP, DOI 10.3791/57648; Zheng ZH, 2021, BRAIN BEHAV IMMUN, V91, P505, DOI 10.1016/j.bbi.2020.11.007; Zhou B, 2019, CNS NEUROSCI THER, V25, P665, DOI 10.1111/cns.13123	80	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22264	10.1096/fj.202101469RR	http://dx.doi.org/10.1096/fj.202101469RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CZ	35333405				2022-12-26	WOS:000772946300001
J	Donoso, DA; Basset, Y; Shik, JZ; Forrister, DL; Uquillas, A; Salazar-Mendez, Y; Arizala, S; Polanco, P; Beckett, S; Dominguez, GD; Barrios, H				Donoso, David A.; Basset, Yves; Shik, Jonathan Z.; Forrister, Dale L.; Uquillas, Adriana; Salazar-Mendez, Yasmin; Arizala, Stephany; Polanco, Pamela; Beckett, Saul; Dominguez, Diego G.; Barrios, Hector			Male ant reproductive investment in a seasonal wet tropical forest: Consequences of future climate change	PLOS ONE			English	Article							LIFE-HISTORY CONTINUUM; NUPTIAL FLIGHTS; ASSEMBLAGE; PHENOLOGY; HYMENOPTERA; TEMPLATES; PATTERNS; TRAITS; TREES	Tropical forests sustain many ant species whose mating events often involve conspicuous flying swarms of winged gynes and males. The success of these reproductive flights depends on environmental variables and determines the maintenance of local ant diversity. However, we lack a strong understanding of the role of environmental variables in shaping the phenology of these flights. Using a combination of community-level analyses and a time-series model on male abundance, we studied male ant phenology in a seasonally wet lowland rainforest in the Panama Canal. The male flights of 161 ant species, sampled with 10 Malaise traps during 58 consecutive weeks (from August 2014 to September 2015), varied widely in number (mean = 9.8 weeks, median = 4, range = 1 to 58). Those species abundant enough for analysis (n = 97) flew mainly towards the end of the dry season and at the start of the rainy season. While litterfall, rain, temperature, and air humidity explained community composition, the time-series model estimators elucidated more complex patterns of reproductive investment across the entire year. For example, male abundance increased in weeks when maximum daily temperature increased and in wet weeks during the dry season. On the contrary, male abundance decreased in periods when rain receded (e.g., at the start of the dry season), in periods when rain fell daily (e.g., right after the beginning of the wet season), or when there was an increase in the short-term rate of litterfall (e.g., at the end of the dry season). Together, these results suggest that the BCI ant community is adapted to the dry/wet transition as the best timing of reproductive investment. We hypothesize that current climate change scenarios for tropical regions with higher average temperature, but lower rainfall, may generate phenological mismatches between reproductive flights and the adequate conditions needed for a successful start of the colony.	[Donoso, David A.; Dominguez, Diego G.] Escuela Politec Nacl, Fac Ciencias, Dept Biol, Quito, Ecuador; [Basset, Yves; Beckett, Saul] Smithsonian Trop Res Inst, ForestGEO, Balboa, Ancon, Panama; [Basset, Yves] Univ South Bohemia, Fac Sci, Ceske Budejovice, Czech Republic; [Basset, Yves] Czech Acad Sci, Biol Ctr, Inst Entomol, Ceske Budejovice, Czech Republic; [Basset, Yves; Polanco, Pamela; Barrios, Hector] Univ Panama, Maestria Entomol, Panama City, Panama; [Shik, Jonathan Z.] Univ Copenhagen, Ctr Social Evolut, Dept Biol, Copenhagen, Denmark; [Shik, Jonathan Z.; Arizala, Stephany] Smithsonian Trop Res Inst, Balboa, Ancon, Panama; [Forrister, Dale L.] Univ Utah, Sch Biol Sci, Salt Lake City, UT USA; [Uquillas, Adriana] Escuela Politec Nacl, Fac Ciencias, Dept Matemat, Quito, Ecuador; [Salazar-Mendez, Yasmin] Escuela Politec Nacl, Fac Ciencias, Dept Econ Cuantitat, Quito, Ecuador; [Arizala, Stephany] Univ Estadual Campinas, UNICAMP, PG IB, Inst Biol, Campinas, SP, Brazil; [Dominguez, Diego G.] Univ Tecn Particular Loja, Dept Ciencias Nat, Loja, Ecuador	Escuela Politecnica Nacional Ecuador; Smithsonian Institution; Smithsonian Tropical Research Institute; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Universidad de Panama; University of Copenhagen; Smithsonian Institution; Smithsonian Tropical Research Institute; Utah System of Higher Education; University of Utah; Escuela Politecnica Nacional Ecuador; Escuela Politecnica Nacional Ecuador; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidad Tecnica Particular de Loja	Donoso, DA (corresponding author), Escuela Politec Nacl, Fac Ciencias, Dept Biol, Quito, Ecuador.	david.donosov@gmail.com	Donoso, David A/A-2059-2016; Basset, Yves/B-6642-2014	Donoso, David A/0000-0002-3408-1457; Shik, Jonathan Zvi/0000-0003-3309-7737; Basset, Yves/0000-0002-1942-5717	EPN Proyecto de Investigacion Grupal [PIGR-19-16]; SENACYT grant [FID14-036]; Smithsonian Institution Barcoding Opportunity [FY013, FY014]; European Research Council [ELEVATE: ERC2017-STG-757810]; Czech Science foundation GACR grant [20-31295S]	EPN Proyecto de Investigacion Grupal; SENACYT grant; Smithsonian Institution Barcoding Opportunity; European Research Council(European Research Council (ERC)European Commission); Czech Science foundation GACR grant	DAD, AU and YZ were supported by EPN Proyecto de Investigacion Grupal PIGR-19-16 to the ECOINT Research Group. This study was supported by SENACYT grant FID14-036 to HB and YB. Grants from the Smithsonian Institution Barcoding Opportunity FY013 and FY014 (to YB), and in-kind help from the Canadian Centre for DNA Barcoding allowed sequencing the insect specimens. JZS was funded by a European Research Council Starting Grant (ELEVATE: ERC2017-STG-757810). Studies on insect population dynamics are supported by Czech Science foundation GACR grant 20-31295S to YB. HB and YB are members of the Sistema Nacional de Investigacio ' n, SENACYT, Panama. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agostinelli C., 2013, R PACKAGE CIRCULAR C; Anderson-Teixeira KJ, 2015, GLOBAL CHANGE BIOL, V21, P528, DOI 10.1111/gcb.12712; Barrios H., 2016, SCIENTIA, V26, P7; Batschelet E, 1981, CIRCULAR STAT BIOL; Boomsma JJ, 2005, ANNU REV ENTOMOL, V50, P395, DOI 10.1146/annurev.ento.50.071803.130416; Bujan J, 2017, J INSECT PHYSIOL, V102, P1, DOI 10.1016/j.jinsphys.2017.08.007; Chapman MG, 1999, MAR ECOL PROG SER, V180, P257, DOI 10.3354/meps180257; Chick LD, 2019, J THERM BIOL, V80, P119, DOI 10.1016/j.jtherbio.2019.01.004; CORNEJO FH, 1994, OIKOS, V70, P183, DOI 10.2307/3545629; Davies SJ, 1999, AM J BOT, V86, P1786, DOI 10.2307/2656675; Dean DA, 2018, SOUTHWEST ENTOMOL, V43, P639, DOI 10.3958/059.043.0309; Donoso DA, 2014, ECOGRAPHY, V37, P490, DOI 10.1111/j.1600-0587.2013.00253.x; Donoso DA, 2013, SOIL BIOL BIOCHEM, V61, P45, DOI 10.1016/j.soilbio.2013.02.004; Donoso DA, 2010, OECOLOGIA, V164, P201, DOI 10.1007/s00442-010-1607-3; Dunn RR, 2007, ECOL ENTOMOL, V32, P135, DOI 10.1111/j.1365-2311.2006.00839.x; Enders W., 1995, APPL ECONOMETRIC TIM; Fabrega J, 2013, HYDROL RES LETT, V7, P23, DOI 10.3178/HRL.7.23; Feitosa RM, 2016, REV BRAS ENTOMOL, V60, P241, DOI 10.1016/j.rbe.2016.05.006; Flo V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0191268; Helms JA, 2015, INSECT SOC, V62, P171, DOI 10.1007/s00040-015-0391-9; Helms JA, 2018, MYRMECOL NEWS, V26, P19; HOLLDOBLER B, 1985, FORTS ZOOL, V31, P237; Imbach P, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193570; Kaspari M, 2001, ECOL ENTOMOL, V26, P245, DOI 10.1046/j.1365-2311.2001.00320.x; Kaspari M, 2001, BEHAV ECOL SOCIOBIOL, V50, P382, DOI 10.1007/s002650100378; Kishimoto-Yamada K, 2015, ENTOMOL SCI, V18, P407, DOI 10.1111/ens.12134; Leigh EGJ., 1997, ECOLOGY TROPICAL FOR; Morellato LPC, 2010, PHENOLOGICAL RESEARCH: METHODS FOR ENVIRONMENTAL AND CLIMATE CHANGE ANALYSIS, P339, DOI 10.1007/978-90-481-3335-2_16; Noordijk J, 2008, INSECT SOC, V55, P266, DOI 10.1007/s00040-008-1002-9; Oksanen J., 2011, **DATA OBJECT**; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Roeder KA, 2021, ECOSPHERE, V12, DOI 10.1002/ecs2.3645; Romer D, 2018, INSECT SOC, V65, P305, DOI 10.1007/s00040-018-0615-x; Shik JZ, 2013, ENTOMOL EXP APPL, V149, P99, DOI 10.1111/eea.12117; Shik JZ, 2012, NATURWISSENSCHAFTEN, V99, P191, DOI 10.1007/s00114-012-0884-6; Stemkovski M, 2020, ECOL LETT, V23, P1589, DOI 10.1111/ele.13583; Torres JA, 2001, SOCIOBIOLOGY, V37, P601; TOWNES H, 1972, Entomological News, V83, P239; Wright SJ, 2018, BIOTROPICA, V50, P374, DOI 10.1111/btp.12522; Zar J.H., 1999, ZAR KUHR 5 2019, V4th	40	2	2	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266222	10.1371/journal.pone.0266222	http://dx.doi.org/10.1371/journal.pone.0266222			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358265	gold, Green Published			2022-12-26	WOS:000799828800080
J	Frohn, BP; Hartel, T; Cox, J; Schwille, P				Frohn, Bela P.; Haertel, Tobias; Cox, Juergen; Schwille, Petra			Tracing back variations in archaeal ESCRT-based cell division to protein domain architectures	PLOS ONE			English	Article							EVOLUTION; ORIGIN	The Endosomal Sorting Complex Required for Transport (ESCRT) system is a multi-protein machinery that is involved in cell division of both Eukaryotes and Archaea. This spread across domains of life suggests that a precursor ESCRT machinery existed already at an evolutionary early stage of life, making it a promising candidate for the (re)construction of a minimal cell division machinery. There are, however, only few experimental data about ESCRT machineries in Archaea, due to high technical challenges in cultivation and microscopy. Here, we analyse the proteins of ESCRT machineries in archaea bioinformatically on a protein domain level, to enable mechanistical comparison without such challenging experiments. First, we infer that there are at least three different cell division mechanisms utilizing ESCRT proteins in archaea, probably similar in their constriction mechanisms but different in membrane tethering. Second, we show that ESCRT proteins in the archaeal super-phylum Asgard are highly similar to eukaryotic ESCRT proteins, strengthening the recently developed idea that all Eukaryotes descended from archaea. Third, we reconstruct a plausible evolutionary development of ESCRT machineries and suggest that a simple ESCRT-based constriction machinery existed in the last archaeal common ancestor. These findings not only give very interesting insights into the likely evolution of cell division in Archaea and Eukaryotes, but also offer new research avenues by suggesting hypothesis-driven experiments for both, cell biology and bottom-up synthetic biology.	[Frohn, Bela P.; Haertel, Tobias; Schwille, Petra] Max Planck Inst Biochem, Dept Cellular & Mol Biophys, Martinsried, Germany; [Frohn, Bela P.; Cox, Juergen] Max Planck Inst Biochem, Computat Syst Biochem Res Grp, Martinsried, Germany; [Cox, Juergen] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway	Max Planck Society; Max Planck Society; University of Bergen	Schwille, P (corresponding author), Max Planck Inst Biochem, Dept Cellular & Mol Biophys, Martinsried, Germany.; Cox, J (corresponding author), Max Planck Inst Biochem, Computat Syst Biochem Res Grp, Martinsried, Germany.; Cox, J (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	cox@biochem.mpg.de; schwille@biochem.mpg.de		Frohn, Bela/0000-0003-3067-9184				Adam PS, 2017, ISME J, V11, P2407, DOI 10.1038/ismej.2017.122; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bernander R, 2010, CURR OPIN MICROBIOL, V13, P747, DOI 10.1016/j.mib.2010.10.005; Buchkovich NJ, 2013, DEV CELL, V27, P201, DOI 10.1016/j.devcel.2013.09.009; Caspi Y, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00174; Dobro MJ, 2013, MOL BIOL CELL, V24, P2319, DOI 10.1091/mbc.E12-11-0785; Drozdetskiy A, 2015, NUCLEIC ACIDS RES, V43, pW389, DOI 10.1093/nar/gkv332; Eme L, 2017, NAT REV MICROBIOL, V15, P711, DOI 10.1038/nrmicro.2017.133; Hatano T., 2021, BIORXIV, DOI [10.1101/2021.08.17.456605, DOI 10.1101/2021.08.17.456605, DOI 10.1101/2021.08.17.456605V1]; Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085; Imachi H, 2020, NATURE, V577, P519, DOI 10.1038/s41586-019-1916-6; Izore T, 2016, ELIFE, V5, DOI 10.7554/eLife.21600; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Kojima R, 2016, J MOL BIOL, V428, P2392, DOI 10.1016/j.jmb.2016.04.007; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Liao Y, 2021, NAT MICROBIOL, V6, P594, DOI 10.1038/s41564-021-00894-z; Lindas AC, 2008, P NATL ACAD SCI USA, V105, P18942, DOI 10.1073/pnas.0809467105; Lu ZY, 2020, MBIO, V11, DOI 10.1128/mBio.00417-20; Makarova Kira S., 2015, Life-Basel, V5, P818, DOI 10.3390/life5010818; Makarova KS, 2010, NAT REV MICROBIOL, V8, P731, DOI 10.1038/nrmicro2406; Marchler-Bauer A, 2015, NUCLEIC ACIDS RES, V43, pD222, DOI 10.1093/nar/gku1221; Mitchell AL, 2019, NUCLEIC ACIDS RES, V47, pD351, DOI 10.1093/nar/gky1100; Moriscot C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021921; Mount David W, 2008, CSH Protoc, V2008, DOI 10.1101/pdb.top39; Nachmias D., 2021, PREPRINT, DOI [10.1101/2021.11.29.470303v1, DOI 10.1101/2021.11.29.470303V1]; Ng KH, 2013, ARCHAEA, V2013, DOI 10.1155/2013/104147; Pelve EA, 2011, MOL MICROBIOL, V82, P555, DOI 10.1111/j.1365-2958.2011.07834.x; Pende N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23099-8; Pulschen AA, 2020, CURR BIOL, V30, P2852, DOI 10.1016/j.cub.2020.05.021; Risa GT, 2020, SCIENCE, V369, P642, DOI 10.1126/science.aaz2532; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Sadler JBA, 2018, P NATL ACAD SCI USA, V115, pE8900, DOI 10.1073/pnas.1805504115; Samson RY, 2011, MOL CELL, V41, P186, DOI 10.1016/j.molcel.2010.12.018; Samson RY, 2008, SCIENCE, V322, P1710, DOI 10.1126/science.1165322; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Schoch CL, 2020, DATABASE-OXFORD, DOI 10.1093/database/baaa062; Sciskala B, 2013, EUKARYOT CELL, V12, P1538, DOI 10.1128/EC.00241-13; Votteler J, 2013, CELL HOST MICROBE, V14, P232, DOI 10.1016/j.chom.2013.08.012; Zaremba-Niedzwiedzka K, 2017, NATURE, V541, P353, DOI 10.1038/nature21031	41	1	1	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266395	10.1371/journal.pone.0266395	http://dx.doi.org/10.1371/journal.pone.0266395			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358274	Green Published, gold			2022-12-26	WOS:000799828800098
J	McCance, K; Wise, H; Simpson, J; Batchelor, B; Hale, H; McDonald, L; Zorzoli, A; Furrie, E; Chopra, C; Muecksch, F; Hatziioannou, T; Bieniasz, PD; Templeton, K; Jenks, S				McCance, Kirsty; Wise, Helen; Simpson, Jennifer; Batchelor, Becky; Hale, Harriet; McDonald, Lindsay; Zorzoli, Azul; Furrie, Elizabeth; Chopra, Charu; Muecksch, Frauke; Hatziioannou, Theodora; Bieniasz, Paul D.; Templeton, Kate; Jenks, Sara			Evaluation of SARS-CoV-2 antibody point of care devices in the laboratory and clinical setting	PLOS ONE			English	Article								SARS-CoV-2 antibody tests have been marketed to diagnose previous SARS-CoV-2 infection and as a test of immune status. There is a lack of evidence on the performance and clinical utility of these tests. We aimed to carry out an evaluation of 14 point of care (POC) SARS-CoV-2 antibody tests. Serum from participants with previous RT-PCR (real-time polymerase chain reaction) confirmed SARS-CoV-2 infection and pre-pandemic serum controls were used to determine specificity and sensitivity of each POC device. Changes in sensitivity with increasing time from infection were determined on a cohort of study participants. Corresponding neutralising antibody status was measured to establish whether the detection of antibodies by the POC device correlated with immune status. Paired capillary and serum samples were collected to ascertain whether POC devices performed comparably on capillary samples. Sensitivity and specificity varied between the POC devices and in general did not meet the manufacturers' reported performance characteristics, which signifies the importance of independent evaluation of these tests. The sensitivity peaked at >= 20 days following onset of symptoms, however sensitivity of 3 of the POC devices evaluated at extended time points showed that sensitivity declined with time. This was particularly marked at >140 days post infection. This is relevant if the tests are to be used for sero-prevalence studies. Neutralising antibody data showed that positive antibody results on POC devices did not necessarily confer high neutralising antibody titres, and that these POC devices cannot be used to determine immune status to the SARS-CoV-2 virus. Comparison of paired serum and capillary results showed that there was a decline in sensitivity using capillary blood. This has implications in the utility of the tests as they are designed to be used on capillary blood by the general population.	[McCance, Kirsty; Wise, Helen; Simpson, Jennifer; McDonald, Lindsay; Zorzoli, Azul; Templeton, Kate; Jenks, Sara] Royal Infirm Edinburgh NHS Trust, Dept Biochem, NHS Lothian, Edinburgh, Midlothian, Scotland; [Batchelor, Becky; Hale, Harriet] NHS Lothian, Western Gen Hosp, Edinburgh, Midlothian, Scotland; [Furrie, Elizabeth] NHS Tayside, Ninewells Hosp & Med Sch, Dundee, Scotland; [Chopra, Charu] NHS Lothian, Dept Immunol, Royal Infirm Edinburgh, Edinburgh, Midlothian, Scotland; [Muecksch, Frauke; Hatziioannou, Theodora; Bieniasz, Paul D.] Rockefeller Univ, Lab Retrovirol, 1230 York Ave, New York, NY 10021 USA; [Bieniasz, Paul D.] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Royal Infirmary of Edinburgh; University of Edinburgh; University of Edinburgh; University of Dundee; Royal Infirmary of Edinburgh; Rockefeller University; Howard Hughes Medical Institute; Rockefeller University	McCance, K (corresponding author), Royal Infirm Edinburgh NHS Trust, Dept Biochem, NHS Lothian, Edinburgh, Midlothian, Scotland.	kirsty.mccance@nhslothian.scot.nhs.uk		McCance, Kirsty/0000-0002-5688-2116	Lothian NRS BioResource	Lothian NRS BioResource	Funding and support for this study was provided by Lothian NRS BioResource obtained by SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addetia A, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.02107-20; [Anonymous], INTERIM GUIDELINES C; [Anonymous], SARS COV 2 DIAGNOSTI; [Anonymous], 2020, TARG PROD PROF ANT T; Bal Antonin., 2021, CLIN MICROBIOL INFEC; Barnes E, 2020, EVALUATION ANTIBODY, DOI 10.1101/2020.04.15.20066407v1.full.pdf; Borremans B., 2020, OPEN SCI FRAMEWORK, DOI [10.7554/eLife.60122 32894217, DOI 10.7554/ELIFE.6012232894217]; Combes AJ, 2021, NATURE, V591, P124, DOI 10.1038/s41586-021-03234-7; Dan JM, 2021, SCIENCE, V371, P587, DOI 10.1126/science.abf4063; Flower B, 2020, THORAX, V75, P1082, DOI 10.1136/thoraxjnl-2020-215732; Guidance and Standard Operating Procedure, COVID 19 VIS TEST NH; Guo L, 2020, CLIN INFECT DIS, V71, P778, DOI 10.1093/cid/ciaa310; Guthmiller JJ, 2021, MBIO, V12, DOI 10.1128/mBio.02940-20; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Horby PW, 2021, LANCET, V397, P605, DOI 10.1016/S0140-6736(21)00149-5; Kadelka S, ARXIV210313951 Q BIO; L'Huillier AG, 2021, CLIN MICROBIOL INFEC, V27, DOI 10.1016/j.cmi.2021.01.005; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Lou B, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.00763-2020; Muecksch F, 2021, J INFECT DIS, V223, P389, DOI 10.1093/infdis/jiaa659; Sabino EC, 2021, LANCET, V397, P452, DOI 10.1016/S0140-6736(21)00183-5; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Tan AT, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2021.108728; van de Veerdonk FL, 2022, NAT MED, V28, P39, DOI 10.1038/s41591-021-01643-9; Vidal SJ, 2021, J VIROL, V95, DOI 10.1128/JVI.00404-21; Wajnberg A, 2020, SCIENCE, V370, P1227, DOI 10.1126/science.abd7728; Wang PF, 2020, EMERG MICROBES INFEC, V9, P2091, DOI 10.1080/22221751.2020.1823890; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	30	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266086	10.1371/journal.pone.0266086	http://dx.doi.org/10.1371/journal.pone.0266086			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358263	Green Published, gold, Green Submitted			2022-12-26	WOS:000799828800064
J	Mikkelsen, AP; Egerup, P; Kolte, AM; Westergaard, D; Nielsen, HS; Lidegaard, O				Mikkelsen, Anders Pretzmann; Egerup, Pia; Kolte, Astrid Marie; Westergaard, David; Nielsen, Henriette Svarre; Lidegaard, Ojvind			Pregnancy loss and risk of multiple sclerosis and autoimmune neurological disorder: A nationwide cohort study	PLOS ONE			English	Article							REPRODUCTIVE HISTORY; ASSOCIATION; REGISTER; ALLELES; NUMBER	Background The loss of one or more pregnancies before viability (i.e. pregnancy loss or miscarriage), has been linked to an increased risk of diseases later in life such as myocardial infarction and stroke. Recurrent pregnancy loss (i.e. three consecutive pregnancy losses) and multiple sclerosis have both been linked to immunological traits, which could predispose to both occurrences. The objective of the current study was to investigate if pregnancy loss is associated with later autoimmune neurological disease. Methods This register-based cohort study, included the Danish female population age 12 or older between 1977-2017. Women were grouped hierarchically: 0, 1, 2, >= 3 pregnancy losses, primary recurrent pregnancy loss (i.e. not preceded by a delivery), and secondary recurrent pregnancy loss (i.e. preceded by a delivery). The main outcome was multiple sclerosis and additional outcomes were amyotrophic lateral sclerosis, Guillain-Barre syndrome, and myasthenia gravis. Bayesian Poisson regression estimated incidence rate ratios [IRR] and 95% credible intervals [CI] adjusted for year, age, live births, family history of an outcome, and education. Results After 40,380,194 years of follow-up, multiple sclerosis was diagnosed among 7,667 out of 1,513,544 included women (0.5%), median age at diagnosis 34.2 years (IQR 27.4-41.4 years), and median age at symptom onset 31.2 years (IQR 24.8-38.2). The adjusted IRR of multiple sclerosis after 1 pregnancy loss was: 1.03 (95% CI 0.95-1.11), 2 losses: 1.02 (95% CI 0.86-1.20), >= 3 non-consecutive losses: 0.81 (95% CI 0.51-1.24), primary recurrent pregnancy loss: 1.18 (95% CI 0.84-1.60), secondary recurrent pregnancy loss: 1.16 (95% CI 0.81-1.63), as compared to women with no pregnancy losses. Seven sensitivity analyses and analyses for additional outcomes did not show significantly elevated adjusted risk estimates. Conclusions In this nationwide study, pregnancy loss was not significantly associated with autoimmune neurological disorder.	[Mikkelsen, Anders Pretzmann; Lidegaard, Ojvind] Univ Copenhagen, Dept Gynaecol, Hosp Rigshosp, Copenhagen, Denmark; [Mikkelsen, Anders Pretzmann; Egerup, Pia; Kolte, Astrid Marie; Nielsen, Henriette Svarre; Lidegaard, Ojvind] Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark; [Egerup, Pia; Nielsen, Henriette Svarre] Copenhagen Univ Hosp Hvidovre, Dept Obstet & Gynaecol, Hvidovre, Denmark; [Egerup, Pia; Kolte, Astrid Marie; Westergaard, David; Nielsen, Henriette Svarre] Copenhagen Univ Hosp, Recurrent Pregnancy Loss Unit, Rigshosp & Hvidovre, Copenhagen, Denmark; [Westergaard, David] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Copenhagen, Denmark; [Westergaard, David] Stat Denmark, Methods & Anal, Copenhagen, Denmark	Rigshospitalet; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Copenhagen	Mikkelsen, AP (corresponding author), Univ Copenhagen, Dept Gynaecol, Hosp Rigshosp, Copenhagen, Denmark.; Mikkelsen, AP (corresponding author), Univ Copenhagen, Dept Clin Med, Copenhagen, Denmark.	anders.mikkelsen@regionh.dk		Mikkelsen, Anders Pretzmann/0000-0002-7583-9826	Research Fund of Rigshospitalet, Copenhagen University Hospital [E-22515-01]; Ole Kirks Foundation	Research Fund of Rigshospitalet, Copenhagen University Hospital; Ole Kirks Foundation	All funding for the study were provided by grants from The Research Fund of Rigshospitalet, Copenhagen University Hospital [grant number E-22515-01] awarded to APM and OL. URL: https://www.forskningspuljer-rh.dk/and Ole Kirks Foundation [no grant number] awarded to HSN. URL: https://www.olekirksfond.dk/).There was no additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen AMN, 2000, BRIT MED J, V320, P1708, DOI 10.1136/bmj.320.7251.1708; [Anonymous], 2019, LANCET NEUROL; Arneth B, 2020, AM J MED, V133, P783, DOI 10.1016/j.amjmed.2020.03.008; Bliddal M, 2018, EUR J EPIDEMIOL, V33, P27, DOI 10.1007/s10654-018-0356-1; Bronnum-Hansen H, 2011, SCAND J PUBLIC HEALT, V39, P62, DOI 10.1177/1403494810390729; Cervera R, 2010, CLIN REV ALLERG IMMU, V39, P148, DOI 10.1007/s12016-009-8179-1; CHRISTIANSEN OB, 1994, TISSUE ANTIGENS, V44, P225, DOI 10.1111/j.1399-0039.1994.tb02387.x; Confavreux C, 1998, NEW ENGL J MED, V339, P285, DOI 10.1056/NEJM199807303390501; Egerup P, 2020, DIABETOLOGIA, V63, P1521, DOI 10.1007/s00125-020-05154-z; Fagnani C, 2015, MULT SCLER J, V21, P1404, DOI 10.1177/1352458514564492; Ford Holly B, 2009, Rev Obstet Gynecol, V2, P76; Gelman A, 1996, STAT SINICA, V6, P733; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Hardy K, 2016, AM J MED GENET A, V170, P2671, DOI 10.1002/ajmg.a.37795; Hedstrom AK, 2014, MULT SCLER J, V20, P406, DOI 10.1177/1352458513498126; Hempel S, 2017, MULT SCLER J, V23, P525, DOI 10.1177/1352458517690270; Hernan MA, 2000, NEUROLOGY, V55, P848, DOI 10.1212/WNL.55.6.848; Hunt JS, 2006, IMMUNOL REV, V213, P36, DOI 10.1111/j.1600-065X.2006.00436.x; Krebs L, 1997, Ugeskr Laeger, V159, P1607; Levison LS, 2019, CLIN EPIDEMIOL, V11, P275, DOI 10.2147/CLEP.S199839; Lidegaard O, 2020, ACTA OBSTET GYN SCAN, V99, P1492, DOI 10.1111/aogs.13860; Lohse Sarah Rytter, 2010, Clin Epidemiol, V2, P247, DOI 10.2147/CLEP.S13815; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Madireddy L, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09773-y; Mason K, 2012, ACTA NEUROL SCAND, V125, P213, DOI 10.1111/j.1600-0404.2011.01558.x; Nguyen AL, 2020, JAMA NEUROL, V77, P1496, DOI 10.1001/jamaneurol.2020.3324; Nielsen NM, 2011, EPIDEMIOLOGY, V22, P546, DOI 10.1097/EDE.0b013e31821c7adc; Ogasawara M, 2000, FERTIL STERIL, V73, P300, DOI 10.1016/S0015-0282(99)00495-1; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Pedersen EG, 2011, NEUROEPIDEMIOLOGY, V37, P120, DOI 10.1159/000331481; Ponsonby AL, 2012, NEUROLOGY, V78, P867, DOI 10.1212/WNL.0b013e31824c4648; Quenby S, 2021, LANCET, V397, P1658, DOI 10.1016/S0140-6736(21)00682-6; R Core Team, 2021, R LANGUAGE ENV STAT; Ranthe MF, 2013, CIRCULATION, V127, P1775, DOI 10.1161/CIRCULATIONAHA.112.000285; Roepke ER, 2017, ACTA OBSTET GYN SCAN, V96, P1365, DOI 10.1111/aogs.13210; Seals RM, 2016, EPIDEMIOLOGY, V27, P188, DOI 10.1097/EDE.0000000000000417; Stan Development Team, 2021, STAN US GUID; Thomsen CK, 2021, J REPROD IMMUNOL, V145, DOI 10.1016/j.jri.2021.103308; Vandenbroucke JP, 2007, EPIDEMIOLOGY, V18, P805, DOI 10.1097/EDE.0b013e3181577511; Westergaard D, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.015069	40	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266203	10.1371/journal.pone.0266203	http://dx.doi.org/10.1371/journal.pone.0266203			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358256	gold, Green Published			2022-12-26	WOS:000799828800078
J	Rasolonjatovo, SM; Scherz, MD; Schmidt, R; Glos, J; Rakotoarison, A; Raselimanana, AP; Vences, M				Rasolonjatovo, Safidy M.; Scherz, Mark D.; Schmidt, Robin; Glos, Julian; Rakotoarison, Andolalao; Raselimanana, Achille P.; Vences, Miguel			Population diversification in the frog Mantidactylus bellyi on an isolated massif in northern Madagascar based on genetic, morphological, bioacoustic and ecological evidence	PLOS ONE			English	Article							MULTILOCUS GENOTYPE DATA; GEOGRAPHIC-VARIATION; ADVERTISEMENT CALLS; MANTELLID FROGS; SPECIES DELIMITATION; BODY-SIZE; SP ANURA; SPECIATION; DIVERSITY; DIVERGENCE	In the processes that give rise to new species, changes first occur at the population level. But with the continuous nature of the divergence process, change in biological properties delimiting the shift from "individuals of divergent populations" towards "individuals of distinct species", as well as abiotic factors driving the change, remain largely ambivalent. Here we study diversification processes at the population level in a semi-aquatic frog, Mantidactylus (Brygoomantis) bellyi, across the diverse vegetation types of Montagne d'Ambre National Park (MANP), Madagascar. Genetic diversity was assessed with seven newly developed microsatellite markers as well as mitochondrial DNA sequences and concordance with patterns of ecological, morphological, and bioacoustic divergence evaluated. We found M. bellyi lacking mitochondrial differentiation within MANP, while microsatellite datasets partitioned them into three highly differentiated, geographically separated subpopulations (with indications for up to five subpopulations). The molecular grouping-primarily clustering individuals by geographic proximity-was coincident with differences in mean depth and width of waters, suggesting a possible role of fluvial characteristics in genetic exchange in this stream-breeding species. Genetic clustering not consistent with differences in call properties, except for dominant call frequencies under the two-subpopulations model. Morphological divergence was mostly consistent with the genetic clustering; subpopulations strongly differed by their snout-vent length, with individuals from high-elevation subpopulations smaller than those from populations below 1000 m above sea level. These results exemplify how mountains and environmental conditions might primarily shape genetic and morphological divergence in frog populations, without strongly affecting their calls.	[Rasolonjatovo, Safidy M.; Rakotoarison, Andolalao; Raselimanana, Achille P.] Univ Antananar, Ment Zool & Biodiversite Anim, Antananarivo, Madagascar; [Rasolonjatovo, Safidy M.; Raselimanana, Achille P.] Assoc Vahatra, Lot VA 38 LBA Ter Ambohidempona Tsiadana, Antananarivo, Madagascar; [Rasolonjatovo, Safidy M.; Scherz, Mark D.; Schmidt, Robin; Rakotoarison, Andolalao; Vences, Miguel] Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany; [Scherz, Mark D.] Univ Copenhagen, Nat Hist Museum Denmark, Copenhagen O, Denmark; [Glos, Julian] Univ Hamburg, Inst Zool Anim Ecol & Conservat, Hamburg, Germany	Braunschweig University of Technology; University of Copenhagen; University of Hamburg	Rasolonjatovo, SM (corresponding author), Univ Antananar, Ment Zool & Biodiversite Anim, Antananarivo, Madagascar.; Rasolonjatovo, SM (corresponding author), Assoc Vahatra, Lot VA 38 LBA Ter Ambohidempona Tsiadana, Antananarivo, Madagascar.; Rasolonjatovo, SM; Vences, M (corresponding author), Tech Univ Carolo Wilhelmina Braunschweig, Zool Inst, Div Evolutionary Biol, Braunschweig, Germany.	safidymalala@yahoo.com; m.vences@tu-braunschweig.de	Scherz, Mark D./C-9870-2019	Scherz, Mark D./0000-0002-4613-7761; Schmidt, Robin/0000-0003-1269-2553; Rasolonjatovo, Safidy Malala/0000-0002-8575-4770	National Geographic Society [WW-121ER-17]; Deutsche Forschungsgemeinschaft [VE 247/13-1]; Deutscher Akademischer Austauschdienst (DAAD) [57440917]; Leona M. & Harry B. Helmsley Charitable Trust	National Geographic Society(National Geographic Society); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Leona M. & Harry B. Helmsley Charitable Trust	The data collection was funded by National Geographic Society (https://www.nationalgeographic.org, grant number WW-121ER17) to SMR and by Deutsche Forschungsgemeinschaft (https://www.dfg.de, grant VE 247/13-1) to MV and MDS. The laboratory work and analyses were funded by the Deutscher Akademischer Austauschdienst (https://www.daad.de/en, DAAD, Research Grants -ShortTerm Grants, 2019 (57440917)) and National Geographic Society (grant number WW-121ER-17) to SMR, and by Deutsche Forschungsgemeinschaft (grant VE 247/13-1) to MV and MDS. Association Vahatra (http://www.vahatra.mg) was funded by Leona M. & Harry B. Helmsley Charitable Trust (https://helmsleytrust.org) under the program 'Development of scientist capacity for Malagasy conservation biologists' and scholarships granted by Jai Shekhawat. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguilera G, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218810; Amezquita A, 2009, BIOL J LINN SOC, V98, P826, DOI 10.1111/j.1095-8312.2009.01324.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Baden AL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52689-2; Beheregaray LB, 2015, FRONT GENET, V5, DOI 10.3389/fgene.2014.00477; Bonin A, 2004, MOL ECOL, V13, P3261, DOI 10.1111/j.1365-294X.2004.02346.x; Boul KE, 2004, COPEIA, P624, DOI 10.1643/CH-03-153R2; Bowen BW, 2013, TRENDS ECOL EVOL, V28, P359, DOI 10.1016/j.tree.2013.01.018; Brenneman RA, 2012, ORYX, V46, P298, DOI 10.1017/S0030605311000159; Bruford Michael W., 1992, P225; Butlin RK, 2008, PHILOS T R SOC B, V363, P2997, DOI 10.1098/rstb.2008.0076; Chernova O F, 2005, Dokl Biol Sci, V405, P446, DOI 10.1007/s10630-005-0161-3; Chikuni AC., 1994, P 13 PLENARY M AETFA; Cocca W, 2020, ZOOKEYS, P133, DOI 10.3897/zookeys.951.51129; Crottini A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040317; D'Cruze N, 2007, HERPETOL CONSERV BIO, V2, P87; D'Cruze Neil, 2008, Madagascar Conservation & Development, V3, P44; D'Cruze Neil C., 2006, Herpetological Bulletin, P17; De Queiroz K, 2007, SYST BIOL, V56, P879, DOI 10.1080/10635150701701083; Dufresnes C, 2020, AMPHIBIA-REPTILIA, V41, P105, DOI 10.1163/15685381-20191312; Dufresnes C, 2020, HEREDITY, V124, P423, DOI 10.1038/s41437-020-0294-z; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Eberhart-Phillips LJ, 2015, ECOL EVOL, V5, P997, DOI 10.1002/ece3.1393; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Everson KM, 2020, J BIOGEOGR, V47, P2059, DOI 10.1111/jbi.13945; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fine PVA, 2015, ANNU REV ECOL EVOL S, V46, P369, DOI 10.1146/annurev-ecolsys-112414-054102; Funk WC, 2016, J EVOLUTION BIOL, V29, P241, DOI 10.1111/jeb.12760; Gautier L., 2018, TERRESTRIAL PROTECTE, P207; Gehring PS, 2012, MOL PHYLOGENET EVOL, V64, P618, DOI 10.1016/j.ympev.2012.05.018; Gerhardt HC., 2002, ACOUSTIC COMMUNICATI; Gilabert A, 2007, CAN J ZOOL, V85, P965, DOI 10.1139/Z07-083; Gingras B, 2013, J ZOOL, V289, P143, DOI 10.1111/j.1469-7998.2012.00973.x; GLAW F, 2007, FIELDGUIDE AMPHIBIAN; Glaw F, 2006, ORG DIVERS EVOL, V6, P236, DOI 10.1016/j.ode.2005.12.001; Godron M., 1968, CODE RELEVE METHODIQ; Goodman S.M., 2018, TERRESTRIAL PROTECTE; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Goodman Steven M., 1996, Ecotropica, V2, P87; Guarino FM, 2019, HERPETOZOA, V32, P39, DOI 10.3897/herpetozoa.32.e35576; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Hillis DM, 2019, J HERPETOL, V53, P3, DOI 10.1670/18-123; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Kelley NP, 2015, BIOL LETTERS, V11, DOI 10.1098/rsbl.2014.0709; Kime NM, 2000, BEHAV ECOL, V11, P71, DOI 10.1093/beheco/11.1.71; Klonoski K, 2019, ECOL EVOL, V9, P2725, DOI 10.1002/ece3.4943; Kohler J, 2017, ZOOTAXA, V4251, P1, DOI 10.11646/zootaxa.4251.1.1; Kohler J, 2015, ZOOTAXA, V4006, P401, DOI 10.11646/zootaxa.4006.3.1; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Lamb JM, 2008, ACTA CHIROPTEROL, V10, P21, DOI 10.3161/150811008X331063; Lee KH, 2016, ECOL EVOL, V6, P3289, DOI 10.1002/ece3.2116; LEMMON PAUL E., 1957, JOUR FOREST, V55, P667; LEMMON PAUL E., 1956, FOREST SCI, V2, P314; Lewton KL, 2016, AM J PHYS ANTHROPOL, V161, P381, DOI 10.1002/ajpa.23038; Liberman U, 2011, GENETICS, V187, P837, DOI 10.1534/genetics.110.123620; Linck E, 2020, J EVOLUTION BIOL, V33, P1643, DOI 10.1111/jeb.13698; Linz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087355; Lowry DB, 2012, BIOL J LINN SOC, V106, P241, DOI 10.1111/j.1095-8312.2012.01867.x; McArdle BH, 2001, ECOLOGY, V82, P290, DOI 10.1890/0012-9658(2001)082[0290:FMMTCD]2.0.CO;2; Menegon M, 2014, INFECT GENET EVOL, V27, P244, DOI 10.1016/j.meegid.2014.07.029; Monsen KJ, 2004, CONSERV GENET, V5, P827, DOI 10.1007/s10592-004-1981-z; Neuwirth Erich, 2014, CRAN; Nicoll M.E., 1989, MADAGASCAR REV CONSE; Nosil P, 2012, OX ECOL EV, P1, DOI 10.1093/acprof:osobl/9780199587100.001.0001; Nowack C, 2016, ANAT REC, V299, P943, DOI 10.1002/ar.23351; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Orozco-Terwengel P, 2013, MOL ECOL, V22, P6074, DOI 10.1111/mec.12558; Orr MR, 1998, TRENDS ECOL EVOL, V13, P502, DOI 10.1016/S0169-5347(98)01511-0; Pabijan M, 2012, J EVOLUTION BIOL, V25, P2310, DOI 10.1111/j.1420-9101.2012.02613.x; Pabijan M, 2015, MOL PHYLOGENET EVOL, V92, P11, DOI 10.1016/j.ympev.2015.05.018; Padial JM, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-16; Perl RGB, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23587-w; Phillimore AB, 2008, AM NAT, V171, P646, DOI 10.1086/587074; Pompanon F, 2005, NAT REV GENET, V6, P847, DOI 10.1038/nrg1707; Poth D, 2013, J NAT PROD, V76, P1548, DOI 10.1021/np400131q; Pritchard JK, 2000, GENETICS, V155, P945; R Core Team, 2021, R LANGUAGE ENV STAT; Rabemananjara FCE, 2007, ZOOTAXA, P31, DOI 10.11646/zootaxa.1501.1.2; Rakotoarivelo AR, 2019, PEERJ, V7, DOI 10.7717/peerj.5866; Ramanamanjato Jean Baptiste, 1999, Occasional Papers of the Museum of Zoology University of Michigan, V728, P1; Rancilhac L, 2020, J NAT HIST, V54, P87, DOI 10.1080/00222933.2020.1748243; Randrianiaina RD, 2011, CONTRIB ZOOL, V80, P17, DOI 10.1163/18759866-08001002; Rasolonjatovo S.M., 2020, MALAGASY NATURE, V14, P57; Rasolonjatovo SM, 2020, MOL PHYLOGENET EVOL, V144, DOI 10.1016/j.ympev.2019.106700; Rasolonjatovo Safidy M., 2018, Herpetology Notes, V11, P747; Rowley J, 2015, AMPHIBIA-REPTILIA, V36, P277, DOI 10.1163/15685381-00003007; Rull V, 2008, MOL ECOL, V17, P2722, DOI 10.1111/j.1365-294X.2008.03789.x; Rundle HD, 2005, ECOL LETT, V8, P336, DOI 10.1111/j.1461-0248.2004.00715.x; Russell AL, 2008, J MAMMAL, V89, P209, DOI 10.1644/07-MAMM-A-044.1; Sandberger-Loua L, 2018, CONSERV GENET, V19, P169, DOI 10.1007/s10592-017-1029-4; Sarkar D., 2016, LATTICEEXTRA EXTRAGR; Scheld S, 2013, SALAMANDRA, V49, P186; Schemske DW, 2010, AM NAT, V176, pS4, DOI 10.1086/657060; Scherz MD, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75431-9; Scherz MD, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0219437; Schluter D, 2001, TRENDS ECOL EVOL, V16, P372, DOI 10.1016/S0169-5347(01)02198-X; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Schulze A, 2016, ACTA HERPETOL, V11, P119, DOI 10.13128/Acta_Herpetol-18009; Serb JM, 2011, ZOOL J LINN SOC-LOND, V163, P571, DOI 10.1111/j.1096-3642.2011.00707.x; Serrano JM, 2020, BIOACOUSTICS, V29, P572, DOI 10.1080/09524622.2019.1631214; Shafer ABA, 2013, ECOL LETT, V16, P940, DOI 10.1111/ele.12120; Simpson G. L., PERMUTE FUNCTIONS GE; Stanton DWG, 2019, CONSERV GENET, V20, P101, DOI 10.1007/s10592-019-01149-5; Sukumaran J, 2017, P NATL ACAD SCI USA, V114, P1607, DOI 10.1073/pnas.1607921114; Valero KCW, 2019, GENES-BASEL, V10, DOI 10.3390/genes10090646; Valero KCW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00155; Vazeille M, 2001, AM J TROP MED HYG, V65, P491, DOI 10.4269/ajtmh.2001.65.491; Vences M, 2003, AFR ZOOL, V38, P67; Vences M., 2018, TERRESTRIAL PROTECTE, V1st, P257; Vences M, 2018, ZOOTAXA, V4486, P575, DOI 10.11646/zootaxa.4486.4.10; Vences M, 2009, TRENDS ECOL EVOL, V24, P456, DOI 10.1016/j.tree.2009.03.011; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H., 2019, **DATA OBJECT**; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wilke CO., 2019, R package cowplot version 1.0.0; Wilkins MR, 2013, TRENDS ECOL EVOL, V28, P156, DOI 10.1016/j.tree.2012.10.002; Wolf S, 2013, SALAMANDRA, V49, P45; Wollenberg KC, 2008, EVOLUTION, V62, P1890, DOI 10.1111/j.1558-5646.2008.00420.x; Wollenberg KC, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-217	120	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0263764	10.1371/journal.pone.0263764	http://dx.doi.org/10.1371/journal.pone.0263764			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358210	gold, Green Published			2022-12-26	WOS:000799828800013
J	Tavoschi, L; Belardi, P; Mazzilli, S; Manenti, F; Pellizzer, G; Abebe, D; Azzimonti, G; Nsubuga, JB; Dall'Oglio, G; Vainieri, M				Tavoschi, Lara; Belardi, Paolo; Mazzilli, Sara; Manenti, Fabio; Pellizzer, Giampietro; Abebe, Desalegn; Azzimonti, Gaetano; Nsubuga, John Bosco; Dall'Oglio, Giovanni; Vainieri, Milena			An integrated hospital-district performance evaluation for communicable diseases in low-and middle-income countries: Evidence from a pilot in three sub-Saharan countries	PLOS ONE			English	Article							CARE; SYSTEMS; FRAMEWORK; PROGRAMS; AFRICA	Introduction The last two decades saw an extensive effort to design, develop and implement integrated and multidimensional healthcare evaluation systems in high-income countries. However, in low- and middle-income countries, few experiences of such systems implementation have been reported in the scientific literature. We developed and piloted an innovative evaluation tool to assess the performance of health services provision for communicable diseases in three sub-Saharan African countries. Material and methods A total of 42 indicators, 14 per each communicable disease care pathway, were developed. A sub-set of 23 indicators was included in the evaluation process. The communicable diseases care pathways were developed for Tuberculosis, Gastroenteritis, and HIV/AIDS, including indicators grouped in four care phases: prevention (or screening), diagnosis, treatment, and outcome. All indicators were calculated for the period 2017-2019, while performance evaluation was performed for the year 2019. The analysis involved four health districts and their relative hospitals in Ethiopia, Tanzania, and Uganda. Results Substantial variability was observed over time and across the four different districts. In the Tuberculosis pathway, the majority of indicators scored below the standards and below-average performance was mainly reported for prevention and diagnosis phases. Along the Gastroenteritis pathway, excellent performance was instead evaluated for most indicators and the highest scores were reported in prevention and treatment phases. The HIV/AIDS pathway indicators related to screening and outcome phases were below the average score, while good or excellent performance was registered within the treatment phase. Conclusions The bottom-up approach and stakeholders' engagement increased local ownership of the process and the likelihood that findings will inform health services performance and quality of care. Despite the intrinsic limitations of data sources, this framework may contribute to promoting good governance, performance evaluation, outcomes measurement and accountability in settings characterised by multiple healthcare service providers.	[Tavoschi, Lara] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Belardi, Paolo; Vainieri, Milena] St Anna Sch Adv Studies, Inst Management, Management & Healthcare Lab, Pisa, Italy; [Belardi, Paolo; Vainieri, Milena] St Anna Sch Adv Studies, Dept EMbeDS, Pisa, Italy; [Mazzilli, Sara] Scuola Normale Super Pisa, Pisa, Italy; [Manenti, Fabio; Pellizzer, Giampietro] Doctors Africa CUAMM, Padua, Italy; [Abebe, Desalegn] St Luke Wolisso Hosp, Doctors Africa CUAMM, Wolisso Catchment Area, Wolisso, Ethiopia; [Azzimonti, Gaetano] Tosamaganga Dist Designated Hosp, Iringa Dist Council, Doctors Africa CUAMM, Iringa, Tanzania; [Nsubuga, John Bosco] St Kizito Matany Hosp Napak Dist, Doctors Africa CUAMM, Matany, Uganda; [Dall'Oglio, Giovanni] Pope John XXIII Aber Hosp Oyam Dist, Doctors Africa CUAMM, Gulu, Uganda	University of Pisa; Scuola Superiore Sant'Anna; Scuola Superiore Sant'Anna; Scuola Normale Superiore di Pisa	Belardi, P (corresponding author), St Anna Sch Adv Studies, Inst Management, Management & Healthcare Lab, Pisa, Italy.; Belardi, P (corresponding author), St Anna Sch Adv Studies, Dept EMbeDS, Pisa, Italy.	p.belardi@santannapisa.it		Belardi, Paolo/0000-0002-8041-8989	Management and Health Laboratory of the Institute of Management of the Sant'Anna School of Advanced Studies; NGO Doctors with Africa CUAMM	Management and Health Laboratory of the Institute of Management of the Sant'Anna School of Advanced Studies; NGO Doctors with Africa CUAMM	This study was conducted within a research collaboration project funded by the Management and Health Laboratory of the Institute of Management of the Sant'Anna School of Advanced Studies and the NGO Doctors with Africa CUAMM. Both entities jointly worked on the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arah OA, 2003, INT J QUAL HEALTH C, V15, P377, DOI 10.1093/intqhc/mzg049; Bhattacharyya O, 2015, GLOBALIZATION HEALTH, V11, DOI 10.1186/s12992-015-0137-5; Chard AN, 2020, MMWR-MORBID MORTAL W, V69, P1706, DOI 10.15585/mmwr.mm6945a7; Diseases and Injuries Collaborators, 2020, LANCET, V396, P1204, DOI [10.1016/S0140-6736(20)30925-9, DOI 10.1016/S0140-6736(20)30925-9]; Fanelli S, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05179-5; Floyd K, 2013, LANCET GLOB HEALTH, V1, pE105, DOI 10.1016/S2214-109X(13)70032-9; Fox MP, 2010, TROP MED INT HEALTH, V15, P1, DOI 10.1111/j.1365-3156.2010.02508.x; Goodman DC, 2013, DARTMOUTH ATLAS CHIL; Gray M, 2017, J ROY SOC MED, V110, P434, DOI 10.1177/0141076817721099; Jha P, 2014, BMC MED, V12, DOI 10.1186/1741-7015-12-19; Kruk ME, 2018, LANCET GLOB HEALTH, V6, pE1196, DOI 10.1016/S2214-109X(18)30386-3; Li H, 2012, INT J QUAL HEALTH C, V24, P403, DOI 10.1093/intqhc/mzs032; Mbondji PE, 2014, J ROY SOC MED, V107, P34, DOI 10.1177/0141076814531750; Noto G, 2019, INT J HEALTH PLAN M, V34, P1408, DOI 10.1002/hpm.2803; Nuti S, 2018, MANAGE DECIS, V56, P2252, DOI 10.1108/MD-09-2017-0907; Nuti Sabina, 2017, Healthc Pap, V17, P56, DOI 10.12927/hcpap.2017.25408; Nuti S, 2016, HEALTH ECON POLICY L, V11, P17, DOI 10.1017/S1744133115000067; OECD, 2015, HLTH GLANC 2015 OECD, DOI [10.1787/health_glance-2015-34-en, DOI 10.1787/HEALTH_GLANCE-2015-EN, 10.1787/health_glance-2015-en]; OECD, 2019, IR COUNTR HLTH PROF; Resch S, 2015, LANCET GLOB HEALTH, V3, pE52, DOI 10.1016/S2214-109X(14)70342-0; Savedoff W., 2003, HLTH SYSTEMS PERFORM; Smith P.C., 2009, PERFORMANCE MEASUREM; Suthar AB, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-027689; UNAIDS, 2020, 90 90 90 AMB TREATM; UNAIDS, 2020, SEIZ MOM TACKL ENTR; Uplekar M, 2015, LANCET, V385, P1799, DOI 10.1016/S0140-6736(15)60570-0; Veillard J, 2005, INT J QUAL HEALTH C, V17, P487, DOI 10.1093/intqhc/mzi072; Veillard J, 2017, MILBANK Q, V95, P836, DOI 10.1111/1468-0009.12301; Westert GP, 2018, INT J QUAL HEALTH C, V30, P731, DOI 10.1093/intqhc/mzy092; WHO, 2015, WHO GLOB STRAT PEOPL; Wild L., 2012, COMMON CONSTRAINTS I; World Health Organisation, 2015, ACC PROGR HIV TUB MA; World Health Organization, 2020, GLOBAL TUBERCULOSIS; World Health Organization, 2013, CONSOLIDATED GUIDELI; World Health Organization, 2015, CONS STRAT INF GUID; World Health Organization, 2000, WORLD HLTH REP 2000; World Health Organization, 2019, PROGR REP HIV VIR HE; World Health Organization, 2016, US ANT DRUGS TREAT P; World Health Organization, 2015, KEY TB IND IND COUNT; World Health Organization, 2014, WHOHTMTB20141; World Health Organization UNICEF, 2018, COR QUEST IND MON WA; World Health Organization (WHO), 2018, INF PREV CONTR ASS F; World Health Organization (WHO), GLOB HLTH SECT STRAT	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266225	10.1371/journal.pone.0266225	http://dx.doi.org/10.1371/journal.pone.0266225			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358254	gold, Green Published			2022-12-26	WOS:000799828800081
J	Shirakihara, T; Yamaguchi, H; Kondo, T; Yashiro, M; Sakai, R				Shirakihara, Takuya; Yamaguchi, Hideki; Kondo, Tadashi; Yashiro, Masakazu; Sakai, Ryuichi			Transferrin receptor 1 promotes the fibroblast growth factor receptor-mediated oncogenic potential of diffused-type gastric cancer	ONCOGENE			English	Article							FGF RECEPTORS; CELL-LINES; K-SAM; PHOSPHORYLATION; CARCINOMA; SEQUENCE; MET; EXPRESSION; INHIBITOR; BINDING	Diffuse-type gastric cancer (DGC) is a highly invasive subtype of gastric adenocarcinoma that frequently exhibits scattered peritoneal metastasis. Previous studies have shown that the genes of receptor tyrosine kinases (RTKs), such as fibroblast growth factor receptor 2 (FGFR2) or Met, are amplified in some DGC cell lines, leading to the constitutive activation of corresponding RTKs. In these cell lines, the survival of cancer cells appears to be dependent on the activation of RTKs. To gain novel insights into the downstream signaling pathways of RTKs specific to DGC, phosphotyrosine-containing proteins associated with activated FGFR2 were purified through two sequential rounds of immunoprecipitation from the lysates of two DGC cell lines. As a result, transferrin receptor 1 (TfR1) was identified as the binding partner of FGFR2. Biochemical analysis confirmed that TfR1 protein binds to FGFR2 and is phosphorylated at tyrosine 20 (Tyr20) in an FGFR2 kinase activity-dependent manner. The knockdown of TfR1 and treatment with an inhibitor of FGFR2 caused significant impairment in iron uptake and suppression of cellular proliferation in vitro. Moreover, the suppression of expression levels of TfR1 in the DGC cells significantly reduced their tumorigenicity and potency of peritoneal dissemination. It was indicated that TfR1, when phosphorylated by the binding partner FGFR2 in DGC cells, promotes proliferation and tumorigenicity of these cancer cells. These results suggest that the control of TfR1 function may serve as a therapeutic target in DGC with activated FGFR2.	[Shirakihara, Takuya; Sakai, Ryuichi] Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa, Japan; [Yamaguchi, Hideki] Sasaki Fdn, Sasaki Inst, Dept Canc Cell Res, Tokyo, Japan; [Kondo, Tadashi] Natl Canc Ctr, Div Rare Canc Res, Tokyo, Japan; [Yashiro, Masakazu] Osaka City Univ, Grad Sch Med, Mol Oncol & Therapeut, Osaka, Japan	Kitasato University; National Cancer Center - Japan; Osaka Metropolitan University	Sakai, R (corresponding author), Kitasato Univ, Sch Med, Dept Biochem, Sagamihara, Kanagawa, Japan.	rsakai@kitasato-u.ac.jp		Sakai, Ryuichi/0000-0001-6833-1103; Shirakihara, Takuya/0000-0002-6222-0143; Yamaguchi, Hideki/0000-0003-2125-9655	JSPS KAKENHI [JP17K08648, JP18K07242, JP21K07105]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank Dr. Kazuyoshi Yanagihara (National Cancer Center, Japan) for providing 44As3 and 58As9 cell lines. This work was supported by JSPS KAKENHI Grants Numbers JP17K08648, JP18K07242, and JP21K07105.	Aisen P, 2004, INT J BIOCHEM CELL B, V36, P2137, DOI 10.1016/j.biocel.2004.02.007; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Cheng Y, 2004, CELL, V116, P565, DOI 10.1016/S0092-8674(04)00130-8; COLLAWN JF, 1993, J BIOL CHEM, V268, P21686; COLLAWN JF, 1990, CELL, V63, P1061, DOI 10.1016/0092-8674(90)90509-D; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Daniels TR, 2012, BBA-GEN SUBJECTS, V1820, P291, DOI 10.1016/j.bbagen.2011.07.016; Dieci MV, 2013, CANCER DISCOV, V3, P264, DOI 10.1158/2159-8290.CD-12-0362; FAULK WP, 1980, LANCET, V2, P390; GALBRAITH GMP, 1980, CELL IMMUNOL, V49, P215, DOI 10.1016/0008-8749(80)90072-6; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Hattori Y, 1996, CLIN CANCER RES, V2, P1373; HATTORI Y, 1990, P NATL ACAD SCI USA, V87, P5983, DOI 10.1073/pnas.87.15.5983; Helsten T, 2016, CLIN CANCER RES, V22, P259, DOI 10.1158/1078-0432.CCR-14-3212; Jabara HH, 2016, NAT GENET, V48, P74, DOI 10.1038/ng.3465; Jian JL, 2011, J BIOL CHEM, V286, P35708, DOI 10.1074/jbc.M111.271585; JING SQ, 1990, J CELL BIOL, V110, P283, DOI 10.1083/jcb.110.2.283; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kawabata H, 2001, BLOOD, V98, P2714, DOI 10.1182/blood.V98.9.2714; Kovalenko D, 2003, J BIOL CHEM, V278, P14087, DOI 10.1074/jbc.C200606200; Kuang YB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1528-y; Kumar N, 2007, PLOS COMPUT BIOL, V3, P35, DOI 10.1371/journal.pcbi.0030004; Kunii K, 2008, CANCER RES, V68, P2340, DOI 10.1158/0008-5472.CAN-07-5229; KUNIYASU H, 1992, BIOCHEM BIOPH RES CO, V189, P227, DOI 10.1016/0006-291X(92)91548-5; Lawrence CM, 1999, SCIENCE, V286, P779, DOI 10.1126/science.286.5440.779; Liu YJ, 2014, BRIT J CANCER, V110, P1169, DOI 10.1038/bjc.2014.61; Mattiuzzi C, 2019, J EPIDEMIOL GLOB HEA, V9, P217, DOI 10.2991/jegh.k.191008.001; Nakamura K, 2006, GASTROENTEROLOGY, V131, P1530, DOI 10.1053/j.gastro.2006.08.030; NAKATANI H, 1990, JPN J CANCER RES, V81, P707, DOI 10.1111/j.1349-7006.1990.tb02631.x; NECKERS LM, 1986, CANCER INVEST, V4, P461, DOI 10.3109/07357908609017524; Porebska N, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010007; Qiu H, 2009, CANCER SCI, V100, P181, DOI 10.1111/j.1349-7006.2008.01004.x; Shen Y, 2018, AM J CANCER RES, V8, P916; Shirakihara T, 2007, MOL BIOL CELL, V18, P3533, DOI 10.1091/mbc.E07-03-0249; Shirakihara T, 2011, EMBO J, V30, P783, DOI 10.1038/emboj.2010.351; TAETLE R, 1986, CANCER RES, V46, P1759; Torti SV, 2020, CANCER RES, V80, P5435, DOI 10.1158/0008-5472.CAN-20-2017; Torti SV, 2013, NAT REV CANCER, V13, P342, DOI 10.1038/nrc3495; Tsang M, 2002, NAT CELL BIOL, V4, P165, DOI 10.1038/ncb749; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wiederschain D, 2009, CELL CYCLE, V8, P498, DOI 10.4161/cc.8.3.7701; Xue X, 2016, CELL METAB, V24, P447, DOI 10.1016/j.cmet.2016.07.015; Yamaguchi H, 2014, CANCER SCI, V105, P528, DOI 10.1111/cas.12387; Yanagihara K, 2005, CANCER SCI, V96, P323, DOI 10.1111/j.1349-7006.2005.00054.x; Yashiro M, 1996, CLIN EXP METASTAS, V14, P43, DOI 10.1007/BF00157685	45	2	2	2	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2587	2596		10.1038/s41388-022-02270-5	http://dx.doi.org/10.1038/s41388-022-02270-5		MAR 2022	10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35338344				2022-12-26	WOS:000780349900001
J	Ghaffar, N; Javad, S; Farrukh, MA; Shah, AA; Gatasheh, MK; Al-Munqedhi, BMA; Chaudhry, O				Ghaffar, Nadia; Javad, Sumera; Farrukh, Muhammad Akhyar; Shah, Anis Ali; Gatasheh, Mansour K.; Al-Munqedhi, Bander M. A.; Chaudhry, Ozair			Metal nanoparticles assisted revival of Streptomycin against MDRS Staphylococcus aureus	PLOS ONE			English	Article							SILVER NANOPARTICLES; GOLD NANOPARTICLES; OXIDE NANOPARTICLES; IN-VITRO; MECHANISM; EFFICACY; CELLS; SHAPE; SIZE	The ability of microorganisms to generate resistance outcompetes with the generation of new and efficient antibiotics. Therefore, it is critically required to develop novel antibiotic agents and treatments to control bacterial infections. Green synthesized metallic and metal oxide nanoparticles are considered as the potential means to target bacteria as an alternative to antibiotics. Nanoconjugates have also attracted attention because of their increased biological activity as compared to free antibiotics. In the present investigation, silver nanoparticles (AgNPs), zinc oxide nanoparticles (ZnO NPs), copper oxide nanoparticles (CuO NPs), and iron oxide nanoparticles (FeO NPs) have been synthesized by using leaf extract of Ricinus communis. Characterization of nanoparticles was done by using UV-Vis Spectroscopy, Fourier Transform Infrared Spectroscopy, Scanning Electron Microscopy, Energy Dispersive X-Ray Analyzer, X-ray Diffraction Analysis, and Dynamic Light Scattering Particle Size Analyzer. Interestingly, Streptomycin when combined with AgNPs, ZnO NPs, CuO NPs, and FeO NPs showed enhanced antibacterial activity against clinical isolates of S. aureus which suggested synergism between the nanoparticles and antibiotics. The highest enhanced antibacterial potential of Streptomycin was observed in conjugation with ZnO NPs (11 +/- 0.5 mm) against S. aureus. Minimum inhibitory concentration of conjugates of AgNPs, ZnO NPs, CuO NPs, and FeO NPs with streptomycin against S. aureus was found to be 3.12, 2.5,10, and 12.5 mu g/mL respectively. The considerable point of the present investigation is that S. aureus, which was resistant to streptomycin becomes highly susceptible to the same antibiotic when combined with nanoparticles. This particular observation opens up windows to mitigate the current crisis due to antibiotic resistance to combat antimicrobial infections efficiently.	[Ghaffar, Nadia; Javad, Sumera] Lahore Coll Women Univ, Dept Bot, Lahore, Pakistan; [Farrukh, Muhammad Akhyar] Forman Christian Coll, Dept Chem, Lahore, Pakistan; [Shah, Anis Ali] Univ Educ, Dept Bot, Lahore, Pakistan; [Gatasheh, Mansour K.] King Saud Univ, Coll Sci, Dept Biochem, Riyadh, Saudi Arabia; [Al-Munqedhi, Bander M. A.] King Saud Univ, Coll Sci, Dept Botony & Microbiol, Riyadh, Saudi Arabia; [Chaudhry, Ozair] Ontario Inst Agrologist, Harriston, ON, Canada	King Saud University; King Saud University	Javad, S (corresponding author), Lahore Coll Women Univ, Dept Bot, Lahore, Pakistan.	zif_4@yahoo.com	Gatasheh, Mansour K./AAP-9414-2021; Farrukh, Muhammad Akhyar/P-1164-2015	Gatasheh, Mansour K./0000-0002-0101-1014; Farrukh, Muhammad Akhyar/0000-0002-1118-8657; Shah, Anis/0000-0003-2071-9939; javad, sumera/0000-0002-4703-9610	King Saud University, Riyadh, Saudi Arabia [RSP2021/393]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	Mansour K. Gatasheh and Bander M. ALMunqedhi received funding in the form of salary from King Saud University, Riyadh, Saudi Arabia. The source of funding was Project Number (RSP2021/393), King Saud University, Riyadh, Saudi Arabia. SEM and particle size analyzer facilities were used from Centre for Advance Studies in Physics (CASP) Govt. College University, (GCU) Lahore, Pakistan. Funders were involved in software bases statistical analysis along with the manuscript writing and its proof reading. The funders had no additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abbaszadegan A, 2015, J NANOMATER, V2015, DOI 10.1155/2015/720654; Ahmad W, 2020, J KING SAUD UNIV SCI, V32, P2358, DOI 10.1016/j.jksus.2020.03.014; Allahverdiyev AM, 2011, EXPERT REV ANTI-INFE, V9, P1035, DOI [10.1586/eri.11.121, 10.1586/ERI.11.121]; Amutha S., 2018, J INNOV PHARM BIOL S, V5, P22; Ann LC, 2014, CERAM INT, V40, P2993, DOI 10.1016/j.ceramint.2013.10.008; Aremu OS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93978-z; Baker SK, 2018, P NATL ACAD SCI USA, V115, pE9687, DOI [10.1073/pnas.1717160115, 10.1073/pnas.1811172115]; Banerjee S, 2020, COLLOID SURFACE B, V190, DOI 10.1016/j.colsurfb.2020.110921; Becker K, 2021, TOXINS, V13, DOI 10.3390/toxins13010061; Borrego B, 2016, NANOMED-NANOTECHNOL, V12, P1185, DOI 10.1016/j.nano.2016.01.021; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen LQ, 2015, CHEM RES TOXICOL, V28, P501, DOI 10.1021/tx500479m; Cheon JY, 2019, INT J NANOMED, V14, P2773, DOI 10.2147/IJN.S196472; Chopra I, 2007, J ANTIMICROB CHEMOTH, V59, P587, DOI 10.1093/jac/dkm006; Cui L, 2013, ANAL CHEM, V85, P5436, DOI 10.1021/ac400245j; Cui Y, 2012, BIOMATERIALS, V33, P2327, DOI 10.1016/j.biomaterials.2011.11.057; Darmanin S, 2009, NAT PROD RES, V23, P561, DOI 10.1080/14786410802228579; Dilnawaz F, 2018, INT J PHARMACEUT, V538, P263, DOI 10.1016/j.ijpharm.2018.01.016; Duran N, 2010, J BRAZIL CHEM SOC, V21, P949, DOI 10.1590/S0103-50532010000600002; Dye C, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0426; Eslami S, 2018, RSC ADV, V8, P26156, DOI 10.1039/c8ra04451a; Filippi A, 2017, AIP CONF PROC, V1873, DOI 10.1063/1.4997133; Foster TJ, 2017, FEMS MICROBIOL REV, V41, P430, DOI 10.1093/femsre/fux007; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; Grace A.N., 2007, BIONANOSCIENCE, V1, P96, DOI DOI 10.1166/JBNS.2007.018; Harshinya M, 2015, ECOTOXICO ENV SAFETY, V3, P231; Isenberg HD., 2004, CLIN MICROBIOLOGY PR, V2; Jones RN, 2007, DIAGN MICR INFEC DIS, V59, P309, DOI 10.1016/j.diagmicrobio.2007.06.004; Kalita S, 2016, MAT SCI ENG C-MATER, V61, P720, DOI 10.1016/j.msec.2015.12.078; Lara HH, 2011, J NANOBIOTECHNOL, V9, DOI 10.1186/1477-3155-9-30; Li P, 2005, NANOTECHNOLOGY, V16, P1912, DOI 10.1088/0957-4484/16/9/082; Li WR, 2011, BIOMETALS, V24, P135, DOI 10.1007/s10534-010-9381-6; Ling DS, 2013, SMALL, V9, P1450, DOI 10.1002/smll.201202111; Luther MK, 2018, CRIT CARE MED, V46, P12, DOI 10.1097/CCM.0000000000002769; Mohsen E, 2020, J RADIAT RES APPL SC, V13, P416, DOI 10.1080/16878507.2020.1748941; Neil J., 2016, REPORT ANTIMICROBIAL; Nesme J, 2015, ENVIRON MICROBIOL, V17, P913, DOI 10.1111/1462-2920.12631; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Nishanthi R, 2019, MAT SCI ENG C-MATER, V96, P693, DOI 10.1016/j.msec.2018.11.050; Parvekar P, 2020, INT BIOMON, V10, P0976; Pauksch L, 2014, ACTA BIOMATER, V10, P439, DOI 10.1016/j.actbio.2013.09.037; Pelgrift RY, 2013, ADV DRUG DELIVER REV, V65, P1803, DOI 10.1016/j.addr.2013.07.011; Tran QH, 2013, ADV NAT SCI-NANOSCI, V4, DOI 10.1088/2043-6262/4/3/033001; Rai MK, 2012, J APPL MICROBIOL, V112, P841, DOI 10.1111/j.1365-2672.2012.05253.x; Rautela A, 2019, J ANAL SCI TECHNOL, V10, DOI 10.1186/s40543-018-0163-z; Romero-Urbina DG, 2015, BEILSTEIN J NANOTECH, V6, P2396, DOI 10.3762/bjnano.6.246; Roshmi T, 2015, GOLD BULL, V48, P63, DOI 10.1007/s13404-015-0162-4; Morones-Ramirez JR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006276; Rudramurthy GR, 2016, MOLECULES, V21, DOI 10.3390/molecules21070836; Salar RK, 2015, RES EFFICIENT TECHNO, V1, P106, DOI DOI 10.1016/J.REFFIT.2015.11.004; Santos-Magalhaes NS, 2010, ADV DRUG DELIVER REV, V62, P560, DOI 10.1016/j.addr.2009.11.024; Sathishkumar P, 2016, J PHOTOCH PHOTOBIO B, V163, P69, DOI 10.1016/j.jphotobiol.2016.08.005; Selim YA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60541-1; Selvaraj V, 2019, J NANOSTRUCTURE CHEM, V9, P153, DOI 10.1007/s40097-019-0306-9; Shaker MA, 2017, INT J PHARMACEUT, V525, P71, DOI 10.1016/j.ijpharm.2017.04.019; Sharma P, 2018, J POLYM ENVIRON, V26, P1795, DOI 10.1007/s10924-017-1081-7; Sharma S, 2019, B MATER SCI, V43, DOI 10.1007/s12034-019-1986-y; Shruthi TS, 2019, MATER TODAY-PROC, V10, P8, DOI 10.1016/j.matpr.2019.02.181; Singh NB, 2015, ADV SCI LETT, V21, P2635, DOI 10.1166/asl.2015.6430; Singh PP, 2009, FOOD CHEM, V114, P1069, DOI 10.1016/j.foodchem.2008.10.020; Slomberg DL, 2013, ACS APPL MATER INTER, V5, P9322, DOI 10.1021/am402618w; Tanomsridachchai W, 2021, ANTIBIOTICS-BASEL, V10, DOI 10.3390/antibiotics10020206; Wang N, 2020, J ETHNOPHARMACOL, V250, DOI 10.1016/j.jep.2019.112467; Weissig V, 2014, INT J NANOMED, V9, P4357, DOI 10.2147/IJN.S46900; Wu DM, 2014, J ENDODONT, V40, P285, DOI 10.1016/j.joen.2013.08.022; Yousaf H, 2020, MAT SCI ENG C-MATER, V112, DOI 10.1016/j.msec.2020.110901; Yu F, 2016, CHEM-EUR J, V10, P1002; Zhang YW, 2008, J COLLOID INTERF SCI, V325, P371, DOI 10.1016/j.jcis.2008.05.063; Zook JM, 2011, NANOTOXICOLOGY, V5, P517, DOI 10.3109/17435390.2010.536615	69	5	5	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264588	10.1371/journal.pone.0264588	http://dx.doi.org/10.1371/journal.pone.0264588			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324924	Green Published, gold			2022-12-26	WOS:000780951300017
J	Colosimo, G; Gentile, G; Vera, CA; Sevilla, C; Gerber, GP; Westermeyer, HD; Lewbart, GA				Colosimo, Giuliano; Gentile, Gabriele; Vera, Carlos A.; Sevilla, Christian; Gerber, Glenn P.; Westermeyer, Hans D.; Lewbart, Gregory A.			Conservation of a flagship species: Health assessment of the pink land iguana, Conolophus marthae	PLOS ONE			English	Article							VALUES; HEMATOLOGY	The pink land iguana, Conolophus marthae, is one of four species of iguanas (three terrestrial and one marine) in the Galapagos Islands, and the only one listed as critically endangered by the IUCN. The species can only be found on the north-west slopes of the highest volcano on Isabela Island and was first described to science in 2009. As part of a population telemetry study, a health assessment was authorized by the Galapagos National Park. Wild adult iguanas were captured on Wolf Volcano in September 2019 and April 2021 to record morphological and physiological parameters including body temperature, heart rate, intraocular pressures, tear formation, and infrared iris images. Blood samples were also collected and analyzed. An i-STAT portable blood analyzer was used to obtain values for base excess in the extracellular fluid compartment (BEecf), glucose (Glu), hematocrit (HctPCV), hemoglobin (Hb), ionized calcium (iCa), partial pressure of carbon dioxide (pCO(2)), partial pressure of oxygen (pO(2))(,) percent oxygen saturation (sO(2)%), pH, potassium (K), and sodium (Na). When possible, data were compared to previously published and available data for the other Galapagos iguanas. The results reported here provide baseline values that will be useful in detecting changes in health status among pink land iguanas affected by climate change, invasive species, anthropogenic threats, or natural disturbances. The collected data also provide an invaluable resource for conservation scientists planning to implement conservation strategies, like translocations, that may temporarily alter these baseline values.	[Colosimo, Giuliano; Gentile, Gabriele] Tor Vergata Univ, Dept Biol, Rome, Italy; [Colosimo, Giuliano; Gerber, Glenn P.] San Diego Zoo Wildlife Alliance, Escondido, CA USA; [Vera, Carlos A.; Sevilla, Christian] Tech Biodivers Res, Direcc Parque Nacl Galapagos, Puerto Ayora, Galapagos, Ecuador; [Westermeyer, Hans D.; Lewbart, Gregory A.] North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA; [Lewbart, Gregory A.] Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Quito, Ecuador; [Lewbart, Gregory A.] Galapagos Sci Ctr GSC, Isla San Cristobal, Galapagos, Ecuador	University of Rome Tor Vergata; University of North Carolina; North Carolina State University	Lewbart, GA (corresponding author), North Carolina State Univ, Coll Vet Med, Raleigh, NC 27695 USA.; Lewbart, GA (corresponding author), Univ San Francisco Quito USFQ, Colegio Ciencias Biol & Ambientales, Quito, Ecuador.; Lewbart, GA (corresponding author), Galapagos Sci Ctr GSC, Isla San Cristobal, Galapagos, Ecuador.	greg_lewbart@ncsu.edu	; Gentile, Gabriele/E-8945-2013	Colosimo, Giuliano/0000-0002-0485-9758; Gentile, Gabriele/0000-0002-1045-6816; Lewbart, Gregory/0000-0003-0716-1387				Alberts AC, 1998, ANIM CONSERV, V1, P165, DOI 10.1111/j.1469-1795.1998.tb00025.x; Arguedas R, 2018, CONSERV PHYSIOL, V6, DOI 10.1093/conphys/coy046; Campbell T. W., 2007, AVIAN EXOTIC ANIMAL; Colosimo G, 2021, J HERED, V112, P590, DOI 10.1093/jhered/esab058; Colosimo G, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71176-7; Dallwig RK, 2011, J ZOO WILDLIFE MED, V42, P205, DOI 10.1638/2008-0202.1; Dennis PM, 2001, J AM VET MED ASSOC, V219, P326, DOI 10.2460/javma.2001.219.326; Di Giambattista L, 2018, CONSERV GENET, V19, P1461, DOI 10.1007/s10592-018-1114-3; Dickens MJ, 2010, BIOL CONSERV, V143, P1329, DOI 10.1016/j.biocon.2010.02.032; Divers SJ, 1996, VET REC, V138, P203, DOI 10.1136/vr.138.9.203; Fabiani A, 2011, ANIM CONSERV, V14, P419, DOI 10.1111/j.1469-1795.2011.00442.x; Geffre A, 2009, VET CLIN PATH, V38, P288, DOI 10.1111/j.1939-165X.2009.00179.x; Gentile G., 2016, CONSERVATION NEW FLA, P315; Gentile G, 2009, ZOOTAXA, P1; Gentile G, 2009, P NATL ACAD SCI USA, V106, P507, DOI 10.1073/pnas.0806339106; Harr KE, 2001, J AM VET MED ASSOC, V218, P915, DOI 10.2460/javma.2001.218.915; Harter TS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov021; Harter TS, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov002; Harter TS, 2014, CONSERV PHYSIOL, V2, DOI 10.1093/conphys/cou037; Hernandez-Divers SJ, 2005, J ZOO WILDLIFE MED, V36, P155, DOI 10.1638/03-120.1; IUCN, 2016, NARDOSTACHYS JATAMAN, DOI DOI 10.2305/IUCN.UK.20213.RLTS.T50126627A88304158.EN; James Stephanie B., 2006, Journal of Herpetological Medicine and Surgery, V16, P93; Klaphake E., 2017, REPTILES, V5th Edition; Lewbart GA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222884; Lewbart GA, 2015, CONSERV PHYSIOL, V3, DOI 10.1093/conphys/cov034; Loreti P, 2020, ANIM BIOTELEM, V8, DOI 10.1186/s40317-020-0192-4; Loreti P, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19050985; Maria R, 2007, J ZOO WILDLIFE MED, V38, P414, DOI 10.1638/1042-7260(2007)38[414:BRIAIM]2.0.CO;2; McCoy ED, 2014, ANIM CONSERV, V17, P56, DOI 10.1111/acv.12145; Nardini Giordano, 2013, Vet Clin North Am Exot Anim Pract, V16, P1, DOI 10.1016/j.cvex.2012.09.001; Onorati M, 2017, ECOL EVOL, V7, P6046, DOI 10.1002/ece3.3077; Peig J, 2009, OIKOS, V118, P1883, DOI 10.1111/j.1600-0706.2009.17643.x; RCore Team, 2020, R LANG ENV STAT COMP; Verissimo D, 2014, CONSERV LETT, V7, P263, DOI 10.1111/conl.12070; Wagner RA, 1999, AM J VET RES, V60, P201; Warton DI, 2012, METHODS ECOL EVOL, V3, P257, DOI 10.1111/j.2041-210X.2011.00153.x	36	1	1	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0257179	10.1371/journal.pone.0257179	http://dx.doi.org/10.1371/journal.pone.0257179			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349571	gold, Green Published			2022-12-26	WOS:000783906500014
J	Kang, MK; Nam, KW; Shin, JH; Kwon, HM; Lee, YS				Kang, Min Kyoung; Nam, Ki-Woong; Shin, Jung Hwan; Kwon, Hyung-Min; Lee, Yong-Seok			Cardiovascular risk scores in asymptomatic carotid stenosis: A validation study with ultrasonographic parameters	PLOS ONE			English	Article							INTIMA-MEDIA THICKNESS; HEART-DISEASE RISK; ARTERY STENOSIS; ATHEROSCLEROSIS RISK; GENERAL-POPULATION; PREDICTION; STROKE; ULTRASOUND; EVENTS; PLAQUE	We evaluated the feasibility of the Framingham stroke risk score (FSRS) and atherosclerotic cardiovascular disease (ASCVD) risk scores for asymptomatic carotid stenosis (ACS). In addition, we developed novel risk prediction models for ischemic stroke and composite outcomes by combining ultrasonographic parameters and conventional cardiovascular risk scores. We retrospectively enrolled 612 patients with ACS greater than 50% over 7 years and evaluated them using transcranial Doppler and carotid duplex ultrasonography. In total, 150 patients were included in the analysis. During the mean 5-year follow-up, 6 ischemic strokes and 25 composite events were detected. Among all ultrasonographic parameters, only a higher peak-systolic velocity/end-diastolic velocity ratio was detected and significantly associated with an increased risk of relevant ischemic stroke (hazard ratio: 1.502, 95% confidence interval: 1.036-1.968). The C-statistics of the FSRS and ASCVD risk scores were 0.646 and 0.649, respectively, for relevant ischemic stroke, and 0.612 and 0.649, respectively, for composite outcomes. C-statistics of the FSRS and ASCVD risk scores combined with ultrasonographic parameters increased to 0.937 and 0.941, respectively, for ischemic stroke, and 0.856 and 0.886, respectively, for composite outcomes. The study suggests that inclusion of ultrasonographic parameters in conventional cardiovascular scores helps identify the risk of further vascular events in ACS patients.	[Kang, Min Kyoung] Uijeongbu Eulji Med Ctr, Dept Neurol, Uijongbu, South Korea; [Nam, Ki-Woong; Kwon, Hyung-Min; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea; [Shin, Jung Hwan; Kwon, Hyung-Min; Lee, Yong-Seok] Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Lee, YS (corresponding author), Seoul Natl Univ, Dept Neurol, Seoul Metropolitan Govt, Boramae Med Ctr, Seoul, South Korea.; Lee, YS (corresponding author), Seoul Natl Univ, Dept Neurol, Coll Med, Seoul, South Korea.	mercades@snu.ac.kr		MinKyoung, Kang/0000-0002-3598-8165	clinical research grant fromSMG-SNUBMC [30-2019-89]	clinical research grant fromSMG-SNUBMC	This work was supported by a clinical research grant from SMG-SNUBMC (30-2019-89). The funding organization had no role in the design, conduct, or preparation of this report.	Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; [Anonymous], 1978, World Health Organ Tech Rep Ser, P7; [Anonymous], 1995, JAMA-J AM MED ASSOC, V273, P1421; [Anonymous], 2016, J NEUROSONOL, V8, P1; Avolio A, 2018, CURR HYPERTENS REP, V20, DOI 10.1007/s11906-018-0822-x; Bos MJ, 2007, STROKE, V38, P2453, DOI 10.1161/STROKEAHA.107.483073; Chambless LE, 1996, ULTRASOUND MED BIOL, V22, P545, DOI 10.1016/0301-5629(96)00039-7; Chia YC, 2014, BMC CARDIOVASC DISOR, V14, DOI 10.1186/1471-2261-14-163; Chung H, 2016, KOREAN CIRC J, V46, P72, DOI 10.4070/kcj.2016.46.1.72; Cleeman JI, 2001, JAMA-J AM MED ASSOC, V285, P2486, DOI 10.1001/jama.285.19.2486; Corrado E, 2006, STROKE, V37, P482, DOI 10.1161/01.STR.0000198813.56398.14; D'Agostino RB, 2008, CIRCULATION, V117, P743, DOI 10.1161/CIRCULATIONAHA.107.699579; de Weerd M, 2014, STROKE, V45, P2366, DOI 10.1161/STROKEAHA.114.005145; de Weerd M, 2010, STROKE, V41, P1294, DOI 10.1161/STROKEAHA.110.581058; de Weerd M, 2009, STROKE, V40, P1105, DOI 10.1161/STROKEAHA.108.532218; den Hartog AG, 2013, STROKE, V44, P1002, DOI 10.1161/STROKEAHA.111.669267; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Giannoukas AD, 2016, EUR J VASC ENDOVASC, V52, P309, DOI 10.1016/j.ejvs.2016.04.013; Goff DC, 2014, J AM COLL CARDIOL, V63, P2935, DOI [10.1016/j.jacc.2013.11.005, 10.1161/01.cir.0000437741.48606.98]; GOLDSTEIN MR, 1995, JAMA-J AM MED ASSOC, V274, P1505, DOI 10.1001/jama.1995.03530190019015; Grant EG, 2003, RADIOLOGY, V229, P340, DOI 10.1148/radiol.2292030516; Greenland P, 2004, JAMA-J AM MED ASSOC, V291, P210, DOI 10.1001/jama.291.2.210; Guan JX, 2013, INTERV NEUROL, V2, P8, DOI 10.1159/000354732; Halliday A, 2010, LANCET, V376, P1074, DOI 10.1016/S0140-6736(10)61197-X; Hirai H, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39049-w; HUNINK MGM, 1993, AM J ROENTGENOL, V160, P619, DOI 10.2214/ajr.160.3.8430567; Inzitari D, 2000, NEW ENGL J MED, V342, P1693, DOI 10.1056/NEJM200006083422302; Jung KJ, 2015, ATHEROSCLEROSIS, V242, P367, DOI 10.1016/j.atherosclerosis.2015.07.033; Kakadiaris IA, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009476; KNOX RA, 1982, BRIT J SURG, V69, P230, DOI 10.1002/bjs.1800690421; Kwater A, 2009, BLOOD PRESSURE, V18, P130, DOI 10.1080/08037050902975114; Kwon H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23125-8; Lee S-J., 2018, J NEUROSONOL NEUROIM, V10, P47, DOI [10.31728/jnn.2018.00023, DOI 10.31728/JNN.2018.00023]; LI RL, 1994, STROKE, V25, P2377, DOI 10.1161/01.STR.25.12.2377; Liu J, 2004, JAMA-J AM MED ASSOC, V291, P2591, DOI 10.1001/jama.291.21.2591; Lloyd-Jones DM, 2019, CIRCULATION, V139, pE1162, DOI 10.1161/CIR.0000000000000638; Muntner P, 2014, JAMA-J AM MED ASSOC, V311, P1406, DOI 10.1001/jama.2014.2630; Nam KW, 2020, EUR J NEUROL, V27, P793, DOI 10.1111/ene.14155; Nambi V, 2012, EUR HEART J, V33, P183, DOI 10.1093/eurheartj/ehr192; Nambi V, 2010, J AM COLL CARDIOL, V55, P1600, DOI 10.1016/j.jacc.2009.11.075; Nicolaides AN, 1996, J ENDOVASC SURG, V3, P158, DOI 10.1583/1074-6218(1996)003<0158:AADGIC>2.0.CO;2; O'Leary DH, 1999, NEW ENGL J MED, V340, P14, DOI 10.1056/NEJM199901073400103; Oates CP, 2009, EUR J VASC ENDOVASC, V37, P251, DOI 10.1016/j.ejvs.2008.10.015; Plantinga Y, 2009, EUR J CARDIOV PREV R, V16, P639, DOI 10.1097/HJR.0b013e3283312ece; Schmidt C, 2003, J INTERN MED, V253, P430, DOI 10.1046/j.1365-2796.2003.01129.x; Shah T, 2009, INT J EPIDEMIOL, V38, P217, DOI 10.1093/ije/dyn217; Singh TD, 2015, CEREBROVASC DIS, V40, P236, DOI 10.1159/000439179; Touboul PJ, 2012, CEREBROVASC DIS, V34, P290, DOI 10.1159/000343145; von Reutern GM, 2012, STROKE, V43, P916, DOI 10.1161/STROKEAHA.111.636084; Webb AJS, 2012, STROKE, V43, P2631, DOI 10.1161/STROKEAHA.112.655837; WOLF PA, 1991, STROKE, V22, P312, DOI 10.1161/01.STR.22.3.312	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265732	10.1371/journal.pone.0265732	http://dx.doi.org/10.1371/journal.pone.0265732			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363777	Green Published, gold			2022-12-26	WOS:000804748600011
J	Kotajarvi, J; Tolppanen, AM; Hartikainen, J; Miettinen, H; Viljakainen, M; Martikainen, J; Roine, RP; Lavikainen, P				Kotajarvi, Jarno; Tolppanen, Anna-Maija; Hartikainen, Juha; Miettinen, Heikki; Viljakainen, Marketta; Martikainen, Janne; Roine, Risto P.; Lavikainen, Piia			Correlation of the disease-specific Canadian Cardiovascular Society (CCS) classification and health-related quality of life (15D) in coronary artery disease patients	PLOS ONE			English	Article							EMERGING GOOD PRACTICES; OUTCOME ASSESSMENTS; CLINICAL-OUTCOMES; INSTRUMENTS; VALIDITY; SF-6D	BackgroundGeneric health-related quality of life (HRQoL) and disease-specific instruments measure HRQoL from different aspects, although generic instruments often contain dimensions that reflect common symptoms. We evaluated how the change in 15D HRQoL and Canadian Cardiovascular Society (CCS) grading of angina severity correlate among coronary artery disease patients during 12-month follow-up. MethodsAltogether 1 271 patients scheduled for coronary angiography between June 2015 and February 2017 returned the 15D HRQoL and CCS questionnaires before angiography and after one-year follow-up as a part of routine clinical practice. Spearman correlations between one-year changes in the CCS and the 15D and its dimensions were evaluated. Changes in 15D were classified into 5 categories based on the reported minimal important difference (MID) for the instrument. ResultsChange in the CCS grade correlated moderately with the MID-based change in the 15D (r = 0.33, 95% confidence interval 0.27-0.39). Correlations between these instruments were similar in different age groups, between sexes and treatment modalities. Of the individual 15D dimensions, changes in breathing (r = 0.40) and vitality (r = 0.30) had the strongest correlations with CCS change. ConclusionThe symptom-based evaluation of the change in the CCS grade may not catch the full benefit or harm of the treatment and vice versa, a generic instrument, such as 15D, likely does not fully capture change in disease-specific symptoms. Thus, generic and disease-specific instruments are complementary and should be used in conjunction.	[Kotajarvi, Jarno; Roine, Risto P.] Univ Eastern Finland, Dept Hlth & Social Management, Kuopio, Finland; [Tolppanen, Anna-Maija] Univ Eastern Finland, Kuopio Res Ctr Geriatr Care, Kuopio, Finland; [Tolppanen, Anna-Maija; Martikainen, Janne; Lavikainen, Piia] Univ Eastern Finland, Sch Pharm, Kuopio, Finland; [Hartikainen, Juha; Miettinen, Heikki; Viljakainen, Marketta; Lavikainen, Piia] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland; [Hartikainen, Juha] Univ Eastern Finland, Sch Med, Kuopio, Finland; [Roine, Risto P.] Kuopio Univ Hosp, Kuopio, Finland	University of Eastern Finland; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Lavikainen, P (corresponding author), Univ Eastern Finland, Sch Pharm, Kuopio, Finland.; Lavikainen, P (corresponding author), Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland.	piia.lavikainen@uef.fi		Lavikainen, Piia/0000-0003-3560-8860	State Clinical Research Fund (VTR) of Kuopio University Hospital [13.11.2014/19]	State Clinical Research Fund (VTR) of Kuopio University Hospital	This study received funding from the State Clinical Research Fund (VTR) of Kuopio University Hospital (award number 13.11.2014/19 ). The funder provided support in the form of salaries for authors [study nurse MV], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Aaronson N., USERS GUIDE IMPLEMEN; Alanne S, 2015, QUAL LIFE RES, V24, P599, DOI 10.1007/s11136-014-0787-4; Bennett JA, 2002, HEART LUNG, V31, P262, DOI 10.1067/mhl.2002.124554; Brazier JE, 2010, EUR J HEALTH ECON, V11, P215, DOI 10.1007/s10198-009-0168-z; CAMPEAU L, 1976, CIRCULATION, V54, P522, DOI 10.1161/circ.54.3.947585; Campeau L, 2002, CAN J CARDIOL, V18, P371; Fisher J D, 1972, Arch Intern Med, V129, P836; Gamst-Klaussen T, 2016, QUAL LIFE RES, V25, P1667, DOI 10.1007/s11136-015-1212-3; Goldsmith KA, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-96; Guyatt GH, 2002, MAYO CLIN PROC, V77, P371, DOI 10.4065/77.4.371; Heiskanen J, 2017, J COMP EFFECT RES, V6, P583, DOI 10.2217/cer-2016-0091; Izawa Kazuhiro P, 2005, J Jpn Phys Ther Assoc, V8, P39, DOI 10.1298/jjpta.8.39; Kaplan RM, 2003, QUAL LIFE RES, V12, P3, DOI 10.1023/A:1023547632545; Kaul P, 2009, CAN J CARDIOL, V25, pE225, DOI 10.1016/S0828-282X(09)70506-9; Khamis H, 2008, J DIAGN MED SONOG, V24, P155, DOI 10.1177/8756479308317006; Knuuti J, 2020, EUR HEART J, V41, P407, DOI 10.1093/eurheartj/ehz425; Kularatna S, 2017, QUAL LIFE RES, V26, P3399, DOI 10.1007/s11136-017-1666-6; Loponen P, 2009, SCAND CARDIOVASC J, V43, P94, DOI 10.1080/14017430802395450; Malkin CJ, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2011-000540; Nordic Medico-Statistical Committee, NOMESCO CLASS SURG P; Oinasmaa S, 2018, EUR HEART J-QUAL CAR, V4, P113, DOI 10.1093/ehjqcco/qcx038; Owlia M, 2019, J AM HEART ASSOC, V8, DOI 10.1161/JAHA.119.012811; PATRICK DL, 1989, MED CARE, V27, pS217, DOI 10.1097/00005650-198903001-00018; Powers JH, 2017, VALUE HEALTH, V20, P2, DOI 10.1016/j.jval.2016.11.005; Rothman M, 2009, VALUE HEALTH, V12, P1075, DOI 10.1111/j.1524-4733.2009.00603.x; Saarni SI, 2007, J CLIN EPIDEMIOL, V60, P1288, DOI 10.1016/j.jclinepi.2007.03.004; Sintonen H, 2001, ANN MED, V33, P328, DOI 10.3109/07853890109002086; Sintonen H., 1994, 41 NAT CTR HLTH PROG; Snyder CF, 2012, QUAL LIFE RES, V21, P1305, DOI 10.1007/s11136-011-0054-x; Stenvall H, 2017, EUR HEART J, V3, P74, DOI 10.1093/ehjqcco/qcw024; Walton MK, 2015, VALUE HEALTH, V18, P741, DOI 10.1016/j.jval.2015.08.006; Weinstein MC, 2009, VALUE HEALTH, V12, pS5, DOI 10.1111/j.1524-4733.2009.00515.x	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266101	10.1371/journal.pone.0266101	http://dx.doi.org/10.1371/journal.pone.0266101			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363816	Green Published, gold			2022-12-26	WOS:000804748600002
J	Mehrgou, A; Teimourian, S				Mehrgou, Amir; Teimourian, Shahram			Update of gene expression/methylation and MiRNA profiling in colorectal cancer; application in diagnosis, prognosis, and targeted therapy	PLOS ONE			English	Article							DNA METHYLATION; PHOSPHOENOLPYRUVATE CARBOXYKINASE; CELL-PROLIFERATION; MOLECULAR-ORIGINS; DOWN-REGULATION; UP-REGULATION; R PACKAGE; EXPRESSION; SOSTDC1; HYPERMETHYLATION	BackgroundColorectal cancer is one of the most deadliest malignancies worldwide. Due to the dearth of appropriate biomarkers, the diagnosis of this mortal disease is usually deferred, in its turn, culminating in the failure of prevention. By the same token, proper biomarkers are at play in determining the quality of prognosis. In other words, the survival rate is contingent upon the regulation of such biomarkers. Materials and methodsThe information regarding expression (GSE41258, and GSE31905), methylation (GSE101764), and miRNA (dbDEMC) were downloaded. MEXPRESS and GEPIA confirmed the validated differentially expressed/methylated genes using TCGA data. Taking advantage of the correlation plots and receiver-operating-characteristic (ROC) curves, expression and methylation profiles were compared. The interactions between validated differentially expressed genes and differentially expressed miRNA were recognized and visualized by miRTarBase and Cytoscape, respectively. Then, the protein-protein interaction (PPI) network and hub genes were established via STRING and Cytohubba plugin. Utilizing R packages (DOSE, Enrichplot, and clusterProfiler) and DAVID database, the Functional Enrichment analysis and the detection of KEGG pathways were performed. Ultimately, in order to recognize the prognostic value of found biomarkers, they were evaluated through drawing survival plots for CRC patients. ResultsIn this research, we found an expression profile (with 13 novel genes), a methylation profile (with two novel genes), and a miRNA profile with diagnostic value. Concerning diagnosis, the expression profile was evaluated more powerful in comparison with the methylation profile. Furthermore, a prognosis-related expression profile was detected. ConclusionIn addition to diagnostic- and prognostic-applicability, the discerned profiles can assist in targeted therapy and current therapeutic strategies.	[Mehrgou, Amir] Iran Univ Med Sci, Sch Med, Dept Med Genet & Mol Biol, Tehran, Iran; [Teimourian, Shahram] Iran Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran	Iran University of Medical Sciences; Iran University of Medical Sciences	Teimourian, S (corresponding author), Iran Univ Med Sci, Sch Med, Dept Med Genet, Tehran, Iran.	teimourian.sh@iums.ac.ir		, SHAHRAM/0000-0002-8642-9128				Anders M, 2013, MOL CARCINOGEN, V52, P29, DOI 10.1002/mc.20874; Andrews SV, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0107-z; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Barrow TM, 2017, J PATHOL, V243, P366, DOI 10.1002/path.4955; Budinska E, 2013, J PATHOL, V231, P63, DOI 10.1002/path.4212; Castellano-Castillo D, 2018, CLIN EPIGENETICS, V10, DOI 10.1186/s13148-018-0493-0; Chandrashekar DS, 2017, NEOPLASIA, V19, P649, DOI 10.1016/j.neo.2017.05.002; Chen EI, 2007, CANCER RES, V67, P1472, DOI 10.1158/0008-5472.CAN-06-3137; Chen GH, 2018, INT J MOL MED, V42, P3424, DOI 10.3892/ijmm.2018.3926; Chen XM, 2018, ONCOL REP, V40, P1855, DOI 10.3892/or.2018.6604; Chou CH, 2018, NUCLEIC ACIDS RES, V46, pD296, DOI 10.1093/nar/gkx1067; Clausen KA, 2011, BREAST CANCER RES TR, V129, P737, DOI 10.1007/s10549-010-1261-9; Copija A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010107; Coppede F, 2014, WORLD J GASTROENTERO, V20, P943, DOI 10.3748/wjg.v20.i4.943; Cui YZ, 2019, AM J CANCER RES, V9, P2331; De Roock W, 2011, LANCET ONCOL, V12, P594, DOI 10.1016/S1470-2045(10)70209-6; Domann FE, 2000, INT J CANCER, V85, P805, DOI 10.1002/(SICI)1097-0215(20000315)85:6<805::AID-IJC12>3.0.CO;2-5; Esteller M, 2008, NEW ENGL J MED, V358, P1148, DOI 10.1056/NEJMra072067; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; Fortin JP, 2017, BIOINFORMATICS, V33, P558, DOI 10.1093/bioinformatics/btw691; Fortin JP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0741-y; Fortin JP, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0503-2; Gong X, 2020, MOL THER-NUCL ACIDS, V21, P804, DOI 10.1016/j.omtn.2020.07.015; Gopal G, 2013, CANCER GENET-NY, V206, P174, DOI 10.1016/j.cancergen.2013.04.005; Grasmann G, 2019, BBA-REV CANCER, V1872, P24, DOI 10.1016/j.bbcan.2019.05.006; Guinney J, 2015, NAT MED, V21, P1350, DOI 10.1038/nm.3967; Hu DG, 2016, CANCER RES, V76, P5881, DOI 10.1158/0008-5472.CAN-15-3372; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Koch A, 2018, NAT REV CLIN ONCOL, V15, P459, DOI 10.1038/s41571-018-0004-4; Larsson C, 2020, NPJ BREAST CANCER, V6, DOI 10.1038/s41523-020-0170-2; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; Leithner K, 2015, ONCOGENE, V34, P1044, DOI 10.1038/onc.2014.47; Li Y, 2015, CANCER RES, V75, P1191, DOI 10.1158/0008-5472.CAN-14-2615; Liang WW, 2015, ONCOTARGET, V6, P31780, DOI 10.18632/oncotarget.5566; Lippi G, 2016, CRIT REV ONCOL HEMAT, V97, P1, DOI 10.1016/j.critrevonc.2015.11.008; Liu L, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0091-9; Liu MX, 2018, ONCOGENE, V37, P1637, DOI 10.1038/s41388-017-0070-6; Liu W, 2018, ONCOL REP, V39, P2527, DOI 10.3892/or.2018.6331; Maksimovic J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv526; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Mao Y, 2013, CANCER METAST REV, V32, P303, DOI 10.1007/s10555-012-9415-3; Mar AC, 2015, J BIOL CHEM, V290, P22212, DOI 10.1074/jbc.M115.644823; Markowitz SD, 2009, NEW ENGL J MED, V361, P2449, DOI 10.1056/NEJMra0804588; Martin ML, 2018, CELL SIGNAL, V42, P97, DOI 10.1016/j.cellsig.2017.09.018; Maunakea AK, 2010, NATURE, V466, P253, DOI 10.1038/nature09165; Men CD, 2017, J GYNECOL ONCOL, V28, DOI 10.3802/jgo.2017.28.e83; Menigatti M, 2001, GENE CHROMOSOME CANC, V31, P357, DOI 10.1002/gcc.1154; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Montal ED, 2015, MOL CELL, V60, P571, DOI 10.1016/j.molcel.2015.09.025; Morgan AE, 2018, P NUTR SOC, V77, P412, DOI 10.1017/S0029665118000150; Oliveros, 2007, VENNY INTERACTIVE TO; Pang B, 2019, FOOD FUNCT, V10, P5339, DOI [10.1039/c9fo01168d, 10.1039/C9FO01168D]; Peters TJ, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/1756-8935-8-6; Phipson B, 2016, BIOINFORMATICS, V32, P286, DOI 10.1093/bioinformatics/btv560; Phipson B, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0465-4; Portela A, 2010, NAT BIOTECHNOL, V28, P1057, DOI 10.1038/nbt.1685; Pou J, 2011, BBA-MOL CELL BIOL L, V1811, P556, DOI 10.1016/j.bbalip.2011.05.014; Punt CJA, 2017, NAT REV CLIN ONCOL, V14, P235, DOI 10.1038/nrclinonc.2016.171; Rawat A, 2014, CELL ONCOL, V37, P409, DOI 10.1007/s13402-014-0204-6; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roseweir AK, 2017, CANCER TREAT REV, V57, P1, DOI 10.1016/j.ctrv.2017.04.006; Roychowdhury S, 2016, CA-CANCER J CLIN, V66, P75, DOI 10.3322/caac.21329; Sarabi MM, 2018, BIOMED PHARMACOTHER, V101, P94, DOI 10.1016/j.biopha.2018.02.077; Sean D, 2007, BIOINFORMATICS, V23, P1846, DOI 10.1093/bioinformatics/btm254; Sheffer M, 2009, P NATL ACAD SCI USA, V106, P7131, DOI 10.1073/pnas.0902232106; Shi L, 2018, J GENET GENOMICS, V45, P205, DOI 10.1016/j.jgg.2018.04.003; Siegel RL, 2017, CA-CANCER J CLIN, V67, P177, DOI 10.3322/caac.21395; Silveira NJF, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-56; Sun T, 2020, INT J ONCOL, V56, P460, DOI 10.3892/ijo.2019.4944; Szklarczyk D, 2019, NUCLEIC ACIDS RES, V47, pD607, DOI 10.1093/nar/gky1131; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Thanki Ketan, 2017, Int Biol Biomed J, V3, P105; Triche TJ, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gkt090; van Vlodrop IJH, 2011, CLIN CANCER RES, V17, P4225, DOI 10.1158/1078-0432.CCR-10-3394; Vincent EE, 2015, MOL CELL, V60, P195, DOI 10.1016/j.molcel.2015.08.013; Vinson KE, 2016, INT J CANCER, V138, P1835, DOI 10.1002/ijc.29800; Wang JK, 2018, ONCOTARGETS THER, V11, P4001, DOI 10.2147/OTT.S160831; Wang LW, 2019, CANCER CELL INT, V19, DOI 10.1186/s12935-019-0950-7; Wu J, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317697564; Xiao B, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4314-9; Yan SP, 2019, J CELL MOL MED, V23, P2656, DOI 10.1111/jcmm.14161; Yang Z, 2017, NUCLEIC ACIDS RES, V45, pD812, DOI 10.1093/nar/gkw1079; Yao LW, 2020, ONCOGENESIS, V9, DOI 10.1038/s41389-020-0198-z; Yu CR, 2019, MOL MED REP, V19, P2065, DOI 10.3892/mmr.2019.9849; Yu GC, 2015, BIOINFORMATICS, V31, P608, DOI 10.1093/bioinformatics/btu684; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhou QY, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1001-3; Zhou QY, 2017, MOL CELL BIOCHEM, V435, P87, DOI 10.1007/s11010-017-3059-0	88	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265527	10.1371/journal.pone.0265527	http://dx.doi.org/10.1371/journal.pone.0265527			34	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333898	Green Published, gold			2022-12-26	WOS:000784335700032
J	Ramadhani, FJ; Bak, DH; Kang, SH; Park, CH; Park, SH; Chung, BY; Bai, HW				Ramadhani, Fatuma Jumapili; Bak, Dong-Ho; Kang, Seong Hee; Park, Chul-hong; Park, Sang Hwa; Chung, Byung Yeoup; Bai, Hyoung-woo			The effects of centipedegrass extract on hair growth via promotion of anagen inductive activity	PLOS ONE			English	Article							DERMAL PAPILLA CELLS; FOLLICLE MORPHOGENESIS; DOWN-REGULATION; DIFFERENTIATION; PROLIFERATION; MINOXIDIL; SYMPTOMS; CATENIN	To investigate the CGE on hair growth and to explore the mechanism that is involved in the acceleration of anagen induction, we investigated the effects of CGE studied on cell proliferation and molecular mechanism in human hair dermal papilla cells (hDPCs) and keratinocytes (HaCaT cells). Additionally, hair growth evaluation was carried out following topical treatment of the dorsal skin of telogen C57BL/6 mice with CGE for 14 days. As result, CGE increased cell viability and ALP activity in hDPCs. Moreover, CGE increased the expression of catenin beta 1 (CTNNB1), ALP, sex-determining region Y-box 2 (SOX2), insulin-like growth factor 1 (IGF1), and vascular endothelial growth factor A (VEGFA) genes in hDPCs. CGE increased the expression of proteins such as ALP, beta-catenin, and phosphorylation of glycogen synthase kinase 3 beta (pGSK3 beta), and protein kinase B (pAKT) in hDPCs. Furthermore, CGE induced the proliferation of HaCaT cells and up-regulated AKT-ERK-GSK beta-beta-catenin signaling in HaCaT cells. Additionally, the anagen induction effects of CGE were confirmed on the telogen-anagen transition mice model. these findings demonstrated that CGE promoted the entering the growth phase of hair follicle via activation of beta-catenin signaling pathways in vivo. Thus, this study suggests that CGE might be a potential therapeutic reagent for hair growth.	[Ramadhani, Fatuma Jumapili; Bak, Dong-Ho; Kang, Seong Hee; Park, Chul-hong; Chung, Byung Yeoup; Bai, Hyoung-woo] Korea Atom Energy Res Inst KAERI, Adv Radiat Technol Inst ARTI, Res Div Biotechnol, Jeongeup, South Korea; [Ramadhani, Fatuma Jumapili; Bai, Hyoung-woo] Univ Sci & Technol UST, Radiat Biotechnol & Appl Radio isotope Sci, Daejeon, South Korea; [Park, Sang Hwa] Nakdonggang Natl Inst Biol Resources NNIBR, Bacteria Res Team, Sangju, South Korea	Korea Atomic Energy Research Institute (KAERI); University of Science & Technology (UST)	Chung, BY; Bai, HW (corresponding author), Korea Atom Energy Res Inst KAERI, Adv Radiat Technol Inst ARTI, Res Div Biotechnol, Jeongeup, South Korea.; Bai, HW (corresponding author), Univ Sci & Technol UST, Radiat Biotechnol & Appl Radio isotope Sci, Daejeon, South Korea.	bychung@kaeri.re.kr; hbai@kaeri.re.kr		Park, Sanghwa/0000-0002-9130-0724	Ministry of Science and ICT, Republic of Korea.	Ministry of Science and ICT, Republic of Korea.	This work was supported by the Nuclear R & D Program of the Ministry of Science and ICT, Republic of Korea.	Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Badaboina S, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-350; Bai HW, 2015, INT J MOL MED, V35, P511, DOI 10.3892/ijmm.2014.2012; Bak DH, 2020, EXP DERMATOL, V29, P341, DOI 10.1111/exd.14051; Basaria S, 2016, J CLIN ENDOCR METAB, V101, P4669, DOI 10.1210/jc.2016-2726; Choi BY, 2016, MOL MED REP, V13, P4014, DOI 10.3892/mmr.2016.5015; Choi BY, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21144915; Choi BY, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19092703; Clavel C, 2012, DEV CELL, V23, P981, DOI 10.1016/j.devcel.2012.10.013; Dinh QQ, 2007, CLIN INTERV AGING, V2, P189; Geyfman M, 2015, BIOL REV, V90, P1179, DOI 10.1111/brv.12151; Harel S, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500973; Huang HC, 2019, ARCH DERMATOL RES, V311, P411, DOI 10.1007/s00403-019-01920-1; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Hyoung-Woo B, 2019, PHYTOMEDICINE, V55, P172, DOI 10.1016/j.phymed.2018.06.039; Irwig MS, 2011, J SEX MED, V8, P1747, DOI 10.1111/j.1743-6109.2011.02255.x; JOHNSON AW, 1970, J NEMATOL, V2, P252; Leiros GJ, 2014, STEM CELL TRANSL MED, V3, P1209, DOI 10.5966/sctm.2013-0217; Kang JI, 2017, MAR DRUGS, V15, DOI 10.3390/md15050130; Kim JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0163433; Kim YJ, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30404-x; Kishimoto J, 2000, GENE DEV, V14, P1181; Kutlubay Z., 2017, HAIR SCALP DISORDERS, V1; Kwack MH, 2012, J INVEST DERMATOL, V132, P1554, DOI 10.1038/jid.2012.24; Lee EM, 2013, RADIAT PHYS CHEM, V91, P108, DOI 10.1016/j.radphyschem.2013.06.010; Lee H., 2016, EVID-BASED COMPL ALT, V2016, DOI [10.1155/2016/1873746, DOI 10.1155/2016/1873746]; Lee SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034152; Leiros GJ, 2012, BRIT J DERMATOL, V166, P1035, DOI 10.1111/j.1365-2133.2012.10856.x; Li W, 2012, MOL BIOL REP, V39, P8687, DOI 10.1007/s11033-012-1725-6; Li YH, 2011, CLIN EXP DERMATOL, V36, P534, DOI 10.1111/j.1365-2230.2011.04019.x; Munkhbayar S, 2016, ANN DERMATOL, V28, P55, DOI 10.5021/ad.2016.28.1.55; Oh JH, 2019, ANN DERMATOL, V31, P164, DOI 10.5021/ad.2019.31.2.164; Rajendran RL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15505-3; Rajoo Y, 2019, BMC PSYCHOL, V7, DOI 10.1186/s40359-019-0324-x; Rishikaysh P, 2014, INT J MOL SCI, V15, P1647, DOI 10.3390/ijms15011647; Rossi A, 2012, RECENT PATENTS INFLA, V6, P130, DOI 10.2174/187221312800166859; Sari Agnes Rosarina Prita, 2016, Int J Trichology, V8, P103, DOI 10.4103/0974-7753.188963; Shin H, 2017, CURR STEM CELL RES T, V12, P524, DOI 10.2174/1574888X12666170504120244; Suchonwanit P, 2019, DRUG DES DEV THER, V13, P2777, DOI 10.2147/DDDT.S214907; Trueb RM, 2018, SKIN APPENDAGE DISOR, V4, P90, DOI 10.1159/000479333; Wang L, 2017, BIOL OPEN, V6, P850, DOI 10.1242/bio.024505; Yardimci G., 2017, HAIR SCALP DISORDERS, V347; Yu NL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10350-w; Yuan SK, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005253; Zhou LL, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160425	45	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265532	10.1371/journal.pone.0265532	http://dx.doi.org/10.1371/journal.pone.0265532			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320304	Green Published, gold			2022-12-26	WOS:000784240600011
J	Wang, SK; Lee, MC; Hung, CL; Chen, HH; Liao, CC; Chiu, YL				Wang, Sheng-Kuang; Lee, Meng-Chih; Hung, Chia-Lien; Chen, Hsin-Hung; Liao, Chun-Cheng; Chiu, Yu-Lung			Association between hypertriglyceridemic waist phenotype and hypogonadism in Taiwanese adult men	PLOS ONE			English	Article							LATE-ONSET HYPOGONADISM; LOW SERUM TESTOSTERONE; METABOLIC SYNDROME; VISCERAL OBESITY; RISK-FACTOR; PREVALENCE; POPULATION; MORTALITY; DIAGNOSIS; DISEASE	BackgroundAging-related hypogonadism in men is related to the deterioration of overall health. Those with this disease rarely receive treatment. The hypertriglyceridemic waist (HTGW) phenotype is a tool for predicting abnormalities of cardiovascular metabolism. However, the relationship between the HTGW phenotype and hypogonadism remains undetermined. This study aimed to determine the association between HTGW phenotype and hypogonadism in different age groups. MethodsData of this cross-sectional study were obtained from MJ Health Screening Center in Taiwan from 2007 to 2016. The HTGW phenotype was divided into four categories based on whether the waist circumference (WC) and triglyceride levels were normal. WC of ResultsOverall, 6442 male participants were divided into three age groups: <50, 50-64, and >= 65 years (n = 4135, 1958, and 349; age groups 1, 2, and 3, respectively). The overall prevalence of hypogonadism was 10.6%. In group 1, participants with HTGW (odds ratio, 1.98; 95% confidence interval (CI), 1.354-2.896) had a higher risk of hypogonadism than those with normal WC and normal triglyceride levels after adjustment for body mass index and fasting blood glucose level. In group 2, participants with HTGW (odds ratio, 1.873; 95% CI, 1.099-3.193) had an increased risk of hypogonadism after adjustment for body mass index, fasting blood glucose level, Cholesterol levels, high-density lipoprotein (HDL) levels, low-density lipoprptein (LDL) levels and smoking status. However, no relationship was observed between HTGW phenotype and hypogonadism in group 3. ConclusionHTGW phenotype was highly associated with hypogonadism in Taiwanese adult men. More attention should be paid to men aged <50 years with HTGW.	[Wang, Sheng-Kuang] Natl Def Med Ctr, Grad Inst Med Sci, Taipei, Taiwan; [Wang, Sheng-Kuang] Taichung Army Forces Gen Hosp, Med Adm Dept, Taichung, Taiwan; [Lee, Meng-Chih] Taichung Hosp, Dept Family Med, Minist Hlth & Welf, Taichung, Taiwan; [Lee, Meng-Chih] Chaoyang Univ Technol, Coll Management, Taichung, Taiwan; [Lee, Meng-Chih] Chung Shan Med Univ, Inst Med, Taichung, Taiwan; [Lee, Meng-Chih] Natl Hlth Res Inst, Inst Populat Hlth Sci, Miaoli, Taiwan; [Hung, Chia-Lien; Liao, Chun-Cheng] Taichung Armed Forces Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan; [Chen, Hsin-Hung] Asia Univ Hosp, Div Endocrinol & Metab, Dept Internal Med, Taichung, Taiwan; [Chen, Hsin-Hung] Chung Shan Med Univ, Sch Med, Taichung, Taiwan; [Chen, Hsin-Hung] Providence Univ, Dept Law, Taichung, Taiwan; [Chen, Hsin-Hung] Chung Sheng clin, Nantou, Taiwan; [Liao, Chun-Cheng] Taichung Armed Forces Gen Hosp, Dept Family Med, Taichung, Taiwan; [Liao, Chun-Cheng] Natl Def Med Ctr, Sch Med, Taipei, Taiwan; [Chiu, Yu-Lung] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chiu, Yu-Lung] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan	National Defense Medical Center; Chaoyang University of Technology; Chung Shan Medical University; National Health Research Institutes - Taiwan; Chung Shan Medical University; Providence University - Taiwan; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center	Liao, CC (corresponding author), Taichung Armed Forces Gen Hosp, Dept Med Educ & Res, Taichung, Taiwan.; Liao, CC (corresponding author), Taichung Armed Forces Gen Hosp, Dept Family Med, Taichung, Taiwan.; Liao, CC (corresponding author), Natl Def Med Ctr, Sch Med, Taipei, Taiwan.; Chiu, YL (corresponding author), Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan.; Chiu, YL (corresponding author), Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan.	milkbottle97@yahoo.com.tw; long_ruth0624@mail.ndmctsgh.edu.tw		Liao, Chun-Cheng/0000-0002-7508-6297; Chiu, Yu-Lung/0000-0002-6963-2116	Taichung Armed Forces General Hospital [MJHRF2021003A]	Taichung Armed Forces General Hospital	This study received assistance by the Department of Medical Education and Research, Taichung Armed Forces General Hospital. All or part of the data used in this research were authorized by and received from MJ Health Research Foundation (Authorization Code: MJHRF2021003A). Any interpretation or conclusion described in this paper does not represent the views of MJ Health Research Foundation.	Amjad S, 2019, ANDROLOGIA, V51, DOI 10.1111/and.13147; Araujo AB, 2007, J CLIN ENDOCR METAB, V92, P4241, DOI 10.1210/jc.2007-1245; Arsenault BJ, 2010, CAN MED ASSOC J, V182, P1427, DOI 10.1503/cmaj.091276; Braga PC, 2020, ANDROLOGY-US, V8, P1530, DOI 10.1111/andr.12765; Brand JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100409; Camacho EM, 2013, EUR J ENDOCRINOL, V168, P445, DOI 10.1530/EJE-12-0890; Corona G, 2015, HORM-INT J ENDOCRINO, V14, P569, DOI 10.14310/horm.2002.1635; Crisostomo L, 2020, MOL CELL ENDOCRINOL, V516, DOI 10.1016/j.mce.2020.110945; Georgiev IP, 2011, RES VET SCI, V90, P196, DOI 10.1016/j.rvsc.2010.05.023; He S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073292; Hitsumoto T, 2019, CARDIOL RES, V10, P106, DOI 10.14740/cr858; Huang IS, 2019, J CHIN MED ASSOC, V82, P477, DOI 10.1097/JCMA.0000000000000099; Huang MY, 2013, VALUE HEALTH, V16, pA70, DOI 10.1016/j.jval.2013.03.315; Huhtaniemi I, 2014, ASIAN J ANDROL, V16, P192, DOI 10.4103/1008-682X.122336; Khaw KT, 2007, CIRCULATION, V116, P2694, DOI 10.1161/CIRCULATIONAHA.107.719005; Kumar P, 2010, J ADV PHARM TECHNOL, V1, P297, DOI 10.4103/0110-5558.72420; Kurobe M, 2018, INT J UROL, V25, P457, DOI 10.1111/iju.13537; Laughlin GA, 2008, J CLIN ENDOCR METAB, V93, P68, DOI 10.1210/jc.2007-1792; Lemieux I, 2000, CIRCULATION, V102, P179, DOI 10.1161/01.CIR.102.2.179; Liu YJ, 2021, ASIAN J ANDROL, V23, DOI [10.4103/aja.aja_59_20, 10.4103/aja.aja_59_20PMID:33154202]; Liu ZS, 2017, J CLIN LAB ANAL, V31, DOI 10.1002/jcla.22073; Livingston M, 2017, INT J CLIN PRACT, V71, DOI 10.1111/ijcp.12995; Lunenfeld B, 2015, AGING MALE, V18, P5, DOI 10.3109/13685538.2015.1004049; Mulligan T, 2006, INT J CLIN PRACT, V60, P762, DOI 10.1111/j.1742-1241.2006.00992.x; Nakashima A, 2017, KIDNEY INT REP, V2, P1160, DOI 10.1016/j.ekir.2017.07.015; Park YW, 2003, ARCH INTERN MED, V163, P427, DOI 10.1001/archinte.163.4.427; Ross A, 2016, UROL CLIN N AM, V43, P163, DOI 10.1016/j.ucl.2016.01.002; Rozenberg S, 2020, MATURITAS, V138, P14, DOI 10.1016/j.maturitas.2020.05.004; Sam S, 2009, DIABETES CARE, V32, P1916, DOI 10.2337/dc09-0412; Seftel AD, 2006, INT J IMPOT RES, V18, P115, DOI 10.1038/sj.ijir.3901397; Sepu N., 2020, J NATL MED ASSOC; Sun K, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-033991; Tchernof A, 2013, PHYSIOL REV, V93, P359, DOI 10.1152/physrev.00033.2011; Turan E, 2020, ANDROLOGIA, V52, DOI 10.1111/and.13548; Vaverkova H, 2015, PHYSIOL RES, V64, pS385, DOI 10.33549/physiolres.933198; Wang NJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep19844; Wu FCW, 2010, NEW ENGL J MED, V363, P123, DOI 10.1056/NEJMoa0911101; Zarotsky V, 2014, JHORMONES, V22, P1, DOI 10.1155/2014/190347; Zhong SR, 2021, DIABET METAB SYND OB, V14, P99, DOI 10.2147/DMSO.S282832	39	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265629	10.1371/journal.pone.0265629	http://dx.doi.org/10.1371/journal.pone.0265629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320301	gold, Green Published			2022-12-26	WOS:000784240600052
J	Guo, LS				Guo, Lishu			Mitochondrial ATP synthase inhibitory factor 1 interacts with the p53-cyclophilin D complex and promotes opening of the permeability transition pore	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							REGULATORY PROTEIN; BOVINE F-1-ATPASE; SUBUNIT; IF1; CHANNEL; BAX; DIMERIZATION; ACTIVATION; APOPTOSIS; MEMBRANE	The mitochondrial permeability transition pore (PTP) is a Ca2+-dependent megachannel that plays an important role in mitochondrial physiology and cell fate. Cyclophilin D (CyPD) is a well-characterized PTP regulator, and its binding to the PTP favors pore opening. It has previously been shown that p53 physically interacts with CyPD and opens the PTP during necrosis. Accumulating studies also suggest that the F-ATP synthase contributes to the regulation and formation of the PTP. F-ATP synthase IF1 (mitochondrial ATP synthase inhibitory factor 1) is a natural inhibitor of F-ATP synthase activity; however, whether IF1 participates in the modulation of PTP opening is basically unknown. Here, we demonstrate using calcium retention capacity assay that IF1 overexpression promotes mitochondrial permeability transition via opening of the PTP. Intriguingly, we show that IF1 can interact with the p53-CyPD complex and facilitate cell death. We also demonstrate that the presence of IF1 is necessary for the formation of p53-CyPD complex. Therefore, we suggest that IF1 regulates the PTP via interaction with the p53-CyPD complex, and that IF1 is necessary for the inducing effect of p53-CyPD complex on PTP opening.	[Guo, Lishu] Fudan Univ, Ctr Mitochondrial Genet & Hlth, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci, Shanghai, Peoples R China; [Guo, Lishu] Tongji Univ, Canc Ctr, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China	Fudan University; Tongji University	Guo, LS (corresponding author), Fudan Univ, Ctr Mitochondrial Genet & Hlth, Greater Bay Area Inst Precis Med Guangzhou, Sch Life Sci, Shanghai, Peoples R China.; Guo, LS (corresponding author), Tongji Univ, Canc Ctr, Shanghai Peoples Hosp 10, Sch Med, Shanghai, Peoples R China.	guolsh15@gmail.com		Guo, Lishu/0000-0002-1492-6766	Shanghai Sailing Program [20YF1453200]	Shanghai Sailing Program	Acknowledgments-This work was sponsored by the Shanghai Sailing Program (grant no.: 20YF1453200) .	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Antoniel M, 2018, EMBO REP, V19, P257, DOI 10.15252/embr.201744705; Bergeaud M, 2013, CELL CYCLE, V12, P2781, DOI 10.4161/cc.25870; Bernardi P, 2015, PHYSIOL REV, V95, P1111, DOI 10.1152/physrev.00001.2015; Burwick NR, 2005, J BIOL CHEM, V280, P1740, DOI 10.1074/jbc.M405947200; Cabezon E, 2000, J BIOL CHEM, V275, P28353, DOI 10.1074/jbc.C000427200; Cabezon E, 2000, J BIOL CHEM, V275, P25460, DOI 10.1074/jbc.M003859200; Cabezon E, 2003, NAT STRUCT BIOL, V10, P744, DOI 10.1038/nsb966; Campanella M, 2008, CELL METAB, V8, P13, DOI 10.1016/j.cmet.2008.06.001; Carraro M, 2020, CELL REP, V32, DOI 10.1016/j.celrep.2020.108095; Carraro M, 2018, CELL PHYSIOL BIOCHEM, V50, P1840, DOI 10.1159/000494864; Carrer A, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25161-x; Carroll J, 2019, P NATL ACAD SCI USA, V116, P12816, DOI 10.1073/pnas.1904005116; Chipuk JE, 2003, CANCER CELL, V4, P371, DOI 10.1016/S1535-6108(03)00272-1; Chipuk JE, 2004, SCIENCE, V303, P1010, DOI 10.1126/science.1092734; Connern CP, 1996, BIOCHEMISTRY-US, V35, P8172, DOI 10.1021/bi9525177; Formentini L, 2012, MOL CELL, V45, P731, DOI 10.1016/j.molcel.2012.01.008; Garcia JJ, 2006, BIOCHEMISTRY-US, V45, P12695, DOI 10.1021/bi060339j; Garcia-Bermudez J, 2015, CELL REP, V12, P2143, DOI 10.1016/j.celrep.2015.08.052; Giorgio V, 2019, BRIT J PHARMACOL, V176, P4247, DOI 10.1111/bph.14513; Giorgio V, 2018, CELL CALCIUM, V70, P56, DOI 10.1016/j.ceca.2017.05.004; Giorgio V, 2017, EMBO REP, V18, P1065, DOI 10.15252/embr.201643354; Giorgio V, 2013, P NATL ACAD SCI USA, V110, P5887, DOI 10.1073/pnas.1217823110; Giorgio V, 2010, BBA-BIOENERGETICS, V1797, P1113, DOI 10.1016/j.bbabio.2009.12.006; Giorgio V, 2009, J BIOL CHEM, V284, P33982, DOI 10.1074/jbc.M109.020115; Gledhill JR, 2007, P NATL ACAD SCI USA, V104, P15671, DOI 10.1073/pnas.0707326104; Guo LS, 2021, BIOCHEM PHARMACOL, V188, DOI 10.1016/j.bcp.2021.114537; Guo LS, 2019, J BIOL CHEM, V294, P10987, DOI 10.1074/jbc.RA119.008775; Guo LS, 2018, J BIOL CHEM, V293, P14632, DOI 10.1074/jbc.RA118.004495; He JY, 2017, P NATL ACAD SCI USA, V114, P9086, DOI 10.1073/pnas.1711201114; He JY, 2017, P NATL ACAD SCI USA, V114, P3409, DOI 10.1073/pnas.1702357114; Martinez-Outschoorn UE, 2017, NAT REV CLIN ONCOL, V14, P11, DOI 10.1038/nrclinonc.2016.60; Masoud R, 2020, CELL REP MED, V1, DOI 10.1016/j.xcrm.2020.100143; Matsuyama S, 1998, MOL CELL, V1, P327, DOI 10.1016/S1097-2765(00)80033-7; Meslar E, 2020, JAAPA-J AM ACAD PHYS, V33, P50, DOI 10.1097/01.JAA.0000718300.59420.6c; Mnatsakanyan N, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13766-2; Neginskaya MA, 2019, CELL REP, V26, P11, DOI 10.1016/j.celrep.2018.12.033; Nicolli A, 1996, J BIOL CHEM, V271, P2185, DOI 10.1074/jbc.271.4.2185; Pinke G, 2020, NAT STRUCT MOL BIOL, V27, P1077, DOI 10.1038/s41594-020-0503-8; Piret JP, 2004, BIOCHEM PHARMACOL, V67, P611, DOI 10.1016/j.bcp.2003.09.026; PULLMAN ME, 1963, J BIOL CHEM, V238, P3762; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robinson GC, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.120164; Sanchez-Cenizo L, 2010, J BIOL CHEM, V285, P25308, DOI 10.1074/jbc.M110.146480; Santamaria G, 2006, CARCINOGENESIS, V27, P925, DOI 10.1093/carcin/bgi315; Urbani A, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12331-1; Vaseva AV, 2012, CELL, V149, P1536, DOI 10.1016/j.cell.2012.05.014; WALKER JE, 1994, CURR OPIN STRUC BIOL, V4, P912, DOI 10.1016/0959-440X(94)90274-7; Walker JE, 2020, P NATL ACAD SCI USA, V117, P2745, DOI 10.1073/pnas.1921409117; Walker JE, 2013, BIOCHEM SOC T, V41, P1, DOI 10.1042/BST20110773; Ward PS, 2012, CANCER CELL, V21, P297, DOI 10.1016/j.ccr.2012.02.014; Yu MF, 2019, JCI INSIGHT, V4, DOI 10.1172/jci.insight.126915	52	1	1	0	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101858	10.1016/j.jbc.2022.101858	http://dx.doi.org/10.1016/j.jbc.2022.101858			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35337801	gold, Green Published			2022-12-26	WOS:000793483000006
J	Hameed, A; Ketley, JM; Woodacre, A; Machado, LR; Marsden, GL				Hameed, Amber; Ketley, Julian M.; Woodacre, Alexandra; Machado, Lee R.; Marsden, Gemma L.			Molecular and in silico typing of the lipooligosaccharide biosynthesis gene cluster in Campylobacter jejuni and Campylobacter coli	PLOS ONE			English	Article							GUILLAIN-BARRE-SYNDROME; LIPO-OLIGOSACCHARIDE; PHASE VARIATION; CHICKEN MEAT; LOCUS CLASS; SP-NOV; INFECTION; STRAINS; COLONIZATION; SPP.	The extensive genetic variation in the lipooligosaccharide (LOS) core biosynthesis gene cluster has led to the development of a classification system; with 8 classes (I-VIII) for Campylobacter coli (C. coli) LOS region and with 23 classes (A-W) or four groups (1-4) for Campylobacter jejuni (C. jejuni) LOS region. PCR based LOS locus type identification for C. jejuni clinical isolates from a UK hospital as well as in silico LOS locus analysis for C. jejuni and C. coli genome sequences from GenBank was carried out to determine the frequencies of various LOS genotypes in C. jejuni and C. coli. Analysis of LOS gene content in 60 clinical C. jejuni isolates and 703 C. jejuni genome sequences revealed that class B (Group 1) was the most abundant LOS class in C. jejuni. The hierarchy of C. jejuni LOS group prevalence (group 1 > group 2 > group 3 > group 4) as well as the hierarchy of the frequency of C. jejuni LOS classes present within the group 1 (B > C > A > R > M > V), group 2 (H/P > O > E > W), group 3 (F > K > S) and group 4 (G > L) was identified. In silico analysis of LOS gene content in 564 C. coli genome sequences showed class III as the most abundant LOS locus type in C. coli. In silico analysis of LOS gene content also identified three novel LOS types of C. jejuni and previously unknown LOS biosynthesis genes in C. coli LOS locus types I, II, III, V and VIII. This study provides C. jejuni and C. coli LOS loci class frequencies in a smaller collection of C. jejuni clinical isolates as well as within the larger, worldwide database of C. jejuni and C. coli.	[Hameed, Amber; Woodacre, Alexandra; Machado, Lee R.] Univ Northampton, Ctr Phys Act & Life Sci, Northampton, England; [Ketley, Julian M.; Woodacre, Alexandra; Machado, Lee R.] Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England; [Marsden, Gemma L.] Healthcare Infect Soc, London, England	University of Northampton; University of Leicester	Machado, LR (corresponding author), Univ Northampton, Ctr Phys Act & Life Sci, Northampton, England.; Machado, LR (corresponding author), Univ Leicester, Dept Genet & Genome Biol, Leicester, Leics, England.	lee.machado@northampton.ac.uk		Marsden, Gemma/0000-0001-8710-1071				Atanassova V, 1999, INT J FOOD MICROBIOL, V51, P187, DOI 10.1016/S0168-1605(99)00120-8; Berndtson E, 1996, INT J FOOD MICROBIOL, V32, P35, DOI 10.1016/0168-1605(96)01102-6; BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Champion OL, 2005, P NATL ACAD SCI USA, V102, P16043, DOI 10.1073/pnas.0503252102; Culebro A, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21438-2; Culebro A, 2016, J BACTERIOL, V198, P2829, DOI 10.1128/JB.00347-16; Ellstrom P, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0740-5; Ellstrom P, 2013, INT J MED MICROBIOL, V303, P134, DOI 10.1016/j.ijmm.2013.01.005; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Funakoshi K, 2006, J NEUROL SCI, V246, P163, DOI 10.1016/j.jns.2006.02.010; GEBHART CJ, 1985, J CLIN MICROBIOL, V21, P715, DOI 10.1128/JCM.21.5.715-720.1985; Gilbert M, 2004, INFECT IMMUN, V72, P1162, DOI 10.1128/IAI.72.2.1162-1165.2004; Gilbert M, 2002, J BIOL CHEM, V277, P327, DOI 10.1074/jbc.M108452200; Godschalk PCR, 2006, MICROBES INFECT, V8, P248, DOI 10.1016/j.micinf.2005.06.022; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Guerry P, 2002, INFECT IMMUN, V70, P787, DOI 10.1128/IAI.70.2.787-793.2002; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Hameed A, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00677; Hameed A, 2019, IMMUNE NETW, V19, DOI 10.4110/in.2019.19.e38; Havelaar AH, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001923; Houliston RS, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.181750; HUMPHREY TJ, 1993, EPIDEMIOL INFECT, V110, P601, DOI 10.1017/S0950268800051025; Inglis GD, 2005, APPL ENVIRON MICROB, V71, P5145, DOI 10.1128/AEM.71.9.5145-5153.2005; Islam Z, 2018, EUR J CLIN MICROBIOL, V37, P723, DOI 10.1007/s10096-017-3165-7; Islam Z, 2014, EUR J CLIN MICROBIOL, V33, P2173, DOI 10.1007/s10096-014-2184-x; Islam Z, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007257; Iwata T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056900; Jiang H, 2010, INT J MOL SCI, V11, P1155, DOI 10.3390/ijms11031155; Karlyshev AV, 2005, FEMS MICROBIOL REV, V29, P377, DOI 10.1016/j.femsre.2005.01.003; Kolehmainen A, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00759-18; Linton D, 2000, MOL MICROBIOL, V37, P501, DOI 10.1046/j.1365-2958.2000.02020.x; MANDRELL RE, 1992, INFECT IMMUN, V60, P1322, DOI 10.1128/IAI.60.4.1322-1328.1992; McCarthy N, 2001, AM J EPIDEMIOL, V153, P610, DOI 10.1093/aje/153.6.610; Moran AP, 1997, J INFECT DIS, V176, pS115, DOI 10.1086/513781; Mortensen NP, 2009, MICROBES INFECT, V11, P988, DOI 10.1016/j.micinf.2009.07.004; Muller J, 2007, J MED MICROBIOL, V56, P1589, DOI 10.1099/jmm.0.47305-0; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; NEILL SD, 1984, AVIAN PATHOL, V13, P777, DOI 10.1080/03079458408418574; Newell DG, 2003, APPL ENVIRON MICROB, V69, P4343, DOI 10.1128/AEM.69.8.4343-4351.2003; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; PERKINS DJ, 1994, AUST NZ J SURG, V64, P55, DOI 10.1111/j.1445-2197.1994.tb02137.x; Pertsemlidis A, 2001, GENOME BIOL, V2; Phongsisay V, 2006, INFECT IMMUN, V74, P1368, DOI 10.1128/IAI.74.2.1368-1372.2006; Piccirillo A, 2016, INT J SYST EVOL MICR, V66, P3468, DOI 10.1099/ijsem.0.001219; Poly F, 2008, INFECT IMMUN, V76, P5655, DOI 10.1128/IAI.00780-08; Quinones B, 2007, APPL ENVIRON MICROB, V73, P3645, DOI 10.1128/AEM.02984-06; Rahimi E, 2010, AFR J MICROBIOL RES, V4, P1620; Revez J, 2012, EUR J CLIN MICROBIOL, V31, P2203, DOI 10.1007/s10096-012-1556-3; Richards VP, 2013, INFECT GENET EVOL, V14, P200, DOI 10.1016/j.meegid.2012.12.010; ROBERTS L, 1980, VET MICROBIOL, V5, P249, DOI 10.1016/0378-1135(80)90012-7; ROBINSON DA, 1981, BRIT MED J, V282, P1584, DOI 10.1136/bmj.282.6276.1584; Sheppard SK, 2013, MOL ECOL, V22, P1051, DOI 10.1111/mec.12162; Sheppard SK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015708; Skarp-de Haan CPA, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-129; St Michael F, 2002, EUR J BIOCHEM, V269, P5119, DOI 10.1046/j.1432-1033.2002.03201.x; van Belkum A, 2009, EUR J CLIN MICROBIOL, V28, P557, DOI 10.1007/s10096-008-0661-9; VANSPREEUWEL JP, 1985, GUT, V26, P945, DOI 10.1136/gut.26.9.945; Wachira VK, 2019, TROP MED INT HEALTH, V24, P132, DOI 10.1111/tmi.13181; Wang CM, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01420-14; Weis AM, 2014, APPL ENVIRON MICROB, V80, P1639, DOI 10.1128/AEM.03393-13; Wilson DJ, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000203; Workman SN, 2005, J CLIN MICROBIOL, V43, P2642, DOI 10.1128/JCM.43.6.2642-2650.2005	65	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265585	10.1371/journal.pone.0265585	http://dx.doi.org/10.1371/journal.pone.0265585			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358234	Green Published, Green Accepted, gold			2022-12-26	WOS:000799828800041
J	Liew, BXW; Feller, JA; Webster, KE				Liew, Bernard X. W.; Feller, Julian A.; Webster, Kate E.			Understanding the psychological mechanisms of return to sports readiness after anterior cruciate ligament reconstruction	PLOS ONE			English	Article							NETWORK ANALYSIS; SELF-EFFICACY; ASSOCIATION; FEAR	Purpose The psychological response to an Anterior Cruciate Ligament (ACL) injury is significant and can negatively impact return to sports outcomes. This study aimed to quantify the association between factors associated with return to sport using network analysis. Methods 441 participants who underwent primary ACL reconstruction. The 12-item ACL Return to Sport after Injury (ACL-RSI) scale was administered to all participants 12 months after surgery. Three network analyses were used to quantify the adjusted correlations between the 12 items of the ACL-RSI scale, and to determine the centrality indices of each item (i.e., the degree of connection with other items in the network). Further subgroup network analyses were conducted for those who had (n = 115) and had not returned (n = 326) to their preinjury level of sport. Results The greatest adjusted correlation was between Q7 and Q9 (fear of re-injury and afraid of accidentally injuring knee) of the ACL-RSI (group 0.48 (95%CI [0.40 to 0.57])) across all three networks. The most important item in the network was Q12 (relaxed about sport) across all three networks. Individuals who did return to sport had greater Strength centrality for Q8 (confidence in knee, P = 0.014) compared to those who did not return to sport. Conclusion Fear of re-injury and being relaxed about playing sport were the two most important nodes in the network models that describe the return to sport readiness. The importance of knee confidence at influencing psychological readiness was greater in athletes who did return to sport compared to those who did not. Our findings provide candidate therapeutic targets that could inform future interventions designed to optimize return to sport rates in athletes post ACL reconstruction.	[Liew, Bernard X. W.] Univ Essex, Sch Sport Rehabil & Exercise Sci, Colchester, Essex, England; [Feller, Julian A.] Epworth Hlth Care, Ortho Sport Victoria, Melbourne, Vic, Australia; [Webster, Kate E.] La Trobe Univ, Sch Allied Hlth Human Serv & Sport, Melbourne, Vic, Australia	University of Essex; La Trobe University	Liew, BXW (corresponding author), Univ Essex, Sch Sport Rehabil & Exercise Sci, Colchester, Essex, England.	bl19622@essex.ac.uk		Liew, Bernard/0000-0002-7057-7548				BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 2006, SELF EFFICACY BELIEF, P307, DOI DOI 10.1017/CBO9781107415324.004; Batty LM, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120946328; Borkulo CV, 2017, J STAT SOFTW; Borsboom D, 2013, ANNU REV CLIN PSYCHO, V9, P91, DOI 10.1146/annurev-clinpsy-050212-185608; Corponi F, 2020, EUR NEUROPSYCHOPHARM, V35, P49, DOI 10.1016/j.euroneuro.2020.03.017; Edwards JR, 2000, PSYCHOL METHODS, V5, P155, DOI 10.1037//1082-989X.5.2.155; Epskamp S, 2018, BEHAV RES METHODS, V50, P195, DOI 10.3758/s13428-017-0862-1; Epskamp S, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i04; Forsdyke D, 2016, BRIT J SPORT MED, V50, DOI 10.1136/bjsports-2015-094850; Fox AS, 2018, SPORTS MED, V48, P1799, DOI 10.1007/s40279-018-0931-3; Foygel R, ADV NEURAL INFORM PR, V210, P604; FREEMAN LC, 1979, SOC NETWORKS, V1, P215, DOI 10.1016/0378-8733(78)90021-7; Friedman J, 2014, R PACK VERSION, P1; Gluck TM, 2017, EUR J PSYCHOTRAUMATO, V8, DOI 10.1080/20008198.2017.1372543; Hart HF, 2020, PHYS THER SPORT, V41, P1, DOI 10.1016/j.ptsp.2019.10.006; Kossakowski JJ, 2016, QUAL LIFE RES, V25, P781, DOI 10.1007/s11136-015-1127-z; Kvist J, 2005, KNEE SURG SPORT TR A, V13, P393, DOI 10.1007/s00167-004-0591-8; Levin ME, 2015, BEHAV MODIF, V39, P870, DOI 10.1177/0145445515603707; Liu H, 2009, J MACH LEARN RES, V10, P2295; Masferrer L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566785; McPherson AL, 2019, AM J SPORT MED, V47, P857, DOI 10.1177/0363546518825258; Meierbachtol A, 2022, J ORTHOP RES, V40, P191, DOI 10.1002/jor.25072; Costa LDM, 2011, EUR J PAIN, V15, P213, DOI 10.1016/j.ejpain.2010.06.014; Nagelli CV, 2019, CLIN BIOMECH, V68, P104, DOI 10.1016/j.clinbiomech.2019.05.031; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Nwachukwu BU, 2019, ORTHOP J SPORTS MED, V7, DOI 10.1177/2325967119845313; Paterno MV, 2022, J ORTHOP RES, V40, P182, DOI 10.1002/jor.25071; Petersen W, 2014, ARCH ORTHOP TRAUM SU, V134, P1417, DOI 10.1007/s00402-014-1992-x; Piussi R, 2022, ARTHROSCOPY, V38, P1267, DOI 10.1016/j.arthro.2021.08.040; Sanders TL, 2016, AM J SPORT MED, V44, P1502, DOI 10.1177/0363546516629944; Scherer JE, 2016, KNEE, V23, P121, DOI 10.1016/j.knee.2015.06.009; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Valente TW, 2012, SCIENCE, V337, P49, DOI 10.1126/science.1217330; van Borkulo C, 2015, JAMA PSYCHIAT, V72, P1219, DOI 10.1001/jamapsychiatry.2015.2079; Webster KE, 2008, PHYS THER SPORT, V9, P9, DOI 10.1016/j.ptsp.2007.09.003; Webster KE, 2021, ORTHOP J SPORTS MED, V9, DOI 10.1177/23259671211031240; Webster KE, 2020, ORTHOP J SPORTS MED, V8, DOI 10.1177/2325967120969425; Webster KE, 2019, AM J SPORT MED, V47, P2557, DOI 10.1177/0363546519865537; Webster KE, 2019, AM J SPORT MED, V47, P578, DOI 10.1177/0363546518819454; Webster KE, 2018, AM J SPORT MED, V46, P1545, DOI 10.1177/0363546518773757	41	0	0	4	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266029	10.1371/journal.pone.0266029	http://dx.doi.org/10.1371/journal.pone.0266029			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325002	Green Published, gold, Green Accepted			2022-12-26	WOS:000780951300097
J	Sala, M; Allain, N; Moreau, M; Jabouille, A; Henriet, E; Abou-Hammoud, A; Uguen, A; Di-Tommaso, S; Dourthe, C; Raymond, AA; Dupuy, JW; Gerard, E; Dugot-Senant, N; Rousseau, B; Merlio, JP; Pham-Ledart, A; Vergier, B; Tartare-Deckert, S; Moreau, V; Saltel, F				Sala, Margaux; Allain, Nathalie; Moreau, Melanie; Jabouille, Arnaud; Henriet, Elodie; Abou-Hammoud, Aya; Uguen, Arnaud; Di-Tommaso, Sylvaine; Dourthe, Cyril; Raymond, Anne-Aurelie; Dupuy, Jean-William; Gerard, Emilie; Dugot-Senant, Nathalie; Rousseau, Benoit; Merlio, Jean-Phillipe; Pham-Ledart, Anne; Vergier, Beatrice; Tartare-Deckert, Sophie; Moreau, Violaine; Saltel, Frederic			Discoidin Domain Receptor 2 orchestrates melanoma resistance combining phenotype switching and proliferation	ONCOGENE			English	Article							DOWN-REGULATION; DDR1; INHIBITION; METASTASIS; ACTIVATION; MUTATIONS; DISCOVERY; FAMILY; CANCER; GENE	Combined therapy with anti-BRAF plus anti-MEK is currently used as first-line treatment of patients with metastatic melanomas harboring the somatic BRAF V600E mutation. However, the main issue with targeted therapy is the acquisition of tumor cell resistance. In a majority of resistant melanoma cells, the resistant process consists in epithelial-to-mesenchymal transition (EMT). This process called phenotype switching makes melanoma cells more invasive. Its signature is characterized by MITF low, AXL high, and actin cytoskeleton reorganization through RhoA activation. In parallel of this phenotype switching phase, the resistant cells exhibit an anarchic cell proliferation due to hyper-activation of the MAP kinase pathway. We show that a majority of human melanoma overexpress discoidin domain receptor 2 (DDR2) after treatment. The same result was found in resistant cell lines presenting phenotype switching compared to the corresponding sensitive cell lines. We demonstrate that DDR2 inhibition induces a decrease in AXL expression and reduces stress fiber formation in resistant melanoma cell lines. In this phenotype switching context, we report that DDR2 control cell and tumor proliferation through the MAP kinase pathway in resistant cells in vitro and in vivo. Therefore, inhibition of DDR2 could be a new and promising strategy for countering this resistance mechanism.	[Sala, Margaux; Allain, Nathalie; Moreau, Melanie; Jabouille, Arnaud; Henriet, Elodie; Abou-Hammoud, Aya; Uguen, Arnaud; Di-Tommaso, Sylvaine; Dourthe, Cyril; Raymond, Anne-Aurelie; Moreau, Violaine; Saltel, Frederic] BoRdeaux Inst OnCol, BRIC, UMR1312, INSERM, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Sala, Margaux; Allain, Nathalie; Moreau, Melanie; Jabouille, Arnaud; Henriet, Elodie; Abou-Hammoud, Aya; Di-Tommaso, Sylvaine; Dourthe, Cyril; Raymond, Anne-Aurelie; Moreau, Violaine; Saltel, Frederic] Bordeaux Univ, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Uguen, Arnaud] Brest Univ Hosp Ctr, Dept Pathol, F-29200 Brest, France; [Di-Tommaso, Sylvaine; Dourthe, Cyril; Raymond, Anne-Aurelie; Saltel, Frederic] UMS 005, Oncoprot, F-33076 Bordeaux, France; [Dupuy, Jean-William] Bordeaux Univ, Plateforme Proteome, F-33000 Bordeaux, France; [Gerard, Emilie] Bordeaux Univ Hosp, Dermatol Dept, 1 Ave Jean Burguet, F-33000 Bordeaux, France; [Dugot-Senant, Nathalie] Histol Plateforme, UMS 005, F-33076 Bordeaux, France; [Rousseau, Benoit] Bordeaux Univ, Common Anim Housing Serv, F-33076 Bordeaux, France; [Merlio, Jean-Phillipe; Pham-Ledart, Anne; Vergier, Beatrice] Bordeaux Res Translat Oncol, Cutaneous Lymphoma Oncogenesis, BaRITOn, INSERM,UMR1053,Team 3, 146 Rue Leo Saignat, F-33076 Bordeaux, France; [Merlio, Jean-Phillipe; Pham-Ledart, Anne; Vergier, Beatrice] Bordeaux Univ Hosp, Tumor Bank & Tumor Biol Lab, Ave Magellan, F-33604 Pessac, France; [Tartare-Deckert, Sophie] Univ Cote dAzur, C3M, INSERM, F-06204 Nice, France; [Henriet, Elodie] Johns Hopkins Univ, Sch Med, Ewalds Lab, Dept Cell Biol, Baltimore, MD USA; [Abou-Hammoud, Aya] Bordeaux Univ, MFP, UMR 5234, 146 Rue Leo Saignat, F-33076 Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Brest; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Johns Hopkins University; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite de Bordeaux	Saltel, F (corresponding author), BoRdeaux Inst OnCol, BRIC, UMR1312, INSERM, 146 Rue Leo Saignat, F-33076 Bordeaux, France.; Saltel, F (corresponding author), Bordeaux Univ, 146 Rue Leo Saignat, F-33076 Bordeaux, France.; Saltel, F (corresponding author), UMS 005, Oncoprot, F-33076 Bordeaux, France.	frederic.saltel@inserm.fr	JABOUILLE, Arnaud/ABC-5823-2020; TARTARE-DECKERT, Sophie/P-6057-2015; Dupuy, Jean-William JWD/F-5335-2012	JABOUILLE, Arnaud/0000-0002-2281-430X; TARTARE-DECKERT, Sophie/0000-0001-8680-5720; Dupuy, Jean-William JWD/0000-0002-2448-4797; Moreau, Violaine/0000-0002-4513-7022; Sala, Margaux/0000-0003-3483-361X; saltel, frederic/0000-0002-0724-9680	Inca (PLBIO Inca) [PLBIO15-135]; SIRIC BRIO 2; Fondation de France; FRM, equipe labellisee [DEQ20180839586]; French ministere superieur de l'enseignement et de la recherche	Inca (PLBIO Inca); SIRIC BRIO 2; Fondation de France(Fondation de France); FRM, equipe labellisee; French ministere superieur de l'enseignement et de la recherche	This work is supported by Inca (PLBIO Inca, PLBIO15-135), SIRIC BRIO 2, Fondation de France, FRM, equipe labellisee (grant number DEQ20180839586). Margaux Sala is financed by a PhD grant from the French ministere superieur de l'enseignement et de la recherche.	Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Arozarena I, 2019, NAT REV CANCER, V19, P377, DOI 10.1038/s41568-019-0154-4; Ascierto PA, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-85; Badiola I, 2011, ONCOL REP, V26, P971, DOI 10.3892/or.2011.1356; Basile KJ, 2014, PIGM CELL MELANOMA R, V27, P479, DOI 10.1111/pcmr.12218; Das S, 2006, CANCER RES, V66, P8123, DOI 10.1158/0008-5472.CAN-06-1215; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Day E, 2008, EUR J PHARMACOL, V599, P44, DOI 10.1016/j.ejphar.2008.10.014; de Moura CR, 2019, PIGM CELL MELANOMA R, V32, P697, DOI 10.1111/pcmr.12809; Deutsch EW, 2020, NUCLEIC ACIDS RES, V48, pD1145, DOI 10.1093/nar/gkz984; Du ZF, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0782-4; El Azreq MA, 2016, ONCOTARGET, V7, P44975, DOI 10.18632/oncotarget.10455; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Girard CA, 2020, CANCER RES, V80, P1927, DOI 10.1158/0008-5472.CAN-19-2914; Girotti MR, 2013, CANCER DISCOV, V3, P158, DOI 10.1158/2159-8290.CD-12-0386; Grither WR, 2018, P NATL ACAD SCI USA, V115, pE7786, DOI 10.1073/pnas.1805020115; Grither WR, 2018, ONCOGENE, V37, P1714, DOI 10.1038/s41388-017-0043-9; Hammerman PS, 2011, CANCER DISCOV, V1, P78, DOI 10.1158/2159-8274.CD-11-0005; Hartman ML, 2015, CELL MOL LIFE SCI, V72, P1249, DOI 10.1007/s00018-014-1791-0; Hedberg ML, 2016, J CLIN INVEST, V126, P169, DOI 10.1172/JCI82066; Henriet E, 2018, CELL ADHES MIGR, V12, P363, DOI 10.1080/19336918.2018.1465156; Hidalgo-Carcedo C, 2011, NAT CELL BIOL, V13, P49, DOI 10.1038/ncb2133; Hugo W, 2015, CELL, V162, P1271, DOI 10.1016/j.cell.2015.07.061; Juin A, 2014, J CELL BIOL, V207, P517, DOI 10.1083/jcb.201404079; Juin A, 2012, MOL BIOL CELL, V23, P297, DOI 10.1091/mbc.E11-07-0594; Keating GM, 2017, DRUGS, V77, P85, DOI 10.1007/s40265-016-0677-x; Kim HG, 2013, ACS CHEM BIOL, V8, P2145, DOI 10.1021/cb400430t; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Kurashige J, 2016, SCI REP-UK, V6, DOI 10.1038/srep22371; Larkin JMG, 2015, J CLIN ONCOL, V33; Leitinger B, 2003, J BIOL CHEM, V278, P16761, DOI 10.1074/jbc.M301370200; Long GV, 2015, LANCET, V386, P444, DOI 10.1016/S0140-6736(15)60898-4; Luke JJ, 2017, NAT REV CLIN ONCOL, V14, P463, DOI 10.1038/nrclinonc.2017.43; Misek SA, 2020, ONCOGENE, V39, P1466, DOI 10.1038/s41388-019-1074-1; Muller J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6712; Nazarian R, 2010, NATURE, V468, P973, DOI 10.1038/nature09626; Ongusaha PP, 2003, EMBO J, V22, P1289, DOI 10.1093/emboj/cdg129; Park JW, 2015, J CANCER RES CLIN, V141, P1973, DOI 10.1007/s00432-015-1967-5; Rammal H, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00055; Ren TT, 2014, J PATHOL, V234, P526, DOI 10.1002/path.4415; Ren TT, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0397-3; Shrivastava A, 1997, MOL CELL, V1, P25, DOI 10.1016/S1097-2765(00)80004-0; Sondergaard JN, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-39; Sullivan RJ, 2013, EUR J CANCER, V49, P1297, DOI 10.1016/j.ejca.2012.11.019; Tsoi J, 2018, CANCER CELL, V33, P890, DOI 10.1016/j.ccell.2018.03.017; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; Villanueva J, 2010, CANCER CELL, V18, P683, DOI 10.1016/j.ccr.2010.11.023; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Wagenaar TR, 2014, PIGM CELL MELANOMA R, V27, DOI 10.1111/pcmr.12171; Wang LQ, 2018, CELL, V173, P1413, DOI 10.1016/j.cell.2018.04.012; Wang YG, 2016, DIGEST DIS SCI, V61, P2272, DOI 10.1007/s10620-016-4116-3; Xie BH, 2015, J EXP CLIN CANC RES, V34, DOI 10.1186/s13046-015-0218-6	52	0	0	1	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2571	2586		10.1038/s41388-022-02266-1	http://dx.doi.org/10.1038/s41388-022-02266-1		MAR 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35322197				2022-12-26	WOS:000772273600002
J	Bresson, J; Doll, J; Vasseur, F; Stahl, M; von Roepenack-Lahaye, E; Kilian, J; Stadelhofer, B; Kremer, JM; Kolb, D; Wenkel, S; Zentgraf, U				Bresson, Justine; Doll, Jasmin; Vasseur, Francois; Stahl, Mark; von Roepenack-Lahaye, Edda; Kilian, Joachim; Stadelhofer, Bettina; Kremer, James M.; Kolb, Dagmar; Wenkel, Stephan; Zentgraf, Ulrike			The genetic interaction of REVOLUTA and WRKY53 links plant development, senescence, and immune responses	PLOS ONE			English	Article							SALICYLIC-ACID; LEAF SENESCENCE; ARABIDOPSIS-THALIANA; TRANSCRIPTION FACTORS; EXPRESSION PROFILES; BASAL RESISTANCE; DEFENSE; GROWTH; PATHOGEN; REVEALS	In annual plants, tight coordination of successive developmental events is of primary importance to optimize performance under fluctuating environmental conditions. The recent finding of the genetic interaction of WRKY53, a key senescence-related gene with REVOLUTA, a master regulator of early leaf patterning, raises the question of how early and late developmental events are connected. Here, we investigated the developmental and metabolic consequences of an alteration of the REVOLUTA and WRKY53 gene expression, from seedling to fruiting. Our results show that REVOLUTA critically controls late developmental phases and reproduction while inversely WRKY53 determines vegetative growth at early developmental stages. We further show that these regulators of distinct developmental phases frequently, but not continuously, interact throughout ontogeny and demonstrated that their genetic interaction is mediated by the salicylic acid (SA). Moreover, we showed that REVOLUTA and WRKY53 are keys regulatory nodes of development and plant immunity thought their role in SA metabolic pathways, which also highlights the role of REV in pathogen defence. Together, our findings demonstrate how late and early developmental events are tightly intertwined by molecular hubs. These hubs interact with each other throughout ontogeny, and participate in the interplay between plant development and immunity.	[Bresson, Justine; Doll, Jasmin; Stahl, Mark; von Roepenack-Lahaye, Edda; Kilian, Joachim; Stadelhofer, Bettina; Kolb, Dagmar; Zentgraf, Ulrike] Univ Tubingen, Gen Genet, ZMBP, Tubingen, Germany; [Vasseur, Francois] INRAE, Montpellier, France; [Vasseur, Francois] Univ Montpellier, LEPSE, INRAE, Inst Agro, Montpellier, France; [Kremer, James M.] Michigan State Univ, Dept Microbiol & Mol Genet, E Lansing, MI USA; [Wenkel, Stephan] Univ Copenhagen, Dept Plant & Environm Sci, Frederiksberg, Denmark; [Bresson, Justine] Univ Paul Valery Montpellier, CEFE, Uinv Montipiller, EPHE,CNRS, Montpellier, France; [Kremer, James M.] JoynBio, Boston, MA USA	Eberhard Karls University of Tubingen; INRAE; INRAE; Institut Agro; Universite de Montpellier; Michigan State University; University of Copenhagen; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier	Bresson, J; Zentgraf, U (corresponding author), Univ Tubingen, Gen Genet, ZMBP, Tubingen, Germany.	j.bresson34@gmail.com; ulrike.zentgraf@zmbp.uni-tuebingen.de		BRESSON, Justine/0000-0003-2365-5985	Institutional Strategy of the University of Tuebingen (Deutsche Forschungsgemeinschaft) [ZUK 63]; Alexander von Humboldt Foundation; Deutsche Forschungsgemeinschaft [CRC1101]	Institutional Strategy of the University of Tuebingen (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	JB was supported by the Institutional Strategy of the University of Tuebingen (Deutsche Forschungsgemeinschaft, ZUK 63) and also funded by the Alexander von Humboldt Foundation. This work was supported by the Deutsche Forschungsgemeinschaft (CRC1101, B06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder provided support in the formof salaries for authors [JB], but did not have any additional role in the study design, data collectionand analysis, decision to publish, or preparation of the manuscript. The specific roles of theseauthors are articulated in the `author contributions' section.	AUSUBEL FM, 1995, P NATL ACAD SCI USA, V92, P4189, DOI 10.1073/pnas.92.10.4189; Bartsch M, 2010, J BIOL CHEM, V285, P25654, DOI 10.1074/jbc.M109.092569; Boyes DC, 2001, PLANT CELL, V13, P1499, DOI 10.1105/tpc.13.7.1499; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brandt R, 2012, PLANT J, V72, P31, DOI 10.1111/j.1365-313X.2012.05049.x; Breeze E, 2011, PLANT CELL, V23, P873, DOI 10.1105/tpc.111.083345; Bresson J, 2018, J EXP BOT, V69, P769, DOI 10.1093/jxb/erx246; Bresson J, 2015, PLANT METHODS, V11, DOI 10.1186/s13007-015-0067-5; Chessel D., 2004, R NEWS, V4, P5; Dean JV, 2005, PLANTA, V221, P287, DOI 10.1007/s00425-004-1430-3; Dhar N, 2020, MOL PLANT MICROBE IN, V33, P754, DOI 10.1094/MPMI-11-19-0329-R; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Eulgem T, 2007, CURR OPIN PLANT BIOL, V10, P366, DOI 10.1016/j.pbi.2007.04.020; Francis KE, 2005, PLANT J, V41, P464, DOI 10.1111/j.1365-313X.2004.02312.x; Gan S., 2016, Increasing leaf longevity and disease resistance by altering salicylic acid catabolism, Patent No. [US20160312239A1, 20160312239]; Garcion C, 2008, PLANT PHYSIOL, V147, P1279, DOI 10.1104/pp.108.119420; Glawischnig E, 2007, PHYTOCHEMISTRY, V68, P401, DOI 10.1016/j.phytochem.2006.12.005; Guo Y, 2004, PLANT CELL ENVIRON, V27, P521, DOI 10.1111/j.1365-3040.2003.01158.x; Guo YF, 2012, PLANT CELL ENVIRON, V35, P644, DOI 10.1111/j.1365-3040.2011.02442.x; Haeffner Eva, 2015, Plants-Basel, V4, P449, DOI 10.3390/plants4030449; Have M, 2017, J EXP BOT, V68, P2513, DOI 10.1093/jxb/erw365; He YH, 2002, PLANT PHYSIOL, V128, P876, DOI 10.1104/pp.010843; Hong SY, 2020, DEVELOPMENT, V147, DOI 10.1242/dev.183681; Hu J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002589; Hu YR, 2012, PLANT SCI, V185, P288, DOI 10.1016/j.plantsci.2011.12.003; Huot B, 2014, MOL PLANT, V7, P1267, DOI 10.1093/mp/ssu049; Juarez MT, 2004, NATURE, V428, P84, DOI 10.1038/nature02363; Karasov TL, 2014, NATURE, V512, P436, DOI 10.1038/nature13439; Lim PO, 2007, ANNU REV PLANT BIOL, V58, P115, DOI 10.1146/annurev.arplant.57.032905.105316; Miao Y, 2004, PLANT MOL BIOL, V55, P853, DOI 10.1007/s11103-005-2142-1; Miao Y, 2007, PLANT MOL BIOL, V65, P63, DOI 10.1007/s11103-007-9198-z; Miao Y, 2007, PLANT CELL, V19, P819, DOI 10.1105/tpc.106.042705; Morris K, 2000, PLANT J, V23, P677, DOI 10.1046/j.1365-313x.2000.00836.x; Murray SL, 2007, MOL PLANT MICROBE IN, V20, P1431, DOI 10.1094/MPMI-20-11-1431; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Otsuga D, 2001, PLANT J, V25, P223, DOI 10.1046/j.1365-313x.2001.00959.x; Pandey SP, 2009, PLANT PHYSIOL, V150, P1648, DOI 10.1104/pp.109.138990; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pourtau N, 2004, PLANTA, V219, P765, DOI 10.1007/s00425-004-1279-5; Quirino BF, 1999, PLANT MOL BIOL, V40, P267, DOI 10.1023/A:1006199932265; Rousseau C, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-17; Rushton PJ, 2010, TRENDS PLANT SCI, V15, P247, DOI 10.1016/j.tplants.2010.02.006; Stice SP, 2020, CURR BIOL, V30, P3130, DOI 10.1016/j.cub.2020.05.092; TALBERT PB, 1995, DEVELOPMENT, V121, P2723; Teal TK, 2006, APPL ENVIRON MICROB, V72, P7324, DOI 10.1128/AEM.01163-06; Thomas H, 2013, NEW PHYTOL, V197, P696, DOI 10.1111/nph.12047; Vaca E, 2017, PHYSIOL PLANTARUM, V161, P322, DOI 10.1111/ppl.12602; Vasseur F, 2014, J EXP BOT, V65, P6457, DOI 10.1093/jxb/eru364; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wenkel S, 2007, PLANT CELL, V19, P3379, DOI 10.1105/tpc.107.055772; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Wingler A, 2006, J EXP BOT, V57, P391, DOI 10.1093/jxb/eri279; Xie Y, 2014, DEVELOPMENT, V141, P4772, DOI 10.1242/dev.117689; Zentgraf U, 2004, PLANT BIOLOGY, V6, P178, DOI 10.1055/s-2004-815735; Zentgraf U, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8120578; Zentgraf U, 2010, EUR J CELL BIOL, V89, P133, DOI 10.1016/j.ejcb.2009.10.014; Zhang KW, 2013, P NATL ACAD SCI USA, V110, P14807, DOI 10.1073/pnas.1302702110	58	2	2	5	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0254741	10.1371/journal.pone.0254741	http://dx.doi.org/10.1371/journal.pone.0254741			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333873	Green Published, Green Submitted, gold			2022-12-26	WOS:000784335700023
J	Dehghanbanadaki, H; Forouzanfar, K; Kakaei, A; Zeidi, S; Salehi, N; Arjmand, B; Razi, F; Hashemi, E				Dehghanbanadaki, Hojat; Forouzanfar, Katayoon; Kakaei, Ardeshir; Zeidi, Samaneh; Salehi, Negar; Arjmand, Babak; Razi, Farideh; Hashemi, Ehsan			The role of CDH2 and MCP-1 mRNAs of blood extracellular vesicles in predicting early-stage diabetic nephropathy	PLOS ONE			English	Article							RENAL-INSUFFICIENCY; ALBUMINURIA; EXPRESSION; ADULTS	BackgroundExtracellular vesicles (EVs), including exosomes and microvesicles, are involved in intercellular communication by transferring biomolecules such as mRNA, which has been shown to be as essential biomarkers for many physiological and pathological conditions such as diabetic nephropathy (DN). This study aimed to investigate the expression of CDH1, CDH2, MCP-1, and PAI-1 mRNAs in blood EVs of DN patients and to determine their accuracy in predicting early-stage DN. MethodsWe recruited 196 participants, including 35 overt DN patients, 53 incipient DN patients, 62 diabetic patients (DM), and 46 healthy individuals. Quantification of the mRNA profile of blood EVs was performed using the qRT-PCR method. The diagnostic performance of mRNA was evaluated using receiver operating characteristic analysis. ResultsThe mRNA expression of CDH2 and MCP-1 was downregulated in overt DN group (0.22-fold change and 0.15-fold change, respectively) and incipient DN group (0.60-fold change and 0.43-fold change, respectively) compared to DM group (1.72-fold change and 2.77-fold change, respectively), while PAI-1 mRNA expression decreased in incipient DN group (0.70-fold change) and DM group (0.58-fold change) compared to control. However, the expression level of CDH1 mRNA was not significantly different among the four groups (p = 0.408). Moreover, CDH2 and MCP-1 mRNAs inversely correlated with creatinine (r = -0.370 and r = -0.361, p<0.001) and Alb/Cr ratio (r = -0.355 and r = -0.297, p<0.001). 1/CDH2 mRNA also predicted overt DN with an accuracy of 0.75 (95%CI: 0.65-0.85) and incipient DN with an accuracy of 0.61 (95%CI: 0.50-0.71) while 1/MCP-1 mRNA had an accuracy of 0.66 (95%CI: 0.55-0.77) for overt DN prediction and an accuracy of 0.61 (95%CI: 0.51-0.71) for incipient DN prediction. ConclusionCDH2 and MCP-1 mRNAs expression in blood EVs was decreased with the development of DN, suggesting the renoprotective effect of these mRNAs in diabetic individuals. Moreover, their quantifications could serve as diagnostic biomarkers for early-stage DN.	[Dehghanbanadaki, Hojat; Zeidi, Samaneh; Salehi, Negar; Razi, Farideh; Hashemi, Ehsan] Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran; [Dehghanbanadaki, Hojat; Kakaei, Ardeshir] Univ Tehran Med Sci, Metabol & Genom Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Forouzanfar, Katayoon; Arjmand, Babak] Univ Tehran Med Sci, Metab Disorders Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Zeidi, Samaneh; Salehi, Negar; Hashemi, Ehsan] Natl Inst Genet Engn & Biotechnol, Dept Anim Biotechnol, Tehran, Iran; [Arjmand, Babak] Univ Tehran Med Sci, Cell Therapy & Regenerat Med Res Ctr, Endocrinol & Metab Mol Cellular Sci Inst, Tehran, Iran; [Razi, Farideh] Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences; Tehran University of Medical Sciences	Razi, F; Hashemi, E (corresponding author), Univ Tehran Med Sci, Diabet Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.; Hashemi, E (corresponding author), Natl Inst Genet Engn & Biotechnol, Dept Anim Biotechnol, Tehran, Iran.; Razi, F (corresponding author), Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran.	F-razi@tums.ac.ir; E_hashemi@nigeb.ac.ir		Dehghanbanadaki, Hojat/0000-0003-1057-0309; zeidi, Samaneh/0000-0003-3632-6187				Abbas SZ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71346-7; Abe H, 2018, J MED INVESTIG, V65, P208, DOI 10.2152/jmi.65.208; Afkarian M, 2016, JAMA-J AM MED ASSOC, V316, P602, DOI 10.1001/jama.2016.10924; Alicic RZ, 2017, CLIN J AM SOC NEPHRO, V12, P2032, DOI 10.2215/CJN.11491116; Barutta F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073798; Campion Carole G, 2017, Can J Kidney Health Dis, V4, p2054358117705371, DOI 10.1177/2054358117705371; Cao YH, 2015, AM J PHYSIOL-RENAL, V309, pF514, DOI 10.1152/ajprenal.00449.2014; Caramori ML, 2003, DIABETES, V52, P1036, DOI 10.2337/diabetes.52.4.1036; Chen B, 2017, EXP THER MED, V14, P6022, DOI 10.3892/etm.2017.5275; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Delic D, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150154; Deshmane SL, 2009, J INTERF CYTOK RES, V29, P313, DOI 10.1089/jir.2008.0027; Feng Y, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-03030-x; Fujitaka K, 2021, BIOMED REP, V14, DOI 10.3892/br.2020.1387; Fukuda A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-75320-1; Garcia-Carro C, 2021, J CLIN MED, V10, DOI 10.3390/jcm10112505; Hashemi E, 2021, J TRANSL MED, V19, DOI 10.1186/s12967-021-02964-6; Huang Y, 2008, J AM SOC NEPHROL, V19, P329, DOI 10.1681/ASN.2007040510; JOHNSTONE RM, 1987, J BIOL CHEM, V262, P9412; Kalani A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060177; Kato S, 1999, KIDNEY INT, V56, P1037, DOI 10.1046/j.1523-1755.1999.00643.x; Kim H, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1983-3; Kramer HJ, 2003, JAMA-J AM MED ASSOC, V289, P3273, DOI 10.1001/jama.289.24.3273; La Marca V, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091974; Lee WC, 2020, J CLIN MED, V9, DOI 10.3390/jcm9041220; Li ZL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114392; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu YF, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00943; Luo M, 2019, LIFE SCI, V239, DOI 10.1016/j.lfs.2019.117092; Mohan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154055; Monickaraj F, 2019, INVEST OPHTH VIS SCI, V60; Murakami T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109074; Narres M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147329; Nishad R, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.685447; Noren Hooten N, 2020, AM J PHYSIOL-CELL PH, V318, pC1189, DOI 10.1152/ajpcell.00536.2019; Oshima M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201535; Peng H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082607; Prabu P, 2019, DIABETES METAB, V45, P276, DOI 10.1016/j.diabet.2018.08.004; Puspitasari NA, 2019, AIP CONF PROC, V2092, DOI 10.1063/1.5096755; Reutens AT, 2011, CONTRIB NEPHROL, V170, P1, DOI 10.1159/000324934; Saenz-Pipaon G, 2021, J CLIN MED, V10, DOI 10.3390/jcm10102046; Tesch GH, 2008, AM J PHYSIOL-RENAL, V294, pF697, DOI 10.1152/ajprenal.00016.2008; Vousden KA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38842-x; Wang C, 2016, SCI REP-UK, V6, DOI 10.1038/srep20032; Xie YJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/6978984; Yang ZJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00900; Yi B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099633; Yokoyama H, 2009, NEPHROL DIAL TRANSPL, V24, P1212, DOI 10.1093/ndt/gfn603; Yuan F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164135; Zeinali F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251697; Zhang YM, 2020, ANN TRANSL MED, V8, DOI 10.21037/atm-20-5171; Zheng M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034824	52	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265619	10.1371/journal.pone.0265619	http://dx.doi.org/10.1371/journal.pone.0265619			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363774	Green Published, gold			2022-12-26	WOS:000804748600056
J	Kim, JH; Jiamsakul, A; Kiertiburanakul, S; Huy, BV; Khusuwan, S; Kumarasamy, N; Ng, OT; Ly, PS; Lee, MP; Chan, YJ; Gani, YM; Azwa, I; Avihingsanon, A; Merati, TP; Pujari, S; Chaiwarith, R; Zhang, FJ; Tanuma, J; Do, CD; Ditangco, R; Yunihastuti, E; Ross, J; Choi, JY				Kim, Jung Ho; Jiamsakul, Awachana; Kiertiburanakul, Sasisopin; Bui Vu Huy; Khusuwan, Suwimon; Kumarasamy, Nagalingeswaran; Ng, Oon Tek; Ly, Penh Sun; Lee, Man-Po; Chan, Yu-Jiun; Gani, Yasmin Mohamed; Azwa, Iskandar; Avihingsanon, Anchalee; Merati, Tuti Parwati; Pujari, Sanjay; Chaiwarith, Romanee; Zhang, Fujie; Tanuma, Junko; Cuong Duy Do; Ditangco, Rossana; Yunihastuti, Evy; Ross, Jeremy; Choi, Jun Yong		IeDEA Asia-Pacific	Patterns and prognosis of holding regimens for people living with HIV in Asian countries	PLOS ONE			English	Article							HIV-1-INFECTED PATIENTS; OBSERVATIONAL DATABASE; ANTIRETROVIRAL TREATMENT; CELL COUNT; RESISTANCE; FAILURE; MORTALITY; EVOLUTION; INFECTION; THERAPY	The use of holding regimens for people living with HIV (PLWH) without effective antiretroviral options can have effects on outcomes and future treatment options. We aimed to investigate the use of holding regimens for PLWH in Asian countries. Data from adults enrolled in routine HIV care in IeDEA Asia-Pacific cohorts were included. Individuals were considered to be on holding regimen if they had been on combination antiretroviral therapy for at least 6 months, had two confirmed viral loads (VL) >= 1000 copies/mL, and had remained on the same medications for at least 6 months. Survival time was analyzed using Fine and Gray's competing risk regression. Factors associated with CD4 changes and VL <1000 copies/mL were analyzed using linear regression and logistic regression, respectively. A total of 425 PLWH (72.9% male; 45.2% high-income and 54.8% low-to-middle-income country) met criteria for being on a holding regimen. From high-income countries, 63.0% were on protease inhibitors (PIs); from low-to-middle-income countries, 58.4% were on non-nucleoside reverse transcriptase inhibitors (NNRTIs); overall, 4.5% were on integrase inhibitors. The combination of lamivudine, zidovudine, and efavirenz was the most commonly used single regimen (n = 46, 10.8%), followed by lamivudine, zidovudine, and nevirapine (n = 37, 8.7%). Forty-one PLWH (9.7%) died during follow-up (mortality rate 2.0 per 100 person-years). Age >50 years compared to age 31-40 years (sub-hazard ratio [SHR] 3.29, 95% CI 1.45-7.43, p = 0.004), and VL >= 1000 copies/ml compared to VL <1000 copies/mL (SHR, 2.14, 95% CI 1.08-4.25, p = 0.029) were associated with increased mortality, while higher CD4 counts were protective. In our Asia regional cohort, there was a diversity of holding regimens, and the patterns of PI vs. NNRTI use differed by country income levels. Considering the high mortality rate of PLWH with holding regimen, efforts to extend accessibility to additional antiretroviral options are needed in our region.	[Kim, Jung Ho; Choi, Jun Yong] Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea; [Jiamsakul, Awachana] UNSW Sydney, Kirby Inst, Sydney, NSW, Australia; [Kiertiburanakul, Sasisopin] Mahidol Univ, Fac Med, Ramathibodi Hosp, Bangkok, Thailand; [Bui Vu Huy] Natl Hosp Trop Dis, Hanoi, Vietnam; [Khusuwan, Suwimon] Chiangrai Prachanukroh Hosp, Chiang Rai, Thailand; [Kumarasamy, Nagalingeswaran] VHS, Chennai Antiviral Res & Treatment Clin Res Site C, VHS Infect Dis Med Ctr, Chennai, Tamil Nadu, India; [Ng, Oon Tek] Tan Tock Seng Hosp, Singapore, Singapore; [Ly, Penh Sun] Natl Ctr HIV AIDS Dermatol & STDs, Phnom Penh, Cambodia; [Lee, Man-Po] Queen Elizabeth Hosp, Kowloon, Hong Kong, Peoples R China; [Chan, Yu-Jiun] Taipei Vet Gen Hosp, Taipei, Taiwan; [Gani, Yasmin Mohamed] Hosp Sungai Buloh, Sungai Buloh, Malaysia; [Azwa, Iskandar] Univ Malaya, Med Ctr, Kuala Lumpur, Malaysia; [Avihingsanon, Anchalee] HIV NAT Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Avihingsanon, Anchalee] Chulalongkorn Univ, Fac Med, TB Res Unit, Bangkok, Thailand; [Merati, Tuti Parwati] Udayana Univ, Fac Med, Denpasar, Bali, Indonesia; [Merati, Tuti Parwati] Sanglah Hosp, Denpasar, Bali, Indonesia; [Pujari, Sanjay] Inst Infect Dis, Pune, Maharashtra, India; [Chaiwarith, Romanee] Res Inst Hlth Sci, Chiang Mai, Thailand; [Zhang, Fujie] Capital Med Univ, Beijing Ditan Hosp, Beijing, Peoples R China; [Tanuma, Junko] Natl Ctr Global Hlth & Med, Tokyo, Japan; [Cuong Duy Do] Bach Mai Hosp, Hanoi, Vietnam; [Ditangco, Rossana] Res Inst Trop Med, Muntinlupa, Philippines; [Yunihastuti, Evy] Univ Indonesia, Dr Cipto Mangunkusumo Gen Hosp, Fac Med, Jakarta, Indonesia; [Ross, Jeremy] amfAR Fdn AIDS Res, TREAT Asia, Bangkok, Thailand	Yonsei University; Yonsei University Health System; University of New South Wales Sydney; Kirby Institute; Mahidol University; National Hospital of Tropical Diseases; Tan Tock Seng Hospital; Taipei Veterans General Hospital; Universiti Malaya; Thai Red Cross Society; Chulalongkorn University; Universitas Udayana; Sanglah General Hospital; Capital Medical University; National Center for Global Health & Medicine - Japan; Research Institute for Tropical Medicine - Philippines; University of Indonesia	Choi, JY (corresponding author), Yonsei Univ, Dept Internal Med, Coll Med, Seoul, South Korea.	seran@yuhs.ac	Azwa, Iskandar/N-9186-2017; Yunihastuti, Evy/AGD-5382-2022	Azwa, Iskandar/0000-0003-1977-6709; Yunihastuti, Evy/0000-0001-6650-0559; Choi, Jun Yong/0000-0002-2775-3315; Kim, Jung Ho/0000-0002-5033-3482	amfAR, The Foundation for AIDS Research; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases; Eunice Kennedy Shriver National Institute of Child Health and Human Development; National Cancer Institute; National Institute of Mental Health; National Institute on Drug Abuse; National Heart, Lung, and Blood Institute; National Institute on Alcohol Abuse and Alcoholism; National Institute of Diabetes and Digestive and Kidney Diseases; Fogarty International Center [IeDEA; U01AI069907]; Australian Government Department of Health and Ageing	amfAR, The Foundation for AIDS Research; U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Alcohol Abuse and Alcoholism(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing)	The TAHOD and TAHOD-LITE studies are initiatives of TREAT Asia, a program of amfAR, The Foundation for AIDS Research, with support from the U.S. National Institutes of Health's National Institute of Allergy and Infectious Diseases, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, the National Cancer Institute, the National Institute of Mental Health, the National Institute on Drug Abuse, the National Heart, Lung, and Blood Institute, the National Institute on Alcohol Abuse and Alcoholism, the National Institute of Diabetes and Digestive and Kidney Diseases, and the Fogarty International Center (IeDEA; U01AI069907). The Kirby Institute is funded by the Australian Government Department of Health and Ageing. The content of this research is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions above.	Gorrod HB, 2020, JAIDS-J ACQ IMM DEF, V84, P107, DOI 10.1097/QAI.0000000000002313; Bell-Gorrod H, 2020, AM J EPIDEMIOL, V189, P811, DOI 10.1093/aje/kwaa049; Clotet B, 2007, LANCET, V369, P1169, DOI 10.1016/S0140-6736(07)60497-8; Cockerham L, 2010, JAIDS-J ACQ IMM DEF, V53, P102, DOI 10.1097/QAI.0b013e3181b79d22; Cooper DA, 2008, NEW ENGL J MED, V359, P355, DOI 10.1056/NEJMoa0708978; Cossarini F, 2013, NEW MICROBIOL, V36, P23; De La Mata NL, 2017, INT J STD AIDS, V28, P1282, DOI 10.1177/0956462417699538; De La Mata NL, 2016, ANTIVIR THER, V21, P517, DOI 10.3851/IMP3041; Dorward P, 2018, LANCET HIV, V5, pE400, DOI 10.1016/S2352-3018(18)30093-6; Dutta A, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001907; Egger M, 2002, LANCET, V360, P119, DOI 10.1016/S0140-6736(02)09411-4; Goetz MB, 2006, JAIDS-J ACQ IMM DEF, V43, P541; Hatano H, 2010, JAIDS-J ACQ IMM DEF, V54, P389, DOI 10.1097/QAI.0b013e3181c42ea4; Inzaule SC, 2019, LANCET INFECT DIS, V19, pE246, DOI 10.1016/S1473-3099(18)30710-2; Jiamsakul A, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19053; Jung IY, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25219; Kantor R, 2004, AIDS, V18, P1503, DOI 10.1097/01.aids.0000131358.29586.6b; Kim NJ, 2019, INFECT CHEMOTHER, V51, P77, DOI 10.3947/ic.2019.51.1.77; Korean Soc AIDS, 2013, INFECT CHEMOTHER, V45, P455, DOI 10.3947/ic.2013.45.4.455; Kumarasamy N, 2019, CLIN INFECT DIS, V68, P1048, DOI 10.1093/cid/ciy763; Ledergerber B, 2004, LANCET, V364, P51, DOI 10.1016/S0140-6736(04)16589-6; Manosuthi W, 2015, AIDS RES THER, V12, DOI 10.1186/s12981-015-0053-z; Meyers T, 2007, J INFECT DIS, V196, pS474, DOI 10.1086/521116; Patten G, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205455; Phanuphak P, 2014, JAIDS-J ACQ IMM DEF, V66, P74, DOI 10.1097/QAI.0000000000000108; Pichenot M, 2012, HIV MED, V13, P148, DOI 10.1111/j.1468-1293.2011.00953.x; Raffanti SP, 2004, JAIDS-J ACQ IMM DEF, V37, P1147, DOI 10.1097/01.qai.0000136738.24090.d0; Sohn AH, 2020, J ADOLESCENT HEALTH, V66, P92, DOI 10.1016/j.jadohealth.2019.07.025; Steigbigel RT, 2008, NEW ENGL J MED, V359, P339, DOI 10.1056/NEJMoa0708975; Teeranaipong P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154221; The World Bank, 2015, COUNTR EC; Vitoria M, 2018, AIDS, V32, P1551, DOI 10.1097/QAD.0000000000001845; Worm SW, 2010, AIDS, V24, P1537, DOI 10.1097/QAD.0b013e32833a0918; Zhou J, 2005, JAIDS-J ACQ IMM DEF, V38, P174, DOI 10.1097/01.qai.0000145351.96815.d5; Zhou J, 2010, HIV MED, V11, P31, DOI 10.1111/j.1468-1293.2009.00738.x	35	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264157	10.1371/journal.pone.0264157	http://dx.doi.org/10.1371/journal.pone.0264157			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353840	Green Published, gold			2022-12-26	WOS:000786647900025
J	Kim, SB; Zoepfl, M; Samanta, P; Zhang, FM; Xia, K; Thara, R; Linhardt, RJ; Doerksen, RJ; McVoy, MA; Pomin, VH				Kim, Seon Beom; Zoepfl, Mary; Samanta, Priyanka; Zhang, Fuming; Xia, Ke; Thara, Reena; Linhardt, Robert J.; Doerksen, Robert J.; McVoy, Michael A.; Pomin, Vitor H.			Fractionation of sulfated galactan from the red alga Botryocladia occidentalis separates its anticoagulant and anti-SARS-CoV-2 properties	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RECEPTOR-BINDING DOMAIN; MILD ACID-HYDROLYSIS; BETA-GALACTAN; HEPARIN; SARS-COV-2; POLYSACCHARIDES; CORONAVIRUS; MECHANISMS; GLYCOSAMINOGLYCANS; OLIGOSACCHARIDES	Sulfation pattern and molecular weight (MW) play a key role in the biological actions of sulfated glycans. Besides anticoagulant effects, certain sulfated glycans can also exhibit antiSARS-CoV-2 properties. To develop a more selective antiviral carbohydrate, an efficient strategy to separate these two actions is required. In this work, low MW fractions derived from the red alga Botryocladia occidentalis sulfated galactan (BoSG) were generated, structurally characterized, and tested for activity against SARS-CoV-2 and blood coagulation. The lowest MW fraction was found to be primarily composed of octasaccharides of monosulfated monosaccharides. Unlike heparin or native BoSG, we found that hydrolyzed BoSG products had weak anticoagulant activities as seen by aPTT and inhibitory assays using purified cofactors. In contrast, lower MW BoSG-derivatives retained anti-SARS-CoV-2 activity using SARS-CoV-2 spike (S)-protein pseudotyped lentivirus vector in HEK-293T-hACE2 cells monitored by GFP. Surface plasmon resonance confirmed that longer chains are necessary for BoSG to interact with coagulation cofactors but is not required for interactions with certain S-protein variants. We observed distinct affinities of BoSG derivatives for the S-proteins of different SARS-CoV-2 strains, including WT, N501Y mutants, and stronger affinity for the N501Y-containing variants. Docking of the four possible monosulfated BoSG di	[Kim, Seon Beom; Samanta, Priyanka; Thara, Reena; Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Dept BioMol Sci, University, MS 38677 USA; [Zoepfl, Mary; McVoy, Michael A.] Virginia Commonwealth Univ, Dept Pediat, Richmond, VA USA; [Zhang, Fuming; Xia, Ke; Linhardt, Robert J.] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY USA; [Doerksen, Robert J.; Pomin, Vitor H.] Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA	University of Mississippi; Virginia Commonwealth University; Rensselaer Polytechnic Institute; University of Mississippi	Pomin, VH (corresponding author), Univ Mississippi, Dept BioMol Sci, University, MS 38677 USA.; Pomin, VH (corresponding author), Univ Mississippi, Sch Pharm, Res Inst Pharmaceut Sci, Oxford, MS 38677 USA.	vpomin@olemiss.edu	Kim, Seon Beom/AGP-7639-2022	Kim, Seon Beom/0000-0001-8015-1404; Zoepfl, Mary/0000-0003-4821-0907; xia, ke/0000-0001-9699-9901	AACP 2019 New Investigator Award; National Institutes of Health [1P20GM130460-01A1-7936, 1R03NS110996-01A1, S10OD028523]; University of Mississippi; National Science Foundation GlycoMIP [DMR 1933525]; Children's Hospital Foundation Research Fund; Virginia Commonwealth University COVID-19 Rapid Research Funding program	AACP 2019 New Investigator Award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Mississippi; National Science Foundation GlycoMIP; Children's Hospital Foundation Research Fund; Virginia Commonwealth University COVID-19 Rapid Research Funding program	This work was supported by funds from the AACP 2019 New Investigator Award (V. H. P.) , the National Institutes of Health [1P20GM130460-01A1-7936 (R. J. D. and V. H. P.) , 1R03NS110996-01A1 (V. H. P.) , and S10OD028523 (F. Z. and R. J. L.) ] , the University of Mississippi (V. H. P.) , the National Science Foundation GlycoMIP DMR 1933525 (F. Z. and R. J. L.) , and by funds from the Children's Hospital Foundation Research Fund (M. A. M.) and the Virginia Commonwealth Uni-versity COVID-19 Rapid Research Funding program (M. A. M.) . The content of the information does not necessarily reflect the position or the policy of the sponsors and no official endorsement should be inferred. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	A. J. Greaney, 2021, bioRxiv, DOI 10.1101/2020.12.31.425021; ALBANO RM, 1990, CARBOHYD RES, V208, P163, DOI 10.1016/0008-6215(90)80096-L; Alves AP, 1997, J BIOL CHEM, V272, P6965, DOI 10.1074/jbc.272.11.6965; Amornrut C, 1999, CARBOHYD RES, V321, P121, DOI 10.1016/S0008-6215(99)00188-3; Aranda P, 2020, RECENT PAT NANOTECH, V14, P328, DOI 10.2174/1872210514666201021145735; Barahona T, 2012, CARBOHYD RES, V347, P114, DOI 10.1016/j.carres.2011.11.014; Baum A, 2020, SCIENCE, V369, P1014, DOI 10.1126/science.abd0831; Beaudet JM, 2011, J PHARM SCI-US, V100, P3396, DOI 10.1002/jps.22527; Bezerra F. F., 2019, ENZYMATIC TECHNOLOGI, P111; Bezerra FF, 2020, J STRUCT BIOL, V209, DOI 10.1016/j.jsb.2019.107407; Carvalhal F, 2019, MAR DRUGS, V17, DOI 10.3390/md17030170; Castro MO, 2009, J BIOL CHEM, V284, P18790, DOI 10.1074/jbc.M109.005702; Chen XY, 2020, INT J BIOL MACROMOL, V164, P331, DOI 10.1016/j.ijbiomac.2020.07.106; Clausen TM, 2020, CELL, V183, P1043, DOI [10.1016/j.cell.2020.09.033, 10.1101/2020.07.14.201616]; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; CURRY N, 1973, ARCH INTERN MED, V132, P744, DOI 10.1001/archinte.132.5.744; de Siqueira IC, 2021, INT J INFECT DIS, V108, P252, DOI 10.1016/j.ijid.2021.05.010; Dwivedi R, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101207; Dwivedi R, 2020, MAR DRUGS, V18, DOI 10.3390/md18100514; Echternach M, 2020, AM J RESP CRIT CARE, V202, P1584, DOI 10.1164/rccm.202009-3438LE; Farias EHC, 2008, GLYCOBIOLOGY, V18, P250, DOI 10.1093/glycob/cwm139; Farias WRL, 2001, THROMB HAEMOSTASIS, V86, P1540, DOI 10.1055/s-0037-1616760; Farias WRL, 2000, J BIOL CHEM, V275, P29299, DOI 10.1074/jbc.M002422200; FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5; FARNDALE RW, 1982, CONNECT TISSUE RES, V9, P247, DOI 10.3109/03008208209160269; Ferron F, 2018, P NATL ACAD SCI USA, V115, pE162, DOI 10.1073/pnas.1718806115; Fonseca RJC, 2008, THROMB HAEMOSTASIS, V99, P539, DOI 10.1160/TH07-10-0603; Fujino T, 2021, EMERG INFECT DIS, V27, P1243, DOI 10.3201/eid2704.210138; GASTEIGER J, 1978, TETRAHEDRON LETT, P3181; GINSBERG JS, 1989, CHEST, V95, pS156, DOI 10.1378/chest.95.2.156S; GINSBERG JS, 1990, THROMB HAEMOSTASIS, V64, P286; Glauser BF, 2013, ADV CLIN CHEM, V62, P269, DOI 10.1016/B978-0-12-800096-0.00007-X; Glauser BF, 2009, THROMB HAEMOSTASIS, V102, P1183, DOI 10.1160/TH09-04-0273; Grubaugh ND, 2020, NAT MICROBIOL, V5, P529, DOI 10.1038/s41564-020-0690-4; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Huang HY, 2021, CELL DEATH DIFFER, V28, P2840, DOI 10.1038/s41418-021-00846-4; Jaitly N, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-87; Jin WH, 2020, INT J BIOL MACROMOL, V163, P1649, DOI 10.1016/j.ijbiomac.2020.09.184; KING DJ, 1984, ANN INTERN MED, V100, P535, DOI 10.7326/0003-4819-100-4-535; Kuhn JH, 2004, CELL MOL LIFE SCI, V61, P2738, DOI 10.1007/s00018-004-4242-5; Lan J, 2020, NATURE, V581, P215, DOI 10.1038/s41586-020-2180-5; Li F, 2005, SCIENCE, V309, P1864, DOI 10.1126/science.1116480; Li F, 2015, J VIROL, V89, P1954, DOI 10.1128/JVI.02615-14; Li JW, 2022, SPECTROCHIM ACTA A, V267, DOI 10.1016/j.saa.2021.120595; Li LY, 2012, ANAL CHEM, V84, P8822, DOI 10.1021/ac302232c; Liu Z, 2020, SSRN ELECT J, DOI [DOI 10.2139/SSRN.3551329, 10.2139/ssrn.3551329]; Marques J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24368; Maxwell E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045474; Melo FR, 2008, BBA-GEN SUBJECTS, V1780, P1047, DOI 10.1016/j.bbagen.2008.05.006; Melo FR, 2008, THROMB HAEMOSTASIS, V99, P531, DOI 10.1160/TH07-10-0649; Melo FR, 2004, J BIOL CHEM, V279, P20824, DOI 10.1074/jbc.M308688200; Moghaddar M, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9102167; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Mourao PAS, 2015, MAR DRUGS, V13, P2770, DOI 10.3390/md13052770; Mycroft-West CJ, 2020, THROMB HAEMOSTASIS, V120, P1700, DOI 10.1055/s-0040-1721319; OKELLY R, 1983, J CLIN ENDOCR METAB, V56, P108, DOI 10.1210/jcem-56-1-108; Peng MH, 2020, BIOMED PHARMACOTHER, V129, DOI 10.1016/j.biopha.2020.110499; Pereira MG, 2005, CARBOHYD RES, V340, P2015, DOI 10.1016/j.carres.2005.05.018; Pomin VH, 2005, GLYCOBIOLOGY, V15, P1376, DOI 10.1093/glycob/cwj030; Pomin VH, 2005, GLYCOBIOLOGY, V15, P369, DOI 10.1093/glycob/cwi021; Pomin VH, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14080714; Pomin VH, 2012, GLYCOBIOLOGY, V22, P826, DOI 10.1093/glycob/cws055; Pomin VH, 2011, ANAL CHEM, V83, P1162, DOI 10.1021/ac1031176; Prajapat M, 2021, INDIAN J PHARMACOL, V53, P310, DOI 10.4103/ijp.ijp_483_21; Queiroz INL, 2016, GLYCOBIOLOGY, V26, P1257, DOI 10.1093/glycob/cww080; Queiroz INL, 2015, GLYCOBIOLOGY, V25, P535, DOI 10.1093/glycob/cwu184; Quindere ALG, 2014, J THROMB HAEMOST, V12, P43, DOI 10.1111/jth.12448; Ramesh S, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9101195; Ray B, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13010136; Romano C. M., 2021, BRAZIL REV I MED TRO, V63; Salih AEM, 2021, MAR DRUGS, V19, DOI 10.3390/md19080406; Sampaio TBP, 2020, INT J BIOL MACROMOL, V158, P471, DOI 10.1016/j.ijbiomac.2020.04.085; Shahhosseini N, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9050926; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Singh AK, 2021, DIABETES METAB SYND, V15, DOI 10.1016/j.dsx.2021.102329; Stadnytskyi V, 2020, P NATL ACAD SCI USA, V117, P11875, DOI 10.1073/pnas.2006874117; Tandon R, 2021, J VIROL, V95, DOI [10.1128/JVI.01987-20, 10.1101/2020.06.08.140236]; Truhlar DG, 2007, J COMPUT CHEM, V28, P73, DOI 10.1002/jcc.20529; TSOU CL, 1951, BIOCHEM J, V49, P362, DOI 10.1042/bj0490362; Vandyck K, 2021, CURR OPIN VIROL, V49, P36, DOI 10.1016/j.coviro.2021.04.006; Vasconcelos AA, 2018, MAR DRUGS, V16, DOI 10.3390/md16090304; Wan YS, 2020, J VIROL, V94, DOI 10.1128/JVI.00127-20; WARKENTIN TE, 1995, NEW ENGL J MED, V332, P1330, DOI 10.1056/NEJM199505183322003; WARKENTIN TE, 1989, ANNU REV MED, V40, P31; Woods R., 2005, COMPLEX CARBOHYDRATE; Zoepfl M, 2021, ANTIVIR RES, V190, DOI 10.1016/j.antiviral.2021.105077; ZUCKER S, 1985, BIOCHIM BIOPHYS ACTA, V828, P196, DOI 10.1016/0167-4838(85)90057-3	87	2	2	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101856	10.1016/j.jbc.2022.101856	http://dx.doi.org/10.1016/j.jbc.2022.101856			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35337800	gold, Green Published			2022-12-26	WOS:000798142000005
J	Imbir, KK; Duda-Golawska, J; Sobieszek, A; Wielgopolan, A; Pastwa, M; Zygierewicz, J				Imbir, Kamil K.; Duda-Golawska, Joanna; Sobieszek, Adam; Wielgopolan, Adrianna; Pastwa, Maciej; Zygierewicz, Jaroslaw			Arousal, subjective significance and the origin of valence aligned words in the processing of an emotional categorisation task	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; LEXICAL DECISION; P300 COMPONENT; ERP EVIDENCE; STROOP TASK; CONCRETENESS; INTERFERENCE; PERFORMANCE; ADJECTIVES; DYNAMICS	An emotional categorisation task allows us to study how emotionality is understood and how emotional factors influence decisions. As emotionality is not only the valence but is also composed of activation (arousal and subjective significance) and the type of process needed to produce emotion (origin), we wanted to test the influence of these emotional factors on with a group of stimuli not differing in valence. We predicted that increasing activation levels should lead to increased classification of stimuli as emotional, with a focus on the late processing stages, when explicit word processing occurs, which on the electrophysiological level corresponds to P300, N450 and LPC components. The behavioural results showed that the emotionality of words increased with increasing levels of arousal and subjective significance. Automatically originated words were assessed as more emotional than reflective ones. The amplitude of the N450 component revealed dissociation for subjective significance and origin effects, showing that these two dimensions ascribe distinct properties of emotionality. Finally, the LPC component was susceptible to all affective dimensions used in manipulation. Our study showed that arousal, subjective significance and origin are dimensions of affect that shape the processing of words' emotionality, when the values of valence were aligned among the stimuli.	[Imbir, Kamil K.; Sobieszek, Adam; Wielgopolan, Adrianna; Pastwa, Maciej] Univ Warsaw, Fac Psychol, Warsaw, Poland; [Duda-Golawska, Joanna; Zygierewicz, Jaroslaw] Univ Warsaw, Fac Phys, Inst Expt Phys, Biomed Phys Div, Warsaw, Poland	University of Warsaw; University of Warsaw	Imbir, KK (corresponding author), Univ Warsaw, Fac Psychol, Warsaw, Poland.	kimbir@psych.uw.edu.pl			National Science Centre [2017/25/B/HS6/00198]	National Science Centre(National Science Centre, Poland)	The research, the data analysis, and manuscript preparation were funded by the National Science Centre on the basis of decision 2017/25/B/HS6/00198. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOSTA VW, 1992, INT J PSYCHOPHYSIOL, V13, P37, DOI 10.1016/0167-8760(92)90018-7; Antosz A, 2017, J COGN PSYCHOL, V29, P151, DOI 10.1080/20445911.2016.1226313; Citron FMM, 2012, BRAIN LANG, V122, P211, DOI 10.1016/j.bandl.2011.12.007; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Delaney-Busch N, 2016, COGN AFFECT BEHAV NE, V16, P415, DOI 10.3758/s13415-016-0402-y; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; DONCHIN E, 1988, BEHAV BRAIN SCI, V11, P357, DOI 10.1017/S0140525X00058027; Dresler T, 2009, PSYCHOL RES-PSYCH FO, V73, P364, DOI 10.1007/s00426-008-0154-6; Epstein S., 2003, HDB PSYCHOL, V5, P159, DOI DOI 10.1002/0471264385.WEI0507; Ferre P, 2018, SECOND LANG RES, V34, P371, DOI 10.1177/0267658317744008; Fischler I, 2006, PROG BRAIN RES, V156, P185, DOI 10.1016/S0079-6123(06)56009-1; Frings C, 2010, Q J EXP PSYCHOL, V63, P42, DOI 10.1080/17470210903156594; Gawronski B., 2013, OXFORD HDB SOCIAL CO, P282, DOI DOI 10.1093/OXFORDHB/9780199730018.013.0014; Gonzalez-Villar A, 2014, COGN AFFECT BEHAV NE, V14, P939, DOI 10.3758/s13415-013-0247-6; Hajcak G, 2010, DEV NEUROPSYCHOL, V35, P129, DOI 10.1080/87565640903526504; Hanslmayr S, 2008, J COGNITIVE NEUROSCI, V20, P215, DOI 10.1162/jocn.2008.20020; Herbert C, 2008, PSYCHOPHYSIOLOGY, V45, P487, DOI 10.1111/j.1469-8986.2007.00638.x; Herbert C, 2006, PSYCHOPHYSIOLOGY, V43, P197, DOI 10.1111/j.1469-8986.2006.00385.x; Hinojosa JA, 2020, LANG COGN NEUROSCI, V35, P877, DOI 10.1080/23273798.2020.1761988; Hinojosa JA, 2010, PSYCHOPHYSIOLOGY, V47, P748, DOI 10.1111/j.1469-8986.2010.00982.x; Hofmann MJ, 2009, COGN AFFECT BEHAV NE, V9, P389, DOI 10.3758/9.4.389; HOLM S, 1979, SCAND J STAT, V6, P65; Imbir K, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00608; Imbir KK, 2021, FRONT HUM NEUROSCI, V15, DOI 10.3389/fnhum.2021.617861; Imbir KK, 2020, FRONT HUM NEUROSCI, V14, DOI 10.3389/fnhum.2020.567220; Imbir KK, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.01981; Imbir KK, 2017, J PSYCHOLINGUIST RES, V46, P1549, DOI 10.1007/s10936-017-9505-z; Imbir KK, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00880; Imbir KK, 2016, NEW IDEAS PSYCHOL, V43, P39, DOI 10.1016/j.newideapsych.2016.04.001; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.01081; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00271; Imbir KK, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00075; Imbir KK, 2015, BEHAV RES METHODS, V47, P860, DOI 10.3758/s13428-014-0509-4; Imbir KK, ROLE VALENCE AROUSAL; Jarymowicz MT, 2015, EMOT REV, V7, P183, DOI 10.1177/1754073914555923; JOHNSON R, 1993, PSYCHOPHYSIOLOGY, V30, P90; Kanske P, 2007, BRAIN RES, V1148, P138, DOI 10.1016/j.brainres.2007.02.044; Kazoj J., 2011, SOWNIK FREKWENCYJNY; Kissler J, 2007, PSYCHOL SCI, V18, P475, DOI 10.1111/j.1467-9280.2007.01924.x; Koole SL, 2007, SELF IDENTITY, V6, P118, DOI 10.1080/15298860601118835; Larsen RJ, 2008, EMOTION, V8, P445, DOI 10.1037/1528-3542.8.4.445; Lin HY, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-58839-1; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Ma JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095198; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Mansor A.A., 2021, NEUROSCIENCE RES NOT, V4, P21, DOI [10.31117/NEUROSCIRN.V4I3.83, DOI 10.31117/NEUROSCIRN.V4I3.83, 10.31117/neuroscirn.v4i3.83]; Marchewka A, 2014, BEHAV RES METHODS, V46, P596, DOI 10.3758/s13428-013-0379-1; Ortiz-Teran E., 2013, NEUROSCI NEUROECONOM, V2, P33, DOI [10.2147/NAN.S48243, DOI 10.2147/NAN.S48243]; Palazova M, 2013, BRAIN LANG, V125, P264, DOI 10.1016/j.bandl.2013.02.008; Perez-Edgar K, 2003, BRAIN COGNITION, V52, P33, DOI 10.1016/S0278-2626(03)00007-1; PICTON TW, 1992, J CLIN NEUROPHYSIOL, V9, P456, DOI 10.1097/00004691-199210000-00002; R Core Team, 2017, R LANG ENV STAT COMP; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; Sass SM, 2010, PSYCHOPHYSIOLOGY, V47, P247, DOI 10.1111/j.1469-8986.2009.00926.x; Schacht A, 2009, BRAIN COGNITION, V69, P538, DOI 10.1016/j.bandc.2008.11.005; Strack F, 2004, PERS SOC PSYCHOL REV, V8, P220, DOI 10.1207/s15327957pspr0803_1; Thomas SJ, 2007, INT J PSYCHOPHYSIOL, V63, P221, DOI 10.1016/j.ijpsycho.2006.10.002; van Hooff JC, 2008, INT J PSYCHOPHYSIOL, V67, P23, DOI 10.1016/j.ijpsycho.2007.09.002; Wang L, 2015, COMPUT INTEL NEUROSC, V2015, DOI 10.1155/2015/108417; West R, 1999, COGNITIVE BRAIN RES, V8, P157, DOI 10.1016/S0926-6410(99)00017-8; West R, 2003, NEUROPSYCHOLOGIA, V41, P1122, DOI 10.1016/S0028-3932(02)00297-X; Yang HP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-45880-y; Yao Z, 2016, INT J PSYCHOPHYSIOL, V110, P231, DOI 10.1016/j.ijpsycho.2016.07.499; Zhang DD, 2014, SOC COGN AFFECT NEUR, V9, P1897, DOI 10.1093/scan/nst188	64	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265537	10.1371/journal.pone.0265537	http://dx.doi.org/10.1371/journal.pone.0265537			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358225	Green Published, gold			2022-12-26	WOS:000799828800039
J	Garai, ME; Roos, T; Eggeling, T; Ganswindt, A; Pretorius, Y; Henley, M				Garai, Marion E.; Roos, Tenisha; Eggeling, Tamara; Ganswindt, Andre; Pretorius, Yolanda; Henley, Michelle			Developing welfare parameters for African elephants (Loxodonta africana) in fenced reserves in South Africa	PLOS ONE			English	Article							FECAL GLUCOCORTICOID METABOLITES; NATIONAL-PARK; PHYSIOLOGICAL STRESS; SOCIAL COMPETENCE; ANIMAL-WELFARE; GAME RESERVE; HOME-RANGE; ECOLOGY; WILD; STEREOTYPIES	South Africa has many fenced reserves harbouring small to medium sized populations of African elephant (Loxodonta africana), most of which have been translocated. Elephants on fenced reserves may be exposed to various management interventions and practices (translocation, hunting, darting, high tourism impact, contraception programs, disruption due to infrastructure maintenance, etc.). These factors may impact the welfare of elephants. Poor elephant welfare may have serious consequences such as increased inter- and intra-species aggression that could result in fatalities. This is the first study to attempt to define behavioural and physiological welfare parameters for free-ranging elephants on small to medium sized reserves. The eight study sites incorporated reserves with different social structure combinations, elephant life-histories, reserve sizes, habitat, management, and tourism intensity. Data collection consisted of behavioural observations (10-minute videos) as well as faecal samples. By incorporating both behavioural and physiological (faecal glucocorticoid metabolite (fGCM) concentration) parameters, we aimed to investigate whether the two parameters showed similar trends. Five behavioural categories were identified (Arousal, Assessing, Ambivalent, Ambivalent/ Body care, and Frustrated behaviour), with various detailed behaviours demonstrated by the elephants that may indicate the influence of anthropogenic disturbance and possibly impact on animal welfare. The study showed significant differences between the selected detailed behaviours, behavioural categories and fGCM concentrations of elephants across the eight reserves. History seemed to be a decisive factor, as reserves with predominantly ex-captive elephants showed higher frequencies of certain behaviours as well as higher fGCM concentrations. Age, sex, reserve size and season were also found to contribute to our defined welfare indices and fGCM concentrations. This indicates that behavioural parameters, indicative of certain behavioural states, are valuable indicators of welfare, as supported by the physiological response of the elephants. The results also highlight the importance of taking multiple specified behaviours from a category into consideration when evaluating the welfare of elephants, to account for individual variation.	[Garai, Marion E.; Roos, Tenisha; Eggeling, Tamara] Elephant Reintegrat Trust, Port Alfred, South Africa; [Ganswindt, Andre] Univ Pretoria, Mammal Res Inst, Pretoria, South Africa; [Pretorius, Yolanda] Southern African Wildlife Coll, Hoedspruit, South Africa; [Henley, Michelle] Univ South Africa, Appl Behav Ecol & Environm Res Unit, Pretoria, South Africa; [Henley, Michelle] Elephants Alive, Hoedspruit, Limpopo, South Africa	University of Pretoria; University of South Africa	Garai, ME (corresponding author), Elephant Reintegrat Trust, Port Alfred, South Africa.	marion@elephantreintegrationtrust.co.za		Henley, Michelle/0000-0002-1675-7388; Garai, Marion/0000-0003-3884-624X	EMS Foundation [168-304NPO]; Elephant Reintegration Trust	EMS Foundation; Elephant Reintegration Trust	This study was funded by the EMS Foundation (Registration number: 168-304NPO). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. TR and TE received grants via the Elephant Reintegration Trust whom they are employees of. The specific roles of these authors are articulated in the `author contributions' section.	Alados CL, 1996, ANIM BEHAV, V51, P437, DOI 10.1006/anbe.1996.0040; Armstrong RA, 2014, OPHTHAL PHYSL OPT, V34, P502, DOI 10.1111/opo.12131; Asher L., 2015, WC1081 DEFRA; Boissy A, 2007, PHYSIOL BEHAV, V92, P375, DOI 10.1016/j.physbeh.2007.02.003; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bouche P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020619; Brakes P, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2020.2718; Briefer EF, 2012, J ZOOL, V288, P1, DOI 10.1111/j.1469-7998.2012.00920.x; Clubb R., 2002, REV WELFARE ZOO ELEP, P303; Creel S, 2013, FUNCT ECOL, V27, P66, DOI 10.1111/j.1365-2435.2012.02029.x; Curtis SE, 1986, ADV ANIMAL WELFARE S, P245; Dall SRX, 2004, ECOL LETT, V7, P734, DOI 10.1111/j.1461-0248.2004.00618.x; de Waal FBM, 2011, ANN NY ACAD SCI, V1224, P191, DOI 10.1111/j.1749-6632.2010.05912.x; Douglas-Hamilton I, 2005, NATURWISSENSCHAFTEN, V92, P158, DOI 10.1007/s00114-004-0606-9; Dublin Holly T., 2004, Human Dimensions of Wildlife, V9, P271, DOI 10.1080/10871200490505701; Fiess M, 1999, GEN COMP ENDOCR, V115, P76, DOI 10.1006/gcen.1999.7287; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Fraser A.F., 1990, FARM ANIMAL BEHAV WE; Ganswindt A, 2003, GEN COMP ENDOCR, V134, P156, DOI 10.1016/S0016-6480(03)00251-X; Ganswindt A, 2002, ZOO BIOL, V21, P27, DOI 10.1002/zoo.10034; Ganswindt A, 2010, WILDLIFE BIOL, V16, P323, DOI 10.2981/09-081; Garai ME., 1997, THESIS U PRETORIA; Garai ME, 2001, ELEFANT MENSCHENHAND, P273; Gobush KS, 2008, CONSERV BIOL, V22, P1590, DOI 10.1111/j.1523-1739.2008.01035.x; Graham MD, 2009, ANIM CONSERV, V12, P445, DOI 10.1111/j.1469-1795.2009.00272.x; Greco BJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144276; Gruber T, 2019, PALGR COMMUN, V5, DOI 10.1057/s41599-019-0271-4; Hampton J, 2018, CONSERV BIOL, V33, DOI [10.1111/cobi.13160, DOI 10.1111/COBI.13160]; Harris Mark, 2008, PICTURES REVOLUTION; Hu J, 2017, J EVOLUTION BIOL, V30, P1612, DOI 10.1111/jeb.13130; Hunninck L, 2017, CONSERV PHYSIOL, V5, DOI 10.1093/conphys/cox067; Ihwagi FW, 2019, J WILDLIFE MANAGE, V83, P1022, DOI 10.1002/jwmg.21688; Ihwagi FW, 2018, ECOL INDIC, V84, P38, DOI 10.1016/j.ecolind.2017.08.039; IUCN, 2021, IUCN SPEC INF SERV S; JACHMANN H, 1980, NETH J ZOOL, V30, P622, DOI 10.1163/002829679X00232; Jachowski DS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031818; Jordan B, 2005, REV SCI TECH OIE, V24, P515, DOI 10.20506/rst.24.2.1588; Kahl M. Philip, 2000, Elephant, V2, P19; Kempes MM, 2008, J COMP PSYCHOL, V122, P62, DOI 10.1037/0735-7036.122.1.62; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Kumar V, 2019, ANIMALS-BASEL, V9, DOI 10.3390/ani9080553; Kurt F, 2007, ASIAN ELEPHANT CAPTI, P196; LANGBAUER WR, 1989, CAN J ZOOL, V67, P2604, DOI 10.1139/z89-368; Latham N, 2010, BEHAV BRAIN RES, V211, P96, DOI 10.1016/j.bbr.2010.03.018; LEE PC, 1986, BEHAV ECOL SOCIOBIOL, V18, P353, DOI 10.1007/BF00299666; Lorenz K., 1988, HIER BIN ICH WO BIST, P24; Martinez-Freiria F, 2016, DIVERS DISTRIB, V22, P432, DOI 10.1111/ddi.12406; Mason GJ, 2010, ZOO BIOL, V29, P237, DOI 10.1002/zoo.20256; MASON GJ, 1991, BEHAV PROCESS, V25, P103, DOI 10.1016/0376-6357(91)90013-P; McComb K, 2001, SCIENCE, V292, P491, DOI 10.1126/science.1057895; Mellor DJ, 2017, ANIMALS-BASEL, V7, DOI 10.3390/ani7080060; Mendl M, 1999, APPL ANIM BEHAV SCI, V65, P221, DOI 10.1016/S0168-1591(99)00088-X; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Moss Cynthia, 1996, P58; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Ngene Shadrack, 2017, International Journal of Biodiversity and Conservation, V9, P9, DOI 10.5897/ijbc2016.1033; Ohl F, 2013, SCOTT NAT HERIT COMM, P1; Palme R, 2019, PHYSIOL BEHAV, V199, P229, DOI 10.1016/j.physbeh.2018.11.021; Paquet PC, 2010, ANIM WELFARE, V19, P177; Pinillos RG, 2016, VET REC, V179, P412, DOI 10.1136/vr.i5470; Poole JH, 1999, ANIM BEHAV, V58, P185, DOI 10.1006/anbe.1999.1117; POOLE JH, 1988, BEHAV ECOL SOCIOBIOL, V22, P385, DOI 10.1007/BF00294975; Poole Joyce H., 2011, P109; Pretorius Y, 2019, ORYX, V53, P757, DOI 10.1017/S0030605317001454; Rasmussen LEL, 1998, ANIM REPROD SCI, V53, P19, DOI 10.1016/S0378-4320(98)00124-9; Richter SH, 2019, APPL ANIM BEHAV SCI, V212, P1, DOI 10.1016/j.applanim.2018.12.012; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Rutherford MC, 2006, STRELITZIA, V19, P29; SAPOLSKY RM, 1989, AM J PRIMATOL, V18, P1, DOI 10.1002/ajp.1350180102; Scholes R. J., 2008, ELEPHANT MANAGEMENT; Selier S.A.J., 2016, RED LIST MAMMALS S A; Shannon G, 2006, AFR ZOOL, V41, P37, DOI 10.3377/1562-7020(2006)41[37:AEHRAH]2.0.CO;2; Shannon G, 2013, FRONT ZOOL, V10, DOI 10.1186/1742-9994-10-62; Szott ID, 2019, J ZOOL, V308, P164, DOI 10.1111/jzo.12661; Szott ID, 2020, WILDLIFE RES, V47, P34, DOI 10.1071/WR19045; Taborsky B, 2012, TRENDS ECOL EVOL, V27, P679, DOI 10.1016/j.tree.2012.09.003; Taborsky B, 2012, ANIM BEHAV, V83, P1067, DOI 10.1016/j.anbehav.2012.01.037; Teixeira CP, 2007, ANIM BEHAV, V73, P1, DOI 10.1016/j.anbehav.2006.06.002; Van der Weyde LK, 2016, GEN COMP ENDOCR, V226, P50, DOI 10.1016/j.ygcen.2015.12.022; van Praag H, 2000, NAT REV NEUROSCI, V1, P191, DOI 10.1038/35044558; Vijayakrishnan S, 2018, GEN COMP ENDOCR, V266, P150, DOI 10.1016/j.ygcen.2018.05.009; Viljoen Jozua J., 2008, Koedoe, V50, P18; Wall J, 2021, CURR BIOL, V31, P2437, DOI 10.1016/j.cub.2021.03.042; WECHSLER B, 1991, ZOO BIOL, V10, P177, DOI 10.1002/zoo.1430100209; WECHSLER B, 1995, APPL ANIM BEHAV SCI, V43, P123, DOI 10.1016/0168-1591(95)00557-9; Wemelsfelder F, 2001, ANIM BEHAV, V62, P209, DOI 10.1006/anbe.2001.1741; Whitehouse AM, 2000, ORYX, V34, P46, DOI 10.1046/j.1365-3008.2000.00093.x; Whitehouse AM, 2002, ORYX, V36, P243, DOI 10.1017/S0030605302000455; Wittemyer G, 2009, P ROY SOC B-BIOL SCI, V276, P3513, DOI 10.1098/rspb.2009.0941; Yon L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210783	90	0	0	3	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264931	10.1371/journal.pone.0264931	http://dx.doi.org/10.1371/journal.pone.0264931			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324916	Green Published, gold			2022-12-26	WOS:000780951300023
J	Sisk, BA; Baldwin, K; Parsons, M; DuBois, JM				Sisk, Bryan A.; Baldwin, Kari; Parsons, Meredith; DuBois, James M.			Ethical, regulatory, and practical barriers to COVID-19 research: A stakeholder-informed inventory of concerns	PLOS ONE			English	Article								Introduction SARS-CoV-2 (COVID-19) has caused death and economic injury around the globe. The urgent need for COVID-19 research created new ethical, regulatory, and practical challenges. The next public health emergency could be worse than COVID-19. We must learn about these challenges from the experiences of researchers and Research Ethics Committee professionals responsible for these COVID-19 studies to prepare for the next emergency. Materials and methods We conducted an online survey to identify the ethical, oversight, and regulatory challenges of conducting COVID-19 research during the early pandemic, and proposed solutions for overcoming these barriers. Using criterion-based, convenience sampling, we invited researchers who proposed or conducted COVID-19 research to complete an anonymous, online survey about their experiences. We administered a separate but related survey to Institutional Review Board (IRB) professionals who reviewed COVID-19 research studies. The surveys included open-ended and demographic items. We performed inductive content analysis on responses to open-ended survey questions. Results IRB professionals (n = 143) and researchers (n = 211) described 19 types of barriers to COVID-19 research, related to 5 overarching categories: policy and regulatory, biases and misperceptions, institutional and inter-institutional conflicts, risks of harm, and pressure of the pandemic. Researchers and IRB professionals described 8 categories of adaptations and solutions to these challenges: enacting technological solutions; developing protocol-based solutions; disposition and team management; establishing and communicating appropriate standards; national guidance and leadership; maintaining high standards; prioritizing studies before IRB review; and identifying and incorporating experts. Discussion and conclusions This inventory of challenges represents ongoing barriers to studying the current pandemic, and they represent a risk to research during future public health emergencies. Delays in studies of a pandemic during a pandemic threatens the health and safety of the public. We urge the development of a national working group to address these issues before the next public health emergency arises.	[Sisk, Bryan A.] Washington Univ, Sch Med, Dept Pediat, Div Hematol Oncol, St Louis, MO 63110 USA; [Sisk, Bryan A.; Baldwin, Kari; Parsons, Meredith; DuBois, James M.] Washington Univ, Sch Med, Dept Med, Div Gen Med Sci,Bioeth Res Ctr, St Louis, MO 63110 USA	Washington University (WUSTL); Washington University (WUSTL)	DuBois, JM (corresponding author), Washington Univ, Sch Med, Dept Med, Div Gen Med Sci,Bioeth Res Ctr, St Louis, MO 63110 USA.	duboisjm@wustl.edu		DuBois, James/0000-0002-3712-7051; Sisk, Bryan/0000-0002-2456-2476	National Institute on Aging [R01AG05825403S1]; National Center for Advancing Translational Science [UL1TR002345]	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Advancing Translational Science	This project was supported by the National Institute on Aging grant R01AG05825403S1 (DuBois, PI) and the National Center for Advancing Translational Science grant UL1TR002345 (DuBois). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. https://www.nia.nih.gov/https://ncats.nih.gov/.	[Anonymous], 1997, JAMA-J AM MED ASSOC, V277, P925; [Anonymous], 2021, CDC MUSEUM COVID 19; [Anonymous], 2021, CDC COVID DATA TRACK; [Anonymous], 2020, FDA GUIDANCE CONDUCT; [Anonymous], 2020, OHRP GUID COVID 19; [Anonymous], 2021, TIMELINE COVID 19 DE; Bahans C, 2021, ETHICS MED PUBLIC HL, V16; Beach MC, 2020, ANN INTERN MED, V173, P926, DOI 10.7326/M20-4631; Blumenthal-Barby J, 2021, J MED ETHICS, V47, P585, DOI 10.1136/medethics-2020-106901; Boetto E, 2021, J MED ETHICS, V47, DOI 10.1136/medethics-2020-106639; Bramstedt KA, 2020, J MED ETHICS, V46, P803, DOI 10.1136/medethics-2020-106494; Branch-Elliman Westyn, 2021, Narrat Inq Bioeth, V11, P8, DOI 10.1353/nib.2021.0003; Brandt Karl, 1949, MED CASE TRIALS WAR; Bull S, 2021, J MED ETHICS, V47, DOI 10.1136/medethics-2020-106504; Citerio G, 2020, INTENS CARE MED, V46, P1521, DOI 10.1007/s00134-020-06155-7; Damschroder LJ, 2009, IMPLEMENT SCI, V4, DOI 10.1186/1748-5908-4-50; DuBois JM, 2018, ACAD MED, V93, P586, DOI 10.1097/ACM.0000000000001804; DuBois JM, 2016, NATURE, V534, P173, DOI 10.1038/534173a; El-Menyar Ayman, 2021, Sci Prog, V104, p368504211016936, DOI 10.1177/00368504211016936; Elo S, 2008, J ADV NURS, V62, P107, DOI 10.1111/j.1365-2648.2007.04569.x; Evans NG, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00669-20; Herper M., 2020, STATE NEWS 0706; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Iyer Alexander A, 2020, Ethics Hum Res, V42, P35, DOI 10.1002/eahr.500061; Jayaweera D, 2021, J CLIN TRANSL SCI, V5, DOI 10.1017/cts.2021.784; Khoo EJ, 2020, ACTA PAEDIATR, V109, P1323, DOI 10.1111/apa.15307; Lapid MI, 2021, MAYO CLIN PROC, V96, P165, DOI 10.1016/j.mayocp.2020.10.021; Largent EA, 2021, ANN INTERN MED, V174, P415, DOI 10.7326/M20-6993; Lipworth W, 2020, J BIOETHIC INQ, V17, P555, DOI 10.1007/s11673-020-10013-y; London AJ, 2020, SCIENCE, V368, P476, DOI 10.1126/science.abc1731; Meyer MN, 2021, CLIN TRIALS, V18, P226, DOI 10.1177/1740774520988669; Moodley K, 2020, SAMJ S AFR MED J, V110, P629, DOI 10.7196/SAMJ.2020.v110i7.14918; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; primrconnect, WEBINAR FOLLOW UP CO; Singh S, 2022, J MED ETHICS, V48, P466, DOI 10.1136/medethics-2020-106858; Sisk BA, 2021, JCO ONCOL PRACT, V17, P359, DOI 10.1200/OP.20.01038; Sisk BA, 2021, CANCER-AM CANCER SOC, V127, P2130, DOI 10.1002/cncr.33467; Sisk BA, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1193; Sisk BA, 2020, AM J BIOETHICS, V20, P62, DOI 10.1080/15265161.2020.1730483; Spector-Bagdady K, 2020, HASTINGS CENT REP, V50, P9, DOI 10.1002/hast.1112; Yeo-Teh NSL, 2021, ACCOUNT RES, V28, P47, DOI 10.1080/08989621.2020.1782203; Zhang H, 2020, JAMA-J AM MED ASSOC, V323, P1844, DOI 10.1001/jama.2020.4362	42	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265252	10.1371/journal.pone.0265252	http://dx.doi.org/10.1371/journal.pone.0265252			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324933	Green Published, gold			2022-12-26	WOS:000780951300034
J	Vlachogiannis, P; Hillered, L; Enblad, P; Ronne-Engstrom, E				Vlachogiannis, Pavlos; Hillered, Lars; Enblad, Per; Ronne-Engstrom, Elisabeth			Temporal patterns of inflammation-related proteins measured in the cerebrospinal fluid of patients with aneurysmal subarachnoid hemorrhage using multiplex Proximity Extension Assay technology	PLOS ONE			English	Article							SOLUBLE CD40 LIGAND; EARLY BRAIN-INJURY; CEREBRAL VASOSPASM; RECEPTOR ANTAGONIST; DOUBLE-BLIND; BLOOD-FLOW; ASSOCIATION; CLAZOSENTAN; ISCHEMIA; WORLD	Background The complexity of the inflammatory response post subarachnoid hemorrhage (SAH) may require temporal analysis of multiple protein biomarkers simultaneously to be more accurately described. Methods Ventricular cerebrospinal fluid was collected at days 1, 4 and 10 after SAH in 29 patients. Levels of 92 inflammation-related proteins were simultaneously measured using Target 96 Inflammation (R) assay (Olink Proteomics, Uppsala, Sweden) based on Proximity Extension Assay (PEA) technology. Twenty-eight proteins were excluded from further analysis due to lack of > 50% of measurable values. Temporal patterns of the remaining 64 proteins were analyzed. Repeated measures ANOVA and its nonparametric equivalent Friedman's ANOVA were used for comparisons of means between time points. Results Four different patterns (Groups A-D) were visually observed with an early peak and gradually decreasing trend (11 proteins), a middle peak (10 proteins), a late peak after a gradually increasing trend (30 proteins) and no specific pattern (13 proteins). Statistically significant early peaks defined as Day 1 > Day 4 values were noticed in 4 proteins; no significant decreasing trends defined as Day 1 > Day 4 > Day 10 values were observed. Two proteins showed significant middle peaks (i.e. Day 1 < Day 4 > Day 10 values). Statistically significant late peaks (i.e. Day 4 < Day 10 values) and increasing trends (i.e. Day 1 < Day 4 < Day 10 values) were observed in 14 and 10 proteins, respectively. Four of Group D proteins showed biphasic peaks and the rest showed stable levels during the observation period. Conclusion The comprehensive data set provided in this explorative study may act as an illustration of an inflammatory profile of the acute phase of SAH showing groups of potential protein biomarkers with similar temporal patterns of activation, thus facilitating further research on their role in the pathophysiology of the disease.	[Vlachogiannis, Pavlos; Hillered, Lars; Enblad, Per; Ronne-Engstrom, Elisabeth] Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden	Uppsala University	Vlachogiannis, P (corresponding author), Uppsala Univ, Dept Neurosci, Neurosurg, Uppsala, Sweden.	pavlos.vlachogiannis@neuro.uu.se			ALF (Avtal om Lakarutbildning och Forskning)	ALF (Avtal om Lakarutbildning och Forskning)	This research project was funded by ALF means (i.e. Avtal om Lakarutbildning och Forskning), that is governmental funding for medical doctors under training for parallel research. This funding had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1578-1; Alaraj A, 2009, NEUROL RES, V31, P651, DOI 10.1179/174313209X382395; Assarsson E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095192; Backryd E, 2017, PAIN, V158, P2487, DOI 10.1097/j.pain.0000000000001061; Budohoski KP, 2014, J NEUROL NEUROSUR PS, V85, P1343, DOI 10.1136/jnnp-2014-307711; Chen XD, 2015, THROMB RES, V136, P24, DOI 10.1016/j.thromres.2015.03.025; Chu SH, 2011, MOL MED REP, V4, P785, DOI 10.3892/mmr.2011.500; Manoel ALD, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00292; Dyhrfort P, 2019, J NEUROTRAUM, V36, P2872, DOI 10.1089/neu.2018.6320; Ericson H, 2019, PAIN, V160, P2603, DOI 10.1097/j.pain.0000000000001649; Fassbender K, 2001, J NEUROL NEUROSUR PS, V70, P534, DOI 10.1136/jnnp.70.4.534; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gadani SP, 2015, NEURON, V87, P47, DOI 10.1016/j.neuron.2015.05.019; Greenwood Christina, 2015, Biomol Detect Quantif, V4, P10, DOI 10.1016/j.bdq.2015.04.002; Gris T, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1629-7; Hanafy KA, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-83; Helbok R, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0809-9; Hollig A, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00694; Hollig A, 2015, CLIN NEUROL NEUROSUR, V138, P177, DOI 10.1016/j.clineuro.2015.08.030; JENNETT B, 1975, LANCET, V1, P480; Johansson M, 2001, STROKE, V32, P2845, DOI 10.1161/hs1201.099416; Kiiski H, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00144; Kim GH, 2008, J NEUROSURG, V109, P38, DOI 10.3171/JNS/2008/109/7/0038; Kubo Y, 2016, CRIT CARE RESUSC, V18, P242; Kusaka G, 2004, J CEREBR BLOOD F MET, V24, P916, DOI 10.1097/01.WCB.0000125886.48838.7E; Lepennetier G, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1601-6; Liu L, 2016, MOL NEUROBIOL, V53, P4529, DOI 10.1007/s12035-015-9386-9; Lucke-Wold BP, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17040497; Lv SY, 2018, WORLD NEUROSURG, V111, pE355, DOI 10.1016/j.wneu.2017.12.076; Macdonald RL, 2008, STROKE, V39, P3015, DOI 10.1161/STROKEAHA.108.519942; Macdonald RL, 2017, LANCET, V389, P655, DOI 10.1016/S0140-6736(16)30668-7; Macdonald RL, 2014, NAT REV NEUROL, V10, P44, DOI 10.1038/nrneurol.2013.246; Macdonald RL, 2011, LANCET NEUROL, V10, P618, DOI 10.1016/S1474-4422(11)70108-9; Mathiesen T, 1997, J NEUROSURG, V87, P215, DOI 10.3171/jns.1997.87.2.0215; Mellergard P, 2010, BRIT J NEUROSURG, V24, P261, DOI 10.3109/02688690903521605; Mohme M, 2020, TRANSL STROKE RES, V11, P1348, DOI 10.1007/s12975-019-00764-1; Niwa A, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0675-7; Ohkuma H, 2000, STROKE, V31, P1621, DOI 10.1161/01.STR.31.7.1621; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Provencio JJ, 2013, ACTA NEUROCHIR SUPPL, V115, P233, DOI 10.1007/978-3-7091-1192-5_42; Sarrafzadeh A, 2010, NEUROCRIT CARE, V13, P339, DOI 10.1007/s12028-010-9432-4; Savarraj JPJ, 2017, NEUROLOGY, V88, P1535, DOI 10.1212/WNL.0000000000003842; Schneider UC, 2018, CURR NEUROPHARMACOL, V16, P1385, DOI 10.2174/1570159X16666180412110919; Schoch B, 2007, NEUROSURGERY, V60, P828, DOI 10.1227/01.NEU.0000255440.21495.80; Sehba FA, 2011, MOL NEUROBIOL, V43, P27, DOI 10.1007/s12035-010-8155-z; TEASDALE GM, 1988, J NEUROL NEUROSUR PS, V51, P1457, DOI 10.1136/jnnp.51.11.1457; Wang Yong, 2007, Neurosci Bull, V23, P151, DOI 10.1007/s12264-007-0022-1; Wicinski M, 2019, BIOMED RES INT, V2019, DOI 10.1155/2019/8759231; Zeiler FA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00379; Zhang WG, 2012, EXP NEUROL, V233, P799, DOI 10.1016/j.expneurol.2011.11.046	50	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0263460	10.1371/journal.pone.0263460	http://dx.doi.org/10.1371/journal.pone.0263460			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324941	Green Published, gold			2022-12-26	WOS:000780951300010
J	Abbas, ME; Zhu, CZ; Fathalla, A; Xiao, YL				Abbas, Mohamed Elsayed; Zhu Chengzhang; Fathalla, Ahmed; Xiao, Yalong			End-to-end antigenic variant generation for H1N1 influenza HA protein using sequence to sequence models	PLOS ONE			English	Article							HEMAGGLUTINATION-INHIBITION; PREDICTION	The growing risk of new variants of the influenza A virus is the most significant to public health. The risk imposed from new variants may have been lethal, as witnessed in the year 2009. Even though the improvement in predicting antigenicity of influenza viruses has rapidly progressed, few studies employed deep learning methodologies. The most recent literature mostly relied on classification techniques, while a model that generates the HA protein of the antigenic variant is not developed. However, the antigenic pair of influenza virus A can be determined in a laboratory setup, the process needs a tremendous amount of time and labor. Antigenic shift and drift which are caused by changes in surface protein favored the influenza A virus in evading immunity. The high frequency of the minor changes in the surface protein poses a challenge to identifying the antigenic variant of an emerging virus. These changes slow down vaccine selection and the manufacturing process. In this vein, the proposed model could help save the time and efforts exerted to identify the antigenic pair of the influenza virus. The proposed model utilized an end-to-end learning methodology relying on deep sequence-to-sequence architecture to generate the antigenic variant of a given influenza A virus using surface protein. Employing the BLEU score to evaluate the generated HA protein of the antigenic variant of influenza virus A against the actual variant, the proposed model achieved a mean accuracy of 97.57%.	[Abbas, Mohamed Elsayed; Zhu Chengzhang; Xiao, Yalong] Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China; [Zhu Chengzhang; Xiao, Yalong] Cent South Univ, Coll Literature & Journalism, Changsha, Peoples R China; [Abbas, Mohamed Elsayed; Zhu Chengzhang] Mobile Hlth Minist Educ, China Mobile Joint Lab, Changsha, Peoples R China; [Fathalla, Ahmed] Suez Canal Univ, Fac Sci, Dept Math, Ismailia, Egypt	Central South University; Central South University; Egyptian Knowledge Bank (EKB); Suez Canal University	Abbas, ME (corresponding author), Cent South Univ, Sch Comp Sci & Engn, Changsha, Peoples R China.; Abbas, ME (corresponding author), Mobile Hlth Minist Educ, China Mobile Joint Lab, Changsha, Peoples R China.	abas0888@gmail.com	Abbas, Mohamed/AAL-1202-2020	Abbas, Mohamed/0000-0002-3141-2900; Fathalla, Ahmed/0000-0001-5432-5407	National Key R\&D Program of China [2018AAA0102100]; Scientific and Technological Innovation Leading Plan of High-tech Industry of Hunan Province [2020GK2021]; National Natural Science Foundation of China [61902434]; Natural Science Foundation of Hunan Province, China [2019JJ50826]	National Key R\&D Program of China; Scientific and Technological Innovation Leading Plan of High-tech Industry of Hunan Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	zhu National Key R\&D Program of China (2018AAA0102100). NO. zhu Scientific and Technological Innovation Leading Plan of High-tech Industry of Hunan Province(2020GK2021). NO. zhu National Natural Science Foundation of China (No. 61902434). NO. zhu Natural Science Foundation of Hunan Province, China (No. 2019JJ50826). NO. Please note that the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Bahdanau D., 2014, NEURAL MACHINE TRANS; Bandi Hari, 2020, MACH LEARN HEALTHC C, P121; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Cho K., 2014, C EMPIRICAL METHODS, P1724; Chopra S., 2016, P 2016 C N AM CHAPT; Chung J., 2014, NIPS 2014 WORKSH DEE; Degoot AM, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46740-5; Devlin J., 2018, ARXIV181004805; Donahue J, 2015, PROC CVPR IEEE, P2625, DOI 10.1109/CVPR.2015.7298878; Fan Y, 2014, PROCEEDINGS OF THE ASME INTERNATIONAL TECHNICAL CONFERENCE AND EXHIBITION ON PACKAGING AND INTEGRATION OF ELECTRONIC AND PHOTONIC MICROSYSTEMS, 2013, VOL 2; Forghani M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12091019; Graves A, 2014, PR MACH LEARN RES, V32, P1764; Hochreiter S., 1997, STUD COMPUT INTELL, DOI DOI 10.1007/978-3-642-24797-2; Jin Q., 2019, ARXIV PREPRINT ARXIV; Kiros R, 2014, PR MACH LEARN RES, V32, P595; Klein Guillaume., 2017, ARXIV PREPRINT ARXIV; Lee EK, 2020, HUM VACC IMMUNOTHER, V16, P2690, DOI 10.1080/21645515.2020.1734397; Liao YC, 2008, BIOINFORMATICS, V24, P505, DOI 10.1093/bioinformatics/btm638; Luong M.-T., 2015, ARXIV PREPRINT ARXIV; Mao J, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.515; Miao YJ, 2015, 2015 IEEE WORKSHOP ON AUTOMATIC SPEECH RECOGNITION AND UNDERSTANDING (ASRU), P167, DOI 10.1109/ASRU.2015.7404790; Mikolov T., 2013, CORR ABS13013781; Nallapati R, 2017, AAAI CONF ARTIF INTE, P3075; Ndifon W, 2009, VACCINE, V27, P2447, DOI 10.1016/j.vaccine.2009.02.047; Neher RA, 2016, P NATL ACAD SCI USA, V113, pE1701, DOI 10.1073/pnas.1525578113; Papineni K, 2002, 40TH ANNUAL MEETING OF THE ASSOCIATION FOR COMPUTATIONAL LINGUISTICS, PROCEEDINGS OF THE CONFERENCE, P311, DOI 10.3115/1073083.1073135; Peng YF, 2019, SIGBIOMED WORKSHOP ON BIOMEDICAL NATURAL LANGUAGE PROCESSING (BIONLP 2019), P58; Peng YS, 2017, SCI REP-UK, V7, DOI 10.1038/srep42051; Peng Yousong., 2020, BIOSAFETY HLTH, V2, P117, DOI [10.1016/j.bsheal.2020.04.002, DOI 10.1016/J.BSHEAL.2020.04.002]; Raffel Colin, 2019, ABS191010683 ARXIV; Rush A. M., 2015, P 2015 C EMPIRICAL M; Sun HL, 2013, MBIO, V4, DOI 10.1128/mBio.00230-13; Sun HL, 2020, P NATL ACAD SCI USA, V117, P17204, DOI 10.1073/pnas.1921186117; Sutskever I., 2014, NEURAL INFORM PROCES, P3104; Szegedy C, 2015, PROC IEEE C COMPUTER, P1, DOI DOI 10.1109/CVPR.2015.7298594; Tenforde MW, 2021, CLIN INFECT DIS, V73, pE4244, DOI 10.1093/cid/ciaa1884; Valkenburg Sophie A, 2022, NAT MED, P1; Xie H, 2015, SCI REP-UK, V5, DOI 10.1038/srep15279; Xu K, 2015, PR MACH LEARN RES, V37, P2048; Yao YH, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01699-z; Yin Rui, 2021, IEEE/ACM Trans Comput Biol Bioinform, VPP, DOI 10.1109/TCBB.2021.3108971; Yin R, 2020, BIOINFORMATICS, V36, P2697, DOI 10.1093/bioinformatics/btaa050; Yin R, 2020, J BIOINF COMPUT BIOL, V18, DOI 10.1142/S0219720020400028; Yin R, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207777; You, 2019, ARXIV PREPRINT ARXIV; Zacour M, 2016, CLIN VACCINE IMMUNOL, V23, P236, DOI 10.1128/CVI.00613-15	47	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266198	10.1371/journal.pone.0266198	http://dx.doi.org/10.1371/journal.pone.0266198			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344562	Green Published, gold			2022-12-26	WOS:000788055200002
J	Alhuthali, S; Kontoravdi, C				Alhuthali, Sakhr; Kontoravdi, Cleo			Population balance modelling captures host cell protein dynamics in CHO cell cultures	PLOS ONE			English	Article							PLASMA-MEMBRANE FLUIDITY; GROWTH-RATE; MONOCLONAL-ANTIBODIES; MATHEMATICAL-MODEL; BATCH CULTIVATION; SIZE DISTRIBUTION; ELEVATED PCO(2); DEATH RATE; KINETICS; VOLUME	Monoclonal antibodies (mAbs) have been extensively studied for their wide therapeutic and research applications. Increases in mAb titre has been achieved mainly by cell culture media/feed improvement and cell line engineering to increase cell density and specific mAb productivity. However, this improvement has shifted the bottleneck to downstream purification steps. The higher accumulation of the main cell-derived impurities, host cell proteins (HCPs), in the supernatant can negatively affect product integrity and immunogenicity in addition to increasing the cost of capture and polishing steps. Mathematical modelling of bioprocess dynamics is a valuable tool to improve industrial production at fast rate and low cost. Herein, a single stage volume-based population balance model (PBM) has been built to capture Chinese hamster ovary (CHO) cell behaviour in fed-batch bioreactors. Using cell volume as the internal variable, the model captures the dynamics of mAb and HCP accumulation extracellularly under physiological and mild hypothermic culture conditions. Model-based analysis and orthogonal measurements of lactate dehydrogenase activity and double-stranded DNA concentration in the supernatant show that a significant proportion of HCPs found in the extracellular matrix is secreted by viable cells. The PBM then served as a platform for generating operating strategies that optimise antibody titre and increase cost-efficiency while minimising impurity levels.	[Alhuthali, Sakhr; Kontoravdi, Cleo] Imperial Coll London, Dept Chem Engn, London, England	Imperial College London	Alhuthali, S (corresponding author), Imperial Coll London, Dept Chem Engn, London, England.	s.alhuthali15@imperial.ac.uk		Kontoravdi, Cleo/0000-0003-0213-4830; Alhuthali, Sakhr/0000-0002-7690-1943				Ahmad W, 2015, CELLULOSE, V22, P151, DOI 10.1007/s10570-014-0529-3; AIBA S, 1971, AICHE J, V17, P608, DOI 10.1002/aic.690170324; Alhuthali S, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22073290; Amribt Z, 2013, BIOCHEM ENG J, V70, P196, DOI 10.1016/j.bej.2012.11.005; ANDERSON EC, 1969, BIOPHYS J, V9, P246, DOI 10.1016/S0006-3495(69)86383-6; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; BELL GI, 1967, BIOPHYS J, V7, P329, DOI 10.1016/S0006-3495(67)86592-5; Bertucco A, 2015, AICHE J, V61, P2702, DOI 10.1002/aic.14893; Bi JX, 2004, BIOTECHNOL BIOENG, V85, P741, DOI 10.1002/bit.20025; Bucala V., 2007, CHEM ENG EDUC, V41, P209; Cadart C, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05393-0; Chakrabarti S, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060913; Charlebois Daniel A., 2018, In Silico Biology, V13, P21, DOI 10.3233/ISB-180470; Chaudhuri S., 2015, J BIOPROCESSING BIOT; Chen WX, 2016, CHEM SCI, V7, P1393, DOI 10.1039/c5sc03826j; Cheung MC, 2013, CYTOM PART A, V83A, P540, DOI 10.1002/cyto.a.22277; Cho MH, 2008, TOXICOL IN VITRO, V22, P1099, DOI 10.1016/j.tiv.2008.02.013; Chormey DS., 2018, FUNDAMENTALS QUORUM; Chrysinas P, 2018, COMPUT CHEM ENG, V112, P27, DOI 10.1016/j.compchemeng.2018.01.021; Cooper S, 2006, THEOR BIOL MED MODEL, V3, DOI 10.1186/1742-4682-3-10; Cossarizza A, 2017, EUR J IMMUNOL, V47, P1584, DOI 10.1002/eji.201646632; del Val IJ, 2016, BIOTECHNOL J, V11, P610, DOI 10.1002/biot.201400663; deZengotita VM, 2002, BIOTECHNOL BIOENG, V77, P369, DOI 10.1002/bit.10176; EAKMAN J. M., 1966, CHEM ENG PROG SYMP SER, V62, P37; Engel P, 2011, COMPUT-AIDED CHEM EN, V29, P1316; Evie IM, 2017, METHODS MOL BIOL, V1601, P137, DOI 10.1007/978-1-4939-6960-9_12; Fadda S, 2012, BIOTECHNOL BIOENG, V109, P772, DOI 10.1002/bit.24351; Fadda S, 2012, BIOTECHNOL BIOENG, V109, P782, DOI 10.1002/bit.24350; Farzan P, 2017, COMPUT CHEM ENG, V97, P271, DOI 10.1016/j.compchemeng.2016.11.037; Fernandes RL, 2011, BIOTECHNOL ADV, V29, P575, DOI 10.1016/j.biotechadv.2011.03.007; Gadgil M, 2015, J CHEM TECHNOL BIOT, V90, P166, DOI 10.1002/jctb.4302; Galluzzi L, 2009, CELL DEATH DIFFER, V16, P1093, DOI 10.1038/cdd.2009.44; Gilgunn S, 2018, CURR OPIN CHEM ENG, V22, P98, DOI 10.1016/j.coche.2018.08.001; Goey CH., 2016, CASCADING EFFECTS BI; Goey CH, 2017, BIOTECHNOL BIOENG, V114, P2771, DOI 10.1002/bit.26437; Goey CH, 2018, MABS-AUSTIN, V10, P476, DOI 10.1080/19420862.2018.1433977; Goey CH, 2018, BIOTECHNOL ADV, V36, P1223, DOI 10.1016/j.biotechadv.2018.03.021; Goranov AI, 2009, GENE DEV, V23, P1408, DOI 10.1101/gad.1777309; Goyal MMZA, 2005, BIOTECHNOL PROGR, V21, P70, DOI 10.1021/bp049815s; Jeldres RI, 2015, ADV COLLOID INTERFAC, V224, P62, DOI 10.1016/j.cis.2015.07.009; Jin M, 2010, BIOTECHNOL BIOENG, V105, P306, DOI 10.1002/bit.22532; Kappatou CD, 2018, IND ENG CHEM RES, V57, P9915, DOI 10.1021/acs.iecr.7b05357; Karra S, 2010, IND ENG CHEM RES, V49, P7990, DOI 10.1021/ie100125a; Kiehl TR, 2011, CYTOM PART A, V79A, P560, DOI 10.1002/cyto.a.21076; Kim T.K., 2001, BIOTECHNOL BIOPROC E, V6, P332; Klein T, 2015, J BIOTECHNOL, V207, P67, DOI 10.1016/j.jbiotec.2015.04.021; Kol S., 2019, MULTIPLEX SECRETOME, DOI [10.1101/647214, DOI 10.1101/647214]; Kontoravdi C, 2013, METHODS MOL BIOL, V1073, P177, DOI 10.1007/978-1-62703-625-2_15; Koutinas M, 2012, COMPUT STRUCT BIOTEC, V3, DOI 10.5936/csbj.201210022; Kumar R, 2021, ELECTROPHORESIS, V42, P735, DOI 10.1002/elps.202000252; KUMAR S, 1980, J BIOL CHEM, V255, P2315; Kurtz MJ, 1998, IND ENG CHEM RES, V37, P4059, DOI 10.1021/ie9708945; Kyriakopoulos S, 2014, BIOTECHNOL BIOENG, V111, P2466, DOI 10.1002/bit.25319; Lee G, 1999, COMPUT CHEM ENG, V23, pS363, DOI 10.1016/S0098-1354(99)80089-1; Levy DL, 2012, ANNU REV CELL DEV BI, V28, P113, DOI 10.1146/annurev-cellbio-092910-154158; Lewis CD, 1982, IND BUSINESS FORECAS; LINARDOS TI, 1991, CAN J CHEM ENG, V69, P429, DOI 10.1002/cjce.5450690205; LINARDOS TI, 1992, BIOTECHNOL BIOENG, V40, P359, DOI 10.1002/bit.260400305; Liu YH, 2007, BIOTECHNOL PROGR, V23, P1198, DOI 10.1021/bp070152z; Lloyd AC, 2013, CELL, V154, P1194, DOI 10.1016/j.cell.2013.08.053; Lopez-Meza J, 2016, CYTOTECHNOLOGY, V68, P1287, DOI 10.1007/s10616-015-9889-2; Maeno E, 2006, FEBS LETT, V580, P6513, DOI 10.1016/j.febslet.2006.10.074; Maes M, 2015, METHODS MOL BIOL, V1250, P349, DOI 10.1007/978-1-4939-2074-7_27; Mahdinia E, 2018, BIOPROC BIOSYST ENG, V41, P195, DOI 10.1007/s00449-017-1857-0; Mahmuda A, 2017, TROP J PHARM RES, V16, P713, DOI 10.4314/tjpr.v16i3.29; Mantzaris NV, 2004, J PROCESS CONTR, V14, P775, DOI 10.1016/j.jprocont.2003.12.001; Mantzaris NV, 2002, CHEM ENG SCI, V57, P1, DOI 10.1016/S0009-2509(01)00356-6; Mantzaris NV, 1999, DYNAMICS & CONTROL OF PROCESS SYSTEMS 1998, VOLUMES 1 AND 2, P571; Marguerat S, 2012, CELL, V151, P671, DOI 10.1016/j.cell.2012.09.019; Marshall WF, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-101; Martin-Calderon JL, 2015, CLIN BIOCHEM, V48, P529, DOI 10.1016/j.clinbiochem.2015.03.005; Masterton RJ, 2014, PHARM BIOPROCESS, V2, P49, DOI 10.4155/PBP.14.3; Mathur D, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196829; Menyhart O, 2016, BBA-REV CANCER, V1866, P300, DOI 10.1016/j.bbcan.2016.10.002; Mongin Alexander A., 2001, Pathophysiology, V8, P77, DOI 10.1016/S0928-4680(01)00074-8; Munzer DGG, 2015, BIOCHEM ENG J, V93, P260, DOI 10.1016/j.bej.2014.10.013; Neurohr G, 2011, SCIENCE, V332, P465, DOI 10.1126/science.1201578; Neurohr GE, 2019, CELL, V176, P1083, DOI 10.1016/j.cell.2019.01.018; Nolan RP, 2011, METAB ENG, V13, P108, DOI 10.1016/j.ymben.2010.09.003; Nopens I, 2015, WATER SCI TECHNOL, V71, P159, DOI 10.2166/wst.2014.500; Padovan-Merhar O, 2015, MOL CELL, V58, P339, DOI 10.1016/j.molcel.2015.03.005; Pan X, 2017, APPL MICROBIOL BIOT, V101, P8101, DOI 10.1007/s00253-017-8531-y; Park JH, 2017, BIOTECHNOL BIOENG, V114, P2267, DOI 10.1002/bit.26360; Park JH, 2017, SCI REP-UK, V7, DOI 10.1038/srep44246; Park S, 2007, PROCESS BIOCHEM, V42, P1671, DOI 10.1016/j.procbio.2007.09.010; Patterson JO, 2019, CURR BIOL, V29, P1379, DOI 10.1016/j.cub.2019.03.011; Pereira S, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700499; Pfizenmaier J, 2015, BIOTECHNOL PROGR, V31, P1212, DOI 10.1002/btpr.2143; Quedeville V, 2018, CHEM ENG RES DES, V132, P966, DOI 10.1016/j.cherd.2018.02.025; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P839, DOI 10.1002/bit.260360814; RAMIREZ OT, 1990, BIOTECHNOL BIOENG, V36, P911, DOI 10.1002/bit.260360906; RAMIREZ OT, 1992, BIOTECHNOL PROGR, V8, P40, DOI 10.1021/bp00013a007; Ramkrishna D., 2000, POPULATION BALANCES; Rehberg M, 2013, J BIOTECHNOL, V164, P489, DOI 10.1016/j.jbiotec.2013.01.018; RENNER WA, 1993, BIOTECHNOL BIOENG, V41, P188, DOI 10.1002/bit.260410204; ROSSO L, 1995, APPL ENVIRON MICROB, V61, P610, DOI 10.1128/AEM.61.2.610-616.1995; Savizi ISP, 2019, APPL MICROBIOL BIOT, V103, P8315, DOI 10.1007/s00253-019-10048-1; SCHOOLFIELD RM, 1981, J THEOR BIOL, V88, P719, DOI 10.1016/0022-5193(81)90246-0; Seewoster T, 1997, BIOTECHNOL BIOENG, V55, P793, DOI 10.1002/(SICI)1097-0290(19970905)55:5<793::AID-BIT9>3.0.CO;2-6; Sellick CA, 2010, METABOLOMICS, V6, P427, DOI 10.1007/s11306-010-0216-9; Selvarasu S, 2012, BIOTECHNOL BIOENG, V109, P1415, DOI 10.1002/bit.24445; Sengupta N, 2011, BIOTECHNOL BIOENG, V108, P82, DOI 10.1002/bit.22890; Seo JS, 2013, APPL MICROBIOL BIOT, V97, P5283, DOI 10.1007/s00253-013-4849-2; Sharifian M, 2009, IRAN J CHEM CHEM ENG, V28, P15; SMITH JA, 1973, P NATL ACAD SCI USA, V70, P1263, DOI 10.1073/pnas.70.4.1263; Solsvik J, 2015, J DISPER SCI TECHNOL, V36, P510, DOI 10.1080/01932691.2014.909318; Sou SN, 2017, BIOTECHNOL BIOENG, V114, P1570, DOI 10.1002/bit.26225; Spens E, 2007, BIOTECHNOL BIOENG, V98, P1183, DOI 10.1002/bit.21509; Spetsieris K, 2012, J BIOTECHNOL, V158, P80, DOI 10.1016/j.jbiotec.2011.08.018; Stamatakis M, 2010, CHEM ENG SCI, V65, P1008, DOI 10.1016/j.ces.2009.09.054; SUBRAMANIAN G, 1970, Bulletin of Mathematical Biophysics, V32, P521, DOI 10.1007/BF02476769; swierniak A., 2016, STRUCTURED MODELS TH, P85; Szeliova D, 2020, METAB ENG, V61, P288, DOI 10.1016/j.ymben.2020.06.002; Tait AS, 2013, BIOTECHNOL PROGR, V29, P688, DOI 10.1002/btpr.1726; Takagi M, 2000, CYTOTECHNOLOGY, V32, P171, DOI 10.1023/A:1008171921282; Tanouchi Y, 2015, NATURE, V523, P357, DOI 10.1038/nature14562; Tzur A, 2009, SCIENCE, V325, P167, DOI 10.1126/science.1174294; Ulonska S, 2018, BIOTECHNOL J, V13, DOI 10.1002/biot.201700395; Valente KN, 2018, CURR OPIN BIOTECH, V53, P144, DOI 10.1016/j.copbio.2018.01.004; Vanderlaan M, 2018, BIOTECHNOL PROGR, V34, P828, DOI 10.1002/btpr.2640; Varsano G, 2017, CELL REP, V20, P397, DOI 10.1016/j.celrep.2017.06.057; Waldherr S, 2018, J R SOC INTERFACE, V15, DOI 10.1098/rsif.2018.0530; Walsh G, 2018, NAT BIOTECHNOL, V36, P1136, DOI 10.1038/nbt.4305; XIE LZ, 1994, CYTOTECHNOLOGY, V15, P17, DOI 10.1007/BF00762376; Xin PP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44980-z; Xing ZZ, 2011, PROCESS BIOCHEM, V46, P1423, DOI 10.1016/j.procbio.2011.03.014; Xing ZZ, 2010, BIOTECHNOL PROGR, V26, P208, DOI 10.1002/btpr.284; Yang B, 2019, J CHROMATOGR B, V1112, P1, DOI 10.1016/j.jchromb.2019.02.020; Zhang J, 2017, BIOTECHNOL PROGR, V33, P708, DOI 10.1002/btpr.2448; Zhu GY, 2000, CHEM ENG SCI, V55, P6155, DOI 10.1016/S0009-2509(00)00208-6; Zhurinsky J, 2010, CURR BIOL, V20, P2010, DOI 10.1016/j.cub.2010.10.002	131	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265886	10.1371/journal.pone.0265886	http://dx.doi.org/10.1371/journal.pone.0265886			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320326	Green Published, gold			2022-12-26	WOS:000784240600028
J	Elliott, CG; Murji, A; Matelski, J; Adekola, AB; Chrzanowski, J; Shirreff, L				Elliott, Cara G.; Murji, Ally; Matelski, John; Adekola, Adebanke Bianca; Chrzanowski, Jessica; Shirreff, Lindsay			Unexpected malignancy at the time of hysterectomy performed for a benign indication: A retrospective review	PLOS ONE			English	Review							MATHEMATICAL-MODELS; ADNEXAL TUMORS; DIAGNOSIS; SURGERY; RISK; COMPLICATIONS; MANAGEMENT; CANCER; MASS	ObjectiveTo determine the proportion of patients undergoing hysterectomy for a benign indication who have unexpected malignancy (UM) on postoperative pathology and characterize the nature of UMs. MethodsThis was a multi-center, retrospective study of patients undergoing hysterectomy for a benign indication from July 2016 to December 2019 at 7 Ontario, Canada hospitals (4 academic, 3 community). Hysterectomies for invasive placentation, malignant, and premalignant indications were excluded. Primary outcome was rate of unexpected malignancy as defined by the number of patients with malignancy on final pathology divided by the total number of hysterectomy cases. Data was extracted from health records and electronic charts. Patient, surgical, and surgeon characteristics were compared between benign and UM groups using bivariate methods. Associations between UM status and perioperative variables were assessed using bivariate logistic regression. ResultsIn the study period, 2779 hysterectomies were performed. UM incidence was 1.8% (51 malignancies/2779 cases), with one patient having two malignancies (total UMs = 52). The most common UM types were endometrial (27/52, 51.9%) and sarcoma (13/52, 25%). Patients with UM were older (57.2 +/- 11.4 years vs. 52.8 +/- 12.5 years, p = .015), had more previous laparotomies (2 (1.25, 2.0) vs. 1 (1.0, 1.0), p < .001), and higher BMI (29.7 +/- 7.2 kg/m(2) vs. 28.0 +/- 5.9 kg/m(2), p = .049) and ASA class (p < .028). Regarding surgical factors, patients with UM had more adhesions (p = .001), transfusions (p = .020), and blood loss (p = .006) compared to those with benign pathology. Patient characteristics most strongly associated with UM were age (OR 2.57, 95% CI 1.78-3.72, p < .001) and preoperative diagnosis of pelvic mass (OR 2.76, 95% CI 1.11-6.20, p = .019). ConclusionIncidence of UM at hysterectomy for benign indication was 1.8%. Several perioperative variables are associated with an increased chance of UM.	[Elliott, Cara G.] Univ Toronto, Fac Med, Toronto, ON, Canada; [Murji, Ally; Adekola, Adebanke Bianca; Chrzanowski, Jessica; Shirreff, Lindsay] Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Murji, Ally; Shirreff, Lindsay] Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada; [Matelski, John] Univ Hlth Network, Toronto Gen Hosp, Biostat Res Unit, Toronto, ON, Canada	University of Toronto; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital	Shirreff, L (corresponding author), Univ Toronto, Mt Sinai Hosp, Dept Obstet & Gynaecol, Toronto, ON, Canada.; Shirreff, L (corresponding author), Univ Toronto, Dept Obstet & Gynaecol, Toronto, ON, Canada.	lindsay.shirreff@sinaihealth.ca						Aarts JWM, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003677.pub5; Bast RC, 2012, INT J GYNECOL CANCER, V22, pS5, DOI 10.1097/IGC.0b013e318251c97d; Caetano SJ, 2018, EUR J CANCER, V90, P130, DOI 10.1016/j.ejca.2017.10.027; DAVIES AP, 1993, BRIT J OBSTET GYNAEC, V100, P927, DOI 10.1111/j.1471-0528.1993.tb15109.x; Einstein MH, 2008, INT J GYNECOL CANCER, V18, P1065, DOI 10.1111/j.1525-1438.2007.01126.x; Giede C, 2013, J OBSTET GYNAECOL CA, V35, P370, DOI 10.1016/S1701-2163(15)30966-X; Kaijser J, 2014, HUM REPROD UPDATE, V20, P449, DOI 10.1093/humupd/dmt059; Mahnert N, 2015, OBSTET GYNECOL, V125, P397, DOI 10.1097/AOG.0000000000000642; Matsushita H, 2014, HUM REPROD, V29, P1912, DOI 10.1093/humrep/deu162; Mowat A, 2016, AM J OBSTET GYNECOL, V215, P21, DOI 10.1016/j.ajog.2016.02.048; Murji A, 2019, J OBSTET GYNAECOL CA, V41, P116, DOI 10.1016/j.jogc.2018.07.016; Muzii L, 2005, J MINIM INVAS GYN, V12, P81, DOI 10.1016/j.jmig.2004.12.019; Ouldamer L, 2014, J MINIM INVAS GYN, V21, P131, DOI 10.1016/j.jmig.2013.08.002; Prompeler HJ, 1997, OBSTET GYNECOL, V89, P428, DOI 10.1016/S0029-7844(96)00507-8; R Core Team, 2013, R LANG ENV STAT COMP; Rowland M, 2012, GYNECOL ONCOL, V127, pS29, DOI 10.1016/j.ygyno.2012.07.080; SASSONE AM, 1991, OBSTET GYNECOL, V78, P70; Schmitt JJ, 2017, OBSTET GYNECOL, V129, P130, DOI 10.1097/AOG.0000000000001756; Takamizawa S, 1999, GYNECOL OBSTET INVES, V48, P193, DOI 10.1159/000010172; Theben JU, 2013, ARCH GYNECOL OBSTET, V287, P455, DOI 10.1007/s00404-012-2559-0; Thurston J, 2019, J OBSTET GYNAECOL CA, V41, P543, DOI 10.1016/j.jogc.2018.12.006; Timmerman D, 2008, ULTRASOUND OBST GYN, V31, P681, DOI 10.1002/uog.5365; Van Holsbeke C, 2009, CLIN CANCER RES, V15, P684, DOI 10.1158/1078-0432.CCR-08-0113; Yamazaki H, 2018, J GYNECOL ONCOL, V29, DOI 10.3802/jgo.2018.29.e19	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266338	10.1371/journal.pone.0266338	http://dx.doi.org/10.1371/journal.pone.0266338			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363824	gold, Green Published			2022-12-26	WOS:000804748600019
J	Hillenmayer, A; Wertheimer, CM; Geerlof, A; Eibl, KH; Priglinger, S; Priglinger, C; Ohlmann, A				Hillenmayer, Anna; Wertheimer, Christian M.; Geerlof, Arie; Eibl, Kirsten H.; Priglinger, Siegfried; Priglinger, Claudia; Ohlmann, Andreas			Galectin-1 and-3 in high amounts inhibit angiogenic properties of human retinal microvascular endothelial cells in vitro	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; NEOVASCULARIZATION; MIGRATION; LECTIN; CANCER; VEGF; SUPPRESSION; RETINOPATHY; EXPRESSION; BLINDNESS	PurposeGalectin-1 and -3 are beta-galactoside binding lectins with varying effects on angiogenesis and apoptosis. Since in retinal pigment epithelial cells high amounts of human recombinant galectin (hr-GAL)1 and 3 inhibit cell adhesion, migration and proliferation, we investigated if hr-GAL1 and 3 have homologous effects on human retinal microvascular endothelial cells (HRMEC) in vitro. MethodsTo investigate the effect of galectin-1 and -3 on HRMEC, proliferation, apoptosis and viability were analyzed after incubation with 30, 60 and 120 mu g/ml hr-GAL1 or 3 by BrdU-ELISA, histone-DNA complex ELISA, live/dead staining and the WST-1 assay, respectively. Further on, a cell adhesion as well as tube formation assay were performed on galectin-treated HRMEC. Migration was investigated by the scratch migration assay and time-lapse microscopy. In addition, immunohistochemical staining on HRMEC for beta-catenin, galectin-1 and -3 were performed and beta-catenin expression was investigated by western blot analysis. ResultsIncubation with hr-GAL1 or 3 lead to a decrease in proliferation, migration, adhesion and tube formation of HRMEC compared to the untreated controls. No toxic effects of hr-GAL1 and 3 on HRMEC were detected. Intriguingly, after treatment of HRMEC with hr-GAL1 or 3, an activation of the proangiogenic Wnt/beta-catenin signaling pathway was observed. However, incubation of HRMEC with hr-GAL1 or 3 drew intracellular galectin-1 and -3 out of the cells, respectively. ConclusionExogenously added hr-GAL1 or 3 inhibit angiogenic properties of HRMEC in vitro, an effect that might be mediated via a loss of intracellular endogenous galectins.	[Hillenmayer, Anna; Wertheimer, Christian M.; Eibl, Kirsten H.; Priglinger, Siegfried; Priglinger, Claudia; Ohlmann, Andreas] Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Ophthalmol, Munich, Germany; [Hillenmayer, Anna; Wertheimer, Christian M.] Univ Hosp Ulm, Dept Ophthalmol, Ulm, Germany; [Geerlof, Arie] Helmholtz Ctr Munich Environm Hlth, Inst Struct Biol, Prot Express & Purificat Facil, Neuherberg, Germany	University of Munich; Ulm University	Ohlmann, A (corresponding author), Ludwig Maximilians Univ Munchen, Univ Hosp, Dept Ophthalmol, Munich, Germany.	andreas.ohlmann@med.uni-muenchen.de		Ohlmann, Andreas/0000-0002-7101-9361; Geerlof, Arie/0000-0001-7295-9948	Deutsche Forschungsgemeinschaft [OH 214/4-3, PR 1248/2-3]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	AO; OH 214/4-3; Deutsche Forschungsgemeinschaft; https://www.dfg.de; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CP; PR 1248/2-3; Deutsche Forschungsgemeinschaft; https://www.dfg.de; The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams L, 1996, BBA-MOL CELL RES, V1312, P137, DOI 10.1016/0167-4889(96)00031-6; Al-Dalahmah O, 2020, STEM CELLS, V38, P1149, DOI 10.1002/stem.3202; Alge CS, 2006, INVEST OPHTH VIS SCI, V47, P415, DOI 10.1167/iovs.05-0308; Alge-Priglinger CS, 2009, MOL VIS, V15, P2162; Bacigalupo ML, 2015, J CELL PHYSIOL, V230, P1298, DOI 10.1002/jcp.24865; Bargagna-Mohan P, 2006, INVEST OPHTH VIS SCI, V47, P4138, DOI 10.1167/iovs.05-1452; Bhat R, 2016, P NATL ACAD SCI USA, V113, pE4820, DOI 10.1073/pnas.1609135113; Cabral Thiago, 2017, Int J Retina Vitreous, V3, P31, DOI 10.1186/s40942-017-0084-9; Califice S, 2004, ONCOGENE, V23, P7527, DOI 10.1038/sj.onc.1207997; Canning P, 2007, EXP DIABETES RES, DOI 10.1155/2007/51837; Chen L, 2015, J OVARIAN RES, V8, DOI 10.1186/s13048-015-0206-7; Chen WS, 2017, INVEST OPHTH VIS SCI, V58, P9, DOI 10.1167/iovs.16-20009; Chung LY, 2012, CLIN CANCER RES, V18, P4037, DOI 10.1158/1078-0432.CCR-11-3348; COOPER DNW, 1990, J CELL BIOL, V110, P1681, DOI 10.1083/jcb.110.5.1681; Cousin JM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091566; Croci DO, 2014, CELL, V156, P744, DOI 10.1016/j.cell.2014.01.043; Cummings RD, 2009, ESSENTIALS GLYCOBIOL, P1857; Davidson PJ, 2006, GLYCOBIOLOGY, V16, P602, DOI 10.1093/glycob/cwj088; Dorrell M, 2007, SURV OPHTHALMOL, V52, pS3, DOI 10.1016/j.survophthal.2006.10.017; dos Santos SN, 2017, ONCOTARGET, V8, P49484, DOI 10.18632/oncotarget.17718; Falavarjani KG, 2013, EYE, V27, P787, DOI 10.1038/eye.2013.107; Fenwick EK, 2012, QUAL LIFE RES, V21, P1771, DOI 10.1007/s11136-012-0110-1; Fujii A, 2015, EXP EYE RES, V137, P71, DOI 10.1016/j.exer.2015.06.010; Griffioen AW, 2014, ANN TRANSL MED, V2, DOI 10.3978/j.issn.2305-5839.2014.09.01; Hafsia N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041486; Haudek KC, 2009, BIOCHEMISTRY-US, V48, P7705, DOI 10.1021/bi900071b; He XW, 2017, SCI REP-UK, V7, DOI 10.1038/srep40994; HENKIND P, 1974, BRIT J OPHTHALMOL, V58, P413, DOI 10.1136/bjo.58.4.413; Hughes RC, 2001, BIOCHIMIE, V83, P667; Iurisci I, 2000, CLIN CANCER RES, V6, P1389; Johannes L, 2018, J CELL SCI, V131, DOI 10.1242/jcs.208884; Jung JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044572; Kanda A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17946; Kocur I, 2002, BRIT J OPHTHALMOL, V86, P716, DOI 10.1136/bjo.86.7.716; Laaf D, 2019, TRENDS BIOTECHNOL, V37, P402, DOI 10.1016/j.tibtech.2018.10.001; Markowska AI, 2010, J EXP MED, V207, P1981, DOI 10.1084/jem.20090121; Masuzzo P, 2016, TRENDS CELL BIOL, V26, P88, DOI 10.1016/j.tcb.2015.09.003; Mello-Bosnic C, 2018, EUR J PHARMACOL, V833, P124, DOI 10.1016/j.ejphar.2018.05.046; Nakahara S, 2006, CANCER RES, V66, P9995, DOI 10.1158/0008-5472.CAN-06-1772; Ngo T. X., 2014, INT J TISSUE REG, V5, P37; Obermann J, 2017, MOL CELL PROTEOMICS, V16, P1528, DOI 10.1074/mcp.M116.066381; Ohlmann A, 2010, J NEUROSCI, V30, P183, DOI 10.1523/JNEUROSCI.3210-09.2010; Ose Rui, 2012, Curr Chem Genomics, V6, P18, DOI 10.2174/1875397301206010018; Patterson RJ, 2015, METHODS MOL BIOL, V1207, P431, DOI 10.1007/978-1-4939-1396-1_28; Perez CV, 2015, SCI REP-UK, V5, DOI 10.1038/srep12259; Perone MJ, 2009, J IMMUNOL, V182, P2641, DOI 10.4049/jimmunol.0800839; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Priglinger CS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070011; Prokofyeva E, 2012, OPHTHALMIC RES, V47, P171, DOI 10.1159/000329603; Quimson SK, 2015, NEONATAL NETW, V34, P284, DOI 10.1891/0730-0832.34.5.284; Ridano ME, 2017, ONCOTARGET, V8, P32505, DOI 10.18632/oncotarget.17129; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Sakaguchi M, 2006, P NATL ACAD SCI USA, V103, P7112, DOI 10.1073/pnas.0508793103; Sciacchitano S, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020379; Seelenmeyer C, 2005, J CELL BIOL, V171, P373, DOI 10.1083/jcb.200506026; Shih TC, 2019, NEURO-ONCOLOGY, V21, P1389, DOI 10.1093/neuonc/noz093; Shimura T, 2005, CANCER RES, V65, P3535, DOI 10.1158/0008-5472.CAN-05-0104; Song SM, 2009, CANCER RES, V69, P1343, DOI 10.1158/0008-5472.CAN-08-4153; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Thijssen VL, 2010, CANCER RES, V70, P6216, DOI 10.1158/0008-5472.CAN-09-4150; Thijssen VLJL, 2006, P NATL ACAD SCI USA, V103, P15975, DOI 10.1073/pnas.0603883103; Thomas L, 2020, MOL NEUROBIOL, V57, P976, DOI 10.1007/s12035-019-01787-3; Tian L, 2017, MOL MED REP, V15, P3840, DOI 10.3892/mmr.2017.6429; Tsai MS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29843-3; Vas V, 2005, STEM CELLS, V23, P279, DOI 10.1634/stemcells.2004-0084; Vogt D, 2018, GRAEF ARCH CLIN EXP, V256, P1589, DOI 10.1007/s00417-018-4033-6; Wertheimer C, 2014, CURR EYE RES, V39, P1000, DOI 10.3109/02713683.2014.888453; Wu D, 2019, FASEB J, V33, P2498, DOI 10.1096/fj.201801227R; Yang N, 2017, EXP EYE RES, V159, P1, DOI 10.1016/j.exer.2017.02.015	69	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265805	10.1371/journal.pone.0265805	http://dx.doi.org/10.1371/journal.pone.0265805			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320287	Green Published, gold			2022-12-26	WOS:000784240600020
J	Iriemenam, NC; Ige, FA; Greby, SM; Mpamugo, A; Abubakar, AG; Dawurung, AB; Esiekpe, MK; Thomas, AN; Okoli, MU; Awala, SS; Ugboaja, BN; Achugbu, CC; Odoh, I; Nwatu, FD; Olaleye, T; Akayi, L; Akinmulero, OO; Dattijo, J; Onokevbagbe, E; Okunoye, O; Mba, N; Agala, NP; Uwandu, M; Aniedobe, M; Stafford, KA; Abimiku, A; Hamada, Y; Swaminathan, M; Okoye, MI; Steinhardt, LC; Audu, R				Iriemenam, Nnaemeka C.; Ige, Fehintola A.; Greby, Stacie M.; Mpamugo, Augustine; Abubakar, Ado G.; Dawurung, Ayuba B.; Esiekpe, Mudiaga K.; Thomas, Andrew N.; Okoli, Mary U.; Awala, Samuel S.; Ugboaja, Blessing N.; Achugbu, Chicago C.; Odoh, Ifeanyichukwu; Nwatu, Felicia D.; Olaleye, Temitope; Akayi, Loveth; Akinmulero, Oluwaseun O.; Dattijo, Joseph; Onokevbagbe, Edewede; Okunoye, Olumide; Mba, Nwando; Agala, Ndidi P.; Uwandu, Mabel; Aniedobe, Maureen; Stafford, Kristen A.; Abimiku, Alash'le; Hamada, Yohhei; Swaminathan, Mahesh; Okoye, McPaul, I; Steinhardt, Laura C.; Audu, Rosemary			Validation of xMAP SARS-CoV-2 Multi-Antigen IgG assay in Nigeria	PLOS ONE			English	Article							CORONAVIRUS; INFECTION; ANTIBODIES	ObjectiveThere is a need for reliable serological assays to determine accurate estimates of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence. Most single target antigen assays have shown some limitations in Africa. To assess the performance of a multi-antigen assay, we evaluated a commercially available SARS-CoV-2 Multi-Antigen IgG assay for human coronavirus disease 2019 (COVID-19) in Nigeria. MethodsValidation of the xMAP SARS-CoV-2 Multi-Antigen IgG assay was carried out using well-characterized SARS-CoV-2 reverse transcription polymerase chain reactive positive (97) and pre-COVID-19 pandemic (86) plasma panels. Cross-reactivity was assessed using pre-COVID-19 pandemic plasma specimens (213) from the 2018 Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS). ResultsThe overall sensitivity of the xMAP SARS-CoV-2 Multi-Antigen IgG assay was 75.3% [95% CI: 65.8%- 82.8%] and specificity was 99.0% [95% CI: 96.8%- 99.7%]. The sensitivity estimate increased to 83.3% [95% CI: 70.4%- 91.3%] for specimens >14 days post-confirmation of diagnosis. However, using the NAIIS pre-pandemic specimens, the false positivity rate was 1.4% (3/213). ConclusionsOur results showed overall lower sensitivity and a comparable specificity with the manufacturer's validation. There appears to be less cross-reactivity with NAIIS pre-pandemic COVID-19 specimens using the xMAP SARS-CoV-2 Multi-Antigen IgG assay. In-country SARS-CoV-2 serology assay validation can help guide the best choice of assays in Africa.	[Iriemenam, Nnaemeka C.; Greby, Stacie M.; Okunoye, Olumide; Swaminathan, Mahesh; Okoye, McPaul, I] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria; [Ige, Fehintola A.; Uwandu, Mabel; Aniedobe, Maureen; Audu, Rosemary] Nigerian Inst Med Res, Ctr Human Virol & Genom, Microbiol Dept, Lagos, Nigeria; [Mpamugo, Augustine; Onokevbagbe, Edewede] Univ Maryland, Abuja, Nigeria; [Abubakar, Ado G.; Dawurung, Ayuba B.; Esiekpe, Mudiaga K.; Thomas, Andrew N.; Awala, Samuel S.; Ugboaja, Blessing N.; Odoh, Ifeanyichukwu; Nwatu, Felicia D.; Olaleye, Temitope; Akayi, Loveth; Akinmulero, Oluwaseun O.; Dattijo, Joseph; Agala, Ndidi P.; Abimiku, Alash'le] Inst Human Virol, Int Res Ctr Excellence, Abuja, Nigeria; [Okoli, Mary U.; Achugbu, Chicago C.; Mba, Nwando] Nigeria Ctr Dis Control Abuja, Natl Reference Lab, Abuja, Nigeria; [Stafford, Kristen A.; Abimiku, Alash'le] Univ Maryland, Sch Med, Baltimore, MD 21201 USA; [Hamada, Yohhei] UCL, Inst Global Hlth, London, England; [Steinhardt, Laura C.] Ctr Dis Control & Prevent, Ctr Global Hlth, Div Parasit Dis & Malaria, Malaria Branch, Atlanta, GA USA	University System of Maryland; University of Maryland Baltimore; University of London; University College London; Centers for Disease Control & Prevention - USA	Iriemenam, NC (corresponding author), Ctr Dis Control & Prevent, Ctr Global Hlth, Div Global HIV & TB, Abuja, Nigeria.	Nlriemenam@cdc.gov		B. Dawurung, Ayuba/0000-0001-9830-3277; Iriemenam, Nnaemeka/0000-0003-2187-8894	President's Emergency Plan for AIDS Relief (PEPFAR) through CDC [U2GGH002108]; Global Funds to Fight AIDS, Tuberculosis, and Malaria through NACA [NGA-H-NACA]	President's Emergency Plan for AIDS Relief (PEPFAR) through CDC; Global Funds to Fight AIDS, Tuberculosis, and Malaria through NACA	NAIIS was supported by the President's Emergency Plan for AIDS Relief (PEPFAR) through CDC under the cooperative agreement #U2GGH002108 to UMB and by the Global Funds to Fight AIDS, Tuberculosis, and Malaria through NACA, under the contract # NGA-H-NACA to UMB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Disclaimer The findings and conclusions in this report are those of the authorsand do not necessarily represent theviewsof the Centers for Disease Control and Prevention.The findings and conclusions of this report are thoseo f the authorsand do notnecessarily representthe officialpositionof theNAIISGroup.LuminexxMAPSARS-CoV-2 Multi-AntigenIgG assayis for informational purposesand doesnot constituteendorsement by theCentersfor DiseaseControland Prevention."	Anderson EM, 2021, CELL, V184, P1858, DOI 10.1016/j.cell.2021.02.010; Dobano C, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.01731-20; Emmerich P, 2021, TROP MED INT HEALTH, V26, P621, DOI 10.1111/tmi.13569; FDA, 2021, EUA AUTH SER TEST PE; Fotis C, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86035-2; Ige F, 2021, MICROBIOL SPECTR, V9, DOI 10.1128/Spectrum.00680-21; Klumpp-Thomas C, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20383-x; Li KN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19943-y; Liu GQ, 2021, ACS SENSORS, V6, P593, DOI 10.1021/acssensors.0c02621; Luminex, 2020, XMAP SARS COV 2 MULT; Manning JE, 2021, MRS BULL, V46, P854, DOI 10.1557/s43577-021-00167-4; Marien J, 2021, J VIROL METHODS, V288, DOI 10.1016/j.jviromet.2020.114025; McBride R, 2014, VIRUSES-BASEL, V6, P2991, DOI 10.3390/v6082991; Ndaye AN, 2021, LANCET GLOB HEALTH, V9, pE588, DOI 10.1016/S2214-109X(21)00060-7; Organization WH, 2020, COR DIS COVID 19 TEC; Qiu MF, 2005, MICROBES INFECT, V7, P882, DOI 10.1016/j.micinf.2005.02.006; Rosado J, 2021, LANCET MICROBE, V2, pE60, DOI 10.1016/S2666-5247(20)30197-X; Schwarz NG, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0176708; Steinhardt LC, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00514-21; Tan SS, 2021, J CLIN PATHOL, V74, P614, DOI 10.1136/jclinpath-2020-206942; Tso FY, 2021, INT J INFECT DIS, V102, P577, DOI 10.1016/j.ijid.2020.10.104; WHO, 2021, EM US LIST; WHO, WHO COR DIS COVID 19; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; World Health Organization (WHO), 2020, TARG PROD PROF PRIOR; Yadouleton A, 2021, EMERG INFECT DIS, V27, P233, DOI 10.3201/eid2701.203281	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266184	10.1371/journal.pone.0266184	http://dx.doi.org/10.1371/journal.pone.0266184			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363818	Green Published, gold			2022-12-26	WOS:000804748600004
J	Pamonag, M; Hinson, A; Burton, EJ; Jafari, N; Sales, D; Babcock, S; Basha, R; Hu, XF; Kubow, KE				Pamonag, Michael; Hinson, Abigail; Burton, Elisha J.; Jafari, Nojan; Sales, Dominic; Babcock, Sarah; Basha, Rozlan; Hu, Xiaofeng; Kubow, Kristopher E.			Individual cells generate their own self-reinforcing contact guidance cues through local matrix fiber remodeling	PLOS ONE			English	Article							COLLAGEN; MIGRATION; DYNAMICS; INVASION; ADHESION; MECHANISM; DIRECTION; FEEDBACK	Directed cell migration arises from cells following a microenvironmental gradient (e.g. of a chemokine) or polarizing feature (e.g. a linear structure). However cells not only follow, but in many cases, also generate directionality cues by modifying their microenvironment. This bi-directional relationship is seen in the alignment of extracellular matrix (ECM) fibers ahead of invading cell masses. The forces generated by many migrating cells cause fiber alignment, which in turn promotes further migration in the direction of fiber alignment via contact guidance and durotaxis. While this positive-feedback relationship has been widely described for cells invading en masse, single cells are also able to align ECM fibers, as well as respond to contact guidance and durotaxis cues, and should therefore exhibit the same relationship. In this study, we directly tested this hypothesis by studying the migration persistence of individual HT-1080 fibrosarcoma cells migrating in photocrosslinked collagen matrices with limited remodeling potential. Our results demonstrate that this positive-feedback relationship is indeed a fundamental aspect of cell migration in fibrillar environments. We observed that the cells' inability to align and condense fibers resulted in a decrease in persistence relative to cells in native collagen matrices and even relative to isotropic (glass) substrates. Further experiments involving 2D collagen and electrospun polymer scaffolds suggest that substrates composed of rigid, randomly oriented fibers reduce cells' ability to follow another directionality cue by forcing them to meander to follow the available adhesive area (i.e. fibers). Finally, our results demonstrate that the bi-directional relationship between cell remodeling and migration is not a "dimensionality" effect, but a fundamental effect of fibrous substrate structure.	[Pamonag, Michael; Hinson, Abigail; Burton, Elisha J.; Jafari, Nojan; Sales, Dominic; Babcock, Sarah; Basha, Rozlan; Kubow, Kristopher E.] James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA; [Hu, Xiaofeng] James Madison Univ, Dept Chem & Biochem, Harrisonburg, VA USA; [Hu, Xiaofeng] James Madison Univ, Ctr Mat Sci, Harrisonburg, VA USA	James Madison University; James Madison University; James Madison University	Kubow, KE (corresponding author), James Madison Univ, Dept Biol, Harrisonburg, VA 22807 USA.	kubowke@jmu.edu	Hu, Xiao/GQI-0007-2022	Hu, Xiao/0000-0003-1128-4099; Kubow, Kristopher/0000-0003-0259-882X				Ahmadzadeh H, 2017, P NATL ACAD SCI USA, V114, pE1617, DOI 10.1073/pnas.1617037114; Baker BM, 2015, NAT MATER, V14, P1262, DOI [10.1038/NMAT4444, 10.1038/nmat4444]; BISSELL MJ, 1982, J THEOR BIOL, V99, P31, DOI 10.1016/0022-5193(82)90388-5; Carey SP, 2016, INTEGR BIOL-UK, V8, P821, DOI 10.1039/c6ib00030d; Charras G, 2014, NAT REV MOL CELL BIO, V15, P813, DOI 10.1038/nrm3897; Conklin MW, 2011, AM J PATHOL, V178, P1221, DOI 10.1016/j.ajpath.2010.11.076; Doyle AD, 2021, DEV CELL, V56, P826, DOI 10.1016/j.devcel.2021.02.017; Dzamba BJ, 2018, CURR TOP DEV BIOL, V130, P245, DOI 10.1016/bs.ctdb.2018.03.006; Fraley SI, 2015, SCI REP-UK, V5, DOI 10.1038/srep14580; Francis-Sedlak ME, 2009, BIOMATERIALS, V30, P1851, DOI 10.1016/j.biomaterials.2008.12.014; Gaudet ID, 2012, BIOINTERPHASES, V7, DOI 10.1007/s13758-012-0025-y; Grinnell F, 2010, ANNU REV CELL DEV BI, V26, P335, DOI 10.1146/annurev.cellbio.042308.113318; Guarnieri D, 2007, J MATER SCI-MATER M, V18, P245, DOI 10.1007/s10856-006-0686-5; Haeger A, 2014, BBA-GEN SUBJECTS, V1840, P2386, DOI 10.1016/j.bbagen.2014.03.020; Hall MS, 2016, P NATL ACAD SCI USA, V113, P14043, DOI 10.1073/pnas.1613058113; HARRIS AK, 1981, NATURE, V290, P249, DOI 10.1038/290249a0; Jana A, 2019, FASEB J, V33, P10618, DOI 10.1096/fj.201900131R; Kim A, 2006, EXP CELL RES, V312, P3683, DOI 10.1016/j.yexcr.2006.08.009; Koch TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033476; Kubow KE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-14745-7; Kubow KE, 2013, CURR BIOL, V23, P1607, DOI 10.1016/j.cub.2013.06.053; Lo Vecchio S, 2020, CELL SYST, V10, P535, DOI 10.1016/j.cels.2020.05.005; Matera DL, 2019, ACS BIOMATER SCI ENG, V5, P2965, DOI 10.1021/acsbiomaterials.9b00141; Nam J, 2011, ACTA BIOMATER, V7, P1516, DOI 10.1016/j.actbio.2010.11.022; Ozcelikkale A, 2017, J R SOC INTERFACE, V14, DOI 10.1098/rsif.2017.0287; Papalazarou Vassilis, 2018, Biophys Rev, V10, P1695, DOI 10.1007/s12551-018-0466-8; Petrie RJ, 2009, NAT REV MOL CELL BIO, V10, P538, DOI 10.1038/nrm2729; Petroll WM, 2003, J CELL SCI, V116, P1481, DOI 10.1242/jcs.00357; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Provenzano PP, 2006, BMC MED, V4, DOI 10.1186/1741-7015-4-38; Puspoki Z, 2016, ADV ANAT EMBRYOL CEL, V219, P69, DOI 10.1007/978-3-319-28549-8_3; Ray A, 2018, INTEGR BIOL-UK, V10, P100, DOI 10.1039/c7ib00152e; Riching KM, 2014, BIOPHYS J, V107, P2546, DOI 10.1016/j.bpj.2014.10.035; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SenGupta S, 2021, NAT REV MOL CELL BIO, V22, P529, DOI 10.1038/s41580-021-00366-6; Sheets K, 2013, ACTA BIOMATER, V9, P7169, DOI 10.1016/j.actbio.2013.03.042; Starke J, 2013, EXP CELL RES, V319, P2424, DOI 10.1016/j.yexcr.2013.04.003; Tamiello C, 2016, CELL MOL BIOENG, V9, P12, DOI 10.1007/s12195-015-0422-7; Valencia AMJ, 2015, ONCOTARGET, V6, P43438, DOI 10.18632/oncotarget.5874; van Helvert S, 2018, NAT CELL BIOL, V20, P8, DOI 10.1038/s41556-017-0012-0; van Helvert S, 2016, ACS APPL MATER INTER, V8, P21946, DOI 10.1021/acsami.6b01755; Wershof E, 2021, LIFE SCI ALLIANCE, V4, DOI 10.26508/lsa.202000880; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wu PH, 2014, P NATL ACAD SCI USA, V111, P3949, DOI 10.1073/pnas.1318967111; Yamada KM, 2019, NAT REV MOL CELL BIO, V20, P738, DOI 10.1038/s41580-019-0172-9; Zamir E, 1999, J CELL SCI, V112, P1655	46	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265403	10.1371/journal.pone.0265403	http://dx.doi.org/10.1371/journal.pone.0265403			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333902	Green Published, gold			2022-12-26	WOS:000784335700028
J	Shaughnessy, MP; Park, CJ; Salvi, PS; Cowles, RA				Shaughnessy, Matthew P.; Park, Christine J.; Salvi, Pooja S.; Cowles, Robert A.			Jejunoileal mucosal growth in mice with a limited microbiome	PLOS ONE			English	Article							CELL-PROLIFERATION; SMALL-BOWEL; GERM-FREE; NECROTIZING ENTEROCOLITIS; INTESTINAL MICROBIOTA; ESCHERICHIA-COLI; HOST-GENOTYPE; MOUSE MODEL; RESECTION; BACTERIA	Previous work demonstrated enhanced enterocyte proliferation and mucosal growth in gnotobiotic mice, suggesting that intestinal flora participate in mucosal homeostasis. Furthermore, broad-spectrum enteral antibiotics are known to induce near germ-free (GF) conditions in mice with conventional flora (CONV). We hypothesized that inducing near GF conditions with broad-spectrum enteral antibiotics would cause ordered small intestinal mucosal growth in CONV mice but would have no effect in GF mice with no inherent microbiome. C57BL/6J CONV and GF mice received either an antibiotic solution (Ampicillin, Ciprofloxacin, Metronidazole, Vancomycin, Meropenem) or a vehicle alone. After treatment, small intestinal villus height (VH), crypt depth (CD), mucosal surface area (MSA), crypt proliferation index (CPI), apoptosis, and villus and crypt cell types were assessed. Antibiotic-treated CONV (Abx-CONV) mice had taller villi, deeper crypts, increased CPI, increased apoptosis, and greater MSA compared to vehicle-treated CONV mice. Minor differences were noted in enterocyte and enterochromaffin cell proportions between groups, but goblet and Paneth cell proportions were unchanged in Abx-CONV mice compared to vehicle-treated CONV mice (p>0.05). Antibiotics caused no significant changes in VH or MSA in GF mice when compared to vehicle-treated GF mice (p>0.05). Enteral administration of broad-spectrum antibiotics to mice with a conventional microbiome stimulates ordered small intestinal mucosal growth. Mucosal growth was not seen in germ-free mice treated with antibiotics, implying that intestinal mucosal growth is associated with change in the microbiome in this model.	[Shaughnessy, Matthew P.; Park, Christine J.; Salvi, Pooja S.; Cowles, Robert A.] Yale Univ, Div Pediat Surg, Dept Surg, New Haven, CT 06520 USA	Yale University	Cowles, RA (corresponding author), Yale Univ, Div Pediat Surg, Dept Surg, New Haven, CT 06520 USA.	robert.cowles@yale.edu						ABRAMS GD, 1977, AM J CLIN NUTR, V30, P1880, DOI 10.1093/ajcn/30.11.1880; Allaband C, 2019, CLIN GASTROENTEROL H, V17, P218, DOI 10.1016/j.cgh.2018.09.017; Allcock S, 2017, GLOB HEALTH EPIDEM G, V2, DOI 10.1017/gheg.2017.4; Bereswill S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020953; Bloom SM, 2011, CELL HOST MICROBE, V9, P390, DOI 10.1016/j.chom.2011.04.009; BOOTH CC, 1959, BRIT J SURG, V46, P403, DOI 10.1002/bjs.18004619821; Brussow H, 2015, ENVIRON MICROBIOL, V17, P2216, DOI 10.1111/1462-2920.12786; Crenn P, 2008, CLIN NUTR, V27, P328, DOI 10.1016/j.clnu.2008.02.005; DiBaise JK, 2006, CLIN GASTROENTEROL H, V4, P11, DOI 10.1016/j.cgh.2005.10.020; Dibner JJ, 2005, POULTRY SCI, V84, P634, DOI 10.1093/ps/84.4.634; Duggan CP, 2017, NEW ENGL J MED, V377, P666, DOI 10.1056/NEJMra1602650; El Aidy S, 2015, CURR OPIN BIOTECH, V32, P14, DOI 10.1016/j.copbio.2014.09.005; GALJAARD H, 1972, EXP CELL RES, V73, P197, DOI 10.1016/0014-4827(72)90120-6; Greig CJ, 2019, PHYSIOL REP, V7, DOI 10.14814/phy2.14278; Greig CJ, 2018, J SURG RES, V231, P331, DOI 10.1016/j.jss.2018.05.055; Greig CJ, 2017, MICROSC RES TECHNIQ, V80, P793, DOI 10.1002/jemt.22866; Gross ER, 2012, GASTROENTEROLOGY, V143, P408, DOI 10.1053/j.gastro.2012.05.007; Hormann N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113080; Huang YH, 2017, J GASTROEN HEPATOL, V32, P1949, DOI 10.1111/jgh.13806; Ichikawa H, 1999, DIGEST DIS SCI, V44, P2119, DOI 10.1023/A:1026647024077; Jensen ML, 2014, AM J PHYSIOL-GASTR L, V306, pG59, DOI 10.1152/ajpgi.00213.2013; Juno RJ, 2003, SURGERY, V134, P582, DOI 10.1016/S0039-6060(03)00281-2; Kang SS, 2008, PLOS MED, V5, P424, DOI 10.1371/journal.pmed.0050041; Kennedy EA, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01534; KENWORTHY R, 1966, J COMP PATHOL, V76, P291, DOI 10.1016/0021-9975(66)90009-0; Korpela K, 2017, JPEN-PARENTER ENTER, V41, P238, DOI 10.1177/0148607115584388; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Martinez-Guryn K, 2019, CELL HOST MICROBE, V26, P314, DOI 10.1016/j.chom.2019.08.011; Morgun A, 2015, GUT, V64, P1732, DOI 10.1136/gutjnl-2014-308820; Naberhuis JK, 2017, JPEN-PARENTER ENTER, V41, P853, DOI 10.1177/0148607115602891; Nigro G, 2014, CELL HOST MICROBE, V15, P792, DOI 10.1016/j.chom.2014.05.003; Olaya J, 1999, IN VITRO CELL DEV-AN, V35, P43; Ouellette AJ, 2011, CELL MOL LIFE SCI, V68, P2215, DOI 10.1007/s00018-011-0714-6; Park CJ, 2019, GASTROENTEROL RES, V12, P88, DOI 10.14740/gr1146; Park CJ, 2019, J GASTROINTEST SURG, V23, P1198, DOI 10.1007/s11605-018-3907-6; Park J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156334; Piper HG, 2018, SEMIN PEDIATR SURG, V27, P223, DOI 10.1053/j.sempedsurg.2018.07.007; Piper HG, 2017, JPEN-PARENTER ENTER, V41, P1202, DOI 10.1177/0148607116658762; Reikvam DH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017996; Romick-Rosendale LE, 2014, METABOLOMICS, V10, P8, DOI 10.1007/s11306-013-0546-5; Rubin DC, 2016, BEST PRACT RES CL GA, V30, P237, DOI 10.1016/j.bpg.2016.03.007; Spor A, 2011, NAT REV MICROBIOL, V9, P279, DOI 10.1038/nrmicro2540; Suh SH, 2019, EMBO REP, V20, DOI 10.15252/embr.201846927; Tanner SM, 2015, AM J PATHOL, V185, P4, DOI 10.1016/j.ajpath.2014.08.028; Tappenden KA, 2014, JPEN-PARENTER ENTER, V38, p23S, DOI 10.1177/0148607114525210; Uzbay T, 2019, CURR OPIN PHARMACOL, V49, P6, DOI 10.1016/j.coph.2019.03.016; WESER E, 1971, GASTROENTEROLOGY, V60, P69; Wu W, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197762; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Zarrinpar A, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05336-9; Zhang L, 2019, J SURG RES, V236, P326, DOI 10.1016/j.jss.2018.11.033	52	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266251	10.1371/journal.pone.0266251	http://dx.doi.org/10.1371/journal.pone.0266251			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349599	gold, Green Published			2022-12-26	WOS:000783906500025
J	Techarang, T; Jariyapong, P; Punsawad, C				Techarang, Tachpon; Jariyapong, Pitchanee; Punsawad, Chuchard			Role of sphingosine kinase and sphingosine-1-phosphate receptor in the liver pathology of mice infected with Plasmodium berghei ANKA	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ERYTHROCYTES; 1-PHOSPHATE; EXPRESSION; APOPTOSIS; ACTIVATION; RESPONSES; HEMOZOIN; CELLS	Decreased serum sphingosine 1-phosphate (S1P) has been reported in severe malaria patients, but the expression of receptors and enzymes associated with S1P has not been investigated in the liver of malaria patients. Therefore, this study aimed to investigate the expression of sphingosine kinase (SphK) and S1P receptors (S1PRs) in the liver of malaria-infected mice. C57BL/6 male mice were divided into a control group (n = 10) and a Plasmodium berghei (PbA)-infected group (n = 10). Mice in the malaria group were intraperitoneally injected with 1x10(6) P. berghei ANKA-infected red blood cells, whereas control mice were intraperitoneally injected with normal saline. Liver tissues were collected on Day 13 of the experiment to evaluate histopathological changes by hematoxylin and eosin staining and to investigate SphK and S1PR expression by immunohistochemistry and real-time PCR. Histological examination of liver tissues from the PbA-infected group revealed sinusoidal dilatation, hemozoin deposition, portal tract inflammation and apoptotic hepatocytes, which were absent in the control group. Immunohistochemical staining showed significant increases in the expression of SphK1 and SphK2 and significant decreases in the expression of S1PR1, S1PR2, and S1PR3 in the endothelium, hepatocytes, and Kupffer cells in liver tissue from the PbA-infected group compared with the control group. Real-time PCR analysis showed the upregulation of SphK1 and the downregulation of S1PR1, S1PR2, and S1PR3 in the liver in the PbA-infected group compared with the control group. In conclusion, this study demonstrates for the first time that SphK1 mRNA expression is upregulated and that S1PR1, S1PR2, and S1PR3 expression is decreased in the liver tissue of PbA-infected mice. Our findings suggest that the decreased levels of S1PR1, S1PR2, and S1PR3 might play an important role in liver injury during malaria infection.	[Techarang, Tachpon; Jariyapong, Pitchanee; Punsawad, Chuchard] Walailak Univ, Sch Med, Dept Med Sci, Nakhon Si Thammarat, Thailand; [Punsawad, Chuchard] Walailak Univ, Res Ctr Trop Pathobiol, Nakhon Si Thammarat, Thailand	Walailak University; Walailak University	Punsawad, C (corresponding author), Walailak Univ, Sch Med, Dept Med Sci, Nakhon Si Thammarat, Thailand.; Punsawad, C (corresponding author), Walailak Univ, Res Ctr Trop Pathobiol, Nakhon Si Thammarat, Thailand.	chuchard.pu@wu.ac.th						ALVES MFC, 1992, MEM I OSWALDO CRUZ, V87, P331, DOI 10.1590/S0074-02761992000700055; Baheti R., 2003, J INDIAN ACAD CLIN M, V4, P34; Bode C, 2010, J CELL BIOCHEM, V109, P1232, DOI 10.1002/jcb.22507; CDC, MAL 2019; CLARK IA, 1987, AM J PATHOL, V129, P192; Davaille J, 2002, J BIOL CHEM, V277, P37323, DOI 10.1074/jbc.M202798200; Deroost K, 2013, AM J RESP CELL MOL, V48, P589, DOI 10.1165/rcmb.2012-0450OC; El-Assaad F, 2013, INFECT IMMUN, V81, P3984, DOI 10.1128/IAI.00428-13; Epiphanio S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000916; Finney CAM, 2011, MOL MED, V17, P717, DOI 10.2119/molmed.2010.00214; Fonager J, 2012, J EXP MED, V209, P93, DOI 10.1084/jem.20110762; Franke-Fayard B, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001032; Gardell SE, 2006, TRENDS MOL MED, V12, P65, DOI 10.1016/j.molmed.2005.12.001; Griffith JW, 2009, J IMMUNOL, V183, P5208, DOI 10.4049/jimmunol.0713552; Gude DR, 2008, FASEB J, V22, P2629, DOI 10.1096/fj.08-107169; Hanel P, 2007, FASEB J, V21, P1202, DOI 10.1096/fj.06-7433com; Hajduch E, 2021, J CLIN MED, V10, DOI 10.3390/jcm10040792; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hla T, 2004, SEMIN CELL DEV BIOL, V15, P513, DOI 10.1016/j.semcdb.2004.05.002; Ishii I, 2004, ANNU REV BIOCHEM, V73, P321, DOI 10.1146/annurev.biochem.73.011303.073731; Kaewdana K, 2021, TROP MED HEALTH, V49, DOI 10.1186/s41182-021-00314-2; Kawahara A, 2009, SCIENCE, V323, P524, DOI 10.1126/science.1167449; Kim J, 2018, CELL PHYSIOL BIOCHEM, V50, P1414, DOI 10.1159/000494604; Li CY, 2009, AM J PATHOL, V175, P1464, DOI 10.2353/ajpath.2009.090037; Li J, 2019, ONCOL LETT, V18, P5374, DOI 10.3892/ol.2019.10910; Maknitikul S, 2018, EXP BIOL MED, V243, P395, DOI 10.1177/1535370218757458; Maknitikul S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181674; Mbengue B, 2016, IMMUN INFLAMM DIS, V4, P24, DOI 10.1002/iid3.89; Medeiros MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081409; Michaud J, 2006, FEBS LETT, V580, P4607, DOI 10.1016/j.febslet.2006.07.035; Murata N, 2000, BIOCHEM J, V352, P809, DOI 10.1042/0264-6021:3520809; Newell ML, 2000, T ROY SOC TROP MED H, V94, P1, DOI 10.1016/S0035-9203(00)90413-9; Ng ML, 2017, INT J MOL MED, V39, P243, DOI 10.3892/ijmm.2017.2855; Obinata H, 2019, INT IMMUNOL, V31, P617, DOI 10.1093/intimm/dxz037; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Prakash H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010657; Punsawad C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180631; Punsawad C, 2015, INT J CLIN EXP PATHO, V8, P10002; Punsawad C, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-260; Serra M, 2010, ADV ENZYME REGUL, V50, P349, DOI 10.1016/j.advenzreg.2009.10.024; Shu XD, 2002, MOL CELL BIOL, V22, P7758, DOI 10.1128/MCB.22.22.7758-7768.2002; Spiegel S, 2003, NAT REV MOL CELL BIO, V4, P397, DOI 10.1038/nrm1103; Sukocheva O, 2013, EXP CELL RES, V319, P455, DOI 10.1016/j.yexcr.2012.10.014; Sukocheva OA, 2020, PHARMACOL THERAPEUT, V207, DOI 10.1016/j.pharmthera.2019.107464; Sukocheva OA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020420; van Hooren KWEM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091346; Venkataraman K, 2008, CIRC RES, V102, P669, DOI 10.1161/CIRCRESAHA.107.165845; Viriyavejakul P, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/3932569; Viriyavejakul P, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-106; Wadgaonkar R, 2009, AM J PHYSIOL-LUNG C, V296, pL603, DOI 10.1152/ajplung.90357.2008; White NJ, 1996, NEW ENGL J MED, V335, P800, DOI 10.1056/NEJM199609123351107; WHO, 2011, WORLD MALARIA REPORT 2011, P1; Xia P, 2002, J BIOL CHEM, V277, P7996, DOI 10.1074/jbc.M111423200; Yogi A, 2011, HYPERTENSION, V57, P809, DOI 10.1161/HYPERTENSIONAHA.110.162719	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266055	10.1371/journal.pone.0266055	http://dx.doi.org/10.1371/journal.pone.0266055			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333897	gold, Green Published			2022-12-26	WOS:000784335700024
J	Xu, DT; Ge, CR; Li, Y; Liu, YJ				Xu, Dongtao; Ge, Changrong; Li, Ying; Liu, Yuejuan			Evaluation the possibility of vortex-induced resonance for a multistage pressure reducing valve	PLOS ONE			English	Article							FLOW	A multistage pressure reducing valve is presented in this paper. The pressure reducing components are specially designed to not only control the flow rate but also effectively prevent the cavitation vibration. However, when the fluid flows through the pressure reducing components, the divergence and shedding of the vortices in the flow field seriously affect the stability of the valve and cause vortex-induced vibration. Especially, the main frequency of the vortex shedding is in the same frequency range as the modal frequency of the valve, the vortex-induced resonance of the valve occurs. It seriously affects the safety of a control system. In this paper, by monitoring the lift coefficient of the vortex cross flow in the valve, the frequency spectrum information of the lift coefficient is used as the novelty indexes to indicate vortex-induced vibration of the fluid in the valve. The main frequency and amplitude of vortex-induced vibration are obtained. The factors affecting the vortex-induced vibration of the fluid are analyzed. The results indicate that vortex-induced vibration is the most serious when the valve is opened or closed. The variation of the flow velocity and the pressure difference have obvious effects on vortex-induced vibration of the valve. The intensity of the variation affects the main frequency and amplitude of vortex-induced vibration. Using thermal-fluid-solid coupling modal analysis instead of traditional modal analysis, the modal frequency under the working state of the valve is obtained. It is compared with the main frequency of vortex shedding, and vortex-induced resonance does not occur in the multistage pressure reducing valve.	[Xu, Dongtao; Ge, Changrong; Li, Ying; Liu, Yuejuan] Univ Sci & Technol Liaoning, Sch Mech Engn & Automat, Anshan, Liaoning, Peoples R China	University of Science & Technology Liaoning	Xu, DT (corresponding author), Univ Sci & Technol Liaoning, Sch Mech Engn & Automat, Anshan, Liaoning, Peoples R China.	as_xudongtao@163.com			Fund Project of Liaoning Education Department, China [LJKZ0299]	Fund Project of Liaoning Education Department, China	We are grateful to editors and reviewers for their suggestions on revision.	Anilkumar A, 2021, J SOUND VIB, V493, DOI 10.1016/j.jsv.2020.115824; Chen F, 2018, AEROSP SCI TECHNOL, V78, P620, DOI 10.1016/j.ast.2018.05.015; [陈佳 Chen Jia], 2017, [仪器仪表学报, Chinese Journal of Scientific Instrument], V38, P1731; Chizfahm A, 2018, RENEW ENERG, V121, P632, DOI 10.1016/j.renene.2018.01.038; [高云 Gao Yun], 2018, [振动与冲击, Journal of Vibration and Shock], V37, P37; Hasan ABMT, 2010, P I MECH ENG C-J MEC, V224, P2165, DOI 10.1243/09544062JMES1823; Hou HP, 2021, J LOW FREQ NOISE V A, V40, P772, DOI 10.1177/1461348420918413; Kang Z., 2017, J VIB SHOCK, V36, DOI [10.13465/j.cnki.jvs.2017.24.033, DOI 10.13465/J.CNKI.JVS.2017.24.033]; [康庄 Kang Zhuang], 2018, [振动与冲击, Journal of Vibration and Shock], V37, P185; [李树勋 Li Shuxun], 2020, [振动与冲击, Journal of Vibration and Shock], V39, P95; Li SX., 2020, J VIB SHOCK, V39, P114, DOI [10.13465/j.cnki.jvs.2020.14.017, DOI 10.13465/J.CNKI.JVS.2020.14.017]; Lisowski E, 2016, ENERG CONVERS MANAGE, V123, P15, DOI 10.1016/j.enconman.2016.06.025; Qiu C, 2019, PROCESSES, V7, DOI 10.3390/pr7110829; Ren RN, 2022, ENERGY SCI ENG, V10, P932, DOI 10.1002/ese3.1074; Semrau S, 2019, J SOUND VIB, V463, DOI 10.1016/j.jsv.2019.114956; [王海民 Wang Haimin], 2018, [振动与冲击, Journal of Vibration and Shock], V37, P202; Wu GX, 2021, WATER-SUI, V13, DOI 10.3390/w13070955; Xu DT., 2020, J PRESS VESSEL TECHN, V143, DOI [10.1115/1.4048418, DOI 10.1115/1.4048418]; Xu H, 2011, ANN NUCL ENERGY, V38, P1427, DOI 10.1016/j.anucene.2011.01.013; [袁昱超 Yuan Yuchao], 2018, [振动与冲击, Journal of Vibration and Shock], V37, P53; Zhou CJ, 2017, J SOUND VIB, V410, P249, DOI 10.1016/j.jsv.2017.08.016	21	0	0	10	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266414	10.1371/journal.pone.0266414	http://dx.doi.org/10.1371/journal.pone.0266414			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363803	Green Published, gold			2022-12-26	WOS:000804748600024
J	Serganov, AA; Udi, Y; Stein, ME; Patel, V; Fridy, PC; Rice, CM; Saeed, M; Jacobs, EY; Chait, BT; Rout, MP				Serganov, Artem A.; Udi, Yael; Stein, Milana E.; Patel, Valay; Fridy, Peter C.; Rice, Charles M.; Saeed, Mohsan; Jacobs, Erica Y.; Chait, Brian T.; Rout, Michael P.			Proteomic elucidation of the targets and primary functions of the picornavirus 2A protease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EUKARYOTIC TRANSLATION INITIATION; NUCLEAR-PORE COMPLEX; FG NUCLEOPORIN NUP98; RNA EXPORT FACTOR; FACTOR 4G EIF4G; MESSENGER-RNA; VIRAL SUBVERSION; LOCALIZATION; CLEAVAGE; PROTEINS	Picornaviruses are small RNA viruses that hijack host cell machinery to promote their replication. During infection, these viruses express two proteases, 2Apro and 3Cpro, which process viral proteins. They also subvert a number of host functions, including innate immune responses, host protein synthesis, and intracellular transport, by utilizing poorly understood mechanisms for rapidly and specifically targeting critical host proteins. Here, we used proteomic tools to characterize 2Apro interacting partners, functions, and targeting mechanisms. Our data indicate that, initially, 2Apro primarily targets just two cellular proteins: eukaryotic translation initiation factor eIF4G (a critical component of the protein synthesis machinery) and Nup98 (an essential component of the nuclear pore complex, responsible for nucleocytoplasmic transport). The protease appears to employ two different cleavage mechanisms; it likely interacts with eIF3L, utilizing the eIF3 complex to proteolytically access the eIF4G protein but also directly binds and degrades Nup98. This Nup98 cleavage results in only a marginal effect on nuclear import of proteins, while nuclear export of proteins and mRNAs were more strongly affected. Collectively, our data indicate that 2Apro selectively inhibits protein translation, key nuclear export pathways, and cellular mRNA localization early in infection to benefit viral replication at the expense of particular cell functions.	[Serganov, Artem A.; Udi, Yael; Stein, Milana E.; Patel, Valay; Fridy, Peter C.; Rout, Michael P.] Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA; [Rice, Charles M.; Saeed, Mohsan] Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA; [Saeed, Mohsan] Boston Univ Sch Med, Dept Biochem, Boston, MA 02118 USA; [Saeed, Mohsan] Boston Univ, Boston Univ Sch Med, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA; [Jacobs, Erica Y.; Chait, Brian T.] Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA; [Jacobs, Erica Y.] St Johns Univ, Chem Dept, Jamaica, NY 11439 USA	Rockefeller University; Rockefeller University; Boston University; Boston University; Rockefeller University; Saint John's University	Udi, Y; Rout, MP (corresponding author), Rockefeller Univ, Lab Cellular & Struct Biol, New York, NY 10065 USA.; Saeed, M (corresponding author), Rockefeller Univ, Lab Virol & Infect Dis, New York, NY 10065 USA.; Saeed, M (corresponding author), Boston Univ Sch Med, Dept Biochem, Boston, MA 02118 USA.; Saeed, M (corresponding author), Boston Univ, Boston Univ Sch Med, Natl Emerging Infect Dis Labs, Boston, MA 02215 USA.; Jacobs, EY; Chait, BT (corresponding author), Rockefeller Univ, Lab Mass Spectrometry & Gaseous Ion Chem, New York, NY 10065 USA.; Jacobs, EY (corresponding author), St Johns Univ, Chem Dept, Jamaica, NY 11439 USA.	yudi@rockefeller.edu; msaeed1@bu.edu; jacobse@stjohns.edu; chait@rockefeller.edu; rout@rockefeller.edu		Stein, Milana/0000-0001-6540-4389; Patel, Valay/0000-0002-1787-5116; Jacobs, Erica/0000-0002-5018-0711; Udi, Yael/0000-0001-8451-2246; Saeed, Mohsan/0000-0001-8505-7054; Fridy, Peter/0000-0002-8208-9154	National Institutes of Health (NIH) [P41 GM109824, R01 CA228351, R01 GM112108]; NIH NIAID [R01 AI091707]; Institut Merieux grant; Leukemia and Lym-phoma Society Translational Research Program [6601-20]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institut Merieux grant; Leukemia and Lym-phoma Society Translational Research Program	This work was supported by grants the National Institutes of Health (NIH) P41 GM109824 (B. T. C., M. P. R.) , NIH R01 CA228351 (M. P. R.) , NIH R01 GM112108 (M. P. R.) , NIH NIAID grant R01 AI091707 (C. M. R.) , an Institut Merieux grant (M. S. and C. M. R.) , and the Leukemia and Lym-phoma Society Translational Research Program Grant Number 6601-20. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abkallo HM, 2011, DRUG DISCOV THER, V5, P286, DOI 10.5582/ddt.2011.v5.6.286; Adam SA, 2008, J BIOL CHEM, V283, P8462, DOI 10.1074/jbc.M709572200; Addetia A, 2021, MBIO, V12, DOI 10.1128/mBio.00065-21; Alvarez E, 2003, J VIROL, V77, P12392, DOI 10.1128/JVI.77.23.12392-12400.2003; Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723; Ann S, 2017, ELIFE, V6, DOI 10.7554/eLife.30244; Aumayr M, 2017, VIROLOGY, V511, P123, DOI 10.1016/j.virol.2017.08.020; Avanzino BC, 2017, P NATL ACAD SCI USA, V114, P9611, DOI 10.1073/pnas.1704390114; Bai XT, 2012, J VIROL, V86, P4559, DOI 10.1128/JVI.06361-11; Beck M, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.82; Blanchard SC, 2004, P NATL ACAD SCI USA, V101, P12893, DOI 10.1073/pnas.0403884101; Borghese F, 2011, J VIROL, V85, P9614, DOI 10.1128/JVI.00480-11; Bosch B, 2021, CELL, V184, P4579, DOI 10.1016/j.cell.2021.06.033; Bovee ML, 1998, VIROLOGY, V245, P241, DOI 10.1006/viro.1998.9172; Castello A, 2006, J BIOL CHEM, V281, P33206, DOI 10.1074/jbc.M604340200; Castello A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/369648; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Cristea IM, 2006, J BIOL CHEM, V281, P30269, DOI 10.1074/jbc.M603980200; Cristea Ileana M, 2011, Cold Spring Harb Protoc, V2011, DOI [10.1101/pdb.prot5611, 10.1101/pdb.prot5610]; Das AT, 2016, CURR GENE THER, V16, P156, DOI 10.2174/1566523216666160524144041; Dicks MDJ, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007408; Domanski Michal, 2012, Biotechniques, V0, P1, DOI 10.2144/000113864; Dougherty JD, 2015, VIRUSES-BASEL, V7, P6127, DOI 10.3390/v7122922; Fan Y, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00396; Faria PA, 2005, MOL CELL, V17, P93, DOI 10.1016/j.molcel.2004.11.023; Feng Q, 2014, J VIROL, V88, P3369, DOI 10.1128/JVI.02712-13; Goldstaub D, 2000, MOL CELL BIOL, V20, P1271, DOI 10.1128/MCB.20.4.1271-1277.2000; Guttler T, 2010, NAT STRUCT MOL BIOL, V17, P1367, DOI 10.1038/nsmb.1931; Guntas G, 2015, P NATL ACAD SCI USA, V112, P112, DOI 10.1073/pnas.1417910112; Hakhverdyan Z, 2015, NAT METHODS, V12, P553, DOI 10.1038/nmeth.3395; Hanson PJ, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00265; Hugel S, 2014, MOL CELL PROTEOMICS, V13, P1286, DOI 10.1074/mcp.M112.026856; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Kane M, 2018, ELIFE, V7, DOI 10.7554/eLife.35738; Kim SJ, 2018, NATURE, V555, P475, DOI 10.1038/nature26003; LaCava J, 2016, JOVE-J VIS EXP, DOI 10.3791/54518(2016); LaCava John, 2016, Cold Spring Harb Protoc, V2016, DOI 10.1101/pdb.top077545; LAMPHEAR BJ, 1995, J BIOL CHEM, V270, P21975, DOI 10.1074/jbc.270.37.21975; Le Sage V, 2013, VIRUSES-BASEL, V5, P2019, DOI 10.3390/v5082019; Luo Y, 2016, NAT MICROBIOL, V1, DOI 10.1038/NMICROBIOL.2016.68; Martinez-Salas E, 2015, VIRUS RES, V206, P62, DOI 10.1016/j.virusres.2015.01.012; Masutani M, 2007, EMBO J, V26, P3373, DOI 10.1038/sj.emboj.7601765; McKendrick L, 2001, MOL CELL BIOL, V21, P3632, DOI 10.1128/MCB.21.11.3632-3641.2001; Mellacheruvu D, 2013, NAT METHODS, V10, P730, DOI 10.1038/nmeth.2557; Miorin L, 2020, P NATL ACAD SCI USA, V117, P28344, DOI 10.1073/pnas.2016650117; Moorman NJ, 2008, CELL HOST MICROBE, V3, P253, DOI 10.1016/j.chom.2008.03.002; Morais ATS, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-205; Mukherjee A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001311; Murphy PM, 2001, NAT IMMUNOL, V2, P116, DOI 10.1038/84214; Nakano K, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00330; Novoa I, 1999, MOL CELL BIOL, V19, P2445; Obado SO, 2016, METHODS MOL BIOL, V1411, P67, DOI 10.1007/978-1-4939-3530-7_3; Oka M, 2010, MOL BIOL CELL, V21, P1885, DOI 10.1091/mbc.E09-12-1041; Park N, 2008, J VIROL, V82, P1647, DOI 10.1128/JVI.01670-07; Park N, 2015, J VIROL, V89, P11069, DOI 10.1128/JVI.00956-15; Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237; Quan BL, 2014, P NATL ACAD SCI USA, V111, P9127, DOI 10.1073/pnas.1409076111; Querol-Audi J, 2013, STRUCTURE, V21, P920, DOI 10.1016/j.str.2013.04.002; Ren Y, 2010, P NATL ACAD SCI USA, V107, P10406, DOI 10.1073/pnas.1005389107; Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8; Saeed M, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008927; Shen QT, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100856; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Stuwe T, 2012, J MOL BIOL, V419, P330, DOI 10.1016/j.jmb.2012.03.024; Suel KE, 2008, PLOS BIOL, V6, P1253, DOI 10.1371/journal.pbio.0060137; Taha MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091465; Tang JW, 2017, VIRULENCE, V8, P1062, DOI 10.1080/21505594.2017.1308620; Terhune SS, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000965; Thompson SR, 2003, VIROLOGY, V315, P259, DOI 10.1016/S0042-6822(03)00544-0; Valasek LS, 2017, NUCLEIC ACIDS RES, V45, P10948, DOI 10.1093/nar/gkx805; Villa N, 2013, J BIOL CHEM, V288, P32932, DOI 10.1074/jbc.M113.517011; Visser LJ, 2019, J VIROL, V93, DOI 10.1128/JVI.00222-19; Walker E, 2016, J VIROL, V90, P11032, DOI 10.1128/JVI.00974-16; Walker EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071316; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; Wang B, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003231; Watters K, 2017, J VIROL, V91, DOI 10.1128/JVI.02472-16; Welch K, 1999, MOL CELL BIOL, V19, P8400; Wu XS, 2001, P NATL ACAD SCI USA, V98, P3191, DOI 10.1073/pnas.051631598; Yang TT, 1996, NUCLEIC ACIDS RES, V24, P4592, DOI 10.1093/nar/24.22.4592; Yang XD, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006901; Yarbrough ML, 2014, TRAFFIC, V15, P127, DOI 10.1111/tra.12137; Zamora M, 2002, J VIROL, V76, P165, DOI 10.1128/JVI.76.1.165-177.2002; Zell R, 2018, ARCH VIROL, V163, P299, DOI 10.1007/s00705-017-3614-8; Zhang K, 2019, NAT MICROBIOL, V4, P1671, DOI 10.1038/s41564-019-0482-x	85	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101882	10.1016/j.jbc.2022.101882	http://dx.doi.org/10.1016/j.jbc.2022.101882			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	3D9BF	35367208	gold, Green Published			2022-12-26	WOS:000829588600001
J	Lechuga, S; Cartagena-Rivera, AX; Khan, A; Crawford, BI; Narayanan, V; Conway, DE; Lehtimaki, J; Lappalainen, P; Rieder, F; Longworth, MS; Ivanov, AI				Lechuga, Susana; Cartagena-Rivera, Alexander X.; Khan, Afshin; Crawford, Bert, I; Narayanan, Vani; Conway, Daniel E.; Lehtimaki, Jaakko; Lappalainen, Pekka; Rieder, Florian; Longworth, Michelle S.; Ivanov, Andrei I.			A myosin chaperone, UNC-45A, is a novel regulator of intestinal epithelial barrier integrity and repair	FASEB JOURNAL			English	Article						adherens junctions; cell migration; epithelial barriers; myosins; tight junctions	E-CADHERIN; CAENORHABDITIS-ELEGANS; CELL-JUNCTIONS; ISOFORMS; ACTOMYOSIN; TENSION; MUTATIONS; COMPLEX; MODULES; ROLES	The actomyosin cytoskeleton serves as a key regulator of the integrity and remodeling of epithelial barriers by controlling assembly and functions of intercellular junctions and cell-matrix adhesions. Although biochemical mechanisms that regulate the activity of non-muscle myosin II (NM-II) in epithelial cells have been extensively investigated, little is known about assembly of the contractile myosin structures at the epithelial adhesion sites. UNC-45A is a cytoskeletal chaperone that is essential for proper folding of NM-II heavy chains and myofilament assembly. We found abundant expression of UNC-45A in human intestinal epithelial cell (IEC) lines and in the epithelial layer of the normal human colon. Interestingly, protein level of UNC-45A was decreased in colonic epithelium of patients with ulcerative colitis. CRISPR/Cas9-mediated knock-out of UNC-45A in HT-29cf8 and SK-CO15 IEC disrupted epithelial barrier integrity, impaired assembly of epithelial adherence and tight junctions and attenuated cell migration. Consistently, decreased UNC-45 expression increased permeability of the Drosophila gut in vivo. The mechanisms underlying barrier disruptive and anti-migratory effects of UNC-45A depletion involved disorganization of the actomyosin bundles at epithelial junctions and the migrating cell edge. Loss of UNC-45A also decreased contractile forces at apical junctions and matrix adhesions. Expression of deletion mutants revealed roles for the myosin binding domain of UNC-45A in controlling IEC junctions and motility. Our findings uncover a novel mechanism that regulates integrity and restitution of the intestinal epithelial barrier, which may be impaired during mucosal inflammation.	[Lechuga, Susana; Khan, Afshin; Crawford, Bert, I; Rieder, Florian; Longworth, Michelle S.; Ivanov, Andrei I.] Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NC22, Cleveland, OH 44195 USA; [Cartagena-Rivera, Alexander X.] Natl Inst Biomed Imaging & Bioengn, Sect Mechanobiol, NIH, Bethesda, MD USA; [Narayanan, Vani; Conway, Daniel E.] Virginia Commonwealth Univ, Dept Biomed Engn, Richmond, VA USA; [Lehtimaki, Jaakko; Lappalainen, Pekka] Univ Helsinki, Inst Biotechnol, Helsinki, Finland; [Lehtimaki, Jaakko; Lappalainen, Pekka] Univ Helsinki, Helsinki Inst Life Sci, Helsinki, Finland; [Rieder, Florian] Cleveland Clin Fdn, Digest Dis & Surg Inst, Dept Gastroenterol Hepatol & Nutr, Cleveland, OH 44195 USA	Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Virginia Commonwealth University; University of Helsinki; University of Helsinki; Cleveland Clinic Foundation	Ivanov, AI (corresponding author), Cleveland Clin Fdn, Lerner Res Inst, Dept Inflammat & Immun, 9500 Euclid Ave,NC22, Cleveland, OH 44195 USA.	ivanova2@ccf.org	longworth, michelle/S-8456-2019; Cartagena-Rivera, Alexander X./I-6101-2016	Narayanan, Vani/0000-0002-5358-8472; Cartagena-Rivera, Alexander X./0000-0001-6227-2499	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [RO1 DK108278, RO1 DK126702]; HHS | NIH | National Institute of General Medical Sciences (NIGMS) [R35 GM119617]; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID) [R21 AI153780]; HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB) [ZIAEB000094]	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); HHS | NIH | National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID); HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB)	HHS | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Grant/Award Number: RO1 DK108278 and RO1 DK126702; HHS | NIH | National Institute of General Medical Sciences (NIGMS), Grant/Award Number: R35 GM119617; HHS | NIH | National Institute of Allergy and Infectious Diseases (NIAID), Grant/Award Number: R21 AI153780; HHS | NIH | National Institute of Biomedical Imaging and Bioengineering (NIBIB), Grant/Award Number: ZIAEB000094	Acharya BR, 2017, CELL REP, V18, P2854, DOI 10.1016/j.celrep.2017.02.078; Anderson JM, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002584; Arsenovic PT, 2016, BIOPHYS J, V110, P34, DOI 10.1016/j.bpj.2015.11.014; Babbin BA, 2009, AM J PATHOL, V174, P436, DOI 10.2353/ajpath.2009.080171; Baranwal S, 2012, MOL BIOL CELL, V23, P3542, DOI 10.1091/mbc.E12-02-0162; Barral JM, 1998, J CELL BIOL, V143, P1215, DOI 10.1083/jcb.143.5.1215; Barral JM, 2002, SCIENCE, V295, P669, DOI 10.1126/science.1066648; Bazzaro M, 2007, AM J PATHOL, V171, P1640, DOI 10.2353/ajpath.2007.070325; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Cartagena-Rivera AX, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aat9934; Cartagena-Rivera AX, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01145-8; Ebrahim S, 2013, CURR BIOL, V23, P731, DOI 10.1016/j.cub.2013.03.039; Eisa NH, 2019, J BIOL CHEM, V294, P5246, DOI 10.1074/jbc.RA118.006597; Esteve C, 2018, AM J HUM GENET, V102, P364, DOI 10.1016/j.ajhg.2018.01.009; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Garrido-Casado M, 2021, ANNU REV CELL DEV BI, V37, P285, DOI 10.1146/annurev-cellbio-042721-105528; Gazda L, 2013, CELL, V152, P183, DOI 10.1016/j.cell.2012.12.025; Green KJ, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000125; Guo W, 2011, J MOL BIOL, V412, P365, DOI 10.1016/j.jmb.2011.07.012; Gupta Shafali, 2021, Fac Rev, V10, P56, DOI 10.12703/r/10-56; Gupton SL, 2006, CELL, V125, P1361, DOI 10.1016/j.cell.2006.05.029; Habicht J, 2021, J CELL SCI, V134, DOI 10.1242/jcs.248815; Habicht J, 2019, CANCER BIOL THER, V20, P1304, DOI 10.1080/15384047.2019.1632637; Hartsock A, 2008, BBA-BIOMEMBRANES, V1778, P660, DOI 10.1016/j.bbamem.2007.07.012; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; Hellerschmied D, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12667-8; Hellerschmied D, 2014, CURR OPIN STRUC BIOL, V25, P9, DOI 10.1016/j.sbi.2013.11.002; HIROKAWA N, 1982, J CELL BIOL, V95, P249, DOI 10.1083/jcb.95.1.249; Hoppe T, 2004, CELL, V118, P337, DOI 10.1016/j.cell.2004.07.014; Iizuka Y, 2017, MOL BIOL CELL, V28, P1337, DOI 10.1091/mbc.E16-06-0381; Ivanov AI, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-12; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Ivanov AI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000658; Ivanov AI, 2008, FRONT BIOSCI-LANDMRK, V13, P6662, DOI 10.2741/3180; Krivosheeva IA, 2020, CANCER CELL INT, V20, DOI 10.1186/s12935-020-01584-2; LEBIVIC A, 1989, P NATL ACAD SCI USA, V86, P9313; Lechuga S, 2019, BBA-MOL CELL RES, V1866, P395, DOI 10.1016/j.bbamcr.2018.10.001; Lechuga S, 2015, AM J PHYSIOL-GASTR L, V308, pG745, DOI 10.1152/ajpgi.00446.2014; Lechuga S, 2014, MOL BIOL CELL, V25, P3133, DOI 10.1091/mbc.E14-03-0815; Lee CF, 2014, INT REV CEL MOL BIO, V313, P103, DOI 10.1016/B978-0-12-800177-6.00004-9; Lee CF, 2011, J CELL SCI, V124, P699, DOI 10.1242/jcs.078964; Lehtimaki JI, 2017, J CELL BIOL, V216, P4053, DOI 10.1083/jcb.201703107; Liu L, 2008, J BIOL CHEM, V283, P13185, DOI 10.1074/jbc.M800757200; Martini E, 2017, CELL MOL GASTROENTER, V4, P33, DOI 10.1016/j.jcmgh.2017.03.007; Meng WX, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002899; Mitchell DM, 2004, IN VITRO CELL DEV-AN, V40, P297; Mooneyham A, 2019, MOL CANCER RES, V17, P370, DOI 10.1158/1541-7786.MCR-18-0670; Narayanan V, 2020, CURR BIOL, V30, P624, DOI 10.1016/j.cub.2019.12.025; Naydenov NG, 2021, CANCERS, V13, DOI 10.3390/cancers13040741; Naydenov NG, 2016, SCI REP-UK, V6, DOI 10.1038/srep24161; Naydenov NG, 2010, MOL BIOL CELL, V21, P3506, DOI 10.1091/mbc.E10-03-0259; Ngo P, 2006, METH MOL B, V341, P103; Ni Weiming, 2015, Subcell Biochem, V78, P133, DOI 10.1007/978-3-319-11731-7_7; Price MG, 2002, J CELL SCI, V115, P4013, DOI 10.1242/jcs.00108; Rera M, 2012, P NATL ACAD SCI USA, V109, P21528, DOI 10.1073/pnas.1215849110; Rera M, 2011, CELL METAB, V14, P623, DOI 10.1016/j.cmet.2011.09.013; ROEDIGER WEW, 1979, GUT, V20, P484, DOI 10.1136/gut.20.6.484; Schoultz I, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8020193; Sluysmans S, 2017, BIOL CELL, V109, P139, DOI 10.1111/boc.201600075; Smutny M, 2010, NAT CELL BIOL, V12, P696, DOI 10.1038/ncb2072; Varadarajan S, 2019, J CELL SCI, V132, DOI 10.1242/jcs.229286; VENOLIA L, 1990, GENETICS, V126, P345; Wang DD, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-019-1241-x; Zaidel-Bar R, 2015, J CELL SCI, V128, P2209, DOI 10.1242/jcs.170068; Zulueta-Coarasa T, 2017, MECH DEVELOP, V144, P43, DOI 10.1016/j.mod.2016.11.004	65	1	1	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22290	10.1096/fj.202200154R	http://dx.doi.org/10.1096/fj.202200154R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0G7GE	35344227	Green Submitted, Green Published			2022-12-26	WOS:000778208100001
J	Cho, J; Park, H; Kang, D; Park, E; Chung, CR; Cho, J; Kudchadkar, SR				Cho, Joongbum; Park, Hyejeong; Kang, Danbee; Park, Esther; Chung, Chi Ryang; Cho, Juhee; Kudchadkar, Sapna R.			Rehabilitation in critically ill children: Findings from the Korean National Health Insurance database	PLOS ONE			English	Article							INTENSIVE-CARE-UNIT; MULTICENTER POINT PREVALENCE; CRITICAL ILLNESS; OUTCOMES; THERAPY	Purpose Intensive care unit (ICU) survivors suffer from physical weakness and challenges returning to daily life. With the importance of rehabilitating patients in the pediatric intensive care unit being increasingly recognized, we evaluated the prevalence of physical and occupational therapy (PT/OT)-provided rehabilitation and factors affecting its use. Methods We conducted a retrospective cohort analysis of rehabilitation between 2013 and 2019 using the Korean National Health Insurance database. All patients aged 28 days to 18 years who had been admitted to 245 ICUs for more than 2 days were included. Neonatal ICUs were excluded. Results Of 13,276 patients, 2,447 (18%) received PT/OT-provided rehabilitation during their hospitalization; prevalence was lowest for patients younger than 3 years (11%). Neurologic patients were most likely to receive rehabilitation (adjusted odds ratio [aOR], 6.47; 95% confidence interval [CI], 5.11-8.20). Longer ICU stay (versus <= 1 week) was associated with rehabilitation (aOR for 1-2 weeks, 3.50 [95% CI, 3.04-4.03]; 2-3 weeks, 6.60 [95% CI, 5.45-8.00]; >3 weeks, 13.69 [95% CI, 11.46-16.35]). Mechanical ventilation >2 days (aOR, 0.78; 95% CI, 0.67-0.91) and hemodialysis (aOR, 0.50; 95% CI, 0.41-0.52) were negatively affecting factors. Conclusion Prevalence of rehabilitation for critically ill children was low and concentrated on patients with a prolonged ICU stay. The finding that mechanical ventilation, a risk factor for ICU-acquired weakness, was an obstacle to rehabilitation highlights the need for studies on early preventive rehabilitation based on individual patient needs.	[Cho, Joongbum; Park, Esther; Chung, Chi Ryang] Sungkyunkwan Univ, Samsung Med Ctr, Dept Crit Care Med, Sch Med, Seoul, South Korea; [Park, Hyejeong; Kang, Danbee; Cho, Juhee] Samsung Med Ctr, Ctr Clin Epidemiol, Seoul, South Korea; [Park, Hyejeong; Kang, Danbee; Cho, Juhee] Sungkyunkwan Univ, Dept Clin Res Design & Evaluat, SAIHST, Seoul, South Korea; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Charlotte R Bloomberg Childrens Ctr, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Sch Med, Dept Pediat, Charlotte R Bloomberg Childrens Ctr, Baltimore, MD 21205 USA; [Kudchadkar, Sapna R.] Johns Hopkins Univ, Dept Phys Med & Rehabil, Sch Med, Baltimore, MD USA	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cho, J (corresponding author), Sungkyunkwan Univ, Samsung Med Ctr, Dept Crit Care Med, Sch Med, Seoul, South Korea.	joongbum.cho@gmail.com		Kudchadkar, Sapna/0000-0003-3089-0318; Cho, Joongbum/0000-0001-5931-7553				Anekwe DE, 2020, PHYSIOTHERAPY, V107, P1, DOI 10.1016/j.physio.2019.12.004; [Anonymous], 2020, KPBMA DURG INFORM; Bergmann JP, 2020, CRIT CARE MED, V48, P1237, DOI 10.1097/CCM.0000000000004421; BUTT W, 1990, CRIT CARE MED, V18, P961, DOI 10.1097/00003246-199009000-00011; Case-Smith J, 1999, CHILD ADOL PSYCH CL, V8, P323; Choong K, 2021, PEDIATR CRIT CARE ME, V22, P181, DOI 10.1097/PCC.0000000000002601; Choong K, 2018, PEDIATR CRIT CARE ME, V19, P145, DOI 10.1097/PCC.0000000000001421; Cuello-Garcia CA, 2018, J PEDIATR-US, V203, P25, DOI 10.1016/j.jpeds.2018.07.037; Fan E, 2014, CRIT CARE MED, V42, P849, DOI 10.1097/CCM.0000000000000040; Fan E, 2012, RESP CARE, V57, P933, DOI 10.4187/respcare.01634; Fiser DH, 2000, CRIT CARE MED, V28, P1173, DOI 10.1097/00003246-200004000-00043; Garcia RU, 2016, EARLY HUM DEV, V96, P45, DOI 10.1016/j.earlhumdev.2016.03.004; Gmmash AS, 2020, PEDIATR PHYS THER, V32, P88, DOI 10.1097/PEP.0000000000000686; Gutenbrunner C, 2022, INT NURS REV, V69, P13, DOI 10.1111/inr.12661; Hodgson CL, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0658-y; Ista E, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-02988-2; Jones S, 2006, PEDIATRICS, V118, P2101, DOI 10.1542/peds.2006-1455; Jung M, 2020, ANN INTENSIVE CARE, V10, DOI 10.1186/s13613-020-00780-7; Jung M, 2019, PEDIATR CRIT CARE ME, V20, pE301, DOI 10.1097/PCC.0000000000001978; Kudchadkar SR, 2020, CRIT CARE MED, V48, P634, DOI 10.1097/CCM.0000000000004291; Lee JH, 2007, ANN REHABIL MED-ARM, V31, P97; Lee YS, 2016, EVID-BASED COMPL ALT, V2016, DOI 10.1155/2016/8160838; Maitre NL, 2015, ARCH DIS CHILD-FETAL, V100, pF534, DOI 10.1136/archdischild-2013-305920; Manning JC, 2018, PEDIATR CRIT CARE ME, V19, P298, DOI 10.1097/PCC.0000000000001476; Mestrovic J, 2008, J PEDIAT, V84, P232, DOI [10.2223/JPED.1779, 10.1590/S0021-75572008000300008]; Morris PE, 2008, CRIT CARE MED, V36, P2238, DOI 10.1097/CCM.0b013e318180b90e; Morris PE, 2007, CRIT CARE CLIN, V23, P1, DOI 10.1016/j.ccc.2006.11.003; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Park E, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11324-4; Park YH, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e101; Pereira Gabriela Alves, 2017, Rev. bras. ter. intensiva, V29, P460, DOI [10.5935/0103-507X.20170066, 10.5935/0103-507x.20170066]; Pun BT, 2019, CRIT CARE MED, V47, P3, DOI 10.1097/CCM.0000000000003482; Schweickert WD, 2011, CHEST, V140, P1612, DOI 10.1378/chest.10-2829; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Wieczorek B, 2015, J PEDIATR INTENSIVE, V4, P212, DOI 10.1055/s-0035-1563386	36	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266360	10.1371/journal.pone.0266360	http://dx.doi.org/10.1371/journal.pone.0266360			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358288	Green Published, gold			2022-12-26	WOS:000799828800096
J	Tang, YH; Lu, PL; Huang, HY; Lin, YC				Tang, Yu-Hsin; Lu, Po-Liang; Huang, Ho-Yin; Lin, Ying-Chi			Clinical effectiveness of beta-lactams versus fluoroquinolones as empirical therapy in patients with diabetes mellitus hospitalized for urinary tract infections: A retrospective cohort study	PLOS ONE			English	Article							ANTIMICROBIAL SUSCEPTIBILITY PROFILES; ESCHERICHIA-COLI; RESISTANCE; EPIDEMIOLOGY; PREVALENCE; SEPSIS; RISK	Background Diabetic patients are at risk of severe urinary tract infections (UTIs). Due to the emerging resistance rates to fluoroquinolones and beta-lactams, we aimed to evaluate the effectiveness of beta-lactams versus fluoroquinolones as empirical therapy for diabetic patients hospitalized for UTIs. Methods A retrospective cohort study was conducted in a medical center in Taiwan between 2016 and 2018. Patients with type 2 diabetes, aged >= 20 and hospitalized for UTIs were enrolled. Patients with UTI diagnosis within one year before the admission, co-infections at the admission, or >= 2 pathogens in the urine cultures were excluded. The primary outcome was empiric treatment failure. Results 298 patients were followed for at least 30 days after the admission. Escherichia coli (61.07%) was the most common pathogen. The resistance rates of the pathogens to levofloxacin were 28.52% and 34.22% according to the historical Clinical and Laboratory Standards Institute (CLSI) breakpoints and the updated 2019 CLSI breakpoints, respectively. The resistance rates of ceftazidime and cefepime were 21.81% and 11.41%, respectively. Empirical beta-lactams were associated with less treatment failure compared to fluoroquinolones (adjusted OR = 0.32, 95% CI = 0.17-0.60). Beta-lactams were associated with less treatment failure than fluoroquinolones when appropriatness was determined by the pre-2019 CLSI breakpoints but not the 2019 CLSI breakpoints. Conclusions In diabetic patients hospitalized for UTIs, beta-lactams were associated with less empiric treatment failure compared to fluoroquinolones when the resistance rate to fluoroquinolone is higher than beta-lactams. The updated 2019 CLSI breakpoint for fluoroquinolone was better than pre-2019 CLSI breakpoints to correlate with treatment outcomes for hospitalized UTIs in diabetic patients.	[Tang, Yu-Hsin; Lin, Ying-Chi] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Master Program Clin Pharm, Kaohsiung, Taiwan; [Tang, Yu-Hsin; Huang, Ho-Yin; Lin, Ying-Chi] Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Coll Med, Sch Postbaccalaureate Med, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Internal Med, Div Infect Dis, Kaohsiung, Taiwan; [Lu, Po-Liang] Kaohsiung Med Univ, Ctr Liquid Biopsy & Cohort Res, Kaohsiung, Taiwan; [Huang, Ho-Yin] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Pharm, Kaohsiung, Taiwan; [Lin, Ying-Chi] Kaohsiung Med Univ, Coll Pharm, Master Degree Program Toxicol, Kaohsiung, Taiwan; [Lin, Ying-Chi] Kaohsiung Med Univ, Coll Pharm, Doctoral Degree Program Toxicol, Kaohsiung, Taiwan	Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University; Kaohsiung Medical University Hospital; Kaohsiung Medical University; Kaohsiung Medical University	Lin, YC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Master Program Clin Pharm, Kaohsiung, Taiwan.; Lin, YC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Sch Pharm, Kaohsiung, Taiwan.; Lin, YC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Master Degree Program Toxicol, Kaohsiung, Taiwan.; Lin, YC (corresponding author), Kaohsiung Med Univ, Coll Pharm, Doctoral Degree Program Toxicol, Kaohsiung, Taiwan.	yclin@kmu.edu.tw	Lin, Ying-Chi/V-7851-2019	Lin, Ying-Chi/0000-0003-0335-3402	Ministry of Science and Technology [MOST 110-2320-B-037-012]; Kaohsiung Medical University Research Foundation [KMU-M110011]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Kaohsiung Medical University Research Foundation	YCL received the Ministry of Science and Technology (MOST 110-2320-B-037-012) and the Kaohsiung Medical University Research Foundation (KMU-M110011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Ashour W, 2018, BMC INFECT DIS, V18, DOI 10.1186/s12879-018-2975-2; Aguilar-Duran S, 2012, J INFECTION, V64, P478, DOI 10.1016/j.jinf.2012.01.010; Amer Diabet Assoc, 2021, DIABETES CARE, V44, pS168, DOI 10.2337/dc21-S012; Bidell MR, 2016, ANTIMICROB AGENTS CH, V60, P3170, DOI 10.1128/AAC.02505-15; Bonkat G, 2021, EAU GUIDELINES UROLO; Carey IM, 2018, DIABETES CARE, V41, P513, DOI 10.2337/dc17-2131; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Clinical and Laboratory Standards Institute, 2019, MR02 CLSI; CLSI, 2022, CLIN LAB STAND I PER; CLSI, 2020, PERF STAND ANT SUSC, V40; Critchley IA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220265; Drusano George, 1998, Clin Microbiol Infect, V4 Suppl 2, pS27; Edelsberg J, 2014, DIAGN MICR INFEC DIS, V78, P255, DOI 10.1016/j.diagmicrobio.2013.11.011; Graves N, 2007, INFECT CONT HOSP EP, V28, P280, DOI 10.1086/512642; Gupta K, 2017, ANN INTERN MED, V167, pITC49, DOI 10.7326/AITC201710030; Huang HY, 2021, ANTIMICROB AGENTS CH, V65, DOI 10.1128/AAC.00074-21; Jean SS, 2016, INT J ANTIMICROB AG, V47, P328, DOI 10.1016/j.ijantimicag.2016.01.008; Johnson JR, 2017, CLIN INFECT DIS, V64, P529, DOI 10.1093/cid/ciw751; Kabbara WK, 2015, THER CLIN RISK MANAG, V11, P639, DOI 10.2147/TCRM.S81280; KALMAN D, 1990, TEX HEART I J, V17, P203; Lu PL, 2012, INT J ANTIMICROB AG, V40, pS37, DOI 10.1016/S0924-8579(12)70008-0; Mnif Mouna Feki, 2013, Indian J Endocrinol Metab, V17, P442, DOI 10.4103/2230-8210.111637; Nitzan O, 2015, DIABET METAB SYND OB, V8, P129, DOI 10.2147/DMSO.S51792; Popejoy MW, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2414-9; Schito GC, 2009, INT J ANTIMICROB AG, V34, P407, DOI 10.1016/j.ijantimicag.2009.04.012; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stamm WE, 2001, J INFECT DIS, V183, pS1, DOI 10.1086/318850; Uppala A, 2019, EUR J CLIN MICROBIOL, V38, P1533, DOI 10.1007/s10096-019-03582-3; van der Starre WE, 2013, DIABETES CARE, V36, pE193, DOI 10.2337/dc13-0903; Van TT, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/JCM.02072-18, 10.1128/jcm.02072-18]; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Wang MC, 2013, J MICROBIOL IMMUNOL, V46, P24, DOI 10.1016/j.jmii.2011.12.024	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266416	10.1371/journal.pone.0266416	http://dx.doi.org/10.1371/journal.pone.0266416			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358291	gold, Green Published			2022-12-26	WOS:000799828800101
J	Ahmed, JA; Sadeta, KK; Lenbo, KH				Ahmed, Junayde Abdurahmen; Sadeta, Kebede Kumsa; Lenbo, Kelil Hussein			Magnitude and factors associated with appropriate complementary feeding practice among mothers of children 6-23 months age in Shashemene town, Oromia- Ethiopia: Community based cross sectional study	PLOS ONE			English	Article								BackgroundInadequate complementary feeding is a major cause of childhood malnutrition. Malnutrition caused by insufficient complementary feeding accounts for more than one-third of all under-five mortality whereas appropriate feeding practices are critical for improving nutritional status and ensuring child survival. Thus, the objective of this study was to assess the prevalence of appropriate complementary feeding practices among mothers having 6-23 months children, from Feb.-march 2020 and associated factors in Shashemene Town, Oromia, Ethiopia. MethodsFrom February to March of 2020, a community-based cross-sectional survey was conducted. 536 mothers with children aged 6 to 23 months were chosen for the study using a two-stage sampling procedure. Data was collected by Face-to-face interviews during home-to-home visits with mothers who had children aged 6-23 months, using a structured questionnaire on the main complementary feeding indicators. The Statistical Package for the Social Sciences (SPSS) software was used to analyze the data. Logistic regression was used to identify factors associated with appropriate complementary feeding practice, with statistical significance set at probability value < 0.05. ResultsThe proportion of children aged 6-23 months who met the criteria for complementary food introduction, minimum meal frequency, minimum dietary diversity, minimum acceptable diet, and appropriate complementary feeding practices was 67.9 percent, 61.7 percent, 42.5 percent, 41.7 percent, and 30 percent, respectively. Child age 12-17 and 18-23 months were the independent factors associated with appropriate complementary feed practice [adjusted odd ratio (AOR): 2.32, 95 percent confidence interval (CI): (1.40-3.82)]. ** 1.91 (1.10-3.32) **. Socioeconomic status: mothers in the wealth index of the household, second, third, and fourth, [AOR: 4.27,95 percent, CI (1.8-10.22) ** 4.02(2.23-9.94) ** 7.02(3.27-15.1) **], number of antenatal care visits greater than or equal to four [AOR: 2.57,95 percent, CI: (1.3-5.05)] **, information sources [AOR: 3.5,95 percent, CI: (1.45-8.26) **]. ConclusionThis study found that children aged 6-23 months had a low level of appropriate complementary feeding practice. Mothers with children aged 6-11 months, the number of antenatal care (ANC) visits, socioeconomic status, sources of information, mothers' knowledge, and positive attitude were all associated with appropriate feeding practices. As a result, nutritional education/counseling intervention on child feeding practices was suggested.	[Ahmed, Junayde Abdurahmen; Sadeta, Kebede Kumsa] Madda Walabu Univ, Sch Publ Hlth, Shashamene Campus, Shashemene, Ethiopia; [Lenbo, Kelil Hussein] Madda Walabu Univ, Sch Nursing, Shashamene Campus, Shashemene, Ethiopia		Ahmed, JA (corresponding author), Madda Walabu Univ, Sch Publ Hlth, Shashamene Campus, Shashemene, Ethiopia.	juneabdu@gmail.com			RMWU [14/84/355]	RMWU	Madda walabu university funded budget for data collection and supervision purposes as part of employer routine activities with this reference number RMWU 14/84/355. But the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aemro M, 2013, J NUTR METAB, V2013, DOI 10.1155/2013/782931; [Anonymous], 2003, GUIDING PRINCIPLES C; Areja Abate, 2017, BMC Nutr, V3, P82, DOI 10.1186/s40795-017-0202-y; Berisha Merita., 2017, KNOWLEDGE ATTITUDES; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Dangura D., 2017, BMC PEDIATR, V17, P9, DOI [10.1186/s12887-016-0763-y, DOI 10.1186/S12887-016-0763-Y]; Disha A., 2012, AFR J FOOD AGR NUTR; EDHS, 2016, ADD AB; Gebremedhin S, 2017, NUTRITION, V33, P163, DOI 10.1016/j.nut.2016.06.002; Hawkes Corinna, 2018, GLOB NUTR REP; Issaka AI, 2015, PUBLIC HEALTH NUTR, V18, P669, DOI 10.1017/S1368980014000834; Kassa T, 2016, BMC PEDIATR, V16, DOI 10.1186/s12887-016-0675-x; Khanal V, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-131; Mancharia CW., 2004, E AFR MED J; Mekbib E., 2014, J FOOD NUTR SCI, V2, P36, DOI [DOI 10.11648/J.JFNS.20140202.13, 10.11648/j.jfns.20140202.13]; Okwori E., 2011, NIGERIAN J NUTR SCI, V32; Oromiya Regional State Shashemene City Administration, 2017, PHYS SOC PROF REP 20; Rao S, 2011, AUSTRALAS MED J, V4, P252, DOI 10.4066/AMJ.2011.607; Semahegn A, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.143.3496; Senarath U, 2012, MATERN CHILD NUTR, V8, P89, DOI 10.1111/j.1740-8709.2011.00370.x; Senarath U, 2012, MATERN CHILD NUTR, V8, P5, DOI 10.1111/j.1740-8709.2011.00371.x; Shams N., 2019, INT J HOMEOPATHY NAT, V5, P1; Tegegne M, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0216-6; Tessema M, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.75.1630; UNICEF, 2016, INF YOUNG CHILD FEED; Victor R, 2014, MATERN CHILD NUTR, V10, P545, DOI 10.1111/j.1740-8709.2012.00435.x; Wagris Mohammed., 8 MINIMUM MEAL FREQU; WHO, 2008, IND ASS IYCFP 1; WHO UNICEF USAID FANTA AED UC DAVIS, 2010, IND ASS I YCFP 2; Wondafrash M, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-235; Yalew BM., 2014, J NUTR DISORDERS	31	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265716	10.1371/journal.pone.0265716	http://dx.doi.org/10.1371/journal.pone.0265716			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349586	Green Published, gold			2022-12-26	WOS:000783906500036
J	Jeromel, L; Ogrinc, N; Siketic, Z; Vavpetic, P; Rupnik, Z; Bucar, K; Jencic, B; Kelemen, M; Vencelj, M; Vogel-Mikus, K; Kovac, J; Heeren, RMA; Flinders, B; Cuypers, E; Barba, A; Pelicon, P				Jeromel, Luka; Ogrinc, Nina; Siketic, Zdravko; Vavpetic, Primoz; Rupnik, Zdravko; Bucar, Klemen; Jencic, Bostjan; Kelemen, Mitja; Vencelj, Matjaz; Vogel-Mikus, Katarina; Kovac, Janez; Heeren, Ron M. A.; Flinders, Bryn; Cuypers, Eva; Barba, Ziga; Pelicon, Primoz			Molecular imaging of humain hair with MeV-SIMS: A case study of cocaine detection and distribution in the hair of a cocaine user	PLOS ONE			English	Article							ION MASS-SPECTROMETRY; SUPERCRITICAL-FLUID EXTRACTION; TOF-SIMS; BENZOYLECGONINE; METABOLITES; CODEINE; MORPHINE; MATRIX; YIELDS; DRUGS	Human hair absorbs numerous biomolecules from the body during its growth. This can act as a fingerprint to determine substance intake of an individual, which can be useful in forensic studies. The cocaine concentration profile along the growth axis of hair indicates the time evolution of the metabolic incorporation of cocaine usage. It could be either assessed by chemical extraction and further analysis of hair bundels, or by direct single hair fibre analysis with mass spectroscopy imaging (MSI). Within this work, we analyzed the cocaine distribution in individual hair samples using MeV-SIMS. Unlike conventional surface analysis methods, we demonstrate high yields of nonfragmented molecular ions from the surface of biological materials, resulting in high chemical sensitivity and non-destructive characterisation. Hair samples were prepared by longitudinally cutting along the axis of growth, leaving half-cylindrical shape to access the interior structure of the hair by the probing ion beam, and attached to the silicon wafer. A focused 5.8 MeV Cl-35(6+) beam was scanned across the intact, chemically pristine hair structure. A non-fragmented protonated [M+ H](+) cocaine molecular peak at m/z = 304 was detected and localized along the cross-section of the hair. Its intensity exhibits strong fluctuations along the direction of the hair's growth, with pronounced peaks as narrow as 50 micrometres, corresponding to a metabolic incorporation time of approx. three hours.	[Jeromel, Luka; Vavpetic, Primoz; Rupnik, Zdravko; Bucar, Klemen; Jencic, Bostjan; Kelemen, Mitja; Vencelj, Matjaz; Vogel-Mikus, Katarina; Kovac, Janez; Barba, Ziga; Pelicon, Primoz] Jozef Stefan Inst, Ljubljana, Slovenia; [Ogrinc, Nina; Heeren, Ron M. A.; Flinders, Bryn; Cuypers, Eva] Maastricht Univ, Maastricht MultiModal Mol Imaging Inst, ER Maastricht, Maastricht, Netherlands; [Siketic, Zdravko] Rudjer Boskovic Inst, Zagreb, Croatia; [Vogel-Mikus, Katarina] Univ Ljubljana, Biotech Fac, Dept Biol, Ljubljana, Slovenia; [Cuypers, Eva] Katholieke Univ Leuven, Toxicol & Pharmacol, Leuven, Belgium	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; Maastricht University; Rudjer Boskovic Institute; University of Ljubljana; KU Leuven	Barba, A (corresponding author), Univ Lille, Inserm U1192, CHU Lille, Prote Reponse Inflammatoire Spectrometrie Masse, Lille, France.	ziga.barba@ijs.si		Kelemen, Mitja/0000-0002-9972-7909; Cuypers, Eva/0000-0002-6411-2461; Vencelj, Matjaz/0000-0001-9033-4626	Slovenian research agency [P1-0112, I00005, J7-9398, N1-0090]; EU [824096]; European Union; European Social Fund; FP7 European Union Marie Curie IAPP Program, BRAINPATH; Fonds Wetenschappelijk Onderzoek (FWO); IAEA CRP projects [F11019, F11021]	Slovenian research agency(Slovenian Research Agency - Slovenia); EU(European Commission); European Union(European Commission); European Social Fund(European Social Fund (ESF)); FP7 European Union Marie Curie IAPP Program, BRAINPATH; Fonds Wetenschappelijk Onderzoek (FWO)(FWO); IAEA CRP projects	Work at JSI was supported by the Slovenian research agency grants No. P1-0112, I00005, J7-9398 and N1-0090. Additionally, resources and within the EU H2020 project No. 824096 "RADIATE " and IAEA CRP projects F11019 "Development of Molecular Concentration Mapping Techniques Using MeV Focused Ion Beams" and F11021 "Enhancing Nuclear Analytical Techniques to Meet the Needs of Forensic Science". N.O. acknowledges funding by the European Union, European Social Fund, and the support from FP7 European Union Marie Curie IAPP Program, BRAINPATH. A traveling grant for a long stay abroad of E.C was awarded by Fonds Wetenschappelijk Onderzoek (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brewer WE, 2001, ANAL CHEM, V73, P2371, DOI 10.1021/ac000871r; Claffey DJ, 2001, J ANAL TOXICOL, V25, P607, DOI 10.1093/jat/25.7.607; Cuypers E, 2014, FORENSIC SCI INT, V242, P103, DOI 10.1016/j.forsciint.2014.06.035; Erne R, 2019, ANAL CHEM, V91, P4132, DOI 10.1021/acs.analchem.8b05866; Fedick PW, 2020, J AM SOC MASS SPECTR, V31, P735, DOI 10.1021/jasms.0c00004; Flinders B, 2017, METHODS MOL BIOL, V1618, P137, DOI 10.1007/978-1-4939-7051-3_12; Flinders B, 2015, DRUG TEST ANAL, V7, P859, DOI 10.1002/dta.1812; Francese S, 2019, ADV SCI TECH SEC APP, pIX; Gilliland WM, 2019, ANAL CHEM, V91, P10816, DOI 10.1021/acs.analchem.9b02464; HEDIN A, 1985, PHYS REV B, V31, P1780, DOI 10.1103/PhysRevB.31.1780; HEDIN A, 1987, PHYS REV B, V35, P7377, DOI 10.1103/PhysRevB.35.7377; HENDERSON GL, 1993, FORENSIC SCI INT, V63, P19, DOI 10.1016/0379-0738(93)90256-A; Hernandez F, 2018, MASS SPECTROM REV, V37, P258, DOI 10.1002/mas.21525; Huang DK, 2009, RAPID COMMUN MASS SP, V23, P957, DOI 10.1002/rcm.3955; Jencic B, 2019, J AM SOC MASS SPECTR, V30, P1801, DOI 10.1007/s13361-019-02258-8; Jencic B, 2016, NUCL INSTRUM METH B, V371, P205, DOI 10.1016/j.nimb.2015.10.047; Jeni B., 2019, J AM SOC MASS SPECTR, V31, P117; Jeromel L, 2014, NUCL INSTRUM METH B, V332, P22, DOI 10.1016/j.nimb.2014.02.022; Jones BN, 2011, SURF INTERFACE ANAL, V43, P249, DOI 10.1002/sia.3520; Kempson IM, 2002, J FORENSIC SCI, V47, P889; Kempson IM, 2011, CHEM SOC REV, V40, P3915, DOI 10.1039/c1cs15021a; Kintz P, 1998, J ANAL TOXICOL, V22, P231, DOI 10.1093/jat/22.3.231; KINTZ P, 1995, J ANAL TOXICOL, V19, P479, DOI 10.1093/jat/19.6.479; Lamont L, 2021, ANAL BIOANAL CHEM, V413, P2779, DOI 10.1007/s00216-021-03210-0; Lopez-Guarnido O, 2013, J APPL TOXICOL, V33, P838, DOI 10.1002/jat.2741; Mahoney CM, 2010, MASS SPECTROM REV, V29, P247, DOI 10.1002/mas.20233; Miki A, 2011, J MASS SPECTROM, V46, P411, DOI 10.1002/jms.1908; Miyaguchi H, 2011, ANALYST, V136, P3503, DOI 10.1039/c0an00850h; Moosmann B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14906; Morrison JF, 1998, ANAL CHEM, V70, P163, DOI 10.1021/ac970465g; Nakata Y, 2008, APPL SURF SCI, V255, P1591, DOI 10.1016/j.apsusc.2008.05.108; Nakata Y, 2009, J MASS SPECTROM, V44, P128, DOI 10.1002/jms.1482; Nielen MWF, 2011, ANAL CHIM ACTA, V700, P63, DOI 10.1016/j.aca.2010.08.009; Pelicon P, 2014, NUCL INSTRUM METH B, V332, P229, DOI 10.1016/j.nimb.2014.02.067; Porta T., 2011, SPECTROSCOPY EUROPE, V23, P6; Porta T, 2011, ANAL CHEM, V83, P4266, DOI 10.1021/ac200610c; Rabbani S, 2011, ANAL CHEM, V83, P3793, DOI 10.1021/ac200288v; Rabbani SSN, 2015, ANAL CHEM, V87, P2367, DOI 10.1021/ac504191m; Rysin L. P., 2007, P SCI C FOREST BIOLO, P83; Scheidweiler KB, 2005, J PHARMACOL EXP THER, V313, P909, DOI 10.1124/jpet.104.082388; Seyyal E, 2019, J AM SOC MASS SPECTR, V30, P595, DOI 10.1007/s13361-018-02127-w; Sheraz S, 2014, SURF INTERFACE ANAL, V46, P51, DOI 10.1002/sia.5606; Siketic Z, 2015, APPL PHYS LETT, V107, DOI 10.1063/1.4930062; Smith JP, 2015, ANALYST, V140, P4932, DOI 10.1039/c5an00797f; Terlier T, 2018, J VAC SCI TECHNOL B, V36, DOI 10.1116/1.5015928; Vickerman JC, 2011, ANALYST, V136, P2199, DOI 10.1039/c1an00008j; Vincenti M, 2013, MASS SPECTROM REV, V32, P312, DOI 10.1002/mas.21364	47	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263338	10.1371/journal.pone.0263338	http://dx.doi.org/10.1371/journal.pone.0263338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333862	Green Submitted, Green Published, gold			2022-12-26	WOS:000784335700013
J	Klomp, A; Omichi, R; Iwasa, Y; Smith, RJ; Usachev, YM; Russo, AF; Narayanan, NS; Lee, A				Klomp, Annette; Omichi, Ryotaro; Iwasa, Yoichiro; Smith, Richard J.; Usachev, Yuriy M.; Russo, Andrew F.; Narayanan, Nandakumar S.; Lee, Amy			The voltage-gated Ca2+ channel subunit alpha(2)delta-4 regulates locomotor behavior and sensorimotor gating in mice	PLOS ONE			English	Article							PSYCHIATRIC-DISORDERS; PREPULSE INHIBITION; CALCIUM-CHANNELS; CHILDREN; COMORBIDITY; CACNA1C; CELLS	Voltage-gated Ca2+ channels are critical for the development and mature function of the nervous system. Variants in the CACNA2D4 gene encoding the alpha(2)delta-4 auxiliary subunit of these channels are associated with neuropsychiatric and neurodevelopmental disorders. alpha(2)delta-4 is prominently expressed in the retina and is crucial for vision, but extra-retinal functions of alpha(2)delta-4 have not been investigated. Here, we sought to fill this gap by analyzing the behavioral phenotypes of alpha(2)delta-4 knockout (KO) mice. alpha(2)delta-4 KO mice (both males and females) exhibited significant impairments in prepulse inhibition that were unlikely to result from the modestly elevated auditory brainstem response thresholds. Whereas alpha(2)delta-4 KO mice of both sexes were hyperactive in various assays, only females showed impaired motor coordination in the rotarod assay. alpha(2)delta-4 KO mice exhibited anxiolytic and anti-depressive behaviors in the elevated plus maze and tail suspension tests, respectively. Our results reveal an unexpected role for alpha(2)delta-4 in sensorimotor gating and motor function and identify alpha(2)delta-4 KO mice as a novel model for studying the pathophysiology associated with CACNA2D4 variants.	[Klomp, Annette] Univ Iowa, Interdisciplinary Grad Program Neurosci, Iowa City, IA USA; [Klomp, Annette; Smith, Richard J.; Usachev, Yuriy M.; Russo, Andrew F.; Narayanan, Nandakumar S.; Lee, Amy] Univ Iowa, Iowa Neurosci Inst, Iowa City, IA 52242 USA; [Klomp, Annette; Smith, Richard J.; Russo, Andrew F.; Lee, Amy] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Omichi, Ryotaro; Iwasa, Yoichiro; Smith, Richard J.; Lee, Amy] Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA; [Omichi, Ryotaro; Iwasa, Yoichiro; Smith, Richard J.] Univ Iowa, Iowa Inst Human Genet, Iowa City, IA USA; [Usachev, Yuriy M.] Univ Iowa, Dept Neurosci & Pharmacol, Iowa City, IA USA; [Russo, Andrew F.; Narayanan, Nandakumar S.; Lee, Amy] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Omichi, Ryotaro] Okayama Univ, Dept Otolaryngol Head & Neck Surg, Grad Sch Med Dent & Pharmaceut Sci, Okayama, Japan; [Iwasa, Yoichiro] Shinshu Univ, Dept Otorhinolaryngol, Sch Med, Matsumoto, Nagano, Japan; [Lee, Amy] Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA	University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; Okayama University; Shinshu University; University of Texas System; University of Texas Austin	Lee, A (corresponding author), Univ Iowa, Iowa Neurosci Inst, Iowa City, IA 52242 USA.; Lee, A (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.; Lee, A (corresponding author), Univ Iowa, Dept Otolaryngol Head & Neck Surg, Iowa City, IA 52242 USA.; Lee, A (corresponding author), Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA.; Lee, A (corresponding author), Univ Texas Austin, Dept Neurosci, Austin, TX 78712 USA.	amy.lee1@austin.utexas.edu		Omichi, Ryotaro/0000-0001-5441-9796; Russo, Andrew/0000-0002-8156-5649	National Institutes of Health [R03NS115653, R01EY026817, NS075599, MH116043, NS113189, DC002842, DC012049, DC017955]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Jussara Hagen for expert technical assistance, Anjali Rajadhyaksha and Charlotte Bavley for helpful input on analysis of behavioral studies.	Ablinger C, 2020, PFLUG ARCH EUR J PHY, V472, P845, DOI 10.1007/s00424-020-02420-2; BRAFF D, 1978, PSYCHOPHYSIOLOGY, V15, P339, DOI 10.1111/j.1469-8986.1978.tb01390.x; Braga RJ, 2013, PSYCHIAT RES, V210, P1, DOI 10.1016/j.psychres.2013.07.030; Can A, 2012, JOVE-J VIS EXP, DOI 10.3791/3769; Carlisle HJ, 2011, J NEUROSCI, V31, P16194, DOI 10.1523/JNEUROSCI.5877-10.2011; Dolphin AC, 2020, NAT REV NEUROSCI, V21, P213, DOI 10.1038/s41583-020-0278-2; Dolphin AC, 2016, J PHYSIOL-LONDON, V594, P5369, DOI 10.1113/JP272262; Dolphin AC, 2013, BBA-BIOMEMBRANES, V1828, P1541, DOI 10.1016/j.bbamem.2012.11.019; Ellenbroek BA, 1996, NEUROSCIENCE, V75, P535, DOI 10.1016/0306-4522(96)00307-7; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Ertel EA, 2000, NEURON, V25, P533, DOI 10.1016/S0896-6273(00)81057-0; Fell B, 2016, J NEUROSCI, V36, P11024, DOI 10.1523/JNEUROSCI.3468-14.2016; Geisler S, 2019, J NEUROSCI, V39, P2581, DOI 10.1523/JNEUROSCI.2234-18.2019; Goghari VM, 2019, PSYCHIAT RES, V275, P310, DOI 10.1016/j.psychres.2019.03.050; Green D, 2009, DEV MED CHILD NEUROL, V51, P311, DOI 10.1111/j.1469-8749.2008.03242.x; Hammer TB, 2011, INT J NEUROPSYCHOPH, V14, P913, DOI 10.1017/S1461145711000034; Jensen RN., 2021, UGESKR LAEGER, V183; Kabir ZD, 2016, J PHYSIOL-LONDON, V594, P5823, DOI 10.1113/JP270673; Kabir ZD, 2017, NEUROPSYCHOPHARMACOL, V42, P2032, DOI 10.1038/npp.2016.271; Kerov V, 2018, J NEUROSCI, V38, P6145, DOI 10.1523/JNEUROSCI.3818-16.2018; Kurshan PT, 2009, NAT NEUROSCI, V12, P1415, DOI 10.1038/nn.2417; Lee AS, 2012, MOL PSYCHIATR, V17, P1054, DOI [10.1038/mp.2012.149, 10.1038/mp.2012.71]; Lee A, 2015, J BIOL CHEM, V290, P1505, DOI 10.1074/jbc.M114.607465; Lense MD, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0327; Lipscombe D, 2013, TRENDS NEUROSCI, V36, P598, DOI 10.1016/j.tins.2013.06.008; MANJIVIONA J, 1995, J AUTISM DEV DISORD, V25, P23, DOI 10.1007/BF02178165; Rees E, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00734-5; Reimherr FW, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0859-6; Schlick B, 2010, NEUROSCIENCE, V167, P786, DOI 10.1016/j.neuroscience.2010.02.037; Schopf CL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.1920827118; Shiotsuki H, 2010, J NEUROSCI METH, V189, P180, DOI 10.1016/j.jneumeth.2010.03.026; Shoji H, 2018, MOL BRAIN, V11, DOI 10.1186/s13041-018-0382-7; Simms BA, 2014, NEURON, V82, P24, DOI 10.1016/j.neuron.2014.03.016; Simonoff E, 2008, J AM ACAD CHILD PSY, V47, P921, DOI 10.1097/CHI.0b013e318179964f; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Striessnig J, 2021, FRONT SYNAPTIC NEURO, V13, DOI 10.3389/fnsyn.2021.634760; Swerdlow NR, 2008, PSYCHOPHARMACOLOGY, V199, P331, DOI 10.1007/s00213-008-1072-4; Tiller JWG, 2013, MED J AUSTRALIA, V199, P28, DOI 10.5694/mjao12.10628; van Loo KMJ, 2019, J NEUROSCI, V39, P3175, DOI 10.1523/JNEUROSCI.1731-18.2019; Wang SY, 2017, J NEUROSCI, V37, P4679, DOI 10.1523/JNEUROSCI.2583-16.2017; Wang YC, 2017, NEURON, V93, P1359, DOI 10.1016/j.neuron.2017.02.021; Yoshimura H, 2019, MOL THER, V27, P681, DOI 10.1016/j.ymthe.2018.12.014	42	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263197	10.1371/journal.pone.0263197	http://dx.doi.org/10.1371/journal.pone.0263197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353835	gold, Green Published			2022-12-26	WOS:000786647900004
J	Lampraki, C; Hoffman, A; Roquet, A; Jopp, DS				Lampraki, Charikleia; Hoffman, Adar; Roquet, Angelique; Jopp, Daniela S.			Loneliness during COVID-19: Development and influencing factors	PLOS ONE			English	Article							EMOTIONAL LONELINESS; OLDER-PEOPLE; ADULTS; PREDICTORS; LOCKDOWN; IMPACT; YOUNG; RISK	In early pandemic waves, when vaccination against COVID-19 was not yet an option, distancing and reduced social contact were the most effective measures to slow down the pandemic. Changes in frequency and forms of social contact have reduced the spread of the COVID-19 virus and thus saved lives, yet there is increasing evidence for negative side effects such as mental health issues. In the present study, we investigate the development of loneliness and its predictors to examine the role of changes in social networks due to social distancing and other COVID-19-related life changes. A total of 737 participants (age range = 18-81 years) completed an online survey in three waves during the last quarter of 2020 at one-month intervals. Latent growth and multilevel modeling revealed that emotional loneliness increased over time, while social loneliness remained stable. Moreover, socially lonely individuals were likely to also develop emotional loneliness over time. Increased social distancing and sanitary measures were accompanied by decreased social interactions and loss of individuals considered SOS contacts and confidants. Changes in specific social network indicators were differentially associated with changes in emotional vs social loneliness: Loss of friends considered confidants was associated with increasing emotional loneliness, whereas loss of friends considered SOS contacts and reduced overall social interactions were related to increasing social loneliness. Lastly, individuals with more family-and-friend SOS contacts, more friends as confidants and an overall higher number of social interactions were more protected from feeling socially or emotionally lonely. Study findings enhance the understanding of underlying mechanisms differentially contributing to social and emotional loneliness and offer practical suggestions to reduce mental-health side effects of social distancing.	[Lampraki, Charikleia; Hoffman, Adar; Roquet, Angelique; Jopp, Daniela S.] Univ Lausanne, Inst Psychol, Lausanne, Vaud, Switzerland; [Lampraki, Charikleia; Hoffman, Adar; Jopp, Daniela S.] Swiss Ctr Expertise Life Course Res, LIVES Ctr, Lausanne, Switzerland	University of Lausanne	Lampraki, C (corresponding author), Univ Lausanne, Inst Psychol, Lausanne, Vaud, Switzerland.; Lampraki, C (corresponding author), Swiss Ctr Expertise Life Course Res, LIVES Ctr, Lausanne, Switzerland.	charikleia.lampraki@unil.ch		Lampraki, Charikleia/0000-0003-4565-7498	NCCR LIVES, a National Centre of Competence in Research - Swiss National Science Foundation [51NF40-160590]	NCCR LIVES, a National Centre of Competence in Research - Swiss National Science Foundation(Swiss National Science Foundation (SNSF))	This work was supported as a part of NCCR LIVES, a National Centre of Competence in Research, funded by the Swiss National Science Foundation (grant number 51NF40-160590).	Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; Banerjee D, 2020, INT J SOC PSYCHIATR, V66, P525, DOI 10.1177/0020764020922269; Boursier V, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.586222; Brooke J, 2020, J CLIN NURS, V29, P2044, DOI 10.1111/jocn.15274; Bu F, 2020, PUBLIC HEALTH, V186, P31, DOI 10.1016/j.puhe.2020.06.036; Cacioppo S, 2015, PERSPECT PSYCHOL SCI, V10, P238, DOI 10.1177/1745691615570616; Carmichael CL, 2015, PSYCHOL AGING, V30, P95, DOI 10.1037/pag0000014; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Cohen-Mansfield J, 2016, INT PSYCHOGERIATR, V28, P557, DOI 10.1017/S1041610215001532; Dahlberg L, 2014, AGING MENT HEALTH, V18, P504, DOI 10.1080/13607863.2013.856863; De Quervain D., 2020, SWISS CORONA STRESS, V24; DEJONGGIERVELD J, 1985, APPL PSYCH MEAS, V9, P289, DOI 10.1177/014662168500900307; DEJONGGIERVELD J, 1987, J PERS SOC PSYCHOL, V53, P119, DOI 10.1037/0022-3514.53.1.119; Diehl K, 2018, INT J ENV RES PUB HE, V15, DOI 10.3390/ijerph15091865; DiTommaso E, 1997, PERS INDIV DIFFER, V22, P417, DOI 10.1016/S0191-8869(96)00204-8; Ellis WE, 2020, CAN J BEHAV SCI, V52, P177, DOI 10.1037/cbs0000215; Elmer T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236337; Fernandes B, 2020, REV PSICOL CLIN NINO, V7, P59, DOI 10.21134/rpcna.2020.mon.2056; Geirdal AO, 2021, J MENT HEALTH, V30, P148, DOI 10.1080/09638237.2021.1875413; Ghisletta P, 2012, STRUCT EQU MODELING, V19, P651, DOI 10.1080/10705511.2012.713275; Green LR, 2001, PERS SOC PSYCHOL B, V27, P281, DOI 10.1177/0146167201273002; Hajek Andre, 2020, Arch Gerontol Geriatr, V89, P104080, DOI 10.1016/j.archger.2020.104080; Haslam SA, 2018, SOC SCI MED, V198, P14, DOI 10.1016/j.socscimed.2017.12.020; Hoffman L, 2009, RES HUM DEV, V6, P97, DOI 10.1080/15427600902911189; Jopp D, 2008, GERONTOLOGIST, V48, P646, DOI 10.1093/geront/48.5.646; Killgore WDS, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113390; Lee CM, 2020, J ADOLESCENT HEALTH, V67, P714, DOI 10.1016/j.jadohealth.2020.08.009; Lewis K, 2020, J PSYCHIATR PRACT, V26, P400, DOI 10.1097/PRA.0000000000000488; Loades ME, 2020, J AM ACAD CHILD PSY, V59, P1218, DOI 10.1016/j.jaac.2020.05.009; Losada-Baltar A, 2021, J GERONTOL B-PSYCHOL, V76, pE10, DOI 10.1093/geronb/gbaa048; Lubben J, 2004, SOCIAL NETWORKS SOCI; Luchetti M, 2020, AM PSYCHOL, V75, P897, DOI 10.1037/amp0000690; Macdonald B, 2021, GERONTOLOGIST, V61, P240, DOI 10.1093/geront/gnaa194; Monin JK, 2020, AM J GERIAT PSYCHIAT, V28, P1299, DOI 10.1016/j.jagp.2020.09.008; Perlman D., 1981, PERSONAL RELATIONSHI, P31, DOI DOI 10.1037/0003-066X.41.2.229; Pinquart M, 2001, BASIC APPL SOC PSYCH, V23, P245, DOI 10.1207/S15324834BASP2304_2; Power JEM, 2018, J THEOR PHILOS PSYCH, V38, P219, DOI 10.1037/teo0000099; Qualter P, 2002, J CHILD PSYCHOL PSYC, V43, P233, DOI 10.1111/1469-7610.00016; R Core Team, 2021, R LANGUAGE ENV STAT; Reger MA, 2020, JAMA PSYCHIAT, V77, P1093, DOI 10.1001/jamapsychiatry.2020.1060; Rogers AH, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113407; Rosseel Y, 2012, J STAT SOFTW, V48, P1, DOI 10.18637/jss.v048.i02; Salo AE, 2020, FAM RELAT, V69, P151, DOI 10.1111/fare.12398; Shanahan L, 2022, PSYCHOL MED, V52, P824, DOI 10.1017/S003329172000241X; Shevlin M, 2020, BRIT J HEALTH PSYCH, V25, P875, DOI 10.1111/bjhp.12430; Shiovitz-Ezra S, 2010, INT PSYCHOGERIATR, V22, P455, DOI 10.1017/S1041610209991426; Smith B, 2020, PUBLIC HEALTH RES PR, V30, DOI 10.17061/phrp3022008; Stevens N, 2001, AGEING SOC, V21, P183, DOI 10.1017/S0144686X01008108; Sun Y, 2020, AM J ADDICTION, V29, P268, DOI 10.1111/ajad.13066; van der Velden PG., 2021, PREVALENCE INCIDENCE; van Tilburg TG, 2021, J GERONTOL B-PSYCHOL, V76, pE249, DOI 10.1093/geronb/gbaa111; Vinceti M, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100457; von Soest T, 2020, DEV PSYCHOL, V56, P1919, DOI 10.1037/dev0001102; Wang CY, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17051729; Weiss R. S, 1973, LONELINESS EXPERIENC; WEISS RS, 1987, J SOC BEHAV PERS, V2, P1; Zhao SZ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17186692	57	4	4	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265900	10.1371/journal.pone.0265900	http://dx.doi.org/10.1371/journal.pone.0265900			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353850	gold, Green Published			2022-12-26	WOS:000786647900049
J	Mehta, RS; Lochhead, P; Wang, YQ; Ma, WJ; Nguyen, LH; Kochar, B; Huttenhower, C; Grodstein, F; Chan, AT				Mehta, Raaj S.; Lochhead, Paul; Wang, Yiqing; Ma, Wenjie; Nguyen, Long H.; Kochar, Bharati; Huttenhower, Curtis; Grodstein, Francine; Chan, Andrew T.			Association of midlife antibiotic use with subsequent cognitive function in women	PLOS ONE			English	Article							GUT MICROBIOTA; DISEASE; RISK	The gut microbiome is increasingly recognized to play a role in cognition and dementia. Antibiotic use impacts the gut microbiome and has been linked with chronic disease. Despite these data, there is no evidence supporting an association between long-term antibiotic use in adults and cognitive function. We conducted a prospective population-based cohort study among 14,542 participants in the Nurses' Health Study II who completed a self-administered computerized neuropsychological test battery between 2014-2018. Multivariate linear regression models were used to assess if chronic antibiotic use in midlife was associated with cognitive impairment assessed later in life. Women who reported at least 2 months of antibiotic exposure in midlife (mean age 54.7, SD 4.6) had lower mean cognitive scores seven years later, after adjustment for age and educational attainment of the spouse and parent, with a mean difference of -0.11 standard units for the global composite score (P-trend <0.0001), -0.13 for a composite score of psychomotor speed and attention (P-trend <0.0001), and -0.10 for a composite score of learning and working memory (P-trend <0.0001) compared with non-antibiotic users. These differences were not materially changed after multivariate adjustment for additional risk factors, including comorbid conditions. As a benchmark, the mean difference in score associated with each additional year of age was (-0.03) for global cognition, (-0.04) for psychomotor speed and attention, and (-0.03) for learning and working memory; thus the relation of antibiotic use to cognition was roughly equivalent to that found for three to four years of aging. Long-term antibiotic use in midlife is associated with small decreases in cognition assessed seven years later. These data underscore the importance of antibiotic stewardship, especially among aging populations.	[Mehta, Raaj S.; Lochhead, Paul; Wang, Yiqing; Ma, Wenjie; Nguyen, Long H.; Kochar, Bharati; Chan, Andrew T.] Harvard Med Sch, Boston, MA USA; [Mehta, Raaj S.; Lochhead, Paul; Wang, Yiqing; Ma, Wenjie; Nguyen, Long H.; Kochar, Bharati; Chan, Andrew T.] Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA; [Huttenhower, Curtis] Harvard TH Chan Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Grodstein, Francine] Rush Med Coll, Dept Internal Med, Chicago, IL USA; [Grodstein, Francine] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL USA; [Chan, Andrew T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Rush University; Rush University; Harvard University; Brigham & Women's Hospital	Chan, AT (corresponding author), Harvard Med Sch, Boston, MA USA.; Chan, AT (corresponding author), Massachusetts Gen Hosp, Clin & Translat Epidemiol Unit, Boston, MA USA.; Chan, AT (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, Boston, MA USA.	achan@mgh.harvard.edu	Chan, Andrew/P-8293-2014	Chan, Andrew/0000-0001-7284-6767	U.S. National Institutes of Health (NIH) [U01 CA176726, K23 DK125838, U01 AG062682, RF1 AG067744]	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This workwas supportedby U.S.NationalInstitutesof Health(NIH)grants[U01CA176726;K23 DK125838; U01 AG062682;RF1AG067744], Stuartand SuzanneSteeleMGHResearchScholar Awardto Dr Chan.The contentissolelythe responsibility of the authors.The fundershad no role in studydesign,data collection,analysis,decisionto publish,or manuscriptpreparation.	Bailey LC, 2014, JAMA PEDIATR, V168, P1063, DOI 10.1001/jamapediatrics.2014.1539; Bhattacharyya S, 2016, NEUROLOGY, V86, P963, DOI 10.1212/WNL.0000000000002455; Cao Y, 2018, GUT, V67, P672, DOI 10.1136/gutjnl-2016-313413; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Chiuve SE, 2012, J NUTR, V142, P1009, DOI 10.3945/jn.111.157222; De Palma G, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6397; Dethlefsen L, 2011, P NATL ACAD SCI USA, V108, P4554, DOI 10.1073/pnas.1000087107; Dodiya HB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64797-5; Dominy SS, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau3333; Fredrickson J, 2010, NEUROEPIDEMIOLOGY, V34, P65, DOI 10.1159/000264823; Frohlich EE, 2016, BRAIN BEHAV IMMUN, V56, P140, DOI 10.1016/j.bbi.2016.02.020; Fugate JE, 2013, CRIT CARE, V17, DOI 10.1186/cc13094; Galvin JE, 2005, ARCH NEUROL-CHICAGO, V62, P758, DOI 10.1001/archneur.62.5.758; Heianza Y, 2019, EUR HEART J, V40, P3838, DOI 10.1093/eurheartj/ehz231; Hsiao EY, 2013, CELL, V155, P1451, DOI 10.1016/j.cell.2013.11.024; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Korpela K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10410; Lochhead P, 2017, GASTROENTEROLOGY, V153, P971, DOI 10.1053/j.gastro.2017.06.061; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mao JH, 2020, MICROBIOME, V8, DOI 10.1186/s40168-020-00817-w; Minter MR, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11047-w; Molloy DW, 2013, INT J GERIATR PSYCH, V28, P463, DOI 10.1002/gps.3846; Palleja A, 2018, NAT MICROBIOL, V3, P1255, DOI 10.1038/s41564-018-0257-9; Petrelli F., 2019, CANCERS, V11, DOI [10.3390/cancers11122031, DOI 10.3390/CANCERS11122031]; Saji N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38218-7; Schulze MB, 2004, JAMA-J AM MED ASSOC, V292, P927, DOI 10.1001/jama.292.8.927; Slykerman RF, 2019, PSYCHOPHARMACOLOGY, V236, P1573, DOI 10.1007/s00213-019-05216-0; Slykerman RF, 2017, ACTA PAEDIATR, V106, P87, DOI 10.1111/apa.13613; Sumner JA, 2017, DEPRESS ANXIETY, V34, P356, DOI 10.1002/da.22600; Doan T, 2020, NEW ENGL J MED, V383, P1941, DOI 10.1056/NEJMoa2002606; Valles-Colomer M, 2019, NAT MICROBIOL, V4, P623, DOI 10.1038/s41564-018-0337-x; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wang RPH, 2019, BRAIN BEHAV IMMUN, V81, P63, DOI 10.1016/j.bbi.2019.07.002; Zhu F, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15457-9	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264649	10.1371/journal.pone.0264649	http://dx.doi.org/10.1371/journal.pone.0264649			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320274	gold, Green Published			2022-12-26	WOS:000784240600057
J	Moaddel, R; Rossi, M; Rodriguez, S; Munk, R; Khadeer, M; Abdelmohsen, K; Gorospe, M; Ferrucci, L				Moaddel, Ruin; Rossi, Martina; Rodriguez, Stephanie; Munk, Rachel; Khadeer, Mohammed; Abdelmohsen, Kotb; Gorospe, Myriam; Ferrucci, Luigi			Identification of gingerenone A as a novel senolytic compound	PLOS ONE			English	Article							SENESCENT CELLS; INFLAMMATORY RESPONSES; CELLULAR SENESCENCE; AGENTS; TARGET	Senescent cells accumulate with aging and have been shown to contribute to age-associated diseases and organ dysfunction. Eliminating senescent cells with senolytic drugs has been shown to improve age phenotypes in mouse models and there is some initial evidence that it may improve the health of persons with chronic diseases. In this study, we employed WI-38 human fibroblasts rendered senescent by exposure to ionizing radiation (IR) to screen several plant extracts for their potential senolytic and/or senomorphic activity. Of these, ginger extract (Zingiber officinale Rosc.) selectively caused the death of senescent cells without affecting proliferating cells. Among the major individual components of ginger extract, gingerenone A and 6-shogaol showed promising senolytic properties, with gingerenone A selectively eliminating senescent cells. Similar to the senolytic cocktail dasatinib and quercetin (D+Q), gingerenone A and 6-shogaol elicited an apoptotic program. Additionally, both D+Q and gingerenone A had a pronounced effect on suppressing the senescence-associated secretory phenotype (SASP). Gingerenone A selectively promotes the death of senescent cells with no effect on non-senescent cells and these characteristics strongly support the idea that this natural compound may have therapeutic benefit in diseases characterized by senescent cell accumulation.	[Moaddel, Ruin; Rodriguez, Stephanie; Khadeer, Mohammed] NIA, Lab Clin Invest, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Rossi, Martina; Munk, Rachel; Abdelmohsen, Kotb; Gorospe, Myriam] NIA, Lab Genet & Genom, Intramural Res Program, NIH, Baltimore, MD USA; [Ferrucci, Luigi] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD USA	National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Moaddel, R (corresponding author), NIA, Lab Clin Invest, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	moaddelru@mail.nih.gov		Rossi, Martina/0000-0001-7738-9841	Intramural Research Program of the National Institute on Aging, National Institutes of Health;  [Z01-AG000297]	Intramural Research Program of the National Institute on Aging, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); 	All this work was supported by the Intramural Research Program of the National Institute on Aging, National Institutes of Health. The annual report number is Z01-AG000297.	Baker DJ, 2011, NATURE, V479, P232, DOI 10.1038/nature10600; Beg Sarwar, 2011, Pharmacogn Rev, V5, P120, DOI 10.4103/0973-7847.91102; Bhaumik D, 2009, AGING-US, V1, P402, DOI 10.18632/aging.100042; Cheng XY, 2017, ONCOTARGET, V8, P22513, DOI 10.18632/oncotarget.15116; Childs BG, 2017, NAT REV DRUG DISCOV, V16, P718, DOI 10.1038/nrd.2017.116; Conrozier T, 2014, ALTERN THER HEALTH M, V20, P32; Dossou KSS, 2013, J NAT PROD, V76, P2060, DOI 10.1021/np400478c; Dugasani S, 2010, J ETHNOPHARMACOL, V127, P515, DOI 10.1016/j.jep.2009.10.004; Han XJ, 2016, AGING CELL, V15, P416, DOI 10.1111/acel.12446; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Kirkland JL, 2020, J INTERN MED, V288, P518, DOI 10.1111/joim.13141; Kuilman T, 2010, GENE DEV, V24, P2463, DOI 10.1101/gad.1971610; Lammermann I, 2018, NPJ AGING MECH DIS, V4, DOI 10.1038/s41514-018-0023-5; Lasry A, 2015, TRENDS IMMUNOL, V36, P217, DOI 10.1016/j.it.2015.02.009; Maciel-Baron LA, 2016, AGE, V38, DOI 10.1007/s11357-016-9886-1; Mashhadi Nafiseh Shokri, 2013, Int J Prev Med, V4, pS36; McHugh D, 2018, J CELL BIOL, V217, P65, DOI 10.1083/jcb.201708092; Ortiz-Espin A, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/2694945; Sandoval M, 2002, PHYTOMEDICINE, V9, P325, DOI 10.1078/0944-7113-00117; Suk S, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201700139; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Tominaga K, 2015, PATHOBIOL AGING AGE, V5, DOI 10.3402/pba.v5.27743; Xu M, 2018, NAT MED, V24, P1246, DOI 10.1038/s41591-018-0092-9; Yasuda M, 2011, ANAL CHEM, V83, P7400, DOI 10.1021/ac201403y; Zhu Y, 2017, AGING-US, V9, P955, DOI 10.18632/aging.101202; Zhu Y, 2016, AGING CELL, V15, P428, DOI 10.1111/acel.12445	26	3	3	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266135	10.1371/journal.pone.0266135	http://dx.doi.org/10.1371/journal.pone.0266135			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349590	gold, Green Published			2022-12-26	WOS:000783906500020
J	Seo, MH; Kim, DW; Kim, YS; Lee, SK				Seo, Mi Hyun; Kim, Dae Won; Kim, Yeon Sook; Lee, Suk Keun			Pentoxifylline-induced protein expression change in RAW 264.7 cells as determined by immunoprecipitation-based high performance liquid chromatography	PLOS ONE			English	Article							PHOSPHODIESTERASE INHIBITOR; CYTOKINE PRODUCTION; EFFICACY; TRANSGLUTAMINASE; DIFFERENTIATION; PROLIFERATION; OSTEONECROSIS; INVOLVEMENT; RELEASE; INJURY	Although pentoxifylline (PTX) was identified as a competitive non-selective phosphodiesterase inhibitor, its pharmacological effect has not been clearly elucidated. The present study explored the effect of low dose 10 mu g/mL PTX (therapeutic dose) compared to high dose 300 mu g/mL PTX (experimental dose) in RAW 264.7 cells through immunoprecipitation-based high performance liquid chromatography (IP-HPLC), immunohistochemistry, and western blot. 10 mu g/mL PTX increased the expression of proliferation (Ki-67, PCNA, cyclin D2, cdc25A), epigenetic modification (KDM4D, PCAF, HMGB1), protein translation (DOHH, DHPS, eIF5A1), RAS signaling (KRAS, pAKT1/2/3, PI3K), NFkB signaling (NFkB, GADD45, p38), protection (HSP70, SOD1, GSTO1/2), survival (pAKT1/2/3, SP1, sirtuin 6), neuromuscular differentiation (NSE gamma, myosin-1a, desmin), osteoblastic differentiation (BMP2, RUNX2, osterix), acute inflammation (TNF alpha, IL-1, CXCR4), innate immunity (beta-defensin 1, lactoferrin, TLR-3, -4), cell-mediated immunity (CD4, CD8, CD80), while decreased the expression of ER stress (eIF2 alpha, eIF2AK3, ATF6 alpha), fibrosis (FGF2, CTGF, collagen 3A1), and chronic inflammation (CD68, MMP-2, -3, COX2) versus the untreated controls. The activation of proliferation by 10 mu g/mL PTX was also supported by the increase of cMyc-MAX heterodimer and beta-catenin-TCF1 complex in double IP-HPLC. 10 mu g/mL PTX enhanced FAS-mediated apoptosis but diminished p53-mediated apoptosis, and downregulated many angiogenesis proteins (angiogenin, VEGF-A, and FLT4), but upregulated HIF1 alpha, VEGFR2, and CMG2 reactively. Whereas, 300 mu g/mL PTX consistently decreased proliferation, epigenetic modification, RAS and NFkB signaling, neuromuscular and osteoblastic differentiation, but increased apoptosis, ER stress, and fibrosis compared to 10 mu g/mL PTX. These data suggest PTX has different biological effect on RWA 264.7 cells depending on the concentration of 10 mu g/mL and 300 mu g/mL PTX. The low dose 10 mu g/mL PTX enhanced RAS/NFkB signaling, proliferation, differentiation, and inflammation, particularly, it stimulated neuromuscular and osteoblastic differentiation, innate immunity, and cell-mediated immunity, but attenuated ER stress, fibrosis, angiogenesis, and chronic inflammation, while the high dose 300 mu g/mL PTX was found to alleviate the 10 mu g/mL PTX-induced biological effects, resulted in the suppression of RAS/NFkB signaling, proliferation, neuromuscular and osteoblastic differentiation, and inflammation.	[Seo, Mi Hyun] Seoul Natl Univ, Coll Dent, Dept Oral & Maxillofacial Surg, Seoul, South Korea; [Kim, Dae Won] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Biochem, Kangnung, South Korea; [Kim, Yeon Sook] Cheongju Univ, Coll Hlth & Med Sci, Dept Dent Hyg, Cheongju, South Korea; [Lee, Suk Keun] Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea; [Lee, Suk Keun] Inst Hydrogen Magnet React Gene Regulat, Dae Jeon, South Korea	Seoul National University (SNU); Kangnung Wonju National University; Cheongju University; Kangnung Wonju National University	Lee, SK (corresponding author), Gangneung Wonju Natl Univ, Coll Dent, Dept Oral Pathol, Kangnung, South Korea.; Lee, SK (corresponding author), Inst Hydrogen Magnet React Gene Regulat, Dae Jeon, South Korea.	sukkeunlee2@naver.com						Akbari Z, 2019, ADV BIOMED RES-INDIA, V8, DOI 10.4103/abr.abr_33_19; ANGELIDES NS, 1986, ANGIOLOGY, V37, P555, DOI 10.1177/000331978603700801; Annamaraju P., 2021, PENTOXIFYLLINE; Arcaro CA, 2018, J APPL PHYSIOL, V124, P704, DOI 10.1152/japplphysiol.00499.2017; Assimakopoulos SF, 2020, MED HYPOTHESES, V143, DOI 10.1016/j.mehy.2020.109926; Bouchard C, 1999, EMBO J, V18, P5321, DOI 10.1093/emboj/18.19.5321; Brugarolas J, 1998, J CELL BIOL, V141, P503, DOI 10.1083/jcb.141.2.503; Chang MY, 2017, AM J PHYSIOL-LUNG C, V313, pL1069, DOI 10.1152/ajplung.00353.2017; CHAO CC, 1992, J INFECT DIS, V166, P847, DOI 10.1093/infdis/166.4.847; Chiao TB, 2005, ANN PHARMACOTHER, V39, P516, DOI 10.1345/aph.1E186; CHUNG SI, 1972, ANN NY ACAD SCI, V202, P240, DOI 10.1111/j.1749-6632.1972.tb16338.x; CHUNG SI, 1970, J BIOL CHEM, V245, P6424; Dhulqarnain AO, 2021, HELIYON, V7, DOI 10.1016/j.heliyon.2021.e06868; Dong JQ, 2018, MOL MED REP, V17, P1141, DOI 10.3892/mmr.2017.7953; ENDRES S, 1991, IMMUNOLOGY, V72, P56; Frueh FS, 2018, EUR SURG RES, V59, P242, DOI 10.1159/000492413; Ghasemnejad-Berenji M, 2021, MED PRIN PRACT, V30, P98, DOI 10.1159/000512234; Golunski G, 2018, CURR PHARM BIOTECHNO, V19, P206, DOI 10.2174/1389201019666180528084641; Heifetz-Li JJ, 2019, OR SURG OR MED OR PA, V128, P491, DOI 10.1016/j.oooo.2019.08.004; Kaidar-Person O, 2018, BREAST J, V24, P816, DOI 10.1111/tbj.13044; Kim HK, 2016, PAIN PHYSICIAN, V19, pE589; Kim JH, 2017, CANCER SCI, V108, P2470, DOI 10.1111/cas.13405; Kim MK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38946-4; Kim MK, 2020, MAX PLAST RECONSTR S, V42, DOI 10.1186/s40902-020-00267-2; Kim SM, 2018, J CRANIO MAXILL SURG, V46, P119, DOI 10.1016/j.jcms.2017.10.017; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P3485, DOI 10.1007/s00405-017-4657-x; Kim SM, 2017, WORLD J SURG ONCOL, V15, DOI 10.1186/s12957-017-1213-5; Kim SM, 2017, EUR ARCH OTO-RHINO-L, V274, P215, DOI 10.1007/s00405-016-4167-2; Kim YS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243975; Kim Yeon Sook, 2019, [The Korean Journal of Oral and Maxillofacial Pathology, 대한구강악안면병리학회지], V43, P255; Kim Yeon Sook, 2015, [The Korean Journal of Oral and Maxillofacial Pathology, 대한구강악안면병리학회지], V39, P615; Kim Yeon Sook, 2014, [The Korean Journal of Oral and Maxillofacial Pathology, 대한구강악안면병리학회지], V38, P381; Lee IS, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22168935; Lee JG, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/1279280; Lee SS, 2020, PEERJ, V8, DOI 10.7717/peerj.9202; Lin SL, 2003, MOL PHARMACOL, V64, P811, DOI 10.1124/mol.64.4.811; Lopez-Iranzo FJ, 2020, CURR PHARM DESIGN, V26, P4515, DOI 10.2174/1381612826666200811180232; Luo MS, 2015, INT J CLIN EXP PATHO, V8, P8990; Napolitano R, 2018, MINI-REV MED CHEM, V18, P287, DOI 10.2174/1389557517666171002162258; Nidhyanandan S, 2017, ANTI-CANCER DRUG, V28, P1002, DOI 10.1097/CAD.0000000000000544; Okunieff P, 2004, J CLIN ONCOL, V22, P2207, DOI 10.1200/JCO.2004.09.101; Pal S, 2019, CALCIFIED TISSUE INT, V105, P294, DOI 10.1007/s00223-019-00567-4; Park MH, 2018, J BIOL CHEM, V293, P18710, DOI 10.1074/jbc.TM118.003341; Poulakis N, 1999, RESP MED, V93, P52, DOI 10.1016/S0954-6111(99)90077-X; Price JT, 2005, CANCER RES, V65, P4929, DOI 10.1158/0008-5472.CAN-04-4458; ROEKAERTS F, 1984, ANGIOLOGY, V35, P396, DOI 10.1177/000331978403500702; Ruan DP, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/6698366; Saaristo A, 2006, AM J PATHOL, V169, P1080, DOI 10.2353/ajpath.2006.051251; Seo MH, 2019, MAX PLAST RECONSTR S, V41, DOI 10.1186/s40902-019-0235-z; Sergeeva Oksana A, 2019, F1000Res, V8, DOI 10.12688/f1000research.19423.1; Shao R, 1999, J BIOL CHEM, V274, P3228, DOI 10.1074/jbc.274.5.3228; SMITH RV, 1986, J PHARM SCI, V75, P47, DOI 10.1002/jps.2600750111; Speer EM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0196352; Speer EM, 2017, PEDIATR RES, V81, P806, DOI 10.1038/pr.2017.6; Strutz F, 2000, NEPHROL DIAL TRANSPL, V15, P1535, DOI 10.1093/ndt/15.10.1535; Taciak B, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0198943; Toriu N, 2019, BONE REP, V10, DOI 10.1016/j.bonr.2018.100187; Tsutsumimoto T, 2002, BONE, V31, P396, DOI 10.1016/S8756-3282(02)00839-6; Windischhofer W, 2002, J BONE MINER RES, V17, P1774, DOI 10.1359/jbmr.2002.17.10.1774; Yalcin-Ulker GM, 2017, J ORAL MAXIL SURG, V75, P2354, DOI 10.1016/j.joms.2017.04.017; Yang YL, 2018, PEERJ, V6, DOI 10.7717/peerj.5434; Yoon CS, 2018, MAX PLAST RECONSTR S, V40, DOI 10.1186/s40902-018-0183-z; Yoon CS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32014-z; Zhang Jinnong, 2003, J Huazhong Univ Sci Technolog Med Sci, V23, P365; Zhang N, 2004, BLOOD, V103, P617, DOI 10.1182/blood-2003-06-1820; Zhu LQ, 2017, CELL DEATH DISCOV, V3, DOI 10.1038/cddiscovery.2017.11	66	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0261797	10.1371/journal.pone.0261797	http://dx.doi.org/10.1371/journal.pone.0261797			44	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333871	gold, Green Published, Green Submitted			2022-12-26	WOS:000784335700018
J	Silva, IN; Duarte, JA; Perret, A; Dousse, N; Wozniak, H; Pinto, BB; Giraud, R; Bendjelid, K				Silva, Ivo Neto; Duarte, Jose Alberto; Perret, Aurelie; Dousse, Nicolas; Wozniak, Hannah; Pinto, Bernardo Bollen; Giraud, Raphael; Bendjelid, Karim			Diaphragm dysfunction and peripheral muscle wasting in septic shock patients: Exploring their relationship over time using ultrasound technology (the MUSiShock protocol)	PLOS ONE			English	Article							ICU-ACQUIRED WEAKNESS; INTENSIVE-CARE-UNIT; MECHANICAL VENTILATION; RELIABLE MEASUREMENT; BEDSIDE ULTRASOUND; CRITICAL ILLNESS; IMPACT; ATROPHY; TOOL	Background Intensive Care Unit (ICU) patients are known to lose muscle mass and function during ICU stay. Ultrasonography (US) application for the assessment of the skeletal muscle is a promising tool and might help detecting muscle changes and thus several dysfunctions during early stages of ICU stay. MUSiShock is a research project aiming to investigate structure and function of diaphragm and peripheral muscles using ultrasound techniques in septic shock patients, and to assess their relevance in several clinical outcomes such as the weaning process. Methods and design This is a research protocol from an observational prospective cohort study. We plan to assess eighty-four septic shock patients during their ICU stay at the following time-points: at 24 hours of ICU admission, then daily until day 5, then weekly, at extubation time and at ICU discharge. At each time-point, we will measure the quadriceps rectus femoris and diaphragm muscles, using innovative US muscle markers such as Shear-Wave Elastography (SWE). In parallel, the Medical Research Council (MRC) sum score for muscle testing and the Airway occlusion pressure (P-0.1) will also be collected. We will describe the association between SWE assessment and other US markers for each muscle. The association between the changes in both diaphragm and rectus femoris US markers over time will be explored as well; finally, the analysis of a combined model of one diaphragm US marker and one limb muscle US marker to predict weaning success/failure will be tested. Discussion By using muscle ultrasound at both diaphragm and limb levels, MUSiShock aims to improve knowledge in the early detection of muscle dysfunction and weakness, and their relationship with muscle strength and MV weaning, in critically ill patients. A better anticipation of these short-term muscle structure and function outcomes may allow clinicians to rapidly implement measures to counteract it.	[Silva, Ivo Neto; Perret, Aurelie; Dousse, Nicolas; Wozniak, Hannah; Giraud, Raphael; Bendjelid, Karim] Geneva Univ Hosp, Dept Acute Med, Intens Care Div, Geneva, Switzerland; [Silva, Ivo Neto; Pinto, Bernardo Bollen; Giraud, Raphael; Bendjelid, Karim] Univ Geneva, Fac Med, Geneva, Switzerland; [Silva, Ivo Neto; Pinto, Bernardo Bollen; Giraud, Raphael; Bendjelid, Karim] Geneva Hemodynam Res Grp, Geneva, Switzerland; [Silva, Ivo Neto; Duarte, Jose Alberto] Univ Porto, Fac Sports, Res Ctr Phys Act CIAFEL, Porto, Portugal; [Pinto, Bernardo Bollen] Geneva Univ Hosp, Dept Acute Med, Anaesthesiol Div, Geneva, Switzerland	University of Geneva; University of Geneva; Universidade do Porto; University of Geneva	Silva, IN (corresponding author), Geneva Univ Hosp, Dept Acute Med, Intens Care Div, Geneva, Switzerland.; Silva, IN (corresponding author), Univ Geneva, Fac Med, Geneva, Switzerland.; Silva, IN (corresponding author), Geneva Hemodynam Res Grp, Geneva, Switzerland.; Silva, IN (corresponding author), Univ Porto, Fac Sports, Res Ctr Phys Act CIAFEL, Porto, Portugal.	ivo.neto@hcuge.ch	Duarte, Jose Alberto/F-1443-2013; Neto Silva, Ivo/AAY-9706-2021; Wozniak, Hannah/GOE-4541-2022	Duarte, Jose Alberto/0000-0003-4756-5917; Neto Silva, Ivo/0000-0002-7391-786X; Wozniak, Hannah/0000-0001-5404-4621	Hppitaux Universitaires de Geneve (HUG), Switzerland	Hppitaux Universitaires de Geneve (HUG), Switzerland	The participation of INS (first author) is supported by a departmental grant from the Hppitaux Universitaires de Geneve (HUG), Switzerland. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachasson D, 2019, J APPL PHYSIOL, V126, P699, DOI 10.1152/japplphysiol.01060.2018; Batt J, 2017, INTENS CARE MED, V43, P1844, DOI 10.1007/s00134-017-4758-4; Boles JM, 2007, EUR RESPIR J, V29, P1033, DOI 10.1183/09031936.00010206; Callahan Leigh Ann, 2009, Crit Care Med, V37, pS354, DOI 10.1097/CCM.0b013e3181b6e439; Cederholm T, 2017, CLIN NUTR, V36, P49, DOI 10.1016/j.clnu.2016.09.004; Chino K, 2018, RESP PHYSIOL NEUROBI, V252, P52, DOI 10.1016/j.resp.2018.03.009; Ciesla N, 2011, JOVE-J VIS EXP, DOI 10.3791/2632; Cohen J.E., 1988, STAT POWER ANAL BEHA; Connolly B, 2015, CRIT CARE MED, V43, P897, DOI 10.1097/CCM.0000000000000821; Connolly BA, 2013, CRIT CARE, V17, DOI 10.1186/cc13052; Creze M, 2018, SKELETAL RADIOL, V47, P457, DOI 10.1007/s00256-017-2843-y; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; De Jonghe B, 2007, CRIT CARE MED, V35, P2007, DOI 10.1097/01.ccm.0000281450.01881.d8; Demoule A, 2013, AM J RESP CRIT CARE, V188, P213, DOI 10.1164/rccm.201209-1668OC; Dube BP, 2017, THORAX, V72, P811, DOI 10.1136/thoraxjnl-2016-209459; Evans L, 2021, INTENS CARE MED, V47, P1181, DOI 10.1007/s00134-021-06506-y; Fan E, 2014, AM J RESP CRIT CARE, V190, P1437, DOI 10.1164/rccm.201411-2011ST; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Flattres A, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-2745-6; Fosse Q, 2020, CRIT CARE, V24, DOI 10.1186/s13054-020-03338-y; Goligher EC, 2018, AM J RESP CRIT CARE, V197, P204, DOI 10.1164/rccm.201703-0536OC; Goligher EC, 2015, AM J RESP CRIT CARE, V192, P1080, DOI 10.1164/rccm.201503-0620OC; Gosselink R, 2011, NETH J CRIT CARE, V15, P66; Grimm A, 2013, CRIT CARE, V17, DOI 10.1186/cc13050; Gruther W, 2008, J REHABIL MED, V40, P185, DOI 10.2340/16501977-0139; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Hermans G, 2012, MUSCLE NERVE, V45, P18, DOI 10.1002/mus.22219; Jaber S, 2011, AM J RESP CRIT CARE, V183, P364, DOI 10.1164/rccm.201004-0670OC; Jung B, 2016, INTENS CARE MED, V42, P853, DOI 10.1007/s00134-015-4125-2; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Lacourpaille L, 2015, MUSCLE NERVE, V51, P284, DOI 10.1002/mus.24445; Lacourpaille L, 2014, J APPL PHYSIOL, V117, P658, DOI 10.1152/japplphysiol.00544.2014; Lacourpaille L, 2012, PHYSIOL MEAS, V33, pN19, DOI 10.1088/0967-3334/33/3/N19; Lee SSM, 2016, CLIN BIOMECH, V31, P20, DOI 10.1016/j.clinbiomech.2015.10.006; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; Llamas-Alvarez AM, 2017, CHEST, V152, P1140, DOI 10.1016/j.chest.2017.08.028; Matamis D, 2013, INTENS CARE MED, V39, P801, DOI 10.1007/s00134-013-2823-1; Mourtzakis M, 2017, ANN AM THORAC SOC, V14, P1495, DOI 10.1513/AnnalsATS.201612-967PS; Mourtzakis M, 2014, CURR OPIN CLIN NUTR, V17, P389, DOI 10.1097/MCO.0000000000000088; Pillen S, 2011, NEUROL RES, V33, P1016, DOI 10.1179/1743132811Y.0000000010; Puthucheary ZA, 2015, CRIT CARE MED, V43, P1603, DOI 10.1097/CCM.0000000000001016; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Reid CL, 2004, CLIN NUTR, V23, P273, DOI 10.1016/S0261-5614(03)00129-8; Seymour CW, 2016, JAMA-J AM MED ASSOC, V315, P762, DOI 10.1001/jama.2016.0288; Supinski GS, 2013, CRIT CARE, V17, DOI 10.1186/cc12792; Telias I, 2018, INTENS CARE MED, V44, P1532, DOI 10.1007/s00134-018-5045-8; Tillquist M, 2014, JPEN-PARENTER ENTER, V38, P886, DOI 10.1177/0148607113501327; Turton P, 2016, BMC ANESTHESIOL, V16, DOI 10.1186/s12871-016-0269-z; Umbrello M, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0894-9; Vandenbroucke JP, 2007, ANN INTERN MED, V147, pW163, DOI 10.7326/0003-4819-147-8-200710160-00010-w1; Vassilakopoulos T, 2004, AM J RESP CRIT CARE, V169, P336, DOI 10.1164/rccm.200304-489CP; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Weijs PJM, 2014, CRIT CARE, V18, DOI 10.1186/cc13189; Zambon M, 2017, INTENS CARE MED, V43, P29, DOI 10.1007/s00134-016-4524-z; Zambon M, 2013, INTENS CARE MED, V39, P986, DOI 10.1007/s00134-013-2882-3	55	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266174	10.1371/journal.pone.0266174	http://dx.doi.org/10.1371/journal.pone.0266174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344570	gold, Green Published			2022-12-26	WOS:000788055200008
J	Nag, I				Nag, Ishika			Development of a combinatory filtration system for pollution and virus abatement by optimized nanoparticle deposition	PLOS ONE			English	Article							FINE PARTICULATE MATTER; PM2.5; ANTIBACTERIAL; EFFICIENCY; IMPACT	PM2.5, particulate matter less than 2.5 microns, is the leading contributor to air pollution which results in cardio-vascular and respiratory diseases. Recent studies also indicate a strong correlation between ambient air pollution and COVID-19 cases, which have affected the lives of billions of people globally. Abatement technologies such as ionic and other high efficiency filtration systems are expensive and unaffordable in communities with limited resources. The goal of this study was to develop a mask with an optimized nanoparticle coating which has a dual capability of particulate matter and virus filtration, while being affordable and safe for human use. The nanoparticles were selected for their filtration and virucidal capabilities. Particle filtration efficiency, tested with a wind tunnel and PM2.5 from incense sticks measured by laser particle detectors, improved by similar to 60% with nanoparticle coatings on KN95 and surgical masks. Virus filtration efficiency, tested using nebulized NaCl particles as a virus surrogate, improved by 95% with coated masks. The nanoparticle retention efficacy, tested by simulating a normal 8-hour workday, was well within the permissible exposure limits. This technology has several applications such as in personal protective equipment for virus protection, and in air-conditioning and car cabin filters for pollution abatement. In conclusion, the chosen combination of nanoparticles provides an effective and safe solution for both particulate matter and viral particle filtration.	[Nag, Ishika] Seminole State Coll, Sanford, FL 32773 USA		Nag, I (corresponding author), Seminole State Coll, Sanford, FL 32773 USA.	ishikanag@yahoo.com		Nag, Ishika/0000-0002-3806-2536	Nanotechnology Center at the University of Central Florida	Nanotechnology Center at the University of Central Florida	The author thanks the Nanotechnology Center at the University of Central Florida for the support and the facilities provided, Dr. Yang Yang (University of Central Florida) for his mentorship and his research assistant Guanzhi Wang (University of Central Florida) for her support with coating masks in the laboratory, and Mr. William Furiosi (Oviedo High School) for his guidance and coaching.	Abatement Technologies, FACTS TRUE HEPA FILT; [Anonymous], 1995, CFR 84; [Anonymous], 2019, DET PART FILT EFF LE; [Anonymous], 2009, N95 RESP SURG MASKS; [Anonymous], 1993, PERMISSIBLE EXPOSURE; Astuti I, 2020, DIABETES METAB SYND, V14, P407, DOI 10.1016/j.dsx.2020.04.020; Automotive Industry Action Group (AIAG), 2010, MEASUREMENT SYSTEMS, V4th; Brook D, WHAT IS AIR IONIZER; Coker ES, 2020, ENVIRON RESOUR ECON, V76, P611, DOI 10.1007/s10640-020-00486-1; Comunian S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17124487; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Du WJ, 2021, COMMUN MATER, V2, DOI 10.1038/s43246-021-00160-z; Fennelly KP, 2020, LANCET RESP MED, V8, P914, DOI 10.1016/S2213-2600(20)30323-4; Giovannetti R, 2017, CATALYSTS, V7, DOI 10.3390/catal7100305; Janczarek M, 2017, CATALYSTS, V7, DOI 10.3390/catal7110317; Kundu S, 2014, ENVIRON SCI-PROC IMP, V16, P1360, DOI 10.1039/c3em00719g; Lui KH, 2016, ENVIRON POLLUT, V213, P524, DOI 10.1016/j.envpol.2016.02.053; Matawle JL, 2017, ENVIRON GEOCHEM HLTH, V39, P1045, DOI 10.1007/s10653-016-9871-8; Mitra P, 2018, ACS OMEGA, V3, P7962, DOI 10.1021/acsomega.8b00568; Morawska L, 2009, J AEROSOL SCI, V40, P256, DOI 10.1016/j.jaerosci.2008.11.002; Nag I, 2021, COLUMBIA JUNIOR SCI; Nolt-Helms C., 2018, EPA600X18163; Ruan DL, 2020, NANOSCALE RES LETT, V15, DOI 10.1186/s11671-019-3225-2; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Szczesniak B, 2017, ADV COLLOID INTERFAC, V243, P46, DOI 10.1016/j.cis.2017.03.007; Le TS, 2015, ADV NAT SCI-NANOSCI, V6, DOI 10.1088/2043-6262/6/1/015016; Turgeon N, 2014, APPL ENVIRON MICROB, V80, P4242, DOI 10.1128/AEM.00767-14; Vijayan VK, 2015, LUNG INDIA, V32, P473, DOI 10.4103/0970-2113.164174; Weiss C, 2020, ACS NANO, V14, P6383, DOI 10.1021/acsnano.0c03697; Wongwatcharapaiboon J, 2019, INT J LOW-CARBON TEC, V14, P394, DOI 10.1093/ijlct/ctz027; World Health Organization (WHO), AIR POLLUTION; Wu X, 2020, MANAGEMENT TRANSFORMATION OF HUAWEI, P1, DOI 10.1017/9781108550987; Xing YF, 2016, J THORAC DIS, V8, pE69, DOI 10.3978/j.issn.2072-1439.2016.01.19; Xiong HM, 2013, ADV MATER, V25, P5329, DOI 10.1002/adma.201301732; Zhang SY, 2018, J MATER CHEM A, V6, P16139, DOI 10.1039/c8ta05506h; Zhong ZX, 2015, ACS APPL MATER INTER, V7, P21538, DOI 10.1021/acsami.5b06810; Zhou JL, 2020, ADV FIBER MATER, V2, P123, DOI 10.1007/s42765-020-00047-7; Zoran MA, 2020, SCI TOTAL ENVIRON, V738, DOI 10.1016/j.scitotenv.2020.139825	38	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264991	10.1371/journal.pone.0264991	http://dx.doi.org/10.1371/journal.pone.0264991			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358232	gold, Green Published			2022-12-26	WOS:000799828800022
J	Pearson, S; Whetton, AD; Pierce, A				Pearson, Stella; Whetton, Anthony D.; Pierce, Andrew			Combination of curaxin and tyrosine kinase inhibitors display enhanced killing of primitive Chronic Myeloid Leukaemia cells	PLOS ONE			English	Article							BETA-CATENIN; STEM-CELLS; IMATINIB; QUIESCENT; EFFICACY; P53	Despite the big increase in precision medicine targeted therapies developing curative treatments for many cancers is still a major challenge due mainly to the development of drug resistance in cancer stem cells. The cancer stem cells are constantly evolving to survive and targeted drug treatment often increases the selective pressure on these cells from which the disease develops. Chronic myeloid leukaemia is a paradigm of cancer stem cell research. Targeted therapies to the causative oncogene, BCR/ABL, have been developed but drug resistance remains a problem. The introduction of tyrosine kinase inhibitors targeting BCR/ABL were transformative in the management of CML. However, patients are rarely cured as the tyrosine kinase inhibitors fail to eradicate the leukaemic stem cell which often leads to loss of response to therapy as drug resistance develops and progression to more fatal forms of acute leukaemia occurs. New treatment strategies targeting other entities within the leukemic stem cell either alone or in combination with tyrosine kinase are therefore required. Drawing on our previous published work on the development of potential novel targets in CML and other myeloproliferative diseases along with analysis of the facilitates chromatin transcription (FACT) complex in CML we hypothesised that curaxin, a drug that targets the FACT complex and is in clinical trial for the treatment of other cancers, could be of use in the treatment of CML. We therefore assessed the curaxin CBL0137 as a new agent to extinguish CML primitive cells and show its ability to preferentially target CML cells compared to healthy control cells, especially in combination with clinically relevant tyrosine kinase inhibitors.	[Pearson, Stella; Whetton, Anthony D.; Pierce, Andrew] Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England; [Whetton, Anthony D.] Univ Surrey, Sch Vet Med, Guildford, Surrey, England; [Pierce, Andrew] Bangor Univ, Coll Human Sci, Sch Med & Hlth Sci, Bangor, Gwynedd, Wales	University of Manchester; University of Surrey; Bangor University	Pierce, A (corresponding author), Univ Manchester, Stem Cell & Leukaemia Prote Lab, Manchester, Lancs, England.; Pierce, A (corresponding author), Bangor Univ, Coll Human Sci, Sch Med & Hlth Sci, Bangor, Gwynedd, Wales.	Andrew.Pierce@manchester.ac.uk		Pierce, Andrew/0000-0001-5995-2469	Blood Cancer UK [19007]	Blood Cancer UK	This work was supported by a Blood Cancer UK (https://bloodcancer.org.uk/) grant awarded to AP and ADW (ref 19007). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SA, 2016, NATURE, V534, P341, DOI 10.1038/nature18288; Affer M, 2011, J ONCOL, V2011, DOI 10.1155/2011/798592; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; Baccarani M, 2021, LEUKEMIA, V35, P2199, DOI 10.1038/s41375-021-01272-8; Baquero P, 2019, LEUKEMIA, V33, P981, DOI 10.1038/s41375-018-0252-4; Bellodi C, 2009, J CLIN INVEST, V119, P1109, DOI 10.1172/JCI35660; Carter DR, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aab1803; Clark RE, 2017, LANCET HAEMATOL, V4, pE310, DOI 10.1016/S2352-3026(17)30066-2; Corbin AS, 2011, J CLIN INVEST, V121, P396, DOI 10.1172/JCI35721; Etienne G, 2017, J CLIN ONCOL, V35, P298, DOI 10.1200/JCO.2016.68.2914; Gao Y, 2017, CANCER RES, V77, P2674, DOI 10.1158/0008-5472.CAN-16-3128; Gasparian AV, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002530; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Griaud F, 2013, LEUKEMIA, V27, P932, DOI 10.1038/leu.2012.283; Gurova KV, 2005, P NATL ACAD SCI USA, V102, P17448, DOI 10.1073/pnas.0508888102; Hamilton A, 2012, BLOOD, V119, P1501, DOI 10.1182/blood-2010-12-326843; Heidel FH, 2012, CELL STEM CELL, V10, P412, DOI 10.1016/j.stem.2012.02.017; Holtz M, 2007, CANCER RES, V67, P1113, DOI 10.1158/0008-5472.CAN-06-2014; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; Jung D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20531-w; Kinstrie R, 2020, LEUKEMIA, V34, P1613, DOI 10.1038/s41375-019-0684-5; Kosti I, 2016, SCI REP-UK, V6, DOI 10.1038/srep24799; Liu CM, 2002, CELL, V108, P837, DOI 10.1016/S0092-8674(02)00685-2; Massimino M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0805-1; Pearson S, 2017, LEUKEMIA, V31, P2717, DOI 10.1038/leu.2017.143; Pearson S, 2020, J PROTEOME RES, V19, P194, DOI 10.1021/acs.jproteome.9b00495; Pierce A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038928; Piquet S, 2018, MOL CELL, V72, P888, DOI 10.1016/j.molcel.2018.09.010; Preet R, 2013, CARCINOGENESIS, V34, P277, DOI 10.1093/carcin/bgs351; Ross DM, 2013, BLOOD, V122, P515, DOI 10.1182/blood-2013-02-483750; Soverini S, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0780-6; Tallman MM, 2021, CANCER LETT, V499, P232, DOI 10.1016/j.canlet.2020.11.027; Unwin RD, 2006, BLOOD, V107, P4687, DOI 10.1182/blood-2005-12-4995; Warfvinge R, 2017, BLOOD, V129, P2384, DOI 10.1182/blood-2016-07-728873; Westerweel PE, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00665; Yost C, 1996, GENE DEV, V10, P1443, DOI 10.1101/gad.10.12.1443	37	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266298	10.1371/journal.pone.0266298	http://dx.doi.org/10.1371/journal.pone.0266298			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358275	Green Published, gold			2022-12-26	WOS:000799828800091
J	Xie, FX; Huo, HP; Hou, XX; Fu, YS; Song, J				Xie, Fuxiang; Huo, Hongpeng; Hou, Xinxin; Fu, Yuesheng; Song, Jian			Experiment on the bract stripping and crushing device of a corn harvester	PLOS ONE			English	Article							SINGLE-PASS; GRAIN	In order to study the mechanism of bract peeling and crushing of a corn harvester, a bract stripping and crushing device was designed that mainly consists of a stripping device, a crushing device, and a frame. The kinematics and dynamics of the roller of bract stripping device were analyzed, and the conditions of bract stripping were obtained. Single factor tests of stripping roller speed and crushing roller speed were carried out. On the basis of single factor tests, orthogonal experiments were carried out to determine crushing roller speed, distance between crushing device axis and stripping device axis, stripping roller speed, and offset angle of stripping roller. The orthogonal experiments showed that the optimum parameters of the device were obtained: the speed of the crushing drum was 1,100 r/min, the axis distance between the stripping and crushing devices was 180 mm, the speed of the stripping roller was 400 r/min, and the offset angle of the stripping roller was 5 degrees. On the basis of orthogonal experiment, three, five, seven, nine and eleven corn feeding and high-speed photography experiments were carried out respectively. The results showed that when three ears of corn were fed at the same time, the effect of corn bract stripping and crushing was the best with the increase of corn number. The stripping roller only grasps most of the bracts of corn at 0.019 s, after stripping the bracts into the crushing device, the bracts were crushed after 0.077 s. The crushing time of bracts was approximately four times as long as that of the bracts.	[Xie, Fuxiang; Song, Jian] Weifang Univ, Sch Mech Elect & Vehicle Engn, Weifang, Peoples R China; [Huo, Hongpeng; Hou, Xinxin; Fu, Yuesheng] Shandong Univ Sci & Technol, Coll Mech & Elect Engn, Qingdao, Peoples R China	Weifang University; Shandong University of Science & Technology	Xie, FX (corresponding author), Weifang Univ, Sch Mech Elect & Vehicle Engn, Weifang, Peoples R China.	xfx608@126.com		Xie, Fuxiang/0000-0002-5441-7771	National Natural Science Foundation of China [51505337]; Natural Science Foundation of Shandong Province [ZR2020ME136]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Shandong Province(Natural Science Foundation of Shandong Province)	YES,Fuxiang Xie,51505337, the National Natural Science Foundation of China, and Fuxiang Xie,ZR2020ME136, Natural Science Foundation of Shandong Province.	[Anonymous], 2019, CORN HARVESTER; [Anonymous], 2008, Corn harvesting machinery Technical conditions, Patent No. [GB/T219622008, 219622008]; Chai Y.S., 2016, J AGR MECH RES, V38, P185; Chen Q.W., 2014, J AGR MECH RES, V36, P257; [陈志 Chen Zhi], 2012, [农业机械学报, Transactions of the Chinese Society of Agricultural Machinery], V43, P44; Cong HongBin, 2010, Transactions of the Chinese Society of Agricultural Engineering, V26, P107; Geng A., 2016, J AGR MECH RES, V38, P251, DOI DOI 10.13427/J.CNKI.NJYI.2016.04.052; [耿端阳 Geng Duanyang], 2019, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V50, P124; Hoseinzadeh B., 2012, American-Eurasian Journal of Agricultural & Environmental Sciences, V12, P275; Igathinathane C, 2010, BIOSYST ENG, V107, P97, DOI 10.1016/j.biosystemseng.2010.07.005; John B., 1990, ENGINES DRIVES, V56, P34; Lin J.S., 2018, J AGR MECH RES, V40, P70; Petkevichius S, 2008, BIOSYST ENG, V99, P532, DOI 10.1016/j.biosystemseng.2008.01.002; Shinners KJ, 2007, T ASABE, V50, P355, DOI 10.13031/2013.22626; Shinners KJ, 2009, T ASABE, V52, P51, DOI 10.13031/2013.25940; [王德福 Wang Defu], 2017, [农业机械学报, Transactions of the Chinese Society for Agricultural Machinery], V48, P165; Wang G.B., 2013, J AGR MECH RES, V35, P221; Xie F X, 2018, J AGR MECH RES, V40, P129; Xie F.X., 2016, RES EXPLORATION LAB, V35, P101; Xie F.X., 2016, TECHNICAL J FACULTY, V39, P95; Xu L.M., 2011, T CHINESE SOC AGR MA, V42, P14; Yang H.G., 2017, J AGR MECH RES, V39, P170; Yang L, 2016, INT J AGR BIOL ENG, V9, P15, DOI 10.3965/j.ijabe.20160903.2380; Zhou J.L., 2016, J AGR MECH RES, V38, P167; Zhu ZhongXiang, 2015, Transactions of the Chinese Society of Agricultural Engineering, V31, P42	25	0	0	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265814	10.1371/journal.pone.0265814	http://dx.doi.org/10.1371/journal.pone.0265814			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358233	Green Published, gold			2022-12-26	WOS:000799828800048
J	Lu, CW; Yang, DF; Klement, JD; Colson, YL; Oberlies, NH; Pearce, CJ; Colby, AH; Grinstaff, MW; Liu, ZQ; Shi, HD; Ding, HF; Liu, KB				Lu, Chunwan; Yang, Dafeng; Klement, John D.; Colson, Yolonda L.; Oberlies, Nicholas H.; Pearce, Cedric J.; Colby, Aaron H.; Grinstaff, Mark W.; Liu, Zhuoqi; Shi, Huidong; Ding, Han-Fei; Liu, Kebin			H3K9me3 represses G6PD expression to suppress the pentose phosphate pathway and ROS production to promote human mesothelioma growth	ONCOGENE			English	Article							OXIDATIVE STRESS; LACTATE-DEHYDROGENASE; CELL-CYCLE; CANCER; METABOLISM; APOPTOSIS; INHIBITION; ACTIVATION; G9A; METHYLATION	The role of glucose-6-phosphate dehydrogenase (G6PD) in human cancer is incompletely understood. In a metabolite screening, we observed that inhibition of H3K9 methylation suppressed aerobic glycolysis and enhances the PPP in human mesothelioma cells. Genome-wide screening identified G6PD as an H3K9me3 target gene whose expression is correlated with increased tumor cell apoptosis. Inhibition of aerobic glycolysis enzyme LDHA and G6PD had no significant effects on tumor cell survival. Ablation of G6PD had no significant effect on human mesothelioma and colon carcinoma xenograft growth in athymic mice. However, activation of G6PD with the G6PD-selective activator AG1 induced tumor cell death. AG1 increased tumor cell ROS production and the resultant extrinsic and intrinsic death pathways, mitochondrial processes, and unfolded protein response in tumor cells. Consistent with increased tumor cell death in vitro, AG1 suppressed human mesothelioma xenograft growth in a dose-dependent manner in vivo. Furthermore, AG1 treatment significantly increased tumor-bearing mouse survival in an intra-peritoneum xenograft athymic mouse model. Therefore, in human mesothelioma and colon carcinoma, G6PD is not essential for tumor growth. G6PD acts as a metabolic checkpoint to control metabolic flux towards the PPP to promote tumor cell apoptosis, and its expression is repressed by its promotor H3K9me3 deposition.	[Lu, Chunwan] Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China; [Lu, Chunwan; Yang, Dafeng; Klement, John D.; Liu, Kebin] Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA; [Yang, Dafeng; Klement, John D.; Liu, Zhuoqi; Shi, Huidong; Ding, Han-Fei; Liu, Kebin] Med Coll Georgia, Georgia Canc Ctr, Augusta, GA 30912 USA; [Yang, Dafeng; Klement, John D.; Liu, Kebin] Charlie Norwood VA Med Ctr, Augusta, GA 30904 USA; [Colson, Yolonda L.] Harvard Med Sch, Massachusetts Gen Hosp, Dept Surg, Div Thorac Surg, Boston, MA 02114 USA; [Oberlies, Nicholas H.] Univ North Carolina Greensboro, Dept Chem & Biochem, Greensboro, NC 27402 USA; [Pearce, Cedric J.] Mycosynthetix Inc, Hillsborough, NC 27278 USA; [Colby, Aaron H.; Grinstaff, Mark W.] Ion Pharmaceut, Brookline, MA 02445 USA; [Colby, Aaron H.; Grinstaff, Mark W.] Boston Univ, Dept Biomed Engn, Boston, MA 02215 USA	Tianjin University; University System of Georgia; Augusta University; University System of Georgia; Augusta University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of North Carolina; University of North Carolina Greensboro; Boston University	Lu, CW (corresponding author), Tianjin Univ, Sch Life Sci, Tianjin 300072, Peoples R China.; Lu, CW (corresponding author), Med Coll Georgia, Dept Biochem & Mol Biol, Augusta, GA 30912 USA.	Chunwanlu@tju.edu.cn	Oberlies, Nicholas/D-8162-2011; Grinstaff, Mark/U-2829-2017	Oberlies, Nicholas/0000-0002-0354-8464; Grinstaff, Mark/0000-0002-5453-3668; Ding, Han-Fei/0000-0001-5702-3439; Shi, Huidong/0000-0003-1137-3390	National Cancer Institute [R01 CA227433, R01CA133085, P01 CA125066, R01CA190429, R01CA236890, F30CA236436]; US Department of Veterans Affairs Award [CX001364]	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); US Department of Veterans Affairs Award(US Department of Veterans Affairs)	We thank Dr. Roni Bollag at the Georgia Cancer Center Biorepository for providing the human mesothelioma specimen and for pathological analysis. We also thank Dr. Natasha Savage for tumor specimen analysis and Dr. Kimya Jones for immunohistochemical analysis of tumor specimen. This work was supported by the National Cancer Institute grants R01 CA227433 (to MWG, YLC, NHO, KL), R01CA133085 (to KL), P01 CA125066 (to NHO), R01CA190429, and R01CA236890 (to H-FD), F30CA236436 (to JDK), and the US Department of Veterans Affairs Award CX001364 (to KL).	Abbosh PH, 2006, CANCER RES, V66, P5582, DOI 10.1158/0008-5472.CAN-05-3575; Aggarwal BB, 2012, BLOOD, V119, P651, DOI 10.1182/blood-2011-04-325225; Amrine CSM, 2018, J IND MICROBIOL BIOT, V45, P1053, DOI 10.1007/s10295-018-2083-8; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Chen L, 2019, NAT METAB, V1, P404, DOI 10.1038/s42255-019-0043-x; Cui WY, 2021, CANCER TREAT REV, V100, DOI 10.1016/j.ctrv.2021.102265; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; Dick TP, 2015, MOL CELL, V59, P519, DOI 10.1016/j.molcel.2015.08.002; Ding H., 2021, SCI ADV, V7, P1; Ding J, 2013, CELL METAB, V18, P896, DOI 10.1016/j.cmet.2013.11.004; Fiehn O, 2008, PLANT J, V53, P691, DOI 10.1111/j.1365-313X.2007.03387.x; Figueroa M, 2012, J ANTIBIOT, V65, P559, DOI 10.1038/ja.2012.69; Fritsch L, 2010, MOL CELL, V37, P46, DOI 10.1016/j.molcel.2009.12.017; Ge TX, 2020, FRONT ENDOCRINOL, V11, DOI 10.3389/fendo.2020.00365; Ghergurovich JM, 2020, CANCER RES, V80, P3820, DOI 10.1158/0008-5472.CAN-19-2486; Ghergurovich JM, 2020, NAT CHEM BIOL, V16, P731, DOI 10.1038/s41589-020-0533-x; Gu Y., 2014, CELL DEATH DIS, V5; Hayes JD, 2020, CANCER CELL, V38, P167, DOI 10.1016/j.ccell.2020.06.001; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hotta K, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2019-000461; Hwang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06447-z; Iurlaro R, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00479-16; Jian SL, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.192; Koo SJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00202; Kowalik MA, 2017, FRONT ONCOL, V7, DOI 10.3389/fonc.2017.00087; Kuehne A, 2015, MOL CELL, V59, P359, DOI 10.1016/j.molcel.2015.06.017; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lemoine J, 2021, CLIN CANCER RES, V27, P6298, DOI 10.1158/1078-0432.CCR-21-1559; Li W, 2021, NAT METAB, V3, P75, DOI 10.1038/s42255-020-00330-2; Liu B, 2019, ACS CHEM NEUROSCI, V10, P2332, DOI 10.1021/acschemneuro.8b00644; Lu CW, 2022, J IMMUNOTHER CANCER, V10, DOI 10.1136/jitc-2021-003543; Lu CW, 2021, J IMMUNOTHER CANCER, V9, DOI 10.1136/jitc-2021-002624; Lu CW, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001365; Lu CW, 2020, CANCER LETT, V476, P87, DOI 10.1016/j.canlet.2020.02.004; Lu CW, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/jnci/djw283; Matei D, 2020, CANCER RES, V80, P3775, DOI 10.1158/0008-5472.CAN-19-3837; McCambridge AJ, 2018, J THORAC ONCOL, V13, P606, DOI 10.1016/j.jtho.2018.02.021; McDonald OG, 2017, NAT GENET, V49, P367, DOI 10.1038/ng.3753; Menon DR, 2020, THERANOSTICS, V10, P6261, DOI 10.7150/thno.42523; Monteiro-Reis S, 2020, CANCERS, V12, DOI 10.3390/cancers12051066; Mozzetta C, 2014, MOL CELL, V53, P277, DOI 10.1016/j.molcel.2013.12.005; Muller MM, 2016, NAT CHEM BIOL, V12, P188, DOI [10.1038/NCHEMBIO.2008, 10.1038/nchembio.2008]; Nagashio R, 2019, BBA-PROTEINS PROTEOM, V1867, P38, DOI 10.1016/j.bbapap.2018.05.005; Nakajima EC, 2022, CLIN CANCER RES, V28, P446, DOI 10.1158/1078-0432.CCR-21-1466; Nakamura M, 2020, J IMMUNOTHER CANCER, V8, DOI 10.1136/jitc-2020-001679; Nicetto D, 2019, SCIENCE, V363, P294, DOI 10.1126/science.aau0583; Olcina MM, 2016, ONCOGENE, V35, P793, DOI 10.1038/onc.2015.134; Oshima N, 2020, CELL REP, V30, P1798, DOI 10.1016/j.celrep.2020.01.039; Paschall AV, 2015, GENOM DATA, V5, P189, DOI 10.1016/j.gdata.2015.05.043; Paschall AV, 2015, J IMMUNOL, V195, P1868, DOI 10.4049/jimmunol.1402243; Pathria G, 2018, EMBO J, V37, DOI 10.15252/embj.201899735; Pinton G, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.678447; Raub AG, 2019, CHEMMEDCHEM, V14, P1321, DOI 10.1002/cmdc.201900341; Redza-Dutordoir M, 2016, BBA-MOL CELL RES, V1863, P2977, DOI 10.1016/j.bbamcr.2016.09.012; Rice JC, 2003, MOL CELL, V12, P1591, DOI 10.1016/S1097-2765(03)00479-9; Salvi A, 2020, MOL CANCER THER, V19, P89, DOI 10.1158/1535-7163.MCT-19-0205; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Stomper J., 2021, CLIN EPIGENETICS, P13; Tu DZ, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1659-1; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Williams D, 2019, CLIN EXP METASTAS, V36, P211, DOI 10.1007/s10585-019-09967-0; Wong CC, 2017, ONCOGENE, V36, P3359, DOI 10.1038/onc.2016.485; Wu SR, 2018, CANCER RES, V78, P4549, DOI 10.1158/0008-5472.CAN-17-4047; Yeung C, 2019, CANCER RES, V79, P5060, DOI 10.1158/0008-5472.CAN-19-0217; Zhang XM, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.85	66	1	1	4	8	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2651	2662		10.1038/s41388-022-02283-0	http://dx.doi.org/10.1038/s41388-022-02283-0		MAR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35351997	Green Accepted			2022-12-26	WOS:000774697300001
J	Akter, T; Zeba, Z; Hosen, I; Al-Mamun, F; Mamun, MA				Akter, Tahmina; Zeba, Zebunnesa; Hosen, Ismail; Al-Mamun, Firoj; Mamun, Mohammed A.			Impact of the COVID-19 pandemic on BMI: Its changes in relation to socio-demographic and physical activity patterns based on a short period	PLOS ONE			English	Article							OBESITY; EXERCISE; LOCKDOWN; RISK	Background The COVID-19 pandemic is undoubtedly a major threat to the world. The preventive strategies designed to minimize the virus transmission by remaining at home, being isolated, and keeping social distance, which would substantially reform people's lifestyle, physical activity, eating habits, etc. Consequently, those measures might create a disturbance in weight management and overweight. Therefore, how the COVID-19 pandemic has changed the physical activities of individuals and its impacts on the Body Mass Index (BMI) is explored herein. Methods An online-based cross-sectional study collected data from 338 Bangladeshi adults in November 2020. The questionnaire included socio-demographics, health-related variables, physical activity-related variables, and diet measurement. Inferential statistics (i.e., chisquare test, McNemar test) were used to measure the associations between BMI and studied variables with a consideration of two scenarios ('before' and 'during' the pandemic inception), where p<0.05 was considered statistically significant. Results Results showed that the prevalence of overweight was 30.5% `before' the COVID-19 pandemic, which increased to 34.9% `during' the pandemic; that means 4.4% of the participants significantly gained weight after the pandemic inception. There was no significant role of socio-demographic (e.g., gender, age, current residence, occupation) or physical activityrelated factors (e.g., unavailability of outdoor space, not performing regular physical exercise, exercising with a partner) in changing the BMI status after the pandemic inception. However, following a proper diet plan during the COVID-19 pandemic was observed to decrease BMI status significantly. Conclusions The present study suggests that a minor portion of the participants reported increasing their overweight status after the pandemic inception, whereas having a proper diet plan during the pandemic can significantly decrease BMI status. Therefore, the importance of the appropriate diet plan should be considered while implementing any policies.	[Akter, Tahmina; Hosen, Ismail; Al-Mamun, Firoj; Mamun, Mohammed A.] CHINTA Res Bangladesh, Dhaka, Bangladesh; [Akter, Tahmina] Bangladesh Univ Hlth Sci, Dept Epidemiol, Dhaka, Bangladesh; [Zeba, Zebunnesa; Hosen, Ismail; Al-Mamun, Firoj; Mamun, Mohammed A.] Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh; [Mamun, Mohammed A.] Daffodil Int Univ, Dept Publ Hlth, Dhaka, Bangladesh	Bangladesh University of Health Sciences (BUHS); Jahangirnagar University; Daffodil International University	Mamun, MA (corresponding author), CHINTA Res Bangladesh, Dhaka, Bangladesh.; Mamun, MA (corresponding author), Jahangirnagar Univ, Dept Publ Hlth & Informat, Dhaka, Bangladesh.; Mamun, MA (corresponding author), Daffodil Int Univ, Dept Publ Hlth, Dhaka, Bangladesh.	mamunphi46@gmail.com	Al Mamun, Firoj/AAX-8208-2021; Hosen, Ismail/GLR-7097-2022	Al Mamun, Firoj/0000-0003-4611-9624; Hosen, Ismail/0000-0001-6406-7325; Mamun, Mohammed/0000-0002-1728-8966				Ahmed SI, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2811; al Mamun F, 2021, PSYCHOL RES BEHAV MA, V14, P645, DOI 10.2147/PRBM.S315961; Anwar S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00154; Auny FM, 2021, RISK MANAG HEALTHC P, V14, P2527, DOI 10.2147/RMHP.S308691; Balanza-Martinez V, 2020, ACTA PSYCHIAT SCAND, V141, P399, DOI 10.1111/acps.13177; Bensimhon DR, 2006, AM HEART J, V151, P598, DOI 10.1016/j.ahj.2005.03.005; Biswas M, 2021, INTERVIROLOGY, V64, P36, DOI 10.1159/000512592; Biswas T, 2017, BMC PUBLIC HEALTH, V17, DOI 10.1186/s12889-017-4494-2; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Chambonniere C, 2021, EUR J INTEGR MED, V43, DOI 10.1016/j.eujim.2021.101308; Chan JFW, 2020, LANCET, V395, P514, DOI 10.1016/S0140-6736(20)30154-9; Chaput JP, 2011, J OBES, V2011, DOI 10.1155/2011/360257; Chouchou F, 2021, SLEEP MED, V77, P297, DOI 10.1016/j.sleep.2020.09.014; Collao N, 2020, INT REV IMMUNOL, V39, P39, DOI 10.1080/08830185.2019.1682569; Villalobos JAC, 2016, CIR CIR, V84, P351, DOI 10.1016/j.circir.2016.08.001; Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5; Ejaz H, 2020, J INFECT PUBLIC HEAL, V13, P1833, DOI 10.1016/j.jiph.2020.07.014; Ernstsen L, 2021, SLEEP MED, V77, P309, DOI 10.1016/j.sleep.2020.08.030; Fezeu L, 2011, OBES REV, V12, P653, DOI 10.1111/j.1467-789X.2011.00864.x; Filgueira TO, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.587146; Galle F, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176171; Gornicka M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12082324; Hill JO, 2005, J APPL PHYSIOL, V99, P765, DOI 10.1152/japplphysiol.00137.2005; Hosen I, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0251151; Hossain MM, 2020, EPIDEMIOL HEALTH, V42, DOI 10.4178/epih.e2020038; Huang QQ, 2018, BEHAV NEUROL, V2018, DOI 10.1155/2018/6585734; Islam F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233754; Jakicic JM, 2018, CLIN CHEM, V64, P99, DOI 10.1373/clinchem.2017.272443; Jia P, 2021, APPETITE, V158, DOI 10.1016/j.appet.2020.105015; Khan MMA, 2019, J BIOSOC SCI, V51, P843, DOI 10.1017/S0021932019000142; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Koski Marja, 2017, Biomed Hub, V2, P1, DOI 10.1159/000458771; Kurukulasuriya LR, 2007, THERAPY, V4, P497, DOI [10. 2217/14750708.4.5.497, DOI 10.2217/14750708.4.5.497]; Kwok S, 2020, CLIN OBES, V10, DOI 10.1111/cob.12403; Lopez-Moreno M, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113445; Luciano F, 2021, EUR J SPORT SCI, V21, P1459, DOI 10.1080/17461391.2020.1842910; Maltoni G, 2021, NUTR METAB CARDIOVAS, V31, P2181, DOI 10.1016/j.numecd.2021.03.018; Mamun MA, 2021, PSYCHOL RES BEHAV MA, V14, P695, DOI 10.2147/PRBM.S315760; Mattioli AV, 2020, NUTR METAB CARDIOVAS, V30, P1409, DOI 10.1016/j.numecd.2020.05.020; Maugeri G, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e04315; Rahman ME, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e05392; Robinson E, 2021, APPETITE, V156, DOI 10.1016/j.appet.2020.104853; Rodriguez-Larrad A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18020369; Rundle AG, 2020, OBESITY, V28, P1008, DOI 10.1002/oby.22813; Salahuddin T, 2018, DAILY STAR; Sanchez-Sanchez E, 2020, NUTRIENTS, V12, DOI 10.3390/nu12092826; Sanchis-Gomar F, 2020, MAYO CLIN PROC, V95, P1445, DOI 10.1016/j.mayocp.2020.05.006; Sattar N, 2020, CIRCULATION, V142, P4, DOI 10.1161/CIRCULATIONAHA.120.047659; Sepulveda-Loyola W, 2020, J NUTR HEALTH AGING, DOI [10.1007/s12603-020-1500-7, 10.1007/s12603-020-1469-2]; Staff MC., 2019, COR DIS 2019 COVID 1; Tanwi TS, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7221-3; Tavakol Z, 2021, J PUBLIC HEALTH-HEID, DOI 10.1007/s10389-020-01468-9; Torres SJ, 2007, NUTRITION, V23, P887, DOI 10.1016/j.nut.2007.08.008; Urzeala C, 2022, HEALTH EXPECT, V25, P522, DOI 10.1111/hex.13282; van der Valk ES, 2018, CURR OBES REP, V7, P193, DOI 10.1007/s13679-018-0306-y; WHO, 2020, WHO COR COVID 19 DAS; WHO, 2016, DIAB COUNTR PROF; Wiklund P, 2016, J SPORT HEALTH SCI, V5, P151, DOI 10.1016/j.jshs.2016.04.001; Woods Jeffrey A, 2020, Sports Med Health Sci, V2, P55, DOI 10.1016/j.smhs.2020.05.006; World Health Organization, 2021, OB OV FACT SHEETS; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	61	5	5	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266024	10.1371/journal.pone.0266024	http://dx.doi.org/10.1371/journal.pone.0266024			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325012	gold, Green Published			2022-12-26	WOS:000780951300094
J	Burnett, NP; Badger, MA; Combes, SA				Burnett, Nicholas P.; Badger, Marc A.; Combes, Stacey A.			Wind and route choice affect performance of bees flying above versus within a cluttered obstacle field	PLOS ONE			English	Article							BUMBLEBEE FLIGHT PERFORMANCE; BODY-SIZE; BOMBUS-TERRESTRIS; SPEED CONTROL; GROUND SPEED; OPTIC FLOW; HONEY-BEE; ENVIRONMENTS; HYMENOPTERA	Bees flying through natural landscapes frequently encounter physical challenges, such as wind and cluttered vegetation, but the influence of these factors on flight performance remains unknown. We analyzed 548 videos of wild-caught honeybees (Apis mellifera) flying through an enclosure containing a field of vertical obstacles that bees could choose to fly within (through open corridors, without maneuvering) or above. We varied obstacle field height and wind condition (still, headwinds or tailwinds), and examined how these factors affected bees' flight altitude, ground speed, and side-to-side casting motions (lateral excursions). When obstacle fields were short, bees flew at altitudes near the midpoint between the tunnel floor and ceiling. When obstacle fields approached or exceeded this midpoint, bees tended to increase their altitude, but they did not always avoid flying through obstacles, despite having the freedom to do so. Bees that flew above the obstacles exhibited 40% faster ground speeds and 36% larger lateral excursions than bees that flew within the obstacle fields. Wind did not affect flight altitude, but bees flew 12-19% faster in tailwinds, and their lateral excursions were 19% larger when flying in headwinds or tailwinds, as compared to still air. Our results show that bees flying through complex environments display flexibility in their route choices (i.e., flying above obstacles in some trials and through them in others), which affects their overall flight performance. Similar choices in natural landscapes could have broad implications for foraging efficiency, pollination, and mortality in wild bees.	[Burnett, Nicholas P.; Badger, Marc A.; Combes, Stacey A.] Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA; [Badger, Marc A.] Univ Penn, Dept Comp & Informat Sci, 200 S 33Rd St, Philadelphia, PA 19104 USA	University of California System; University of California Davis; University of Pennsylvania	Burnett, NP (corresponding author), Univ Calif Davis, Dept Neurobiol Physiol & Behav, Davis, CA 95616 USA.	burnettnp@gmail.com		Burnett, Nicholas/0000-0003-4438-8062	National Science Foundation [1711980]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (https://www.nsf.gov/) with grant number 1711980 to NPB.	Altshuler DL, 2005, P NATL ACAD SCI USA, V102, P18213, DOI 10.1073/pnas.0506590102; Baird E, 2021, P ROY SOC B-BIOL SCI, V288, DOI 10.1098/rspb.2020.3051; Baird E, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.2988; Baird E, 2013, P NATL ACAD SCI USA, V110, P18686, DOI 10.1073/pnas.1314311110; Baird E, 2012, J COMP PHYSIOL A, V198, P869, DOI 10.1007/s00359-012-0757-7; Baird E, 2010, J EXP BIOL, V213, P1625, DOI 10.1242/jeb.038802; Barron A, 2006, J EXP BIOL, V209, P978, DOI 10.1242/jeb.02085; Burnett NP, 2020, J EXP BIOL, V223, DOI 10.1242/jeb.222471; Chang JJ, 2016, J EXP BIOL, V219, P2819, DOI 10.1242/jeb.137976; Combes SA, 2009, P NATL ACAD SCI USA, V106, P9105, DOI 10.1073/pnas.0902186106; Copley S, 2018, J EXP BIOL, V221, DOI 10.1242/jeb.178210; Couvillon M, 2015, APIDOLOGIE, V46, P61, DOI 10.1007/s13592-014-0302-5; Crall JD, 2017, INTERFACE FOCUS, V7, DOI 10.1098/rsfs.2016.0086; Crall JD, 2015, J EXP BIOL, V218, P2728, DOI 10.1242/jeb.121293; de Ibarra NH, 2009, J EXP BIOL, V212, P3193, DOI 10.1242/jeb.029751; de Langre E, 2008, ANNU REV FLUID MECH, V40, P141, DOI 10.1146/annurev.fluid.40.111406.102135; Foster DJ, 2011, J EXP BIOL, V214, P1896, DOI 10.1242/jeb.051730; Fuller SB, 2014, P NATL ACAD SCI USA, V111, pE1182, DOI 10.1073/pnas.1323529111; Goulson D, 2002, ANIM BEHAV, V64, P123, DOI 10.1006/anbe.2002.3041; Hedrick TL, 2008, BIOINSPIR BIOMIM, V3, DOI 10.1088/1748-3182/3/3/034001; Heikkila J, 1997, PROC CVPR IEEE, P1106, DOI 10.1109/CVPR.1997.609468; Hennessy G, 2020, ANIM BEHAV, V161, P23, DOI 10.1016/j.anbehav.2019.12.018; Hung KLJ, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2017.2140; Jakobi T, 2018, BIOL OPEN, V7, DOI 10.1242/bio.034074; KENNEDY JS, 1951, PHILOS T ROY SOC B, V235, P163, DOI 10.1098/rstb.1951.0003; Khurana TR, 2016, ELIFE, V5, DOI 10.7554/eLife.14449; Lecoeur J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-44187-2; Lenth RV, 2016, J STAT SOFTW, V69, P1, DOI 10.18637/jss.v069.i01; Linander N, 2016, J COMP PHYSIOL A, V202, P97, DOI 10.1007/s00359-015-1055-y; Linander N, 2015, J EXP BIOL, V218, P1051, DOI 10.1242/jeb.107409; Loyola RD, 2008, BASIC APPL ECOL, V9, P735, DOI 10.1016/j.baae.2007.06.016; Mountcastle AM, 2016, BIOL LETTERS, V12, DOI 10.1098/rsbl.2016.0294; MUNKRES J, 1957, J SOC IND APPL MATH, V5, P32, DOI 10.1137/0105003; Nachtigall W, 1995, J COMP PHYSIOL B, V165, P484, DOI 10.1007/BF00261303; Ohashi K, 2008, BEHAV ECOL, V19, P936, DOI 10.1093/beheco/arn048; Ong M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184343; Pinheiro J, 2020, R PACKAGE VERSION 31; Poorter H, 2012, NEW PHYTOL, V193, P30, DOI 10.1111/j.1469-8137.2011.03952.x; Randlkofer B, 2010, BASIC APPL ECOL, V11, P383, DOI 10.1016/j.baae.2010.03.003; Ravi S, 2020, P NATL ACAD SCI USA, V117, P31494, DOI 10.1073/pnas.2016872117; Ravi S, 2019, J EXP BIOL, V222, DOI 10.1242/jeb.184135; Ravi S, 2016, SCI REP-UK, V6, DOI 10.1038/srep35043; Ravi S, 2013, J EXP BIOL, V216, P4299, DOI 10.1242/jeb.090845; RCore Team, 2020, R LANG ENV STAT COMP; Roulston TH, 2000, J KANSAS ENTOMOL SOC, V73, P129; SRINIVASAN MV, 1991, VISUAL NEUROSCI, V6, P519, DOI 10.1017/S095252380000136X; Srinivasan MV, 1996, J EXP BIOL, V199, P237; Srinivasan MV, 2000, BIOL CYBERN, V83, P171, DOI 10.1007/s004220000162; Vicens N, 2000, ENVIRON ENTOMOL, V29, P413, DOI 10.1603/0046-225X-29.3.413; Walker JA, 1998, J EXP BIOL, V201, P981; Westoby M, 2002, ANNU REV ECOL SYST, V33, P125, DOI 10.1146/annurev.ecolsys.33.010802.150452; WILLIS MA, 1991, J COMP PHYSIOL A, V169, P427; Zhang ZY, 2000, IEEE T PATTERN ANAL, V22, P1330, DOI 10.1109/34.888718; Zuur AF, 2009, DEALING HETEROGENEIT, P71, DOI [10.1007/978-0-387-87458-6_4, DOI 10.1007/978-0-387-87458-6_4]	54	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265911	10.1371/journal.pone.0265911	http://dx.doi.org/10.1371/journal.pone.0265911			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325004	Green Submitted, gold, Green Published			2022-12-26	WOS:000780951300085
J	Lian, YY; Wang, AQ; Zeng, B; Yang, HM; Li, JL; Peng, SH; Zhou, SH				Lian, Yuyang; Wang, Aqiang; Zeng, Bei; Yang, Heming; Li, Jinlei; Peng, Sihua; Zhou, Shihao			Identification of male and female pupal characteristics of Zeugodacus cucurbitae (Coquillett) via machine vision	PLOS ONE			English	Article							DIPTERA; FLY; ERADICATION; TEPHRITIDAE	Images of original pupae of Zeugodacus cucurbitae (Coquillett) were normalized, grayed, and segmented to identify male and female pupae of this species via machine vision. The image of each pupa was divided into 25 small areas. The differences in surface texture features in each small area within 11 days were compared. The texture characteristics of both male and female pupae were screened by combining the eclosion of both sexes of Z. cucurbitae (Coquillett). Results indicated that the pectinate setae on the abdominal backplane could be used as a basis for the identification of the male and female pupa of Z. cucurbitae (Coquillett). Moreover, machine vision correctly identified these characteristics with an accuracy of 96.0%. This study lays a foundation for the identification of male and female pupae using machine vision and also for the comprehensive control of Z. cucurbitae (Coquillett).	[Lian, Yuyang; Wang, Aqiang; Zeng, Bei; Yang, Heming; Li, Jinlei; Peng, Sihua; Zhou, Shihao] Hainan Univ, Sanya Nanfan Res Inst, Sanya, Hainan, Peoples R China	Hainan University	Zhou, SH (corresponding author), Hainan Univ, Sanya Nanfan Res Inst, Sanya, Hainan, Peoples R China.	zsh88200939@126.com			High-level Talent Project of Hainan Natural Science Foundation [320RC499]; Key R&D Projects of Hainan Province [ZDYF2019096]; Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program Project [QCXM201908]; Natural Science Foundation of China [31760518]; Open Project of Key LaboratoryFruit Tree Biology of Hainan Province [KFZX2020001]	High-level Talent Project of Hainan Natural Science Foundation; Key R&D Projects of Hainan Province; Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program Project; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Open Project of Key LaboratoryFruit Tree Biology of Hainan Province	This study was supported by High-level Talent Project of Hainan Natural Science Foundation (320RC499), Key R&D Projects of Hainan Province(ZDYF2019096), Hainan Provincial Association for Science and Technology Youth Science and Technology Talents Academic Innovation Program Project (QCXM201908), Natural Science Foundation of China (31760518), The Open Project of Key LaboratoryFruit Tree Biology of Hainan Province (KFZX2020001). Funders play a large role in research design, data collection and analysis, publication decisions or manuscript preparation.	Chen Bingqi, 2018, Science & Technology Review, V36, P54, DOI 10.3981/j.issn.1000-7857.2018.11.006; Chen YH, 2008, AGR MECH RES, P209; CUNNINGHAM RT, 1966, ANN ENTOMOL SOC AM, V59, P864, DOI 10.1093/aesa/59.4.864a; Deng LL, 2020, J INTELL FUZZY SYST, V38, P379, DOI 10.3233/JIFS-179413; Dyck VA, 2021, STERILE INSECT TECHNIQUE, 2 EDITION, P1, DOI 10.1201/9781003035572; Fina F, 2013, INT J ADV BIOTECHNOL, V4, P189; Gong P, 2014, AGR MECH RES, V36, P206; Isasawin S, 2012, EUR J ENTOMOL, V109, P331, DOI 10.14411/eje.2012.043; Jiang CM., 2005, POPULATION SYSTEM IN; KNIPLING EF, 1955, J ECON ENTOMOL, V48, P459, DOI 10.1093/jee/48.4.459; Li WJ, 2021, INSECT MOL BIOL, V30, P605, DOI 10.1111/imb.12729; Li WJ, 2021, ENTOMOL GEN, V41, P279, DOI 10.1127/entomologia/2021/1037; Lin Jinbei, 2021, Journal of South China Agricultural University, V42, P70, DOI 10.7671/j.issn.1001-411X.202012033; Martineau M, 2017, PATTERN RECOGN, V65, P273, DOI 10.1016/j.patcog.2016.12.020; MCINNIS DO, 1994, ANN ENTOMOL SOC AM, V87, P231, DOI 10.1093/aesa/87.2.231; Najib M.A., 2019, T SCI TECHNOLOGY, V6, P210; [潘鹏亮 Pan Pengliang], 2019, [植物保护, Plant Protection], V45, P71; Papathanos PA, 2018, PARASITE VECTOR, V11, DOI 10.1186/s13071-018-3222-9; Peng Wei, 2020, Acta Entomologica Sinica, V63, P902, DOI 10.16380/j.kcxb.2020.07.013; Phuc HK, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-11; Rendon P., 2000, Area-wide control of fruit flies and other insect pests. Joint proceedings of the international conference on area-wide control of insect pests, 28 May-2 June, 1998 and the Fifth International Symposium on Fruit Flies of Economic Importance, Penang, Malaysia, 1-5 June, 1998, P517; Shelly T, 2019, FLA ENTOMOL, V102, P278, DOI 10.1653/024.102.0154; STEINER LF, 1965, J ECON ENTOMOL, V58, P519, DOI 10.1093/jee/58.3.519; Steinitz H, 2016, FLA ENTOMOL, V99, P192, DOI 10.1653/024.099.sp123; Yang HW, 2005, CHINA J BIOINFORMATI, P133; Zhang Hong-Tao, 2019, Huanjing Kunchong Xuebao, V41, P908; ZHANG Hongtao, 2020, Tobacco Science & Technology, V53, P21, DOI 10.16135/j.issn1002-0861.2019.0127; Zhang QS., 2002, PLANT PROTECTION TEC, P14; Zheng XY, 2019, NATURE, V572, P56, DOI 10.1038/s41586-019-1407-9; Zhu LQ, 2011, J ZHEJIANG U-SCI C, V12, P44, DOI 10.1631/jzus.C0910740	30	0	0	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264227	10.1371/journal.pone.0264227	http://dx.doi.org/10.1371/journal.pone.0264227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324918	Green Published, gold			2022-12-26	WOS:000780951300015
J	Ntiyani, N; Letamo, G; Keetile, M				Ntiyani, Nchidzi; Letamo, Gobopamang; Keetile, Mpho			Prevalence of and factors associated with hypertension, diabetes, stroke and heart attack multimorbidity in Botswana: Evidence from STEPS 2014 survey	PLOS ONE			English	Article							PRIMARY-CARE; PATTERNS	Background Botswana, like other Sub-Saharan Africa (SSA) countries is currently undergoing demographic and epidemiological transitions which are shown by an increase in chronic non-communicable diseases (NCDs) and their associated risk factors. The aim of this study was to examine the prevalence of and factors associated with hypertension, diabetes and stroke/heart attack multimorbidity in Botswana. The definition of multimorbidity used in this study is the presence of two or more NCDs in an individual. Methods This study used secondary data derived from the Botswana WHO STEPS 2014 survey. The survey employed a nationally representative multi-stage sampling design. The study sample consisted of 3527 respondents aged 20-69 years of age who had successfully completed the questionnaire and met the inclusion criteria. Multivariable logistic regression analyses were used to assess factors associated with multimorbidity. All comparisons were considered to be statistically significant at 5% level. Statistical tests were performed using Statistical Package for Social Sciences (SPSS) version 25. Results Prevalence of hypertension, diabetes and stroke/heart attack multimorbidity was estimated to be at 3.5% in the sampled population. The odds of reporting multimorbidity were highest among females (AOR = 9.73, 95% CI = 8.30-11.42) than males and among respondents aged 35-49 (AOR = 1.20, 95% C.I. = 1.10-1.31) and 50-69 years (AOR = 1.52, 95% C.I. = 1.23-1.67) than individuals aged 20-24 years. Moreover, the odds of multimorbidity were significantly higher among married (AOR = 15.92, 95% C.I. = 13.40-18.92) and living together (AOR = 6.68, 95% C.I. = 5.72-7.81) couples; and individuals who reported that they earn an average annual household income of BWP >= 20 000 (AOR = 2.25, 95% CI = 1.84-2.75) compared to their counterparts. Behavioural risk factors significantly associated with higher odds of multimorbidity were obesity (AOR = 6.79, 95% C.I. = 6.20-7.90), physical inactivity (AOR = 4.41, 95% C.I. = 3.65-5.31) and hazardous alcohol consumption (AOR = 1.49, 95% CI = 1.23-1.81). On the other hand the odds of reporting multimorbidity were significantly low among individuals with sufficient consumption of fruits and vegetables (AOR = 0.47, 95% C.I. = 0.39-0.56) and non-tobacco users (AOR = 0.58, 95% CI = 0.49-0.68). Conclusion Multimorbidity was more common among females, the elderly people and was associated with obesity, poor fruit and vegetable intake, and tobacco use. Strategies to combat NCDs and multimorbidity should be aimed to target early stages of life since behavioural factors and lifestyles that increase the likelihood of disease are entrenched in earlier stages of life.	[Ntiyani, Nchidzi; Letamo, Gobopamang; Keetile, Mpho] Univ Botswana, Dept Populat Studies, Gaborone, Botswana	University of Botswana	Keetile, M (corresponding author), Univ Botswana, Dept Populat Studies, Gaborone, Botswana.	mphokeet@yahoo.com	Keetile, Mpho/B-8058-2019	Keetile, Mpho/0000-0003-1776-4835				Abebe Fantu, 2020, J Comorb, V10, p2235042X20961919, DOI 10.1177/2235042X20961919; Agborsangaya CB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-201; Alaba O, 2013, INT J EQUITY HEALTH, V12, DOI 10.1186/1475-9276-12-63; [Anonymous], 2016, DEATHS CAUS AG SEX C; Bertheussen GF, 2011, MED SCI SPORT EXER, V43, P1220, DOI 10.1249/MSS.0b013e318206c66e; Chase NL, 2009, AM J HYPERTENS, V22, P417, DOI 10.1038/ajh.2009.6; Chung RY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140040; Di Renzo L., 2018, OXID MED CELL LONGEV, P1; Fortin M, 2005, ANN FAM MED, V3, P223, DOI 10.1370/afm.272; Fortin M, 2007, BMJ-BRIT MED J, V334, P1016, DOI 10.1136/bmj.39201.463819.2C; Fortin M, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-686; Fortin M, 2012, ANN FAM MED, V10, P142, DOI 10.1370/afm.1337; Glynn LG, 2011, FAM PRACT, V28, P516, DOI 10.1093/fampra/cmr013; Jerliu N, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-22; Kautzky-Willer A, 2016, ENDOCR REV, V37, P278, DOI 10.1210/er.2015-1137; Keetile M, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239334; Keetile M, 2015, J PUBLIC HEALTH-HEID, V23, P311, DOI 10.1007/s10389-015-0682-7; Khanam MA, 2011, J HEALTH POPUL NUTR, V29, P406, DOI 10.3329/jhpn.v29i4.8458; Marengoni A, 2008, AM J PUBLIC HEALTH, V98, P1198, DOI 10.2105/AJPH.2007.121137; Marengoni A, 2011, AGEING RES REV, V10, P430, DOI 10.1016/j.arr.2011.03.003; Melo Laércio Almeida de, 2019, Rev. bras. geriatr. gerontol., V22, pe180154, DOI 10.1590/1981-22562019022.180154; Mercer S., 2014, ABC MULTIMORBIDITY; Ministry of Health and World Health Organization, 2015, BOTSW STEPS SURV REP; Nimako BA, 2013, GLOBALIZATION HEALTH, V9, DOI 10.1186/1744-8603-9-61; Ha NT, 2015, INT J EQUITY HEALTH, V14, DOI 10.1186/s12939-015-0177-8; Nunes BP, 2018, REV SAUDE PUBL, V52, DOI [10.11606/S1518-8787.2018052000637, 10.11606/s1518-8787.2018052000637]; Pandey A R, 2015, J Nepal Health Res Counc, V13, P20; Pati S, 2015, ANN FAM MED, V13, P446, DOI 10.1370/afm.1843; Pedersen BK, 2015, SCAND J MED SCI SPOR, V25, P1, DOI 10.1111/sms.12581; Prazeres F, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2015-009287; Ruel G, 2014, CLIN NUTR, V33, P513, DOI 10.1016/j.clnu.2013.07.009; Sakib MN, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-6567-x; Singer L, 2019, SSM-POPUL HLTH, V8, DOI 10.1016/j.ssmph.2019.100413; Statistics Botswana, 2017, HLTH STAT REP 2010; Steiner C.A., 2013, NATIONWIDE INPATIENT, V10, DOI [10. 5888/pcd10.120292, DOI 10.5888/PCD10.120292]; Taylor AW, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-718; Vancampfort D, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0602-z; Violan C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102149; Weimann A, 2016, SOC SCI MED, V163, P144, DOI 10.1016/j.socscimed.2016.06.055; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2010, SOCIAL DETERMINANTS, DOI DOI 10.13016/17CR-AQB9; World Health Organization, 2018, NONC DIS; World Health Organization, 2017, REG FRAM INT ESS NCD; World Health Organization, 2016, MULT TECHN SER SAF P; Xu XL, 2017, J GLOB HEALTH, V7, DOI 10.7189/jogh.07.010414; Yamada T., 2013, J TROPICAL DIS, V1, P117, DOI [10.4172/2329-891X.1000117, DOI 10.4172/2329-891X.1000117]; Zhang J, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-036664	47	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265722	10.1371/journal.pone.0265722	http://dx.doi.org/10.1371/journal.pone.0265722			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324986	Green Published, gold			2022-12-26	WOS:000780951300061
J	Peyton, J; Hadjistylli, M; Tziortzis, I; Erotokritou, E; Demetriou, M; Samuel, Y; Anastasi, V; Fyttis, G; Hadjioannou, L; Ieronymidou, C; Kassinis, N; Kleitou, P; Kletou, D; Mandoulaki, A; Michailidis, N; Papatheodoulou, A; Payiattas, G; Sparrow, D; Sparrow, R; Turvey, K; Tzirkalli, E; Varnava, AI; Pescott, OL				Peyton, J.; Hadjistylli, M.; Tziortzis, I; Erotokritou, E.; Demetriou, M.; Samuel, Y.; Anastasi, V; Fyttis, G.; Hadjioannou, L.; Ieronymidou, C.; Kassinis, N.; Kleitou, P.; Kletou, D.; Mandoulaki, A.; Michailidis, N.; Papatheodoulou, A.; Payiattas, G.; Sparrow, D.; Sparrow, R.; Turvey, K.; Tzirkalli, E.; Varnava, A., I; Pescott, O. L.			Using expert-elicitation to deliver biodiversity monitoring priorities on a Mediterranean island	PLOS ONE			English	Article							CITIZEN-SCIENCE; KNOWLEDGE; SHORTFALL; TAXONOMY; FUTURE	Biodiversity monitoring plays an essential role in tracking changes in ecosystems, species distributions and abundances across the globe. Data collected through both structured and unstructured biodiversity recording can inform conservation measures designed to reduce, prevent, and reverse declines in valued biodiversity of many types. However, given that resources for biodiversity monitoring are limited, it is important that funding bodies prioritise investments relative to the requirements in any given region. We addressed this prioritisation requirement for a biodiverse Mediterranean island (Cyprus) using a three-stage process of expert-elicitation. This resulted in a structured list of twenty biodiversity monitoring needs; specifically, a hierarchy of three groups of these needs was created using a consensus approach. The most highly prioritised biodiversity monitoring needs were those related to the development of robust survey methodologies, and those ensuring that sufficiently skilled citizens are available to contribute. We discuss ways that the results of our expert-elicitation process could be used to support current and future biodiversity monitoring in Cyprus.	[Peyton, J.; Turvey, K.; Pescott, O. L.] UK Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Hadjistylli, M.] Minist Agr Rural Dev & Environm, Dept Agr, Nicosia, Cyprus; [Tziortzis, I] Minist Agr Rural Dev & Environm, Water Dev Dept, Nicosia, Cyprus; [Erotokritou, E.] Minist Agr Rural Dev & Environm, Dept Environm, Nicosia, Cyprus; [Demetriou, M.; Samuel, Y.; Fyttis, G.] Univ Cyprus, Dept Biol Sci, Nicosia, Cyprus; [Samuel, Y.] Univ Cyprus, Oceanog Ctr, Nicosia, Cyprus; [Anastasi, V] Terra Cypria Cyprus Conservat Fdn, Nicosia, Cyprus; [Anastasi, V; Ieronymidou, C.] BirdLife Cyprus, Nicosia, Cyprus; [Fyttis, G.; Papatheodoulou, A.] IA CO Environm & Water Consultants Ltd, Nicosia, Cyprus; [Hadjioannou, L.] Enalia Physis Environm Res Ctr, Nicosia, Cyprus; [Hadjioannou, L.] CMMI Cyprus Marine & Maritime Inst, Larnax, Cyprus; [Kassinis, N.] Minist Interior, Game & Fauna Serv, Nicosia, Cyprus; [Kleitou, P.; Kletou, D.] Marine & Environm Res MER Lab, Lemesos, Cyprus; [Kleitou, P.] Univ Plymouth, Sch Biol & Marine Sci, Plymouth, Devon, England; [Kletou, D.] Frederick Univ, Dept Maritime Transport & Commerce, Lemesos, Cyprus; [Mandoulaki, A.; Varnava, A., I] Cyprus Univ Technol, Dept Agr Sci Biotechnol & Food Sci, Lemesos, Cyprus; [Michailidis, N.; Payiattas, G.] Minist Agr Rural Dev & Environm, Dept Fisheries & Marine Res, Nicosia, Cyprus; [Sparrow, D.; Sparrow, R.] Cyprus Dragonfly Study Grp, Pafos, Cyprus; [Tzirkalli, E.] Open Univ Cyprus, Sch Pure & Appl Sci, Nicosia, Cyprus; [Tzirkalli, E.] Univ Ioannina, Dept Biol Applicat & Technol, Ioannina, Greece	UK Centre for Ecology & Hydrology (UKCEH); University of Cyprus; University of Cyprus; University of Plymouth; Cyprus University of Technology; Open University of Cyprus; University of Ioannina	Peyton, J (corresponding author), UK Ctr Ecol & Hydrol, Wallingford, Oxon, England.	joyt@ceh.ac.uk	; Hadjioannou, Louis/F-3272-2018	Peyton, Jodey/0000-0002-8313-6194; Tzirkalli, Elli/0000-0002-7839-2150; Hadjioannou, Louis/0000-0001-5864-5467; Tziortzis, Iakovos/0000-0002-9315-7773; Kleitou, Periklis/0000-0002-9168-4721	UK Defra Darwin Initiative Plus [DarwinPlus056, DPLUS088]; Natural Environment Research Council as part of the UK-SCAPE programme delivering National Capability [NE/R016429/1]	UK Defra Darwin Initiative Plus; Natural Environment Research Council as part of the UK-SCAPE programme delivering National Capability(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	The authors are grateful to the UK Defra Darwin Initiative Plus for funding this study (reference DarwinPlus056 Assessment of current and future Invasive Alien Species in Cyprus and DPLUS088 Addressing drivers of ecological change in Lake Akrotiri SBA, Cyprus). This work was supported by the Natural Environment Research Council award number NE/R016429/1 as part of the UK-SCAPE programme delivering National Capability. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnarsson I, 2007, SYST BIOL, V56, P531, DOI 10.1080/10635150701424546; August T, 2015, BIOL J LINN SOC, V115, P731, DOI 10.1111/bij.12534; Beck J, 2013, DIVERS DISTRIB, V19, P1043, DOI 10.1111/ddi.12083; Bell S, 2008, BIODIVERS CONSERV, V17, P3443, DOI 10.1007/s10531-008-9357-9; Bongaarts J, 2019, POPUL DEV REV, V45, P680, DOI 10.1111/padr.12283; Boxshall G., 2011, UK TAXONOMY SYSTEMAT; Brereton T.M., 2017, UK BUTTERFLY MONITOR; Brito D, 2010, BASIC APPL ECOL, V11, P709, DOI 10.1016/j.baae.2010.09.007; Brown J. H., 1998, BIOGEOGRAPHY; CBD CoBD, 2010, 4 NAT REP UN CONV BI; Christodoulou C, 2003, IMPACT ACACIA SALIGN; CIESM ICfSEotMS, CIESM JELLYWATCH PRO; Coll M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011842; Colson AR, 2018, REV ENV ECON POLICY, V12, P113, DOI 10.1093/reep/rex022; Comont R, 2019, BEEWALK ANN REPORT 2; Crall AW, 2012, BIOL INVASIONS, V14, P2461, DOI 10.1007/s10530-012-0256-3; de Carvalho MR, 2007, EVOL BIOL, V34, P140, DOI 10.1007/s11692-007-9011-6; Delipetrou P, 2008, MEDITERRANEAN ISLAND, P170, DOI DOI 10.1007/978-1-4020-5064-0_9; Department for Environment Food and Rural Affairs, 2018, GREEN FUT OUR 25 YEA; Erotokritou Elena, 2019, Ecologia Mediterranea, V45, P31; Franklin J, 2017, GLOBAL ECOL BIOGEOGR, V26, P6, DOI 10.1111/geb.12501; Franz NM, 2018, DATABASE-OXFORD, DOI 10.1093/database/bax100; Garcia-Baron I, 2021, J APPL ECOL; Giannakopoulos P., 2010, ADV GEOSCI, V23, P17, DOI [DOI 10.5194/ADGEO-23-17-2010, 10.5194/adgeo-23-17-2010]; Giovos I, 2019, BIOL INVASIONS, V21, P3707, DOI 10.1007/s10530-019-02083-w; Gitzen R.A., 2012, DESIGN ANAL LONG TER; Grace M, 2021, ENVIRON SCI POLICY, V116, P56, DOI 10.1016/j.envsci.2020.10.003; Groom Q, 2019, CITIZEN SCI THEORY P, V4; Groom QJ, 2015, MANAG BIOL INVASION, V6, P119, DOI 10.3391/mbi.2015.6.2.02; Hadjinicolaou P, 2011, REG ENVIRON CHANGE, V11, P441, DOI 10.1007/s10113-010-0153-1; Hall CM, 2010, J HERIT TOUR, V5, P253, DOI 10.1080/1743873X.2010.517843; Hand R, FLORA CYPRUS A DYNAM; Hayhow D.B., 2019, STATE NATURE 2019; Hochkirch A, 2021, CONSERV BIOL, V35, P502, DOI 10.1111/cobi.13589; Hochkirch A, 2016, NATURE, V539, P141, DOI 10.1038/539141a; Isaac NJB, 2015, BIOL J LINN SOC, V115, P522, DOI 10.1111/bij.12532; Juanes F, 2018, J NAT CONSERV, V42, P7, DOI 10.1016/j.jnc.2018.01.003; Kampen H, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-014-0604-5; Kim KC, 2006, ECOL RES, V21, P794, DOI 10.1007/s11284-006-0035-7; Kleitou P, 2021, J ENVIRON MANAGE, V280, DOI 10.1016/j.jenvman.2020.111690; Kleitou P, 2019, BIOINVASIONS REC, V8, P252, DOI 10.3391/bir.2019.8.2.06; Manolaki P, 2020, LAND USE POLICY, V92, DOI 10.1016/j.landusepol.2019.104336; MCNEELY JA, 1992, BIODIVERS CONSERV, V1, P2, DOI 10.1007/BF00700247; Moreira F, 2019, CONSERV SCI PRACT, V1, DOI 10.1111/csp2.118; Morris Roger, 2012, British Journal of Entomology and Natural History, V25, P143; Nieto A., 2017, EUROPEAN RED LIST BE; Pescott OL, 2015, BIOL J LINN SOC, V115, P505, DOI 10.1111/bij.12581; Piaggio AJ, 2014, MOL ECOL RESOUR, V14, P374, DOI 10.1111/1755-0998.12180; Pocock MJO, 2015, BIOL J LINN SOC, V115, P475, DOI 10.1111/bij.12548; Pocock MJO, 2015, J APPL ECOL, V52, P686, DOI 10.1111/1365-2664.12423; Preston C. D., 2013, New Journal of Botany, V3, P2, DOI 10.1179/2042349713Y.0000000020; Roy HE, 2020, GLOBAL CHANGE BIOL, V26, P3181, DOI 10.1111/gcb.15062; Roy HE, 2015, BIOL J LINN SOC, V115, P469, DOI 10.1111/bij.12575; Roy HE, 2014, GLOBAL CHANGE BIOL, V20, P3859, DOI 10.1111/gcb.12603; Sala OE, 2000, SCIENCE, V287, P1770, DOI 10.1126/science.287.5459.1770; Sanchez-Bayo F, 2019, BIOL CONSERV, V232, P8, DOI 10.1016/j.biocon.2019.01.020; Sevilleja C, 2020, EUROPEAN BUTTERFLY M; Sparrow D. J., 2016, INTRO WILDLIFE CYPRU; Sutherland WJ, 2020, TRENDS ECOL EVOL, V35, P81, DOI 10.1016/j.tree.2019.10.010; Sutherland WJ, 2015, NATURE, V526, P317, DOI 10.1038/526317a; Sutherland WJ, 2015, BIOL J LINN SOC, V115, P779, DOI 10.1111/bij.12576; Termaat T, 2019, DIVERS DISTRIB, V25, P936, DOI 10.1111/ddi.12913; Tsikliras AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121188; Tsintides T, 2007, CYPRUS FORESTRY ASS, V465; Varnava AI, 2020, ZOOKEYS, P1, DOI 10.3897/zookeys.924.38328; Vogiatzakis IN, 2016, INTRO WILDLIFE CYPRU; Wetzel FT, 2018, BIOL CONSERV, V221, P78, DOI 10.1016/j.biocon.2017.12.024	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0256777	10.1371/journal.pone.0256777	http://dx.doi.org/10.1371/journal.pone.0256777			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324899	Green Submitted, Green Published, Green Accepted, gold			2022-12-26	WOS:000780951300004
J	Ambaru, B; Gangadharan, GM; Subramanya, HS; Gupta, CM				Ambaru, Bindu; Gangadharan, Ganesh Muthu; Subramanya, Hosahalli S.; Gupta, Chhitar M.			Profilin is involved in G1 to S phase progression and mitotic spindle orientation during Leishmania donovani cell division cycle	PLOS ONE			English	Article							TRYPANOSOMA-BRUCEI; GENE-EXPRESSION; FUNCTIONAL-CHARACTERIZATION; MOLECULAR CHARACTERIZATION; SUBCELLULAR-LOCALIZATION; ACTIN DYNAMICS; PROTEIN; TRANSPORTER; COMPLEX; IMPORT	Profilin is a multi-ligand binding protein, which is a key regulator of actin dynamics and involved in regulating several cellular functions. It is present in all eukaryotes, including trypanosomatids such as Leishmania. However, not much is known about its functions in these organisms. Our earlier studies have shown that Leishmania parasites express a single homologue of profilin (LdPfn) that binds actin, phosphoinositides and poly- L- proline motives, and depletion of its intracellular pool to 50%of normal levels affects the cell growth and intracellular trafficking. Here, we show, employing affinity pull-down and mass spectroscopy, that LdPfn interacted with a large number of proteins, including those involved in mRNA processing and protein translation initiation, such as eIF4A1. Further, we reveal, using mRNA Seq analysis, that depletion of LdPfn in Leishmania cells (LdPfn(+/-)) resulted in significantly reduced expression of genes which encode proteins involved in cell cycle regulation, mRNA translation initiation, nucleosides and amino acids transport. In addition, we show that in LdPfn(+/-) cells, cellular levels of eIF4A1 protein were significantly decreased, and during their cell division cycle, G1-to-S phase progression was delayed and orientation of mitotic spindle altered. These changes were, however, reversed to normal by episomal expression of GFP-LdPfn in LdPfn(+/-) cells. Taken together, our results indicate that profilin is involved in regulation of G1-to-S phase progression and mitotic spindle orientation in Leishmania cell cycle, perhaps through its interaction with elF4A1 protein.	[Ambaru, Bindu; Gangadharan, Ganesh Muthu; Subramanya, Hosahalli S.; Gupta, Chhitar M.] Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India; [Ambaru, Bindu] Manipal Acad Higher Educ, Manipal, Karnataka, India; [Gangadharan, Ganesh Muthu] Inst Stem Cell Sci & Regenerat Med, Bengaluru, Karnataka, India	Manipal Academy of Higher Education (MAHE); Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem	Gupta, CM (corresponding author), Inst Bioinformat & Appl Biotechnol, Bengaluru, Karnataka, India.	cm44gupta@gmail.com		Ambaru (Ph.D), Purna Sudha Bindu/0000-0003-0131-0353	Corpus grant by Infosys Foundation; Department of IT, BT, and S&T, Government of Karnataka; Women Scientist Grant by DST, GOI [SR/WOS-A/LS-352/2017 (G)]	Corpus grant by Infosys Foundation; Department of IT, BT, and S&T, Government of Karnataka; Women Scientist Grant by DST, GOI	This study was supported by a Corpus grant by Infosys Foundation to IBAB and by the Department of IT, BT, and S&T, Government of Karnataka. BA is the recipient of the Women Scientist Grant by DST, GOI (No: SR/WOS-A/LS-352/2017 (G)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AFFRANCHINO JL, 1985, MOL BIOCHEM PARASIT, V16, P289, DOI 10.1016/0166-6851(85)90071-4; Aguiar BG, 2018, CELL MICROBIOL, V20, DOI 10.1111/cmi.12867; Alsford S, 2011, GENOME RES, V21, P915, DOI 10.1101/gr.115089.110; Ambaru B, 2020, MOL BIOCHEM PARASIT, V238, DOI 10.1016/j.molbiopara.2020.111280; Ambrosio DL, 2007, MEM I OSWALDO CRUZ, V102, P97, DOI 10.1590/S0074-02762007000100017; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; BANGS JD, 1993, J CELL SCI, V105, P1101; Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105; Bergstralh DT, 2017, DEVELOPMENT, V144, P1137, DOI 10.1242/dev.140764; Bibis SS, 2014, MOL BIOCHEM PARASIT, V196, P90, DOI 10.1016/j.molbiopara.2014.08.005; Bijlmakers MJ, 2021, FRONT CHEM, V8, DOI 10.3389/fchem.2020.630888; Branquinha MH, 2013, CURR MED CHEM, V20, P3174; Brennand A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130365; Bubb MR, 1998, CELL MOTIL CYTOSKEL, V39, P134, DOI 10.1002/(SICI)1097-0169(1998)39:2<134::AID-CM4>3.0.CO;2-6; Cadavid-Restrepo G, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-46; Carter NS, 2008, ADV EXP MED BIOL, V625, P141, DOI 10.1007/978-0-387-77570-8_12; Carvalho S, 2015, MOL MICROBIOL, V96, P581, DOI 10.1111/mmi.12957; Chan KY, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001050; Chen M, 2001, APMIS, V109, P801, DOI 10.1034/j.1600-0463.2001.091201.x; Chi TB, 1998, MOL BIOCHEM PARASIT, V92, P29, DOI 10.1016/S0166-6851(97)00222-3; Clayton CE, 2016, CURR OPIN MICROBIOL, V32, P46, DOI 10.1016/j.mib.2016.04.018; Clayton C, 2019, OPEN BIOL, V9, DOI 10.1098/rsob.190072; Colineau L, 2017, MED MICROBIOL IMMUN, V206, P235, DOI 10.1007/s00430-017-0500-7; Damianou A, 2020, PLOS PATHOG, V16, DOI 10.1371/journal.ppat.1008455; Dan-Goor M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079287; Davey Rhonda J, 2020, Biophys Rev, V12, P827, DOI 10.1007/s12551-020-00723-3; de Souza W, 2009, INT J BIOCHEM CELL B, V41, P2069, DOI 10.1016/j.biocel.2009.04.007; Dey R, 2010, MOL MICROBIOL, V77, P399, DOI 10.1111/j.1365-2958.2010.07214.x; Dhalia R, 2005, MOL BIOCHEM PARASIT, V140, P23, DOI 10.1016/j.molbiopara.2004.12.001; Dhalia R, 2006, NUCLEIC ACIDS RES, V34, P2495, DOI 10.1093/nar/gkl290; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Diaz JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190618; Downey N, 2005, EUKARYOT CELL, V4, P765, DOI 10.1128/EC.4.4.765-774.2005; Downing T, 2011, GENOME RES, V21, P2143, DOI 10.1101/gr.123430.111; Dubessay P, 2006, MOL MICROBIOL, V59, P1162, DOI 10.1111/j.1365-2958.2005.05013.x; Osorio-Mendez JF, 2016, BIOCHEM BIOPH RES CO, V480, P709, DOI 10.1016/j.bbrc.2016.10.044; Fyfe PK, 2008, J BIOL CHEM, V283, P17672, DOI 10.1074/jbc.M801850200; Gassen A, 2012, NUCLEIC ACIDS RES, V40, P10302, DOI 10.1093/nar/gks801; Gowri VS, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-621; Gupta I, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26532-z; Hassan P, 2001, MOL BIOCHEM PARASIT, V113, P189, DOI 10.1016/S0166-6851(01)00220-1; HAUGWITZ M, 1994, CELL, V79, P303, DOI 10.1016/0092-8674(94)90199-6; Janetopoulos C, 2006, J CELL BIOL, V174, P485, DOI 10.1083/jcb.200603156; Janmey PA, 2018, BIOCHEM BIOPH RES CO, V506, P307, DOI 10.1016/j.bbrc.2018.07.155; Janzen CJ, 2006, MOL CELL, V23, P497, DOI 10.1016/j.molcel.2006.06.027; Joshi PB, 2002, MOL BIOCHEM PARASIT, V120, P33, DOI 10.1016/S0166-6851(01)00432-7; Karamysheva ZN, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082981; Kima PE, 2016, CELL IMMUNOL, V309, P19, DOI 10.1016/j.cellimm.2016.09.004; King-Keller S, 2015, EUKARYOT CELL, V14, P486, DOI 10.1128/EC.00019-15; Kovarova J, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1006953; Kramer S, 2012, MOL BIOCHEM PARASIT, V181, P61, DOI 10.1016/j.molbiopara.2011.10.002; Krishnan Kannan, 2009, Biophys Rev, V1, P71, DOI 10.1007/s12551-009-0010-y; Kronja I, 2011, PHILOS T R SOC B, V366, P3638, DOI 10.1098/rstb.2011.0084; Kunda P, 2009, TRENDS CELL BIOL, V19, P174, DOI 10.1016/j.tcb.2009.01.006; Kursula I, 2008, STRUCTURE, V16, P1638, DOI 10.1016/j.str.2008.09.008; Kushawaha PK, 2011, J IMMUNOL, V187, P6417, DOI 10.4049/jimmunol.1102081; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Laranjeira-Silva MF, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007140; LEBOWITZ JH, 1993, GENE DEV, V7, P996, DOI 10.1101/gad.7.6.996; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Leprohon P, 2006, EUKARYOT CELL, V5, P1713, DOI 10.1128/EC.00152-06; Li ZY, 2002, J BIOL CHEM, V277, P42686, DOI 10.1074/jbc.M207183200; Liang XH, 2003, EUKARYOT CELL, V2, P830, DOI 10.1128/EC.2.5.830-840.2003; Libusova L, 2004, EXP CELL RES, V295, P375, DOI 10.1016/j.yexcr.2004.01.009; Listovsky T, 2011, BIOCHEM BIOPH RES CO, V408, P71, DOI 10.1016/j.bbrc.2011.03.118; Lombrana R, 2016, CELL REP, V16, P1774, DOI 10.1016/j.celrep.2016.07.007; Lypaczewski P, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34812-x; MAHAPATRA S, 1994, NUCLEIC ACIDS RES, V22, P3381, DOI 10.1093/nar/22.16.3381; Mahapatra S, 1996, J BIOL CHEM, V271, P20432, DOI 10.1074/jbc.271.34.20432; Mani J, 2017, SCI REP-UK, V7, DOI 10.1038/srep40738; Mani J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7646; Marchese L, 2018, PATHOGENS, V7, DOI 10.3390/pathogens7020036; Martinez-Calvillo S, 2003, MOL CELL, V11, P1291, DOI 10.1016/S1097-2765(03)00143-6; Meleppattu S, 2015, NUCLEIC ACIDS RES, V43, P6222, DOI 10.1093/nar/gkv564; MENZ B, 1991, MOL BIOCHEM PARASIT, V47, P101, DOI 10.1016/0166-6851(91)90152-V; Morales J, 2009, J BIOL CHEM, V284, P7255, DOI 10.1074/jbc.M806623200; Niemann M, 2017, P NATL ACAD SCI USA, V114, pE7679, DOI 10.1073/pnas.1711430114; Olson EN, 2010, NAT REV MOL CELL BIO, V11, P353, DOI 10.1038/nrm2890; Ouameur AA, 2008, MOL BIOCHEM PARASIT, V162, P155, DOI 10.1016/j.molbiopara.2008.08.007; Panigrahi AK, 2009, PROTEOMICS, V9, P434, DOI 10.1002/pmic.200800477; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Pastor-Anglada M, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00606; Pertea Geo, 2020, F1000Res, V9, P304, DOI 10.12688/f1000research.23297.1; Pino P, 2012, CELL HOST MICROBE, V12, P824, DOI 10.1016/j.chom.2012.10.016; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Plonski NM, 2018, GENE, V656, P95, DOI 10.1016/j.gene.2018.02.063; Portman N, 2010, INT J PARASITOL, V40, P135, DOI 10.1016/j.ijpara.2009.10.005; Pusnik M, 2009, MOL BIOL EVOL, V26, P671, DOI 10.1093/molbev/msn288; Pusnik M, 2011, CURR BIOL, V21, P1738, DOI 10.1016/j.cub.2011.08.060; Pyronnet S, 2001, CURR OPIN GENET DEV, V11, P13, DOI 10.1016/S0959-437X(00)00150-7; Rajan KS, 2019, NUCLEIC ACIDS RES, V47, P7633, DOI 10.1093/nar/gkz477; Requena JM, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/301326; Saas J, 2000, J BIOL CHEM, V275, P2745, DOI 10.1074/jbc.275.4.2745; Sahasrabuddhe AA, 2004, MOL BIOCHEM PARASIT, V134, P105, DOI 10.1016/j.molbiopara.2003.11.008; Sanchez MA, 2004, MOL MEMBR BIOL, V21, P11, DOI 10.1080/0968768031000140845; Schneider A, 2000, TRENDS CELL BIOL, V10, P509, DOI 10.1016/S0962-8924(00)01854-7; Shukla D, 2018, CYTOKINE, V104, P110, DOI 10.1016/j.cyto.2017.10.005; Steinmann ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0188219; Swenerton RK, 2011, J BIOL CHEM, V286, P429, DOI 10.1074/jbc.M110.138313; Tammana TVS, 2010, J CELL SCI, V123, P1894, DOI 10.1242/jcs.068494; Tasbihi M, 2019, MICROB PATHOGENESIS, V133, DOI 10.1016/j.micpath.2019.103542; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tyson JJ, 2008, CURR BIOL, V18, pR759, DOI 10.1016/j.cub.2008.07.001; Van Hellemond JJ, 2000, J BIOL CHEM, V275, P8315, DOI 10.1074/jbc.275.12.8315; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wilkies DE, 2003, J EUKARYOT MICROBIOL, V50, P252, DOI 10.1111/j.1550-7408.2003.tb00130.x; Wilson W, 1997, GENE, V187, P201, DOI 10.1016/S0378-1119(96)00749-4; Witke W, 2004, TRENDS CELL BIOL, V14, P461, DOI 10.1016/j.tcb.2004.07.003; Witke W, 2001, P NATL ACAD SCI USA, V98, P3832, DOI 10.1073/pnas.051515498; Zhang WW, 2013, EUKARYOT CELL, V12, P70, DOI 10.1128/EC.00263-12	112	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265692	10.1371/journal.pone.0265692	http://dx.doi.org/10.1371/journal.pone.0265692			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316283	gold, Green Published			2022-12-26	WOS:000834238000034
J	Abd El-Rahman, SS; Fayed, HM				Abd El-Rahman, Sahar S.; Fayed, Hany M.			Improved cognition impairment by activating cannabinoid receptor type 2: Modulating CREB/BDNF expression and impeding TLR-4/NF kappa Bp65/M1 microglia signaling pathway in D-galactose-injected ovariectomized rats	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; CB2 RECEPTOR; ALZHEIMERS-DISEASE; INDUCED APOPTOSIS; MOUSE MODEL; AGONIST; INFLAMMATION; INDUCTION; DEFICITS; NEURONS	Alzheimer's disease (AD) is characterized by an active inflammatory response induced by the brain's deposition and accumulation of amyloid-beta (A beta). Cannabinoid receptor type 2 (CB2R) is expressed in specific brain areas, modulating functions, and pathophysiologies in CNS. Herein, we aimed to evaluate whether activation of CB2R can improve the cognitive impairment in the experimental AD-like model and determine the involved intracellular signaling pathway. Injection of D-galactose (150 mg/kg, i.p.) was performed to urge AD-like features in bilaterally ovariectomized female rats (OVC/D-gal rats) for 8-weeks. Then, AM1241, a CB2R-agonist (3 and 6 mg/kg), was injected intraperitoneally starting from the 6(th) week. Treatment with AM1241, significantly down-regulated; Toll-like receptor4 (TLR4), Myd88 (TLR4-adaptor protein) genes expression, and the pro-inflammatory cytokines (NF kappa B p65, TNF-alpha, IL-6, and IL-12). In contrast, it enhanced BDNF (the brain-derived neurotrophic factor) and CREB (the cyclic AMP response element-binding protein) as well as the immune-modulatory cytokines (IL-4 and IL-10) levels. Moreover, AM1241 lessened the immune-expression of GFAP, CD68, caspase-3, and NF kappa B p65 markers and mended the histopathological damage observed in OVC/D-gal rats by decreasing the deposition of amyloid plaques and degenerative neuronal lesions, as well as improving their recognition and learning memory in both novel object recognition and Morris water maze tests. In conclusion, activating CB2R by the selective agonist AM1241 can overrun cognitive deficits in OVC/D-gal rats through modulation of TLR4/ NF kappa B p65 signaling, mediated by modulating CREB/BDNF pathway, thereby can be applied as a potential therapeutic strategy in AD treatment.	[Abd El-Rahman, Sahar S.] Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt; [Fayed, Hany M.] Natl Res Ctr, Med Res & Clin Studies Inst, Pharmacol Dept, Giza, Egypt	Egyptian Knowledge Bank (EKB); Cairo University; Egyptian Knowledge Bank (EKB); National Research Centre (NRC)	Abd El-Rahman, SS (corresponding author), Cairo Univ, Fac Vet Med, Dept Pathol, Giza, Egypt.	saharsamirmah@cu.edu.eg	Fayed, Hany/GSJ-1008-2022	Fayed, Hany/0000-0002-3673-5733				Abd-ElRaouf A, 2021, INT J RADIAT BIOL, V97, P632, DOI 10.1080/09553002.2021.1893856; Adhikary S, 2011, J NEUROTRAUM, V28, P2417, DOI 10.1089/neu.2011.1853; Alawdi SH, 2017, MOL NEUROBIOL, V54, P1906, DOI 10.1007/s12035-016-9762-0; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Anukulthanakorn K, 2013, GEN COMP ENDOCR, V181, P316, DOI 10.1016/j.ygcen.2012.07.034; Aso E, 2013, J ALZHEIMERS DIS, V35, P847, DOI 10.3233/JAD-130137; Avraham HK, 2014, BRIT J PHARMACOL, V171, P468, DOI 10.1111/bph.12478; Aydin AF, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12939; Barutta F, 2011, DIABETES, V60, P2386, DOI 10.2337/db10-1809; BEACH TG, 1988, BRAIN RES, V463, P357, DOI 10.1016/0006-8993(88)90410-6; Benito C, 2008, BRIT J PHARMACOL, V153, P277, DOI 10.1038/sj.bjp.0707505; Benusa SD., 2020, NEUROIMMUNOLOGY NEUR, V7, P248; Bierhaus A, 2005, J MOL MED, V83, P876, DOI 10.1007/s00109-005-0688-7; Bigger JW, 1944, LANCET, V2, P497; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Calvo-Rodriguez M, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01588; Cheng CY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155748; Choi IY, 2013, AM J PATHOL, V182, P928, DOI 10.1016/j.ajpath.2012.11.024; Colucci-D'Amato L, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21207777; Concannon RM, 2015, EXP NEUROL, V269, P133, DOI 10.1016/j.expneurol.2015.04.007; DeTure MA, 2019, MOL NEURODEGENER, V14, DOI 10.1186/s13024-019-0333-5; Du YC, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3765898; Du ZD, 2015, MOL MED REP, V12, P7883, DOI 10.3892/mmr.2015.4430; Ewida FS., 2015, AL AZHAR MEDICAL J, V44, P295; Fernandez-Ruiz J, 2015, HANDB EXP PHARMACOL, V231, P233, DOI 10.1007/978-3-319-20825-1_8; Ferreira FF, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00441; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Gambuzza ME, 2014, CNS NEUROL DISORD-DR, V13, P1542, DOI 10.2174/1871527313666140806124850; Gomez-Galvez Y, 2016, PROG NEURO-PSYCHOPH, V64, P200, DOI 10.1016/j.pnpbp.2015.03.017; Gu MQ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101351; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Hua XD, 2007, LIFE SCI, V80, P1897, DOI 10.1016/j.lfs.2007.02.030; Ibrahim WW, 2016, PSYCHONEUROENDOCRINO, V74, P240, DOI 10.1016/j.psyneuen.2016.09.013; Isokawa M, 2009, NEUROSCI LETT, V457, P53, DOI 10.1016/j.neulet.2009.04.003; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jeong HJ, 2007, J NEUROSCI RES, V85, P896, DOI 10.1002/jnr.21168; Kamel AS, 2018, MOL NEUROBIOL, V55, P8188, DOI 10.1007/s12035-018-0966-3; Kemal S, 2019, J EXP MED, V216, P2451, DOI 10.1084/jem.20191536; Khajuria DK, 2012, REV BRAS REUMATOL, V52, P462; Liu WF, 2019, FOOD NUTR RES, V63, DOI 10.29219/fnr.v63.1516; Lu J, 2010, BRAIN PATHOL, V20, P598, DOI 10.1111/j.1750-3639.2009.00339.x; Martin-Moreno AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-8; Miron J, 2018, J ALZHEIMERS DIS, V63, P1547, DOI 10.3233/JAD-171160; Muhammad T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11030648; Nielsen HM, 2010, GLIA, V58, P1235, DOI 10.1002/glia.21004; Okun E, 2009, BRAIN RES REV, V59, P278, DOI 10.1016/j.brainresrev.2008.09.001; Olsen M, 2018, MOL IMAGING BIOL, V20, P605, DOI 10.1007/s11307-017-1153-z; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Pacher P, 2011, PROG LIPID RES, V50, P193, DOI 10.1016/j.plipres.2011.01.001; Paudel YN, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9020383; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Prinz M, 2019, CELL, V179, P292, DOI 10.1016/j.cell.2019.08.053; Ransohoff RM, 2016, NAT NEUROSCI, V19, P987, DOI 10.1038/nn.4338; Srikanth V, 2011, NEUROBIOL AGING, V32, P763, DOI 10.1016/j.neurobiolaging.2009.04.016; Stucky A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160585; Suvarna SK., 2013, BANCROFTS THEORY PRA, VSeventh Edition, P95; Takanishi R, 2017, PROMOTING THE EDUCATIONAL SUCCESS OF CHILDREN AND YOUTH LEARNING ENGLISH: PROMISING FUTURES, P1, DOI 10.1111/pin.12520; Tejera D, 2019, EMBO J, V38, DOI 10.15252/embj.2018101064; Velazquez R, 2019, AGING CELL, V18, DOI 10.1111/acel.13037; Viscomi MT, 2009, J NEUROSCI, V29, P4564, DOI 10.1523/JNEUROSCI.0786-09.2009; Wang HT, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00255; Wang W, 2009, LIFE SCI, V85, P127, DOI 10.1016/j.lfs.2009.05.003; Wang Y, 2013, MOL MED REP, V7, P1137, DOI 10.3892/mmr.2013.1322; Xia CF, 2020, J FUNCT FOODS, V69, DOI 10.1016/j.jff.2020.103938; Yang JL, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00724; Yang P, 2019, BMC IMMUNOL, V20, DOI 10.1186/s12865-019-0289-9; Zimbone S, 2018, AGING CELL, V17, DOI 10.1111/acel.12684	67	1	1	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265961	10.1371/journal.pone.0265961	http://dx.doi.org/10.1371/journal.pone.0265961			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349580	Green Published, gold			2022-12-26	WOS:000783906500031
J	Buades, A; Lisani, JL; Martorell, O				Buades, Antoni; Lisani, Jose Luis; Martorell, Onofre			Efficient joint noise removal and multi exposure fusion	PLOS ONE			English	Article							IMAGE FUSION; DENSE SIFT	Multi-exposure fusion (MEF) is a technique that combines different snapshots of the same scene, captured with different exposure times, into a single image. This combination process (also known as fusion) is performed in such a way that the parts with better exposure of each input image have a stronger influence. Therefore, in the result image all areas are well exposed. In this paper, we propose a new method that performs MEF and noise removal. Rather than denoising each input image individually and then fusing the obtained results, the proposed strategy jointly performs fusion and denoising in the Discrete Cosinus Transform (DCT) domain, which leads to a very efficient algorithm. The method takes advantage of spatio-temporal patch selection and collaborative 3D thresholding. Several experiments show that the obtained results are significantly superior to the existing state of the art.	[Buades, Antoni; Lisani, Jose Luis; Martorell, Onofre] Univ Illes Balears, Inst Appl Comp Community Codeand, Dept Math & Comp, Palma De Mallorca, Spain	Universitat de les Illes Balears	Martorell, O (corresponding author), Univ Illes Balears, Inst Appl Comp Community Codeand, Dept Math & Comp, Palma De Mallorca, Spain.	o.martorell@uib.cat	Martorell, Onofre/AIB-6994-2022; Lisani, Jose-Luis/K-8069-2014	Martorell, Onofre/0000-0002-9071-778X; Lisani, Jose-Luis/0000-0002-7004-2252	Ministerio de Ciencia, Innovacion y Universidades (MCIU); Agencia Estatal de Investigacion (AEI); European Regional Development Funds (ERDF) [TIN2017-85572-P]	Ministerio de Ciencia, Innovacion y Universidades (MCIU)(Spanish Government); Agencia Estatal de Investigacion (AEI); European Regional Development Funds (ERDF)(European Commission)	The authors acknowledge the Ministerio de Ciencia, Innovacion y Universidades (MCIU), the Agencia Estatal de Investigacion (AEI) and the European Regional Development Funds (ERDF) for its support to the project TIN2017-85572-P.	Ahmad A, 2016, IEEE SENS J, V16, P5123, DOI 10.1109/JSEN.2016.2556715; Akyuz AO, 2007, J VIS COMMUN IMAGE R, V18, P366, DOI 10.1016/j.jvcir.2007.04.001; An J, 2011, INT CONF ACOUST SPEE, P1565; Ancuti CO, 2017, IEEE T IMAGE PROCESS, V26, P65, DOI 10.1109/TIP.2016.2621674; Bertalmio M, 2013, IEEE T IMAGE PROCESS, V22, P712, DOI 10.1109/TIP.2012.2221730; Buades A, 2016, IEEE T IMAGE PROCESS, V25, P2573, DOI 10.1109/TIP.2016.2551639; BURT PJ, 1983, IEEE T COMMUN, V31, P532, DOI 10.1109/TCOM.1983.1095851; Cho TS, 2010, PROC CVPR IEEE, P169, DOI 10.1109/CVPR.2010.5540214; Dabov K, 2007, IEEE T IMAGE PROCESS, V16, P2080, DOI 10.1109/TIP.2007.901238; Delbracio M, 2015, IEEE T COMPUT IMAG, V1, P270, DOI 10.1109/TCI.2015.2501245; Delbracio M, 2015, IEEE T IMAGE PROCESS, V24, DOI 10.1109/TIP.2015.2442914; Gonzalez R. C., DIGITAL IMAGE PROCES, V2nd; Goshtasby AA, 2005, IMAGE VISION COMPUT, V23, P611, DOI 10.1016/j.imavis.2005.02.004; Gu B, 2012, J VIS COMMUN IMAGE R, V23, P604, DOI 10.1016/j.jvcir.2012.02.009; Hafner David, 2015, Scale Space and Variational Methods in Computer Vision. 5th International Conference, SSVM 2015. Proceedings: LNCS 9087, P425, DOI 10.1007/978-3-319-18461-6_34; Haro G, 2012, SIAM J IMAGING SCI, V5, P1055, DOI 10.1137/120873923; Hayat N, 2019, MEF SIFT SOURCE CODE; Hayat N, 2019, J VIS COMMUN IMAGE R, V62, P295, DOI 10.1016/j.jvcir.2019.06.002; He KM, 2013, IEEE T PATTERN ANAL, V35, P1397, DOI 10.1109/TPAMI.2012.213; Hessel C., 2019, EEF SOURCE CODE; Hessel C, 2019, IMAGE PROCESS ON LIN, V9, P453, DOI 10.5201/ipol.2019.278; Hu J, 2012, LECT NOTES COMPUT SC, V7572, P499, DOI 10.1007/978-3-642-33718-5_36; Hu J, 2013, PROC CVPR IEEE, P1163, DOI 10.1109/CVPR.2013.154; Kai Zeng, 2014, 2014 Sixth International Workshop on Quality of Multimedia Experience (QoMEX), P7, DOI 10.1109/QoMEX.2014.6982278; Kalantari NK, 2017, ACM T GRAPHIC, V36, DOI 10.1145/3072959.3073609; Kou F, 2018, J VIS COMMUN IMAGE R, V53, P235, DOI 10.1016/j.jvcir.2018.03.020; Kou F, 2017, IEEE INT CON MULTI, P1105, DOI 10.1109/ICME.2017.8019529; Kuk JG, 2011, INT CONF ACOUST SPEE, P1461; Laparra V, 2017, J OPT SOC AM A, V34, P1511, DOI 10.1364/JOSAA.34.001511; Lee DK., 2014, INT J COMPUTER GRAPH, V4, P1, DOI [10.5121/ijcga.2014.4401, DOI 10.5121/IJCGA.2014.4401]; Li H, 2018, CNNFEAT SOURCE CODE; Li H, 2018, IEEE IMAGE PROC, P1723, DOI 10.1109/ICIP.2018.8451689; Li ST, 2013, IEEE T IMAGE PROCESS, V22, P2864, DOI 10.1109/TIP.2013.2244222; Li ST, 2012, IEEE T CONSUM ELECTR, V58, P626, DOI 10.1109/TCE.2012.6227469; Li ZG, 2012, IEEE T IMAGE PROCESS, V21, P4672, DOI 10.1109/TIP.2012.2207396; Li ZG, 2017, IEEE T IMAGE PROCESS, V26, P1243, DOI 10.1109/TIP.2017.2651366; Li ZG, 2014, IEEE T IMAGE PROCESS, V23, P4372, DOI 10.1109/TIP.2014.2349432; Liu Y, 2015, J VIS COMMUN IMAGE R, V31, P208, DOI 10.1016/j.jvcir.2015.06.021; Ma KD, 2018, IEEE T COMPUT IMAG, V4, P60, DOI 10.1109/TCI.2017.2786138; Ma KD, 2017, IEEE T IMAGE PROCESS, V26, P2519, DOI 10.1109/TIP.2017.2671921; Ma K, 2015, IEEE T IMAGE PROCESS, V24, P3345, DOI 10.1109/TIP.2015.2442920; Ma KD, 2015, IEEE T IMAGE PROCESS, V24, P3086, DOI [10.1109/TIP.2015.2436340, 10.1109/TIP.2015.2456638]; Martorell O, 2019, SIGNAL PROCESS-IMAGE, V78, P409, DOI 10.1016/j.image.2019.07.020; Mertens T, 2009, COMPUT GRAPH FORUM, V28, P161, DOI 10.1111/j.1467-8659.2008.01171.x; Mertens T, 2007, PACIFIC GRAPHICS 2007: 15TH PACIFIC CONFERENCE ON COMPUTER GRAPHICS AND APPLICATIONS, P382, DOI 10.1109/PG.2007.17; Min TH, 2011, SIGNAL IMAGE VIDEO P, V5, P315, DOI 10.1007/s11760-010-0203-7; Ocampo-Blandon C. F., 2016, IBEROAMERICAN C PATT, P484; Paul S, 2016, J CIRCUIT SYST COMP, V25, DOI 10.1142/S0218126616501231; Perez P, 2003, ACM T GRAPHIC, V22, P313, DOI 10.1145/882262.882269; Piella G, 2009, INT J COMPUT VISION, V83, P1, DOI 10.1007/s11263-009-0206-4; Prabhakar KR, 2019, IEEE INT CONF COMPUT; Prabhakar KR, 2017, IEEE I CONF COMP VIS, P4724, DOI 10.1109/ICCV.2017.505; Prabhakar KR, 2016, INT CONF ACOUST SPEE, P1766, DOI 10.1109/ICASSP.2016.7471980; RAMAN S, 2009, P EUR, P1; Ramanath R, 2005, IEEE SIGNAL PROC MAG, V22, P34, DOI 10.1109/MSP.2005.1407713; Raskar R., 2005, ACM SIGGRAPH 2005 CO, P4; Rav-Acha A, 2005, PATTERN RECOGN LETT, V26, P311, DOI 10.1016/j.patrec.2004.10.017; Roman Steven, 2005, ADV LINEAR ALGEBRA; Sie WR, 2014, IEEE IMAGE PROC, P1802, DOI 10.1109/ICIP.2014.7025361; Singh H, 2014, SCI WORLD J, DOI 10.1155/2014/659217; Sun J, 2013, INFORM FUSION, V14, P241, DOI 10.1016/j.inffus.2012.07.003; Tico M, 2010, IEEE IMAGE PROC, P3321, DOI 10.1109/ICIP.2010.5651532; Tomasi C, 1998, SIXTH INTERNATIONAL CONFERENCE ON COMPUTER VISION, P839, DOI 10.1109/ICCV.1998.710815; Wu SZ, 2018, LECT NOTES COMPUT SC, V11206, P120, DOI 10.1007/978-3-030-01216-8_8; Xu H, 2020, FUSIONDN SOURCE CODE; Xu H, 2020, AAAI CONF ARTIF INTE, V34, P12484; Xu H, 2022, IEEE T PATTERN ANAL, V44, P502, DOI 10.1109/TPAMI.2020.3012548; Xu H, 2020, IEEE T IMAGE PROCESS, V29, P7203, DOI 10.1109/TIP.2020.2999855; Yu GS, 2011, IMAGE PROCESS ON LIN, V1, P292, DOI 10.5201/ipol.2011.ys-dct; Zhang H, 2020, AAAI CONF ARTIF INTE, V34, P12797; Zhang W, 2017, INFORM SCIENCES, V415, P19, DOI 10.1016/j.ins.2017.05.019; Zhang W, 2017, INFORM SCIENCES, V376, P190, DOI 10.1016/j.ins.2016.10.020; Zhang W, 2012, IEEE T IMAGE PROCESS, V21, P2318, DOI 10.1109/TIP.2011.2170079; Zhang Y, 2019, IFCNN SOURCE CODE; Zhang Y, 2020, INFORM FUSION, V54, P99, DOI 10.1016/j.inffus.2019.07.011; Zheng JH, 2015, IEEE IMAGE PROC, P4516, DOI 10.1109/ICIP.2015.7351661; Zheng MY, 2020, IEEE SENS J, V20, P8062, DOI 10.1109/JSEN.2020.2981719; Zhu ZQ, 2021, IEEE T INSTRUM MEAS, V70, DOI 10.1109/TIM.2020.3024335	78	0	0	5	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265464	10.1371/journal.pone.0265464	http://dx.doi.org/10.1371/journal.pone.0265464			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333884	Green Submitted, gold, Green Published			2022-12-26	WOS:000784335700025
J	Hsiao, C; Lin, HH; Kang, SR; Hung, CY; Sun, PY; Yu, CC; Toh, KL; Yu, PJ; Ju, YT				Hsiao, Chen; Lin, Hsin-Hung; Kang, Shann-Ren; Hung, Chien-Yi; Sun, Pei-Yu; Yu, Chieh-Cheng; Toh, Kok-Lin; Yu, Pei-Ju; Ju, Yu-Ten			Development of 16 novel EST-SSR markers for species identification and cross-genus amplification in sambar, sika, and red deer	PLOS ONE			English	Article							MICROSATELLITE MARKERS; MITOCHONDRIAL-DNA; CERVUS-NIPPON; VELVET ANTLER; C-ELAPHUS; TRANSCRIPTOME; SOFTWARE; CERVIDAE; INTROGRESSION; HYBRIDIZATION	Deer genera around the globe are threatened by anthropogenic interference. The translocation of alien species and their subsequent genetic introgression into indigenous deer populations is particularly harmful to the species of greatest conservation concern. Products derived from deer, including venison and antler velvet, are also at risk of fraudulent labeling. The current molecular markers used to genetically identify deer species were developed from genome sequences and have limited applicability for cross-species amplification. The absence of efficacious diagnostic techniques for identifying deer species has hampered conservation and wildlife crime investigation efforts. Expressed sequence tag-simple sequence repeat (EST-SSR) markers are reliable tools for individual and species identification, especially in terms of cross-species genotyping. We conducted transcriptome sequencing of sambar (Rusa unicolor) antler velvet and acquired 11,190 EST-SSRs from 65,074 newly assembled unigenes. We identified a total of 55 unambiguous amplicons in sambar (n = 45), which were selected as markers to evaluate cross-species genotyping in sika deer (Cervus nippon, n = 30) and red deer (Cervus elaphus, n = 46), resulting in cross-species amplification rates of 94.5% and 89.1%, respectively. Based on polymorphic information content (>0.25) and genotyping fidelity, we selected 16 of these EST-SSRs for species identification. This marker set revealed significant genetic differentiation based on the fixation index and genetic distance values. Principal coordinate analysis and STRUCTURE analysis revealed distinct clusters of species and clearly identified red-sika hybrids. These markers showed applicability across different genera and proved suitable for identification and phylogenetic analyses across deer species.	[Hsiao, Chen; Hung, Chien-Yi; Sun, Pei-Yu; Yu, Chieh-Cheng; Toh, Kok-Lin; Yu, Pei-Ju; Ju, Yu-Ten] Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan; [Lin, Hsin-Hung; Kang, Shann-Ren] Kaohsiung Anim Propagat Stn, Pingdong, Taiwan	National Taiwan University	Ju, YT (corresponding author), Natl Taiwan Univ, Dept Anim Sci & Technol, Taipei, Taiwan.	ytju@ntu.edu.tw		Hsiao, Chen/0000-0002-6360-2215	Ministry of Science and Technology, Taiwan [102-2313-B-002-024-MY3, 108-2313-B-002-013, 109-2313-B- 002-005-, 110-2313-B-002-053-]; Kenting National Park headquarters [489-103-01]	Ministry of Science and Technology, Taiwan(Ministry of Science and Technology, Taiwan); Kenting National Park headquarters	The research is funded by the Ministry of Science and Technology, Taiwan (102-2313-B- 002-024-MY3,108-2313-B-002-013-,109-2313- B-002-005-, 110-2313-B-002-053-) and Kenting National Park headquarters (489-103-01) to Dr. Yu-Ten Ju. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asher GW, 2005, ANIM REPROD SCI, V90, P287, DOI 10.1016/j.anireprosci.2005.01.020; Ba HX, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5560-1; Ba HX, 2018, G3-GENES GENOM GENET, V8, P2173, DOI 10.1534/g3.118.200417; Barbara T, 2007, MOL ECOL, V16, P3759, DOI 10.1111/j.1365-294X.2007.03439.x; Belkhir K, 2004, GENETIX 4 05; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Cao SM, 2018, GENE, V658, P54, DOI 10.1016/j.gene.2018.03.019; Chen C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221040; Costa Vania, 2012, BMC Res Notes, V5, P479, DOI 10.1186/1756-0500-5-479; Dawson DA, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-176; Dawson DA, 2010, MOL ECOL RESOUR, V10, P475, DOI 10.1111/j.1755-0998.2009.02775.x; Deng TX, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147132; Dieringer D, 2003, MOL ECOL NOTES, V3, P167, DOI 10.1046/j.1471-8286.2003.00351.x; Fernandez ME, 2013, GENET MOL BIOL, V36, P185, DOI 10.1590/S1415-47572013000200008; Gilbert C, 2006, MOL PHYLOGENET EVOL, V40, P101, DOI 10.1016/j.ympev.2006.02.017; Guo XH, 2019, J PHARMACEUT BIOMED, V165, P18, DOI 10.1016/j.jpba.2018.10.009; Harris RB, 2015, IUCN RED LIST THREAT, DOI [DOI 10.2305/IUCN.UK.2015-2.RLTS.T41788A22155877.EN, 10.2305/IUCN.UK.2015-2.RLTS.T41788A22155877.en]; Herrero-Medrano JM, 2013, ANIM GENET, V44, P259, DOI 10.1111/age.12001; Hoffmann GS, 2015, MOL BIOL REP, V42, P1059, DOI 10.1007/s11033-014-3845-7; Hu PF, 2019, MOL GENET GENOMICS, V294, P431, DOI 10.1007/s00438-018-1520-8; Oklander LI, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185867; Ito H, 2015, SCI REP-UK, V5, DOI 10.1038/srep13171; Jia BY, 2020, HEREDITAS, V157, DOI 10.1186/s41065-020-00137-x; Jiang C, 2018, MITOCHONDRIAL DNA A, V29, P266, DOI 10.1080/24701394.2016.1275599; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Kaltenbrunner M, 2018, FOOD CHEM, V269, P486, DOI 10.1016/j.foodchem.2018.07.023; Kaltenbrunner M, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25299-7; Khimoun A, 2017, MOL ECOL RESOUR, V17, P893, DOI 10.1111/1755-0998.12642; Kim YH, 2012, J ANIM SCI, V90, P2075, DOI 10.2527/jas.2011-4421; Koressaar T, 2007, BIOINFORMATICS, V23, P1289, DOI 10.1093/bioinformatics/btm091; Krutzen M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0189200; Lovari S., IUCN RED LIST THREAT, DOI [10.2305/IUCN.UK.2018-2.RLTS.T55997072A142404453.en, DOI 10.2305/IUCN.UK.2018-2.RLTS.T55997072A142404453.EN]; Maduna SN, 2017, ECOL EVOL, V7, P1462, DOI 10.1002/ece3.2770; Maduna Simo N., 2014, BMC Research Notes, V7, P352, DOI 10.1186/1756-0500-7-352; Matos ELS, 2013, ANN APPL BIOL, V163, P298, DOI 10.1111/aab.12053; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mitrus J, 2013, ANN ZOOL, V63, P517, DOI 10.3161/000345413X676731; Muir PD, 1997, J HERED, V88, P366, DOI 10.1093/oxfordjournals.jhered.a023120; Ndiaye NP, 2015, VET WORLD, V8, P994, DOI 10.14202/vetworld.2015.994-1005; Ni Zhouxian, 2018, J Genet, V97, pe53; Nie QH, 2011, DNA RES, V18, P343, DOI 10.1093/dnares/dsr021; Pashley CH, 2006, J HERED, V97, P381, DOI 10.1093/jhered/esl013; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Primmer CR, 2005, J AVIAN BIOL, V36, P348; Pritchard JK, 2000, GENETICS, V155, P945; Prothero D.R., 2007, EVOLUTION ARTIODACTY; Ross CT, 2014, AM J PRIMATOL, V76, P313, DOI 10.1002/ajp.22235; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Russell T, 2019, G3-GENES GENOM GENET, V9, P911, DOI 10.1534/g3.118.200838; Senn HV, 2009, MOL ECOL, V18, P862, DOI 10.1111/j.1365-294X.2008.04051.x; Smith SL, 2018, ECOL EVOL, V8, P2122, DOI 10.1002/ece3.3767; Song XH, 2016, J HERED, V107, P423, DOI 10.1093/jhered/esw024; Sorkheh K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06084-4; Takatsuki Seiki, 2009, P365, DOI 10.1007/978-4-431-09429-6_26; Tardy C, 2020, MOL BIOL REP, V47, P6983, DOI 10.1007/s11033-020-05757-0; Thiel T, 2003, THEOR APPL GENET, V106, P411, DOI 10.1007/s00122-002-1031-0; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Yan QL, 2008, J GENET GENOMICS, V35, P261, DOI 10.1016/S1673-8527(08)60037-5; Zeng LL, 2019, ANIM BIOTECHNOL, V30, P95, DOI 10.1080/10495398.2017.1416392	62	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265311	10.1371/journal.pone.0265311	http://dx.doi.org/10.1371/journal.pone.0265311			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363791	Green Published, gold			2022-12-26	WOS:000804748600042
J	Mohler, F; Fadillioglu, C; Stein, T				Moehler, Felix; Fadillioglu, Cagla; Stein, Thorsten			Changes in spatiotemporal parameters, joint and CoM kinematics and leg stiffness in novice runners during a high-intensity fatigue protocol	PLOS ONE			English	Article							RUNNING-INDUCED FATIGUE; LOWER-EXTREMITY; MOVEMENT VARIABILITY; INJURIES; MECHANISMS; ENDURANCE; FORCE; MODEL; COST	Even though running enjoys growing popularity, the effects of fatigue on the running kinematics of novices have rarely been studied. This is surprising, given the risk of running-related injuries when detrimental movement patterns are adopted. Therefore, the goal of the present study was to characterize the effects of fatigue induced by a high-intensity running protocol on spatiotemporal and stiffness parameters as well as on joint kinematics and center of mass (CoM) motion in novice runners. 14 participants performed a standardized treadmill familiarization and ran at 13 km/h until voluntary exhaustion. Kinematics were captured using a 3D motion capture system. Spatiotemporal and stiffness parameters as well as the range of motion (RoM) of the joints and CoM were compared by use of paired t-tests. Time series of the joint angles and CoM motion were analyzed by the statistical parametric mapping method. The results revealed that novice runners did not change spatiotemporal or stiffness parameters, but showed adaptations in joint kinematics, e.g. decreased dorsiflexion and increased pronation in the ankle joint during the swing phase. The findings of this study underline the importance of strengthening the ankle joint to prevent excessive pronation and increase its stability in novice runners.	[Moehler, Felix; Fadillioglu, Cagla; Stein, Thorsten] Karlsruhe Inst Technol, Inst Sports & Sports Sci IfSS, BioMot Ctr, Karlsruhe, Germany	Helmholtz Association; Karlsruhe Institute of Technology	Mohler, F (corresponding author), Karlsruhe Inst Technol, Inst Sports & Sports Sci IfSS, BioMot Ctr, Karlsruhe, Germany.	felix.moehler@kit.edu	Fadillioglu, Cagla/AGB-3528-2022	Fadillioglu, Cagla/0000-0003-4283-281X; Mohler, Felix/0000-0002-2082-4811				Apte S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.646042; Baida SR, 2018, SCAND J MED SCI SPOR, V28, P1320, DOI 10.1111/sms.13036; Bartlett JD, 2011, J SPORT SCI, V29, P547, DOI 10.1080/02640414.2010.545427; BLICKHAN R, 1989, J BIOMECH, V22, P1217, DOI 10.1016/0021-9290(89)90224-8; BORG GAV, 1982, MED SCI SPORT EXER, V14, P377, DOI 10.1249/00005768-198205000-00012; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Dutto DJ, 2002, MED SCI SPORT EXER, V34, P1324, DOI 10.1097/00005768-200208000-00014; Ferber R, 2003, CLIN BIOMECH, V18, P350, DOI 10.1016/S0268-0033(03)00025-1; Ferber R, 2009, SPORTS HEALTH, V1, P242, DOI 10.1177/1941738109334272; Gao ZX, 2020, SYMMETRY-BASEL, V12, DOI 10.3390/sym12050720; Garcia-Pinillos F, 2020, GAIT POSTURE, V76, P259, DOI 10.1016/j.gaitpost.2019.12.018; Garcia-Pinillos F, 2019, J SPORT HEALTH SCI, V8, P442, DOI 10.1016/j.jshs.2016.11.003; Garcia-Pinillos F, 2017, J SPORT HEALTH SCI, V6, P54, DOI 10.1016/j.jshs.2016.08.010; Hartel T., 2006, J BIOMECH, V39, P549, DOI [10.1016/S0021-9290(06)85262-0, DOI 10.1016/S0021-9290(06)85262-0]; Helgerud J, 2007, MED SCI SPORT EXER, V39, P665, DOI 10.1249/mss.0b013e3180304570; HINRICHS RN, 1987, INT J SPORT BIOMECH, V3, P242, DOI 10.1123/ijsb.3.3.242; Jones AM, 1996, J SPORT SCI, V14, P321, DOI 10.1080/02640419608727717; Kemler E, 2018, PHYSICIAN SPORTSMED, V46, P485, DOI 10.1080/00913847.2018.1507410; Koblbauer IF, 2014, J SCI MED SPORT, V17, P419, DOI 10.1016/j.jsams.2013.05.013; Lavcanska V, 2005, HUM MOVEMENT SCI, V24, P544, DOI 10.1016/j.humov.2005.08.001; Leitch J, 2011, GAIT POSTURE, V33, P130, DOI 10.1016/j.gaitpost.2010.06.009; Lieberman DE, 2015, J EXP BIOL, V218, P3406, DOI 10.1242/jeb.125500; Maas E, 2018, SPORT BIOMECH, V17, P350, DOI 10.1080/14763141.2017.1347193; MANN RA, 1986, AM J SPORT MED, V14, P501, DOI 10.1177/036354658601400614; Matsas A, 2000, GAIT POSTURE, V11, P46, DOI 10.1016/S0966-6362(99)00048-X; Maurer C, 2013, PHYSIOL REP, V1, DOI 10.1002/phy2.49; Mizrahi J, 2000, ANN BIOMED ENG, V28, P463, DOI 10.1114/1.284; Mo SW, 2018, GAIT POSTURE, V64, P7, DOI 10.1016/j.gaitpost.2018.05.021; Moehler F, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.634258; Mohler F, 2019, HUM MOVEMENT SCI, V66, P133, DOI 10.1016/j.humov.2019.03.016; Mohler Felix, 2021, Front Sports Act Living, V3, P634258, DOI 10.3389/fspor.2021.634258; Moore IS, 2016, SPORTS MED, V46, P793, DOI 10.1007/s40279-016-0474-4; Moore IS, 2012, MED SCI SPORT EXER, V44, P1756, DOI 10.1249/MSS.0b013e318255a727; Morin JB, 2005, J APPL BIOMECH, V21, P167, DOI 10.1123/jab.21.2.167; Novacheck TF, 1998, GAIT POSTURE, V7, P77, DOI 10.1016/S0966-6362(97)00038-6; Pappas P, 2015, HUM MOVEMENT SCI, V40, P273, DOI 10.1016/j.humov.2015.01.005; Pataky TC, 2013, J BIOMECH, V46, P2394, DOI 10.1016/j.jbiomech.2013.07.031; Preatoni E, 2013, SPORT BIOMECH, V12, P69, DOI 10.1080/14763141.2012.738700; Quan WJ, 2021, FRONT BIOENG BIOTECH, V9, DOI 10.3389/fbioe.2021.746761; Schmitz A, 2014, GAIT POSTURE, V40, P82, DOI 10.1016/j.gaitpost.2014.02.014; Schutte KH, 2018, GAIT POSTURE, V59, P222, DOI 10.1016/j.gaitpost.2017.10.021; Strohrmann C, 2012, IEEE T INF TECHNOL B, V16, P983, DOI 10.1109/TITB.2012.2201950; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; van Oeveren BT, 2021, SPORT BIOMECH, DOI 10.1080/14763141.2021.1873411; Videbaek S, 2015, SPORTS MED, V45, P1017, DOI 10.1007/s40279-015-0333-8; Yu PM, 2021, TECHNOL HEALTH CARE, V29, P231, DOI 10.3233/THC-202195	47	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265550	10.1371/journal.pone.0265550	http://dx.doi.org/10.1371/journal.pone.0265550			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363776	Green Published, gold			2022-12-26	WOS:000804748600033
J	Powell, AC; Goldstein, JP; Long, JW; Simmons, JD; DeFrance, A				Powell, Adam C.; Goldstein, Jason P.; Long, James W.; Simmons, Jeffrey D.; DeFrance, Anthony			The association between provider characteristics and post-catheterization interventions	PLOS ONE			English	Article							FRACTIONAL FLOW RESERVE; PERCUTANEOUS CORONARY INTERVENTION; CARDIOVASCULAR ANGIOGRAPHY; AMERICAN-COLLEGE; MEDICAL THERAPY; ARTERY-DISEASE; FOLLOW-UP; CARE; SOCIETY; PERFORMANCE	ObjectivesTo examine whether the demographics of providers' prior year patient cohorts, providers' historic degree of catheter-based fractional flow reserve (FFR) utilization, and other provider characteristics were associated with post-catheterization performance of percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). Study designA retrospective, observational analysis of outpatient claims data was performed. MethodsAll 2018 outpatient catheterization claims from a national organization offering commercial and Medicare Advantage health plans were examined. Claims were excluded if the patient had a prior catheterization in 2018, had any indications of CABG or valvular heart disease in the prior year of claims, or if the provider had <= 10 catheterization claims in 2017. Downstream PCI and CABG were determined by examining claims 0-30 days post-catheterization. Using multivariate mixed effects logistic regression with provider identity random effects, the association between post-catheterization procedures and provider characteristics was assessed, controlling for patient characteristics. ResultsThe sample consisted of 31,920 catheterization claims pertaining to procedures performed by 964 providers. Among the catheterization claims, 8,554 (26.8%) were followed by PCI and 1,779 (5.6%) were followed by CABG. Catheterizations performed by providers with older prior year patient cohorts were associated with higher adjusted odds of PCI (1.78; CI: 1.26-2.53), even after controlling for patient age. Catheterizations performed by providers with greater historic use of FFR had significantly higher adjusted odds of being followed by PCI (1.73; CI: 1.26-2.37). ConclusionProvider characteristics may impact whether patients receive a procedure post-catheterization. Further research is needed to characterize this relationship.	[Powell, Adam C.; Goldstein, Jason P.; DeFrance, Anthony] HealthHelp, Houston, TX 77060 USA; [Long, James W.; Simmons, Jeffrey D.] Humana Inc, Louisville, KY USA	Humana Inc.	Powell, AC (corresponding author), HealthHelp, Houston, TX 77060 USA.	powellad@healthhelp.com		Powell, Adam/0000-0001-6519-3120				Ahn JM, 2017, CIRCULATION, V135, P2241, DOI 10.1161/CIRCULATIONAHA.116.024433; Bailey SR, 2013, J AM BOARD FAM MED, V26, P669, DOI 10.3122/jabfm.2013.06.130018; cdc, ADULT OBESITY PREVAL; census, S1903 US CENS BUR; cms, DME RURAL ZIP AND FO; Cutler D, 2019, AM ECON J-ECON POLIC, V11, P192, DOI 10.1257/pol.20150421; De Maria GL, 2020, CIRC-CARDIOVASC INTE, V13, DOI 10.1161/CIRCINTERVENTIONS.119.008487; Fihn SD, 2014, J AM COLL CARDIOL, V64, P1929, DOI 10.1016/j.jacc.2014.07.017; Hachamovitch R, 2003, CIRCULATION, V107, P2900, DOI 10.1161/01.CIR.0000072790.23090.41; Hannawi B, 2014, TEX HEART I J, V41, P579, DOI 10.14503/THIJ-13-3917; Hong CS, 2010, JAMA-J AM MED ASSOC, V304, P1107, DOI 10.1001/jama.2010.1287; Kralewski J, 2015, HEALTH SERV RES, V50, P710, DOI 10.1111/1475-6773.12242; Levine GN, 2011, CIRCULATION, V124, pE574, DOI 10.1161/CIR.0b013e31823ba622; Lotfi A, 2014, CATHETER CARDIO INTE, V83, P509, DOI 10.1002/ccd.25222; Montalescot G, 2018, J AM COLL CARDIOL, V72, P2744, DOI 10.1016/j.jacc.2018.09.036; Pijls NHJ, 1996, NEW ENGL J MED, V334, P1703, DOI 10.1056/NEJM199606273342604; Pijls NHJ, 2007, J AM COLL CARDIOL, V49, P2105, DOI 10.1016/j.jacc.2007.01.087; Qaseem A, 2012, ANN INTERN MED, V157, P735, DOI 10.7326/0003-4819-157-10-201211200-00011; Thuesen AL, 2018, J AM COLL CARDIOL, V72, P2732, DOI 10.1016/j.jacc.2018.09.043; Westert GP, 2018, INT J QUAL HEALTH C, V30, P731, DOI 10.1093/intqhc/mzy092; Writing Committee Members, 2022, J Am Coll Cardiol, V79, pe21, DOI 10.1016/j.jacc.2021.09.006; Zimmermann FM, 2019, EUR HEART J, V40, P180, DOI 10.1093/eurheartj/ehy812; Zimmermann FM, 2015, EUR HEART J, V36, P3182, DOI 10.1093/eurheartj/ehv452	23	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266544	10.1371/journal.pone.0266544	http://dx.doi.org/10.1371/journal.pone.0266544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363833	gold, Green Published			2022-12-26	WOS:000804748600006
J	Price, CL; Warrilow, AGS; Rolley, NJ; Parker, JE; Thoss, V; Kelly, DE; Corcionivoschi, N; Kelly, SL				Price, Claire L.; Warrilow, Andrew G. S.; Rolley, Nicola J.; Parker, Josie E.; Thoss, Vera; Kelly, Diane E.; Corcionivoschi, Nicolae; Kelly, Steven L.			Cytochrome P450 168A1 from Pseudomonas aeruginosa is involved in the hydroxylation of biologically relevant fatty acids	PLOS ONE			English	Article							AZOLE-BINDING-PROPERTIES; 20-HYDROXYEICOSATETRAENOIC ACID; STEROL 14-ALPHA-DEMETHYLASE; EXPRESSION; OXIDATION; CYP51; MONOOXYGENASES; PURIFICATION; SUBSTRATE; PROTEIN	The cytochrome P450 CYP168A1 from Pseudomonas aeruginosa was cloned and expressed in Escherichia coli followed by purification and characterization of function. CYP168A1 is a fatty acid hydroxylase that hydroxylates saturated fatty acids, including myristic (0.30 min(-1)), palmitic (1.61 min(-1)) and stearic acids (1.24 min(-1)), at both the omega-1- and omega-2-positions. However, CYP168A1 only hydroxylates unsaturated fatty acids, including palmitoleic (0.38 min(-1)), oleic (1.28 min(-1)) and linoleic acids (0.35 min(-1)), at the omega-1-position. CYP168A1 exhibited a catalytic preference for palmitic, oleic and stearic acids as substrates in keeping with the phosphatidylcholine-rich environment deep in the lung that is colonized by P. aeruginosa.	[Price, Claire L.; Warrilow, Andrew G. S.; Rolley, Nicola J.; Parker, Josie E.; Kelly, Diane E.; Kelly, Steven L.] Swansea Univ, Med Sch, Ctr Cytochrome P450 Biodivers, Inst Life Sci, Swansea, W Glam, Wales; [Thoss, Vera] Bangor Univ, Sch Chem, Plant Chem Grp, Bangor, Gwynedd, Wales; [Corcionivoschi, Nicolae] Agrifood & Biosci Inst, Vet Sci Div, Bacteriol Branch, Stoney Rd, Belfast, Antrim, North Ireland; [Corcionivoschi, Nicolae] Banat Univ Agr Sci & Vet Med, Fac Bioengn Anim Resources, King Michael I Romania, Timisoara, Romania	Swansea University; Bangor University; Agri-Food & Biosciences Institute; Banat University of Agricultural Sciences & Veterinary Medicine	Kelly, SL (corresponding author), Swansea Univ, Med Sch, Ctr Cytochrome P450 Biodivers, Inst Life Sci, Swansea, W Glam, Wales.	s.l.kelly@swansea.ac.uk		Parker, Josie/0000-0002-3855-4194; Price, Claire/0000-0002-6045-4835				Bellamine A, 1999, P NATL ACAD SCI USA, V96, P8937, DOI 10.1073/pnas.96.16.8937; Bhattarai S, 2013, ARCH BIOCHEM BIOPHYS, V539, P63, DOI 10.1016/j.abb.2013.09.008; Capdevila JH, 1996, J BIOL CHEM, V271, P22663, DOI 10.1074/jbc.271.37.22663; Capyk JK, 2009, J BIOL CHEM, V284, P35534, DOI 10.1074/jbc.M109.072132; Chun YJ, 2007, J BIOL CHEM, V282, P17486, DOI 10.1074/jbc.M700863200; Copeland RA, 2013, EVALUATION OF ENZYME INHIBITORS IN DRUG DISCOVERY: A GUIDE FOR MEDICINAL CHEMISTS AND PHARMACOLOGISTS, 2ND EDITION, P1, DOI 10.1002/9781118540398; Correia MA., 2005, CYTOCHROMES P450 STR, Vthird, P619; Cryle MJ, 2008, P NATL ACAD SCI USA, V105, P15696, DOI 10.1073/pnas.0805983105; Cryle MJ, 2003, ORG LETT, V5, P3341, DOI 10.1021/ol035254e; Dierks EA, 1998, BIOCHEMISTRY-US, V37, P1839, DOI 10.1021/bi972458s; Eschenfeldt WH, 2003, APPL ENVIRON MICROB, V69, P5992, DOI 10.1128/AEM.69.10.5992-5999.2003; Estabrook RW., 1972, METHODS PHARM, Vvol 2, P303; Green AJ, 2001, J BIOL INORG CHEM, V6, P523, DOI 10.1007/s007750100229; Gustafsson MCU, 2004, BIOCHEMISTRY-US, V43, P5474, DOI 10.1021/bi035904m; Hargrove TY, 2011, J BIOL CHEM, V286, P26838, DOI 10.1074/jbc.M111.237099; Harmon SD, 2006, PROSTAG LEUKOTR ESS, V75, P169, DOI 10.1016/j.plefa.2006.05.005; Hoch U, 2001, J BIOL CHEM, V276, P11339, DOI 10.1074/jbc.M009969200; Huang FC, 2014, APPL ENVIRON MICROB, V80, P766, DOI 10.1128/AEM.02886-13; Jefcoate C R, 1978, Methods Enzymol, V52, P258; Johnston JB, 2009, P NATL ACAD SCI USA, V106, P20687, DOI 10.1073/pnas.0907398106; Kang Y, 2008, MICROBIOL-SGM, V154, P1584, DOI 10.1099/mic.0.2008/018135-0; Khatri Y, 2015, FEBS J, V282, P74, DOI 10.1111/febs.13104; Kim D, 2007, ARCH BIOCHEM BIOPHYS, V464, P213, DOI 10.1016/j.abb.2007.02.032; Kitazume T, 2000, J BIOL CHEM, V275, P39734, DOI 10.1074/jbc.M005617200; KUNDU RK, 1993, J LIPID RES, V34, P1187; Lamb DC, 1999, BIOCHEMISTRY-US, V38, P8733, DOI 10.1021/bi9825089; Lamb DC, 2002, J BIOL CHEM, V277, P24000, DOI 10.1074/jbc.M111109200; Lasker JM, 2000, J BIOL CHEM, V275, P4118, DOI 10.1074/jbc.275.6.4118; Lepesheva GI, 2003, BIOCHEMISTRY-US, V42, P9091, DOI 10.1021/bi034663f; Lim YR, 2010, J MICROBIOL BIOTECHN, V20, P574, DOI 10.4014/jmb.0909.09007; Locuson CW, 2007, DRUG METAB DISPOS, V35, P614, DOI 10.1124/dmd.106.012609; Luthra A, 2011, ARCH BIOCHEM BIOPHYS, V507, P26, DOI 10.1016/j.abb.2010.12.008; Lutz JD, 2009, BIOCHEM PHARMACOL, V77, P258, DOI 10.1016/j.bcp.2008.10.012; Lyczak JB, 2002, CLIN MICROBIOL REV, V15, P194, DOI 10.1128/CMR.15.2.194-222.2002; Malca SH, 2012, CHEM COMMUN, V48, P5115, DOI 10.1039/c2cc18103g; Matsunaga I, 2000, LIPIDS, V35, P365, DOI 10.1007/s11745-000-533-y; Nakano M, 2009, DRUG METAB DISPOS, V37, P2119, DOI 10.1124/dmd.109.028530; OMURA T, 1964, J BIOL CHEM, V239, P2370; Parker JE, 2011, APPL ENVIRON MICROB, V77, P1460, DOI 10.1128/AEM.01332-10; Parsons JB, 2012, J BACTERIOL, V194, P5294, DOI 10.1128/JB.00743-12; Pinot F, 2011, FEBS J, V278, P195, DOI 10.1111/j.1742-4658.2010.07948.x; Scheller U, 1998, J BIOL CHEM, V273, P32528, DOI 10.1074/jbc.273.49.32528; Schenkman John B, 2006, Methods Mol Biol, V320, P11; SCOPES RK, 1974, ANAL BIOCHEM, V59, P277, DOI 10.1016/0003-2697(74)90034-7; Scott EE, 2017, J BIOL CHEM, V292, P5622, DOI 10.1074/jbc.H117.775494; SLIGAR SG, 1976, BIOCHEMISTRY-US, V15, P5399, DOI 10.1021/bi00669a029; Son MS, 2007, INFECT IMMUN, V75, P5313, DOI 10.1128/IAI.01807-06; SONESSON A, 1993, FEMS MICROBIOL LETT, V106, P315, DOI 10.1016/0378-1097(93)90421-W; Sun ZX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103778; Tang ZM, 2010, ARCH BIOCHEM BIOPHYS, V494, P86, DOI 10.1016/j.abb.2009.11.017; Tooker BC, 2021, PSEUDOMONAS AERUGINO, DOI [10.1101/2021.10.19.465045v1, DOI 10.1101/2021.10.19.465045V1]; Urlacher VB, 2006, TRENDS BIOTECHNOL, V24, P324, DOI 10.1016/j.tibtech.2006.05.002; Van Bogaert INA, 2011, FEBS J, V278, P206, DOI 10.1111/j.1742-4658.2010.07949.x; Warrilow AG, 2013, ANTIMICROB AGENTS CH, V57, P1352, DOI 10.1128/AAC.02067-12; Warrilow AGS, 2016, ANTIMICROB AGENTS CH, V60, P4530, DOI 10.1128/AAC.00349-16; Warrilow AGS, 2016, SCI REP-UK, V6, DOI 10.1038/srep27690; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4235, DOI 10.1128/AAC.00587-10; Warrilow AGS, 2010, ANTIMICROB AGENTS CH, V54, P4225, DOI 10.1128/AAC.00316-10; Warrilow AGS, 2009, ANTIMICROB AGENTS CH, V53, P1157, DOI 10.1128/AAC.01237-08; Whitehouse CJC, 2012, CHEM SOC REV, V41, P1218, DOI 10.1039/c1cs15192d; Williams C, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11115152	61	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265227	10.1371/journal.pone.0265227	http://dx.doi.org/10.1371/journal.pone.0265227			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312722	gold, Green Published			2022-12-26	WOS:000803647900046
J	Tangmonkongvoragul, C; Chokesuwattanaskul, S; Khankaeo, C; Punyasevee, R; Nakkara, L; Moolsan, S; Unruan, O				Tangmonkongvoragul, Chulaluck; Chokesuwattanaskul, Susama; Khankaeo, Chetupon; Punyasevee, Ruethairat; Nakkara, Lapat; Moolsan, Suttipat; Unruan, Onpreeya			Prevalence of symptomatic dry eye disease with associated risk factors among medical students at Chiang Mai University due to increased screen time and stress during COVID-19 pandemic	PLOS ONE			English	Article							MEIBOMIAN GLAND DYSFUNCTION; LIPID LAYER THICKNESS; TEAR FILM; DEFINITION; DEPRESSION; USERS	Dry eye disease (DED) is one of the most common ophthalmological disorders, resulting from several systemic and ocular etiologies including meibomian gland dysfunction (MGD). During the COVID-19 pandemic, medical students are among the high-risk group for DED, mainly due to the increasing use of a visual display terminal (VDT) for online lectures and psychological stress from encountering several changes. Our study aimed to explore the prevalence of DED using the symptom-based definition and potential risk factors in medical students. This is a prospective cross-sectional study that included medical students at Chiang Mai University between November 2020 and January 2021. All participants were assessed using the Ocular Surface Disease Index (OSDI) questionnaire, the Thai version of the 10-Item Perceived Stress Scale-10 (T-PSS-10), the LipiView (R) II interferometer, and an interview for other possible risk factors. Overall, 528 participants were included in the study; half of the participants were female. The prevalence of DED was 70.8%. In the univariate analysis, female sex, contact lens wear, and T-PSS-10 stress scores were significantly higher in the DED group (P = 0.002, 0.002, and <0.001, respectively). Moreover, participants with severe DED were likely to have higher meibomian gland tortuosity but not statistically significant. In the multivariate analysis, contact lens use and T-PSS-10 score were significant risk factors associated with the severity of DED. In conclusions, the prevalence of DED in medical students was as high as 70.8%. Contact lens use and psychological stress evaluated using the T-PSS-10 questionnaire had a significant correlation with a risk of DED. Female gender and duration of VDT use were also associated. Most of the risk factors were modifiable and may be used as initial management in patients with DED.	[Tangmonkongvoragul, Chulaluck; Chokesuwattanaskul, Susama] Chiang Mai Univ, Dept Ophthalmol, Facultyof Med, Chiang Mai, Thailand; [Khankaeo, Chetupon; Punyasevee, Ruethairat; Nakkara, Lapat; Moolsan, Suttipat; Unruan, Onpreeya] Chiang Mai Univ, Fac Med, ChiangMai, Chiang Mai, Thailand	Chiang Mai University; Chiang Mai University	Tangmonkongvoragul, C (corresponding author), Chiang Mai Univ, Dept Ophthalmol, Facultyof Med, Chiang Mai, Thailand.	chulaluck.t@cmu.ac.th		Tangmonkongvoragul, Chulaluck/0000-0003-2254-2532	Faculty of medicine, Chiang Mai University, Chiang Mai, Thailand [043/2564]	Faculty of medicine, Chiang Mai University, Chiang Mai, Thailand	We would like to thank Ms. Barbara Metzler, a director of the Chiang Mai University English Language Team, for help with manuscript editing.	Adil MY, 2019, AM J OPHTHALMOL, V200, P16, DOI 10.1016/j.ajo.2018.12.006; Amparo F, 2015, OPHTHALMOLOGY, V122, P1498, DOI 10.1016/j.ophtha.2015.02.037; Asiedu K, 2017, EYE CONTACT LENS, V43, P262, DOI 10.1097/ICL.0000000000000256; Craig JP, 2017, OCUL SURF, V15, P276, DOI 10.1016/j.jtos.2017.05.008; de Castro JS, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20273-9; Eom Y, 2013, AM J OPHTHALMOL, V155, P1104, DOI 10.1016/j.ajo.2013.01.008; Fayyadh RA., 2020, IRAQ ANN TROPICAL ME, V23, P23; Fernandez CA, 2013, INVEST OPHTH VIS SCI, V54, P3666, DOI 10.1167/iovs.13-11635; Fineide F, 2021, OCUL SURF, V19, P133, DOI 10.1016/j.jtos.2020.05.004; Finis D, 2013, CORNEA, V32, P1549, DOI 10.1097/ICO.0b013e3182a7f3e1; Gomes JAP, 2017, OCUL SURF, V15, P511, DOI 10.1016/j.jtos.2017.05.004; Halleran C., 2016, AM AC OPT ANN M NOV; Han SB, 2011, ARCH OPHTHALMOL-CHIC, V129, P633, DOI 10.1001/archophthalmol.2011.78; Hyon JY, 2019, EYE CONTACT LENS, V45, P310, DOI 10.1097/ICL.0000000000000567; Hyon J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40539-0; Iqbal M., 2018, OPHTHALMOL RES, V8, P1, DOI [10.9734/OR/2018/38436, DOI 10.9734/OR/2018/38436]; 윤철민, 2012, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V53, P505, DOI 10.3341/jkos.2012.53.4.505; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lemp MA, 2012, CORNEA, V31, P472, DOI 10.1097/ICO.0b013e318225415a; Li SS, 2018, BMC OPHTHALMOL, V18, DOI 10.1186/s12886-018-0825-z; Miljanovic B, 2007, AM J OPHTHALMOL, V143, P409, DOI 10.1016/j.ajo.2006.11.060; Na KS, 2015, CORNEA, V34, P733, DOI 10.1097/ICO.0000000000000464; Nelson JD, 2011, INVEST OPHTH VIS SCI, V52, P1930, DOI 10.1167/iovs.10-6997b; Nichols JJ, 2006, INVEST OPHTH VIS SCI, V47, P1319, DOI 10.1167/iovs.05-1392; Pavithra S., 2020, INT J RES PHARM SCI, V11, P1202; Rabensteiner DF, 2018, ACTA OPHTHALMOL, V96, pE707, DOI 10.1111/aos.13732; Schaumberg DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076121; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; SHIMAZAKI J, 1995, ARCH OPHTHALMOL-CHIC, V113, P1266, DOI 10.1001/archopht.1995.01100100054027; Song JY, 2016, CORNEA, V35, P193, DOI 10.1097/ICO.0000000000000727; Stapleton F, 2017, OCUL SURF, V15, P334, DOI 10.1016/j.jtos.2017.05.003; Tuladhar S., 2019, J GANDAKI MEDICAL CO, V12, P5, DOI [10.3126/jgmcn.v12i1.22600, DOI 10.3126/JGMCN.V12I1.22600]; Uchino M, 2008, AM J OPHTHALMOL, V146, P925, DOI 10.1016/j.ajo.2008.06.030; Uchino M, 2008, OPHTHALMOLOGY, V115, P1982, DOI 10.1016/j.ophtha.2008.06.022; Uchino M, 2014, AM J OPHTHALMOL, V157, P294, DOI 10.1016/j.ajo.2013.10.014; Uchino M, 2013, AM J OPHTHALMOL, V156, P759, DOI 10.1016/j.ajo.2013.05.040; Vehof J, 2018, OCUL SURF, V16, P242, DOI 10.1016/j.jtos.2018.01.001; Wolffsohn JS, 2017, OCUL SURF, V15, P539, DOI 10.1016/j.jtos.2017.05.001; Wongpakaran N, 2010, BIOPSYCHOSOC MED, V4, DOI 10.1186/1751-0759-4-6; Yang I, 2019, INVEST OPHTH VIS SCI, V60; Yokoi N, 2015, AM J OPHTHALMOL, V159, P748, DOI 10.1016/j.ajo.2014.12.019	41	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265733	10.1371/journal.pone.0265733	http://dx.doi.org/10.1371/journal.pone.0265733			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320310	Green Published, gold			2022-12-26	WOS:000784240600007
J	Wan, HX; Chen, XY; Zhang, FL; Chen, J; Chu, FL; Sellers, ZM; Xu, F; Dong, H				Wan, Hanxing; Chen, Xiong Ying; Zhang, Fenglian; Chen, Jun; Chu, Fenglan; Sellers, Zachary M.; Xu, Feng; Dong, Hui			Capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption by blocking TRPV4 channels in healthy and colitic mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							K+; ACTIVATION; EXPRESSION; MECHANISM; PROTECTS; CANCER	Although capsaicin has been studied extensively as an activator of the transient receptor potential vanilloid cation channel subtype 1 (TRPV1) channels in sensory neurons, little is known about its TRPV1-independent actions in gastrointestinal health and disease. Here, we aimed to investigate the pharmacological actions of capsaicin as a food additive and medication on intestinal ion transporters in mouse models of ulcerative colitis (UC). The short-circuit current (I-sc) of the intestine from WT, TRPV1-, and TRPV4-KO mice were measured in Ussing chambers, and Ca2+ imaging was performed on small intestinal epithelial cells. We also performed Western blots, immunohistochemistry, and immunofluorescence on intestinal epithelial cells and on intestinal tissues following UC induction with dextran sodium sulfate. We found that capsaicin did not affect basal intestinal I-sc but significantly inhibited carbachol-and caffeine-induced intestinal I-sc in WT mice. Capsaicin similarly inhibited the intestinal I-sc in TRPV1 KO mice, but this inhibition was absent in TRPV4 KO mice. We also determined that Ca2+ influx via TRPV4 was required for cholinergic signaling-mediated intestinal anion secretion, which was inhibited by capsaicin. Moreover, the glucose-induced jejunal I-sc via Na+/glucose cotransporter was suppressed by TRPV4 activation, which could be relieved by capsaicin. Capsaicin also stimulated ouabain-and amiloridesensitive colonic I-sc. Finally, we found that dietary capsaicin ameliorated the UC phenotype, suppressed hyperaction of TRPV4 channels, and rescued the reduced ouabain-and amiloride-sensitive I-sc. We therefore conclude that capsaicin inhibits intestinal Cl- secretion and promotes Na+ absorption predominantly by blocking TRPV4 channels to exert its beneficial anti-colitic action.	[Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China; [Wan, Hanxing; Chen, Xiong Ying; Xu, Feng; Dong, Hui] Chongqing Key Lab Pediat, Chongqing, Peoples R China; [Zhang, Fenglian; Chen, Jun; Chu, Fenglan; Dong, Hui] Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China; [Sellers, Zachary M.] Stanford Univ, Sch Med, Pediat Gastroenterol Hepatol & Nutr, Palo Alto, CA 94304 USA; [Dong, Hui] Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA	Chongqing Medical University; Army Medical University; Stanford University; University of California System; University of California San Diego	Xu, F; Dong, H (corresponding author), Chongqing Med Univ, Dept Pediat Intens Care Unit, Childrens Hosp, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Natl Clin Res Ctr Child Hlth & Disorders, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Minist Educ, Key Lab Child Dev & Disorders, Chongqing, Peoples R China.; Xu, F; Dong, H (corresponding author), Chongqing Key Lab Pediat, Chongqing, Peoples R China.; Dong, H (corresponding author), Army Med Univ, Xinqiao Hosp, Dept Gastroenterol, Chongqing, Peoples R China.; Dong, H (corresponding author), Univ Calif San Diego, Sch Med, Dept Med, San Diego, CA 92103 USA.	xufeng9899@163.com; h2dong@ucsd.edu	Sellers, Zachary/AAI-1356-2020	Sellers, Zachary/0000-0001-5352-7760	National Natural Science Foundation of China [81972328, 81873544]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding and additional information-These studies were supported by research grants from the National Natural Science Foundation of China (81972328 to X. H. W and No. 81873544 to H. D) .	Abdel-Salam OME, 1997, J PHYSIOL-PARIS, V91, P151, DOI 10.1016/S0928-4257(97)89479-X; Bader S, 2017, BRIT J PHARMACOL, V174, P880, DOI 10.1111/bph.13761; Baumgart DC, 2021, NEW ENGL J MED, V385, P1302, DOI 10.1056/NEJMra1907607; Bouyer PG, 2013, AM J PHYSIOL-GASTR L, V304, pG142, DOI 10.1152/ajpgi.00483.2011; BRAEGGER CP, 1992, LANCET, V339, P89, DOI 10.1016/0140-6736(92)90999-J; Ferreira LGB, 2020, EUR J PHARMACOL, V887, DOI 10.1016/j.ejphar.2020.173356; Chang JT, 2020, NEW ENGL J MED, V383, P2652, DOI 10.1056/NEJMra2002697; Clarke LL, 2009, AM J PHYSIOL-GASTR L, V296, pG1151, DOI 10.1152/ajpgi.90649.2008; D'Aldebert E, 2011, GASTROENTEROLOGY, V140, P275, DOI 10.1053/j.gastro.2010.09.045; Domotor A, 2006, EUR J PHARMACOL, V534, P280, DOI 10.1016/j.ejphar.2006.01.017; Domotor Andras, 2005, Inflammopharmacology, V13, P161, DOI 10.1163/156856005774423737; du Sert NP, 2020, J CEREBR BLOOD F MET, V40, P1769, DOI 10.1177/0271678X20943823; Eijkelkamp N, 2007, AM J PHYSIOL-GASTR L, V293, pG749, DOI 10.1152/ajpgi.00114.2007; Engel MA, 2012, J GASTROENTEROL, V47, P256, DOI 10.1007/s00535-011-0495-6; Gao X, 2021, NATURE, V589, P591, DOI 10.1038/s41586-020-03057-y; Goodman MB, 2002, NATURE, V415, P1039, DOI 10.1038/4151039a; GOSO C, 1993, EUR J PHARMACOL, V249, P185, DOI 10.1016/0014-2999(93)90431-G; Harraz OF, 2018, ELIFE, V7, DOI 10.7554/eLife.38689; Hirota CL, 2009, BRIT J PHARMACOL, V156, P1085, DOI 10.1111/j.1476-5381.2009.00122.x; HOLZER P, 1989, GASTROENTEROLOGY, V96, P1425, DOI 10.1016/0016-5085(89)90508-8; Holzer P, 2011, PHARMACOL THERAPEUT, V131, P142, DOI 10.1016/j.pharmthera.2011.03.006; Kankanamge D, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100702; KAWADA T, 1984, TOXICOL APPL PHARM, V72, P449, DOI 10.1016/0041-008X(84)90121-2; Keita AV, 2018, J CROHNS COLITIS, V12, P1200, DOI 10.1093/ecco-jcc/jjy045; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; Kraft KH, 2014, P NATL ACAD SCI USA, V111, P6165, DOI 10.1073/pnas.1308933111; Lee J, 2012, AUTON NEUROSCI-BASIC, V166, P72, DOI 10.1016/j.autneu.2011.07.008; Leung FW, 2008, LIFE SCI, V83, P1, DOI 10.1016/j.lfs.2008.04.018; Matsumoto K, 2018, BRIT J PHARMACOL, V175, P84, DOI 10.1111/bph.14072; Meir M, 2019, J CLIN INVEST, V129, P2824, DOI 10.1172/JCI120261; Michielan A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/628157; Motte J, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1165-x; Ng SC, 2019, AM J GASTROENTEROL, V114, P107, DOI 10.1038/s41395-018-0233-2; Ng WK, 2016, INTEST RES, V14, P111, DOI 10.5217/ir.2016.14.2.111; OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H; Rajendran VM, 2015, J BIOL CHEM, V290, P25487, DOI 10.1074/jbc.M115.654277; de Mattos BRR, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493012; Richards BL, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008921.pub2; Rizopoulos T, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7060061; Rogalski SL, 2001, J BIOL CHEM, V276, P14855, DOI 10.1074/jbc.M010097200; Rollyson W, 2014, FASEB J, V28; Rollyson WD, 2014, J CONTROL RELEASE, V196, P96, DOI 10.1016/j.jconrel.2014.09.027; Rosca AE, 2020, MOLECULES, V25, DOI 10.3390/molecules25235681; Saha P, 2015, BBA-BIOMEMBRANES, V1848, P702, DOI 10.1016/j.bbamem.2014.11.005; Shigematsu H, 2010, J BIOL CHEM, V285, P11210, DOI 10.1074/jbc.M109.090712; Singh U, 2014, PROG DRUG RES, V68, P147, DOI 10.1007/978-3-0348-0828-6_6; SKOU JC, 1990, FEBS LETT, V268, P314, DOI 10.1016/0014-5793(90)81278-V; Sonkusare SK, 2012, SCIENCE, V336, P597, DOI 10.1126/science.1216283; SULPICE JC, 1994, J BIOL CHEM, V269, P6347; Tuo BG, 2012, AM J PHYSIOL-ENDOC M, V303, pE111, DOI 10.1152/ajpendo.00575.2011; Wan HX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02562-x; Wang PJ, 2012, DIABETES, V61, P2155, DOI 10.2337/db11-1503; Watanabe H, 2003, NATURE, V424, P434, DOI 10.1038/nature01807; Wirtz S, 2017, NAT PROTOC, V12, P1295, DOI 10.1038/nprot.2017.044; Yamawaki H, 2014, AM J PHYSIOL-GASTR L, V307, pG33, DOI 10.1152/ajpgi.00105.2013; Yasuda M, 2011, J PHARMACOL SCI, V116, P274, DOI 10.1254/jphs.11037FP; Yu SY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1708-9; Zhang FL, 2019, BRIT J PHARMACOL, V176, P1700, DOI 10.1111/bph.14640; Zhang LY, 2022, J ADV RES, V39, P291, DOI 10.1016/j.jare.2021.11.001; Zheng WW, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2017762118	60	2	2	5	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101847	10.1016/j.jbc.2022.101847	http://dx.doi.org/10.1016/j.jbc.2022.101847			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35314195	gold, Green Published			2022-12-26	WOS:000793483000008
J	Christodoulou, J; Fehrenbacher, AE; Shaw, EH; Vincent, EM; Saleska, JL				Christodoulou, Joan; Fehrenbacher, Anne E.; Shaw, Elizabeth H.; Vincent, Eleanor M.; Saleska, Jessica L.			COVID-19 prevention behaviors, trust, and intent to vaccinate among youth at risk for HIV	PLOS ONE			English	Article							HERD-IMMUNITY; UNITED-STATES; ADOLESCENTS	The current study examines COVID-19 prevention behaviors and vaccine intentions among 83 youth at high risk for HIV. Most youth self-identified as Latinx (52%), cisgender men (84%), and homosexual (66%). Youth self-reported COVID-19 prevention behaviors and intentions to vaccinate. Participants reported wearing face masks, washing hands, and staying six feet apart, but fewer reported leaving home only for essential needs. About one-third reported that they would not get a vaccine, and lack of trust in their doctors and the government were significantly associated with non-intention. To improve efforts towards herd immunity, interventions to improve health messaging from trusted sources for at-risk youth may be necessary to achieve higher vaccine uptake.	[Christodoulou, Joan; Shaw, Elizabeth H.; Vincent, Eleanor M.] Palo Alto Univ, Dept Psychol, Palo Alto, CA 94304 USA; [Fehrenbacher, Anne E.; Saleska, Jessica L.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, Semel Inst, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles	Shaw, EH (corresponding author), Palo Alto Univ, Dept Psychol, Palo Alto, CA 94304 USA.	eshaw@paloaltou.edu		Shaw, Elizabeth/0000-0003-0763-1764	UCLA Center for HIV Identification, Prevention and Treatment Services [P30MH058107]; National Institute of Mental Health [T32MH109205]	UCLA Center for HIV Identification, Prevention and Treatment Services; National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	All funding was received by JC. This work was supported by the UCLA Center for HIV Identification, Prevention and Treatment Services (https://chipts.ucla.edu/) under Grant P30MH058107; National Institute of Mental Health (https://www.nimh.nih.gov/) under Grant T32MH109205. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrasfay T, 2022, AM J PUBLIC HEALTH, V112, P169, DOI 10.2105/AJPH.2021.306565; Andrews JL, 2020, TRENDS COGN SCI, V24, P585, DOI 10.1016/j.tics.2020.05.001; [Anonymous], 2020, CANC DISCOV, V10, pOF8; Aschwanden C, 2021, NATURE, V591, P520, DOI 10.1038/d41586-021-00728-2; Azzari C, 2020, EUR J PEDIATR, V179, P547, DOI 10.1007/s00431-019-03511-8; Balzer D., 2021, COVID 19 DELTA VARIA; Boehmer TK, 2020, MMWR-MORBID MORTAL W, V69, P1404, DOI 10.15585/mmwr.mm6939e1; Bosman J., 2021, NY TIMES        0804; Brumfiel G., 2021, VACCINE REFUSAL MAY; Burgess RA, 2021, LANCET, V397, P8, DOI 10.1016/S0140-6736(20)32642-8; Burki TK, 2021, LANCET RESP MED, V9, P135, DOI 10.1016/S2213-2600(20)30555-5; CDC, COVID 19 VACC CAS TR; Chantler T, 2019, APPL HEALTH ECON HEA, V17, P265, DOI 10.1007/s40258-019-00460-z; Cohen RIS, 2020, PEDIATRICS, V146, DOI 10.1542/peds.2020-1306; Dawson L, 2021, RED CRESC IMP COV 19; Duca LM, 2021, MMWR-MORBID MORTAL W, V69, P1664; Emgard M, 2021, ANTIMICROB RESIST IN, V10, DOI 10.1186/s13756-021-00952-5; Fernandes B., 2021, JAMA; Fridman I, 2020, JMIR PUBLIC HLTH SUR, V6, P398, DOI 10.2196/22060; Ghosh A, 2021, AM J DRUG ALCOHOL AB, V47, P154, DOI 10.1080/00952990.2020.1865996; Gutierrez M, 2022, LOS ANGELES TIMES, P20; Jaiswal J, 2020, AIDS BEHAV, V24, P2776, DOI 10.1007/s10461-020-02925-y; KUEHN BM, 2020, JAMA-J AM MED ASSOC, V323, P2240, DOI DOI 10.1001/jama.2020.8854; Lazarus JV, 2020, NAT MED, V26, P1005, DOI 10.1038/s41591-020-0950-0; Madewell Zachary J, 2020, medRxiv, DOI 10.1101/2020.07.29.20164590; Morgan L, 2021, JAMA PEDIATR, V175, P995, DOI 10.1001/jamapediatrics.2021.1855; Nivette A, 2021, SOC SCI MED, V268, DOI 10.1016/j.socscimed.2020.113370; Office of Governor Gavin Newsom, 2021, CAL BEC 1 STAT NAT A; Palamenghi L, 2020, EUR J EPIDEMIOL, V35, P785, DOI 10.1007/s10654-020-00675-8; Patel JA, 2020, PUBLIC HEALTH, V183, P110, DOI 10.1016/j.puhe.2020.05.006; Public Health Institute, 2022, PROM EQ COVID 19 VAC; Public Health Institute, 2022, PEER VACC ED PUBL HL; Quinn KG ., 2020, ARCH SEX BEHAV, P1, DOI 10.1007/s10508-020-01627-9; Quinn SC, 2019, VACCINE, V37, P1168, DOI 10.1016/j.vaccine.2019.01.033; Roberts JR, 2015, VACCINE, V33, P1748, DOI 10.1016/j.vaccine.2015.01.068; Scherer AM, 2021, MMWR-MORBID MORTAL W, V70, DOI 10.15585/mmwr.mm7028e1; Sevelius JM, 2021, JAIDS-J ACQ IMM DEF, V88, pS27, DOI 10.1097/QAI.0000000000002808; Silverman RD, 2019, NEW ENGL J MED, V381, P104, DOI 10.1056/NEJMp1905814; Statista, 2022, TOT NUMB CAS COVID 1; Swendeman D, 2019, JMIR RES PROTOC, V8, DOI 10.2196/11165; Velavan TP, 2020, INT J INFECT DIS, V98, P14, DOI 10.1016/j.ijid.2020.06.065; Verger P, 2020, EXPERT REV VACCINES, V19, P991, DOI 10.1080/14760584.2020.1825945; Viner RM, 2021, JAMA PEDIATR, V175, P143, DOI 10.1001/jamapediatrics.2020.4573; WHO, 2020, COVID 19 VACC RES DO; Wiysonge CS, 2022, HUM VACC IMMUNOTHER, V18, P1, DOI 10.1080/21645515.2021.1893062; Yan H., 2022, CNN             0105; Youthnet, 2005, YOUTH PEER ED TOOLK; Zhu Y, 2020, CLIN INFECT DIS, DOI [DOI 10.1093/CID/CIAA1825, 10.1093/cid/ciaa1825]	48	1	1	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266321	10.1371/journal.pone.0266321	http://dx.doi.org/10.1371/journal.pone.0266321			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358278	gold, Green Published			2022-12-26	WOS:000799828800093
J	Moriyama, Y; Yamada, T; Shimamura, R; Ohmi, T; Hirosawa, M; Yamauchi, T; Tazawa, T; Kato, J				Moriyama, Yoshinao; Yamada, Takumi; Shimamura, Ryota; Ohmi, Takehiro; Hirosawa, Masaki; Yamauchi, Tomoyuki; Tazawa, Tomohiro; Kato, Junpei			Movement patterns of the functional reach test do not reflect physical function in healthy young and older participants	PLOS ONE			English	Article							PERFORMANCE-MEASURES; PREDICTIVE-VALIDITY; POSTURAL CONTROL; ELDERLY-WOMEN; FALLS RISK; STRATEGIES; BALANCE; MOBILITY; ADULTS; INDIVIDUALS	The relationship of the Functional Reach Test (FRT) value with the Center of Pressure Excursion (COPE) and physical function remains unclear, and would be influenced by different population characteristics and movement patterns used in the FRT. Therefore, we explored the relationship between the FRT value and the COPE and physical function in healthy young and older individuals classified according to movement patterns. In 21 healthy young participants (42 sides) and 20 older participants (40 sides), three-dimensional motion analysis was performed during the FRT and physical function assessments. The participants were assigned to two clusters after performing a motion analysis during the FRT. Kinematic and kinetic parameters during the FRT and physical function assessment results were compared between the clusters for both groups. Correlation analysis was performed to investigate the relationships of the FRT value with COPE and physical function parameters in each cluster, in young and older individuals separately. The results showed that the hip strategies could be divided into two groups according to the degree of use (Small Hip Strategy, SHS Group; Large Hip Strategy, LHS Group). In the older SHS group, the FRT values were significantly correlated with the COPE (r = 0.75), toe grip strength (r = 0.62), and the five-times sit-to-stand test time (r = -0.52). In the older LHS group and in both groups of young individuals, there were no significant correlations of the FRT value with any parameters. The FRT value reflects the COPE and physical function only in older individuals using the SHS. This could explain previous discrepant results. As there is no simple relationship between the FRT value and physical function, it is important to include movement strategy assessment when using the FRT in clinical evaluations.	[Moriyama, Yoshinao; Shimamura, Ryota; Hirosawa, Masaki] Tokyo Metropolitan Rehabil Hosp, Dept Rehabil, Div Phys Therapy, Tokyo, Japan; [Yamada, Takumi] Tokyo Metropolitan Univ, Fac Hlth Sci, Dept Phys Therapy, Tokyo, Japan; [Ohmi, Takehiro] Tokyo Med & Dent Univ, Clin Ctr Sports Med & Sports Dent, Tokyo, Japan; [Yamauchi, Tomoyuki] Nihon Univ Hosp, Dept Rehabil, Tokyo, Japan; [Tazawa, Tomohiro] Sonodakai Joint Replacement Ctr Hosp, Dept Rehabil, Tokyo, Japan; [Kato, Junpei] NEC Livex Ltd, Karadacare Business Dev Off, Tokyo, Japan	Tokyo Metropolitan University; Tokyo Medical & Dental University (TMDU); Nihon University	Moriyama, Y (corresponding author), Tokyo Metropolitan Rehabil Hosp, Dept Rehabil, Div Phys Therapy, Tokyo, Japan.	moriyamayoshinao2020@gmail.com		Moriyama, Yoshinao/0000-0001-7924-2827; Yamauchi, Tomoyuki/0000-0003-3000-8946				Abiko T., 2018, JPN J HLTH PROMOT PH, V8, P7, DOI [10.9759/hppt.8.7, DOI 10.9759/HPPT.8.7]; ALEXANDER NB, 1994, J AM GERIATR SOC, V42, P93, DOI 10.1111/j.1532-5415.1994.tb06081.x; Arai T., 2011, J JPN PHYS THER ASS, V38, P489; Behrman AL, 2002, ARCH PHYS MED REHAB, V83, P538, DOI 10.1053/apmr.2002.30934; Bergland A, 2004, INJURY PREV, V10, P308, DOI 10.1136/ip.2003.004721; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Buatois S, 2010, PHYS THER, V90, P550, DOI 10.2522/ptj.20090158; Dai J., 2007, JPN J TEST MEAS HLTH, V7, P37; de Waroquier-Leroy L., 2014, Annals of Physical and Rehabilitation Medicine, V57, P452, DOI 10.1016/j.rehab.2014.03.003; DUNCAN PW, 1992, J GERONTOL, V47, pM93, DOI 10.1093/geronj/47.3.M93; DUNCAN PW, 1990, J GERONTOL, V45, pM192, DOI 10.1093/geronj/45.6.M192; Fujimoto A, 2015, GERONTOLOGY, V61, P109, DOI 10.1159/000363571; Fujisawa H., 2005, J JPN PHYS THER ASS, V32, P416; HORAK FB, 1986, J NEUROPHYSIOL, V55, P1369, DOI 10.1152/jn.1986.55.6.1369; HORAK FB, 1989, NEUROBIOL AGING, V10, P727, DOI 10.1016/0197-4580(89)90010-9; Huang HC, 2003, PUBLIC HEALTH NURS, V20, P399, DOI 10.1046/j.1525-1446.2003.20508.x; Jonsson E, 2003, J REHABIL MED, V35, P26, DOI 10.1080/16501970306099; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Koda H., 2014, JPN J CLIN BIOMECH, V35, P285; Kojima S., 1998, RIGAKURYOHO KAGAKU, V13, P85, DOI [10.1589/rika.13.85, DOI 10.1589/RIKA.13.85]; Lord SR, 2002, J GERONTOL A-BIOL, V57, pM539, DOI 10.1093/gerona/57.8.M539; Lundebjerg N, 2001, J AM GERIATR SOC, V49, P664, DOI 10.1046/j.1532-5415.2001.49115.x; Maeoka H., 2006, RIGAKURYOHO KAGAKU, V21, P197, DOI [10.1589/rika.21.197, DOI 10.1589/RIKA.21.197]; Makizako H., 2008, SPORTS SCI RES, V5, P71; Maranesi E, 2014, GAIT POSTURE, V39, P501, DOI 10.1016/j.gaitpost.2013.08.035; Mitani Y., 2012, J ALLIED HLTH SCI, V3, P25; Morita M, 2005, AGING CLIN EXP RES, V17, P211; Mourey F, 2000, J GERONTOL A-BIOL, V55, pB425, DOI 10.1093/gerona/55.9.B425; Nakamura I., 2006, RIGAKURYOHO KAGAKU, V21, P335, DOI [10.1589/rika.21.335, DOI 10.1589/RIKA.21.335]; Nakatani T, 2002, JPN J PHYS ED HLTH S, V47, P451, DOI DOI 10.5432/jjpehss.KJ00003390725; OBrien K, 1997, J GERONTOL A-BIOL, V52, pB221, DOI 10.1093/gerona/52A.4.B221; Papa E, 2000, J BIOMECH, V33, P1113, DOI 10.1016/S0021-9290(00)00046-4; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Portnoy S, 2017, EUR J PHYS REHAB MED, V53, P685, DOI 10.23736/S1973-9087.17.04522-1; Rosa MV, 2019, ARCH GERONTOL GERIAT, V81, P149, DOI 10.1016/j.archger.2018.11.015; Sasaki K., 2009, RIGAKURYOHO KAGAKU, V24, P813, DOI [10.1589/rika.24.813, DOI 10.1589/RIKA.24.813]; Satoh Yoshinao, 2019, J Phys Ther Sci, V31, P498, DOI 10.1589/jpts.31.498; SCHENKMAN M, 1990, PHYS THER, V70, P638, DOI 10.1093/ptj/70.10.638; SCHULTZ AB, 1992, J BIOMECH, V25, P1383, DOI 10.1016/0021-9290(92)90052-3; Shumway-Cook A., 2013, MOTOR CONTROL TRANSL; Soma M, 2014, J PHYS THER SCI, V26, P1955, DOI 10.1589/jpts.26.1955; Takasaki K, 2011, J PHYS THER SCI, V23, P773; THAPA PB, 1994, J AM GERIATR SOC, V42, P493, DOI 10.1111/j.1532-5415.1994.tb04970.x; Thomas JI, 2005, ARCH PHYS MED REHAB, V86, P1636, DOI 10.1016/j.apmr.2005.03.004; Tsujino A., 2007, RIGAKURYOHO KAGAKU, V22, P245, DOI [10.1589/rika.22.245, DOI 10.1589/RIKA.22.245]; Tsushima E., 2001, RIGAKURYOHO KAGAKU, V16, P159, DOI [10.1589/rika.16.159, DOI 10.1589/RIKA.16.159]; Uritani D, 2016, J AGING PHYS ACTIV, V24, P459, DOI 10.1123/japa.2015-0123; VELLAS B, 1987, AGE AGEING, V16, P189, DOI 10.1093/ageing/16.3.189; Wallmann HW, 2001, J GERONTOL A-BIOL, V56, pM580, DOI 10.1093/gerona/56.9.M580; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WEINER DK, 1992, J AM GERIATR SOC, V40, P203, DOI 10.1111/j.1532-5415.1992.tb02068.x; Wernick-Robinson M, 1999, ARCH PHYS MED REHAB, V80, P262, DOI 10.1016/S0003-9993(99)90136-3	53	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266195	10.1371/journal.pone.0266195	http://dx.doi.org/10.1371/journal.pone.0266195			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358272	gold, Green Published			2022-12-26	WOS:000799828800077
J	Rybashlykov, D; Brennan, J; Lin, ZX; Efimov, IR; Syunyaev, R				Rybashlykov, Dmitry; Brennan, Jaclyn; Lin, Zexu; Efimov, Igor R.; Syunyaev, Roman			Open-source low-cost cardiac optical mapping system	PLOS ONE			English	Article							TRANSIENT OUTWARD CURRENT; INTACT MOUSE HEART; NADH FLUORESCENCE; K+ CURRENT; 4-AMINOPYRIDINE; REPOLARIZATION; BLOCK	Fluorescent imaging with voltage- or calcium-sensitive dyes, known as optical mapping, is one of the indispensable modern techniques to study cardiac or neural electrophysiology, unsurpassed by temporal and spatial resolution. High-speed CMOS cameras capable of optical registration of action potential propagation are in general very costly. We present a complete solution priced below US$1,000 (including camera and lens) at the moment of publication with an open-source image acquisition and processing software. We demonstrate that the iDS UI-3130CP rev.2 camera we used in this study is capable of 200x200 977 frames per second (FPS) action potential recordings from rodent hearts, with the signal-to-noise-ratio of a conditioned signal of 16 +/- 10. A comparison with a specialized MiCAM Ultimate-L camera has shown that signal-to-noise ratio (SNR) while lower is sufficient for accurate measurements of AP waveform, conduction velocity (+/- 0.04 m/s) and action potential duration (+/- 7ms) in mouse and rat hearts. We used 4-aminopyridine to prolong the action potential duration in mouse heart, thus demonstrating that the proposed system is adequate for pharmacological studies.	[Rybashlykov, Dmitry; Syunyaev, Roman] Moscow Inst Phys & Technol, Human Physiol Lab, Moscow, Russia; [Brennan, Jaclyn; Lin, Zexu; Efimov, Igor R.] George Washington Univ, Dept Biomed Engn, Washington, DC 20052 USA; [Syunyaev, Roman] Sechenov Univ, Moscow, Russia	Moscow Institute of Physics & Technology; George Washington University; Sechenov First Moscow State Medical University	Syunyaev, R (corresponding author), Moscow Inst Phys & Technol, Human Physiol Lab, Moscow, Russia.; Efimov, IR (corresponding author), George Washington Univ, Dept Biomed Engn, Washington, DC 20052 USA.; Syunyaev, R (corresponding author), Sechenov Univ, Moscow, Russia.	irefimov@gmail.com; roman.syunyaev@gmail.com			Russian Foundation for Basic Research [19-29-04111]; Leducq Foundation	Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Leducq Foundation(Leducq Foundation)	The research was supported by Russian Foundation for Basic Research (https://www.rfbr.ru/rffi/eng) grant 19-29-04111 (to RS) and Leducq Foundation (https://www.fondationleducq.org/) project RHYTHM (to IE). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayly PV, 1998, IEEE T BIO-MED ENG, V45, P563, DOI 10.1109/10.668746; Bernus O, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2709661; Boukens Bas J, 2014, IEEE Rev Biomed Eng, V7, P115, DOI 10.1109/RBME.2013.2286296; CASTLE NA, 1993, J PHARMACOL EXP THER, V264, P1450; Cathey B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36809-y; COHEN LB, 1978, REV PHYSIOL BIOCH P, V83, P35, DOI 10.1007/3-540-08907-1_2; Doevendans PA, 1998, CARDIOVASC RES, V39, P34, DOI 10.1016/S0008-6363(98)00073-X; EFIMOV IR, 1994, CIRCULATION, V90, P1469, DOI 10.1161/01.CIR.90.3.1469; Eloff BC, 2001, CARDIOVASC RES, V51, P681, DOI 10.1016/S0008-6363(01)00341-8; Fiset C, 1997, J PHYSIOL-LONDON, V504, P557, DOI 10.1111/j.1469-7793.1997.557bd.x; Forman DE, 1997, J AM COLL CARDIOL, V30, P1872, DOI 10.1016/S0735-1097(97)00411-7; Gloschat C, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-21333-w; Golovko V, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12447; Huang CLH, 2017, PHYSIOL REV, V97, P283, DOI 10.1152/physrev.00007.2016; Huang SY, 1999, LAB ANIM SCI, V49, P276; Knollmann BC, 2001, J CARDIOVASC ELECTR, V12, P1286, DOI 10.1046/j.1540-8167.2001.01286.x; Knollmann BC, 2007, AM J PHYSIOL-HEART C, V292, pH614, DOI 10.1152/ajpheart.01085.2005; Kostadinova I, 2019, PHARMACIA, V66, P67, DOI 10.3897/pharmacia.66.e35976; Lang D, 2011, JOVE-J VIS EXP, DOI 10.3791/3275; Laughner JI, 2012, AM J PHYSIOL-HEART C, V303, pH753, DOI 10.1152/ajpheart.00404.2012; Lee P, 2017, SCI REP-UK, V7, DOI 10.1038/srep43217; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li XY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52976-y; Lin SF, 1999, J BIOMED OPT, V4, P200, DOI 10.1117/1.429910; LOEW LM, 1982, J BIOCHEM BIOPH METH, V6, P243, DOI 10.1016/0165-022X(82)90047-1; Marina-Breysse M, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.696270; Mercader M, 2012, AM J PHYSIOL-HEART C, V302, pH2131, DOI 10.1152/ajpheart.01141.2011; NABAUER M, 1993, CIRC RES, V73, P386, DOI 10.1161/01.RES.73.2.386; O'Shea C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-38263-2; Ripplinger CM., 2012, CARDIAC MAPPING, P90, DOI [10.1002/9781118481585.ch10, DOI 10.1002/9781118481585.CH10]; SALAMA G, 1987, AM J PHYSIOL, V252, pH384, DOI 10.1152/ajpheart.1987.252.2.H384; SALAMA G, 1976, SCIENCE, V191, P485, DOI 10.1126/science.191.4226.485; SALZBERG BM, 1973, NATURE, V246, P508, DOI 10.1038/246508a0; SIMURDA J, 1989, PFLUG ARCH EUR J PHY, V415, P244, DOI 10.1007/BF00370600; Stein M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020310; Takahashi A, 1999, PHYSIOL REV, V79, P1089, DOI 10.1152/physrev.1999.79.4.1089; Vetter FJ, 1998, PROG BIOPHYS MOL BIO, V69, P157, DOI 10.1016/S0079-6107(98)00006-6; Wegener JW, 1998, J CARDIOVASC PHARM, V32, P134, DOI 10.1097/00005344-199807000-00021; Witkowski FX, 1998, NATURE, V392, P78, DOI 10.1038/32170	39	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0259174	10.1371/journal.pone.0259174	http://dx.doi.org/10.1371/journal.pone.0259174			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358183	Green Published, Green Submitted, gold			2022-12-26	WOS:000799828800003
J	Ando, M; Furuichi, M				Ando, Michihito; Furuichi, Masato			The association of COVID-19 employment shocks with suicide and safety net use: An early-stage investigation	PLOS ONE			English	Article							UNEMPLOYMENT; RECESSIONS	This paper examines whether the COVID-19-induced employment shocks are associated with increases in suicides and safety net use in the second and third quarters of 2020. We exploit plausibly exogenous regional variation in the magnitude of the employment shocks in Japan and adopt a difference-in-differences research design to examine and control for possible confounders. Our preferred point estimates suggest that a one-percentage-point increase in the unemployment rate in the second quarter of 2020 is associated with, approximately, an additional 0.52 suicides, 28 unemployment benefit recipients, 88 recipients of a temporary loan program, and 10 recipients of public assistance per 100,000 population per month. A simple calculation based on these estimates suggests that if a region experienced a one-percentage-point increase in the unemployment rate caused by the COVID-19 crisis in the second quarter of 2020, which is roughly equivalent to the third-highest regional employment shock, this would be associated with 37.4%, 60.5%, and 26.5% increases in the total, female, and male suicide rates respectively in July 2020 compared with July 2019. These results are primarily correlational rather than causal due to the limitation of our data and research design, but our baseline findings are robust to several different model specifications.	[Ando, Michihito] Rikkyo Univ, Dept Econ, Tokyo, Japan; [Furuichi, Masato] Teikyo Univ, Dept Econ, Tokyo, Japan	Rikkyo University; Teikyo University	Ando, M (corresponding author), Rikkyo Univ, Dept Econ, Tokyo, Japan.	michihito.ando@rikkyo.ac.jp		Ando, Michihito/0000-0002-5294-2994	JSPS (Japan Society For the Promotion of Science) KAKENHI [JP20K01733]	JSPS (Japan Society For the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	M.A. currently receives research grants from JSPS (Japan Society For the Promotion of Science) KAKENHI and he has used one of the research grants for this study. The grant number is JP20K01733. The website of JSPS (Japan Society For the Promotion of Science) is as follows: https://www.jsps.go.jp/english/index.html No party, including JSPS, had the right to review this manuscript prior to its circulation.	Adams-Prassl A, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104245; Ando M, 2020, NATL TAX J, V73, P901, DOI 10.17310/ntj.2020.3.12; [Anonymous], 2020, THE JAPAN TIMES; Arthi V, 2021, EXPLOR ECON HIST, V79, DOI 10.1016/j.eeh.2020.101381; Bitler M, 2016, J LABOR ECON, V34, pS403, DOI 10.1086/683096; Bitler MP, 2020, BROOKINGS PAP ECO AC, P119, DOI 10.1353/eca.2020.0008; Bitler MP, 2020, NATL TAX J, V73, P759, DOI 10.17310/ntj.2020.3.06; Breuer C, 2015, HEALTH ECON, V24, P936, DOI 10.1002/hec.3073; Brodeur A, 2021, J PUBLIC ECON, V193, DOI 10.1016/j.jpubeco.2020.104346; Brulhart M, 2021, NATURE, V600, P121, DOI 10.1038/s41586-021-04099-6; Chen J, 2015, SOC INDIC RES, V121, P253, DOI 10.1007/s11205-014-0635-5; Chen J, 2012, J ECON SURV, V26, P271, DOI 10.1111/j.1467-6419.2010.00645.x; Chen J, 2009, JPN WORLD ECON, V21, P140, DOI 10.1016/j.japwor.2008.06.001; Chetty R., 2020, EC IMPACTS COVID 19; Eguchi A, 2021, PSYCHIAT RES, V305, DOI 10.1016/j.psychres.2021.114173; Fetzer T, 2021, REV ECON STAT, V103, P968, DOI 10.1162/rest_a_00946; Frasquilho D, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-2720-y; Ganong P, 2018, AM ECON J-ECON POLIC, V10, P153, DOI 10.1257/pol.20140016; Google LLC, 2021, GOOGL COVID 19 COMM; Gunnell D, 2020, LANCET PSYCHIAT, V7, P468, DOI 10.1016/S2215-0366(20)30171-1; Hoshi K, HETEROGENEOUS EFFECT, V2021, P21045, DOI [10.1016/j.jjie.2021.101170, DOI 10.1016/J.JJIE.2021.101170]; Hoshi K, 2021, JPN ECON REV, V72, P683, DOI 10.1007/s42973-021-00092-w; Huikari S, 2021, APPL ECON, V53, P1540, DOI 10.1080/00036846.2020.1838430; Huikari S, 2016, SOC INDIC RES, V128, P1103, DOI 10.1007/s11205-015-1071-x; Isumi A, 2020, CHILD ABUSE NEGLECT, V110, DOI 10.1016/j.chiabu.2020.104680; Kawohl W, 2020, LANCET PSYCHIAT, V7, P389, DOI 10.1016/S2215-0366(20)30141-3; Kikuchi S, 2021, J JPN INT ECON, V59, DOI 10.1016/j.jjie.2020.101117; Kitazawa K., 2015, JAPAN LABOR REV, V12, P124; Kuroki M., 2010, J SOCIO-ECON, V39, P683, DOI [10.1016/j. socec.2010.06.009, DOI 10.1016/J.SOCEC.2010.06.009]; Matsubayashi T, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-8264-1; Moffitt RA, 2020, FISC STUD, V41, P515, DOI 10.1111/1475-5890.12243; Nagasu M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247705; Neumayer E, 2004, SOC SCI MED, V58, P1037, DOI 10.1016/S0277-9536(03)00276-4; Nomura S, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113622; Pirkis J, 2021, LANCET PSYCHIAT, V8, P579, DOI 10.1016/S2215-0366(21)00091-2; Ruhm CJ, 2015, J HEALTH ECON, V42, P17, DOI 10.1016/j.jhealeco.2015.03.004; Ruhm CJ, 2000, Q J ECON, V115, P617, DOI 10.1162/003355300554872; Sakai T., NIKKEI, V2021; Sakamoto H, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2020.37378; Saloner B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240080; Solon G, 2015, J HUM RESOUR, V50, P301, DOI 10.3368/jhr.50.2.301; Sueki H, 2022, CRISIS, V43, P315, DOI 10.1027/0227-5910/a000797; Tanaka T, 2021, NAT HUM BEHAV, V5, P229, DOI 10.1038/s41562-020-01042-z; Ueda M, 2022, J PUBLIC HEALTH-UK, V44, P541, DOI 10.1093/pubmed/fdab113; Ueda M, 2020, PSYCHIAT CLIN NEUROS, V74, P505, DOI 10.1111/pcn.13105	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264829	10.1371/journal.pone.0264829	http://dx.doi.org/10.1371/journal.pone.0264829			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0K7DW	35324902	Green Published, gold			2022-12-26	WOS:000780951300020
J	Brooks, MB; Millones, AK; Puma, D; Contreras, C; Jimenez, J; Tzelios, C; Jenkins, HE; Yuen, CM; Keshavjee, S; Lecca, L; Becerra, MC				Brooks, Meredith B.; Millones, Ana Karina; Puma, Daniela; Contreras, Carmen; Jimenez, Judith; Tzelios, Christine; Jenkins, Helen E.; Yuen, Courtney M.; Keshavjee, Salmaan; Lecca, Leonid; Becerra, Mercedes C.			Mapping local hot spots with routine tuberculosis data: A pragmatic approach to identify spatial variability	PLOS ONE			English	Article								Objective To use routinely collected data, with the addition of geographic information and census data, to identify local hot spots of rates of reported tuberculosis cases. Design Residential locations of tuberculosis cases identified from eight public health facilities in Lima, Peru (2013-2018) were linked to census data to calculate neighborhood-level annual case rates. Heat maps of tuberculosis case rates by neighborhood were created. Local indicators of spatial autocorrelation, Moran's I, were used to identify where in the study area spatial clusters and outliers of tuberculosis case rates were occurring. Age- and sex-stratified case rates were also assessed. Results We identified reports of 1,295 TB cases across 74 neighborhoods during the five-year study period, for an average annual rate of 124.2 reported TB cases per 100,000 population. In evaluating case rates by individual neighborhood, we identified a median rate of reported cases of 123.6 and a range from 0 to 800 cases per 100,000 population. Individuals aged 15-44 years old and men had higher case rates than other age groups and women. Locations of both hot and cold spots overlapped across age- and gender-specific maps. Conclusions There is significant geographic heterogeneity in rates of reported TB cases and evident hot and cold spots within the study area. Characterization of the spatial distribution of these rates and local hot spots may be one practical tool to inform the work of local coalitions to target TB interventions in their zones.	[Brooks, Meredith B.; Tzelios, Christine; Yuen, Courtney M.; Keshavjee, Salmaan; Lecca, Leonid; Becerra, Mercedes C.] Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA; [Millones, Ana Karina; Puma, Daniela; Contreras, Carmen; Jimenez, Judith; Tzelios, Christine; Keshavjee, Salmaan; Lecca, Leonid; Becerra, Mercedes C.] Socios Salud Sucursal Peru, Lima, Peru; [Jenkins, Helen E.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Yuen, Courtney M.; Keshavjee, Salmaan] Brigham & Womens Hosp, Div Global Hlth Equ, 75 Francis St, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Boston University; Harvard University; Brigham & Women's Hospital	Becerra, MC (corresponding author), Harvard Med Sch, Dept Global Hlth & Social Med, Boston, MA 02115 USA.; Becerra, MC (corresponding author), Socios Salud Sucursal Peru, Lima, Peru.	Mercedes_Becerra@hms.harvard.edu		Lecca, Leonid/0000-0003-1363-3985; Keshavjee, Salmaan/0000-0002-6967-3305	Cassell Family Fund; Johnson and Johnson Global Public Health; Harvard Medical School Center for Global Health Delivery; American Lung Association [CA-683831]; National Institute of Allergy and Infectious Diseases of the National Institutes of Health [K01AI151083]; National Institutes of Health [1DP2MD015102]	Cassell Family Fund; Johnson and Johnson Global Public Health; Harvard Medical School Center for Global Health Delivery; American Lung Association; National Institute of Allergy and Infectious Diseases of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Geospatial data collection was supported by grants from the Cassell Family Fund, Johnson and Johnson Global Public Health, and the Harvard Medical School Center for Global Health Delivery. MBB was supported by awards from the American Lung Association (CA-683831) and the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (award number K01AI151083); CMY, HEJ, and MBB were supported by an award from the National Institutes of Health (award number 1DP2MD015102). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The content is solely the responsibility of the authors and does not necessarily represent the official views of the funding organizations.	Alarcon Valentina, 2017, Rev Peru Med Exp Salud Publica, V34, P299, DOI 10.17843/rpmesp.2017.342.2384; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Cohen T, 2007, J R SOC INTERFACE, V4, P523, DOI 10.1098/rsif.2006.0193; Dangisso MH, 2015, GLOBAL HEALTH ACTION, V8, DOI 10.3402/gha.v8.29443; Davis JL, 2013, LANCET INFECT DIS, V13, P147, DOI 10.1016/S1473-3099(12)70232-3; Horton KC, 2016, PLOS MED, V13, DOI [10.1371/journal.pmed.1002119, 10.1371/journal.pmed.1002152]; Keshavjee S., 2020, CLIN TUBERCULOSIS, V6th, P401; Kiani B, 2021, BMC PUBLIC HEALTH, V21; Martinez L, 2019, LANCET RESP MED, V7, P544, DOI 10.1016/S2213-2600(19)30137-7; McCreesh N, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-23797-2; National Institute of Statistics and Informatics Peru, 2017, CENS CAR; Robsky KO, 2020, INFECT DIS POVERTY, V9, DOI 10.1186/s40249-020-00687-2; Sasson C, 2012, ACAD EMERG MED, V19, P139, DOI 10.1111/j.1553-2712.2011.01284.x; Shabanikiya H, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08911-2; Shaweno D, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1178-4; Theron G, 2015, LANCET, V386, P2324, DOI 10.1016/S0140-6736(15)00321-9; WHO, 2021, B WORLD HEALTH ORGAN, DOI DOI 10.2471/BLT.21.286807; World Health Organization, 2019 COUNTR PROF PER; Yuen CM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247411	19	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265826	10.1371/journal.pone.0265826	http://dx.doi.org/10.1371/journal.pone.0265826			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324987	gold, Green Published			2022-12-26	WOS:000780951300076
J	Acacio, M; Atkinson, PW; Silva, JP; Franco, AMA				Acacio, Marta; Atkinson, Philip W.; Silva, Joao Paulo; Franco, Aldina M. A.			Performance of GPS/GPRS tracking devices improves with increased fix interval and is not affected by animal deployment	PLOS ONE			English	Article							GLOBAL POSITIONING SYSTEM; RADIO-COLLAR PERFORMANCE; LOCATION DATA; GPS; HABITAT; ACCURACY; MOVEMENT; BIAS; BEHAVIOR; ORIENTATION	The use of GPS tracking technologies has revolutionized the study of animal movement providing unprecedentedly detailed information. The characterization of GPS accuracy and precision under different conditions is essential to correctly identify the spatial and temporal resolution at which studies can be conducted. Here, we examined the influence of fix acquisition interval and device deployment on the performance of a new GPS/GSM solar powered device. Horizontal and vertical accuracy and precision of locations were obtained under different GPS fix acquisition intervals (1min, 20 min and 60 min) in a stationary test. The test devices were deployed on pre-fledgling white storks (Ciconia ciconia) and we quantified accuracy and precision after deployment while controlling for bias caused by variation in habitat, topography, and animal movement. We also assessed the performance of GPS-Error, a metric provided by the device, at identifying inaccurate locations (> 10 m). Average horizontal accuracy varied between 3.4 to 6.5 m, and vertical accuracy varied between 4.9 to 9.7 m, in high (1 min) and low frequency (60 min) GPS fix intervals. These values were similar after the deployment on white storks. Over 84% of GPS horizontal positions and 71% of vertical positions had less than 10m error in accuracy. Removing 3% of data with highest GPS-Error eliminated over 99% of inaccurate positions in high GPS frequency intervals, but this metric was not effective in the low frequency intervals. We confirmed the suitability of these devices for studies requiring horizontal and vertical accuracies of 5-10m. For higher accuracy data, intensive GPS fix intervals should be used, but this requires more sophisticated battery management, or larger batteries and devices.	[Acacio, Marta; Franco, Aldina M. A.] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England; [Atkinson, Philip W.] British Trust Ornithol, Nunnery, Thetford, England; [Silva, Joao Paulo] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, Lab Associado, CIBIO InBio, Vairao, Portugal; [Silva, Joao Paulo] Univ Lisbon, Ctr Invest Biodiversidade & Recursos Genet, Inst Super Agron, Lab Associado,CIBIO InBio, Lisbon, Portugal; [Silva, Joao Paulo] Univ Porto, BIOPOLIS Program Genom Biodivers & Land Planning, Vairao, Portugal	University of East Anglia; British Trust for Ornithology; Universidade do Porto; Universidade de Lisboa; Universidade do Porto	Acacio, M (corresponding author), Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England.	m.serra-acacio@uea.ac.uk	Acácio, Marta/GLR-5221-2022; Franco, Aldina/G-2144-2010	Acácio, Marta/0000-0002-9947-1181; Franco, Aldina/0000-0001-6055-7378	Natural Environment Research Council (NERC); Engineering and Physical Sciences Research Council (EPSRC), via the NEXUSS CDT Training in the Smart and Autonomous Observation of the Environment [NE/N012070/1]; NERC via the EnvEast DTP [NE/K006312]; Norwich Research Park Translational Fund; University of East Anglia Innovation Funds; Earth and Life Systems Alliance funds; FEDER Funds through the Operational Competitiveness Factors Program - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT) [POCI-01-0145-FEDER-028176]; FCT [SFRH/BPD/111084/2015];  [NE/ K006312]	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Engineering and Physical Sciences Research Council (EPSRC), via the NEXUSS CDT Training in the Smart and Autonomous Observation of the Environment(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); NERC via the EnvEast DTP; Norwich Research Park Translational Fund; University of East Anglia Innovation Funds; Earth and Life Systems Alliance funds; FEDER Funds through the Operational Competitiveness Factors Program - COMPETE; Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); 	This research was funded by Natural Environment Research Council (NERC) and Engineering and Physical Sciences Research Council (EPSRC), via the NEXUSS CDT Training in the Smart and Autonomous Observation of the Environment (NE/N012070/1). Funding for this project was also provided by NERC via the EnvEast DTP (NE/K006312), Norwich Research Park Translational Fund, University of East Anglia Innovation Funds and Earth and Life Systems Alliance funds. This research also benefited from FEDER Funds through the Operational Competitiveness Factors Program - COMPETE and by national funds through Fundacao para a Ciencia e Tecnologia (FCT) within the scope of the project POCI-01-0145-FEDER-028176. JPS was funded by the FCT project SFRH/BPD/111084/2015. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068496; Augustine BC, 2011, ECOL MODEL, V222, P3616, DOI 10.1016/j.ecolmodel.2011.08.026; Belant JL, 2009, NORTHEAST NAT, V16, P577, DOI 10.1656/045.016.n407; Bjorneraas K, 2010, J WILDLIFE MANAGE, V74, P1361, DOI 10.2193/2009-405; Bouten W, 2013, J ORNITHOL, V154, P571, DOI 10.1007/s10336-012-0908-1; Bridge ES, 2011, BIOSCIENCE, V61, P689, DOI 10.1525/bio.2011.61.9.7; Byrne ME, 2017, CONDOR, V119, P389, DOI 10.1650/CONDOR-16-76.1; Cain JW, 2005, WILDLIFE SOC B, V33, P926, DOI 10.2193/0091-7648(2005)33[926:IOTAGF]2.0.CO;2; Cargnelutti B, 2007, J WILDLIFE MANAGE, V71, P1380, DOI 10.2193/2006-257; D'Eon RG, 2005, J APPL ECOL, V42, P383, DOI 10.1111/j.1365-2664.2005.01010.x; D'Eon RG, 2003, J WILDLIFE MANAGE, V67, P858, DOI 10.2307/3802693; D'Eon RG, 2002, WILDLIFE SOC B, V30, P430; DeCesare NJ, 2005, WILDLIFE SOC B, V33, P935, DOI 10.2193/0091-7648(2005)33[935:EOFCOG]2.0.CO;2; Dewhirst OP, 2016, ECOL EVOL, V6, P6210, DOI 10.1002/ece3.2359; Direccao Geral do Territorio, RED GEOD INT; Dussault C, 2001, WILDLIFE SOC B, V29, P171; Fischer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199617; Forin-Wiart MA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129271; Frair JL, 2010, PHILOS T R SOC B, V365, P2187, DOI 10.1098/rstb.2010.0084; Frair JL, 2004, J APPL ECOL, V41, P201, DOI 10.1111/j.0021-8901.2004.00902.x; Gilbert NI, 2016, MOV ECOL, V4, DOI 10.1186/s40462-016-0070-0; Graves TA, 2006, J WILDLIFE MANAGE, V70, P844, DOI 10.2193/0022-541X(2006)70[844:UTCOMG]2.0.CO;2; Hansen MC, 2008, J WILDLIFE MANAGE, V72, P518, DOI 10.2193/2006-493; Hijmans R. J., 2019, R PACKAGE VERSION 1, DOI DOI 10.1093/sysbio/syv088; Ironside KE, 2017, WILDLIFE BIOL, DOI 10.2981/wlb.00229; Jiang Z, 2008, ECOL RES, V23, P581, DOI 10.1007/s11284-007-0412-x; Katzner TE, 2020, FRONT ECOL EVOL, V7, DOI 10.3389/fevo.2019.00519; Khosravifard S, 2020, WILDLIFE SOC B, V44, P191, DOI 10.1002/wsb.1056; Kolzsch A., 2016, ANIM BIOTELEM, V4; Laver PN, 2015, ECOL INFORM, V27, P11, DOI 10.1016/j.ecoinf.2015.02.001; Lewis JS, 2007, J APPL ECOL, V44, P663, DOI 10.1111/j.1365-2664.2007.01286.x; MacGougan GD, 2003, THESIS U CALGARY CAN; Mattisson J, 2010, J WILDLIFE MANAGE, V74, P557, DOI 10.2193/2009-157; Mayer M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0256608; Mills KJ, 2006, WILDLIFE SOC B, V34, P1463, DOI 10.2193/0091-7648(2006)34[1463:EOVSFO]2.0.CO;2; Moen R, 1997, J WILDLIFE MANAGE, V61, P530, DOI 10.2307/3802612; Montgomery RA, 2011, J WILDLIFE MANAGE, V75, P702, DOI 10.1002/jwmg.96; Morehouse AT, 2013, WILDLIFE SOC B, V37, P596, DOI 10.1002/wsb.292; Nathan R, 2008, P NATL ACAD SCI USA, V105, P19052, DOI 10.1073/pnas.0800375105; Poessel SA, 2018, J APPL ECOL, V55, P2064, DOI 10.1111/1365-2664.13135; Quaglietta L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029235; Quectel Wireless Solutions Co. Ltd, QUECT INT; Ramos RF, 2019, J ORNITHOL, V160, P463, DOI 10.1007/s10336-019-01635-0; RCore Team, 2020, R LANG ENV STAT COMP; Recio MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028225; Sager-Fradkin KA, 2007, J WILDLIFE MANAGE, V71, P1298, DOI 10.2193/2006-367; Santos CD, 2020, J ANIM ECOL, V89, P1317, DOI 10.1111/1365-2656.13201; Schaub T, 2020, IBIS, V162, P520, DOI 10.1111/ibi.12788; Soriano-Redondo A, 2021, SCI TOTAL ENVIRON, V782, DOI 10.1016/j.scitotenv.2021.146843; Soriano-Redondo A, 2020, IBIS, V162, P581, DOI 10.1111/ibi.12809; Swaisgood, 2015, ANIM BIOTELEM, V3, P1, DOI DOI 10.1186/S40317-015-0087-Y; Tomkiewicz SM, 2010, PHILOS T R SOC B, V365, P2163, DOI 10.1098/rstb.2010.0090; Tracey JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101205; Weaver SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124696; Webb SL, 2013, WILDLIFE BIOL, V19, P257, DOI 10.2981/12-038; Wikelski M., 2020, MOVEBANK ARCH ANAL S	56	0	0	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265541	10.1371/journal.pone.0265541	http://dx.doi.org/10.1371/journal.pone.0265541			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353826	Green Accepted, gold, Green Published			2022-12-26	WOS:000786647900044
J	Baecklund, F; Alexanderson, KAE; Mittendorfer-Rutz, E; Chen, LJ				Baecklund, Fredrik; Alexanderson, Kristina A. E.; Mittendorfer-Rutz, Ellenor; Chen, Lingjing			Sickness absence and disability pension trajectories in childhood cancer survivors and references- a Swedish prospective cohort study	PLOS ONE			English	Article							ADULT SURVIVORS; POPULATION; IMPACT; UNEMPLOYMENT; ADOLESCENCE; EMPLOYMENT; EDUCATION; OUTCOMES; DISEASE	BackgroundChildhood cancer survivors are at high risk of chronic health conditions. We aimed to explore future long-term sickness absence and disability pension in young adult childhood cancer survivors and matched references. MethodsWe performed a prospective cohort study using microdata from five Swedish nationwide registers. Among all individuals born 1976-1998 and living in Sweden, we included 3632 childhood cancer survivors and 17,468 matched references that could be followed-up for 15, 10, or 5 years, respectively. A group-based trajectory model was applied to identify trajectories of mean annual sickness absence and/or disability pension days (SADP) in each sub-cohort, with 95% confidence intervals (CI). Potential risk factors for trajectory belonging were explored using chi(2) test and multinomial logistic regression. ResultsMost young adult childhood cancer survivors (90.2-96.5%) and references (97.4-98.8%) followed a No SADP trajectory. A larger proportion of childhood cancer survivors than references followed a Moderate (33-102 days/year) or High (115-260 days/year) SADP trajectory (15-year follow-up cohorts: Moderate 4.6% versus 1.2%; High 5.1% versus 1.5%). Childhood cancer survivors of central nervous system (CNS) tumors were at higher risk of the High SADP trajectory than childhood cancer survivors of hematological or non-CNS solid tumors (hematological versus CNS: odds ratio = 2.30, 95% CI 1.23-4.30; hematological versus non-CNS: odds ratio = 0.32, 95% CI 0.13-0.79). ConclusionsAlthough most young adult childhood cancer survivors had no SADP during follow-up, 9.7% experienced moderate or high numbers of SADP days/year throughout the 15-year follow-up; compared to 2.7% among references. CNS tumor survivors were at particular risk of SADP long-term and need extra attention in their future work prospect.	[Baecklund, Fredrik] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Baecklund, Fredrik] Karolinska Univ Hosp, Pediat Oncol Unit, Stockholm, Sweden; [Alexanderson, Kristina A. E.; Mittendorfer-Rutz, Ellenor; Chen, Lingjing] Karolinska Inst, Dept Clin Neurosci, Div Insurance Med, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Baecklund, F (corresponding author), Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden.; Baecklund, F (corresponding author), Karolinska Univ Hosp, Pediat Oncol Unit, Stockholm, Sweden.	fredrik.baecklund@ki.se			Swedish Childhood Cancer Foundation [PR2020-0095]; Swedish Research Council [2017-00624]	Swedish Childhood Cancer Foundation(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission)	L.C. was supported by the Swedish Childhood Cancer Foundation (PR2020-0095). The data utilized was from the REWHARD consortium, supported by the Swedish Research Council (2017-00624). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had no role in study design, data collection or analysis, decision to publish, or preparation of the manuscript.	Ahomaki R, 2017, J CANCER SURVIV, V11, P284, DOI 10.1007/s11764-016-0574-z; [Anonymous], MICRODATA ANALYSES S; [Anonymous], 2019, SOCIAL INSURANCE FIG; [Anonymous], 2013, CHILDHOOD CANC INCID; [Anonymous], 1957, MAN INT STAT CLASS D; Armstrong GT, 2014, J CLIN ONCOL, V32, P1218, DOI 10.1200/JCO.2013.51.1055; Bhakta N, 2017, LANCET, V390, P2569, DOI 10.1016/S0140-6736(17)31610-0; Blinder VS, 2020, J CLIN ONCOL, V38, P302, DOI 10.1200/JCO.19.01856; Boman KK, 2010, CANCER-AM CANCER SOC, V116, P1385, DOI 10.1002/cncr.24840; Brinkman TM, 2018, J CLIN ONCOL, V36, DOI 10.1200/JCO.2017.76.5552; Brooke HL, 2017, EUR J EPIDEMIOL, V32, P765, DOI 10.1007/s10654-017-0316-1; Burton K., 2006, IS WORK GOOD YOUR HL; Chen LJ, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245246; Childhood Cancer Survivor Study, 2016, BAS DAT ST JUD CHILD; de Boer AGEM, 2006, CANCER, V107, P1, DOI 10.1002/cncr.21974; Dieluweit U, 2011, PEDIATR BLOOD CANCER, V56, P432, DOI 10.1002/pbc.22806; Dumas A, 2016, BRIT J CANCER, V114, P1060, DOI 10.1038/bjc.2016.62; Frederiksen LE, 2019, INT J CANCER, V144, P1796, DOI 10.1002/ijc.31789; Frobisher C, 2017, INT J CANCER, V140, P2678, DOI 10.1002/ijc.30696; Ghaderi S, 2013, BRIT J CANCER, V108, P1525, DOI 10.1038/bjc.2013.107; Gunnes MW, 2016, CANCER-AM CANCER SOC, V122, P3873, DOI 10.1002/cncr.30253; Hjern A, 2007, J CLIN ONCOL, V25, P5262, DOI 10.1200/JCO.2007.12.3802; Johansson E, 2012, J EPIDEMIOL COMMUN H, V66, P901, DOI 10.1136/jech-2011-200317; Jones B, 2019, TRAJ GROUP BASED MOD; Kirchhoff AC, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv057; Ludvigsson JF, 2019, EUR J EPIDEMIOL, V34, P423, DOI 10.1007/s10654-019-00511-8; Ludvigsson JF, 2015, CLIN EPIDEMIOL, V7, P491, DOI 10.2147/CLEP.S90589; Ludvigsson JF, 2016, EUR J EPIDEMIOL, V31, P125, DOI 10.1007/s10654-016-0117-y; Lund LW, 2011, PEDIATR BLOOD CANCER, V56, P532, DOI 10.1002/pbc.22883; Maule M, 2017, EUR J CANCER PREV, V26, P351, DOI 10.1097/CEJ.0000000000000258; Multi-generation register, 2013, DESCR CONT QUAL, P2; Nagin DS, 2014, ANN NUTR METAB, V65, P205, DOI 10.1159/000360229; Nagin DS, 2010, ANNU REV CLIN PSYCHO, V6, P109, DOI 10.1146/annurev.clinpsy.121208.131413; Shiri R, 2021, INT ARCH OCC ENV HEA, V94, P843, DOI 10.1007/s00420-020-01630-6; Vassal G, 2016, J Cancer Policy, V8, P17, DOI 10.1016/j.jcpo.2016.03.007; Vuotto SC, 2017, CANCER-AM CANCER SOC, V123, P521, DOI 10.1002/cncr.30348; Wikman A, 2005, J EPIDEMIOL COMMUN H, V59, P450, DOI 10.1136/jech.2004.025346; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053; www.socialstyrelsen.se, SWEDISH CANC REGISTE	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265827	10.1371/journal.pone.0265827	http://dx.doi.org/10.1371/journal.pone.0265827			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363802	Green Published, gold			2022-12-26	WOS:000804748600047
J	Gebrecherkos, T; Kiros, YK; Challa, F; Abdella, S; Gebreegzabher, A; Leta, D; Desta, A; Hailu, A; Tasew, G; Abdulkader, M; Tessema, M; Tollera, G; Kifle, T; Arefaine, ZG; Schallig, HHDF; Adams, ER; Urban, BC; de Wit, TFR; Wolday, D				Gebrecherkos, Teklay; Kiros, Yazezew Kebede; Challa, Feyissa; Abdella, Saro; Gebreegzabher, Atsbeha; Leta, Dereje; Desta, Abraham; Hailu, Ataklti; Tasew, Geremew; Abdulkader, Mahmud; Tessema, Masresha; Tollera, Getachew; Kifle, Tsigereda; Arefaine, Zekarias Gessesse; Schallig, Henk H. D. F.; Adams, Emily R.; Urban, Britta C.; de Wit, Tobias F. Rinke; Wolday, Dawit			Longitudinal profile of antibody response to SARS-CoV-2 in patients with COVID-19 in a setting from Sub-Saharan Africa: A prospective longitudinal study	PLOS ONE			English	Article							DIAGNOSIS	BackgroundSerological testing for SARS-CoV-2 plays an important role for epidemiological studies, in aiding the diagnosis of COVID-19, and assess vaccine responses. Little is known on dynamics of SARS-CoV-2 serology in African settings. Here, we aimed to characterize the longitudinal antibody response profile to SARS-CoV-2 in Ethiopia. MethodsIn this prospective study, a total of 102 PCR-confirmed COVID-19 patients were enrolled. We obtained 802 plasma samples collected serially. SARS-CoV-2 antibodies were determined using four lateral flow immune-assays (LFIAs), and an electrochemiluminescent immunoassay. We determined longitudinal antibody response to SARS-CoV-2 as well as seroconversion dynamics. ResultsSerological positivity rate ranged between 12%-91%, depending on timing after symptom onset. There was no difference in positivity rate between severe and non-severe COVID-19 cases. The specificity ranged between 90%-97%. Agreement between different assays ranged between 84%-92%. The estimated positive predictive value (PPV) for IgM or IgG in a scenario with seroprevalence at 5% varies from 33% to 58%. Nonetheless, when the population seroprevalence increases to 25% and 50%, there is a corresponding increases in the estimated PPVs. The estimated negative-predictive value (NPV) in a low seroprevalence scenario (5%) is high (>99%). However, the estimated NPV in a high seroprevalence scenario (50%) for IgM or IgG is reduced significantly to 80% to 85%. Overall, 28/102 (27.5%) seroconverted by one or more assays tested, within a median time of 11 (IQR: 9-15) days post symptom onset. The median seroconversion time among symptomatic cases tended to be shorter when compared to asymptomatic patients [9 (IQR: 6-11) vs. 15 (IQR: 13-21) days; p = 0.002]. Overall, seroconversion reached 100% 5.5 weeks after the onset of symptoms. Notably, of the remaining 74 COVID-19 patients included in the cohort, 64 (62.8%) were positive for antibody at the time of enrollment, and 10 (9.8%) patients failed to mount a detectable antibody response by any of the assays tested during follow-up. ConclusionsLongitudinal assessment of antibody response in African COVID-19 patients revealed heterogeneous responses. This underscores the need for a comprehensive evaluation of seroassays before implementation. Factors associated with failure to seroconvert needs further research.	[Gebrecherkos, Teklay; Kiros, Yazezew Kebede; Abdulkader, Mahmud; Arefaine, Zekarias Gessesse; Wolday, Dawit] Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia; [Challa, Feyissa; Abdella, Saro; Gebreegzabher, Atsbeha; Leta, Dereje; Tasew, Geremew; Tessema, Masresha; Tollera, Getachew; Kifle, Tsigereda; Wolday, Dawit] Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia; [Desta, Abraham; Hailu, Ataklti] Tigray Hlth Res Inst, Mekelle, Ethiopia; [Schallig, Henk H. D. F.] Univ Amsterdam, Amsterdam Inst Infect & Immun, Acad Med Ctr, Dept Med Microbiol, Amsterdam, Netherlands; [Schallig, Henk H. D. F.] Univ Amsterdam, Amsterdam Inst Infect & Immun, Acad Med Ctr, Infect Prevent,Expt Parasitol Unit, Amsterdam, Netherlands; [Adams, Emily R.; Urban, Britta C.] Univ Liverpool Liverpool Sch Trop Med, Liverpool, Merseyside, England; [de Wit, Tobias F. Rinke] Univ Amsterdam, Acad Med Ctr, Amsterdam Inst Global Hlth & Dev, Amsterdam, Netherlands	Mekelle University; University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; Liverpool School of Tropical Medicine; University of Amsterdam; Academic Medical Center Amsterdam	Wolday, D (corresponding author), Mekelle Univ, Coll Hlth Sci, Mekelle, Ethiopia.; Wolday, D (corresponding author), Ethiopian Publ Hlth Inst, Addis Ababa, Ethiopia.	dawwol@gmail.com		waka, Feyissa Challa/0000-0002-2624-6661; Tasew, Geremew/0000-0002-2797-824X	European and Developing Countries Clinical Trials Partnership (EDCTP) -European Union [RIA-2020EF-2095]	European and Developing Countries Clinical Trials Partnership (EDCTP) -European Union	This research is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) -European Union (Grant #: RIA-2020EF-2095).	Abraha HE, 2021, INT J INFECT DIS, V105, P776, DOI 10.1016/j.ijid.2021.03.037; Basgalupp S, 2021, DIAGNOSTICS, V11, DOI 10.3390/diagnostics11081441; Bastos ML, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m2516; Bohn MK, 2020, CLIN CHEM LAB MED, V58, P1037, DOI 10.1515/cclm-2020-0722; Boum Y, 2021, LANCET INFECT DIS, V21, P1089, DOI 10.1016/S1473-3099(21)00132-8; Charlton CL, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01361-20; Chen SY, 2020, EMERG MICROBES INFEC, V9, P2157, DOI 10.1080/22221751.2020.1825016; Fai KN, 2021, SCI AFR, V12, DOI 10.1016/j.sciaf.2021.e00802; Gudbjartsson DF, 2020, NEW ENGL J MED, V383, P1724, DOI 10.1056/NEJMoa2026116; International Severe Acute Respiratory and Emerging Infection Consortium (ISARIC), COVID 19 CRF; Long QX, 2020, NAT MED, V26, P845, DOI 10.1038/s41591-020-0897-1; Ma H, 2020, CELL MOL IMMUNOL, V17, P773, DOI 10.1038/s41423-020-0474-z; Margolin E, 2020, NAT REV MICROBIOL, V18, P690, DOI 10.1038/s41579-020-00441-3; Ndaye AN, 2021, LANCET GLOB HEALTH, V9, pE588, DOI 10.1016/S2214-109X(21)00060-7; Okba NMA, 2020, EMERG INFECT DIS, V26, P1478, DOI 10.3201/eid2607.200841; Ong DSY, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.05.028; Oved K, 2020, ECLINICALMEDICINE, V29-30, DOI 10.1016/j.eclinm.2020.100651; Peeling RW, 2020, LANCET RESP MED, V8, P836, DOI 10.1016/S2213-2600(20)30313-1; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Rijkers G, 2020, J INFECT DIS, V222, P1265, DOI 10.1093/infdis/jiaa463; Serre-Miranda C, 2021, INT J INFECT DIS, V104, P661, DOI 10.1016/j.ijid.2021.01.038; Sethuraman N, 2020, JAMA-J AM MED ASSOC, V323, P2249, DOI 10.1001/jama.2020.8259; Therrien C, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02511-20; Trombetta BA, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06257-7; Tso FY, 2021, INT J INFECT DIS, V102, P577, DOI 10.1016/j.ijid.2020.10.104; Van Elslande J, 2020, CLIN MICROBIOL INFEC, V26, P1082, DOI 10.1016/j.cmi.2020.05.023; Wajnberg A, 2020, LANCET MICROBE, V1, pE283, DOI 10.1016/S2666-5247(20)30120-8; Whitman JD, 2020, NAT BIOTECHNOL, V38, P1174, DOI [10.1038/s41587-020-0659-0, 10.1101/2020.04.25.20074856]; World Health Organization, REP WHO CHIN JOINT M; Yadouleton A, 2021, EMERG INFECT DIS, V27, P233, DOI 10.3201/eid2701.203281; Zhang YC, 2020, EMERG MICROBES INFEC, V9, P833, DOI 10.1080/22221751.2020.1756699; Zhao JJ, 2020, CLIN INFECT DIS, V71, P2027, DOI 10.1093/cid/ciaa344	32	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263627	10.1371/journal.pone.0263627	http://dx.doi.org/10.1371/journal.pone.0263627			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320286	Green Published, Green Accepted, gold			2022-12-26	WOS:000784240600017
J	Lei, H; Haney, S; Jernigan, CM; Guo, XJ; Cook, CN; Bazhenov, M; Smith, BH				Lei, Hong; Haney, Seth; Jernigan, Christopher M.; Guo, Xiaojiao; Cook, Chelsea N.; Bazhenov, Maxim; Smith, Brian H.			Novelty detection in early olfactory processing of the honey bee, Apis mellifera	PLOS ONE			English	Article							LATENT INHIBITION; MUSHROOM BODIES; ANTENNAL MOVEMENTS; REPRESENTATION; PLASTICITY; RESPONSES; BRAIN; ORGANIZATION; MEMORY; ODORS	Animals are constantly bombarded with stimuli, which presents a fundamental problem of sorting among pervasive uninformative stimuli and novel, possibly meaningful stimuli. We evaluated novelty detection behaviorally in honey bees as they position their antennae differentially in an air stream carrying familiar or novel odors. We then characterized neuronal responses to familiar and novel odors in the first synaptic integration center in the brain-the antennal lobes. We found that the neurons that exhibited stronger initial responses to the odor that was to be familiarized are the same units that later distinguish familiar and novel odors, independently of chemical identities. These units, including both tentative projection neurons and local neurons, showed a decreased response to the familiar odor but an increased response to the novel odor. Our results suggest that the antennal lobe may represent familiarity or novelty to an odor stimulus in addition to its chemical identity code. Therefore, the mechanisms for novelty detection may be present in early sensory processing, either as a result of local synaptic interaction or via feedback from higher brain centers.	[Lei, Hong; Jernigan, Christopher M.; Guo, Xiaojiao; Cook, Chelsea N.; Smith, Brian H.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA; [Haney, Seth; Bazhenov, Maxim] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Guo, Xiaojiao] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14853 USA; [Cook, Chelsea N.] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Beijing 100101, Peoples R China; [Bazhenov, Maxim] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA	Arizona State University; Arizona State University-Tempe; University of California System; University of California San Diego; Cornell University; Chinese Academy of Sciences; Institute of Zoology, CAS; Marquette University	Smith, BH (corresponding author), Arizona State Univ, Sch Life Sci, Tempe, AZ 85281 USA.	brian.h.smith@asu.edu	Lei, Hong/ABH-1356-2020		NIH NIGMS [R01GM113967]; NSF [1556337]; DARPA [HR00111990034]; ONR [N000141612829]; NSF/CIHR/DFG/FRQ/UKRI-MRC Next Generation Networks for Neuroscience Program	NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NSF(National Science Foundation (NSF)); DARPA(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); ONR(Office of Naval Research); NSF/CIHR/DFG/FRQ/UKRI-MRC Next Generation Networks for Neuroscience Program(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Funding: This work was funded by NIH NIGMS R01GM113967 and NSF 1556337 to BHS, DARPA HR00111990034 to BHS and MB, ONR N000141612829 to MB, and a subaward to BHS as part of the NSF/CIHR/DFG/FRQ/UKRI-MRC Next Generation Networks for Neuroscience Program. The funders had no role in study design, data	Arbuckle EP, 2015, JOVE-J VIS EXP, DOI 10.3791/52615; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Bazhenov M, 2005, NEURON, V46, P483, DOI 10.1016/j.neuron.2005.03.022; Berridge KC, 2008, SOC COGNITION, V26, P621, DOI 10.1521/soco.2008.26.5.621; Birgiolas J, 2017, JOVE-J VIS EXP, DOI 10.3791/56803; Chandra SBC, 2010, ANIM COGN, V13, P805, DOI 10.1007/s10071-010-0329-6; Chandra SBC, 2000, J COMP PSYCHOL, V114, P86, DOI 10.1037//0735-7036.114.1.86; Chen JY, 2015, J NEUROSCI, V35, P179, DOI 10.1523/JNEUROSCI.2345-14.2015; Chole H, 2015, LEARN MEMORY, V22, P604, DOI 10.1101/lm.038448.115; Connor EG, 2018, EXP FLUIDS, V59, DOI 10.1007/s00348-018-2591-3; Conway ARA., 2006, VARIATION WORKING ME; Crimaldi J, 2022, J COMPUT NEUROSCI, V50, P1, DOI 10.1007/s10827-021-00798-1; Das S, 2011, P NATL ACAD SCI USA, V108, pE646, DOI 10.1073/pnas.1106411108; Deisig N, 2006, EUR J NEUROSCI, V24, P1161, DOI 10.1111/j.1460-9568.2006.04959.x; Farooqui T, 2003, J NEUROSCI, V23, P5370; Fernandez PC, 2009, J NEUROSCI, V29, P10191, DOI 10.1523/JNEUROSCI.1874-09.2009; Grabenhorst F, 2007, J NEUROSCI, V27, P13532, DOI 10.1523/JNEUROSCI.3337-07.2007; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Grunewald B, 1999, J COMP NEUROL, V404, P114; Hallem EA, 2006, CELL, V125, P143, DOI 10.1016/j.cell.2006.01.050; HAMMER M, 1995, J NEUROSCI, V15, P1617, DOI 10.1523/JNEUROSCI.15-03-01617.1995; HAMMER M, 1993, NATURE, V366, P59, DOI 10.1038/366059a0; Hattori D, 2017, CELL, V169, P956, DOI 10.1016/j.cell.2017.04.028; Heisenberg M, 1998, LEARN MEMORY, V5, P1; Hodge RD, 2019, NATURE, V573, P61, DOI 10.1038/s41586-019-1506-7; Hu AQ, 2010, P NATL ACAD SCI USA, V107, P10262, DOI 10.1073/pnas.0914912107; Huston SJ, 2015, NEURON, V88, P403, DOI 10.1016/j.neuron.2015.09.007; Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040; Johnson BA, 1999, J COMP NEUROL, V409, P529; Johnson BA, 2002, J COMP NEUROL, V449, P180, DOI 10.1002/cne.10284; KEVAN PG, 1985, P NATL ACAD SCI USA, V82, P4750, DOI 10.1073/pnas.82.14.4750; Kisch J, 1999, BEHAV BRAIN RES, V99, P93, DOI 10.1016/S0166-4328(98)00076-X; Lei H, 2004, J NEUROSCI, V24, P11108, DOI 10.1523/JNEUROSCI.3677-04.2004; Lewis-Peacock JA, 2018, ANN NY ACAD SCI, V1424, P33, DOI 10.1111/nyas.13714; Li F, 2020, ELIFE, V9, DOI 10.7554/eLife.62576; Locatelli FF, 2016, J EXP BIOL, V219, P2752, DOI 10.1242/jeb.141465; Locatelli FF, 2013, EUR J NEUROSCI, V37, P63, DOI 10.1111/ejn.12021; LOVELACE CT, 1995, CHEM SENSES, V20, P183, DOI 10.1093/chemse/20.2.183; LUBOW RE, 1959, J COMP PHYSIOL PSYCH, V52, P415, DOI 10.1037/h0046700; Ma LM, 2012, P NATL ACAD SCI USA, V109, P5481, DOI 10.1073/pnas.1117491109; MACKINTOSH NJ, 1975, PSYCHOL REV, V82, P276, DOI 10.1037/h0076778; Martin JP, 2011, PROG NEUROBIOL, V95, P427, DOI 10.1016/j.pneurobio.2011.09.007; Matsumoto Y, 2006, BIOL LETT-UK, V2, P608, DOI 10.1098/rsbl.2006.0540; McAfee A, 2017, SCI REP-UK, V7, DOI 10.1038/srep46171; Meyer A, 2013, J NEUROPHYSIOL, V110, P2465, DOI 10.1152/jn.00260.2013; Mondet F, 2021, NAT CHEM BIOL, V17, P524, DOI 10.1038/s41589-020-00720-3; Nawrot MP, 2010, SPR SER COMPUT NEURO, V7, P37, DOI 10.1007/978-1-4419-5675-0_3; Nawrot MP, 2003, BIOL CYBERN, V88, P321, DOI 10.1007/s00422-002-0391-5; Nishiyama K, 2007, J COMP PHYSIOL A, V193, P963, DOI 10.1007/s00359-007-0249-3; Oberauer K, 2018, ANN NY ACAD SCI, V1424, P239, DOI 10.1111/nyas.13603; Ramaswami M, 2014, NEURON, V82, P1216, DOI 10.1016/j.neuron.2014.04.035; Riffell JA, 2013, SCIENCE, V339, P200, DOI 10.1126/science.1225483; Rogers LJ, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00280; RYBAK J, 1993, J COMP NEUROL, V334, P444, DOI 10.1002/cne.903340309; Sachse S, 1999, EUR J NEUROSCI, V11, P3970, DOI 10.1046/j.1460-9568.1999.00826.x; Smith BH, 2014, JOVE-J VIS EXP, DOI 10.3791/51057; Strausfeld NJ, 2002, J COMP NEUROL, V450, P4, DOI 10.1002/cne.10285; Sudhakaran IP, 2012, J NEUROSCI, V32, P7225, DOI 10.1523/JNEUROSCI.1099-12.2012; Trevino Mario, 2011, Int Arch Med, V4, P26, DOI 10.1186/1755-7682-4-26; Wright GA, 2005, P ROY SOC B-BIOL SCI, V272, P2417, DOI 10.1098/rspb.2005.3252; Zheng ZH, 2018, CELL, V174, P730, DOI 10.1016/j.cell.2018.06.019	61	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265009	10.1371/journal.pone.0265009	http://dx.doi.org/10.1371/journal.pone.0265009			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353837	Green Published, Green Submitted, gold			2022-12-26	WOS:000786647900023
J	Matimba, HH; Joachim, A; Mizinduko, MM; Maseke, IA; Nyanga, SK; Kelly, ME; Nyanga, AS; Mghamba, JM; Majigo, MV; Mohamed, AA				Matimba, Hamza Hamad; Joachim, Agricola; Mizinduko, Mucho Michael; Maseke, Irene Anthony; Nyanga, Salum Kassim; Kelly, Maria Ezekiely; Nyanga, Ali Said; Mghamba, Janneth Maridadi; Majigo, Mtebe Venance; Mohamed, Ahmed Abade			Genetic relatedness, virulence factors and antibiotics susceptibility pattern of Vibrio cholerae isolates from various regions during cholera outbreak in Tanzania	PLOS ONE			English	Article							EL-TOR STRAINS; MOLECULAR CHARACTERIZATION; VARIANT; O1; BIOTYPE; ORIGIN	BackgroundCholera continues to cause morbidity and mortality in developing countries, including Tanzania. Since August 2015, Tanzania Mainland has experienced cholera outbreaks affecting 26 regions and a 1.6% case fatality rate. The current study determined the virulence factors, genetic relatedness and antimicrobial susceptibility patterns of the Vibrio cholerae isolated from different regions in Tanzania. MethodsA cross-sectional study that involved the genetic characterization of V. cholerae isolates from eleven regions in Tanzania was carried out. There were 99 V. cholerae isolates collected between January 2016 and December 2017. The study perfomed a Multi-locus Variable-number tandem-repeat analysis for genetic relatedness and Mismatch Amplification Mutation Analysis polymerase chain reaction for analyzing toxin genes. All the isolates were tested for antimicrobial susceptibility using the Kirby Bauer disk diffusion method. Data were generally analyzed using Microsoft excel, where genetic relatedness was analyzed using eBurst software v3. ResultsAll isolates were V. cholerae O1. Ogawa was the most predominant 97(98%) serotype. Isolates were genetically related with a small genetic diversity and were positive for ctxA, tcpA El Tor virulence genes. All isolates (100%) were sensitive to doxycycline, trimethoprim-sulphamethoxazole, tetracycline, ceftriaxone, and chloramphenicol, while 87.8% were sensitive to ciprofloxacin. A high resistance rate (100%) was detected towards erythromycin, nalidixic acid, amoxicillin, and ampicillin. ConclusionThe V.cholerae O1 serotypes Ogawa, El Tor variant predominantly caused cholera outbreaks in Tanzania with strains clonally related regardless of the place and time of the outbreak. Most of the isolates were susceptible to the antibiotic regimen currently used in Tanzania. The high resistance rate detected for the other common antibiotics calls for continuous antimicrobial susceptibility testing during outbreaks.	[Matimba, Hamza Hamad; Mizinduko, Mucho Michael] Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania; [Matimba, Hamza Hamad; Mghamba, Janneth Maridadi; Mohamed, Ahmed Abade] Muhimbili Univ Hlth & Allied Sci, Tanzania Field Epidemiol Lab Training Program, Dar Es Salaam, Tanzania; [Joachim, Agricola; Majigo, Mtebe Venance] Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania; [Maseke, Irene Anthony; Nyanga, Salum Kassim; Kelly, Maria Ezekiely] Natl Hlth Lab Qual Assurance & Training Ctr, Dar Es Salaam, Tanzania; [Nyanga, Ali Said; Mghamba, Janneth Maridadi] Minist Hlth Community Dev Gender Elderly & Childr, Dar Es Salaam, Tanzania	Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences; Muhimbili University of Health & Allied Sciences	Matimba, HH (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Epidemiol & Biostat, Dar Es Salaam, Tanzania.; Matimba, HH (corresponding author), Muhimbili Univ Hlth & Allied Sci, Tanzania Field Epidemiol Lab Training Program, Dar Es Salaam, Tanzania.; Joachim, A (corresponding author), Muhimbili Univ Hlth & Allied Sci, Dept Microbiol & Immunol, Dar Es Salaam, Tanzania.	hamtimba@yahoo.com; agricolaj@yahoo.com		Majigo, Mtebe/0000-0003-3726-2816				Ali M, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003832; Ang GY, 2010, J CLIN MICROBIOL, V48, P3963, DOI 10.1128/JCM.01086-10; Ansaruzzaman M, 2004, EMERG INFECT DIS, V10, P2057, DOI 10.3201/eid1011.040682; Bopp CA, 1999, LAB METHODS DIAGNOSI; CDC, ANT TREATM REC US AN; Chin CS, 2011, NEW ENGL J MED, V364, P33, DOI 10.1056/NEJMoa1012928; Clinical and Laboratory Standards Institute, 2018, M100 CLIN LAB STAND, V28th, DOI DOI 10.1108/08876049410065598; Divya MP, 2014, ANTIMICROB AGENTS CH, V58, P4982, DOI 10.1128/AAC.03189-14; Goel AK, 2010, WORLD J MICROB BIOT, V26, P281, DOI 10.1007/s11274-009-0171-7; Hossain ZZ, 2018, LETT APPL MICROBIOL, V67, P329, DOI 10.1111/lam.13046; Hounmanou YMG, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007934; Kachwamba Y, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2252-9; KAPER JB, 1995, CLIN MICROBIOL REV, V8, P48, DOI 10.1128/CMR.8.1.48; KEASLER SP, 1993, LANCET, V341, P1661, DOI 10.1016/0140-6736(93)90792-F; Keddy KH, 2007, J MED MICROBIOL, V56, P1644, DOI 10.1099/jmm.0.47230-0; Kendall EA, 2010, J BACTERIOL, V192, P4367, DOI 10.1128/JB.00698-10; Kiiru J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074829; Levinson W., 2006, REV MED MICROBIOLOGY, V9 th ed, P143; Mercy N, 2014, PAN AFR MED J, V19, DOI 10.11604/pamj.2014.19.8.2496; Morita M, 2008, MICROBIOL IMMUNOL, V52, P314, DOI 10.1111/j.1348-0421.2008.00041.x; Naha A, 2013, J CLIN MICROBIOL, V51, P1040, DOI 10.1128/JCM.03162-12; Nair GB, 2006, J CLIN MICROBIOL, V44, P4211, DOI 10.1128/JCM.01304-06; Nair GB, 2002, J CLIN MICROBIOL, V40, P3296, DOI 10.1128/JCM.40.9.3296-3299.2002; Okada K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030863; Safa A, 2008, EMERG INFECT DIS, V14, P987, DOI 10.3201/eid1406.080129; Siriphap A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169324; STROEHER UH, 1992, P NATL ACAD SCI USA, V89, P2566, DOI 10.1073/pnas.89.7.2566; Urassa WK, 2000, E AFR MED J, V77, P350; World Health Organization, 2008, CHOL COUNTR PROF UN; Yamasaki S, 1999, FEMS MICROBIOL LETT, V179, P115, DOI 10.1111/j.1574-6968.1999.tb08716.x	30	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265868	10.1371/journal.pone.0265868	http://dx.doi.org/10.1371/journal.pone.0265868			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333909	gold, Green Published			2022-12-26	WOS:000784335700031
J	Sulea, T; Baardsnes, J; Stuible, M; Rohani, N; Tran, A; Parat, M; Donates, YC; Duchesne, M; Plante, P; Kour, G; Durocher, Y				Sulea, Traian; Baardsnes, Jason; Stuible, Matthew; Rohani, Nazanin; Tran, Anh; Parat, Marie; Donates, Yuneivy Cepero; Duchesne, Melanie; Plante, Pierre; Kour, Guneet; Durocher, Yves			Structure-based dual affinity optimization of a SARS-CoV-1/2 cross-reactive single-domain antibody	PLOS ONE			English	Article							BINDING; PROTEIN; CORONAVIRUS; PREDICTION	The SARS coronavirus 2 (SARS-CoV-2) spike (S) protein binding to the human ACE2 receptor is the molecular event that initiates viral entry into host cells and leads to infection and virus replication. There is a need for agents blocking viral entry into host cells that are cross-reactive with emerging virus variants. VHH-72 is an anti-SARS-CoV-1 single-domain antibody that also exhibits cross-specificity with SARS-CoV-2 but with decreased binding affinity. Here we applied a structure-based approach to affinity-mature VHH-72 for the SARS-CoV-2 spike protein while retaining the original affinity for SARS-CoV-1. This was achieved by employing the computational platform ADAPT in a constrained dual-affinity optimization mode as a means of broadening specificity. Select mutants designed by ADAPT were formatted as fusions with a human IgG1-Fc fragment. These mutants demonstrated improved binding to the SARS-CoV-2 spike protein due to decreased dissociation rates. Functional testing for virus neutralization revealed improvements relative to the parental VHH72-Fc up to 10-fold using a SARS-CoV-2 pseudotyped lentivirus and 20-fold against the SARS-CoV-2 authentic live virus (Wuhan variant). Binding and neutralization improvements were maintained for some other SARS-CoV-2 variants currently in circulation. These improved VHH-72 mutants are predicted to establish novel interactions with the S antigen. They will be useful, alone or as fusions with other functional modules, in the global quest for treatments of COVID-19 infections.	[Sulea, Traian; Baardsnes, Jason; Stuible, Matthew; Rohani, Nazanin; Parat, Marie; Donates, Yuneivy Cepero; Duchesne, Melanie; Plante, Pierre; Kour, Guneet; Durocher, Yves] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada; [Tran, Anh] Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Ottawa, ON, Canada	National Research Council Canada; National Research Council Canada	Sulea, T (corresponding author), Natl Res Council Canada, Human Hlth Therapeut Res Ctr, Montreal, PQ, Canada.	traian.sulea@nrc.cnrc.gc.ca	Rohani, Nazanin/GPG-3958-2022	Tran, Anh/0000-0003-0644-6014				Akache B, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-01363-7; Colwill K, 2022, CLIN TRANSL IMMUNOL, V11, DOI 10.1002/cti2.1380; Conchuir SO, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130433; CORNELL WD, 1995, J AM CHEM SOC, V117, P5179, DOI 10.1021/ja00124a002; Cote J, 1998, BIOTECHNOL BIOENG, V59, P567, DOI 10.1002/(SICI)1097-0290(19980905)59:5<567::AID-BIT6>3.3.CO;2-Z; Crawford KHD, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050513; Du LY, 2021, CELL MOL IMMUNOL, V18, P2293, DOI 10.1038/s41423-021-00752-2; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Imai M, 2020, P NATL ACAD SCI USA, V117, P16587, DOI 10.1073/pnas.2009799117; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Ksiazek TG, 2003, NEW ENGL J MED, V348, P1953, DOI 10.1056/NEJMoa030781; Manson JJ, 2020, LANCET RHEUMATOL, V2, pE594, DOI 10.1016/S2665-9913(20)30275-7; Naim M, 2007, J CHEM INF MODEL, V47, P122, DOI 10.1021/ci600406v; Planas D, 2021, NATURE, V596, P276, DOI 10.1038/s41586-021-03777-9; Raybould Matthew I J, 2021, Bioinformatics, V37, P734, DOI 10.1093/bioinformatics/btaa739; Rohl CA, 2004, METHOD ENZYMOL, V383, P66; Schepens B, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.abi7826; Schrag JD, 2019, MABS-AUSTIN, V11, P1300, DOI 10.1080/19420862.2019.1632114; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Shields RL, 2001, J BIOL CHEM, V276, P6591, DOI 10.1074/jbc.M009483200; Starr TN, 2020, CELL, V182, P1295, DOI 10.1016/j.cell.2020.08.012; Stuible M, 2021, J BIOTECHNOL, V326, P21, DOI 10.1016/j.jbiotec.2020.12.005; Sulea T, 2020, MABS-AUSTIN, V12, DOI 10.1080/19420862.2019.1682866; Sulea T, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20599-4; Sulea T, 2016, J CHEM INF MODEL, V56, P1292, DOI 10.1021/acs.jcim.6b00043; Sulea T, 2012, METHODS MOL BIOL, V819, P295, DOI 10.1007/978-1-61779-465-0_19; Tian XL, 2020, EMERG MICROBES INFEC, V9, P382, DOI 10.1080/22221751.2020.1729069; Vivcharuk V, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0181490; Wang PF, 2021, CELL HOST MICROBE, V29, P747, DOI 10.1016/j.chom.2021.04.007; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wrapp D, 2020, CELL, V181, P1004, DOI 10.1016/j.cell.2020.04.031; Yang JY, 2020, NATURE, V586, P572, DOI 10.1038/s41586-020-2599-8; Yang Lifei, 2020, Antib Ther, V3, P205, DOI 10.1093/abt/tbaa020; Yuan M, 2020, SCIENCE, V368, P630, DOI 10.1126/science.abb7269; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	37	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266250	10.1371/journal.pone.0266250	http://dx.doi.org/10.1371/journal.pone.0266250			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353868	Green Published, gold			2022-12-26	WOS:000786647900019
J	Zhang, Q; Yang, XL; Sun, ZK				Zhang, Qian; Yang, XiaoLi; Sun, ZhongKui			Classification of Alzheimer's disease progression based on sMRI using gray matter volume and lateralization index	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; VOXEL-BASED MORPHOMETRY; ASYMMETRY; DEMENTIA; SIGNALS; ATROPHY	Note that identifying Mild Cognitive Impairment (MCI) is crucial to early detection and diagnosis of Alzheimer's disease (AD). This work explores how classification features and experimental algorithms influence classification performances on the ADNI database. Based on structural Magnetic Resonance Images (sMRI), two features including gray matter (GM) volume and lateralization index (LI) are firstly extracted through hypothesis testing. Afterward, several classifier algorithms including Random Forest (RF), Decision Tree (DT), K-Nearest Neighbor(KNN) and Support Vector Machine (SVM) with RBF kernel, Linear kernel or Polynomial kernel are established to realize binary classification among Normal Control (NC), Early Mild Cognitive Impairment (EMCI), Late Mild Cognitive Impairment (LMCI) and AD groups. The main experimental results are as follows. (1) The classification performance in the feature of LI is poor compared with those in the feature of GM volume or the combined feature of LI and GM volume, i.e., the classification accuracies in the feature of LI are relatively low and unstable for most classifier models and subject groups. (2) Comparing with the classification performances in the feature of GM volume and the combined feature of LI and GM volume, the classification accuracy of NC group versus AD group is relatively stable for different classifier models, moreover, the accuracy of AD group versus NC group is almost the highest, with the most classification accuracy of 98.0909%. (3) For different subject groups, the SVM classifier algorithm with Polynomial kernel and the KNN classifier algorithm show relatively stable and high classification accuracy, while DT classifier algo-rithm shows relatively unstable and lower classification accuracy. (4) Except the groups of EMCI versus LMCI and NC versus EMCI, the classification accuracies are significantly enhanced by emerging the LI into the original feature of GM volume, with the maximum accuracy increase of 5.6364%. These results indicate that various factors of subject data, feature types and experimental algorithms influence classification performances remarkably, especially the newly introduced feature of LI into the feature of GM volume is helpful to improve classification results in some certain extent.	[Zhang, Qian; Yang, XiaoLi] Shaanxi Normal Univ, Coll Math & Stat, Xian 710119, Peoples R China; [Sun, ZhongKui] Northwestern Polytech Univ, Dept Appl Math, Xian 710129, Peoples R China	Shaanxi Normal University; Northwestern Polytechnical University	Yang, XL (corresponding author), Shaanxi Normal Univ, Coll Math & Stat, Xian 710119, Peoples R China.	yangxiaoli@snnu.edu.cn			National Natural Science Foundation of China [11972217]; Fundamental Funds Research for the Central Universities [GK201901008]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Funds Research for the Central Universities(Fundamental Research Funds for the Central Universities)	This work is partially supported by the National Natural Science Foundation of China (Grant No.11972217), the Fundamental Funds Research for the Central Universities (Grant Nos. GK201901008).	Beheshti I, 2017, J ALZHEIMERS DIS, V55, P1571, DOI 10.3233/JAD-160850; Ben Ahmed O, 2015, MULTIMED TOOLS APPL, V74, P1249, DOI 10.1007/s11042-014-2123-y; Budson Andrew E, 2012, Pract Neurol, V12, P88, DOI 10.1136/practneurol-2011-000145; Busatto GF, 2003, NEUROBIOL AGING, V24, P221, DOI 10.1016/S0197-4580(02)00084-2; Canditiis D., 2019, ENCY BIOINFORMATICS, P698, DOI [10.1016/B978-0-12-809633-8.20357-9, DOI 10.1016/B978-0-12-809633-8.20357-9]; Chen G, 2011, RADIOLOGY, V259, P213, DOI 10.1148/radiol.10100734; Chetelat G, 2002, NEUROREPORT, V13, P1939; Daliri MR, 2012, J MED SYST, V36, P995, DOI 10.1007/s10916-011-9738-6; den Heijer T, 2006, ARCH GEN PSYCHIAT, V63, P57, DOI 10.1001/archpsyc.63.1.57; Fan Y, 2008, NEUROIMAGE, V39, P1731, DOI 10.1016/j.neuroimage.2007.10.031; Fayed N, 2017, MAGN RESON IMAGING, V38, P27, DOI 10.1016/j.mri.2016.12.010; Frisoni GB, 2002, J NEUROL NEUROSUR PS, V73, P657, DOI 10.1136/jnnp.73.6.657; Gaser C, 2016, HBM, V2016, P336; Iturria-Medina Y, 2011, CEREB CORTEX, V21, P56, DOI 10.1093/cercor/bhq058; John TN, 2018, COGN NEURODYNAMICS, V12, P183, DOI 10.1007/s11571-017-9467-8; Karas GB, 2004, NEUROIMAGE, V23, P708, DOI 10.1016/j.neuroimage.2004.07.006; Kim JH, 2012, NEUROBIOL AGING, V33, P1959, DOI 10.1016/j.neurobiolaging.2011.06.026; Kloppel S, 2008, BRAIN, V131, P681, DOI 10.1093/brain/awm319; Nasrolahzadeh M, 2018, COGN NEURODYNAMICS, V12, P583, DOI 10.1007/s11571-018-9499-8; Ratnarajah N, 2013, NEUROIMAGE, V75, P187, DOI 10.1016/j.neuroimage.2013.02.052; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Schmitter D, 2015, NEUROIMAGE-CLIN, V7, P7, DOI 10.1016/j.nicl.2014.11.001; Smith CD, 2007, NEUROLOGY, V68, P1268, DOI 10.1212/01.wnl.0000259542.54830.34; Suk HI, 2015, BRAIN STRUCT FUNCT, V220, P841, DOI 10.1007/s00429-013-0687-3; Tang XY, 2016, MAGN RESON IMAGING, V34, P1087, DOI 10.1016/j.mri.2016.05.001; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Visser PJ, 1999, J NEUROL, V246, P477, DOI 10.1007/s004150050387; Wang JY, 2019, COGN NEURODYNAMICS, V13, P513, DOI 10.1007/s11571-019-09536-x; Yang WL, 2011, LECT NOTES COMPUT SC, V7062, P265, DOI 10.1007/978-3-642-24955-6_32; Yang XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047406; Young JM, 2015, PROBABILISTIC PREDIC	31	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0262722	10.1371/journal.pone.0262722	http://dx.doi.org/10.1371/journal.pone.0262722			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353825	gold, Green Published			2022-12-26	WOS:000786647900038
J	Zhang, Q; Zhang, Y; Chai, YP				Zhang, Qiang; Zhang, Yan; Chai, Yiping			Optimization of CRISPR/LbCas12a-mediated gene editing in Arabidopsis	PLOS ONE			English	Article							TARGETED MUTAGENESIS; CPF1; RNA; SYSTEM; RICE	CRISPR/LbCas12a system (LbCpf1) has been widely used for genome modification including plant species. However, the efficiency of CRISPR/LbCas12a varied considerably in different plant species and tissues, and the editing efficiency needs to be further improved. In this study, we tried to improve the editing efficiency of CRISPR/LbCas12a in Arabidopsis by optimizing the crRNA expression strategies and Pol II promoters. Notably, the combination of tRNA-crRNA fusion strategy and RPS5A promoter in CRISPR/LbCas12a system has highest editing efficiency, while CRISPR/LbCas12a driven by EC1f-in(crR)p had the highest ratio of homozygous & bi-allelic mutants. In addition, all homozygous & bi-allelic mutants can be stably inherited to the next generation and have no phenotypic separation. In this study, the editing efficiency of the CRISPR/LbCas12a system was improved by selecting the optimal crRNA expression strategies and promoter of LbCas12a in Arabidopsis, which will prove useful for optimization of CRISPR/LbCas12a methods in other plants.	[Zhang, Qiang] Shandong Agr Univ, Coll Plant Protect, Tai An, Peoples R China; [Zhang, Qiang; Zhang, Yan; Chai, Yiping] Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China	Shandong Agricultural University; Jiangsu Academy of Agricultural Sciences	Zhang, Q (corresponding author), Shandong Agr Univ, Coll Plant Protect, Tai An, Peoples R China.; Zhang, Q (corresponding author), Jiangsu Acad Agr Sci, Nanjing, Jiangsu, Peoples R China.	1012224278@qq.com			Jiangsu Provincial Key Research and Development Program [BE2019545]; Shandong Zhongyan Industry Co., Ltd Science and Technology Project [202102004]	Jiangsu Provincial Key Research and Development Program; Shandong Zhongyan Industry Co., Ltd Science and Technology Project	This research was funded by Jiangsu Provincial Key Research and Development Program (BE2019545) and Shandong Zhongyan Industry Co., Ltd Science and Technology Project (202102004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Castel B, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0204778; Chen KL, 2019, ANNU REV PLANT BIOL, V70, P667, DOI 10.1146/annurev-arplant-050718-100049; Ding D, 2018, MOL PLANT, V11, P542, DOI 10.1016/j.molp.2018.02.005; Fonfara I, 2016, NATURE, V532, P517, DOI 10.1038/nature17945; Gao XH, 2016, PLANT PHYSIOL, V171, P1794, DOI 10.1104/pp.16.00663; Hahn F, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00424; Hahn F, 2017, FRONT PLANT SCI, V8, DOI 10.3389/fpls.2017.00039; Hu XX, 2017, J GENET GENOMICS, V44, P71, DOI 10.1016/j.jgg.2016.12.001; Hur JK, 2016, NAT BIOTECHNOL, V34, P807, DOI 10.1038/nbt.3596; Kim D, 2016, NAT BIOTECHNOL, V34, P863, DOI 10.1038/nbt.3609; Li JF, 2013, NAT BIOTECHNOL, V31, P688, DOI 10.1038/nbt.2654; Ma Xingliang, 2016, Curr Protoc Mol Biol, V115, DOI 10.1002/cpmb.10; Malzahn AA, 2019, BMC BIOL, V17, DOI 10.1186/s12915-019-0629-5; Mao YF, 2013, MOL PLANT, V6, P2008, DOI 10.1093/mp/sst121; Nekrasov V, 2013, NAT BIOTECHNOL, V31, P691, DOI 10.1038/nbt.2655; Shan QW, 2013, NAT BIOTECHNOL, V31, P686, DOI 10.1038/nbt.2650; Tang X, 2017, NAT PLANTS, V3, DOI 10.1038/nplants.2017.103; Wang MG, 2018, J INTEGR PLANT BIOL, V60, P626, DOI 10.1111/jipb.12667; Wang MG, 2017, MOL PLANT, V10, P1011, DOI 10.1016/j.molp.2017.03.001; Wang ZP, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0715-0; Xu PH, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.01007; Xu RF, 2019, PLANT BIOTECHNOL J, V17, P553, DOI 10.1111/pbi.13028; Xu RF, 2017, PLANT BIOTECHNOL J, V15, P713, DOI 10.1111/pbi.12669; Xu RF, 2014, RICE, V7, DOI 10.1186/s12284-014-0005-6; Yan LH, 2015, MOL PLANT, V8, P1820, DOI 10.1016/j.molp.2015.10.004; Zetsche B, 2015, CELL, V163, P759, DOI 10.1016/j.cell.2015.09.038; Zhang H, 2014, PLANT BIOTECHNOL J, V12, P797, DOI 10.1111/pbi.12200; Zhang Q, 2018, PLANT MOL BIOL, V96, P445, DOI 10.1007/s11103-018-0709-x; Zhong ZH, 2018, MOL PLANT, V11, P999, DOI 10.1016/j.molp.2018.03.008	29	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265114	10.1371/journal.pone.0265114	http://dx.doi.org/10.1371/journal.pone.0265114			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333864	gold, Green Published			2022-12-26	WOS:000784335700016
J	Zhao, YL; Fan, SX; Yuan, PT; Li, GX				Zhao, Yinli; Fan, Shengxin; Yuan, Pengtao; Li, Guoxi			Expression characteristics and interaction networks of microRNAs in spleen tissues of grass carp (Ctenopharyngodon idella)	PLOS ONE			English	Article							T-CELL DIFFERENTIATION; INNATE IMMUNE-RESPONSE; RAINBOW-TROUT; TRANSCRIPTION FACTORS; IDENTIFICATION; INFECTION; GENES; ACTIVATION; MIR-142-3P; PROLIFERATION	The spleen is an important immune organ in fish. MicroRNAs (miRNAs) have been shown to play an important role in the regulation of immune function. However, miRNA expression profiles and their interaction networks associated with the postnatal late development of spleen tissue are still poorly understood in fish. The grass carp (Ctenopharyngodon idella) is an important economic aquaculture species in China. Here, two small RNA libraries were constructed from the spleen tissue of healthy grass carp at one-year-old and three-year-old. A total of 324 known conserved miRNAs and 9 novel miRNAs were identified by using bioinformatic analysis. Family analysis showed that 23 families such as let-7, mir-1, mir-10, mir-124, mir-8, mir-7, mir-9, and mir-153 were highly conserved between vertebrates and invertebrates. In addition, 14 families such as mir-459, mir-430, mir-462, mir-7147, mir-2187, and mir-722 were present only in fish. Expression analysis showed that the expression patterns of miRNAs in the spleen of one-year-old and three-year-old grass carp were highly consistent, and the percentage of miRNAs with TPM > 100 was above 39%. Twenty significant differentially expressed (SDE) miRNAs were identified. Gene ontology (GO) and the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis showed that these SDE miRNAs were primarily involved in erythrocyte differentiation, lymphoid organ development, immune response, lipid metabolic process, the B cell receptor signaling pathway, the T cell receptor signaling pathway, and the PPAR signaling pathway. In addition, the following miRNA-mRNA interaction networks were constructed: immune and hematopoietic, cell proliferation and differentiation, and lipid metabolism. This study determined the miRNA transcriptome as well as miRNA-mRNA interaction networks in normal spleen tissue during the late development stages of grass carp. The results expand the number of known miRNAs in grass carp and are a valuable resource for better understanding the molecular biology of the spleen development in grass carp.	[Zhao, Yinli] Henan Univ Technol, Coll Biol Engn, Zhengzhou, Henan, Peoples R China; [Fan, Shengxin; Yuan, Pengtao; Li, Guoxi] Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China	Henan University of Technology; Henan Agricultural University	Li, GX (corresponding author), Henan Agr Univ, Coll Anim Sci & Technol, Zhengzhou, Henan, Peoples R China.	liguoxi0914@126.com		Li, Guoxi/0000-0001-8442-8861	Project of Henan University of Technology (CN) [2017XTCX04]	Project of Henan University of Technology (CN)	This work was supported by grants from the Project of Henan University of Technology (CN) (No.2017XTCX04).	Ambros V, 2003, RNA, V9, P277, DOI 10.1261/rna.2183803; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bezman NA, 2011, J EXP MED, V208, P2717, DOI 10.1084/jem.20111386; Bi DK, 2017, MOL IMMUNOL, V83, P107, DOI 10.1016/j.molimm.2017.01.016; Bizuayehu TT, 2014, GENOME BIOL EVOL, V6, P1911, DOI 10.1093/gbe/evu151; Brendolan A, 2007, BIOESSAYS, V29, P166, DOI 10.1002/bies.20528; Cao YS, 2019, FISH SHELLFISH IMMUN, V91, P350, DOI 10.1016/j.fsi.2019.05.048; Carrington JC, 2003, SCIENCE, V301, P336, DOI 10.1126/science.1085242; Chapman LM, 2017, IMMUNOL RES, V65, P828, DOI 10.1007/s12026-017-8919-x; Chaves-Pozo E, 2005, CELL TISSUE RES, V320, P61, DOI 10.1007/s00441-004-1063-7; Che TD, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193552; Chen LM, 2019, J FISH BIOL, V94, P132, DOI 10.1111/jfb.13875; Chen LQ, 2016, J BIOL CHEM, V291, P14706, DOI 10.1074/jbc.M115.700252; Chen ZY, 2017, CELL REP, V20, P2584, DOI 10.1016/j.celrep.2017.08.060; Cho S, 2016, J EXP MED, V213, P235, DOI 10.1084/jem.20150990; Chu F, 2018, CLIN EXP IMMUNOL, V191, P166, DOI 10.1111/cei.13067; Chu Q, 2016, FISH SHELLFISH IMMUN, V54, P537, DOI 10.1016/j.fsi.2016.05.007; Cruz LO, 2017, J CLIN INVEST, V127, P530, DOI 10.1172/JCI88415; dos Santos NMS, 2000, FISH SHELLFISH IMMUN, V10, P583, DOI 10.1006/fsim.2000.0273; Du HQ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200385; Ebhardt HA, 2009, NUCLEIC ACIDS RES, V37, P2461, DOI 10.1093/nar/gkp093; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; ESPENES A, 1995, CELL TISSUE RES, V282, P41, DOI 10.1007/BF00319131; Fang Y, 2020, DEV COMP IMMUNOL, V106, DOI 10.1016/j.dci.2020.103611; Ferretti C, 2014, CELL MOL IMMUNOL, V11, P215, DOI 10.1038/cmi.2014.5; Fordham JB, 2015, J LEUKOCYTE BIOL, V98, P195, DOI 10.1189/jlb.1A1014-519RR; Friedlander MR, 2012, NUCLEIC ACIDS RES, V40, P37, DOI 10.1093/nar/gkr688; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Gagnon JD, 2019, CELL REP, V28, P2169, DOI 10.1016/j.celrep.2019.07.064; Gong WB, 2018, GENOMICS, V110, P414, DOI 10.1016/j.ygeno.2018.09.017; Gong WB, 2017, COMPUT BIOL CHEM, V68, P92, DOI 10.1016/j.compbiolchem.2017.02.010; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guan XL, 2019, FISH SHELLFISH IMMUN, V87, P220, DOI 10.1016/j.fsi.2019.01.017; Guo CY, 2015, DEV COMP IMMUNOL, V52, P226, DOI 10.1016/j.dci.2015.05.014; He LG, 2019, FISH SHELLFISH IMMUN, V93, P589, DOI 10.1016/j.fsi.2019.07.063; He LB, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3562-4; Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599; Hoffman BG, 2006, GENES IMMUN, V7, P101, DOI 10.1038/sj.gene.6364270; Hsu AY, 2019, P NATL ACAD SCI USA, V116, P18561, DOI 10.1073/pnas.1905221116; Huang Y, 2019, MOL IMMUNOL, V107, P1, DOI 10.1016/j.molimm.2018.12.027; Huang Y, 2017, GENOMICS, V109, P258, DOI 10.1016/j.ygeno.2017.04.007; Jazdzewski K, 2009, P NATL ACAD SCI USA, V106, P1502, DOI 10.1073/pnas.0812591106; Jiang S, 2018, CANCER LETT, V434, P130, DOI 10.1016/j.canlet.2018.07.027; JONES JF, 1983, LYMPHOLOGY, V16, P83; Kadri S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029217; Klopfenstein DV, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28948-z; Labbaye C, 2012, J HEMATOL ONCOL, V5, DOI 10.1186/1756-8722-5-13; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Langenau DM, 2002, MECH DEVELOP, V117, P243, DOI 10.1016/S0925-4773(02)00187-9; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lee HM, 2016, BMB REP, V49, P311, DOI 10.5483/BMBRep.2016.49.6.056; Lenti E, 2016, J CLIN INVEST, V126, P2452, DOI 10.1172/JCI82956; Li CH, 2016, DEV COMP IMMUNOL, V65, P377, DOI 10.1016/j.dci.2016.08.008; Li GX, 2019, FISH SHELLFISH IMMUN, V84, P148, DOI 10.1016/j.fsi.2018.09.077; Li GX, 2017, FISH SHELLFISH IMMUN, V60, P400, DOI 10.1016/j.fsi.2016.12.012; Li GX, 2015, FISH SHELLFISH IMMUN, V44, P420, DOI 10.1016/j.fsi.2015.03.014; Li GX, 2014, J CELL BIOCHEM, V115, P1768, DOI 10.1002/jcb.24843; Li GX, 2011, J CELL BIOCHEM, V112, P1318, DOI 10.1002/jcb.23045; Lim SP, 2018, J LEUKOCYTE BIOL, V103, P855, DOI 10.1002/JLB.1A0817-325RR; Lindner SE, 2017, EMBO REP, V18, P1604, DOI 10.15252/embr.201643735; Liu HY, 2016, CELL MOL BIOL, V62, P87; Liu XG, 2010, J IMMUNOL, V185, P7244, DOI 10.4049/jimmunol.1001573; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ma F, 2011, NAT IMMUNOL, V12, P861, DOI 10.1038/ni.2073; Mok YT, 2013, J IMMUNOL, V191, P3037, DOI 10.4049/jimmunol.1301289; Naqvi AR, 2015, J IMMUNOL, V194, P1916, DOI 10.4049/jimmunol.1401893; Nielsen M, 2010, ANIM GENET, V41, P159, DOI 10.1111/j.1365-2052.2009.01981.x; PEARSON MP, 1991, FISH PHYSIOL BIOCHEM, V9, P39, DOI 10.1007/BF01987610; Peng R, 2018, CELL PHYSIOL BIOCHEM, V46, P1065, DOI 10.1159/000488837; Petrie-Hanson L, 2000, VET IMMUNOL IMMUNOP, V73, P129, DOI 10.1016/S0165-2427(99)00155-5; Raida MK, 2008, FISH SHELLFISH IMMUN, V25, P533, DOI 10.1016/j.fsi.2008.07.008; Reza AMT, 2018, SCI DATA, V5, DOI 10.1038/sdata.2017.199; Ruan Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.47; Sang W, 2016, CELL IMMUNOL, V306, P35, DOI 10.1016/j.cellimm.2016.05.007; Schulte LN, 2013, NUCLEIC ACIDS RES, V41, P542, DOI 10.1093/nar/gks1030; Sha ZX, 2014, DEV COMP IMMUNOL, V44, P59, DOI 10.1016/j.dci.2013.11.014; Sontheimer EJ, 2005, CELL, V122, P9, DOI 10.1016/j.cell.2005.06.030; Steiner DF, 2011, IMMUNITY, V35, P169, DOI 10.1016/j.immuni.2011.07.009; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Su ZH, 2014, INT J BIOCHEM CELL B, V49, P53, DOI 10.1016/j.biocel.2014.01.005; Wang AQ, 2015, INT J MOL SCI, V16, P22904, DOI 10.3390/ijms160922904; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wang L, 2014, MOL IMMUNOL, V59, P163, DOI 10.1016/j.molimm.2014.02.004; Wheeler BM, 2009, EVOL DEV, V11, P50, DOI 10.1111/j.1525-142X.2008.00302.x; Whyte SK, 2007, FISH SHELLFISH IMMUN, V23, P1127, DOI 10.1016/j.fsi.2007.06.005; Williams AE, 2008, CELL MOL LIFE SCI, V65, P545, DOI 10.1007/s00018-007-7355-9; Wu MZ, 2017, NAT CELL BIOL, V19, P1286, DOI 10.1038/ncb3615; Xie C, 2011, NUCLEIC ACIDS RES, V39, pW316, DOI 10.1093/nar/gkr483; Xu P, 2019, BLOOD, V133, P2518, DOI 10.1182/blood.2018854604; Xu TJ, 2018, J IMMUNOL, V201, P982, DOI 10.4049/jimmunol.1800377; Xu XY, 2015, FISH SHELLFISH IMMUN, V45, P94, DOI 10.1016/j.fsi.2015.02.008; Xu XY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112722; Yang Y, 2016, ONCOTARGET, V7, P17520, DOI 10.18632/oncotarget.8161; Yi SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096336; Yuan XY, 2018, J LEUKOCYTE BIOL, V104, P515, DOI 10.1002/JLB.3MR0218-079R; Zapata A, 2006, FISH SHELLFISH IMMUN, V20, P126, DOI 10.1016/j.fsi.2004.09.005; Zhang TF, 2018, J IMMUNOL, V201, P2165, DOI 10.4049/jimmunol.1800230; Zhou QH, 2013, J IMMUNOL, V190, P6579, DOI 10.4049/jimmunol.1202993; Zhu QY, 2010, J IMMUNOL, V185, P7435, DOI 10.4049/jimmunol.1000798; Zhu YL, 2019, CELL MOL IMMUNOL, V16, P112, DOI 10.1038/cmi.2017.164; Zietara N, 2013, P NATL ACAD SCI USA, V110, P7407, DOI 10.1073/pnas.1221984110	101	1	1	6	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266189	10.1371/journal.pone.0266189	http://dx.doi.org/10.1371/journal.pone.0266189			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344574	gold, Green Published			2022-12-26	WOS:000788055200004
J	Kutil, Z; Meleshin, M; Baranova, P; Havlinova, B; Schutkowski, M; Barinka, C				Kutil, Zsofia; Meleshin, Marat; Baranova, Petra; Havlinova, Barbora; Schutkowski, Mike; Barinka, Cyril			Characterization of the class IIa histone deacetylases substrate specificity	FASEB JOURNAL			English	Article						class IIa histone deacetylases; deacetylation; peptide library; sequence specificity; substrates	CONTROLS CHONDROCYTE HYPERTROPHY; CATALYTIC-ACTIVITY; ACETYLATION; H3; PHOSPHORYLATION; PROTEINS; SIR3	Class IIa histone deacetylases (HDACs) play critical roles in vertebrate development and physiology, yet direct evidence of their intrinsic deacetylase activity and on substrate specificity regarding the peptide sequence is still missing. In this study, we designed and synthesized a combinatorial peptide library allowing us to profile class IIa HDACs sequence specificity at positions +3 through -3 from the central lysine modified by the well-accepted trifluoroacetyl function. Our data revealed a strong preference for bulky aromatic acids directly flanking the central trifluoroacetyllysine, while all class IIa HDACs disfavor positively charged residues and proline at the +1/-1 positions. The chemical nature of amino acid residues N-terminally to the central trifluoroacetyllysine has a more profound effect on substrate recognition as compared to residues located C-terminally. These findings were validated by designing selected favored and disfavored peptide sequences, with the favored ones are accepted with catalytic efficacy of 75 000 and 525 000 M-1 s(-1) for HDAC7 and HDAC5, respectively. Results reported here could help in developing class IIa HDACs inhibitors and also in the search for new natural class IIa HDACs substrates.	[Kutil, Zsofia; Baranova, Petra; Havlinova, Barbora; Barinka, Cyril] Czech Acad Sci, Inst Biotechnol, BIOCEV, Vestec, Czech Republic; [Meleshin, Marat; Schutkowski, Mike] Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany	Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; Martin Luther University Halle Wittenberg	Schutkowski, M (corresponding author), Martin Luther Univ Halle Wittenberg, Charles Tanford Prot Ctr, Inst Biochem & Biotechnol, Dept Enzymol, Kurt Mothes Str 3a, D-06120 Halle, Saale, Germany.; Barinka, C (corresponding author), Inst Biotechnol, Lab Struct Biol, Prumyslova 595, Vestec 25250, Czech Republic.	mike.schutkowski@biochemtech.uni-halle.de; cyril.barinka@ibt.cas.cz		Kutil, Zsofia/0000-0001-9936-9518	CAS [86652036]; Grantova Agentura Ceske Republiky (GACR) [21-31806]	CAS(Chinese Academy of Sciences); Grantova Agentura Ceske Republiky (GACR)(Grant Agency of the Czech Republic)	CAS, Grant/Award Number: RVO and 86652036; Grantova Agentura Ceske Republiky (GACR), Grant/Award Number: 21-31806	Arnold MA, 2007, DEV CELL, V12, P377, DOI 10.1016/j.devcel.2007.02.004; Bradner JE, 2010, NAT CHEM BIOL, V6, P238, DOI 10.1038/NCHEMBIO.313; Chang SR, 2006, CELL, V126, P321, DOI 10.1016/j.cell.2006.05.040; Chang SR, 2004, MOL CELL BIOL, V24, P8467, DOI 10.1128/MCB.24.19.8467-8476.2004; Cheung P, 2000, MOL CELL, V5, P905, DOI 10.1016/S1097-2765(00)80256-7; Fischle W, 2002, MOL CELL, V9, P45, DOI 10.1016/S1097-2765(01)00429-4; Fischle W, 1999, J BIOL CHEM, V274, P11713, DOI 10.1074/jbc.274.17.11713; Grozinger CM, 2000, P NATL ACAD SCI USA, V97, P7835, DOI 10.1073/pnas.140199597; Gurard-Levin ZA, 2008, BIOCHEMISTRY-US, V47, P6242, DOI 10.1021/bi800053v; He S, 2003, P NATL ACAD SCI USA, V100, P12033, DOI 10.1073/pnas.2035256100; HECHT A, 1995, CELL, V80, P583, DOI 10.1016/0092-8674(95)90512-X; JOHNSON LM, 1990, P NATL ACAD SCI USA, V87, P6286, DOI 10.1073/pnas.87.16.6286; Jones P, 2008, BIOORG MED CHEM LETT, V18, P1814, DOI 10.1016/j.bmcl.2008.02.025; Joshi P, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.26; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kutil Z, 2019, FASEB J, V33, P4035, DOI 10.1096/fj.201801680R; Kutil Z, 2018, ACS CHEM BIOL, V13, P685, DOI 10.1021/acschembio.7b00942; Lahm A, 2007, P NATL ACAD SCI USA, V104, P17335, DOI 10.1073/pnas.0706487104; Li MY, 2002, J BIOL CHEM, V277, P50607, DOI 10.1074/jbc.C200578200; Liokatis S, 2012, NAT STRUCT MOL BIOL, V19, P819, DOI 10.1038/nsmb.2310; Liu NN, 2015, SCI REP-UK, V5, DOI 10.1038/srep16869; Luo LQ, 2019, CELL REP, V29, P749, DOI 10.1016/j.celrep.2019.09.023; Masch A., 2015, EPIGENETIC TECHNOLOG, P169; McKinsey TA, 2000, NATURE, V408, P106, DOI 10.1038/35040593; Moreno-Yruela C, 2018, CELL CHEM BIOL, V25, P849, DOI 10.1016/j.chembiol.2018.04.007; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Rauh D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3327; Scholz C, 2015, NAT BIOTECHNOL, V33, P415, DOI 10.1038/nbt.3130; Shimada M, 2008, CELL, V132, P221, DOI 10.1016/j.cell.2007.12.013; Skultetyova L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11739-3; Toro TB, 2021, BIOCHEMISTRY-US, V60, P2524, DOI 10.1021/acs.biochem.1c00384; Toro TB, 2020, FASEB J, V34, P13140, DOI 10.1096/fj.202001301RR; Vega RB, 2004, CELL, V119, P555, DOI 10.1016/j.cell.2004.10.024; Wang B, 2011, CELL, V145, P596, DOI 10.1016/j.cell.2011.04.013; Zessin M, 2019, BIOCHEMISTRY-US, V58, P4777, DOI 10.1021/acs.biochem.9b00786; Zhang LL, 2015, PROTEIN CELL, V6, P42, DOI 10.1007/s13238-014-0102-8	36	0	0	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22287	10.1096/fj.202101663R	http://dx.doi.org/10.1096/fj.202101663R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0G8CR	35349187				2022-12-26	WOS:000778267400001
J	Liu, LP; Lucas, RM; Nanson, JD; Li, Y; Whitfield, J; Curson, JEB; Tuladhar, N; Alexandrov, K; Mobli, M; Sweet, MJ; Kobe, B; Stow, JL; Luo, L				Liu, Liping; Lucas, Richard M.; Nanson, Jeffrey D.; Li, Yan; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Alexandrov, Kirill; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin			The transmembrane adapter SCIMP recruits tyrosine kinase Syk to phosphorylate Toll-like receptors to mediate selective inflammatory outputs	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SRC-FAMILY KINASES; TIR-DOMAIN; PULL-DOWN; LPS; RECOGNITION; DECTIN-1; SIGNAL; INDUCTION; RESPONSES; REVEALS	Innate immune signaling by Toll-like receptors (TLRs) involves receptor phosphorylation, which helps to shape and drive key inflammatory outputs, yet our understanding of the kinases and mechanisms that mediate TLR phosphorylation is incomplete. Spleen tyrosine kinase (Syk) is a nonreceptor protein tyrosine kinase, which is known to relay adaptive and innate immune signaling, including from TLRs. However, TLRs do not contain the conserved dual immunoreceptor tyrosine based activation motifs that typically recruit Syk to many other receptors. One possibility is that the Syk-TLR association is indirect, relying on an intermediary scaffolding protein. We previously identified a role for the palmitoylated trans membrane adapter protein SCIMP in scaffolding the Src tyrosine kinase Lyn, for TLR phosphorylation, but the role of SCIMP in mediating the interaction between Syk and TLRs has not yet been investigated. Here, we show that SCIMP recruits Syk in response to lipopolysaccharide-mediated TLR4 activation. We also show that Syk contributes to the phosphorylation of SCIMP and TLR4 to enhance their binding. Further evidence pinpoints two specific phosphorylation sites in SCIMP critical for its interaction with Syk-SH2 domains in the absence of immunoreceptor tyrosine-based activation motifs. Finally, using inhibitors and primary macrophages from SCIMP-/-mice, we confirm a functional role for SCIMP-mediated Syk interaction in modulating TLR4 phosphorylation, signaling, and cytokine outputs. In conclusion, we identify SCIMP as a novel, immune-specific Syk scaffold, which can contribute to inflammation through selective TLR-driven inflammatory responses.	[Liu, Liping; Lucas, Richard M.; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin] Inst Mol Biosci, Brisbane, Qld, Australia; [Liu, Liping; Lucas, Richard M.; Whitfield, Jason; Curson, James E. B.; Tuladhar, Neeraj; Mobli, Mehdi; Sweet, Matthew J.; Kobe, Bostjan; Stow, Jennifer L.; Luo, Lin] IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia; [Nanson, Jeffrey D.; Li, Yan; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld, Australia; [Alexandrov, Kirill] Queensland Univ Technol, Sch Biol & Environm Sci, Ctr Agr & Bioecon, CSIRO QUT Synthet Biol Alliance, Brisbane, Qld, Australia; [Mobli, Mehdi] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Queensland University of Technology (QUT); University of Queensland	Stow, JL; Luo, L (corresponding author), Inst Mol Biosci, Brisbane, Qld, Australia.; Stow, JL; Luo, L (corresponding author), IMB Ctr Inflammat & Dis Res, Brisbane, Qld, Australia.	j.stow@imb.uq.edu.au; l.luo@imb.uq.edu.au	; Kobe, Bostjan/D-1292-2009; Luo, Lin/B-7845-2016; Sweet, Matthew/F-2229-2011	Nanson, Jeff/0000-0003-1306-1948; Lucas, Richard/0000-0001-8798-6172; Kobe, Bostjan/0000-0001-9413-9166; Luo, Lin/0000-0001-5556-7096; Sweet, Matthew/0000-0002-0406-8139; Liu, Liping/0000-0003-2369-7771	Australian Research Council DECRA Fellowship [DE180100524]; National Health and Medical Research Council of Australia Investigator Grant [APP1176209, APP1138723, APP1194406]; National Health and Medical Research Council of Australia Project Grant [APP1159106]	Australian Research Council DECRA Fellowship(Australian Research Council); National Health and Medical Research Council of Australia Investigator Grant(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council of Australia Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	and additional information-This work was supported by Australian Research Council DECRA Fellowship DE180100524 (L. Luo.) , National Health and Medical Research Council of Australia Investigator Grant APP1176209 and Project grant APP1138723 (J. L. S.) , National Health and Medical Research Council of Australia Project Grant APP1159106 (L. Luo and J. L. S) , and National Health and Medical Research Council of Australia Investigator Grant APP1194406 (M. J. S.) .	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Berton G, 2005, TRENDS IMMUNOL, V26, P208, DOI 10.1016/j.it.2005.02.002; Bieghs V, 2013, TRENDS IMMUNOL, V34, P446, DOI 10.1016/j.it.2013.04.005; Biswas C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200913; Bonnerot C, 1998, EMBO J, V17, P4606, DOI 10.1093/emboj/17.16.4606; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; CHAN AC, 1992, CELL, V71, P649, DOI 10.1016/0092-8674(92)90598-7; Chattopadhyay S, 2014, CYTOKINE GROWTH F R, V25, P533, DOI 10.1016/j.cytogfr.2014.06.002; Chaudhary A, 2007, IMMUNOL CELL BIOL, V85, P249, DOI 10.1038/sj.icb7100030; Curson JEB, 2022, IMMUNOL CELL BIOL, V100, P267, DOI 10.1111/imcb.12540; Curson JEB, 2018, J LEUKOCYTE BIOL, V103, P1011, DOI 10.1002/JLB.2RI1117-474R; Deng GM, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00078; Dozmorov MG, 2014, EPIGENETICS-US, V9, P276, DOI 10.4161/epi.27021; Fitzgerald KA, 2020, CELL, V180, P1044, DOI 10.1016/j.cell.2020.02.041; Fuller GLJ, 2007, J BIOL CHEM, V282, P12397, DOI 10.1074/jbc.M609558200; Gay NJ, 2014, NAT REV IMMUNOL, V14, P546, DOI 10.1038/nri3713; Goodridge HS, 2009, IMMUNOL REV, V230, P38, DOI 10.1111/j.1600-065X.2009.00793.x; Gordon S, 2002, CELL, V111, P927, DOI 10.1016/S0092-8674(02)01201-1; Hamerman JA, 2005, NAT IMMUNOL, V6, P579, DOI 10.1038/ni1204; Han CF, 2010, NAT IMMUNOL, V11, P734, DOI 10.1038/ni.1908; Heizmann B, 2010, P NATL ACAD SCI USA, V107, P18563, DOI 10.1073/pnas.1009048107; Jang TH, 2014, J MOL BIOL, V426, P3305, DOI 10.1016/j.jmb.2014.07.024; Jansen IE, 2019, NAT GENET, V51, P404, DOI 10.1038/s41588-018-0311-9; Kopf M, 2010, NAT REV DRUG DISCOV, V9, P703, DOI 10.1038/nrd2805; Kralova J, 2016, J BIOL CHEM, V291, P16530, DOI 10.1074/jbc.M116.717157; Lee KG, 2012, P NATL ACAD SCI USA, V109, P5791, DOI 10.1073/pnas.1119238109; Lin YC, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003973; Lin YC, 2010, MOL IMMUNOL, V47, P1569, DOI 10.1016/j.molimm.2010.01.008; Liu DL, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-017-0512-1; Lucas RM, 2021, CELL REP, V36, DOI 10.1016/j.celrep.2021.109662; Luo L, 2020, J CELL SCI, V133, DOI 10.1242/jcs.239194; Luo L, 2020, J LEUKOCYTE BIOL, V107, P251, DOI 10.1002/JLB.2MA0819-138RR; Luo L, 2017, IMMUNOL CELL BIOL, V95, P564, DOI 10.1038/icb.2017.10; Luo L, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14133; Luo L, 2014, PROTEOMICS, V14, P19, DOI 10.1002/pmic.201300315; Medvedev AE, 2007, J BIOL CHEM, V282, P16042, DOI 10.1074/jbc.M606781200; Miller YI, 2012, BRIT J PHARMACOL, V167, P990, DOI 10.1111/j.1476-5381.2012.02097.x; Mitchell J, 2018, BIOCHEM PHARMACOL, V147, P119, DOI 10.1016/j.bcp.2017.11.015; Mocsai A, 2004, P NATL ACAD SCI USA, V101, P6158, DOI 10.1073/pnas.0401602101; Mocsai A, 2010, NAT REV IMMUNOL, V10, P387, DOI 10.1038/nri2765; N'Diaye EN, 2009, J CELL BIOL, V184, P215, DOI 10.1083/jcb.200808080; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Rogers NC, 2005, IMMUNITY, V22, P507, DOI 10.1016/j.immuni.2005.03.004; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Sabroe I, 2003, J IMMUNOL, V171, P1630, DOI 10.4049/jimmunol.171.4.1630; Sanjuan MA, 2006, J CELL BIOL, V172, P1057, DOI 10.1083/jcb.200508058; Sedlik C, 2003, J IMMUNOL, V170, P846, DOI 10.4049/jimmunol.170.2.846; Stepanek O, 2013, J IMMUNOL, V190, P1807, DOI 10.4049/jimmunol.1202401; Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603; Strich JR, 2021, J INFECT DIS, V223, P981, DOI 10.1093/infdis/jiaa789; Ve T, 2017, NAT STRUCT MOL BIOL, V24, P743, DOI 10.1038/nsmb.3444; Verstak B, 2014, J LEUKOCYTE BIOL, V96, P427, DOI 10.1189/jlb.2A0913-487R; Xiong YB, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.375493; Xu YK, 2005, IMMUNITY, V22, P9, DOI 10.1016/j.immuni.2004.12.004; Zanoni I, 2017, IMMUNITY, V47, P697, DOI 10.1016/j.immuni.2017.09.010; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	56	1	1	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101857	10.1016/j.jbc.2022.101857	http://dx.doi.org/10.1016/j.jbc.2022.101857			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35337798	Green Published, gold			2022-12-26	WOS:000798142000007
J	Luquero, A; Vilahur, G; Casani, L; Badimon, L; Borrell-Pages, M				Luquero, Aureli; Vilahur, Gemma; Casani, Laura; Badimon, Lina; Borrell-Pages, Maria			Differential cholesterol uptake in liver cells: A role for PCSK9	FASEB JOURNAL			English	Article						cholesterol uptake; hepatic stellate cells; liver; LRP5; PCSK9	DENSITY-LIPOPROTEIN RECEPTOR; AGGREGATED LDL UPTAKE; SMOOTH-MUSCLE-CELLS; KNOCKOUT MICE; ATHEROSCLEROTIC LESIONS; SCAVENGER RECEPTOR; PLASMA-CHOLESTEROL; LIPID-COMPOSITION; GENE-TRANSFER; WNT PATHWAY	The clearance of low-density lipoprotein (LDL) particles from the circulation is regulated by the LDL receptor (LDLR) and proprotein convertase subtilisin/kexin 9 (PCSK9) interaction. Its disruption reduces blood cholesterol levels and delays atherosclerosis progression. Whether other members of the LDLR superfamily are in vivo targets of PCSK9 has been poorly explored. The aim of this work was to study the interaction between PCSK9 and members of the LDLR superfamily in the regulation of liver cholesterol homeostasis in an in vivo low-density lipoprotein receptor related protein 5 (LRP5) deficient mice model challenged with high-fat diet. Our results show that Wt and Lrp5(-/-) mice fed a hypercholesterolemic diet (HC) have increased cholesterol ester accumulation and decreased liver LDLR and LRP5 gene and protein expression. Very low-density lipoprotein receptor (VLDLR), LRP6, LRP2, and LRP1 expression levels were analyzed in liver samples and show that they do not participate in Lrp5(-/-) liver cholesterol uptake. Immunoprecipitation experiments show that LRP5 forms a complex with PCSK9 in liver-specific fat-storing stellate cells but not in structural HepG2 cells. Hepatic stellate cells silenced for LRP5 and/or PCSK9 expression and challenged with lipids show reduced cholesterol ester accumulation, indicating that both proteins are involved in lipid processing in the liver. Our results indicate that cholesterol esters accumulate in livers of Wt mice in a LDLR-family-members dependent manner as VLDLR, LRP2, and LRP6 show increased expression in HC mice. However, this increase is lost in livers of Lrp5(-/-) mice, where scavenger receptors are involved in cholesterol uptake. PCSK9 expression is strongly downregulated in mice livers after HC feeding. However PCSK9 and LRP5 bind in the cytoplasm of fat storing liver cells, indicating that this PCSK9-LRP5 interaction is cell-type specific and that both proteins contribute to lipid uptake.	[Luquero, Aureli; Vilahur, Gemma; Casani, Laura; Badimon, Lina; Borrell-Pages, Maria] IIB St Pau, Cardiovasc Program ICCC, Hosp Santa Creu & St Pau, Res Inst, Barcelona, Spain; [Vilahur, Gemma; Badimon, Lina; Borrell-Pages, Maria] Inst Salud Carlos III, CIBER CV, Madrid, Spain; [Badimon, Lina] UAB, Cardiovasc Res Chair, Barcelona, Spain	Hospital of Santa Creu i Sant Pau; CIBER - Centro de Investigacion Biomedica en Red; CIBERCV; Instituto de Salud Carlos III; Autonomous University of Barcelona	Borrell-Pages, M (corresponding author), Cardiovasc Program ICCC, IR Hosp Santa Creu & St Pau, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	mborrellpa@santpau.cat	Borrell-Pages, Maria/Q-6307-2019	Borrell-Pages, Maria/0000-0002-1759-9756; Luquero, Aureli/0000-0002-1104-5963	Ministerio de Ciencia e Innovacion (MICINN) [PID2019--107160RB--I00, PGC 2018--094025--B--I00]; MINECO | Instituto de Salud Carlos III (ISCIII) [IBERCV CB16/11/00411, TERCEL RD16/0011/018, FIS2020--01282]; Generalitat de Catalunya (Government of Catalonia) [2017SGR1480]; Sociedad Espanola de Cardiologia (Spanish Society of Cardiology) [FEC2019, FEC2020]; Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR) [2016PROD00043]	Ministerio de Ciencia e Innovacion (MICINN)(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); MINECO | Instituto de Salud Carlos III (ISCIII)(Spanish Government); Generalitat de Catalunya (Government of Catalonia); Sociedad Espanola de Cardiologia (Spanish Society of Cardiology); Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR)	Ministerio de Ciencia e Innovacion (MICINN), Grant/Award Number: PID2019--107160RB--I00 and PGC 2018--094025--B--I00; MINECO | Instituto de Salud Carlos III (ISCIII), Grant/Award Number: CIBERCV CB16/11/00411, TERCEL RD16/0011/018 and FIS2020--01282; Generalitat de Catalunya (Government of Catalonia), Grant/Award Number: 2017SGR1480; Sociedad Espanola de Cardiologia (Spanish Society of Cardiology), Grant/Award Number: FEC2019 and FEC2020; Government of Catalonia | Agencia de Gestio d'Ajuts Universitaris i de Recerca (AGAUR), Grant/Award Number: 2016PROD00043	Abifadel M, 2003, NAT GENET, V34, P154, DOI 10.1038/ng1161; Accad M, 1998, CURR BIOL, V8, pR601, DOI 10.1016/S0960-9822(98)70386-0; ASMIS R, 1995, EUR J BIOCHEM, V233, P171, DOI 10.1111/j.1432-1033.1995.171_1.x; Awan Z, 2011, ATHEROSCLEROSIS, V219, P455, DOI 10.1016/j.atherosclerosis.2011.08.035; Badimon L, 2021, CARDIOVASC RES, V117, P2054, DOI 10.1093/cvr/cvaa254; Badimon L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0218098; Barker N, 2000, ADV CANCER RES, V77, P1; Blaner WS, 2009, BBA-MOL CELL BIOL L, V1791, P467, DOI 10.1016/j.bbalip.2008.11.001; Borrell-Pages M, 2016, BASIC RES CARDIOL, V111, DOI 10.1007/s00395-016-0585-y; Borrell-Pages M, 2014, ATHEROSCLEROSIS, V235, P363, DOI 10.1016/j.atherosclerosis.2014.05.922; Borrell-Pages M, 2015, IMMUNOL CELL BIOL, V93, P653, DOI 10.1038/icb.2015.41; Borrell-Pages M, 2015, J CELL MOL MED, V19, P770, DOI 10.1111/jcmm.12396; Borrell-Pages M, 2014, J CELL MOL MED, V18, P314, DOI 10.1111/jcmm.12190; Borrell-Pages M, 2011, EUR HEART J, V32, P2841, DOI 10.1093/eurheartj/ehr062; BROWN MS, 1986, SCIENCE, V232, P34, DOI 10.1126/science.3513311; Brundert M, 2011, J LIPID RES, V52, P745, DOI 10.1194/jlr.M011981; Canuel M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064145; Cui YJ, 2011, NAT MED, V17, P684, DOI 10.1038/nm.2388; Dubuc G, 2004, ARTERIOSCL THROM VAS, V24, P1454, DOI 10.1161/01.ATV.0000134621.14315.43; Fujino T, 2003, P NATL ACAD SCI USA, V100, P229, DOI 10.1073/pnas.0133792100; Go Gwang-woong, 2012, Yale Journal of Biology and Medicine, V85, P19; Hiltunen TP, 1998, CIRCULATION, V97, P1079, DOI 10.1161/01.CIR.97.11.1079; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100; HUA XX, 1993, P NATL ACAD SCI USA, V90, P11603, DOI 10.1073/pnas.90.24.11603; ISHIBASHI S, 1993, J CLIN INVEST, V92, P883, DOI 10.1172/JCI116663; Jeon H, 2005, ANNU REV BIOCHEM, V74, P535, DOI 10.1146/annurev.biochem.74.082803.133354; Keramati AR, 2011, P NATL ACAD SCI USA, V108, P1914, DOI 10.1073/pnas.1019443108; Kobayashi K, 1996, J BIOL CHEM, V271, P6852, DOI 10.1074/jbc.271.12.6852; Krieger M, 2001, J CLIN INVEST, V108, P793, DOI 10.1172/JCI200114011; KRUTH HS, 1984, AM J PATHOL, V114, P201; Kysenius K, 2012, CELL MOL LIFE SCI, V69, P1903, DOI 10.1007/s00018-012-0977-6; Lambert G, 2009, ATHEROSCLEROSIS, V203, P1, DOI 10.1016/j.atherosclerosis.2008.06.010; LAURELL S, 1971, ACTA MED SCAND, V189, P65; Libby P, 2019, NAT REV DIS PRIMERS, V5, DOI [10.1038/s41572-019-0116-x, 10.1038/s41572-019-0106-z]; Liu ML, 2010, J LIPID RES, V51, P2611, DOI 10.1194/jlr.M006635; Llorente-Cortes V, 1998, ARTERIOSCL THROM VAS, V18, P738, DOI 10.1161/01.ATV.18.5.738; Llorente-Cortes V, 2006, ARTERIOSCL THROM VAS, V26, P117, DOI 10.1161/01.ATV.0000193618.32611.8b; Llorente-Cortes V, 2005, ARTERIOSCL THROM VAS, V25, P497, DOI 10.1161/01.ATV.0000154280.62072.fd; Llorente-Cortes V, 2002, CIRCULATION, V106, P3104, DOI 10.1161/01.CIR.0000041434.28573.0B; Llorente-Cortes V, 2000, ARTERIOSCL THROM VAS, V20, P1572, DOI 10.1161/01.ATV.20.6.1572; Llorente-Cortes V, 2007, CARDIOVASC RES, V74, P526, DOI 10.1016/j.cardiores.2007.02.020; Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200; Miller JR, 1999, ONCOGENE, V18, P7860, DOI 10.1038/sj.onc.1203245; MORIWAKI H, 1988, J LIPID RES, V29, P1523; Nicholls SJ, 2016, JAMA-J AM MED ASSOC, V316, P2373, DOI 10.1001/jama.2016.16951; Poirier S, 2008, J BIOL CHEM, V283, P2363, DOI 10.1074/jbc.M708098200; Puri P, 2007, HEPATOLOGY, V46, P1081, DOI 10.1002/hep.21763; Rashid S, 2005, P NATL ACAD SCI USA, V102, P5374, DOI 10.1073/pnas.0501652102; Rohlmann A, 1998, J CLIN INVEST, V101, P689, DOI 10.1172/JCI1240; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Schmidt RJ, 2008, BIOCHEM BIOPH RES CO, V370, P634, DOI 10.1016/j.bbrc.2008.04.004; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Seidah NG, 2009, EXPERT OPIN THER TAR, V13, P19, DOI 10.1517/14728220802600715 ; SHENG ZQ, 1995, P NATL ACAD SCI USA, V92, P935, DOI 10.1073/pnas.92.4.935; Walley KR, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008782; WILLNOW TE, 1994, SCIENCE, V264, P1471, DOI 10.1126/science.7515194; Ye ZJ, 2012, J BIOL CHEM, V287, P1335, DOI 10.1074/jbc.M111.295287	58	1	1	3	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22291	10.1096/fj.202101660RR	http://dx.doi.org/10.1096/fj.202101660RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SI	35344222				2022-12-26	WOS:000773602800001
J	Ayabe, T; Takahashi, C; Ohya, R; Ano, Y				Ayabe, Tatsuhiro; Takahashi, Chika; Ohya, Rena; Ano, Yasuhisa			beta-Lactolin improves mitochondrial function in A beta-treated mouse hippocampal neuronal cell line and a human iPSC-derived neuronal cell model of Alzheimer's disease	FASEB JOURNAL			English	Article						Alzheimer's disease; amyloid beta; mitochondria; neuronal cell	OXIDATIVE STRESS; DYSFUNCTION; DYNAMICS; FUSION; FRAGMENTATION; PRESENILIN-1; PATHOGENESIS; INFLAMMATION; MITOFUSINS; FISSION	Mitochondrial dysfunctions are a key hallmark of Alzheimer's disease (AD). beta-Lactolin, a whey-derived glycine-threonine-tryptophan-tyrosine tetrapeptide, has been previously reported to prevent AD-like pathologies in an AD mouse model via regulation of microglial functions. However, the direct effect of beta-lactolin on neuronal cells and neuronal mitochondrial functions remains unknown. Here, we investigated the effects of beta-lactolin on mitochondrial functions in amyloid beta (A beta)-treated mouse hippocampal neuronal HT22 cells and human induced-pluripotent cell (hiPSC)-derived AD model neurons. Adding beta-lactolin to A beta-treated HT22 cells increased both the oxygen consumption rate and cellular ATP concentrations, suggesting that beta-lactolin improves mitochondrial respiration and energy production. Using high content image analysis, we found that beta-lactolin improved mitochondrial fragmentation, membrane potential, and oxidative stress in A beta-treated cells, eventually preventing neuronal cell death. From a mechanistic perspective, we found that beta-lactolin increased gene expression of mitofusin-2, which contributes to mitochondrial fusion events. Finally, we showed that beta-lactolin improves both mitochondrial morphologies and membrane potentials in hiPSC-derived AD model neurons. Taken together, beta-lactolin improved mitochondrial functions AD-related neuronal cell models and prevented neuronal cell death. The dual function of beta-lactolin on both neuron and microglia marks an advantage in maintaining neuronal health.	[Ayabe, Tatsuhiro; Takahashi, Chika; Ohya, Rena; Ano, Yasuhisa] Kirin Holdings Co Ltd, Kirin Cent Res Inst, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan	Kirin Holdings Co Ltd	Ayabe, T (corresponding author), Kirin Holdings Co Ltd, Kirin Cent Res Inst, 26-1,Muraoka Higashi 2 Chome, Fujisawa, Kanagawa 2518555, Japan.	Tatsuhiro_Ayabe@kirin.co.jp			Kirin Holdings Company Limited	Kirin Holdings Company Limited	This study was supported by Kirin Holdings Company Limited.	Amor S, 2010, IMMUNOLOGY, V129, P154, DOI 10.1111/j.1365-2567.2009.03225.x; Ano Y., 2021, CURR DEV NUTR, V5, P889; Ano Y, 2021, J CLIN MED, V10, DOI 10.3390/jcm10030480; Ano Y, 2020, AGING-US, V12, P18660, DOI 10.18632/aging.103951; Ano Y, 2020, J ALZHEIMERS DIS, V73, P1331, DOI 10.3233/JAD-190997; Ano Y, 2019, J NUTR SCI VITAMINOL, V65, P430, DOI 10.3177/jnsv.65.430; Ano Y, 2018, NEUROBIOL AGING, V72, P23, DOI 10.1016/j.neurobiolaging.2018.07.016; Ano Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118512; Archer SL, 2013, NEW ENGL J MED, V369, P2236, DOI 10.1056/NEJMra1215233; Ayabe T, 2020, BIOSCI BIOTECH BIOCH, V84, P1039, DOI 10.1080/09168451.2020.1714424; Ayabe T, 2019, NUTRIENTS, V11, DOI 10.3390/nu11102469; Bertholet AM, 2016, NEUROBIOL DIS, V90, P3, DOI 10.1016/j.nbd.2015.10.011; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Cadonic C, 2016, MOL NEUROBIOL, V53, P6078, DOI 10.1007/s12035-015-9515-5; Calkins MJ, 2011, HUM MOL GENET, V20, P4515, DOI 10.1093/hmg/ddr381; Camfield DA, 2011, BRIT J NUTR, V106, P159, DOI 10.1017/S0007114511000158; Caspersen C, 2005, FASEB J, V19, P2040, DOI 10.1096/fj.05-3735fje; Cerejeira J, 2012, Front Neurol, V3, P73, DOI 10.3389/fneur.2012.00073; Cha MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034929; Chandrasekaran K, 1996, EXP NEUROL, V142, P80, DOI 10.1006/exnr.1996.0180; Chen HC, 2003, J CELL BIOL, V160, P189, DOI 10.1083/jcb.200211046; Connolly NMC, 2018, CELL DEATH DIFFER, V25, P542, DOI 10.1038/s41418-017-0020-4; Connolly NMC, 2014, J NEUROSCI, V34, P10192, DOI 10.1523/JNEUROSCI.3127-13.2014; de la Torre JC, 2020, NEUROPHARMACOLOGY, V171, DOI 10.1016/j.neuropharm.2019.107841; Dixit S, 2017, FREE RADICAL BIO MED, V112, P515, DOI 10.1016/j.freeradbiomed.2017.08.021; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Du H, 2010, P NATL ACAD SCI USA, V107, P18670, DOI 10.1073/pnas.1006586107; Fabiani M, 2014, NEUROIMAGE, V85, P592, DOI 10.1016/j.neuroimage.2013.04.113; Fu YJ, 2009, CELL MOL NEUROBIOL, V29, P649, DOI 10.1007/s10571-009-9359-5; FUKUYAMA H, 1994, J NUCL MED, V35, P1; Fung A, 2012, BRAIN RES, V1446, P144, DOI 10.1016/j.brainres.2012.01.061; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Hauptmann S, 2009, NEUROBIOL AGING, V30, P1574, DOI 10.1016/j.neurobiolaging.2007.12.005; Honda M, 2016, BIOCHEM BIOPH RES CO, V469, P587, DOI 10.1016/j.bbrc.2015.12.025; Hoppins S, 2007, ANNU REV BIOCHEM, V76, P751, DOI 10.1146/annurev.biochem.76.071905.090048; Kang S, 2018, CELL DEATH DISCOV, V4, DOI 10.1038/s41420-017-0023-4; Kita M, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00399; Kita M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070899; Kuperstein I, 2010, EMBO J, V29, P3408, DOI 10.1038/emboj.2010.211; Manji H, 2012, NAT REV NEUROSCI, V13, P293, DOI 10.1038/nrn3229; Mansur A, 2021, J CEREBR BLOOD F MET, V41, P771, DOI 10.1177/0271678X20928149; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; Mishra A, 2020, BEHAV BRAIN RES, V378, DOI 10.1016/j.bbr.2019.112304; Mishra A, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104463; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Ortiz JMP, 2019, BRIT J PHARMACOL, V176, P3489, DOI 10.1111/bph.14585; Ozawa M, 2013, AM J CLIN NUTR, V97, P1076, DOI 10.3945/ajcn.112.045575; Park J, 2015, J NEUROCHEM, V132, P687, DOI 10.1111/jnc.12984; Park YH, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21113879; Pauwels K, 2012, J BIOL CHEM, V287, P5650, DOI 10.1074/jbc.M111.264473; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Ramsay RR, 2016, PROG NEURO-PSYCHOPH, V69, P81, DOI 10.1016/j.pnpbp.2016.02.005; Reddy PH, 2018, HUM MOL GENET, V27, P2502, DOI 10.1093/hmg/ddy154; Reddy PH, 2017, J ALZHEIMERS DIS, V58, P147, DOI 10.3233/JAD-170051; Reddy PH, 2016, J INVEST MED, V64, P1220, DOI 10.1136/jim-2016-000240; Shin SJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20123030; Tarantini S, 2018, AGING CELL, V17, DOI 10.1111/acel.12731; Tarantini S, 2017, EXP GERONTOL, V94, P52, DOI 10.1016/j.exger.2016.11.004; Terada T, 2020, NEUROLOGY, V94, pE1592, DOI 10.1212/WNL.0000000000009249; Wang XL, 2009, J NEUROSCI, V29, P9090, DOI 10.1523/JNEUROSCI.1357-09.2009; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x; Wisniewski T, 1998, NEUROREPORT, V9, P217, DOI 10.1097/00001756-199801260-00008; Wu ZF, 2014, MOL NEUROBIOL, V50, P986, DOI 10.1007/s12035-014-8675-z	63	0	0	4	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22277	10.1096/fj.202101366RR	http://dx.doi.org/10.1096/fj.202101366RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319792				2022-12-26	WOS:000772957100011
J	Tan, JY; Saleski, TE; Lin, XN				Tan, James Y.; Saleski, Tatyana E.; Lin, Xiaoxia Nina			The effect of droplet size on syntrophic dynamics in droplet-enabled microbial co-cultivation	PLOS ONE			English	Article							ESCHERICHIA-COLI; SINGLE CELLS; BACTERIA	Co-cultivation in microfluidic droplets has emerged as a versatile tool for the study of natural and synthetic microbial communities. In particular, the identification and characterization of syntrophic interactions in these communities is attracting increasing interest due to their critical importance for the functioning of environmental and host-associated communities as well as new biotechnological applications. However, one critical parameter in droplet-enabled co-cultivation that has evaded appropriate evaluation is the droplet size. Given the same number of initial cells, a larger droplet size can increase the length scale secreted metabolites must diffuse as well as dilute the initial concentration of cells and exchanged metabolites, impacting the community dynamics. To evaluate the effect of droplet size on a spectrum of syntrophic interactions, we cultivated a synthetic model system consisting of two E. coli auxotrophs, whose interactions could be modulated through supplementation of related amino acids in the medium. Our results demonstrate that the droplet size impacts substantially numerous aspects of the growth of a cross-feeding bi-culture, particularly the growth capacity, maximum specific growth rate, and lag time, depending on the degree of the interaction. This work heavily suggests that one droplet size does not fit all types of interactions; this parameter should be carefully evaluated and chosen in experimental studies that aim to utilize droplet-enabled co-cultivation to characterize or elucidate microbial interactions.	[Tan, James Y.; Saleski, Tatyana E.; Lin, Xiaoxia Nina] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Lin, XN (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	ninalin@umich.edu		Tan, James/0000-0002-0550-932X	University of Michigan Integrated Training in Microbial Systems - Burroughs Wellcome Fund	University of Michigan Integrated Training in Microbial Systems - Burroughs Wellcome Fund	JYT was supported in part by a fellowship from the University of Michigan Integrated Training in Microbial Systems (ITiMS) program funded by the Burroughs Wellcome Fund (https://www.bwfund.org/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackerley DF, 2006, J BACTERIOL, V188, P3371, DOI 10.1128/JB.188.9.3371-3381.2006; Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Aldunate M, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00164; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Atsumi S, 2010, APPL MICROBIOL BIOT, V85, P651, DOI 10.1007/s00253-009-2085-6; Baret JC, 2009, LAB CHIP, V9, P1850, DOI 10.1039/b902504a; Barrios AFG, 2006, J BACTERIOL, V188, P305, DOI 10.1128/JB.188.1.305-316.2006; Boedicker JQ, 2009, ANGEW CHEM INT EDIT, V48, P5908, DOI 10.1002/anie.200901550; Burmeister A, 2020, CURR OPIN BIOTECH, V62, P106, DOI 10.1016/j.copbio.2019.09.001; Carruthers DN, 2017, INTEGR BIOL-UK, V9, P687, DOI 10.1039/c6ib00241b; Hansen RH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155080; Hsu RH, 2019, CELL SYST, V9, P229, DOI 10.1016/j.cels.2019.06.008; Jackman CM, 2019, INTEGR BIOL-UK, V11, P69, DOI 10.1093/intbio/zyz006; Jahn M, 2016, MICROB CELL FACT, V15, DOI 10.1186/s12934-016-0610-8; Kaprelyants AS, 1996, TRENDS MICROBIOL, V4, P237, DOI 10.1016/0966-842X(96)10035-4; Kehe J, 2019, P NATL ACAD SCI USA, V116, P12804, DOI 10.1073/pnas.1900102116; Kerner A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034032; Li J, 2007, J BACTERIOL, V189, P6011, DOI 10.1128/JB.00014-07; LONGSWORTH LG, 1953, J AM CHEM SOC, V75, P5705, DOI 10.1021/ja01118a065; Mahler L, 2021, ELIFE, V10, DOI 10.7554/eLife.64774; Mazutis L, 2013, NAT PROTOC, V8, P870, DOI 10.1038/nprot.2013.046; McInerney MJ, 2008, ANN NY ACAD SCI, V1125, P58, DOI 10.1196/annals.1419.005; Mee MT, 2014, P NATL ACAD SCI USA, V111, pE2149, DOI 10.1073/pnas.1405641111; Munch KM, 2015, APPL ENVIRON MICROB, V81, P5976, DOI 10.1128/AEM.00807-15; O'Hanlon DE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080074; Pande S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7238; Park J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017019; Peng XF, 2021, NAT MICROBIOL, V6, P499, DOI 10.1038/s41564-020-00861-0; Pin C, 2006, APPL ENVIRON MICROB, V72, P2163, DOI 10.1128/AEM.72.3.2163-2169.2006; Raina JB, 2019, NAT REV MICROBIOL, V17, P284, DOI 10.1038/s41579-019-0182-9; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Saleski TE, 2019, METAB ENG, V54, P232, DOI 10.1016/j.ymben.2019.04.007; Scholz SA, 2019, CELL SYST, V8, P212, DOI 10.1016/j.cels.2019.02.004; Seshadri R, 2018, NAT BIOTECHNOL, V36, P359, DOI 10.1038/nbt.4110; Shitut S, 2019, ENVIRON MICROBIOL, V21, P1306, DOI 10.1111/1462-2920.14539; Svartstrom O, 2017, ISME J, V11, P2538, DOI 10.1038/ismej.2017.108; Swinnen IAM, 2004, INT J FOOD MICROBIOL, V94, P137, DOI 10.1016/j.ijfoodmicro.2004.01.006; Tan JY, 2020, INTEGR BIOL-UK, V12, P263, DOI 10.1093/intbio/zyaa021; Terekhov SS, 2018, P NATL ACAD SCI USA, V115, P9551, DOI 10.1073/pnas.1811250115; Villa MM, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00864-19; Voloshin SA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1268, DOI 10.1007/s10541-005-0072-9; Watterson WJ, 2020, ELIFE, V9, DOI 10.7554/eLife.56998; Welch JLM, 2017, P NATL ACAD SCI USA, V114, pE9105, DOI 10.1073/pnas.1711596114; Zelezniak A, 2015, P NATL ACAD SCI USA, V112, P6449, DOI 10.1073/pnas.1421834112; Zhao XN, 2021, LAB CHIP, V21, P1492, DOI 10.1039/d0lc01204a	45	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266282	10.1371/journal.pone.0266282	http://dx.doi.org/10.1371/journal.pone.0266282			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358282	Green Published, gold			2022-12-26	WOS:000799828800089
J	Garcia-Dominguez, DJ; Hajji, N; Lopez-Alemany, R; Sanchez-Molina, S; Figuerola-Bou, E; Civanto, FJM; Rello-Varona, S; Andres-Leon, E; Benito, A; Keun, HC; Mora, J; Tirado, OM; de Alava, E; Hontecillas-Prieto, L				Garcia-Dominguez, Daniel J.; Hajji, Nabil; Lopez-Alemany, Roser; Sanchez-Molina, Sara; Figuerola-Bou, Elisabet; Civanto, Francisco J. Moron; Rello-Varona, Santiago; Andres-Leon, Eduardo; Benito, Adrian; Keun, Hector C.; Mora, Jaume; Tirado, Oscar M.; de Alava, Enrique; Hontecillas-Prieto, Lourdes			Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1	ONCOGENE			English	Article							CANCER METASTASIS; SIALIDASE NEU1; METHYLATION; AUTOPHAGY; CELLS; OVEREXPRESSION; PROLIFERATION; APOPTOSIS; INVASION; MIMICRY	Ewing sarcoma (EWS) is an aggressive bone and soft tissue tumor with high susceptibility to metastasize. The underlying molecular mechanisms leading to EWS metastases remain poorly understood. Epigenetic changes have been implicated in EWS tumor growth and progression. Linking epigenetics and metastases may provide insight into novel molecular targets in EWS and improve its treatment. Here, we evaluated the effects of a selective G9a histone methyltransferase inhibitor (BIX01294) on EWS metastatic process. Our results showed that overexpression of G9a in tumors from EWS patients correlates with poor prognosis. Moreover, we observe a significantly higher expression of G9a in metastatic EWS tumor as compared to either primary or recurrent tumor. Using functional assays, we demonstrate that pharmacological G9a inhibition using BIX01294 disrupts several metastatic steps in vitro, such as migration, invasion, adhesion, colony formation and vasculogenic mimicry. Moreover, BIX01294 reduces tumor growth and metastases in two spontaneous metastases mouse models. We further identified the sialidase NEU1 as a direct target and effector of G9a in the metastatic process in EWS. NEU1 overexpression impairs migration, invasion and clonogenic capacity of EWS cell lines. Overall, G9a inhibition impairs metastases in vitro and in vivo through the overexpression of NEU1. G9a has strong potential as a prognostic marker and may be a promising therapeutic target for EWS patients.	[Garcia-Dominguez, Daniel J.; Civanto, Francisco J. Moron; de Alava, Enrique; Hontecillas-Prieto, Lourdes] Hosp Univ Virgen del Rocio, Inst Biomed Seville IBiS, CSIC, CIBERONC, Seville, Spain; [Hajji, Nabil] Imperial Coll London, Div Brain Sci, London, England; [Sanchez-Molina, Sara; Figuerola-Bou, Elisabet; Mora, Jaume] Hosp St Joan de Deu, Dev Tumour Biol Lab, Barcelona, Spain; [Andres-Leon, Eduardo] Consejo Super Invest Cient IPBLN CSIC, Bioinformat Unit, Inst Parasitol & Biomed Lopez Neyra, Granada, Spain; [Benito, Adrian; Keun, Hector C.] Imperial Coll London, Div Canc, Canc Metab & Syst Toxicol Grp, London, England; [de Alava, Enrique] Univ Seville, Pathol Unit, Univ Virgen del Rocio, CIBERONC,CSIC, Seville, Spain; [de Alava, Enrique] Univ Seville, Sch Med, Dept Normal & Pathol Cytol & Histol, Seville 41009, Spain; [Garcia-Dominguez, Daniel J.; Hontecillas-Prieto, Lourdes] Univ Seville, Sch Med, Dept Med Biochem & Mol Biol, Virgen Macarena Univ Hosp, Seville, Spain	CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Imperial College London; University of Barcelona; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Parasitologia y Biomedicina Lopez-Neyra (IPBLN); Imperial College London; CIBER - Centro de Investigacion Biomedica en Red; CIBERONC; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; University of Sevilla; Hospital Universitario Virgen Macarena; University of Sevilla	Garcia-Dominguez, DJ; de Alava, E; Hontecillas-Prieto, L (corresponding author), Hosp Univ Virgen del Rocio, Inst Biomed Seville IBiS, CSIC, CIBERONC, Seville, Spain.; Garcia-Dominguez, DJ; Hontecillas-Prieto, L (corresponding author), Univ Seville, Sch Med, Dept Med Biochem & Mol Biol, Virgen Macarena Univ Hosp, Seville, Spain.	dgarcia-ibis@us.es; enrique.alava.sspa@juntadeandalucia.es; lhontecillas-ibis@us.es	de Alava, Enrique/GOH-0368-2022; Andrés-León., Eduardo/K-8944-2014; Rello-Varona, Santi/A-4882-2009; Sanchez-Molina, Sara/B-2148-2017	de Alava, Enrique/0000-0001-8400-046X; Andrés-León., Eduardo/0000-0002-0621-9914; Figuerola-Bou, Elisabet/0000-0002-6839-9586; Rello-Varona, Santi/0000-0002-7500-5522; Sanchez-Molina, Sara/0000-0002-1430-131X; Hajji, Nabil/0000-0002-0695-920X	Asociacion Espanola Contra el Cancer" (AECC); Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC) [PI2000003, RD06/0020/0059]; CIBERONC [CB16/12/00361]; Consejeria de Salud de la Junta de Andalucia [PI-0013-2018]; Asociacion Alba Perez lucha contra el cancer infantil"; Catalan Agency for the Management of University and Research Grants [AGAUR 2017 SGR 332]	Asociacion Espanola Contra el Cancer" (AECC); Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC); CIBERONC; Consejeria de Salud de la Junta de Andalucia(Junta de Andalucia); Asociacion Alba Perez lucha contra el cancer infantil"; Catalan Agency for the Management of University and Research Grants	Research in the EDA and OMT labs are supported by "Asociacion Espanola Contra el Cancer" (AECC). EDA lab is also supported by the Ministry of Economy and Competitiveness of Spain-FEDER (CIBERONC, PI2000003, RD06/0020/0059). DGD and LHP are supported by CIBERONC (CB16/12/00361)S. LHP is funded by the Consejeria de Salud de la Junta de Andalucia (PI-0013-2018). SRV is supported by "Asociacion Alba Perez lucha contra el cancer infantil". The OMT lab is supported by the Catalan Agency for the Management of University and Research Grants (AGAUR 2017 SGR 332).	Bachman KE, 2003, CANCER CELL, V3, P89, DOI 10.1016/S1535-6108(02)00234-9; Balamuth NJ, 2010, LANCET ONCOL, V11, P184, DOI 10.1016/S1470-2045(09)70286-4; Bergin CJ, 2021, ONCOGENE, V40, P1191, DOI 10.1038/s41388-020-01591-7; Boulias K, 2004, NUCLEIC ACIDS RES, V32, P6096, DOI 10.1093/nar/gkh947; Casciello F, 2017, P NATL ACAD SCI USA, V114, P7077, DOI 10.1073/pnas.1618706114; Chen MW, 2010, CANCER RES, V70, P7830, DOI 10.1158/0008-5472.CAN-10-0833; Chen RJ, 2017, ONCOTARGET, V8, P62081, DOI 10.18632/oncotarget.19060; Crompton BD, 2014, CANCER DISCOV, V4, P1326, DOI 10.1158/2159-8290.CD-13-1037; Dang NN, 2020, AGING-US, V12, P2393, DOI 10.18632/aging.102750; de Nigris F, 2021, BONE, V143, DOI 10.1016/j.bone.2020.115605; Folberg R, 2000, AM J PATHOL, V156, P361, DOI 10.1016/S0002-9440(10)64739-6; Garcia-Dominguez DJ, 2021, ONCOGENE, V40, P5843, DOI 10.1038/s41388-021-01974-4; Garcia-Dominguez Daniel Jose, 2018, Oncotarget, V9, P31397, DOI 10.18632/oncotarget.25829; Gaspar N, 2015, J CLIN ONCOL, V33, P3036, DOI 10.1200/JCO.2014.59.5256; Gilmour AM, 2013, CELL SIGNAL, V25, P2587, DOI 10.1016/j.cellsig.2013.08.008; Grunewald TGP, 2018, NAT REV DIS PRIMERS, V4, DOI 10.1038/s41572-018-0003-x; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hontecillas-Prieto L, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.578011; Hou GJ, 2016, ONCOTARGET, V7, P64957, DOI 10.18632/oncotarget.11778; Hu L, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0322-6; Kim K, 2018, BIOCHEM BIOPH RES CO, V496, P758, DOI 10.1016/j.bbrc.2018.01.074; Kim Y, 2013, AUTOPHAGY, V9, P2126, DOI 10.4161/auto.26308; Kramer JM, 2016, BIOCHEM CELL BIOL, V94, P26, DOI 10.1139/bcb-2015-0017; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Li F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138390; Li XL, 2018, SPRINGERBRIEF MATH, P1, DOI 10.1007/978-3-319-89617-5_1; Liao HY, 2018, ONCOTARGETS THER, V11, P6947, DOI 10.2147/OTT.S172190; Lopez-Alemany R, 2021, METHODS MOL BIOL, V2226, P201, DOI 10.1007/978-1-0716-1020-6_16; Mabe NW, 2020, CELL REP, V33, DOI 10.1016/j.celrep.2020.108341; Mackintosh C, 2012, ONCOGENE, V31, P1287, DOI 10.1038/onc.2011.317; Oh SY, 2015, MOL CELLS, V38, P528, DOI 10.14348/molcells.2015.0026; Orr FW, 2000, J PATHOL, V190, P310, DOI 10.1002/(SICI)1096-9896(200002)190:3<310::AID-PATH525>3.0.CO;2-P; Pang ALY, 2014, ONCOL LETT, V7, P1819, DOI 10.3892/ol.2014.2034; Papait R, 2017, CIRCULATION, V136, P1233, DOI 10.1161/CIRCULATIONAHA.117.028561; Qin J, 2018, ONCOL LETT, V15, P8611, DOI 10.3892/ol.2018.8446; Ren AS, 2015, BIOCHEM BIOPH RES CO, V459, P10, DOI 10.1016/j.bbrc.2015.01.068; Ren LR, 2016, MOL CELL BIOCHEM, V411, P213, DOI 10.1007/s11010-015-2583-z; Sechler M, 2017, ONCOGENE, V36, P4150, DOI 10.1038/onc.2017.44; Segovia C, 2019, NAT MED, V25, P1073, DOI 10.1038/s41591-019-0499-y; Steeg PS, 2016, NAT REV CANCER, V16, P201, DOI 10.1038/nrc.2016.25; Talmadge JE, 2010, CANCER RES, V70, P5649, DOI 10.1158/0008-5472.CAN-10-1040; Tirode F, 2007, CANCER CELL, V11, P421, DOI 10.1016/j.ccr.2007.02.027; Uemura T, 2009, ONCOGENE, V28, P1218, DOI 10.1038/onc.2008.471; van der Schaft DWJ, 2005, CANCER RES, V65, P11520, DOI 10.1158/0008-5472.CAN-05-2468; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Wagenblast E, 2015, NATURE, V520, P358, DOI 10.1038/nature14403; Wei L, 2017, J HEPATOL, V67, P758, DOI 10.1016/j.jhep.2017.05.015; Wozniak RJ, 2007, ONCOGENE, V26, P77, DOI 10.1038/sj.onc.1209763; Yin C, 2019, FASEB J, V33, P14036, DOI 10.1096/fj.201900233RR; Yokoyama M, 2017, ONCOTARGET, V8, P21315, DOI 10.18632/oncotarget.15528	51	3	3	2	2	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2638	2650		10.1038/s41388-022-02279-w	http://dx.doi.org/10.1038/s41388-022-02279-w		MAR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35354905	Green Published, hybrid			2022-12-26	WOS:000775854600001
J	Mazhar, MW; Ishtiaq, M; Hussain, I; Parveen, A; Bhatti, KH; Azeem, M; Thind, S; Ajaib, M; Maqbool, M; Sardar, T; Muzammil, K; Nasir, N				Mazhar, Muhammad Waqas; Ishtiaq, Muhammad; Hussain, Iqbal; Parveen, Abida; Bhatti, Khizar Hayat; Azeem, Muhammad; Thind, Sumaira; Ajaib, Muhammad; Maqbool, Mehwish; Sardar, Tauqeer; Muzammil, Khursheed; Nasir, Nazim			Seed nano-priming with Zinc Oxide nanoparticles in rice mitigates drought and enhances agronomic profile	PLOS ONE			English	Article							ZEA-MAYS L.; ZNO NANOPARTICLES; STRESS; PLANTS; TOLERANCE; YIELD	All cereal crops, particularly rice are perpetually affected due to drastic climatic changes which triggers different stressors resulting in food shortage scenarios across the globe. In modern era, application of nanotechnology holds the pledge in combating the climate change mediated environmental stressors through nanomaterials such as pesticides, nanobiosensors, nano-clays and nano-seed priming technologies. Current study is a part of experiment conducted to comprehend the behaviour of rice plants raised from Zinc Oxide nanoparticles (ZnONPs) primed seeds under the water shortage environment. The seed priming treatment concentrations included 0, 5, 10, 15, 25 and 50 ppm. In the experimental results an increase in plant height, total chlorophyll contents, plant fresh and dry weights was obtained by use of seed priming with ZnONPs. The study results proved that seed priming with 25ppm of ZnONPs increased seed and straw yield with value of 85.333 and 123.333, respectively under water deficit environment. The analysis depicted that 25 ppm has been found more suitable for increasing the 1000 paddy weight of rice plants under both well irrigated and water shortage conditions. Seed priming with ZnONPs results in 53% reduction in MDA contents of water stressed rice plants Drought stress leads to reduction in plant height by 31%, plant fresh weight by 22% and plant dry weight by 28%. Seed priming treatments imparted in current study show significance increase in plant biomass. Priming with ZnONPs further enhances the levels of proline amino acid facilitating the plant to combat water shortage stress. A further elevation in activities of SOD, CAT and POD takes place in rice plants raised from ZnONPs primed seeds by 11%, 13% and 38%, respectively. An elevation in activities of antioxidant enzymes was found and the levels of oxidative stress indicators decreased upon seed priming with ZnONPs. Furthermore the yield characteristics such as panicle length, number of tillers, paddy yield and straw yield of the rice plants raised through ZnONPs primed seeds enhanced. The ZnONPs at concentration of 25 ppm proved optimum in alleviating drought induced damages. It can be inferred that seed pre conditioning with ZnONPs is helpful in increasing yield attributes under the water shortage environment.	[Mazhar, Muhammad Waqas; Ishtiaq, Muhammad; Ajaib, Muhammad; Maqbool, Mehwish; Sardar, Tauqeer] Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Ajk, Pakistan; [Hussain, Iqbal; Parveen, Abida; Thind, Sumaira] Govt Coll Univ Faisalabad, Dept Bot, Faisalabad, Pakistan; [Bhatti, Khizar Hayat] Univ Gujrat, Dept Bot, Gujrat, Pakistan; [Azeem, Muhammad] Univ Bahrain, Coll Sci, Dept Biol, Zallaq, Bahrain; [Muzammil, Khursheed] King Khalid Univ, Coll Appl Med Sci, Dept Publ Hlth, Khamis Mushait Campus, Abha, Saudi Arabia; [Nasir, Nazim] King Khalid Univ, Coll Appl Med Sci, Dept Basic Med Sci, Khamis Mushait Campus, Abha, Saudi Arabia	Government College University Faisalabad; University of Gujrat; University of Bahrain; King Khalid University; King Khalid University	Ishtiaq, M (corresponding author), Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, Ajk, Pakistan.	drishtiaq.bot@must.edu.pk	MUZAMMIL, KHURSHEED/GWZ-9736-2022; Ishtiaq, Muhammad/F-5152-2010; Hussain, Iqbal/B-2295-2013; Ishtiaq, Muhammad/GSN-4278-2022; Nasir, Nazim/F-9460-2019	Ishtiaq, Muhammad/0000-0003-2468-1413; Hussain, Iqbal/0000-0002-8449-0494; Nasir, Nazim/0000-0003-0873-0502; Muzammil, Khursheed/0000-0003-1676-8092				Adnan R, 2021, NOT BOT HORTI AGROBO, V49, DOI [/10.1016/j.plaphy. 2020.11.011, DOI 10.1016/J.PLAPHY.2020.11.011]; Adrees M, 2020, CHEMOSPHERE, V238, DOI 10.1016/j.chemosphere.2019.124681; Aghdam MTB, 2016, BRAZ J BOT, V39, P139, DOI 10.1007/s40415-015-0227-x; Ahmed A.U., 2019, STATUS CLIMATE CHANG, P125, DOI [10.1007/978-3-319-99347-8_7, DOI 10.1007/978-3-319-99347-8_8, DOI 10.1007/978-3-319-99347-8_7]; Ali Q, 2011, J AGRON CROP SCI, V197, P258, DOI 10.1111/j.1439-037X.2010.00463.x; Ali Q, 2017, PLANT PHYSIOL BIOCH, V119, P50, DOI 10.1016/j.plaphy.2017.08.010; Anjum SA, 2011, AFR J AGR RES, V6, P2026; ARNON DI, 1949, PLANT PHYSIOL, V24, P1, DOI 10.1104/pp.24.1.1; Arshad MF, 2021, INT J PLANT SCI PHYT, V1, P116; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; CAKMAK I, 1991, PHYSIOL PLANTARUM, V83, P463, DOI 10.1111/j.1399-3054.1991.tb00121.x; Cavalcanti FR, 2007, J PLANT PHYSIOL, V164, P591, DOI 10.1016/j.jplph.2006.03.004; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chhipa H, 2017, ENVIRON CHEM LETT, V15, P15, DOI 10.1007/s10311-016-0600-4; Dawood S, 2021, CHEMOSPHERE, V278, DOI 10.1016/j.chemosphere.2021.130469; Elshayb OM, 2021, MOLECULES, V26, DOI 10.3390/molecules26030584; Faiz S, 2022, INT J PHYTOREMEDIAT, V24, P364, DOI 10.1080/15226514.2021.1949263; GIANNOPOLITIS CN, 1977, PLANT PHYSIOL, V59, P309, DOI 10.1104/pp.59.2.309; Giraldo JP, 2019, NAT NANOTECHNOL, V14, P541, DOI 10.1038/s41565-019-0470-6; GORNALL AG, 1949, J BIOL CHEM, V177, P751; Hussain HA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-40362-7; Itroutwar PD, 2020, J PLANT GROWTH REGUL, V39, P717, DOI 10.1007/s00344-019-10012-3; Jamil N., 2018, IOP C SER MAT SCI EN, V414, P12029, DOI DOI 10.1088/1757-899X/414/1/012029; Karki HP, 2018, APPL SURF SCI, V435, P599, DOI 10.1016/j.apsusc.2017.11.166; Kasim WA., 2007, INT J BOT, V1, P440; Khan I, 2021, ENVIRON SCI POLLUT R, V28, P13712, DOI 10.1007/s11356-020-11612-3; Khan MU, 2007, SARHAD J AGRIC, V23, P1019; Khanra S, 2018, ACS APPL NANO MATER, V1, P1175, DOI 10.1021/acsanm.7b00344; Latef AAHA, 2017, J PLANT GROWTH REGUL, V36, P60, DOI 10.1007/s00344-016-9618-x; Liu Y, 2022, J HAZARD MATER, V423, DOI 10.1016/j.jhazmat.2021.126866; Lowry GV, 2019, NAT NANOTECHNOL, V14, P517, DOI 10.1038/s41565-019-0461-7; Mahakham W, 2016, SCI TOTAL ENVIRON, V573, P1089, DOI 10.1016/j.scitotenv.2016.08.120; Maroufi K., 2011, Advances in Environmental Biology, V5, P3743; Mazhar M, 2021, SABRAO J BREED GENET, V53; Minx JC, 2017, ENVIRON SCI POLICY, V77, P252, DOI 10.1016/j.envsci.2017.05.014; Mir NA, 2019, FOOD HYDROCOLLOID, V96, P433, DOI 10.1016/j.foodhyd.2019.05.052; Mushtaq W, INT J PLANT SCI PHYT, V1, P102; Muthayya S, 2014, ANN NY ACAD SCI, V1324, P7, DOI 10.1111/nyas.12540; Noman A, 2018, CHEMOSPHERE, V195, P175, DOI 10.1016/j.chemosphere.2017.12.059; Palmqvist NGM, 2017, NANOSCALE RES LETT, V12, DOI 10.1186/s11671-017-2404-2; Popovic V, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9121804; Powell SR, 2000, J NUTR, V130, p1447S, DOI 10.1093/jn/130.5.1447S; Ramzan M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-88797-1; Rizwan M, 2019, ENVIRON POLLUT, V248, P358, DOI 10.1016/j.envpol.2019.02.031; Sajedi Nour Ali, 2011, Physiology and Molecular Biology of Plants, V17, P215, DOI 10.1007/s12298-011-0067-5; Santo Pereira AD, 2021, NANOMATERIALS-BASEL, V11, DOI 10.3390/nano11020267; Sullivan JT, 1935, IND ENG CHEM, V7, P0311, DOI 10.1021/ac50097a010; Tondey M, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11040729; Vazin F., 2012, Cercetari Agronomice in Moldova, V45, P15; Velikova V, 2000, PLANT SCI, V151, P59, DOI 10.1016/S0168-9452(99)00197-1; Vishwakarma V, 2018, CONSTR BUILD MATER, V162, P96, DOI 10.1016/j.conbuildmat.2017.11.174; Yan FY, 2020, ECOTOX ENVIRON SAFE, V206, DOI 10.1016/j.ecoenv.2020.111358; Yang KY, 2018, BOTANY, V96, P175, DOI 10.1139/cjb-2017-0124; Yasmeen F, 2017, BBA-PROTEINS PROTEOM, V1865, P28, DOI 10.1016/j.bbapap.2016.10.001; Zafar S, 2020, J KING SAUD UNIV SCI, V32, P1116, DOI 10.1016/j.jksus.2019.10.017; Zhang W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098958	56	6	6	9	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264967	10.1371/journal.pone.0264967	http://dx.doi.org/10.1371/journal.pone.0264967			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324949	gold, Green Published			2022-12-26	WOS:000780951300025
J	Takeuchi, M; Yoshida, S; Kawakami, C; Kawakami, K; Ito, S				Takeuchi, Masato; Yoshida, Satomi; Kawakami, Chihiro; Kawakami, Koji; Ito, Shuichi		Japan Environm Childrens Study Grp	Association of maternal heavy metal exposure during pregnancy with isolated cleft lip and palate in offspring: Japan Environment and Children's Study (JECS) cohort study	PLOS ONE			English	Article							CADMIUM EXPOSURE; EPIDEMIOLOGY; BIRTH	Background Cleft lip and palate (cleft L/P) is one of the most common congenital anomalies and its etiology is assumed to be multifactorial. Recent epidemiological data involving a small number of participants suggested an association between perinatal exposure to heavy metals and cleft L/P in affected children. However, this association requires further investigation in a large cohort. Methods This nested case-control study used a dataset of The Japan Environment and Children's Study, which is an ongoing research project to investigate the association between environmental factors and mother-child health. Participants were enrolled between 2011 and 2014. From the records of fetuses/children, we extracted data of isolated cleft L/P cases and matched children without cleft L/P at a ratio of 1:10. The exposures of interest were in utero exposure to four metals (mercury [Hg], lead [Pb], cadmium [Cd], and manganese [Mn]), which were sampled from mothers in the second/third trimester. Conditional logistic regression was used to assess the association between heavy metal exposure and isolated cleft L/P. Three sensitivity analyses were conducted to test the robustness of the findings, including the change in case definition and statistical methods. Results Of 104,062 fetal records involving both live-birth and stillbirth, we identified 192 children with isolated cleft L/P and 1,920 matched controls. Overall, the blood metal levels were low (for example, median Pb level was 5.85, 6.22, and 5.75 mu g/L in the total cohort, cases, and controls, respectively). Univariate and multivariate analyses showed that levels of none of the four heavy metals in the mother's blood during pregnancy were associated with the risk of cleft L/P in offspring; the adjusted odds ratios (per 1 mu g/L increase) with 95% intervals were 0.96 (0.91-1.03), 1.01 (0.94-1.08), 1.00 (0.61-1.63) and 1.00 (0.97-1.03) for Hg, Pb, Cd and Mn, respectively. The results were consistent in all sensitivity analyses. Conclusions Exposure to these four metals during pregnancy was not associated with isolated cleft L/P at the low exposure level in our cohort.	[Takeuchi, Masato; Yoshida, Satomi; Kawakami, Koji] Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan; [Kawakami, Chihiro; Ito, Shuichi] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa, Japan	Kyoto University; Yokohama City University	Takeuchi, M (corresponding author), Kyoto Univ, Grad Sch Med & Publ Hlth, Dept Pharmacoepidemiol, Kyoto, Japan.	takeuchi.masato.3c@kyoto-u.ac.jp	Kawakami, Koji/GZA-6582-2022	Kawakami, Koji/0000-0002-7477-4071; Takeuchi, Masato/0000-0002-2990-2687	Ministry of the Environment, Japan	Ministry of the Environment, Japan(Ministry of the Environment, Japan)	The JECS was funded by the Ministry of the Environment, Japan. The findings and conclusions of this article are solely the responsibility of the authors and do not represent the official views of the above government.	Al osman M, 2019, BIOMETALS, V32, P563, DOI 10.1007/s10534-019-00193-5; Axelson Olav, 2004, Int J Occup Med Environ Health, V17, P115; Bernheim N, 2006, B-ENT, P11; Borgan O, 2018, CH CRC HANDB MOD STA, P329; CHERNOFF N, 1973, TERATOLOGY, V8, P29, DOI 10.1002/tera.1420080105; Crockett DJ, 2014, FACIAL PLAST SURG CL, V22, P573, DOI 10.1016/j.fsc.2014.07.002; Dixon MJ, 2011, NAT REV GENET, V12, P167, DOI 10.1038/nrg2933; Feng CY, 2013, STAT MED, V32, P230, DOI 10.1002/sim.5486; Furukawa TA, 2008, INT J METH PSYCH RES, V17, P152, DOI 10.1002/mpr.257; Gu Xing S., 1993, J COMPUTATIONAL GRAP, V2, P405, DOI [DOI 10.1080/10618600.1993.10474623, DOI 10.7326/0003-4819-152-6-201003160-00008]; Hozyasz KK, 2010, PEDIAT POLSKA, V85, P609; Ikeda M, 2011, BIOL TRACE ELEM RES, V139, P269, DOI 10.1007/s12011-010-8661-x; Ishitsuka K, 2017, ENVIRON HEALTH PREV, V22, DOI 10.1186/s12199-017-0667-y; Kawamoto T, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-25; Liew Z, 2015, INT J EPIDEMIOL, V44, P345, DOI 10.1093/ije/dyu249; Gasca-Sanchez FM, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16142488; Mbuyi-musanzayi S, 2018, J CRANIO MAXILL SURG, V46, P1051, DOI 10.1016/j.jcms.2018.05.006; Mezawa H, 2019, J EPIDEMIOL, V29, P247, DOI 10.2188/jea.JE20180014; Michikawa T, 2018, J EPIDEMIOL, V28, P99, DOI 10.2188/jea.JE20170018; Mossey PA, 2009, LANCET, V374, P1773, DOI 10.1016/S0140-6736(09)60695-4; Nakayama SF, 2019, J EXPO SCI ENV EPID, V29, P633, DOI 10.1038/s41370-019-0139-0; Ni WL, 2018, ENVIRON SCI TECHNOL, V52, P10787, DOI 10.1021/acs.est.8b02404; Overmatching Kirian M., 2012, ENCY EPIDEMIOLOGY, DOI [10.1016/j.jaad.2012.02.018, DOI 10.1016/J.JAAD.2012.02.018]; Pan LB, 2018, ENVIRON SCI POLLUT R, V25, P1055, DOI 10.1007/s11356-017-0513-1; Panamonta Vipawee, 2015, Journal of the Medical Association of Thailand, V98, pS11; Pastor AJS, 2021, EXPOS HEALTH, V13, P173, DOI 10.1007/s12403-020-00371-8; Pi X, 2018, ENVIRON POLLUT, V242, P1652, DOI 10.1016/j.envpol.2018.07.112; Raz R, 2018, AM J EPIDEMIOL, V187, P2292, DOI 10.1093/aje/kwy172; Reiter R, 2011, INT J PEDIATR OTORHI, V75, P85, DOI 10.1016/j.ijporl.2010.10.015; Rossignol DA, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.4; Rousenbaum P R., 2020, DESIGN OBSERVATIONAL, V2nd; Salvatori F, 2004, NEUROTOXICOL TERATOL, V26, P673, DOI 10.1016/j.ntt.2004.05.001; Suhl J, 2018, BIRTH DEFECTS RES, V110, P603, DOI 10.1002/bdr2.1202; Tanaka SA, 2012, PLAST RECONSTR SURG, V129, p511E, DOI 10.1097/PRS.0b013e3182402dd1; Van Buuren S., 2018, FLEXIBLE IMPUTATION, DOI [DOI 10.1201/9780429492259, 10.1201/9780429492259]; Watkins SE, 2014, CLIN PLAST SURG, V41, P149, DOI 10.1016/j.cps.2013.12.003; Westreich D., 2020, EPIDEMIOLOGY DESIGN; Worley ML, 2018, CLIN PERINATOL, V45, P661, DOI 10.1016/j.clp.2018.07.006; Yang WL, 2021, ECOTOX ENVIRON SAFE, V208, DOI 10.1016/j.ecoenv.2020.111415; Yokoyama Y, 2016, J EPIDEMIOL, V26, P420, DOI 10.2188/jea.JE20150064; Yoshida S, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035817	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265648	10.1371/journal.pone.0265648	http://dx.doi.org/10.1371/journal.pone.0265648			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324965	Green Published, gold			2022-12-26	WOS:000780951300054
J	Arora, P; Sidarovich, A; Graichen, L; Hornich, B; Hahn, A; Hoffmann, M; Pohlmann, S				Arora, Prerna; Sidarovich, Anzhalika; Graichen, Luise; Hoernich, Bojan; Hahn, Alexander; Hoffmann, Markus; Poehlmann, Stefan			Functional analysis of polymorphisms at the S1/S2 site of SARS-CoV-2 spike protein	PLOS ONE			English	Article							VARIANT B.1.1.7; ENTRY DRIVEN; CORONAVIRUS; TRANSMISSION; INFECTION; TMPRSS2; CELLS; ACE2	Several SARS-CoV-2 variants emerged that harbor mutations in the surface unit of the viral spike (S) protein that enhance infectivity and transmissibility. Here, we analyzed whether ten naturally-occurring mutations found within the extended loop harboring the S1/S2 cleavage site of the S protein, a determinant of SARS-CoV-2 cell tropism and pathogenicity, impact S protein processing and function. None of the mutations increased but several decreased S protein cleavage at the S1/S2 site, including S686G and P681H, the latter of which is found in variants of concern B.1.1.7 (Alpha variant) and B.1.1.529 (Omicron variant). None of the mutations reduced ACE2 binding and cell-cell fusion although several modulated the efficiency of host cell entry. The effects of mutation S686G on viral entry were cell-type dependent and could be linked to the availability of cathepsin L for S protein activation. These results show that polymorphisms at the S1/S2 site can modulate S protein processing and host cell entry.	[Arora, Prerna; Sidarovich, Anzhalika; Graichen, Luise; Hoffmann, Markus; Poehlmann, Stefan] German Primate Ctr, Infect Biol Unit, Gottingen, Germany; [Arora, Prerna; Sidarovich, Anzhalika; Hoffmann, Markus; Poehlmann, Stefan] Georg August Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany; [Hoernich, Bojan; Hahn, Alexander] German Primate Ctr, Infect Biol Unit, Jr Res Grp Herpesviruses, Gottingen, Germany	Deutsches Primatenzentrum (DPZ); University of Gottingen; Deutsches Primatenzentrum (DPZ)	Hoffmann, M; Pohlmann, S (corresponding author), German Primate Ctr, Infect Biol Unit, Gottingen, Germany.; Hoffmann, M; Pohlmann, S (corresponding author), Georg August Univ Gottingen, Fac Biol & Psychol, Gottingen, Germany.	mhoffmann@dpz.eu; spoehlmann@dpz.eu	Hoffmann, Markus/J-7836-2018; Pöhlmann, Stefan/H-2395-2011	Hoffmann, Markus/0000-0003-4603-7696; Pöhlmann, Stefan/0000-0001-6086-9136; Hahn, Alexander/0000-0003-4171-2744; Sidarovich, Anzhalika/0000-0003-4367-207X	Bundesministerium fur Bildung und Forschung [01KI2006D, 01KI20328A, 01KI20396, 01KX2021]; Niedersachsiches Ministerium fur Wissenschaft und Kultur [14-76103-184]; Deutsche Forschungsgemeinschaft (DFG) [PO 716/11-1, PO 716/14-1]; Deutsche Forschungsgemeinschaft [HA 6013/6-1]	Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); Niedersachsiches Ministerium fur Wissenschaft und Kultur; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	S.P. acknowledges funding by Bundesministerium fur Bildung und Forschung (01KI2006D, 01KI20328A, 01KI20396, 01KX2021), the Niedersachsiches Ministerium fur Wissenschaft und Kultur (14-76103-184, MWK HZI COVID-19) and the Deutsche Forschungsgemeinschaft (DFG; PO 716/11-1, PO 716/14-1). A.S.H. acknowledges funding from the Deutsche Forschungsgemeinschaft (HA 6013/6-1).	[Anonymous], 2012, Wkly Epidemiol Rec, V87, P461; Bestle D, 2020, LIFE SCI ALLIANCE, V3, DOI 10.26508/lsa.202000786; Brinkmann C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189073; Buchrieser J, 2020, EMBO J, V39, DOI 10.15252/embj.2020106267; Bussani R, 2020, EBIOMEDICINE, V61, DOI 10.1016/j.ebiom.2020.103104; Cai YF, 2020, SCIENCE, V369, P1586, DOI [10.1126/science.abd4251, 10.1101/2020.05.16.099317]; Calistri P, 2021, INT J INFECT DIS, V105, P753, DOI 10.1016/j.ijid.2021.03.005; Campbell F, 2021, EUROSURVEILLANCE, V26, DOI 10.2807/1560-7917.ES.2021.26.24.2100509; Cao YL, 2022, NATURE, V602, P657, DOI 10.1038/s41586-021-04385-3; Cele S, 2022, NATURE, V602, P654, DOI 10.1038/s41586-021-04387-1; Chen RTE, 2021, NAT MED, V27, DOI 10.1038/s41591-021-01294-w; Collier DA, 2021, NATURE, V593, P136, DOI 10.1038/s41586-021-03412-7; Davies NG, 2021, SCIENCE, V372, P149, DOI 10.1126/science.abg3055; Frampton D, 2021, LANCET INFECT DIS, V21, P1246, DOI 10.1016/S1473-3099(21)00170-5; Gobeil SMC, 2021, CELL REP, V34, DOI 10.1016/j.celrep.2020.108630; Gonzalez-Hernandez M, 2019, VIROLOGY, V532, P22, DOI 10.1016/j.virol.2019.03.020; Graham MS, 2021, LANCET PUBLIC HEALTH, V6, pE335, DOI 10.1016/S2468-2667(21)00055-4; Guruprasad L, 2021, PROTEINS, V89, P569, DOI 10.1002/prot.26042; Heurich A, 2014, J VIROL, V88, P1293, DOI 10.1128/JVI.02202-13; Hornich BF, 2021, J VIROL, V95, DOI 10.1128/JVI.00002-21; Hoffmann M, 2022, CELL, V185, P447, DOI 10.1016/j.cell.2021.12.032; Hoffmann M, 2021, NAT MICROBIOL, V6, P828, DOI 10.1038/s41564-021-00931-x; Hoffmann M, 2021, CELL, V184, P2384, DOI 10.1016/j.cell.2021.03.036; Hoffmann M, 2020, CELL, V181, P271, DOI 10.1016/j.cell.2020.02.052; Hoffmann M, 2020, MOL CELL, V78, P779, DOI 10.1016/j.molcel.2020.04.022; Hoffmann M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072942; Hoffmann Markus, 2018, ACTIVATION VIRUSES H; Hou YXJ, 2020, SCIENCE, V370, P1464, DOI 10.1126/science.abe8499; Johnson BA, 2021, NATURE, V591, P293, DOI 10.1038/s41586-021-03237-4; Karim SSA, 2021, LANCET, V398, P2126, DOI 10.1016/S0140-6736(21)02758-6; Kawase M, 2012, J VIROL, V86, P6537, DOI 10.1128/JVI.00094-12; Kleine-Weber H, 2019, J VIROL, V93, DOI 10.1128/JVI.01381-18; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kuzmina A, 2021, CELL HOST MICROBE, V29, P522, DOI 10.1016/j.chom.2021.03.008; Lamers MM, 2021, ELIFE, V10, DOI 10.7554/eLife.66815; Lau SY, 2020, EMERG MICROBES INFEC, V9, P837, DOI 10.1080/22221751.2020.1756700; Leung K, 2021, EUROSURVEILLANCE, V26, P15, DOI 10.2807/1560-7917.ES.2020.26.1.2002106; Liu C, 2021, CELL, V184, P4220, DOI 10.1016/j.cell.2021.06.020; Liu JY, 2021, NATURE, V596, P273, DOI 10.1038/s41586-021-03693-y; Liu LH, 2022, NATURE, V602, P676, DOI 10.1038/s41586-021-04388-0; Lubinski B, 2022, ISCIENCE, V25, DOI 10.1016/j.isci.2021.103589; Ou XY, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15562-9; Park JE, 2016, P NATL ACAD SCI USA, V113, P12262, DOI 10.1073/pnas.1608147113; Peacock TP, 2021, NAT MICROBIOL, V6, P899, DOI 10.1038/s41564-021-00908-w; Peacock TP., 2021, BIORXIV, DOI [10.1101/2021.05.28.446163, DOI 10.1101/2021.05.28.446163]; Planas D, 2021, NAT MED, V27, P917, DOI 10.1038/s41591-021-01318-5; Plante JA, 2021, CELL HOST MICROBE, V29, P508, DOI 10.1016/j.chom.2021.02.020; Rentsch MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025858; Robson F, 2020, MOL CELL, V79, P710, DOI 10.1016/j.molcel.2020.07.027; Saito A., 2021, BIORXIV, DOI [10.1101/2021.06.17.448820, DOI 10.1101/2021.06.17.448820]; Shang J, 2020, P NATL ACAD SCI USA, V117, P11727, DOI 10.1073/pnas.2003138117; Shen XY, 2021, CELL HOST MICROBE, V29, P529, DOI 10.1016/j.chom.2021.03.002; Singanayagam A, 2022, LANCET INFECT DIS, V22, P183, DOI 10.1016/S1473-3099(21)00648-4; Supasa P, 2021, CELL, V184, P2201, DOI 10.1016/j.cell.2021.02.033; Viana R, 2022, NATURE, V603, P679, DOI 10.1038/s41586-022-04411-y; Volz E, 2021, CELL, V184, P64, DOI 10.1016/j.cell.2020.11.020; Wall EC, 2021, LANCET, V397, P2331, DOI 10.1016/S0140-6736(21)01290-3; Walls AC, 2020, CELL, V181, P281, DOI [10.1016/j.cell.2020.02.058, 10.1016/j.cell.2020.11.032]; Wang PF, 2021, NATURE, V593, P130, DOI 10.1038/s41586-021-03398-2; Wang P, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23166-0; Washington NL, 2021, CELL, V184, P2587, DOI 10.1016/j.cell.2021.03.052; Winstone H, 2021, J VIROL, V95, DOI 10.1128/JVI.02422-20; Yurkovetskiy L, 2020, CELL, V183, P739, DOI 10.1016/j.cell.2020.09.032; Zhao S, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab011; Zhou B, 2021, NATURE, V592, P122, DOI 10.1038/s41586-021-03361-1; Zhou DM, 2021, CELL, V184, P2348, DOI 10.1016/j.cell.2021.02.037; Zhou P, 2020, NATURE, V579, P270, DOI 10.1038/s41586-020-2012-7	68	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265453	10.1371/journal.pone.0265453	http://dx.doi.org/10.1371/journal.pone.0265453			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333910	gold, Green Published			2022-12-26	WOS:000784335700005
J	Barnett-Neefs, C; Sullivan, G; Zoellner, C; Wiedmann, M; Ivanek, R				Barnett-Neefs, Cecil; Sullivan, Genevieve; Zoellner, Claire; Wiedmann, Martin; Ivanek, Renata			Using agent-based modeling to compare corrective actions for Listeria contamination in produce packinghouses	PLOS ONE			English	Article							MONOCYTOGENES CONTAMINATION; INTERVENTION STRATEGIES; MULTISTATE OUTBREAK; PERSISTENCE; IMPACT; PLANTS	The complex environment of a produce packinghouse can facilitate the spread of pathogens such as Listeria monocytogenes in unexpected ways. This can lead to finished product contamination and potential foodborne disease cases. There is a need for simulation-based decision support tools that can test different corrective actions and are able to account for a facility's interior cross-contamination dynamics. Thus, we developed agent-based models of Listeria contamination dynamics for two produce packinghouse facilities; agents in the models represented equipment surfaces and employees, and models were parameterized using observations, values from published literature and expert opinion. Once validated with historical data from Listeria environmental sampling, each model's baseline conditions were investigated and used to determine the effectiveness of corrective actions in reducing prevalence of agents contaminated with Listeria and concentration of Listeria on contaminated agents. Evaluated corrective actions included reducing incoming Listeria, modifying cleaning and sanitation strategies, and reducing transmission pathways, and combinations thereof. Analysis of Listeria contamination predictions revealed differences between the facilities despite their functional similarities, highlighting that one-size-fits-all approaches may not always be the most effective means for selection of corrective actions in fresh produce packinghouses. Corrective actions targeting Listeria introduced in the facility on raw materials, implementing risk-based cleaning and sanitation, and modifying equipment connectivity were shown to be most effective in reducing Listeria contamination prevalence. Overall, our results suggest that a well-designed cleaning and sanitation schedule, coupled with good manufacturing practices can be effective in controlling contamination, even if incoming Listeria spp. on raw materials cannot be reduced. The presence of water within specific areas was also shown to influence corrective action performance. Our findings support that agent-based models can serve as effective decision support tools in identifying Listeria-specific vulnerabilities within individual packinghouses and hence may help reduce risks of food contamination and potential human exposure.	[Barnett-Neefs, Cecil; Sullivan, Genevieve; Ivanek, Renata] Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA; [Sullivan, Genevieve; Wiedmann, Martin] Cornell Univ, Coll Agr & Life Sci, Dept Food Sci, Ithaca, NY USA; [Zoellner, Claire] IFood DecisSci, Seattle, WA USA	Cornell University; Cornell University	Barnett-Neefs, C (corresponding author), Cornell Univ, Dept Populat Med & Diagnost Sci, Ithaca, NY USA.	cwb96@cornell.edu	Wiedmann, Martin/A-9683-2008	Wiedmann, Martin/0000-0002-4168-5662; Barnett-Neefs, Cecil/0000-0003-0810-3728; Sullivan, Genevieve/0000-0002-6821-0296	Center for Produce Safety [2020CPS10]; Florida Department of Agriculture and Consumer Services Specialty (FLDACS) [USDA-AMS-TMSCBGP-G-18-003]; iFoodDecisionSciences, Inc. [2020-67021-32855, USDA-AMS-TM-SCBGPG-19-003, 2019-51181-30016]	Center for Produce Safety; Florida Department of Agriculture and Consumer Services Specialty (FLDACS); iFoodDecisionSciences, Inc.	R.I., 2019CPS06, Center for Produce Safety, https://doi.org/10.13039/100008678 M.W., 2020CPS10, Center for Produce Safety, https://doi.org/10.13039/100008678 R.I., USDA-AMS-TMSCBGP-G-18-003, Florida Department of Agriculture and Consumer Services Specialty (FLDACS), https://doi.org/10.13039/100011508 I.T., 2020-67021-32855, USDA | National Institute of Food and Agriculture (NIFA), https://doi.org/10.13039/100005825 M.W., USDA-AMS-TM-SCBGPG-19-003, Washington State Department of Agriculture (WSDA), https://doi.org/10.13039/100010251 M.W., 2019-51181-30016, USDA | National Institute of Food and Agriculture (NIFA), https://doi.org/10.13039/100005825 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CZ, iFoodDecisionSciences, Inc. https://www.ifoodds.com/The funder provided support in the form of salaries for author C.Z. but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of this author are articulated in the `author contributions' section.	Allende A, 2015, INT J ENV RES PUB HE, V12, P7457, DOI 10.3390/ijerph120707457; Angelo KM, 2017, EPIDEMIOL INFECT, V145, P848, DOI 10.1017/S0950268816003083; Beno SM, 2016, J FOOD PROTECT, V79, P2095, DOI 10.4315/0362-028X.JFP-16-241; Berrang ME, 2012, J FOOD PROTECT, V75, P1328, DOI 10.4315/0362-028X.JFP-12-021; Berrang ME, 2010, J FOOD PROTECT, V73, P286, DOI 10.4315/0362-028X-73.2.286; Bolocan AS, 2015, J FOOD PROTECT, V78, P1664, DOI 10.4315/0362-028X.JFP-14-539; Carpentier B, 2011, INT J FOOD MICROBIOL, V145, P1, DOI 10.1016/j.ijfoodmicro.2011.01.005; Centers for Disease Control and Prevention, 2011, MULTISTATE OUTBREAK, P3; Chambers MK, 2009, J ENVIRON MANAGE, V90, P961, DOI 10.1016/j.jenvman.2008.03.008; Chen Y, 2016, APPL ENVIRON MICROB, V82, P7030, DOI 10.1128/AEM.01486-16; Chen YQ, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8526104; Dowle M., 2020, PACKAGE DATA TABLE E, P1; Esteban JI, 2008, INT J FOOD MICROBIOL, V123, P177, DOI 10.1016/j.ijfoodmicro.2007.12.012; Estrada EM, 2020, J FOOD PROTECT, V83, P277, DOI 10.4315/0362-028X.JFP-19-411; FARBER JM, 1992, LETT APPL MICROBIOL, V15, P103, DOI 10.1111/j.1472-765X.1992.tb00737.x; FDA, 2020, GUIDANCE IND CONTROL, P1; Ferreira V, 2014, J FOOD PROTECT, V77, P150, DOI 10.4315/0362-028X.JFP-13-150; Fisher MJ, 2009, AUST CRIT CARE, V22, P93, DOI 10.1016/j.aucc.2008.11.003; Food and Drug Administration, 2017, GOOD MAN PRACT 21 CE; Food and Drug Administration, 2017, CONTR LIST MON READ; Food and Drug Administration/Food Safety and Inspection Service, 2013, INT RISK ASS LIST MO; Fox EM, 2015, FOOD MICROBIOL, V51, P81, DOI 10.1016/j.fm.2015.05.002; Harrell FE., 2020, PACKAGE HMISC HARREL, P1; Hitchins AD., 2017, BACTERIOLOGICAL ANAL, P99; Hoelzer K, 2012, INT J FOOD MICROBIOL, V157, P267, DOI 10.1016/j.ijfoodmicro.2012.05.019; Lappi VR, 2004, J FOOD PROTECT, V67, P2500, DOI 10.4315/0362-028X-67.11.2500; Lappi VR, 2004, J FOOD PROTECT, V67, P1163, DOI 10.4315/0362-028X-67.6.1163; Malley TJV, 2013, J FOOD PROTECT, V76, P796, DOI 10.4315/0362-028X.JFP-12-236; Marriott NG., 2018, FOOD CONTAMINATION S, P83, DOI [10.1007/978-3-319-67166-6_5, DOI 10.1007/978-3-319-67166-6_5]; Meireles A, 2016, FOOD RES INT, V82, P71, DOI 10.1016/j.foodres.2016.01.021; Muhterem-Uyar M, 2015, FOOD CONTROL, V51, P94, DOI 10.1016/j.foodcont.2014.10.042; Nyarko E, 2018, FOOD CONTROL, V85, P177, DOI 10.1016/j.foodcont.2017.09.033; Pietrysiak E, 2019, COMPR REV FOOD SCI F, V18, P1705, DOI 10.1111/1541-4337.12496; RCore Team, 2020, R LANG ENV STAT COMP; Rorvik LM, 2000, INT J FOOD MICROBIOL, V62, P183, DOI 10.1016/S0168-1605(00)00334-2; Russell RE, 2017, EMERG INFECT DIS, V23, P1, DOI 10.3201/eid2301.161452; Spanu C, 2020, COMPR REV FOOD SCI F, V19, P2843, DOI 10.1111/1541-4337.12619; Stevenson M., 2020, PACKAGE EPIR TOOLS A, P1; Strawn LK, 2013, APPL ENVIRON MICROB, V79, P7618, DOI 10.1128/AEM.02831-13; Sullivan G, 2021, APPL ENVIRON MICROB, V87, DOI 10.1128/AEM.00799-21; Sullivan G, 2020, J FOOD PROTECT, V83, P1656, DOI 10.4315/JFP-20-094; Tompkin RB, 2002, J FOOD PROTECT, V65, P709, DOI 10.4315/0362-028X-65.4.709; Walls I, 2005, J FOOD PROTECT, V68, P1932; White JW, 2014, OIKOS, V123, P385, DOI 10.1111/j.1600-0706.2013.01073.x; Wilensky U., 1999, NETLOGO; World Health Organization, 2018, LATEST GLOBAL CANC D; Yan W, 2005, WACV 2005: SEVENTH IEEE WORKSHOP ON APPLICATIONS OF COMPUTER VISION, PROCEEDINGS, P370; Ziegler M, 2018, ITAL J FOOD SAF, V7, P142, DOI 10.4081/ijfs.2018.7581; Zoellner C, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36654-z	49	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265251	10.1371/journal.pone.0265251	http://dx.doi.org/10.1371/journal.pone.0265251			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320292	Green Submitted, Green Published, gold			2022-12-26	WOS:000784240600003
J	Branas, F; Galindo, MJ; Torralba, M; Antela, A; Vergas, J; Ramirez, M; Ryan, P; Dronda, F; Busca, C; Machuca, I; Bustinduy, MJ; Cabello, A; Sanchez-Conde, M				Branas, Fatima; Jose Galindo, Ma; Torralba, Miguel; Antela, Antonio; Vergas, Jorge; Ramirez, Margarita; Ryan, Pablo; Dronda, Fernando; Busca, Carmen; Machuca, Isabel; Jesus Bustinduy, Ma; Cabello, Alfonso; Sanchez-Conde, Matilde		FUNCFRAIL Study Grp	Different profiles among older adults with HIV according to their chronological age and the year of HIV diagnosis: The FUNCFRAIL cohort study (GeSIDA 9817)	PLOS ONE			English	Article							LONG-TERM SURVIVORS; FRAILTY TRANSITIONS; PHYSICAL FUNCTION; INFECTION; MORTALITY; PREDICTION; PHENOTYPE; PEOPLE; IMPACT; CARE	BackgroundPeople in their fifties with HIV are considered older adults, but they appear not to be a homogeneous group. ObjectiveTo evaluate the differences among older adults with HIV according to their chronological age and the year of HIV diagnosis. MethodsCross-sectional study of the FUNCFRAIL cohort. Patients 50 or over with HIV were included and were stratified by both chronological age and the year of HIV diagnosis: before 1996 (long-term HIV survivors [LTHS]) and after 1996. We recorded sociodemographic data, HIV-related factors, comorbidities, frailty, physical function, other geriatric syndromes, and quality of life (QOL). ResultsWe evaluated 801 patients. Of these, 24.7% were women, 47.0% were LTHS, and 14.7% were 65 or over. Of the 65 or over patients, 73% were diagnosed after 1996. Higher rates of comorbidities among LTHS were found, being the more prevalent: COPD, history of cancer, osteoarthritis, depression, and other psychiatric disorders while the more prevalent among the 65 or over patients were: hypertension, diabetes, dyslipidemia, cancer, and osteoarthritis. LTHS showed a significantly worse QOL. There were no differences by the year of HIV diagnosis regarding frailty and functional impairment (SPPB <10) but they were more than twice as prevalent in the 65 or over patients compared to the other chronological age groups. ConclusionsA LTHS and a 65 or over person are both "older adults with HIV," but their characteristics and requirements differ markedly. It is mandatory to design specific approaches focused on the real needs of the different profiles.	[Branas, Fatima] Hosp Univ Infanta Leonor, Geriatr Dept, Madrid, Spain; [Branas, Fatima; Ryan, Pablo] Univ Complutense, Fdn Invest & Innovac Biomed, HU Infanta Leonor, Madrid, Spain; [Branas, Fatima; Ryan, Pablo] Univ Complutense, HU Sureste, Madrid, Spain; [Jose Galindo, Ma] Hosp Univ Clin Valencia, Internal Med Infect Dis Dept, Valencia, Spain; [Torralba, Miguel] Univ Alcala, Hosp Univ Guadalajara, Internal Med Dept, Madrid, Spain; [Antela, Antonio] Univ Santiago de Compostela, Hosp Clin, Infect Dis Unit, Santiago De Compostela, Spain; [Vergas, Jorge] Hosp Univ Clin San Carlos, Internal Med, Infect Dis Dept, Madrid, Spain; [Ramirez, Margarita] Hosp Gen Univ Gregorio Maranon, Infect Dis Unit, Madrid, Spain; [Ryan, Pablo] Hosp Univ Infanta Leonor, HIV Clin, Madrid, Spain; [Dronda, Fernando; Sanchez-Conde, Matilde] Hosp Univ Ramon y Cajal, Infect Dis Dept, IRYCIS, Madrid, Spain; [Busca, Carmen] Hosp Univ La Paz, HIV Unit, IdiPAZ, Internal Med Dept, Madrid, Spain; [Machuca, Isabel] Hosp Univ Reina Sofia, Infect Dis Dept, Cordoba, Spain; [Jesus Bustinduy, Ma] Hosp Donostia, Infect Dis Dept, San Sebastian, Spain; [Cabello, Alfonso] Fdn Jimenez Diaz, Infect Dis Dept, Madrid, Spain	Hospital Universitario Infanta Leonor; Complutense University of Madrid; Complutense University of Madrid; Universidad de Alcala; Complexo Hospitalario Universitario de Santiago de Compostela; Universidade de Santiago de Compostela; General University Gregorio Maranon Hospital; Hospital Universitario Infanta Leonor; Hospital Universitario Ramon y Cajal; Hospital Universitario La Paz; University Hospital Donostia	Branas, F (corresponding author), Hosp Univ Infanta Leonor, Geriatr Dept, Madrid, Spain.; Branas, F (corresponding author), Univ Complutense, Fdn Invest & Innovac Biomed, HU Infanta Leonor, Madrid, Spain.; Branas, F (corresponding author), Univ Complutense, HU Sureste, Madrid, Spain.; Sanchez-Conde, M (corresponding author), Hosp Univ Ramon y Cajal, Infect Dis Dept, IRYCIS, Madrid, Spain.	fbranas@gmail.com; msconde@gmail.com	Troya-García, Jesus/Y-9721-2019; RYAN, PABLO/GRF-3462-2022; Ryan, Pablo/AAM-1924-2021	Troya-García, Jesus/0000-0001-7323-114X; RYAN, PABLO/0000-0002-4212-7419; Ryan, Pablo/0000-0002-4212-7419; Torralba, Miguel/0000-0003-2166-7405; , Carmen/0000-0002-4549-7749	Instituto de Salud Carlos III (European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future") [PI17/00859]; Merck SharpDohme Corp [IISP57179]	Instituto de Salud Carlos III (European Regional Development Fund/European Social Fund "A way to make Europe"/"Investing in your future"); Merck SharpDohme Corp(Merck & Company)	FUNCFRAIL study has been funded by Instituto de Salud Carlos III through the project PI17/00859 (Co-funded by European Regional Development Fund/European Social Fund "A way to make Europe" Investing in your future") and partially supported by an Investigator Studies Program (MISP) research grant from Merck Sharp&Dohme Corp (IISP57179). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbafati C, 2020, LANCET, V396, P1204, DOI 10.1016/S0140-6736(20)30925-9; Barnett K, 2012, LANCET, V380, P37, DOI 10.1016/S0140-6736(12)60240-2; Blanco JR, 2012, AIDS RES HUM RETROV, V28, P800, DOI [10.1089/aid.2011.0377, 10.1089/AID.2011.0377]; Branas F, 2008, AM J MED, V121, P820, DOI 10.1016/j.amjmed.2008.05.027; Branas F, 2017, AGE AGEING, V46, P522, DOI 10.1093/ageing/afx013; Brandt CP, 2016, AIDS CARE, V28, P432, DOI 10.1080/09540121.2015.1100704; Burke W J, 1991, J Geriatr Psychiatry Neurol, V4, P173, DOI 10.1177/089198879100400310; CAO YZ, 1995, NEW ENGL J MED, V332, P201, DOI 10.1056/NEJM199501263320401; Desquilbet L, 2009, JAIDS-J ACQ IMM DEF, V50, P299, DOI 10.1097/QAI.0b013e3181945eb0; Drummond MB, 2010, QUAL LIFE RES, V19, P1295, DOI 10.1007/s11136-010-9701-x; Falutz J, 2021, CURR OPIN HIV AIDS, V16, P133, DOI 10.1097/COH.0000000000000677; FERBAS J, 1995, J INFECT DIS, V172, P329, DOI 10.1093/infdis/172.2.329; Ferrucci L, 2018, NAT REV CARDIOL, V15, P505, DOI 10.1038/s41569-018-0064-2; Fried Linda P, 2021, Nat Aging, V1, P36, DOI 10.1038/s43587-020-00017-z; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fulop T, 2018, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01960; Greene M, 2015, JAIDS-J ACQ IMM DEF, V69, P161, DOI 10.1097/QAI.0000000000000556; Guaraldi G, 2018, BMC GERIATR, V18, DOI 10.1186/s12877-018-0789-0; Guaraldi G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118531; Guerra SG, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1173-4; GURALNIK JM, 1994, J GERONTOL, V49, pM85, DOI 10.1093/geronj/49.2.M85; Keeler E, 2010, J GERONTOL A-BIOL, V65, P727, DOI 10.1093/gerona/glq029; Kellinghaus C, 2006, EUR J MED RES, V11, P245; Krentz HB, 2018, INT J STD AIDS, V29, P1098, DOI 10.1177/0956462418778705; Lazarus JV, 2016, BMC MED, V14, DOI 10.1186/s12916-016-0640-4; McNeil T, 2019, INTERN MED J, V49, P592, DOI 10.1111/imj.14165; Nanditha NGA, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-041734; Nanni MG, 2015, CURR PSYCHIAT REP, V17, DOI 10.1007/s11920-014-0530-4; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; O'Cleirigh C, 2003, J PSYCHOSOM RES, V54, P225, DOI 10.1016/S0022-3999(02)00524-X; Peck S, 2008, NURS FORUM, V43, P91, DOI 10.1111/j.1744-6198.2008.00100.x; Pelloquin R, 2020, JAIDS-J ACQ IMM DEF, V85, P372, DOI 10.1097/QAI.0000000000002455; Piggott DA, 2020, AIDS, V34, P1217, DOI 10.1097/QAD.0000000000002527; Piggott DA, 2017, J GERONTOL A-BIOL, V72, P389, DOI 10.1093/gerona/glw142; Rooney AS, 2019, J AFFECT DISORDERS, V251, P1, DOI 10.1016/j.jad.2019.03.025; Sanchez-Conde M, 2019, EPIGENOMICS-UK, V11, P501, DOI 10.2217/epi-2018-0130; Smit M, 2015, LANCET INFECT DIS, V15, P810, DOI 10.1016/S1473-3099(15)00056-0; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Tavoschi L, 2017, LANCET HIV, V4, pE514, DOI 10.1016/S2352-3018(17)30155-8; Tsao Jennie C I, 2012, J Pain Manag, V5, P111; UNAIDS, 2020, DAT 2020 PROGR HIV A, P1; Verheij E, 2021, JAIDS-J ACQ IMM DEF, V86, P110, DOI 10.1097/QAI.0000000000002532; WHO, 2015, WORLD REP AG HLTH	43	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266191	10.1371/journal.pone.0266191	http://dx.doi.org/10.1371/journal.pone.0266191			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353855	gold, Green Published			2022-12-26	WOS:000786647900059
J	Chen, X; Shen, YT; Wang, YY; Li, Y; Guo, SY; Liang, Y; Wang, XY; Zhou, SY; Hu, XJ; Ma, KW; Tian, R; Fei, WT; Sheng, YQ; Cao, HJ; Que, HF				Chen, Xin; Shen, Yiting; Wang, Yuying; Li, Yang; Guo, Shuyu; Liang, Yue; Wang, Xuanyu; Zhou, Siyuan; Hu, Xiaojie; Ma, Kaiwen; Tian, Rui; Fei, Wenting; Sheng, Yuqin; Cao, Hengjie; Que, Huafa			Decreased accuracy of erythrocyte sedimentation rate in diagnosing osteomyelitis in diabetic foot infection patients with severe renal impairment: A retrospective cross-sectional study	PLOS ONE			English	Article							ULCERS; POPULATION; RISK	BackgroundRapid diagnosis and treatment of diabetic foot osteomyelitis (DFO) could reduce the risk of amputation and death in patients with diabetic foot infection (DFI). Erythrocyte sedimentation rate (ESR) is considered the most useful serum inflammatory marker for the diagnosis of DFO. However, whether severe renal impairment (SRI) affects its diagnostic accuracy has not been reported previously. ObjectiveTo investigate the accuracy of ESR in diagnosing DFO in DFI patients with and without SRI. MethodsThis was a retrospective cross-sectional study. From the inpatient electronic medical record system, the investigators extracted demographic information, diagnostic information, and laboratory test results of patients with DFI who had been hospitalized in Longhua Hospital from January 1, 2016 to September 30, 2021. Logistic regression was performed to analyze the interaction between ESR and SRI with adjustment for potential confounders. The area under the curve (AUC), cutoff point, sensitivity, specificity, prevalence, positive predictive value (PPV), negative predictive value (NPV), positive likelihood ratio (LR+), and negative likelihood ratio (LR-) were analyzed by receiver operating characteristic (ROC) curve analysis and VassarStats. ResultsA total of 364 DFI patients were included in the analysis. The logistic regression analysis results showed that elevated ESR increased the probability of diagnosing DFO (adjusted odds ratio [OR], 2.40; 95% confidence interval [CI], 1.75-3.28; adjusted P < 0.001); SRI was not associated with the diagnosis of DFO (adjusted OR, 3.20; 95% CI, 0.40-25.32; adjusted P = 0.271), but it had an obstructive effect on the diagnosis of DFO by ESR (adjusted OR, 0.48; 95% CI, 0.23-0.99; adjusted P = 0.048). ROC analysis in DFI patients without SRI revealed that the AUC of ESR to diagnose DFO was 0.76 (95% CI, 0.71-0.81), with the cutoff value of 45 mm/h (sensitivity, 67.8%; specificity, 78.0%; prevalence, 44.7%; PPV, 71.3%; NPV, 75.0%; LR+, 3.08; LR-, 0.41). In contrast, in patients with SRI, the AUC of ESR to diagnose DFO was 0.57 (95% CI, 0.40-0.75), with the cutoff value of 42 mm/h (sensitivity, 95.0%; specificity, 29.2%; prevalence, 45.5%; PPV, 52.8%; NPV, 87.5%; LR+, 1.34; LR-, 0.17). ConclusionsThe accuracy of ESR in diagnosing DFO in DFI patients with SRI is reduced, and it may not have clinical diagnostic value in these patients.	[Chen, Xin; Shen, Yiting; Wang, Yuying; Guo, Shuyu; Liang, Yue; Wang, Xuanyu; Zhou, Siyuan; Hu, Xiaojie; Ma, Kaiwen; Tian, Rui; Fei, Wenting; Sheng, Yuqin; Cao, Hengjie; Que, Huafa] Shanghai Univ Tradit Chinese Med, Dept Surg Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China; [Chen, Xin; Wang, Yuying; Li, Yang; Liang, Yue; Zhou, Siyuan; Hu, Xiaojie; Ma, Kaiwen; Tian, Rui; Fei, Wenting; Sheng, Yuqin; Cao, Hengjie] Shanghai Univ Tradit Chinese Med, Longhua Med Coll, Shanghai, Peoples R China; [Li, Yang] Shanghai Univ Tradit Chinese Med, Dept Thorac Surg, Longhua Hosp, Shanghai, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine	Que, HF (corresponding author), Shanghai Univ Tradit Chinese Med, Dept Surg Tradit Chinese Med, Longhua Hosp, Shanghai, Peoples R China.	huafaque@126.com	wang, xuan/GXF-3679-2022	Chen, Xin/0000-0001-7539-257X	Shanghai Key Clinical Specialty [LH 02.91.002]; Shanghai Municipal Health Commission	Shanghai Key Clinical Specialty; Shanghai Municipal Health Commission	HQ received research grant from the Shanghai Key Clinical Specialty (LH 02.91.002), from the Shanghai Municipal Health Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsomaili MI, 2015, SAUDI J KIDNEY DIS T, V26, P1149, DOI 10.4103/1319-2442.168589; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Balsells M, 1997, DIABETES RES CLIN PR, V38, P123, DOI 10.1016/S0168-8227(97)00100-9; BATHON J, 1987, AM J KIDNEY DIS, V10, P34, DOI 10.1016/S0272-6386(87)80008-2; Bilen Y, 2014, RENAL FAILURE, V36, P69, DOI 10.3109/0886022X.2013.832310; Brouillard H, 1996, NEPHROL DIAL TRANSPL, V11, P2244, DOI 10.1093/oxfordjournals.ndt.a027143; Cao X, 2019, MED SCI MONITOR, V25, P6446, DOI 10.12659/MSM.915917; Chen SY, 2017, CLIN INFECT DIS, V64, P326, DOI 10.1093/cid/ciw736; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Gouta Esma Leila, 2018, Tunis Med, V96, P875; Guo SZ, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-020-00584-7; Hicks CW, 2016, ANN VASC SURG, V33, P149, DOI 10.1016/j.avsg.2015.11.025; Jia LM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177916; Kee KK, 2019, J WOUND CARE, V28, pS4, DOI 10.12968/jowc.2019.28.Sup1.S4; Koye DN, 2018, ADV CHRONIC KIDNEY D, V25, P121, DOI 10.1053/j.ackd.2017.10.011; Lavery LA, 2019, CLIN ORTHOP RELAT R, V477, P1594, DOI 10.1097/CORR.0000000000000718; Lavery LA, 2009, DIABETES RES CLIN PR, V83, P347, DOI 10.1016/j.diabres.2008.11.030; Lipsky BA, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3280; Lipsky BA, 2016, DIABETES-METAB RES, V32, P45, DOI 10.1002/dmrr.2699; Macdonald KE, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4923-1; Michail M, 2013, INT J LOW EXTR WOUND, V12, P94, DOI 10.1177/1534734613486152; Moallemi SK, 2020, ARCH ACAD EMERG MED, V8; Ndosi M, 2018, DIABETIC MED, V35, P78, DOI 10.1111/dme.13537; Ricci L, 2017, DIABETES RES CLIN PR, V131, P12, DOI 10.1016/j.diabres.2017.06.006; SHUSTERMAN N, 1985, ARCH INTERN MED, V145, P1796, DOI 10.1001/archinte.145.10.1796; Tiwari S, 2012, J INFECT DEV COUNTR, V6, P329, DOI 10.3855/jidc.1827; Truong DH, 2019, J FOOT ANKLE SURG, V58, P1064, DOI 10.1053/j.jfas.2019.08.013; Wu WX, 2017, INT J LOW EXTR WOUND, V16, P173, DOI 10.1177/1534734617725410; Xie P, 2013, INT UROL NEPHROL, V45, P1057, DOI 10.1007/s11255-012-0325-7; Xu J, 2021, INT J LOW EXTR WOUND, V20, P227, DOI 10.1177/1534734620923278	30	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265769	10.1371/journal.pone.0265769	http://dx.doi.org/10.1371/journal.pone.0265769			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320298	Green Published, gold			2022-12-26	WOS:000784240600022
J	Chrystal, PV; Greenhalgh, S; Macelline, SP; Dorigam, JCD; Selle, PH; Liu, SY				Chrystal, Peter, V; Greenhalgh, Shiva; Macelline, Shemil P.; Dorigam, Juliano C. de Paula; Selle, Peter H.; Liu, Sonia Y.			A multivariate Box-Behnken assessment of elevated branched-chain amino acid concentrations in reduced crude protein diets offered to male broiler chickens	PLOS ONE			English	Article							EXCESS LEUCINE; ISOLEUCINE; MUSCLE; VALINE; SUPPLEMENTATION; REQUIREMENTS; NUTRITION	In a Box-Behnken assessment of elevated branched-chain amino acids (BCAA), 13 nutritionally equivalent maize-based diets were offered to a total of 390 off-sex male Ross 308 broiler chickens from 7 to 28 days post-hatch. The BCAA concentrations investigated in reduced-crude protein diets were 12.5, 15.5, 18.3 g/kg leucine (125, 155, 183); 8.9, 10.2, 12.5 g/kg valine (89, 102, 125) and 7.2, 8.9, 10.8 g/kg isoleucine (72, 89, 109), where their relativity to 11.0 g/kg digestible lysine are shown in parentheses. Determined parameters included growth performance, relative abdominal fat-pad weights, nutrient utilisation, apparent digestibility coefficients, disappearance rates of 16 amino acids and free amino acid systemic plasma concentrations. Increasing dietary leucine linearly depressed weight gain and quadratically influenced FCR where the estimated minimum FCR of 1.418 was with 14.99 g/kg leucine. Polynomial regression analysis and surface response curves of determined parameters were generated for significant (P < 0.05) BCAA variables, based on lack of fit (P > 0.005). Quadratic and cross-product responses were observed for weight gain, FCR, AME, AME(n), N retention and apparent digestibility of 13 amino acids. Relative fat-pad weights declined linearly with increasing isoleucine and valine. The lowest N retention was estimated at a combination of 15.25 and 10.50 g/kg leucine and valine respectively whilst the highest mean digestibility coefficient (0.793) of amino acids was estimated at a combination of 15.74 and 10.47 g/kg of leucine and valine respectively. The remaining parameter minima or maxima responses were not able to be determined since they were outside the extreme BCAA treatment levels. Increasing dietary BCAA significantly increased apparent ileal digestibilities and disappearance rates of BCAA. Systemic plasma concentrations of valine increased (P < 0.001) with increasing dietary valine but leucine was not influenced (P > 0.25). Systemic plasma concentration of isoleucine was maximised (P < 0.001) only when accompanied by elevated dietary leucine. Also, dietary treatments influenced (P < 0.05) apparent disappearance rates of all the essential amino acids analysed, with the exception of methionine. Whilst overall growth performance was not disadvantaged (P > 0.10) by elevated BCAA levels, compared with 2019 Ross 308 performance objectives, polynomial regression analysis suggested both interaction and antagonism between BCAA.	[Chrystal, Peter, V; Greenhalgh, Shiva; Macelline, Shemil P.; Selle, Peter H.; Liu, Sonia Y.] Univ Sydney, Poultry Res Fdn, Fac Sci, Camden, NSW, Australia; [Chrystal, Peter, V; Greenhalgh, Shiva; Macelline, Shemil P.; Liu, Sonia Y.] Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia; [Dorigam, Juliano C. de Paula] Evonik Operat GmbH, Hanau, Germany	University of Sydney; University of Sydney	Liu, SY (corresponding author), Univ Sydney, Poultry Res Fdn, Fac Sci, Camden, NSW, Australia.; Liu, SY (corresponding author), Univ Sydney, Fac Sci, Sch Life & Environm Sci, Sydney, NSW, Australia.	sonia.liu@sydney.edu.au		Macelline, Shemil Priyan/0000-0001-6771-3804; Chrystal, Peter/0000-0001-7421-5109				BELO PS, 1976, J NUTR, V106, P1135, DOI 10.1093/jn/106.8.1135; BOLDIZSAR HK, 1973, BRIT J NUTR, V30, P501, DOI 10.1079/BJN19730056; BURNHAM D, 1992, BRIT POULTRY SCI, V33, P71, DOI 10.1080/00071669208417445; BUSE MG, 1975, J CLIN INVEST, V56, P1250, DOI 10.1172/JCI108201; Chrystal PV, 2021, ANIM FEED SCI TECH, V275, DOI 10.1016/j.anifeedsci.2021.114867; COHEN SA, 1993, ANAL BIOCHEM, V211, P279, DOI 10.1006/abio.1993.1270; Columbus D, 2015, AMINO ACIDS, V47, P259, DOI 10.1007/s00726-014-1866-0; De Leon AC, 2010, WORLD POULTRY SCI J, V66, P699, DOI 10.1017/S0043933910000668; Deng HL, 2014, POULTRY SCI, V93, P114, DOI 10.3382/ps.2013-03287; DMELLO JPF, 1970, BRIT POULTRY SCI, V11, P313, DOI 10.1080/00071667008415821; Duan YH, 2015, FRONT BIOSCI-LANDMRK, V20, P796, DOI 10.2741/4338; Farran MT, 2003, ANIM FEED SCI TECH, V103, P171, DOI 10.1016/S0377-8401(02)00289-4; FARRAN MT, 1990, POULTRY SCI, V69, P757, DOI 10.3382/ps.0690757; Farran MT, 1987, BRANCHED CHAIN AMINO; Greenhalgh S, 2021, AUSTR POULTR SCI S 2; HARPER AE, 1984, ANNU REV NUTR, V4, P409, DOI 10.1146/annurev.nu.04.070184.002205; HARPER AE, 1970, PHYSIOL REV, V50, P428, DOI 10.1152/physrev.1970.50.3.428; HARPER AE, 1956, NUTR REV, V14, P225, DOI 10.1111/j.1753-4887.1956.tb01587.x; HILL FW, 1958, J NUTR, V64, P587, DOI 10.1093/jn/64.4.587; Hundal HS, 2009, AM J PHYSIOL-ENDOC M, V296, pE603, DOI 10.1152/ajpendo.91002.2008; Kidd MT, 2021, J ANIM SCI BIOTECHNO, V12, DOI 10.1186/s40104-020-00535-1; Kidd MT, 2013, J APPL POULTRY RES, V22, P583, DOI 10.3382/japr.2012-00690; Langer S, 2000, BRIT J NUTR, V83, P43, DOI 10.1017/S0007114500000088; Liu SY, 2015, WORLD POULTRY SCI J, V71, P297, DOI 10.1017/S0043933915000306; Ma QQ, 2020, FOOD FUNCT, V11, P2279, DOI 10.1039/c9fo03084k; Maynard CW, 2021, ANIM FEED SCI TECH, V271, DOI 10.1016/j.anifeedsci.2020.114710; Maynard CW, 2022, ANIM NUTR, V10, P1, DOI 10.1016/j.aninu.2021.11.010; Monirujjaman M., 2014, ADV MOL BIOL, V2014, P1, DOI [10.1155/2014/364976, DOI 10.1155/2014/364976]; Ospina-Rojas IC, 2017, POULTRY SCI, V96, P914, DOI 10.3382/ps/pew319; Scalise M, 2018, FRONT CHEM, V6, DOI 10.3389/fchem.2018.00243; SIRIWAN P, 1993, BRIT POULTRY SCI, V34, P939, DOI 10.1080/00071669308417654; SMITH TK, 1978, J NUTR, V108, P1180, DOI 10.1093/jn/108.7.1180; Waldroup P. W., 2002, International Journal of Poultry Science, V1, P136; Wu GY, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-34; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Zeitz JO, 2019, POULTRY SCI, V98, P6772, DOI 10.3382/ps/pez396; Zeitz JO, 2019, ARCH ANIM NUTR, V73, P75, DOI 10.1080/1745039X.2019.1583519	37	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266080	10.1371/journal.pone.0266080	http://dx.doi.org/10.1371/journal.pone.0266080			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353869	gold, Green Published			2022-12-26	WOS:000786647900041
J	Cummings, KJ; Beckman, J; Frederick, M; Harrison, R; Nguyen, A; Snyder, R; Chan, ELA; Gibb, K; Rodriguez, A; Wong, JS; Murray, EL; Jain, S; Vergara, X				Cummings, Kristin J.; Beckman, John; Frederick, Matthew; Harrison, Robert; Nguyen, Alyssa; Snyder, Robert; Chan, Elena; Gibb, Kathryn; Rodriguez, Andrea; Wong, Jessie; Murray, Erin L.; Jain, Seema; Vergara, Ximena			Disparities in COVID-19 fatalities among working Californians	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; WORKPLACE OUTBREAKS; ETHNIC DISPARITIES; INDUSTRY SECTOR; UNITED-STATES; WORKERS; JANUARY; HEALTH; TRENDS; RACE	BackgroundInformation on U.S. COVID-19 mortality rates by occupation is limited. We aimed to characterize 2020 COVID-19 fatalities among working Californians to inform preventive strategies. MethodsWe identified laboratory-confirmed COVID-19 fatalities with dates of death in 2020 by matching death certificates to the state's COVID-19 case registry. Working status for decedents aged 18-64 years was determined from state employment records, death certificates, and case registry data and classified as "confirmed working," "likely working," or "not working." We calculated age-adjusted overall and occupation-specific COVID-19 mortality rates using 2019 American Community Survey denominators. ResultsCOVID-19 accounted for 8,050 (9.9%) of 81,468 fatalities among Californians 18-64 years old. Of these decedents, 2,486 (30.9%) were matched to state employment records and classified as "confirmed working." The remainder were classified as "likely working" (n = 4,121 [51.2%]) or "not working" (n = 1,443 [17.9%]) using death certificate and case registry data. Confirmed and likely working COVID-19 decedents were predominantly male (76.3%), Latino (68.7%), and foreign-born (59.6%), with high school or less education (67.9%); 7.8% were Black. The overall age-adjusted COVID-19 mortality rate was 30.0 per 100,000 workers (95% confidence interval [CI], 29.3-30.8). Workers in nine occupational groups had age-adjusted mortality rates higher than this overall rate, including those in farming (78.0; 95% CI, 68.7-88.2); material moving (77.8; 95% CI, 70.2-85.9); construction (62.4; 95% CI, 57.7-67.4); production (60.2; 95% CI, 55.7-65.0); and transportation (57.2; 95% CI, 52.2-62.5) occupations. While occupational differences in mortality were evident across demographic groups, mortality rates were three-fold higher for male compared with female workers and three- to seven-fold higher for Latino and Black workers compared with Asian and White workers. ConclusionCalifornians in manual labor and in-person service occupations experienced disproportionate COVID-19 mortality, with the highest rates observed among male, Latino, and Black workers; these occupational group should be prioritized for prevention.	[Cummings, Kristin J.; Beckman, John; Frederick, Matthew; Harrison, Robert; Chan, Elena; Gibb, Kathryn; Rodriguez, Andrea; Wong, Jessie; Vergara, Ximena] Calif Dept Publ Hlth, Occupat Hlth Branch, Richmond, CA 94804 USA; [Beckman, John; Frederick, Matthew; Chan, Elena; Gibb, Kathryn; Rodriguez, Andrea; Wong, Jessie] Publ Hlth Inst, Oakland, CA USA; [Nguyen, Alyssa; Snyder, Robert; Jain, Seema] Calif Dept Publ Hlth, Infect Dis Branch, Richmond, CA USA; [Murray, Erin L.] Calif Dept Publ Hlth, Immunizat Branch, Richmond, CA USA; [Vergara, Ximena] Heluna Hlth, City Of Industry, CA USA	California Department of Public Health; Public Health Institute; California Department of Public Health; California Department of Public Health	Cummings, KJ (corresponding author), Calif Dept Publ Hlth, Occupat Hlth Branch, Richmond, CA 94804 USA.	Kristin.Cummings@cdph.ca.gov	Snyder, Robert E./AAD-4433-2020	Snyder, Robert E./0000-0001-9743-0872; Gibb, Kathryn/0000-0002-6044-5867	California Department of Public Health; National Institute for Occupational Safety and Health; Centers for Disease Control and Prevention	California Department of Public Health; National Institute for Occupational Safety and Health(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was supported by the California Department of Public Health, with funding from the National Institute for Occupational Safety and Health and the Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonauto D, 2006, J OCCUP ENVIRON MED, V48, P840, DOI 10.1097/01.jom.0000225062.88285.b3; Bui DP, 2020, MMWR-MORBID MORTAL W, V69, P1133, DOI 10.15585/mmwr.mm6933e3; California Department of Public Health-Fusion Center, DAT BRIEF 2020 INCR; California State Public Health Officer, ESS WORKF; Carlsten C, 2021, AM J IND MED, V64, P227, DOI 10.1002/ajim.23222; Centers for Disease Control and Prevention, COVID 19 WORKPL BUS; Centers for Disease Control And Prevention, SCI BRIEF SARS COV 2; Centers for Disease Control and Prevention, OPT PERS PROT EQ PPE; Chen YH, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0252454; Contreras Z, 2021, EMERG INFECT DIS, V27, P1759, DOI 10.3201/eid2707.210425; Cote D, 2021, AM J IND MED, V64, P551, DOI 10.1002/ajim.23256; Cox-Ganser JM, 2021, AM J PREV MED, V60, P621, DOI 10.1016/j.amepre.2020.12.016; Cummings KJ, 2008, JAMA-J AM MED ASSOC, V299, P448, DOI 10.1001/jama.299.4.448; Dingel JI, 2020, J PUBLIC ECON, V189, DOI 10.1016/j.jpubeco.2020.104235; European Centre for Disease Prevention and Control, COVID 19 CLUST OUTBR; Feaster M, 2020, EMERG INFECT DIS, V26, P2416, DOI 10.3201/eid2610.202694; Garcia E, 2021, ANN EPIDEMIOL, V58, P69, DOI 10.1016/j.annepidem.2021.03.006; Gold JAW, 2020, MMWR-MORBID MORTAL W, V69, P1517, DOI 10.15585/mmwr.mm6942e1; Gomez JMD, 2021, J WOMENS HEALTH, V30, P646, DOI 10.1089/jwh.2020.8948; Graham MR., 2007, TP200702 US CENS BUR; Hanage WP, 2020, EUR J EPIDEMIOL, V35, P995, DOI 10.1007/s10654-020-00689-2; Hawkins D, 2021, AM J IND MED, V64, P238, DOI 10.1002/ajim.23227; Hawkins D, 2020, AM J IND MED, V63, P817, DOI 10.1002/ajim.23145; Heinzerling A, 2020, MMWR-MORBID MORTAL W, V69, P472, DOI 10.15585/mmwr.mm6915e5; Mora AM, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.24116; Murti M, 2021, J OCCUP ENVIRON MED, V63, P574, DOI 10.1097/JOM.0000000000002201; Mutambudzi M, 2021, OCCUP ENVIRON MED, V78, P307, DOI 10.1136/oemed-2020-106731; National Institute for Occupational Safety and Health, NIOSH IND OCC COMP C; Page KR, 2021, NEW ENGL J MED, V384, P5, DOI 10.1056/NEJMp2024897; Prather KA, 2020, SCIENCE, V370, P303, DOI 10.1126/science.abf0521; Public Health England, COR COVID 19 UK DEAT; Romano SD, 2021, MMWR-MORBID MORTAL W, V70, P560, DOI 10.15585/mmwr.mm7015e2externalicon; Rossen LM, 2020, MMWR-MORBID MORTAL W, V69, P1522, DOI [10.1101/2020.06.06.20120857v1.full.pdf, 10.15585/mmwr.mm6942e2]; Siegel M, 2022, J RACIAL ETHN HEALTH, V9, P886, DOI 10.1007/s40615-021-01028-1; Spellberg B, 2020, JAMA-J AM MED ASSOC, V323, P1966, DOI 10.1001/jama.2020.4958; State of California, COVID 19 CAS DASHB; State of California. Division of Occupational Safety and Health (Cal/OSHA), COVID 19 PREV EM TEM; State of California. Employment Development Department (EDD), UND EC OP; State of California. Employment Development Department (EDD), LAB MARK INF; State of California Employment Development Department (EDD), Q CENS EMPL WAG; State of California. Executive Department, 3320 STAT CAL EX DEP; State of California. Legislative Analyst's Office, COVID 19 LAB MARK WH; Tang JW, 2021, J HOSP INFECT, V110, P89, DOI 10.1016/j.jhin.2020.12.022; Tang JW, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n913; Thomas MD, 2022, SSM-POPUL HLTH, V17, DOI 10.1016/j.ssmph.2021.101016; U.S. Census Bureau, 2019 AM COMM SURV 1; U.S. Department of Health and Human Services, COVID 19 STAT PROF R; UK Office for National Statistics, COR COVID 19 REL DEA; Waltenburg MA, 2021, EMERG INFECT DIS, V27, P243, DOI 10.3201/eid2701.203821; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; Yen Liu Y., SINKING UNDERGROUND; Zwald ML, 2020, MMWR-MORBID MORTAL W, V69, P419, DOI 10.15585/mmwr.mm6914e3	52	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266058	10.1371/journal.pone.0266058	http://dx.doi.org/10.1371/journal.pone.0266058			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349589	gold, Green Submitted, Green Published			2022-12-26	WOS:000783906500019
J	Gonzalez, R; Pena, MA; Torres, NS; Torrado, G				Gonzalez, Rocio; Angeles Pena, Ma; Sofia Torres, Norma; Torrado, Guillermo			Design, development, and characterization of amorphous rosuvastatin calcium tablets	PLOS ONE			English	Article							DRUG-EXCIPIENT COMPATIBILITY; SEDEM DIAGRAM; IN-VITRO	This work proposes a methodology for the design, development, optimisation, and evaluation of amorphous rosuvastatin calcium tablets (BCS class II drug). The main goal was to ensure rapid disintegration and high dissolution rate of the active ingredient, thus enhancing its bioavailability. The design started from a careful selection of excipients, which due to their characteristics and proportions within the formulation allowed the use of their properties such as fluidity or granulometric distribution. The formulation was characterised using scanning electron microscopy (SEM), differential scanning calorimetry (DSC), thermogravimetry (TGA), Fourier transform infrared spectroscopy (FT-IR) and powder X-ray diffraction (PXRD) methods. The galenic SeDeM methodology was used to establish the profile of the active ingredient-excipient mixture and guarantee its suitability for producing tablets by the direct compression method. The results demonstrate that the amorphous rosuvastatin calcium tablets formulation developed made it possible to obtain cost-effective tablets by direct compression with optimal pharmacotechnical characteristics that showed a remarkable disintegration and dissolution rate. The manufactured tablets complied with the pharmacopoeia guidelines regarding content uniformity, tablet hardness, thickness, friability, in vitro disintegration time and dissolution profile.	[Gonzalez, Rocio; Angeles Pena, Ma; Sofia Torres, Norma; Torrado, Guillermo] Univ Alcala, Fac Pharm, Dept Biomed Sci, Madrid, Spain	Universidad de Alcala	Pena, MA (corresponding author), Univ Alcala, Fac Pharm, Dept Biomed Sci, Madrid, Spain.	angeles.pena@uah.es		Gonzalez Crespo, Rocio/0000-0003-3191-5900				Angelo ML, 2019, BRAZ J PHARM SCI, V55, DOI 10.1590/s2175-97902019000117520; [Anonymous], 2011, EUROPEAN PHARMACOPOE, V7; [Anonymous], 2011, EUROPEAN PHARMACOPOE, VSeventh; [Anonymous], 2015, REAL FARMACOPEA ESPA; [Anonymous], 2011, REAL FARMACOPEA ESPA; [Anonymous], 2010, REAL FARMACOPEA ESPA; [Anonymous], 2005, EUROPEAN PHARMACOPOE; [Anonymous], 2008, REAL FARMACOPEA ESPA; Arida AI., 2008, JORDAN J PHARM SCI, V1, P111; Belozerova NM, 2020, RSC ADV, V10, P33585, DOI 10.1039/d0ra06108e; Blatte F, 2011, CRYSTALLINE FORM ROS; BOLHUIS GK, 1995, DRUG DEV IND PHARM, V21, P2057, DOI 10.3109/03639049509065890; Brites FD., 2012, FISIOPATOLOGIA DIAGN; Buhler V., 2005, POLYVINYLPYRROLIDONE; Casar Z, 2008, PROCESS PREPARING AM; Chadha R, 2014, J PHARMACEUT BIOMED, V87, P82, DOI 10.1016/j.jpba.2013.06.016; Chaves LL, 2013, J THERM ANAL CALORIM, V111, P2179, DOI 10.1007/s10973-012-2775-7; Clavijo J., 2013, ELEMENTOS, V3, P133, DOI [10.15765/e.v3i3.420, DOI 10.15765/E.V3I3.420]; Creekmore JR, 2002, European Pa-tent Office. Patent, Patent No. [EP1223918, 1223918]; Aguilar-Diaz JE, 2014, DRUG DEV IND PHARM, V40, P222, DOI 10.3109/03639045.2012.756007; Gibson M, 2009, PHARM PREFORMULATION, V2nd; Hirpara MR, 2018, INT J BIOL MACROMOL, V107, P2190, DOI 10.1016/j.ijbiomac.2017.10.086; Karazniewicz-Lada Marta, 2018, Polim Med, V48, P77, DOI 10.17219/pim/102978; Kishore CRP, 2017, ANAL CHEM RES, V12, P17, DOI [10.1016/j.ancr.2016.11.002, DOI 10.1016/J.ANCR.2016.11.002]; Kiss D, 2006, J THERM ANAL CALORIM, V84, P447, DOI 10.1007/s10943-005-7257-9; Koh PT, 2013, INDIAN J PHARM SCI, V75, P291, DOI 10.4103/0250-474X.117434; Kumar B, 2019, CUREUS, V11, DOI 10.7759/cureus.4898; Lahsen R., 2014, REV M DICA 150 NICA, V25, P47; LANDIN M, 1994, EUR J PHARM SCI, V2, P245, DOI 10.1016/0928-0987(94)90029-9; Lee AY, 2011, ANNU REV CHEM BIOMOL, V2, P259, DOI 10.1146/annurev-chembioeng-061010-114224; Lee BJ., 2008, PHARM MANUFACTURING; Lima G., 2012, REV 101 NCIAS FARMAC, V33, P27; Narang AS, 2017, DEVELOPING SOLID ORAL DOSAGE FORMS: PHARMACEUTICAL THEORY AND PRACTICE, 2ND EDITION, P151, DOI 10.1016/B978-0-12-802447-8.00006-6; Pharma J., 2020, PAGINA WEB JRS PHARM; Potur RG, 2014, STABLE PHARM COMPOSI; Rios M., 2008, PHARM TECHNOL, V2, P36; Rohini P., 2014, INT J PHARM SCI REV, V24, P209; Rowe R., 2010, HDB PHARM EXCIPIENTS; Rowe R.C., 2006, HDB PHARM EXCIPIENTS; Sachin TV., 2014, INT J PHARM TECHNOLO, V6, P6388; Schwartz JB., 2002, PHARM PROCESS SCALE; Shekhawat PB, 2017, ACTA PHARM SIN B, V7, P260, DOI 10.1016/j.apsb.2016.09.005; Singh J., 2014, J DRUG DELIVERY THER, V4, P173, DOI [10.22270/jddt.v4i5.947, DOI 10.22270/JDDT.V4I5.947]; Sune JM., 2005, CIENCIA TECNOLOGIA P, V3, P125; Negre JMS, 2013, WOODH PUB SER BIOMED, P109, DOI 10.1533/9781908818508.109; Sune-Negre JM, 2008, EUR J PHARM BIOPHARM, V69, P1029, DOI 10.1016/j.ejpb.2008.01.020; Tannebaum EJ., 2005, GOOD DESIGN PRACTICE, V2nd ed; Vindas C, 2013, REV M D COSTA RICA C, V70, P529; Zhou CY, 2013, CARBOHYD POLYM, V96, P156, DOI 10.1016/j.carbpol.2013.03.094	49	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265263	10.1371/journal.pone.0265263	http://dx.doi.org/10.1371/journal.pone.0265263			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312730	Green Published, gold			2022-12-26	WOS:000803647900041
J	Kay, R; Katrycz, CW; Heimlich, EJ; Hatton, BD				Kay, Raphael; Katrycz, Charlie W.; Heimlich, Ethan J.; Hatton, Benjamin D.			Programmable droplets: Leveraging digitally-responsive flow fields to actively tune liquid morphologies	PLOS ONE			English	Article							PHASE-CHANGE; GLYCEROL; VISCOSITY; FLUID	Stimulus-responsive materials enable programmable and adaptive behaviors. Typical solid-phase systems can only achieve small deformations for applications where shape transformations are beneficial or required. Liquids, in contrast, can self-assemble and achieve very high strains in a multifluid environment. Here we report liquid droplet formation by tuning flow potential within a confined fluidic cell. We digitally inject small volumes of liquid-pigment into an otherwise-transparent liquid layer, generating macroscopic droplet assembly over large areas constrained between closely-spaced plates. Droplet morphology is actively controlled by modulating outlet conditions to tune flow fields. Pattern stability is maintained through control over injection rate, interfacial viscosity difference, and interfacial surface tension. We demonstrate time-dependent droplet formation and migration to achieve spatially-tunable optical properties. Applied as a multi-cell array, we imagine this liquid mechanism will enable scalable pattern dynamics for active shading and visual display technologies.	[Kay, Raphael] Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada; [Kay, Raphael; Katrycz, Charlie W.; Hatton, Benjamin D.] Univ Toronto, Dept Mat Sci & Engn, Toronto, ON, Canada; [Heimlich, Ethan J.] Univ Toronto, Dept Stat Sci, Toronto, ON, Canada	University of Toronto; University of Toronto; University of Toronto	Kay, R (corresponding author), Univ Toronto, Dept Mech & Ind Engn, Toronto, ON, Canada.; Kay, R; Hatton, BD (corresponding author), Univ Toronto, Dept Mat Sci & Engn, Toronto, ON, Canada.	raphael.kay@mail.utoronto.ca; benjamin.hatton@utoronto.ca		Kay, Raphael/0000-0002-6382-351X	Canadian Foundation for Innovation (CFI) [31799]; Canada Graduate Scholarship; C.W. Bowman Graduate Scholarship; Bert Wasmund Graduate Fellowship	Canadian Foundation for Innovation (CFI)(Canada Foundation for Innovation); Canada Graduate Scholarship; C.W. Bowman Graduate Scholarship; Bert Wasmund Graduate Fellowship	Canadian Foundation for Innovation (CFI) #31799 (BDH) Percy Edward Hart Professorship, University of Toronto (BDH) RK was supported by a Canada Graduate Scholarship, a C.W. Bowman Graduate Scholarship, and a Bert Wasmund Graduate Fellowship.	Addington M, 2009, ARCHIT DESIGN, P12; Bischofberger I, 2016, PHYS TODAY, V69, P70, DOI 10.1063/PT.3.3307; Bischofberger I, 2015, SOFT MATTER, V11, P7428, DOI 10.1039/c5sm00943j; Bischofberger I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6265; Bjelobrk N, 2016, PHYS REV FLUIDS, V1, DOI 10.1103/PhysRevFluids.1.063902; Cao WW, 1999, P NATL ACAD SCI USA, V96, P8330, DOI 10.1073/pnas.96.15.8330; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Chen HW, 2016, NATURE, V532, P85, DOI 10.1038/nature17189; CHEN YM, 1987, IND ENG CHEM RES, V26, P1670, DOI 10.1021/ie00068a030; Chow TT, 2013, BUILD ENVIRON, V60, P45, DOI 10.1016/j.buildenv.2012.11.010; Chow TT, 2011, INT J THERM SCI, V50, P140, DOI 10.1016/j.ijthermalsci.2010.10.006; Correa D, 2015, 3D PRINT ADDIT MANUF, V2, P106, DOI 10.1089/3dp.2015.0022; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; Donadio L., ELECT POTENTIAL ELEC; Formentini M, 2018, AUTOMAT CONSTR, V85, P220, DOI 10.1016/j.autcon.2017.10.006; Hatton BD, 2013, SOL ENERG MAT SOL C, V117, P429, DOI 10.1016/j.solmat.2013.06.027; Ichimura K, 2000, SCIENCE, V288, P1624, DOI 10.1126/science.288.5471.1624; Ismail KAR, 2001, APPL THERM ENG, V21, P1909, DOI 10.1016/S1359-4311(01)00058-8; Katrycz CW., 2018, BIOINSPIRED ENG THER; Kay R, 2022, J BUILD ENG, V48, DOI 10.1016/j.jobe.2021.103942; Kay R, 2020, ECAADE PROC, P233; Liu Y, 2012, SOFT MATTER, V8, P1764, DOI 10.1039/c1sm06564e; Liu Z, 2020, POLYM CHEM-UK, V11, P6047, DOI 10.1039/d0py01060j; McHale G, 2011, PHYS REV LETT, V107, DOI 10.1103/PhysRevLett.107.186101; Menges A, 2012, ARCHIT DESIGN, V82, P52, DOI 10.1002/ad.1379; Mor H, 2020, PROCEEDINGS OF THE 2020 CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS (CHI'20), DOI 10.1145/3313831.3376129; NEURINGER JL, 1964, PHYS FLUIDS, V7, P1927, DOI 10.1063/1.1711103; Oliveira RM, 2020, PHYS REV FLUIDS, V5, DOI 10.1103/PhysRevFluids.5.124003; Raviv D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07422; REILLY S, 1990, SOL ENERG MATER, V20, P277, DOI 10.1016/0165-1633(90)90060-E; ROSENSWEIG RE, 1983, J MAGN MAGN MATER, V39, P127, DOI 10.1016/0304-8853(83)90416-X; Rossiter J, 2012, BIOINSPIR BIOMIM, V7, DOI 10.1088/1748-3182/7/3/036009; SAFFMAN PG, 1958, PROC R SOC LON SER-A, V245, P312, DOI 10.1098/rspa.1958.0085; SEGUR JB, 1951, IND ENG CHEM, V43, P2117, DOI 10.1021/ie50501a040; Seibold Z., 2018, FLUID EQUILIBRIUM MA; Stopper J, 2013, FLUID GLASS FACADE E; Sun QQ, 2019, NAT MATER, V18, P936, DOI 10.1038/s41563-019-0440-2; Takamura K, 2012, J PETROL SCI ENG, V98-99, P50, DOI 10.1016/j.petrol.2012.09.003; Tibbits S, 2014, ARCHIT DESIGN, V84, P116, DOI 10.1002/ad.1710; Tolley MT, 2014, SMART MATER STRUCT, V23, DOI 10.1088/0964-1726/23/9/094006; Xu CY, 2018, SCIENCE, V359, P1495, DOI 10.1126/science.aar5191	41	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264141	10.1371/journal.pone.0264141	http://dx.doi.org/10.1371/journal.pone.0264141			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320284	Green Published, gold			2022-12-26	WOS:000784240600040
J	Santana, AP; Korn, L; Betsch, C; Bohm, R				Santana, Ana Paula; Korn, Lars; Betsch, Cornelia; Bohm, Robert			Lessons learned about willingness to adopt various protective measures during the early COVID-19 pandemic in three countries	PLOS ONE			English	Article							BEHAVIOR; MODEL	BackgroundRegarding the COVID-19 pandemic, concerted efforts have been invested in research to investigate and communicate the importance of complying with protective behaviors, such as handwashing and mask wearing. Protective measures vary in how effective they are in protecting the individual against infection, how much experience people have with them, whether they provide individual or societal protection, and how they are perceived on these dimensions. MethodsThis study assessed the willingness to follow recommended measures, depending on these features, among participants from Germany (n = 333), Hong Kong (n = 367), and the U.S. (n = 495). From April 24(th) to May 1(st), 2020, individuals completed an online survey that assessed the antecedents of interest. ResultsIt was shown that assumed effectiveness, previous experience, and intended self- and other-protection positively predicted willingness to comply across countries. When measures were mainly perceived as protecting others (vs. the self), individuals were less prone to adopt them. When a measure's effectiveness to protect the individual was perceived as lower, willingness to adopt the measure increased with higher levels of prior experience and collectivism. Moreover, protecting others was more strongly related to adoption when individuals had higher levels of collectivism and lower levels of individualism. ConclusionsEmphasizing the benefit for others could be a means to lower the potential detrimental effects of low assumed effectiveness for individual protection.	[Santana, Ana Paula; Bohm, Robert] Univ Copenhagen, Dept Psychol, Copenhagen, Denmark; [Korn, Lars; Betsch, Cornelia] Univ Erfurt, Media & Commun Sci, Erfurt, Germany; [Korn, Lars; Betsch, Cornelia] Univ Erfurt, Ctr Empir Res Econ & Behav Sci CEREB, Erfurt, Germany; [Korn, Lars; Betsch, Cornelia] Bernhard Nocht Inst Trop Med, Dept Implementat Res, Hlth Commun, Hamburg, Germany; [Bohm, Robert] Univ Vienna, Fac Psychol, Vienna, Austria; [Bohm, Robert] Univ Copenhagen, Copenhagen Ctr Social Data Sci SODAS, Copenhagen, Denmark	University of Copenhagen; University of Erfurt; University of Erfurt; Bernhard Nocht Institut fur Tropenmedizin; University of Vienna; University of Copenhagen	Santana, AP (corresponding author), Univ Copenhagen, Dept Psychol, Copenhagen, Denmark.	apss@psy.ku.dk		Bohm, Robert/0000-0001-6806-0374; Souza Santana, Ana Paula/0000-0002-6079-774X	German Research Foundation (DFG) [BE 3970/8-2, BE 3970/11-1, BE 3970/12-1, BO-4466/2-2]	German Research Foundation (DFG)(German Research Foundation (DFG))	The work was funded by grants from the German Research Foundation (DFG, https://www.dfg.de/en/) to CB (BE 3970/8-2, BE 3970/11-1, BE 3970/12-1) and RB (BO-4466/2-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Betsch C, 2020, P NATL ACAD SCI USA, V117, P21851, DOI 10.1073/pnas.2011674117; Biderman N, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-24907-x; Bish A, 2010, BRIT J HEALTH PSYCH, V15, P797, DOI 10.1348/135910710X485826; CDC, 2022, PROTECT YOURSELF OTH; Chambon M, 2022, SOC PSYCHOL PERS SCI, V13, P233, DOI 10.1177/19485506211002420; Conner M, 2016, HEALTH PSYCHOL, V35, P219, DOI 10.1037/hea0000261; CRONBACH LJ, 1970, PSYCHOL BULL, V74, P68, DOI 10.1037/h0029382; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Gardner B., 2019, OXFORD RES ENCY PSYC, DOI [10.1093/acrefore/9780190236557.013.129, DOI 10.1093/ACREFORE/9780190236557.013.129]; Gelfand MJ, 2011, SCIENCE, V332, P1100, DOI 10.1126/science.1197754; Green P, 2016, METHODS ECOL EVOL, V7, P493, DOI 10.1111/2041-210X.12504; Habersaat KB, 2020, NAT HUM BEHAV, V4, P677, DOI 10.1038/s41562-020-0906-x; Harper CA, 2021, INT J MENT HEALTH AD, V19, P1875, DOI 10.1007/s11469-020-00281-5; Haug N, RANKING EFFECTIVENES; Heffner J, 2021, PERS INDIV DIFFER, V170, DOI 10.1016/j.paid.2020.110420; International Organization for Standardisation (ISO), 2009, ISOIEC 263622009; Jordan JJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97617-5; Jorgensen F, 2021, BRIT J HEALTH PSYCH, V26, P679, DOI 10.1111/bjhp.12519; Korn L, 2021, EUR PSYCHOL, V26, P359, DOI 10.1027/1016-9040/a000462; Lampridis E, 2017, INT J ADOLESC YOUTH, V22, P268, DOI 10.1080/02673843.2014.890114; Lau JTF, 2004, EMERG INFECT DIS, V10, P587, DOI 10.3201/eid1004.030628; Leder J, 2020, EVEN PROSOCIALLY ORI; Lindell MK, 2012, RISK ANAL, V32, P616, DOI 10.1111/j.1539-6924.2011.01647.x; Maekelae MJ, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200644; McKelvey T., 2020, BBC NEWS 0720; Morand S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22014-4; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Pinheiro JC, 2000, MIXED EFFECTS MODELS, P201, DOI DOI 10.1007/0-387-22747-4_5; Pogrebna G., 2020, IMPACT CROSS CULTURA, V10, P1, DOI DOI 10.13140/RG.2.2.23764.96649; R Core Team, 2020, R LANG ENV STAT COMP; Rad RE, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-10500-w; ROSENSTOCK IM, 1988, HEALTH EDUC QUART, V15, P175, DOI 10.1177/109019818801500203; Rothan HA, 2021, PEDIAT ALLERG IMM-UK, V32, P17, DOI 10.1111/pai.13361; Smith GD, 2020, J CLIN NURS, V29, P3580, DOI 10.1111/jocn.15401; Tett RP, 2003, J APPL PSYCHOL, V88, P500, DOI 10.1037/0021-9010.88.3.500; Huynh TLD, 2020, SAFETY SCI, V130, DOI 10.1016/j.ssci.2020.104872; Triandis HC, 1998, J PERS SOC PSYCHOL, V74, P118, DOI 10.1037/0022-3514.74.1.118; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Vietri JT, 2012, MED DECIS MAKING, V32, P447, DOI 10.1177/0272989X11427762; WEINSTEIN ND, 1989, PSYCHOL BULL, V105, P31, DOI 10.1037/0033-2909.105.1.31; WHO, 2020, ADV US MASKS CONT CO, P1, DOI [10.1101/2020.04.01.20049528, DOI 10.1101/2020.04.01.20049528]; WHO, 2020, MASK USE CONTEXT COV; Zajenkowski M, 2020, PERS INDIV DIFFER, V166, DOI 10.1016/j.paid.2020.110199; Zettler I, 2022, SOC PSYCHOL PERS SCI, V13, P299, DOI 10.1177/19485506211001680; Zickfeld JH, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.564083	46	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265892	10.1371/journal.pone.0265892	http://dx.doi.org/10.1371/journal.pone.0265892			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349583	gold, Green Published			2022-12-26	WOS:000783906500005
J	Sim, BZ; Conway, L; Smith, LK; Fairhead, L; Der, YS; Payne, L; Binotto, E; Smith, S; Hanson, J				Sim, Beatrice Z.; Conway, Luke; Smith, Laura K.; Fairhead, Lee; Der, Yi Shan; Payne, Lara; Binotto, Enzo; Smith, Simon; Hanson, Josh			The aetiology and clinical characteristics of cryptococcal infections in Far North Queensland, tropical Australia	PLOS ONE			English	Article							BRITISH-COLUMBIA; GATTII INFECTION; ENVIRONMENTAL SOURCES; AMPHOTERICIN-B; NEOFORMANS; EPIDEMIOLOGY; MANIFESTATIONS; PATHOGEN; CANADA; HOST	Cryptococcal infections are an important cause of morbidity and mortality in tropical Australia. This retrospective audit was conducted to characterise the aetiology, temporospatial epidemiology, and clinical course of 49 cryptococcal infections in Far North Queensland between 1 January 1999 and 31 December 2019. Cryptococcus gattii was identified in 15/32 (47%) in whom it was possible to speciate the organism. Among these 15 patients, 13 (87%) had a rural residential address, 10 (67%) were Indigenous Australians and 11 (73%) presented during the May-November dry season. When compared to the 17 patients with Cryptococcus neoformans infection, patients with C. gattii were less likely to be immunocompromised (0/15 versus 8/17 (47%), p = 0.003). Neurosurgery was necessary in 5/15 C. gattii cases and 3/17 (18%) C. neoformans cases (p = 0.42). Outcomes were generally good with 42/49 (86%) cases-and 14/15 (93%) with C. gattii infection-surviving to hospital discharge. These positive outcomes are likely to be explained by the development of standardised treatment guidelines during the study period, low rates of comorbidity in the patients with C. gattii infection and access to liposomal amphotericin and neurosurgical support in the well-resourced Australian healthcare system.	[Sim, Beatrice Z.; Conway, Luke; Smith, Laura K.; Fairhead, Lee; Der, Yi Shan; Payne, Lara; Binotto, Enzo; Smith, Simon; Hanson, Josh] Cairns Hosp, Dept Med, Cairns, Australia; [Sim, Beatrice Z.] Univ Queensland, Sch Med, Brisbane, Qld, Australia; [Hanson, Josh] Univ New South Wales, Kirby Inst, Sydney, NSW, Australia	University of Queensland; University of New South Wales Sydney; Kirby Institute	Hanson, J (corresponding author), Cairns Hosp, Dept Med, Cairns, Australia.; Hanson, J (corresponding author), Univ New South Wales, Kirby Inst, Sydney, NSW, Australia.	jhanson@kirby.unsw.edu.au	Sim, Beatrice/AGY-5823-2022	Sim, Beatrice/0000-0003-1845-4476; Smith, Simon/0000-0002-7770-3738				[Anonymous], 2009, FONDLY WE HOPE FERVE; [Anonymous], 2021, AUSTR VIRT HERB; BOWMAN DMJS, 1993, J ECOL, V81, P297, DOI 10.2307/2261499; CHAN KH, 1989, NEUROSURGERY, V25, P44, DOI 10.1097/00006123-198907000-00008; Chang CC, 2016, J FUNGI, V2, DOI 10.3390/jof2010001; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chastain DB, 2022, PATHOGENS, V11, DOI 10.3390/pathogens11020205; Chen S, 2000, CLIN INFECT DIS, V31, P499, DOI 10.1086/313992; Chen SCA, 2014, CLIN MICROBIOL REV, V27, P980, DOI 10.1128/CMR.00126-13; Chen SCA, 2012, CLIN INFECT DIS, V55, P789, DOI 10.1093/cid/cis529; Cheng JH., 2021, OPEN FORUM INFECT DI, V8, pofab296, DOI [10.1093/ofid/ofab296, DOI 10.1093/OFID/OFAB296]; Cho EH, 2019, DIAGN MICR INFEC DIS, V93, P107, DOI 10.1016/j.diagmicrobio.2018.08.008; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; ELLIS DH, 1990, LANCET, V336, P923, DOI 10.1016/0140-6736(90)92283-N; ELLIS DH, 1990, J CLIN MICROBIOL, V28, P1642, DOI 10.1128/JCM.28.7.1642-1644.1990; FISHER D, 1993, AUST NZ J MED, V23, P678, DOI 10.1111/j.1445-5994.1993.tb04726.x; Galanis E, 2010, EMERG INFECT DIS, V16, P251, DOI [10.3201/eid1602.090900, 10.3201/eid1601.090900]; Gassiep I, 2018, MYCOSES, V61, P633, DOI 10.1111/myc.12783; Hanson J, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009544; Hanson J, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236339; Harris J, 2012, MED MYCOL, V50, P113, DOI 10.3109/13693786.2011.607854; Hughes CM, 2020, INFECT DIS HEALTH, V25, P34, DOI 10.1016/j.idh.2019.08.003; International Diabetes Federation, 2019, IDF DIABETES ATLAS, VNinth; Jenney A, 2004, J CLIN MICROBIOL, V42, P3865, DOI 10.1128/JCM.42.8.3865-3868.2004; Johnson PC, 2002, ANN INTERN MED, V137, P105, DOI 10.7326/0003-4819-137-2-200207160-00008; Kidd SE, 2007, APPL ENVIRON MICROB, V73, P1433, DOI 10.1128/AEM.01330-06; Krockenberger MB, 2010, MYCOPATHOLOGIA, V170, P315, DOI 10.1007/s11046-010-9328-z; Krockenberger MB, 2002, MED MYCOL, V40, P263, DOI 10.1080/mmy.40.3.263.272; Lin YY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119090; MacDougall L, 2006, J CLIN MICROBIOL, V44, P1851, DOI 10.1128/JCM.44.5.1851-1852.2006; MacDougall L, 2011, EMERG INFECT DIS, V17, P193, DOI 10.3201/eid1702.101020; Marr KA, 2012, EXPERT REV ANTI-INFE, V10, P637, DOI [10.1586/eri.12.48, 10.1586/ERI.12.48]; McGrail Matthew R, 2009, Aust New Zealand Health Policy, V6, P28, DOI 10.1186/1743-8462-6-28; McMullan BJ, 2013, FUTURE MICROBIOL, V8, P1613, DOI 10.2217/fmb.13.123; Mistro S, 2012, CLIN INFECT DIS, V54, P1774, DOI 10.1093/cid/cis290; Pourbaix A, 2020, CLIN INFECT DIS, V71, P1106, DOI 10.1093/cid/ciaa001; Salaveria K, 2022, AM J TROP MED HYG, V106, P257, DOI 10.4269/ajtmh.21-0615; Simou E, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-022344; Smith S, 2021, EMERG INFECT DIS, V27, P3119, DOI 10.3201/eid2712.211302; Smith S, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007929; Sorrell TC, 1996, J CLIN MICROBIOL, V34, P1261, DOI 10.1128/JCM.34.5.1261-1263.1996; SPEED B, 1995, CLIN INFECT DIS, V21, P28, DOI 10.1093/clinids/21.1.28; Stewart AGA, 2019, PLOS NEGLECT TROP D, V13, DOI 10.1371/journal.pntd.0007583; Stewart JD, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005411; The health of Queenslanders, 2020, REP CHIEF HLTH OFF Q; Vardanega J, 2022, INT J INFECT DIS, V118, P1, DOI 10.1016/j.ijid.2022.02.026	46	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265739	10.1371/journal.pone.0265739	http://dx.doi.org/10.1371/journal.pone.0265739			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353860	gold, Green Published			2022-12-26	WOS:000786647900058
J	Tanaka, SI; Fujioka, Y; Tsujino, T; Ishida, T; Hirata, KI				Tanaka, Shin-ichiro; Fujioka, Yoshio; Tsujino, Takeshi; Ishida, Tatsuro; Hirata, Ken-ichi			Association between urinary N-acetyl-beta-glucosaminidase activity-urinary creatinine concentration ratio and risk of disability and all-cause mortality	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; CORONARY-HEART-DISEASE; RENAL TUBULAR DAMAGE; GENERAL-POPULATION; BLOOD-PRESSURE; CARDIOVASCULAR EVENTS; KLOTHO; HORMONE; DEATH; ALBUMINURIA	BackgroundRecent studies have suggested that chronic kidney disease is associated with cardiovascular disease, dementia, and frailty, all of which cause disability and early death. We investigated whether increased activity of urinary N-acetyl-beta-glucosaminidase (NAG), a marker of kidney injury, is associated with risk of disability or all-cause mortality in a general population. MethodsFollow-up data from the Hidaka Cohort Study, a population-based cohort study of members of a Japanese rural community, were obtained via questionnaires completed by participants or their relatives. Multivariable analyses were used to investigate relations between urinary NAG activity-urinary creatinine concentration ratio and risk of disability or all-cause mortality. ResultsA total of 1182 participants were followed up for a median of 12.4 years. The endpoints were receipt of support under the public long-term care insurance program, and all-cause mortality. A total of 122 participants (10.3%) were reported to be receiving long-term care and 230 (19.5%) had died. After adjustment for cardiovascular risk factors along with physical activity, and using the quartile 1 results as a reference, the odds ratio (OR) for disability was 2.12 [95% confidence interval (95% confidence interval [CI]), 1.04-4.33; p = 0.038) and the hazard ratio (HR) for all-cause mortality was 1.65 (95% CI, 1.05-2.62; p = 0.031) in participants with urinary NAG/creatinine ratio in quartile 4. Similar results were obtained in participants without proteinuria: OR for disability, 2.46 (95% CI, 1.18-5.16; p = 0.017); and HR for all-cause mortality, 1.62 (95% CI, 1.00-2.63; p = 0.049). ConclusionsIncreased urinary NAG/creatinine ratio was associated with risk of disability or all-cause mortality in a general population.	[Tanaka, Shin-ichiro] Toyooka Hosp Hidaka Med Ctr, Dept Internal Med, Toyooka, Hyogo, Japan; [Fujioka, Yoshio] Kobe Gakuin Univ, Fac Nutr, Div Clin Nutr, Kobe, Japan; [Tsujino, Takeshi] Hyogo Univ Hlth Sci, Sch Pharm, Dept Pharm, Kobe, Japan; [Ishida, Tatsuro; Hirata, Ken-ichi] Kobe Univ Grad Sch Med, Div Cardiovasc Med, Kobe, Japan	Kobe Gakuin University; Kobe University	Tanaka, SI (corresponding author), Toyooka Hosp Hidaka Med Ctr, Dept Internal Med, Toyooka, Hyogo, Japan.	shinichirou-tanaka@toyookahp-kumiai.or.jp		Tanaka, Shin-ichiro/0000-0003-4217-6859				AGARDH CD, 1987, DIABETES CARE, V10, P604, DOI 10.2337/diacare.10.5.604; Campbell JC, 2000, HEALTH AFFAIR, V19, P26, DOI 10.1377/hlthaff.19.3.26; Crasto CL, 2012, REJUV RES, V15, P295, DOI 10.1089/rej.2011.1268; Dalrymple LS, 2013, CLIN J AM SOC NEPHRO, V8, P2091, DOI 10.2215/CJN.02870313; Damman K, 2011, EUR HEART J, V32, P2705, DOI 10.1093/eurheartj/ehr190; Fassett RG, 2011, KIDNEY INT, V80, P806, DOI 10.1038/ki.2011.198; Fukuda M, 2008, HYPERTENSION, V52, P1155, DOI 10.1161/HYPERTENSIONAHA.108.115329; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Imai E, 2009, CLIN EXP NEPHROL, V13, P621, DOI 10.1007/s10157-009-0199-x; Ix JH, 2012, J AM COLL CARDIOL, V60, P200, DOI 10.1016/j.jacc.2012.03.040; Kern EFO, 2010, AM J KIDNEY DIS, V55, P824, DOI 10.1053/j.ajkd.2009.11.009; Kim SR, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0497-7; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; KUNIN CM, 1978, PEDIATRICS, V62, P751; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Levey AS, 2005, KIDNEY INT, V67, P2089, DOI 10.1111/j.1523-1755.2005.00365.x; Lu RH, 2015, NAT REV NEPHROL, V11, P707, DOI 10.1038/nrneph.2015.131; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; MANSELL MA, 1978, LANCET, V2, P803; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Matsushita K, 2010, LANCET, V375, P2073, DOI 10.1016/S0140-6736(10)60674-5; NOTO A, 1983, CLIN CHEM, V29, P1713; Pavik I, 2013, NEPHROL DIAL TRANSPL, V28, P352, DOI 10.1093/ndt/gfs460; Rustom R, 1998, AM J NEPHROL, V18, P179, DOI 10.1159/000013334; Sarnak MJ, 2003, CIRCULATION, V108, P2154, DOI 10.1161/01.CIR.0000095676.90936.80; Seliger SL, 2004, J AM SOC NEPHROL, V15, P1904, DOI 10.1097/01.asn.0000131529.60019.fa; Semba RD, 2011, J GERONTOL A-BIOL, V66, P794, DOI 10.1093/gerona/glr058; Shardell M, 2016, J GERONTOL A-BIOL, V71, P677, DOI 10.1093/gerona/glv140; SHERMAN RL, 1983, ARCH INTERN MED, V143, P1183, DOI 10.1001/archinte.143.6.1183; Solbu MD, 2016, J AM SOC NEPHROL, V27, P533, DOI 10.1681/ASN.2014100960; Souma N, 2016, J CLIN ENDOCR METAB, V101, P3779, DOI 10.1210/jc.2016-2215; Tanaka S, 2018, LIPIDS HEALTH DIS, V17, DOI 10.1186/s12944-018-0822-5; Tanaka S, 2013, ARTERIOSCL THROM VAS, V33, P1098, DOI 10.1161/ATVBAHA.113.301297; Tanaka S, 2011, J ATHEROSCLER THROMB, V18, P584, DOI 10.5551/jat.6585; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; Vaidya VS, 2011, KIDNEY INT, V79, P464, DOI 10.1038/ki.2010.404; WELLWOOD JM, 1975, BRIT MED J, V3, P408, DOI 10.1136/bmj.3.5980.408; Yamagata K, 2007, KIDNEY INT, V71, P159, DOI 10.1038/sj.ki.5002017; Yamamoto M, 2005, J BIOL CHEM, V280, P38029, DOI 10.1074/jbc.M509039200	40	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265637	10.1371/journal.pone.0265637	http://dx.doi.org/10.1371/journal.pone.0265637			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P6KD	35333903	gold, Green Published			2022-12-26	WOS:000784335700012
J	Vallecillo, D; Guillemain, M; Authier, M; Bouchard, C; Cohez, D; Vialet, E; Massez, G; Vandewalle, P; Champagnon, J				Vallecillo, David; Guillemain, Matthieu; Authier, Matthieu; Bouchard, Colin; Cohez, Damien; Vialet, Emmanuel; Massez, Gregoire; Vandewalle, Philippe; Champagnon, Jocelyn			Accounting for detection probability with overestimation by integrating double monitoring programs over 40 years	PLOS ONE			English	Article							N-MIXTURE MODELS; AERIAL SURVEYS; ESTIMATING ABUNDANCE; VISIBILITY BIAS; IMPERFECT DETECTION; PROCESS NOISE; MAGPIE GOOSE; COUNT DATA; POPULATION; DENSITY	In the context of wildlife population declines, increasing computer power over the last 20 years allowed wildlife managers to apply advanced statistical techniques that has improved population size estimates. However, respecting the assumptions of the models that consider the probability of detection, such as N-mixture models, requires the implementation of a rigorous monitoring protocol with several replicate survey occasions and no double counting that are hardly adaptable to field conditions. When the logistical, economic and ecological constraints are too strong to meet model assumptions, it may be possible to combine data from independent surveys into the modelling framework in order to understand population dynamics more reliably. Here, we present a state-space model with an error process modelled on the log scale to evaluate wintering waterfowl numbers in the Camargue, southern France, while taking a conditional probability of detection into consideration. Conditional probability of detection corresponds to estimation of a detection probability index, which is not a true probability of detection, but rather conditional on the difference to a particular baseline. The large number of sites (wetlands within the Camargue delta) and years monitored (44) provide significant information to combine both terrestrial and aerial surveys (which constituted spatially and temporally replicated counts) to estimate a conditional probability of detection, while accounting for false-positive counting errors and changes in observers over the study period. The model estimates abundance indices of wintering Common Teal, Mallard and Common Coot, all species abundant in the area. We found that raw counts were underestimated compared to the predicted population size. The model-based data integration approach as described here seems like a promising solution that takes advantage of as much as possible of the data collected from several methods when the logistic constraints do not allow the implementation of a permanent monitoring and analysis protocol that takes into account the detectability of individuals.	[Vallecillo, David; Cohez, Damien; Champagnon, Jocelyn] Res Inst Conservat Mediterranean Wetlands, Tour Valat Res, Arles, France; [Vallecillo, David; Guillemain, Matthieu] Un Avifaune migratrice, OFB, La Tour Valat, Arles, France; [Authier, Matthieu] LR Univ, CNRS UMS 3462, Observ Pelagis, ADERA, La Rochelle, France; [Bouchard, Colin] Univ Pau & Pays Adour, UMR Ecobiop, INRAE, e2S, St Pee Sur Nivelle, France; [Vialet, Emmanuel] Parc Nat Reg Camargue, Mas Pont Rousty, Arles, France; [Massez, Gregoire] Amis Marais Vigueirat, Chemin Etourneau, Arles, France; [Vandewalle, Philippe] SNPN RNN Camargue, Arles, France	Office Francais de la Biodiversite OFB; INRAE; Universite de Pau et des Pays de l'Adour	Vallecillo, D (corresponding author), Res Inst Conservat Mediterranean Wetlands, Tour Valat Res, Arles, France.; Vallecillo, D (corresponding author), Un Avifaune migratrice, OFB, La Tour Valat, Arles, France.	vallecillo@tourduvalat.org		Champagnon, Jocelyn/0000-0003-4850-8033; Bouchard, Colin/0000-0003-0845-9492				Abadi F, 2010, ECOLOGY, V91, P7, DOI 10.1890/08-2235.1; Banks Richard C., 1994, Studies in Avian Biology, V15, P134; Barker RJ, 2018, BIOMETRICS, V74, P369, DOI 10.1111/biom.12734; BARKER RJ, 1992, WILDLIFE 2001 : POPULATIONS, P182; Bart J, 2002, AUK, V119, P36, DOI 10.1642/0004-8038(2002)119[0036:DSTEDA]2.0.CO;2; Bas Y, 2008, BIODIVERS CONSERV, V17, P3403, DOI 10.1007/s10531-008-9420-6; BAYLISS P, 1990, AUST WILDLIFE RES, V17, P1; Brooks SP, 1998, J COMPUT GRAPH STAT, V7, P434, DOI 10.2307/1390675; BROOME LS, 1985, AUST WILDLIFE RES, V12, P57; Buckland ST., 2004, ADV DISTANCE SAMPLIN; Campbell M, 2011, AUK, V128, P303, DOI 10.1525/auk.2011.10005; Conn PB, 2018, ECOL MONOGR, V88, P526, DOI 10.1002/ecm.1314; Costa H, 2015, ISPRS INT J GEO-INF, V4, P2496, DOI 10.3390/ijgi4042496; Crawford BA, 2018, BIOL CONSERV, V222, P33, DOI 10.1016/j.biocon.2018.03.023; De Valpine P, 2002, ECOL MONOGR, V72, P57, DOI 10.1890/0012-9615(2002)072[0057:FPMIPN]2.0.CO;2; Denes FV, 2015, METHODS ECOL EVOL, V6, P543, DOI 10.1111/2041-210X.12333; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; DERVIEUX A, 1980, TERRE VIE-REV ECOL A, V34, P69; DEXTER N, 1990, AUST WILDLIFE RES, V17, P447; DIEM KENNETH L., 1960, JOUR WILDLIFE MANAGEMENT, V24, P113, DOI 10.2307/3796737; Dorazio RM, 2014, GLOBAL ECOL BIOGEOGR, V23, P1472, DOI 10.1111/geb.12216; Duarte A, 2018, ECOL MODEL, V374, P51, DOI 10.1016/j.ecolmodel.2018.02.007; Frederick PC, 1996, CONDOR, V98, P837, DOI 10.2307/1369865; Furrer R, 2016, J ORNITHOL, V157, P787, DOI 10.1007/s10336-016-1324-8; Gabry J, 2019, J R STAT SOC A STAT, V182, P389, DOI 10.1111/rssa.12378; Gilbert AD, 2021, WILDLIFE SOC B, V45, P6, DOI 10.1002/wsb.1150; Green MC, 2008, J WILDLIFE MANAGE, V72, P697, DOI 10.2193/2006-391; Guillemain M, 2002, BIOL CONSERV, V103, P183, DOI 10.1016/S0006-3207(01)00120-3; Guillemain M, 2010, WILDLIFE BIOL, V16, P215, DOI 10.2981/09-042; Isaac NJB, 2020, TRENDS ECOL EVOL, V35, P56, DOI 10.1016/j.tree.2019.08.006; Kery M, 2012, BAYESIAN POPULATION ANALYSIS USING WINBUGS: A HIERARCHICAL PERSPECTIVE, P1; Kery M, 2008, COMMUNITY ECOL, V9, P207, DOI 10.1556/ComEc.9.2008.2.10; Kery M, 2008, AUK, V125, P336, DOI 10.1525/auk.2008.06185; Kery M, 2009, J APPL ECOL, V46, P1163, DOI 10.1111/j.1365-2664.2009.01724.x; Ketz AC, 2018, ECOL APPL, V28, P816, DOI 10.1002/eap.1692; Kingsford RT, 1999, FRESHWATER BIOL, V41, P425, DOI 10.1046/j.1365-2427.1999.00440.x; LANGE KL, 1989, J AM STAT ASSOC, V84, P881, DOI 10.2307/2290063; Laursen K, 2008, WILDLIFE BIOL, V14, P165, DOI 10.2981/0909-6396(2008)14[165:AOTCOW]2.0.CO;2; Link WA, 2010, BAYESIAN INFERENCE WITH ECOLOGICAL APPLICATIONS, P1; Link WA, 2018, ECOLOGY, V99, P1547, DOI 10.1002/ecy.2362; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; MARSH H, 1989, J WILDLIFE MANAGE, V53, P1017, DOI 10.2307/3809604; Martin J, 2011, METHODS ECOL EVOL, V2, P595, DOI 10.1111/j.2041-210X.2011.00113.x; Martin TG, 2005, ECOL LETT, V8, P1235, DOI 10.1111/j.1461-0248.2005.00826.x; Miller DA, 2011, ECOLOGY, V92, P1422, DOI 10.1890/10-1396.1; Miller DAW, 2019, METHODS ECOL EVOL, V10, P22, DOI 10.1111/2041-210X.13110; Newman KB, 1998, BIOMETRICS, V54, P1290, DOI 10.2307/2533659; Newson SE, 2013, BIRD STUDY, V60, P384, DOI 10.1080/00063657.2013.805729; Nichols JD, 2000, AUK, V117, P393, DOI 10.1642/0004-8038(2000)117[0393:ADOAFE]2.0.CO;2; Pacifici K, 2019, ECOLOGY, V100, DOI 10.1002/ecy.2709; Pagano AM, 2009, J WILDLIFE MANAGE, V73, P686, DOI 10.2193/2007-524; Pearse AT, 2008, J WILDLIFE MANAGE, V72, P808, DOI 10.2193/2007-274; Pimm SL, 2014, SCIENCE, V344, P987, DOI 10.1126/science.1246752; Plummer M., 2003, P 3 INT WORKSH DISTR; POLLOCK KH, 1987, J WILDLIFE MANAGE, V51, P502, DOI 10.2307/3801040; RCore Team, 2020, R LANG ENV STAT COMP; Rodgers JA, 2005, WATERBIRDS, V28, P230, DOI 10.1675/1524-4695(2005)028[0230:AOASOW]2.0.CO;2; Roy C, 2022, WILDLIFE BIOL, V2022, DOI 10.1002/wlb3.01003; Royle JA, 2004, BIOMETRICS, V60, P108, DOI 10.1111/j.0006-341X.2004.00142.x; Royle JA, 2009, HIERARCHICAL MODELING AND INFERENCE IN ECOLOGY: THE ANALYSIS OF DATA FROM POPULATIONS, METAPOPULATIONS AND COMMUNITIES, P1; Sanz-Perez A, 2020, BIODIVERS CONSERV, V29, P1747, DOI 10.1007/s10531-020-01948-0; SAUER JR, 1994, AUK, V111, P50, DOI 10.2307/4088504; Schroeder NM, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.191482; Seber GA, 2002, ESTIMATION ANIMAL AB, pxvii; Smith G.C., 1995, 5 US DEP INT NAT BIO; Sollmann R, 2016, METHODS ECOL EVOL, V7, P529, DOI 10.1111/2041-210X.12518; Su Y-S, 2015, **DATA OBJECT**; Tamisier A., 1981, REV D COLOGIE, V35, P563; Tamisier A., 1999, CAMARGUE CANARDS FOU; Thompson WL, 2002, AUK, V119, P18, DOI 10.1642/0004-8038(2002)119[0018:TRBSAF]2.0.CO;2; Vallecillo D, 2021, ECOL EVOL, V11, P2249, DOI 10.1002/ece3.7191; Vorisek Petr, 2008, Revista Catalana d'Ornitologia, V24, P4; Wenger SJ, 2008, ECOLOGY, V89, P2953, DOI 10.1890/07-1127.1; Williams B. K., 2002, ANAL MANAGEMENT ANIM; Yoshizaki J, 2009, ECOLOGY, V90, P3, DOI 10.1890/08-0304.1; Zipkin EF, 2018, BIOL CONSERV, V217, P240, DOI 10.1016/j.biocon.2017.10.017	76	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265730	10.1371/journal.pone.0265730	http://dx.doi.org/10.1371/journal.pone.0265730			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333894	Green Published, gold			2022-12-26	WOS:000784335700017
J	Wanichwecharungruang, B; Amornpetchsathaporn, A; Wongwijitsook, W; Kongsomboon, K; Chantra, S				Wanichwecharungruang, Boonsong; Amornpetchsathaporn, Anyarak; Wongwijitsook, Wisakorn; Kongsomboon, Kittipong; Chantra, Somporn			Evaluation of ocular biometry in primary angle-closure disease with two swept source optical coherence tomography devices	PLOS ONE			English	Article							INTRAOCULAR-LENS POWER; PERIPHERAL IRIDOTOMY; GLAUCOMA; PHACOEMULSIFICATION; PREVALENCE; OUTCOMES	PurposeTo investigate agreement between 2 swept source OCT biometers, IOL Master700 and Anterion, in various ocular biometry and intraocular lens (IOL) calculations of primary angle-closure disease (PACD). SettingRajavithi Hospital, Bangkok, Thailand. DesignProspective comparative study. MethodsThis study conducted in a tertiary eye care center involving biometric measurements obtained with 2 devices in phakic eye with diagnosis of PACD. Mean difference and intraclass correlation coefficient (ICC) with confidence limits were assessed, and calculations of estimated residual refraction of the IOL were analysed using Barrett's formula. ResultsSixty-nine eyes from 45 PACD patients were enrolled for the study. Excellent agreement of various parameters was revealed, with ICC (confidence limits) of K1 = 0.953 (0.861-0.979), K2 = 0.950 (0.778-0.98), ACD = 0.932 (0.529-0.978), WTW = 0.775 (0.477-0.888), and LT = 0.947 (0.905-0.97). Mean difference of axial length (AL) was -0.01 +/- 0.02 mm with ICC of 1.000. IOL calculation was assessed with Barrett's formula, and Bland-Altman plot showed excellent agreement in the results of the 2 devices for the IOL power and estimated post-operative residual refraction (EPR). ConclusionsMean differences of biometric parameters, obtained with IOL Master700 and Anterion, were small, and ICC showed excellent concordance. No clinical relevance in calculation of IOL power was found, and the two devices appeared to be comparably effective in clinical practice.	[Wanichwecharungruang, Boonsong; Amornpetchsathaporn, Anyarak; Wongwijitsook, Wisakorn; Chantra, Somporn] Rajavithi Hosp, Dept Ophthalmol, Bangkok, Thailand; [Wanichwecharungruang, Boonsong; Amornpetchsathaporn, Anyarak; Wongwijitsook, Wisakorn; Chantra, Somporn] Rangsit Med Coll, Bangkok, Thailand; [Wanichwecharungruang, Boonsong] Priest Hosp, Dept Ophthalmol, Bangkok, Thailand; [Kongsomboon, Kittipong] Srinakharinwirot Univ, Fac Med, Dept Prevent & Social Med, Nakhon Nayok, Thailand	Rajavithi Hospital; Srinakharinwirot University	Chantra, S (corresponding author), Rajavithi Hosp, Dept Ophthalmol, Bangkok, Thailand.; Chantra, S (corresponding author), Rangsit Med Coll, Bangkok, Thailand.	chantrasomporn@yahoo.com		Chantra, Somporn/0000-0003-0319-4384	Rajavithi research funds [241/2563]	Rajavithi research funds	SC received fund from Rajavithi research funds with grant number 241/2563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abulafia A, 2015, J CATARACT REFR SURG, V41, P548, DOI 10.1016/j.jcrs.2014.06.033; Azuara-Blanco A, 2016, LANCET, V388, P1389, DOI 10.1016/S0140-6736(16)30956-4; Billheimer J, 2019, SCREEN CLASSIC, P59; Carmona-Gonzalez D, 2021, EUR J OPHTHALMOL, V31, P2370, DOI 10.1177/1120672120962030; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Fisus AD, 2021, J CATARACT REFR SURG, V47, P87, DOI 10.1097/j.jcrs.0000000000000373; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; Gazzard G, 2002, ARCH OPHTHALMOL-CHIC, V120, P1636; He MG, 2007, OPHTHALMOLOGY, V114, P494, DOI 10.1016/j.ophtha.2006.06.053; Jacobi PC, 2002, OPHTHALMOLOGY, V109, P1597, DOI 10.1016/S0161-6420(02)01123-5; Kim KY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0244590; Lam DSC, 2008, OPHTHALMOLOGY, V115, P1134, DOI 10.1016/j.ophtha.2007.10.033; Marchini G, 1998, OPHTHALMOLOGY, V105, P2091, DOI 10.1016/S0161-6420(98)91132-0; Meduri E, 2020, J GLAUCOMA, V29, P1030, DOI 10.1097/IJG.0000000000001654; Montes-Mico R, 2020, EXPERT REV MED DEVIC, V17, P969, DOI 10.1080/17434440.2020.1816463; Nongpiur ME, 2011, OPHTHALMOLOGY, V118, P474, DOI 10.1016/j.ophtha.2010.07.025; Oh R, 2021, BMC OPHTHALMOL, V21, DOI 10.1186/s12886-021-01826-5; Olsen T, 2007, ACTA OPHTHALMOL SCAN, V85, P472, DOI 10.1111/j.1600-0420.2007.00879.x; Pardeshi AA, 2020, TRANSL VIS SCI TECHN, V9, DOI 10.1167/tvst.9.9.14; Pereira FAS, 2003, OPHTHALMOLOGY, V110, P1799, DOI 10.1016/S0161-6420(03)00623-7; Ruiz-Mesa R, 2020, EXPERT REV MED DEVIC, V17, P591, DOI 10.1080/17434440.2020.1772050; Schiano-Lomoriello D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-79674-4; Srivannaboon S, 2015, J CATARACT REFR SURG, V41, P2224, DOI 10.1016/j.jcrs.2015.03.019; Tana-Rivero P, 2021, J CATARACT REFR SURG, V47, P488, DOI 10.1097/j.jcrs.0000000000000483; Tana-Rivero P, 2021, INT OPHTHALMOL, V41, P57, DOI 10.1007/s10792-020-01552-9; Tana-Rivero P, 2021, EUR J OPHTHALMOL, V31, P1709, DOI 10.1177/1120672120944022; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wanichwecharungruang B, 2021, CLIN OPHTHALMOL, V15, P2823, DOI 10.2147/OPTH.S315747	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265844	10.1371/journal.pone.0265844	http://dx.doi.org/10.1371/journal.pone.0265844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312733	Green Published, gold			2022-12-26	WOS:000803647900021
J	Aoyagi, Y; Kano, Y; Tohyama, K; Matsudera, S; Kumaki, Y; Takahashi, K; Mitsumura, T; Harada, Y; Sato, A; Nakamura, H; Sueoka, E; Aragane, N; Kimura, K; Onishi, I; Takemoto, A; Akahoshi, K; Ono, H; Ishikawa, T; Tokunaga, M; Nakagawa, T; Oshima, N; Nakamura, R; Takagi, M; Asakage, T; Uetake, H; Tanabe, M; Miyake, S; Kinugasa, Y; Ikeda, S				Aoyagi, Yasuko; Kano, Yoshihito; Tohyama, Kohki; Matsudera, Shotaro; Kumaki, Yuichi; Takahashi, Kenta; Mitsumura, Takahiro; Harada, Yohei; Sato, Akemi; Nakamura, Hideaki; Sueoka, Eisaburo; Aragane, Naoko; Kimura, Koichiro; Onishi, Iichiro; Takemoto, Akira; Akahoshi, Keiichi; Ono, Hiroaki; Ishikawa, Toshiaki; Tokunaga, Masanori; Nakagawa, Tsuyoshi; Oshima, Noriko; Nakamura, Reiko; Takagi, Masatoshi; Asakage, Takahiro; Uetake, Hiroyuki; Tanabe, Minoru; Miyake, Satoshi; Kinugasa, Yusuke; Ikeda, Sadakatsu			Clinical utility of comprehensive genomic profiling in Japan: Result of PROFILE-F study	PLOS ONE			English	Article								Introduction Clinical sequencing has provided molecular and therapeutic insights into the field of clinical oncology. However, despite its significance, its clinical utility in Japanese patients remains unknown. Here, we examined the clinical utility of tissue-based clinical sequencing with FoundationOne((R)) CDx and FoundationOne((R)) Heme. Between August 2018 and August 2019, 130 Japanese pretreated patients with advanced solid tumors were tested with FoundationOne((R)) CDx or FoundationOne((R)) Heme. Results The median age of 130 patients was 60.5 years (range: 3 to 84 years), and among them, 64 were males and 66 were females. Major cancer types were gastrointestinal cancer (23 cases) and hepatic, biliary, and pancreatic cancer (21 cases). A molecular tumor board had been completed on all 130 cases by October 31, 2019. The median number of gene alterations detected by Foundation testing, excluding variants of unknown significance (VUS) was 4 (ranged 0 to 21) per case. Of the 130 cases, one or more alterations were found in 123 cases (94.6%), and in 114 cases (87.7%), actionable alterations with candidates for therapeutic agents were found. In 29 (22.3%) of them, treatment corresponding to the gene alteration was performed. Regarding secondary findings, 13 cases (10%) had an alteration suspected of a hereditary tumor. Of the 13 cases, only one case received a definite diagnosis of hereditary tumor. Conclusions Our study showed that clinical sequencing might be useful for detecting gene alterations in various cancer types and exploring treatment options. However, many issues still need to be improved.	[Aoyagi, Yasuko; Kano, Yoshihito; Tohyama, Kohki; Matsudera, Shotaro; Ikeda, Sadakatsu] Tokyo Med & Dent Univ, Ctr Innovat Canc Treatment, Dept Precis Canc Med, Tokyo, Japan; [Aoyagi, Yasuko; Tokunaga, Masanori; Kinugasa, Yusuke] Tokyo Med & Dent Univ, Dept Gastrointestinal Surg, Tokyo, Japan; [Kano, Yoshihito; Miyake, Satoshi] Tokyo Med & Dent Univ, Dept Clin Oncol, Tokyo, Japan; [Matsudera, Shotaro; Kumaki, Yuichi; Ishikawa, Toshiaki; Nakagawa, Tsuyoshi; Uetake, Hiroyuki] Tokyo Med & Dent Univ, Dept Specialized Surg, Tokyo, Japan; [Matsudera, Shotaro] Dokkyo Med Univ, First Dept Surg, Mibu, Tochigi, Japan; [Takahashi, Kenta; Oshima, Noriko; Nakamura, Reiko] Tokyo Med & Dent Univ, Dept Obstet & Gynecol, Tokyo, Japan; [Mitsumura, Takahiro] Tokyo Med & Dent Univ, Dept Resp Med, Tokyo, Japan; [Harada, Yohei; Aragane, Naoko] Saga Univ, Fac Med, Div Hematol Resp Med & Oncol, Saga, Japan; [Sato, Akemi; Nakamura, Hideaki; Sueoka, Eisaburo] Saga Univ Hosp, Dept Transfus Med, Saga, Japan; [Kimura, Koichiro] Tokyo Med & Dent Univ, Dept Radiol, Tokyo, Japan; [Onishi, Iichiro] Tokyo Med & Dent Univ, Dept Pathol, Tokyo, Japan; [Takemoto, Akira] Tokyo Med & Dent Univ, Dept Bioresource Res Ctr, Tokyo, Japan; [Akahoshi, Keiichi; Ono, Hiroaki; Tanabe, Minoru] Tokyo Med & Dent Univ, Dept HepatoBiliary Pancreat Surg, Tokyo, Japan; [Takagi, Masatoshi] Tokyo Med & Dent Univ, Dept Pediat, Tokyo, Japan; [Asakage, Takahiro] Tokyo Med & Dent Univ, Dept Head & Neck Surg, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Dokkyo Medical University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Saga University; Saga University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Aoyagi, Y; Ikeda, S (corresponding author), Tokyo Med & Dent Univ, Ctr Innovat Canc Treatment, Dept Precis Canc Med, Tokyo, Japan.	aoyagi.srg1@tmd.ac.jp; ikeda.canc@tmd.ac.jp	Kimura, Koichiro/GPF-8036-2022	Kimura, Koichiro/0000-0003-3190-8508; Aoyagi, Yasuko/0000-0002-1856-4336; Mitsumura, Takahiro/0000-0003-4583-7667; Nakamura, Hideaki/0000-0002-0449-7830	Chugai Pharmaceutical, Co. Ltd. [2F142]	Chugai Pharmaceutical, Co. Ltd.	This study was supported by Chugai Pharmaceutical, Co. Ltd. Institutional funding number 2F142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bieg-Bourne CC, 2017, CANCER RES, V77, P6313, DOI 10.1158/0008-5472.CAN-17-1569; Ebi Hiromichi, 2019, JCO Precis Oncol, V3, DOI 10.1200/PO.19.00291; Endo S., 2020, HAIGAN, V60, P429, DOI [10.2482/haigan.60.429, DOI 10.2482/HAIGAN.60.429]; Flaherty KT, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.03010; Frampton GM, 2013, NAT BIOTECHNOL, V31, P1023, DOI 10.1038/nbt.2696; Hayashi H, 2018, PANCREATOLOGY, V18, P647, DOI 10.1016/j.pan.2018.07.006; He J, 2016, BLOOD, V127, P3004, DOI 10.1182/blood-2015-08-664649; Hirshfield KM, 2016, ONCOLOGIST, V21, P1315, DOI 10.1634/theoncologist.2016-0049; Ikeda S, 2018, ONCOLOGIST, V23, P586, DOI 10.1634/theoncologist.2017-0479; Kou T, 2017, CANCER SCI, V108, P1440, DOI 10.1111/cas.13265; Nagahashi M, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0387-8; Saotome K, 2020, CANCER MED-US, V9, P7407, DOI 10.1002/cam4.3383; Sohal DPS, 2016, JNCI-J NATL CANCER I, V108, DOI 10.1093/jnci/djv332; Sunami K, 2021, INT J CLIN ONCOL, V26, P443, DOI 10.1007/s10147-020-01844-1; Sunami K, 2019, CANCER SCI, V110, P1480, DOI 10.1111/cas.13969; Takagi M, 2017, JNCI-J NATL CANCER I, V109, DOI 10.1093/.inci/djx062; Takeda M, 2021, ONCOLOGIST, V26, pE588, DOI 10.1002/onco.13639	17	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266112	10.1371/journal.pone.0266112	http://dx.doi.org/10.1371/journal.pone.0266112			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358259	Green Published, gold			2022-12-26	WOS:000799828800072
J	Rosenbaum, R				Rosenbaum, Robert			On the relationship between predictive coding and backpropagation	PLOS ONE			English	Article							FREE-ENERGY PRINCIPLE; VISUAL-CORTEX	Artificial neural networks are often interpreted as abstract models of biological neuronal networks, but they are typically trained using the biologically unrealistic backpropagation algorithm and its variants. Predictive coding has been proposed as a potentially more biologically realistic alternative to backpropagation for training neural networks. This manuscript reviews and extends recent work on the mathematical relationship between predictive coding and backpropagation for training feedforward artificial neural networks on supervised learning tasks. Implications of these results for the interpretation of predictive coding and deep neural networks as models of biological learning are discussed along with a repository of functions, Torch2PC, for performing predictive coding with PyTorch neural network models.	[Rosenbaum, Robert] Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA	University of Notre Dame	Rosenbaum, R (corresponding author), Univ Notre Dame, Dept Appl & Computat Math & Stat, Notre Dame, IN 46556 USA.	Robert.Rosenbaum@nd.edu		Rosenbaum, Robert/0000-0003-2105-9282	National Science Foundation [NSF DMS 1654268]; NSF Neuronex [DBI 1707400]; Air Force Office of Scientific Research (ASOFR) [FA9550-21-1-0223]	National Science Foundation(National Science Foundation (NSF)); NSF Neuronex; Air Force Office of Scientific Research (ASOFR)(United States Department of DefenseAir Force Office of Scientific Research (AFOSR))	This work was supported by National Science Foundation grants NSF DMS 1654268, NSF Neuronex DBI 1707400, and the Air Force Office of Scientific Research (ASOFR) award number FA9550-21-1-0223. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljadeff J, 2019, ARXIV PREPRINT ARXIV; Andrew Zisserman, 2015, Arxiv, DOI arXiv:1409.1556; Attinger A, 2017, CELL, V169, P1291, DOI 10.1016/j.cell.2017.05.023; Bastos AM, 2012, NEURON, V76, P695, DOI 10.1016/j.neuron.2012.10.038; Bogacz R, 2017, J MATH PSYCHOL, V76, P198, DOI 10.1016/j.jmp.2015.11.003; Buckley CL, 2017, J MATH PSYCHOL, V81, P55, DOI 10.1016/j.jmp.2017.09.004; Clark A., 2015, SURFING UNCERTAINTY; Clark DG, 2021, ARXIV PREPRINT ARXIV; Friston KJ, 2010, NAT REV NEUROSCI, V11, P127, DOI 10.1038/nrn2787; Gillon C.J., 2021, BIORXIV; Goodfellow I, 2016, ADAPT COMPUT MACH LE, P1; Hertag L, 2020, ELIFE, V9, DOI 10.7554/eLife.57541; Homann J., 2017, PREDICTIVE CODING NO, DOI 10.1101/197608; Huang YP, 2011, WIRES COGN SCI, V2, P580, DOI 10.1002/wcs.142; Izhikevich EM, 2007, CEREB CORTEX, V17, P2443, DOI 10.1093/cercor/bhl152; Keller GB, 2018, NEURON, V100, P424, DOI 10.1016/j.neuron.2018.10.003; Keller GB, 2012, NEURON, V74, P809, DOI 10.1016/j.neuron.2012.03.040; Krizhevsky A., 2009, LEARNING MULTIPLE LA; Kunin D, 2020, PR MACH LEARN RES, V119; Lillicrap TP, 2020, NAT REV NEUROSCI, V21, P335, DOI 10.1038/s41583-020-0277-3; Lillicrap TP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13276; Majaj N.J., 2018, BIORXIV, DOI 10.1101/407007; Millidge B, ARXIV PREPRINT ARXIV; Millidge B., 2021, ARXIV PREPRINT ARXIV; Paszke A, 2019, ADV NEUR IN, V32; Payeur A, 2021, NAT NEUROSCI, V24, P1010, DOI 10.1038/s41593-021-00857-x; Rao RPN, 1999, NAT NEUROSCI, V2, P79, DOI 10.1038/4580; Russakovsky O, 2015, INT J COMPUT VISION, V115, P211, DOI 10.1007/s11263-015-0816-y; Salvatori T, 2021, ARXIV PREPRINT ARXIV; Scellier B, 2017, FRONT COMPUT NEUROSC, V11, DOI 10.3389/fncom.2017.00024; Schrimpf M, 2020, NEURON, V108, P413, DOI 10.1016/j.neuron.2020.07.040; Song Yuhang, 2020, Adv Neural Inf Process Syst, V33, P22566; Spratling MW, 2017, BRAIN COGNITION, V112, P92, DOI 10.1016/j.bandc.2015.11.003; Urbanczik R, 2014, NEURON, V81, P521, DOI 10.1016/j.neuron.2013.11.030; Whittington JCR, 2019, TRENDS COGN SCI, V23, P235, DOI 10.1016/j.tics.2018.12.005; Whittington JCR, 2017, NEURAL COMPUT, V29, P1229, DOI 10.1162/NECO_a_00949; Zmarz P, 2016, NEURON, V92, P766, DOI 10.1016/j.neuron.2016.09.057	38	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266102	10.1371/journal.pone.0266102	http://dx.doi.org/10.1371/journal.pone.0266102			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358258	gold, Green Submitted, Green Published			2022-12-26	WOS:000799828800068
J	Mezo, M; Gonzalez-Warleta, M; Castro-Hermida, JA; Martinez-Sernandez, V; Ubeira, FM				Mezo, Mercedes; Gonzalez-Warleta, Marta; Antonio Castro-Hermida, Jose; Martinez-Sernandez, Victoria; Ubeira, Florencio M.			Field evaluation of the enhanced MM3-COPRO ELISA test for the diagnosis of Fasciola hepatica infection in sheep	PLOS ONE			English	Article							LINKED-IMMUNOSORBENT-ASSAY; FECAL EGG COUNT; COPROANTIGEN ELISA; REFERENCE INTERVALS; ANTHELMINTIC RESISTANCE; CONFIDENCE-INTERVALS; IGG ANTIBODIES; REDUCTION TEST; DAIRY-CATTLE; TRICLABENDAZOLE	Fasciolosis is a severe zoonosis responsible for major economic losses in livestock. The enhanced MM3-COPRO test (eMM3-COPRO) and the commercial version BIO K 201 (BioX Diagnostics, Rochefort, Belgium) are widely used as immunodiagnostic tools for the specific detection of coproantigens released by Fasciola during the late prepatent and patent stages of infection. However, performance of the eMM3-COPRO has never been evaluated under field conditions. To address this gap, a large number of ovine faecal samples, collected in a region where fasciolosis is endemic (Galicia, NW Spain), were analyzed. Two groups of sheep flocks were selected according to the Fasciola infection status: 'Fasciolafree' and `Fasciola-infected' flocks. `Fasciola-free' flocks were seronegative flocks with no history of fasciolosis detected by either coproscopy or necropsy in the last 5 years. Faecal samples from these sheep were used to calculate a cut-off value for infection (OD = 0.021). The cut-off was calculated using a bootstrap resampling method that enables estimation of the sampling distribution of the statistical parameters without making assumptions about the underlying data distribution. 'Fasciola-infected' flocks were characterized by high seroprevalence, a history of fasciolosis and periodical treatment with flukicides. Samples from these flocks were used to estimate the diagnostic accuracy of the eMM3-COPRO relative to coproscopy, which although limited by poor sensitivity is the only reference test available for diagnosing fasciolosis in vivo. To overcome this limitation, all animals classified positive by eMM3-COPRO were treated with triclabendazole and then retested. The eMM3-COPRO displayed higher sensitivity than coproscopy, as it detected coproantigens in all samples with positive coproscopy and in 12% of samples with negative coproscopy. The test also proved highly specific as coproantigens disappeared after the treatment. The eMM3-COPRO was less time consuming than coproscopy, particularly when the procedure involved numerous samples, and showed promise as a tool for monitoring flukicide efficacy.	[Mezo, Mercedes; Gonzalez-Warleta, Marta; Antonio Castro-Hermida, Jose] Ctr Invest Agr Mabegondo, Lab Parasitol, AGACAL, Abegondo, A Coruna, Spain; [Martinez-Sernandez, Victoria; Ubeira, Florencio M.] Univ Santiago de Compostela, Fac Farm, Lab Parasitol, Santiago De Compostela, Spain	Universidade de Santiago de Compostela	Mezo, M (corresponding author), Ctr Invest Agr Mabegondo, Lab Parasitol, AGACAL, Abegondo, A Coruna, Spain.	mercedes.mezo.menendez@xunta.es	Antonio, Castro Hermida José/R-9075-2019; Mezo, Mercedes/R-4703-2019; González-Warleta, Marta/R-5124-2019	Antonio, Castro Hermida José/0000-0001-8008-1055; Mezo, Mercedes/0000-0001-8819-453X; González-Warleta, Marta/0000-0003-3315-5757	Ministerio de Ciencia e Innovacion of Spain; European Regional Development Fund (INIA) [RTA2017-00010-C02-01/02]; Xunta de Galicia [AC2021C-04]	Ministerio de Ciencia e Innovacion of Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Regional Development Fund (INIA); Xunta de Galicia(Xunta de GaliciaEuropean Commission)	This work was funded by the Ministerio de Ciencia e Innovacio ' n of Spain and the European Regional Development Fund (INIA project RTA2017-00010-C02-01/02) and by the Xunta de Galicia (project AC2021C-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Rahman SM, 1998, AM J VET RES, V59, P533; AbdelKhalek A, 2020, J ANTIBIOT, V73, P392, DOI 10.1038/s41429-020-0288-3; Valero MA, 2012, TROP MED INT HEALTH, V17, P630, DOI 10.1111/j.1365-3156.2012.02964.x; Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Andreasson U, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00179; Apple FS, 2005, CLIN CHEM, V51, P2198, DOI 10.1373/clinchem.2005.052886; Arifin MI, 2016, VET PARASITOL, V232, P8, DOI 10.1016/j.vetpar.2016.11.003; Becker AC, 2016, PARASITOL RES, V115, P2581, DOI 10.1007/s00436-016-5003-8; Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012; Brockwell YM, 2014, INT J PARASITOL-DRUG, V4, P48, DOI 10.1016/j.ijpddr.2013.11.005; Calvani NED, 2018, VET PARASITOL, V251, P85, DOI 10.1016/j.vetpar.2018.01.004; Calvani NED, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005931; CAMPBELL MJ, 1988, BRIT MED J, V296, P1454, DOI 10.1136/bmj.296.6634.1454; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Castro-Hermida JA, 2021, TRENDS PARASITOL, V37, P430, DOI 10.1016/j.pt.2020.12.003; Chakravarthy SN, 2019, INDIAN J CLIN BIOCHE, V34, P89, DOI 10.1007/s12291-017-0712-z; Charlier J, 2008, VET PARASITOL, V153, P44, DOI 10.1016/j.vetpar.2008.01.035; CLSI, 2014, EP15A3 CLSI; CLSI guideline EP28, 2010, DEFINING ESTABLISHIN, V3rd Ed; COLES GC, 1992, VET PARASITOL, V44, P35, DOI 10.1016/0304-4017(92)90141-U; Conceicao MAP, 2002, VET PARASITOL, V105, P337, DOI 10.1016/S0304-4017(02)00016-X; DAFWA, 2013, DET TREM EGGS EIM LE, V26, pp1; Demerdash ZA, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-176; Elliott TP, 2015, VET PARASITOL, V209, P117, DOI 10.1016/j.vetpar.2015.02.014; ESPINO AM, 1994, J CLIN MICROBIOL, V32, P190, DOI 10.1128/JCM.32.1.190-193.1994; Estuningsih E, 2009, J PARASITOL, V95, P450, DOI 10.1645/GE-1672.1; Fairweather I, 2020, INT J PARASITOL-DRUG, V12, P39, DOI 10.1016/j.ijpddr.2019.11.003; Flanagan A, 2011, VET PARASITOL, V176, P170, DOI 10.1016/j.vetpar.2010.10.057; Flanagan AM, 2011, VET PARASITOL, V176, P34, DOI 10.1016/j.vetpar.2010.10.037; FRASER CG, 1991, ANN CLIN BIOCHEM, V28, P207, DOI 10.1177/000456329102800301; French AS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162420; Friedrichs KR, 2012, VET CLIN PATH, V41, P441, DOI 10.1111/vcp.12006; George SD, 2017, VET PARASITOL, V246, P60, DOI 10.1016/j.vetpar.2017.08.028; Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014; Gordon DK, 2012, VET PARASITOL, V187, P436, DOI 10.1016/j.vetpar.2012.02.009; Guidi GC, 2010, BIOCHEM MEDICA, V20, P165; Hanna REB, 2015, VET PARASITOL, V207, P34, DOI 10.1016/j.vetpar.2014.11.016; HAPPICH FA, 1969, AUST VET J, V45, P326, DOI 10.1111/j.1751-0813.1969.tb05009.x; Hayward AD, 2021, INT J PARASITOL, V51, P913, DOI 10.1016/j.ijpara.2021.02.006; Higgins V, 2019, CLIN BIOCHEM, V71, P14, DOI 10.1016/j.clinbiochem.2019.06.006; Horn PS, 2003, CLIN CHIM ACTA, V334, P5, DOI 10.1016/S0009-8981(03)00133-5; Kajugu PE, 2015, VET PARASITOL, V212, P181, DOI 10.1016/j.vetpar.2015.07.018; Kajugu PE, 2012, VET REC, V171, DOI 10.1136/vr.101041; Kamaludeen J, 2019, VET REC, V184, DOI 10.1136/vr.105209; Kelley JM, 2021, VET PARASITOL, V298, DOI 10.1016/j.vetpar.2021.109504; Kelley JM, 2020, VET PARASITOL, V277, DOI 10.1016/j.vetpar.2019.109019; Levecke B, 2012, VET PARASITOL, V188, P194, DOI 10.1016/j.vetpar.2012.03.017; Levecke B, 2011, PARASITOL RES, V109, P953, DOI 10.1007/s00436-011-2338-z; Lopez-Diaz MC, 1998, THERIOGENOLOGY, V50, P587, DOI 10.1016/S0093-691X(98)00163-0; Martinez-Perez JM, 2012, VET PARASITOL, V190, P80, DOI 10.1016/j.vetpar.2012.06.002; Martinez-Sernandez V, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004872; Martinez-Sernandez V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001376; May K, 2020, VET PARASITOL, V277, DOI 10.1016/j.vetpar.2019.109016; Mazeri S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07396-1; Mazeri S, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161621; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001; Mezo M, 2008, VET PARASITOL, V157, P235, DOI 10.1016/j.vetpar.2008.07.032; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Mezo M, 2011, VET PARASITOL, V180, P237, DOI 10.1016/j.vetpar.2011.03.009; Mezo M, 2010, VET PARASITOL, V168, P36, DOI 10.1016/j.vetpar.2009.10.007; Ministry of Agriculture Fisheries and Food (MAFF), 1971, TECHNICAL B, V18; Novobilsky A, 2012, VET PARASITOL, V190, P272, DOI 10.1016/j.vetpar.2012.06.022; OIE, 2018, TERR MAN MEAS UNC, P206; OIE. Terrestrial Manual, 2018, DEV OPT ANT DET ASS, P185; Palmer DG, 2014, AUST VET J, V92, P357, DOI 10.1111/avj.12224; Peeling RW, 2006, NAT REV MICROBIOL, pS2, DOI [10.1038/nrmicro1522, 10.1038/nrmicro1568, 10.1038/nrmico1522]; Pi HF, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9081697; Rapsch C, 2006, INT J PARASITOL, V36, P1153, DOI 10.1016/j.ijpara.2006.06.001; Reigate C, 2021, VET PARASITOL, V294, DOI 10.1016/j.vetpar.2021.109435; Robles-Perez D, 2013, VET PARASITOL, V197, P277, DOI 10.1016/j.vetpar.2013.05.006; Thienpont D, 1979, DIAGNOSTICO HELMINT; Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156	73	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265569	10.1371/journal.pone.0265569	http://dx.doi.org/10.1371/journal.pone.0265569			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324959	gold, Green Published			2022-12-26	WOS:000780951300048
J	Tang, ZF; Yang, T; Lin, X; Li, XX; Cao, R; Li, W				Tang, Zhenfei; Yang, Ting; Lin, Xin; Li, Xinxin; Cao, Rong; Li, Wei			Future changes in the risk of compound hot and dry events over China estimated with two large ensembles	PLOS ONE			English	Article							EXTREME TEMPERATURE; DEGREES-C; PRECIPITATION; REDUCTION; DROUGHT; TRENDS	Under the context of global warming, compound dry and hot events (CDHEs) will increase and bring serious losses to society and the economy. The projection of CDHEs is of great significance for policy-making and risk assessment. In this paper, two large ensemble simulations, CanESM2-LE and CESM-LE, are used to estimate the risk of extreme CDHEs under different warming scenarios in China. First, the biases of the model in the simulation of the temperature and precipitation over the China region are corrected, and the index of CDHEs is established based on a copula function. The results show that extreme CDHEs will occur more often in China with the increase in global warming and the more severe extreme CDHEs are, the greater the risk will be in the future with higher uncertainties. Events that would be attained once every 50 and 100 years in the current climate from CESM-LE (CAanESM2-LE) will be 1.2/1.6 (1.1/1.5) times and 1.3/2.3 (1.5/2.0) times more likely to occur in a 1.5 degrees C/2.0 degrees C warmer climate, respectively. Northwestern China will experience the greatest increase in the risk of extreme CDHEs. Extreme CDHEs expected once every 100 years in the current period over NW China are expected to occur approximately every 5 and 4 years under a 4.0 degrees C warmer world in CanESM2-LE and CESM-LE, respectively.	[Tang, Zhenfei; Li, Wei] Nanjing Univ Informat Sci & Technol, Collaborat Innovat Ctr Forecast & Evaluat Meteoro, Joint Int Res Lab Climate & Environm Change, Nanjing, Peoples R China; [Tang, Zhenfei; Lin, Xin; Li, Xinxin; Cao, Rong] Fujian Prov Meteorol Bur, Fujian Climate Ctr, Fuzhou, Peoples R China; [Tang, Zhenfei] Fujian Prov Meteorol Bur, Fujian Key Lab Severe Weather, Fuzhou, Peoples R China; [Yang, Ting] Fujian Prov Meteorol Bur, Fujian Meteorol Serv Ctr, Fuzhou, Peoples R China	Nanjing University of Information Science & Technology	Yang, T (corresponding author), Fujian Prov Meteorol Bur, Fujian Meteorol Serv Ctr, Fuzhou, Peoples R China.	tingyang2020@126.com		Tang, Zhenfei/0000-0002-5965-6376; Yang, Ting/0000-0002-1736-3997; Li, Xinxin/0000-0002-1027-4959	National Key Research and Development Program of China [2018YFC1505805]	National Key Research and Development Program of China	Z. T is supported by the National Key Research and Development Program of China (grant 2017YFA0603800), (http://en.most.gov.cn/ programmes1/200610/t20061009_36223.htm). T. Y is supported by the National Key Research and Development Program of China (grant 2018YFC1505805), (http://en.most.gov.cn/programmes1/200610/t20061009_36223.htm).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AghaKouchak A, 2014, GEOPHYS RES LETT, V41, P8847, DOI 10.1002/2014GL062308; Bezak N, 2020, WATER-SUI, V12, DOI 10.3390/w12123543; Cannon AJ, 2015, J CLIMATE, V28, P6938, DOI 10.1175/JCLI-D-14-00754.1; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Coumou D, 2012, NAT CLIM CHANGE, V2, P491, DOI 10.1038/NCLIMATE1452; Dai A, 2019, CLIM DYNAM, V52, P289, DOI 10.1007/s00382-018-4132-4; Dai AG, 2013, NAT CLIM CHANGE, V3, P52, DOI [10.1038/nclimate1633, 10.1038/NCLIMATE1633]; David E, 2020, GLOBAL CLIMATE RISK; Donat M, 2013, B AM METEOROL SOC, V94, P997, DOI 10.1175/BAMS-D-12-00109.1; Donat MG, 2018, GEOPHYS RES LETT, V45, P10627, DOI 10.1029/2018GL079128; Feddersen H, 1999, J CLIMATE, V12, P1974, DOI 10.1175/1520-0442(1999)012<1974:ROMSEB>2.0.CO;2; Feng Y, 2021, INT J CLIMATOL, V41, pE1085, DOI 10.1002/joc.6755; Folland C, 2002, J CLIMATE, V15, P2954, DOI 10.1175/1520-0442(2002)015<2954:ECEUER>2.0.CO;2; Giorgi F, 2015, ANNU REV ENV RESOUR, V40, P467, DOI 10.1146/annurev-environ-102014-021217; Hao ZC, 2018, WATER-SUI, V10, DOI 10.3390/w10060718; Hao ZC, 2017, J GEOPHYS RES-ATMOS, V122, P9050, DOI 10.1002/2017JD027030; Intergov Panel Clim Chg, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P1, DOI 10.1017/CBO9781139177245; Kay JE, 2015, B AM METEOROL SOC, V96, P1333, DOI 10.1175/BAMS-D-13-00255.1; Kong QQ, 2020, WEATHER CLIM EXTREME, V28, DOI 10.1016/j.wace.2019.100242; Leonard M, 2014, WIRES CLIM CHANGE, V5, P113, DOI 10.1002/wcc.252; Li W, 2021, J CLIMATE, V34, P6023, DOI 10.1175/JCLI-D-20-0656.1; Li W, 2021, INT J CLIMATOL, V41, pE1980, DOI 10.1002/joc.6826; Ma SM, 2015, INT J CLIMATOL, V35, P4631, DOI 10.1002/joc.4312; Otto FEL, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2011GL050422; Qian W, 2005, METEOROL ATMOS PHYS, V90, P193, DOI 10.1007/s00703-004-0101-z; van der Wiel K, 2019, GEOPHYS RES LETT, V46, P2093, DOI 10.1029/2019GL081967; Wu XY, 2020, J HYDROL, V583, DOI 10.1016/j.jhydrol.2020.124580; Yu B, 2020, CLIM DYNAM, V55, P869, DOI 10.1007/s00382-020-05296-1; Yu HP, 2022, INT J CLIMATOL, V42, P889, DOI 10.1002/joc.7279; Yu R, 2020, WEATHER CLIM EXTREME, V30, DOI 10.1016/j.wace.2020.100295; Zhang M, 2020, CLIMATIC CHANGE, V162, P603, DOI 10.1007/s10584-020-02725-2; Zhang M, 2019, INT J CLIMATOL, V39, P3348, DOI 10.1002/joc.6025; Zscheischler J, 2018, NAT CLIM CHANGE, V8, P469, DOI 10.1038/s41558-018-0156-3	33	0	0	15	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264980	10.1371/journal.pone.0264980	http://dx.doi.org/10.1371/journal.pone.0264980			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324940	Green Published, gold			2022-12-26	WOS:000780951300027
J	Yamada, Y; Minatoguchi, S; Baba, S; Shibata, S; Takashima, S; Wakao, S; Okura, H; Dezawa, M; Minatoguchi, S				Yamada, Yoshihisa; Minatoguchi, Shingo; Baba, Shinya; Shibata, Sanae; Takashima, Satoshi; Wakao, Shohei; Okura, Hiroyuki; Dezawa, Mari; Minatoguchi, Shinya			Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; REPAIR; HEART	Background We recently reported that multilineage-differentiating stress enduring (Muse) cells intravenously administered after acute myocardial infarction (AMI), selectively engrafted to the infarct area, spontaneously differentiated into cardiomyocytes and vessels, reduced the infarct size, improved the left ventricular (LV) function and remodeling in rabbits. We aimed to clarify the efficiency of Muse cells in a larger animal AMI model of mini-pigs using a semiclinical grade human Muse cell product. Method and result Mini-pigs underwent 30 min of coronary artery occlusion followed by 2 weeks of reperfusion. Semi-clinical grade human Muse cell product (1x10(7), Muse group, n = 5) or saline (Vehicle group, n = 7) were intravenously administered at 24 h after reperfusion. The infarct size, LV function and remodeling were evaluated by echocardiography. Arrhythmias were evaluated by an implantable loop recorder. The infarct size was significantly smaller in the Muse group (10.5 +/- 3.3%) than in the Vehicle group (21.0 +/- 2.0%). Both the LV ejection fraction and fractional shortening were significantly greater in the Muse group than in the Vehicle group. The LV end-systolic and end-diastolic dimensions were significantly smaller in the Muse group than in the Vehicle group. Human Muse cells homed into the infarct border area and expressed cardiac troponin I and vascular endothelial CD31. No arrhythmias and no blood test abnormality were observed. Conclusion Muse cell product might be promising for AMI therapy based on the efficiency and safety in a mini-pig AMI.	[Yamada, Yoshihisa; Minatoguchi, Shingo; Okura, Hiroyuki] Gifu Univ, Dept Cardiol, Grad Sch Med, Gifu, Japan; [Baba, Shinya; Minatoguchi, Shinya] Gifu Municipal Hosp, Gifu, Japan; [Shibata, Sanae; Takashima, Satoshi] Gifu Univ, Anim Teaching Hosp Anesthesiol, Fac Appl Biol Sci, Gifu, Japan; [Wakao, Shohei; Dezawa, Mari] Tohoku Univ, Dept Stem Cell Biol & Histol, Grad Sch Med, Sendai, Miyagi, Japan; [Minatoguchi, Shinya] Gifu Univ, Dept Circulatory & Resp Adv Med, Grad Sch Med, Gifu, Japan	Gifu University; Gifu Municipal Hospital; Gifu University; Tohoku University; Gifu University	Minatoguchi, S (corresponding author), Gifu Municipal Hosp, Gifu, Japan.; Minatoguchi, S (corresponding author), Gifu Univ, Dept Circulatory & Resp Adv Med, Grad Sch Med, Gifu, Japan.	minatos@gifu-u.ac.jp			Japan Agency for Medical Research and Development; JSPS KAKENHI, Japan [JP20K08400]	Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED)); JSPS KAKENHI, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a grant-in-aid from the Japan Agency for Medical Research and Development, and JSPS KAKENHI Grant Number JP20K08400, Japan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This was newly included in the main text.	Almeida Shone O, 2015, Card Electrophysiol Clin, V7, P357, DOI 10.1016/j.ccep.2015.03.012; Fisher SA, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006536.pub4; George JC, 2010, TRANSL RES, V155, P10, DOI 10.1016/j.trsl.2009.06.009; Heneidi S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064752; Kuroda Y, 2013, NAT PROTOC, V8, P1391, DOI 10.1038/nprot.2013.076; Kuroda Y, 2010, P NATL ACAD SCI USA, V107, P8639, DOI 10.1073/pnas.0911647107; Kushida Y, 2018, ADV EXP MED BIOL, V1103, P43, DOI 10.1007/978-4-431-56847-6_3; Menasche P, 2008, CIRCULATION, V117, P1189, DOI 10.1161/CIRCULATIONAHA.107.734103; Misao Y, 2006, CARDIOVASC RES, V69, P476, DOI 10.1016/j.cardiores.2005.11.001; Nagaya N, 2004, AM J PHYSIOL-HEART C, V287, pH2670, DOI 10.1152/ajpheart.01071.2003; Noda T, 2020, CIRC J, V84, P1189, DOI 10.1253/circj.CJ-20-0307; Ogura F, 2014, STEM CELLS DEV, V23, P717, DOI 10.1089/scd.2013.0473; Shake JG, 2002, ANN THORAC SURG, V73, P1919, DOI 10.1016/S0003-4975(02)03517-8; Tanaka T, 2018, CIRC J, V82, P561, DOI 10.1253/circj.CJ-17-0552; Wakao S, 2011, P NATL ACAD SCI USA, V108, P9875, DOI 10.1073/pnas.1100816108; Yamada Y, 2018, CIRC RES, V122, P1069, DOI 10.1161/CIRCRESAHA.117.311648; Yamada Y, 2013, AM J PHYSIOL-HEART C, V304, pH1124, DOI 10.1152/ajpheart.00707.2012; Yokoyama S, 2006, J MOL CELL CARDIOL, V40, P24, DOI 10.1016/j.yjmcc.2005.06.008	18	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265347	10.1371/journal.pone.0265347	http://dx.doi.org/10.1371/journal.pone.0265347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324926	gold, Green Published			2022-12-26	WOS:000780951300036
J	Liu, Z; Li, JH; Ding, Y; Ma, M; Chen, J; Lei, W; Li, L; Yao, YY; Yu, X; Zhong, M; Liao, Q; Fang, WD; Fan, LW; Huang, CY; Zhong, HG; Wen, Q; Fang, Z; Chen, JY; Huang, SS; Xiong, JP; Xiang, XJ; Deng, J				Liu, Zhen; Li, Junhe; Ding, Yun; Ma, Mei; Chen, Jun; Lei, Wan; Li, Li; Yao, Yangyang; Yu, Xin; Zhong, Min; Liao, Quan; Fang, Weidan; Fan, Linwei; Huang, Chunye; Zhong, Hongguang; Wen, Qin; Fang, Zi; Chen, Jingyi; Huang, Shanshan; Xiong, Jianpin; Xiang, Xiaojun; Deng, Jun			USP49 mediates tumor progression and poor prognosis through a YAP1-dependent feedback loop in gastric cancer	ONCOGENE			English	Article							HIPPO PATHWAY; GROWTH; CHEMORESISTANCE; PROLIFERATION; MECHANISMS; LATS	The importance of the Hippo-Yes-associated protein 1 (YAP1) pathway in gastric carcinogenesis and metastasis has attracted considerable research attention; however, the regulatory network of YAP1 in gastric cancer (GC) is not completely understood. In this study, ubiquitin-specific peptidase 49 (USP49) was identified as a novel deubiquitinase of YAP1, knockdown of USP49 inhibited the proliferation, metastasis, chemoresistance, and peritoneal metastasis of GC cells. Overexpression of USP49 showed opposing biological effects. Moreover, USP49 was transcriptionally activated by the YAP1/TEAD4 complex, which formed a positive feedback loop with YAP1 to promote the malignant progression of GC cells. Finally, we collected tissue samples and clinical follow-up information from 482 GC patients. The results showed that USP49 expression was high in GC cells and positively correlated with the expression of YAP1 and its target genes, connective tissue growth factor (CTGF) and cysteine-rich angiogenic inducer 61 (CYR61). Survival and Cox regression analysis showed that high USP49 expression was associated with poor prognosis and was an independent prognostic factor. Moreover, patients with high USP49 and YAP1 expression had extremely short overall survival. The findings of this study reveal that the aberrant activation of the USP49/YAP1 positive feedback loop plays a critical role in the malignant progression of GC, thus providing potential novel prognostic factors and therapeutic targets for GC.	[Liu, Zhen; Li, Junhe; Ding, Yun; Ma, Mei; Chen, Jun; Lei, Wan; Li, Li; Yao, Yangyang; Yu, Xin; Zhong, Min; Liao, Quan; Fang, Weidan; Fan, Linwei; Huang, Chunye; Zhong, Hongguang; Wen, Qin; Fang, Zi; Chen, Jingyi; Huang, Shanshan; Xiong, Jianpin; Xiang, Xiaojun; Deng, Jun] Nanchang Univ, Dept Oncol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China; [Liu, Zhen; Ding, Yun; Ma, Mei; Yu, Xin; Zhong, Min; Liao, Quan; Fang, Weidan; Fan, Linwei; Fang, Zi] Jiangxi Key Lab Individual Canc Therapy, 17 Yongwai St, Nanchang 330006, Jiangxi, Peoples R China	Nanchang University	Huang, SS; Xiong, JP (corresponding author), Nanchang Univ, Dept Oncol, Affiliated Hosp 1, Nanchang 330006, Jiangxi, Peoples R China.	923834857@qq.com; Jpxiong0630@outlook.com; xjxiang_nc@ncu.edu.cn; dengjun19871106@ncu.edu.cn			JiangXi Province General Projects [20202BBGL73036]; National Natural Science Foundation of China [81760432, 8216100370]; Key Laboratory Fund of Jiangxi Province [20202BCD42011]; Jiangxi Provincial Outstanding Young Talents projects [2019BCB23020]; Science and Technology Department of Jiangxi Province [20202BBGL73055, 20202BAB216028]; Jiangxi Provincial Young Talents projects [20204BCJ23016]; Jiangxi Provincial Outstanding Youth projects [2018ACB21037]; CSCO-Bayer Cancer Research Fund [Y-bayer202001/zb-0007]; Department of Health of Jiangxi Province Projects [2019A058]	JiangXi Province General Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory Fund of Jiangxi Province; Jiangxi Provincial Outstanding Young Talents projects; Science and Technology Department of Jiangxi Province; Jiangxi Provincial Young Talents projects; Jiangxi Provincial Outstanding Youth projects; CSCO-Bayer Cancer Research Fund; Department of Health of Jiangxi Province Projects	This work was supported by JiangXi Province General Projects (grant 20202BBGL73036), the National Natural Science Foundation of China (grant 81760432), Key Laboratory Fund of Jiangxi Province (grant number: 20202BCD42011), Jiangxi Provincial Outstanding Young Talents projects (grant 2019BCB23020), the Science and Technology Department of Jiangxi Province (grant 20202BBGL73055), Jiangxi Provincial Young Talents projects (grant 20204BCJ23016), the National Natural Science Foundation of China (grant 8216100370), Jiangxi Provincial Outstanding Youth projects (grant 2018ACB21037), the CSCO-Bayer Cancer Research Fund (grant Y-bayer202001/zb-0007), the Science and Technology Department of Jiangxi Province (grant 20202BAB216028), and the Department of Health of Jiangxi Province Projects (grant 2019A058).	Ajani JA, 2021, GUT, V70, P55, DOI 10.1136/gutjnl-2019-319748; An LW, 2020, J EXP MED, V217, DOI 10.1084/jem.20191817; D'Arcy P, 2014, CLIN CANCER RES, V20, P3908, DOI 10.1158/1078-0432.CCR-14-0568; Deng J, 2016, ONCOTARGET, V7, P10037, DOI 10.18632/oncotarget.7048; Fang ZL, 2018, ELIFE, V7, DOI 10.7554/eLife.31275; Harrigan JA, 2018, NAT REV DRUG DISCOV, V17, P57, DOI 10.1038/nrd.2017.152; Harvey KF, 2013, NAT REV CANCER, V13, P246, DOI 10.1038/nrc3458; Huang SS, 2020, J CELL MOL MED, V24, P11133, DOI 10.1111/jcmm.15613; Jiao S, 2018, J EXP MED, V215, P699, DOI 10.1084/jem.20171116; Kategaya L, 2017, NATURE, V550, P534, DOI 10.1038/nature24006; Li L, 2018, GENE, V641, P240, DOI 10.1016/j.gene.2017.09.071; Liu Z, 2018, BIOCHEM BIOPH RES CO, V505, P843, DOI 10.1016/j.bbrc.2018.09.191; Liu Z, 2018, BIOCHEM BIOPH RES CO, V503, P2370, DOI 10.1016/j.bbrc.2018.06.163; Luo KT, 2017, EMBO J, V36, P1434, DOI 10.15252/embj.201695669; Ma XJ, 2017, P NATL ACAD SCI USA, V114, P1934, DOI 10.1073/pnas.1621359114; Marti P, 2015, HEPATOLOGY, V62, P1497, DOI 10.1002/hep.27992; Meng ZP, 2016, GENE DEV, V30, P1, DOI 10.1101/gad.274027.115; Mevissen TET, 2017, ANNU REV BIOCHEM, V86, P159, DOI 10.1146/annurev-biochem-061516-044916; Moroishi T, 2016, CELL, V167, P1525, DOI 10.1016/j.cell.2016.11.005; Pan BQ, 2020, PROTEIN CELL, V11, P138, DOI 10.1007/s13238-019-00674-w; Pan T, 2019, ELIFE, V8, DOI 10.7554/eLife.48318; Qian WL, 2020, ONCOGENE, V39, P6802, DOI 10.1038/s41388-020-01471-0; Shah MA, 2015, J CLIN ONCOL, V33, P1760, DOI 10.1200/JCO.2014.60.1799; Smyth EC, 2020, LANCET, V396, P635, DOI 10.1016/S0140-6736(20)31288-5; Sun TS, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01262-x; Sung HH, 2022, CLIN EXP HYPERTENS, V44, P146, DOI 10.1080/10641963.2021.2007943; Tang Y, 2020, CANCER CELL, V38, P115, DOI 10.1016/j.ccell.2020.05.019; Togasaki K, 2021, GASTROENTEROLOGY, V160, P823, DOI 10.1053/j.gastro.2020.10.047; Toloczko A, 2017, CANCER RES, V77, P4921, DOI 10.1158/0008-5472.CAN-16-3413; Tu RF, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0475-3; Yang LB, 2020, MOL CELL BIOCHEM, V474, P263, DOI 10.1007/s11010-020-03850-3; Yao F, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04620-y; Zanconato F, 2016, CANCER CELL, V29, P783, DOI 10.1016/j.ccell.2016.05.005; Zhang ZK, 2019, MOL CELL, V73, P7, DOI 10.1016/j.molcel.2018.10.030; Zhang Z, 2013, GENE DEV, V27, P1581, DOI 10.1101/gad.211037.112; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhou ZA, 2020, CANCER RES, V80, P2550, DOI 10.1158/0008-5472.CAN-19-3718; Zhu H, 2020, CANCER RES, V80, P2204, DOI 10.1158/0008-5472.CAN-19-2388; Zhu LL, 2020, GENE, V742, DOI 10.1016/j.gene.2020.144556; Zhu WJ, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.698751; Zhuang YY, 2021, CELL DEATH DISCOV, V7, DOI 10.1038/s41420-021-00494-0	42	1	1	7	16	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2555	2570		10.1038/s41388-022-02267-0	http://dx.doi.org/10.1038/s41388-022-02267-0		MAR 2022	16	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35318441				2022-12-26	WOS:000771890400001
J	Stoy, PC; Khan, AM; Wipf, A; Silverman, N; Powell, SL				Stoy, Paul C.; Khan, Anam M.; Wipf, Aaron; Silverman, Nick; Powell, Scott L.			The spatial variability of NDVI within a wheat field: Information content and implications for yield and grain protein monitoring	PLOS ONE			English	Article							IN-SEASON PREDICTION; WINTER-WHEAT; NITROGEN STATUS; REFLECTANCE MEASUREMENTS; SPRING WHEAT; IMAGERY; LAWS	Wheat is a staple crop that is critical for feeding a hungry and growing planet, but its nutritive value has declined as global temperatures have warmed. The price offered to producers depends not only on yield but also grain protein content (GPC), which are often negatively related at the field scale but can positively covary depending in part on management strategies, emphasizing the need to understand their variability within individual fields. We measured yield and GPC in a winter wheat field in Sun River, Montana, USA, and tested the ability of normalized difference vegetation index (NDVI) measurements from an unoccupied aerial vehicle (UAV) on spatial scales of similar to 10 cm and from Landsat on spatial scales of 30 m to predict them. Landsat observations were poorly related to yield and GPC measurements. A multiple linear model using information from four (three) UAV flyovers was selected as the most parsimonious and predicted 26% (40%) of the variability in wheat yield (GPC). We sought to understand the optimal spatial scale for interpreting UAV observations given that the similar to 10 cm pixels yielded more than 12 million measurements at far finer resolution than the 12 m scale of the harvester. The variance in NDVI observations was "averaged out" at larger pixel sizes but only similar to 20% of the total variance was averaged out at the spatial scale of the harvester on some measurement dates. Spatial averaging to the scale of the harvester also made little difference in the total information content of NDVI fit using Beta distributions as quantified using the Kullback-Leibler divergence. Radially-averaged power spectra of UAV-measured NDVI revealed relatively steep power-law relationships with exponentially less variance at finer spatial scales. Results suggest that larger pixels can reasonably capture the information content of within-field NDVI, but the 30 m Landsat scale is too coarse to describe some of the key features of the field, which are consistent with topography, historic management practices, and edaphic variability. Future research should seek to determine an `optimum' spatial scale for NDVI observations that minimizes effort (and therefore cost) while maintaining the ability of producers to make management decisions that positively impact wheat yield and GPC.	[Stoy, Paul C.] Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53706 USA; [Stoy, Paul C.; Khan, Anam M.] Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA; [Wipf, Aaron; Powell, Scott L.] Montana State Univ, Dept Land Resources & Environm Sci, Bozeman, MT 59717 USA; [Silverman, Nick] Adapt Hydrol LLC, Missoula, MT USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; Montana State University System; Montana State University Bozeman	Stoy, PC (corresponding author), Univ Wisconsin, Dept Biol Syst Engn, Madison, WI 53706 USA.; Stoy, PC (corresponding author), Univ Wisconsin, Nelson Inst Environm Studies, Madison, WI 53706 USA.	pcstoy@wisc.edu		Stoy, Paul/0000-0002-6053-6232	Montana Wheat and Barley Committee; United States National Science Foundation [DEB-1552976]	Montana Wheat and Barley Committee; United States National Science Foundation(National Science Foundation (NSF))	PS: Montana Wheat and Barley Committee. https://agrwbc.mt.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. PS: United States National Science Foundation. DEB-1552976 https://nsf.gov.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aasen H, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00593; Aboelghar M, 2014, ARAB J GEOSCI, V7, P465, DOI 10.1007/s12517-012-0772-6; AHLRICHS JS, 1983, AGRON J, V75, P987, DOI 10.2134/agronj1983.00021962007500060029x; Anderegg J, 2020, FRONT PLANT SCI, V10, DOI 10.3389/fpls.2019.01749; Aparicio N, 2000, AGRON J, V92, P83, DOI 10.2134/agronj2000.92183x; Asaka D, 2006, SOIL SCI PLANT NUTR, V52, P578, DOI [10.1111/j.1747-0765.2006.079_10.x, DOI 10.1111/J.1747-0765.2006.079_10.X]; Asseng S, 2019, GLOBAL CHANGE BIOL, V25, P155, DOI 10.1111/gcb.14481; Astaoui G, 2021, AGRIENGINEERING, V3, P29, DOI 10.3390/agriengineering3010003; BALE MD, 1977, AM J AGR ECON, V59, P530, DOI 10.2307/1239655; Barton K, 2020, MUMIN MULTIMODEL INF; Begue A, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10010099; Bogard M, 2010, J EXP BOT, V61, P4303, DOI 10.1093/jxb/erq238; Bongiovanni RG, 2007, COMPUT ELECTRON AGR, V58, P13, DOI 10.1016/j.compag.2007.01.018; Changwei Tan, 2011, Proceedings of the 2011 International Conference on Remote Sensing, Environment and Transportation Engineering (RSETE 2011), P5165, DOI 10.1109/RSETE.2011.5965478; Damgaard CF, 2019, J ECOL, V107, P2747, DOI 10.1111/1365-2745.13200; Dechant B, 2022, REMOTE SENS ENVIRON, V268, DOI 10.1016/j.rse.2021.112763; Feng MC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0080989; Fernandez E, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0211889; Franke J, 2007, PRECIS AGRIC, V8, P161, DOI 10.1007/s11119-007-9036-y; Fu ZP, 2022, EUR J AGRON, V132, DOI 10.1016/j.eja.2021.126405; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Gozdowski D, 2020, REMOTE SENS APPL, V20, DOI 10.1016/j.rsase.2020.100409; Haley SD, 2012, J PLANT REGIST, V6, P306, DOI 10.3198/jpr2011.12.0673crc; Hansen PM, 2002, J AGR SCI-CAMBRIDGE, V139, P307, DOI 10.1017/S0021859602002320; Hassan MA, 2019, PLANT SCI, V282, P95, DOI 10.1016/j.plantsci.2018.10.022; Hassan MA, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060809; Jia LL, 2012, IFIP ADV INF COMM TE, V369, P174; Jia M, 2021, EUR J AGRON, V122, DOI 10.1016/j.eja.2020.126192; Kasampalis DA, 2018, J IMAGING, V4, DOI 10.3390/jimaging4040052; Khan A.M., 2021, BIOGEOSCIENCES, V18, P4117, DOI [10.5194/bg-18- 4117-2021, DOI 10.5194/BG-18-4117-2021]; Khan MR, 2010, INT J APPL EARTH OBS, V12, P36, DOI 10.1016/j.jag.2009.09.010; Lai YR, 2018, INT J APPL EARTH OBS, V72, P99, DOI 10.1016/j.jag.2018.07.013; Li ZH, 2020, FIELD CROP RES, V248, DOI 10.1016/j.fcr.2019.107711; Liu LY, 2006, INT J REMOTE SENS, V27, P737, DOI 10.1080/01431160500296867; Lollato RP, 2019, FIELD CROP RES, V236, P42, DOI 10.1016/j.fcr.2019.03.005; Lopes MS, 2012, J EXP BOT, V63, P3789, DOI 10.1093/jxb/ers071; Luschei EC, 2001, WEED SCI, V49, P536, DOI 10.1614/0043-1745(2001)049[0536:IACOFW]2.0.CO;2; Macnack N, 2014, COMMUN SOIL SCI PLAN, V45, P2480, DOI 10.1080/00103624.2014.904337; Magney TS, 2016, AGR FOREST METEOROL, V217, P46, DOI 10.1016/j.agrformet.2015.11.009; Marquet PA, 2005, J EXP BIOL, V208, P1749, DOI 10.1242/jeb.01588; Marti J, 2007, ANN APPL BIOL, V150, P253, DOI 10.1111/j.1744-7348.2007.00126.x; Merrick T., 2021, BIOGEOSCIENCES, P1, DOI [10.5194/bg-2021-95, DOI 10.5194/BG-2021-95]; MILLER MP, 1988, SOIL SCI SOC AM J, V52, P1133, DOI 10.2136/sssaj1988.03615995005200040045x; Pantazi XE, 2016, COMPUT ELECTRON AGR, V121, P57, DOI 10.1016/j.compag.2015.11.018; Poveda G, 2004, REMOTE SENS ENVIRON, V93, P391, DOI 10.1016/j.rse.2004.08.001; R Core Team, 2020, R LANG ENV STAT COMP; Raun WR, 2001, AGRON J, V93, P131, DOI 10.2134/agronj2001.931131x; Rodrigues FA, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10060930; Serrano L, 2000, CROP SCI, V40, P723, DOI 10.2135/cropsci2000.403723x; Shou L, 2007, J PLANT NUTR, V30, P1669, DOI 10.1080/01904160701615533; SIMMONDS NW, 1995, J SCI FOOD AGR, V67, P309, DOI 10.1002/jsfa.2740670306; Song X, 2016, PRECIS AGRIC, V17, P721, DOI 10.1007/s11119-016-9445-x; Song XY, 2017, REMOTE SENS-BASEL, V9, DOI 10.3390/rs9030237; Stoy PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128935; Stoy PC, 2009, LANDSCAPE ECOL, V24, P971, DOI 10.1007/s10980-009-9367-3; Szentpetery Z, 2005, CEREAL RES COMMUN, V33, P619, DOI 10.1556/CRC.33.2005.2-3.128; Tan CW, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228500; Tian Q, 2001, INT J REMOTE SENS, V22, P2329, DOI 10.1080/014311601300229845; Uieda L., 2013, P 12 PYTH SCI C, P96, DOI [10.25080/majora-8b375195-010, DOI 10.25080/MAJORA-8B375195-010, 10.25080/Majora-8b375195-010]; Wang LG, 2014, FIELD CROP RES, V164, P178, DOI 10.1016/j.fcr.2014.05.001; Wang ZJ, 2004, FIELD CROP RES, V90, P311, DOI 10.1016/j.fcr.2004.04.004; West GB, 2000, SFI S SCI C, P87; Whelan BM, 2009, CROP PASTURE SCI, V60, P808, DOI 10.1071/CP08343; Wright D.L., 2004, GISCI REMOTE SENS, V41, P287, DOI 10.2747/1548-1603.41.4.287; Xu XB, 2020, REMOTE SENS-BASEL, V12, DOI 10.3390/rs12081349; Xue LH, 2007, PEDOSPHERE, V17, P646, DOI 10.1016/S1002-0160(07)60077-0; Zhang CH, 2012, PRECIS AGRIC, V13, P693, DOI 10.1007/s11119-012-9274-5; Zhao CJ, 2005, INT J APPL EARTH OBS, V7, P1, DOI 10.1016/j.jag.2004.10.002; Zhao HT, 2019, REMOTE SENS-BASEL, V11, DOI 10.3390/rs11141724; Zhou XB, 2021, PLANT PROD SCI, V24, P137, DOI 10.1080/1343943X.2020.1819165	70	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265243	10.1371/journal.pone.0265243	http://dx.doi.org/10.1371/journal.pone.0265243			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316290	Green Published, gold			2022-12-26	WOS:000834238000020
J	Burdette, DL; Lazerwith, S; Yang, J; Chan, HLY; Delaney, WE IV; Fletcher, SP; Cihlar, T; Feierbach, B				Burdette, Dara L.; Lazerwith, Scott; Yang, Jenny; Chan, Henry L. Y.; Delaney, William E.; Fletcher, Simon P.; Cihlar, Tomas; Feierbach, Becket			Ongoing viral replication and production of infectious virus in patients with chronic hepatitis B virus suppressed below the limit of quantitation on long-term nucleos(t)ide therapy	PLOS ONE			English	Article							TENOFOVIR DISOPROXIL FUMARATE; HEPATOCELLULAR-CARCINOMA; HUMANIZED LIVER; RISK; MOUSE; MODEL; MICE; HCC	Nucleos(t)ide analogs are standard-of-care for the treatment of chronic hepatitis B and can effectively reduce hepatitis B virus (HBV) replication but rarely leads to cure. Nucleos(t)ide analogs do not directly eliminate the viral episome, therefore treatment cessation typically leads to rapid viral rebound. While treatment is effective, HBV DNA is still detectable (although not quantifiable) in the periphery of the majority of nucleos(t)ide analog treated HBV patients, even after prolonged treatment. Addressing whether the detectable HBV DNA represents infectious virus is a key unknown and has important implications for the development of a curative treatment for HBV. The minimum HBV genome equivalents required to establish infection in human liver chimeric mice was determined by titration of HBV patient sera and the infectivity in chimeric mice of serum from patients (n = 7) suppressed to the limit of detection on nucleos(t)ide analog therapy was evaluated. A minimum of 5 HBV genome equivalents were required to establish infection in the chimeric mice, confirming this model has sufficient sensitivity to determine whether serum from virally suppressed patients contains infectious virus. Strikingly, serum from 75% (n = 3 out of 4) of nucleos(t)ide-treated HBV patients with DNA that was detectable, but below the lower limit of quantitation, also established infection in the chimeric mice. These results demonstrate that infectious virus is still present in some HBV patients on suppressive nucleos(t)ide therapy. This residual virus may support viral persistence via continuous infection and explain the ongoing risk for HBV-related complications despite long-term suppression on therapy. Thus, additional treatment intensification may facilitate HBV cure.	[Burdette, Dara L.; Delaney, William E.; Fletcher, Simon P.; Cihlar, Tomas] Gilead Sci, Discovery Virol, Foster City, CA USA; [Lazerwith, Scott] Gilead Sci, Med Chem, Foster City, CA USA; [Yang, Jenny] Gilead Sci, Clin Res, Foster City, CA USA; [Chan, Henry L. Y.] Chinese Univ Hong Kong, Hong Kong, Peoples R China; [Feierbach, Becket] Gilead Sci, Clin Virol, Foster City, CA 94404 USA; [Burdette, Dara L.] Tempest Therapeut, San Francisco, CA USA; [Yang, Jenny] Allovir, Cambridge, MA USA; [Delaney, William E.] Assembly Biosci, San Francisco, CA USA	Gilead Sciences; Gilead Sciences; Gilead Sciences; Chinese University of Hong Kong; Gilead Sciences	Feierbach, B (corresponding author), Gilead Sci, Clin Virol, Foster City, CA 94404 USA.	Becket.Feierbach@Gilead.com	Chan, Henry Lik-Yuen/B-9636-2008	Chan, Henry Lik-Yuen/0000-0002-7790-1611; Burdette, Dara/0000-0003-3856-0815	Gilead Sciences, Inc. [GS-US-203-0101]	Gilead Sciences, Inc.(Gilead Sciences)	We thank Stacey Leventhal, Stacey Eng, Joanne Song, and Meghan Holdorf for proofreading the manuscript. We thank PhoenixBio USA Corporation, especially Yoshio Morikawa, Masakazu Kakuni, Chise Tateno-Mukaidani, Yoshinori Miyata, Daniel Radiloff, Matthew Baginski, and Sachi Ikemoto who facilitated and conducted the in vivo experiments.	Allweiss L, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9060156; Allweiss L, 2018, GUT, V67, P542, DOI 10.1136/gutjnl-2016-312162; Asabe S, 2009, J VIROL, V83, P9652, DOI 10.1128/JVI.00867-09; Balagopal A, 2020, JCI INSIGHT, V5, DOI 10.1172/jci.insight.140584; Boyd A, 2016, J HEPATOL, V65, P683, DOI 10.1016/j.jhep.2016.05.014; Buti M, 2015, DIGEST DIS SCI, V60, P1457, DOI 10.1007/s10620-014-3486-7; Buti M, 2015, HEPATOL INT, V9, P243, DOI 10.1007/s12072-015-9614-4; Chakraborty A, 2020, CELL MICROBIOL, V22, DOI 10.1111/cmi.13250; Chan HLY, 2014, GASTROENTEROLOGY, V146, P1240, DOI 10.1053/j.gastro.2014.01.044; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen G, 2006, AM J GASTROENTEROL, V101, P1797, DOI 10.1111/j.1572-0241.2006.00647.x; Cho JY, 2014, GUT, V63, P1943, DOI 10.1136/gutjnl-2013-306409; Dandri M, 2017, BEST PRACT RES CL GA, V31, P273, DOI 10.1016/j.bpg.2017.04.014; Dupinay T, 2013, HEPATOLOGY, V58, P1610, DOI 10.1002/hep.26428; Gish R, 2012, LANCET INFECT DIS, V12, P341, DOI 10.1016/S1473-3099(11)70314-0; Glebe D, 2005, GASTROENTEROLOGY, V129, P234, DOI 10.1053/j.gastro.2005.03.090; Hosaka T, 2013, HEPATOLOGY, V58, P98, DOI 10.1002/hep.26180; Huang Q, 2021, HEPATOLOGY, V73, P41, DOI 10.1002/hep.31240; Ishida Y, 2018, HEPATOLOGY, V68, P473, DOI 10.1002/hep.29891; Kim JH, 2017, HEPATOLOGY, V66, P335, DOI 10.1002/hep.28916; Lai CL, 2013, HEPATOLOGY, V57, P399, DOI 10.1002/hep.25937; Lebosse F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-78001-1; Lutgehetmann M, 2012, HEPATOLOGY, V55, P685, DOI 10.1002/hep.24758; Lythgoe KA, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veaa063; Marcellin P., 2014, 65 ANN M AM ASS STUD; Nelson NP, 2016, CLIN LIVER DIS, V20, P607, DOI 10.1016/j.cld.2016.06.006; Suslov A, 2021, J HEPATOL, V74, P794, DOI 10.1016/j.jhep.2020.11.003; Tateno C, 2004, AM J PATHOL, V165, P901, DOI 10.1016/S0002-9440(10)63352-4; Tateno C, 2015, TOXICOL PATHOL, V43, P233, DOI 10.1177/0192623314544378; Tsuge M, 2005, HEPATOLOGY, V42, P1046, DOI 10.1002/hep.20892; Walter E, 1996, HEPATOLOGY, V24, P1, DOI 10.1002/hep.510240101; Ward JW, 2019, GASTROENTEROLOGY, V156, P297, DOI 10.1053/j.gastro.2018.10.048; World Health Organization (WHO), HEP B INTR; Wu CY, 2014, GASTROENTEROLOGY, V147, P143, DOI 10.1053/j.gastro.2014.03.048; Zoulim F, 2009, GASTROENTEROLOGY, V137, P1593, DOI 10.1053/j.gastro.2009.08.063	35	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0262516	10.1371/journal.pone.0262516	http://dx.doi.org/10.1371/journal.pone.0262516			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363817	Green Published, gold			2022-12-26	WOS:000804748600046
J	Ishtiaq, M; Khanum, H; Hussain, I; Parveen, A; Maqbool, M; Thind, S; Hussain, T; Azeem, M; Shabir, F; Elansary, HO				Ishtiaq, Muhammad; Khanum, Humaira; Hussain, Iqbal; Parveen, Abida; Maqbool, Mehwish; Thind, Sumaira; Hussain, Tanveer; Azeem, Muhammad; Shabir, Farah; Elansary, Hosam O.			Ethnobotanical inventory and medicinal perspectives of herbal flora of Shiwalik mountainous range of District Bhimber, Azad Jammu and Kashmir, Pakistan	PLOS ONE			English	Article							INDIGENOUS KNOWLEDGE; NATIONAL-PARK; PLANTS; BIODIVERSITY; PROVINCE; VALLEY; DIVERSITY; PEOPLE; HILLS; AJK	The present study was carried out to document traditional ethnobotanical knowledge (TEK) of herbal flora of District Bhimber, Azad Jammu and Kashmir (AJK), Pakistan to explore medicinal potential of wild indigenous plants (WIPs) for drug discovery. The research data was conducted during years 2015-2017 using questionnaire proforma employing structured and semi-structured interview models. The informants belonged from indigenous communities comprising of both genders with age ranging from 35-105 years. The interviews were conducted using local translator or guide who knew the dialects of all local languages. The study produced ethnobotanical inventory of 173 herbal species belonging to 45 families and out of these Poaceae was dominant family with 27 species. It was explored that maximum herbal species depicted multi-usage especially food, fodder and fuel. Among 173 herbal plant species, 69% species were used as fodder, 72% species as fuel source, 9.8% as ethnoveterinary medicines, 16% for home construction, 12% for cosmetics, 5.2% as honeybee plants and 2.7% were used as fiber source by the local people. Many local plants have been in promulgation for cure of different diseases in traditional cultures such as for cure of stomach problems, cough, cancer, jaundice, kidney diseases, diabetes, snake biting and tooth problems. Different parts of plants such as leaf, root, stem bark, flower, seed and gums are used for the treatment of different diseases by the local people. The major aliments being cured are classified into 12 disease categories by using informant consensus factor (ICF) protocol. According to ICF, the highest numbers of plant species were used against wound healing, snake bite, skin diseases, eye diseases and asthma. Fidelity level (FL) was assessed to check the reliability and use consistency of herbal drugs by the indigenous communities of the study area. The use value index (UVI) of different herb species ranged from 0.29 to 0.57 while the highest value was calculated for Alternanthera pungens L. (UVI: 0.57). Relative frequency of citation (RFC) value was calculated on the bases of the response of the interviewees recorded during survey in correlation with authenticating of traditional data. The RFC values represented the relative popularity of individual species in study area according to their use values. The highest value was calculated for Alternanthera pungens L. (0.90) and followed by Achyranthes aspera L. (0.80. The study reveals that many species are known for commonly used in traditional ethnomedicines (TEMs). Due to different biotic and abiotic factors in conjunction with climatic changes many herbal flora of Shiwalik mountain range (SMR) of District Bhimber of AJK is under threat. The factors like habitat loss, overgrazing, construction of communication infrastructure, silviculture practices, shelter construction (houses) and other more domestic use of wild land by clearing wild lands are boosting towards plant biodiversity loss. There is dare need to work on comprehensive exploration of TEMs to discover neo drugs from wild indigenous plants and do work for conservation of wild flora of the area for future generations.	[Ishtiaq, Muhammad; Khanum, Humaira; Maqbool, Mehwish; Hussain, Tanveer] Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, AJK, Pakistan; [Hussain, Iqbal; Parveen, Abida; Thind, Sumaira] Govt Coll Univ Faisalabad, Dept Bot, Faisalabad, Pakistan; [Azeem, Muhammad] Univ Bahrain, Coll Sci, Dept Biol, Zallaq, Bahrain; [Shabir, Farah] Govt Associate Coll Women Layyah, Dept Bot, Layyah, Pakistan; [Elansary, Hosam O.] King Saud Univ, Coll Food & Agr Sci, Plant Prod Dept, Riyadh, Saudi Arabia	Government College University Faisalabad; University of Bahrain; King Saud University	Ishtiaq, M (corresponding author), Mirpur Univ Sci & Technol MUST, Dept Bot, Mirpur, AJK, Pakistan.	drishtiaq.bot@must.edu.pk	Ishtiaq, Muhammad/GSN-4278-2022; Hussain, Tanveer/GWQ-5172-2022; Ishtiaq, Muhammad/F-5152-2010; Hussain, Iqbal/B-2295-2013; Elansary, Hosam O./E-3684-2019	Ishtiaq, Muhammad/0000-0003-2468-1413; Hussain, Iqbal/0000-0002-8449-0494; Elansary, Hosam O./0000-0002-4476-2408	King Saud University [RSP-2021/118]	King Saud University(King Saud University)	The current project is supported by the following Funding proejct of: King Saud University (RSP-2021/118).	Abbasi AM, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-84; Ahmad I, 2011, J INEQUAL APPL, DOI 10.1186/1029-242X-2011-75; Ahmad KS, 2012, PAK J BOT, V44, P195; Ajaib M., 2016, FUUAST J BIOL, V6, P247; Ajaib Muhammad, 2014, International Journal of Biology and Biotechnology, V11, P71; Alexiades MN., 1996, SELECTED GUIDELINES; Ali SI., 1990, FLORA PAKISTAN FASCI; Ali SI., 2001, FLORA PAKISTAN FASCI; Amjad Muhammad Shoaib, 2015, Asian Pacific Journal of Tropical Biomedicine, V5, P234, DOI 10.1016/S2221-1691(15)30011-3; Bibi T, 2014, J ETHNOPHARMACOL, V157, P79, DOI 10.1016/j.jep.2014.08.042; Bussmann RW, 2002, MODERN TRENDS APPL T, DOI 10.1007/978-1-4615-0223-4 18.; Cunningham A. B., 2001, Applied ethnobotany: people, wild plant use and conservation; Farooq S., 2012, PAKISTAN J WEED SCI, V18; Govindan S, 1999, J ETHNOPHARMACOL, V66, P205, DOI 10.1016/S0378-8741(98)00160-3; Husain SZ, 2008, PAK J BOT, V40, P1897; Hussain F, 1996, P 1 TRAIN WORKSH ETH, P207; Hussain J., 2012, J AM SCI, V6, P231; Ishtiaq C. M., 2006, Pakistan Journal of Biological Sciences, V9, P2546, DOI 10.3923/pjbs.2006.2546.2555; Ishtiaq M., 2017, INT J BIOSCI, V10, P265, DOI DOI 10.12692/ijb/10.3.265-274; Ishtiaq M., 2016, J MED PLANTS, V3, P97; Ishtiaq M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0243151; Ishtiaq M, 2013, PAK J BOT, V45, P157; Ishtiaq M, 2012, PAK J BOT, V44, P245; Ishtiaq Muhammad, 2007, Pak J Biol Sci, V10, P2241, DOI 10.3923/pjbs.2007.2241.2256; Ju Y, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-28; Khan K. Y., 2011, Journal of Applied Pharmaceutical Science, V1, P209; Khan M. A., 2012, Pakistan Journal of Weed Science Research, V18, P495; Leto C, 2013, J ETHNOPHARMACOL, V146, P90, DOI 10.1016/j.jep.2012.11.042; Mahmood A, 2011, J MED PLANTS RES, V5, P4493; Maqbool M., 2019, P PAKISTAN ACAD SCI, V56, P55; Martens P., 2015, HLTH PEOPLE PLACES P, V477; Martin GJ., 2010, ETHNOBOTANY METHODS; Mughal R, 2016, J PLEIONE, V11, P367; Mugisha MK, 2014, J ETHNOPHARMACOL, V155, P194, DOI 10.1016/j.jep.2014.05.012; Muhammad Ishtiaq, 2012, African Journal of Biotechnology, V11, P3087; Nasir E., 1970, FLORA W PAKISTAN KAS; Priya P., 2010, Pharmacognosy Journal, V2, P400; Qureshi R., 2004, THESIS SHAH ABDUL LA, V1, P1; Qureshi R, 2008, FITOTERAPIA, V79, P468, DOI 10.1016/j.fitote.2008.03.010; Rehman MN, 2017, REV BRAS FARMACOGN, V27, P751, DOI 10.1016/j.bjp.2017.09.004; Shafi F, 2021, INT J PLANT SCI PHYT, V1, P62; Shaukat S. A., 2012, Scientific Journal of Agricultural, V1, P105; Sheikh N., 2013, J MED PLANTS, V1, P62; Shinwari MI, 2000, J ETHNOPHARMACOL, V69, P45, DOI 10.1016/S0378-8741(99)00135-X; Song MJ, 2013, J ETHNOBIOL ETHNOMED, V9, DOI 10.1186/1746-4269-9-48; Thind S., 2021, INT J PLANT SCI PHYT, V1, P134; Ugulu I, 2009, J MED PLANTS RES, V3, P345; Umair M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0177912; Vijayakumar S, 2015, J ETHNOPHARMACOL, V161, P238, DOI 10.1016/j.jep.2014.12.006; Vitalini S, 2013, J ETHNOPHARMACOL, V145, P517, DOI 10.1016/j.jep.2012.11.024	50	0	0	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265028	10.1371/journal.pone.0265028	http://dx.doi.org/10.1371/journal.pone.0265028			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349579	gold, Green Published			2022-12-26	WOS:000783906500034
J	Kitenge, MK; Laxmeshwar, C; Aza, EB; Ford-Kamara, E; Van Cutsem, G; Gcwensa, N; Casas, EC; Hlophe, K; Isaakidis, P; Ohler, L				Kitenge, Marcel K.; Laxmeshwar, Chinmay; Aza, Elkin Bermudez; Ford-Kamara, Ellie; Van Cutsem, Gilles; Gcwensa, Ntombi; Casas, Esther C.; Hlophe, Khanyo; Isaakidis, Petros; Ohler, Liesbet			Acceptability of unsupervised peer-based distribution of HIV oral self-testing for the hard-to-reach in rural KwaZulu Natal, South Africa: Results from a demonstration study	PLOS ONE			English	Article							FEMALE SEX WORKERS; POPULATION; SERVICES	BackgroundInnovative models to distribute oral HIV self-tests (HIVST) provide an opportunity to increase access to HIV testing, especially for hard-to-reach populations. This study aimed to describe the acceptability of unsupervised peer-distribution of HIVST as a method to scale-up HIV testing. MethodsIn this study, lay counsellors or community health workers provided HIVST kits to primary recipients (PRs) for distribution to their sexual partners, anyone in their social network (termed secondary recipients) or for self-testing, from September 2018 to March 2020. The study was conducted in Eshowe and Mbongolwane areas in KwaZulu-Natal, South Africa. A structured questionnaire was administered during the recruitment and passive follow-up, when people came for confirmatory HIV testing. Electronic records were retrospectively examined to determine initiation of antiretroviral treatment (ART) for all HIVST users and non-users. ResultsAmong 36,708 people approached to be primary recipients, 9,891 (26.9%) accepted; 31,341 HIVST kits were distributed with a median of three (IQR: 2-4) per peer. PRs were predominately recruited at primary health clinics (PHCs). However, acceptability of HIVST was thrice as high at community-based testing sites compared to PHCs (64.5% vs. 21.0%; p<0.001). During the study period, 34,715 adults were tested for HIV at both PHCs and community-based testing sites; of these, 1,089 individuals reported HIVST use. Among HIVST users, 893 (82.0%) returned to the clinic for confirmatory testing after testing negative on HIVST; 196 (17.9%) were confirmed HIV positive following a positive HIVST. After excluding 36/196 (18.4%) participants for whom clinical records could not be found in electronic register and 25/160 (15.6%) who were already on ART before receiving HIVST, 129/135 (95.5%) initiated ART, whereas 2,362/2685 (88%) of HIV positive HIVST non-users-initiated ART. ConclusionUnsupervised peer-distribution of HIVST was feasible and acceptable, with more than 25% accepting to be peer-distributors. Acceptability of HIVST was thrice as high in community sites compared to clinics.	[Kitenge, Marcel K.; Laxmeshwar, Chinmay; Ford-Kamara, Ellie; Gcwensa, Ntombi; Ohler, Liesbet] Medecins Sans Frontieres MSF, Eshowe, Kwazulu Natal, South Africa; [Kitenge, Marcel K.] Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa; [Aza, Elkin Bermudez] Int Off, Medecins Sans Frontieres MSF, Amsterdam, Netherlands; [Van Cutsem, Gilles; Casas, Esther C.; Isaakidis, Petros] Medecins Sans Frontieres MSF, Southern Africa Med Unit, Cape Town, South Africa; [Van Cutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa; [Hlophe, Khanyo] Dept Hlth, Kwa Zulu, South Africa	Stellenbosch University; University of Cape Town	Kitenge, MK (corresponding author), Medecins Sans Frontieres MSF, Eshowe, Kwazulu Natal, South Africa.; Kitenge, MK (corresponding author), Stellenbosch Univ, Fac Med & Hlth Sci, Dept Global Hlth, Div Epidemiol & Biostat, Cape Town, South Africa.	msfocb-eshowe-epi@brussels.msf.org		Laxmeshwar, Chinmay/0000-0003-1561-3857; Isaakidis, Petros/0000-0002-7881-1554; Kitenge, Marcel/0000-0002-8245-4043				Choko AT, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002719; Choko AT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208191; Choko AT, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001873; Choko AT, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21610; Deville W, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215353; Harichund C, 2018, AIDS BEHAV, V22, P560, DOI 10.1007/s10461-017-1848-9; Hatzold K., 2020, ZAMBIA ZIMBABWE, V22, P43; Indravudh PP, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-4430-4; Jamil MS, 2021, ECLINICALMEDICINE, V38, DOI 10.1016/j.eclinm.2021.100991; Jobson G, 2019, JAIDS-J ACQ IMM DEF, V81, pE160, DOI 10.1097/QAI.0000000000002078; Johnson CC, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.1.21594; Lebina L, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4785-7; Makusha T, 2017, PUBLIC HEALTH, V143, P1, DOI 10.1016/j.puhe.2016.10.017; Masters SH, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002166; Matovu JKB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236141; Medecins Sans Frontieres, 2019, MBONGOLWANE ESHOWE H, V2; Napierala S, 2019, B WORLD HEALTH ORGAN, V97, P764, DOI 10.2471/BLT.18.223560; Neuman M, 2019, J INT AIDS SOC, V22, DOI 10.1002/jia2.25238; Njau B, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7685-1; Olaru ID, 2017, J INT AIDS SOC, V20, DOI 10.7448/IAS.20.7.21751; Organization WH., 2016, GUID HIV SELF TEST P; Perez GM, 2016, TROP MED INT HEALTH, V21, P759, DOI 10.1111/tmi.12703; Pettifor A, 2020, ECLINICALMEDICINE, V21, DOI 10.1016/j.eclinm.2020.100327; SA HIV Clinicians Society, 2017, S AFR HIV SELF TEST; South African National Department of Health, 2018, NAT HIV SELF SCREEN; Statistics South Africa, 2018, MIDYEAR POPULATION E; Thirumurthy H, 2016, LANCET HIV, V3, pE266, DOI 10.1016/S2352-3018(16)00041-2; UN General Assembly, 2016, POL DECL HIV AIDS FA, V17020, P1; UNAIDS, 2018, GLOB HIV STAT 2019, P1; UNAIDS 2020, 2020, TACKL ENTR IN END EP; WHO/UNITAID, 2018, LANDSC HIV RAP DIAGN	31	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264442	10.1371/journal.pone.0264442	http://dx.doi.org/10.1371/journal.pone.0264442			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353823	Green Published, gold			2022-12-26	WOS:000786647900016
J	Onagawa, R; Mukai, K; Kudo, K				Onagawa, Ryoji; Mukai, Kae; Kudo, Kazutoshi			Different planning policies for the initial movement velocity depending on whether the known uncertainty is in the cursor or in the target: Motor planning in situations where two potential movement distances exist	PLOS ONE			English	Article							VISION; PROPRIOCEPTION; SPECIFICATION; INFORMATION; DECISIONS; DIRECTION; PREMOTOR; CORTEX; SPEED; GAZE	During goal-directed behaviors, individuals can be required to start a movement before deciding on the final goal. Previous studies have focused on the initial movement direction in situations involving multiple targets in different directions from the starting position and have shown that the movement is initiated in the average direction among the target directions. However, the previous studies only included situations with targets at equivalent distances, and the characteristics of motor planning in situations with multiple movement possibilities over different potential distances are unclear. In such situations, movement velocity is another important control variable. Furthermore, while previous studies examined situations with an uncertain motor target position, uncertainty can also exist in the effector position (e.g., body or tool locations). Therefore, we examined (1) whether the average output is confirmed in the initial movement velocity during execution in situations involving two potential movements with different distances. In addition, we examined (2) whether planning of the movement velocity can differ depending on the presence of uncertainty in the cursor or the target. In the main conditions, the participants were required to start a reaching movement with two potential movement distances; in the two-cursor condition, two cursors were presented before the start of the trial, and in the two-target condition, two targets were presented. As a control condition, a distance condition corresponding to each main condition was also performed. In the control condition, the initial movement velocity varied linearly with distance. Then, we tested whether the initial movement velocity in situations with two potential movement distances would follow the averaging output of the corresponding control condition. The results revealed that while the initial movement velocity in the two-target condition was slower than the averaging output, that in the two-cursor condition approached the averaging output. These results suggest that the velocity profile of the goal-directed movement is not simply averaged in a situation where two potential targets exist, and that there is a difference in the planning policy of the initial movement depending on whether the known uncertainty is for the movement goal or the effector.	[Onagawa, Ryoji; Kudo, Kazutoshi] Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Lab Sports Sci, Tokyo, Japan; [Onagawa, Ryoji; Mukai, Kae] Japan Soc Promot Sci, Tokyo, Japan; [Onagawa, Ryoji; Mukai, Kae] Waseda Univ, Fac Sci & Engn, Tokyo, Japan	University of Tokyo; Japan Society for the Promotion of Science; Waseda University	Onagawa, R; Kudo, K (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Life Sci, Lab Sports Sci, Tokyo, Japan.; Onagawa, R (corresponding author), Japan Soc Promot Sci, Tokyo, Japan.; Onagawa, R (corresponding author), Waseda Univ, Fac Sci & Engn, Tokyo, Japan.	ryoji.onagawa@gmail.com; kudo@idaten.c.u-tokyo.ac.jp	Kudo, Kazutoshi/GVT-3733-2022	Onagawa, Ryoji/0000-0002-4722-1981	JSPS KAKENHI [26560344];  [18J23290]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); 	The research was supported by Grant-Aid for JSPS Fellows No. 18J23290 awarded to R.O. and by JSPS KAKENHI No. 26560344 awarded to K.K. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Bagesteiro LB, 2006, EXP BRAIN RES, V171, P358, DOI 10.1007/s00221-005-0272-y; Chapman CS, 2010, COGNITION, V116, P168, DOI 10.1016/j.cognition.2010.04.008; Christopoulos V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004402; Christopoulos V, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004104; Churchland MM, 2006, J NEUROPHYSIOL, V96, P3130, DOI 10.1152/jn.00307.2006; Cisek P, 2005, NEURON, V45, P801, DOI 10.1016/j.neuron.2005.01.027; COHEN J, 1973, EDUC PSYCHOL MEAS, V33, P107, DOI 10.1177/001316447303300111; Cos I, 2014, J NEUROPHYSIOL, V112, P1256, DOI 10.1152/jn.00147.2014; Cos I, 2012, J NEUROPHYSIOL, V108, P1764, DOI 10.1152/jn.00081.2012; Cos I, 2011, J NEUROPHYSIOL, V105, P3022, DOI 10.1152/jn.00975.2010; de Brouwer AJ, 2018, J NEUROPHYSIOL, V120, P2522, DOI 10.1152/jn.00182.2018; Dean M, 2007, J VISION, V7, DOI 10.1167/7.5.10; Dekleva BM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05959-y; Dekleva BM, 2016, ELIFE, V5, DOI [10.7554/eLife.14316, 10.7554/eLife:14316]; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; FITTS PM, 1954, J EXP PSYCHOL, V47, P381, DOI 10.1037/h0055392; Franklin DW, 2011, NEURON, V72, P425, DOI 10.1016/j.neuron.2011.10.006; Gallivan JP, 2018, NAT REV NEUROSCI, V19, P519, DOI 10.1038/s41583-018-0045-9; Gallivan JP, 2016, J NEUROPHYSIOL, V115, P3113, DOI 10.1152/jn.00951.2015; Gallivan JP, 2016, NAT NEUROSCI, V19, P320, DOI 10.1038/nn.4214; Gallivan JP, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8428; Gallivan JP, 2011, PSYCHOL SCI, V22, P803, DOI 10.1177/0956797611408733; Ghez C, 1997, EXP BRAIN RES, V115, P217, DOI 10.1007/PL00005692; Haith AM, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004171; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; Hesse C, 2020, COGNITION, V205, DOI 10.1016/j.cognition.2020.104426; Hudson TE, 2007, J NEUROPHYSIOL, V98, P3034, DOI 10.1152/jn.00858.2007; Izawa J, 2008, J NEUROSCI, V28, P2883, DOI 10.1523/JNEUROSCI.5359-07.2008; Kruger M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00041; Kurtzer IL, 2020, J NEUROPHYSIOL, V124, P1013, DOI 10.1152/jn.00336.2020; LOEWENSTEIN GF, 1993, PSYCHOL REV, V100, P91, DOI 10.1037/0033-295X.100.1.91; Messier J, 1999, EXP BRAIN RES, V125, P139, DOI 10.1007/s002210050669; MYERSON J, 1995, J EXP ANAL BEHAV, V64, P263, DOI 10.1901/jeab.1995.64-263; Nashed JY, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10996-6; Nashed JY, 2012, J NEUROPHYSIOL, V108, P999, DOI 10.1152/jn.01089.2011; Neggers SFW, 2000, J NEUROPHYSIOL, V83, P639, DOI 10.1152/jn.2000.83.2.639; Neggers SFW, 2001, J NEUROPHYSIOL, V86, P961, DOI 10.1152/jn.2001.86.2.961; Onagawa R., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Plamondon R, 1997, BEHAV BRAIN SCI, V20, P279, DOI 10.1017/S0140525X97001441; ROSSETTI Y, 1995, J NEUROPHYSIOL, V74, P457, DOI 10.1152/jn.1995.74.1.457; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Sarlegna FR, 2009, ADV EXP MED BIOL, V629, P317, DOI 10.1007/978-0-387-77064-2_16; Shadmehr R, 2010, J NEUROSCI, V30, P10507, DOI 10.1523/JNEUROSCI.1343-10.2010; Smyrnis N, 2000, EXP BRAIN RES, V134, P21, DOI 10.1007/s002210000416; Stewart BM, 2014, CURR BIOL, V24, pR953, DOI 10.1016/j.cub.2014.08.046; Stewart BM, 2013, J NEUROPHYSIOL, V110, P807, DOI 10.1152/jn.00131.2013; Stewart EEM, 2020, J VISION, V20, DOI 10.1167/jov.20.12.2; van Beers RJ, 2002, CURR BIOL, V12, P834, DOI 10.1016/S0960-9822(02)00836-9; Wong AL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14624; Wu SW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008228	51	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265943	10.1371/journal.pone.0265943	http://dx.doi.org/10.1371/journal.pone.0265943			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353863	Green Published, gold			2022-12-26	WOS:000786647900047
J	Phillips, S; Chen, YM; Masese, R; Noisette, L; Jordan, K; Jacobs, S; Hsu, LL; Melvin, CL; Treadwell, M; Shah, NR; Tanabe, P; Kanter, J				Phillips, Shannon; Chen, Yumei; Masese, Rita; Noisette, Laurence; Jordan, Kasey; Jacobs, Sara; Hsu, Lewis L.; Melvin, Cathy L.; Treadwell, Marsha; Shah, Nirmish; Tanabe, Paula; Kanter, Julie			Perspectives of individuals with sickle cell disease on barriers to care	PLOS ONE			English	Article							HEALTH; CHILDREN; COMMUNICATION; QUALITY; PEOPLE; ADULTS; LIFE	IntroductionSickle cell disease (SCD) is an inherited hemoglobinopathy that predominantly affects African Americans in the United States. The disease is associated with complications leading to high healthcare utilization rates, including emergency department (ED) visits and hospitalizations. Optimal SCD care requires a multidisciplinary approach involving SCD specialists to ensure preventive care, minimize complications and prevent unnecessary ED visits and hospitalizations. However, most individuals with SCD receive sub-optimal care or are unaffiliated with care (have not seen an SCD specialist). We aimed to identify barriers to care from the perspective of individuals with SCD in a multi-state sample. MethodsWe performed a multiple methods study consisting of surveys and interviews in three comprehensive SCD centers from March to June 2018. Interviews were transcribed and coded, exploring themes around barriers to care. Survey questions on the specific themes identified in the interviews were analyzed using summary statistics. ResultsWe administered surveys to 208 individuals and conducted 44 in-depth interviews. Barriers to care were identified and classified according to ecological level (i.e., individual, family/interpersonal, provider, and socio-environmental/organizational level). Individual-level barriers included lack of knowledge in self-management and disease severity. Family/interpersonal level barriers were inadequate caregiver support and competing life demands. Provider level barriers were limited provider knowledge, provider inexperience, poor provider-patient relationship, being treated differently, and the provider's lack of appreciation of the patient's SCD knowledge. Socio-environmental/organizational level barriers included limited transportation, lack of insurance, administrative barriers, poor care coordination, and reduced access to care due to limited clinic availability, services provided or clinic refusal to provide SCD care. ConclusionParticipants reported several multilevel barriers to SCD care. Strategies tailored towards reducing these barriers are warranted. Our findings may also inform interventions aiming to locate and link unaffiliated individuals to care.	[Phillips, Shannon; Jordan, Kasey] Med Univ South Carolina, Coll Nursing, Charleston, SC USA; [Chen, Yumei] UCSF Benioff Childrens Hosp Oakland, Dept Hematol Oncol, Oakland, CA USA; [Masese, Rita; Tanabe, Paula] Duke Univ, Sch Nursing, Durham, NC USA; [Noisette, Laurence] Med Univ South Carolina, Dept Pediat, Charleston, SC USA; [Jacobs, Sara] RTI Int, Translat Hlth Res Div, Res Triangle Pk, NC USA; [Hsu, Lewis L.] Univ Illinois, Comprehens Sickle Cell Ctr, Dept Pediat, Chicago, IL USA; [Melvin, Cathy L.] Med Univ South Carolina, Dept Publ Hlth Sci, Charleston, SC USA; [Treadwell, Marsha] UCSF Benioff Childrens Hosp Oakland, Dept Pediat, Div Hematol, Oakland, CA USA; [Shah, Nirmish] Duke Univ, Sch Med, Durham, NC USA; [Kanter, Julie] Univ Alabama Birmingham, Div Hematol & Oncol, Birmingham, AL USA	Medical University of South Carolina; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Duke University; Medical University of South Carolina; Research Triangle Institute; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Medical University of South Carolina; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Duke University; University of Alabama System; University of Alabama Birmingham	Phillips, S (corresponding author), Med Univ South Carolina, Coll Nursing, Charleston, SC USA.	phillipss@musc.edu		PHillips, Shannon/0000-0001-5697-9156; Shah, Nirmish/0000-0002-7506-0935; Jacobs, Sara/0000-0002-0617-4285; Noisette, M. Laurence/0000-0001-6138-7753; Jordan, Kasey/0000-0002-8437-1823	US Federal Government from the National Heart Lung and Blood Institute [HL133948, HL133964, HL133990, HL133996, HL133994, HL133997, HL134004, HL134007, HL134042]; National Heart Lung and Blood Institute; National Institute on Minority Health and Health Disparities (Bethesda, MD)	US Federal Government from the National Heart Lung and Blood Institute; National Heart Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Minority Health and Health Disparities (Bethesda, MD)	The study is part of the Sickle Cell Disease Implementation Consortium which has been supported by US Federal Government cooperative agreements HL133948, HL133964, HL133990, HL133996, HL133994, HL133997, HL134004, HL134007, and HL134042 from the National Heart Lung and Blood Institute and the National Institute on Minority Health and Health Disparities (Bethesda, MD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen EM, 2017, MED CARE, V55, P207, DOI 10.1097/MLR.0000000000000644; Bemrich-Stolz C J, 2015, Int J Hematol Ther, V1, DOI 10.15436/2381-1404.15.003; Blinder MA, 2013, PEDIATR BLOOD CANCER, V60, P828, DOI 10.1002/pbc.24459; Brennan-Cook J, 2018, PROF CASE MANAG, V23, P213, DOI 10.1097/NCM.0000000000000260; Brousseau DC, 2010, JAMA-J AM MED ASSOC, V303, P1288, DOI 10.1001/jama.2010.378; Bulgin D, 2018, ISSUES MENT HEALTH N, V39, P675, DOI 10.1080/01612840.2018.1443530; Cabana Michael D, 2019, Glob Pediatr Health, V6, p2333794X19847026, DOI 10.1177/2333794X19847026; Caiola C, 2014, ADV NURS SCI, V37, P287, DOI 10.1097/ANS.0000000000000046; Callahan ST, 2010, J ADOLESCENT HEALTH, V46, P407, DOI 10.1016/j.jadohealth.2009.09.010; Charmaz K., 2003, HDB INTERVIEW RES CO, P675, DOI [10.1111/papt.12337, DOI 10.1111/PAPT.12337]; Crosby LE, 2012, ANEMIA, V2012, DOI 10.1155/2012/492428; Crosby LE, 2009, J PEDIAT HEMATOL ONC, V31, P571, DOI 10.1097/MPH.0b013e3181acd889; Curry L., 2015, SAGE MIXED METHODS R, P1; Desai RJ, 2020, ANN HEMATOL, V99, P2497, DOI 10.1007/s00277-020-04233-w; DiMartino LD, 2018, AM J HEMATOL, V93, pE391, DOI 10.1002/ajh.25282; Glassberg J, 2013, AM J HEMATOL, V88, P532, DOI 10.1002/ajh.23441; Hankivsky O, 2012, SOC SCI MED, V74, P1712, DOI 10.1016/j.socscimed.2011.11.029; Harris PA, 2019, J BIOMED INFORM, V95, DOI 10.1016/j.jbi.2019.103208; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hassell KL, 2010, AM J PREV MED, V38, pS512, DOI 10.1016/j.amepre.2009.12.022; Haywood C, 2014, PATIENT EDUC COUNS, V96, P159, DOI 10.1016/j.pec.2014.05.013; Haywood C, 2009, J NATL MED ASSOC, V101, P1022, DOI 10.1016/S0027-9684(15)31069-5; Hemker BG, 2011, AM J HEMATOL, V86, P863, DOI 10.1002/ajh.22106; Hodges JR, 2020, BLOOD ADV, V4, P4463, DOI 10.1182/bloodadvances.2020001701; Hsu LL, 2016, AM J PREV MED, V51, pS87, DOI 10.1016/j.amepre.2016.01.016; Hussein A., 2009, J COMP SOCIAL WORK, V4, P106, DOI [10.31265/jcsw.v4i1.48, DOI 10.31265/JCSW.V4I1.48]; Jacob E, 2016, J ADV NURS, V72, P1417, DOI 10.1111/jan.12756; Kanter J, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.6016; Landers S, 2016, AM J PUBLIC HEALTH, V106, P591, DOI 10.2105/AJPH.2016.303099; Lane PA, 2002, PEDIATRICS, V109, P526; Lee EO, 2013, NEW ENGL J MED, V368, P6, DOI 10.1056/NEJMp1209500; Lee L, 2019, PUBLIC HEALTH REP, V134, P599, DOI 10.1177/0033354919881438; Linton Elizabeth A, 2020, Ann Emerg Med, V76, pS64, DOI 10.1016/j.annemergmed.2020.08.013; Masese RV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216414; Matthie N, 2016, J ADV NURS, V72, P1441, DOI 10.1111/jan.12760; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Modi AC, 2009, CHILD HEALTH CARE, V38, P107, DOI 10.1080/02739610902813245; Pack-Mabien A, 2009, J AM ACAD NURSE PRAC, V21, P250, DOI 10.1111/j.1745-7599.2009.00401.x; Palermo TM, 2002, J BEHAV MED, V25, P269, DOI 10.1023/A:1015332828213; PLATT OS, 1994, NEW ENGL J MED, V330, P1639, DOI 10.1056/NEJM199406093302303; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Shen MJ, 2018, J RACIAL ETHN HEALTH, V5, P117, DOI 10.1007/s40615-017-0350-4; Smith-Whitley K, 2020, BLOOD, V136, DOI 10.1182/blood-2020-136742; Treadwell M.J., 2020, J CLIN OUTCOMES MANA, V27, P213, DOI [10.12788/0019, DOI 10.12788/0019, 10.12788/jcom.0019, DOI 10.12788/JCOM.0019]; Treadwell MJ., 2015, JCOM, V22, P8	45	3	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265342	10.1371/journal.pone.0265342	http://dx.doi.org/10.1371/journal.pone.0265342			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320302	Green Published, gold			2022-12-26	WOS:000784240600053
J	Stewart-Williams, S; Wong, XL; Chang, CYM; Thomas, AG				Stewart-Williams, Steve; Wong, Xiu Ling; Chang, Chern Yi Marybeth; Thomas, Andrew G.			People react more positively to female- than to male-favoring sex differences: A direct replication of a counterintuitive finding	PLOS ONE			English	Article							GENDER; SELECTION; BIAS	We report a direct replication of our earlier study looking at how people react to research on sex differences depending on whether the research puts men or women in a better light. Three-hundred-and-three participants read a fictional popular-science article about fabricated research finding that women score higher on a desirable trait/lower on an undesirable one (female-favoring difference) or that men do (male-favoring difference). Consistent with our original study, both sexes reacted less positively to the male-favoring differences, with no difference between men and women in the strength of this effect. Also consistent with our original study, belief in male privilege and a left-leaning political orientation predicted less positive reactions to the male-favoring sex differences; neither variable, however, predicted reactions to the female-favoring sex differences (in the original study, male-privilege belief predicted positive reactions). As well as looking at how participants reacted to the research, we looked at their predictions about how the average man and woman would react. Consistent with our earlier results, participants of both sexes predicted that the average man and woman would exhibit considerable own-sex favoritism. In doing so, they exaggerated the magnitude of the average woman's own-sex favoritism and predicted strong own-sex favoritism from the average man when in fact the average man exhibited modest other-sex favoritism. A greater awareness of people's tendency to exaggerate own-sex bias could help to ameliorate conflict between the sexes.	[Stewart-Williams, Steve; Wong, Xiu Ling] Univ Nottingham Malaysia, Sch Psychol, Semenyih, Selangor Darul, Malaysia; [Chang, Chern Yi Marybeth] Univ Nottingham, Sch Med, Nottingham, England; [Thomas, Andrew G.] Swansea Univ, Dept Psychol, Swansea, W Glam, Wales	University of Nottingham Malaysia; University of Nottingham; Swansea University	Stewart-Williams, S (corresponding author), Univ Nottingham Malaysia, Sch Psychol, Semenyih, Selangor Darul, Malaysia.	steve.stewart-williams@nottingham.edu.my		Thomas, Andrew/0000-0001-5251-7923; Stewart-Williams, Steve/0000-0001-8568-6846				Althouse A, 2005, SCIENTISTS REMEMBER; Baumeister R. F., 2010, IS THERE ANYTHING GO; EAGLY AH, 1986, PSYCHOL BULL, V100, P283, DOI 10.1037/0033-2909.100.3.283; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; FeldmanHall O, 2016, SOC PSYCHOL PERS SCI, V7, P542, DOI 10.1177/1948550616647448; Glick P, 1997, PSYCHOL WOMEN QUART, V21, P119, DOI 10.1111/j.1471-6402.1997.tb00104.x; Hayes AF., 2017, MEDIATION MODERATION, V2nd edn; Henrich J, 2004, J ECON BEHAV ORGAN, V53, P3, DOI 10.1016/S0167-2681(03)00094-5; Iacobucci D, 2017, BEHAV RES METHODS, V49, P403, DOI 10.3758/s13428-016-0827-9; Jussim L., 2012, SOCIAL PERCEPTION SO, DOI 10.1093/acprof:oso/9780195366600.003.0074; Martin CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108732; Nesse RM, 2005, EVOL HUM BEHAV, V26, P88, DOI 10.1016/j.evolhumbehav.2004.08.002; OLSEN NJ, 1978, J GENET PSYCHOL, V133, P203, DOI 10.1080/00221325.1978.10533378; Reynolds T, 2020, ORGAN BEHAV HUM DEC, V161, P120, DOI 10.1016/j.obhdp.2020.05.002; Ritchie SJ., 2016, INTELLIGENCE ALL MAT; Rudman LA, 2004, J PERS SOC PSYCHOL, V87, P494, DOI 10.1037/0022-3514.87.4.494; Ruggeri K, 2021, NAT HUM BEHAV, V5, P1369, DOI 10.1038/s41562-021-01092-x; Shatz S., 2012, BERKELEY J GENDER LA, V27, P64; Stewart-Williams S, 2002, SEX ROLES, V46, P177, DOI 10.1023/A:1019665803317; Stewart-Williams S, 2018, APE UNDERSTOOD UNIVE; Stewart-Williams S, 2021, BRIT J PSYCHOL, V112, P389, DOI 10.1111/bjop.12463; Winegard B. M., 2018, EQUALITARIANISM SOUR	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266171	10.1371/journal.pone.0266171	http://dx.doi.org/10.1371/journal.pone.0266171			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353872	gold, Green Published			2022-12-26	WOS:000786647900030
J	Wanotayan, R; Wongsanit, S; Boonsirichai, K; Sukapirom, K; Buppaungkul, S; Charoenphun, P; Songprakhon, P; Jangpatarapongsa, K; Uttayarat, P				Wanotayan, Rujira; Wongsanit, Sarinya; Boonsirichai, Kanokporn; Sukapirom, Kasama; Buppaungkul, Sakchai; Charoenphun, Putthiporn; Songprakhon, Pucharee; Jangpatarapongsa, Kulachart; Uttayarat, Pimpon			Quantification of histone H2AX phosphorylation in white blood cells induced by ex vivo gamma irradiation of whole blood by both flow cytometry and foci counting as a dose estimation in rapid triage	PLOS ONE			English	Article							ACUTE-RADIATION-SYNDROME; DNA-DAMAGE; IONIZING-RADIATION; HUMAN-LYMPHOCYTES; BIODOSIMETRY; REPAIR; ASSAY; MANAGEMENT; BIOMARKER; EXERCISE	A quick, reliable, and reproducible biological assay to distinguish individuals with possible life-threatening risk following radiological or nuclear incidents remains a quest in biodosimetry. In this paper, we examined the use of a gamma-H2AX assay as an early dose estimation for rapid triage based on both flow cytometry and image analyses. In the experiment, whole blood from 11 donors was irradiated ex vivo inside a water phantom by gamma rays from Co-60 at 0.51 Gy/min. After the lysis of red blood cells, the white blood cells were collected for immunofluorescence labeling of gamma-H2AX, CD45, and nuclear stained for signal collection and visualization. Analysis by flow cytometry showed that the relative gamma-H2AX intensities of lymphocytes and granulocytes increased linearly with absorbed doses from 0 to 6 Gy with a large variation among individuals observed above 2 Gy. The relative gamma-H2AX intensities of lymphocytes assessed by two different laboratories were highly correlated (ICC = 0.979). Using confocal microscopic images, gamma-H2AX foci were observed to be discretely distributed inside the nuclei and to increase proportionally with doses from 0 to 2 Gy, whereas large plagues of merged foci appeared at 4 and 6 Gy, resulting in the saturation of foci counts above 4 Gy. The number of total foci per cell as well as the number of foci per plane were significantly different at 0 vs 1 and 2 vs 4 Gy doses (p < 0.01). Blind tests at 0.5 Gy and 1 Gy doses showed that dose estimation by flow cytometry had a mean absolute difference of less than 0.5 Gy from the actual value. In conclusion, while flow cytometry can provide a dose estimation with an uncertainty of 0.5 Gy at doses <= 1 Gy, foci counting can identify merged foci that are prominent at doses >= 4 Gy.	[Wanotayan, Rujira] Mahidol Univ, Fac Med Technol, Dept Radiol Technol, Nakhon Pathom, Thailand; [Wongsanit, Sarinya; Boonsirichai, Kanokporn; Uttayarat, Pimpon] Thailand Inst Nucl Technol Publ Org, Nucl Technol Res & Dev Ctr, Ongkarak, Nakhon Nayok, Thailand; [Sukapirom, Kasama] Siriraj Hosp, Fac Med, Siriraj Ctr Res Excellence Microparticle & Exosom, Res Dept, Bangkok, Thailand; [Buppaungkul, Sakchai] Minist Publ Hlth, Bur Radiat & Med Devices, SSDL, Bangkok, Thailand; [Charoenphun, Putthiporn] Mahidol Univ, Fac Med, Ramathibodi Hosp, Div Nucl Med,Dept Diagnost & Therapeut Radiol, Nakhon Pathom, Thailand; [Songprakhon, Pucharee] Mahidol Univ, Div Mol Med, Fac Med, Siriraj Hosp,Res Dept, Bangkok, Thailand; [Jangpatarapongsa, Kulachart] Mahidol Univ, Fac Med Technol, Ctr Res & Innovat, Nakhon Pathom, Thailand	Mahidol University; Mahidol University; Ministry of Public Health - Thailand; Mahidol University; Mahidol University; Mahidol University	Wanotayan, R (corresponding author), Mahidol Univ, Fac Med Technol, Dept Radiol Technol, Nakhon Pathom, Thailand.; Uttayarat, P (corresponding author), Thailand Inst Nucl Technol Publ Org, Nucl Technol Res & Dev Ctr, Ongkarak, Nakhon Nayok, Thailand.	rujira.wan@mahidol.edu; pimponu@tint.or.th		Boonsirichai, Kanokporn/0000-0002-5706-3665; Uttayarat, Pimpon/0000-0002-8196-2185; Wanotayan, Rujira/0000-0002-6844-2687	Thailand Institute of Nuclear Technology (Public Organization) [62410003, 63410009]	Thailand Institute of Nuclear Technology (Public Organization)	The authors would like to thank Ms. Rattanakorn Chiangnoon, Ms. Chanika Chaiwongtorn and Ms. Patcharapan Suwannin for their help with preparing the reagents used in all the experiments, staff at SSDL for access to the facility, Dr. Sakaorat Lertjuthaporn for her advises on flow cytometry, and Mr. Polkrit Cherdchai and Ms. Waraporn Sudchai at Radiation Dose Measurement and Assessment Laboratory, Thailand Institute of Nuclear Technology (Public Organization) for the dose measurement of nanoDotsTM. The authors also would like to acknowledge the Office of Atoms for Peace of Thailand for all the workshops and trainings on biodosimetry.	Andrievski A, 2009, INT J RADIAT BIOL, V85, P369, DOI 10.1080/09553000902781147; Barnard S, 2015, RADIAT PROT DOSIM, V164, P265, DOI 10.1093/rpd/ncu259; Barnard Stephen, 2013, Genome Integr, V4, P1, DOI 10.1186/2041-9414-4-1; Beaton Lindsay A, 2013, ISRN Radiol, V2013, P704659, DOI 10.5402/2013/704659; Beels L, 2010, INT J RADIAT BIOL, V86, P760, DOI 10.3109/09553002.2010.484479; Borras-Fresneda M, 2016, SCI REP-UK, V6, DOI 10.1038/srep27043; Chaurasia RK, 2021, MUTAT RES-GEN TOX EN, V866, DOI 10.1016/j.mrgentox.2021.503354; Einbeck J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207464; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Garty G, 2011, INT J RADIAT BIOL, V87, P776, DOI 10.3109/09553002.2011.573612; Gonzalez JE, 2010, INT J RADIAT BIOL, V86, P752, DOI 10.3109/09553002.2010.484476; Gruel G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145786; Heylmann D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-81058-1; Horn S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025113; Ismail IH, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1169; Ji JP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171582; Johansson P, 2017, CYTOM PART B-CLIN CY, V92, P534, DOI 10.1002/cyto.b.21374; Kovalchuk IP, 2014, RADIAT RES, V182, P683, DOI 10.1667/RR13697.1; Kuo LJ, 2008, IN VIVO, V22, P305; Lee Y, 2019, RADIAT ONCOL, V14, DOI 10.1186/s13014-019-1344-7; Moquet J, 2017, INT J RADIAT BIOL, V93, P58, DOI 10.1080/09553002.2016.1207822; Moroni M, 2013, INT J MOL SCI, V14, P14119, DOI 10.3390/ijms140714119; Nenoi M, 2012, CURRENT TOPICS IN IONIZING RADIATION RESEARCH, P1, DOI 10.5772/2027; Nuciforo PG, 2007, CARCINOGENESIS, V28, P2082, DOI 10.1093/carcin/bgm108; Ostheim P, 2021, INT J RADIAT BIOL, V97, P474, DOI 10.1080/09553002.2021.1876953; Pan Yan, 2016, Genome Integr, V7, P10, DOI 10.4103/2041-9414.197167; Raavi V, 2021, MUTAT RES-REV MUTAT, V787, DOI 10.1016/j.mrrev.2020.108350; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Redon CE, 2009, ADV SPACE RES, V43, P1171, DOI 10.1016/j.asr.2008.10.011; Roch-Lefevre S, 2010, RADIAT RES, V174, P185, DOI 10.1667/RR1775.1; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rothkamm K, 2013, RADIAT RES, V180, P149, DOI 10.1667/RR3238.1; Rothkamm K, 2015, ENVIRON MOL MUTAGEN, V56, P491, DOI 10.1002/em.21944; Rothkamm K, 2013, MUTAT RES-GEN TOX EN, V756, P170, DOI 10.1016/j.mrgentox.2013.04.012; Rungsimaphorn Benchawan, 2016, Genome Integr, V7, P8, DOI 10.4103/2041-9414.197165; Schultz LB, 2000, J CELL BIOL, V151, P1381, DOI 10.1083/jcb.151.7.1381; Sharma PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121083; Sullivan JM, 2013, HEALTH PHYS, V105, P540, DOI 10.1097/HP.0b013e31829cf221; Swartz HM, 2014, RADIAT ENVIRON BIOPH, V53, P221, DOI 10.1007/s00411-014-0522-0; Turner HC, 2014, RADIAT ENVIRON BIOPH, V53, P265, DOI 10.1007/s00411-014-0514-0; Viau M, 2015, MUTAT RES-GEN TOX EN, V793, P123, DOI 10.1016/j.mrgentox.2015.05.009; Wang ZD, 2014, RADIAT ENVIRON BIOPH, V53, P283, DOI 10.1007/s00411-014-0530-0; Waselenko JK, 2004, ANN INTERN MED, V140, P1037, DOI 10.7326/0003-4819-140-12-200406150-00015; Wilkins Ruth C, 2017, Genome Integr, V8, P7, DOI 10.4103/2041-9414.198912	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265643	10.1371/journal.pone.0265643	http://dx.doi.org/10.1371/journal.pone.0265643			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320288	Green Published, gold			2022-12-26	WOS:000784240600032
J	Flova, JS; Habibi, NR; Yap, JQ; Cleary, SR; Fang, X; Kekenes-Huskey, PM; Espinoza-Fonseca, LM; Bossuyt, JB; Robia, SL				Flova, Jaroslava Se; Habibi, Nima R.; Yap, John Q.; Cleary, Sean R.; Fang, Xuan; Kekenes-Huskey, Peter M.; Espinoza-Fonseca, L. Michel; Bossuyt, Julie B.; Robia, Seth L.			Fluorescence lifetime imaging microscopy reveals sodium pump dimers in live cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESONANCE ENERGY-TRANSFER; P-TYPE ATPASE; NA+/K+-ATPASE; PHOSPHOLAMBAN OLIGOMERIZATION; ERYTHROCYTE CA-2+-ATPASE; TRANSMEMBRANE PROTEINS; CARDIAC-GLYCOSIDES; CRYSTAL-STRUCTURE; NA/K-ATPASE; PHOSPHOLEMMAN	The sodium-potassium ATPase (Na/K-ATPase, NKA) establishes ion gradients that facilitate many physiological functions including action potentials and secondary transport processes. NKA comprises a catalytic subunit (alpha) that in-teracts closely with an essential subunit (beta) and regulatory transmembrane micropeptides called FXYD proteins. In the heart, a key modulatory partner is the FXYD protein phos-pholemman (PLM, FXYD1), but the stoichiometry of the alpha-beta-PLM regulatory complex is unknown. Here, we used fluorescence lifetime imaging and spectroscopy to inves-tigate the structure, stoichiometry, and affinity of the NKA-regulatory complex. We observed a concentration-dependent binding of the subunits of NKA-PLM regulatory complex, with avid association of the alpha subunit with the essential beta subunit as well as lower affinity alpha-alpha and alpha- PLM interactions. These data provide the first evidence that, in intact live cells, the regulatory complex is composed of two alpha subunits associated with two beta subunits, decorated with two PLM regulatory subunits. Docking and molecular dynamics (MD) simulations generated a structural model of the complex that is consistent with our experimental observations. We propose that alpha-alpha subunit interactions support conformational coupling of the catalytic subunits, which may enhance NKA turnover rate. These observations provide insight into the pathophysiology of heart failure, wherein low NKA expression may be insufficient to support formation of the complete regulatory complex with the stoichiometry (alpha-beta-PLM)2.	[Flova, Jaroslava Se; Yap, John Q.; Cleary, Sean R.; Fang, Xuan; Kekenes-Huskey, Peter M.; Robia, Seth L.] Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60660 USA; [Habibi, Nima R.; Bossuyt, Julie B.] Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA; [Espinoza-Fonseca, L. Michel] Univ Michigan, Ctr Arrhythmia Res, Dept Internal Med, Div Cardiovasc Med, Ann Arbor, MI USA	Loyola University Chicago; University of California System; University of California Davis; University of Michigan System; University of Michigan	Robia, SL (corresponding author), Loyola Univ Chicago, Dept Cell & Mol Physiol, Maywood, IL 60660 USA.; Bossuyt, JB (corresponding author), Univ Calif Davis, Dept Pharmacol, Davis, CA 95616 USA.	jbossuyt@ucdavis.edu; srobia@luc.edu	Fang, Xuan/CAG-5381-2022	Fang, Xuan/0000-0001-6394-4015; Yap, John/0000-0003-4185-2480	American Heart Association Postdoctoral Fellowship [830562]; National Institute of Health [HL092321, HL143816, R35 GM124977, R01GM120142, R01HL142282-04]	American Heart Association Postdoctoral Fellowship(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This research was supported by American Heart Association Postdoctoral Fellowship 830562 (to J. S.) and the National Institute of Health grants HL092321 and HL143816 (to S. L. R.) , R35 GM124977 (to P.M. K.-H.) , R01GM120142 (to L. M. E.-F.) , and R01HL142282-04 (to J. B. B.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Abrol N, 2015, J BIOL CHEM, V290, P7130, DOI 10.1074/jbc.M114.630319; Abrol N, 2014, J BIOL CHEM, V289, P25855, DOI 10.1074/jbc.M114.562579; Alford RF, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004398; ANDERSEN JP, 1989, BIOCHIM BIOPHYS ACTA, V988, P47, DOI 10.1016/0304-4157(89)90003-8; ASKARI A, 1987, J BIOENERG BIOMEMBR, V19, P359, DOI 10.1007/BF00768539; Beevers AJ, 2006, PROTEIN SCI, V15, P1127, DOI 10.1110/ps.051899406; Bidwell P, 2011, J BIOL CHEM, V286, P35044, DOI 10.1074/jbc.M111.266759; Blackwell DJ, 2016, BIOPHYS J, V111, P1192, DOI 10.1016/j.bpj.2016.08.005; Boldyrev AA, 2001, BIOCHEMISTRY-MOSCOW+, V66, P821, DOI 10.1023/A:1011964832767; Bossuyt J, 2005, CIRC RES, V97, P558, DOI 10.1161/01.RES.0000181172.27931.c3; Bossuyt J, 2006, J BIOL CHEM, V281, P32765, DOI 10.1074/jbc.M606254200; Bossuyt J, 2009, J BIOL CHEM, V284, P26749, DOI 10.1074/jbc.M109.047357; Bovo E, 2020, BIOPHYS J, V119, P1456, DOI 10.1016/j.bpj.2020.08.025; Cechova P, 2016, J CHEM INF MODEL, V56, P2434, DOI 10.1021/acs.jcim.6b00353; Chan H, 2010, J MOL MICROB BIOTECH, V19, P5, DOI 10.1159/000319588; Chaudhury S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022477; Clarke RJ, 2007, BIOPHYS J, V93, P4187, DOI 10.1529/biophysj.107.111591; Clarke RJ, 2007, BIOCHEMISTRY-US, V46, P7034, DOI 10.1021/bi700619s; Correll RN, 2014, CIRC RES, V114, P249, DOI 10.1161/CIRCRESAHA.114.302293; Desta IT, 2020, STRUCTURE, V28, P1071, DOI 10.1016/j.str.2020.06.006; Digitalis Investigation Group, 1997, NEW ENGL J MED, V336, P525, DOI DOI 10.1056/NEJM199702203360801; Donnet C, 2001, J BIOL CHEM, V276, P7357, DOI 10.1074/jbc.M009131200; FORSTER T, 1948, ANN PHYS-BERLIN, V2, P55, DOI 10.1002/andp.19484370105; Froehlich JP, 1997, ANN NY ACAD SCI, V834, P280, DOI 10.1111/j.1749-6632.1997.tb52259.x; Gabizon R, 2014, FRONT CHEM, V2, DOI 10.3389/fchem.2014.00009; GANJEIZADEH M, 1995, J BIOL CHEM, V270, P15707, DOI 10.1074/jbc.270.26.15707; Geering K, 2005, J BIOENERG BIOMEMBR, V37, P387, DOI 10.1007/s10863-005-9476-x; Goodsell DS, 2000, ANNU REV BIOPH BIOM, V29, P105, DOI 10.1146/annurev.biophys.29.1.105; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; H. S.Young, 2019, bioRxiv, DOI 10.1101/2019.12.19.883355; Himes RD, 2016, BIOCHEMISTRY-US, V55, P6196, DOI 10.1021/acs.biochem.6b00633; Hou ZJ, 2008, J BIOL CHEM, V283, P28996, DOI 10.1074/jbc.M804782200; Hou ZJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040369; Hou ZJ, 2010, J MOL BIOL, V402, P210, DOI 10.1016/j.jmb.2010.07.023; Kanai R, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2020438118; Kanai R, 2013, NATURE, V502, P201, DOI 10.1038/nature12578; Kanczewska J, 2005, P NATL ACAD SCI USA, V102, P11675, DOI 10.1073/pnas.0504498102; Kelly EM, 2008, J BIOL CHEM, V283, P12202, DOI 10.1074/jbc.M707590200; KOSKKOSICKA D, 1988, J BIOL CHEM, V263, P18184; KOSKKOSICKA D, 1989, J BIOL CHEM, V264, P19495; Kozakov D, 2017, NAT PROTOC, V12, P255, DOI 10.1038/nprot.2016.169; Kozakov D, 2013, PROTEINS, V81, P2159, DOI 10.1002/prot.24403; Kozma D, 2013, NUCLEIC ACIDS RES, V41, pD524, DOI 10.1093/nar/gks1169; Laviv T, 2016, NAT METHODS, V13, P989, DOI [10.1038/NMETH.4046, 10.1038/nmeth.4046]; Levi V, 2002, BIOPHYS J, V82, P437, DOI 10.1016/S0006-3495(02)75408-8; Mahaney JE, 2005, BIOCHEMISTRY-US, V44, P7713, DOI 10.1021/bi048011i; MOLLER JV, 1980, J BIOL CHEM, V255, P1912; Morth JP, 2007, NATURE, V450, P1043, DOI 10.1038/nature06419; Newman RA, 2008, MOL INTERV, V8, P36, DOI 10.1124/mi.8.1.8; Okkeri J, 2002, EUR J BIOCHEM, V269, P1579, DOI 10.1046/j.1432-1033.2002.02810.x; OTTOLENGHI P, 1983, BIOCHIM BIOPHYS ACTA, V727, P89, DOI 10.1016/0005-2736(83)90372-3; Pallikkuth S, 2013, BIOPHYS J, V105, P1812, DOI 10.1016/j.bpj.2013.08.045; PALMER CJ, 1991, J BIOL CHEM, V266, P11126; REPKE KRH, 1973, ACTA BIOL MED GER, V31, pK19; Rui H, 2016, ELIFE, V5, DOI 10.7554/eLife.16616; Sackett DL, 1996, J BIOL CHEM, V271, P9987, DOI 10.1074/jbc.271.17.9987; Salomon-Ferrer R, 2013, J CHEM THEORY COMPUT, V9, P3878, DOI 10.1021/ct400314y; Santoro L, 2011, CEPHALALGIA, V31, P808, DOI 10.1177/0333102411399351; Schaaf TM, 2018, BIOSENSORS-BASEL, V8, DOI 10.3390/bios8040099; Schlingmann KP, 2018, AM J HUM GENET, V103, P808, DOI 10.1016/j.ajhg.2018.10.004; Singh DR, 2019, J MOL BIOL, V431, P4429, DOI 10.1016/j.jmb.2019.07.037; Singh RB, 2010, CAN J PHYSIOL PHARM, V88, P388, DOI 10.1139/Y10-012; Song H, 2014, J PHYSIOL-LONDON, V592, P941, DOI 10.1113/jphysiol.2013.266866; Song QJ, 2011, J BIOL CHEM, V286, P9120, DOI 10.1074/jbc.M110.198036; Spadaro M, 2004, NEUROGENETICS, V5, P177, DOI 10.1007/s10048-004-0183-2; STEIN WD, 1973, P NATL ACAD SCI USA, V70, P275, DOI 10.1073/pnas.70.1.275; Tian C, 2020, J CHEM THEORY COMPUT, V16, P528, DOI 10.1021/acs.jctc.9b00591; Toustrup-Jensen M, 2002, J BIOL CHEM, V277, P38607, DOI 10.1074/jbc.M203665200; Tusnady GE, 2005, NUCLEIC ACIDS RES, V33, pD275, DOI 10.1093/nar/gki002; Tusnady GE, 2004, BIOINFORMATICS, V20, P2964, DOI 10.1093/bioinformatics/bth340; Vajda S, 2017, PROTEINS, V85, P435, DOI 10.1002/prot.25219; VANDERKOOI JM, 1977, BIOCHEMISTRY-US, V16, P1262, DOI 10.1021/bi00626a003; Wong A, 2008, SOLID STATE NUCL MAG, V33, P72, DOI 10.1016/j.ssnmr.2008.04.003; Yap JQ, 2021, J GEN PHYSIOL, V153, DOI 10.1085/jgp.202012633; Zacchia M, 2016, KIDNEY DIS-BASEL, V2, P72, DOI 10.1159/000446268	75	0	0	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101865	10.1016/j.jbc.2022.101865	http://dx.doi.org/10.1016/j.jbc.2022.101865			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35339486	Green Published, gold			2022-12-26	WOS:000804436700010
J	Borchel, A; Komisarczuk, AZ; Nilsen, F				Borchel, Andreas; Komisarczuk, Anna Zofia; Nilsen, Frank			Sex differences in the early life stages of the salmon louse Lepeophtheirus salmonis (Copepoda: Caligidae)	PLOS ONE			English	Article							HEAT-SHOCK PROTEINS; GENE-EXPRESSION; KNOCK-DOWN; LICE; RATIOS; PATTERNS; KROYER	Salmon lice are ectoparasites on salmonids and feed on blood, mucus, and skin from their hosts. This causes high annual costs for treatment and control for the aquaculture industry. Salmon lice have a life cycle consisting of eight life stages. Sex determination by eye is only possible from the sixth stage onwards. A molecular sex determination has not been carried out so far, even though few individual sex-linked SNPs have been reported. In the present study, we used known sex-specific SNPs as a basis to sequence the complete sex-specific gene variants and used the sequence information to develop a sex determination assay. This assay could be used to determine the developmental speed of the two sexes already in the earliest life stages. Additionally, we sampled salmon lice in the nauplius II stage, determined the sex of each individual, pooled their RNA according to their sex, and used RNA sequencing to search for differences in gene expression and further sex-specific SNPs. We succeeded in developing a sex-determination assay that works on DNA or RNA from even the earliest larval stages of the salmon louse after hatching. At these early developmental stages, male salmon lice develop slightly quicker than females. We detected several previously unknown, sex-specific SNPs in our RNA-data seq, but only very few genes showed a differential expression between the sexes. Potential connections between SNPs, gene expression, and development are discussed.	[Borchel, Andreas; Komisarczuk, Anna Zofia; Nilsen, Frank] Univ Bergen, SLRC Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway	University of Bergen	Borchel, A (corresponding author), Univ Bergen, SLRC Sea Lice Res Ctr, Dept Biol Sci, Bergen, Norway.	andreas.borchel@uib.no		Borchel, Andreas/0000-0002-1408-7261	Norwegian Research Council, SFI Sea Lice Research Centre [203513/O30]; Research Council of Norway [245979/F50]; Bergen Research Foundation (BFS) [BFS2017TMT04, BFS2017TMT08]	Norwegian Research Council, SFI Sea Lice Research Centre; Research Council of Norway(Research Council of Norway); Bergen Research Foundation (BFS)	The overall project was funded by the Norwegian Research Council as a part of the SFI Sea Lice Research Centre [203513/O30]. The Genomics Core Facility (GCF) at the University of Bergen, which is a part of the NorSeq consortium, provided services on RNA sequencing; GCF is supported in part by major grants from the Research Council of Norway [grant no. 245979/F50] and Bergen Research Foundation (BFS) [grant no. BFS2017TMT04, BFS2017TMT08]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander HJ, 2015, J EVOLUTION BIOL, V28, P2196, DOI 10.1111/jeb.12743; Bavelloni A, 2015, IUBMB LIFE, V67, P239, DOI 10.1002/iub.1366; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Borchel A, 2019, GENES-BASEL, V10, DOI 10.3390/genes10121004; Borchel A, 2018, MOL REPROD DEV, V85, P478, DOI 10.1002/mrd.22984; Borchel A, 2018, CELL STRESS CHAPERON, V23, P127, DOI 10.1007/s12192-017-0830-9; Boulange-Lecomte C, 2014, CELL STRESS CHAPERON, V19, P591, DOI 10.1007/s12192-013-0482-3; Boxaspen K, 2006, ICES J MAR SCI, V63, P1304, DOI 10.1016/j.icesjms.2006.04.017; Carmichael SN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077832; Carroni M, 2017, SCI REP-UK, V7, DOI 10.1038/srep40188; Charles JP, 2010, INSECT BIOCHEM MOLEC, V40, P205, DOI 10.1016/j.ibmb.2009.12.005; Chen JS, 2021, RNA BIOL, V18, P1747, DOI 10.1080/15476286.2020.1868680; Costello MJ, 2009, J FISH DIS, V32, P115, DOI 10.1111/j.1365-2761.2008.01011.x; Cox R, 2017, ECOSPHERE, V8, DOI 10.1002/ecs2.2040; Dalvin S, 2009, INT J PARASITOL, V39, P1407, DOI 10.1016/j.ijpara.2009.04.004; DEGREGORI J, 1995, MOL CELL BIOL, V15, P4215; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Eichner C, 2018, J FISH DIS, V41, P1005, DOI 10.1111/jfd.12770; Eichner C, 2015, EXP PARASITOL, V159, P79, DOI 10.1016/j.exppara.2015.09.001; Eichner C, 2015, PARASITOL INT, V64, P86, DOI 10.1016/j.parint.2014.10.006; Eichner C, 2014, EXP PARASITOL, V140, P44, DOI 10.1016/j.exppara.2014.03.014; Ewels P, 2016, BIOINFORMATICS, V32, P3047, DOI 10.1093/bioinformatics/btw354; Farlora R, 2015, GENE, V564, P73, DOI 10.1016/j.gene.2015.03.045; Frost P, 2003, VET PARASITOL, V118, P169, DOI 10.1016/j.vetpar.2003.09.020; Gusmao LFM, 2009, J PLANKTON RES, V31, P1101, DOI 10.1093/plankt/fbp059; Hamre LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073539; Hamre LA, 2009, PARASITOL INT, V58, P451, DOI 10.1016/j.parint.2009.08.009; Hamre LA, 2019, AQUACULT ENV INTERAC, V11, P429, DOI 10.3354/aei00320; Hamre LA, 2011, DIS AQUAT ORGAN, V97, P47, DOI 10.3354/dao02397; Hon T, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-00743-4; Hull MQ, 1998, PHILOS T ROY SOC B, V353, P753, DOI 10.1098/rstb.1998.0241; Jalili V, 2020, NUCLEIC ACIDS RES, V48, pW395, DOI 10.1093/nar/gkaa434; JOHNSON SC, 1991, CAN J ZOOL, V69, P929, DOI 10.1139/z91-138; Kapustin Y, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-20; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; KORPELAINEN H, 1990, BIOL REV, V65, P147, DOI 10.1111/j.1469-185X.1990.tb01187.x; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Messmer AM, 2018, MAR GENOM, V40, P45, DOI 10.1016/j.margen.2018.03.005; Michaud DR, 2019, FACETS, V4, P254, DOI 10.1139/facets-2018-0016; Montero-Pau J, 2008, LIMNOL OCEANOGR-METH, V6, P218, DOI 10.4319/lom.2008.6.218; Moroy T, 2004, INT J BIOCHEM CELL B, V36, P1424, DOI 10.1016/S1357-2725(03)00432-1; Muller H, 2000, BBA-REV CANCER, V1470, pM1, DOI 10.1016/S0304-419X(99)00030-X; Mykles DL, 2011, J STEROID BIOCHEM, V127, P196, DOI 10.1016/j.jsbmb.2010.09.001; Nunez-Acuna G, 2019, MAR GENOM, V45, P38, DOI 10.1016/j.margen.2019.01.005; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Poley JD, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2835-7; Poley JD, 2015, AQUACULTURE, V448, P445, DOI 10.1016/j.aquaculture.2015.06.026; Qiu XB, 2006, CELL MOL LIFE SCI, V63, P2560, DOI 10.1007/s00018-006-6192-6; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Romani WA, 2013, EUR J APPL PHYSIOL, V113, P2503, DOI 10.1007/s00421-013-2686-8; RUSCH ME, 1958, NATURWISSENSCHAFTEN, V45, P69; Shiozaki T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245936; Skern-Mauritzen R, 2021, GENOMICS, V113, P3666, DOI 10.1016/j.ygeno.2021.08.002; The Norwegian Ministry of Trade; Industry and Fisheries, 2016, FORSKRIFT BEKJEMPELS; Thompson CRS, 2021, J FISH DIS, V44, P863, DOI 10.1111/jfd.13345; Westcott JD, 2008, DIS AQUAT ORGAN, V79, P119, DOI 10.3354/dao01887	58	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266022	10.1371/journal.pone.0266022	http://dx.doi.org/10.1371/journal.pone.0266022			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358250	Green Published, gold			2022-12-26	WOS:000799828800061
J	Sun, H; Wu, GM; Zhang, JY; Wang, Y; Qiu, Y; Man, HY; Zhang, GL; Li, ZH; Yue, YH; Tian, Y				Sun, He; Wu, Guangmou; Zhang, Jiyuan; Wang, Yu; Qiu, Yue; Man, Hongyang; Zhang, Guoli; Li, Zehong; Yue, Yuhuan; Tian, Yuan			Characterization of an intracellular humanized single-chain antibody to matrix protein (M1) of H5N1 virus	PLOS ONE			English	Article							AVIAN INFLUENZA; SCFV; NS1	We developed a human intracellular antibody based on the M1 protein from avian influenza virus H5N1 (A/meerkat/Shanghai/SH-1/2012) and then characterized the properties of this antibody. The M1 protein sequence was amplified by RT-PCR using the cDNA of the H5N1 virus as a template, expressed in bacterial expression system BL21 (DE3) and purified. A human strain, high affinity, and single chain antibody (HuScFv) against M1 protein was obtained by phage antibody library screening using M1 as an antigen. A recombinant TAT-HuScFv protein was expressed by fusion with the TAT protein transduction domain (PTD) gene of HIV to prepare a human intracellular antibody against avian influenza virus. Further analysis demonstrated that TAT-HuScFv could inhibit the hemagglutination activity of the 300 TCID50 H1N1 virus, thus providing preliminary validation of the universality of the antibody. After two rounds of M1 protein decomposition, the TAT-HuScFv antigen binding site was identified as Alanine (A) at position 239. Collectively, our data describe a recombinant antibody with high binding activity against the conserved sequences of avian influenza viruses. This intracellular recombinant antibody blocked the M1 protein that infected intracellular viruses, thus inhibiting the replication and reproduction of H5N1 viruses.	[Sun, He; Wang, Yu; Qiu, Yue; Man, Hongyang; Li, Zehong] Jilin Agr Univ, Coll Life Sci, Changchun, Peoples R China; [Sun, He; Wu, Guangmou; Wang, Yu; Qiu, Yue; Man, Hongyang; Zhang, Guoli; Yue, Yuhuan; Tian, Yuan] Chinese Acad Agr Sci, Changchun Vet Res Inst, Changchun, Peoples R China; [Zhang, Jiyuan] Changchun Univ, Tourism Coll, Changchun, Peoples R China	Jilin Agricultural University; Chinese Academy of Agricultural Sciences; Changchun University	Yue, YH; Tian, Y (corresponding author), Chinese Acad Agr Sci, Changchun Vet Res Inst, Changchun, Peoples R China.	yhyue2013@163.com; wyaycem@163.com		Yue, Yuhuan/0000-0002-8563-6205; Sun, He/0000-0002-8378-3789	Jilin Province Science and technology development plan [20200404113YY, 20190304038YY]	Jilin Province Science and technology development plan	We received two grants, Jilin Province Science and technology development plan. 20200404113YY, 20190304038YY, Please find the attached file A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abd Raman HS, 2020, PEERJ, V7, DOI 10.7717/peerj.7954; Alizadeh S, 2021, IRAN J BASIC MED SCI, V24, P17, DOI 10.22038/ijbms.2020.43508.10219; Ascione A, 2009, ANTIVIR RES, V83, P238, DOI 10.1016/j.antiviral.2009.05.005; Chen HL, 2009, SCI CHINA SER C, V52, P419, DOI 10.1007/s11427-009-0068-6; Dong-din-on F, 2015, VIRUSES-BASEL, V7, P154, DOI 10.3390/v7010154; Joseph U, 2017, INFLUENZA OTHER RESP, V11, P74, DOI 10.1111/irv.12412; Li CJ, 2014, TRENDS BIOTECHNOL, V32, P147, DOI 10.1016/j.tibtech.2014.01.001; Li TW, 2016, ARCH VIROL, V161, P19, DOI 10.1007/s00705-015-2625-6; Lin BY, 2015, ANN NY ACAD SCI, V1350, P17, DOI 10.1111/nyas.12858; Mok BWY, 2017, MICROBES INFECT, V19, P587, DOI 10.1016/j.micinf.2017.08.011; Noisumdaeng P, 2021, PEERJ, V9, DOI 10.7717/peerj.11021; Paterson D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003019; Pissawong T, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-148; Poungpair O, 2010, BIOCONJUGATE CHEM, V21, P1134, DOI 10.1021/bc900251u; Pounpair O, 2009, J VIROL METHODS, V159, P105, DOI 10.1016/j.jviromet.2009.03.010; Poursiyami M, 2019, REP BIOCHEM MOL BIOL, V8, P301; Shim BS, 2018, J IMMUNOL RES, V2018, DOI 10.1155/2018/9830701; Terrier O, 2012, VIROLOGY, V432, P204, DOI 10.1016/j.virol.2012.05.019; Wu J, 2014, J MICROBIOL BIOTECHN, V24, P704, DOI 10.4014/jmb.1311.11107; Xu YL., 2016, HEILONGJIANG XUMU SH, DOI [10.13881/j.cnki.hljxmsy.2016.0007, DOI 10.13881/J.CNKI.HLJXMSY.2016.0007]; Yee KS, 2009, COMP IMMUNOL MICROB, V32, P325, DOI 10.1016/j.cimid.2008.01.005; Yin Y, 2020, EMERG MICROBES INFEC, V9, P1933, DOI 10.1080/22221751.2020.1812436	22	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266220	10.1371/journal.pone.0266220	http://dx.doi.org/10.1371/journal.pone.0266220			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358257	Green Published, gold			2022-12-26	WOS:000799828800079
J	Zeng, J; Sun, PS; Ping, QH; Jiang, S; Hu, YJ				Zeng, Jing; Sun, Peisong; Ping, Quanhong; Jiang, Shan; Hu, Yuanjing			Clinical outcome of FIGO 2018 stage IB3/IIA2 cervical cancer treated by neoadjuvant chemotherapy followed by radical surgery due to lack of radiotherapy equipment: A retrospective comparison with concurrent chemoradiotherapy	PLOS ONE			English	Article							ADJUVANT CHEMOTHERAPY; IB2; IIB; CARCINOMA; SURVIVAL; CHEMORADIATION; ADENOCARCINOMA; HYSTERECTOMY; REGIMENS; EFFICACY	This study aimed to assess neoadjuvant chemotherapy's clinical outcomes such as efficacy, toxicity, and survival outcomes followed by radical hysterectomy ((NACT-RS) among women with cervical cancer stage IB3 and IIA2, by comparing concurrent chemoradiotherapy (CCRT) and NACT-RS. The study retrospectively reviewed patients with (2018 FIGO) stage IB3 and IIA2 cervical cancer who received preoperative neoadjuvant chemotherapy followed by NACT-RS or concurrent chemoradiotherapy (CCRT). The outcome measures were the 5-year survival and complication rates between the two groups. The median follow-up was 75 months. In total, 218 patients had stage IIA2, 136 patients had stage IB3, 201 patients received CCRT, and 153 patients received preoperative NACT-RS. In the CCRT group, the incidence of early complications (myelosuppression, gastrointestinal and urinary) was higher compared with that in the NACT-RS group (76.1 vs. 26.1%; p < 0.001, respectively). There was no significant difference between the two study groups concerning late complications. Five-year PFS was 79.9% and 85.5% in the NACT-RS and CCRT groups, respectively (p = 0.093). Five-year OS was 86.9% and 85.5% in the NACT-RS and CCRT groups, respectively (p = 0.97). In the multivariate clinicopathologic characteristics analysis for OS, initial tumor size > 4.3 cm (HR 5.11; p < 0.001), AC/ASC (HR 1.89; p = 0.02), histologic grade 2-3 (HR 2.25; p = 0.04), and 2018 FIGO stage IIA2 (HR 8.67; p < 0.001) were independent risk factors. The survival of patients with stage IB3 and IIA2 cervical cancer treated with NACT-RS was similar to that of patients treated with CCRT without increasing side effects.	[Zeng, Jing; Sun, Peisong; Ping, Quanhong; Hu, Yuanjing] Nankai Univ, Tianjin Cent Hosp Gynecol & Obstet, Tianjin Clin Res Ctr Obstet & Gynecol, Dept Gynecol Oncol,Affiliated Hosp, Tianjin, Peoples R China; [Jiang, Shan] Tianjin Univ, Sch Mech Engn, Tianjin, Peoples R China	Nankai University; Tianjin University	Hu, YJ (corresponding author), Nankai Univ, Tianjin Cent Hosp Gynecol & Obstet, Tianjin Clin Res Ctr Obstet & Gynecol, Dept Gynecol Oncol,Affiliated Hosp, Tianjin, Peoples R China.	huyuanjingzxfck@163.com			Health Science and Technology Project of Tianjin [KJ20149, ZC20111]	Health Science and Technology Project of Tianjin	This study was supported by the Health Science and Technology Project of Tianjin (No. KJ20149 and ZC20111). Jing Zeng designed the study and collected and analyzed the data. Quanhong Ping prepared the manuscript, and Peisong Sun decided to publish it.	Bhatla N, 2018, INT J GYNECOL OBSTET, V143, P22, DOI 10.1002/ijgo.12611; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chargui R, 2006, AM J OBSTET GYNECOL, V194, P43, DOI 10.1016/j.ajog.2005.06.029; CHASSAGNE D, 1993, RADIOTHER ONCOL, V26, P195, DOI 10.1016/0167-8140(93)90260-F; Cho YH, 2009, J GYNECOL ONCOL, V20, P22, DOI 10.3802/jgo.2009.20.1.22; Chun M, 2009, J GYNECOL ONCOL, V20, P201, DOI 10.3802/jgo.2009.20.4.201; FREI E, 1982, CANCER, V50, P1979, DOI 10.1002/1097-0142(19821115)50:10<1979::AID-CNCR2820501002>3.0.CO;2-D; Gien LT, 2009, J SURG ONCOL, V99, P242, DOI 10.1002/jso.21199; Greggi S, 2019, INT J GYNECOL CANCER, V29, pA12, DOI 10.1136/ijgc-2019-ESGO.13; Gupta S, 2018, J CLIN ONCOL, V36, P1548, DOI 10.1200/JCO.2017.75.9985; Hu K, 2018, RADIAT ONCOL, V13, DOI 10.1186/s13014-018-1197-5; Hu T, 2012, EUR J CANCER, V48, P2353, DOI 10.1016/j.ejca.2012.03.015; Hwang YY, 2001, GYNECOL ONCOL, V82, P88, DOI 10.1006/gyno.2001.6204; Katsumata N, 2010, J CLIN ONCOL, V28, DOI [10.1200/jco.2010.28.15_suppl.5047, DOI 10.1200/JCO.2010.28.15_SUPPL.5047]; KIM DS, 1988, GYNECOL ONCOL, V29, P321, DOI 10.1016/0090-8258(88)90231-4; Kim HS, 2013, EJSO-EUR J SURG ONC, V39, P115, DOI 10.1016/j.ejso.2012.09.003; Kim HS, 2010, GYNECOL ONCOL, V119, P217, DOI 10.1016/j.ygyno.2010.06.017; Kim Min-Jeong, 2008, J Gynecol Oncol, V19, P181, DOI 10.3802/jgo.2008.19.3.181; Kim SI, 2019, GYNECOL ONCOL, V153, P3, DOI 10.1016/j.ygyno.2019.01.008; Koh WJ, 2019, J NATL COMPR CANC NE, V17, P64, DOI 10.6004/jnccn.2019.0001; Kornovski Y, 2012, Akush Ginekol (Sofiia), V51, P18; Li S, 2016, ONCOTARGET, V7, P21054, DOI 10.18632/oncotarget.8245; Lukas R, 2013, EXPERT REV ANTICANC, V13, P861, DOI 10.1586/14737140.2013.811147; Minig L, 2014, WORLD J CLIN ONCOL, V5, P86, DOI 10.5306/wjco.v5.i2.86; PANICI PB, 1988, OBSTET GYNECOL, V71, P344; Querleu D, 2017, ANN SURG ONCOL, V24, P3406, DOI 10.1245/s10434-017-6031-z; Ryu HS, 2007, INT J GYNECOL CANCER, V17, P132, DOI 10.1111/j.1525-1438.2007.00803.x; Sardi JE, 2005, CURR OPIN OBSTET GYN, V17, P43; Sedlis A, 1999, GYNECOL ONCOL, V73, P177, DOI 10.1006/gyno.1999.5387; Shoji T, 2013, CANCER CHEMOTH PHARM, V71, P657, DOI 10.1007/s00280-012-2052-2; Sturdza A, 2016, RADIOTHER ONCOL, V120, P428, DOI 10.1016/j.radonc.2016.03.011; Sugalski JM, 2019, J ONCOL PRACT, V15, pE458, DOI 10.1200/JOP.18.00563; Tang J, 2012, GYNECOL ONCOL, V125, P297, DOI 10.1016/j.ygyno.2012.01.033; Tewari KS, 2014, NEW ENGL J MED, V370, P734, DOI 10.1056/NEJMoa1309748; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Uegaki K, 2014, INT J CLIN ONCOL, V19, P348, DOI 10.1007/s10147-013-0559-0; Wang M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86786-y; Williams NL, 2015, CURR ONCOL REP, V17, DOI 10.1007/s11912-015-0440-6; Yee GPC, 2013, CURR CANCER DRUG TAR, V13, P205; Zhao YB, 2012, ASIAN PAC J CANCER P, V13, P1487, DOI 10.7314/APJCP.2012.13.4.1487; Zhou J, 2017, INT J SURG, V41, P16, DOI 10.1016/j.ijsu.2017.03.024	41	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266001	10.1371/journal.pone.0266001	http://dx.doi.org/10.1371/journal.pone.0266001			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324998	Green Published, gold			2022-12-26	WOS:000780951300091
J	Battista, MR; Grigoletto, A; Tedeschini, T; Cellucci, A; Colaceci, F; Laufer, R; Pasut, G; Di Marco, A				Battista, Maria Rosaria; Grigoletto, Antonella; Tedeschini, Tommaso; Cellucci, Antonella; Colaceci, Fabrizio; Laufer, Ralph; Pasut, Gianfranco; Di Marco, Annalise			Efficacy of PEGylated ciliary neurotrophic factor superagonist variant in diet-induced obesity mice	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; SITE-SPECIFIC PEGYLATION; STABILITY; CONJUGATION; PROTEINS; POTENCY; BINDING; WEIGHT	Ciliary neurotrophic factor (CNTF) is a neurotrophic cytokine able to induce appetite reduction, weight loss and antidiabetic effects. However, its susceptibility to neutralizing anti-CNTF antibodies in patients hampered its use for treatment of human obesity and diabetes. In addition, CNTF has a very short plasma half-life, which limits its use as a therapeutic agent. Solutions, directed to prolong its in vivo effects, vary from the implantation of encapsulated secreting cells to identification of more active variants or chemical modification of the protein itself. PEGylation is a widely used modification for shielding proteins from circulating antibodies and for increasing their plasma half-life. Here, we have selected DH-CNTF, a CNTF variant which has a 40-fold higher affinity for the CNTF receptor a accompanied by an increased activity in cellular assays. The PEGylated DH-CNTF retained the biological activity of native protein in vitro and showed a significant improvement of pharmacokinetic parameters. In an acute model of glucose tolerance, the PEG-DH-CNTF was able to reduce the glycemia in diet-induced obese animals, with a performance equaled by a 10-fold higher dose of DH-CNTF. In addition, the PEGylated DH-CNTF analog demonstrated a more potent weight loss effect than the unmodified protein, opening to the use of CNTF as weight reducing agent with treatment regimens that can better meet patient compliance thanks to reduced dosing schedules.	[Battista, Maria Rosaria; Cellucci, Antonella; Colaceci, Fabrizio; Di Marco, Annalise] IRBM SpA, Rome, Italy; [Grigoletto, Antonella; Tedeschini, Tommaso; Pasut, Gianfranco] Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy; [Laufer, Ralph] Lysogene, Neuilly Sur Seine, France	University of Padua	Di Marco, A (corresponding author), IRBM SpA, Rome, Italy.; Pasut, G (corresponding author), Univ Padua, Dept Pharmaceut & Pharmacol Sci, Padua, Italy.	gianfranco.pasut@unipd.it; a.dimarco@irbm.com	Pasut, Gianfranco/I-5944-2012	Pasut, Gianfranco/0000-0002-8754-0899; Di Marco, Annalise/0000-0001-5211-6230	Collezione Nazionale di Composti Chimici e Centro Screening (CNCCS) consortium	Collezione Nazionale di Composti Chimici e Centro Screening (CNCCS) consortium	This research was funded by Collezione Nazionale di Composti Chimici e Centro Screening (CNCCS) consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADLER R, 1979, SCIENCE, V204, P1434, DOI 10.1126/science.451576; ARAKAWA T, 1993, J PROTEIN CHEM, V12, P525, DOI 10.1007/BF01025117; Balan S, 2007, BIOCONJUGATE CHEM, V18, P61, DOI 10.1021/bc0601471; Basu A, 2006, BIOCONJUGATE CHEM, V17, P618, DOI 10.1021/bc050322y; BAZAN JF, 1991, NEURON, V7, P197, DOI 10.1016/0896-6273(91)90258-2; Bluher S, 2004, DIABETES, V53, P2787, DOI 10.2337/diabetes.53.11.2787; Bonetto A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022538; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; DiMarco A, 1996, P NATL ACAD SCI USA, V93, P9247, DOI 10.1073/pnas.93.17.9247; DiMarco A, 1997, J BIOL CHEM, V272, P23069, DOI 10.1074/jbc.272.37.23069; DITTRICH F, 1994, ANN NEUROL, V35, P151, DOI 10.1002/ana.410350206; Gloaguen I, 1997, P NATL ACAD SCI USA, V94, P6456, DOI 10.1073/pnas.94.12.6456; Grigoletto A, 2017, J DRUG TARGET, V25, P856, DOI 10.1080/1061186X.2017.1363211; Grigoletto A, 2016, MACROMOL BIOSCI, V16, P50, DOI 10.1002/mabi.201500282; Itkonen J, 2020, PHARMACEUTICS, V12, DOI 10.3390/pharmaceutics12070611; Kaur N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217234; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambert PD, 2001, P NATL ACAD SCI USA, V98, P4652, DOI 10.1073/pnas.061034298; Maso K, 2020, J CONTROL RELEASE, V324, P228, DOI 10.1016/j.jconrel.2020.05.015; MCDONALD NQ, 1995, EMBO J, V14, P2689, DOI 10.1002/j.1460-2075.1995.tb07269.x; Mero A, 2016, POLYM CHEM-UK, V7, P6545, DOI 10.1039/c6py01616b; Murakami M, 2019, IMMUNITY, V50, P812, DOI 10.1016/j.immuni.2019.03.027; Nilsson C, 2012, ACTA PHARMACOL SIN, V33, P173, DOI 10.1038/aps.2011.203; Pasut G, 2012, J CONTROL RELEASE, V161, P461, DOI 10.1016/j.jconrel.2011.10.037; PENNICA D, 1995, J BIOL CHEM, V270, P10915, DOI 10.1074/jbc.270.18.10915; Raso SW, 2005, PROTEIN SCI, V14, P2246, DOI 10.1110/ps.051489405; SAGGIO I, 1995, EMBO J, V14, P3045, DOI 10.1002/j.1460-2075.1995.tb07307.x; Severi I, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00263; Shimazaki T, 2001, J NEUROSCI, V21, P7642, DOI 10.1523/JNEUROSCI.21-19-07642.2001; Sleeman M W, 2000, Pharm Acta Helv, V74, P265, DOI 10.1016/S0031-6865(99)00050-3; Ueno N, 2007, ENDOCRINE, V32, P192, DOI 10.1007/s12020-007-9016-z; Xu BJ, 2016, NAT REV NEUROSCI, V17, P282, DOI 10.1038/nrn.2016.24; Zalipsky S, 2020, POLYMER-PROTEIN CONJUGATES: FROM PEGYLATION AND BEYOND, P3, DOI 10.1016/B978-0-444-64081-9.00001-2; Zhang C, 2017, INT J PHARMACEUT, V529, P275, DOI 10.1016/j.ijpharm.2017.06.074	34	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265749	10.1371/journal.pone.0265749	http://dx.doi.org/10.1371/journal.pone.0265749			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316287	Green Published, gold			2022-12-26	WOS:000834238000037
J	Sprenger, R; Hackl, D; Kossack, N; Schiffner-Rohe, J; Wohlleben, J; von Eiff, C				Sprenger, Ralf; Haeckl, Dennis; Kossack, Nils; Schiffner-Rohe, Julia; Wohlleben, Jessica; von Eiff, Christof			Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time	PLOS ONE			English	Article								Background Pneumococcal vaccination is recommended by the German Standing Committee on Vaccination (STIKO) for infants, elderly 60+ years and patients at risk. In 2016, a sequential pneumococcal vaccination schedule (conjugate vaccine followed by polysaccharide vaccine 6-12 months later) supplemented this recommendation for immunocompromised patients >= 2 years of age. Previous research showed low pneumococcal vaccination rates (pnc-VR) in this vulnerable group. Moreover, no evidence is available on adherence to the newer sequential schedule. This study aimed to analyze the development of pnc-VRs in immunocompromised patients and rates of sequential vaccinations according to the STIKO recommendations. Methods Using a representative health claims database, we assigned incident immunocompromised patients >= 2 years of age to one of two successive cohorts to observe trends over time: cohort A (first diagnosis of immunocompromised condition between 01/2013 and 12/2014), and cohort B (first diagnosis between 01/ 2015 and 12/2017). Pnc-VR within two years after first diagnosis and cumulative pnc-VR was compared among both cohorts. In cohort B, we assessed sequential pnc-VR within 15 months of the first vaccination. For additional analyses, patients were stratified by age, gender and immunocompromising condition. Results Cohort A and B comprised 193,521 and 289,279 patients, respectively. Overall pnc-VR increased over time from 4.3% (cohort A; 95%-confidence interval: 4.3%-4.4%) to 6.0% (cohort B; 5.9%-6.1%), with highest pnc-VRs in men >= 60 years (11.3%: 11.1%-11.6%) and HIV patients (15.2%: 13.1%-17.4%). Cumulative pnc-VRs in cohort B were higher in anyquarter following diagnosis when compared with cohort A. Overall sequential pnc-VR in cohort B was 4.0% (3.7%-4.3%), with a higher rate observed in patients aged 16-59 (6.8%: 6.0%-7.7%) vs. patients aged >= 60 years (3.1%: 2.8%-3.4%). Conclusion While some improvements were seen over time, pnc-VRs remain very low in immunocompromised patients, as did sequential vaccination rates. Current recommendations to protect immunocompromised patients from pneumococcal infections are not being sufficiently implemented.	[Sprenger, Ralf; Schiffner-Rohe, Julia; Wohlleben, Jessica; von Eiff, Christof] Pfizer Pharma GmbH, Berlin, Germany; [Haeckl, Dennis; Kossack, Nils] Sci Inst Hlth Econ Andfig Hlth Syst Res WIG2 GmbH, Leipzig, Germany; [Haeckl, Dennis] Univ Leipzig, Leipzig, Germany	Pfizer; Leipzig University	Sprenger, R (corresponding author), Pfizer Pharma GmbH, Berlin, Germany.	ralf.sprenger@pfizer.com		Sprenger, Ralf/0000-0003-2721-110X	Pfizer Pharma GmbH	Pfizer Pharma GmbH(Pfizer)	This study was supported by an unrestricted research grant from Pfizer Pharma GmbH. The funder provided support in the form of salaries for authors (RS, CvE, JW, JSR), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the author contribution section.	Braeken DCW, 2021, INFECTION, V49, P533, DOI 10.1007/s15010-021-01605-w; Campling J, 2019, PNEUMONIA, V11, DOI 10.1186/s41479-019-0063-z; Campling J, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000703; Di Pasquale MF, 2019, CLIN INFECT DIS, V68, P1482, DOI 10.1093/cid/ciy723; Gemeinsamer Bundesausschuss, 2021, RICHTL GEM BUND SCHU; IQTIG-Institut fur Qualitatssicherung und Transparenz im Gesundheitswesen, QUAL 2020; McAdam-Marx C, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4263-2; Pelton SI, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1162-y; RKI, 2020, EPIDEMIOLOGISCHES B, V47; Robert Koch-Institut, 2021, EPID B; Robert Koch-Institut, 2020, EPIDEMIOLOGISCHES B, V34; Robert Koch-Institut, NEUER AKT EMPF STAND; Robert Koch-Institut (RKI), EPIDEMIOLOGISCHES B; Schmedt N, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220848; Schmedt N, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-018-3861-8; Shoar S, 2020, PNEUMONIA, V12, DOI 10.1186/s41479-020-00074-3; Stander S, 2020, ACTA DERM-VENEREOL, V100, DOI 10.2340/00015555-3655; Theidel U, 2013, DTSCH ARZTEBL INT, V110, P743, DOI 10.3238/arztebl.2013.0743; Theilacker C, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253118	20	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265433	10.1371/journal.pone.0265433	http://dx.doi.org/10.1371/journal.pone.0265433			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316288	Green Published, gold			2022-12-26	WOS:000834238000025
J	Allahyari, N; Kargaran, A; Hosseiny, A; Jafari, GR				Allahyari, Nastaran; Kargaran, Amir; Hosseiny, Ali; Jafari, G. R.			The structure balance of gene-gene networks beyond pairwise interactions	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SOCIAL NETWORKS; DYNAMICS; GENOME; YEAST	Despite its high and direct impact on nearly all biological processes, the underlying structure of gene-gene interaction networks is investigated so far according to pair connections. To address this, we explore the gene interaction networks of the yeast Saccharomyces cerevisiae beyond pairwise interaction using the structural balance theory (SBT). Specifically, we ask whether essential and nonessential gene interaction networks are structurally balanced. We study triadic interactions in the weighted signed undirected gene networks and observe that balanced and unbalanced triads are over and underrepresented in both networks, thus beautifully in line with the strong notion of balance. Moreover, we note that the energy distribution of triads is significantly different in both essential and nonessential networks compared to the shuffled networks. Yet, this difference is greater in the essential network regarding the frequency as well as the energy of triads. Additionally, results demonstrate that triads in the essential gene network are more interconnected through sharing common links, while in the nonessential network they tend to be isolated. Last but not least, we investigate the contribution of all-length signed walks and its impact on the degree of balance. Our findings reveal that interestingly when considering longer cycles, not only, both essential and nonessential gene networks are more balanced compared to their corresponding shuffled networks, but also, the nonessential gene network is more balanced compared to the essential network.	[Allahyari, Nastaran; Kargaran, Amir; Hosseiny, Ali; Jafari, G. R.] Shahid Beheshti Univ, Dept Phys, Tehran, Iran; [Jafari, G. R.] Irkutsk Natl Res Tech Univ, Inst Informat Technol & Data Sci, Irkutsk, Russia	Shahid Beheshti University; Irkutsk National Research Technical University (INRTU)	Jafari, GR (corresponding author), Shahid Beheshti Univ, Dept Phys, Tehran, Iran.; Jafari, GR (corresponding author), Irkutsk Natl Res Tech Univ, Inst Informat Technol & Data Sci, Irkutsk, Russia.	g_jafari@sbu.ac.ir	Jafari, Gholamreza/AAJ-9707-2021	Jafari, Gholamreza/0000-0002-0448-5549				Abell P, 2009, J MATH SOCIOL, V33, P129, DOI 10.1080/00222500902718239; ACHARYA BD, 1980, J GRAPH THEOR, V4, P1, DOI 10.1002/jgt.3190040102; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Allahyari N, 2021, ARXIV210713300; Antal T, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.036121; Antal T, 2006, PHYSICA D, V224, P130, DOI 10.1016/j.physd.2006.09.028; Aref S, 2019, J COMPLEX NETW, V7, P163, DOI 10.1093/comnet/cny015; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Baryshnikova A, 2010, NAT METHODS, V7, P1017, DOI 10.1038/NMETH.1534; Belaza AM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183696; Blomen VA, 2015, SCIENCE, V350, P1092, DOI 10.1126/science.aac7557; Bongiorno C, 2021, EPL-EUROPHYS LETT, V133, DOI 10.1209/0295-5075/133/48001; CARTWRIGHT D, 1956, PSYCHOL REV, V63, P277, DOI 10.1037/h0046049; Castellano C, 2009, REV MOD PHYS, V81, P591, DOI 10.1103/RevModPhys.81.591; Costanzo M, 2016, SCIENCE, V353, DOI 10.1126/science.aaf1420; Costanzo M, 2010, SCIENCE, V327, P425, DOI 10.1126/science.1180823; DasGupta B, 2007, BIOSYSTEMS, V90, P161, DOI 10.1016/j.biosystems.2006.08.001; DAVIS JA, 1967, HUM RELAT, V20, P181, DOI 10.1177/001872676702000206; Doreian P., 2015, J SOC STRUCT, V16, P1; Easley D., 2010, ECON THEOR, V26, pb1, DOI [10.1017/S0266466609990685, DOI 10.1017/S0266466609990685, 10.1017/s0266466609990685]; Estrada E, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.042802; Facchetti G, 2011, P NATL ACAD SCI USA, V108, P20953, DOI 10.1073/pnas.1109521108; Gawronski P, 2005, ARXIVPHYSICS0501160; HARARY F, 1980, MATH SOC SCI, V1, P131, DOI 10.1016/0165-4896(80)90010-4; HARARY F, 1959, BEHAV SCI, V4, P316; HART J, 1974, J PEACE RES, V11, P229, DOI 10.1177/002234337401100307; Hedayatifar L, 2017, PHYSICA A, V483, P109, DOI 10.1016/j.physa.2017.04.132; Heider F, 1946, J PSYCHOL, V21, P107, DOI 10.1080/00223980.1946.9917275; Hummon NP, 2003, SOC NETWORKS, V25, P17, DOI 10.1016/S0378-8733(02)00019-9; Humphries MD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002051; Iacono G, 2010, IET SYST BIOL, V4, P223, DOI 10.1049/iet-syb.2009.0040; Ilany A, 2013, ANIM BEHAV, V85, P1397, DOI 10.1016/j.anbehav.2013.03.032; Jalan S, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.046118; Kargaran A, 2020, PHYS REV E, V102, DOI 10.1103/PhysRevE.102.012310; Khanafiah D, 2014, ARXIVNLIN0405041; Kirkley A, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.012320; Krawczyk MJ, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47697-1; Kulakowski K, 2005, INT J MOD PHYS C, V16, P707, DOI 10.1142/S012918310500742X; Lerner J, 2016, SOC NETWORKS, V45, P66, DOI 10.1016/j.socnet.2015.12.002; Leskovec J, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1361; Li ZJ, 2011, NAT BIOTECHNOL, V29, P361, DOI 10.1038/nbt.1832; Ma'ayan A, 2008, IET SYST BIOL, V2, P103, DOI 10.1049/iet-syb:20070036; Marvel SA, 2011, P NATL ACAD SCI USA, V108, P1771, DOI 10.1073/pnas.1013213108; Marvel SA, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.198701; Masoumi R, 2021, PHYS REV E, V103, DOI 10.1103/PhysRevE.103.052301; Moradimanesh Z, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80330-0; Muldoon SF, 2016, SCI REP-UK, V6, DOI 10.1038/srep22057; Namaki A, 2011, INT J MOD PHYS C, V22, P371, DOI 10.1142/S0129183111016300; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; NORMAN RZ, 1972, J MATH PSYCHOL, V9, P66, DOI 10.1016/0022-2496(72)90006-5; Oloomi F, 2021, PHYS REV E, V103, DOI 10.1103/PhysRevE.103.022307; Parapouli M, 2020, AIMS MICROBIOL, V6, P1, DOI [10.3934/microbiol.2020001, 10.3934/microbio1.2020001]; Pradhan P, 2020, IEEE T NETW SCI ENG, V7, P3008, DOI 10.1109/TNSE.2020.3008999; Rabbani F, 2019, PHYS REV E, V99, DOI 10.1103/PhysRevE.99.062302; Saeedian M, 2019, PHYSICA A, V526, DOI 10.1016/j.physa.2019.04.028; Saiz H, 2017, ECOGRAPHY, V40, P733, DOI 10.1111/ecog.02561; Sheykhali S, 2020, PHYSICA A, V548, DOI 10.1016/j.physa.2019.123882; Sontag Eduardo D, 2007, Syst Synth Biol, V1, P59, DOI 10.1007/s11693-007-9005-9; Srinivasan A, 2011, P NATL ACAD SCI USA, V108, P1751, DOI 10.1073/pnas.1018901108; Terzi E., 2011, LECT NOTES COMPUTER, P6732, DOI [10.1007/978-3-642-21286-4_1, DOI 10.1007/978-3-642-21286-4_1]; Traag VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060063; van de Rijt A, 2011, J MATH SOCIOL, V35, P94, DOI 10.1080/0022250X.2010.532262; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901; Zheng XL, 2015, INFORM SYST FRONT, V17, P1077, DOI 10.1007/s10796-014-9483-8; Zhou XZ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5212	67	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0258596	10.1371/journal.pone.0258596	http://dx.doi.org/10.1371/journal.pone.0258596			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353818	Green Published, gold, Green Submitted			2022-12-26	WOS:000786647900031
J	Holmes, L; Watts-Overall, TM; Slettevold, E; Gruia, DC; Rieger, G				Holmes, Luke; Watts-Overall, Tuesday M.; Slettevold, Erlend; Gruia, Dragos C.; Rieger, Gerulf			The relationship between finger length ratio, masculinity, and sexual orientation in women: A correlational study	PLOS ONE			English	Article							PERSONALITY; BUTCH; FEMME; MEN	Homosexual women are, on average, more masculine in their appearance and behavior than heterosexual women. We hypothesized that their masculinity was influenced by exposure to elevated levels of prenatal androgen during early development. We recruited 199 women (including 67 homosexual women) and measured their masculinity via self-report and observer ratings. Our measure of prenatal androgen exposure was the ratio of the index to ring finger (2D:4D), which is hypothesized to be lower in women exposed to elevated levels of androgens during prenatal development. Homosexual women were substantially more masculine than heterosexual women in both self-report and observer ratings. However, homosexual women neither had more male-typical finger length ratios, nor did their finger length ratios relate to their masculinity in any predicted direction. Thus, we found no evidence that increased prenatal androgen exposure influenced masculinity in homosexual women.	[Holmes, Luke; Rieger, Gerulf] Univ Essex, Dept Psychol, Colchester, Essex, England; [Watts-Overall, Tuesday M.] Univ East London, Sch Psychol, Stratford, NJ USA; [Slettevold, Erlend] Univ East Anglia, Fac Med & Hlth Serv, Norwich, Norfolk, England; [Gruia, Dragos C.] Imperial Coll London, Dept Brain Sci, London, England	University of Essex; University of East Anglia; Imperial College London	Holmes, L (corresponding author), Univ Essex, Dept Psychol, Colchester, Essex, England.	lukeholmesphd@gmail.com	Slettevold, Erlend/GWU-8555-2022	Holmes, Luke/0000-0002-5739-1052	American Institute of Bisexuality [RSC2519]; University of Essex [DG00832]	American Institute of Bisexuality; University of Essex	This research was supported by grants awarded to G. R. by the American Institute of Bisexuality (RSC2519; https://www. americaninstituteofbisexuality.org/) and the University of Essex (DG00832; https://www.essex. ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaway HC, 2009, AM J HUM BIOL, V21, P365, DOI 10.1002/ajhb.20892; Bailey JM, 2016, PSYCHOL SCI PUBL INT, V17, P45, DOI 10.1177/1529100616637616; BAILEY JM, 1995, DEV PSYCHOL, V31, P43, DOI 10.1037/0012-1649.31.1.43; Bailey JM, 1997, J PERS SOC PSYCHOL, V73, P960, DOI 10.1037/0022-3514.73.5.960; Barrett ES, 2018, J DEV ORIG HLTH DIS, V9, P307, DOI 10.1017/S2040174417001118; Breedlove SM, 2017, ARCH SEX BEHAV, V46, P1583, DOI 10.1007/s10508-016-0904-2; Brown WM, 2002, HORM BEHAV, V42, P380, DOI 10.1006/hbeh.2002.1830; Brown WM, 2002, ARCH SEX BEHAV, V31, P123, DOI 10.1023/A:1014091420590; Galis F, 2010, ARCH SEX BEHAV, V39, P57, DOI 10.1007/s10508-009-9485-7; Gottschalk L, 2003, J GENDER STUD, V12, P35, DOI 10.1080/0958923032000067808; Grimbos T, 2010, BEHAV NEUROSCI, V124, P278, DOI 10.1037/a0018764; Hall LS, 2000, J SEX RES, V37, P315, DOI 10.1080/00224490009552053; Jantz RL, 2022, AM J HUM BIOL, V34, DOI 10.1002/ajhb.23625; Kinsey AC., 1953, SEXUAL BEHAV HUMAN F; Li G, 2017, DEV PSYCHOL, V53, P764, DOI 10.1037/dev0000281; Lippa RA, 2015, PUZZL SEX OR M LETHB, V07; Lippa RA, 2008, ARCH SEX BEHAV, V37, P173, DOI 10.1007/s10508-007-9267-z; Lippa RA, 2005, ANN REV SEX RES, V16, P119; Lippa RA, 2020, ARCH SEX BEHAV, V49, P607, DOI 10.1007/s10508-020-01643-9; McCormic CM, 2020, HORM BEHAV, V120, DOI 10.1016/j.yhbeh.2020.104710; McFadden D, 1998, P NATL ACAD SCI USA, V95, P2709, DOI 10.1073/pnas.95.5.2709; Meyer-Bahlburg HFL, 2008, ARCH SEX BEHAV, V37, P85, DOI 10.1007/s10508-007-9265-1; Morris JA, 2004, NAT NEUROSCI, V7, P1034, DOI 10.1038/nn1325; Pasterski VL, 2005, CHILD DEV, V76, P264, DOI 10.1111/j.1467-8624.2005.00843.x; Preacher KJ, 2008, BEHAV RES METHODS, V40, P879, DOI 10.3758/BRM.40.3.879; Rahman Q, 2003, PSYCHONEUROENDOCRINO, V28, P288, DOI 10.1016/S0306-4530(02)00022-7; Rieger G, GENDER NONCONFORMITY; Rieger G, 2008, DEV PSYCHOL, V44, P46, DOI 10.1037/0012-1649.44.1.46; Rieger G, 2020, ARCH SEX BEHAV, V49, P2469, DOI 10.1007/s10508-020-01709-8; Rieger G, 2016, J PERS SOC PSYCHOL, V111, P265, DOI 10.1037/pspp0000077; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Swift-Gallant A, 2020, HORM BEHAV, V120, DOI 10.1016/j.yhbeh.2020.104686; Tortorice JL., 2002, WRITTEN BODY BUTCH F; Tskhay KO, 2013, PERS SOC PSYCHOL REV, V17, P72, DOI 10.1177/1088868312461308; Watts TM., 2018, ARCH SEX BEHAV, P1, DOI [10.1007/s10508-017-1007-4, DOI 10.1007/S10508-017-1007-4]; Watts TM, 2018, DEV PSYCHOL, V54, P788, DOI 10.1037/dev0000461; Xu Y, 2019, DEV PSYCHOL, V55, P1226, DOI 10.1037/dev0000704	37	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0259637	10.1371/journal.pone.0259637	http://dx.doi.org/10.1371/journal.pone.0259637			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0V0SA	35344564	Green Published, gold			2022-12-26	WOS:000788055200021
J	Pausawasdi, N; Hongsrisuwan, P; Chalermwai, WV; Butt, AS; Maipang, K; Charatchareonwitthaya, P				Pausawasdi, Nonthalee; Hongsrisuwan, Penprapai; Chalermwai, Wipapat Vicki; Butt, Amna Subhan; Maipang, Kotchakon; Charatchareonwitthaya, Phunchai			The diagnostic performance of combined conventional cytology with smears and cell block preparation obtained from endoscopic ultrasound-guided fine needle aspiration for intra-abdominal mass lesions	PLOS ONE			English	Article							GASTROENTEROLOGY EUROPEAN-SOCIETY; SOLID LESIONS; TRUCUT NEEDLE; BIOPSY; ACCURACY; FNA; COMPLICATIONS; PANCREAS; MALIGNANCY; IMPACT	Background/AimEndoscopic ultrasound-guided fine needle aspiration (EUS-FNA) is the primary method for tissue acquisition of intra-abdominal masses. However, the main limitation of cytology alone is the lack of tissue architecture and inadequate samples. This study aimed to evaluate the diagnostic performance of combined conventional cytology and cell block preparation obtained from EUS-FNA of intra-abdominal masses without Rapid On-site Evaluation (ROSE). MethodsCytologic smears and cell block slides of 166 patients undergoing EUS-FNA during 2010-2015 were reviewed by an experienced cytopathologist blinded to clinical data. Results125 patients had neoplastic lesions. Pancreatic adenocarcinoma was the most common etiology (35.5%), followed by lymph node metastasis (27.7%). The mean mass size was 2.5 +/- 1.3 cm. The mean number of passes was 1.9 +/- 1.28. Tissue adequacy for conventional cytology and cell block preparation was 78.9% and 78.1%, respectively. Factors associated with tissue adequacy were assessed. For cytology, lesions of > 2.1 cm, masses in the pancreatic body or tail, malignancy, and pancreatic cancer were positively associated with adequate cellularity. For cell block preparation, lesions of > 3 cm and malignancy were associated with increased tissue adequacy. The conventional cytology alone had a sensitivity of 68.5%, a specificity of 95.7%, and an area under the receiver operating characteristics (AUROC) of 0.821. The cell block preparation alone had a sensitivity of 65.4%, a specificity of 96%, and an AUROC of 0.807. The combined conventional cytology and cell block preparation performed significantly better than either method alone (p<0.05), as demonstrated by an increased AUROC of 0.853. Furthermore, cell block detected malignancy in 9.3% of cases where the cytologic smears failed to identify malignant cells. ConclusionsThe combined conventional cytology and cell block preparation increased the diagnostic accuracy of EUS-FNA compared to either method alone. This approach should be implemented in routine practice, especially where ROSE is unavailable.	[Pausawasdi, Nonthalee; Hongsrisuwan, Penprapai; Butt, Amna Subhan; Maipang, Kotchakon; Charatchareonwitthaya, Phunchai] Mahidol Univ, Fac Med, Siriraj GI Endoscopy Ctr, Siriraj Hosp, Bangkok, Thailand; [Pausawasdi, Nonthalee; Charatchareonwitthaya, Phunchai] Mahidol Univ, Fac Med, Dept Med, Div Gastroenterol,Siriraj Hosp, Bangkok, Thailand; [Chalermwai, Wipapat Vicki] Mahidol Univ, Fac Med, Dept Pathol, Siriraj Hosp, Bangkok, Bangkok, Thailand; [Butt, Amna Subhan] AgaKhan Univ Hosp, Dept Med, Sect Gastroenterol, Karachi, Pakistan	Mahidol University; Mahidol University; Mahidol University	Pausawasdi, N (corresponding author), Mahidol Univ, Fac Med, Siriraj GI Endoscopy Ctr, Siriraj Hosp, Bangkok, Thailand.; Pausawasdi, N (corresponding author), Mahidol Univ, Fac Med, Dept Med, Div Gastroenterol,Siriraj Hosp, Bangkok, Thailand.	nonthaleep7@gmail.com		Pausawasdi, Nonthalee/0000-0002-3737-8555; Chalermwai, Wipapat Vicki/0000-0001-9608-4461				Ardengh Jose Celso, 2008, Acta Gastroenterologica Latinoamericana, V38, P246; Binmoeller KF, 1998, GASTROINTEST ENDOSC, V47, P121, DOI 10.1016/S0016-5107(98)70343-8; Cermak TS, 2012, CANCER CYTOPATHOL, V120, P319, DOI 10.1002/cncy.21201; Chong CCN, 2020, ENDOSCOPY, V52, P856, DOI 10.1055/a-1172-6027; Eloubeidi MA, 2004, CANCER CYTOPATHOL, V102, P253, DOI 10.1002/cncr.20369; Facciorusso A, 2020, GASTROINTEST ENDOSC, V91, P14, DOI 10.1016/j.gie.2019.07.018; Gines A, 2005, GASTROINTEST ENDOSC, V62, P597, DOI 10.1016/j.gie.2005.04.049; Haba S, 2013, J GASTROENTEROL, V48, P973, DOI 10.1007/s00535-012-0695-8; Iglesias-Garcia J, 2007, WORLD J GASTROENTERO, V13, P289, DOI 10.3748/wjg.v13.i2.289; Iglesias-Garcia J, 2011, AM J GASTROENTEROL, V106, P1705, DOI 10.1038/ajg.2011.119; Iwashita T, 2015, GASTROINTEST ENDOSC, V81, P177, DOI 10.1016/j.gie.2014.08.040; Jhala NC, 2004, CANCER CYTOPATHOL, V102, P239, DOI 10.1002/cncr.20451; Kim TH, 2013, GUT LIVER, V7, P605, DOI 10.5009/gnl.2013.7.5.605; Klapman JB, 2003, AM J GASTROENTEROL, V98, P1289, DOI 10.1016/S0002-9270(03)00246-6; Koss L. G., 2005, KOSS DIAGNOSTIC CYTO; Layfield LJ, 2014, DIAGN CYTOPATHOL, V42, P292, DOI 10.1002/dc.23078; Lee LS, 2005, CLIN GASTROENTEROL H, V3, P231, DOI 10.1016/S1542-3565(04)00618-4; Li H, 2018, MEDICINE, V97, DOI 10.1097/MD.0000000000010207; Lipnik AJ, 2015, RADIOL CLIN N AM, V53, P1049, DOI 10.1016/j.rcl.2015.05.007; Mitsuhashi T, 2006, CYTOPATHOLOGY, V17, P34, DOI 10.1111/j.1365-2303.2006.00277.x; Mizuno N, 2011, PANCREATOLOGY, V11, P40, DOI 10.1159/000323502; Moller K, 2009, GASTROINTEST ENDOSC, V70, P60, DOI 10.1016/j.gie.2008.10.008; Noda Y, 2010, J GASTROENTEROL, V45, P868, DOI 10.1007/s00535-010-0217-5; O'Toole D, 2001, GASTROINTEST ENDOSC, V53, P470, DOI 10.1067/mge.2001.112839; Olson MT, 2012, ACTA CYTOL, V56, P340, DOI 10.1159/000338646; Pitman MB., 2015, PAPANICOLAOU SOC CYT, V15, P96; Polkowski M, 2012, ENDOSCOPY, V44, P190, DOI 10.1055/s-0031-1291543; Polkowski M, 2017, ENDOSCOPY, V49, P989, DOI 10.1055/s-0043-119219; Qin SY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108762; Storch I, 2006, GASTROINTEST ENDOSC, V64, P505, DOI 10.1016/j.gie.2006.02.056; Uehara H, 2011, J GASTROEN HEPATOL, V26, P1256, DOI 10.1111/j.1440-1746.2011.06747.x; van Riet PA, 2021, ENDOSCOPY, V53, P411, DOI 10.1055/a-1206-5552; Voss M, 2000, GUT, V46, P244, DOI 10.1136/gut.46.2.244; Weynand B, 2013, CYTOPATHOLOGY, V24, P177, DOI 10.1111/j.1365-2303.2011.00924.x; Wittmann J, 2006, CYTOPATHOLOGY, V17, P27, DOI 10.1111/j.1365-2303.2006.00313.x	35	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263982	10.1371/journal.pone.0263982	http://dx.doi.org/10.1371/journal.pone.0263982			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320282	gold, Green Published			2022-12-26	WOS:000784240600030
J	Brenlla, ME; Germano, G; Seivane, MS; Da Lama, RF; Ogden, R				Elena Brenlla, Maria; Germano, Guadalupe; Seivane, Mariana S.; Fernandez da Lama, Rocio; Ogden, Ruth			Experiences of distortions to the passage of time during the Argentinian Covid-19 pandemic	PLOS ONE			English	Article							PERCEPTION; BOREDOM	The Coronavirus-19 global pandemic has forced many governments around the world to enforce "lockdowns" to curtail the spread of the virus. Studies conducted in the UK, France, Italy and Brazil have demonstrated that one consequence of these lockdowns is significant distortion to the speed of the passage of time. The current study sought to establish how the passage of time was experienced during the Argentinian lockdown. An online questionnaire was used to measure passage of time judgments for the day and the week, physical activity, satisfaction with social interaction, the extent to which daily routines had changed due to covid and demographic data. The results show that distortions to the passage of time were widely experienced during the lockdown in Argentina. There was a tendency for participants to report time passing more quickly than normal. A faster passage of time was associated with being a woman, of younger age and more physically active. A slower passage of time was therefore associated with being a man, of older age and less physically active. The results indicate that whilst distortions to the passage of time during the covid-19 crisis appear to be a global phenomenon, cross-cultural differences are apparent in the factors which influence temporal experience.	[Elena Brenlla, Maria; Germano, Guadalupe; Seivane, Mariana S.; Fernandez da Lama, Rocio] Univ Catolica Argentina, Ctr Invest Psicol & Psicopedag CIPP, Buenos Aires, DF, Argentina; [Ogden, Ruth] Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England	Pontifical Catholic University of Argentina; Liverpool John Moores University; University of Liverpool	Ogden, R (corresponding author), Liverpool John Moores Univ, Sch Psychol, Liverpool, Merseyside, England.	r.s.ogden@ljmu.ac.uk		Germano, Guadalupe/0000-0003-2896-6272; Ogden, Ruth/0000-0002-0931-1986; Fernandez Da Lama, Rocio Giselle/0000-0003-1529-2926; Brenlla, Maria Elena/0000-0003-2536-9499; Seivane, Mariana Soledad/0000-0002-9162-6935				[Anonymous], US; Armitage R, 2020, LANCET PUBLIC HEALTH, V5, pE256, DOI 10.1016/S2468-2667(20)30061-X; Banerjee D, 2020, INT J SOC PSYCHIATR, V66, P525, DOI 10.1177/0020764020922269; Behm DG, 2020, FRONT PHYSIOL, V11, DOI 10.3389/fphys.2020.00770; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Canet-Juric L, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.565688; Cellini N, 2020, J SLEEP RES, V29, DOI 10.1111/jsr.13074; Costoya V., EVIDENCE ARGENTINA; Cravo A. M., 2021, PSYARXIV, DOI [10.31234/osf.io/6jg4r, DOI 10.31234/OSF.IO/6JG4R]; Cummings ML, 2016, HUM FACTORS, V58, P279, DOI 10.1177/0018720815609503; de Mola CL, 2021, BRAZ J PSYCHIAT, V43, P337, DOI 10.1590/1516-4446-2020-1628; Droit-Volet S, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236465; Droit-Volet S, 2019, TIME SOC, V28, P60, DOI 10.1177/0961463X16656852; Droit-Volet S, 2015, ACTA PSYCHOL, V156, P77, DOI 10.1016/j.actpsy.2015.01.006; FLAHERTY MG, 1991, SOC PSYCHOL QUART, V54, P76, DOI 10.2307/2786790; FLAHERTY MG, 1993, SOCIOL INQ, V63, P394, DOI 10.1111/j.1475-682X.1993.tb00320.x; Friedman WJ, 2010, ACTA PSYCHOL, V134, P130, DOI 10.1016/j.actpsy.2010.01.004; Girard V, 2020, POPUL SOCIET, P1; Groarke JM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239698; Hall E.T., 1959, SILENT LANGUAGE; Inno L, 2020, NAT ASTRON, V4, P1114, DOI 10.1038/s41550-020-01258-z; Janssen SMJ, 2013, TIME SOC, V22, P274, DOI 10.1177/0961463X13478052; Larson E, 2006, ECOL PSYCHOL, V18, P113, DOI 10.1207/s15326969eco1802_3; Levine R.V., 2008, GEOGRAPHY TIME TEMPO; Martinelli N, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.616169; Nonis SA, 2005, INT J INTERCULT REL, V29, P409, DOI 10.1016/j.ijntrel.2005.05.002; OECD, GEND EQ G20 ADD AN T; Office for National Statistics, 2020, PAR LOCKD COR EFF WO; Ogden R., 2021, COGNITIVE PSYCHOL B, V6; Ogden R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250412; Ogden RS, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0235871; Oreffice Sonia, IZA DISCUSSION PAPER; Persing DL., 1999, J MANAGE PSYCHOL, DOI DOI 10.1108/02683949910254675; Pierce M, 2020, LANCET PSYCHIAT, V7, P883, DOI 10.1016/S2215-0366(20)30308-4; Rodrguez Espinola S., 2020, INFORME TCNICO SERIE; Santini ZI, 2020, LANCET PUBLIC HEALTH, V5, pE62, DOI 10.1016/S2468-2667(19)30230-0; Schwartz S.H, 2008, CULTURAL VALUE ORIEN; Seghi F, 2021, EUR ARCH PSY CLIN N, V271, P401, DOI 10.1007/s00406-020-01154-7; Torboli D, 2021, CURR PSYCHOL, DOI 10.1007/s12144-021-01811-7; United Nations, POP FACTS LIV ARR OL; United Nations, HOUS SIZ COMP WORLD; Wearden J., 2016, PSYCHOL TIME PERCEPT; Wearden JH, 2015, CONSCIOUS COGN, V38, P165, DOI 10.1016/j.concog.2015.06.005; Wearden JH, 2008, LANG LEARN, V58, P149, DOI 10.1111/j.1467-9922.2008.00468.x; Wearden J.H., 2014, SUBJECTIVE TIME PHIL, P287; Webb L, 2021, J PSYCHIATR MENT HLT, V28, P300, DOI 10.1111/jpm.12644; Winkler I., 2017, TIMING TIME PERCEPT, V5, P168, DOI [DOI 10.1163/22134468-00002088, https://doi.org/10.1163/22134468-00002088]; Wittmann M, 2005, PSYCHOL REP, V97, P921, DOI 10.2466/pr0.97.3.921-935; Wittmann M, 2020, KRONOSCOPE, V20, P260, DOI 10.1163/15685241-12341471; World Bank, FERT RAT; World Bank, WORLD BANK ARG; World Health Organisation, ARG COV 19 CAS STUD; World Health Organization, LIF EXP BIRTH YEARS	53	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266261	10.1371/journal.pone.0266261	http://dx.doi.org/10.1371/journal.pone.0266261			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358294	Green Published, Green Accepted, gold			2022-12-26	WOS:000799828800086
J	Laitinen, P; Vaananen, MA; Kolari, IL; Makinen, PI; Kaikkonen, MU; Weinberg, MS; Morris, KV; Korhonen, P; Malm, T; Yla-Herttuala, S; Roberts, TC; Turunen, MP; Turunen, TA				Laitinen, Pia; Vaananen, Mari-Anna; Kolari, Ida-Liisa; Makinen, Petri, I; Kaikkonen, Minna U.; Weinberg, Marc S.; Morris, Kevin, V; Korhonen, Paula; Malm, Tarja; Yla-Herttuala, Seppo; Roberts, Thomas C.; Turunen, Mikko P.; Turunen, Tiia A.			Nuclear microRNA-466c regulates Vegfa expression in response to hypoxia	PLOS ONE			English	Article							GENE-EXPRESSION; HUMAN-CELLS; RNA; PROMOTER; TRANSCRIPTION; ACTIVATION; GROWTH; INTERFERENCE; SIRNAS	MicroRNAs are well characterized in their role in silencing gene expression by targeting 3'-UTR of mRNAs in cytoplasm. However, recent studies have shown that miRNAs have a role in the regulation of genes in the nucleus, where they are abundantly located. We show here that in mouse endothelial cell line (C166), nuclear microRNA miR-466c participates in the regulation of vascular endothelial growth factor a (Vegfa) gene expression in hypoxia. Upregulation of Vegfa expression in response to hypoxia was significantly compromised after removal of miR-466c with CRISPR-Cas9 genomic deletion. We identified a promoter-associated long non-coding RNA on mouse Vegfa promoter and show that miR-466c directly binds to this transcript to modulate Vegfa expression. Collectively, these observations suggest that miR-466c regulates Vegfa gene transcription in the nucleus by targeting the promoter, and expands on our understanding of the role of miRNAs well beyond their canonical role.	[Laitinen, Pia; Vaananen, Mari-Anna; Kolari, Ida-Liisa; Makinen, Petri, I; Kaikkonen, Minna U.; Korhonen, Paula; Malm, Tarja; Yla-Herttuala, Seppo; Turunen, Mikko P.; Turunen, Tiia A.] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland; [Laitinen, Pia; Turunen, Mikko P.; Turunen, Tiia A.] RNatives Oy, Kuopio, Finland; [Weinberg, Marc S.] Scripps Res Inst, Dept Mol & Expt Med, 10666 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Weinberg, Marc S.] Univ Witwatersrand, Sch Pathol, Wits SAMRC Antiviral Gene Therapy Res Unit, Witwaterstrand, South Africa; [Morris, Kevin, V] City Hope Natl Med Ctr, Beckman Res Inst, Ctr Gene Therapy, Duarte, CA USA; [Morris, Kevin, V] Griffith Univ, Sch Med Sci, Menzies Hlth Inst Queensland, Gold Coast Campus, Nathan, Qld, Australia; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Heart Ctr, Kuopio, Finland; [Yla-Herttuala, Seppo] Kuopio Univ Hosp, Gene Therapy Unit, Kuopio, Finland; [Roberts, Thomas C.] Univ Oxford, Dept Paediat, Oxford, England; [Roberts, Thomas C.] MDUK Oxford Neuromuscular Ctr, Oxford, England	University of Eastern Finland; Scripps Research Institute; University of Witwatersrand; City of Hope; Beckman Research Institute of City of Hope; Griffith University; Kuopio University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; University of Oxford	Turunen, MP (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Kuopio, Finland.; Turunen, MP (corresponding author), RNatives Oy, Kuopio, Finland.	mikko.turunen@uef.fi	Turunen, Tiia/AAQ-2086-2021	Turunen, Tiia/0000-0001-7536-451X; Kolari, Ida-Liisa/0000-0003-3132-6735	RNatives Oy; Academy of Finland Center of Excellence; Academy of Finland [268376]; Finnish Foundation for Cardiovascular Research; Eye and Tissue Bank Foundation; Instrumentarium Science Foundation; ERC	RNatives Oy; Academy of Finland Center of Excellence(Academy of Finland); Academy of Finland(Academy of Finland); Finnish Foundation for Cardiovascular Research; Eye and Tissue Bank Foundation; Instrumentarium Science Foundation; ERC(European Research Council (ERC)European Commission)	This work was funded by RNatives Oy (PL, TT, MPT), Academy of Finland Center of Excellence (SYH), Academy of Finland project funding #268376 (MPT), The Finnish Foundation for Cardiovascular Research (MPT), Eye and Tissue Bank Foundation (PL), Instrumentarium Science Foundation (PL) and ERC Advanced Grant CleverGenes (SYH). The funder [RNatives Oy] provided support in the form of salaries for authors [PL, TAT, MPT] and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Arcondeguy T, 2013, NUCLEIC ACIDS RES, V41, P7997, DOI 10.1093/nar/gkt539; Berezhna SY, 2006, P NATL ACAD SCI USA, V103, P7682, DOI 10.1073/pnas.0600148103; Biasiolo M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023854; Burger K, 2017, J CELL BIOL, V216, P2373, DOI 10.1083/jcb.201612131; Chang TH, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S4; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Gagnon KT, 2014, NAT PROTOC, V9, P2045, DOI 10.1038/nprot.2014.135; Gagnon KT, 2014, CELL REP, V6, P211, DOI 10.1016/j.celrep.2013.12.013; Goda N, 2003, MOL CELL BIOL, V23, P359, DOI 10.1128/MCB.23.1.359-369.2003; Ha M, 2014, NAT REV MOL CELL BIO, V15, P509, DOI 10.1038/nrm3838; Han J, 2007, P NATL ACAD SCI USA, V104, P12422, DOI 10.1073/pnas.0701635104; Han JH, 2011, TRENDS CELL BIOL, V21, P336, DOI 10.1016/j.tcb.2011.03.003; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Ji Z, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.69; Kaikkonen MU, 2017, CIRC-CARDIOVASC GENE, V10, DOI 10.1161/CIRCGENETICS.117.001702; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kutner RH, 2009, NAT PROTOC, V4, P495, DOI 10.1038/nprot.2009.22; Laham-Karam N, 2018, ANTIOXID REDOX SIGN, V29, P813, DOI 10.1089/ars.2017.7248; Leucci E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02535; Leung AKL, 2015, TRENDS CELL BIOL, V25, P601, DOI 10.1016/j.tcb.2015.07.005; Li DH, 2018, TRENDS PHARMACOL SCI, V39, P982, DOI 10.1016/j.tips.2018.09.001; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Liao JY, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010563; Liu J, 2012, NUCLEIC ACIDS RES, V40, P1240, DOI 10.1093/nar/gkr780; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Lopez P, 2016, MOL CELL BIOL, V36, P1480, DOI 10.1128/MCB.01096-15; Meng FL, 2014, CELL, V159, P1538, DOI 10.1016/j.cell.2014.11.014; Min IM, 2011, GENE DEV, V25, P742, DOI 10.1101/gad.2005511; Mojiri A, 2013, ARTERIOSCL THROM VAS, V33, P1329, DOI 10.1161/ATVBAHA.113.301359; Morris KV, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000258; Morris KV, 2004, SCIENCE, V305, P1289, DOI 10.1126/science.1101372; Napoli S, 2009, EMBO J, V28, P1708, DOI 10.1038/emboj.2009.139; Nieminen Tiina, 2018, Non-Coding RNA, V4, P34, DOI 10.3390/ncrna4040034; Place RF, 2008, P NATL ACAD SCI USA, V105, P1608, DOI 10.1073/pnas.0707594105; Roberts TC, 2014, MOL THER-NUCL ACIDS, V3, DOI 10.1038/mtna.2014.40; Sarker D, 2020, CLIN CANCER RES, V26, P3936, DOI 10.1158/1078-0432.CCR-20-0414; Step SE, 2014, GENE DEV, V28, P1018, DOI 10.1101/gad.237628.114; Telese F, 2015, NEURON, V86, P696, DOI 10.1016/j.neuron.2015.03.033; Turunen MP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089979; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Turunen TA, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46841-1; Voutila J, 2017, MOL THER, V25, P2705, DOI 10.1016/j.ymthe.2017.07.018; Wang QW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-204; WASSENEGGER M, 1994, CELL, V76, P567, DOI 10.1016/0092-8674(94)90119-8; Wei Y, 2014, J BIOL CHEM, V289, P10270, DOI 10.1074/jbc.C113.541417; Wu SR, 2013, CANCER RES, V73, P1787, DOI 10.1158/0008-5472.CAN-12-0366; Zhang F, 2015, P NATL ACAD SCI USA, V112, P1380, DOI 10.1073/pnas.1424228112; Zhang XM, 2005, P NATL ACAD SCI USA, V102, P4459, DOI 10.1073/pnas.0501076102; 2014, bioRxiv, DOI 10.1101/005439	54	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265948	10.1371/journal.pone.0265948	http://dx.doi.org/10.1371/journal.pone.0265948			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358280	Green Published, gold			2022-12-26	WOS:000799828800054
J	Metaane, S; Monteil, V; Ayrault, S; Bordier, L; Levi-Meyreuis, C; Norel, F				Metaane, Selma; Monteil, Veronique; Ayrault, Sophie; Bordier, Louise; Levi-Meyreuis, Corinne; Norel, Francoise			The stress sigma factor sigma(S)/RpoS counteracts Fur repression of genes involved in iron and manganese metabolism and modulates the ionome of Salmonella enterica serovar Typhimurium	PLOS ONE			English	Article							ESCHERICHIA-COLI; RYHB PARALOGS; LAG PHASE; COBALT; RNA; TRANSPORT; VIRULENCE; POTASSIUM; NICKEL; MG2+	In many Gram-negative bacteria, the stress sigma factor of RNA polymerase, sigma(S)/RpoS, remodels global gene expression to reshape the physiology of quiescent cells and ensure their survival under non-optimal growth conditions. In the foodborne pathogen Salmonella enterica serovar Typhimurium, sigma(S) is also required for biofilm formation and virulence. We have previously identified sRNAs genes positively controlled by sigma(S) in Salmonella, including the two paralogous sRNA genes, ryhB1 and ryhB2/isrE. Expression of ryhB1 and ryhB2 is repressed by the ferric uptake regulator Fur when iron is available. In this study, we show that sigma(S) alleviates Fur-mediated repression of the ryhB genes and of additional Fur target genes. Moreover, sigma(S) induces transcription of the manganese transporter genes mntH and sitABCD and prevents their repression, not only by Fur, but also by the manganese-responsive regulator MntR. These findings prompted us to evaluate the impact of a Delta rpoS mutation on the Salmonella ionome. Inductively coupled plasma mass spectrometry analyses revealed a significant effect of the Delta rpoS mutation on the cellular concentration of manganese, magnesium, cobalt and potassium. In addition, transcriptional fusions in several genes involved in the transport of these ions were regulated by sigma(S). This study suggests that sigma(S) controls fluxes of ions that might be important for the fitness of quiescent cells. Consistent with this hypothesis, the Delta rpoS mutation extended the lag phase of Salmonella grown in rich medium supplemented with the metal ion chelator EDTA, and this effect was abolished when magnesium, but not manganese or iron, was added back. These findings unravel the importance of sigma(S) and magnesium in the regrowth potential of quiescent cells.	[Metaane, Selma; Monteil, Veronique; Levi-Meyreuis, Corinne; Norel, Francoise] Univ Paris, Inst Pasteur, Biochim Interact Macromol, CNRS UMR3528, F-75015 Paris, France; [Ayrault, Sophie; Bordier, Louise] Univ Paris Saclay, Lab Sci Climat & Environm, LSCE IPSL, CEA CNRS UVSQ, F-91191 Gif Sur Yvette, France; [Levi-Meyreuis, Corinne] Univ Paris Saclay, F-91400 Orsay, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Saclay; CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Norel, F (corresponding author), Univ Paris, Inst Pasteur, Biochim Interact Macromol, CNRS UMR3528, F-75015 Paris, France.	francoise.norel@pasteur.fr		Metaane, Selma/0000-0002-2543-1646	French National Research Agency [ANR-19-CE44-0005-01]; Foundation for Medical Research [FRM FDM201806005943]	French National Research Agency(French National Research Agency (ANR)); Foundation for Medical Research	This work was supported by the French National Research Agency (ANR-19-CE44-0005-01 to FN, https://anr.fr) and the Foundation for Medical Research (FRM FDM201806005943 to SM, https://www.frm.org).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achard MES, 2013, BIOCHEM J, V454, P543, DOI 10.1042/BJ20121771; Akanuma G, 2014, J BACTERIOL, V196, P3820, DOI 10.1128/JB.01896-14; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Ashraf KU, 2016, STRUCTURE, V24, P741, DOI 10.1016/j.str.2016.03.017; Baichoo N, 2002, J BACTERIOL, V184, P5826, DOI 10.1128/JB.184.21.5826-5832.2002; Banerjee R, 2020, MBIO, V11, DOI 10.1128/mBio.00351-20; Barras F, 2011, METALLOMICS, V3, P1130, DOI 10.1039/c1mt00099c; Bertrand RL, 2019, J BACTERIOL, V201, DOI 10.1128/JB.00697-18; Bertrand RL, 2014, J THEOR BIOL, V359, P72, DOI 10.1016/j.jtbi.2014.05.039; Blahut M, 2020, BBA-MOL CELL RES, V1867, DOI 10.1016/j.bbamcr.2020.118829; Bogomolnaya LM, 2020, MBIO, V11, DOI 10.1128/mBio.00528-20; Chareyre S, 2018, MICROBIOL SPECTR, V6, DOI 10.1128/microbiolspec.RWR-0010-2017; Chen BJ, 2021, VET RES, V52, DOI 10.1186/s13567-021-00915-z; Cho BK, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-4; Colgan AM, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006258; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dong T, 2010, INFECT IMMUN, V78, P887, DOI 10.1128/IAI.00882-09; Ellermeier CD, 2002, GENE, V290, P153, DOI 10.1016/S0378-1119(02)00551-6; Epstein W, 2003, PROG NUCLEIC ACID RE, V75, P293, DOI 10.1016/S0079-6603(03)75008-9; Erickson KE, 2017, MSPHERE, V2, DOI 10.1128/mSphere.00009-17; Gerlach RG, 2009, APPL ENVIRON MICROB, V75, P1575, DOI 10.1128/AEM.02509-08; Groisman EA, 2013, ANNU REV GENET, V47, P625, DOI 10.1146/annurev-genet-051313-051025; Hengge Regine, 2011, EcoSal Plus, V4, DOI 10.1128/ecosalplus.5.6.3; Huang KS, 2018, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02656; Imlay JA, 2003, ANNU REV MICROBIOL, V57, P395, DOI 10.1146/annurev.micro.57.030502.090938; Johnstone TC, 2015, DALTON T, V44, P6320, DOI 10.1039/c4dt03559c; Karlinsey JE, 2010, MOL MICROBIOL, V78, P669, DOI 10.1111/j.1365-2958.2010.07357.x; Kim JN, 2016, MICROBIOL RES, V186, P146, DOI 10.1016/j.micres.2016.04.004; Kim JN, 2013, MICROBIOL RES, V168, P621, DOI 10.1016/j.micres.2013.06.002; Koch D, 2007, BIOMETALS, V20, P759, DOI 10.1007/s10534-006-9039-6; Lago M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02362-3; Landini P, 2014, ENV MICROBIOL REP, V6, P1, DOI 10.1111/1758-2229.12112; Lee CR, 2010, MOL MICROBIOL, V78, P1468, DOI 10.1111/j.1365-2958.2010.07419.x; Levi-Meyrueis C, 2015, NUCLEIC ACIDS RES, V43, P1456, DOI 10.1093/nar/gku1379; Levi-Meyrueis C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096918; Maguire ME, 2002, BIOMETALS, V15, P203, DOI 10.1023/A:1016058229972; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Martin JE, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00949-19; Miller J.H., 1972, EXPT MOL GENETICS; Moomaw AS, 2008, PHYSIOLOGY, V23, P275, DOI 10.1152/physiol.00019.2008; Muller S, 2009, BIOMETALS, V22, P691, DOI 10.1007/s10534-009-9217-4; Nierhaus KH, 2014, J BACTERIOL, V196, P3817, DOI 10.1128/JB.02297-14; Oglesby-Sherrouse AG, 2013, METALLOMICS, V5, P276, DOI 10.1039/c3mt20224k; Okamoto S, 2011, METALLOMICS, V3, P963, DOI 10.1039/c1mt00056j; Ortega AD, 2012, RNA BIOL, V9, P469, DOI 10.4161/rna.19317; Osman D, 2011, ADV MICROB PHYSIOL, V58, P175, DOI 10.1016/B978-0-12-381043-4.00005-2; Otoupal PB, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00122; Padalon-Brauch G, 2008, NUCLEIC ACIDS RES, V36, P1913, DOI 10.1093/nar/gkn050; Papp-Wallace KM, 2006, ANNU REV MICROBIOL, V60, P187, DOI 10.1146/annurev.micro.60.080805.142149; Papp-Wallace Krisztina M, 2008, EcoSal Plus, V3, DOI 10.1128/ecosalplus.5.4.4.2; Peralta DR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157799; Porcheron Gaelle, 2013, Front Cell Infect Microbiol, V3, P90, DOI 10.3389/fcimb.2013.00090; Porcheron G, 2015, VET MICROBIOL, V179, P2, DOI 10.1016/j.vetmic.2015.03.024; Robbe-Saule V, 2006, J BACTERIOL, V188, P3983, DOI 10.1128/JB.00033-06; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Rodionov DA, 2006, J BACTERIOL, V188, P317, DOI 10.1128/JB.188.1.317-327.2006; Rodrigue A, 2005, J BACTERIOL, V187, P2912, DOI 10.1128/JB.187.8.2912-2916.2005; Rolfe MD, 2012, J BACTERIOL, V194, P686, DOI 10.1128/JB.06112-11; Salvail H, 2012, WIRES RNA, V3, P26, DOI 10.1002/wrna.102; Sambrook J, 1989, MOL CLONING LAB MANU, V2nd, DOI DOI 10.1016/0092-8674(90)90210-6; Santos-Zavaleta A, 2019, NUCLEIC ACIDS RES, V47, pD212, DOI 10.1093/nar/gky1077; Schellhorn HE, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.560099; SCHMIEGER H, 1972, MOL GEN GENET, V119, P75, DOI 10.1007/BF00270447; Sharma R, 2016, J BACTERIOL, V198, P1868, DOI 10.1128/JB.01029-15; SILVER S, 1971, J BIOL CHEM, V246, P569; SILVER S, 1972, J BACTERIOL, V110, P186, DOI 10.1128/JB.110.1.186-195.1972; STERNBERG NL, 1991, METHOD ENZYMOL, V204, P18; Thorgersen MP, 2007, J BACTERIOL, V189, P7774, DOI 10.1128/JB.00962-07; Troxell B, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-236; Verkhovskaya ML, 2001, MICROBIOL-SGM, V147, P3005, DOI 10.1099/00221287-147-11-3005; Westermann AJ, 2016, NATURE, V529, P496, DOI 10.1038/nature16547; Yin KY, 2018, PLOS PATHOG, V14, DOI 10.1371/journal.ppat.1007272	72	2	2	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265511	10.1371/journal.pone.0265511	http://dx.doi.org/10.1371/journal.pone.0265511			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358211	Green Published, gold			2022-12-26	WOS:000799828800035
J	Yang, YS; Jia, XZ; Lu, QY; Cai, SL; Huang, XT; Yang, SH; Wood, C; Wang, YH; Zhou, JJ; Chen, YD; Yang, JS; Yang, WJ				Yang, Yao-Shun; Jia, Xi-Zheng; Lu, Qian-Yun; Cai, Sun-Li; Huang, Xue-Ting; Yang, Shu-Hua; Wood, Chris; Wang, Yue-Hong; Zhou, Jiao-Jiao; Chen, Yi-Ding; Yang, Jin-Shu; Yang, Wei-Jun			Exosomal DEK removes chemoradiotherapy resistance by triggering quiescence exit of breast cancer stem cells	ONCOGENE			English	Article							PREDICTS POOR-PROGNOSIS; PROTEIN; ONCOPROTEIN; GENE; DNA; OVEREXPRESSION; CHROMATIN; HETEROGENEITY; EXPRESSION; INHIBITOR	Tumor therapeutics often target the primary tumor bulk but fail to eradicate therapy-resistant cancer stem cells (CSCs) in quiescent state. These can then become activated to initiate recurrence and/or metastasis beyond therapy. Here, we identified and isolated chemoradiotherapy-resistant CSCs in quiescent state with high capacity of tumor-initiation and tumorsphere formation from three types of breast tumors in mice. Experiments of knockdown and rescue revealed DEK, a nuclear protein, as essential for CSC activation. Exogenous DEK was then used to trigger quiescence exit of CSCs. ChIP-seq and ATAC-seq showed that DEK directly binds to chromatin, facilitating its genome-wide accessibility. The resulting epigenetic events upregulate the expression of cellular activation-related genes including MYC targets, whereas cellular quiescence-related genes including the p53 signaling pathway are silenced. However, twinned with DEK-induced activation, formerly resistant CSCs were then destroyed by chemotherapy in vitro. In mice, traditional chemoradiotherapy concurrent with the injection of DEK-containing exosomes resulted in eradication of primary tumors together with formerly resistant CSCs without recurrence or metastasis. Our findings advance knowledge of the mechanism of quiescent CSC activation and may provide novel clinical opportunities for removal of quiescence-linked therapy resistance.	[Yang, Yao-Shun; Jia, Xi-Zheng; Lu, Qian-Yun; Cai, Sun-Li; Huang, Xue-Ting; Yang, Shu-Hua; Wood, Chris; Yang, Jin-Shu; Yang, Wei-Jun] Zhejiang Univ, Coll Life Sci, MOE Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Peoples R China; [Wang, Yue-Hong] Zhejiang Univ, Affiliated Hosp 1, Coll Med, Dept Resp Med, Hangzhou, Peoples R China; [Zhou, Jiao-Jiao; Chen, Yi-Ding] Zhejiang Univ, Affiliated Hosp 2, Coll Med, Dept Surg Oncol, Hangzhou, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University	Yang, WJ (corresponding author), Zhejiang Univ, Coll Life Sci, MOE Lab Biosyst Homeostasis & Protect, Hangzhou 310058, Peoples R China.	w_jyang@zju.edu.cn	Huang, Xueting/HGT-9440-2022	Huang, Xueting/0000-0001-7893-168X; Jia, Xi-Zheng/0000-0002-6656-0997; Wood, Christopher/0000-0002-5517-9496; Cai, Sunli/0000-0003-3784-7048; Yang, Shuhua/0000-0002-1125-8088	National Major Research and Development Project [2016YFA0101201]; National Natural Science Foundation of China [31730084]	National Major Research and Development Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Major Research and Development Project (2016YFA0101201) and the National Natural Science Foundation of China (Project No. 31730084).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bajaj J, 2020, J CELL BIOL, V219, DOI 10.1083/jcb.201911053; Batlle E, 2017, NAT MED, V23, P1124, DOI 10.1038/nm.4409; Boichuk S, 2013, CANCER RES, V73, P5120, DOI 10.1158/0008-5472.CAN-13-0579; Buenrostro JD, 2013, NAT METHODS, V10, P1213, DOI [10.1038/NMETH.2688, 10.1038/nmeth.2688]; Capitano ML, 2019, J CLIN INVEST, V129, P2555, DOI 10.1172/JCI127460; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Dagogo-Jack I, 2018, NAT REV CLIN ONCOL, V15, P81, DOI 10.1038/nrclinonc.2017.166; Dai L, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00453-16; Damen MPF, 2021, FEBS J, V288, P6286, DOI 10.1111/febs.15626; Ewton DZ, 2011, MOL CANCER THER, V10, P2104, DOI 10.1158/1535-7163.MCT-11-0498; Gao H, 2012, CELL, V150, P764, DOI 10.1016/j.cell.2012.06.035; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Hacker KE, 2018, NEOPLASIA, V20, P1209, DOI 10.1016/j.neo.2018.10.005; Hidayat M, 2019, BOSNIAN J BASIC MED, V19, P355, DOI 10.17305/bjbms.2019.4227; Holohan C, 2013, NAT REV CANCER, V13, P714, DOI 10.1038/nrc3599; Hu HG, 2007, BIOCHEM BIOPH RES CO, V358, P1008, DOI 10.1016/j.bbrc.2007.05.019; Hua Y, 2009, SCI CHINA SER C, V52, P637, DOI 10.1007/s11427-009-0088-2; Jia WH, 2019, BIOCHEM J, V476, P1753, DOI 10.1042/BCJ20190169; Johnsen KB, 2014, BBA-REV CANCER, V1846, P75, DOI 10.1016/j.bbcan.2014.04.005; Kavanaugh GM, 2011, NUCLEIC ACIDS RES, V39, P7465, DOI 10.1093/nar/gkr454; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Khodadoust MS, 2009, CANCER RES, V69, P6405, DOI 10.1158/0008-5472.CAN-09-1063; Khoo WH, 2019, BLOOD, V134, P30, DOI 10.1182/blood.2018880930; Koleva RI, 2012, BLOOD, V119, P4878, DOI 10.1182/blood-2011-10-383083; LEE MS, 1991, P NATL ACAD SCI USA, V88, P9675, DOI 10.1073/pnas.88.21.9675; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liu SP, 2012, PATHOL INT, V62, P176, DOI 10.1111/j.1440-1827.2011.02775.x; Marusyk A, 2020, CANCER CELL, V37, P471, DOI 10.1016/j.ccell.2020.03.007; Mor-Vaknin N, 2006, MOL CELL BIOL, V26, P9484, DOI 10.1128/MCB.01030-06; Najafi M, 2019, LIFE SCI, V234, DOI 10.1016/j.lfs.2019.116781; Piao JJ, 2014, DIAGN PATHOL, V9, DOI 10.1186/1746-1596-9-67; Recasens A, 2019, TRENDS PHARMACOL SCI, V40, P128, DOI 10.1016/j.tips.2018.12.004; Saha AK, 2013, P NATL ACAD SCI USA, V110, P6847, DOI 10.1073/pnas.1220751110; Saito Y, 2010, NAT BIOTECHNOL, V28, P275, DOI 10.1038/nbt.1607; Sanden C, 2015, LEUKEMIA, V29, P1632, DOI 10.1038/leu.2015.72; Sanden C, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-215; Sansone P, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10442; Sistigu A, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.02166; Steinbichler TB, 2018, SEMIN CANCER BIOL, V53, P156, DOI 10.1016/j.semcancer.2018.11.006; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun J, 2017, ONCOL REP, V37, P857, DOI 10.3892/or.2016.5302; Teng Y, 2018, CURR CANCER DRUG TAR, V18, P256, DOI 10.2174/1568009617666170522094730; Vinnedge LMP, 2015, ONCOGENE, V34, P2325, DOI 10.1038/onc.2014.173; Waldmann T, 2004, GENE, V343, P1, DOI 10.1016/j.gene.2004.08.029; Waldmann T, 2002, J BIOL CHEM, V277, P24988, DOI 10.1074/jbc.M204045200; Wang XY, 2014, INT J CLIN EXP PATHO, V7, P5016; Wise-Draper TM, 2005, J VIROL, V79, P14309, DOI 10.1128/JVI.79.22.14309-14317.2005; Ye S, 2019, CANCER RES, V79, P4729, DOI 10.1158/0008-5472.CAN-19-1084; Yi HC, 2015, MOL MED REP, V11, P1318, DOI 10.3892/mmr.2014.2781; Zeng X., 2021, PHARM RES-DORDR, V163	52	1	1	3	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2624	2637		10.1038/s41388-022-02278-x	http://dx.doi.org/10.1038/s41388-022-02278-x		MAR 2022	14	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35351996				2022-12-26	WOS:000774697100001
J	Dieye, Y; Hull, DM; Wane, AA; Harden, L; Fall, C; Sambe-Ba, B; Seck, A; Fedorka-Cray, PJ; Thakur, S				Dieye, Yakhya; Hull, Dawn M.; Wane, Abdoul Aziz; Harden, Lyndy; Fall, Cheikh; Sambe-Ba, Bissoume; Seck, Abdoulaye; Fedorka-Cray, Paula J.; Thakur, Siddhartha			Genomics of human and chicken Salmonella isolates in Senegal: Broilers as a source of antimicrobial resistance and potentially invasive nontyphoidal salmonellosis infections	PLOS ONE			English	Article							MULTIDRUG-RESISTANT; RISK-FACTORS; ENTERICA; DAKAR; SURVEILLANCE; EMERGENCE; SLAUGHTERHOUSE; CONTAMINATION; EPIDEMIOLOGY; PREVALENCE	Salmonella enterica is the most common foodborne pathogen worldwide. It causes two types of diseases, a self-limiting gastroenteritis and an invasive, more threatening, infection. Salmonella gastroenteritis is caused by several serotypes and is common worldwide. In contrast, invasive salmonellosis is rare in high-income countries (HIC) while frequent in lowand middle-income countries (LMIC), especially in sub-Saharan Africa (sSA). Invasive Non-typhoidal Salmonella (iNTS), corresponding to serotypes other than Typhi and Paratyphi, have emerged in sSA and pose a significant risk to public health. We conducted a whole-genome sequence (WGS) analysis of 72 strains of Salmonella isolated from diarrheic human patients and chicken meat sold in multipurpose markets in Dakar, Senegal. Antimicrobial susceptibility testing combined with WGS data analysis revealed frequent resistance to fluoroquinolones and the sulfamethoxazole-trimethoprim combination that are among the most used treatments for invasive Salmonella. In contrast, resistance to the historical firstline drugs chloramphenicol and ampicillin, and to cephalosporins was rare. Antimicrobial resistance (AMR) was lower in clinical isolates compared to chicken strains pointing to the concern posed by the excessive use of antimicrobials in farming. Phylogenetic analysis suggested possible transmission of the emerging multidrug resistant (MDR) Kentucky ST198 and serotype Schwarzengrund from chicken to human. These results stress the need for active surveillance of Salmonella and AMR in order to address invasive salmonellosis caused by nontyphoidal Salmonella strains and other important bacterial diseases in sSA.	[Dieye, Yakhya; Wane, Abdoul Aziz; Fall, Cheikh; Sambe-Ba, Bissoume; Seck, Abdoulaye] Inst Pasteur, Pole Microbiol, Dakar, Senegal; [Dieye, Yakhya] Univ Cheikh Anta Diop, Dept Genie Chim & Biol Appl, Ecole Super Polytech, Dakar, Senegal; [Hull, Dawn M.; Harden, Lyndy; Fedorka-Cray, Paula J.; Thakur, Siddhartha] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Dakar; University Cheikh Anta Diop Dakar; University of North Carolina; North Carolina State University	Dieye, Y (corresponding author), Inst Pasteur, Pole Microbiol, Dakar, Senegal.; Dieye, Y (corresponding author), Univ Cheikh Anta Diop, Dept Genie Chim & Biol Appl, Ecole Super Polytech, Dakar, Senegal.	yakhya.dieye@pasteur.sn	Dieye, Yakhya/HGA-5389-2022	Dieye, Yakhya/0000-0003-2461-6558; Thakur, Siddhartha/0000-0003-3787-9939; , Dawn/0000-0002-2065-7400	World Academy of Science (TWAS) [17-507 RG/BIO/AF/AC_G -FR3240300142];  [1U18FD00678801]	World Academy of Science (TWAS); 	The whole genome sequencing was completed by the FDA GenomeTrakr program funded grant 1U18FD00678801 (https://www.fda.gov/food/whole-genome-sequencing-wgsprogram/genometrakr-network).YD was supported by The World Academy of Science (TWAS, http://www.twas.org) Grant No. 17-507 RG/BIO/AF/AC_G -FR3240300142. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antipov D, 2016, BIOINFORMATICS, V32, P3380, DOI 10.1093/bioinformatics/btw493; Antunes P, 2016, CLIN MICROBIOL INFEC, V22, P110, DOI 10.1016/j.cmi.2015.12.004; BOL,, SHOV ASS BACT IS GEN; Bopp CA, 1999, MANUAL CLIN MICROBIO, P459; Bortolaia V, 2020, J ANTIMICROB CHEMOTH, V75, P3491, DOI 10.1093/jac/dkaa345; Brenner FW, 2000, J CLIN MICROBIOL, V38, P2465, DOI 10.1128/JCM.38.7.2465-2467.2000; Cardinale E, 2005, INT J FOOD MICROBIOL, V103, P157, DOI 10.1016/j.ijfoodmicro.2004.12.023; Cardinale E, 2005, BRIT POULTRY SCI, V46, P204, DOI 10.1080/00071660500065029; Cardinale E, 2004, PREV VET MED, V63, P151, DOI 10.1016/j.prevetmed.2004.03.002; Cardinale E, 2001, J CLIN MICROBIOL, V39, P2373, DOI 10.1128/JCM.39.6.2373-2374.2001; Carey ME, 2020, CLIN INFECT DIS, V71, pS102, DOI 10.1093/cid/ciaa367; Chambron J, 1971, REV ELEV MED VET PAY; Chatham-Stephens K, 2019, MMWR-MORBID MORTAL W, V68, P11, DOI [10.15585/mmwr.mm6801a3, 10.1128/mBio.02112-18]; COLQUHOUN J, 1950, LANCET, V259, P621; Crump JA, 2015, CLIN MICROBIOL REV, V28, P901, DOI 10.1128/CMR.00002-15; Diop A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157683; Doutre M P, 1976, Rev Elev Med Vet Pays Trop, V29, P205; Doutre M-P, 1976, REV ELEV MED VET PAY; Doutre M-P, 1973, REV ELEV MED VET PAY; Dubreuil JD, 2019, J MICROBIOL, V57, P541, DOI 10.1007/s12275-019-8651-4; Etter AJ, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01065-19; Fall-Niang NK, 2019, FOODBORNE PATHOG DIS, V16, P130, DOI 10.1089/fpd.2018.2459; Gilchrist James J, 2019, EcoSal Plus, V8, DOI 10.1128/ecosalplus.ESP-0007-2018; GitHub-tseemann/abricate, MASS SCREEN CONT ANT; Harrois D, 2014, CLIN MICROBIOL INFEC, V20, pO109, DOI 10.1111/1469-0691.12339; Hawkey J, 2019, MICROB GENOMICS, V5, DOI 10.1099/mgen.0.000269; Henderson IR, 1999, INFECT IMMUN, V67, P5587, DOI 10.1128/IAI.67.11.5587-5596.1999; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jajere SM, 2019, VET WORLD, V12, P504, DOI 10.14202/vetworld.2019.504-521; Kaas RS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104984; Kalonji LM, 2015, CLIN INFECT DIS, V61, pS346, DOI 10.1093/cid/civ713; Kariuki S, 2015, CLIN INFECT DIS, V61, pS317, DOI 10.1093/cid/civ711; Keelara S, 2013, APPL ENVIRON MICROB, V79, P5167, DOI 10.1128/AEM.01419-13; Landers TF, 2012, PUBLIC HEALTH REP, V127, P4, DOI 10.1177/003335491212700103; Larsen MV, 2012, J CLIN MICROBIOL, V50, P1355, DOI 10.1128/JCM.06094-11; Le Hello S, 2012, ANTIMICROB AGENTS CH, V56, P5096, DOI 10.1128/AAC.00732-12; Magiorakos AP, 2012, CLIN MICROBIOL INFEC, V18, P268, DOI 10.1111/j.1469-0691.2011.03570.x; Mahon BE, 2016, MICROBIOL SPECTR, V4, DOI 10.1128/microbiolspec.EI10-0015-2016; Marks F, 2017, LANCET GLOB HEALTH, V5, pE310, DOI 10.1016/S2214-109X(17)30022-0; Mirza SH, 1996, J MED MICROBIOL, V44, P317, DOI 10.1099/00222615-44-5-317; Missohou A, 2011, TROP ANIM HEALTH PRO, V43, P983, DOI 10.1007/s11250-011-9795-3; Nurk S, 2013, J COMPUT BIOL, V20, P714, DOI 10.1089/cmb.2013.0084; Pande VV, 2016, FRONT MICROBIOL, V7, DOI 10.3389/fmicb.2016.00203; Park SE, 2021, BMJ GLOB HEALTH, V6, DOI 10.1136/bmjgh-2021-005659; Pokharel BM, 2006, INT J INFECT DIS, V10, P434, DOI 10.1016/j.ijid.2006.07.001; Pokharel P, 2019, MICROORGANISMS, V7, DOI 10.3390/microorganisms7120594; Pouillot R, 2012, RISK ANAL, V32, P1798, DOI 10.1111/j.1539-6924.2012.01796.x; Pulford CV, 2021, NAT MICROBIOL, V6, P327, DOI 10.1038/s41564-020-00836-1; Rehydration O., 2003, TREATM DIARRH DIS; ROWE B, 1991, LANCET, V337, P1422, DOI 10.1016/0140-6736(91)93116-Q; Sambe-Ba B, 2013, J GLOB ANTIMICROB RE, V1, P231, DOI 10.1016/j.jgar.2013.06.004; Stevens A, 2008, INT J FOOD MICROBIOL, V123, P191, DOI 10.1016/j.ijfoodmicro.2008.01.007; Stevens A, 2006, INT J FOOD MICROBIOL, V110, P178, DOI 10.1016/j.ijfoodmicro.2006.04.018; Takem EN, MALARIA J; Tauxe RV, 1998, BACTERIAL INFECT HUM, V3rd, P613; Uche IV, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005118; Verdonck F, 2004, J MOL MICROB BIOTECH, V7, P155, DOI 10.1159/000079825; Wigley P, 2017, AVIAN PATHOL, V46, P119, DOI 10.1080/03079457.2016.1240866; Zamora M, 2020, MICROBIOL MOL BIOL R, V84, DOI 10.1128/MMBR.00030-17; Zankari E, 2017, J ANTIMICROB CHEMOTH, V72, P2764, DOI 10.1093/jac/dkx217; Zhang SK, 2019, APPL ENVIRON MICROB, V85, DOI 10.1128/AEM.01746-19	61	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266025	10.1371/journal.pone.0266025	http://dx.doi.org/10.1371/journal.pone.0266025			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325007	gold, Green Published			2022-12-26	WOS:000780951300095
J	Dong, YL; Ruano, SH; Mishra, A; Pennington, KA; Yallampalli, C				Dong, Yuanlin; Ruano, Simone Hernandez; Mishra, Akansha; Pennington, Kathleen A.; Yallampalli, Chandrasekhar			Adrenomedullin and its receptors are expressed in mouse pancreatic beta-cells and suppresses insulin synthesis and secretion	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; PREGNANCY; PEPTIDES; TRANSCRIPTION; ADAPTATION; APOPTOSIS; EXPOSURE; GROWTH	Gestational diabetes mellitus (GDM) is associated with defective pancreatic beta-cell adaptation in pregnancy, but the underlying mechanism remains obscure. Our previous studies demonstrated that GDM women display increased plasma adrenomedullin (ADM) levels, and non-obese GDM mice show decreased serum concentrations of insulin and the number of beta-cells in pancreas islets. The aims of this study is to examine if ADM and its receptors are expressed in female mouse pancreas, and if so, whether insulin secretion is regulated by ADM in mouse beta-cell line, NIT-1 cells and isolated mouse pancreatic islets. Present study shows that ADM and its receptor components CRLR, RAMPs are present in mouse pancreatic islets and co-localized with insulin. The expressions of ADM, CRLR and RAMP2 in islets from pregnant mice are reduced compared to that of non-pregnant mice. NIT-1-beta cells express ADM and its receptor mRNA, and glucose dose-dependently stimulates expressions. Furthermore, ADM inhibits NIT-1-beta cell growth, and this inhibition is reversed by ADM antagonist, ADM22-52. The glucose-induced insulin secretion was suppressed by ADM in NIT-1-beta cells and isolated pancreatic islets from pregnant mice. These inhibitory effects are accompanied by upregulation of endoplasmic reticulum (ER) stress biomarker genes in NIT-1-beta cells. This study unveils that reduced ADM and its receptors may play a role in beta-cell adaptation during pregnancy, while increased plasma ADM in GDM may contribute to the beta-cells dysfunction, and blockade of ADM may reverse beta-cell insulin production.	[Dong, Yuanlin; Ruano, Simone Hernandez; Mishra, Akansha; Pennington, Kathleen A.; Yallampalli, Chandrasekhar] Texas Childrens Hosp, Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA	Baylor College of Medicine	Yallampalli, C (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Dept Obstet & Gynecol, Houston, TX 77030 USA.	cyallamp@bcm.edu		Yallampalli, Chandra/0000-0003-4873-8314	NIH [R01 HD091503, R01 HL058144]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	CY: NIH R01 HD091503 and NIH R01 HL058144 The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BELLMANN O, 1975, AM J OBSTET GYNECOL, V122, P829, DOI 10.1016/0002-9378(75)90723-1; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Chavey A, 2014, DIABETES METAB, V40, P323, DOI 10.1016/j.diabet.2014.02.003; Dabelea D, 2000, DIABETES, V49, P2208, DOI 10.2337/diabetes.49.12.2208; Devlieger R, 2008, ACTA OBSTET GYN SCAN, V87, P1266, DOI 10.1080/00016340802443863; Dong YL, 2019, J CLIN ENDOCR METAB, V104, P697, DOI 10.1210/jc.2018-01119; Dong YL, 2017, J CLIN ENDOCR METAB, V102, P3425, DOI 10.1210/jc.2017-00920; Dong YL, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.135665; Efrat S, 2012, TRENDS ENDOCRIN MET, V23, P278, DOI 10.1016/j.tem.2012.03.005; Ferrara A, 2007, DIABETES CARE, V30, pS141, DOI 10.2337/dc07-s206; Hayashi M, 1997, LANCET, V350, P1449, DOI 10.1016/S0140-6736(05)64211-0; Iwasaki H, 1998, ENDOCRINOLOGY, V139, P3432, DOI 10.1210/en.139.8.3432; Kato J, 2002, HYPERTENS RES, V25, P887; Keller DM, 2007, J BIOL CHEM, V282, P32084, DOI 10.1074/jbc.M700899200; Khoo S, 2003, J BIOL CHEM, V278, P32969, DOI 10.1074/jbc.M301198200; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Laybutt DR, 2007, DIABETOLOGIA, V50, P752, DOI 10.1007/s00125-006-0590-z; Lee HS, 2009, J PROTEOME RES, V8, P2851, DOI 10.1021/pr900009y; Lopez J, 1999, GEN COMP ENDOCR, V115, P309, DOI 10.1006/gcen.1999.7335; Martinez A, 1998, CELL TISSUE RES, V293, P95, DOI 10.1007/s004410051101; Martinez A, 1999, PEPTIDES, V20, P1471, DOI 10.1016/S0196-9781(99)00158-8; Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626; Martinez A, 2000, ENDOCRINOLOGY, V141, P406, DOI 10.1210/en.141.1.406; McLatchie LM, 1998, NATURE, V393, P333, DOI 10.1038/30666; Minamino N, 2002, MICROSC RES TECHNIQ, V57, P28, DOI 10.1002/jemt.10048; Mulder H, 1996, REGUL PEPTIDES, V62, P107, DOI 10.1016/0167-0115(96)00005-5; Neuman JC, 2014, JOVE-J VIS EXP, DOI 10.3791/50374; Nussdorfer GG, 1997, PEPTIDES, V18, P1079, DOI 10.1016/S0196-9781(97)00046-6; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; PARSONS JA, 1992, ENDOCRINOLOGY, V130, P1459, DOI 10.1210/en.130.3.1459; Pennington KA, 2017, BIOL REPROD, V96, P435, DOI 10.1095/biolreprod.116.144543; Pennington KA, 2012, ENDOCRINOLOGY, V153, P4556, DOI 10.1210/en.2012-1119; ROBERTSON RP, 1991, DIABETES, V40, P1, DOI 10.2337/diabetes.40.1.1; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Sekine N, 2006, AM J PHYSIOL-ENDOC M, V291, pE9, DOI 10.1152/ajpendo.00213.2005; Talton OO, 2016, ENDOCRINOLOGY, V157, P2636, DOI 10.1210/en.2016-1039; Urano F, 2014, NAT REV ENDOCRINOL, V10, P129, DOI 10.1038/nrendo.2013.261; Witlin AG, 2002, BIOL REPROD, V67, P1025, DOI 10.1095/biolreprod.101.002196; Wollheim CB, 2002, DIABETES, V51, pS37, DOI 10.2337/diabetes.51.2007.S37; Yallampalli C, 2013, CURR VASC PHARMACOL, V11, P641, DOI 10.2174/1570161111311050007; Zudaire E, 2003, REGUL PEPTIDES, V112, P121, DOI 10.1016/S0167-0115(03)00030-2	43	0	0	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265890	10.1371/journal.pone.0265890	http://dx.doi.org/10.1371/journal.pone.0265890			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324977	Green Published, gold			2022-12-26	WOS:000780951300079
J	Li, TT; Li, YJ; Yang, YQ; Li, J; Hu, ZY; Wang, L; Pu, W; Wei, T; Lu, M				Li, Tingting; Li, Yanjie; Yang, Yingqi; Li, Juan; Hu, ZiYue; Wang, Lu; Pu, Wei; Wei, Ting; Lu, Man			Logistic regression analysis of ultrasound findings in predicting the malignant and benign phyllodes tumor of breast	PLOS ONE			English	Article							NEEDLE CORE BIOPSY; HISTOLOGICAL FEATURES; SURGICAL-TREATMENT; DIAGNOSIS; RESECTION	Objective To evaluate ultrasound characteristics in the prediction of malignant and benign phyllodes tumor of the breast (PTB) by using Logistic regression analysis. Methods 79 lesions diagnosed as PTB by pathology were analyzed retrospectively. The ultrasound features of PTB were recorded and compared between benign and malignant tumors by using single factor and multiple stepwise Logistic regression analysis. Moreover, the Logistic regression model for malignancy prediction was also established. Results There were 79 patients with PTB, including 39 benign PTBs and 40 malignant PTBs (33 borderline PTBs and 7 malignant PTBs by pathologic classification). The area under the ROC curve (AUC) of lesion size and age were 0.737 and 0.850 respectively. There were significant differences in age, lesion size, shape, internal echo, liquefaction, and blood flow between malignant and benign PTBs by using single-factor analysis (P<0.05). Age, internal echo, and liquefaction were significant features by using Logistic regression analysis. The corresponding regression equation In (p/(1 - p) = -3.676+2.919 internal echo +3.029 liquefaction +4.346 age). Conclusion Internal echo, age, and liquefaction are independent ultrasound characteristics in predicting the malignancy of PTBs.	[Li, Tingting; Li, Yanjie; Yang, Yingqi; Li, Juan; Hu, ZiYue; Wang, Lu; Pu, Wei; Wei, Ting; Lu, Man] Univ Elect Sci & Technol China, Sichuan Canc Hosp Inst, Sichuan Canc Ctr, Sch Med,Dept Ultrasound, Chengdu, Peoples R China	University of Electronic Science & Technology of China	Lu, M (corresponding author), Univ Elect Sci & Technol China, Sichuan Canc Hosp Inst, Sichuan Canc Ctr, Sch Med,Dept Ultrasound, Chengdu, Peoples R China.	graceof@163.com		Lu, Man/0000-0002-3455-834X				[Anonymous], 1993, AM J SURG; Barth RJ, 2009, ANN SURG ONCOL, V16, P2288, DOI 10.1245/s10434-009-0489-2; Ben hassouna J, 2006, AM J SURG, V192, P141, DOI 10.1016/j.amjsurg.2006.04.007; Chao TC, 2002, ULTRASOUND OBST GYN, V20, P64, DOI 10.1046/j.1469-0705.2002.00736.x; Chen WH, 2005, J SURG ONCOL, V91, P185, DOI 10.1002/jso.20334; Choi J, 2012, PATHOL INT, V62, P120, DOI 10.1111/j.1440-1827.2011.02761.x; Dillon MF, 2006, SURGERY, V140, P779, DOI 10.1016/j.surg.2006.03.022; Duman L, 2016, BREAST CARE, V11, P123, DOI 10.1159/000444377; Efared Boubacar, 2018, Breast Dis, V37, P139, DOI 10.3233/BD-170297; Farria DM, 1996, AM J ROENTGENOL, V167, P187, DOI 10.2214/ajr.167.1.8659370; Guerrero MA, 2003, SURG ONCOL, V12, P27, DOI 10.1016/S0960-7404(03)00005-7; Hamid S. A., 2018, MED US, V97, DOI [10.1097/MD, DOI 10.1097/MD]; Jacklin RK, 2006, J CLIN PATHOL, V59, P454, DOI 10.1136/jcp.2005.025866; Kalambo M, 2018, AM J ROENTGENOL, V210, pW173, DOI 10.2214/AJR.17.18554; Kinoshita Takayuki, 2004, Breast J, V10, P232, DOI 10.1111/j.1075-122X.2004.21316.x; Lee AHS, 2007, HISTOPATHOLOGY, V51, P336, DOI 10.1111/j.1365-2559.2007.02786.x; Liberman L, 1996, RADIOLOGY, V198, P121, DOI 10.1148/radiology.198.1.8539362; Onkendi EO, 2014, ANN SURG ONCOL, V21, P3304, DOI 10.1245/s10434-014-3909-x; Reinfuss M, 1996, CANCER-AM CANCER SOC, V77, P910, DOI 10.1002/(SICI)1097-0142(19960301)77:5<910::AID-CNCR16>3.0.CO;2-6; Rosen P, 1993, FIBROEPITHELIAL NEOP; Tse GMK, 2010, BREAST CANCER-TOKYO, V17, P29, DOI 10.1007/s12282-009-0114-z; Xiao MS, 2015, J ULTRAS MED, V34, P1631, DOI 10.7863/ultra.15.14.11012; Yabuuchi H, 2006, RADIOLOGY, V241, P702, DOI 10.1148/radiol.2413051470; Youn I, 2013, ULTRASOUND MED BIOL, V39, P987, DOI 10.1016/j.ultrasmedbio.2013.01.004	24	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265952	10.1371/journal.pone.0265952	http://dx.doi.org/10.1371/journal.pone.0265952			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35325009	Green Published, gold			2022-12-26	WOS:000780951300089
J	Lin, WQ; Ngian, ZK; Koh, TW; Ong, CT				Lin, Wei-Qi; Ngian, Zhen-Kai; Koh, Tong-Wey; Ong, Chin-Tong			Altered stability of nuclear lamin-B marks the onset of aging in male Drosophila	PLOS ONE			English	Article								Epigenetic alterations occur during aging, but it remains unclear what epigenetic features are associated with the onset of physiological decline in animals. Nuclear lamin-B forms the filamentous meshwork underneath the nuclear envelope, providing the structural scaffold necessary for genome organization and gene regulation. We found that reduced level of nuclear lamin-B protein coincides with the decline in locomotor activity and stress resistance in young adult male Drosophila. Ubiquitous lamin-B expression improves locomotor activity of the male flies at the expense of lower stress resistance and shorten lifespan. This observation suggests that tissue-specific expression of lamin-B may regulate different aspects of animal physiology during aging. To test this hypothesis, specific GAL-4 lines were used to drive the expression of lamin-B in specific neuronal populations and muscle tissues in male flies. Ectopic expression of lamin-B in the dopaminergic neurons within the protocerebral anterior medial region of the brain improves the locomotor activity of the male flies with little impact on their stress responses and lifespan. Interestingly, age-dependent decrease in the level of lamin-B protein is independent of its mRNA expression. Instead, cellular thermal shift assay showed that lamin-B and CP190 insulator protein undergo significant change in their solubility during aging. This suggests that the increased solubility of lamin-B protein may contribute to its reduced stability and degradation during aging.	[Lin, Wei-Qi; Ngian, Zhen-Kai; Koh, Tong-Wey; Ong, Chin-Tong] Natl Univ Singapore, Temasek Life Sci Lab, Singapore, Singapore; [Ong, Chin-Tong] Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore	National University of Singapore; National University of Singapore	Ong, CT (corresponding author), Natl Univ Singapore, Temasek Life Sci Lab, Singapore, Singapore.; Ong, CT (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore, Singapore.	chintong@tll.org.sg		Ong, Chin-Tong/0000-0002-5450-4760	Temasek Life Sciences Laboratory [3160]	Temasek Life Sciences Laboratory(National University of Singapore)	The work is supported by Temasek Life Sciences Laboratory core funding 3160. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adusumalli S, 2019, AGING CELL, V18, DOI 10.1111/acel.12928; Bedrosian TA, 2021, EMBO J, V40, DOI 10.15252/embj.2020105819; Benayoun BA, 2015, NAT REV MOL CELL BIO, V16, P593, DOI 10.1038/nrm4048; Brandt A, 2008, AGING CELL, V7, P541, DOI 10.1111/j.1474-9726.2008.00406.x; Chen HY, 2016, AGING CELL, V15, P542, DOI 10.1111/acel.12465; Chen HY, 2014, CELL, V159, P829, DOI 10.1016/j.cell.2014.10.028; de Leeuw R, 2018, TRENDS CELL BIOL, V28, P34, DOI 10.1016/j.tcb.2017.08.004; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Frost B, 2016, CURR BIOL, V26, P129, DOI 10.1016/j.cub.2015.11.039; Gargano JW, 2005, EXP GERONTOL, V40, P386, DOI 10.1016/j.exger.2005.02.005; Jafari R, 2014, NAT PROTOC, V9, P2100, DOI 10.1038/nprot.2014.138; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Murray-Nerger LA, 2021, NUCLEIC ACIDS RES, V49, P2044, DOI 10.1093/nar/gkab019; Naeem AS, 2015, CELL DEATH DIFFER, V22, P2123, DOI 10.1038/cdd.2015.62; Ngian ZK, 2021, AGING CELL, V20, DOI 10.1111/acel.13348; Ong CT, 2018, J GENET GENOMICS, V45, P177, DOI 10.1016/j.jgg.2017.09.012; Ong CT, 2013, CELL, V155, P148, DOI 10.1016/j.cell.2013.08.052; Oyston LJ, 2018, CELL STRESS, V2, P225, DOI 10.15698/cst2018.09.152; Rao RA, 2019, EMBO REP, V20, DOI 10.15252/embr.201643260; Riemensperger T, 2013, CELL REP, V5, P952, DOI 10.1016/j.celrep.2013.10.032; Seroude L, 2002, AGING CELL, V1, P47, DOI 10.1046/j.1474-9728.2002.00007.x; Shimi T, 2011, GENE DEV, V25, P2579, DOI 10.1101/gad.179515.111; Tatli M, 2018, CURR OPIN CELL BIOL, V54, P72, DOI 10.1016/j.ceb.2018.05.001; van Steensel B, 2017, CELL, V169, P780, DOI 10.1016/j.cell.2017.04.022	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265223	10.1371/journal.pone.0265223	http://dx.doi.org/10.1371/journal.pone.0265223			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324942	Green Published, gold			2022-12-26	WOS:000780951300033
J	Okazaki, S; Boku, S; Watanabe, Y; Otsuka, I; Horai, T; Morikawa, R; Kimura, A; Shimmyo, N; Tanifuji, T; Someya, T; Hishimoto, A				Okazaki, Satoshi; Boku, Shuken; Watanabe, Yuichiro; Otsuka, Ikuo; Horai, Tadasu; Morikawa, Ryo; Kimura, Atsushi; Shimmyo, Naofumi; Tanifuji, Takaki; Someya, Toshiyuki; Hishimoto, Akitoyo			Polymorphisms in the hypoxia inducible factor binding site of the macrophage migration inhibitory factor gene promoter in schizophrenia	PLOS ONE			English	Article							FACTOR MIF EXPRESSION; PREFRONTAL CORTEX; RISK; BRAIN; IDENTIFICATION; PROLIFERATION; PSYCHOSIS; INSIGHTS; DOPAMINE; MODEL	Background Macrophage migration inhibitory factor (MIF) is a multifunctional cytokine that promotes neurogenesis and neuroprotection. MIF is predominantly expressed in astrocytes in the brain. The serum MIF level and microsatellites/single nucleotide polymorphisms (SNPs) in the MIF gene promoter region are known to be associated with schizophrenia (SCZ). Interestingly, previous studies reported that hypoxia, an environmental risk factor for SCZ, induced MIF expression through binding of the hypoxia inducible factor (HIF)-1 to the hypoxia response element (HRE) in the MIF promoter. Methods We investigated the involvement of MIF in SCZ while focusing on the HIF pathway. First, we conducted an association study of the SNP rs17004038 (C>A) in the HRE of the MIF promoter between 1758 patients with SCZ and 1507 controls. Next, we investigated the effect of hypoxia on MIF expression in primary cultured astrocytes derived from neonatal mice forebrain. Results SNP rs17004038 was significantly associated with SCZ (p = 0.0424, odds ratio = 1.445), indicating that this SNP in the HRE of the MIF promoter was a genetic risk factor for SCZ. Hypoxia induced MIF mRNA expression and MIF protein production and increased HIF-1 binding to the MIF promoter, while the activity of the MIF promoter was suppressed by mutations in the HRE and by deletion of the HRE in astrocytes. Conclusion These results suggest that SNP rs17004038 in the HRE of the MIF promoter was significantly associated with SCZ and may be involved in the pathophysiology of SCZ via suppression of hypoxia and HIF pathway-induced MIF expression.	[Okazaki, Satoshi; Boku, Shuken; Otsuka, Ikuo; Horai, Tadasu; Kimura, Atsushi; Shimmyo, Naofumi; Tanifuji, Takaki; Hishimoto, Akitoyo] Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo, Japan; [Boku, Shuken] Kumamoto Univ Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan; [Watanabe, Yuichiro; Morikawa, Ryo; Someya, Toshiyuki] Niigata Univ, Dept Psychiat, Grad Sch Med & Dent Sci, Niigata, Japan; [Hishimoto, Akitoyo] Yokohama City Univ, Dept Psychiat, Grad Sch Med, Yokohama, Kanagawa, Japan	Kobe University; Niigata University; Yokohama City University	Boku, S (corresponding author), Kobe Univ, Dept Psychiat, Grad Sch Med, Kobe, Hyogo, Japan.; Boku, S (corresponding author), Kumamoto Univ Fac Life Sci, Dept Neuropsychiat, Kumamoto, Japan.	boku.shuken@kuh.kumamoto-u.ac.jp	Watanabe, Yuichiro/ABB-7176-2021; Someya, Toshiyuki/ABD-1878-2021	Watanabe, Yuichiro/0000-0002-5496-5997; Okazaki, Satoshi/0000-0001-5953-5526	Japan Society of the Promotion of Science (JSPS) KAKENHI [15K19727, 18K15483, 21K07520, 15K09805, 18K07556, 17H04249]	Japan Society of the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partly supported by grants from Japan Society of the Promotion of Science (JSPS) KAKENHI grant numbers 15K19727, 18K15483, and 21K07520 (SO), 15K09805 and 18K07556 (SB), as well as 17H04249 (AH), https://www.jsps.go.jp/j-grantsinaid/.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Bach JP, 2009, CANCER-AM CANCER SOC, V115, P2031, DOI 10.1002/cncr.24245; Bacher M, 1998, MOL MED, V4, P217, DOI 10.1007/BF03401919; Bae SH, 2020, NEURAL REGEN RES, V15, P1483, DOI 10.4103/1673-5374.274340; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Baugh JA, 2006, BIOCHEM BIOPH RES CO, V347, P895, DOI 10.1016/j.bbrc.2006.06.148; Cannon TD, 2000, SCHIZOPHRENIA BULL, V26, P379, DOI 10.1093/oxfordjournals.schbul.a033460; Cannon TD, 2008, BIOL PSYCHIAT, V64, P797, DOI 10.1016/j.biopsych.2008.04.012; Cattane N, 2020, NEUROSCI BIOBEHAV R, V117, P253, DOI 10.1016/j.neubiorev.2018.07.001; Chai XJ, 2020, FRONT MOL NEUROSCI, V13, DOI 10.3389/fnmol.2020.00147; Chan MK, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.91; Chang MC, 2019, NEURAL REGEN RES, V14, P1230, DOI 10.4103/1673-5374.251330; Clifton NE, 2019, TRANSL PSYCHIAT, V9, DOI 10.1038/s41398-019-0405-x; Conboy L, 2011, MOL PSYCHIATR, V16, P533, DOI 10.1038/mp.2010.15; Davies C, 2020, LANCET PSYCHIAT, V7, P399, DOI 10.1016/S2215-0366(20)30057-2; Davis J, 2016, NEUROSCI BIOBEHAV R, V65, P185, DOI 10.1016/j.neubiorev.2016.03.017; Dickinson D, 2020, AM J PSYCHIAT, V177, P298, DOI 10.1176/appi.ajp.2019.19050527; ElKhodor BF, 1997, EXP NEUROL, V145, P118, DOI 10.1006/exnr.1997.6437; Fineberg AM, 2013, SCHIZOPHRENIA BULL, V39, P1037, DOI 10.1093/schbul/sbs084; Gellen B, 2017, J PROTEOMICS, V153, P53, DOI 10.1016/j.jprot.2016.06.027; Giannopoulou I, 2018, HORM-INT J ENDOCRINO, V17, P25, DOI 10.1007/s42000-018-0007-7; Hefter D, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00106; Hossmann KA, 1999, ADV EXP MED BIOL, V474, P155; Howell KR, 2016, MOL NEUROBIOL, V53, P3267, DOI 10.1007/s12035-015-9265-4; Ikeda M, 2019, SCHIZOPHRENIA BULL, V45, P824, DOI 10.1093/schbul/sby140; Ito K, 2008, DEV COMP IMMUNOL, V32, P664, DOI 10.1016/j.dci.2007.10.007; Itoi F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047512; Kaelin WG, 2008, NAT REV CANCER, V8, P865, DOI 10.1038/nrc2502; Kaida A, 2012, BIOCHEM BIOPH RES CO, V421, P855, DOI 10.1016/j.bbrc.2012.04.102; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kusumi I, 2015, PSYCHIAT CLIN NEUROS, V69, P243, DOI 10.1111/pcn.12242; Lam M, 2019, NAT GENET, V51, P1670, DOI 10.1038/s41588-019-0512-x; Leyton-Jaimes MF, 2018, EXP NEUROL, V301, P83, DOI 10.1016/j.expneurol.2017.06.021; Marder SR, 2019, NEW ENGL J MED, V381, P1753, DOI 10.1056/NEJMra1808803; Maruyama S, 2020, PSYCHIAT CLIN NEUROS, V74, P311, DOI 10.1111/pcn.12986; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Merk M, 2009, J IMMUNOL, V182, P6896, DOI 10.4049/jimmunol.0803710; Mueser KT, 2004, LANCET, V363, P2063, DOI 10.1016/S0140-6736(04)16458-1; Muz B, 2015, HYPOXIA, V3, P83, DOI 10.2147/HP.S93413; Nadri C, 2007, NEUROCHEM INT, V51, P447, DOI 10.1016/j.neuint.2007.03.013; O'Brien HE, 2018, GENOME BIOL, V19, DOI 10.1186/s13059-018-1567-1; O'Reilly C, 2016, MED RES REV, V36, P440, DOI 10.1002/med.21385; Ohta S, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0275-6; Ohta S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074315; Ohta S, 2012, J CELL SCI, V125, P3210, DOI 10.1242/jcs.102210; Okazaki S, 2021, J PSYCHIATR RES, V135, P237, DOI 10.1016/j.jpsychires.2021.01.033; Okazaki S, 2018, PROG NEURO-PSYCHOPH, V83, P33, DOI 10.1016/j.pnpbp.2018.01.001; Okazaki S, 2014, PROG NEURO-PSYCHOPH, V50, P151, DOI 10.1016/j.pnpbp.2013.12.006; Ortiz-Barahona A, 2010, NUCLEIC ACIDS RES, V38, P2332, DOI 10.1093/nar/gkp1205; Paquin V, 2021, ANNU REV CLIN PSYCHO, V17, P285, DOI 10.1146/annurev-clinpsy-081219-103805; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Savaskan Nic E, 2012, Int J Cell Biol, V2012, P139573, DOI 10.1155/2012/139573; Schmidt-Kastner R, 2012, MOL PSYCHIATR, V17, P1194, DOI 10.1038/mp.2011.183; Schmidt-Kastner R, 2006, SCHIZOPHR RES, V84, P253, DOI 10.1016/j.schres.2006.02.022; Schwarz E, 2012, MOL PSYCHIATR, V17, P494, DOI 10.1038/mp.2011.42; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Song SH, 2002, NATURE, V417, P39, DOI 10.1038/417039a; Stanley AC, 2010, PHYSIOLOGY, V25, P218, DOI 10.1152/physiol.00017.2010; Su Y, 2017, ONCOTARGET, V8, P2719, DOI 10.18632/oncotarget.13739; Suzuki M, 2004, J BIOL CHEM, V279, P21406, DOI 10.1074/jbc.M311416200; Ursini G, 2018, NAT MED, V24, P792, DOI 10.1038/s41591-018-0021-y; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wang LJ, 2009, STROKE, V40, P973, DOI 10.1161/STROKEAHA.108.530535; Zhang XJ, 2013, INT J BIOL SCI, V9, P1108, DOI 10.7150/ijbs.7232; Zis O, 2015, MOL NEUROBIOL, V51, P155, DOI 10.1007/s12035-014-8727-4; Zornberg GL, 2000, AM J PSYCHIAT, V157, P196, DOI 10.1176/appi.ajp.157.2.196	67	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265738	10.1371/journal.pone.0265738	http://dx.doi.org/10.1371/journal.pone.0265738			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324982	Green Published, gold			2022-12-26	WOS:000780951300063
J	Song, HJ; Wang, JQ; Wang, XJ; Yuan, BL; Li, D; Hu, AP; Guo, YH; Cai, S; Jin, SK; Zhou, Y; Li, QL; Chen, G; Gao, HY; Zheng, LD; Tong, QS				Song, Huajie; Wang, Jianqun; Wang, Xiaojing; Yuan, Boling; Li, Dan; Hu, Anpei; Guo, Yanhua; Cai, Shuang; Jin, Shikai; Zhou, Yi; Li, Qilan; Chen, Guo; Gao, Haiyang; Zheng, Liduan; Tong, Qiangsong			HNF4A-AS1-encoded small peptide promotes self-renewal and aggressiveness of neuroblastoma stem cells via eEF1A1-repressed SMAD4 transactivation	ONCOGENE			English	Article							SENESCENCE; PROGRESSION; ACTIVATION; PROTEIN; CLASSIFICATION; IDENTIFICATION; STRATEGIES	Cancer stem cells play crucial roles in tumorigenesis and aggressiveness, while regulatory mechanisms in neuroblastoma (NB), a pediatric extracranial malignancy with highest incidence, are still unknown. Herein, a small 51-amino acid peptide (sPEP1) encoded by hepatocyte nuclear factor 4 alpha antisense RNA 1 (HNF4A-AS1) was identified in tumor tissues and cells, which facilitated self-renewal and aggressiveness of NB stem cells. MiRNA-409-5p interacted with HNF4A-AS1 to facilitate sPEP1 translation via recruiting eukaryotic translation initiation factor 3 subunit G, while sPEP1 repressed serum deprivation-induced senescence and promoted sphere formation, growth, or metastasis of NB stem cells. Mechanistically, sPEP1 directly interacted with eukaryotic translation elongation factor 1 alpha 1 (eEF1A1) to facilitate its binding to SMAD family member 4 (SMAD4), resulting in repression of SMAD4 transactivation and transcriptional upregulation of stem cell genes associated with tumor progression. Rescue experiments revealed that sPEP1 exerted oncogenic roles via facilitating physical interaction between eEF1A1 and SMAD4. Notably, knockdown of sPEP1 significantly repressed the self-renewal and metastasis of NB stem cells in vivo. High sPEP1 or eEF1A1 levels in clinical NB tissues were linked to poor patients' survival. These findings suggest that HNF4A-AS1-encoded sPEP1 promotes self-renewal and aggressive features of NB stem cells by eEF1A1-repressed SMAD4 transactivation.	[Song, Huajie; Wang, Jianqun; Yuan, Boling; Li, Dan; Hu, Anpei; Guo, Yanhua; Jin, Shikai; Li, Qilan; Chen, Guo; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Wang, Xiaojing] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Geriatr, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Cai, Shuang; Zhou, Yi; Zheng, Liduan] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Gao, Haiyang] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Gastrointestinal Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China; [Zheng, Liduan; Tong, Qiangsong] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Genom Res, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology	Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pediat Surg, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.; Zheng, LD (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Dept Pathol, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.; Zheng, LD; Tong, QS (corresponding author), Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Clin Ctr Human Genom Res, 1277 Jiefang Ave, Wuhan 430022, Hubei, Peoples R China.	ld_zheng@hotmail.com; qs_tong@hotmail.com			National Natural Science Foundation of China [81773094, 81772967, 81874085, 81874066, 81802925, 81903011, 81903008, 82072801, 82173316]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We are grateful for Dr. Ralf Janknecht for providing vectors. This work was granted by the National Natural Science Foundation of China (81773094, 81772967, 81874085, 81874066, 81802925, 81903011, 81903008, 82072801, 82173316).	Abbas W, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00075; Anders L, 2011, CANCER CELL, V20, P620, DOI 10.1016/j.ccr.2011.10.001; Balko JM, 2013, CANCER RES, V73, P6346, DOI 10.1158/0008-5472.CAN-13-1385; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Chiba T, 2010, HEPATOLOGY, V52, P1111, DOI 10.1002/hep.23793; Choi, 2019, SCI REP-UK, V9; Choi SW, 2019, BRIEF BIOINFORM, V20, P1853, DOI 10.1093/bib/bby055; Edmonds BT, 1996, J CELL SCI, V109, P2705; Fang EH, 2020, THERANOSTICS, V10, P1555, DOI 10.7150/thno.37383; Fang EH, 2019, ADV SCI, V6, DOI 10.1002/advs.201900581; Fujimaki K, 2019, P NATL ACAD SCI USA, V116, P22624, DOI 10.1073/pnas.1915905116; GREIDER CW, 1985, CELL, V43, P405, DOI 10.1016/0092-8674(85)90170-9; Hansford LM, 2007, CANCER RES, V67, P11234, DOI 10.1158/0008-5472.CAN-07-0718; Hernandez AL, 2019, MOL CARCINOGEN, V58, P1648, DOI 10.1002/mc.23049; Huang JZ, 2017, MOL CELL, V68, P171, DOI 10.1016/j.molcel.2017.09.015; Johnsson A, 2000, BRIT J CANCER, V83, P1047, DOI 10.1054/bjoc.2000.1420; Kojima K, 2007, CANCER RES, V67, P8121, DOI 10.1158/0008-5472.CAN-06-4167; Kopp F, 2018, CELL, V172, P393, DOI 10.1016/j.cell.2018.01.011; Li, 2018, NAT COMMUN, V9; Li D, 2018, CANCER RES, V78, P1169, DOI 10.1158/0008-5472.CAN-17-2295; Li HH, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910835; Li XY, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15909; Lindemann C, 2017, BIOL CHEM, V398, P687, DOI 10.1515/hsz-2017-0104; Magny EG, 2013, SCIENCE, V341, P1116, DOI 10.1126/science.1238802; Matsumoto A, 2017, NATURE, V541, P228, DOI 10.1038/nature21034; Milanovic M, 2018, NATURE, V553, P96, DOI 10.1038/nature25167; Mishra AK, 2007, P NATL ACAD SCI USA, V104, P13930, DOI 10.1073/pnas.0704915104; Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173; Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001; Pandian V, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0002-8; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Pinto NR, 2015, J CLIN ONCOL, V33, P3008, DOI 10.1200/JCO.2014.59.4648; Pringle Eric S, 2019, Curr Protoc Mol Biol, V125, pe79, DOI 10.1002/cpmb.79; Rennie W, 2014, NUCLEIC ACIDS RES, V42, pW114, DOI 10.1093/nar/gku376; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Slavoff SA, 2013, NAT CHEM BIOL, V9, P59, DOI [10.1038/NCHEMBIO.1120, 10.1038/nchembio.1120]; Song HJ, 2020, J HEMATOL ONCOL, V13, DOI 10.1186/s13045-020-00857-7; Takenobu H, 2011, ONCOGENE, V30, P97, DOI 10.1038/onc.2010.383; Tan H, 2019, EBIOMEDICINE, V43, P82, DOI 10.1016/j.ebiom.2019.03.082; Thomas SK, 2004, J BIOL CHEM, V279, P27994, DOI 10.1074/jbc.M312663200; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Vera M, 2014, ELIFE, V3, DOI 10.7554/eLife.03164; Vincent T, 2009, NAT CELL BIOL, V11, P943, DOI 10.1038/ncb1905; Wang, 2020, J EXP MED, V217, pe20190950; Wu P, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-1147-3; Yang G, 2010, INT J BIOL SCI, V6, P1; Yu CC, 2011, J ONCOL, V2011, DOI 10.1155/2011/609259; Zhao X, 2016, ONCOGENE, V35, P3565, DOI 10.1038/onc.2015.422; Zhao X, 2020, MOL THER, V28, P946, DOI 10.1016/j.ymthe.2019.12.013; Zhao X, 2018, MOL THER, V26, P755, DOI 10.1016/j.ymthe.2017.12.017	50	2	2	5	9	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2022	41	17					2505	2519		10.1038/s41388-022-02271-4	http://dx.doi.org/10.1038/s41388-022-02271-4		MAR 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0R6YF	35318442				2022-12-26	WOS:000771890400002
J	Vainio, L; Vainio, M				Vainio, Lari; Vainio, Martti			Interaction between grasping and articulation: How vowel and consonant pronunciation influences precision and power grip responses	PLOS ONE			English	Article							PHONETIC SYMBOLISM; INFERIOR AREA-6; LANGUAGE; EVOLUTION; SOUND; HAND; ORGANIZATION; MOVEMENTS; GESTURES; MONKEY	Grasping and mouth movements have been proposed to be integrated anatomically, functionally and evolutionarily. In line with this, we have shown that there is a systematic interaction between particular speech units and grip performance. For example, when the task requires pronouncing a speech unit simultaneously with grasp response, the speech units [i] and [t] are associated with relatively rapid and accurate precision grip responses, while [a] and [k] are associated with power grip responses. This study is aimed at complementing the picture about which vowels and consonants are associated with these grasp types. The study validated our view that the high-front vowels and the alveolar consonants are associated with precision grip responses, while low and high-back vowels as well as velar consonants or those whose articulation involves the lowering of the tongue body are associated with power grip responses. This paper also proposes that one reason why small/large concepts are associated with specific speech sounds in the sound-magnitude symbolism is because articulation of these sounds is programmed within the overlapping mechanisms of precision or power grasping.	[Vainio, Lari; Vainio, Martti] Univ Helsinki, Dept Digital Humanities, Phonet & Speech Synth Res Grp, Helsinki, Finland; [Vainio, Lari] Univ Helsinki, Fac Med, Dept Psychol & Logoped, Percept Act & Cognit Res Grp, Helsinki, Finland	University of Helsinki; University of Helsinki	Vainio, L (corresponding author), Univ Helsinki, Dept Digital Humanities, Phonet & Speech Synth Res Grp, Helsinki, Finland.; Vainio, L (corresponding author), Univ Helsinki, Fac Med, Dept Psychol & Logoped, Percept Act & Cognit Res Grp, Helsinki, Finland.	lari.vainio@helsinki.fi		Vainio, Martti/0000-0003-2570-0196; Vainio, Lari/0000-0001-7754-9745	 [342627]		Grant receiver: MV Grant number: 342627 Funer: Academy of Finland URL: https://www.aka.fi/en/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arbib MA, 2005, BEHAV BRAIN SCI, V28, P105, DOI 10.1017/S0140525X05000038; Berlin B, 2006, J ROY ANTHROPOL INST, pS23; Blasi DE, 2016, P NATL ACAD SCI USA, V113, P10818, DOI 10.1073/pnas.1605782113; Chodroff E, 2014, J ACOUST SOC AM, V136, P2762, DOI 10.1121/1.4896470; Darwin C., 1872, P374; Desmurget M, 2014, P NATL ACAD SCI USA, V111, P5718, DOI 10.1073/pnas.1321909111; Ehrsson HH, 2000, J NEUROPHYSIOL, V83, P528, DOI 10.1152/jn.2000.83.1.528; Falk D, 2004, BEHAV BRAIN SCI, V27, P491; Fant G., 1960, ACOUSTIC THEORY SPEE; Forrester GS, 2015, COGNITION, V141, P103, DOI 10.1016/j.cognition.2015.04.012; Frohlich M, 2019, BIOL REV, V94, P1809, DOI 10.1111/brv.12535; Gallace A, 2006, PERCEPT PSYCHOPHYS, V68, P1191, DOI 10.3758/BF03193720; Gentilucci M, 2001, J NEUROPHYSIOL, V86, P1685, DOI 10.1152/jn.2001.86.4.1685; Gentilucci M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019793; Graziano MSA, 2007, NEUROSCIENTIST, V13, P138, DOI 10.1177/1073858406295918; Halverson HM, 1931, GENET PSYCHOL MONOGR, V10, P107; Haryu Etsuko, 2007, Shinrigaku Kenkyu, V78, P424; Hassemer J, 2016, GESTURE, V15, P404, DOI 10.1075/gest.15.3.07has; HEWES GW, 1973, CURR ANTHROPOL, V14, P5, DOI 10.1086/201401; Higginbotham DR, 2008, EXP BRAIN RES, V186, P603, DOI 10.1007/s00221-007-1265-9; Hinton L., 2006, SOUND SYMBOLISM; Imai M, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0298; JOHNSON RC, 1967, J VERB LEARN VERB BE, V6, P508, DOI 10.1016/S0022-5371(67)80008-2; Jongman A, 2000, J ACOUST SOC AM, V108, P1252, DOI 10.1121/1.1288413; Kawahara S., 2021, ARXIV; Kawahara S., 2020, LANG LINGUIST COMPAS, V14, DOI DOI 10.1111/lnc3.12376; Kawahara S, 2019, P ISAPH, P421; Kawahara Shigeto., 2005, NEW DIRECTIONS COGNI; Kendon A, 2017, PSYCHON B REV, V24, P163, DOI 10.3758/s13423-016-1117-3; Knoeferle K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05965-y; KORNBLUM S, 1990, PSYCHOL REV, V97, P253, DOI 10.1037/0033-295X.97.2.253; Kumagai G., 2017, P 31 ANN M PHON SOC, P49; LAMBERTS K, 1992, ACTA PSYCHOL, V79, P115, DOI 10.1016/0001-6918(92)90028-C; Margiotoudi K, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69528-4; NAPIER JR, 1956, J BONE JOINT SURG BR, V38, P902, DOI 10.1302/0301-620X.38B4.902; Newman SS, 1933, AM J PSYCHOL, V45, P53, DOI 10.2307/1414186; Nielsen A, 2011, CAN J EXP PSYCHOL, V65, P115, DOI 10.1037/a0022268; OHALA JJ, 1983, PHONETICA, V40, P1, DOI 10.1159/000261678; Ohala JJ, 1987, HONOR ILSE LEHISTE, P207; Paget R, 1930, HUMAN SPEECH; Paget R A, 1944, Science, V99, P14, DOI 10.1126/science.99.2558.14; Ramachandran V, 2001, J CONSCIOUSNESS STUD, V8, P3; Recasens D, 2012, SPEECH COMMUN, V54, P368, DOI 10.1016/j.specom.2011.10.001; RIZZOLATTI G, 1988, EXP BRAIN RES, V71, P491, DOI 10.1007/BF00248742; Rizzolatti G, 1998, TRENDS NEUROSCI, V21, P188, DOI 10.1016/S0166-2236(98)01260-0; RIZZOLATTI G, 1987, EXP BRAIN RES, V67, P220, DOI 10.1007/BF00269468; Sapir E, 1929, J EXP PSYCHOL, V12, P225, DOI 10.1037/h0070931; Schielzeth H, 2020, METHODS ECOL EVOL, V11, P1141, DOI 10.1111/2041-210X.13434; Schramm P, 2019, ARE REACTION TIME TR; SHADLE CH, 1985, J ACOUST SOC AM, V78, P1562, DOI 10.1121/1.392792; Shinohara K., 2016, P 36 ANN M BERKELEY, DOI [10.3765/bls.v36i1.3926, DOI 10.3765/BLS.V36I1.3926]; Shinohara K, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.589797; Sidhu DM, 2018, PSYCHON B REV, V25, P1619, DOI 10.3758/s13423-017-1361-1; SIMON JR, 1969, J EXP PSYCHOL, V81, P174, DOI 10.1037/h0027448; Spence C, 2011, ATTEN PERCEPT PSYCHO, V73, P971, DOI 10.3758/s13414-010-0073-7; TAYLOR IK, 1963, PSYCHOL BULL, V60, P200, DOI 10.1037/h0040632; TAYLOR IK, 1962, CAN J PSYCHOLOGY, V16, P344, DOI 10.1037/h0083261; Thompson PD, 2011, Q J EXP PSYCHOL, V64, P2392, DOI 10.1080/17470218.2011.605898; Tiainen M, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00516; Tiainen M, 2017, Q J EXP PSYCHOL, V70, P1590, DOI 10.1080/17470218.2016.1195416; Vainio L, 2021, J MEM LANG, V118, DOI 10.1016/j.jml.2020.104213; Vainio L, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.718700; Vainio L, 2019, NEUROSCI BIOBEHAV R, V100, P211, DOI 10.1016/j.neubiorev.2019.03.005; Vainio L, 2018, Q J EXP PSYCHOL, V71, P2129, DOI 10.1177/1747021817738732; Vainio L, 2018, EXP BRAIN RES, V236, P153, DOI 10.1007/s00221-017-5114-1; Vainio L, 2015, EXP BRAIN RES, V233, P2951, DOI 10.1007/s00221-015-4365-y; Vainio L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053061; Wacewicz S, 2017, LANG COMMUN, V54, P1, DOI 10.1016/j.langcom.2016.10.001; Wallace AR, 1881, NATURE, V24, P242; WHALEN DH, 1995, J PHONETICS, V23, P349, DOI 10.1016/S0095-4470(95)80165-0; Wiik K, 1966, FINNISH ENGLISH LATE; Winter B., 2021, GLOSSA-UK, V6, P79, DOI DOI 10.5334/GJGL.1646; Zywiczynski P, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2020.0204	73	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265651	10.1371/journal.pone.0265651	http://dx.doi.org/10.1371/journal.pone.0265651			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316305	Green Published, gold			2022-12-26	WOS:000834238000031
J	Bommi-Reddy, A; Park-Chouinard, S; Mayhew, DN; Terzo, E; Hingway, A; Steinbaugh, MJ; Wilson, JE; Sims, RJ; Conery, AR				Bommi-Reddy, Archana; Park-Chouinard, Sungmi; Mayhew, David N.; Terzo, Esteban; Hingway, Aparna; Steinbaugh, Michael J.; Wilson, Jonathan E.; Sims, Robert J., III; Conery, Andrew R.			CREBBP/EP300 acetyltransferase inhibition disrupts FOXA1-bound enhancers to inhibit the proliferation of ER plus breast cancer cells	PLOS ONE			English	Article							TRANSCRIPTION; FOXA1; P300/CBP; ALPHA; ACETYLATION; RECRUITMENT; CHROMATIN; BINDING; GATA3; IDENTIFICATION	Therapeutic targeting of the estrogen receptor (ER) is a clinically validated approach for estrogen receptor positive breast cancer (ER+ BC), but sustained response is limited by acquired resistance. Targeting the transcriptional coactivators required for estrogen receptor activity represents an alternative approach that is not subject to the same limitations as targeting estrogen receptor itself. In this report we demonstrate that the acetyltransferase activity of coactivator paralogs CREBBP/EP300 represents a promising therapeutic target in ER+ BC. Using the potent and selective inhibitor CPI-1612, we show that CREBBP/EP300 acetyltransferase inhibition potently suppresses in vitro and in vivo growth of breast cancer cell line models and acts in a manner orthogonal to directly targeting ER. CREBBP/EP300 acetyltransferase inhibition suppresses ER-dependent transcription by targeting lineage-specific enhancers defined by the pioneer transcription factor FOXA1. These results validate CREBBP/EP300 acetyltransferase activity as a viable target for clinical development in ER+ breast cancer.	[Bommi-Reddy, Archana; Park-Chouinard, Sungmi; Mayhew, David N.; Terzo, Esteban; Hingway, Aparna; Steinbaugh, Michael J.; Wilson, Jonathan E.; Sims, Robert J., III; Conery, Andrew R.] Constellat Pharmaceut, Cambridge, MA 02142 USA; [Mayhew, David N.] Foghorn Therapeut, Cambridge, MA USA; [Terzo, Esteban] Eloxx Pharmaceut, Watertown, MA USA; [Hingway, Aparna] Novartis Inst Biomed Res, Cambridge, MA USA; [Steinbaugh, Michael J.] 28 7 Therapeut, Cambridge, MA USA; [Wilson, Jonathan E.; Sims, Robert J., III] Flare Therapeut, Cambridge, MA USA; [Conery, Andrew R.] Triana Biomed, Waltham, MA 02451 USA	Novartis	Conery, AR (corresponding author), Constellat Pharmaceut, Cambridge, MA 02142 USA.; Conery, AR (corresponding author), Triana Biomed, Waltham, MA 02451 USA.	arconery@gmail.com	Steinbaugh, Michael/E-9175-2012	Steinbaugh, Michael/0000-0002-2403-2221; CONERY, ANDREW/0000-0003-3638-7633				Ali S, 2011, ANNU REV MED, V62, P217, DOI 10.1146/annurev-med-052209-100305; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Bernardo GM, 2013, ONCOGENE, V32, P554, DOI 10.1038/onc.2012.62; Bihani T, 2017, CLIN CANCER RES, V23, P4793, DOI 10.1158/1078-0432.CCR-16-2561; Bojcsuk D, 2017, NUCLEIC ACIDS RES, V45, P3693, DOI 10.1093/nar/gkw1283; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Caswell-Jin JL, 2018, JNCI CANCER SPECT, V2, DOI 10.1093/jncics/pky062; Chi D, 2019, P NATL ACAD SCI USA, V116, P11437, DOI 10.1073/pnas.1819155116; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Corces MR, 2018, SCIENCE, V362, P420, DOI 10.1126/science.aav1898; Corces MR, 2017, NAT METHODS, V14, P959, DOI [10.1038/NMETH.4396, 10.1038/nmeth.4396]; Dancy BM, 2015, CHEM REV, V115, P2419, DOI 10.1021/cr500452k; Didion JP, 2017, PEERJ, V5, DOI 10.7717/peerj.3720; Frank CL, 2016, EPIGENET CHROMATIN, V9, DOI 10.1186/s13072-016-0065-5; Fu XY, 2019, P NATL ACAD SCI USA, V116, P26823, DOI 10.1073/pnas.1911584116; Glont SE, 2019, CELL REP, V26, P2558, DOI 10.1016/j.celrep.2019.02.036; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hogg SJ, 2021, MOL CELL, V81, P2183, DOI 10.1016/j.molcel.2021.04.015; Hulsen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-488; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Jiang GJ, 2019, THERANOSTICS, V9, P6501, DOI 10.7150/thno.34874; Jin QH, 2011, EMBO J, V30, P249, DOI 10.1038/emboj.2010.318; Jozwik KM, 2016, CELL REP, V17, P2715, DOI 10.1016/j.celrep.2016.11.028; Kim MY, 2006, MOL ENDOCRINOL, V20, P1479, DOI 10.1210/me.2005-0531; Kong SL, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.59; Korsunsky I, 2019, NAT METHODS, V16, P1289, DOI 10.1038/s41592-019-0619-0; Lasko LM, 2017, NATURE, V550, P128, DOI 10.1038/nature24028; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li ZJ, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1642-2; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Lin HY, 2017, ONCOTARGET, V8, P34750, DOI 10.18632/oncotarget.16160; Liu ZJ, 2014, CELL, V159, P358, DOI 10.1016/j.cell.2014.08.027; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Miller TW, 2011, CANCER DISCOV, V1, P338, DOI 10.1158/2159-8290.CD-11-0101; Narita T, 2021, MOL CELL, V81, P2166, DOI 10.1016/j.molcel.2021.03.008; Osborne CK, 2011, ANNU REV MED, V62, P233, DOI 10.1146/annurev-med-070909-182917; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Pelham-Webb B, 2021, MOL CELL, V81, P1732, DOI 10.1016/j.molcel.2021.02.032; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Rosenberg PS, 2015, JNCI-J NATL CANCER I, V107, DOI 10.1093/jnci/djv159; Saint-Andre V, 2016, GENOME RES, V26, P385, DOI 10.1101/gr.197590.115; Schep AN, 2017, NAT METHODS, V14, P975, DOI [10.1038/NMETH.4401, 10.1038/nmeth.4401]; Soneson Charlotte, 2015, F1000Res, V4, P1521, DOI 10.12688/f1000research.7563.1; Stuart T, 2021, NAT METHODS, V18, P1333, DOI 10.1038/s41592-021-01282-5; Theodorou V, 2013, GENOME RES, V23, P12, DOI 10.1101/gr.139469.112; Waddell A, 2021, CANCERS, V13, DOI 10.3390/cancers13112799; Wang L, 2008, CURR OPIN STRUC BIOL, V18, P741, DOI 10.1016/j.sbi.2008.09.004; Weinert BT, 2018, CELL, V174, P231, DOI 10.1016/j.cell.2018.04.033; Welboren WJ, 2009, EMBO J, V28, P1418, DOI 10.1038/emboj.2009.88; Wilson JE, 2020, ACS MED CHEM LETT, V11, P1324, DOI 10.1021/acsmedchemlett.0c00155; Xu SLY, 2014, METHODS MOL BIOL, V1150, P97, DOI 10.1007/978-1-4939-0512-6_5; Yi P, 2017, MOL CELL, V67, P733, DOI 10.1016/j.molcel.2017.07.026; Yi P, 2015, MOL CELL, V57, P1047, DOI 10.1016/j.molcel.2015.01.025; Yu CN, 2016, NAT BIOTECHNOL, V34, P419, DOI 10.1038/nbt.3460; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zhang GH, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1501473	57	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0262378	10.1371/journal.pone.0262378	http://dx.doi.org/10.1371/journal.pone.0262378			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353838	gold, Green Submitted, Green Published			2022-12-26	WOS:000786647900020
J	Boujemaa, M; Mighri, N; Chouchane, L; Boubaker, MS; Abdelhak, S; Boussen, H; Hamdi, Y				Boujemaa, Maroua; Mighri, Najah; Chouchane, Lotfi; Boubaker, Mohamed Samir; Abdelhak, Sonia; Boussen, Hamouda; Hamdi, Yosr			Health influenced by genetics: A first comprehensive analysis of breast cancer high and moderate penetrance susceptibility genes in the Tunisian population	PLOS ONE			English	Article							LINKAGE DISEQUILIBRIUM; ASSOCIATION; EXPRESSION; VARIANTS; RISK	Significant advances have been made to understand the genetic basis of breast cancer. High, moderate and low penetrance variants have been identified with inter-ethnic variability in mutation frequency and spectrum. Genome wide association studies (GWAS) are widely used to identify disease-associated SNPs. Understanding the functional impact of these risk-SNPs will help the translation of GWAS findings into clinical interventions. Here we aim to characterize the genetic patterns of high and moderate penetrance breast cancer susceptibility genes and to assess the functional impact of non-coding SNPs. We analyzed BRCA1/2, PTEN, STK11, TP53, ATM, BRIP1, CHEK2 and PALB2 genotype data obtained from 135 healthy participants genotyped using Affymetrix Genome-Wide Human SNP-Array 6.0. Haplotype analysis was performed using Haploview.V4.2 and PHASE.V2.1. Population structure and genetic differentiation were assessed using principal component analysis (PCA) and fixation index (FST). Functional annotation was performed using In Silico web-based tools including RegulomeDB and VARAdb. Haplotype analysis showed distinct LD patterns with high levels of recombination and haplotype blocks of moderate to small size. Our findings revealed also that the Tunisian population tends to have a mixed origin with European, South Asian and Mexican footprints. Functional annotation allowed the selection of 28 putative regulatory variants. Of special interest were BRCA1_ rs8176318 predicted to alter the binding sites of a tumor suppressor miRNA hsa-miR-149 and PALB2_ rs120963 located in tumorigenesis-associated enhancer and predicted to strongly affect the binding of P53. Significant differences in allele frequencies were observed with populations of African and European ancestries for rs8176318 and rs120963 respectively. Our findings will help to better understand the genetic basis of breast cancer by guiding upcoming genome wide studies in the Tunisian population. Putative functional SNPs may be used to develop an efficient polygenic risk score to predict breast cancer risk leading to better disease prevention and management.	[Boujemaa, Maroua; Mighri, Najah; Boubaker, Mohamed Samir; Abdelhak, Sonia; Boussen, Hamouda; Hamdi, Yosr] Univ Tunis El Manar, Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia; [Chouchane, Lotfi] Weill Cornell Med, Dept Genet Med, New York, NY USA; [Chouchane, Lotfi] Weill Cornell Med, Dept Microbiol & Immunol, New York, NY USA; [Chouchane, Lotfi] Weill Cornell Med Qatar, Lab Genet Med & Immunol, Doha, Qatar; [Boubaker, Mohamed Samir; Hamdi, Yosr] Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia; [Boussen, Hamouda] Univ Tunis El Manar, Abderrahman Mami Hosp, Fac Med Tunis, Med Oncol Dept, Tunis, Tunisia	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Cornell University; Cornell University; Qatar Foundation (QF); Weill Cornell Medical College Qatar; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte de Medecine de Tunis (FMT); Hopital Abderrahmene Mami	Hamdi, Y (corresponding author), Univ Tunis El Manar, Inst Pasteur Tunis, Lab Biomed Genom & Oncogenet, Tunis, Tunisia.; Hamdi, Y (corresponding author), Inst Pasteur Tunis, Lab Human & Expt Pathol, Tunis, Tunisia.	yosr.hamdi@pasteur.utm.tn	Hamdi, Yosr/GLT-7117-2022	Hamdi, Yosr/0000-0002-2815-1834; Boujemaa, Maroua/0000-0001-7409-9240	Qatar National Research Foundation [NPRP 08-083-3-031]; Tunisian Ministry of Higher Education and Scientific Research; Tunisian Ministry of Health; MOBIDOC fellowship; EU through EMORI program	Qatar National Research Foundation(National Research Foundation of Korea); Tunisian Ministry of Higher Education and Scientific Research; Tunisian Ministry of Health; MOBIDOC fellowship; EU through EMORI program	Funding: This work was supported by Qatar National Research Foundation [NPRP 08-083-3-031], the Tunisian Ministry of Higher Education and Scientific Research and the Tunisian Ministry of Health. MB isa recipient of a MOBIDOC fellowship, funded by the EU through the EMORI program and managed by the ANPR. The funders & nbsp;had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apostolou P, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/747318; Bao FF, 2017, CELL CYCLE, V16, P2073, DOI 10.1080/15384101.2017.1361064; Bouguerra H, 2014, ASIAN PAC J CANCER P, V15, P6805, DOI 10.7314/APJCP.2014.15.16.6805; Boussen H, 2010, CANCER-AM CANCER SOC, V116, P2730, DOI 10.1002/cncr.25175; Boyle AP, 2012, GENOME RES, V22, P1790, DOI 10.1101/gr.137323.112; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cano-Gamez E, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00424; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen PZ, 2008, CLIN CANCER RES, V14, P5931, DOI 10.1158/1078-0432.CCR-08-0429; Chimusa ER, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005052; Choi SW, 2020, NAT PROTOC, V15, P2759, DOI 10.1038/s41596-020-0353-1; Clarke L, 2012, NAT METHODS, V9, P1, DOI [10.1038/NMETH.1974, 10.1038/nmeth.1974]; Dorairaj JJ, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-421; Economopoulou P, 2015, CANCER TREAT REV, V41, P1, DOI 10.1016/j.ctrv.2014.10.008; Ferreira MA, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-08053-5; Fourati A, 2014, ASIA-PAC J CLIN ONCO, V10, pE69, DOI 10.1111/ajco.12034; Frigi S, 2017, HOMO, V68, P298, DOI 10.1016/j.jchb.2017.05.003; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Ghoussaini M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5999; Gopi LK, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21707-1; Hamdi Y, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-5133-8; Jalkh N, 2017, BMC MED GENOMICS, V10, DOI 10.1186/s12920-017-0244-7; Kadouri L, 2007, J MED GENET, V44, P467, DOI 10.1136/jmg.2006.048173; Kefi R, 2015, MITOCHONDR DNA, V26, P593, DOI 10.3109/19401736.2013.879649; Klemm SL, 2019, NAT REV GENET, V20, P207, DOI 10.1038/s41576-018-0089-8; Kumar S, 2016, MOL BIOL EVOL, V33, P1870, DOI [10.1093/molbev/msw054, 10.1093/molbev/msv279]; Li L, 2014, CANCER CELL INT, V14, DOI 10.1186/1475-2867-14-39; Li MJ, 2015, BRIEF BIOINFORM, V16, P393, DOI 10.1093/bib/bbu018; Li SM, 2018, THORAC CANCER, V9, P794, DOI 10.1111/1759-7714.12647; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Mahfoudh W, 2012, MOL BIOL REP, V39, P1037, DOI 10.1007/s11033-011-0829-8; Marsman J, 2012, BBA-GENE REGUL MECH, V1819, P1217, DOI 10.1016/j.bbagrm.2012.10.008; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Missaoui N, 2011, ASIAN PAC J CANCER P, V12, P169; Mueller CR, 2003, BREAST CANCER RES, V5, P45, DOI 10.1186/bcr557; Mughal M., 2013, TUNISIA; Oscanoa J, 2020, NUCLEIC ACIDS RES, V48, pW185, DOI 10.1093/nar/gkaa420; Pan Q, 2021, NUCLEIC ACIDS RES, V49, pD1431, DOI 10.1093/nar/gkaa922; Pelletier C, 2011, CELL CYCLE, V10, P90, DOI 10.4161/cc.10.1.14359; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Romdhane L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-52; Sawyer SL, 2005, EUR J HUM GENET, V13, P677, DOI 10.1038/sj.ejhg.5201368; Shan JX, 2012, BREAST CANCER RES TR, V135, P715, DOI 10.1007/s10549-012-2202-6; Smyth C, 2015, MOL GENET GENOM MED, V3, P182, DOI 10.1002/mgg3.129; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Sueta A, 2012, BREAST CANCER RES TR, V132, P711, DOI 10.1007/s10549-011-1904-5; Sze CC, 2020, SCI ADV, V6, DOI 10.1126/sciadv.aaz4764; Tak YG, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0050-4; Tishkoff SA, 2002, NAT REV GENET, V3, P611, DOI 10.1038/nrg865; Wu YY, 2018, ONCOL RES TREAT, V41, P780, DOI 10.1159/000492827; Xiao ZD, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2016.1187322; Yanes T, 2020, BREAST CANCER RES, V22, DOI 10.1186/s13058-020-01260-3; Zhang GX, 2018, NUCLEIC ACIDS RES, V46, pD78, DOI 10.1093/nar/gkx920; Zhao YL, 2019, EPIGENET CHROMATIN, V12, DOI 10.1186/s13072-019-0272-y; Zhi YR, 2018, CELL PROLIFERAT, V51, DOI 10.1111/cpr.12465	56	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265638	10.1371/journal.pone.0265638	http://dx.doi.org/10.1371/journal.pone.0265638			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333900	gold, Green Published			2022-12-26	WOS:000784335700038
J	Ghosh, AK; Venkatraman, S; Reshetnyak, E; Rajan, M; An, A; Chae, JK; Unruh, MA; Abramson, D; DiMaggio, C; Hupert, N				Ghosh, Arnab K.; Venkatraman, Sara; Reshetnyak, Evgeniya; Rajan, Mangala; An, Anjile; Chae, John K.; Unruh, Mark A.; Abramson, David; DiMaggio, Charles; Hupert, Nathaniel			Association between city-wide lockdown and COVID-19 hospitalization rates in multigenerational households in New York City	PLOS ONE			English	Article								BackgroundCity-wide lockdowns and school closures have demonstrably impacted COVID-19 transmission. However, simulation studies have suggested an increased risk of COVID-19 related morbidity for older individuals inoculated by house-bound children. This study examines whether the March 2020 lockdown in New York City (NYC) was associated with higher COVID-19 hospitalization rates in neighborhoods with larger proportions of multigenerational households. MethodsWe obtained daily age-segmented COVID-19 hospitalization counts in each of 166 ZIP code tabulation areas (ZCTAs) in NYC. Using Bayesian Poisson regression models that account for spatiotemporal dependencies between ZCTAs, as well as socioeconomic risk factors, we conducted a difference-in-differences study amongst ZCTA-level hospitalization rates from February 23 to May 2, 2020. We compared ZCTAs in the lowest quartile of multigenerational housing to other quartiles before and after the lockdown. FindingsAmong individuals over 55 years, the lockdown was associated with higher COVID-19 hospitalization rates in ZCTAs with more multigenerational households. The greatest difference occurred three weeks after lockdown: Q2 vs. Q1: 54% increase (95% Bayesian credible intervals: 22-96%); Q3 vs. Q1: 48% (17-89%); Q4 vs. Q1: 66% (30-211%). After accounting for pandemic-related population shifts, a significant difference was observed only in Q4 ZCTAs: 37% (7-76%). InterpretationBy increasing house-bound mixing across older and younger age groups, city-wide lockdown mandates imposed during the growth of COVID-19 cases may have inadvertently, but transiently, contributed to increased transmission in multigenerational households.	[Ghosh, Arnab K.; Reshetnyak, Evgeniya; Rajan, Mangala; Chae, John K.] Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA; [Venkatraman, Sara] Cornell Univ, Dept Stat & Data Sci, Ithaca, NY USA; [An, Anjile; Unruh, Mark A.; Hupert, Nathaniel] Cornell Univ, Dept Populat Hlth Sci, Weill Cornell Med Coll, New York, NY 10021 USA; [Abramson, David] NYU, Sch Global Publ Hlth, New York, NY USA; [DiMaggio, Charles] NYU, Dept Surg, Sch Med, New York, NY 10016 USA; [Hupert, Nathaniel] Cornell Univ, Cornell Ctr Dis & Disaster Preparedness, Weill Cornell Med Coll, New York, NY 10021 USA	Cornell University; Cornell University; Cornell University; New York University; New York University; Cornell University	Ghosh, AK (corresponding author), Cornell Univ, Weill Cornell Med Coll, Dept Med, New York, NY 10021 USA.	akg9010@med.cornell.edu		Chae, John/0000-0001-9998-9100	National Center for Advancing Translational Sciences (NCATS) of the Clinical and Translational Science Center at Weill Cornell Medical College [KL2-TR-002385]; Clinical and Translational Science Center at Weill Cornell Medical College [1-UL1-TR002384-01]	National Center for Advancing Translational Sciences (NCATS) of the Clinical and Translational Science Center at Weill Cornell Medical College; Clinical and Translational Science Center at Weill Cornell Medical College	Dr. Ghosh is supported by National Center for Advancing Translational Sciences (NCATS) grant KL2-TR-002385 of the Clinical and Translational Science Center at Weill Cornell Medical College. Website: https://ncats.nih.gov/ Anjile An, MPH is in part supported by the Clinical and Translational Science Center at Weill Cornell Medical College (1-UL1-TR002384-01). Website: https://ncats.nih.gov/ The funders played no role in the study design, data collection and analysis, decision to public, or preparation of the manuscript.	AARP, 2019, GRANDP TOD NAT SURV; Abedi V, 2021, J RACIAL ETHN HEALTH, V8, P732, DOI [10.1007/s40615-020-00833-4, 10.1101/2020.04.26.20079756]; Ahmad K, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241327; Alfano V, 2020, APPL HEALTH ECON HEA, V18, P509, DOI 10.1007/s40258-020-00596-3; [Anonymous], 2020, NEW YORK CITY CLOSE; [Anonymous], 2020, ALL MAP DATA NEW YOR; Arasteh K, 2021, J RACIAL ETHN HEALTH, V8, P863, DOI 10.1007/s40615-020-00844-1; Auger KA, 2020, JAMA-J AM MED ASSOC, V324, P859, DOI 10.1001/jama.2020.14348; Bernstein L, 2020, WASHINGTON POST 0729; Bilal U., 2021, ANN INTERN MED; Brown KA, 2021, JAMA INTERN MED, V181, P229, DOI 10.1001/jamainternmed.2020.6466; CDC COVID-19 Response Team, 2020, MMWR-MORBID MORTAL W, V69, P343, DOI [10.15585/mmwr.mm6912e2, 10.15585/mmwr.mm6915e4]; Courtemanche C, 2020, HEALTH AFFAIR, V39, P1237, DOI 10.1377/hlthaff.2020.00608; DiMaggio C, 2020, ANN EPIDEMIOL, V51, P7, DOI 10.1016/j.annepidem.2020.08.012; Emeruwa UN, 2020, JAMA-J AM MED ASSOC, V324, P390, DOI 10.1001/jama.2020.11370; Germann TC, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.100348; Ghosh AK., 2021, ASS OVERCROWDED HOUS; Gu T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25197; Guzman S, 2019, MULTIGENERATIONAL HO; Magleby R, 2021, CLIN INFECT DIS, V73, pE4197, DOI 10.1093/cid/ciaa851; Meo SA, 2020, EUR J MED RES, V25, DOI 10.1186/s40001-020-00456-9; Nafilyan V, 2021, J ROY SOC MED, V114, P182, DOI 10.1177/0141076821999973; Ogedegbe G, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.26881; Park SS, 2019, POPUL DEV REV, V45, P351, DOI 10.1111/padr.12233; Quealy K., 2020, NEW YORK TIMES 0515; Reyes AM, 2018, J MARRIAGE FAM, V80, P119, DOI 10.1111/jomf.12445; Rice K, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m3588; Rozhnova G, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-21899-6; Scott S, 2020, NEW YORTK CITYS FRON; Selden TM, 2020, HEALTH AFFAIR, V39, P1624, DOI 10.1377/hlthaff.2020.00897; Sun KY, 2021, SCIENCE, V371, P254, DOI 10.1126/science.abe2424; United G, 2020, COVID 19 FACT SHEET; Wang L, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18836-4; Westblade LF, 2020, CANCER CELL, V38, P661, DOI 10.1016/j.ccell.2020.09.007; Wodarz Dominik, 2020, medRxiv, DOI 10.1101/2020.10.07.20208231	35	0	0	4	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266127	10.1371/journal.pone.0266127	http://dx.doi.org/10.1371/journal.pone.0266127			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353857	gold, Green Submitted, Green Published			2022-12-26	WOS:000786647900040
J	Keronen, S; Martola, L; Finne, P; Burton, IS; Tong, XYF; Kroger, H; Honkanen, E				Keronen, Satu; Martola, Leena; Finne, Patrik; Burton, Inari S.; Tong, Xiaoyu F.; Kroger, Heikki; Honkanen, Eero			Bone volume, mineral density, and fracture risk after kidney transplantation	PLOS ONE			English	Article							RENAL OSTEODYSTROPHY; HISTOMORPHOMETRIC ANALYSIS; TRABECULAR BONE; DISEASE; RECIPIENTS; DISORDERS; FRAGILITY; TURNOVER; DIALYSIS	BackgroundDisordered mineral metabolism reverses incompletely after kidney transplantation in numerous patients. Post-transplantation bone disease is a combination of pre-existing chronic kidney disease and mineral disorder and often evolving osteoporosis. These two frequently overlapping conditions increase the risk of post-transplantation fractures. Material and methodsWe studied the prevalence of low bone volume in bone biopsies obtained from kidney transplant recipients who were biopsied primarily due to the clinical suspicion of persistent hyperparathyroidism between 2000 and 2015 at the Hospital District of Helsinki and Uusimaa. Parameters of mineral metabolism, results of dual-energy x-ray absorptiometry scans, and the history of fractures were obtained concurrently.One hundred nine bone biopsies taken at a median of 31 (interquartile range, IQR, 18-70) months after transplantation were included in statistical analysis. Bone turnover was classified as high in 78 (72%) and normal/low in 31 (28%) patients. The prevalence of low bone volume (n = 47, 43%) was higher among patients with low/normal turnover compared to patients with high turnover [18 (58%) vs. 29 (37%), P = 0.05]. Thirty-seven fragility fractures in 23 (21%) transplant recipients corresponding to fracture incidence 15 per 1000 person-years occurred during a median follow-up 9.1 (IQR, 6.3-12.1) years. Trabecular bone volume did not correlate with incident fractures. Accordingly, low bone mineral density at the lumbar spine correlated with low trabecular bone volume, but not with incident fractures. The cumulative corticosteroid dose was an important determinant of low bone volume, but not of incident fractures. ConclusionsDespite the high prevalence of trabecular bone loss among kidney transplant recipients, the number of fractures was limited. The lack of association between trabecular bone volume and fractures suggests that the bone cortical compartment and quality are important determinants of bone strength and post-transplantation fracture.	[Keronen, Satu; Martola, Leena; Finne, Patrik; Honkanen, Eero] Univ Helsinki, Abdominal Ctr, Dept Nephrol, Helsinki, Finland; [Keronen, Satu; Martola, Leena; Finne, Patrik; Honkanen, Eero] Helsinki Univ Hosp, Helsinki, Finland; [Burton, Inari S.; Tong, Xiaoyu F.] Univ Eastern Finland, Kuopio Musculoskeletal Res Unit KMRU, Kuopio, Finland; [Kroger, Heikki] Kuopio Univ Hosp, Dept Orthoped Traumatol & Hand Surg, Kuopio, Finland	University of Helsinki; University of Helsinki; Helsinki University Central Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland	Keronen, S (corresponding author), Univ Helsinki, Abdominal Ctr, Dept Nephrol, Helsinki, Finland.; Keronen, S (corresponding author), Helsinki Univ Hosp, Helsinki, Finland.	satu.keronen@hus.fi		Finne, Patrik/0000-0002-3742-1576; Keronen, Satu/0000-0002-7954-5729				Akaberi S, 2008, AM J TRANSPLANT, V8, P2647, DOI 10.1111/j.1600-6143.2008.02423.x; Altman AM, 2018, CURR OSTEOPOROS REP, V16, P703, DOI 10.1007/s11914-018-0490-4; Altman DG., 1999, PRACTICAL STAT MED R; Marques IDB, 2019, J AM SOC NEPHROL, V30, P355, DOI 10.1681/ASN.2018060656; Borchhardt K, 2007, AM J TRANSPLANT, V7, P2515, DOI 10.1111/j.1600-6143.2007.01950.x; Bouquegneau A, 2016, CLIN J AM SOC NEPHRO, V11, P1282, DOI 10.2215/CJN.11371015; Carvalho C, 2016, NEPHROLOGY, V21, P55, DOI 10.1111/nep.12570; Cho ME, 2010, TRANSPL P, V42, P3554, DOI 10.1016/j.transproceed.2010.06.027; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Dempster DW., 2001, PRINCIPLES PRACTICE, V3rd Ed, P541; Evenepoel P, 2021, NEPHROL DIAL TRANSPL, V36, P42, DOI 10.1093/ndt/gfaa192; Evenepoel P, 2019, KIDNEY INT, V95, P1461, DOI 10.1016/j.kint.2018.12.024; Evenepoel P, 2020, NEPHROL DIAL TRANSPL, V35, P697, DOI 10.1093/ndt/gfy306; Evenepoel P, 2017, NEPHROL DIAL TRANSPL, V32, P1608, DOI 10.1093/ndt/gfw468; Evenepoel P, 2017, KIDNEY INT, V91, P469, DOI 10.1016/j.kint.2016.10.008; Hirukawa T, 2015, CLIN EXP NEPHROL, V19, P543, DOI 10.1007/s10157-015-1117-z; Iimori S, 2012, NEPHROL DIAL TRANSPL, V27, P345, DOI 10.1093/ndt/gfr317; Keronen S, 2019, CLIN J AM SOC NEPHRO, V14, P894, DOI 10.2215/CJN.09950818; Keronen S, 2016, CLIN NEPHROL, V85, P127, DOI 10.5414/CN108709; Kowarik A, 2016, J STAT SOFTW, V74, DOI 10.18637/jss.v074.i07; Lehmann G, 2007, TRANSPL P, V39, P3153, DOI 10.1016/j.transproceed.2007.10.001; Leonard MB, 2009, SEMIN NEPHROL, V29, P133, DOI 10.1016/j.semnephrol.2009.01.006; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Malluche HH, 2018, OSTEOPOROSIS INT, V29, P125, DOI 10.1007/s00198-017-4228-4; Malluche HH, 2006, CLIN NEPHROL, V65, P235; McNerny EMB, 2017, CURR OSTEOPOROS REP, V15, P207, DOI 10.1007/s11914-017-0366-z; Nair SS, 2014, AM J TRANSPLANT, V14, P943, DOI 10.1111/ajt.12652; Naylor KL, 2016, TRANSPLANTATION, V100, P167, DOI 10.1097/TP.0000000000000808; Naylor KL, 2015, CLIN J AM SOC NEPHRO, V10, P646, DOI 10.2215/CJN.06040614; Naylor KL, 2013, TRANSPLANTATION, V95, P1461, DOI 10.1097/TP.0b013e31828eead8; Neves CL, 2013, TRANSPLANTATION, V96, P290, DOI 10.1097/TP.0b013e3182985468; Nickolas TL, 2013, J BONE MINER RES, V28, P1811, DOI 10.1002/jbmr.1916; Nikkel LE, 2012, AM J TRANSPLANT, V12, P649, DOI 10.1111/j.1600-6143.2011.03872.x; Nikkel LE, 2009, TRANSPLANTATION, V87, P1846, DOI 10.1097/TP.0b013e3181a6bbda; Ott SM, 2018, AM J NEPHROL, V47, P373, DOI 10.1159/000489672; Perrin P, 2013, AM J TRANSPLANT, V13, P2653, DOI 10.1111/ajt.12425; Perrin P, 2017, TRANSPLANTATION, V101, P1897, DOI 10.1097/TP.0000000000001449; Pimentel A, 2017, KIDNEY INT, V92, P1343, DOI 10.1016/j.kint.2017.07.021; REHMAN MTA, 1994, J CLIN PATHOL, V47, P529, DOI 10.1136/jcp.47.6.529; Salam SN, 2014, AM J KIDNEY DIS, V63, P1049, DOI 10.1053/j.ajkd.2013.12.016; Sharma AK, 2018, CLIN TRANSPLANT, V32, DOI 10.1111/ctr.13347; Sharma AK, 2018, AM J NEPHROL, V47, P376, DOI 10.1159/000489671; Vellanki K, 2018, AM J KIDNEY DIS, V71, P710, DOI 10.1053/j.ajkd.2017.12.019	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0261686	10.1371/journal.pone.0261686	http://dx.doi.org/10.1371/journal.pone.0261686			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349587	Green Published, gold			2022-12-26	WOS:000783906500032
J	Nakajima, D; Mihara, T; Hijikata, T; Tomita, M; Goto, T				Nakajima, Daisuke; Mihara, Takahiro; Hijikata, Toshiyuki; Tomita, Makoto; Goto, Takahisa			Effectiveness of acupuncture therapy for preventing emergence agitation in children: A protocol for systematic review and meta-analysis with trial sequential analysis	PLOS ONE			English	Article							SEVOFLURANE ANESTHESIA; PROPOFOL; EFFICACY; MYRINGOTOMY; STRENGTH; DELIRIUM; FENTANYL; QUALITY; END	Pain, autonomic distress, and emergence agitation occur commonly in children undergoing general anesthesia. While acupuncture therapy has been reported to effectively reduce such pain and autonomic distress in children, its effect in preventing emergence agitation remains unclear. Therefore, we will conduct a systematic review and meta-analysis with trial sequential analysis to evaluate the effect of acupuncture therapy in preventing emergence agitation in children undergoing general anesthesia.& nbsp;Methods and analysis: This protocol was prepared according to the 2015 Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) for Protocols guidelines. We will conduct a search for randomized controlled trials that evaluated the effect of acupuncture therapy in preventing emergence agitation. The following databases will be searched for relevant articles: MEDLINE, CENTRAL, Embase, and Web of Science; four pre-registration sites will be accessed from inception to April 1, 2021. No language restrictions will be applied. Two authors will independently scan and select eligible studies, extract the data, and assess the risk of bias. The incidence of emergence agitation will be combined as a risk ratio with a 95% confidence interval using a random-effect model. The I-2 statistics will be used to assess heterogeneity. We will evaluate the quality of the clinical trials using the Cochrane methodology and assess the quality of evidence using the Grading of Recommendation Assessment, Development, and Evaluation approach. If appropriate, a trial sequential analysis will be performed. Expected outcomes: This meta-analysis will be the first to evaluate the effect of acupuncture therapy in preventing emergence agitation in children. The findings from this meta-analysis have the potential to reveal pivotal factors that affect the clinical effect of acupuncture therapy, thereby supporting the optimization of acupuncture therapy for emergence agitation.Protocol registration University Hospital Medical Information Network Clinical Trials Registry.	[Nakajima, Daisuke; Mihara, Takahiro; Hijikata, Toshiyuki; Tomita, Makoto] Yokohama City Univ, Grad Sch Data Sci, Dept Hlth Data Sci, Yokohama, Japan; [Goto, Takahisa] Yokohama City Univ, Sch Med, Dept Anesthesiol, Yokohama, Japan	Yokohama City University; Yokohama City University	Mihara, T (corresponding author), Yokohama City Univ, Grad Sch Data Sci, Dept Hlth Data Sci, Yokohama, Japan.	meta.analysis.r@gmail.com						Acar HV, 2012, PEDIATR ANESTH, V22, P1105, DOI 10.1111/j.1460-9592.2012.03876.x; Aouad MT, 2007, ANESTHESIOLOGY, V107, P733, DOI 10.1097/01.anes.0000287009.46896.a7; Atkins D, 2004, BMJ-BRIT MED J, V328, P1490; Bodeker G., 2005, GLOBAL ATLAS TRADITI; Brok J, 2008, J CLIN EPIDEMIOL, V61, P763, DOI 10.1016/j.jclinepi.2007.10.007; Chan Joseph, 2002, Acupunct Med, V20, P74; Chernyak GV, 2005, ANESTHESIOLOGY, V102, P1031, DOI 10.1097/00000542-200505000-00024; Costi D, 2015, PEDIATR ANESTH, V25, P517, DOI 10.1111/pan.12617; Cumpston M, 2019, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000142; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Galinkin JL, 2000, ANESTHESIOLOGY, V93, P1378, DOI 10.1097/00000542-200012000-00006; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hijikata T, 2016, EUR J ANAESTH, V33, P535, DOI 10.1097/EJA.0000000000000379; IntHout J, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-25; Jindal V, 2008, J PEDIAT HEMATOL ONC, V30, P431, DOI 10.1097/MPH.0b013e318165b2cc; Khalafallah A, 2010, MEDITERR J HEMATOL I, V2, DOI [10.4084/MJHID.2010.005, 10.1136/bmj.l4898]; Kim MS, 2013, BRIT J ANAESTH, V110, P274, DOI 10.1093/bja/aes382; Kim MR, 2005, NEUROSCI LETT, V387, P17, DOI 10.1016/j.neulet.2005.07.007; Lee IS, 2019, EVID-BASED COMPL ALT, V2019, DOI 10.1155/2019/1304152; Lin YC, 2009, PEDIATR ANESTH, V19, P1096, DOI 10.1111/j.1460-9592.2009.03129.x; Malviya S, 2006, PEDIATR ANESTH, V16, P554, DOI 10.1111/j.1460-9592.2006.01818.x; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Nakamura N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204533; Ouzzani M, 2016, SYST REV-LONDON, V5, DOI 10.1186/s13643-016-0384-4; Reinthal M, 2011, CHIN MED-UK, V6, DOI 10.1186/1749-8546-6-28; Sikich N, 2004, ANESTHESIOLOGY, V100, P1138, DOI 10.1097/00000542-200405000-00015; Amorim MAS, 2017, REV BRAS ANESTESIOL, V67, P193, DOI [10.1016/j.bjane.2016.02.007, 10.1016/j.bjan.2016.02.015]; Thorlund K, 2009, INT J EPIDEMIOL, V38, P276, DOI 10.1093/ije/dyn179; Usichenko TI, 2016, CLIN J PAIN, V32, P82, DOI 10.1097/AJP.0000000000000222; Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8; Yang MH, 2007, J CLIN NURS, V16, P308, DOI 10.1111/j.1365-2702.2006.01428.x; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004	33	0	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264197	10.1371/journal.pone.0264197	http://dx.doi.org/10.1371/journal.pone.0264197			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349573	gold, Green Published			2022-12-26	WOS:000783906500015
J	Sangsuwannukul, T; Supimon, K; Chieochansin, T; Choomee, K; Sujjitjoon, J; Junking, M; Yenchitsomanus, PT				Sangsuwannukul, Thanich; Supimon, Kamonlapat; Chieochansin, Thaweesak; Choomee, Kornkan; Sujjitjoon, Jatuporn; Junking, Mutita; Yenchitsomanus, Pa-Thai			Antitumor activity of T cells secreting alpha CD133-alpha CD3 bispecific T-cell engager against cholangiocarcinoma	PLOS ONE			English	Article							GLIOBLASTOMA STEM-CELLS; ESTABLISHMENT; ANTIBODY; LINE	Cholangiocarcinoma (CCA) is a lethal cancer of bile duct epithelial cells with a high mortality rate and limited therapeutic options. An effective treatment is, therefore, urgently needed to improve treatment outcomes for these patients. To develop a new therapeutic option, we engineered T cells secreting alpha CD133-alpha CD3 bispecific T-cell engager and evaluated their antitumor effects against CD133-expressing CCA cells. The cDNA encoding alpha CD133-alpha CD3 bispecific T-cell engager (alpha CD133-alpha CD3-ENG) was cloned into pCDH lentiviral construct and its expression was tested in Lenti-X 293T cells. T cells from healthy donors were then transduced with engineered lentiviruses to create T cells secreting alpha CD133-alpha CD3 engager to evaluate their antitumor activities. The average transduction efficiency into T cells was approximately 60.03 +/- 21.65%. In the co-culture system containing T cells secreting alpha CD133-alpha CD3 engager (as effector cells) and mWasabi-luciferase-expressing CCA cells (KKU-100 and KKU-213A; as target cells), the effector T cells exhibited significantly higher cytolytic activities against the target CCA cells (49.0 +/- 9.76% and 64.10 +/- 13.18%, respectively) than those observed against the untransduced T cells (10.97 +/- 10.65%; p = 0.0103 and 9.80 +/- 11.05%; p = 0.0054) at an effector-to-target ratio of 5:1. In addition, the secreted alpha CD133-alpha CD3 engager significantly redirected both transduced T cells and bystander T cells to kill the target CCA cells (up to 73.20 +/- 1.68%; p<0.05). Moreover, the transduced and bystander T cells could kill the target CCA spheroids at a rate approximately 5-fold higher than that of the no treatment control condition (p = 0.0011). Our findings demonstrate proof-of-principle that T cells secreting alpha CD133-alpha CD3 engager can be an alternative approach to treating CD133-positive CCA, and they pave the way for future in vivo study and clinical trials.	[Sangsuwannukul, Thanich; Supimon, Kamonlapat; Chieochansin, Thaweesak; Choomee, Kornkan; Sujjitjoon, Jatuporn; Junking, Mutita; Yenchitsomanus, Pa-Thai] Mahidol Univ, Fac Med, Siriraj Ctr Res Excellence Canc Immunotherapy SiC, Res Dept,Siriraj Hosp, Bangkok, Thailand; [Sangsuwannukul, Thanich; Supimon, Kamonlapat; Chieochansin, Thaweesak; Choomee, Kornkan; Sujjitjoon, Jatuporn; Junking, Mutita; Yenchitsomanus, Pa-Thai] Mahidol Univ, Fac Med, Res Dept, Div Mol Med,Siriraj Hosp, Bangkok, Thailand	Mahidol University; Mahidol University	Junking, M; Yenchitsomanus, PT (corresponding author), Mahidol Univ, Fac Med, Siriraj Ctr Res Excellence Canc Immunotherapy SiC, Res Dept,Siriraj Hosp, Bangkok, Thailand.; Junking, M; Yenchitsomanus, PT (corresponding author), Mahidol Univ, Fac Med, Res Dept, Div Mol Med,Siriraj Hosp, Bangkok, Thailand.	njunking@gmail.com; parhai.yen@mahidol.edu	Sujjitjoon, Jatuporn/ADE-1978-2022; Junking, Mutita/GOG-8176-2022	Sujjitjoon, Jatuporn/0000-0002-5459-8031; Yenchitsomanus, Pa-thai/0000-0001-9779-5927	International Research Network [IRN58W0001, IRN5801PHDW04]; Siriraj Research Fund of Faculty of Medicine Siriraj Hospital, Mahidol University [R016034008, R016334002]; Siriraj Chalermphrakiat Grant from Faculty of Medicine Siriraj Hospital, Mahidol University; Specific League Funds from Mahidol University	International Research Network; Siriraj Research Fund of Faculty of Medicine Siriraj Hospital, Mahidol University; Siriraj Chalermphrakiat Grant from Faculty of Medicine Siriraj Hospital, Mahidol University; Specific League Funds from Mahidol University	PY was supported by grants from the International Research Network (grant numbers IRN58W0001) and the Siriraj Research Fund of the Faculty of Medicine Siriraj Hospital, Mahidol University (grant numbers R016034008 and R016334002). TS was supported by a grant from the International Research Network (grant numbersIRN5801PHDW02).KS was supported by a grant from the International Research Network( grant number IRN5801PHDW04). MJ was supported by a Siriraj Chalermphrakiat Grant from the Faculty of Medicine Siriraj Hospital, Mahidol University and Specific League Funds from Mahidol University. The funders have played no role in the research. There was no additional external funding received for this study.	Fajardo CA, 2017, CANCER RES, V77, P2052, DOI 10.1158/0008-5472.CAN-16-1708; Arakawa F, 1996, J BIOCHEM, V120, P657; Banales JM, 2020, NAT REV GASTRO HEPAT, V17, P557, DOI 10.1038/s41575-020-0310-z; Banales JM, 2016, NAT REV GASTRO HEPAT, V13, P261, DOI 10.1038/nrgastro.2016.51; Behrooz AB, 2019, J DRUG TARGET, V27, P257, DOI 10.1080/1061186X.2018.1479756; Bialkowska K, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21176225; Blanco B, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01792; Blanco B, 2019, TRENDS IMMUNOL, V40, P243, DOI 10.1016/j.it.2019.01.008; Bonifant CL, 2016, MOL THER, V24, P1615, DOI 10.1038/mt.2016.116; Busch DH, 2016, SEMIN IMMUNOL, V28, P28, DOI 10.1016/j.smim.2016.02.001; Cai XB, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1423-9; Dai HR, 2020, ONCOIMMUNOLOGY, V9, DOI 10.1080/2162402X.2020.1846926; Dhatchinamoorthy K, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.636568; Einsele H, 2020, CANCER-AM CANCER SOC, V126, P3192, DOI 10.1002/cncr.32909; Feng KC, 2017, J HEMATOL ONCOL, V10, DOI 10.1186/s13045-016-0378-7; Goebeler ME, 2020, NAT REV CLIN ONCOL, V17, P418, DOI 10.1038/s41571-020-0347-5; Guo YL, 2018, PROTEIN CELL, V9, P516, DOI 10.1007/s13238-017-0394-6; Hoffman LM, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00063; Iwahori K, 2015, MOL THER, V23, P171, DOI 10.1038/mt.2014.156; Jones Benjamin S, 2014, Front Pharmacol, V5, P254, DOI 10.3389/fphar.2014.00254; June CH, 2018, NEW ENGL J MED, V379, P64, DOI 10.1056/NEJMra1706169; Kokuryo T, 2012, J HEPATO-BIL-PAN SCI, V19, P606, DOI 10.1007/s00534-012-0542-6; Labbe RP, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13081528; Leelawat K, 2011, WORLD J GASTROENTERO, V17, P1192, DOI 10.3748/wjg.v17.i9.1192; Leick MB, 2021, MOL THER, V29, P433, DOI 10.1016/j.ymthe.2020.10.022; Liu QJ, 2020, PROTEIN CELL, V11, P549, DOI 10.1007/s13238-020-00707-9; Liu X, 2016, BLOOD CANCER J, V6, DOI 10.1038/bcj.2016.38; Maruyama M, 2004, TRANSPLANTATION, V77, P446, DOI 10.1097/01.TP.0000110292.73873.25; Mathema Vivek Bhakta, 2015, Asian Pac J Cancer Prev, V16, P1307; Maude SL, 2018, NEW ENGL J MED, V378, P439, DOI 10.1056/NEJMoa1709866; McGrath NA, 2020, INT J ONCOL, V57, P397, DOI 10.3892/ijo.2020.5074; Milone MC, 2018, LEUKEMIA, V32, P1529, DOI 10.1038/s41375-018-0106-0; Prasad S, 2015, CANCER RES, V75, P2166, DOI 10.1158/0008-5472.CAN-14-2415; Pulte ED, 2018, ONCOLOGIST, V23, P1366, DOI 10.1634/theoncologist.2018-0179; Rizvi S, 2018, NAT REV CLIN ONCOL, V15, P95, DOI 10.1038/nrclinonc.2017.157; Sangsuwannukul T, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107069; Slaney CY, 2018, CANCER DISCOV, V8, P924, DOI 10.1158/2159-8290.CD-18-0297; Sripa B, 2005, WORLD J GASTROENTERO, V11, P3392, DOI 10.3748/wjg.v11.i22.3392; Sripa B, 2020, HUM CELL, V33, P695, DOI 10.1007/s13577-020-00334-w; Supimon K, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85747-9; Tian Z, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01084-4; Velasquez MP, 2016, SCI REP-UK, V6, DOI 10.1038/srep27130; Wang Y, 2018, ONCOIMMUNOLOGY, V7, DOI 10.1080/2162402X.2018.1440169; Wu HJ, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174154; Zhang DX, 2018, SEMIN CANCER BIOL, V52, P94, DOI 10.1016/j.semcancer.2018.05.001; Zhao L, 2015, J IMMUNOTHER, V38, P217, DOI 10.1097/CJI.0000000000000086; Zhu XK, 2015, ONCOTARGET, V6, P171, DOI 10.18632/oncotarget.2767	47	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265773	10.1371/journal.pone.0265773	http://dx.doi.org/10.1371/journal.pone.0265773			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312724	gold, Green Published			2022-12-26	WOS:000803647900012
J	Tuz-Sasik, MU; Boije, H; Manuel, R				Tuz-Sasik, Melek Umay; Boije, Henrik; Manuel, Remy			Characterization of locomotor phenotypes in zebrafish larvae requires testing under both light and dark conditions	PLOS ONE			English	Article							DANIO-RERIO; LATERAL-LINE; BEHAVIORAL REPERTOIRE; ESCAPE; STRESS; RESPONSES; MODEL; FISH; CELL; AGE	Despite growing knowledge, much remains unknown regarding how signaling within neural networks translate into specific behaviors. To pursue this quest, we need better understanding of the behavioral output under different experimental conditions. Zebrafish is a key model to study the relationship between network and behavior and illumination is a factor known to influence behavioral output. By only assessing behavior under dark or light conditions, one might miss behavioral phenotypes exclusive to the neglected illumination setting. Here, we identified locomotor behavior, using different rearing regimes and experimental illumination settings, to showcase the need to assess behavior under both light and dark conditions. Characterization of free-swimming zebrafish larvae, housed under continuous darkness or a day/night cycle, did not reveal behavioral differences; larvae were most active during light conditions. However, larvae housed under a day/night cycle moved a shorter distance, had lower maximum velocity and maximum acceleration during the startle response under light conditions. Next, we explored if we could assess behavior under both dark and light conditions by presenting these conditions in sequence, using the same batch of larvae. Our experiments yielded similar results as observed for naive larvae: higher activity during light conditions, regardless of order of illumination (i.e. dark-light or light-dark). Finally, we conducted these sequenced illumination conditions in an experimental setting by characterizing behavioral phenotypes in larvae following neuromast ablation. Depending on the illumination during testing, the behavioral phenotype following ablation was characterized differently. In addition, the results indicate that the order in which the light and dark conditions are presented has to be considered, as habituation may occur. Our study adds to existing literature on illumination-related differences in zebrafish behavior and emphasize the need to explore behavioral phenotypes under both light and dark condition to maximize our understanding of how experimental permutations affect behavior.	[Tuz-Sasik, Melek Umay; Boije, Henrik; Manuel, Remy] Uppsala Univ, Dept Immunol Genet & Pathol, Cell & Neurobiol, Uppsala, Sweden	Uppsala University	Tuz-Sasik, MU; Manuel, R (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Cell & Neurobiol, Uppsala, Sweden.	umaytuz@gmail.com; remym@me.com		Manuel, Remy/0000-0001-6938-4864	Olle Engkvists Stiftelse [204-0243]; Brain foundation [FO2020-0129]; Swedish research council [2020-03365]; Ragnar Soderberg foundation [1235/17]	Olle Engkvists Stiftelse; Brain foundation; Swedish research council(Swedish Research CouncilEuropean Commission); Ragnar Soderberg foundation	RM: Olle Engkvists Stiftelse 204-0243 (https://engkviststiftelserna.se) MUT-S: Brain foundation FO2020-0129 (https://www.hjarnfonden.se) HB: Swedish research council 2020-03365 (https://vr.se) HB: Ragnar Soderberg foundation 1235/17 (https://ragnar.soderbergs. org) HB: Brain foundation FO2020-0129 (https:// www.hjarnfonden.se)	[Anonymous], DANIOVISION ADD ONS; Basnet RM, 2019, BIOMEDICINES, V7, DOI 10.3390/biomedicines7010023; Burgess HA, 2010, CURR BIOL, V20, P381, DOI 10.1016/j.cub.2010.01.022; Champagne DL, 2010, BEHAV BRAIN RES, V214, P332, DOI 10.1016/j.bbr.2010.06.001; Clow A, 2010, NEUROSCI BIOBEHAV R, V35, P97, DOI 10.1016/j.neubiorev.2009.12.011; Colwill RM, 2011, REV NEUROSCIENCE, V22, P63, DOI 10.1515/RNS.2011.008; DAVIS H, 1977, PHYSIOL PSYCHOL, V5, P280, DOI 10.3758/BF03335331; de Esch C, 2012, NEUROTOXICOL TERATOL, V34, P425, DOI 10.1016/j.ntt.2012.03.002; del Pozo A, 2020, ENEURO, V7, DOI 10.1523/ENEURO.0047-20.2020; Emran F, 2010, P NATL ACAD SCI USA, V107, P6034, DOI 10.1073/pnas.0914718107; Faria M, 2019, SCI TOTAL ENVIRON, V672, P121, DOI 10.1016/j.scitotenv.2019.03.469; Fero K, 2011, NEUROMETHODS, V52, P249, DOI 10.1007/978.1.60761.922.2_12; Fraser TWK, 2017, TOXICOL LETT, V276, P62, DOI 10.1016/j.toxlet.2017.05.021; Gerlai R, 2000, PHARMACOL BIOCHEM BE, V67, P773, DOI 10.1016/S0091-3057(00)00422-6; Haehnel M, 2012, J COMP NEUROL, V520, P1376, DOI 10.1002/cne.22798; Han E, 2020, NEUROTOXICOLOGY, V78, P134, DOI 10.1016/j.neuro.2020.03.005; Harris JA, 2003, JARO-J ASSOC RES OTO, V4, P219, DOI 10.1007/s10162-002-3022-x; Havermans A, 2021, TOXICS, V9, DOI 10.3390/toxics9100250; Irons TD, 2010, NEUROTOXICOL TERATOL, V32, P84, DOI 10.1016/j.ntt.2009.04.066; Jung CM, 2010, J BIOL RHYTHM, V25, P208, DOI 10.1177/0748730410368413; Kenyon EJ, 2021, JCI INSIGHT, V6, DOI 10.1172/jci.insight.145704; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; King CD, 2003, BRAIN RES, V987, P214, DOI 10.1016/S0006-8993(03)03339-0; Kristofco LA, 2016, AQUAT TOXICOL, V170, P344, DOI 10.1016/j.aquatox.2015.09.011; Li Q, 2015, PSYCHOPHARMACOLOGY, V232, P197, DOI 10.1007/s00213-014-3656-5; MacPhail RC, 2009, NEUROTOXICOLOGY, V30, P52, DOI 10.1016/j.neuro.2008.09.011; Maeda H, 2021, BIOMEDICINES, V9, DOI 10.3390/biomedicines9080884; Manuel R, 2016, J FISH BIOL, V88, P2175, DOI 10.1111/jfb.12989; Mueller KP, 2010, CURR BIOL, V20, pR159, DOI 10.1016/j.cub.2009.12.028; Ogungbemi A, 2019, ENVIRON SCI EUR, V31, DOI 10.1186/s12302-019-0270-5; Padilla S, 2011, NEUROTOXICOL TERATOL, V33, P624, DOI 10.1016/j.ntt.2011.08.005; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Rankin CH, 2009, NEUROBIOL LEARN MEM, V92, P135, DOI 10.1016/j.nlm.2008.09.012; Roberts AC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029132; Steenbergen PJ, 2011, BEHAV BRAIN RES, V222, P15, DOI 10.1016/j.bbr.2011.03.025; Suli A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029727; Tabor KM, 2014, J NEUROPHYSIOL, V112, P834, DOI 10.1152/jn.00228.2014; Wolf S, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00310-3	38	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266491	10.1371/journal.pone.0266491	http://dx.doi.org/10.1371/journal.pone.0266491			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363826	gold, Green Published			2022-12-26	WOS:000804748600017
J	Wang, ZP; Tian, JC; Feng, KP				Wang, Zhanping; Tian, Juncang; Feng, Kepeng			Response of runoff towards land use changes in the Yellow River Basin in Ningxia, China	PLOS ONE			English	Article							WATER ASSESSMENT-TOOL; HYDROLOGICAL RESPONSE; SEDIMENT DISCHARGE; LANDSCAPE PATTERN; CLIMATE-CHANGE; COVER CHANGES; STORM-RUNOFF; IMPACTS; STREAMFLOW; MODEL	Since the Yellow River is a main source of water in Ningxia China, maintaining its healthy ecological environment is vital to Ningxia and the neighboring areas. Changes of land use caused by human activities such as population growth, urbanizing process, and industrial and mining construction would affect the balance and cycle of water in the Basin. Therefore, investigating hydrological responses of land use changes can provide insights into the characteristics and evolution of runoff the Yellow River Basin in the Ningxia section. This has imperative and practical significance to the rational use, allocation, and planning of water resources in a changing environment. In this paper, we analyzed the meteorological and hydrological elements of changing characteristics of the Yellow River Basin in the Ningxia section. Then we selected a distribution-based hydrology model of SWAT in combination with GIS to simulate annual and monthly runoff under different land use scenarios. Finally, we analyzed the influence caused by the changes of land use on runoff. We concluded that it is appropriate to lay a decision-making foundation to manage water resources of the Yellow River Basin in the Ningxia section.	[Wang, Zhanping] Ningxia Univ, Sch Math & Stat, Yinchuan, Ningxia, Peoples R China; [Wang, Zhanping; Tian, Juncang; Feng, Kepeng] Ningxia Res Ctr Technol Water Saving Irrigat & Wa, Yinchuan, Ningxia, Peoples R China; [Wang, Zhanping; Tian, Juncang; Feng, Kepeng] Engn Res Ctr Efficient Use Water Resources Modern, Yinchuan, Ningxia, Peoples R China; [Tian, Juncang; Feng, Kepeng] Ningxia Univ, Coll Civil & Hydraul Engn, Yinchuan, Ningxia, Peoples R China	Ningxia University; Ningxia University	Tian, JC (corresponding author), Ningxia Res Ctr Technol Water Saving Irrigat & Wa, Yinchuan, Ningxia, Peoples R China.; Tian, JC (corresponding author), Engn Res Ctr Efficient Use Water Resources Modern, Yinchuan, Ningxia, Peoples R China.; Tian, JC (corresponding author), Ningxia Univ, Coll Civil & Hydraul Engn, Yinchuan, Ningxia, Peoples R China.	wang_zp@nxu.edu.cn			Priority Research and Projects for Ningxia in China [2020BEG03021]; First-class Major Foundation of Ningxia Institutions of High Education in China [NXYLXK2021A03]; Natural Science Foundation of Ningxia Province [2020AAC03058, 2021AAC02007]; First-class Discipline Construction Project in Ningxia Universities; Scientific Research Project of Ningxia Colleges and Universities, China [NGY2020006]	Priority Research and Projects for Ningxia in China; First-class Major Foundation of Ningxia Institutions of High Education in China; Natural Science Foundation of Ningxia Province; First-class Discipline Construction Project in Ningxia Universities; Scientific Research Project of Ningxia Colleges and Universities, China	Funding: The research has obtained the support from the Priority Research and Projects for Ningxia in China (2020BEG03021), the First-class Major Foundation of Ningxia Institutions of High Education in China (NXYLXK2021A03), Natural Science Foundation of Ningxia Province (2020AAC03058, 2021AAC02007), the First-class Discipline Construction Project in Ningxia Universities: Mathematics, and the Scientific Research Project of Ningxia Colleges and Universities, China(NGY2020006).	Arnold JG, 1998, J AM WATER RESOUR AS, V34, P73, DOI 10.1111/j.1752-1688.1998.tb05961.x; Baker TJ, 2013, J HYDROL, V486, P100, DOI 10.1016/j.jhydrol.2013.01.041; Bommarco R, 2013, TRENDS ECOL EVOL, V28, P230, DOI 10.1016/j.tree.2012.10.012; Bormann H., 2007, ECOLOGICAL MODELING, P29; Cabral AIR, 2017, APPL GEOGR, V82, P115, DOI 10.1016/j.apgeog.2017.03.010; Ellis EC, 2011, PHILOS T R SOC A, V369, P1010, DOI 10.1098/rsta.2010.0331; Fan M, 2015, ECOL INDIC, V50, P79, DOI 10.1016/j.ecolind.2014.11.003; Gao P, 2011, HYDROL EARTH SYST SC, V15, P1, DOI 10.5194/hess-15-1-2011; Gao P, 2010, HYDROLOG SCI J, V55, P275, DOI 10.1080/02626660903546191; Gassman PW, 2007, T ASABE, V50, P1211, DOI 10.13031/2013.23637; Hao RF, 2017, SCI TOTAL ENVIRON, V579, P718, DOI 10.1016/j.scitotenv.2016.11.036; Jennings DB, 2002, LANDSCAPE ECOL, V17, P471, DOI 10.1023/A:1021211114125; Jiang SH, 2012, HYDROL RES, V43, P3, DOI 10.2166/nh.2011.133; Kim Y, 2002, J HYDROL ENG, V7, P245, DOI 10.1061/(ASCE)1084-0699(2002)7:3(245); Liu YB, 2006, HYDROL PROCESS, V20, P533, DOI 10.1002/hyp.5920; Lorup JK, 1998, J HYDROL, V205, P147, DOI 10.1016/S0168-1176(97)00311-9; Mamat Z, 2014, ENVIRON MONIT ASSESS, V186, P335, DOI 10.1007/s10661-013-3377-y; MEA, 2005, SCENARIOS, V2; Miao CY, 2010, PROG PHYS GEOG, V34, P541, DOI 10.1177/0309133310369434; Neitsch S. L., 2005, DIFFUS POLLUT C DUBL, V10, P494; Nie WM, 2011, J HYDROL, V407, P105, DOI 10.1016/j.jhydrol.2011.07.012; Niehoff D, 2002, J HYDROL, V267, P80, DOI 10.1016/S0022-1694(02)00142-7; Ren LL, 2012, HYDROL RES, V43, P38, DOI 10.2166/nh.2011.135; Smith P., 2016, CONTRIBUTION WORKING, V167, P78, DOI [10.1146/annurevenviron-020411-130608, DOI 10.1146/ANNUREVENVIRON-020411-130608]; Tamm O, 2018, CATENA, V167, P78, DOI 10.1016/j.catena.2018.04.029; Wagener T, 2007, HYDROL PROCESS, V21, P3233, DOI 10.1002/hyp.6873; Wang GX, 2006, SCI CHINA SER D, V49, P1098, DOI 10.1007/s11430-006-1098-6; Yang XL, 2012, HYDROL RES, V43, P23, DOI 10.2166/nh.2011.120; Zhao GJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091048; Zhou F, 2013, J HYDROL, V485, P113, DOI 10.1016/j.jhydrol.2012.12.040; Zuo DP, 2016, SCI TOTAL ENVIRON, V544, P238, DOI 10.1016/j.scitotenv.2015.11.060	31	0	0	12	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265931	10.1371/journal.pone.0265931	http://dx.doi.org/10.1371/journal.pone.0265931			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363797	gold, Green Published			2022-12-26	WOS:000804748600005
J	Wu, SS; He, YL; Wei, Y; Fan, PY; Ni, WG; Zhong, DB; Zhou, GF; Zheng, XL				Wu, Shanshan; He, Yulan; Wei, Yong; Fan, Peiyang; Ni, Weigui; Zhong, Daibin; Zhou, Guofa; Zheng, Xueli			Effects of Guangzhou seasonal climate change on the development of Aedes albopictus and its susceptibility to DENV-2	PLOS ONE			English	Article							WEST-NILE-VIRUS; CULEX-TARSALIS DIPTERA; DENGUE VIRUS; TEMPERATURE-FLUCTUATIONS; ANOPHELES-CULICIFACIES; EXTRINSIC INCUBATION; VECTOR COMPETENCE; HOST-DEFENSE; TRANSMISSION; CULICIDAE	The susceptibility of Asian tiger mosquitoes to DENV-2 in different seasons was observed in simulated field environments as a reference to design dengue fever control strategies in Guangzhou. The life table experiments of mosquitoes in four seasons were carried out in the field. The susceptibility of Ae. albopictus to dengue virus was observed in both environments in Guangzhou in summer and winter. Ae. albopictus was infected with dengue virus by oral feeding. On day 7 and 14 after infection, the viral load in the head, ovary, and midgut of the mosquito was detected using real-time fluorescent quantitative PCR. Immune-associated gene expression in infected mosquitoes was performed using quantitative real-time reverse transcriptase PCR. The hatching rate and pupation rate of Ae. albopictus larvae in different seasons differed significantly. The winter hatching rate of larvae was lower than that in summer, and the incubation time was longer than in summer. In the winter field environment, Ae. albopictus still underwent basic growth and development processes. Mosquitoes in the simulated field environment were more susceptible to DENV-2 than those in the simulated laboratory environment. In the midgut, viral RNA levels on day 7 in summer were higher than those on day 7 in winter (F = 14.459, P = 0.01); ovarian viral RNA levels on day 7 in summer were higher than those on day 7 in winter (F = 8.656, P < 0.001), but there was no significant difference in the viral load at other time points (P > 0.05). Dicer-2 mRNA expression on day 7 in winter was 4.071 times than that on day 7 in summer: the viral load and Dicer-2 expression correlated moderately. Ae. albopictus could still develop and transmit dengue virus in winter in Guangzhou. Mosquitoes under simulated field conditions were more susceptible to DENV-2 than those under simulated laboratory conditions.	[Wu, Shanshan; He, Yulan; Wei, Yong; Fan, Peiyang; Ni, Weigui; Zheng, Xueli] Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangzhou, Peoples R China; [Zhong, Daibin; Zhou, Guofa] Univ Calif Irvine, Coll Hlth Sci, Program Publ Hlth, Irvine, CA USA	Southern Medical University - China; University of California System; University of California Irvine	Zheng, XL (corresponding author), Southern Med Univ, Sch Publ Hlth, Dept Pathogen Biol, Guangzhou, Peoples R China.	zhengxueli2001@126.com	Zhong, Daibin/GRF-0564-2022	Zheng, Xueli/0000-0003-0646-9398	Natural Science Foundation of China [31630011]; Natural Science Foundation of Guangdong Province [2017A030313625]; Science and Technology Planning Project of Guangzhou [201804020084]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Technology Planning Project of Guangzhou	This work was supported by the Natural Science Foundation of China (No. 31630011), the Natural Science Foundation of Guangdong Province (No. 2017A030313625), and the Science and Technology Planning Project of Guangzhou (No. 201804020084). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman ZN, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002239; Allin KH, 2009, J CLIN ONCOL, V27, P2217, DOI 10.1200/JCO.2008.19.8440; Anglero-Rodriguez YI, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02050; [Anonymous], 2009, DENG GUID DIAGN TREA; Antonova Y, 2009, INSECT BIOCHEM MOLEC, V39, P303, DOI 10.1016/j.ibmb.2009.01.007; Bara J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126703; Bhatt S, 2013, NATURE, V496, P504, DOI 10.1038/nature12060; Bian G, 2005, P NATL ACAD SCI USA, V102, P13568, DOI 10.1073/pnas.0502815102; Bonizzoni M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050512; Brady OJ, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-351; Brustolin M, 2018, MED VET ENTOMOL, V32, P393, DOI 10.1111/mve.12325; Cabral S, 2020, INSECTS, V11, DOI 10.3390/insects11020095; Campbell KM, 2013, AM J TROP MED HYG, V89, P1066, DOI 10.4269/ajtmh.13-0321; Carrington LB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058824; Carrington LB, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002190; Carrington LB, 2013, AM J TROP MED HYG, V88, P689, DOI 10.4269/ajtmh.12-0488; Carrington LB, 2013, J MED ENTOMOL, V50, P43, DOI 10.1603/ME11242; Chan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050972; Colpitts TM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002189; Couret J, 2014, BMC ECOL, V14, DOI 10.1186/1472-6785-14-3; Danforth ME, 2015, J MED ENTOMOL, V52, P1083, DOI 10.1093/jme/tjv082; Di Luca M, 2016, EUROSURVEILLANCE, V21, P6, DOI 10.2807/1560-7917.ES.2016.21.18.30223; Duan Heng-lu, 2017, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V28, P205; Ebi KL, 2016, ENVIRON RES, V151, P115, DOI 10.1016/j.envres.2016.07.026; Farjana T, 2012, MED VET ENTOMOL, V26, P210, DOI 10.1111/j.1365-2915.2011.00971.x; Fragkoudis R, 2008, INSECT MOL BIOL, V17, P647, DOI 10.1111/j.1365-2583.2008.00834.x; Franz AWE, 2015, VIRUSES-BASEL, V7, P3741, DOI 10.3390/v7072795; Goic B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12410; GUBLER DJ, 1979, AM J TROP MED HYG, V28, P1045, DOI 10.4269/ajtmh.1979.28.1045; HARDY JL, 1983, ANNU REV ENTOMOL, V28, P229, DOI 10.1146/annurev.en.28.010183.001305; Kumar A, 2018, INSECTS, V9, DOI 10.3390/insects9030095; Lai SJ, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0336-1; Lambrechts L, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2437; Lambrechts L, 2011, P NATL ACAD SCI USA, V108, P7460, DOI 10.1073/pnas.1101377108; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615; Li Ju-lin, 2015, Zhongguo Xue Xi Chong Bing Fang Zhi Za Zhi, V27, P59; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Liu SS, 1986, INSECT KNOWLEDGE, P41; Liu ZZ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02337; Luo L, 2017, INFECT DIS POVERTY, V6, DOI 10.1186/s40249-017-0352-9; MEYER RP, 1990, J MED ENTOMOL, V27, P607, DOI 10.1093/jmedent/27.4.607; Paaijmans KP, 2010, P NATL ACAD SCI USA, V107, P15135, DOI 10.1073/pnas.1006422107; Paradkar PN, 2012, P NATL ACAD SCI USA, V109, P18915, DOI 10.1073/pnas.1205231109; Pdnn S, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0166806; Qi-Yong L., 2019, Zhongguo Meijie Shengwuxue ji Kongzhi Zazhi = Chinese Journal of Vector Biology and Control, V30, P1; Reinhold JM, 2018, INSECTS, V9, DOI 10.3390/insects9040158; REISEN WK, 1979, J MED ENTOMOL, V16, P207, DOI 10.1093/jmedent/16.3.207; Reisen WK, 2006, J MED ENTOMOL, V43, P309, DOI 10.1603/0022-2585(2006)043[0309:EOTOTT]2.0.CO;2; REISEN WK, 1980, J MED ENTOMOL, V17, P211, DOI 10.1093/jmedent/17.3.211; REISEN WK, 1982, J MED ENTOMOL, V19, P413, DOI 10.1093/jmedent/19.4.413; Richard V, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138161; Robert MA, 2019, EPIDEMICS-NETH, V28, DOI 10.1016/j.epidem.2019.05.003; Robinson ML, 2017, CURR OPIN INFECT DIS, V30, P449, DOI 10.1097/QCO.0000000000000394; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Service M. W., 1993, FIELD SAMPLING METHO; Sim S, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002295; Sim S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010678; Teng HJ, 2000, J MED ENTOMOL, V37, P40, DOI 10.1603/0022-2585-37.1.40; Tesla B, 2018, P ROY SOC B-BIOL SCI, V285, DOI 10.1098/rspb.2018.0795; [王芹 WANG Qin], 2009, [中华流行病学杂志, Chinese Journal of Epidemiology], V30, P802; WATTS DM, 1987, AM J TROP MED HYG, V36, P143, DOI 10.4269/ajtmh.1987.36.143; Wei Y, 2021, FRONT CELL INFECT MI, V11, DOI 10.3389/fcimb.2021.649975; Wimalasiri-Yapa BMCR, 2021, OPEN BIOL, V11, DOI 10.1098/rsob.200246; Xia Yi, 2016, Zhongguo Meijieshengwuxue Ji Kongzhi Zazhi, V27, P209; Xiao Fang-zhen, 2012, Chinese Journal of Zoonoses, V28, P108; [严子锵 YAN Ziqiang], 2007, [中国媒介生物学及控制杂志, Chinese Journal of Vector Biology and Control], V18, P193; Yang DZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229829; Yang DZ., 2019, EFFECTS SEASONAL CLI; Zhang MC, 2010, AM J TROP MED HYG, V83, P700, DOI 10.4269/ajtmh.2010.10-0193; Zhao H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0156548; Zheng NX., 2003, STRAIT J PREVENTIVE, P8; Zheng XL., 2010, ACTA PARASIT MED ENT, V10, P47; Zhong ZL., 1988, J SUN YAT SEN MEDICA, P35	76	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266128	10.1371/journal.pone.0266128	http://dx.doi.org/10.1371/journal.pone.0266128			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363810	Green Published, gold, Green Submitted			2022-12-26	WOS:000804748600043
J	Yazdani, K; Dolguikh, K; Zhang, WY; Shayegi-Nik, S; Ly, J; Cooper, S; Trigg, J; Bartlett, S; Barrios, R; Montaner, JSG; Salters, K				Yazdani, Kiana; Dolguikh, Katerina; Zhang, Wendy; Shayegi-Nik, Sara; Ly, Jessica; Cooper, Shaughna; Trigg, Jason; Bartlett, Sophia; Barrios, Rolando; Montaner, Julio S. G.; Salters, Kate			Knowledge of hepatitis C and awareness of reinfection risk among people who successfully completed direct acting antiviral therapy	PLOS ONE			English	Article							LATENT CLASS ANALYSIS; INFECTION; CANADA	BackgroundHepatitis C virus (HCV) education may be changing following the simplification of HCV treatment and emergence of direct acting antiviral (DAA). We aimed to characterize HCV knowledge among people who recently completed DAA therapy. MethodsThe Per-SVR (Preservation of Sustained Virologic Response) is a prospective cohort of patients who achieved a sustained virologic response upon successful completion of DAA therapy. The per-SVR study provided the sampling frame of participants who completed a psychometrically validated 19-item HCV knowledge scale at cohort entry (n = 227). To score the questionnaire, for each correct response one point was awarded, with no point for incorrect response. We assessed mean HCV knowledge score in the overall sample and mutually exclusive populations: people who inject drug (PWID) (n = 71); people with co-occurring HIV (n = 23); PWID and co-occurring HIV (n = 29), and others (n = 104) Using a latent class analysis based on distal outcome, we identified unobserved subgroups and assessed HCV knowledge amongst them. ResultsTotal mean (SD) percent of correct responses were 83 (11) in the overall sample; 83 (10) in PWID; 79 (12) in people with co-occurring HIV; 81 (10) in PWID and co-occurring HIV, and 84 (11) in rest of the sample Three latent groups were identified: baby boomers who ever experienced homelessness (n = 126); women sex workers who ever experienced homelessness (n = 68); men who inject drug, ever experienced homelessness and had ever diagnosis of mental health disorders (n = 18). Mean percent of correct responses were 85 (8), 82 (11), 85 (10), in latent class 1, 2, and 3, respectively. ConclusionPatients successfully treated with DAAs had a high HCV knowledge. High knowledge and awareness of reinfection among complex patient groups often facing barriers to HCV care is encouraging and emphasizes the positive outcomes of universal access to treatment.	[Yazdani, Kiana; Dolguikh, Katerina; Zhang, Wendy; Shayegi-Nik, Sara; Ly, Jessica; Cooper, Shaughna; Trigg, Jason; Barrios, Rolando; Montaner, Julio S. G.; Salters, Kate] British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada; [Shayegi-Nik, Sara] Univ British Columbia, Dept Med, Expt Med Program, Vancouver, BC, Canada; [Bartlett, Sophia; Barrios, Rolando] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada; [Bartlett, Sophia] British Columbia Ctr Dis Control, Vancouver, BC, Canada; [Salters, Kate] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; University of British Columbia; Simon Fraser University	Salters, K (corresponding author), British Columbia Ctr Excellence HIV AIDS, Vancouver, BC, Canada.; Salters, K (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC, Canada.	ksalters@bccfe.ca	Yazdani, Kiana/GQQ-3120-2022; Bartlett, Sofia/U-3708-2018	Yazdani, Kiana/0000-0003-1929-729X; Trigg, Jason/0000-0002-7815-0725; Bartlett, Sofia/0000-0003-0699-2250	Merck Canada Incorporation; British Columbia Ministry of Health Services; University of British Columbia Strategic Excellence Fund	Merck Canada Incorporation; British Columbia Ministry of Health Services; University of British Columbia Strategic Excellence Fund	The study was supported by the Merck Canada Incorporation, British Columbia Ministry of Health Services, and University of British Columbia Strategic Excellence Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2020, BABY BOOMERS HEPATIT; Babor T.F., 2001, ALCOHOL USE DISORDER; Balfour L, 2009, SCAND J CARING SCI, V23, P801, DOI 10.1111/j.1471-6712.2008.00668.x; Bartlett SR, 2019, LIVER INT, V39, P2261, DOI 10.1111/liv.14227; Blach S, 2017, LANCET GASTROENTEROL, V2, P161, DOI 10.1016/S2468-1253(16)30181-9; Cachay ER, 2018, OPEN FORUM INFECT DI, V5, DOI 10.1093/ofid/ofy173; Chaquisse E, 2018, AIDS CARE, V30, P1161, DOI 10.1080/09540121.2018.1466984; Chen EY, 2013, J VIRAL HEPATITIS, V20, P708, DOI 10.1111/jvh.12095; Clementi E, 2020, INT J INFECT DIS, V100, P27, DOI 10.1016/j.ijid.2020.08.035; Grebely J, 2012, HEPATOLOGY, V55, P1058, DOI 10.1002/hep.24754; Hanafiah KM, 2013, HEPATOLOGY, V57, P1333, DOI 10.1002/hep.26141; Janjua NZ, 2016, EBIOMEDICINE, V12, P189, DOI 10.1016/j.ebiom.2016.08.035; Jost JJ, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16111958; Lanza S.T., 2013, HDB PSYCHOL, V2nd Edn, P691, DOI [10.1002/9781118133880.hop202024, DOI 10.1002/9781118133880.HOP202024]; Lanza ST, 2013, STRUCT EQU MODELING, V20, P1, DOI 10.1080/10705511.2013.742377; Larose C, 2016, STAT METHODOL, V32, P107, DOI 10.1016/j.stamet.2016.04.004; Liu JP., 2001, COCHRANE DB SYST REV, pCD003183, DOI [10.1002/14651858.CD003183, DOI 10.1002/14651858.CD003183]; Mah A, 2017, INT J DRUG POLICY, V47, P137, DOI 10.1016/j.drugpo.2017.02.006; Muncan B, 2021, SUBST USE MISUSE, V56, P728, DOI 10.1080/10826084.2021.1892142; Nsibirwa S, 2020, BMC COMPLEMENT MED, V20, DOI 10.1186/s12906-020-02959-8; Nylund-Gibson K., 2018, TRANSL ISS PSYCH SCI, V4, P440, DOI [DOI 10.1037/TPS0000176, 10.1037/tps0000176]; O'Donnell ML, 2017, CLIN PSYCHOL REV, V57, P208, DOI 10.1016/j.cpr.2017.08.009; Pham ST, 2010, HEPATOLOGY, V52, P1564, DOI 10.1002/hep.23885; Quinn K, 2019, DRUG ALCOHOL DEPEN, V194, P453, DOI 10.1016/j.drugalcdep.2018.11.010; Reau N., NATL EXAMINATION HCV; Rose M., 2019, OPEN FORUM INFECT DI, V6, pS159; Ryerson AB, 2020, MMWR-MORBID MORTAL W, V69, P399, DOI 10.15585/mmwr.mm6914a2; Seeff LB, 2015, GASTROENTEROLOGY, V148, P517, DOI 10.1053/j.gastro.2014.12.004; Sherbuk JE, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00409-9; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Ti LP, 2017, CAN MED ASSOC J, V189, pE870, DOI 10.1503/cmaj.733111; Trubnikov M, 2014, Can Commun Dis Rep, V40, P429; Weller BE, 2020, J BLACK PSYCHOL, V46, P287, DOI 10.1177/0095798420930932; Wilson H, 2017, PSYCHOL HEALTH MED, V22, P625, DOI 10.1080/13548506.2016.1189582; Yousafzai MT, 2021, J VIRAL HEPATITIS, V28, P1340, DOI 10.1111/jvh.13574; Yudko E, 2007, J SUBST ABUSE TREAT, V32, P189, DOI 10.1016/j.jsat.2006.08.002; Zibbell JE, 2015, MMWR-MORBID MORTAL W, V64, P453	38	0	0	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265811	10.1371/journal.pone.0265811	http://dx.doi.org/10.1371/journal.pone.0265811			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320316	gold, Green Published			2022-12-26	WOS:000784240600005
J	Forzisi, E; Yu, W; Rajwade, P; Sesti, F				Forzisi, Elena; Yu, Wei; Rajwade, Parth; Sesti, Federico			Antagonistic roles of Ras-MAPK and Akt signaling in integrin-K+ channel complex-mediated cellular apoptosis	FASEB JOURNAL			English	Article						apoptosis; integrin; neuroscience; oxidative stress; potassium channel	BAD PHOSPHORYLATION; PROTEIN-KINASE; DEATH; ACTIVATION; PROLIFERATION; ASSOCIATION; MODULATION; MECHANISMS; OXIDATION; PATHWAYS	Complexes formed with alpha 5-integrins and the voltage-gated potassium (K+) channel KCNB1 (Kv2.1), known as IKCs, transduce the electrical activity at the plasma membrane into biochemical events that impinge on cytoskeletal remodeling, cell differentiation, and migration. However, when cells are subject to stress of oxidative nature IKCs turn toxic and cause inflammation and death. Here, biochemical, pharmacological, and cell viability evidence demonstrates that in response to oxidative insults, IKCs activate an apoptotic Mitogen-activated protein kinase/extracellular signal-regulated kinase (Ras-MAPK) signaling pathway. Simultaneously, wild-type (WT) KCNB1 channels sequester protein kinase B (Akt) causing dephosphorylation of BCL2-associated agonist of cell death (BAD), a major sentinel of apoptosis progression. In contrast, IKCs formed with C73A KCNB1 variant that does not induce apoptosis (IKCC73A), do not sequester Akt and thus are able to engage cell survival mechanisms. Taken together, these data suggest that apoptotic and survival forces co-exist in IKCs. Integrins send death signals through Ras-MAPK and KCNB1 channels simultaneously sabotage survival mechanisms. Thus, the combined action of integrins and KCNB1 channels advances life or death.	[Forzisi, Elena; Yu, Wei; Rajwade, Parth; Sesti, Federico] Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA	Rutgers State University New Brunswick; Rutgers State University Medical Center	Sesti, F (corresponding author), Rutgers State Univ, Robert Wood Johnson Med Sch, Dept Neurosci & Cell Biol, 683 Hoes Lane West, Piscataway, NJ 08854 USA.	federico.sesti@rutgers.edu			NIA [R01AG060919]; NSF [2030348]	NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NSF(National Science Foundation (NSF))	This work was supported by an NIA grant (R01AG060919) and a NSF (2030348) to FS	Al-Owais MMA, 2012, J BIOL CHEM, V287, P24754, DOI 10.1074/jbc.M112.357012; Bergmann A, 2002, DEV CELL, V3, P607, DOI 10.1016/S1534-5807(02)00328-3; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Bossy-Wetzel E, 2004, NEURON, V41, P351, DOI 10.1016/S0896-6273(04)00015-7; Burlacu A, 2003, J CELL MOL MED, V7, P249, DOI 10.1111/j.1582-4934.2003.tb00225.x; Cagnol Sebastien, 2011, J Signal Transduct, V2011, P834948, DOI 10.1155/2011/834948; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cherubini A, 2005, MOL BIOL CELL, V16, P2972, DOI 10.1091/mbc.E04-10-0940; Cotella D, 2013, FASEB J, V27, P1381, DOI 10.1096/fj.12-222778; Cotella D, 2012, J NEUROSCI, V32, P4133, DOI 10.1523/JNEUROSCI.6153-11.2012; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dramsi S, 2002, J BIOL CHEM, V277, P6399, DOI 10.1074/jbc.M109990200; Fang XJ, 1999, ONCOGENE, V18, P6635, DOI 10.1038/sj.onc.1203076; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Girault A, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0263-x; He K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129498; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hu XY, 2011, AM J PHYSIOL-CELL PH, V301, pC362, DOI 10.1152/ajpcell.00013.2010; Kapp TG, 2017, SCI REP-UK, V7, DOI 10.1038/srep39805; Klumpp S, 2002, CURR OPIN PHARMACOL, V2, P458, DOI 10.1016/S1471-4892(02)00176-5; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lizcano JM, 2000, BIOCHEM J, V349, P547, DOI 10.1042/bj3490547; Lodish H, 2008, MOL CELL BIOL; Lyons JF, 2001, ENDOCR-RELAT CANCER, V8, P219, DOI 10.1677/erc.0.0080219; Mankouri J, 2009, P NATL ACAD SCI USA, V106, P15903, DOI 10.1073/pnas.0906798106; McCord MC, 2013, P NATL ACAD SCI USA, V110, P13988, DOI 10.1073/pnas.1306238110; McLaughlin B, 2001, J NEUROSCI, V21, P3303, DOI 10.1523/JNEUROSCI.21-10-03303.2001; Mebratu Y, 2009, CELL CYCLE, V8, P1168, DOI 10.4161/cc.8.8.8147; Mohapatra DP, 2009, CHANNELS, V3, P46, DOI 10.4161/chan.3.1.7655; Noordzij M, 2010, NEPHROL DIAL TRANSPL, V25, P1388, DOI 10.1093/ndt/gfp732; Pal S, 2003, J NEUROSCI, V23, P4798; Pal SK, 2006, CELL DEATH DIFFER, V13, P661, DOI 10.1038/sj.cdd.4401792; Redman PT, 2007, P NATL ACAD SCI USA, V104, P3568, DOI 10.1073/pnas.0610159104; Scheid MP, 1999, J BIOL CHEM, V274, P31108, DOI 10.1074/jbc.274.43.31108; Speca DJ, 2014, GENES BRAIN BEHAV, V13, P394, DOI 10.1111/gbb.12120; Tan Y, 2000, J BIOL CHEM, V275, P25865, DOI 10.1074/jbc.M004199200; Vachon Pierre H, 2011, J Signal Transduct, V2011, P738137, DOI 10.1155/2011/738137; Wei JF, 2008, J CELL PHYSIOL, V217, P544, DOI 10.1002/jcp.21530; Wei Y, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0886-1; Wu XL, 2013, J BIOL CHEM, V288, P4128, DOI 10.1074/jbc.M112.440933; Yu W., 2019, FASEB J, V33, P14680, DOI DOI 10.1096/FJ.201901792R; Yu W, 2017, CELL DEATH DIS, V8, DOI 10.1038/cddis.2017.160; Yu W, 2016, J NEUROSCI, V36, P11084, DOI 10.1523/JNEUROSCI.2273-16.2016; Zha JP, 1996, CELL, V87, P619, DOI 10.1016/S0092-8674(00)81382-3; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105	45	2	2	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22292	10.1096/fj.202200180R	http://dx.doi.org/10.1096/fj.202200180R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0D8GT	35357039	Green Accepted			2022-12-26	WOS:000776227800001
J	Navas, LE; Zahn, M; Bajwa, H; Grigg, JC; Wolf, ME; Chan, ACK; Murphy, MEP; McGeehan, JE; Eltis, LD				Navas, Laura E.; Zahn, Michael; Bajwa, Harbir; Grigg, Jason C.; Wolf, Megan E.; Chan, Anson C. K.; Murphy, Michael E. P.; McGeehan, John E.; Eltis, Lindsay D.			Characterization of a phylogenetically distinct extradiol dioxygenase involved in the bacterial catabolism of lignin-derived aromatic compounds	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							2,3-DIHYDROXYBIPHENYL 1,2-DIOXYGENASE; MICROBIAL-DEGRADATION; RHODOCOCCUS; BIPHENYL; PURIFICATION; METABOLISM; STEROIDS; PRODUCT; PATHWAY; RHA1	The actinobacterium Rhodococcus jostii RHA1 grows on a remarkable variety of aromatic compounds and has been studied for applications ranging from the degradation of polychlorinated biphenyls to the valorization of lignin, an underutilized component of biomass. In RHA1, the catabolism of two classes of lignin-derived compounds, alkylphenols and alkylguaiacols, involves a phylogenetically distinct extradiol dioxygenase, AphC, previously misannotated as BphC, an enzyme involved in biphenyl catabolism. To better understand the role of AphC in RHA1 catabolism, we first showed that purified AphC had highest apparent specificity for 4-propylcatechol (kcat/KM X106 M-1 s(-1)), and its apparent specificity for 4-alkylated substrates followed the trend for alkylguaiacols: propyl > ethyl > methyl > phenyl > unsubstituted. We also show AphC only poorly cleaved 3-phenylcatechol, the preferred substrate of BphC. Moreover, AphC and BphC cleaved 3-phenylcatechol and 4-phenylcatechol with different regiospecificities, likely due to the substrates' binding mode. A crystallographic structure of the AphC.4-ethylcatechol binary complex to 1.59 & ANGS; resolution revealed that the catechol is bound to the active site iron in a bidentate manner and that the substrate's alkyl side chain is accommodated by a hydrophobic pocket. Finally, we show RHA1 grows on a mixture of 4-ethylguaiacol and guaiacol, simultaneously catabolizing these substrates through meta -cleavage and ortho-cleavage pathways, respectively, suggesting that the specificity of AphC helps to prevent the routing of catechol through the Aph pathway. Overall, this study contributes to our understanding of the bacterial catabolism of aromatic compounds derived from lignin, and the determinants of specificity in extradiol dioxygenases.	[Navas, Laura E.; Bajwa, Harbir; Grigg, Jason C.; Wolf, Megan E.; Chan, Anson C. K.; Murphy, Michael E. P.; Eltis, Lindsay D.] Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada; [Zahn, Michael; McGeehan, John E.] Univ Portsmouth, Sch Biol Sci, Ctr Enzyme Innovat, Portsmouth, Hants, England	University of British Columbia; University of Portsmouth	Eltis, LD (corresponding author), Univ British Columbia, Life Sci Inst, Dept Microbiol & Immunol, Vancouver, BC, Canada.	leltis@mail.ubc.ca		Grigg, Jason/0000-0002-5627-273X; McGeehan, John/0000-0002-6750-1462; Zahn, Michael/0000-0002-5709-8665; Bajwa, Harbir/0000-0003-2725-031X; Navas, Laura/0000-0002-8303-8439	Natural Sciences and Engineering Research Council of Canada [STPGP 506595, DG 171359, DG 04802]; Canada Research Chair; Research England	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Research Chair(Natural Resources CanadaCanadian Forest ServiceCanada Research Chairs); Research England(UK Research & Innovation (UKRI))	This study was supported by the following grants from the Natural Sciences and Engineering Research Council of Canada: STPGP 506595 to 17 and DG 171359 to L. D. E.; and DG 04802 to M. E. P. M. L. D. E. is the recipient of a Canada Research Chair. M. Z. and J. E. M. acknowledge Research England for E3 funding.	Ausubel F. M., 2002, SHORT PROTOCOLS MOL; Becker J, 2019, BIOTECHNOL ADV, V37, DOI 10.1016/j.biotechadv.2019.02.016; CATELANI D, 1971, BIOCHEM J, V121, P89, DOI 10.1042/bj1210089; CATELANI D, 1973, BIOCHEM J, V134, P1063, DOI 10.1042/bj1341063; CERDAN P, 1995, EUR J BIOCHEM, V229, P113, DOI 10.1111/j.1432-1033.1995.0113l.x; Chen HP, 2012, APPL ENVIRON MICROB, V78, P586, DOI 10.1128/AEM.06876-11; Cho JH, 2009, J BIOL CHEM, V284, P34321, DOI 10.1074/jbc.M109.031054; Cornish-Bowden A., 1995, ANAL ENZYME KINETIC; DAGLEY S, 1960, NATURE, V188, P560, DOI 10.1038/188560a0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eltis L.D., 2018, LIGNIN VALORIZATION, P290, DOI [10.1039/9781788010351-00290, DOI 10.1039/9781788010351-00290]; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fetherolf MM, 2020, P NATL ACAD SCI USA, V117, P25771, DOI 10.1073/pnas.1916349117; Fielding AJ, 2014, J BIOL INORG CHEM, V19, P491, DOI 10.1007/s00775-014-1122-9; Fortin PD, 2005, J BIOL CHEM, V280, P42307, DOI 10.1074/jbc.M510456200; Furukawa K, 2000, J GEN APPL MICROBIOL, V46, P283, DOI 10.2323/jgam.46.283; Goncalves ER, 2006, APPL ENVIRON MICROB, V72, P6183, DOI 10.1128/AEM.00947-06; HAIGLER BE, 1990, J BACTERIOL, V172, P465, DOI 10.1128/JB.172.1.465-468.1990; Holm L, 2020, PROTEIN SCI, V29, P128, DOI 10.1002/pro.3749; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Krissinel Evgeny, 2012, J Mol Biochem, V1, P76; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Levy-Booth DJ, 2019, FRONT MICROBIOL, V10, DOI 10.3389/fmicb.2019.01862; Liao YH, 2020, SCIENCE, V367, P1385, DOI 10.1126/science.aau1567; McLeod MP, 2006, P NATL ACAD SCI USA, V103, P15582, DOI 10.1073/pnas.0607048103; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; Patrauchan MA, 2005, J BACTERIOL, V187, P4050, DOI 10.1128/JB.187.12.4050-4063.2005; Sakai M, 2002, J BIOSCI BIOENG, V93, P421, DOI 10.1263/jbb.93.421; Sambrock J., 1990, MOL CLONING MANUAL L; Seah SYK, 2000, J BIOL CHEM, V275, P15701, DOI 10.1074/jbc.275.21.15701; SETO M, 1995, APPL ENVIRON MICROB, V61, P4510, DOI 10.1128/AEM.61.12.4510-4513.1995; Syed Ibrahim B., 2010, [Crystal structure of 2,3-Dihydroxy biphenyl dioxygenase from Rhodo-coccus sp. (strain RHA1), PDB], DOI 10.2210/pdb3lm4/pdb; Takeo M, 2007, BIOSCI BIOTECH BIOCH, V71, P1668, DOI 10.1271/bbb.70079; Tickle I.J., 2018, STARANISO; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Vaillancourt FH, 1998, J BIOL CHEM, V273, P34887, DOI 10.1074/jbc.273.52.34887; Vaillancourt FH, 2002, J AM CHEM SOC, V124, P2485, DOI 10.1021/ja0174682; Vaillancourt FH, 2006, CRIT REV BIOCHEM MOL, V41, P241, DOI 10.1080/10409230600817422; Van der Geize R, 2007, P NATL ACAD SCI USA, V104, P1947, DOI 10.1073/pnas.0605728104; Williams CJ, 2018, PROTEIN SCI, V27, P293, DOI 10.1002/pro.3330; Yam KC, 2011, CAN J MICROBIOL, V57, P155, DOI 10.1139/W10-115; Yam KC, 2010, MICROBIOL MONOGR, V16, P133, DOI 10.1007/978-3-642-12937-7_6	44	0	0	7	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101871	10.1016/j.jbc.2022.101871	http://dx.doi.org/10.1016/j.jbc.2022.101871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35346686	gold, Green Published			2022-12-26	WOS:000798142000010
J	Schwank, K; Schmid, C; Fremter, T; Milkereit, P; Griesenbeck, J; Tschochner, H				Schwank, Katrin; Schmid, Catharina; Fremter, Tobias; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert			RNA polymerase I (Pol I) lobe-binding subunit Rpa12.2 promotes RNA cleavage and proofreading	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTIONAL FIDELITY; A12.2 SUBUNIT; NUCLEOTIDE INCORPORATION; STRUCTURAL BASIS; ELONGATION; TFIIS; RPB9; ARCHITECTURE; MECHANISMS; TERMINATION	Elongating nuclear RNA polymerases (Pols) frequently pause, backtrack, and are then reactivated by endonucleolytic cleavage. Pol backtracking and RNA cleavage are also crucial for proofreading, which contributes to transcription fidelity. RNA polymerase I (Pol I) of the yeast Saccharomyces cerevisiae synthesizes exclusively 35S rRNA, the precursor transcript of mature ribosomal 5.8S, 18S, and 25S rRNA. Pol I contains the specific heterodimeric subunits Rpa34.5/49 and subunit Rpa12.2, which have been implicated in RNA cleavage and elongation activity, respectively. These subunits are associated with the Pol I lobe structure and encompass different structural domains, but the contribution of these domains to RNA elongation is unclear. Here, we used Pol I mutants or reconstituted Pol I enzymes to study the effects of these subunits and/or their distinct domains on RNA cleavage, backtracking, and transcription fidelity in defined in vitro systems. Our findings suggest that the presence of the intact C-terminal domain of Rpa12.2 is sufficient to support the cleavage reaction, but that the N-terminal domains of Rpa12.2 and the heterodimer facilitate backtracking and RNA cleavage. Since both N-terminal and C-terminal domains of Rpa12.2 were also required to faithfully incorporate NTPs in the growing RNA chain, efficient backtracking and RNA cleavage might be a prerequisite for transcription fidelity. We propose that RNA Pols containing efficient RNA cleavage activity are able to add and remove nucleotides until the matching nucleotide supports RNA chain elongation, whereas cleavage-deficient enzymes can escape this proofreading process by incorporating incorrect nucleotides.	[Schwank, Katrin; Schmid, Catharina; Fremter, Tobias; Milkereit, Philipp; Griesenbeck, Joachim; Tschochner, Herbert] Univ Regensburg, Lehrstuhl Biochemie 3, Regensburg Ctr Biochem RCB, Regensburg, Germany	University of Regensburg	Milkereit, P; Griesenbeck, J; Tschochner, H (corresponding author), Univ Regensburg, Lehrstuhl Biochemie 3, Regensburg Ctr Biochem RCB, Regensburg, Germany.	philipp.milkereit@ur.de; joachim.griesenbeck@ur.de; herbert.tschochner@ur.de		Griesenbeck, Joachim/0000-0002-7817-6095	Deutsche For-schungsgemeinschaft [SFB 960]	Deutsche For-schungsgemeinschaft(German Research Foundation (DFG))	Acknowledgments-We are grateful to members of the chair Biochemistry III and especially to Christoph Engel and the members of his group for critical discussion. Michael Pilsl?s advice for development and improvement of methods is greatly appreciated. This work was supported through grants of the Deutsche For-schungsgemeinschaft (grant no.: SFB 960) .	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Appling FD, 2018, BIOPHYS J, V114, P2507, DOI 10.1016/j.bpj.2018.04.015; Appling FD, 2017, BIOCHEMISTRY-US, V56, P5654, DOI 10.1021/acs.biochem.7b00370; Appling FD, 2015, BIOPHYS J, V109, P2382, DOI 10.1016/j.bpj.2015.10.037; Awrey DE, 1997, J BIOL CHEM, V272, P14747, DOI 10.1074/jbc.272.23.14747; Beckouet F, 2008, MOL CELL BIOL, V28, P1596, DOI 10.1128/MCB.01464-07; Burke D., 2000, METHODS YEAST GENETI; Cheung ACM, 2011, NATURE, V471, P249, DOI 10.1038/nature09785; CIPRESPALACIN G, 1994, P NATL ACAD SCI USA, V91, P8087, DOI 10.1073/pnas.91.17.8087; Engel C, 2018, ANNU REV BIOPHYS, V47, P425, DOI 10.1146/annurev-biophys-070317-033058; Engel C, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12129; Engel C, 2013, NATURE, V502, P650, DOI 10.1038/nature12712; ERIE DA, 1993, SCIENCE, V262, P867, DOI 10.1126/science.8235608; Fernandez-Tornero C, 2013, NATURE, V502, P644, DOI 10.1038/nature12636; Geiger SR, 2010, MOL CELL, V39, P583, DOI 10.1016/j.molcel.2010.07.028; Gout JF, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1701484; GU WG, 1995, J BIOL CHEM, V270, P11238, DOI 10.1074/jbc.270.19.11238; Han Y, 2017, ELIFE, V6, DOI 10.7554/eLife.27414; Hemming SA, 2000, J BIOL CHEM, V275, P35506, DOI 10.1074/jbc.M004721200; Hierlmeier T, 2013, NUCLEIC ACIDS RES, V41, P1191, DOI 10.1093/nar/gks1056; HULL MW, 1995, GENE DEV, V9, P481, DOI 10.1101/gad.9.4.481; Jennebach S, 2012, NUCLEIC ACIDS RES, V40, P5591, DOI 10.1093/nar/gks220; Jeon C, 1996, P NATL ACAD SCI USA, V93, P13677, DOI 10.1073/pnas.93.24.13677; JEON CJ, 1994, P NATL ACAD SCI USA, V91, P9106, DOI 10.1073/pnas.91.19.9106; Kettenberger H, 2003, CELL, V114, P347, DOI 10.1016/S0092-8674(03)00598-1; Khatter H, 2017, CURR OPIN STRUC BIOL, V47, P88, DOI 10.1016/j.sbi.2017.05.008; Knippa K, 2013, BIOCHEMISTRY-US, V52, P7807, DOI 10.1021/bi4009566; Knutson BA, 2020, BIOCHEM SOC T, V48, P1917, DOI 10.1042/BST20190848; Kuhn CD, 2007, CELL, V131, P1260, DOI 10.1016/j.cell.2007.10.051; Kujirai T, 2020, CURR OPIN STRUC BIOL, V61, P42, DOI 10.1016/j.sbi.2019.10.007; Lisica A, 2016, P NATL ACAD SCI USA, V113, P2946, DOI 10.1073/pnas.1517011113; Luse DS, 2011, RNA BIOL, V8, P581, DOI 10.4161/rna.8.4.15389; Merkl P, 2014, MOL CELL BIOL, V34, P3817, DOI 10.1128/MCB.00395-14; Merkl PE, 2020, J BIOL CHEM, V295, P4782, DOI 10.1074/jbc.RA119.011827; Nesser NK, 2006, P NATL ACAD SCI USA, V103, P3268, DOI 10.1073/pnas.0511330103; Neyer S, 2016, NATURE, V540, P607, DOI 10.1038/nature20561; Gonzalez MN, 2021, NAT REV MOL CELL BIO, V22, P3, DOI 10.1038/s41580-020-00308-8; NOGI Y, 1993, MOL CELL BIOL, V13, P114, DOI 10.1128/MCB.13.1.114; Pilsl M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12126; Prescott EM, 2004, P NATL ACAD SCI USA, V101, P6068, DOI 10.1073/pnas.0401393101; Roldan E, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.062411; Ruan WJ, 2011, J BIOL CHEM, V286, P18701, DOI 10.1074/jbc.M111.222273; Sambrock J, 1989, MOL CLONING LAB MANU, V1; SCHIESTL RH, 1989, CURR GENET, V16, P339, DOI 10.1007/BF00340712; Schweikhard V, 2014, P NATL ACAD SCI USA, V111, P6642, DOI 10.1073/pnas.1405181111; Scull CE, 2021, BIOPHYS J, V120, P1883, DOI 10.1016/j.bpj.2021.03.007; Sydow JF, 2009, CURR OPIN STRUC BIOL, V19, P732, DOI 10.1016/j.sbi.2009.10.009; Sydow JF, 2009, MOL CELL, V34, P710, DOI 10.1016/j.molcel.2009.06.002; Tafur L, 2016, MOL CELL, V64, P1135, DOI 10.1016/j.molcel.2016.11.013; Thomas MJ, 1998, CELL, V93, P627, DOI 10.1016/S0092-8674(00)81191-5; Van Mullem V, 2002, MOL MICROBIOL, V43, P1105; Vannini A, 2012, MOL CELL, V45, P439, DOI 10.1016/j.molcel.2012.01.023; Wang D, 2009, SCIENCE, V324, P1203, DOI 10.1126/science.1168729; Xu L, 2015, CRIT REV BIOCHEM MOL, V50, P503, DOI 10.3109/10409238.2015.1087960; Xu L, 2014, DNA REPAIR, V19, P71, DOI 10.1016/j.dnarep.2014.03.024; Zhang CF, 2005, MOL CELL BIOL, V25, P3583, DOI 10.1128/MCB.25.9.3583-3595.2005; Zhang CF, 2004, J MOL BIOL, V342, P1085, DOI 10.1016/j.jmb.2004.07.070; Zhang CF, 2003, J BIOL CHEM, V278, P50101, DOI 10.1074/jbc.M307590200; Zhao D, 2021, CELL DISCOV, V7, DOI 10.1038/s41421-021-00335-5	59	0	0	0	0	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101862	10.1016/j.jbc.2022.101862	http://dx.doi.org/10.1016/j.jbc.2022.101862			19	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35341765	Green Published, gold			2022-12-26	WOS:000817175700010
J	Walker, EJ; Bettinger, JQ; Welle, KA; Hryhorenko, JR; Vargas, AMM; O'Connell, MR; Ghaemmaghami, S				Walker, Ethan J.; Bettinger, John Q.; Welle, Kevin A.; Hryhorenko, Jennifer R.; Vargas, Adrian M. Molina; O'Connell, Mitchell R.; Ghaemmaghami, Sina			Protein folding stabilities are a major determinant of oxidation rates for buried methionine residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLONY-STIMULATING FACTOR; ANTIOXIDANT DEFENSE; CONFORMATIONAL STABILITY; MASS-SPECTROMETRY; SULFOXIDE; ROLES; FLEXIBILITY; REDUCTASES; PREVENTION	The oxidation of protein-bound methionines to form methionine sulfoxides has a broad range of biological ramifi-cations, making it important to delineate factors that influence methionine oxidation rates within a given protein. This is especially important for biopharmaceuticals, where oxidation can lead to deactivation and degradation. Previously, neighboring residue effects and solvent accessibility have been shown to impact the susceptibility of methionine residues to oxidation. In this study, we provide proteome-wide evidence that oxidation rates of buried methionine residues are also strongly influenced by the thermodynamic folding stability of proteins. We surveyed the Escherichia coli proteome using several proteomic methodologies and globally measured oxidation rates of methionine residues in the presence and absence of tertiary structure, as well as the folding stabilities of methionine-containing domains. These data indicated that buried methionines have a wide range of protection factors against oxidation that correlate strongly with folding stabilities. Consistent with this, we show that in comparison to E. coli, the proteome of the thermophile Thermus thermophilus is significantly more stable and thus more resistant to methionine oxidation. To demonstrate the utility of this correlation, we used native methionine oxidation rates to survey the folding stabilities of E. coli and T. thermophilus proteomes at various temperatures and propose a model that relates the temperature dependence of the folding stabilities of these two species to their optimal growth temperatures. Overall, these results indicate that oxidation rates of buried methionines from the native state of proteins can be used as a metric of folding stability.	[Walker, Ethan J.; Bettinger, John Q.; Ghaemmaghami, Sina] Univ Rochester, Dept Biol, New York, NY USA; [Walker, Ethan J.; O'Connell, Mitchell R.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, New York, NY USA; [Welle, Kevin A.; Hryhorenko, Jennifer R.; Ghaemmaghami, Sina] Univ Rochester, Univ Rochester Mass Spectrometry Resource Lab, New York, NY USA; [Vargas, Adrian M. Molina] Univ Rochester, Sch Med & Dent, Dept Biomed Genet, New York, NY USA; [Vargas, Adrian M. Molina; O'Connell, Mitchell R.] Univ Rochester, Ctr RNA Biol, New York, NY USA	University of Rochester; University of Rochester; University of Rochester; University of Rochester; University of Rochester	Ghaemmaghami, S (corresponding author), Univ Rochester, Dept Biol, New York, NY USA.; Ghaemmaghami, S (corresponding author), Univ Rochester, Univ Rochester Mass Spectrometry Resource Lab, New York, NY USA.	sina.ghaemmaghami@rochester.edu		Ghaemmaghami, Sina/0000-0002-8696-2950; Walker, Ethan/0000-0002-4376-7864; O'Connell, Mitchell/0000-0002-8642-3973; MOLINA VARGAS, ADRIAN MOISES/0000-0003-4090-1180; Bettinger, John/0000-0003-2534-0880	National Institutes of Health [R35 GM119502, S10 OD025242, R35 GM133462]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by grants from the National Institutes of Health (R35 GM119502 and S10 OD025242 to S. G, and R35 GM133462 to M. R. O?C.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aledo JC, 2017, BMC BIOINFORMATICS, V18, DOI 10.1186/s12859-017-1848-9; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bettinger JQ, 2020, J PROTEOME RES, V19, P624, DOI 10.1021/acs.jproteome.9b00505; Bigelow DJ, 2005, BBA-PROTEINS PROTEOM, V1703, P121, DOI 10.1016/j.bbapap.2004.09.012; Braselmann E, 2013, TRENDS BIOCHEM SCI, V38, P337, DOI 10.1016/j.tibs.2013.05.001; BROT N, 1983, ARCH BIOCHEM BIOPHYS, V223, P271, DOI 10.1016/0003-9861(83)90592-1; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chao CC, 1997, P NATL ACAD SCI USA, V94, P2969, DOI 10.1073/pnas.94.7.2969; Chu JW, 2004, BIOCHEMISTRY-US, V43, P1019, DOI 10.1021/bi0356000; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dalle-Donne I, 2002, FREE RADICAL BIO MED, V32, P927, DOI 10.1016/S0891-5849(02)00799-2; Delmar JA, 2021, MOL THER-METH CLIN D, V21, P466, DOI 10.1016/j.omtm.2021.03.023; Erickson JR, 2008, CELL, V133, P462, DOI 10.1016/j.cell.2008.02.048; Fremont S, 2017, J CELL SCI, V130, P1509, DOI 10.1242/jcs.202028; Ghesquiere B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006866; Griffiths SW, 2002, BIOCHEMISTRY-US, V41, P6245, DOI 10.1021/bi025599p; Griffiths SW, 2002, J CHROMATOGR A, V942, P133, DOI 10.1016/S0021-9673(01)01350-4; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Hoshi T, 2001, J PHYSIOL-LONDON, V531, P1, DOI 10.1111/j.1469-7793.2001.0001j.x; Huyghues-Despointes B M, 2001, Methods Mol Biol, V168, P69; Jumper J, 2021, NATURE, V596, P583, DOI 10.1038/s41586-021-03819-2; Karshikoff A, 2015, FEBS J, V282, P3899, DOI 10.1111/febs.13343; Konermann L, 2008, J MASS SPECTROM, V43, P1021, DOI 10.1002/jms.1435; Lam XM, 1997, J PHARM SCI, V86, P1250, DOI 10.1021/js970143s; Leuenberger P, 2017, SCIENCE, V355, DOI 10.1126/science.aai7825; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 2000, IUBMB LIFE, V50, P301, DOI 10.1080/15216540051081056; Liu D, 2008, BIOCHEMISTRY-US, V47, P5088, DOI 10.1021/bi702238b; M. Mirdita, 2021, bioRxiv, DOI 10.1101/2021.08.15.456425; Manavalan B, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36992-y; Manta B, 2017, FREE RADICAL BIO MED, V109, P141, DOI 10.1016/j.freeradbiomed.2017.02.010; Mateus A, 2017, PROTEOME SCI, V15, DOI 10.1186/s12953-017-0122-4; Moskovitz J, 2005, CURR PHARM DESIGN, V11, P1451, DOI 10.2174/1381612053507846; Moskovitz J, 2005, BBA-PROTEINS PROTEOM, V1703, P213, DOI 10.1016/j.bbapap.2004.09.003; Mulinacci F, 2011, J PHARM SCI-US, V100, P451, DOI 10.1002/jps.22293; Pace C N, 1986, Methods Enzymol, V131, P266; Pace C. N., 1997, PROTEIN STRUCTURE PR, V2, P299; Pan B, 2006, BIOCHEMISTRY-US, V45, P15430, DOI 10.1021/bi061855c; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Salas CO, 2020, BIOCHEM SOC T, V48, P613, DOI 10.1042/BST20190866; Sankar K, 2018, MABS-AUSTIN, V10, P1281, DOI 10.1080/19420862.2018.1518887; SCHELLMAN JA, 1987, ANNU REV BIOPHYS BIO, V16, P115, DOI 10.1146/annurev.bb.16.060187.000555; SCHONEICH C, 1993, BIOCHIM BIOPHYS ACTA, V1158, P307, DOI 10.1016/0304-4165(93)90030-C; Sharp JS, 2004, ANAL CHEM, V76, P672, DOI 10.1021/ac0302004; SMITH CD, 1991, P NATL ACAD SCI USA, V88, P10540, DOI 10.1073/pnas.88.23.10540; Stadtman ER, 2005, BBA-PROTEINS PROTEOM, V1703, P135, DOI 10.1016/j.bbapap.2004.08.010; Swann PG, 2008, CURR OPIN IMMUNOL, V20, P493, DOI 10.1016/j.coi.2008.05.013; Thirumangalathu R, 2007, BIOCHEMISTRY-US, V46, P6213, DOI 10.1021/bi700321g; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Veredas FJ, 2017, SCI REP-UK, V7, DOI 10.1038/srep40403; VONECKARDSTEIN A, 1991, J LIPID RES, V32, P1465; Walker EJ, 2019, P NATL ACAD SCI USA, V116, P6081, DOI 10.1073/pnas.1819851116; West GM, 2008, ANAL CHEM, V80, P4175, DOI 10.1021/ac702610a; Xu KR, 2012, PROTEIN PEPTIDE LETT, V19, P688, DOI 10.2174/092986612800494084; Yang R, 2017, MABS-AUSTIN, V9, P646, DOI 10.1080/19420862.2017.1290753; Yin J, 2004, PHARM RES-DORDR, V21, P2377, DOI 10.1007/s11095-004-7692-4; Younan ND, 2012, J BIOL CHEM, V287, P28263, DOI 10.1074/jbc.M112.354779; Zang L, 2012, J CHROMATOGR B, V895, P71, DOI 10.1016/j.jchromb.2012.03.016; Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104	59	2	2	5	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101872	10.1016/j.jbc.2022.101872	http://dx.doi.org/10.1016/j.jbc.2022.101872			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J7FX	35346688	Green Published, gold, Green Submitted			2022-12-26	WOS:000798082100002
J	Zeng, RH; Liu, B; Guo, TT; Guo, JW; Yu, G; Xu, YN; Lin, R; Tan, XZ; Xie, KQ; Zhou, YB				Zeng, Ruhui; Liu, Bin; Guo, Tingting; Guo, Jinwei; Yu, Gang; Xu, Yineng; Lin, Rui; Tan, Xiangzhai; Xie, Kaiqi; Zhou, Yingbi			Prostaglandin F-2 alpha evokes vasoconstrictor and vasodepressor activities that are both independent of the F prostanoid receptor	FASEB JOURNAL			English	Article						blood pressure; prostanoid; prostanoid receptor; vasoconstriction	ENDOTHELIUM-DEPENDENT CONTRACTIONS; PROSTACYCLIN SYNTHESIS; LATANOPROST ACID; TP-RECEPTORS; RELAXATION; EXPRESSION; AORTA; THROMBOXANE; MECHANISM; F2-ALPHA	The F prostanoid receptor (FP), which accounts for the therapeutic effect of PGF(2 alpha) in uterine atony that leads to postpartum hemorrhage and maternal morbidity, could possibly mediate vasoconstrictor effect in small or resistance arteries to elevate blood pressure that limits the clinical use of the agent in patients with cardiovascular disorders. This study aimed to test the above hypothesis with genetically altered mice. Ex vivo and in vivo experiments were performed on control wild-type (WT) mice and mice with deficiencies in FP (FP-/-) or thromboxane (Tx)-prostanoid receptor (the original receptor of TxA(2); TP-/-), and/or those with an additional deficiency in E prostanoid receptor-3 (one of the vasoconstrictor receptors of PGE(2); EP3(-/-)). Here, we show that PGF(2 alpha) indeed evoked vasoconstrictor responses in the above-mentioned tissues of WT mice, which were however unaltered by FP-/-. Interestingly, such contractile responses were reversed into dilations by TP-/-/EP3(-/-). A similar pattern of results was observed with the pressor effect of PGF(2 alpha) under in vivo conditions. However, TP-/- alone (which could largely remove the contractile responses) did not result in relaxation to PGF(2 alpha). Also, either the ex vivo vasodilator effect or the in vivo depressor response of PGF(2 alpha) obtained after the removal of TP and EP3-mediated actions was unaltered by FP-/-. Therefore, both the ex vivo vasoconstrictor action in small or resistance arteries and the systemic pressor effect of PGF(2 alpha) can reflect vasoconstrictor activities derived from the non-FP receptors TP and EP3 outweighing a concurrently activated dilator effect, which is again independent of FP.	[Zeng, Ruhui] Shantou Univ, Affiliated Hosp 1, Dept Gynaecol & Obstet, Med Coll, Shantou, Peoples R China; [Zeng, Ruhui; Liu, Bin; Guo, Tingting; Guo, Jinwei; Yu, Gang; Xu, Yineng; Lin, Rui; Tan, Xiangzhai; Xie, Kaiqi; Zhou, Yingbi] Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China; [Liu, Bin; Guo, Jinwei; Xie, Kaiqi] Shantou Univ, Guangdong Prov Key Lab Infect Dis & Mol Immunopat, Med Coll, Shantou, Peoples R China	Shantou University; Shantou University; Shantou University	Liu, B; Zhou, YB (corresponding author), Shantou Univ, Cardiovasc Res Ctr, Med Coll, 22 Xin Ling Rd, Shantou 515041, Peoples R China.	bliu@stu.edu.cn; yz_sumc@163.com			National Natural Science Foundation of China [81970433, 82070506]; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation) [2019A1515011650]; Medical Scientific Research Foundation of Guangdong Province [A2021324]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation)(National Natural Science Foundation of Guangdong Province); Medical Scientific Research Foundation of Guangdong Province	National Natural Science Foundation of China, Grant/Award Number: 81970433; 82070506; Natural Science Foundation of Guangdong Province (Guangdong Natural Science Foundation), Grant/Award Number: 2019A1515011650; The Medical Scientific Research Foundation of Guangdong Province, Grant/Award Number: A2021324	Abe S, 2013, J OCUL PHARMACOL TH, V29, P55, DOI 10.1089/jop.2011.0197; Astin M, 1997, EUR J PHARMACOL, V340, P195, DOI 10.1016/S0014-2999(97)01414-3; Astin M, 1998, J OCUL PHARMACOL TH, V14, P119, DOI 10.1089/jop.1998.14.119; Boersma JI, 1999, BRIT J PHARMACOL, V128, P1505, DOI 10.1038/sj.bjp.0702965; Chandraharan E, 2017, BMJ-BRIT MED J, V358, DOI 10.1136/bmj.j3875; CHEN J, 1995, BRIT J PHARMACOL, V116, P3035, DOI 10.1111/j.1476-5381.1995.tb15960.x; Chen Y, 2021, PHARMACOLOGY, V106, P477, DOI 10.1159/000516631; Cirillo R, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.010; Daray FM, 2003, BRIT J PHARMACOL, V139, P1409, DOI 10.1038/sj.bjp.0705375; Dong YL, 2000, BIOL REPROD, V62, P533, DOI 10.1095/biolreprod62.3.533; DORN GW, 1992, J BIOL CHEM, V267, P24897; Errasti AE, 2009, EUR J PHARMACOL, V610, P68, DOI 10.1016/j.ejphar.2009.03.022; FUCHS AR, 1987, J STEROID BIOCHEM, V27, P1073, DOI 10.1016/0022-4731(87)90192-0; Georgescu A, 2003, FUND CLIN PHARMACOL, V17, P683, DOI 10.1046/j.1472-8206.2003.00196.x; GILES H, 1991, BRIT J PHARMACOL, V104, P541, DOI 10.1111/j.1476-5381.1991.tb12465.x; Gluais P, 2005, BRIT J PHARMACOL, V146, P834, DOI 10.1038/sj.bjp.0706390; Gross GA, 1998, P NATL ACAD SCI USA, V95, P11875, DOI 10.1073/pnas.95.20.11875; HAUGEN G, 1991, GYNECOL OBSTET INVES, V31, P208, DOI 10.1159/000293160; HAUGEN G, 1992, SCAND J CLIN LAB INV, V52, P141, DOI 10.3109/00365519209088778; HAYASHI S, 1985, J PHARMACOL EXP THER, V233, P628; Hu CJ, 2018, EUR J PHARMACOL, V836, P11, DOI 10.1016/j.ejphar.2018.08.012; Islam MZ, 2017, MICROVASC RES, V114, P52, DOI 10.1016/j.mvr.2017.06.001; Jones RL, 2011, BRIT J PHARMACOL, V162, P521, DOI 10.1111/j.1476-5381.2010.01039.x; JONES RL, 1982, BRIT J PHARMACOL, V76, P423, DOI 10.1111/j.1476-5381.1982.tb09236.x; Kashiwagi H, 2019, THROMB HAEMOSTASIS, V119, P1311, DOI 10.1055/s-0039-1688906; KAWAI Y, 1991, AM J PHYSIOL, V260, pH1538, DOI 10.1152/ajpheart.1991.260.5.H1538; LAWRENCE RA, 1992, BRIT J PHARMACOL, V105, P817, DOI 10.1111/j.1476-5381.1992.tb09063.x; Li ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42167; Liu B, 2020, FASEB J, V34, P16105, DOI 10.1096/fj.202000845RR; Liu B, 2020, FASEB J, V34, P2568, DOI 10.1096/fj.201901611R; Liu B, 2019, FASEB J, V33, P2451, DOI 10.1096/fj.201801064RR; Liu B, 2017, EUR J PHARMACOL, V813, P140, DOI 10.1016/j.ejphar.2017.08.015; Liu B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09288-w; Liu B, 2012, AM J PHYSIOL-RENAL, V302, pF1133, DOI 10.1152/ajprenal.00604.2011; Liu B, 2012, EXP PHYSIOL, V97, P277, DOI 10.1113/expphysiol.2011.062034; Narumiya S, 1999, PHYSIOL REV, V79, P1193, DOI 10.1152/physrev.1999.79.4.1193; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Saito O, 2003, AM J PHYSIOL-RENAL, V284, pF1164, DOI 10.1152/ajprenal.00441.2002; SENIOR J, 1992, BRIT J PHARMACOL, V107, P215, DOI 10.1111/j.1476-5381.1992.tb14489.x; Snetkov VA, 2006, J PHYSIOL-LONDON, V571, P147, DOI 10.1113/jphysiol.2005.101394; Sugimoto Y, 1997, SCIENCE, V277, P681, DOI 10.1126/science.277.5326.681; TODA N, 1988, J CARDIOVASC PHARM, V11, P354, DOI 10.1097/00005344-198803000-00014; Wang YY, 2018, DIABETES, V67, P1748, DOI 10.2337/db17-1521; Wong SL, 2009, CIRC RES, V104, P228, DOI 10.1161/CIRCRESAHA.108.179770; Xiao B, 2015, ARTERIOSCL THROM VAS, V35, P1687, DOI 10.1161/ATVBAHA.115.305445; Yu Y, 2009, P NATL ACAD SCI USA, V106, P7985, DOI 10.1073/pnas.0811834106; Zhang YZ, 2021, EUR J PHARMACOL, V893, DOI 10.1016/j.ejphar.2020.173828; Zhou YB, 2005, AM J PHYSIOL-HEART C, V289, pH1027, DOI 10.1152/ajpheart.00226.2005	48	0	0	3	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22293	10.1096/fj.202101908R	http://dx.doi.org/10.1096/fj.202101908R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0A6EG	35349198				2022-12-26	WOS:000774044800001
J	Dong, DD; Zhang, Y; He, H; Zhu, Y; Ou, HL				Dong, Doudou; Zhang, Yun; He, Hui; Zhu, Yuan; Ou, Hailong			Alpinetin inhibits macrophage infiltration and atherosclerosis by improving the thiol redox state: Requirement of GSk3 beta/Fyn-dependent Nrf2 activation	FASEB JOURNAL			English	Article						alpinetin; atherosclerosis; macrophage infiltration; Nrf2; redox state	INFLAMMATORY RESPONSE; CELL-PROLIFERATION; OXIDATIVE STRESS; UP-REGULATION; ACCUMULATION; THIOREDOXIN; EXPRESSION; PATHWAY; INJURY	Alpinetin is a plant flavonoid isolated from Alpinia katsumadai Hayata with antioxidant and anti-inflammatory properties. Monocyte infiltration into the intima promotes atherosclerotic development and causes plaque instability at the later stage, which is profoundly influenced by various oxidants. In this study, we investigated whether alpinetin restores the redox state to inhibit monocyte infiltration and ameliorates atherosclerosis. ApoE-deficient (ApoE(-/-)) mice were fed a high-fat diet and treated with alpinetin. We found that alpinetin significantly attenuated atherosclerotic lesions and reduced necrotic core size associated with the reduction in infiltrated macrophages within the plaques. Alpinetin inhibited macrophage adhesion and migration, and the expression of chemokines and adhesion molecules, such as MCP-1, VCAM-1, and ICAM-1. Intraplaque MMP2 and MMP9 were reduced, while collagen contents were increased and elastin fiber was prevented from degradation in the alpinetin-treated mice. Data further showed that alpinetin reduced reactive oxygen species generation and promoted thiol-dependent glutathione and thioredoxin antioxidant systems in macrophages. Alpinetin activated Nfr2, an upstream activator of the thiol-dependent redox signaling by increasing the nuclear translocation. The nuclear accumulation of Nrf2 was enhanced by reducing nuclear export, which was achieved through the regulation of the GSk3 beta/Fyn pathway. Finally, inhibition of Nrf2 in HFD-apoE(-/-) mice blockaded the effect of alpinetin, which increased aortic macrophage recruitment and aggravated atherosclerosis concurrently with elevating the expression of MCP-1, VCAM-1, and ICAM-1. Altogether, these findings indicated that alpinetin improved Nrf2-mediated redox homeostasis, which consequently inhibited macrophage infiltration and atherosclerosis, suggesting a useful compound for treating atherosclerosis.	[Dong, Doudou; Zhang, Yun; He, Hui; Zhu, Yuan; Ou, Hailong] Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang 550025, Guizhou, Peoples R China	Guizhou Medical University	Ou, HL (corresponding author), Guizhou Med Univ, Sch Basic Med Sci, Dept Biochem & Mol Biol, Guiyang 550025, Guizhou, Peoples R China.	ouhailong@gmc.edu.cn		Ou, Hailong/0000-0001-7298-1977	National Natural Science Foundation of China (NSFC) [81760088, 32060219, 82060232]; Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China [[2019]4008]; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China [[2020]1Z060, ZK[2022]038]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China	National Natural Science Foundation of China (NSFC), Grant/Award Number: 81760088, 32060219 and 82060232; Special grant for central government Supporting local Science and technology development, Science and Technology Department of Guizhou province, China, Grant/Award Number: [2019]4008; Science and Technology Plan Project of Guizhou Province (Basic Science and Technology Cooperation), China, Grant/Award Number: [2020]1Z060 and ZK[2022]038	Abdelhamid AM, 2020, LIFE SCI, V256, DOI 10.1016/j.lfs.2020.117908; Ajsuvakova OP, 2020, COORDIN CHEM REV, V417, DOI 10.1016/j.ccr.2020.213343; BABAEV VR, 1993, ATHEROSCLEROSIS, V100, P237, DOI 10.1016/0021-9150(93)90210-L; DREW AF, 1995, ARTERIOSCL THROM VAS, V15, P1563, DOI 10.1161/01.ATV.15.10.1563; Farr SA, 2016, J ALZHEIMERS DIS, V54, P1339, DOI 10.3233/JAD-160416; Gao Y, 2020, INFLAMMATION, V43, P1742, DOI 10.1007/s10753-020-01248-3; He XX, 2016, SCI REP-UK, V6, DOI 10.1038/srep28370; Hu K, 2013, EUR J PHARMACOL, V721, P96, DOI 10.1016/j.ejphar.2013.09.049; Hu ZP, 2020, VASC PHARMACOL, V127, DOI 10.1016/j.vph.2020.106659; Huang Y, 2015, INT IMMUNOPHARMACOL, V28, P1003, DOI 10.1016/j.intimp.2015.08.002; IKEDA U, 1993, ATHEROSCLEROSIS, V104, P61, DOI 10.1016/0021-9150(93)90176-U; Itoh K, 2004, FREE RADICAL BIO MED, V36, P1208, DOI 10.1016/j.freeradbiomed.2004.02.075; Jain AK, 2007, J BIOL CHEM, V282, P16502, DOI 10.1074/jbc.M611336200; Jiang ZM, 2015, BIOTECHNOL APPL BIOC, V62, P840, DOI 10.1002/bab.1328; Kapoor R, 2019, J NUTR BIOCHEM, V70, P215, DOI 10.1016/j.jnutbio.2019.05.003; Kaspar JW, 2009, FREE RADICAL BIO MED, V47, P1304, DOI 10.1016/j.freeradbiomed.2009.07.035; Kim M, 2021, ANTIOXIDANTS-BASEL, V10, DOI 10.3390/antiox10050787; Lee MY, 2012, INFLAMMATION, V35, P746, DOI 10.1007/s10753-011-9370-0; Li XM, 2020, FOOD CHEM TOXICOL, V144, DOI 10.1016/j.fct.2020.111644; Li X, 2020, OXID MED CELL LONGEV, V2020, DOI 10.1155/2020/6286984; Li YJ, 2004, J ASIAN NAT PROD RES, V6, P87, DOI 10.1080/1028602031000135558; Liang YJ, 2018, INT IMMUNOPHARMACOL, V62, P309, DOI 10.1016/j.intimp.2018.07.010; Lin SK, 2008, ARTHRITIS RHEUM, V58, P3145, DOI 10.1002/art.23937; Liu BY, 2018, J NUTR BIOCHEM, V52, P115, DOI 10.1016/j.jnutbio.2017.09.025; Liu P, 2020, FASEB J, V34, P1481, DOI 10.1096/fj.201901629RR; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; McAlpine CS, 2012, ARTERIOSCL THROM VAS, V32, P82, DOI 10.1161/ATVBAHA.111.237941; Nakashima Y, 2007, ARTERIOSCL THROM VAS, V27, P1159, DOI 10.1161/ATVBAHA.106.134080; Newby AC, 1999, CARDIOVASC RES, V41, P345, DOI 10.1016/S0008-6363(98)00286-7; Ouyang YF, 2018, METALLOMICS, V10, P218, DOI 10.1039/c7mt00327g; Pan J, 2021, INT IMMUNOPHARMACOL, V95, DOI 10.1016/j.intimp.2021.107527; Qian B, 2021, DIABETOLOGIA, V64, P2037, DOI 10.1007/s00125-021-05489-1; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Sarkar A, 2015, ENVIRON TOXICOL, V30, P396, DOI 10.1002/tox.21901; Shimura T, 2019, FASEB J, V33, P6867, DOI 10.1096/fj.201802246RR; Tan Y, 2018, AM J MED SCI, V355, P377, DOI 10.1016/j.amjms.2018.01.002; Tavakoli S, 2012, ANTIOXID REDOX SIGN, V17, P1785, DOI 10.1089/ars.2012.4638; Tikellis C, 2008, ATHEROSCLEROSIS, V199, P55, DOI 10.1016/j.atherosclerosis.2007.10.038; Tonelli C, 2018, ANTIOXID REDOX SIGN, V29, P1727, DOI 10.1089/ars.2017.7342; Tong GZ, 2020, BIOCHEM BIOPH RES CO, V527, P15, DOI 10.1016/j.bbrc.2020.04.053; Wang ZT, 2001, J CARDIOVASC PHARM, V37, P596, DOI 10.1097/00005344-200105000-00011; Wu D, 2020, INT IMMUNOPHARMACOL, V89, DOI 10.1016/j.intimp.2020.107073; Xing HY, 2020, FRONT PHARMACOL, V11, DOI 10.3389/fphar.2020.01065; Xue JL, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/3690561; Zhang T, 2020, J CELL MOL MED, V24, P8430, DOI 10.1111/jcmm.15371; Zhang X, 2020, CELL DEATH DIFFER, V27, P540, DOI 10.1038/s41418-019-0372-z; Zhou JJ, 2017, INFLAMM RES, V66, P177, DOI 10.1007/s00011-016-1004-4; Zhou Y, 2018, BIOMED PHARMACOTHER, V97, P1397, DOI 10.1016/j.biopha.2017.10.035	48	3	3	10	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22261	10.1096/fj.202101567R	http://dx.doi.org/10.1096/fj.202101567R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZY7CO	35332570				2022-12-26	WOS:000772741400001
J	Chen, YH; Wang, GY; Zhang, HX; Zhang, N; Jiang, J; Song, ZZ				Chen, Yahui; Wang, Guangyu; Zhang, Hongxia; Zhang, Ning; Jiang, Jiang; Song, Zhizhong			Transcriptome analysis of Tamarix ramosissima leaves in response to NaCl stress	PLOS ONE			English	Article							ENHANCES SALT-TOLERANCE; GLUTATHIONE-REDUCTASE; DROUGHT; IDENTIFICATION; GENE; OVEREXPRESSION; ANNOTATION; REDOX	Halophyte Tamarix ramosissima. Lcdcb (T. ramosissima) are known as the representative of Tamarix plants that are widely planted in salinized soil. However, molecular mechanisms towards salt tolerance and adaptation are largely rare. In this study, we carried out RNA-sequence and transcriptome analysis of T. ramosissima in response to NaCl stress, screened differentially expressed genes (DEGs) and further verified by qRT-PCR. Results showed that 105702 unigenes were spliced from the raw data of transcriptome sequencing, where 54238 unigenes were retrieved from KEGG, KOG, NR, and SwissProt. After 48 hours of NaCl treatment, the expression levels of 6374 genes were increased, and 5380 genes were decreased in leaves. After 168 hours, the expression levels of 3837 genes were up-regulated and 7808 genes were down-regulated. In particular, 8 transcription factors annotated to the KEGG Pathway were obtained, involving the WRKY and bZIP transcription family. In addition, KEGG pathway annotation showed that expression of 39 genes involved in ROS scavenging mechanisms were significantly changed, in which 21 genes were up-regulated and 18 genes were down-regulated after 48 hours as well as 15 genes were up-regulated and 24 genes were down-regulated after 168h. Simultaneously, the enzyme activities of SOD and POD were significantly enhanced under NaCl treatment, but the enzyme activity of CAT was not significantly enhanced. Moreover, WRKY, MYB and bZIP may participate in the process of salt resistance in T. ramosissima. This study provides gene resources and a theoretical basis for further molecular mechanisms of salt tolerance in T. ramosissima.	[Chen, Yahui; Jiang, Jiang] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China; [Chen, Yahui; Wang, Guangyu; Zhang, Ning] Univ British Columbia, Dept Forest Resources Management, Vancouver, BC, Canada; [Zhang, Hongxia; Song, Zhizhong] Ludong Univ, Engn Res Inst Agr & Forestry, Yantai, Shandong, Peoples R China; [Wang, Guangyu] Univ British Columbia, Forest Sci Ctr, Dept Forest Resources Management, Vancouver, BC, Canada; [Zhang, Hongxia] Ludong Univ, Coll Agr, Yantai, Shandong, Peoples R China; [Jiang, Jiang] Nanjing Forestry Univ, Fac Foresty, Nanjing, Jiangsu, Peoples R China	Nanjing Forestry University; University of British Columbia; Ludong University; University of British Columbia; Ludong University; Nanjing Forestry University	Jiang, J (corresponding author), Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China.; Zhang, N (corresponding author), Univ British Columbia, Dept Forest Resources Management, Vancouver, BC, Canada.; Song, ZZ (corresponding author), Ludong Univ, Engn Res Inst Agr & Forestry, Yantai, Shandong, Peoples R China.; Jiang, J (corresponding author), Nanjing Forestry Univ, Fac Foresty, Nanjing, Jiangsu, Peoples R China.	zhangningswing@outlook.com; ecologyjiang@gmail.com; 3614@ldu.edu.cn	Jiang, Jiang/H-1080-2012; jiang, jiang/GRX-1861-2022	Jiang, Jiang/0000-0001-5058-8664; Zhang, Ning/0000-0002-1691-6203	Agricultural Variety Improvement Project of Shandong Province [2019LZGC009]; China's National Science Foundation [32071612]; China Scholarship Council [202108320311]; Agricultural Variety Improvement Project of Shandong Province, China's National Science Foundation	Agricultural Variety Improvement Project of Shandong Province; China's National Science Foundation; China Scholarship Council(China Scholarship Council); Agricultural Variety Improvement Project of Shandong Province, China's National Science Foundation	This work was jointly supported by the following grants: the Agricultural Variety Improvement Project of Shandong Province (2019LZGC009), China's National Science Foundation through grants (32071612), and the China Scholarship Council (202108320311). Agricultural Variety Improvement Project of Shandong Province provided experimental materials (Hongxia Zhang). China's National Science Foundation through grants (Jiang Jiang) and the China Scholarship Council provide test sites and data collection(Yahui Chen). Agricultural Variety Improvement Project of Shandong Province, China's National Science Foundation through grants and the China Scholarship Council provided great help in research design, data collection and analysis.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; ALSCHER RG, 1989, PHYSIOL PLANTARUM, V77, P457, DOI 10.1111/j.1399-3054.1989.tb05667.x; Bahieldin A, 2015, CR BIOL, V338, P285, DOI 10.1016/j.crvi.2015.03.010; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; CHANCE B, 1955, METHOD ENZYMOL, V2, P764, DOI 10.1016/S0076-6879(55)02300-8; Chen F, 2017, CRIT REV PLANT SCI, V36, P311, DOI 10.1080/07352689.2018.1441103; Chen HC, 2017, PLANT MOL BIOL, V94, P531, DOI 10.1007/s11103-017-0624-6; Chen SF, 2018, BIOINFORMATICS, V34, P884, DOI 10.1093/bioinformatics/bty560; Cheng Y, 2019, BMC PLANT BIOL, V19, DOI 10.1186/s12870-019-2080-8; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Dai ZG, 2021, PLANT CELL TISS ORG, V147, P157, DOI 10.1007/s11240-021-02115-1; Deng Z, 2015, PLANT PHYSIOL BIOCH, V96, P53, DOI 10.1016/j.plaphy.2015.07.022; Dietz KJ, 2016, PLANT PHYSIOL, V171, P1541, DOI 10.1104/pp.16.00375; Ding N, 2017, BMC PLANT BIOL, V17, DOI 10.1186/s12870-017-1179-z; Dong W, 2020, PLANT PHYSIOL BIOCH, V155, P709, DOI 10.1016/j.plaphy.2020.08.015; Du C, 2017, J PLANT PHYSIOL, V215, P48, DOI 10.1016/j.jplph.2017.05.002; Fancy NN, 2017, PLANT CELL ENVIRON, V40, P462, DOI 10.1111/pce.12707; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Grant JJ, 2000, PLANT PHYSIOL, V124, P21, DOI 10.1104/pp.124.1.21; Gupta H, 1999, PHYSIOL PLANTARUM, V106, P262; Han DG, 2018, J PLANT INTERACT, V13, P163, DOI 10.1080/17429145.2018.1447698; Hao YC, 2021, INT J GENOMICS, V2021, DOI 10.1155/2021/6289174; Horvath E, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21072349; Huang CJ, 2016, DNA CELL BIOL, V35, P776, DOI 10.1089/dna.2016.3251; Huang SB, 2016, PLANT PHYSIOL, V171, P1551, DOI 10.1104/pp.16.00166; Jiang WQ, 2019, PEERJ, V7, DOI 10.7717/peerj.8062; Jiang XQ, 2018, PLANT MOL BIOL REP, V36, P406, DOI 10.1007/s11105-018-1094-y; Lazzarotto F, 2011, NEW PHYTOL, V191, P234, DOI 10.1111/j.1469-8137.2011.03659.x; Lei XJ, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.653791; Li M, 2021, PLANT MOL BIOL, V105, P333, DOI 10.1007/s11103-020-01091-y; Li SF, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2562-0; Li ZY, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11010148; Lin JH, 2019, PLANT PHYSIOL BIOCH, V145, P43, DOI 10.1016/j.plaphy.2019.08.013; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; [鲁艳 Lu Yan], 2014, [中国沙漠, Journal of Desert Research], V34, P1509; Mao XZ, 2005, BIOINFORMATICS, V21, P3787, DOI 10.1093/bioinformatics/bti430; Miller G, 2010, PLANT CELL ENVIRON, V33, P453, DOI 10.1111/j.1365-3040.2009.02041.x; Nianiou-Obeidat I, 2017, PLANT CELL REP, V36, P791, DOI 10.1007/s00299-017-2139-7; Noctor G, 2018, SEMIN CELL DEV BIOL, V80, P3, DOI 10.1016/j.semcdb.2017.07.013; [屈兴红 Qu Xinghong], 2019, [分子植物育种, Molecular Plant Breeding], V17, P3515; Acosta-Motos JR, 2017, AGRONOMY-BASEL, V7, DOI 10.3390/agronomy7010018; Sandalio LM, 2015, ANN BOT-LONDON, V116, P475, DOI 10.1093/aob/mcv074; Shen XJ, 2017, PLANT PHYSIOL BIOCH, V112, P302, DOI 10.1016/j.plaphy.2017.01.015; Wang SJ, 2014, PLANT CELL REP, V33, P1687, DOI 10.1007/s00299-014-1647-y; Wang YJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192382; Wang YC, 2010, J PLANT PHYSIOL, V167, P222, DOI 10.1016/j.jplph.2009.09.008; Wang YJ, 2021, BMC PLANT BIOL, V21, DOI 10.1186/s12870-021-03083-6; Wei QH, 2017, PLANT SCI, V265, P112, DOI 10.1016/j.plantsci.2017.09.020; Wicker T, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-275; Wilson H, 2017, INT J PHYTOREMEDIAT, V19, P587, DOI 10.1080/15226514.2016.1244163; Wu TM, 2013, PLANT MOL BIOL, V83, P379, DOI 10.1007/s11103-013-0095-3; Yan F, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06823-4; Yao WJ, 2016, TREE PHYSIOL, V36, P896, DOI 10.1093/treephys/tpw004; Zhang J, 2021, PEERJ, V9, DOI 10.7717/peerj.11076; Zhang X, 2021, PLANT GROWTH REGUL, V94, P49, DOI 10.1007/s10725-021-00695-8; Zhao P, 2020, INT J BIOL MACROMOL, V161, P155, DOI 10.1016/j.ijbiomac.2020.06.032; Zhou L, 2015, PLANT PHYSIOL BIOCH, V96, P311, DOI 10.1016/j.plaphy.2015.08.016; Zhu JK, 2016, CELL, V167, P313, DOI 10.1016/j.cell.2016.08.029	58	4	4	20	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265653	10.1371/journal.pone.0265653	http://dx.doi.org/10.1371/journal.pone.0265653			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358228	Green Published, gold			2022-12-26	WOS:000799828800042
J	Hathibelagal, AR; Prajapati, V; Jayagopi, I; Jalali, S; Ganeshrao, SB				Hathibelagal, Amithavikram R.; Prajapati, Vishal; Jayagopi, Indrani; Jalali, Subhadra; Ganeshrao, Shonraj Ballae			Age-related decline in function of ON and OFF visual pathways	PLOS ONE			English	Article							RECEPTIVE-FIELDS; DARKS; RETINA; EYE	Purpose A simple psychophysical paradigm is available as a digital application in iOS devices such as iPad to measure the function of ON and OFF visual pathways. However, an age-matched normative database is not readily available. The purpose of the study is to evaluate the response of ON and OFF visual pathways as a function of age. Methods 158 normal healthy adults (84 males and 74 females) whose age ranged 18-80 years participated in the study. None of them had any ocular disease (except cataract of grade II or less) and visual acuity of <= 20/25. Monocular testing (only one eye) was performed on the 'Eye-Speed' application on an iPad at 40cm distance. The targets ranged between 1 to 3 light or dark squares presented randomly in a noise background and participants responded by indicating the number of squares by touching the screen as fast as possible. The main outcome variables are reaction time, accuracy and performance index (1 / speed * accuracy). Results The median reaction time was shorter (Median (IQR): 1.53s (0.49) [dark] Vs 1.76s (0.58) [light], p < 0.001) and accuracy was higher (97.21% (3.30) [dark] Vs 95.15% (5.10) [light], p < 0.001) for dark targets than the light targets. Performance index and reaction time for both target types significantly correlated with age (rho = -0.41 to -0.43; p < 0.001). Conclusions This normative database will be useful to quantify disease-specific defects. More importantly, the ON pathway function can potentially serve as a surrogate for rod photoreceptor function.	[Hathibelagal, Amithavikram R.; Prajapati, Vishal; Jayagopi, Indrani] LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, India; [Hathibelagal, Amithavikram R.; Prajapati, Vishal; Jayagopi, Indrani] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, India; [Jalali, Subhadra] LV Prasad Eye Inst, Srimati Kanuri Santhamma Ctr Vitreoretinal Dis, Hyderabad, India; [Jalali, Subhadra] LV Prasad Eye Inst, Jasti V Ramanamma Childrens Eye Care Ctr, Hyderabad, India; [Ganeshrao, Shonraj Ballae] Manipal Acad Higher Educ MAHE, Manipal Coll Hlth Profess, Dept Optometry, Manipal, Karnataka, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE)	Hathibelagal, AR (corresponding author), LV Prasad Eye Inst, Brien Holden Inst Optometry & Vis Sci, Hyderabad, India.; Hathibelagal, AR (corresponding author), LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, India.	amithavikram@lvpei.org		Ballae Ganeshrao, Shonraj/0000-0002-4323-6035				Ahmad KM, 2003, VISUAL NEUROSCI, V20, P189, DOI 10.1017/S0952523803202091; ALEXANDER KR, 1992, INVEST OPHTH VIS SCI, V33, P477; Balasubramanian V, 2009, J PHYSIOL-LONDON, V587, P2753, DOI 10.1113/jphysiol.2009.170704; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; DEVANEY KO, 1980, J GERONTOL, V35, P836, DOI 10.1093/geronj/35.6.836; Hartline HK, 1938, AM J PHYSIOL, V121, P400, DOI 10.1152/ajplegacy.1938.121.2.400; Hathibelagal Amithavikram R, 2022, J Vis, V22, P1, DOI 10.1167/jov.22.3.1; Hathibelagal AR, 2021, OPHTHAL PHYSL OPT, V41, P874, DOI 10.1111/opo.12799; Hathibelagal AR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232784; Hathibelagal AR, 2018, J OPT SOC AM A, V35, pB78, DOI 10.1364/JOSAA.35.000B78; Hathibelagal AR, 2018, J OPT SOC AM A, V35, pB72, DOI 10.1364/JOSAA.35.000B72; Hathibelagal AR, 2016, J OPT SOC AM A, V33, pA93, DOI 10.1364/JOSAA.33.000A93; Jin JZ, 2011, NAT NEUROSCI, V14, P232, DOI 10.1038/nn.2729; Jin JZ, 2008, NAT NEUROSCI, V11, P88, DOI 10.1038/nn2029; Komban SJ, 2014, NEURON, V82, P224, DOI 10.1016/j.neuron.2014.02.020; Komban SJ, 2011, J NEUROSCI, V31, P8654, DOI 10.1523/JNEUROSCI.0504-11.2011; Kremkow J, 2014, P NATL ACAD SCI USA, V111, P3170, DOI 10.1073/pnas.1310442111; Nelson R, 2004, VISUAL NEUROSCIENCES, V1, P260; Pandarinath C, 2010, J NEUROSCI, V30, P10006, DOI 10.1523/JNEUROSCI.5616-09.2010; Peirce J, 2019, BEHAV RES METHODS, V51, P195, DOI 10.3758/s13428-018-01193-y; Pons C, 2019, J NEUROSCI, V39, P6276, DOI 10.1523/JNEUROSCI.3215-18.2019; Pons C, 2017, J VISION, V17, DOI 10.1167/17.14.5; Ratliff CP, 2010, P NATL ACAD SCI USA, V107, P17368, DOI 10.1073/pnas.1005846107; SCHILLER PH, 1982, NATURE, V297, P580, DOI 10.1038/297580a0; Van Halewyck F, 2014, HUM MOVEMENT SCI, V36, P80, DOI 10.1016/j.humov.2014.05.005; Wang YS, 2015, NAT NEUROSCI, V18, P97, DOI 10.1038/nn.3878; Westheimer G, 2003, OPTOMETRY VISION SCI, V80, P749, DOI 10.1097/00006324-200311000-00011; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Yadav G, 2022, CLIN EXP OPTOM, V105, P313, DOI 10.1080/08164622.2021.1916384; ZEMON V, 1988, VISUAL NEUROSCI, V1, P145, DOI 10.1017/S0952523800001085; Zhao L, 2015, INVEST OPHTH VIS SCI, V56, P7000, DOI 10.1167/iovs.15-16753	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0261489	10.1371/journal.pone.0261489	http://dx.doi.org/10.1371/journal.pone.0261489			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316274	Green Submitted, Green Published, gold			2022-12-26	WOS:000834238000003
J	Amir, A; Finkelstein, I; Shalev, Y; Uziel, J; Chalaf, O; Freud, L; Neumann, R; Gadot, Y				Amir, Ayala; Finkelstein, Israel; Shalev, Yiftah; Uziel, Joe; Chalaf, Ortal; Freud, Liora; Neumann, Ronny; Gadot, Yuval			Residue analysis evidence for wine enriched with vanilla consumed in Jerusalem on the eve of the Babylonian destruction in 586 BCE	PLOS ONE			English	Article							GAS-CHROMATOGRAPHY; IRON-AGE; MASS-SPECTROMETRY; OLIVE OIL; TRADE; CERAMICS; MARKERS; AMPHORA; REGION; JUDAH	The article presents results of residue analysis, based on Gas Chromatograph Mass Spectrometer (GC-MS) measurements, conducted on 13 ceramic storage jars unearthed in the Babylonian destruction layer (586 BCE) in Jerusalem. Five of the jars bear rosette stamp impressions on their handles, indicating that their content was related to the kingdom of Judah's royal economy. The identification of the original contents remains is significant for the understanding of many aspects related to the nutrition, economy and international trade in the ancient Levant. The study shed light on the contents of the jars and the destruction process of the buildings in which they were found. The jars were used alternatively for storing wine and olive oil. The wine was flavored with vanilla. These results attest to the wine consumption habits of the Judahite elite and echo Jerusalem's involvement in the trans-regional South Arabian trade of spices and other lucrative commodities on the eve of its destruction by Nebuchadnezzar.	[Amir, Ayala; Finkelstein, Israel; Gadot, Yuval] Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, Tel Aviv, Israel; [Amir, Ayala; Neumann, Ronny] Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel; [Finkelstein, Israel] Univ Haifa, Sch Archaeol & Maritime Cultures, Haifa, Israel; [Shalev, Yiftah; Uziel, Joe; Chalaf, Ortal; Freud, Liora] Israel Antiqu Author, Jerusalem, Israel	Tel Aviv University; Weizmann Institute of Science; University of Haifa	Amir, A (corresponding author), Tel Aviv Univ, Sonia & Marco Nadler Inst Archaeol, Tel Aviv, Israel.; Amir, A (corresponding author), Weizmann Inst Sci, Dept Organ Chem, Rehovot, Israel.	ayalaalbeck@gmail.com		Amir, Ayala/0000-0002-9077-3503; Chalaf, Ortal/0000-0002-0646-1057				Amir A, 2021, J ARCHAEOL SCI-REP, V36, DOI 10.1016/j.jasrep.2021.102904; [Anonymous], 2011, TEL AVIV, V38, P220, DOI [10.1179/033443511x13099584885466, DOI 10.1179/033443511X13099584885466]; [Anonymous], 1995, ARCHAEOMETRY, DOI DOI 10.1111/J.1475-4754.1995.TB00730.X; Arie E, 2020, TEL AVIV, V47, P5, DOI 10.1080/03344355.2020.1732046; Beeston RF., 2006, HESPERIA SUPPLEMENTS, P413; Beit-Arieh Itzhaq, 2015, ANCIENT POTTERY ISRA, V1, P365; Ben-Yosef E, 2017, P NATL ACAD SCI USA, V114, P2160, DOI 10.1073/pnas.1615797114; Biasoto ACT, 2010, FOOD QUAL PREFER, V21, P755, DOI 10.1016/j.foodqual.2010.07.005; Boskou D., 2011, Vegetable oils in food technology: composition, properties and uses, P243; Chalaf O., 2018, CITY DAVID STUDIES A, V13, p17*; CHARTERS S, 1993, ARCHAEOMETRY, V35, P211, DOI 10.1111/j.1475-4754.1993.tb01036.x; Conde C, 2007, FOOD, V22, DOI DOI 10.1186/S12864-016-2660-Z; Danielson AJ, 2021, TEL AVIV, V48, P87, DOI 10.1080/03344355.2021.1904683; Drieu L, 2020, SCI TECHNOL ARCHAEOL, V6, P16, DOI 10.1080/20548923.2020.1738728; Evershed RP, 2008, ARCHAEOMETRY, V50, P895, DOI 10.1111/j.1475-4754.2008.00446.x; EVERSHED RP, 1990, ANALYST, V115, P1339, DOI 10.1039/an9901501339; FAIX O, 1990, HOLZ ROH WERKST, V48, P281, DOI 10.1007/BF02626519; FINKELSTEIN I, 1992, Z DEUT PALASTINA-VER, V108, P156; Finkelstein I., 2021, ESSAYS BIBLICAL HIST, DOI [10.1628/978-3-16-160854-4, DOI 10.1628/978-3-16-160854-4]; Finkelstein I, 2021, PALEST EXPLOR Q, DOI 10.1080/00310328.2021.1949531; Foley BP, 2012, J ARCHAEOL SCI, V39, P389, DOI 10.1016/j.jas.2011.09.025; Foley BP, 2009, HESPERIA, V78, P269, DOI 10.2972/hesp.78.2.269; Gadot Y, 2017, TEL AVIV, V44, P123, DOI 10.1080/03344355.2017.1357273; Gamier N, 2016, J ARCHAEOL SCI, V74, P195, DOI 10.1016/j.jas.2016.03.003; Garcia E, 2003, FOOD SCI TECHNOL INT, V9, P33, DOI [10.1177/1082013203009001006, 10.1177/1082013202008001941]; Geva H, 2014, TEL AVIV, V41, P131, DOI 10.1179/0334435514Z.00000000041; Gilboa A, 2015, RADIOCARBON, V57, P265, DOI 10.2458/azu_rc.57.18562; Gitin Seymour, 2015, ANCIENT POTTERY ISRA, V1, P345; Guasch-Jane MR, 2004, ANAL CHEM, V76, P1672, DOI 10.1021/ac035082z; JOHNSTON A, 1991, HESPERIA, V60, P363, DOI 10.2307/148070; Kennedy JA, 2006, AM J ENOL VITICULT, V57, P239; Koch I, 2013, Z DEUT PALASTINA-VER, V129, P55; Koh AJ, 2010, MEDITERR ARCHAEOL AR, V10, P15; Koh AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106406; Lawall ML, 2000, HESPERIA, V69, P3, DOI 10.2307/148365; Lawall ML, 2000, P 6 SCI M HELL POTT, P445; Lemaire A., 2012, NEW INSCRIPTIONS SEA, P93, DOI [10.2307/j.ctt32bzp2.12, DOI 10.2307/J.CTT32BZP2.12]; Linares V, 2019, J ARCHAEOL SCI-REP, V25, P77, DOI 10.1016/j.jasrep.2019.03.034; Lipschits O., 2021, MOSAICS STUDIES ANCI, V2, DOI [10.5325/j.ctv1nc6rgw, DOI 10.5325/J.CTV1NC6RGW]; Tebes JM, 2007, HISTORY COMPASS, V5, P619, DOI 10.1111/j.1478-0542.2007.00416.x; McGovern P, 2017, P NATL ACAD SCI USA, V114, pE10309, DOI 10.1073/pnas.1714728114; McGovern PE, 2013, P NATL ACAD SCI USA, V110, P10147, DOI 10.1073/pnas.1216126110; McGovern PE, 2009, P NATL ACAD SCI USA, V106, P7361, DOI 10.1073/pnas.0811578106; McGovern PE, 2019, PRINC SCI LIBR, P1; McGovern PE, 2004, P NATL ACAD SCI USA, V101, P17593, DOI 10.1073/pnas.0407921102; McGovern PE, 1996, NATURE, V381, P480, DOI 10.1038/381480a0; Mendel-Geberovich A, 2020, B AM SCH ORIENTAL RE, V384, P159, DOI 10.1086/710385; Modugno F, 2006, J CHROMATOGR A, V1134, P298, DOI 10.1016/j.chroma.2006.09.010; Namdar D, 2015, ISR J PLANT SCI, V62, P65, DOI 10.1080/07929978.2014.960733; Namdar D, 2009, J ARCHAEOL SCI, V36, P629, DOI 10.1016/j.jas.2008.10.004; Pecci A, 2017, J ARCHAEOL SCI-REP, V12, P515, DOI 10.1016/j.jasrep.2017.02.025; Pecci A, 2020, J ARCHAEOL SCI, V123, DOI 10.1016/j.jas.2020.105256; Pecci A, 2013, J ARCHAEOL SCI, V40, P109, DOI 10.1016/j.jas.2012.05.001; Riley F. R., 2002, OXFORD J ARCHAEOL, V21, P63, DOI [DOI 10.1111/1468-0092.00149, 10.1111/1468-0092.00149]; Roffet-Salque M., 2018, RELENTLESSLY PLAIN 7, P354, DOI [10.2307/j.ctvh1dhb9.22, DOI 10.2307/J.CTVH1DHB9.22]; Shalev Y, 2020, TEL AVIV, V47, P149, DOI 10.1080/03344355.2020.1707451; Shiloh Y., 1987, PEQ, V119, P9, DOI [DOI 10.1179/PEQ.1987.119.1.9, 10.1179/peq.1987.119.1.9]; Stolba V., 2002, GRAFFITI DIPINTI PAN, V1, P228, DOI [10.1016/s0002-9394(01)01373-3, DOI 10.1016/S0002-9394(01)01373-3]; TAXEL I., 2011, THAREANI, V2011, P315; Vaknin Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237029; Weiner S., 2010, MICROARCHAEOLOGY VIS, DOI [10.1017/CBO9780511811210, DOI 10.1017/CBO9780511811210, 10.1017/cbo9780511811210]	61	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266085	10.1371/journal.pone.0266085	http://dx.doi.org/10.1371/journal.pone.0266085			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349581				2022-12-26	WOS:000783906500006
J	Le, K; Nguyen, M				Le, Kien; Nguyen, My			Droughts and child health in Bangladesh	PLOS ONE			English	Article							RAINFALL SHOCKS; ECONOMIC-GROWTH; CONSEQUENCES; CONFLICT; EXPOSURE; DISTRICT; OUTCOMES	This paper investigates the extent to which in-utero exposure to droughts influences the health outcomes of Bangladeshi children in early childhood. Exploiting the plausibly exogenous deviations of rainfall from the location-specific norms, we find that deficient rainfall during the prenatal period is harmful to child health. Specifically, in-utero exposure to droughts decreases the height-for-age, weight-for-height, and weight-for-age z-scores by 0.10, 0.11, and 0.11 standard deviations among children under five years old, respectively. Our heterogeneity analyses reveal that the adverse health setbacks fall disproportionately on children of disadvantaged backgrounds. Exploring the differential effects by trimesters of exposure, we further show that experiencing droughts during the second and the third trimesters leaves injurious effects on early childhood health.	[Le, Kien; Nguyen, My] Ho Chi Minh City Open Univ, Fac Econ & Publ Management, Ho Chi Minh City, Vietnam	Ho Chi Minh City Open University	Le, K (corresponding author), Ho Chi Minh City Open Univ, Fac Econ & Publ Management, Ho Chi Minh City, Vietnam.	kien.le@ou.edu.vn		Nguyen, My/0000-0001-6201-5783; Le, Kien/0000-0003-2892-2720				Akresh R., 2014, NATL BUREAU EC RES; [Anonymous], DOWNL GADM DAT VERS; Barrios S, 2010, REV ECON STAT, V92, P350, DOI 10.1162/rest.2010.11212; Bauer JM, 2017, ECON HUM BIOL, V24, P74, DOI 10.1016/j.ehb.2016.10.010; Bjorkman-Nyqvist M, 2013, J DEV ECON, V105, P237, DOI 10.1016/j.jdeveco.2013.07.013; Briend A, 2016, LANCET GLOB HEALTH, V4, pE590, DOI 10.1016/S2214-109X(16)30152-8; Brown L, 2014, PUBLIC HEALTH, V128, P29, DOI 10.1016/j.puhe.2013.09.006; Bruckner M, 2011, ECONOMETRICA, V79, P923, DOI 10.3982/ECTA8183; Burgert C. R., 2013, DHS SPATIAL ANAL REP; Cole R., 1989, OXFAM GB; Cooper MW, 2019, P NATL ACAD SCI USA, V116, P17219, DOI 10.1073/pnas.1905228116; Cornwell K, 2015, J DEV STUD, V51, P865, DOI 10.1080/00220388.2014.976618; De Alwis D, 2017, COST BEING WEATHER D; Dell M, 2012, AM ECON J-MACROECON, V4, P66, DOI 10.1257/mac.4.3.66; Dey N. C., 2011, Journal of Environmental Science and Natural Resources, V4, P89, DOI 10.3329/jesnr.v4i2.10141; Di Falco S, 2008, LAND ECON, V84, P83, DOI 10.3368/le.84.1.83; Dimitrova A, 2020, GLOBAL ENVIRON CHANG, V64, DOI 10.1016/j.gloenvcha.2020.102130; Dimitrova A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231479; Doyle O, 2009, ECON HUM BIOL, V7, P1, DOI 10.1016/j.ehb.2009.01.002; Englund-Ogge L, 2019, EUR J CLIN NUTR, V73, P1270, DOI 10.1038/s41430-018-0356-y; Epstein A, 2020, AM J TROP MED HYG, V102, P644, DOI 10.4269/ajtmh.19-0412; Fiala K., 2014, J ENV GEOGR, V7, P43, DOI 10.2478/jengeo-2014-0011; Field T, 2008, INT J NEUROSCI, V118, P1181, DOI 10.1080/00207450701820944; Field T, 2006, INFANT BEHAV DEV, V29, P445, DOI 10.1016/j.infbeh.2006.03.003; Grace K, 2017, POPUL ENVIRON, V38, P369, DOI 10.1007/s11111-016-0268-5; Habiba U., 2013, LIVELIHOOD ADAPTATIO, P227, DOI [10.1007/978-4-431-54249-0_13, DOI 10.1007/978-4-431-54249-0_13]; Harris I, 2020, SCI DATA, V7, DOI 10.1038/s41597-020-0453-3; Hidalgo FD, 2010, REV ECON STAT, V92, P505, DOI 10.1162/REST_a_00007; Hoddinott J, 2001, OXFORD B ECON STAT, V63, P409, DOI 10.1111/1468-0084.t01-1-00227; Hoegh-Guldberg O., 2018, GLOBAL WARMING 1 5C; ICF, AV DAT DHS PROGR WEB; Jayachandran S, 2006, J POLIT ECON, V114, P538, DOI 10.1086/503579; Kidane D, 2020, FOOD POLICY, V92, DOI 10.1016/j.foodpol.2020.101838; Kumar S, 2016, POPUL DEV REV, V42, P53, DOI 10.1111/j.1728-4457.2016.00107.x; Le K, 2020, ECON HUM BIOL, V39, DOI 10.1016/j.ehb.2020.100921; Le K, 2020, WORLD DEV, V133, DOI 10.1016/j.worlddev.2020.105005; Le KH, 2022, J ASIAN NAT PROD RES, V24, P596, DOI 10.1080/10286020.2021.1949301; Lohmann S, 2015, WORLD DEV, V72, P432, DOI 10.1016/j.worlddev.2015.03.003; Lumey LH, 1998, PLACENTA, V19, P105; MacCini S, 2009, AM ECON REV, V99, P1006, DOI 10.1257/aer.99.3.1006; MacVicar S, 2017, SOC SCI MED, V187, P39, DOI 10.1016/j.socscimed.2017.06.021; Mardy T, 2018, CLIMATE, V6, DOI 10.3390/cli6020023; Menne MJ, 2018, J CLIMATE, V31, P9835, DOI 10.1175/JCLI-D-18-0094.1; Miguel E, 2004, J POLIT ECON, V112, P725, DOI 10.1086/421174; Miller R, 2017, WORLD DEV, V99, P350, DOI 10.1016/j.worlddev.2017.05.017; Minoiu C, 2014, J DEV ECON, V108, P237, DOI 10.1016/j.jdeveco.2014.03.003; Miyan MA, 2015, WEATHER CLIM EXTREME, V7, P8, DOI 10.1016/j.wace.2014.06.003; Newman KL, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz011; Ngai M, 2020, TRENDS PARASITOL, V36, P127, DOI 10.1016/j.pt.2019.12.005; Oskorouchi HR, 2019, POPUL DEV REV, V45, P275, DOI 10.1111/padr.12229; Ramakrishnan U, 2004, AM J CLIN NUTR, V79, P17; Ramamasy S., 2007, Case Study - Institutions for Rural Development, FAO; Rao S, 2003, EUR J CLIN NUTR, V57, P531, DOI 10.1038/sj.ejcn.1601582; Skoufias E, 2012, ECON HUM BIOL, V10, P54, DOI 10.1016/j.ehb.2011.06.001; Tapsoba A, 2020, ANCIENT PLAGUES MODE; United Nations Children's Fund (UNICEF), 2020, LEVELS TRENDS CHILD; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; Woldemichael A, 2017, TECHNICAL REPORT; World Health Organization (WHO), 2008, TRAIN COURS CHILD GR; Yang D, 2007, WORLD BANK ECON REV, V21, P219, DOI 10.1093/wber/lhm003	60	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265617	10.1371/journal.pone.0265617	http://dx.doi.org/10.1371/journal.pone.0265617			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312716	gold, Green Published			2022-12-26	WOS:000803647900053
J	Thirumurthy, H; Milkman, KL; Volpp, KG; Buttenheim, AM; Pope, DG				Thirumurthy, Harsha; Milkman, Katherine L.; Volpp, Kevin G.; Buttenheim, Alison M.; Pope, Devin G.			Association between statewide financial incentive programs and COVID-19 vaccination rates	PLOS ONE			English	Article								To promote COVID-19 vaccination, many states in the US introduced financial incentives ranging from small, guaranteed rewards to lotteries that give vaccinated individuals a chance to win large prizes. There is limited evidence on the effectiveness of these programs and conflicting evidence from survey experiments and studies of individual states' lotteries. To assess the effectiveness of COVID-19 vaccination incentive programs, we combined information on statewide incentive programs in the US with data on daily vaccine doses administered in each state. Leveraging variation across states in the daily availability of incentives, our difference-in-differences analyses showed that statewide programs were not associated with a significant change in vaccination rates. Furthermore, there was no significant difference in vaccination trends between states with and without incentives in any of the 14 days before or after incentives were introduced. Heterogeneity analyses indicated that neither lotteries nor guaranteed rewards were associated with significant change in vaccination rates.	[Thirumurthy, Harsha; Volpp, Kevin G.] Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA; [Milkman, Katherine L.] Univ Penn, Wharton Sch, Dept Operat Informat & Decis, Philadelphia, PA 19104 USA; [Buttenheim, Alison M.] Univ Penn, Sch Nursing, Dept Family & Community Hlth, Philadelphia, PA 19104 USA; [Pope, Devin G.] Univ Chicago, Booth Sch Business, Chicago, IL 60637 USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; University of Chicago	Thirumurthy, H (corresponding author), Univ Penn, Perelman Sch Med, Dept Med Eth & Hlth Policy, Philadelphia, PA 19104 USA.	hthirumu@upenn.edu						Barber A., 2021, CONDITIONAL CASH LOT; Gandhi L, EXPT EVALUATING IMPA; Giles EL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090347; Grossman G, 2020, P NATL ACAD SCI USA, V117, P24144, DOI 10.1073/pnas.2007835117; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Kluver H, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2109543118; National Governors Association, COVID 19 VACC INC; Pink SL, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2106559118; Robertson C, 2021, ARE VACCINE LOTTERIE; US Centers for Disease Control and Prevention, COVID 19 VACC US JUR; Walkey AJ, 2021, JAMA-J AM MED ASSOC, V326, P766, DOI 10.1001/jama.2021.11048	11	10	10	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263425	10.1371/journal.pone.0263425	http://dx.doi.org/10.1371/journal.pone.0263425			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353815	gold, Green Published			2022-12-26	WOS:000786647900022
J	Pyrshev, K; Khayyat, NH; Stavniichuk, A; Tomilin, VN; Zaika, O; Ramkumar, N; Pochynyuk, O				Pyrshev, Kyrylo; Khayyat, Naghmeh Hassanzadeh; Stavniichuk, Anna; Tomilin, Viktor N.; Zaika, Oleg; Ramkumar, Nirupama; Pochynyuk, Oleh			ClC-K2 Cl- channel allows identification of A- and B-type of intercalated cells in split-opened collecting ducts	FASEB JOURNAL			English	Article						acid-base disorders; AE1; intracellular pH; pendrin; V-ATPase	CHLORIDE CHANNEL; BASOLATERAL MEMBRANE; METABOLIC-ACIDOSIS; CONNECTING TUBULE; RAT; TRANSPORT; EXPRESSION; PENDRIN; LOCALIZATION; ADAPTATION	The collecting duct is a highly adaptive terminal part of the nephron, which is essential for maintaining systemic homeostasis. Principal and intercalated cells perform different physiological tasks and exhibit distinctive morphology. However, acid-secreting A- and base secreting B-type of intercalated cells cannot be easily separated in functional studies. We used BCECF-sensitive intracellular pH (pH(i)) measurements in split-opened collecting ducts followed by immunofluorescent microscopy in WT and intercalated cell-specific ClC-K2(-/-) mice to demonstrate that ClC-K2 inhibition enables to distinguish signals from A- and B-intercalated cells. We show that ClC-K2 Cl- channel is expressed on the basolateral side of intercalated cells, where it governs Cl--dependent H+/HCO3- transport. ClC-K2 blocker, NPPB, caused acidification or alkalization in different subpopulations of intercalated cells in WT but not ClC-K2(-/-) mice. Immunofluorescent assessment of the same collecting ducts revealed that NPPB increased pH(i) in AE1-positive A-type and decreased pH(i) in pendrin-positive B-type of intercalated cells. Induction of metabolic acidosis led to a significantly augmented abundance and H+ secretion in A-type and decreased proton transport in B-type of intercalated cells, whereas metabolic alkalosis caused the opposite changes in intercalated cell function, but did not substantially change their relative abundance. Overall, we show that inhibition of ClC-K2 can be employed to discriminate between A- and B-type of intercalated cells in split-opened collecting duct preparations. We further demonstrate that this method can be used to independently monitor changes in the functional status and abundance of A- and B-type in response to systemic acid/base stimuli.	[Pyrshev, Kyrylo; Khayyat, Naghmeh Hassanzadeh; Stavniichuk, Anna; Tomilin, Viktor N.; Zaika, Oleg; Pochynyuk, Oleh] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA; [Ramkumar, Nirupama] Univ Utah Hlth, Div Nephrol & Hypertens, Salt Lake City, UT USA	University of Texas System; University of Texas Health Science Center Houston; Utah System of Higher Education; University of Utah	Pochynyuk, O (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin, Houston, TX 77030 USA.	Oleh.M.Pochynyuk@uth.tmc.edu	Pyrshev, Kyrylo/P-3003-2018	Pyrshev, Kyrylo/0000-0001-5722-0707	NIH-NIDDK [DK095029, DK117865]; AHA [EIA35260097];  [AHA-19CDA34660148]	NIH-NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); AHA(American Heart Association); 	This research was supported by NIH--NIDDK DK095029, DK117865, AHA EIA35260097 (to O. Pochynyuk), and AHA--19CDA34660148 (to V. N. Tomilin)	ADACHI S, 1994, J BIOL CHEM, V269, P17677; Alper SL, 2002, ANNU REV PHYSIOL, V64, P899, DOI 10.1146/annurev.physiol.64.092801.141759; ALPER SL, 1989, P NATL ACAD SCI USA, V86, P5429, DOI 10.1073/pnas.86.14.5429; Andrini O, 2015, AM J PHYSIOL-RENAL, V308, pF1324, DOI 10.1152/ajprenal.00004.2015; ATKINS JL, 1985, AM J PHYSIOL, V249, pF485, DOI 10.1152/ajprenal.1985.249.4.F485; Berg P, 2020, J AM SOC NEPHROL, V31, P1711, DOI 10.1681/ASN.2020010053; Bernardinelli E, 2016, CELL PHYSIOL BIOCHEM, V38, P1984, DOI 10.1159/000445559; Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Estevez R, 2001, NATURE, V414, P558, DOI 10.1038/35107099; Hennings JC, 2017, J AM SOC NEPHROL, V28, P209, DOI 10.1681/ASN.2016010085; Jeck N, 2004, KIDNEY INT, V65, P190, DOI 10.1111/j.1523-1755.2004.00363.x; Khayyat NH, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100347; KIEFERLE S, 1994, P NATL ACAD SCI USA, V91, P6943, DOI 10.1073/pnas.91.15.6943; Kim YH, 2002, AM J PHYSIOL-RENAL, V283, pF744, DOI 10.1152/ajprenal.00037.2002; Kobayashi K, 2001, J AM SOC NEPHROL, V12, P1327, DOI 10.1681/ASN.V1271327; Limbutara K, 2020, J AM SOC NEPHROL, V31, P1255, DOI 10.1681/ASN.2020010071; Lourdel S, 2003, J GEN PHYSIOL, V121, P287, DOI 10.1085/jgp.200208737; Madsen KM., 1986, AM J PHYSIOL, V250, pF1; Mamenko M, 2016, J AM SOC NEPHROL, V27, P2035, DOI 10.1681/ASN.2014121200; Mamenko Mykola, 2013, Methods Mol Biol, V998, P371, DOI 10.1007/978-1-62703-351-0_29; Matsumura Y, 1999, NAT GENET, V21, P95, DOI 10.1038/5036; Miller RL, 2009, KIDNEY INT, V75, P435, DOI 10.1038/ki.2008.569; Mironova Elena, 2013, Methods Mol Biol, V998, P341, DOI 10.1007/978-1-62703-351-0_27; Nissant A, 2006, AM J PHYSIOL-RENAL, V290, pF1421, DOI 10.1152/ajprenal.00274.2005; PALMER LG, 1986, P NATL ACAD SCI USA, V83, P2767, DOI 10.1073/pnas.83.8.2767; Pearce D, 2015, CLIN J AM SOC NEPHRO, V10, P135, DOI 10.2215/CJN.05760513; Pham TD, 2020, J AM SOC NEPHROL, V31, P483, DOI 10.1681/ASN.2019050551; Purkerson JM, 2010, KIDNEY INT, V78, P993, DOI 10.1038/ki.2010.195; Rice WL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057051; Roy A, 2015, CLIN J AM SOC NEPHRO, V10, P305, DOI 10.2215/CJN.08880914; Sage CL, 2001, HEARING RES, V160, P1, DOI 10.1016/S0378-5955(01)00308-2; Sands JM, 2006, ANN INTERN MED, V144, P186, DOI 10.7326/0003-4819-144-3-200602070-00007; Schild L, 1996, NEPHROLOGIE, V17, P395; SCHUSTER VL, 1993, ANNU REV PHYSIOL, V55, P267, DOI 10.1146/annurev.ph.55.030193.001411; Schwartz GJ, 2002, J CLIN INVEST, V109, P89, DOI 10.1172/JCI13292; SCHWARTZ GJ, 1985, NATURE, V318, P368, DOI 10.1038/318368a0; Sile S, 2009, J HYPERTENS, V27, P298, DOI 10.1097/HJH.0b013e3283140c9e; Simon DB, 1997, NAT GENET, V17, P171, DOI 10.1038/ng1097-171; Staruschenko A, 2012, COMPR PHYSIOL, V2, P1541, DOI 10.1002/cphy.c110052; THOMAS JA, 1979, BIOCHEMISTRY-US, V18, P2210, DOI 10.1021/bi00578a012; Tomilin V, 2019, AM J PHYSIOL-RENAL, V316, pF948, DOI 10.1152/ajprenal.00043.2019; Tomilin VN, 2018, PFLUG ARCH EUR J PHY, V470, P339, DOI 10.1007/s00424-017-2084-x; Tsuruoka S, 1996, J CLIN INVEST, V97, P1076, DOI 10.1172/JCI118500; UCHIDA S, 1993, J BIOL CHEM, V268, P3821; VERLANDER J W, 1987, American Journal of Physiology, V253, pF1142; Verlander JW, 1996, KIDNEY INT, V50, pS137; Wall SM, 2020, PHYSIOL REV, V100, P1119, DOI 10.1152/physrev.00011.2019; Zaidman NA, 2020, P NATL ACAD SCI USA, V117, P26470, DOI 10.1073/pnas.2007620117; Zaika O, 2020, AM J PHYSIOL-RENAL, V318, pF870, DOI 10.1152/ajprenal.00572.2019; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pP923, DOI 10.1152/ajprenal.00577.2015; Zaika O, 2016, AM J PHYSIOL-RENAL, V310, pF311, DOI 10.1152/ajprenal.00436.2015; Zaika O, 2015, AM J PHYSIOL-RENAL, V308, pF39, DOI 10.1152/ajprenal.00545.2014	53	0	0	4	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22275	10.1096/fj.202200160R	http://dx.doi.org/10.1096/fj.202200160R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0K2CZ	35349181				2022-12-26	WOS:000780602600001
J	Tebbe, L; Sakthivel, H; Makia, MS; Kakakhel, M; Conley, SM; Al-Ubaidi, MR; Naash, MI				Tebbe, Lars; Sakthivel, Haarthi; Makia, Mustafa S.; Kakakhel, Mashal; Conley, Shannon M.; Al-Ubaidi, Muayyad R.; Naash, Muna, I			Prph2 disease mutations lead to structural and functional defects in the RPE	FASEB JOURNAL			English	Article						AB_571111; AB_628459; AB_785511; AB_839504; AB_2285290; AB_2533073; AB_2535792; AB_2535794; AB_2536180; AB_2833006; AB_10003146; macular degeneration; phagocytosis; Prph2; RPE	RETINAL-PIGMENT EPITHELIUM; OUTER SEGMENT MEMBRANES; LIGHT-EVOKED RESPONSES; PERIPHERIN RDS GENE; CONE-ROD DYSTROPHY; MACULAR DYSTROPHY; R172W MUTATION; RETINITIS-PIGMENTOSA; PATTERN DYSTROPHY; POINT MUTATION	Prph2 is a photoreceptor-specific tetraspanin with an essential role in the structure and function of photoreceptor outer segments. PRPH2 mutations cause a multitude of retinal diseases characterized by the degeneration of photoreceptors as well as defects in neighboring tissues such as the RPE. While extensive research has analyzed photoreceptors, less attention has been paid to these secondary defects. Here, we use different Prph2 disease models to evaluate the damage of the RPE arising from photoreceptor defects. In Prph2 disease models, the RPE exhibits structural abnormalities and cell loss. Furthermore, RPE functional defects are observed, including impaired clearance of phagocytosed outer segment material and increased microglia activation. The severity of RPE damage is different between models, suggesting that the different abnormal outer segment structures caused by Prph2 disease mutations lead to varying degrees of RPE stress and thus influence the clinical phenotype observed in patients.	[Tebbe, Lars; Sakthivel, Haarthi; Makia, Mustafa S.; Kakakhel, Mashal; Al-Ubaidi, Muayyad R.; Naash, Muna, I] Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd Room 2027, Houston, TX 77204 USA; [Conley, Shannon M.] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA	University of Houston System; University of Houston; University of Oklahoma System; University of Oklahoma Health Sciences Center	Al-Ubaidi, MR; Naash, MI (corresponding author), Univ Houston, Dept Biomed Engn, 3517 Cullen Blvd Room 2027, Houston, TX 77204 USA.	mnaash@central.uh.edu; malubaid@central.uh.edu		kakakhel, mashal/0000-0001-9516-8161; Conley, Shannon/0000-0002-7550-3898	National Institutes of Health [EY10609, EY018656, P20 GM125528, R01--AG070915]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the National Institutes of Health (EY10609 & EY018656--MIN&MRA, P20 GM125528, R01--AG070915--SMC)	ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659; Baeken MW, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9102315; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Bazzoni G, 2004, PHYSIOL REV, V84, P869, DOI 10.1152/physrev.00035.2003; Boesze-Battaglia K, 1998, BIOCHEMISTRY-US, V37, P9477, DOI 10.1021/bi980173p; Boon CJF, 2008, PROG RETIN EYE RES, V27, P213, DOI 10.1016/j.preteyeres.2008.01.002; BOSCH E, 1993, J HISTOCHEM CYTOCHEM, V41, P253, DOI 10.1177/41.2.8419462; Bressler SB, 2009, OPHTHALMOLOGY, V116, pS1, DOI 10.1016/j.ophtha.2009.06.045; Chakraborty D, 2008, BIOCHEMISTRY-US, V47, P1144, DOI 10.1021/bi701807c; Chakraborty D, 2020, FASEB J, V34, P1211, DOI 10.1096/fj.201901888R; Chakraborty D, 2016, HUM MOL GENET, V25, P3500, DOI 10.1093/hmg/ddw193; Chakraborty D, 2009, HUM MOL GENET, V18, P797, DOI 10.1093/hmg/ddn406; Cheng T, 1997, J NEUROSCI, V17, P8118, DOI 10.1523/jneurosci.17-21-08118.1997; Cheng XT, 2018, AUTOPHAGY, V14, P1472, DOI 10.1080/15548627.2018.1482147; Conley S, 2007, INVEST OPHTH VIS SCI, V48, P5397, DOI 10.1167/iovs.07-0663; Conley SM, 2008, CURR OPIN MOL THER, V10, P456; Conley SM, 2017, HUM MOL GENET, V26, P509, DOI 10.1093/hmg/ddw408; Conley SM, 2014, HUM MOL GENET, V23, P3102, DOI 10.1093/hmg/ddu014; Cook NR, 2004, TRAFFIC, V5, P685, DOI 10.1111/j.1600-0854.2004.00212.x; Cunha-Vaz J, 2011, EUR J OPHTHALMOL, V21, pS3, DOI 10.5301/EJO.2010.6049; Dhingra A, 2018, ADV EXP MED BIOL, V1074, P609, DOI 10.1007/978-3-319-75402-4_74; Ding XQ, 2004, HUM MOL GENET, V13, P2075, DOI 10.1093/hmg/ddh211; Dornonville de la Cour M, 1993, Acta Ophthalmol Suppl, P1; Eskelinen Eeva-Liisa, 2006, Molecular Aspects of Medicine, V27, P495, DOI 10.1016/j.mam.2006.08.005; Esteve-Rudd J, 2018, P NATL ACAD SCI USA, V115, P5468, DOI 10.1073/pnas.1709211115; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjood F, 2017, MOL VIS, V23, P431; Feher J, 2006, NEUROBIOL AGING, V27, P983, DOI 10.1016/j.neurobiolaging.2005.05.012; Fossarello M, 1996, ARCH OPHTHALMOL-CHIC, V114, P448, DOI 10.1001/archopht.1996.01100130444016; Francis PJ, 2005, BRIT J OPHTHALMOL, V89, P1115, DOI 10.1136/bjo.2004.062695; Frost LS, 2015, MOL NEUROBIOL, V52, P1135, DOI 10.1007/s12035-014-8920-5; Futter CE, 2006, PIGM CELL RES, V19, P104, DOI 10.1111/j.1600-0749.2006.00303.x; Gocho K, 2016, OSLI RETINA, V47, P1115, DOI 10.3928/23258160-20161130-05; Goldberg AFX, 2001, J BIOL CHEM, V276, P42700, DOI 10.1074/jbc.M107511200; Goldberg AFX, 2000, METHOD ENZYMOL, V316, P671; Gourier HCY, 2015, J CLIN MED, V4, P874, DOI 10.3390/jcm4050874; Grace MS, 1996, BRAIN RES, V735, P93; Green W R, 1999, Mol Vis, V5, P27; Gu SM, 1997, NAT GENET, V17, P194, DOI 10.1038/ng1097-194; Guziewicz KE, 2017, PROG RETIN EYE RES, V58, P70, DOI 10.1016/j.preteyeres.2017.01.005; Han Z, 2012, INVEST OPHTH VIS SCI, V53, P361, DOI 10.1167/iovs.11-8635; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P291; HERMAN KG, 1982, INVEST OPHTH VIS SCI, V23, P277; Huynh KK, 2007, EMBO J, V26, P313, DOI 10.1038/sj.emboj.7601511; Jones BW, 2016, EXP EYE RES, V150, P149, DOI 10.1016/j.exer.2016.03.018; Kauppinen A, 2016, CELL MOL LIFE SCI, V73, P1765, DOI 10.1007/s00018-016-2147-8; Kevany BM, 2010, PHYSIOLOGY, V25, P8, DOI 10.1152/physiol.00038.2009; Khani SC, 2003, INVEST OPHTH VIS SCI, V44, P3570, DOI 10.1167/iovs.02-1287; Kim JY, 2013, CELL, V154, P365, DOI 10.1016/j.cell.2013.06.012; Kim SY, 2014, INVEST OPHTH VIS SCI, V55, P6031, DOI 10.1167/iovs.14-15091; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Kuny S, 2015, INVEST OPHTH VIS SCI, V56, P7109, DOI 10.1167/iovs.15-17567; Lakkaraju A, 2020, PROG RETIN EYE RES, V78, DOI 10.1016/j.preteyeres.2020.100846; LAVAIL MM, 1976, SCIENCE, V194, P1071, DOI 10.1126/science.982063; Loewen CJR, 2000, J BIOL CHEM, V275, P5370, DOI 10.1074/jbc.275.8.5370; MACKENZIE D, 1984, BIOCHEMISTRY-US, V23, P6544, DOI 10.1021/bi00321a041; Marneros AG, 2005, AM J PATHOL, V167, P1451, DOI 10.1016/S0002-9440(10)61231-X; Michaelides M, 2005, OPHTHALMOLOGY, V112, P1592, DOI 10.1016/j.ophtha.2005.04.004; MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50; Morimura H, 1998, P NATL ACAD SCI USA, V95, P3088, DOI 10.1073/pnas.95.6.3088; Moritz OL, 1996, INVEST OPHTH VIS SCI, V37, P352; Nakazawa M, 1995, RETINA-J RET VIT DIS, V15, P518, DOI 10.1097/00006982-199515060-00011; Nandrot EF, 2014, ADV EXP MED BIOL, V801, P77, DOI 10.1007/978-1-4614-3209-8_10; Naylor A, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21010211; NICHOLS BE, 1993, NAT GENET, V3, P202, DOI 10.1038/ng0393-202; OAKLEY B, 1978, J MEMBRANE BIOL, V44, P281, DOI 10.1007/BF01944225; OAKLEY B, 1976, J NEUROPHYSIOL, V39, P1117, DOI 10.1152/jn.1976.39.5.1117; OAKLEY B, 1977, J GEN PHYSIOL, V70, P405, DOI 10.1085/jgp.70.4.405; Piguet B, 1996, OPHTHALMIC GENET, V17, P175, DOI 10.3109/13816819609057891; Piippo N, 2014, BBA-MOL CELL RES, V1843, P3038, DOI 10.1016/j.bbamcr.2014.09.015; Poloschek CM, 2010, INVEST OPHTH VIS SCI, V51, P4253, DOI 10.1167/iovs.09-4655; REIG C, 1995, OPHTHALMIC GENET, V16, P39, DOI 10.3109/13816819509056911; Saadat KASM, 2014, FEBS OPEN BIO, V4, P1007, DOI 10.1016/j.fob.2014.11.003; Samuels IS, 2010, J NEUROPHYSIOL, V104, P391, DOI 10.1152/jn.00088.2010; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Song DL, 2016, EXP EYE RES, V151, P122, DOI 10.1016/j.exer.2016.08.008; Sparrrow JR, 2010, CURR MOL MED, V10, P802; STEINBERG RH, 1985, DOC OPHTHALMOL, V60, P327, DOI 10.1007/BF00158922; STEINBERG RH, 1970, NATURE, V227, P728, DOI 10.1038/227728a0; STEINBERG RH, 1973, EXP EYE RES, V16, P365, DOI 10.1016/0014-4835(73)90130-9; STEINBERG RH, 1983, VISION RES, V23, P1315, DOI 10.1016/0042-6989(83)90107-4; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Stricker HM, 2005, BIOCHEM J, V388, P605, DOI 10.1042/BJ20041960; Stuck MW, 2014, HUM MOL GENET, V23, P6260, DOI 10.1093/hmg/ddu345; Taubit T, 2018, PEERJ, V6, DOI 10.7717/peerj.5215; Telegina DV, 2017, SCI REP-UK, V7, DOI 10.1038/srep41533; TERMAN JS, 1993, BRAIN RES, V605, P256; WALD G, 1956, NATURE, V177, P174, DOI 10.1038/177174a0; Wavre-Shapton ST, 2014, J CELL SCI, V127, P3852, DOI 10.1242/jcs.154757; WELEBER RG, 1993, ARCH OPHTHALMOL-CHIC, V111, P1531, DOI 10.1001/archopht.1993.01090110097033; Wickham L, 2009, INVEST OPHTH VIS SCI, V50, P3553, DOI 10.1167/iovs.08-2715; Wimmers S, 2007, PROG RETIN EYE RES, V26, P263, DOI 10.1016/j.preteyeres.2006.12.002; WITKOVSKY P, 1975, J GEN PHYSIOL, V65, P119, DOI 10.1085/jgp.65.2.119; Wrigley JDJ, 2000, J BIOL CHEM, V275, P13191, DOI 10.1074/jbc.C900853199; WROBLEWSKI JJ, 1994, OPHTHALMOLOGY, V101, P12; YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61; YOUNG RW, 1969, J CELL BIOL, V42, P392, DOI 10.1083/jcb.42.2.392; YOUNG RW, 1977, J ULTRA MOL STRUCT R, V61, P172, DOI 10.1016/S0022-5320(77)80084-1; YOUNG RW, 1978, INVEST OPHTH VIS SCI, V17, P105; Zhang K, 2002, ARCH OPHTHALMOL-CHIC, V120, P485; Zhang Q, 2019, MOL VIS, V25, P70; Zhang Y, 2017, MOL VIS, V23, P228	102	0	0	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22284	10.1096/fj.202101562RR	http://dx.doi.org/10.1096/fj.202101562RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SK	35344225				2022-12-26	WOS:000773603000001
J	Tsai, SJ; Ai, YW; Guo, CX; Gould, SJ				Tsai, Shang Jui; Ai, Yiwei; Guo, Chenxu; Gould, Stephen J.			Degron tagging of BleoR and other antibiotic-resistance genes selects for higher expression of linked transgenes and improved exosome engineering	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							MEDIATED DELIVERY; MESSENGER-RNA; PROTEINS; CLONING; VIRUS; BIOGENESIS; ENHANCER; VECTORS; MARKER	Five antibiotic resistance (AR) genes have been used to select for transgenic eukaryotic cell lines, with the BleoR, PuroR, HygR, NeoR, and BsdR cassettes conferring resistance to zeocin, puromycin, hygromycin, geneticin/G418, and blasticidin, respectively. We recently demonstrated that each AR gene establishes a distinct threshold of transgene expression below which no cell can survive, with BleoR selecting for the highest level of transgene expression, nearly similar to 10-fold higher than in cells selected using the NeoR or BsdR markers. Here, we tested the hypothesis that there may be an inverse proportionality between AR protein function and the expression of linked, transgene-encoded, recombinant proteins. Specifically, we fused each AR protein to proteasome-targeting degron tags, used these to select for antibiotic-resistant cell lines, and then measured the expression of the linked, recombinant protein, mCherry, as a proxy marker of transgene expression. In each case, degron-tagged AR proteins selected for higher mCherry expression than their cognate WT AR proteins. ER50BleoR selected for the highest level of mCherry expression, greater than twofold higher than BleoR or any other AR gene. Interestingly, use of ER50BleoR as the selectable marker translated to an even higher, 3.5-fold increase in the exosomal loading of the exosomal cargo protein, CD63/Y235A. Although a putative CD63-binding peptide, CP05, has been used to decorate exosome membranes in a technology known as "exosome painting," we show here that CP05 binds equally well to CD63(-/-) cells, WT 293F cells, and CD63-overexpressing cells, indicating that CP05 may bind membranes nonspecifically. These results are of high significance for cell engineering and especially for exosome engineering.	[Tsai, Shang Jui; Ai, Yiwei; Guo, Chenxu; Gould, Stephen J.] Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21218 USA	Johns Hopkins University	Gould, SJ (corresponding author), Johns Hopkins Univ, Dept Biol Chem, Baltimore, MD 21218 USA.	sgould@jhmi.edu		Tsai, Shang-Jui/0000-0002-9602-2823; Guo, Chenxu/0000-0002-9651-4203	Capricor; Johns Hopkins University; National Institutes of Health	Capricor; Johns Hopkins University(Johns Hopkins University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was conducted with support from Capricor, Johns Hopkins University, and the National Institutes of Health (grant no.: UG3CA241687-02)	Boni MF, 2020, NAT MICROBIOL, V5, P1408, DOI 10.1038/s41564-020-0771-4; BOSHART M, 1985, CELL, V41, P521, DOI 10.1016/S0092-8674(85)80025-8; Chalberg TW, 2006, J MOL BIOL, V357, P28, DOI 10.1016/j.jmb.2005.11.098; Dhara VG, 2018, BIODRUGS, V32, P571, DOI 10.1007/s40259-018-0319-9; Diamond Michael, 2021, Res Sq, DOI 10.21203/rs.3.rs-228079/v1; Donello JE, 1998, J VIROL, V72, P5085, DOI 10.1128/JVI.72.6.5085-5092.1998; Dong X, 2021, THERANOSTICS, V11, P5107, DOI 10.7150/thno.54755; Dooley K, 2021, MOL THER, V29, P1729, DOI 10.1016/j.ymthe.2021.01.020; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Fonseca JP, 2019, ACS SYNTH BIOL, V8, P2593, DOI 10.1021/acssynbio.9b00322; Fordjour F. K., 2019, BIORXIV, DOI [10.1101/545228v1, DOI 10.1101/545228V1, 10.1101/545228, DOI 10.1101/545228]; Gan X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029421; Gao XJ, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aat0195; Gaspar V, 2015, EXPERT OPIN BIOL TH, V15, P353, DOI 10.1517/14712598.2015.996544; GATIGNOL A, 1988, FEBS LETT, V230, P171, DOI 10.1016/0014-5793(88)80665-3; Ghilardi N, 2020, ANNU REV IMMUNOL, V38, P249, DOI 10.1146/annurev-immunol-101619-031510; GRUSS P, 1979, P NATL ACAD SCI USA, V76, P4317, DOI 10.1073/pnas.76.9.4317; Guo CX, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100838; Huang KYA, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009352; Imai J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20225606; Iwamoto M, 2010, CHEM BIOL, V17, P981, DOI 10.1016/j.chembiol.2010.07.009; JOYNER A, 1982, P NATL ACAD SCI-BIOL, V79, P1573, DOI 10.1073/pnas.79.5.1573; KASTER KR, 1983, NUCLEIC ACIDS RES, V11, P6895, DOI 10.1093/nar/11.19.6895; KIMURA M, 1994, MOL GEN GENET, V242, P121, DOI 10.1007/BF00391004; Kjaer J, 2018, J VIROL, V92, DOI 10.1128/JVI.02218-17; Kurosaki T, 2019, NAT REV MOL CELL BIO, V20, P406, DOI 10.1038/s41580-019-0126-2; Luke GA, 2010, BIOTECHNOL GENET ENG, V26, P223; Miyazaki Y, 2012, J AM CHEM SOC, V134, P3942, DOI 10.1021/ja209933r; MULLIGAN RC, 1980, SCIENCE, V209, P1422, DOI 10.1126/science.6251549; MULSANT P, 1988, SOMAT CELL MOLEC GEN, V14, P243, DOI 10.1007/BF01534585; Ochmann MT, 2021, VIRUSES-BASEL, V13, DOI 10.3390/v13010076; OKAYAMA H, 1983, MOL CELL BIOL, V3, P280, DOI 10.1128/MCB.3.2.280; Pegtel DM, 2019, ANNU REV BIOCHEM, V88, P487, DOI 10.1146/annurev-biochem-013118-111902; Rakhit R, 2014, CHEM BIOL, V21, P1238, DOI 10.1016/j.chembiol.2014.08.011; Segel M, 2021, SCIENCE, V373, P882, DOI 10.1126/science.abg6155; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Shen BY, 2011, J BIOL CHEM, V286, P44162, DOI 10.1074/jbc.M111.274803; SOUTHERN P J, 1982, Journal of Molecular and Applied Genetics, V1, P327; Tipanee J, 2017, HUM GENE THER, V28, P1087, DOI 10.1089/hum.2017.128; Turan S, 2013, GENE, V515, P1, DOI 10.1016/j.gene.2012.11.016; VARA J, 1985, GENE, V33, P197, DOI 10.1016/0378-1119(85)90094-0; Varshavsky A, 2019, P NATL ACAD SCI USA, V116, P358, DOI 10.1073/pnas.1816596116; Wang T, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.659783; YATES JL, 1985, NATURE, V313, P812, DOI 10.1038/313812a0; Zhang F, 2007, BLOOD, V110, P1448, DOI 10.1182/blood-2006-12-060814; Zuo BF, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15569-2	47	0	0	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101846	10.1016/j.jbc.2022.101846	http://dx.doi.org/10.1016/j.jbc.2022.101846			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35314197	gold, Green Published			2022-12-26	WOS:000804923000011
J	Lamuedra, A; Gratal, P; Calatrava, L; Ruiz-Perez, VL; Palencia-Campos, A; Portal-Nunez, S; Mediero, A; Herrero-Beaumont, G; Largo, R				Lamuedra, Ana; Gratal, Paula; Calatrava, Lucia; Ruiz-Perez, Victor Luis; Palencia-Campos, Adrian; Portal-Nunez, Sergio; Mediero, Aranzazu; Herrero-Beaumont, Gabriel; Largo, Raquel			Blocking chondrocyte hypertrophy in conditional Evc knockout mice does not modify cartilage damage in osteoarthritis	FASEB JOURNAL			English	Article						cartilage; chondrocyte hypertrophy; Ellis-van Creveld; Hedgehog; osteoarthritis	INDIAN HEDGEHOG; PRIMARY CILIA; MURINE OSTEOARTHRITIS; PROTEIN MODIFICATION; ARTICULAR-CARTILAGE; EXPRESSION; PATHWAY; JOINT; CYCLOPAMINE; INHIBITION	Chondrocytes in osteoarthritic (OA) cartilage acquire a hypertrophic-like phenotype, where Hedgehog (Hh) signaling is pivotal. Hh overexpression causes OA-like cartilage lesions, whereas its downregulation prevents articular destruction in mouse models. Mutations in EVC and EVC2 genes disrupt Hh signaling, and are responsible for the Ellis-van Creveld syndrome skeletal dysplasia. Since Ellis-van Creveld syndrome protein (Evc) deletion is expected to hamper Hh target gene expression we hypothesized that it would also prevent OA progression avoiding chondrocyte hypertrophy. Our aim was to study Evc as a new therapeutic target in OA, and whether Evc deletion restrains chondrocyte hypertrophy and prevents joint damage in an Evc tamoxifen induced knockout (Evc(cKO)) model of OA. For this purpose, OA was induced by surgical knee destabilization in wild-type (WT) and Evc(cKO) adult mice, and healthy WT mice were used as controls (n = 10 knees/group). Hypertrophic markers and Hh genes were measured by qRT-PCR, and metalloproteinases (MMP) levels assessed by western blot. Human OA chondrocytes and cartilage samples were obtained from patients undergoing knee joint replacement surgery. Cyclopamine (CPA) was used for Hh pharmacological inhibition and IL-1 beta as an inflammatory insult. Our results showed that tamoxifen induced inactivation of Evc inhibited Hh overexpression and partially prevented chondrocyte hypertrophy during OA, although it did not ameliorate cartilage damage in DMM-Evc(cKO) mice. Hh pathway inhibition did not modify the expression of proinflammatory mediators induced by IL-1 beta in human OA chondrocytes in culture. We found that hypertrophic-IHH-and inflammatory-COX-2-markers co-localized in OA cartilage samples. We concluded that tamoxifen induced inactivation of Evc partially prevented chondrocyte hypertrophy in DMM-Evc(cKO) mice, but it did not ameliorate cartilage damage. Overall, our results suggest that chondrocyte hypertrophy per se is not a pathogenic event in the progression of OA.	[Lamuedra, Ana; Gratal, Paula; Mediero, Aranzazu; Herrero-Beaumont, Gabriel; Largo, Raquel] Autonomous Univ Madrid, IIS Fdn Jimenez Diaz, Serv Rheumatol, Bone & Joint Res Unit, Madrid, Spain; [Calatrava, Lucia; Ruiz-Perez, Victor Luis; Palencia-Campos, Adrian] CSIC UAM, Inst Invest Biomed Alberto Sols, Madrid, Spain; [Calatrava, Lucia; Ruiz-Perez, Victor Luis] ISCIII, CIBER Enfermedades Raras CIBERER, Madrid, Spain; [Ruiz-Perez, Victor Luis] Hosp Univ La Paz IdiPaz UAM, Inst Genet Med & Mol INGEMM, Madrid, Spain; [Portal-Nunez, Sergio] Univ San Pablo CEU, Appl Mol Med Inst IMMA, Bone Physiopathol Lab, Madrid, Spain	Autonomous University of Madrid; Fundacion Jimenez Diaz; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas Alberto Sols (IIBM); CIBER - Centro de Investigacion Biomedica en Red; CIBERER; Instituto de Salud Carlos III; Hospital Universitario La Paz; San Pablo CEU University	Herrero-Beaumont, G (corresponding author), IIS Fdn Jimenez Diaz UAM, Rheumatol Dept, Bone & Joint Res Unit, Reyes Catolicos 2, Madrid 28040, Spain.	GHerrero@fjd.es	Portal-Núñez, Sergio/L-7391-2014; Ruiz-Perez, Victor Luis/K-6066-2014; Largo, Raquel/B-2949-2009	Portal-Núñez, Sergio/0000-0003-0659-1545; Mediero, Aranzazu/0000-0002-5368-574X; Ruiz-Perez, Victor Luis/0000-0003-0635-3619; Largo, Raquel/0000-0001-6525-2944; Herrero-Beaumont, Gabriel/0000-0002-3241-991X	Instituto de Salud Carlos III [PI20/00349, PI16/00065, PI18/00261]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Ministry of Science and Innovatin (MICINN) [SAF-2013-43365-R, SAF2016-75434-R]; Fundacion Conchita Rabago	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Fondo Europeo de Desarrollo Regional (FEDER)(European CommissionSpanish Government); Spanish Ministry of Science and Innovatin (MICINN); Fundacion Conchita Rabago	This work was financially supported by grants from the Instituto de Salud Carlos III [PI20/00349, PI16/00065, PI18/00261] and Fondo Europeo de Desarrollo Regional (FEDER); and by the Spanish Ministry of Science and Innovatin (MICINN) [SAF-2013-43365-R and SAF2016-75434-R] to VLR-P. AL and PG were funded by Fundacion Conchita Rabago. The authors thank Dr. David Santamaria for providing UBC--CreERT2 mice and Maria Gracia Gonzalez Bueno for helping to organize mouse crosses and technical work.	Abe Y, 2017, J DEV BIOL, V5, DOI 10.3390/jdb5040012; Andres-Bergos J, 2012, J BIOL CHEM, V287, P33615, DOI 10.1074/jbc.M112.354241; Anvarian Z, 2019, NAT REV NEPHROL, V15, P199, DOI 10.1038/s41581-019-0116-9; Briscoe J, 2013, NAT REV MOL CELL BIO, V14, P416, DOI 10.1038/nrm3598; Bruce SJ, 2010, J BIOL CHEM, V285, P27967, DOI 10.1074/jbc.M109.091785; Burleigh A, 2012, ARTHRITIS RHEUM-US, V64, P2278, DOI 10.1002/art.34420; Caparros-Martin JA, 2013, HUM MOL GENET, V22, P124, DOI 10.1093/hmg/dds409; Chang CF, 2012, OSTEOARTHR CARTILAGE, V20, P152, DOI 10.1016/j.joca.2011.11.009; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cortes JE, 2019, CANCER TREAT REV, V76, P41, DOI 10.1016/j.ctrv.2019.04.005; Didiasova M, 2018, MOLECULES, V23, DOI 10.3390/molecules23051003; Dunaeva M, 2017, CELL MOL LIFE SCI, V74, P3481, DOI 10.1007/s00018-017-2534-9; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Giarretta I, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215270; Glasson SS, 2007, OSTEOARTHR CARTILAGE, V15, P1061, DOI 10.1016/j.joca.2007.03.006; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gosset M, 2008, NAT PROTOC, V3, P1253, DOI 10.1038/nprot.2008.95; Gratal P, 2019, OSTEOARTHR CARTILAGE, V27, P1229, DOI 10.1016/j.joca.2019.04.013; Gratal P., 2021, AUTHOREA, DOI [10.22541/au.162949181.11616718/v1, DOI 10.22541/AU.162949181.11616718/V1]; Gutzmer R, 2019, TARGET ONCOL, V14, P253, DOI 10.1007/s11523-019-00648-2; Herrero-Beaumont G, 2019, BIOCHEM PHARMACOL, V165, P24, DOI 10.1016/j.bcp.2019.02.030; Kozhemyakina E, 2015, DEVELOPMENT, V142, P817, DOI 10.1242/dev.105536; Lacouture ME, 2016, ONCOLOGIST, V21, P1218, DOI 10.1634/theoncologist.2016-0186; Lamuedra A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-67518-0; Larranaga-Vera A, 2017, ARTHRITIS RES THER, V19, DOI 10.1186/s13075-017-1473-z; Lee JJ, 2016, P NATL ACAD SCI USA, V113, pE7545, DOI 10.1073/pnas.1616447113; Li R, 2015, J PHARM PHARMACOL, V67, P963, DOI 10.1111/jphp.12379; Lin AC, 2009, NAT MED, V15, P1421, DOI 10.1038/nm.2055; Liu QB, 2019, GENE, V712, DOI 10.1016/j.gene.2019.143959; Loeser RF, 2012, ARTHRITIS RHEUM-US, V64, P1697, DOI 10.1002/art.34453; Lorenz J, 2014, METHODS MOL BIOL, V1194, P401, DOI 10.1007/978-1-4939-1215-5_23; Martel-Pelletier J, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.72; McGlashan SR, 2008, DEV DYNAM, V237, P2013, DOI 10.1002/dvdy.21501; Mediero A, 2016, FASEB J, V30, P3835, DOI 10.1096/fj.201600615R; Muscatello LV, 2015, VET PATHOL, V52, P957, DOI 10.1177/0300985815588610; Pacheco M, 2012, BONE, V50, P28, DOI 10.1016/j.bone.2011.08.025; Peer E, 2019, CANCERS, V11, DOI 10.3390/cancers11040538; Peluso MO, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090534; Perez-Baos S, 2019, J INFLAMM-LOND, V16, DOI 10.1186/s12950-019-0206-2; Petrova R, 2014, DEVELOPMENT, V141, P3445, DOI 10.1242/dev.083691; Pietrobono S, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00556; POTOCKI L, 1995, AM J MED GENET, V59, P295, DOI 10.1002/ajmg.1320590306; Rimkus TK, 2016, CANCERS, V8, DOI 10.3390/cancers8020022; Ripmeester EGJ, 2018, FRONT BIOENG BIOTECH, V6, DOI 10.3389/fbioe.2018.00018; Rohatgi R, 2009, P NATL ACAD SCI USA, V106, P3196, DOI 10.1073/pnas.0813373106; Ruhlen R, 2014, OSTEOARTHR CARTILAGE, V22, P1071, DOI 10.1016/j.joca.2014.05.011; Ruiz-Perez VL, 2007, DEVELOPMENT, V134, P2903, DOI 10.1242/dev.007542; Sasai N, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.01103; Shen F, 2013, MOL PHARMACOL, V83, P691, DOI 10.1124/mol.112.082511; Singh P, 2019, ANN NY ACAD SCI, V1442, P17, DOI 10.1111/nyas.13930; Takada S, 2020, J ORTHOP RES, V38, P609, DOI 10.1002/jor.24494; Tao FH, 2020, CELL PROLIFERAT, V53, DOI 10.1111/cpr.12765; Tardio L, 2014, OSTEOARTHR CARTILAGE, V22, P259, DOI 10.1016/j.joca.2013.12.001; Thompson CL, 2014, OSTEOARTHR CARTILAGE, V22, P490, DOI 10.1016/j.joca.2013.12.016; Thompson CL, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0891-z; Villalvilla A, 2016, MATURITAS, V85, P27, DOI 10.1016/j.maturitas.2015.12.001; Wang CQ, 2019, J DEV BIOL, V7, DOI 10.3390/jdb7030014; Wang Y, 2012, CANCER CELL, V21, P374, DOI 10.1016/j.ccr.2011.12.028; Wei F, 2012, OSTEOARTHR CARTILAGE, V20, P755, DOI 10.1016/j.joca.2012.03.010; Will AJ, 2017, NAT GENET, V49, P1539, DOI 10.1038/ng.3939; Xu T, 2017, J ORAL PATHOL MED, V46, P284, DOI 10.1111/jop.12497; Zarebska JM, 2017, OSTEOARTHR CARTILAGE, V25, P406, DOI 10.1016/j.joca.2016.10.008; Zhang CM, 2014, INT J MOL SCI, V15, P7250, DOI 10.3390/ijms15057250; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhou JM, 2014, CONNECT TISSUE RES, V55, P257, DOI 10.3109/03008207.2014.925885; Zhou JM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4437; Zhou XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044121; Zhu LY, 2020, ACR OPEN RHEUMATOL, V2, P605, DOI 10.1002/acr2.11176	68	1	1	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22258	10.1096/fj.202101791RR	http://dx.doi.org/10.1096/fj.202101791RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0CF	35334131	Green Published			2022-12-26	WOS:000772944300001
J	Crase, S; Thennadil, SN				Crase, Simon; Thennadil, Suresh N.			An analysis framework for clustering algorithm selection with applications to spectroscopy	PLOS ONE			English	Article								Cluster analysis is a valuable unsupervised machine learning technique that is applied in a multitude of domains to identify similarities or clusters in unlabelled data. However, its performance is dependent of the characteristics of the data it is being applied to. There is no universally best clustering algorithm, and hence, there are numerous clustering algorithms available with different performance characteristics. This raises the problem of how to select an appropriate clustering algorithm for the given analytical purposes. We present and validate an analysis framework to address this problem. Unlike most current literature which focuses on characterizing the clustering algorithm itself, we present a wider holistic approach, with a focus on the user's needs, the data's characteristics and the characteristics of the clusters it may contain. In our analysis framework, we utilize a softer qualitative approach to identify appropriate characteristics for consideration when matching clustering algorithms to the intended application. These are used to generate a small subset of suitable clustering algorithms whose performance are then evaluated utilizing quantitative cluster validity indices. To validate our analysis framework for selecting clustering algorithms, we applied it to four different types of datasets: three datasets of homemade explosives spectroscopy, eight datasets of publicly available spectroscopy data covering food and biomedical applications, a gene expression cancer dataset, and three classic machine learning datasets. Each data type has discernible differences in the composition of the data and the context within which they are used. Our analysis framework, when applied to each of these challenges, recommended differing subsets of clustering algorithms for final quantitative performance evaluation. For each application, the recommended clustering algorithms were confirmed to contain the top performing algorithms through quantitative performance indices.	[Crase, Simon; Thennadil, Suresh N.] Charles Darwin Univ, Coll Engn IT & Environm, Darwin, NT, Australia; [Crase, Simon] Def Sci & Technol Grp, Edinburgh, SA, Australia; [Thennadil, Suresh N.] Charles Darwin Univ, Energy & Resources Inst, Darwin, NT, Australia	Charles Darwin University; Defence Science & Technology; Charles Darwin University	Thennadil, SN (corresponding author), Charles Darwin Univ, Coll Engn IT & Environm, Darwin, NT, Australia.; Thennadil, SN (corresponding author), Charles Darwin Univ, Energy & Resources Inst, Darwin, NT, Australia.	suresh.thennadil@cdu.edu.au		Crase, Simon/0000-0001-7168-0195; Thennadil, Suresh/0000-0001-9392-7857	Commonwealth of Australia; Defence Science and Technology Group of the Department of Defence; Australian Government Research Training Program (RTP) Scholarship	Commonwealth of Australia(Australian Government); Defence Science and Technology Group of the Department of Defence; Australian Government Research Training Program (RTP) Scholarship(Australian GovernmentDepartment of Industry, Innovation and Science)	YES SC is supported through a scholarship by the Commonwealth of Australia as represented by the Defence Science and Technology Group of the Department of Defence, and by an Australian Government Research Training Program (RTP) Scholarship. www.dst.defence.gov.au www.dese.gov.au/research-blockgrants/research-training-program Defence Science and Technology group provided the explosives datasets for this study. The funders had no role in study design, decision to publish, or preparation of the manuscript.	Ackerman M., 2010, COLT; Ackerman M., 2010, ADV NEURAL INFORM PR; Ackerman M, 2016, J MACH LEARN RES, V17; Adolfsson A, 2019, PATTERN RECOGN, V88, P13, DOI 10.1016/j.patcog.2018.10.026; Aldenderfer MS., 1984, CLUSTER ANAL; AlJowder O, 1997, FOOD CHEM, V59, P195, DOI 10.1016/S0308-8146(96)00289-0; Ankerst M, 1999, SIGMOD RECORD, VOL 28, NO 2 - JUNE 1999, P49; [Anonymous], 2010, P 19 INT C WORLD WID; [Anonymous], 2019, **DATA OBJECT**; [Anonymous], 2019, FUZZY C MEANS IMPLEM; [Anonymous], 2016, GEN EXPR CANC RNA SE; [Anonymous], 1995, BREAST CANC WISCONSI; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; BLASHFIELD RK, 1991, J CLASSIF, V8, P277; Brohee S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-488; Campello Ricardo J. G. B., 2013, Advances in Knowledge Discovery and Data Mining. 17th Pacific-Asia Conference (PAKDD 2013). Proceedings, P160, DOI 10.1007/978-3-642-37456-2_14; Christensen J, 2004, J NEAR INFRARED SPEC, V12, P63, DOI 10.1255/jnirs.408; Comaniciu D, 2002, IEEE T PATTERN ANAL, V24, P603, DOI 10.1109/34.1000236; Crase S., 2017, FTIR SPECTROSCOPY RE, DOI [10.25913/7bh8-bv76, DOI 10.25913/7BH8-BV76]; Crase S, 2021, CMC-COMPUT MATER CON, V69, P1945, DOI 10.32604/cmc.2021.018517; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Demsar J, 2013, J MACH LEARN RES, V14, P2349; Downey G, 1997, J AGR FOOD CHEM, V45, P4357, DOI 10.1021/jf970337t; DUBES R, 1976, PATTERN RECOGN, V8, P247, DOI 10.1016/0031-3203(76)90045-5; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Dunn J.C., 1973, J CYBERNETICS, V3, P32, DOI [10.1080/01969727308546046, DOI 10.1080/01969727308546046]; Dunn J.C., 1974, J CYBERNETICS, V4, P95, DOI 10.1080/01969727408546059; Erman J., 2006, P 2006 SIGCOMM WORKS, DOI 10.1145/11 62678.1162679; Ester M., 1996, P 2 INT C KNOWLEDGE, P226; FISHER L, 1971, BIOMETRIKA, V58, P91, DOI 10.2307/2334320; Frey BJ, 2007, SCIENCE, V315, P972, DOI 10.1126/science.1136800; Geron A., 2019, HANDS ON MACHINE LEA, V2nd; Guyeux C, 2019, J SENS ACTUAT NETW, V8, DOI 10.3390/jsan8040056; Hennig C, 2015, PATTERN RECOGN LETT, V64, P53, DOI 10.1016/j.patrec.2015.04.009; Holland JK, 1998, J SCI FOOD AGR, V76, P263, DOI 10.1002/(SICI)1097-0010(199802)76:2<263::AID-JSFA943>3.0.CO;2-F; Jain AK, 2004, INT C PATT RECOG, P260, DOI 10.1109/ICPR.2004.1334073; Jain AK, 2000, IEEE T PATTERN ANAL, V22, P4, DOI 10.1109/34.824819; Jain AK, 1999, ACM COMPUT SURV, V31, P264, DOI 10.1145/331499.331504; Jain AK, 2005, INT C PATTERN RECOGN; Jain AK, 2010, PATTERN RECOGN LETT, V31, P651, DOI 10.1016/j.patrec.2009.09.011; Kinnunen T, 2011, PATTERN RECOGN LETT, V32, P1604, DOI 10.1016/j.patrec.2011.06.023; Kleinberg J.M., 2003, ADV NEURAL INFORM PR, V15, P463; Kou G, 2014, INFORM SCIENCES, V275, P1, DOI 10.1016/j.ins.2014.02.137; Maimon O, 2010, DATA MINING AND KNOWLEDGE DISCOVERY HANDBOOK, SECOND EDITION, P1, DOI 10.1007/978-0-387-09823-4; MARTENS H, 1991, J PHARMACEUT BIOMED, V9, P625, DOI 10.1016/0731-7085(91)80188-F; Maulik U, 2002, IEEE T PATTERN ANAL, V24, P1650, DOI 10.1109/TPAMI.2002.1114856; McInnes L, 2017, INT CONF DAT MIN WOR, P33, DOI 10.1109/ICDMW.2017.12; Meila M., 2015, HDB CLUSTER ANAL, P1; Munawar A., 2019, **DATA OBJECT**, DOI 10.17632/b9d6s7hr33.1; Munawar AA, 2019, DATA BRIEF, V27, DOI 10.1016/j.dib.2019.104789; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Peng YH, 2002, LECT NOTES COMPUT SC, V2534, P141; Pirim H, 2012, COMPUT OPER RES, V39, P3046, DOI 10.1016/j.cor.2012.03.008; Quadram Institute, 2021, EX DAT DOWNL; Rasmussen CE, 2000, ADV NEUR IN, V12, P554; Rodriguez MZ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0210236; Rosenberg A, 2007, V MEASURE CONDITIONA, V7, P1; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; SCHEIBLER D, 1985, MULTIVAR BEHAV RES, V20, P283, DOI 10.1207/s15327906mbr2003_4; Skov T, 2008, ANAL CHIM ACTA, V615, P18, DOI 10.1016/j.aca.2008.03.045; Strehl A., 2003, Journal of Machine Learning Research, V3, P583, DOI 10.1162/153244303321897735; Tapp HS, 2003, J AGR FOOD CHEM, V51, P6110, DOI 10.1021/jf030232s; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; Toplak M., 2017, Synchrotron Radiation News, V30, P40, DOI 10.1080/08940886.2017.1338424; University of Copenhagen, PUBL DAT SETS MULT D; van der Maaten L, 2008, J MACH LEARN RES, V9, P2579; Vega-Pons S, 2011, INT J PATTERN RECOGN, V25, P337, DOI 10.1142/S0218001411008683; Verma Deepak, 2003, U OFWASHINGTON TECH, V1, P1; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weinstein JN, 2013, NAT GENET, V45, P1113, DOI 10.1038/ng.2764; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Zhang T., 1996, P 1996 ACM SIGMOD IN, DOI [10.1145/235968.233324, DOI 10.1145/235968.233324]	74	1	1	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266369	10.1371/journal.pone.0266369	http://dx.doi.org/10.1371/journal.pone.0266369			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358292	gold, Green Published			2022-12-26	WOS:000799828800097
J	Fida, S; Jalil, A; Habib, R; Akhlaq, M; Mahmood, A; Minhas, MU; Khan, KU; Nawaz, A				Fida, Saima; Jalil, Aamir; Habib, Rukhshanda; Akhlaq, Muhammad; Mahmood, Arshad; Minhas, Muhammad Usman; Khan, Kifayat Ullah; Nawaz, Asif			Development of mucus-penetrating iodine loaded self-emulsifying system for local vaginal delivery	PLOS ONE			English	Article							IN-VITRO; BI2O3 NANOPARTICLES; S-SNEDDS; DESIGN; FORMULATION; BIOAVAILABILITY; CYTOTOXICITY; DISSOLUTION; TOXICITY; QUALITY	The major goal of this project was to formulate iodine-based self nano-emulsifying drug delivery system to provide improve antimicrobial activity and enhanced mucosal residence time via mucus penetration. Iodine SNEDDS (Self nano-emulsifying drug delivery system) with different concentration were formulated using castor oil as the oil phase, cremophor ethoxylated (CrEL) as a surfactant and after screening a number of vehicles, PEG 400 was employed as co-surfactant. Self-emulsification time, thermodynamic stability tests, robustness to dilution, percent transmittance, droplet size, and drug release were measured. Ternary phase diagrams were plotted to determine the area of emulsification. When compared to the commercial formulation, dissolving experiments revealed that the iodine from the SNEDDS enhanced aqueous solubility. In-vitro iodine release was determined to be around 15% per hour, with muco-adhesive and, muco-penetrating characteristics showing a 38-fold improvement. Furthermore, SNEDDS demonstrated significant antibacterial efficacy against Escherichia coli and Staphylococcus aureus. Similarly, when compared to marketed drugs, in-vitro drug absorption profile from the manufactured SNEDDS shown to be much higher. According to these results iodine containing SNEDDS could be a useful new formulation for iodine mucosal usage.	[Fida, Saima; Habib, Rukhshanda; Akhlaq, Muhammad; Nawaz, Asif] Gomal Univ, Fac Pharm, Dept Pharmaceut, Dera Ismail Khan, Pakistan; [Jalil, Aamir] Bahauddin Zakariya Univ, Fac Pharm, Dept Pharmaceut, Multan, Pakistan; [Mahmood, Arshad] Al Ain Univ, Coll Pharm, Abu Dhabi Campus, Abu Dhabi, U Arab Emirates; [Mahmood, Arshad] Al Ain Univ, AAU Hlth & Biomed Res Ctr, Abu Dhabi, U Arab Emirates; [Minhas, Muhammad Usman] Univ Sargodha, Coll Pharm, Univ Rd, Sargodha City, Punjab, Pakistan; [Khan, Kifayat Ullah] Quaid e Azam Coll Pharm, Sahiwal, Punjab, Pakistan	Gomal University; Bahauddin Zakariya University; University of Sargodha	Akhlaq, M (corresponding author), Gomal Univ, Fac Pharm, Dept Pharmaceut, Dera Ismail Khan, Pakistan.	Dr.akhlaq@gu.edu.pk		Khan, Kifayat Ullah/0000-0002-8108-5880	Gomal University Dera Ismail Khan, KPK, Pakistan	Gomal University Dera Ismail Khan, KPK, Pakistan	This research was supported by the Gomal University Dera Ismail Khan, KPK, Pakistan.	Ahamed M, 2021, POLYMERS-BASEL, V13, DOI 10.3390/polym13193350; Ahamed M, 2021, ACS OMEGA, V6, P17353, DOI 10.1021/acsomega.1c01467; Ahamed M, 2022, METHODS, V199, P28, DOI 10.1016/j.ymeth.2021.04.020; Ahamed M, 2019, CHEMOSPHERE, V216, P823, DOI 10.1016/j.chemosphere.2018.10.214; Ahmad J, 2014, SCI ADV MATER, V6, P1778, DOI 10.1166/sam.2014.1884; Akhter MH, 2014, J PHARM INNOV, V9, P121, DOI 10.1007/s12247-014-9179-0; Asim MH, 2019, FUTURE MICROBIOL, V14, P411, DOI 10.2217/fmb-2018-0288; Au-Duong AN, 2017, MAT SCI ENG C-MATER, V76, P477, DOI 10.1016/j.msec.2017.03.114; Balakumar K, 2013, COLLOID SURFACE B, V112, P337, DOI 10.1016/j.colsurfb.2013.08.025; Date AA, 2007, INT J PHARMACEUT, V329, P166, DOI 10.1016/j.ijpharm.2006.08.038; Din FU, 2017, ACTA BIOMATER, V54, P239, DOI 10.1016/j.actbio.2017.03.007; Durani P, 2008, INT WOUND J, V5, P376, DOI 10.1111/j.1742-481X.2007.00405.x; Gursoy RN, 2004, BIOMED PHARMACOTHER, V58, P173, DOI 10.1016/j.biopha.2004.02.001; He S, 2012, ACS APPL MATER INTER, V4, P2116, DOI 10.1021/am300094f; Inugala S, 2015, EUR J PHARM SCI, V74, P1, DOI 10.1016/j.ejps.2015.03.024; Kalepu S, 2013, ACTA PHARM SIN B, V3, P361, DOI 10.1016/j.apsb.2013.10.001; Kanagalingam J, 2015, INT J CLIN PRACT, V69, P1247, DOI 10.1111/ijcp.12707; Khan AW, 2015, DRUG DELIV, V22, P552, DOI 10.3109/10717544.2013.878003; Khan KU, 2022, J DRUG DELIV SCI TEC, V67, DOI 10.1016/j.jddst.2021.102952; Khan KU, 2022, LIFE SCI, V291, DOI 10.1016/j.lfs.2022.120301; Lachapelle J.-M., 2013, FUTURE MED, V10, P579; McDonnell G, 2001, CLIN MICROBIOL REV, V14, P227; Porter CJH, 2008, ADV DRUG DELIVER REV, V60, P673, DOI 10.1016/j.addr.2007.10.014; Pouton CW, 2008, ADV DRUG DELIVER REV, V60, P625, DOI 10.1016/j.addr.2007.10.010; Rizvi SZH, 2019, INT J PHARMACEUT, V560, P136, DOI 10.1016/j.ijpharm.2019.02.002; ROBINSON JR, 1994, J CONTROL RELEASE, V28, P87, DOI 10.1016/0168-3659(94)90156-2; Setthacheewakul S, 2010, EUR J PHARM BIOPHARM, V76, P475, DOI 10.1016/j.ejpb.2010.07.011; Shafiq S, 2007, EUR J PHARM BIOPHARM, V66, P227, DOI 10.1016/j.ejpb.2006.10.014; Shakeel F, 2013, J MOL LIQ, V180, P89, DOI 10.1016/j.molliq.2013.01.008; Suchaoin W, 2016, INT J PHARMACEUT, V510, P255, DOI 10.1016/j.ijpharm.2016.06.045; Talegaonkar S, 2010, J DISPER SCI TECHNOL, V31, P690, DOI 10.1080/01932690903120540; Wang T, 2011, J INCL PHENOM MACRO, V69, P255, DOI 10.1007/s10847-010-9836-y; ZAMORA JL, 1986, AM J SURG, V151, P400, DOI 10.1016/0002-9610(86)90477-0; Zidan AS, 2007, INT J PHARM, V332, P55, DOI 10.1016/j.ijpharm.2006.09.060	34	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266296	10.1371/journal.pone.0266296	http://dx.doi.org/10.1371/journal.pone.0266296			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358270	Green Published, gold			2022-12-26	WOS:000799828800090
J	Terasa, MI; Holtz, P; Carstens, N; Kaps, S; Faupel, F; Vahl, A; Adelung, R				Terasa, Maik-Ivo; Holtz, Pia; Carstens, Niko; Kaps, Soren; Faupel, Franz; Vahl, Alexander; Adelung, Rainer			Sparse CNT networks with implanted AgAu nanoparticles: A novel memristor with short-term memory bordering between diffusive and bipolar switching	PLOS ONE			English	Article							PLASMONIC MEMRISTOR; NANOFILAMENTS	With this work we introduce a novel memristor in a lateral geometry whose resistive switching behaviour unifies the capabilities of bipolar switching with decelerated diffusive switching showing a biologically plausible short-term memory. A new fabrication route is presented for achieving lateral nano-scaled distances by depositing a sparse network of carbon nanotubes (CNTs) via spin-coating of a custom-made CNT dispersion. Electrochemical metallization-type (ECM) resistive switching is obtained by implanting AgAu nanoparticles with a Haberland-type gas aggregation cluster source into the nanogaps between the CNTs and shows a hybrid behaviour of both diffusive and bipolar switching. The resistance state resets to a high resistive state (HRS) either if the voltage is removed with a retention time in the second- to sub-minute scale (diffusive) or by applying a reverse voltage (bipolar). Furthermore, the retention time is positively correlated to the duration of the Set voltage pulse. The potential for low-voltage operation makes this approach a promising candidate for short-term memory applications in neuromorphic circuits. In addition, the lateral fabrication approach opens the pathway towards integrating sensor-functionality and offers a general starting point for the scalable fabrication of nanoscaled devices.	[Terasa, Maik-Ivo; Holtz, Pia; Kaps, Soren; Adelung, Rainer] Univ Kiel, Fac Engn, Inst Mat Sci, Chair Funct Nanomat, Kiel, Germany; [Carstens, Niko; Faupel, Franz; Vahl, Alexander] Univ Kiel, Fac Engn, Inst Mat Sci, Chair Multicomponent Mat, Kiel, Germany	University of Kiel; University of Kiel	Adelung, R (corresponding author), Univ Kiel, Fac Engn, Inst Mat Sci, Chair Funct Nanomat, Kiel, Germany.	ra@tf.uni-kiel.de		Terasa, Maik-Ivo/0000-0001-5838-3807	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) [434434223 - SFB 1461]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)(German Research Foundation (DFG))	This work is funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) - Project-ID 434434223 - SFB 1461. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnes BK, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-20598-5; Chakrabarti B, 2017, SCI REP-UK, V7, DOI 10.1038/srep42429; Chang-Jian CW, 2018, COMPOS PART B-ENG, V136, P46, DOI 10.1016/j.compositesb.2017.10.004; Chaudhary D, 2018, CARBON, V130, P553, DOI 10.1016/j.carbon.2018.01.058; Choi BJ, 2013, NANO LETT, V13, P3213, DOI 10.1021/nl401283q; CHUA LO, 1971, IEEE T CIRCUITS SYST, VCT18, P507, DOI 10.1109/TCT.1971.1083337; Edwards AH, 2015, P IEEE, V103, P1004, DOI 10.1109/JPROC.2015.2441752; Emboras A, 2013, NANO LETT, V13, P6151, DOI 10.1021/nl403486x; Han JW, 2011, AIP ADV, V1, DOI 10.1063/1.3645967; Hansen M, 2015, SCI REP-UK, V5, DOI 10.1038/srep13753; Hoessbacher C, 2014, OPTICA, V1, P198, DOI 10.1364/OPTICA.1.000198; Ielmini D, 2018, NAT ELECTRON, V1, P333, DOI 10.1038/s41928-018-0092-2; Jeong DS, 2012, REP PROG PHYS, V75, DOI 10.1088/0034-4885/75/7/076502; Kwon DH, 2010, NAT NANOTECHNOL, V5, P148, DOI [10.1038/nnano.2009.456, 10.1038/NNANO.2009.456]; Le PY, 2020, ADV ELECTRON MATER, V6, DOI 10.1002/aelm.202000081; Lubben M, 2019, ADV ELECTRON MATER, V5, DOI 10.1002/aelm.201800933; Menzel S, 2013, PHYS CHEM CHEM PHYS, V15, P6945, DOI 10.1039/c3cp50738f; Merolla PA, 2014, SCIENCE, V345, P668, DOI 10.1126/science.1254642; Mirigliano M, 2021, ADV PHYS-X, V6, DOI 10.1080/23746149.2021.1908847; Peng SS, 2012, APPL PHYS LETT, V100, DOI 10.1063/1.3683523; Polonskyi O, 2012, THIN SOLID FILMS, V520, P4155, DOI 10.1016/j.tsf.2011.04.100; Puzyrev YS, 2017, APPL PHYS LETT, V111, DOI 10.1063/1.5008265; Raharnan SZ, 2017, LANGMUIR, V33, P4654, DOI 10.1021/acs.langmuir.7b00479; Ratchford DC, 2017, NANO LETT, V17, P6047, DOI 10.1021/acs.nanolett.7b02366; Shih A, 2010, NANOTECHNOLOGY, V21, DOI 10.1088/0957-4484/21/12/125201; Sokolov A, 2021, ADV ELECTRON MATER, V7, DOI 10.1002/aelm.202000866; Strukov DB, 2008, NATURE, V453, P80, DOI 10.1038/nature06932; Terai M, 2010, IEEE ELECTR DEVICE L, V31, P204, DOI 10.1109/LED.2009.2039021; Vahl A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53720-2; Vahl A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39008-5; Vahl A, 2017, NANOTECHNOLOGY, V28, DOI 10.1088/1361-6528/aa66ef; Valov I, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/25/254003; Wang W, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-018-07979-0; Wang ZR, 2017, NAT MATER, V16, P101, DOI [10.1038/nmat4756, 10.1038/NMAT4756]; Waser R, 2009, ADV MATER, V21, P2632, DOI 10.1002/adma.200900375; Yao J, 2010, NANO LETT, V10, P4105, DOI 10.1021/nl102255r; Yao P, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15199; Yoshida C, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2818691; Yu SM, 2018, P IEEE, V106, P260, DOI 10.1109/JPROC.2018.2790840; Zhu JD, 2020, APPL PHYS REV, V7, DOI 10.1063/1.5118217	40	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264846	10.1371/journal.pone.0264846	http://dx.doi.org/10.1371/journal.pone.0264846			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358187	Green Published, gold			2022-12-26	WOS:000799828800020
J	Akpan, GE; Bawo, L; Amo-Addae, M; Kennedy, J; Wesseh, CS; Whesseh, F; Adewuyi, P; Sanvee-Blebo, L; Babalola, J; Sesay, HWW; Yeabah, TO; Jackson, D; Shannon, F; Umeokonkwo, CD; Nyenswah, AW; Macauley, J; Jallah, W				Akpan, Godwin E.; Bawo, Luke; Amo-Addae, Maame; Kennedy, Jallah; Wesseh, C. Sanford; Whesseh, Faith; Adewuyi, Peter; Sanvee-Blebo, Lily; Babalola, Joseph; Sesay, Himiede W. W.; Yeabah, Trokon O.; Jackson, Dikena; Shannon, Fulton; Umeokonkwo, Chukwuma David; Nyenswah, Abraham W.; Macauley, Jane; Jallah, Wilhelmina			COVID-19 reinfection in Liberia: Implication for improving disease surveillance	PLOS ONE			English	Article								COVID-19 remains a serious disruption to human health, social, and economic existence. Reinfection with the virus intensifies fears and raises more questions among countries, with few documented reports. This study investigated cases of COVID-19 reinfection using patients' laboratory test results between March 2020 and July 2021 in Liberia. Data obtained from Liberia's Ministry of Health COVID-19 surveillance was analyzed in Excel 365 and Arc-GIS Pro 2.8.2. Results showed that with a median interval of 200 days (Range: 99-415), 13 out of 5,459 cases were identified and characterized as reinfection in three counties during the country's third wave of the outbreak. Eighty-six percent of the COVID-19 reinfection cases occurred in Montserrado County within high clusters, which accounted for over 80% of the randomly distributed cases in Liberia. More cases of reinfection occurred among international travelers within populations with high community transmissions. This study suggests the need for continued public education and surveillance to encourage longer-term COVID-19 preventive practices even after recovery.	[Akpan, Godwin E.; Amo-Addae, Maame; Whesseh, Faith; Adewuyi, Peter; Sanvee-Blebo, Lily; Babalola, Joseph; Sesay, Himiede W. W.; Umeokonkwo, Chukwuma David] African Field Epidemiol Network, Div Field Epidemiol Training Program, Monrovia, Liberia; [Bawo, Luke; Wesseh, C. Sanford; Jackson, Dikena; Shannon, Fulton] Minist Hlth, Dept Planning Res & Dev, Monrovia, Liberia; [Kennedy, Jallah] Rd Hlth Rd Rural & Vulnerable Populat Hlth, Off Execut Director, Galloway, NJ USA; [Yeabah, Trokon O.; Nyenswah, Abraham W.] Natl Publ Hlth Inst Liberia, Div Infect Dis & Epidemiol, Monrovia, Liberia; [Umeokonkwo, Chukwuma David] Alex Ekwueme Fed Univ Teaching Hosp, Dept Community Med, Abakaliki, Ebonyi State, Nigeria; [Macauley, Jane] Natl Publ Hlth Inst Liberia, Off Director Gen, Monrovia, Liberia; [Jallah, Wilhelmina] Minist Hlth, Off Minister, Monrovia, Liberia		Akpan, GE (corresponding author), African Field Epidemiol Network, Div Field Epidemiol Training Program, Monrovia, Liberia.	profjedidiah@yahoo.com	Adewuyi, Adebayo Peter/AAY-2190-2021; ADEWUYI, PETER/GVU-0444-2022; Umeokonkwo, Chukwuma David/U-7112-2019	Adewuyi, Adebayo Peter/0000-0001-8375-1632; Umeokonkwo, Chukwuma David/0000-0002-0050-2874; Akpan, Godwin/0000-0001-8204-9219				Abu-Raddad LJ, 2021, CLIN INFECT DIS, V73, pE1830, DOI 10.1093/cid/ciaa1846; Ahmadian S, 2021, CLIN CASE REP, V9, DOI 10.1002/ccr3.4257; Arcuri Hope, 2021, DELTA OTHER COVID VA; BNO, 2020, BNO NEWS; CDC, REINF COVID 19 CDC, P2021; CDC, 2021, CONT TRAC COVID 19 C, P1; dos Santos LA, 2021, J INFECTION, V82, P399, DOI 10.1016/j.jinf.2021.01.020; ECDC, 2021, RISK SARS COV 2 TRAN; Escando K, BMC INFECT DIS, V21, P1, DOI [10.1186/s12879-020, DOI 10.1186/S12879-020]; Faria J, 2021, STATITICA; Health Information and Quality Authority, 2021, DUR IMM PROT REINF; Ibn-Mohammed T, 2021, RESOUR CONSERV RECY, V164, DOI 10.1016/j.resconrec.2020.105169; Iwasaki A, 2021, LANCET INFECT DIS, V21, P3, DOI 10.1016/S1473-3099(20)30783-0; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n124; Mohsin AKM, 2021, SAGE OPEN, V11, DOI 10.1177/21582440211008875; Morgan A.K., 2021, SUSTAIN SCI PR POLIC, V17, P76, DOI [10.1080/15487733.2020.1860345, DOI 10.1080/15487733.2020.1860345]; National Public Health Emergency Operations Center Liberia, 2021, COVID 19 NAT GUID; National Public Health Emergency Operations Center Liberia, 2021, REV NAT COVID 19 GUI; National Public Health Emergency Operations Center Liberia, 2021, LIB COVID 19 DAIL SI, V503; Novazzi F, 2021, J MED VIROL, V93, P5648, DOI 10.1002/jmv.27066; O'Grady NP, 2002, CLIN INFECT DIS, V35, P1281, DOI 10.1086/344188; Reuters, 2021, GLOBAL NEWS; Sander J., 2010, ENCY MACHINE LEARNIN, P270, DOI [DOI 10.1007/978-0-387-30164-8_211, 10.1007/978-0-387-30164-8_211]; Schuchat A, 2020, MMWR-MORBID MORTAL W, V69, P551, DOI 10.15585/mmwr.mm6918e2; SeyedAlinaghi SeyedAhmad, 2020, World J Virol, V9, P79, DOI 10.5501/wjv.v9.i5.79; Sguazzin A., S AFRICA HAS FOUND 4, V2021, P1; Siraj A, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003055; Tang XJ, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.663045; Verschuur J, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0248818; Vitenu-Sackey PA, 2021, ECON FINANCE LETT, V8, P32, DOI 10.18488/journal.29.2021.81.32.43; Wang JZ, 2021, J INVEST MED, V69, P1253, DOI 10.1136/jim-2021-001853; Wilkinson E, 2021, PREPR SERV HLTH SCI, P27, DOI [10.1126/ science.abj4336, DOI 10.1126/SCIENCE.ABJ4336]; World Health Organisation, COVID 19 WEEKL EP UP, V2021; World Population Review, 2021, LIBERIA POPULATION 2; Zhang J, 2021, NATL SCI REV, V8, DOI 10.1093/nsr/nwab006	35	1	1	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265768	10.1371/journal.pone.0265768	http://dx.doi.org/10.1371/journal.pone.0265768			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324956	gold, Green Published			2022-12-26	WOS:000780951300070
J	Brown, K; Monk, J; Williams, J; Carroll, A; Harasti, D; Barrett, N				Brown, Kristy; Monk, Jacquomo; Williams, Joel; Carroll, Andrew; Harasti, David; Barrett, Neville			Depth and benthic habitat influence shallow and mesophotic predatory fishes on a remote, high-latitude coral reef	PLOS ONE			English	Article							COMMUNITIES; ECOSYSTEMS; REGRESSION; ELIZABETH; ABUNDANCE; MIDDLETON; SELECTION; PATTERNS; ISLANDS; BIOMASS	Predatory fishes on coral reefs continue to decline globally despite playing key roles in ecosystem functioning. Remote atolls and platform reefs provide potential refugia for predator populations, but quantitative information on their spatial distribution is required to establish accurate baselines for ongoing monitoring and conservation management. Current knowledge of predatory fish populations has been derived from targeted shallow diver-based surveys (< 15 m). However, the spatial distribution and extent of predatory fishes on outer mesophotic shelf environments has remained under described. Middleton Reef is a remote, high-latitude, oceanic platform reef that is located within a no-take area in the Lord Howe Marine Park off eastern Australia. Here we used baited remote underwater stereo video to sample predatory fishes across lagoon and outer shelf habitats from depths 0-100 m, extending knowledge on use of mesophotic depths and habitats. Many predatory fish demonstrated clear depth and habitat associations over this depth range. Carcharhinid sharks and Carangid fishes were the most abundant predators sampled on Middleton Reef, with five predatory fishes accounting for over 90% of the predator fish biomass. Notably, Galapagos shark (Carcharhinus galapagensis) and the protected black rockcod (Epinephelus daemelii) dominated the predator fish assemblage. A higher richness of predator fish species was sampled on reef areas north and south of the lagoon. The more exposed southern aspect of the reef supported a different suite of predator fish across mesophotic habitats relative to the assemblage recorded in the north and lagoonal habitats, a pattern potentially driven by differences in hard coral cover. Biomass of predatory fishes in the more sheltered north habitats was twice that of other areas, predominantly driven by high abundances of Galapagos shark. This work adds to the growing body of literature highlighting the conservation value of isolated oceanic reefs and the need to ensure that lagoon, shallow and mesophotic habitats in these systems are adequately protected, as they support vulnerable ecologically and economically important predator fish assemblages.	[Brown, Kristy; Monk, Jacquomo; Williams, Joel; Barrett, Neville] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Williams, Joel; Harasti, David] NSW Dept Primary Ind, Port Stephens Fisheries Inst, Fisheries Res, Taylors Beach, NSW, Australia; [Carroll, Andrew] Geosci Australia, Canberra, ACT, Australia	University of Tasmania; NSW Department of Primary Industries; Geoscience Australia	Monk, J (corresponding author), Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia.	jacquomo.monk@utas.edu.au			Australian Government's National Environmental Science Program (NESP); Parks Australia	Australian Government's National Environmental Science Program (NESP)(Australian Government); Parks Australia	This work was funded through the Australian Government's National Environmental Science Program (NESP) and Parks Australia.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Alexander MP, 2018, AM J KIDNEY DIS, V72, P325, DOI 10.1053/j.ajkd.2018.03.017; Althaus F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141039; Anderson M.J., 2008, PERMANOVA PRIMER GUI; [Anonymous], 2019, VEGAN COMMUNITY ECOL; Asher J, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-03568-1; Barley SC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0165113; Barnett A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036574; Bejarano I, 2014, CORAL REEFS, V33, P313, DOI 10.1007/s00338-014-1125-6; Boaden AE, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00292.1; Bosch NE, 2022, CONSERV BIOL, V36, DOI 10.1111/cobi.13807; Bureau of Meteorology, 2020, BUR MET CLIM GLOSS; Campanella F, FRONT MAR SCI, V8, P693; Cappo M., 2003, AQUATIC PROTECTED AR, P455; Carroll AG, 2021, POSTSURVEY REPORT; Choat JH, 2006, REPORT ECOLOGICAL SU, P66; Collins DL, 2017, METHODS ECOL EVOL, V8, P116, DOI 10.1111/2041-210X.12650; DeMartini EE, 2008, MAR ECOL PROG SER, V365, P199, DOI 10.3354/meps07501; Edgar GJ, 2018, BIODIVERSITY SURVEYS; Eisele MH, 2021, J FISH BIOL, V98, P1074, DOI 10.1111/jfb.14639; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Fisher R, 2018, ECOL EVOL, V8, P6104, DOI 10.1002/ece3.4134; Foo SA, 2021, ECOL APPL, V31, DOI 10.1002/eap.2213; Foster SD, 2020, METHODS ECOL EVOL, V11, P95, DOI 10.1111/2041-210X.13321; Friedlander AM, 2002, MAR ECOL PROG SER, V230, P253, DOI 10.3354/meps230253; Frisch AJ, 2016, CORAL REEFS, V35, P459, DOI 10.1007/s00338-016-1415-2; Gaither MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028913; Gibran FZ, 2007, NEOTROP ICHTHYOL, V5, P387, DOI 10.1590/S1679-62252007000300018; Glass JR, 2020, MAR ECOL PROG SER, V641, P195, DOI 10.3354/meps13305; Gove JM, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10581; Hardinge J, 2013, J EXP MAR BIOL ECOL, V449, P250, DOI 10.1016/j.jembe.2013.09.018; Harvey ES, 2012, FISH RES, V125, P108, DOI 10.1016/j.fishres.2012.01.026; Henry L., GGPLOT2; Hobbs JPA, 2008, CORAL REEFS, V27, P15, DOI 10.1007/s00338-007-0301-3; Hobson ES., 1963, FEEDING BEHAV 3 SPEC; Hoey A, 2018, STATUS TRENDS SHALLO, P1; Hopley D, 2007, GEOMORPHOLOGY OF THE GREAT BARRIER REEF: DEVELOPMENT, DIVERSITY, AND CHANGE, P1, DOI 10.1017/CBO9780511535543; HUGIE DM, 1994, J FISH BIOL, V45, P151, DOI 10.1111/j.1095-8649.1994.tb01090.x; HURVICH CM, 1989, BIOMETRIKA, V76, P297, DOI 10.2307/2336663; Jimenez J, 2019, BIOL CONSERV, V238, DOI 10.1016/j.biocon.2019.108234; Kahng SE, 2010, CORAL REEFS, V29, P255, DOI 10.1007/s00338-010-0593-6; Ke ZX, 2018, CORAL REEFS, V37, P919, DOI 10.1007/s00338-018-1717-7; Keene J., 2008, SEDIMENTOLOGY GEOMOR, P262; Kennedy DM, 2004, AUST J EARTH SCI, V51, P847, DOI 10.1111/j.1400-0952.2004.01089.x; Kleypas JA, 1999, AM ZOOL, V39, P146; Komyakova V, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202206; Komyakova V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083178; Langlois T, 2020, METHODS ECOL EVOL, V11, P1401, DOI 10.1111/2041-210X.13470; Laptikhovsky V, 2021, J APPL ICHTHYOL, V37, P38, DOI 10.1111/jai.14122; Larsen DP, 2008, J AGR BIOL ENVIR ST, V13, P243, DOI 10.1198/108571108X336593; Letessier TB, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000366; Lindfield SJ, 2016, CORAL REEFS, V35, P125, DOI 10.1007/s00338-015-1386-8; MacNeil MA, 2020, NATURE, V583, P801, DOI 10.1038/s41586-020-2519-y; Myers RA, 2007, SCIENCE, V315, P1846, DOI 10.1126/science.1138657; Oke PR, 2019, PROG OCEANOGR, V176, DOI 10.1016/j.pocean.2019.102139; Oxley W, 2004, MARINE SURVEYS UNDER; Papastamatiou YP, 2015, MAR ECOL PROG SER, V521, P155, DOI 10.3354/meps11110; Pinheiro HT, 2016, CORAL REEFS, V35, P139, DOI 10.1007/s00338-015-1381-0; Preti A., 2020, TROPHIC ECOLOGY 9 TO; Przeslawski R, 2011, DEEP-SEA RES PT II, V58, P959, DOI 10.1016/j.dsr2.2010.10.051; Ritchie EG, 2009, ECOL LETT, V12, P982, DOI 10.1111/j.1461-0248.2009.01347.x; Rocha LA, 2018, SCIENCE, V361, P281, DOI 10.1126/science.aaq1614; Roff G, 2016, TRENDS ECOL EVOL, V31, P395, DOI 10.1016/j.tree.2016.02.014; RStudio Team, 2020, R STUDIO INTEGRATED; Ruppert JLW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074648; Sherman CS, 2020, MAR ECOL PROG SER, V641, P145, DOI 10.3354/meps13307; Sih TL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11452-1; Sivy KJ, 2018, OIKOS, V127, P607, DOI 10.1111/oik.04647; Skinner C, 2020, MAR BIOL, V167, DOI 10.1007/s00227-019-3634-x; Skinner C, 2019, J ANIM ECOL, V88, P1564, DOI 10.1111/1365-2656.13056; Speed CW, 2019, ECOL EVOL, V9, P10553, DOI 10.1002/ece3.5575; Stefanoudis PV, 2019, ROY SOC OPEN SCI, V6, DOI 10.1098/rsos.190958; Stuart-Smith RD, 2013, NATURE, V501, P539, DOI 10.1038/nature12529; THRESHER RE, 1986, B MAR SCI, V38, P253; VERON JEN, 1979, AUST J MAR FRESH RES, V30, P203, DOI 10.1071/MF9790203; Hackradt CW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098206; Williams I. D., 2011, J MAR BIOL, V2011, P14, DOI DOI 10.1155/2011/826234; Williams J, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0206778; Woodroffe CD, 2004, CORAL REEFS, V23, P249, DOI 10.1007/s00338-004-0374-1	79	0	0	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265067	10.1371/journal.pone.0265067	http://dx.doi.org/10.1371/journal.pone.0265067			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324946	gold, Green Published, Green Accepted			2022-12-26	WOS:000780951300029
J	Luo, MD; Chen, Y; Cheng, Y; Li, N; Qing, H				Luo, Mengdi; Chen, Yang; Cheng, Yuan; Li, Na; Qing, He			Association between hematocrit and the 30-day mortality of patients with sepsis: A retrospective analysis based on the large-scale clinical database MIMIC-IV	PLOS ONE			English	Article								This research sought to ascertain the relationship between hematocrit (HCT) and mortality in patients with sepsis. Methods: A retrospective analysis was conducted on the clinical data of septic patients who were hospitalized between 2008 and 2019 in an advanced academic medical center in Boston, Massachusetts, registered in the Medical Information Mart for Intensive Care IV (MIMIC-IV) database, We analyzed basic information including gender, age, race, and types of the first admission, laboratory indicators including HCT, platelets, white blood cells, albumin, bilirubin, hemoglobin, and serum creatinine, and 30-day mortality. A Cox proportional hazards regression model was utilized to analyze the relationship between HCT and 30-day mortality in patients with sepsis. Results: This research recruited 2057 patients who met the research requirements from 2008 to 2019. According to the HCT level, it was classified into the low HCT level, the regular HCT level, and the high HCT level. The 30-day mortality rate was 62.6%, 27.5%, and 9.9% for patients with the low HCT level, the regular HCT level, and the high HCT level, respectively (p < 0.05). The multivariate Cox proportional hazard regression model analysis displayed that compared with patients with the regular HCT level, the 30-day mortality of patients with the low HCT level increased by 58.9% (hazard ratio = 1.589, 95% confidence interval (CI) = 1.009-2.979, p < 0.05). Conclusion: The low HCT level is an independent risk factor for the increase of the 30-day mortality in patients with sepsis and can be used as a significant predictor of the clinical outcome of sepsis.	[Luo, Mengdi; Chen, Yang; Cheng, Yuan; Qing, He] Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, ICU, Affiliated Hosp, Chengdu, Sichuan, Peoples R China; [Li, Na] Southwest Jiaotong Univ, Chengdu, Sichuan, Peoples R China	Southwest Jiaotong University; Southwest Jiaotong University	Qing, H (corresponding author), Southwest Jiaotong Univ, Peoples Hosp Chengdu 3, ICU, Affiliated Hosp, Chengdu, Sichuan, Peoples R China.	kk555888@126.com		Chen, Yang/0000-0002-2808-6286	Chengdu Science and Technology Bureau [2017FZ0058]; Health Department of Sichuan Province [17PJ474]	Chengdu Science and Technology Bureau; Health Department of Sichuan Province	This study was supported by (the Chengdu Science and Technology Bureau (No.2017FZ0058)) and (the Health Department of Sichuan Province (No.17PJ474)).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscrip.	Aird WC, 2003, MAYO CLIN PROC, V78, P869, DOI 10.4065/78.7.869; Arango-Granados María Camila, 2021, Rev. bras. ter. intensiva, V33, P154, DOI [10.5935/0103-507X.20210017, 10.5935/0103-507x.20210017]; Boffetta P, 2013, INT J EPIDEMIOL, V42, P601, DOI 10.1093/ije/dyt013; Cecconi M, 2018, LANCET, V392, P75, DOI 10.1016/S0140-6736(18)30696-2; Chaturvedi R, 2022, J INTENSIVE CARE MED, V37, P46, DOI 10.1177/0885066620967925; Chen JC, 2021, ARCH GYNECOL OBSTET, V303, P767, DOI 10.1007/s00404-020-05822-w; Danielski LG, 2020, INFLAMMATION, V43, P24, DOI 10.1007/s10753-019-01124-9; Fagerberg SK, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2100-3; Gong Yan, 2017, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V29, P481, DOI 10.3760/cma.j.issn.2095-4352.2017.06.001; Hu ZD, 2020, CLIN BIOCHEM, V77, P1, DOI 10.1016/j.clinbiochem.2020.01.001; Janz DR, 2013, CRIT CARE MED, V41, P784, DOI 10.1097/CCM.0b013e3182741a54; Johnson A, 2020, MIMIC-IV (version 0.4), DOI [10.13026/a3wn-hq05, DOI 10.13026/A3WN-HQ05]; Johnson AEW, 2018, J AM MED INFORM ASSN, V25, P32, DOI 10.1093/jamia/ocx084; Juncal VR, 2011, J BRAS PNEUMOL, V37, P85, DOI 10.1590/S1806-37132011000100013; Kempe DS, 2007, J MOL MED-JMM, V85, P269, DOI 10.1007/s00109-006-0123-8; Loisa P, 2003, ACTA ANAESTH SCAND, V47, P319, DOI 10.1034/j.1399-6576.2003.00004.x; Maharaj R, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.15305; Shankar-Hari M, 2016, CURR INFECT DIS REP, V18, DOI 10.1007/s11908-016-0544-7; Shankar-Hari M, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1276-7; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Stanski NL, 2020, NAT REV NEPHROL, V16, P20, DOI 10.1038/s41581-019-0199-3; Stavropoulos K, 2017, SEMIN THROMB HEMOST, V43, P591, DOI 10.1055/s-0037-1602663; Totsimon K, 2017, CLIN HEMORHEOL MICRO, V65, P119, DOI 10.3233/CH-16136; Zhang Shaolei, 2020, Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, V32, P1085, DOI 10.3760/cma.j.cn121430-20200714-00522; Zhang X, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/6804938	25	1	1	13	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265758	10.1371/journal.pone.0265758	http://dx.doi.org/10.1371/journal.pone.0265758			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324947	Green Published, gold			2022-12-26	WOS:000780951300069
J	Williams, G; Llewelyn, A; Thatcher, R; Hardisty, KM; Loddo, M				Williams, Gareth; Llewelyn, Alexander; Thatcher, Robert; Hardisty, Keeda-Marie; Loddo, Marco			Utilisation of semiconductor sequencing for the detection of predictive biomarkers in glioblastoma	PLOS ONE			English	Article							ADJUVANT TEMOZOLOMIDE; MOLECULAR-PATHOLOGY; GENE FUSIONS; MUTATION; RADIOTHERAPY; CONCOMITANT; MANAGEMENT; LANDSCAPE; IMPACT; TUMORS	The standard treatment for glioblastoma involves a combination of surgery, radiation and chemotherapy but have limited impact on survival. The exponential increase in targeted agents directed at pivotal oncogenic pathways now provide new therapeutic opportunities for this tumour type. However, lack of comprehensive precision oncology testing at diagnosis means such therapeutic opportunities are potentially overlooked. To investigate the role of semiconductor sequencing for detection of predictive biomarkers in routine glioblastoma samples we have undertaken analysis of test trending data generated by a clinically validated next generation sequencing platform designed to capture actionable genomic variants distributed across 505 genes. Analysis was performed across a cohort of 55 glioblastoma patients. Analysis of trending data has revealed a complex and rich actionable mutational landscape in which 166 actionable mutations were detected across 36 genes linked to 17 off label targeted therapy protocols and 111 clinical trials. The majority of patients harboured three or more actionable mutations affecting key cancer related regulatory networks including the PI3K/AKT/MTOR and RAS/RAF/MEK/MAPK signalling pathways, DNA-damage repair pathways and cell cycle checkpoints. Linkage with immunotherapy and PARP inhibitors was identified in 44% of glioblastoma patients as a consequence of alterations in DNA-damage repair genes. Taken together our data indicates that precision oncology testing utilising semiconductor sequencing can be used to identify a broad therapeutic armamentarium of targeted therapies and immunotherapies that can be potentially employed for the improved clinical management of glioblastoma patients.	[Williams, Gareth; Llewelyn, Alexander; Thatcher, Robert; Hardisty, Keeda-Marie; Loddo, Marco] Oncol UK Ltd, Cambridge, England		Williams, G; Loddo, M (corresponding author), Oncol UK Ltd, Cambridge, England.	gareth.williams@oncologica.com; marco.loddo@oncologica.com		Llewelyn, Alexander/0000-0003-2177-1421; Loddo, Marco/0000-0003-2815-6528				Alphandery E, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00879; Arkenau H-T., 2017, ONCOLOGYPRO; Berger AC, 2018, CANCER CELL, V33, P690, DOI 10.1016/j.ccell.2018.03.014; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; Bignell GR, 2010, NATURE, V463, P893, DOI 10.1038/nature08768; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Chae YK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-39594-4; Chae Young Kwang, 2018, Oncotarget, V9, P7949, DOI 10.18632/oncotarget.23742; Deans ZC, 2017, VIRCHOWS ARCH, V470, P5, DOI 10.1007/s00428-016-2025-7; Di Carlo DT, 2019, NEUROSURG REV, V42, P263, DOI 10.1007/s10143-017-0928-7; Di Stefano AL, 2015, CLIN CANCER RES, V21, P3307, DOI 10.1158/1078-0432.CCR-14-2199; Fulci G, 2000, ONCOGENE, V19, P3816, DOI 10.1038/sj.onc.1203700; Gaines ME., 2019, ASCO CONNECTION; Haslem Derrick S, 2018, Oncotarget, V9, P12316, DOI 10.18632/oncotarget.24384; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Kaley T, 2018, J CLIN ONCOL, V36, P3477, DOI 10.1200/JCO.2018.78.9990; Kalyana-Sundaram S, 2012, NEOPLASIA, V14, P702, DOI 10.1593/neo.12914; Kanemaru Y, 2019, ACTA NEUROPATHOL COM, V7, DOI 10.1186/s40478-019-0774-7; Kumar-Sinha C, 2015, GENOME MED, V7, DOI 10.1186/s13073-015-0252-1; Lawson NL, 2020, MODERN PATHOL, V33, P518, DOI 10.1038/s41379-019-0372-z; Lesueur P, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5413-y; Li MM, 2017, J MOL DIAGN, V19, P4, DOI 10.1016/j.jmoldx.2016.10.002; Lieberman Frank, 2017, F1000Res, V6, P1892, DOI 10.12688/f1000research.11493.1; Litak J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215347; Loddo M, 2020, J CLIN ONCOL, V38; Mamdani H, 2019, J CLIN ONCOL, V37; Marquart J, 2018, JAMA ONCOL, V4, P1093, DOI 10.1001/jamaoncol.2018.1660; Mateo J, 2018, ANN ONCOL, V29, P1895, DOI 10.1093/annonc/mdy263; Mertens F, 2015, NAT REV CANCER, V15, P371, DOI 10.1038/nrc3947; Moon JJ, 2019, EXP BIOL MED, V244, P227, DOI 10.1177/1535370219826031; Nduom EK, 2016, NEURO-ONCOLOGY, V18, P195, DOI 10.1093/neuonc/nov172; Nie Q, 2020, J CLIN NEUROSCI, V71, P311, DOI 10.1016/j.jocn.2019.11.035; Ohgaki H, 2007, AM J PATHOL, V170, P1445, DOI 10.2353/ajpath.2007.070011; Ostrom QT, 2018, JAMA ONCOL, V4, P1254, DOI 10.1001/jamaoncol.2018.1789; Pearson JRD, 2017, SIGNAL TRANSDUCT TAR, V2, DOI 10.1038/sigtrans.2017.40; Pikor L, 2013, CANCER METAST REV, V32, P341, DOI 10.1007/s10555-013-9429-5; Prelaj A, 2019, EUR J CANCER, V106, P144, DOI 10.1016/j.ejca.2018.11.002; Preusser M, 2011, ANN NEUROL, V70, P9, DOI 10.1002/ana.22425; Qin BD, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00229; Schwaederle M, 2015, J CLIN ONCOL, V33, P3817, DOI 10.1200/JCO.2015.61.5997; Senhaji N, 2017, BIOMED RES INT, V2017, DOI 10.1155/2017/8045859; Sharma P, 2020, NAT REV IMMUNOL, V20, P75, DOI 10.1038/s41577-020-0275-8; Shergalis A, 2018, PHARMACOL REV, V70, P412, DOI 10.1124/pr.117.014944; Shih K, 2018, NEURO-ONCOLOGY, V20, P17; Stransky N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5846; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Touat M, 2017, ANN ONCOL, V28, P1457, DOI 10.1093/annonc/mdx106; Tsimberidou Apostolia-Maria, 2017, JCO Precis Oncol, V2017, DOI 10.1200/PO.17.00002; Tuna Musaffe, 2019, Oncotarget, V10, P2095, DOI 10.18632/oncotarget.26777; Turnbull C, 2018, ANN ONCOL, V29, P784, DOI 10.1093/annonc/mdy054; Vikas P, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00570; Weinberg R, 2007, CYTOPLASMIC SIGNALLI, DOI [10.1201/9780429258794, DOI 10.1201/9780429258794]; Williams GH, 2012, J PATHOL, V226, P352, DOI 10.1002/path.3022; Williams GH, 2020, J CLIN ONCOL, V38; Woo Peter Y M, 2019, Oncotarget, V10, P3818; Yi M, 2018, MOL CANCER, V17, DOI 10.1186/s12943-018-0864-3	57	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0245817	10.1371/journal.pone.0245817	http://dx.doi.org/10.1371/journal.pone.0245817			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324914	Green Published, Green Submitted, gold			2022-12-26	WOS:000780951300001
J	Augustin, J; Wolf, S; Stephan, B; Augustin, M; Andrees, V				Augustin, Jobst; Wolf, Sandra; Stephan, Brigitte; Augustin, Matthias; Andrees, Valerie			Psoriasis comorbidities in Germany: A population-based study on spatiotemporal variations	PLOS ONE			English	Article							PREVALENCE	Psoriasis is a chronic disease with high impact on patients' health and their quality of life. Psoriasis often occurs along with other comorbidities, but it is not yet clear what role the comorbidities play in regional psoriasis prevalence. This study investigates the temporal and regional variation of the psoriasis comorbidities diabetes mellitus type II, obesity, hypertension, affective disorders in Germany and their association with psoriasis prevalence. This analysis based on the population set of ambulatory claims data (2010-2017) of the statutory health insurance (SHI) in Germany (approx. 70.3 million people in 2017). Psoriasis comorbidities rates were determined on county level. We performed descriptive spatiotemporal analyses of psoriasis comorbidity prevalence rates. In addition, we identified and compared spatial clusters and examined regional variations using spatial statistical methods. The results show strong regional variations (northeast to south gradient) and an increasing psoriasis prevalence (max. 28.8%) within the observation period. Considering the comorbidities, results indicate comparable spatial prevalence patterns for diabetes mellitus type II, obesity and hypertension. This means that the highest prevalence of comorbidities tends to be found where the psoriasis prevalence is highest. The spatiotemporal cluster analyses could once again confirm the results. An exception to this is to be found in the case of affective disorders with different spatial patterns. The results of the studies show the first spatiotemporal association between psoriasis prevalence and comorbidities in Germany. The causalities must be investigated in more detail in order to be able to derive measures for improved care.	[Augustin, Jobst; Wolf, Sandra; Stephan, Brigitte; Augustin, Matthias; Andrees, Valerie] Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf	Augustin, J (corresponding author), Univ Med Ctr Hamburg Eppendorf UKE, Inst Hlth Serv Res Dermatol & Nursing IVDP, Hamburg, Germany.	jo.augustin@uke.de						Andrees V, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-047806; Augustin J, 2020, J EUR ACAD DERMATOL, V34, P1736, DOI 10.1111/jdv.16228; Augustin J., 2017, GEOGRAFIE GESUNDHEIT; BESAG J, 1991, ANN I STAT MATH, V43, P1, DOI 10.1007/BF00116466; Boehncke WH, 2009, ACTAS DERMO-SIFILOGR, V100, P22, DOI 10.1016/S0001-7310(09)73374-5; Boehncke WH, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00579; Boehncke WH, 2015, LANCET, V386, P983, DOI 10.1016/S0140-6736(14)61909-7; Boehncke WH, 2011, EXP DERMATOL, V20, P303, DOI 10.1111/j.1600-0625.2011.01261.x; Campione Elena, 2021, J Exp Pharmacol, V13, P725, DOI 10.2147/JEP.S265632; Caputo V, 2021, GENES-BASEL, V12, DOI 10.3390/genes12091398; Caputo V, 2020, J CELL MOL MED, V24, P13554, DOI 10.1111/jcmm.15742; Cliff A, 1973, SPATIAL AUTOCORRELAT; Deutsches Institut fur Menschenrechte, 2021, ENTW MENSCH DEUTSCHL; Eklund A, 2015, BEESWARM BEE SWARM P; ESRI, 2020, FUNKT RAUML AUT GLOB; Gini C., 1914, METRON INT J STAT, V63, P1; Grintsova O, 2014, INT J EQUITY HEALTH, V13, DOI 10.1186/1475-9276-13-43; Han J, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0056-6; Hayashino Y, 2014, METABOLISM, V63, P431, DOI 10.1016/j.metabol.2013.08.018; HENSELER T, 1995, J AM ACAD DERMATOL, V32, P982, DOI 10.1016/0190-9622(95)91336-X; Ibanez B, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-60; Jacobson CC, 2011, J AM ACAD DERMATOL, V65, P870, DOI 10.1016/j.jaad.2009.05.047; Jensen P, 2016, DERMATOLOGY, V232, P633, DOI 10.1159/000455840; Kauhl B, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-017-5017-x; Kauhl B, 2016, INT J HEALTH GEOGR, V15, DOI 10.1186/s12942-016-0068-2; Kopec-Pyciarz K, 2018, MEDIAT INFLAMM, V2018, DOI 10.1155/2018/4016939; Kulldorff M, 2018, SATSCAN USER GUIDE; Maier W, 2013, DIABETIC MED, V30, pE78, DOI 10.1111/dme.12062; Mazzilli S, 2020, J DERMATOL, V47, P578, DOI 10.1111/1346-8138.15293; Michalek IM, 2017, J EUR ACAD DERMATOL, V31, P205, DOI 10.1111/jdv.13854; Molina-Leyva A, 2015, J EUR ACAD DERMATOL, V29, P1710, DOI 10.1111/jdv.12960; Nestle FO, 2009, NEW ENGL J MED, V361, P496, DOI 10.1056/NEJMra0804595; Olives C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060308; Parisi R, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1590; Peralta C, 2019, CUREUS, V11, DOI 10.7759/cureus.6369; Puig L, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010058; Radtke MA, 2017, J EUR ACAD DERMATOL, V31, P151, DOI 10.1111/jdv.13813; RCore Team, 2020, R LANG ENV STAT COMP; RKI, 2017, 12 MONTH PREV HYP GE; de Oliveira MDSP, 2015, AN BRAS DERMATOL, V90, P9, DOI 10.1590/abd1806-4841.20153038; Sommer R, 2019, HAUTARZT, V70, P520, DOI 10.1007/s00105-019-4411-y; Springate DA, 2017, BRIT J DERMATOL, V176, P650, DOI 10.1111/bjd.15021; Steffen A, 2020, J AFFECT DISORDERS, V271, P239, DOI 10.1016/j.jad.2020.03.082; Swart E, 2015, GESUNDHEITSWESEN, V77, P120, DOI [10.1055/s-0034-1396815, 10.1055/s-0035-1562981]; Swart E, 2014, ROUTINEDATEN GESUNDH, V2nd; Takeshita J, 2017, J AM ACAD DERMATOL, V76, P377, DOI 10.1016/j.jaad.2016.07.064; Tamayo T, 2016, DTSCH ARZTEBL INT, V113, P177, DOI 10.3238/arztebl.2016.0177; Trojacka Ewelina, 2015, Pol Merkur Lekarski, V38, P169; Voiculescu V M, 2014, J Med Life, V7, P468; Wolf S, 2022, HAUTARZT, V73, P15, DOI 10.1007/s00105-021-04914-1; World Health Organization, 2016, GLOBAL REPORT PSORIA	51	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265741	10.1371/journal.pone.0265741	http://dx.doi.org/10.1371/journal.pone.0265741			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316303	gold, Green Published			2022-12-26	WOS:000834238000036
J	Drouillard, KG; Tomkins, A; Lackie, S; Laengert, S; Baker, A; Clase, CM; De Lannoy, CF; Cavallo-Medved, D; Porter, LA; Rudman, RS				Drouillard, Ken G.; Tomkins, Amanda; Lackie, Sharon; Laengert, Scott; Baker, Allison; Clase, Catherine M.; De Lannoy, Charles F.; Cavallo-Medved, Dora; Porter, Lisa A.; Rudman, Rebecca S.			Fitted filtration efficiency and breathability of 2-ply cotton masks: Identification of cotton consumer categories acceptable for home-made cloth mask construction	PLOS ONE			English	Article							AIRBORNE TRANSMISSION; PERFORMANCE	The objective of this study was to characterize commercially-available cotton fabrics to determine their suitability as materials for construction of cloth masks for personal and public use to reduce infectious disease spread. The study focused on cottons because of their widespread availability, moderate performance and they are recommended for inclusion in home-made masks by international health authorities. Fifty-two cottons were analyzed by electron microscopy to determine fabric characteristics and fabric weights. Sixteen fabrics were selected to test for breathability and to construct 2-ply cotton masks of a standard design to use in quantitative fit testing on a human participant. Cotton mask fitted filtration efficiencies (FFEs) for 0.02-1 mu m ambient and aerosolized sodium chloride particles ranged from 40 to 66% compared with the mean medical mask FFE of 55 +/- 2%. Pressure differentials across 2-ply materials ranged from 0.57 to > 12 mm H2O/cm(2) on samples of equal surface area with 6 of 16 materials exceeding the recommended medical mask limit. Models were calibrated to predict 2-ply cotton mask FFEs and differential pressures for each fabric based on pore characteristics and fabric weight. Models indicated cotton fabrics from 6 of 9 consumer categories can produce cloth masks with adequate breathability and FFEs equivalent to a medical mask: T-shirt, fashion fabric, mass-market quilting cotton, home decor fabric, bed sheets and high-quality quilting cotton. Masks from one cloth mask and the medical mask were re-tested with a mask fitter to distinguish filtration from leakage. The fabric and medical masks had 3.7% and 41.8% leakage, respectively. These results indicate a well fitted 2-ply cotton mask with overhead ties can perform similarly to a disposable 3-ply medical mask on ear loops due primarily to the superior fit of the cloth mask which compensates for its lower material filtration efficiency.	[Drouillard, Ken G.; Lackie, Sharon] Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada; [Tomkins, Amanda] McMaster Univ, Sch Biomed Engn, Hamilton, ON, Canada; [Laengert, Scott; De Lannoy, Charles F.] McMaster Univ, Dept Chem Engn, Hamilton, ON, Canada; [Baker, Allison; Cavallo-Medved, Dora; Porter, Lisa A.] Univ Windsor, Dept Biomed Sci, Windsor, ON, Canada; [Clase, Catherine M.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Rudman, Rebecca S.] Community Volunteer Grp, Windsor Essex Sewing Force, Windsor, ON, Canada	University of Windsor; McMaster University; McMaster University; University of Windsor; McMaster University	Drouillard, KG (corresponding author), Univ Windsor, Great Lakes Inst Environm Res, Windsor, ON, Canada.	kgd@uwindsor.ca		Clase, Catherine/0000-0002-4538-5958; Porter, Lisa A./0000-0002-9234-1712	WE-Spark Igniting Discovery Grant; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant	WE-Spark Igniting Discovery Grant; Natural Sciences and Engineering Research Council (NSERC) Discovery Grant(Natural Sciences and Engineering Research Council of Canada (NSERC))	This research was funded by a WE-Spark Igniting Discovery Grant to KGD, LAP and RSR. https://www.wesparkhealth.com.The funders did not play a role in the study design, data collection, data analysis, decision to publish or preparation of the manuscript. However, LAP is the Executive Director of WE-SPARK Health Institute. Her role in the research described by this study was independent of the her role as Executive Director of the Health Institute. Additional support for fabric ESEM characterization was provided by a UNatural Sciences and Engineering Research Council (NSERC) Discovery Grant to KGD. https://www.nserc-crsng.gc.ca.The funders did not play a role in the study design, data collection, data analysis, decision to publish or preparation of the manuscript.	Akhtar J, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0035072; Aydin O, 2020, EXTREME MECH LETT, V40, DOI 10.1016/j.eml.2020.100924; Bhattacharjee S, 2021, ACS BIOMATER SCI ENG, V7, P2791, DOI 10.1021/acsbiomaterials.1c00368; Bhattacharjee S, 2020, BMJ OPEN RESPIR RES, V7, DOI 10.1136/bmjresp-2020-000698; Bowen L.E., 2010, APPL BIOSAF, V15, P67, DOI [10.1177/153567601001500204, DOI 10.1177/153567601001500204]; Brooks JT, 2021, MMWR-MORBID MORTAL W, V70, P254, DOI 10.15585/mmwr.mm7007e1externalicon; Burnett ML, 2020, DISASTER MED PUBLIC, V14, pE47, DOI 10.1017/dmp.2020.320; Chaabna K, 2021, INT J INFECT DIS, V104, P198, DOI 10.1016/j.ijid.2020.09.1434; Chiurciu IA, 2016, VISION 2020: INNOVATION MANAGEMENT, DEVELOPMENT SUSTAINABILITY, AND COMPETITIVE ECONOMIC GROWTH, 2016, VOLS I - VII, P2521; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Clapp PW, 2021, JAMA INTERN MED, V181, P463, DOI 10.1001/jamainternmed.2020.8168; Clase CM, 2020, MAYO CLIN PROC, V95, P2204, DOI 10.1016/j.mayocp.2020.07.020; COOPER DW, 1983, AM IND HYG ASSOC J, V44, P720, DOI 10.1202/0002-8894(1983)044<0720:CMFERP>2.3.CO;2; Crilley LR, 2021, ENVIRON SCI-NANO, V8, P1603, DOI 10.1039/d1en00277e; Das A, 2013, WOODHEAD PUBL SER TE, P41, DOI 10.1533/9780857095633.1.41; Dato VM, 2006, EMERG INFECT DIS, V12, P1033, DOI 10.3201/eid1206.051468; Davies A, 2013, DISASTER MED PUBLIC, V7, P413, DOI 10.1017/dmp.2013.43; Derrick JL, 2005, J HOSP INFECT, V59, P365, DOI 10.1016/j.jhin.2004.10.013; Eikenberry SE, 2020, INFECT DIS MODEL, V5, P293, DOI 10.1016/j.idm.2020.04.001; Eke UA, 2021, EXPERT REV RESP MED, V15, P441, DOI 10.1080/17476348.2021.1865812; Fischer EP, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abd3083; Greenhalgh T, 2021, LANCET, V397, P1603, DOI 10.1016/S0140-6736(21)00869-2; Hao WX, 2021, J OCCUP ENVIRON HYG, V18, P128, DOI 10.1080/15459624.2020.1868482; Howard J, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2014564118; Joo T, 2021, AEROSOL SCI TECH, V55, P930, DOI 10.1080/02786826.2021.1905149; Jung H, 2014, AEROSOL AIR QUAL RES, V14, P991, DOI 10.4209/aaqr.2013.06.0201; Konda A, 2020, ACS NANO, V14, P6339, DOI 10.1021/acsnano.0c03252; Kwong LH, 2021, ACS NANO, V15, P5904, DOI 10.1021/acsnano.0c10146; Leung NHL, 2020, NAT MED, V26, P676, DOI 10.1038/s41591-020-0843-2; Li J, 2021, OPEN FORUM INFECT DI, V8, DOI 10.1093/ofid/ofaa442; Lindsley WG, 2021, AEROSOL SCI TECH, V55, P1125, DOI 10.1080/02786826.2021.1933377; Lustig SR, 2020, ACS NANO, V14, P7651, DOI 10.1021/acsnano.0c03972; Lyu W, 2020, HEALTH AFFAIR, V39, P1419, DOI 10.1377/hlthaff.2020.00818; Mahase E, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n432; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Mueller AV, 2020, MATTER-US, V3, P950, DOI 10.1016/j.matt.2020.07.006; Neupane BB, 2020, PEERJ, V8, DOI 10.7717/peerj.9647; Neupane BB, 2019, PEERJ, V7, DOI 10.7717/peerj.7142; O'Kelly E, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245688; Okeagu CN, 2021, BEST PRAC RES-CL ANA, V35, P369, DOI 10.1016/j.bpa.2020.11.007; Radney JG, 2021, ACS NANO, V15, P12860, DOI 10.1021/acsnano.1c05182; Rengasamy S, 2010, ANN OCCUP HYG, V54, P789, DOI 10.1093/annhyg/meq044; Reutman SR, 2021, J OCCUP ENVIRON HYG, V18, P334, DOI 10.1080/15459624.2021.1925124; Richterich A, 2020, HEALTH SOCIOL REV, V29, P158, DOI 10.1080/14461242.2020.1784772; Roberge RJ, 2022, DISASTER MED PUBLIC, V16, P726, DOI 10.1017/dmp.2020.354; Robinson JF, 2021, PHYS FLUIDS, V33, DOI 10.1063/5.0047622; Rogak SN, 2021, AEROSOL SCI TECH, V55, P398, DOI 10.1080/02786826.2020.1855321; Sabnani N, 2022, TEXTILE, V20, P274, DOI 10.1080/14759756.2021.1929735; Shaffer RE, 2009, J NANOPART RES, V11, P1661, DOI 10.1007/s11051-009-9649-3; Shakya KM, 2017, J EXPO SCI ENV EPID, V27, P352, DOI 10.1038/jes.2016.42; Stutt ROJH, 2020, P ROY SOC A-MATH PHY, V476, DOI 10.1098/rspa.2020.0376; Ueki H, 2020, MSPHERE, V5, DOI 10.1128/mSphere.00637-20; van der Sande M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002618; Varallyay C, 2021, DISASTER MED PUBLIC, V15, pE26, DOI 10.1017/dmp.2020.262; Zangmeister CD, 2020, ACS NANO, V14, P9188, DOI 10.1021/acsnano.0c05025; Zhang RY, 2020, P NATL ACAD SCI USA, V117, P14857, DOI 10.1073/pnas.2009637117; Zhao M, 2020, NANO LETT, V20, P5544, DOI 10.1021/acs.nanolett.0c02211	57	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0264090	10.1371/journal.pone.0264090	http://dx.doi.org/10.1371/journal.pone.0264090			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316263	Green Published, gold			2022-12-26	WOS:000834238000006
J	Bone, J; Joseph, KS; Mayer, C; Platt, R; Lisonkova, S				Bone, Jeffrey; Joseph, K. S.; Mayer, Chantal; Platt, Robert; Lisonkova, Sarka			The association between pre-pregnancy body mass index and perinatal death and the role of gestational age at delivery	PLOS ONE			English	Article							MEDIATION ANALYSIS; MATERNAL OBESITY; CAUSAL INFERENCE; EFFECT DECOMPOSITION; NATURAL DIRECT; INFANT-DEATH; RISK; PREGNANCY; INTERVENTIONS; STILLBIRTH	IntroductionThe pathophysiology behind the association between obesity and perinatal death is not fully understood but may be in part due to higher rates of pregnancy complications at earlier gestation amongst obese women. We aimed to quantify the proportion of perinatal deaths amongst obese and overweight women mediated by gestational age at stillbirth or live birth. MethodsThe study included all singleton births at >= 20 weeks' gestation in British Columbia, 2004-2017, and excluded pregnancy terminations. The proportion of the association between BMI and perinatal death mediated by gestational age at delivery (in weeks) was estimated using natural effect models, with adjustment for potential confounders. Sensitivity analyses for unmeasured confounding and women missing BMI were conducted. ResultsOf 392,820 included women, 20.6% were overweight and 12.8% obese. Women with higher BMI had a lower gestational age at delivery. Perinatal mortality was 0.5% (1834 pregnancies); and was elevated in overweight (adjusted odds ratio [AOR] = 1.22, 95% confidence interval [CI] 1.08-1.37) and obese women (AOR = 1.55, 95% CI 1.36-1.77). Mediation analysis showed that 63.1% of the association between obesity and perinatal death was mediated by gestational age at delivery (natural indirect effect AOR = 1.32, 95% CI 1.23-1.42, natural direct effect AOR = 1.18, 95% CI 1.05-1.32). Similar, but smaller effects were seen when comparing overweight women vs. women with a normal BMI. Estimated effects were not affected by adjustment for additional risk factors for perinatal death or sensitivity analyses for missing data. ConclusionObese pregnancies have a higher risk of perinatal death in part mediated by a lower gestational age at delivery.	[Bone, Jeffrey; Joseph, K. S.; Mayer, Chantal; Lisonkova, Sarka] Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada; [Bone, Jeffrey; Joseph, K. S.; Mayer, Chantal; Lisonkova, Sarka] Childrens & Womens Hosp & Hlth Ctr British Columb, Vancouver, BC, Canada; [Platt, Robert] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Platt, Robert] McGill Univ, Dept Pediat, Montreal, PQ, Canada	University of British Columbia; McGill University; McGill University	Bone, J (corresponding author), Univ British Columbia, Dept Obstet & Gynaecol, Vancouver, BC, Canada.; Bone, J (corresponding author), Childrens & Womens Hosp & Hlth Ctr British Columb, Vancouver, BC, Canada.	jeffrey.bone@cw.bc.ca		Bone, Jeffrey/0000-0001-7704-1677; Lisonkova, Sarka/0000-0002-1220-310X	Sick Kids Foundation [NI18-1272]; Canadian Institute of Health Research; BC Children's Hospital Research Institute; Michael Smith Foundation for Health Research	Sick Kids Foundation; Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); BC Children's Hospital Research Institute; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research)	This research was supported by the Sick Kids Foundation (Grant #NI18-1272) and the Canadian Institute of Health Research. KSJ is supported by an Investigator award from the BC Children's Hospital Research Institute and SL is supported by a Scholar award from the Michael Smith Foundation for Health Research. RWP holds the Albert Boehringer I Chair in pharmacoepidemiology at McGill University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aune D, 2014, JAMA-J AM MED ASSOC, V311, P1536, DOI 10.1001/jama.2014.2269; Bodnar LM, 2015, AM J CLIN NUTR, V102, P858, DOI 10.3945/ajcn.115.112250; Bukowski R, 2011, JAMA-J AM MED ASSOC, V306, P2459, DOI 10.1001/jama.2011.1823; Cedergren MI, 2004, OBSTET GYNECOL, V103, P219, DOI 10.1097/01.AOG.0000107291.46159.00; Chen C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202183; Chu SY, 2007, AM J OBSTET GYNECOL, V197, P223, DOI 10.1016/j.ajog.2007.03.027; Cnattingius S, 2013, JAMA-J AM MED ASSOC, V309, P2362, DOI 10.1001/jama.2013.6295; Cole SR, 2002, INT J EPIDEMIOL, V31, P163, DOI 10.1093/ije/31.1.163; Daniel RM, 2015, BIOMETRICS, V71, P1, DOI 10.1111/biom.12248; Davies GAL, 2010, INT J GYNECOL OBSTET, V110, P167, DOI 10.1016/j.ijgo.2010.03.008; Denison FC, 2008, BJOG-INT J OBSTET GY, V115, P720, DOI 10.1111/j.1471-0528.2008.01694.x; Ding P, 2016, BIOMETRIKA, V103, P483, DOI 10.1093/biomet/asw012; Ezzati M, 2017, LANCET, V390, P2627, DOI 10.1016/S0140-6736(17)32129-3; Frosst G, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0563-7; Greenland S, 2003, EPIDEMIOLOGY, V14, P300, DOI 10.1097/00001648-200305000-00009; Harper LM, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.04.028; Hernan MA, 2008, INT J OBESITY, V32, pS8, DOI 10.1038/ijo.2008.82; Hernan MA, 2004, J EPIDEMIOL COMMUN H, V58, P265, DOI 10.1136/jech.2002.006361; Hernan MA, 2011, EPIDEMIOLOGY, V22, P368, DOI 10.1097/EDE.0b013e3182109296; Imai K, 2010, STAT SCI, V25, P51, DOI 10.1214/10-STS321; Joseph K S, 2004, J Obstet Gynaecol Can, V26, P953; Joseph KS, 2018, ACTA OBSTET GYN SCAN, V97, P454, DOI 10.1111/aogs.13194; Khatibi A, 2012, AM J OBSTET GYNECOL, V207, DOI 10.1016/j.ajog.2012.06.002; Kristensen J, 2005, BJOG-INT J OBSTET GY, V112, P403, DOI 10.1111/j.1471-0528.2005.00437.x; Lange T, 2012, AM J EPIDEMIOL, V176, P190, DOI 10.1093/aje/kwr525; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lisonkova S, 2017, JAMA-J AM MED ASSOC, V318, P1777, DOI 10.1001/jama.2017.16191; Navaneelan T., ADJUSTING SCALES OBE; Ovesen P, 2011, OBSTET GYNECOL, V118, P305, DOI 10.1097/AOG.0b013e3182245d49; Pearl J, 2010, EPIDEMIOLOGY, V21, P872, DOI 10.1097/EDE.0b013e3181f5d3fd; RCore Team, 2020, R LANG ENV STAT COMP; Rubin DB., 1987, MULTIPLE IMPUTATION, DOI 10.1002/9780470316696; Services PB., BRIT COLUMBIA PERINA; Steen J., MEDFLEX R PACKAGE FL; Stephansson O, 2001, AM J OBSTET GYNECOL, V184, P463, DOI 10.1067/mob.2001.109591; Tennant PWG, 2011, HUM REPROD, V26, P1501, DOI 10.1093/humrep/der052; van der Laan MJ, 2005, AM J EPIDEMIOL, V162, P621, DOI 10.1093/aje/kwi256; VanderWeele TJ, 2019, EUR J EPIDEMIOL, V34, pCP3, DOI 10.1007/s10654-019-00494-6; VanderWeele TJ, 2016, INT J EPIDEMIOL, V45, P1904, DOI 10.1093/ije/dyw277; VanderWeele TJ, 2016, ANNU REV PUBL HEALTH, V37, P17, DOI 10.1146/annurev-publhealth-032315-021402; VanderWeele TJ, 2014, EPIDEMIOLOGY, V25, P300, DOI 10.1097/EDE.0000000000000034; VanderWeele TJ, 2013, J CAUSAL INFERENCE, V1, P1, DOI 10.1515/jci-2012-0002; VanderWeele TJ, 2009, STAT INTERFACE, V2, P457; Vansteelandt S., 2012, EPIDEMIOL METHOD, V1, P131, DOI DOI 10.1515/2161-962X.1014; Vansteelandt S, 2017, EPIDEMIOLOGY, V28, P258, DOI 10.1097/EDE.0000000000000596; Vansteelandt S, 2012, BIOMETRICS, V68, P1019, DOI 10.1111/j.1541-0420.2012.01777.x; Vogel L, 2017, CAN MED ASSOC J, V189, pE1202, DOI 10.1503/cmaj.109-5472; Yao RF, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2014.01.044	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264565	10.1371/journal.pone.0264565	http://dx.doi.org/10.1371/journal.pone.0264565			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320271	Green Published, gold			2022-12-26	WOS:000784240600012
J	DeRose, L; Kim, J; Farahmand, M; Shinbashi, MY; Joo, NS; Wine, JJ				DeRose, Lesje; Kim, Jeeyeon; Farahmand, Miesha; Shinbashi, Meagan Y.; Joo, Nam Soo; Wine, Jeffrey J.			Variation in CFTR-dependent 'beta-sweating' among healthy adults	PLOS ONE			English	Article							CONDUCTANCE REGULATOR GENE; MESSENGER-RNA TRANSCRIPTS; CYSTIC-FIBROSIS; CODING SEQUENCES; CELL-TYPES; SECRETION; PENETRANCE; DELETION	The genetic disease cystic fibrosis (CF) results when mutations in the gene for the anion channel CFTR reduce CFTR's activity below a critical level. CFTR activity = N center dot P-O center dot gamma (number of channels x open probability x channel conductance). Small molecules are now available that partially restore CFTR function with dramatic improvements in health of CF subjects. Continued evaluation of these and other compounds in development will be aided by accurate assessments of CFTR function. However, measuring CFTR activity in vivo is challenging and estimates vary widely. The most accurate known measure of CFTR activity in vivo is the 'beta/M' ratio of sweat rates, which is produced by stimulation with a beta-adrenergic agonist cocktail referenced to the same individual's methacholine-stimulated sweat rate. The most meaningful metric of CFTR activity is to express it as a percent of normal function, so it is critical to establish beta/M carefully in a population of healthy control subjects. Here, we analyze beta/M from a sample of 50 healthy adults in which sweat rates to cholinergic and beta-adrenergic agonists were measured repeatedly (3 times) in multiple, (~50) identified sweat glands from each individual (giving ~20,000 measurements). The results show an approximately 7-fold range, 26-187% of the WT average set to 100%. These provide a benchmark against which other measures of CFTR activity can be compared. Factors contributing to beta/M variation in healthy controls are discussed.	[DeRose, Lesje; Kim, Jeeyeon; Farahmand, Miesha; Shinbashi, Meagan Y.; Joo, Nam Soo; Wine, Jeffrey J.] Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA; [Wine, Jeffrey J.] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA; [Wine, Jeffrey J.] Stanford Univ, Dept Psychol, Stanford, CA 94305 USA; [DeRose, Lesje] UCSF Benioff Childrens Hosp, Dept Pediat, Oakland, CA USA; [Kim, Jeeyeon] Tulane Univ, Sch Med, Dept Pediat, New Orleans, LA 70118 USA; [Farahmand, Miesha] Stanford Univ, Sch Med, Dept Phys Med & Rehabil, Stanford, CA USA; [Shinbashi, Meagan Y.] Virginia Commonwealth Univ, Med Coll Virginia, Sch Med, Richmond, VA 23298 USA	Stanford University; Stanford University; Stanford University; University of California System; University of California San Francisco; UCSF Medical Center; UCSF Benioff Children's Hospital Oakland; Tulane University; Stanford University; Virginia Commonwealth University	Wine, JJ (corresponding author), Stanford Univ, Cyst Fibrosis Res Lab, Stanford, CA 94305 USA.; Wine, JJ (corresponding author), Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA.; Wine, JJ (corresponding author), Stanford Univ, Dept Psychol, Stanford, CA 94305 USA.	wine@stanford.edu			JJW-Cystic Fibrosis Foundation Therapeutics [WINE17G1]; Cystic Fibrosis Research Inc.	JJW-Cystic Fibrosis Foundation Therapeutics; Cystic Fibrosis Research Inc.	Funding: JJW-Cystic Fibrosis Foundation Therapeutics, Grant WINE17G1 http://www.cff.org/ research/cfft/ and Cystic Fibrosis Research Inc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou Alaiwa MH, 2014, P NATL ACAD SCI USA, V111, P18703, DOI 10.1073/pnas.1422091112; BEHM JK, 1987, PEDIATR RES, V22, P271, DOI 10.1203/00006450-198709000-00007; Bishop MD, 2005, HUM GENET, V118, P372, DOI 10.1007/s00439-005-0059-z; Callen A, 2000, J PEDIATR-US, V137, P849, DOI 10.1067/mpd.2000.109198; Char JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088564; CHU CS, 1991, EMBO J, V10, P1355, DOI 10.1002/j.1460-2075.1991.tb07655.x; CHU CS, 1993, NAT GENET, V3, P151, DOI 10.1038/ng0293-151; CHU CS, 1992, J CLIN INVEST, V90, P785, DOI 10.1172/JCI115952; Collaco JM, 2016, AM J RESP CRIT CARE, V194, P1375, DOI 10.1164/rccm.201603-0459OC; Cuppens H, 1998, J CLIN INVEST, V101, P487, DOI 10.1172/JCI639; DELANEY SJ, 1993, NAT GENET, V4, P426, DOI 10.1038/ng0893-426; EMRICH HM, 1968, PEDIATR RES, V2, P464, DOI 10.1203/00006450-196811000-00004; Joo NS, 2001, AM J PHYSIOL-LUNG C, V281, pL458, DOI 10.1152/ajplung.2001.281.2.L458; Kuno Y., 1956, HUMAN PERSPIRATION; Miller AC, 2020, P NATL ACAD SCI USA, V117, P1621, DOI 10.1073/pnas.1914912117; Pezzulo AA, 2012, NATURE, V487, P109, DOI 10.1038/nature11130; Quinton P, 2012, AM J RESP CRIT CARE, V186, P732, DOI 10.1164/rccm.201205-0922OC; REDDY MM, 1992, AM J PHYSIOL, V262, pC891, DOI 10.1152/ajpcell.1992.262.4.C891; REDDY MM, 1992, AM J PHYSIOL, V262, pC287, DOI 10.1152/ajpcell.1992.262.2.C287; Reddy MM, 1997, AM J PHYSIOL-CELL PH, V273, pC426, DOI 10.1152/ajpcell.1997.273.2.C426; Reddy MM, 1996, AM J PHYSIOL-CELL PH, V271, pC486, DOI 10.1152/ajpcell.1996.271.2.C486; Rosen BH, 2018, AM J RESP CRIT CARE, V197, P1308, DOI 10.1164/rccm.201708-1616OC; SATO K, 1983, AM J PHYSIOL, V245, pR203, DOI 10.1152/ajpregu.1983.245.2.R203; SATO K, 1993, J MEMBRANE BIOL, V134, P93; SATO K, 1984, J CLIN INVEST, V73, P1763, DOI 10.1172/JCI111385; SATO K, 1988, J LAB CLIN MED, V111, P511; Shah VS, 2016, P NATL ACAD SCI USA, V113, P5382, DOI 10.1073/pnas.1604905113; SUZUKI Y, 1991, J MEMBRANE BIOL, V123, P33, DOI 10.1007/BF01993960; TAKEMURA T, 1991, J MEMBRANE BIOL, V119, P211, DOI 10.1007/BF01868726; Toyomoto T, 1997, AM J PHYSIOL-REG I, V273, pR270, DOI 10.1152/ajpregu.1997.273.1.R270; Vecchio-Pagan Briana, 2016, Hum Genome Var, V3, P16038; Willmott AGB, 2021, J CYST FIBROS, V20, P485, DOI 10.1016/j.jcf.2020.07.013; Wilschanski M, 2006, AM J RESP CRIT CARE, V174, P787, DOI 10.1164/rccm.200509-1377OC; Wine JJ, 2019, J CYST FIBROS, V18, P8, DOI 10.1016/j.jcf.2018.10.005; Wine JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077114; Wine JJ, 2011, METHODS MOL BIOL, V742, P93, DOI 10.1007/978-1-61779-120-8_6; Zlotogora J, 2003, GENET MED, V5, P347, DOI 10.1097/01.GIM.0000086478.87623.69	37	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265432	10.1371/journal.pone.0265432	http://dx.doi.org/10.1371/journal.pone.0265432			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312728	Green Published, gold			2022-12-26	WOS:000803647900037
J	Lee, S; Lee, HJ; Lee, KG; Kim, J				Lee, Sami; Lee, Haeng-Jin; Lee, Kyoung Geun; Kim, Jihan			Obesity and high myopia in children and adolescents: Korea National Health and Nutrition Examination Survey	PLOS ONE			English	Article							PREVALENCE; RISK; EPIDEMIOLOGY; REFRACTION; ETIOLOGY	PurposeThe prevalence of both obesity and myopia are increasing in Korean children and adolescents. The purpose of this study is to examine the impact of obesity on the prevalence of myopia in Korean children and adolescents. MethodsThis study used the data of a nationally representative cross-sectional survey, the Korea National Health and Nutrition Examination Survey (KNHANES) VII conducted from 2016 to 2018. Of the 1237 children and adolescents aged 5-18 years who participated in the KNHANES VII and underwent ophthalmologic examinations for the survey, 1114 were selected for review, excluding those whose data on refractive error, family history of myopia, or waist circumference were missing. Body mass index (BMI) was classified into four groups: underweight (< 5th percentile), normal weight (>= 5th percentile, < 85th percentile), overweight (>= 85th percentile, < 95th percentile), and obese (>= 95th percentile). Myopia was defined by the level of refractive error <= -0.5 diopters (D) and classified as mild (<= -0.5 D, > -3.0 D), moderate (<= -3.0 D, > -6.0 D), or high (<= -6.0 D) myopia. The relationship between BMI and myopia was analyzed using complex sample logistic regression. Age and family history were corrected followed by an analysis of the odds ratios. ResultsCompared to those with normal weights (controls), being underweight, overweight, or obese showed no significant odds of developing mild and moderate myopia. Conversely, when compared with that of controls, the odds ratio of developing high myopia in the underweight, overweight, and obese groups was 0.77 (95% CI, 0.22-2.65), 1.37 (95% CI, 0.51-3.66), and 3.77 (95% CI, 1.98-7.16), respectively. Furthermore, in a separate analysis by sex and BMI, the odds ratio of developing high myopia was 2.84 (95% CI, 1.10-7.35) in boys with obesity and 4.23 (95% CI,1.19-15.09) and 5.04 (95% CI,1.77-14.34) in overweight and obese girls, respectively. ConclusionsAn association exists between obesity in childhood and adolescence and high myopia. Being overweight in girls was also found to be associated with high myopia. Thus, efforts to maintain a healthy weight during childhood and adolescence are of great importance.	[Lee, Sami] Chungnam Natl Univ Sejong Hosp, Dept Family Med, Sejong, South Korea; [Lee, Haeng-Jin] Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Res Inst Clin Med, Biomed Res Inst, Jeonju, South Korea; [Lee, Haeng-Jin] Jeonbuk Natl Univ Coll Med, Dept Ophthalmol, Jeonju, South Korea; [Lee, Kyoung Geun] Geumnam Publ Hlth Ctr, Sejong, South Korea; [Kim, Jihan] Sejong Trinium Womans Hosp, Dept Family Med, Sejong, South Korea; [Kim, Jihan] Chungnam Natl Univ, Res Inst Med Sci, Dept Family Med, Sch Med, Daejeon, South Korea	Jeonbuk National University; Jeonbuk National University Hospital; Chungnam National University	Lee, HJ (corresponding author), Jeonbuk Natl Univ, Jeonbuk Natl Univ Hosp, Res Inst Clin Med, Biomed Res Inst, Jeonju, South Korea.; Lee, HJ (corresponding author), Jeonbuk Natl Univ Coll Med, Dept Ophthalmol, Jeonju, South Korea.	leehaengjin@hanmail.net		Lee, Haeng Jin/0000-0002-5824-7589; Kim, Jihan/0000-0003-1364-5169	National Research Foundation of Korea (NRF) - Korea government (MSIT) [2021R1G1A1009844]	National Research Foundation of Korea (NRF) - Korea government (MSIT)(National Research Foundation of KoreaMinistry of Science, ICT & Future Planning, Republic of Korea)	This work is supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2021R1G1A1009844). The funding organization had no role in the design or conduct of this research.	Cordain L, 2002, ACTA OPHTHALMOL SCAN, V80, P125, DOI 10.1034/j.1600-0420.2002.800203.x; Cumberland PM, 2018, BRIT J OPHTHALMOL, V102, P1407, DOI 10.1136/bjophthalmol-2017-311557; Fredrick DR, 2002, BRIT MED J, V324, P1195, DOI 10.1136/bmj.324.7347.1195; Furushima M, 1999, JPN J OPHTHALMOL, V43, P398, DOI 10.1016/S0021-5155(99)00098-2; Galvis V, 2016, MED HYPOTHESES, V90, P32, DOI 10.1016/j.mehy.2016.02.006; Gunes Alime, 2015, Korean J Ophthalmol, V29, P220, DOI 10.3341/kjo.2015.29.4.220; Harrington SC, 2019, BRIT J OPHTHALMOL, V103, P1803, DOI [10.1136/bjophthalmol-2018-313325, 10.1136/bjophthalmol-2019-315509]; Holden BA, 2016, OPHTHALMOLOGY, V123, P1036, DOI 10.1016/j.ophtha.2016.01.006; Huang HM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140419; Jung SK, 2012, INVEST OPHTH VIS SCI, V53, P5579, DOI 10.1167/iovs.12-10106; Kim H, 2020, BMC OPHTHALMOL, V20, DOI 10.1186/s12886-020-1316-6; Kim Y, 2014, EPIDEMIOL HEALTH, V36, DOI 10.4178/epih/e2014002; Korean Ministry of Health and Welfare Korea Centers for Disease Control and Prevention, KOREA YOUTH RISK BEH; Kumar S, 2017, MAYO CLIN PROC, V92, P251, DOI 10.1016/j.mayocp.2016.09.017; Lee DC, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18926-2; Lim DH, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0207690; Lin SC, 2016, ASIA-PAC J OPHTHALMO, V5, P115, DOI 10.1097/APO.0000000000000169; Morgan IG, 2012, LANCET, V379, P1739, DOI 10.1016/S0140-6736(12)60272-4; Sampasa-Kanyinga H, 2020, OBES SCI PRACT, V6, P196, DOI 10.1002/osp4.389; Saw SM, 2002, INVEST OPHTH VIS SCI, V43, P1408; Sinha R, 2002, NEW ENGL J MED, V346, P802, DOI 10.1056/NEJMoa012578; Tideman JWL, 2018, BRIT J OPHTHALMOL, V102, P243, DOI 10.1136/bjophthalmol-2017-310292; Warner N, 2016, CURR OPIN OPHTHALMOL, V27, P402, DOI 10.1097/ICU.0000000000000292; Wen LB, 2020, BRIT J OPHTHALMOL, V104, P1542, DOI 10.1136/bjophthalmol-2019-315258; Wong TY, 2014, AM J OPHTHALMOL, V157, P9, DOI 10.1016/j.ajo.2013.08.010; World Health Organization, OB OV; Yi DY, 2019, PEDIATR GASTROENTERO, V22, P1, DOI 10.5223/pghn.2019.22.1.1; Yoon Kyung-Chul, 2011, Korean J Ophthalmol, V25, P421, DOI 10.3341/kjo.2011.25.6.421	28	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265317	10.1371/journal.pone.0265317	http://dx.doi.org/10.1371/journal.pone.0265317			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333875	gold, Green Published			2022-12-26	WOS:000784335700015
J	Modrzejewska, J; Modrzejewska, A; Czepczor-Bernat, K; Matusik, P				Modrzejewska, Justyna; Modrzejewska, Adriana; Czepczor-Bernat, Kamila; Matusik, Pawel			The role of body mass index, healthy eating-related apps and educational activities on eating motives and behaviours among women during the COVID-19 pandemic: A cross sectional study	PLOS ONE			English	Article							MINDFULNESS-BASED INTERVENTIONS; WEIGHT-LOSS; SMARTPHONE; OBESITY	The COVID-19 related lockdown made it much more difficult for people to control their eating behaviours and body weight with the methods and means they had used before. This is reflected in reports that show that eating behaviours deteriorated significantly during the COVID-19 pandemic (including in Poland). Therefore, it is important to determine what factors may be conducive to healthy eating behaviours among people with different BMI. As previous studies show, the use of healthy eating related-apps and training programs may be a protective factor against the development of unhealthy eating behaviours. Therefore, it is worth checking whether their action will be a protective factor during COVID-19. The aim of this cross sectional study was to analyse whether the current use of healthy eating-related apps and previous participation in training in this field (educational activities) as well as body mass index may play a role in eating motives and behaviours among women during COVID-19. Our final sample included 1,447 women (age: M = 31.34 +/- 11.05). Participants completed: the Eating Motivation Survey, the Emotional Overeating Questionnaire, the Mindful Eating Questionnaire, socio-demographic survey and questions about healthy eating-related apps and training (educational activities). Referring to the selected significant results, our study shows that during COVID-19, the use of healthy eating-related apps alone, as well as the use of apps and prior training participation promote healthy eating motives and behaviours. It suggests that promoting the use of healthy eating applications and the acquisition of knowledge and skills in this field could be one way of shaping resources that can be effectively used to deal with crisis situations.	[Modrzejewska, Justyna] Univ Bielsko Biala, Inst Pedag, Bielsko Biala, Poland; [Modrzejewska, Adriana] Med Univ Silesia, Sch Hlth Sci Katowice, Dept Psychol, Katowice, Poland; [Czepczor-Bernat, Kamila] Univ Wroclaw, Inst Psychol, Wroclaw, Poland; [Matusik, Pawel] Med Univ Silesia, Fac Med Sci Katowice, Dept Pediat Pediat Obes & Metab Bone Dis, Katowice, Poland	University of Bielsko-Biala; Medical University Silesia; University of Wroclaw; Medical University Silesia	Modrzejewska, J (corresponding author), Univ Bielsko Biala, Inst Pedag, Bielsko Biala, Poland.	jmodrzejewska@ath.bielsko.pl	Modrzejewska, Justyna/ABE-7863-2021	Modrzejewska, Justyna/0000-0002-6243-8150; Czepczor-Bernat, Kamila/0000-0002-1707-0000	University of Bielsko-Biala, Poland	University of Bielsko-Biala, Poland	The publication is partially financed by University of Bielsko-Biala, Poland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accenture Consulting, 2016, ACC 2016 COST SURV P; Al-Musharaf S, 2020, NUTRIENTS, V12, DOI 10.3390/nu12102923; Allman-Farinelli M, 2017, CURR DIABETES REP, V17, DOI 10.1007/s11892-017-0937-5; Ang C, 2020, FITNESS APPS GREW NE; Armitage CJ, 2015, J PUBLIC HEALTH-UK, V37, P438, DOI 10.1093/pubmed/fdv054; Artiles RF, 2019, OBES REV, V20, P1619, DOI 10.1111/obr.12918; Bittmann RM, 2007, EXPERT SYST, V24, P171, DOI 10.1111/j.1468-0394.2007.00428.x; Carriere K, 2018, OBES REV, V19, P164, DOI 10.1111/obr.12623; Carroll EA, 2013, INT CONF AFFECT, P252, DOI 10.1109/ACII.2013.48; Carter MC, 2013, BRIT J NUTR, V109, P539, DOI 10.1017/S0007114512001353; Carter MC, 2013, J MED INTERNET RES, V15, DOI 10.2196/jmir.2283; Chacko SA, 2016, COMPLEMENT THER MED, V28, P13, DOI 10.1016/j.ctim.2016.07.001; Ismail LC, 2021, BRIT J NUTR, V126, P757, DOI 10.1017/S0007114520004547; Chen J, 2017, J HUM NUTR DIET, V30, P439, DOI 10.1111/jhn.12446; Chen PJ, 2020, FOODS, V9, DOI 10.3390/foods9121898; Clementi C, 2017, J NUTR EDUC BEHAV, V49, P352, DOI 10.1016/j.jneb.2017.01.016; Coughlin Steven S, 2015, Jacobs J Food Nutr, V2, P021; Di Renzo L, 2020, J TRANSL MED, V18, DOI 10.1186/s12967-020-02399-5; Drew DA, 2020, SCIENCE, V368, P1362, DOI 10.1126/science.abc0473; Duncan MJ, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17176200; Ferrara G, 2019, JMIR MHEALTH UHEALTH, V7, DOI 10.2196/mhealth.9232; Fila SA, 2006, INT J BEHAV NUTR PHY, V3, DOI 10.1186/1479-5868-3-11; Franco RZ, 2016, JMIR MHEALTH UHEALTH, V4, DOI 10.2196/mhealth.5846; Gasser R, 2006, LECT NOTES COMPUT SC, V3962, P27; Goetzel RZ, 2016, N C MED J, V67, P428, DOI [10.18043/ncm.67.6.428, DOI 10.18043/NCM.67.6.428]; Hutchesson MJ, 2015, J ACAD NUTR DIET, V115, P87, DOI 10.1016/j.jand.2014.07.036; Khazen W, 2020, J MED INTERNET RES, V22, DOI 10.2196/15619; Kondylakis H, 2020, J MED INTERNET RES, V22, DOI 10.2196/23170; Konttinen H, 2020, P NUTR SOC, V79, P283, DOI 10.1017/S0029665120000166; Kose G, 2020, PROG NUTR, V22, P528, DOI 10.23751/pn.v22i2.9268; Krebs P, 2015, JMIR MHEALTH UHEALTH, V3, P107, DOI 10.2196/mhealth.4924; Kristeller J, 2014, MINDFULNESS, V5, P282, DOI 10.1007/s12671-012-0179-1; Lyzwinski LN, 2019, JMIR MENT HEALTH, V6, DOI 10.2196/12820; Macht M, 2011, EMOTION REGULATION AND WELL-BEING, P281, DOI 10.1007/978-1-4419-6953-8_17; Maffoni S. I., 2021, NFS Journal, V22, P6, DOI 10.1016/j.nfs.2020.12.002; Mantzios M, 2015, CURR OBES REP, V4, P141, DOI 10.1007/s13679-014-0131-x; Marty Lucile, 2021, Appetite, V157, P105005, DOI 10.1016/j.appet.2020.105005; Masheb RM, 2006, INT J EAT DISORDER, V39, P141, DOI 10.1002/eat.20221; Matsungo Tonderayi Mathew, 2020, BMJ Nutr Prev Health, V3, P205, DOI 10.1136/bmjnph-2020-000124; Mattioli AV, 2020, EUR J CLIN NUTR, V74, P852, DOI 10.1038/s41430-020-0646-z; Mendiola MF, 2015, JMIR MHEALTH UHEALTH, V3, DOI 10.2196/mhealth.4283; O'Reilly GA, 2014, OBES REV, V15, P453, DOI 10.1111/obr.12156; Obra-Ratwatte R, 2021, GREAT TIME UPSKILL M; Pellegrini Christine A, 2015, Adv Health Care Technol, V1, P13; Perkins S, 2020, AM J LIFESTYLE MED, V14, P316, DOI 10.1177/1559827619872733; Phillipou A, 2020, INT J EAT DISORDER, V53, P1158, DOI 10.1002/eat.23317; Renner B, 2012, APPETITE, V59, P117, DOI 10.1016/j.appet.2012.04.004; Robertson M, 2021, APPETITE, V159, DOI 10.1016/j.appet.2020.105062; Samoggia A, 2020, FOOD RES INT, V128, DOI 10.1016/j.foodres.2019.108766; Schoeppe S, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0538-3; Schoeppe S, 2016, INT J BEHAV NUTR PHY, V13, DOI 10.1186/s12966-016-0454-y; Shinozaki N, 2020, NUTRIENTS, V12, DOI 10.3390/nu12113327; Sidor A, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061657; Snuggs S, 2021, FOOD QUAL PREFER, V89, DOI 10.1016/j.foodqual.2020.104145; Tanagra Dimitra, 2013, F1000Res, V2, P201, DOI 10.12688/f1000research.2-201.v1; The British Psychological Society Obesity Task and Finish Group, 2019, PSYCHOL PERSPECTIVES; Traill WB, 2010, OBES REV, V11, P895, DOI 10.1111/j.1467-789X.2010.00717.x; Vandevijvere S, 2021, PUBLIC HEALTH NUTR, V24, P950, DOI 10.1017/S1368980020005005; Walthouwer MJL, 2015, APPETITE, V87, P152, DOI 10.1016/j.appet.2014.12.214; Wang Q, 2016, JMIR MHEALTH UHEALTH, V4, P202, DOI 10.2196/mhealth.5114; Warren JM, 2017, NUTR RES REV, V30, P272, DOI 10.1017/S0954422417000154; Wharton CM, 2014, J NUTR EDUC BEHAV, V46, P440, DOI 10.1016/j.jneb.2014.04.291; Whatnall MC, 2021, PUBLIC HEALTH NUTR, V24, P5686, DOI 10.1017/S1368980021001129; WHO, 2020, STAT PHYS MENT HLTH; WHO, 2020, COVID 19 SIGN IMP HL; World Health Organization, 2020, COVID 19 DISR MENT H; WorldHealth Organization (WHO), 2020, MENT HLTH PSYCH RES; Zupo R, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17197073	68	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266016	10.1371/journal.pone.0266016	http://dx.doi.org/10.1371/journal.pone.0266016			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344563	Green Published, gold			2022-12-26	WOS:000788055200017
J	Wang, JJ; Yu, XH; Zheng, DX; Zhao, YL; Lv, Y; Shu, B; Jiang, WM; Liu, S; Li, JP; Hou, GY; Peng, C; Wang, SC; Yu, JM; Li, Y; Liu, HL				Wang, Jingjing; Yu, Xiaohui; Zheng, Dongxia; Zhao, Yunling; Lv, Yan; Shu, Bo; Jiang, Wenming; Liu, Shuo; Li, Jinping; Hou, Guangyu; Peng, Cheng; Wang, Suchun; Yu, Jianmin; Li, Yang; Liu, Hualei			Continuous surveillance revealing a wide distribution of class I Newcastle disease viruses in China from 2011 to 2020	PLOS ONE			English	Article							LIVE BIRD MARKETS; DOMESTIC DUCKS; WATERFOWL; VIRULENCE; DIVERSITY; OUTBREAKS; SEQUENCE; CHICKEN; STRAINS	The risk-based active surveillance for Newcastle disease virus (NDV) was carried out in China from 2011 to 2020. A total of 110,018 swabs were collected from 28 provinces. 2,389 class I NDVs were isolated and identified by RT-PCR and sequencing. The average annual positivity rate of class I NDVs from 2011 to 2020 was 2.17%. In the last 10 years, the positivity rate was highest in 2011 (4.76%), and has since decreased. Most viruses were isolated from chickens, while others were collected from ducks, geese and pigeons, as well as from the environment. The positivity rates for class I NDVs in poultry ranged from 0.55% to 2.40%. The viruses were isolated from 373 sampling sites in 24 provinces, mainly in East, Central, South and Southwest China. The positivity rates of NDVs in wholesale markets (51.58%) and retail markets (42.83%) were much higher than those in poultry farms (7.14%) and slaughterhouses (3.85%). Phylogenetic analyses showed that most isolates belonged to sub-genotype 1.1.2, while only 22 viruses belonged to sub-genotype 1.2, indicating the viruses in sub-genotype 1.1.2 were the predominant strains in China. The F and HN genes of six strains in the two sub-genotypes were sequenced and analyzed. The cleavage sites of F protein in the six viruses were (112)ERQER/L-117, (112)ERQGR/L-117 or (112)GRQERL(117), which were typical of low virulence NDV. Several mutations were identified in the functional domains of F and HN proteins, including fusion peptide, heptad repeat region, transmembrane domains and neutralizing epitopes. This study revealed the distribution, genetic and phylogenetic characteristics of class I NDVs in China, and could help us to better understand the epidemiological context of class I NDVs in China.	[Wang, Jingjing; Yu, Xiaohui; Zheng, Dongxia; Zhao, Yunling; Lv, Yan; Shu, Bo; Jiang, Wenming; Liu, Shuo; Li, Jinping; Hou, Guangyu; Peng, Cheng; Wang, Suchun; Yu, Jianmin; Li, Yang; Liu, Hualei] China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao, Peoples R China; [Shu, Bo] Jiangxi Agr Univ, Coll Anim Sci & Technol, Nanchang, Peoples R China	China Animal Health & Epidemiology Center; Jiangxi Agricultural University	Liu, HL (corresponding author), China Anim Hlth & Epidemiol Ctr, OIE Reference Lab Newcastle Dis, Qingdao, Peoples R China.	hualeiliuwy@163.com		Wang, Jingjing/0000-0003-0931-7023	National Key R&D Program of China [2016YFD0500800]	National Key R&D Program of China	This work was funded by the National Key R&D Program of China (2016YFD0500800). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALEXANDER DJ, 1992, VET REC, V130, P65, DOI 10.1136/vr.130.4.65; Cho SH, 2007, VIRUS GENES, V35, P293, DOI 10.1007/s11262-007-0078-z; Czegledi A, 2006, VIRUS RES, V120, P36, DOI 10.1016/j.virusres.2005.11.009; Dimitrov KM, 2019, INFECT GENET EVOL, V74, DOI 10.1016/j.meegid.2019.103917; Dimitrov KM, 2016, INFECT GENET EVOL, V39, P22, DOI 10.1016/j.meegid.2016.01.008; Guo HB, 2013, ARCH VIROL, V158, P1121, DOI 10.1007/s00705-012-1572-8; Hu SL, 2010, VET MICROBIOL, V140, P92, DOI 10.1016/j.vetmic.2009.07.029; Hu Y, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.01347-16; Jindal N, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-191; Kim LM, 2007, J VIROL, V81, P12641, DOI 10.1128/JVI.00843-07; Kim LM, 2007, J CLIN MICROBIOL, V45, P1310, DOI 10.1128/JCM.02594-06; Liu HL, 2010, VIRUS GENES, V40, P365, DOI 10.1007/s11262-010-0452-0; Liu XF, 2003, ARCH VIROL, V148, P1387, DOI 10.1007/s00705-003-0014-z; Liu XW, 2009, AVIAN PATHOL, V38, P377, DOI 10.1080/03079450903183637; Meng CC, 2016, J VIROL, V90, P2052, DOI 10.1128/JVI.01801-15; Meng CC, 2012, ARCH VIROL, V157, P869, DOI 10.1007/s00705-012-1248-4; Shengqing Y, 2002, VIROLOGY, V301, P206, DOI 10.1006/viro.2002.1539; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Takakuwa H, 1998, JPN J VET RES, V45, P207; Umali DV, 2014, VIRUS GENES, V49, P89, DOI 10.1007/s11262-014-1075-7; Wang JJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158771; Wu W, 2015, INFECT GENET EVOL, V32, P34, DOI 10.1016/j.meegid.2015.02.016; Yu Y, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-120	23	0	0	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264936	10.1371/journal.pone.0264936	http://dx.doi.org/10.1371/journal.pone.0264936			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349584	gold, Green Published			2022-12-26	WOS:000783906500013
J	Weiss, L; Gaelings, L; Reiner, T; Mergner, J; Kuster, B; Feher, A; Hensel, G; Gahrtz, M; Kumlehn, J; Engelhardt, S; Hukelhoven, R				Weiss, Lukas; Gaelings, Lana; Reiner, Tina; Mergner, Julia; Kuster, Bernhard; Feher, Attila; Hensel, Goetz; Gahrtz, Manfred; Kumlehn, Jochen; Engelhardt, Stefan; Hueckelhoven, Ralph			Posttranslational modification of the RHO of plants protein RACB by phosphorylation and cross-kingdom conserved ubiquitination	PLOS ONE			English	Article							POWDERY MILDEW FUNGUS; RECOGNITION RECEPTOR FLS2; CELL-MIGRATION; MOLECULAR SWITCH; RAS SUPERFAMILY; BINDING DOMAIN; S-ACYLATION; E3 LIGASE; GTPASE; BARLEY	Small RHO-type G-proteins act as signaling hubs and master regulators of polarity in eukaryotic cells. Their activity is tightly controlled, as defective RHO signaling leads to aberrant growth and developmental defects. Two major processes regulate G-protein activity: canonical shuttling between different nucleotide bound states and posttranslational modification (PTM), of which the latter can support or suppress RHO signaling, depending on the individual PTM. In plants, regulation of Rho of plants (ROPs) signaling activity has been shown to act through nucleotide exchange and GTP hydrolysis, as well as through lipid modification, but there is little data available on phosphorylation or ubiquitination of ROPs. Hence, we applied proteomic analyses to identify PTMs of the barley ROP RACB. We observed in vitro phosphorylation by barley ROP binding kinase 1 and in vivo ubiquitination of RACB. Comparative analyses of the newly identified RACB phosphosites and human RHO protein phosphosites revealed conservation of modified amino acid residues, but no overlap of actual phosphorylation patterns. However, the identified RACB ubiquitination site is conserved in all ROPs from Hordeum vulgare, Arabidopsis thaliana and Oryza sativa and in mammalian Rac1 and Rac3. Point mutation of this ubiquitination site leads to stabilization of RACB. Hence, this highly conserved lysine residue may regulate protein stability across different kingdoms.	[Weiss, Lukas; Gaelings, Lana; Reiner, Tina; Engelhardt, Stefan; Hueckelhoven, Ralph] Tech Univ Munich TUM, Chair Phytopathol, Freising Weihenstephan, Germany; [Mergner, Julia; Kuster, Bernhard] Tech Univ Munich TUM, Chair Prote & Bioanalyt, Freising Weihenstephan, Germany; [Kuster, Bernhard] TUM, Bavarian Biomol Mass Spectrometry Ctr BayBioMS, Freising Weihenstephan, Germany; [Feher, Attila] Univ Szeged, Inst Plant Biol, Chair Plant Biol, Biol Res Ctr, Szeged, Hungary; [Hensel, Goetz; Gahrtz, Manfred; Kumlehn, Jochen] Inst Plant Genet & Crop Plant Res IPK, Gatersleben, Germany	Technical University of Munich; Technical University of Munich; Technical University of Munich; Eotvos Lorand Research Network; Hungarian Academy of Sciences; Hungarian Biological Research Center; Szeged University; Leibniz Institut fur Pflanzengenetik und Kulturpflanzenforschung	Hukelhoven, R (corresponding author), Tech Univ Munich TUM, Chair Phytopathol, Freising Weihenstephan, Germany.	hueckelhoven@wzw.tum.de	Hensel, Goetz/ABA-8238-2020	Hensel, Goetz/0000-0002-5539-3097; Engelhardt, Stefan/0000-0003-1933-1160	German Research Foundation [SFB924]; National Research, Development and Innovation Office [K101112]	German Research Foundation(German Research Foundation (DFG)); National Research, Development and Innovation Office(National Research, Development & Innovation Office (NRDIO) - Hungary)	Funding: This work was supported by a research grant to R.H. from the German Research Foundation in frame of the collaborative research center SFB924. The contribution of A.F. was supported by a grant from the National Research,& nbsp;Development, and Innovation Office(#K101112;Hungary).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdrabou A, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7120263; Abdul-Manan N, 1999, NATURE, V399, P379, DOI 10.1038/20726; Akamatsu A, 2013, CELL HOST MICROBE, V13, P465, DOI 10.1016/j.chom.2013.03.007; Berken A, 2006, CELL MOL LIFE SCI, V63, P2446, DOI 10.1007/s00018-006-6197-1; Berken A, 2005, NATURE, V436, P1176, DOI 10.1038/nature03883; Berken A, 2008, PLANT PHYSIOL BIOCH, V46, P380, DOI 10.1016/j.plaphy.2007.12.008; Boulter Etienne, 2010, Small GTPases, V1, P65; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Castillo-Lluva S, 2013, ONCOGENE, V32, P1735, DOI 10.1038/onc.2012.189; Chang FM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028587; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Dong S, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-76; Dorjgotov D, 2009, FEBS LETT, V583, P1175, DOI 10.1016/j.febslet.2009.02.047; Ebine K, 2011, NAT CELL BIOL, V13, P853, DOI 10.1038/ncb2270; Ellerbroek SM, 2003, J BIOL CHEM, V278, P19023, DOI 10.1074/jbc.M213066200; Enders TA, 2017, PLANT J, V92, P68, DOI 10.1111/tpj.13635; Engelhardt S., 2019, BARLEY RIC157 IS INV, P848226; Engler C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003647; Fodor-Dunai C, 2011, PLANT J, V66, P669, DOI 10.1111/j.1365-313X.2011.04528.x; Forget MA, 2002, BIOCHEM J, V361, P243, DOI 10.1042/0264-6021:3610243; Fricke I, 2009, FEBS LETT, V583, P75, DOI 10.1016/j.febslet.2008.12.008; Goehre V, 2008, CURR BIOL, V18, P1824, DOI 10.1016/j.cub.2008.10.063; Hensel Goetz, 2009, Int J Plant Genomics, V2009, P835608, DOI 10.1155/2009/835608; Hoefle C, 2011, PLANT CELL, V23, P2422, DOI 10.1105/tpc.110.082131; Hua ZH, 2011, ANNU REV PLANT BIOL, V62, P299, DOI 10.1146/annurev-arplant-042809-112256; Huesmann C, 2012, PLANT PHYSIOL, V159, P311, DOI 10.1104/pp.111.191940; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Jank T, 2013, NAT STRUCT MOL BIOL, V20, P1273, DOI 10.1038/nsmb.2688; Jones MA, 2002, PLANT CELL, V14, P763, DOI 10.1105/tpc.010359; Jurca ME, 2008, PLANT CELL REP, V27, P739, DOI 10.1007/s00299-007-0494-5; Katoh K, 2010, BIOINFORMATICS, V26, P1899, DOI 10.1093/bioinformatics/btq224; Klahre U, 2006, PLANT CELL, V18, P3033, DOI 10.1105/tpc.106.045336; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kwon T, 2000, J BIOL CHEM, V275, P423, DOI 10.1074/jbc.275.1.423; Lang P, 1996, EMBO J, V15, P510, DOI 10.1002/j.1460-2075.1996.tb00383.x; Lawson CD, 2018, J CELL BIOL, V217, P447, DOI 10.1083/jcb.201612069; LAZO GR, 1991, BIO-TECHNOL, V9, P963, DOI 10.1038/nbt1091-963; Lin YK, 1997, PLANT CELL, V9, P1647, DOI 10.1105/tpc.9.9.1647; Lu DP, 2011, SCIENCE, V332, P1439, DOI 10.1126/science.1204903; MacLean B, 2010, BIOINFORMATICS, V26, P966, DOI 10.1093/bioinformatics/btq054; Marx H, 2013, NAT BIOTECHNOL, V31, P557, DOI 10.1038/nbt.2585; McCollum C, 2020, PLANT PHYSIOL, V184, P823, DOI 10.1104/pp.20.00742; Mergner J, 2020, NATURE, V579, P409, DOI 10.1038/s41586-020-2094-2; MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Opalski KS, 2005, PLANT J, V41, P291, DOI 10.1111/j.1365-313X.2004.02292.x; Ozdamar B, 2005, SCIENCE, V307, P1603, DOI 10.1126/science.1105718; PAI EF, 1989, NATURE, V341, P209, DOI 10.1038/341209a0; Pathuri IP, 2008, PLANT CELL REP, V27, P1877, DOI 10.1007/s00299-008-0607-9; Peng JM, 2003, NAT BIOTECHNOL, V21, P921, DOI 10.1038/nbt849; Rademacher EH, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00250; Reiner T, 2016, MOL PLANT PATHOL, V17, P184, DOI 10.1111/mpp.12271; Reiner T, 2015, PLANT CELL REP, V34, P457, DOI 10.1007/s00299-014-1725-1; Rolli-Derkinderen M, 2005, CIRC RES, V96, P1152, DOI 10.1161/01.RES.0000170084.88780.ea; Ruprecht B, 2017, METHODS MOL BIOL, V1550, P47, DOI 10.1007/978-1-4939-6747-6_5; Ruprecht B, 2017, METHODS MOL BIOL, V1550, P83, DOI 10.1007/978-1-4939-6747-6_8; Schaefer A, 2011, BIOPOLYMERS, V95, P420, DOI 10.1002/bip.21601; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Schultheiss H, 2003, PLANT J, V36, P589, DOI 10.1046/j.1365-313X.2003.01905.x; Schultheiss H, 2002, PLANT PHYSIOL, V128, P1447, DOI 10.1104/pp.010805; Schultheiss H, 2008, CELL MICROBIOL, V10, P1815, DOI 10.1111/j.1462-5822.2008.01167.x; Schweizer P, 1999, MOL PLANT MICROBE IN, V12, P647, DOI 10.1094/MPMI.1999.12.8.647; Slynko V, 2009, J AM CHEM SOC, V131, P1274, DOI 10.1021/ja808682v; Sorek N, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00333-17; Sorek N, 2011, PLANT PHYSIOL, V155, P706, DOI 10.1104/pp.110.166850; Sorek N, 2010, CURR BIOL, V20, P914, DOI 10.1016/j.cub.2010.03.057; Sormo CG, 2006, PHYTOCHEMISTRY, V67, P2332, DOI 10.1016/j.phytochem.2006.08.011; Stanislas T, 2015, NAT PLANTS, V1, DOI [10.1038/NPLANTS.2015.162, 10.1038/nplants.2015.162]; Studer G, 2020, BIOINFORMATICS, V36, P1765, DOI 10.1093/bioinformatics/btz828; Tang J, 2014, J NEUROSCI, V34, P7425, DOI 10.1523/JNEUROSCI.5449-13.2014; Thomas C, 2007, MOL CELL, V25, P141, DOI 10.1016/j.molcel.2006.11.023; Tong JF, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147103; Torrino S, 2011, DEV CELL, V21, P959, DOI 10.1016/j.devcel.2011.08.015; Vickers CE, 2003, PLANT CELL REP, V22, P135, DOI 10.1007/s00299-003-0667-9; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Wang HR, 2003, SCIENCE, V302, P1775, DOI 10.1126/science.1090772; Waterhouse A, 2018, NUCLEIC ACIDS RES, V46, pW296, DOI 10.1093/nar/gky427; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wei JX, 2013, BBA-MOL CELL RES, V1833, P2757, DOI 10.1016/j.bbamcr.2013.07.005; Wennerberg K, 2005, J CELL SCI, V118, P843, DOI 10.1242/jcs.01660; Worby CA, 2009, MOL CELL, V34, P93, DOI 10.1016/j.molcel.2009.03.008; Wu G, 2000, PLANT PHYSIOL, V124, P1625, DOI 10.1104/pp.124.4.1625; Yalovsky S, 2015, J EXP BOT, V66, P1617, DOI 10.1093/jxb/erv057; Yang ZB, 2008, ANNU REV CELL DEV BI, V24, P551, DOI 10.1146/annurev.cellbio.23.090506.123233; Zhao J, 2013, FASEB J, V27, P2611, DOI 10.1096/fj.12-223099; Zolg DP, 2018, MOL CELL PROTEOMICS, V17, P1850, DOI 10.1074/mcp.TIR118.000783; Zolg DP, 2017, PROTEOMICS, V17, DOI 10.1002/pmic.201700263	87	0	0	4	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0258924	10.1371/journal.pone.0258924	http://dx.doi.org/10.1371/journal.pone.0258924			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333858	Green Published, Green Submitted, gold			2022-12-26	WOS:000784335700019
J	Wu, Y; Wang, YR; Shi, HM; Hu, HB; Yi, LX; Hou, JH				Wu, Yang; Wang, Yaru; Shi, Huimin; Hu, Haibo; Yi, Liuxi; Hou, Jianhua			Time-course transcriptome and WGCNA analysis revealed the drought response mechanism of two sunflower inbred lines	PLOS ONE			English	Article							HELIANTHUS-ANNUUS L.; STRESS TOLERANCE; GENE-EXPRESSION; ABSCISIC-ACID; WATER-STRESS; GENOME-WIDE; ANTIOXIDATIVE ENZYMES; SIGNALING PATHWAYS; METHYL JASMONATE; MAIZE SEEDLINGS	Drought is one of the most serious abiotic stress factors limiting crop yields. Although sunflower is considered a moderate drought-tolerant plant, drought stress still has a negative impact on sunflower yield as cultivation expands into arid regions. The extent of drought stress is varieties and time-dependent, however, the molecular response mechanisms of drought tolerance in sunflower with different varieties are still unclear. Here, we performed comparative physiological and transcriptome analyses on two sunflower inbred lines with different drought tolerance at the seedling stage. The analysis of nine physiological and biochemical indicators showed that the leaf surface area, leaf relative water content, and cell membrane integrity of drought tolerance inbred line were higher than those of drought-sensitive inbred line under drought stress, indicating that DT had stronger drought resistance. Transcriptome analyses identified 24,234 differentially expressed genes (DEGs). Gene ontology (GO) analysis showed the up-regulated genes were mainly enriched in gibberellin metabolism and rRNA processing, while the down-regulated genes were mainly enriched in cell-wall, photosynthesis, and terpene metabolism. Kyoto Encyclopedia of Genes and Genomes(KEGG) pathway analysis showed genes related to GABAergic synapse, ribosome biogenesis were up-regulated, while genes related with amino sugar and nucleotide sugar metabolism, starch and sucrose metabolism, photosynthesis were down-regulated. Mapman analysis revealed differences in plant hormone-signaling genes over time and between samples. A total of 1,311 unique putative transcription factors (TFs) were identified from all DEGs by iTAK, among which the high abundance of transcription factor families include bHLH, AP2/ERF, MYB, C2H2, etc. Weighted gene co-expression network analysis (WGCNA) revealed a total of 2,251 genes belonging to two modules(blue 4, lightslateblue), respectively, which were significantly associated with six traits. GO and KEGG enrichment analysis of these genes was performed, followed by visualization with Cytoscape software, and the top 20 Hub genes were screened using the CytoHubba plugin.	[Wu, Yang; Wang, Yaru; Shi, Huimin; Hu, Haibo; Yi, Liuxi; Hou, Jianhua] Inner Mongolia Agr Univ, Agr Coll, Coll Agr, Hohhot, Peoples R China	Inner Mongolia Agricultural University	Yi, LX; Hou, JH (corresponding author), Inner Mongolia Agr Univ, Agr Coll, Coll Agr, Hohhot, Peoples R China.	yiliuxivip@163.com; houjh@imau.edu.cn		Wu, Yang/0000-0001-5785-9981	National Natural Science Foundation of China [32160450, 31760396]; Inner Mongolia Agricultural University animal and plant breed Breeding special project [YZGC2017004]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Inner Mongolia Agricultural University animal and plant breed Breeding special project	This work was financially supported by the National Natural Science Foundation of China (grant number 32160450, 31760396), and Inner Mongolia Agricultural University animal and plant breed Breeding special project (grant number: YZGC2017004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abobatta W.F., 2019, ADV AGR ENV SCI, V2, P62, DOI [10.30881/aaeoa.00021, DOI 10.30881/AAEOA.00021]; Agurla S, 2018, ADV EXP MED BIOL, V1081, P215, DOI 10.1007/978-981-13-1244-1_12; Agusti J, 2012, J EXP BOT, V63, P6079, DOI 10.1093/jxb/ers270; AHARONI N, 1978, PLANT PHYSIOL, V61, P658, DOI 10.1104/pp.61.4.658; Al Hakimi A., 1995, Journal of Genetics and Breeding, V49, P237; Albacete A, 2015, J EXP BOT, V66, P863, DOI 10.1093/jxb/eru448; Anjum SA, 2011, AFR J AGR RES, V6, P2026; [Anonymous], 1990, PLANT BIOL US; [Anonymous], 2021, STAT YB WORLD FOOD A; Apel K, 2004, ANNU REV PLANT BIOL, V55, P373, DOI 10.1146/annurev.arplant.55.031903.141701; Badouin H, 2017, NATURE, V546, P148, DOI 10.1038/nature22380; Baek D, 2017, MOL CELLS, V40, P697, DOI 10.14348/molcells.2017.0192; Bajji M, 2002, PLANT GROWTH REGUL, V36, P61, DOI 10.1023/A:1014732714549; Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Baldoni E, 2015, INT J MOL SCI, V16, P15811, DOI 10.3390/ijms160715811; Baloglu MC, 2012, TURK J BOT, V36, P707, DOI 10.3906/bot-1111-20; Bashir Khurram, 2019, F1000Res, V8, DOI 10.12688/f1000research.18424.1; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; BEYER WF, 1987, ANAL BIOCHEM, V161, P559, DOI 10.1016/0003-2697(87)90489-1; Buriro M., 2015, International Journal of Agricultural Technology, V11, P1547; Buti M, 2018, FUNCT INTEGR GENOMIC, V18, P627, DOI 10.1007/s10142-018-0615-y; Campos H, 2004, FIELD CROP RES, V90, P19, DOI 10.1016/j.fcr.2004.07.003; Chaves MM, 2009, ANN BOT-LONDON, V103, P551, DOI 10.1093/aob/mcn125; Cheng WH, 2002, PLANT CELL, V14, P2723, DOI 10.1105/tpc.006494; CHIMENTI CA, 1994, PLANT SOIL, V166, P101, DOI 10.1007/BF02185486; Chmielewska K, 2016, FRONT PLANT SCI, V7, DOI 10.3389/fpls.2016.01108; DUBOIS M, 1951, NATURE, V168, P167, DOI 10.1038/168167a0; ES AR, 2020, PHYSIOL PLANTARUM; Escalante M., 2020, PLANT MOL BIOL REP, P1; Farooq M, 2009, SUSTAINABLE AGRICULTURE, P153, DOI 10.1051/agro:2008021; Fatemi S. N., 2014, Annual Research & Review in Biology, V4, P3459; FERERES E, 1986, AUST J AGR RES, V37, P573, DOI 10.1071/AR9860573; Fernandez C, 2012, STRESS HORMONE LEVEL, P249; Fernandez P, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-11; Finkelstein RR, 2002, PLANT CELL, V14, pS15, DOI 10.1105/tpc.010441; Galmes J, 2011, PLANT CELL ENVIRON, V34, P245, DOI 10.1111/j.1365-3040.2010.02239.x; Germ M., 2005, Acta Agriculturae Slovenica, V85, P135; Gershenzon J, 2007, NAT CHEM BIOL, V3, P408, DOI 10.1038/nchembio.2007.5; Ghobadi M, 2013, IND CROP PROD, V50, P29, DOI 10.1016/j.indcrop.2013.07.009; Guo RR, 2018, FRONT PLANT SCI, V9, DOI 10.3389/fpls.2018.00545; Hammad S. A. R., 2014, Annals of Agricultural Science (Cairo), V59, P133, DOI 10.1016/j.aoas.2014.06.018; HAVIR EA, 1987, PLANT PHYSIOL, V84, P450, DOI 10.1104/pp.84.2.450; Hazrati S, 2017, AGR WATER MANAGE, V181, P66, DOI 10.1016/j.agwat.2016.11.026; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hoekstra FA, 2001, TRENDS PLANT SCI, V6, P431, DOI 10.1016/S1360-1385(01)02052-0; Huerta-Cepas J, 2019, NUCLEIC ACIDS RES, V47, pD309, DOI 10.1093/nar/gky1085; Hussain M, 2008, J AGRON CROP SCI, V194, P193, DOI 10.1111/j.1439-037X.2008.00305.x; Hussain M, 2009, J AGRON CROP SCI, V195, P98, DOI 10.1111/j.1439-037X.2008.00354.x; Hussain M, 2018, AGR WATER MANAGE, V201, P152, DOI 10.1016/j.agwat.2018.01.028; Jan AU, 2019, PAK J BOT, V51, P809, DOI [10.30848/PJB2019-3(4), 10.30848/pjb2019-3(4)]; Javaid T., 2015, INT J PLANT SCI ECOL, V1, P6; Kang JF, 2017, PLANT BIOTECHNOL J, V15, P1175, DOI 10.1111/pbi.12707; Kaspal M, 2021, PLANTS-BASEL, V10, DOI 10.3390/plants10102178; Kazan K, 2013, MOL PLANT, V6, P686, DOI 10.1093/mp/sss128; Khaksefidi RE, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00741; Kim D, 2015, NAT METHODS, V12, P357, DOI [10.1038/NMETH.3317, 10.1038/nmeth.3317]; Kramer P.J., 1995, WATER RELATIONS PLAN; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Laxa M, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8040094; Lei L, 2015, PLANT J, V84, P1206, DOI 10.1111/tpj.13073; Lemoine R, 2013, DURAND; Li H, 2017, MOL GENET GENOMICS, V292, P1091, DOI 10.1007/s00438-017-1330-4; Li JJ, 2021, INT J BIOL MACROMOL, V189, P72, DOI 10.1016/j.ijbiomac.2021.08.072; Li JJ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241965; Li W., 2021, SCI REP-UK, V11, P1, DOI [10.1038/s41598-020-79139-8, DOI 10.1038/S41598-020-79139-8]; Liang CB, 2017, BOT STUD, V58, DOI 10.1186/s40529-017-0197-3; Licausi F, 2013, NEW PHYTOL, V199, P639, DOI 10.1111/nph.12291; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lutts S, 1996, ANN BOT-LONDON, V78, P389, DOI 10.1006/anbo.1996.0134; Lopez CM, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9040445; Miransari M., 2012, ENV ADAPTATIONS STRE, P381, DOI DOI 10.1007/978-1-4614-0815-4_17; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Moschen S, 2017, PLANT MOL BIOL, V94, P549, DOI 10.1007/s11103-017-0625-5; Nagatoshi Y., 2021, BIORXIV; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Narayanan S, 2018, PLANT CELL ENVIRON, V41, P1749, DOI 10.1111/pce.13156; Nazarli H., 2011, Cercetari Agronomice in Moldova, V44, P35; Ouyang SQ, 2010, PLANT J, V62, P316, DOI 10.1111/j.1365-313X.2010.04146.x; PALANISWAMY KM, 1974, AGRON J, V66, P430, DOI 10.2134/agronj1974.00021962006600030027x; Palmer-Young EC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127296; Pan L, 2018, BMC PLANT BIOL, V18, DOI 10.1186/s12870-018-1239-z; Passricha N, 2019, SENESCENCE SIGNALLING AND CONTROL IN PLANTS, P199, DOI 10.1016/B978-0-12-813187-9.00012-3; Margutti MP, 2019, ENVIRON EXP BOT, V158, P150, DOI 10.1016/j.envexpbot.2018.11.023; Pereyra-Irujo GA, 2007, PLANT BREEDING, V126, P445, DOI 10.1111/j.1439-0523.2007.01375.x; Pertea M, 2015, NAT BIOTECHNOL, V33, P290, DOI 10.1038/nbt.3122; Qin YX, 2015, BIOCHEM BIOPH RES CO, V464, P428, DOI 10.1016/j.bbrc.2015.06.128; RACHIDI F, 1993, AGR WATER MANAGE, V24, P49, DOI 10.1016/0378-3774(93)90061-E; Rizhsky L, 2002, PLANT PHYSIOL, V130, P1143, DOI 10.1104/pp.006858; Rosa P. M., 2009, Helia, V32, P145, DOI 10.2298/HEL0950145R; Saeed Rauf, 2008, Communications in Biometry and Crop Science, V3, P29; Safdar Hussain, 2013, Pakistan Journal of Nutrition, V12, P345; Sanchez-Romera B, 2014, PLANT CELL ENVIRON, V37, P995, DOI 10.1111/pce.12214; Sarazin V, 2017, ENVIRON EXP BOT, V142, P45, DOI 10.1016/j.envexpbot.2017.08.005; Schiessl SV, 2020, PLANT SCI, V297, DOI 10.1016/j.plantsci.2020.110515; SGHERRI CLM, 1993, PHYSIOL PLANTARUM, V87, P211, DOI 10.1111/j.1399-3054.1993.tb00144.x; Shan XH, 2013, PLANT MOL BIOL REP, V31, P1485, DOI 10.1007/s11105-013-0622-z; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharkey TD, 2008, ANN BOT-LONDON, V101, P5, DOI 10.1093/aob/mcm240; Singh A, 2012, J PLANT BIOCHEM BIOT, V21, pS100, DOI 10.1007/s13562-012-0150-1; SMIRNOFF N, 1993, NEW PHYTOL, V125, P27, DOI 10.1111/j.1469-8137.1993.tb03863.x; Soleimanzadeh H., 2012, World Applied Sciences Journal, V17, P1115; Suhita D, 2003, PLANT SCI, V164, P481, DOI 10.1016/S0168-9452(02)00432-6; Sultan MARF, 2012, CZECH J GENET PLANT, V48, P178, DOI 10.17221/21/2012-CJGPB; Sun X, 2018, BIOCHEM BIOPH RES CO, V503, P397, DOI 10.1016/j.bbrc.2018.07.123; Sunarpi, 2005, PLANT J, V44, P928, DOI 10.1111/j.1365-313X.2005.02595.x; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tagliotti ME, 2021, PLANT BREEDING, V140, P654, DOI 10.1111/pbr.12938; Tripathi P, 2014, PLANTA, V239, P255, DOI 10.1007/s00425-013-1985-y; Vickers CE, 2009, NAT CHEM BIOL, V5, P283, DOI 10.1038/nchembio.158; Waraich EA, 2011, AUST J CROP SCI, V5, P764; Wasternack C, 2007, ANN BOT-LONDON, V100, P681, DOI 10.1093/aob/mcm079; Yong T, 2006, COLLOID SURFACE B, V49, P60, DOI 10.1016/j.colsurtb.2006.02.014; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zenda T, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20061268; Zhang BH, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051441; Zhang FQ, 2007, CHEMOSPHERE, V67, P44, DOI 10.1016/j.chemosphere.2006.10.007; Zhang GY, 2009, J EXP BOT, V60, P3781, DOI 10.1093/jxb/erp214; Zhang JH, 2006, FIELD CROP RES, V97, P111, DOI 10.1016/j.fcr.2005.08.018; Zhang JX, 1996, NEW PHYTOL, V132, P361, DOI 10.1111/j.1469-8137.1996.tb01856.x; Zhao XP, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103595; Zheng HX, 2020, PLANT PHYSIOL BIOCH, V149, P11, DOI 10.1016/j.plaphy.2020.01.027; Zheng Y, 2016, MOL PLANT, V9, P1667, DOI 10.1016/j.molp.2016.09.014; Zhou XJ, 2021, AGRONOMY-BASEL, V11, DOI 10.3390/agronomy11020246; Zhu Q, 2010, GENE, V457, P1, DOI 10.1016/j.gene.2010.02.011; Zia R, 2021, MICROBIOL RES, V242, DOI 10.1016/j.micres.2020.126626	126	2	2	12	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265447	10.1371/journal.pone.0265447	http://dx.doi.org/10.1371/journal.pone.0265447			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363798	Green Published, gold			2022-12-26	WOS:000804748600020
J	Zhang, L; Wang, XQ; Chen, JX; Kleyman, TR; Sheng, SH				Zhang, Lei; Wang, Xueqi; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu			Accessibility of ENaC extracellular domain central core residues	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPITHELIAL SODIUM-CHANNEL; NA+ CHANNEL; ALPHA-SUBUNIT; HISTIDINE-RESIDUES; SELF-INHIBITION; GAMMA-SUBUNIT; BINDING; IDENTIFICATION; ACTIVATION; COMPLEX	The epithelial Na+ channel (ENaC)/degenerin family has a similar extracellular architecture, where specific regulatory factors interact and alter channel gating behavior. The extra cellular palm domain serves as a key link to the channel pore. In this study, we used cysteine-scanning mutagenesis to assess the functional effects of Cys-modifying reagents on palm domain beta 10 strand residues in mouse ENaC. Of the 13 ENaC alpha subunit mutants with Cys substitutions examined, only mutants at sites in the proximal region of beta 10 exhibited changes in channel activity in response to methanethiosulfonate reagents. Additionally, Cys substitutions at three proximal sites of beta and gamma subunit beta 10 strands also rendered mutant channels methanethiosulfonate-responsive. Moreover, multiple Cys mutants were activated by low concentrations of thiophilic Cd2+. Using the Na+ self-inhibition response to assess ENaC gating behavior, we identified four alpha, two beta, and two gamma subunit beta 10 strand mutations that changed the Na+ self-inhibition response. Our results suggest that the proximal regions of beta 10 strands in all three subunits are accessible to small aqueous compounds and Cd(2+ )and have a role in modulating ENaC gating. These results are consistent with a structural model of mouse ENaC that predicts the presence of aqueous tunnels adjacent to the proximal part of beta 10 and with previously resolved structures of a related family member where palm domain structural transitions were observed with channels in an open or closed state.	[Zhang, Lei; Wang, Xueqi; Chen, Jingxin; Kleyman, Thomas R.; Sheng, Shaohu] Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA; [Zhang, Lei; Wang, Xueqi] Cent South Univ, Xiangya Hosp 2, Dept Nephrol, Hunan Key Lab Kidney Dis & Blood Purificat, Changsha, Hunan, Peoples R China; [Zhang, Lei; Wang, Xueqi] Cent South Univ, Xiangya Hosp 3, Changsha, Hunan, Peoples R China; [Kleyman, Thomas R.] Univ Pittsburgh, Cell Biol, Pittsburgh, PA 15260 USA; [Kleyman, Thomas R.] Univ Pittsburgh, Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA; [Wang, Xueqi] Capital Med Univ, Beijing Friendship Hosp, Dept Nephrol, Beijing 10050, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Central South University; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Capital Medical University	Kleyman, TR (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.; Kleyman, TR (corresponding author), Univ Pittsburgh, Cell Biol, Pittsburgh, PA 15260 USA.; Kleyman, TR (corresponding author), Univ Pittsburgh, Pharmacol & Chem Biol, Pittsburgh, PA 15260 USA.	kleyman@pitt.edu	Sheng, Shaohu/G-7052-2016	Sheng, Shaohu/0000-0002-7198-1702	National Institutes of Health [R01 HL147818, P30 DK079307]; Xiangya Scholar Fund; Third Xiangya Hospital, Central South University, China	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Xiangya Scholar Fund; Third Xiangya Hospital, Central South University, China	This work was supported by National Institutes of Health Grants R01 HL147818 and P30 DK079307 and the Xiangya Scholar Fund (to L. Z. and X. W.) from The Third Xiangya Hospital, Central South University, China.	Azad AK, 2009, HUM MUTAT, V30, P1093, DOI 10.1002/humu.21011; Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bertoni M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09654-8; Carattino MD, 2004, J BIOL CHEM, V279, P4120, DOI 10.1074/jbc.M311783200; Chen JX, 2015, J BIOL CHEM, V290, P25140, DOI 10.1074/jbc.M115.665398; Chen JX, 2013, AM J PHYSIOL-RENAL, V304, pF207, DOI 10.1152/ajprenal.00563.2012; Chen JX, 2011, J BIOL CHEM, V286, P27436, DOI 10.1074/jbc.M111.232058; Chraibi A, 2002, J GEN PHYSIOL, V120, P133, DOI 10.1085/jgp.20028612; Collier DM, 2014, J GEN PHYSIOL, V144, P337, DOI 10.1085/jgp.201411208; Collier DM, 2012, J BIOL CHEM, V287, P40907, DOI 10.1074/jbc.M112.417519; Collier DM, 2011, J BIOL CHEM, V286, P6027, DOI 10.1074/jbc.M110.198127; Collier DM, 2009, J BIOL CHEM, V284, P29320, DOI 10.1074/jbc.M109.046771; Collier DM, 2009, J BIOL CHEM, V284, P792, DOI 10.1074/jbc.M806954200; Dawson RJP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1917; Della Vecchia MC, 2013, J BIOL CHEM, V288, P5487, DOI 10.1074/jbc.M112.441964; Donald JE, 2011, PROTEINS, V79, P898, DOI 10.1002/prot.22927; Hughey RP, 2004, J BIOL CHEM, V279, P18111, DOI 10.1074/jbc.C400080200; Jasti J, 2007, NATURE, V449, P316, DOI 10.1038/nature06163; Kashlan OB, 2015, J BIOL CHEM, V290, P568, DOI 10.1074/jbc.M114.606152; Kashlan OB, 2011, AM J PHYSIOL-RENAL, V301, pF684, DOI 10.1152/ajprenal.00259.2011; Kleyman TR, 2020, AM J PHYSIOL-CELL PH, V318, pC150, DOI 10.1152/ajpcell.00418.2019; Kleyman TR, 2018, ANNU REV PHYSIOL, V80, P263, DOI 10.1146/annurev-physiol-021317-121143; Krauson AJ, 2013, J BIOL CHEM, V288, P34375, DOI 10.1074/jbc.M113.504324; Li JQ, 2003, J BIOL CHEM, V278, P13867, DOI 10.1074/jbc.M300149200; Linsdell Paul, 2015, BioMolecular Concepts, V6, P191, DOI 10.1515/bmc-2015-0013; Lu M, 2008, J BIOL CHEM, V283, P11981, DOI 10.1074/jbc.M708001200; Madeira F, 2019, NUCLEIC ACIDS RES, V47, pW636, DOI 10.1093/nar/gkz268; Molina R, 2011, BBA-BIOMEMBRANES, V1808, P1818, DOI 10.1016/j.bbamem.2011.03.004; Mutchler SM, 2021, HYPERTENSION, V77, P759, DOI 10.1161/HYPERTENSIONAHA.120.14481; Nie HG, 2010, AM J PHYSIOL-RENAL, V298, pF323, DOI 10.1152/ajprenal.00307.2009; Noreng S, 2020, ELIFE, V9, DOI 10.7554/eLife.59038; Noreng S, 2018, ELIFE, V7, DOI 10.7554/eLife.39340; Pitzer AL, 2020, CURR HYPERTENS REP, V22, DOI 10.1007/s11906-020-01067-9; Rauh R, 2010, J PHYSIOL-LONDON, V588, P1211, DOI 10.1113/jphysiol.2009.180224; Ray EC, 2016, AM J PHYSIOL-RENAL, V311, pF908, DOI 10.1152/ajprenal.00426.2016; Renauld S, 2008, CELL PHYSIOL BIOCHEM, V22, P101, DOI 10.1159/000149787; Roy S, 2013, FASEB J, V27, P5034, DOI 10.1096/fj.13-230680; Salih M, 2017, J AM SOC NEPHROL, V28, P3290, DOI 10.1681/ASN.2016111163; Schild L, 1997, J GEN PHYSIOL, V109, P15, DOI 10.1085/jgp.109.1.15; Schrodinger LLC, 2021, PYMOL MOL GRAPHICS S; Sheng SH, 2004, J BIOL CHEM, V279, P31687, DOI 10.1074/jbc.M405224200; Sheng SH, 2004, J BIOL CHEM, V279, P9743, DOI 10.1074/jbc.M311952200; Sheng SH, 2002, J BIOL CHEM, V277, P50098, DOI 10.1074/jbc.M209975200; Sheng SH, 2007, J BIOL CHEM, V282, P20180, DOI 10.1074/jbc.M611761200; Sheng SH, 2018, J BIOL CHEM, V293, P17582, DOI 10.1074/jbc.RA118.003618; Shi SJ, 2011, J BIOL CHEM, V286, P14753, DOI 10.1074/jbc.M110.191734; Springauf A, 2011, J BIOL CHEM, V286, P24374, DOI 10.1074/jbc.M111.230797; VANDRIESSCHE W, 1985, PHYSIOL REV, V65, P833, DOI 10.1152/physrev.1985.65.4.833; Wichmann L, 2019, J BIOL CHEM, V294, P12507, DOI 10.1074/jbc.RA119.008255; Wu YY, 2019, ELIFE, V8, DOI 10.7554/eLife.45851; Yoder N, 2020, ELIFE, V9, DOI 10.7554/eLife.56527; Yoder N, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202134; Yoder N, 2018, NATURE, V555, P397, DOI 10.1038/nature25782; Yu L, 2007, AM J PHYSIOL-RENAL, V293, pF236, DOI 10.1152/ajprenal.00002.2007	55	1	1	1	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101860	10.1016/j.jbc.2022.101860	http://dx.doi.org/10.1016/j.jbc.2022.101860			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35339489	gold, Green Published			2022-12-26	WOS:000798142000001
J	Akinkugbe, AA; Brickhouse, TH; Bandyopadhyay, D; Nascimento, MM; Slade, GD				Akinkugbe, Aderonke A.; Brickhouse, Tegwyn H.; Bandyopadhyay, Dipankar; Nascimento, Marcelle M.; Slade, Gary D.			Prepregnancy BMI, gestational weight gain and offspring caries experience: Avon longitudinal study of parents and children	PLOS ONE			English	Article							PREGNANCY OUTCOMES; ENAMEL DEFECTS; BIRTH-WEIGHT; RISK-FACTORS; OBESITY; SMOKING; PREVALENCE; HEALTH; ASSOCIATION; OVERWEIGHT	Pre-existing maternal overweight/obesity and pregnancy weight gain are associated with adverse birth outcomes such as low birth weight and prematurity, which may increase the risk of developmental tooth defects and early childhood caries. We sought to investigate the association between prepregnancy BMI, gestational weight gain (GWG) and the risk of early childhood caries. Data from 1,429 mother-offspring participants of the 1991/1992 Avon Longitudinal Study of Parents and Children were analyzed. The exposures were prepregnancy BMI (under/normal weight vs. overweight/obese), and gestational weight gain (GWG) based on the Institute of Medicine's recommended levels. The main outcome measured was offspring caries experience determined by clinical oral examinations at three time points. Log binomial regression estimated risk ratios and 95% confidence intervals. Seventy six percent (76%) of the mothers were under/normal weight prepregnancy, 39% and 26% respectively gained less and more than the recommended weight for their prepregnancy BMI during pregnancy. Being overweight/obese prepregnancy was associated with unadjusted RR (95% CI) of offspring caries of 1.16 (0.90, 1.51) at 31-months, 1.20 (0.96, 1.49) at 43-months and 1.09 (0.91, 1.30) at 61-months. GWG less than recommended was associated with higher unadjusted offspring caries experience of 1.13 (0.86, 1.48), 1.17 (0.92, 1.48) and 1.04 (0.87, 1.25) at 31-months, 43-months and 61-months respectively. There was insufficient evidence to indicate an association between prepregnancy BMI and gestational weight gain on offspring caries experience risk.	[Akinkugbe, Aderonke A.; Brickhouse, Tegwyn H.] Virginia Commonwealth Univ, Sch Dent, Dept Dent Publ Hlth & Policy, Richmond, VA 23284 USA; [Akinkugbe, Aderonke A.; Brickhouse, Tegwyn H.] Virginia Commonwealth Univ, Inst Inclus Inquiry & Innovat, Richmond, VA 23284 USA; [Bandyopadhyay, Dipankar] Virginia Commonwealth Univ, Sch Med, Dept Biostat, Richmond, VA USA; [Nascimento, Marcelle M.] Univ Florida, Coll Dent, Dept Restorat Dent Sci, Gainesville, FL USA; [Slade, Gary D.] Univ N Carolina, Pediat Publ Hlth Dept, Adams Sch Dent, Chapel Hill, NC 27515 USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; State University System of Florida; University of Florida; University of North Carolina; University of North Carolina Chapel Hill	Akinkugbe, AA (corresponding author), Virginia Commonwealth Univ, Sch Dent, Dept Dent Publ Hlth & Policy, Richmond, VA 23284 USA.; Akinkugbe, AA (corresponding author), Virginia Commonwealth Univ, Inst Inclus Inquiry & Innovat, Richmond, VA 23284 USA.	aaakinkugbe@vcu.edu	Akinkugbe, Ronke/P-7870-2019	Akinkugbe, Ronke/0000-0003-1207-9732	National Institutes of Health/National Institute of Dental and Craniofacial Research [R03DE028403, L40DE028120]	National Institutes of Health/National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by the National Institutes of Health/National Institute of Dental and Craniofacial Research (Grant No.: R03DE028403 and L40DE028120) to A.A. https://www.nidcr.nih.gov/The views expressed are solely the authors and does not represent the official views of the NIH/NIDCR. The funding source was not involved in the design, analysis, interpretation or decision to submit this article for publication.	Barker DJP, 2012, PUBLIC HEALTH, V126, P185, DOI 10.1016/j.puhe.2011.11.014; Berlin I, 2018, NICOTINE TOB RES, V20, P663, DOI 10.1093/ntr/nty035; Boyd A, 2013, INT J EPIDEMIOL, V42, P111, DOI 10.1093/ije/dys064; Branum Amy M, 2016, Natl Vital Stat Rep, V65, P1; Broadbent JM, 2016, J DENT RES, V95, P808, DOI 10.1177/0022034516634663; Cabral M, 2018, NICOTINE TOB RES, V20, P674, DOI 10.1093/ntr/ntx117; Caufield PW, 2012, J DENT RES, V91, P544, DOI 10.1177/0022034512444929; Chu SY, 2009, MATERN CHILD HLTH J, V13, P614, DOI 10.1007/s10995-008-0388-3; Cnattingius S, 2004, NICOTINE TOB RES, V6, pS125, DOI 10.1080/14622200410001669187; Djelantik AAAMJ, 2012, BJOG-INT J OBSTET GY, V119, P283, DOI 10.1111/j.1471-0528.2011.03205.x; Dodds L, 2011, J AUTISM DEV DISORD, V41, P891, DOI 10.1007/s10803-010-1114-8; Dunlop AL, 2015, ADV NEONAT CARE, V15, P377, DOI 10.1097/ANC.0000000000000218; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Fraser A, 2013, INT J EPIDEMIOL, V42, P97, DOI 10.1093/ije/dys066; Fraser A, 2010, CIRCULATION, V121, P2557, DOI 10.1161/CIRCULATIONAHA.109.906081; Galtier-Dereure F, 2000, AM J CLIN NUTR, V71, p1242S, DOI 10.1093/ajcn/71.5.1242s; Gan WQ, 2005, CHEST, V127, P558, DOI 10.1378/chest.127.2.558; Golding J, 2001, PAEDIATR PERINAT EP, V15, P74; Hayden C, 2013, COMMUNITY DENT ORAL, V41, P289, DOI 10.1111/cdoe.12014; Julihn A, 2018, JDR Clin Trans Res, V3, P395, DOI 10.1177/2380084418788066; Julihn A, 2009, EUR J EPIDEMIOL, V24, P753, DOI 10.1007/s10654-009-9399-7; Kassebaum NJ, 2017, J DENT RES, V96, P380, DOI 10.1177/0022034517693566; Kay EJ, 2010, COMMUNITY DENT ORAL, V38, P408, DOI 10.1111/j.1600-0528.2010.00548.x; Lam CU, 2017, CARIES RES, V51, P271, DOI 10.1159/000471811; Lawlor DA, 2012, NAT REV ENDOCRINOL, V8, P679, DOI 10.1038/nrendo.2012.176; Mizutani T, 2007, OBESITY, V15, P3133, DOI 10.1038/oby.2007.373; Morozumi T, 2004, J CLIN PERIODONTOL, V31, P267, DOI 10.1111/j.1600-051X.2004.00476.x; Plonka KA, 2013, CARIES RES, V47, P117, DOI 10.1159/000345073; Rasmussen KM, 2009, WEIGHT GAIN DURING PREGNANCY: REEXAMINING THE GUIDELINES, P1; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Salanitri S, 2013, AUST DENT J, V58, P133, DOI 10.1111/adj.12039; Shen AQ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216227; Silva MJ, 2019, AUST DENT J, V64, pS4, DOI 10.1111/adj.12672; Silva MJ, 2019, PEDIATRICS, V143, DOI 10.1542/peds.2018-3499; Stettler N, 2000, AM J CLIN NUTR, V72, P378; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Vello MA, 2010, ORAL DIS, V16, P257, DOI 10.1111/j.1601-0825.2009.01629.x; Westreich D, 2013, AM J EPIDEMIOL, V177, P292, DOI 10.1093/aje/kws412; White IR, 2011, STAT MED, V30, P377, DOI 10.1002/sim.4067; Wigen TI, 2011, EUR J ORAL SCI, V119, P463, DOI 10.1111/j.1600-0722.2011.00862.x; World Health Organization (WHO), 2013, ORAL HLTH SURVEYS BA; Wu Q, 2006, OBES REV, V7, P201, DOI 10.1111/j.1467-789X.2006.00232.x	42	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266247	10.1371/journal.pone.0266247	http://dx.doi.org/10.1371/journal.pone.0266247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358251	gold, Green Published			2022-12-26	WOS:000799828800084
J	Bushong, A; McKeon, T; Boland, MR; Field, J				Bushong, Anna; McKeon, Thomas; Boland, Mary Regina; Field, Jeffrey			Publicly available data reveals association between asthma hospitalizations and unconventional natural gas development in Pennsylvania	PLOS ONE			English	Article							PEDIATRIC ASTHMA	Since the early 2000s, unconventional natural gas development (UNGD) has rapidly grown throughout Pennsylvania. UNGD extracts natural gas using a relatively new method known as hydraulic fracturing (HF). Here we addressed the association of HF with asthma Hospitalization Admission Rates (HAR) using publicly available data. Using public county-level data from the Pennsylvania Department of Health (PA-DOH) and the Pennsylvania Department of Environmental Protection for the years 2001-2014, we constructed regression models to study the previously observed association between asthma exacerbation and HF. After considering multicollinearity, county-level demographics and area-level covariables were included to account for known asthma risk factors. We found a significant positive association between the asthma HAR and annual well density for all the counties in the state (3% increase in HAR attributable to HF, p<0.001). For a sensitivity analysis, we excluded urban counties (urban counties have higher asthma exacerbations) and focused on rural counties for the years 2005-2014 and found a significant association (3.31% increase in HAR attributable to HF in rural counties, p<0.001). An even stronger association was found between asthma hospitalization admission rates (HAR) and PM2.5 levels (7.52% increase in HAR attributable to PM2.5, p<0.001). As expected, asthma HAR was significantly higher in urban compared to rural counties and showed a significant racial disparity. We conclude that publicly available data at the county-level supports an association between an increase in asthma HAR and UNGD in rural counties in Pennsylvania.	[Bushong, Anna] Ctr Coll Danville, Biol Program, Danville, KY USA; [Bushong, Anna; Field, Jeffrey] Univ Penn, Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA; [McKeon, Thomas; Boland, Mary Regina; Field, Jeffrey] Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA; [McKeon, Thomas] Temple Univ, Dept Geog & Urban Studies, Philadelphia, PA 19122 USA; [Boland, Mary Regina] Perelman Sch Med, Dept Biostat Epidemiol & Informat, Philadelphia, PA USA; [Bushong, Anna] Purdue Univ, Dept Forestry & Nat Resources, W Lafayette, IN 47907 USA	University of Pennsylvania; University of Pennsylvania; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Pennsylvania; Pennsylvania Medicine; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Field, J (corresponding author), Univ Penn, Sch Med, Dept Syst Pharmacol & Translat Therapeut, Philadelphia, PA 19104 USA.; Field, J (corresponding author), Univ Penn, Ctr Excellence Environm Toxicol, Philadelphia, PA 19104 USA.	jfield@upenn.edu		Boland, Mary Regina/0000-0001-8576-6408; Bushong, Anna/0000-0002-4963-0578; McKeon, Thomas P./0000-0002-2999-9175; Field, Jeffrey/0000-0001-7161-7284	National Institute of Health [R25ES021649, P30ES013508]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This study was supported in part by the National Institute of Health R25ES021649 and P30ES013508 to JF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adgate JL, 2014, ENVIRON SCI TECHNOL, V48, P8307, DOI 10.1021/es404621d; Akinbami LJ, 2014, J ALLERGY CLIN IMMUN, V134, P547, DOI 10.1016/j.jaci.2014.05.037; Aligne CA, 2000, AM J RESP CRIT CARE, V162, P873; American Lung Association, ASTHM TRENDS BURD; Anenberg SC, 2018, ENVIRON HEALTH PERSP, V126, DOI [10.1289/ehp3766, 10.1289/EHP3766]; [Anonymous], 1995, PENNS SPAT DAT ACC; [Anonymous], 2021, MOST RECENT ASTHMA S; Banan Z, 2021, ENERG POLICY, V148, DOI 10.1016/j.enpol.2020.111979; Bivand R.R., 2020, RGEOS INTERFACE GEOM, P5; Bowers R., 2017, NATURAL GAS HAS DISP; Brown B., 2019, US LEADS GLOBAL PETR; Brown David, 2014, Reviews on Environmental Health, V29, P277, DOI 10.1515/reveh-2014-0002; Budesonide, 2021, FORM CLINCALC DRUGST; Cardet JC, 2018, J ALLERGY CLIN IMMUN, V141, P754, DOI 10.1016/j.jaci.2017.04.036; Colborn T, 2014, HUM ECOL RISK ASSESS, V20, P86, DOI 10.1080/10807039.2012.749447; Currie J, 2017, SCI ADV, V3, DOI 10.1126/sciadv.1603021; Czolowski ED, 2017, ENVIRON HEALTH PERSP, V125, DOI [10.1289/EHP1535, 10.1289/ehp1535]; Denham A., 2021, ENVIRON RES, V195, P110872, DOI [10.1016/j.envres.2021.110872, DOI 10.1016/J.ENVRES.2021.110872]; Erfanian E., 2019, AIR QUALITY ASTHMA H; gis dep pa, PA OIL GAS MAPP; Guarnieri M, 2014, LANCET, V383, P1581, DOI 10.1016/S0140-6736(14)60617-6; health pa, ENTERPRISE DATA DISS; Jemielita T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131093; Kahle D, 2013, R J, V5, P144; Kassambara A., 2020, GGPUBRGGPLOT2 BASED; Lawson JA, 2017, BMC PULM MED, V17, DOI 10.1186/s12890-016-0355-5; Leong AB, 2012, CLIN REV ALLERG IMMU, V43, P156, DOI 10.1007/s12016-011-8263-1; Matz CJ, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/s12940-015-0075-y; McAlexander TP, 2020, J AM COLL CARDIOL, V76, P2862, DOI 10.1016/j.jacc.2020.10.023; Paciencia Ines, 2020, Porto Biomed J, V5, pe57, DOI 10.1097/j.pbj.0000000000000057; Pebesma E.J., 2005, R NEWS, V5, P9; Pebesma E, 2018, R J, V10, P439; Pennsylvania Department of Health, 2012, ASTHM BURD REP; Pennsylvania Insurance Department, 2018, FACT SHEET PROP AFF; Quality R.W.A., 2019, WORLD AIR QUALITY RE; Rasmussen SG, 2016, JAMA INTERN MED, V176, P1334, DOI 10.1001/jamainternmed.2016.2436; Rodriguez A, 2019, THORAX, V74, P1020, DOI 10.1136/thoraxjnl-2018-211793; Schmidt Charles W, 2011, Environ Health Perspect, V119, pA348, DOI 10.1289/ehp.119-a348; TIGERweb, 2020, TIGERWEBMAIN TIGERWE; United States Government Accountability Office, 2018, RUR HOSP CLOS NUMB C; Vig RS, 2006, ANN NY ACAD SCI, V1088, P65, DOI 10.1196/annals.1366.023; Wark PAB, 2006, THORAX, V61, P909, DOI 10.1136/thx.2005.045187; Whitworth KW, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180966; Wickham H., 2019, J OPEN SOURCE SOFTW, V4, P1686, DOI [10.21105/joss.01686, DOI 10.21105/JOSS.01686]; Wickham H., 2020, DPLYR GRAMMAR DATA M; Wickham H, 2014, J STAT SOFTW, V59, P1; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willis MD, 2018, ENVIRON RES, V166, P402, DOI 10.1016/j.envres.2018.06.022	48	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265513	10.1371/journal.pone.0265513	http://dx.doi.org/10.1371/journal.pone.0265513			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358226	gold, Green Published			2022-12-26	WOS:000799828800036
J	Sutton, J; Shahtahmassebi, G; Ribeiro, HV; Hanley, QS				Sutton, Jack; Shahtahmassebi, Golnaz; Ribeiro, Haroldo, V; Hanley, Quentin S.			Population density and spreading of COVID-19 in England and Wales	PLOS ONE			English	Article							TRANSMISSION	We investigated daily COVID-19 cases and deaths in the 337 lower tier local authority regions in England and Wales to better understand how the disease propagated over a 15-month period. Population density scaling models revealed residual variance and skewness to be sensitive indicators of the dynamics of propagation. Lockdowns and schools reopening coincided with increased variance indicative of conditions with local impact and country scale heterogeneity. University reopening and December holidays reduced variance indicative of country scale homogenisation which reached a minimum in mid-January 2021. Homogeneous propagation was associated with better correspondence with normally distributed residuals while heterogeneous propagation was more consistent with skewed models. Skewness varied from strongly negative to strongly positive revealing an unappreciated feature of community propagation. Hot spots and super-spreading events are well understood descriptors of regional disease dynamics that would be expected to be associated with positively skewed distributions. Positively skewed behaviour was observed; however, negative skewness indicative of "cold-spots" and "super-isolation" dominated for approximately 8 months during the period of study. In contrast, death metrics showed near constant behaviour in scaling, variance, and skewness metrics over the full period with rural regions preferentially affected, an observation consistent with regional age demographics in England and Wales. Regional positions relative to density scaling laws were remarkably persistent after the first 5-9 days of the available data set. The determinants of this persistent behaviour probably precede the pandemic and remain unchanged.	[Sutton, Jack; Shahtahmassebi, Golnaz; Hanley, Quentin S.] Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham, England; [Ribeiro, Haroldo, V] Univ Estadual Maringa, Dept Fis, Maringa, Parana, Brazil	Nottingham Trent University; Universidade Estadual de Maringa	Hanley, QS (corresponding author), Nottingham Trent Univ, Sch Sci & Technol, Clifton Lane, Nottingham, England.	quentin.hanley@ntu.ac.uk	Ribeiro, Haroldo Valentin/C-8614-2012	Ribeiro, Haroldo Valentin/0000-0002-9532-5195; Hanley, Quentin/0000-0002-8189-9550; Sutton, Jack/0000-0002-7635-6578	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [407690/2018-2, 303121/2018-1]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	H.V.R was supported by Conselho Nacional de Desenvolvimento Cienti ' fico e Tecnolo ' gico (CNPq) Grant Nos. 407690/2018-2 and 303121/2018-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves LGA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069580; Anderson EL, 2020, RISK ANAL, V40, P902, DOI 10.1111/risa.13500; Asadi S, 2020, AEROSOL SCI TECH, V54, P635, DOI 10.1080/02786826.2020.1749229; Ascani A, 2021, J REGIONAL SCI, V61, P407, DOI 10.1111/jors.12510; Bettencourt LMA, 2007, P NATL ACAD SCI USA, V104, P7301, DOI 10.1073/pnas.0610172104; Bettencourt LMA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013541; Bivand R, 2019, RGDAL BINDINGS GEOSP, V1, P4; Bivand R., 2020, SPDATA DATASETS SPAT; Bivand Roger, 2020, CRAN; Bokanyi E, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192913; Cardoso BHF, 2021, EPL-EUROPHYS LETT, V133, DOI 10.1209/0295-5075/133/58001; Cheshire J, 2013, INTRO SPATIAL DATA G; Delignette-Muller ML, 2015, J STAT SOFTW, V64, P1, DOI 10.18637/jss.v064.i04; Dragulescu A., 2020, XLSX READ WRITE FORM; Faraggi D, 2002, STAT MED, V21, P3093, DOI 10.1002/sim.1228; Finance O, 2019, ENVIRON PLAN B-URBAN, V46, P1663, DOI 10.1177/2399808318785634; Fukui M., 2020, MEDRXIV, P1, DOI [https%3A//doi.org/10.1101/2020.10.21.20216895, DOI 10.1101/2020.10.21.20216895]; Gross J., 2015, NORTEST TESTS NORMAL; Hanley QS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149546; Hijmans R.J., 2020, RASTER GEOGRAPHIC DA; Kain MP, 2021, EPIDEMICS-NETH, V34, DOI [10.1101/2020.06.30.20143115, 10.1016/j.epidem.2020.100430]; Lau MSY, 2020, P NATL ACAD SCI USA, V117, P22430, DOI 10.1073/pnas.2011802117; Lemon J., 2021, plotrix: Various Plotting Functions; Li LX, 2020, INFECT DIS MODEL, V5, P282, DOI 10.1016/j.idm.2020.03.002; Lovelace R., 2017, Natl Cent Res Methods Work Pap 08/14, DOI 10.5281/zenodo.889551; Lovelace R., 2015, Tutorial, DOI 10.5281/zenodo.889551; Melo HPM, 2021, PHYS REV RES, V3, DOI 10.1103/PhysRevResearch.3.013032; Meyer D, 2020, proxy: Distance and Similarity Measures; Morawska L, 2020, ENVIRON INT, V139, DOI 10.1016/j.envint.2020.105730; Moreau VH, 2020, BRAZ J MICROBIOL, V51, P1109, DOI 10.1007/s42770-020-00331-z; Neuwirth Erich, 2014, CRAN; Novomestky F, 2015, [moments: Moments, cumulants, skewness, kurtosis and related tests, R package version 0.14]; Pebesma E, 2018, R J, V10, P439; Prather KA, 2020, SCIENCE, V368, P1422, DOI 10.1126/science.abc6197; R Development Core Team, 2019, R LANG ENV STAT COMP; Reich O., 2020, MEDRXIV, DOI [10.1101/2020.04.30.20081828, DOI 10.1101/2020.04.30.20081828]; Revelle William, 2020, CRAN; Ribeiro HV, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239699; Ribeiro HV, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11184-y; Ribeiro HV, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192931; Roques L, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.201382; Schlapfer M, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0789; Schlosser F, 2020, P NATL ACAD SCI USA, V117, P32883, DOI 10.1073/pnas.2012326117; Stier A., 2020, COVID 19 ATTACK RATE, DOI [10.1101/2020.03.22.20041004v2, DOI 10.1101/2020.03.22.20041004V2]; Sutton J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74015-x; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; Urbanek S., 2013, PNG READ WRITE PNG I; Warnes GR, 2020, GENTLEMAN R R PACKAG; Wickham Hadley, 2020, CRAN; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wickham H, 2011, J STAT SOFTW, V40, P1, DOI 10.18637/jss.v040.i01; Wong F, 2020, P NATL ACAD SCI USA, V117, P29416, DOI 10.1073/pnas.2018490117; Wuertz D, 2020, RMETRICSAUTOREGRESSI; Xu ZJ, 2019, EPIDEMICS-NETH, V27, P19, DOI 10.1016/j.epidem.2018.12.003; Zeileis Achim, 2018, R Packag version 101	55	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0261725	10.1371/journal.pone.0261725	http://dx.doi.org/10.1371/journal.pone.0261725			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358202	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000799828800005
J	Tagami, M; Kakehashi, A; Katsuyama-Yoshikawa, A; Misawa, N; Sakai, A; Wanibuchi, H; Azumi, A; Honda, S				Tagami, Mizuki; Kakehashi, Anna; Katsuyama-Yoshikawa, Atsuko; Misawa, Norihiko; Sakai, Atsushi; Wanibuchi, Hideki; Azumi, Atsushi; Honda, Shigeru			FOXP3 and CXCR4-positive regulatory T cells in the tumor stroma as indicators of tumor immunity in the conjunctival squamous cell carcinoma microenvironment	PLOS ONE			English	Article							TRANSCRIPTION; EPIDEMIOLOGY; NIVOLUMAB; RECURRENT; HEAD	Conjunctival squamous cell carcinoma (SCC) is the most common ocular surface neoplasia. The purpose of this retrospective study was to examine the role of regulatory T cell (Treg) activity in tumor immunity and investigate the tumor microenvironment as a new treatment focus in conjunctival SCC. Cancer progression gene array and immunohistochemical analyses of FOXP3 as a Treg marker, CD8 as a tumor-infiltrating lymphocyte marker, and CXCR4 expression on activated Tregs were conducted in a series of 31 conjunctival SCC cases. The objective was to investigate the immunoreactive response in tumor cells and stromal cells in the cancer microenvironment. The stroma ratio in tumor cells was investigated by monitoring alpha-smooth muscle actine (SMA) expression between carcinoma in situ (Tis) and advanced carcinoma (Tadv) (P<0.01). No significant change in PD-L1 expression was observed in this study (P = 0.15). Staining patterns of FOXP3, CD8, and CXCR4 were examined separately between tumor cells and stromal cells in SCC tumors. Differences in staining of FOXP3 in Tregs and CD8 in tumor-infiltrating lymphocytes in tumor stroma in the Tis group were observed compared with the Tadv group (each P<0.01). In addition, double immunostaining of CXCR4/FOXP3 was correlated with progression-free survival (P = 0.049). Double immunostaining of CXCR4/FOXP3 correlated with American Joint Committee on Cancer T-stage, independent of age or Ki67 index (P<0.01). Our results show that FOXP3 and the CXCR4/FOXP3 axis are important pathologic and prognostic factors of ocular surface neoplasia, including SCC. The tumor microenvironment of conjunctival SCC should be considered in the future development of treatment options.	[Tagami, Mizuki; Misawa, Norihiko; Sakai, Atsushi; Honda, Shigeru] Osaka City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Osaka, Japan; [Tagami, Mizuki; Katsuyama-Yoshikawa, Atsuko; Azumi, Atsushi] Kobe Kaisei Hosp, Ophthalmol Dept, Kobe, Hyogo, Japan; [Tagami, Mizuki; Katsuyama-Yoshikawa, Atsuko; Azumi, Atsushi] Kobe Kaisei Hosp, Eye Ctr, Kobe, Hyogo, Japan; [Kakehashi, Anna; Wanibuchi, Hideki] Osaka City Univ, Grad Sch Med, Dept Mol Pathol, Osaka, Japan; [Katsuyama-Yoshikawa, Atsuko] Kobe Univ, Grad Sch Med, Dept Surg, Div Ophthalmol, Kobe, Hyogo, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Kobe University	Tagami, M (corresponding author), Osaka City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Osaka, Japan.; Tagami, M (corresponding author), Kobe Kaisei Hosp, Ophthalmol Dept, Kobe, Hyogo, Japan.; Tagami, M (corresponding author), Kobe Kaisei Hosp, Eye Ctr, Kobe, Hyogo, Japan.	tagami.mizuki@med.osaka-cu.ac.jp	Kakehashi, Anna/ABF-2986-2020	Kakehashi, Anna/0000-0003-1149-1450; Tagami, Mizuki/0000-0002-8771-7252				Al-Shibli KI, 2008, CLIN CANCER RES, V14, P5220, DOI 10.1158/1078-0432.CCR-08-0133; Chauhan S, 2018, APPL IMMUNOHISTO M M, V26, pE70, DOI 10.1097/PAI.0000000000000592; Chauhan SK, 2009, J IMMUNOL, V182, P1247, DOI 10.4049/jimmunol.182.3.1247; Ferris RL, 2016, NEW ENGL J MED, V375, P1856, DOI 10.1056/NEJMoa1602252; Freeman A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110928; Gabrilovich DI, 1996, NAT MED, V2, P1096, DOI 10.1038/nm1096-1096; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gobert M, 2009, CANCER RES, V69, P2000, DOI 10.1158/0008-5472.CAN-08-2360; Harrington KJ, 2017, LANCET ONCOL, V18, P1104, DOI 10.1016/S1470-2045(17)30421-7; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Kiire CA, 2019, EYE, V33, P283, DOI 10.1038/s41433-018-0217-x; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Leach DR, 1996, SCIENCE, V271, P1734, DOI 10.1126/science.271.5256.1734; LEE GA, 1995, SURV OPHTHALMOL, V39, P429, DOI 10.1016/S0039-6257(05)80054-2; Maubec E, 2020, J CLIN ONCOL, V38, DOI 10.1200/JCO.19.03357; McClellan AJ, 2013, CORNEA, V32, P1354, DOI 10.1097/ICO.0b013e31829e3c80; Migden MR, 2020, FUTURE ONCOL, V16, P11, DOI 10.2217/fon-2019-0762; Nagarajan P, 2019, INVEST OPHTH VIS SCI, V60, P2388, DOI 10.1167/iovs.19-26894; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Saliba M, 2021, CANCER IMMUNOL IMMUN, V70, P1907, DOI 10.1007/s00262-020-02821-3; Serrels A, 2015, CELL, V163, P160, DOI 10.1016/j.cell.2015.09.001; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Shimizu J, 1999, J IMMUNOL, V163, P5211; Socie G, 2014, BLOOD, V124, P374, DOI 10.1182/blood-2014-01-514752; Spranger S, 2015, NATURE, V523, P231, DOI 10.1038/nature14404; Stefanescu-Dima AS, 2019, ROM J MORPHOL EMBRYO, V60, P455; Sugiyama D, 2013, P NATL ACAD SCI USA, V110, P17945, DOI 10.1073/pnas.1316796110; Sun EC, 1997, CANCER EPIDEM BIOMAR, V6, P73; Tagami M, 2021, GRAEF ARCH CLIN EXP, V259, P3127, DOI 10.1007/s00417-021-05236-7; Vizcaino MA, 2019, HUM PATHOL, V94, P92, DOI 10.1016/j.humpath.2019.08.020; Wang LQ, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-66139-x; Yan M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2869	34	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0263895	10.1371/journal.pone.0263895	http://dx.doi.org/10.1371/journal.pone.0263895			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358193	gold, Green Published			2022-12-26	WOS:000799828800014
J	Choi, JH; Shim, IK; Shin, MJ; Lee, YN; Koh, KH				Choi, Jae Hee; Shim, In Kyong; Shin, Myung Jin; Lee, Yu Na; Koh, Kyoung Hwan			Stem cell sheet interpositioned between the tendon and bone would be better for healing than stem cell sheet overlaid above the tendon-to-bone junction in rotator cuff repair of rats	PLOS ONE			English	Article							MODEL; PATCH; DIFFERENTIATION; TENOCYTES; QUALITY; BIOLOGY; INJURY; TISSUE	Background Although stem cells might enhance natural enthesis healing in surgical rotator cuff repair, not much attention has been given to the delivery and location of delivering stem cells. The purpose of this study to know where to locate those stem cells during repair. Methods Animal model of chronic rotator cuff tear was created in 24 rats. Adipose-derived stem cells were engineered as a sheet and transplanted 1) between a torn tendon and humerus (interposition group) or 2) over a repaired tendon-to-bone junction (overlay group) at the time of surgical repair. Tracking of stem cells with overexpression of green fluorescent protein (GFP) were carried out at the time of sacrifice in additional 4 shoulders in each group. Histological and Biomechanical evaluation was performed to compare the differences in tendonto-bone healing. Results Histology showed increased fibrocartilage, a clear boundary at the mineralized fibrocartilage, abundant collagen type III, and higher total scores, especially in the interposition group. GFP-overexpression was observed at the transplanted site at 2 weeks after repair. Although two groups where stem cell sheets applied showed higher load to failure than the repair-only group, the load to failure was not different between the interposition and overlay group. Conclusion In the chronic rotator cuff repair model, stem cell sheets enhanced regeneration of the tendon-to-bone junction. This regeneration was effective when the stem cell sheet was interpositioned at the tendon-to-bone interface.	[Choi, Jae Hee; Shim, In Kyong; Lee, Yu Na] Univ Ulsan, Asan Med Ctr, Asan Inst Life Sci, Coll Med, Seoul, South Korea; [Shin, Myung Jin] Himchan Hosp Bupyeong, Incheon, South Korea; [Koh, Kyoung Hwan] Univ Ulsan, Asan Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center	Koh, KH (corresponding author), Univ Ulsan, Asan Med Ctr, Dept Orthopaed Surg, Coll Med, Seoul, South Korea.	osdoc.koh@gmail.com		Koh, Kyoung Hwan/0000-0002-6181-9621	Korean Fund for Regenerative Medicine - Ministry of Science and ICT; Ministry of Health and Welfare (Republic of Korea) [21C0701L1-11]; Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea [2021IP0042-1]	Korean Fund for Regenerative Medicine - Ministry of Science and ICT; Ministry of Health and Welfare (Republic of Korea)(Ministry of Health & Welfare (MOHW), Republic of Korea); Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea	This research was supported by Korean Fund for Regenerative Medicine funded by Ministry of Science and ICT, and Ministry of Health and Welfare (21C0701L1-11, Republic of Korea) and by a grant from the Asan Institute for Life Sciences, Asan Medical Center, Seoul, Korea (no. 2021IP0042-1). The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Ackermann PW, 2001, J ORTHOP RES, V19, P372, DOI 10.1016/S0736-0266(00)90029-9; Bedeir YH, 2018, ORTHOP REV, V10, DOI 10.4081/or.2018.7593; Benjamin M, 2008, J ANAT, V212, P211, DOI 10.1111/j.1469-7580.2008.00864.x; Burkhart SS, 2019, ARTHROSCOPY, V35, P12, DOI 10.1016/j.arthro.2018.11.002; Chona DV, 2017, J SHOULDER ELB SURG, V26, P2054, DOI 10.1016/j.jse.2017.07.015; Chung SW, 2016, AM J SPORT MED, V44, P1153, DOI 10.1177/0363546515627816; Dai LH, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0560-7; Denard PJ, 2011, ARTHROSCOPY, V27, P1409, DOI 10.1016/j.arthro.2011.05.015; Foolen J, 2018, MATRIX BIOL, V65, P14, DOI 10.1016/j.matbio.2017.06.002; Friese N, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21155177; Gelberman RH, 2017, CLIN ORTHOP RELAT R, V475, P2318, DOI 10.1007/s11999-017-5369-7; Grognuz A, 2016, CELL TRANSPLANT, V25, P463, DOI 10.3727/096368915X688515; Hashimoto E, 2016, J SHOULDER ELB SURG, V25, P2025, DOI 10.1016/j.jse.2016.04.024; Iannotti JP, 2013, J BONE JOINT SURG AM, V95A, P965, DOI 10.2106/JBJS.L.00708; Ide J, 2018, J ORTHOP SCI, V23, P207, DOI 10.1016/j.jos.2017.11.018; Jackson JE, 2020, J ORTHOP SURG RES, V15, DOI 10.1186/s13018-020-01692-9; Killian ML, 2016, FASEB J, V30, P301, DOI 10.1096/fj.14-258236; Kim KC, 2018, J ORTHOP SURG RES, V13, DOI 10.1186/s13018-018-0921-z; Kim SR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18490-9; Kishore V, 2012, BIOMATERIALS, V33, P2137, DOI 10.1016/j.biomaterials.2011.11.066; Lee JY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017531; Lee KW, 2017, J BIOMED MATER RES B, V105, P1840, DOI 10.1002/jbm.b.33716; Li YH, 2015, SCI REP-UK, V5, DOI 10.1038/srep13149; Liu JP, 2015, CELL PHYSIOL BIOCHEM, V35, P1831, DOI 10.1159/000373994; Liu XN, 2018, CLIN ORTHOP SURG, V10, P99, DOI 10.4055/cios.2018.10.1.99; Lorbach O, 2015, KNEE SURG SPORT TR A, V23, P530, DOI 10.1007/s00167-014-3487-2; Lui PPY, 2015, STEM CELLS CLONING, V8, P163, DOI 10.2147/SCCAA.S60832; Maffulli N, 2008, CLIN ORTHOP RELAT R, V466, P1605, DOI 10.1007/s11999-008-0261-0; Manning CN, 2011, J ORTHOP RES, V29, P1099, DOI 10.1002/jor.21301; Morikawa D, 2020, ARTHROSCOPY, V36, P80, DOI 10.1016/j.arthro.2019.07.024; Mutsuzaki H, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2614-0; Ni Ming, 2011, Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi, V25, P1103; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pak S, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29617-x; Peach MS, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174789; Peviani SM, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-27239-x; Pietschmann MF, 2013, J MATER SCI-MATER M, V24, P211, DOI 10.1007/s10856-012-4791-3; Plate JF, 2014, AM J SPORT MED, V42, P859, DOI 10.1177/0363546513518418; Qin TW, 2015, BIOMATERIALS, V51, P43, DOI 10.1016/j.biomaterials.2015.01.070; Shaw HM, 2007, SCAND J MED SCI SPOR, V17, P303, DOI 10.1111/j.1600-0838.2007.00689.x; Shimokobe H, 2017, J ORTHOP SURG RES, V12, DOI 10.1186/s13018-017-0643-7; Shin MJ, 2020, AM J SPORT MED, V48, P3347, DOI 10.1177/0363546520964445; Stanco D, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212192; Tellado SF, 2015, ADV DRUG DELIVER REV, V94, P126, DOI 10.1016/j.addr.2015.03.004; Thangarajah Tanujan, 2017, Shoulder Elbow, V9, P178, DOI 10.1177/1758573217696450; Xu H, 2012, J SHOULDER ELB SURG, V21, P580, DOI 10.1016/j.jse.2011.03.014; Yang G, 2017, TISSUE ENG PT A, V23, P166, DOI [10.1089/ten.tea.2015.0498, 10.1089/ten.TEA.2015.0498]; Yin Z, 2016, STEM CELL TRANSL MED, V5, P1106, DOI 10.5966/sctm.2015-0215; Zhu M, 2019, J SHOULDER ELB SURG, V28, P949, DOI 10.1016/j.jse.2018.11.044; Zhu Q, 2019, RSC ADV, V9, P15582, DOI 10.1039/c8ra09849b	50	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266030	10.1371/journal.pone.0266030	http://dx.doi.org/10.1371/journal.pone.0266030			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324992	gold, Green Published			2022-12-26	WOS:000780951300098
J	Urmston, J; Hyrenbach, KD; Swindle, K				Urmston, Jennifer; Hyrenbach, K. David; Swindle, Keith			Quantifying wedge-tailed shearwater (Ardenna pacifica) fallout after changes in highway lighting on Southeast O'ahu, Hawai'i	PLOS ONE			English	Article							MORTALITY; ATTRACTION; SEABIRDS	Attraction to artificial light at night (ALAN) poses a threat to many fledgling seabirds leaving their nests for the first time. In Hawai`i, fledgling wedge-tailed shearwaters disoriented by lights may become grounded due to exhaustion or collision, exposing them to additional threats from road traffic and predation. While the timing and magnitude of shearwater fallout varies from year to year, little is known about how changing lighting and environmental conditions influence the risk of grounding for this species. We analyzed 8 years (2012-2019) of observations of road-killed shearwaters along the Kalaniana`ole Highway on O`ahu to quantify the timing and magnitude of fallout during the fledging season (November-December). Our goal was to compare fallout before (2012-15) and after (2016-19) a transition in highway lighting from unshielded high-pressure sodium (HPS) to full-cutoff light-emitting diode (LED) streetlights. To detect the shearwater response to the lighting regime, we also accounted for three potential environmental drivers of interannual variability in fallout: moon illumination, wind speed, and wind direction. The effects of these environmental drivers varied across years, with moon illumination, wind speed and wind direction significantly affecting fallout in at least one year. Altogether, the interaction between moon illumination and wind speed was the most important predictor, suggesting that fallout increases during nights with low moon and strong winds. The lack of an increase in fallout after the change from HPS to shielded 3000K - 4000K LED streetlights suggests the new streetlights did not worsen the light pollution impacts on wedge-tailed shearwaters on Southeast O`ahu. However, due to potential species-specific disparities in the behavior and light attraction of petrels, similar studies are needed before energy saving LED lights are implemented throughout the Hawaiian archipelago.	[Urmston, Jennifer; Hyrenbach, K. David] Hawaii Pacific Univ, Waimanalo, HI 96813 USA; [Urmston, Jennifer; Hyrenbach, K. David] Oikonos Ecosyst Knowledge, Kailua, HI 96734 USA; [Swindle, Keith] US Fish & Wildlife Serv USFWS, US Embassy, Nairobi, Kenya; [Urmston, Jennifer] US Fish & Wildlife Serv USFWS, Migratory Bird Permit Off, Portland, OR USA		Urmston, J (corresponding author), Hawaii Pacific Univ, Waimanalo, HI 96813 USA.; Urmston, J (corresponding author), Oikonos Ecosyst Knowledge, Kailua, HI 96734 USA.	Jennifer_Urmston@fws.gov		Urmston, Jennifer/0000-0002-1909-8779	Experiment. com (Blinded by the light: reducing shearwater deaths along a coastal highway in O 'ahu, Hawai'i); Eppley Foundation for Research (Blinded by the Light: Shearwater Deaths Along a Coastal Highway in O'ahu)	Experiment. com (Blinded by the light: reducing shearwater deaths along a coastal highway in O 'ahu, Hawai'i); Eppley Foundation for Research (Blinded by the Light: Shearwater Deaths Along a Coastal Highway in O'ahu)	This work was supported by Experiment. com (Blinded by the light: reducing shearwater deaths along a coastal highway in O 'ahu, Hawai'i) and The Eppley Foundation for Research (Blinded by the Light: Shearwater Deaths Along a Coastal Highway in O'ahu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ainley DG, 2001, STUD AVIAN BIOL-SER, P108; [Anonymous], 2019, MODEL SELECTION MULT; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Cianchetti-Benedetti M, 2018, EUR J WILDLIFE RES, V64, DOI 10.1007/s10344-018-1178-x; de Grissac S, 2017, ECOL EVOL, V7, P6766, DOI 10.1002/ece3.3210; Esri Inc, 2020, ARCGIS PRO VERS 2 5; Fayet AL, 2020, J ANIM ECOL, V89, P16, DOI 10.1111/1365-2656.13162; Friswold B, 2020, MAR ORNITHOL, V48, P245; Glass JP, 2013, AFR J MAR SCI, V35, P589, DOI 10.2989/1814232X.2013.860049; Hart NS, 2004, J EXP BIOL, V207, P1229, DOI 10.1242/jeb.00857; Hoef JMV, 2007, ECOLOGY, V88, P2766, DOI 10.1890/07-0043.1; Hyrenbach K. David, 2011, Elepaio, V71, P17; Hyrenbach KD, 2021, ELEPAIO, V82, P1; Le Corre M, 2002, BIOL CONSERV, V105, P93, DOI 10.1016/S0006-3207(01)00207-5; LEOPOLD LB, 1949, J METEOROL, V6, P312, DOI 10.1175/1520-0469(1949)006<0312:TIOTWA>2.0.CO;2; Longcore T, 2018, HAZARD HOPE RES LIGH, V70, P52; Longcore T, 2018, J EXP ZOOL PART A, V329, P511, DOI 10.1002/jez.2184; Michael PE, 2014, FISH OCEANOGR, V23, P18, DOI 10.1111/fog.12039; Pacific Islands Ocean Observing System (PacIOOS), 2019, WEATH OBS MOK O AH; Podolsky R, 1998, COLON WATERBIRD, V21, P20, DOI 10.2307/1521727; Raine H, 2007, LIGHT POLLUTION ITS; RCore Team, 2020, R LANG ENV STAT COMP; REED JR, 1985, AUK, V102, P377, DOI 10.2307/4086782; Rodriguez A, 2012, ANIM CONSERV, P00477, DOI [10.1111/j.1469-1795.2011, DOI 10.1111/J.1469-1795.2011]; Rodriguez A, 2017, J NAT CONSERV, V39, P68, DOI 10.1016/j.jnc.2017.07.001; Rodriguez A, 2017, CONSERV BIOL, V31, P986, DOI 10.1111/cobi.12900; Rodriguez A, 2015, J ORNITHOL, V156, P893, DOI 10.1007/s10336-015-1232-3; Rodriguez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110114; Rodriguez A, 2009, IBIS, V151, P299, DOI 10.1111/j.1474-919X.2009.00925.x; Schulte-Romer N, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11216160; Syposz M, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97986-x; Syposz M, 2018, IBIS, V160, P846, DOI 10.1111/ibi.12594; TELFER TC, 1987, WILDLIFE SOC B, V15, P406; Travers MS, 2021, AVIAN CONSERV ECOL, V16, DOI 10.5751/ACE-01841-160115; U.S. Naval Observatory, 2018, FRACT MOON ILL; Work TM, 1999, J WILDLIFE DIS, V35, P487, DOI 10.7589/0090-3558-35.3.487	36	1	1	5	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265832	10.1371/journal.pone.0265832	http://dx.doi.org/10.1371/journal.pone.0265832			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324966	gold, Green Published			2022-12-26	WOS:000780951300077
J	Veseli, B; Sandner, S; Studte, S; Clement, M				Veseli, Besarta; Sandner, Sabrina; Studte, Sinika; Clement, Michel			The impact of COVID-19 on blood donations	PLOS ONE			English	Article							PLANNED BEHAVIOR; MORTALITY SALIENCE; DONOR; SATISFACTION; MOTIVATION	During a crisis, society calls for individuals to take prosocial actions that promote crisis management. Indeed, individuals show higher willingness to help after a disaster. However, the COVID-19 pandemic presents significant differences as it is an ongoing crisis that affects all individuals and has the potential to pose a direct health threat to anyone. Therefore, we propose that the pandemic may also negatively affect willingness to help, specifically blood donation intentions. It requires a high level of willingness to donate blood beyond the crisis outbreak, as more blood will be needed when postponed surgeries resume. When comparing blood donation intentions from a pre-pandemic study to results from a six-wave (biweekly) panel study conducted in Germany during the first pandemic phase (April to June 2020), we find lower medium and long-term blood donation intentions. While active donors show increased awareness of ability and eligibility to donate at the beginning of the pandemic compared to pre-pandemic, they feel significantly less able to donate as the pandemic progresses. Furthermore, inactive donors' perceived ability to donate significantly decreases in the pandemic phase compared to the pre-pandemic phase. Crucially, both active and inactive donors feel less responsible and less morally obliged to donate, resulting in an overall negative pandemic effect on blood donation intentions. The COVID-19 pandemic compromises blood donations endangering the life-saving blood supply. These alarming results offer evidence-based grounds for practical implications for driving donations in the event of a pandemic.	[Veseli, Besarta; Sandner, Sabrina; Studte, Sinika; Clement, Michel] Univ Hamburg, Hamburg Business Sch, Inst Mkt, Hamburg, Germany	University of Hamburg	Clement, M (corresponding author), Univ Hamburg, Hamburg Business Sch, Inst Mkt, Hamburg, Germany.	michel.clement@uni-hamburg.de	Clement, Michel/GQQ-1785-2022	Sandner, Sabrina/0000-0002-2534-7372; Veseli, Besarta/0000-0002-0212-802X; Clement, Michel/0000-0001-6769-6709	German Red Cross Blood Donation Services	German Red Cross Blood Donation Services	The author(s) received no specific funding for this work. We wish to note that Sinika Studte receives a scholarship from the German Red Cross Blood Donation Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A rzteZeitung, 2021, BED BLUTSP DIES SOMM; AJZEN I, 1991, ORGAN BEHAV HUM DEC, V50, P179, DOI 10.1016/0749-5978(91)90020-T; American Red Cross, IMP BLOOD SUPPL; Armitage CJ, 2001, BRIT J SOC PSYCHOL, V40, P471, DOI 10.1348/014466601164939; Bandura A., 1997, SELF EFFICACY EXERCI, P36, DOI 10.1007/SpringerReference_223312; Berman JZ, 2018, PSYCHOL SCI, V29, P834, DOI 10.1177/0956797617747648; Blackie LER, 2011, PSYCHOL SCI, V22, P998, DOI 10.1177/0956797611415542; Cryder CE, 2013, ORGAN BEHAV HUM DEC, V120, P15, DOI 10.1016/j.obhdp.2012.08.002; Dariotis J, 2001, TRANSFUSION, V41, P1181, DOI 10.1046/j.1537-2995.2001.41101181.x; Diamond WD, 1997, J APPL SOC PSYCHOL, V27, P915, DOI 10.1111/j.1559-1816.1997.tb00278.x; Donovan L, 2021, CITY LIMITS; Duncan B, 2004, J PUBLIC ECON, V88, P2159, DOI 10.1016/S0047-2727(03)00037-9; Erlandsson A, 2015, ORGAN BEHAV HUM DEC, V127, P1, DOI 10.1016/j.obhdp.2014.11.003; Eschner K., 2021, FORTUNE; Feeny S, 2007, AUST ECON REV, V40, P24, DOI 10.1111/j.1467-8462.2007.00439.x; Ferguson E, 2012, TRANSFUSION, V52, P343, DOI 10.1111/j.1537-2995.2011.03279.x; Ferraro R, 2005, J CONSUM RES, V32, P65, DOI 10.1086/429601; Giles M, 2004, HEALTH EDUC RES, V19, P380, DOI 10.1093/her/cyg063; Goette L, 2020, J ECON BEHAV ORGAN, V170, P52, DOI 10.1016/j.jebo.2019.11.021; Grant AM, 2007, ORGAN BEHAV HUM DEC, V103, P53, DOI 10.1016/j.obhdp.2006.05.004; Haw J, 2021, VOX SANG, V116, P363, DOI 10.1111/vox.12974; Hess JR, 2003, TRANSFUSION, V43, P1622, DOI 10.1046/j.1537-2995.2003.00576.x; Hutchinson Bill, 2020, ABC NEWS; Ja hnert C., 2020, TAGESSCHAU; Kessler JB, 2018, MANAGE SCI, V64, P845, DOI 10.1287/mnsc.2016.2582; Lee LC, 1999, SOC PSYCHOL QUART, V62, P276, DOI 10.2307/2695864; Lemmens KPH, 2009, BRIT J PSYCHOL, V100, P71, DOI 10.1348/000712608X310237; Manstead ASR, 2000, APPL SOCIAL RES ATTI; Markowitz EM, 2013, JUDGM DECIS MAK, V8, P397; Nepogodiev D, 2020, BRIT J SURG, V107, P1440, DOI 10.1002/bjs.11746; Newman GE, 2019, NONPROF VOLUNT SEC Q, V48, P71, DOI 10.1177/0899764018794903; ntv, 2020, OP WARD NACHG BLUTB; Piliavin J. A., 1991, GIVING BLOOD DEV ALT; Poier A., 2021, SWR; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Shehu E, 2015, EUR J HEALTH ECON, V16, P733, DOI 10.1007/s10198-014-0625-1; Smith JR, 2007, J COMMUNITY APPL SOC, V17, P363, DOI 10.1002/casp.906; Spekman MLC, 2021, TRANSFUSION, V61, P1822, DOI 10.1111/trf.16334; Studte S, 2019, TRANSFUSION, V59, P1002, DOI 10.1111/trf.15085; Thomas SA, 2015, INT J RES MARK, V32, P48, DOI 10.1016/j.ijresmar.2014.09.001; van Dongen A, 2015, TRANSFUSION MED, V25, P227, DOI 10.1111/tme.12249; Verbeek M., 2009, GUIDE MODERN ECONOME, V3rd; Veseli Besarta, 2021, ISBT Sci Ser, V16, P158, DOI 10.1111/voxs.12626; Yu A., 2020, WHYY; Zaleskiewicz T, 2015, J EXP SOC PSYCHOL, V59, P67, DOI 10.1016/j.jesp.2015.03.005; Zou SM, 2006, TRANSFUS MED REV, V20, P181, DOI 10.1016/j.tmrv.2006.03.001	46	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265171	10.1371/journal.pone.0265171	http://dx.doi.org/10.1371/journal.pone.0265171			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324952	gold, Green Published			2022-12-26	WOS:000780951300031
J	Diaz-Seradilla, E; Rodriguez-Fernandez, A; Rodriguez-Marroyo, JA; Castillo, D; Raya-Gonzalez, J; Vicente, JGV				Diaz-Seradilla, Elba; Rodriguez-Fernandez, Alejandro; Rodriguez-Marroyo, Jose Antonio; Castillo, Daniel; Raya-Gonzalez, Javier; Villa Vicente, Jose Gerardo			Inter- and intra-microcycle external load analysis in female professional soccer players: A playing position approach	PLOS ONE			English	Article							TRAINING-LOAD; PHYSICAL PERFORMANCE; INJURY RISK; QUANTIFICATION; SEASON; PERIODIZATION; VARIABILITY; WORKLOAD; DEMANDS; PERIODS	This study analyzes the inter- and intra-differences in external load across the microcycle in professional female soccer players. External load during four consecutive microcycles (i.e., M1, M2, M3, and M4) and training sessions (i.e., MD-4, MD-3, MD-2, and MD-1) and a match day (i.e., MD) were registered in seventeen female professional soccer players (age: 26.3 +/- 4.6 years; height: 166.3 +/- 6.1 cm; body mass: 59.8 +/- 6.8 kg; and body mass index: 21.6 +/- 1.7 kg.m-2) who belonged to the same team in Spanish first division. A 10-Hz GPS that integrated a 100-Hz triaxial accelerometer was used to register external load. The results showed lower decelerations in M2 compared to M1 and M3 (p < 0.05), lower highintensity distance (>16.0 km.h(-1)) in M3 vs. M2, and greater relative sprint distance (>21.0 km.min(-1)) in M4 vs. M1 and M3 (p < 0.05). MD-3 registered the highest load for all variables (p < 0.05). Forwards (FWs) performed (p < 0.05) significantly more sprints (meters and number > 21.0 km.h(-1)) than central midfielders (CMs) and central defenders (CDs) in MD-2 and MD. Both, fitness and conditioning staff should pay special attention to the external loads for each playing position in training sessions to optimize the training process.	[Diaz-Seradilla, Elba; Villa Vicente, Jose Gerardo] Univ Leon, Fac Sci Phys Act & Sports, Leon, Spain; [Rodriguez-Fernandez, Alejandro; Rodriguez-Marroyo, Jose Antonio] Univ Leon, Fac Sci Phys Act & Sports, Inst Biomed IBIOMED, VALFIS Res Grp, Leon, Spain; [Castillo, Daniel; Raya-Gonzalez, Javier] Univ Isabel I, Fac Hlth Sci, Burgos, Spain; [Villa Vicente, Jose Gerardo] Univ Valladolid, Fac Sci Educ, Soria, Spain	Universidad de Leon; Universidad de Leon; Universidad de Valladolid	Rodriguez-Fernandez, A (corresponding author), Univ Leon, Fac Sci Phys Act & Sports, Inst Biomed IBIOMED, VALFIS Res Grp, Leon, Spain.	alrof@unileon.es	Raya-González, Javier/GQZ-1235-2022; Rodríguez, Alejandro/GSI-6215-2022	Raya-Gonzalez, Javier/0000-0002-3570-7159; Rodriguez-Fernandez, Alejandro/0000-0002-0893-7573; Diaz-Serradilla, Elba/0000-0003-3618-6292; Castillo, Daniel/0000-0002-4159-6475				Ade JD, 2014, INT J SPORT PHYSIOL, V9, P471, DOI [10.1123/ijspp.2013-0390, 10.1123/IJSPP.2013-0390]; Andersson HA, 2010, J STRENGTH COND RES, V24, P912, DOI 10.1519/JSC.0b013e3181d09f21; Bradley PS, 2018, INT J SPORT PHYSIOL, V13, P656, DOI 10.1123/ijspp.2017-0433; Bradley PS, 2015, INT J SPORT PHYSIOL, V10, P112, DOI 10.1123/ijspp.2014-0212; Bradley PS, 2014, HUM MOVEMENT SCI, V33, P159, DOI 10.1016/j.humov.2013.07.024; Bradley PS, 2010, J STRENGTH COND RES, V24, P2343, DOI 10.1519/JSC.0b013e3181aeb1b3; Buchheit M, 2019, SPORTS PERFOR SCI RE, V53, P1; Buchheit M, 2018, INT J SPORT PHYSIOL, V13, P577, DOI 10.1123/ijspp.2017-0045; Bush MD, 2015, INT J SPORT PHYSIOL, V10, P865, DOI 10.1123/ijspp.2014-0484; Carling C, 2016, J SPORT SCI, V34, P2215, DOI 10.1080/02640414.2016.1176228; Carling C, 2012, J SPORT SCI, V30, P325, DOI 10.1080/02640414.2011.652655; Castillo D, 2021, J STRENGTH COND RES, V35, P3453, DOI 10.1519/JSC.0000000000003363; Clemente FM, 2021, BIOL SPORT, V38, P37, DOI 10.5114/biolsport.2020.97068; Clemente FM, 2020, BIOL SPORT, V37, P389, DOI 10.5114/biolsport.2020.96852; Datson N, 2017, J STRENGTH COND RES, V31, P2379, DOI 10.1519/JSC.0000000000001575; Gomez-Carmona CD, 2018, SPORTS, V6, DOI 10.3390/sports6040173; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Duhig S, 2016, BRIT J SPORT MED, V50, P1536, DOI 10.1136/bjsports-2015-095679; Fessi MS, 2016, J SPORT SCI, V34, P2189, DOI 10.1080/02640414.2016.1171891; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gentles JA, 2018, SPORTS, V6, DOI 10.3390/sports6010016; Hulin BT, 2016, BRIT J SPORT MED, V50, P231, DOI 10.1136/bjsports-2015-094817; Krustrup P, 2005, MED SCI SPORT EXER, V37, P1242, DOI 10.1249/01.mss.0000170062.73981.94; Malone JJ, 2017, INT J SPORT PHYSIOL, V12, P18, DOI 10.1123/ijspp.2016-0236; Malone JJ, 2015, INT J SPORT PHYSIOL, V10, P489, DOI 10.1123/ijspp.2014-0352; Malone S, 2017, J SCI MED SPORT, V20, P250, DOI 10.1016/j.jsams.2016.08.005; Mara JK, 2015, INT J SPORT PHYSIOL, V10, P664, DOI 10.1123/ijspp.2014-0345; Martin-Garcia A, 2018, J STRENGTH COND RES, V32, P3511, DOI 10.1519/JSC.0000000000002816; McFadden BA, 2020, J STRENGTH COND RES, V34, P969, DOI 10.1519/JSC.0000000000003485; Meylan C, 2017, INT J SPORT PHYSIOL, V12, P310, DOI 10.1123/ijspp.2015-0520; Mohr M, 2008, J STRENGTH COND RES, V22, P341, DOI 10.1519/JSC.0b013e318165fef6; Mujika I, 2018, INT J SPORT PHYSIOL, V13, P538, DOI 10.1123/ijspp.2018-0093; Munoz-Lopez A, 2017, J HUM SPORT EXERC, V12, P156, DOI 10.14198/jhse.2017.121.13; Oliveira R, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0209393; Otte FW, 2020, J SPORT SCI, V38, P1465, DOI 10.1080/02640414.2019.1643202; Owen AL, 2017, INT J SPORTS SCI COA, V12, P665, DOI 10.1177/1747954117727851; Pedersen AV, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00762; Stevens TGA, 2017, SCI MED FOOTBALL, V1, P117, DOI 10.1080/24733938.2017.1282163; Strauss A, 2019, J SPORT SCI MED, V18, P73; Thorpe RT, 2017, INT J SPORT PHYSIOL, V12, P27, DOI 10.1123/ijspp.2016-0434; Vescovi JD, 2019, EUR J SPORT SCI, V19, P141, DOI 10.1080/17461391.2018.1491628; Vescovi JD, 2014, INT J SPORT PHYSIOL, V9, P405, DOI 10.1123/IJSPP.2013-0526; Walker GJ, 2018, STRENGTH COND J, V40, P72, DOI 10.1519/SSC.0000000000000345	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0264908	10.1371/journal.pone.0264908	http://dx.doi.org/10.1371/journal.pone.0264908			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316297	Green Published, gold			2022-12-26	WOS:000834238000013
J	Anto, EO; Coall, DA; Asiamah, EA; Afriyie, OO; Addai-Mensah, O; Wiafe, YA; Owiredu, W; Obirikorang, C; Annani-Akollor, ME; Titiloye, NA; Adua, E; Acheampong, E; Adu, EA; Opoku, S; Anto, AO; Tawiah, A; Wang, YX; Wang, W				Anto, Enoch Odame; Coall, David Antony; Asiamah, Emmanuel Akomanin; Afriyie, Osei-Owusu; Addai-Mensah, Otchere; Wiafe, Yaw Amo; Owiredu, Wkba; Obirikorang, Christian; Annani-Akollor, Max Efui; Titiloye, Nicholas Akinwale; Adua, Eric; Acheampong, Emmanuel; Adu, Evans Asamoah; Opoku, Stephen; Anto, Agartha Odame; Tawiah, Augustine; Wang, Youxin; Wang, Wei			Placental lesions and differential expression of pro-and anti-angiogenic growth mediators and oxidative DNA damage marker in placentae of Ghanaian suboptimal and optimal health status pregnant women who later developed preeclampsia	PLOS ONE			English	Article							SYNCYTIAL KNOTS; UMBILICAL-CORD; EARLY-ONSET; HYPERTENSION; PATHOGENESIS; PREDICTION; RECEPTOR-1; MANAGEMENT; STRESS; RATIO	BackgroundAngiogenic growth mediators (AGMs) and oxidative stress (OS) both play essential roles in normal placental vascular development and as such, placental alterations in these factors contribute to pre-eclampsia (PE). Suboptimal health status (SHS), an intermediate between health and disease, has been associated with imbalanced AGMs and OS biomarkers. Thus, SHS pregnant women may be at increased risk of developing PE and may present abnormal placental alteration and expression of AGMs and OS compared to optimal health status (OHS) pregnant women. We examined the histopathological morphology, immunohistochemical expression of AGMs antibodies and oxidative DNA damage marker in the placentae of SHS and OHS pregnant women who developed early-onset PE (EO-PE) and late-onset (LO-PE) compared to normotensive pregnancy (NTN-P). MethodsThis nested case-control study recruited 593 singleton normotensive pregnant women at baseline (10-20 weeks gestation) from the Ghanaian Suboptimal Health Status Cohort Study (GHOACS) undertaken at the Komfo Anokye Teaching Hospital, Ghana. Socio-demographic, clinical and obstetrics data were collected, and a validated SHS questionnaire-25 (SHSQ-25) was used in classifying participants into SHS (n = 297) and OHS (n = 296). Participants were followed until the time of PE diagnosis and delivery (32-42 weeks gestation). Blood samples were collected at the two-time points and were assayed for AGMs; soluble fms-like tyrosine kinase-1 (sFlt-1), placental growth factor (PIGF), vascular endothelial growth factor-A (VEGF-A), and soluble endoglin (sEng), and OS biomarkers; 8-hydroxydeoxyguanosine (8-OHdG), 8-epiprostaglandinF2-alpha (8- epi-PGF2 alpha) and total antioxidant capacity (TAC) using ELISA. Placental samples were collected for histopathological and immunohistochemical analysis. ResultsOf the 593 pregnant women, 498 comprising 248 SHS and 250 OHS women returned for delivery and were included in the final analysis. Of the 248 SHS women, 56, 97 and 95 developed EO-PE, LO-PE and NTN-P, respectively, whereas 14, 30 and 206 of the 250 OHS mothers developed EO-PE, LO-PE and NTN-P, respectively. At baseline, SHS_NTN pregnant women had a significant imbalance in AGMs and OS biomarkers compared to OHS_NTN pregnant women (p<0.0001). At the time of PE diagnosis, SHS_NTN-P women who developed EO-PE, LO-PE, and NTN-P had lower serum levels of P1GF, VEGF-A and TAC and correspondingly higher levels of sEng, sFlt-1, 8-epiPGF2 alpha, and 8-OHdG than OHS-NTN-P women who developed EO-PE and LO-PE, NTN-P (p<0.0001). A reduced placental size, increased foetal/placental weight ratio, and a significantly higher proportion of fibrinoid necrosis, infarction, villous fibrin, syncytial knots, calcification, chorangiosis, tunica media/vascular wall hypertrophy and chorioamnionitis was associated with the SHS group who developed PE (EO-PE>LO-PE) more than OHS groups who developed PE (EO-PE>LO-PE) when all were compared to NTN-P (p<0.0001). The intensity of antibody expression of PIGF and VEGF-A were significantly reduced, whereas Flt-1, Eng and 8-OHdG were significantly increased in placentae from SHS-pregnant women who developed EO-PE>LO-PE more than OHS- pregnant women who developed EO-PE>LO-PE when all were compared to NTN-P (p<0.0001). ConclusionIncreased lesions, oxidative DNA damage, and imbalanced expression between pro-and anti-AGMs are associated more with SHS-embodied PE placentae rather than OHS-embodied PE subtypes, thus potentially allowing differential evaluation of PE.	[Anto, Enoch Odame; Addai-Mensah, Otchere; Wiafe, Yaw Amo; Opoku, Stephen] Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Dept Med Diagnost, Kumasi, Ghana; [Anto, Enoch Odame; Coall, David Antony; Adua, Eric; Acheampong, Emmanuel; Wang, Wei] Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia; [Anto, Enoch Odame; Coall, David Antony; Acheampong, Emmanuel; Wang, Wei] Edith Cowan Univ, Ctr Precis Hlth, ECU Strateg Res Ctr, Perth, WA, Australia; [Asiamah, Emmanuel Akomanin] Univ Hlth & Allied Sci, Sch Allied Hlth Sci, Dept Med Lab Sci, Ho, Ghana; [Afriyie, Osei-Owusu] Ghana Police Hosp, Dept Pathol, Accra, Ghana; [Afriyie, Osei-Owusu; Titiloye, Nicholas Akinwale] Komfo Anokye Teaching Hosp, Dept Pathol, Kumasi, Ghana; [Owiredu, Wkba; Obirikorang, Christian; Annani-Akollor, Max Efui; Adu, Evans Asamoah] Kwame Nkrumah Univ Sci & Technol, Dept Mol Med, Kumasi, Ghana; [Adua, Eric] Univ New South Wales, Rural Clin Sch, Med & Hlth, Wagga Wagga, NSW, Australia; [Anto, Agartha Odame] Univ Hlth & Allied Sci, Sch Allied Hlth Sci, Dept Nursing & Midwifery, Ho, Ghana; [Tawiah, Augustine] Komfo Anokye Teaching Hosp, Dept Obstet & Gynaecol, Kumasi, Ghana; [Wang, Youxin] Capital Med Univ, Sch Publ Hlth, Beijing Key Lab Clin Epidemiol, Beijing, Peoples R China	Kwame Nkrumah University Science & Technology; Edith Cowan University; Edith Cowan University; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; University of New South Wales Sydney; Kwame Nkrumah University Science & Technology; Capital Medical University	Anto, EO (corresponding author), Kwame Nkrumah Univ Sci & Technol, Coll Hlth Sci, Dept Med Diagnost, Kumasi, Ghana.; Anto, EO (corresponding author), Edith Cowan Univ, Sch Med & Hlth Sci, Perth, WA, Australia.; Anto, EO (corresponding author), Edith Cowan Univ, Ctr Precis Hlth, ECU Strateg Res Ctr, Perth, WA, Australia.	odameenoch@yahoo.com	liu, li/HGC-0900-2022; ASIAMAH, EMMANUEL AKOMANIN/CAA-5947-2022	Opoku, Stephen/0000-0002-1949-2338; ASIAMAH, EMMANUEL/0000-0001-7910-3704; wang, wei/0000-0002-1430-1360	Joint Project of the Australian National Health and Medical Research Council [NHMRC-APP1112767]; National Natural Science Foundation of China [NSFC-81561128020]; Edith Cowan University (ECU)-Collaborative Enhancement scheme Round 1 [G1003363]	Joint Project of the Australian National Health and Medical Research Council; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Edith Cowan University (ECU)-Collaborative Enhancement scheme Round 1	This study was partially supported by the Joint Project of the Australian National Health and Medical Research Council, # (NHMRC-APP1112767), the National Natural Science Foundation of China, #(NSFC-81561128020) and Edith Cowan University (ECU)-Collaborative Enhancement scheme Round1, #(G1003363)to WW and EOA. The funders had no role in study design, data collection and analysis, decision to publish,or preparation of the manuscripT.	Agrawal S, 2018, HYPERTENSION, V71, P306, DOI 10.1161/HYPERTENSIONAHA.117.10182; Ahenkorah L., 2009, METABOLIC SYNDROME O, DOI [10.1111/j.1582-4934.2008.00363.x, DOI 10.1111/J.1582-4934.2008.00363.X]; Anto EO, 2020, FREE RADICAL RES, V54, P27, DOI 10.1080/10715762.2019.1685668; Anto EO, 2019, EPMA J, V10, P211, DOI 10.1007/s13167-019-00183-0; Anto Enoch Odame, 2018, Current Pharmacogenomics & Personalized Medicine, V16, P167, DOI 10.2174/1875692117666181207120011; Anto EO, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200581; Aouache R, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19051496; Armaly Z, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.00973; Baltajian K, 2014, HYPERTENS PREGNANCY, V33, P427, DOI 10.3109/10641955.2014.926914; Blanco MV, 2011, J CLIN HYPERTENS, V13, P30, DOI 10.1111/j.1751-7176.2010.00384.x; Burton GJ, 2019, BMJ-BRIT MED J, V366, DOI 10.1136/bmj.l2381; Caillon H, 2018, ANN LAB MED, V38, P95, DOI 10.3343/alm.2018.38.2.95; Chau K, 2017, J HUM HYPERTENS, V31, P782, DOI 10.1038/jhh.2017.61; Fukushima K, 2011, AM J HYPERTENS, V24, P829, DOI 10.1038/ajh.2011.40; Girish BL, 2015, J EVOL MED DENT SCI-, V4, P14444, DOI 10.14260/jemds/2015/2055; Goswami P., 2015, INT J RES MED SCI, V3, P1081; Goswami PR, 2016, INT J SCI STUDY, V4, P58, DOI 10.17354/ijss/2016/526; Gu Y, 2008, J CLIN ENDOCR METAB, V93, P260, DOI 10.1210/jc.2007-1550; Guller S, 2008, ANN NY ACAD SCI, V1127, P129, DOI 10.1196/annals.1434.015; Gunyeli I, 2011, J TURK-GER GYNECOL A, V12, P75, DOI 10.5152/jtgga.2011.19; Heazell AEP, 2007, PLACENTA, V28, pS33, DOI 10.1016/j.placenta.2006.10.007; Herman HG, 2019, J PERINATOL, V39, P581, DOI 10.1038/s41372-019-0327-8; Honigberg MC, 2016, J PERINATOL, V36, P172, DOI 10.1038/jp.2015.170; Husse S, 2014, Z GEBURTSH NEONATOL, V218, P34, DOI 10.1055/s-0034-1368713; Kahveci B, 2018, BMC PREGNANCY CHILDB, V18, DOI 10.1186/s12884-018-1984-x; Kovo M, 2012, PRENATAL DIAG, V32, P632, DOI 10.1002/pd.3872; Krielessi V, 2012, OBSTET GYNECOL INT, V2012, DOI 10.1155/2012/684083; Kupaev V, 2016, EPMA J, V7, DOI 10.1186/s13167-016-0068-0; Lana YH, 2018, HYPERTENS PREGNANCY, V37, P105, DOI 10.1080/10641955.2017.1420799; Linde LE, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194814; Nahar L, 2015, Mymensingh Med J, V24, P9; Ojha K., 2018, NEPALESE MED J, V1, P32; Owiredu W., 2010, J GHANA SCI ASS, V12, P48; Pereira RD, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/814543; Phipps E, 2016, CLIN J AM SOC NEPHRO, V11, P1102, DOI 10.2215/CJN.12081115; Pratt A, 2015, ANGIOGENESIS, V18, P115, DOI 10.1007/s10456-014-9452-3; Rajakumar A, 2012, HYPERTENSION, V59, P256, DOI 10.1161/HYPERTENSIONAHA.111.182170; Roberts JM, 2013, OBSTET GYNECOL, V122, P1122, DOI 10.1097/01.AOG.0000437382.03963.88; Roberts JM, 2012, PREGNANCY HYPERTENS, V2, P72, DOI 10.1016/j.preghy.2012.01.001; Rutherford JN, 2019, PLACENTA, V85, P40, DOI 10.1016/j.placenta.2019.08.076; Salmani Deepalaxmi, 2014, J Nat Sci Biol Med, V5, P352, DOI 10.4103/0976-9668.136182; Sankar KD, 2012, ANAT CELL BIOL, V45, P86, DOI 10.5115/acb.2012.45.2.86; Schoots MH, 2018, PLACENTA, V69, P153, DOI 10.1016/j.placenta.2018.03.003; Seki H, 2014, ACTA OBSTET GYN SCAN, V93, P959, DOI 10.1111/aogs.12473; Takagi Y, 2004, VIRCHOWS ARCH, V444, P49, DOI 10.1007/s00428-003-0903-2; Tranquilli AL, 2013, PREGNANCY HYPERTENS, V3, P44, DOI [10.1016/j.preghy.2012.11.001, 10.1016/j.preghy.2013.04.006]; Tripathi R, 2008, ANN ANAT, V190, P477, DOI 10.1016/j.aanat.2008.08.002; Turpin CA, 2015, BMC PREGNANCY CHILDB, V15, DOI 10.1186/s12884-015-0624-y; Wang W, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-28; Wang YX, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15101-5; Wang YX, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-1046-y; Weel IC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157584; Wu F, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/293271; Yan YX, 2009, J EPIDEMIOL, V19, P333, DOI 10.2188/jea.JE20080086; Yasoob M, 2014, PAK J MED HEALTH SCI, V8, P545; Zhang XJ, 2016, BIOL TRACE ELEM RES, V170, P119, DOI 10.1007/s12011-015-0438-9	56	0	0	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265717	10.1371/journal.pone.0265717	http://dx.doi.org/10.1371/journal.pone.0265717			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312727	gold, Green Published			2022-12-26	WOS:000803647900029
J	Belay, DG; Andualem, Z				Belay, Daniel Gashaneh; Andualem, Zewdu			Limited access to improved drinking water, unimproved drinking water, and toilet facilities among households in Ethiopia: Spatial and mixed effect analysis	PLOS ONE			English	Article							BRIEF CONCEPTUAL TUTORIAL; SOCIAL EPIDEMIOLOGY; MULTILEVEL ANALYSIS; SANITATION; DISEASE	BackgroundMost people in sub-Saharan countries had limited drinking water services and toilet facilities. The collection of water can affect the health of the whole family, particularly children. Therefore this study aims to investigate determinants of limited access to drinking water services and spatial distributions of limited access to drinking water services, unimproved drinking water sources, and toilet facilities among households in Ethiopia. MethodCross-sectional collected secondary data analysis was conducted based on the 2016 Ethiopian Demographic and Health Survey (EDHS). A mixed-effect logistic regression model was used for analysis. The total weighted sample of 10, 183 households was included in the analysis. The study population is comprised of all households who had recorded the time taken to fetch improved drinking water during the survey. The primary outcome of this study is the proportion of households that have limited access to drinking water services. Whereas the secondary outcomes are determinants of limited access to drinking water services and spatial distributions of limited drinking water services, unimproved drinking water sources, and toilet facilities among households in Ethiopia. ResultsIn this study, 39.74% [95% CI: 38.79, 40.69] of households in Ethiopia had limited access to drinking water services. This proportion ranges from 2.64% in Addis Ababa to 57.35% in the Somali region. Household head, education, residence, and regions were associated with limited access to drinking water services. The spatial analysis showed that the eastern part of Amhara, Afar and the Somali region predicted the highest limited drinking water services. The unimproved drinking water source was detected in the Central part of Amhara, Somalia regions. Almost all regions except Addis Ababa and Diredewa predicted the highest prevalence of unimproved toilet facilities. ConclusionAccess to improved drinking water is relatively poor throughout Ethiopia, with some regions experiencing more limited access than others. From individual level variables age, educational level, and sex household head, whereas from community level variables residences, and region were factors significantly associated with access to limited drinking water services. The spatial analysis confirmed that there are inequalities in unimproved drinking water sources, and toilet facilities between regions in Ethiopia. The government of Ethiopia should work to increase the accessibility of improved drinking water at the national level and to narrow the gap in its accessibility between urban and rural residences and between regions. Accessibility to drinking water programs should focus on the disadvantaged group such as non-educated, male head households and living rural residences. All stalk holders should work to improve the quality of drinking water and sanitation facilities.	[Belay, Daniel Gashaneh] Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia; [Belay, Daniel Gashaneh] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia; [Andualem, Zewdu] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Environm & Occupat Hlth & Safety, Gondar, Ethiopia	University of Gondar; University of Gondar; University of Gondar	Belay, DG (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Sch Med, Dept Human Anat, Gondar, Ethiopia.; Belay, DG (corresponding author), Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Dept Epidemiol & Biostat, Gondar, Ethiopia.	danielgashaneh28@gmail.com		Belay, Daniel Gashaneh/0000-0002-5724-6234; Andualem, Zewudu/0000-0002-4731-1696				Armah FA, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00931; Azage M, 2020, HELIYON, V6, DOI 10.1016/j.heliyon.2020.e03828; Bain R, 2020, NPJ CLEAN WATER, V3, DOI 10.1038/s41545-020-00085-z; Beyene A, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1804-4; Bluma M, GLOBAL MAJORITY E J; Cassivi A, 2018, J WATER HEALTH, V16, P661, DOI 10.2166/wh.2018.009; Centers for Disease Control and Prevention, 2021, GLOB WAT SAN HYG WAS; Croft, 2020, GUIDE DHS STAT; Freeman MC, 2017, INT J HYG ENVIR HEAL, V220, P928, DOI 10.1016/j.ijheh.2017.05.007; Gebremichael S.G., 2020, BIORXIV; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Liyew AM, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08934-9; McMillen DP, 2004, AM J AGR ECON, V86, P554, DOI 10.1111/j.0002-9092.2004.600_2.x; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P1022, DOI 10.1136/jech.2004.028035; Merlo J, 2005, J EPIDEMIOL COMMUN H, V59, P443, DOI 10.1136/jech.2004.023473; Mills JE., 2016, DFID EVIDENCE PAPER; Morakinyo OM, 2015, ARCH PUBLIC HEALTH, V73, DOI 10.1186/s13690-015-0105-9; Mulenga J.N., 2017, INT J DEV SUSTAIN, V6, P746; Pickering AJ, 2012, ENVIRON SCI TECHNOL, V46, P2391, DOI 10.1021/es203177v; Pruss A, 2002, ENVIRON HEALTH PERSP, V110, P537, DOI 10.1289/ehp.02110537; Pruss-Ustun A, 2019, INT J HYG ENVIR HEAL, V222, P765, DOI 10.1016/j.ijheh.2019.05.004; Sarmento D.R., 2015, TIMOR LESTE ASSESSIN; SDG Knowledge Hub, 2020, WHO PUBL GLOB REV WA; Simelane Maswati S., 2020, ADV PUBLIC HLTH; Supply W.U.J.W., 2005, WATER LIFE MAKING IT; Thi THT, 2016, AIMS PUBLIC HEALTH, V3, P880, DOI 10.3934/publichealth.2016.4.880; UNICEF, 2016, COLL WAT IS OFT COL; UNICEF, 2021, WATER SANITATION HYG; UNICEF, 2020, KEN WAT CRIS KEN WAT; United Nations Children's Fund (UNICEF), 2019, PROGR HOUS DRINK WAT; USAID, 2011, WOM WAT WAT ALL CAMP; WHO/UNICEF, 2017, SAF MAN DRINK WAT TH; WHO/UNICEF-Joint Monitoring Program, 2010, PROGR SAN DRINK WAT; WHO W.H.O. World Health Organization (WHO) and the United Nations Children's Fund (UNICEF), 2017, JMP METH; Women U., 2014, BURDENSOME REALITY W; Worldometer, 2021, AFR COUNTR POP 2021	36	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266555	10.1371/journal.pone.0266555	http://dx.doi.org/10.1371/journal.pone.0266555			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363836	Green Published, gold			2022-12-26	WOS:000804748600053
J	Gao, YK; Guo, RJ; Xu, X; Huang, XF; Song, Y; Zhang, DD; Chen, N; Wang, XW; Liang, CX; Kong, P; Han, M				Gao, Ya-Kun; Guo, Rui-Juan; Xu, Xin; Huang, Xiao-Fu; Song, Yu; Zhang, Dan-Dan; Chen, Ning; Wang, Xiao-Wei; Liang, Chen-Xi; Kong, Peng; Han, Mei			A regulator of G protein signaling 5 marked subpopulation of vascular smooth muscle cells is lost during vascular disease	PLOS ONE			English	Article							BLOOD-PRESSURE; DIFFERENTIATION; ATHEROSCLEROSIS; HETEROGENEITY; EXPRESSION; ORIGIN; RGS5; AORTA	Vascular smooth muscle cell (VSMC) subpopulations relevant to vascular disease and injury repair have been depicted in healthy vessels and atherosclerosis profiles. However, whether VSMC subpopulation associated with vascular homeostasis exists in the healthy artery and how are their nature and fate in vascular remodeling remains elusive. Here, using single-cell RNA-sequencing (scRNA-seq) to detect VSMC functional heterogeneity in an unbiased manner, we showed that VSMC subpopulations in healthy artery presented transcriptome diversity and that there was significant heterogeneity in differentiation state and development within each subpopulation. Notably, we detected an independent subpopulation of VSMCs that highly expressed regulator of G protein signaling 5 (RGS5), upregulated the genes associated with inhibition of cell proliferation and construction of cytoskeleton compared with the general subpopulation, and mainly enriched in descending aorta. Additionally, the proportion of RGS5(high) VSMCs was markedly decreased or almost disappeared in the vascular tissues of neointimal formation, abdominal aortic aneurysm and atherosclerosis. Specific spatiotemporal characterization of RGS5(high) VSMC subpopulation suggested that this subpopulation was implicated in vascular homeostasis. Together, our analyses identify homeostasis-relevant transcriptional signatures of VSMC subpopulations in healthy artery, which may explain the regional vascular resistance to atherosclerosis at some extent.	[Gao, Ya-Kun; Guo, Rui-Juan; Xu, Xin; Huang, Xiao-Fu; Song, Yu; Zhang, Dan-Dan; Chen, Ning; Kong, Peng; Han, Mei] Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol,Key Lab Med Biotechnol He, Key Lab Neural & Vasc Biol,Minist Educ, Shijiazhuang, Hebei, Peoples R China; [Wang, Xiao-Wei; Liang, Chen-Xi] Hebei Med Univ, Inst Basic Med, Lab Lipid Metab, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University	Han, M (corresponding author), Hebei Med Univ, Coll Basic Med, Dept Biochem & Mol Biol,Key Lab Med Biotechnol He, Key Lab Neural & Vasc Biol,Minist Educ, Shijiazhuang, Hebei, Peoples R China.	hanmei@hebmu.edu.cn	Han, Mei/GXH-8347-2022		National Natural Science Foundation of China [91739301, 91849102]; Key Natural Science Foundation Projects of Hebei Province [H2019206028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation Projects of Hebei Province	This work was supported by the National Natural Science Foundation of China 91739301 and 91849102 (to Mei Han.), and the Key Natural Science Foundation Projects of Hebei Province H2019206028 (to Mei Han).	Alencar GF, 2020, CIRCULATION, V142, P2045, DOI 10.1161/CIRCULATIONAHA.120.046672; Alexander MR, 2012, ANNU REV PHYSIOL, V74, P13, DOI 10.1146/annurev-physiol-012110-142315; Arnold C, 2018, FASEB J, V32, P2021, DOI 10.1096/fj.201700384RR; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Cheng WL, 2015, BRIT J PHARMACOL, V172, P5676, DOI 10.1111/bph.12991; Cho H, 2008, MOL CELL BIOL, V28, P2590, DOI 10.1128/MCB.01889-07; Daniel JM, 2016, ARTERIOSCL THROM VAS, V36, P317, DOI 10.1161/ATVBAHA.115.305974; Demirel E, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071748; Dobnikar L, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06891-x; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Frismantiene A, 2018, CELL SIGNAL, V52, P48, DOI 10.1016/j.cellsig.2018.08.019; Gunaje JJ, 2011, AM J PHYSIOL-CELL PH, V301, pC478, DOI 10.1152/ajpcell.00348.2010; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hao HY, 2003, ARTERIOSCL THROM VAS, V23, P1510, DOI 10.1161/01.ATV.0000090130.85752.ED; Hauser AS, 2018, CELL, V172, P41, DOI 10.1016/j.cell.2017.11.033; Holobotovskyy V, 2013, CIRC RES, V112, P781, DOI 10.1161/CIRCRESAHA.111.300142; Hong K, 2017, HYPERTENSION, V70, P1264, DOI 10.1161/HYPERTENSIONAHA.117.09757; Kaur H, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms15700; Li J, 2004, J VASC SURG, V40, P519, DOI 10.1016/j.jvs.2004.06.021; Majesky MW, 2007, ARTERIOSCL THROM VAS, V27, P1248, DOI 10.1161/ATVBAHA.107.141069; Miano JM, 2021, CIRCULATION, V143, P2110, DOI 10.1161/CIRCULATIONAHA.120.049922; Nagao M, 2020, CIRC RES, V126, P517, DOI 10.1161/CIRCRESAHA.119.315968; O'Flanagan CH, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1830-0; Owens AP, 2010, CIRC RES, V106, P611, DOI 10.1161/CIRCRESAHA.109.212837; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Pan HZ, 2020, CIRCULATION, V142, P2060, DOI 10.1161/CIRCULATIONAHA.120.048378; Pfaltzgraff ER, 2015, DEV DYNAM, V244, P410, DOI 10.1002/dvdy.24247; Rensen SSM, 2007, NETH HEART J, V15, P100, DOI 10.1007/BF03085963; Shanahan CM, 1998, ARTERIOSCL THROM VAS, V18, P333, DOI 10.1161/01.ATV.18.3.333; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Takata Y, 2008, P NATL ACAD SCI USA, V105, P4277, DOI 10.1073/pnas.0708647105; Trigueros-Motos L, 2013, ARTERIOSCL THROM VAS, V33, P1248, DOI 10.1161/ATVBAHA.112.300539; VanderLaan PA, 2004, ARTERIOSCL THROM VAS, V24, P12, DOI 10.1161/01.ATV.0000105054.43931.f0; Wirka RC, 2019, NAT MED, V25, P1280, DOI 10.1038/s41591-019-0512-5; Zhang HJ, 2012, FASEB J, V26, P181, DOI 10.1096/fj.11-185454	35	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265132	10.1371/journal.pone.0265132	http://dx.doi.org/10.1371/journal.pone.0265132			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320283	gold, Green Published			2022-12-26	WOS:000784240600001
J	Intharakham, K; Panerai, RB; Robinson, TG				Intharakham, Kannakorn; Panerai, Ronney B.; Robinson, Thompson G.			The scalability of common paradigms for assessment of cognitive function: A functional transcranial Doppler study	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; LANGUAGE LATERALIZATION; BRAIN ACTIVITY; HEMODYNAMIC-CHANGES; NEURAL ACTIVATION; HEALTHY CONTROLS; CENTRAL COMMAND; TASK; PATTERNS; VELOCITY	Cognitive paradigms induce changes in cerebral blood flow (CBF) associated with increased metabolic demand, namely neurovascular coupling (NVC). We tested the hypothesis that the effect of complexity and duration of cognitive paradigms will either enhance or inhibit the NVC response. Bilateral CBF velocity (CBFV) in the middle cerebral arteries (MCAs) via transcranial Doppler ultrasound (TCD), blood pressure (BP), electrocardiogram (ECG) and end-tidal CO2 (EtCO2) of 16 healthy participants (aged 21-71 years) were simultaneously recorded at rest and during randomized paradigms of different complexities (naming words beginning with P-,R-,V- words and serial subtractions of 100-2,100-7,1000-17), and durations (5s, 30s and 60s). CBFV responses were population mean normalized from a 30-s baseline period prior to task initiation. A significant increase in bilateral CBFV response was observed at the start of all paradigms and provided a similar pattern in most responses, irrespective of complexity or duration. Although significant inter-hemispherical differences were found during performance of R-word and all serial subtraction paradigms, no lateralisation was observed in more complex naming word tasks. Also, the effect of duration was manifested at late stages of 100-7, but not for other paradigms. CBFV responses could not distinguish different levels of complexity or duration with a single presentation of the cognitive paradigm. Further studies of the ordinal scalability of the NVC response are needed with more advanced modelling techniques, or different types of neural stimulation.	[Intharakham, Kannakorn; Panerai, Ronney B.; Robinson, Thompson G.] Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England; [Panerai, Ronney B.; Robinson, Thompson G.] British Heart Fdn Cardiovasc Res Ctr, Glenfield Hosp, NIHR Leicester Biomed Res Ctr, Leicester, Leics, England	University of Leicester; University Hospitals of Leicester NHS Trust; University of Leicester; Glenfield Hospital	Intharakham, K (corresponding author), Univ Leicester, Dept Cardiovasc Sci, Leicester, Leics, England.	ki44@leicester.ac.uk		Ladthavorlaphatt, Kannaphob/0000-0003-3588-3619	Ministry of Higher Education, Science, Research and Innovation of the Royal Thai Government [ST G5420]; National Institute for Health Research (NIHR) [NIHR201309]	Ministry of Higher Education, Science, Research and Innovation of the Royal Thai Government; National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR))	Kannakorn Intharakham (KI) is supported by a PhD scholarship of the Ministry of Higher Education, Science, Research and Innovation of the Royal Thai Government, Grant number ST G5420. Professor Thompson G Robinson (TGR) is a National Institute for Health Research (NIHR) Senior Investigator, Grant number NIHR201309. The views expressed in this article are those of the author(s) and not necessarily of NIHR or the Department of Health and Social Care. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AASLID R, 1987, STROKE, V18, P771, DOI 10.1161/01.STR.18.4.771; Adams RJ, 2005, PEDIATR RADIOL, V35, P229, DOI 10.1007/s00247-005-1409-7; Ances BM, 2000, J CEREBR BLOOD F MET, V20, P921, DOI 10.1097/00004647-200006000-00004; Badcock NA, 2012, LATERALITY, V17, P694, DOI 10.1080/1357650X.2011.615128; Beishon L, 2017, J NEUROSCI METH, V291, P131, DOI 10.1016/j.jneumeth.2017.08.019; Beishon L, 2021, PFLUG ARCH EUR J PHY, V473, P735, DOI 10.1007/s00424-020-02508-9; Beishon LC, 2018, J ALZHEIMERS DIS REP, V2, P153, DOI 10.3233/ADR-180068; Beishon LC, 2018, J NEUROPHYSIOL, V119, P1084, DOI 10.1152/jn.00698.2017; Bendall RCA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum2016.00529; Boban M, 2014, PSYCHIAT CLIN NEUROS, V68, P795, DOI 10.1111/pcn.12191; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Burma JS, 2021, PHYSIOL REP, V9, DOI 10.14814/phy2.15020; Carp J, 2012, NEUROIMAGE, V59, P853, DOI 10.1016/j.neuroimage.2011.07.064; Csipo T, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0250043; Debreczeni R, 2009, TOHOKU J EXP MED, V217, P147, DOI 10.1620/tjem.217.147; Deppe M, 2004, J NEUROIMAGING, V14, P226, DOI 10.1177/1051228404264936; Deppe M, 1997, J NEUROSCI METH, V75, P147, DOI 10.1016/S0165-0270(97)00067-8; Deppe M, 2000, J CEREBR BLOOD F MET, V20, P263, DOI 10.1097/00004647-200002000-00006; Ducrocq X, 1998, J NEUROL SCI, V160, P41, DOI 10.1016/S0022-510X(98)00188-9; Duschek S, 2003, PSYCHOPHYSIOLOGY, V40, P436, DOI 10.1111/1469-8986.00046; Duschek S, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13305; Duschek S, 2008, J PSYCHOPHYSIOL, V22, P81, DOI 10.1027/0269-8803.22.2.81; Fehr T, 2007, BRAIN RES, V1172, P93, DOI 10.1016/j.brainres.2007.07.043; Feig SL, 2000, EUR J NEUROSCI, V12, P2195, DOI 10.1046/j.1460-9568.2000.00093.x; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Fu CHY, 2002, NEUROIMAGE, V17, P871, DOI 10.1006/nimg.2002.1189; GILLER CA, 1993, NEUROSURGERY, V32, P737, DOI 10.1227/00006123-199305000-00006; Girouard H, 2006, J APPL PHYSIOL, V100, P328, DOI 10.1152/japplphysiol.00966.2005; Goghari VM, 2009, BRAIN COGNITION, V71, P72, DOI 10.1016/j.bandc.2009.04.004; GOLDENBERG G, 1989, NEUROPSYCHOLOGIA, V27, P641, DOI 10.1016/0028-3932(89)90110-3; Grinband J, 2017, HUM BRAIN MAPP, V38, P3538, DOI 10.1002/hbm.23608; Helton WS, 2010, NEUROPSYCHOLOGIA, V48, P1683, DOI 10.1016/j.neuropsychologia.2010.02.014; Hock C, 1997, BRAIN RES, V755, P293, DOI 10.1016/S0006-8993(97)00122-4; Hosford PS, 2019, NEUROSCI BIOBEHAV R, V96, P174, DOI 10.1016/j.neubiorev.2018.11.011; Iadecola C, 2004, NAT REV NEUROSCI, V5, P347, DOI 10.1038/nrn1387; Jamadar SD, 2020, NEUROPSYCHOLOGIA, V142, DOI 10.1016/j.neuropsychologia.2020.107446; Jasdzewski G, 2003, NEUROIMAGE, V20, P479, DOI 10.1016/S1053-8119(03)00311-2; Kim SJ, 2008, J NUCL MED, V49, P39, DOI 10.2967/jnumed.107.045724; Knecht S, 1998, STROKE, V29, P82, DOI 10.1161/01.STR.29.1.82; Knecht S, 1998, STROKE, V29, P1155, DOI 10.1161/01.STR.29.6.1155; Kreutzer JS., 2011, ENCY CLIN NEUROPSYCH, DOI DOI 10.1007/978-0-387-79948-3_1315; Kwak SK, 2017, KOREAN J ANESTHESIOL, V70, P407, DOI 10.4097/kjae.2017.70.4.407; Lisak M, 2012, TRANSL NEUROSCI, V3, P28, DOI 10.2478/s13380-012-0006-0; Llwyd O, 2017, EUR J APPL PHYSIOL, V117, P2191, DOI 10.1007/s00421-017-3707-9; Logothetis NK, 2001, NATURE, V412, P150, DOI 10.1038/35084005; Matteis M, 2009, EUR J NEUROL, V16, P81, DOI 10.1111/j.1468-1331.2008.02351.x; Menon V, 2010, ZDM-MATH EDUC, V42, P515, DOI 10.1007/s11858-010-0242-0; Meyer GF, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00552; Miller KL, 2001, HUM BRAIN MAPP, V13, P1, DOI 10.1002/hbm.1020; Mioshi E, 2006, INT J GERIATR PSYCH, V21, P1078, DOI 10.1002/gps.1610; Montoro CI, 2015, NEUROPSYCHOLOGY, V29, P173, DOI 10.1037/neu0000138; Moody M, 2005, AM J PHYSIOL-REG I, V288, pR1581, DOI 10.1152/ajpregu.00837.2004; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panczel G, 1999, STROKE, V30, P619, DOI 10.1161/01.STR.30.3.619; Panerai RB, 2005, J APPL PHYSIOL, V99, P2352, DOI 10.1152/japplphysiol.00631.2005; Panerai RB, 1998, PHYSIOL MEAS, V19, P305, DOI 10.1088/0967-3334/19/3/001; Panerai RB, 2012, AM J PHYSIOL-HEART C, V302, pH459, DOI 10.1152/ajpheart.00890.2011; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Paulson OB, 2002, EUR NEUROPSYCHOPHARM, V12, P495, DOI 10.1016/S0924-977X(02)00098-6; Payne H, 2015, NEUROPSYCHOLOGIA, V72, P59, DOI 10.1016/j.neuropsychologia.2015.04.019; Pennekamp CWA, 2011, CURR OPIN ANESTHESIO, V24, P693, DOI 10.1097/ACO.0b013e32834c7aa1; Peterson EC, 2011, INT J VASC MED, V2011, DOI 10.1155/2011/823525; Rigamonti A, 2008, CAN J ANAESTH, V55, P112, DOI 10.1007/BF03016323; Rosch RE, 2012, NEUROPSYCHOLOGIA, V50, P810, DOI 10.1016/j.neuropsychologia.2012.01.015; Rosengarten B, 2004, ULTRASCHALL MED, V25, P116, DOI 10.1055/s-2004-813101; Rosengarten B, 2007, J NEUROL SCI, V257, P149, DOI 10.1016/j.jns.2007.01.032; Salinet ASM, 2015, J APPL PHYSIOL, V118, P170, DOI 10.1152/japplphysiol.00620.2014; Salinet ASM, 2013, J NEUROL, V260, P2588, DOI 10.1007/s00415-013-7022-z; Salinet ASM, 2013, J APPL PHYSIOL, V114, P1406, DOI 10.1152/japplphysiol.01448.2012; Sato A, 2001, INT J DEV NEUROSCI, V19, P327, DOI 10.1016/S0736-5748(01)00017-X; Sato K, 2009, EXP PHYSIOL, V94, P1139, DOI 10.1113/expphysiol.2009.048587; Schlosser R, 1998, J NEUROL NEUROSUR PS, V64, P492, DOI 10.1136/jnnp.64.4.492; Senhorini MCT, 2011, J CLIN EXP NEUROPSYC, V33, P864, DOI 10.1080/13803395.2011.561299; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; Settakis G, 2002, J NEUROIMAGING, V12, P252, DOI 10.1177/10528402012003007; Shin J, 2018, SCI DATA, V5, DOI 10.1038/sdata.2018.3; SILVESTRINI M, 1994, J CEREBR BLOOD F MET, V14, P643, DOI 10.1038/jcbfm.1994.80; Smirl JD, 2016, J NEUROSCI METH, V270, P92, DOI 10.1016/j.jneumeth.2016.06.007; Sorond FA, 2011, ANN NEUROL, V70, P213, DOI 10.1002/ana.22433; Spence EEM, 2021, PHYSIOL BEHAV, V229, DOI 10.1016/j.physbeh.2020.113198; Stroobant N, 2000, NEUROPSYCHOL REV, V10, P213, DOI 10.1023/A:1026412811036; Sturzenegger M, 1996, STROKE, V27, P2256, DOI 10.1161/01.STR.27.12.2256; Szirmai I, 2005, COGNITIVE BRAIN RES, V24, P33, DOI 10.1016/j.cogbrainres.2004.12.011; Thaler D, 2018, LANCET NEUROL, V17, P573, DOI 10.1016/S1474-4422(18)30198-4; Tiecks FP, 1998, J CEREBR BLOOD F MET, V18, P735, DOI 10.1097/00004647-199807000-00004; Vingerhoets G, 1999, STROKE, V30, P2152, DOI 10.1161/01.STR.30.10.2152; Vogan VM, 2016, DEV COGN NEUROS-NETH, V17, P19, DOI 10.1016/j.dcn.2015.10.008; Williams CAL, 2017, J NEUROSCI METH, V284, P57, DOI 10.1016/j.jneumeth.2017.04.013; Williamson JW, 2010, EXP PHYSIOL, V95, P1043, DOI 10.1113/expphysiol.2009.051870; Yarkoni T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004257; Zhang YT, 2005, CHINESE MED J-PEKING, V118, P633	92	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266048	10.1371/journal.pone.0266048	http://dx.doi.org/10.1371/journal.pone.0266048			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344567	Green Published, gold			2022-12-26	WOS:000788055200018
J	Kamo, M; Murakami, M; Naito, W; Takeshita, J; Yasutaka, T; Imoto, S				Kamo, Masashi; Murakami, Michio; Naito, Wataru; Takeshita, Jun-ichi; Yasutaka, Tetsuo; Imoto, Seiya			COVID-19 testing systems and their effectiveness in small, semi-isolated groups for sports events	PLOS ONE			English	Article								In this study, we quantitatively assessed the effectiveness of systems for COVID-19 testing in small groups of sport teams that are semi-isolated from the general population by countermeasures against infection. Two types of group were assumed, and the dynamics of infection within each group was modeled by using a compartment model of infectious disease. One group (Group A) comprised domestic professional sports teams that play many games over a season while remaining within a relatively small region. Polymerase chain reaction (PCR) tests were routinely conducted once every 2 weeks, and the number of infected individuals that could not be quarantined after identification by testing or checking for symptoms was defined as the risk. The other group (Group B) comprised teams that travel across borders for mass-gathering events like the Olympic and Paralympic Games. The teams were isolated for 2 weeks at their destination; frequent testing and checking for symptoms was conducted, and any infected individuals were quarantined. The number of infected individuals participating in games after the isolation period was defined as the risk. In Group A, the number of infected individuals detected by routinely conducted PCR testing was lower than the number of infected individuals detected by checking for symptoms, indicating that routine testing every 2 weeks was not very effective. In Group B, daily PCR testing was the most effective, followed by daily antigen testing. Dual testing, in which individuals with a positive antigen test were given an additional PCR test, was the least effective with an effect equal to PCR testing every other day. These results indicate that repeated testing does not necessarily increase the detection of infected individuals.	[Kamo, Masashi; Naito, Wataru; Takeshita, Jun-ichi] Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan; [Murakami, Michio] Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka, Japan; [Yasutaka, Tetsuo] Natl Inst Adv Ind Sci & Technol, Res Inst Georesources & Environm, Geol Survey Japan, Tsukuba, Ibaraki, Japan; [Imoto, Seiya] Univ Tokyo, Inst Med Sci, Human Genome Ctr, Div Hlth Med Intelligence, Minato Ku, Tokyo, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Osaka University; National Institute of Advanced Industrial Science & Technology (AIST); University of Tokyo	Kamo, M (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sci Safety & Sustainabil, Tsukuba, Ibaraki, Japan.	masashi-kamo@aist.go.jp	; Naito, Wataru/M-1928-2018; Kamo, Masashi/C-6049-2015	Imoto, Seiya/0000-0002-2989-308X; Naito, Wataru/0000-0003-2064-7170; Kamo, Masashi/0000-0002-6972-3333				Agarwal V., 2020, INT J ADV SCI TECHNO, V29, P432; ANDERSON R M, 1991; Brummer LE, 2021, PLOS MED, V18, DOI 10.1371/journal.pmed.1003735; Dickens BL, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa141; Du ZW, 2021, LANCET PUBLIC HEALTH, V6, pE184, DOI 10.1016/S2468-2667(21)00002-5; Government VS, 2021, STRICT QUAR RUL SERV; He WQ, 2020, J MED VIROL, V92, P2543, DOI 10.1002/jmv.26041; He X, 2020, NAT MED, V26, DOI 10.1038/s41591-020-0869-5; International Olympic Committee, 2021, PLAYB BROADC VERS 2; Khalsaraei MM, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9233082; Kucirka LM, 2020, ANN INTERN MED, V173, P262, DOI 10.7326/M20-1495; Liu Y, 2021, J TRAVEL MED, V28, DOI 10.1093/jtm/taab124; Meksianis Z Ndii YAA., 2020, COMMUN MATH BIOL NEU; Mina MJ, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2025631; Ndii MZ, 2020, COMMUNICATION BIOMAT, V3, P19, DOI DOI 10.5614/CBMS.2020.3.1.3; Panovska-Griffiths J, 2020, LANCET CHILD ADOLESC, V4, P817, DOI 10.1016/S2352-4642(20)30250-9; Ritchie Hannah, 2020, CORONAVIRUS PANDEMIC; SHANNON CE, 1949, P IRE, V37, P10, DOI 10.1109/JRPROC.1949.232969; Shokri A, 2022, J APPL COMPUT MECH, V8, P196, DOI 10.22055/JACM.2021.36545.2863; UEFA, 2020, UEFA RET PLAY PROT V; World Health Organization (WHO), 2020, WHO COR DIS COVID 19	22	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266197	10.1371/journal.pone.0266197	http://dx.doi.org/10.1371/journal.pone.0266197			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349588	Green Published, Green Submitted, gold			2022-12-26	WOS:000783906500024
J	Rios-Garaizar, J; Iriarte, E; Arnold, LJ; Sanchez-Romero, L; Marin-Arroyo, AB; San Emeterio, A; Gomez-Olivencia, A; Perez-Garrido, C; Demuro, M; Campana, I; Bourguignon, L; Benito-Calvo, A; Iriarte, MJ; Aranburu, A; Arranz-Otaegi, A; Garate, D; Silva-Gago, M; Lahaye, C; Ortega, I				Rios-Garaizar, Joseba; Iriarte, Eneko; Arnold, Lee J.; Sanchez-Romero, Laura; Marin-Arroyo, Ana B.; San Emeterio, Aixa; Gomez-Olivencia, Asier; Perez-Garrido, Carflos; Demuro, Martina; Campana, Isidoro; Bourguignon, Laurence; Benito-Calvo, Alfonso; Iriarte, Maria J.; Aranburu, Arantza; Arranz-Otaegi, Amaia; Garate, Diego; Silva-Gago, Maria; Lahaye, Christelle; Ortega, Illuminada			The intrusive nature of the Chatelperronian in the Iberian Peninsula	PLOS ONE			English	Article							LABEKO KOBA; SITE; MIDDLE; GROTTE; CHRONOLOGY; HUMANS; FRANCE; EUROPE; ORIGIN; RENNE	Multiple factors have been proposed to explain the disappearance of Neandertals between ca. 50 and 40 kyr BP. Central to these discussions has been the identification of new techno-cultural complexes that overlap with the period of Neandertal demise in Europe. One such complex is the Chatelperronian, which extends from the Paris Basin to the Northern Iberian Peninsula between 43,760-39,220 BP. In this study we present the first open-air Chatelperronian site in the Northern Iberian Peninsula, Aranbaltza II. The technological features of its stone tool assemblage show no links with previous Middle Paleolithic technology in the region, and chronological modeling reveals a gap between the latest Middle Paleolithic and the Chatelperronian in this area. We interpret this as evidence of local Neandertal extinction and replacement by other Neandertal groups coming from southern France, illustrating how local extinction episodes could have played a role in the process of disappearance of Neandertals.	[Rios-Garaizar, Joseba] Arkeol Museoa, Bilbao, Spain; [Rios-Garaizar, Joseba; San Emeterio, Aixa; Benito-Calvo, Alfonso; Silva-Gago, Maria] Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain; [Iriarte, Eneko] Univ Burgos, Dept Hist Geog & Comunicac, Lab Evoluc Humana, Burgos, Spain; [Arnold, Lee J.; Demuro, Martina] Univ Adelaide, Sch Phys Sci, Environm Inst, Adelaide, SA, Australia; [Arnold, Lee J.; Demuro, Martina] Univ Adelaide, Inst Photon & Adv Sensing IPAS, Adelaide, SA, Australia; [Sanchez-Romero, Laura] Univ Calif Berkeley, Human Evolut Res Ctr, Berkeley, CA 94720 USA; [Marin-Arroyo, Ana B.] Univ Cantabria, Dept Ciencias Hist, Grp I D I EVOADAPTA Evoluc Humana & Adaptac Econ, Santander, Spain; [Marin-Arroyo, Ana B.] Univ Cambridge, Dept Archaeol, Cambridge, England; [Gomez-Olivencia, Asier; Aranburu, Arantza] Univ Pais Vasco Euskal Herriko Unibertsitatea UPV, Fac Ciencia & Tecnol, Dept Geol, Leioa, Spain; [Gomez-Olivencia, Asier] Ctr UCM ISCIII Invest Evoluc & Comportamiento Hum, Madrid, Spain; [Gomez-Olivencia, Asier] Soc Ciencias Aranzadi, Donostia San Sebastian, Spain; [Perez-Garrido, Carflos] Univ Complutense Madrid, Fac Ciencias Geol, Dept Mineral & Petrol, Madrid, Spain; [Campana, Isidoro] Univ Malaga, Fac Ciencias, Dept Ecol & Geol, Malaga, Spain; [Bourguignon, Laurence] Inrap AnTet Arscan UMR7041, Lotissement Actipolis Impasse Rue Dionysos, Villeneuve Les Beziers, France; [Iriarte, Maria J.] Univ Basque Country Vitoria Gasteiz, Geog Prehist & Archaeol Dept, Vitoria, Spain; [Iriarte, Maria J.] Basque Fdn Sci, Ikerbasque, Bilbao, Spain; [Arranz-Otaegi, Amaia] Museum Natl Hist Nat, Archeozool Archeobot Soc Prat & Environm AASPE, UMR 7209, Paris, France; [Arranz-Otaegi, Amaia] Univ Copenhagen, Dept Cross Cultural & Reg Studies, Copenhagen, Denmark; [Garate, Diego] Univ Cantabria, Inst Int Invest Prehistor Cantabria IIIPC, Gobierno Cantabria, Santander, Spain; [Lahaye, Christelle] Univ Bordeaux Montaigne, Geochronol, IRAMAT CRP2A UMR 5060, Pessac, France; [Ortega, Illuminada] Inst Natl Rech Archeol Prevent INRAP, Paris, France	Centro Nacional de Investigacion de La Evolucion Humana (CENIEH); Universidad de Burgos; University of Adelaide; University of Adelaide; University of California System; University of California Berkeley; Universidad de Cantabria; University of Cambridge; University of Basque Country; Complutense University of Madrid; Universidad de Malaga; University of Basque Country; Basque Foundation for Science; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Museum National d'Histoire Naturelle (MNHN); University of Copenhagen; Universidad de Cantabria; Instituto Internacional de Investigaciones Prehistoricas de Cantabria (IIIPC)	Rios-Garaizar, J (corresponding author), Arkeol Museoa, Bilbao, Spain.; Rios-Garaizar, J (corresponding author), Ctr Nacl Invest Evoluc Humana CENIEH, Burgos, Spain.	jorios76@gmail.com	Marín-Arroyo, Ana B./C-4828-2015; Gómez-Olivencia, Asier/D-6531-2015; Iriarte, Eneko/L-4707-2014; Marín-Arroyo, Ana B./AAT-6209-2020; Rios-Garaizar, Joseba/M-5604-2018; Arnold, Lee/J-4356-2018	Marín-Arroyo, Ana B./0000-0003-3353-5581; Gómez-Olivencia, Asier/0000-0001-7831-3902; Iriarte, Eneko/0000-0001-8365-5616; Sanchez-Romero, Laura/0000-0003-2027-9996; Rios-Garaizar, Joseba/0000-0001-8474-2156; Arnold, Lee/0000-0001-9603-3824	Diputacion Foral de Bizkaia (2013-2020); Gobierno Vasco-Eusko Jaurlaritza (2014-2015); Harpea Kultur Elkartea (2013-2017); Australian Research Council [FT200100816]; Ramon y Cajal fellowship [RYC-2017-22558]; Edestiaurre Arkeologi Elkartea (2018)	Diputacion Foral de Bizkaia (2013-2020); Gobierno Vasco-Eusko Jaurlaritza (2014-2015); Harpea Kultur Elkartea (2013-2017); Australian Research Council(Australian Research Council); Ramon y Cajal fellowship(Spanish Government); Edestiaurre Arkeologi Elkartea (2018)	Research at Aranbaltza site has been funded by Diputacion Foral de Bizkaia (2013-2020), Gobierno Vasco-Eusko Jaurlaritza (2014-2015), Harpea Kultur Elkartea (2013-2017), Edestiaurre Arkeologi Elkartea (2018). OSL dating research conducted by M.D. and L.J.A. was partly supported by Australian Research Council Future Fellowship grant FT200100816. AGO was supported by Ramon y Cajal fellowship (RYC-2017-22558). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2001, ESPACIO TIEMPO FOR 1; Arnold LJ, 2016, QUAT GEOCHRONOL, V36, P78, DOI 10.1016/j.quageo.2016.07.003; Arnold LJ, 2013, BOREAS, V42, P285, DOI 10.1111/j.1502-3885.2012.00262.x; Arrizabalaga A., 2000, MUNIBE ANTROPOLOGIA, V42, P193; Arrizabalaga A, 2015, QUATERN INT, V364, P181, DOI 10.1016/j.quaint.2014.07.051; Bachellerie F., 2011, QUELLE UNITE CHATELP; Bachellerie F., 2007, PALEO, V19, P259; Baillet M., 2017, ECLARIAGE TRACEOLOGI; Baillet M., 2018, PALEO, V29, P29; Baillet M., 2014, PALEO, V25, P7; Balzeau A, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77611-z; Banks WE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003972; Bar-Yosef O, 2010, J HUM EVOL, V59, P586, DOI 10.1016/j.jhevol.2010.06.009; Barandiaran J.M., 1960, ESTACION KURTZIA BAR; Bertran P, 2013, J ARCHAEOL SCI, V40, P2274, DOI 10.1016/j.jas.2013.01.012; Bilbao-Lasa P, 2020, FRONT EARTH SC-SWITZ, V8, DOI 10.3389/feart.2020.00047; Blott SJ, 2012, SEDIMENTOLOGY, V59, P2071, DOI 10.1111/j.1365-3091.2012.01335.x; Bodu P., 2017, GALL PREHISTOIRE, V57, P3, DOI DOI 10.4000/GALLIAP.478; Buisson D., 1990, PALEOLITHIQUE MOYEN, P189; Campana I, 2016, SEDIMENT GEOL, V346, P72, DOI 10.1016/j.sedgeo.2016.09.010; Cava A., 2013, ANEJOS VELEIA SERIES, V13, P269; Colonge D, 2015, QUATERN INT, V364, P109, DOI 10.1016/j.quaint.2014.12.007; Connet N., 2002, CHATELPERRONIEN REFL; Cresswell R, 1982, TECHNIQUES CULTURE, V2, P143; de Andres-Herrero M, 2009, MUNIBE ANTROPOLOGIA, V60, P35; de Sonneville-Bordes D, 1954, BULL SOC PREHIST FR, V51, P327, DOI 10.3406/bspf.1954.3106; Degioanni A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0216742; Demuro M, 2013, QUAT GEOCHRONOL, V15, P67, DOI 10.1016/j.quageo.2012.11.003; Eixea A, 2018, J ARCHAEOL SCI-REP, V21, P643, DOI 10.1016/j.jasrep.2018.08.039; Fewlass H, 2020, NAT ECOL EVOL, V4, P794, DOI 10.1038/s41559-020-1136-3; Gomez-Olivencia A, 2014, BOREAS, V43, P286, DOI 10.1111/bor.12037; Goni MFS, 2008, QUATERNARY SCI REV, V27, P1136, DOI 10.1016/j.quascirev.2008.03.003; Gravina B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33084-9; Greenbaum G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12862-7; Grigoletto F., 2008, SOCIETES PALEOLITHIQ; Hajdinjak M, 2021, NATURE, V592, P253, DOI 10.1038/s41586-021-03335-3; Haws JA, 2020, P NATL ACAD SCI USA, V117, P25414, DOI 10.1073/pnas.2016062117; Higham T, 2010, P NATL ACAD SCI USA, V107, P20234, DOI 10.1073/pnas.1007963107; Hublin JJ, 2020, NATURE, V581, P299, DOI 10.1038/s41586-020-2259-z; Hublin JJ, 2015, QUATERNARY SCI REV, V118, P194, DOI 10.1016/j.quascirev.2014.08.011; Hublin JJ, 2012, P NATL ACAD SCI USA, V109, P18743, DOI 10.1073/pnas.1212924109; Jones JR, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-32493-0; Karlin C., 1991, OBSERVER LACTION TEC, P101; Kuo CY, 2000, TRANSPORT RES REC, P57, DOI 10.3141/1721-07; LEMONNIER P, 1986, J ANTHROPOL ARCHAEOL, V5, P147, DOI 10.1016/0278-4165(86)90012-7; Maillo Fernandez J., 2003, TRANSICION PALEOLITI; Maillo Fernandez J. M., 2008, FERVEDES, V5, P127; Maillo-Fernandez J. M., 2005, TRABAJOS PREHIST, V62, P47, DOI [10.3989/tp.2005.v62.i1.55, DOI 10.3989/TP.2005.V62.I1.55]; Mallol C, 2012, QUATERN INT, V275, P4, DOI 10.1016/j.quaint.2011.07.026; Marin-Arroyo AB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0194708; Maroto J., 2002, PREHISTOIRES MEDITER, V10, P39; Mazo Perez C., 2012, MAINAKE, V33, P187; Menendez M, 2018, QUATERN INT, V474, P71, DOI 10.1016/j.quaint.2017.08.061; Morales JI, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215832; Moreno A, 2010, J QUATERNARY SCI, V25, P1076, DOI 10.1002/jqs.1265; Pelegrin J., 1995, TECHNOLOGIE LITHIQUE, V20; Ramsey CB, 2009, RADIOCARBON, V51, P1023, DOI 10.1017/S0033822200034093; Ramsey CB, 2009, RADIOCARBON, V51, P337, DOI 10.1017/S0033822200033865; Rios L, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-38571-1; Rios-Garaizar J, 2012, IND LITICA SOC TRANS; Rios-Garaizar J., 2008, MUNIBE ANTROPOLOGIA, V59, P25; Rios-Garaizar J., 2020, ACTUALIDAD INVESTIGA, P29; Rios-Garaizar J., 2012, MUNIBE ANTROPOLOGIA, V63, P81; Rios-Garaizar J., 2005, MONOGRAFIAS MUSEO NA, P333; Rios-Garaizar J, 2021, ARCHAEOL ANTHROP SCI, V13, DOI 10.1007/s12520-021-01360-x; Rios-Garaizar J, 2020, J ARCHAEOL SCI-REP, V30, DOI 10.1016/j.jasrep.2020.102201; Rios-Garaizar J, 2018, PLOS ONE, V13, DOI [10.1371/Journal.pone.0195044, 10.1371/journal.pone.0195044]; Rios-Garaizar J, 2017, QUATERN INT, V433, P50, DOI 10.1016/j.quaint.2016.02.020; Rios-Garaizar J, 2012, ANTHROPOLOGIE, V116, P532, DOI 10.1016/j.anthro.2012.10.001; Rodriguez-Almagro M, 2021, BOREAS, V50, P686, DOI 10.1111/bor.12501; Roussel M, 2016, J HUM EVOL, V95, P13, DOI 10.1016/j.jhevol.2016.02.003; Ruebens K, 2015, J HUM EVOL, V86, P55, DOI 10.1016/j.jhevol.2015.06.011; Ruiz Idarraga R., 1990, MUNIBE, V42, P23; Sanchez Fernandez G., 2007, ZONA ARQUEOLOGICA, V7, P264; Santisteban JI, 2004, J PALEOLIMNOL, V32, P287, DOI 10.1023/B:JOPL.0000042999.30131.5b; Sonneville-Bordes D., 1956, BULL SOC PREHIST FR, V53, P547; Sonneville-Bordes D., 1956, BULL SOC PREHIST FR, V53, P408, DOI [10.3406/bspf.1956.3357, DOI 10.3406/BSPF.1956.3357]; Sonneville-Bordes D., 1955, BULL SOC PREHIST FR, V52, P76, DOI [10.3406/bspf.1955.3156, DOI 10.3406/BSPF.1955.3156]; Vernot B, 2021, SCIENCE, V372, P590, DOI 10.1126/science.abf1667; Welker F, 2016, P NATL ACAD SCI USA, V113, P11162, DOI 10.1073/pnas.1605834113; Wolf D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25343-6; Wood RE, 2014, J HUM EVOL, V69, P91, DOI 10.1016/j.jhevol.2013.12.017; Wood R, 2018, QUATERN INT, V474, P56, DOI 10.1016/j.quaint.2016.03.005; Zilhao J, 2006, P NATL ACAD SCI USA, V103, P12643, DOI 10.1073/pnas.0605128103	84	3	3	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265219	10.1371/journal.pone.0265219	http://dx.doi.org/10.1371/journal.pone.0265219			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353845	Green Published, Green Accepted, gold			2022-12-26	WOS:000786647900011
J	Taylor, KS; Taylor, JW				Taylor, Kathryn S.; Taylor, James W.			Interval forecasts of weekly incident and cumulative COVID-19 mortality in the United States: A comparison of combining methods	PLOS ONE			English	Article							COMBINATION; AGGREGATION; WEATHER	BackgroundA combined forecast from multiple models is typically more accurate than an individual forecast, but there are few examples of studies of combining in infectious disease forecasting. We investigated the accuracy of different ways of combining interval forecasts of weekly incident and cumulative coronavirus disease-2019 (COVID-19) mortality. MethodsWe considered weekly interval forecasts, for 1- to 4-week prediction horizons, with out-of-sample periods of approximately 18 months ending on 8 January 2022, for multiple locations in the United States, using data from the COVID-19 Forecast Hub. Our comparison involved simple and more complex combining methods, including methods that involve trimming outliers or performance-based weights. Prediction accuracy was evaluated using interval scores, weighted interval scores, skill scores, ranks, and reliability diagrams. ResultsThe weighted inverse score and median combining methods performed best for forecasts of incident deaths. Overall, the leading inverse score method was 12% better than the mean benchmark method in forecasting the 95% interval and, considering all interval forecasts, the median was 7% better than the mean. Overall, the median was the most accurate method for forecasts of cumulative deaths. Compared to the mean, the median's accuracy was 65% better in forecasting the 95% interval, and 43% better considering all interval forecasts. For all combining methods except the median, combining forecasts from only compartmental models produced better forecasts than combining forecasts from all models. ConclusionsCombining forecasts can improve the contribution of probabilistic forecasting to health policy decision making during epidemics. The relative performance of combining methods depends on the extent of outliers and the type of models in the combination. The median combination has the advantage of being robust to outlying forecasts. Our results support the Hub's use of the median and we recommend further investigation into the use of weighted methods.	[Taylor, Kathryn S.] Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxfordshire, England; [Taylor, James W.] Univ Oxford, Said Business Sch, Oxford, England	University of Oxford; University of Oxford	Taylor, KS (corresponding author), Univ Oxford, Nuffield Dept Primary Care Hlth Sci, Oxford, Oxfordshire, England.	kathryn.taylor@phc.ox.ac.uk		Taylor, Kathryn/0000-0001-6589-5456	National Institute for Health Research Applied Research Collaboration Oxford and Thames Valley Health NHS Foundation Trust	National Institute for Health Research Applied Research Collaboration Oxford and Thames Valley Health NHS Foundation Trust	& nbsp;This research was partly supported by National Institute for Health Research Applied Research Collaboration Oxford and Thames Valley Health NHS Foundation Trust. The views expressed in this publication are those of the author(s) and not necessarily those of the NIHR or Department of Health and Social Care. The had no role in study design, data collection analysis, decision to publish, or preparation of manuscript.	Adam D, 2020, NATURE, V580, P316, DOI 10.1038/d41586-020-01003-6; BATES JM, 1969, OPER RES QUART, V20, P451, DOI 10.2307/3008764; Bracher J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-25207-0; Bracher J, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1008618; Buckee CO, 2020, EUR J EPIDEMIOL, V35, P731, DOI 10.1007/s10654-020-00667-8; Busetti F, 2017, OXFORD B ECON STAT, V79, P495, DOI 10.1111/obes.12163; Chen LP, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0244536; Claeskens G, 2016, INT J FORECASTING, V32, P754, DOI 10.1016/j.ijforecast.2015.12.005; Dean NE, 2020, VACCINE, V38, P7213, DOI 10.1016/j.vaccine.2020.09.031; DIEBOLD FX, 1995, J BUS ECON STAT, V13, P253, DOI 10.2307/1392185; Ehwerhemuepha Louis, 2021, Intell Based Med, V5, P100030, DOI 10.1016/j.ibmed.2021.100030; Gaba A, 2017, DECIS ANAL, V14, P1, DOI 10.1287/deca.2016.0340; Girardi P, 2022, BIOMETRICAL J, V64, P523, DOI 10.1002/bimj.202100129; Gneiting T, 2007, J AM STAT ASSOC, V102, P359, DOI 10.1198/016214506000001437; Holmdahl I, 2020, NEW ENGL J MED, V383, P303, DOI 10.1056/NEJMp2016822; Hora SC, 2013, DECIS ANAL, V10, P279, DOI 10.1287/deca.2013.0282; Ioannidis JPA, 2022, INT J FORECASTING, V38, P423, DOI 10.1016/j.ijforecast.2020.08.004; Jewell NP, 2020, JAMA-J AM MED ASSOC, V323, P1893, DOI 10.1001/jama.2020.6585; Johansson MA, 2019, P NATL ACAD SCI USA, V116, P24268, DOI 10.1073/pnas.1909865116; Jose VRR, 2014, MANAGE SCI, V60, P463, DOI 10.1287/mnsc.2013.1781; Koning AJ, 2005, INT J FORECASTING, V21, P397, DOI 10.1016/j.ijforecast.2004.10.003; Krishnamurti TN, 1999, SCIENCE, V285, P1548, DOI 10.1126/science.285.5433.1548; Lipsitch M, 2019, CURR TOP MICROBIOL, V424, P59, DOI 10.1007/82_2019_172; Looi MK, 2020, BMJ-BRIT MED J, V371, DOI 10.1136/bmj.m4113; Melnick ER, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1924; Mingione M., 2021, SPATIAL STATIST; Moran KR, 2016, J INFECT DIS, V214, pS404, DOI 10.1093/infdis/jiw375; Paiva HM, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236386; Panovska-Griffiths J., 2020, CORONAVIRUS WEVE HAD; Park S, 2015, JUDGM DECIS MAK, V10, P130; Petropoulos F, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231236; Phelan AL, 2020, JAMA-J AM MED ASSOC, V323, P709, DOI 10.1001/jama.2020.1097; Ray EL., 2020, ENSEMBLE FORECASTS C, DOI 10.1101/2020.08.19.20177493; Reich NG, 2019, PLOS COMPUT BIOL, V15, DOI [10.1371/journal.pcbi.1007486, 10.1371/journal.pcbi.1007486.r001, 10.1371/journal.pcbi.1007486.r002, 10.1371/journal.pcbi.1007486.r003, 10.1371/journal.pcbi.1007486.r004]; Smith J, 2009, OXFORD B ECON STAT, V71, P331, DOI 10.1111/j.1468-0084.2008.00541.x; Sridhar D, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1567; Surowiecki James, 2004, WISDOM CROWDS WHY MA; Taylor JW, 2023, EUR J OPER RES, V304, P25, DOI 10.1016/j.ejor.2021.06.044; Timmermann A, 2006, HBK ECON, V24, P135, DOI 10.1016/S1574-0706(05)01004-9; Winkler RL, 2019, DECIS ANAL, V16, P239, DOI 10.1287/deca.2019.0391; Wise J, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3702; Yamana TK, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005801; Yeh RW, 2018, CIRC-CARDIOVASC QUAL, V11, DOI 10.1161/CIRCOUTCOMES.118.004736	43	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266096	10.1371/journal.pone.0266096	http://dx.doi.org/10.1371/journal.pone.0266096			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349605	Green Published, gold			2022-12-26	WOS:000783906500023
J	Tesfau, YB; Gebrehiwot, TG; Debeb, HG; Kahsay, AB				Tesfau, Yemane Berhane; Gebrehiwot, Tesfay Gebregzabher; Debeb, Hagos Godefay; Kahsay, Alemayehu Bayray			"Mothers will be lucky if utmost receive a single scheduled postnatal home visit": An exploratory qualitative study, Northern Ethiopia	PLOS ONE			English	Article							COMMUNITY-HEALTH WORKERS; CARE; COUNTRIES; PROGRAM	BackgroundPostnatal home visits (PNHVs) have been endorsed as strategy for delivery of postnatal care (PNC) to reduce newborn mortality and improve maternal outcomes. Despite the important role of the Health Extension Workers (HEWs) in improving the overall healthcare coverage, PNHV remains as a missed opportunity in rural Ethiopia. Thus, this study aimed to explore the barriers and facilitators of scheduled postnatal home visits in Northern Ethiopia. MethodsWe conducted an exploratory qualitative study on a total of 16 in-depth interviews with HEWs and mothers who gave birth one year prior to the study. In addition, focus group discussions were conducted with HEWs and key informant interviews were conducted with women development group leaders, supervisors, and healthcare authorities from April to June 2019 in two rural districts of Northern Ethiopia. Discussions and interviews were audio recorded and transcribed verbatim in the local language (Tigrigna) and translated into English. The translated scripts were thematically coded using Atlas ti scientific software. Field notes were also taken during the discussion and while conducting the interviews. ResultsHealth system factors, community context, and individual level factors were considered as the barriers and facilitators of scheduled PNHVs. Leadership, governance, management, support and supervision, referral linkages, overwhelming workload, capacity building, logistics and supplies are the major sub-themes identified as health system factors. Physical characteristics like geographical location and topography, distance, and coverage of the catchment; and community support and participation like support from women's development groups (WDGs), awareness of the community on the presence of the service and cultural and traditional beliefs were community contexts that affect PNHVs. Self-motivation to support and intrinsic job satisfaction were individual level factors that were considered as barriers and facilitators. ConclusionThe finding of this study suggested that the major barriers of postnatal home visits were poor attention of healthcare authorities of the government bodies, lack of effective supervision, poor functional linkages, inadequate logistics and supplies, unrealistic catchment area coverage, poor community participation and support, and lack of motivation of HEWs. Henceforth, to achieve the scheduled PNHV in rural Ethiopia, there should be strong political commitment and healthcare authorities should provide attention to postnatal care both at facility and home with a strong controlling system.	[Tesfau, Yemane Berhane] Adigrat Univ, Coll Med & Hlth Sci, Adigrat, Ethiopia; [Tesfau, Yemane Berhane; Gebrehiwot, Tesfay Gebregzabher; Kahsay, Alemayehu Bayray] Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia; [Debeb, Hagos Godefay] Tigray Reg Hlth Bur, Mekelle, Ethiopia	Mekelle University	Tesfau, YB (corresponding author), Adigrat Univ, Coll Med & Hlth Sci, Adigrat, Ethiopia.; Tesfau, YB (corresponding author), Mekelle Univ, Coll Hlth Sci, Sch Publ Hlth, Mekelle, Ethiopia.	yemaneberhane12@gmail.com			Bill and Melinda Gates foundation; World Health Organization [201526690]	Bill and Melinda Gates foundation(Bill & Melinda Gates Foundation); World Health Organization(World Health Organization)	This study was carried out by Adigrat University and the "Tigray KMC Project" which is funded by Bill and Melinda Gates foundation and World Health Organization [Grant Number: 201526690]. The funding body had no role in the design of the study, collection, analysis, interpretation of data, and in writing the manuscript.	Abbott L, 2011, HEALTH CARE WOMEN IN, V32, P225, DOI 10.1080/07399332.2010.529217; Akibu M, 2018, J PREGNANCY, V2018, DOI 10.1155/2018/8625437; ALAUDDIN M, 1986, STUD FAMILY PLANN, V17, P13, DOI 10.2307/1966951; Alvarado R, 1999, STUD FAMILY PLANN, V30, P133, DOI 10.1111/j.1728-4465.1999.00133.x; Amare Y, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5922-7; Bang RA, 2004, BJOG-INT J OBSTET GY, V111, P231, DOI 10.1111/j.1471-0528.2004.00063.x; Berhanu D, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05151-3; Bilal NK., YES AFRICA CAN SUCCE, P433; Callaghan-Koru JA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-55; Callaghan-Koru JA, 2012, AM J TROP MED HYG, V87, P61, DOI 10.4269/ajtmh.2012.11-0665; Central SA., 2019, ETH MIN HLTH SURV; Colvin D., WHAT MOTIVATES COMMU; DiBari JN, 2014, J PREGNANCY, V2014, DOI 10.1155/2014/530769; Furth R., 2012, IMPROVING CHW PROGRA; Gebretsadik A, 2018, PEDIATR HEALTH MED T, V9, P147, DOI 10.2147/PHMT.S179339; Gogia S, 2010, B WORLD HEALTH ORGAN, V88, P658, DOI 10.2471/BLT.09.069369; Haines A, 2007, LANCET, V369, P2121, DOI 10.1016/S0140-6736(07)60325-0; Hill Z, 2014, GLOBAL HEALTH ACTION, V7, P1, DOI 10.3402/gha.v7.24085; Hodgins S., POSTNATAL CARE FOCUS; Jaskiewicz W, 2012, HUM RESOUR HEALTH, V10, DOI 10.1186/1478-4491-10-38; Kalyango JN, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-282; Kerie MW., CONTRIBUTION HLTH SE; Kok MC, 2015, HEALTH POLICY PLANN, V30, P1207, DOI 10.1093/heapol/czu126; Kok MC, 2015, HEALTH RES POLICY SY, V13, DOI 10.1186/s12961-015-0001-3; Limenih MA., 2016, INT J REPROD MED; McPherson R, 2018, J GLOB HEALTH, V8, DOI 10.7189/jogh.08.010422; Namazzi G, 2017, GLOBAL HEALTH ACTION, V10, DOI 10.1080/16549716.2017.1345495; Ndima SD, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0063-x; Ochieng BM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-S1-S4; Probandari A, 2017, BMC HEALTH SERV RES, V17, DOI 10.1186/s12913-017-2490-y; Razee H, 2012, SOC SCI MED, V75, P828, DOI 10.1016/j.socscimed.2012.04.013; Roberton T, 2015, HUM RESOUR HEALTH, V13, DOI 10.1186/s12960-015-0010-x; Sacks E, 2017, MATERN CHILD HLTH J, V21, P599, DOI 10.1007/s10995-016-2144-4; Schneider H, 2008, HEALTH POLICY PLANN, V23, P179, DOI 10.1093/heapol/czn006; Scott K, 2018, HUM RESOUR HEALTH, V16, DOI 10.1186/s12960-018-0304-x; Seutloali T, 2018, AFR J PRIM HEALTH CA, V10, DOI 10.4102/phcfm.v10i1.1558; SEZAO. (South-eastern Zone Administrative Office) of Tigray region, 2018, ANNU REP PROG CHEM; Shaban IA, 2018, HOME HEALTH CARE SER, V37, P247, DOI 10.1080/01621424.2018.1454865; Shega SA, 2014, EXPLORING FACTORS AF; Sinha LN, 2014, WEST PAC SURVEILL RE, V5, P22, DOI [10.5365/wpsar.2014.5.1.006, 10.5365/WPSAR.2014.5.1.006]; Sitrin D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068930; Smith S, 2014, HUM RESOUR HEALTH, V12, DOI 10.1186/1478-4491-12-24; Tarekegn SM, 2014, BMC PREGNANCY CHILDB, V14, DOI 10.1186/1471-2393-14-161; Teklehaimanot A., 2007, ETHIOP J HEALTH DEV, V21; Tesfau YB, 2020, BMC PREGNANCY CHILDB, V20, DOI 10.1186/s12884-020-03003-w; Teshome M., 2018, HOME BASED NEONATAL; Ugboaja Joseph O, 2013, Niger Med J, V54, P45, DOI 10.4103/0300-1652.108895; Varma DS., 2013, J FAM WELFARE, V56, P31; Victora CG, 2016, LANCET, V387, P2049, DOI 10.1016/S0140-6736(15)00519-X; Willis-Shattuck M, 2008, BMC HEALTH SERV RES, V8, DOI 10.1186/1472-6963-8-247; Workineh YG, 2014, SCI J PUBLIC HLTH, V2, P169, DOI [10.11648/j.sjph.20140203.15, DOI 10.11648/J.SJPH.20140203.15]; World Health Organization (WHO), 2007, COMMUNITY HLTH WORKE; World Hlth Org, 1999, BIRTH-ISS PERINAT C, V26, P255; Yared A., NONFINANCIAL INCENTI; Ye-Ebiyo Y., 2007, ETHIOP J HEALTH DEV, V21	55	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265301	10.1371/journal.pone.0265301	http://dx.doi.org/10.1371/journal.pone.0265301			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353832	Green Published, gold			2022-12-26	WOS:000786647900051
J	Waldmann, E; Wu, LY; Busygina, KG; Altenhofer, J; Henze, K; Folwaczny, A; Parhofer, K				Waldmann, Elisa; Wu, Liya; Busygina, Kristina G.; Altenhofer, Julia; Henze, Kerstin; Folwaczny, Alexander; Parhofer, Klaus			Effect of PCSK9 inhibition with evolocumab on lipoprotein subfractions in familial dysbetalipoproteinemia (type III hyperlipidemia)	PLOS ONE			English	Article							APOLIPOPROTEIN-E ISOFORMS; SUBTILISIN/KEXIN TYPE 9; SUBTYPE DISTRIBUTION; DIABETES-MELLITUS; REDUCING LIPIDS; HEART-DISEASE; LDL-SUBTYPES; SIMVASTATIN; ATORVASTATIN; FENOFIBRATE	Background and aimsFamilial dysbetalipoproteinemia (FDBL) is a rare inborn lipid disorder characterized by the formation of abnormal triglyceride- and cholesterol-rich lipoproteins (remnant particles). Patients with FDBL have a high risk for atherosclerotic disease. The effect of PCSK9 inhibition on lipoproteins and its subfractions has not been evaluated in FDBL. MethodsThree patients (65 +/- 7 years, 23 +/- 3 kg/m(2), 2 females) with FDBL (diagnosed by isoelectrofocusing) and atherosclerosis (coronary and/or cerebro-vascular and/or peripheral arterial disease) resistant or intolerant to statin and fibrate therapy received evolocumab (140mg every 14 days). In addition to a fasting lipid profile (preparative ultracentrifugation), apoB and cholesterol concentrations were determined in 15 lipoprotein-subfractions (density gradient ultracentrifugation; d 1.006-1.21g/ml) before and after 12 weeks of evolocumab treatment. Patients with LDL-hypercholesterolemia (n = 8, 56 +/- 8 years, 31 +/- 7 kg/m(2)) and mixed hyperlipidemia (n = 5, 68 +/- 12 years, 30 +/- 1 kg/m(2)) also receiving evolocumab for 12 weeks were used for comparison. ResultsAll patients tolerated PCSK9 inhibition well. PCSK9 inhibitors reduced cholesterol (29-37%), non-HDL-cholesterol (36-50%) and apoB (40-52%) in all patient groups including FDBL. In FDBL, PCSK9 inhibition reduced VLDL-cholesterol and the concentration of apoB containing lipoproteins throughout the whole density spectrum (VLDL, IDL, remnants, LDL). Lipoprotein(a) was decreased in all patient groups to a similar extent. ConclusionsThis indicates that the dominant fraction of apoB-containing lipoproteins is reduced with PCSK9 inhibition, i.e. LDL in hypercholesterolemia and mixed hyperlipidemia, and cholesterol-rich VLDL, remnants and LDL in FDBL. PCSK9 inhibition may be a treatment option in patients with FDBL resistant or intolerant to statin and/or fibrate therapy.	[Waldmann, Elisa; Wu, Liya; Busygina, Kristina G.; Altenhofer, Julia; Henze, Kerstin; Folwaczny, Alexander; Parhofer, Klaus] LMU Klinikum Grosshadern, Med Dept 4, Munich, Germany; [Wu, Liya] Univ Med Ctr Goettingen, Dept Gastroenterol Gastrointestinal Oncol & Endoc, Gottingen, Germany	University of Munich; University of Gottingen	Parhofer, K (corresponding author), LMU Klinikum Grosshadern, Med Dept 4, Munich, Germany.	klaus.parhofer@med.uni-muenchen.de		Parhofer, Klaus/0000-0001-9873-0412				Berneis K, 2010, EUR HEART J, V31, P1633, DOI 10.1093/eurheartj/ehq181; BREDIE SJH, 1995, AM J CARDIOL, V75, P348, DOI 10.1016/S0002-9149(99)80552-9; Busygina Kristina, 2018, MMW Fortschr Med, V160, P43, DOI 10.1007/s15006-018-0091-2; Chan DC, 2015, CLIN SCI, V128, P379, DOI 10.1042/CS20140559; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Devaraj S, 1998, AM J MED, V104, P445, DOI 10.1016/S0002-9343(98)00089-8; Dijk W, 2018, TRENDS ENDOCRIN MET, V29, P420, DOI 10.1016/j.tem.2018.03.013; DROOD JM, 1991, J CLIN PHARMACOL, V31, P641, DOI 10.1002/j.1552-4604.1991.tb03750.x; Frost RJA, 2001, AM J CARDIOL, V87, P44, DOI 10.1016/S0002-9149(00)01270-4; GAW A, 1993, ARTERIOSCLER THROMB, V13, P170, DOI 10.1161/01.ATV.13.2.170; Geiss HC, 2006, METABOLISM, V55, P599, DOI 10.1016/j.metabol.2005.11.015; Geiss HC, 2003, EXP CLIN ENDOCR DIAB, V111, P322, DOI 10.1055/s-2003-42720; Geiss HC, 2002, EXP CLIN ENDOCR DIAB, V110, P182, DOI 10.1055/s-2002-32150; Geiss HC, 2001, METABOLISM, V50, P983, DOI 10.1053/meta.2001.24879; GHISELLI G, 1982, LANCET, V2, P405; Kappelle PJWH, 2010, BBA-MOL CELL BIOL L, V1801, P89, DOI 10.1016/j.bbalip.2009.09.021; Koren MJ, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002224; Li TT, 2021, BMC CARDIOVASC DISOR, V21, DOI 10.1186/s12872-020-01827-0; Macchi C, 2021, AM J PATHOL, V191, P1385, DOI 10.1016/j.ajpath.2021.04.016; Marais D, 2015, CURR OPIN LIPIDOL, V26, P292, DOI 10.1097/MOL.0000000000000192; MARCEL YL, 1988, ARTERIOSCLEROSIS, V8, P832, DOI 10.1161/01.ATV.8.6.832; O'Keefe James H Jr, 2004, Prev Cardiol, V7, P154, DOI 10.1111/j.1520-037X.2004.03594.x; Phillips MC, 2014, IUBMB LIFE, V66, P616, DOI 10.1002/iub.1314; Rizos CV, 2015, J CARDIOVASC PHARM T, V20, P276, DOI 10.1177/1074248414549419; Robinson JG, 2015, NEW ENGL J MED, V372, P1489, DOI 10.1056/NEJMoa1501031; Ruscica M, 2021, PHARMACOL RES, V173, DOI 10.1016/j.phrs.2021.105812; Sabatine MS, 2017, NEW ENGL J MED, V376, P1713, DOI [10.1056/NEJMoa1615664, 10.4997/JRCPE.2017.212]; Sabatine MS, 2015, NEW ENGL J MED, V372, P1500, DOI 10.1056/NEJMoa1500858; Schamberger BM, 2000, J LIPID RES, V41, P727; Schwartz GG, 2018, NEW ENGL J MED, V379, P2097, DOI 10.1056/NEJMoa1801174; Varbo A, 2013, CIRCULATION, V128, P1298, DOI 10.1161/CIRCULATIONAHA.113.003008; WEINTRAUB MS, 1987, J CLIN INVEST, V80, P1571, DOI 10.1172/JCI113243; Winkler K, 2004, EXP CLIN ENDOCR DIAB, V112, P241, DOI 10.1055/s-2004-817970	33	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265838	10.1371/journal.pone.0265838	http://dx.doi.org/10.1371/journal.pone.0265838			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320320	gold, Green Published			2022-12-26	WOS:000784240600038
J	Isoe, J; Petchampai, N; Joseph, V; Scaraffia, PY				Isoe, Jun; Petchampai, Natthida; Joseph, Vena; Scaraffia, Patricia Y.			Ornithine decarboxylase deficiency critically impairs nitrogen metabolism and survival in Aedes aegypti mosquitoes	FASEB JOURNAL			English	Article						ammonia metabolism; glucose metabolism; oxidative stress; polyamines; survival	AMMONIA METABOLISM; POLYAMINES; SPERMINE; AUTOPHAGY; PROMOTES	Ornithine decarboxylase (ODC; EC 4.1.1.17) catalyzes the conversion of ornithine to putrescine, the rate-limiting first step for de novo polyamine biosynthesis. Previously, we reported that genetic knockdown of xanthine dehydrogenase 1 (XDH1)-a gene encoding the enzyme involved in the last two steps of uric acid synthesis-causes an increase in ODC transcript levels in fat body of blood-fed Aedes aegypti mosquitoes, suggesting a crosstalk at molecular level between XDH1 and ODC during nitrogen disposal. To further investigate the role of ODC in nitrogen metabolism, we conducted several biochemical and genetic analyses in sugar- and blood-fed A. aegypti females. Distinct ODC gene and protein expression patterns were observed in mosquito tissues dissected during the first gonotrophic cycle. Both pharmacological and RNA interference-mediated knockdown of ODC negatively impacted mosquito survival, disrupted nitrogen waste disposal, delayed oviposition onset, and decreased fecundity in vitellogenic blood-fed females. A lag in the expression of two major digestive serine proteases, a reduction of blood meal digestion in the midgut, and a decrease in vitellogenin yolk protein uptake in ovarian follicles were observed by western blots in ODC-deficient females. Moreover, genetic silencing of ODC showed a broad transcriptional modulation of genes encoding proteins involved in multiple metabolic pathways in mosquito fat body, midgut, and Malpighian tubules prior to and after blood feeding. All together, these data demonstrate that ODC plays an essential role in mosquito metabolism, and that ODC crosstalks with multiple genes and proteins to prevent deadly nitrogen perturbations in A. aegypti females.	[Isoe, Jun] Univ Arizona, Dept Entomol, Tucson, AZ 85721 USA; [Petchampai, Natthida; Joseph, Vena; Scaraffia, Patricia Y.] Tulane Univ, Vector Borne Infect Dis Res Ctr, Sch Publ Hlth & Trop Med, Dept Trop Med, New Orleans, LA USA	University of Arizona; Tulane University	Scaraffia, PY (corresponding author), Vector Borne Infect Dis Res Ctr, Dept Trop Med, 1430 Tulane Ave,SL-17 J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu		Scaraffia, Patricia/0000-0003-2985-933X	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health; National Institute of Allergy and Infectious Diseases [R01AI146199]	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Corine Adams Baines Professorship Award; Carol Lavin Bernick Faculty Grants; National Institutes of Health; National Institute of Allergy and Infectious Diseases, Grant/Award Number: R01AI146199	Bachmann AS, 2018, J BIOL CHEM, V293, P18757, DOI 10.1074/jbc.TM118.003336; Bae DH, 2018, BBA-GEN SUBJECTS, V1862, P2053, DOI 10.1016/j.bbagen.2018.06.004; BIRNBAUM MJ, 1990, J COMP PHYSIOL B, V160, P145, DOI 10.1007/BF00300946; Cardoso VV, 2009, BRAZ J BIOL, V69, P149, DOI 10.1590/S1519-69842009000100019; Cayre M, 1996, BEHAV NEUROSCI, V110, P1117; Chang L, 2021, INSECTS, V12, DOI 10.3390/insects12070624; Coni S, 2021, ELIFE, V10, DOI 10.7554/eLife.69269; Eisenberg T, 2009, NAT CELL BIOL, V11, P1305, DOI 10.1038/ncb1975; Firpo MR, 2020, BIOMOLECULES, V10, DOI 10.3390/biom10040628; Gupta VK, 2013, NAT NEUROSCI, V16, P1453, DOI 10.1038/nn.3512; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Horvath TD, 2021, TRENDS PARASITOL, V37, P747, DOI 10.1016/j.pt.2021.03.010; Horvath TD, 2018, FASEB J, V32, P466, DOI 10.1096/fj.201700657R; Huang MY, 2020, INFECT DRUG RESIST, V13, P4335, DOI 10.2147/IDR.S262024; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Isoe J, 2017, FASEB J, V31, P2276, DOI 10.1096/fj.201601185R; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Isoe J, 2009, INSECT BIOCHEM MOLEC, V39, P903, DOI 10.1016/j.ibmb.2009.10.008; Kahana C, 2018, J BIOL CHEM, V293, P18730, DOI 10.1074/jbc.TM118.003339; Kogan PH, 2000, J INSECT PHYSIOL, V46, P1079, DOI 10.1016/S0022-1910(99)00084-0; Leon KE, 2020, BIOCHEM BIOPH RES CO, V523, P429, DOI 10.1016/j.bbrc.2019.12.078; Li C, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01289-7; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Minois N, 2011, AGING-US, V3, P716, DOI 10.18632/aging.100361; Mounce BC, 2017, MICROBIOL MOL BIOL R, V81, DOI 10.1128/MMBR.00029-17; Nanduri B, 2021, PNEUMONIA, V13, DOI 10.1186/s41479-021-00082-x; Nishimura K, 2009, INT J BIOCHEM CELL B, V41, P2251, DOI 10.1016/j.biocel.2009.04.021; Pegg AE, 2006, J BIOL CHEM, V281, P14529, DOI 10.1074/jbc.R500031200; Petchampai N, 2020, INSECT BIOCHEM MOLEC, V121, DOI 10.1016/j.ibmb.2020.103366; Phillips MA, 2018, J BIOL CHEM, V293, P18746, DOI 10.1074/jbc.TM118.003342; Rider JE, 2007, AMINO ACIDS, V33, P231, DOI 10.1007/s00726-007-0513-4; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Stewart TM, 2018, J BIOL CHEM, V293, P18736, DOI 10.1074/jbc.TM118.003337; Tain LS, 2020, AGING CELL, V19, DOI 10.1111/acel.13043; Vannini L, 2014, INSECT BIOCHEM MOLEC, V44, P33, DOI 10.1016/j.ibmb.2013.11.002; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; Zhang ZC, 2008, ENTOMOL EXP APPL, V129, P18, DOI 10.1111/j.1570-7458.2008.00742.x	41	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22279	10.1096/fj.202200008R	http://dx.doi.org/10.1096/fj.202200008R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SA	35344219				2022-12-26	WOS:000773602000001
J	Jiang, HJ; Chiang, CY; Chen, Z; Nathan, S; D'Agostino, G; Paulo, JA; Song, G; Zhu, H; Gabelli, SB; Cole, PA				Jiang, Hanjie; Chiang, Claire Y.; Chen, Zan; Nathan, Sara; D'Agostino, Gabriel; Paulo, Joao A.; Song, Guang; Zhu, Heng; Gabelli, Sandra B.; Cole, Philip A.			Enzymatic analysis of WWP2 E3 ubiquitin ligase using protein microarrays identifies autophagy-related substrates	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SELECTIVE AUTOPHAGY; NEDD4 FAMILY; INSIGHTS; UBIQUITYLATION; RNA; RECRUITMENT; ACTIVATION; MECHANISMS; RECEPTORS; CATALYSIS	WWP2 is a HECT E3 ligase that targets protein Lys residues for ubiquitination and is comprised of an N-terminal C2 domain, four central WW domains, and a C-terminal catalytic HECT domain. The peptide segment between the middle WW domains, the 2,3-linker, is known to autoinhibit the catalytic domain, and this autoinhibition can be relieved by phosphorylation at Tyr369. Several protein substrates of WWP2 have been identified, including the tumor suppressor lipid phos-phatase PTEN, but the full substrate landscape and biological functions of WWP2 remain to be elucidated. Here, we used protein microarray technology and the activated enzyme phosphomimetic mutant WWP2(Y369E )to identify potential WWP2 substrates. We identified 31 substrate hits for WWP2(Y369E )using protein microarrays, of which three were known autophagy receptors (NDP52, OPTN, and SQSTM1). These three hits were validated with in vitro and cell-based transfection assays and the Lys ubiquitination sites on these proteins were mapped by mass spectrometry. Among the mapped ubiquitin sites on these autophagy receptors, many had been previously identified in the endogenous proteins. Finally, we observed that WWP2 KO SH-SH5Y neuroblastoma cells using CRISPR-Cas9 showed a defect in mitophagy, which could be rescued by WWP2(Y369E )transfection. These studies suggest that WWP2-mediated ubiquitination of the autophagy receptors NDP52, OPTN, and SQSTM1 may positively contribute to the regulation of autophagy	[Jiang, Hanjie; Chiang, Claire Y.; D'Agostino, Gabriel; Cole, Philip A.] Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA; [Jiang, Hanjie; Chiang, Claire Y.; D'Agostino, Gabriel; Cole, Philip A.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jiang, Hanjie; Chen, Zan; Song, Guang; Zhu, Heng; Cole, Philip A.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA; [Chen, Zan; Paulo, Joao A.] Harvard Med Sch, Dept Cell Biol, Boston, MA 02115 USA; [Chen, Zan; Nathan, Sara; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Biophys & Biophys Chem, Baltimore, MD 21205 USA; [Zhu, Heng; Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Oncol, Baltimore, MD 21205 USA; [Gabelli, Sandra B.] Johns Hopkins Univ, Sch Med, Dept Med, Baltimore, MD 21205 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins Medicine; Harvard University; Harvard Medical School; Johns Hopkins University; Johns Hopkins University; Johns Hopkins University	Cole, PA (corresponding author), Brigham & Womens Hosp, Dept Med, Div Genet, 75 Francis St, Boston, MA 02115 USA.; Cole, PA (corresponding author), Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.; Cole, PA (corresponding author), Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21205 USA.	pacole@bwh.harvard.edu	Jiang, Hanjie/AAT-8422-2021	Chiang, Claire/0000-0002-0999-9856; Jiang, Hanjie/0000-0001-6090-4552	National Institutes of Health [R01CA74305, R01 GM136148, R01GM132129, GM67945]; NIH training [T32GM095450]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	Funding and additional information-This work was supported by National Institutes of Health Grant R01CA74305 (P. A. C.) . This work was partially funded by R01 GM136148 (S. B. G.) as well as R01GM132129 and GM67945 (J. A. P.) . This work was also sup-ported by NIH training T32GM095450 for work by G. D. The content is solely the responsibility of the authors and does not represent the official views of the National Institutes of Health.	Aslam B, 2017, J CHROMATOGR SCI, V55, P182, DOI 10.1093/chromsci/bmw167; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001; Buetow L, 2016, NAT REV MOL CELL BIO, V17, P626, DOI 10.1038/nrm.2016.91; Caron P, 2019, GENE DEV, V33, P684, DOI 10.1101/gad.321943.118; Chen A, 2009, MOL CELL BIOL, V29, P5348, DOI 10.1128/MCB.00407-09; Chen C, 2007, CANCER METAST REV, V26, P587, DOI 10.1007/s10555-007-9091-x; Chen Z, 2017, MOL CELL, V66, P345, DOI 10.1016/j.molcel.2017.03.020; Chen Z, 2016, BIOCHEMISTRY-US, V55, P3658, DOI 10.1021/acs.biochem.6b00448; Chhangani D, 2014, SCI REP-UK, V4, DOI 10.1038/srep05077; Dempsey DR, 2018, J AM CHEM SOC, V140, P9374, DOI 10.1021/jacs.8b05098; Dikic I, 2018, NAT REV MOL CELL BIO, V19, P349, DOI 10.1038/s41580-018-0003-4; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Elias JE, 2010, METHODS MOL BIOL, V604, P55, DOI 10.1007/978-1-60761-444-9_5; Erpapazoglou Zoi, 2014, Cells, V3, P1027, DOI 10.3390/cells3041027; Fajner V, 2017, FEBS LETT, V591, P2636, DOI 10.1002/1873-3468.12775; Farre JC, 2016, NAT REV MOL CELL BIO, V17, P537, DOI 10.1038/nrm.2016.74; French ME, 2017, J BIOL CHEM, V292, P10398, DOI 10.1074/jbc.M117.789479; French ME, 2009, J BIOL CHEM, V284, P12071, DOI 10.1074/jbc.M901106200; Glick D, 2010, J PATHOL, V221, P3, DOI 10.1002/path.2697; Grimsey NJ, 2018, CELL REP, V24, P3312, DOI 10.1016/j.celrep.2018.08.061; Harper JW, 2021, ANNU REV BIOCHEM, V90, P403, DOI 10.1146/annurev-biochem-090120-013613; Heo JM, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aay4624; Heo JM, 2015, MOL CELL, V60, P7, DOI 10.1016/j.molcel.2015.08.016; Hu SH, 2009, CELL, V139, P610, DOI 10.1016/j.cell.2009.08.037; Huang X, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-2142-8; Iconomou M, 2016, BIOCHEM J, V473, P4083, DOI 10.1042/BCJ20160719; Ingham RJ, 2004, ONCOGENE, V23, P1972, DOI 10.1038/sj.onc.1207436; Jia XM, 2021, EXP CELL RES, V402, DOI 10.1016/j.yexcr.2021.112506; Jiang Hanjie, 2021, Curr Protoc, V1, pe14, DOI 10.1002/cpz1.14; Jiang HJ, 2019, J BIOL CHEM, V294, P17421, DOI 10.1074/jbc.RA119.009211; Kamadurai HB, 2013, ELIFE, V2, DOI 10.7554/eLife.00828; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Katayama H, 2011, CHEM BIOL, V18, P1042, DOI 10.1016/j.chembiol.2011.05.013; Kim HC, 2011, EMBO REP, V12, P334, DOI 10.1038/embor.2011.23; Kirkin V, 2019, MOL CELL, V76, P268, DOI 10.1016/j.molcel.2019.09.005; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Lee DE, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2242-5; Lee Y, 2017, CELL REP, V19, P188, DOI 10.1016/j.celrep.2017.03.030; Lee YR, 2019, SCIENCE, V364, P651, DOI 10.1126/science.aau0159; Li H, 2007, MOL CELL BIOL, V27, P5296, DOI 10.1128/MCB.01667-06; Lin Q, 2017, J CELL SCI, V130, P3839, DOI 10.1242/jcs.207068; Liu ZZ, 2014, CANCER CELL, V26, P106, DOI 10.1016/j.ccr.2014.05.015; Lorenz S, 2018, BIOL CHEM, V399, P127, DOI 10.1515/hsz-2017-0184; Lu JY, 2008, MOL CELL PROTEOMICS, V7, P35, DOI 10.1074/mcp.M700353-MCP200; Maddika S, 2011, NAT CELL BIOL, V13, P728, DOI 10.1038/ncb2240; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Nazio F, 2016, J CELL BIOL, V215, P841, DOI 10.1083/jcb.201605089; Onishi M, 2021, EMBO J, V40, DOI 10.15252/embj.2020104705; Palacios-Moreno J, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004130; Pan JA, 2016, MOL CELL, V61, P720, DOI 10.1016/j.molcel.2016.02.007; Perez-Riverol Y, 2022, NUCLEIC ACIDS RES, V50, pD543, DOI 10.1093/nar/gkab1038; Persaud A, 2011, METHODS MOL BIOL, V759, P215, DOI 10.1007/978-1-61779-173-4_13; Persaud A, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.85; Platta HW, 2012, BIOCHEM J, V441, P399, DOI 10.1042/BJ20111424; Qian H, 2020, J TRANSL INTERN MED, V8, P71, DOI 10.2478/jtim-2020-0012; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i; Riling C, 2015, J BIOL CHEM, V290, P23875, DOI 10.1074/jbc.M115.649269; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Sanarico AG, 2018, LEUKEMIA, V32, P911, DOI 10.1038/leu.2017.342; Scott DC, 2016, CELL, V166, P1198, DOI 10.1016/j.cell.2016.07.027; Senft D, 2018, NAT REV CANCER, V18, P69, DOI 10.1038/nrc.2017.105; Skaar JR, 2013, NAT REV MOL CELL BIO, V14, P369, DOI 10.1038/nrm3582; Soond SM, 2011, ONCOGENE, V30, P2451, DOI 10.1038/onc.2010.617; Sun AQ, 2017, AUTOPHAGY, V13, P522, DOI 10.1080/15548627.2016.1268301; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Syu GD, 2020, MOL CELL PROTEOMICS, V19, P916, DOI 10.1074/mcp.R120.001936; Tumbarello DA, 2012, NAT CELL BIOL, V14, P1024, DOI 10.1038/ncb2589; Uzoma Ijeoma, 2013, Genomics Proteomics & Bioinformatics, V11, P18, DOI 10.1016/j.gpb.2012.12.005; Wang H, 2016, FASEB J, V30, P2549, DOI 10.1096/fj.201500119; Wang YY, 2020, J CELL SCI, V133, DOI 10.1242/jcs.228072; Wang Z, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11224-7; Weber J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00370; Wienken CJ, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1093; Xie WH, 2022, CELL DEATH DIFFER, V29, P40, DOI 10.1038/s41418-021-00833-9; Xu HM, 2004, J BIOL CHEM, V279, P23495, DOI 10.1074/jbc.M400516200; Zhang W, 2016, MOL CELL, V62, P121, DOI 10.1016/j.molcel.2016.02.005; Zhu H, 2001, SCIENCE, V293, P2101, DOI 10.1126/science.1062191; Zhu K, 2017, EMBO REP, V18, P1618, DOI 10.15252/embr.201744454	83	0	0	8	10	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101854	10.1016/j.jbc.2022.101854	http://dx.doi.org/10.1016/j.jbc.2022.101854			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35331737	gold, Green Published			2022-12-26	WOS:000793483000009
J	Killoy, KM; Harlan, BA; Pehar, M; Vargas, MR				Killoy, Kelby M.; Harlan, Benjamin A.; Pehar, Mariana; Vargas, Marcelo R.			NR1D1 downregulation in astrocytes induces a phenotype that is detrimental to cocultured motor neurons	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; astrocytes; inflammation; motor neurons; NR1D1; Rev-erb alpha	AMYOTROPHIC-LATERAL-SCLEROSIS; REV-ERB-ALPHA; BODY-MASS INDEX; CU,ZN SUPEROXIDE-DISMUTASE; DISEASE ONSET; REACTIVE ASTROGLIOSIS; CIRCADIAN BEHAVIOR; NRF2 ACTIVATION; SPINAL-CORD; ALS	Nuclear receptor subfamily 1 group D member 1 (NR1D1, also known as Reverb alpha) is a nuclear transcription factor that is part of the molecular clock encoding circadian rhythms and may link daily rhythms with metabolism and inflammation. NR1D1. unlike most nuclear receptors, lacks a ligand-dependent activation function domain 2 and is a constitutive transcriptional repressor. Amyotrophic lateral sclerosis (ALS) is the most common adult-onset motor neuron disease, caused by the progressive degeneration of motor neurons in the spinal cord, brain stem, and motor cortex. Approximately 10%-20% of familial ALS is caused by a toxic gain-of-function induced by mutations of the Cu/Zn superoxide dismutase (SODI). Dysregulated clock and clock-controlled gene expression occur in multiple tissues from mutant hSOD1-linked ALS mouse models. Here we explore NR1D1 dysregulation in the spinal cord of ALS mouse models and its consequences on astrocyte-motor neuron interaction. NR1D1 protein and mRNA expression are significantly downregulated in the spinal cord of symptomatic mice expressing mutant hSOD1. while no changes were observed in age-matched animals overexpressing wild-type hSOD1. In addition, NR1D1 downregulation in primary astrocyte cultures induces a pro-inflammatory phenotype and decreases the survival of cocultured motor neurons. NR1D1 orchestrates the cross talk between physiological pathways identified to be disrupted in ALS (e.g., metabolism, inflammation, redox homeostasis, and circadian rhythms) and we observed that downregulation of NR1D1 alters astrocyte-motor neuron interaction. Our results suggest that NR1D1 could be a potential therapeutic target to prevent astrocyte-mediated motor neuron toxicity in ALS.	[Killoy, Kelby M.; Vargas, Marcelo R.] Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA; [Harlan, Benjamin A.] Med Univ South Carolina, Biomed Sci Training Program, Charleston, SC 29425 USA; [Pehar, Mariana] Univ Wisconsin, Dept Med, Div Geriatr & Gerontol, Madison, WI 53792 USA; [Pehar, Mariana] Vet Affairs Med Ctr, Geriatr Res Educ Clin Ctr, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; Medical University of South Carolina; University of Wisconsin System; University of Wisconsin Madison; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA)	Vargas, MR (corresponding author), Univ Wisconsin, Dept Neurol, 600 Highland Ave,CSC K6-444, Madison, WI 53792 USA.	mvargas@wisc.edu			National Institutes of Health (NIH) [R21NS102599, R01NS089640]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	HHS vertical bar National Institutes of Health (NIH), Grant/Award Number: R21NS102599 and R01NS089640	Arnold ES, 2013, P NATL ACAD SCI USA, V110, pE736, DOI 10.1073/pnas.1222809110; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Barbeito LH, 2004, BRAIN RES REV, V47, P263, DOI 10.1016/j.brainresrev.2004.05.003; Barca-Mayo O, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14336; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; BENSIMON G, 1994, NEW ENGL J MED, V330, P585, DOI 10.1056/NEJM199403033300901; Bouteloup C, 2009, J NEUROL, V256, P1236, DOI 10.1007/s00415-009-5100-z; Brancaccio M, 2017, NEURON, V93, P1420, DOI 10.1016/j.neuron.2017.02.030; Brown RH, 2017, NEW ENGL J MED, V377, P1602, DOI [10.1038/nrdp.2017.85, 10.1056/NEJMra1603471, 10.1056/NEJMc1710379, 10.1016/S0140-6736(17)31287-4, 10.1016/S0140-6736(10)61156-7, 10.1038/nrdp.2017.71]; Bruijn LI, 1997, NEURON, V18, P327, DOI 10.1016/S0896-6273(00)80272-X; Chen H, 2015, J CLIN INVEST, V125, P1033, DOI 10.1172/JCI69097; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; de Boer AS, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009351; Desport JC, 1999, NEUROLOGY, V53, P1059, DOI 10.1212/WNL.53.5.1059; Di Giorgio FP, 2007, NAT NEUROSCI, V10, P608, DOI 10.1038/nn1885; Ditsworth D, 2017, ACTA NEUROPATHOL, V133, P907, DOI 10.1007/s00401-017-1698-6; Dupuis L, 2008, NEUROLOGY, V70, P1004, DOI 10.1212/01.wnl.0000285080.70324.27; Dupuis L, 2011, LANCET NEUROL, V10, P75, DOI 10.1016/S1474-4422(10)70224-6; Gallo V, 2013, NEUROLOGY, V80, P829, DOI 10.1212/WNL.0b013e3182840689; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gray E, 2015, AMYOTROPH LAT SCL FR, V16, P456, DOI 10.3109/21678421.2015.1053490; Griffin P, 2019, P NATL ACAD SCI USA, V116, P5102, DOI 10.1073/pnas.1812405116; GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258; Haidet-Phillips AM, 2011, NAT BIOTECHNOL, V29, P824, DOI 10.1038/nbt.1957; Hall ED, 1998, GLIA, V23, P249, DOI 10.1002/(SICI)1098-1136(199807)23:3<249::AID-GLIA7>3.0.CO;2-#; HARDING HP, 1993, MOL CELL BIOL, V13, P3113, DOI 10.1128/MCB.13.5.3113; HARDING HP, 1995, MOL CELL BIOL, V15, P4791; Harlan BA, 2020, EXP NEUROL, V327, DOI 10.1016/j.expneurol.2020.113219; Harlan BA, 2019, FASEB J, V33, P7084, DOI 10.1096/fj.201802752R; Harlan BA, 2016, J BIOL CHEM, V291, P10836, DOI 10.1074/jbc.M115.698779; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Huisman MHB, 2015, JAMA NEUROL, V72, P1155, DOI 10.1001/jamaneurol.2015.1584; Kia A, 2018, GLIA, V66, P1016, DOI 10.1002/glia.23298; Killoy KM, 2021, FASEB J, V35, DOI 10.1096/fj.202000386RR; Killoy KM, 2020, GLIA, V68, P2693, DOI 10.1002/glia.23879; KUSHNER PD, 1991, J NEUROPATH EXP NEUR, V50, P263, DOI 10.1097/00005072-199105000-00008; Lawton KA, 2012, AMYOTROPH LATERAL SC, V13, P110, DOI 10.3109/17482968.2011.619197; Lee J, 2020, AGING CELL, V19, DOI 10.1111/acel.13078; Marin B, 2016, NEURODEGENER DIS, V16, P225, DOI 10.1159/000442444; Maury E, 2014, DIABETES METAB, V40, P338, DOI 10.1016/j.diabet.2013.12.005; McKee CA, 2020, CELL MOL LIFE SCI, V77, P1049, DOI 10.1007/s00018-019-03314-y; Meyer K, 2014, P NATL ACAD SCI USA, V111, P829, DOI 10.1073/pnas.1314085111; Miquel E, 2014, FREE RADICAL BIO MED, V70, P204, DOI 10.1016/j.freeradbiomed.2014.02.019; Nagai M, 2001, J NEUROSCI, V21, P9246, DOI 10.1523/JNEUROSCI.21-23-09246.2001; Nagai M, 2007, NAT NEUROSCI, V10, P615, DOI 10.1038/nn1876; NAGY D, 1994, J NEUROSCI RES, V38, P336, DOI 10.1002/jnr.490380312; O'Reilly EJ, 2013, AMYOTROPH LAT SCL FR, V14, P205, DOI 10.3109/21678421.2012.735240; OREILLY SA, 1995, EXP NEUROL, V131, P203, DOI 10.1016/0014-4886(95)90042-X; Paganoni S, 2011, MUSCLE NERVE, V44, P20, DOI 10.1002/mus.22114; Pehar M, 2017, CURR PHARM DESIGN, V23, P5010, DOI 10.2174/1381612823666170622095802; Pehar M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103438; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Pradat PF, 2010, AMYOTROPH LATERAL SC, V11, P166, DOI 10.3109/17482960902822960; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Qian K, 2017, STEM CELL REP, V8, P843, DOI 10.1016/j.stemcr.2017.03.003; Raghuram S, 2007, NAT STRUCT MOL BIOL, V14, P1207, DOI 10.1038/nsmb1344; Renaud JP, 2000, MOL ENDOCRINOL, V14, P700, DOI 10.1210/me.14.5.700; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; ROSEN DR, 1993, NATURE, V364, P362, DOI 10.1038/364362c0; Saneto RP., 1987, NEUROCHEMISTRY PRACT, P27; Sato TK, 2004, NEURON, V43, P527, DOI 10.1016/j.neuron.2004.07.018; Sawada H, 2017, EXPERT OPIN PHARMACO, V18, P735, DOI 10.1080/14656566.2017.1319937; Schibler U, 2015, COLD SH Q B, V80, P223, DOI 10.1101/sqb.2015.80.027490; Schiffer D, 1996, J NEUROL SCI, V139, P27, DOI 10.1016/0022-510X(96)00073-1; Schiffer D, 2004, AMYOTROPH LATERAL SC, V5, P22, DOI 10.1080/14660820310016822; Schnell A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099883; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Song S, 2016, NAT MED, V22, P397, DOI 10.1038/nm.4052; Stubblefield JJ, 2012, TRENDS ENDOCRIN MET, V23, P326, DOI 10.1016/j.tem.2012.03.007; Sun SY, 2015, P NATL ACAD SCI USA, V112, pE6993, DOI 10.1073/pnas.1520639112; Swarup V, 2011, J EXP MED, V208, P2429, DOI 10.1084/jem.20111313; Tso CF, 2017, CURR BIOL, V27, P1055, DOI 10.1016/j.cub.2017.02.037; Ueda HR, 2002, NATURE, V418, P534, DOI 10.1038/nature00906; Vanderheyden W.M., 2021, CURR RES NEUROBIOL, V2; Vargas MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056625; Vargas MR, 2011, NEUROBIOL DIS, V43, P543, DOI 10.1016/j.nbd.2011.04.025; Vargas MR, 2010, NEUROTHERAPEUTICS, V7, P471, DOI 10.1016/j.nurt.2010.05.012; Vargas MR, 2008, J NEUROSCI, V28, P13574, DOI 10.1523/JNEUROSCI.4099-08.2008; Vargas MR, 2006, J NEUROCHEM, V97, P687, DOI 10.1111/j.1471-4159.2006.03742.x; Vargas MR, 2005, J BIOL CHEM, V280, P25571, DOI 10.1074/jbc.M501920200; Wang J, 2002, NEUROBIOL DIS, V10, P128, DOI 10.1006/nbdi.2002.0498; Wang LJ, 2011, HUM MOL GENET, V20, P286, DOI 10.1093/hmg/ddq463; Wang S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-06568-5; WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Yin L, 2007, SCIENCE, V318, P1786, DOI 10.1126/science.1150179	86	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22262	10.1096/fj.202101275R	http://dx.doi.org/10.1096/fj.202101275R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35319791	Green Published			2022-12-26	WOS:000772957100001
J	Wang, C; Leavenworth, J; Zhang, C; Liu, ZC; Yuan, KY; Wang, YC; Zhang, GX; Wang, SB; Cui, XL; Zhang, Y; Bae, S; Zhou, JB; Wang, LZ; Liu, RH				Wang, Chao; Leavenworth, Jonathan; Zhang, Chao; Liu, Zhichao; Yuan, Katherine Y.; Wang, Yicun; Zhang, Guangxin; Wang, Shuaibin; Cui, Xuelian; Zhang, Yue; Bae, Sejong; Zhou, Jiangbing; Wang, Lizhong; Liu, Runhua			Epigenetic regulation of EIF4A1 through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling in prostate cancer	ONCOGENE			English	Article							TRANSLATION INITIATION; GENE-EXPRESSION	In prostate cancers, elongation initiation factor 4A1 (eIF4A1) supports an oncogenic translation program and is highly expressed, but its role remains elusive. By the use of human specimens and cell models, we addressed the role of eIF4A1 in prostate cancer in vitro and in vivo. EIF4A1 expression, as determined by mRNA and protein levels, was higher in primary prostate cancers relative to normal prostate tissue. Also, for primary prostate cancers, elevated mRNA levels of EIF4A1 correlated with DNA hypomethylation levels in the CpG-rich island of EIF4A1. Using a DNMT3a CRISPR-Cas9-based tool for specific targeting of DNA methylation, we characterized, in human prostate cancer cells, the epigenetic regulation of EIF4A1 transcripts through DNA methylation in the CpG-rich island of EIF4A1. Next, we investigated the oncogenic effect of EIF4A1 on cancer cell proliferation in vitro and tumor growth in vivo. For prostate cancer cells, EIF4A1 heterozygous knockout or knockdown inhibited protein translation and tumor growth. In addition, using RNA immunoprecipitation with RNA sequencing, we discovered the eIF4A1-mediated translational regulation of the oncogene BRD2, which contains the most enriched eIF4A1-binding motifs in its 5 ' untranslated region, establishing an eIF4A1-BRD2 axis for oncogenic translation. Finally, we found a positive correlation between expression levels of eIF4A1 and BRD2 in primary prostate cancers. Our results demonstrate, for prostate cancer cells, epigenetic regulation of EIF4A1 transcripts through DNA methylation and an oncogenic role of eIF4A1 through BRD2 signaling.	[Wang, Chao; Leavenworth, Jonathan; Zhang, Chao; Liu, Zhichao; Yuan, Katherine Y.; Wang, Yicun; Zhang, Guangxin; Wang, Shuaibin; Cui, Xuelian; Zhang, Yue; Wang, Lizhong; Liu, Runhua] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35487 USA; [Bae, Sejong; Wang, Lizhong; Liu, Runhua] Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35487 USA; [Bae, Sejong] Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA; [Zhou, Jiangbing] Yale Univ, Dept Neurosurg, New Haven, CT USA; [Zhou, Jiangbing] Yale Univ, Dept Biomed Engn, New Haven, CT USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Yale University; Yale University	Wang, LZ; Liu, RH (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35487 USA.; Wang, LZ; Liu, RH (corresponding author), Univ Alabama Birmingham, ONeal Comprehens Canc Ctr, Birmingham, AL 35487 USA.	lwang12@uab.edu; runhua@uab.edu		Leavenworth, Jonathan/0000-0002-6120-8185; bae, sejong/0000-0001-9982-3223; Zhang, Yue/0000-0003-3817-8253	Department of Defense [W81XWH-15-1-0323, W81XWH-20-1-0426, W81XWH-21-1-0100]; National Cancer Institute [CA118948]; Mike Slive Foundation for Prostate Cancer Research	Department of Defense(United States Department of Defense); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mike Slive Foundation for Prostate Cancer Research	We thank Dr Donald Hill for editorial assistance in preparing this paper. This work was supported by grants from the Department of Defense (W81XWH-15-1-0323 and W81XWH-20-1-0426 for RL and W81XWH-21-1-0100 for LW), the National Cancer Institute (CA118948 for LW), and the Mike Slive Foundation for Prostate Cancer Research (RL).	Asangani IA, 2014, NATURE, V510, P278, DOI 10.1038/nature13229; Chan K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13086-5; Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014; Dang CV, 1999, MOL CELL BIOL, V19, P1; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; de la Parra C, 2018, CURR OPIN GENET DEV, V48, P82, DOI 10.1016/j.gde.2017.11.001; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Faivre EJ, 2020, NATURE, V578, P306, DOI 10.1038/s41586-020-1930-8; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Gao CC, 2020, ACTA BIOCH BIOPH SIN, V52, P310, DOI 10.1093/abbs/gmz168; Jackson RJ, 2010, NAT REV MOL CELL BIO, V11, P113, DOI 10.1038/nrm2838; Jin C, 2013, ONCOGENE, V32, P2179, DOI 10.1038/onc.2012.236; Kregel S, 2019, CLIN CANCER RES, V25, P4038, DOI 10.1158/1078-0432.CCR-18-3776; Kumar A, 2021, ELIFE, V10, DOI [10.7554/eLife.72873, 10.7554/eLife.72873.sa1, 10.7554/eLife.72873.sa2]; Leppek K, 2018, NAT REV MOL CELL BIO, V19, P158, DOI 10.1038/nrm.2017.103; Liu XS, 2016, CELL, V167, P233, DOI 10.1016/j.cell.2016.08.056; Malina A, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a012377; Malka-Mahieu H, 2017, CLIN CANCER RES, V23, P21, DOI 10.1158/1078-0432.CCR-14-2362; Modelska A, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.542; Muhar M, 2018, SCIENCE, V360, P800, DOI 10.1126/science.aao2793; Quinn CM, 1999, GENOMICS, V62, P468, DOI 10.1006/geno.1999.6031; Ramamurthy VP, 2017, CURR OPIN ONCOL, V29, P210, DOI 10.1097/CCO.0000000000000367; Raman D, 2020, CANCER REP-US, DOI 10.1002/cnr2.1299; Remondini D, 2005, P NATL ACAD SCI USA, V102, P6902, DOI 10.1073/pnas.0502081102; Rubio CA, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0476-1; Schrecengost R, 2013, SEMIN ONCOL, V40, P244, DOI 10.1053/j.seminoncol.2013.04.001; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Sridharan S, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.01311; Urbanucci A, 2017, CELL REP, V19, P2045, DOI 10.1016/j.celrep.2017.05.049; Waldron JA, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1901-2; Waldron JA, 2018, NUCLEIC ACIDS RES, V46, P3075, DOI 10.1093/nar/gky108; Wolfe AL, 2014, NATURE, V513, P65, DOI 10.1038/nature13485; Yu GC, 2015, BIOINFORMATICS, V31, P2382, DOI 10.1093/bioinformatics/btv145; Zeller KI, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-10-r69; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137	35	1	1	3	3	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAY 6	2022	41	19					2778	2785		10.1038/s41388-022-02272-3	http://dx.doi.org/10.1038/s41388-022-02272-3		MAR 2022	8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	1A5QI	35361883	Green Accepted			2022-12-26	WOS:000777357500001
J	Archer, NS; Bluff, A; Eddy, A; Nikhil, CK; Hazell, N; Frank, D; Johnston, A				Archer, Nicholas S.; Bluff, Andrew; Eddy, Andrew; Nikhil, Chreshall K.; Hazell, Nick; Frank, Damian; Johnston, Andrew			Odour enhances the sense of presence in a virtual reality environment	PLOS ONE			English	Article							EXPOSURE	Virtual reality (VR) headsets provide immersive audio-visual experiences for users, but usually neglect to provide olfactory cues that can provide additional information about our environment in the real world. This paper examines whether the introduction of smells into the VR environment enhances users' experience, including their sense of presence through collection of both psychological and physiological measures. Using precise odour administration with an olfactometer, study participants were exposed to smells while they were immersed in the popular PlayStation VR game "Resident Evil 7". A within-subject study design was undertaken where participants (n = 22) walked-through the same VR environment twice, with or without the introduction of associated congruent odour stimuli. Directly after each gameplay, participants completed a questionnaire to determine their sense of presence from the overall gameplay and their sense of immersion in each of the virtual scenes. Additionally, physiological measurements (heart rate, body temperature and skin electrodermal activity) were collected from participants (n = 11) for each gameplay. The results showed the addition of odours significantly increased participants' sense of spatial presence in the VR environment compared to VR with no odour. Participants also rated the realism of VR experience with odour higher compared to no odour, however odour addition did not result in change in emotional state of participants (arousal, pleasure, dominance). Further, the participants' physiological responses were impacted by the addition of odour. Odour mediated physiological changes were dependent on whether the VR environment was novel, as the effect of odour on physiological response was lost when participants experienced the aroma on the second gameplay. Overall, the results indicate the addition of odours to a VR environment had a significant effect on both the psychological and physiological experience showing the addition of smell enhanced the VR environment. The incorporation of odours to VR environments presents an opportunity to create a more immersive experience to increase a person's presence within a VR environment. In addition to gaming, the results have broader applications for virtual training environments and virtual reality exposure therapy.	[Archer, Nicholas S.; Frank, Damian] CSIRO, Agr & Food, Sydney, NSW, Australia; [Bluff, Andrew; Hazell, Nick; Johnston, Andrew] Univ Technol Sydney, UTS Anim Log Acad, Fac Engn & IT, Sydney, NSW, Australia; [Nikhil, Chreshall K.] Univ Technol Sydney, Fac Engn & IT, Sydney, NSW, Australia; [Frank, Damian] AII G Foods, Sydney, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Technology Sydney; University of Technology Sydney	Archer, NS (corresponding author), CSIRO, Agr & Food, Sydney, NSW, Australia.; Johnston, A (corresponding author), Univ Technol Sydney, UTS Anim Log Acad, Fac Engn & IT, Sydney, NSW, Australia.	Nicholas.Archer@csiro.au; Andrew.Johnston@uts.edu.au		, Chreshall Nikhil/0000-0001-6150-4841; Archer, Nicholas/0000-0003-3612-2950	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Active Integrated Matter (AIM) Future Science Platform	Commonwealth Scientific and Industrial Research Organisation (CSIRO) Active Integrated Matter (AIM) Future Science Platform	This work was supported by the Commonwealth Scientific and Industrial Research Organisation (CSIRO) Active Integrated Matter (AIM) Future Science Platform. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ariyakul Y, 2012, IEEE SENSOR, P1025; Baus O, 2019, BEHAV INFORM TECHNOL, V38, P1369, DOI 10.1080/0144929X.2019.1590458; Baus O, 2017, VIRTUAL REAL-LONDON, V21, P59, DOI 10.1007/s10055-016-0299-3; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Flavian C, 2021, J BUS RES, V123, P289, DOI 10.1016/j.jbusres.2020.09.036; Grassini S, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.00349; Hacklander RPM, 2019, PSYCHON B REV, V26, P401, DOI 10.3758/s13423-018-1545-3; Ischer M, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00736; Jones L, 2004, HUMAN PERFORMANCE, SITUATION AWARENESS AND AUTOMATION: CURRENT RESEARCH AND TRENDS, VOL 2, P282; Kadohisa M, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00066; Kelley K, 2007, BEHAV RES METHODS, V39, P979, DOI 10.3758/BF03192993; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Lessiter J, 2001, PRESENCE-TELEOP VIRT, V10, P282, DOI 10.1162/105474601300343612; Loos HM, 2020, INT J PSYCHOPHYSIOL, V158, P143, DOI 10.1016/j.ijpsycho.2020.08.014; Masaoka Y, 2012, CHEM SENSES, V37, P379, DOI 10.1093/chemse/bjr120; McGann JP, 2017, SCIENCE, V356, DOI 10.1126/science.aam7263; Menghini L, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13441; Milstein N, 2020, FRONT BEHAV NEUROSCI, V14, DOI 10.3389/fnbeh.2020.00148; Munyan BG, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157568; Nakamoto T, 2006, P IEEE VIRT REAL ANN, P291, DOI 10.1109/VR.2006.102; Niimi J, 2014, INT DAIRY J, V39, P222, DOI 10.1016/j.idairyj.2014.07.002; R Core Team, R LANG ENV STAT COMP; Slater M, 2009, ANU PSICOL, V40, P193; Sowndhararajan K, 2016, SCI PHARM, V84, P724, DOI 10.3390/scipharm84040724; Stevenson RJ, 2010, CHEM SENSES, V35, P3, DOI 10.1093/chemse/bjp083; Torchiano M., EFFSIZE A PACKAGE EF; Turin L., 2018, PERFUMES GUIDE 2018; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1	30	1	1	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265039	10.1371/journal.pone.0265039	http://dx.doi.org/10.1371/journal.pone.0265039			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353816	Green Published, gold			2022-12-26	WOS:000786647900039
J	Lammers, NA; Van den Berg, NS; Lugtmeijer, S; Smits, AR; Pinto, Y; de Haan, EHF				Lammers, Nikki A.; Van den Berg, Nils S.; Lugtmeijer, Selma; Smits, Anouk R.; Pinto, Yair; de Haan, Edward H. F.		Visual Brain Grp	Mid-range visual deficits after stroke: Prevalence and co-occurrence	PLOS ONE			English	Article							QUALITY-OF-LIFE; MOVEMENT VISION; DISTURBANCE; IMPAIRMENT; AGNOSIA; AREAS; POST	Visual deficits are common after stroke and are powerful predictors for the chronic functional outcome. However, while basic visual field and recognition deficits are relatively easy to assess with standardized methods, selective deficits in visual primitives, such as shape or motion, are harder to identify, as they often require a symmetrical bilateral posterior lesion in order to provoke full field deficits. Therefore, we do not know how often they occur. Nevertheless, they can have severe repercussions for daily-life functioning. We aimed to investigate the prevalence and co-occurrence of hemifield "mid-range" visual deficits (i.e. color, shape, location, orientation, correlated motion, contrast, texture and glossiness), using a novel experimental set-up with a gaze-contingent presentation of the stimuli. To this end, a prospective cohort of 220 ischemic (sub)cortical stroke patients and a healthy control group was assessed with this set-up. When comparing performance of patients with controls, the results showed that deficits in motion-perception were most prevalent (26%), followed by color (22%), texture (22%), location (21%), orientation (18%), contrast (14%), shape (14%) and glossiness (13%). 63% of the stroke patients showed one or more mid-range visual deficits. Overlap of deficits was small; they mostly occurred in isolation or co-occurred with only one or two other deficits. To conclude, it was found that deficits in "mid-range" visual functions were very prevalent. These deficits are likely to affect the chronic post-stroke condition. Since we found no strong patterns of co-occurrences, we suggest that an assessment of deficits at this level of visual processing requires screening the full range of visual functions.	[Lammers, Nikki A.; Van den Berg, Nils S.; Lugtmeijer, Selma; Smits, Anouk R.; Pinto, Yair; de Haan, Edward H. F.] Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands; [Lammers, Nikki A.] Univ Med Ctr Amsterdam, Dept Neurol, Amsterdam, Netherlands; [Van den Berg, Nils S.] Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Lugtmeijer, Selma] Radboud Univ Nijmegen, Donders Inst Brain Cognit & Behav, Nijmegen, Netherlands; [Smits, Anouk R.] Univ Med Ctr Utrecht, Dept Neurol, Utrecht, Netherlands; [de Haan, Edward H. F.] St Hughs Coll, Oxford, England	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen; Radboud University Nijmegen; Utrecht University; Utrecht University Medical Center; University of Oxford	de Haan, EHF (corresponding author), Univ Amsterdam, Dept Psychol, Amsterdam, Netherlands.; de Haan, EHF (corresponding author), St Hughs Coll, Oxford, England.	e.h.f.dehaan@uva.nl	Lugtmeijer, Selma/HII-6826-2022; Lugtmeijer, Selma/GQH-8635-2022	Lugtmeijer, Selma/0000-0003-4864-7391; van den Berg, Nils/0000-0003-3202-5598	European Research Council (ERC) Advanced Grant [339374]	European Research Council (ERC) Advanced Grant(European Research Council (ERC))	This work was financially supported by the European Research Council (ERC) Advanced Grant [grant number 339374] to E.H.F. de Haan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The following authors received a salary of the abovementioned funder: N.A. Lammers, N.S. van den Berg, S. Lugtmeijer,A. R. Smits,Y. Pinto,E.H.F.de Haan,N. Seijdel.	Beaudoin AJ, 2013, AUST OCCUP THER J, V60, P260, DOI 10.1111/1440-1630.12046; Brodatz P, 1966, TEXTURES PHOTOGRAPHI; Chen CS, 2009, TOP STROKE REHABIL, V16, P445, DOI 10.1310/tsr1606-445; DAVIDOFF J, 1993, NEUROPSYCHOLOGIA, V31, P83, DOI 10.1016/0028-3932(93)90083-C; de Haan EHF, 2011, TRENDS COGN SCI, V15, P460, DOI 10.1016/j.tics.2011.08.005; DEHAAN EHF, 1995, J NEUROL NEUROSUR PS, V58, P350, DOI 10.1136/jnnp.58.3.350; Dougherty RF, 2003, J VISION, V3, P586, DOI 10.1167/3.10.1; Duchaine B, 2007, COGN NEUROPSYCHOL, V24, P419, DOI 10.1080/02643290701380491; Hepworth LR, 2021, J STROKE CEREBROVASC, V30, DOI 10.1016/j.jstrokecerebrovasdis.2021.105759; Jones SA, 2006, AGE AGEING, V35, P560, DOI 10.1093/ageing/afl074; Kauranen T, 2015, J STROKE CEREBROVASC, V24, P1715, DOI 10.1016/j.jstrokecerebrovasdis.2015.03.049; Larsson J, 2006, J NEUROSCI, V26, P13128, DOI 10.1523/JNEUROSCI.1657-06.2006; LIVINGSTONE M, 1988, SCIENCE, V240, P740, DOI 10.1126/science.3283936; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Neumann G, 2016, NEUROREHAB NEURAL RE, V30, P187, DOI 10.1177/1545968315585355; Nijboer TCW, 2008, J NEUROPSYCHOL, V2, P287, DOI 10.1348/174866407X256563; Nyberg L, 1997, STROKE, V28, P716, DOI 10.1161/01.STR.28.4.716; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Nys GMS, 2005, NEUROLOGY, V64, P821, DOI 10.1212/01.WNL.0000152984.28420.5A; Rowe F, 2009, STRABISMUS, V17, P24, DOI 10.1080/09273970802678537; Rowe FJ, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-029578; Rowe FJ, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213035; Rowe FJ, 2011, EXPERT REV OPHTHALMO, V6, P133, DOI 10.1586/EOP.11.14; Sand KM, 2013, ACTA NEUROL SCAND, V127, P52, DOI 10.1111/ane.12050; Short RA, 2001, NEUROCASE, V7, P331, DOI 10.1076/neur.7.4.331.16257; Torfs K, 2014, BEHAV RES METHODS, V46, P472, DOI 10.3758/s13428-013-0382-6; Van Den Berg NS, 2019, NEUROCASE, V25, P202, DOI 10.1080/13554794.2019.1656751; van Essen D.C., 1985, P259; Vancleef K, 2015, J NEUROPSYCHOL, V9, P271, DOI 10.1111/jnp.12050; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; ZIHL J, 1991, BRAIN, V114, P2235, DOI 10.1093/brain/114.5.2235	31	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0262886	10.1371/journal.pone.0262886	http://dx.doi.org/10.1371/journal.pone.0262886			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363793	Green Published, gold			2022-12-26	WOS:000804748600037
J	Lukambagire, AS; Shirima, GM; Shayo, DD; Mathew, C; Yapi, RB; Kasanga, CJ; Mmbaga, BT; Kazwala, RR; Halliday, JEB				Lukambagire, AbdulHamid Settenda; Shirima, Gabriel Mkulima; Shayo, Damas Davis; Mathew, Coletha; Yapi, Richard B.; Kasanga, Christopher Julius; Mmbaga, Blandina Theophile; Kazwala, Rudovick Reuben; Halliday, Jo E. B.			Brucellosis testing patterns at health facilities in Arusha region, northern Tanzania	PLOS ONE			English	Article							DIAGNOSIS	BackgroundBrucellosis is listed as one of six priority zoonoses in Tanzania's One Health strategic plan which highlights gaps in data needed for the surveillance and estimation of human brucellosis burdens. This study collected data on current testing practices and test results for human brucellosis in Arusha region, northern Tanzania. MethodsRetrospective data were extracted from records at 24 health facilities in Arusha region for the period January 2012 to May 2018. Data were captured on: the test reagents used for brucellosis, procurement and testing protocols, the monthly number of patients tested for brucellosis and the monthly number testing positive. Generalised linear mixed models were used to evaluate relationships between health facility characteristics and the probability that brucellosis testing was conducted in a given month, and the proportion of individuals testing positive. ResultsFour febrile Brucella agglutination tests were used widely. The probability of testing for brucellosis in a given month was significantly associated with an interaction between year of testing and facility ownership. Test probability increased over time with more pronounced increases in privately owned as compared to government facilities. The proportion of individuals testing positive for brucellosis was significantly associated with facility type and district, with individuals tested in hospitals in Meru, Monduli and Ngorongoro districts more likely to test positive. ConclusionsFebrile Brucella agglutination tests, known for their poor performance, were the mainstay of brucellosis testing at health facilities in northern Tanzania. The study indicates that historical data on human brucellosis in Arusha and other regions are likely to provide an inaccurate measure of true disease burden due to poor performance of the tests used and variation in testing practices. Measures to address these identified shortcomings could greatly improve quality of testing and surveillance data on brucellosis and ultimately inform prevention and control of this priority disease.	[Lukambagire, AbdulHamid Settenda; Mathew, Coletha; Kasanga, Christopher Julius; Kazwala, Rudovick Reuben] Sokoine Univ Agr, Coll Vet Med & Biomed Sci, Morogoro, Tanzania; [Lukambagire, AbdulHamid Settenda; Mmbaga, Blandina Theophile] Kilimanjaro Christian Med Univ Coll, Kilimanjaro Clin Res Inst, Moshi, Tanzania; [Shirima, Gabriel Mkulima] Nelson Mandela African Inst Sci & Technol, Arusha, Tanzania; [Shayo, Damas Davis] Reg Hlth Management Team, Arusha Reg Med Off, Arusha, Tanzania; [Yapi, Richard B.] Univ Alassane Ouattara, Ctr Entomol Med & Vet, Bouake, Cote Ivoire; [Yapi, Richard B.] Ctr Suisse Rech Sci & Cote Ivoire, Abidjan, Cote Ivoire; [Mmbaga, Blandina Theophile] Kilimanjaro Christian Med Univ Coll, Moshi, Tanzania; [Mmbaga, Blandina Theophile] Duke Global Hlth Inst, Durham, NC USA; [Halliday, Jo E. B.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow, Scotland	Sokoine University of Agriculture; Nelson Mandela African Institution of Science & Technology; Duke University; University of Glasgow	Lukambagire, AS (corresponding author), Sokoine Univ Agr, Coll Vet Med & Biomed Sci, Morogoro, Tanzania.; Lukambagire, AS (corresponding author), Kilimanjaro Christian Med Univ Coll, Kilimanjaro Clin Res Inst, Moshi, Tanzania.	lukhamid@gmail.com		Halliday, Jo/0000-0002-1329-9035	DELTAS Africa Initiative Afrique One-ASPIRE scholarship scheme [ASPIRE/DEL-15-008]; Zoonoses and Emerging Livestock Systems program [BB/L018845];  [One-ASPIRE/DEL-15-008]	DELTAS Africa Initiative Afrique One-ASPIRE scholarship scheme; Zoonoses and Emerging Livestock Systems program; 	ASL, CM, RBY, RRK were supported by the DELTAS Africa Initiative Afrique One-ASPIRE scholarship scheme (Afrique One-ASPIRE/DEL-15-008, http://afriqueoneaspire.org) GMS, BTM, JEBH were supported by the Zoonoses and Emerging Livestock Systems program grant number BB/L018845 http://www.bbsrc.ac.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Dahouk S, 2011, EXPERT REV ANTI-INFE, V9, P833, DOI [10.1586/eri.11.55, 10.1586/ERI.11.55]; Alton G G, 1975, Monogr Ser World Health Organ, P1; Alumasa L, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0008977; Bodenham FR, 2020, SCI REP-UK, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Bouley AJ, 2012, AM J TROP MED HYG, V87, P1105, DOI 10.4269/ajtmh.2012.12-0327; Carugati M, 2018, T ROY SOC TROP MED H, V112, P136, DOI 10.1093/trstmh/try033; Cash-Goldwasser S, 2018, AM J TROP MED HYG, V98, P598, DOI 10.4269/ajtmh.17-0125; Center for Disease Control and Prevention, 2017, BRUC REF GUID EXP TE, P1; Corbel M.J, 2006, BRUC HUM AN; Crump JA, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002324; de Glanville WA, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0005508; Dieckhaus KD, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx237; Ducrotoy MJ, 2018, PREV VET MED, V151, P57, DOI 10.1016/j.prevetmed.2018.01.005; Ducrotoy MJ, 2017, ACTA TROP, V165, P33, DOI 10.1016/j.actatropica.2016.10.004; Gabriel SM., 2005, EPIDEMIOLOGY BRUCELL; Government of Tanzania (GOT), 2015, NAT ON HLTH STRAT PL; Hartig F., 2022, DHARMA RESIDUAL DIAG; John K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009968; Kansiime C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105276; Kapologwe NA, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-5057-2; Kunda JS., 2005, EPIDEMIOLOGY HUMAN B; Leonard K, 2006, SOC SCI MED, V63, P2330, DOI 10.1016/j.socscimed.2006.06.003; Lukambagire A., 2021, J INFECT PUBLIC HEAL, V1, P1; Lukambagire AS, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-82906-w; Mahundi MH, 2018, ELECTR J INF SYS DEV, V84, DOI 10.1002/isd2.12031; Makala R, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-4873-7; Ministry of Health and Social Welfare (MoHSW) [Tanzania Mainland] Ministry of Health (MoH) [Zanzibar] (NBS) NB of S Statistician(OCGS) O of the CG International I, 2015, DAR SALAAM, DOI [10.1186/s12913-015-1203-7, DOI 10.1186/S12913-015-1203-7]; Ministry of Health Community Development Gender E and C (MoHCDGEC) [Tanzania Mainland] Ministry of Health (MoH) [Zanzibar] National Bureau of Statistics (NBS) Office of the Chief government Statistician (OCGS) IC, 2016, TANZ DEM HLTH SURV M; Mligo JB., 2021, BMC ONE HEAL OUTLOOK, DOI [10.1186/s42522-021-00056-5, DOI 10.1186/S42522-021-00056-5]; Mngumi Elifuraha B, 2016, Trop Med Health, V44, P34, DOI 10.1186/s41182-016-0034-5; Munyua P, 2021, PLOS NEGLECT TROP D, V15, DOI 10.1371/journal.pntd.0009049; Munyua P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161576; National Bureau of Statistics T, 2012, TANZ NAT BUR STAT 20; Nicks BA, 2012, AFR J EMERG MED, V2, P97, DOI 10.1016/j.afjem.2012.06.002; Nkowane BM., 2019, STREAMLINING STRENGT; Nkowane BM., 2019, DAR SALAAM; Nonga HE., 2017, TANZANIA VET J, V32, P34; Orsel K, 2015, TANZ J HLTH RES, V17, P1, DOI DOI 10.4314/THRB.V17I4.2; Pastoralists Indigenous Non-Governmental Organization's Forum (PINGO), 2016, SOC CONTR PAST LIV S; Ramsey K, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-S2-S6; RCore Team, 2020, R LANG ENV STAT COMP; Rubach MP, 2013, CURR OPIN INFECT DIS, V26, P404, DOI 10.1097/QCO.0b013e3283638104; Rumisha S F, 2007, Tanzan Health Res Bull, V9, P1; Schroeder LF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134578; Sekamatte M, 2018, PLOS ONE, V13, DOI [10.1371/journal.pone.019679, 10.1371/journal.pone.0196799]; Shirima G. M., 2010, Tanzania Journal of Health Research, V12, P203; Swai ES, 2009, ZOONOSES PUBLIC HLTH, V56, P183, DOI 10.1111/j.1863-2378.2008.01175.x; Tennekes M, 2018, J STAT SOFTW, V84, P1, DOI 10.18637/jss.v084.i06; The United Republic of Tanzania (URT), 2018, NAT STRAT PREV CONTR, DOI [10.1111/fcre.12333, DOI 10.1111/FCRE.12333]; URT, 2018, GUIDELINES SURVEILLA; URT PMI USAID Centers for Disease Control and Prevention (CDC), 2018, DAR SALAAM; Wilms MC, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-91; Wolfl M, 2014, NAT PROTOC, V9, P950, DOI 10.1038/nprot.2014.064; Wu TSJ, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0200858	54	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265612	10.1371/journal.pone.0265612	http://dx.doi.org/10.1371/journal.pone.0265612			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320293	Green Accepted, Green Published, gold			2022-12-26	WOS:000784240600006
J	Peng, JL; Wang, MY; Peng, C; Hu, K				Peng, Junlong; Wang, Mengyao; Peng, Chao; Hu, Ke			Research on extremely short construction period of engineering project based on labor balance under resource tolerance	PLOS ONE			English	Article								Under the condition of resource tolerance, engineering construction projects face the problem of labor force balance in the working face. Notably, a deviation occurs between the distribution and certain demand of the labor force in the limited working face, which affects the realization of an extremely short construction period. To address this problem, we first introduced the stochastic coefficient of labor force equilibrium to measure the degree of labor balance. Second, a labor force equilibrium model with the realization goal of an extremely short construction period was established. Then, the standard particle swarm optimization (PSO) algorithm was improved from two perspectives to solve the proposed model. The update equation was rounded to solve practical project problems, and a dynamic variable inertia weight was adopted to ensure the PSO algorithm accuracy and convergence speed. Finally, through case analysis, we determined the extremely short construction period and best labor force distribution scheme. Moreover, the case results revealed that the established model is simple, operable and practical and that the proposed algorithm achieves a high search accuracy and efficiency in the model solution process. Overall, under the condition of resource tolerance, this study provides scientific and effective references for managers to realize an extremely short construction period.	[Peng, Junlong; Wang, Mengyao; Peng, Chao; Hu, Ke] Changsha Univ Sci & Technol, Coll Transportat Engn, Changsha, Peoples R China	Changsha University of Science & Technology	Wang, MY (corresponding author), Changsha Univ Sci & Technol, Coll Transportat Engn, Changsha, Peoples R China.	1732057408@qq.com	peng, junlong/GWV-2872-2022		Natural Science Foundation of Hunan Province, China [2021JJ30746, 2015JJ32004]	Natural Science Foundation of Hunan Province, China(Natural Science Foundation of Hunan Province)	The authors gratefully acknowledge the funding and support provided by the Natural Science Foundation of Hunan Province, China (No: 2021JJ30746), (No: 2015JJ32004).	Aibinu AA, 2006, J CONSTR ENG M, V132, P667, DOI 10.1061/(ASCE)0733-9364(2006)132:7(667); Alsuliman JA, 2019, ALEX ENG J, V58, P801, DOI 10.1016/j.aej.2019.07.002; Aminbakhsh S, 2016, EXPERT SYST APPL, V51, P177, DOI 10.1016/j.eswa.2015.12.041; Bai Y, 2006, J BRIDGE ENG, V11, P266, DOI 10.1061/(ASCE)1084-0702(2006)11:3(266); Bayram S, 2017, KSCE J CIV ENG, V21, P2049, DOI 10.1007/s12205-016-0691-2; Bergh, 2001, ANAL PARTICLE SWARM; Bergner D., 2012, LEADERSHIP MANAGEMEN, V12, P126; BLAZEWICZ J, 1983, DISCRETE APPL MATH, V5, P11, DOI 10.1016/0166-218X(83)90012-4; Chan D.W.M., 2002, INT J PROJ MANAG, V20, P23, DOI [10.1016/S0263-7863(00)00032-6, DOI 10.1016/S0263-7863(00)00032-6]; Cheng MY, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001548; Cian S., 2021, SWARM EVOL COMPUT; Doloi H, 2012, INT J PROJ MANAG, V30, P479, DOI 10.1016/j.ijproman.2011.10.004; Duran D.M., 2019, J CONSTR ENG M, V145; Eberhart R., 1995, P 6 INT S MICR MACH, P39; El-Abbasy MS, 2017, J COMPUT CIVIL ENG, V31, DOI 10.1061/(ASCE)CP.1943-5487.0000659; Faghihi V, 2014, EXPERT SYST APPL, V41, P7565, DOI 10.1016/j.eswa.2014.05.047; Fan CJ, 2017, NAT HAZARDS REV, V18, DOI 10.1061/(ASCE)NH.1527-6996.0000253; Frederick H., PROJECT SCHEDULING R; Goncalves JF, 2008, EUR J OPER RES, V189, P1171, DOI 10.1016/j.ejor.2006.06.074; Jin R., 2015, J CONSTR ENG M; Kannimuthu M, 2020, ENG CONSTR ARCHIT MA, V27, P893, DOI 10.1108/ECAM-03-2019-0156; Khatib B.A., 2020, SUSTAINABILITY-BASEL, V12; Kolisch R, 2006, EUR J OPER RES, V174, P23, DOI 10.1016/j.ejor.2005.01.065; Kong F., 2021, J CONSTR ENG M, V147; Liu J, 2018, J CONSTR ENG M, V144, DOI 10.1061/(ASCE)CO.1943-7862.0001507; Liu Q., 2016, INT J APPL DECISION, V9; Lu G, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0155662; McLaren M, 2019, INT J PROJ MANAG, V37, P979, DOI 10.1016/j.ijproman.2019.09.003; Pellerin R, 2020, EUR J OPER RES, V280, P395, DOI 10.1016/j.ejor.2019.01.063; [彭武良 Peng Wuliang], 2010, [系统工程, Systems Engineering], V28, P84; [任子晖 REN Zi-hui], 2009, [计算机科学, Computer Science], V36, P227; Sun C., 2020, ARCHIT CULT, V4, P12; Sun J, 2004, IEEE C EVOL COMPUTAT, P325; Suresh M, 2015, ASIA PAC J OPER RES, V32, DOI 10.1142/S0217595915500487; Suresh V., 2021, INDIAN J PHARMACOL, V53; Viktoria A.H., 2020, COMPUT IND ENG, V150; [王海鑫 Wang Haixin], 2017, [管理工程学报, Journal of Industrial Engineering and Engineering Management], V31, P220; Wang J, 2017, P 2017 2 INT C ADV M, P8; Wang WS, 2021, J MANAGE ENG, V37, DOI 10.1061/(ASCE)ME.1943-5479.0000922; Xi J.P., 2020, THE PEOPLES DAILY; Xie L., 2021, APPL SCI, V11, DOI [10.3390/app11125314, DOI 10.3390/APP11125314]; Zhang H, 2005, AUTOMAT CONSTR, V14, P393, DOI 10.1016/j.autcon.2004.08.006; Zhang H., 2018, MATH PROBL ENG, V2018; Zhang LY, 2014, J MANAGE ENG, V30, P163, DOI 10.1061/(ASCE)ME.1943-5479.0000189	44	0	0	6	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266036	10.1371/journal.pone.0266036	http://dx.doi.org/10.1371/journal.pone.0266036			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353862	gold, Green Published			2022-12-26	WOS:000786647900045
J	Pfenninger, M; Doria, HB; Nickel, J; Thielsch, A; Schwenk, K; Cordellier, M				Pfenninger, Markus; Doria, Halina Binde; Nickel, Jana; Thielsch, Anne; Schwenk, Klaus; Cordellier, Mathilde			Spontaneous rate of clonal single nucleotide mutations in Daphnia galeata	PLOS ONE			English	Article							POPULATION-SIZE; ADAPTATION; DYNAMICS; GENOMICS; ACCUMULATION; EVOLUTION; SELECTION; MODELS; GENES	Mutations are the ultimate source of heritable variation and therefore the fuel for evolution, but direct estimates of mutation rates exist only for few species. We estimated the spontaneous single nucleotide mutation rate among clonal generations in the waterflea Daphnia galeata with a short-term mutation accumulation approach. Individuals from eighteen mutation accumulation lines over five generations were deep sequenced to count de novo mutations that were not present in a pool of F1 individuals, representing the parental genotype. We identified 12 new nucleotide mutations in 90 clonal generational passages. This resulted in an estimated single nucleotide mutation rate of 0.745 x 10(-9) (95% c.f. 0.39 x 10(-9)-1.26 x 10(-9)), which is slightly lower than recent estimates for other Daphnia species. We discuss the implications for the population genetics of Cladocerans.	[Pfenninger, Markus; Doria, Halina Binde] Senckenberg Biodivers & Climate Res Ctr, Dept Mol Ecol, Frankfurt, Germany; [Pfenninger, Markus] Johannes Gutenberg Univ Mainz, Inst Mol & Organism Evolut, Mainz, Germany; [Pfenninger, Markus; Doria, Halina Binde] Senckenberg Biodivers & Climate Res Ctr, LOEWE Ctr Translat Biodivers Genom, Frankfurt, Germany; [Nickel, Jana; Cordellier, Mathilde] Univ Hamburg, Inst Zool, Fak Math Informat & Naturwissensch, Hamburg, Germany; [Thielsch, Anne; Schwenk, Klaus] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); Johannes Gutenberg University of Mainz; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN); University of Hamburg; University of Koblenz & Landau	Doria, HB (corresponding author), Senckenberg Biodivers & Climate Res Ctr, Dept Mol Ecol, Frankfurt, Germany.; Doria, HB (corresponding author), Senckenberg Biodivers & Climate Res Ctr, LOEWE Ctr Translat Biodivers Genom, Frankfurt, Germany.	halina.binde-doria@senckenberg.de		Pfenninger, Markus/0000-0002-1547-7245; Nickel, Jana/0000-0002-5584-1160; Doria, Halina Binde/0000-0002-7166-925X				Akashi H, 1998, GENETICA, V102-3, P49, DOI 10.1023/A:1017078607465; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Bull JK, 2019, G3-GENES GENOM GENET, V9, P61, DOI 10.1534/g3.118.200797; Burkholder AB, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4753-3; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; De Meester L, 2002, ACTA OECOL, V23, P121, DOI 10.1016/S1146-609X(02)01145-1; Doria HB, 2021, ENVIRON POLLUT, V272, DOI 10.1016/j.envpol.2020.116004; Dukic M, 2019, J EVOLUTION BIOL, V32, P619, DOI 10.1111/jeb.13443; Flynn JM, 2017, MOL BIOL EVOL, V34, P160, DOI 10.1093/molbev/msw234; Herrmann M, 2018, MOL ECOL, V27, P387, DOI 10.1111/mec.14450; Ho EKH, 2020, MOL BIOL EVOL, V37, P3258, DOI 10.1093/molbev/msaa142; Ho SYW, 2014, TRENDS ECOL EVOL, V29, P496, DOI 10.1016/j.tree.2014.07.004; Huylmans AK, 2016, GENOME BIOL EVOL, V8, P3120, DOI 10.1093/gbe/evw221; Ishida S, 2007, MOL ECOL, V16, P569, DOI 10.1111/j.1365-294X.2006.03160.x; Johnson T, 2005, PHILOS T R SOC B, V360, P1411, DOI 10.1098/rstb.2005.1667; Keightley PD, 2015, MOL BIOL EVOL, V32, P239, DOI 10.1093/molbev/msu302; Keith N, 2016, GENOME RES, V26, P60, DOI 10.1101/gr.191338.115; KIMURA M, 1962, GENETICS, V47, P713; KLUTTGEN B, 1994, WATER RES, V28, P743, DOI 10.1016/0043-1354(94)90157-0; Korneliussen TS, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/s12859-014-0356-4; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lohr JN, 2015, EVOLUTION, V69, P3109, DOI 10.1111/evo.12802; Long HA, 2016, GENOME BIOL EVOL, V8, P3629, DOI 10.1093/gbe/evw223; Lynch M, 2017, GENETICS, V206, P315, DOI 10.1534/genetics.116.190611; M. Pfenninger, 2022, bioRxiv, DOI 10.1101/2020.06.16.154054; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Messer PW, 2013, TRENDS ECOL EVOL, V28, P659, DOI 10.1016/j.tree.2013.08.003; Miner BE, 2012, P ROY SOC B-BIOL SCI, V279, P1873, DOI 10.1098/rspb.2011.2404; MURTAUGH PA, 1985, HYDROBIOLOGIA, V123, P47, DOI 10.1007/BF00006614; Nickel J, 2021, GENOME BIOL EVOL, V13, DOI 10.1093/gbe/evab267; Oppold AM, 2017, EVOL LETT, V1, P86, DOI 10.1002/evl3.8; Pankajam AV, 2020, G3-GENES GENOM GENET, V10, P3309, DOI 10.1534/g3.120.401551; PETERSEN F, 1983, HOLARCTIC ECOL, V6, P285; Pfenninger M, 2015, MOL ECOL, V24, P5446, DOI 10.1111/mec.13397; Robinson JT, 2017, CANCER RES, V77, pE31, DOI 10.1158/0008-5472.CAN-17-0337; Schiffels S, 2014, NAT GENET, V46, P919, DOI 10.1038/ng.3015; Sniegowski PD, 2010, PHILOS T R SOC B, V365, P1255, DOI 10.1098/rstb.2009.0290; Tams V, 2018, PEERJ, V6, DOI 10.7717/peerj.5746; Waldvogel AM, 2021, GENOME RES, V31, P1582, DOI 10.1101/gr.275168.120; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Williams JS, 2019, DNA REPAIR, V84, DOI 10.1016/j.dnarep.2019.102641; Winter DJ, 2018, BIOINFORMATICS, V34, P2659, DOI 10.1093/bioinformatics/bty165; Zaffagnini F., 1987, Memorie dell'Istituto Italiano di Idrobiologia Dott Marco de Marchi, V45, P245; Zhang C, 2019, EVOL APPL, V12, P977, DOI 10.1111/eva.12772	44	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265632	10.1371/journal.pone.0265632	http://dx.doi.org/10.1371/journal.pone.0265632			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363773	gold, Green Published			2022-12-26	WOS:000804748600044
J	Singh, H; Kaur, J; Bala, R; Srivastava, P; Sharma, A; Grover, G; Dhillon, GS; Singh, RP; Chhuneja, P; Bains, NS				Singh, Harpreet; Kaur, Jaspal; Bala, Ritu; Srivastava, Puja; Sharma, Achla; Grover, Gomti; Dhillon, Guriqbal Singh; Singh, Rupinder Pal; Chhuneja, Parveen; Bains, Navtej Singh			Residual effect of defeated stripe rust resistance genes/QTLs in bread wheat against prevalent pathotypes of Puccinia striiformis f. sp. tritici	PLOS ONE			English	Article							GENE-EXPRESSION; PROTEIN; LOCATION; PATTERN	The periodic breakdowns of stripe rust resistance due to emergence of new virulent and more aggressive pathotypes of Puccinia striiformis f. sp. tritici have resulted in severe epidemics in India. This necessitates the search for new and more durable resistance sources against stripe rust. The three bread wheat cultivars PBW 343 (carries Yr9 and Yr27), PBW 621 (carries Yr17) and HD 2967 (gene not known) were highly popular among the farmers after their release in 2011. But presently all three cultivars are highly susceptible to stripe rust at seedling as well as at adult plant stages as their resistance has been broken down due to emergence of new pathotypes of the pathogen (110S119, 238S119). In previous study, the crosses of PBW 621 with PBW 343 and HD 2967 and evaluation of further generations (up to F-4) against pathotype 78S84 resulted in resistant segregants. In the present study, the F-5 and F-6 RIL populations have been evaluated against new pathotypes of Pst. The RILs categorized based on the disease severity on the P (Penultimate leaf) and F (flag) leaf into three categories i.e., high, moderate and low level of APR (adult plant resistance) having 1-200, 201-400 and >400 values of AUDPC, respectively, upon infection with stripe rust. The various APR components (latent period, lesion growth rate, spore production and uredial density) were studied on each category, i.e., resistant, moderately resistant and susceptible. The values of APR parameters decreased as the level of resistance increased. Based on molecular analysis, the lines (representing different categories of cross PBW 621 X PBW 343) containing the genes Yr9 and Yr17 due to their interactive effect provide resistance. Based on BSA using 35k SNPs and KASP markers association with phenotypic data of the RIL population (PBW 621 X HD 2967) showed the presence of two QTLs (Q.Pst.pau-6B, Q.Pst.pau-5B) responsible for the residual resistance and two SNPs AX-94891670 and AX-94454107 were found to be associated with the trait of interest on chromosome 6B and 5B respectively. The present study concludes that in the population of both the crosses (PBW 621 X PBW 343 and PBW 621 X HD 2967) major defeated gene contributed towards residual resistance by interacting with minor gene/QTLs.	[Singh, Harpreet] PAU, Dept Fruit Sci, Ludhiana, Punjab, India; [Kaur, Jaspal; Bala, Ritu; Srivastava, Puja; Sharma, Achla; Grover, Gomti; Singh, Rupinder Pal; Bains, Navtej Singh] PAU, Dept Plant Breeding & Genet, Ludhiana, Punjab, India; [Dhillon, Guriqbal Singh] Thapar Inst Engn & Technol, Dept Biotechnol, Patiala, Punjab, India; [Chhuneja, Parveen] PAU, Sch Agr Biotechnol, Ludhiana, Punjab, India	Punjab Agricultural University; Punjab Agricultural University; Thapar Institute of Engineering & Technology; Punjab Agricultural University	Kaur, J (corresponding author), PAU, Dept Plant Breeding & Genet, Ludhiana, Punjab, India.	jassu75@pau.edu		Dhillon, Guriqbal/0000-0001-6766-810X; Sharma, Achla/0000-0002-7932-3499				Afzal SN, 2007, PAK J BOT, V39, P2127; [Anonymous], 2018, WHEAT GEN; Babiychuk E, 2011, P NATL ACAD SCI USA, V108, P6674, DOI 10.1073/pnas.1103442108; Bouzroud S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193517; BRODNY U, 1986, PHYTOPATHOLOGY, V76, P546, DOI 10.1094/Phyto-76-546; Cabuk E, 2011, GENET MOL RES, V10, P3463, DOI 10.4238/2011.December.5.2; Chen XZ, 2017, MOL PLANT, V10, P427, DOI 10.1016/j.molp.2016.08.008; Chen XM, 2005, CAN J PLANT PATHOL, V27, P314; Chen XM, 2003, CROP SCI, V43, P2058, DOI 10.2135/cropsci2003.2058; Feuillet C, 1997, PLANT J, V11, P45, DOI 10.1046/j.1365-313X.1997.11010045.x; Fu J, 2011, FRONT PLANT SCI, V2, DOI 10.3389/fpls.2011.00074; Ghanashyam C, 2009, PLANT SIGNAL BEHAV, V4, P846, DOI 10.4161/psb.4.9.9376; Gu Q, 2015, NEW PHYTOL, V206, P315, DOI 10.1111/nph.13158; Harpreet Singh, 2019, Agricultural Research Journal, V56, P698, DOI 10.5958/2395-146X.2019.00108.X; Helguera M, 2003, CROP SCI, V43, P1839, DOI 10.2135/cropsci2003.1839; LEONARD KJ, 1980, ANNU REV PHYTOPATHOL, V18, P237, DOI 10.1146/annurev.py.18.090180.001321; Li LL, 2021, FORESTS, V12, DOI 10.3390/f12040507; McDonald DB, 2004, EUPHYTICA, V136, P239, DOI 10.1023/B:EUPH.0000032709.59324.45; McIntosh R.A, 2019, CATALOGUE GENE SYMBO; McIntosh RA., 2003, P 10 INT WHEAT GENET, V4, P8; Pan ZY, 2019, G3-GENES GENOM GENET, V9, P2677, DOI 10.1534/g3.119.400265; Pecenkova T, 2011, J EXP BOT, V62, P2107, DOI 10.1093/jxb/erq402; PEDERSEN WL, 1988, ANNU REV PHYTOPATHOL, V26, P369, DOI 10.1146/annurev.py.26.090188.002101; Peng J, 2012, SCI CHINA LIFE SCI, V55, P497, DOI 10.1007/s11427-012-4332-9; PETERSON RF, 1948, CAN J RES C, V26, P496, DOI 10.1139/cjr48c-033; Prashar M, 2007, AUST J AGR RES, V58, P602, DOI 10.1071/AR07126; Qin B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049718; Rajaram S., 1983, P 6 INT WHEAT GENETI, P613; RILEY R, 1973, ANN APPL BIOL, V75, P128, DOI 10.1111/j.1744-7348.1973.tb01345.x; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Samborski D. J., 1982, Canadian Journal of Plant Pathology, V4, P152; Sharma A, 2021, FRONT PLANT SCI, V12, DOI 10.3389/fpls.2021.570408; Singh K, 2021, MOL GENET GENOMICS, V296, P1051, DOI 10.1007/s00438-021-01796-9; Singh R., 2016, THESIS PUNJAB AGR U; Singh RP, 2017, J CROP IMPROV, V31, P183, DOI 10.1080/15427528.2016.1263262; Singh RP, 2017, INDIAN J GENET PL BR, V77, P10, DOI 10.5958/0975-6906.2017.00002.5; Stakman EC., 1962, IDENTIFICATION PHYSL, P1; Stubbs R., 1986, CEREAL DIS METHODOLO, P46; Subramanyam S, 2013, ARTHROPOD-PLANT INTE, V7, P389, DOI 10.1007/s11829-013-9253-4; Tang DZ, 2017, PLANT CELL, V29, P618, DOI 10.1105/tpc.16.00891; Toffolatti S.L., 2021, BIOCONTROL AGENTS SE, P401, DOI [10.1016/B978-0-12-822919-4.00016-8, DOI 10.1016/B978-0-12-822919-4.00016-8]; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19; van den Burg HA, 2008, PLANT CELL, V20, P697, DOI 10.1105/tpc.107.056978; VAN DER PLANK J. E., 1963, Plant Diseases: Epidemics and Control.; Vanderplank JE., 1968, DIS RESISTANCE PLANT; Vardhan H., 2015, PLANTOMICS OMICS PLA, P573; Wang M., 2017, STRIPE RUST, P353, DOI DOI 10.1007/978-94-024-1111-9_5; WILCOXSON RD, 1975, ANN APPL BIOL, V80, P275, DOI 10.1111/j.1744-7348.1975.tb01633.x; Zhou HB, 2007, PLANT J, V52, P420, DOI 10.1111/j.1365-313X.2007.03246.x	50	0	0	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266482	10.1371/journal.pone.0266482	http://dx.doi.org/10.1371/journal.pone.0266482			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363829	gold, Green Published			2022-12-26	WOS:000804748600035
J	Soliman, MG; Davies, HA; Sharkey, J; Levy, R; Madine, J				Soliman, Mahmoud G.; Davies, Hannah A.; Sharkey, Jack; Levy, Raphael; Madine, Jillian			Development of amyloid beta gold nanorod aggregates as optoacoustic probes	PLOS ONE			English	Article							STEM-CELLS; NANOPARTICLES; TRANSMISSION; SENSITIVITY; CONTRIBUTES; PATHOLOGY; POLYMER; SEEDS	Propagation of small amyloid beta (A beta) aggregates (or seeds) has been suggested as a potential mechanism of Alzheimer's disease progression. Monitoring the propagation of A beta seeds in an organism would enable testing of this hypothesis and, if confirmed, provide mechanistic insights. This requires a contrast agent for long-term tracking of the seeds. Gold nanorods combine several attractive features for this challenging task, in particular, their strong absorbance in the infrared (enabling optoacoustic imaging) and the availability of several established protocols for surface functionalisation. In this work, polymer-coated gold nanorods were conjugated with anti-A beta antibodies and attached to pre-formed A beta seeds. The resulting complexes were characterised for their optical properties by UV/Vis spectroscopy and multispectral optoacoustic tomography. The complexes retained their biophysical properties, i.e. their ability to seed A beta fibril formation. They remained stable in biological media for at least 2 days and showed no toxicity to SH-SY5Y neuroblastoma cells up to 1.5 nM and 6 mu M of gold nanorods and A beta seeds, respectively. Taken together, this study describes the first steps in the development of probes for monitoring the spread of A beta seeds in animal models.	[Soliman, Mahmoud G.; Davies, Hannah A.; Madine, Jillian] Univ Liverpool, Inst Syst Mol & Integrat Biol, Liverpool, England; [Soliman, Mahmoud G.] Al Azhar Univ, Fac Sci Phys, Dept Egypt, Cairo, Egypt; [Sharkey, Jack] Univ Liverpool, Ctr Preclin Imaging, Liverpool, England; [Levy, Raphael] Univ Sorbonne Paris Nord, LVTS, INSERM, Paris, France; [Levy, Raphael] Univ Paris, INSERM, LVTS, Paris, France	University of Liverpool; Egyptian Knowledge Bank (EKB); Al Azhar University; University of Liverpool; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Madine, J (corresponding author), Univ Liverpool, Inst Syst Mol & Integrat Biol, Liverpool, England.	j.madine@liverpool.ac.uk	Madine, Jillian/AAM-6232-2021; Soliman, Mahmoud G./L-5280-2017	Madine, Jillian/0000-0001-9963-5871; Soliman, Mahmoud G./0000-0003-4260-0808	Alzheimer's Research UK [ARUK-PPG2017B019]	Alzheimer's Research UK(Alzheimer's Research UK (ARUK))	Alzheimer's Research UK provided funding for this work to JM (ARUK-PPG2017B019) https://www.alzheimersresearchuk.org/.The funders played no role in study design, data collection or analysis, decision to publish or preparation of the manuscript.	Bartczak D, 2011, LANGMUIR, V27, P10119, DOI 10.1021/la2022177; Bell A G, 1881, Science, V2, P242, DOI 10.1126/science.os-2.49.242; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Cohen M, 2016, PRION, V10, P9, DOI 10.1080/19336896.2015.1123371; Collinge J, 2016, NATURE, V535, pE2, DOI 10.1038/nature18603; Comenge J, 2018, ELIFE, V7, DOI 10.7554/eLife.33140; Comenge J, 2016, ACS NANO, V10, P7106, DOI 10.1021/acsnano.6b03246; Cui D, 2008, AMYLOID, V15, P77, DOI 10.1080/13506120802005833; Davidson AM, 2017, ANAL CHEM, V89, P6807, DOI 10.1021/acs.analchem.7b01229; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Feeney C, 2016, NATURE, V535, pE1, DOI 10.1038/nature18602; Huang XH, 2009, ADV MATER, V21, P4880, DOI 10.1002/adma.200802789; Jaunmuktane Z, 2015, NATURE, V525, P247, DOI 10.1038/nature15369; Jucker M, 2011, ANN NEUROL, V70, P532, DOI 10.1002/ana.22615; Kisilevsky Robert, 2004, V299, P237; Krpetic Z, 2013, ACS NANO, V7, P8881, DOI 10.1021/nn403350v; Lin CAJ, 2008, SMALL, V4, P334, DOI 10.1002/smll.200700654; Luk KC, 2012, SCIENCE, V338, P949, DOI 10.1126/science.1227157; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Mirsadeghi S, 2015, NANOSCALE, V7, P5004, DOI 10.1039/c4nr06009a; Ntziachristos V, 2010, CHEM REV, V110, P2783, DOI 10.1021/cr9002566; O'Brien J, 2000, EUR J BIOCHEM, V267, P5421, DOI 10.1046/j.1432-1327.2000.01606.x; Pecho-Vrieseling E, 2014, NAT NEUROSCI, V17, P1064, DOI 10.1038/nn.3761; Phelan MM, 2017, METABOLOMICS, V13, DOI 10.1007/s11306-017-1289-5; Razansky D, 2009, MED PHYS, V36, P939, DOI 10.1118/1.3077120; Soliman MG, 2015, CHEM MATER, V27, P990, DOI 10.1021/cm5043167; Sponarova J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003308; Stangou AJ, 1998, TRANSPLANTATION, V66, P229, DOI 10.1097/00007890-199807270-00016; Stoffels I, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad1278; Sun X, 2019, APPL MATER TODAY, V15, P267, DOI 10.1016/j.apmt.2018.12.006; Taheri RA, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26393-6; Taruttis A, 2014, NANOSCALE, V6, P13451, DOI 10.1039/c4nr04164j; Taruttis A, 2010, OPT EXPRESS, V18, P19592, DOI 10.1364/OE.18.019592; Tripathi K, 2018, ACS OMEGA, V3, P8253, DOI 10.1021/acsomega.8b00591; Tzoumas S, 2015, J BIOPHOTONICS, V8, P629, DOI 10.1002/jbio.201400056; Wang LV, 2009, NAT PHOTONICS, V3, P503, DOI 10.1038/NPHOTON.2009.157; Westermark GT, 2010, TRENDS MOL MED, V16, P501, DOI 10.1016/j.molmed.2010.08.004; Xu M, 2018, ACS NANO, V12, P10104, DOI 10.1021/acsnano.8b04906; Ye XC, 2012, ACS NANO, V6, P2804, DOI 10.1021/nn300315j; Zhang BR, 2008, P NATL ACAD SCI USA, V105, P7263, DOI 10.1073/pnas.0800367105	40	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0259608	10.1371/journal.pone.0259608	http://dx.doi.org/10.1371/journal.pone.0259608			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333865	gold, Green Submitted, Green Published			2022-12-26	WOS:000784335700040
J	Zhang, LY; Yick, KL; Li, PL; Yip, J; Ng, SP				Zhang, Liying; Yick, Kit-lun; Li, Pui-ling; Yip, Joanne; Ng, Sun-pui			Foot deformation analysis with different load-bearing conditions to enhance diabetic footwear designs	PLOS ONE			English	Article							CUSTOM-MADE FOOTWEAR; PLANTAR PRESSURE; GENDER-DIFFERENCES; RISK-FACTORS; ULCERS; SHAPE; FOREFOOT; INSOLE; RECURRENCE; PREVENTION	In-depth analyses of foot surface measurements upon weight bearing are crucial to understand how the dorsal and plantar surfaces of the foot deform during motion to enhance the fit of footwear, which is particularly important for diabetic patients with stringent fit requirements to redistribute the plantar weight forces. This study analyzes diabetic foot deformations under 3 different weight bearing conditions (no weight bearing, half weight bearing, and 80% weight bearing) by using a novel foot scanning method that enables efficient scanning of the dorsal and plantar surfaces of the foot simultaneously. The feet of 48 patients with diabetes mellitus (DM) are scanned. With increased load on the feet, the width of the forefoot increases by 9.7%-10.4%, height of the midfoot decreases by 15.1%-18.2%, forefoot and midfoot rotate to the medial side by 16.9%-23.9% while the rearfoot rotates to the lateral side by 15.2% simultaneously, and the plantar of the foot increases contact with the floor by 11.4%-23.0%. Gender differences in foot shape are also found between males and females, males have a broader foot than females for the same foot length. Precise anthropometric information of foot changes and deformation therefore enables adequate foot protection, fit and comfort when designing footwear. This research contributes to shoe design considerations that focus on the deformation of the foot under different loads.	[Zhang, Liying; Yick, Kit-lun; Yip, Joanne] Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China; [Zhang, Liying; Yick, Kit-lun; Li, Pui-ling] Lab Artificial Intelligence Design, Hong Kong Sci Pk, Hong Kong, Peoples R China; [Ng, Sun-pui] Hong Kong Polytech Univ, Hong Kong Community Coll, Kowloon, Hong Kong, Peoples R China	Hong Kong Polytechnic University; Hong Kong Polytechnic University	Yick, KL (corresponding author), Hong Kong Polytech Univ, Inst Text & Clothing, Kowloon, Hong Kong, Peoples R China.; Yick, KL (corresponding author), Lab Artificial Intelligence Design, Hong Kong Sci Pk, Hong Kong, Peoples R China.	tcyick@polyu.edu.hk	Yip, Joanne/P-6942-2014; Yick, Kit Lun/P-8043-2014	Yip, Joanne/0000-0002-3270-4702; Yick, Kit Lun/0000-0002-9043-1781; NG, Sun-Pui/0000-0002-7529-9129	Innovation and Technology Fund [RP1-2]	Innovation and Technology Fund	This research is funded by the Laboratory for Artificial Intelligence in Design (Project code: RP1-2), Innovation and Technology Fund. All authors have no conflicts of interest in the study.	Actis RL, 2008, MED BIOL ENG COMPUT, V46, P363, DOI 10.1007/s11517-008-0311-5; Afroz A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-46766-9; Ahmed S, 2020, J FOOT ANKLE RES, V13, DOI 10.1186/s13047-020-00400-4; Akambase JA., 2019, TRANSL RES ANAT, V16, DOI DOI 10.1016/J.TRIA.2019.100048; Alexiadou Kleopatra, 2012, Diabetes Ther, V3, P4, DOI 10.1007/s13300-012-0004-9; Armstrong DG, 2017, NEW ENGL J MED, V376, P2367, DOI 10.1056/NEJMra1615439; Bsc J., 2019, ARE LEFT RIGHT LIMBS; Bus SA, 2013, DIABETES CARE, V36, P4109, DOI 10.2337/dc13-0996; Bus SA, 2009, GAIT POSTURE, V29, P618, DOI 10.1016/j.gaitpost.2009.01.003; Chantelau E, 2002, GERONTOLOGY, V48, P241, DOI 10.1159/000058357; Chiles NS, 2014, J DIABETES COMPLICAT, V28, P91, DOI 10.1016/j.jdiacomp.2013.08.007; D'Aout K, 2009, FOOTWEAR SCI, V1, P81, DOI 10.1080/19424280903386411; Dubsky M, 2013, INT WOUND J, V10, P555, DOI 10.1111/j.1742-481X.2012.01022.x; Duffy, 2008, HDB DIGITAL HUMAN MO, V1st; Evans PMS, 1999, BRIT MED J, V319, P318, DOI 10.1136/bmj.319.7205.318; Fard AS, 2007, INT J CLIN PRACT, V61, P1931, DOI 10.1111/j.1742-1241.2007.01534.x; Grau S, 2018, FOOTWEAR SCI, V10, P179, DOI 10.1080/19424280.2018.1529062; Guldemond NA, 2007, CLIN BIOMECH, V22, P81, DOI 10.1016/j.clinbiomech.2006.08.004; Harrison SJ, 2007, INT J CLIN PRACT, V61, P1900, DOI 10.1111/j.1742-1241.2007.01554.x; Healy A, 2013, J DIABETES COMPLICAT, V27, P391, DOI 10.1016/j.jdiacomp.2013.03.001; Hill M, 2017, APPL ERGON, V59, P243, DOI 10.1016/j.apergo.2016.08.012; Hirpha N, 2020, DIABET METAB SYND OB, V13, P4779, DOI 10.2147/DMSO.S285929; Hong YL, 2011, SPORT BIOMECH, V10, P85, DOI 10.1080/14763141.2011.569567; Houston VL, 2006, J AM PODIAT MED ASSN, V96, P330, DOI 10.7547/0960330; Ibrahim M, 2013, CLIN BIOMECH, V28, P68, DOI 10.1016/j.clinbiomech.2012.09.003; Ito K, 2017, ROY SOC OPEN SCI, V4, DOI 10.1098/rsos.171086; Kloos C, 2009, DIABETES CARE, V32, P894, DOI 10.2337/dc08-0490; Kouchi M, 2000, ANTHROPOL SCI, V108, P331, DOI 10.1537/ase.108.331; Kouchi Makiko, 2003, J Hum Ergol (Tokyo), V32, P23; Levangie CCN P.K., 2001, JOINT STRUCTURE FUNC; Li L, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1547-y; Li PL, 2016, TEXT BIOENG INFORM S, P242; Lung CW, 2020, J TISSUE VIABILITY, V29, P61, DOI 10.1016/j.jtv.2020.03.003; Luo GM, 2009, J AM PODIAT MED ASSN, V99, P383, DOI 10.7547/0990383; MacConaill MA., 1944, CHEM SCI, V50, P265; Maciejewski ML, 2004, DIABETES CARE, V27, P1774, DOI 10.2337/diacare.27.7.1774; Manna Indranil, 2001, Journal of Physiological Anthropology and Applied Human Science, V20, P241, DOI 10.2114/jpa.20.241; Martinez-Santos A, 2019, J FOOT ANKLE RES, V12, DOI 10.1186/s13047-019-0344-z; Mclnnes AD, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-9; Mishra SC, 2017, BMJ-BRIT MED J, V359, DOI 10.1136/bmj.j5064; Mohamed O., 2004, JPO J PROSTHETICS OR, V16; Morena S., 2019, SHINING 3D EINSCAN P, V4218, P135; Morio C, 2009, J BIOMECH, V42, P2081, DOI 10.1016/j.jbiomech.2009.06.015; Mueller MJ, 2003, J BIOMECH, V36, P1009, DOI 10.1016/S0021-9290(03)00078-2; Sacco IDN, 2009, ACTA ORTOP BRAS, V17, P13, DOI 10.1590/S1413-78522009000100002; Novak B, 2014, GAIT POSTURE, V40, P87, DOI 10.1016/j.gaitpost.2014.02.015; Oliver T.I, 2021, DIABETIC FOOT ULCER; Paton J, 2016, J FOOT ANKLE RES, V9, DOI 10.1186/s13047-016-0172-3; Paton JS, 2012, J FOOT ANKLE RES, V5, DOI 10.1186/1757-1146-5-31; Pourkazemi A, 2020, BMC ENDOCR DISORD, V20, DOI 10.1186/s12902-020-0512-y; Priyadarshini J., 2018, DERMATOLOGY OPEN J, V3, P4; Priyadharshini R., 2017, ANTHROPOLOGIST, V28, P139; Robertson DD, 2002, J BONE JOINT SURG AM, V84A, P1395, DOI 10.2106/00004623-200208000-00016; ROSSI WA, 1988, J TEST EVAL, V16, P393; Sacco ICN, 2014, GAIT POSTURE, V40, P570, DOI 10.1016/j.gaitpost.2014.06.018; Saeedi P, 2019, DIABETES RES CLIN PR, V157, DOI 10.1016/j.diabres.2019.107843; Saghazadeh M, 2015, J FOOT ANKLE RES, V8, DOI 10.1186/s13047-015-0087-4; Schaper NC, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3266; Tang UH., 2017, J AO, P10; Tang UH, 2014, J CLIN TRANSL ENDOCR, V1, P121, DOI 10.1016/j.jcte.2014.06.002; Teli G., 2017, INT J PHARM PHARM SC, V9, P138; Tsai Y., 2007, J BIOMECHANICS J BIO, P40; Tsung BYS, 2003, J REHABIL RES DEV, V40, P517, DOI 10.1682/JRRD.2003.11.0517; Tsung Y-sB., 2003, INSOLE DESIGN BASED; Ulbrecht JS, 2014, DIABETES CARE, V37, P1982, DOI 10.2337/dc13-2956; van Melick N, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189876; van Netten JJ, 2018, J FOOT ANKLE RES, V11, DOI 10.1186/s13047-017-0244-z; Waaijman R, 2013, DIABETES CARE, V36, P1613, DOI 10.2337/dc12-1330; Wibowo Dwi Basuki, 2017, J Phys Ther Sci, V29, P2068, DOI 10.1589/jpts.29.2068; Wunderlich RE, 2001, MED SCI SPORT EXER, V33, P605; Xiong SP, 2009, ANTHROPOL SCI, V117, P77, DOI 10.1537/ase.070915	71	1	1	6	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264233	10.1371/journal.pone.0264233	http://dx.doi.org/10.1371/journal.pone.0264233			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P5DL	35320281	gold, Green Published			2022-12-26	WOS:000784240600025
J	Ko, MS; Cohen, SN; Polley, S; Mahata, SK; Biswas, T; Huxford, T; Ghosh, G				Ko, Myung Soo; Cohen, Samantha N.; Polley, Smarajit; Mahata, Sushil K.; Biswas, Tapan; Huxford, Tom; Ghosh, Gourisankar			Regulatory subunit NEMO promotes polyubiquitin-dependent induction of NF-kappa B through a targetable second interaction with upstream activator IKK2	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CRYSTAL-STRUCTURE; UBIQUITIN CHAINS; STRUCTURAL BASIS; KINASE-ACTIVITY; BETA; PHOSPHORYLATION; BINDING; GAMMA; RECOGNITION; SPECIFICITY	Canonical NF-kappa B signaling through the inhibitor of kappa B kinase (IKK) complex requires induction of IKK2/IKK beta subunit catalytic activity via specific phosphorylation within its activation loop. This process is known to be dependent upon the accessory ubiquitin (Ub)-binding subunit NF-kappa B essential modulator (NEMO)/IKK gamma as well as poly-Ub chains. However, the mechanism through which poly-Ub binding serves to promote IKK catalytic activity is unclear. Here, we show that binding of NEMO/IKK gamma to linear poly-Ub promotes a second interaction between NEMO/IKK gamma and IKK2/IKK beta, distinct from the well-characterized interaction of the NEMO/IKK gamma N terminus to the "NEMO-binding domain" at the C terminus of IKK2/IKK beta. We mapped the location of this second interaction to a stretch of roughly six amino acids immediately N-terminal to the zinc finger domain in human NEMO/IKK gamma. We also showed that amino acid residues within this region of NEMO/IKK gamma are necessary for binding to IKK2/IKK beta through this secondary interaction in vitro and for full activation of IKK2/IKK beta in cultured cells. Furthermore, we identified a docking site for this segment of NEMO/IKK gamma on IKK2/IKK beta within its scaffold-dimerization domain proximal to the kinase domain-Ub-like domain. Finally, we showed that a peptide derived from this region of NEMO/IKK gamma is capable of interfering specifically with canonical NF-kappa B signaling in transfected cells. These in vitro biochemical and cell culture-based experiments suggest that, as a consequence of its association with linear poly-Ub, NEMO/IKK gamma plays a direct role in priming IKK2/IKK beta for phosphorylation and that this process can be inhibited to specifically disrupt canonical NF-kappa B signaling.	[Ko, Myung Soo; Polley, Smarajit; Biswas, Tapan; Ghosh, Gourisankar] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA; [Ko, Myung Soo; Cohen, Samantha N.; Huxford, Tom] San Diego State Univ, Struct Biochem Lab, Dept Chem & Biochem, San Diego, CA 92182 USA; [Mahata, Sushil K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Mahata, Sushil K.] VA San Diego Hlth Care Syst, Med, San Diego, CA USA	University of California System; University of California San Diego; California State University System; San Diego State University; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Ghosh, G (corresponding author), Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.	gghosh@ucsd.edu		Polley, Smarajit/0000-0003-3494-5267; Huxford, Tom/0000-0002-1939-7373	National Institutes of Health [CA197999, MD012397]; University of California Tobacco-Related Disease Research Program; American Association for Cancer Research; California Metabolic Research Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of California Tobacco-Related Disease Research Program(University of California System); American Association for Cancer Research; California Metabolic Research Foundation	This research was supported by grants from the National Institutes of Health (grant nos.: CA141722 and AI163327), the University of California Tobacco-Related Disease Research Program, and American Association for Cancer Research (to G. G.) and National Institutes of Health (grant nos.: CA197999 and MD012397; to T. H.). S. N. C. is a recipient of the Arne N. Wick predoctoral fellowship and is a Phillips Gausewitz, MD scholar of the Rees-Stealy Research Foundation. Biochemistry research at San Diego State University is supported in part by the California Metabolic Research Foundation. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bollrath J., 2007, NF; Chen JQ, 2013, CURR OPIN IMMUNOL, V25, P4, DOI 10.1016/j.coi.2012.12.005; Chen ZJ, 1996, CELL, V84, P853, DOI 10.1016/S0092-8674(00)81064-8; Delhase M, 1999, SCIENCE, V284, P309, DOI 10.1126/science.284.5412.309; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Gamble C, 2012, BRIT J PHARMACOL, V165, P802, DOI 10.1111/j.1476-5381.2011.01608.x; Hacker Hans, 2006, Sci STKE, V2006, pre13, DOI 10.1126/stke.3572006re13; Hadian K, 2011, J BIOL CHEM, V286, P26107, DOI 10.1074/jbc.M111.233163; Hauenstein AV, 2017, J MOL BIOL, V429, P3793, DOI 10.1016/j.jmb.2017.10.026; Hauenstein AV, 2014, BIOCHEMISTRY-US, V53, P2064, DOI 10.1021/bi401551r; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hu HB, 2016, CELL RES, V26, P457, DOI 10.1038/cr.2016.40; Huxford T, 2011, CURR TOP MICROBIOL, V349, P1, DOI 10.1007/82_2010_99; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kensche T, 2012, J BIOL CHEM, V287, P23626, DOI 10.1074/jbc.M112.347195; Kirisako T., 2009, NAT; Ko MS, 2020, BBA-PROTEINS PROTEOM, V1868, DOI 10.1016/j.bbapap.2020.140526; Larabi A, 2013, CELL REP, V3, P734, DOI 10.1016/j.celrep.2013.01.034; Liu SP, 2013, J BIOL CHEM, V288, P22758, DOI 10.1074/jbc.M113.482596; Lo YC, 2009, MOL CELL, V33, P602, DOI 10.1016/j.molcel.2009.01.012; Lopez-Castejon G, 2011, CYTOKINE GROWTH F R, V22, P189, DOI 10.1016/j.cytogfr.2011.10.001; Mahlitin E, 2007, ANAL BIOCHEM, V365, P215, DOI 10.1016/j.ab.2007.03.020; May MJ, 2002, J BIOL CHEM, V277, P45992, DOI 10.1074/jbc.M206494200; May MJ, 2000, SCIENCE, V289, P1550, DOI 10.1126/science.289.5484.1550; Mulero MC, 2019, ADV EXP MED BIOL, V1172, P207, DOI 10.1007/978-981-13-9367-9_10; Mulero MC, 2018, BIOCHEMISTRY-US, V57, P2943, DOI 10.1021/acs.biochem.8b00158; Nagashima K, 2006, BLOOD, V107, P4266, DOI 10.1182/blood-2005-09-3852; Napoleon JV, 2021, CHEM COMMUN, V57, P4678, DOI 10.1039/d1cc01245b; Polley S, 2016, CELL REP, V17, P1907, DOI 10.1016/j.celrep.2016.10.067; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; Rahighi S, 2009, CELL, V136, P1098, DOI 10.1016/j.cell.2009.03.007; Rothwarf DM, 1998, NATURE, V395, P297, DOI 10.1038/26261; Rudolph D, 2000, GENE DEV, V14, P854; Rushe M, 2008, STRUCTURE, V16, P798, DOI 10.1016/j.str.2008.02.012; Sarkar G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028881; Schmidt-Supprian M, 2000, MOL CELL, V5, P981, DOI 10.1016/S1097-2765(00)80263-4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schrofelbauer B, 2012, MOL CELL, V47, P111, DOI 10.1016/j.molcel.2012.04.020; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shaffer R, 2019, BIOCHEMISTRY-US, V58, P2906, DOI 10.1021/acs.biochem.8b01316; Shaul JD, 2008, BIOCHEM BIOPH RES CO, V374, P592, DOI 10.1016/j.bbrc.2008.07.082; Taniguchi K, 2018, NAT REV IMMUNOL, V18, P309, DOI 10.1038/nri.2017.142; Tu D., 2013, CELL REP; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3; Xu GZ, 2011, NATURE, V472, P325, DOI 10.1038/nature09853; Zhang JZ, 2014, BIOCHEM J, V461, P531, DOI 10.1042/BJ20140444	47	0	0	6	6	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101864	10.1016/j.jbc.2022.101864	http://dx.doi.org/10.1016/j.jbc.2022.101864			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1F0TV	35339487	gold, Green Published			2022-12-26	WOS:000794890400002
J	Al-Dahshan, A; Selim, N; Al-Kubaisi, N; Mahfoud, Z; Kehyayan, V				Al-Dahshan, Ayman; Selim, Nagah; Al-Kubaisi, Noora; Mahfoud, Ziyad; Kehyayan, Vahe			Primary care physicians' knowledge of travel vaccine and malaria chemoprophylaxis and associated predictors in Qatar	PLOS ONE			English	Article							MEDICINE; PRACTITIONERS; ADVICE	Background In an era of globalization, travel-related illnesses have become a focus of public health concern, especially in the Arab region where travel health services are insufficient and not well-established. This study was conducted to assess travel vaccine and malaria chemoprophylaxis knowledge and associated predictors among primary care physicians (PCPs) in Qatar. Methods This was a cross-sectional study. A structured questionnaire was used to collect data from all physicians working at all 27 primary healthcare centers from March 1st to May 31st 2020. Knowledge scores were computed and a multivariable linear regression model was built to identify predictors of higher knowledge. Results A total of 364 PCPs participated (response rate of 89.2%). Participants' mean age was 44.5 (7.8) with 59.1% being males. Their overall mean knowledge score was 9.54/16 (+/- 3.24). Significant predictors of higher knowledge included: aged 40-49 years (1.072; 95% CI: 0.230, 1.915), had medical degree from non-Arab countries (0.748; 95% CI: 0.065, 1.432), had training in TM (1.405; 95% CI: 0.407, 2.403), and provided >= 10 consultations/month (2.585; 95% CI:1.294, 3.876). Online information was the main reported resource of travel medicine consultation. Conclusions The overall PCPs' mean percentage knowledge score of travel medicine was 59.6% (+/- 20.3). A high volume of pretravel consultation, prior training, middle age group, and medical degree from non-Arab countries were significant predictors of higher knowledge. Continuing education and training provided by recognised international institutions for all PCPs is highly recommended to narrow the gap in travel medicine knowledge.	[Al-Dahshan, Ayman] Hamad Med Corp, Dept Med Educ, Community Med Residency Program, Doha, Qatar; [Selim, Nagah] Cairo Univ, Kasr Alainy Fac Med, Dept Publ Hlth & Prevent Med, Cairo, Egypt; [Al-Kubaisi, Noora] Primary Hlth Care Corp, Dept Clin Affairs, Doha, Qatar; [Mahfoud, Ziyad] Weill Cornell Med Coll, Dept Global & Publ Hlth, Doha, Qatar; [Kehyayan, Vahe] Univ Calgary Qatar, Doha, Qatar	Hamad Medical Corporation; Egyptian Knowledge Bank (EKB); Cairo University; Hamad Medical Corporation; Primary Health Care Corporation (PHCC); Qatar Foundation (QF); Weill Cornell Medical College Qatar	Al-Dahshan, A (corresponding author), Hamad Med Corp, Dept Med Educ, Community Med Residency Program, Doha, Qatar.	ayman.aldahshan@hotmail.com		Alkubaisi, Noora/0000-0003-2776-3211; Mahfoud, Ziyad/0000-0003-4098-6401; AL DAHSHAN, AYMAN/0000-0001-6132-3223	Ayman Al-Dahshan (AAD) [MRC-01-19-324]; Medical Research Center (MRC) at Hamad Medical Corporation, Doha, Qatar; Qatar National Library	Ayman Al-Dahshan (AAD); Medical Research Center (MRC) at Hamad Medical Corporation, Doha, Qatar; Qatar National Library(Qatar National Research Fund (QNRF))	Initials of the authors who received each award: Ayman Al-Dahshan (AAD) Grant numbers awarded to each author:MRC-01-19-324. The full name of each funder: Medical Research Center (MRC) at Hamad Medical Corporation, Doha, Qatar URL of each funder website: https://www.hamad.qa/EN/Education-and-research/Medical_Research/Pages/default.aspx Open Access funding provided by the Qatar National Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aba YT, 2019, MED MALADIES INFECT, V49, P257, DOI 10.1016/j.medmal.2018.11.008; Abukhattab M., INT J TRAVEL MED GLO, V6, P161; Al-Hajri M, 2011, SE ASIAN J TROP MED, V42, P1546; Alduraibi RK, 2020, BMC FAM PRACT, V21, DOI 10.1186/s12875-020-01273-z; Angelo KM, 2017, J TRAVEL MED, V24, DOI 10.1093/jtm/tax046; Aw B, 2014, CAN FAM PHYSICIAN, V60, P1091; Centres for Disease Control and Prevention, TRAV HLTH; *CHIN TOUR AC, 2018, ANN REP CHIN OUTB TO; Dallas A, 2015, FAM PRACT, V32, P49, DOI 10.1093/fampra/cmu069; Farag E, 2018, MEDITERR J HEMATOL I, V10, DOI 10.4084/MJHID.2018.050; Felkai P, 2010, ASIAN PAC J TROP MED, V3, P74, DOI 10.1016/S1995-7645(10)60038-7; Frost & Sullivan & Insights Middle East, 2019, SHAP FUT TRAV GULF C; Gabr I., MENOFIA MEDICAL J, V28, P587; Hatz C, 1997, TROP MED INT HEALTH, V2, P6, DOI 10.1046/j.1365-3156.1997.d01-130.x; Jeffery R, 2012, J MED INTERNET RES, V14, P431, DOI 10.2196/jmir.2105; Kogelman L, 2014, J TRAVEL MED, V21, P104, DOI 10.1111/jtm.12097; Kurup PJ, 2019, E MEDITERR HEALTH J, V25, P40, DOI 10.26719/emhj.18.027; Leggat P.A, INFECT DIS-NOR, V1, P235; Leggat PA, 1999, J TRAVEL MED, V6, P60, DOI 10.1111/j.1708-8305.1999.tb00833.x; Piotte E, 2013, J TRAVEL MED, V20, P221, DOI 10.1111/jtm.12030; Porter JFH, 2004, J TRAVEL MED, V11, P347, DOI 10.2310/7060.2004.19202; Primary Health Care Corporation, NAT PRIM HLTH CAR ST; Primary Health Care Corporation, HLTH CTR, V2019; Ropers GD, 2004, J TRAVEL MED, V11, P287, DOI 10.2310/7060.2004.19104; Roupa Zoe, 2012, Mater Sociomed, V24, P131, DOI 10.5455/msm.2012.24.131-134; Sanford C, 2016, AM FAM PHYSICIAN, V94, P620; Tavakol M, 2011, INT J MED EDUC, V2, P53, DOI 10.5116/ijme.4dfb.8dfd; Thava Seelan S, 2003, Travel Med Infect Dis, V1, P185, DOI 10.1016/S1477-8939(03)00018-8; United Nations Sustainable Developmental Group, POL BRIEF IMP COVID; United Nations World Tourism Organization, GROWTH INT TOUR ARR	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265953	10.1371/journal.pone.0265953	http://dx.doi.org/10.1371/journal.pone.0265953			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358236	gold, Green Published			2022-12-26	WOS:000799828800055
J	Lu, YF; Jin, XF; Yu, MJ				Lu, Yi-Fei; Jin, Xiao-Feng; Yu, Ming-Jian			Carex borealifujianica (Cyperaceae), a new species of the core Carex clade from Fujian, southeastern China	PLOS ONE			English	Article							SECT. RHOMBOIDALES; TAXONOMIC REVISION; HAINAN; PHYLOGENY; SEQUENCES; CARICEAE; SEDGE; MITRATAE; ZHEJIANG; GUANGXI	A new species, Carex borealifujianica Y.F. Lu & X.F. Jin (Cyperaceae, sect. Occlusae of core Carex clade) is described and illustrated from northern Fujian, China. In addition to morphological comparisons with its relatives, comparative micromorphology of utricles and achenes of seven species in Carex sect. Occlusae was examined. Micromorphology of utricles and achenes revealed the similarity of Carex borealifujianica and C. ligulata. Morphologically, this new species is similar to Carex ligulata in having lateral spikes remote and densely flowered, as well as utricles densely hispidulous, but differs in having 2 or 3 narrowly clavate staminate spikes, leaves 2.5-5 mm wide with sheaths sparsely pilose, and achenes emarginate at the apex. The phylogenetic analysis from two nuclear DNA regions (ETS and ITS) and two chloroplast DNA regions (matK and trnL-F) of 68 taxa resolved C. borealifujianica as a distinct species.	[Lu, Yi-Fei; Yu, Ming-Jian] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Jin, Xiao-Feng] Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Zhejiang Prov Key Lab Forest Aromat Plants Based, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang A&F University	Yu, MJ (corresponding author), Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China.; Jin, XF (corresponding author), Zhejiang A&F Univ, State Key Lab Subtrop Silviculture, Zhejiang Prov Key Lab Forest Aromat Plants Based, Sch Forestry & Biotechnol, Hangzhou, Zhejiang, Peoples R China.	docxfjin@163.com; fishmj@zju.edu.cn			National Natural Science Foundation of China [32070218, 31770212]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant Nos. 32070218, 31770212). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike H, 1973, INFORM THEORY EXTENS, P267, DOI DOI 10.1007/978-1-4612-1694-0_15; Chen CD., 1999, CHIN BIODIVERS, V7, P320; Chen WJ, 2015, PHYTOTAXA, V233, P281, DOI 10.11646/phytotaxa.233.3.5; Dai LK., 2010, FLORA CHINA 23, P285; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Deng YF, 2014, PHYTOTAXA, V178, P181, DOI 10.11646/phytotaxa.178.3.3; Egorova T.V., 1999, SEDGES CAREX L RUSSI; Ford BA, 2017, SYST BOT, V42, P402, DOI [10.1600/036364417X695998, 10.1600/036364417x695998]; Govaerts R., 2020, WORLD CHECKLIST CYPE; IUCN, 2012, IUCN RED LIST CATEGO, V2nd ed., P32; Jimenez-Mejias P, 2016, SYST BOT, V41, P500, DOI 10.1600/036364416X692497; Jin XF., 2013, TAXONOMY CAREX SECT, P1; Jin XF, 2020, PHYTOTAXA, V429, P135, DOI 10.11646/phytotaxa.429.2.4; Jin XF, 2017, PHYTOTAXA, V317, P29, DOI 10.11646/phytotaxa.317.1.3; Jin XF, 2015, PHYTOTAXA, V231, P165, DOI 10.11646/phytotaxa.231.2.5; Jin XF, 2015, PHYTOTAXA, V217, P117, DOI 10.11646/phytotaxa.217.2.2; Jin XF, 2014, BOT J LINN SOC, V175, P123, DOI 10.1111/boj.12149; Jin XF, 2012, SYST BOT, V37, P929, DOI 10.1600/036364412X656617; Jin XF, 2011, NORD J BOT, V29, P63, DOI 10.1111/j.1756-1051.2010.00977.x; Jin XF, 2010, NORD J BOT, V28, P709, DOI 10.1111/j.1756-1051.2010.00817.x; Jin X, 2020, FATIGUE FRACT ENG M, V43, P2247, DOI 10.1111/ffe.13251; Katoh K, 2019, BRIEF BIOINFORM, V20, P1160, DOI 10.1093/bib/bbx108; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Larridon I, 2021, J SYST EVOL, V59, P852, DOI 10.1111/jse.12757; Lu YF, 2018, PHYTOTAXA, V372, P203, DOI 10.11646/phytotaxa.372.3.3; Lu YF, 2017, NORD J BOT, V35, P573, DOI 10.1111/njb.01565; Lu ZC, 2020, TAIWANIA, V65, P391, DOI 10.6165/tai.2020.65.391; Martin-Bravo S, 2019, J SYST EVOL, V57, P695, DOI 10.1111/jse.12549; Roalson EH, 2021, J SYST EVOL, V59, P726, DOI 10.1111/jse.12722; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rstudio Team, 2019, RSTUDIO INTEGRATED D; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Starr JR, 2003, INT J PLANT SCI, V164, P213, DOI 10.1086/346168; Starr JR, 2015, MOL PHYLOGENET EVOL, V88, P105, DOI 10.1016/j.ympev.2015.04.001; Starr JR, 2009, BOT REV, V75, P110, DOI 10.1007/s12229-008-9020-x; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; Vaidya G, 2011, CLADISTICS, V27, P171, DOI 10.1111/j.1096-0031.2010.00329.x; Villaverde T, 2020, BOT J LINN SOC, V194, P141; Wang QL, 2012, PHYTOTAXA, V75, P65; Waterway MJ, 2015, BOT J LINN SOC, V179, P1, DOI 10.1111/boj.12298; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Yang HJ, 2017, PHYTOTAXA, V308, P239, DOI 10.11646/phytotaxa.308.2.5; Yang HB, 2020, PHYTOTAXA, V461, P72, DOI [10.11646/phytotaxa.461.2.1, 10.11646/PHYTOTAXA.461.2.1]; Yang HB, 2016, PHYTOTAXA, V283, P155, DOI 10.11646/phytotaxa.283.2.4; Yang HB, 2015, PHYTOTAXA, V201, P207, DOI 10.11646/phytotaxa.201.3.4; Yang HB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136373; Yang HB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097658; Yano O, 2014, J PLANT RES, V127, P99, DOI 10.1007/s10265-013-0578-y; Zhang SR, 2018, NORD J BOT, V36, DOI 10.1111/njb.01900; Zhao LQ, 2013, ANN BOT FENN, V50, P32, DOI 10.5735/085.050.0104; Zhao YJ, 2011, NORD J BOT, V29, P670, DOI 10.1111/j.1756-1051.2011.01132.x; Zhou YY, 2014, PHYTOTAXA, V164, P133, DOI 10.11646/phytotaxa.164.2.7	53	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264419	10.1371/journal.pone.0264419	http://dx.doi.org/10.1371/journal.pone.0264419			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358191	Green Published, gold			2022-12-26	WOS:000799828800018
J	Alharbey, RA; Aljahdaly, NH				Alharbey, R. A.; Aljahdaly, Noufe H.			On fractional numerical simulation of HIV infection for CD8(+) T-cells and its treatment	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; MATHEMATICAL-ANALYSIS; DYNAMICS; MODELS	The AIDS is a chronic disease and the researchers still exert their high efforts to reach the cure of HIV infection. The most common treatment is the antiretroviral therapy (cART) and the virus can be more effected if the patients stop using cART. The other problem is that the CD8(+) T cells might be exhausted by persistent immune activation by cART. This paper introduces fractional-order into a mathematical model of HIV infection combining with stem cell therapy and control the infection by the immune system cells (CD8(+) T cells). The paper introduced the numerical solutions for the mathematical model. The results show that the stem cell therapy with the activation of immune system cells might causes the cure for a HIV patient. This results are consistent with medical studies. Also, we proposed the effect of the fractional order (a) on the figures of the components.	[Alharbey, R. A.] King AbdulAziz Univ, Fac Sci, Math Dept, Al Sulymania Womens Campus, Jeddah, Saudi Arabia; [Aljahdaly, Noufe H.] King Abdulaziz Univ, Fac Sci & Arts, Math Dept, Rabigh, Saudi Arabia	King Abdulaziz University; King Abdulaziz University	Alharbey, RA (corresponding author), King AbdulAziz Univ, Fac Sci, Math Dept, Al Sulymania Womens Campus, Jeddah, Saudi Arabia.	rallehabi@kau.edu.sa	Aljahdaly, Noufe/C-8116-2018		Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah [G56-2471442]; DSR	Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah; DSR	The project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant No.(G56-2471442). The authors, therefore, acknowledge with thanks DSR technical and financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders had role in technical support and financially.; The project was funded by the Deanship of Scientific Research (DSR), King Abdulaziz University, Jeddah under grant No.(G56-247-1442). The authors, therefore, acknowledge with thanks DSR technical and financial support.	Alba-Perez J, 2021, ADV DIFFER EQU-NY, V2021, DOI 10.1186/s13662-021-03322-y; Aljahdaly NH, 2022, J OCEAN ENG SCI, V7, P492, DOI 10.1016/j.joes.2021.10.001; Aljahdaly NH, 2021, J TAIBAH UNIV SCI, V15, P971, DOI 10.1080/16583655.2021.2012373; Aljahdaly NH, 2021, EUR PHYS J PLUS, V136, DOI 10.1140/epjp/s13360-021-02087-3; Aljahdaly NH, 2021, ROM REP PHYS, V73; Aljahdaly NH, 2021, AIMS MATH, V6, P6715, DOI 10.3934/math.2021394; Aljahdaly NH, 2021, MATHEMATICS-BASEL, V9, DOI 10.3390/math9040432; Aljahdaly NH, 2020, AIP CONF PROC, V2293, DOI 10.1063/5.0026424; Aljahdaly NH, 2020, CHAOS, V30, DOI 10.1063/1.5132557; Aljahdaly NH, 2019, COMPUT MATH METHOD M, V2019, DOI 10.1155/2019/4849393; Aljahdaly NH, 2019, RESULTS PHYS, V13, DOI 10.1016/j.rinp.2019.102272; Alqudah MA, 2020, J COMPUT SCI-NETH, V45, DOI 10.1016/j.jocs.2020.101176; Ammassari A, 2001, J ACQ IMMUN DEF SYND, V28, P445, DOI 10.1097/00042560-200112150-00006; Arshad S, 2017, ADV DIFFER EQU-NY, DOI 10.1186/s13662-017-1143-0; Ashi HA, 2020, COMMUN NONLINEAR SCI, V85, DOI 10.1016/j.cnsns.2020.105237; Behera S, 2021, J BIOMOL STRUCT DYN, DOI [10.1080/07391102.2021.1938681, 10.1080/15440478.2021.1904483]; CAPUTO M, 1967, GEOPHYS J ROY ASTR S, V13, P529, DOI 10.1111/j.1365-246X.1967.tb02303.x; Diethelm K, 2013, NONLINEAR DYNAM, V71, P613, DOI 10.1007/s11071-012-0475-2; Duffin RP, 2002, J THEO MED, V4, P215, DOI [10.1080/1027366021000051772, DOI 10.1080/1027366021000051772]; Gupta RK, 2020, LANCET HIV, V7, pE340, DOI 10.1016/S2352-3018(20)30069-2; Henrich TJ, 2014, ANN INTERN MED, V161, P319, DOI 10.7326/M14-1027; Kirschner D., 1996, NOTICES AM MATH SOC, V43, P191; Mannheimer SB, 2005, AIDS CARE, V17, P10, DOI 10.1080/09540120412331305098; Martinez VM, 2021, CHAOS SOLITON FRACT, V152, DOI 10.1016/j.chaos.2021.111398; Nelson PW, 2002, MATH BIOSCI, V179, P73, DOI 10.1016/S0025-5564(02)00099-8; Ngina PM, 2017, APPL MATH-US, V8, P1153, DOI [10.4236/am. 2017.88087, DOI 10.4236/AM.2017.88087]; Ngina Purity, 2017, Int Sch Res Notices, V2017, P2124789, DOI 10.1155/2017/2124789; Odibat Zaid M., 2008, Journal of Applied Mathematics and Informatics, V26, P15; Chavez JP, 2019, COMMUN NONLINEAR SCI, V75, P109, DOI 10.1016/j.cnsns.2019.03.021; Perelson AS, 1999, SIAM REV, V41, P3, DOI 10.1137/S0036144598335107; Qureshi S, 2019, CHAOS SOLITON FRACT, V122, P111, DOI 10.1016/j.chaos.2019.03.020; Ribeiro RM, 2007, IMMUNOL CELL BIOL, V85, P287, DOI 10.1038/sj.icb.7100056; Srivastava VK, 2014, AIN SHAMS ENG J, V5, P625, DOI 10.1016/j.asej.2013.12.012; Warren M, 2019, NATURE, V567, P7749	35	0	0	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265627	10.1371/journal.pone.0265627	http://dx.doi.org/10.1371/journal.pone.0265627			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324957	gold, Green Published			2022-12-26	WOS:000780951300050
J	Belay, AT; Fenta, SM; Agegn, SB; Muluneh, MW				Belay, Alebachew Taye; Fenta, Setegn Much; Agegn, Setegn Bayabil; Muluneh, Mitiku Wale			Prevalence and risk factors associated with rural women's protected against tetanus in East Africa: Evidence from demographic and health surveys of ten East African countries	PLOS ONE			English	Article							TOXOID IMMUNIZATION; NEONATAL TETANUS; VACCINATION; MORTALITY	Background Tetanus is a deadly bacterial infection caused by Clostridium tetani wound contamination characterized muscular spasms and autonomic nervous system dysfunction. Maternal and neonatal tetanus occurs under improper hygiene practices during childbirth. Globally, an estimated 3.3 million newborn deaths occur every year, and about 9,000 babies die every day in the first 28 days of life. This study sought to identify risk factors associated with the immunization of rural women against tetanus in rural areas in ten East African countries. Method The data used in this study were taken from the Demographic and Health Survey (DHS) of ten East African countries (Ethiopia, Burundi, Comoros, Zimbabwe, Kenya, Malawi, Ruanda, Tanzania, Uganda and, Zambia). Multivariable binary logistic regression is used to determine the risk factors associated with tetanus-protected women in east Africa. Results The weighted total samples of 73735 rural women were included in the analysis. The combined prevalence of tetanus immunization among protected rural women in ten East African countries was 50.4%. Those women with age of 24-34 (AOR = 0.778; 95%CI: 0.702-0.861), higher educational level (AOR = 4.010; 95%CI: 2.10-5.670), rich women (AOR = 3.097;95%CI: 2.680-3.583), mass media coverage (AOR = 1.143; 95%CI: 1.030-1.269), having above three antenatal care follow up (AOR = 1.550; 95% CI: 1.424-1.687), big problem of distance to health facility (AOR = 0.676; CI: 0.482-0.978) and place of delivery health facility (AOR = 1.103; 95% CI: 1.005-1.210) had a significant effect on women's protected from tetanus. Conclusion The coverage of tetanus immunization in East Africa was very low. Public health programs target rural mothers who are uneducated, poor households, longer distances from health facilities, mothers who have the problem of media exposure, and mothers who have not used maternal health care services to promote TT immunization.	[Belay, Alebachew Taye; Fenta, Setegn Much; Agegn, Setegn Bayabil; Muluneh, Mitiku Wale] Debre Tabor Univ, Dept Stat, Debre Tabor, Ethiopia		Belay, AT (corresponding author), Debre Tabor Univ, Dept Stat, Debre Tabor, Ethiopia.	alex016stat@gmail.com	Fenta, Setegn Muche/ABB-7296-2020; Muluneh, Mitiku Wale/ABC-5470-2021	Fenta, Setegn Muche/0000-0003-4006-3455; Muluneh, Mitiku Wale/0000-0002-2413-8026				Abadura SA, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2315-z; Abdella A, 2010, ETHIOP J HEALTH DEV, V24, P115; Adeiga A., 2005, African Journal of Clinical and Experimental Microbiology, V6, P233; Anatea MD, 2018, BMC INT HEALTH HUM R, V18, DOI 10.1186/s12914-018-0168-0; [Anonymous], 2017, Wkly Epidemiol Rec, V92, P53; Azzari C, 2020, EUR J PEDIATR, V179, P547, DOI 10.1007/s00431-019-03511-8; Bethancourt CN, 2017, CURR OPIN PEDIATR, V29, P737, DOI 10.1097/MOP.0000000000000553; Biswas S. C., 2001, Pakistan Development Review, V40, P57; Blencowe H, 2010, INT J EPIDEMIOL, V39, P102, DOI 10.1093/ije/dyq027; Burgess C, 2017, LANCET, V389, P1380, DOI 10.1016/S0140-6736(17)30635-9; Croft TN, 2018, GUIDE DHS STAT DHS 7; Englund J.A, 2015, MATERNAL IMMUNIZATIO; Gebremedhin TS, 2020, BIOMED RES INT, V2020, DOI 10.1155/2020/4023031; Haile ZT, 2013, J COMMUN HEALTH, V38, P492, DOI 10.1007/s10900-012-9638-9; Hilton S, 2013, VACCINE, V31, P2543, DOI 10.1016/j.vaccine.2013.04.023; Khan REA, 2013, ASIAN DEV POLICY REV, V1, P1; Khan R, 2015, INT J WOMENS HEALTH, V7, P171, DOI 10.2147/IJWH.S50539; Liyew A.M., ARCH PUBLIC HEALTH, V79, P1; Mamoro MD, 2018, J NUTR METAB, V2018, DOI 10.1155/2018/2839579; Maral I, 2001, PUBLIC HEALTH, V115, P359, DOI 10.1038/sj.ph.1900780; Marchant A, 2017, LANCET INFECT DIS, V17, pE197, DOI 10.1016/S1473-3099(17)30229-3; Mehanna A, 2020, J EGYPT PUBLIC HEAL, V95, DOI 10.1186/s42506-020-00049-8; Messeret Eshetu Shibeshi, 2018, J Immunol Sci, VSuppl, P103; Mohammad M., 2008, INTERNET J HLTH, P8; Njuguna H. N., 2020, Weekly Epidemiological Record, V95, P173; Organization W.H, 2002, MAT NEON TET ELIM 20; Orimadegun AE, 2014, ITAL J PEDIATR, V40, DOI 10.1186/1824-7288-40-29; Owusu-Darko S., 2012, REV OBSTET GYNECOLOG, V5, P151; Roosihermiatie Betty, 2000, Southeast Asian Journal of Tropical Medicine and Public Health, V31, P91; Roper MH, 2007, LANCET, V370, P1947, DOI 10.1016/S0140-6736(07)61261-6; Teklay Kidane, 2004, Ethiopian Journal of Health Development, V18, P153; Teshale AB, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243071; Tranmer M., 2008, PAPER, P20; Unicef P, 2010, MAT NEON TET ELIM IN; Vickers NJ, 2017, CURR BIOL, V27, pR713, DOI 10.1016/j.cub.2017.05.064; Who U. World Bank, 2009, STAT WORLDS VACC IMM, P130; Yaya S, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08985-y; Yeshaw Y, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0253126	38	2	2	4	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265906	10.1371/journal.pone.0265906	http://dx.doi.org/10.1371/journal.pone.0265906			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324988	gold, Green Published			2022-12-26	WOS:000780951300082
J	Mohammed, AD; Hall, N; Chatzistamou, I; Jolly, A; Kubinak, JL				Mohammed, Ahmed Dawood; Hall, Nia; Chatzistamou, Ioulia; Jolly, Amy; Kubinak, Jason Lee			Gluten-free diet exposure prohibits pathobiont expansion and gluten sensitive enteropathy in B cell deficient J(H)(-/-) mice	PLOS ONE			English	Article							IMMUNOGLOBULIN-A DEFICIENCY; CELIAC-DISEASE; T-CELLS; TISSUE TRANSGLUTAMINASE; INTESTINAL MICROBIOTA; DEGRADING BACTERIA; MOUSE MODEL; GUT; GLIADIN; ANTIBODIES	In humans, celiac disease (CeD) is a T-cell-driven gluten-sensitive enteropathy (GSE) localized to the small bowel (duodenum). The presence of antibodies specific for gluten- and self-antigens are commonly used diagnostic biomarkers of CeD and are considered to play a role in GSE pathogenesis. Previously, we have described an apparent T-cell-mediated GSE in CD19(-/-) mice, which develop weak and abnormal B cell responses. Here, we expand on this observation and use a mouse model of complete B cell deficiency (J(H)(-/-) mice), to show that absence of a humoral immune response also promotes development of a GSE. Furthermore, 16S analysis of microbial communities in the small intestine demonstrates that a gluten-free diet suppresses the expansion of anaerobic bacteria in the small intestine and colonization of the small intestine by a specific pathobiont. Finally, we also observe that SI enteropathy in mice fed a gluten-rich diet is positively correlated with the abundance of several microbial peptidase genes, which supports that bacterial metabolism of gluten may be an important driver of GSE in our model. Collectively, results from our experiments indicate that J(H)(-/-) mice will be a useful resource to investigators seeking to empirically delineate the contribution of humoral immunity on GSE pathogenesis, and support the hypothesis that humoral immunity promotes tolerance to gluten.	[Mohammed, Ahmed Dawood; Hall, Nia; Chatzistamou, Ioulia; Jolly, Amy; Kubinak, Jason Lee] Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA	University of South Carolina System; University of South Carolina Columbia	Kubinak, JL (corresponding author), Univ South Carolina, Sch Med, Dept Pathol Microbiol & Immunol, Columbia, SC 29208 USA.	Jason.Kubinak@uscmed.sc.edu		Kubinak, Jason/0000-0001-9866-8225	National Institute of Allergy and Infectious Diseases [R21AI142409, R01AI155887]; National Institute of General Medical Sciences [P20GM103641]	National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported in the form of funding by the National Institute of Allergy and Infectious Diseases (Grant Nos. R21AI142409 and R01AI155887) awarded to JLK, and by the National Institute of General Medical Sciences (Grant No. P20GM103641) awarded to JLK.	Aaron L, 2019, CLIN IMMUNOL, V199, P37, DOI 10.1016/j.clim.2018.12.008; Abadie V, 2020, NATURE, V578, P600, DOI 10.1038/s41586-020-2003-8; Barnett TC, 2015, CELL MICROBIOL, V17, P1721, DOI 10.1111/cmi.12531; Bascunan KA, 2020, ADV NUTR, V11, P160, DOI 10.1093/advances/nmz080; Berger M, 2015, EXP BIOL MED, V240, P917, DOI 10.1177/1535370214564748; Biesiekierski JR, 2017, J GASTROEN HEPATOL, V32, P78, DOI 10.1111/jgh.13703; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Caio G, 2020, NUTRIENTS, V12, DOI 10.3390/nu12061832; Caja S, 2011, CELL MOL IMMUNOL, V8, P103, DOI 10.1038/cmi.2010.65; Caminero A, 2016, GASTROENTEROLOGY, V151, P670, DOI 10.1053/j.gastro.2016.06.041; Caminero A, 2014, FEMS MICROBIOL ECOL, V88, P309, DOI 10.1111/1574-6941.12295; CUNNINGHAMRUNDLES C, 1986, J CLIN IMMUNOL, V6, P381, DOI 10.1007/BF00915377; CUNNINGHAMRUNDLES C, 1984, AM J MED, V76, P181, DOI 10.1016/0002-9343(84)90771-X; DePaolo RW, 2011, NATURE, V471, P220, DOI 10.1038/nature09849; Dieterich W, 1997, NAT MED, V3, P797, DOI 10.1038/nm0797-797; du Pre MF, 2020, J EXP MED, V217, DOI 10.1084/jem.20190860; Esposito C, 2002, GUT, V51, P177, DOI 10.1136/gut.51.2.177; Fadlallah J, 2018, SCI TRANSL MED, V10, DOI 10.1126/scitranslmed.aan1217; Fagarasan S, 2002, SCIENCE, V298, P1424, DOI 10.1126/science.1077336; Flores-Diaz M, 2016, MICROBIOL MOL BIOL R, V80, P597, DOI 10.1128/MMBR.00082-15; Freitag TL, 2009, GUT, V58, P1597, DOI 10.1136/gut.2009.186361; Frossard CP, 2004, J ALLERGY CLIN IMMUN, V114, P377, DOI 10.1016/j.jaci.2004.03.040; Fujihashi K, 2001, ACTA ODONTOL SCAND, V59, P301, DOI 10.1080/000163501750541174; Galipeau HJ, 2015, AM J PATHOL, V185, P2969, DOI 10.1016/j.ajpath.2015.07.018; Galipeau HJ, 2011, J IMMUNOL, V187, P4338, DOI 10.4049/jimmunol.1100854; Gardby E, 2000, EUR J IMMUNOL, V30, P1861, DOI 10.1002/1521-4141(200007)30:7<1861::AID-IMMU1861>3.0.CO;2-A; Hausch F, 2002, AM J PHYSIOL-GASTR L, V283, pG996, DOI 10.1152/ajpgi.00136.2002; Helmerhorst EJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013264; Herran AR, 2017, RES MICROBIOL, V168, P673, DOI 10.1016/j.resmic.2017.04.008; Herrera P, 2009, ANAEROBE, V15, P44, DOI 10.1016/j.anaerobe.2008.11.003; Hundsberger H, 2017, SLAS DISCOV, V22, P1035, DOI 10.1177/2472555217697435; Cardenas-Torres FI, 2021, MEDICINA-LITHUANIA, V57, DOI 10.3390/medicina57060526; Jabri B, 2017, J IMMUNOL, V198, P3005, DOI 10.4049/jimmunol.1601693; Kato LM, 2014, IMMUNOL REV, V260, P67, DOI 10.1111/imr.12185; Kato LM, 2014, IMMUNOL CELL BIOL, V92, P49, DOI 10.1038/icb.2013.54; Kawamoto S, 2014, IMMUNITY, V41, P152, DOI 10.1016/j.immuni.2014.05.016; Kawamoto S, 2012, SCIENCE, V336, P485, DOI 10.1126/science.1217718; Koiv V, 2021, APPL MICROBIOL BIOT, V105, P3045, DOI 10.1007/s00253-021-11263-5; Kuang ZZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027091; Kubinak JL, 2016, NAT REV IMMUNOL, V16, P767, DOI 10.1038/nri.2016.114; Kumar V, 2002, CLIN DIAGN LAB IMMUN, V9, P1295, DOI 10.1128/CDLI.9.6.1295-1300.2002; Lagkouvardos I, 2019, MICROBIOME, V7, DOI 10.1186/s40168-019-0637-2; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lebwohl B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4347; Lejeune T, 2021, GASTROENTEROLOGY, V160, P2608, DOI 10.1053/j.gastro.2021.02.063; Leonard MM, 2017, JAMA-J AM MED ASSOC, V318, P647, DOI 10.1001/jama.2017.9730; Mohammed AD, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02484; Molberg O, 1998, NAT MED, V4, P713, DOI 10.1038/nm0698-713; Nakajima A, 2018, J EXP MED, V215, P2019, DOI 10.1084/jem.20180427; Pecora F, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00957; Petersen J, 2020, NAT STRUCT MOL BIOL, V27, P49, DOI 10.1038/s41594-019-0353-4; Peterson DA, 2007, CELL HOST MICROBE, V2, P328, DOI 10.1016/j.chom.2007.09.013; Poddighe D, 2020, WORLD J GASTROENTERO, V26, P1365, DOI 10.3748/wjg.v26.i12.1365; RICKERT RC, 1995, NATURE, V376, P352, DOI 10.1038/376352a0; Sanchez D, 2021, MICROORGANISMS, V9, DOI 10.3390/microorganisms9030547; Shahin RY, 2020, CENT EUR J IMMUNOL, V45, P184, DOI 10.5114/ceji.2020.97907; Simons M, 2018, AM J MED, V131, P83, DOI 10.1016/j.amjmed.2017.07.021; Smeekens JM, 2021, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.599637; Swain S, 2019, J TRANSL AUTOIMMUN, V2, DOI 10.1016/j.jtauto.2019.100025; Taraghikhah N, 2020, BMC GASTROENTEROL, V20, DOI 10.1186/s12876-020-01390-0; Torsten M, 2018, FRONT PEDIATR, V6, DOI 10.3389/fped.2018.00389; Uhde M, 2020, GASTROENTEROLOGY, V159, P1965, DOI 10.1053/j.gastro.2020.07.032; Yu J, 2015, J BIOL CHEM, V290, P19081, DOI 10.1074/jbc.M115.643338; Zoetendal EG, 2012, ISME J, V6, P1415, DOI 10.1038/ismej.2011.212	64	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264977	10.1371/journal.pone.0264977	http://dx.doi.org/10.1371/journal.pone.0264977			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324937	gold, Green Published			2022-12-26	WOS:000780951300026
J	Deb, LC; Hove, H; Miller, T; Pinks, K; Njau, G; Hagan, J; Jansen, R				Chandra Deb, Liton; Hove, Hannah; Miller, Tracy K.; Pinks, Kodi; Njau, Grace; Hagan, John; Jansen, Rick J.			Epidemiology of Hepatitis C virus infection among incarcerated populations in North Dakota	PLOS ONE			English	Article							UNITED-STATES; PREVALENCE; PRISONERS; INMATES; CARE; HIV	This retrospective cohort study was conducted to determine the prevalence of HCV infections among individuals incarcerated in a state prison system and identify potential contributing factors to HCV infection. North Dakota Department of Corrections and Rehabilitation (NDDOCR) data from 2009 to 2018 was used and period prevalence was calculated for this 10-year time period. The period prevalence of HCV infection was (15.13% (95% CI 14.39-15.90) with a marginally significant (p-value: 0.0542) increasing linear trend in annual prevalence over this period. Multivariate logistic regression analysis was used to identify risk factors associated with HCV infection. The main significant independent risk factors for HCV infection in this incarcerated population were age >40 years [OR: 1.78 (1.37-2.32)]; sex [OR: 1.21 (1.03-1.43)]; race/ethnicity [OR: 1.97 (1.69-2.29)]; history of intravenous drug use (IVDU) [OR: 7.36 (6.41-8.44)]; history of needle or syringe sharing [OR: 7.57 (6.62-8.67)]; and alcohol use [OR: 0.87 (0.77-0.99)]. Study limitations include uncollected information on sexual history, frequency or duration of injection drug use and blood transfusion history of the incarcerated population. Considering the high prevalence of HCV infection and its associated risk factors, it is important to implement prevention programs such as syringe/needle exchanges and counsel with imprisoned IVD users.	[Chandra Deb, Liton; Hove, Hannah; Jansen, Rick J.] North Dakota State Univ, Dept Publ Hlth, Fargo, ND USA; [Chandra Deb, Liton] North Carolina State Univ, Coll Vet Med, Dept Populat Hlth & Pathobiol, Raleigh, NC USA; [Hove, Hannah] Univ North Dakota, Sch Med & Hlth Sci, Grand Forks, ND USA; [Miller, Tracy K.; Pinks, Kodi; Njau, Grace] North Dakota Dept Hlth, Bismarck, ND USA; [Hagan, John] North Dakota Dept Correct & Rehabil, Bismarck, ND USA; [Jansen, Rick J.] North Dakota State Univ, Genom Phen & Bioinformat Program, Fargo, ND USA; [Jansen, Rick J.] North Dakota State Univ, Ctr Immunizat Res & Educ CIRE, Fargo, ND USA; [Jansen, Rick J.] North Dakota State Univ, Ctr Diagnost & Therapeut Strategies Pancreat Canc, Fargo, ND USA	North Dakota State University Fargo; University of North Carolina; North Carolina State University; University of North Dakota Grand Forks; North Dakota State University Fargo; North Dakota State University Fargo; North Dakota State University Fargo	Jansen, R (corresponding author), North Dakota State Univ, Dept Publ Hlth, Fargo, ND USA.; Jansen, R (corresponding author), North Dakota State Univ, Genom Phen & Bioinformat Program, Fargo, ND USA.; Jansen, R (corresponding author), North Dakota State Univ, Ctr Immunizat Res & Educ CIRE, Fargo, ND USA.; Jansen, R (corresponding author), North Dakota State Univ, Ctr Diagnost & Therapeut Strategies Pancreat Canc, Fargo, ND USA.	rick.jansen@ndsu.edu	Chandra Deb, Liton/HHN-7213-2022	Chandra Deb, Liton/0000-0003-3018-988X	Department of Health and Human Services [G17.1102]	Department of Health and Human Services	The authors thank the North Dakota Department of Corrections and Rehabilitation (NDDOCR) and North Dakota Department of Health (NDDoH) for data management.	[Anonymous], N AM SYRINGE EXCHANG; Backus LI, 2014, AM J PUBLIC HEALTH, V104, pS555, DOI 10.2105/AJPH.2014.302090; Behzadifar M, 2018, HARM REDUCT J, V15, DOI 10.1186/s12954-018-0231-0; Binswanger IA, 2012, ADDICT SCI CLIN PRAC, V7, DOI 10.1186/1940-0640-7-3; Centers for Disease Control and Prevention (CDC), 2003, MMWR Recomm Rep, V52, P1; Cotter Thomas G, 2018, Clin Liver Dis (Hoboken), V12, P170, DOI 10.1002/cld.739; Ditah I, 2014, J HEPATOL, V60, P691, DOI 10.1016/j.jhep.2013.11.014; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Edlin BR, 2015, HEPATOLOGY, V62, P1353, DOI 10.1002/hep.27978; Fiore V, 2021, INT J DRUG POLICY, V90, DOI 10.1016/j.drugpo.2020.103055; Forde KA, 2014, CLIN GASTROENTEROL H, V12, P738, DOI 10.1016/j.cgh.2013.06.006; Fox RK, 2005, CLIN INFECT DIS, V41, P177, DOI 10.1086/430913; Hammett TM, 2002, AM J PUBLIC HEALTH, V92, P1789, DOI 10.2105/AJPH.92.11.1789; He TH, 2016, ANN INTERN MED, V164, P84, DOI 10.7326/M15-0617; Hofmeister MG, 2019, HEPATOLOGY, V69, P1020, DOI 10.1002/hep.30297; Kaffashian A., 2011, J ISFAHAN MED SCH, V28; Khajedaluee M, 2016, HEPAT MON, V16, DOI 10.5812/hepatmon.31541; Kronfli N, 2018, INT J DRUG POLICY, V57, P95, DOI 10.1016/j.drugpo.2018.04.003; Kwon JA, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245896; Larney S, 2014, AM J PUBLIC HEALTH, V104, pE69, DOI 10.2105/AJPH.2014.301943; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Ly KN, 2016, CLIN INFECT DIS, V62, P1287, DOI 10.1093/cid/ciw111; Macalino GE, 2004, AM J PUBLIC HEALTH, V94, P1218, DOI 10.2105/AJPH.94.7.1218; Miller ER, 2009, INT J INFECT DIS, V13, P201, DOI 10.1016/j.ijid.2008.06.011; Mohamed AA, 2015, WORLD J HEPATOL, V7, P2676, DOI 10.4254/wjh.v7.i26.2676; Moore KJ, 2019, J INFECT PUBLIC HEAL, V12, P32, DOI 10.1016/j.jiph.2018.08.003; Puga MAM, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169195; de la Hoya PS, 2011, EUR J CLIN MICROBIOL, V30, P857, DOI 10.1007/s10096-011-1166-5; Schiff ER, 1997, HEPATOLOGY, V26, pS39, DOI 10.1002/hep.510260707; Seeff LB, 2000, ANN INTERN MED, V132, P105, DOI 10.7326/0003-4819-132-2-200001180-00003; Semaille C, 2013, Euro Surveill, V18, DOI 10.2807/1560-7917.ES2013.18.28.20524; Solomon L, 2004, J URBAN HEALTH, V81, P25, DOI 10.1093/jurban/jth085; Spradling PR, 2012, CLIN INFECT DIS, V55, P1047, DOI 10.1093/cid/cis616; Vescio MF, 2008, J EPIDEMIOL COMMUN H, V62, P305, DOI 10.1136/jech.2006.051599; Zampino R, 2015, WORLD J HEPATOL, V7, P2323, DOI 10.4254/wjh.v7.i21.2323	35	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266047	10.1371/journal.pone.0266047	http://dx.doi.org/10.1371/journal.pone.0266047			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349606	Green Published, gold			2022-12-26	WOS:000783906500003
J	Chen, ZB; Xiong, H; Shen, H; You, QS				Chen, Zhubei; Xiong, Hui; Shen, Hao; You, Qingsheng			Autophagy characteristics and establishment of autophagy prognostic models in lung adenocarcinoma and lung squamous cell carcinoma	PLOS ONE			English	Article							TUMOR MICROENVIRONMENT; CANCER; EXPRESSION; MUTATIONS	BackgroundNon-small cell lung cancer (NSCLC), which makes up the majority of lung cancers, remains one of the deadliest malignancies in the world. It has a poor prognosis due to its late detection and lack of response to chemoradiaiton. Therefore, it is urgent to find a new prognostic marker. MethodsWe evaluated biological function and immune cell infiltration in lung adenocarcinoma (LUAD) and lung squamous cell carcinoma (LUSC) patients from TCGA and GEO databases between different clusters based on autophagy related hub genes. Autophagy scores were used to assess the degree of autophagy in each individual by using component analysis. ResultsThree different clusters were obtained. Gene set variation analysis, single-sample gene set enrichment analysis and survive analysis showed differences among these three clusters. We demonstrated that the autophagy score of each patient could predict tumor stage and prognosis. Patients with a high autophagy score had a better prognosis, higher immune infiltration, and were more sensitive to immunotherapy and conventional chemotherapy. ConclusionIt was uncovered that autophagy played an irreplaceable role in NSCLC. Quantified autophagy scores for each NSCLC patient would help guide effective treatment strategies.	[Chen, Zhubei; Xiong, Hui; Shen, Hao; You, Qingsheng] Nantong Univ, Dept Cardiothorac Surg, Affiliated Hosp, Nantong, Peoples R China; [Chen, Zhubei; Xiong, Hui; Shen, Hao] Nantong Univ, Med Sch, Nantong, Peoples R China	Nantong University; Nantong University	You, QS (corresponding author), Nantong Univ, Dept Cardiothorac Surg, Affiliated Hosp, Nantong, Peoples R China.	yqscy@126.com						An JY, 2015, BIOINFORMATICS, V31, P1463, DOI 10.1093/bioinformatics/btu842; Buchbinder EI, 2016, AM J CLIN ONCOL-CANC, V39, P98, DOI 10.1097/COC.0000000000000239; Cai JC, 2018, NAT CELL BIOL, V20, P465, DOI 10.1038/s41556-018-0065-8; Charoentong P, 2017, CELL REP, V18, P248, DOI 10.1016/j.celrep.2016.12.019; Chen SL, 2019, PEERJ, V7, DOI 10.7717/peerj.7873; Chen Y, 2021, AM J TRANSL RES, V13, P1051; Deng ZM, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08331-4; Huang YF, 2020, MED SCI MONITOR, V26, DOI 10.12659/MSM.919786; Jin SK, 2001, J CELL SCI, V114, P4139; La Fleur L, 2019, LUNG CANCER, V130, P50, DOI 10.1016/j.lungcan.2019.01.003; Levine B, 2007, NATURE, V446, P745, DOI 10.1038/446745a; Li M, 2021, J CANCER, V12, P2582, DOI 10.7150/jca.52454; Li SS, 2020, ONCOL LETT, V20, DOI 10.3892/ol.2020.12143; Liu D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.663495; Liu GB, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020367; Liu JH, 2020, INT IMMUNOPHARMACOL, V88, DOI 10.1016/j.intimp.2020.106884; Liu Quan, 2008, Ai Zheng, V27, P25; Lu MZ, 2021, BMC CANCER, V21, DOI 10.1186/s12885-021-08308-3; Ma F, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-03200-7; MacDonagh L, 2018, CANCER LETT, V428, P117, DOI 10.1016/j.canlet.2018.04.008; Mah LY, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008821; Mihailidis V, 2018, J THORAC DIS, V10, P5435, DOI 10.21037/jtd.2018.08.139; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Mogi A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/583929; Nasim F, 2019, MED CLIN N AM, V103, P463, DOI 10.1016/j.mcna.2018.12.006; Perera R, 2015, NATURE, V524, P361, DOI 10.1038/nature14587; Qin N, 2020, THERANOSTICS, V10, P11264, DOI 10.7150/thno.47039; Schaeffer V, 2012, BRAIN, V135, P2169, DOI 10.1093/brain/aws143; Song CK, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.01300; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Sun GT, 2021, WORLD J SURG ONCOL, V19, DOI 10.1186/s12957-021-02246-x; Wang Q, 2021, J INFLAMM RES, V14, P461, DOI 10.2147/JIR.S299298; Xiao GL, 2021, AGING-US, V13, P13239, DOI 10.18632/aging.203008; Xie KP, 2016, INT J CANCER, V139, P1564, DOI 10.1002/ijc.30205; Yang D, 2019, BIOMED PHARMACOTHER, V120, DOI 10.1016/j.biopha.2019.109433; Yi M, 2021, CANCER IMMUNOL IMMUN, V70, P1705, DOI 10.1007/s00262-020-02817-z; Yu Y, 2020, MEDICINE, V99, DOI 10.1097/MD.0000000000020183; Zhang LH, 2021, FRONT MOL BIOSCI, V8, DOI 10.3389/fmolb.2021.607090; Zhang XZ, 2020, J CANCER, V11, P3124, DOI 10.7150/jca.38057; Zhang XN, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/8864436; Zhao TY, 2021, CANCER CELL INT, V21, DOI 10.1186/s12935-021-01965-1; Zhu J, 2020, PEERJ, V8, DOI 10.7717/peerj.8288	43	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266070	10.1371/journal.pone.0266070	http://dx.doi.org/10.1371/journal.pone.0266070			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333893	Green Published, gold			2022-12-26	WOS:000784335700041
J	Duarte, INH; Bessa, AFD; Rola, LD; Genuino, MVH; Rocha, IM; Marcondes, CR; Regitano, LCD; Munari, DP; Berry, DP; Buzanskas, ME				Herculano Duarte, Igor Nelson; de Oliveira Bessa, Ayrton Fernandes; Rola, Luciana Diniz; Henrique Genuino, Maria Victoria; Rocha, Iasmin Marques; Marcondes, Cintia Righetti; de Almeida Regitano, Luciana Correia; Munari, Danisio Prado; Berry, Donagh Pearse; Buzanskas, Marcos Eli			Cross-population selection signatures in Canchim composite beef cattle	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; POSITIVE SELECTION; TARGET GENE; IDENTIFICATION; POLYMORPHISM; TRAITS; STRESS; SCAN	Analyses of livestock genomes have been used to detect selection signatures, which are genomic regions associated with traits under selection leading to a change in allele frequency. The objective of the present study was to characterize selection signatures in Canchim composite beef cattle using cross-population analyses with the founder Nelore and Charolais breeds. High-density single nucleotide polymorphism genotypes were available on 395 Canchim representing the target population, along with genotypes from 809 Nelore and 897 Charolais animals representing the reference populations. Most of the selection signatures were co-located with genes whose functions agree with the expectations of the breeding programs; these genes have previously been reported to associate with meat quality, as well as reproductive traits. Identified genes were related to immunity, adaptation, morphology, as well as behavior, could give new perspectives for understanding the genetic architecture of Canchim. Some selection signatures identified genes that were recently introduced in Canchim, such as the loci related to the polled trait.	[Herculano Duarte, Igor Nelson; de Oliveira Bessa, Ayrton Fernandes; Rola, Luciana Diniz; Henrique Genuino, Maria Victoria; Rocha, Iasmin Marques; Buzanskas, Marcos Eli] Univ Fed Paraiba, Dept Zootecnia, Areia, Paraiba, Brazil; [Marcondes, Cintia Righetti; de Almeida Regitano, Luciana Correia] Embrapa Southeast Livestock, Sao Carlos, SP, Brazil; [Munari, Danisio Prado] Univ Estadual Paulista, Dept Engn & Ciencias Exatas, Jaboticabal, SP, Brazil; [Berry, Donagh Pearse] TEAGASC, Anim & Grassland Res & Innovat Ctr, Moorepark, Cork, Ireland	Universidade Federal da Paraiba; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA); Universidade Estadual Paulista; Teagasc	Buzanskas, ME (corresponding author), Univ Fed Paraiba, Dept Zootecnia, Areia, Paraiba, Brazil.	marcosbuz@gmail.com	Munari, Danisio P/C-6384-2012; Buzanskas, Marcos Eli/C-8147-2012	Munari, Danisio P/0000-0001-6915-038X; Buzanskas, Marcos Eli/0000-0002-2728-079X	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) [001]; National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil); CNPq [430379/2018-8]; Produtividade em Pesquisa PROPESQ/PRPG/UFPB [PVN13100-2020]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Produtividade em Pesquisa PROPESQ/PRPG/UFPB	Ayrton Fernandes de Oliveira Bessa received a scholarship from the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior Brasil (CAPES) - Finance Code 001. Marcos Eli Buzanskas, Luciana Correia de Almeida Regitano, and Danisio Prado Munari helds productivity research fellowship from the National Council for Scientific and Technological Development (Conselho Nacional de Desenvolvimento Cientifico e Tecnologico, CNPq, Brazil). This study was financially supported by CNPq (project number 430379/2018-8) and by the Public Call n. 01/2021 Produtividade em Pesquisa PROPESQ/PRPG/UFPB (proposal code PVN13100-2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alencar MM., 1988, BOVINORAA CANCHIM OR; Beiki H, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-3176-2; Ben-Jemaa S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76576-3; Browning BL, 2009, AM J HUM GENET, V84, P210, DOI 10.1016/j.ajhg.2009.01.005; Buzanskas ME, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171660; Cai ZZ, 2020, GENET SEL EVOL, V52, DOI 10.1186/s12711-020-00538-6; Campos GS, 2020, J ANIM BREED GENET, V137, P449, DOI 10.1111/jbg.12458; Capitan A, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-33; Cardoso DF, 2018, GENET SEL EVOL, V50, DOI 10.1186/s12711-018-0381-2; Ceriani MF, 1999, SCIENCE, V285, P553, DOI 10.1126/science.285.5427.553; Chai ZX, 2020, BMC EVOL BIOL, V20, DOI 10.1186/s12862-020-01702-8; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen YB, 2020, J CONTEMP CHINA, V29, P1, DOI [10.1080/01932691.2020.1791172, 10.1080/10670564.2019.1621526]; Coleman DN, 2020, J ANIM SCI, V98, pS175, DOI 10.1093/jas/skaa138; Crespo-Piazuelo D, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70894-2; Daneshvar H, 2018, IRAN J PARASITOL, V13, P515; Neto FRD, 2020, REPROD DOMEST ANIM, V55, P1565, DOI 10.1111/rda.13811; De Leon C, 2019, GENET MOL RES, V18, DOI 10.4238/gmr18373; de Lima AO, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00189; Dias MM, 2015, GENET MOL RES, V14, P234, DOI 10.4238/2015.January.16.7; Ding RR, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00619; Diniz WJS, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00210; dos Santos FC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0169163; Embrapa, 2020, REL TOUR CANCH MA CH; Evans LM, 2014, NAT GENET, V46, P1089, DOI 10.1038/ng.3075; Flori L, 2014, MOL ECOL, V23, P3241, DOI 10.1111/mec.12816; Foger N, 2011, J EXP MED, V208, P1777, DOI 10.1084/jem.20101757; Fortes MRS, 2018, ANIM GENET, V49, P539, DOI 10.1111/age.12721; Franzin AM, 2017, PARASITE VECTOR, V10, DOI 10.1186/s13071-016-1945-z; Gao YH, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3636-3; Gautier M, 2017, MOL ECOL RESOUR, V17, P78, DOI 10.1111/1755-0998.12634; Guan DL, 2016, SCI REP-UK, V6, DOI 10.1038/srep36372; Gutierrez-Gil B, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-56; Gutierrez-Gil B, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00167; Hoglund JK, 2015, BMC GENET, V16, DOI 10.1186/s12863-015-0269-x; Jiang Y, 2020, ASIAN AUSTRAL J ANIM, V33, P1400, DOI 10.5713/ajas.19.0411; Kamprath K, 2009, GENES BRAIN BEHAV, V8, P203, DOI 10.1111/j.1601-183X.2008.00463.x; Khayatzadeh N, 2019, J DAIRY SCI, V102, P11217, DOI 10.3168/jds.2019-16899; Leal-Gutierrez JD, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5518-3; Leal-Gutierrez JD, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00532; Li BJ, 2018, BMC GENOMICS, V19, DOI 10.1186/s12864-018-4747-1; Li C, 2016, SCI REP-UK, V6, DOI 10.1038/srep26813; Liu XF, 2021, EVOL APPL, V14, P860, DOI 10.1111/eva.13168; Makina SO, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0173-x; Mallikarjunappa S, 2018, J DAIRY SCI, V101, P7280, DOI 10.3168/jds.2018-14388; Marcondes CR., 2018, ANAIS CONVEN O NACL, V1st ed, P68; Mariasegaram M, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-370; Medugorac I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039477; Moe M, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-405; Mokry FB, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-47; Mota RR, 2017, J ANIM BREED GENET, V134, P484, DOI 10.1111/jbg.12299; Mukiibi R, 2019, J ANIM SCI, V97, P4386, DOI 10.1093/jas/skz315; Nani JP, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-6758-y; Naserkheil M, 2020, ANIMALS-BASEL, V10, DOI 10.3390/ani10101836; Neupane M, 2018, ANIM GENET, V49, P527, DOI 10.1111/age.12718; Nonneman DJ, 2013, J ANIM SCI, V91, P4043, DOI 10.2527/jas.2013-6255; Pant SD, 2016, LIVEST SCI, V187, P40, DOI 10.1016/j.livsci.2016.02.006; Patel AK, 2013, GENOMICS, V101, P57, DOI 10.1016/j.ygeno.2012.10.001; Penagaricano F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072302; Qanbari S, 2010, ANIM GENET, V41, P377, DOI 10.1111/j.1365-2052.2009.02016.x; R Core Team, 2021, R LANGUAGE ENV STAT; Ramayo-Caldas Y, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0216-y; Richardson IW, 2016, GENET SEL EVOL, V48, DOI 10.1186/s12711-016-0197-x; Riley DG, 2020, LIVEST SCI, V233, DOI 10.1016/j.livsci.2020.103943; Rodriguez-Valera Y, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-29453-z; Rosen BD, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giaa021; Saatchi M, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1004; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Salleh SM., 2018, J GENETICS GENOME RE, V5, P1, DOI [10.23937/2378-3648/1410035, DOI 10.23937/2378-3648/1410035]; Sarakul M, 2018, ANIM REPROD SCI, V197, P324, DOI 10.1016/j.anireprosci.2018.09.002; Seong J, 2016, GENES GENOM, V38, P529, DOI 10.1007/s13258-016-0401-y; Silva DO., 2018, EST ASS GENM HAB PER; Silva-Vignato B, 2017, BMC GENOMICS, V18, DOI 10.1186/s12864-017-3897-x; Somavilla AL, 2014, ANIM GENET, V45, P771, DOI 10.1111/age.12210; Srikanth K, 2017, CELL STRESS CHAPERON, V22, P29, DOI 10.1007/s12192-016-0739-8; Stafuzza NB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202978; Sun T, 2020, GIGASCIENCE, V9, DOI 10.1093/gigascience/giz166; Takasuga A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005433; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; Taye M, 2017, ANIM SCI J, V88, P1889, DOI 10.1111/asj.12851; Thomsen B, 2010, NEUROGENETICS, V11, P175, DOI 10.1007/s10048-009-0214-0; Tizioto PC, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-014-0083-3; Urbinati I, 2016, J ANIM SCI BIOTECHNO, V7, DOI 10.1186/s40104-016-0089-5; Walker BN, 2020, BIOL REPROD, V102, P784, DOI 10.1093/biolre/ioaa015; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Wilcox AG, 2017, J BIOL RHYTHM, V32, P433, DOI 10.1177/0748730417722631; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu LY, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-53274-3; Yamashita-Sugahara Y, 2013, J BIOL CHEM, V288, P4522, DOI 10.1074/jbc.M112.440792; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966; Yudin NS, 2017, BMC GENET, V18, DOI 10.1186/s12863-017-0580-9; Zhao FP, 2015, GENET SEL EVOL, V47, DOI 10.1186/s12711-015-0127-3; Zucchelli M, 2009, INFLAMM BOWEL DIS, V15, P1562, DOI 10.1002/ibd.20963	94	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264279	10.1371/journal.pone.0264279	http://dx.doi.org/10.1371/journal.pone.0264279			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363779	Green Published, gold			2022-12-26	WOS:000804748600025
J	Kasneci, E; Kasneci, G; Trautwein, U; Appel, T; Tibus, M; Jaeggi, SM; Gerjets, P				Kasneci, Enkelejda; Kasneci, Gjergji; Trautwein, Ulrich; Appel, Tobias; Tibus, Maike; Jaeggi, Susanne M.; Gerjets, Peter			Do your eye movements reveal your performance on an IQ test? A study linking eye movements and socio-demographic information to fluid intelligence	PLOS ONE			English	Article							WORKING-MEMORY; CRYSTALLIZED INTELLIGENCE; INDIVIDUAL-DIFFERENCES; PUPIL DIAMETER; ATTENTION; BRAIN; MICROSACCADES; MOTIVATION; RESPONSES; CAPACITY	Understanding the main factors contributing to individual differences in fluid intelligence is one of the main challenges of psychology. A vast body of research has evolved from the theoretical framework put forward by Cattell, who developed the Culture-Fair IQ Test (CFT 20-R) to assess fluid intelligence. In this work, we extend and complement the current state of research by analysing the differential and combined relationship between eye-movement patterns and socio-demographic information and the ability of a participant to correctly solve a CFT item. Our work shows that a participant's eye movements while solving a CFT item contain discriminative information and can be used to predict whether the participant will succeed in solving the test item. Moreover, the information related to eye movements complements the information provided by socio-demographic data when it comes to success prediction. In combination, both types of information yield a significantly higher predictive performance than each information type individually. To better understand the contributions of features related to eye movements and socio-demographic information to predict a participant's success in solving a CFT item, we employ state-of-the-art explainability techniques and show that, along with socio-demographic variables, eye-movement data. Especially the number of saccades and the mean pupil diameter, significantly increase the discriminating power. The eye-movement features are likely indicative of processing efficiency and invested mental effort. Beyond the specific contribution to research on how eye movements can serve as a means to uncover mechanisms underlying cognitive processes, the findings presented in this work pave the way for further in-depth investigations of factors predicting individual differences in fluid intelligence.	[Kasneci, Enkelejda] Univ Tubingen, Dept Comp Sci, Human Comp Interact, Tubingen, Germany; [Kasneci, Gjergji] Univ Tubingen, Dept Comp Sci, Data Sci & Analyt, Tubingen, Germany; [Trautwein, Ulrich; Appel, Tobias; Tibus, Maike] Univ Tubingen, Hector Res Inst Educ Sci & Psychol, Tubingen, Germany; [Jaeggi, Susanne M.] Univ Calif Irvine, Sch Educ, Irvine, CA USA; [Gerjets, Peter] Leibniz Inst Wissensmed, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of California System; University of California Irvine; Leibniz Institut fur Wissensmedien	Kasneci, E (corresponding author), Univ Tubingen, Dept Comp Sci, Human Comp Interact, Tubingen, Germany.	Enkelejda.Kasneci@uni-tuebingen.de		Kasneci, Gjergji/0000-0002-3123-7268	LEAD Graduate School \& Research Network [GSC1028]; Machine Learning Cluster of Excellence, EXC [2064/1, 390727645]	LEAD Graduate School \& Research Network; Machine Learning Cluster of Excellence, EXC	This research was supported as part of the LEAD Graduate School \& Research Network [GSC1028], which was funded within the framework of the Excellence Initiative of the German federal and state governments. Enkelejda Kasneci is a member of the Machine Learning Cluster of Excellence, EXC number 2064/1 Project number 390727645.	AHERN S, 1979, SCIENCE, V205, P1289, DOI 10.1126/science.472746; Appel T, 2021, IEEE T AFFECT COMPUT; Appel T, 2019, ICMI'19: PROCEEDINGS OF THE 2019 INTERNATIONAL CONFERENCE ON MULTIMODAL INTERACTION, P154, DOI 10.1145/3340555.3353735; Appel T, 2018, 2018 ACM SYMPOSIUM ON EYE TRACKING RESEARCH & APPLICATIONS (ETRA 2018), DOI 10.1145/3204493.3204531; Bavelier D, 2012, ANNU REV NEUROSCI, V35, P391, DOI 10.1146/annurev-neuro-060909-152832; BETHELLFOX CE, 1984, INTELLIGENCE, V8, P205, DOI 10.1016/0160-2896(84)90009-6; Borisov V., 2021, COMPUTERS HUMAN BEHA, V4, DOI [10.1016/j.chbr.2021.100116, DOI 10.1016/J.CHBR.2021.100116]; Bornemann B, 2010, ZDM-MATH EDUC, V42, P555, DOI 10.1007/s11858-010-0253-x; Brito NH, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00276; Castner N., 2018, P 2018 ACM S EYE TRA, P1; Castner N, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0223941; Castro J, 2009, COMPUT OPER RES, V36, P1726, DOI 10.1016/j.cor.2008.04.004; CATTELL RB, 1963, J EDUC PSYCHOL, V54, P1, DOI 10.1037/h0046743; Chen SY, 2014, HUM-COMPUT INTERACT, V29, P390, DOI 10.1080/07370024.2014.892428; Chen T., 2016, KDD16 P 22 ACM, DOI DOI 10.1145/2939672.2939785; Conway ARA, 2002, INTELLIGENCE, V30, P163, DOI 10.1016/S0160-2896(01)00096-4; Curie A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149717; Deckers T, 2017, SOCIOECONOMIC STATUS; Donaldson SI, 2002, J BUS PSYCHOL, V17, P245, DOI 10.1023/A:1019637632584; Duckworth AL, 2011, P NATL ACAD SCI USA, V108, P7716, DOI 10.1073/pnas.1018601108; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Fatima SS, 2008, ARTIF INTELL, V172, P1673, DOI 10.1016/j.artint.2008.05.003; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gao H, 2021, EMICS 21; Gottfredson LS, 1997, INTELLIGENCE, V24, P79, DOI 10.1016/S0160-2896(97)90014-3; Hackman DA, 2010, NAT REV NEUROSCI, V11, P651, DOI 10.1038/nrn2897; Hafed ZM, 2002, VISION RES, V42, P2533, DOI 10.1016/S0042-6989(02)00263-8; Halford GS, 2007, TRENDS COGN SCI, V11, P236, DOI 10.1016/j.tics.2007.04.001; Haug J, 2021, ARXIV PREPRINT ARXIV; Hayes TR, 2016, J COGNITIVE NEUROSCI, V28, P308, DOI 10.1162/jocn_a_00895; Hayes TR, 2015, INTELLIGENCE, V48, P1, DOI 10.1016/j.intell.2014.10.005; Hayes TR, 2011, J VISION, V11, DOI 10.1167/11.10.10; He J, 2010, ATTEN PERCEPT PSYCHO, V72, P308, DOI 10.3758/APP.72.2.308; Hill BD, 2018, APPL NEUROPSYCH-ADUL, V25, P312, DOI 10.1080/23279095.2018.1458502; Hillman CH, 2008, NAT REV NEUROSCI, V9, P58, DOI 10.1038/nrn2298; Houtkamp R, 2006, J EXP PSYCHOL HUMAN, V32, P423, DOI 10.1037/0096-1523.32.2.423; Irwin D.E., 2010, MACQUARIE MONOGRAPHS, P121; Jaeggi SM, 2008, P NATL ACAD SCI USA, V105, P6829, DOI 10.1073/pnas.0801268105; Kasneci E, 2020, **DATA OBJECT**, DOI [10.7910/DVN/JGOCKI, DOI 10.7910/DVN/JGOCKI]; Kasneci E, 2021, SCI DATA, V8, DOI 10.1038/s41597-021-00938-3; Kaufman AS, 2009, ARCH CLIN NEUROPSYCH, V24, P153, DOI 10.1093/arclin/acp015; Krejtz K, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203629; Kubler TC, 2017, BEHAV RES METHODS, V49, P1048, DOI 10.3758/s13428-016-0765-6; Kuncheva LI, 2003, MACH LEARN, V51, P181, DOI 10.1023/A:1022859003006; Lang FB, 2020, INT J SCI EDUC, V42, P350, DOI 10.1080/09500693.2019.1710875; Laurence PG, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.00380; Leigh J.R., 2015, NEUROLOGY EYE MOVEME, Vfifth, DOI DOI 10.1093/MED/9780199969289.001.0001; Logie R, 2018, J APPL RES MEM COGN, V7, P471; Lundberg S.M, 2018, CONSISTENT INDIVIDUA; Lundberg SM, 2017, ADV NEUR IN, V30; Meghanathan RN, 2015, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.01063; Murphy R, 2011, J PSYCHOL AFR, V21, P91, DOI 10.1080/14330237.2011.10820433; Pawelczyk M, 2021, ARXIV PREPRINT ARXIV; Pawelczyk M, 2020, WEB CONFERENCE 2020: PROCEEDINGS OF THE WORLD WIDE WEB CONFERENCE (WWW 2020), P3126, DOI 10.1145/3366423.3380087; Ribeiro MT, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P1135, DOI 10.1145/2939672.2939778; Rindermann H, 2010, LEARN INDIVID DIFFER, V20, P544, DOI 10.1016/j.lindif.2010.07.002; Rokach L, 2010, ARTIF INTELL REV, V33, P1, DOI 10.1007/s10462-009-9124-7; Salvucci D.D., 2000, P 2000 S EYE TRACK R, P71, DOI [10.1145/355017.355028, DOI 10.1145/355017.355028]; Sargezeh BA, 2019, EXP BRAIN RES, V237, P15, DOI 10.1007/s00221-018-5392-2; Scharinger C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130608; Shapley Lloyd S., 1953, CONTRIBUTIONS THEORY, P307, DOI [10.3390/atmos10110723, DOI 10.1515/9781400881970-018]; Sheppard LD, 2008, PERS INDIV DIFFER, V44, P535, DOI 10.1016/j.paid.2007.09.015; Siegenthaler E, 2014, EUR J NEUROSCI, V39, P287, DOI 10.1111/ejn.12395; Sigman M, 1997, INFANT BEHAV DEV, V20, P133, DOI 10.1016/S0163-6383(97)90016-3; Slevc LR, 2016, COGNITION, V152, P199, DOI 10.1016/j.cognition.2016.03.017; Snow RE., 1980, APTITUDE LEARNING IN, V1, P27; SoSci, 2019, SOSCI SURV SOL PROF; Troncoso XG, 2008, J VISION, V8, DOI 10.1167/8.14.15; Tsukahara JS, 2016, COGNITIVE PSYCHOL, V91, P109, DOI 10.1016/j.cogpsych.2016.10.001; Vakil E, 2012, RES DEV DISABIL, V33, P645, DOI 10.1016/j.ridd.2011.11.009; Valsecchi M, 2009, PSYCHOL RES-PSYCH FO, V73, P23, DOI 10.1007/s00426-008-0142-x; Van der Meer E, 2010, PSYCHOPHYSIOLOGY, V47, P158, DOI 10.1111/j.1469-8986.2009.00884.x; van der Wel P, 2018, PSYCHON B REV, V25, P2005, DOI 10.3758/s13423-018-1432-y; Vigneau F, 2006, INTELLIGENCE, V34, P261, DOI 10.1016/j.intell.2005.11.003; Vista AD, 2010, J PSYCHOEDUC ASSESS, V28, P236, DOI 10.1177/0734282909344416; Waris O, 2019, COMPUT HUM BEHAV, V97, P94, DOI 10.1016/j.chb.2019.03.005; Watanabe M, 2013, J NEUROPHYSIOL, V110, P522, DOI 10.1152/jn.01096.2012; Wei&beta; R.H., 2006, CFT 20 R GRUNDINTELL; Willeke KF, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11711-x; Zhang Q, 2019, DEVELOPMENTAL SCI, V22, DOI 10.1111/desc.12748	80	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264316	10.1371/journal.pone.0264316	http://dx.doi.org/10.1371/journal.pone.0264316			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349582	Green Submitted, Green Published, gold			2022-12-26	WOS:000783906500028
J	Pattillo, DA; Hager, JV; Cline, DJ; Roy, LA; Hanson, TR				Pattillo, D. Allen; Hager, Janelle, V; Cline, David J.; Roy, Luke A.; Hanson, Terrill R.			System design and production practices of aquaponic stakeholders	PLOS ONE			English	Article							COMMERCIAL AQUAPONICS; WHITE SHRIMP; CHALLENGES	Aquaponics is an agricultural practice incorporating aquaculture and hydroponic principles. This study assesses the current system design and production practices of the aquaponic industry, compares these metrics by stakeholder group, identifies trends, and provides recommendations for future development. An electronic survey of aquaponic stakeholders was conducted from December 2019 to June 2020 targeting hobbyists, producers, and educators from various aquaponic-focused professional associations, email and social media groups. Of 378 total responses, 84% came from the United States and were clustered in plant hardiness zones five to nine. Aquaponic systems were commonly homemade/do-it-yourself (DIY), many of which incorporated commercially available (turn-key) technology. Most growers used coupled systems that integrated recirculating aquaculture systems and either deep-water culture (DWC) or media bed hydroponic units. Common plant lighting sources were sunlight and light emitting diode (LED). Water sources were typically municipal or wells. Personal labor input was typically less than 20 hrs/wk. Funding sources were primarily personal funds, followed by government grants, and private investor funds. System sizes varied greatly, but the median area was 50 to 500 ft(2) for hobbyists and educators and 500 to 3,000 ft(2) for producers. Respondents commonly sold vegetable produce, training and education, food fish, and microgreens. Tilapia and ornamental fish were commonly grown, with 16 other species reported. Common crops were lettuce, leafy greens, basil, tomatoes, peppers, and herbs with many additional lesser-grown crops reported, including cannabis. Overall, the industry still growing, with a large portion of stakeholders having less than two years of experience. However, veteran growers have remained in operation, particularly in the producer and educator groups. The survey results suggest a shift away from outdoor systems, media beds, tomatoes, ornamental fish, and perch production, and a shift toward decoupled systems, DWC, drip irrigation, and wicking beds, larger system area, leafy greens, and trout/salmon production compared to previous industry surveys. The reduced diversity of plant species grown suggest some level of crop standardization. Commercial producers tended to sell more types of products than other stakeholders, suggesting that diversification of offerings may be key to profitability. The combined production area specified by respondents indicates the industry has grown substantially in recent years. Finally, the presence of bank loan-funded operations suggests increased knowledge and comfort with aquaponics among lenders.	[Pattillo, D. Allen] Univ Maryland, Environm Nat Resources & Sea Grant Extens, Queenstown, MD 21658 USA; [Hager, Janelle, V] Kentucky State Univ, Sch Aquaculture & Aquat Sci, Frankfort, KY USA; [Cline, David J.; Roy, Luke A.; Hanson, Terrill R.] Auburn Univ, Sch Fisheries Aquaculture & Aquat Sci, Auburn, AL 36849 USA	Kentucky State University; Auburn University System; Auburn University	Pattillo, DA (corresponding author), Univ Maryland, Environm Nat Resources & Sea Grant Extens, Queenstown, MD 21658 USA.	dapatt@umd.edu		Pattillo, David Allen/0000-0002-8929-4273; Hanson, Terrill/0000-0001-5578-5333	Agriculture and Food Research Initiative Competitive [2017-38420-26765]; USDA National Institute of Food and Agriculture; Alabama Agricultural Experiment Station	Agriculture and Food Research Initiative Competitive; USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); Alabama Agricultural Experiment Station	This project was supported by Agriculture and Food Research Initiative Competitive grant no. 2017-38420-26765 from the USDA National Institute of Food and Agriculture (TRH) and by the Alabama Agricultural Experiment Station. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, FST51 UHCTAHR; Avgoustaki DD, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12051965; Ayipio E, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11226511; Baganz G, 2020, AQUAC RES, V51, P2711, DOI 10.1111/are.14610; Bailey DS, 2017, AQUACULT REP, V7, P77, DOI 10.1016/j.aqrep.2017.06.002; Baltar F, 2012, INTERNET RES, V22, P57, DOI 10.1108/10662241211199960; Blanchard C, 2020, HORTICULTURAE, V6, DOI 10.3390/horticulturae6010010; Boxman SE, 2015, AQUACULT ENG, V69, P23, DOI 10.1016/j.aquaeng.2015.09.001; Brewer A., 2019, THESIS U MICHIGAN BR; Browne K., 2005, INT J SOC RES METHOD, V8, P47, DOI DOI 10.1080/1364557032000081663; Diver S, 2006, ATTRA NATL SUSTAINAB; Dorick J, 2021, FOOD MICROBIOL, V99, DOI 10.1016/j.fm.2021.103801; Eaves J, 2018, CAN J AGR ECON, V66, P43, DOI 10.1111/cjag.12161; Ebel R, 2020, HORTTECHNOLOGY, V30, P13, DOI 10.21273/HORTTECH04310-19; Engle CR., 2015, S REG AQUAC CTR, V5006, P1; Evans JD, 1996, STRAIGHTFORWARD STAT; FDA, 2019, ESCH COL E COL; Genello L., 2015, EUR J HEAL BIOL ED, V4, P9, DOI [10.20897/lectito.201502, DOI 10.20897/LECTITO.201502, 10.12973/ejhbe.2015.213p]; Ghamkhar R, 2020, J CLEAN PROD, V244, DOI 10.1016/j.jclepro.2019.118767; Goddek S., 2019, SPRINGER NATURE, DOI [10.1007/978-3-030-15943-6, DOI 10.1007/978-3-030-15943-6]; Goddek S, 2019, AGR SYST, V171, P143, DOI 10.1016/j.agsy.2019.01.010; Goddek S, 2015, SUSTAINABILITY-BASEL, V7, P4199, DOI 10.3390/su7044199; Greenfeld A, 2020, J ENVIRON MANAGE, V257, DOI 10.1016/j.jenvman.2019.109979; Greenfeld A, 2019, REV AQUACULT, V11, P848, DOI 10.1111/raq.12269; Hart ER, 2014, FISHERIES, V39, P525, DOI 10.1080/03632415.2014.966353; Hollyer J., 2009, FST38 UHCTAHR; Joesting HM, 2016, AQUACULT REP, V3, P108, DOI 10.1016/j.aqrep.2016.01.004; Junge R., 2014, PROC 3 CON INT PARTI, P234, DOI 10.21256/zhaw-4300; Junge R, 2017, WATER-SUI, V9, DOI 10.3390/w9030182; Kaiser C., 2016, HYDROPONIC LETTUCE C; Konig B, 2018, J CLEAN PROD, V180, P232, DOI 10.1016/j.jclepro.2018.01.037; Ku┬nig B., 2016, ECOCYCLES, V2, P26, DOI [10.19040/ecocycles.v2i1.50, DOI 10.19040/ecocycles.v2i1.50]; Kyaw TY, 2017, ENRGY PROCED, V143, P342, DOI 10.1016/j.egypro.2017.12.694; Love DC, 2015, J AGRIC FOOD SYST CO, V6, P161, DOI 10.5304/jafscd.2015.061.013; Love DC, 2015, AQUACULT ENG, V68, P19, DOI 10.1016/j.aquaeng.2015.07.003; Love DC, 2015, AQUACULTURE, V435, P67, DOI 10.1016/j.aquaculture.2014.09.023; Love DC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102662; Mariscal-Lagarda MM, 2012, AQUACULTURE, V366, P76, DOI 10.1016/j.aquaculture.2012.09.003; Monsees H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0183056; NASS, 2013, 2013 CENS AQ; NASS, 2005, 2005 CENS AQ; NASS, 2018, 2018 CENS AQ; Nelson JA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099010; Niman Ranch, 2021, NIM RANCH START ON F; Oliver LP, 2018, J WORLD AQUACULT SOC, V49, P837, DOI 10.1111/jwas.12471; Palm HW, 2018, AQUACULT INT, V26, P813, DOI 10.1007/s10499-018-0249-z; Pattillo DA, 2020, HORTTECHNOLOGY, V30, P624, DOI 10.21273/HORTTECH04655-20; Pattillo DA., AQUAPONICS IND SURVE, DOI [10.35099/aurora-92, DOI 10.35099/AURORA-92]; Pattillo DA., 2017, NCRAC TECHNICAL B; Pattillo DA., 2017, NCRAC TECHNICAL B, V123; Pickens JM, 2020, HORTICULTURAE, V6, DOI 10.3390/horticulturae6030044; Pickens JM., 2016, SO REGIONAL AQUACULT, V5008; Pickens JM., 2016, SO REGIONAL AQUACULT, V5009; Pinheiro I, 2017, ECOL ENG, V100, P261, DOI 10.1016/j.ecoleng.2016.12.024; Quagrainie Kwamena K., 2018, Journal of Applied Aquaculture, V30, P1, DOI 10.1080/10454438.2017.1414009; Rakocy JE, 2004, ACTA HORTIC, P63, DOI 10.17660/ActaHortic.2004.648.8; Semananda NPK, 2020, IRRIGATION SCI, V38, P117, DOI 10.1007/s00271-019-00651-5; Suhl J, 2016, AGR WATER MANAGE, V178, P335, DOI 10.1016/j.agwat.2016.10.013; Timmons MB., 2013, RECIRCULATING AQUACU, V3rd ed.; Tokunaga K, 2015, J WORLD AQUACULT SOC, V46, P20, DOI 10.1111/jwas.12173; Tomlinson L., 2015, SUSTAINABLE DEV LAW, V16, P16; Turnsek M, 2020, WATER-SUI, V12, DOI 10.3390/w12010306; USDA ARS, 2021, PLANT HARD ZON MAP; Villarroel M, 2016, WATER-SUI, V8, DOI 10.3390/w8100468; Xie K., 2015, 2015 ASABE ANN INT M; Xinyi District Health Center Taipei City Government, 2021, THESIS AUBURN U; Yep B, 2020, IND CROP PROD, V157, DOI 10.1016/j.indcrop.2020.112881; Yep B, 2019, J CLEAN PROD, V228, P1586, DOI 10.1016/j.jclepro.2019.04.290	68	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266475	10.1371/journal.pone.0266475	http://dx.doi.org/10.1371/journal.pone.0266475			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363828	Green Published, gold			2022-12-26	WOS:000804748600050
J	Raymond, SJ; Baker, S; Liu, YZ; Bustamante, MJ; Ley, B; Horzewski, MJ; Camarillo, DB; Cornfield, DN				Raymond, Samuel J.; Baker, Sam; Liu, Yuzhe; Bustamante, Mauricio J.; Ley, Brett; Horzewski, Michael J.; Camarillo, David B.; Cornfield, David N.			A low-cost, highly functional, emergency use ventilator for the COVID-19 crisis	PLOS ONE			English	Article							ACUTE RESPIRATORY-DISTRESS; MECHANICAL VENTILATION	Respiratory failure complicates most critically ill patients with COVID-19 and is characterized by heterogeneous pulmonary parenchymal involvement, profound hypoxemia and pulmonary vascular injury. The high incidence of COVID-19 related respiratory failure has exposed critical shortages in the supply of mechanical ventilators, and providers with the necessary skills to treat. Traditional mass-produced ventilators rely on an internal compressor and mixer to moderate and control the gas mixture delivered to a patient. However, the current emergency has energized the pursuit of alternative designs, enabling greater flexibility in supply chain, manufacturing, storage, and maintenance considerations. To achieve this, we hypothesized that using the medical gasses and flow interruption strategy would allow for a high performance, low cost, functional ventilator. A low-cost ventilator designed and built-in accordance with the Emergency Use guidance from the US Food and Drug Administration (FDA) is presented wherein pressurized medical grade gases enter the ventilator and time limited flow interruption determines the ventilator rate and tidal volume. This simple strategy obviates the need for many components needed in traditional ventilators, thereby dramatically shortening the time from storage to clinical deployment, increasing reliability, while still providing life-saving ventilatory support. The overall design philosophy and its applicability in this new crisis is described, followed by both bench top and animal testing results used to confirm the precision, safety and reliability of this low cost and novel approach to mechanical ventilation. The ventilator meets and exceeds the critical requirements included in the FDA emergency use guidelines. The ventilator has received emergency use authorization from the FDA.	[Raymond, Samuel J.; Liu, Yuzhe; Camarillo, David B.] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA; [Baker, Sam] Stanford Univ, Dept Comparat Med, Stanford, CA 94305 USA; [Bustamante, Mauricio J.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA USA; [Ley, Brett] Kaiser Pulmonol & Crit Care, Fontana, CA USA; [Horzewski, Michael J.; Camarillo, David B.] O2U Inc, Stanford, CA USA; [Camarillo, David B.] Stanford Univ, Dept Mech Engn, Stanford, CA 94305 USA; [Camarillo, David B.] Stanford Univ, Dept Neurosurg, Stanford, CA 94305 USA; [Cornfield, David N.] Stanford Univ, Dept Pediat Pulm Med, Stanford, CA 94305 USA	Stanford University; Stanford University; University of California System; University of California Berkeley; Stanford University; Stanford University; Stanford University	Raymond, SJ (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	sjray@stanford.edu		Camarillo, David/0000-0003-4965-2977	Camarillo-CZ Biohub Award-COVID-19 gift; National Institutes of Heath (NIH) [HD092316]; Camarillo COVID Research gift	Camarillo-CZ Biohub Award-COVID-19 gift; National Institutes of Heath (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Camarillo COVID Research gift	This work was funded by Camarillo-CZ Biohub Award-COVID-19 gift and the Camarillo COVID Research gift to DBC. Funding was also received from the National Institutes of Heath (NIH) to DNC, HD092316. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AAMI, 2020, EM US VENT EUV DES G; Al Husseini Abdul Mohsen, 2010, J Med Device, V4, P027514, DOI 10.1115/1.3442790; ASHBAUGH DG, 1967, LANCET, V2, P319; Branson R, 2021, CHEST, V159, P634, DOI 10.1016/j.chest.2020.09.085; Clark A, 2020, LANCET GLOB HEALTH, V8, P1003, DOI 10.1016/S2214-109X(20)30264-3; del Rio C, 2020, JAMA-J AM MED ASSOC, V323, P1339, DOI 10.1001/jama.2020.3072; Dickson RP, 2011, CRIT CARE MED, V39, P527, DOI 10.1097/CCM.0b013e318206b99b; Dobler CC, 2020, MAYO CLIN PROC, V95, P2594, DOI 10.1016/j.mayocp.2020.10.001; Edmunds J., 2020, LOW COST DIFFERENTIA; Forum W.E., 2020, VENTILATOR PRODUCTIO; Fraher EP, 2020, NEW ENGL J MED, V382, P2181, DOI 10.1056/NEJMp2006376; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Jacobs, 2020, NEW YORK TIMES; Li H., 2020, UTAH STANFORD VENTIL, P13; Matthay MA, 2019, NAT REV DIS PRIMERS, V5, DOI 10.1038/s41572-019-0069-0; Odone A, 2020, LANCET PUBLIC HEALTH, V5, pE310, DOI 10.1016/S2468-2667(20)30099-2; Pai M., 2021, WASH POST; Pastore CV, 2011, BIOL RES, V44, P219, DOI /S0716-97602011000300002; Poston JT, 2020, JAMA-J AM MED ASSOC, V323, P1839, DOI 10.1001/jama.2020.4914; Sarangi S, 2018, J ANAESTH CLIN PHARM, V34, P99, DOI 10.4103/joacp.JOACP_274_16; Wadhera RK, 2020, JAMA-J AM MED ASSOC, V323, P2192, DOI 10.1001/jama.2020.7197; Wells CR, 2020, LANCET INFECT DIS, V20, P1123, DOI 10.1016/S1473-3099(20)30315-7; West JB, 2018, PHYSIOL REP, V6, DOI 10.14814/phy2.13903; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046	24	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266173	10.1371/journal.pone.0266173	http://dx.doi.org/10.1371/journal.pone.0266173			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353851	Green Published, gold			2022-12-26	WOS:000786647900018
J	Sato, O; Sakai, T; Choo, YY; Ikebe, R; Watanabe, TM; Ikebe, M				Sato, Osamu; Sakai, Tsuyoshi; Choo, Young-yeon; Ikebe, Reiko; Watanabe, Tomonobu M.; Ikebe, Mitsuo			Mitochondria-associated myosin 19 processively transports mitochondria on actin tracks in living cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLOBULAR TAIL DOMAIN; AXONAL-TRANSPORT; NECK LENGTH; MOTOR; MECHANISM; BINDING; VI; DIMERIZATION; COMPLEX; PROTEIN	Mitochondria are fundamentally important in cell function, and their malfunction can cause the development of cancer, cardiovascular disease, and neuronal disorders. Myosin 19 (Myo19) shows discrete localization with mitochondria and is thought to play an important role in mitochondrial dynamics and function; however, the function of Myo19 in mitochondrial dynamics at the cellular and molecular levels is poorly understood. Critical missing information is whether Myo19 is a processive motor that is suitable for transportation of mitochondria. Here, we show for the first time that single Myo19 molecules processively move on actin filaments and can transport mitochondria in cells. We demonstrate that Myo19 dimers having a leucine zipper processively moved on cellular actin tracks in demembraned cells with a velocity of 50 to 60 nm/s and a run length of X0.4 mu m, similar to the movement of isolated mitochondria from Myo19 dimer-transfected cells on actin tracks, suggesting that the Myo19 dimer can transport mitochondria. Furthermore, we show single molecules of Myo19 dimers processively moved on single actin filaments with a large step size of X34 nm. Importantly, WT Myo19 single molecules without the leucine zipper processively move in filopodia in living cells similar to Myo19 dimers, whereas deletion of the tail domain abolished such active movement. These results suggest that Myo19 can processively move on actin filaments when two Myo19 monomers form a dimer, presumably as a result of tail- tail association. In conclusion, Myo19 molecules can directly transport mitochondria on actin tracks within living cells.	[Sato, Osamu; Sakai, Tsuyoshi; Choo, Young-yeon; Ikebe, Reiko; Ikebe, Mitsuo] Univ Texas Tyler, Dept Cellular & Mol Biol, Hlth Sci Ctr, Tyler, TX 75799 USA; [Watanabe, Tomonobu M.] RIKEN Ctr Biosyst Dynam Res, Lab Comprehens Bioimaging, Kobe, Hyogo, Japan	University of Texas System; University of Texas at Tyler; University of Texas-Health Sciences Center at Tyler (UTHSCT); RIKEN	Ikebe, M (corresponding author), Univ Texas Tyler, Dept Cellular & Mol Biol, Hlth Sci Ctr, Tyler, TX 75799 USA.	Mitsuo.lkebe@uthct.edu		Sato, Osamu/0000-0001-9913-1745	TEXAS STARS PLUS award; National Institutes of Health [RO1 HL142853]	TEXAS STARS PLUS award; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work is supported by the TEXAS STARS PLUS award and National Institutes of Health Grant (RO1 HL142853) to M. I.	Adikes RC, 2013, CYTOSKELETON, V70, P281, DOI 10.1002/cm.21110; AMBROSE EJ, 1956, NATURE, V178, P1194, DOI 10.1038/1781194a0; Berg JS, 2001, MOL BIOL CELL, V12, P780, DOI 10.1091/mbc.12.4.780; Brenner B, 2006, J MUSCLE RES CELL M, V27, P173, DOI 10.1007/s10974-006-9056-7; Cao QJ, 2019, J BIOL CHEM, V294, P11333, DOI 10.1074/jbc.RA119.007384; Coluccio L.M., 2008, MYOS SUP MOL MOT, P95; De La Cruz EM, 1999, P NATL ACAD SCI USA, V96, P13726, DOI 10.1073/pnas.96.24.13726; FISCHER R, 1988, J BIOL CHEM, V263, P17055; Gama JB, 2017, J CELL BIOL, V216, P943, DOI 10.1083/jcb.201610108; Glater EE, 2006, J CELL BIOL, V173, P545, DOI 10.1083/jcb.200601067; Hawthorne JL, 2016, CYTOSKELETON, V73, P286, DOI 10.1002/cm.21305; Jung HS, 2008, MOL BIOL CELL, V19, P3234, DOI 10.1091/mbc.E08-02-0206; Kerber ML, 2009, CURR BIOL, V19, P967, DOI 10.1016/j.cub.2009.03.067; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; Kincaid MM, 2006, CELL CYCLE, V5, P2733, DOI 10.4161/cc.5.23.3521; Kruppa AJ, 2021, J CELL SCI, V134, DOI 10.1242/jcs.226084; LEWIS AK, 1992, J CELL BIOL, V119, P1219, DOI 10.1083/jcb.119.5.1219; Li XD, 2005, J BIOL CHEM, V280, P17815, DOI 10.1074/jbc.M413295200; Li XD, 2008, P NATL ACAD SCI USA, V105, P1140, DOI 10.1073/pnas.0709741105; Li XD, 2006, J BIOL CHEM, V281, P21789, DOI 10.1074/jbc.M602957200; Lister I, 2004, EMBO J, V23, P1729, DOI 10.1038/sj.emboj.7600180; Lopez-Domenech G, 2018, EMBO J, V37, P321, DOI 10.15252/embj.201696380; Los GV, 2008, ACS CHEM BIOL, V3, P373, DOI 10.1021/cb800025k; Lu ZK, 2014, J BIOL CHEM, V289, P18535, DOI 10.1074/jbc.M114.569087; Machiyama H, 2017, BIOPHYS PHYSICOBIOL, V14, P119, DOI 10.2142/biophysico.14.0_119; Melkov A, 2018, CELL MOL LIFE SCI, V75, P163, DOI 10.1007/s00018-017-2590-1; Nelson SR, 2009, BIOPHYS J, V97, P509, DOI 10.1016/j.bpj.2009.04.052; Nishikawa M, 2006, BIOCHEM BIOPH RES CO, V343, P1159, DOI 10.1016/j.bbrc.2006.03.057; Odronitz F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r196; Oeding SJ, 2018, J CELL SCI, V131, DOI 10.1242/jcs.219469; Okada Y, 1999, SCIENCE, V283, P1152, DOI 10.1126/science.283.5405.1152; OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029; Park H, 2006, MOL CELL, V21, P331, DOI 10.1016/j.molcel.2005.12.015; Phichith D, 2009, P NATL ACAD SCI USA, V106, P17320, DOI 10.1073/pnas.0909748106; Quintero OA, 2012, P NATL ACAD SCI USA, V109, P17313, DOI 10.1073/pnas.1216035109; Quintero OA, 2009, CURR BIOL, V19, P2008, DOI 10.1016/j.cub.2009.10.026; Rohn JL, 2014, CURR BIOL, V24, P2598, DOI 10.1016/j.cub.2014.09.045; Ross JL, 2008, CURR OPIN CELL BIOL, V20, P41, DOI 10.1016/j.ceb.2007.11.006; Sakai T, 2015, J BIOL CHEM, V290, P17587, DOI 10.1074/jbc.M114.599365; Sakai T, 2011, P NATL ACAD SCI USA, V108, P7028, DOI 10.1073/pnas.1009188108; Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P16203, DOI 10.1021/bi0512086; Sakamoto T, 2003, J BIOL CHEM, V278, P29201, DOI 10.1074/jbc.M303662200; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Sato O, 2017, J BIOL CHEM, V292, P10950, DOI 10.1074/jbc.M116.765966; Sato O, 2017, SCI REP-UK, V7, DOI 10.1038/srep44237; Shneyer BI, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11002-9; Shneyer BI, 2016, J CELL SCI, V129, P543, DOI 10.1242/jcs.175349; Spudich G, 2007, NAT CELL BIOL, V9, P176, DOI 10.1038/ncb1531; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Stowers RS, 2002, NEURON, V36, P1063, DOI 10.1016/S0896-6273(02)01094-2; STUDIER FW, 1986, J MOL BIOL, V189, P113, DOI 10.1016/0022-2836(86)90385-2; Sun Y, 2010, NAT STRUCT MOL BIOL, V17, P485, DOI 10.1038/nsmb.1785; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Toutenhoofd SL, 1998, CELL CALCIUM, V23, P323, DOI 10.1016/S0143-4160(98)90028-8; Umeki N, 2011, NAT STRUCT MOL BIOL, V18, P783, DOI 10.1038/nsmb.2065; Umeki N, 2009, P NATL ACAD SCI USA, V106, P8483, DOI 10.1073/pnas.0812930106; Usaj M, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-11984-6; van Spronsen M, 2013, NEURON, V77, P485, DOI 10.1016/j.neuron.2012.11.027; Veigel C, 2002, NAT CELL BIOL, V4, P59, DOI 10.1038/ncb732; Watanabe TM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012224; Watanabe TM, 2010, J BIOL CHEM, V285, P19605, DOI 10.1074/jbc.M109.093864; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398; Yu C, 2009, CELL, V138, P537, DOI 10.1016/j.cell.2009.05.030	64	1	1	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101883	10.1016/j.jbc.2022.101883	http://dx.doi.org/10.1016/j.jbc.2022.101883			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35367209	Green Published, gold			2022-12-26	WOS:000798142000008
J	Sun, ZL; Su, ZY; Zhou, ZY; Wang, SJ; Wang, Z; Tong, X; Li, C; Wang, YX; Chen, XY; Lei, Z; Zhang, HT				Sun, Zelong; Su, Zhiyue; Zhou, Zhengyu; Wang, Shengjie; Wang, Zhao; Tong, Xin; Li, Chang; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao			RNA demethylase ALKBH5 inhibits TGF-beta-induced EMT by regulating TGF-beta/SMAD signaling in non-small cell lung cancer	FASEB JOURNAL			English	Article						ALKBH5; m(6)A; NSCLC; TGF-beta-induced EMT; YTHDF1/2/3	MESSENGER-RNA; MESENCHYMAL TRANSITION; EXPRESSION; PROLIFERATION; TRANSLATION; STABILITY	AlkB homolog 5 (ALKBH5) has been revealed as a key RNA N-6-methyladenosine (m(6)A) demethylase that is implicated in development and diseases. However, the function of ALKBH5 in TGF-beta-induced epithelial-mesenchymal transition (EMT) and tumor metastasis of non-small-cell lung cancer (NSCLC) remains unknown. Here, we firstly show that ALKBH5 expression is significantly reduced in metastatic NSCLC. ALKBH5 overexpression inhibits TGF-beta-induced EMT and invasion of NSCLC cells, whereas ALKBH5 knockdown promotes the corresponding phenotypes. ALKBH5 overexpression suppresses TGF-beta-stimulated NSCLC cell metastasis in vivo. ALKBH5 overexpression decreases the expression and mRNA stability of TGF beta R2 and SMAD3 but increases those of SMAD6, while ALKBH5 knockdown causes the opposite results. Importantly, ALKBH5 overexpression or knockdown leads respectively to an attenuated or augmented phosphorylation of SMAD3, an indispensable downstream effector that activates TGF-beta/SMAD signaling. Moreover, m(6)A-binding proteins YTHDF1/3 promotes TGF beta R2 and SMAD3 expression, and YTHDF2 inhibits SMAD6 expression. YTHDF1/2/3 facilitates TGF-beta-stimulated EMT and invasion of NSCLC cells. Mechanistically, ALKBH5 affects TGF beta R2, SMAD3 and SMAD6 expression and mRNA stability by erasing m(6)A modification in NSCLC cells. ALKBH5 weakens YTHDF1/3-mediated TGF beta R2 and SMAD3 mRNA stabilization, and abolishes YTHDF2-mediated SMAD6 mRNA degradation, supporting the notion that ALKBH5 inhibits TGF-beta-induced EMT and invasion of NSCLC cells via YTHD1/2/3-mediated mechanism. Taken together, our findings highlight an important role of ALKBH5 in regulating TGF-beta/SMAD signaling, and establish a mechanistic interaction of ALKBH5 with TGF-beta R2/SMAD3/SMAD6 for controlling TGF-beta-induced EMT in NSCLCs.	[Sun, Zelong; Su, Zhiyue; Wang, Shengjie; Wang, Zhao; Tong, Xin; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao] Soochow Univ, Suzhou Med Coll, Lab Canc Mol Genet, Suzhou, Peoples R China; [Sun, Zelong; Su, Zhiyue; Wang, Zhao; Tong, Xin; Wang, Yuxin; Chen, Xiaoyan; Lei, Zhe; Zhang, Hong-Tao] Soochow Univ, Suzhou Med Coll, Sch Biol & Basic Med Sci, Dept Genet, Suzhou, Peoples R China; [Zhou, Zhengyu] Soochow Univ, Suzhou Med Coll, Lab Anim Ctr, Suzhou, Peoples R China; [Wang, Shengjie] Nanjing Med Univ, Kangda Coll, Dept Basic Med, Lianyungang, Peoples R China; [Li, Chang] Soochow Univ, Affiliated Hosp 1, Suzhou Med Coll, Dept Thorac Surg, Suzhou, Peoples R China; [Zhang, Hong-Tao] Suzhou Key Lab Mol Canc Genet, Suzhou, Peoples R China	Soochow University - China; Soochow University - China; Soochow University - China; Nanjing Medical University; Soochow University - China	Zhang, HT (corresponding author), Soochow Univ, Med Coll, Lab Canc Mol Genet, 199 Renai Rd, Suzhou 215123, Jiangsu, Peoples R China.	htzhang@suda.edu.cn	Chen, Xiao/GQA-8928-2022; Lei, Zhe/AGZ-4963-2022; Zhang, Hong-Tao/P-9661-2017	Chen, Xiao/0000-0002-9797-8384; Zhang, Hong-Tao/0000-0003-4182-421X	National Natural Science Foundation of China [82073198, 81872343]; Suzhou Key Laboratory for Molecular Cancer Genetics [SZS201209]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Suzhou Key Laboratory for Molecular Cancer Genetics; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	We are grateful for participation and cooperation from the patients with NSCLC. Funding was provided by grants from National Natural Science Foundation of China (82073198, 81872343), and Suzhou Key Laboratory for Molecular Cancer Genetics (SZS201209), and A Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Chen XY, 2019, MOL CANCER, V18, DOI 10.1186/s12943-019-1033-z; Chen YH, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01239-w; Chen Z, 2014, NAT REV CANCER, V14, P535, DOI 10.1038/nrc3775; Deng XL, 2018, CELL RES, V28, P507, DOI 10.1038/s41422-018-0034-6; Dominissini D, 2012, NATURE, V485, P201, DOI 10.1038/nature11112; Dongre A, 2019, NAT REV MOL CELL BIO, V20, P69, DOI 10.1038/s41580-018-0080-4; Du H, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12626; Gao YF, 2019, CELL RES, V29, P767, DOI 10.1038/s41422-019-0210-3; Guo XY, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01158-w; Hayashi H, 1997, CELL, V89, P1165, DOI 10.1016/S0092-8674(00)80303-7; Hirsch FR, 2017, LANCET, V389, P299, DOI 10.1016/S0140-6736(16)30958-8; Hua W, 2020, CELL MOL LIFE SCI, V77, P2103, DOI 10.1007/s00018-019-03398-6; Imamura T, 1997, NATURE, V389, P622, DOI 10.1038/39355; Jeon HS, 2010, J THORAC ONCOL, V5, P417, DOI 10.1097/JTO.0b013e3181ce3afd; Jin D, 2020, MOL CANCER, V19, DOI 10.1186/s12943-020-01161-1; Jin D, 2019, J HEMATOL ONCOL, V12, DOI 10.1186/s13045-019-0830-6; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Li XC, 2019, THERANOSTICS, V9, P3853, DOI 10.7150/thno.31868; Li Y, 2021, CELL DEATH DIS, V12, DOI 10.1038/s41419-021-03763-z; Liu J, 2019, TRENDS CELL BIOL, V29, P487, DOI 10.1016/j.tcb.2019.02.008; Park OH, 2019, MOL CELL, V74, P494, DOI 10.1016/j.molcel.2019.02.034; Pastushenko I, 2019, TRENDS CELL BIOL, V29, P212, DOI 10.1016/j.tcb.2018.12.001; PERRY RP, 1975, CELL, V4, P387, DOI 10.1016/0092-8674(75)90159-2; Ping XL, 2014, CELL RES, V24, P177, DOI 10.1038/cr.2014.3; Puisieux A, 2014, NAT CELL BIOL, V16, P488, DOI 10.1038/ncb2976; Roundtree IA, 2017, CELL, V169, P1187, DOI 10.1016/j.cell.2017.05.045; Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297; Sheng H, 2020, CARCINOGENESIS, V41, P541, DOI 10.1093/carcin/bgz152; Shi HL, 2017, CELL RES, V27, P315, DOI 10.1038/cr.2017.15; Tang B, 2020, MOL CANCER, V19, DOI 10.1186/s12943-019-1128-6; ten Dijke P, 2004, TRENDS BIOCHEM SCI, V29, P265, DOI 10.1016/j.tibs.2004.03.008; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Tong X, 2020, ONCOGENE, V39, P2890, DOI 10.1038/s41388-020-1189-4; Wang L, 2016, ONCOGENE, V35, P867, DOI 10.1038/onc.2015.141; Wang MY, 2020, LIFE SCI, V257, DOI 10.1016/j.lfs.2020.118082; Wang SJ, 2021, EMBO REP, V22, DOI 10.15252/embr.202052079; Wang X, 2015, CELL, V161, P1388, DOI 10.1016/j.cell.2015.05.014; Xu YR, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.629560; Yang HP, 2015, LUNG CANCER, V87, P249, DOI 10.1016/j.lungcan.2014.12.015; Zaccara S, 2020, CELL, V181, P1582, DOI 10.1016/j.cell.2020.05.012; Zaccara S, 2019, NAT REV MOL CELL BIO, V20, P608, DOI 10.1038/s41580-019-0168-5; Zhang CZ, 2016, P NATL ACAD SCI USA, V113, pE2047, DOI 10.1073/pnas.1602883113; Zhang J, 2019, J PHYSIOL BIOCHEM, V75, P379, DOI 10.1007/s13105-019-00690-8; Zhang SC, 2017, CANCER CELL, V31, P591, DOI 10.1016/j.ccell.2017.02.013; Zhao W, 2020, MOL THER-NUCL ACIDS, V20, P1, DOI 10.1016/j.omtn.2020.01.033	46	2	2	9	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22283	10.1096/fj.202200005RR	http://dx.doi.org/10.1096/fj.202200005RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SF	35344216				2022-12-26	WOS:000773602500001
J	Ayubov, MS; Buriev, ZT; Mirzakhmedov, MK; Yusupov, AN; Usmanov, DE; Shermatov, SE; Ubaydullaeva, KA; Abdurakhmonov, IY				Ayubov, Mirzakamol S.; Buriev, Zabardast T.; Mirzakhmedov, Mukhammadjon K.; Yusupov, Abdurakhmon N.; Usmanov, Dilshod E.; Shermatov, Shukhrat E.; Ubaydullaeva, Khurshida A.; Abdurakhmonov, Ibrokhim Y.			Profiling of the most reliable mutations from sequenced SARS-CoV-2 genomes scattered in Uzbekistan	PLOS ONE			English	Article							SPIKE	Due to rapid mutations in the coronavirus genome over time and re-emergence of multiple novel variants of concerns (VOC), there is a continuous need for a periodic genome sequencing of SARS-CoV-2 genotypes of particular region. This is for on-time development of diagnostics, monitoring and therapeutic tools against virus in the global pandemics condition. Toward this goal, we have generated 18 high-quality whole-genome sequence data from 32 SARS-CoV-2 genotypes of PCR-positive COVID-19 patients, sampled from the Tashkent region of Uzbekistan. The nucleotide polymorphisms in the sequenced sample genomes were determined, including nonsynonymous (missense) and synonymous mutations in coding regions of coronavirus genome. Phylogenetic analysis grouped fourteen whole genome sample sequences (1, 2, 4, 5, 8, 10-15, 17, 32) into the G clade (or GR sub-clade) and four whole genome sample sequences (3, 6, 25, 27) into the S clade. A total of 128 mutations were identified, consisting of 45 shared and 83 unique mutations. Collectively, nucleotide changes represented one unique frameshift mutation, four upstream region mutations, six downstream region mutations, 50 synonymous mutations, and 67 missense mutations. The sequence data, presented herein, is the first coronavirus genomic sequence data from the Republic of Uzbekistan, which should contribute to enrich the global coronavirus sequence database, helping in future comparative studies. More importantly, the sequenced genomic data of coronavirus genotypes of this study should be useful for comparisons, diagnostics, monitoring, and therapeutics of COVID-19 disease in local and regional levels.	[Ayubov, Mirzakamol S.; Buriev, Zabardast T.; Mirzakhmedov, Mukhammadjon K.; Yusupov, Abdurakhmon N.; Usmanov, Dilshod E.; Shermatov, Shukhrat E.; Ubaydullaeva, Khurshida A.; Abdurakhmonov, Ibrokhim Y.] Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Qibray Region, Uzbekistan	Academy of Sciences of Uzbekistan; Center of Genomics & Bioinformatics	Ayubov, MS (corresponding author), Acad Sci Uzbek, Ctr Genom & Bioinformat, Tashkent, Qibray Region, Uzbekistan.	mirzo.ayubov@gmail.com	Shermatov, Shukhrat/H-1186-2015; Abdurakhmonov, Ibrokhim Y./F-5588-2015	Shermatov, Shukhrat/0000-0002-1864-8126; Abdurakhmonov, Ibrokhim Y./0000-0001-9563-0686; Buriev, Zabardast/0000-0001-7737-9168	Ministry of Innovative Development, Republic of Uzbekistan [-2021-2]	Ministry of Innovative Development, Republic of Uzbekistan	This study has been supported by the research grant from the Ministry of Innovative Development, Republic of Uzbekistan (Research Grant number: -2021-2)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsaadi EAJ, 2019, FUTURE VIROL, V14, P275, DOI 10.2217/fvl-2018-0144; C. N.Soares, 2020, bioRxiv, DOI 10.1101/2020.06.25.171744; Chaw SM, 2020, J BIOMED SCI, V27, DOI 10.1186/s12929-020-00665-8; Chen JH, 2020, J MOL BIOL, V432, P5212, DOI 10.1016/j.jmb.2020.07.009; Chiara M, 2020, BIORXIV, DOI [10.1101/2020.03.30.016790, DOI 10.1101/2020.03.30.016790]; clades.nextstrain, US; covid19.who, US; Cui J, 2019, NAT REV MICROBIOL, V17, P181, DOI 10.1038/s41579-018-0118-9; gisaid, US; Isabel S, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-70827-z; Joshi M, 2021, FRONT GENET, V12, DOI 10.3389/fgene.2021.586569; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Lee N, 2003, NEW ENGL J MED, V348, P1986, DOI 10.1056/NEJMoa030685; Li QQ, 2020, CELL, V182, P1284, DOI 10.1016/j.cell.2020.07.012; Liu LH, 2020, NATURE, V584, P450, DOI 10.1038/s41586-020-2571-7; Liu R, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-92851-3; Mercatelli D, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.01800; ncbi.nlm, US; Piccoli L, 2020, CELL, V183, P1024, DOI 10.1016/j.cell.2020.09.037; Sanjuan R, 2010, J VIROL, V84, P9733, DOI 10.1128/JVI.00694-10; Shu YL, 2017, EUROSURVEILLANCE, V22, P2, DOI 10.2807/1560-7917.ES.2017.22.13.30494; Singh D, 2021, EXP MOL MED, V53, P537, DOI 10.1038/s12276-021-00604-z; Siqueira JD, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab013; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; viprbrc, US; Wrapp D, 2020, SCIENCE, V367, P1260, DOI [10.1101/2020.02.11.944462, 10.1126/science.abb2507]; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Zaki AM, 2012, NEW ENGL J MED, V367, P1814, DOI 10.1056/NEJMoa1211721	28	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266417	10.1371/journal.pone.0266417	http://dx.doi.org/10.1371/journal.pone.0266417			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358277	gold, Green Published, Green Submitted			2022-12-26	WOS:000799828800102
J	Gnerre, M; Abati, D; Bina, M; Confalonieri, F; De Battisti, S; Biassoni, F				Gnerre, Martina; Abati, Daniela; Bina, Manuela; Confalonieri, Federica; De Battisti, Silvia; Biassoni, Federica			Risk perception and travel satisfaction associated with the use of public transport in the time of COVID-19. The case of Turin, Italy	PLOS ONE			English	Article							SEX-DIFFERENCES; IMPACT; SCALE; PASSENGERS; ACCIDENT; SERVICE; USAGE; CYCLE	The present study examined the association between risk perception and travel satisfaction related to the use of public transport (PT) during COVID-19 pandemic in Turin, Italy. A total of 448 PT users took part in an online survey conducted from January to March 2021. It investigated safety and risk perception related to the use of PT, and the users' subjective experience, measured through the Satisfaction with Travel Scale (STS). These perceptions were compared for three time scenarios: before the pandemic, during the pandemic, and in the future at the end of the pandemic emergency. Results showed that COVID-19 influenced respondents risk perception both during the pandemic and in their projections about the future, especially for females. The risk of contagion from COVID-19 is perceived as higher inside a PT vehicle than in the adjacent/waiting spaces. Regarding travel satisfaction, the overall scores of the STS indicated that the pandemic has impacted reported well-being while travelling, both now and in the future. The dimension of activation shifted towards the negative pole and did not indicate a return to risk perception before the pandemic levels at the end of the crisis (especially for females). Respondents reported a significant decrease in their level of pleasure and satisfaction during the pandemic, but expect that in the future these levels will go back to the levels previously experienced. Regarding travel satisfaction, PT users aged 36 to 50 years reported the highest level of satisfaction, while younger users (18 to 35 years) reported the lowest degree of satisfaction in all three time scenarios. Overall, the results clearly pinpoint that health-related perceived risk is becoming a key determinant for PT use. Within this context, different dimensions of travel satisfaction proved to be impacted differently by the pandemic, for both current and future scenarios.	[Gnerre, Martina; Abati, Daniela; Bina, Manuela; Confalonieri, Federica; De Battisti, Silvia; Biassoni, Federica] Univ Cattolica Sacro Cuore, Milan, Italy	Catholic University of the Sacred Heart	Biassoni, F (corresponding author), Univ Cattolica Sacro Cuore, Milan, Italy.	federica.biassoni@unicatt.it	bina, manuela/GWR-1295-2022		Metropolitan City of Turin	Metropolitan City of Turin	This work was supported by Metropolitan City of Turin (CMTo).	Abenoza RF, 2017, TRANSPORT RES A-POL, V95, P64, DOI 10.1016/j.tra.2016.11.011; [Anonymous], 2008, J TRANSP RES FORUM; Barbieri DM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245886; BBC News, 2020, BBC NEWS; Beck MJ, 2020, TRANSPORT POLICY, V96, P76, DOI 10.1016/j.tranpol.2020.07.001; Biassoni F, 2016, APPL COGNITIVE PSYCH, V30, P946, DOI 10.1002/acp.3283; Borkowski P, 2021, J TRANSP GEOGR, V90, DOI 10.1016/j.jtrangeo.2020.102906; Campisi T, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12218829; Cao XY, 2014, J TRANSP LAND USE, V7, P93, DOI 10.5198/jtlu.v7i3.485; Carrel A, 2016, J INTELL TRANSPORT S, V20, P345, DOI 10.1080/15472450.2016.1149699; Ceccato R, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13126596; Davis PM., 2009, CONT ERGONOMICS, P73; De Vos Jonas, 2020, Transp Res Interdiscip Perspect, V5, P100121, DOI 10.1016/j.trip.2020.100121; De Vos J, 2015, TRANSPORT RES F-TRAF, V29, P121, DOI 10.1016/j.trf.2015.01.007; DEJOY DM, 1992, ACCIDENT ANAL PREV, V24, P237, DOI 10.1016/0001-4575(92)90003-2; Delbosc A, 2012, TRANSPORT POLICY, V24, P302, DOI 10.1016/j.tranpol.2012.09.009; DGE, 2004, RECL CIT STREETS PEO; Dong HM, 2021, TRANSPORT POLICY, V101, P81, DOI 10.1016/j.tranpol.2020.12.004; Ettema DF, 2018, TRANSP RES BOARD 95, P116; Ettema D, 2013, TRANSPORT POLICY, V27, P171, DOI 10.1016/j.tranpol.2012.12.006; Ettema D, 2011, TRANSPORT RES F-TRAF, V14, P167, DOI 10.1016/j.trf.2010.11.002; Figler SA, 2011, TRANSPORT RES REC, P148, DOI 10.3141/2216-16; FINN P, 1986, ACCIDENT ANAL PREV, V18, P289, DOI 10.1016/0001-4575(86)90043-6; Friman M, 2013, TRANSPORT RES A-POL, V48, P132, DOI 10.1016/j.tra.2012.10.012; Fyhri A, 2012, ACCIDENT ANAL PREV, V49, P470, DOI 10.1016/j.aap.2012.03.017; Gaglione F, 2020, TEMA, V13, P265, DOI 10.6092/1970-9870/7096; Galli G, 2011, J NEUROSCI, V31, P12364, DOI 10.1523/JNEUROSCI.1619-11.2011; Gao Y., 2018, THESIS EINDHOVEN U T; Gerhold L., 2020, PSYARXIV, DOI [10.31234/OSF.IO/XMPK4, DOI 10.31234/OSF.IO/XMPK4, 10.31234/osf.io/xmpk4]; Glasgow TE, 2018, TRANSPORT RES F-TRAF, V59, P318, DOI 10.1016/j.trf.2018.09.014; Iannello P, 2015, NEUROPSYCHOL TRENDS, P47, DOI 10.7358/neur-2015-017-iann; Ivers R, 2009, AM J PUBLIC HEALTH, V99, P1638, DOI 10.2105/AJPH.2008.150367; Lanciano T, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.580053; Le-Klahn DT, 2014, J PUBLIC TRANSPORT, V17, P68, DOI 10.5038/2375-0901.17.3.5; Mackiewicz KL, 2006, P NATL ACAD SCI USA, V103, P14200, DOI 10.1073/pnas.0601648103; Minelgaite A, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12219154; Moen B.E., 2006, RISK MANAGEMENT, V8, P43, DOI [10.1057/palgrave.rm.8250003, DOI 10.1057/PALGRAVE.RM.8250003]; Nathanail E, 2008, TRANSPORT RES A-POL, V42, P48, DOI 10.1016/j.tra.2007.06.006; Olsson LE, 2012, J RETAIL CONSUM SERV, V19, P413, DOI 10.1016/j.jretconser.2012.04.002; Ouali LAB, 2020, J R STAT SOC A STAT, V183, P737, DOI 10.1111/rssa.12558; Ozbilen Basar, 2021, Transp Res Interdiscip Perspect, V10, P100326, DOI 10.1016/j.trip.2021.100326; Przybylowski A, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13010364; Rahimi E, 2021, TRANSPORT RES F-TRAF, V81, P271, DOI 10.1016/j.trf.2021.06.012; Rana IA, 2021, INT J DISAST RISK RE, V55, DOI 10.1016/j.ijdrr.2021.102096; Rhodes N, 2011, ACCIDENT ANAL PREV, V43, P923, DOI 10.1016/j.aap.2010.11.015; Rodriguez-Besteiro S, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18083908; Rosa E.A., 2003, SOCIAL AMPLIFICATION, P47; Rundmo T, 2011, SAFETY SCI, V49, P226, DOI 10.1016/j.ssci.2010.08.003; RUSSELL JA, 1980, J PERS SOC PSYCHOL, V39, P1161, DOI 10.1037/h0077714; Savadori L, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.577331; Scorrano M, 2021, RES TRANSP ECON, V86, DOI 10.1016/j.retrec.2021.101031; Shelat S, PREPRINT; Shibayama T, 2021, EUR J TRANSP INFRAST, V21, P70, DOI 10.18757/ejtir.2021.21.1.5135; Shiwakoti N, 2019, TRANSPORT POLICY, V84, P12, DOI 10.1016/j.tranpol.2019.10.002; Singleton PA, 2019, TRANSPORT RES F-TRAF, V60, P399, DOI 10.1016/j.trf.2018.10.029; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; Slovic P., 1988, CARCINOGEN RISK ASSE, P171; Slovic P, 2006, CURR DIR PSYCHOL SCI, V15, P322, DOI 10.1111/j.1467-8721.2006.00461.x; Smith MJ, 2008, SECUR J, V21, P117, DOI 10.1057/palgrave.sj.8350071; St-Louis E, 2014, TRANSPORT RES F-TRAF, V26, P160, DOI 10.1016/j.trf.2014.07.004; Stradling S, 2007, TRANSPORT POLICY, V14, P283, DOI 10.1016/j.tranpol.2007.02.003; Thevathasan A, 2007, 30 AUSTR TRANSP RES; UIC, 2020, MAN COVID 19 POT MEA; UITP, 2020, COVID 19 PAND RES PU; Vastfjall D, 2002, SCAND J PSYCHOL, V43, P19, DOI 10.1111/1467-9450.00265; Volk AA, 2021, PERS INDIV DIFFER, V168, DOI 10.1016/j.paid.2020.110398; World Health Organization, WHO DIR GEN OP REM M, DOI DOI 10.1016/J.ENVPOL.2020.114280; Yang M, 2015, TRANSPORT RES D-TR E, V34, P179, DOI 10.1016/j.trd.2014.11.004; Zhang L, 2021, IEEE T INTELL TRANSP, V22, P2371, DOI 10.1109/TITS.2020.3014097	69	2	2	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265245	10.1371/journal.pone.0265245	http://dx.doi.org/10.1371/journal.pone.0265245			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358209	Green Published, gold			2022-12-26	WOS:000799828800027
J	Ishak, A; Wong, FY; Seurot, A; Cocking, S; Pullinger, SA				Ishak, Asmadi; Wong, Fui Yen; Seurot, Antoine; Cocking, Scott; Pullinger, Samuel Andrew			The influence of recovery period following a pre-load stimulus on physical performance measures in handball players	PLOS ONE			English	Article							POST-ACTIVATION POTENTIATION; PROFESSIONAL RUGBY PLAYERS; POSTACTIVATION POTENTIATION; EXPLOSIVE PERFORMANCES; ELITE HANDBALL; BENCH PRESS; TIME; RELIABILITY; POWER; JUMP	The purpose of this research was to establish the optimal recovery duration following a pre-load stimulus on performance measures related to handball players. Seventeen senior male University handball players (mean +/- SD: age 23.6 +/- 2.3 yrs., height 1.79 +/- 0.06 m and body mass 72.5 +/- 10.7 kg) performed three experimental sessions. All sessions consisted of a standardised warm-up followed by a pre-load stimulus (HSR) back squats followed by a passive rest for either 4-min (PAP(4)), 8-min (PAP(8)), or 12-min (PAP(12)). Following the completion of the passive recovery, players then performed a countermovement jump (CMJ), a 20-m linear sprint and a modified agility t-test. The significance level was set at P < 0.05. There was a significant main effect of passive rest duration after the pre-load stimulus. The PAP(12) condition improved CMJ scores (2.3-2.6%; effect size = small), 20-m linear sprint times (3.3-3.7%; effect size = small to moderate) and agility times (1.6-1.9%; effect size = trivial) compared to PAP(4) and PAP(8) conditions (P < 0.0005). Values of heart rate and rating of perceived exertion were also significantly lower during the PAP(12) condition compared to the PAP(4) and PAP(8) conditions (P < 0.0005). A positive Pearson correlation was established between agility and CMJ for all conditions (P < 0.001). The findings provide novel data observing that a pre-load stimulus, followed by 12-min of recovery, results in greater maximal jump, sprint and agility measures when compared with a 4-min or 8-min recovery in male handball players.	[Ishak, Asmadi] Univ Pendidikan Sultan Idris, Fac Sports Sci & Coaching, Perak Darul Ridzuan, Malaysia; [Wong, Fui Yen] Natl Def Univ Malaysia, Acad Def Fitness, Kuala Lumpur, Malaysia; [Seurot, Antoine] Swiss Olymp Med Ctr, Dept Physiotherapie, Meyrin, Switzerland; [Cocking, Scott; Pullinger, Samuel Andrew] Aspire Acad, Sports Sci Dept, Doha, Qatar; [Pullinger, Samuel Andrew] Inspire Inst Sport, Sport Sci Dept, Vijayanagar, India	Universiti Pendidikan Sultan Idris; Universiti Pertahanan Nasional Malaysia; Aspire Academy for Sports Excellence	Ishak, A (corresponding author), Univ Pendidikan Sultan Idris, Fac Sports Sci & Coaching, Perak Darul Ridzuan, Malaysia.; Pullinger, SA (corresponding author), Aspire Acad, Sports Sci Dept, Doha, Qatar.; Pullinger, SA (corresponding author), Inspire Inst Sport, Sport Sci Dept, Vijayanagar, India.	Asmadi@fsskj.upsi.edu.my; pullinger.s@hotmail.com	Ishak, Asmadi/AAA-6301-2019	Ishak, Asmadi/0000-0003-0893-9648; Pullinger, Samuel/0000-0001-7680-3991; Cocking, Scott/0000-0003-4669-6595				Altmann S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0220982; Baechle TR., 2008, ESSENTIALS STRENGTH, V3rd; Batista MAB, 2007, J STRENGTH COND RES, V21, P837, DOI 10.1519/00124278-200708000-00031; Batterham AM, 2006, INT J SPORT PHYSIOL, V1, P50, DOI 10.1123/ijspp.1.1.50; Bevan HR, 2010, J STRENGTH COND RES, V24, P701, DOI 10.1519/JSC.0b013e3181c7b68a; Bevan HR, 2009, J STRENGTH COND RES, V23, P1780, DOI 10.1519/JSC.0b013e3181b3f269; Byrne PJ, 2020, J STRENGTH COND RES, V34, P717, DOI 10.1519/JSC.0000000000002720; Cardinale M, 2017, INT J SPORT PHYSIOL, V12, P908, DOI 10.1123/ijspp.2016-0314; Chiu LZF, 2003, J STRENGTH COND RES, V17, P671, DOI 10.1519/1533-4287(2003)017<0671:PPRIAA>2.0.CO;2; Darrall-Jones JD, 2016, J STRENGTH COND RES, V30, P1359, DOI 10.1519/JSC.0000000000001233; Ferreira SLD, 2012, J STRENGTH COND RES, V26, P739, DOI 10.1519/JSC.0b013e318225f371; Dello Iacono A, 2018, J SPORT SCI, V36, P1269, DOI 10.1080/02640414.2017.1374657; Dello Iacono A, 2016, J SPORT MED PHYS FIT, V56, P1455; Dello Iacono A, 2016, J STRENGTH COND RES, V30, P3122, DOI 10.1519/JSC.0000000000001393; Edwards BJ, 2013, CHRONOBIOL INT, V30, P486, DOI 10.3109/07420528.2012.741174; Fletcher IM, 2010, J STRENGTH COND RES, V24, P1179, DOI 10.1519/JSC.0b013e3181ceec0f; Gorostiaga EM, 2005, INT J SPORTS MED, V26, P225, DOI 10.1055/s-2004-820974; Guerra MA, 2022, J STRENGTH COND RES, V36, P1643, DOI 10.1519/JSC.0000000000003711; Haff G., 2016, ESSENTIALS STRENGTH, VFourth; Hamada T, 2000, J APPL PHYSIOL, V88, P2131, DOI 10.1152/jappl.2000.88.6.2131; Hodgson M, 2005, SPORTS MED, V35, P585, DOI 10.2165/00007256-200535070-00004; Hodgson MJ, 2008, INT J SPORT PHYSIOL, V3, P219, DOI 10.1123/ijspp.3.2.219; Jo E, 2010, J STRENGTH COND RES, V24, P343, DOI 10.1519/JSC.0b013e3181cc22a4; Karcher C, 2014, SPORTS MED, V44, P797, DOI 10.1007/s40279-014-0164-z; Kilduff LP, 2008, J SPORT SCI, V26, P795, DOI 10.1080/02640410701784517; Kilduff LP, 2007, J STRENGTH COND RES, V21, P1134, DOI 10.1519/00124278-200711000-00026; Kinnear P.R., 1999, SPSS WINDOWS MADE SI; Koklu Y, 2022, J STRENGTH COND RES, V36, P534, DOI 10.1519/JSC.0000000000003435; KOMI PV, 1978, MED SCI SPORT EXER, V10, P261; Lijewski M, 2019, ACTA BIOENG BIOMECH, V21, P147, DOI 10.37190/ABB-01471-2019-02; Markovic G, 2004, J STRENGTH COND RES, V18, P551, DOI 10.1519/00124278-200408000-00028; Matthews M, 2004, RES SPORTS MED, V12, P151, DOI [10.1080/15438620490460503, DOI 10.1080/15438620490460503]; McLaren T, 2017, J SPORT MED PHYS FIT, V57, P930, DOI 10.23736/S0022-4707.16.06418-5; Mitchell CJ, 2011, EUR J APPL PHYSIOL, V111, P1957, DOI 10.1007/s00421-010-1823-x; Mola JN, 2014, J STRENGTH COND RES, V28, P1529, DOI 10.1519/JSC.0000000000000313; Povoas SCA, 2012, J STRENGTH COND RES, V26, P3365, DOI 10.1519/JSC.0b013e318248aeee; Pullinger S, 2019, CHRONOBIOL INT, V36, P392, DOI 10.1080/07420528.2018.1552596; Pullinger SA, 2020, CHRONOBIOL INT, V37, P451, DOI 10.1080/07420528.2019.1703732; Racinais Sebastien, 2017, Temperature (Austin), V4, P227, DOI 10.1080/23328940.2017.1356427; Rassier DE, 2000, BRAZ J MED BIOL RES, V33, P499, DOI 10.1590/S0100-879X2000000500003; Rixon KP, 2007, J STRENGTH COND RES, V21, P500, DOI 10.1519/00124278-200705000-00037; Sassi RH, 2009, J STRENGTH COND RES, V23, P1644, DOI 10.1519/JSC.0b013e3181b425d2; Scott DJ, 2018, J STRENGTH COND RES, V32, P2510, DOI 10.1519/JSC.0000000000002464; Tillin NA, 2009, SPORTS MED, V39, P147, DOI 10.2165/00007256-200939020-00004	44	0	0	16	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0249969	10.1371/journal.pone.0249969	http://dx.doi.org/10.1371/journal.pone.0249969			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358204	gold, Green Published			2022-12-26	WOS:000799828800001
J	Anthonysamy, WJB; Dreslik, MJ; Baker, SJ; Davis, MA; Douglas, MR; Douglas, ME; Phillips, CA				Anthonysamy, Whitney J. B.; Dreslik, Michael J.; Baker, Sarah J.; Davis, Mark A.; Douglas, Marlis R.; Douglas, Michael E.; Phillips, Christopher A.			Limited gene flow and pronounced population genetic structure of Eastern Massasauga (Sistrurus catenatus) in a Midwestern prairie remnant	PLOS ONE			English	Article							MICROSATELLITE LOCI; ENDANGERED RATTLESNAKE; THREATENED SNAKE; C-CATENATUS; SOFTWARE; MOVEMENT; LANDSCAPE; PROGRAM; ECOLOGY; NUMBER	As anthropogenic changes continue to ecologically stress wildlife, obtaining measures of gene flow and genetic diversity are crucial for evaluating population trends and considering management and conservation strategies for small, imperiled populations. In our study, we conducted a molecular assessment to expand on previous work to elucidate patterns of diversity and connectivity in the remaining disjunct Eastern Massasauga Rattlesnake (Sistrurus catenatus) hibernacula in Illinois. We assayed genetic data for 327 samples collected during 1999-2015 from the Carlyle Lake study area across 21 microsatellite loci. We found hibernacula formed distinct genetic clusters corresponding to the three main study areas (Dam Recreation Areas, Eldon Hazlet State Park, and South Shore State Park). Genetic structuring and low estimates of dispersal indicated that connectivity among these study areas is limited and each is demographically independent. Hibernacula exhibited moderate levels of heterozygosity (0.60-0.73), but estimates of effective population size (5.2-41.0) were low and track census sizes generated via long-term mark-recapture data. Hibernacula at Carlyle Lake, which represent the only Eastern Massasauga remaining in Illinois, are vulnerable to future loss of genetic diversity through lack of gene flow as well as demographic and environmental stochastic processes. Our work highlights the need to include population-level genetic data in recovery planning and suggests that recovery efforts should focus on managing the three major study areas as separate conservation units in order to preserve and maintain long-term adaptive potential of these populations. Specific management goals should include improving connectivity among hibernacula, maintaining existing wet grassland habitat, and minimizing anthropogenic sources of mortality caused by habitat management (e.g., mowing, prescribed fire) and recreational activities. Our molecular study provides additional details about demographic parameters and connectivity at Carlyle Lake that can be used to guide recovery of Eastern Massasauga in Illinois and throughout its range.	[Anthonysamy, Whitney J. B.] Univ Hlth Sci & Pharm St Louis, Dept Basic Sci, St Louis, MO 63110 USA; [Dreslik, Michael J.; Davis, Mark A.; Phillips, Christopher A.] Univ Illinois, Prairie Res Inst, Illinois Nat Hist Survey, Champaign, IL USA; [Baker, Sarah J.] McNeese State Univ, Dept Biol, Lake Charles, LA 70605 USA; [Douglas, Marlis R.; Douglas, Michael E.] Univ Arkansas, Dept Biol Sci, Fayetteville, AR 72701 USA	Illinois Natural History Survey; University of Illinois System; University of Illinois Urbana-Champaign; University of Louisiana System; McNeese State University; University of Arkansas System; University of Arkansas Fayetteville	Anthonysamy, WJB (corresponding author), Univ Hlth Sci & Pharm St Louis, Dept Basic Sci, St Louis, MO 63110 USA.	whitney.anthonysamy@uhsp.edu		Anthonysamy, Whitney/0000-0002-9047-6701	University of Illinois Urbana-Champaign [E-66-R-1]; Illinois Department of Natural Resources [E-66-R-1]; UIUC [RR15-4228]; Illinois State Toll Highway Authority [RR15-4228]; University of Arkansas Endowment: the Bruker Professorship in Life Sciences; University of Arkansas Endowment: 21st Century Chair in Global Change Biology	University of Illinois Urbana-Champaign; Illinois Department of Natural Resources; UIUC; Illinois State Toll Highway Authority; University of Arkansas Endowment: the Bruker Professorship in Life Sciences; University of Arkansas Endowment: 21st Century Chair in Global Change Biology	Funding for this project was provided through a grant between the University of Illinois Urbana-Champaign and the Illinois Department of Natural Resources (E-66-R-1; https://www2.illinois.gov/dnr/Pages/default.aspx) using United States Fish and Wildlife Services Section 6 funding that was awarded to WJBA, MJD, SJB, MAD and CAP. Funding was also provided, in terms of staff employment, through a contract between UIUC and the Illinois State Toll Highway Authority (RR15-4228; https://www.illinoistollway.com/) that was awarded to MJD and CAP. In addition, this research was supported by two University of Arkansas Endowments: the Bruker Professorship in Life Sciences to MRD and the 21st Century Chair in Global Change Biology to MED (https://www.uark.edu/).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLENDORF FW, 1986, ZOO BIOL, V5, P181, DOI 10.1002/zoo.1430050212; Anderson CD, 2010, COPEIA, P54, DOI 10.1643/CH-08-121; Andre MA., 2003, GENETIC POPULATION S; Anthonysamy WJB, 2018, ANIM CONSERV, V21, P137, DOI 10.1111/acv.12365; Armesto JJ, 2010, LAND USE POLICY, V27, P148, DOI 10.1016/j.landusepol.2009.07.006; Bailey RL, 2011, HERPETOLOGICA, V67, P167, DOI 10.1655/HERPETOLOGICA-D-10-00005.1; Baker SJ, 2018, COPEIA, V106, P414, DOI 10.1643/CG-17-682; Baker SJ, 2016, HERPETOL CONSERV BIO, V11, P335; Baker SJ., 2016, LIFE DEATH CORN DESE; Bell DA, 2019, TRENDS ECOL EVOL, V34, P1070, DOI 10.1016/j.tree.2019.06.006; Bernazzani P, 2012, ENVIRON MANAGE, V49, P1103, DOI 10.1007/s00267-012-9853-2; Blais BR, 2022, ZOO BIOL, V41, P346, DOI 10.1002/zoo.21682; Bradke DR, 2018, J HERPETOL, V52, P387, DOI 10.1670/18-026; Bushar LM, 2015, HERPETOLOGICA, V71, P203, DOI 10.1655/HERPETOLOGICA-D-14-00030; Bushar LM, 2014, COPEIA, P694, DOI 10.1643/CE-14-047; Castoe TA, 2010, MOL ECOL RESOUR, V10, P341, DOI 10.1111/j.1755-0998.2009.02750.x; Chiucchi JE, 2010, MOL ECOL, V19, P5345, DOI 10.1111/j.1365-294X.2010.04860.x; Crutzen P.J., 2006, EARTH SYSTEM SCI ANT, P13, DOI 10.1007/3-540-26590-2_3; Cullingham CI, 2020, MOL ECOL, V29, P862, DOI 10.1111/mec.15374; Degregorio BA, 2011, HERPETOLOGICA, V67, P71, DOI 10.1655/09-049R1.1; Dileo MF, 2013, MOL ECOL, V22, P4483, DOI 10.1111/mec.12411; Doak DF, 2015, BIOSCIENCE, V65, P189, DOI 10.1093/biosci/biu215; Douglas MR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230735; Dreslik MJ., 2017, BIOL RATTLESNAKES 2; Dreslik MJ., 2005, ECOLOGY E MASSASAUGA; Durbian FE, 2008, J WILDLIFE MANAGE, V72, P754, DOI 10.2193/2007-710; ESRI, 2020, ARCMAP 10 8 0; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Frankham R, 2017, GENETIC MANAGEMENT OF FRAGMENTED ANIMAL AND PLANT POPULATIONS, P1, DOI 10.1093/oso/9780198783398.001.0001; Frankham R, 2015, MOL ECOL, V24, P2610, DOI 10.1111/mec.13139; Frei M, 2016, J NAT CONSERV, V32, P22, DOI 10.1016/j.jnc.2016.04.002; Funk WC, 2019, CONSERV GENET, V20, P115, DOI 10.1007/s10592-018-1096-1; Funk WC, 2012, TRENDS ECOL EVOL, V27, P489, DOI 10.1016/j.tree.2012.05.012; Gibbs HL, 2011, CONSERV GENET, V12, P433, DOI 10.1007/s10592-010-0151-3; Gibbs HL, 1997, MOL ECOL, V6, P1123, DOI 10.1046/j.1365-294X.1997.00284.x; Gibbs HL, 1998, J HERED, V89, P169, DOI 10.1093/jhered/89.2.169; GIBBS HL, 1994, MOL ECOL, V3, P329, DOI 10.1111/j.1365-294X.1994.tb00072.x; Gilpin M.E., 1986, P19; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Harvey DS, 2006, J HERPETOL, V40, P66, DOI 10.1670/89-05A.1; Holycross AT, 2002, MOL ECOL NOTES, V2, P537, DOI 10.1046/j.1471-8286.2002.00310.x; Iverson LR, 1988, LANDSCAPE ECOL, V2, P45, DOI 10.1007/BF00138907; Jaeger CP, 2016, ECOL EVOL, V6, P3991, DOI 10.1002/ece3.2159; Jellen BC, 2007, J HERPETOL, V41, P451, DOI 10.1670/0022-1511(2007)41[451:MMABSA]2.0.CO;2; Jones PC, 2012, J WILDLIFE MANAGE, V76, P1576, DOI 10.1002/jwmg.418; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; King R, 2004, HERPETOLOGICA, V60, P429, DOI 10.1655/03-01; Kopelman NM, 2015, MOL ECOL RESOUR, V15, P1179, DOI 10.1111/1755-0998.12387; Kropiewnicki R, 2008, INVESTIGATING POPULA; Kubatko LS, 2011, SYST BIOL, V60, P393, DOI 10.1093/sysbio/syr011; Li YL, 2018, MOL ECOL RESOUR, V18, P176, DOI 10.1111/1755-0998.12719; Lomas E, 2019, HERPETOLOGICA, V75, P153, DOI 10.1655/D-17-00060; Lougheed SC, 2000, J HERED, V91, P458, DOI 10.1093/jhered/91.6.458; Marshall JC, 2006, HERPETOLOGICA, V62, P141, DOI 10.1655/04-12.1; MARUYAMA T, 1985, GENETICS, V111, P675; McCartney-Melstad E, 2015, MOL ECOL, V24, P5084, DOI 10.1111/mec.13391; Meirmans PG, 2014, MOL ECOL RESOUR, V14, P726, DOI 10.1111/1755-0998.12216; Meirmans PG, 2011, MOL ECOL RESOUR, V11, P5, DOI 10.1111/j.1755-0998.2010.02927.x; Ochoa A, 2021, MOL ECOL, V30, P5454, DOI 10.1111/mec.16147; Ochoa A, 2020, MOL ECOL, V29, P2612, DOI 10.1111/mec.15517; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pierson JC, 2016, FRONT ECOL ENVIRON, V14, P433, DOI 10.1002/fee.1323; Pritchard JK, 2000, GENETICS, V155, P945; Puechmaille SJ, 2016, MOL ECOL RESOUR, V16, P608, DOI 10.1111/1755-0998.12512; Ralls K, 2020, BIOL CONSERV, V251, DOI 10.1016/j.biocon.2020.108784; Ray JW, 2013, J FISH WILDL MANAG, V4, P104, DOI 10.3996/032012-JFWM-026; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Rodrigues ASL, 2019, PHILOS T R SOC B, V374, DOI 10.1098/rstb.2019.0220; Roe JH, 2015, HERPETOL CONSERV BIO, V10, P711; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shepard DB, 2008, ANIM CONSERV, V11, P288, DOI 10.1111/j.1469-1795.2008.00183.x; Shepard DB, 2008, COPEIA, P350, DOI 10.1643/CE-06-276; SMITH PHILIP W., 1961, ILLINOIS NAT HIST SURV BULL, V28, P1; Sovic MG, 2016, HEREDITY, V117, P358, DOI 10.1038/hdy.2016.56; Sovic M, 2019, EVOL APPL, V12, P664, DOI 10.1111/eva.12731; Szymanski J., 1998, STATUS ASSESSMENT E; Szymanski J, 2015, US FISH WILDL SERV; U.S. Fish and Wildlife Service (USFWS), 2016, FED REGISTER, V81, P67193; United States Fish and Wildlife Service, 2019, DRAFT REC PLAN E MAS; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Villarreal X, 1996, J HERED, V87, P152, DOI 10.1093/oxfordjournals.jhered.a022973; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Wilson GA, 2003, GENETICS, V163, P1177; Wood DA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231744; WRIGHT BERTRAND ALBERT, 1941, AMER MIDLAND NAT, V25, P659, DOI 10.2307/2420721	89	0	0	6	174	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265666	10.1371/journal.pone.0265666	http://dx.doi.org/10.1371/journal.pone.0265666			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324968	Green Published, gold			2022-12-26	WOS:000780951300058
J	Khouri, M; Lassri, D; Cohen, N				Khouri, Marlyn; Lassri, Dana; Cohen, Noga			Job burnout among Israeli healthcare workers during the first months of COVID-19 pandemic: The role of emotion regulation strategies and psychological distress	PLOS ONE			English	Article							COPING STRATEGIES; HOSPITAL STAFF; INDIVIDUAL-DIFFERENCES; ANXIETY; STRESS; IMPACT; SARS; DEPRESSION; WORRY; NURSES	The current worldwide COVID-19 pandemic has elicited widespread concerns and stress. Arguably, healthcare workers are especially vulnerable to experience burnout during these times due to the nature of their work. Indeed, high prevalence of burnout was found among healthcare workers during the outbreak. However, the individual differences predicting burnout among healthcare workers during the pandemic have been understudied. The aim of the current study was, therefore, to identify risk and protective factors contributing to the severity of burnout among healthcare workers, above and beyond levels of current psychological distress. The survey was distributed online during the period April 13-28, 2020, approximately two months after the first COVID-19 case was identified in Israel. Ninety-eight healthcare workers completed an online survey administered cross-sectionally via the Qualtrics platform that included questionnaires assessing habitual emotion regulation strategies (i.e., trait worry, reappraisal, and suppression), psychological distress, COVID-19 related concerns, and burnout. A hierarchical linear regression analysis revealed that only trait worry and psychological distress were significant predictors of job burnout among healthcare workers. These findings highlight the role of maladaptive emotion regulation tendencies, specifically trait worry, in job burnout among healthcare workers. These findings have implications for both the assessment and treatment of healthcare workers. We discuss potential mechanisms and implications for practice.	[Khouri, Marlyn; Cohen, Noga] Univ Haifa, Fac Educ, Haifa, Israel; [Lassri, Dana] Hebrew Univ Jerusalem, Paul Baerwald Sch Social Work & Social Welf, Jerusalem, Israel; [Lassri, Dana] UCL Univ Coll London, Res Dept Clin Educ & Hlth Psychol, London, England; [Cohen, Noga] Univ Haifa, Edmond J Safra Brain Res Ctr, Haifa, Israel	University of Haifa; Hebrew University of Jerusalem; University of London; University College London; University of Haifa	Khouri, M (corresponding author), Univ Haifa, Fac Educ, Haifa, Israel.	mkhouri89@gmail.com	Lassri, Dana/ABB-8617-2020	Lassri, Dana/0000-0001-6461-312X				Ahola K., 2014, BURNOUT RES, V1, P29, DOI [10.1016/j.burn.2014.03.003, DOI 10.1016/J.BURN.2014.03.003]; Aldao A, 2013, PERSPECT PSYCHOL SCI, V8, P155, DOI 10.1177/1745691612459518; Aldao A, 2010, CLIN PSYCHOL REV, V30, P217, DOI 10.1016/j.cpr.2009.11.004; Alhasan K, 2021, HEALTHCARE-BASEL, V9, DOI 10.3390/healthcare9111566; Alizadeh A, 2020, BMC PSYCHIATRY, V20, DOI 10.1186/s12888-020-02889-2; Anderson VL, 1999, SCHOOL PSYCHOL QUART, V14, P3, DOI 10.1037/h0088995; [Anonymous], 2020, AM PSYCHOL ASS; [Anonymous], 2006, CANADIAN J COMMUNITY, V25, P89, DOI [10.7870/cjcmh-2006-0015, DOI 10.7870/CJCMH-2006-0015]; Arnold KA, 2015, J OCCUP HEALTH PSYCH, V20, P481, DOI 10.1037/a0039045; Awa WL, 2010, PATIENT EDUC COUNS, V78, P184, DOI 10.1016/j.pec.2009.04.008; Bai Y, 2004, PSYCHIAT SERV, V55, P1055, DOI 10.1176/appi.ps.55.9.1055; Bamonti P, 2019, J APPL GERONTOL, V38, P92, DOI 10.1177/0733464817716970; Bianchi R, 2013, J HEALTH PSYCHOL, V18, P782, DOI 10.1177/1359105313481079; Birk JL, 2016, EMOTION, V16, P657, DOI 10.1037/emo0000157; Donoso LMB, 2015, INT J NURS STUD, V52, P804, DOI 10.1016/j.ijnurstu.2015.01.002; Bonanno GA, 2004, PSYCHOL SCI, V15, P482, DOI 10.1111/j.0956-7976.2004.00705.x; Bonanno GA, 2020, ASSESSMENT, V27, P261, DOI 10.1177/1073191118820131; Bonanno GA, 2013, PERSPECT PSYCHOL SCI, V8, P591, DOI 10.1177/1745691613504116; BORKOVEC TD, 1995, J BEHAV THER EXP PSY, V26, P25, DOI 10.1016/0005-7916(94)00064-S; BORKOVEC TD, 1983, BEHAV RES THER, V21, P9, DOI 10.1016/0005-7967(83)90121-3; Brooks SK, 2020, LANCET, V395, P912, DOI [10.1016/S0140-6736(20)30460-8., 10.1016/S0140-6736(20)30460-8]; Burisch M, 2002, WORK STRESS, V16, P1, DOI 10.1080/02678370110112506; Burton CL, 2016, PSYCHOL ASSESSMENT, V28, P929, DOI 10.1037/pas0000231; CESLOWITZ SB, 1989, J ADV NURS, V14, P553, DOI 10.1111/j.1365-2648.1989.tb01590.x; Chang D, 2020, JAMA-J AM MED ASSOC, V323, P1092, DOI 10.1001/jama.2020.1623; Chaukos D, 2017, ACAD PSYCHIATR, V41, P189, DOI 10.1007/s40596-016-0628-6; Cheristanidis Stavros, 2021, Acta Med Acad, V50, P252, DOI 10.5644/ama2006-124.341; Coles ME, 2005, COGNITIVE THER RES, V29, P47, DOI 10.1007/s10608-005-1647-x; Collins LM, 2001, PSYCHOL METHODS, V6, P330, DOI 10.1037//1082-989X.6.4.330; Conti C, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242538; del Carmen MG, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2019.0554; Perez-Fuentes MD, 2020, PSICOTHEMA, V32, P444, DOI 10.7334/psicothema2019.373; Dixon-Gordon KL, 2015, PERS INDIV DIFFER, V86, P271, DOI 10.1016/j.paid.2015.06.011; Dobson H, 2021, AUSTRALAS PSYCHIATRY, V29, P26, DOI 10.1177/1039856220965045; Duarte I, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09980-z; Fornes-Vives J, 2019, PERS INDIV DIFFER, V138, P286, DOI 10.1016/j.paid.2018.10.014; Fox S, 2018, POSTGRAD MED J, V94, P162, DOI 10.1136/postgradmedj-2017-135212; Garnefski N, 2002, J ADOLESCENCE, V25, P603, DOI 10.1006/jado.2002.0507; Garnefski N, 2001, PERS INDIV DIFFER, V30, P1311, DOI 10.1016/S0191-8869(00)00113-6; Gomez-Salgado J, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17113947; Gross JJ, 2003, J PERS SOC PSYCHOL, V85, P348, DOI 10.1037/0022-3514.85.2.348; GROSS JJ, 1993, J PERS SOC PSYCHOL, V64, P970, DOI 10.1037/0022-3514.64.6.970; Gupta S, 2011, J ABNORM PSYCHOL, V120, P635, DOI 10.1037/a0023541; Halbesleben JRB, 2004, J MANAGE, V30, P859, DOI 10.1016/j.jm.2004.06.004; Han M, 2012, J SOC WORK EDUC, V48, P439, DOI 10.5175/JSWE.2011.201000053; Helgeson VS, 2006, J CONSULT CLIN PSYCH, V74, P797, DOI 10.1037/0022-006X.74.5.797; Henry JD, 2005, BRIT J CLIN PSYCHOL, V44, P227, DOI 10.1348/014466505X29657; Hill AP, 2016, PERS SOC PSYCHOL REV, V20, P269, DOI [10.1177/1088868315596286, 10.1109/EPE.2015.7309385]; Hirsch CR, 2012, BEHAV RES THER, V50, P636, DOI 10.1016/j.brat.2012.06.007; Ijaz T, 2020, PAKISTAN J PSYCHOL R, P473; Jackson-Koku G, 2019, OCCUP MED-OXFORD, V69, P9, DOI 10.1093/occmed/kqz004; Jansen PGM, 1996, INT J NURS STUD, V33, P407, DOI 10.1016/0020-7489(95)00060-7; Kafle K, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246784; Katana M, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01097; Koutsimani P, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.00284; Kristensen TS, 2005, WORK STRESS, V19, P192, DOI 10.1080/02678370500297720; Kumar S, 2016, HEALTHCARE-BASEL, V4, DOI 10.3390/healthcare4030037; Kunzmann U, 2005, PSYCHOL AGING, V20, P144, DOI 10.1037/0882-7974.20.1.144; Lai JB, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.3976; Lapa TA, 2017, MINERVA ANESTESIOL, V83, P191, DOI 10.23736/S0375-9393.16.11379-3; Lee HF, 2015, COMMUNITY MENT HLT J, V51, P733, DOI 10.1007/s10597-014-9818-4; Lenzo V, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.623033; Lenzo V, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233173; Levy-Gigi E, 2016, STRESS, V19, P1, DOI 10.3109/10253890.2015.1113523; Liang SW, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.02231; Liu XH, 2012, COMPR PSYCHIAT, V53, P15, DOI 10.1016/j.comppsych.2011.02.003; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Lu MY, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.705657; Lung FW, 2009, PSYCHIAT QUART, V80, P107, DOI 10.1007/s11126-009-9095-5; Main A, 2011, J COUNS PSYCHOL, V58, P410, DOI 10.1037/a0023632; Masiero M, 2018, J CLIN NURS, V27, P2691, DOI 10.1111/jocn.14376; Maslach C, 2016, WORLD PSYCHIATRY, V15, P103, DOI 10.1002/wps.20311; MATHEWS A, 1990, BEHAV RES THER, V28, P455, DOI 10.1016/0005-7967(90)90132-3; Maunder R, 2003, CAN MED ASSOC J, V168, P1245; McCain RS, 2018, POSTGRAD MED J, V94, P43, DOI 10.1136/postgradmedj-2016-134683; MEYER TJ, 1990, BEHAV RES THER, V28, P487, DOI 10.1016/0005-7967(90)90135-6; Moen F, 2016, J PHYS ED SPORTS MAN, V3, P88; Mosheva M, 2020, DEPRESS ANXIETY, V37, P965, DOI 10.1002/da.23085; Muller AE, 2020, PSYCHIAT RES, V293, DOI 10.1016/j.psychres.2020.113441; Prados ABN, 2022, HEALTH SOC CARE COMM, V30, P244, DOI 10.1111/hsc.13397; Nickell LA, 2004, CAN MED ASSOC J, V170, P793, DOI 10.1503/cmaj.1031077; Nishimura Y, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18052434; Ochs E, 1996, ANNU REV ANTHROPOL, V25, P19, DOI 10.1146/annurev.anthro.25.1.19; Orru G, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18010337; Palgi Y, 2020, J AFFECT DISORDERS, V275, P109, DOI 10.1016/j.jad.2020.06.036; Pappa S, 2021, BRAIN BEHAV IMMUN, V92, P209, DOI 10.1016/j.bbi.2020.11.025; Payne N, 2001, J ADV NURS, V33, P396, DOI 10.1046/j.1365-2648.2001.01677.x; Purdon C, 2001, BEHAV RES THER, V39, P1163, DOI 10.1016/S0005-7967(00)00092-9; Raio CM, 2013, P NATL ACAD SCI USA, V110, P15139, DOI 10.1073/pnas.1305706110; Ramirez-Baena L, 2019, J CLIN MED, V8, DOI 10.3390/jcm8010092; Reynaud E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032413; Rossi R, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.10185; Saddik Basema, 2021, Int J Public Health, V66, P1604369, DOI 10.3389/ijph.2021.1604369; Salari N, 2020, GLOBALIZATION HEALTH, V16, DOI 10.1186/s12992-020-00589-w; Salvarani V, 2019, J NURS MANAGE, V27, P765, DOI 10.1111/jonm.12771; Santi G, 2021, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.601743; Schaufeli WB, 2001, PSYCHOL HEALTH, V16, P501, DOI 10.1080/08870440108405523; Serafini G, 2020, QJM-INT J MED, V113, P529, DOI 10.1093/qjmed/hcaa201; Shallcross AJ, 2015, EMERG TRENDS SOC BEH, P1; Sheppes G, 2014, J EXP PSYCHOL GEN, V143, P163, DOI 10.1037/a0030831; Shin H, 2014, PROF PSYCHOL-RES PR, V45, P44, DOI 10.1037/a0035220; Shirom A., 2006, INT J STRESS MANAGE, V13, P176, DOI [10.1037/1072-5245.13.2.176, DOI 10.1037/1072-5245.13.2.176]; Siren C, 2018, LONG RANGE PLANN, V51, P953, DOI 10.1016/j.lrp.2018.05.002; Styra R, 2008, J PSYCHOSOM RES, V64, P177, DOI 10.1016/j.jpsychores.2007.07.015; Swider BW, 2010, J VOCAT BEHAV, V76, P487, DOI 10.1016/j.jvb.2010.01.003; Tam CWC, 2004, PSYCHOL MED, V34, P1197, DOI 10.1017/S0033291704002247; Taylor S, 2020, J ANXIETY DISORD, V76, DOI 10.1016/j.janxdis.2020.102327; Turnipseed DL, 1998, PSYCHOL REP, V82, P627, DOI 10.2466/PR0.82.2.627-642; Vahedian-Azimi A, 2019, J INTENSIVE CARE MED, V34, P311, DOI 10.1177/0885066617696853; WEGNER DM, 1994, J PERS, V62, P615, DOI 10.1111/j.1467-6494.1994.tb00311.x; Weilenmann S, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.594340; Wenzlaff EM, 2000, ANNU REV PSYCHOL, V51, P59, DOI 10.1146/annurev.psych.51.1.59; Winstanley S, 2002, WORK STRESS, V16, P302, DOI 10.1080/0267837021000058650; Wong TW, 2005, EUR J EMERG MED, V12, P13, DOI 10.1097/00063110-200502000-00005; Xiao X, 2020, J AFFECT DISORDERS, V274, P405, DOI 10.1016/j.jad.2020.05.081	115	2	2	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265659	10.1371/journal.pone.0265659	http://dx.doi.org/10.1371/journal.pone.0265659			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0K7DW	35324961	gold, Green Published			2022-12-26	WOS:000780951300056
J	Tamanaha, E; Zhang, YH; Tanner, NA				Tamanaha, Esta; Zhang, Yinhua; Tanner, Nathan A.			Profiling RT-LAMP tolerance of sequence variation for SARS-CoV-2 RNA detection	PLOS ONE			English	Article							ISOTHERMAL AMPLIFICATION; MUTATION; SYSTEM	The ongoing SARS-CoV-2 pandemic has necessitated a dramatic increase in our ability to conduct molecular diagnostic tests, as accurate detection of the virus is critical in preventing its spread. However, SARS-CoV-2 variants continue to emerge, with each new variant potentially affecting widely-used nucleic acid amplification diagnostic tests. RT-LAMP has been adopted as a quick, inexpensive diagnostic alternative to RT-qPCR, but as a newer method, has not been studied as thoroughly. Here we interrogate the effect of SARS-CoV-2 sequence mutations on RT-LAMP amplification, creating 523 single point mutation "variants" covering every position of the LAMP primers in 3 SARS-CoV-2 assays and analyzing their effects with over 4,500 RT-LAMP reactions. Remarkably, we observed only minimal effects on amplification speed and no effect on detection sensitivity at positions equivalent to those that significantly impact RT-qPCR assays. We also created primer sets targeting a specific short deletion and observed that LAMP is able to amplify even with a primer containing multiple consecutive mismatched bases, albeit with reduced speed and sensitivity. This highlights RT-LAMP as a robust technique for viral RNA detection that can tolerate most mutations in the primer regions. Additionally, where variant discrimination is desired, we describe the use of molecular beacons to sensitively distinguish and identify variant RNA sequences carrying short deletions. Together these data add to the growing body of knowledge on the utility of RT-LAMP and increase its potential to further our ability to conduct molecular diagnostic tests outside of the traditional clinical laboratory environment.	[Tamanaha, Esta; Zhang, Yinhua; Tanner, Nathan A.] New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA	New England Biolabs	Tanner, NA (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA.	tanner@neb.com		Tanner, Nathan/0000-0001-7601-7077	New England Biolabs	New England Biolabs	New England Biolabs (www.neb.com) has funded this study. All authors (ET, YZ, NT) are employees and shareholders of New England Biolabs, manufacturer of LAMP reagents described in the manuscript.	Amato L, 2021, EMERG MICROBES INFEC, V10, P1148, DOI 10.1080/22221751.2021.1933609; Artesi M, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.01598-20; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Campbell M., 2021, PRIMER MONITOR ONLIN; FDA, 2021, POL EV IMP VIR MUT C; Ganguli A, 2020, P NATL ACAD SCI USA, V117, P22727, DOI 10.1073/pnas.2014739117; Genomics C., EMERGENCY USE AUTHOR; Jain A, 2021, INT J INFECT DIS, V102, P460, DOI 10.1016/j.ijid.2020.10.086; Joung J, 2020, NEW ENGL J MED, V383, P1492, DOI 10.1056/NEJMc2026172; Little S, 2001, Curr Protoc Hum Genet, VChapter 9, DOI 10.1002/0471142905.hg0908s07; Ludwig KU, 2021, NAT BIOTECHNOL, V39, P1556, DOI 10.1038/s41587-021-00966-9; Nagamine K, 2002, MOL CELL PROBE, V16, P223, DOI 10.1006/mcpr.2002.0415; Nakabayashi T, BIORXIV2021202101194; NEWTON CR, 1989, NUCLEIC ACIDS RES, V17, P2503, DOI 10.1093/nar/17.7.2503; Notomi T, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.12.e63; Peto L, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.03271-20; Rabe BA, 2020, P NATL ACAD SCI USA, V117, P24450, DOI 10.1073/pnas.2011221117; Sherrill-Mix Scott, 2021, J Biomol Tech, V32, P98, DOI 10.7171/jbt.21-3203-004; Sherrill-Mix S, 2021, GENOME BIOL, V22, DOI 10.1186/s13059-021-02387-y; Stadhouders R, 2010, J MOL DIAGN, V12, P109, DOI 10.2353/jmoldx.2010.090035; Tahan S, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.00075-21; Tamura S, 2017, J MICROBIOL METH, V141, P108, DOI 10.1016/j.mimet.2017.08.008; Thompson D, 2020, SENSOR ACTUATOR REP, V2, DOI 10.1016/j.snr.2020.100017; Vanaerschot M, 2021, J CLIN MICROBIOL, V59, DOI 10.1128/JCM.02369-20; Vogels CBF, 2021, PLOS BIOL, V19, DOI 10.1371/journal.pbio.3001236; Zhang Y., 2020, RAPID MOL DETECTION, V2, P1, DOI [10.1101/2020.02.26.20028373, DOI 10.1101/2020.02.26.20028373]; Zhang YH, 2021, BIOTECHNIQUES, V70, P167, DOI 10.2144/btn-2020-0157; Zhang Yinhua, 2020, Biotechniques, V69, P178, DOI 10.2144/btn-2020-0078; Zimmermann F, 2022, J VIROL METHODS, V299, DOI 10.1016/j.jviromet.2021.114352	29	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0259610	10.1371/journal.pone.0259610	http://dx.doi.org/10.1371/journal.pone.0259610			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324900	Green Submitted, Green Published, gold			2022-12-26	WOS:000780951300006
J	Zulkifly, MFM; Lehr, A; van de Velden, D; Khan, A; Focke, NK; Wolters, CH; Paulus, W				Zulkifly, Mohd Faizal Mohd; Lehr, Albert; van de Velden, Daniel; Khan, Asad; Focke, Niels K.; Wolters, Carsten H.; Paulus, Walter			Directionality of the injected current targeting the P20/N20 source determines the efficacy of 140 Hz transcranial alternating current stimulation (tACS)-induced aftereffects in the somatosensory cortex	PLOS ONE			English	Article							NONINVASIVE BRAIN-STIMULATION; WORKING-MEMORY; MOTOR CORTEX; FUNCTIONAL-ORGANIZATION; EEG; EXCITABILITY; PLASTICITY; TDCS; LOCALIZATION; OSCILLATIONS	Interindividual anatomical differences in the human cortex can lead to suboptimal current directions and may result in response variability of transcranial electrical stimulation methods. These differences in brain anatomy require individualized electrode stimulation montages to induce an optimal current density in the targeted area of each individual subject. We aimed to explore the possible modulatory effects of 140 Hz transcranial alternating current stimulation (tACS) on the somatosensory cortex using personalized multi-electrode stimulation montages. In two randomized experiments using either tactile finger or median nerve stimulation, we measured by evoked potentials the plasticity aftereffects and oscillatory power changes after 140 Hz tACS at 1.0 mA as compared to sham stimulation (n = 17, male = 9). We found a decrease in the power of oscillatory mu-rhythms during and immediately after tactile discrimination tasks, indicating an engagement of the somatosensory system during stimulus encoding. On a group level both the oscillatory power and the evoked potential amplitudes were not modulated by tACS neither after tactile finger stimulation nor after median nerve stimulation as compared to sham stimulation. On an individual level we could however demonstrate that lower angular difference (i.e., differences between the injected current vector in the target region and the source orientation vector) is associated with significantly higher changes in both P20/N20 and N30/P30 source activities. Our findings suggest that the higher the directionality of the injected current correlates to the dipole orientation the greater the tACS-induced aftereffects are.	[Zulkifly, Mohd Faizal Mohd; Lehr, Albert; van de Velden, Daniel; Focke, Niels K.; Paulus, Walter] Georg August Univ, Univ Med Ctr, Dept Clin Neurophysiol, Gottingen, Germany; [Zulkifly, Mohd Faizal Mohd] Univ Sains Malaysia, Dept Neurosci, Sch Med Sci, Hlth Campus, Kota Baharu, Kelantan, Malaysia; [Zulkifly, Mohd Faizal Mohd] Univ Sains Malaysia, Sch Med Sci, Brain & Behav Cluster, Hlth Campus, Kota Baharu, Kelantan, Malaysia; [Khan, Asad; Wolters, Carsten H.] Univ Munster, Inst Biomagnetism & Biosignalanal, Munster, Germany; [Wolters, Carsten H.] Univ Munster, Otto Creutzfeldt Ctr Cognit Neurosci, Munster, Germany; [Paulus, Walter] Ludwig Maximilians Univ Munchen, Dept Neurol, Marchioninistr, Munich, Germany	University of Gottingen; Universiti Sains Malaysia; Universiti Sains Malaysia; University of Munster; University of Munster; University of Munich	Zulkifly, MFM (corresponding author), Georg August Univ, Univ Med Ctr, Dept Clin Neurophysiol, Gottingen, Germany.; Zulkifly, MFM (corresponding author), Univ Sains Malaysia, Dept Neurosci, Sch Med Sci, Hlth Campus, Kota Baharu, Kelantan, Malaysia.; Zulkifly, MFM (corresponding author), Univ Sains Malaysia, Sch Med Sci, Brain & Behav Cluster, Hlth Campus, Kota Baharu, Kelantan, Malaysia.	faizal.zulkifly@usm.my	Paulus, Walter/A-3544-2009; Zulkifly, Faizal/GPX-6987-2022	Paulus, Walter/0000-0001-5549-8377; Mohd Zulkifly, Mohd Faizal/0000-0003-4925-9972; van de Velden, Daniel/0000-0003-2834-4457	Ministry of Education (MOE), Malaysia; Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) of the Georg-August-Universitat Gottingen; German Research Foundation (DFG) [WO1425/5-2, SPP1665, WO1425/10-1]	Ministry of Education (MOE), Malaysia; Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) of the Georg-August-Universitat Gottingen; German Research Foundation (DFG)(German Research Foundation (DFG))	MFMZ was supported by the Ministry of Education (MOE), Malaysia. This work was partly supported by the Gottingen Graduate Center for Neurosciences, Biophysics, and Molecular Biosciences (GGNB) of the Georg-August-Universitat Gottingen. AK and CHW were supported by the priority program SPP1665 of the German Research Foundation (DFG), project WO1425/5-2, and by DFG project WO1425/10-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberra AS, 2020, BRAIN STIMUL, V13, P175, DOI 10.1016/j.brs.2019.10.002; Agboada D, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-54621-0; ALLISON T, 1991, BRAIN, V114, P2465, DOI 10.1093/brain/114.6.2465; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Antonakakis M, 2020, NEUROIMAGE, V223, DOI 10.1016/j.neuroimage.2020.117353; Antonakakis M, 2019, HUM BRAIN MAPP, V40, P5011, DOI 10.1002/hbm.24754; Batsikadze G, 2013, J PHYSIOL-LONDON, V591, P1987, DOI 10.1113/jphysiol.2012.249730; Bland NS, 2019, EXP BRAIN RES, V237, P3071, DOI 10.1007/s00221-019-05666-0; Cancelli A, 2015, BRAIN STIMUL, V8, P555, DOI 10.1016/j.brs.2015.01.398; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Del Felic A, 2019, NEUROIMAGE-CLIN, V22, DOI 10.1016/j.nicl.2019.101768; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fernandez-Corazza M, 2020, NEUROIMAGE, V209, DOI 10.1016/j.neuroimage.2019.116403; Ferree TC, 2000, IEEE T BIO-MED ENG, V47, P1584, DOI 10.1109/10.887939; Feurra M, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00013; Filmer HL, 2019, NEUROIMAGE, V196, P41, DOI 10.1016/j.neuroimage.2019.04.026; Fuchs M, 1998, ELECTROEN CLIN NEURO, V107, P93, DOI 10.1016/S0013-4694(98)00046-7; Ghasemian-Shirvan E, 2020, BRAIN STIMUL, V13, P1588, DOI 10.1016/j.brs.2020.09.004; Gotz T, 2014, J CLIN NEUROPHYSIOL, V31, P253, DOI 10.1097/WNP.0000000000000048; Gundlach C, 2020, NEUROIMAGE, V221, DOI 10.1016/j.neuroimage.2020.117175; Hannah R, 2022, NEUROIMAGE, V251, DOI 10.1016/j.neuroimage.2022.118975; Hannah R, 2019, BRAIN STIMUL, V12, P684, DOI 10.1016/j.brs.2019.01.016; HARI R, 1993, EUR J NEUROSCI, V5, P724, DOI 10.1111/j.1460-9568.1993.tb00536.x; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Hill AT, 2019, CORTEX, V113, P37, DOI 10.1016/j.cortex.2018.11.022; Jamil A, 2017, J PHYSIOL-LONDON, V595, P1273, DOI 10.1113/JP272738; Kaarre O, 2018, ADDICT BIOL, V23, P268, DOI 10.1111/adb.12486; Kasten FH, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13417-6; Khan A, 2022, CLIN NEUROPHYSIOL, V134, P9, DOI 10.1016/j.clinph.2021.10.016; Kim JH, 2014, NEUROSCI LETT, V564, P6, DOI 10.1016/j.neulet.2014.01.054; Klimesch W, 2007, BRAIN RES REV, V53, P63, DOI 10.1016/j.brainresrev.2006.06.003; Klink K, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120932; Komssi S, 2004, CLIN NEUROPHYSIOL, V115, P534, DOI 10.1016/j.clinph.2003.10.034; Krieg TD, 2013, BRAIN STIMUL, V6, P898, DOI 10.1016/j.brs.2013.05.007; Laakso I, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37226-x; Laakso I, 2015, BRAIN STIMUL, V8, P906, DOI 10.1016/j.brs.2015.05.002; Lee S, 2018, EUR J NEUROSCI, V48, P2001, DOI 10.1111/ejn.14085; Li K, 2016, COMPUT INTEL NEUROSC, V2016, DOI 10.1155/2016/1349851; Li LM, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00181; Lisman JE, 2001, J PHYSIOL-LONDON, V532, P285, DOI 10.1111/j.1469-7793.2001.0285f.x; Lucka F, 2012, NEUROIMAGE, V61, P1364, DOI 10.1016/j.neuroimage.2012.04.017; Luu P, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00377; Manzo N, 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Matsunaga K, 2004, CLIN NEUROPHYSIOL, V115, P456, DOI 10.1016/S1388-2457(03)00362-6; Mehta AR, 2015, BRAIN STIMUL, V8, P260, DOI 10.1016/j.brs.2014.11.003; Moliadze V, 2012, BRAIN STIMUL, V5, P505, DOI 10.1016/j.brs.2011.11.004; Moliadze V, 2010, J PHYSIOL-LONDON, V588, P4891, DOI 10.1113/jphysiol.2010.196998; Murphy OW, 2020, BRAIN STIMUL, V13, P1370, DOI 10.1016/j.brs.2020.07.001; Nikolin S, 2018, BRAIN STIMUL, V11, P518, DOI 10.1016/j.brs.2018.01.003; Nitsche MA, 2000, J PHYSIOL-LONDON, V527, P633, DOI 10.1111/j.1469-7793.2000.t01-1-00633.x; Nitsche MA, 2012, J PHYSIOL-LONDON, V590, P4641, DOI 10.1113/jphysiol.2012.232975; Nitsche MA, 2011, RESTOR NEUROL NEUROS, V29, P463, DOI 10.3233/RNN-2011-0618; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Oostenveld R, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/156869; Parazzini M, 2017, IEEE T BIO-MED ENG, V64, P184, DOI 10.1109/TBME.2016.2553177; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; Peirce JW, 2009, FRONT NEUROINFORM, V2, DOI 10.3389/neuro.11.010.2008; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Piastra MC, 2021, HUM BRAIN MAPP, V42, P978, DOI 10.1002/hbm.25272; Pleger B, 2006, J NEUROSCI, V26, P1945, DOI 10.1523/JNEUROSCI.4097-05.2006; Premoli I, 2017, NEUROIMAGE, V163, P1, DOI 10.1016/j.neuroimage.2017.09.023; Radecke JO, 2020, IEEE ACCESS, V8, P182610, DOI 10.1109/ACCESS.2020.3028618; Rahman A, 2013, J PHYSIOL-LONDON, V591, P2563, DOI 10.1113/jphysiol.2012.247171; Rawji V, 2018, BRAIN STIMUL, V11, P289, DOI 10.1016/j.brs.2017.11.001; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Rezaei A, 2021, NEUROIMAGE, V245, DOI 10.1016/j.neuroimage.2021.118726; Rezaei A, 2020, BRAIN SCI, V10, DOI 10.3390/brainsci10120934; Ridding MC, 2010, J PHYSIOL-LONDON, V588, P2291, DOI 10.1113/jphysiol.2010.190314; Romo R, 1999, NATURE, V399, P470, DOI 10.1038/20939; Russell GS, 2005, CLIN NEUROPHYSIOL, V116, P1130, DOI 10.1016/j.clinph.2004.12.022; Saier MH, 2007, WATER AIR SOIL POLL, V181, P1, DOI 10.1007/s11270-007-9372-6; Saito K, 2019, BEHAV BRAIN RES, V375, DOI 10.1016/j.bbr.2019.112168; Salman A, 2016, CONCURR COMP-PRACT E, V28, P2213, DOI 10.1002/cpe.3510; Saturnino GB, 2019, NEUROIMAGE, V188, P821, DOI 10.1016/j.neuroimage.2018.12.053; Schmidt C, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/046028; Smith MJ, 1999, NEUROLOGY, V53, P2069, DOI 10.1212/WNL.53.9.2069; Stropahl M, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00309; Sun FQ, 2021, CLIN NEUROPHYSIOL, V132, P487, DOI 10.1016/j.clinph.2020.11.032; Tame L, 2012, J COGNITIVE NEUROSCI, V24, P2306, DOI 10.1162/jocn_a_00272; Tremblay S, 2017, BRAIN STIMUL, V10, P744, DOI 10.1016/j.brs.2017.03.009; Vieira PG, 2020, PLOS BIOL, V18, DOI 10.1371/journal.pbio.3000834; Viola FC, 2009, CLIN NEUROPHYSIOL, V120, P868, DOI 10.1016/j.clinph.2009.01.015; Vorwerk J, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00531; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Wagner S, 2016, NEUROIMAGE, V140, P163, DOI 10.1016/j.neuroimage.2016.04.005; Wischnewski M, 2019, BRAIN STIMUL, V12, P1381, DOI 10.1016/j.brs.2019.07.023; Wittenberg MA., 2019, FRONT NEUROSCI, V13, P1, DOI [10.3389/fnins.2019.00001, DOI 10.3389/FNINS.2019.00001]; Ziemann U, 2015, CLIN NEUROPHYSIOL, V126, P1847, DOI 10.1016/j.clinph.2014.08.028; Zulkifly MFM, 2021, CLIN NEUROPHYSIOL, V132, P1367, DOI 10.1016/j.clinph.2021.01.024; Zulkifly MFM, 2021, PSYCHONEUROENDOCRINO, V127, DOI 10.1016/j.psyneuen.2021.105201; Zulkifly MFM, 2020, CLIN NEUROPHYSIOL, V131, P778, DOI 10.1016/j.clinph.2019.11.062	93	0	0	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266107	10.1371/journal.pone.0266107	http://dx.doi.org/10.1371/journal.pone.0266107			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324989	Green Published, gold			2022-12-26	WOS:000780951300101
J	Kojima, Y; Misawa, N; Yamamoto, T; Honda, S				Kojima, Yuka; Misawa, Norihiko; Yamamoto, Tatsunori; Honda, Shigeru			Intraoperative alteration in the vital signs of diabetic patients during cataract surgery with local anesthesia	PLOS ONE			English	Article							BLOOD-PRESSURE; MELLITUS; EVENTS	Purpose Diabetic patients often have systemic circulation diseases which may cause serious systemic complications during ophthalmic surgeries with local anesthesia. The purpose of this study is to evaluate the intraoperative alteration of the vital signs in diabetic patients during cataract surgery with local anesthesia. Methods Clinical records of 428 patients who underwent cataract surgeries with local anesthesia were reviewed. The parameters measured were systolic/diastolic blood pressures and pulse rates at pre-operation, 5, 10 and 15 minutes during the surgeries. The factors were compared between non-diabetic patients (n = 325) and diabetic patients (n = 103). Results Diabetic patients had significantly higher fasting blood sugar and preoperative pulse rate. Diabetic patients showed significantly higher systolic blood pressure compared to non-diabetic patients at 5 and 10 minutes from the beginning of surgery (p = 0.0093 and 0.0075, respectively). In the non-diabetic patients, the pulse rate was significantly decreased at 5 minutes from the beginning of surgery (p = 4.74 x 10- 8) which was maintained during the surgery, but no change was observed in the pulse rate of the diabetic patients. Conclusions Diabetic patients showed higher systolic blood pressure and pulse rate during cataract surgeries with local anesthesia, which should be monitored carefully by the physicians to avoid possible systemic complications.	[Kojima, Yuka; Misawa, Norihiko; Yamamoto, Tatsunori; Honda, Shigeru] Osaka City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Osaka, Japan	Osaka Metropolitan University	Honda, S (corresponding author), Osaka City Univ, Grad Sch Med, Dept Ophthalmol & Visual Sci, Osaka, Japan.	honda.shigeru@med.osaka-cu.ac.jp						Aronow WS, 2018, ANN TRANSL MED, V6, DOI 10.21037/atm.2018.04.36; Barker P, 2015, ANAESTHESIA, V70, P1427, DOI 10.1111/anae.13233; Basta B, 2011, MINERVA ANESTESIOL, V77, P877; Fotheringham J, 2015, HYPERTENSION, V65, P510, DOI 10.1161/HYPERTENSIONAHA.114.04656; Grossman A, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-016-0485-3; Ianchulev T, 2016, OPHTHALMOLOGY, V123, P723, DOI 10.1016/j.ophtha.2015.12.020; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Khalighinejad Pooyan, 2015, Adv Biomed Res, V4, P222, DOI 10.4103/2277-9175.166645; Laederach-Hofmann K, 1999, CLIN PHYSIOL, V19, P97; Pavlou DI, 2018, MATURITAS, V112, P71, DOI 10.1016/j.maturitas.2018.03.013; Poorolajal J, 2016, PUBLIC HEALTH, V133, P14, DOI 10.1016/j.puhe.2015.10.014; Schwall B, 2000, ACTA ANAESTH SCAND, V44, P343, DOI 10.1034/j.1399-6576.2000.440322.x; Sharwood PL, 2008, CLIN EXP OPHTHALMOL, V36, P842, DOI 10.1111/j.1442-9071.2009.01924.x; Vaidya V, 2015, EXPERT REV PHARM OUT, V15, P487, DOI 10.1586/14737167.2015.1024661	14	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265135	10.1371/journal.pone.0265135	http://dx.doi.org/10.1371/journal.pone.0265135			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316307	gold, Green Published			2022-12-26	WOS:000834238000018
J	Foh, B; Buhre, JS; Lunding, HB; Moreno-Fernandez, ME; Konig, P; Sina, C; Divanovic, S; Ehlers, M				Foeh, Bandik; Buhre, Jana Sophia; Lunding, Hanna B.; Moreno-Fernandez, Maria E.; Koenig, Peter; Sina, Christian; Divanovic, Senad; Ehlers, Marc			Microbial metabolite butyrate promotes induction of IL-10(+)IgM(+) plasma cells	PLOS ONE			English	Article							CHAIN FATTY-ACIDS; B-CELLS; GUT MICROBIOTA; DIETARY FIBER; PROTEIN; ACTIVATION; AUTOIMMUNE; ROLES; DIFFERENTIATION; SIALYLATION	The microbially-derived short-chain fatty acid butyrate is a central inhibitor of inflammatory innate and adaptive immune responses. Emerging evidence suggests that butyrate induces differentiation of IL-10-producing (IL-10(+)) regulatory B cells. However, the underlying mechanisms of butyrate-driven modulation of B cell differentiation are not fully defined. Given the dominant role of regulatory plasma cells (PCs) as the main source of anti-inflammatory cytokines including IL-10 and the observation that butyrate also induces the differentiation of PCs, we here investigated the effect of the microbial metabolite butyrate on the induction of regulatory IL-10(+) PCs and underlying mechanisms. Here we show that butyrate induces the differentiation of IL-10(+)IgM(+) PCs. Ex vivo, butyrate, but hardly propionate, another microbially-derived short-chain fatty acid, induced the differentiation of IL-10(+)IgM(+) CD138(high) PCs from isolated splenic murine B cells. In vivo, administration of butyrate via drinking water or by daily intraperitoneal injection increased the number of IL-10(+)IgM(+) CD138(high) PCs in the spleens of Ovalbumin (Ova)/complete Freund's adjuvant-immunized mice. The induction of these regulatory PCs was associated with an increase of anti-Ova IgM, but a reduction of anti-Ova class-switched pathogenic IgG2b serum antibodies. Based on the knowledge that butyrate inhibits histone deacetylases (HDACs) thereby increasing histone acetylation, we identified here that HDAC3 inhibition was sufficient to induce PC differentiation and IL-10(+) expression. Furthermore, reduced mitochondrial superoxide levels following butyrate treatment and HDAC3 inhibition were necessary for PC differentiation, but not IL-10 expression. In summary, the microbial metabolite butyrate promotes the differentiation of IgM(+) PCs and their expression of IL-10. HDAC3 inhibition may be involved as an underlying pathway for both PC differentiation and IL-10 expression, while reduced mitochondrial superoxide levels are crucial only for PC differentiation. The induction of regulatory IL-10(+)IgM(+) PCs and the inhibition of class switching to antigen-specific pathogenic IgG subclasses might represent important pathways of butyrate to limit inflammation.	[Foeh, Bandik; Buhre, Jana Sophia; Lunding, Hanna B.; Sina, Christian; Ehlers, Marc] Univ Lubeck, Inst Nutr Med, Lubeck, Germany; [Foeh, Bandik; Buhre, Jana Sophia; Lunding, Hanna B.; Sina, Christian; Ehlers, Marc] Univ Hosp Schleswig Holstein, Lubeck, Germany; [Foeh, Bandik; Buhre, Jana Sophia; Lunding, Hanna B.; Sina, Christian; Ehlers, Marc] Univ Hosp Schleswig Holstein, Dept Med 1, Lubeck, Germany; [Moreno-Fernandez, Maria E.; Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Div Immunobiol, Cincinnati, OH USA; [Koenig, Peter] Univ Lubeck, Inst Anat, Lubeck, Germany; [Divanovic, Senad] Univ Cincinnati, Dept Pediat, Coll Med, Cincinnati, OH USA; [Divanovic, Senad] Cincinnati Childrens Hosp Med Ctr, Ctr Inflammat & Tolerance, Cincinnati, OH USA; [Ehlers, Marc] Univ Lubeck, Airway Res Ctr North, German Ctr Lung Res DZL, Lubeck, Germany	University of Lubeck; University of Kiel; Schleswig Holstein University Hospital; University of Kiel; Schleswig Holstein University Hospital; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; University of Lubeck; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center; University of Lubeck	Ehlers, M (corresponding author), Univ Lubeck, Inst Nutr Med, Lubeck, Germany.; Ehlers, M (corresponding author), Univ Hosp Schleswig Holstein, Lubeck, Germany.; Ehlers, M (corresponding author), Univ Hosp Schleswig Holstein, Dept Med 1, Lubeck, Germany.; Ehlers, M (corresponding author), Univ Lubeck, Airway Res Ctr North, German Ctr Lung Res DZL, Lubeck, Germany.	Marc.Ehlers@uksh.de	König, Peter/AAK-2021-2020; Ehlers, Marc/C-9441-2011	Ehlers, Marc/0000-0002-5383-8603	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the International Research Training Group - IRTG [1911]	Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the International Research Training Group - IRTG(German Research Foundation (DFG))	The project and B.F. were funded by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) as part of the International Research Training Group - IRTG 1911.	Arpaia N, 2013, NATURE, V504, P451, DOI 10.1038/nature12726; Bartsch YC, 2020, J ALLERGY CLIN IMMUN, V146, P652, DOI 10.1016/j.jaci.2020.04.059; Bartsch YC, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01183; Bellanti JA, 2020, PEDIATR RES, V87, P378, DOI 10.1038/s41390-019-0644-9; Bigarella CL, 2014, DEVELOPMENT, V141, P4206, DOI 10.1242/dev.107086; Braza F, 2014, ALLERGY, V69, P1454, DOI 10.1111/all.12490; Cait A, 2018, MUCOSAL IMMUNOL, V11, P785, DOI 10.1038/mi.2017.75; Campbell E, 2021, MUCOSAL IMMUNOL, V14, P4, DOI 10.1038/s41385-020-00350-x; Carotta S, 2014, J EXP MED, V211, P2169, DOI 10.1084/jem.20140425; Chang PV, 2014, P NATL ACAD SCI USA, V111, P2247, DOI 10.1073/pnas.1322269111; Chi ZX, 2020, MOL CELL, V80, P43, DOI 10.1016/j.molcel.2020.08.015; Constantinescu CS, 2011, BRIT J PHARMACOL, V164, P1079, DOI 10.1111/j.1476-5381.2011.01302.x; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; Davie JR, 2003, J NUTR, V133, p2485S, DOI 10.1093/jn/133.7.2485S; den Besten G, 2013, J LIPID RES, V54, P2325, DOI 10.1194/jlr.R036012; Epp A, 2018, J ALLERGY CLIN IMMUN, V141, P399, DOI 10.1016/j.jaci.2017.06.021; Epp A, 2016, CURR ALLERGY ASTHM R, V16, DOI 10.1007/s11882-016-0658-x; Fillatreau S, 2002, NAT IMMUNOL, V3, P944, DOI 10.1038/ni833; Fillatreau S, 2019, BIOMED J, V42, P233, DOI 10.1016/j.bj.2019.05.008; Fillatreau S, 2015, CURR OPIN PHARMACOL, V23, P1, DOI 10.1016/j.coph.2015.04.006; Gao ZG, 2009, DIABETES, V58, P1509, DOI 10.2337/db08-1637; Huang R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096246; Irvine EB, 2020, GLYCOBIOLOGY, V30, P241, DOI 10.1093/glycob/cwaa018; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Jang KJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7750; Jennewein MF, 2017, TRENDS IMMUNOL, V38, P358, DOI 10.1016/j.it.2017.02.004; Kim CH, 2018, IMMUNOLOGY, V154, P220, DOI 10.1111/imm.12930; Kim DS, 2021, J AUTOIMMUN, V119, DOI 10.1016/j.jaut.2021.102611; Kim DS, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01525; Kim M, 2016, CELL HOST MICROBE, V20, P202, DOI 10.1016/j.chom.2016.07.001; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Krautkramer KA, 2016, MOL CELL, V64, P982, DOI 10.1016/j.molcel.2016.10.025; Lilienthal GM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00958; Luu M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08711-2; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Martin F, 2004, IMMUNITY, V20, P517, DOI 10.1016/S1074-7613(04)00112-8; Maslowski KM, 2009, NATURE, V461, P1282, DOI 10.1038/nature08530; Matsumoto M, 2014, IMMUNITY, V41, P1040, DOI 10.1016/j.immuni.2014.10.016; Mauri C, 2015, INT IMMUNOL, V27, P479, DOI 10.1093/intimm/dxv038; Mollica MP, 2017, DIABETES, V66, P1405, DOI 10.2337/db16-0924; Mottawea W, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13419; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neves P, 2010, IMMUNITY, V33, P777, DOI 10.1016/j.immuni.2010.10.016; Nimmerjahn F, 2006, IMMUNITY, V24, P19, DOI 10.1016/j.immuni.2005.11.010; Nimmerjahn F, 2005, IMMUNITY, V23, P41, DOI 10.1016/j.immuni.2005.05.010; O'Neill SK, 2007, FRONT BIOSCI-LANDMRK, V12, P1722, DOI 10.2741/2184; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Pascal M, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01584; Recaldin T, 2016, CLIN EXP IMMUNOL, V183, P65, DOI 10.1111/cei.12702; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rosser EC, 2020, CELL METAB, V31, P837, DOI 10.1016/j.cmet.2020.03.003; Rosser EC, 2015, IMMUNITY, V42, P607, DOI 10.1016/j.immuni.2015.04.005; Russell SL, 2012, EMBO REP, V13, P440, DOI 10.1038/embor.2012.32; Sanchez HN, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-019-13603-6; Scharer CD, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04125-8; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Shaffer AL, 2002, IMMUNITY, V17, P51, DOI 10.1016/S1074-7613(02)00335-7; Shen P, 2014, NATURE, V507, P366, DOI 10.1038/nature12979; Shukla Vipul, 2014, Front Biol (Beijing), V9, P269; Shutt DC, 2010, CANCER BIOL THER, V9, P853, DOI 10.4161/cbt.9.11.11632; Silva LG, 2018, J ANIM SCI, V96, P5244, DOI 10.1093/jas/sky373; Sina C, 2009, J IMMUNOL, V183, P7514, DOI 10.4049/jimmunol.0900063; Singh N, 2010, J BIOL CHEM, V285, P27601, DOI 10.1074/jbc.M110.102947; Smith PM, 2013, SCIENCE, V341, P569, DOI 10.1126/science.1241165; Swindle EJ, 2002, J IMMUNOL, V169, P5866, DOI 10.4049/jimmunol.169.10.5866; Takahashi D, 2020, EBIOMEDICINE, V58, DOI 10.1016/j.ebiom.2020.102913; Tan J, 2016, CELL REP, V15, P2809, DOI 10.1016/j.celrep.2016.05.047; Tay RE, 2020, J EXP MED, V217, DOI 10.1084/jem.20191453; Traba J, 2016, JOVE-J VIS EXP, DOI 10.3791/54918; Trompette A, 2014, NAT MED, V20, P159, DOI 10.1038/nm.3444; Usami M, 2008, NUTR RES, V28, P321, DOI 10.1016/j.nutres.2008.02.012; Vinolo MAR, 2011, J NUTR BIOCHEM, V22, P849, DOI 10.1016/j.jnutbio.2010.07.009; Vinolo MAR, 2009, CLIN SCI, V117, P331, DOI 10.1042/CS20080642; Wang QL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017234; Wang Y, 2006, BIOCHEM PHARMACOL, V72, P881, DOI 10.1016/j.bcp.2006.06.032; Wang YC, 2010, BIOORG MED CHEM LETT, V20, P493, DOI 10.1016/j.bmcl.2009.11.112; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Xu HH, 2019, J IMMUNOL RES, V2019, DOI 10.1155/2019/7546047; Yip W, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.628453; Zhang X, 2020, TRENDS MOL MED, V26, P862, DOI 10.1016/j.molmed.2020.04.001; Zheng DP, 2020, CELL RES, V30, P492, DOI 10.1038/s41422-020-0332-7	81	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266071	10.1371/journal.pone.0266071	http://dx.doi.org/10.1371/journal.pone.0266071			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333906	gold, Green Published			2022-12-26	WOS:000784335700043
J	Pala, D; Casella, V; Larizza, C; Malovini, A; Bellazzi, R				Pala, Daniele; Casella, Vittorio; Larizza, Cristiana; Malovini, Alberto; Bellazzi, Riccardo			Impact of COVID-19 lockdown on PM concentrations in an Italian Northern City: A year-by-year assessment	PLOS ONE			English	Article							AIR-POLLUTION	In the last century, the increase in traffic, human activities and industrial production have led to a diffuse presence of air pollution, which causes an increase of risk of several health conditions such as respiratory diseases. In Europe, air pollution is a serious concern that affects several areas, one of the worst ones being northern Italy, and in particular the Po Valley, an area characterized by low air quality due to a combination of high population density, industrial activity, geographical factors and weather conditions. Public health authorities and local administrations are aware of this problem, and periodically intervene with temporary traffic limitations and other regulations, often insufficient to solve the problem. In February 2020, this area was the first in Europe to be severely hit by the SARS-CoV-2 virus causing the COVID-19 disease, to which the Italian government reacted with the establishment of a drastic lockdown. This situation created the condition to study how significant is the impact of car traffic and industrial activity on the pollution in the area, as these factors were strongly reduced during the lockdown. Differently from some areas in the world, a drastic decrease in pollution measured in terms of particulate matter (PM) was not observed in the Po Valley during the lockdown, suggesting that several external factors can play a role in determining the severity of pollution. In this study, we report the case study of the city of Pavia, where data coming from 23 air quality sensors were analyzed to compare the levels measured during the lockdown with the ones coming from the same period in 2019. Our results show that, on a global scale, there was a statistically significant reduction in terms of PM levels taking into account meteorological variables that can influence pollution such as wind, temperature, humidity, rain and solar radiation. Differences can be noticed analyzing daily pollution trends too, as-compared to the study period in 2019-during the study period in 2020 pollution was higher in the morning and lower in the remaining hours.	[Pala, Daniele; Larizza, Cristiana; Bellazzi, Riccardo] Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy; [Casella, Vittorio] Univ Pavia, Dept Civil Engn & Architecture, Pavia, Italy; [Malovini, Alberto] Ist Clin Sci Maugeri SpA SB IRCCS, Pavia, Italy	University of Pavia; University of Pavia	Pala, D (corresponding author), Univ Pavia, Dept Elect Comp & Biomed Engn, Pavia, Italy.	daniele.pala@unipv.it		CASELLA, Vittorio/0000-0003-2086-7931; Pala, Daniele/0000-0001-5741-3349	European Commission [GA-727816, GA-101016233]	European Commission(European CommissionEuropean Commission Joint Research Centre)	The work has been funded by the European Commission with Grant Agreements GA-727816 and GA-101016233. All authors received funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aj W., 1991, EXPLANATION TRENDS B, V66, P85; Anjum N.A., 2020, GOOD WORST COVID 19, DOI [10.20944/preprints202004.0069.v1, DOI 10.20944/PREPRINTS202004.0069.V1]; Bawazir A, 2018, J INFECT PUBLIC HEAL, V11, P89, DOI 10.1016/j.jiph.2017.05.003; Bigi A, 2012, J ENVIRON MONITOR, V14, P552, DOI 10.1039/c1em10728c; Boyle JP, 2001, DIABETES CARE, V24, P1936, DOI 10.2337/diacare.24.11.1936; Collivignarelli MC, 2020, SCI TOTAL ENVIRON, V732, DOI 10.1016/j.scitotenv.2020.139280; contributors PL, PURPLEAIR; Donzelli G, 2020, ATMOSPHERE-BASEL, V11, DOI 10.3390/atmos11101118; Franchini M, 2007, J THROMB HAEMOST, V5, P2169, DOI 10.1111/j.1538-7836.2007.02750.x; Kumar P, 2015, ENVIRON INT, V75, P199, DOI 10.1016/j.envint.2014.11.019; Mazzei F, 2008, SCI TOTAL ENVIRON, V401, P81, DOI 10.1016/j.scitotenv.2008.03.008; Menut L, 2020, SCI TOTAL ENVIRON, V741, DOI 10.1016/j.scitotenv.2020.140426; Pala D, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20072105; Pala D, 2019, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00084; Pearce N, 2007, THORAX, V62, P758, DOI 10.1136/thx.2006.070169; redazione, 2015, SCI NET; Rita V., 2020, GALILEO; S.r.l LF, NITR DIOX FIN PART A; Venter ZS, 2020, P NATL ACAD SCI USA, V117, P18984, DOI 10.1073/pnas.2006853117; Wang MC, 2021, AIR QUAL ATMOS HLTH, V14, P591, DOI 10.1007/s11869-020-00963-y; Wang Y, 2021, REMOTE SENS-BASEL, V13, DOI 10.3390/rs13183742	21	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263265	10.1371/journal.pone.0263265	http://dx.doi.org/10.1371/journal.pone.0263265			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344546	Green Published, gold			2022-12-26	WOS:000788055200014
J	Yasuda, T; Tahara, K; Sawada, T				Yasuda, Takuya; Tahara, Koichiro; Sawada, Tetsuji			Detection of salivary citrullinated cytokeratin 13 in healthy individuals and patients with rheumatoid arthritis by proteomics analysis	PLOS ONE			English	Article							DEIMINATED PROTEINS; SYNOVIAL-FLUID; PEPTIDES; AUTOANTIBODIES; IDENTIFICATION; ANTIBODIES; FILAGGRIN	The immune response to citrullinated peptides in the mucosa has been suggested to play an important role in the transition from pre-onset rheumatoid arthritis (RA) to clinically evident RA. Although there are reports indicating the presence of anti-citrullinated peptide antibodies in the saliva, few studies have reported citrullinated peptide detection in human saliva. This study aimed to identify citrullinated peptides in human saliva and discuss their clinical significance. Saliva samples were collected from 11 patients with RA and from 20 healthy individuals. Citrullinated peptides were detected using an anti-modified citrulline (AMC) antibody. Saliva from the healthy individuals was subjected to two-dimensional protein electrophoresis to isolate citrullinated peptides, which were analyzed by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and mass spectrometry by peptide mass fingerprinting. The results were corroborated by immunoprecipitation (IP)-western blotting. The signal intensities of the bands precipitated with anti-cytokeratin 13 (CK13) and AMC antibodies were quantified. The signal intensity ratio of the band produced by the AMC antibody was divided by that of the band produced by the anti-CK13 antibody to calculate the citrullinated CK13 (Cit-CK13) ratio. A citrullinated peptide band corresponding to a molecular weight of approximately 50 kDa was detected in the saliva of healthy individuals, and identified as CK13 via mass spectrometry and IP-western blotting. No significant difference was observed between the salivary Cit-CK13 ratios of patients with RA and healthy participants (p = 0.605). This is the first study to show that Cit-CK13 is present in human saliva, and that there is no significant difference between the Cit-CK13 ratios of patients with RA and healthy individuals, suggesting that salivary Cit-CK13 content and RA development may not be associated. The physiological and pathological roles of Cit-CK13 in the oral cavity, and its responsiveness to mucosal immunity, remain unknown and will be the subject of further investigation.	[Yasuda, Takuya; Tahara, Koichiro; Sawada, Tetsuji] Tokyo Med Univ Hosp, Dept Rheumatol, Tokyo, Japan	Tokyo Medical University	Yasuda, T (corresponding author), Tokyo Med Univ Hosp, Dept Rheumatol, Tokyo, Japan.	t_yasuda@tokyo-med.ac.jp	Sawed, Tetsuji/GRX-6582-2022	Yasuda, Takuya/0000-0002-1630-3706				Aguet F, 2020, SCIENCE, V369, P1318, DOI 10.1126/science.aaz1776; [Anonymous], 2013, Ann Rheum Dis, V72 Suppl 3, pA1, DOI 10.1136/annrheumdis-2013-eular.1; Arita S, 2018, J PERIODONTAL RES, V53, P750, DOI 10.1111/jre.12561; BECKS H., 1934, Journal of Dental Research, V14, P387, DOI 10.1177/00220345340140050601; Berridge MJ, 2000, NAT REV MOL CELL BIO, V1, P11, DOI 10.1038/35036035; Curran AM, 2020, NAT REV RHEUMATOL, V16, P301, DOI 10.1038/s41584-020-0409-1; De Benedetto A, 2008, J INVEST DERMATOL, V128, P1594, DOI 10.1038/sj.jid.5701208; Fernandez J, 1998, ELECTROPHORESIS, V19, P1036, DOI 10.1002/elps.1150190619; Gould RM, 2000, J NEUROCHEM, V75, P1834, DOI 10.1046/j.1471-4159.2000.0751834.x; GRAY PTA, 1988, J PHYSIOL-LONDON, V406, P35, DOI 10.1113/jphysiol.1988.sp017367; Gyorgy B, 2006, INT J BIOCHEM CELL B, V38, P1662, DOI 10.1016/j.biocel.2006.03.008; INAGAKI M, 1989, J BIOL CHEM, V264, P18119; James EA, 2010, ARTHRITIS RHEUM-US, V62, P2909, DOI 10.1002/art.27594; Joshua V, 2017, BEST PRACT RES CL RH, V31, P31, DOI 10.1016/j.berh.2017.08.002; Kan SH, 1996, ZOOL SCI, V13, P673, DOI 10.2108/zsj.13.673; Kelmenson LB, 2020, ARTHRITIS RHEUMATOL, V72, P251, DOI 10.1002/art.41091; Kimura E, 2014, MOD RHEUMATOL, V24, P766, DOI 10.3109/14397595.2013.879413; Kinloch A, 2008, ARTHRITIS RHEUM, V58, P2287, DOI 10.1002/art.23618; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Laurent L, 2011, ANN RHEUM DIS, V70, P1052, DOI 10.1136/ard.2010.142091; Li FJ, 2021, SCI TRANSL MED, V13, DOI 10.1126/scitranslmed.aba2927; Ljungberg KR, 2020, ARTHRITIS RES THER, V22, DOI 10.1186/s13075-020-02363-0; Maeda Y, 2016, ARTHRITIS RHEUMATOL, V68, P2646, DOI 10.1002/art.39783; Masson-Bessiere C, 2001, J IMMUNOL, V166, P4177, DOI 10.4049/jimmunol.166.6.4177; Matson S, 2021, ARTHRITIS RHEUMATOL, V73, P592; Page RC, 2007, J PERIODONTOL, V78, P1387, DOI 10.1902/jop.2007.060264; Rasmussen E, 2021, ARTHRITIS RHEUMATOL, V73, P2484; Sakaguchi W, 2019, ARCH ORAL BIOL, V108, DOI 10.1016/j.archoralbio.2019.104510; SENSHU T, 1992, ANAL BIOCHEM, V203, P94, DOI 10.1016/0003-2697(92)90047-B; Sieghart D, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00876; Song SZ, 2019, FRONT ONCOL, V9, DOI 10.3389/fonc.2019.00304; Sugawara E, 2020, AUTOPHAGY, V16, P946, DOI 10.1080/15548627.2019.1664144; Sugihara Shuntaro., 2018, J JAPANESE SOC PERIO, V60, P183; Svard A, 2020, CLIN EXP RHEUMATOL, V38, P699; Svard A, 2020, CLIN EXP IMMUNOL, V199, P143, DOI 10.1111/cei.13381; Svard A, 2013, IMMUNOBIOLOGY, V218, P232, DOI 10.1016/j.imbio.2012.04.011; Tabushi Y, 2008, ANN CLIN BIOCHEM, V45, P413, DOI 10.1258/acb.2007.007205; Takizawa Y, 2006, ANN RHEUM DIS, V65, P1013, DOI 10.1136/ard.2005.044743; Tanikawa C, 2009, CANCER RES, V69, P8761, DOI 10.1158/0008-5472.CAN-09-2280; Tar I, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-93008-y; Ueno M, 2020, ASIA-PAC J PUBLIC HE, V32, P346, DOI 10.1177/1010539520944721; Umeda Naoto, 2017, Nihon Rinsho Meneki Gakkai Kaishi, V40, P391, DOI 10.2177/jsci.40.391; Vossenaar ER, 2003, BIOESSAYS, V25, P1106, DOI 10.1002/bies.10357; Wang L, 2017, CANCER RES, V77, P5755, DOI 10.1158/0008-5472.CAN-17-0150; Zhu DW, 2021, MOL CANCER, V20, DOI 10.1186/s12943-021-01373-z	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265687	10.1371/journal.pone.0265687	http://dx.doi.org/10.1371/journal.pone.0265687			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320820	gold, Green Published			2022-12-26	WOS:000784240600031
J	Tachida, Y; Miura, S; Muto, Y; Takuwa, H; Sahara, N; Shindo, A; Matsuba, Y; Saito, T; Taniguchi, N; Kawaguchi, Y; Tomimoto, H; Saido, T; Kitazume, S				Tachida, Yuriko; Miura, Saori; Muto, Yui; Takuwa, Hiroyuki; Sahara, Naruhiko; Shindo, Akihiro; Matsuba, Yukio; Saito, Takashi; Taniguchi, Naoyuki; Kawaguchi, Yasushi; Tomimoto, Hidekazu; Saido, Takaomi; Kitazume, Shinobu			Endothelial expression of human amyloid precursor protein leads to amyloid beta in the blood and induces cerebral amyloid angiopathy in knock-in mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ALZHEIMERS-DISEASE; A-BETA; TRANSGENIC MICE; MOUSE MODELS; HEMORRHAGE; PEPTIDE; ACTIVATION; CLEARANCE; AIOLOS; CELLS	The deposition of amyloid P (A beta) in blood vessels of the brain, known as cerebral amyloid angiopathy (CAA), is observed in most patients with Alzheimer's disease (AD). Compared with the pathology of CAA in humans, the pathology in most mouse models of AD is not as evident, making it difficult to examine the contribution of CAA to the pathogenesis of AD. On the basis of biochemical analyses that showed blood levels of soluble amyloid precursor protein (APP) in rats and mice were markedly lower than those measured in human samples, we hypothesized that endothelial APP expression would be markedly lower in rodents and subsequently generated mice that specifically express human WT APP (APP770) in endothelial cells (ECs). The resulting ECAPP770(+) mice exhibited increased levels of serum A beta and soluble APP, indicating that endothelial APP makes a critical contribution to blood AP levels. Even though aged EC-APP770(+) mice did not exhibit A beta deposition in the cortical blood vessels, crossing these animals with APP knock-in mice (App(NL-F/NL-F)) led to an expanded CAA pathology, as evidenced by increased amounts of amyloid accumulated in the cortical blood vessels. These results highlight an overlooked interplay between neuronal and endothelial APP in brain vascular A beta deposition. We propose that these EC-APP770(+):App(NL-F/NL-F) mice may be useful to study the basic molecular mechanisms behind the possible breakdown of the blood-brain barrier upon administration of anti-A beta antibodies.	[Tachida, Yuriko; Taniguchi, Naoyuki; Kitazume, Shinobu] Dis Glyc Team, Glycobiol Res Grp, Global Res Cluster, RIKEN, Saitama, Japan; [Miura, Saori; Kitazume, Shinobu] Fukushima Med Univ Sch Med, Sch Hlth Sci, Dept Clin Lab Sci, Fukushima, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Dept Microbiol & Immunol, Div Mol Virol, Tokyo, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Int Res Ctr Infect Dis, Dept Infect Dis Control, Tokyo, Japan; [Muto, Yui; Kawaguchi, Yasushi] Univ Tokyo, Inst Med Sci, Res Ctr Asian Infect Dis, Tokyo, Japan; [Takuwa, Hiroyuki; Sahara, Naruhiko] Natl Inst Radiol Sci, Dept Funct Brain Imaging Res, Chiba, Japan; [Shindo, Akihiro; Tomimoto, Hidekazu] Mie Univ, Grad Sch Med, Dept Neurol, Mie, Japan; [Matsuba, Yukio; Saito, Takashi; Saido, Takaomi] RIKEN Brain Sci Inst, Lab Proteolyt Neurosci, Saitama, Japan; [Saito, Takashi] Nagoya City Univ Grad Sch Med Sci, Inst Brain Sci, Dept Neurocognit Sci, Nagoya, Japan; [Kitazume, Shinobu] Osaka Int Canc Ctr, Dept Glyco Oncol & Med Biochem, Osaka, Japan	Fukushima Medical University; University of Tokyo; University of Tokyo; University of Tokyo; National Institutes for Quantum Science & Technology; Mie University; RIKEN; Nagoya City University	Kitazume, S (corresponding author), Dis Glyc Team, Glycobiol Res Grp, Global Res Cluster, RIKEN, Saitama, Japan.; Kitazume, S (corresponding author), Fukushima Med Univ Sch Med, Sch Hlth Sci, Dept Clin Lab Sci, Fukushima, Japan.; Kitazume, S (corresponding author), Osaka Int Canc Ctr, Dept Glyco Oncol & Med Biochem, Osaka, Japan.	shinobuk@fmu.ac.jp	Taniguchi, Naoyuki/I-4182-2014	Taniguchi, Naoyuki/0000-0001-5889-5968	Japan Agency for Medical Research and Development (AMED) [JP18am0101036]; Mitsubishi Foundation [16K08601, 25840043]; KAKENHI grant	Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Mitsubishi Foundation; KAKENHI grant(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding and additional information-This work was supported by the Japan Agency for Medical Research and Development (AMED) (grant no.: JP18am0101036 [to S. K.] ) , the Mitsubishi Foundation (to S. K.) , and KAKENHI grant (grant nos.: 16K08601 [to S. K.] and 25840043 to [Y. T.] ) .	Attems J, 2005, ACTA NEUROPATHOL, V110, P345, DOI 10.1007/s00401-005-1074-9; Auriel E, 2012, CURR ATHEROSCLER REP, V14, P343, DOI 10.1007/s11883-012-0254-z; Austin SA, 2009, J NEUROSCI, V29, P14451, DOI 10.1523/JNEUROSCI.3107-09.2009; Burgermeister P, 2000, ANN NY ACAD SCI, V903, P307, DOI 10.1111/j.1749-6632.2000.tb06381.x; BUSH AI, 1990, J BIOL CHEM, V265, P15977; Charidimou A, 2013, J NEUROL NEUROSUR PS, V84, P624, DOI 10.1136/jnnp-2012-304434; Charidimou A, 2012, J NEUROL NEUROSUR PS, V83, P124, DOI 10.1136/jnnp-2011-301308; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; d'Uscio LV, 2017, PHYSIOLOGY, V32, P20, DOI 10.1152/physiol.00021.2016; Davis J, 2004, J BIOL CHEM, V279, P20296, DOI 10.1074/jbc.M312946200; Eisele YS, 2010, SCIENCE, V330, P980, DOI 10.1126/science.1194516; Fukuchi K, 1996, AM J PATHOL, V149, P219; Gallardo G, 2017, CSH PERSPECT MED, V7, DOI 10.1101/cshperspect.a024331; Greenberg SM, 2020, NAT REV NEUROL, V16, P30, DOI 10.1038/s41582-019-0281-2; Han BH, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-86; Hawkes CA, 2011, ACTA NEUROPATHOL, V121, P431, DOI 10.1007/s00401-011-0801-7; Herzig MC, 2004, NAT NEUROSCI, V7, P954, DOI 10.1038/nn1302; Higuchi M, 2005, NAT NEUROSCI, V8, P527, DOI 10.1038/nn1422; KANEGAE Y, 1995, NUCLEIC ACIDS RES, V23, P3816, DOI 10.1093/nar/23.19.3816; Kisanuki YY, 2001, DEV BIOL, V230, P230, DOI 10.1006/dbio.2000.0106; Kitazume S, 2010, J BIOL CHEM, V285, P40097, DOI 10.1074/jbc.M110.144626; Kumpers P, 2009, ANN RHEUM DIS, V68, P1638, DOI 10.1136/ard.2008.094664; Mathys H, 2019, NATURE, V570, P332, DOI 10.1038/s41586-019-1195-2; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Miura S, 2020, J BIOL CHEM, V295, P13194, DOI 10.1074/jbc.RA120.012904; Morgan B, 1997, EMBO J, V16, P2004, DOI 10.1093/emboj/16.8.2004; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nakamura A, 2018, NATURE, V554, P249, DOI 10.1038/nature25456; Nakayama Y, 2017, J IMMUNOL, V199, P2388, DOI 10.4049/jimmunol.1601725; Nicoll JAR, 2003, NAT MED, V9, P448, DOI 10.1038/nm840; Pfeifer M, 2002, SCIENCE, V298, P1379, DOI 10.1126/science.1078259; PRELLI F, 1988, J NEUROCHEM, V51, P648, DOI 10.1111/j.1471-4159.1988.tb01087.x; Ray B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020405; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Sasaguri H, 2017, EMBO J, V36, P2473, DOI 10.15252/embj.201797397; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Sunshine S, 2016, J VIROL, V90, P4511, DOI 10.1128/JVI.01617-15; TAMAOKA A, 1992, P NATL ACAD SCI USA, V89, P1345, DOI 10.1073/pnas.89.4.1345; Tarasoff-Conway JM, 2015, NAT REV NEUROL, V11, P457, DOI 10.1038/nrneurol.2015.119; WERTKIN AM, 1993, P NATL ACAD SCI USA, V90, P9513, DOI 10.1073/pnas.90.20.9513; Wiseman SJ, 2016, STROKE, V47, P2722, DOI 10.1161/STROKEAHA.116.014330; Xu F, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13527; Yan RQ, 2014, LANCET NEUROL, V13, P319, DOI 10.1016/S1474-4422(13)70276-X	44	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	JUN	2022	298	6							101880	10.1016/j.jbc.2022.101880	http://dx.doi.org/10.1016/j.jbc.2022.101880			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1X9DZ	35367207	Green Published, gold			2022-12-26	WOS:000807750700012
J	Babaei-Abraki, S; Karamali, F; Nasr-Esfahani, MH				Babaei-Abraki, Shahnaz; Karamali, Fereshteh; Nasr-Esfahani, Mohammad Hossein			Monitoring the induction of ferroptosis following dissociation in human embryonic stem cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							APOPTOSIS; CANCER; INHIBITOR; REGULATOR; PATHWAY; DEATH; NRF2; P53; PROLIFERATION; EXPRESSION	Human embryonic stem cells (hESCs) are vulnerable to cell death upon dissociation. Thus, dissociation is an obstacle in culturing, maintaining, and differentiating of hESCs. To date, apoptosis has become the focus of research into the nature of cell death triggered by cellular detachment; it remains baffling whether another form of cell death can occur upon dissociation in hESCs. Here, we demonstrate that iron accumulation and subsequently lipid peroxidation are responsible for dissociation-mediated hESC death. Moreover, we found that a decrease of glutathione peroxidase 4 because of iron accumulation promotes ferroptosis. Inhibition of lipid peroxidation (ferrostatin-1) or chelating iron (deferoxamine) largely suppresses iron accumulation-induced ferroptosis in dissociated hESCs. The results show that P53 mediates the dissociation induced ferroptosis in hESCs, which is suppressed by pifi-thrin alpha. Multiple genes involved in ferroptosis are regulated by the nuclear factor erythroid 2-related factor 2 (Nrf2). In this study, solute carrier family 7 member 11 and glutathione peroxidase 4 are involved in GSH synthesis decreased upon dissociation as a target of Nrf2. In conclusion, our study demonstrates that iron accumulation as a consequence of cytoskeleton disruption appears as a pivotal factor in the initiation of ferroptosis in dissociated hESCs. Nrf2 inhibits ferroptosis via its downstream targets. Our study suggests that the antiferroptotic target might be a good candidate for the maintenance of hESCs.	[Babaei-Abraki, Shahnaz] Univ Isfahan, Fac Biol Sci & Technol, Dept Plant & Anim Biol, Esfahan, Iran; [Karamali, Fereshteh; Nasr-Esfahani, Mohammad Hossein] ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran	University of Isfahan; Academic Center for Education, Culture & Research (ACECR)	Nasr-Esfahani, MH (corresponding author), ACECR, Royan Inst Biotechnol, Dept Anim Biotechnol, Cell Sci Res Ctr, Esfahan, Iran.	mh.nasresfahani@royaninstitute.org		Nasr-Esfahani, Mohammad-Hossein/0000-0003-1983-3435; babaei abraki, shahnaz/0000-0003-1425-0900				Angeli JPF, 2017, TRENDS PHARMACOL SCI, V38, P489, DOI 10.1016/j.tips.2017.02.005; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Baharvand H, 2006, DEV GROWTH DIFFER, V48, P117, DOI 10.1111/j.1440-169x.2006.00851.x; BANNAI S, 1984, BIOCHIM BIOPHYS ACTA, V779, P289, DOI 10.1016/0304-4157(84)90014-5; BARRADAS MA, 1989, FEBS LETT, V245, P105, DOI 10.1016/0014-5793(89)80201-7; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown CW, 2018, J BIOL CHEM, V293, P12741, DOI 10.1074/jbc.RA118.003017; Brown CW, 2017, J CELL BIOL, V216, P4287, DOI 10.1083/jcb.201701136; Chen MJ, 2017, BIOL REPROD, V97, P438, DOI 10.1093/biolre/iox099; Dai XZ, 2020, TRENDS MOL MED, V26, P185, DOI 10.1016/j.molmed.2019.09.007; Dixon SJ, 2014, ELIFE, V3, DOI 10.7554/eLife.02523; Dixon SJ, 2014, NAT CHEM BIOL, V10, P9, DOI 10.1038/nchembio.1416; Dixon SJ, 2012, CELL, V149, P1060, DOI 10.1016/j.cell.2012.03.042; Dodson M, 2019, REDOX BIOL, V23, DOI 10.1016/j.redox.2019.101107; Doll S., 2017, NAT, VChem; El Hout M, 2018, SEMIN CANCER BIOL, V53, P125, DOI 10.1016/j.semcancer.2018.07.009; ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6; Fan Z, 2017, ONCOGENESIS, V6, DOI 10.1038/oncsis.2017.65; Frisch SM, 2001, CURR OPIN CELL BIOL, V13, P555, DOI 10.1016/S0955-0674(00)00251-9; Funauchi Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep16497; Gao MH, 2015, MOL CELL, V59, P298, DOI 10.1016/j.molcel.2015.06.011; Gnanapradeepan K, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00124; Han ZB, 2020, FEBS OPEN BIO, V10, P726, DOI 10.1002/2211-5463.12811; Han ZB, 2019, STEM CELLS, V37, P489, DOI 10.1002/stem.2967; Ishii T, 2014, REDOX BIOL, V2, P786, DOI 10.1016/j.redox.2014.04.008; Jang JW, 2014, STEM CELLS, V32, P2616, DOI 10.1002/stem.1764; Jiang L, 2015, NATURE, V520, P57, DOI 10.1038/nature14344; Jin LF, 2019, SCI TOTAL ENVIRON, V666, P713, DOI 10.1016/j.scitotenv.2019.02.307; La Rosa P, 2021, REDOX BIOL, V38, DOI 10.1016/j.redox.2020.101791; Lei YG, 2013, P NATL ACAD SCI USA, V110, pE5039, DOI 10.1073/pnas.1309408110; Liu J, 2019, J MOL CELL BIOL, V11, P284, DOI 10.1093/jmcb/mjy070; Liu JC, 2013, CELL STEM CELL, V13, P483, DOI 10.1016/j.stem.2013.07.018; Liu ZX, 2020, TOXICOL APPL PHARM, V407, DOI 10.1016/j.taap.2020.115241; Lo M, 2008, J CELL PHYSIOL, V215, P593, DOI 10.1002/jcp.21366; Masuda S, 2016, NAT REV CARDIOL, V13, P574, DOI 10.1038/nrcardio.2016.129; Mbah NE, 2022, J BIOL CHEM, V298, DOI 10.1016/j.jbc.2022.101617; Musunuru K, 2010, ANNU REV CELL DEV BI, V26, P667, DOI 10.1146/annurev-cellbio-100109-103948; Nguyen T, 2009, J BIOL CHEM, V284, P13291, DOI 10.1074/jbc.R900010200; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Qin H, 2007, J BIOL CHEM, V282, P5842, DOI 10.1074/jbc.M610464200; RAPOPORT TA, 1991, FASEB J, V5, P2792, DOI 10.1096/fasebj.5.13.1916103; Sart S, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/105135; Sato H, 1999, J BIOL CHEM, V274, P11455, DOI 10.1074/jbc.274.17.11455; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Setoguchi K, 2016, J MOL BIOL, V428, P1465, DOI 10.1016/j.jmb.2015.07.019; Sperber H, 2015, NAT CELL BIOL, V17, P1523, DOI 10.1038/ncb3264; Sun X, 2015, ONCOGENE, V34, P5617, DOI 10.1038/onc.2015.32; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Viswanathan VS, 2017, NATURE, V547, P453, DOI 10.1038/nature23007; Wang SJ, 2016, MOL CELL ONCOL, V3, DOI 10.1080/23723556.2015.1046581; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Wu YH, 2016, THERIOGENOLOGY, V85, P302, DOI 10.1016/j.theriogenology.2015.09.020; Xie Y, 2016, CELL DEATH DIFFER, V23, P369, DOI 10.1038/cdd.2015.158; Xu X, 2010, BIOTECHNOL PROGR, V26, P827, DOI 10.1002/btpr.368; Yang WS, 2008, CHEM BIOL, V15, P234, DOI 10.1016/j.chembiol.2008.02.010; Yang WS, 2016, P NATL ACAD SCI USA, V113, pE4966, DOI 10.1073/pnas.1603244113; Yang WS, 2014, CELL, V156, P317, DOI 10.1016/j.cell.2013.12.010; Yant LJ, 2003, FREE RADICAL BIO MED, V34, P496, DOI 10.1016/S0891-5849(02)01360-6; Yu HT, 2017, J CELL MOL MED, V21, P648, DOI 10.1111/jcmm.13008; Zhang L, 2018, EXP CELL RES, V369, P226, DOI 10.1016/j.yexcr.2018.05.024; Zhang L, 2016, HUM REPROD, V31, P832, DOI 10.1093/humrep/dew011	62	2	2	2	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101855	10.1016/j.jbc.2022.101855	http://dx.doi.org/10.1016/j.jbc.2022.101855			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35337799	gold, Green Published			2022-12-26	WOS:000793483000007
J	Andersen-Civil, AIS; Myhill, LJ; Gokgoz, NB; Engstrom, MT; Mejer, H; Zhu, L; Zeller, WE; Salminen, JP; Krych, L; Lauridsen, C; Nielsen, DS; Thamsborg, SM; Williams, AR				Andersen-Civil, Audrey Inge Schytz; Myhill, Laura J.; Gokgoz, Nilay Budeyri; Engstrom, Marica T.; Mejer, Helena; Zhu, Ling; Zeller, Wayne E.; Salminen, Juha-Pekka; Krych, Lukasz; Lauridsen, Charlotte; Nielsen, Dennis S.; Thamsborg, Stig M.; Williams, Andrew R.			Dietary proanthocyanidins promote localized antioxidant responses in porcine pulmonary and gastrointestinal tissues during Ascaris suum-induced type 2 inflammation	FASEB JOURNAL			English	Article						Ascaris suum; gut microbiota; helminth; pig; polyphenols; proanthocyandins	INFECTION; EXPRESSION; PIG; RESISTANCE; MICROBIOTA; PATHWAYS; COCOA; ACID; B2	Proanthocyanidins (PAC) are dietary polyphenols with putative anti-inflammatory and immunomodulatory effects. However, whether dietary PAC can regulate type-2 immune function and inflammation at mucosal surfaces remains unclear. Here, we investigated if diets supplemented with purified PAC modulated pulmonary and intestinal mucosal immune responses during infection with the helminth parasite Ascaris suum in pigs. A. suum infection induced a type-2 biased immune response in lung and intestinal tissues, characterized by pulmonary granulocytosis, increased Th2/Th1 T cell ratios in tracheal-bronchial lymph nodes, intestinal eosinophilia, and modulation of genes involved in mucosal barrier function and immunity. Whilst PAC had only minor effects on pulmonary immune responses, RNA-sequencing of intestinal tissues revealed that dietary PAC significantly enhanced transcriptional responses related to immune function and antioxidant responses in the gut of both naive and A. suum-infected animals. A. suum infection and dietary PAC induced distinct changes in gut microbiota composition, primarily in the jejunum and colon, respectively. Notably, PAC consumption substantially increased the abundance of Limosilactobacillus reuteri. In vitro experiments with porcine macrophages and intestinal epithelial cells supported a role for both PAC polymers and PAC-derived microbial metabolites in regulating oxidative stress responses in host tissues. Thus, dietary PAC may have distinct beneficial effects on intestinal health during infection with mucosal pathogens, while having a limited activity to modulate naturally-induced type-2 pulmonary inflammation. Our results shed further light on the mechanisms underlying the health-promoting properties of PAC-rich foods, and may aid in the design of novel dietary supplements to regulate mucosal inflammatory responses in the gastrointestinal tract.	[Andersen-Civil, Audrey Inge Schytz; Myhill, Laura J.; Mejer, Helena; Zhu, Ling; Thamsborg, Stig M.; Williams, Andrew R.] Univ Copenhagen, Dept Vet & Anim Sci, Dyrlaegevej 100, DK-1870 Frederiksberg C, Denmark; [Gokgoz, Nilay Budeyri; Krych, Lukasz; Nielsen, Dennis S.] Univ Copenhagen, Dept Food Sci, Frederiksberg, Denmark; [Engstrom, Marica T.; Salminen, Juha-Pekka] Univ Turku, Dept Chem, Nat Chem Res Grp, Turku, Finland; [Zeller, Wayne E.] USDA ARS, US Dairy Forage Res Ctr, Madison, WI 53706 USA; [Lauridsen, Charlotte] Aarhus Univ, Dept Anim Sci, Tjele, Denmark	University of Copenhagen; University of Copenhagen; University of Turku; United States Department of Agriculture (USDA); Aarhus University	Williams, AR (corresponding author), Univ Copenhagen, Dept Vet & Anim Sci, Dyrlaegevej 100, DK-1870 Frederiksberg C, Denmark.	arw@sund.ku.dk		Andersen-Civil, Audrey Inge/0000-0003-2175-8972; Engstrom, Marica/0000-0003-4123-6039	Independent Research Fund Denmark [7026-0094B]	Independent Research Fund Denmark	This work was funded by the Independent Research Fund Denmark (Grant #7026-0094B). Data were generated through accessing research infrastructure at the University of Copenhagen, including FOODHAY (Food and Health Open Innovation Laboratory, Danish Roadmap for Research Infrastructure)	Andersen-Civil AIS, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.637603; Andersen-Civil AIS, 2021, COMMUN BIOL, V4, DOI 10.1038/s42003-021-02408-3; Dang AT, 2019, MUCOSAL IMMUNOL, V12, P843, DOI 10.1038/s41385-019-0160-6; Appeldoorn MM, 2009, J NUTR, V139, P1469, DOI 10.3945/jn.109.106765; AUGUST DA, 1985, CANCER-AM CANCER SOC, V55, P1490, DOI 10.1002/1097-0142(19850401)55:7<1490::AID-CNCR2820550712>3.0.CO;2-N; Bolyen E, 2019, NAT BIOTECHNOL, V37, P852, DOI 10.1038/s41587-019-0209-9; Bouron A, 2020, CELLS-BASEL, V9, DOI 10.3390/cells9081800; Brosschot TP, 2018, MUCOSAL IMMUNOL, V11, P1039, DOI 10.1038/s41385-018-0008-5; Canibe N, 2007, J ANIM SCI, V85, P2959, DOI 10.2527/jas.2006-744; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Cabral PC, 2019, FRONT CELL INFECT MI, V9, DOI 10.3389/fcimb.2019.00425; Choy YY, 2014, FOOD FUNCT, V5, P2298, DOI [10.1039/c4fo00325j, 10.1039/C4FO00325J]; Chu HQ, 2016, ENVIRON TOXICOL PHAR, V41, P159, DOI 10.1016/j.etap.2015.11.018; Colombo SAP, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.01286; CURTIS SE, 1987, CAN J VET RES, V51, P525; Dawson H, 2009, INFECT IMMUN, V77, P2576, DOI 10.1128/IAI.00827-07; De Coster W, 2018, BIOINFORMATICS, V34, P2666, DOI 10.1093/bioinformatics/bty149; Dicksved J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046399; Engstrom MT, 2015, J AGR FOOD CHEM, V63, P4068, DOI 10.1021/acs.jafc.5b00595; Engstrom MT, 2014, J AGR FOOD CHEM, V62, P3390, DOI 10.1021/jf500745y; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Finkelman FD, 2004, IMMUNOL REV, V201, P139, DOI 10.1111/j.0105-2896.2004.00192.x; Garnier S, 2021, R PACKAGE VIRIDIS; Gauer JS, 2018, BIOCHEM PHARMACOL, V152, P11, DOI 10.1016/j.bcp.2018.03.011; Gazzinelli-Guimaraes PH, 2013, INT J PARASITOL, V43, P697, DOI 10.1016/j.ijpara.2013.02.009; Glabska D, 2020, J CLIN MED, V9, DOI 10.3390/jcm9030771; Goedhart J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-76603-3; Gonzalez-Quilen C, 2020, NUTRIENTS, V12, DOI 10.3390/nu12010130; Jakobsen SR, 2019, VET IMMUNOL IMMUNOP, V211, P6, DOI 10.1016/j.vetimm.2019.03.012; Jang S, 2017, NUTRIENTS, V9, DOI 10.3390/nu9101113; Jang S, 2016, J NUTR, V146, P673, DOI 10.3945/jn.115.222968; Kassambara, 2020, PACKAGE GGPUBR; Lee T, 2012, J CLIN IMMUNOL, V32, P1292, DOI 10.1007/s10875-012-9742-8; Li XL, 2011, MOLECULES, V16, P6721, DOI 10.3390/molecules16086721; Liu W, 2017, MOL NUTR FOOD RES, V61, DOI 10.1002/mnfr.201601082; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Masure D, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002588; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; MINOWADA G, 1995, J CLIN INVEST, V95, P3, DOI 10.1172/JCI117655; Morgan ER, 2019, TRENDS PARASITOL, V35, P52, DOI 10.1016/j.pt.2018.10.006; Murrell KD, 1997, J PARASITOL, V83, P255, DOI 10.2307/3284450; Nogueira DS, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004382; Oksanen J., **DATA OBJECT**; Piekarska-Radzik L, 2021, EUR FOOD RES TECHNOL, V247, P9, DOI 10.1007/s00217-020-03603-y; RCore Team, 2020, R LANG ENV STAT COMP; Reynolds LA, 2014, GUT MICROBES, V5, P522, DOI 10.4161/gmic.32155; Roager HM, 2016, NAT MICROBIOL, V1, DOI [10.1038/nmicrobiol.2016.93, 10.1038/NMICROBIOL.2016.93]; Rodriguez-Daza MC, 2021, FRONT NUTR, V8, DOI 10.3389/fnut.2021.689456; Rodriguez-Ramiro I, 2012, EUR J NUTR, V51, P881, DOI 10.1007/s00394-011-0269-1; Roepstorff A, 1997, PARASITOLOGY, V115, P443, DOI 10.1017/S0031182097001480; Roepstorff A, 2011, VET PARASITOL, V180, P72, DOI 10.1016/j.vetpar.2011.05.029; Schewe T, 2001, BIOL CHEM, V382, P1687, DOI 10.1515/BC.2001.204; Sehm J, 2007, J ANIM PHYSIOL AN N, V91, P289, DOI 10.1111/j.1439-0396.2006.00650.x; Skallerup P, 2012, INT J PARASITOL, V42, P383, DOI 10.1016/j.ijpara.2012.02.010; Slotved HC, 1997, ACTA VET SCAND, V38, P207; Snyder R, 2012, J MOL ENDOCRINOL, V48, P99, DOI 10.1530/JME-11-0095; Spinler JK, 2008, ANAEROBE, V14, P166, DOI 10.1016/j.anaerobe.2008.02.001; Tao WY, 2019, COMPR REV FOOD SCI F, V18, P971, DOI 10.1111/1541-4337.12444; TJORNEHOJ K, 1992, PARASITOL RES, V78, P525, DOI 10.1007/BF00931575; Tsuji T, 2013, INT J MOL MED, V31, P1037, DOI 10.3892/ijmm.2013.1294; Tzounis X, 2011, AM J CLIN NUTR, V93, P62, DOI 10.3945/ajcn.110.000075; Van Tassell ML, 2011, NUTRIENTS, V3, P613, DOI 10.3390/nu3050613; Walk ST, 2010, INFLAMM BOWEL DIS, V16, P1841, DOI 10.1002/ibd.21299; Weatherhead JE, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.594520; Wickham H, 2007, J STAT SOFTW, V21, P1; Williams AR, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186546; Williams AR, 2017, VET IMMUNOL IMMUNOP, V189, P43, DOI 10.1016/j.vetimm.2017.06.004; Wu Y, 2019, J NUTR, V149, P1523, DOI 10.1093/jn/nxz102; Yagi K, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms221910872; Zaiss DM, 2006, SCIENCE, V314, P1746, DOI 10.1126/science.1133715; Zhu L, 2022, J NUTR BIOCHEM, V100, P8887, DOI 10.1016/j.jnutbio.2021.108887	73	1	1	6	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22256	10.1096/fj.202101603RR	http://dx.doi.org/10.1096/fj.202101603RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZY9ZR	35333423	Green Submitted			2022-12-26	WOS:000772937700001
J	Abdelhafiz, AS; Ali, A; Maaly, AM; Mahgoub, MA; Ziady, HH; Sultan, EA				Abdelhafiz, Ahmed Samir; Ali, Asmaa; Maaly, Ayman Mohamed; Mahgoub, Mohamed Anwar; Ziady, Hany Hassan; Sultan, Eman Anwar			Predictors of post-COVID symptoms in Egyptian patients: Drugs used in COVID-19 treatment are incriminated	PLOS ONE			English	Article							SURVIVORS	Objectives COVID-19 is a multisystem disease, and some patients suffer from physical or psychological symptoms for weeks or even months after infection, which is described as post-COVID syndrome. The goal of this study is evaluating the prevalence of post-COVID-19 symptoms among Egyptian patients and detecting the factors associated with the presence of these symptoms. Methods An on-line cross-sectional survey using Google Forms was used to conduct the present study, which took place between June and August 2021. Results Three hundred and ninety-six participants filled in the survey. The mean age of participants was 41.4 years. Most participants had mild to moderate COVID-19 (81.31%). The prevalence of post-COVID-19 symptoms was 87.63%, where the most frequent symptom was fatigue (60.86%). Female sex, the presence of comorbidities, lower degree of education, longer disease duration, as well as severe and critical forms of the disease were significantly associated with the presence of post-COVID symptoms. Using regression analysis, the predictors of post-COVID symptoms were severe and critical forms of the disease and intake of antibiotics and corticosteroids for treatment of COVID-19. Conclusions COVID-19 is followed by high prevalence of post-COVID symptoms. To the best of our knowledge, this is the first study to report the relationship between the use of antibiotics and the development of post-COVID symptoms. We recommend further studies to understand this relationship. We also recommend restricting the use of these drugs to indicated cases according to the international guidelines. More studies are needed to gain better understanding of post-COVID symptoms especially in females.	[Abdelhafiz, Ahmed Samir] Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt; [Ali, Asmaa] MOH, Dept Pulm Med, Abbassia Chest Hosp, Cairo, Egypt; [Ali, Asmaa] Alexandria Univ, Fac Med, Dept Anaesthesia & Surg Intens Care, Alexandria, Egypt; [Maaly, Ayman Mohamed] Alexandria Univ, High Inst Publ Hlth, Dept Microbiol, Alexandria, Egypt; [Mahgoub, Mohamed Anwar] Alexandria Univ, Fac Med, Dept Community Med, Alexandria, Egypt; [Ziady, Hany Hassan; Sultan, Eman Anwar] Jiangsu Univ, Sch Med, Dept Lab Med, Zhenjiang, Jiangsu, Peoples R China	Egyptian Knowledge Bank (EKB); Cairo University; National Cancer Institute - Egypt; Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Abbassia Chest Hospital; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Egyptian Knowledge Bank (EKB); Alexandria University; Jiangsu University	Abdelhafiz, AS (corresponding author), Cairo Univ, Natl Canc Inst, Dept Clin Pathol, Cairo, Egypt.	ahmed.samir@nci.cu.edu.eg		Sultan, Eman/0000-0002-9801-0607				Abdelhafiz AS, 2021, VIROLOGY, V563, P74, DOI 10.1016/j.virol.2021.08.012; Abdelhafiz AS, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.590190; Ahmed H, 2020, J REHABIL MED, V52, DOI 10.2340/16501977-2694; Amenta EM, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa509; Belot A, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.22.2001010; Biehl Michelle, 2020, Cleve Clin J Med, DOI 10.3949/ccjm.87a.ccc055; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; CDC, POST COVID COND; Colafrancesco S, 2020, AUTOIMMUN REV, V19, DOI 10.1016/j.autrev.2020.102573; D'Cruz RF, 2021, ERJ OPEN RES, V7, DOI 10.1183/23120541.00655-2020; Dani M, 2021, CLIN MED, V21, pE63, DOI 10.7861/clinmed.2020-0896; Fathi N, 2020, CELL BIOL INT, V44, P1792, DOI 10.1002/cbin.11403; Greenhalgh T, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3026; Halpin SJ, 2021, J MED VIROL, V93, P1013, DOI 10.1002/jmv.26368; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Inoue S, 2019, ACUTE MED SURG, V6, P233, DOI 10.1002/ams2.415; Iqbal A, 2021, CUREUS, V13, DOI 10.7759/cureus.13080; Kamal M, 2021, INT J CLIN PRACT, V75, DOI 10.1111/ijcp.13746; Lam MHB, 2009, ARCH INTERN MED, V169, P2142, DOI 10.1001/archinternmed.2009.384; Lan L, 2020, JAMA-J AM MED ASSOC, V323, P1502, DOI 10.1001/jama.2020.2783; Leow MKS, 2005, CLIN ENDOCRINOL, V63, P197, DOI 10.1111/j.1365-2265.2005.02325.x; Lu YP, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100484; Miyazato Y, 2020, OPEN FORUM INFECT DI, V7, DOI 10.1093/ofid/ofaa507; Moldofsky H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-37; Morris SB, 2020, MMWR-MORBID MORTAL W, V69, P1450, DOI 10.15585/mmwr.mm6940e1; Nabavi N, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3489; Pavli A, 2021, ARCH MED RES, V52, P575, DOI 10.1016/j.arcmed.2021.03.010; Peckham H, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-19741-6; Perrin R, 2020, MED HYPOTHESES, V144, DOI 10.1016/j.mehy.2020.110055; Poyraz BC, 2021, PSYCHIAT RES, V295, DOI 10.1016/j.psychres.2020.113604; Raman B, 2021, ECLINICALMEDICINE, V31, DOI 10.1016/j.eclinm.2020.100683; Rawal G, 2017, J TRANSL INTERN MED, V5, P90, DOI 10.1515/jtim-2016-0016; Sarkar S, 2021, J MED VIROL, V93, P1538, DOI 10.1002/jmv.26483; Taboada M, 2021, J INFECTION, V82, pE31, DOI 10.1016/j.jinf.2020.12.022; Tavakolpour S, 2020, IMMUNOL LETT, V225, P31, DOI 10.1016/j.imlet.2020.06.013; Tay MZ, 2020, NAT REV IMMUNOL, V20, P363, DOI 10.1038/s41577-020-0311-8; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI [10.15585/mmwr.mm6930e1, 10.15585/mmwr.mm6930e1externalicon]; Toubiana J, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m2094; Townsend L, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0240784; Truffaut L, 2021, RESP RES, V22, DOI 10.1186/s12931-021-01625-y; Valent A, 2020, ANAESTH CRIT CARE PA, V39, P740, DOI 10.1016/j.accpm.2020.10.001; van den Borst B, 2021, CLIN INFECT DIS, V73, pE1089, DOI 10.1093/cid/ciaa1750; Whittaker E, 2020, JAMA-J AM MED ASSOC, V324, P259, DOI 10.1001/jama.2020.10369; Wijeratne T, 2020, J NEUROL SCI, V419, DOI 10.1016/j.jns.2020.117179; Wu F., 2020, MEDRXIV, DOI [10.1101/2020.03.30.20047365, 10.1101/2020.03.30.20047365v2, 10.1101/2020.03.30.20047365., DOI 10.1101/2020.03.30.20, 10.2139/ssrn.3566211]; Yuan ML, 2020, SHOCK, V54, P638, DOI 10.1097/SHK.0000000000001574; Zha L, 2020, MED J AUSTRALIA, V212, P416, DOI 10.5694/mja2.50577	47	3	3	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266175	10.1371/journal.pone.0266175	http://dx.doi.org/10.1371/journal.pone.0266175			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358268	gold, Green Published			2022-12-26	WOS:000799828800076
J	Li, BB; Zhang, SB; Lv, YY; Wei, S; Hu, YS				Li, Bang-Bang; Zhang, Shuai-Bing; Lv, Yang-Yong; Wei, Shan; Hu, Yuan-Sen			Reactive oxygen species-induced protein carbonylation promotes deterioration of physiological activity of wheat seeds	PLOS ONE			English	Article							PROTEOMIC ANALYSIS; OXIDATIVE STRESS; CELL-DEATH; L. SEEDS; ARABIDOPSIS; MITOCHONDRIAL; EXPRESSION; SEEDLINGS; MUTATION	During the seed aging process, reactive oxygen species (ROS) can induce the carbonylation of proteins, which changes their functional properties and affects seed vigor. However, the impact and regulatory mechanisms of protein carbonylation on wheat seed vigor are still unclear. In this study, we investigated the changes in wheat seed vigor, carbonyl protein content, ROS content and embryo cell structure during an artificial aging process, and we analyzed the correlation between protein carbonylation and seed vigor. During the artificial wheat-seed aging process, the activity levels of antioxidant enzymes and the contents of non-enzyme antioxidants decreased, leading to the accumulation of ROS and an increase in the carbonyl protein content, which ultimately led to a decrease in seed vigor, and there was a significant negative correlation between seed vigor and carbonyl protein content. Moreover, transmission electron microscopy showed that the contents of protein bodies in the embryo cells decreased remarkably. We postulate that during the wheat seed aging process, an imbalance in ROS production and elimination in embryo cells leads to the carbonylation of proteins, which plays a negative role in wheat seed vigor.	[Li, Bang-Bang; Zhang, Shuai-Bing; Lv, Yang-Yong; Wei, Shan; Hu, Yuan-Sen] Henan Univ Technol, Coll Biol Engn, Zhengzhou 450001, Peoples R China	Henan University of Technology	Hu, YS (corresponding author), Henan Univ Technol, Coll Biol Engn, Zhengzhou 450001, Peoples R China.	hys308@126.com	Lv, Yangyong/HDN-1832-2022		Innovative Funds Plan of Henan University of Technology [2020ZKCJ01]; Cultivation Programme for Young Backbone Teachers in Henan University of Technology [21420114]	Innovative Funds Plan of Henan University of Technology; Cultivation Programme for Young Backbone Teachers in Henan University of Technology	This work was supported by the Innovative Funds Plan of Henan University of Technology (2020ZKCJ01), Cultivation Programme for Young Backbone Teachers in Henan University of Technology (21420114). We thank International Science Editing (http://www.internationalscienceediting.com) for editing this manuscript.	Adebisi MA, 2008, SEED SCI TECHNOL, V36, P379, DOI 10.15258/sst.2008.36.2.11; Bailly C, 2008, CR BIOL, V331, P806, DOI 10.1016/j.crvi.2008.07.022; Benamar A, 2003, SEED SCI RES, V13, P35, DOI 10.1079/SSR2002122; BISHOP NI, 1995, FEBS LETT, V367, P158, DOI 10.1016/0014-5793(95)00510-G; Bizzozero O.A., 2009, HDB NEUROCHEMISTRY M, P543, DOI DOI 10.1007/978-0-387-30375-8_23; Boucelha L, 2021, FUNCT PLANT BIOL, V48, P611, DOI 10.1071/FP21001; Chen HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078471; Chen XL, 2018, PLANT PHYSIOL BIOCH, V130, P455, DOI 10.1016/j.plaphy.2018.07.022; Chen ZY, 2019, SCI HORTIC-AMSTERDAM, V244, P379, DOI 10.1016/j.scienta.2018.09.062; Demidchik V, 2015, ENVIRON EXP BOT, V109, P212, DOI 10.1016/j.envexpbot.2014.06.021; Dong JM., 2021, J SOUTHWEST FOR UNIV, V41, P47, DOI [10.11929/j.swfii.201912009, DOI 10.11929/J.SWFII.201912009]; Ebone LA, 2019, PLANT PHYSIOL BIOCH, V145, P34, DOI 10.1016/j.plaphy.2019.10.028; Griesser E, 2017, REDOX BIOL, V11, P438, DOI 10.1016/j.redox.2016.12.028; Hu D, 2012, PLANT CELL ENVIRON, V35, P2045, DOI 10.1111/j.1365-3040.2012.02535.x; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Katsuya-Gaviria K, 2020, PLANTS-BASEL, V9, DOI 10.3390/plants9060679; Kong LQ, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00158; Kurek K, 2019, PLANTS-BASEL, V8, DOI 10.3390/plants8060174; Lee J, 2012, PLANT BIOTECHNOL J, V10, P164, DOI 10.1111/j.1467-7652.2011.00650.x; Li Y, 2017, PLANT PHYSIOL BIOCH, V114, P72, DOI 10.1016/j.plaphy.2017.02.023; Lim TK, 2013, EDIBLE MED NONMEDICI, V5, P385, DOI [10.1007/978-94-007-5653-3_20, DOI 10.1007/978-94-007-5653-3_20]; Liu H, 2020, J FORESTRY RES, V31, P769, DOI 10.1007/s11676-018-0840-1; Lv YY, 2018, PEERJ, V6, DOI 10.7717/peerj.5874; Lv YY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162851; Madian AG, 2010, J PROTEOME RES, V9, P3766, DOI 10.1021/pr1002609; McDonald MB, 1999, SEED SCI TECHNOL, V27, P177; Min CW, 2017, J PROTEOMICS, V169, P125, DOI 10.1016/j.jprot.2017.06.022; Mittler R, 2017, TRENDS PLANT SCI, V22, P11, DOI 10.1016/j.tplants.2016.08.002; Moller IM, 2007, ANNU REV PLANT BIOL, V58, P459, DOI 10.1146/annurev.arplant.58.032806.103946; Moller IM, 2011, J PROTEOMICS, V74, P2228, DOI 10.1016/j.jprot.2011.05.004; Moller IM, 2010, TRENDS PLANT SCI, V15, P370, DOI 10.1016/j.tplants.2010.04.008; Moller IM, 2006, FREE RADICAL BIO MED, V40, P430, DOI 10.1016/j.freeradbiomed.2005.08.036; Morscher F, 2015, ANN BOT-LONDON, V116, P669, DOI 10.1093/aob/mcv108; Norris SR, 1998, PLANT PHYSIOL, V117, P1317, DOI 10.1104/pp.117.4.1317; Qin GZ, 2009, PROTEOMICS, V9, P4241, DOI 10.1002/pmic.200900133; Rajjou L, 2008, PLANT PHYSIOL, V148, P620, DOI 10.1104/pp.108.123141; Rao KVM, 2000, PLANT SCI, V157, P113, DOI 10.1016/S0168-9452(00)00273-9; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Satour P, 2018, PLANT CELL ENVIRON, V41, P2183, DOI 10.1111/pce.13194; Shacter E, 2000, DRUG METAB REV, V32, P307, DOI 10.1081/DMR-100102336; Stadtman ER, 2006, FREE RADICAL RES, V40, P1250, DOI 10.1080/10715760600918142; STADTMAN ER, 1992, SCIENCE, V257, P1220, DOI 10.1126/science.1355616; Nguyen PT, 2015, J EXP BOT, V66, P6399, DOI 10.1093/jxb/erv348; Tian PP, 2019, J STORED PROD RES, V80, P50, DOI 10.1016/j.jspr.2018.11.009; Wong CM, 2010, ANTIOXID REDOX SIGN, V12, P393, DOI 10.1089/ars.2009.2805; Wu XQ, 2016, J PROTEOMICS, V147, P197, DOI 10.1016/j.jprot.2016.06.005; Xia FS, 2015, ACTA PHYSIOL PLANT, V37, DOI 10.1007/s11738-015-1825-8; Xin X, 2014, J PLANT PHYSIOL, V171, P140, DOI 10.1016/j.jplph.2013.09.016; Xin X, 2011, PHYSIOL PLANTARUM, V143, P126, DOI 10.1111/j.1399-3054.2011.01497.x; Yamaguchi O, 2012, CARDIOVASC RES, V96, P46, DOI 10.1093/cvr/cvs236; Yao Z, 2012, J PLANT PHYSIOL, V169, P1477, DOI 10.1016/j.jplph.2012.06.001; Yin GK, 2017, SCI REP-UK, V7, DOI 10.1038/srep40611; Yin GK, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148013; Yu H, 2008, PLANT CELL, V20, P1134, DOI 10.1105/tpc.108.058263; Zhang SB, 2017, J STORED PROD RES, V72, P161, DOI 10.1016/j.jspr.2017.05.002; Zheng J, 2010, FREE RADICAL RES, V44, P258, DOI 10.3109/10715760903456092	56	3	3	6	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0263553	10.1371/journal.pone.0263553	http://dx.doi.org/10.1371/journal.pone.0263553			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358205	Green Published, Green Submitted, gold			2022-12-26	WOS:000799828800011
J	Choi, SI; Cho, Y; Ki, M; Kim, BH; Lee, IJ; Kim, TH; Kim, SH; Koh, YH; Kim, HB; Hong, EK; Kim, CM; Park, JW				Choi, Sang Il; Cho, Yuri; Ki, Moran; Kim, Bo Hyun; Lee, In Joon; Kim, Tae Hyun; Kim, Seong Hoon; Koh, Young Hwan; Kim, Hyun Beom; Hong, Eun Kyung; Kim, Chang-Min; Park, Joong-Won			Better survival of patients with hepatitis B virus-related hepatocellular carcinoma in South Korea: Changes in 16-years cohorts	PLOS ONE			English	Article							PRIMARY LIVER-CANCER; CLINICAL-OUTCOMES; LAMIVUDINE; ENTECAVIR; THERAPY; PROGRAM	Aims The incidence and mortality of hepatocellular carcinoma (HCC) have decreased over time in South Korea, where hepatitis B virus (HBV) in endemic. This study investigated the changes in the characteristics and clinical outcomes of HCC patients in Korea. Methods Patients initially diagnosed with HCC and treated at the National Cancer Center, Korea between 2000 and 2015 (n = 4,291) were followed up until February 2017. Differences in patient characteristics and outcomes were compared between chronological cohorts: cohort A (2000-2004, n = 1,157) vs. B (2005-2009, n = 1,678) vs. C (2010-2015, n = 1,456). Results The median age of the patient cohort was 57 years (range, 13-98 years), and male predominance was noted (81.6%). HBV infection was the most common etiology (74.8%). The proportion of patients diagnosed with good liver function and small tumors (< 2 cm) increased significantly over time: 74.6%, 79.9%, and 87.4% for Child-Pugh class A (p< 0.001) and 8.0%, 8.5%, and 12.0% for modified UICC stage I (p< 0.001) in cohorts A, B, and C, respectively. Median overall survival improved significantly over time: 14.4 months (95% confidence interval [CI], 12.0-16.8 months), 22.9 months (95% CI, 20.3-25.5 months), and 53.6 months (95% CI, 45.7-61.5 months) in cohorts A, B, and C, respectively. HBV-related patients showed significantly improved survival (12.7 vs. 20.4 vs. 64.5 months, p< 0.001) associated with the use of antiviral treatments (adjusted hazard ratio, 0.72; 95% CI, 0.64-0.80). Conclusions The survival of patients with HCC, especially HBV-related HCC, has improved significantly over time in Korea.	[Choi, Sang Il; Cho, Yuri; Kim, Bo Hyun; Kim, Tae Hyun; Kim, Seong Hoon; Hong, Eun Kyung; Kim, Chang-Min; Park, Joong-Won] Natl Canc Ctr, Ctr Liver & Pancreatobiliary Canc, Goyang, South Korea; [Ki, Moran; Park, Joong-Won] Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea; [Lee, In Joon; Koh, Young Hwan; Kim, Hyun Beom] Natl Canc Ctr, Dept Radiol, Goyang, South Korea; [Kim, Tae Hyun] Natl Canc Ctr, Ctr Proton Therapy, Goyang, South Korea	National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC); National Cancer Center - Korea (NCC)	Park, JW (corresponding author), Natl Canc Ctr, Ctr Liver & Pancreatobiliary Canc, Goyang, South Korea.; Park, JW (corresponding author), Natl Canc Ctr, Grad Sch Canc Sci & Policy, Goyang, South Korea.	jwpark@ncc.re.kr		Cho, Yuri/0000-0002-4488-5352	National Cancer Center, Korea [1510520]	National Cancer Center, Korea	This study was supported by a grant from the National Cancer Center, Korea (#1510520, JWP). The funder provided support in the form of salaries for authors [SIC, YC, MK, BHK, IJL, THK, SHK, YHK, HBK, EKH, CMK, and JWP], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bosch FX, 2004, GASTROENTEROLOGY, V127, pS5, DOI 10.1053/j.gastro.2004.09.011; Chang TT, 2006, NEW ENGL J MED, V354, P1001, DOI 10.1056/NEJMoa051285; Cheng AL, 2009, LANCET ONCOL, V10, P25, DOI 10.1016/S1470-2045(08)70285-7; Chiang CJ, 2015, HEPATOLOGY, V61, P1154, DOI 10.1002/hep.27630; Chiang CJ, 2013, JAMA-J AM MED ASSOC, V310, P974, DOI 10.1001/jama.2013.276701; Choi J, 2021, HEPATOLOGY, V73, P2155, DOI 10.1002/hep.31610; Chon YE, 2021, CLIN MOL HEPATOL, V27, P512, DOI 10.3350/cmh.2021.0171; Di Maio M, 2009, NAT REV CLIN ONCOL, V6, P505, DOI 10.1038/nrclinonc.2009.114; Ha I, 2020, J GASTROEN HEPATOL, V35, P1774, DOI 10.1111/jgh.15031; Hanouneh IA, 2019, CLIN MOL HEPATOL, V25, P264, DOI 10.3350/cmh.2019.1001; Iloeje UH, 2007, CLIN GASTROENTEROL H, V5, P921, DOI 10.1016/j.cgh.2007.06.015; Jung KW, 2017, CANCER RES TREAT, V49, P292, DOI 10.4143/crt.2017.118; Kamath PS, 2001, HEPATOLOGY, V33, P464, DOI 10.1053/jhep.2001.22172; Kim BH, 2018, CLIN MOL HEPATOL, V24, P1, DOI 10.3350/cmh.2017.0112; Kim JH, 2016, GUT LIVER, V10, P939, DOI 10.5009/gnl15527; Korean Liver Cancer Study Group and National Cancer Center Korea, 2009, Korean J Hepatol, V15, P391, DOI 10.3350/kjhep.2009.15.3.391; Korean-Liver-Canc-Study-Grp-KLCSG, 2015, GUT LIVER, V9, P267, DOI 10.5009/gnl14460; Kwak HW, 2014, J GASTROEN HEPATOL, V29, P820, DOI 10.1111/jgh.12470; Lai CL, 2006, NEW ENGL J MED, V354, P1011, DOI 10.1056/NEJMoa051287; Lee SW, 2021, CLIN MOL HEPATOL, V27, P402, DOI 10.3350/cmh.2021.0179; Lee SW, 2020, GUT, V69, P1301, DOI 10.1136/gutjnl-2019-318947; Llovet JM, 1999, SEMIN LIVER DIS, V19, P329, DOI 10.1055/s-2007-1007122; McGlynn KA, 2021, HEPATOLOGY, V73, P4, DOI 10.1002/hep.31288; Papatheodoridis GV, 2020, J HEPATOL, V73, P1037, DOI 10.1016/j.jhep.2020.06.011; Park B, 2012, CANCER RES TREAT, V44, P113, DOI 10.4143/crt.2012.44.2.113; Park JW, 2019, GUT LIVER, V13, P227, DOI 10.5009/gnl19024; Park KW, 2008, J GASTROEN HEPATOL, V23, P467, DOI 10.1111/j.1440-1746.2007.05112.x; PUGH RNH, 1973, BRIT J SURG, V60, P646, DOI 10.1002/bjs.1800600817; Reig M, 2022, J HEPATOL, V76, P681, DOI 10.1016/j.jhep.2021.11.018; Sinn DH, 2017, CLIN MOL HEPATOL, V23, P189, DOI 10.3350/cmh.2017.0033; Suh M, 2013, ASIAN PAC J CANCER P, V14, P6459, DOI 10.7314/APJCP.2013.14.11.6459; Ueno S, 2002, HEPATOL RES, V24, P395, DOI 10.1016/S1386-6346(02)00144-4; Wong JSW, 2011, ALIMENT PHARM THER, V33, P1104, DOI 10.1111/j.1365-2036.2011.04634.x; Zhang BH, 2004, J CANCER RES CLIN, V130, P417, DOI 10.1007/s00432-004-0552-0	34	5	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265668	10.1371/journal.pone.0265668	http://dx.doi.org/10.1371/journal.pone.0265668			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324973	gold, Green Published			2022-12-26	WOS:000780951300060
J	Reinhardt, B; Taylor, R; Dawkins, C; Banks, T; Watson, N; Sundaram, A; Ewing, D; Danko, JR				Reinhardt, Brian; Taylor, Robert; Dawkins, Colin; Banks, Taylor; Watson, Nora; Sundaram, Appavu; Ewing, Daniel; Danko, Janine Ruth			The use of dried blood spot cards to assess serologic responses of individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster	PLOS ONE			English	Article							IMMUNOGLOBULIN-G; SAMPLES; VIRUS; IGG; QUANTIFICATION; RNA	Traditional blood sampling by venipuncture is cumbersome and relatively expensive. Dried blood spot (DBS) sampling is desirable because of its ease of sample collection, transportation and storage. It has been used in clinical diagnosis but not been thoroughly studied for the potential use to assess the immune status of individuals following natural infection or preventive vaccination. The goal of this study was to compare DBS to traditional blood samplings in detection of antibodies in individuals vaccinated against measles, hepatitis A, tetanus, influenza and varicella zoster. Enzyme linked immunosorbent assay (ELISA) was used to test DBS eluates and serum samples for antibodies against measles, varicella, tetanus and hepatitis A. Sensitivities, specificities, and correlation coefficients were evaluated to compare optical density (OD) values of paired serum and DBS samples. The long-term stability of DBS samples at different temperatures was assessed using simulated immune measles blood. DBS OD was highly correlated with serum OD for antibodies to measles (r = 0.93), varicella (r = 0.82), and tetanus (r = 0.91). Sensitivities of DBS OD ranged from 86-99% and specificities ranged from 96-100% using cut-offs established by each assay. By contrast, the hepatitis A data showed a low sensitivity (31%) and weak correlation (r = 0.14) between DBS and serum samples. Antibody titers in serum samples for anti-influenza A (H1N1 and H3N1) failed to correlate in DBS eluates in HAI and MN assays. DBS samples were stable for 4 weeks when stored at room temperature and for 6 months at 4 degrees C. DBS sampling was sensitive, specific, and highly correlated with traditional venipuncture sampling in detection of antibodies against measles, tetanus and varicella zoster, but not hepatitis A and influenza. Thus, the success of using DBS sampling to assess the antibody levels in immunized individuals may be dependent on the pathogens and the development of the assay used.	[Reinhardt, Brian; Taylor, Robert; Watson, Nora] Walter Reed Natl Mil Med Ctr, Dept Res Programs, Bethesda, MD USA; [Dawkins, Colin; Sundaram, Appavu] Henry Jackson Fdn, Bethesda, MD USA; [Banks, Taylor] Naval Med Ctr Portsmouth, Dept Allergy Immunol, Portsmouth, VA USA; [Sundaram, Appavu; Ewing, Daniel] Naval Med Res Ctr, Dept Viral & Rickettsial Dis, Silver Spring, MD USA; [Danko, Janine Ruth] Walter Reed Natl Mil Med Ctr, Infect Dis Serv, Bethesda, MD 20814 USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Walter Reed National Military Medical Center	Danko, JR (corresponding author), Walter Reed Natl Mil Med Ctr, Infect Dis Serv, Bethesda, MD 20814 USA.	Janine.r.danko.mil@mail.mil			Defense Health Agency Immunization Healthcare Branch [IHBG-15-07]	Defense Health Agency Immunization Healthcare Branch	This project was supported by grant number IHBG-15-07 from the Defense Health Agency Immunization Healthcare Branch (https://www.health.mil/Military-Health-Topics/HealthReadiness/Immunization-Healthcare).JD.	[Anonymous], 2020, FRONT MICROBIOL, V11, P373, DOI [10.3389/ fmicb.2020.00373, DOI 10.3389/FMICB.2020.00373]; Carpentieri D, 2021, BIOPRESERV BIOBANK, V19, P136, DOI 10.1089/bio.2020.0131; Colson K, 2015, J MED VIROL, V87, P1491, DOI 10.1002/jmv.24136; CONDORELLI F, 1994, J VIROL METHODS, V49, P25, DOI 10.1016/0166-0934(94)90052-3; Defang GN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048229; Dokubo EK, 2014, J CLIN VIROL, V59, P223, DOI 10.1016/j.jcv.2014.01.014; Flores GL, 2018, J MED VIROL, V90, P1863, DOI 10.1002/jmv.25275; Gil A, 1997, EPIDEMIOL INFECT, V118, P189, DOI 10.1017/S0950268896007297; Guthrie R, 1969, Triangle, V9, P104; Helfand RF, 2001, J MED VIROL, V65, P751, DOI 10.1002/jmv.2100; Higgins SG, 2019, MSPHERE, V4, DOI 10.1128/mSphere.00112-19; Meesters RJW, 2013, BIOANALYSIS, V5, P2187, DOI [10.4155/BIO.13.175, 10.4155/bio.13.175]; Melgaco JG, 2011, J MED VIROL, V83, P208, DOI 10.1002/jmv.21973; NIKOLETTI S, 1994, EPIDEMIOL INFECT, V112, P161, DOI 10.1017/S0950268800057526; Ostler MW, 2014, JOVE-J VIS EXP, DOI 10.3791/50973; Qiu Y, 2010, SCAND J IMMUNOL, V72, P425, DOI 10.1111/j.1365-3083.2010.02456.x; R Studio Team, 2016, RSTUDIO INT DEV ENV; Riddell MA, 2003, B WORLD HEALTH ORGAN, V81, P701; Rottinghaus EK, 2012, CLIN INFECT DIS, V54, P1187, DOI 10.1093/cid/cis015; Sarkar S, 2015, LANCET INFECT DIS, V15, P1005, DOI 10.1016/S1473-3099(15)00226-1; Singh MP, 2014, J MED VIROL, V86, P713, DOI 10.1002/jmv.23874; Su X, 2018, J INFECT PUBLIC HEAL, V11, P373, DOI 10.1016/j.jiph.2017.09.014; Tuaillon E, FRONT MICROBIOL; Viljoen J, 2010, JAIDS-J ACQ IMM DEF, V55, P290, DOI 10.1097/QAI.0b013e3181edaaf5; Villar LM, 2011, J MED VIROL, V83, P1522, DOI 10.1002/jmv.22138; Weldon WC, 2016, METHODS MOL BIOL, V1387, P145, DOI 10.1007/978-1-4939-3292-4_8; WHO, 2012, SURV GUID MEASL RUB; World Health Organization (WHO), WHO MAN AN INFL DIAG; Yamamoto C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60703-1	29	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265813	10.1371/journal.pone.0265813	http://dx.doi.org/10.1371/journal.pone.0265813			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324972	gold, Green Published			2022-12-26	WOS:000780951300075
J	Rocchetti, G; Vitali, M; Zappaterra, M; Righetti, L; Sirri, R; Lucini, L; Dall'Asta, C; Davoli, R; Galaverna, G				Rocchetti, Gabriele; Vitali, Marika; Zappaterra, Martina; Righetti, Laura; Sirri, Rubina; Lucini, Luigi; Dall'Asta, Chiara; Davoli, Roberta; Galaverna, Gianni			A molecular insight into the lipid changes of pig Longissimus thoracis muscle following dietary supplementation with functional ingredients	PLOS ONE			English	Article							FATTY-ACID-COMPOSITION; ADIPOCYTE DIFFERENTIATION; EXTRACELLULAR-MATRIX; FINISHING PIGS; MEAT QUALITY; EXPRESSION; PROFILE; PORK; DIACYLGLYCEROL; INFLAMMATION	In this work, the Longissimus thoracis pig skeletal muscle was used as a model to investigate the impact of two different diets, supplemented with n-3 polyunsaturated fatty acids from extruded linseed (L) and polyphenols from grape skin and oregano extracts (L+P), on the lipidomic profile of meat. A standard diet for growing-finishing pigs (CTRL) was used as a control. Changes in lipids profile were investigated through an untargeted lipidomics and transcriptomics combined investigation. The lipidomics identified 1507 compounds, with 195 compounds fitting with the MS/MS spectra of LipidBlast database. When compared with the CTRL group, the L+P diet significantly increased 15 glycerophospholipids and 8 sphingolipids, while the L diet determined a marked up-accumulation of glycerolipids. According to the correlations outlined between discriminant lipids and genes, the L diet may act preventing adipogenesis and the related inflammation processes, while the L+P diet promoted the expression of genes involved in lipids' biosynthesis and adipogenic extracellular matrix formation and functioning.	[Rocchetti, Gabriele] Univ Cattolica Sacro Cuore, Dept Anim Sci Food & Nutr, Piacenza, Italy; [Vitali, Marika; Sirri, Rubina; Davoli, Roberta] Univ Bologna, Interdept Ctr Ind Agrifood Res CIRI AGRO, Cesena, Italy; [Vitali, Marika; Zappaterra, Martina; Sirri, Rubina; Davoli, Roberta] Univ Bologna, Dept Agr & Food Sci DISTAL, Alma Mater Studiorum, Bologna, Italy; [Righetti, Laura; Dall'Asta, Chiara; Galaverna, Gianni] Dept Food & Drug, Parco Area Sci, Parma, Italy; [Lucini, Luigi] Univ Cattolica Sacro Cuore, Dept Sustainable Food Proc, Piacenza, Italy	Catholic University of the Sacred Heart; University of Bologna; University of Bologna; Catholic University of the Sacred Heart	Zappaterra, M (corresponding author), Univ Bologna, Dept Agr & Food Sci DISTAL, Alma Mater Studiorum, Bologna, Italy.; Righetti, L (corresponding author), Dept Food & Drug, Parco Area Sci, Parma, Italy.	martina.zappaterra2@unibo.it; laura.righetti@unipr.it	Dall'Asta, Chiara/C-3173-2008; Lucini, Luigi/L-1503-2013; Galaverna, Gianni/GNW-5335-2022; Righetti, Laura/Y-6208-2019	Dall'Asta, Chiara/0000-0003-0716-8394; Lucini, Luigi/0000-0002-5133-9464; Galaverna, Gianni/0000-0001-9042-2378; Righetti, Laura/0000-0003-4238-0665; Zappaterra, Martina/0000-0001-5085-4811; Vitali, Marika/0000-0002-8373-0898; DAVOLI, ROBERTA/0000-0003-4600-8326	Regione Emilia-Romagna POR-FESR 2014-2020 "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche"e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla sa [PG/2015/730542]	Regione Emilia-Romagna POR-FESR 2014-2020 "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche"e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla sa	This research was funded by Regione Emilia-Romagna POR-FESR 2014-2020(URL: https://fesr.regione.emilia-romagna.it/) "Innovare la filiera suina mediante la valorizzazione di sottoprodotti vegetali e l'impiego di avanzate tecnologie "omiche"e di processo, per la produzione sostenibile di carne e salumi ad impatto positivo sulla salute"-GreenCharcuterie grantn.PG/2015/730542.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funding was received by RD and GG.	Aaslyng MD, 2017, MEAT SCI, V132, P112, DOI 10.1016/j.meatsci.2017.04.012; Abd El-Samee LD, 2019, B NATL RES CENT, V43; Aboagye G, 2020, FOOD CHEM, V305, DOI 10.1016/j.foodchem.2019.125445; Alonso V, 2015, MEAT SCI, V107, P49, DOI 10.1016/j.meatsci.2015.04.011; Nguyen A, 2014, J BIOL CHEM, V289, P1688, DOI 10.1074/jbc.M113.515320; Azorin-Ortuno M, 2012, J NUTR BIOCHEM, V23, P829, DOI 10.1016/j.jnutbio.2011.04.007; Barupal DK, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15231-w; Bauters D, 2015, BBA-GEN SUBJECTS, V1850, P1449, DOI 10.1016/j.bbagen.2015.04.003; Belmonte AM, 2021, ITAL J FOOD SCI, V33, P117, DOI 10.15586/ijfs.v33i2.2005; Breslow DK, 2010, MOL CELL, V40, P267, DOI 10.1016/j.molcel.2010.10.005; Cimmino R, 2018, BMC VET RES, V14, DOI 10.1186/s12917-018-1513-1; de Tonnac A, 2018, ANIMAL, V12, P1527, DOI 10.1017/S1751731117002877; Dei Cas M, 2018, NUTRIENTS, V10, DOI 10.3390/nu10070940; Dominguez R, 2019, ANTIOXIDANTS-BASEL, V8, DOI 10.3390/antiox8100429; Evangelisti C, 2006, EUR J HISTOCHEM, V50, P9; Fiesel A, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0196-5; Flachowsky G, 2008, J ANIM FEED SCI, V17, P363, DOI 10.22358/jafs/66619/2008; Gaber EM, 2014, EXP PHYSIOL, V99, P881, DOI 10.1113/expphysiol.2013.077594; Goddeke S, 2018, INT J OBESITY, V42, P1039, DOI 10.1038/s41366-018-0022-4; Goto K, 2006, BBA-MOL CELL BIOL L, V1761, P535, DOI 10.1016/j.bbalip.2006.04.001; Goudriaan JR, 2001, ARTERIOSCL THROM VAS, V21, P1488, DOI 10.1161/hq0901.095147; Guillou H, 2010, PROG LIPID RES, V49, P186, DOI 10.1016/j.plipres.2009.12.002; Hac-Wydro K, 2007, CHEM PHYS LIPIDS, V150, P22, DOI 10.1016/j.chemphyslip.2007.06.211; Herchi W, 2009, PLANT PHYSIOL BIOCH, V47, P880, DOI 10.1016/j.plaphy.2009.07.001; Hernandez-Lopez SH, 2016, MEAT SCI, V116, P186, DOI 10.1016/j.meatsci.2016.02.018; Jaturasitha S, 2016, MEAT SCI, V120, P157, DOI 10.1016/j.meatsci.2016.04.014; Ju LP, 2018, BIOCHEM BIOPH RES CO, V506, P485, DOI 10.1016/j.bbrc.2018.10.034; Levental KR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15203-1; Li WY, 2020, BIOCHEM BIOPH RES CO, V526, P813, DOI 10.1016/j.bbrc.2020.03.121; Liu YQ, 2021, NATURE, V590, DOI 10.1038/s41586-020-03091-w; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Matthews KR, 2000, BRIT J NUTR, V83, P637, DOI 10.1017/S0007114500000817; Mi S, 2019, FOOD CONTROL, V100, P305, DOI 10.1016/j.foodcont.2019.02.001; O'Sullivan TA, 2013, AM J PUBLIC HEALTH, V103, pE31, DOI 10.2105/AJPH.2013.301492; Okrouhla M, 2013, CZECH J ANIM SCI, V58, P279, DOI 10.17221/6826-CJAS; Palazon A, 2015, HHS PUBLIC ACCESS, V41, P518; Pang ZQ, 2020, METABOLITES, V10, DOI 10.3390/metabo10050186; Peiretti PG, 2015, FOOD SCI TECH-BRAZIL, V35, P633, DOI 10.1590/1678-457X.6653; Pogorzelska-Nowicka E, 2018, MOLECULES, V23, DOI 10.3390/molecules23020307; Quaresma MAG, 2016, SMALL RUMINANT RES, V134, P49, DOI 10.1016/j.smallrumres.2015.12.009; Raphael W, 2013, INT J MOL SCI, V14, P21167, DOI 10.3390/ijms141021167; Righetti L, 2018, FOOD CHEM, V240, P775, DOI 10.1016/j.foodchem.2017.08.020; Russell J, 2017, CARDIOVASC DIABETOL, V16, DOI 10.1186/s12933-017-0638-z; Salek RM, 2013, GIGASCIENCE, V2, DOI [10.1186/2047-217X-2-13, 10.1186/2047-217X-2-8]; Salvatori G, 2008, MEAT SCI, V80, P623, DOI 10.1016/j.meatsci.2008.02.013; Senizza A, 2020, SCI REP-UK, V10, P1, DOI [10.1038/s41598-019-56847-4, DOI 10.1038/S41598-019-56847-4]; Sirri R, 2018, J ANIM SCI BIOTECHNO, V9, DOI 10.1186/s40104-018-0297-2; Tao H, 2011, BIOCHEM PHARMACOL, V82, P1950, DOI 10.1016/j.bcp.2011.09.003; Tsugawa H, 2015, NAT METHODS, V12, P523, DOI 10.1038/nmeth.3393; Ullah M, 2013, MATRIX BIOL, V32, P452, DOI 10.1016/j.matbio.2013.07.001; Vitali M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0204869; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xu ZY, 2021, J CACHEXIA SARCOPENI, V12, P109, DOI 10.1002/jcsm.12643; Zhao ZZ, 2009, BIOCHEMISTRY-US, V48, P7313, DOI 10.1021/bi900214u	54	1	1	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264953	10.1371/journal.pone.0264953	http://dx.doi.org/10.1371/journal.pone.0264953			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324931	Green Published, gold			2022-12-26	WOS:000780951300024
J	Ibanga, J; Zhang, EL; Eitzen, G; Guo, YT				Ibanga, Jeremies; Zhang, Eric L.; Eitzen, Gary; Guo, Yitian			Mast cell granule motility and exocytosis is driven by dynamic microtubule formation and kinesin-1 motor function	PLOS ONE			English	Article							NEUROENDOCRINE CELLS; SECRETORY GRANULES; CA2+ MOBILIZATION; ACTIN; DEGRANULATION; TRANSPORT; CALCIUM; PROTEINS; IGE; PHOSPHORYLATION	Mast cells are tissue-resident immune cells that have numerous cytoplasmic granules which contain preformed pro-inflammatory mediators. Upon antigen stimulation, sensitized mast cells undergo profound changes to their morphology and rapidly release granule mediators by regulated exocytosis, also known as degranulation. We have previously shown that Rho GTPases regulate exocytosis, which suggests that cytoskeleton remodeling is involved in granule transport. Here, we used live-cell imaging to analyze cytoskeleton remodeling and granule transport in real-time as mast cells were antigen stimulated. We found that granule transport to the cell periphery was coordinated by de novo microtubule formation and not Factin. Kinesore, a drug that activates the microtubule motor kinesin-1 in the absence of cargo, inhibited microtubule-granule association and significantly reduced exocytosis. Likewise, shRNA knock-down of Kif5b, the kinesin-1 heavy chain, also reduced exocytosis. Imaging showed granules accumulated in the perinuclear region after kinesore treatment or Kif5b knock-down. Complete microtubule depolymerization with nocodazole or colchicine resulted in the same effect. A biochemically enriched granule fraction showed kinesin-1 levels increase in antigen-stimulated cells, but are reduced by pre-treatment with kinesore. Kinesore had no effect on the levels of Slp3, a mast cell granule cargo adaptor, in the granule-enriched fraction which suggests that cargo adaptor recruitment to granules is independent of motor association. Taken together, these results show that granules associate with microtubules and are driven by kinesin-1 to facilitate exocytosis.	[Ibanga, Jeremies; Zhang, Eric L.; Eitzen, Gary] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Eitzen, Gary; Guo, Yitian] Univ Alberta, Dept Med, Edmonton, AB, Canada	University of Alberta; University of Alberta	Eitzen, G (corresponding author), Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada.; Eitzen, G (corresponding author), Univ Alberta, Dept Med, Edmonton, AB, Canada.	Gary.Eitzen@ualberta.ca		Zhang, Eric/0000-0002-3429-9149; Eitzen, Gary/0000-0003-1867-1526	Undergraduate Student Research Award (USRA) from The Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research; China Scholarship Council; Natural Sciences and Engineering Research Council of Canada [RGPIN-2019-05466]	Undergraduate Student Research Award (USRA) from The Natural Sciences and Engineering Research Council of Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); China Scholarship Council(China Scholarship Council); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	J. I. is the recipient of an Undergraduate Student Research Award (USRA) from The Natural Sciences and Engineering Research Council of Canada (https://www.nserc-crsng.gc.ca/index_eng.asp).E.L.Z.is the recipient of a studentship from the Canadian Institutes of Health Research (https://cihr-irsc.gc.ca/e/193.html).Y.G.is the recipient of a studentship from the China Scholarship Council (https://www.chinesescholarshipcouncil.com).This work was supported by a Discovery Grant from The Natural Sciences and Engineering Research Council of Canada (RGPIN-2019-05466) to G.E. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano T, 2001, J BIOCHEM-TOKYO, V129, P739, DOI 10.1093/oxfordjournals.jbchem.a002914; Arimura N, 2009, DEV CELL, V16, P675, DOI 10.1016/j.devcel.2009.03.005; Baier A, 2014, J LEUKOCYTE BIOL, V95, P763, DOI 10.1189/jlb.0513281; Blank U, 2004, TRENDS IMMUNOL, V25, P266, DOI 10.1016/j.it.2004.03.005; BOROVIKOV YS, 1995, J CELL SCI, V108, P657; Boucrot E, 2005, SCIENCE, V308, P1174, DOI 10.1126/science.1110225; Cohen R, 2012, J CELL SCI, V125, P2986, DOI 10.1242/jcs.102632; Colin-York H, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0322-9; Conte IL, 2016, J CELL SCI, V129, P592, DOI 10.1242/jcs.178285; Draber P, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00130; Efergan A, 2016, J IMMUNOL, V196, P1091, DOI 10.4049/jimmunol.1500731; Eitzen G, 2003, BBA-MOL CELL RES, V1641, P175, DOI 10.1016/S0167-4889(03)00087-9; Galli SJ, 2012, NAT MED, V18, P693, DOI 10.1038/nm.2755; Gasman S, 2004, MOL BIOL CELL, V15, P520, DOI 10.1091/mbc.E03-06-0402; GIBSON S, 1986, IMMUNOLOGY, V58, P101; Gilfillan AM, 2009, IMMUNOL REV, V228, P149, DOI 10.1111/j.1600-065X.2008.00742.x; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hong-Geller E, 2001, P NATL ACAD SCI USA, V98, P1154, DOI 10.1073/pnas.98.3.1154; Ikeya M, 2014, BIOCHEM BIOPH RES CO, V451, P62, DOI 10.1016/j.bbrc.2014.07.060; Ishida M, 2015, SCI REP-UK, V5, DOI 10.1038/srep08238; Keren-Kaplan T, 2021, CURR BIOL, V31, P540, DOI 10.1016/j.cub.2020.10.071; Klebanovych A, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040345; Koberle M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00106; KOKKONEN JO, 1985, J BIOL CHEM, V260, P4756; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Kurowska M, 2012, BLOOD, V119, P3879, DOI 10.1182/blood-2011-09-382556; Malacombe M, 2006, BBA-MOL CELL RES, V1763, P1175, DOI 10.1016/j.bbamcr.2006.09.004; Marti-Verdeaux S, 2003, J CELL SCI, V116, P325, DOI 10.1242/jcs.00216; Masuda ES, 2000, FEBS LETT, V470, P61, DOI 10.1016/S0014-5793(00)01288-6; Meiri D, 2012, MOL CELL, V45, P642, DOI 10.1016/j.molcel.2012.01.027; Menasche G, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.652077; Merriam EB, 2013, J NEUROSCI, V33, P16471, DOI 10.1523/JNEUROSCI.0661-13.2013; Metcalfe DD, 2006, J ALLERGY CLIN IMMUN, V117, P1227, DOI 10.1016/j.jaci.2006.03.031; Montagnac G, 2009, CURR BIOL, V19, P184, DOI 10.1016/j.cub.2008.12.043; Munoz I, 2016, J CELL BIOL, V215, P203, DOI 10.1083/jcb.201605073; Nightingale TD, 2012, TRENDS CELL BIOL, V22, P329, DOI 10.1016/j.tcb.2012.03.003; Nishida K, 2005, J CELL BIOL, V170, P115, DOI 10.1083/jcb.200501111; Norman JC, 1996, MOL BIOL CELL, V7, P1429, DOI 10.1091/mbc.7.9.1429; Oka T, 2005, J IMMUNOL, V174, P4584, DOI 10.4049/jimmunol.174.8.4584; Oka T, 2002, BRIT J PHARMACOL, V136, P837, DOI 10.1038/sj.bjp.0704788; Passante E, 2009, INFLAMM RES, V58, P737, DOI 10.1007/s00011-009-0074-y; Peterson JR, 2002, CHEM BIOL, V9, P1275, DOI 10.1016/S1074-5521(02)00284-3; Randall TS, 2017, P NATL ACAD SCI USA, V114, P13738, DOI 10.1073/pnas.1715115115; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rosa-Ferreira C, 2011, DEV CELL, V21, P1171, DOI 10.1016/j.devcel.2011.10.007; Sanderson MP, 2010, MOL IMMUNOL, V48, P171, DOI 10.1016/j.molimm.2010.08.012; Sheshachalam A, 2017, J LEUKOCYTE BIOL, V102, P71, DOI 10.1189/jlb.2A0616-279RRR; Smith AJ, 2003, TRAFFIC, V4, P302, DOI 10.1034/j.1600-0854.2003.00084.x; Stanton RA, 2011, MED RES REV, V31, P443, DOI 10.1002/med.20242; Stepanova T, 2003, J NEUROSCI, V23, P2655; Sulimenko V, 2006, J IMMUNOL, V176, P7243, DOI 10.4049/jimmunol.176.12.7243; Sulimenko V, 2015, J IMMUNOL, V194, P4099, DOI 10.4049/jimmunol.1402459; Suzuki R, 2021, BIOCHEM BIOPH RES CO, V534, P714, DOI 10.1016/j.bbrc.2020.11.012; Tran DT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10098; Xu YZ, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/246126	56	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265122	10.1371/journal.pone.0265122	http://dx.doi.org/10.1371/journal.pone.0265122			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316306	Green Published, gold			2022-12-26	WOS:000834238000017
J	Mansoor, MM; Shad, SA				Mansoor, Muhammad Mudassir; Shad, Sarfraz Ali			Methoxyfenozide tolerance in Chrysoperla carnea: Inheritance, dominance and preliminary detoxification mechanisms	PLOS ONE			English	Article							CROSS-RESISTANCE PATTERNS; LITURA LEPIDOPTERA-NOCTUIDAE; THURINGIENSIS TOXIN CRY1AC; BACILLUS-THURINGIENSIS; REALIZED HERITABILITY; DIAMONDBACK MOTH; CHLORPYRIFOS RESISTANCE; INCREASED FITNESS; RISK-ASSESSMENT; BEET ARMYWORM	Lacewings exist in insecticide-dominant cropping systems. They are prime biological control agents due to outstanding ability of insecticide resistance development. This study examines occurrence of methoxyfenozide resistance and its subsequent effects on cross-resistance to other insecticides, inheritance and mechanism of resistance in C. carnea. Methoxy-SEL strain of C. carnea selected for 15 generations developed 3531.67-fold resistance to methoxyfenozide. Overlapping fiducial limits of LC(50)s of F-1 and F-1' (reciprocal crosses) suggested an autosomal and incompletely dominant mode of inheritance. Resistance to methoxyfenozide was polygenic and its realized heritability value was high (h(2) = 0.62). Both PBO and DEF significantly changed LC(50)s indicating cytochrome P450-dependent monooxygenases and esterases detoxifying the resistance in Methoxy-SEL strain. Resistance to all tested insecticide was unstable but decrease rate was very negligible. These results have implications forpreservation of biological control and effective use in insecticide-dominant cropping systems.	[Mansoor, Muhammad Mudassir] Fatima Sugar Mills Ltd, Fatima Sugar Res & Dev Ctr, Muzaffargarh, Punjab, Pakistan; [Mansoor, Muhammad Mudassir; Shad, Sarfraz Ali] Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan, Punjab, Pakistan	Bahauddin Zakariya University	Mansoor, MM (corresponding author), Fatima Sugar Mills Ltd, Fatima Sugar Res & Dev Ctr, Muzaffargarh, Punjab, Pakistan.; Mansoor, MM; Shad, SA (corresponding author), Bahauddin Zakariya Univ, Fac Agr Sci & Technol, Dept Entomol, Multan, Punjab, Pakistan.	honybeepak@gmail.com; sarfrazshad@bzu.edu.pk	MANSOOR, MUHAMMAD MUDASSIR/AAP-5639-2020	MANSOOR, MUHAMMAD MUDASSIR/0000-0003-2205-271X				Abbas N, 2014, B ENTOMOL RES, V104, P707, DOI 10.1017/S0007485314000522; Abbas N, 2014, CROP PROT, V58, P49, DOI 10.1016/j.cropro.2014.01.002; Abbott WS, 1925, J ECON ENTOMOL, V18, P265, DOI 10.1093/jee/18.2.265a; Afzal MBS, 2015, PESTIC BIOCHEM PHYS, V119, P42, DOI 10.1016/j.pestbp.2015.02.008; Attique MNR, 2006, J APPL ENTOMOL, V130, P122, DOI 10.1111/j.1439-0418.2006.01035.x; Bale JS, 2008, PHILOS T R SOC B, V363, P761, DOI 10.1098/rstb.2007.2182; Bourguet D, 1998, J EVOLUTION BIOL, V11, P103, DOI 10.1046/j.1420-9101.1998.11010103.x; Bourguet D, 2000, J ECON ENTOMOL, V93, P1588, DOI 10.1603/0022-0493-93.6.1588; Desneux N, 2007, ANNU REV ENTOMOL, V52, P81, DOI 10.1146/annurev.ento.52.110405.091440; Devine GJ, 2007, AGR HUM VALUES, V24, P281, DOI 10.1007/s10460-007-9067-z; Dhadialla TS, 1998, ANNU REV ENTOMOL, V43, P545, DOI 10.1146/annurev.ento.43.1.545; Ejaz M, 2017, PESTIC BIOCHEM PHYS, V137, P8, DOI 10.1016/j.pestbp.2016.09.001; Falconer D. S., 1989, Introduction to quantitative genetics.; Finney DJ., 1971, PROBIT ANAL, V35; FRANZ JM, 1980, ENTOMOPHAGA, V25, P231, DOI 10.1007/BF02371922; Gentz MC, 2010, BIOL CONTROL, V52, P208, DOI 10.1016/j.biocontrol.2009.07.012; Georghiou G. P., 1983, Pest resistance to pesticides, P769; Hewa-Kapuge S, 2003, J ECON ENTOMOL, V96, P1083, DOI 10.1603/0022-0493-96.4.1083; IRAC, 2020, IRAC MOD ACT CLASS S; LANDE R, 1981, GENETICS, V99, P541; LITCHFIELD JT, 1949, J PHARMACOL EXP THER, V96, P99; Liu ZW, 2003, PEST MANAG SCI, V59, P1355, DOI 10.1002/ps.768; Mansoor MM, 2020, EGYPT J BIOL PEST CO, V30, DOI 10.1186/s41938-020-0213-x; Mansoor MM, 2020, CHEMOSPHERE, V260, DOI 10.1016/j.chemosphere.2020.127620; Mansoor MM, 2020, PEST MANAG SCI, V76, P4009, DOI 10.1002/ps.5952; Mansoor MM, 2019, ARCH PHYTOPATH PLANT, V52, P884, DOI 10.1080/03235408.2019.1660561; Mansoor MM, 2019, BIOL CONTROL, V129, P123, DOI 10.1016/j.biocontrol.2018.10.008; Mansoor MM, 2017, PESTIC BIOCHEM PHYS, V135, P59, DOI 10.1016/j.pestbp.2016.06.004; Mansoor MM, 2013, ECOTOXICOLOGY, V22, P1232, DOI 10.1007/s10646-013-1111-8; MCKENZIE JA, 1992, GENETICS, V130, P613; Mosallanejad H, 2008, ARCH INSECT BIOCHEM, V67, P36, DOI 10.1002/arch.20220; Moulton JK, 2002, J ECON ENTOMOL, V95, P414, DOI 10.1603/0022-0493-95.2.414; Pathan AK, 2008, J ECON ENTOMOL, V101, P1676, DOI 10.1603/0022-0493(2008)101[1676:EOFRTO]2.0.CO;2; Pathan AK, 2010, J ECON ENTOMOL, V103, P823, DOI 10.1603/EC09260; Rehan A, 2014, PESTIC BIOCHEM PHYS, V110, P7, DOI 10.1016/j.pestbp.2014.02.001; ROBERTSON J.L., 2017, BIOASSAYS ARTHROPODS, V3rd; Robertson JL., 1992, PESTICIDE BIOASSAYS; Roubos CR, 2014, BIOL CONTROL, V75, P28, DOI 10.1016/j.biocontrol.2014.01.006; Sayyed AH, 2000, APPL ENVIRON MICROB, V66, P1509, DOI 10.1128/AEM.66.4.1509-1516.2000; Sayyed AH, 2001, PEST MANAG SCI, V57, P413, DOI 10.1002/ps.313; Sayyed AH, 2010, PESTIC BIOCHEM PHYS, V98, P325, DOI 10.1016/j.pestbp.2010.07.004; Schneider MI, 2004, BIOL CONTROL, V31, P189, DOI 10.1016/j.biocontrol.2004.04.013; Shah RM, 2018, NEOTROP ENTOMOL, V47, P709, DOI 10.1007/s13744-018-0604-9; Shah RM, 2017, PEST MANAG SCI, V73, P254, DOI 10.1002/ps.4296; Smagghe G, 2003, PEST MANAG SCI, V59, P1203, DOI 10.1002/ps.756; Smirle MJ, 2002, J ECON ENTOMOL, V95, P820, DOI 10.1603/0022-0493-95.4.820; Sokal R. R, 1981, BIOMETRY; STONE BF, 1968, B WORLD HEALTH ORGAN, V38, P325; TABASHNIK BE, 1992, J ECON ENTOMOL, V85, P1551, DOI 10.1093/jee/85.5.1551	49	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265304	10.1371/journal.pone.0265304	http://dx.doi.org/10.1371/journal.pone.0265304			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316289	gold, Green Published			2022-12-26	WOS:000834238000022
J	Salehabadi, E; Motamedian, E; Shojaosadati, SA				Salehabadi, Ehsan; Motamedian, Ehsan; Shojaosadati, Seyed Abbas			Reconstruction of a generic genome-scale metabolic network for chicken: Investigating network connectivity and finding potential biomarkers	PLOS ONE			English	Article							CONSTRAINT-BASED MODELS; GLOBAL RECONSTRUCTION; OBESITY; LIVER; PREDICTION; SEQUENCE; DATABASE; CANCER; ENERGY	Chicken is the first sequenced avian that has a crucial role in human life for its meat and egg production. Because of various metabolic disorders, study the metabolism of chicken cell is important. Herein, the first genome-scale metabolic model of a chicken cell named iES1300, consists of 2427 reactions, 2569 metabolites, and 1300 genes, was reconstructed manually based on KEGG, BiGG, CHEBI, UNIPROT, REACTOME, and MetaNetX databases. Interactions of metabolic genes for growth were examined for E. coli, S. cerevisiae, human, and chicken metabolic models. The results indicated robustness to genetic manipulation for iES1300 similar to the results for human. iES1300 was integrated with transcriptomics data using algorithms and Principal Component Analysis was applied to compare context-specific models of the normal, tumor, lean and fat cell lines. It was found that the normal model has notable metabolic flexibility in the utilization of various metabolic pathways, especially in metabolic pathways of the carbohydrate metabolism, compared to the others. It was also concluded that the fat and tumor models have similar growth metabolisms and the lean chicken model has a more active lipid and carbohydrate metabolism.	[Salehabadi, Ehsan; Motamedian, Ehsan; Shojaosadati, Seyed Abbas] Tarbiat Modares Univ, Dept Chem Engn, Biotechnol Grp, Tehran, Iran	Tarbiat Modares University	Shojaosadati, SA (corresponding author), Tarbiat Modares Univ, Dept Chem Engn, Biotechnol Grp, Tehran, Iran.	shoja_sa@modares.ac.ir						Amelio I, 2014, TRENDS BIOCHEM SCI, V39, P191, DOI 10.1016/j.tibs.2014.02.004; Athar A, 2019, NUCLEIC ACIDS RES, V47, pD711, DOI 10.1093/nar/gky964; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Becker SA, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000082; Bordbar A, 2014, NAT REV GENET, V15, P107, DOI 10.1038/nrg3643; Brunk E, 2018, NAT BIOTECHNOL, V36, P272, DOI 10.1038/nbt.4072; Cakir Tunahan, 2014, Front Bioeng Biotechnol, V2, P62, DOI 10.3389/fbioe.2014.00062; Calmels C, 2019, METAB ENG, V51, P9, DOI 10.1016/j.ymben.2018.09.009; Cherian G, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0029-9; Chou KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009931; Coble DJ, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1084; Duarte NC, 2007, P NATL ACAD SCI USA, V104, P1777, DOI 10.1073/pnas.0610772104; Fabbrini E, 2010, HEPATOLOGY, V51, P679, DOI 10.1002/hep.23280; Fabregat A, 2018, NUCLEIC ACIDS RES, V46, pD649, DOI [10.1093/nar/gkx1132, 10.1093/nar/gkz1031]; Folger O, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.35; Font-Burgada J, 2016, CELL METAB, V23, P48, DOI 10.1016/j.cmet.2015.12.015; Forster J, 2003, GENOME RES, V13, P244, DOI 10.1101/gr.234503; FREUDENRICH C C, 1992, American Journal of Physiology, V262, pC1024; Galgani J, 2008, INT J OBESITY, V32, pS109, DOI 10.1038/ijo.2008.246; Gu CD, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1730-3; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Hastings J, 2013, NUCLEIC ACIDS RES, V41, pD456, DOI 10.1093/nar/gks1146; Hefzi H, 2016, CELL SYST, V3, P434, DOI 10.1016/j.cels.2016.10.020; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jamialahmadi O, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1006936; Julian RJ, 2005, VET J, V169, P350, DOI 10.1016/j.tvjl.2004.04.015; Kanehisa M, 2019, NUCLEIC ACIDS RES, V47, pD590, DOI 10.1093/nar/gky962; Karimian E, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65659-w; King ZA, 2016, NUCLEIC ACIDS RES, V44, pD515, DOI 10.1093/nar/gkv1049; Lane AN, 2015, NUCLEIC ACIDS RES, V43, P2466, DOI 10.1093/nar/gkv047; Larsberg F, 2021, ANIMALS-BASEL, P1, DOI [10.3390/ani12010001, DOI 10.3390/ANI12010001]; Lavoie ET, 2005, ARCH ENVIRON CON TOX, V48, P552, DOI 10.1007/s00244-004-0128-7; Lewis NE, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.47; Machado D, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003580; Machicao J, 2018, SCI REP-UK, V8, P1, DOI [10.1038/s41598-017-17765-5, DOI 10.1038/S41598-017-17765-5]; Mardinoglu A, 2013, MOL SYST BIOL, V9, DOI 10.1038/msb.2013.5; Mellouk N, 2018, INT J ENDOCRINOL, V2018, DOI 10.1155/2018/4579734; Metayer-Coustard S, 2021, FRONT PHYSIOL, V12, DOI 10.3389/fphys.2021.643580; Mo ML, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-37; Monk J, 2014, NAT BIOTECHNOL, V32, P447, DOI 10.1038/nbt.2870; Moretti S, 2021, NUCLEIC ACIDS RES, V49, pD570, DOI 10.1093/nar/gkaa992; Motamedian E, 2017, BIOINFORMATICS, V33, P1057, DOI 10.1093/bioinformatics/btw772; Motamedian E, 2015, IRAN J BASIC MED SCI, V18, P267; O'Leary NA, 2016, NUCLEIC ACIDS RES, V44, pD733, DOI 10.1093/nar/gkv1189; Oberhardt MA, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.77; Orth JD, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.65; Orth JD, 2010, BIOTECHNOL BIOENG, V107, P403, DOI 10.1002/bit.22844; Orth JD, 2010, NAT BIOTECHNOL, V28, P245, DOI 10.1038/nbt.1614; Peng ML, 2016, SCI REP-UK, V6, DOI 10.1038/srep32580; Rudin C, 2019, NAT MACH INTELL, V1, P206, DOI 10.1038/s42256-019-0048-x; Saha R, 2014, CURR OPIN BIOTECH, V29, P39, DOI 10.1016/j.copbio.2014.02.011; Schellenberger J, 2011, NAT PROTOC, V6, P1290, DOI 10.1038/nprot.2011.308; Sheikh K, 2005, BIOTECHNOL PROGR, V21, P112, DOI 10.1021/bp0498138; Sigurdsson MI, 2010, BMC SYST BIOL, V4, DOI 10.1186/1752-0509-4-140; Simonyan V, 2016, DATABASE-OXFORD, DOI 10.1093/database/baw022; Sinclair R, 1974, In Vitro, V10, P295, DOI 10.1007/BF02615311; Stern CD, 2005, DEV CELL, V8, P9, DOI 10.1016/j.devcel.2004.11.018; Suksaweang S, 2004, DEV BIOL, V266, P109, DOI 10.1016/j.ydbio.2003.10.010; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Sun L, 2015, CELL STRESS CHAPERON, V20, P939, DOI 10.1007/s12192-015-0621-0; Swainston N, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1051-4; Thiele I, 2013, NAT BIOTECHNOL, V31, P419, DOI 10.1038/nbt.2488; Thiele I, 2010, NAT PROTOC, V5, P93, DOI 10.1038/nprot.2009.203; Thornton PK, 2010, PHILOS T R SOC B, V365, P2853, DOI 10.1098/rstb.2010.0134; van den Biggelaar RHGA, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00141; Villa E, 2019, CANCERS, V11, DOI 10.3390/cancers11050688; Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193; Xu CM, 2019, GENOME BIOL, V20, DOI 10.1186/s13059-019-1689-0; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zampieri G, 2019, PLOS COMPUT BIOL, V15, DOI 10.1371/journal.pcbi.1007084	71	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0254270	10.1371/journal.pone.0254270	http://dx.doi.org/10.1371/journal.pone.0254270			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316277	gold, Green Submitted, Green Published			2022-12-26	WOS:000834238000001
J	Barman, M; Samanta, S; Chakraborty, S; Samanta, A; Tarafdar, J				Barman, Mritunjoy; Samanta, Snigdha; Chakraborty, Swati; Samanta, Arunava; Tarafdar, Jayanta			Copy number variation of two begomovirus acquired and inoculated by different cryptic species of whitefly, Bemisia tabaci in Okra	PLOS ONE			English	Article							MOLECULAR-IDENTIFICATION; BIOTYPE; VIRUSES; DISEASE	The whitefly, B.tabaci is a major pest of agricultural crops which transmits begomovirus in a species-specific manner. Yellow vein mosaic disease (YVMD) and okra leaf curl disease (OLCD) caused by distinct begomovirus are a major limitation to production of okra in India. In this framework the present investigation reports, for the first time, comparative study of begomovirus species viz. yellow vein mosaic virus (YVMV) and okra enation leaf curl virus (OELCuV) ingested and egested by two cryptic species (Asia I and Asia II 5) of B.tabaci at different time interval using detached leaf assay. A gradual increase of both virus copies were observed with increased feeding exposure in Asia I and Asia II 5. Both the genetic groups of whitefly could acquire the viruses within just 5 minutes of active feeding however, a significant amount of variation was noted in virus uptake by the both. At 24 hours of active feeding Asia II 5 acquired more of YVMV whereas, Asia I ingested more OELCuV. Similarly, the genetic group acquiring higher titre of virus egested higher amount during inoculation period. On the whole, it can be presumed that Asia I is a more effective transmitter of OELCuV whereas, Asia II 5 of YVMV further suggesting increased risk of virus pandemics (both YVMV and OELCuV) in regions where Asia I and Asia II 5 is dominant.	[Barman, Mritunjoy; Samanta, Snigdha; Samanta, Arunava] BCKV, Dept Agr Entomol, Mohanpur, W Bengal, India; [Chakraborty, Swati; Tarafdar, Jayanta] BCKV, Dept Plant Pathol, Nadia, W Bengal, India; [Tarafdar, Jayanta] BCKV, Directorate Res, Kalyani, W Bengal, India	Bidhan Chandra Agricultural University; Bidhan Chandra Agricultural University; Bidhan Chandra Agricultural University	Tarafdar, J (corresponding author), BCKV, Dept Plant Pathol, Nadia, W Bengal, India.; Tarafdar, J (corresponding author), BCKV, Directorate Res, Kalyani, W Bengal, India.	tarafdar.jayanta@bckv.edu.in		Tarafdar, Jayanta/0000-0001-6848-3270; Barman, Mritunjoy/0000-0002-5817-2054				Ahmed MZ, 2011, PEST MANAG SCI, V67, P307, DOI 10.1002/ps.2067; Alhudaib Khalid Abdullah, 2014, Journal of Biological Sciences, V14, P494; Ashfaq M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104485; BROWN JK, 1995, ANNU REV ENTOMOL, V40, P511, DOI 10.1146/annurev.en.40.010195.002455; Czosnek H, 2017, VIRUSES-BASEL, V9, DOI 10.3390/v9100273; Maxwell Douglas P., 2007, P409, DOI 10.1007/978-1-4020-4769-5_24; Fauquet CM, 2005, ARCH VIROL, V150, P2151, DOI 10.1007/s00705-005-0583-0; Fauquet CM, 2003, ANN APPL BIOL, V142, P165, DOI 10.1111/j.1744-7348.2003.tb00241.x; Guo T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15432; Hogenhout SA, 2008, ANNU REV PHYTOPATHOL, V46, P327, DOI 10.1146/annurev.phyto.022508.092135; Jiu M, 2006, J PHYTOPATHOL, V154, P587, DOI 10.1111/j.1439-0434.2006.01151.x; Jones DR, 2003, EUR J PLANT PATHOL, V109, P195, DOI 10.1023/A:1022846630513; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kollenberg M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111968; KRIEG PA, 1990, NUCLEIC ACIDS RES, V18, P6463, DOI 10.1093/nar/18.21.6463; Liu J, 2010, J ZHEJIANG UNIV-SC B, V11, P30, DOI 10.1631/jzus.B0900213; Lowe S., 2000, 100 WORLDS WORST INV, DOI DOI 10.1525/9780520948433-159; Navas-Castillo J, 2011, ANNU REV PHYTOPATHOL, V49, P219, DOI 10.1146/annurev-phyto-072910-095235; Prasanna HC, 2015, J INTEGR AGR, V14, P1786, DOI 10.1016/S2095-3119(14)60931-X; Qin L, 2016, INSECT SCI, V23, P215, DOI 10.1111/1744-7917.12296; Rehman M, 2021, PHYTOPARASITICA, V49, P869, DOI 10.1007/s12600-021-00909-9; Roumagnac P, 2022, ARCH VIROL, V167, P695, DOI 10.1007/s00705-021-05309-2; Roy B, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258933; Sambrook J., 2001, MOL CLONING LAB MANU; Shatters RG, 2009, J ECON ENTOMOL, V102, P750, DOI 10.1603/029.102.0236; Varma A, 2003, ANN APPL BIOL, V142, P145, DOI 10.1111/j.1744-7348.2003.tb00240.x; Venkataravanappa V, 2015, ACTA VIROL, V59, P125, DOI 10.4149/av_2015_02_125; Venkataravanappa V, 2015, PLANT PATHOL, V64, P508, DOI 10.1111/ppa.12292; Venkataravanappa V, 2015, EUR J PLANT PATHOL, V141, P217, DOI 10.1007/s10658-014-0463-0; Venkataravanappa V, 2013, 3 BIOTECH, V3, P461, DOI 10.1007/s13205-012-0107-z; Venkataravanappa V, 2012, VIRUS GENES, V44, P522, DOI 10.1007/s11262-012-0732-y; Venkataravanappa V., 2017, INT J PURE APPL BIOS, V5, P558, DOI 10.18782/2320-7051.2726	32	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265991	10.1371/journal.pone.0265991	http://dx.doi.org/10.1371/journal.pone.0265991			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353870	Green Published, gold			2022-12-26	WOS:000786647900034
J	Ferrucci, R; Mameli, F; Ruggiero, F; Reitano, M; Miccoli, M; Gemignani, A; Conversano, C; Dini, M; Zago, S; Piacentini, S; Poletti, B; Priori, A; Orru, G				Ferrucci, Roberta; Mameli, Francesca; Ruggiero, Fabiana; Reitano, Mariella; Miccoli, Mario; Gemignani, Angelo; Conversano, Ciro; Dini, Michelangelo; Zago, Stefano; Piacentini, Silvie; Poletti, Barbara; Priori, Alberto; Orru, Graziella			Alternate fluency in Parkinson's disease: A machine learning analysis	PLOS ONE			English	Article							EXECUTIVE FUNCTIONS; DYSFUNCTION; DEMENTIA; AGE	ObjectiveThe aim of the present study was to investigate whether patients with Parkinson's Disease (PD) had changes in their level of performance in extra-dimensional shifting by implementing a novel analysis method, utilizing the new alternate phonemic/semantic fluency test. MethodWe used machine learning (ML) in order to develop high accuracy classification between PD patients with high and low scores in the alternate fluency test. ResultsThe models developed resulted to be accurate in such classification in a range between 80% and 90%. The predictor which demonstrated maximum efficiency in classifying the participants as low or high performers was the semantic fluency test. The optimal cut-off of a decision rule based on this test yielded an accuracy of 86.96%. Following the removal of the semantic fluency test from the system, the parameter which best contributed to the classification was the phonemic fluency test. The best cut-offs were identified and the decision rule yielded an overall accuracy of 80.43%. Lastly, in order to evaluate the classification accuracy based on the shifting index, the best cut-offs based on an optimal single rule yielded an overall accuracy of 83.69%. ConclusionWe found that ML analysis of semantic and phonemic verbal fluency may be used to identify simple rules with high accuracy and good out of sample generalization, allowing the detection of executive deficits in patients with PD.	[Ferrucci, Roberta; Dini, Michelangelo; Priori, Alberto] Univ Milan, Aldo Ravelli Res Ctr, Dept Hlth Sci, Milan, Italy; [Ferrucci, Roberta; Reitano, Mariella; Priori, Alberto] ASST St Paolo & Carlo Hosp, Milan, Italy; [Ferrucci, Roberta; Mameli, Francesca; Ruggiero, Fabiana; Zago, Stefano] Policlin Milan, IRCCS Ca Granda Fdn, Milan, Italy; [Miccoli, Mario] Univ Pisa, Dept Clin & Expt Med, Pisa, Italy; [Gemignani, Angelo; Conversano, Ciro; Orru, Graziella] Univ Pisa, Dept Surg Med Mol & Crit Area Pathol, Pisa, Italy; [Piacentini, Silvie] IRCCS Fdn Neurol Inst Carlo Besta, Milan, Italy; [Poletti, Barbara] Auxol Italian Inst IRCCS, Milan, Italy	University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Pisa; University of Pisa; IRCCS Istituto Neurologico Besta	Ferrucci, R (corresponding author), Univ Milan, Aldo Ravelli Res Ctr, Dept Hlth Sci, Milan, Italy.; Ferrucci, R (corresponding author), ASST St Paolo & Carlo Hosp, Milan, Italy.; Ferrucci, R (corresponding author), Policlin Milan, IRCCS Ca Granda Fdn, Milan, Italy.	roberta.ferrucci@unimi.it		Orru, Graziella/0000-0002-8769-7693; gemignani, angelo/0000-0001-7249-874X; MICCOLI, MARIO/0000-0002-8632-6145				Bermingham ML, 2015, SCI REP-UK, V5, DOI 10.1038/srep10312; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Bouckaert R.R., 2013, WEKA MANUAL VERSION; Coin A, 2009, ARCH GERONTOL GERIAT, V49, P35, DOI 10.1016/j.archger.2009.09.010; Costa A, 2014, NEUROL SCI, V35, P365, DOI 10.1007/s10072-013-1520-8; Dirnberger G, 2013, J NEUROPSYCHOL, V7, P193, DOI 10.1111/jnp.12028; Fisk JE, 2004, J CLIN EXP NEUROPSYC, V26, P874, DOI 10.1080/13803390490510680; Hall MA., 2009, ACM SIGKDD EXPLOR NE, V11, P8; HOLTE RC, 1993, MACH LEARN, V11, P63, DOI 10.1023/A:1022631118932; James G, 2013, SPRINGER TEXTS STAT, V103, P1, DOI 10.1007/978-1-4614-7138-7; Kehagia AA, 2010, CURR OPIN NEUROBIOL, V20, P199, DOI 10.1016/j.conb.2010.01.007; Kudlicka A, 2011, MOVEMENT DISORD, V26, P2305, DOI 10.1002/mds.23868; Le TH, 1998, J NEUROPHYSIOL, V79, P1535, DOI 10.1152/jn.1998.79.3.1535; Lepore M, 2005, NEUROPSICOLOGIA LOBI; Lewis SJG, 2005, NEUROPSYCHOLOGIA, V43, P823, DOI 10.1016/j.neuropsychologia.2004.10.001; Libbrecht MW, 2015, NAT REV GENET, V16, P321, DOI 10.1038/nrg3920; MacPherson SE, 2002, PSYCHOL AGING, V17, P598, DOI 10.1037//0882-7974.17.4.598; Mazza C, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0227113; Mazza C, 2019, FRONT PSYCHIATRY, V10, DOI 10.3389/fpsyt.2019.00389; Muslimovic D, 2005, NEUROLOGY, V65, P1239, DOI 10.1212/01.wnl.0000180516.69442.95; Muslimovic D, 2007, J INT NEUROPSYCH SOC, V13, P920, DOI 10.1017/S1355617707071160; Obermeyer Z, 2016, NEW ENGL J MED, V375, P1216, DOI 10.1056/NEJMp1606181; Orru G, 2020, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.02970; Orru G, 2020, FRONT MED-LAUSANNE, V6, DOI 10.3389/fmed.2019.00319; Orru G, 2012, NEUROSCI BIOBEHAV R, V36, P1140, DOI 10.1016/j.neubiorev.2012.01.004; Pace G, 2019, FRONT PSYCHOL, V10, DOI 10.3389/fpsyg.2019.01650; Rabinovici Gil D, 2015, Continuum (Minneap Minn), V21, P646, DOI 10.1212/01.CON.0000466658.05156.54; Uekermann J, 2004, J NEURAL TRANSM-SUPP, P39; van der Zee S, 2021, MOVEMENT DISORD, V36, P642, DOI 10.1002/mds.28360; Vlagsma TT, 2017, ARCH PHYS MED REHAB, V98, P2181, DOI 10.1016/j.apmr.2017.03.016; Williams-Gray CH, 2007, BRAIN, V130, P1787, DOI 10.1093/brain/awm111; Yarkoni T, 2017, PERSPECT PSYCHOL SCI, V12, P1100, DOI 10.1177/1745691617693393; Ziabreva I, 2006, NEUROBIOL AGING, V27, P433, DOI 10.1016/j.neurobiolaging.2005.02.004	33	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265803	10.1371/journal.pone.0265803	http://dx.doi.org/10.1371/journal.pone.0265803			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320291	Green Published, gold			2022-12-26	WOS:000784240600015
J	Ghosh, N; Nandi, S; Saha, I				Ghosh, Nimisha; Nandi, Suman; Saha, Indrajit			Phylogenetic analysis of 17271 Indian SARS-CoV-2 genomes to identify temporal and spatial hotspot mutations	PLOS ONE			English	Article							SEQUENCE	The second wave of SARS-CoV-2 has hit India hard and though the vaccination drive has started, moderate number of COVID affected patients is still present in the country, thereby leading to the analysis of the evolving virus strains. In this regard, multiple sequence alignment of 17271 Indian SARS-CoV-2 sequences is performed using MAFFT followed by their phylogenetic analysis using Nextstrain. Subsequently, mutation points as SNPs are identified by Nextstrain. Thereafter, from the aligned sequences temporal and spatial analysis are carried out to identify top 10 hotspot mutations in the coding regions based on entropy. Finally, to judge the functional characteristics of all the non-synonymous hotspot mutations, their changes in proteins are evaluated as biological functions considering the sequences by using PolyPhen-2 while I-Mutant 2.0 evaluates their structural stability. For both temporal and spatial analysis, there are 21 non-synonymous hotspot mutations which are unstable and damaging.	[Ghosh, Nimisha] Univ Warsaw, Fac Math Informat & Mech, Warsaw, Poland; [Ghosh, Nimisha] Siksha O Anusandhan Deemed Univ, Inst Tech Educ & Res, Dept Comp Sci & Informat Technol, Bhubaneswar, Odisha, India; [Nandi, Suman; Saha, Indrajit] Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, W Bengal, India	University of Warsaw; Siksha 'O' Anusandhan University; National Institute of Technical Teachers Training & Research, Kolkata	Saha, I (corresponding author), Natl Inst Tech Teachers Training & Res, Dept Comp Sci & Engn, Kolkata, W Bengal, India.	indrajit@nittrkol.ac.in			Science and Engineering Research Board (SERB), Department of Science and Technology, Govt. of India [CVD/2020/000991]	Science and Engineering Research Board (SERB), Department of Science and Technology, Govt. of India	This work was carried out during the tenure of an ERCIM `Alain Bensoussan' Fellowship Program awarded to Dr. Nimisha Ghosh. This work has also been partially supported by CRG short term research grant on COVID-19 (CVD/2020/000991) from Science and Engineering Research Board (SERB), Department of Science and Technology, Govt. of India. However, it does not provide any publication fees.	Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Alam I, 2020, LANCET INFECT DIS, V21, P602, DOI 10.1016/S1473-3099(21)00078-5; Alenquer M, 2021, PLOS PATHOG, V17, DOI 10.1371/journal.ppat.1009772; Ascoli CA, 2021, NAT BIOTECHNOL, V39, P274, DOI 10.1038/s41587-021-00845-3; Capriotti E, 2005, NUCLEIC ACIDS RES, V33, pW306, DOI 10.1093/nar/gki375; Cheng L, 2021, BRIEF BIOINFORM, V22, P1442, DOI 10.1093/bib/bbab042; Fountain-Jones NM, 2020, VIRUS EVOL, V6, DOI 10.1093/ve/veaa082; Guruprasad L, 2021, PROTEINS, V89, P569, DOI 10.1002/prot.26042; Hadfield J, 2018, BIOINFORMATICS, V34, P4121, DOI 10.1093/bioinformatics/bty407; Harvey WT, 2021, NAT REV MICROBIOL, V19, P409, DOI 10.1038/s41579-021-00573-0; Jangra S, 2021, LANCET MICROBE, V2, pE283, DOI 10.1016/S2666-5247(21)00068-9; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Maitra A, 2020, J BIOSCIENCES, V45, DOI 10.1007/s12038-020-00046-1; Makoni M, 2021, LANCET, V397, P267, DOI 10.1016/S0140-6736(21)00144-6; Nagy A, 2021, INT J ANTIMICROB AG, V57, DOI 10.1016/j.ijantimicag.2020.106272; Raghav S, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.594928; Saha I, 2021, BRIEF BIOINFORM, V22, P1106, DOI 10.1093/bib/bbab025; Sarkar R, 2021, ARCH VIROL, V166, P801, DOI 10.1007/s00705-020-04911-0; Tan YJ, 2021, VIRUS EVOL, V7, DOI 10.1093/ve/veab014; Tang JLW, 2021, J INFECTION, V82, pE8, DOI 10.1016/j.jinf.2021.01.007; Tang XL, 2020, NATL SCI REV, V7, P1012, DOI 10.1093/nsr/nwaa036; Wang R, 2020, J CHEM INF MODEL, V60, P5853, DOI 10.1021/acs.jcim.0c00501; Weber S, 2020, VIRUS RES, V289, DOI 10.1016/j.virusres.2020.198170; Yuan FF, 2021, TRANSBOUND EMERG DIS, V68, P3288, DOI 10.1111/tbed.13931	24	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265579	10.1371/journal.pone.0265579	http://dx.doi.org/10.1371/journal.pone.0265579			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344550	Green Published, gold			2022-12-26	WOS:000788055200010
J	Ose, N; Takeuchi, Y; Sakamaki, Y; Kadota, Y; Urasaki, K; Tsuji, H; Kawahara, K; Noguchi, M; Shintani, Y				Ose, Naoko; Takeuchi, Yukiyasu; Sakamaki, Yasushi; Kadota, Yoshihisa; Urasaki, Koji; Tsuji, Hiromi; Kawahara, Kunimitsu; Noguchi, Mayuko; Shintani, Yasushi			Detection of lymph node metastasis in non-small cell lung cancer using the new system of one-step nucleic acid amplification assay	PLOS ONE			English	Article							EARLY BREAST-CANCER; TOTAL TUMORAL LOAD; MOLECULAR-DETECTION; OSNA ASSAY; MULTICENTER; PREDICTION; DISSECTION	IntroductionThe prognosis of non-small cell lung cancer greatly depends on the presence of lymph node metastasis, which limits the need for surgery and adjuvant therapy for advanced cancer. One-step nucleic acid amplification of cytokeratin19 (CK19) mRNA was used to detect lymph node metastasis. Automated Gene Amplification Detector RD-200 and the LYNOAMP CK19 gene amplification reagent as components of the new one-step nucleic acid amplification system, which has increased gene amplification efficiency by improving the reagent composition, have shorter preprocessing and measurement times than conventional systems. We aimed to compare the clinical performance of the new system with that of histopathology and the conventional system. Materials and methods199 lymph nodes from 58 non-small cell lung cancer patients who underwent lymph node dissection were examined intraoperatively using the new system, conventional system, and histopathology. ResultsLymph node metastasis was diagnosed in 32, 42, and 44 patients using histopathological analysis, the new system, and the conventional system, respectively. Compared with histopathological analysis, the concordance rate, sensitivity, specificity, positive predictive value, and negative predictive value of the new system were 92.0%, 90.6%, 92.2%, 69.0%, and 98.1%, respectively, and compared with the conventional system, the values were 95.0%, 86.4%, 97.4%, 90.5%, and 96.2%, respectively. ConclusionThe clinical performance of the new one-step nucleic acid amplification system in detecting lymph node metastasis of lung cancer is comparable to that of histopathology and the conventional system; its performance was sufficient for determining the appropriate clinical treatment. The new rapid system can be effectively utilized during lung cancer treatment intraoperatively and postoperatively.	[Ose, Naoko; Shintani, Yasushi] Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan; [Takeuchi, Yukiyasu] Osaka Toneyama Med Ctr, Dept Gen Thorac Surg, Osaka, Japan; [Sakamaki, Yasushi] Osaka Police Hosp, Dept Chest Surg, Osaka, Japan; [Kadota, Yoshihisa] Osaka Habikino Med Ctr, Dept Gen Thorac Surg, Osaka, Japan; [Urasaki, Koji] Osaka Toneyama Med Ctr, Dept Lab Med & Pathol, Osaka, Japan; [Tsuji, Hiromi] Osaka Police Hosp, Dept Pathol, Osaka, Japan; [Kawahara, Kunimitsu] Osaka Habikino Med Ctr, Dept Pathol, Osaka, Japan; [Noguchi, Mayuko] Sysmex Corp, Gene Testing Business, Kobe, Hyogo, Japan	Osaka University; Osaka Police Hospital; Osaka Police Hospital; Sysmex Corporation	Ose, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Gen Thorac Surg, Osaka, Japan.	naokoose@thoracic.med.osaka-u.ac.jp			Sysmex Corporation; Sysmex	Sysmex Corporation; Sysmex	This study was supported by the Sysmex Corporation for purchasing agents and maintaining laboratory instruments. NO,YS, YK, YT, and YS received grant support from Sysmex. MN is an employee of Sysmex Corporation. The funders had a role in study design, data collection and analysis, but no role of decision to publish, or preparation of the manuscript.	Asamura H, 2015, J THORAC ONCOL, V10, P1675, DOI 10.1097/JTO.0000000000000678; Bernet L, 2014, REV SENOL PATOL MAMA, V27, P43, DOI DOI 10.1016/J.SENOL.2013.11.003; Blasberg JD, 2010, J THORAC ONCOL, V5, P1583, DOI 10.1097/JTO.0b013e3181e77604; Deambrogio C, 2014, J CLIN PATHOL, V67, P702, DOI 10.1136/jclinpath-2014-202384; Perez ME, 2019, J TRANSL MED, V17, DOI 10.1186/s12967-019-1974-4; Espinosa-Bravo M, 2013, EJSO-EUR J SURG ONC, V39, P766, DOI 10.1016/j.ejso.2013.03.011; Ferlay J, 2019, INT J CANCER, V144, P1941, DOI 10.1002/ijc.31937; Greene FL., 2017, 2017 AJCC CANC STAGI, P891; Guller U, 2012, CANCER-AM CANCER SOC, V118, P6039, DOI 10.1002/cncr.27667; Han H, 2017, J THORAC DIS, V9, P2102, DOI 10.21037/jtd.2017.06.04; Inoue M, 2012, LUNG CANCER, V78, P212, DOI 10.1016/j.lungcan.2012.08.018; Itabashi M, 2020, ANN SURG ONCOL, V27, P1077, DOI 10.1245/s10434-019-07971-y; Kumagai K, 2014, GASTRIC CANCER, V17, P273, DOI 10.1007/s10120-013-0271-9; Nakagawa K, 2016, LUNG CANCER, V97, P1, DOI 10.1016/j.lungcan.2016.03.015; Osako T, 2017, BRIT J CANCER, V117, P1470, DOI 10.1038/bjc.2017.311; Peg V, 2017, BREAST, V33, P8, DOI 10.1016/j.breast.2017.02.011; Peg V, 2013, BREAST CANCER RES TR, V139, P87, DOI 10.1007/s10549-013-2524-z; Postmus PE, 2017, ANN ONCOL, V28, P1, DOI 10.1093/annonc/mdx222; Rubio IT, 2014, BREAST CANCER RES TR, V147, P371, DOI 10.1007/s10549-014-3108-2; Seki A., 2019, SYSMEX J INT, V29; Shimazu K, 2019, MED ONCOL, V36, DOI 10.1007/s12032-019-1277-x; Shimazu K, 2019, ANTICANCER RES, V39, P1447, DOI 10.21873/anticanres.13261; Shimazu K, 2018, ANN SURG ONCOL, V25, P2603, DOI 10.1245/s10434-018-6633-0; Sun X, 2019, CANCER MANAG RES, V11, P9715, DOI 10.2147/CMAR.S226733; Tamaki Y, 2009, CLIN CANCER RES, V15, P2879, DOI 10.1158/1078-0432.CCR-08-1881; Terrenato I, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171517; Yamamoto H, 2011, ANN SURG ONCOL, V18, P1891, DOI 10.1245/s10434-010-1539-5	27	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265603	10.1371/journal.pone.0265603	http://dx.doi.org/10.1371/journal.pone.0265603			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312731	Green Published, gold			2022-12-26	WOS:000803647900022
J	Pahalagedara, ASNW; Flint, S; Palmer, J; Brightwell, G; Gupta, TB				Pahalagedara, Amila S. N. W.; Flint, Steve; Palmer, Jon; Brightwell, Gale; Gupta, Tanushree B.			Antibacterial efficacy and possible mechanism of action of 2-hydroxyisocaproic acid (HICA)	PLOS ONE			English	Article							LISTERIA-MONOCYTOGENES; D-2-HYDROXYISOCAPROATE DEHYDROGENASE; ORGANIC-ACIDS; LACTIC-ACID; RESISTANCE; BACTERIA; IDENTIFICATION; RESPONSES; LEUCINE; SPORES	The exploitation of natural antimicrobial compounds that can be used in food preservation has been fast tracked by the development of antimicrobial resistance to existing antimicrobials and the increasing consumer demand for natural food preservatives. 2-hydroxyisocaproic acid (HICA) is a natural compound produced through the leucine degradation pathway and is produced in humans and by certain microorganisms such as lactic acid bacteria and Clostridium species. The present study investigated the antibacterial efficacy of HICA against some important bacteria associated with food quality and safety and provided some insights into its possible antimicrobial mechanisms against bacteria. The results revealed that HICA was effective in inhibiting the growth of tested Gram-positive and Gram-negative bacteria including a multi-drug resistant P. aeruginosa strain in this study. The underlying mechanism was investigated by measuring the cell membrane integrity, membrane permeability, membrane depolarisation, and morphological and ultrastructural changes after HICA treatment in bacterial cells. The evidence supports that HICA exerts its activity via penetration of the bacterial cell membranes, thereby causing depolarisation, rupture of membranes, subsequent leakage of cellular contents and cell death. The current study suggests that HICA has potential to be used as an antibacterial agent against food spoilage and food-borne pathogenic bacteria, targeting the bacterial cell envelope.	[Pahalagedara, Amila S. N. W.; Brightwell, Gale; Gupta, Tanushree B.] Massey Univ, Hopkirk Res Inst, AgRes Ltd, Food Syst Integr Team, Palmerston North, New Zealand; [Pahalagedara, Amila S. N. W.; Flint, Steve; Palmer, Jon] Massey Univ, Sch Food & Adv Technol, Palmerston North, New Zealand; [Brightwell, Gale] Massey Univ, New Zealand Food Safety Sci & Res Ctr, Palmerston North, New Zealand; [Pahalagedara, Amila S. N. W.] Aarhus Univ, Dept Food Sci, Aarhus, Denmark	AgResearch - New Zealand; Massey University; Massey University; Massey University; Aarhus University	Gupta, TB (corresponding author), Massey Univ, Hopkirk Res Inst, AgRes Ltd, Food Syst Integr Team, Palmerston North, New Zealand.	tanushree.gupta@agresearch.co.nz		Brightwell, Gale/0000-0002-3980-4108; Weligala Pagalagedara, Amila Srilal Nawarathna/0000-0002-4926-1100	Strategic Science Investment Fund (SSIF), AgResearch Ltd., New Zealand	Strategic Science Investment Fund (SSIF), AgResearch Ltd., New Zealand	This work was funded by the Strategic Science Investment Fund (SSIF), AgResearch Ltd., New Zealand. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alakomi HL, 2000, APPL ENVIRON MICROB, V66, P2001, DOI 10.1128/AEM.66.5.2001-2005.2000; Alqadeeri F, 2019, MOLECULES, V24, DOI 10.3390/molecules24173095; [Anonymous], 2018, APPROVED ADDITIVES N; [Anonymous], 2 HYDROXY 4 METHYLVA; Arslan S, 2011, J DAIRY SCI, V94, P5851, DOI 10.3168/jds.2011-4676; Bagge D, 2001, APPL ENVIRON MICROB, V67, P2319, DOI 10.1128/AEM.67.5.2319-2325.2001; BERNARD N, 1994, EUR J BIOCHEM, V224, P439, DOI 10.1111/j.1432-1033.1994.00439.x; BROOKS JB, 1984, J CLIN MICROBIOL, V20, P539, DOI 10.1128/JCM.20.3.539-548.1984; Cushnie TPT, 2016, CELL MOL LIFE SCI, V73, P4471, DOI 10.1007/s00018-016-2302-2; de Arauz LJ, 2009, TRENDS FOOD SCI TECH, V20, P146, DOI 10.1016/j.tifs.2009.01.056; de Bentzmann Sophie, 2011, Environ Microbiol, V13, P1655, DOI 10.1111/j.1462-2920.2011.02469.x; Delcour AH, 2009, BBA-PROTEINS PROTEOM, V1794, P808, DOI 10.1016/j.bbapap.2008.11.005; Ercolini D, 2009, APPL ENVIRON MICROB, V75, P1990, DOI 10.1128/AEM.02762-08; Ghai I, 2018, INFECT DRUG RESIST, V11, P523, DOI 10.2147/IDR.S156995; Gopal N, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.01418; GORDEN J, 1993, INFECT IMMUN, V61, P364, DOI 10.1128/IAI.61.1.364-367.1993; Gyawali R., 2015, HDB NATURAL ANTIMICR, P49; Hamasaki Yoshikatsu, 2006, Biocontrol Science, V11, P43; Hamid A, 1997, J ANTIMICROB CHEMOTH, V39, P129, DOI 10.1093/jac/39.2.129; Hartmann M, 2010, ANTIMICROB AGENTS CH, V54, P3132, DOI 10.1128/AAC.00124-10; Helander IM, 2000, J APPL MICROBIOL, V88, P213, DOI 10.1046/j.1365-2672.2000.00971.x; HIETALA PK, 1979, NUTR METAB, V23, P227; HOFFER LJ, 1993, J NUTR, V123, P1513, DOI 10.1093/jn/123.9.1513; Hsiao CP, 1999, INT J FOOD MICROBIOL, V47, P189, DOI 10.1016/S0168-1605(99)00012-4; HUMMEL W, 1985, APPL MICROBIOL BIOT, V21, P7; Kim SA, 2014, J FOOD PROTECT, V77, P419, DOI 10.4315/0362-028X.JFP-13-234; Kovach KN., 2019, BIORXIV2019598979, P598979, DOI [10.1101/598979, DOI 10.1101/598979]; Liu YJ, 2015, J FOOD SCI, V80, pM2904, DOI 10.1111/1750-3841.13142; Lucera Annalisa, 2012, Front Microbiol, V3, P287, DOI 10.3389/fmicb.2012.00287; MALONEY PC, 1974, P NATL ACAD SCI USA, V71, P3896, DOI 10.1073/pnas.71.10.3896; Mero AA, 2010, J INT SOC SPORT NUTR, V7, DOI 10.1186/1550-2783-7-1; MING XT, 1993, J FOOD PROTECT, V56, P944, DOI 10.4315/0362-028X-56.11.944; Muheim C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17772-6; Pahalagedara ASNW, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.608998; Park B, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-10948-0; Riss TL, 2004, ASSAY GUIDANCE MANUA; Sakko M, 2014, MYCOSES, V57, P214, DOI 10.1111/myc.12145; Sakko M, 2012, INT J ANTIMICROB AG, V39, P539, DOI 10.1016/j.ijantimicag.2012.02.006; Selis D, 2019, J ENDODONT, V45, P578, DOI 10.1016/j.joen.2019.01.012; Senouci-Rezkallah K, 2011, FOOD MICROBIOL, V28, P364, DOI 10.1016/j.fm.2010.09.003; Smit BA, 2004, APPL MICROBIOL BIOT, V64, P396, DOI 10.1007/s00253-003-1447-8; Soni A, 2016, COMPR REV FOOD SCI F, V15, P1139, DOI 10.1111/1541-4337.12231; Stanojevic-Nikolic S, 2016, J FOOD PROCESS PRES, V40, P990, DOI 10.1111/jfpp.12679; te Winkel JD, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00029; VANWYK CJ, 1967, J FOOD SCI, V32, P664, DOI 10.1111/j.1365-2621.1967.tb00859.x; Verheul A, 1997, APPL ENVIRON MICROB, V63, P3451, DOI 10.1128/AEM.63.9.3451-3457.1997; Wilks JC, 2009, APPL ENVIRON MICROB, V75, P981, DOI 10.1128/AEM.01652-08; Wimley WC, 2011, J MEMBRANE BIOL, V239, P27, DOI 10.1007/s00232-011-9343-0; Wu JT, 2014, APPL ENVIRON MICROB, V80, P4108, DOI 10.1128/AEM.01001-14; Xing YH, 2014, ACTA PHARMACOL SIN, V35, P211, DOI 10.1038/aps.2013.159; Yeaman MR, 2003, PHARMACOL REV, V55, P27, DOI 10.1124/pr.55.1.2; Yvon M, 2001, INT DAIRY J, V11, P185, DOI 10.1016/S0958-6946(01)00049-8; Zink DL, 1997, EMERG INFECT DIS, V3, P467, DOI 10.3201/eid0304.970408	53	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266406	10.1371/journal.pone.0266406	http://dx.doi.org/10.1371/journal.pone.0266406			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363830	Green Published, gold			2022-12-26	WOS:000804748600038
J	Umugire, A; Choi, Y; Lee, S; Cho, HH				Umugire, Alphonse; Choi, Youngmi; Lee, Sungsu; Cho, Hyong-Ho			Efficiency of antioxidant Avenanthramide-C on high-dose methotrexate-induced ototoxicity in mice	PLOS ONE			English	Article							CHEMOTHERAPY; THERAPY; PHARMACOKINETICS; NEUROTOXICITY; LEUCOVORIN; TOXICITY; CHILDREN	Methotrexate (MTX) has been used in treating various types of cancers but can also cause damage to normal organs and cell types. Folinic acid (FA) is a well-known MTX antidote that protects against toxicity caused by the drug and has been used for decades. Since hearing loss caused by MTX treatment is not well studied, herein we aimed to investigate the efficiency of the antioxidant Avenanthramide-C (AVN-C) on high-dose MTX (HDMTX) toxicity in the ear and provide insights into the possible mechanism involved in MTX-induced hearing loss in normal adult C57Bl/6 mice and HEI-OC1 cells. Our results show that the levels of MTX increased in the serum and perilymph 30 minutes after systemic administration. MTX increased hearing thresholds in mice, whereas AVN-C and FA preserved hearing within the normal range. MTX also caused a decrease in wave I amplitude, while AVN-C and FA maintained it at higher levels. MTX considerably damaged the cochlear synapses and neuronal integrity, and both AVN-C and FA rescued the synapses. MTX reduced the cell viability and increased the reactive oxygen species (ROS) level in HEI-OC1 cells, but AVN-C and FA reversed these changes. Apoptosis- and ROS-related genes were significantly upregulated in MTX-treated HEI-OC1 cells; however, they were downregulated by AVN-C and FA treatment. We show that MTX can cause severe hearing loss; it can cross the blood-labyrinth barrier and cause damage to the cochlear neurons and outer hair cells (OHCs). The antioxidant AVN-C exerts a strong protective effect against MTX-induced ototoxicity and preserved the inner ear structures (synapses, neurons, and OHCs) from MTX-induced damage. The mechanism of AVN-C against MTX suggests that ROS is involved in HDMTX-induced ototoxicity.	[Umugire, Alphonse; Choi, Youngmi; Lee, Sungsu; Cho, Hyong-Ho] Chonnam Natl Univ, Med Sch, Dept Otolaryngol Head & Neck Surg, Gwangju, South Korea; [Umugire, Alphonse; Choi, Youngmi; Lee, Sungsu; Cho, Hyong-Ho] Chonnam Natl Univ Hosp, Gwangju, South Korea; [Umugire, Alphonse; Cho, Hyong-Ho] Chonnam Natl Univ, Coll Med, BK21 Plus Ctr Creat Biomed Scientists, Dept Biomed Sci,Grad Sch, Gwangju, South Korea	Chonnam National University; Chonnam National University; Chonnam National University Hospital; Chonnam National University	Cho, HH (corresponding author), Chonnam Natl Univ, Med Sch, Dept Otolaryngol Head & Neck Surg, Gwangju, South Korea.; Cho, HH (corresponding author), Chonnam Natl Univ Hosp, Gwangju, South Korea.; Cho, HH (corresponding author), Chonnam Natl Univ, Coll Med, BK21 Plus Ctr Creat Biomed Scientists, Dept Biomed Sci,Grad Sch, Gwangju, South Korea.	victocho@hanmail.net			Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2020R1A2C1007473];  [BCRI20038]	Basic Science Research Program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; 	This research was supported by a grant (NRF-2020R1A2C1007473) from the Basic Science Research Program through the National Research Foundation of Korea, funded by the Ministry of Education, Science and Technology. It was also supported by a grant from the Chonnam National University Hospital Biomedical Research Institute (BCRI20038). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aquerreta I, 2002, ANN PHARMACOTHER, V36, P1344; Bernard S, 2021, ANN HEMATOL, V100, P979, DOI 10.1007/s00277-020-04341-7; Buran BN, 2020, JARO-J ASSOC RES OTO, V21, P225, DOI 10.1007/s10162-020-00754-3; Colmenarez-Raga AC, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00356; Csordas K, 2013, ANTI-CANCER DRUG, V24, P189, DOI 10.1097/CAD.0b013e32835b8662; Ding DL, 2012, ANAT REC, V295, P1851, DOI 10.1002/ar.22577; Eren SB, 2017, INT J PEDIATR OTORHI, V100, P132, DOI 10.1016/j.ijporl.2017.06.035; Fetoni AR, 2019, FREE RADICAL BIO MED, V135, P46, DOI 10.1016/j.freeradbiomed.2019.02.022; Flombaum CD, 1999, J CLIN ONCOL, V17, P1589, DOI 10.1200/JCO.1999.17.5.1589; FREI E, 1980, AM J MED, V68, P370, DOI 10.1016/0002-9343(80)90105-9; Gomes A, 2005, J BIOCHEM BIOPH METH, V65, P45, DOI 10.1016/j.jbbm.2005.10.003; Halliwell B, 1999, FREE RADICAL BIO MED, P53; HOLLAND JF, 1958, AM J OBSTET GYNECOL, V75, P195, DOI 10.1016/0002-9378(58)90571-4; Holmboe L, 2012, BRIT J CLIN PHARMACO, V73, P106, DOI 10.1111/j.1365-2125.2011.04054.x; Howard SC, 2016, ONCOLOGIST, V21, P1471, DOI 10.1634/theoncologist.2015-0164; Hsu CH, 2001, ANTICANCER RES, V21, P711; Huang CC, 2005, APOPTOSIS, V10, P895, DOI 10.1007/s10495-005-2947-z; Kitchlu A., 2019, J ONCO NEPHROLOGY, V3, P11; Kohrman DC, 2020, CSH PERSPECT MED, V10, DOI 10.1101/cshperspect.a035493; Kozminski P, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21103483; LaCasce AS., 2014, THERAPEUTIC USE TOXI; Leite RA, 2020, ARQ NEURO-PSIQUIAT, V78, P63, DOI [10.1590/0004-282X20190139, 10.1590/0004-282x20190139]; Llufrio EM, 2018, REDOX BIOL, V16, P381, DOI 10.1016/j.redox.2018.03.004; Ma KF, 2021, FRONT CELL DEV BIOL, V9, DOI 10.3389/fcell.2021.720902; Malaviya AN, 2010, INT J RHEUM DIS, V13, P288, DOI 10.1111/j.1756-185X.2010.01564.x; Matthews G, 2010, NAT REV NEUROSCI, V11, P812, DOI 10.1038/nrn2924; Mengoli Marco, 2011, Recenti Progressi in Medicina, V102, P253, DOI 10.1701/893.9843; Meydani M, 2009, NUTR REV, V67, P731, DOI 10.1111/j.1753-4887.2009.00256.x; Morrison PF., 1987, DRINK WAT HLTH, V8; Murphy, 1997, Medscape Womens Health, V2, P2; Nam JH, 2014, BIOPHYS J, V106, P2426, DOI 10.1016/j.bpj.2014.04.018; Nie L, 2006, ATHEROSCLEROSIS, V186, P260, DOI 10.1016/j.atherosclerosis.2005.07.027; OSMAN AMM, 1994, CHEMOTHERAPY, V40, P227, DOI 10.1159/000239197; Phillips DC, 2003, BRIT J PHARMACOL, V138, P501, DOI 10.1038/sj.bjp.0705054; Poortmans PMP, 2003, J CLIN ONCOL, V21, P4483, DOI 10.1200/JCO.2003.03.108; Richardson RT, 2006, AUDIOL NEURO-OTOL, V11, P343, DOI 10.1159/000095896; Sheppard A, 2014, ACTA OTORHINOLARYNGO, V34, P79; Suzuki J, 2016, SCI REP-UK, V6, DOI 10.1038/srep24907; Tirzaman O, 2000, ANN OTO RHINOL LARYN, V109, P710, DOI 10.1177/000348940010900802; Umugire A, 2019, CELL DEATH DISCOV, V5, DOI 10.1038/s41420-019-0195-1; van Dam PS, 2002, DIABETES-METAB RES, V18, P176, DOI 10.1002/dmrr.287; Vendemiale G, 1999, INT J CLIN LAB RES, V29, P49, DOI 10.1007/s005990050063; Verhulst S, 2016, TRENDS HEAR, V20, DOI 10.1177/2331216516672186; Villavisanis DF, 2020, OTOL NEUROTOL, V41, P290, DOI 10.1097/MAO.0000000000002507; Widemann BC, 2006, ONCOLOGIST, V11, P694, DOI 10.1634/theoncologist.11-6-694; Yoshikawa N, 2021, J CLIN LAB ANAL, V35, DOI 10.1002/jcla.23661; Youssef AA, 2015, EGYPT J RADIOL NUC M, V46, P1149, DOI 10.1016/j.ejrnm.2015.07.015; Zhang TO, 2020, J INT SOC SPORT NUTR, V17, DOI 10.1186/s12970-020-00368-3	48	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266108	10.1371/journal.pone.0266108	http://dx.doi.org/10.1371/journal.pone.0266108			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353852	gold, Green Published			2022-12-26	WOS:000786647900009
J	Maya, TG; Komba, EV; Mensah, GI; Mbelele, PM; Mpagama, SG; Mfinanga, SG; Addo, KK; Kazwala, RR				Maya, Togolani Godfrey; Komba, Erick Vitus; Mensah, Gloria Ivy; Mbelele, Peter Masunga; Mpagama, Stella George; Mfinanga, Sayoki Godfrey; Addo, Kennedy Kwasi; Kazwala, Rudovick Reuben			Drug susceptibility profiles and factors associated with non-tuberculous mycobacteria species circulating among patients diagnosed with pulmonary tuberculosis in Tanzania	PLOS ONE			English	Article							LUNG-DISEASE; RESISTANCE; IDENTIFICATION; INFECTIONS; CM/AS	Background While most Non-tuberculous mycobacteria (NTM) are saprophytic, several species have been associated with human diseases, from localized infection to disseminated diseases. Pulmonary NTM infections lead to TB-like disease called NTM pulmonary disease (NTMPD). Due to variation in treatment options among NTM species, it is necessary to identify the species and determine drug susceptibility profiles to inform the choice of appropriate regimen for the disease. Design A total of 188 culture-positive isolates from patients diagnosed with TB were screened for NTM at the Central Tuberculosis Reference Laboratory. All NTM were further speciated using GenoType (R) Mycobacterium-Common Mycobacterium and Additional species (GenoType (R) CM/AS) kit. Mycobacteria avium complex (MAC) and Mycobacteria abscessus complex (MABC) which could not be identified with the test to species were subjected to GenoType (R) Mycobacteria NTM-DR for further speciation. Using the same test, identified MAC and MABC were genotyped to determine the drug susceptibility profile for each isolate to macrolide and aminoglycosides. Results Of all isolates identified as mycobacteria, 24 (13%) were NTM. Fifteen isolates could be identified to species level of which prevalent species was M. avium sub. intracellulare 4 (27%). A total of 10 isolates were MAC (n = 6) and MABC (n = 4) were subjected to GenoType (R) Mycobacteria NTM-DR for determination of macrolide and aminoglycoside susceptibility. Three of the four MABC had a mutation at the T28 position of the erm (41). All MAC were susceptible to both drugs. Conclusion In this study, MAC was the most frequently isolated NTM species followed by MABC. While all MAC and MABC identified, were susceptible to aminoglycosides, three MABC were resistant to the macrolides due to mutation at position 28 of the erm (41) gene. For this, it is important for clinicians need to rule out NTM, understand species and their drug susceptibility for optimal case management.	[Maya, Togolani Godfrey; Komba, Erick Vitus; Kazwala, Rudovick Reuben] Sokoine Univ Agr, Coll Vet Med & Biomed Sci, Dept Vet Med & Publ Hlth, Morogoro, Tanzania; [Mensah, Gloria Ivy; Addo, Kennedy Kwasi] Univ Ghana, Noguchi Mem Inst Med Res, Dept Bacteriol, Accra, Ghana; [Mbelele, Peter Masunga; Mpagama, Stella George] Kibongoto Infect Dis Hosp, Moshi, Tanzania; [Mfinanga, Sayoki Godfrey] Natl Inst Med Res, Muhimbili Res Ctr, Dar Es Salaam, Tanzania	Sokoine University of Agriculture; University of Ghana; National Institute of Medical Research	Maya, TG (corresponding author), Sokoine Univ Agr, Coll Vet Med & Biomed Sci, Dept Vet Med & Publ Hlth, Morogoro, Tanzania.	tmaya.tz@gmail.com		Maya, Togolani/0000-0003-0654-8088	DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust [107753/A/15/Z]; UK government	DELTAS Africa Initiative; African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA); New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency; Wellcome Trust(Wellcome Trust); UK government	The research for this paper was carried out within the framework of the DELTAS Africa Initiative [Afrique One-ASPIRE/DEL-15-008]. Afrique One-ASPIRE is funded by a consortium of donor including the African Academy of Sciences (AAS) Alliance for Accelerating Excellence in Science in Africa (AESA), the New Partnership for Africa's Development Planning and Coordinating (NEPAD) Agency, the Wellcome Trust [107753/A/15/Z] and the UK government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addo KK, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2853-3; Bastian S, 2011, ANTIMICROB AGENTS CH, V55, P775, DOI 10.1128/AAC.00861-10; Brown-Elliott BA, 2012, CLIN MICROBIOL REV, V25, P545, DOI 10.1128/CMR.05030-11; Crump JA, 2009, EMERG INFECT DIS, V15, P53, DOI 10.3201/eid1501.081093; Daley CL, 2020, CLIN INFECT DIS, V71, pE1, DOI 10.1093/cid/ciaa241; Dodd PJ, 2016, AM J EPIDEMIOL, V183, P156, DOI 10.1093/aje/kwv160; Ephraim Z, 2014, ARTICLE J AGR SCI TE, V4; Evans SA, 1996, THORAX, V51, P1248, DOI 10.1136/thx.51.12.1248; Forbes BA, 2018, CLIN MICROBIOL REV, V31, DOI 10.1128/CMR.00038-17; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Harris KA, 2015, WHOLE GENOME SEQUENC, P60; Haworth CS, 2017, THORAX, V72, DOI 10.1136/thoraxjnl-2017-210927; Honda JR, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02029; Honda JR, 2015, CLIN CHEST MED, V36, P1, DOI 10.1016/j.ccm.2014.10.001; Hoza Abubakar S, 2016, BMC Res Notes, V9, P109, DOI 10.1186/s13104-016-1928-3; Hoza AS, 2016, TANZANIA J HLTH RES, V18, P1; Huh HJ, 2019, J CLIN MICROBIOL, V57, DOI [10.1128/jcm.00516-19, 10.1128/JCM.00516-19]; Katale BZ, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0616-y; Kendall BA, 2011, EMERG INFECT DIS, V17, P506, DOI 10.3201/eid1703.101164; Kim C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174240; Lee AS, 2009, J MED MICROBIOL, V58, P900, DOI 10.1099/jmm.0.007484-0; Makinen J, 2006, CLIN MICROBIOL INFEC, V12, P481, DOI 10.1111/j.1469-0691.2006.01380.x; Gonzalez SM, 2017, ARCH BRONCONEUMOL, V53, P554, DOI 10.1016/j.arbres.2017.02.014; Mbelele PM, 2019, AAS OPEN RES, P2, DOI [10.12688/ aasopenres.12911.2, DOI 10.12688/AASOPENRES.12911.2]; Mbugi EV, 2015, TUBERCULOSIS, V95, P170, DOI 10.1016/j.tube.2014.11.006; McCarthy KD, 2012, AM J RESP CRIT CARE, V185, P981, DOI 10.1164/rccm.201107-1327OC; McShane PJ, 2015, CHEST, V148, P1517, DOI 10.1378/chest.15-0458; Mertaniasih NM, 2017, INT J MYCOBACT, V6, P9, DOI 10.4103/2212-5531.201894; Mfinanga S G M, 2004, East Afr Med J, V81, P171; Mnyambwa NP, 2017, INT J GEN MED, V10, P199, DOI 10.2147/IJGM.S137469; Mnyambwa NP, 2018, GENOME SEQUENCE MYCO, DOI [10.1016/j.ijid.2018.04.796, DOI 10.1016/J.IJID.2018.04.796]; Mougari F, 2017, J ANTIMICROB CHEMOTH, V72, P1669, DOI 10.1093/jac/dkx021; Nishiuchi Y, 2017, FRONT MED-LAUSANNE, V4, DOI 10.3389/fmed.2017.00027; Okoi C, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-12175-z; Olivier KN, 2003, AM J RESP CRIT CARE, V167, P828, DOI 10.1164/rccm.200207-678OC; Park S, 2019, BMC GERIATR, V19, DOI 10.1186/s12877-019-1140-0; Parte AC, 2020, INT J SYST EVOL MICR, V70, P5607, DOI 10.1099/ijsem.0.004332; Ryu YJ, 2016, TUBERC RESPIR DIS, V79, P74, DOI 10.4046/trd.2016.79.2.74; Shteinberg M, 2018, EUROPEAN RESP J EURO, V51; Tb N, 2017, NATL TUBERCULOSIS LE; Tuberculosis A, 2014, DIS L PREVALENCE DRU, V20; van Ingen J, 2013, SEMIN RESP CRIT CARE, V34, P103, DOI 10.1055/s-0033-1333569; Wallace RJ, 1996, ANTIMICROB AGENTS CH, V40, P1676, DOI 10.1128/AAC.40.7.1676; Zhang ZXZ, 2019, BMC INFECT DIS, V19, DOI 10.1186/s12879-019-3909-3	44	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265358	10.1371/journal.pone.0265358	http://dx.doi.org/10.1371/journal.pone.0265358			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324922	Green Published, gold			2022-12-26	WOS:000780951300038
J	Sage, MAG; Cranmer, KD; Semeraro, ML; Ma, S; Galkina, EV; Tran, Y; Wycoff, KL; Sharp, JA				Sage, Megan A. G.; Cranmer, Katelyn D.; Semeraro, Michele L.; Ma, Shelby; Galkina, Elena, V; Tran, Y.; Wycoff, Keith L.; Sharp, Julia A.			A Factor H-Fc fusion protein increases complement-mediated opsonophagocytosis and killing of community associated methicillin-resistant Staphylococcus aureus	PLOS ONE			English	Article							MULTIPLEX PCR ASSAY; IMMUNE EVASION; MONOCLONAL-ANTIBODIES; ACTIVATION; INHIBITOR; BINDING; GENES; CELLS; C3B	Staphylococcus aureus employs a multitude of immune-evasive tactics to circumvent host defenses including the complement system, a component of innate immunity central to controlling bacterial infections. With antibiotic resistance becoming increasingly common, there is a dire need for novel therapies. Previously, we have shown that S. aureus binds the complement regulator factor H (FH) via surface protein SdrE to inhibit complement. To address the need for novel therapeutics and take advantage of the FH:SdrE interaction, we examined the effect of a fusion protein comprised of the SdrE-interacting domain of FH coupled with IgG Fc on complement-mediated opsonophagocytosis and bacterial killing of community associated methicillinresistant S. aureus. S. aureus bound significantly more FH-Fc compared to Fc-control proteins and FH-Fc competed with serum FH for S. aureus binding. FH-Fc treatment increased C3-fragment opsonization of S. aureus for both C3b and iC3b, and boosted generation of the anaphylatoxin C5a. In 5 and 10% serum, FH-Fc treatment significantly increased S. aureus killing by polymorphonuclear cells. This anti-staphylococcal effect was evident in 75% (3/4) of clinical isolates tested. This study demonstrates that FH-Fc fusion proteins have the potential to mitigate the protective effects of bound serum FH rendering S. aureus more vulnerable to the host immune system. Thus, we report the promise of virulence-factor-targeted fusion-proteins as an avenue for prospective anti-staphylococcal therapeutic development.	[Sage, Megan A. G.; Cranmer, Katelyn D.; Semeraro, Michele L.; Ma, Shelby; Galkina, Elena, V; Sharp, Julia A.] Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA; [Tran, Y.; Wycoff, Keith L.] Planet Biotechnol Inc, Hayward, CA USA	Eastern Virginia Medical School	Sharp, JA (corresponding author), Eastern Virginia Med Sch, Dept Microbiol & Mol Cell Biol, Norfolk, VA 23501 USA.	sharpja@evms.edu		Sage, Megan/0000-0002-7112-5164	U.S. Department of Defense [W81XWH19-1-0119, HL142129]	U.S. Department of Defense(United States Department of Defense)	U.S. Department of Defense, W81XWH19-1-0119 to KLW and JAS; https://www.defense.gov/National Institutes of Health, HL142129, EVG; https://www.nih.gov The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Battle SE, 2009, FEMS MICROBIOL LETT, V290, P70, DOI 10.1111/j.1574-6968.2008.01406.x; Blom AM, 2017, J IMMUNOL, V199, P3828, DOI 10.4049/jimmunol.1700426; Chen H, 2010, P NATL ACAD SCI USA, V107, P17621, DOI 10.1073/pnas.1003750107; Cunnion KM, 2001, INFECT IMMUN, V69, P6796, DOI 10.1128/IAI.69.11.6796-6803.2001; Dati F, 1996, EUR J CLIN CHEM CLIN, V34, P517; De Jong NWM, 2019, MICROBIOL SPECTR, V7, DOI 10.1128/microbiolspec.GPP3-0061-2019; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Esparza-Gordillo J, 2004, IMMUNOGENETICS, V56, P77, DOI 10.1007/s00251-004-0660-7; Ferreira VP, 2010, MOL IMMUNOL, V47, P2187, DOI 10.1016/j.molimm.2010.05.007; Ferreira VP, 2009, J IMMUNOL, V182, P7009, DOI 10.4049/jimmunol.0804031; Foster TJ, 2014, NAT REV MICROBIOL, V12, P49, DOI 10.1038/nrmicro3161; Gulati S, 2019, PLOS BIOL, V17, DOI 10.1371/journal.pbio.3000323; Hair PS, 2008, J INFECT DIS, V198, P125, DOI 10.1086/588825; Hezareh M, 2001, J VIROL, V75, P12161, DOI 10.1128/JVI.75.24.12161-12168.2001; Holers VM, 2014, ANNU REV IMMUNOL, V32, P433, DOI 10.1146/annurev-immunol-032713-120154; Jongerius I, 2010, J BIOL CHEM, V285, P14973, DOI 10.1074/jbc.M109.091975; Karmakar A, 2018, J PATHOG, V2018, DOI 10.1155/2018/4518541; Lei XY, 2015, SCI REP-UK, V5, DOI 10.1038/srep07824; Liszewski MK, 2008, VACCINE, V26, pI22, DOI 10.1016/j.vaccine.2008.11.001; Mao XR, 2021, J BIOCHEM, V169, P543, DOI 10.1093/jb/mvaa142; McGuinness WA, 2016, PATHOGENS, V5, DOI 10.3390/pathogens5010032; MICHAELSEN TE, 1991, EUR J IMMUNOL, V21, P11, DOI 10.1002/eji.1830210103; Miguel CPV, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0212029; Miller LS, 2020, FEMS MICROBIOL REV, V44, P123, DOI 10.1093/femsre/fuz030; Moore GL, 2010, MABS-AUSTIN, V2, P181, DOI 10.4161/mabs.2.2.11158; Morgan HP, 2011, NAT STRUCT MOL BIOL, V18, P463, DOI 10.1038/nsmb.2018; Olinger GG, 2012, P NATL ACAD SCI USA, V109, P18030, DOI 10.1073/pnas.1213709109; Pier GB, 2013, HUM VACC IMMUNOTHER, V9, P1865, DOI 10.4161/hv.25182; Ram S, 2016, IMMUNOBIOLOGY, V221, P1110, DOI 10.1016/j.imbio.2016.05.016; Ricklin D, 2009, J IMMUNOL, V183, P2565, DOI 10.4049/jimmunol.0901443; de Cordoba SR, 2012, IMMUNOBIOLOGY, V217, P1034, DOI 10.1016/j.imbio.2012.07.021; Rooijakkers SHM, 2005, NAT IMMUNOL, V6, P920, DOI 10.1038/ni1235; Rooijakkers SHM, 2006, CELL MICROBIOL, V8, P1282, DOI 10.1111/j.1462-5822.2006.00709.x; Sabat A, 2006, J CLIN MICROBIOL, V44, P1135, DOI 10.1128/JCM.44.3.1135-1138.2006; Sharp JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038407; Sharp JA, 2011, MOL IMMUNOL, V48, P683, DOI 10.1016/j.molimm.2010.11.014; Shaughnessy J, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.583305; Strasser R, 2008, PLANT BIOTECHNOL J, V6, P392, DOI 10.1111/j.1467-7652.2008.00330.x; Tan L, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00055; Wang G, 2016, MOL CELL, V63, P135, DOI 10.1016/j.molcel.2016.05.016; Wong SM, 2016, FRONT CELL INFECT MI, V6, DOI 10.3389/fcimb.2016.00040; Wycoff K, 2015, PLANT BIOTECHNOL J, V13, P1078, DOI 10.1111/pbi.12441; Wycoff KL, 2011, ANTIMICROB AGENTS CH, V55, P132, DOI 10.1128/AAC.00592-10; Zelek WM, 2018, IMMUNOBIOLOGY, V223, P744, DOI 10.1016/j.imbio.2018.07.016; Zhang KY, 2012, MOL CELL PROBE, V26, P218, DOI 10.1016/j.mcp.2012.04.002; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005; Zhang YJ, 2017, BIOCHEM J, V474, P1619, DOI 10.1042/BCJ20170085	48	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265774	10.1371/journal.pone.0265774	http://dx.doi.org/10.1371/journal.pone.0265774			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324969	gold, Green Published			2022-12-26	WOS:000780951300072
J	Sousa, FAB; Manchado-Gobatto, FB; Rodrigues, NA; Gobatto, CA				Sousa, Filipe A. B.; Manchado-Gobatto, Fulvia B.; Rodrigues, Natalia A.; Gobatto, Claudio A.			Comparison of parameters derived from a three-minute all-out test with classical benchmarks for running exercise	PLOS ONE			English	Article							PEAK OXYGEN-UPTAKE; CRITICAL POWER; TIME RELATIONSHIP; WORK CAPACITY; RELIABILITY; VALIDITY; INTENSITY; RESPONSES; CYCLISTS; PROVIDE	This study aimed to compare four constructs from the three-minute all-out test (AO3)-end power (EP), the area above EP (WEP), maximum power (Pmax), and attained ((V)over dot)O-2peak-to those derived from the classical CP model in tethered running. Seventeen male recreational runners underwent two experiments to test for reliability and agreement of AO3 parameters with those obtained from the classical CP model (W' and CP), a graded exercise test (((V)over dot)O-2max) and a 30-second all-out test (AO30s; Pmax); all performed on a non-motorized treadmill (NMT). Significance levels were set at p< 0.05. There were no significant differences between test-retest for Pmax (p = 0.51), WEP (p = 0.39), and EP (p = 0.64), showing generally close to zero bias. Further, retest ICC were high for Pmax and EP (ICC > 0.86) but moderate for WEP (ICC = 0.69). Pmax showed no difference between AO3 and AO30s (p = 0.18; CV% = 9.5%). EP and WEP disagreed largely with their classical critical power model counterparts (p = 0.05; CV%>32.7% and p = 0.23; CV%>39.7%, respectively), showing greater error than their test-retest reliability. ((V)over dot)O-2peak from AO3 was not different (p = 0.13) and well related (CV% = 8.4; ICC = 0.87) to the incremental test ((V)over dot) O-2max. Under the studied conditions, the agreement of EP and WEP to CP and W0 was not strong enough to assure their use interchangeably. Pmax and ((V)over dot)O-2max were closer to their criterion parameters.	[Sousa, Filipe A. B.; Manchado-Gobatto, Fulvia B.; Rodrigues, Natalia A.; Gobatto, Claudio A.] Univ Estadual Campinas, Lab Appl Sport Physiol, Campinas, SP, Brazil; [Sousa, Filipe A. B.] Univ Fed Alagoas, Inst Phys Educ & Sport, Postgrad Program Nutr, Maceio, Alagoas, Brazil	Universidade Estadual de Campinas; Universidade Federal de Alagoas	Sousa, FAB (corresponding author), Univ Estadual Campinas, Lab Appl Sport Physiol, Campinas, SP, Brazil.; Sousa, FAB (corresponding author), Univ Fed Alagoas, Inst Phys Educ & Sport, Postgrad Program Nutr, Maceio, Alagoas, Brazil.	filipe.sousa@iefe.ufal.br	Sousa, Filipe A B/H-2444-2017; Sousa, Filipe/GLR-0616-2022; Rodrigues, Natalia A/H-7405-2017	Rodrigues, Natalia A/0000-0003-4265-9586	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/08535-5, 2012/06355-2, 2013/16710-7]; CNPq -Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [461559/2014-5]	FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq -Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	C.A.G 2009/08535-5 F.A.B.S. 2013/16710-7 F.B.M. 2012/06355-2 FAPESP -Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (protocol no. 2009/08535-5; 2012/06355-2 and 2013/16710-7) https://fapesp.br/C.A.G 461559/2014-5 CNPq -Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (protocol no. 461559/2014-5) http://portal.cnpq.br/The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Sousa FAB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0179378; Bartram JC, 2017, INT J SPORT PHYSIOL, V12, P783, DOI 10.1123/ijspp.2016-0376; Bergstrom HC, 2014, J STRENGTH COND RES, V28, P592, DOI 10.1519/JSC.0b013e31829b576d; Bergstrom HC, 2013, J SPORT SCI, V31, P537, DOI 10.1080/02640414.2012.738925; Bergstrom HC, 2012, J STRENGTH COND RES, V26, P656, DOI 10.1519/JSC.0b013e31822b7304; Black MI, 2017, J APPL PHYSIOL, V122, P446, DOI 10.1152/japplphysiol.00942.2016; Broxterman RM, 2013, RESP PHYSIOL NEUROBI, V185, P380, DOI 10.1016/j.resp.2012.08.024; Burnley M, 2006, MED SCI SPORT EXER, V38, P1995, DOI 10.1249/01.mss.0000232024.06114.a6; Cheng CF, 2012, EUR J APPL PHYSIOL, V112, P1251, DOI 10.1007/s00421-011-2081-2; Chidnok W, 2013, EUR J APPL PHYSIOL, V113, P529, DOI 10.1007/s00421-012-2478-6; Clark IE, 2016, J STRENGTH COND RES, V30, P825, DOI 10.1519/JSC.0000000000001169; Clark IE, 2013, J STRENGTH COND RES, V27, P2104, DOI 10.1519/JSC.0b013e3182785041; DAVIES CTM, 1989, EUR J APPL PHYSIOL O, V58, P838, DOI 10.1007/BF02332216; Dekerle J, 2014, J SCI MED SPORT, V17, P640, DOI 10.1016/j.jsams.2013.09.003; Dicks ND, 2016, INT J SPORT PHYSIOL, V11, P197, DOI 10.1123/ijspp.2015-0116; Driss T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/589361; Flueck JL, 2015, INT J SPORTS MED, V36, P809, DOI 10.1055/s-0035-1548811; Gama MCT, 2017, INT J SPORTS MED, V38, P613, DOI 10.1055/s-0035-1565238; Gobatto CA, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-65420-3; HILL DW, 1994, J SPORT MED PHYS FIT, V34, P23; Hopkins WG., 2015, SPORTSCIENCE, V19, P36; Iannetta D, 2022, MED SCI SPORT EXER, V54, P622, DOI 10.1249/MSS.0000000000002831; Iannetta D, 2020, AM J PHYSIOL-REG I, V319, pR315, DOI 10.1152/ajpregu.00126.2020; Johnson TM, 2011, MED SCI SPORT EXER, V43, P2375, DOI 10.1249/MSS.0b013e318224cb0f; Kalva CA, 2017, J SPORT MED PHYS FIT, V57, P1126, DOI 10.23736/S0022-4707.16.06461-6; Karsten B, 2014, INT J SPORTS MED, V35, P304, DOI 10.1055/s-0033-1349093; Kirby BS, 2019, MED SCI SPORT EXER, V51, P308, DOI 10.1249/MSS.0000000000001774; Kramer M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0201389; Manchado-Gobatto FB, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-63297-w; Maturana FM, 2018, J SCI MED SPORT, V21, P742, DOI 10.1016/j.jsams.2017.11.015; Maturana FM, 2016, APPL PHYSIOL NUTR ME, V41, P1197, DOI 10.1139/apnm-2016-0248; McClave SA, 2011, J STRENGTH COND RES, V25, P3093, DOI 10.1519/JSC.0b013e318212dafc; Mitchell LJG, 2018, EUR J SPORT SCI, V18, P307, DOI 10.1080/17461391.2017.1413138; MONOD H, 1965, ERGONOMICS, V8, P329, DOI 10.1080/00140136508930810; Pettitt RW, 2012, INT J SPORTS MED, V33, P426, DOI 10.1055/s-0031-1299749; Piatrikova E, 2018, INT J SPORT PHYSIOL, V13, P1190, DOI 10.1123/ijspp.2018-0018; Polglaze T, 2018, MED SCI SPORT EXER, V50, P1487, DOI 10.1249/MSS.0000000000001575; Poole DC, 2017, J APPL PHYSIOL, V122, P997, DOI 10.1152/japplphysiol.01063.2016; Robergs RA, 2010, SPORTS MED, V40, P95, DOI 10.2165/11319670-000000000-00000; Saari A, 2019, J STRENGTH COND RES, V33, P1678, DOI 10.1519/JSC.0000000000002120; Schulte Marlene J, 2018, Int J Exerc Sci, V11, P585; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sousa F, 2015, J HUM KINET, V49, P245, DOI 10.1515/hukin-2015-0127; Sperlich B, 2011, INT J SPORTS MED, V32, P433, DOI 10.1055/s-0031-1271770; Sperlich B, 2014, INT J SPORT PHYSIOL, V9, P805, DOI 10.1123/ijspp.2013-0265; Gama MCT, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0192552; Tsai MC, 2017, INT J SPORT PHYSIOL, V12, P27, DOI 10.1123/ijspp.2015-0479; Vanhatalo A, 2008, MED SCI SPORT EXER, V40, P1693, DOI 10.1249/MSS.0b013e318177871a; Vanhatalo A, 2007, MED SCI SPORT EXER, V39, P548, DOI 10.1249/mss.0b013e31802dd3e6; Vanhatalo A, 2016, J PHYSIOL-LONDON, V594, P4407, DOI 10.1113/JP271879; Vanhatalo A, 2011, AM J PHYSIOL-REG I, V300, pR700, DOI 10.1152/ajpregu.00761.2010; Wright J, 2017, INT J SPORTS MED, V38, P462, DOI 10.1055/s-0043-102944; Zajac A, 1999, J STRENGTH COND RES, V13, P16, DOI 10.1519/00124278-199902000-00003	53	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266012	10.1371/journal.pone.0266012	http://dx.doi.org/10.1371/journal.pone.0266012			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324999	Green Published, gold			2022-12-26	WOS:000780951300092
J	Arnoletti, JP; Reza, J; Rosales, A; Monreal, A; Fanaian, N; Whisner, S; Srivastava, M; Rivera-Otero, J; Yu, GX; Phanstiel, O; Altomare, DA; Tran, Q; Litherland, SA				Arnoletti, Juan Pablo; Reza, Joseph; Rosales, Armando; Monreal, Alberto; Fanaian, Na'im; Whisner, Suzanne; Srivastava, Milan; Rivera-Otero, Julia; Yu, Gongxin; Phanstiel, Otto; Altomare, Deborah A.; Quang Tran; Litherland, Sally A.			Pancreatic Ductal Adenocarcinoma (PDAC) circulating tumor cells influence myeloid cell differentiation to support their survival and immunoresistance in portal vein circulation	PLOS ONE			English	Article							GM-CSF; CANCER; MACROPHAGES; IMMUNE; SUPPRESSION; METASTASIS; INVASION; PACKAGE; BLOOD; FLOW	The portal venous circulation provides a conduit for pancreatic ductal adenocarcinoma (PDAC) tumor cells to the liver parenchyma sinusoids, a frequent site of metastasis. Turbulent flow in the portal circulation promotes retention of PDAC shed circulating tumor cells (CTC) and myeloid-derived immunosuppressor cells (MDSC). Excessive colony stimulating factor-1 receptor (CSF1R) signaling can induce myeloid differentiation to MDSC and transformation of MDSC to myeloid-derived fibroblasts (M-FB). Interactions between PDAC CTC and M-FB in the portal blood promotes the formation of immunoresistant clusters that enhance CTC proliferation, migration, and survival. Analysis of portal and peripheral blood samples collected intraoperatively from 30 PDAC patients undergoing pancreatico-duodenectomy showed that PDAC patient plasma contained high levels of macrophage colony stimulating factor (M-CSF/CSF1), granulocyte-macrophage colony stimulating factor (GMCSF/CSF2), interleukin-8 (IL-8), and interleukin-34 (IL-34) compared to healthy control levels. Moreover, the level of M-CSF in portal blood was significantly higher than that detected in the peripheral blood of PDAC patients. PDAC CTC aseptically isolated by fluorescence activated cell sorting (FACS) out of freshly collected patient portal blood mononuclear cells (PortalBMC) had elevated RNA expression of IL34 (IL-34 gene) and CSF1 (M-CSF/CSF1 gene) which both signal through CSF1R. PDAC CTC also had high levels of RNA expression for CXCL8, the gene encoding chemokine interleukin-8 (IL-8) which can attract myeloid cells through their CXCR2 receptors. FACS-isolated portal PDAC CTC and M-FB co-cultured ex vivo had increased CTC proliferation, motility, and cluster formation compared to CTC cultured alone. CSF1R and CXCR2 cell surface expression were found on PDAC portal blood CTC and M-FB, suggesting that both cell types may respond to M-CSF, IL-34, and IL-8-mediated signaling. Portal PDAC CTC displayed enhanced RNA expression of CSF1 and IL34, while CTC+M-FB+ clusters formed in vivo had increased RNA expression of CSF2 and IL34. Portal M-FB were found to have high CSF1R RNA expression. CTC isolated from ex vivo 7-day cultures of PDAC patient portal blood mononuclear cells (PortalBMC) expressed elevated CSF1, IL34, and IL8 RNA, and CSF1 expression was elevated in M-FB. Treatment with rabbit anti-CSF1R antibodies decreased CTC proliferation. Treatment of PortalBMC cultures with humanized anti-CSF1R, humanized anti-IL-8, or anti-IL-34 antibodies disrupted CTC cluster formation and increased CTC apoptosis. U937 myeloid precursor cell line cultures treated with conditioned media from PortalBMC ex vivo cultures without treatment or treated with anti-IL-8 and/or anti-CSF1R did not prevent myeloid differentiation in the myeloid precursor cell line U937 to macrophage, dendritic cell, MDSC, and M-FB phenotypes; whereas, U937 cultures treated with conditioned media from PortalBMC ex vivo cultures exposed to anti-IL-34 were significantly inhibited in their myeloid differentiation to all but the M-FB phenotype. PDAC patient T cells that were found phenotypically anergic (CD3+CD25+CTLA4+PD1L1+) in PortalBMC could be re-activated (CD3+CD25 +CTLA4-PD1L1-), and displayed increased interferon gamma (IFN.) production when PortalBMC ex vivo cultures were treated with anti-CSF1R, anti-IL-8, and anti-IL-34 antibodies alone or in combination. These findings suggest that PDAC CTC have the potential to influence myeloid differentiation and/or antigen presenting cell activation in the PDAC portal blood microenvironment, and that disruption of CTC/M-FB interactions may be potential targets for reversing the immunosuppression supporting CTC survival in the portal blood.	[Arnoletti, Juan Pablo; Rosales, Armando] AdventHlth Canc Inst, Ctr Surg Oncol, Orlando, FL USA; [Reza, Joseph; Monreal, Alberto] AdventHlth, Gen SurgeryResidency Program, Orlando, FL USA; [Fanaian, Na'im] Cent Florida Pathol Associates, Orlando, FL USA; [Whisner, Suzanne; Srivastava, Milan; Rivera-Otero, Julia; Yu, Gongxin] AdventHlth Res Inst, Orlando, FL USA; [Phanstiel, Otto] Univ Cent Florida, Coll Med, Dept Med Educ, Orlando, FL USA; [Altomare, Deborah A.] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Orlando, FL USA; [Quang Tran; Litherland, Sally A.] AdventHlth Canc Inst, Translat Res, Winter Pk, FL 32792 USA	Adventist Health Services; AdventHealth; Adventist Health Services; AdventHealth; Adventist Health Services; AdventHealth; (AdventHealth) Central Florida Division; Central Florida Hospital - South; AdventHealth Orlando; State University System of Florida; University of Central Florida; State University System of Florida; University of Central Florida	Litherland, SA (corresponding author), AdventHlth Canc Inst, Translat Res, Winter Pk, FL 32792 USA.	sally.litherland@adventhealth.com	Reza, Joseph/GYV-1173-2022	Rosales, Armando/0000-0002-1611-4104; Monreal, Alberto/0000-0002-6991-7672; Rivera Otero, Julia/0000-0001-5339-7046	Bristol Myers Squibb [BMS CA025-016]; Phi Beta Psi Philanthropic Sorority; Fraternal Order of Eagles President's Charity; State of Florida Health Department Bankhead-Coley Research; AdventHealth Foundation	Bristol Myers Squibb(Bristol-Myers Squibb); Phi Beta Psi Philanthropic Sorority; Fraternal Order of Eagles President's Charity; State of Florida Health Department Bankhead-Coley Research; AdventHealth Foundation	Research funding was provided by grants from Bristol Myers Squibb (BMS CA025-016, SAL; bms.fasttrack.com), Phi Beta Psi Philanthropic Sorority (SAL/JPA;www.phibetapsi.org), Fraternal Order of Eagles President's Charity (JPA/SAL, SAL/JPA; https://clicktime.symantec.com/35XhzGkkVbmaV4i997mRESa6xU?u=www.foe.com), State of Florida Health Department Bankhead-Coley Research (OP/JPA/SAL; floridahealth.gov/research) and AdventHealth Foundation philanthropic gifts (adventhealth.com/adventhealthfoundation). The funders had no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.	Abrams ZB, 2019, BMC BIOINFORMATICS, V20, DOI 10.1186/s12859-019-3247-x; Agarwal A, 2018, CANCER J, V24, P70, DOI 10.1097/PPO.0000000000000310; [Anonymous], 2019, NATL CANC I PANCREAT; Arnoletti JP, 2018, CANCER BIOL THER, V19, P887, DOI 10.1080/15384047.2018.1480292; Arnoletti JP, 2017, PANCREAS, V46, P116, DOI 10.1097/MPA.0000000000000667; Baardman J, 2015, EPIGENOMICS-UK, V7, P1155, DOI 10.2217/epi.15.71; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Candido JB, 2018, CELL REP, V23, P1448, DOI 10.1016/j.celrep.2018.03.131; Chen C, 2018, J HEMATOL ONCOL, V11, DOI 10.1186/s13045-018-0605-5; Cheung KJ, 2016, SCIENCE, V352, P167, DOI 10.1126/science.aaf6546; Chiang SPH, 2016, AM J PHYSIOL-CELL PH, V311, pC1, DOI 10.1152/ajpcell.00238.2015; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Cossarizza A, 2019, EUR J IMMUNOL, V49, P1457, DOI 10.1002/eji.201970107; Das S, 2020, CANCER RES, V80, P1088, DOI 10.1158/0008-5472.CAN-19-2080; Dazzi F, 2013, BLOOD, V122, P1093, DOI 10.1182/blood-2013-06-509620; Ding CL, 2019, J IMMUNOL, V202, P1623, DOI 10.4049/jimmunol.1801112; Egea L, 2010, EXPERT REV GASTROENT, V4, P723, DOI [10.1586/egh.10.73, 10.1586/EGH.10.73]; Foucher ED, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056045; Franze E, 2020, CANCERS, V12, DOI 10.3390/cancers12010252; Gemenetzis G, 2018, ANN SURG, V268, P408, DOI 10.1097/SLA.0000000000002925; Haigis KM, 2019, SCIENCE, V363, P1150, DOI 10.1126/science.aaw3472; Hama N, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101584; Kassambara A., 2017, EXTRACT VISUALIZE RE; Kurtovic Nermina Ovcina, 2018, Med Arch, V72, P410, DOI 10.5455/medarh.2018.72.410-413; Laban-Guceva Nevenka, 2007, Med Arh, V61, P203; Law Charity W, 2016, F1000Res, V5, DOI 10.12688/f1000research.9005.3; Lee CK, 2019, SCIENCE, V363, P644, DOI 10.1126/science.aav0173; Li JY, 2019, SCIENCE, V363, P1038, DOI 10.1126/science.aau9861; Lin WY, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02019; Looi CK, 2019, J EXP CLIN CANC RES, V38, DOI 10.1186/s13046-019-1153-8; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Padillo-Ruiz J, 2021, CANCERS, V13, DOI 10.3390/cancers13246153; Pandey V, 2019, EXPERT REV ANTICANC, V19, P473, DOI 10.1080/14737140.2019.1622417; Reinsberg J, 2000, CLIN CHEM, V46, P1387; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Roh-Johnson M, 2017, DEV CELL, V43, P549, DOI 10.1016/j.devcel.2017.11.003; Rumore-Maton B, 2008, CLIN DEV IMMUNOL, DOI 10.1155/2008/769795; Takiishi T, 2017, TISSUE BARRIERS, V5, DOI 10.1080/21688370.2017.1373208; Tang K, 2019, INFECT DIS-NOR, V51, P847, DOI 10.1080/23744235.2019.1672887; Van Overmeire E, 2016, CANCER RES, V76, P35, DOI 10.1158/0008-5472.CAN-15-0869; Wachsberg RH, 2002, RADIOGRAPHICS, V22, P123, DOI 10.1148/radiographics.22.1.g02ja20123; Willms A, 2016, ONCOTARGET, V7, P30867, DOI 10.18632/oncotarget.9018; Winograd R, 2021, BRIT J CANCER, V124, P1754, DOI 10.1038/s41416-021-01303-2; Xie XH, 2021, FRONT ONCOL, V11, DOI 10.3389/fonc.2021.672687; Yu GC, 2016, MOL BIOSYST, V12, P477, DOI 10.1039/c5mb00663e; Yu GC, 2012, OMICS, V16, P284, DOI 10.1089/omi.2011.0118; Zhang H, 2013, BLOOD, V122, P1105, DOI 10.1182/blood-2012-08-449413; Zhang YX, 2021, CANCER MANAG RES, V13, P7649, DOI 10.2147/CMAR.S330473; Zhu Y, 2014, CANCER RES, V74, P5057, DOI 10.1158/0008-5472.CAN-13-3723	49	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265725	10.1371/journal.pone.0265725	http://dx.doi.org/10.1371/journal.pone.0265725			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316296	gold, Green Published			2022-12-26	WOS:000834238000035
J	Cheng, H; Xiong, GQ; Li, Y; Zhu, JQ; Xiong, XH; Wang, QY; Zhang, LC; Dong, HL; Zhu, C; Liu, G; Chen, HP				Cheng, Hong; Xiong, Guoqing; Li, Yi; Zhu, Jiaqi; Xiong, Xianghua; Wang, Qingyang; Zhang, Liancheng; Dong, Haolong; Zhu, Chen; Liu, Gang; Chen, Huipeng			Increased yield of AP-3 by inactivation of asm25 in Actinosynnema pretiosum ssp. auranticum ATCC 31565	PLOS ONE			English	Article							ENHANCED PRODUCTION; AGENT ANSAMITOCIN; TUMOR INHIBITORS; FERMENTATION; MAYTANSINE; P-3	Asamitocins are maytansinoids produced by Actinosynnema pretiosum ssp. auranticum ATCC 31565 (A. pretiosum ATCC 31565), which have a structure similar to that of maytansine, therefore serving as a precursor of maytansine in the development of antibody-drug conjugates (ADCs). Currently, there are more than 20 known derivatives of ansamitocins, among which ansamitocin P-3 (AP-3) exhibits the highest antitumor activity. Despite its importance, the application of AP-3 is restricted by low yield, likely due to a substrate competition mechanism underlying the synthesis pathways of AP-3 and its byproducts. Given that N-demethylansamitocin P-3, the precursor of AP-3, is regulated by asm25 and asm10 to synthesize AGP-3 and AP-3, respectively, asm25 is predicted to be an inhibitory gene for AP-3 production. In this study, we inactivated asm25 in A. pretiosum ATCC 31565 by CRISPR-Cas9-guided gene editing. asm25 depletion resulted in a more than 2-fold increase in AP-3 yield. Surprisingly, the addition of isobutanol further improved AP-3 yield in the asm25 knockout strain by more than 6 times; in contrast, only a 1.53-fold increase was found in the WT strain under the parallel condition. Thus, we uncovered an unknown function of asm25 in AP-3 yield and identified asm25 as a promising target to enhance the large-scale industrial production of AP-3.	[Cheng, Hong; Xiong, Guoqing] Anhui Univ, Inst Phys Sci, Hefei, Peoples R China; [Cheng, Hong; Xiong, Guoqing; Li, Yi; Zhu, Jiaqi; Xiong, Xianghua; Wang, Qingyang; Zhang, Liancheng; Dong, Haolong; Zhu, Chen; Liu, Gang; Chen, Huipeng] Acad Mil Med Sci, Beijing, Peoples R China; [Zhu, Jiaqi] Dalian Univ, Sch Life Sci & Technol, Dalian, Peoples R China	Anhui University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Academy of Military Medical Sciences - China; Dalian University	Zhu, C; Liu, G (corresponding author), Acad Mil Med Sci, Beijing, Peoples R China.	jueliu@sohu.com; huipengchen@yeah.net		Wang, Qingyang/0000-0002-9999-3019	National Natural Science Foundation of China [31900669]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by a fund from the National Natural Science Foundation of China (31900669) to H. D.	Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Cassady JM, 2004, CHEM PHARM BULL, V52, P1, DOI 10.1248/cpb.52.1; Chung J, 2003, U.S. patent, Patent No. [0157694A1, 0157694]; Du ZQ, 2017, BIOTECHNOL BIOENG, V114, P2794, DOI 10.1002/bit.26396; Gordon MR, 2015, BIOCONJUGATE CHEM, V26, P2198, DOI 10.1021/acs.bioconjchem.5b00399; HUANG AB, 1985, BIOCHEM BIOPH RES CO, V128, P1239, DOI 10.1016/0006-291X(85)91073-3; ISSELL BF, 1978, CANCER TREAT REV, V5, P199, DOI 10.1016/S0305-7372(78)80014-0; Khongorzul P, 2020, MOL CANCER RES, V18, P3, DOI 10.1158/1541-7786.MCR-19-0582; KUPCHAN SM, 1977, J ORG CHEM, V42, P2349, DOI 10.1021/jo00434a001; KUPCHAN SM, 1972, J AM CHEM SOC, V94, P1354, DOI 10.1021/ja00759a054; Lin JX, 2011, BIORESOURCE TECHNOL, V102, P1863, DOI 10.1016/j.biortech.2010.09.102; Liu C, 1997, Expert Opin Investig Drugs, V6, P169, DOI 10.1517/13543784.6.2.169; Liu T, 2020, J BIOSCI BIOENG, V130, P36, DOI 10.1016/j.jbiosc.2020.02.013; Liu XL, 2016, CHIN J NAT MEDICINES, V14, P286, DOI 10.1016/S1875-5364(16)30029-2; Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x; Lu CH, 2004, J ANTIBIOT, V57, P348, DOI 10.7164/antibiotics.57.348; Ma J, 2007, ARCH PHARM RES, V30, P670, DOI 10.1007/BF02977625; Martin K, 2014, CANCER IMMUNOL IMMUN, V63, P925, DOI 10.1007/s00262-014-1565-4; Muller P, 2014, ONCOIMMUNOLOGY, V3, DOI 10.4161/21624011.2014.954460; Ning XJ, 2017, BIOTECHNOL J, V12, DOI 10.1002/biot.201700484; Pan WQ, 2013, SCI CHINA LIFE SCI, V56, P601, DOI 10.1007/s11427-013-4502-4; REMILLARD S, 1975, SCIENCE, V189, P1002, DOI 10.1126/science.1241159; Senter PD, 2009, CURR OPIN CHEM BIOL, V13, P235, DOI 10.1016/j.cbpa.2009.03.023; Singh ND, 2016, PLANT BIOTECHNOL J, V14, P1034, DOI 10.1111/pbi.12476; TANIDA S, 1981, J ANTIBIOT, V34, P489, DOI 10.7164/antibiotics.34.489; TANIDA S, 1980, J ANTIBIOT, V33, P192, DOI 10.7164/antibiotics.33.192; Venghateri JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075182; Yu TW, 2002, P NATL ACAD SCI USA, V99, P7968, DOI 10.1073/pnas.092697199; Zhao PJ, 2008, CHEM BIOL, V15, P863, DOI 10.1016/j.chembiol.2008.06.007; Zhong CQ, 2019, CURR MICROBIOL, V76, P954, DOI 10.1007/s00284-018-1521-1	30	0	0	7	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265517	10.1371/journal.pone.0265517	http://dx.doi.org/10.1371/journal.pone.0265517			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316825	Green Published, gold			2022-12-26	WOS:000834238000026
J	Gao, L; Chen, ZS; Yang, HH; Wan, XH; Wang, MZ				Gao, Lin; Chen, Zengshun; Yang, Huihui; Wan, Xiaohui; Wang, Mingzhen			Hydrodynamic pressure law of ground-rested circular RC tank under bi-directional horizontal seismic action	PLOS ONE			English	Article							LIQUID STORAGE TANK; DYNAMIC-BEHAVIOR; EARTHQUAKE; TESTS	The research object is the ground-rested circular RC tank. The innovation is to reveal the hydrodynamic pressure law of ground-rested circular RC tanks under bi-directional horizontal seismic action. The relationship between the sloshing wave height and hydrodynamic pressure is determined, the hydrodynamic pressure components and their combination are verified, calculation methods for hydrodynamic pressure are developed, and their distribution laws are presented. The results show that convective hydrodynamic pressure cannot be ignored when the tank is subjected to seismic action. Hydrodynamic pressure under unidirectional horizontal seismic action in X or Y direction is obtained by square root of the sum of impulsive pressure squared and convective pressure squared. Total hydrodynamic pressure under bi-directional horizontal seismic action is obtained by the square root of the sum of X-direction hydrodynamic pressure squared and Y-direction hydrodynamic pressure squared. This method can ensure the accuracy and reliability of hydrodynamic pressure calculation.	[Gao, Lin; Yang, Huihui; Wan, Xiaohui; Wang, Mingzhen] Chongqing Univ Arts & Sci, Sch Civil Engn, Chongqing, Peoples R China; [Gao, Lin; Chen, Zengshun] Chongqing Univ, Sch Civil Engn, Chongqing, Peoples R China	Chongqing University of Arts & Sciences; Chongqing University	Wang, MZ (corresponding author), Chongqing Univ Arts & Sci, Sch Civil Engn, Chongqing, Peoples R China.	wmz917@126.com		Gao, Lin/0000-0001-5186-2469	Chongqing Natural Science Foundation of China [CSTC2019jcyj-msxmX0781]; Youth Project of Science and Technology Research Program of Chongqing Education Commission of China [KJQN201901332]	Chongqing Natural Science Foundation of China; Youth Project of Science and Technology Research Program of Chongqing Education Commission of China	This study was supported by the Chongqing Natural Science Foundation of China (CSTC2019jcyj-msxmX0781) and the Youth Project of Science and Technology Research Program of Chongqing Education Commission of China (KJQN201901332). The funders provide financial support for this study.	American Concrete Institute (ACI), 2001, SEISMIC DESIGN LIQUI; American Petroleum Institute, 2012, 650 API; [Anonymous], 1996, D10096 AWWA; [Anonymous], 2014, 503412014 GB; Beijing Municipal Commission of Housing and Urban-Rural Development, 1979, TJ3278 BEIJ MUN COMM; Chen Peng, 2009, Journal of Qingdao Technological University, V30, P30; Compile Group of earthquake engineering, 1985, EARTHQ ENG CONSP, VSecond; Department of Earthquake Disaster Prevention China Earthquake Administration, REPORT STRONG EARTHQ, V12, P1; Ding Y, 2018, MAR STRUCT, V58, P301, DOI 10.1016/j.marstruc.2017.12.004; Gao Guangyun, 2000, GEOTECHNICAL INVESTI, P29; Gao L, 2021, APPL MATH NONLIN SCI, V6, P293, DOI 10.2478/amns.2021.2.00013; Gao L, 2018, INTELL AUTOM SOFT CO, V24, P643, DOI 10.31209/2018.100000031; Ghaemmaghami AR, 2010, J STRUCT ENG, V136, P441, DOI 10.1061/(ASCE)ST.1943-541X.0000123; HAROUN MA, 1983, EARTHQUAKE ENG STRUC, V11, P179, DOI 10.1002/eqe.4290110204; Hashemi S, 2013, EARTHQ ENG STRUCT D, V42, P1637, DOI 10.1002/eqe.2291; Housner G.W., 1957, B SEISMOL SOC AM, V47, P15; Hwang I. -T., 1989, J PRESS VESS-T ASME, V111, P435; Japanese Industrial Standard, 1985, B85011985 JIS; Jing W, 2019, J APPL FLUID MECH, V12, P907, DOI 10.29252/jafm.12.03.29180; Jing W, 2018, ARAB J SCI ENG, V43, P1911, DOI 10.1007/s13369-017-2814-6; Ju Rongchu, 1983, COUPLED VIBRATION TH; Kianoush MR, 2011, ENG STRUCT, V33, P2186, DOI 10.1016/j.engstruct.2011.03.009; Kildashti K, 2018, THIN WALL STRUCT, V123, P382, DOI 10.1016/j.tws.2017.11.041; Kotrasova K, 2017, ADV MATH PHYS, V2017, DOI 10.1155/2017/1492035; Lee CB, 2021, APPL SCI-BASEL, V11, DOI 10.3390/app11104688; Ministry of Housing and Urban -Rural Development of the People's Republic of China, 2003, GB500322003 MIN HOUS; Moslemi M, 2012, ENG STRUCT, V42, P214, DOI 10.1016/j.engstruct.2012.04.026; Nicolici S, 2013, NUCL ENG DES, V258, P51, DOI 10.1016/j.nucengdes.2012.12.024; Pandit AR, 2019, OCEAN ENG, V187, DOI 10.1016/j.oceaneng.2019.106197; Park JH, 2016, INT J STEEL STRUCT, V16, P935, DOI [10.1007/s13296-016-0172-y, 10.1007/s13296-015-0068-2]; Radnic J, 2018, J FLUID STRUCT, V81, P97, DOI 10.1016/j.jfluidstructs.2018.04.020; Rawat A, 2015, ADV STRUCT ENG, P1155; Vakilazadsarabi A, 2015, INT J ENG SCI TECHNO, V7, P148, DOI IJEST15-07-03-030; Wang Yayong, 1990, EARTHQUAKE RESISTANT, P38; Yu CC, 2021, ENG STRUCT, V233, DOI 10.1016/j.engstruct.2020.111589; Yu CC, 2020, J ENG MECH, V146, DOI 10.1061/(ASCE)EM.1943-7889.0001831	36	0	0	5	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265528	10.1371/journal.pone.0265528	http://dx.doi.org/10.1371/journal.pone.0265528			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316826	gold, Green Published			2022-12-26	WOS:000834238000027
J	Wamsley, EJ				Wamsley, Erin J.			Constructive episodic simulation in dreams	PLOS ONE			English	Article							MEMORY REPLAY; SLEEP; FUTURE; HIPPOCAMPUS; COGNITION; INSIGHTS; IMAGINE; NETWORK	Memories of the past help us adaptively respond to similar situations in the future. Originally described by Schacter & Addis in 2007, the "constructive episodic simulation" hypothesis proposes that waking thought combines fragments of various past episodes into imagined simulations of events that may occur in the future. This same framework may be useful for understanding the function of dreaming. N = 48 college students were asked to identify waking life sources for a total of N = 469 dreams. Participants frequently traced dreams to at least one past or future episodic source (53.5% and 25.7% of dreams, respectively). Individual dreams were very often traced to multiple waking sources (43.9% of all dreams with content), with fragments of past memory incorporated into scenarios that anticipated future events. Waking-life dream sources are described in terms of their phenomenology and distribution across time and sleep stage, providing new evidence that dreams not only reflect the past, but also utilize memory in simulating potential futures.	[Wamsley, Erin J.] Furman Univ, Dept Psychol, Greenville, SC 29613 USA; [Wamsley, Erin J.] Furman Univ, Program Neurosci, Greenville, SC 29613 USA		Wamsley, EJ (corresponding author), Furman Univ, Dept Psychol, Greenville, SC 29613 USA.; Wamsley, EJ (corresponding author), Furman Univ, Program Neurosci, Greenville, SC 29613 USA.	erin.wamsley@furman.edu			BIAL Foundation [83/12]	BIAL Foundation(Bial Foundation)	This work was supported by Bursaries award 83/12 from the BIAL Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; Addis DR, 2020, REV PHILOS PSYCHOL, V11, P233, DOI 10.1007/s13164-020-00470-0; American Academy of Sleep Medicine, 2007, AASM MANUAL SCORING; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Arnulf I, 2014, CONSCIOUS COGN, V29, P36, DOI 10.1016/j.concog.2014.06.010; Baird B, 2011, CONSCIOUS COGN, V20, P1604, DOI 10.1016/j.concog.2011.08.007; Bates D., 2014, ARXIV, DOI DOI 10.48550/ARXIV.1406.5823; Beaty RE, 2018, J COGNITIVE NEUROSCI, V30, P1939, DOI 10.1162/jocn_a_01327; Benoit RG, 2015, NEUROPSYCHOLOGIA, V75, P450, DOI 10.1016/j.neuropsychologia.2015.06.034; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; BREGER L, 1971, PSYCHOL ISSUES, V7, P1; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Dang-Vu TT, 2010, SLEEP, V33, P1589, DOI 10.1093/sleep/33.12.1589; Diekelmann S, 2013, SLEEP, V36, P149, DOI 10.5665/sleep.2322; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Djonlagic I, 2009, LEARN MEMORY, V16, P751, DOI 10.1101/lm.1634509; Domhoff G. W., 2018, EMERGENCE DREAMING M; Domhoff G. W., 2011, INT J DREAM RES, V4, P50; Domhoff GW, 2019, DREAMING, V29, P265, DOI 10.1037/drm0000119; Dresler M., 2015, MULTIFUNCTIONALITY D; Durrant SJ, 2011, NEUROPSYCHOLOGIA, V49, P1322, DOI 10.1016/j.neuropsychologia.2011.02.015; Erlacher D, 2011, J PSYCHOL, V145, P331, DOI 10.1080/00223980.2011.574166; Fosse MJ, 2003, J COGNITIVE NEUROSCI, V15, P1, DOI 10.1162/089892903321107774; Foulkes D, 1985, DREAMING COGNITIVE P; Frazer MA, 2021, CURR SLEEP MED REP, V7, P221, DOI 10.1007/s40675-021-00204-3; Graveline YM, 2017, NEUROBIOL LEARN MEM, V141, P19, DOI 10.1016/j.nlm.2017.03.008; Grenier J, 2005, MEM COGNITION, V33, P280, DOI 10.3758/BF03195317; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; HODDES E, 1973, PSYCHOPHYSIOLOGY, V10, P431, DOI 10.1111/j.1469-8986.1973.tb00801.x; Horton CL, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00874; JOHNS MW, 1991, SLEEP, V14, P540, DOI 10.1093/sleep/14.6.540; Kuznetsova A, 2017, J STAT SOFTW, V82, P1, DOI 10.18637/jss.v082.i13; Lenth RV., 2021, EMMEANS ESTIMATED MA; Lewis PA, 2018, TRENDS COGN SCI, V22, P491, DOI 10.1016/j.tics.2018.03.009; Lewis PA, 2011, TRENDS COGN SCI, V15, P343, DOI 10.1016/j.tics.2011.06.004; Llewellyn S, 2016, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01961; Malinowski JE, 2021, CONSCIOUS COGN, V88, DOI 10.1016/j.concog.2020.103071; Malinowski J, 2014, DREAMING, V24, P18, DOI 10.1037/a0036017; Malinowski JE, 2014, DREAMING, V24, P253, DOI 10.1037/a0037817; Maquet P, 2005, PROG BRAIN RES, V150, P219, DOI 10.1016/S0079-6123(05)50016-5; MCCLELLAND JL, 1995, PSYCHOL REV, V102, P419, DOI 10.1037/0033-295X.102.3.419; MEDNICK SA, 1962, PSYCHOL REV, V69, P220, DOI 10.1037/h0048850; Mildner JN, 2019, TRENDS NEUROSCI, V42, P763, DOI 10.1016/j.tins.2019.09.001; Mills C, 2021, PHILOS T R SOC B, V376, DOI 10.1098/rstb.2019.0692; Mohr C, 2001, J PSYCHOLINGUIST RES, V30, P475, DOI 10.1023/A:1010461429079; Nguyen ND, 2013, SLEEP, V36, P1051, DOI 10.5665/sleep.2808; Nielsen T.., 2018, 30 MICRODREAM NEUROP, P411; Nielsen T, 2011, PRINCIPLES PRACTICE, V5th, P9; Nielsen TA, 2005, NATURE, V437, P1286, DOI 10.1038/nature04288; Nielsen T, 2007, SLEEP, V30, P1162, DOI 10.1093/sleep/30.9.1162; Paller KA, 2021, ANNU REV PSYCHOL, V72, P123, DOI 10.1146/annurev-psych-010419-050815; Plailly J, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51497-y; RCore Team, 2020, R LANG ENV STAT COMP; Revonsuo A, 2015, OPEN MIND; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; Schoch SF, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12754; Schredl M, 2010, INT REV NEUROBIOL, V92, P135, DOI 10.1016/S0074-7742(10)92007-2; Scullin MK, 2010, PSYCHOL SCI, V21, P1028, DOI 10.1177/0956797610373373; Speth J, 2017, CONSCIOUS COGN, V48, P180, DOI 10.1016/j.concog.2016.11.006; Speth J, 2016, CONSCIOUS COGN, V45, P235, DOI 10.1016/j.concog.2016.08.014; Stickgold R, 2000, SCIENCE, V290, P350, DOI 10.1126/science.290.5490.350; Stickgold R, 2013, NAT NEUROSCI, V16, P139, DOI 10.1038/nn.3303; Szpunar KK, 2010, PERSPECT PSYCHOL SCI, V5, P142, DOI 10.1177/1745691610362350; Tamminen J, 2013, J NEUROSCI, V33, P15376, DOI 10.1523/JNEUROSCI.5093-12.2013; Tamminen J, 2010, J NEUROSCI, V30, P14356, DOI 10.1523/JNEUROSCI.3028-10.2010; Vallat R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185262; Valli K, 2009, AM J PSYCHOL, V122, P17; Wagner U, 2004, NATURE, V427, P352, DOI 10.1038/nature02223; Wamsley EJ, 2009, NEUROSCIENCE SLEEP, P330; Wamsley EJ, 2019, J SLEEP RES, V28, DOI 10.1111/jsr.12749; Wamsley EJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165141; Wamsley EJ, 2010, CURR BIOL, V20, pR1010, DOI 10.1016/j.cub.2010.10.045; Wamsley EJ, 2010, SLEEP, V33, P59, DOI 10.1093/sleep/33.1.59; Wilhelm I, 2011, J NEUROSCI, V31, P1563, DOI 10.1523/JNEUROSCI.3575-10.2011; Zhang J, 2019, PSYCHOPHYSIOLOGY, V56, DOI 10.1111/psyp.13368	76	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0264574	10.1371/journal.pone.0264574	http://dx.doi.org/10.1371/journal.pone.0264574			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316266	gold, Green Published			2022-12-26	WOS:000834238000010
J	Costa, D; Fernandes, N; Arantes, J; Keating, J				Costa, Daniela; Fernandes, Nuno; Arantes, Joana; Keating, Jose			A dual-process approach to prosocial behavior under COVID-19 uncertainty	PLOS ONE			English	Article							COOPERATION; DECISIONS; DILEMMAS	Uncertainty has been shown to reduce the willingness to cooperate in various social dilemmas and negatively affect prosocial behavior. However, some studies showed that uncertainty does not always decrease prosocial behavior, depending on the type of uncertainty. More specifically, recent research has shown that prosocial behavior tends to increase under impact uncertainty-uncertainty about the consequences for others if they become infected. In addition, researchers have argued that intuition favors prosocial behavior while deliberation leads to selfish behavior. Our study explored how intuitive (time pressure) or deliberate mental processing, under outcome, or impact uncertainty affect prosocial behavior in the context of the COVID-19 pandemic. Our sample consists of 496 participants, and we used a 4 (COVID-19 scenario: Control vs. Impact Uncertainty vs. Worst-Case vs. Indirect Transmission) by 2 (decision time: time delay vs. time pressure) between-subjects design. Results suggest that participants are more inclined to stay at home (prosocial intention) when forced to make their decisions intuitively rather than deliberately. Additionally, we found that uncertainty does not always decrease prosocial behavior. It seems that uncertainty does not affect the prosocial intention in a scenario with a real infectious disease. These findings suggest that the distinction between outcome and impact uncertainty may be due to the realism of experimental stimuli interventions.	[Costa, Daniela; Fernandes, Nuno; Arantes, Joana; Keating, Jose] Univ Minho, Psychol Res Ctr, Braga, Portugal	Universidade do Minho	Costa, D (corresponding author), Univ Minho, Psychol Res Ctr, Braga, Portugal.	id7743@alunos.uminho.pt		Fernandes, Nuno/0000-0003-1959-7671; Ferreira da Costa, Daniela Cristina/0000-0002-8565-0058	Portuguese Foundation for Science and Technology (FCT) [UIDB/01662/2020]; FCT [PD/BD/143025/2018]	Portuguese Foundation for Science and Technology (FCT)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This study was conducted at the Psychology Research Centre (CIPsi/UM), School of Psychology, University of Minho, supported by the Portuguese Foundation for Science and Technology (FCT) through the State Budget (UIDB/01662/2020). The FCT also supported Daniela Costa through a PhD fellowship (PD/BD/143025/2018).	[Anonymous], 2019, INTUITION DELIBERATI; Bear A, 2016, P NATL ACAD SCI USA, V113, P936, DOI 10.1073/pnas.1517780113; BUDESCU DV, 1990, EUR J SOC PSYCHOL, V20, P475; Campos-Mercade P, 2021, J PUBLIC ECON, V195, DOI 10.1016/j.jpubeco.2021.104367; Capraro V., 2019, DUAL PROCESS APPROAC, DOI DOI 10.31234/OSF.IO/432YW; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Capraro V, 2021, APPL COGNITIVE PSYCH, V35, P693, DOI 10.1002/acp.3793; Capraro V, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0237; Cone J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115756; DAVIS MH, 1983, J PERS SOC PSYCHOL, V44, P113, DOI 10.1037/0022-3514.44.1.113; de Kwaadsteniet EW, 2007, PERS SOC PSYCHOL B, V33, P1648, DOI 10.1177/0146167207307490; De Neys W, 2019, CURR DIR PSYCHOL SCI, V28, P503, DOI 10.1177/0963721419855658; Ellemers N, 2017, EUR MON SOC PSYCH, P1; Evans JST, 2013, PERSPECT PSYCHOL SCI, V8, P223, DOI 10.1177/1745691612460685; Evans JSBT, 2010, PSYCHOL INQ, V21, P313, DOI 10.1080/1047840X.2010.521057; Exley CL, 2016, REV ECON STUD, V83, P587, DOI 10.1093/restud/rdv051; Fakhruddin B, 2020, PROG DISASTER SCI, V7, DOI 10.1016/j.pdisas.2020.100102; Gachter S, 2004, J ECON BEHAV ORGAN, V55, P505, DOI 10.1016/j.jebo.2003.11.006; Garcia T, 2020, EUR ECON REV, V124, DOI 10.1016/j.euroecorev.2020.103412; Gino F, 2016, J ECON PERSPECT, V30, P189, DOI 10.1257/jep.30.3.189; Gong M, 2009, J RISK UNCERTAINTY, V39, P251, DOI 10.1007/s11166-009-9080-2; Greene Joshua., 2013, MORAL TRIBES EMOTION; Gustafsson M, 1999, ACTA PSYCHOL, V103, P47, DOI 10.1016/S0001-6918(99)00024-4; Haisley EC, 2010, GAME ECON BEHAV, V68, P614, DOI 10.1016/j.geb.2009.08.002; Han E, 2020, LANCET, V396, P1525, DOI 10.1016/S0140-6736(20)32007-9; Hubner AY, 2020, RISK ANAL, V40, P1212, DOI 10.1111/risa.13456; Jones BA, 2009, J EXP ANAL BEHAV, V91, P61, DOI 10.1901/jeab.2009.91-61; Jordan J, 2015, MORAL BRAIN: A MULTIDISCIPLINARY PERSPECTIVE, P87; Jordan JJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-97617-5; Kahneman D, 2003, AM PSYCHOL, V58, P697, DOI 10.1037/0003-066X.58.9.697; Kahneman D, 2015, FORTUNE, V172, P20; Kappes A, 2018, NAT HUM BEHAV, V2, P573, DOI 10.1038/s41562-018-0372-x; Leder J, 2020, COMPR RESULTS SOC PS, P1, DOI [10.1080/23743603.2020.1828850, DOI 10.1080/23743603.2020.1828850]; Limpo T, 2010, LAB PSICOLOGIA, V8, P171, DOI [10.14417/lp.640, DOI 10.14417/LP.640]; Mazey S, 2020, POLIT QUART, V91, P561, DOI 10.1111/1467-923X.12893; Miyajima T, 2021, FRONT PSYCHOL, V12, DOI 10.3389/fpsyg.2021.605059; Mizumoto K, 2020, EUROSURVEILLANCE, V25, P2, DOI 10.2807/1560-7917.ES.2020.25.10.2000180; Muller S, 2021, J PUBLIC ECON, V194, DOI 10.1016/j.jpubeco.2020.104322; Murphy RO, 2011, JUDGM DECIS MAK, V6, P771; Nishiura H, 2020, INT J INFECT DIS, V94, P154, DOI 10.1016/j.ijid.2020.03.020; Petrocchi S, 2022, CURR PSYCHOL, V41, P437, DOI 10.1007/s12144-021-01601-1; Pfattheicher S, 2020, PSYCHOL SCI, V31, P1363, DOI 10.1177/0956797620964422; Phillips J, 2017, P NATL ACAD SCI USA, V114, P4649, DOI 10.1073/pnas.1619717114; Rand DG, 2016, PSYCHOL SCI, V27, P1192, DOI 10.1177/0956797616654455; Rand DG, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00300; Rand DG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4677; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; RCore Team, 2020, R LANG ENV STAT COMP; Thielmann I, 2020, PSYCHOL BULL, V146, P30, DOI 10.1037/bul0000217; Thompson VA, 2014, PSYCHOL LEARN MOTIV, V60, P35, DOI 10.1016/B978-0-12-800090-8.00002-0; Tomasello M, 2009, WHY WE COOPERATE, P1; Van Bavel JJ, 2020, NAT HUM BEHAV, V4, P460, DOI 10.1038/s41562-020-0884-z; Van Dijk E., 2004, CONT PSYCHOL RES SOC, P315; Wei ZY, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00952; Wise T, 2020, ROY SOC OPEN SCI, V7, DOI 10.1098/rsos.200742; World Health Organization, 2021, NOV COR 2019 NCOV SI; World Health Organization. Regional Office for Europe, 2020, PAND FAT REINV PUBL; Zettler I, 2022, SOC PSYCHOL PERS SCI, V13, P299, DOI 10.1177/19485506211001680	58	2	2	10	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266050	10.1371/journal.pone.0266050	http://dx.doi.org/10.1371/journal.pone.0266050			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349603	gold, Green Published			2022-12-26	WOS:000783906500037
J	Ghosh, A; Sarmah, P; Patel, H; Mukerjee, N; Mishra, R; Alkahtani, S; Varma, RS; Baishya, D				Ghosh, Arabinda; Sarmah, Pranjal; Patel, Harun; Mukerjee, Nobendu; Mishra, Rajbardhan; Alkahtani, Saad; Varma, Rajender S.; Baishya, Debabrat			Nonlinear molecular dynamics of quercetin in Gynocardia odorata and Diospyros malabarica fruits: Its mechanistic role in hepatoprotection	PLOS ONE			English	Article							ACUTE LIVER-INJURY; CARBON-TETRACHLORIDE; OXIDATIVE STRESS; EXTRACT	Liver performs number of critical physiological functions in human system. Intoxication of liver leads to accumulation of free radicals that eventually cause damage, fibrosis, cirrhosis and cancer. Carbon tetrachloride (CCl4) belongs to hepatotoxin is converted to a highly reactive free radical by cytochrome P450 enzymes that causes liver damage. Plant extracts derived quercetin has substantial role in hepatoprotection. This study highlights the possible mechanism by which quercetin plays significant role in hepatoprotection. HPLC analysis revealed the abundance of quercetin in the fruit extracts of Gynocardia odorata and Diospyros malabarica, were isolated, purified and subjected to liver function analysis on Wistar rats. Post quercetin treatment improved liver function parameters in the hepatotoxic Wistar rats by augmenting bilirubin content, SGOT and SGPT activity. Gene expression profile of quercetin treated rats revealed down regulation of HGF, TIMP1 and MMP2 expressed during CCl4 induction. In silico molecular mechanism prediction suggested that quercetin has a high affinity for cell signaling pathway proteins BCL-2, JAK2 and Cytochrome P450 Cyp2E1, which all play a significant role in CCl4 induced hepatotoxicity. In silico molecular docking and molecular dynamics simulation have shown that quercetin has a plausible affinity for major signaling proteins in liver. MMGBSA studies have revealed high binding of quercetin (Delta G) -41.48 +/- 11.02, -43.53 +/- 6.55 and -39.89 +/- 5.78 kcal/mol, with BCL-2, JAK2 and Cyp2E1, respectively which led to better stability of the quercetin bound protein complexes. Therefore, quercetin can act as potent inhibitor against CCl4 induced hepatic injury by regulating BCL-2, JAK2 and Cyp2E1.	[Ghosh, Arabinda] Gauhati Univ, Dept Bot, Microbiol Div, Gauhati, Assam, India; [Sarmah, Pranjal; Baishya, Debabrat] Gauhati Univ, GUIST, Dept Bioengn & Technol, Gauhati, Assam, India; [Patel, Harun] RC Patel Inst Pharmaceut Educ & Res, Shirpur, Maharastra, India; [Mukerjee, Nobendu] Ramakrishna Mission Vivekananda Centenary Coll, Dept Microbiol, Kolkata, W Bengal, India; [Mishra, Rajbardhan] Czech Acad Sci, Vvi, Inst Microbiol, Lab Immunotherapy, Prague, Czech Republic; [Alkahtani, Saad] King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia; [Varma, Rajender S.] Palacky Univ, Czech Adv Technol & Res Inst, Reg Ctr Adv Technol & Mat, Olomouc, Czech Republic	Gauhati University; Gauhati University; Czech Academy of Sciences; Institute of Microbiology of the Czech Academy of Sciences; King Saud University; Palacky University Olomouc	Baishya, D (corresponding author), Gauhati Univ, GUIST, Dept Bioengn & Technol, Gauhati, Assam, India.; Alkahtani, S (corresponding author), King Saud Univ, Coll Sci, Dept Zool, Riyadh, Saudi Arabia.	salkahtani@ksu.edu.sa; drbaishya@gmail.com	Varma, Rajender S/M-8774-2013; Mukerjee, Nobendu/AAT-8758-2021; Patel, Harun Miyalal/L-7942-2019	Varma, Rajender S/0000-0001-9731-6228; Mukerjee, Nobendu/0000-0002-7129-7003; Patel, Harun Miyalal/0000-0003-0920-1266; Ghosh, Arabinda/0000-0002-3891-5949	King Saud University, Riyadh, Saudi Arabia [RSP- 2021/26]	King Saud University, Riyadh, Saudi Arabia(King Saud University)	Authors are thankful to DST FIST support, Govt. of India to the Department of Botany, Gauhati University and also thankful to Department of Bioengineering and Technology, Gauhati University for proving conducive environment and support to carry out this work. This work is funded by Researchers Supporting Project (RSP- 2021/26), King Saud University, Riyadh, Saudi Arabia.	Adewale OB, 2014, J PHYTOPHARMACOLOGY, V3, P1; Amin ZA, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-160; Ansar S, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1322-7; Bedada SK, 2018, EUR J CLIN PHARMACOL, V74, P91, DOI 10.1007/s00228-017-2345-9; Bowers K.J., 2006, SC 06 P 2006 ACM IEE; Chang SN, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22031083; Chow E., 2008, DESRESTR200801; Cordero-Perez P, 2013, PHARMACOGN RES, V5, P150, DOI 10.4103/0974-8490.112417; Cui CP, 2009, HEPATOL RES, V39, P200, DOI 10.1111/j.1872-034X.2008.00447.x; Duarte S, 2015, MATRIX BIOL, V44-46, P147, DOI 10.1016/j.matbio.2015.01.004; Esposito C, 2005, KIDNEY INT, V67, P2143, DOI 10.1111/j.1523-1755.2005.00319.x; Hafez MM, 2015, BIOL RES, V48, DOI [10.1186/s40659-015-0022-y, 10.1186/S40659-015-0022-Y]; Hossain M. S., 2017, Biomedical & Pharmacology Journal, V10, P1267, DOI 10.13005/bpj/1229; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kagami LP, 2020, COMPUT BIOL CHEM, V87, DOI 10.1016/j.compbiolchem.2020.107322; Kalita BC., 2018, J PHARMACOGNOSY PHYT, V7, P2458; Kim S. H., 2021, Cell and Tissue Biology, V15, P381, DOI 10.1134/S1990519X21040039; Li S, 2015, INT J MOL SCI, V16, P26087, DOI 10.3390/ijms161125942; Liu Y, 2018, INT J MOL MED, V42, P755, DOI 10.3892/ijmm.2018.3651; LOWRY OH, 1951, J BIOL CHEM, V193, P265; LUDWIG THOMAS G., 1956, JOUR DENTAL RES, V35, P90, DOI 10.1177/00220345560350012301; Luper S, 1999, Altern Med Rev, V4, P178; Luper S, 1998, Altern Med Rev, V3, P410; Mahli A., 2015, CLIN PHYTOSCIENCE, V1, P1, DOI [10.1186/s40816-015-0006-z, DOI 10.1186/S40816-015-0006-Z, 10.1186/s40816-015-0006]; Malik S. K., 2019, Pakistan Journal of Science, V71, P272; MARTYNA GJ, 1992, J CHEM PHYS, V97, P2635, DOI 10.1063/1.463940; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Menezes C., 2011, INT J PHARM SCI NANO, V4, P1501; Miltonprabu S, 2017, FOOD CHEM TOXICOL, V108, P365, DOI 10.1016/j.fct.2016.08.034; Mohan C J, 2013, LEAF INT J RES PHARM, V2, P351; Mondal Susanta Kumar, 2006, Indian J Exp Biol, V44, P39; O'Boyle NM, 2011, J CHEMINFORMATICS, V3, DOI 10.1186/1758-2946-3-33; Ohta Y, 2008, J CLIN BIOCHEM NUTR, V42, P118, DOI 10.3164/jcbn.2008017; Okokon JE, 2017, AVICENNA J PHYTOMEDI, V7, P27; Piao LH, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20010224; Sahin K, 2021, ACS PHARMACOL TRANSL, V4, P1111, DOI 10.1021/acsptsci.0c00210; Sengupta Mahuya, 2011, Asian Pacific Journal of Tropical Biomedicine, V1, P193, DOI 10.1016/S2221-1691(11)60026-9; Shivakumar D, 2010, J CHEM THEORY COMPUT, V6, P1509, DOI 10.1021/ct900587b; SINGLETON V. L., 1965, AMER J ENOL VITICULT, V16, P144; Toukmaji AY, 1996, COMPUT PHYS COMMUN, V95, P73, DOI 10.1016/0010-4655(96)00016-1; Trease G.E., 1978, TXB PHARMACOGNOSY, Veleventh; Trease GE, 2002, PHARMACOGNOSY, V15th, P42; Vargas-Mendoza N, 2014, WORLD J HEPATOL, V6, P144, DOI 10.4254/wjh.v6.i3.144; Xiang C, 2018, RSC ADV, V8, P15366, DOI 10.1039/c8ra02523a; Yousef MI, 2010, FOOD CHEM TOXICOL, V48, P3246, DOI 10.1016/j.fct.2010.08.034	45	1	1	4	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0263917	10.1371/journal.pone.0263917	http://dx.doi.org/10.1371/journal.pone.0263917			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35313329	Green Published, gold			2022-12-26	WOS:000803647900052
J	Kenny, JES; Barjaktarevic, I; Eibl, AM; Parrotta, M; Long, BF; Elfarnawany, M; Eibl, JK				Kenny, Jon-Emile S.; Barjaktarevic, Igor; Eibl, Andrew M.; Parrotta, Matthew; Long, Bradley F.; Elfarnawany, Mai; Eibl, Joseph K.			Temporal concordance between pulse contour analysis, bioreactance and carotid doppler during rapid preload changes	PLOS ONE			English	Article							CARDIAC-OUTPUT; STROKE VOLUME	PurposeWe describe the temporal concordance of 3 hemodynamic monitors. Materials and methodsHealthy volunteers performed preload changes while simultaneously wearing a non-invasive, pulse-contour stroke volume (SV) monitor, a bioreactance SV monitor and a wireless, wearable Doppler ultrasound patch over the common carotid artery. The sensitivity and specificity for detecting preload change over 3 temporal windows (early, middle and late) was assessed. Results40 preload changes were recorded in total (20 increase, 20 decrease). Immediately, the wearable Doppler had high sensitivity (100%) and specificity (100%) for detecting preload change with an area under the receiver operator curve (AUROC) of 0.98 for both velocity time integral (VTI, 10.5% threshold) and corrected flow time (FTc, 2.5% threshold). The sensitivity, specificity and AUROC for non-invasive pulse contour were equally good (9% SV threshold). For bioreactance, a 13% SV threshold immediately detected preload change with a sensitivity, specificity and AUROC of 60%, 95% and 0.75, respectively. After two SV outputs following preload change, the sensitivity, specificity and AUROC of bioreactance improved to 70%, 90% and 0.85, respectively. ConclusionsCarotid Doppler ultrasound and non-invasive pulse contour detected rapid hemodynamic change with equal accuracy; bioreactance improved over time. Algorithm-lag should be considered when interpreting clinical studies.	[Kenny, Jon-Emile S.; Eibl, Andrew M.; Parrotta, Matthew; Long, Bradley F.; Elfarnawany, Mai; Eibl, Joseph K.] Hlth Sci North Res Inst, Sudbury, ON, Canada; [Barjaktarevic, Igor] UCLA, David Geffen Sch Med, Dept Med, Div Pulm & Crit Care, Los Angeles, CA USA; [Long, Bradley F.; Eibl, Joseph K.] Northern Ontario Sch Med, Sudbury, ON, Canada	Health Sciences North; Northern Ontario School of Medicine; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Northern Ontario School of Medicine	Kenny, JES (corresponding author), Hlth Sci North Res Inst, Sudbury, ON, Canada.	jon-emile@heart-lung.org						Barjaktarevic I, 2018, CRIT CARE MED, V46, pE1040, DOI 10.1097/CCM.0000000000003356; Beier L, 2020, J ULTRAS MED, V39, P1965, DOI 10.1002/jum.15301; Chebl RB, 2019, AM J EMERG MED, V37, P1460, DOI 10.1016/j.ajem.2018.10.047; Hadian M, 2010, CRIT CARE, V14, DOI 10.1186/cc9335; HANSON P, 1995, BRIT HEART J, V74, P154; Kenny J-ES., 2020, INTENSIVE CARE MED E; Kenny JES, 2020, J EMERG CRIT CARE ME, V4, P17; Kenny Jon-Emile S, 2021, Front Med Technol, V3, P676995, DOI 10.3389/fmedt.2021.676995; Kenny JES, 2021, BRIT J ANAESTH, V127, pE60, DOI 10.1016/j.bja.2021.05.007; Kenny JES, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87116-y; Kenny JES, 2021, CRIT CARE, V25, DOI 10.1186/s13054-021-03498-5; Kenny Jon-Emile S, 2020, Crit Care Explor, V2, pe0072, DOI 10.1097/CCE.0000000000000072; LEWIS BS, 1980, EUR J CARDIOL, V11, P405; Li JK, 2019, INFORMATION, V10, DOI 10.3390/info10060199; Mackenzie DC., 2014, CRIT CARE, V18, pP131; Marik PE, 2013, CHEST, V143, P364, DOI 10.1378/chest.12-1274; ODONNELL TV, 1962, AM HEART J, V64, P347, DOI 10.1016/0002-8703(62)90149-7; Thiele RH, 2015, CRIT CARE MED, V43, P177, DOI 10.1097/CCM.0000000000000608; Wu YF, 2014, CRIT CARE, V18, DOI 10.1186/cc13891; Zhang J, 2016, J CLIN MONIT COMPUT, V30, P519, DOI 10.1007/s10877-016-9835-7	20	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265711	10.1371/journal.pone.0265711	http://dx.doi.org/10.1371/journal.pone.0265711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320307	gold, Green Published			2022-12-26	WOS:000784240600044
J	Kreps, S; Kriner, DL				Kreps, Sarah; Kriner, Douglas L.			Communication about vaccine efficacy and COVID-19 vaccine choice: Evidence from a survey experiment in the United States	PLOS ONE			English	Article							MISINFORMATION; PREFERENCES; INFLUENZA; SCOTLAND	While mass vaccination campaigns against COVID-19 have inoculated almost 200 million Americans and billions more worldwide, significant pockets of vaccine hesitancy remain. Research has firmly established that vaccine efficacy is an important driver of public vaccine acceptance and choice. However, current vaccines offer widely varying levels of protection against different adverse health outcomes of COVID-19. This study employs an experiment embedded on a survey of 1,194 US adults in June 2021 to examine how communications about vaccine efficacy affect vaccine choice. The experiment manipulated how vaccine efficacy was defined across four treatments: (1) protection against symptomatic infection; (2) protection against severe illness; (3) protection against hospitalization/death; (4) efficacy data on all three metrics. The control group received no efficacy information. Subjects were asked to choose between a pair of vaccines-a one-dose viral vector vaccine or two-dose mRNA vaccine-whose efficacy data varied across the four experimental treatment groups. Efficacy data for each vaccine on each dimension were adapted from clinical trial data on the Johnson & Johnson/Janssen and Pfizer/BioNTech vaccines. Among all respondents, only modest preference gaps between the two vaccines emerged in the control group and when the two vaccines' roughly equivalent efficacy data against hospitalization and death were reported. Strong preferences for a two-dose mRNA vaccine emerged in treatments where its higher efficacy against symptomatic or severe illness was reported, as well as in the treatment where data on all three efficacy criteria were reported. Unvaccinated respondents preferred a one-dose viral vector vaccine when only efficacy data against hospitalization or death was presented. Black and Latino respondents were significantly more likely to choose the one-shot viral vector vaccine in the combined efficacy treatment than were whites. Results speak to the importance of understanding how communications about vaccine efficacy affect public preferences in an era of increasing uncertainty about efficacy against variants.	[Kreps, Sarah; Kriner, Douglas L.] Cornell Univ, Dept Govt, Ithaca, NY 14850 USA	Cornell University	Kriner, DL (corresponding author), Cornell Univ, Dept Govt, Ithaca, NY 14850 USA.	kriner@cornell.edu						Anthes E., 2021, NEW YORK TIMES; Baraniuk C, 2021, BMJ-BRIT MED J, V374, DOI 10.1136/bmj.n1960; Bergwerk M, 2021, NEW ENGL J MED, V385, P1474, DOI 10.1056/NEJMoa2109072; Bian LL, 2021, EXPERT REV VACCINES, V20, P1201, DOI 10.1080/14760584.2021.1976153; Bokemper SE, 2021, VACCINE, V39, P825, DOI 10.1016/j.vaccine.2020.12.048; Borriello A, 2021, VACCINE, V39, P473, DOI 10.1016/j.vaccine.2020.12.032; Coppock A, 2019, RES POLITICS, V6, DOI 10.1177/2053168018822174; Daily UK, 2020, DAILY UK; Dasgupta N, 2021, LANCET DIGIT HEALTH, V3, pE278, DOI 10.1016/S2589-7500(21)00021-2; Determann D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102505; Dong D, 2020, HEALTH EXPECT, V23, P1543, DOI 10.1111/hex.13140; Dror AA, 2021, EUR J EPIDEMIOL, V36, P709, DOI 10.1007/s10654-021-00758-0; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Fisher KA, 2020, ANN INTERN MED, V173, P964, DOI 10.7326/M20-3569; Head KJ, 2020, SCI COMMUN, V42, P698, DOI 10.1177/1075547020960463; Hoffman J., 2020, SLOWING CORONAVIRUS; Johnson & Johnson, 2021, JOHNS JOHNS COVID 19; Kaplan RM, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2021726118; Klugar M, 2021, BIOLOGY-BASEL, V10, DOI 10.3390/biology10080752; Knoll MD, 2021, LANCET, V397, P72, DOI 10.1016/S0140-6736(20)32623-4; Kreps S, 2021, NPJ VACCINES, V6, DOI 10.1038/s41541-021-00335-2; Kreps S, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.25594; Larson HJ, 2021, AM J PUBLIC HEALTH, V111, P1058, DOI 10.2105/AJPH.2021.306293; Lee K, 2009, GLOB INST, P1; Livingston Edward H, 2021, JAMA, V325, P1575, DOI 10.1001/jama.2021.2927; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Luchsinger LL, 2021, SCIENCE, V371, P1116, DOI 10.1126/science.abg9461; McPhedran R, 2021, ECON LETT, V200, DOI 10.1016/j.econlet.2021.109747; Momplaisir F, 2021, CLIN INFECT DIS, V73, P1784, DOI 10.1093/cid/ciab102; Moore JP, 2021, JAMA-J AM MED ASSOC, V325, P1251, DOI 10.1001/jama.2021.3465; Motta M, 2021, SOC SCI MED, V272, DOI 10.1016/j.socscimed.2020.113642; Petit J, 2021, SCI COMMUN, V43, P407, DOI 10.1177/10755470211009887; pfizer, 2021, PFIZ BIONT CONF HIGH; Quinn SC, 2021, AM J PUBLIC HEALTH, V111, P355, DOI 10.2105/AJPH.2020.306036; Riad A, 2021, PHARMACEUTICALS-BASE, V14, DOI 10.3390/ph14101049; Riad A, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph18157859; Salerno L, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9080927; Schwarzinger M, 2021, LANCET PUBLIC HEALTH, V6, pE210, DOI 10.1016/S2468-2667(21)00012-8; Sheikh A, 2021, LANCET, V397, P2461, DOI 10.1016/S0140-6736(21)01358-1; Shono A, 2014, VACCINE, V32, P5071, DOI 10.1016/j.vaccine.2014.07.002; Simpson CR, 2012, LANCET INFECT DIS, V12, P696, DOI 10.1016/S1473-3099(12)70133-0; Sudharsanan N., 2021, EFFECT FRAMING COMMU, P1, DOI [10.1186/s13063-020-04976-x, DOI 10.1186/S13063-020-04976-X]; Thompson HS, 2021, JAMA NETW OPEN, V4, DOI 10.1001/jamanetworkopen.2021.11629; Torjesen I, 2021, BMJ-BRIT MED J, V375, DOI 10.1136/bmj.n2943; Vraga EK, 2017, SCI COMMUN, V39, P621, DOI 10.1177/1075547017731776; Wernau J, 2021, WALL STR J; Woko C, 2020, J HEALTH COMMUN, V25, P819, DOI 10.1080/10810730.2020.1864521	47	1	1	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265011	10.1371/journal.pone.0265011	http://dx.doi.org/10.1371/journal.pone.0265011			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353846	Green Published, gold			2022-12-26	WOS:000786647900001
J	Layos, JKN; Geromo, RB; Espina, DM; Nishibori, M				Layos, John King N.; Geromo, Ronel B.; Espina, Dinah M.; Nishibori, Masahide			Insights on the historical biogeography of Philippine domestic pigs and its relationship with continental domestic pigs and wild boars	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; ISLAND SOUTHEAST-ASIA; POPULATION-GROWTH; CONTROL REGION; ANCIENT DNA; SUS-SCROFA; MIGRATION; EXPANSION; ORIGIN; PHYLOGEOGRAPHY	The Philippine archipelago was believed to have never been connected to the Asian continent even during the severe Quaternary sea-level drops. As a result, the history of domestic pig (Sus scrofa) dispersal in the Philippines remains controversial and must have some anthropogenic origin associated with human migration events. In this study, the context of origin, dispersal, and the level of genetic introgression in Philippine domestic pigs were deduced using mitochondrial DNA D-loop analysis altogether with domestic pigs and wild boar corresponding to their geographic origin. The results revealed considerable genetic diversity (0.900 +/- 0.016) and widespread Asian pig-ancestry (94.60%) in the phylogenetic analysis, with admixed European pig-origin (5.10%) harboring various fractions of ancestry from Berkshire and Landrace. The close genetic connection between the continental wild boars and domestic pigs present in the Philippine domestic pigs corroborates our hypothesis of a genetic signal that may be associated with the recently reported multiple waves of human migrations to the Philippines. The Haplogroup D7, reported to occur only in Indo-Burma Biodiversity Hotspots, included a high frequency of Philippine domestic pig haplotypes (54.08%), which poses an interesting challenge because its distribution is not consistent with the hypothesized migration route of Neolithic Austronesian-speaking populations. We detected the first Pacific Clade signature and ubiquitously distributed D2 haplotypes (Asian major) on several Philippine islands. The analyses of mismatch distribution and neutrality test were consistent with the Bayesian skyline plot which showed a long stationary period of effective population size. The population decline was consistent with the pronounced population bottleneck in Asian and European pigs during the interglacial periods of the Pleistocene. The results of this study will support the conservation strategies and improvements of economically important genetic resources in the Philippines.	[Layos, John King N.; Nishibori, Masahide] Hiroshima Univ, Grad Sch Integrated Sci Life, Lab Anim Genet, Higashihiroshima, Japan; [Layos, John King N.] Capiz State Univ, Coll Agr & Forestry, Mambusao, Capiz, Philippines; [Geromo, Ronel B.; Espina, Dinah M.; Nishibori, Masahide] Visayas State Univ, Dept Anim Sci, Baybay City, Philippines	Hiroshima University; Visayas State University	Layos, JKN; Nishibori, M (corresponding author), Hiroshima Univ, Grad Sch Integrated Sci Life, Lab Anim Genet, Higashihiroshima, Japan.; Layos, JKN (corresponding author), Capiz State Univ, Coll Agr & Forestry, Mambusao, Capiz, Philippines.; Nishibori, M (corresponding author), Visayas State Univ, Dept Anim Sci, Baybay City, Philippines.	johnkinglayos5@gmail.com; nishibo@hiroshim-u.ac.jp		LAYOS, JOHN KING/0000-0002-4561-7288				Amano N, 2013, J ISL COAST ARCHAEOL, V8, P317, DOI 10.1080/15564894.2013.781084; Amills M, 2018, ECOLOGY, CONSERVATION AND MANAGEMENT OF WILD PIGS AND PECCARIES, P376; Baker PA, 2014, EARTH-SCI REV, V135, P38, DOI 10.1016/j.earscirev.2014.04.001; BANDELT HJ, 1995, GENETICS, V141, P743; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bellwood P., 2005, AUSTRONESIAN STUD, V1, P1, DOI [DOI 10.29884/JAS.200506.0001, 10.29884/JAS.200506.0001]; Bellwood P., 1985, ASIAN PERSPECT, V26, P107; Bellwood P, 2013, TERRA AUSTRALIS, V40, P67; Bianco E., 1793, CHIMERICAL GENOME IS; Bird MI, 2005, QUATERNARY SCI REV, V24, P2228, DOI 10.1016/j.quascirev.2005.04.004; Bondoc OL., 2008, ANIMAL BREEDING PRIN; Bouckaert R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003537; Bruford MW, 2003, NAT REV GENET, V4, P900, DOI 10.1038/nrg1203; Deli T, 2019, BMC EVOL BIOL, V19, DOI 10.1186/s12862-019-1423-2; Dobney Keith, 2008, Asian Perspectives, V47, P59, DOI 10.1353/asi.2008.0009; Dorcus KM., 2020, GENETIC DIVERSITY GL, DOI [10.1101/2020.01.29.924696, DOI 10.1101/2020.01.29.924696]; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Epstein J., 1984, PIG EVOLUTION DOMEST, P145; Eusebio EJ., 1969, SCI PRACTICE SWINE P; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Fang MY, 2006, P R SOC B, V273, P1803, DOI 10.1098/rspb.2006.3514; Fauvelot C, 2003, EVOLUTION, V57, P1571; Fox R., 1967, PHILIPPINE STUDIES, V15, P41; Frantz L, 2016, ANNU REV ANIM BIOSCI, V4, P61, DOI 10.1146/annurev-animal-021815-111155; Frantz LAF, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r107; Fu YX, 1997, GENETICS, V147, P915; Giuffra E, 2000, GENETICS, V154, P1785; Gongora J, 2004, MOL PHYLOGENET EVOL, V33, P339, DOI 10.1016/j.ympev.2004.06.004; Green M.R., 2012, MOL CLONING LAB MANU; Groenen MAM, 2012, NATURE, V491, P393, DOI 10.1038/nature11622; Groves CP, 1997, ZOOL J LINN SOC-LOND, V120, P163; Groves CP., 1983, J SOC OCEANISTES, V39, P105; HARPENDING HC, 1994, HUM BIOL, V66, P591; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Heaney L. R., 1997, MEGADIVERSITY EARTHS, P236; Heller R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062992; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Ingicco T, 2017, INT J OSTEOARCHAEOL, V27, P768, DOI 10.1002/oa.2592; Larena M, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2026132118; Larson G, 2005, SCIENCE, V307, P1618, DOI 10.1126/science.1106927; Larson G., 2007, PIGS HUMANS 10000 YE, P30; Larson G, 2007, P NATL ACAD SCI USA, V104, P4834, DOI 10.1073/pnas.0607753104; Larson G, 2010, P NATL ACAD SCI USA, V107, P7686, DOI 10.1073/pnas.0912264107; Li KT, 2015, B INST HIST PHILOL, V86, P607; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Luskin MS., 2018, ECOLOGY CONSERVATION, P176; Lyrholm T, 1996, MOL BIOL EVOL, V13, P1318, DOI 10.1093/oxfordjournals.molbev.a025578; Martel C, 2004, MAR ECOL PROG SER, V273, P163, DOI 10.3354/meps273163; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naderi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001012; Okumura N, 1996, BIOCHEM GENET, V34, P179, DOI 10.1007/BF02407018; Okumura N, 2001, ANIM GENET, V32, P139, DOI 10.1046/j.1365-2052.2001.00757.x; Oliver WLR., 1995, IBEX JME, V3, P26; Oppenheimer S., 1999, EDEN E; Penalba FF., 1993, ANIM PROD TECH, V8, P2; Pesole G, 1999, J MOL EVOL, V48, P427, DOI 10.1007/PL00006487; Piper PJ, 2009, ANTIQUITY, V83, P687, DOI 10.1017/S0003598X00098914; Posa MRC, 2008, BIOSCIENCE, V58, P231, DOI 10.1641/B580309; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Ramirez O, 2009, MOL BIOL EVOL, V26, P2061, DOI 10.1093/molbev/msp118; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Ruvinsky A, 2011, GENETICS OF THE PIG, 2ND EDITION, P1, DOI 10.1079/9781845937560.0001; Sanchez G, 2020, REV FISH BIOL FISHER, V30, P519, DOI 10.1007/s11160-020-09609-9; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, MAMMAL REV, V41, P125, DOI 10.1111/j.1365-2907.2010.00182.x; Scott WH., 1990, PHILIPP Q CULT SOC, V18, P291; Solheim WG., 2006, ARCHAEOLOGY CULTURE; Sulandari S., 2008, HAYATI J BIOSCI, V15, P145; TAJIMA F, 1989, GENETICS, V123, P597; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tanaka K, 2008, ANIM SCI J, V79, P417, DOI 10.1111/j.1740-0929.2008.00546.x; Thomson VA, 2014, P NATL ACAD SCI USA, V111, P4826, DOI 10.1073/pnas.1320412111; Velickovic N, 2016, HEREDITY, V117, P348, DOI 10.1038/hdy.2016.53; Vilaca ST, 2014, J BIOGEOGR, V41, P987, DOI 10.1111/jbi.12268; Voris HK, 2000, J BIOGEOGR, V27, P1153, DOI 10.1046/j.1365-2699.2000.00489.x; Wang C, 2019, J INTEGR AGR, V18, P2338, DOI 10.1016/S2095-3119(19)62731-0; WATANABE T, 1985, BIOCHEM GENET, V23, P105, DOI 10.1007/BF00499116; Wu GS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r245; Wurster CM, 2010, P NATL ACAD SCI USA, V107, P15508, DOI 10.1073/pnas.1005507107	85	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0254299	10.1371/journal.pone.0254299	http://dx.doi.org/10.1371/journal.pone.0254299			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344556	gold, Green Submitted, Green Published			2022-12-26	WOS:000788055200020
J	Lempke, AFD; Hertel, J				Lempke, Alexandra F. DeJong; Hertel, Jay			Influence of the COVID-19 pandemic on running behaviors, motives, and running-related injury: A one-year follow-up survey	PLOS ONE			English	Article							MENTAL-HEALTH; ETIOLOGY	The purpose of this study was to compare running behaviors, motives, and injury during the first full year of the pandemic compared to the year prior, and month of eased restrictions. 466 runners responded to this follow-up survey. Paired t-tests were used to compare timepoints. Logistic regressions were used to assess demographic influences on behaviors. During the first full year of the pandemic, runners were more likely to increase their weekly runs (Mean Differences [MD]: 0.29 +/- 0.10, p < .001), yet had fewer motives (MD: -0.20 +/- 0.06, p = .02) compared to the month of eased restrictions. 18-25-year-olds were most likely to increase running volume (Odds Ratio [OR]: 2.79 [1.06, 7.32], p = .04) during the first full year of the pandemic compared to the year prior. Inexperienced runners reported fewer motives (OR: 3.00-4.41, p = .02-.04), and reduced sustained runs (OR: 2.36 [1.13, 4.96], p = .02) during the first full year of the pandemic compared to the year prior. Inexperienced runners and runners who lost access to preferred locations were at increased injury risk (OR: 1.98-2.63, p: .01-.04) during the first full year of the pandemic compared to the year prior. Our findings highlight pandemic-related changes among the running community that are likely to influence behaviors and injury risk.	[Lempke, Alexandra F. DeJong] Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA; [Lempke, Alexandra F. DeJong] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Lempke, Alexandra F. DeJong; Hertel, Jay] Exercise & Sport Injury Lab, Charlottesville, VA 22903 USA	Harvard University; Boston Children's Hospital	Lempke, AFD (corresponding author), Boston Childrens Hosp, Div Sports Med, Boston, MA 02115 USA.; Lempke, AFD (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.; Lempke, AFD (corresponding author), Exercise & Sport Injury Lab, Charlottesville, VA 22903 USA.	alexandra.dejong@childrens.harvard.edu		DeJong Lempke, PhD, ATC, Alexandra F/0000-0002-5702-9184				Andersen J.J., 2020, STATE RUNNING 2019; Bazett-Jones DM, 2020, FRONT SPORTS ACT LIV, V2, DOI 10.3389/fspor.2020.586141; Bertelsen ML, 2017, SCAND J MED SCI SPOR, V27, P1170, DOI 10.1111/sms.12883; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; CDC, 2022, COVID DAT TRACK; DeJong AF, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246300; Ferreira AC, 2012, REV BRAS MED ESPORTE, V18, P252, DOI 10.1590/S1517-86922012000400007; Fokkema T, 2019, J SCI MED SPORT, V22, P106, DOI 10.1016/j.jsams.2018.06.003; Ghorbani F, 2014, J RES HEALTH SCI, V14, P264; Holmes HH, 2021, FRONT SPORTS ACT LIV, V3, DOI 10.3389/fspor.2021.637516; Hossain Md Mahbub, 2020, F1000Res, V9, P636, DOI 10.12688/f1000research.24457.1; Hu SJ, 2020, FRONT PSYCHIATRY, V11, DOI 10.3389/fpsyt.2020.587557; Janssen M, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17072276; Kemler E, 2018, PHYSICIAN SPORTSMED, V46, P485, DOI 10.1080/00913847.2018.1507410; MACERA CA, 1989, ARCH INTERN MED, V149, P2565, DOI 10.1001/archinte.149.11.2565; Nielsen RO, 2012, INT J SPORTS PHYS TH, V7, P58; Nielsen RO, 2013, INT J SPORTS PHYS TH, V8, P172; Paluska SA, 2000, SPORTS MED, V29, P167, DOI 10.2165/00007256-200029030-00003; Parra-Camacho D, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030925; Pereira HV, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245242; Ramskov D, 2018, J ORTHOP SPORT PHYS, V48, P740, DOI 10.2519/jospt.2018.8062; Running USA, 2020, 2020 RUNN US US RUN; Simpson RJ., 2020, CAN EXERCISE AFFECT, V15; Yan Z, 2020, REDOX BIOL, V32, DOI 10.1016/j.redox.2020.101508; Zhang Y, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17103722	25	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264361	10.1371/journal.pone.0264361	http://dx.doi.org/10.1371/journal.pone.0264361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353824	gold, Green Published			2022-12-26	WOS:000786647900002
J	Muir, ER; Chandra, SB; Narayanan, D; Zhang, VC; Zhang, IK; Jiang, Z; Kiel, JW; Duong, TQ				Muir, Eric R.; Chandra, Saurav B.; Narayanan, Divya; Zhang, Vincent; Zhang, Ike; Jiang, Zhao; Kiel, Jeffrey W.; Duong, Timothy Q.			Effects of chronic mild hyperoxia on retinal and choroidal blood flow and retinal function in the DBA/2J mouse model of glaucoma	PLOS ONE			English	Article							PRIMARY OPEN-ANGLE; INTRAOCULAR-PRESSURE; OCULAR HYPERTENSION; OXYGEN DISTRIBUTION; HYPERBARIC-OXYGEN; CARBON-DIOXIDE; VISUAL-FIELD; ELECTRORETINOGRAM; MRI; DYSFUNCTION	PurposeTo test the hypothesis that mild chronic hyperoxia treatment would improve retinal function despite a progressive decline in ocular blood flow in the DBA/2J mouse model of glaucoma. Materials and methodsDBA/2J mice were treated with chronic mild hyperoxia (30% O-2) beginning at 4.5 months of age or were untreated by giving normal room air. Retinal and choroidal blood flow (RBF and ChBF, respectively) were measured at 4, 6, and 9 months of age by MRI. Blood flow was additionally measured under hypercapnia challenge (5% CO2 inhalation) to assess vascular reactivity. Intraocular pressure (IOP) was measured using a rebound tonometer at the same time points. Scotopic flash electroretinograms (ERGs) were recorded at 9 months of age. ResultsBoth ChBF and RBF were reduced and significantly affected by age (p < 0.01), but neither were significantly affected by O-2-treatment (p > 0.05). ChBF significantly increased in response to hypercapnia (p < 0.01), which was also unaffected by O-2-treatment. Significant effects of age (p < 0.001) and of the interaction of age with treatment (p = 0.028) were found on IOP. IOP significantly decreased in O-2-treated mice at 6 months compared to 4 months of age (p < 0.001), while IOP trended to increase with age in untreated mice. The amplitude of the b-wave from ERG was significantly increased in O-2-treated DBA/2J compared to the untreated mice (p = 0.012), while the a-wave and oscillatory potentials were not significantly affected (p > 0.05). ConclusionThis study investigated the effects of chronic mild hyperoxia on retinal function and on retinal and choroidal blood flow in a mouse model of glaucoma. Retinal function was improved in the O-2-treated mice at late stage, despite a progressive decline of RBF and ChBF with age that was comparable to untreated mice.	[Muir, Eric R.; Zhang, Ike; Jiang, Zhao] SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA; [Chandra, Saurav B.] Univ Texas Hlth San Antonio, Res Imaging Inst, San Antonio, TX USA; [Narayanan, Divya; Kiel, Jeffrey W.] Univ Texas Hlth San Antonio, Dept Ophthalmol, San Antonio, TX USA; [Zhang, Vincent; Duong, Timothy Q.] Albert Einstein Coll Med, Dept Radiol, Bronx, NY USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; Yeshiva University; Albert Einstein College of Medicine	Muir, ER (corresponding author), SUNY Stony Brook, Dept Radiol, Stony Brook, NY 11794 USA.	eric.muir@stonybrook.edu		Duong, Tim/0000-0001-6403-2827	National Institutes of Health [R01EY027751]; IIMS/CTSA Pilot Grant sub-award [UL1RR025767]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); IIMS/CTSA Pilot Grant sub-award	This work was supported by the National Institutes of Health under Grant R01EY027751 (TQD); and an IIMS/CTSA Pilot Grant sub-award (ERM) from a Clinical Translational Science Award from the National Institutes of Health under parent Grant UL1RR025767. DN received funding in the form of salary from the commercial company Biogen. SC received funding in the form of salary from the commercial company Calyx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALM A, 1972, ACTA PHYSIOL SCAND, V84, P306, DOI 10.1111/j.1748-1716.1972.tb05182.x; Anderson B Jr, 1978, Trans Am Ophthalmol Soc, V76, P116; Ashimatey BS, 2019, INVEST OPHTH VIS SCI, V60, P2468, DOI 10.1167/iovs.18-26417; Baltan S, 2010, J NEUROSCI, V30, P5644, DOI 10.1523/JNEUROSCI.5956-09.2010; Bayer AU, 2001, INVEST OPHTH VIS SCI, V42, P1258; Block F, 1998, GEN PHARMACOL-VASC S, V30, P281, DOI 10.1016/S0306-3623(97)00359-5; BOJIC L, 1993, ACTA OPHTHALMOL, V71, P315; BRESNICK GH, 1975, ARCH OPHTHALMOL-CHIC, V93, P1300; Bui BV, 2013, J OPHTHALMOL, V2013, DOI 10.1155/2013/262467; Burroughs SL, 2011, INVEST OPHTH VIS SCI, V52, P3654, DOI 10.1167/iovs.10-7106; Calkins DJ, 2008, INVEST OPHTH VIS SCI, V49, P5083, DOI 10.1167/iovs.08-2205; Chandra S, 2016, INVEST OPHTH VIS SCI, V57, P826, DOI 10.1167/iovs.15-18291; Chidlow G, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00478; Cioffi George A, 2005, Trans Am Ophthalmol Soc, V103, P592; Derrick B, 2017, J MOD APPL STAT METH, V16, P137, DOI 10.22237/jmasm/1493597280; Diaz F, 2010, INVEST OPHTH VIS SCI, V51, P946, DOI 10.1167/iovs.09-3667; Drance S, 2001, AM J OPHTHALMOL, V131, P699, DOI 10.1016/S0002-9394(01)00964-3; Drasdo N, 2002, LANCET, V359, P2251, DOI 10.1016/S0140-6736(02)09265-6; Ersanli D, 2006, UNDERSEA HYPERBAR M, V33, P1; Flammer J, 2002, PROG RETIN EYE RES, V21, P359, DOI 10.1016/S1350-9462(02)00008-3; FRISTON KJ, 1995, NEUROIMAGE, V2, P166, DOI 10.1006/nimg.1995.1019; GALLINCOHEN PF, 1980, INVEST OPHTH VIS SCI, V19, P43; Geyman LS, 2017, BRIT J OPHTHALMOL, V101, P1261, DOI 10.1136/bjophthalmol-2016-309642; Gottanka J, 2005, INVEST OPHTH VIS SCI, V46, P4170, DOI 10.1167/iovs.05-0289; Gui DM, 2011, INT J OPHTHALMOL-CHI, V4, P40, DOI 10.3980/j.issn.2222-3959.2011.01.09; Harazny J, 2009, DOC OPHTHALMOL, V119, P181, DOI 10.1007/s10633-009-9194-5; Harris A, 1996, BRIT J OPHTHALMOL, V80, P209, DOI 10.1136/bjo.80.3.209; Harris A, 1999, PROG RETIN EYE RES, V18, P669; Heijl A, 2002, ARCH OPHTHALMOL-CHIC, V120, P1268, DOI 10.1001/archopht.120.10.1268; Hosking SL, 2004, BRIT J OPHTHALMOL, V88, P406, DOI 10.1136/bjo.2002.008995; HOWARD DR, 1975, AM J VET RES, V36, P81; Howell GR, 2013, EXP NEUROL, V246, P54, DOI 10.1016/j.expneurol.2012.01.014; Inman DM, 2006, INVEST OPHTH VIS SCI, V47, P986, DOI 10.1167/iovs.05-0925; John SWM, 1998, INVEST OPHTH VIS SCI, V39, P951; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Lavery WJ, 2012, INVEST OPHTH VIS SCI, V53, P560, DOI 10.1167/iovs.11-8429; Lei B, 2006, INVEST OPHTH VIS SCI, V47, P2732, DOI 10.1167/iovs.05-1461; Libby RT, 2005, VISUAL NEUROSCI, V22, P637, DOI 10.1017/S0952523805225130; LINSENMEIER RA, 1983, INVEST OPHTH VIS SCI, V24, P37; Maleki N, 2011, INVEST OPHTH VIS SCI, V52, P6867, DOI 10.1167/iovs.10-6762; McLeod SD, 2016, OPHTHALMOLOGY, V123, pP41, DOI 10.1016/j.ophtha.2015.10.053; Mead B, 2018, INVEST OPHTH VIS SCI, V59, P5473, DOI 10.1167/iovs.18-25310; Mocko JA, 2011, INVEST OPHTH VIS SCI, V52, P4223, DOI 10.1167/iovs.10-6750; Muir ER, 2008, MAGN RESON MED, V60, P744, DOI 10.1002/mrm.21721; Muir ER, 2011, MAGN RESON MED, V66, P1416, DOI 10.1002/mrm.22935; Muir ER, 2011, NMR BIOMED, V24, P216, DOI 10.1002/nbm.1576; Pease ME, 2011, INVEST OPHTH VIS SCI, V52, P858, DOI 10.1167/iovs.10-5556; de Lara MJP, 2014, EXP EYE RES, V122, P40, DOI 10.1016/j.exer.2014.02.022; Porciatti V, 2007, INVEST OPHTH VIS SCI, V48, P745, DOI 10.1167/iovs.06-0733; Rangarajan KV, 2011, CURR EYE RES, V36, P481, DOI 10.3109/02713683.2010.549600; Reszec J, 2012, FOLIA HISTOCHEM CYTO, V50, P456, DOI [10.5603/19757, 10.5603/FHC.2012.0063]; Saleh M, 2007, INVEST OPHTH VIS SCI, V48, P4564, DOI 10.1167/iovs.07-0483; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Siegfried CJ, 2010, INVEST OPHTH VIS SCI, V51, P5731, DOI 10.1167/iovs.10-5666; Stewart WC, 2000, AM J OPHTHALMOL, V130, P274, DOI 10.1016/S0002-9394(00)00487-6; Stone J., 2008, EYE RETINA VISUAL SY; Tezel G, 2004, ARCH OPHTHALMOL-CHIC, V122, P1348, DOI 10.1001/archopht.122.9.1348; Tomic L, 2005, ACTA OPHTHALMOL SCAN, V83, P705, DOI 10.1111/j.1600-0420.2005.00522.x; Wang XL, 2015, GRAEF ARCH CLIN EXP, V253, P1557, DOI 10.1007/s00417-015-3095-y; Williams PA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072282; Yamada H, 1999, J CELL PHYSIOL, V179, P149, DOI 10.1002/(SICI)1097-4652(199905)179:2<149::AID-JCP5>3.3.CO;2-U; YANCEY CM, 1989, INVEST OPHTH VIS SCI, V30, P600; YANCEY CM, 1988, INVEST OPHTH VIS SCI, V29, P700	63	1	1	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266192	10.1371/journal.pone.0266192	http://dx.doi.org/10.1371/journal.pone.0266192			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333901	gold, Green Published			2022-12-26	WOS:000784335700042
J	Namit, A; Dowell, W; Matiasek, S; Webster, J; Stachura, DL				Namit, Aleeza; Dowell, William; Matiasek, Sandrine; Webster, Jackson; Stachura, David L.			Pentachlorophenol has significant adverse effects on hematopoietic and immune system development in zebrafish (Danio rerio)	PLOS ONE			English	Article							AORTIC ENDOTHELIUM; BLOOD; DEGRADATION; VOLATILE; WILDFIRE; MODEL; FIRE	In November 2018, the Camp Fire devastated the mountain community of Paradise, CA. The burning of plastic pipes, wiring, construction materials, paint, and car batteries released toxic chemicals into the environment, contaminating the air, soil, and local waterways. Examples of toxins that were identified in the creeks and waterways in and around Paradise included pentachlorophenol (PCP), chrysene, and polyaromatic hydrocarbons. The effects of some of these chemicals on embryonic development, hematopoiesis (blood formation), and the immune system have not been thoroughly studied. Defining safe levels and the long-term effects of exposure is imperative to understanding and mitigating potential negative future outcomes. To perform these studies, we utilized zebrafish (Danio rerio), a commonly used vertebrate model system to study development. We observed the adverse effects of PCP on the development of zebrafish by using fluorescence microscopy, and saw that increased concentrations of PCP decreased the numbers of normal red blood cells and myeloid cells. Additionally, we observed that animal survival decreased in response to increasing concentrations of PCP. Furthermore, the prevalence of characteristic physical deformities such as tail curvature were greater in the treatment groups. Lastly, runx1, cmyb, and cd41 expression was reduced in fish treated with PCP. These results suggest that PCP has a previously underappreciated effect on blood and immune cell development and future studies should be performed to determine the molecular mechanisms involved.	[Namit, Aleeza; Dowell, William; Stachura, David L.] Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA; [Matiasek, Sandrine] Calif State Univ Chico, Dept Geol & Environm Sci, Chico, CA USA; [Webster, Jackson] Calif State Univ Chico, Dept Civil Engn, Chico, CA USA	California State University System; California State University Chico; California State University System; California State University Chico; California State University System; California State University Chico	Stachura, DL (corresponding author), Calif State Univ Chico, Dept Biol Sci, Chico, CA 95929 USA.	dstachura@csuchico.edu		Stachura, David/0000-0002-8993-0938				ALADHAMI MA, 1977, DEV GROWTH DIFFER, V19, P171; Bertrand JY, 2007, DEVELOPMENT, V134, P4147, DOI 10.1242/dev.012385; Bertrand JY, 2010, NATURE, V464, P108, DOI 10.1038/nature08738; Cassar S, 2020, CHEM RES TOXICOL, V33, P95, DOI 10.1021/acs.chemrestox.9b00335; Chen MJ, 2012, CELL STEM CELL, V10, P345, DOI 10.1016/j.stem.2012.02.002; Cooper GS, 2008, ENVIRON HEALTH PERSP, V116, P1001, DOI 10.1289/ehp.11081; Daniel V, 2001, ARCH ENVIRON HEALTH, V56, P77, DOI 10.1080/00039890109604057; DETRICH HW, 1995, P NATL ACAD SCI USA, V92, P10713, DOI 10.1073/pnas.92.23.10713; Frame JM, 2017, METHOD CELL BIOL, V138, P165, DOI 10.1016/bs.mcb.2016.08.004; Gore AV, 2018, WIRES DEV BIOL, V7, DOI 10.1002/wdev.312; Goss M, 2020, ENVIRON RES LETT, V15, DOI 10.1088/1748-9326/ab83a7; Hewitt F, 2017, CHEMOSPHERE, V173, P580, DOI 10.1016/j.chemosphere.2016.12.079; Isaacson KP, 2021, ENVIRON SCI-WAT RES, V7, P274, DOI [10.1039/D0EW00836B, 10.1039/d0ew00836b]; Kalev-Zylinska ML, 2002, DEVELOPMENT, V129, P2015; Kissa K, 2010, NATURE, V464, P112, DOI 10.1038/nature08761; Kushnir Y, 2002, GEOPHYS RES LETT, V29, DOI 10.1029/2002GL015874; Lonnermark A, 2006, CHEMOSPHERE, V62, P1043, DOI 10.1016/j.chemosphere.2005.05.002; Massawe R, 2017, TOXICOL MECH METHOD, V27, P223, DOI 10.1080/15376516.2016.1275906; McAllister KA, 1996, BIODEGRADATION, V7, P1, DOI 10.1007/BF00056556; Proudfoot Alex T., 2003, Toxicological Reviews, V22, P3; Radeloff VC, 2005, ECOL APPL, V15, P799, DOI 10.1890/04-1413; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ruokojarvi P, 2000, CHEMOSPHERE, V41, P825, DOI 10.1016/S0045-6535(99)00549-4; Simms LA, 2021, J ENVIRON SCI, V103, P135, DOI 10.1016/j.jes.2020.10.003; Smith HG, 2011, J HYDROL, V396, P170, DOI 10.1016/j.jhydrol.2010.10.043; Stachura DL, 2016, METHOD CELL BIOL, V133, P11, DOI 10.1016/bs.mcb.2016.03.022; Stec AA, 2019, CHEMOSPHERE, V226, P576, DOI 10.1016/j.chemosphere.2019.03.153; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; U.S. Environmental Protection Agency (EPA), 1999, INT RISK INF SYST IR; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Xu T, 2016, SCI REP-UK, V6, DOI 10.1038/srep25929; Yu LQ, 2014, ENVIRON TOXICOL CHEM, V33, P170, DOI 10.1002/etc.2408; Zheng WW, 2011, ENVIRON SCI TECHNOL, V45, P4668, DOI 10.1021/es1043563	33	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265618	10.1371/journal.pone.0265618	http://dx.doi.org/10.1371/journal.pone.0265618			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333877	Green Published, gold			2022-12-26	WOS:000784335700039
J	Yang, Y; Liu, HY				Yang, Yang; Liu, Haiyan			Sensitivity analysis of disease-information coupling propagation dynamics model parameters	PLOS ONE			English	Article							SYSTEMS; OUTPUT	The disease-information coupling propagation dynamics model is a widely used model for studying the spread of infectious diseases in society, but the parameter settings and sensitivity are often overlooked, which leads to enlarged errors in the results. Exploring the influencing factors of the disease-information coupling propagation dynamics model and identifying the key parameters of the model will help us better understand its coupling mechanism and make accurate recommendations for controlling the spread of disease. In this paper, Sobol global sensitivity analysis algorithm is adopted to conduct global sensitivity analysis on 6 input parameters (different cross regional jump probabilities, information dissemination rate, information recovery rate, epidemic transmission rate, epidemic recovery rate, and the probability of taking preventive actions) of the disease-information coupling model with the same interaction radius and heterogeneous interaction radius. The results show that: (1) In the coupling model with the same interaction radius, the parameters that have the most obvious influence on the peak density of nodes in state A(I) and the information dissemination scale of the information are the information dissemination rate beta(I) and the information recovery rate mu(I). In the coupling model of heterogeneous interaction radius, the parameters that have the most obvious impact on the peak density of nodes in the A(I) state of the information layer are: information spread rate beta(I), disease recovery rate mu(E), and the parameter that has a significant impact on the scale of information spread is the information spread rate beta(I) and information recovery rate mu(I). (2) Under the same interaction radius and heterogeneous interaction radius, the parameters that have the most obvious influence on peak density of nodes in state S-E and the disease transmission scale of the disease layer are the disease transmission rate beta(E), the disease recovery rate mu(E), and the probability of an individual moving across regions p(jump).	[Liu, Haiyan] China Univ Geosci Beijing, Sch Econ & Management, Beijing, Peoples R China	China University of Geosciences	Liu, HY (corresponding author), China Univ Geosci Beijing, Sch Econ & Management, Beijing, Peoples R China.	liuhy@cugb.edu.cn			National Natural Science Foundation of China [71673256]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 71673256).	Archer GEB, 1997, J STAT COMPUT SIM, V58, P99, DOI 10.1080/00949659708811825; Beaudouin R, 2008, ECOL MODEL, V218, P29, DOI 10.1016/j.ecolmodel.2008.06.033; CUKIER RI, 1973, J CHEM PHYS, V59, P3873, DOI 10.1063/1.1680571; Dancik GM, 2010, J THEOR BIOL, V262, P398, DOI 10.1016/j.jtbi.2009.10.007; Fonoberova M, 2013, RELIAB ENG SYST SAFE, V118, P8, DOI 10.1016/j.ress.2013.04.004; Fonoberova M, 2012, JASSS-J ARTIF SOC S, V15, DOI 10.18564/jasss.1921; Happe K., 2005, 11 INT C EAAE COP DE; Huang YH, 2016, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2016/10/103501; Hunter W.G, 2005, STAT EXPERIMENTERS D, V2nd; IMAN RL, 1988, RISK ANAL, V8, P71, DOI 10.1111/j.1539-6924.1988.tb01155.x; Luo Yue, 2018, Journal of Zhejiang University (Engineering Science), V52, P2007, DOI 10.3785/j.issn.1008-973X.2018.10.021; Perez L, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-50; Ren Qiwei, 2010, Acta Scientiarum Naturalium Universitatis Sunyatseni, V49, P127; Saltelli A, 1999, TECHNOMETRICS, V41, P39, DOI 10.2307/1270993; SALTELLI A, 1992, COMPUT STAT DATA AN, V13, P73, DOI 10.1016/0167-9473(92)90155-9; Saltelli A., 2008, GLOBAL SENSITIVITY A; Saltelli A, 2010, COMPUT PHYS COMMUN, V181, P259, DOI 10.1016/j.cpc.2009.09.018; Savolainen J, 2013, SIMUL MODEL PRACT TH, V36, P1, DOI 10.1016/j.simpat.2013.04.003; Segovia-Juarez JL, 2004, J THEOR BIOL, V231, P357, DOI 10.1016/j.jtbi.2004.06.031; Sobol IM, 2010, COMPUT PHYS COMMUN, V181, P1212, DOI 10.1016/j.cpc.2010.03.006; Sobol' I. M., 1967, Zhurnal Vychislitel'noi Matematiki i Matematicheskoi Fiziki, V7, P784; Sobol I. M., 1976, USSR COMP MATH MATH, V16, DOI [10.1016/0041-5553(76)90154-3, DOI 10.1016/0041-5553(76)90154-3]; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Song JW, 2015, P I MECH ENG O-J RIS, V229, P237, DOI 10.1177/1748006X15578571; Yang Y, 2021, CMC-COMPUT MATER CON, V67, P3311, DOI 10.32604/cmc.2021.014628; Zhang QC, 2020, INT J AUTOM COMPUT, V17, P83, DOI 10.1007/s11633-019-1193-8; Zhang QC, 2017, IEEE T AUTOMAT CONTR, V62, P2936, DOI 10.1109/TAC.2016.2604683; Zhou CC, 2017, J ENG MECH, V143, DOI 10.1061/(ASCE)EM.1943-7889.0001373	28	0	0	6	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265273	10.1371/journal.pone.0265273	http://dx.doi.org/10.1371/journal.pone.0265273			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333868	gold, Green Published			2022-12-26	WOS:000784335700008
J	Pattanaik, B; Hammarlund, M; Mjornstedt, F; Ulleryd, MA; Zhong, W; Uhlen, M; Gummesson, A; Bergstrom, G; Johansson, ME				Pattanaik, Bagmi; Hammarlund, Maria; Mjornstedt, Filip; Ulleryd, Marcus A.; Zhong, Wen; Uhlen, Mathias; Gummesson, Anders; Bergstrom, Goran; Johansson, Maria E.			Polymorphisms in alpha 7 nicotinic acetylcholine receptor gene, CHRNA7, and its partially duplicated gene, CHRFAM7A, associate with increased inflammatory response in human peripheral mononuclear cells	FASEB JOURNAL			English	Article						alpha 7 nicotinic acetylcholine receptor; CHRFAM7A; CHRNA7; immune response; inflammation; polymorphisms; alpha 7nAChR	CHOLINERGIC ANTIINFLAMMATORY PATHWAY; VAGUS NERVE-STIMULATION; CYTOKINE PRODUCTION; EXPRESSION; SUBUNIT; DISEASE; MODULATION; REGULATOR; SEVERITY; VARIANT	The vagus nerve can, via the alpha 7 nicotinic acetylcholine receptor (alpha 7nAChR), regulate inflammation. The gene coding for the alpha 7nAChR, CHRNA7, can be partially duplicated, that is, CHRFAM7A, which is reported to impair the anti-inflammatory effect mediated via the alpha 7nAChR. Several single nucleotide polymorphisms (SNPs) have been described in both CHRNA7 and CHRFAM7A, however, the functional role of these SNPs for immune responses remains to be investigated. In the current study, we set out to investigate whether genetic variants of CHRNA7 and CHRFAM7A can influence immune responses. By investigating data available from the Swedish SciLifeLab SCAPIS Wellness Profiling (S3WP) study, in combination with droplet digital PCR and freshly isolated PBMCs from the S3WP participants, challenged with lipopolysaccharide (LPS), we show that CHRNA7 and CHRFAM7A are expressed in human PBMCs, with approximately four times higher expression of CHRFAM7A compared with CHRNA7. One SNP in CHRFAM7A, rs34007223, is positively associated with hsCRP in healthy individuals. Furthermore, gene ontology (GO)-terms analysis of plasma proteins associated with gene expression of CHRNA7 and CHRFAM7A demonstrated an involvement for these genes in immune responses. This was further supported by in vitro data showing that several SNPs in both CHRNA7 and CHRFAM7A are significantly associated with cytokine response. In conclusion, genetic variants of CHRNA7 and CHRFAM7A alters cytokine responses. Furthermore, given that CHRFAM7A SNP rs34007223 is associated with inflammatory marker hsCRY in healthy individuals suggests that CHRFAM7A may have a more pronounced role in regulating inflammatory processes in humans than previously been recognized.	[Pattanaik, Bagmi; Hammarlund, Maria; Mjornstedt, Filip; Ulleryd, Marcus A.; Johansson, Maria E.] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden; [Zhong, Wen; Uhlen, Mathias] KTH Royal Inst Technol, Dept Prot Sci, Sci Life Lab, Stockholm, Sweden; [Gummesson, Anders; Bergstrom, Goran] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab Cardiovasc & Metab Res, Gothenburg, Sweden	University of Gothenburg; Royal Institute of Technology; University of Gothenburg	Johansson, ME (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Physiol, Box 432, S-40530 Gothenburg, Sweden.	maria.e.johansson@neuro.gu.se		Johansson, Maria/0000-0002-2569-2977	Swedish Research Council; Swedish Heart-Lung Foundation; Swedish Stroke Association; Mary von Sydow foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells foundation; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Swedish government; ALF [ALF GBG-723131]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Swedish Stroke Association; Mary von Sydow foundation; Stiftelsen Langmanska kulturfonden; Stiftelsen Gamla tjanarinnor; OE and Edla Johanssons vetenskapliga stiftelse; Stiftelsen Tornspiran; Emil and Wera Cornells foundation; Dr. Felix Neuberghs Foundation; Emelle Foundation; Wilhelm and Martina Lundgren foundation; Swedish government; ALF	The authors thank the data analysis support from the Bioinformatics Core Facility at Sahlgrenska Academy and National bioinformatics infrastructure Sweden (NBIS). This work was supported by the FSwedish Research Council, the Swedish Heart-Lung Foundation, The Swedish Stroke Association, Mary von Sydow foundation, Stiftelsen Langmanska kulturfonden, Stiftelsen Gamla tjanarinnor, OE and Edla Johanssons vetenskapliga stiftelse, Stiftelsen Tornspiran, Emil and Wera Cornells foundation, Dr. Felix Neuberghs Foundation, Emelle Foundation, Wilhelm and Martina Lundgren foundation and grants from the Swedish state under the agreement between the Swedish government and the county councils, the ALF-agreement (ALF GBG-723131).	Araud T, 2011, BIOCHEM PHARMACOL, V82, P904, DOI 10.1016/j.bcp.2011.06.018; Baird A, 2016, BBA CLIN, V5, P66, DOI 10.1016/j.bbacli.2015.12.003; Bergstrom G, 2015, J INTERN MED, V278, P645, DOI 10.1111/joim.12384; Bonaz B, 2016, NEUROGASTROENT MOTIL, V28, P948, DOI 10.1111/nmo.12792; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Cedillo JL, 2015, J INFECT DIS, V211, P146, DOI 10.1093/infdis/jiu425; Chan T, 2019, NEUROSCI LETT, V690, P126, DOI 10.1016/j.neulet.2018.10.010; Chang CC, 2015, GIGASCIENCE, V4, DOI 10.1186/s13742-015-0047-8; Chen XY, 2016, BIOINFORMATICS, V32, P1220, DOI 10.1093/bioinformatics/btv710; Corradi J, 2016, MOL PHARMACOL, V90, P288, DOI 10.1124/mol.116.104240; Costantini TW, 2019, P NATL ACAD SCI USA, V116, P7932, DOI 10.1073/pnas.1821853116; Costantini TW, 2015, MOL MED, V21, P323, DOI 10.2119/molmed.2015.00018; Costantini TW, 2015, J LEUKOCYTE BIOL, V97, P247, DOI 10.1189/jlb.4RU0814-381R; Courties A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-91417-7; Courties A, 2020, ARTHRITIS RHEUMATOL, V72, P2072, DOI 10.1002/art.41429; Dang XT, 2015, FASEB J, V29, P2292, DOI 10.1096/fj.14-268037; de Lucas-Cerrillo AM, 2011, J BIOL CHEM, V286, P594, DOI 10.1074/jbc.M110.180067; De Rosa MJ, 2005, J NEUROIMMUNOL, V160, P154, DOI 10.1016/j.jneuroim.2004.11.010; Feher A, 2009, DEMENT GERIATR COGN, V28, P56, DOI 10.1159/000230036; Freedman Robert, 2003, Curr Psychiatry Rep, V5, P155, DOI 10.1007/s11920-003-0032-2; Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085; Garcia-Moreno A., 2021, GENECODIS 4 EXPANDIN; Gault J, 1998, GENOMICS, V52, P173, DOI 10.1006/geno.1998.5363; Green RC, 2013, GENET MED, V15, P565, DOI 10.1038/gim.2013.73; Hammarlund ME, 2021, BIOSCIENCE REP, V41, DOI 10.1042/BSR20210736; Hong CJ, 2004, NEUROSCI LETT, V355, P69, DOI 10.1016/j.neulet.2003.10.043; Hoover DB, 2017, PHARMACOL THERAPEUT, V179, P1, DOI 10.1016/j.pharmthera.2017.05.002; Hoskin JL, 2019, NICOTINE TOB RES, V21, P370, DOI 10.1093/ntr/nty116; Hua SS, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/718769; Huang W, 2019, J NEUROTRAUM, V36, P3026, DOI 10.1089/neu.2018.6200; Huston JM, 2006, J EXP MED, V203, P1623, DOI 10.1084/jem.20052362; Iwata Y, 2007, NEUROSCI RES, V57, P194, DOI 10.1016/j.neures.2006.10.002; Jin Y, 2010, INT J IMMUNOGENET, V37, P361, DOI 10.1111/j.1744-313X.2010.00933.x; Johansson ME, 2014, ARTERIOSCL THROM VAS, V34, P2632, DOI 10.1161/ATVBAHA.114.303892; Kiss A, 2017, ACTA PHYSIOL, V221, P174, DOI 10.1111/apha.12861; Koopman FA, 2016, P NATL ACAD SCI USA, V113, P8284, DOI 10.1073/pnas.1605635113; Kuhlmann K, 2021, BIOL PROCED ONLINE, V23, DOI 10.1186/s12575-021-00144-w; Kunii Y, 2015, AM J PSYCHIAT, V172, P1122, DOI 10.1176/appi.ajp.2015.14080978; Leonard S, 2001, Nicotine Tob Res, V3, P203; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Maldifassi MC, 2018, J BIOL CHEM, V293, P13874, DOI 10.1074/jbc.RA118.003443; Maston GA, 2006, ANNU REV GENOM HUM G, V7, P29, DOI 10.1146/annurev.genom.7.080505.115623; Pena G, 2010, EUR J IMMUNOL, V40, P2580, DOI 10.1002/eji.201040540; Quik M, 2015, BIOCHEM PHARMACOL, V97, P399, DOI 10.1016/j.bcp.2015.06.014; Robert F, 2018, FRONT GENET, V9, DOI 10.3389/fgene.2018.00507; Russo P, 2017, CURR DRUG TARGETS, V18, P1179, DOI 10.2174/1389450116666151001111826; Severance EG, 2008, GENES BRAIN BEHAV, V7, P37, DOI 10.1111/j.1601-183X.2007.00323.x; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Sinkus ML, 2015, NEUROPHARMACOLOGY, V96, P274, DOI 10.1016/j.neuropharm.2015.02.006; Sinkus ML, 2009, BRAIN RES, V1291, P1, DOI 10.1016/j.brainres.2009.07.041; Stephens SH, 2009, SCHIZOPHR RES, V109, P102, DOI 10.1016/j.schres.2008.12.017; Stranneheim H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1090; Taylor SC, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02217-x; Tebani A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-18148-7; The FO, 2007, GASTROENTEROLOGY, V133, P1219, DOI 10.1053/j.gastro.2007.07.022; Ulleryd MA, 2019, ATHEROSCLEROSIS, V287, P122, DOI 10.1016/j.atherosclerosis.2019.06.903; van der Zanden EP, 2012, NEUROIMMUNOMODULAT, V19, P255, DOI 10.1159/000335185; Van Westerloo DJ, 2006, GASTROENTEROLOGY, V130, P1822, DOI 10.1053/j.gastro.2006.02.022; Villiger Y, 2002, J NEUROIMMUNOL, V126, P86, DOI 10.1016/S0165-5728(02)00057-7; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Weng PH, 2016, SCI REP-UK, V6, DOI 10.1038/srep27231; Weng PH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084059; Yang L, 2015, EUR J HUM GENET, V23, P1019, DOI 10.1038/ejhg.2014.229; Zhong W, 2020, GENOME MED, V12, DOI 10.1186/s13073-020-00755-0; Zoheir N, 2012, INFLAMM RES, V61, P915, DOI 10.1007/s00011-012-0513-z	65	2	2	2	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22271	10.1096/fj.202101898R	http://dx.doi.org/10.1096/fj.202101898R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ9SE	35344211				2022-12-26	WOS:000773602400001
J	Anan, I; Suhr, OB; Liszewska, K; Baranda, JM; Pilebro, B; Wixner, J; Ihse, E				Anan, Intissar; Suhr, Ole B.; Liszewska, Katarzyna; Baranda, Jorge Mejia; Pilebro, Bjorn; Wixner, Jonas; Ihse, Elisabet			Amyloid fibril composition type is consistent over time in patients with Val30Met (p.Val50Met) transthyretin amyloidosis	PLOS ONE			English	Article							LIVER-TRANSPLANTATION; POLYNEUROPATHY; ONSET; MECHANISM; DEPOSITS; AGE	Background We have previously shown that transthyretin (TTR) amyloidosis patients have amyloid fibrils of either of two compositions; type A fibrils consisting of large amounts of C-terminal TTR fragments in addition to full-length TTR, or type B fibrils consisting of only full-length TTR. Since type A fibrils are associated with an older age in ATTRVal30Met (p.Val50Met) amyloidosis patients, it has been discussed if the TTR fragments are derived from degradation of the amyloid deposits as the patients are aging. The present study aimed to investigate if the fibril composition type changes over time, especially if type B fibrils can shift to type A fibrils as the disease progresses. Material and methods Abdominal adipose tissue biopsies from 29 Swedish ATTRVal30Met amyloidosis patients were investigated. The fibril type in the patients initial biopsy taken for diagnostic purposes was compared to a biopsy taken several years later (ranging between 2 and 13 years). The fibril composition type was determined by western blot. Results All 29 patients had the same fibril composition type in both the initial and the follow-up biopsy (8 type A and 21 type B). Even patients with a disease duration of more than 12 years and an age over 75 years at the time of the follow-up biopsy had type B fibrils in both biopsies. Discussion The result clearly shows that the amyloid fibril composition containing large amounts of C-terminal fragments (fibril type A) is a consequence of other factors than a slow degradation process occurring over time.	[Anan, Intissar; Suhr, Ole B.; Pilebro, Bjorn; Wixner, Jonas] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden; [Anan, Intissar] Umea Univ, Wallenberg Ctr Mol Med, Umea, Sweden; [Liszewska, Katarzyna; Baranda, Jorge Mejia] Pitea Hosp, Dept Med, Pitea, Sweden; [Ihse, Elisabet] Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden	Umea University; Umea University; Uppsala University	Ihse, E (corresponding author), Uppsala Univ, Dept Immunol Genet & Pathol, Uppsala, Sweden.	elisabet.ihse@igp.uu.se			FAMYNorrbotten, FAMY-Vasterbotten och the AMYL foundation; Erik, Karin and Gosta Selanders Foundation; P.O. Zetterling Foundation; Swedish Heart and Lung foundation [20160787]; Swedish Research Council [2019-01338]; Region of Vasterbotten; Knut and Alice Wallenberg foundation	FAMYNorrbotten, FAMY-Vasterbotten och the AMYL foundation; Erik, Karin and Gosta Selanders Foundation; P.O. Zetterling Foundation; Swedish Heart and Lung foundation(Swedish Heart-Lung Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Region of Vasterbotten; Knut and Alice Wallenberg foundation(Knut & Alice Wallenberg Foundation)	This work was supported by: FAMYNorrbotten, FAMY-Vasterbotten och the AMYL foundation, https://www.famy.se/and https://www.famynorrbotten.se/sv-SE (IA, EI, OBS); Erik, Karin and Gosta Selanders Foundation, https://www.stiftelsemedel.se/erik-karin-och-gsta-selanders-stiftelse/(EI); the P.O. Zetterling Foundation, https://www.uaf.se/stiftelse/?s=91271 (EI); Swedish Heart and Lung foundation, grant no. 20160787, https://www3.hjart-lungfonden.se/(OBS); the Swedish Research Council, grant no. 2019-01338, https://www.vr.se (JW, BP, IA); the Knut and Alice Wallenberg foundation, https://kaw.wallenberg.org/(IA); Research grants from the Region of Va<spacing diaeresis>sterbotten, https://regionvasterbotten.se/forskninghttp-adress (JW, BP, IA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves-Ferreira M, 2018, MOL NEUROBIOL, V55, P3676, DOI 10.1007/s12035-017-0593-4; Bergstrom J, 2005, J PATHOL, V206, P224, DOI 10.1002/path.1759; Bergstrom J, 2004, LAB INVEST, V84, P981, DOI 10.1038/labinvest.3700124; Buxbaum JN, 2009, CELL MOL LIFE SCI, V66, P3095, DOI 10.1007/s00018-009-0109-0; Conceicao I, 2016, J PERIPHER NERV SYST, V21, P5, DOI 10.1111/jns.12153; Ericzon BG, 2015, TRANSPLANTATION, V99, P1847, DOI 10.1097/TP.0000000000000574; Gustafsson S, 2012, TRANSPLANTATION, V93, P1017, DOI 10.1097/TP.0b013e31824b3749; Hou X, 2007, FEBS J, V274, P1637, DOI 10.1111/j.1742-4658.2007.05712.x; Ihse E, 2008, J PATHOL, V216, P253, DOI 10.1002/path.2411; Ihse E, 2013, AMYLOID, V20, P142, DOI 10.3109/13506129.2013.797890; Ihse E, 2011, J MOL MED, V89, P171, DOI 10.1007/s00109-010-0695-1; Koike H, 2004, NEUROLOGY, V63, P129, DOI 10.1212/01.WNL.0000132966.36437.12; Koike H, 2002, ARCH NEUROL-CHICAGO, V59, P1771, DOI 10.1001/archneur.59.11.1771; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Marcoux J, 2015, EMBO MOL MED, V7, P1337, DOI 10.15252/emmm.201505357; Oshima T, 2014, J NEUROL NEUROSUR PS, V85, P740, DOI 10.1136/jnnp-2013-305973; Plante-Bordeneuve V, 2019, EXPERT OPIN PHARMACO, V20, P473, DOI 10.1080/14656566.2018.1554648; Rossi M, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11040309; Rowczenio DM, 2014, HUM MUTAT, V35, pE2403, DOI 10.1002/humu.22619; Santos D, 2018, J NEUROL NEUROSUR PS, V89, P300, DOI 10.1136/jnnp-2017-316657; Schmidt M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13038-z; Soares ML, 2005, HUM MOL GENET, V14, P543, DOI 10.1093/hmg/ddi051; Suhr OB, 2006, AMYLOID, V13, P154, DOI 10.1080/13506120600876849; Ueda M, 2019, J BIOL CHEM, V294, P11259, DOI 10.1074/jbc.RA119.007851; Verona G, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00338-x; Westermark GT, 2018, METHODS MOL BIOL, V1779, P401, DOI 10.1007/978-1-4939-7816-8_24; Westermark GT, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a024323; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P2843, DOI 10.1073/pnas.87.7.2843; Westermark P, 2005, FEBS J, V272, P5942, DOI 10.1111/j.1742-4658.2005.05024.x; Westermark P, 2012, METHODS MOL BIOL, V849, P363, DOI 10.1007/978-1-61779-551-0_24	30	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266092	10.1371/journal.pone.0266092	http://dx.doi.org/10.1371/journal.pone.0266092			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358243	Green Published, gold			2022-12-26	WOS:000799828800066
J	Hidrus, A; Kueh, YC; Norsa'adah, B; Kim, Y; Chang, YK; Kuan, G				Hidrus, Aizuddin; Kueh, Yee Cheng; Norsa'adah, Bachok; Kim, YoungHo; Chang, Yu-Kai; Kuan, Garry			Structural equation model of psychological constructs of transtheoretical model, motives for physical activity, and amount of physical activity among people with type 2 diabetes mellitus in Malaysia	PLOS ONE			English	Article							SELF-EFFICACY; EXERCISE BEHAVIOR; BODY-COMPOSITION; ADULTS; MOTIVATION; BARRIERS; MEN; ADOLESCENTS; MAINTENANCE; PREDICTORS	Background This study aimed determine the structural relationship between psychological constructs of the transtheoretical model (TTM; processes of change, decisional balance, and exercise self-efficacy), motives for physical activity (PA), and amount of PA among Malaysians with type 2 diabetes mellitus (T2DM). Method All participants were recruited from the Hospital Universiti Sains Malaysia using a cross-sectional study design with purposive) sampling method. A total of 331 participants were recruited for the present study. Before participation in the study, they were informed that participation in the study was totally voluntary. Those who agreed to participate voluntarily were required to complete the self-administered questionnaire set, which included the processes of change, decisional balance, exercise self-efficacy, physical activity and leisure motivation, and international physical activity questionnaires. Data analysis of structural equation modeling was performed using Mplus 8. Results From the 331 participants, most of whom were male (52%) and Malay (89.4%), with a mean age of 62.6 years (standard deviation = 10.29). The final structural equation model fit the data well based on several fit indices [Root Mean Square Error of Approximation (RMSEA) = 0.059, Comparative Fit Index (CFI) = 0.953, Tucker-Lewis Index (TLI) = 0.925, Standardized Root Mean Square Residual (SRMR) = 0.031]. A total of 16 significant path relationships linked between the TTM, motives for PA, and amount of PA. Conclusion The pros of decisional balance, others' expectations, and psychological condition were constructs that directly affected PA, whereas the other constructs had a significant indirect relationship with the amount of PA. A positive mindset is crucial in deciding a behavioral change toward an active lifestyle in people with T2DM.	[Hidrus, Aizuddin; Kueh, Yee Cheng; Norsa'adah, Bachok] Univ Sains Malaysia, Sch Med Sci, Biostat & Res Methodol Unit, Kubang Kerian, Kelantan, Malaysia; [Hidrus, Aizuddin] Univ Malaysia Sabah, Fac Med & Hlth Sci, Publ Hlth Med Dept, Kota Kinabalu, Sabah, Malaysia; [Kueh, Yee Cheng] Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia; [Kim, YoungHo] Seoul Natl Univ Sci & Technol, Dept Sport Sci, Seoul, South Korea; [Chang, Yu-Kai] Natl Taiwan Normal Univ, Dept Phys Educ & Sport Sci, Taipei, Taiwan; [Chang, Yu-Kai] Natl Taiwan Normal Univ, Inst Res Excellence Learning Sci, Taipei, Taiwan; [Kuan, Garry] Univ Sains Malaysia, Sch Hlth Sci, Exercise & Sports Sci, Kubang Kerian, Kelantan, Malaysia; [Kuan, Garry] Brunel Univ London, Dept Life Sci, London, England	Universiti Sains Malaysia; Universiti Malaysia Sabah; Universiti Sains Malaysia; Seoul National University of Science & Technology; National Taiwan Normal University; National Taiwan Normal University; Universiti Sains Malaysia; Brunel University	Hidrus, A; Kueh, YC; Norsa'adah, B (corresponding author), Univ Sains Malaysia, Sch Med Sci, Biostat & Res Methodol Unit, Kubang Kerian, Kelantan, Malaysia.; Hidrus, A (corresponding author), Univ Malaysia Sabah, Fac Med & Hlth Sci, Publ Hlth Med Dept, Kota Kinabalu, Sabah, Malaysia.; Kueh, YC (corresponding author), Hosp Univ Sains Malaysia, Kubang Kerian, Kelantan, Malaysia.; Kuan, G (corresponding author), Univ Sains Malaysia, Sch Hlth Sci, Exercise & Sports Sci, Kubang Kerian, Kelantan, Malaysia.; Kuan, G (corresponding author), Brunel Univ London, Dept Life Sci, London, England.	aizuddin88@ums.edu.my; yckueh@usm.my; norsaadah@usm.my; garry@usm.my	Hidrus, Aizuddin/Q-6264-2018; Kueh, Yee Cheng/N-3991-2015	Hidrus, Aizuddin/0000-0002-1524-541X; Kueh, Yee Cheng/0000-0003-2125-7297	Ministry of Higher Education Malaysia [FRGS/1/2020/SKK06/USM/03/1]	Ministry of Higher Education Malaysia(Ministry of Education, Malaysia)	Yee Cheng Kueh has received the Ministry of Higher Education Malaysia for Fundamental Research Grant Scheme (FRGS) with Project Code: FRGS/1/2020/SKK06/USM/03/1 (Funder website: https://www.mohe.gov.my/en/services/research/mygrants).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaltonen S, 2012, INT J SPORTS MED, V33, P157, DOI 10.1055/s-0031-1287848; Adeniyi AF, 2012, ETHIOP J HEALTH SCI, V22, P113; Ainsworth BE, 2012, PHYSICAL ACTIVITY AND PUBLIC HEALTH PRACTICE, pVII; American Diabetes Association, 2021, TYPE 2 DIABETES; Andre N, 2012, J AGING PHYS ACTIV, V20, P231, DOI 10.1123/japa.20.2.231; Baert V, 2011, AGEING RES REV, V10, P464, DOI 10.1016/j.arr.2011.04.001; BANDURA A, 1977, PSYCHOL REV, V84, P191, DOI 10.1037/0033-295X.84.2.191; Bandura A., 1997, SELF EFFICACY EXERCI; Barlow J, 2002, PATIENT EDUC COUNS, V48, P177, DOI 10.1016/S0738-3991(02)00032-0; Beekman E, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-71; Benitez TJTNCKKC., 2017, J HLTH DISPARITIES R, V10, P20; Burkholder GJ, 2003, STRUCT EQU MODELING, V10, P465, DOI 10.1207/S15328007SEM1003_8; Burkholder GJ., 2002, OVERVIEW TRANSTHEORE, P57; Chouinard Maud-Christine, 2005, Nurs Res, V54, P243; Chu AHY, 2015, ASIA-PAC J PUBLIC HE, V27, pNP2381, DOI 10.1177/1010539512444120; Church TS, 2004, DIABETES CARE, V27, P83, DOI 10.2337/diacare.27.1.83; Ferrand C, 2008, HEALTH SOC CARE COMM, V16, P511, DOI 10.1111/j.1365-2524.2008.00773.x; Fletcher GF, 1996, CIRCULATION, V94, P857, DOI 10.1161/01.CIR.94.4.857; Glanz K, 2008, HLTH BEHAV HLTH ED T, DOI 10.1007/s12160-008-9042-y; Gould D, 2002, J APPL SPORT PSYCHOL, V14, P172, DOI 10.1080/10413200290103482; Hair J., 2010, MULTIVARIATE DATA AN, V7; Hidrus A, 2020, MALAYS J MED SCI, V27, P125, DOI 10.21315/mjms2020.27.3.13; Hidrus A, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17030922; Jahan H. R., 2017, Asian Journal of Sports Medicine, V8, pe13736, DOI 10.5812/asjsm.13736; Karstoft K, 2013, DIABETES CARE, V36, P228, DOI 10.2337/dc12-0658; Kim YH, 2010, J EXERC SCI FIT, V8, P97, DOI 10.1016/S1728-869X(10)60015-9; Kim YH, 2007, INT J NURS STUD, V44, P936, DOI 10.1016/j.ijnurstu.2006.03.008; Kim YI, 2021, INT J PROD RES, V59, P5236, DOI 10.1080/00207543.2020.1775910; Kirk A, 2010, PSYCHOL SPORT EXERC, V11, P320, DOI 10.1016/j.psychsport.2010.03.001; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Kokkinos P, 2010, CIRCULATION, V122, P1637, DOI 10.1161/CIRCULATIONAHA.110.948349; Korkiakangas E, 2011, HEALTH SOC CARE COMM, V19, P15, DOI 10.1111/j.1365-2524.2010.00942.x; Kosma M, 2012, DISABIL HEALTH J, V5, P1, DOI 10.1016/j.dhjo.2011.09.002; Kuan G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0230644; Kueh YC, 2019, INT J SPORT EXERC PS, V17, P250, DOI 10.1080/1612197X.2017.1321029; Liu KT, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02402; Maddison R, 2006, PEDIATR EXERC SCI, V18, P351, DOI 10.1123/pes.18.3.351; MARCUS BH, 1992, HEALTH PSYCHOL, V11, P386, DOI 10.1037/0278-6133.11.6.386; Mastellos N, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008066.pub3; Middelkamp PJC., 2017, TRANSTHEORETICAL MOD; Molanorouzi K, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-909; Napolitano MA, 2008, HEALTH PSYCHOL, V27, P409, DOI 10.1037/0278-6133.27.4.409; Nigg C., 1999, ANN BEHAV MED, V21, pS79; Pinto BM, 2015, J CARDIOPULM REHABIL, V35, P13, DOI 10.1097/HCR.0000000000000065; Pinto BM, 2013, HEALTH PSYCHOL, V32, P616, DOI 10.1037/a0029886; Plotnikoff R. C., 2001, Measurement in Physical Education and Exercise Science, V5, P191, DOI 10.1207/S15327841MPEE0504_01; Plotnikoff RC, 2010, ANN BEHAV MED, V40, P138, DOI 10.1007/s12160-010-9193-5; Raaijmakers LGM, 2014, PATIENT EDUC COUNS, V97, P75, DOI 10.1016/j.pec.2014.06.016; Rogers H., 2003, NEW APPROACHES EXERC; Romain AJ, 2018, AM J HEALTH PROMOT, V32, P16, DOI 10.1177/0890117116686900; Sabo A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0215698; Shah KN, 2016, HEALTH PSYCHOL, V35, P563, DOI 10.1037/hea0000311; Shin Y, 2001, RES NURS HEALTH, V24, P68, DOI 10.1002/1098-240X(200102)24:1<68::AID-NUR1008>3.3.CO;2-3; Sigal RJ, 2004, DIABETES CARE, V27, P2518, DOI 10.2337/diacare.27.10.2518; Wang J., 2019, STRUCTURAL EQUATION, V2nd ed.; Wei M, 2000, ANN INTERN MED, V132, P605, DOI 10.7326/0003-4819-132-8-200004180-00002; Wilson PM, 2008, CAN PSYCHOL, V49, P250, DOI 10.1037/a0012762; Xiong S., 2017, JTRM KINESIOLOGY, P1; Yuan KH, 2000, SOCIOL METHODOL, V30, P165, DOI 10.1111/0081-1750.00078	59	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266104	10.1371/journal.pone.0266104	http://dx.doi.org/10.1371/journal.pone.0266104			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358248	Green Published, gold			2022-12-26	WOS:000799828800070
J	Liu, YP; Chen, ZH; Kang, LL; He, RX; Song, JQ; Liu, Y; Shi, CY; Chen, JY; Dong, H; Zhang, Y; Ma, YY; Wu, TF; Wang, Q; Ding, Y; Li, XY; Li, DX; Li, MQ; Jin, Y; Qin, J; Yang, YL				Liu, Yupeng; Chen, Zhehui; Kang, Lulu; He, Ruxuan; Song, Jinqing; Liu, Yi; Shi, Chunyan; Chen, Junya; Dong, Hui; Zhang, Yao; Ma, Yanyan; Wu, Tongfei; Wang, Qiao; Ding, Yuan; Li, Xiyuan; Li, Dongxiao; Li, Mengqiu; Jin, Ying; Qin, Jiong; Yang, Yanling			Comparing amniotic fluid mass spectrometry assays and amniocyte gene analyses for the prenatal diagnosis of methylmalonic aciduria	PLOS ONE			English	Article							INBORN-ERRORS; ACIDEMIA; METABOLISM; HOMOCYSTEINE; DISORDERS	Background Methylmalonic aciduria (MMA), a rare inherited disorder, is the most common organic aciduria in China, and prenatal diagnosis has contributed to its prevention. However, the prenatal diagnosis of MMA using cultured amniocytes or chorionic villi to detect gene mutations is exclusively applicable to families with a definite genetic diagnosis. To evaluate the reliability of mass spectrometry assays for the prenatal diagnosis of MMA, we conducted a retrospective study of our 10 years' experience. Materials and methods This retrospective compare study reviewed the medical records for maternal and fetuses data for 287 mothers with a family history of MMA from June 2010 to December 2020. Methylmalonate and propionylcarnitine in cell-free amniotic fluid were measured using a stable isotope dilution method (GC/MS) and MS/MS-based method (LC/MS/MS). Total homocysteine (tHcy) was measured by fluorescence polarization immunoassay. Depending on the presence of disease-causing gene mutations in probands, gene studies on amniocytes from 222 pregnant women were performed. Results For 222 fetuses of the families with definite genetic diagnosis, gene analyses were performed using cultured amniocytes. 52 fetuses were affected by MMA, whereas 170 were "unaffected". For GC/MS and LC/MS/MS, the specificity was 96.5% and 95.9%, sensitivity was 71.2% and 84.6%, respectively. The positive and negative predictive values were 86.0% and 91.6% and 86.3% and 95.3%, respectively. Propionylcarnitine/butyrylcarnitine ratio showed the highest accuracy and could thus serve as a sensitive indicator to identify those at a risk for MMA. When GC/MS and LC/MS/MS were performed in parallel, the specificity was 92.5% and sensitivity was 95.6%. When evaluating tHcy, the positive and negative predictive values were 95.0% and 96.1%, respectively. In 65 fetuses without family genetic diagnosis, 11 were finally confirmed to have MMA and 54 were "unaffected" by amniotic fluid biochemical assays. The 54 children showed normal urine organic acids and healthy development after birth. Conclusions Amniotic fluid biochemical assays using GC/MS and LC/MS/MS in parallel increased the accuracy of prenatal diagnosis of MMA. Propionylcarnitine is a more reliable marker than methylmalonic acid in amniotic fluid. Further, tHcy is recommended for the prenatal diagnosis of combined MMA and homocysteinemia.	[Liu, Yupeng; Qin, Jiong] Peking Univ Peoples Hosp, Dept Pediat, Beijing, Peoples R China; [Liu, Yupeng; Chen, Zhehui; Kang, Lulu; He, Ruxuan; Song, Jinqing; Liu, Yi; Dong, Hui; Zhang, Yao; Li, Mengqiu; Jin, Ying; Yang, Yanling] Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China; [Shi, Chunyan; Chen, Junya] Peking Univ First Hosp, Dept Gynaecol & Obstet, Beijing, Peoples R China; [Ma, Yanyan] Qinghai Univ, Dept Pediat, Affiliated Hosp, Xining, Peoples R China; [Wu, Tongfei] Capital Med Univ, Clin Lab Ctr, Beijing, Peoples R China; [Wang, Qiao; Ding, Yuan] Capital Med Univ, Beijing Childrens Hosp, Dept Endocrinol Genet & Metab, Beijing, Peoples R China; [Li, Xiyuan] Tianjin Med Univ, Dept Precise Med, Gen Hosp, Tianjin, Peoples R China; [Li, Dongxiao] Zhengzhou Univ, Childrens Hosp, Zhengzhou, Peoples R China	Peking University; Qinghai University; Capital Medical University; Capital Medical University; Tianjin Medical University; Zhengzhou University	Qin, J (corresponding author), Peking Univ Peoples Hosp, Dept Pediat, Beijing, Peoples R China.; Yang, YL (corresponding author), Peking Univ First Hosp, Dept Pediat, Beijing, Peoples R China.	qinjiong@pkuph.edu.cn; organic.acid@126.com	MA, YAN/HHN-2912-2022		National Key Research and Development Program of China [2019YFC1005100, 2017YFC1001700]; Beijing Municipal Science and Technology Commission [Z141107004414036, Z151100003915126]; Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics [2199000726]	National Key Research and Development Program of China; Beijing Municipal Science and Technology Commission(Beijing Municipal Science & Technology Commission); Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics	This project was supported by grants from the National Key Research and Development Program of China (No. 2019YFC1005100, 2017YFC1001700), and Beijing Municipal Science and Technology Commission (No. Z141107004414036, Z151100003915126), and the Foundation of 2018 Beijing Key Clinical Specialty Construction Project-Pediatrics (No. 2199000726).	Ben-Omran TI, 2007, AM J MED GENET A, V143A, P979, DOI 10.1002/ajmg.a.31671; Carrillo-Carrasco N, 2012, J INHERIT METAB DIS, V35, P103, DOI 10.1007/s10545-011-9365-x; Cavicchi C, 2006, CLIN GENET, V69, P72, DOI 10.1111/j.1399-0004.2005.00547.x; Chen T, 2021, ORPHANET J RARE DIS, V16, DOI 10.1186/s13023-021-01762-z; Coelho D, 2008, NEW ENGL J MED, V358, P1454, DOI 10.1056/NEJMoa072200; Forny P, 2021, J INHERIT METAB DIS, V44, P566, DOI 10.1002/jimd.12370; FOWLER B, 1989, J INHERIT METAB DIS, V12, P105, DOI 10.1007/BF01799290; Fraser JL, 2016, CURR OPIN PEDIATR, V28, P682, DOI 10.1097/MOP.0000000000000422; Hasegawa Y, 2005, J CHROMATOGR B, V823, P13, DOI 10.1016/j.jchromb.2005.04.020; He RX, 2020, NEUROLOGY, V95, pE3129, DOI 10.1212/WNL.0000000000010912; Hu S, 2018, BMC MED GENET, V19, DOI 10.1186/s12881-018-0666-x; Inoue Y, 2002, J CHROMATOGR B, V776, P71, DOI 10.1016/S1570-0232(02)00076-4; Inoue Y, 2011, ANAL BIOANAL CHEM, V400, P1953, DOI 10.1007/s00216-011-4805-x; JAKOBS C, 1990, PRENATAL DIAG, V10, P265, DOI 10.1002/pd.1970100410; Ji X, 2019, PRENATAL DIAG, V39, P993, DOI 10.1002/pd.5519; Kang LL, 2020, J INHERIT METAB DIS, V43, P409, DOI 10.1002/jimd.12183; Kimura H, 1999, TOHOKU J EXP MED, V188, P317, DOI 10.1620/tjem.188.317; Liu MY, 2012, JIMD REP, V6, P55, DOI 10.1007/8904_2011_117; Liu Y, 2018, Zhonghua Er Ke Za Zhi, V56, P414, DOI 10.3760/cma.j.issn.0578-1310.2018.06.003; LUO HY, 1984, CHINESE MED J-PEKING, V97, P7; Ma XW, 2011, BRAIN DEV-JPN, V33, P790, DOI 10.1016/j.braindev.2011.06.001; Morel CF, 2005, MOL GENET METAB, V86, P160, DOI 10.1016/j.ymgme.2005.07.018; NAYLOR G, 1980, CLIN CHIM ACTA, V107, P175, DOI 10.1016/0009-8981(80)90445-3; Shi CC, 2022, FRONT PEDIATR, V10, DOI 10.3389/fped.2022.824399; Shigematsu Y, 1996, PEDIATR RES, V39, P680, DOI 10.1203/00006450-199604000-00020; VAMOS E, 1984, ENZYME, V32, P47, DOI 10.1159/000469449; Weisfeld-Adams JD, 2010, MOL GENET METAB, V99, P116, DOI 10.1016/j.ymgme.2009.09.008; Wilcken B, 2003, NEW ENGL J MED, V348, P2304, DOI 10.1056/NEJMoa025225; Yang YL, 2006, J CHILD NEUROL, V21, P1020, DOI 10.1177/7010.2006.00231; Yao Z, 2008, CHINESE MED J-PEKING, V121, P216, DOI 10.1097/00029330-200802010-00006; Zhang C, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69565-z	31	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265766	10.1371/journal.pone.0265766	http://dx.doi.org/10.1371/journal.pone.0265766			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358224	gold, Green Published			2022-12-26	WOS:000799828800046
J	Rossi, R; Fang, MY; Zhu, L; Jiang, CY; Yu, C; Flesia, C; Nie, C; Li, WY; Ferlini, A				Rossi, Rachele; Fang, Mingyan; Zhu, Lin; Jiang, Chongyi; Yu, Cong; Flesia, Cristina; Nie, Chao; Li, Wenyan; Ferlini, Alessandra			Calculating and comparing codon usage values in rare disease genes highlights codon clustering with disease-and tissue- specific hierarchy	PLOS ONE			English	Article							BIAS; SELECTION; MECHANISMS; MUTATIONS; EVOLUTION; VARIANTS; PATTERNS; ORIGINS; INDEX	We designed a novel strategy to define codon usage bias (CUB) in 6 specific small cohorts of human genes. We calculated codon usage (CU) values in 29 non-disease-causing (NDC) and 31 disease-causing (DC) human genes which are highly expressed in 3 distinct tissues, kidney, muscle, and skin. We applied our strategy to the same selected genes annotated in 15 mammalian species. We obtained CUB hierarchical clusters for each gene cohort which showed tissue-specific and disease-specific CUB fingerprints. We showed that DC genes (especially those expressed in muscle) display a low CUB, well recognizable in codon hierarchical clustering. We defined the extremely biased codons as "zero codons" and found that their number is significantly higher in all DC genes, all tissues, and that this trend is conserved across mammals. Based on this calculation in different gene cohorts, we identified 5 codons which are more differentially used across genes and mammals, underlining that some genes have favorite synonymous codons in use. Since of the muscle genes clear clusters, and, among these, dystrophin gene surprisingly does not show any "zero codon" we adopted a novel approach to study CUB, we called "mapping-on-codons". We positioned 2828 dystrophin missense and nonsense pathogenic variations on their respective codon, highlighting that its frequency and occurrence is not dependent on the CU values. We conclude our strategy consents to identify a hierarchical clustering of CU values in a gene cohort-specific fingerprints, with recognizable trend across mammals. In DC muscle genes also a disease-related fingerprint can be observed, allowing discrimination between DC and NDC genes. We propose that using our strategy which studies CU in specific gene cohorts, as rare disease genes, and tissue specific genes, may provide novel information about the CUB role in human and medical genetics, with implications on synonymous variations interpretation and codon optimization algorithms.	[Rossi, Rachele; Ferlini, Alessandra] Univ Ferrara, Dept Med Sci, Unit Med Genet, Ferrara, Italy; [Rossi, Rachele; Ferlini, Alessandra] UCL, Inst Child Hlth, Dubowitz Neuromuscular Unit, London, England; [Fang, Mingyan; Zhu, Lin; Jiang, Chongyi; Nie, Chao] BGI Shenzhen, Shenzhen, Peoples R China; [Zhu, Lin] Zhengzhou Univ, BGI Coll, Zhengzhou, Peoples R China; [Zhu, Lin] Zhengzhou Univ, Henan Inst Med & Pharmaceut Sci, Zhengzhou, Peoples R China; [Yu, Cong] BGI Shenzhen, BGI Genom, Shenzhen, Peoples R China; [Flesia, Cristina] Univ Milano Bicocca, Dept Earth & Environm Sci, Milan, Italy; [Li, Wenyan] BGI Shenzhen, MGI, Shenzhen, Peoples R China	University of Ferrara; University of London; University College London; Beijing Genomics Institute (BGI); Zhengzhou University; Zhengzhou University; Beijing Genomics Institute (BGI); University of Milano-Bicocca; Beijing Genomics Institute (BGI)	Ferlini, A (corresponding author), Univ Ferrara, Dept Med Sci, Unit Med Genet, Ferrara, Italy.; Ferlini, A (corresponding author), UCL, Inst Child Hlth, Dubowitz Neuromuscular Unit, London, England.	fla@unife.it		FERLINI, ALESSANDRA/0000-0001-8385-9870	SOLVE-RD H2020 EU projects [779257]; National Natural Science Foundation of China [31800765]	SOLVE-RD H2020 EU projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The SOLVE-RD (grant agreement n. 779257) H2020 EU projects (to AF as full partner) and the National Natural Science Foundation of China (No. 31800765, to MF) are acknowledged The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript and the authors received no specific funding from them for this work, but Authors wish to acknowledge them for their support of AF and MF omics researches.	[Anonymous], 2019, EXAC; [Anonymous], 2019, CLINVAR; [Anonymous], 2019, NUCC; Aoki Y, 2008, HUM MUTAT, V29, P992, DOI 10.1002/humu.20748; Bali V, 2015, INT J BIOCHEM CELL B, V64, P58, DOI 10.1016/j.biocel.2015.03.011; Bartoszewski R, 2016, CELL MOL BIOL LETT, V21, DOI 10.1186/s11658-016-0025-x; BAUER DF, 1972, J AM STAT ASSOC, V67, P687, DOI 10.2307/2284469; Behura SK, 2013, BIOL REV, V88, P49, DOI 10.1111/j.1469-185X.2012.00242.x; Blood Atlas, 2019, HUMAN PROTEIN ATLAS; Chakraborty S, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/9836256; Chakraborty S, 2019, GENOMICS, V111, P167, DOI 10.1016/j.ygeno.2018.01.013; Das D, 2020, GENE, V747, DOI 10.1016/j.gene.2020.144673; De Mandal S, 2020, GENOMICS, V112, P304, DOI 10.1016/j.ygeno.2019.02.010; den Dunnen Johan T, 2016, Curr Protoc Hum Genet, V90, DOI 10.1002/cphg.2; Dhindsa RS, 2020, AM J HUM GENET, V107, P83, DOI 10.1016/j.ajhg.2020.05.011; Dixit R, 2019, MUTAT RES-FUND MOL M, V813, P31, DOI 10.1016/j.mrfmmm.2018.12.002; Ensemble, 2019, PUB GRCH37 CURRENT G; Forcelloni S, 2020, J MOL EVOL, V88, P164, DOI 10.1007/s00239-019-09921-4; Goncearenco A, 2014, BIOL DIRECT, V9, DOI 10.1186/s13062-014-0029-2; Goncearenco A, 2014, NUCLEIC ACIDS RES, V42, P2879, DOI 10.1093/nar/gkt1336; Goodman DB, 2013, SCIENCE, V342, P475, DOI 10.1126/science.1241934; Gould Nathan, 2014, Front Bioeng Biotechnol, V2, P41, DOI 10.3389/fbioe.2014.00041; GRIMM T, 1994, J MED GENET, V31, P183, DOI 10.1136/jmg.31.3.183; Guimaraes JC, 2020, GENOME BIOL, V21, DOI 10.1186/s13059-020-1943-5; Halder Binata, 2017, Bioinformation, V13, P46, DOI 10.6026/97320630013046; Hanson G, 2018, NAT REV MOL CELL BIO, V19, P20, DOI 10.1038/nrm.2017.91; Hudson NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025457; Jung H, 2018, CELL, V172, P667, DOI 10.1016/j.cell.2018.01.013; Keeling Kim M, 2016, Diseases, V4, DOI 10.3390/diseases4040032; Kirchner S, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228748; Komar AA, 2016, HUM MOL GENET, V25, pR77, DOI 10.1093/hmg/ddw207; Lenstra R, 2014, J THEOR BIOL, V347, P95, DOI 10.1016/j.jtbi.2014.01.002; Li J, 2015, G3-GENES GENOM GENET, V5, P2027, DOI 10.1534/g3.115.019877; Li Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059706; LOVD, 2019, SHARED GENES DMD; Ma LN, 2014, BIOL DIRECT, V9, DOI 10.1186/1745-6150-9-17; Maloy S., 2013, BRENNERS ENCY GENETI, V2nd ed., DOI [10.1016/B978-0-12-374984-0.01483-2, DOI 10.1016/B978-0-12-374984-0.01483-2]; Marin A, 1998, NUCLEIC ACIDS RES, V26, P4540, DOI 10.1093/nar/26.19.4540; Muntoni F, 2003, LANCET NEUROL, V2, P731, DOI 10.1016/S1474-4422(03)00585-4; Naldaiz-Gastesi N, 2018, J ANAT, V233, P275, DOI 10.1111/joa.12840; NCBI, 2019, PUBMED; Neri M, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00131; Oikonomopoulos S, 2020, FRONT GENET, V11, DOI 10.3389/fgene.2020.00606; OMIM, 2020, US; Patsalos A, 2021, SEMIN CELL DEV BIOL, V119, P89, DOI 10.1016/j.semcdb.2021.05.005; Peterson TA, 2010, BIOINFORMATICS, V26, P2458, DOI 10.1093/bioinformatics/btq447; r-project, 2018, R VERSION 3 4 4 R; Ranaghan MJ, 2021, BMC BIOL, V19, DOI 10.1186/s12915-021-00968-8; Richards S, 2015, GENET MED, V17, P405, DOI 10.1038/gim.2015.30; Robertson MP, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a003608; Schmid P, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-87; Schulze KV, 2020, GENET MED, V22, P1407, DOI 10.1038/s41436-020-0813-6; Shah P, 2011, P NATL ACAD SCI USA, V108, P10231, DOI 10.1073/pnas.1016719108; SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281; Shen X, 2013, 2013 35 ANN INT C IE; Song H, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01419; Suzuki H, 2004, GENE, V335, P19, DOI 10.1016/j.gene.2004.03.001; Trotta E, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2692-4; Weissbach H., 2012, MOL MECH PROTEIN BIO, V736, P3; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Xu Y, 2013, NATURE, V495, P116, DOI 10.1038/nature11942; Yang ZH, 2008, MOL BIOL EVOL, V25, P568, DOI 10.1093/molbev/msm284; Yarus M, 2005, ANNU REV BIOCHEM, V74, P179, DOI 10.1146/annurev.biochem.74.082803.133119; Zeng ZS, 2019, FRONT GENET, V10, DOI 10.3389/fgene.2019.00914	64	0	0	5	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265469	10.1371/journal.pone.0265469	http://dx.doi.org/10.1371/journal.pone.0265469			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358230	Green Published, gold			2022-12-26	WOS:000799828800032
J	Breslin, G; Wills, W; Bartington, S; Bontoft, C; Fakoya, O; Freethy, I; Garcia-Iglesias, J; Howlett, N; Jones, J; Lebcir, R; Lloyd, N; Newby, K; Smeeton, N; Wagner, AP; Wellings, A; Wellsted, D; Brown, K				Breslin, Gavin; Wills, Wendy; Bartington, Suzanne; Bontoft, Charis; Fakoya, Olujoke; Freethy, Imogen; Garcia-Iglesias, Jaime; Howlett, Neil; Jones, Julia; Lebcir, Reda; Lloyd, Nigel; Newby, Katie; Smeeton, Nigel; Wagner, Adam P.; Wellings, Amander; Wellsted, David; Brown, Katherine			Evaluation of a whole system approach to diet and healthy weight in the east of Scotland: Study protocol	PLOS ONE			English	Article								Obesity is a global epidemic affecting all age groups, populations and income levels across continents. The causes of obesity are complex and are routed in health behaviours, environmental factors, government policy and the cultural and built environment. Consequently, a Whole System Approach (WSA) which considers the many causes of obesity and shifts the focus away from individuals as points of intervention and puts an emphasis on understanding and improving the system in which people live in is required. This protocol describes a programme of research that will: critically evaluate the evidence for WSAs; assess longitudinally the implementation of a WSA to diet and healthy weight to explore the range of levers (drivers) and opportunities to influence relevant partnerships and interventions to target obesity in East Scotland. The programme consists of four workstreams within a mixed methods framework: 1) Systematic review of reviews of WSAs to diet and healthy weight; 2) Longitudinal qualitative process evaluation of implementing two WSAs in Scotland; 3) Quantitative and Qualitative momentary analysis evaluation of a WSA; and 4) the application of System Dynamics Modelling (SDM) methodology to two council areas in Scotland. A Public Involvement in Research group (PIRg) have informed each stage of the research process. The research programme's breadth and its novel nature, mean that it will provide valuable findings for the increasing numbers who commission, deliver, support and evaluate WSAs to diet and healthy weight nationally and internationally.	[Breslin, Gavin] Ulster Univ, Bamford Ctr Mental Hlth & Wellbeing, Sch Psychol, Coleraine, Londonderry, North Ireland; [Wills, Wendy; Jones, Julia; Smeeton, Nigel] Univ Hertfordshire, Sch Hlth & Social Work, Hatfield, Herts, England; [Wills, Wendy; Wagner, Adam P.] Natl Inst Hlth Res NIHR Appl Res Collaborat ARC E, Cambridge, England; [Bartington, Suzanne] Univ Birmingham, Inst Appl Hlth Res, Birmingham, W Midlands, England; [Bontoft, Charis; Fakoya, Olujoke; Freethy, Imogen; Garcia-Iglesias, Jaime; Howlett, Neil; Lloyd, Nigel; Newby, Katie; Wellings, Amander; Wellsted, David; Brown, Katherine] Univ Hertfordshire, Sch Life & Med Sci, Dept Psychol Sport & Geog, Hatfield, Herts, England; [Lebcir, Reda] Univ Hertfordshire, Hertfordshire Business Sch, Hatfield, Herts, England; [Wagner, Adam P.] Univ East Anglia, Norwich Med Sch, Norwich, Norfolk, England	Ulster University; University of Hertfordshire; University of Birmingham; University of Hertfordshire; University of Hertfordshire; University of East Anglia	Breslin, G (corresponding author), Ulster Univ, Bamford Ctr Mental Hlth & Wellbeing, Sch Psychol, Coleraine, Londonderry, North Ireland.	g.breslin1@ulster.ac.uk	Garcia Iglesias, Jaime/GXN-3138-2022; Breslin, Gavin/H-5310-2015	Garcia Iglesias, Jaime/0000-0002-8841-5635; Lloyd, Nigel/0000-0003-4218-1957; Howlett, Neil/0000-0002-6502-9969; Jones, Julia/0000-0003-3221-7362; Smeeton, Nigel/0000-0001-9460-5411; Newby, Katie/0000-0002-9348-0116; Brown, Katherine/0000-0003-2472-5754; Breslin, Gavin/0000-0003-2481-0860; Bartington, Suzanne/0000-0002-8179-7618; Wellsted, David/0000-0002-2895-7838; Wagner, Adam/0000-0002-9101-3477	NIHR [NIHR134423, NIHR131573]; National Institute for Health Research (NIHR) Applied Research Collaboration East of England	NIHR(National Institute for Health Research (NIHR)); National Institute for Health Research (NIHR) Applied Research Collaboration East of England(National Institute for Health Research (NIHR))	This work is part of the NIHR-funded evaluation "Whole System Approach to Diet and Healthy Weight -Community Pilots Project" conducted by the PHIRST (Public Health Intervention Responsive Studies Team; Project reference NIHR134423; Award reference NIHR131573). All authors were funded. WWand APW are part-funded by the National Institute for Health Research (NIHR) Applied Research Collaboration East of England (https://www.nihr.ac.uk/).The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care, or Public Health Scotland. The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bagnall AM, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-018-6274-z; Gale NK, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-117; Jalali MS, 2019, SOC SCI MED, V224, P67, DOI 10.1016/j.socscimed.2018.12.021; Lee BY, 2017, NUTR REV, V75, P94, DOI 10.1093/nutrit/nuw049; Lounsbury D., 2015, OBESITY DIS INTERCON, P306; Public Health England, 2019, WHOL SYST APPR OB PR; Scottish Government and COSLA. Public health reform,, 2019, SCOTL PUBL HLTH PRIO; Shiffman S, 2008, ANNU REV CLIN PSYCHO, V4, P1, DOI 10.1146/annurev.clinpsy.3.022806.091415; Swanson J, 2002, J OPER RES SOC, V53, P472, DOI 10.1057/palgrave.jors.2601336	9	0	0	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265667	10.1371/journal.pone.0265667	http://dx.doi.org/10.1371/journal.pone.0265667			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324971	gold, Green Published, Green Accepted			2022-12-26	WOS:000780951300059
J	Jayasinghe, S; Herath, MP; Beckett, JM; Ahuja, KDK; Street, SJ; Byrne, NM; Hills, AP				Jayasinghe, Sisitha; Herath, Manoja P.; Beckett, Jeffrey M.; Ahuja, Kiran D. K.; Street, Steven J.; Byrne, Nuala M.; Hills, Andrew P.			Gestational weight gain and postpartum weight retention in Tasmanian women: The Baby-bod Study	PLOS ONE			English	Article							PREGNANCY OUTCOMES; MASS INDEX; OBESITY; OVERWEIGHT; MOTHERS; HEALTH; ASSOCIATION; NUTRITION; COHORT	Many factors can negatively impact perinatal outcomes, including inappropriate gestational weight gain (GWG). Despite having the greatest potential to influence maternal and infant health, there is a lack of consensus regarding the GWG consistent with a healthy pregnancy. To date, GWG in Northern Tasmania remains understudied. We investigated how maternal pre-pregnancy body mass index (BMI) is related to weight gain during pregnancy and weight retention post-partum, and how maternal pre-pregnancy BMI is related to the mode of delivery. Approximately 300 Tasmanian mothers (n = 291 for mode of delivery and n = 282 for GWG) were included in this study. Analysis of variance and chi square tests were conducted to assess differences in BW of mothers across BMI categories and differences between categorical variables; respectively. Based on pre-pregnancy BMI, mothers were assigned to one of three groups, with healthy weight (<25 kg m(-2)), with overweight (25-29.9 kg m(-2)), or with obesity (>30 kg m(-2)). Pre-pregnancy BMI and body weight (BW) were significantly associated (p< 0.001) with post-partum BW at 3 and 6 months. Only 25% of mothers with a normal weight BMI, 34% with overweight and 13% with obesity, achieved the Institute of Medicine (IOM) recommendation for GWG. Interestingly, a number of women in our cohort lost weight during gestation (1.5, 9 and 37% in < 25, 25-29.9 and > 30 kg m(-2) groups, respectively). Further, women with obesity showed the lowest level of BW fluctuation and retained less weight post-partum. The highest number of caesarean sections were observed in mothers who exceeded GWG recommendations. Most mothers either exceeded or failed to achieve IOM recommendations for GWG. To improve the generalisability of these findings, this study should be replicated in a larger representative sample of the Tasmanian maternal population.	[Jayasinghe, Sisitha; Herath, Manoja P.; Beckett, Jeffrey M.; Ahuja, Kiran D. K.; Street, Steven J.; Byrne, Nuala M.; Hills, Andrew P.] Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Launceston, Tas, Australia	University of Tasmania	Jayasinghe, S (corresponding author), Univ Tasmania, Coll Hlth & Med, Sch Hlth Sci, Launceston, Tas, Australia.	Sisitha.jayasinghe@utas.edu.au	Jayasinghe, Sisitha/GWV-0455-2022	Jayasinghe, Sisitha/0000-0001-8805-385X	International Atomic Energy Agency [CRP E43028, 20880]; Bill & Melinda Gates Foundation [OPP1143641]; St.LukesHealth	International Atomic Energy Agency(International Atomic Energy Agency); Bill & Melinda Gates Foundation(Bill & Melinda Gates FoundationCGIAR); St.LukesHealth	APH, NMB, KDKA, SJS This work was supported, in part, by the International Atomic Energy Agency (CRP E43028 Contract Number 20880), the Bill & Melinda Gates Foundation (OPP1143641), and St.LukesHealth. The study funder had no role in study design, collection, analysis or interpretation of the data, in writing the report, or in the decision to submit the article for publication. The contents of this article are the responsibility of the authors and do not reflect the views of the funding bodies. https://www.iaea.org/https://www.gatesfoundation.org/https://stlukes.com.au/.	Andres A, 2015, OBESITY, V23, P1252, DOI 10.1002/oby.21078; Ha AVV, 2019, OBES RES CLIN PRACT, V13, P143, DOI 10.1016/j.orcp.2019.02.001; Australian Bureau of Statistics, 2018, NAT HLTH SURV 1 RES; Beyerlein A, 2009, AM J CLIN NUTR, V90, P1552, DOI 10.3945/ajcn.2009.28026; Bish CL, 2009, MATERN CHILD HLTH J, V13, P286, DOI 10.1007/s10995-008-0349-x; Callaway LK, 2006, MED J AUSTRALIA, V184, P56, DOI 10.5694/j.1326-5377.2006.tb00115.x; Casirola DM, 2003, AM J CLIN NUTR, V78, P1178, DOI 10.1093/ajcn/78.6.1178; Cheney K, 2017, BMC PREGNANCY CHILDB, V17, DOI 10.1186/s12884-017-1482-6; de Onis Mercedes, 2004, Food Nutr Bull, V25, pS15; Farpour-Lambert NJ, 2018, FRONT ENDOCRINOL, V9, DOI 10.3389/fendo.2018.00546; Feig DS, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001425; Fyfe EM, 2012, BMC PREGNANCY CHILDB, V12, DOI 10.1186/1471-2393-12-112; Gilmore LA, 2015, SEMIN PERINATOL, V39, P296, DOI 10.1053/j.semperi.2015.05.009; Goldstein RF, 2018, BMC MED, V16, DOI 10.1186/s12916-018-1128-1; Goldstein RF, 2017, JAMA-J AM MED ASSOC, V317, P2207, DOI 10.1001/jama.2017.3635; Hill B, 2016, WOMEN HEALTH ISS, V26, P123, DOI 10.1016/j.whi.2015.09.012; Hull HR, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.04.004; Johnson J, 2013, OBSTET GYNECOL, V121, P969, DOI 10.1097/AOG.0b013e31828aea03; Kac G, 2004, J NUTR, V134, P661, DOI 10.1093/jn/134.3.661; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Kominiarek MA, 2013, AM J OBSTET GYNECOL, V209, DOI 10.1016/j.ajog.2013.04.035; Langford A, 2011, MATERN CHILD HLTH J, V15, P860, DOI 10.1007/s10995-008-0318-4; Ma DF, 2015, CLIN NUTR, V34, P291, DOI 10.1016/j.clnu.2014.04.010; McIntyre HD, 2012, MED J AUSTRALIA, V196, P184, DOI 10.5694/mja11.11120; Moehlecke M, 2016, AJP REP, V6, pE77, DOI 10.1055/s-0035-1566309; Nehring I, 2011, AM J CLIN NUTR, V94, P1225, DOI 10.3945/ajcn.111.015289; Penn Z, 2001, BEST PRACT RES CL OB, V15, P1, DOI 10.1053/beog.2000.0146; Porteous HE, 2014, WOMEN BIRTH, V27, P196, DOI 10.1016/j.wombi.2014.04.001; Robillard PY, 2018, HELIYON, V4, DOI 10.1016/j.heliyon.2018.e00615; Rooney BL, 2002, OBSTET GYNECOL, V100, P245, DOI 10.1016/S0029-7844(02)02125-7; Schumacher TL, 2018, MIDWIFERY, V60, P13, DOI 10.1016/j.midw.2018.01.017; Schummers L, 2015, OBSTET GYNECOL, V125, P133, DOI 10.1097/AOG.0000000000000591; Shin D, 2015, J MATERN-FETAL NEO M, V28, P1679, DOI 10.3109/14767058.2014.964675; Skouteris H, 2015, AUST NZ J OBSTET GYN, V55, P397, DOI 10.1111/ajo.12341; Stang J, 2016, J ACAD NUTR DIET, V116, P677, DOI 10.1016/j.jand.2016.01.008; Thangaratinam S, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e2088; Tikellis G, 2012, INT J OBESITY, V36, P496, DOI 10.1038/ijo.2011.261; Voerman E, 2019, JAMA-J AM MED ASSOC, V321, P1702, DOI 10.1001/jama.2019.3820; Whitaker K, 2014, MATERN CHILD HLTH J, V18, P2209, DOI 10.1007/s10995-014-1470-7	39	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0264744	10.1371/journal.pone.0264744	http://dx.doi.org/10.1371/journal.pone.0264744			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316273	Green Published, gold, Green Accepted			2022-12-26	WOS:000834238000011
J	Chen, H; Zhang, K; Jiang, YB; Shi, Z				Chen, Huan; Zhang, Ke; Jiang, Yibo; Shi, Zheng			Prediction and forewarning of axial force of steel bracing in foundation pit based on verhulst model	PLOS ONE			English	Article							NUMERICAL-ANALYSIS; EXCAVATION	The axial force of steel bracing is one of the essential indexes to measure the stability of the bracing system of a foundation pit. The steel bracing system of a foundation pit in Ningbo City, China was taken as the research object to guarantee the stability of the steel bracing system of the foundation pit. Besides, the change of axial force between the two steel bracing structures was analyzed to predict the axial force data of the steel bracing and perform the safety forewarning of the steel bracing system. Firstly, GM (1,1) and Verhulst models in the gray model were selected for prediction based on the characteristics of poor information and the small sample size of original monitoring data of the steel bracing. Secondly, the precision of the GM (1,1) model and Verhulst model was compared to determine a more accurate prediction method. Finally, the safety forewarning model of the confidence interval estimation method was established based on the data obtained from the prediction model and the deformation characteristics and indexes of the steel bracing. With the significance levels alpha = 5% and alpha = 2% as the demarcating points, the forewarning grades of the steel bracing system of the deep foundation pit were divided, and then the operating state of the current steel bracing system was determined. The results demonstrated that the Verhulst model had better prediction precision compared with the ordinary GM (1, 1) model. Besides, the steel bracing system was in the safe operation range, and the judgment results of the model were consistent with the actual situation of the foundation pit of the steel bracing system. Thus, the Verhulst prediction model and the confidence interval security early forewarning model could be used to judge the stability of the steel bracing system.	[Chen, Huan; Zhang, Ke; Shi, Zheng] Hohai Univ, Coll Business, Nanjing, Peoples R China; [Jiang, Yibo] Jiangsu Huaiyin Water Conservancy Construct Co Lt, Huaiyin, Peoples R China	Hohai University	Chen, H (corresponding author), Hohai Univ, Coll Business, Nanjing, Peoples R China.; Jiang, YB (corresponding author), Jiangsu Huaiyin Water Conservancy Construct Co Lt, Huaiyin, Peoples R China.	522383974@qq.com; 16920170@qq.com		Chen, Huan/0000-0002-7089-0892				Akan Recep, 2021, Arabian Journal of Geosciences, V14, DOI 10.1007/s12517-021-08347-x; Akan R, 2019, SN APPL SCI, V1, DOI 10.1007/s42452-019-0883-8; Akan R, 2015, PROCED EARTH PLAN SC, V15, P299, DOI 10.1016/j.proeps.2015.08.072; [Anonymous], 2015, CHINESE J MANAGEMENT, DOI [10.16381/j.cnki.issn1003-207x.2015.11.014, DOI 10.16381/J.CNKI.ISSN1003-207X.2015.11.014]; Avcar M, 2015, INT J ADV COMPUT SC, V6, P94; Goh ATC, 2017, COMPUT GEOTECH, V86, P141, DOI 10.1016/j.compgeo.2017.01.012; Guo Jin-hai, 2015, Control and Decision, V30, P1251, DOI 10.13195/j.kzyjc.2014.0635; Han YZ., 2019, J SHANDONG U SCI TEC, V38, P39, DOI [10.16452/j.cnki.sdkjzk.2019.05.005, DOI 10.16452/J.CNKI.SDKJZK.2019.05.005]; He JP, 2018, WATER SCI ENG, V11, P61, DOI 10.1016/j.wse.2018.03.002; Hu ZF, 2020, SCI TECHNOLOGY ENG, V20, P9163; Jena MC, 2015, STUDY RELIABILITY VA, V2, P43; Lee PC, 2020, KSCE J CIV ENG, V24, P715, DOI 10.1007/s12205-020-1462-7; Li HJ., 2020, SCI TECHNOLOGY ENG, V20, P11442; [李军亮 LI Jun-liang], 2010, [系统工程理论与实践, Systems Engineering-Theory & Practice], V30, P490; [刘庆丰 Liu Qingfeng], 2020, [现代隧道技术, Modern Tunnelling Technology], V57, P142; Liu SF, 2010, UNDERST COMPLEX SYST, P1; Liu ZT., 2003, J NANJING U TECHNOLO, V25, P1; Luo QY., 2017, J WATER RESOURCES AR, V15, P32; [齐先军 Qi Xianjun], 2015, [电力系统保护与控制, Power System Protection and Control], V43, P81; Wang CT, 2020, ROCK SOIL MECH, V41, P1670, DOI 10.16285/j.rsm.2019.0519; [吴相豪 Wu Xianghao], 2020, [中国安全科学学报, China Safety Science Journal（CSSJ）], V30, P127; Xu YZ., 2016, COLLIERY MECH ELECT, P17, DOI [10.16545/j.cnki.cmet.2016.06.005, DOI 10.16545/J.CNKI.CMET.2016.06.005]; Xue Y., 2020, SCI DECISION, V12, P73, DOI [10.3773/jissn.1006-4885.2020.12.073, DOI 10.3773/JISSN.1006-4885.2020.12.073]; Yu QQ, 2019, B SCI TECHNOLOGY, V35, P181, DOI [10.13774/j.cnki.kjtb.2019.10.035, DOI 10.13774/J.CNKI.KJTB.2019.10.035]; Zhang Chuang, 2017, Journal of Central South University (Science and Technology), V48, P3030, DOI 10.11817/j.issn.1672-7207.2017.11.025; Zhang LB., 2018, WATER POWER, V44, P103; Zhang RH, 2021, ACTA GEOTECH, V16, P1615, DOI 10.1007/s11440-020-01129-x; [章润红 Zhang Runhong], 2018, [防灾减灾工程学报, Journal of Disaster Prevention and Mitigation Engineering], V38, P857; Zhang WG, 2018, GEOMECH ENG, V15, P965, DOI 10.12989/gae.2018.15.4.965; Zhang YL., 2019, WATER RESOURCES HYDR, V50, P104, DOI [10.13928/j.cnki.wrahe.2019.10.014, DOI 10.13928/J.CNKI.WRAHE.2019.10.014]; [张忠苗 Zhang Zhongmiao], 2010, [岩石力学与工程学报, Chinese Journal of Rock Mechanics and Engineering], V29, P1270; Zhao KP., 2015, YELLOW RIVER, P120; Zhu Kai, 2013, Water Resources and Power, V31, P65	33	2	2	12	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265845	10.1371/journal.pone.0265845	http://dx.doi.org/10.1371/journal.pone.0265845			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333895	Green Published, gold			2022-12-26	WOS:000784335700033
J	Castellaro, AM; Velez, P; Merlera, GG; Duenas, JR; Condat, F; Gallardo, J; Makhoul, A; Cinalli, C; Cavaglieri, LR; Di Cola, G; Sicilia, P; Lopez, L; Bocco, JL; Barbas, MG; Cardozo, DH; Pisano, MB; Re, V; Belaus, A; Castro, G				Marcos Castellaro, Andres; Velez, Pablo; Giaj Merlera, Guillermo; Rondan Duenas, Juan; Condat, Felix; Gallardo, Jesica; Makhoul, Aylen; Cinalli, Camila; Rosales Cavaglieri, Lorenzo; Di Cola, Guadalupe; Sicilia, Paola; Lopez, Laura; Luis Bocco, Jose; Gabriela Barbas, Maria; Hernan Cardozo, Diego; Belen Pisano, Maria; Re, Viviana; Belaus, Andrea; Castro, Gonzalo		Fac Ciencias Quimicas UNC Grp	SARS-CoV-2 detection in multi-sample pools in a real pandemic scenario: A screening strategy of choice for active surveillance	PLOS ONE			English	Article							TESTING CAPACITY; PREVALENCE; DIAGNOSIS; COST	BackgroundThe current COVID-19 pandemic has overloaded the diagnostic capacity of laboratories by the gold standard method rRT-PCR. This disease has a high spread rate and almost a quarter of infected individuals never develop symptoms. In this scenario, active surveillance is crucial to stop the virus propagation. MethodsBetween July 2020 and April 2021, 11,580 oropharyngeal swab samples collected in closed and semi-closed institutions were processed for SARS-CoV-2 detection in pools, implementing this strategy for the first time in Cordoba, Argentina. Five-sample pools were constituted before nucleic acid extraction and amplification by rRT-PCR. Comparative analysis of cycle threshold (Ct) values from positive pools and individual samples along with a cost-benefit report of the whole performance of the results was performed. ResultsFrom 2,314 5-sample pools tested, 158 were classified as positive (6.8%), 2,024 as negative (87.5%), and 132 were categorized as indeterminate (5.7%). The Ct value shift due to sample dilution showed an increase in Ct of 2.6 +/- 1.53 cycles for N gene and 2.6 +/- 1.78 for ORF1ab gene. Overall, 290 pools were disassembled and 1,450 swabs were analyzed individually. This strategy allowed correctly identifying 99.8% of the samples as positive (7.6%) or negative (92.2%), avoiding the execution of 7,806 rRT-PCR reactions which represents a cost saving of 67.5%. ConclusionThis study demonstrates the feasibility of pooling samples to increase the number of tests performed, helping to maximize molecular diagnostic resources and reducing the work overload of specialized personnel during active surveillance of the COVID-19 pandemic.	[Marcos Castellaro, Andres; Luis Bocco, Jose] Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Cordoba, Argentina; [Marcos Castellaro, Andres; Luis Bocco, Jose] Univ Nacl Cordoba, Ctr Invest Bioquim Clin & Inmunol CIBICI, CONICET, Cordoba, Argentina; [Velez, Pablo; Giaj Merlera, Guillermo; Rondan Duenas, Juan; Condat, Felix; Gallardo, Jesica; Makhoul, Aylen; Cinalli, Camila; Rosales Cavaglieri, Lorenzo; Belaus, Andrea] Ctr Excelencia Prod & Proc Cordoba CEPROCOR, Unidad Biol Mol, Cordoba, Argentina; [Di Cola, Guadalupe; Belen Pisano, Maria; Re, Viviana] Univ Nacl Cordoba, Fac Ciencias Med, Inst Virol Doctor Jose Maria Vanella, Cordoba, Argentina; [Di Cola, Guadalupe; Belen Pisano, Maria; Re, Viviana] Consejo Nacl Invest Cient & Tecn CONICET, Cordoba, Argentina; [Sicilia, Paola; Castro, Gonzalo] Minist Salud Prov Cordoba, Lab Cent, Cordoba, Argentina; [Lopez, Laura] Minist Salud Prov Cordoba, Direcc Epidemiol, Cordoba, Argentina; [Gabriela Barbas, Maria; Hernan Cardozo, Diego] Minist Salud Prov Cordoba, Secretaria Prevenc & Promoc Salud, Cordoba, Argentina	National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Cordoba; National University of Cordoba; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Castellaro, AM (corresponding author), Univ Nacl Cordoba, Fac Ciencias Quim, Dept Bioquim Clin, Cordoba, Argentina.; Castellaro, AM (corresponding author), Univ Nacl Cordoba, Ctr Invest Bioquim Clin & Inmunol CIBICI, CONICET, Cordoba, Argentina.	andres.castellaro@unc.edu.ar		Castellaro, Andres Marcos/0000-0003-2360-0175	Ministry of Health of the Province of Cordoba, Argentina; National University of Cordoba	Ministry of Health of the Province of Cordoba, Argentina; National University of Cordoba	This study was funded by the Ministry of Health of the Province of Cordoba, Argentina as part of the program for active surveillance for SARS-CoV-2 dissemination and received material support from the National University of Cordoba. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalhamid B, 2020, AM J CLIN PATHOL, V153, P715, DOI [10.1093/ajcp/aqaa064, 10.1093/AJCP/AQAA064, 10.1101/2020.04.03.20050195]; Alcoba-Florez J, 2021, INT J INFECT DIS, V103, P19, DOI 10.1016/j.ijid.2020.11.155; Alene M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249090; Ambrosis N, 2021, FRONT MED-LAUSANNE, V8, DOI 10.3389/fmed.2021.640688; [Anonymous], 2020, CORONAVIRUS COVID 19; Bharti AR, 2009, AM J TROP MED HYG, V81, P754, DOI 10.4269/ajtmh.2009.09-0274; Blumenthal D, 2020, NEW ENGL J MED, V383, P1483, DOI 10.1056/NEJMsb2021088; Alvargonzalez JJC, 2020, BMC INFECT DIS, V20, DOI 10.1186/s12879-020-05446-0; Chong BSW, 2020, PATHOLOGY, V52, P796, DOI 10.1016/j.pathol.2020.09.005; de Salazar A, 2020, CLIN MICROBIOL INFEC, V26, DOI 10.1016/j.cmi.2020.09.008; Dwyre DM, 2011, VOX SANG, V100, P92, DOI 10.1111/j.1423-0410.2010.01426.x; Farfan Mauricio J., 2020, Rev. chil. infectol., V37, P276, DOI 10.4067/s0716-10182020000300276; Garcia Z, 1996, J MED VIROL, V49, P218, DOI 10.1002/(SICI)1096-9071(199607)49:3&lt;218::AID-JMV10&gt;3.0.CO;2-8; Gdlpd Cordoba., 2021, INFORME DIARIO CASOS; Grant MC, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234765; Hogan CA, 2020, JAMA-J AM MED ASSOC, V323, P1967, DOI 10.1001/jama.2020.5445; Kaye AD, 2021, BEST PRAC RES-CL ANA, V35, P293, DOI 10.1016/j.bpa.2020.11.009; Lohse S, 2020, LANCET INFECT DIS, V20, P1231, DOI 10.1016/S1473-3099(20)30362-5; Mahmoud SA, 2021, BMC INFECT DIS, V21, DOI 10.1186/s12879-021-06061-3; Meo SA, 2021, EUR REV MED PHARMACO, V25, P8012, DOI 10.26355/eurrev_202112_27652; Praharaj I, 2020, INDIAN J MED RES, V152, P88, DOI 10.4103/ijmr.IJMR_2304_20; Regen F, 2020, INT J INFECT DIS, V100, P324, DOI 10.1016/j.ijid.2020.08.063; Shyu Daniel, 2020, Mo Med, V117, P184; Sunjaya AF, 2020, DISASTER MED PUBLIC, V14, pE42, DOI 10.1017/dmp.2020.246; Syangtan G, 2021, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.587374; Torres I, 2020, J MED VIROL, V92, P2306, DOI 10.1002/jmv.25971; Van TT, 2012, J CLIN MICROBIOL, V50, P891, DOI 10.1128/JCM.05631-11; van Zyl GU, 2011, CLIN INFECT DIS, V52, P264, DOI 10.1093/cid/ciq084; Yelin I, 2020, CLIN INFECT DIS, V71, P2073, DOI 10.1093/cid/ciaa531; Younes N, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12060582; Zhou YY, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0241469	31	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266408	10.1371/journal.pone.0266408	http://dx.doi.org/10.1371/journal.pone.0266408			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363805	Green Published, gold, Green Submitted			2022-12-26	WOS:000804748600027
J	Ward, AS; Hsiung, CH; Kesterson, DG; Kamath, VG; McKee, EE				Ward, Avery S.; Hsiung, Chia-Heng; Kesterson, Daniel G.; Kamath, Vasudeva G.; McKee, Edward E.			Entecavir competitively inhibits deoxyguanosine and deoxyadenosine phosphorylation in isolated mitochondria and the perfused rat heart	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							THYMIDINE KINASE 2; IN-VITRO SUPPLEMENTATION; DNA DEPLETION; HEPATITIS-B; SUBSTRATE-SPECIFICITY; DEOXYRIBONUCLEOTIDE POOLS; LACTIC-ACIDOSIS; METABOLISM; DEOXYNUCLEOSIDE; TOXICITY	Deoxyguanosine kinase (dGK) is reported responsible for the phosphorylation of deoxyadenosine (dA) and deoxyguanosine (dG) in the mitochondrial purine salvage pathway. Antiviral nucleoside analogs known as nucleoside reverse transcriptase inhibitors (NRTIs) must be phosphorylated by host enzymes for the analog to become active. We address the possibility that NRTI purine analogs may be competitive inhibitors of dGK. From a group of such analogs, we demonstrate that entecavir (ETV) competitively inhibited the phosphorylation of dG and dA in rat mitochondria. Mitochondria from the brain, heart, kidney, and liver showed a marked preference for phosphorylation of dG over dA (10-30-fold) and ETV over dA (2.5-4fold). We found that ETV inhibited the phosphorylation of dG with an IC50 of 15.3 +/- 2.2 mu M and that ETV and dG were both potent inhibitors of dA phosphorylation with IC50s of 0.034 +/- 0.007 and 0.028 +/- 0.006 mu M, respectively. In addition, the phosphorylation of dG and ETV followed Michaelis- Menten kinetics and each competitively inhibited the phosphorylation of the other. We observed that the kinetics of dA phosphorylation were strikingly different from those of dG phosphorylation, with an exponentially lower affinity for dGK and no effect of dA on dG or ETV phosphorylation. Finally, in an isolated heart perfusion model, we demonstrated that dG, dA, and ETV were phosphorylated and dG phosphorylation was inhibited by ETV. Taken together, these data demonstrate that dGK is inhibited by ETV and that the primary role of dGK is in the phosphorylation of dG rather than dA.	[Ward, Avery S.; Hsiung, Chia-Heng; Kesterson, Daniel G.; Kamath, Vasudeva G.; McKee, Edward E.] Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA; [Hsiung, Chia-Heng] Westlake Univ, Westlake Inst Adv Study, Sch Sci, Hangzhou, Zhejiang, Peoples R China; [Kesterson, Daniel G.] Univ Michigan Ann Arbor, Sch Publ Hlth, Dept Hlth Management & Policy, Ann Arbor, MI USA; [Kamath, Vasudeva G.] Touro Coll Osteopath Med, Dept Basic Med Sci, Middletown, NY USA	Central Michigan University; Westlake University; University of Michigan System; University of Michigan	McKee, EE (corresponding author), Cent Michigan Univ, Coll Med, Dept Fdn Sci, Mt Pleasant, MI 48859 USA.	mckee1ee@cmich.edu		Hsiung, Chia-Heng/0000-0003-3542-587X	National Institute of Health Grant [R01/HL096480]	National Institute of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported, in whole or in part, by National Institute of Health Grant R01/HL096480. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ARNER ESJ, 1995, PHARMACOL THERAPEUT, V67, P155, DOI 10.1016/0163-7258(95)00015-9; Arya VB, 2019, CLIN ENDOCRINOL, V91, P900, DOI 10.1111/cen.14084; Bulst S, 2012, MOL GENET METAB, V107, P95, DOI 10.1016/j.ymgme.2012.04.022; Bulst S, 2009, HUM MOL GENET, V18, P1590, DOI 10.1093/hmg/ddp074; Camara Y, 2014, HUM MOL GENET, V23, P2459, DOI 10.1093/hmg/ddt641; Chang TT, 2010, HEPATOLOGY, V51, P422, DOI 10.1002/hep.23327; Cohen SM, 2009, J CLIN GASTROENTEROL, V43, P1008, DOI 10.1097/MCG.0b013e31819c3945; de Fuenmayor-Fernndez de la Hoz C. P., 2021, MOL GENET METAB REP, V26; Dominguez-Gonzalez C, 2019, ORPHANET J RARE DIS, V14, DOI 10.1186/s13023-019-1071-z; El-Hattab AW, 2016, CELL CALCIUM, V60, P199, DOI 10.1016/j.ceca.2016.03.003; Garone C, 2018, J MED GENET, V55, P515, DOI 10.1136/jmedgenet-2017-105012; Garone C, 2014, EMBO MOL MED, V6, P1016, DOI 10.15252/emmm.201404092; Johansson K, 2001, NAT STRUCT BIOL, V8, P616, DOI 10.1038/89661; Kamath VG, 2015, J BIOL CHEM, V290, P2034, DOI 10.1074/jbc.M114.624213; Kicska GA, 2001, P NATL ACAD SCI USA, V98, P4593, DOI 10.1073/pnas.071050798; LAMPERTH L, 1991, LAB INVEST, V65, P742; Lange CM, 2009, HEPATOLOGY, V50, P2001, DOI 10.1002/hep.23346; LEWIS W, 1995, NAT MED, V1, P417, DOI 10.1038/nm0595-417; Lin SC, 2019, EMBO MOL MED, V11, DOI 10.15252/emmm.201910849; Lynx MD, 2006, BIOCHEM PHARMACOL, V71, P1342, DOI 10.1016/j.bcp.2006.01.003; Mathews CK, 2006, FASEB J, V20, P1300, DOI 10.1096/fj.06-5730rev; Mazzucco CE, 2008, ANTIMICROB AGENTS CH, V52, P598, DOI 10.1128/AAC.01122-07; McCann KA, 2012, J NEUROCHEM, V122, P126, DOI 10.1111/j.1471-4159.2012.07765.x; MCKEE EE, 1990, AM J PHYSIOL, V258, pE503, DOI 10.1152/ajpendo.1990.258.3.E503; MCKEE EE, 1990, AM J PHYSIOL, V258, pE492, DOI 10.1152/ajpendo.1990.258.3.E492; Morris GW, 2010, ANTIVIR THER, V15, P587, DOI 10.3851/IMP1567; Morris GW, 2009, BIOCHEM J, V422, P513, DOI 10.1042/BJ20082427; Osborn Melissa, 2011, Infect Drug Resist, V4, P55, DOI 10.2147/IDR.S4188; PODZUWEIT T, 1995, CELL SIGNAL, V7, P733, DOI 10.1016/0898-6568(95)00042-N; Robinson DM, 2006, DRUGS, V66, P1605, DOI 10.2165/00003495-200666120-00009; Saada A, 2004, DNA CELL BIOL, V23, P797; Saada A, 2001, NAT GENET, V29, P342, DOI 10.1038/ng751; Saada A, 2008, MOL GENET METAB, V95, P169, DOI 10.1016/j.ymgme.2008.07.007; Salviati L, 2002, ANN NEUROL, V52, P311, DOI 10.1002/ana.10284; Sang L, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.570656; Sezer T, 2015, J CHILD NEUROL, V30, P124, DOI 10.1177/0883073813517000; Sjoberg AH, 1998, MOL PHARMACOL, V53, P270, DOI 10.1124/mol.53.2.270; Snowdin JW, 2015, ANTIMICROB AGENTS CH, V59, P6328, DOI 10.1128/AAC.01180-15; SNYDER FF, 1982, BIOCHIM BIOPHYS ACTA, V696, P299, DOI 10.1016/0167-4781(82)90061-6; Sun R, 2014, BIOCHEM BIOPH RES CO, V450, P1021, DOI 10.1016/j.bbrc.2014.06.098; Susan-Resiga D, 2007, ANTIMICROB AGENTS CH, V51, P1142, DOI 10.1128/AAC.01227-06; Taanman JW, 2003, HUM MOL GENET, V12, P1839, DOI 10.1093/hmg/ddg192; Van Rompay AR, 2003, PHARMACOL THERAPEUT, V100, P119, DOI 10.1016/j.pharmthera.2003.07.001; Vanden Avond MA, 2021, J INHERIT METAB DIS, V44, P492, DOI 10.1002/jimd.12354; Waich S, 2019, J PEDIATR GASTR NUTR, V68, pE1, DOI 10.1097/MPG.0000000000002149; WANG LY, 1993, J BIOL CHEM, V268, P22847; Wheeler LJ, 2011, J BIOL CHEM, V286, P16992, DOI 10.1074/jbc.M111.236968; Wong GLH, 2013, HEPATOLOGY, V58, P1537, DOI 10.1002/hep.26301; Xu YJ, 2008, J BIOL CHEM, V283, P1563, DOI 10.1074/jbc.M707997200; Yamanaka G, 1999, ANTIMICROB AGENTS CH, V43, P190, DOI 10.1128/AAC.43.1.190; Zhou Li, 2012, Zhonghua Gan Zang Bing Za Zhi, V20, P751, DOI 10.3760/cma.j.issn.1007-3418.2012.10.009	51	0	0	1	1	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101876	10.1016/j.jbc.2022.101876	http://dx.doi.org/10.1016/j.jbc.2022.101876			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T7QP	35358513	Green Published, gold			2022-12-26	WOS:000804923000006
J	Harrison, NE; Meram, S; Li, XR; White, MB; Henry, S; Gupta, S; Zhu, DX; Pang, P; Levy, P				Harrison, Nicholas Eric; Meram, Sarah; Li, Xiangrui; White, Morgan B.; Henry, Sarah; Gupta, Sushane; Zhu, Dongxiao; Pang, Peter; Levy, Phillip			Hemodynamic profiles by non-invasive monitoring of cardiac index and vascular tone in acute heart failure patients in the emergency department: External validation and clinical outcomes	PLOS ONE			English	Article							ARTERIAL-BLOOD PRESSURE; RISK-STRATIFICATION; FINGER CUFF; PATHOPHYSIOLOGY; IDENTIFICATION; ASSOCIATION; DYSFUNCTION; GUIDELINES; MANAGEMENT; MORTALITY	Background Non-invasive finger-cuff monitors measuring cardiac index and vascular tone (SVRI) classify emergency department (ED) patients with acute heart failure (AHF) into three otherwise-indistinguishable subgroups. Our goals were to validate these "hemodynamic profiles" in an external cohort and assess their association with clinical outcomes. Methods AHF patients (n = 257) from five EDs were prospectively enrolled in the validation cohort (VC). Cardiac index and SVRI were measured with a ClearSight finger-cuff monitor (formerly NexFin, Edwards Lifesciences) as in a previous study (derivation cohort, DC, n = 127). A control cohort (CC, n = 127) of ED patients with sepsis was drawn from the same study as the DC. K-means cluster analysis previously derived two-dimensional (cardiac index and SVRI) hemodynamic profiles in the DC and CC (k = 3 profiles each). The VC was subgrouped de novo into three analogous profiles by unsupervised K-means consensus clustering. PERMANOVA tested whether VC profiles 1-3 differed from profiles 1-3 in the DC and CC, by multivariate group composition of cardiac index and vascular tone. Profiles in the VC were compared by a primary outcome of 90-day mortality and a 30-day ranked composite secondary outcome (death, mechanical cardiac support, intubation, new/emergent dialysis, coronary intervention/surgery) as time-to-event (survival analysis) and binary events (odds ratio, OR). Descriptive statistics were used to compare profiles by two validated risk scores for the primary outcome, and one validated score for the secondary outcome. Results The VC had median age 60 years (interquartile range {49-67}), and was 45% (n = 116) female. Multivariate profile composition by cardiac index and vascular tone differed significantly between VC profiles 1-3 and CC profiles 1-3 (p = 0.001, R-2 = 0.159). A difference was not detected between profiles in the VC vs. the DC (p = 0.59, R-2 = 0.016). VC profile 3 had worse 90-day survival than profiles 1 or 2 (HR = 4.8, 95%CI 1.4-17.1). The ranked secondary outcome was more likely in profile 1 (OR = 10.0, 1.2-81.2) and profile 3 (12.8, 1.7-97.9) compared to profile 2. Diabetes prevalence and blood urea nitrogen were lower in the high-risk profile 3 (p<0.05). No significant differences between profiles were observed for other clinical variables or the 3 clinical risk scores. Conclusions Hemodynamic profiles in ED patients with AHF, by non-invasive finger-cuff monitoring of cardiac index and vascular tone, were replicated de novo in an external cohort. Profiles showed significantly different risks of clinically-important adverse patient outcomes.	[Harrison, Nicholas Eric; Meram, Sarah; Henry, Sarah; Gupta, Sushane; Levy, Phillip] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48202 USA; [Harrison, Nicholas Eric; White, Morgan B.; Pang, Peter] Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA; [Li, Xiangrui] Washington Univ, Sch Med, Div Biostat, St Louis, MO USA; [Zhu, Dongxiao] Wayne State Univ, Dept Comp Sci, Coll Engn, Detroit, MI USA	Wayne State University; Indiana University System; Indiana University Bloomington; Washington University (WUSTL); Wayne State University	Harrison, NE (corresponding author), Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI 48202 USA.; Harrison, NE (corresponding author), Indiana Univ Sch Med, Dept Emergency Med, Indianapolis, IN 46202 USA.	Harrisne@iu.edu		Pang, Peter/0000-0003-3444-2811; Harrison, Nicholas/0000-0002-8331-7833	ClearSight monitor's manufacturer, Edwards Lifesciences Corporation	ClearSight monitor's manufacturer, Edwards Lifesciences Corporation	The ClearSight monitor's manufacturer, Edwards Lifesciences Corporation, provided funding for this study in the form of the Edwards Lifesciences Investigator-Initiated Grant. The funding was used for research assistant time and the monitors used in the study. Edwards Lifesciences Corporation also provided salary support for PL. The specific roles of these authors are articulated in the `author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad T, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145881; Ameloot K, 2015, CURR OPIN CRIT CARE, V21, P232, DOI 10.1097/MCC.0000000000000198; Beeson MS, 2020, J EMERG MED, V59, P96, DOI 10.1016/j.jemermed.2020.03.018; Benjamin EJ, 2019, CIRCULATION, V139, pE56, DOI 10.1161/CIR.0000000000000659; Bilchick KC, 2018, J CARD FAIL, V24, P43, DOI 10.1016/j.cardfail.2017.07.001; Butler J, 1998, AM J CARDIOL, V81, P41, DOI 10.1016/S0002-9149(97)00851-5; Chang PP, 2018, CIRCULATION, V138, P12, DOI 10.1161/CIRCULATIONAHA.117.027551; Chaudhry A, 2008, AM J EMERG MED, V26, P196, DOI 10.1016/j.ajem.2007.04.029; Collins SP, 2019, CIRCULATION, V139, P1157, DOI 10.1161/CIRCULATIONAHA.118.038472; Collins SP, 2018, ACAD EMERG MED, V25, P85, DOI 10.1111/acem.13331; Collins SP, 2015, JACC-HEART FAIL, V3, P737, DOI 10.1016/j.jchf.2015.05.007; Collins SP, 2015, ACAD EMERG MED, V22, P94, DOI 10.1111/acem.12538; Collins Sean P, 2009, Crit Pathw Cardiol, V8, P99, DOI 10.1097/HPC.0b013e3181b5a534; Favot M, 2019, ULTRASOUND J, V11, DOI 10.1186/s13089-019-0125-8; FORRESTER JS, 1976, NEW ENGL J MED, V295, P1404, DOI 10.1056/NEJM197612162952505; Fudim M, 2017, J AM HEART ASSOC, V6, DOI 10.1161/JAHA.117.006817; Garg N, 2021, WEST J EMERG MED, V22, P672, DOI 10.5811/westjem.2021.1.48978; de Almeida GLG, 2018, ARQ BRAS CARDIOL, V110, P270, DOI 10.5935/abc.20180046; Harjola VP, 2017, EUR J HEART FAIL, V19, P821, DOI 10.1002/ejhf.872; Harrison N, 2021, CURR HYPERTENS REP, V23, DOI 10.1007/s11906-021-01127-8; Harrison Nicholas, 2019, Curr Heart Fail Rep, V16, P21, DOI 10.1007/s11897-019-0420-5; Hernandez GA, 2019, J CARD FAIL, V25, P364, DOI 10.1016/j.cardfail.2019.03.004; Hollenberg SM, 2019, J AM COLL CARDIOL, V74, P1966, DOI 10.1016/j.jacc.2019.08.001; Lee DS, 2019, CIRCULATION, V139, P1146, DOI 10.1161/CIRCULATIONAHA.118.035509; Lee DS, 2010, CIRC-HEART FAIL, V3, P228, DOI 10.1161/CIRCHEARTFAILURE.109.885285; Martina JR, 2012, ANESTHESIOLOGY, V116, P1092, DOI 10.1097/ALN.0b013e31824f94ed; McCausland JB, 2010, ACAD EMERG MED, V17, P108, DOI 10.1111/j.1553-2712.2009.00623.x; Nohria A, 2003, J AM COLL CARDIOL, V41, P1797, DOI 10.1016/S0735-1097(03)00309-7; Nowak RM, 2017, AM J EMERG MED, V35, P536, DOI 10.1016/j.ajem.2016.12.003; Obokata M, 2017, J CARD FAIL, V23, P216, DOI 10.1016/j.cardfail.2016.10.001; Pandey A, 2018, JAMA CARDIOL, V3, P489, DOI 10.1001/jamacardio.2018.0579; Peterson PN, 2010, CIRC-CARDIOVASC QUAL, V3, P25, DOI 10.1161/CIRCOUTCOMES.109.854877; Ponikowski P, 2016, EUR HEART J, V37, P2129, DOI 10.1093/eurheartj/ehw128; Reddy YNV, 2017, J AM COLL CARDIOL, V70, P136, DOI 10.1016/j.jacc.2017.05.029; Saugel B, 2020, BRIT J ANAESTH, V125, P25, DOI 10.1016/j.bja.2020.03.013; Sax DR, 2021, ANN EMERG MED, V77, P237, DOI 10.1016/j.annemergmed.2020.09.436; Shiraishi Y, 2016, AM HEART J, V171, P33, DOI 10.1016/j.ahj.2015.10.008; Suzuki S, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.117.008316; Viau DM, 2015, HEART, V101, P1861, DOI 10.1136/heartjnl-2015-307461; von Elm E, 2007, PLOS MED, V4, P1623, DOI [10.1371/journal.pmed.0040296, 10.1371/journal.pmed.0040297]; Weil BR, 2019, JACC-BASIC TRANSL SC, V4, P527, DOI 10.1016/j.jacbts.2019.04.002; Weil BR, 2018, J AM COLL CARDIOL, V71, P2906, DOI 10.1016/j.jacc.2018.04.029; Wilkerson MD, 2010, BIOINFORMATICS, V26, P1572, DOI 10.1093/bioinformatics/btq170	43	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265895	10.1371/journal.pone.0265895	http://dx.doi.org/10.1371/journal.pone.0265895			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358231	Green Submitted, gold, Green Published			2022-12-26	WOS:000799828800051
J	Sakai, Y; Yamamoto, S; Karasawa, T; Sato, M; Nitta, K; Okada, M; Takeshige, K; Ikegami, S; Imamura, H; Horiuchi, H				Sakai, Yasunari; Yamamoto, Shuhei; Karasawa, Tatsunori; Sato, Masaaki; Nitta, Kenichi; Okada, Mayumi; Takeshige, Kanako; Ikegami, Shota; Imamura, Hiroshi; Horiuchi, Hiroshi			Effects of early rehabilitation in sepsis patients by a specialized physical therapist in an emergency center on the return to activities of daily living independence: A retrospective cohort study	PLOS ONE			English	Article							QUALITY-OF-LIFE; CRITICAL ILLNESS; CRITICALLY-ILL; EARLY EXERCISE; ORGAN FAILURE; CARE-UNIT; SURVIVORS; GUIDELINES; MORTALITY; RECOVERY	Background Early rehabilitation allows patients to better perform the activities of daily living after hospital discharge. A specialized physical therapist has been assigned as part of the early rehabilitation, but the effectiveness of the program remains unclear. We investigated how early rehabilitation provided by a specialized physical therapist affects ADL in patients with sepsis. Methods This was a retrospective cohort study. This study's subjects were sepsis patients who entered the advanced emergency critical care center of Shinshu University Hospital between April 2014 and March 2020. Electronic medical records were reviewed to obtain information on demographic characteristics, severity score, primary source of infection, therapeutic medication, the number of days after hospital admittance until rehabilitation begins, length of hospital stay, discharge to home, and an assessment of daily living activities for each patient. The patients were divided into two groups based on whether they were treated before or after a specialized physical therapist had been hired by the advanced emergency critical care center. Results Assigning a physical therapist to a patient significantly shortened the number of days until rehabilitation began. In a multivariable model, the strongest predictors of return to independent living after hospital discharge were (1) assigning a specialized physical therapist (odds ratio = 2.40; 95% confidence interval = 1.09-5.79; P = 0.050) and (2) the number of days until rehabilitation started (odds ratio = 0.24; 95% confidence interval = 0.08-0.76; P = 0.014). Conclusions Assigning a specialized physical therapist to sepsis patients at an advanced emergency critical care center significantly shortened the number of days until a patient can begin rehabilitation after hospital admittance and improved activities of daily living after hospital discharge.	[Sakai, Yasunari; Yamamoto, Shuhei; Karasawa, Tatsunori; Ikegami, Shota; Horiuchi, Hiroshi] Shinshu Univ Hosp, Dept Rehabil, Matsumoto, Nagano, Japan; [Sato, Masaaki] Shinshu Univ, Sch Hlth Sci, Dept Occupat Therapy, Matsumoto, Nagano, Japan; [Nitta, Kenichi; Okada, Mayumi; Takeshige, Kanako; Imamura, Hiroshi] Shinshu Univ Hosp, Crit Care Ctr, Dept Adv Emergency, Matsumoto, Nagano, Japan	Shinshu University; Shinshu University; Shinshu University	Sakai, Y (corresponding author), Shinshu Univ Hosp, Dept Rehabil, Matsumoto, Nagano, Japan.	yasunari_sakai1028@yahoo.co.jp	Sakai, Yasunari/GSN-8273-2022	Sakai, Yasunari/0000-0002-8279-4654	JSPS KAKENHI [JP 20K19410]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI Grant Number JP 20K19410.	Adler Joseph, 2012, Cardiopulm Phys Ther J, V23, P5; Ahn JY, 2018, YONSEI MED J, V59, P843, DOI 10.3349/ymj.2018.59.7.843; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Bailey P, 2007, CRIT CARE MED, V35, P139, DOI 10.1097/01.CCM.0000251130.69568.87; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Burtin C, 2009, CRIT CARE MED, V37, P2499, DOI 10.1097/CCM.0b013e3181a38937; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Collin C, 1988, Int Disabil Stud, V10, P61; Danai Pajman, 2005, Curr Infect Dis Rep, V7, P329, DOI 10.1007/s11908-005-0005-1; Dellinger RP, 2008, CRIT CARE MED, V36, P296, DOI 10.1097/01.CCM.0000298158.12101.41; Dick A, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-432; Goodwin AJ, 2015, CRIT CARE MED, V43, P738, DOI 10.1097/CCM.0000000000000859; Hermans G, 2008, CRIT CARE, V12, DOI 10.1186/cc7100; Hodgson CL, 2013, CRIT CARE, V17, DOI 10.1186/cc11820; Hofhuis JGM, 2008, ANESTH ANALG, V107, P1957, DOI 10.1213/ane.0b013e318187bbd8; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Kanda Y, 2013, BONE MARROW TRANSPL, V48, P452, DOI 10.1038/bmt.2012.244; Kayambu G, 2013, CRIT CARE MED, V41, P1543, DOI 10.1097/CCM.0b013e31827ca637; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Lagu T, 2012, CRIT CARE MED, V40, P754, DOI 10.1097/CCM.0b013e318232db65; Latronico N, 2011, LANCET NEUROL, V10, P931, DOI 10.1016/S1474-4422(11)70178-8; Morandi A, 2011, CURR OPIN CRIT CARE, V17, P43, DOI 10.1097/MCC.0b013e3283427243; Needham DM, 2012, CRIT CARE MED, V40, P502, DOI 10.1097/CCM.0b013e318232da75; Prescott HC, 2014, AM J RESP CRIT CARE, V190, P62, DOI 10.1164/rccm.201403-0471OC; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Sossdorf M, 2013, CRIT CARE MED, V41, pE246, DOI 10.1097/CCM.0b013e31828a2ae3; Stevens RD, 2007, INTENS CARE MED, V33, P1876, DOI 10.1007/s00134-007-0772-2; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weycker D, 2003, CRIT CARE MED, V31, P2316, DOI 10.1097/01.CCM.0000085178.80226.0B; Yende S, 2016, CRIT CARE MED, V44, P1461, DOI 10.1097/CCM.0000000000001658	30	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266348	10.1371/journal.pone.0266348	http://dx.doi.org/10.1371/journal.pone.0266348			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358285	gold, Green Published			2022-12-26	WOS:000799828800095
J	Zhang, N; Wang, YY; Hu, HJ; Lu, G; Xu, X; Dou, YQ; Cui, W; Gao, SJ; Han, M				Zhang, Ning; Wang, Ying-Ying; Hu, Hai-Juan; Lu, Gang; Xu, Xin; Dou, Yong-Qing; Cui, Wei; Gao, She-Jun; Han, Mei			Assessing serum levels of SM22 alpha as a new biomarker for patients with aortic aneurysm/dissection	PLOS ONE			English	Article							SMOOTH-MUSCLE-CELLS; C-REACTIVE PROTEIN; IN-VITRO; D-DIMER; DISSECTION; IMMUNOASSAY; STABILIZATION; ANEURYSM	Background Aortic aneurysm/dissection (AAD) is now encountered more often because of the increasing prevalence of atherosclerosis and hypertension in the population. Despite many therapeutic improvements, in particular timely and successful surgery, in-hospital mortality rates are still higher. Timely identification of patients at high risk will help improve the overall prognosis of AAD. Since early clinical and radiological signs are nonspecific, there is an urgent need for accurate biomarkers. Smooth muscle 22 alpha (SM22 alpha) is a potential marker for AAD because of its abundant expression in vascular smooth muscle, which is involved in development of AAD. Methods We prepared three different mouse models, including abdominal aortic aneurysm, neointimal hyperplasia and atherosclerosis. SM22 alpha levels were assessed in serum and vascular tissue of the mice. Next, the relationships between serum SM22 alpha level and vascular lesion were studied in mice. Finally, serum from 41 patients with AAD, 107 carotid artery stenosis (CAS) patients and 40 healthy volunteers were tested for SM22 alpha. Serum levels of SM22 alpha were measured using an enzyme-linked immunosorbent assay (ELISA). Results Compared with the controls, serum SM22 alpha levels were reduced in the models of aortic aneurysm, neointimal formation and atherosclerosis, and elevated in mice with ruptured aneurysm. Serum SM22 alpha level was negatively correlated with apoptosis rate of vascular smooth muscle cells (VSMC), ratio of intima/ media (I/M) area and plaque size. Patients with AAD had significantly higher serum SM22 alpha levels than patients with only CAS, or normal controls. Conclusion Serum SM22 alpha could be a potential predictive marker for AAD, and regulation of VSMC is a possible mechanism for the effects of SM22 alpha.	[Zhang, Ning; Wang, Ying-Ying; Xu, Xin; Dou, Yong-Qing; Han, Mei] Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Dept Biochem & Mol Biol, Coll Basic Med,Cardiovasc Med Sci Ctr, Shijiazhuang, Hebei, Peoples R China; [Zhang, Ning; Wang, Ying-Ying] Hebei Med Univ, Affiliated Hosp 4, Dept Funct Reg Diag, Shijiazhuang, Hebei, Peoples R China; [Hu, Hai-Juan; Cui, Wei] Hebei Med Univ, Affiliated Hosp 2, Dept Cardiovasc Med, Shijiazhuang, Hebei, Peoples R China; [Lu, Gang; Gao, She-Jun] Hebei Med Univ, Affiliated Hosp 4, Dept Clin Lab, Shijiazhuang, Hebei, Peoples R China; [Dou, Yong-Qing] Hebei Univ Chinese Med, Coll Integrated Chinese & Western Med, Key Lab Integrat Med Liver Kidney Patterns Hebei, Shijiazhuang, Hebei, Peoples R China	Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei Medical University; Hebei University of Chinese Medicine	Han, M (corresponding author), Hebei Med Univ, Key Lab Med Biotechnol Hebei Prov, Dept Biochem & Mol Biol, Coll Basic Med,Cardiovasc Med Sci Ctr, Shijiazhuang, Hebei, Peoples R China.	hanmei@hebmu.edu.cn	wang, yan/GSE-6489-2022; wang, yi/GVT-8516-2022; wang, yingying/GRS-3058-2022; Han, Mei/GXH-8347-2022		National Natural Science Foundation of China [91739301, 91849102]; Key Natural Science Foundation Projects of Hebei Province [H2019206028]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Natural Science Foundation Projects of Hebei Province	This work was supported by the National Natural Science Foundation of China 91739301 and 91849102 (to Mei Han.), and the Key Natural Science Foundation Projects of Hebei Province H2019206028 (to Mei Han).	Ailawadi G, 2009, J THORAC CARDIOV SUR, V138, P1392, DOI 10.1016/j.jtcvs.2009.07.075; Eggebrecht H, 2004, J AM COLL CARDIOL, V44, P804, DOI 10.1016/j.jacc.2004.04.053; Fan YN, 2020, LIFE SCI, V240, DOI 10.1016/j.lfs.2019.117069; Feil S, 2014, CIRC RES, V115, P662, DOI 10.1161/CIRCRESAHA.115.304634; Goldfinger JZ, 2014, J AM COLL CARDIOL, V64, P1725, DOI 10.1016/j.jacc.2014.08.025; He YC, 2019, BMC CARDIOVASC DISOR, V19, DOI 10.1186/s12872-019-1267-0; Huang XY, 2016, ATHEROSCLEROSIS, V246, P44, DOI 10.1016/j.atherosclerosis.2015.12.024; Kaplan-Albuquerque N, 2003, AM J PHYSIOL-HEART C, V285, pH1444, DOI 10.1152/ajpheart.00306.2003; KATOH H, 1995, J IMMUNOL METHODS, V185, P57, DOI 10.1016/0022-1759(95)00104-I; KATOH H, 1995, LANCET, V345, P191, DOI 10.1016/S0140-6736(95)90194-9; LopezCandales A, 1997, AM J PATHOL, V150, P993; Luo F, 2009, AGEING RES REV, V8, P31, DOI 10.1016/j.arr.2008.08.001; Lv P, 2021, OXID MED CELL LONGEV, V2021, DOI 10.1155/2021/5564884; Lv P, 2012, CIRC RES, V111, P697, DOI 10.1161/CIRCRESAHA.112.272013; Miao SB, 2017, ARTERIOSCL THROM VAS, V37, P1849, DOI 10.1161/ATVBAHA.117.309378; Michel JB, 2018, CARDIOVASC RES, V114, P578, DOI 10.1093/cvr/cvy006; Nienaber CA, 2016, NAT REV DIS PRIMERS, V2, DOI [10.1038/nrdp.2016.53, 10.1038/nrdp.2016.71]; Olin JW, 2003, ARTERIOSCL THROM VAS, V23, P1721, DOI 10.1161/01.ATV.0000093222.33222.D2; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Papoutsis K, 2018, ACTA PHARMACOL SIN, V39, P1243, DOI 10.1038/aps.2018.8; Ranasinghe AM, 2010, J AM COLL CARDIOL, V56, P1535, DOI 10.1016/j.jacc.2010.01.076; Schellekens DHSM, 2018, ANN SURG, V268, P120, DOI 10.1097/SLA.0000000000002278; Schillinger M, 2002, INTENS CARE MED, V28, P740, DOI 10.1007/s00134-002-1299-1; Shen JB, 2010, CIRC RES, V106, P1351, DOI 10.1161/CIRCRESAHA.109.213900; Shinohara Tadashi, 2004, J Cardiol, V43, P96; Shu YN, 2017, CARDIOVASC RES, V113, P1198, DOI 10.1093/cvr/cvx048; Shu YN, 2015, J MOL CELL CARDIOL, V84, P191, DOI 10.1016/j.yjmcc.2015.04.020; Suzuki T, 1996, CIRCULATION, V93, P1244, DOI 10.1161/01.CIR.93.6.1244; Vele E, 2016, J THROMB HAEMOST, V14, P2298, DOI 10.1111/jth.13487; Wamhoff BR, 2004, CIRC RES, V95, P981, DOI 10.1161/01.RES.0000147961.09840.fb; Weber T, 2003, CHEST, V123, P1375, DOI 10.1378/chest.123.5.1375; Zhao GZ, 2017, CIRC RES, V121, P1331, DOI 10.1161/CIRCRESAHA.117.311450; Zhao ZM, 2019, AM J TRANSL RES, V11, P509; Zhong LT, 2019, ARTERIOSCL THROM VAS, V39, pE10, DOI 10.1161/ATVBAHA.118.311917; Zuo SW, 2017, ANN VASC SURG, V45, P186, DOI 10.1016/j.avsg.2017.05.024	35	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264942	10.1371/journal.pone.0264942	http://dx.doi.org/10.1371/journal.pone.0264942			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358189	Green Published, gold			2022-12-26	WOS:000799828800021
J	Al-Ali, Z; Yasseen, AA; Al-Dujailli, A; Al-Karaqully, AJ; McAllister, KA; Jumaah, AS				Al-Ali, Zainab; Yasseen, Akeel Abed; Al-Dujailli, Arafat; Al-Karaqully, Ahmed Jafar; McAllister, Katherine Ann; Jumaah, Alaa Salah			The oxytocin receptor gene polymorphism rs2268491 and serum oxytocin alterations are indicative of autism spectrum disorder: A case-control paediatric study in Iraq with personalized medicine implications	PLOS ONE			English	Article							PLASMA OXYTOCIN; SAMPLE-SIZE; CHILDREN; OXTR; ASSOCIATION; ADOLESCENTS; DIAGNOSIS	Background Impairment of social functioning skills is a key hallmark of autism. The neuropeptide oxytocin (OXT) is a blood-based biomarker of social functioning, and a candidate for individualized treatment of ASD. The effects of OXT on the social brain are mediated by the OXT receptor (OXTR). This study assessed the clinical utility of blood OXT serum levels and the OXT receptor (OXTR) genotype as biomarkers of autism and its severity in a pediatric population in Iraq. Methods Blood samples were collected from patients with a clinical diagnosis of ASD (n = 60) and corresponding age and gender matched healthy controls (n = 60). All clinical samples were processed at the Department of Pathology and Forensic Medicine, Faculty of Medicine, University of Kufa in Iraq. Blood serum was assayed for OXT by sandwich ELISA. Receiver operator analysis (ROC) determined area under the curve (AUC), cutoff values, and sensitivity and specificity of OXT values for accuracy of diagnosis of ASD. Isolated genomic DNA was genotyped for the OXTR gene rs2268491(C/T) SNP using allele-specific PCR. The significance of genotype (CC, CT, and TT) and allele (C and T) distributions in different patient groups was assessed using odd ratios (OR) with 95% confidence intervals (CI) and the Chisquare test. All statistical analysis was performed used SPSS software. Results Study characteristics in the ASD population revealed a high level of consanguinity (36.66%), and ASD recurrence rate (11.66%) and family history (28.33%). OXT levels in patients with ASD (157.58 +/- 28.81 pg/ml) were significantly higher (p = 0.003) compared to controls (75.03 +/- 6.38 pg/ml). Within stratified ASD severity groups-OXT levels were significantly different (P = 0.032). ROC analysis determined similar AUC values for overall ASD (0.807), and stratified mild (0.793), moderate (0.889), and severe categories (0.795). The best cutoff for diagnosis of ASD was 83.8 pg/ml OXT with a sensitivity and specificity of 80% and 72.1% respectively. OXTR gene rs2268491(C/T) genotyping found that ASD patients have significantly lower (p = 0.021) genotype CC frequency and a significantly higher (p = 0.04) occurrence of the heterozygous CT genotype relative to controls. ASD subjects produced highest OXT levels with the TT genotype. T allele distribution was higher in ASD males. ASD males had significantly lower distribution of the CC genotype (48.89%) compared to females (80%) (Chi-square test: chi(2) = 4.43, df = 1, p = 0.035). Whereas distribution of the CT genotype was significantly higher in autistic males (44.45%) compared to females (13.33%) (Chi-square test: chi(2) = 4.68, df = 1, p = 0.03). Conclusion Peripheral OXT levels and OXTR genetic alterations are potential biomarkers of social functioning in the ASD patient setting. The stratification of patients with ASD into severity categories shows significant differences both in OXT levels and OXTR (rs2268491, C/T) genotype and allele distributions, that can be sex dependent. OXT based therapies will require personalized medicine tactics to correctly identify patients with ASD who require neuropeptide boosting in social settings.	[Al-Ali, Zainab] Univ Kerbala, Fac Med, Dept Pathol & Forens Med, Kerbala, Kerbala Governo, Iraq; [Yasseen, Akeel Abed; Jumaah, Alaa Salah] Univ Kufa, Fac Med, Dept Pathol & Forens Med, Kufa, Iraq; [Al-Dujailli, Arafat] Univ Kufa, Fac Med, Dept Internal Med, Kufa, Najaf Governora, Iraq; [Al-Karaqully, Ahmed Jafar] Alhussain Teaching Hosp, Psychiat Dept, Kerbala City, Kerbala Governo, Iraq; [McAllister, Katherine Ann] Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland	University of Kerbala; University of Kufa; University of Kufa; Ulster University	McAllister, KA (corresponding author), Ulster Univ, Sch Biomed Sci, Coleraine, Londonderry, North Ireland.	k.mcallister@ulster.ac.uk	Jumaah, Alaa Salah/AAE-5723-2021	Jumaah, Alaa Salah/0000-0001-9709-1460; McAllister, Katherine/0000-0002-2893-7706				Abdulamir HA, 2016, SAUDI MED J, V37, P29, DOI 10.15537/smj.2016.1.13183; American Psychiatric Association, 2013, DIAGN STAT MAN MENT, V5th, DOI [10.1176/appi.books.9780890425596.744053, DOI 10.1176/APPI.BOOKS.9780890425596]; Andrade C, 2020, INDIAN J PSYCHOL MED, V42, P102, DOI 10.4103/IJPSYM.IJPSYM_504_19; Bakermans-Kranenburg MJ, 2014, PSYCHIAT GENET, V24, P45, DOI 10.1097/YPG.0b013e3283643684; Bittles AH, 2010, P NATL ACAD SCI USA, V107, P1779, DOI 10.1073/pnas.0906079106; Bougeard C, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.744709; Elsabbagh M, 2012, AUTISM RES, V5, P160, DOI 10.1002/aur.239; Hollocks MJ, 2019, PSYCHOL MED, V49, P559, DOI 10.1017/S0033291718002283; Hong Eun Pyo, 2012, Genomics & Informatics, V10, P117, DOI 10.5808/GI.2012.10.2.117; Horiai M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-79109-0; Husarova VM, 2016, PSYCHIAT INVEST, V13, P174, DOI 10.4306/pi.2016.13.2.174; Jacob S, 2007, NEUROSCI LETT, V417, P6, DOI 10.1016/j.neulet.2007.02.001; Jacobson JD, 2014, PSYCHONEUROENDOCRINO, V40, P159, DOI 10.1016/j.psyneuen.2013.11.014; Jansen LMC, 2006, J AUTISM DEV DISORD, V36, P891, DOI 10.1007/s10803-006-0124-z; LoParo D, 2015, MOL PSYCHIATR, V20, P640, DOI 10.1038/mp.2014.77; Lord C, 2018, LANCET, V392, P508, DOI 10.1016/S0140-6736(18)31129-2; Lyall K, 2017, ANNU REV PUBL HEALTH, V38, P81, DOI [10.1146/annurev-publhealth-031816-044318, DOI 10.1146/annurev-publhealth-031816-044318]; McGraw LA, 2010, TRENDS NEUROSCI, V33, P103, DOI 10.1016/j.tins.2009.11.006; Modahl C, 1998, BIOL PSYCHIAT, V43, P270, DOI 10.1016/S0006-3223(97)00439-3; Ozonoff S, 2005, J CLIN CHILD ADOLESC, V34, P523, DOI 10.1207/s15374424jccp3403_8; Paloyelis Y, 2016, BIOL PSYCHIAT, V79, P693, DOI 10.1016/j.biopsych.2014.10.005; Parker KJ, 2017, P NATL ACAD SCI USA, V114, P8119, DOI 10.1073/pnas.1705521114; Parker KJ, 2014, P NATL ACAD SCI USA, V111, P12258, DOI 10.1073/pnas.1402236111; Patra P., 2012, INT J MED SCI PUBLIC, V1, P5; Rahmani Z, 2021, HUM GENOMICS, V15, DOI 10.1186/s40246-021-00319-2; Ronald A, 2011, AM J MED GENET B, V156B, P255, DOI 10.1002/ajmg.b.31159; Roy N, 2020, CURR PSYCHIAT REP, V22, DOI 10.1007/s11920-019-1124-y; Sambrook J., 1989, MOL CLONING A LAB MA; Tadmouri Ghazi O, 2009, Reprod Health, V6, P17, DOI 10.1186/1742-4755-6-17; Taurines R, 2014, ADHD-ATTEND DEFICIT, V6, P231, DOI 10.1007/s12402-014-0145-y; Uzefovsky F, 2019, MOL AUTISM, V10, DOI 10.1186/s13229-019-0258-4; Waterhouse L, 2017, AUTISM RES, V10, P1182, DOI 10.1002/aur.1832; Wu SP, 2005, BIOL PSYCHIAT, V58, P74, DOI 10.1016/j.biopsych.2005.03.013; Yang SH, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00221	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265217	10.1371/journal.pone.0265217	http://dx.doi.org/10.1371/journal.pone.0265217			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316293	Green Published, gold			2022-12-26	WOS:000834238000019
J	Chen, CX; Zhu, A				Chen, Caixiang; Zhu, An			Using individual preferences and BWM with entropy measures to modify the Global Entrepreneurship Index	PLOS ONE			English	Article							LEVEL	The Global Entrepreneurship and Development Institute (GEDI) annually releases the Global Entrepreneurship Index (GEI) to measure the quality and dynamics of entrepreneurship ecosystems at a national and regional level. The published Global Entrepreneurship Index takes the arithmetic mean value of the individual level of entrepreneurial attitudes, abilities and aspirations. In this paper, we alternatively consider all individual preferences among these three sub-indices, the performance results of which are obtained by means of a sophisticated manner. The entropy values of these performance results are derived to reduce the information redundancy. The best-worst method (BWM) is employed to determine the common weights with respect to each individual preference. An empirical study using the data of GEI-2019 is performed to indicate the validness of our methodology.	[Chen, Caixiang] Zhejiang Wanli Univ, Logist & ECommerce Coll, Ningbo, Peoples R China; [Zhu, An] Zheliang Wanli Univ, Fac Design & Architecture, Ningbo, Peoples R China	Zhejiang Wanli University	Chen, CX (corresponding author), Zhejiang Wanli Univ, Logist & ECommerce Coll, Ningbo, Peoples R China.	cxiang1983@126.com						Acs ZJ, 2015, REG STUD, V49, P1977, DOI 10.1080/00343404.2014.888712; Acs ZJ, 2014, RES POLICY, V43, P476, DOI 10.1016/j.respol.2013.08.016; Baker T, 2005, J INT BUS STUD, V36, P492, DOI 10.1057/palgrave.jibs.8400153; Bonyadi E., 2021, J GLOB ENTREP RES, P1, DOI [10.1007/s40497-021-00302-0, DOI 10.1007/S40497-021-00302-0]; Du K, 2018, SMALL BUS ECON, V50, P91, DOI 10.1007/s11187-017-9904-4; Fu YL, 2021, ENERG ECON, V96, DOI 10.1016/j.eneco.2021.105139; Hessels J, 2011, SMALL BUS ECON, V37, P255, DOI 10.1007/s11187-009-9233-3; Inacio E, 2021, J INTELLECT CAP, V22, P190, DOI 10.1108/JIC-09-2019-0218; Lai KK, 2005, COMPUT OPER RES, V32, P1059, DOI 10.1016/j.cor.2003.09.012; Marcotte C, 2013, ENTREP REGION DEV, V25, P174, DOI 10.1080/08985626.2012.710264; Melkonyan T, 2016, MANAGE SCI, V62, P2651, DOI 10.1287/mnsc.2015.2255; Rezaei J, 2016, OMEGA-INT J MANAGE S, V64, P126, DOI 10.1016/j.omega.2015.12.001; Rezaei J, 2015, OMEGA-INT J MANAGE S, V53, P49, DOI 10.1016/j.omega.2014.11.009; SAATY TL, 1986, MANAGE SCI, V32, P841, DOI 10.1287/mnsc.32.7.841; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sutter C, 2019, J BUS VENTURING, V34, P197, DOI 10.1016/j.jbusvent.2018.06.003; Szerb Laszlo., 2011, GLOBAL ENTREPRENEURS, DOI [10.1039/c0dt01842b, DOI 10.1039/C0DT01842B]; Terjesen S, 2016, J MANAGE, V42, P299, DOI 10.1177/0149206313486259; Valliere D, 2009, ENTREP REGION DEV, V21, P459, DOI 10.1080/08985620802332723; van Praag CM, 2007, SMALL BUS ECON, V29, P351, DOI 10.1007/s11187-007-9074-x; van Stel A, 2005, SMALL BUS ECON, V24, P311, DOI 10.1007/s11187-005-1996-6; Wang TJ, 2020, SOC INDIC RES, V149, P1, DOI 10.1007/s11205-019-02236-3; Zoltan J Acs RappaiGabor., 2011, INDEX BUILDING SYSTE, DOI [10.2139/ssrn.1945346, DOI 10.2139/SSRN.1945346]	23	0	0	7	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266187	10.1371/journal.pone.0266187	http://dx.doi.org/10.1371/journal.pone.0266187			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P6KD	35333907	gold, Green Published			2022-12-26	WOS:000784335700003
J	Elshami, M; Tuffaha, A; Yaseen, A; Alser, M; Al-Slaibi, I; Jabr, H; Ubaiat, S; Khader, S; Khraishi, R; Jaber, I; Abu Arafeh, Z; Al-Madhoun, S; Alqattaa, A; Hadi, AA; Barhoush, O; Hijazy, M; Eleyan, T; Alser, A; Abu Hziema, A; Shatat, A; Almakhtoob, F; Mohamad, B; Farhat, W; Abuamra, Y; Mousa, H; Adawi, R; Musallam, A; Abu-El-Noor, N; Bottcher, B				Elshami, Mohamedraed; Tuffaha, Aya; Yaseen, Areej; Alser, Mohammed; Al-Slaibi, Ibrahim; Jabr, Hadeel; Ubaiat, Sara; Khader, Salma; Khraishi, Reem; Jaber, Inas; Abu Arafeh, Zeina; Al-Madhoun, Sondos; Alqattaa, Aya; Hadi, Asmaa Abd El; Barhoush, Ola; Hijazy, Maysun; Eleyan, Tamara; Alser, Amany; Abu Hziema, Amal; Shatat, Amany; Almakhtoob, Falasteen; Mohamad, Balqees; Farhat, Walaa; Abuamra, Yasmeen; Mousa, Hanaa; Adawi, Reem; Musallam, Alaa; Abu-El-Noor, Nasser; Bottcher, Bettina			Awareness of ovarian cancer risk and protective factors: A national cross-sectional study from Palestine	PLOS ONE			English	Article							KNOWLEDGE; SYMPTOMS; BARRIERS; BELIEFS; THERAPY; HEALTH; WOMEN	IntroductionHaving a good awareness of ovarian cancer (OC) risk and protective factors could facilitate early diagnosis. This study aimed to assess Palestinian women's awareness about OC risk and protective factors and to identify the factors associated with having good awareness. MethodsA cross-sectional study was conducted from July 2019 to March 2020 in the two main areas of Palestine: the West Bank and Jerusalem (WBJ) and the Gaza Strip. A translated-into-Arabic version of the validated OC awareness measure was utilized. Adult women attending hospitals, primary healthcare centers, and public spaces at 11 governorates were invited to participate. The awareness level was categorized based on the number of factors recognized: poor (0 to 5), fair (6 to 10) and good (11 to 15). ResultsOf the 6095 women approached, 5618 agreed and completed the questionnaire (response rate = 92.1%). The final analysis included 5411 questionnaires. The most identified modifiable OC risk factor was 'being a smoker' (n = 4024, 74.4%), whereas the least identified was 'having in vitro fertilization treatment' (n = 1652, 30.5%). The most identified non-modifiable OC risk factor was 'having ovarian cysts' (n = 3136, 58.0%), whereas the least identified was 'having endometriosis' (n = 1880, 34.7%). The most identified OC protective factor was 'breastfeeding' (n = 4770, 88.2%), whereas the least identified was 'using the pill for a long time' (n = 930, 17.2%). Only 820 women (15.2%) displayed good awareness of OC risk and protective factors. Women from the Gaza Strip were slightly more likely than women from the WBJ to have good awareness (16.4% vs. 14.2%). In contrast, post-secondary education, higher monthly income, being married, and knowing someone with cancer were associated with an increase in the likelihood of displaying good awareness. ConclusionThe overall awareness of OC risk and protective factors in this study was low. Educational interventions are needed to improve Palestinian women's awareness.	[Elshami, Mohamedraed] Univ Hosp Cleveland Med Ctr, Dept Surg, Div Surg Oncol, Cleveland, OH 44106 USA; [Elshami, Mohamedraed; Alser, Mohammed] Minist Hlth, Gaza, Palestine; [Tuffaha, Aya; Khraishi, Reem] Najah Natl Univ, Fac Med, Nablus, Palestine; [Yaseen, Areej; Khader, Salma; Jaber, Inas; Abu Arafeh, Zeina; Barhoush, Ola; Eleyan, Tamara; Adawi, Reem] Al Quds Univ, Fac Med, Jerusalem, Palestine; [Al-Slaibi, Ibrahim] Almakassed Hosp, Jerusalem, Palestine; [Jabr, Hadeel; Alqattaa, Aya; Hadi, Asmaa Abd El; Hijazy, Maysun; Abu Hziema, Amal; Shatat, Amany; Mousa, Hanaa; Bottcher, Bettina] Islamic Univ Gaza, Fac Med, Gaza, Palestine; [Ubaiat, Sara] Al Quds Univ, Fac Med, Bethlehem, Palestine; [Al-Madhoun, Sondos; Abuamra, Yasmeen] Al Azhar Univ Gaza, Fac Med, Gaza, Palestine; [Alser, Amany] Al Shiffa Hosp, Gaza, Palestine; [Almakhtoob, Falasteen] Palestine Polytech Univ, Fac Med, Hebron, Palestine; [Mohamad, Balqees] Beit Jala Govt Hosp, Bethlehem, Palestine; [Farhat, Walaa] Al Quds Univ, Fac Med, Jenin, Palestine; [Musallam, Alaa] Al Aqsa Hosp, Deir Albalah, Palestine; [Abu-El-Noor, Nasser] Islamic Univ Gaza, Fac Nursing, Gaza, Palestine	University Hospitals of Cleveland; An Najah National University	Elshami, M (corresponding author), Univ Hosp Cleveland Med Ctr, Dept Surg, Div Surg Oncol, Cleveland, OH 44106 USA.; Elshami, M (corresponding author), Minist Hlth, Gaza, Palestine.	mohamedraed.elshami@gmail.com		Elshami, Mohamedraed/0000-0002-9977-0923				[Anonymous], 2020, INT AGENCY RES CANC; Beral V, 2008, LANCET, V371, P303, DOI 10.1016/S0140-6736(08)60167-1; Bottcher B, 2019, BMC WOMENS HEALTH, V19, DOI 10.1186/s12905-019-0869-0; Brain KE, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-171; Brand NR, 2019, ONCOLOGIST, V24, pE1371, DOI 10.1634/theoncologist.2019-0057; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Danforth KN, 2007, CANCER CAUSE CONTROL, V18, P517, DOI 10.1007/s10552-007-0130-2; Donnelly C, 2017, EUR J PUBLIC HEALTH, V27, P808, DOI 10.1093/eurpub/ckx064; ElMokhallalati Y, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0262512; Elshami M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-12044-5; Elshami M, 2021, BMC WOMENS HEALTH, V21, DOI 10.1186/s12905-021-01510-2; Elshami M, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11792-8; Elshami M, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-020-06044-1; Elshami M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-08553-4; Elshami M, 2019, J GLOB ONCOL, V5, DOI 10.1200/JGO.18.00252; Elshami M, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.18.00095; Fallowfield L, 2010, BRIT J CANCER, V103, P454, DOI 10.1038/sj.bjc.6605809; Feng YH, 2015, GYNECOL MINIM INVASI, V4, P102, DOI 10.1016/j.gmit.2015.03.003; Freij M, 2018, CLIN NURS RES, V27, P826, DOI 10.1177/1054773817704749; Fujita M, 2008, TOHOKU J EXP MED, V216, P297, DOI 10.1620/tjem.216.297; Gaudineau A, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-175; Harvard Humanitarian Initiative, KOBOTOOLBOX; Hvidberg L, 2015, PREV MED, V71, P107, DOI 10.1016/j.ypmed.2014.12.007; International Agency for Research on Cancer, 2020, GLOBAL CANC OBSERVAT; Ipoke for Information Technology, SOC MED REP PAL 2019; Jubran J SA JK, 2018, PATHWAY SURVIVALTHE; Keng Soon Lean, 2015, Asian Pac J Cancer Prev, V16, P537; Lacey JV, 2006, JNCI-J NATL CANCER I, V98, P1397, DOI 10.1093/jnci/djj375; Lockwood-Rayermann S, 2009, AM J NURS, V109, P36, DOI 10.1097/01.NAJ.0000360309.08701.73; Mohamed H., 2016, J NURSING ED PRACTIC, V6, P10; Momenimovahed Z, 2019, INT J WOMENS HEALTH, V11, P287, DOI 10.2147/IJWH.S197604; Moorman PG, 2008, AM J EPIDEMIOL, V167, P1059, DOI 10.1093/aje/kwn006; Nagle CM, 2008, EUR J CANCER, V44, P2477, DOI 10.1016/j.ejca.2008.07.009; Okunowo AA, 2018, J EPIDEMIOL GLOB HEA, V8, P34, DOI 10.2991/j.jegh.2018.07.002; Palestinian Central Bureau of Statistics, PAL CENTR BUR STAT P; Palestinian Central Bureau of Statistics, 2017, PCBS LEV LIV PAL; Palestinian Central Bureau of Statistics, 2020, OCC INT WORK DAY HE; Pedersen AF, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4287-8; Puckett MC, 2018, J CANCER EDUC, V33, P1285, DOI 10.1007/s13187-017-1245-0; Rebbeck TR, 2009, JNCI-J NATL CANCER I, V101, P80, DOI 10.1093/jnci/djn442; Reid F, 2021, INT J GYNECOL CANCER, V31, P238, DOI 10.1136/ijgc-2019-000983; Russo A, 2009, CRIT REV ONCOL HEMAT, V69, P28, DOI 10.1016/j.critrevonc.2008.06.003; Saki S, 2021, J PUBLIC HEALTH RES, V10, DOI 10.4081/jphr.2021.2073; Simon AE, 2012, J FAM PLAN REPROD H, V38, P167, DOI 10.1136/jfprhc-2011-100118; United Nations Childrens Fund, 2020, BOOST BREASTF BRING; United Nations Relief and Works Agency for Palestine Refugees in the Near East, 2021, WE WORK GAZA STRIP; United Nations Relief and Works Agency for Palestine Refugees in the Near East, MED TERM STRAT 2016; United Nations Relief and Works Agency for Palestine Refugees in the Near East, 2021, WE WORK W BANK; UNRWA (UN Relief and Works Agency), 2016, 132 UNRWA; Viswanath K, 2006, J HEALTH COMMUN, V11, P1, DOI 10.1080/10810730600637426; World Population Review, PAL POP 2021; Zhou B, 2008, GYNECOL ONCOL, V108, P641, DOI 10.1016/j.ygyno.2007.12.003	52	4	4	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265452	10.1371/journal.pone.0265452	http://dx.doi.org/10.1371/journal.pone.0265452			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312720	Green Published, gold			2022-12-26	WOS:000803647900003
J	Hazard, R; Bagenda, D; Patterson, AJ; Hoffman, JT; Lisco, SJ; Urayeneza, O; Ntihinyurwa, P; Moore, CC				Hazard, Riley; Bagenda, Danstan; Patterson, Andrew J.; Hoffman, Julia T.; Lisco, Steven J.; Urayeneza, Olivier; Ntihinyurwa, Polyphile; Moore, Christopher C.			Performance of the Universal Vital Assessment (UVA) mortality risk score in hospitalized adults with infection in Rwanda: A retrospective external validation study	PLOS ONE			English	Article							QSOFA SCORE; SEPSIS; TUBERCULOSIS	BackgroundWe previously derived a Universal Vital Assessment (UVA) score to better risk-stratify hospitalized patients in sub-Saharan Africa, including those with infection. Here, we aimed to externally validate the performance of the UVA score using previously collected data from patients hospitalized with acute infection in Rwanda. MethodsWe performed a secondary analysis of data collected from adults >= 18 years with acute infection admitted to Gitwe District Hospital in Rwanda from 2016 until 2017. We calculated the UVA score from the time of admission and at 72 hours after admission. We also calculated quick sepsis-related organ failure assessment (qSOFA) and modified early warning scores (MEWS). We calculated amalgamated qSOFA scores by inserting UVA cut-offs into the qSOFA score, and modified UVA scores by removing the HIV criterion. The performance of each score determined by the area under the receiver operator characteristic curve (AUC) was the primary outcome measure. ResultsWe included 573 hospitalized adult patients with acute infection of whom 40 (7%) died in-hospital. The admission AUCs (95% confidence interval [CI]) for the prediction of mortality by the scores were: UVA, 0.77 (0.68-0.85); modified UVA, 0.77 (0.68-0.85); qSOFA, 0.66 (0.56-0.75), amalgamated qSOFA, 0.71 (0.61-0.80); and MEWS, 0.74 (0.64, 0.83). The positive predictive values (95% CI) of the scores at commonly used cut-offs were: UVA >4, 0.35 (0.15-0.59); modified UVA >4, 0.35 (0.15-0.59); qSOFA >1, 0.14 (0.07-0.24); amalgamated qSOFA >1, 0.44 (0.20-0.70); and MEWS >5, 0.14 (0.08-0.22). The 72 hour (N = 236) AUC (95% CI) for the prediction of mortality by UVA was 0.59 (0.43-0.74). The Chi-Square test for linear trend did not identify an association between mortality and delta UVA score at 72 hours (p = 0.82). ConclusionsThe admission UVA score and amalgamated qSOFA score had good predictive ability for mortality in adult patients admitted to hospital with acute infection in Rwanda. The UVA score could be used to assist with triage decisions and clinical interventions, for baseline risk stratification in clinical studies, and in a clinical definition of sepsis in Africa.	[Hazard, Riley] Univ Melbourne, Sch Populat & Global Hlth, Melbourne, Australia; [Bagenda, Danstan; Hoffman, Julia T.; Lisco, Steven J.] Univ Nebraska Med Ctr, Dept Anesthesiol, Omaha, NE USA; [Patterson, Andrew J.] Emory Univ, Dept Anesthesiol, Atlanta, GA USA; [Urayeneza, Olivier] Univ Gitwe, Sch Med, Gitwe, Rwanda; [Urayeneza, Olivier] Calif Hosp Med Ctr, Dept Surg, Los Angeles, CA USA; [Ntihinyurwa, Polyphile] Univ Rwanda, Dept Obstet & Gynecol, Kigali, Rwanda; [Moore, Christopher C.] Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA	University of Melbourne; University of Nebraska System; University of Nebraska Medical Center; Emory University; University of Rwanda; University of Virginia	Moore, CC (corresponding author), Univ Virginia, Dept Med, Div Infect Dis & Int Hlth, Charlottesville, VA USA.	ccm5u@virginia.edu		Moore, Christopher/0000-0003-4649-0511	Life Priority Fund; Hellman Foundation; King Baudouin Foundation; European Society of Intensive Care Medicine; Society of Critical Care Medicine through the Surviving Sepsis Campaign; University of Virginia Global Infectious Diseases Institute	Life Priority Fund; Hellman Foundation; King Baudouin Foundation; European Society of Intensive Care Medicine; Society of Critical Care Medicine through the Surviving Sepsis Campaign; University of Virginia Global Infectious Diseases Institute	The original study enrollment, the data from which the authors performed retrospective analyses, was funded by the Life Priority Fund, the Hellman Foundation, and the King Baudouin Foundation. The original research project was also supported by the European Society of Intensive Care Medicine and the Society of Critical Care Medicine through the Surviving Sepsis Campaign. The secondary analysis described in this paper was supported by the University of Virginia Global Infectious Diseases Institute. The funders had no additional role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript.	Aluisio AR, 2018, AM J EMERG MED, V36, P2010, DOI 10.1016/j.ajem.2018.03.014; Amir A, 2016, J CRIT CARE, V33, P78, DOI 10.1016/j.jcrc.2016.01.023; Andrews B, 2017, JAMA-J AM MED ASSOC, V318, P1233, DOI 10.1001/jama.2017.10913; Asiimwe SB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089879; Cummings MJ, 2022, CRIT CARE, V26, DOI 10.1186/s13054-022-03907-3; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Gupta RK, 2015, AIDS, V29, P1987, DOI 10.1097/QAD.0000000000000802; Hazard RH, 2019, OPEN FORUM INFECT DI, V6, DOI 10.1093/ofid/ofz140; Huson MAM, 2017, INFECTION, V45, P893, DOI 10.1007/s15010-017-1057-5; Huson MAM, 2017, TRAVEL MED INFECT DI, V15, P76, DOI 10.1016/j.tmaid.2016.10.014; Kerkhoff AD, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09895-7; Klinger A, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-040361; Lewis JM, 2020, CLIN INFECT DIS, V71, P2547, DOI 10.1093/cid/ciz1119; Madut DB, 2021, TROP MED INT HEALTH, V26, P1668, DOI 10.1111/tmi.13683; Moore CC, 2019, CLIN INFECT DIS, V68, P266, DOI 10.1093/cid/ciy472; Moore CC, 2017, BMJ GLOB HEALTH, V2, DOI 10.1136/bmjgh-2017-000344; Nakitende I, 2020, CLIN MED, V20, P67, DOI 10.7861/clinmed.2019-0196; Rudd KE, 2020, LANCET, V395, P200, DOI 10.1016/S0140-6736(19)32989-7; Rudd KE, 2018, JAMA-J AM MED ASSOC, V320, P2039, DOI 10.1001/jama.2018.14477; Schmedding M, 2019, AM J TROP MED HYG, V100, P202, DOI 10.4269/ajtmh.18-0577; Singer M, 2016, JAMA-J AM MED ASSOC, V315, P801, DOI 10.1001/jama.2016.0287; Subbe CP, 2001, QJM-MON J ASSOC PHYS, V94, P521, DOI 10.1093/qjmed/94.10.521; Urayeneza O, 2018, CRIT CARE MED, V46, P1357, DOI 10.1097/CCM.0000000000003227; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120	24	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265713	10.1371/journal.pone.0265713	http://dx.doi.org/10.1371/journal.pone.0265713			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320314	gold, Green Published			2022-12-26	WOS:000784240600047
J	Kim, IJ; Na, H				Kim, In Jung; Na, Hyuntae			An efficient algorithm calculating common solvent accessible volume	PLOS ONE			English	Article							HYDRATION SHELL-MODEL; SOLUTE MOLECULES; FREE-ENERGIES; SURFACE-AREA; DYNAMICS; MACROMOLECULES; SOLVATION; MECHANICS; PROTEINS; PACKING	The solvent accessible surface area and the solvent accessible volume are measurements commonly used in implicit solvent models to include the effect of forces exerted by solvents on the protein surfaces (or the atoms on protein surfaces). The two measurements have limitations in describing interactions between proteins (or proteins' atoms) mediated/bridged by solvents. This is because describing the interactions between proteins should be able to capture the chain of protein-solvent-protein interactions while the solvent accessible surface area or the solvent accessible volume can capture only protein-solvent interactions. If we represent the solvent as a continuous medium, we can consider an atom of a protein can effectively interact with the solvent within a certain distance from its surface (or its own solvent-interacting sphere). In this case, the protein-solvent-protein interactions can be measured by the amount of solvent interacting with two proteins' atoms at the same time (or the volume shared by the two atoms' solvent-interacting spheres excluding the volumes occupied by proteins' atoms). We call the shared volume as the common solvent accessible volume (CSAV); there has been no method developed to determine the CSAV. In this work, we propose a new sweep-line-based method that efficiently calculates the common solvent accessible volume. The performance and accuracy of the proposed sweep-line-based method are compared with those of the naive voxel-based method. The proposed method takes log-linear time to the number of atoms involved in a CSAV calculation and linear time to the resolution. Our results, tested with 52 protein structures of various sizes, show that the proposed sweep-line-based method is superior to the voxel-based method in both computational efficiency and accuracy.	[Kim, In Jung; Na, Hyuntae] Penn State Harrisburg, Dept Comp Sci, Middletown, PA 17057 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University	Na, H (corresponding author), Penn State Harrisburg, Dept Comp Sci, Middletown, PA 17057 USA.	hzn17@psu.edu		Kim, In Jung/0000-0001-5797-8235; Na, Hyuntae/0000-0002-9793-7363				Ahmad M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1258; Chen CR, 2015, BMC BIOINFORMATICS, V16, DOI 10.1186/s12859-015-0531-2; CONNOLLY ML, 1985, J AM CHEM SOC, V107, P1118, DOI 10.1021/ja00291a006; Fogarty AC, 2013, CHEM SOC REV, V42, P5672, DOI 10.1039/c3cs60091b; Fogolari F, 2003, BIOPHYS J, V85, P159, DOI 10.1016/S0006-3495(03)74462-2; Georgiev GD, 2020, ALGORITHM MOL BIOL, V15, DOI 10.1186/s13015-020-00168-z; GERSTEIN M, 1995, J MOL BIOL, V249, P955, DOI 10.1006/jmbi.1995.0351; GIBSON KD, 1987, J PHYS CHEM-US, V91, P4121, DOI 10.1021/j100299a035; Hayryan S, 2005, J COMPUT CHEM, V26, P334, DOI 10.1002/jcc.20125; KANG YK, 1987, J PHYS CHEM-US, V91, P4105, DOI 10.1021/j100299a032; KANG YK, 1987, J PHYS CHEM-US, V91, P4118, DOI 10.1021/j100299a034; KANG YK, 1987, J PHYS CHEM-US, V91, P4109, DOI 10.1021/j100299a033; Kleinjung J, 2014, CURR OPIN STRUC BIOL, V25, P126, DOI 10.1016/j.sbi.2014.04.003; Koga K, 1997, J CHEM PHYS, V106, P9781, DOI 10.1063/1.473867; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Majumdar AB, 2020, PHYS BIOL, V17, DOI 10.1088/1478-3975/ab74b3; Mongan J, 2007, J CHEM THEORY COMPUT, V3, P156, DOI 10.1021/ct600085e; MULLER JJ, 1983, J APPL CRYSTALLOGR, V16, P74, DOI 10.1107/S0021889883009978; PAVANI R, 1982, COMPUT CHEM, V6, P133, DOI 10.1016/0097-8485(82)80006-5; PAVLOV MY, 1983, BIOPOLYMERS, V22, P1507, DOI 10.1002/bip.360220607; PETITJEAN M, 1994, J COMPUT CHEM, V15, P507, DOI 10.1002/jcc.540150504; PONDER JW, 1987, J COMPUT CHEM, V8, P1016, DOI 10.1002/jcc.540080710; Qiu D, 1997, J PHYS CHEM A, V101, P3005, DOI 10.1021/jp961992r; RASHIN AA, 1986, BIOCHEMISTRY-US, V25, P3619, DOI 10.1021/bi00360a021; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; RICHARDS FM, 1974, J MOL BIOL, V82, P1, DOI 10.1016/0022-2836(74)90570-1; RICHMOND TJ, 1984, J MOL BIOL, V178, P63, DOI 10.1016/0022-2836(84)90231-6; ROWLINSON JS, 1963, MOL PHYS, V6, P517, DOI 10.1080/00268976300100581; Shamos M., 1976, 17 ANN S FDN COMP SC, P208; STILL WC, 1990, J AM CHEM SOC, V112, P6127, DOI 10.1021/ja00172a038; Wagoner JA, 2006, P NATL ACAD SCI USA, V103, P8331, DOI 10.1073/pnas.0600118103	32	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265614	10.1371/journal.pone.0265614	http://dx.doi.org/10.1371/journal.pone.0265614			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312721	gold, Green Published			2022-12-26	WOS:000803647900007
J	Oliveira, R; Pinho, E; Sousa, AL; Dias, O; Azevedo, NF; Almeida, C				Oliveira, Ricardo; Pinho, Eva; Sousa, Ana Luisa; Dias, Oscar; Azevedo, Nuno Filipe; Almeida, Carina			Modelling aptamers with nucleic acid mimics (NAM): From sequence to three-dimensional docking	PLOS ONE			English	Article							WEB SERVER; GENETIC ALGORITHM; PROTEIN-PROTEIN; DNA APTAMER; SELEX; SELECTION	Aptamers are single-stranded oligonucleotides, formerly evolved by Systematic Evolution of Ligands by EXponential enrichment (SELEX), that fold into functional three-dimensional structures. Such conformation is crucial for aptamers' ability to bind to a target with high affinity and specificity. Unnatural nucleotides have been used to develop nucleic acid mimic (NAM) aptamers with increased performance, such as biological stability. Prior knowledge of aptamer-target interactions is critical for applying post-SELEX modifications with unnatural nucleotides since it can affect aptamers' structure and performance. Here, we describe an easy-to-apply in silico workflow using free available software / web servers to predict the tertiary conformation of NAM, DNA and RNA aptamers, as well as the docking with the target molecule. Representative 2MODIFIER LETTER PRIME-O-methyl (2MODIFIER LETTER PRIMEOMe), locked nucleic acid (LNA), DNA and RNA aptamers, with experimental data deposited in Protein Data Bank, were selected to validate the workflow. All aptamers' tertiary structure and docking models were successfully predicted with good structural similarity to the experimental data. Thus, this workflow will boost the development of aptamers, particularly NAM aptamers, by assisting in the rational modification of specific nucleotides and avoiding trial-and-error approaches.	[Oliveira, Ricardo; Pinho, Eva; Sousa, Ana Luisa; Almeida, Carina] INIAV Natl Inst Agrarian & Veterinarian Res, Rua Lagidos, Vila Do Conde, Portugal; [Oliveira, Ricardo; Pinho, Eva; Azevedo, Nuno Filipe; Almeida, Carina] Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Rua Dr Roberto Frias, Porto, Portugal; [Dias, Oscar; Almeida, Carina] Univ Minho, Ctr Biol Engn CEB, Campus Gualtar, Braga, Portugal; [Dias, Oscar] Associate Lab, LABBELS, Guimaraes, Portugal	Universidade do Porto; Universidade do Minho	Almeida, C (corresponding author), INIAV Natl Inst Agrarian & Veterinarian Res, Rua Lagidos, Vila Do Conde, Portugal.; Almeida, C (corresponding author), Univ Porto, Fac Engn, LEPABE Lab Proc Engn Environm Biotechnol & Energy, Rua Dr Roberto Frias, Porto, Portugal.; Almeida, C (corresponding author), Univ Minho, Ctr Biol Engn CEB, Campus Gualtar, Braga, Portugal.	carina.almeida@iniav.pt	Pinho, Eva/AAD-6446-2020; Dias, Oscar/A-4359-2010	Pinho, Eva/0000-0002-0321-9089; Dias, Oscar/0000-0002-1765-7178; Almeida, Carina/0000-0002-0175-1119	FEDER funds through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI) [POCI-01-0145-FEDER-028659]; national funds (PIDDAC) through FCT/MCTES; Laboratory for Process Engineering, Environment, Biotechnology and Energy -LEPABE - national funds through the FCT/MCTES (PIDDAC) [UIDB/00511/2020]; FCT [SFRH/BD/138883/2018]	FEDER funds through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI); national funds (PIDDAC) through FCT/MCTES(Portuguese Foundation for Science and Technology); Laboratory for Process Engineering, Environment, Biotechnology and Energy -LEPABE - national funds through the FCT/MCTES (PIDDAC)(Portuguese Foundation for Science and Technology); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was financially supported by: Project POCI-01-0145-FEDER-028659, funded by FEDER funds through COMPETE2020 -Programa Operacional Competitividade e Internacionalizacao (POCI) and by national funds (PIDDAC) through FCT/MCTES; Base Funding -UIDB/00511/2020 of the Laboratory for Process Engineering, Environment, Biotechnology and Energy -LEPABE-funded by national funds through the FCT/MCTES (PIDDAC). RO thanks FCT for the PhD Fellowship SFRH/BD/138883/2018. OD acknowledges FCT for the Assistant Research contract obtained under CEEC Individual 2018.	Ahmad NA, 2021, J MOL GRAPH MODEL, V105, DOI 10.1016/j.jmgm.2021.107872; Allouche AR, 2011, J COMPUT CHEM, V32, P174, DOI 10.1002/jcc.21600; Andersen ES, 2010, NEW BIOTECHNOL, V27, P184, DOI 10.1016/j.nbt.2010.02.012; Bruno J., 2017, J BIONANOSCI, V11, P183, DOI [10.1166/jbns.2017.1437, DOI 10.1166/JBNS.2017.1437]; Buglak AA, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21228420; Cai SD, 2018, ANALYST, V143, P5317, DOI 10.1039/c8an01467a; Cheng CY, 2015, METHOD ENZYMOL, V553, P35, DOI 10.1016/bs.mie.2014.10.051; Dans PD, 2019, CHEM-US, V5, P51, DOI 10.1016/j.chempr.2018.09.015; Darmostuk M, 2015, BIOTECHNOL ADV, V33, P1141, DOI 10.1016/j.biotechadv.2015.02.008; Davlieva M, 2014, NUCLEIC ACIDS RES, V42, P10795, DOI 10.1093/nar/gku743; Duhovny D, 2002, LECT NOTES COMPUT SC, V2452, P185; Gao SX, 2016, ANAL BIOANAL CHEM, V408, P4567, DOI 10.1007/s00216-016-9556-2; Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188; Heiat M, 2016, J BIOTECHNOL, V230, P34, DOI 10.1016/j.jbiotec.2016.05.021; Hernandez LI, 2015, CURR TOP MED CHEM, V15, P1066, DOI 10.2174/1568026615666150413153717; Hopfinger MC, 2020, NUCLEIC ACIDS RES, V48, P8901, DOI 10.1093/nar/gkaa654; Jeddi I, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-01348-5; Jones G, 1997, J MOL BIOL, V267, P727, DOI 10.1006/jmbi.1996.0897; Jossinet F, 2015, 2015 IEEE 1ST INTERNATIONAL WORKSHOP ON VIRTUAL AND AUGMENTED REALITY FOR MOLECULAR SCIENCE (VARMS@IEEEVR), P37, DOI 10.1109/VARMS.2015.7151721; Kato K, 2016, NAT STRUCT MOL BIOL, V23, P395, DOI 10.1038/nsmb.3200; Kim YS, 2014, ADV BIOCHEM ENG BIOT, V140, P29, DOI 10.1007/10_2013_225; Klingler C, 2020, FASEB J, V34, P4573, DOI 10.1096/fj.201902696; Krieger E, 2015, J COMPUT CHEM, V36, P996, DOI 10.1002/jcc.23899; Kruger A, 2018, BIOMOLECULES, V8, DOI 10.3390/biom8030083; Lapa SA, 2016, MOL BIOTECHNOL, V58, P79, DOI 10.1007/s12033-015-9907-9; Lebars I, 2007, NUCLEIC ACIDS RES, V35, P6103, DOI 10.1093/nar/gkm655; Martinez HM, 2008, J BIOMOL STRUCT DYN, V25, P669, DOI 10.1080/07391102.2008.10531240; Miller MT, 2016, PROTEIN SCI, V25, P46, DOI 10.1002/pro.2776; Morihiro K, 2017, MOL BIOSYST, V13, P235, DOI 10.1039/c6mb00538a; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Parisien M, 2009, RNA, V15, P1875, DOI 10.1261/rna.1700409; Phillips JC, 2020, J CHEM PHYS, V153, DOI 10.1063/5.0014475; Popenda M, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks339; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Ruigrok VJB, 2012, INT J MOL SCI, V13, P10537, DOI 10.3390/ijms130810537; Sabri MZ, 2020, BIOPHYS CHEM, V267, DOI 10.1016/j.bpc.2020.106492; Salentin S, 2015, NUCLEIC ACIDS RES, V43, pW443, DOI 10.1093/nar/gkv315; Savory N, 2010, BIOSENS BIOELECTRON, V26, P1386, DOI 10.1016/j.bios.2010.07.057; Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004; Sharma TK, 2017, BIOTECHNOL ADV, V35, P275, DOI 10.1016/j.biotechadv.2017.01.003; Stasiewicz J, 2019, BMC STRUCT BIOL, V19, DOI 10.1186/s12900-019-0103-1; Stoltenburg R, 2007, BIOMOL ENG, V24, P381, DOI 10.1016/j.bioeng.2007.06.001; Tinoco I, 1999, J MOL BIOL, V293, P271, DOI 10.1006/jmbi.1999.3001; Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206; Tuszynska I, 2015, NUCLEIC ACIDS RES, V43, pW425, DOI 10.1093/nar/gkv493; van Dijk M, 2009, NUCLEIC ACIDS RES, V37, pW235, DOI 10.1093/nar/gkp287; Vorobyeva MA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19020470; Wang J, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv141; Wang J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20174116; Wang T, 2019, BIOTECHNOL ADV, V37, P28, DOI 10.1016/j.biotechadv.2018.11.001; Xayaphoummine A, 2005, NUCLEIC ACIDS RES, V33, pW605, DOI 10.1093/nar/gki447; Yan YM, 2017, NUCLEIC ACIDS RES, V45, pW365, DOI 10.1093/nar/gkx407; Zhang Y, 2020, COMPUT STRUCT BIOTEC, V18, P2416, DOI 10.1016/j.csbj.2020.08.017; Zhao CH, 2017, METHODS MOL BIOL, V1654, P3, DOI 10.1007/978-1-4939-7231-9_1; Zhou QT, 2015, J CHEM THEORY COMPUT, V11, P5939, DOI 10.1021/acs.jctc.5b00707; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	56	2	2	6	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264701	10.1371/journal.pone.0264701	http://dx.doi.org/10.1371/journal.pone.0264701			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320268	Green Published, gold			2022-12-26	WOS:000784240600046
J	Wilson, S; Mouet, A; Jeanne-Leroyer, C; Borgey, F; Odinet-Raulin, E; Humbert, X; Le Hello, S; Thibon, P				Wilson, Sarah; Mouet, Audrey; Jeanne-Leroyer, Camille; Borgey, France; Odinet-Raulin, Emmanuelle; Humbert, Xavier; Le Hello, Simon; Thibon, Pascal			Professional practice for COVID-19 risk reduction among health care workers: A cross-sectional study with matched case-control comparison	PLOS ONE			English	Article							TRANSMISSION	BackgroundHealth care workers (HCWs) are particularly exposed to COVID-19 and therefore it is important to study preventive measures in this population. AimTo investigate socio-demographic factors and professional practice associated with the risk of COVID-19 among HCWs in health establishments in Normandy, France. MethodsA cross-sectional and 3 case-control studies using bootstrap methods were conducted in order to explore the possible risk factors that lead to SARS-CoV2 transmission within HCWs. Case-control studies focused on risk factors associated with (a) care of COVID-19 patients, (b) care of non COVID-19 patients and (c) contacts between colleagues. Participants2,058 respondents, respectively 1,363 (66.2%) and 695 (33.8%) in medical and medico-social establishments, including HCW with and without contact with patients. Results301 participants (14.6%) reported having been infected by SARS-CoV2. When caring for COVID-19 patients, HCWs who declared wearing respirators, either for all patient care (ORa 0.39; 95% CI: 0.29-0.51) or only when exposed to aerosol-generating procedures (ORa 0.56; 95% CI: 0.43-0.70), had a lower risk of infection compared with HCWs who declared wearing mainly surgical masks. During care of non COVID-19 patients, wearing mainly a respirator was associated with a higher risk of infection (ORa 1.84; 95% CI: 1.06-3.37). An increased risk was also found for HCWs who changed uniform in workplace changing rooms (ORa 1.93; 95% CI: 1.63-2.29). ConclusionCorrect use of PPE adapted to the situation and risk level is essential in protecting HCWs against infection.	[Wilson, Sarah; Mouet, Audrey; Jeanne-Leroyer, Camille; Le Hello, Simon] CHU, Serv Hyg Hosp & Controle Infect, Caen, Normandie, France; [Borgey, France; Thibon, Pascal] CHU, Ctr Appui Prevent Infect Associees Soins, CPias Normandie, Caen, Normandie, France; [Odinet-Raulin, Emmanuelle] Agence Reg Sante Normandie, Caen, Normandie, France; [Humbert, Xavier] Normandie Univ, Dept Med Gen, UNICAEN, UFR Sante, Caen, Normandie, France; [Le Hello, Simon] Normandie Univ, Grp Rech Adaptat Microbienne GRAM 2 0, EA2656, UNIROUEN,UNICAEN, Caen, Normandie, France	CHU de Caen NORMANDIE; Universite de Caen Normandie; CHU de Caen NORMANDIE; Universite de Caen Normandie; Universite de Caen Normandie; Universite de Caen Normandie	Thibon, P (corresponding author), CHU, Ctr Appui Prevent Infect Associees Soins, CPias Normandie, Caen, Normandie, France.	thibon-p@chu-caen.fr	Le Hello, Simon/GWM-8436-2022	Wilson, Sarah/0000-0002-5579-6996				Actualisation des Prcautions standard, ET SANT ET MED SOC S; [Anonymous], 2020, RECOMMANDATIONS SF2H; [Anonymous], RATIONAL USE PERSONA; [Anonymous], AVIS RELATIF MESURES; [Anonymous], RECENSEMENT NATL CAS; [Anonymous], 2020, BILAN DMOGRAPHIQUE 2; ars.sante, RAPPORT DACTIVIT 201; Ather B, 2021, AIRBORNE PRECAUTIONS; Canton R, 2021, REV ESP QUIM, V34, P419, DOI 10.37201/req/071.2021; Celebi G, 2020, AM J INFECT CONTROL, V48, P1225, DOI 10.1016/j.ajic.2020.07.039; Chou R, 2020, ANN INTERN MED, V173, P120, DOI 10.7326/M20-1632; Chu DK, 2020, LANCET, V395, P1973, DOI 10.1016/S0140-6736(20)31142-9; Cook TM, 2020, ANAESTHESIA, V75, P920, DOI 10.1111/anae.15071; Dhama K, 2020, CLIN MICROBIOL REV, V33, DOI 10.1128/CMR.00028-20; Harris RJ, 2021, NEW ENGL J MED, V385, P759, DOI 10.1056/NEJMc2107717; JHU, COVID 19 DASHB CTR S; Lee K, 2009, GLOB INST, P1; Lentz RJ, 2021, INFECT CONT HOSP EP, V42, P381, DOI 10.1017/ice.2020.455; Liu Y, 2020, NATURE, V582, P557, DOI 10.1038/s41586-020-2271-3; Ng K, 2020, ANN INTERN MED, V172, P766, DOI 10.7326/L20-0175; Picheansanthian Wilawan, 2015, JBI Database System Rev Implement Rep, V13, P188, DOI 10.11124/jbisrir-2015-1817; Sahu AK, 2020, AM J EMERG MED, V38, P1727, DOI 10.1016/j.ajem.2020.05.113; Tang JW, 2021, J HOSP INFECT, V110, P89, DOI 10.1016/j.jhin.2020.12.022; van Doremalen N, 2020, NEW ENGL J MED, V382, P1564, DOI [10.1056/NEJMc2004973, 10.1101/2020.03.09.20033217]; Violante T, 2020, MED LAV, V111, P365, DOI 10.23749/mdl.v111i5.9692; Wiersinga WJ, 2020, JAMA-J AM MED ASSOC, V324, P782, DOI 10.1001/jama.2020.12839	26	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264232	10.1371/journal.pone.0264232	http://dx.doi.org/10.1371/journal.pone.0264232			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35313328	Green Published, Green Submitted, gold			2022-12-26	WOS:000803647900020
J	Harold, LK; Jinich, A; Hards, K; Cordeiro, A; Keighley, LM; Cross, A; McNeil, MB; Rhee, K; Cook, GM				Harold, Liam K.; Jinich, Adrian; Hards, Kiel; Cordeiro, Alexandra; Keighley, Laura M.; Cross, Alec; McNeil, Matthew B.; Rhee, Kyu; Cook, Gregory M.			Deciphering functional redundancy and energetics of malate oxidation in mycobacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CITRIC-ACID CYCLE; TUBERCULOSIS; DEHYDROGENASE; PROTEIN; METABOLISM; SMEGMATIS; HYPOXIA; GENE; MICE	Oxidation of malate to oxaloacetate, catalyzed by either malate dehydrogenase (Mdh) or malate quinone oxidoreduc-tase (Mqo), is a critical step of the tricarboxylic acid cycle. Both Mqo and Mdh are found in most bacterial genomes, but the level of functional redundancy between these enzymes remains unclear. A bioinformatic survey revealed that Mqo was not as widespread as Mdh in bacteria but that it was highly conserved in mycobacteria. We therefore used mycobacteria as a model genera to study the functional role(s) of Mqo and its redun-dancy with Mdh. We deleted mqo from the environmental saprophyte Mycobacterium smegmatis, which lacks Mdh, and found that Mqo was essential for growth on nonfermentable carbon sources. On fermentable carbon sources, the Delta mqo mutant exhibited delayed growth and lowered oxygen con-sumption and secreted malate and fumarate as terminal end products. Furthermore, heterologous expression of Mdh from the pathogenic species Mycobacterium tuberculosis shortened the delayed growth on fermentable carbon sources and restored growth on nonfermentable carbon sources at a reduced growth rate. In M. tuberculosis, CRISPR interference of either mdh or mqo expression resulted in a slower growth rate compared to controls, which was further inhibited when both genes were knocked down simultaneously. These data reveal that exergonic Mqo activity powers mycobacterial growth under nonenergy limiting conditions and that ender-gonic Mdh activity complements Mqo activity, but at an energetic cost for mycobacterial growth. We propose Mdh is maintained in slow-growing mycobacterial pathogens for use under conditions such as hypoxia that require reductive tricarboxylic acid cycle activity.	[Harold, Liam K.; Hards, Kiel; Keighley, Laura M.; Cross, Alec; McNeil, Matthew B.; Cook, Gregory M.] Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin, New Zealand; [Harold, Liam K.; Hards, Kiel; McNeil, Matthew B.; Cook, Gregory M.] Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand; [Jinich, Adrian; Rhee, Kyu] Weill Cornell Med Coll, Weill Dept Med, Div Infect Dis, New York, NY USA	University of Otago; University of Auckland; Cornell University	Harold, LK; Cook, GM (corresponding author), Univ Otago, Sch Biomed Sci, Dept Microbiol & Immunol, Dunedin, New Zealand.; Harold, LK; Cook, GM (corresponding author), Univ Auckland, Maurice Wilkins Ctr Mol Biodiscovery, Auckland, New Zealand.	liamharold@gmail.com; greg.cook@otago.ac.nz		Jinich, Adrian/0000-0001-8616-9250	Maurice Wilkins Centre; Marsden Fund; Royal Society; Hanna Gray Fellowship; Howard Hughes Medical Institute	Maurice Wilkins Centre; Marsden Fund(Royal Society of New ZealandMarsden Fund (NZ)); Royal Society(Royal Society of London); Hanna Gray Fellowship; Howard Hughes Medical Institute(Howard Hughes Medical Institute)	This work was financially supported by the Maurice Wilkins Centre for Molecular Bio-discovery and the Marsden Fund, Royal Society of New Zealand. A. J. was supported by a Hanna Gray Fellowship, Howard Hughes Medical Institute.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asnicar F, 2015, PEERJ, V3, DOI 10.7717/peerj.1029; Aung HL, 2015, MICROBIOL-SGM, V161, P648, DOI 10.1099/mic.0.000015; Aung HL, 2014, J BACTERIOL, V196, P3091, DOI 10.1128/JB.01771-14; Basu P, 2018, J BIOL CHEM, V293, P5695, DOI 10.1074/jbc.RA118.001839; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Berney M, 2014, P NATL ACAD SCI USA, V111, P11479, DOI 10.1073/pnas.1407034111; Berney M, 2012, MOL MICROBIOL, V84, P664, DOI 10.1111/j.1365-2958.2012.08053.x; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Blokpoel MCJ, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni023; Eoh HJ, 2013, P NATL ACAD SCI USA, V110, P6554, DOI 10.1073/pnas.1219375110; Fedrizzi T, 2017, SCI REP-UK, V7, DOI 10.1038/srep45258; Gourdon P, 2000, APPL ENVIRON MICROB, V66, P2981, DOI 10.1128/AEM.66.7.2981-2987.2000; Greening C, 2014, P NATL ACAD SCI USA, V111, P4257, DOI 10.1073/pnas.1320586111; Hards K, 2020, PROG BIOPHYS MOL BIO, V152, P35, DOI 10.1016/j.pbiomolbio.2019.11.003; Hards K, 2015, J ANTIMICROB CHEMOTH, V70, P2028, DOI 10.1093/jac/dkv054; Harold LK, 2019, J BIOL CHEM, V294, P2903, DOI 10.1074/jbc.RA118.006237; Hartuti ED, 2018, BBA-BIOENERGETICS, V1859, P191, DOI 10.1016/j.bbabio.2017.12.004; Jain P, 2014, MBIO, V5, DOI 10.1128/mBio.01245-14; Lamprecht DA, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12393; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Maksymiuk C, 2015, P NATL ACAD SCI USA, V112, pE5834, DOI 10.1073/pnas.1510932112; McNeil MB, 2020, ANTIMICROB AGENTS CH, V64, DOI 10.1128/AAC.00492-20; McNeil MB, 2019, ANTIMICROB AGENTS CH, V63, DOI 10.1128/AAC.00629-19; Mogi T, 2009, J BIOCHEM, V146, P491, DOI 10.1093/jb/mvp096; Molenaar D, 2000, J BACTERIOL, V182, P6884, DOI 10.1128/JB.182.24.6884-6891.2000; Molenaar D, 1998, EUR J BIOCHEM, V254, P395, DOI 10.1046/j.1432-1327.1998.2540395.x; Nandakumar Madhumitha, 2015, Methods Mol Biol, V1285, P105, DOI 10.1007/978-1-4939-2450-9_6; Pecsi I, 2014, MBIO, V5, DOI 10.1128/mBio.01093-14; Puckett S, 2017, P NATL ACAD SCI USA, V114, pE2225, DOI 10.1073/pnas.1617655114; Rickman L, 2005, MOL MICROBIOL, V56, P1274, DOI 10.1111/j.1365-2958.2005.04609.x; Rittershaus ESC, 2018, CELL CHEM BIOL, V25, P1495, DOI 10.1016/j.chembiol.2018.09.009; Robson J, 2009, J MOL BIOL, V390, P353, DOI 10.1016/j.jmb.2009.05.006; Rock JM, 2017, NAT MICROBIOL, V2, DOI 10.1038/nmicrobiol.2016.274; Ruecker N, 2017, CELL CHEM BIOL, V24, P306, DOI 10.1016/j.chembiol.2017.01.005; Sambandamurthy VK, 2002, NAT MED, V8, P1171, DOI 10.1038/nm765; SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x; Tews I, 2005, SCIENCE, V308, P1020, DOI 10.1126/science.1107642; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; van der Rest ME, 2000, J BACTERIOL, V182, P6892, DOI 10.1128/JB.182.24.6892-6899.2000; Vilcheze C, 2005, ANTIMICROB AGENTS CH, V49, P708, DOI 10.1128/AAC.49.2.708-720.2005; Wang QY, 2010, J BIOL CHEM, V285, P10408, DOI 10.1074/jbc.M109.085787; Watanabe S, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002287; Wu F, 2015, ANGEW CHEM INT EDIT, V54, P1851, DOI 10.1002/anie.201409336	45	2	2	2	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101859	10.1016/j.jbc.2022.101859	http://dx.doi.org/10.1016/j.jbc.2022.101859			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1T0NM	35337802	gold, Green Published			2022-12-26	WOS:000804436700004
J	Beg, BM; Hussain, T; Ahmad, M; Areej, S; Majeed, A; Rasheed, MA; Ahmad, MM; Shoaib, QUA; Aroosa, S				Beg, Bilal Mahmood; Hussain, Tariq; Ahmad, Mehmood; Areej, Sadaf; Majeed, Arfa; Rasheed, Muhammad Adil; Ahmad, Muhammad Moin; Shoaib, Qurat-Ul-Ain; Aroosa, Sadaf			Perceived risk and perceptions of COVID-19 vaccine: A survey among general public in Pakistan	PLOS ONE			English	Article							HYPERTENSION; COUNTRIES; IMPACT	Background The coronavirus disease has become a global pandemic, and it continues to wreak havoc on global health and the economy. The development of vaccines may offer a potential eradication of COVID-19. This study evaluated the general knowledge, attitude, and perception of COVID-19 vaccines in the Pakistani population. Methods A self-reporting e-survey and questionnaire-based survey from vaccination centers of different cities of Pakistan among 502 participants were conducted. The questionnaire comprised four sections inquiring demographics, vaccination status, and perception or attitude towards the vaccine. Univariate logistic regression was applied to predict the knowledge, attitude and behavior of participants. Results The mean age of participants was 50.8 +/- 20.3 years. 53% of the participants have both doses of vaccine administered. Pain on the site of injection (49.8%) was the most common symptom, followed by asthenia (43.0%), muscle pain (29.5%), and swelling (24.5%) on the site of vaccine administration. Females complain of more symptoms than males. More severe symptoms were reported after the first dose of vaccine administration; these symptoms subsided within a week for most participants. Overall, the respondents have a positive attitude towards the vaccine. 47.4% are sure about the vaccine's efficacy, 48.6% said getting vaccinated was their own decision, and 79.9% also recommended others to get vaccinated. Conclusion The study concluded that the Pakistani population has a positive attitude but inadequate knowledge towards COVID-19 vaccines. Immediate awareness and vaccination education programs should be conducted by the authorities to complete the mass vaccination schedule.	[Beg, Bilal Mahmood; Areej, Sadaf; Majeed, Arfa; Rasheed, Muhammad Adil; Aroosa, Sadaf] Univ Vet & Anim Sci Lahore, Dept Pharmacol & Toxicol, Lahore, Pakistan; [Hussain, Tariq] Coll Vet & Anim Sci Jhang, Dept Basic Sci, Jhang, Pakistan; [Ahmad, Mehmood] Riphah Int Univ Lahore, Dept Pharmacol, Lahore, Pakistan; [Ahmad, Muhammad Moin] Univ Oslo, Inst Hlth & Soc, Dept Community Med & Global Hlth, Oslo, Norway; [Shoaib, Qurat-Ul-Ain] Akhtar Saeed Coll Pharmaceut Sci Lahore, Dept Pharmaceut, Lahore, Pakistan	University of Veterinary & Animal Science - Pakistan; University of Oslo	Ahmad, M (corresponding author), Riphah Int Univ Lahore, Dept Pharmacol, Lahore, Pakistan.	mahmed.rcvets@riphah.edu.pk		Beg, Bilal Mahmood/0000-0001-6797-4879				Ahamed F, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11620-z; Ahmad M, 2021, FRONT PUBLIC HEALTH, V9, DOI 10.3389/fpubh.2021.644199; Ahmed TF, 2021, EXPERT REV VACCINES, V20, P1185, DOI 10.1080/14760584.2021.1964963; Al Hosany F, 2021, J GLOB HEALTH, V11, DOI 10.7189/jogh.11.03050; Al-Mohaithef M, 2020, J MULTIDISCIP HEALTH, V13, P1657, DOI 10.2147/JMDH.S276771; Alam S E, 1998, J Pak Med Assoc, V48, P64; Ali I, 2022, DISASTER MED PUBLIC, V16, P316, DOI 10.1017/dmp.2020.329; Anesi J, 2021, AM J TRANSPLANT, V21, P897, DOI 10.1111/ajt.16480; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Barello S, 2020, EUR J EPIDEMIOL, V35, P781, DOI 10.1007/s10654-020-00670-z; Chandir S, 2020, VACCINE, V38, P7146, DOI 10.1016/j.vaccine.2020.08.019; Control CfD Prevention, 2020, CDC IS MAKING COVID; Detoc M, 2020, VACCINE, V38, P7002, DOI 10.1016/j.vaccine.2020.09.041; Dolgin E, 2021, NATURE, V595, P161, DOI 10.1038/d41586-021-01609-4; Fang L, 2020, LANCET RESP MED, V8, pE21, DOI 10.1016/S2213-2600(20)30116-8; Gilani SI, 2013, POPUL HEALTH METR, V11, DOI 10.1186/1478-7954-11-16; Guan WJ, 2020, EUR RESPIR J, V55, DOI 10.1183/13993003.00547-2020; Guo WN, 2020, DIABETES-METAB RES, V36, DOI 10.1002/dmrr.3319; Iacobellis G, 2020, DIABETES RES CLIN PR, V162, DOI 10.1016/j.diabres.2020.108125; Islam MS, 2021, BMC PUBLIC HEALTH, V21, DOI 10.1186/s12889-021-11880-9; Jayadevan R., 2021, SURVEY SYMPTOMS FOLL; Jin Q, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9070757; Karlinsky Ariel, 2021, medRxiv, DOI 10.1101/2021.01.27.21250604; Kashte S, 2021, HUM CELL, V34, P711, DOI 10.1007/s13577-021-00512-4; Khan YH, 2020, AM J TROP MED HYG, V103, P603, DOI 10.4269/ajtmh.20-0654; Kim JH, 2021, NAT MED, V27, P205, DOI 10.1038/s41591-021-01230-y; Kriss JL, 2021, MMWR-MORBID MORTAL W, V70, P389, DOI 10.15585/mmwr.mm7011e2; Lazarus JV, 2021, NAT MED, V27, P225, DOI 10.1038/s41591-020-1124-9; Le TT, 2020, NAT REV DRUG DISCOV, V19, P667, DOI 10.1038/d41573-020-00151-8; Liu MA, 2019, VACCINES-BASEL, V7, DOI 10.3390/vaccines7020037; Lloyd-Sherlock P, 2014, INT J EPIDEMIOL, V43, P116, DOI 10.1093/ije/dyt215; Loomba S, 2021, NAT HUM BEHAV, V5, P337, DOI 10.1038/s41562-021-01056-1; Mahmood S, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.602434; Majeed A, 2020, BRAZ J PHARM SCI, V56, DOI 10.1590/s2175-97902019000418669; Malik AA, 2020, ECLINICALMEDICINE, V26, DOI 10.1016/j.eclinm.2020.100495; Malik A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0257237; Mathioudakis AG, 2021, LIFE-BASEL, V11, DOI 10.3390/life11030249; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Pakistan N, 2020, COVID 19 HLTH ADV PL; Arolas HPI, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-83040-3; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Quinn SC, 2021, AM J PUBLIC HEALTH, V111, P355, DOI 10.2105/AJPH.2020.306036; Riad A, 2021, J CLIN MED, V10, DOI 10.3390/jcm10071428; Rodriguez-Morales AJ, 2020, TRAVEL MED INFECT DI, V34, DOI 10.1016/j.tmaid.2020.101623; Saeed BQ, 2021, INT J INFECT DIS, V111, P219, DOI 10.1016/j.ijid.2021.08.013; Saied SM, 2021, J MED VIROL, V93, P4280, DOI 10.1002/jmv.26910; Saleem S., 2021, J SHALAMAR MEDICAL D, V2, P6; Sallam M, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020160; Shekhar R, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9020119; Singh AK, 2020, DIABETES METAB SYND, V14, P1625, DOI 10.1016/j.dsx.2020.08.032; Voysey M, 2021, LANCET, V397, P881, DOI 10.1016/S0140-6736(21)00432-3; Wang ZJ, 2021, NATURE, V595, P426, DOI 10.1038/s41586-021-03696-9; Whitworth J, 2020, T ROY SOC TROP MED H, V114, P227, DOI 10.1093/trstmh/traa025; Woolf SH, 2021, JAMA-J AM MED ASSOC, V325, P123, DOI 10.1001/jama.2020.24865; Yan YX, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9040349; Yang J, 2020, INT J INFECT DIS, V94, P91, DOI 10.1016/j.ijid.2020.03.017; Yang Y, 2021, J COMMUN HEALTH, V46, P1090, DOI 10.1007/s10900-021-00993-2; Zhou F, 2020, LANCET, V395, P1054, DOI 10.1016/S0140-6736(20)30566-3; Zhou Y, 2021, DIABETES-METAB RES, V37, DOI 10.1002/dmrr.3377; Zhu H, 2010, OSTEOPOROSIS INT, V21, P765, DOI 10.1007/s00198-009-1010-2; Zuin M, 2020, J INFECTION, V81, pE84, DOI 10.1016/j.jinf.2020.03.059	62	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266028	10.1371/journal.pone.0266028	http://dx.doi.org/10.1371/journal.pone.0266028			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324978	Green Published, gold			2022-12-26	WOS:000780951300096
J	Sajid, M; Marriam, S; Mukhtar, H; Sohail, S; Sehgal, SA				Sajid, Muhammad; Marriam, Saigha; Mukhtar, Hamid; Sohail, Summar; Sehgal, Sheikh Arslan			Epitope-based peptide vaccine design and elucidation of novel compounds against 3C like protein of SARS-CoV-2	PLOS ONE			English	Article							FAST INTERACTION REFINEMENT; DOCKING; PREDICTION; FIREDOCK; DATABASE	Coronaviruses (CoVs) are positive-stranded RNA viruses with short clubs on their edges. CoVs are pathogenic viruses that infect several animals and plant organisms, as well as humans (lethal respiratory dysfunctions). A noval strain of CoV has been reported and named as SARS-CoV-2. Numerous COVID-19 cases were being reported all over the World. COVID-19 and has a high mortality rate. In the present study, immunoinformatics techniques were utilized to predict the antigenic epitopes against 3C like protein. B-cell epitopes and Cytotoxic T-lymphocyte (CTL) were designed computationally against SARS-CoV-2. Multiple Sequence Alignment (MSA) of seven complete strains (HCoV-229E, HCoV-NL63, HCoV-OC43, HCoV-HKU1, SARS-CoV, MERS-CoV, and SARS-CoV-2) was performed to elucidate the binding domain and interacting residues. MHC-I binding epitopes were evaluated by analyzing the binding affinity of the top-ranked peptides having HLA molecule. By utilizing the docked complexes of CTL epitopes with antigenic sites, the binding relationship and affinity of top-ranked predicted peptides with the MHC-I HLA protein were investigated. The molecular docking analyses were conducted on the ZINC database library and twelve compounds having least binding energy were scrutinized. In conclusion, twelve CTL epitopes (GTDLEGNFY, TVNVLAWLY, GSVGFNIDY, SEDMLNPNY, LSQTGIAV, VLDMCASLK, LTQDHVDIL, TTLNDFNLV, CTSEDMLNP, TTITVNVLA, YNGSPSGVY, and SMQNCVLKL) were identified against SARS-CoV-2.	[Sajid, Muhammad] Univ Okara, Dept Biotechnol, Okara, Pakistan; [Marriam, Saigha] Univ Okara, Dept Microbiol & Mol Genet, Okara, Pakistan; [Mukhtar, Hamid] Univ Okara, Sch Law, Okara, Pakistan; [Sohail, Summar] Kohsar Univ Murree, Dept Forestry, Murree, Pakistan; [Sehgal, Sheikh Arslan] Univ Okara, Dept Bioinformat, Okara, Pakistan		Sajid, M (corresponding author), Univ Okara, Dept Biotechnol, Okara, Pakistan.; Sehgal, SA (corresponding author), Univ Okara, Dept Bioinformat, Okara, Pakistan.	said@uo.edu.pk; arslansehgal@yahoo.com						An LL, 2005, LEUKEMIA RES, V29, P535, DOI 10.1016/j.leukres.2004.11.009; Andrusier N, 2007, PROTEINS, V69, P139, DOI 10.1002/prot.21495; Ayati A, 2012, DARU, V20, DOI 10.1186/2008-2231-20-46; Burley SK, 2019, NUCLEIC ACIDS RES, V47, pD464, DOI 10.1093/nar/gky1004; Cavasotto CN, 2021, MOL INFORM, V40, DOI 10.1002/minf.202000115; Chandra A, 2022, J BIOMOL STRUCT DYN, V40, P5507, DOI 10.1080/07391102.2020.1871416; Chew MF, 2017, INT J MED SCI, V14, P1342, DOI 10.7150/ijms.21875; Dallakyan S, 2015, METHODS MOL BIOL, V1263, P243, DOI 10.1007/978-1-4939-2269-7_19; de Wilde AH, 2018, CURR TOP MICROBIOL, V419, P1, DOI 10.1007/82_2017_25; Desforges M, 2014, VIRUS RES, V194, P145, DOI 10.1016/j.virusres.2014.09.011; Dijkman R, 2009, J FORMOS MED ASSOC, V108, P270, DOI 10.1016/S0929-6646(09)60066-8; Guy JS, 2000, J CLIN MICROBIOL, V38, P4523, DOI 10.1128/JCM.38.12.4523-4526.2000; Hornbeck PV, 2012, NUCLEIC ACIDS RES, V40, pD261, DOI 10.1093/nar/gkr1122; Ibrahim MAA, 2021, J BIOMOL STRUCT DYN, V39, P5756, DOI 10.1080/07391102.2020.1791958; Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+; Ji W, 2020, J MED VIROL, V92, P433, DOI 10.1002/jmv.25682; Kingsford CL, 2005, BIOINFORMATICS, V21, P1028, DOI 10.1093/bioinformatics/bti144; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Lamiable A, 2016, NUCLEIC ACIDS RES, V44, pW449, DOI 10.1093/nar/gkw329; Lefevre F, 1997, NUCLEIC ACIDS RES, V25, P447, DOI 10.1093/nar/25.2.447; Lim Yvonne Xinyi, 2016, Diseases, V4, DOI 10.3390/diseases4030026; Liu W, 2014, BIOORGAN MED CHEM, V22, P292, DOI 10.1016/j.bmc.2013.11.028; Martina BEE, 2003, NATURE, V425, P915, DOI 10.1038/425915a; Mashiach E, 2008, NUCLEIC ACIDS RES, V36, pW229, DOI 10.1093/nar/gkn186; Maupetit J, 2007, PROTEINS, V69, P394, DOI 10.1002/prot.21505; MCCLAIN CS, 1995, PERSPECT BIOL MED, V38, P624; Mirza MU, 2016, SCI REP-UK, V6, DOI 10.1038/srep37313; Nair DT, 2002, J IMMUNOL, V168, P2371, DOI 10.4049/jimmunol.168.5.2371; Noor A JF, 2020, BIOMED LETT, V6, P112; PARKER JMR, 1986, BIOCHEMISTRY-US, V25, P5425, DOI 10.1021/bi00367a013; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ponomarenko J, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-514; Riva L, 2020, NATURE, V586, P113, DOI 10.1038/s41586-020-2577-1; Robertson D, 2020, VIROLOGICAL ORG; Sajid M SM, 2021, BIOMED LETT, V7, P72; Sehgal SA, 2018, QUICK GUIDELINE COMP; Sharma S, 2021, CURR PHARM DESIGN, V27, P1015, DOI 10.2174/1381612826666201118094502; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Sievers F, 2014, CURRENT PROTOCOLS BI, V48; Sievers F, 2018, PROTEIN SCI, V27, P135, DOI 10.1002/pro.3290; Stohlman SA, 2001, BRAIN PATHOL, V11, P92; Tahir RA, 2021, COMB CHEM HIGH T SCR; van den Brand JMA, 2015, J PATHOL, V235, P175, DOI 10.1002/path.4458; Vilar S, 2008, CURR TOP MED CHEM, V8, P1555, DOI 10.2174/156802608786786624; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang YH, 2013, EXP PARASITOL, V135, P606, DOI 10.1016/j.exppara.2013.09.019; Waqas M, 2021, BIOMED RES INT, V2021, DOI 10.1155/2021/1596834; Waqas M, 2020, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.00227; Wu F, 2020, NATURE, V579, P265, DOI 10.1038/s41586-020-2008-3; Wu P, 2020, EUROSURVEILLANCE, V25, P4, DOI 10.2807/1560-7917.ES.2020.25.3.2000044; Yang D, 2015, VIRUS RES, V206, P120, DOI 10.1016/j.virusres.2015.02.025	52	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264700	10.1371/journal.pone.0264700	http://dx.doi.org/10.1371/journal.pone.0264700			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324925	gold, Green Published			2022-12-26	WOS:000780951300018
J	Wang, S; Yu, Y; Jiang, TY; Nie, J				Wang, Shuang; Yu, Yang; Jiang, Tangyang; Nie, Jun			Analysis on carbon emissions efficiency differences and optimization evolution of China's industrial system: An input-output analysis	PLOS ONE			English	Article							ENERGY EFFICIENCY; CO2 EMISSIONS; DIOXIDE EMISSIONS; CONSUMPTION; DRIVERS; SECTOR; DEA	The excessive carbon emissions not only intensify the global climate change, but also seriously restrict the sustainable development of social economy. However, improving industrial carbon emissions efficiency is the most directly effective way to reduce emissions. Therefore, accurate measurement and analysis of carbon emissions efficiency and evolution characteristics of China's industrial system is the basis for China to improve carbon emissions efficiency. Based on this, we adopted energy consumption method and input-output method to calculate and analyze the industrial carbon emissions efficiency and evolution characteristics of China from 2002 to 2015. The results show that (1) If carbon emissions from cement production are ignored and only energy-related carbon emissions are considered, the calculation results of carbon emissions efficiency of heavy industry will be overestimated about 30%. (2) Compared with 2002, China's industrial carbon emissions efficiency increased by about twice in 2015. Specifically, the optimization of carbon emissions efficiency in agriculture, construction, light industry and service industry is very obvious, which has increased by 5.65, 5.00, 4.69 and 4.68 times respectively; The optimization of carbon emissions efficiency in power sector, heavy industry, transportation and chemical industry was obvious, which increased by 2.55, 2.01, 1.86 and 1.47 times respectively; The carbon emissions efficiency of the fossil energy sector has decreased by 0.36 times. (3) The carbon emissions efficiency of various industries has significant differences. Among them, agriculture, service industry, light industry and construction industry are generally industries with higher carbon emissions efficiency, while power sector, fossil energy sector, transportation industry, chemical industry and heavy industry are generally industries with lower carbon emissions efficiency, especially power and fossil energy sectors. Based on these, this paper provides policy implications and scientific evidence for accurately improving carbon emissions efficiency from the perspective of carbon emissions efficiency.	[Wang, Shuang; Nie, Jun] Chongqing Univ, Sch Publ Affairs, Chongqing, Peoples R China; [Yu, Yang] Hainan Univ, Sch Econ, Haikou, Hainan, Peoples R China; [Yu, Yang] China Ctr Competit Policy, Haikou, Hainan, Peoples R China; [Jiang, Tangyang] Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China	Chongqing University; Hainan University; Anhui University	Nie, J (corresponding author), Chongqing Univ, Sch Publ Affairs, Chongqing, Peoples R China.; Yu, Y (corresponding author), Hainan Univ, Sch Econ, Haikou, Hainan, Peoples R China.; Yu, Y (corresponding author), China Ctr Competit Policy, Haikou, Hainan, Peoples R China.; Jiang, TY (corresponding author), Anhui Univ, Sch Internet, Hefei, Anhui, Peoples R China.	yuyang_0715@163.com; jiang_tangyang@163.com; niejun2018@163.com		Yu, Yang/0000-0003-1641-135X	Hainan Provincial philosophy and social science planning [HNSK(JD)21-16]	Hainan Provincial philosophy and social science planning	We are grateful for the financial support provided by Hainan Provincial philosophy and social science planning (HNSK(JD)21-16), awarded to YY. Any remaining errors or omissions are our sole responsibility.	Abbasi KR, 2021, ENVIRON SCI POLLUT R, V28, P23323, DOI 10.1007/s11356-020-12217-6; Andersson FNG, 2018, ENERG POLICY, V123, P349, DOI 10.1016/j.enpol.2018.08.045; Cheng ZH, 2018, RENEW SUST ENERG REV, V94, P330, DOI 10.1016/j.rser.2018.06.015; Alves EEC, 2019, ENERG POLICY, V125, P317, DOI 10.1016/j.enpol.2018.10.064; Fang GC, 2018, APPL ENERG, V211, P1039, DOI 10.1016/j.apenergy.2017.12.001; Fearnside PM, 2000, CLIMATIC CHANGE, V46, P115, DOI 10.1023/A:1005569915357; Gao P, 2021, J CLEAN PROD, V283, DOI 10.1016/j.jclepro.2020.124655; Griffin PW, 2017, ENRGY PROCED, V105, DOI 10.1016/j.egypro.2017.03.913; Henson SA, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14682; Iftikhar Y, 2018, ENERGY, V147, P197, DOI 10.1016/j.energy.2018.01.012; Jia JS, 2018, J CLEAN PROD, V183, P843, DOI 10.1016/j.jclepro.2018.02.116; Lin BQ, 2018, ENERG POLICY, V120, P302, DOI 10.1016/j.enpol.2018.05.050; Lin BQ, 2016, RENEW SUST ENERG REV, V58, P1387, DOI 10.1016/j.rser.2015.12.348; Liu BQ, 2018, J CLEAN PROD, V197, P1374, DOI 10.1016/j.jclepro.2018.06.295; Liu Z, 2015, NATURE, V524, P335, DOI 10.1038/nature14677; Meng FY, 2016, APPL ENERG, V183, P1, DOI 10.1016/j.apenergy.2016.08.158; Mousavi-Avval SH, 2011, ENERGY, V36, P909, DOI 10.1016/j.energy.2010.12.020; Ocal O, 2013, RENEW SUST ENERG REV, V28, P494, DOI 10.1016/j.rser.2013.08.036; Olanrewaju OA, 2012, ENERGY, V46, P629, DOI 10.1016/j.energy.2012.07.037; Pardo N, 2011, ENERGY, V36, P3244, DOI 10.1016/j.energy.2011.03.016; Stokes LC, 2013, ENERG POLICY, V56, P490, DOI 10.1016/j.enpol.2013.01.009; Wang K, 2014, APPL ENERG, V130, P617, DOI 10.1016/j.apenergy.2014.03.010; Wang YD, 2021, ENVIRON SCI POLLUT R, V28, P14131, DOI 10.1007/s11356-020-11557-7; Wang Y, 2019, J CLEAN PROD, V206, P850, DOI 10.1016/j.jclepro.2018.09.185; Wang ZH, 2015, J CLEAN PROD, V103, P715, DOI 10.1016/j.jclepro.2014.04.069; Weng QQ, 2018, RENEW SUST ENERG REV, V91, P613, DOI 10.1016/j.rser.2018.04.026; Wu F, 2012, ENERG POLICY, V49, P164, DOI 10.1016/j.enpol.2012.05.035; Wu JN, 2016, APPL ENERG, V183, P430, DOI 10.1016/j.apenergy.2016.08.192; Xu B, 2020, ENERGY, V206, DOI 10.1016/j.energy.2020.118159; Xu JP, 2018, ENERG POLICY, V123, P184, DOI 10.1016/j.enpol.2018.08.043; Yao X, 2015, ENERG POLICY, V84, P142, DOI 10.1016/j.enpol.2015.05.001; Yu YT, 2021, ENERG ECON, V96, DOI 10.1016/j.eneco.2021.105125; Zhang YF, 2020, J CLEAN PROD, V265, DOI 10.1016/j.jclepro.2020.121843; Zhang YJ, 2016, APPL ENERG, V174, P213, DOI 10.1016/j.apenergy.2016.04.109; Zhou D, 2020, ENVIRON SCI POLLUT R, V27, P25149, DOI 10.1007/s11356-020-08993-w; Zhou YX, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118322	36	4	4	44	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0258147	10.1371/journal.pone.0258147	http://dx.doi.org/10.1371/journal.pone.0258147			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324897	gold, Green Published			2022-12-26	WOS:000780951300005
J	Jin, ZX; Wang, CX; Yu, SK; Zhang, S; Ding, XM				Jin, Zhenxing; Wang, Chengxin; Yu, Shangkun; Zhang, Shuai; Ding, Xiaoming			Spatiotemporal evolution and influencing factors of urban shrinkage in the Yellow River Basin, China	PLOS ONE			English	Article							CITIES	The phenomenon of urban shrinkage has spread across the world as the political and economic landscape changes worldwide. The urban development in China has entered a post-development era characterized by coexisting urban expansion and local shrinkage whilst urbanization continues to progress in this country. This paper investigates the urban shrinkage of 80 cities in the Yellow River, China from the perspective of population and economy, based on urban shrinkage models drawing from western countries. It also analyzes the spatiotemporal evolution and influencing factors of urban shrinkage in this area using a spatial panel data model. The results show the following. (1) The phenomenon of urban shrinkage in the Yellow River Basin has gradually occurred and the degree of shrinkage has aggravated. (2) The shrinking cities in the Yellow River Basin are mainly population-related and potential. (3) The phenomenon of urban shrinkage in the Yellow River Basin shows significant spatiotemporal differences. Shrinking cities are mainly distributed in the upper and middle reaches of the Yellow River Basin and the number of shrinking cities has gradually increased over time. (4) In terms of influencing factors, financial, traffic, and medical conditions have a greater impact on population-related and economy-related shrinkage in these cities.	[Jin, Zhenxing; Wang, Chengxin; Yu, Shangkun; Ding, Xiaoming] Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China; [Jin, Zhenxing; Wang, Chengxin; Yu, Shangkun; Ding, Xiaoming] Collaborat Innovat Ctr Human Nat & Green Dev Univ, Jinan, Peoples R China; [Zhang, Shuai] Shandong Prov Party Sch, Communist Party China, Jinan, Peoples R China	Shandong Normal University	Wang, CX (corresponding author), Shandong Normal Univ, Coll Geog & Environm, Jinan, Peoples R China.; Wang, CX (corresponding author), Collaborat Innovat Ctr Human Nat & Green Dev Univ, Jinan, Peoples R China.	404122665@qq.com			National Social Science Foundation of China [20BJY070]; Social Science Planning Project of Shandong Province [19CDNJ36]	National Social Science Foundation of China; Social Science Planning Project of Shandong Province	The study was supported by the National Social Science Foundation of China (No. 20BJY070) and the Social Science Planning Project of Shandong Province (No. 19CDNJ36). The sponsors or funders play no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blanco H, 2009, PROG PLANN, V71, P153, DOI 10.1016/j.progress.2009.03.001; [陈肖飞 Chen Xiaofei], 2020, [经济地理, Economic Geography], V40, P37; Chen Y, 2021, INT J ENV RES PUB HE, V18, DOI 10.3390/ijerph181910231; [程钰 Cheng Yu], 2020, [经济地理, Economic Geography], V40, P133; Deng TT, 2019, CITIES, V86, P210, DOI 10.1016/j.cities.2018.09.017; Doringer S, 2020, EUR PLAN STUD, V28, P1693, DOI 10.1080/09654313.2019.1604635; [杜志威 Du Zhiwei], 2019, [热带地理, Tropical Geography], V39, P20; [杜志威 Du Zhiwei], 2017, [地理学报, Acta Geographica Sinica], V72, P1800; Guan DJ, 2021, SUSTAIN CITIES SOC, V65, DOI 10.1016/j.scs.2020.102611; [郭源园 Guo Yuanyuan], 2019, [地理科学, Scientia Geographica Sinica], V39, P52; Haase D, 2012, ENVIRON MODELL SOFTW, V35, P92, DOI 10.1016/j.envsoft.2012.02.012; Hau&beta;ermann H., 1988, SOZIOLOGISCHE STADTF; He SY, 2017, CITIES, V60, P75, DOI 10.1016/j.cities.2016.07.009; Hoekveld J. J., 2012, BUILD ENVIRON, V38, P179, DOI [10.2148/benv.38.2.179, DOI 10.2148/BENV.38.2.179]; Hospers GJ, 2013, URBAN DES INT, V18, P78, DOI 10.1057/udi.2012.29; Howe SR, 1998, URBAN GEOGR, V19, P714, DOI 10.2747/0272-3638.19.8.714; Li X., 2015, MOD URBAN RES, V9, P36; [李郇 Li Xun], 2017, [地理研究, Geographical Research], V36, P1997; Lin XB., 2017, HUM GEOGR, V32, P82, DOI DOI 10.13959/J.ISSN.1003-2398.2017.01.012; [刘贵文 Liu Guiwen], 2019, [经济地理, Economic Geography], V39, P50; Liu HL, 2016, MODERN URBAN RES, V31, P17; [刘振 Liu Zhen], 2019, [地理科学, Scientia Geographica Sinica], V39, P1525; Long Y, 2016, ENVIRON PLANN A, V48, P220, DOI 10.1177/0308518X15621631; [马佐澎 Ma Zuopeng], 2021, [地理学报, Acta Geographica Sinica], V76, P767; Martinez-Fernandez C, 2016, PROG PLANN, V105, P1, DOI 10.1016/j.progress.2014.10.001; Martinez-Fernandez C, 2012, INT J URBAN REGIONAL, V36, P213, DOI 10.1111/j.1468-2427.2011.01092.x; Oswalt P, 2006, ATLAS SHRINKING CITI, DOI [10.1053/j.ajkd.2006.09.011, DOI 10.1053/J.AJKD.2006.09.011]; Schetke S, 2008, ENVIRON IMPACT ASSES, V28, P483, DOI 10.1016/j.eiar.2007.09.004; Shen Y, 2020, URBAN PLANNING INT, V35, P47; Sun Q, 2019, URBAN PROBLEMS, P24; Tong Y, 2021, SUSTAIN CITIES SOC, V68, DOI 10.1016/j.scs.2021.102811; Tong Y, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0231159; Wang M, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13042402; Wang RL, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258524; [王晓楠 Wang Xiaonan], 2020, [地理科学进展, Progress in Geography], V39, P1643; Wen J., 2019, URBAN PROBL, V38, P4; Wiechmann T, 2008, INT PLAN STUD, V13, P431, DOI 10.1080/13563470802519097; Wu JG, 2011, ECOL COMPLEX, V8, P1, DOI 10.1016/j.ecocom.2010.03.002; Wu K., 2015, MOD URBAN RES, V9, P26; [吴康 Wu Kang], 2021, [地理研究, Geographical Research], V40, P213; [吴康 Wu Kang], 2017, [经济地理, Economic Geography], V37, P59; Xu B., 2014, ECONOMIST, P5; Yang J, 2021, DIVERSITY-BASEL, V13, DOI 10.3390/d13070308; Yang L., 2018, J HUMAN SETTLEMENTS, V33, P21; Yang Q, 2020, URBAN PROBLEMS, P58; Yang Y, 2021, CITIES, V118, DOI 10.1016/j.cities.2021.103346; Yang Z, 2018, REG STUD, V52, P1111, DOI 10.1080/00343404.2017.1335865; Yang ZS., 2019, HUMAN GEOGRAPHY, V34, P63; Zhang MD., 2020, URBAN PROBLEMS, P33; [张帅 Zhang Shuai], 2020, [中国人口·资源与环境, China Population Resources and Environment], V30, P72; [张伟 Zhang Wei], 2019, [城市发展研究, Urban Studies], V26, P32; Zhang X.L, 2018, J CHONGQING U SOC SC, V24, P1, DOI [10.11835/j.issn.1008-5831.2018.06.001, DOI 10.11835/J.ISSN.1008-5831.2018.06.001]; Zhang YJ, 2019, J GEOMATICS, V44, P16; [赵建吉 Zhao Jianji], 2020, [资源科学, Resources Science], V42, P159; Zhou Y, 2021, CITIES, V118, DOI 10.1016/j.cities.2021.103373; Zhou Y, 2019, SUSTAINABILITY-BASEL, V11, DOI 10.3390/su11246906	56	2	2	31	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0264236	10.1371/journal.pone.0264236	http://dx.doi.org/10.1371/journal.pone.0264236			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316267	Green Published, gold			2022-12-26	WOS:000834238000007
J	Marcus, IM; White, D; Backus, EA; Walker, SL; Roper, MC				Marcus, Ian M.; White, Daniel; Backus, Elaine A.; Walker, Sharon L.; Roper, M. Caroline			Fluid dynamic simulations at the interface of the blue-green sharpshooter functional foregut and grapevine xylem sap with implications for transmission of Xylella fastidiosa	PLOS ONE			English	Article							PIERCES DISEASE BACTERIUM; HEMIPTERA CICADELLIDAE; WATER-STRESS; WAVE-FORM; MECHANISM; VECTOR; COLONIZATION; INOCULATION; ACQUISITION; EGESTION	Xylella fastidiosa is a multi-continental, lethal, plant pathogenic bacterium that is transmitted by sharpshooter leafhoppers (Insecta: Hemiptera: Cicadellidae: Cicadellinae) and adult spittlebugs (Hemiptera: Aphrophoridae). The bacterium forms biofilms in plant xylem and the functional foregut of the insect. These biofilms serve as sources of inoculum for insect acquisition and subsequent inoculation to a healthy plant. In this study, 3D fluid dynamic simulations were performed for bidirectional cibarial propulsion of xylem sap through tube-like grapevine xylem and an anatomically accurate model of the functional foregut of the bluegreen sharpshooter, Graphocephala atropunctata. The analysis supports a model of how fluid dynamics influence X. fastidiosa transmission. The model supports the hypothesis that X. fastidiosa inoculation is mostly driven by detachment of bacteria from the foregut due to high-velocity flow during egestion (outward fluid flow from the stylets). Acquisition occurs by fluid dynamics during both egestion and ingestion (fluid uptake through the stylets and swallowing). These simulation results are supported by previously reported X. fastidiosa colonization patterns in the functional foregut and sharpshooter stylet probing behaviors. The model indicates that xylem vessel diameter influences drag forces imposed on xylem walladherent bacteria; thus, vessel diameter may be an important component of the complex transmission process. Results from this study are directly applicable to development of novel grapevine resistance traits via electropenetrographic monitoring of vector acquisition and inoculation behaviors.	[Marcus, Ian M.; Walker, Sharon L.] Drexel Univ, Dept Civil Architectural & Environm Engn, Philadelphia, PA 19104 USA; [White, Daniel; Walker, Sharon L.] Univ Calif Riverside, Dept Chem & Environm Engn, Riverside, CA 92521 USA; [Backus, Elaine A.] USDA ARS, San Joaquin Valley Agr Sci Ctr, Parlier, CA USA; [Roper, M. Caroline] Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA	Drexel University; University of California System; University of California Riverside; United States Department of Agriculture (USDA); University of California System; University of California Riverside	Roper, MC (corresponding author), Univ Calif Riverside, Dept Microbiol & Plant Pathol, Riverside, CA 92521 USA.	mcroper@ucr.edu		Marcus, Ian/0000-0001-8673-0722; Roper, Caroline/0000-0003-4637-6225	United States National Science Foundation [1631776]; United States Department of Agriculture National Institute of Food and Agriculture [2019-67014-29358]	United States National Science Foundation(National Science Foundation (NSF)); United States Department of Agriculture National Institute of Food and Agriculture(United States Department of Agriculture (USDA))	DW -1631776 funded by United States National Science Foundation -https://www.nsf.gov/No, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. CMR - 2019-67014-29358 funded by United States Department of Agriculture National Institute of Food and Agriculture www.usda.gov No, The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexis ME, 2018, OPEN J FLUID DYNAMIC, V8, P404; Almeida RPP, 2006, ANN ENTOMOL SOC AM, V99, P884, DOI 10.1603/0013-8746(2006)99[884:POXFCO]2.0.CO;2; Alston JM, 2013, J AGR RESOUR ECON, V38, P269; Andrews KB., 2010, P PIERCES DIS RES S; Azeredo J, 2017, CRIT REV MICROBIOL, V43, P313, DOI 10.1080/1040841X.2016.1208146; Backus EA, 2021, J ECON ENTOMOL, V114, P1991, DOI 10.1093/jee/toab141; Backus EA, 2021, PEST MANAG SCI, V77, P1132, DOI 10.1002/ps.6087; Backus EA, 2020, J INSECT SCI, V20, DOI 10.1093/jisesa/ieaa055; Backus EA, 2015, PHYTOPATHOLOGY, V105, P608, DOI 10.1094/PHYTO-09-14-0258-R; Backus EA, 2012, J INSECT PHYSIOL, V58, P949, DOI 10.1016/j.jinsphys.2012.04.011; Backus EA, 2011, PHYTOPATHOLOGY, V101, P912, DOI 10.1094/PHYTO-09-10-0231; Backus EA, 2009, ANN ENTOMOL SOC AM, V102, P847, DOI 10.1603/008.102.0512; Bouda M, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-13673-6; Carniello V, 2018, ADV COLLOID INTERFAC, V261, P1, DOI 10.1016/j.cis.2018.10.005; Cervantes FA, 2018, J INSECT PHYSIOL, V109, P21, DOI 10.1016/j.jinsphys.2018.05.008; De la Fuente L, 2007, APPL ENVIRON MICROB, V73, P2690, DOI 10.1128/AEM.02649-06; Del Cid C, 2018, ENVIRON ENTOMOL, V47, P1471, DOI 10.1093/ee/nvy136; Dugravot S, 2008, J INSECT PHYSIOL, V54, P1467, DOI 10.1016/j.jinsphys.2008.05.008; EFSA, 2018, EFSA J, V16, DOI 10.2903/j.efsa.2018.5408; Ghidaoui M. S., 2005, Applied Mechanics Review, V58, P49, DOI 10.1115/1.1828050; GOODCHILD AJ, 1966, BIOL REV, V41, P97, DOI 10.1111/j.1469-185X.1966.tb01540.x; Janissen R, 2015, SCI REP-UK, V5, DOI 10.1038/srep09856; Krugner R, 2014, J ECON ENTOMOL, V107, P66, DOI 10.1603/EC13219; Kyrkou I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.02141; Lindow S, 2019, PHYTOPATHOLOGY, V109, P210, DOI 10.1094/PHYTO-09-18-0325-PER; Lovisolo C, 1998, J EXP BOT, V49, P693, DOI 10.1093/jexbot/49.321.693; Monteiro MP, 2017, COLLOID SURFACE B, V159, P174, DOI 10.1016/j.colsurfb.2017.07.075; Newman KL, 2004, P NATL ACAD SCI USA, V101, P1737, DOI 10.1073/pnas.0308399100; Purcell A. H., 1999, California Agriculture, V53, P26, DOI 10.3733/ca.v053n02p26; PURCELL AH, 1979, PHYTOPATHOLOGY, V69, P393, DOI 10.1094/Phyto-69-393; PURCELL AH, 1979, SCIENCE, V206, P839, DOI 10.1126/science.206.4420.839; Purcell AH, 2003, P PIERCES DIS RES S; Purcell AH, 2003, CHARACTERIZATION STU; Ranieri E, 2020, J INSECT PHYSIOL, V120, DOI 10.1016/j.jinsphys.2019.103995; Rapicavoli J, 2018, MOL PLANT PATHOL, V19, P786, DOI 10.1111/mpp.12585; Rapicavoli JN, 2015, APPL ENVIRON MICROB, V81, P8145, DOI 10.1128/AEM.02383-15; RAVEN JA, 1983, ADV ECOL RES, V13, P135, DOI 10.1016/S0065-2504(08)60109-9; Roper MC, 2015, XYLELLA FASTIDIOSA I; Ruschioni S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0213318; Stroock AD, 2014, ANNU REV FLUID MECH, V46, P615, DOI 10.1146/annurev-fluid-010313-141411; Tumber KP, 2014, CALIF AGR, V68, P20, DOI 10.3733/ca.v068n01p20; WELLS JM, 1987, INT J SYST BACTERIOL, V37, P136, DOI 10.1099/00207713-37-2-136; White D, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-85954-4	43	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265762	10.1371/journal.pone.0265762	http://dx.doi.org/10.1371/journal.pone.0265762			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316301	gold, Green Published			2022-12-26	WOS:000834238000040
J	Rasella, D; Morais, GAD; Anderle, RV; da Silva, AF; Lua, I; Coelho, R; Rubio, FA; Magno, L; Machado, D; Pescarini, J; Souza, LE; Macinko, J; Dourado, I				Rasella, Davide; de Sampaio Morais, Gabriel Alves; Anderle, Rodrigo Volmir; da Silva, Andrea Ferreira; Lua, Iracema; Coelho, Ronaldo; Rubio, Felipe Alves; Magno, Laio; Machado, Daiane; Pescarini, Julia; Souza, Luis Eugenio; Macinko, James; Dourado, Ines			Evaluating the impact of social determinants, conditional cash transfers and primary health care on HIV/AIDS: Study protocol of a retrospective and forecasting approach based on the data integration with a cohort of 100 million Brazilians	PLOS ONE			English	Article							POISSON REGRESSION APPROACH; CAUSAL-INFERENCE; TRANSFER PROGRAM; HIV; PREVENTION; MORTALITY; STRATEGY	Background Despite the great progress made over the last decades, stronger structural interventions are needed to end the HIV/AIDS pandemic in Low and Middle-Income Countries (LMIC). Brazil is one of the largest and data-richest LMIC, with rapidly changing socioeconomic characteristics and an important HIV/AIDS burden. Over the last two decades Brazil has also implemented the world's largest Conditional Cash Transfer programs, the Bolsa Familia Program (BFP), and one of the most consolidated Primary Health Care (PHC) interventions, the Family Health Strategy (FHS). Objective We will evaluate the effects of socioeconomic determinants, BFP exposure and FHS coverage on HIV/AIDS incidence, treatment adherence, hospitalizations, case fatality, and mortality using unprecedently large aggregate and individual-level longitudinal data. Moreover, we will integrate the retrospective datasets and estimated parameters with comprehensive forecasting models to project HIV/AIDS incidence, prevalence and mortality scenarios up to 2030 according to future socioeconomic conditions and alternative policy implementations. Methods and analysis We will combine individual-level data from all national HIV/AIDS registries with large-scale databases, including the "100 Million Brazilian Cohort", over a 19-year period (2000-2018). Several approaches will be used for the retrospective quasi-experimental impact evaluations, such as Regression Discontinuity Design (RDD), Random Administrative Delays (RAD) and Propensity Score Matching (PSM), combined with multivariable Poisson regressions for cohort analyses. Moreover, we will explore in depth lagged and long-term effects of changes in living conditions and in exposures to BFP and FHS. We will also investigate the effects of the interventions in a wide range of subpopulations. Finally, we will integrate such retrospective analyses with microsimulation, compartmental and agent-based models to forecast future HIV/AIDS scenarios. Conclusion The unprecedented datasets, analyzed through state-of-the-art quasi-experimental methods and innovative mathematical models will provide essential evidences to the understanding and control of HIV/AIDS epidemic in LMICs such as Brazil.	[Rasella, Davide; de Sampaio Morais, Gabriel Alves; Anderle, Rodrigo Volmir; da Silva, Andrea Ferreira; Lua, Iracema; Rubio, Felipe Alves; Magno, Laio; Souza, Luis Eugenio; Dourado, Ines] Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil; [Rasella, Davide] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain; [Rasella, Davide; Machado, Daiane; Pescarini, Julia] Oswaldo Cruz Fdn FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Goncalo Moniz Inst, Salvador, BA, Brazil; [Coelho, Ronaldo] Minist Hlth DCCI SVS MS, Dept Hlth Surveillance, Dept Chron Condit & Sexually Transmitted Infect, Brasilia, DF, Brazil; [Magno, Laio] Univ Estado Bahia, Life Sci Dept, Salvador, BA, Brazil; [Macinko, James] Univ Calif Los Angeles, UCLA Fielding Sch Publ Hlth, Los Angeles, CA USA	Universidade Federal da Bahia; ISGlobal; University of Barcelona; Hospital Clinic de Barcelona; Fundacao Oswaldo Cruz; Universidade do Estado Bahia; University of California System; University of California Los Angeles	Rasella, D (corresponding author), Univ Fed Bahia, Inst Collect Hlth, Salvador, BA, Brazil.; Rasella, D (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona, Spain.; Rasella, D (corresponding author), Oswaldo Cruz Fdn FIOCRUZ, Ctr Data & Knowledge Integrat Hlth CIDACS, Goncalo Moniz Inst, Salvador, BA, Brazil.	davide.rasella@gmail.com	Magno, Laio/M-9366-2019; Ferreira da Silva, Andréa/GRT-0003-2022; Anderle, Rodrigo Volmir/U-3034-2017	Magno, Laio/0000-0003-3752-0782; Macinko, James/0000-0001-8055-5441; Alves Rubio, Felipe/0000-0002-3428-5919; B Machado, Daiane/0000-0003-2959-4650; Anderle, Rodrigo Volmir/0000-0002-2618-5926; Pescarini, Julia/0000-0001-8711-9589; Rasella, Davide/0000-0002-7260-4386	National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH) -USA [1R01AI152938]	National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH) -USA	Principal Investigator: Davide Rasella. Grant Number:1R01AI152938. Funder: National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Health (NIH) -USA. URL: https://www.niaid.nih.gov/.The funders had and will not have a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JW, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-6304-x; Alsallaq RA, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175447; [Anonymous], 2015, NEW ENGL J MED, V373, P1277, DOI [10.1056/NEJMc1509056, DOI 10.1056/NEJMC1509056]; Bae JW, 2016, PROCEDIA COMPUT SCI, V80, P507, DOI 10.1016/j.procs.2016.05.331; Baggaley RF, 2017, LANCET HIV, V4, pE465, DOI 10.1016/S2352-3018(17)30123-6; Ballas D, 2018, PRACT SPAT ANAL ESSA, P69, DOI [10.1007/978-3-319-89806-3_4, DOI 10.1007/978-3-319-89806-3_4]; Barreto M, 2017, INT J POPUL DATA SCI, V1, DOI [10.23889/ijpds.v1i1.276, DOI 10.23889/IJPDS.V1I1.276]; Barreto ML, 2022, INT J EPIDEMIOL, V51, pE27, DOI 10.1093/ije/dyab213; Bermudez LG, 2018, AIDS BEHAV, V22, P3763, DOI 10.1007/s10461-018-2173-7; Bonabeau E, 2002, P NATL ACAD SCI USA, V99, P7280, DOI 10.1073/pnas.082080899; Bor J, 2014, EPIDEMIOLOGY, V25, P729, DOI 10.1097/EDE.0000000000000138; Carter DJ, 2019, BMJ GLOB HEALTH, V4, DOI 10.1136/bmjgh-2018-001029; cidacs.bahia.fiocruz.br, COHORT 100 MILLION B; da Fonseca EM, 2018, INT J HEALTH PLAN M, V33, pE238, DOI 10.1002/hpm.2452; Dean HD, 2010, PUBLIC HEALTH REP, V125, P1, DOI 10.1177/00333549101250S401; Dehejia RH, 2002, REV ECON STAT, V84, P151, DOI 10.1162/003465302317331982; Dourado I, 2011, MED CARE, V49, P577, DOI 10.1097/MLR.0b013e31820fc39f; Ferrer SR, 2008, INT J EPIDEMIOL, V37, P805, DOI 10.1093/ije/dyn093; Gantenberg JR, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199915; Giabbanelli PJ, 2017, COMPUT MATH METHOD M, V2017, DOI 10.1155/2017/5742629; Gopalappa C, 2017, AIDS, V31, P2533, DOI 10.1097/QAD.0000000000001653; Hall HI, 2016, JAIDS-J ACQ IMM DEF, V72, pE57, DOI 10.1097/QAI.0000000000000989; Heise L, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.18615; Hone T, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002306; Hone T, 2017, HEALTH AFFAIR, V36, P149, DOI 10.1377/hlthaff.2016.0966; Ibrahim K, 2010, INT J NURS PRACT, V16, P87, DOI 10.1111/j.1440-172X.2010.01816.x; JAS -mine, BRINGING REAL SIMULA; Khandker S., 2009, HDB IMPACT EVALUATIO, DOI 10.1596/978-0-8213-8028-4; Kilburn K, 2019, AIDS BEHAV, V23, P1178, DOI 10.1007/s10461-018-2329-5; Kopec JA, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-710; Leber W, 2015, LANCET HIV, V2, pE229, DOI 10.1016/S2352-3018(15)00059-4; Li Y, 2016, PREV CHRONIC DIS, V13, DOI 10.5888/pcd13.150561; Linden A, 2012, J EVAL CLIN PRACT, V18, P317, DOI 10.1111/j.1365-2753.2011.01768.x; Lindert K., 2007, NUTS BOLTS BRAZILS B; Machado DB, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208925; Macinko J, 2007, SOC SCI MED, V65, P2070, DOI 10.1016/j.socscimed.2007.06.028; Macinko J, 2015, NEW ENGL J MED, V372, P2177, DOI 10.1056/NEJMp1501140; Macinko J, 2011, AM J PUBLIC HEALTH, V101, P1963, DOI 10.2105/AJPH.2010.198887; McMahan LD, 2022, HEALTH SOC CARE COMM, V30, pE739, DOI 10.1111/hsc.13444; Nery JS, 2017, INT J TUBERC LUNG D, V21, P790, DOI 10.5588/ijtld.16.0599; Nery JS, 2019, LANCET GLOB HEALTH, V7, pE1226, DOI [10.1016/s2214-109x(19)30260-8, 10.1016/S2214-109X(19)30260-8]; Nery JS, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003357; Nianogo RA, 2015, AM J PUBLIC HEALTH, V105, pE20, DOI 10.2105/AJPH.2014.302426; Nunn AS, 2009, HEALTH AFFAIR, V28, P1103, DOI 10.1377/hlthaff.28.4.1103; Oldenburg Catherine E, 2016, Curr Epidemiol Rep, V3, P233; Owusu-Addo E, 2018, HEALTH POLICY PLANN, V33, P675, DOI 10.1093/heapol/czy020; Patorno E, 2013, EPIDEMIOL BIOSTAT PU, V10, DOI 10.2427/8940; Pega F, 2017, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011135.pub2; Pettifor A, 2012, AIDS BEHAV, V16, P1729, DOI 10.1007/s10461-012-0240-z; Pinto C, 2017, COMP MED SY, P515, DOI 10.1109/CBMS.2017.64; Pita R, 2017, INT J POPUL DATA SCI, V1, DOI [10.23889/ijpds.v1i1.223, DOI 10.23889/IJPDS.V1I1.223]; Pita R, 2018, IEEE J BIOMED HEALTH, V22, P346, DOI 10.1109/JBHI.2018.2796941; Rasella D, 2014, BMJ-BRIT MED J, V349, DOI 10.1136/bmj.g4014; Rasella D, 2013, LANCET, V382, P57, DOI 10.1016/S0140-6736(13)60715-1; Rasella D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-380; Rodrigues A., QUE; Rudgard WE, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5962-z; Rutter CM, 2011, MED DECIS MAKING, V31, P10, DOI 10.1177/0272989X10369005; Singh K, 2018, ARTIF LIFE, V24, P128, DOI [10.1162/ARTL_a_00260, 10.1162/artl_a_00260]; thelancet.com, ASTANA DECLARATION F; Thrun MW, 2014, LGBT HEALTH, V1, P75, DOI 10.1089/lgbt.2014.0007; Tully S, 2013, J THEOR BIOL, V337, P125, DOI 10.1016/j.jtbi.2013.08.014; unaids.org, UNAIDS LEADS WORLDS; worldbank.org, BRAZIL DATA; wwp.org.br, UNIFIED REGISTRY WWP; Yelland LN, 2011, AM J EPIDEMIOL, V174, P984, DOI 10.1093/aje/kwr183; Yotebieng M, 2016, JAIDS-J ACQ IMM DEF, V72, pS124, DOI 10.1097/QAI.0000000000001062; Yourkavitch J, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0197239; Zou GY, 2013, STAT METHODS MED RES, V22, P661, DOI 10.1177/0962280211427759; Zou GY, 2004, AM J EPIDEMIOL, V159, P702, DOI 10.1093/aje/kwh090	70	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265253	10.1371/journal.pone.0265253	http://dx.doi.org/10.1371/journal.pone.0265253			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316304	Green Published, gold			2022-12-26	WOS:000834238000021
J	Baehr, LA; Kaimal, G; Hiremath, SV; Trost, Z; Finley, M				Baehr, Laura A.; Kaimal, Girija; Hiremath, Shivayogi V.; Trost, Zina; Finley, Margaret			Staying active after rehab: Physical activity perspectives with a spinal cord injury beyond functional gains	PLOS ONE			English	Article							QUALITATIVE RESEARCH; EXERCISE; INDIVIDUALS; PARTICIPATION; REHABILITATION; RESILIENCE; RESPONSES; OUTCOMES; SPORTS; PEOPLE	Lifestyle physical activity following spinal cord injury (SCI) is critical for functional independence, mental wellness, and social participation, yet nearly 50% of individuals with SCI report no regular exercise. The objective of this study was to better understand factors leading to this participation gap by capturing the physical activity perspectives of individuals living with SCI. We completed small group interviews with nine individuals living with SCI across the United States. Iterative thematic analysis systematically revealed meaningful core concepts related to physical activity engagement with SCI. Emergent themes revealed challenges to lifestyle physical activity behavior including gaps in physical activity education, isolation during psychological adjustment, and knowledge limitations in community exercise settings. A secondary theme related to the COVID-19 pandemic emerged, highlighting additional environmental constraints affecting participation. Our findings suggest that most physical activity education is delivered during inpatient rehabilitation and is related to physical function. Lifetime physical activity strategies are achieved through self-education and peer networking. Personal motivators for physical activity include secondary condition prevention, while social and emotional barriers prevent regular adherence. These findings can inform the development and delivery of physical activity programs to maximize physical activity engagement in individuals living with chronic SCI.	[Baehr, Laura A.; Finley, Margaret] Drexel Univ, Dept Phys Therapy & Rehabil Sci, Philadelphia, PA 19104 USA; [Kaimal, Girija] Drexel Univ, Creat Arts Therapies Dept, Philadelphia, PA 19104 USA; [Hiremath, Shivayogi V.] Temple Univ, Dept Hlth & Rehabil Sci, Philadelphia, PA 19122 USA; [Trost, Zina] Virginia Commonwealth Univ, Dept Phys Med & Rehabil, Richmond, VA USA	Drexel University; Drexel University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Virginia Commonwealth University	Baehr, LA (corresponding author), Drexel Univ, Dept Phys Therapy & Rehabil Sci, Philadelphia, PA 19104 USA.	lab397@drexel.edu	Hiremath, Shivayogi V./X-8758-2019	Hiremath, Shivayogi V./0000-0002-9708-1411; Baehr, Laura/0000-0001-9941-5975				Aartun I, 2022, SPORT EDUC SOC, V27, P1, DOI 10.1080/13573322.2020.1821182; Ankeny DP, 2009, NEUROSCIENCE, V158, P1112, DOI 10.1016/j.neuroscience.2008.07.001; Anneken V, 2010, SPINAL CORD, V48, P393, DOI 10.1038/sc.2009.137; Archer K.R., 2018, CURR PHYS MED REHAB, V6, P15, DOI https://doi.org/10.1007/s40141-018-0169-x; Bassett RL, 2009, SPINAL CORD, V47, P496, DOI 10.1038/sc.2008.174; Bethea JR, 2002, CURR OPIN NEUROL, V15, P355, DOI 10.1097/00019052-200206000-00021; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Charlifue S, 2010, PHYS MED REH CLIN N, V21, P383, DOI 10.1016/j.pmr.2009.12.002; Chen HY, 2010, J ADV NURS, V66, P1132, DOI 10.1111/j.1365-2648.2010.05271.x; Chen YY, 2011, ARCH PHYS MED REHAB, V92, P391, DOI 10.1016/j.apmr.2010.06.030; Cowan RE, 2013, SPINAL CORD, V51, P27, DOI 10.1038/sc.2012.53; Creswell JW, 2000, THEOR PRACT, V39, P124, DOI 10.1207/s15430421tip3903_2; Curtis K., 2014, J SPINAL CORD MED, V37, P631; de Oliveira BIR, 2016, SPINAL CORD, V54, P855, DOI 10.1038/sc.2015.235; DeJong G, 2013, ARCH PHYS MED REHAB, V94, pS87, DOI 10.1016/j.apmr.2012.10.037; Dijkers MPJM, 2005, J REHABIL RES DEV, V42, P87, DOI 10.1682/JRRD.2004.08.0100; Driver S, 2016, J SPINAL CORD MED, V39, P77, DOI 10.1179/2045772314Y.0000000270; Finley MA, 2020, J SPINAL CORD MED, V43, P497, DOI 10.1080/10790268.2019.1565717; Finley MK.R., 2002, IMPACT PHYS EXERCISE, V26, P21; Forchheimer M, 2004, NEUROREHABILITATION, V19, P103; Froehlich-Grobe K, 2014, ARCH PHYS MED REHAB, V95, P20, DOI 10.1016/j.apmr.2013.07.006; Ginis KAM, 2010, ARCH PHYS MED REHAB, V91, P722, DOI 10.1016/j.apmr.2009.12.027; Guest G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0232076; Guetterman T.C., 2015, FORUM QUAL SOZIALFOR, V16; Hausmann O, 2003, SPINAL CORD, V41, P369, DOI 10.1038/sj.sc.3101483; Hicks AL, 2003, SPINAL CORD, V41, P34, DOI 10.1038/sj.sc.3101389; Jette AM, 2019, PHYS THER, V99, P819, DOI 10.1093/ptj/pzz070; Kilic SA, 2013, SPINAL CORD, V51, P553, DOI 10.1038/sc.2013.25; Kornhaber R, 2018, J ADV NURS, V74, P23, DOI 10.1111/jan.13396; Latimer AE, 2006, REHABIL PSYCHOL, V51, P273, DOI 10.1037/0090-5550.51.4.273; Levins SM, 2004, PHYS THER, V84, P496, DOI 10.1093/ptj/84.6.496; Nash Mark S, 2005, J Neurol Phys Ther, V29, P87; Nicholas MK, 2011, PHYS THER, V91, P765, DOI 10.2522/ptj.20100278; P. A. and D. National Center on Health, 2021, COMM HLTH INCL; Ploughman M, 2015, PEERJ, V3, DOI 10.7717/peerj.1158; Post MWM, 2012, SPINAL CORD, V50, P382, DOI 10.1038/sc.2011.182; Price M, 2010, SPORTS MED, V40, P681, DOI 10.2165/11531960-000000000-00000; Price MJ, 1999, SPINAL CORD, V37, P772, DOI 10.1038/sj.sc.3100907; Prosek EA, 2021, J COUNS DEV, V99, P167, DOI 10.1002/jcad.12364; Rimmer J, 2017, DISABIL REHABIL, V39, P173, DOI 10.3109/09638288.2015.1047967; Tasiemski T, 2004, ADAPT PHYS ACT Q, V21, P364, DOI 10.1123/apaq.21.4.364; Tasiemski T, 2000, SPINAL CORD, V38, P173, DOI 10.1038/sj.sc.3100981; Tian WQ, 2013, ARCH PHYS MED REHAB, V94, pS125, DOI 10.1016/j.apmr.2012.10.039; Tomasone J. R., 2013, KINESIOLOGY REV, V2, P113, DOI [10.1123/krj.2.2.113., DOI 10.1123/KRJ.2.2.113]; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; U. of Alabama, 2020, NATL SPINAL CORD INJ; Vercambre MN, 2009, BMC PUBLIC HEALTH, V9, DOI [10.1186/1471-2458-9-168, 10.1186/1471-2458-9-333]; Wang YT, 2015, J PHYS EDUC RECREAT, V86, P27, DOI 10.1080/07303084.2015.1022673; Williams TL, 2018, DISABIL REHABIL, V40, P52, DOI 10.1080/09638288.2016.1242176; Xia RP, 2016, PHYS THER, V96, P410, DOI 10.2522/ptj.20140529	50	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265807	10.1371/journal.pone.0265807	http://dx.doi.org/10.1371/journal.pone.0265807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320294	Green Published, gold			2022-12-26	WOS:000784240600014
J	Palmieri, M; Joseph, TE; O'Brien, CA; Gomez-Acevedo, H; Manolagas, SC; Ambrogini, E				Palmieri, Michela; Joseph, Teenamol E.; O'Brien, Charles A.; Gomez-Acevedo, Horacio; Manolagas, Stavros C.; Ambrogini, Elena			Deletion of the scavenger receptor Scarb1 in osteoblast progenitors does not affect bone mass	PLOS ONE			English	Article							B TYPE-I; CHOLESTERYL ESTER; EXPRESSION; DIFFERENTIATION; ROLES; CELLS; VARIANT; MICE; LDL	The scavenger receptor class B member 1 (SR-B1 or Scarb1) is a cell surface receptor for high density lipoproteins. It also binds oxidized low density lipoproteins and phosphocholine-containing oxidized phospholipids (PC-OxPL), which adversely affect bone homeostasis. Overexpression of a single chain form of the antigen-binding domain of E06 IgM-a natural antibody that recognizes PC-OxPL-increases trabecular and cortical bone mass in female and male mice by stimulating bone formation. We have previously reported that Scarb1 is the most abundant scavenger receptor for PC-OxPL in calvaria-derived osteoblastic cells. Additionally, bone marrow- and calvaria-derived osteoblasts from Scarb1 knockout mice (Scarb1 KO) are protected from the pro-apoptotic and anti-differentiating effects of OxPL. Previous skeletal analysis of Scarb1 KO mice has produced contradictory results, with some studies reporting elevated bone mass but another study reporting low bone mass. To clarify the role of Scarb1 in osteoblasts, we deleted Scarb1 specifically in cells of the osteoblast lineage using Osx1-Cre transgenic mice. We observed no difference in bone mineral density measured by DXA in either female or male Osx1-Cre;Scarb1(fl/fl) mice compared to wild type (WT), Osx1-Cre, or Scarb1(fl/fl) littermate controls. Additionally, microCT analysis of 6-month-old females and 7-month-old males did not detect any difference in trabecular or cortical bone mass between genotypes. These results indicate that expression of Scarb1 in cells of the osteoblast lineage does not play an important role in bone homeostasis and, therefore, it is not essential for the effects of PC-OxPL on these cells.	[Palmieri, Michela; Joseph, Teenamol E.; O'Brien, Charles A.; Manolagas, Stavros C.; Ambrogini, Elena] Univ Arkansas Med Sci, Div Endocrinol & Metab, Ctr Osteoporosis & Metab Bone Dis, Little Rock, AR USA; [Palmieri, Michela; Joseph, Teenamol E.; O'Brien, Charles A.; Manolagas, Stavros C.; Ambrogini, Elena] Univ Arkansas Med Sci, Ctr Musculoskeletal Dis Res, Little Rock, AR USA; [Palmieri, Michela; Joseph, Teenamol E.; O'Brien, Charles A.; Manolagas, Stavros C.; Ambrogini, Elena] Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA; [Gomez-Acevedo, Horacio] Univ Arkansas Med Sci, Dept Biomed Informat, Little Rock, AR USA	University of Arkansas System; University of Arkansas Medical Sciences; University of Arkansas System; University of Arkansas Medical Sciences; US Department of Veterans Affairs; Veterans Health Administration (VHA); Central Arkansas Veterans Healthcare System; University of Arkansas System; University of Arkansas Medical Sciences	Ambrogini, E (corresponding author), Univ Arkansas Med Sci, Ctr Musculoskeletal Dis Res, Little Rock, AR USA.; Ambrogini, E (corresponding author), Cent Arkansas Vet Healthcare Syst, Little Rock, AR USA.	eambrogini@uams.edu		Ambrogini, Elena/0000-0002-5704-6072; Gomez-Acevedo, Horacio/0000-0002-1570-1606	Biomedical Laboratory Research and Development Service of the Veterans Administration Office of Research and Development [1I01BX003901-01A2, 2I01BX001405-05A2]; National Institutes of Health [P20 GM125503, P01 AG13918]; University of Arkansas for Medical Sciences Tobacco Funds and Translational Research Institute [239 G1-50893-01, 1UL1 RR-029884]; University of Arkansas for Medical Sciences Barton Endowment funding [271 G1-51451-99]	Biomedical Laboratory Research and Development Service of the Veterans Administration Office of Research and Development; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Arkansas for Medical Sciences Tobacco Funds and Translational Research Institute; University of Arkansas for Medical Sciences Barton Endowment funding	This work was supported by the Biomedical Laboratory Research and Development Service of the Veterans Administration Office of Research and Development (1I01BX003901-01A2 to EA, 2I01BX001405-05A2 to SCM), the National Institutes of Health (P20 GM125503 to CAO, P01 AG13918 to SCM), the University of Arkansas for Medical Sciences Tobacco Funds and Translational Research Institute (239 G1-50893-01; 1UL1 RR -029884 to EA) and the University of Arkansas for Medical Sciences Barton Endowment funding (271 G1-51451-99 to EA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida M, 2013, J CLIN INVEST, V123, P394, DOI 10.1172/JCI65910; Ambrogini E, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04047-5; Binder CJ, 2016, NAT REV IMMUNOL, V16, P485, DOI 10.1038/nri.2016.63; Bradley A, 2012, MAMM GENOME, V23, P580, DOI 10.1007/s00335-012-9422-2; Brodeur MR, 2008, J BONE MINER RES, V23, P326, DOI 10.1359/JBMR.071022; Brodeur MR, 2008, FREE RADICAL BIO MED, V44, P506, DOI 10.1016/j.freeradbiomed.2007.08.030; Brundert M, 2005, ARTERIOSCL THROM VAS, V25, P143, DOI 10.1161/01.ATV.0000149381.16166.c6; Davey RA, 2012, TRANSGENIC RES, V21, P885, DOI 10.1007/s11248-011-9581-z; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Gillotte-Taylor K, 2001, J LIPID RES, V42, P1474; Hoekstra M, 2017, CURR OPIN LIPIDOL, V28, P255, DOI 10.1097/MOL.0000000000000413; Hoekstra M, 2012, CURR OPIN LIPIDOL, V23, P127, DOI 10.1097/MOL.0b013e3283508c09; Hoekstra M, 2009, J LIPID RES, V50, P1039, DOI 10.1194/jlr.M800410-JLR200; Iyer S, 2014, J BIOL CHEM, V289, P24069, DOI 10.1074/jbc.M114.561803; JILKA RL, 1986, BONE, V7, P29, DOI 10.1016/8756-3282(86)90149-3; Jilka RL, 2014, J BONE MINER RES, V29, P103, DOI 10.1002/jbmr.2007; Liu Y, 2016, AM J PHYSIOL-ENDOC M, V310, pE762, DOI 10.1152/ajpendo.00501.2015; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martineau C, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12117; Martineau C, 2014, J ENDOCRINOL, V222, P277, DOI 10.1530/JOE-14-0147; Martineau C, 2014, AM J PHYSIOL-ENDOC M, V306, pE48, DOI 10.1152/ajpendo.00421.2013; O'Brien CA, 2005, AM J PHYSIOL-ENDOC M, V289, pE784, DOI 10.1152/ajpendo.00029.2005; Palmieri M, 2021, AGING CELL, V20, DOI 10.1111/acel.13442; Palmieri M, 2021, J BONE MINER RES, V36, P170, DOI 10.1002/jbmr.4173; Rodda SJ, 2006, DEVELOPMENT, V133, P3231, DOI 10.1242/dev.02480; Shen WJ, 2018, J LIPID RES, V59, P1114, DOI 10.1194/jlr.R083121; Takemura K, 2010, BIOCHEM BIOPH RES CO, V391, P1675, DOI 10.1016/j.bbrc.2009.12.126; Terrier CSP, 2017, J INFECTION, V75, P281, DOI 10.1016/j.jinf.2017.07.007; Tourkova IL, 2019, LAB INVEST, V99, P1850, DOI 10.1038/s41374-019-0311-0; Vergeer M, 2011, NEW ENGL J MED, V364, P136, DOI 10.1056/NEJMoa0907687; Vishnyakova TG, 2003, J BIOL CHEM, V278, P22771, DOI 10.1074/jbc.M211032200; Wang L, 2015, CALCIFIED TISSUE INT, V96, P129, DOI 10.1007/s00223-014-9945-5; Xiong JH, 2018, BONE, V112, P1, DOI 10.1016/j.bone.2018.04.001; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Xu JF, 2012, MOL CELL BIOCHEM, V371, P55, DOI 10.1007/s11010-012-1422-8; Zanoni P, 2016, SCIENCE, V351, P1166, DOI 10.1126/science.aad3517; Zhang YZ, 2005, J CLIN INVEST, V115, P2870, DOI 10.1172/JCI25327	37	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265893	10.1371/journal.pone.0265893	http://dx.doi.org/10.1371/journal.pone.0265893			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349600	gold, Green Published			2022-12-26	WOS:000783906500002
J	Saylor, K; Donnan, B; Zhang, CM				Saylor, Kyle; Donnan, Ben; Zhang, Chenming			Computational mining of MHC class II epitopes for the development of universal immunogenic proteins	PLOS ONE			English	Article							HETEROZYGOTE ADVANTAGE; NICOTINE VACCINE; HLA; EFFICACY; SAFETY; PREDICTION; BINDING	The human leukocyte antigen (HLA) gene complex, one of the most diverse gene complexes found in the human genome, largely dictates how our immune systems recognize pathogens. Specifically, HLA genetic variability has been linked to vaccine effectiveness in humans and it has likely played some role in the shortcomings of the numerous human vaccines that have failed clinical trials. This variability is largely impossible to evaluate in animal models, however, as their immune systems generally 1) lack the diversity of the HLA complex and/or 2) express major histocompatibility complex (MHC) receptors that differ in specificity when compared to human MHC. In order to effectively engage the majority of human MHC receptors during vaccine design, here, we describe the use of HLA population frequency data from the USA and MHC epitope prediction software to facilitate the in silico mining of universal helper T cell epitopes and the subsequent design of a universal human immunogen using these predictions. This research highlights a novel approach to using in silico prediction software and data processing to direct vaccine development efforts.	[Saylor, Kyle; Donnan, Ben; Zhang, Chenming] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA; [Saylor, Kyle; Donnan, Ben; Zhang, Chenming] Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Zhang, CM (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA.; Zhang, CM (corresponding author), Virginia Tech, Dept Biol Syst Engn, Blacksburg, VA USA.	chzhang2@vt.edu			American Association of Immunologists Careers in Immunology Fellowship Program; National Institute on Drug Abuse [U01DA036850]; Immune Epitope Database	American Association of Immunologists Careers in Immunology Fellowship Program; National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Immune Epitope Database	Funding was provided by the American Association of Immunologists Careers in Immunology Fellowship Program (https://www.aai.org/Careers/Fellowships/CIFP) and the National Institute on Drug Abuse (U01DA036850, https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-institute-drug-abuse-nida) to CZ. Funding was also provided by the Immune Epitope Database to KS for his attendance of the 2019 IEDB & nbsp;User Workshop. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreatta M, 2015, IMMUNOGENETICS, V67, P641, DOI 10.1007/s00251-015-0873-y; Bateman A, 2006, NUCLEIC ACIDS RES, V34, pD1, DOI 10.1093/nar/gkj150; Blackwell JM, 2009, CLIN MICROBIOL REV, V22, P370, DOI 10.1128/CMR.00048-08; BROMME D, 1994, J BIOL CHEM, V269, P30238; Brown MJ, 2009, NAT REV CARDIOL, V6, P639, DOI 10.1038/nrcardio.2009.156; Chowell D, 2019, NAT MED, V25, P1715, DOI 10.1038/s41591-019-0639-4; Chowell D, 2018, SCIENCE, V359, P582, DOI 10.1126/science.aao4572; Cornuz J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002547; Dendrou CA, 2018, NAT REV IMMUNOL, V18, P325, DOI 10.1038/nri.2017.143; Esterlis I, 2013, AM J PSYCHIAT, V170, P399, DOI 10.1176/appi.ajp.2012.12060793; Ferrante A, 2007, J IMMUNOL, V178, P7181, DOI 10.4049/jimmunol.178.11.7181; Gartland AJ, 2014, J VIROL, V88, P8242, DOI 10.1128/JVI.01164-14; Gragert L, 2013, HUM IMMUNOL, V74, P1313, DOI 10.1016/j.humimm.2013.06.025; Grifoni A, 2020, CELL HOST MICROBE, V27, P671, DOI 10.1016/j.chom.2020.03.002; Haralambieva IH, 2013, EXPERT REV VACCINES, V12, P57, DOI [10.1586/erv.12.134, 10.1586/ERV.12.134]; Hatsukami DK, 2011, CLIN PHARMACOL THER, V89, P392, DOI 10.1038/clpt.2010.317; Hatsukami DK, 2005, CLIN PHARMACOL THER, V78, P456, DOI 10.1016/j.clpt.2005.08.007; Hraber P, 2007, HEPATOLOGY, V46, P1713, DOI 10.1002/hep.21889; Hu Y., 2019, NEUROSCIENCE NICOTIN, V1st edition; Hu Y, 2018, BIOMATERIALS, V182, P72, DOI 10.1016/j.biomaterials.2018.08.015; Janeway C, 2005, IMMUNOBIOLOGY IMMUNE, p[xxiii, 823]; Jensen KK, 2018, IMMUNOLOGY, V154, P394, DOI 10.1111/imm.12889; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Madeleine MM, 2008, CANCER RES, V68, P3532, DOI 10.1158/0008-5472.CAN-07-6471; Maurer P, 2005, EUR J IMMUNOL, V35, P2031, DOI 10.1002/eji.200526285; Michel-Todo L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02698; Moise Leonard, 2013, R I Med J (2013), V96, P19; Moore TV, 2020, NAT REV CLIN ONCOL, V17, P71, DOI 10.1038/s41571-019-0315-0; Moss AJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071376; Nielsen M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-238; Paul S, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01795; Saylor K, 2020, J CHROMATOGR A, V1631, DOI 10.1016/j.chroma.2020.461567; Saylor K, 2020, FRONT IMMUNOL, V11, DOI 10.3389/fimmu.2020.00283; Saylor K, 2016, TOXICOL APPL PHARM, V307, P150, DOI 10.1016/j.taap.2016.07.017; ten Broeke T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a016873; Thursz MR, 1997, NAT GENET, V17, P11, DOI 10.1038/ng0997-11; Vaithilingam A, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-35; Vita R, 2019, NUCLEIC ACIDS RES, V47, pD339, DOI 10.1093/nar/gky1006; Wagena EJ, 2008, NICOTINE TOB RES, V10, P213, DOI 10.1080/14622200701704921; Walsh NC, 2017, ANNU REV PATHOL-MECH, V12, P187, DOI 10.1146/annurev-pathol-052016-100332; Wang P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000048; WATARI E, 1987, J EXP MED, V165, P459, DOI 10.1084/jem.165.2.459; Yao YF, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00428; Zhao ZM, 2018, NANOMED-NANOTECHNOL, V14, P1655, DOI 10.1016/j.nano.2018.04.016; Zimmermann P, 2019, CLIN MICROBIOL REV, V32, DOI 10.1128/CMR.00084-18	45	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265644	10.1371/journal.pone.0265644	http://dx.doi.org/10.1371/journal.pone.0265644			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P0IK	35349604	Green Published, gold			2022-12-26	WOS:000783906500033
J	Tsumura, Y; Tsushima, Y; Tamura, A; Kato, H; Kobayashi, T				Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Kato, Hirotsugu; Kobayashi, Tsunefumi			Disruptions in hepatic glucose metabolism are involved in the diminished efficacy after chronic treatment with glucokinase activator	PLOS ONE			English	Article							PLASMA-GLUCOSE; BETA-CELLS; TYPE-2; EXPRESSION; MK-0941; AZD1656; MICE	Glucokinase activators are regarded as potent candidates for diabetes treatment, however, in clinical studies on patients with type 2 diabetes, a diminishing efficacy was observed after chronic treatment with them. The mechanism of this reduction has not been elucidated, and whether it is a class effect of glucokinase activators remains inconclusive. Here, we firstly identified a diabetic animal model that shows the diminished efficacy after long-term treatment with MK-0941, a glucokinase activator that exhibited diminished efficacy in a clinical study, and we analyzed the mechanism underlying its diminished efficacy. In addition, we evaluated the long-term efficacy of another glucokinase activator, TMG-123. Goto-Kakizaki rats were treated with MK-0941 and TMG-123 for 24 weeks. The results showed that glycated hemoglobin A1C levels and plasma glucose levels decreased transiently but increased over time with the continuation of treatment in the MK-0941-treated group, while decreased continuously in the TMG-123-treated group. Only in the TMG-123-treated group, higher plasma insulin levels were shown at the later stage of the treatment period. For the mechanism analysis, we conducted a hepatic enzyme assay and liver perfusion study in Goto-Kakizaki rats after chronic treatment with MK-0941 and TMG-123, and revealed that, only in the MK-0941-treated group, the activity of glucose-6-phosphatase was increased, and hepatic glucose utilization was decreased compared to the non-treated group. These data indicate that disruptions in hepatic glucose metabolism are involved in the diminished efficacy of glucokinase activators.	[Tsumura, Yoshinori; Tsushima, Yu; Tamura, Azusa; Kato, Hirotsugu; Kobayashi, Tsunefumi] Teijin Pharma Ltd, Teijin Inst Biomed Res, Pharmacol Res Dept, Tokyo, Japan; [Tsumura, Yoshinori] Teijin Pharma Ltd, Pharmaceut Dev Coordinat Dept, Chiyoda Ku, Tokyo, Japan; [Kato, Hirotsugu] Teijin Pharma Ltd, Legal & Intellectual Property Strategy Dept, Hino, Tokyo, Japan; [Kobayashi, Tsunefumi] Teijin Pharma Ltd, Res Dev & Technol Unit, Chiyoda Ku, Tokyo, Japan	Teijin Pharma Limited; Teijin Pharma Limited; Teijin Pharma Limited; Teijin Pharma Limited	Tsumura, Y (corresponding author), Teijin Pharma Ltd, Teijin Inst Biomed Res, Pharmacol Res Dept, Tokyo, Japan.; Tsumura, Y (corresponding author), Teijin Pharma Ltd, Pharmaceut Dev Coordinat Dept, Chiyoda Ku, Tokyo, Japan.	y.tsumura@teijin.co.jp		Tsumura, Yoshinori/0000-0002-7223-6018	Teijin Pharma Limited	Teijin Pharma Limited(Teijin Pharma Limited)	Funding: This study was supported by Teijin Pharma Limited. Teijin Pharma Limited provided support in the form of salaries for all authors[Y. Tsumura, Y.Tsushima, AT, HK, and TK], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al Jobori H, 2018, J CLIN ENDOCR METAB, V103, P1402, DOI 10.1210/jc.2017-01838; Al-Oanzi ZH, 2017, DIABETES OBES METAB, V19, P1078, DOI 10.1111/dom.12910; Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS73, DOI 10.2337/dc18-S008; Atlas D., 2015, IDF DIABETES ATLAS, V7th; BURCHELL A, 1988, CLIN CHIM ACTA, V173, P183, DOI 10.1016/0009-8981(88)90256-2; Desai UJ, 2001, DIABETES, V50, P2287, DOI 10.2337/diabetes.50.10.2287; Egan A, 2019, EXPERT OPIN INV DRUG, V28, P741, DOI 10.1080/13543784.2019.1654993; Eiki J, 2011, MOL PHARMACOL, V80, P1156, DOI 10.1124/mol.111.074401; FARESE RV, 1994, P NATL ACAD SCI USA, V91, P11040, DOI 10.1073/pnas.91.23.11040; Ferre T, 1996, FASEB J, V10, P1213, DOI 10.1096/fasebj.10.10.8751724; Ford BE, 2020, DIABETES OBES METAB, V22, P1985, DOI 10.1111/dom.14111; IYNEDJIAN PB, 1986, P NATL ACAD SCI USA, V83, P1998, DOI 10.1073/pnas.83.7.1998; Kiyosue A, 2013, DIABETES OBES METAB, V15, P923, DOI 10.1111/dom.12100; Koyama M, 1998, AM J PATHOL, V153, P537, DOI 10.1016/S0002-9440(10)65596-4; MATSCHINSKY FM, 1990, DIABETES, V39, P647, DOI 10.2337/diabetes.39.6.647; Matschinsky FM, 2009, NAT REV DRUG DISCOV, V8, P399, DOI 10.1038/nrd2850; Meininger GE, 2011, DIABETES CARE, V34, P2560, DOI 10.2337/dc11-1200; Merovci A, 2015, J CLIN ENDOCR METAB, V100, P1927, DOI 10.1210/jc.2014-3472; Nissim I, 2012, BIOCHEM J, V444, P537, DOI 10.1042/BJ20120163; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; Roma LP, 2015, AM J PHYSIOL-ENDOC M, V309, pE632, DOI 10.1152/ajpendo.00154.2015; Thilagavathi R, 2022, CHEM BIOL DRUG DES, V99, P247, DOI 10.1111/cbdd.13979; Tornovsky-Babeay S, 2014, CELL METAB, V19, P109, DOI 10.1016/j.cmet.2013.11.007; Tsumura Y, 2019, ANAL SCI, V35, P455, DOI 10.2116/analsci.18P427; Tsumura Y, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172252; Wilding JPH, 2013, DIABETES OBES METAB, V15, P750, DOI 10.1111/dom.12088	26	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265761	10.1371/journal.pone.0265761	http://dx.doi.org/10.1371/journal.pone.0265761			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312718	Green Published, gold			2022-12-26	WOS:000803647900015
J	Frappier-Brinton, T; Lehman, SM				Frappier-Brinton, Tristan; Lehman, Shawn M.			The burning island: Spatiotemporal patterns of fire occurrence in Madagascar	PLOS ONE			English	Article							FOREST FRAGMENTATION; MANGROVE FORESTS; CLIMATE-CHANGE; DEFORESTATION; CONSERVATION; AMAZON; AREA; BIODIVERSITY; MANAGEMENT; DYNAMICS	Anthropogenic fire use is widespread across Madagascar and threatens the island's unprecedented endemic biodiversity. The vast majority (96%) of lemur species are already threatened with extinction, and Madagascar has already lost more than 44% of its forests. Previous conservation assessments have noted the role of fire in the rampant deforestation and habitat degradation across Madagascar, but published, quantified data on fire use across the island are incredibly limited. Here, we present the first quantification of spatiotemporal patterns in fire occurrence across Madagascar using VIIRS satellite fire detection data. We assess which regions of Madagascar have the most prevalent fire use, how fire use is changing over time, and what this means for Madagascar's remaining forest ecosystems. An average of 356,189 fires were detected every year in Madagascar from 2012-2019, averaging 0.604 fires/km(2). Fire use was near-ubiquitous across the island, but was most prevalent in the western dry deciduous forests and succulent woodlands ecoregions. Fire frequency in the eastern lowlands was highest around the remaining humid rainforest, and fire frequency was increasing over time around much of the remaining humid and dry forest. We found that 18.6% of all remaining forest was within 500 m of a fire within a single year, and 39.3% was within 1 km. More than half of remaining forest was within 1 km of a fire in a single year in the dry deciduous forests, succulent woodlands, and mangroves ecoregions. However, fire frequency within national park protected areas was, on average, 65% lower than their surroundings. Only 7.1% of national park forest was within 500 m of a fire within one year, and 17.1% was within 1 km, suggesting that national parks are effective at reducing fire frequency in Madagascar's tropical forests.	[Frappier-Brinton, Tristan] Duke Univ, Dept Biol, Durham, NC USA; [Lehman, Shawn M.] Univ Toronto, Dept Anthropol, Toronto, ON, Canada	Duke University; University of Toronto	Lehman, SM (corresponding author), Univ Toronto, Dept Anthropol, Toronto, ON, Canada.	shawn.lehman@utoronto.ca		Lehman, Shawn/0000-0003-0191-7139	Natural Sciences and Engineering Research Council of Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	SML, No grant number, Discovery Grant from the Natural Sciences and Engineering Research Council of Canada, https://www.nserccrsng.gc.ca/index_eng.asp.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allnutt TF, 2008, CONSERV LETT, V1, P173, DOI 10.1111/j.1755-263X.2008.00027.x; Alvarado ST, 2014, S AFR J BOT, V94, P79, DOI 10.1016/j.sajb.2014.06.001; Andela N, 2017, SCIENCE, V356, P1356, DOI 10.1126/science.aal4108; Archibald S, 2009, GLOBAL CHANGE BIOL, V15, P613, DOI 10.1111/j.1365-2486.2008.01754.x; Axel AC, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10030371; Barlow J, 2006, BIODIVERS CONSERV, V15, P985, DOI 10.1007/s10531-004-3952-1; Barlow J, 2003, ECOL LETT, V6, P6, DOI 10.1046/j.1461-0248.2003.00394.x; Barlow Jos, 2009, P543, DOI 10.1007/978-3-540-77381-8_19; Bloesch U, 1999, APPL VEG SCI, V2, P117, DOI 10.2307/1478888; Brand J, 1998, AGR ECOSYST ENVIRON, V71, P169, DOI 10.1016/S0167-8809(98)00139-X; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Bruner AG, 2001, SCIENCE, V291, P125, DOI 10.1126/science.291.5501.125; Burney DA, 1996, COLLOQ SEMI, P49; CIESINCenter for International Earth Science Information NetworkColumbia University, 2018, GRIDDED POPULATION W; Cochrane MA, 2003, NATURE, V421, P913, DOI 10.1038/nature01437; Cochrane MA, 1999, BIOTROPICA, V31, P2, DOI 10.1111/j.1744-7429.1999.tb00112.x; Cochrane MA, 2002, J TROP ECOL, V18, P311, DOI 10.1017/S0266467402002237; Cochrane MA, 1999, SCIENCE, V284, P1832, DOI 10.1126/science.284.5421.1832; Csiszar I, 2014, J GEOPHYS RES-ATMOS, V119, P803, DOI 10.1002/2013JD020453; Davidson EA, 2012, NATURE, V481, P321, DOI 10.1038/nature10717; De Jager NR, 2013, METHODS ECOL EVOL, V4, P789, DOI 10.1111/2041-210X.12068; Dunham AE, 2008, BIOL CONSERV, V141, P287, DOI 10.1016/j.biocon.2007.10.006; Dunham AE, 2011, GLOBAL CHANGE BIOL, V17, P219, DOI 10.1111/j.1365-2486.2010.02205.x; Friess DA, 2019, ANNU REV ENV RESOUR, V44, P89, DOI 10.1146/annurev-environ-101718-033302; Ganzhorn JU, 2001, ORYX, V35, P346, DOI 10.1046/j.1365-3008.2001.00201.x; Gardner CJ, 2018, BIOL CONSERV, V220, P29, DOI 10.1016/j.biocon.2018.02.011; Gardner CJ, 2016, BIODIVERS CONSERV, V25, P1773, DOI 10.1007/s10531-016-1160-4; Gautier L., 2018, TERRESTRIAL PROTECTE, P207; Giglio L, 2007, REMOTE SENS ENVIRON, V108, P407, DOI 10.1016/j.rse.2006.11.018; Giglio L, 2016, REMOTE SENS ENVIRON, V178, P31, DOI 10.1016/j.rse.2016.02.054; Giglio L, 2013, J GEOPHYS RES-BIOGEO, V118, P317, DOI 10.1002/jgrg.20042; Goldammer JG., 1996, BIOMASS BURNING GLOB, P236; Goldammer JG., 2012, FIRE TROPICAL BIOTA; Golden CD, 2009, ORYX, V43, P386, DOI 10.1017/S0030605309000131; Goodman SM, 2005, ORYX, V39, P73, DOI 10.1017/S0030605305000128; Harper GJ, 2007, ENVIRON CONSERV, V34, P325, DOI 10.1017/S0376892907004262; Hill, 2018, THESIS; Irwin MT, 2010, BIOL CONSERV, V143, P2351, DOI 10.1016/j.biocon.2010.01.023; IUCN, 2020, IUCN RED LIST THREAT; Jolly WM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8537; Jones TG, 2015, J MAR SCI ENG, V3, P793, DOI 10.3390/jmse3030793; Juffe-Bignoli D, 2014, PROTECTED PLANET REP; Klein J, 2007, SOC NATUR RESOUR, V20, P451, DOI 10.1080/08941920701211900; Kull C., 2004, ISLE FIRE POLITICAL; Kull Christian A., 2009, P171, DOI 10.1007/978-3-540-77381-8_7; Laurance WF, 2003, TRENDS ECOL EVOL, V18, P209, DOI 10.1016/S0169-5347(03)00064-8; Lehman SM, 2006, AM J PHYS ANTHROPOL, V129, P232, DOI 10.1002/ajpa.20241; Minten B, 2013, ENERGY SUSTAIN DEV, V17, P106, DOI 10.1016/j.esd.2012.08.004; Morelli TL, 2020, NAT CLIM CHANGE, V10, P89, DOI 10.1038/s41558-019-0647-x; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nellemann, 2007, LAST STAND ORANGUTAN; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parr CL, 2003, AUSTRAL ECOL, V28, P384, DOI 10.1046/j.1442-9993.2003.01296.x; Peres CA, 1999, J TROP ECOL, V15, P535, DOI 10.1017/S0266467499000991; Polivka TN, 2016, IEEE T GEOSCI REMOTE, V54, P5503, DOI 10.1109/TGRS.2016.2566665; Rakotomavo A, 2010, FOREST ECOL MANAG, V259, P1161, DOI 10.1016/j.foreco.2010.01.002; Rasolofoson RA, 2015, BIOL CONSERV, V184, P271, DOI 10.1016/j.biocon.2015.01.027; Roy DP, 2008, REMOTE SENS ENVIRON, V112, P3690, DOI 10.1016/j.rse.2008.05.013; SALDARRIAGA JG, 1986, QUATERNARY RES, V26, P358, DOI 10.1016/0033-5894(86)90095-5; Sankaran M, 2005, NATURE, V438, P846, DOI 10.1038/nature04070; SAUNDERS DA, 1991, CONSERV BIOL, V5, P18, DOI 10.1111/j.1523-1739.1991.tb00384.x; Scales H, HAKAI MAGAZINE; Scales IR, 2019, WETL ECOL MANAG, V27, P609, DOI 10.1007/s11273-019-09680-5; Scales IR, 2011, ENVIRON HIST-UK, V17, P499, DOI 10.3197/096734011X13150366551481; Schroeder W, 2014, REMOTE SENS ENVIRON, V143, P85, DOI 10.1016/j.rse.2013.12.008; Sharma A, 2017, ATMOSPHERE-BASEL, V8, DOI 10.3390/atmos8060095; Shlisky Ayn, 2009, P65, DOI 10.1007/978-3-540-77381-8_3; Silvestrini RA, 2011, ECOL APPL, V21, P1573, DOI 10.1890/10-0827.1; Steffens TS., NEW NATURAL HIST MAD; Styger E, 2007, AGR ECOSYST ENVIRON, V119, P257, DOI 10.1016/j.agee.2006.07.012; Tabor K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0190119; Thampanya U, 2006, ESTUAR COAST SHELF S, V68, P75, DOI 10.1016/j.ecss.2006.01.011; United Nations, 2019, WORLD POPULATION PRO; Vadrevu K, 2018, REMOTE SENS-BASEL, V10, DOI 10.3390/rs10070978; Vadrevu KP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-43940-x; van der Werf GR, 2010, ATMOS CHEM PHYS, V10, P11707, DOI 10.5194/acp-10-11707-2010; Vieilledent G, 2018, BIOL CONSERV, V222, P189, DOI 10.1016/j.biocon.2018.04.008; Waeber PO, 2015, INT FOREST REV, V17, P127, DOI 10.1505/146554815815834822; Wilme L, 2006, SCIENCE, V312, P1063, DOI 10.1126/science.1122806	79	4	4	7	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0263313	10.1371/journal.pone.0263313	http://dx.doi.org/10.1371/journal.pone.0263313			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358197	gold, Green Published			2022-12-26	WOS:000799828800010
J	Musthafa, MM; Abdullah, F; Koivula, MJ				Musthafa, Muneeb M.; Abdullah, Fauziah; Koivula, Matti J.			The functioning of different beetle (Coleoptera) sampling methods across altitudinal gradients in Peninsular Malaysia	PLOS ONE			English	Article							SPECIES GROUP; GROUND BEETLES; STAPHYLINIDAE; ELEVATION; TRAPS; SCARABAEIDAE; BIODIVERSITY; MOUNTAINS; DIVERSITY; PATTERNS	Biodiversity research relies largely on knowledge about species responses to environmental gradients, assessed using some commonly applied sampling method. However, the consistency of detected responses using different sampling methods, and thus the generality of findings, has seldom been assessed in tropical ecosystems. Hence, we studied the response consistency and indicator functioning of beetle assemblages in altitudinal gradients from two mountains in Malaysia, using Malaise, light, and pitfall traps. The data were analyzed using generalized linear mixed-effects models (GLMM), non-metric multidimensional scaling (NMDS), multivariate regression trees (MRT), and indicator species analysis (IndVal). We collected 198 morpho-species of beetles representing 32 families, with a total number of 3,052 individual beetles. The richness measures generally declined with increasing altitude. The mountains differed little in terms of light and Malaise trap data but differed remarkably in pitfall-trap data. Only light traps (but not the other trap types) distinguished high from middle or low altitudes in terms of beetle richness and assemblage composition. The lower altitudes hosted about twice as many indicators as middle or high altitudes, and many species were trap-type specific in our data. These results suggest that the three sampling methods reflected the altitudinal gradient in different ways and the detection of community variation in the environment thus depends on the chosen sampling method. However, also the analytical approach appeared important, further underlining the need to use multiple methods in environmental assessments.	[Musthafa, Muneeb M.] South Eastern Univ Sri Lanka, Fac Technol, Dept Biosyst Technol, Univ Pk, Oluvil, Sri Lanka; [Musthafa, Muneeb M.; Abdullah, Fauziah] Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia; [Musthafa, Muneeb M.; Abdullah, Fauziah] Univ Malaya, Inst Postgrad Studies, Toxicol Lab, B513, Kuala Lumpur, Malaysia; [Abdullah, Fauziah] Univ Malaya, Ctr Biotechnol Agr, Kuala Lumpur, Malaysia; [Koivula, Matti J.] Nat Resources Inst Finland LUKE, Helsinki, Finland	South Eastern University of Sri Lanka; Universiti Malaya; Universiti Malaya; Universiti Malaya; Natural Resources Institute Finland (Luke)	Musthafa, MM (corresponding author), South Eastern Univ Sri Lanka, Fac Technol, Dept Biosyst Technol, Univ Pk, Oluvil, Sri Lanka.; Musthafa, MM (corresponding author), Univ Malaya, Fac Sci, Inst Biol Sci, Kuala Lumpur, Malaysia.; Musthafa, MM (corresponding author), Univ Malaya, Inst Postgrad Studies, Toxicol Lab, B513, Kuala Lumpur, Malaysia.	muneeb@seu.ac.lk	Musthafa, Muneeb/AAK-8940-2021		University of Malaya [RP004E/13SUS, PG059/2014B]	University of Malaya(Universiti Malaya)	We thank the University of Malaya for financing this study (grant numbers RP004E/13SUS and PG059/2014B). The amended Role of Funder: The University of Malaya funded by two grants namely, RP004E/13SUS and PG059/2014B mainly for field works, travelling and sample collection.	Abdullah F., 2019, MALAYSIA FORESTER, V82, P247; Anzaldo SS, 2017, ZOOKEYS, P51, DOI 10.3897/zookeys.683.12080; Ashton LA, 2016, AUSTRAL ECOL, V41, P197, DOI 10.1111/aec.12309; Assing Volker, 2008, Beitraege zur Entomologie, V58, P455; Barnes B.V., 1999, FOREST ECOLOGY, VFourth; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Borg I., 2005, SPRINGER SERIES STAT, V2; Bouzan AM, 2015, ZOOKEYS, P103, DOI 10.3897/zookeys.547.9723; Chao A, 2012, ECOLOGY, V93, P2533, DOI 10.1890/11-1952.1; Cheong C., 2013, FRASERS HILLA LUSH H; Cox CB, 2016, BIOGEOGRAPHY ECOLOGI; De Caceres M, 2010, OIKOS, V119, P1674, DOI 10.1111/j.1600-0706.2010.18334.x; De Cceres M, 2016, **DATA OBJECT**; De'Ath G, 2002, ECOLOGY, V83, P1105, DOI 10.2307/3071917; Death G, 2014, MVPART MULTIVARIATE; Devigne C, 2014, BIODIVERS J, V5, P165; Doll HM, 2014, RAFFLES B ZOOL, V62, P549; Dufrene M, 1997, ECOL MONOGR, V67, P345, DOI 10.1890/0012-9615(1997)067[0345:SAAIST]2.0.CO;2; Ekroos J, 2020, BIOL CONSERV, V241, DOI 10.1016/j.biocon.2019.108255; Elsen PR, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15881-x; Elsen PR, 2015, NAT CLIM CHANGE, V5, P772, DOI [10.1038/nclimate2656, 10.1038/NCLIMATE2656]; Escobar F, 2005, GLOBAL ECOL BIOGEOGR, V14, P327, DOI 10.1111/j.1466-822x.2005.00161.x; Filippini V, 2016, ZOOKEYS, P63, DOI 10.3897/zookeys.621.7565; Fox J., 2019, R COMPANION APPL REG, V.; Freeman DB, 1999, J HIST GEOGR, V25, P17, DOI 10.1006/jhge.1998.0105; GILCHRIST GW, 1995, AM NAT, V146, P252, DOI 10.1086/285797; Grootaert P., 2010, MANUAL FIELD RECORDI, P377, DOI 10.1128/AEM.00759-10; Hlavac P, 2011, ZOOTAXA, P1; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Hsieh T.C., 2020, INEXT 2020; Kiew R, 1998, SEED PLANT FLORA FRA; Koller M, 2016, J STAT SOFTW, V75, P1, DOI 10.18637/jss.v075.i06; Korner C, 1999, ALPINE PLANT LIFE FU; Lamarre GPA, 2012, ZOOKEYS, P43, DOI 10.3897/zookeys.216.3332; Makranczy G, 2017, ACTA ZOOL ACAD SCI H, V63, P143, DOI 10.17109/AZH.63.2.143.2017; MATTHEWS R W, 1971, Michigan Entomologist, V4, P117; McCain C.M., 2010, ENCY LIFE SCI ELS, DOI 10.1002/9780470015902.a0022548; MCGEACHIE WJ, 1989, B ENTOMOL RES, V79, P185, DOI 10.1017/S0007485300018162; Millard J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-021-23228-3; Missa O, 2009, J INSECT CONSERV, V13, P103, DOI 10.1007/s10841-007-9130-5; Mittermeier R.A., 2011, BIODIVERSITY HOTSPOT, P3, DOI DOI 10.1007/978-3-642-20992-5_1; Mohamedsaid MS, 2004, CATALOGUE MALAYSIAN; Musthafa MM, 2018, J INSECT CONSERV, V22, P757, DOI 10.1007/s10841-018-0099-z; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Naomi Shun-Ichiro, 2006, Japanese Journal of Systematic Entomology, V12, P39; Nowinszky L., 2017, BIOL CONTROL PEST VE, P97; Nunes CA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0157442; Oksanen J., 2017, COMMUNITY ECOLOGY PA; Peh KSH, 2011, BIOSCIENCE, V61, P27, DOI 10.1525/bio.2011.61.1.8; Perumal B, 1998, RECORDED MOUNTAIN TR; PIGGOTT A G, 1977, Gardens' Bulletin (Singapore), V30, P31; PRAAGMAN J, 1985, EUR J OPER RES, V19, P144, DOI 10.1016/0377-2217(85)90321-2; Prathapan KD, 2011, ZOOKEYS, P1, DOI 10.3897/zookeys.87.1294; Rangwala I, 2012, CLIMATIC CHANGE, V114, P527, DOI 10.1007/s10584-012-0419-3; Ryvkin Alexandr B., 2011, Baltic Journal of Coleopterology, V11, P57; Saavedra S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3350; Saito Masahiro, 2003, Elytra, V31, P321; Sasakawa K, 2017, J ASIA-PAC ENTOMOL, V20, P7, DOI 10.1016/j.aspen.2016.11.001; Schawaller W, 2012, ZOOKEYS, P83, DOI 10.3897/zookeys.243.3879; Schawaller Wolfgang, 2006, Stuttgarter Beitraege zur Naturkunde Serie A (Biologie), P1; Schimmel R., 2007, GENUS, V14, P89; Sheikh AH., 2016, INT J CURR RES, V8, P40868; Shi HL, 2013, ZOOKEYS, P1, DOI 10.3897/zookeys.284.3983; Stone BC., 1981, FEDERATION MUSEUM J, V26, P157; Ulyshen MD, 2005, CAN ENTOMOL, V137, P251; Ya'cob Z, 2016, ACTA TROP, V153, P57, DOI 10.1016/j.actatropica.2015.10.007; Yamazaki D, 2017, GEOPHYS RES LETT, V44, P5844, DOI 10.1002/2017GL072874; Zuur Alain F., 2009, P1	69	1	1	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266076	10.1371/journal.pone.0266076	http://dx.doi.org/10.1371/journal.pone.0266076			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358260	Green Published, gold			2022-12-26	WOS:000799828800063
J	Saber, AZ				Saber, Ayad Zaki			Prediction and developing of shear strength of reinforced high strength concrete beams with and without steel fibers using multiple mathematical models	PLOS ONE			English	Article							DESIGN; BEHAVIOR; FAILURE; FORMULA	One of the methods to improve the structural design of concrete is by updating the factors given in standard codes, especially when non-conventional materials are used in concrete beams. Accordingly, this study focuses on the colorations between the compressive strength and shear strength of high-strength concrete beams with and without steel fibers. For that purpose, different models are proposed to predict shear strength of high-strength concrete beams, by taking different combinations of the main variables: beam cross-section dimension (width and effective depth), reinforcement index, concrete compressive strength, shear span ratio, and steel fiber properties (volumetric content, fiber aspect ratio, and type of steel fibers). Multi-linear and non-linear regression analyses are used with large database experimental results found in the literature. The predicted results from the proposed equations are composed with different available models from codes, standards, and literatures. The calculated results showed better correlations and were close enough to the experimental data. Based on the data given in the standard codes, the shear strength is proportional to compressive strength (f(0)') of the power 0.5. However, this value may not be adequate for modern cement and concrete containing steel fibers. Therefore, the mentioned power value must be reduced 5 times to 0.1.	[Saber, Ayad Zaki] Erbil Polytech Univ, Erbil Tech Engn Coll, Dept Civil Engn, Erbil, Iraq	Erbil Polytechnic University	Saber, AZ (corresponding author), Erbil Polytech Univ, Erbil Tech Engn Coll, Dept Civil Engn, Erbil, Iraq.	ayad.saber@epu.edu.iq						Al-Kamal MK, 2019, ADV CONCR CONSTR, V7, P1, DOI 10.12989/acc.2019.7.1.001; Al-Nu'man B.S., 2007, J ENG DEV, V11, P39; [Anonymous], 1995, CEBFIP 1990 CODIGA M; [Anonymous], 2002, 31862 ACI; [Anonymous], 1995, 3101 NZS; [Anonymous], 1999, 31899 ACI; [Anonymous], 31819 ACI; [Anonymous], 1994, AS36001994; [Anonymous], 1997, BS81101997; Arslan G, 2008, MATER STRUCT, V41, P113, DOI 10.1617/s11527-007-9223-3; ASHOUR SA, 1992, ACI STRUCT J, V89, P176; Bae YH, 2006, MAG CONCRETE RES, V58, P193, DOI 10.1680/macr.2006.58.4.193; BAZANT ZP, 1984, J AM CONCRETE I, V81, P456; BAZANT ZP, 1984, ACI J, V81, P456; BIS, 2000, IS456 BIS; Bohigas A.C, 2002, THESIS POLYTECHNIC U; C3A Canadian Standard Association, 1994, DESIGN CONCRETE SCTR; Campione G, 2019, FRONT BUILT ENVIRON, V5, DOI 10.3389/fbuil.2019.00042; CEB-FIP, 1993, CEB FIP MODEL CODE 1; Comision Permanente del Hormigon, 2008, 2008 EHE; Committee Euro-International Du Beton, 1991, CEB FIP MODEL CODE 1; Darwin D., 2016, DESIGN CONCRETE STRU, Vfifteenth; Eubuomwan N.F.O., 2013, RES APPL STRUCTURAL, P1603; European Committee for Standardization, 2002, EURO CODE 2 DESIGN C; Fujita M., 2002, JSCE, V711, P113; Gastebled OJ, 2001, ACI STRUCT J, V98, P184; Gomaa S., 2019, INT INTERACT S ULTRA, DOI DOI 10.21838/UHPC.9731; Hammad Y.H., 2002, STRUCTURAL COMPOSITE; JOHNSON MK, 1989, ACI STRUCT J, V86, P376; JSCE, 1996, STANDARD SPECIFICATI; Kim D, 1999, ACI STRUCT J, V96, P586; Kolhapure B.K, 2013, INT J ENG ADV TECHNO, V2, P7; Motamed J, 2012, GREENWICH ACAD LIT A; Mphonde A.G., 1984, SP 87 10, P179; Narayanam R., 1984, INDIAN CONCR J, V58, P100; Niwa J., 1986, DOBOKU GAKKAI ROMBUN, V372/V-5, P167, DOI DOI 10.2208/JSCEJ.1986.372_167; Polak MA, 1996, CAN J CIVIL ENG, V23, P809, DOI 10.1139/l96-890; Radmila S.G, 2011, C PAPER, P127; Radmila S.G, 2009, POTENTIAL CONSTRUCTI, V52, P17; Reddy S., 2011, CIVIL ENG DIMENSION, V13, P50; ROLLER JJ, 1990, ACI STRUCT J, V87, P191; Russo G, 2004, MATER STRUCT, V37, P680, DOI 10.1007/BF02480513; Russo G, 2013, ENG STRUCT, V51, P226, DOI 10.1016/j.engstruct.2013.01.024; Saghair H.M., 2009, J ENG SCI ASSIUT U, V27, P1369; Santos S.P.F., STEEL FIBERS SHEAR R; SARSAM KF, 1992, ACI STRUCT J, V89, P658; Shady G., 2019, TRANSITIONING SHEAR; Swamy R.N., 1974, MECH FIBER REINFORCE, V44, P1; Tahenni T, 2016, CONSTR BUILD MATER, V105, P14, DOI 10.1016/j.conbuildmat.2015.12.010; Tan V.T., 2008, MINIMUM SHEAR REINFO; VALLE M, 1993, ACI MATER J, V90, P122; Xie TY, 2018, J MATER CIVIL ENG, V30, DOI 10.1061/(ASCE)MT.1943-5533.0002304; Yavas A, 2020, MATERIALS, V13, DOI 10.3390/ma13071525; Yehia A.D., 2003, ALEX ENG J, V42, P601; Yong Yu., 2020, MATERIALS; Yuan TF, 2020, INT J CONCR STRUCT M, V14, DOI 10.1186/s40069-020-0396-2; Zsutty T. C., 1968, J P, V65, P943	57	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265677	10.1371/journal.pone.0265677	http://dx.doi.org/10.1371/journal.pone.0265677			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358237	gold, Green Published			2022-12-26	WOS:000799828800043
J	Murakami, D; Matsuda, K; Iwamoto, H; Mitani, Y; Mizumoto, Y; Nakamura, Y; Matsuzaki, I; Iwamoto, R; Takahashi, Y; Kojima, F; Murata, SI; Yamaue, H				Murakami, Daisuke; Matsuda, Kenji; Iwamoto, Hiromitsu; Mitani, Yasuyuki; Mizumoto, Yuki; Nakamura, Yuki; Matsuzaki, Ibu; Iwamoto, Ryuta; Takahashi, Yuichi; Kojima, Fumiyoshi; Murata, Shin-Ichi; Yamaue, Hiroki			Prognostic value of CD155/TIGIT expression in patients with colorectal cancer	PLOS ONE			English	Article							CD155 EXPRESSION; T-CELLS; TIGIT; MOLECULES; ADHESION	Introduction The interaction of CD155 with its ligand, the T cell immunoreceptor with Ig and ITIM domains (TIGIT), is being studied owing to its potential to act as a target in the treatment of various solid tumors. However, the relationship between CD155 and TIGIT in colorectal cancer (CRC) prognosis is not known. We hypothesized that the TIGIT-CD155 pathway suppresses the attack of T cells on tumors, thereby affecting CRC prognosis. Methods We examined the expression of CD155 and TIGIT using immunohistochemical staining in 100 consecutive patients with CRC who underwent complete resection of <= Stage III tumors at Wakayama Medical University Hospital between January and December 2013. We assessed the correlation between CD155 and TIGIT expressions and prognosis as well as the clinicopathological background of CD155 and TIGIT. Results Patients with high CD155 and TIGIT expressions showed worse prognosis than those with other levels of expression (p = 0.026). In multivariate analysis that also included the existing prognostic markers, high CD155 and TIGIT expressions were identified as independent poor prognostic factors. Conclusions The interaction between CD155 and TIGIT possibly plays an important role in the immunological mechanism of CRC. Therefore, it may be possible to effectively predict the postoperative prognosis of CRC by evaluating the combined expression of CD155 and TIGIT. The study findings suggest that CD155 and TIGIT can predict clinical outcomes, thereby contributing to the personalized care of CRC.	[Murakami, Daisuke; Matsuda, Kenji; Iwamoto, Hiromitsu; Mitani, Yasuyuki; Mizumoto, Yuki; Nakamura, Yuki; Yamaue, Hiroki] Wakayama Med Univ, Dept Surg 2, Wakayama, Japan; [Matsuzaki, Ibu; Iwamoto, Ryuta; Takahashi, Yuichi; Kojima, Fumiyoshi; Murata, Shin-Ichi] Wakayama Med Univ, Dept Human Pathol, Wakayama, Japan	Wakayama Medical University; Wakayama Medical University	Matsuda, K (corresponding author), Wakayama Med Univ, Dept Surg 2, Wakayama, Japan.	kmatsuda@wakayama-med.ac.jp						Atsumi S, 2013, ONCOL LETT, V5, P1771, DOI 10.3892/ol.2013.1280; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Casado JG, 2009, CANCER IMMUNOL IMMUN, V58, P1517, DOI 10.1007/s00262-009-0682-y; Chauvin JM, 2015, J CLIN INVEST, V125, P2046, DOI 10.1172/JCI80445; Del Alcazar CRG, 2017, CANCER DISCOV, V7, P1098, DOI 10.1158/2159-8290.CD-17-0222; Dina A, 2019, J EGYPT NATL CANC I, V31, P1, DOI [10.1186/s43046-019-0002-3, DOI 10.1186/S43046-019-0002-3]; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dougall WC, 2017, IMMUNOL REV, V276, P112, DOI 10.1111/imr.12518; Duan XG, 2019, MOL MED REP, V20, P3773, DOI 10.3892/mmr.2019.10641; Fang J, 2020, BIOSCIENCE REP, V40, DOI 10.1042/BSR20201054; Ghafar MTA, 2021, J INVEST MED, V69, P1222, DOI 10.1136/jim-2020-001744; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He WL, 2017, CANCER RES, V77, P6375, DOI 10.1158/0008-5472.CAN-17-0381; Herbst RS, 2018, NATURE, V553, P446, DOI 10.1038/nature25183; Hodi FS, 2010, NEW ENGL J MED, V363, P711, DOI 10.1056/NEJMoa1003466; Huang DW, 2017, ONCOTARGETS THER, V10, P3817, DOI 10.2147/OTT.S141476; Inozume T, 2016, J INVEST DERMATOL, V136, P255, DOI 10.1038/JID.2015.404; Iwai Y, 2002, P NATL ACAD SCI USA, V99, P12293, DOI 10.1073/pnas.192461099; Nakai R, 2010, CANCER SCI, V101, P1326, DOI 10.1111/j.1349-7006.2010.01530.x; Nishiwada S, 2015, ANTICANCER RES, V35, P2287; Oda T, 2004, BIOCHEM BIOPH RES CO, V319, P1253, DOI 10.1016/j.bbrc.2004.05.111; Qu P, 2015, HISTOPATHOLOGY, V66, P706, DOI 10.1111/his.12584; Sharma P, 2015, SCIENCE, V348, P56, DOI 10.1126/science.aaa8172; Solomon BL, 2018, CANCER IMMUNOL IMMUN, V67, P1659, DOI 10.1007/s00262-018-2246-5; Sun HY, 2019, HEPATOLOGY, V70, P168, DOI 10.1002/hep.30347; Sun Y, 2020, INT IMMUNOPHARMACOL, V80, DOI 10.1016/j.intimp.2020.106198; Takai Y, 2008, NAT REV MOL CELL BIO, V9, P603, DOI 10.1038/nrm2457; Tang WW, 2019, ONCOIMMUNOLOGY, V8, DOI 10.1080/2162402X.2019.1593807; Togashi Y, 2019, NAT REV CLIN ONCOL, V16, P356, DOI 10.1038/s41571-019-0175-7; Topalian SL, 2012, NEW ENGL J MED, V366, P2443, DOI 10.1056/NEJMoa1200690; Venook A, 2005, ONCOLOGIST, V10, P250, DOI 10.1634/theoncologist.10-4-250; Wu L, 2019, CANCER IMMUNOL RES, V7, P1700, DOI 10.1158/2326-6066.CIR-18-0725; Xiao YP, 2015, CANCER DISCOV, V5, P16, DOI 10.1158/2159-8290.CD-14-1397; Xu DH, 2020, IMMUNOBIOLOGY, V225, DOI 10.1016/j.imbio.2020.151915; Xu YL, 2019, ONCOL LETT, V17, P2960, DOI 10.3892/ol.2019.9910; Zhao KK, 2021, FRONT MOL BIOSCI, V7, DOI 10.3389/fmolb.2020.608404	36	4	4	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265908	10.1371/journal.pone.0265908	http://dx.doi.org/10.1371/journal.pone.0265908			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324958	gold, Green Published			2022-12-26	WOS:000780951300084
J	Rothschild, D; Leviatan, S; Hanemann, A; Cohen, Y; Weissbrod, O; Segal, E				Rothschild, Daphna; Leviatan, Sigal; Hanemann, Ariel; Cohen, Yossi; Weissbrod, Omer; Segal, Eran			An atlas of robust microbiome associations with phenotypic traits based on large-scale cohorts from two continents	PLOS ONE			English	Article							GUT MICROBIOME; HERITABILITY; GENETICS; REVEALS; ECOLOGY; HEALTH; IMPACT	Numerous human conditions are associated with the microbiome, yet studies are inconsistent as to the magnitude of the associations and the bacteria involved, likely reflecting insufficiently employed sample sizes. Here, we collected diverse phenotypes and gut microbiota from 34,057 individuals from Israel and the U.S.. Analyzing these data using a much-expanded microbial genomes set, we derive an atlas of robust and numerous unreported associations between bacteria and physiological human traits, which we show to replicate in cohorts from both continents. Using machine learning models trained on microbiome data, we show prediction accuracy of human traits across two continents. Subsampling our cohort to smaller cohort sizes yielded highly variable models and thus sensitivity to the selected cohort, underscoring the utility of large cohorts and possibly explaining the source of discrepancies across studies. Finally, many of our prediction models saturate at these numbers of individuals, suggesting that similar analyses on larger cohorts may not further improve these predictions.	[Rothschild, Daphna; Leviatan, Sigal; Segal, Eran] Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel; [Rothschild, Daphna; Leviatan, Sigal; Segal, Eran] Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel; [Hanemann, Ariel; Cohen, Yossi] DayTwo LTD, Tel Aviv, Israel; [Weissbrod, Omer] Harvard TH Chan Sch Publ Hlth, Epidemiol Dept, Boston, MA USA	Weizmann Institute of Science; Weizmann Institute of Science; Harvard University; Harvard T.H. Chan School of Public Health	Segal, E (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, Rehovot, Israel.; Segal, E (corresponding author), Weizmann Inst Sci, Dept Comp Sci & Appl Math, Rehovot, Israel.	eran.segal@weizmann.ac.il			European Research Council [786344]; Israel Science Foundation [292/20]; Daytwo Ltd.	European Research Council(European Research Council (ERC)European Commission); Israel Science Foundation(Israel Science Foundation); Daytwo Ltd.	The funders of this study are the European Research Council 786344 and the Israel Science Foundation 292/20. The rest of E.S. support in general but not directly for this project. Daytwo Ltd. provided support for this study in the form of salaries for A.H. and Y.C. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chen TQ, 2016, KDD'16: PROCEEDINGS OF THE 22ND ACM SIGKDD INTERNATIONAL CONFERENCE ON KNOWLEDGE DISCOVERY AND DATA MINING, P785, DOI 10.1145/2939672.2939785; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Cotillard A, 2013, NATURE, V500, P585, DOI 10.1038/nature12480; Coyte KZ, 2015, SCIENCE, V350, P663, DOI 10.1126/science.aad2602; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Douglas GM, 2020, NAT BIOTECHNOL, V38, P685, DOI 10.1038/s41587-020-0548-6; Falony G, 2016, SCIENCE, V352, P560, DOI 10.1126/science.aad3503; Golan D, 2014, P NATL ACAD SCI USA, V111, pE5272, DOI 10.1073/pnas.1419064111; Goodrich JK, 2016, CELL HOST MICROBE, V19, P731, DOI 10.1016/j.chom.2016.04.017; Ho DE, 2011, J STAT SOFTW, V42; Huang S, 2020, MSYSTEMS, V5, DOI 10.1128/mSystems.00630-19; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kong FL, 2019, GUT MICROBES, V10, P210, DOI 10.1080/19490976.2018.1494102; Kong FL, 2016, CURR BIOL, V26, pR832, DOI 10.1016/j.cub.2016.08.015; Kurilshikov A., 2020, GENETICS HUMAN GUT M, DOI [10.1101/2020.06.26.173724, DOI 10.1101/2020.06.26.173724]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Lee SH, 2011, AM J HUM GENET, V88, P294, DOI 10.1016/j.ajhg.2011.02.002; Lundberg SM, 2017, ADV NEUR IN, V30; Lynch SV, 2016, NEW ENGL J MED, V375, P2369, DOI 10.1056/NEJMra1600266; Marco-Sola S, 2012, NAT METHODS, V9, P1185, DOI [10.1038/NMETH.2221, 10.1038/nmeth.2221]; McDonald D, 2018, MSYSTEMS, V3, DOI 10.1128/mSystems.00031-18; Mendes-Soares H, 2019, JAMA NETW OPEN, V2, DOI 10.1001/jamanetworkopen.2018.8102; Morton JT, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10656-5; Nayfach S, 2016, GENOME RES, V26, P1612, DOI 10.1101/gr.201863.115; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ondov BD, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0997-x; Pasaniuc B, 2017, NAT REV GENET, V18, P117, DOI 10.1038/nrg.2016.142; Pasolli E, 2019, CELL, V176, P649, DOI 10.1016/j.cell.2019.01.001; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rothschild D, 2018, NATURE, V555, P210, DOI 10.1038/nature25973; Sanna S, 2019, NAT GENET, V51, P600, DOI 10.1038/s41588-019-0350-x; Scher JU, 2015, ARTHRITIS RHEUMATOL, V67, P128, DOI 10.1002/art.38892; Segata N, 2012, NAT METHODS, V9, P811, DOI [10.1038/NMETH.2066, 10.1038/nmeth.2066]; Siljander H, 2019, EBIOMEDICINE, V46, P512, DOI 10.1016/j.ebiom.2019.06.031; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Sudlow C, 2015, PLOS MED, V12, DOI 10.1371/journal.pmed.1001779; Suez J, 2014, NATURE, V514, P181, DOI 10.1038/nature13793; Sze MA, 2016, MBIO, V7, DOI 10.1128/mBio.01018-16; Tuddenham SA, 2020, CLIN INFECT DIS, V70, P615, DOI 10.1093/cid/ciz258; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wilmanski T, 2021, NAT METAB, V3, P274, DOI 10.1038/s42255-021-00348-0; Yang J, 2012, NAT GENET, V44, P369, DOI 10.1038/ng.2213; Yang JA, 2010, NAT GENET, V42, P565, DOI 10.1038/ng.608; Yang YC, 1997, DIABETES CARE, V20, P988, DOI 10.2337/diacare.20.6.988; Zeevi D, 2019, NATURE, V568, P43, DOI 10.1038/s41586-019-1065-y; Zhernakova A, 2016, SCIENCE, V352, P565, DOI 10.1126/science.aad3369	50	3	3	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265756	10.1371/journal.pone.0265756	http://dx.doi.org/10.1371/journal.pone.0265756			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324954	gold, Green Published, Green Submitted			2022-12-26	WOS:000780951300068
J	van der Zee, TJ; Kuo, AD				van der Zee, Tim J.; Kuo, Arthur D.			TimTrack: A drift-free algorithm for estimating geometric muscle features from ultrasound images	PLOS ONE			English	Article							B-MODE ULTRASOUND; FASCICLE LENGTH; RELIABILITY; PENNATION; TRACKING	Ultrasound imaging is valuable for non-invasively estimating fascicle lengths and other features of pennate muscle, especially when performed computationally. Effective analysis techniques to date typically use optic flow to track displacements from image sequences, but are sensitive to integration drift for longer sequences. We here present an alternative algorithm that objectively estimates geometric features of pennate muscle from ultrasound images, without drift sensitivity. The algorithm identifies aponeuroses and estimates fascicle angles to derive fascicle lengths. Length estimates of human vastus lateralis and gastrocnemius fascicles in healthy subjects (N = 9 and N = 17 respectively) compared well (overall root-mean-square difference, RMSD = 0.52 cm) to manual estimates by independent observers (n = 3), with overall coefficient of multiple correlation (CMC) of 0.98. Our tests yielded accuracy (CMC, RMSD) and processing speed similar to or exceeding that of stateof-the-art algorithms. The algorithm requires minimal manual intervention and can optionally extrapolate fascicle lengths that extend beyond the image frame. It thus facilitates automated analysis of ultrasound images without drift.	[van der Zee, Tim J.; Kuo, Arthur D.] Univ Calgary, Fac Kinesiol, Biomed Engn Grad Program, Calgary, AB, Canada	University of Calgary	van der Zee, TJ (corresponding author), Univ Calgary, Fac Kinesiol, Biomed Engn Grad Program, Calgary, AB, Canada.	tim.vanderzee@ucalgary.ca		van der Zee, Tim/0000-0001-9037-2366	Natural Sciences and Engineering Research Council of Canada (NSERC Discovery); Natural Sciences and Engineering Research Council of Canada (Canada Research Chair, Tier 1); Dr. Benno Nigg Research Chair in Biomechanics	Natural Sciences and Engineering Research Council of Canada (NSERC Discovery)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Natural Sciences and Engineering Research Council of Canada (Canada Research Chair, Tier 1); Dr. Benno Nigg Research Chair in Biomechanics	This work was supported in part by the Natural Sciences and Engineering Research Council of Canada (NSERC Discovery and Canada Research Chair, Tier 1) and the Dr. Benno Nigg Research Chair in Biomechanics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBOTT BC, 1952, J PHYSIOL-LONDON, V117, P77; Azizi E, 2008, P NATL ACAD SCI USA, V105, P1745, DOI 10.1073/pnas.0709212105; Beck ON., BIORXIV2021021043066, V2021; Cronin NJ, 2011, J APPL PHYSIOL, V111, P1491, DOI 10.1152/japplphysiol.00530.2011; Drazan JF, 2019, PEERJ, V7, DOI 10.7717/peerj.7120; DUDA RO, 1972, COMMUN ACM, V15, P11, DOI 10.1145/361237.361242; Farris DJ, 2016, COMPUT METH PROG BIO, V128, P111, DOI 10.1016/j.cmpb.2016.02.016; Ferrari A, 2010, GAIT POSTURE, V31, P540, DOI 10.1016/j.gaitpost.2010.02.009; Frangi AF, 1998, LECT NOTES COMPUT SC, V1496, P130, DOI 10.1007/BFb0056195; Fukunaga T, 1997, J APPL PHYSIOL, V82, P354, DOI 10.1152/jappl.1997.82.1.354; Han P, 2013, BIOMED ENG ONLINE, V12, DOI 10.1186/1475-925X-12-6; Hendriks CL., 2004, QI200401 QUANT IM GR; HERZOG W, 1988, PFLUG ARCH EUR J PHY, V411, P642, DOI 10.1007/BF00580860; Hill AV, 1938, PROC R SOC SER B-BIO, V126, P136, DOI 10.1098/rspb.1938.0050; ISHIDA Y, 1992, AM J HUM BIOL, V4, P511, DOI 10.1002/ajhb.1310040410; Joumaa V, 2013, J BIOMECH, V46, P1135, DOI 10.1016/j.jbiomech.2013.01.008; Koo TK, 2016, J CHIROPR MED, V15, P155, DOI 10.1016/j.jcm.2016.02.012; Kroon Dirk-Jan, HESSIAN BASED FRANGI; Marzilger R, 2018, EUR J APPL PHYSIOL, V118, P291, DOI 10.1007/s00421-017-3769-8; Rana M, 2009, J BIOMECH, V42, P2068, DOI 10.1016/j.jbiomech.2009.06.003; RUTHERFORD OM, 1992, EUR J APPL PHYSIOL O, V65, P433, DOI 10.1007/BF00243510; Ryan DS, 2019, J BIOMECH, V86, P160, DOI 10.1016/j.jbiomech.2019.01.054; Seynnes OR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229034; van der Zee TJ, 2021, J EXP BIOL, V224, DOI 10.1242/jeb.233965; Van Hooren B, 2020, J APPL PHYSIOL, V128, P978, DOI 10.1152/japplphysiol.00835.2019; Zhou GQ, 2015, ULTRASONICS, V57, P72, DOI 10.1016/j.ultras.2014.10.020; Zhou YJ, 2008, ULTRASOUND MED BIOL, V34, P1474, DOI 10.1016/j.ultrasmedbio.2008.02.009; Zhou YJ, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-63	28	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265752	10.1371/journal.pone.0265752	http://dx.doi.org/10.1371/journal.pone.0265752			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324967	Green Published, gold, Green Submitted			2022-12-26	WOS:000780951300067
J	Abbott, JK; Chan, SK; MacBeth, M; Crooks, JL; Hancock, C; Knight, V; Gelfand, EW				Abbott, Jordan K.; Chan, Sanny K.; MacBeth, Morgan; Crooks, James L.; Hancock, Cathy; Knight, Vijaya; Gelfand, Erwin W.			Fluctuations in quality of life and immune responses during intravenous immunoglobulin infusion cycles	PLOS ONE			English	Article							REGULATORY T-CELLS; AUTOIMMUNE; DISEASE; REPLACEMENT	Despite adequate infection prophylaxis, variation in self-reported quality of life (QOL) throughout the intravenous immunoglobulin (IVIG) infusion cycle is a widely reported but infrequently studied phenomenon. To better understand this phenomenon, subjects with humoral immunodeficiency receiving replacement doses of IVIG were studied over 3 infusion cycles. Questionnaire data from 6 time points spread over 3 IVIG infusions cycles (infusion day and 7 days after each infusion) were collected in conjunction with monitoring the blood for number of regulatory T-cells (Treg) and levels of 40 secreted analytes: primarily cytokines, chemokines, and growth factors. At day 7, self-reported well-being increased, and self-reported fatigue decreased, reflecting an overall improvement in QOL 7 days after infusion. Over the same period, percentage of Treg cells in the blood increased (p< 0.01). Multiple inflammatory chemokine and cytokine levels increased in the blood by 1 hour after infusion (CCL4 (MIP-1b), CCL3 (MIP-1a), CCL2 (MCP-1), TNF-alpha, granzyme B, IL-10, IL-1RA, IL-8, IL-6, GM-CSF, and IFN-gamma). The largest changes in analytes occurred in subjects initiated on IVIG during the study. A significant decrease in IL-25 (IL-17E) following infusion was seen in most intervals among subjects already receiving regular infusions prior to study entry. These findings reveal several short-term effects of IVIG given in replacement doses to patients with humoral immunodeficiency: QOL consistently improves in the first week of infusion, levels of a collection of monocyte-associated cytokines increase immediately after infusion whereas IL-25 levels decrease, and Treg levels increase. Moreover, patients that are new to IVIG experience more significant fluctuations in cytokine levels than those receiving it regularly.	[Abbott, Jordan K.; Chan, Sanny K.; MacBeth, Morgan; Hancock, Cathy; Knight, Vijaya; Gelfand, Erwin W.] Natl Jewish Hlth, Div Pediat Allergy Immunol, Denver, CO 80206 USA; [Abbott, Jordan K.; Chan, Sanny K.; MacBeth, Morgan; Hancock, Cathy; Knight, Vijaya; Gelfand, Erwin W.] Natl Jewish Hlth, Immunodeficiency Diag & Treatment Program, Denver, CO 80206 USA; [Chan, Sanny K.; Crooks, James L.] Natl Jewish Hlth, Dept Immunol & Genom Med, Denver, CO USA; [Crooks, James L.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Abbott, Jordan K.; Knight, Vijaya] Univ Colorado, Sch Med, Dept Pediat, Sect Allergy & Immunol, Denver, CO 80204 USA	National Jewish Health; National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver	Abbott, JK (corresponding author), Natl Jewish Hlth, Div Pediat Allergy Immunol, Denver, CO 80206 USA.; Abbott, JK (corresponding author), Natl Jewish Hlth, Immunodeficiency Diag & Treatment Program, Denver, CO 80206 USA.; Abbott, JK (corresponding author), Univ Colorado, Sch Med, Dept Pediat, Sect Allergy & Immunol, Denver, CO 80204 USA.	jordan.abbott@cuasnchutz.edu	Abbott, Jordan K/P-2509-2016	Abbott, Jordan K/0000-0001-6334-5266; MacBeth, Morgan/0000-0003-1299-0999	CSL Behring Inc.; NIH [K08AI141734]	CSL Behring Inc.; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was carried out under an unrestricted grant from CSL Behring Inc. SKC, JKA and EWG. CSL Behring Inc. played no role in the study design, data collection, analysis, or manuscript preparation. The manuscript was reviewed but not edited by CSL Behring prior to submission. JKA receives funding from NIH K08AI141734. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audet MC, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00416; AUKRUST P, 1994, BLOOD, V84, P2136; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bayry J, 2012, J RHEUMATOL, V39, P450, DOI 10.3899/jrheum.111123; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Christensen R., 2019, ORDINAL REGRESSION M; Gelfand EW, 2012, NEW ENGL J MED, V367, P2015, DOI 10.1056/NEJMra1009433; Ibanez C, 2005, BIODRUGS, V19, P59; Kasztalska K, 2011, CLIN DRUG INVEST, V31, P299, DOI 10.2165/11586710-000000000-00000; Maddur MS, 2015, CELL MOL IMMUNOL, V12, P650, DOI 10.1038/cmi.2014.117; Misbah SA, 2014, CLIN EXP IMMUNOL, V178, P70, DOI 10.1111/cei.12517; Olivito B, 2010, CLIN EXP RHEUMATOL, V28, pS93; Orange J., 2006, J ALLERGY CLIN IMMUN; Perreau M, 2014, J EXP MED, V211, P2033, DOI 10.1084/jem.20140039; Quinti I, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.00697; RCore Team, 2020, R LANG ENV STAT COMP; Rider NL, 2017, J CLIN IMMUNOL, V37, P461, DOI 10.1007/s10875-017-0404-8; Roan F, 2019, J CLIN INVEST, V129, P1441, DOI 10.1172/JCI124606; Rojavin MA, 2016, J CLIN IMMUNOL, V36, P210, DOI 10.1007/s10875-016-0243-z; Siedlar M, 2011, CLIN IMMUNOL, V139, P122, DOI 10.1016/j.clim.2011.01.002; Tsurikisawa N, 2012, J RHEUMATOL, V39, P1019, DOI 10.3899/jrheum.110981; Vaida F., 2015, PACKAGE LMEC R, P1	22	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265852	10.1371/journal.pone.0265852	http://dx.doi.org/10.1371/journal.pone.0265852			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316278	Green Published, gold, Green Submitted			2022-12-26	WOS:000834238000041
J	Allen, MS; Lewis, T; Porch, N				Allen, Melinda S.; Lewis, Tara; Porch, Nick			Lost bioscapes: Floristic and arthropod diversity coincident with 12(th) century Polynesian settlement, Nuku Hiva, Marquesas Islands	PLOS ONE			English	Article							COLEOPTERA ZOPHERIDAE PYCNOMERINI; FRENCH-POLYNESIA; SOCIETY ISLANDS; ARCHAEOLOGICAL SITES; KEY SITE; COLONIZATION; IMPACT; TRANSFORMATION; CONSERVATION; BIOGEOGRAPHY	Knowledge of biodiversity in the past, and the timing, nature, and drivers of human-induced ecological change, is important for gaining deep time perspectives and for modern conservation efforts. The Marquesas Islands (Polynesia) are one of the world's most remote archipelagos and illustrate the vulnerability of indigenous bioscapes to anthropogenic activities. Characterised by high levels of endemism across many biotic groups, the full spectrum of the group's flora and fauna is nonetheless incompletely known. Several centuries of Polynesian settlement reshaped biotic communities in ways that are not yet fully understood, and historically-introduced mammalian herbivores have devastated the indigenous lowland flora. We report here on archaeological recovery of a diverse assemblage of plant and arthropod subfossils from a waterlogged deposit on the largest Marquesan island: Nuku Hiva. These materials offer new perspectives on the composition of lowland plant and arthropod communities pene-contemporaneous with human arrival. Bayesian analysis of multiple C-14 results from short-lived materials date the assemblages to the mid-12(th) century AD (1129-1212 cal. AD, 95.4% HPD). Evidence for human activities in the catchment coincident with deposit formation includes Polynesian associated arthropods, microcharcoal, and an adzed timber. Plant macrofossils (seeds, fruits, vegetative structures) and microfossils (pollen, phytoliths) reveal coastal and lowland wet-moist forest communities unlike those observed today. Several apparently extinct taxa are identified, along with extant taxa currently constrained to high altitude and/or interior areas. A diverse inventory of subfossil arthropods-the first pre-18(th) century records for the islands-includes more than 100 distinct taxa, with several new archipelago records and one previously unreported for eastern Polynesia. The assemblages provide new insights into lowland Marquesan forest communities coincident with human arrival, and portend the considerable anthropogenic transformations that followed. These records also have implications for human colonisation of the Marquesas Islands and East Polynesia at large.	[Allen, Melinda S.] Univ Auckland, Sch Social Sci, Anthropol, Auckland, New Zealand; [Allen, Melinda S.] Univ Auckland Host, Te Punaha Matatini, Ctr Res Excellence Complex Syst, Auckland, New Zealand; [Lewis, Tara; Porch, Nick] Deakin Univ, Sch Life & Environm Sci, Geelong, Vic, Australia	University of Auckland; Deakin University	Allen, MS (corresponding author), Univ Auckland, Sch Social Sci, Anthropol, Auckland, New Zealand.; Allen, MS (corresponding author), Univ Auckland Host, Te Punaha Matatini, Ctr Res Excellence Complex Syst, Auckland, New Zealand.	ms.allen@auckland.ac.nz		Allen, Melinda S./0000-0001-5041-5106	University of Auckland Faculty of Arts Research Development Fund [3700147]; AMS analyses by the Australian Institute of Nuclear Sciences & Engineering Ltd. [06/002, 07/001, 09/005]; Australian Research Council DECRA [DE130101453]; New Zealand Tertiary Education Commission; Te Punaha Matatini; Centre of Research Excellence for Complex Systems [UOA 9167-3705716]	University of Auckland Faculty of Arts Research Development Fund; AMS analyses by the Australian Institute of Nuclear Sciences & Engineering Ltd.; Australian Research Council DECRA(Australian Research Council); New Zealand Tertiary Education Commission; Te Punaha Matatini; Centre of Research Excellence for Complex Systems	Archaeological excavations, sample collection, 14C dating and some specialised analyses were supported by University of Auckland Faculty of Arts Research Development Fund [Grant no. 3700147 to MSA], AMS analyses by the Australian Institute of Nuclear Sciences & Engineering Ltd. (https://www.ainse.edu.au) [Grant nos. 06/002, 07/001, and 09/005 to MSA] and the arthropod and botanical analyses by an Australian Research Council DECRA (https://www.arc.gov.au) [Grant no. DE130101453 to NP]. MSA received support funding from New Zealand Tertiary Education Commission, Te Punaha Matatini, Centre of Research Excellence for Complex Systems (https://www.tepunahamatatini.ac.nz) Grant no. UOA 9167-3705716. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamson AM, 1932, BP BISHOP MUSEUM B; Adamson AM, 1936, BP BISHOP MUSEUM B; Addison DJ, 2006, THESIS U HAWAII HONO; Allen MS, 2021, ARCHAEOL OCEAN, V56, P73, DOI 10.1002/arco.5233; Allen MS, 2014, J PAC ARCHAEOL, V5, P1; Allen MS, 2013, J PAC ARCHAEOL, V4, P90; Allen MS, 2014, RADIOCARBON, V56, P257, DOI 10.2458/56.16784; Allen MS, 2013, J ARCHAEOL SCI, V40, P2799, DOI 10.1016/j.jas.2013.02.011; Allen MS, 2011, HOLOCENE, V21, P473, DOI 10.1177/0959683610385726; Allen MS, 2010, ARCHAEOL OCEAN, V45, P54, DOI 10.1002/j.1834-4453.2010.tb00080.x; ANDERSON A, 2002, ASIAN PERSPECT, V41, P242, DOI DOI 10.1353/ASI.2003.0002; Anderson A, 2019, J PAC ARCHAEOL, V10, P1; Anderson A, 2009, BIOL INVASIONS, V11, P1503, DOI 10.1007/s10530-008-9403-2; Athens J. Stephen, 2002, Archaeology in Oceania, V37, P57; Athens SJ, 1993, ASIAN PERSPECT, V32, P205; Austin CC, 1999, NATURE, V397, P113, DOI 10.1038/16365; Boivin NL, 2016, P NATL ACAD SCI USA, V113, P6388, DOI 10.1073/pnas.1525200113; Bronk Ramsey C, 2021, OXCAL VER 4 4; Brown FBH, 1935, BP BISHOP MUSEUM B, V130; Brown FBH, 1931, BP BISHOP MUSEUM B; Brown FBH., 1935, BP BISHOP MUSEUM B; Butaud Jean-Francois, 2017, Palms, V61, P139; Cauchard G., 1978, CAHIERS PACIFIQUE, V21, P75; Charleux M, 2014, J PAC ARCHAEOL, V5, P75; Christensen CC, 2018, PAC SCI, V72, P95, DOI 10.2984/72.1.7; Conte E., 2003, ASIAN PERSPECT, V42, P155, DOI DOI 10.1353/ASI.2003.0018; Conte E, 2014, ARCHAEOL OCEAN, V49, P121, DOI 10.1002/arco.5037; Decker BG, 1991, ATOLL RES BULL, V363; Decker BG, 1970, THESIS U CALIFORNIA; Dickinson W.R., 2009, GSA TODAY, V19, P4, DOI DOI 10.1130/GSATG35A.1; Dickinson WR, 2003, J COASTAL RES, V19, P489; Dotte-Sarout E, 2017, QUATERN INT, V457, P6, DOI 10.1016/j.quaint.2016.10.032; Duncan RP, 2013, P NATL ACAD SCI USA, V110, P6436, DOI 10.1073/pnas.1216511110; Fall PL, 2011, PAC SCI, V65, P143, DOI 10.2984/65.2.143; FLENLEY JR, 1991, J QUATERNARY SCI, V6, P85, DOI 10.1002/jqs.3390060202; Florence J, 2004, COLLECTION FAUNE FLO, V2; Florence J, 1997, COLLECTION FAUNE FLO, V1; Florence Jacques, 1997, Allertonia, V7, P226; FOLK RL, 1954, J GEOL, V62, P344, DOI 10.1086/626171; FRANKLIN J, 1991, CONSERV BIOL, V5, P506, DOI 10.1111/j.1523-1739.1991.tb00358.x; Galzin R., 2016, BIODIVERSITE TERREST, P3; Gideon O. G., 2009, Science in New Guinea, V29, P132; Gillespie RG, 2008, PHILOS T R SOC B, V363, P3335, DOI 10.1098/rstb.2008.0124; Gillespie TW, 2014, ORYX, V48, P337, DOI 10.1017/S0030605313000264; Gillett GW, 1973, U CALIFORNIA PUBLICA; Hall KA, 2013, PAC SCI, V67, P493, DOI 10.2984/67.4.1; Hembry DH, 2018, J BIOGEOGR, V45, P1713, DOI 10.1111/jbi.13378; Hogg AG, 2020, RADIOCARBON, V62, P759, DOI 10.1017/RDC.2020.59; Horrocks M, 2005, J ARCHAEOL SCI, V32, P1169, DOI 10.1016/j.jas.2005.02.014; Horrocks M., 2017, PLANT MICROFOSSIL AN; Huebert JM, 2020, J ANTHROPOL ARCHAEOL, V57, DOI 10.1016/j.jaa.2019.101122; Huebert JM, 2016, QUATERNARY SCI REV, V137, P79, DOI 10.1016/j.quascirev.2016.01.017; Huebert JM, 2015, HOLOCENE, V25, P1039, DOI 10.1177/0959683615574868; Ioannidis AG, 2021, NATURE, V597, P522, DOI 10.1038/s41586-021-03902-8; JAYAWEERA DON M. A., 1964, J ARNOLD ARBORETUM, V45, P101; Kahn JG, 2015, HOLOCENE, V25, P333, DOI 10.1177/0959683614558649; Keppel Gunnar, 2014, Pacific Conservation Biology, V20, P136; Kirch P V, 2017, MONUMENTA ARCHAEOLOG, DOI [10.1177/1098612X16663595, DOI 10.1177/1098612X16663595]; Kirch PV, 2007, EARTH ENV SCI T R SO, V98, P85, DOI 10.1017/S1755691007000011; Kirch PV, 2005, ANNU REV ENV RESOUR, V30, P409, DOI 10.1146/annurev.energy.29.102403.140700; KIRCH PV, 1982, PAC SCI, V36, P1; Kolibac J, 2021, ZOOL J LINN SOC-LOND, V191, P846; Laurent V., 2016, BIODIVERSITE TERREST, P105; Lincoln N, 2014, J ARCHAEOL SCI, V49, P192, DOI 10.1016/j.jas.2014.05.008; Lorence D. H., 2016, BIODIVERSITE TERREST, P311; Lorence D. H, 2020, FLORA MARQUESAS ISLA; Lorence DH, 2019, FLORA MARQUESAS ISLA, V1; Martin L, 2019, RADIOCARBON, V61, P173, DOI 10.1017/RDC.2018.118; MAURY RC, 2014, GEOL FR, P111; McLaughlin J., 2004, MUSSAENDAS S FLORIDA; McWethy DB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111328; Meyer J-Y, 2016, BIODIVERSITE TERREST, P497; Meyer Jean-Yves, 2004, Pacific Science, V58, P357, DOI 10.1353/psc.2004.0032; Millerstrom S., 2008, ASIAN PERSPECT, V47, P330; MOLLE GUILLAUME, 2011, THESIS U FRENCH POLY; Montgomery S.L., 1980, Elepaio, V40, P152; Moore JW, 1933, BP BISHOP MUSEUM B; Moore P.D., 1991, BLACKWELL SCI PUBLI; Mueller-Dombois D, 1998, VEGETATION TROPICAL, DOI [10.1007/s004420050367, DOI 10.1007/S004420050367]; Museum Bisho., 1935, PACIFIC ENTOMOLOGICA; Museum Bishop, 1939, PACIFIC ENTOMOLOGICA; Museum Bishop, 1932, PACIFIC ENTOMOLOGICA; Okal EA, 2002, SEISMOL RES LETT, V73, P490, DOI DOI 10.1785/GSSRL.73.4.490; Orliac C., 2000, EASTER ISLAND ARCHAE, P119; Oskam CL, 2012, QUATERNARY SCI REV, V52, P41, DOI 10.1016/j.quascirev.2012.07.007; Paris R, 2020, SEDIMENTOLOGY, V67, P1207, DOI 10.1111/sed.12582; Perry GLW, 2012, GLOBAL CHANGE BIOL, V18, P1609, DOI 10.1111/j.1365-2486.2011.02631.x; Porch N, 2008, HDB LANDSCAPE ARCHAE; Porch N, 2020, ZOOTAXA, V4718, P239, DOI 10.11646/zootaxa.4718.2.5; Porch N, 2017, ZOOTAXA, V4237, P154, DOI 10.11646/zootaxa.4237.1.8; Prebble M, 2008, QUATERNARY SCI REV, V27, P2546, DOI 10.1016/j.quascirev.2008.09.015; Prebble M, 2019, P NATL ACAD SCI USA, V116, P8824, DOI 10.1073/pnas.1821732116; Prebble M, 2016, J BIOGEOGR, V43, P2438, DOI 10.1111/jbi.12807; Pregill GK, 2004, J HERPETOL, V38, P15, DOI 10.1670/73-03A; Ramage T, 2017, ZOOSYSTEMA, V39, P213, DOI 10.5252/z2017n2a3; Ramage Thibault, 2014, Bulletin de la Societe Entomologique de France, V119, P145; Rick TC, 2013, ANTHROPOCENE, V4, P33, DOI 10.1016/j.ancene.2013.08.002; Rieth T., 2013, HAWAIIAN ARCHAEOLOGY, V13, P3; Roderick GK, 2016, BIODIVERSITE TERREST, P391; ROLETT BV, 1995, J POLYNESIAN SOC, V104, P195; Rolett BV, 1998, HANAMIAI PREHISTORIC; Schindele F, 2006, CR GEOSCI, V388, P1133; Sear DA, 2020, P NATL ACAD SCI USA, V117, P8813, DOI 10.1073/pnas.1920975117; Sinoto Y. H., 1970, STUDIES OCEANIC CULT, V1, P105; SINOTO YH, 1966, J POLYNESIAN SOC, V75, P287; Smedmark JEE, 2007, AM J BOT, V94, P1491, DOI 10.3732/ajb.94.9.1491; SPRIGGS M, 1993, ANTIQUITY, V67, P200, DOI 10.1017/S0003598X00045324; Steadman DW, 2006, EXTINCTION BIOGEOGRA; Stevenson J, 2017, HOLOCENE, V27, P1963, DOI 10.1177/0959683617715690; Suggs R. C., 1961, ARCHAEOLOGY NUKU HIV; van Dyke EC, 1932, BISHOP MUSEUM B, P237; Wacker L, 2020, RADIOCARBON, V62, P873, DOI 10.1017/RDC.2020.49; Wagner WL, 2013, PHYTOKEYS, V30, P33, DOI 10.3897/phytokeys.30.6147; Wagner WL., 2002, FLORA MARQUESAS ISLA; Whistler W, 2009, PLANTS CANOE PEOPLE; White AW, 2010, P NATL ACAD SCI USA, V107, P15512, DOI 10.1073/pnas.1005780107; Whitmore TC, 2008, GENUS MACARANGA PROD; WHITTIER H O, 1973, Bryologist, V76, P174, DOI 10.2307/3241238; Whittier HO., 1976, MOSSES SOC ISLANDS	119	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265224	10.1371/journal.pone.0265224	http://dx.doi.org/10.1371/journal.pone.0265224			38	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0T0FS	35353828	Green Published, gold			2022-12-26	WOS:000786647900052
J	Cavalcanti, JD; Fregonezi, GAF; Sarmento, AJ; Bezerra, T; Gualdi, LP; Pennati, F; Aliverti, A; Resqueti, VR				Cavalcanti, Jessica D.; Fregonezi, Guilherme Augusto F.; Sarmento, Antonio J.; Bezerra, Thiago; Gualdi, Lucien P.; Pennati, Francesca; Aliverti, Andrea; Resqueti, Vanessa R.			Electrical activity and fatigue of respiratory and locomotor muscles in obstructive respiratory diseases during field walking test	PLOS ONE			English	Article							HEALTHY-SUBJECTS; REFERENCE VALUES; BLOOD-FLOW; EXERCISE; POWER; ELECTROMYOGRAM; LIMITATION; SIGNALS; DYSPNEA; DRIVE	IntroductionIn subjects with obstructive respiratory diseases the increased work of breathing during exercise can trigger greater recruitment and fatigue of respiratory muscles. Associated with these changes, lower limb muscle dysfunctions, further contribute to exercise limitations. We aimed to assess electrical activity and fatigue of two respiratory and one locomotor muscle during Incremental Shuttle Walking Test (ISWT) in individuals with obstructive respiratory diseases and compare with healthy. MethodsThis is a case-control study. Seventeen individuals with asthma (asthma group) and fifteen with chronic obstructive pulmonary disease (COPD group) were matched with healthy individuals (asthma and COPD control groups). Surface electromyographic (sEMG) activity of sternocleidomastoid (SCM), scalene (ESC), and rectus femoris (RF) were recorded during ISWT. sEMG activity was analyzed in time and frequency domains at baseline and during the test (33%, 66%, and 100% of ISWT total time) to obtain, respectively, signal amplitude and power spectrum density (EMG median frequency [MF], high- and low-frequency bands, and high/low [H/L] ratio). ResultsAsthma group walked a shorter distance than controls (p = 0.0007). sEMG amplitudes of SCM, ESC, and RF of asthma and COPD groups were higher at 33% and 66% of ISWT compared with controls groups (all p<0.05). SCM and ESC of COPD group remained higher until 100% of the test. MF of ESC and RF decreased in asthma group (p = 0.016 and p < 0.0001, respectively) versus controls, whereas MF of SCM (p < 0.0001) decreased in COPD group compared with controls. H/L ratio of RF decreased (p = 0.002) in COPD group versus controls. ConclusionReduced performance is accompanied by increased electromyographic activity of SCM and ESC and activation of RF in individuals with obstructive respiratory diseases during ISWT. These are susceptible to be more pronounced respiratory and peripheral muscle fatigue than healthy subjects during exercise.	[Cavalcanti, Jessica D.; Fregonezi, Guilherme Augusto F.; Sarmento, Antonio J.; Bezerra, Thiago; Resqueti, Vanessa R.] Univ Fed Rio Grande do Norte, Lab PneumoCardioVasc, Dept Fisioterapia, Hosp Univ Onofre Lopes,Empresa Brasileira Serv Ho, Natal, RN, Brazil; [Cavalcanti, Jessica D.; Fregonezi, Guilherme Augusto F.; Sarmento, Antonio J.; Bezerra, Thiago; Resqueti, Vanessa R.] Univ Fed Rio Grande do Norte, Lab Inovacao Tecnol Reabilitacao, Natal, RN, Brazil; [Gualdi, Lucien P.] Univ Fed Rio Grande do Norte, Fac Ciencias Saude Trairi, Santa Cruz, RN, Brazil; [Pennati, Francesca; Aliverti, Andrea] Politecn Milan, Dipartimento Elettron Informaz & Bioingn, Milan, Italy	Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Universidade Federal do Rio Grande do Norte; Polytechnic University of Milan	Resqueti, VR (corresponding author), Univ Fed Rio Grande do Norte, Lab PneumoCardioVasc, Dept Fisioterapia, Hosp Univ Onofre Lopes,Empresa Brasileira Serv Ho, Natal, RN, Brazil.; Resqueti, VR (corresponding author), Univ Fed Rio Grande do Norte, Lab Inovacao Tecnol Reabilitacao, Natal, RN, Brazil.	vanessa.resqueti@ufrn.br			Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) [001]; CNPq [312876/2018-1, 315580/2018-6]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was financed in part by the Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior - Brasil (CAPES) - Finance Code 001. G.A.F.F received a grant from CNPq number 312876/2018-1 and V.R.R received a grant from CNPq number 315580/2018-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldrich TK, 2002, AM J RESP CRIT CARE, V166, P548, DOI 10.1164/rccm.166.4.518; Aliverti A, 2016, BREATHE, V12, P165, DOI 10.1183/20734735.008116; Allison GT, 2002, CLIN BIOMECH, V17, P464, DOI 10.1016/S0268-0033(02)00033-5; [Anonymous], 2017, PNEUMOLOGIE, V71, P9; [Anonymous], SENIAM-Surface ElectroMyoGraphy for the Non-Invasive Assessment of Muscles; AUBIER M, 1981, J APPL PHYSIOL, V50, P538, DOI 10.1152/jappl.1981.50.3.538; Ball N, 2013, J APPL BIOMECH, V29, P600, DOI 10.1123/jab.29.5.600; Basmajian J., 1985, MUSCLES ALIVE THEIR; Beck TW, 2014, MUSCLE NERVE, V50, P95, DOI 10.1002/mus.24098; Camic CL, 2010, EUR J APPL PHYSIOL, V108, P337, DOI 10.1007/s00421-009-1239-7; Canuto FF, 2012, REV PORT PNEUMOL, V18, P160, DOI 10.1016/j.rppneu.2012.02.008; Cifrek M, 2000, MEASUREMENT, V27, P85, DOI 10.1016/S0263-2241(99)00059-7; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Cunha A. P. D. N. D, 2005, SAUDE REV, V7, P13; Decramer M, 1996, AM J RESP CRIT CARE, V153, P1958, DOI 10.1164/ajrccm.153.6.8665061; DECRAMER M, 1994, AM J RESP CRIT CARE, V150, P11, DOI 10.1164/ajrccm.150.1.8025735; Dempsey JA, 2002, RESP PHYSIOL NEUROBI, V130, P3, DOI 10.1016/S0034-5687(01)00327-9; Diefenthaeler Fernando, 2012, Rev. bras. cineantropom. desempenho hum., V14, P243, DOI 10.5007/1980-0037.2012v14n3p243; Dominelli PB, 2017, EXP PHYSIOL, V102, P1535, DOI 10.1113/EP086566; Duiverman ML, 2009, RESP PHYSIOL NEUROBI, V167, P195, DOI 10.1016/j.resp.2009.04.018; Ertl P, 2016, J ELECTROMYOGR KINES, V30, P216, DOI 10.1016/j.jelekin.2016.08.002; Falla D, 2002, CLIN NEUROPHYSIOL, V113, P57, DOI 10.1016/S1388-2457(01)00708-8; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GINAGlobal Initiative for Asthma, GLOB STRAT ASTHM MAN; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Jolley CJ, 2009, EUR RESPIR REV, V18, P66, DOI 10.1183/09059180.00000809; Jolley CJ, 2009, EUR RESPIR J, V33, P289, DOI 10.1183/09031936.00093408; Jurgensen SP, 2011, RESPIRATION, V81, P223, DOI 10.1159/000319037; Konrad P., 2006, ABC EMG A PRACTICAL; Maltais F, 2014, AM J RESP CRIT CARE, V189, P1121, DOI 10.1164/rccrn.201402-0373ST; MARTIN J, 1980, AM REV RESPIR DIS, V121, P441, DOI 10.1164/arrd.1980.121.3.441; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; MILLS KR, 1982, J PHYSIOL-LONDON, V326, P401, DOI 10.1113/jphysiol.1982.sp014201; MORITANI T, 1987, EUR J APPL PHYSIOL, V56, P260, DOI 10.1007/BF00690890; Neder JA, 1999, BRAZ J MED BIOL RES, V32, P719, DOI 10.1590/S0100-879X1999000600007; O'Donnell DE, 2001, AM J RESP CRIT CARE, V164, P770, DOI 10.1164/ajrccm.164.5.2012122; Pereira Carlos Alberto de Castro, 2007, J. bras. pneumol., V33, P397, DOI 10.1590/S1806-37132007000400008; Ramos E, 2015, MULTIDISCIP RESP MED, V10, DOI 10.1186/2049-6958-10-3; Reilly CC, 2013, EXP PHYSIOL, V98, P1190, DOI 10.1113/expphysiol.2012.071415; de Araujo PRS, 2012, J BRAS PNEUMOL, V38, P700, DOI 10.1590/S1806-37132012000600004; Sheel AW, 2018, J APPL PHYSIOL, V125, P820, DOI 10.1152/japplphysiol.00189.2018; SINGH SJ, 1992, THORAX, V47, P1019, DOI 10.1136/thx.47.12.1019; Spruit MA, 2013, AM J RESP CRIT CARE, V188, pE13, DOI 10.1164/rccm.201309-1634ST; Tomczak M, 2014, TRENDS SPORT SCI, V21, P19; Vermeulen F, 2016, RESP MED, V117, P122, DOI 10.1016/j.rmed.2016.06.003; Vikne H, 2012, MUSCLE NERVE, V45, P527, DOI 10.1002/mus.22315; Vogiatzis I, 2010, AM J RESP CRIT CARE, V182, P1105, DOI 10.1164/rccm.201002-0172OC; Vollestad NK, 1997, J NEUROSCI METH, V74, P219, DOI 10.1016/S0165-0270(97)02251-6; Weatherald J, 2017, EUR RESPIR REV, V26, DOI 10.1183/16000617.0015-2017	50	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266365	10.1371/journal.pone.0266365	http://dx.doi.org/10.1371/journal.pone.0266365			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363800	gold, Green Published			2022-12-26	WOS:000804748600034
J	Chen, TC; Chang, SW				Chen, Tsan-Chi; Chang, Shu-Wen			Repeated cell sorting ensures the homogeneity of ocular cell populations expressing a transgenic protein	PLOS ONE			English	Article							HUMAN CORNEAL FIBROBLASTS; MITOMYCIN-C; SECRETION; MIGRATION; LINES	Transgenic proteins can be routinely expressed in various mammalian cell types via different transgenic systems, but the efficiency of transgene expression is constrained by the complex interplay among factors such as the temporal consistency of expression and compatibility with specific cell types, including ocular cells. Here, we report a more efficient way to express an enhanced green fluorescent protein (EGFP) in human corneal fibroblasts, corneal epithelial cells, and conjunctival epithelial cells through a lentiviral expression system. The relative transducing unit criterion for EGFP-expressing pseudovirions was first determined in HEK-293T cells. Homogeneous populations of EGFP-positive and EGFP-negative cells could be isolated by cell sorting. The half-maximal inhibitory concentration (IC50) value for puromycin was calculated according to viability curves for each cell type. The results revealed that cell types differed with respect to EGFP expression efficiency after transduction with the same amount of EGFP-encoding pseudovirions. Using a cell sorter, the homogeneity of EGFP-positive cells reached >95%. In the initial sorting stage, however, the efficiency of EGFP expression in the sorted cells was noticeably reduced after two rounds of sequential culture, but repeated sorting for up to four rounds yielded homogeneous EGFP-positive human corneal fibroblasts that could be maintained in continuous culture in vitro. The sorted EGFP-positive cells retained their proper morphology and cell type-specific protein expression patterns. Puromycin resistance was found to depend on cell type, indicating that the IC50 for puromycin must be determined for each cell type to ensure the isolation of homogeneous EGFP-positive cells. Taken together, repeated cell sorting is an efficient means of obtaining homogeneous populations of ocular cells expressing a transgenic protein during continuous culture without the potential confounding effects of antibiotics.	[Chen, Tsan-Chi; Chang, Shu-Wen] Far Eastern Mem Hosp, Dept Ophthalmol, New Taipei City, Taiwan; [Chang, Shu-Wen] Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan	Far Eastern Memorial Hospital; National Taiwan University; National Taiwan University Hospital	Chang, SW (corresponding author), Far Eastern Mem Hosp, Dept Ophthalmol, New Taipei City, Taiwan.; Chang, SW (corresponding author), Natl Taiwan Univ Hosp, Dept Ophthalmol, Taipei, Taiwan.	swchang2007@ntu.edu.tw	Chen, Tsan-Chi/E-7758-2010	Chen, Tsan-Chi/0000-0001-5221-9707; CHANG, SHU-WEN/0000-0001-5323-3922	Far Eastern Memorial Hospital for Shu-Wen Chang [FEMH -2011-C-004, FEMH-2013-C-004, FEMH-2020-C-004, FEMH-104-2314-B-418-012, FEMH-108 -2314-B-418-015, FEMH-99-C-023, FEMH-108-2314-B-418-016]; Ministry of Science and Technology [MOST-104-2314-B-418-012, MOST-108-2314-B-418-015, MOST-108-2314-B-418-016]	Far Eastern Memorial Hospital for Shu-Wen Chang; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea)	This study were supported in part for materials by Far Eastern Memorial Hospital for Shu-Wen Chang (FEMH -2011-C-004, FEMH-2013-C-004, FEMH-2020-C-004, FEMH-104-2314-B-418-012, FEMH-108 -2314-B-418-015) and Tsan-Chi Chen (FEMH-99-C-023, FEMH-108-2314-B-418-016) and the Ministry of Science and Technology, Taiwan for Shu-Wen Chang (MOST-104-2314-B-418-012, MOST-108-2314-B-418-015) and Tsan-Chi Chen (MOST-108-2314-B-418-016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alfranca A, 2018, TRENDS MOL MED, V24, P825, DOI 10.1016/j.molmed.2018.08.001; Alipourfard I, 2021, CURR MOL MED, V21, P257, DOI 10.2174/1566524020666200427102209; Alzate-Correa D, 2020, METHODS MOL BIOL, V2050, P145, DOI 10.1007/978-1-4939-9740-4_15; Aviner R, 2020, COMPUT STRUCT BIOTEC, V18, P1074, DOI 10.1016/j.csbj.2020.04.014; Betterle N, 2020, FRONT PLANT SCI, V11, DOI 10.3389/fpls.2020.00237; Boura JS, 2013, HUM GENE THER METHOD, V24, P38, DOI 10.1089/hgtb.2012.185; Bravo FE, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69709-1; Bussow K, 2015, CURR OPIN STRUC BIOL, V32, P81, DOI 10.1016/j.sbi.2015.03.002; Chan HC, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.118.010240; Chen Si, 2020, Methods Mol Biol, V2102, P195, DOI 10.1007/978-1-0716-0223-2_10; Chen TC, 2013, BRIT J PHARMACOL, V168, P1341, DOI 10.1111/bph.12015; Chen TC, 2021, EUR J PHARMACOL, V910, DOI 10.1016/j.ejphar.2021.174414; Chen TC, 2019, EUR J PHARMACOL, V865, DOI 10.1016/j.ejphar.2019.172752; Chen TC, 2012, INVEST OPHTH VIS SCI, V53, P1539, DOI 10.1167/iovs.11-9203; Chen TC, 2010, INVEST OPHTH VIS SCI, V51, P1389, DOI 10.1167/iovs.09-3494; Chicaybam L, 2017, FRONT BIOENG BIOTECH, V4, DOI 10.3389/fbioe.2016.00099; Das J, 2016, SCI REP-UK, V6, DOI 10.1038/srep29197; de Luzy IR, 2019, J NEUROSCI, V39, P9521, DOI 10.1523/JNEUROSCI.1160-19.2019; Gutierrez-Granados S, 2018, CRIT REV BIOTECHNOL, V38, P918, DOI 10.1080/07388551.2017.1419459; Hacker DL, 2016, CURR OPIN STRUC BIOL, V38, P129, DOI 10.1016/j.sbi.2016.06.005; Hay E D, 1979, Curr Top Eye Res, V1, P1; He L, 2020, FRONT MICROBIOL, V11, DOI 10.3389/fmicb.2020.00769; Hindman HB, 2010, INVEST OPHTH VIS SCI, V51, P1935, DOI 10.1167/iovs.09-3823; Ho WT, 2014, EXP EYE RES, V124, P86, DOI 10.1016/j.exer.2014.05.007; Inada M, 2016, INT J MOL MED, V37, P1521, DOI 10.3892/ijmm.2016.2568; Jhan YY, 2020, INT J PHARMACEUT, V573, DOI 10.1016/j.ijpharm.2019.118802; Jonsdottir HR, 2019, VIRUSES-BASEL, V11, DOI 10.3390/v11080747; Jung JH, 2019, CANCERS, V11, DOI 10.3390/cancers11040582; Kobayashi H, 2019, NAT PROTOC, V14, P1084, DOI 10.1038/s41596-019-0129-7; Kodama H, 2019, BIOELECTROCHEMISTRY, V130, DOI 10.1016/j.bioelechem.2019.107328; Luo A, 2020, INT J BIOL SCI, V16, P2580, DOI 10.7150/ijbs.45693; Maishi N, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20184595; Maurisse R, 2010, BMC BIOTECHNOL, V10, DOI 10.1186/1472-6750-10-9; Mitani A, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0222454; Pei Y, 2004, EXP EYE RES, V79, P705, DOI 10.1016/j.exer.2004.08.002; Sharma G, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12444-7; Stepanenko AA, 2017, MUTAT RES-REV MUTAT, V773, P91, DOI 10.1016/j.mrrev.2017.05.002; Tazzyman SJ, 2015, MOL BIOL EVOL, V32, P3079, DOI 10.1093/molbev/msu293; Theelen WSME, 2016, J PATHOL CLIN RES, V2, P223, DOI 10.1002/cjp2.51; Torres R, 2014, GENE THER, V21, P343, DOI 10.1038/gt.2014.1; Wein T, 2020, CURR BIOL, V30, P3841, DOI 10.1016/j.cub.2020.07.019; Wein T, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-10600-7; You DW, 2015, CELL REP, V10, P2055, DOI 10.1016/j.celrep.2015.02.056; Yu H, 2014, BLOOD, V124, P1737, DOI 10.1182/blood-2013-10-534735	44	0	0	3	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265183	10.1371/journal.pone.0265183	http://dx.doi.org/10.1371/journal.pone.0265183			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333876	gold, Green Published			2022-12-26	WOS:000784335700026
J	Chuaychai, A; Sriplung, H				Chuaychai, Aungkana; Sriplung, Hutcha			A rapid rise in hormone receptor-positive and HER2-positive breast cancer subtypes in Southern Thai women: A population-based study in Songkhla	PLOS ONE			English	Article							ESTROGEN; PREDICTION; TRENDS	The incidence of breast cancer is increasing in low- and middle-income countries, including Thailand. However, its molecular immunohistochemical (M-IHC) subtypes have not been summarized in a population-based cancer registry. Thus, we aimed to estimate the breast cancer incidence and trends based on the hormone receptor and human epidermal growth factor receptor 2 (HER2) status. This cross-sectional study included 2,883 women diagnosed with primary invasive breast cancer between 2009 and 2018 from the Songkhla Cancer Registry. After imputing the missing values of estrogen receptor (ER), progesterone receptor (PR), and HER2 status, the cases were classified into four subtypes: HR+/HER2-, HR+/HER2+, HR-/HER2-, and HR-/HER2+. The age-specific incidence rate of 5-year age groups and age-standardized incidence rate (ASR) were calculated. An age-period-cohort (APC) model was used to describe the effects of age, birth cohort, and period of diagnosis. Finally, the incidence trends were extrapolated to 2030 based on the APC and joinpoint models. The results showed, HR+/HER2- had the highest ASR in breast cancer. The incidence trends of HR+/HER2- and HR+/HER2+ increased with an annual percent change of 5.4% (95%CI: 2.5% to 8.3%) and 10.1% (95%CI: 4.9% to 15.5%), respectively. The rate ratio was high in the younger generation and recent period of diagnosis. The joinpoint and APC model projections showed that the ASR of HR+/HER2- would reach 30.0 and 29.2 cases per 100,000 women, while ASR of the HR+/HER2+ would reach 8.8 and 10.4 cases per 100,000 women in 2030. On the other hand, the incidence trends of the HR-/HER2- and HR-/HER2+ subtypes were stable. The rising trends of HR-positive and a part of HER2-positive breast cancer forecast a dynamicity of the future health care budgeting, resource allocation, and provision of facilities.	[Chuaychai, Aungkana; Sriplung, Hutcha] Prince Songkla Univ, Fac Med, Dept Epidemiol, Hat Yai, Thailand; [Chuaychai, Aungkana] Walailak Univ, Sch Pharm, Nakhon Si Thammarat, Thailand	Prince of Songkla University; Walailak University	Sriplung, H (corresponding author), Prince Songkla Univ, Fac Med, Dept Epidemiol, Hat Yai, Thailand.	hutcha.s@psu.ac.th	Sriplung, Hutcha/A-5987-2017	Sriplung, Hutcha/0000-0002-8483-0460; Chuaychai, Aungkana/0000-0002-7847-5888				Acheampong T, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.13226; Aekphakorn W., 2016, THAI NATL HLTH EXAM, V1st; Anderson KN, 2014, BREAST CANCER RES TR, V144, P1, DOI 10.1007/s10549-014-2852-7; Anderson WF, 2013, INT J CANCER, V133, P2201, DOI 10.1002/ijc.28222; Anderson WF, 2011, J NATL CANCER I, V103, P1397, DOI 10.1093/jnci/djr257; [Anonymous], 1996, THAI NATL HLTH EX SU, V1st ed, P271; [Anonymous], 2014, THAI J OBSTET GYNAEC; [Anonymous], JOINP REGR PROGR; Bray F, CANC INCIDENCE 5 CON, VXI; Chuaychai A., 2021, 1000 imputed data set of receptor status for breast cancer, DOI 10.17026/dans-xn5-5286; Collaborative Grp Hormonal Factors, 2019, LANCET, V394, P1159, DOI 10.1016/S0140-6736(19)31709-X; Drug and Medical Supply Information Center Ministry of Public Health, MED REIMB CRIT CANC; Ellingjord-Dale M, 2017, BREAST CANCER RES, V19, DOI 10.1186/s13058-016-0798-x; Glass AG, 2007, JNCI-J NATL CANCER I, V99, P1152, DOI 10.1093/jnci/djm059; Health Data Center Ministry of Public Health, PERC HLTH SCH THAIL; International Agency for Research on Cancer (IARC), 2010, GLOSS TERM; International Agency for Research on Cancer (IARC), CANC TOD; International Agency for Research on Cancer (IARC), 2021, POP FACT SHEETS THAI; Jones G., 2011, IMPACT DEMOGRAPHIC C, V1st; Kongsakon R, 2019, VALUE HEALTH REG ISS, V18, P47, DOI 10.1016/j.vhri.2018.08.004; Lambertini M, 2016, CANCER TREAT REV, V49, P65, DOI 10.1016/j.ctrv.2016.07.006; Li H, 2017, J EPIDEMIOL, V27, P143, DOI 10.1016/j.je.2016.05.002; Mathew A, 2018, J GLOB ONCOL, V4, DOI 10.1200/JGO.17.00188; Medical Council of Thailand, LIST TOT NUMB DOCT S; Mesa-Eguiagaray I, 2020, BRIT J CANCER, V123, P852, DOI 10.1038/s41416-020-0938-z; Mistry M, 2011, BRIT J CANCER, V105, P1795, DOI 10.1038/bjc.2011.430; Moller B, 2002, EUR J CANCER PREV, V11, pS1; Mullooly M, 2017, EUR J CANCER, V86, P326, DOI 10.1016/j.ejca.2017.08.031; Munsell MF, 2014, EPIDEMIOL REV, V36, P114, DOI 10.1093/epirev/mxt010; National Comprehensive Cancer Network`, 2021, NCCN CLIN PRACTICE G, DOI 10.6004/jnccn.2009.0057; National Health Security Office (NHSO), 2018, GUID AD CANC TREAT T, V1st; National Statistical Office, TNSO POP HOUS; Noipayak P, 2017, BMC WOMENS HEALTH, V17, DOI 10.1186/s12905-017-0371-5; Office of the National Economic and Social Development Board, 2013, POPULATION PROJECTIO; Peek C., 2015, STATE THAILANDS POPU, P18; Poosari A, 2014, J EPIDEMIOL, V24, P216, DOI 10.2188/jea.JE20130121; Porapakkham Y., 2006, THAI NATL HLTH EX SU, V1st ed; Ratanawichitrasin Adune, 2002, Journal of the Medical Association of Thailand, V85, P583; Sasat S, 2013, GERONTOLOGIST, V53, P711, DOI 10.1093/geront/gnt038; Songkhla Provincial Statistical Office, 2020, SONGKHL PROV STAT RE; Sripan P, 2019, ASIAN BIOMED, V13, P11, DOI 10.1515/abm-2019-0034; Sumriddetchkajorn K, 2019, B WORLD HEALTH ORGAN, V97, P415, DOI 10.2471/BLT.18.223693; Sung H, 2021, CA-CANCER J CLIN, V71, P209, DOI 10.3322/caac.21660; Sung H, 2020, INT J CANCER, V147, P829, DOI 10.1002/ijc.32812; Suzuki R, 2009, INT J CANCER, V124, P698, DOI 10.1002/ijc.23943; Topothai C, 2021, INT BREASTFEED J, V16, DOI 10.1186/s13006-021-00386-0; van Buuren S, 2011, J STAT SOFTW, V45, P1; Virani S, 2018, CANCER EPIDEMIOL, V54, P82, DOI 10.1016/j.canep.2018.02.007; Virani S, 2017, CANCERS, V9, DOI [10.3390/cancers9080108, 10.3390/cancers9080]; Virani S, 2014, CANCER EPIDEMIOL, V38, P235, DOI 10.1016/j.canep.2014.03.003	50	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265417	10.1371/journal.pone.0265417	http://dx.doi.org/10.1371/journal.pone.0265417			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344552	Green Published, gold			2022-12-26	WOS:000788055200011
J	Filion, A; Deschamps, L; Niebuhr, CN; Poulin, R				Filion, Antoine; Deschamps, Lucas; Niebuhr, Chris N.; Poulin, Robert			Anthropogenic landscape alteration promotes higher disease risk in wild New Zealand avian communities	PLOS ONE			English	Article							MALARIA PLASMODIUM-RELICTUM; INFECTIOUS-DISEASES; CLIMATE-CHANGE; VECTOR-BORNE; R PACKAGE; EPIZOOTIOLOGY; HAEMOPROTEUS; BIODIVERSITY; PARASITES; ECOLOGY	Anthropogenic changes can have dramatic effects on wild populations. Moreover, by promoting the emergence of vector-borne diseases in many ecosystems, those changes can lead to local extinction of native wildlife. One of those diseases, avian malaria, has been shown to be on the rise in New Zealand, threatening native bird species that are among the most extinction-prone in the world. It is thus of prime importance to better understand the potential cascading effects that anthropogenic modifications have on those fragile species. Here, we aim to test how long-lasting modification to regional environmental filters can subsequently alter local biotic filters, in turn promoting the emergence of avian malaria in New Zealand avian communities. To this end, we used Bayesian structural equation modelling to unravel the drivers of disease emergence within the complex interplay between landscape and local species pools. We show that altered landscape, quantified through a lower enhanced vegetation index, leads to more infections in Turdus spp. and modification in avian community composition, potentially raising the probability of infection for other species in the community. In addition, we show that climatic variables associated with the presence of vectors play a predominant role in shaping the regional pattern of avian malaria occurrence. Our results suggest long-lasting impacts of anthropogenic changes on regional environmental filters and demonstrate that conservation efforts should align toward restoring the landscape to prevent further emergence of infectious diseases in wild ecosystems.	[Filion, Antoine; Poulin, Robert] Univ Otago, Dept Zool, Dunedin, New Zealand; [Deschamps, Lucas] Univ Quebec Trois Rivieres, Dept Environm Sci, Trois Rivieres, PQ, Canada; [Niebuhr, Chris N.] Manaaki Whenua Landcare Res, Lincoln, New Zealand	University of Otago; University of Quebec; University of Quebec Trois Rivieres; Landcare Research - New Zealand	Filion, A (corresponding author), Univ Otago, Dept Zool, Dunedin, New Zealand.	afilion90@gmail.com	Poulin, Robert/C-3117-2008	Poulin, Robert/0000-0003-1390-1206; Filion, Antoine/0000-0003-1198-3017; Niebuhr, Chris/0000-0002-8892-3605	University of Otago; New Zealand Ministry of Business, Innovation and Employment	University of Otago; New Zealand Ministry of Business, Innovation and Employment(New Zealand Ministry of Business, Innovation and Employment (MBIE))	AF has been supported by the University of Otago doctoral scholarship grants and CNN was supported by a Strategic Science Investment Funding from the New Zealand Ministry of Business, Innovation and Employment awarded to Manaaki Whenua -Landcare Research.the funder provided support in the form of salaries for authors AF, RP and CNN, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the `author contributions' section.	Altizer S, 2013, SCIENCE, V341, P514, DOI 10.1126/science.1239401; Atkinson CT, 2010, J AVIAN BIOL, V41, P357, DOI 10.1111/j.1600-048X.2009.04915.x; Barrow LN, 2019, ECOL LETT, V22, P987, DOI 10.1111/ele.13263; Bosenbecker C, 2020, ECOL EVOL, V10, P9073, DOI 10.1002/ece3.6485; Burkner PC, 2017, J STAT SOFTW, V80, P1, DOI 10.18637/jss.v080.i01; Clark NJ, 2014, INT J PARASITOL, V44, P329, DOI 10.1016/j.ijpara.2014.01.004; Cohen JM, 2016, P NATL ACAD SCI USA, V113, pE3359, DOI 10.1073/pnas.1521657113; Cressler CE, 2016, PARASITOLOGY, V143, P915, DOI 10.1017/S003118201500092X; Cunningham AA, 1996, CONSERV BIOL, V10, P349, DOI 10.1046/j.1523-1739.1996.10020349.x; Dambros C, 2020, BIODIVERS CONSERV, V29, P3609, DOI 10.1007/s10531-020-02040-3; Daszak P, 2000, SCIENCE, V287, P443, DOI 10.1126/science.287.5452.443; Day JF, 2001, ANNU REV ENTOMOL, V46, P111, DOI 10.1146/annurev.ento.46.1.111; Didan K., 2015, MYD13Q1 MODIS AQUA V, DOI DOI 10.5067/MODIS/MYD13Q1.006; Driscoll DA, 2013, TRENDS ECOL EVOL, V28, P605, DOI 10.1016/j.tree.2013.06.010; Fahrig L, 2011, ECOL LETT, V14, P101, DOI 10.1111/j.1461-0248.2010.01559.x; Fecchio A, 2019, MOL ECOL, V28, P2681, DOI 10.1111/mec.15094; Ferraguti M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29002; Fick SE, 2017, INT J CLIMATOL, V37, P4302, DOI 10.1002/joc.5086; Filion A, 2020, OECOLOGIA, V194, P723, DOI 10.1007/s00442-020-04782-x; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Galardo AKR, 2009, MED VET ENTOMOL, V23, P335, DOI 10.1111/j.1365-2915.2009.00839.x; Giraudoux P, 2003, PARASITOLOGY, V127, pS121, DOI 10.1017/S0031182003003512; Gottdenker NL, 2014, ECOHEALTH, V11, P619, DOI 10.1007/s10393-014-0941-z; Hackett SJ, 2008, SCIENCE, V320, P1763, DOI 10.1126/science.1157704; Harvey-Samuel T., 2021, CABI AGR BIOSCI, V9; Hellgren O, 2004, J PARASITOL, V90, P797, DOI 10.1645/GE-184R1; Howe L, 2012, PARASITOL RES, V110, P913, DOI 10.1007/s00436-011-2577-z; LaPointe DA, 2012, ANN NY ACAD SCI, V1249, P211, DOI 10.1111/j.1749-6632.2011.06431.x; LaPointe DA, 2010, J PARASITOL, V96, P318, DOI 10.1645/GE-2290.1; Loiseau C, 2013, SCI REP-UK, V3, DOI 10.1038/srep01126; Lymbery Alan J., 2014, International Journal for Parasitology Parasites and Wildlife, V3, P171, DOI 10.1016/j.ijppaw.2014.04.002; MCCALLUM H, 1995, TRENDS ECOL EVOL, V10, P190, DOI 10.1016/S0169-5347(00)89050-3; McGill BJ, 2010, SCIENCE, V328, P575, DOI 10.1126/science.1188528; McIntyre R., 2007, HIST HERITAGE HIGH C, P174; Mills JN, 2010, ENVIRON HEALTH PERSP, V118, P1507, DOI 10.1289/ehp.0901389; Myers E.A., 2012, NATURE ED KNOWLEDGE, V3, P23; Niebuhr CN, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0165918; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; Pulgarin PC, 2018, ECOL EVOL, V8, P3800, DOI 10.1002/ece3.3785; R Core Team, 2021, R LANG ENV STAT; Revell LJ, 2012, METHODS ECOL EVOL, V3, P217, DOI 10.1111/j.2041-210X.2011.00169.x; Rocklov J, 2020, NAT IMMUNOL, V21, P479, DOI 10.1038/s41590-020-0648-y; Schoener ER, 2014, NEW ZEAL VET J, V62, P189, DOI 10.1080/00480169.2013.871195; SEUTIN G, 1991, CAN J ZOOL, V69, P82, DOI 10.1139/z91-013; Suzan G, 2015, ECOL EVOL, V5, P865, DOI 10.1002/ece3.1404; Tompkins DM, 2006, J ROY SOC NEW ZEAL, V36, P51, DOI 10.1080/03014223.2006.9517799; Tompkins DM, 2015, TRENDS PARASITOL, V31, P149, DOI 10.1016/j.pt.2015.01.007; Tompkins DM., 2006, PARASITES BIOL INVAS, P461; Valkinas G., 2005, AVIAN MALARIA PARASI, P934; van Schalkwyk J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-71724-1; VANRIPER C, 1986, ECOL MONOGR, V56, P327, DOI 10.2307/1942550; Vehtari A, 2017, STAT COMPUT, V27, P1413, DOI 10.1007/s11222-016-9696-4; Veltman CJ, 1996, AM NAT, V147, P542, DOI 10.1086/285865; Vijith H, 2020, REMOTE SENS APPL, V18, DOI 10.1016/j.rsase.2020.100311; Wilson KJ, 2007, LAND BIRDS OVERVIEW; Woolhouse MEJ, 1997, P NATL ACAD SCI USA, V94, P338, DOI 10.1073/pnas.94.1.338	56	1	1	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265568	10.1371/journal.pone.0265568	http://dx.doi.org/10.1371/journal.pone.0265568			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333899	gold, Green Published			2022-12-26	WOS:000784335700030
J	Ghazeeri, G; Ibrahim, N; Khalifeh, F; Beyrouthy, C; El-Taha, L; Bizri, M				Ghazeeri, Ghina; Ibrahim, Nour; Khalifeh, Fatin; Beyrouthy, Christine; El-Taha, Lina; Bizri, Maya			Character strengths of women with polycystic ovary syndrome in a single center	PLOS ONE			English	Article							QUALITY-OF-LIFE; MOOD DYSFUNCTION; TESTOSTERONE; SATISFACTION; TRAITS; HEALTH	PurposeTo investigate the difference in character strengths (CSs) between patients with and without polycystic ovary syndrome (PCOS) and the association between biological (i.e., testosterone levels) and psychological factors (i.e., character strengths). Patients and methodsA total of 99 women divided into PCOS (49) and non-PCOS (50) groups who presented to the gynecological clinics at the women's center in the American University of Beirut Medical Center in 2017 were included. Women were assessed for testosterone bioavailable levels and completed a questionnaire that included Hospital Anxiety and Depression Scale and Values in Action Survey-72. Univariate and multivariable analyses were performed to examine the association of CSs between the two groups and its predictors. ResultsThe scores of hope, judgement, perspective, and transcendence of the PCOS group were significantly higher in comparison with healthy participants. An increase in free androgen index was negatively correlated to the score of judgement only. ConclusionWomen with PCOS have their own profile of character strengths and virtues that constitute judgement, hope, perspective, and transcendence. This in turn can be utilized to reinforce those personality strengths and thus decrease the psychological distress and mood disorders accompanied with this disease.	[Ghazeeri, Ghina; Khalifeh, Fatin; Beyrouthy, Christine; El-Taha, Lina] Amer Univ Beirut, Fac Med, Dept Obstet & Gynecol, Med Ctr, Beirut, Lebanon; [Ibrahim, Nour; Bizri, Maya] Amer Univ Beirut, Fac Med, Dept Psychiat, Med Ctr, Beirut, Lebanon	American University of Beirut; American University of Beirut	Bizri, M (corresponding author), Amer Univ Beirut, Fac Med, Dept Psychiat, Med Ctr, Beirut, Lebanon.	mb112@aub.edu.lb	Bizri, Maya/AHB-6348-2022	Bizri, Maya/0000-0003-0350-6157; Ibrahim, Nour/0000-0002-0690-4401				Alvergne A, 2010, PERS INDIV DIFFER, V49, P840, DOI 10.1016/j.paid.2010.07.006; Apicella CL, 2008, EVOL HUM BEHAV, V29, P384, DOI 10.1016/j.evolhumbehav.2008.07.001; Azziz R, 2005, J CLIN ENDOCR METAB, V90, P4650, DOI 10.1210/jc.2005-0628; Azziz R, 2006, J CLIN ENDOCR METAB, V91, P4237, DOI 10.1210/jc.2006-0178; Bain J, 2007, CLIN INTERV AGING, V2, P567; Barry JA, 2011, J PSYCHOSOM OBST GYN, V32, P104, DOI 10.3109/0167482X.2011.568129; Bazarganipour F, 2013, IRAN J REPROD MED, V11, P829; Campbell BC, 2010, PHYSIOL BEHAV, V99, P451, DOI 10.1016/j.physbeh.2009.12.011; Celec P, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00012; Elsenbruch S, 2003, J CLIN ENDOCR METAB, V88, P5801, DOI 10.1210/jc.2003-030562; Goel N, 2008, ENDOCRINOLOGY, V149, P6399, DOI 10.1210/en.2008-0433; Hahn S, 2005, EUR J ENDOCRINOL, V153, P853, DOI 10.1530/eje.1.02024; Himelein MJ, 2006, OBSTET GYNECOL SURV, V61, P723, DOI 10.1097/01.ogx.0000243772.33357.84; Hung JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097041; Maattanen I, 2013, PSYCHONEUROENDOCRINO, V38, P2243, DOI 10.1016/j.psyneuen.2013.04.009; Moran L, 2009, HUM REPROD UPDATE, V15, P477, DOI 10.1093/humupd/dmp008; Naz MSG, 2019, PSYCHOL RES BEHAV MA, V12, P715, DOI 10.2147/PRBM.S207727; Niemiec R.M., 2018, CHARACTER STRENGTHS, DOI [10.1027/00492-000, DOI 10.1027/00492-000]; Peterson C., 2006, J POSIT PSYCHOL, V1, P17, DOI [10.1080/17439760500372739, DOI 10.1080/17439760500372739]; PETERSON CHRISTOPHER, 2004, CHARACTER STRENGTHS; Qin JZ, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-56; Sirmans SM, 2014, CLIN EPIDEMIOL, V6, P1, DOI 10.2147/CLEP.S37559; Tajima-Pozo K, 2015, INDIAN J PSYCHOL MED, V37, P317, DOI 10.4103/0253-7176.162956; Teede H, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-41; Weiner CL, 2004, PSYCHOSOM MED, V66, P356, DOI 10.1097/01.psy.0000127871.46309.fe; Yan TT, 2020, J ADV NURS, V76, P1567, DOI 10.1111/jan.14356	26	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266398	10.1371/journal.pone.0266398	http://dx.doi.org/10.1371/journal.pone.0266398			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363827	gold, Green Published			2022-12-26	WOS:000804748600049
J	Lavallee-Bourget, MH; Campeau-Lecours, A; Tittley, J; Bielmann, M; Bouyer, LJ; Roy, JS				Lavallee-Bourget, Marie-Helene; Campeau-Lecours, Alexandre; Tittley, Jean; Bielmann, Mathieu; Bouyer, Laurent J.; Roy, Jean-Sebastien			The use of a three-dimensional dynamic arm support prevents the development of muscle fatigue during repetitive manual tasks in healthy individuals	PLOS ONE			English	Article							MUSCULAR FATIGUE; SHOULDER; POSTURE	Work-related upper extremity disorders are costly to society due to resulting medical costs, presenteeism and absenteeism. Although their aetiology is likely multifactorial, physical workplace factors are known to play an important role in their development. Promising options for preventing work-related upper extremity disorders include assistive technologies such as dynamic arm supports designed to follow the movement of the arm while compensating for its weight. The objective of this study was to assess the effects of a dynamic arm support on perceived exertion, muscle activity and movement patterns of the upper limb during repetitive manual tasks in healthy individuals. Thirty healthy right-handed individuals were allocated either a static or a dynamic task to perform with and without a dynamic arm support. During the task, surface electromyographic activity (anterior and middle deltoid, upper trapezius) and upper limb kinematics (elbow, shoulder, sternoclavicular) were measured using surface EMG and inertial sensors. Results showed that the dynamic arm support significantly reduced perceived exertion during the tasks and limited the development of muscular fatigue of the anterior and middle deltoid as demonstrated by EMG signal mean epoch amplitudes and median frequency of the EMG power spectrum. The dynamic arm support also prevented a decrease in shoulder elevation and an increase in total shoulder joint excursion during static and dynamic task, respectively. These results denote the potential benefits of dynamic arm supports in work environments. Further studies should focus on their efficacy, acceptability and implementability in work settings.	[Lavallee-Bourget, Marie-Helene; Campeau-Lecours, Alexandre; Tittley, Jean; Bielmann, Mathieu; Bouyer, Laurent J.; Roy, Jean-Sebastien] Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada; [Lavallee-Bourget, Marie-Helene; Bielmann, Mathieu; Bouyer, Laurent J.; Roy, Jean-Sebastien] Univ Laval, Fac Med, Quebec City, PQ, Canada; [Campeau-Lecours, Alexandre] Univ Laval, Fac Sci & Engn, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Roy, JS (corresponding author), Ctr Interdisciplinary Res Rehabil & Social Integr, Quebec City, PQ, Canada.; Roy, JS (corresponding author), Univ Laval, Fac Med, Quebec City, PQ, Canada.	jean-sebastien.roy@fmed.ulaval.ca	Bouyer, Laurent/A-9255-2010	Bouyer, Laurent/0000-0003-2034-4516; Roy, Jean-Sebastien/0000-0003-2853-9940; Tittley, Jean/0000-0002-0160-4143	Natural Sciences and Engineering Research Council of Canada (NSERC) [EGP 531078-18]; Fonds de recherche du Quebec-Sante	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Fonds de recherche du Quebec-Sante(Fonds de la Recherche en Sante du Quebec)	This study was funded by the Natural Sciences and Engineering Research Council of Canada (NSERC) - Engage Grants for universities (EGP 531078-18) received by J-SR. J-SR and ACL are supported by salary awards from the the Fonds de recherche du Quebec-Sante. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemi MM, 2019, J ELECTROMYOGR KINES, V47, P25, DOI 10.1016/j.jelekin.2019.05.003; Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Bar M, 2021, APPL ERGON, V94, DOI 10.1016/j.apergo.2021.103385; Borg G., 1998, BORGS PERCEIVED EXER; Buckle PW, 2002, APPL ERGON, V33, P207, DOI 10.1016/S0003-6870(02)00014-5; Carroll TJ, 2017, J APPL PHYSIOL, V122, P1068, DOI 10.1152/japplphysiol.00775.2016; Cifrek M, 2009, CLIN BIOMECH, V24, P327, DOI 10.1016/j.clinbiomech.2009.01.010; Cook C, 2004, APPL ERGON, V35, P285, DOI 10.1016/j.apergo.2003.12.005; Cote JN, 2002, EXP BRAIN RES, V146, P394, DOI 10.1007/s00221-002-1186-6; Cowley JC, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172835; DE LUCA CJ, 1984, CRIT REV BIOMED ENG, V11, P251; de Vries AW, 2021, ERGONOMICS, V64, P712, DOI 10.1080/00140139.2020.1868581; Del Ferraro S, 2020, INT J ENV RES PUB HE, V17, DOI 10.3390/ijerph17207374; Dupuis F, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249403; Enoka RM, 2016, MED SCI SPORT EXER, V48, P2228, DOI 10.1249/MSS.0000000000000929; Essers J, 2020, SENSORS-BASEL, V20, DOI 10.3390/s20174864; Fernandez JE, 1999, INT J IND ERGONOM, V24, P493, DOI 10.1016/S0169-8141(98)00076-6; Fuller JR, 2009, J ELECTROMYOGR KINES, V19, P1043, DOI 10.1016/j.jelekin.2008.10.009; HAGBERG M, 1981, AM J PHYS MED REHAB, V60, P111; Hebert LJ, 2012, VALUATION FORCE MUSC, V3; Hermens HJ, 2000, J ELECTROMYOGR KINES, V10, P361, DOI 10.1016/S1050-6411(00)00027-4; Hunt MA, 2017, J ELECTROMYOGR KINES, V35, P24, DOI 10.1016/j.jelekin.2017.05.007; Kim S, 2018, APPL ERGON, V70, P323, DOI 10.1016/j.apergo.2018.02.024; Kim S, 2018, APPL ERGON, V70, P315, DOI 10.1016/j.apergo.2018.02.025; Lebrasseur ABE, 2019, ASSIST TECHNOL, P17; Lewis J, 2015, J ORTHOP SPORT PHYS, V45, P923, DOI 10.2519/jospt.2015.5941; MacIsaac DT, 2003, P ANN INT IEEE EMBS, V25, P2487, DOI 10.1109/IEMBS.2003.1280420; Maurice P, 2020, IEEE T NEUR SYS REH, V28, P152, DOI 10.1109/TNSRE.2019.2945368; Nag PK, 2009, APPL ERGON, V40, P286, DOI 10.1016/j.apergo.2008.04.016; NIEMINEN H, 1995, CLIN BIOMECH, V10, P309, DOI 10.1016/0268-0033(95)00041-I; Poirson E., 2019, HUMAN FACTORS ERGONO; Poitras I, 2019, SENSORS-BASEL, V19, DOI 10.3390/s19081885; Potvin JR, 1997, J APPL PHYSIOL, V82, P144, DOI 10.1152/jappl.1997.82.1.144; Rashedi E, 2014, ERGONOMICS, V57, P1864, DOI 10.1080/00140139.2014.952682; Rempel P, 2011, WORK, V39, P195, DOI 10.3233/WOR-2011-1166; Schmalz T, 2019, INT J ENV RES PUB HE, V16, DOI 10.3390/ijerph16234792; Spanhove V, 2021, ANN PHYS REHABIL MED, V64, DOI 10.1016/j.rehab.2020.10.008; van der Heide Loek A, 2013, IEEE Int Conf Rehabil Robot, V2013, P6650491, DOI 10.1109/ICORR.2013.6650491; Van Eerd D, 2016, OCCUP ENVIRON MED, V73, P62, DOI 10.1136/oemed-2015-102992; Vedsted P, 2006, EUR J APPL PHYSIOL, V96, P165, DOI 10.1007/s00421-004-1216-0; Veeger HEJ, 2007, J BIOMECH, V40, P2119, DOI 10.1016/j.jbiomech.2006.10.016; Vzina M, 2011, ENQUTE QUBCOISE COND; Waters TR, 2007, J OCCUP ENVIRON MED, V49, P172, DOI 10.1097/JOM.0b013e3180322559; Wattanaprakornkul D, 2011, J SCI MED SPORT, V14, P376, DOI 10.1016/j.jsams.2011.01.001	44	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266390	10.1371/journal.pone.0266390	http://dx.doi.org/10.1371/journal.pone.0266390			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363820	Green Published, gold			2022-12-26	WOS:000804748600057
J	Mazur, R; Beczek, M; Janiszewski, J; Koperski, W; Polakowski, C; Fikus, B; Sochan, A; Wozniak, R; Gozdzik, D; Ryzak, M; Banda, M; Bieganowski, A				Mazur, Rafal; Beczek, Michal; Janiszewski, Jacek; Koperski, Wojciech; Polakowski, Cezary; Fikus, Bartosz; Sochan, Agata; Wozniak, Ryszard; Gozdzik, Dawid; Ryzak, Magdalena; Banda, Maciej; Bieganowski, Andrzej			Experimental investigations of crater formation as a result of high-velocity impacts on sand bed	PLOS ONE			English	Article							QUARTZ SAND; PROJECTILE PENETRATION; HYPERVELOCITY IMPACT; SHOCK METAMORPHISM; LUNAR CRATERS; MORPHOLOGY; SIMULATIONS; DENSITY; TARGETS; DEPTH	The formation of craters is an important issue in the investigations of the surface of the earth and other planets. The aim of the study was to check whether the different textures of sand beds affect the size and dynamics of the formation of craters and ejection curtain after high-velocity impacts. The experiments were conducted using an aluminium impactor at two impact speeds (~700 and ~1300 m center dot s(-1)) and a sand bed composed of either a broad range of sizes (<2.0 mm) or any of the three fractions obtained from it (<0.5, 0.5-1, 1-2 mm). The diameters, depths, wall slope, and rim heights of the resulting craters were measured. The ejecta curtain was characterized by the inclination angle of walls, base diameter, and expansion velocity. The mass of the transferred material and the depth of the impactor penetration were also determined. Additionally, the results were used to calculate dimensionless parameters commonly considered in crater studies (pi(V), pi(2) and alpha). The texture of the sand most clearly influenced the diameters of the craters, its effect could also be seen in the case of the distance covered by the ejected material. This information appears to be relevant for future research, providing some rationale to help assess in which aspects of the phenomenon the texture may be important.	[Mazur, Rafal; Beczek, Michal; Polakowski, Cezary; Sochan, Agata; Ryzak, Magdalena; Banda, Maciej; Bieganowski, Andrzej] Polish Acad Sci, Inst Agrophys, Lublin, Poland; [Janiszewski, Jacek; Koperski, Wojciech; Fikus, Bartosz; Wozniak, Ryszard; Gozdzik, Dawid] Mil Univ Technol, Fac Mechatron Armament & Aerosp, Warsaw, Poland	Polish Academy of Sciences; Bohdan Dobrzanski Institute of Agrophysics of the Polish Academy of Sciences; Military University of Technology in Warsaw	Beczek, M (corresponding author), Polish Acad Sci, Inst Agrophys, Lublin, Poland.	m.beczek@ipan.lublin.pl	Polakowski, Cezary/H-7294-2013	Polakowski, Cezary/0000-0002-1658-8334; Sochan, Agata/0000-0002-1987-0220; Fikus, Bartosz/0000-0002-0383-6984; Gozdzik, Dawid/0000-0003-3190-5745; Banda, Maciej/0000-0002-7144-5459; Janiszewski, Jacek/0000-0003-3783-8774; , Ryszard Bogumil Wozniak/0000-0002-5555-3126; Mazur, Rafal/0000-0002-5520-3863	National Science Centre, Poland [2017/26/D/ST10/01026]; Institute of Agrophysics, Polish Academy of Sciences, Poland; Military University of Technology, Poland [23-780/2020]; Faculty of Mechatronics, Armament and Aerospace, Military University of Technology, Warsaw, Poland	National Science Centre, Poland(National Science Centre, Poland); Institute of Agrophysics, Polish Academy of Sciences, Poland; Military University of Technology, Poland; Faculty of Mechatronics, Armament and Aerospace, Military University of Technology, Warsaw, Poland	This work was partially supported by (a)the National Science Centre, Poland, in the frame work of the project No. 2017/26/D/ST10/01026headedby AS; (b) Institute of Agrophysics, Polish Academy of Sciences, Poland, in the frame & nbsp;of statutory research;(c) a University Research Grant from the Military University of Technology, Poland(Project No. 23-780/2020) headed by RW;(d) Faculty of Mechatronics, Armament and Aerospace, Military University of Technology, Warsaw, Poland, in the frame of statutory research.	Agarwal N, 2019, PLANET SPACE SCI, V167, P42, DOI 10.1016/j.pss.2019.01.003; Al-Hashemi HMB, 2018, POWDER TECHNOL, V330, P397, DOI 10.1016/j.powtec.2018.02.003; [Anonymous], 2012, 9331 BS EN; Atkins WW, 1960, P 4 S HYP IMP FLOR E, V6th; BAKER JR, 1993, INT J IMPACT ENG, V14, P73, DOI 10.1016/0734-743X(93)90010-5; Baker JR, 1995, INT J IMPACT ENG, V17, P25, DOI 10.1016/0734-743X(95)99832-C; Barnouin-Jha OS, 2007, ICARUS, V188, P506, DOI 10.1016/j.icarus.2007.01.009; Beczek M, 2018, GEOMORPHOLOGY, V303, P357, DOI 10.1016/j.geomorph.2017.12.019; Bless SJ, 2009, AIP CONF PROC, V1195, P1361; Borg JP, 2013, INT J IMPACT ENG, V51, P23, DOI 10.1016/j.ijimpeng.2012.07.009; Borvik T, 2015, INT J IMPACT ENG, V75, P123, DOI 10.1016/j.ijimpeng.2014.07.016; Bragov AM, 2018, INT J IMPACT ENG, V122, P197, DOI 10.1016/j.ijimpeng.2018.08.012; Carlucci D., 2014, BALLISTICS THEORY DE; Chian SC, 2017, INT J IMPACT ENG, V105, P80, DOI 10.1016/j.ijimpeng.2017.03.026; Cintala MJ, 1999, METEORIT PLANET SCI, V34, P605, DOI 10.1111/j.1945-5100.1999.tb01367.x; Collins GS, 2012, ELEMENTS, V8, P25, DOI 10.2113/gselements.8.1.25; Daubar IJ, 2014, J GEOPHYS RES-PLANET, V119, P2620, DOI 10.1002/2014JE004671; Deboeuf S, 2009, PHYS REV E, V79, DOI 10.1103/PhysRevE.79.041306; Emady HN, 2011, POWDER TECHNOL, V212, P69, DOI 10.1016/j.powtec.2011.04.030; FORRESTAL MJ, 1992, INT J IMPACT ENG, V12, P427, DOI 10.1016/0734-743X(92)90167-R; Guzman IL, 2021, GRANUL MATTER, V23, DOI 10.1007/s10035-021-01131-4; Guzman IL, 2015, MECH RES COMMUN, V70, P4, DOI 10.1016/j.mechrescom.2015.08.008; Guzman IL, 2014, GRANUL MATTER, V16, P829, DOI 10.1007/s10035-014-0528-y; Hermalyn B, 2011, ICARUS, V216, P269, DOI 10.1016/j.icarus.2011.09.008; Hermalyn B, 2010, ICARUS, V209, P866, DOI 10.1016/j.icarus.2010.05.025; HOLSAPPLE KA, 1993, ANNU REV EARTH PL SC, V21, P333, DOI 10.1146/annurev.ea.21.050193.002001; Horabik J, 2018, POWDER TECHNOL, V340, P52, DOI 10.1016/j.powtec.2018.09.004; Housen KR, 2011, ICARUS, V211, P856, DOI 10.1016/j.icarus.2010.09.017; Jakielaszek Z, 2017, J MAR ENG TECHNOL, V16, P319, DOI 10.1080/20464177.2017.1369719; Katsuragi H, 2016, LECT NOTES PHYS, V910, P1, DOI 10.1007/978-4-431-55648-0; Kondic L, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.011305; Kuang SB, 2013, POWDER TECHNOL, V239, P319, DOI 10.1016/j.powtec.2013.02.017; Li YJ, 2016, POWDER TECHNOL, V288, P303, DOI 10.1016/j.powtec.2015.11.022; Lohse D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.198003; Mahanti P, 2018, ICARUS, V299, P475, DOI 10.1016/j.icarus.2017.08.018; Marston JO, 2012, J FLUID MECH, V704, P5, DOI 10.1017/jfm.2012.141; Mazur R, 2020, CATENA, V185, DOI 10.1016/j.catena.2019.104277; Melosh H.J., 2011, PLANETARY SURFACE PR, DOI 10.1017/CBO9780511977848; Miranda CS, 2019, ICARUS, V325, P84, DOI 10.1016/j.icarus.2019.02.006; Miura K., 1997, SOILS FOUND, V37, P89, DOI [10.1248/cpb.37.3229, DOI 10.1248/CPB.37.3229]; Mizutani H., 1983, Journal of Geophysical Research, V88, P835, DOI 10.1029/JB088iS02p0A835; Omidvar M., 2019, SHOCK PHENOMENA GRAN, P137, DOI [10.1007/978-3-030-23002-9_5, DOI 10.1007/978-3-030-23002-9_5]; Omidvar M, 2015, INT J IMPACT ENG, V85, P146, DOI 10.1016/j.ijimpeng.2015.06.002; Omidvar M, 2014, INT J IMPACT ENG, V66, P60, DOI 10.1016/j.ijimpeng.2013.12.004; Pacheco-Vazquez F, 2019, PHYS REV LETT, V122, DOI 10.1103/PhysRevLett.122.164501; Prieur NC, 2017, J GEOPHYS RES-PLANET, V122, P1704, DOI 10.1002/2017JE005283; Sabuwala T, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.264501; Savvateev AF, 2001, INT J IMPACT ENG, V26, P675, DOI 10.1016/S0734-743X(01)00132-4; Schmidt R.M., 1987, INT J IMPACT ENG, V5, P543, DOI [DOI 10.1016/0734-743X(87)90069-8, 10.1016/0734-743X(87)90069-8]; Schmidt RM, 1980, P 11 LUN PLAN SCI C, V11, P2099; SCHULTZ PH, 1985, J GEOPHYS RES-SOLID, V90, P3701, DOI 10.1029/JB090iB05p03701; Shoemaker EM, 1977, P S PLAN CRAT MECH F, P1; Sochan A, 2015, SEDIMENT GEOL, V327, P14, DOI 10.1016/j.sedgeo.2015.07.007; STOFFLER D, 1975, J GEOPHYS RES, V80, P4062, DOI 10.1029/JB080i029p04062; Toh W, 2019, INT J IMPACT ENG, V130, P239, DOI 10.1016/j.ijimpeng.2019.04.016; Tsujido S, 2015, ICARUS, V262, P79, DOI 10.1016/j.icarus.2015.08.035; Walsh JM, 1965, P 7 HYP IMP S FLOR M, V6th; Watanabe K., 2011, AOARD094011, P8; Wilbeck JS., 1985, SHORT COURSE PENETRA; Wlodarski W, 2017, GEOMORPHOLOGY, V295, P586, DOI 10.1016/j.geomorph.2017.08.025; Wunnemann K, 2016, METEORIT PLANET SCI, V51, P1762, DOI 10.1111/maps.12710; Yamamoto S, 2006, ICARUS, V183, P215, DOI 10.1016/j.icarus.2006.02.002; Zhao RC, 2015, P NATL ACAD SCI USA, V112, P342, DOI 10.1073/pnas.1419271112	63	0	0	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265546	10.1371/journal.pone.0265546	http://dx.doi.org/10.1371/journal.pone.0265546			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333882	Green Published, gold			2022-12-26	WOS:000784335700029
J	Murugiah, K; Chen, L; Dreyer, RP; Bouras, G; Safdar, B; Khera, R; Lu, Y; Spatz, ES; Ng, VG; Gupta, A; Bueno, H; Tweet, MS; Spertus, JA; Hayes, SN; Lansky, A; Krumholz, HM				Murugiah, Karthik; Chen, Lian; Dreyer, Rachel P.; Bouras, Georgios; Safdar, Basmah; Khera, Rohan; Lu, Yuan; Spatz, Erica S.; Ng, Vivian G.; Gupta, Aakriti; Bueno, Hector; Tweet, Marysia S.; Spertus, John A.; Hayes, Sharonne N.; Lansky, Alexandra; Krumholz, Harlan M.			Health status outcomes after spontaneous coronary artery dissection and comparison with other acute myocardial infarction: The VIRGO experience	PLOS ONE			English	Article							QUALITY-OF-LIFE; DISPARITIES; RECOVERY	BackgroundData on health status outcomes after spontaneous coronary artery dissection (SCAD) are limited. Methods and findingsUsing the Variation in Recovery: Role of Gender on Outcomes of Young AMI Patients (VIRGO) study we compared patients with SCAD and other acute myocardial infarction (AMI) at presentation (baseline), 1-month, and-12 months using standardized health status instruments. Among 3572 AMI patients <= 55 years, 67 had SCAD. SCAD patients were younger (median age (IQR) 45 (40.5-51) years vs. 48 (44-52) in other AMI, p = 0.003), more often female (92.5% vs. 66.6%), have college education (73.1% vs. 51.7%) and household income >$100,000 (43.3% vs. 17.7% (All p<0.001). SCAD patients at baseline had higher mean +/- SD Short Form-12 [SF-12] physical component scores [PCS] (48.7 +/- 10.2 vs. 43.8 +/- 12.1, p<0.001) and mental component scores [MCS] (49.6 +/- 12.4 vs. 45.4 +/- 12.5, p = 0.008), and at 12-months [PCS (50.1 +/- 9.0 vs. 44.3 +/- 12.3, p<0.001) and MCS (53 +/- 10.1 vs 50.2 +/- 11.0, p = 0.045)]. The Euro-Quality of Life Scale [EQ-5D] VAS and EQ-5D index scores were similar at baseline, but higher at 12-months for SCAD (EQ-5D VAS: 82.2 +/- 10.2 vs. 72.3 +/- 21.0, p<0.001; EQ-5D index scores; 90.2 +/- 15.3 vs. 83.7 +/- 19.8, p = 0.012). SCAD patients had better baseline Seattle Angina Questionnaire [SAQ] physical limitation (88.8 +/- 20.1 vs. 81.2 +/- 25.4, p = 0.017). At 12-months SCAD patients had better physical limitation (98.0 +/- 8.5 vs. 91.4 +/- 18.8, p = 0.007), angina frequency (96.4 +/- 8.8 vs. 91.3 +/- 16.8, p = 0.018) and quality of life scores (80.7 +/- 14.7 vs 72.2 +/- 23.2, p = 0.005). Magnitude of change in health status from baseline to 12-months was not statistically different between the groups. After adjustment for time and comorbidities there remained no difference in most health status outcomes. ConclusionsSCAD patients fare marginally better than other AMI patients on most health status instruments and have similar 12-month health status recovery. Better pre-event health status suggests a need to modify exercise prescriptions and cardiac rehabilitation protocols to better assist this physically active population to recover.	[Murugiah, Karthik; Khera, Rohan; Lu, Yuan; Spatz, Erica S.; Lansky, Alexandra; Krumholz, Harlan M.] Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA; [Murugiah, Karthik; Chen, Lian; Dreyer, Rachel P.; Khera, Rohan; Lu, Yuan; Spatz, Erica S.; Krumholz, Harlan M.] Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT USA; [Dreyer, Rachel P.; Safdar, Basmah] Yale Sch Med, Dept Emergency Med, New Haven, CT USA; [Bouras, Georgios] 417 NIMTS Vet Fund Hosp Athens, Athens, Greece; [Ng, Vivian G.] Columbia Univ, Div Cardiovasc Med, Irving Med Ctr, New York, NY USA; [Gupta, Aakriti] Smidt Heart Inst, Cedars Sinai Med Ctr, Los Angeles, CA USA; [Bueno, Hector] Ctr Nacl Invest Cardiovasc CNIC, Madrid, Spain; [Bueno, Hector] Hosp Univ 12 Octubre, Cardiol Dept, Madrid, Spain; [Bueno, Hector] Hosp Univ 12 Octubre, Inst Invest i 12, Madrid, Spain; [Bueno, Hector] Univ Complutense Madrid, Fac Med, Madrid, Spain; [Tweet, Marysia S.; Hayes, Sharonne N.] Mayo Clin, Dept Cardiovasc Dis, Coll Med & Sci, Rochester, MN USA; [Spertus, John A.] St Lukes Mid Amer Heart Inst, Kansas City, MO USA; [Spertus, John A.] Univ Missouri Kansas City, Kansas City, MO USA; [Krumholz, Harlan M.] Yale Sch Publ Hlth, New Haven, CT USA	Yale University; Yale University; Yale University; Columbia University; NewYork-Presbyterian Hospital; Cedars Sinai Medical Center; Centro Nacional de Investigaciones Cardiovasculares (CNIC); Hospital Universitario 12 de Octubre; Hospital Universitario 12 de Octubre; Complutense University of Madrid; Mayo Clinic; Saint Luke's Mid America Heart Institute; University of Missouri System; University of Missouri Kansas City; Yale University	Krumholz, HM (corresponding author), Yale Sch Med, Sect Cardiovasc Med, Dept Internal Med, New Haven, CT USA.; Krumholz, HM (corresponding author), Yale New Haven Med Ctr, Ctr Outcomes Res & Evaluat, New Haven, CT USA.; Krumholz, HM (corresponding author), Yale Sch Publ Hlth, New Haven, CT USA.	harlan.krumholz@yale.edu	Bueno, Hector/I-3910-2015; Khera, Rohan/AAQ-6838-2021; BUENO, HECTOR/GQP-1780-2022	Bueno, Hector/0000-0003-0277-7596; Khera, Rohan/0000-0001-9467-6199; Chen, Lian/0000-0001-8486-8074; Murugiah, Karthik/0000-0001-7932-382X	National Heart, Lung, and Blood Institute [5R01HL081153, PI 081614]; Fondo de Investigaciones Sanitarias del Instituto Carlos III, Ministry of Science and Technology; Centro Nacional de Investigaciones Cardiovasculares (CNIC)	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Fondo de Investigaciones Sanitarias del Instituto Carlos III, Ministry of Science and Technology(Instituto de Salud Carlos III); Centro Nacional de Investigaciones Cardiovasculares (CNIC)	The VIRGO study was supported by a 4-year National Heart, Lung, and Blood Institute grant [number 5R01HL081153). IMJOVEN was supported in Spain by grant PI 081614 from the Fondo de Investigaciones Sanitarias del Instituto Carlos III, Ministry of Science and Technology, and additional funds from the Centro Nacional de Investigaciones Cardiovasculares (CNIC).	Braveman PA, 2010, AM J PUBLIC HEALTH, V100, pS186, DOI 10.2105/AJPH.2009.166082; Chan PS, 2014, CIRC-CARDIOVASC QUAL, V7, P640, DOI 10.1161/CIRCOUTCOMES.114.000967; Dodson JA, 2012, AM HEART J, V163, P790, DOI 10.1016/j.ahj.2012.02.024; Edwards KS, 2019, J CARDIOPULM REHABIL, V39, pE20, DOI 10.1097/HCR.0000000000000460; Hayes SN, 2020, J AM COLL CARDIOL, V76, P961, DOI 10.1016/j.jacc.2020.05.084; Hayes SN, 2018, CIRCULATION, V137, pE523, DOI 10.1161/CIR.0000000000000564; Johnson AK, 2020, J AM HEART ASSOC, V9, DOI 10.1161/JAHA.119.014372; Kosinski M, 1995, SF 12 SCORE SF 12 PH; Krittanawong C, 2016, AM J CARDIOL, V117, P1604, DOI 10.1016/j.amjcard.2016.02.034; Liang JJ, 2014, J CARDIOPULM REHABIL, V34, P138, DOI 10.1097/HCR.0000000000000030; Lichtman JH, 2010, CIRC-CARDIOVASC QUAL, V3, P684, DOI 10.1161/CIRCOUTCOMES.109.928713; Luo N, 2010, MED CARE, V48, P365, DOI 10.1097/MLR.0b013e3181c162a2; Maruish M, 2011, USERS MANUAL SF36V2, V3rd; Nakashima T, 2016, INT J CARDIOL, V207, P341, DOI 10.1016/j.ijcard.2016.01.188; Patterson MA., 2016, J CLIN EXERC PHYSIOL, V5, P6, DOI [10.31189/2165-6193-5.1.6, DOI 10.31189/2165-6193-5.1.6]; Reynolds HR, 2021, CIRCULATION, V143, P624, DOI 10.1161/CIRCULATIONAHA.120.052008; Safdar B, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.009174; Saw J, 2019, EUR HEART J, V40, P1188, DOI 10.1093/eurheartj/ehz007; Saw J, 2017, J AM COLL CARDIOL, V70, P1148, DOI 10.1016/j.jacc.2017.06.053; Saw J, 2014, CAN J CARDIOL, V30, P814, DOI 10.1016/j.cjca.2014.01.011; Saw J, 2014, CATHETER CARDIO INTE, V84, P1115, DOI 10.1002/ccd.25293; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; SPERTUS JA, 1994, AM J CARDIOL, V74, P1240, DOI 10.1016/0002-9149(94)90555-X; SPERTUS JA, 1995, J AM COLL CARDIOL, V25, P333, DOI 10.1016/0735-1097(94)00397-9; Tweet MS, 2014, CIRC-CARDIOVASC INTE, V7, P777, DOI 10.1161/CIRCINTERVENTIONS.114.001659; Tweet MS, 2012, CIRCULATION, V126, P579, DOI 10.1161/CIRCULATIONAHA.112.105718; Ware JE, 1996, MED CARE, V34, P220, DOI 10.1097/00005650-199603000-00003; WILLIAMS A, 1990, HEALTH POLICY, V16, P199; Wyrwich KW, 2005, QUAL LIFE RES, V14, P285, DOI 10.1007/s11136-004-0705-2	29	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265624	10.1371/journal.pone.0265624	http://dx.doi.org/10.1371/journal.pone.0265624			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P5DL	35320296	gold, Green Published			2022-12-26	WOS:000784240600054
J	Walker, AR; Trollor, JN; Florio, T; Srasuebkul, P				Walker, Adrian Raymond; Trollor, Julian Norman; Florio, Tony; Srasuebkul, Preeyaporn			Predictors and outcomes of recognition of intellectual disability for adults during hospital admissions: A retrospective data linkage study in NSW, Australia	PLOS ONE			English	Article							PEOPLE	Adults with intellectual disability have high health care needs. Despite frequent contact with health services, they often receive inadequate health care. One method to improve health care delivery is reasonable adjustments, that is, the adaptation of health care delivery such that barriers to participation are removed for the person with disability. A starting point for the provision of reasonable adjustments is recognition of intellectual disability during the health care contact. To determine rates and predictors of the recognition of intellectual disability during hospital admissions, and its impact on admission metrics, we examined a population of adults with intellectual disability identified from disability services datasets from New South Wales, Australia between 2005 and 2014. Recognition of intellectual disability was determined by the recording of an International Classification of Diseases 10(th) revision (ICD-10) diagnostic code for intellectual disability during a given hospital admission. We examined how recognition of intellectual disability related to length of hospital episodes. We found an overall low rate of recognition of intellectual disability (23.79%) across all hospital episodes, with the proportion of hospital episodes recognising intellectual disability decreasing from 2005-2015. Admissions for adults with complex health profiles (e.g., those with many comorbidities, those with Autism Spectrum Disorder, and those admitted for urgent treatment) were more likely to recognise intellectual disability, but admissions for adults with complexity in other domains (i.e., for those in custody, or those with drug and alcohol disorders) were less likely to recognise intellectual disability. Recognition of intellectual disability was associated with longer episodes of care, possibly indicating the greater provision of reasonable adjustments. To improve the recognition of intellectual disability for adults during health service contacts, we advocate for the implementation of targeted initiatives (such as a nationwide disability flag to be included in health service records) to improve the provision of reasonable adjustments.	[Walker, Adrian Raymond; Trollor, Julian Norman; Srasuebkul, Preeyaporn] Univ New South Wales Sydney, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia; [Florio, Tony] Australian Catholic Univ, Brisbane, NSW, Australia	University of New South Wales Sydney; Australian Catholic University	Trollor, JN (corresponding author), Univ New South Wales Sydney, Dept Dev Disabil Neuropsychiat, Sydney, NSW, Australia.	j.trollor@unsw.edu.au		Srasuebkul, Preeyaporn/0000-0002-6252-1368; Walker, Adrian/0000-0003-0801-2316	National Health and Medical Research Council Australia [APP1056128]; National Health and Medical Research Council Australia Project [APP1123033]; Chair of Intellectual Disability Mental Health by the Mental Health Branch of the NSW Ministry of Health	National Health and Medical Research Council Australia(National Health and Medical Research Council (NHMRC) of Australia); National Health and Medical Research Council Australia Project(National Health and Medical Research Council (NHMRC) of Australia); Chair of Intellectual Disability Mental Health by the Mental Health Branch of the NSW Ministry of Health	This study was funded by a National Health and Medical Research Council Australia (https://www.nhmrc.gov.au/) funded Partnerships for Better Health grant (APP1056128; Title: Improving the Mental Health Outcomes of People with an Intellectual Disability; Awarded to JT) and a National Health and Medical Research Council Australia Project grant (APP1123033; Title: Understanding health service system needs for people with intellectual disability; Awarded to JT). JT is funded as the Chair of Intellectual Disability Mental Health by the Mental Health Branch of the NSW Ministry of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Australian Bureau of Statistics, 2013, 2033 0 55 001 CENS P; Australian Bureau of Statistics, 2013, 1270 0 55 005 AUSTR; Australian Government, 2020, NAT DIS DAT; Australian Institute of Health and Welfare, 2021, METEOR EP ADM PAT CA; Australian Institute of Health and Welfare, HOSP INF DOWNL GLOSS; Australian Institute of Health and Welfare, 2021, METEOR SEP; Australian Institute of Health and Welfare, 2021, ALC TOB OTH DRUGS AU; Beck A, 2016, EUR J EMERG MED, V23, P351, DOI 10.1097/MEJ.0000000000000349; Bourke J, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019113; Brown M, 2012, J INTELL DISABIL RES, V56, P1161, DOI 10.1111/j.1365-2788.2011.01511.x; Brugha TS, 2016, BRIT J PSYCHIAT, V209, P498, DOI 10.1192/bjp.bp.115.174649; Carey IM, 2016, BRIT J GEN PRACT, V66, pE264, DOI 10.3399/bjgp16X684301; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Heslop Pauline, 2019, Nurs Stand, V34, P29, DOI 10.7748/ns.2019.e11172; Hosking FJ, 2017, ANN FAM MED, V15, P462, DOI 10.1370/afm.2104; Kenten C, 2019, J APPL RES INTELLECT, V32, P1176, DOI 10.1111/jar.12608; Li X, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-018613; Michael J, 2008, TIZARD LEARN DISABIL, V13, P28, DOI 10.1108/13595474200800036; Moloney M, 2021, BMJ OPEN, V11, DOI 10.1136/bmjopen-2020-039647; National Health Service Digital, REAS ADJ FLAG; New South Wales Health, 2017, RESP NEEDS PEOPL DIS; New South Wales Health, 2013, NSW HLTH AG DIS HOM; New South Wales Health, INTELLECTUAL DISABIL; New South Wales Health, 2018, LOC HLTH DISTR SPEC; Phillips L., 2019, NURS TIMES, V115, P38; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Reppermund S, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-031624; Royal Commission into Violence, 2020, ROYAL COMMISSION VIO; Salomon C., 2020, FINDINGS; Srasuebkul P, 2021, MED J AUSTRALIA, V215, P325, DOI 10.5694/mja2.51166; StataCorp, 2021, STATA STAT SOFTWARE; Trofimovs J, 2021, J INTELL DISABIL RES, V65, P589, DOI 10.1111/jir.12836; Trollor J, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013489; Tuffrey-Wijne I, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004606; Weise JC, 2021, MED J AUSTRALIA, V215, P31, DOI 10.5694/mja2.51088; World Health Organization, 1992, INT STAT CLASS DIS R	36	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266051	10.1371/journal.pone.0266051	http://dx.doi.org/10.1371/journal.pone.0266051			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P6KD	35333913	Green Published, gold			2022-12-26	WOS:000784335700027
J	Li, HP; Barbour, JA; Zhu, XQ; Wong, JWH				Li, Huaping; Barbour, Jayne A.; Zhu, Xiaoqiang; Wong, Jason W. H.			Gene expression is a poor predictor of steady-state metabolite abundance in cancer cells	FASEB JOURNAL			English	Article						cell line; gene expression; machine learning; metabolite; pan-cancer	HETEROGENEITY; PROTEOMICS	Metabolic reprogramming is a hallmark of cancer characterized by global changes in metabolite levels. However, compared with the study of gene expression, profiling of metabolites in cancer samples remains relatively understudied. We obtained metabolomic profiling and gene expression data from 454 human solid cancer cell lines across 24 cancer types from the Cancer Cell Line Encyclopedia (CCLE) database, to evaluate the feasibility of inferring metabolite levels from gene expression data. For each metabolite, we trained multivariable LASSO regression models to identify gene sets that are most predictive of the level of each metabolite profiled. Even when accounting for cell culture conditions or cell lineage in the model, few metabolites could be accurately predicted. In some cases, the inclusion of the upstream and downstream metabolites improved prediction accuracy, suggesting that gene expression is a poor predictor of steady-state metabolite levels. Our analysis uncovered a single robust relationship between the expression of nicotinamide N-methyltransferase (NNMT) and 1-methylnicotinamide (MNA), however, this relationship could only be validated in cancer samples with high purity, as NNMT is not expressed in immune cells. Together, we have trained models that use gene expression profiles to predict the level of individual metabolites. Our analysis suggests that inferring metabolite levels based on the expression of genes is generally challenging in cancer.	[Li, Huaping; Barbour, Jayne A.; Zhu, Xiaoqiang; Wong, Jason W. H.] Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Hong Kong, Peoples R China	University of Hong Kong	Wong, JWH (corresponding author), Univ Hong Kong, LKS Fac Med, Sch Biomed Sci, Pokfulam, L1-51 Lab Block,21 Sassoon Rd, Hong Kong, Peoples R China.	jwhwong@hku.hk			Research Grants Council [17100920]	Research Grants Council(Hong Kong Research Grants Council)	The project was supported by the Research Grants Council, HK (17100920) to JWHW	Andrejeva G, 2017, CELL METAB, V26, P49, DOI 10.1016/j.cmet.2017.06.004; [Anonymous], 2020, CELL, DOI DOI 10.1016/j.cell.2020.05.032; Ayuso JM, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abc2331; Chai T, 2014, GEOSCI MODEL DEV, V7, P1247, DOI 10.5194/gmd-7-1247-2014; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Djoumbou-Feunang Y, 2019, J CHEMINFORMATICS, V11, DOI 10.1186/s13321-018-0324-5; Eckert MA, 2019, NATURE, V569, P723, DOI 10.1038/s41586-019-1173-8; Edwards NJ, 2015, J PROTEOME RES, V14, P2707, DOI 10.1021/pr501254j; Faubert B, 2020, SCIENCE, V368, P152, DOI 10.1126/science.aaw5473; FELIG P, 1973, METABOLISM, V22, P179, DOI 10.1016/0026-0495(73)90269-2; Gui DY, 2016, CELL METAB, V24, P716, DOI 10.1016/j.cmet.2016.09.006; Hanzelmann S, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-7; Hakimi AA, 2016, CANCER CELL, V29, P104, DOI 10.1016/j.ccell.2015.12.004; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hoadley KA, 2014, CELL, V158, P929, DOI 10.1016/j.cell.2014.06.049; Hu J, 2013, NAT BIOTECHNOL, V31, P522, DOI 10.1038/nbt.2530; Kaushik AK, 2018, BBA-REV CANCER, V1870, P2, DOI 10.1016/j.bbcan.2018.04.009; Kim J, 2019, CELL METAB, V30, P434, DOI 10.1016/j.cmet.2019.08.013; Leeuwenburgh VC, 2021, CANCER METAB, V9, DOI 10.1186/s40170-021-00272-7; Leone RD, 2020, NAT REV CANCER, V20, P516, DOI 10.1038/s41568-020-0273-y; Li HX, 2019, NAT MED, V25, P850, DOI 10.1038/s41591-019-0404-8; Li JB, 2015, J HEPATOL, V63, P1378, DOI 10.1016/j.jhep.2015.07.039; Liberti MV, 2016, TRENDS BIOCHEM SCI, V41, P211, DOI 10.1016/j.tibs.2015.12.001; Lv HW, 2021, CELL METAB, V33, P110, DOI 10.1016/j.cmet.2020.10.021; Martin-Martin N, 2018, FRONT CELL DEV BIOL, V5, DOI 10.3389/fcell.2017.00119; Muir A, 2017, ELIFE, V6, DOI 10.7554/eLife.27713; Neinast M, 2019, ANNU REV PHYSIOL, V81, P139, DOI 10.1146/annurev-physiol-020518-114455; Nusinow DP, 2020, CELL, V180, P387, DOI 10.1016/j.cell.2019.12.023; Ortmayr K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09695-9; Patel CH, 2019, NAT REV DRUG DISCOV, V18, P669, DOI 10.1038/s41573-019-0032-5; Peng XX, 2018, CELL REP, V23, P255, DOI 10.1016/j.celrep.2018.03.077; Reed GF, 2002, CLIN DIAGN LAB IMMUN, V9, P1235, DOI 10.1128/CDLI.9.6.1235-1239.2002; Reina-Campos M, 2017, CURR OPIN CELL BIOL, V48, P47, DOI 10.1016/j.ceb.2017.05.006; Sinkala M, 2019, COMMUN BIOL, V2, DOI 10.1038/s42003-019-0666-1; Sternak M, 2010, PHARMACOL REP, V62, P483, DOI 10.1016/S1734-1140(10)70304-2; Sun HY, 2020, CANCER RES, V80, P1143, DOI 10.1158/0008-5472.CAN-19-3392; Sun HY, 2019, GENOM PROTEOM BIOINF, V17, P273, DOI 10.1016/j.gpb.2018.12.006; T'jollyn H, 2011, DRUG METAB DISPOS, V39, P2066, DOI 10.1124/dmd.111.039982; Tang ZF, 2017, NUCLEIC ACIDS RES, V45, pW98, DOI 10.1093/nar/gkx247; Terunuma A, 2014, J CLIN INVEST, V124, P398, DOI 10.1172/JCI71180; Tomczak Katarzyna, 2015, Contemp Oncol (Pozn), V19, pA68, DOI 10.5114/wo.2014.47136; Traverso N, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/972913; Xu K, 2021, SCIENCE, V371, P405, DOI 10.1126/science.abb2683; Yoon MS, 2016, NUTRIENTS, V8, DOI 10.3390/nu8070405; Yoshihara K, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3612; Zhang G, 2013, CLIN CANCER RES, V19, P4983, DOI 10.1158/1078-0432.CCR-13-0209	47	1	1	1	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22296	10.1096/fj.202101921RR	http://dx.doi.org/10.1096/fj.202101921RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E5AZ	35363392				2022-12-26	WOS:000776695600001
J	Chen, BJ; Sterling, KL; Bluestein, MA; Penedo, E; Kuk, AE; Harrell, MB; Perry, CL; Perez, A				Chen, Baojiang; Sterling, Kymberle L.; Bluestein, Meagan A.; Penedo, Elena; Kuk, Arnold E.; Harrell, Melissa B.; Perry, Cheryl L.; Perez, Adriana			Age of initiation of cigarillo use among young adults: Findings from the Population Assessment of Tobacco and Health (PATH) study, 2013-2017	PLOS ONE			English	Article							AFRICAN-AMERICAN; NATIONAL-SURVEY; MARIJUANA USE; DRUG-USE; SMOKERS; CIGARETTES; PRODUCTS; PATTERNS; SALES; YOUTH	Significance Young adults, especially those who identify as racial/ethnic minorities, are legal targets of the tobacco industry. Cigarillo initiation is a risk among these vulnerable groups. Estimating the age of initiation of cigarillo use among young adults may inform the timing of prevention interventions. Methods Weighted interval-censored survival analyses of the Population Assessment of Tobacco and Health (PATH) young adult (ages 18-24 at their first wave of adult participation) annual datasets were conducted (2013-2017). Young adult never cigarillo users (n = 7,101; represents N = 24,023,488) at their first wave of adult participation (2013-2016) were followed-up through 2014-2017 to estimate the age of initiation of ever, past 30-day and fairly regular cigarillo use outcomes. Differences by sex and by race/ethnicity, accounting for previous use of other tobacco products and marijuana and blunt use, were assessed using weighted interval-censored Cox proportional hazards models. Results Among PATH young adults, by age 21, 5.8% initiated ever cigarillo use, 4.1% initiated past 30-day cigarillo use, and 1.4% initiated fairly regular cigarillo use. By age 26, 15% initiated ever cigarillo use, and 10.4% initiated past 30-day cigarillo use. Males had higher risk of initiating ever (AHR: 1.63, 95% CI: 1.37-1.95) and past 30-day cigarillo use (AHR: 1.65, 95% CI: 1.32-2.06) at earlier ages than females. Non-Hispanic Blacks had higher risk of initiating ever (AHR: 2.81, 95% CI: 2.26-3.50), past 30-day (AHR: 4.88, 95% CI: 2.95-5.09) and fairly regular cigarillo use (AHR: 4.62, 95% CI: 2.70-7.93) at earlier ages than non-Hispanic Whites. Hispanics had higher risk of initiating past 30-day cigarillo use at earlier ages than non-Hispanic Whites (AHR: 1.51, 95% CI: 1.12-2.03). Non-Hispanic Other race (i.e., Asian, multiracial, etc.) had lower risk of initiating ever (AHR: 0.43, 95% CI: 0.28-0.65) and past 30-day cigarillo use (AHR: 0.40, 95% CI: 0.26-0.63) at earlier ages than Non-Hispanic Whites. Conclusion Along with those aged 21 and younger, interventions should target young adults over the age of 21, specifically males, non-Hispanic Black and Hispanic young adults, to stall initiation and progression of cigarillo use behaviors.	[Chen, Baojiang; Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Biostat & Data Sci, Austin Campus, Austin, TX 78701 USA; [Chen, Baojiang; Bluestein, Meagan A.; Penedo, Elena; Kuk, Arnold E.; Harrell, Melissa B.; Perry, Cheryl L.; Perez, Adriana] Univ Texas Hlth Sci Ctr Houston UTHlth, Michael & Susan Dell Ctr Hlth Living, Sch Publ Hlth, Austin Campus, Austin, TX 78701 USA; [Sterling, Kymberle L.; Perry, Cheryl L.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Hlth Promot & Behav Sci, Dallas Campus, Dallas, TX USA; [Harrell, Melissa B.] Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Epidemiol Human Genet & Environm Sci, Austin Campus, Austin, TX USA		Perez, A (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Sch Publ Hlth, Dept Biostat & Data Sci, Austin Campus, Austin, TX 78701 USA.; Perez, A (corresponding author), Univ Texas Hlth Sci Ctr Houston UTHlth, Michael & Susan Dell Ctr Hlth Living, Sch Publ Hlth, Austin Campus, Austin, TX 78701 USA.	adriana.perez@uth.tmc.edu			National Cancer Institute (NCI) [R01CA2342051]; Food and Drug Administration (FDA) Center for Tobacco Products (CTP)	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Food and Drug Administration (FDA) Center for Tobacco Products (CTP)(United States Department of Health & Human Services)	Research reported in this publication was supported by grant number [R01CA2342051] from the National Cancer Institute (NCI) and the Food and Drug Administration (FDA) Center for Tobacco Products (CTP) to Dr. Adriana Perez. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health (NIH), NCI or FDA.	Allem JP, 2017, J MED INTERNET RES, V19, DOI 10.2196/jmir.7634; [Anonymous], Tobacco 21; [Anonymous], 2020, HEAT TOB PROD GLOB R; Antognoli E, 2018, SUBST USE MISUSE, V53, P654, DOI 10.1080/10826084.2017.1355388; Barrington-Trimis JL, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.19022; Cantrell J, 2013, AM J PUBLIC HEALTH, V103, P1902, DOI 10.2105/AJPH.2013.301362; Cohn A, 2015, NICOTINE TOB RES, V17, P1473, DOI 10.1093/ntr/ntv022; Cohn A, 2015, ADDICT BEHAV, V48, P79, DOI 10.1016/j.addbeh.2015.02.005; FINKELSTEIN DM, 1986, BIOMETRICS, V42, P845, DOI 10.2307/2530698; Gammon DG, 2016, TOB CONTROL, V25, P538, DOI 10.1136/tobaccocontrol-2015-052343; Giovenco DP, 2018, DRUG ALCOHOL DEPEN, V185, P347, DOI 10.1016/j.drugalcdep.2017.12.011; Giovenco DP, 2017, NICOTINE TOB RES, V19, P1359, DOI 10.1093/ntr/ntw182; Golub Andrew, 2005, J Ethn Subst Abuse, V4, P1; Gonzalez SJK, 2017, J ETHN SUBST ABUSE, V16, P66, DOI 10.1080/15332640.2015.1081117; Goodall RL, 2004, STAT MED, V23, P1131, DOI 10.1002/sim.1682; Hair EC, 2021, DRUG ALCOHOL DEPEN, V226, DOI 10.1016/j.drugalcdep.2021.108821; Judkins DR., 1990, J OFF STAT, V6, P223, DOI DOI 10.1016/J.AMJMED.2017.09.025.(ADVANCE; Kasza KA, 2020, TOB CONTROL, V29, pS191, DOI 10.1136/tobaccocontrol-2020-055671; Klein JP., 2003, SURVIVAL ANAL TECHNI; Lienemann BA, 2019, NICOTINE TOB RES, V21, P300, DOI 10.1093/ntr/nty220; Mantey DS, 2021, PSYCHOL ADDICT BEHAV, V35, P514, DOI 10.1037/adb0000702; Montgomery L, 2018, J SUBST USE, V23, P436, DOI 10.1080/14659891.2018.1444108; Montgomery L, 2017, SUBST USE MISUSE, V52, P1449, DOI 10.1080/10826084.2017.1284238; Moran MB, 2019, ADDICT BEHAV, V96, P100, DOI 10.1016/j.addbeh.2019.04.024; NAHDAP, 2021, TOB CO QUOT MARK KID; National Cancer Institute, 2010, CIG SMOK CANC; National Cancer Institute, 1998, SMOKING TOBACCO CONT, V9; O'Brien EK, 2019, TOB CONTROL, V28, P532, DOI 10.1136/tobaccocontrol-2018-054549; Public Health Law Center, 2021, US; Richardson A, 2012, NICOTINE TOB RES, V14, P927, DOI 10.1093/ntr/ntr306; Ross JC, 2020, DRUG ALCOHOL DEPEN, V211, DOI 10.1016/j.drugalcdep.2020.107964; Rostron BL, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3510-2; Schauer GL, 2016, NICOTINE TOB RES, V18, P281, DOI 10.1093/ntr/ntv093; Shen MJ, 2017, AM J HEALTH BEHAV, V41, P194, DOI [10.5993/ajhb.41.2.11, 10.5993/AJHB.41.2.11]; Sinclair CF, 2012, AM J PREV MED, V42, P61, DOI 10.1016/j.amepre.2011.08.023; Stanford Center for Population Health Sciences, 2021, OPT SES V4 0 RED DAT, DOI [10.57761/bykd-vz30, DOI 10.57761/BYKD-VZ30]; Stanton CA, 2020, TOB CONTROL, V29, pS178, DOI 10.1136/tobaccocontrol-2019-055573; Sterling KL, 2016, NICOTINE TOB RES, V18, P827, DOI 10.1093/ntr/ntv151; Sterling KL, 2016, NICOTINE TOB RES, V18, P2234, DOI 10.1093/ntr/ntw170; Timberlake DS, 2013, DRUG ALCOHOL DEPEN, V130, P129, DOI 10.1016/j.drugalcdep.2012.10.022; U.S. Department of Health and Human Services, 2016, E CIG US YOUTH YOUNG; University Of London IOE, 2020, BRIT COH STUD RESP D; US Department of Health and Human Services, 2012, PREV TOB UYOUTH YO	43	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264168	10.1371/journal.pone.0264168	http://dx.doi.org/10.1371/journal.pone.0264168			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358201	Green Published, gold			2022-12-26	WOS:000799828800016
J	Hartmann, W; Brunn, ML; Stetter, N; Gabriel, G; Breloer, M				Hartmann, Wiebke; Brunn, Marie-Luise; Stetter, Nadine; Gabriel, Guelsah; Breloer, Minka			Pre-existing helminth infection impairs the efficacy of adjuvanted influenza vaccination in mice	PLOS ONE			English	Article							2009 PANDEMIC H1N1; HUMORAL RESPONSES; ADENYLATE-CYCLASE; IMMUNE-RESPONSE; IMMUNIZATION; SUPPRESS; VACCINES; VIRUSES; MALARIA; INTERFERENCE	The world health organization estimates that more than a quarter of the human population is infected with parasitic worms that are called helminths. Many helminths suppress the immune system of their hosts to prolong their survival. This helminth-induced immunosuppression "spills over" to unrelated antigens and can suppress the immune response to vaccination against other pathogens. Indeed, several human studies have reported a negative correlation between helminth infections and responses to vaccinations. Using mice that are infected with the parasitic nematode Litomosoides sigmodontis as a model for chronic human filarial infections, we reported previously that concurrent helminth infection impaired the vaccination-induced protection against the human pathogenic 2009 pandemic H1N1 influenza A virus (2009 pH1N1). Vaccinated, helminth-infected mice produced less neutralizing, influenza-specific antibodies than vaccinated naive control mice. Consequently helminth-infected and vaccinated mice were not protected against a challenge infection with influenza virus but displayed high virus burden in the lung and a transient weight loss. In the current study we tried to improve the vaccination efficacy using vaccines that are licensed for humans. We either introduced a prime-boost vaccination regimen using the non-adjuvanted anti-influenza vaccine Begripal or employed the adjuvanted influenza vaccine Fluad. Although both strategies elevated the production of influenza-specific antibodies and protected mice from the transient weight loss that is caused by an influenza challenge infection, sterile immunity was not achieved. Helminth-infected vaccinated mice still had high virus burden in the lung while non-helminth-infected vaccinated mice rapidly cleared the virus. In summary we demonstrate that basic improvements of influenza vaccination regimen are not sufficient to confer sterile immunity on the background of helminth-induced immunosuppression, despite amelioration of pathology i.e. weight loss. Our findings highlight the risk of failed vaccinations in helminth-endemic areas, especially in light of the ongoing vaccination campaign to control the COVID-19 pandemic.	[Hartmann, Wiebke; Brunn, Marie-Luise; Stetter, Nadine; Breloer, Minka] Bernhard Nocht Inst Trop Med, Sect Mol Biol & Immunol, Helminth Immunol Grp, Hamburg, Germany; [Gabriel, Guelsah] Leibniz Inst Expt Virol, Res Dept Viral Zoonoses One Hlth, Hamburg, Germany; [Gabriel, Guelsah] Univ Vet Med, Inst Virol, Hannover, Germany; [Breloer, Minka] Univ Hamburg, Dept Biol, Hamburg, Germany	Bernhard Nocht Institut fur Tropenmedizin; Heinrich Pette Institute; University of Veterinary Medicine Hannover, Foundation; University of Hamburg	Breloer, M (corresponding author), Bernhard Nocht Inst Trop Med, Sect Mol Biol & Immunol, Helminth Immunol Grp, Hamburg, Germany.; Breloer, M (corresponding author), Univ Hamburg, Dept Biol, Hamburg, Germany.	Breloer@bnitm.de	breloer, minka/F-3999-2018	breloer, minka/0000-0001-6199-4908; Brunn, Marie-Luise/0000-0001-7497-3612	German Research Association DFG [3754/2-1/2-2]	German Research Association DFG(German Research Foundation (DFG))	MB was supported by the German Research Association DFG (https://www.dfg.de/) project 3754/2-1/2-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdoli A, 2020, ACS PHARMACOL TRANSL, V3, P1039, DOI 10.1021/acsptsci.0c00141; Allen JE, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000217; Apiwattanakul N, 2014, VACCINE, V32, P5405, DOI 10.1016/j.vaccine.2014.07.107; Awate S, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00114; Borkow G, 2008, TRENDS PARASITOL, V24, P243, DOI 10.1016/j.pt.2008.02.009; Calabro S, 2011, VACCINE, V29, P1812, DOI 10.1016/j.vaccine.2010.12.090; Caldera F, 2021, VACCINE, V39, pA15, DOI 10.1016/j.vaccine.2020.11.037; Coelho CH, 2019, VACCINE, V37, P1038, DOI 10.1016/j.vaccine.2019.01.027; Cooper PJ, 2001, INFECT IMMUN, V69, P1574, DOI 10.1128/IAI.69.3.1574-1580.2001; Da'Dara AA, 2006, VACCINE, V24, P5211, DOI 10.1016/j.vaccine.2006.03.078; Dormitzer PR, 2011, IMMUNOL REV, V239, P167, DOI 10.1111/j.1600-065X.2010.00974.x; Dupuis M, 1998, CELL IMMUNOL, V186, P18, DOI 10.1006/cimm.1998.1283; Elias D, 2006, PARASITE IMMUNOL, V28, P507, DOI 10.1111/j.1365-3024.2006.00854.x; Esen M, 2012, VACCINE, V30, P7621, DOI 10.1016/j.vaccine.2012.10.026; Finlay CM, 2020, PARASITE IMMUNOL, V42, DOI 10.1111/pim.12708; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Graham AL, 2005, MICROBES INFECT, V7, P612, DOI 10.1016/j.micinf.2004.12.019; Haben I, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003170; Hartmann W, 2019, CELL REP, V29, P2243, DOI 10.1016/j.celrep.2019.10.051; Hartmann W, 2015, EUR J IMMUNOL, V45, P2568, DOI 10.1002/eji.201545503; Hartmann W, 2012, EXP PARASITOL, V132, P69, DOI 10.1016/j.exppara.2011.06.001; Hartmann W, 2011, J IMMUNOL, V187, P4088, DOI 10.4049/jimmunol.1004136; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; King CH, 2019, ADV PARASIT, V103, P11, DOI 10.1016/bs.apar.2018.08.001; Kolbaum J, 2012, EUR J IMMUNOL, V42, P890, DOI 10.1002/eji.201141955; Maines TR, 2009, SCIENCE, V325, P484, DOI 10.1126/science.1177238; Maizels RM, 2016, CLIN MICROBIOL INFEC, V22, P481, DOI 10.1016/j.cmi.2016.04.024; Maizels RM, 2020, ALLERGY, V75, P524, DOI 10.1111/all.13944; McSorley HJ, 2012, CLIN MICROBIOL REV, V25, P585, DOI 10.1128/CMR.05040-11; Mosca F, 2008, P NATL ACAD SCI USA, V105, P10501, DOI 10.1073/pnas.0804699105; Nakaya HI, 2016, P NATL ACAD SCI USA, V113, P1853, DOI 10.1073/pnas.1519690113; Noland GS, 2010, VACCINE, V28, P2917, DOI 10.1016/j.vaccine.2010.02.055; Otte A, 2011, VIRULENCE, V2, P563, DOI 10.4161/viru.2.6.18148; Otte A, 2011, AM J PATHOL, V179, P230, DOI 10.1016/j.ajpath.2011.03.041; Ritzwoller DP, 2005, PEDIATRICS, V116, P153, DOI 10.1542/peds.2005-0049; Shollenberger LM, 2013, VACCINE, V31, P2050, DOI 10.1016/j.vaccine.2013.02.037; Stetter N, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.784141; Su Z, 2006, INFECT IMMUN, V74, P2138, DOI 10.1128/IAI.74.4.2138-2144.2006; Tartz S, 2006, INFECT IMMUN, V74, P2277, DOI 10.1128/IAI.74.4.2277-2285.2006; Tartz S, 2008, VACCINE, V26, P5935, DOI 10.1016/j.vaccine.2008.08.057; Tregoning JS, 2018, HUM VACC IMMUNOTHER, V14, P550, DOI 10.1080/21645515.2017.1415684; Urban JF, 2007, VET PARASITOL, V148, P14, DOI 10.1016/j.vetpar.2007.05.006; van Riet E, 2008, VACCINE, V26, P3690, DOI 10.1016/j.vaccine.2008.04.067; van Riet E, 2007, J INFECT DIS, V196, P1671, DOI 10.1086/522010; Wait LF, 2020, VACCINE, V38, P5582, DOI 10.1016/j.vaccine.2020.06.064; Wolday D, 2021, FRONT IMMUNOL, V12, DOI 10.3389/fimmu.2021.693269	46	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266456	10.1371/journal.pone.0266456	http://dx.doi.org/10.1371/journal.pone.0266456			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358281	gold, Green Published			2022-12-26	WOS:000799828800103
J	Kawabe, Y; Kamihira, M				Kawabe, Yoshinori; Kamihira, Masamichi			Novel cell lines derived from Chinese hamster kidney tissue	PLOS ONE			English	Article							IMMORTALIZATION; PHENOTYPE; KARYOTYPE	Immortalized kidney cell lines are widely used in basic and applied research such as cell permeability tests and drug screening. Although many cell lines have been established from kidney tissues, the immortalization process has not been clarified in these cell lines. In this study, we analyzed the phenotypic changes that occurred during the immortalization of kidney cells derived from Chinese hamster tissue in terms of karyotype and gene expression profiles. In the newly established cell line, designated as CHK-Q, gene expression profiles at each stage of the immortalization process and during the adaptation to serum-free conditions were analyzed by DNA microarray. Renal stem cell markers CD24 and CD133 were expressed in CHK-Q cells, suggesting that CHK-Q cells were transformed from renal stem cells. Kyoto encyclopedia of genes and genomes (KEGG) pathway enrichment analysis to identify the pathways of upregulated and downregulated genes revealed that the immortalization of CHK-Q cells was associated with increased fluctuations in the expression of specific proto-oncogenes. Karyotype analysis of spontaneously immortalized CHK-Q cells indicated that CHK-Q chromosomes had a typical modal number of 23 but possessed slight chromosomal abnormalities. In this study, we investigated the mechanism of cell environmental adaptation by analyzing gene expression behavior during the immortalization process and serum-free adaptation. CHK-Q cells are applicable to the fields of biotechnology and biomedical science by utilizing their characteristics as kidney-derived cells.	[Kawabe, Yoshinori; Kamihira, Masamichi] Kyushu Univ, Fac Engn, Dept Chem Engn, Fukuoka, Japan; [Kawabe, Yoshinori; Kamihira, Masamichi] Mfg Technol Assoc Biol, Kobe, Hyogo, Japan	Kyushu University	Kamihira, M (corresponding author), Kyushu Univ, Fac Engn, Dept Chem Engn, Fukuoka, Japan.; Kamihira, M (corresponding author), Mfg Technol Assoc Biol, Kobe, Hyogo, Japan.	kamihira@chem-eng.kyushu-u.ac.jp		Kamihira, Masamichi/0000-0003-2570-5712	Ministry of Economy, Trade and Industry, Japan (METI); Japan Agency for Medical Research and Development (AMED) [JP17ae0101003]	Ministry of Economy, Trade and Industry, Japan (METI); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED))	This work was supported in part by developing key technologies for discovering and manufacturing pharmaceuticals used for next-generation treatment and diagnoses both from the Ministry of Economy, Trade and Industry, Japan (METI), and from the Japan Agency for Medical Research and Development (AMED) under grand number JP17ae0101003.	Abaandou L, 2021, CELLS-BASEL, V10, DOI 10.3390/cells10071667; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Baycin-Hizal D, 2012, J PROTEOME RES, V11, P5265, DOI 10.1021/pr300476w; Becker J, 2011, J BIOTECHNOL, V156, P227, DOI 10.1016/j.jbiotec.2011.09.014; Bhat AA, 2019, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01942; Binz RL, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47002-0; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brodaczewska KK, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0565-8; Cao YH, 2012, BIOTECHNOL BIOENG, V109, P1357, DOI 10.1002/bit.24347; Challen GA, 2004, J AM SOC NEPHROL, V15, P2344, DOI 10.1097/01.ASN.0000136779.17837.8F; Chen JP, 2014, BIOSCI TRENDS, V8, P1, DOI 10.5582/bst.8.1; Chong SJF, 2020, TRENDS CELL BIOL, V30, P537, DOI 10.1016/j.tcb.2020.03.004; Dankner M, 2018, ONCOGENE, V37, P3183, DOI 10.1038/s41388-018-0171-x; Delpire E, 2021, AM J PHYSIOL-CELL PH, V320, pC324, DOI 10.1152/ajpcell.00566.2020; Durocher Y, 2009, CURR OPIN BIOTECH, V20, P700, DOI 10.1016/j.copbio.2009.10.008; Fridman AL, 2008, ONCOGENE, V27, P5975, DOI 10.1038/onc.2008.213; Fukuda T, 2021, ISCIENCE, V24, DOI 10.1016/j.isci.2020.101929; GAUSH CR, 1966, P SOC EXP BIOL MED, V122, P931; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; GRAHAM FL, 1977, J GEN VIROL, V36, P59, DOI 10.1099/0022-1317-36-1-59; Ha TK, 2022, BIOTECHNOL ADV, V54, DOI 10.1016/j.biotechadv.2021.107831; HAKOMORI S, 1995, J BIOCHEM, V118, P1091, DOI 10.1093/oxfordjournals.jbchem.a124992; HANDLER JS, 1986, KIDNEY INT, V30, P208, DOI 10.1038/ki.1986.173; Hendry CE, 2013, J AM SOC NEPHROL, V24, P1424, DOI 10.1681/ASN.2012121143; Holbro T, 2003, P NATL ACAD SCI USA, V100, P8933, DOI 10.1073/pnas.1537685100; Hong JK, 2018, CURR OPIN CHEM ENG, V22, P1, DOI 10.1016/j.coche.2018.08.002; Hong SY, 2018, CANCER RES, V78, P4984, DOI 10.1158/0008-5472.CAN-17-3858; JENSEN FC, 1964, P NATL ACAD SCI USA, V52, P53, DOI 10.1073/pnas.52.1.53; Katayama M, 2019, J CELL PHYSIOL, V234, P6709, DOI 10.1002/jcp.27417; Kou B, 2018, ONCOL REP, V39, P101, DOI 10.3892/or.2017.6091; Kumari R, 2021, FRONT CELL DEV BIOL, V09, DOI 10.3389/fcell.2021.645593; LAVIALLE C, 1975, ARCH VIROL, V49, P127, DOI 10.1007/BF01317532; Lewis NE, 2013, NAT BIOTECHNOL, V31, P759, DOI 10.1038/nbt.2624; Lodi D., 2013, STEM CELL DISCOV, V3, P211; MACPHERSON I, 1962, VIROLOGY, V16, P147, DOI 10.1016/0042-6822(62)90290-8; Matsui A, 2020, J RADIAT RES, V61, P1, DOI 10.1093/jrr/rrz080; Natoli TA, 2020, CELL SIGNAL, V69, DOI 10.1016/j.cellsig.2020.109526; Omeir R, 2015, CHROMOSOME RES, V23, P663, DOI 10.1007/s10577-015-9474-8; PUCK TT, 1958, J EXP MED, V108, P945, DOI 10.1084/jem.108.6.945; Romagnani P, 2013, NAT REV NEPHROL, V9, P137, DOI 10.1038/nrneph.2012.290; Simon-Friedt BR, 2015, BIOL TRACE ELEM RES, V166, P66, DOI 10.1007/s12011-015-0339-y; Stepanenko AA, 2015, GENE, V569, P182, DOI 10.1016/j.gene.2015.05.065; Tihanyi Borbala, 2020, Drug Discov Today Technol, V38, P25, DOI 10.1016/j.ddtec.2021.02.003; Wegler C, 2021, J PHARM SCI-US, V110, P388, DOI 10.1016/j.xphs.2020.09.039; Xu X, 2011, NAT BIOTECHNOL, V29, P735, DOI 10.1038/nbt.1932; Yamano-Adachi N, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-74735-0; Yang GL, 2018, ANAL CHEM, V90, P14294, DOI 10.1021/acs.analchem.8b03520; Yang HP, 2019, FRONT CELL DEV BIOL, V7, DOI 10.3389/fcell.2019.00272; Yang MY, 2015, SCI REP-UK, V5, DOI 10.1038/srep17409; Yasumura Y., 1988, VERO CELLS ORIGIN PR, P1; Yu H, 2016, CELL PHYSIOL BIOCHEM, V39, P700, DOI 10.1159/000445661	51	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266061	10.1371/journal.pone.0266061	http://dx.doi.org/10.1371/journal.pone.0266061			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358245	gold, Green Published			2022-12-26	WOS:000799828800062
J	Newman, PA; Reid, L; Tepjan, S; Fantus, S; Allan, K; Nyoni, T; Guta, A; Williams, CC				Newman, Peter A.; Reid, Luke; Tepjan, Suchon; Fantus, Sophia; Allan, Kate; Nyoni, Thabani; Guta, Adrian; Williams, Charmaine C.			COVID-19 vaccine hesitancy among marginalized populations in the US and Canada: Protocol for a scoping review	PLOS ONE			English	Review							HEALTH; DISPARITIES; CHALLENGES; REFUSAL; RISKS	Introduction Despite the development of safe and highly efficacious COVID-19 vaccines, extensive barriers to vaccine deployment and uptake threaten the effectiveness of vaccines in controlling the pandemic. Notably, marginalization produces structural and social inequalities that render certain populations disproportionately vulnerable to COVID-19 incidence, morbidity, and mortality, and less likely to be vaccinated. The purpose of this scoping review is to provide a comprehensive overview of definitions/conceptualizations, elements, and determinants of COVID-19 vaccine hesitancy among marginalized populations in the U.S. and Canada. Materials and methods The proposed scoping review follows the framework outlined by Arksey and O'Malley, and further developed by the Joanna Briggs Institute. It will comply with reporting guidelines from the Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR). The overall research question is: What are the definitions/conceptualizations and factors associated with vaccine hesitancy in the context of COVID-19 vaccines among adults from marginalized populations in the U.S. and Canada. Search strategies will be developed using controlled vocabulary and selected keywords, and customized for relevant databases, in collaboration with a research librarian. The results will be analyzed and synthesized quantitatively (i.e., frequencies) and qualitatively (i.e., thematic analysis) in relation to the research questions, guided by a revised WHO Vaccine Hesitancy Matrix. Discussion This scoping review will contribute to honing and advancing the conceptualization of COVID-19 vaccine hesitancy and broader elements and determinants of underutilization of COVID-19 vaccination among marginalized populations, identify evidence gaps, and support recommendations for research and practice moving forward.	[Newman, Peter A.; Reid, Luke; Allan, Kate; Nyoni, Thabani; Williams, Charmaine C.] Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada; [Tepjan, Suchon] Voices Thailand Fdn, Chiang Mai, Thailand; [Fantus, Sophia] Univ Texas Arlington, Sch Social Work, Arlington, TX 76019 USA; [Guta, Adrian] Univ Windsor, Sch Social Work, Windsor, ON, Canada	University of Toronto; University of Texas System; University of Texas Arlington; University of Windsor	Newman, PA (corresponding author), Univ Toronto, Factor Inwentash Fac Social Work, Toronto, ON, Canada.	p.newman@utoronto.ca	Newman, Peter A/P-7056-2019	Newman, Peter A/0000-0003-0444-5915; Fantus, Sophia/0000-0002-8800-2697	Canadian Institutes of Health Research [GA3-177731]; International Development Research Centre [109555]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); International Development Research Centre	This work is supported by the Canadian Institutes of Health Research, Operating Grant (GA3-177731; Project VOICES) and the International Development Research Centre (109555).	Ahonen EQ, 2007, SCAND J WORK ENV HEA, V33, P96, DOI 10.5271/sjweh.1112; Amin AB, 2017, NAT HUM BEHAV, V1, P873, DOI 10.1038/s41562-017-0256-5; APM Research Lab Staff, 2021, APM TERM ZPMC ENT ST; Baah FO, 2019, NURS INQ, V26, DOI 10.1111/nin.12268; Baden LR, 2021, NEW ENGL J MED, V384, P403, DOI 10.1056/NEJMoa2035389; Bedford H, 2018, VACCINE, V36, P6556, DOI 10.1016/j.vaccine.2017.08.004; Benecke Olivia, 2019, Glob Pediatr Health, V6, p2333794X19862949, DOI 10.1177/2333794X19862949; Betsch C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208601; Betsch C, 2010, J HEALTH PSYCHOL, V15, P446, DOI 10.1177/1359105309353647; Bogart LM, 2021, JAIDS-J ACQ IMM DEF, V86, P200, DOI 10.1097/QAI.0000000000002570; Bowleg L, 2020, AM J PUBLIC HEALTH, V110, P917, DOI 10.2105/AJPH.2020.305766; Broniatowski DA, 2018, AM J PUBLIC HEALTH, V108, P1378, DOI 10.2105/AJPH.2018.304567; Cascini F, 2021, ECLINICALMEDICINE, V40, DOI 10.1016/j.eclinm.2021.101113; CDC, 2022, WHAT IS VACC CONF BU; CDC, 2016, VAXVIEW; Centers for Disease Control and Prevention, 2022, RISK COVID 19 INF HO; Centers for Disease Control and Prevention (CDC), 1999, MMWR Morb Mortal Wkly Rep, V48, P241; Chen WW, 2017, CLIN PEDIATR, V56, P348, DOI 10.1177/0009922816660540; City of Toronto, 2021, COVID 19 STAT CAS TO; Colgrove J, 2022, AM J PUBLIC HEALTH, V112, P234, DOI 10.2105/AJPH.2021.306504; D'Souza RS, 2021, LANCET, V397, P1348, DOI 10.1016/S0140-6736(21)00624-3; da Silva DT, 2021, VACCINES-BASEL, V9, DOI 10.3390/vaccines9030204; de Figueiredo A, 2020, LANCET, V396, P898, DOI 10.1016/S0140-6736(20)31558-0; Farres-Juste O, 2019, PHILOSOPHICAL AND METHODOLOGICAL DEBATES IN PUBLIC HEALTH, P125, DOI 10.1007/978-3-030-28626-2_9; Forman R, 2021, HEALTH POLICY, V125, P553, DOI 10.1016/j.healthpol.2021.03.013; Garritty C, 2021, J CLIN EPIDEMIOL, V130, P13, DOI 10.1016/j.jclinepi.2020.10.007; Gerstein Science Information Centre, 2021, COVID 19 2019 NOV CO; Greenwood B, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0433; Greyson D, 2021, COMMUN HLTH MEDIA MA, V117; Griffith J, 2021, J MED INTERNET RES, V23, DOI 10.2196/26874; Hatzenbuehler ML, 2013, AM J PUBLIC HEALTH, V103, P813, DOI 10.2105/AJPH.2012.301069; Heslin KC, 2021, MMWR-MORBID MORTAL W, V70, P149, DOI 10.15585/mmwr.mm7005a1; Jarrett C, 2015, VACCINE, V33, P4180, DOI 10.1016/j.vaccine.2015.04.040; Johnston RD, 2022, AM J PUBLIC HEALTH, V112, P227, DOI 10.2105/AJPH.2021.306583; Kaida A, 2022, AIDS BEHAV, V26, P2242, DOI 10.1007/s10461-022-03577-w; Kalichman SC, 2015, J HEALTH COMMUN, V20, P259, DOI 10.1080/10810730.2013.852274; Karaca-Mandic P, 2021, JAMA INTERN MED, V181, P131, DOI 10.1001/jamainternmed.2020.3857; Kirksey Lee, 2021, Cleve Clin J Med, DOI 10.3949/ccjm.88a.ccc079; Larson HJ, 2018, HUM VACC IMMUNOTHER, V14, P1599, DOI 10.1080/21645515.2018.1459252; Larson HJ, 2016, EBIOMEDICINE, V12, P295, DOI 10.1016/j.ebiom.2016.08.042; Larson HJ, 2015, VACCINE, V33, P4165, DOI 10.1016/j.vaccine.2015.04.037; Larson HJ, 2014, VACCINE, V32, P2150, DOI 10.1016/j.vaccine.2014.01.081; Laurencin CT, 2021, J RACIAL ETHN HEALTH, V8, P543, DOI 10.1007/s40615-021-01025-4; Leask J, 2012, BMC PEDIATR, V12, DOI 10.1186/1471-2431-12-154; Lei JY, 2020, NEW ENGL J MED, V383, P1340, DOI 10.1056/NEJMoa1917338; MacDonald NE, 2015, VACCINE, V33, P4161, DOI 10.1016/j.vaccine.2015.04.036; Mosby I, 2021, CAN MED ASSOC J, V193, pE381, DOI 10.1503/cmaj.210112; Newman PA, 2021, JMIR RES PROTOC, V10, DOI 10.2196/34381; Newman PA, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2017-019206; Ng E., 2021, COVID 19 DEATHS IMMI; Omer SB, 2009, NEW ENGL J MED, V360, P1981, DOI 10.1056/NEJMsa0806477; Page KR, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMp2005953; Kelly EP, 2021, SUPPORT CARE CANCER, V29, P7195, DOI 10.1007/s00520-021-06382-8; Peters M.D.J., 2020, JBI MANUAL EVIDENCE, DOI [DOI 10.46658/JBIMES-20-01, 10.46658/JBIMES-20-12,%20JBI,%202020, DOI 10.46658/JBIMES-20-12]; Polack FP, 2020, NEW ENGL J MED, V383, P2603, DOI 10.1056/NEJMoa2034577; Prokopenko E., 2020, VULNERABILITIES RELA; Ramasamy MN, 2020, LANCET, V396, P1979, DOI 10.1016/S0140-6736(20)32466-1; Razai MS, 2021, BMJ-BRIT MED J, V372, DOI 10.1136/bmj.n513; Schmidt H, 2021, NAT MED, V27, P1298, DOI 10.1038/s41591-021-01379-6; Schuster M, 2015, VACCINE, V33, P4157, DOI 10.1016/j.vaccine.2015.04.035; Secretary's Advisory Committee Office of Disease Prevention and Health. Promotion US Department of Health & Human Services, 2010, HLTH PEOPL 2020 OPP; Shachar C, 2022, AM J PUBLIC HEALTH, V112, P229, DOI 10.2105/AJPH.2021.306636; Sharma M, 2014, J HEALTH CARE POOR U, V25, P663, DOI 10.1353/hpu.2014.0102; Smith TC, 2017, OPEN FORUM INFECT DI, V4, DOI 10.1093/ofid/ofx146; Subedi R, 2020, COVID 19 MORTALITY R; Thangaraju P, 2019, CUKUROVA MED J, V44, P1150, DOI 10.17826/cumj.514157; Thompson Emily, 2021, Can Commun Dis Rep, V47, P300, DOI 10.14745/ccdr.v47i78a02; Thomson A, 2016, VACCINE, V34, P1018, DOI 10.1016/j.vaccine.2015.11.065; Tricco AC, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0465-6; U.S. Department of State, 2021, US RELATIONS BRAZIL; van Daalen KR, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-003549; Wallach S, 2020, HEALTH HUM RIGHTS, V22, P313; Warren RC, 2020, NEW ENGL J MED, V383, DOI 10.1056/NEJMp2030033; Washington HA., 2007, MED APARTHEID DARK H; Webb Hooper M, 2020, JAMA-J AM MED ASSOC, V323, P2466, DOI 10.1001/jama.2020.8598; World Health Organization, 2020, BEH CONS ACC UPT COV; World Health Organization, 2019, MEASL; Yancy CW, 2020, JAMA-J AM MED ASSOC, V323, P1891, DOI 10.1001/jama.2020.6548	79	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266120	10.1371/journal.pone.0266120	http://dx.doi.org/10.1371/journal.pone.0266120			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358267	Green Submitted, Green Published, gold			2022-12-26	WOS:000799828800073
J	Prguda-Mujic, J; Hasanic, O; Besic, L; Asic, A; Halilovic, S; Cesic, AK; Ljevakovic, N; Muminovic, F; Huseinovic, S; Ler, D; Salihefendic, L; Konjhodzic, R; Primorac, D; Marjanovic, D				Prguda-Mujic, Jasminka; Hasanic, Osman; Besic, Larisa; Asic, Adna; Halilovic, Sabina; Cesic, Aida Kulo; Ljevakovic, Neira; Muminovic, Fildesa; Huseinovic, Sukrija; Ler, Daria; Salihefendic, Lana; Konjhodzic, Rijad; Primorac, Dragan; Marjanovic, Damir			Antibody seroprevalence against SARS-CoV-2 within the Canton of Sarajevo, Bosnia and Herzegovina-One year later	PLOS ONE			English	Article							WORKERS	Background Serostudies are important resources when following pandemics and predicting their further spread, as well as determining the length of protection against reinfection and vaccine development. The aim of this study was to update data on the prevalence of seropositive individuals in Canton Sarajevo, Bosnia and Herzegovina (B&H) from September 2020 to May 2021. Methods Anti-SARS-CoV-2 antibodies were quantified using an electrochemiluminescence immunoassay. Results Compared to the period April-July 2020, when anti-SARS-CoV-2 antibodies were detected in 3.77% of samples, one year later (May 2021) the estimated percentage within the same population of the urban Canton Sarajevo was 29.9% (5,406/18,066). Of all anti-SARS-CoV-2 Ig-positive individuals, 53.27% were men, and 69.00% were of 50 years of age or younger. Also, the current update found the individuals 50 years of age or younger to be more frequently anti-SARS-CoV-2 Ig positive compared to older individuals. On the other hand, higher median anti-SARS-CoV-2 Ig levels were found in individuals > 50 years old than in younger individuals, as well as in men compared to women. Seropositivity gradually increased from September 2020 to May 2021, with the lowest frequency of positive cases (3.5%) observed in September 2020, and the highest frequency (77.7%) in January 2021. Conclusion Our results provided important seroprevalence data that could help in planning restrictive local public health measures to protect the population of Sarajevo Canton, especially considering that at the time of the study the vaccines were virtually inaccessible to the general population not belonging to any of the high-priority groups for vaccination.	[Prguda-Mujic, Jasminka] Eurofarm Ctr, Eurofarm Mol Diagnost Lab, Sarajevo, Bosnia & Herceg; [Hasanic, Osman; Besic, Larisa; Asic, Adna; Halilovic, Sabina; Ljevakovic, Neira; Muminovic, Fildesa; Huseinovic, Sukrija; Ler, Daria; Marjanovic, Damir] Int Burch Univ, Dept Genet & Bioengn, Sarajevo, Bosnia & Herceg; [Cesic, Aida Kulo] Univ Sarajevo, Dept Pharmacol Clin Pharmacol & Toxicol, Med Fac, Sarajevo, Bosnia & Herceg; [Salihefendic, Lana; Konjhodzic, Rijad] Hlth Inst Alea Dr Kandic, Alea Genet Ctr, Sarajevo, Bosnia & Herceg; [Primorac, Dragan] St Catherine Specialty Hosp, Zagreb, Croatia; [Primorac, Dragan] Penn State Univ, Eberly Coll Sci, State Coll, PA USA; [Primorac, Dragan] Univ New Haven, Henry C Lee Coll Criminal Justice & Forens Sci, West Haven, CT USA; [Primorac, Dragan] Univ Split, Med Sch, Split, Croatia; [Primorac, Dragan] Josip Juraj Strossmayer Univ Osijek, Fac Dent Med & Hlth, Sch Med, Osijek, Croatia; [Primorac, Dragan] Josip Juraj Strossmayer Univ Osijek, Sch Med, Osijek, Croatia; [Primorac, Dragan] Univ Rijeka, Fac Med, Rijeka, Croatia; [Primorac, Dragan] Med Sch REGIOMED, Coburg, Germany; [Marjanovic, Damir] Univ Zagreb, Inst Anthropol Res, Zagreb, Croatia	University of Sarajevo; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; University New Haven; University of Split; University of JJ Strossmayer Osijek; University of JJ Strossmayer Osijek; University of Rijeka; Institute for Anthropological Research Zagreb; University of Zagreb	Prguda-Mujic, J (corresponding author), Eurofarm Ctr, Eurofarm Mol Diagnost Lab, Sarajevo, Bosnia & Herceg.	jasminka.mujic@gmail.com	Primorac, Dragan/GYJ-1505-2022; Asic, Adna/D-2366-2018	Asic, Adna/0000-0001-6197-9572				[Anonymous], 2021, PUBLIC HLTH DEP SARA; [Anonymous], SARS COV 2 VARIANT C; [Anonymous], 2021, MINISTRY CIVIL AFFAI; [Anonymous], COVID 19 SITUATION U; [Anonymous], 2013, CENSUS POPULATION BO; Asic A, 2021, ARCH MED SCI, V17, P823, DOI 10.5114/aoms/134143; Eckerle I, 2020, LANCET, V396, P514, DOI 10.1016/S0140-6736(20)31482-3; General Assembly of the World Medical Association, 2014, J Am Coll Dent, V81, P14; Hassanmirzaei B, 2022, POSTGRAD MED J, V98, P529, DOI 10.1136/postgradmedj-2021-140176; Hukic M, 2021, BOSNIAN J BASIC MED, V21, P111, DOI 10.17305/bjbms.2020.5081; Jerkovic I, 2021, J OCCUP ENVIRON MED, V63, P32, DOI 10.1097/JOM.0000000000002020; Kadkhoda K, 2020, EUROSURVEILLANCE, V25, P23, DOI 10.2807/1560-7917.ES.2020.25.30.2001374; Kontou PI, 2020, DIAGNOSTICS, V10, DOI 10.3390/diagnostics10050319; Krammer F, 2020, SCIENCE, V368, P1060, DOI 10.1126/science.abc1227; Loeffelholz MJ, 2020, EMERG MICROBES INFEC, V9, P747, DOI 10.1080/22221751.2020.1745095; McDonald J.H., 2014, HDB BIOL STAT; Pollan M, 2020, LANCET, V396, P535, DOI 10.1016/S0140-6736(20)31483-5; Public Health Agency of Sweden, 2020, CHANGE USE TOBACCO S; Ristic M, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0254516; Song SK, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e269; Stephens DS, 2020, JAMA-J AM MED ASSOC, V324, P1279, DOI 10.1001/jama.2020.16656; Stringhini S, 2020, LANCET, V396, P313, DOI 10.1016/S0140-6736(20)31304-0; Tang YW, 2020, J CLIN MICROBIOL, V58, DOI 10.1128/JCM.00512-20; Tsitsilonis OE, 2020, LIFE-BASEL, V10, DOI 10.3390/life10090214; Venugopal U, 2021, INT J INFECT DIS, V102, P63, DOI 10.1016/j.ijid.2020.10.036; Xiang F, 2020, CLIN INFECT DIS, V71, P1930, DOI 10.1093/cid/ciaa461; Xu X, 2020, NAT MED, V26, P1193, DOI 10.1038/s41591-020-0949-6	27	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265431	10.1371/journal.pone.0265431	http://dx.doi.org/10.1371/journal.pone.0265431			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358214	Green Published, gold			2022-12-26	WOS:000799828800030
J	Shahzad, MN; Ahmad, S; Tousif, MI; Ahmad, I; Rao, H; Ahmad, B; Basit, A				Shahzad, Muhammad Nadeem; Ahmad, Saeed; Tousif, Muhammad Imran; Ahmad, Imtiaz; Rao, Huma; Ahmad, Bilal; Basit, Abdul			Profiling of phytochemicals from aerial parts of Terminalia neotaliala using LC-ESI-MS2 and determination of antioxidant and enzyme inhibition activities	PLOS ONE			English	Article							FREE-RADICALS; HYDROLYZABLE TANNINS; EXTRACTS; PLANTS; CONSTITUENTS; CATAPPA; DISEASE; BARK	Objectives Owing to extraordinary healing power, Terminalia species have been used in traditional medicine systems to treat various diseases. Many folklore uses of Terminalia neotaliala (Madagascar's almond) included treating arterial hypertension, diabetes, diarrhea, dysentery, colic, oral and digestive candidiasis, intestinal parasitic infections, inflammatory skin conditions, postpartum care, and mycotic infections but nevertheless scientifically explored for its medicinal and pharmacological importance. Therefore, the current study intended to prepare methanolic extract and its fractionation with hexane, chloroform, and butanol followed by evaluation of their polyphenolic content, biological activities, and LCMS analysis. The biological study included antioxidant activity and enzyme inhibition assay i.e., alpha-glucosidase and urease. The insight study of biologically active secondary metabolites of butanol fraction (BUAE) was performed through LCMS. Methods The total phenolic content (TPC) and total flavonoid content (TFC) of hydroalcoholic and its fractions were estimated using the Folin-Ciocalteu and aluminum chloride method. The total tannin content (TTC) was determined using the Folin-Denis spectrophotometric method. Similarly, the antioxidant potential of HAAE, HEAE, CFAE, and BUAE was determined using four methods as DPPH (1,1-diphenyl-2-picrylhydrazyl), 2,2-azinobis(3-ethylbenothiazoline)-6-sulfonic acid, cupric reducing antioxidant capacity (CUPRAC), and ferric reducing antioxidant power (FRAP). The sample extracts were also evaluated against two clinically important enzymes i.e., alpha-glucosidase and urease. Results The BUAE (butanol aerial fraction) showed the highest TPC (234.79 0.12 mg.GAE.g(-1) DE), TFC (320.75 +/- 12.50 mg.QE.g(-1) DE), and TTC (143.36 +/- 4.32 mg.TA.Eq.g(-1) DE). The BUAE also showed the highest scavenging potential determined by DPPH (642.65 +/- 1.11 mg.TEq.g(-1) DE) and ABTS (543.17 +/- 1.11 mg.TEq.g(-1) DE), and the metal-reducing capacity determined by CUPRAC (1510.41 +/- 4.45 mg.TEq.g(-1) DE) and FRAP (739.81 +/- 19.32 mg.TEq.g(-1) DE). The LCMS of BUAE identified 18 different biologically active phytoconstituents validating a rich source of hydrolyzable tannins including ellagitannins and gallitannins. Conclusion The present study concluded that T. neotaliala is a rich source of polyphenols capable of neutralizing the damage caused by free radical accumulation in the cells and tissues. The significant antioxidant results and identification of high molecular weight hydrolyzable tannins enlightened the medicinal importance of T. neotaliala.	[Shahzad, Muhammad Nadeem; Ahmad, Saeed; Ahmad, Imtiaz; Rao, Huma; Ahmad, Bilal; Basit, Abdul] Islamia Univ Bahawalpur, Dept Pharmaceut Chem, Bahawalpur, Pakistan; [Tousif, Muhammad Imran] DG Khan Campus Univ Educ, Dept Chem, Lahore, Pakistan; [Ahmad, Imtiaz] Univ Minnesota, Coll Pharm, Dept Med Chem, Minneapolis, MN 55455 USA	Islamia University of Bahawalpur; University of Minnesota System; University of Minnesota Twin Cities	Shahzad, MN; Ahmad, S (corresponding author), Islamia Univ Bahawalpur, Dept Pharmaceut Chem, Bahawalpur, Pakistan.	shahzad_sca@yahoo.com; rsahmed_iub@yahoo.com	Rao, Huma/HHS-0521-2022; shahzad, Muhammad/GQB-0599-2022; Ghalloo, Bilal Ahmad/GLT-5271-2022	shahzad, Muhammad/0000-0001-6565-1777; Ghalloo, Bilal Ahmad/0000-0002-8664-2252; ahmad, imtiaz/0000-0002-0925-466X; Tousif, muhammad Imran/0000-0002-5777-6112				Abu-Reidah IM, 2015, FOOD CHEM, V166, P179, DOI 10.1016/j.foodchem.2014.06.011; Akbar N, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-52738-w; Amadi SW, 2016, PHARM BIOL, V54, P2761, DOI 10.3109/13880209.2016.1173068; Amtul Z, 2002, CURR MED CHEM, V9, P1323, DOI 10.2174/0929867023369853; Baratelli TD, 2012, BIOCHEM SYST ECOL, V41, P119, DOI 10.1016/j.bse.2011.12.008; Barbehenn RV, 2006, J CHEM ECOL, V32, P2253, DOI 10.1007/s10886-006-9143-7; Barry KM, 2001, PHYTOCHEM ANALYSIS, V12, P120, DOI 10.1002/pca.548; Ben Said R, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18030512; Bognan A.J.A.A, 2013, ANTIFUNGAL ACTIVITY; Celik SE, 2008, INT J FOOD PROP, V11, P747, DOI 10.1080/10942910701594210; Che CT, 2017, PHARMACOGNOSY: FUNDAMENTALS, APPLICATIONS AND STRATEGIES, P15, DOI 10.1016/B978-0-12-802104-0.00002-0; Cock IE, 2015, INFLAMMOPHARMACOLOGY, V23, P203, DOI 10.1007/s10787-015-0246-z; Ekambaram SP, 2020, INFLAMMOPHARMACOLOGY, V28, P275, DOI 10.1007/s10787-019-00629-x; El-Sayed MA, 2021, EGYPT J CHEM, V64, P793, DOI [10.21608/ejchem.2020.45694.2933, 10.21608/EJCHEM.2020.45694.2933]; Ezebo R., 2021, WORLD NEWS NATURAL S, V37, P151; Fahmy N., 2015, MED AROMAT PLANTS, V4, P1, DOI DOI 10.4172/2167-0412.1000218; Fathoni A, 2017, AIP CONF PROC, V1862, DOI 10.1063/1.4991183; Fischer UA, 2011, FOOD CHEM, V127, P807, DOI 10.1016/j.foodchem.2010.12.156; Grochowski DM, 2019, INT J ENVIRON HEAL R, V29, P237, DOI 10.1080/09603123.2018.1533532; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Kaneshima T, 2017, BIOSCI BIOTECH BIOCH, V81, P1461, DOI 10.1080/09168451.2017.1320517; Khan KM, 2014, EUR J MED CHEM, V74, P314, DOI 10.1016/j.ejmech.2014.01.001; ALI KHAN Mohammed Safwan, 2017, Arq. Gastroenterol., V54, P183, DOI [10.1590/S0004-2803.201700000-21, 10.1590/s0004-2803.201700000-21]; Kramberger K, 2020, METABOLITES, V10, DOI 10.3390/metabo10100403; Kuo PL, 2005, PLANTA MED, V71, P237, DOI 10.1055/s-2005-837823; Lesbani A, 2015, INDONES J CHEM, V15, P64, DOI 10.22146/ijc.21225; Li Y, 2022, FOOD CHEM, V374, DOI 10.1016/j.foodchem.2021.131688; Liu WK, 2012, BIOORG MED CHEM LETT, V22, P5008, DOI 10.1016/j.bmcl.2012.06.014; Liu YQ, 2018, J SEP SCI, V41, P3022, DOI 10.1002/jssc.201800480; MARTINEZCAYUELA M, 1995, BIOCHIMIE, V77, P147, DOI 10.1016/0300-9084(96)88119-3; Mekam PN, 2019, S AFR J BOT, V127, P319, DOI 10.1016/j.sajb.2019.11.001; Mena P, 2012, MOLECULES, V17, P14821, DOI 10.3390/molecules171214821; Middleton E, 2000, PHARMACOL REV, V52, P673; Napiroon T, 2018, J APPL PHARM SCI, V8, P1, DOI [10.7324/JAPS.2018.8901, DOI 10.7324/JAPS.2018.8901]; Nimse SB, 2015, RSC ADV, V5, P27986, DOI 10.1039/c4ra13315c; Nishimori I, 2007, BIOORG MED CHEM LETT, V17, P3585, DOI 10.1016/j.bmcl.2007.04.063; Oboh G, 2007, J FOOD BIOCHEM, V31, P456, DOI 10.1111/j.1745-4514.2007.00123.x; Pandhair V, 2006, J PLANT BIOCHEM BIOT, V15, P71, DOI 10.1007/BF03321907; Qaisar MN, 2014, TROP J PHARM RES, V13, P1833, DOI 10.4314/tjpr.v13i11.9; Shukla P, 2012, INT J PHARM SCI RES, V3, P1520, DOI 10.13040/IJPSR.0975-8232.3(5).1520-22; Smeriglio A, 2017, BRIT J PHARMACOL, V174, P1244, DOI 10.1111/bph.13630; Swiatek L, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22147621; Toghueo RMK, 2017, S AFR J BOT, V109, P146, DOI 10.1016/j.sajb.2016.12.021; Uddin G, 2016, NAT PROD RES, V30, P1411, DOI 10.1080/14786419.2015.1062378; Uyoh E. A., 2013, American Journal of Plant Sciences, V4, P222, DOI 10.4236/ajps.2013.42029; Wyrepkowski CC, 2014, MOLECULES, V19, P16039, DOI 10.3390/molecules191016039; Yasmin S, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.01895; Yisimayili Z, 2019, J CHROMATOGR A, V1604, DOI 10.1016/j.chroma.2019.460472; Young IS, 2001, J CLIN PATHOL, V54, P176, DOI 10.1136/jcp.54.3.176; Zengin G, 2016, EUR J INTEGR MED, V8, P286, DOI 10.1016/j.eujim.2015.12.004; Zengin G, 2014, AFR J TRADIT COMPLEM, V11, P481, DOI 10.4314/ajtcam.v11i2.37	51	4	4	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266094	10.1371/journal.pone.0266094	http://dx.doi.org/10.1371/journal.pone.0266094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358239	Green Published, gold			2022-12-26	WOS:000799828800067
J	Swarna, NR; Anjum, I; Hamid, NN; Rabbi, GA; Islam, T; Evana, ET; Islam, N; Rayhan, MI; Morshed, K; Miah, AMJ				Swarna, Nahrin Rahman; Anjum, Iffat; Hamid, Nimmi Nusrat; Rabbi, Golam Ahmed; Islam, Tariqul; Evana, Ezzat Tanzila; Islam, Nazia; Rayhan, Md Israt; Morshed, Kam; Miah, Abu Said Md Juel			Understanding the impact of COVID-19 on the informal sector workers in Bangladesh	PLOS ONE			English	Article								The COVID-19 pandemic put dents on every sector of the affected countries, and the informal sector was no exception. This study is based on the quantitative analyses of the primary data of 1,867 informal workers of Bangladesh to shed light on the impact of the pandemic-induced economic crisis on this working class. The survey was conducted between 8 July and 13 August 2020 across the eight administrative divisions of the country. Analysis points out that about ninety percent of these workers faced an income and food expenditure drop during the lockdown. The effect was higher in males, particularly among the urban-centric and educated males engaged in services and sales. The findings suggest that policy support is needed for the informal workers to face such a crisis.	[Swarna, Nahrin Rahman; Anjum, Iffat; Hamid, Nimmi Nusrat; Rabbi, Golam Ahmed; Islam, Tariqul; Evana, Ezzat Tanzila; Islam, Nazia; Morshed, Kam; Miah, Abu Said Md Juel] BRAC Ctr, Advocacy Social Change, Dhaka, Bangladesh; [Rayhan, Md Israt] Univ Dhaka, Inst Stat Res & Training ISRT, Dhaka, Bangladesh	Bangladesh Rural Advancement Committee BRAC; University of Dhaka	Rayhan, MI (corresponding author), Univ Dhaka, Inst Stat Res & Training ISRT, Dhaka, Bangladesh.	israt@isrt.ac.bd		Rayhan, Md. Israt/0000-0002-0451-3976				ACHEN C. H., 1982, INTERPRETING USING R; ADB, 2012, INF SECT INF EMPL BA; ANDERSONSPRECHER R, 1994, AM STAT, V48, P113, DOI 10.2307/2684259; Australian Bureau of Statistics, 2017, 65030 HOUS EXP SURV; Barkat A., 2020, CORONAVIRUS 19 SHOMB; BBS, 2017, LAB FORC SURV; BBS, 2020, STAT YB BANGL 2019; BBS, 2020, CONS PRIC IND; Bhattacharjee J., 2020, BANGLADESH COVID 19; BRAC, 2020, BANGL RUR ADV COMM R; Cochran WG., 1963, SAMPLING TECHNIQUES; CPD-BILS, 2021, IMP COVID 19 LAB MAR; Dang HAH, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105296; Das T.K., 2020, BUSINESS STANDARD; Demirguc-Kunt A., 2018, GLOBAL FINDEX DATABA, DOI 10.1596/978-1-4648-1259-0; Enano J., 2020, PHILIPPINE DAILY INQ; ESPON, 2022, TERR IMP COV 19 POL; Gentilini U., 2020, SOCIAL PROTECTION JO; Greene W. H., 1997, ECONOMETRIC ANAL; Gujarati D.N., 2012, BASIC ECONOMETRICS; Guo F, 2022, CHINA ECON REV, V71, DOI 10.1016/j.chieco.2021.101722; Haque Md Rajwanul, 2022, PLoS One, V17, pe0262141, DOI 10.1371/journal.pone.0262141; Harvey J., 2022, NEW LABOR FORUM, V31, P60, DOI [10.1177/10957960211062873, DOI 10.1177/10957960211062873]; Hossain M.I., 2021, S ASIAN SURVEY, V28, P57, DOI [10.1177/0971523121995072, DOI 10.1177/0971523121995072]; ILO, 2020, COVID 19 CRIS INF EC; ILO International Labour Organization, 2020, JOB LOSS ESC NEARL H; Imran S., 2020, INNOVISION; International Labor Office [ILO], 1990, ISCO88 ILO; Islam R., 2020, IMPACT COVID 19 EMPL; Islam R., 2020, CORONA FALLOUT SPELL; Islam S, 2020, PROG DISASTER SCI, V8, DOI 10.1016/j.pdisas.2020.100135; Kamruzzaman M., 2020, CORONAVIRUS POOR INC; Kansiime MK, 2021, WORLD DEV, V137, DOI 10.1016/j.worlddev.2020.105199; Khondker B.H., 2019, FINANCIAL EXPRESS; Komin W, 2021, ASIA PAC J SOC WORK, V31, P80, DOI 10.1080/02185385.2020.1832564; Kumar B, 2021, J PUBLIC AFF, V21, DOI 10.1002/pa.2556; Leyva G., 2020, INFORMAL LABOR MARKE; Mahmud M.A.F., 2020, LANKA BANGLA ASSET M; Mahmud M, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105318; Martinez L, 2022, DATA BRIEF, V40, DOI 10.1016/j.dib.2021.107728; Mohammad Ali, 2020, BUSINESS STANDARD; Mujeri M. K., 2020, DAILY STAR; Narula R, 2020, J INT BUS POLICY, V3, P302, DOI 10.1057/s42214-020-00059-5; OAS, 2020, ORG AM STAT COVID 19; Office of the High Commissioner for Human Rights, 2020, COVID 19 HUM RIGHTS; Onyekwena C., 2020, UNDERSTANDING IMPACT; Pitoyo AJ, 2020, E3S WEB CONF, V200, DOI 10.1051/e3sconf/202020003014; Rahman HZ., 2020, LIVELIHOODS COPING S; Rahman M., 2009, LABOR EC WORKING PAP, V22303; Raihan S., 2018, FEMALE EMPLOYMENT ST; Raza M.E, 2020, LOSING LIVELIHOODS L; Romanello M., 2022, COVID 19 INT DEV, DOI [10.1007/978-3-030-82339-9_7, DOI 10.1007/978-3-030-82339-9_7, 10.1007/978-3-030-82339-9_]; Sakamoto M, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12135296; Shammi M, 2021, ENVIRON DEV SUSTAIN, V23, P6148, DOI 10.1007/s10668-020-00867-y; Shawon A.A., 2020, DHAKA TRIBUNE RETRIE; Stoop N, 2021, WORLD DEV, V140, DOI 10.1016/j.worlddev.2020.105352; UN Women, 2020, COVID 19 ITS EC TOLL; Wallace M, 2020, SLEEK APR; Wasima S, 2022, J SOC SERV RES, V48, P163, DOI 10.1080/01488376.2022.2029799; WHO, 2022, AB; Women in Informal Employment: Globalizing and Organizing (WIEGO), 2020, IMP PUBL HLTH MEAS I; World Bank, 2020, BANGL MUST RAMP UP C; World Bank, 2020, LOS LIV LAB MARK IMP; Zambrano A., 2021, ROLE INFORMAL SECTOR; Zollmann J., 2020, BFA GLOBAL FINANCIAL	65	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266014	10.1371/journal.pone.0266014	http://dx.doi.org/10.1371/journal.pone.0266014			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358241	gold, Green Published			2022-12-26	WOS:000799828800060
J	Watson, JW; Muench, A; Hyder, K; Sibly, R				Watson, Joseph W.; Muench, Angela; Hyder, Kieran; Sibly, Richard			Factors affecting fisher decisions: The case of the inshore fishery for European sea bass (Dicentrarchus labrax)	PLOS ONE			English	Article							LOCAL ECOLOGICAL KNOWLEDGE; FISHING EFFORT; BEHAVIOR; MANAGEMENT; MODEL; PERFORMANCE; EFFICIENCY; DYNAMICS; ACCESS; SPACE	Fishery management relies on forecasts of fish abundance over time and space, on scales of months and kilometres. While much research has focussed on the drivers of fish populations, there has been less investigation of the decisions made day-to-day by fishers and their subsequent impact on fishing pressure. Studies that focus on the fisher decisions of smaller vessels may be particularly important due to the prevalence of smaller vessels in many fisheries and their potential vulnerability to bad weather and economic change. Here we outline a methodology with which to identify the factors affecting fisher decisions and success as well as quantifying their effects. We analyse first the decision of when to leave port, and then the success of the fishing trip. Fisher behaviour is here analysed in terms of the decisions taken by fishers in response to bio-physical and socio-economic changes and to illustrate our method, we describe its application to the under 10-meter fleet targeting sea bass in the UK. We document the effects of wave height and show with increasing wave height fewer vessels left port to go fishing. The decision to leave port was only substantially affected by time of high tide at one of the four ports investigated. We measured the success of fishing trips by the landings of sea bass (kg) per metre of vessel length. Fishing success was lower when wave height was greater and when fish price had increased relative to the previous trip. Fuel price was unimportant, but a large proportion of the variation in success was explained by variation between individual vessels, presumably due to variation in skipper ability or technical restrictions due to vessel characteristics. The results are discussed in the context of management of sea bass and other small-scale inshore fisheries.	[Watson, Joseph W.; Sibly, Richard] Univ Reading, Sch Biol Sci, Reading, Berks, England; [Watson, Joseph W.; Muench, Angela; Hyder, Kieran] Lowestoft Lab, Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England; [Muench, Angela; Hyder, Kieran] Univ East Anglia, Sch Environm Sci, Norwich, Norfolk, England	University of Reading; Centre for Environment Fisheries & Aquaculture Science; University of East Anglia	Watson, JW (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.; Watson, JW (corresponding author), Lowestoft Lab, Ctr Environm Fisheries & Aquaculture Sci, Lowestoft, Suffolk, England.	joseph.watson@Cefas.co.uk		Hyder, Kieran/0000-0003-1428-5679; Watson, Joseph/0000-0002-7040-0494	NERC PhD studentship [NE/L002566/1]; Cefas	NERC PhD studentship(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Cefas	JW was funded by a NERC PhD studentship [grant number NE/L002566/1] with CASE sponsorship from Cefas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott JK, 2012, ECOL APPL, V22, P762, DOI 10.1890/11-1319.1; Abernethy KE, 2010, ICES J MAR SCI, V67, P1076, DOI 10.1093/icesjms/fsp289; Andrews EJ, 2021, FISH FISH, V22, P489, DOI 10.1111/faf.12529; Bailey RM, 2019, SUSTAIN SCI, V14, P259, DOI 10.1007/s11625-018-0579-9; Bastardie F, 2010, FISH RES, V106, P501, DOI 10.1016/j.fishres.2010.09.025; Bennett NJ, 2020, COAST MANAGE, V48, P336, DOI 10.1080/08920753.2020.1766937; Boyd RJ, 2020, PROG OCEANOGR, V183, DOI 10.1016/j.pocean.2020.102299; Boyd R, 2018, ECOL MODEL, V382, P9, DOI 10.1016/j.ecolmodel.2018.04.015; Branch TA, 2006, CAN J FISH AQUAT SCI, V63, P1647, DOI 10.1139/F06-072; Cheung WWL, 2012, AQUAT CONSERV, V22, P368, DOI 10.1002/aqc.2248; DeAngelis Donald L, 2014, F1000Prime Rep, V6, P39, DOI 10.12703/P6-39; Dorn MW, 2001, ICES J MAR SCI, V58, P238, DOI 10.1006/jmsc.2000.1006; Dreyfus-Leon MJ, 1999, ECOL MODEL, V120, P287; FAO, 2020, STAT WORLD FISH AQ, P26, DOI 10.4060/ca9229-n; Fulton EA, 2011, FISH FISH, V12, P2, DOI 10.1111/j.1467-2979.2010.00371.x; Gerritsen H., 2018, DATA VISUALISATION M; GOV.UK, 2019, BASS FISH GUID 2019; GOV.UK, 2016, GOV UK COMM RECR BAS; GOV.UK, 2018, BASS FISH GUID; GOV.UK, 2020, BASS FISH GUID 2020; GOV.UK, 2017, BASS FISH GUID 2017; Graddy K, 2006, J ECON PERSPECT, V20, P207, DOI 10.1257/jep.20.2.207; Heath MR, 2012, AQUAT CONSERV, V22, P337, DOI 10.1002/aqc.2244; Henry AM, 2015, MAR COAST FISH, V7, P33, DOI 10.1080/19425120.2014.984086; Hilborn R, 2007, FISH FISH, V8, P285, DOI 10.1111/j.1467-2979.2007.00263_2.x; Hilborn R, 2020, P NATL ACAD SCI USA, V117, P2218, DOI 10.1073/pnas.1909726116; Hill NAO, 2010, OCEAN COAST MANAGE, V53, P659, DOI 10.1016/j.ocecoaman.2010.04.011; ICES, 2021, 2 ICES, V2, P40, DOI [10.17895/ICES.PUB.5978, DOI 10.17895/ICES.PUB.5978]; Kuhn W, 2008, J MARINE SYST, V74, P329, DOI 10.1016/j.jmarsys.2008.02.002; Lindkvist E, 2020, FRONT MAR SCI, V6, DOI 10.3389/fmars.2019.00733; McCluskey SM, 2008, FISH FISH, V9, P188, DOI 10.1111/j.1467-2979.2008.00283.x; Millischer L, 2006, AQUAT LIVING RESOUR, V19, P1, DOI 10.1051/alr:2006001; Pawson MG, 2007, ICES J MAR SCI, V64, P346, DOI 10.1093/icesjms/fsl030; Pet-Soede C, 2001, FISHERIES MANAG ECOL, V8, P15, DOI 10.1046/j.1365-2400.2001.00215.x; Pickett GD., 1994, SEA BASS BIOL, V124, P643, DOI [10.1577/1548-8659-124.4.643, DOI 10.1577/1548-8659-124.4.643]; Poisson F, 2010, FISH B-NOAA, V108, P268; Politikos D., 2013, ICES CM 2013 N 12 BE, P2, DOI [10.1080/17513758.2013.826826, DOI 10.1080/17513758.2013.826826]; R Core Team, 2021, R LANGUAGE ENV STAT; Sainsbury NC, 2018, NAT CLIM CHANGE, V8, P655, DOI 10.1038/s41558-018-0206-x; Salas S, 2004, FISH FISH, V5, P153, DOI 10.1111/j.1467-2979.2004.00146.x; Sharples J, 2013, PROG OCEANOGR, V117, P130, DOI 10.1016/j.pocean.2013.06.014; Shepperson J, 2016, ENVIRON MODELL SOFTW, V86, P116, DOI 10.1016/j.envsoft.2016.09.013; Shepperson JL, 2018, ICES J MAR SCI, V75, P988, DOI 10.1093/icesjms/fsx230; Stoner AW, 2004, J FISH BIOL, V65, P1445, DOI 10.1111/j.0022-1112.2004.00593.x; THORLINDSSON T, 1988, HUM ORGAN, V47, P199, DOI 10.17730/humo.47.3.1584t42x24702552; Thoya P, 2019, FISH RES, V212, P146, DOI 10.1016/j.fishres.2018.12.018; Valcic B, 2009, MAR POLICY, V33, P215, DOI 10.1016/j.marpol.2008.06.001; van Putten IE, 2012, FISH FISH, V13, P216, DOI 10.1111/j.1467-2979.2011.00430.x; Venables WN., 2002, MODERN APPL STAT S 4; Walker ND, 2020, ECOL MODEL, V431, DOI 10.1016/j.ecolmodel.2020.109179; Wijermans N, 2020, FISH FISH, V21, P872, DOI 10.1111/faf.12466; Wilen JE, 2002, B MAR SCI, V70, P553; Williams C, 2018, MAR POLICY, V95, P199, DOI 10.1016/j.marpol.2018.02.011; Xu HA, 2010, IEEE T INFORM THEORY, V56, P3561, DOI 10.1109/TIT.2010.2048503; Young T, 2019, ICES J MAR SCI, V76, P93, DOI 10.1093/icesjms/fsy140; Zukowski S, 2011, FISH RES, V110, P120, DOI 10.1016/j.fishres.2011.03.020	56	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266170	10.1371/journal.pone.0266170	http://dx.doi.org/10.1371/journal.pone.0266170			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358266	Green Accepted, Green Published, gold			2022-12-26	WOS:000799828800075
J	Cohen, RE; Frasier, KE; Baumann-Pickering, S; Wiggins, SM; Rafter, MA; Baggett, LM; Hildebrand, JA				Cohen, Rebecca E.; Frasier, Kaitlin E.; Baumann-Pickering, Simone; Wiggins, Sean M.; Rafter, Macey A.; Baggett, Lauren M.; Hildebrand, John A.			Identification of western North Atlantic odontocete echolocation click types using machine learning and spatiotemporal correlates	PLOS ONE			English	Article							DOLPHINS CEPHALORHYNCHUS-COMMERSONII; WHALES MESOPLODON-BIDENS; BEAKED-WHALE; TURSIOPS-TRUNCATUS; CLASSIFICATION; RISSOS; VOCALIZATIONS; CALLS	A combination of machine learning and expert analyst review was used to detect odontocete echolocation clicks, identify dominant click types, and classify clicks in 32 years of acoustic data collected at 11 autonomous monitoring sites in the western North Atlantic between 2016 and 2019. Previously-described click types for eight known odontocete species or genera were identified in this data set: Blainville's beaked whales (Mesoplodon densirostris), Cuvier's beaked whales (Ziphius cavirostris), Gervais' beaked whales (Mesoplodon europaeus), Sowerby's beaked whales (Mesoplodon bidens), and True's beaked whales (Mesoplodon mirus), Kogia spp., Risso's dolphin (Grampus griseus), and sperm whales (Physeter macrocephalus). Six novel delphinid echolocation click types were identified and named according to their median peak frequencies. Consideration of the spatiotemporal distribution of these unidentified click types, and comparison to historical sighting data, enabled assignment of the probable species identity to three of the six types, and group identity to a fourth type. UD36, UD26, and UD28 were attributed to Risso's dolphin (G. griseus), short-finned pilot whale (G. macrorhynchus), and short-beaked common dolphin (D. delphis), respectively, based on similar regional distributions and seasonal presence patterns. UD19 was attributed to one or more species in the subfamily Globicephalinae based on spectral content and signal timing. UD47 and UD38 represent distinct types for which no clear spatiotemporal match was apparent. This approach leveraged the power of big acoustic and big visual data to add to the catalog of known species-specific acoustic signals and yield new inferences about odontocete spatiotemporal distribution patterns. The tools and call types described here can be used for efficient analysis of other existing and future passive acoustic data sets from this region.	[Cohen, Rebecca E.; Frasier, Kaitlin E.; Baumann-Pickering, Simone; Wiggins, Sean M.; Rafter, Macey A.; Baggett, Lauren M.; Hildebrand, John A.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography	Cohen, RE (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	rec022@ucsd.edu		Cohen, Rebecca/0000-0003-4658-3080; Hildebrand, John/0000-0002-5418-9799	National Oceanic and Atmospheric Administration Cooperative Institute for Marine Ecosystems and Climate award [NA10OAR4320156]; Duke University [283-0280]; HDR MSA [1000300000780]	National Oceanic and Atmospheric Administration Cooperative Institute for Marine Ecosystems and Climate award; Duke University; HDR MSA	Funding was provided to JAH for data collection by National Oceanic and Atmospheric Administration Cooperative Institute for Marine Ecosystems and Climate award NA10OAR4320156, Duke University (Subcontract Number: 283-0280), and HDR MSA 1000300000780.	Allen AN, 2021, FRONT MAR SCI, V08, DOI 10.3389/fmars.2021.607321; Au W. W., 1993, SONAR DOLPHINS; Au WWL, 1998, J ACOUST SOC AM, V103, P41, DOI 10.1121/1.423234; Baumann-Pickering S, 2015, ENDANGER SPECIES RES, V28, P97, DOI 10.3354/esr00685; Baumann-Pickering S, 2013, J ACOUST SOC AM, V134, P2293, DOI 10.1121/1.4817832; Baumann-Pickering S, 2013, J ACOUST SOC AM, V133, P4321, DOI 10.1121/1.4804316; Baumann-Pickering S, 2010, J ACOUST SOC AM, V128, P2212, DOI 10.1121/1.3479549; Beijbom O, 2015, QUANTIFICATION IN TH; BERTA A., 1999, MARINE MAMMALS EVOLU; Biemann C., 2020, P TEXTGRAPHS 1 WORK, P73; Cholewiak D, 2013, J ACOUST SOC AM, V134, P3905, DOI 10.1121/1.4823843; Clarke E, 2019, J ACOUST SOC AM, V146, P307, DOI 10.1121/1.5111336; DeAngelis AI, 2018, J ACOUST SOC AM, V144, P2691, DOI 10.1121/1.5067379; DEBREU G, 1960, AM ECON REV, V50, P186; Frasier KE, 2021, PLOS COMPUT BIOL, V17, DOI 10.1371/journal.pcbi.1009613; Frasier KE, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005823; Frasier KE, 2016, J ACOUST SOC AM, V140, P1918, DOI 10.1121/1.4962279; Frasier KE, 2016, MAR MAMMAL SCI, V32, P911, DOI 10.1111/mms.12303; Frasier KE., 2015, DENSITY ESTIMATION D; Gillespie D, 2009, J ACOUST SOC AM, V125, P3428, DOI 10.1121/1.3110832; Glorot X., 2011, P 14 INT C ART INT S, P315; Gonzalez P, 2017, LIMNOL OCEANOGR-METH, V15, P221, DOI 10.1002/lom3.10151; GOOLD JC, 1995, J ACOUST SOC AM, V98, P1279, DOI 10.1121/1.413465; Halpin P, 2011, OCEANOGRAPHY, V22, P104; Henderson EE, 2011, J ACOUST SOC AM, V130, P557, DOI 10.1121/1.3592213; Hildebrand JA, 2022, J ACOUST SOC AM, V151, P414, DOI 10.1121/10.0009270; Hildebrand JA, 2015, SCI REP-UK, V5, DOI 10.1038/srep16343; Hodge LEW, 2018, N247015D8006 NAV FAC; Jensen FH, 2018, CURR BIOL, V28, P3878, DOI 10.1016/j.cub.2018.10.037; Johnson M, 2008, P ROY SOC B-BIOL SCI, V275, P133, DOI 10.1098/rspb.2007.1190; Johnson M, 2004, P ROY SOC B-BIOL SCI, V271, pS383, DOI 10.1098/rsbl.2004.0208; Johnson M, 2006, J EXP BIOL, V209, P5038, DOI 10.1242/jeb.02596; Kyhn LA, 2010, J EXP BIOL, V213, P1940, DOI 10.1242/jeb.042440; Leroy EC, 2018, J ACOUST SOC AM, V144, P740, DOI 10.1121/1.5049803; Madsen PT, 2005, BIOACOUSTICS, V15, P195, DOI 10.1080/09524622.2005.9753547; Madsen PT, 2005, J EXP BIOL, V208, P181, DOI 10.1242/jeb.01327; Madsen PT, 2004, J ACOUST SOC AM, V116, P1909, DOI 10.1121/1.1788726; Madsen PT, 2004, J EXP BIOL, V207, P1811, DOI 10.1242/jeb.00966; Marten Ken, 2000, Aquatic Mammals, V26, P45; Merkens K, 2018, MAR MAMMAL SCI, V34, P963, DOI 10.1111/mms.12488; Mohl B, 2000, J ACOUST SOC AM, V107, P638, DOI 10.1121/1.428329; Moreno-Torres JG, 2012, PATTERN RECOGN, V45, P521, DOI 10.1016/j.patcog.2011.06.019; Nowacek DP, 2005, MAR MAMMAL SCI, V21, P587, DOI 10.1111/j.1748-7692.2005.tb01253.x; Orenstein EC, 2020, LIMNOL OCEANOGR-METH, V18, P739, DOI 10.1002/lom3.10399; Pedersen MB, 2021, J ACOUST SOC AM, V149, P1923, DOI 10.1121/10.0003762; Rankin S, 2017, MAR MAMMAL SCI, V33, P520, DOI 10.1111/mms.12381; Rankin S, 2011, J ACOUST SOC AM, V130, pEL339, DOI 10.1121/1.3646026; Rendell LE, 1999, J ZOOL, V249, P403, DOI 10.1017/S0952836999009875; Reyes MVR, 2015, J ACOUST SOC AM, V138, P2046, DOI 10.1121/1.4929899; Roch M., 2008, CAN ACOUST, V36, P41, DOI DOI 10.1007/3-540-35375-5; Roch MA, 2007, J ACOUST SOC AM, V121, P1737, DOI 10.1121/1.2400663; Roch MA, 2011, J ACOUST SOC AM, V130, P2212, DOI 10.1121/1.3624821; Roch MA, 2011, J ACOUST SOC AM, V129, P467, DOI 10.1121/1.3514383; Scheer M, 2013, AQUAT MAMM, V39, P306, DOI 10.1578/AM.39.3.2013.306; Shiu Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-57549-y; Smith AB, 2019, J ACOUST SOC AM, V145, P3595, DOI 10.1121/1.5111347; Soldevilla MS, 2008, J ACOUST SOC AM, V124, P609, DOI 10.1121/1.2932059; Soldevilla MS, 2017, J ACOUST SOC AM, V142, P599, DOI 10.1121/1.4996002; Wahlberg M, 2011, J ACOUST SOC AM, V130, P2263, DOI 10.1121/1.3624822; WHITEHEAD H, 1990, J ACOUST SOC AM, V87, P1798, DOI 10.1121/1.399376; Wiggins SM, 2007, 2007 SYMPOSIUM ON UNDERWATER TECHNOLOGY AND WORKSHOP ON SCIENTIFIC USE OF SUBMARINE CABLES AND RELATED TECHNOLOGIES, VOLS 1 AND 2, P594; Zimmer WMX, 2005, J ACOUST SOC AM, V117, P3919, DOI 10.1121/1.1910225; Zimmer WMX, 2005, J ACOUST SOC AM, V118, P3337, DOI 10.1121/1.2082707	63	2	2	3	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264988	10.1371/journal.pone.0264988	http://dx.doi.org/10.1371/journal.pone.0264988			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324943	Green Published, gold			2022-12-26	WOS:000780951300028
J	Kim, H; Kim, HR				Kim, Hyunjin; Kim, Hye Rim			Production of coffee-dyed bacterial cellulose as a bio-leather and using it as a dye adsorbent	PLOS ONE			English	Article							METHYLENE-BLUE; DEODORIZING PROPERTIES; ACTIVATED CARBON; REMOVAL; ADSORPTION; COTTON; FABRICATION; FASTNESS; ARABICA; SLUDGE	Owing to its sustainability and environmentally friendliness, bacterial cellulose (BC) has received attention as a zero-waste textile material. Since the color of original BC was mostly yellowish white, a dyeing process is necessary to suggest BC as a textile. Thus, this study aimed to suggest a natural dyeing method using coffee to produce an eco-friendly coffee-dyed bacterial cellulose (BC-COF) bio-leather and to propose a reusing method as a dye adsorbent. To determine the dyeing and mordanting conditions with the highest color strength value, parameters such as dyeing temperature, time, mordanting methods were evaluated. Fourier-transform infrared spectroscopy and X-ray diffraction analysis confirmed that BC-COF was successfully colorized with coffee without changing its chemical and crystalline structures. In addition, field-emission scanning electron microscopy and Brunauer-Emmett-Teller surface area analysis confirmed that coffee molecules were successfully incorporated into fiber structures of BC. The effects of pH, concentration, temperature, and time on the adsorption of methylene blue dye using BC-COF bio-leather were also evaluated using ultraviolet-visible spectroscopy and zeta potential measurement. The results showed that BC-COF was found to be most effective when pH 6 of methylene blue solution with a concentration of 50 mg/L was adsorbed for 30 minutes at 25 degrees C. Moreover, BC-COF could be reused for multiple times and had better dye adsorption rate compared to the original BC. From the results, it was confirmed that BC-COF could be employed as a dye adsorbent.	[Kim, Hyunjin; Kim, Hye Rim] Sookmyung Womens Univ, Dept Clothing & Text, Seoul, South Korea	Sookmyung Women's University	Kim, HR (corresponding author), Sookmyung Womens Univ, Dept Clothing & Text, Seoul, South Korea.	khyerim@sookmyung.ac.kr		Kim, Hye Rim/0000-0003-3456-8617; Kim, Hyunjin/0000-0003-2445-7016	National Research Foundation of Korea (NRF) - Korean government (MSIT) [NRF2019R1A2C1009217]	National Research Foundation of Korea (NRF) - Korean government (MSIT)(National Research Foundation of KoreaMinistry of Science & ICT (MSIT), Republic of Korea)	This work has supported by the National Research Foundation of Korea (NRF) grant funded by the Korean government (MSIT) (NRF2019R1A2C1009217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali I, 2019, ENVIRON RES, V170, P389, DOI 10.1016/j.envres.2018.12.066; Ali I, 2018, PHOTOCHEM PHOTOBIOL, V94, P935, DOI 10.1111/php.12937; Ali I, 2017, J MOL LIQ, V241, P123, DOI 10.1016/j.molliq.2017.06.005; Almasi H, 2020, WATER ENVIRON RES, V92, P1334, DOI 10.1002/wer.1331; Alothman ZA, 2020, SEP SCI TECHNOL, V55, P1766, DOI 10.1080/01496395.2019.1608242; ALOthman ZA, 2012, MATERIALS, V5, P2874, DOI 10.3390/ma5122874; Amin NK, 2009, J HAZARD MATER, V165, P52, DOI 10.1016/j.jhazmat.2008.09.067; Andrade FK, 2019, CELLULOSE, V26, P5851, DOI 10.1007/s10570-019-02512-y; Azhar A, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9050776; Chan CK, 2018, CLOTH TEXT RES J, V36, P33, DOI 10.1177/0887302X17737177; Chen SY, 2009, J HAZARD MATER, V161, P1355, DOI 10.1016/j.jhazmat.2008.04.098; Chen X, 2020, CARBOHYD POLYM, V229, DOI 10.1016/j.carbpol.2019.115512; Clifford MN, 2008, FOOD CHEM, V106, P379, DOI 10.1016/j.foodchem.2007.05.081; Costa AFD, 2019, INT J BIOL MACROMOL, V121, P580, DOI 10.1016/j.ijbiomac.2018.10.066; Craig AP, 2012, FOOD CHEM, V132, P1368, DOI 10.1016/j.foodchem.2011.11.121; Davulcu A, 2014, CELLULOSE, V21, P4671, DOI 10.1007/s10570-014-0427-8; de Sa FP, 2013, CHEM ENG J, V215, P122, DOI 10.1016/j.cej.2012.11.024; Deng C, 2012, CHEM ENG J, V200, P452, DOI 10.1016/j.cej.2012.06.059; Fernandes M, 2019, MICROB BIOTECHNOL, V12, P650, DOI 10.1111/1751-7915.13387; Garcia C, 2019, MICROB BIOTECHNOL, V12, P582, DOI 10.1111/1751-7915.13306; Ghaheh FS, 2014, J CLEAN PROD, V72, P139, DOI 10.1016/j.jclepro.2014.02.050; Gorgieva S, 2019, NANOMATERIALS-BASEL, V9, DOI 10.3390/nano9101352; Gupta R., 2021, ANN ROMANIAN SOC CEL, V25, P7317, DOI DOI 10.1016/J.INDCROP.2018.10.034; Han J, 2019, TEXT RES J, V89, P1094, DOI 10.1177/0040517518763989; Hong KH, 2018, FASH TEXT, V5, DOI 10.1186/s40691-018-0151-3; Huang X, 2020, COLLOID SURFACE A, V586, DOI 10.1016/j.colsurfa.2019.124163; Hwang EK, 2008, FIBER POLYM, V9, P334, DOI 10.1007/s12221-008-0054-9; KEMSLEY EK, 1995, FOOD CHEM, V54, P321, DOI 10.1016/0308-8146(95)00030-M; Kenawy ER, 2018, J ENVIRON MANAGE, V219, P285, DOI 10.1016/j.jenvman.2018.04.121; Khamkeaw A, 2019, SEP SCI TECHNOL, V54, P2180, DOI 10.1080/01496395.2018.1541906; Khan MA, 2020, J HAZARD MATER, V400, DOI 10.1016/j.jhazmat.2020.123247; Kim Chun Whan, 2018, [The Journal of the Korean Society of International Agriculture, 한국국제농업개발학회지], V30, P120, DOI 10.12719/KSIA.2018.30.2.120; Kim Hyunjin, 2021, [Journal of the Korean Society of Clothing and Textiles, 한국의류학회지], V45, P866; Kim H, 2021, CELLULOSE, V28, P3183, DOI 10.1007/s10570-021-03705-0; Kim  H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233952; Kim H, 2020, TEXT RES J, V90, P1517, DOI 10.1177/0040517519893717; KISSA E, 1995, J AM OIL CHEM SOC, V72, P793, DOI 10.1007/BF02541027; Kumari S, 2016, CHEM ENG J, V304, P728, DOI 10.1016/j.cej.2016.07.008; Kuswandi B, 2012, FOOD ANAL METHOD, V5, P881, DOI 10.1007/s12161-011-9326-x; Lafi R, 2019, ADSORPT SCI TECHNOL, V37, P160, DOI 10.1177/0263617418819227; Lafi R, 2014, KOREAN J CHEM ENG, V31, P2198, DOI 10.1007/s11814-014-0171-7; Lee Hye Bin, 2018, [Fashion & Textile Research Journal, 한국의류산업학회지], V20, P323, DOI 10.5805/SFTI.2018.20.3.323; Lee YH, 2007, J APPL POLYM SCI, V103, P251, DOI 10.1002/app.25221; Li DW, 2020, CHEM ENG J, V383, DOI 10.1016/j.cej.2019.123127; Li XL, 2018, MOLECULES, V23, DOI 10.3390/molecules23051010; Liu Q, 2021, CARBOHYD POLYM, V255, DOI 10.1016/j.carbpol.2020.117402; Lyman DJ, 2011, INT J SPECTROSC, DOI 10.1155/2011/815304; Marsudi Maradhana Agung, 2021, Key Engineering Materials, V891, P62, DOI 10.4028/www.scientific.net/KEM.891.62; Mestre A, 2011, CIENCE TECNOL MAT, V23, P52; Mittal A, 2016, DESALIN WATER TREAT, V57, P21863, DOI 10.1080/19443994.2015.1125805; Naushad M, 2019, J MOL LIQ, V293, DOI 10.1016/j.molliq.2019.111442; Naushad M, 2019, J CLEAN PROD, V241, DOI 10.1016/j.jclepro.2019.118263; Nono PN, 2016, CHEM SCI T, V5, P661, DOI [10.7598/cst2016.1247, DOI 10.7598/CST2016.1247]; Oliveira LS, 2008, J HAZARD MATER, V155, P507, DOI 10.1016/j.jhazmat.2007.11.093; Park Soon-Ja, 2017, [The Korean Society of Community Living Science, 한국지역사회생활과학회지], V28, P143, DOI 10.7856/kjcls.2017.28.1.143; Paul D, 2017, J SCI ENG, V4, P388; Pirich CL, 2015, CELLULOSE, V22, P1773, DOI 10.1007/s10570-015-0626-y; Pourjavaher S, 2017, CARBOHYD POLYM, V156, P193, DOI 10.1016/j.carbpol.2016.09.027; Pujol D, 2013, IND CROP PROD, V50, P423, DOI 10.1016/j.indcrop.2013.07.056; Qiao Q, 2020, J CHEM ENG DATA, V65, P360, DOI 10.1021/acs.jced.9b00701; Rivera W, 2011, PROC FOOD SCI, V1, P385, DOI 10.1016/j.profoo.2011.09.059; Rossi E, 2018, J ENVIRON CHEM ENG, V6, P6844, DOI 10.1016/j.jece.2018.10.055; Saeed A, 2009, J HAZARD MATER, V168, P406, DOI 10.1016/j.jhazmat.2009.02.058; Saleh AK, 2021, BIOMASS CONVERS BIOR, DOI 10.1007/s13399-021-01973-1; Sanchez PM, 2018, J BRAZIL CHEM SOC, V29, P168, DOI 10.21577/0103-5053.20170125; Sanchez-Martin J, 2010, J HAZARD MATER, V174, P9, DOI 10.1016/j.jhazmat.2009.09.008; Segal L., 1959, TEXT RES J, V29, P786, DOI [DOI 10.1177/004051755902901003, 10.1177/004051755902901003]; Singh O, 2017, FOOD SCI BIOTECHNOL, V26, P1019, DOI 10.1007/s10068-017-0143-x; Song JE, 2019, FRONT BIOENG BIOTECH, V7, DOI 10.3389/fbioe.2019.00332; Song JE, 2020, TEXT RES J, V90, P166, DOI 10.1177/0040517519862886; Song JE, 2018, AMB EXPRESS, V8, DOI 10.1186/s13568-018-0552-0; Song JE, 2017, ENG LIFE SCI, V17, P1108, DOI 10.1002/elsc.201700085; Song W-S., 2004, NATURAL DYEING OUR B, V1st; Ul-Islam M, 2012, CARBOHYD POLYM, V88, P596, DOI 10.1016/j.carbpol.2012.01.006; Wabaidur SM, 2020, J MOL LIQ, V317, DOI 10.1016/j.molliq.2020.113916; Yan TG, 2013, BIORESOURCES, V8, P4722; Yi XT, 2021, MATER CHEM PHYS, V272, DOI 10.1016/j.matchemphys.2021.124985; Yusuf M, 2017, NAT PRODUCT BIOPROSP, V7, P123, DOI 10.1007/s13659-017-0119-9; Zhang TM, 2021, CELLULOSE, V28, P4281, DOI 10.1007/s10570-021-03737-6; Zhuang ST, 2019, J MOL LIQ, V294, DOI 10.1016/j.molliq.2019.111682	80	0	0	10	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265743	10.1371/journal.pone.0265743	http://dx.doi.org/10.1371/journal.pone.0265743			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324974	gold, Green Published			2022-12-26	WOS:000780951300065
J	Okada, Y; Kimoto, M; Iio, T; Shimohara, K; Nittono, H; Shiomi, M				Okada, Yuka; Kimoto, Mitsuhiko; Iio, Takamasa; Shimohara, Katsunori; Nittono, Hiroshi; Shiomi, Masahiro			Kawaii emotions in presentations: Viewing a physical touch affects perception of affiliative feelings of others toward an object	PLOS ONE			English	Article								We investigated how a presenter's touching behaviors of an object during its explanation affect the observer's perceived feelings of kawaii, a Japanese word that means "cute," toward the object and the presenter. We conducted a face-to-face experiment with a robot presenter as well as a web survey experiment with both robot and human presenters. Based on the phenomenon that people more firmly touch an object when their perceived kawaii feeling is overwhelmingly strong, we investigated the effects of touching behavior with emphasized styles. First, we conducted a face-to-face experiment with a robot presenter where participants observed their presentations about an object to explain its characteristics. The results showed that participants who observed the robot's touch behaviors perceived the object to be more kawaii and thought that the robot also felt the object was more kawaii. On the other hand, the results did not effectively show any increase in the participant's feelings of kawaii toward the robot or the emphasized touch style. Based on these results, we next conducted a web survey experiment to investigate whether such knowledge about touching effects is applicable for human presenters. The results resembled those obtained when the presenter was a robot, i.e., viewing a touch behavior increased both the presenter's perceived feelings of kawaii toward the object and the participant's feelings of kawaii toward it. These results suggest that viewing the touch behaviors of others influenced the perceived emotional feelings toward both presenters and objects.	[Okada, Yuka; Kimoto, Mitsuhiko; Iio, Takamasa; Shimohara, Katsunori; Nittono, Hiroshi; Shiomi, Masahiro] Adv Telecommun Res Inst Int, Dept Agent Interact Design Lab, Kyoto, Japan; [Okada, Yuka; Shimohara, Katsunori] Doshisha Univ, Dept Informat Syst Design, Kyoto, Japan; [Kimoto, Mitsuhiko] Keio Univ, Dept Informat & Comp Sci, Yokohama, Kanagawa, Japan; [Iio, Takamasa] Doshisha Univ, Fac Culture & Informat Sci, Kyoto, Japan; [Nittono, Hiroshi] Osaka Univ, Grad Sch Human Sci, Suita, Osaka, Japan	Advanced Telecommunications Research Institute International; Doshisha University; Keio University; Doshisha University; Osaka University	Okada, Y (corresponding author), Adv Telecommun Res Inst Int, Dept Agent Interact Design Lab, Kyoto, Japan.; Okada, Y (corresponding author), Doshisha Univ, Dept Informat Syst Design, Kyoto, Japan.	okada2019@sil.doshisha.ac.jp	Nittono, Hiroshi/C-4043-2009	Nittono, Hiroshi/0000-0001-5671-609X; Kimoto, Mitsuhiko/0000-0001-8441-8815	JST CREST Grant, Japan [JPMJCR18A1]; JST PRESTO, Japan [JPMJPR1851]; JSPS KAKENHI [JP19J01290, JP21H04897]	JST CREST Grant, Japan; JST PRESTO, Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially supported by JST CREST Grant, Number JPMJCR18A1, Japan, JST PRESTO Grant Number JPMJPR1851, Japan, and JSPS KAKENHI Grant Numbers JP19J01290 and JP21H04897. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aragon OR, 2015, PSYCHOL SCI, V26, P259, DOI 10.1177/0956797614561044; Asch S. E., 1951, GROUPS LEADERSHIP ME, P177; Berque D., 2019, CUTENESS JAPANESE DE, P392; Bickmore T, 2008, INT J SEMANT COMPUT, V2, P47, DOI 10.1142/S1793351X08000348; Bickmore TW, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P1265; Bremner P, 2015, ACMIEEE INT CONF HUM, P255, DOI 10.1145/2696454.2696496; Bremner P, 2016, FRONT PSYCHOL, V7, DOI 10.3389/fpsyg.2016.00183; Brooks V., 1960, PERCEPT MOTOR SKILL; Caudwell C, 2020, PROCEEDINGS OF THE 31ST AUSTRALIAN CONFERENCE ON HUMAN-COMPUTER-INTERACTION (OZCHI'19), P64, DOI 10.1145/3369457.3369463; Caudwell C, 2020, CONVERGENCE-US, V26, P956, DOI 10.1177/1354856519837792; Downs JS, 2010, CHI2010: PROCEEDINGS OF THE 28TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P2399; Duffy BR, 2003, ROBOT AUTON SYST, V42, P177, DOI 10.1016/S0921-8890(02)00374-3; Glas DF, 2016, IEEE ROMAN, P22, DOI 10.1109/ROMAN.2016.7745086; Grana M, 2019, CYBERNET SYST, V50, P40, DOI 10.1080/01969722.2018.1558013; Hashimoto T., 2006, P SICE ICASE INT JOI, P5423, DOI DOI 10.1109/SICE.2006.315537; Heikkila P, 2019, LECT NOTES ARTIF INT, V11876, P548, DOI 10.1007/978-3-030-35888-4_51; Iio T., 2019, INT J SOC ROBOT; Jung MF, 2017, ACMIEEE INT CONF HUM, P263, DOI 10.1145/2909824.3020224; Kinsella Sharon, 2013, WOMEN MEDIA CONSUMPT, P230; Kirby R, 2010, ROBOT AUTON SYST, V58, P322, DOI 10.1016/j.robot.2009.09.015; Law T, 2021, INT J SOC ROBOT, V13, P1967, DOI 10.1007/s12369-020-00711-3; Lieber-Milo S, 2019, STUDIES, V3, P13, DOI [10.18910/73599, DOI 10.18910/73599]; Lieber-Milo S, 2019, SAGE OPEN, V9, DOI 10.1177/2158244019869904; Lorenz K., 1943, Zeitschrift fuer Tierpsychologie Berlin, V5, P235; Lutkebohle I, 2010, IEEE INT CONF ROBOT, P3384, DOI 10.1109/ROBOT.2010.5509173; Myrick JG, 2015, COMPUT HUM BEHAV, V52, P168, DOI 10.1016/j.chb.2015.06.001; Niemela M., 2019, SOCIAL ROBOTS TECHNO, P119; Nishio S., 2007, HUM ROBOTS NEW DEV, V14, P343, DOI [DOI 10.5772/4876, 10.5772/4876]; Nishiyama K, 2015, EVOL PSYCHOL-US, V13, P470; Nittono H., 2016, E ASIAN J POPULAR CU, V2, P79, DOI [10.1386/eapc.2.1.79_1, DOI 10.1386/EAPC.2.1.79_1]; Nittono H, 2017, SAGE OPEN, V7, DOI 10.1177/2158244017709321; Nittono H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046362; Oppenheimer DM, 2009, J EXP SOC PSYCHOL, V45, P867, DOI 10.1016/j.jesp.2009.03.009; Proverbio A.M., 2011, PSYCHOLOGY, V02, P931, DOI DOI 10.4236/PSYCH.2011.29140; Qie N., 2019, KAWAII ENG, P225; Shiomi M, 2019, ADV ROBOTICS, V33, P756, DOI 10.1080/01691864.2019.1617781; Spatola N, 2021, COMPUT HUM BEHAV, V124, DOI 10.1016/j.chb.2021.106934; Spatola N, 2020, IEEE ROBOT AUTOM MAG, V27, P73, DOI 10.1109/MRA.2019.2928823; Stavropoulos KKM, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00300; Sugano S., 2019, KAWAII ENG, P77, DOI [10.1007/978-981-13-7964-2_4, DOI 10.1007/978-981-13-7964-2_4]; Thuruthel TG, 2018, SOFT ROBOT, V5, P149, DOI 10.1089/soro.2017.0007; van Breemen A., 2005, P 4 INT JOINT C AUTO, P143; Vollmer AL, 2018, SCI ROBOT, V3, DOI 10.1126/scirobotics.aat7111; Zecca Massimiliano, 2008, 2008 8th IEEE-RAS International Conference on Humanoid Robots (Humanoids 2008), P487, DOI 10.1109/ICHR.2008.4755969	44	0	0	4	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264736	10.1371/journal.pone.0264736	http://dx.doi.org/10.1371/journal.pone.0264736			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324906	Green Published, gold			2022-12-26	WOS:000780951300019
J	Santos-Rosa, FJ; Montero-Carretero, C; Gomez-Landero, LA; Torregrossa, M; Cervello, E				Santos-Rosa, Francisco J.; Montero-Carretero, Carlos; Arturo Gomez-Landero, Luis; Torregrossa, Miquel; Cervello, Eduardo			Positive and negative spontaneous self-talk and performance in gymnastics: The role of contextual, personal and situational factors	PLOS ONE			English	Article							COMPETITIVE STATE ANXIETY; PERCEIVED MOTIVATIONAL CLIMATE; PSYCHOLOGICAL SKILLS USE; ACHIEVEMENT GOALS; PSYCHOMETRIC PROPERTIES; TENNIS; COACH; GAME; QUESTIONNAIRE; ORIENTATIONS	The purpose of this study was to analyse whether contextual (perception of motivational climate and positive and negative spontaneous self-talk in sports), personal (positivity) and situational variables (positive and negative spontaneous self-talk employed in competition and precompetitive anxiety) predict performance in a competition of ensembles of rhythmic gymnastics. 258 female gymnasts between ages14 and 20 (M = 15.24, SD = 1.46) participated in the study, completing pre- and post-competition measures. The results of the path-analysis showed that both the task-involving climate and positivity predicted positive self-talk in sport. This predicted self-confidence which, in turn, positively predicted positive situational self-talk in competition. For its part, the perception of an ego-involving climate positively predicted the use of both negative and positive self-talk in sport. Negative self-talk in sports predicted negative situational self-talk in competition and somatic and cognitive anxiety. In turn, cognitive anxiety positively predicted negative situational self-talk. Finally, performance was positively predicted by positive situational self-talk and negatively by negative situational self-talk. These results explain the functioning of spontaneous self-talk at different levels of generality and its relationship with sports performance.	[Santos-Rosa, Francisco J.; Arturo Gomez-Landero, Luis] Univ Pablo de Olavide, Dept Sports & Comp Sci, Seville, Spain; [Montero-Carretero, Carlos; Cervello, Eduardo] Univ Miguel Hernandez Elche, Sports Res Ctr, Dept Sport Sci, Elche, Spain; [Torregrossa, Miquel] Univ Autonoma Barcelona, Dept Basic Educ & Dev Psychol, Barcelona, Spain; [Torregrossa, Miquel] Univ Autonoma Barcelona, Sport Res Inst, Barcelona, Spain	Universidad Pablo de Olavide; Universidad Miguel Hernandez de Elche; Autonomous University of Barcelona; Autonomous University of Barcelona	Montero-Carretero, C (corresponding author), Univ Miguel Hernandez Elche, Sports Res Ctr, Dept Sport Sci, Elche, Spain.	cmontero@umh.es	Torregrossa, Miquel/A-1706-2014	Torregrossa, Miquel/0000-0003-1117-9977; Gomez-Landero, Luis Arturo/0000-0002-4426-6682; Montero, Carlos/0000-0002-1565-8169	Andalusian Gymnastics Federation; Pablo de Olavide University [2019/00183/001]	Andalusian Gymnastics Federation; Pablo de Olavide University	Financial support provided by the Andalusian Gymnastics Federation and the Pablo de Olavide University. Project reference: 2019/00183/001. Author who received the award: Luis Arturo Go ' mez-Landero. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ada EN, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13115764; Amado D, 2019, J HUM KINET, V70, P245, DOI 10.2478/hukin-2019-0116; AMES C, 1992, MOTIVATION IN SPORT AND EXERCISE, P161; Fernandez EMA, 2007, PSICOTHEMA, V19, P150; Balaguer I., 1997, REV PSICOL DEPORTE, V11, P41; Brisimis E, 2020, J ED SOC BEHAV SCI, V33, P112; Butt J, 2003, SPORT PSYCHOL, V17, P35, DOI 10.1123/tsp.17.1.35; Byrne D., 2009, SAGE HDB CASE BASED; Caprara GV, 2019, ASIAN J SOC PSYCHOL, V22, P126, DOI 10.1111/ajsp.12325; Caprara GV, 2012, PSYCHOL ASSESSMENT, V24, P701, DOI 10.1037/a0026681; Caprara GV, 2009, BEHAV GENET, V39, P277, DOI 10.1007/s10519-009-9267-y; Caprara GV, 2017, J HAPPINESS STUD, V18, P353, DOI DOI 10.1007/s10902-016-9728-y; Cea Dancona M.A., 2002, ANALISIS MULTIVARIAB; Cervello E, 2007, J APPL SPORT PSYCHOL, V19, P304, DOI 10.1080/10413200701329134; Cheng WNK, 2016, PSYCHOL SPORT EXERC, V22, P255, DOI 10.1016/j.psychsport.2015.07.006; Conroy DE, 2004, J SPORT EXERCISE PSY, V26, P69, DOI 10.1123/jsep.26.1.69; Cox RH, 2003, J SPORT EXERCISE PSY, V25, P519, DOI 10.1123/jsep.25.4.519; Dallas G, 2019, SCI GYMNAST J, V11, P299; de la Fuente J, 2021, FRONT PSYCHIATRY, V12, DOI 10.3389/fpsyt.2021.596453; De Muynck GJ, 2020, SCAND J MED SCI SPOR, V30, P602, DOI 10.1111/sms.13609; Dickens YL, 2018, SPORT PSYCHOL, V32, P66, DOI 10.1123/tsp.2016-0073; Diener E, 2009, SOC INDIC RES SER, V38, P229, DOI 10.1007/978-90-481-2352-0_11; Fritsch J, 2022, J APPL SPORT PSYCHOL, V34, P518, DOI 10.1080/10413200.2020.1821406; Georgakaki S.K., 2017, PSYCHOLOGY, V8, P677, DOI [DOI 10.4236/PSYCH.2017.85044, 10.4236/psych.2017.85044]; Hardy J, 2001, SPORT PSYCHOL, V15, P306, DOI 10.1123/tsp.15.3.306; Hardy J, 2016, ROUTLEDGE INT HDB SP, P449; Harwood C, 2004, J APPL SPORT PSYCHOL, V16, P318, DOI 10.1080/10413200490517986; Hatzigeorgiadis A, 2009, PSYCHOL SPORT EXERC, V10, P186, DOI 10.1016/j.psychsport.2008.07.009; Hatzigeorgiadis A, 2007, J APPL SPORT PSYCHOL, V19, P240, DOI 10.1080/10413200701230621; Henderson N, 2003, RESILIENCIA ESCUELAS; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Hyphantis T, 2013, J PSYCHOSOM RES, V75, P362, DOI 10.1016/j.jpsychores.2013.08.014; JONES G, 1995, BRIT J PSYCHOL, V86, P449, DOI 10.1111/j.2044-8295.1995.tb02565.x; Karamitrou A., 2020, SELF TALK SPORT, P77, DOI [https://doi.org/10.4324/9780429460623-6, DOI 10.4324/9780429460623-6]; Kline R.B., 2005, PRINCIPLES PRACTICE, V2, DOI DOI 10.1038/156278A0; Laborde S, 2016, PSYCHOL SPORT EXERC, V26, P9, DOI 10.1016/j.psychsport.2016.05.009; Landin D, 1999, J APPL SPORT PSYCHOL, V11, P263, DOI 10.1080/10413209908404204; Lane AM, 2009, SOC BEHAV PERSONAL, V37, P195, DOI 10.2224/sbp.2009.37.2.195; Latinjak AT, 2019, SPORT EXERC PERFORM, V8, P353, DOI 10.1037/spy0000160; Latinjak AT, 2018, REV PSICOL DEPORTE, V27, P75; Latinjak AT, 2017, J APPL SPORT PSYCHOL, V29, P150, DOI 10.1080/10413200.2016.1213330; Latinjak AT, 2016, INT J SPORT EXERC PS, V14, P402, DOI 10.1080/1612197X.2015.1055287; Loewenthal K.M., 1996, INTROD PSYCHOL TESTS; Lois Rio G., 2014, MEDIDA ANSIEDAD PREC; Mallett CJ, 1997, SPORT PSYCHOL, V11, P72, DOI 10.1123/tsp.11.1.72; Marjanovic M, 2019, MOTIV EMOTION, V43, P592, DOI 10.1007/s11031-019-09760-2; Murcia JAM, 2008, SPAN J PSYCHOL, V11, P181, DOI 10.1017/S1138741600004224; Newton M, 2000, J SPORT SCI, V18, P275, DOI 10.1080/026404100365018; NEWTON M, 1993, J SPORT EXERCISE PSY, V15, P437, DOI 10.1123/jsep.15.4.437; Nicholls J., 1989, COMPETITIVE ETHOS DE; Norem JK, 2008, SOC PERSONAL PSYCHOL, V2, P121, DOI 10.1111/j.1751-9004.2007.00053.x; Ntoumanis N, 1999, J SPORT SCI, V17, P643, DOI 10.1080/026404199365678; Perkos S, 2002, SPORT PSYCHOL, V16, P368, DOI 10.1123/tsp.16.4.368; Raglin JS, 2000, EMOTIONS SPORT, P39, DOI [10.1034/j.1600-0838.2000.010001051.x, DOI 10.1034/J.1600-0838.2000.010001051.X]; Randle S, 1997, SPORT PSYCHOL, V11, P160, DOI 10.1123/tsp.11.2.160; Seligman MEP, 2000, AM PSYCHOL, V55, P5, DOI 10.1037/0003-066X.56.1.89; Thelma S., 2008, ADV SPORT PSYCHOL, P157; Thelwell RC, 2009, INT J SPORT EXERC PS, V7, P203, DOI 10.1080/1612197X.2009.9671900; Theodorakis Y, 2001, PERCEPT MOTOR SKILL, V92, P309, DOI 10.2466/PMS.92.1.309-315; Thibodeaux J, 2022, RES Q EXERCISE SPORT, V93, P769, DOI 10.1080/02701367.2021.1918323; Thibodeaux J, 2018, PSYCHOL SPORT EXERC, V38, P126, DOI 10.1016/j.psychsport.2018.06.006; Vallerand RJ, 1997, ADV EXP SOC PSYCHOL, V29, P271, DOI 10.1016/S0065-2601(08)60019-2; van de Pol PKC, 2011, PSYCHOL SPORT EXERC, V12, P176, DOI 10.1016/j.psychsport.2010.09.005; Van Raalte JL, 2016, PSYCHOL SPORT EXERC, V22, P139, DOI 10.1016/j.psychsport.2015.08.004; VANRAALTE JL, 1994, J SPORT EXERCISE PSY, V16, P400, DOI 10.1123/jsep.16.4.400; Woodman T, 2009, J SPORT EXERCISE PSY, V31, P169, DOI 10.1123/jsep.31.2.169; Zourbanos N, 2016, J APPL SPORT PSYCHOL, V28, P97, DOI 10.1080/10413200.2015.1074630; Zourbanos N, 2015, PSYCHOL SPORT EXERC, V18, P32, DOI 10.1016/j.psychsport.2014.12.003; Zourbanos N, 2011, PSYCHOL SPORT EXERC, V12, P407, DOI 10.1016/j.psychsport.2011.03.001; Zourbanos N, 2010, J SPORT EXERCISE PSY, V32, P764, DOI 10.1123/jsep.32.6.764; Zourbanos N, 2009, SPORT PSYCHOL, V23, P233, DOI 10.1123/tsp.23.2.233	71	0	0	6	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265809	10.1371/journal.pone.0265809	http://dx.doi.org/10.1371/journal.pone.0265809			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0K7DW	35325003	Green Published, gold			2022-12-26	WOS:000780951300074
J	Thio-Pera, A; De Carlo, M; Manzoni, A; D'Elia, F; Cerone, GL; Putame, G; Terzini, M; Gazzoni, M; Bignardi, C; Vieira, T				Thio-Pera, Alba; De Carlo, Matteo; Manzoni, Andrea; D'Elia, Fabrizio; Cerone, Giacinto Luigi; Putame, Giovanni; Terzini, Mara; Gazzoni, Marco; Bignardi, Cristina; Vieira, Taian			Are the forearm muscles excited equally in different, professional piano players?	PLOS ONE			English	Article							MUSCULOSKELETAL DISORDERS; PREVALENCE; FINGER; MUSICIANS; NOVICE; HAND	Background and objectives Professional pianists tend to develop playing-related musculoskeletal disorders mostly in the forearm. These injuries are often due to overuse, suggesting the existence of a common forearm region where muscles are often excited during piano playing across subjects. Here we use a grid of electrodes to test this hypothesis, assessing where EMGs with greatest amplitude are more likely to be detected when expert pianists perform different excerpts. Methods Tasks were separated into two groups: classical excerpts and octaves, performed by eight, healthy, professional pianists. Monopolar electromyograms (EMGs) were sampled with a grid of 96 electrodes, covering the forearm region where hand and wrist muscles reside. Regions providing consistently high EMG amplitude across subjects were assessed with a non-parametric permutation test, designed for the statistical analysis of neuroimaging experiments. Spatial consistency across trials was assessed with the Binomial test. Results Spatial consistency of muscle excitation was found across subjects but not across tasks, confining at most 20% of the electrodes in the grid. These local groups of electrodes providing high EMG amplitude were found at the ventral forearm region during classical excerpts and at the dorsal region during octaves, when performed both at preferred and at high, playing speeds. Discussion Our results revealed that professional pianists consistently load a specific forearm region, depending on whether performing octaves or classical excerpts. This spatial consistency may help furthering our understanding on the incidence of playing-related musculardisorders and provide an anatomical reference for the study of active muscle loading in piano players using surface EMG.	[Thio-Pera, Alba; Cerone, Giacinto Luigi; Gazzoni, Marco; Vieira, Taian] Politecn Torino, Lab Engn Neuromuscular Syst LISiN, Turin, Italy; [De Carlo, Matteo; Cerone, Giacinto Luigi; Putame, Giovanni; Terzini, Mara; Gazzoni, Marco; Bignardi, Cristina; Vieira, Taian] Politecn Torino, PolitoBIOMed Lab, Turin, Italy; [De Carlo, Matteo; Putame, Giovanni; Terzini, Mara; Bignardi, Cristina] Politecn Torino, Dept Mech & Aerosp Engn, Turin, Italy; [Manzoni, Andrea; D'Elia, Fabrizio] Another Mus Records, Paris, France	Polytechnic University of Turin; Polytechnic University of Turin; Polytechnic University of Turin	Thio-Pera, A (corresponding author), Politecn Torino, Lab Engn Neuromuscular Syst LISiN, Turin, Italy.	thioalbs@gmail.com	Terzini, Mara/M-7358-2019	Terzini, Mara/0000-0002-5699-6009; CERONE, GIACINTO LUIGI/0000-0002-5295-5314; Gazzoni, Marco/0000-0001-5939-6212; PUTAME, GIOVANNI/0000-0002-4585-0979; Bignardi, Cristina/0000-0002-7065-2552				Aoyama T, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0236254; Baeyens JP, 2020, MED PROBL PERFORM AR, V35, P81, DOI 10.21091/mppa.2020.2013; Bragge P, 2006, OCCUP MED-OXFORD, V56, P28, DOI 10.1093/occmed/kqi177; Bruno S, 2008, INT ARCH OCC ENV HEA, V81, P855, DOI 10.1007/s00420-007-0279-8; Cerone GL, 2019, IEEE T BIO-MED ENG, V66, P3371, DOI 10.1109/TBME.2019.2904398; Chong HJ, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.01277; FAULKNER JA, 1993, PHYS THER, V73, P911, DOI 10.1093/ptj/73.12.911; Ferrario VF, 2007, MED PROBL PERFORM AR, V22, P18; Furuya S, 2008, BIOMECHANICS UPPER E; Furuya S, 2008, EXP BRAIN RES, V185, P581, DOI 10.1007/s00221-007-1184-9; Furuya S, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00173; Furuya S, 2012, HUM MOVEMENT SCI, V31, P26, DOI 10.1016/j.humov.2011.01.002; Gallina A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00367; Gerard MJ, 1999, AM IND HYG ASSOC J, V60, P762; Goolsby TW, 1996, J RES MUSIC EDUC, V44, P286, DOI 10.2307/3345442; Goubault E, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-87403-8; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Hu XG, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00279; James B, 2018, FRONT PSYCHOL, V9, DOI 10.3389/fpsyg.2018.02125; Johnson KVB, 2004, EXP BRAIN RES, V154, P479, DOI 10.1007/s00221-003-1678-z; Kaufman-Cohen Y, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208788; Kok LM, 2013, CLIN RHEUMATOL, V32, P487, DOI 10.1007/s10067-013-2199-1; Kok LM, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-9; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; Niu R., 2020, CURR OPIN NEUROBIOL; Oikawa N, 2011, HONG KONG J OCCUP TH, V21, P41, DOI 10.1016/j.hkjot.2011.06.002; Pak CH, 2001, MED PROBL PERFORM AR, V16, P17; Readi NG, 2015, SCAND J MED SCI SPOR, V25, pe339, DOI 10.1111/sms.12319; Serafino F, 2021, BMC MUSCULOSKEL DIS, V22, DOI 10.1186/s12891-021-04287-5; Silva AG, 2015, MED PROBL PERFORM AR, V30, P8, DOI 10.21091/mppa.2015.1002; Vieira TM, 2021, EXERC SPORT SCI REV, V49, P23, DOI 10.1249/JES.0000000000000240; Zaza C, 1998, SOC SCI MED, V47, P2013, DOI 10.1016/S0277-9536(98)00307-4	32	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265575	10.1371/journal.pone.0265575	http://dx.doi.org/10.1371/journal.pone.0265575			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316295	gold, Green Published			2022-12-26	WOS:000834238000029
J	Zafar, Z; Fatima, S; Bhatti, MF; Shah, FA; Saud, Z; Butt, TM				Zafar, Zeeshan; Fatima, Sidra; Bhatti, Muhammad Faraz; Shah, Farooq A.; Saud, Zack; Butt, Tariq M.			Odorant Binding Proteins (OBPs) and Odorant Receptors (ORs) of Anopheles stephensi: Identification and comparative insights	PLOS ONE			English	Article							MALARIA VECTOR; AEDES-AEGYPTI; MOLECULAR DOCKING; PHEROMONE-BINDING; MOSQUITO; GENE; GAMBIAE; EXPRESSION; DIPTERA; ANNOTATION	Anopheles stephensi is an important vector of malaria in the South Asia, the Middle East, and Eastern Africa. The olfactory system of An. stephensi plays an important role in host-seeking, oviposition, and feeding. Odorant binding proteins (OBPs) are globular proteins that play a pivotal role in insect olfaction by transporting semiochemicals through the sensillum lymph to odorant receptors (ORs). Custom motifs designed from annotated OBPs of Aedes aegypti, Drosophila melanogaster, and Anopheles gambiae were used for the identification of putative OBPs from protein sequences of the An. stephensi Indian strain. Further, BLASTp was also performed to identify missing OBPs and ORs. Subsequently, the presence of domains common to OBPs was confirmed. Identified OBPs were further classified into three sub-classes. Phylogenetic and syntenic analyses were carried out to find homology, and thus the evolutionary relationship between An. stephensi OBPs and ORs with those of An. gambiae, Ae. aegypti and D. melanogaster. Gene structure and physicochemical properties of the OBPs and ORs were also predicted. A total of 44 OBPs and 45 ORs were predicted from the protein sequences of An. stephensi. OBPs were further classified into the classic (27), atypical (10) and plus-C (7) OBP subclasses. The phylogeny revealed close relationship of An. stephensi OBPs and ORs with An. gambiae homologs whereas only five OBPs and two ORs of An. stephensi were related to Ae. aegypti OBPs and ORs, respectively. However, D. melanogaster OBPs and ORs were distantly rooted. Synteny analyses showed the presence of collinear block between the OBPs and ORs of An. stephensi and An. gambiae as well as Ae. aegypti's. No homology was found with D. melanogaster OBPs and ORs. As an important component of the olfactory system, correctly identifying a species' OBPs and ORs provide a valuable resource for downstream translational research that will ultimately aim to better control the malaria vector An. stephensi.	[Zafar, Zeeshan; Fatima, Sidra; Bhatti, Muhammad Faraz] Natl Univ Sci & Technol NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Sect H-12, Islamabad, Pakistan; [Shah, Farooq A.] Razbio Ltd, Bridgend, Wales; [Saud, Zack; Butt, Tariq M.] Swansea Univ, Dept Biol Sci, Swansea, W Glam, Wales	National University of Sciences & Technology - Pakistan; Swansea University	Bhatti, MF (corresponding author), Natl Univ Sci & Technol NUST, Atta Ur Rahman Sch Appl Biosci ASAB, Sect H-12, Islamabad, Pakistan.; Butt, TM (corresponding author), Swansea Univ, Dept Biol Sci, Swansea, W Glam, Wales.	mfbhatti@asab.nust.edu.pk; t.butt@swansea.ac.uk						Bailey TL, 2015, NUCLEIC ACIDS RES, V43, pW39, DOI 10.1093/nar/gkv416; Basak SC, 2020, CURR MED CHEM, V27, P32, DOI [10.2174/0929867325660181029105413, 10.2174/0929867325666181029165413]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bezerra-Silva PC, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150008; Bhadoriya KS, 2013, MED CHEM RES, V22, P2312, DOI 10.1007/s00044-012-0226-4; Bohbot J, 2007, INSECT MOL BIOL, V16, P525, DOI 10.1111/j.1365-2583.2007.00748.x; Brito NF, 2016, J INSECT PHYSIOL, V95, P51, DOI 10.1016/j.jinsphys.2016.09.008; Chen C., 2020, TBTOOLS TOOLKIT BIOL, V289660, P289660, DOI DOI 10.1101/289660; Chen MS, 2008, INSECT SCI, V15, P101, DOI 10.1111/j.1744-7917.2008.00190.x; Chertemps T., 2021, INSECT PHEROMONE BIO, V2nd ed., P619, DOI DOI 10.1016/B978-0-12-819628-1.00019-5; Damberger FF, 2013, P NATL ACAD SCI USA, V110, P18680, DOI 10.1073/pnas.1317706110; de Castro E, 2006, NUCLEIC ACIDS RES, V34, pW362, DOI 10.1093/nar/gkl124; Dekker T, 2002, MED VET ENTOMOL, V16, P91, DOI 10.1046/j.0269-283x.2002.00345.x; Devillers J, 2018, SAR QSAR ENVIRON RES, V29, P693, DOI 10.1080/1062936X.2018.1513218; Djadid ND, 2006, ACTA TROP, V97, P65, DOI 10.1016/j.actatropica.2005.08.003; Faulde MK, 2014, ACTA TROP, V139, P39, DOI 10.1016/j.actatropica.2014.06.016; Gakhar SK, 2013, INDIAN J EXP BIOL, V51, P273; Gao Q, 1999, GENOMICS, V60, P31, DOI 10.1006/geno.1999.5894; Gholizadeh S, 2013, ACTA TROP, V126, P63, DOI 10.1016/j.actatropica.2012.11.003; Ghosh SK, 2008, J BIOSCIENCES, V33, P333, DOI 10.1007/s12038-008-0052-5; Gopal JV, 2013, INTERDISCIP SCI, V5, P280, DOI 10.1007/s12539-013-0152-2; Graham LA, 2002, GENE, V292, P43, DOI 10.1016/S0378-1119(02)00672-8; Gupta KK, 2016, J VECTOR DIS, V53, P179; He P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028921; Healy TP, 2002, MED VET ENTOMOL, V16, P126, DOI 10.1046/j.1365-2915.2002.00353.x; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hoffman SA, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-27; Kumar S, 2018, MOL BIOL EVOL, V35, P1547, DOI 10.1093/molbev/msy096; Letunic I, 2019, NUCLEIC ACIDS RES, V47, pW256, DOI 10.1093/nar/gkz239; Li ZX, 2005, ARCH INSECT BIOCHEM, V58, P175, DOI 10.1002/arch.20047; Liu NY, 2018, COMP BIOCHEM PHYS D, V25, P73, DOI 10.1016/j.cbd.2017.11.003; Manoharan M, 2013, GENOME BIOL EVOL, V5, P163, DOI 10.1093/gbe/evs131; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Mazumder S, 2019, BIOCHEMISTRY-US, V58, P4530, DOI 10.1021/acs.biochem.9b00737; Nie XP, 2018, J APPL ENTOMOL, V142, P149, DOI 10.1111/jen.12417; Oliferenko PV, 2017, COMPUTATIONAL DESIGN, P39; Pelletier J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006237; PELOSI P, 1995, COMP BIOCHEM PHYS B, V111, P503, DOI 10.1016/0305-0491(95)00019-5; Pelosi P, 2018, SENSORS-BASEL, V18, DOI 10.3390/s18103248; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Ray A, 2014, J BIOSCIENCES, V39, P555, DOI 10.1007/s12038-014-9447-7; Rickman LS, 1990, PLASMODIUM FALCIPARU; Rinker DC, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-749; Sengul MS, 2008, INSECT MOL BIOL, V17, P631, DOI 10.1111/j.1365-2583.2008.00837.x; Sengul MS, 2010, INSECT MOL BIOL, V19, P49, DOI 10.1111/j.1365-2583.2009.00929.x; Seyfarth M, 2019, PARASITOL RES, V118, P725, DOI 10.1007/s00436-019-06213-0; Shiao MS, 2013, ZOOL STUD, V52, DOI 10.1186/1810-522X-52-42; Speth Z, 2021, INSECTS, V12, DOI 10.3390/insects12070593; Sun JS, 2018, OPEN BIOL, V8, DOI 10.1098/rsob.180208; Tadesse FG, 2021, EMERG INFECT DIS, V27, P603, DOI 10.3201/eid2702.200019; Takken W, 2019, EMERG INFECT DIS, V25, P1431, DOI 10.3201/eid2507.190301; Venthur H, 2018, FRONT PHYSIOL, V9, DOI 10.3389/fphys.2018.01163; Vogt RG, 2002, J CHEM ECOL, V28, P2371, DOI 10.1023/A:1021009311977; VOGT RG, 1981, NATURE, V293, P161, DOI 10.1038/293161a0; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Wang J, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-60242-9; Wang Y, 2012, MCSCANX TOOLKIT DETE, V40, P49, DOI [10.1093/nar/, DOI 10.1093/NAR]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Wolfe D, 2013, BIODATA MIN, V6, DOI 10.1186/1756-0381-6-18; Xu PX, 2003, INSECT MOL BIOL, V12, P549, DOI 10.1046/j.1365-2583.2003.00440.x; Yu G-Q, 2018, DECIPHERING ODORANT, V8, P1; Zhou JJ, 2008, INSECT MOL BIOL, V17, P147, DOI 10.1111/j.1365-2583.2007.00789.x; Zhou JJ, 2010, VITAM HORM, V83, P241, DOI 10.1016/S0083-6729(10)83010-9	63	1	1	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265896	10.1371/journal.pone.0265896	http://dx.doi.org/10.1371/journal.pone.0265896			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316281	gold, Green Published			2022-12-26	WOS:000834238000042
J	Zamorano, P; Tellez, A; Munoz, P; Sapag, JC; Martinez, M				Zamorano, Paula; Tellez, Alvaro; Munoz, Paulina; Sapag, Jaime C.; Martinez, Mayra			Effect of COVID-19 pandemic on the implementation of a multimorbidity person-centered care model: A qualitative study from health teams' perspective	PLOS ONE			English	Article								The COVID-19 pandemic has abruptly changed care priority and delivery, delaying others like the multimorbidity approach. The Centro de Innovacio ' n en Salud ANCORA UC, the Health National Fund, and the Servicio de Salud Metropolitano Sur Oriente implemented a Multimorbidity Patient-Centered Care Model as a pilot study in the public health network from 2017 to 2020. Its objective was to reorganize the single diagnosis standard care into a new one based on multimorbidity integrated care. It included incorporating new roles, services, and activities according to each patient's risk stratification. This study aims to describe the perception of the health care teams regarding the impact of the COVID-19 pandemic on four main topics: how the COVID-19 pandemic affected the MCPM implementation, how participants adapted it, lessons learned, and recommendations for sustainability. We conducted a qualitative study with 35 semi-structured interviews between October and December 2020. Data analysis was codified, triangulated, and consolidated using MAXQDA 2020. Results showed that the pandemic paused the total of the implementation practically. Positive effects were the improvement of remote health care services, the activation of selfmanagement, and the cohesion of the teamwork. In contrast, frequent abrupt changes and reorganization forced by pandemic evolution were negative effects. This study revealed the magnitude of the pandemic in the cancelation of health services and identified the urgent need to restart chronic services incorporating patient-centered care in our system.	[Zamorano, Paula; Tellez, Alvaro; Munoz, Paulina; Sapag, Jaime C.; Martinez, Mayra] Pontificia Univ Catolica Chile, Fac Med, Ctr Innovac Salud ANCORA UC, Santiago, Chile; [Zamorano, Paula] Pontificia Univ Catolica Chile, Ctr Clin Res, Hlth Technol Assessment Unit, Santiago, Chile; [Tellez, Alvaro] Pontificia Univ Catolica Chile, Dept Family Med, Santiago, Chile; [Sapag, Jaime C.] Pontificia Univ Catolica Chile, Dept Publ Hlth, Santiago, Chile; [Sapag, Jaime C.] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada	Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile; University of Toronto	Zamorano, P (corresponding author), Pontificia Univ Catolica Chile, Fac Med, Ctr Innovac Salud ANCORA UC, Santiago, Chile.; Zamorano, P (corresponding author), Pontificia Univ Catolica Chile, Ctr Clin Res, Hlth Technol Assessment Unit, Santiago, Chile.	pzamoranop@med.puc.cl	TELLEZ, ALVARO/HCI-4359-2022	Zamorano, Paula/0000-0002-4921-518X				Altuntas O., 2020, RES SQ, V17, P1; Arroyo C., 2020, INFORM EVOLUCION EPI; Cancer S, NCCN, V20, P19; ECLAC; PAHO, 2020, HLTH EC CONV NEED AD; FONASA, 2020, CAR SOC SOC POBL AS, P1; Given L., 2016, PASAA INTERNET, V52, P255; Leijten FRM, 2018, HEALTH POLICY, V122, P12, DOI 10.1016/j.healthpol.2017.06.002; Linn L, 2020, ORGAN PANAM SALUDORG, P1; Ministerio de Salud; Gobierno de Chile, 2020, CUID SAL PERS CON EN; MINSAL, 2021, INF SEM DEF COVID 19; OPS, 2020, INF EV RAP PREST SER; Organizacion Mundial de la Salud (OMS), 2019, J CHEM INF MODEL, V53, P1689; Palmer K, 2018, HEALTH POLICY, V122, P4, DOI 10.1016/j.healthpol.2017.09.006; Polizzi C, 2020, CLIN NEUROPSYCHIATR, V17, P59, DOI 10.36131/CN20200204; Posici DDE, GENERACION RESILIENC; Sapag Munoz De La Pena J, 2020, MARCO INTEGRAL EVALU; Schinasi DA, 2021, FRONT PEDIATR, V9, DOI 10.3389/fped.2021.647937; Siches I, 2020, COL MEDI COCHILE, P1; Tellez A, 2020, MODELO ATENCION CENT; Tellez P. F., 2019, PROPUESTA ESCALABILI; WHO, 2020, RESP COMM SPREAD COV, P1, DOI DOI 10.1017/DMP.2020.166; Zamorano P, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0261953	22	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265091	10.1371/journal.pone.0265091	http://dx.doi.org/10.1371/journal.pone.0265091			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316285	Green Published, gold			2022-12-26	WOS:000834238000015
J	Gu, YH; Guo, YY; Gao, N; Fang, Y; Xu, C; Hu, GM; Guo, MX; Ma, YX; Zhang, YF; Zhou, J; Luo, YL; Zhang, HF; Wen, Q; Qiao, HL				Gu, Yuhan; Guo, Yuanyuan; Gao, Na; Fang, Yan; Xu, Chen; Hu, Guiming; Guo, Mengxue; Ma, Yaxing; Zhang, Yunfei; Zhou, Jun; Luo, Yanlin; Zhang, Haifeng; Wen, Qiang; Qiao, Hailing			The proteomic characterization of the peritumor microenvironment in human hepatocellular carcinoma	ONCOGENE			English	Article							THYMIDINE PHOSPHORYLASE EXPRESSION; PROTEOGENOMIC CHARACTERIZATION; CANCER; HETEROGENEITY; PROGRESSION; PROGNOSIS; DATABASE; DENSITY; EVASION; TARGET	The tumor microenvironment (TME) was usually studied in tumor tissue and in relation to only tumor progression, with little involved in occurrence, recurrence and metastasis of tumor. Thus, a new concept "peritumor microenvironment (PME)" was proposed in the proteomic characterization of peritumor liver tissues in human hepatocellular carcinoma (HCC). The PME for occurrence (PME-O) and progression (PME-P) were almost totally different at proteome composition and function. Proteins for occurrence and progression rarely overlapped and crossed. Immunity played a central role in PME-O, whereas inflammation, angiogenesis and metabolism were critical in PME-P. Proteome profiling identified three PME subtypes with different features of HCC. Thymidine phosphorylase (TYMP) was validated as an antiangiogenic target in an orthotopic HCC mouse model. Overall, the proteomic characterization of the PME revealed that the entire processes of HCC occurrence and progression differ substantially. These findings could enable advances in cancer biology, diagnostics and therapeutics.	[Gu, Yuhan; Guo, Yuanyuan; Gao, Na; Fang, Yan; Xu, Chen; Hu, Guiming; Guo, Mengxue; Ma, Yaxing; Zhang, Haifeng; Wen, Qiang; Qiao, Hailing] Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou, Peoples R China; [Guo, Yuanyuan] Zhengzhou Univ, Dept Pharm, Affiliated Hosp 1, Zhengzhou, Peoples R China; [Zhang, Yunfei; Luo, Yanlin] Zhengzhou Univ, Affiliated Canc Hosp, Zhengzhou, Peoples R China; [Zhou, Jun] Zhengzhou Univ, Affiliated Peoples Hosp, Zhengzhou, Peoples R China	Zhengzhou University; Zhengzhou University; Zhengzhou University; Zhengzhou University	Qiao, HL (corresponding author), Zhengzhou Univ, Inst Clin Pharmacol, Zhengzhou, Peoples R China.	qiaohl@zzu.edu.cn		Gu, yuhan/0000-0002-6021-7215	National Natural Science Foundation of China (NSFC) [81473279, 81673507, 81872931, 82073930]; Zhengzhou Major Scientific and Technological Innovation Projects [2020CXZX0076]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Zhengzhou Major Scientific and Technological Innovation Projects	This work was supported by National Natural Science Foundation of China (NSFC) (Nos. 81473279, 81673507, 81872931 and 82073930), Zhengzhou Major Scientific and Technological Innovation Projects (No.2020CXZX0076). We thank Prof. Xiaohong Qian and Yangjun Zhang (State Key Laboratory of Proteomics) for technical support of mass spectrometry detection and suggestions for data processing.	Affo S, 2017, ANNU REV PATHOL-MECH, V12, P153, DOI 10.1146/annurev-pathol-052016-100322; Archer TC, 2018, CANCER CELL, V34, P396, DOI 10.1016/j.ccell.2018.08.004; Billan S, 2020, LANCET ONCOL, V21, pE463, DOI 10.1016/S1470-2045(20)30328-4; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brunet JP, 2004, P NATL ACAD SCI USA, V101, P4164, DOI 10.1073/pnas.0308531101; Cancer Genome Atlas Research Network. Electronic address: andrew_aguirre@dfci.harvard.edu, 2017, Cancer Cell, V32, P185, DOI 10.1016/j.ccell.2017.07.007; Casanova E, 2006, J MED CHEM, V49, P5562, DOI 10.1021/jm0605379; Chakrabarti S, 2021, PHARMACOL THERAPEUT, V224, DOI 10.1016/j.pharmthera.2021.107823; Chapouly C, 2015, BRAIN, V138, P1548, DOI 10.1093/brain/awv077; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Croft D, 2014, NUCLEIC ACIDS RES, V42, pD472, DOI 10.1093/nar/gkt1102; De Clercq E, 2011, MED RES REV, V31, P118, DOI 10.1002/med.20179; de Palma M, 2017, NAT REV CANCER, V17, P457, DOI 10.1038/nrc.2017.51; Forget A, 2019, ADV MATER, V31, DOI 10.1002/adma.201808050; FURUKAWA T, 1992, NATURE, V356, P668, DOI 10.1038/356668a0; Furukawa T, 2018, PHARMACOL RES, V132, P15, DOI 10.1016/j.phrs.2018.03.019; Gao J, 2018, MOL CARCINOGEN, V57, P1371, DOI 10.1002/mc.22851; Gao J, 2018, J PHARMACOL EXP THER, V365, P398, DOI 10.1124/jpet.117.245555; Gao N, 2016, EUR J PHARM SCI, V92, P86, DOI 10.1016/j.ejps.2016.06.015; Gao Q, 2019, CELL, V179, P561, DOI 10.1016/j.cell.2019.08.052; Ge S, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03121-2; Goliwas KF, 2021, PHYSIOL REV, V101, P417, DOI 10.1152/physrev.00008.2020; Greten FR, 2019, IMMUNITY, V51, P27, DOI 10.1016/j.immuni.2019.06.025; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hinshaw DC, 2019, CANCER RES, V79, P4557, DOI 10.1158/0008-5472.CAN-18-3962; Imazono Y, 1997, J CLIN ONCOL, V15, P2570, DOI 10.1200/JCO.1997.15.7.2570; Javaid S, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0225056; Jiang LH, 2020, CELL, V183, P269, DOI 10.1016/j.cell.2020.08.036; Jiang Y, 2019, NATURE, V567, P257, DOI 10.1038/s41586-019-0987-8; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Lawson KA, 2020, NATURE, V586, P120, DOI 10.1038/s41586-020-2746-2; Li W, 2018, TRENDS CARDIOVAS MED, V28, P157, DOI 10.1016/j.tcm.2017.10.003; Li W, 2014, CIRC RES, V115, P997, DOI 10.1161/CIRCRESAHA.115.304591; Liberzon A, 2015, CELL SYST, V1, P417, DOI 10.1016/j.cels.2015.12.004; Liekens S, 2004, J BIOL CHEM, V279, P29598, DOI 10.1074/jbc.M402602200; Liekens S, 2006, MOL PHARMACOL, V70, P501, DOI 10.1124/mol.105.021188; Lin C, 2019, GUT, V68, P1764, DOI 10.1136/gutjnl-2018-316324; Mascaux C, 2019, NATURE, V571, P570, DOI 10.1038/s41586-019-1330-0; McGranahan N, 2017, CELL, V168, P613, DOI 10.1016/j.cell.2017.01.018; McLaughlin M, 2020, NAT REV CANCER, V20, P203, DOI 10.1038/s41568-020-0246-1; Ortmayr K, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09695-9; PAGET S, 1989, CANCER METAST REV, V8, P98; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Toi M, 1999, CLIN CANCER RES, V5, P1131; Toi M, 2005, LANCET ONCOL, V6, P158, DOI 10.1016/S1470-2045(05)01766-3; von Mering C, 2003, NUCLEIC ACIDS RES, V31, P258, DOI 10.1093/nar/gkg034; Wishart DS, 2008, NUCLEIC ACIDS RES, V36, pD901, DOI 10.1093/nar/gkm958; Yao YX, 2001, CLIN CANCER RES, V7, P4021; Yoshihama S, 2016, P NATL ACAD SCI USA, V113, P5999, DOI 10.1073/pnas.1602069113; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438; Zhang HF, 2016, J PHARMACOL EXP THER, V358, P83, DOI 10.1124/jpet.116.233635; Zhang HF, 2015, SCI REP-UK, V5, DOI 10.1038/srep17671; Zhou YY, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09234-6	59	1	1	8	18	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2022	41	17					2480	2491		10.1038/s41388-022-02264-3	http://dx.doi.org/10.1038/s41388-022-02264-3		MAR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0R6YF	35314790	Green Published, hybrid			2022-12-26	WOS:000771325000001
J	Fallatah, W; De, RNK; Burks, D; Azad, RK; Jagadeeswaran, P				Fallatah, Weam; De, Ronika; Burks, David; Azad, Rajeev K.; Jagadeeswaran, Pudur			Analysis of transcribed sequences from young and mature zebrafish thrombocytes	PLOS ONE			English	Article							EXPRESSION; GATA1	The zebrafish is an excellent model system to study thrombocyte function and development. Due to the difficulties in separating young and mature thrombocytes, comparative transcriptomics between these two cell types has not been performed. It is important to study these differences in order to understand the mechanism of thrombocyte maturation. Here, we performed single-cell RNA sequencing of the young and mature zebrafish thrombocytes and compared the two datasets for young and mature thrombocyte transcripts. We found a total of 9143 genes expressed cumulatively in both young and mature thrombocytes, and among these, 72% of zebrafish thrombocyte-expressed genes have human orthologs according to the Ensembl human genome annotation. We also found 397 uniquely expressed genes in young and 2153 uniquely expressed genes in mature thrombocytes. Of these 397 and 2153 genes, 272 and 1620 corresponded to human orthologous genes, respectively. Of all genes expressed in both young and mature thrombocytes, 4224 have been reported to be expressed in human megakaryocytes, and 1603 were found in platelets. Among these orthologs, 156 transcription factor transcripts in thrombocytes were found in megakaryocytes and 60 transcription factor transcripts were found in platelets including a few already known factors such as Nfe2 and Nfe212a (related to Nfe2) that are present in both megakaryocytes, and platelets. These results indicate that thrombocytes have more megakaryocyte features and since platelets are megakaryocyte fragments, platelets also appear to be thrombocyte equivalents. In conclusion, our study delineates the differential gene expression patterns of young and mature thrombocytes, highlighting the processes regulating thrombocyte maturation. Future knockdown studies of these young and mature thrombocyte-specific genes are feasible and will provide the basis for understanding megakaryocyte maturation.	[Fallatah, Weam; De, Ronika; Burks, David; Azad, Rajeev K.; Jagadeeswaran, Pudur] Univ North Texas, Dept Biol Sci, Denton, TX USA; [De, Ronika; Burks, David; Azad, Rajeev K.] Univ North Texas, BioDiscovery Inst, Denton, TX USA; [Azad, Rajeev K.] Univ North Texas, Dept Math, Denton, TX USA	University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton; University of North Texas System; University of North Texas Denton	Jagadeeswaran, P (corresponding author), Univ North Texas, Dept Biol Sci, Denton, TX USA.	jag@unt.edu		Jagadeeswaran, Pudur/0000-0001-8892-4969	NIH [DK117384]	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by NIH grant DK117384.The fundershad no role in studydesign,data collectionand analysis,decisiontopublish,or preparationof the manuscript	Aredo B, 2021, INVEST OPHTH VIS SCI, V62; Can H, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-020-06860-z; Crispino JD, 2005, SEMIN CELL DEV BIOL, V16, P137, DOI 10.1016/j.semcdb.2004.11.002; Fallatah W, 2019, BLOOD ADV, V3, P1406, DOI 10.1182/bloodadvances.2018023960; Gregory M, 2002, BLOOD CELL MOL DIS, V28, P418, DOI 10.1006/bcmd.2002.0527; Howe K, 2013, NATURE, V496, P498, DOI 10.1038/nature12111; Jagadeeswaran P, 2016, CIRC RES, V118, P1363, DOI 10.1161/CIRCRESAHA.115.306823; Jagadeeswaran P, 2010, BLOOD CELL MOL DIS, V44, P175, DOI 10.1016/j.bcmd.2009.12.012; Kulkarni V, 2012, BLOOD CELL MOL DIS, V48, P183, DOI 10.1016/j.bcmd.2011.12.006; Levin J, 2019, EVOLUTION MAMMALIAN, P1; Liu JP, 2021, 12TH ACM CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS (ACM-BCB 2021), DOI 10.1145/3459930.3469544; Ma DD, 2011, BLOOD, V118, P289, DOI 10.1182/blood-2010-12-327403; Martin JF, 2019, BIOL LETTERS, V15, DOI 10.1098/rsbl.2019.0374; Mi HY, 2019, NAT PROTOC, V14, P703, DOI 10.1038/s41596-019-0128-8; Patro R, 2017, NAT METHODS, V14, P417, DOI 10.1038/nmeth.4197; Radhakrishnan U, 2018, PLATELETS, V29, P811, DOI 10.1080/09537104.2017.1361524; Smeeton J, 2021, DEVELOPMENT, V148, DOI 10.1242/dev.193409; Sugimoto K, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-1237-7; Sun SJ, 2013, PHYSIOL GENOMICS, V45, P217, DOI 10.1152/physiolgenomics.00056.2012; Sundaramoorthi H, 2015, PLATELETS, V26, P613, DOI 10.3109/09537104.2015.1018879; Thattaliyath B, 2005, BLOOD, V106, P118, DOI 10.1182/blood-2004-10-4118; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Yagi M, 2006, J THROMB HAEMOST, V4, P2028, DOI 10.1111/j.1538-7836.2006.02092.x; Yamamoto M, 1997, GENES CELLS, V2, P107, DOI 10.1046/j.1365-2443.1997.1080305.x; Zimmet J, 2000, EXP HEMATOL, V28, P3, DOI 10.1016/S0301-472X(99)00124-1	25	1	1	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0264776	10.1371/journal.pone.0264776	http://dx.doi.org/10.1371/journal.pone.0264776			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320267	Green Published, gold			2022-12-26	WOS:000784240600055
J	Gaveau, DLA; Locatelli, B; Salim, MA; Husnayaen; Manurung, T; Descals, A; Angelsen, A; Meijaard, E; Sheil, D				Gaveau, David L. A.; Locatelli, Bruno; Salim, Mohammad A.; Husnayaen; Manurung, Timer; Descals, Adria; Angelsen, Arild; Meijaard, Erik; Sheil, Douglas			Slowing deforestation in Indonesia follows declining oil palm expansion and lower oil prices	PLOS ONE			English	Article							AREA	Much concern about tropical deforestation focuses on oil palm plantations, but their impacts remain poorly quantified. Using nation-wide interpretation of satellite imagery, and sample-based error calibration, we estimated the impact of large-scale (industrial) and smallholder oil palm plantations on natural old-growth ("primary") forests from 2001 to 2019 in Indonesia, the world's largest palm oil producer. Over nineteen years, the area mapped under oil palm doubled, reaching 16.24 Mha in 2019 (64% industrial; 36% smallholder), more than the official estimates of 14.72 Mha. The forest area declined by 11% (9.79 Mha), including 32% (3.09 Mha) ultimately converted into oil palm, and 29% (2.85 Mha) cleared and converted in the same year. Industrial plantations replaced more forest than detected smallholder plantings (2.13 Mha vs 0.72 Mha). New plantations peaked in 2009 and 2012 and declined thereafter. Expansion of industrial plantations and forest loss were correlated with palm oil prices. A price decline of 1% was associated with a 1.08% decrease in new industrial plantations and with a 0.68% decrease of forest loss. Deforestation fell below pre-2004 levels in 2017-2019 providing an opportunity to focus on sustainable management. As the price of palm oil has doubled since the start of the COVID-19 pandemic, effective regulation is key to minimising future forest conversion.	[Gaveau, David L. A.; Salim, Mohammad A.; Husnayaen] TheTreeMap, Martel, France; [Locatelli, Bruno] Univ Montpellier, CIRAD Forests & Soc, Montpellier, France; [Manurung, Timer] Auriga Nusantara, Bogor, Jawa Barat, Indonesia; [Descals, Adria] CREAF, Ctr Recerca Ecol & Aplicac Forestals, Bellaterra, Catalonia, Spain; [Angelsen, Arild] Norwegian Univ Life Sci NMBU, Sch Econ & Business, As, Norway; [Meijaard, Erik] Borneo Futures, Spg 88, Kg Kiulap, Bandar Seri Beg, Brunei Darussal; [Meijaard, Erik] Univ Kent, Durrell Inst Conservat & Ecol Canterbury, Canterbury, Kent, England; [Sheil, Douglas] Norwegian Univ Life Sci NMBU, Dept Ecol & Nat Resource Management INA, As, Norway; [Sheil, Douglas] Wageningen Univ & Res, Forest Ecol & Forest Management Grp, Wageningen, Netherlands	Universite de Montpellier; Centro de Investigacion Ecologica y Aplicaciones Forestales (CREAF); Norwegian University of Life Sciences; University of Kent; Norwegian University of Life Sciences; Wageningen University & Research	Gaveau, DLA (corresponding author), TheTreeMap, Martel, France.	d.gaveau@thetreemap.com	Locatelli, Bruno/C-9957-2009; Sheil, Douglas/A-3867-2015	Locatelli, Bruno/0000-0003-2983-1644; Sheil, Douglas/0000-0002-1166-6591	WWF-US; Global Environment Facility (GEF) under the Good Growth Partnership; Trase Initiative	WWF-US; Global Environment Facility (GEF) under the Good Growth Partnership; Trase Initiative	This work was funded by the WWF-US and Global Environment Facility (GEF) under the Good Growth Partnership, and in collaboration with the Trase Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamgir M, 2019, SCI REP-UK, V9, DOI [10.1038/s41598-018-36594-8, 10.1038/s41598-019-51237-2]; Arshad FM., 2012, REV EC FINANCE, P48; Astuti R, 2015, THIRD WORLD Q, V36, P2273, DOI 10.1080/01436597.2015.1082422; AURIGA, 2019, OIL PALM COV IND; Austin KG, 2019, ENVIRON RES LETT, V14, DOI 10.1088/1748-9326/aaf6db; Busch J, 2015, P NATL ACAD SCI USA, V112, P1328, DOI 10.1073/pnas.1412514112; Chazdon RL, 2009, CONSERV BIOL, V23, P1406, DOI 10.1111/j.1523-1739.2009.01338.x; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; CPO, 2020, AV YEARL PRIC CRUD P; Crude_Oil_Price, 2020, CRUD OIL PETR MONTHL; d'Annunzio R, 2015, FOREST ECOL MANAG, V352, P124, DOI 10.1016/j.foreco.2015.03.014; Descals A., 2020, EARTH SYST SCI DATA, DOI [10.5194/essd-2020-159, DOI 10.5194/ESSD-2020-159]; Fitzherbert EB, 2008, TRENDS ECOL EVOL, V23, P538, DOI 10.1016/j.tree.2008.06.012; Foga S, 2017, REMOTE SENS ENVIRON, V194, P379, DOI 10.1016/j.rse.2017.03.026; ForestHints, 2020, MIN SETS LEG MEAS FO; Gaveau DLA, 2021, EARTH SYST SCI DATA, V13, P5353, DOI 10.5194/essd-13-5353-2021; Gaveau DLA, 2019, CONSERV LETT, V12, DOI 10.1111/conl.12622; Gaveau DLA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32017; Gaveau DLA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069887; Gaveau DLA, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/3/034013; Gorelick N, 2017, REMOTE SENS ENVIRON, V202, P18, DOI 10.1016/j.rse.2017.06.031; Groom B, 2022, P NATL ACAD SCI USA, V119, DOI 10.1073/pnas.2102613119; Hansen MC, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/3/034008; Hanson MA, 2012, SCIENCE, V335, P851, DOI [10.1126/science.1244693, 10.1126/science.1215904]; Holmes DA., 2002, HAVE ALL FORESTS GON; Ia Melbourne, 2020, IND OMN BILL TYP MIS; Jelsma I, 2017, LAND USE POLICY, V69, P281, DOI 10.1016/j.landusepol.2017.08.012; Jepson P, 2001, SCIENCE, V292, P859, DOI 10.1126/science.1061727; Jong H., 2020, MONGABAY NEWS; Lambin EF, 2018, NAT CLIM CHANGE, V8, P109, DOI 10.1038/s41558-017-0061-1; Laurance WF, 2020, NAT ECOL EVOL, V4, P1438, DOI 10.1038/s41559-020-1263-x; Margono BA, 2014, NAT CLIM CHANGE, V4, P730, DOI [10.1038/nclimate2277, 10.1038/NCLIMATE2277]; Meijaard E, 2020, NAT PLANTS, V6, P1418, DOI 10.1038/s41477-020-00813-w; Meijaard E, 2019, FRONT FOR GLOB CHANG, V2, DOI 10.3389/ffgc.2019.00022; Ministry of Agriculture Indonesia, 2020, TREE CROP ESTATE STA; MoEF [Ministry of Environment and Forestry], 2018, STAT IND FOR 2018; Nikonovas T, 2020, COMMUN EARTH ENVIRON, V1, DOI 10.1038/s43247-020-00069-4; Nurrochmat DR, 2020, FOREST POLICY ECON, V119, DOI 10.1016/j.forpol.2020.102291; Olofsson P, 2014, REMOTE SENS ENVIRON, V148, P42, DOI 10.1016/j.rse.2014.02.015; Rudel TK, 2005, GLOBAL ENVIRON CHANG, V15, P23, DOI 10.1016/j.gloenvcha.2004.11.001; Santika T, 2019, PEOPLE NAT, V1, P204, DOI 10.1002/pan3.25; Schoneveld GC, 2019, ENVIRON RES LETT, V14, DOI [10.1088/1748-9326/aaf044, 10.1088/1748-9326/ab4870]; Shigetomi Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-77458-4; Sloan S, 2017, GLOBAL ENVIRON CHANG, V47, P95, DOI 10.1016/j.gloenvcha.2017.10.001; Teng SS, 2020, J CLEAN PROD, V274, DOI 10.1016/j.jclepro.2020.122901; Xu Y., 2019, **DATA OBJECT**, DOI [10.5281/zenodo.3467071, DOI 10.5281/ZENODO.3467071]; Xu YD, 2020, EARTH SYST SCI DATA, V12, P847, DOI 10.5194/essd-12-847-2020	47	6	6	3	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266178	10.1371/journal.pone.0266178	http://dx.doi.org/10.1371/journal.pone.0266178			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0P0IK	35349594	Green Published, Green Submitted, gold			2022-12-26	WOS:000783906500021
J	Lee, JJB; Lee, E; Choi, WH; Kim, J; Chang, KH; Kim, DW; Shin, HB; Kim, TH; Byun, HK; Cho, J				Lee, Jason Joon Bock; Lee, Eungman; Choi, Won Hoon; Kim, Jihun; Chang, Kyung Hwan; Kim, Dong Wook; Shin, Han Back; Kim, Tae Hyung; Byun, Hwa Kyung; Cho, Jaeho			Dosimetric outcomes of preoperative treatment planning with intraoperative optimization using stranded seeds in prostate brachytherapy	PLOS ONE			English	Article							QUALITY-OF-LIFE; EXTERNAL-BEAM RADIATION; INTERSTITIAL BRACHYTHERAPY; PERMANENT BRACHYTHERAPY; I-125 SEEDS; PSA BOUNCE; CANCER; IMPLANT; DISPLACEMENT; SELECTION	This study aimed to evaluate the quality of low-dose-rate (LDR) prostate brachytherapy (BT) based on treatment-related dosimetric outcomes. Data of 100 patients treated using LDR BT with stranded seeds from November 2012 to November 2017 were collected. The prescription dose for the prostate was 145 Gy. The dose constraints for the preoperative plan were: V100% >= 95%, V150% <= 60%, V200% <= 20% for the prostate; V100% for rectum, <= 1 cc; and V200 Gy for urethra, 0.0 cc. Intraoperative real-time dose calculation and postoperative dose distribution analysis on days 0 and 30 were performed. Median dosimetric outcomes on days 0 and 30 respective were: V100% 92.28% and 92.23%, V200% 18.63% and 25.02%, and D90% 150.88 Gy and 151.46 Gy for the prostate; V100% for the rectum, 0.11 cc and 0.22 cc; and V200 Gy for the urethra, 0.00 cc and 0.00 cc, respectively. Twenty patients underwent additional seed implantation to compensate for insufficient dose coverage of the prostate. No loss or substantial migration of seeds or severe toxicity was reported. With stranded seed implantation and intraoperative optimization, appropriate dose delivery to the prostate without excessive dose to the organs at risk could be achieved.	[Lee, Jason Joon Bock; Lee, Eungman; Kim, Jihun; Kim, Dong Wook; Shin, Han Back; Kim, Tae Hyung; Byun, Hwa Kyung; Cho, Jaeho] Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Lee, Jason Joon Bock] Sungkyunkwan Univ, Kangbuk Samsung Hosp, Dept Radiat Oncol, Sch Med, Seoul, South Korea; [Lee, Eungman] Ewha Womans Univ, Dept Radiat Oncol, Coll Med, Seoul, South Korea; [Choi, Won Hoon] INFINITT Healthcare, Seoul, South Korea; [Chang, Kyung Hwan] Douzone Bizon, Dept Digital Hlth Solut, Seoul, South Korea; [Kim, Tae Hyung] Nowon Eulji Med Ctr, Dept Radiat Oncol, Seoul, South Korea	Yonsei University; Yonsei University Health System; Sungkyunkwan University (SKKU); Samsung Medical Center; Ewha Womans University	Cho, J (corresponding author), Yonsei Univ, Yonsei Canc Ctr, Dept Radiat Oncol, Coll Med, Seoul, South Korea.	jjhmd@yuhs.ac	; Kim, Dong Wook/I-8636-2014	Cho, Jaeho/0000-0001-9966-5157; Lee, Jason Joon Bock/0000-0003-3170-1427; Kim, Tae Hyung/0000-0002-5205-3775; Kim, Dong Wook/0000-0002-5819-9783; Byun, Hwa Kyung/0000-0002-8964-6275; Kim, Jihun/0000-0003-4856-6305				Acher P, 2008, INT J RADIAT ONCOL, V71, P1518, DOI 10.1016/j.ijrobp.2008.03.065; Agarwal M, 2018, BRACHYTHERAPY, V17, P882, DOI 10.1016/j.brachy.2018.07.001; Al-Qaisieh B, 2004, INT J RADIAT ONCOL, V59, P397, DOI 10.1016/j.ijrobp.2003.10.034; Albert JM, 2013, BRACHYTHERAPY, V12, P30, DOI 10.1016/j.brachy.2012.03.009; Birekhead BJ, 2016, BRACHYTHERAPY, V15, P714, DOI 10.1016/j.brachy.2016.07.004; Blanchard P, 2018, BJU INT, V121, P540, DOI 10.1111/bju.14021; Bloemen-van Gurp EJ, 2009, INT J RADIAT ONCOL, V73, P314, DOI 10.1016/j.ijrobp.2008.08.040; Bowes D, 2013, BRACHYTHERAPY, V12, P38, DOI 10.1016/j.brachy.2012.03.007; Brown D, 2000, INT J RADIAT ONCOL, V47, P353, DOI 10.1016/S0360-3016(00)00433-8; Butler WM, 2000, MED PHYS, V27, P381, DOI 10.1118/1.598842; Caloglu M, 2011, INT J RADIAT ONCOL, V80, P735, DOI 10.1016/j.ijrobp.2010.02.021; Cha CM, 1999, INT J RADIAT ONCOL, V45, P391, DOI 10.1016/S0360-3016(99)00187-X; Cherpak AJ, 2014, BRACHYTHERAPY, V13, P169, DOI 10.1016/j.brachy.2013.11.004; Crook J, 2007, INT J RADIAT ONCOL, V69, P426, DOI 10.1016/j.ijrobp.2007.03.031; Fuller Donald B, 2004, Brachytherapy, V3, P10, DOI 10.1016/j.brachy.2004.02.003; Henderson A, 2004, EUR UROL, V45, P134, DOI 10.1016/j.eururo.2003.09.015; Jani Ashesh B, 2004, Med Dosim, V29, P42, DOI 10.1016/j.meddos.2003.09.005; Kollmeier MA, 2003, INT J RADIAT ONCOL, V57, P645, DOI 10.1016/S0360-3016(03)00627-8; Kollmeier MA, 2012, BRACHYTHERAPY, V11, P271, DOI 10.1016/j.brachy.2011.11.002; Kono Y, 2010, JPN J CLIN ONCOL, V40, P1159, DOI 10.1093/jjco/hyq118; Kudchadker RJ, 2008, INT J RADIAT ONCOL, V72, P623, DOI 10.1016/j.ijrobp.2008.03.001; Kudchadker RJ, 2012, MED DOSIM, V37, P387, DOI 10.1016/j.meddos.2012.03.001; Kunogi H, 2016, J CONTEMP BRACHYTHER, V8, P167, DOI 10.5114/jcb.2016.60452; Lardas M, 2017, EUR UROL, V72, P869, DOI 10.1016/j.eururo.2017.06.035; LING CC, 1994, INT J RADIAT ONCOL, V28, P971, DOI 10.1016/0360-3016(94)90117-1; Matzkin H, 2013, RADIAT ONCOL, V8, DOI 10.1186/1748-717X-8-288; Melchert C, 2018, J CONTEMP BRACHYTHER, V10, P232, DOI 10.5114/jcb.2018.76748; Merrell KW, 2019, BRACHYTHERAPY, V18, P306, DOI 10.1016/j.brachy.2019.01.007; Morris WJ, 2014, BRACHYTHERAPY, V13, P32, DOI 10.1016/j.brachy.2013.08.006; Peschel RE, 2004, CANCER J, V10, P170, DOI 10.1097/00130404-200405000-00006; Reed DR, 2007, BRACHYTHERAPY, V6, P129, DOI 10.1016/j.brachy.2007.01.003; Sanda MG, 2008, NEW ENGL J MED, V358, P1250, DOI 10.1056/NEJMoa074311; Sasaki H, 2014, INT J UROL, V21, P572, DOI 10.1111/iju.12373; Shukla G, 2017, BRACHYTHERAPY, V16, P490, DOI 10.1016/j.brachy.2016.12.014; Steggerda MJ, 2017, RADIOTHER ONCOL, V124, P68, DOI 10.1016/j.radonc.2017.05.017; Stish BJ, 2018, TRANSL ANDROL UROL, V7, P341, DOI 10.21037/tau.2017.12.15; Stone NN, 2002, EUR UROL, V41, P427, DOI 10.1016/S0302-2838(02)00019-2; Sugawara A, 2011, RADIAT ONCOL, V6, DOI 10.1186/1748-717X-6-130; Sylvester JE, 2003, INT J RADIAT ONCOL, V57, P944, DOI 10.1016/S0360-3016(03)00739-9; Taussky D, 2017, J CONTEMP BRACHYTHER, V9, P304, DOI 10.5114/jcb.2017.68467; Thaker NG, 2016, BRACHYTHERAPY, V15, P274, DOI 10.1016/j.brachy.2016.01.003; Tisseverasinghe S, 2021, BRACHYTHERAPY, V20, P849, DOI 10.1016/j.brachy.2021.03.005; van Tol-Geerdink JJ, 2013, BRIT J CANCER, V108, P1784, DOI 10.1038/bjc.2013.181	43	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265143	10.1371/journal.pone.0265143	http://dx.doi.org/10.1371/journal.pone.0265143			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353847	Green Published, gold			2022-12-26	WOS:000786647900043
J	Methi, F; Hernaes, KH; Skyrud, KD; Magnusson, K				Methi, Fredrik; Hernaes, Kjersti Helene; Skyrud, Katrine Damgaard; Magnusson, Karin			Pandemic trends in health care use: From the hospital bed to self-care with COVID-19	PLOS ONE			English	Article								AimTo explore whether the acute 30-day burden of COVID-19 on health care use has changed from February 2020 to February 2022. MethodsIn all Norwegians (N = 493 520) who tested positive for SARS-CoV-2 in four pandemic waves (February 26(th), 2020 -February 16(th), 2021 (1(st) wave dominated by the Wuhan strain), February 17(th)-July 10(th), 2021 (2(nd) wave dominated by the Alpha variant), July 11(th)-December 27(th), 2021 (3(rd) wave dominated by the Delta variant), and December 28(th), 2021 -January 14(th), 2022 (4(th) wave dominated by the Omicron variant)), we studied the age- and sex-specific share of patients (by age groups 1-19, 20-67, and 68 or more) who had: 1) Relied on self-care, 2) used outpatient care (visiting general practitioners or emergency ward for COVID-19), and 3) used inpatient care (hospitalized >= 24 hours with COVID-19). ResultsWe find a remarkable decline in the use of health care services among COVID-19 patients for all age/sex groups throughout the pandemic. From 83% [95%CI = 83%-84%] visiting outpatient care in the first wave, to 80% [81%-81%], 69% [69%-69%], and 59% [59%-59%] in the second, third, and fourth wave. Similarly, from 4.9% [95%CI = 4.7%-5.0%] visiting inpatient care in the first wave, to 3.6% [3.4%-3.7%], 1.4% [1.3%-1.4%], and 0.5% [0.4%-0.5%]. Of persons testing positive for SARS-CoV-2, 41% [41%-41%] relied on self-care in the 30 days after testing positive in the fourth wave, compared to 16% [15%-16%] in the first wave. ConclusionFrom 2020 to 2022, the use of COVID-19 related outpatient care services decreased with 29%, whereas the use of COVID-19 related inpatient care services decreased with 80%.	[Methi, Fredrik; Hernaes, Kjersti Helene; Skyrud, Katrine Damgaard; Magnusson, Karin] Norwegian Inst Publ Hlth, Cluster Hlth Serv Res, Oslo, Norway; [Magnusson, Karin] Lund Univ, Fac Med, Dept Clin Sci Lund, Clin Epidemiol Unit, Lund, Sweden	Norwegian Institute of Public Health (NIPH); Lund University	Methi, F (corresponding author), Norwegian Inst Publ Hlth, Cluster Hlth Serv Res, Oslo, Norway.	fredrik.methi@fhi.no		Magnusson, Karin/0000-0003-4851-5794; Methi, Fredrik/0000-0002-7091-0806				Ahrenfeldt LJ, 2021, WIEN KLIN WOCHENSCHR, V133, P393, DOI [10.1007/s00508-020-01793-9, 10.21203/rs.3.rs-61444/v1]; Alexander GC, 2020, JAMA NETW OPEN, V3, DOI 10.1001/jamanetworkopen.2020.21476; Bagi HM, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0258697; Bakken IJ, 2020, SCAND J PUBLIC HEALT, V48, P49, DOI 10.1177/1403494819859737; Bergman J, 2021, EUR J EPIDEMIOL, V36, P287, DOI 10.1007/s10654-021-00732-w; Docherty AB, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1985; Faktisk.no, 2020, ARE CORONA RELATED D; Guan W, 2020, NEW ENGL J MED, V382, P1708, DOI 10.1056/NEJMoa2002032; Gutierrez-Gutierrez B, 2021, LANCET INFECT DIS, V21, P783, DOI 10.1016/S1473-3099(21)00019-0; Menachemi N, 2021, J PUBLIC HEALTH MAN, V27, P246, DOI 10.1097/PHH.0000000000001331; Nagy A, 2021, INT J ANTIMICROB AG, V57, DOI 10.1016/j.ijantimicag.2020.106272; Nalbandian A, 2021, NAT MED, V27, P601, DOI 10.1038/s41591-021-01283-z; Norwegian Institute of Public Health, 2021, VACC SCEN; Norwegian Institute of Public Health, 2020, NORW EM PREP REG BE; Norwegian Institute of Public Health, 2020, UPD COR GUID; Norwegian Institute of Public Health, 2020, TEST CRIT SARS COV 2; Norwegian Institute of Public Health, 2021, NEW VAR SARS COV2 KN; Park S, 2020, BMJ-BRIT MED J, V370, DOI 10.1136/bmj.m3691; Pulliam J.R.C., 2021, INCREASED RISK SARS, DOI [10.1101/2021.11.11.21266068, DOI 10.1101/2021.11.11.21266068, 10.1101/2021.11.11.21266068.]; Reilev M, 2020, INT J EPIDEMIOL, V49, P1468, DOI 10.1093/ije/dyaa140; Richardson S, 2020, JAMA-J AM MED ASSOC, V323, P2052, DOI 10.1001/jama.2020.6775; Skyrud KD., 2021, MEDRXIV, DOI [10.1101/2021.02.16.21251807, DOI 10.1101/2021.02.16.21251807]; Sporaland Geir Lindquist, 2019, Tidsskr Nor Laegeforen, V139, DOI 10.4045/tidsskr.18.0440; Varmdal T, 2016, SCAND J PUBLIC HEALT, V44, P143, DOI 10.1177/1403494815621641; Veneti L, 2022, EUROSURVEILLANCE, V27, DOI 10.2807/1560-7917.ES.2022.27.4.2200077; Veneti L, 2022, INT J INFECT DIS, V115, P178, DOI 10.1016/j.ijid.2021.12.321; Whittaker R, 2021, J INFECTION, V83, pE14, DOI 10.1016/j.jinf.2021.07.025	27	2	2	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265812	10.1371/journal.pone.0265812	http://dx.doi.org/10.1371/journal.pone.0265812			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320323	Green Published, gold			2022-12-26	WOS:000784240600010
J	Rice, A; Sirovic, A; Hildebrand, JA; Wood, M; Carbaugh-Rutland, A; Baumann-Pickering, S				Rice, Ally; Sirovic, Ana; Hildebrand, John A.; Wood, Megan; Carbaugh-Rutland, Alex; Baumann-Pickering, Simone			Update on frequency decline of Northeast Pacific blue whale (Balaenoptera musculus) calls	PLOS ONE			English	Article							LONG-TERM; CALIFORNIA; VARIABILITY; BEHAVIOR; NOISE; SOUND; SONG	Worldwide, the frequency (pitch) of blue whale (Balaenoptera musculus) calls has been decreasing since first recorded in the 1960s. This frequency decline occurs over annual and inter-annual timescales and has recently been documented in other baleen whale species, yet it remains unexplained. In the Northeast Pacific, blue whales produce two calls, or units, that, when regularly repeated, are referred to as song: A and B calls. In this population, frequency decline has thus far only been examined in B calls. In this work, passive acoustic data collected in the Southern California Bight from 2006 to 2019 were examined to determine if A calls are also declining in frequency and whether the call pulse rate was similarly impacted. Additionally, frequency measurements were made for B calls to determine whether the rate of frequency decline is the same as was calculated when this phenomenon was first reported in 2009. We found that A calls decreased at a rate of 0.32 Hz yr(-1) during this period and that B calls were still decreasing, albeit at a slower rate (0.27 Hz yr(-1)) than reported previously. The A call pulse rate also declined over the course of the study, at a rate of 0.006 pulses/s yr(-1). With this updated information, we consider the various theories that have been proposed to explain frequency decline in blue whales. We conclude that no current theory adequately accounts for all aspects of this phenomenon and consider the role that individual perception of song frequency may play. To understand the cause behind call frequency decline, future studies might want to explore the function of these songs and the mechanism for their synchronization. The ubiquitous nature of the frequency shift phenomenon may indicate a consistent level of vocal plasticity and fine auditory processing abilities across baleen whale species.	[Rice, Ally; Hildebrand, John A.; Baumann-Pickering, Simone] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Sirovic, Ana; Wood, Megan; Carbaugh-Rutland, Alex] Texas A&M Univ Galveston, Galveston, TX USA; [Sirovic, Ana] Norwegian Univ Sci & Technol, Trondhjem Biol Stn, Trondheim, Norway; [Carbaugh-Rutland, Alex] Univ Miami, Abess Ctr Ecosyst Sci & Policy, Coral Gables, FL 33124 USA	University of California System; University of California San Diego; Scripps Institution of Oceanography; Texas A&M University System; Texas A&M University College Station; Norwegian University of Science & Technology (NTNU); University of Miami	Rice, A (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA.	arice@ucsd.edu		Rice, Ally/0000-0001-9734-8537; Hildebrand, John/0000-0002-5418-9799				Amante C., 2009, PSYCHOLOGIST, DOI [10.7289/V5C8276M, DOI 10.7289/V5C8276M]; Amante C, 2009, NGDC24 NOAA NESDIS; Andrew R. K., 2002, Acoustics Research Letters Online, V3, P65, DOI 10.1121/1.1461915; Angeloni C, 2018, CURR OPIN NEUROBIOL, V49, P8, DOI 10.1016/j.conb.2017.10.012; Barlow DR, 2020, MAR ECOL PROG SER, V642, P207, DOI 10.3354/meps13339; Barlow DR., 2021, SCI REP-UK, V11, P10, DOI [10.1038/s41598-020-79544-z, DOI 10.1038/S41598-020-79544-Z]; Calambokidis, 2020, NMFSSWFSC634 US DEP; Carbaugh-Rutland A, 2021, ENDANGER SPECIES RES, V46, P19, DOI 10.3354/esr01145; de Cheveigne A., 2010, OXFORD HDB AUDITORY, P1; Eriksen N, 2007, ANAT REC, V290, P83, DOI 10.1002/ar.20404; Gavrilov AN, 2012, J ACOUST SOC AM, V131, P4476, DOI 10.1121/1.4707425; Gavrilov AN, 2011, J ACOUST SOC AM, V130, P3651, DOI 10.1121/1.3651817; Hoffman MD, 2010, J ACOUST SOC AM, V128, P490, DOI 10.1121/1.3446099; Leroy EC, 2018, J GEOPHYS RES-OCEANS, V123, P8568, DOI 10.1029/2018JC014352; Lewis LA, 2018, ROY SOC OPEN SCI, V5, DOI 10.1098/rsos.180241; Lewis LA, 2018, MAR MAMMAL SCI, V34, P311, DOI 10.1111/mms.12458; Malige F, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64613-0; McDonald MA, 2001, J ACOUST SOC AM, V109, P1728, DOI 10.1121/1.1353593; McDonald Mark A., 2006, Journal of Cetacean Research and Management, V8, P55; McDonald MA, 2006, J ACOUST SOC AM, V120, P711, DOI 10.1121/1.2216565; McDonald Mark A., 2009, Endangered Species Research, V9, P13, DOI 10.3354/esr00217; Miksis-Olds JL, 2018, J ACOUST SOC AM, V144, P3618, DOI 10.1121/1.5084269; Miksis-Olds JL, 2013, J ACOUST SOC AM, V134, P3464, DOI 10.1121/1.4821537; Miller BS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107740; Miller BS, 2014, J ACOUST SOC AM, V135, P1616, DOI 10.1121/1.4863647; Monnahan CC, 2015, MAR MAMMAL SCI, V31, P279, DOI 10.1111/mms.12157; Monnahan CC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098974; Oleson EM, 2007, ANIM BEHAV, V74, P881, DOI 10.1016/j.anbehav.2007.01.022; Oleson EM, 2007, MAR ECOL PROG SER, V330, P269, DOI 10.3354/meps330269; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Parks SE, 2007, J ACOUST SOC AM, V122, P3725, DOI 10.1121/1.2799904; Parks SE, 2011, BIOL LETTERS, V7, P33, DOI 10.1098/rsbl.2010.0451; R Core Team, 2021, R LANG ENV STAT; Rocha Robert C. Jr, 2014, U S National Marine Fisheries Service Marine Fisheries Review, V76, P37; Sirovic A, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-09979-4; Sirovic A, 2016, BIOACOUSTICS, V25, P145, DOI 10.1080/09524622.2015.1124248; Sirovic A, 2015, ENDANGER SPECIES RES, V28, P61, DOI 10.3354/esr00676; Stafford KM, 1998, J ACOUST SOC AM, V104, P3616, DOI 10.1121/1.423944; Szesciorka AR, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64855-y; Thode AM, 2017, J ACOUST SOC AM, V142, P1482, DOI 10.1121/1.5001064; Thompson PO, 1996, MAR MAMMAL SCI, V12, P288, DOI 10.1111/j.1748-7692.1996.tb00578.x; Thompson PO., 1965, 1290 US NAV EL LAB; Ward R, 2017, J ACOUST SOC AM, V142, pEL231, DOI 10.1121/1.4998608; Weirathmueller MJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0186127; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiggins SM, 2007, 2007 SYMPOSIUM ON UNDERWATER TECHNOLOGY AND WORKSHOP ON SCIENTIFIC USE OF SUBMARINE CABLES AND RELATED TECHNOLOGIES, VOLS 1 AND 2, P594	46	3	3	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266469	10.1371/journal.pone.0266469	http://dx.doi.org/10.1371/journal.pone.0266469			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363831	gold, Green Published			2022-12-26	WOS:000804748600010
J	Shahid, A; Huang, M; Liu, M; Shamim, MA; Parsa, C; Orlando, R; Huang, Y				Shahid, Ayaz; Huang, Matthew; Liu, Mandy; Shamim, Md Abdullah; Parsa, Cyrus; Orlando, Robert; Huang, Ying			The medicinal mushroom Ganoderma lucidum attenuates UV-induced skin carcinogenesis and immunosuppression	PLOS ONE			English	Article							NF-KAPPA-B; CONTACT HYPERSENSITIVITY; KI67 INDEX; T-CELL; CANCER; CHEMOPREVENTION; OVEREXPRESSION; INFLAMMATION; SUPPRESSION; SYSTEM	The medicinal mushroom Ganoderma lucidum is traditionally used for treating multiple diseases, including cancer. This study examined skin cancer preventive activity of a commercial product containing spore and fruiting body in 30:8 ratio (GLSF). Extracts of GLSF and spore component (GLS) were prepared using artificial gastrointestinal juice and examined on JB6 cells. GLSF and GLS dose-dependently inhibited epidermal growth factor-induced JB6 transformation at non-toxic concentrations. SKH-1 mice which were fed with diets containing GLSF (1.25%), GLS (0.99%) or the fruiting body (GLF) (0.26%) were exposed to chronic low-dose ultraviolet (UV) radiation to assess their effects on skin carcinogenesis. GLSF, but not GLS or GLF, reduced skin tumor incidence and multiplicity. In non-tumor skin tissues of mice, GLSF attenuated UV-induced epidermal thickening, expression of Ki-67, COX-2 and NF-kappa B, while in tumor tissues, GLSF increased expression of CD8 and Granzyme B. To examine the effects of GLSF on UV-induced immunosuppression, mice which were fed with GLSF were evaluated for the contact hypersensitivity (CHS) response to dinitrofluorobenzene (DNFB). GLSF significantly reversed UV-mediated suppression of DNFB-induced CHS by increasing CD8+ and decreasing CD4+ and FoxP3+ T-cells in mouse ears. Therefore, GLSF prevents skin cancer probably via attenuating UV-induced immunosuppression.	[Shahid, Ayaz; Huang, Matthew; Liu, Mandy; Shamim, Md Abdullah; Huang, Ying] Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA; [Parsa, Cyrus; Orlando, Robert] Western Univ Hlth Sci, Coll Osteopath Med Pacific, Pomona, CA USA; [Parsa, Cyrus; Orlando, Robert] Beverly Hosp, Dept Pathol, Montebello, CA USA	Western University of Health Sciences; Western University of Health Sciences	Shahid, A; Huang, Y (corresponding author), Western Univ Hlth Sci, Coll Pharm, Dept Pharmaceut Sci, Pomona, CA 91766 USA.	ashahid@westernu.edu; yhuang@westernu.edu		SHAMIM, MD ABDULLAH/0000-0002-8587-9493	Beijing Tong Ren Tang Chinese Medicine Co., Ltd.; Western University of Health Sciences Intramural Student Funds as part of the Graduate Program	Beijing Tong Ren Tang Chinese Medicine Co., Ltd.; Western University of Health Sciences Intramural Student Funds as part of the Graduate Program	Research reported in the publication was partly supported by Beijing Tong Ren Tang Chinese Medicine Co., Ltd. This work was also supported by Western University of Health Sciences Intramural Student Funds as part of the Graduate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2004, CANCER CELL, V6, P203, DOI 10.1016/j.ccr.2004.09.003; Akiba H, 2002, J IMMUNOL, V168, P3079, DOI 10.4049/jimmunol.168.6.3079; [Anonymous], 2013, BULL ENVIRON PHARMAC, V2, P38; Anwikar Shraddha, 2010, Int J Ayurveda Res, V1, P167, DOI 10.4103/0974-7788.72489; Barbieri A, 2017, NUTRIENTS, V9, DOI 10.3390/nu9030210; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Batra P, 2013, INT J MED MUSHROOMS, V15, P127, DOI 10.1615/IntJMedMushr.v15.i2.20; Bernard JJ, 2019, NAT REV IMMUNOL, V19, P688, DOI 10.1038/s41577-019-0185-9; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Chang A, 2015, CANCER PREV RES, V8, P31, DOI 10.1158/1940-6207.CAPR-14-0193; Chen CF, 2019, CANCER BIOL MED, V16, P575, DOI 10.20892/j.issn.2095-3941.2018.0423; Christensen AD, 2012, APMIS, V120, P1, DOI 10.1111/j.1600-0463.2011.02832.x; Chrubasik S, 2000, PHYTOMEDICINE, V6, P469, DOI 10.1016/S0944-7113(00)80076-8; Chun KS, 2007, MOL CARCINOGEN, V46, P699, DOI 10.1002/mc.20354; Ciancio N, 2012, MULTIDISCIP RESP MED, V7, DOI 10.1186/2049-6958-7-29; Cleveland KH, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0217038; Cor D, 2018, MOLECULES, V23, DOI 10.3390/molecules23030649; Dudhgaonkar S, 2009, INT IMMUNOPHARMACOL, V9, P1272, DOI 10.1016/j.intimp.2009.07.011; Elmets CA, 2014, DERMATOL CLIN, V32, P277, DOI 10.1016/j.det.2014.03.005; Euvrard S, 2003, NEW ENGL J MED, V348, P1681, DOI 10.1056/NEJMra022137; Feehan RP, 2016, BIOCHEM J, V473, P2973, DOI 10.1042/BCJ20160471; Gupta S, 2002, CANCER METAST REV, V21, P363, DOI 10.1023/A:1021275330385; Guy GP, 2015, MMWR-MORBID MORTAL W, V64, P591; Hooghe B, 2008, NUCLEIC ACIDS RES, V36, pW128, DOI 10.1093/nar/gkn195; Huang KM, 2017, CANCER PREV RES, V10, P598, DOI 10.1158/1940-6207.CAPR-17-0132; Ishihara M, 2013, ONCOLOGY-BASEL, V84, P135, DOI 10.1159/000345321; Josefsson A, 2012, SCAND J UROL NEPHROL, V46, P247, DOI 10.3109/00365599.2012.669791; Katiyar SK, 2007, CANCER LETT, V255, P1, DOI 10.1016/j.canlet.2007.02.010; Khodaeiani Effat, 2013, Indian J Dermatol, V58, P181, DOI 10.4103/0019-5154.110824; Kim C, 2014, EMBO MOL MED, V6, P970, DOI 10.15252/emmm.201303541; Kladar NV, 2016, EUR J CANCER PREV, V25, P462, DOI 10.1097/CEJ.0000000000000204; Kloppel G, 2004, ANN NY ACAD SCI, V1014, P13, DOI 10.1196/annals.1294.002; Kondo S, 1996, J INVEST DERMATOL, V106, P993, DOI 10.1111/1523-1747.ep12338505; Kripke ML, 2013, J INVEST DERMATOL, V133, P27, DOI 10.1038/jid.2012.234; Liu CD, 2015, INFLAMM BOWEL DIS, V21, P1918, DOI 10.1097/MIB.0000000000000439; Menon SS, 2019, CLIN CHIM ACTA, V491, P39, DOI 10.1016/j.cca.2019.01.011; Nathan C, 2002, NATURE, V420, P846, DOI 10.1038/nature01320; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; PRESTONMARTIN S, 1990, CANCER RES, V50, P7415; Quinones OG, 2019, CURR CANCER DRUG TAR, V19, P5, DOI 10.2174/1568009618666180430125201; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; Sahu RP, 2012, PHOTOCHEM PHOTOBIOL, V88, P490, DOI 10.1111/j.1751-1097.2011.01071.x; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Segal BH, 2000, MEDICINE, V79, P170, DOI 10.1097/00005792-200005000-00004; Shirendeb U, 2009, ACTA HISTOCHEM CYTOC, V42, P181, DOI 10.1267/ahc.09030; Siegel RL, 2019, CA-CANCER J CLIN, V69, P7, DOI 10.3322/caac.21551; Sohretoglu D, 2018, ANTI-CANCER AGENT ME, V18, P667, DOI 10.2174/1871520617666171113121246; Sorbye SW, 2012, BMC CLIN PATHOL, V12, DOI 10.1186/1472-6890-12-7; Sorbye SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047068; Steele VE, 1996, J CELL BIOCHEM, P29; Suarez-Arroyo IJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057431; Sun LX, 2014, CELL PHYSIOL BIOCHEM, V33, P289, DOI 10.1159/000356669; Surh YJ, 2008, GENES NUTR, V2, P313, DOI 10.1007/s12263-007-0063-0; Vaid M, 2011, CANCER PREV RES, V4, P238, DOI 10.1158/1940-6207.CAPR-10-0224; Wang HL, 2009, J IMMUNOL, V183, P4755, DOI 10.4049/jimmunol.0900521; Xu H, 1996, J EXP MED, V183, P1001, DOI 10.1084/jem.183.3.1001; Yeung S, 2022, ACTA CHROMATOGR, V34, P100, DOI 10.1556/1326.2020.00825; Yoon HM, 2013, EXP THER MED, V5, P957, DOI 10.3892/etm.2013.895	58	2	2	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265615	10.1371/journal.pone.0265615	http://dx.doi.org/10.1371/journal.pone.0265615			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312729	gold, Green Published			2022-12-26	WOS:000803647900005
J	Song, WQ; Xiao, N; Zhou, SH; Yu, WJ; Wang, N; Shao, LN; Duan, Y; Chen, M; Pan, LZ; Xia, YX; Zhang, L; Liu, M				Song, Wenqian; Xiao, Nan; Zhou, Shihang; Yu, Weijian; Wang, Ni; Shao, Linnan; Duan, Ying; Chen, Mei; Pan, Lingzi; Xia, Yuexin; Zhang, Li; Liu, Ming			Non-invasive prenatal paternity testing by analysis of Y-chromosome mini-STR haplotype using next-generation sequencing	PLOS ONE			English	Article							MATERNAL PLASMA; FETAL DNA; RECOMMENDATIONS; GENETICS; CHINESE	ObjectivesTo assess the efficacy of Y-chromosome mini-STR-based next-generation sequencing (NGS) for non-invasive prenatal paternity testing (NIPPT). MethodsDNA was extracted from the plasma of 24 pregnant women, and cell-free fetal DNA (cffDNA) haplotyping was performed at 12 Y-chromosome mini-STR loci using the Illumina NextSeq 500 system. The cffDNA haplotype was validated by the paternal haplotype. Subsequentlly, the paternity testing parameters were attributed to each case quantitatively. ResultsThe biological relationship between the alleged fathers and infants in all 24 family cases were confirmed by capillary electrophoresis (CE). The Y-chromosome mini-STR haplotypes of all 14 male cffDNA were obtained by NGS without any missing loci. The alleles of cffDNA and paternal genomic DNA were matched in 13 cases, and a mismatched allele was detected at the DYS393 locus in one case and considered as mutation. No allele was detected in the 10 female cffDNA. The combined paternity index (CPI) and probability of paternity calculation was based on 6 loci Y-haplotype distributions of a local population. The probability of paternity was 98.2699-99.8828% for the cases without mutation, and 14.8719% for the case harboring mutation. ConclusionsOur proof-of-concept study demonstrated that Y-chromosome mini-STR can be used for NGS-based NIPPT with high accuracy in real cases, and is a promising tool for familial searching, paternity exclusion and sex selection in forensic and medical applications.	[Song, Wenqian; Xiao, Nan; Zhou, Shihang; Yu, Weijian; Wang, Ni; Shao, Linnan; Duan, Ying; Chen, Mei; Pan, Lingzi; Xia, Yuexin; Zhang, Li] Dalian Blood Ctr, Dalian, Peoples R China; [Liu, Ming] Dalian Med Univ, Inst Cytobiol, Dalian, Peoples R China	Dalian Medical University	Liu, M (corresponding author), Dalian Med Univ, Inst Cytobiol, Dalian, Peoples R China.	liuminglinxi@163.com			Dalian Municipal Youth Science and Technology Star grant [2017RQ169]; Dalian Municipal Science and Technology Bureau, Dalian, China	Dalian Municipal Youth Science and Technology Star grant; Dalian Municipal Science and Technology Bureau, Dalian, China	WS received research support by a Dalian Municipal Youth Science and Technology Star grant (2017RQ169) from Dalian Municipal Science and Technology Bureau, Dalian, China (http://www.kjj.dl.gov.cn/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aly S M, 2015, Arch Med Sadowej Kryminol, V65, P260; Bai X, 2010, ELECTROPHORESIS, V31, P2944, DOI 10.1002/elps.201000163; Barra GB, 2015, FORENSIC SCI INT-GEN, V15, P105, DOI 10.1016/j.fsigen.2014.11.006; Beta J, 2018, MINERVA GINECOL, V70, P215, DOI 10.23736/S0026-4784.17.04178-8; Biesecker LG, 2005, SCIENCE, V310, P1122, DOI 10.1126/science.1116608; Borsting C, 2015, FORENSIC SCI INT-GEN, V18, P78, DOI 10.1016/j.fsigen.2015.02.002; Breveglieri G, 2019, MOL DIAGN THER, V23, P291, DOI 10.1007/s40291-019-00385-2; Butler JM, 2004, ELECTROPHORESIS, V25, P1397, DOI 10.1002/elps.200305822; Chan KCA, 2004, CLIN CHEM, V50, P88, DOI 10.1373/clinchem.2003.024893; Chang MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep37153; Christiansen SL, 2019, INT J LEGAL MED, V133, P1361, DOI 10.1007/s00414-019-02106-0; de Jong A, 2010, EUR J HUM GENET, V18, P272, DOI 10.1038/ejhg.2009.203; Ellegren H, 2004, NAT REV GENET, V5, P435, DOI 10.1038/nrg1348; Gjertson DW, 2007, FORENSIC SCI INT-GEN, V1, P223, DOI 10.1016/j.fsigen.2007.06.006; Guo F, 2017, FORENSIC SCI INT-GEN, V29, pE35, DOI 10.1016/j.fsigen.2017.04.012; Hyland CA, 2017, PATHOLOGY, V49, P757, DOI 10.1016/j.pathol.2017.08.010; Jiang HJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0159385; Kayser M, 2017, HUM GENET, V136, P621, DOI 10.1007/s00439-017-1776-9; Lo YMD, 2008, CLIN CHEM, V54, P461, DOI 10.1373/clinchem.2007.100016; Lo YMD, 1999, AM J HUM GENET, V64, P218, DOI 10.1086/302205; Lo YMD, 1997, LANCET, V350, P485, DOI 10.1016/S0140-6736(97)02174-0; Morling N, 2002, FORENSIC SCI INT, V129, P148, DOI 10.1016/S0379-0738(02)00289-X; Palomaki GE., 2019, GENOMIC APPL PATHOLO, P561; Peterson RW., 1982, SANTA CLARA L REV, V22, P667; Primacio R., 2017, J PREGNANCY CHILD HL, V4; Roewer L., 2019, REV FORENSIC SCI, V1, pe1336, DOI [10.1002/wfs2.1336, DOI 10.1002/WFS2.1336]; Roewer L, 2020, FORENSIC SCI INT-GEN, V48, DOI 10.1016/j.fsigen.2020.102308; Rolf B, 2001, INT J LEGAL MED, V115, P12, DOI 10.1007/s004140000201; Ryan A, 2013, GENET MED, V15, P473, DOI 10.1038/gim.2012.155; Song WQ, 2015, CLIN CHEM LAB MED, V53, P1943, DOI 10.1515/cclm-2015-0011; Tam JCW, 2020, PRENATAL DIAG, V40, P497, DOI 10.1002/pd.5595; Thompson R, 2012, METHODS MOL BIOL, V830, P3, DOI 10.1007/978-1-61779-461-2_1; Zhang SS, 2018, LEGAL MED-TOKYO, V32, P98, DOI 10.1016/j.legalmed.2018.03.009; Zhou ZH, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1083	34	0	0	2	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266332	10.1371/journal.pone.0266332	http://dx.doi.org/10.1371/journal.pone.0266332			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363835	Green Published, gold			2022-12-26	WOS:000804748600016
J	Khan, S; Mentrup, HL; Novak, EA; Siow, VS; Wang, Q; Crawford, EC; Schneider, C; Comerford, TE; Firek, B; Rogers, MB; Loughran, P; Morowitz, MJ; Mollen, KP				Khan, Sidrah; Mentrup, Heather L.; Novak, Elizabeth A.; Siow, Vei Shaun; Wang, Qian; Crawford, Erin C.; Schneider, Corinne; Comerford, Thomas E.; Firek, Brian; Rogers, Matt B.; Loughran, Patricia; Morowitz, Michael J.; Mollen, Kevin P.			Cyclic GMP-AMP synthase contributes to epithelial homeostasis in intestinal inflammation via Beclin-1-mediated autophagy	FASEB JOURNAL			English	Article						cGAS; colitis; DSS; intestinal epithelium	SIROLIMUS RAPAMYCIN; CROHNS-DISEASE; BOWEL-DISEASE; COLITIS; APOPTOSIS; CGAS; PROTECTS; STIMULATION; INDUCTION; RELEVANCE	Inflammatory bowel disease (IBD) represents a set of idiopathic and chronic inflammatory diseases of the gastrointestinal tract. Central to the pathogenesis of IBD is a dysregulation of normal intestinal epithelial homeostasis. cGAS is a DNA-sensing receptor demonstrated to promote autophagy, a mechanism that removes dysfunctional cellular components. Beclin-1 is a crucial protein involved in the initiation of autophagy. We hypothesized that cGAS plays a key role in intestinal homeostasis by upregulating Beclin-1-mediated autophagy. We evaluated intestinal cGAS levels in humans with IBD and in murine colonic tissue after performing a 2% dextran sulfate sodium (DSS) colitis model. Autophagy and cell death mechanisms were studied in cGAS KO and WT mice via qPCR, WB analysis, H&E, IF, and TUNEL staining. Autophagy was measured in stimulated intestinal epithelial cells (IECs) via WB analysis. Our data demonstrates cGAS to be upregulated during human and murine colitis. Furthermore, cGAS deficiency leads to worsened colitis and decreased levels of autophagy proteins including Beclin-1 and LC3-II. Co-IP demonstrates a direct binding between cGAS and Beclin-1 in IECs. Transfection of cGAS in stimulated HCT-116 cells leads to increased autophagy. IECs isolated from cGAS KO have diminished autophagic flux. cGAS KO mice subjected to DSS have increased cell death and cleaved caspase-3. Lastly, treatment of cGAS KO mice with rapamycin decreased the severity of colitis. Our data suggest that cGAS maintains intestinal epithelial homeostasis during human IBD and murine colitis by upregulating Beclin-1-mediated autophagy and preventing IEC death. Rescue of autophagy can attenuate the severity of colitis associated with cGAS deficiency.	[Khan, Sidrah; Mentrup, Heather L.; Novak, Elizabeth A.; Siow, Vei Shaun; Firek, Brian; Rogers, Matt B.; Loughran, Patricia; Morowitz, Michael J.; Mollen, Kevin P.] Univ Pittsburgh, Dept Surg, Sch Med, 200 Lothrop St, Pittsburgh, PA 15203 USA; [Mentrup, Heather L.; Novak, Elizabeth A.; Schneider, Corinne; Firek, Brian; Rogers, Matt B.; Morowitz, Michael J.; Mollen, Kevin P.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Surg, Med Ctr, Pittsburgh, PA 15203 USA; [Wang, Qian] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Dept Pathol, Med Ctr, Pittsburgh, PA 15203 USA; [Crawford, Erin C.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Gastroenterol, Med Ctr, Pittsburgh, PA 15203 USA; [Comerford, Thomas E.] Univ Buffalo, Jacobs Sch Med & Biomed Sci, Buffalo, NY USA; [Loughran, Patricia] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15203 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Khan, S (corresponding author), Univ Pittsburgh, Dept Surg, Sch Med, 200 Lothrop St, Pittsburgh, PA 15203 USA.	Khans8@upmc.edu	Loughran, Patricia/AAB-1184-2021	Khan, Sidrah/0000-0002-9545-1247	U.S. National Institutes of Health (NIH) [R01 DK120986]; Burroughs Wellcome Fund	U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund)	This work was supported by U.S. National Institutes of Health (NIH) Grant R01 DK120986 (to K.P.M) and the Burroughs Wellcome Fund (to S.K.). The University of Pittsburgh holds a Physician--Scientist Institutional Award from the Burroughs Wellcome Fund	Ahn J, 2017, CELL REP, V21, P3873, DOI 10.1016/j.celrep.2017.11.101; Araki Y, 2010, ONCOL REP, V24, P869, DOI 10.3892/or_00000932; Benjamin JL, 2013, CELL HOST MICROBE, V13, P723, DOI 10.1016/j.chom.2013.05.004; Boya P, 2005, MOL CELL BIOL, V25, P1025, DOI 10.1128/MCB.25.3.1025-1040.2005; Cavlar T, 2012, IMMUNOL CELL BIOL, V90, P474, DOI 10.1038/icb.2012.11; Chassaing Benoit, 2014, Curr Protoc Immunol, V104, DOI 10.1002/0471142735.im1525s104; Choi AMK, 2013, NEW ENGL J MED, V368, P651, DOI [10.1056/NEJMra1205406, 10.1056/NEJMc1303158]; Cooney R, 2010, NAT MED, V16, P90, DOI 10.1038/nm.2069; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; de Souza HSP, 2016, NAT REV GASTRO HEPAT, V13, P13, DOI [10.1038/nrgastro.2016.186, 10.1038/nrgastro.2015.186]; Eisenberg-Lerner A, 2009, CELL DEATH DIFFER, V16, P966, DOI 10.1038/cdd.2009.33; Elinav E, 2011, CELL, V145, P745, DOI 10.1016/j.cell.2011.04.022; Feng YC, 2014, CELL RES, V24, P24, DOI 10.1038/cr.2013.168; Gatica D, 2018, NAT CELL BIOL, V20, P233, DOI 10.1038/s41556-018-0037-z; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Guan YT, 2015, J IMMUNOL, V195, P339, DOI 10.4049/jimmunol.1303356; Gui X, 2019, NATURE, V567, P262, DOI 10.1038/s41586-019-1006-9; Hampe J, 2007, NAT GENET, V39, P207, DOI 10.1038/ng1954; Han YL, 2020, J IMMUNOL, V204, P1437, DOI 10.4049/jimmunol.1900869; Haq S, 2019, J BIOMED SCI, V26, DOI 10.1186/s12929-019-0512-2; Hotte NSC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037932; Hu SQ, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2105747118; Hu SR, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154564; Kaplan GG, 2015, NAT REV GASTRO HEPAT, V12, P720, DOI 10.1038/nrgastro.2015.150; Katakura K, 2005, J CLIN INVEST, V115, P695, DOI 10.1172/JCI200522996; Kato K, 2017, ANNU REV BIOCHEM, V86, P541, DOI 10.1146/annurev-biochem-061516-044813; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Lauzier A, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-47659-7; Lei Z, 2018, AM J PHYSIOL-GASTR L, V314, pG655, DOI 10.1152/ajpgi.00326.2017; Li KL, 2017, TUMOR BIOL, V39, DOI 10.1177/1010428317706213; Li X, 2013, IMMUNITY, V39, P1019, DOI 10.1016/j.immuni.2013.10.019; Liang QM, 2014, CELL HOST MICROBE, V15, P228, DOI 10.1016/j.chom.2014.01.009; Lin XK, 2018, BIOSCIENCE REP, V38, DOI 10.1042/BSR20181822; Macias-Ceja DC, 2017, BRIT J PHARMACOL, V174, P2501, DOI 10.1111/bph.13860; Massey DCO, 2008, GUT, V57, P1294, DOI 10.1136/gut.2008.157297; Mauthe M, 2018, AUTOPHAGY, V14, P1435, DOI 10.1080/15548627.2018.1474314; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Mutalib M, 2014, J CROHNS COLITIS, V8, P1730, DOI 10.1016/j.crohns.2014.08.014; NEURATH MF, 1995, J EXP MED, V182, P1281, DOI 10.1084/jem.182.5.1281; Perng YC, 2018, NAT REV MICROBIOL, V16, P423, DOI 10.1038/s41579-018-0020-5; Ramachandran A, 2000, J GASTROEN HEPATOL, V15, P109, DOI 10.1046/j.1440-1746.2000.02059.x; Rampton DS., 2016, FAST FACTS INFLAMMAT; Ratsimandresy RA, 2017, CELL MOL IMMUNOL, V14, P127, DOI 10.1038/cmi.2016.35; Renehan AG, 2001, CAN J GASTROENTEROL, V15, P166, DOI 10.1155/2001/164727; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Tsuboi K, 2015, J BIOL CHEM, V290, P20511, DOI 10.1074/jbc.M114.632257; TYSK C, 1988, GUT, V29, P990, DOI 10.1136/gut.29.7.990; Valcifahmetoglu-Norberg H, 2015, J CLIN INVEST, V125, P5, DOI 10.1172/JCI73937; Vincent G, 2020, ANTIOXID REDOX SIGN, V33, P1, DOI 10.1089/ars.2018.7702; Walters W, 2016, MSYSTEMS, V1, DOI 10.1128/mSystems.00009-15; Wang Y, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/192329; Wang Y, 2007, CELL RES, V17, P858, DOI 10.1038/cr.2007.81; Wang ZH, 2021, THERANOSTICS, V11, P7491, DOI 10.7150/thno.59196; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Xu Y, 2007, IMMUNITY, V27, P135, DOI 10.1016/j.immuni.2007.05.022; Yang ZF, 2010, CURR OPIN CELL BIOL, V22, P124, DOI 10.1016/j.ceb.2009.11.014; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yoshii SR, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18091865; Zhong M., 2020, FRONT PHARMACOL, V11	60	0	0	0	1	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22282	10.1096/fj.202200138R	http://dx.doi.org/10.1096/fj.202200138R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0A0AX	35344224				2022-12-26	WOS:000773625500001
J	Takagi, H; Tamura, I; Fujimura, T; Doi-Tanaka, Y; Shirafuta, Y; Mihara, Y; Maekawa, R; Taketani, T; Sato, S; Tamura, H; Sugino, N				Takagi, Haruka; Tamura, Isao; Fujimura, Taishi; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro			Transcriptional coactivator PGC-1 alpha contributes to decidualization by forming a histone-modifying complex with C/EBP beta and p300	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FACTOR-BINDING PROTEIN-1; ENDOMETRIAL STROMAL CELLS; GAMMA COACTIVATOR-1-ALPHA; ACETYLATION STATUS; PROMOTER REGION; GRANULOSA-CELLS; PROGESTERONE-RECEPTOR; PGC-1 COACTIVATORS; ENERGY-METABOLISM; DNA METHYLATION	We previously reported that CCAAT/enhancer-binding protein beta (C/EBP beta) is the pioneer factor inducing tran-scription enhancer mark H3K27 acetylation (H3K27ac) in the promoter and enhancer regions of genes encoding insulin-like growth factor-binding protein-1 (IGFBP-1) and prolactin (PRL) and that this contributes to decidualization of human endometrial stromal cells (ESCs). Peroxisome proliferator- activated receptor gamma coactivator 1-alpha (PGC-1 alpha; PPARGC1A) is a transcriptional coactivator known to regulate H3K27ac. However, although PGC-1 alpha is expressed in ESCs, the potential role of PGC-1 alpha in mediating decidualization is un-clear. Here, we investigated the involvement of PGC-1 alpha in the regulation of decidualization. We incubated ESCs with cAMP to induce decidualization and knocked down PPARGC1A to inhibit cAMP-induced expression of IGFBP-1 and PRL. We found cAMP increased the recruitment of PGC-1 alpha and p300 to C/EBP beta-binding sites in the promoter and enhancer regions of IGFBP-1 and PRL, corresponding with increases in H3K27ac. Moreover, PGC-1 alpha knockdown inhibited these increases, suggesting PGC-1 alpha forms a histone-modifying complex with C/EBP beta and p300 at these regions. To further investigate the regulation of PGC-1 alpha, we focused on C/EBP beta upstream of PGC-1 alpha. We found cAMP increased C/EBP beta recruitment to the novel enhancer regions of PPARGC1A. Deletion of these enhancers decreased PGC-1 alpha expression, indicating that C/EBP beta upregulates PGC-1 alpha expression by binding to novel enhancer regions. In conclusion, PGC-1 alpha is upregulated by C/EBP beta recruitment to novel enhancers and contributes to decidualization by forming a histone-modifying complex with C/EBP beta and p300, thereby inducing epigenomic changes in the promoters and enhancers of IGFBP-1 and PRL.	[Takagi, Haruka; Tamura, Isao; Fujimura, Taishi; Doi-Tanaka, Yumiko; Shirafuta, Yuichiro; Mihara, Yumiko; Maekawa, Ryo; Taketani, Toshiaki; Sato, Shun; Tamura, Hiroshi; Sugino, Norihiro] Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan	Yamaguchi University	Tamura, I (corresponding author), Yamaguchi Univ, Dept Obstet & Gynecol, Grad Sch Med, Ube, Yamaguchi, Japan.	isao@yamaguchi-u.ac.jp			JSPS KAKENHI [16K20191, 17K11239, 18K09230, 20K09645, 20K18191, 20H03825]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding and additional information-This work was supported in part by JSPS KAKENHI (Grant Number 16K20191, 17K11239, 18K09230, 20K09645, 20K18191, and 20H03825) .	Agostinis C, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.02387; Bengsch B, 2016, IMMUNITY, V45, P358, DOI 10.1016/j.immuni.2016.07.008; Bombail V, 2008, HUM REPROD, V23, P2782, DOI 10.1093/humrep/den298; Cesena TI, 2007, J BIOL CHEM, V282, P956, DOI 10.1074/jbc.M511451200; Charos AE, 2012, GENOME RES, V22, P1668, DOI 10.1101/gr.127761.111; Cirillo LA, 2002, MOL CELL, V9, P279, DOI 10.1016/S1097-2765(02)00459-8; Dankel SN, 2010, BBA-MOL CELL RES, V1803, P1013, DOI 10.1016/j.bbamcr.2010.05.008; Du QQ, 2019, CANCER SCI, V110, P2050, DOI 10.1111/cas.14011; Eisele PS, 2015, BIOCHEM BIOPH RES CO, V464, P692, DOI 10.1016/j.bbrc.2015.06.166; Fakhouri THI, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001060; Fernandez-Marcos PJ, 2011, AM J CLIN NUTR, V93, p884S, DOI 10.3945/ajcn.110.001917; Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794; Fuglerud BM, 2018, EPIGENET CHROMATIN, V11, DOI 10.1186/s13072-018-0208-y; Fukui Y, 2019, REPROD MED BIOL, V18, P234, DOI 10.1002/rmb2.12280; Gao JG, 1999, MOL CELL ENDOCRINOL, V153, P11, DOI 10.1016/S0303-7207(99)00096-9; Gellersen B, 2003, J ENDOCRINOL, V178, P357, DOI 10.1677/joe.0.1780357; Gerlach JM, 2017, P NATL ACAD SCI USA, V114, pE9224, DOI 10.1073/pnas.1705816114; Hu WB, 2019, J CELL BIOCHEM, V120, P14908, DOI 10.1002/jcb.28753; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jozaki K, 2019, REPRODUCTION, V157, P457, DOI 10.1530/REP-18-0393; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Karamanlidis G, 2007, J BIOL CHEM, V282, P24660, DOI 10.1074/jbc.M703101200; Kim JJ, 2005, BIOL REPROD, V73, P833, DOI 10.1095/biolreprod.105.043182; Kim JJ, 2003, BIOL REPROD, V68, P24, DOI 10.1095/biolreprod.102.009316; Kimura H, 2008, CELL STRUCT FUNCT, V33, P61, DOI 10.1247/csf.07035; Kohlmeier A, 2020, ENDOCRINOLOGY, V161, DOI 10.1210/endocr/bqaa070; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Lai AY, 2011, NAT REV CANCER, V11, P588, DOI 10.1038/nrc3091; Lee HJ, 2008, FEBS LETT, V582, P627, DOI 10.1016/j.febslet.2008.01.033; Lee L, 2013, ENDOCRINOLOGY, V154, P458, DOI 10.1210/en.2012-1610; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li GL, 2012, CELL, V148, P84, DOI 10.1016/j.cell.2011.12.014; Liu X, 2017, BIOL TRACE ELEM RES, V175, P440, DOI 10.1007/s12011-016-0799-8; Maekawa R, 2019, BMC GENOMICS, V20, DOI 10.1186/s12864-019-5695-0; Maekawa R, 2016, MOL ENDOCRINOL, V30, P335, DOI 10.1210/me.2015-1058; Matsuoka A, 2010, J CLIN ENDOCR METAB, V95, pE291, DOI 10.1210/jc.2010-0619; Mihara Y, 2020, J CLIN ENDOCR METAB, V105, DOI 10.1210/clinem/dgaa618; Mink S, 1997, MOL CELL BIOL, V17, P6609, DOI 10.1128/MCB.17.11.6609; Misra J, 2013, NUCLEIC ACIDS RES, V41, P6960, DOI 10.1093/nar/gkt429; Nishigaki A, 2020, REPROD MED BIOL, V19, P189, DOI 10.1002/rmb2.12323; NOYES RW, 1950, FERTIL STERIL, V1, P3, DOI 10.1016/s0015-0282(16)30062-0; Okada M, 2016, ENDOCRINOLOGY, V157, P3344, DOI 10.1210/en.2016-1264; Olmos Y, 2013, ANTIOXID REDOX SIGN, V19, P1507, DOI 10.1089/ars.2012.4713; Pohnke Y, 1999, J BIOL CHEM, V274, P24808, DOI 10.1074/jbc.274.35.24808; Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368; Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Salker M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010287; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Shinagawa M, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-36566-y; Spruce C, 2020, GENE DEV, V34, P398, DOI 10.1101/gad.333542.119; Sterner DE, 2000, MICROBIOL MOL BIOL R, V64, P435, DOI 10.1128/MMBR.64.2.435-459.2000; Sultana S, 2017, REPROD MED BIOL, V16, P170, DOI 10.1002/rmb2.12028; Tamura I, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.101150; Tamura I, 2021, MOL CELL ENDOCRINOL, V520, DOI 10.1016/j.mce.2020.111085; Tamura I, 2020, J BIOL CHEM, V295, P4673, DOI 10.1074/jbc.RA120.012841; Tamura I, 2018, J BIOL CHEM, V293, P5270, DOI 10.1074/jbc.RA117.000234; Tamura I, 2017, ENDOCRINOLOGY, V158, P3696, DOI 10.1210/en.2017-00478; Tamura I, 2014, MOL ENDOCRINOL, V28, P1656, DOI 10.1210/me.2014-1117; Tamura I, 2014, ENDOCRINOLOGY, V155, P275, DOI 10.1210/en.2013-1569; Tamura I, 2012, ENDOCRINOLOGY, V153, P5612, DOI 10.1210/en.2012-1420; Tamura I, 2011, J CLIN ENDOCR METAB, V96, pE1073, DOI 10.1210/jc.2010-2489; Tang MY, 2005, MOL HUM REPROD, V11, P237, DOI 10.1093/molehr/gah149; Teles A, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00158; Thomas LR, 2015, MOL CELL, V58, P440, DOI 10.1016/j.molcel.2015.02.028; Ticconi C, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20215332; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; Tie F, 2009, DEVELOPMENT, V136, P3131, DOI 10.1242/dev.037127; Vacca P, 2011, P NATL ACAD SCI USA, V108, P2402, DOI 10.1073/pnas.1016257108; Vasquez YM, 2015, MOL ENDOCRINOL, V29, P421, DOI 10.1210/me.2014-1292; Wallberg AE, 2003, MOL CELL, V12, P1137, DOI 10.1016/S1097-2765(03)00391-5; Wang H, 2008, MOL ENDOCRINOL, V22, P1596, DOI 10.1210/me.2007-0388; Wang LL, 2008, BIOCHEM J, V416, P407, DOI 10.1042/BJ20081085; Wang SB, 2016, PHARMACOL RES, V111, P76, DOI 10.1016/j.phrs.2016.02.028; Wang W, 2012, MOL ENDOCRINOL, V26, P2016, DOI 10.1210/me.2012-1169; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Watanabe K, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-34290-1; Wu L, 2020, CELL DEATH DIS, V11, DOI 10.1038/s41419-020-2426-z; Wu Tao, 2016, Biochem Biophys Rep, V5, P374, DOI 10.1016/j.bbrep.2016.01.014; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Yazawa T, 2010, MOL ENDOCRINOL, V24, P485, DOI 10.1210/me.2009-0352; Zhang Qian, 2016, Reproductive Medicine and Biology, V15, P95, DOI 10.1007/s12522-015-0226-4; Zhang YB, 2013, NATURE, V504, P306, DOI 10.1038/nature12716; Zhu H, 2014, GENE, V551, P1, DOI 10.1016/j.gene.2014.08.047	84	1	1	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101874	10.1016/j.jbc.2022.101874	http://dx.doi.org/10.1016/j.jbc.2022.101874			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35358514	gold, Green Submitted, Green Published			2022-12-26	WOS:000798142000002
J	Wu, SZ; Huang, YC; Selby, CP; Gao, M; Sancar, A; Hu, JC				Wu, Sizhong; Huang, Yanchao; Selby, Christopher P.; Gao, Meng; Sancar, Aziz; Hu, Jinchuan			A new technique for genome-wide mapping of nucleotide excision repair without immunopurification of damaged DNA	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TRANSCRIPTION-COUPLED REPAIR; ESCHERICHIA-COLI; UV DAMAGE; DIMERIC LESIONS; CHROMATIN STATE; MECHANISMS; INDUCTION; LANDSCAPE; INCREASES; ALIGNMENT	Nucleotide excision repair functions to protect genome integrity, and ongoing studies using excision repair sequencing (XR-seq) have contributed to our understanding of how cells prioritize repair across the genome. In this method, the products of excision repair bearing damaged DNA are captured, sequenced, and then mapped genome-wide at single-nucleotide resolution. However, reagent requirements and complex procedures have limited widespread usage of this technique. In addition to the expense of these reagents, it has been hypothesized that the immunoprecipitation step using antibodies directed against damaged DNA may introduce bias in different sequence contexts. Here, we describe a newly developed adaptation called dA-tailing and adaptor ligation (ATL)-XR-seq, a relatively simple XR-seq method that avoids the use of immunoprecipitation targeting damaged DNA. ATL-XR-seq captures repair products by 3'-dA-tailing and 5'-adapter ligation instead of the original 5'- and 3'-dual adapter ligation. This new approach avoids adapter dimer formation during subsequent PCR, omits inefficient and time-consuming purification steps, and is very sensitive. In addition, poly(dA) tail length heterogeneity can serve as a molecular identifier, allowing more repair hotspots to be mapped. Importantly, a comparison of both repair mapping methods showed that no major bias is introduced by the anti-UV damage antibodies used in the original XR-seq procedure. Finally, we also coupled the described dA-tailing approach with quantitative PCR in a new method to quantify repair products. These new methods provide powerful and user-friendly tools to qualitatively and quantitatively measure excision repair.	[Wu, Sizhong; Huang, Yanchao; Gao, Meng; Hu, Jinchuan] Fudan Univ, Shanghai Peoples Hosp 5, Shanghai, Peoples R China; [Wu, Sizhong; Huang, Yanchao; Gao, Meng; Hu, Jinchuan] Fudan Univ, Inst Biomed Sci, Minist Sci & Technol, Shanghai Key Lab Med Epigenet,Int Colab Med Epige, Shanghai, Peoples R China; [Selby, Christopher P.; Sancar, Aziz] Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA	Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Hu, JC (corresponding author), Fudan Univ, Shanghai Peoples Hosp 5, Shanghai, Peoples R China.; Hu, JC (corresponding author), Fudan Univ, Inst Biomed Sci, Minist Sci & Technol, Shanghai Key Lab Med Epigenet,Int Colab Med Epige, Shanghai, Peoples R China.; Sancar, A (corresponding author), Univ N Carolina, Dept Biochem & Biophys, Sch Med, Chapel Hill, NC 27515 USA.	aziz_sancar@med.unc.edu; hujinchuan@fudan.edu.cn		Hu, Jinchuan/0000-0001-7096-0195	National Natural Science Foundation of China (NSFC) [31870804]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program; National Institutes of Health [GM118102, ES033414]; Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019); innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019); innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program	This work was supported by National Natural Science Foundation of China (NSFC, 31870804) , Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (2019) , innovative research team of high-level local university in Shanghai; Shanghai Outstanding Young Talent Program (2019, to J. H.) , and National Institutes of Health (GM118102, ES033414 to A. S.) . The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adar S, 2016, P NATL ACAD SCI USA, V113, pE2124, DOI 10.1073/pnas.1603388113; Adebali O, 2017, J BIOL CHEM, V292, P18386, DOI 10.1074/jbc.C117.818807; Adebali O, 2017, P NATL ACAD SCI USA, V114, pE2116, DOI 10.1073/pnas.1700230114; Akkose U, 2021, BMC GENOMICS, V22, DOI 10.1186/s12864-021-07898-3; Bryan DS, 2014, GENOME RES, V24, P1534, DOI 10.1101/gr.174052.114; Canturk F, 2016, P NATL ACAD SCI USA, V113, P4706, DOI 10.1073/pnas.1604097113; Chen C, 2014, SOURCE CODE BIOL MED, V9, DOI 10.1186/1751-0473-9-8; Chiou YY, 2018, J BIOL CHEM, V293, P2476, DOI 10.1074/jbc.RA117.000971; Choi JH, 2015, J BIOL CHEM, V290, P28812, DOI 10.1074/jbc.M115.690354; Choi JH, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1179; Crowley DJ, 1998, J BACTERIOL, V180, P3345, DOI 10.1128/JB.180.13.3345-3352.1998; Deger N, 2019, J BIOL CHEM, V294, P18092, DOI 10.1074/jbc.AC119.011448; Douki T, 2000, J BIOL CHEM, V275, P11678, DOI 10.1074/jbc.275.16.11678; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Gonzalez-Perez A, 2019, CELL, V177, P101, DOI 10.1016/j.cell.2019.02.051; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Hu JC, 2019, NAT PROTOC, V14, P248, DOI 10.1038/s41596-018-0093-7; Hu JC, 2017, J BIOL CHEM, V292, P15588, DOI 10.1074/jbc.R117.807453; Hu JC, 2017, P NATL ACAD SCI USA, V114, P6758, DOI 10.1073/pnas.1706522114; Hu JC, 2017, PHOTOCHEM PHOTOBIOL, V93, P199, DOI 10.1111/php.12668; Hu JC, 2016, P NATL ACAD SCI USA, V113, P11507, DOI 10.1073/pnas.1614430113; Hu JC, 2015, GENE DEV, V29, P948, DOI 10.1101/gad.261271.115; Hu JC, 2013, J BIOL CHEM, V288, P20918, DOI 10.1074/jbc.M113.482257; Jiang YC, 2021, J BIOL CHEM, V296, DOI 10.1016/j.jbc.2021.100581; Jin SG, 2021, SCI ADV, V7, DOI 10.1126/sciadv.abi6508; Karbaschi Mahsa, 2012, Methods Mol Biol, V920, P163, DOI 10.1007/978-1-61779-998-3_12; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lehmann AR, 2011, DNA REPAIR, V10, P730, DOI 10.1016/j.dnarep.2011.04.023; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li WT, 2018, P NATL ACAD SCI USA, V115, pE3408, DOI 10.1073/pnas.1801687115; Li WT, 2017, P NATL ACAD SCI USA, V114, P6752, DOI 10.1073/pnas.1706021114; Liakos A, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-14566-9; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; Mao P, 2019, DNA REPAIR, V81, DOI 10.1016/j.dnarep.2019.102645; Mao P, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05064-0; Mao P, 2016, P NATL ACAD SCI USA, V113, P9057, DOI 10.1073/pnas.1606667113; Marteijn JA, 2014, NAT REV MOL CELL BIO, V15, P465, DOI 10.1038/nrm3822; MELLON I, 1987, CELL, V51, P241, DOI 10.1016/0092-8674(87)90151-6; MELLON I, 1989, NATURE, V342, P95, DOI 10.1038/342095a0; MORI T, 1991, PHOTOCHEM PHOTOBIOL, V54, P225, DOI 10.1111/j.1751-1097.1991.tb02010.x; Oztas O, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-03922-5; Perera D, 2016, NATURE, V532, P259, DOI 10.1038/nature17437; Premi S, 2019, P NATL ACAD SCI USA, V116, P24196, DOI 10.1073/pnas.1907860116; Quinlan Aaron R, 2014, Curr Protoc Bioinformatics, V47, DOI 10.1002/0471250953.bi1112s47; Ramirez F, 2016, NUCLEIC ACIDS RES, V44, pW160, DOI 10.1093/nar/gkw257; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sabarinathan R, 2016, NATURE, V532, P264, DOI 10.1038/nature17661; Sancar A, 2016, ANGEW CHEM INT EDIT, V55, P8502, DOI 10.1002/anie.201601524; Seplyarskiy VB, 2019, NAT GENET, V51, P36, DOI 10.1038/s41588-018-0285-7; Tarasov A, 2015, BIOINFORMATICS, V31, P2032, DOI 10.1093/bioinformatics/btv098; Titov DV, 2011, NAT CHEM BIOL, V7, P182, DOI [10.1038/nchembio.522, 10.1038/NCHEMBIO.522]; van den Heuvel D, 2021, TRENDS CELL BIOL, V31, P359, DOI 10.1016/j.tcb.2021.02.007; van der Weegen Y, 2020, NAT COMMUN, V11, DOI 10.1038/s41467-020-15903-8; Wu DN, 2018, J CHROMATOGR B, V1096, P135, DOI 10.1016/j.jchromb.2018.08.015; Yang YY, 2018, P NATL ACAD SCI USA, V115, pE4777, DOI 10.1073/pnas.1804493115	55	0	0	15	17	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101863	10.1016/j.jbc.2022.101863	http://dx.doi.org/10.1016/j.jbc.2022.101863			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1D0EH	35339490	Green Published, gold			2022-12-26	WOS:000793483000005
J	Dickson, MJ; Bishop, JV; Hansen, TR; Sheldon, IM; Bromfield, JJ				Dickson, Mackenzie J.; Bishop, Jeanette, V; Hansen, Thomas R.; Sheldon, I. Martin; Bromfield, John J.			The endometrial transcriptomic response to pregnancy is altered in cows after uterine infection	PLOS ONE			English	Article							TOLL-LIKE RECEPTORS; PERITONEAL-MACROPHAGES; INFLAMMATORY DISEASES; IMPLANTATION; EXPRESSION; PATHWAY; EMBRYO; INTERLEUKIN-6; PARTURITION; WOMEN	Pregnancy induces changes in the transcriptome of the bovine endometrium from 15 days after insemination. However, pregnancy is less likely to occur if cows had a postpartum bacterial infection of the uterus, even after the resolution of disease. We hypothesized that uterine bacterial infection alters the endometrial transcriptomic signature of pregnancy after the resolution of disease. To examine the endometrial transcriptomic signature of pregnancy, cows were inseminated 130 days after intrauterine infusion of pathogenic Escherichia coli and Trueperella pyogenes, subsequently endometrium was collected 16 days after insemination for RNA sequencing. We found 171 pregnancy regulated genes in cows 146 days after bacterial infection. When comparing our findings with previous studies that described the endometrial transcriptomic signature of pregnancy in healthy cows, 24 genes were consistently differentially expressed in pregnancy, including MX1, MX2 and STAT1. However, 12 pregnancy regulated genes were found only in the endometrium of healthy cows, including ISG15 and TRANK1. Furthermore, 28 pregnancy regulated genes were found only in the endometrium of cows following bacterial infection and these were associated with altered iNOS, TLR, and IL-7 signaling pathways. Although 94 predicted upstream regulators were conserved amongst the studies, 14 were found only in the endometrium of pregnant healthy cows, and 5 were found only in cows following bacterial infection, including AIRE, NFKBIA, and DUSP1. In conclusion, there were both consistent and discordant features of the endometrial transcriptomic signature of pregnancy 146 days after intrauterine bacterial infusion. These findings imply that there is an essential transcriptomic signature of pregnancy, but that infection induces long-term changes in the endometrium that affect the transcriptomic response to pregnancy.	[Dickson, Mackenzie J.; Bromfield, John J.] Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA; [Bishop, Jeanette, V; Hansen, Thomas R.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Sheldon, I. Martin] Swansea Univ, Med Sch, Swansea, W Glam, Wales	State University System of Florida; University of Florida; Colorado State University; Swansea University	Bromfield, JJ (corresponding author), Univ Florida, Dept Anim Sci, Gainesville, FL 32611 USA.	jbromfield@ufl.edu	Hansen, Thomas/GWZ-2858-2022; Bromfield, John/A-8830-2014	Bromfield, John/0000-0001-5438-2137	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [R01HD084316]; Animal Health and Production and Animal Products: Animal Reproduction from the USDA National Institute of Food and Agriculture [2019-05310]	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; Animal Health and Production and Animal Products: Animal Reproduction from the USDA National Institute of Food and Agriculture	This study was supported by Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number R01HD084316. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. In addition, this work is supported by Animal Health and Production and Animal Products: Animal Reproduction grant no. 2019-05310 from the USDA National Institute of Food and Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2001, NAT IMMUNOL, V2, P675, DOI 10.1038/90609; Amos MR, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115972; Babicki S, 2016, NUCLEIC ACIDS RES, V44, pW147, DOI 10.1093/nar/gkw419; Barroso RP, 1998, MOL HUM REPROD, V4, P503, DOI 10.1093/molehr/4.5.503; Bauersachs S, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094771; Bazer FW, 1997, AM J REPROD IMMUNOL, V37, P412; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Carvalho MR, 2019, J DAIRY SCI, V102, P11701, DOI 10.3168/jds.2019-17025; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Davies D, 2008, REPROD BIOL ENDOCRIN, V6, DOI 10.1186/1477-7827-6-53; Dickson MJ, 2020, BIOL REPROD, V103, P508, DOI 10.1093/biolre/ioaa069; Edelhoff INF, 2020, J DAIRY SCI, V103, P11970, DOI 10.3168/jds.2020-19070; ELLIOTT L, 1968, AM J VET RES, V29, P77; Estrada-Cortes E, 2019, TRANSL ANIM SCI, V3, P60, DOI 10.1093/tas/txz009; Ezz MA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0214516; Forde N, 2012, PHYSIOL GENOMICS, V44, P799, DOI 10.1152/physiolgenomics.00067.2012; Fry TJ, 2005, J IMMUNOL, V174, P6571, DOI 10.4049/jimmunol.174.11.6571; Gabler C, 2009, THERIOGENOLOGY, V71, P993, DOI 10.1016/j.theriogenology.2008.11.009; GRIFFIN J F T, 1974, Theriogenology, V1, P91, DOI 10.1016/0093-691X(74)90052-1; Herath S, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-55; Horlock AD, 2020, REPRODUCTION, V160, P93, DOI 10.1530/REP-19-0564; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; Kwon H, 2004, BIOL REPROD, V70, P679, DOI 10.1095/biolreprod.103.023184; LeBlanc SJ, 2002, J DAIRY SCI, V85, P2223, DOI 10.3168/jds.S0022-0302(02)74302-6; Liu XR, 2019, ANIM PROD SCI, V59, P1803, DOI 10.1071/AN18426; Metsalu T, 2015, NUCLEIC ACIDS RES, V43, pW566, DOI 10.1093/nar/gkv468; Mor G, 2005, CRIT REV IMMUNOL, V25, P375, DOI 10.1615/CritRevImmunol.v25.i5.30; Mor G, 2011, ANN NY ACAD SCI, V1221, P80, DOI 10.1111/j.1749-6632.2010.05938.x; Moran B, 2017, REPROD FERT DEVELOP, V29, P274, DOI 10.1071/RD15128; mousephenotype, INT MOUSE PHENOTYPIN; Mudunuri U, 2009, BIOINFORMATICS, V25, P555, DOI 10.1093/bioinformatics/btn654; Osborn BH, 2002, FERTIL STERIL, V77, P46, DOI 10.1016/S0015-0282(01)02940-5; Piersanti RL, 2019, REPRODUCTION, V158, P35, DOI 10.1530/REP-19-0037; Ponce C, 2009, REPRODUCTION, V137, P727, DOI 10.1530/REP-08-0407; Purcell TL, 1999, MOL HUM REPROD, V5, P467, DOI 10.1093/molehr/5.5.467; Ribeiro ES, 2016, J DAIRY SCI, V99, P2201, DOI 10.3168/jds.2015-10337; Rytkonen KT, 2019, REPROD SCI, V26, P323, DOI 10.1177/1933719118802056; Salilew-Wondim D, 2010, PHYSIOL GENOMICS, V42, P201, DOI 10.1152/physiolgenomics.00047.2010; Santos JEP, 2004, ANIM REPROD SCI, V82-3, P513, DOI 10.1016/j.anireprosci.2004.04.015; Sheldon IM, 2019, ANNU REV ANIM BIOSCI, V7, P361, DOI 10.1146/annurev-animal-020518-115227; Sheldon IM, 2009, BIOL REPROD, V81, P1025, DOI 10.1095/biolreprod.109.077370; Sheldon IM, 2002, REPRODUCTION, V123, P837, DOI 10.1530/rep.0.1230837; Soumya V, 2016, AM J REPROD IMMUNOL, V76, P224, DOI 10.1111/aji.12538; Su LJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087867; Tagoma A, 2019, AM J REPROD IMMUNOL, V82, DOI 10.1111/aji.13188; Thatcher WW, 2001, THERIOGENOLOGY, V56, P1435, DOI 10.1016/S0093-691X(01)00645-8; Wang YY, 2017, GENOMICS, V109, P43, DOI 10.1016/j.ygeno.2016.11.007; Wiltbank MC, 2016, THERIOGENOLOGY, V86, P239, DOI 10.1016/j.theriogenology.2016.04.037; Wu AL, 2019, EUR J OBSTET GYN R B, V237, P209, DOI 10.1016/j.ejogrb.2018.12.006; Wu L, 2016, AM J REPROD IMMUNOL, V76, P454, DOI 10.1111/aji.12588; Wu MY, 1999, AM J REPROD IMMUNOL, V41, P106; Yates AD, 2020, NUCLEIC ACIDS RES, V48, pD682, DOI 10.1093/nar/gkz966	52	0	0	3	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265062	10.1371/journal.pone.0265062	http://dx.doi.org/10.1371/journal.pone.0265062			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358206	Green Published, gold			2022-12-26	WOS:000799828800023
J	Li, J; Liu, D; Cai, MY				Li, Jing; Liu, Di; Cai, Mengyuan			Water pollution and administrative division adjustments: A quasi-natural experiment in Chaohu Lake, China	PLOS ONE			English	Article							COSTS; URBANIZATION; CONSEQUENCES; SECURITY; BORDERS; SCALE	Administrative division adjustments, such as agglomerations, upgrading, and revocation, introduce a series of uncertain impacts on the social and economic development in administrative regions. Previous studies have focused more on the economic effects of administrative division adjustments, but in this paper, we also consider the environmental effects of such adjustments. In 2011, with the approval of the State Council, the prefecture-level Chaohu city was officially revoked, resulting in a county-level Chaohu city. One district and four counties under the jurisdiction of the original Chaohu city were placed under the jurisdiction of Hefei, Wuhu, and Ma'anshan. This adjustment made Chaohu Lake an inner lake of Hefei city. The administrative division adjustment of Chaohu Lake, China, is used as a quasi-natural experiment to explore the influence of such an adjustment on pollution control. The synthetic control method (SCM) is used in this study to evaluate the effect of the administrative division adjustment on the water quality indicators of Chaohu Lake. The following conclusions are drawn. First, after the administrative division adjustment, some water quality indicators, such as ammonia nitrogen, improved; however, other major pollution indicators, such as chemical oxygen demand (COD) and dissolved oxygen (DO), worsened to varying degrees. Second, the results reveal that improper development ideas, excessive industrial expansion, and the shift in economic growth and environmental goals were problems after the adjustment. Returning to the original intention of the administrative division adjustment, rationalizing the Chaohu Lake management system and designing a sound and feasible accountability mechanism are fundamental measures for reducing pollution.	[Li, Jing; Liu, Di] Hefei Univ Technol, Sch Econ, Hefei, Anhui, Peoples R China; [Cai, Mengyuan] Nanyang Technol Univ, Sch Social Sci, Econ Div, Singapore, Singapore	Hefei University of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Cai, MY (corresponding author), Nanyang Technol Univ, Sch Social Sci, Econ Div, Singapore, Singapore.	mengyuan002@e.ntu.edu.sg		Cai, Mengyuan/0000-0001-6412-9581	National Natural Science Foundation of China [71974051]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This research is supported by the National Natural Science Foundation of China (No. 71974051, Grant Recipient: Jing Li).	Abadie A, 2003, AM ECON REV, V93, P113, DOI 10.1257/000282803321455188; Abadie A, 2015, AM J POLIT SCI, V59, P495, DOI 10.1111/ajps.12116; Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; Alfano V, 2021, HEALTH POLICY, V125, P1200, DOI 10.1016/j.healthpol.2021.06.010; Becker R, 2000, J POLIT ECON, V108, P379, DOI 10.1086/262123; Bertrand M, 2004, Q J ECON, V119, P249, DOI 10.1162/003355304772839588; BOYNE G, 1995, POLICY POLIT, V23, P213, DOI 10.1332/030557395782453446; Cai HB, 2016, J ENVIRON ECON MANAG, V76, P86, DOI 10.1016/j.jeem.2015.01.002; Chen JD, 2022, ENERG POLICY, V161, DOI 10.1016/j.enpol.2021.112730; Chen JH, 2019, SUSTAIN CITIES SOC, V47, DOI 10.1016/j.scs.2019.101477; Chen PY, 2019, CLUSTER COMPUT, V22, pS6335, DOI 10.1007/s10586-018-2043-0; Chen Z, 2018, J ENVIRON ECON MANAG, V88, P468, DOI 10.1016/j.jeem.2018.01.010; Downey TJ, 1998, CAN PUBLIC ADMIN, V41, P210, DOI 10.1111/j.1754-7121.1998.tb01537.x; Feng RD, 2022, J ENVIRON MANAGE, V302, DOI 10.1016/j.jenvman.2021.113993; Fujii H, 2017, WATER-SUI, V9, DOI 10.3390/w9080586; He SW, 2018, APPL SPAT ANAL POLIC, V11, P103, DOI 10.1007/s12061-016-9203-5; Jaramillo P, 2018, SUSTAIN CITIES SOC, V41, P907, DOI 10.1016/j.scs.2017.04.005; Jun Nie HC., 2013, EC RES GUIDE, V3, P132; Kahn ME, 2015, AM ECON J-ECON POLIC, V7, P223, DOI 10.1257/pol.20130367; Lechner Michael, 2011, Foundations and Trends in Econometrics, V4, P165, DOI 10.1561/0800000014; Lemos S, 2009, LABOUR ECON, V16, P224, DOI 10.1016/j.labeco.2008.07.003; Lipscomb M, 2017, REV ECON STUD, V84, P464, DOI 10.1093/restud/rdw023; List JA, 2003, OXFORD ECON PAP, V55, P657, DOI 10.1093/oep/55.4.657; Ma LJC, 2005, POLIT GEOGR, V24, P477, DOI 10.1016/j.polgeo.2004.10.005; Redding SJ, 2008, AM ECON REV, V98, P1766, DOI 10.1257/aer.98.5.1766; Sancton A, 1996, CAN PUBLIC ADMIN, V39, P267, DOI 10.1111/j.1754-7121.1996.tb00133.x; She Y, 2019, J CLEAN PROD, V220, P919, DOI 10.1016/j.jclepro.2019.02.031; State Council,, 2007, APPR PROV EV INSP AS; Tang HL, 2020, J CLEAN PROD, V254, DOI 10.1016/j.jclepro.2020.120011; Tang YS, 2020, ENVIRON SCI POLLUT R, V27, P2773, DOI 10.1007/s11356-019-07241-0; Temple J, 1999, J ECON LIT, V37, P112, DOI 10.1257/jel.37.1.112; Wagenaar DA, 2004, ARTIF LIFE, V10, P181, DOI 10.1162/106454604773563603; Wang FL, 2015, CHINESE GEOGR SCI, V25, P98, DOI 10.1007/s11769-014-0713-2; Wang M, 2008, J ENVIRON MANAGE, V86, P648, DOI 10.1016/j.jenvman.2006.12.019; Xin MW, 2021, TRANSPORT POLICY, V111, P1, DOI 10.1016/j.tranpol.2021.07.006; Yang XD, 2021, J CLEAN PROD, V287, DOI 10.1016/j.jclepro.2020.125015; Yang ZS, 2017, POPUL SPACE PLACE, V23, DOI 10.1002/psp.1996; Yao MT, 2016, SUSTAIN CITIES SOC, V26, P255, DOI 10.1016/j.scs.2016.06.020; Yu CY, 2021, SCI TOTAL ENVIRON, V773, DOI 10.1016/j.scitotenv.2020.144645; Yu H, 2018, CHINESE GEOGR SCI, V28, P758, DOI 10.1007/s11769-018-0990-2; Yu YT, 2019, J CLEAN PROD, V229, P501, DOI 10.1016/j.jclepro.2019.04.316; Zhang JX, 2006, REG STUD, V40, P3, DOI 10.1080/00343400500449085; Zhao C., 2006, ECON GEOGR, V26, P421; Zheng SQ, 2013, J ECON LIT, V51, P731, DOI 10.1257/jel.51.3.731; Zhou ZF, 2021, J ENVIRON MANAGE, V295, DOI 10.1016/j.jenvman.2021.113048	45	0	0	15	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0257067	10.1371/journal.pone.0257067	http://dx.doi.org/10.1371/journal.pone.0257067			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358184	Green Published, gold, Green Submitted			2022-12-26	WOS:000799828800002
J	Matsudaira, K; Reichard, UH; Ishida, T; Malaivijitnond, S				Matsudaira, Kazunari; Reichard, Ulrich H.; Ishida, Takafumi; Malaivijitnond, Suchinda			Introgression and mating patterns between white-handed gibbons (Hylobates lar) and pileated gibbons (Hylobates pileatus) in a natural hybrid zone	PLOS ONE			English	Article							EXTRA-PAIR COPULATIONS; HYBRIDIZATION PATTERNS; H-PILEATUS; DNA; INHERITANCE; DIVERSITY; EVOLUTION; PATERNITY; BABOONS; GENOME	Gibbons (Family Hylobatidae) are a suitable model for exploring hybridization in pair-living primates as several species form hybrid zones. In Khao Yai National Park, Thailand, white-handed gibbons (Hylobates lar) and pileated gibbons (Hylobates pileatus) are distributed parapatrically and hybridize in a narrow zone. Their phenotypic characteristics suggest limited inter-species gene flow, although this has never been assessed. To uncover the history and degree of gene flow between the two species, we studied the genetic structure of gibbons in the hybrid zone by analyzing fecal DNA samples, phenotypic characteristics, vocalizations and individuals' social status. We determined eight autosomal single nucleotide variant (SNV) loci, and mitochondrial DNA (mtDNA) and Y-chromosomal haplotypes of 72 gibbons. We compared these markers with reference types of wild pureblood white-handed gibbons (n = 12) in Kaeng Krachan National Park and pureblood pileated gibbons (n = 4) in Khao Soi Dao Wildlife Sanctuary. Autosomal genotypic analyses confirmed the various levels of mixed ancestry for several adult gibbons with or without atypical phenotypic traits in Khao Yai National Park. In some other adult gibbons, the mixed ancestry was not detected in either autosomal SNVs or their phenotypic traits but the mtDNA. Both male and female adult hybrids formed reproductive units mainly with a phenotypic pureblood partner and many of them produced offspring. Taken together, our results suggest that once hybridization occurs, white-handed-pileated-gibbon hybrids can reproduce with either parental species and that the backcrossing and thus introgression may occur in successive generations, with no drastic changes in phenotypic appearance.	[Matsudaira, Kazunari; Malaivijitnond, Suchinda] Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand; [Reichard, Ulrich H.] Southern Illinois Univ, Dept Anthropol, Carbondale, IL USA; [Reichard, Ulrich H.] Southern Illinois Univ, Ctr Ecol, Carbondale, IL USA; [Ishida, Takafumi] Univ Tokyo, Sch Sci, Dept Biol Sci, Tokyo, Japan; [Malaivijitnond, Suchinda] Chulalongkorn Univ, Natl Primate Res Ctr Thailand, Sara Buri, Thailand; [Matsudaira, Kazunari; Ishida, Takafumi] Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan	Chulalongkorn University; Southern Illinois University System; Southern Illinois University; Southern Illinois University System; Southern Illinois University; University of Tokyo; Chulalongkorn University; Kyoto University	Matsudaira, K (corresponding author), Chulalongkorn Univ, Fac Sci, Dept Biol, Bangkok, Thailand.; Matsudaira, K (corresponding author), Kyoto Univ, Grad Sch Asian & African Area Studies, Kyoto, Japan.	kaz.matsudaira@gmail.com		Matsudaira, Kazunari/0000-0003-2893-9928	JSPS Postdoctoral Fellowship for Research Abroad [H25-68]; Postdoctoral Fellowship under Rachadapisaek Sompote Fund, The Graduate School, Chulalongkorn University	JSPS Postdoctoral Fellowship for Research Abroad(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Postdoctoral Fellowship under Rachadapisaek Sompote Fund, The Graduate School, Chulalongkorn University	KM, Grant No. H25-68, JSPS Postdoctoral Fellowship for Research Abroad, https://www.jsps.go.jp/english/index.html KM, Postdoctoral Fellowship under Rachadapisaek Sompote Fund, The Graduate School, Chulalongkorn University, https://www.grad.chula.ac.th/en/The founders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts SC, 2001, AM J PRIMATOL, V53, P139, DOI 10.1002/ajp.1; Arnold ML, 2006, ZOOLOGY, V109, P261, DOI 10.1016/j.zool.2006.03.006; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Barelli C, 2008, ANIM BEHAV, V75, P991, DOI 10.1016/j.anbehav.2007.08.012; Barelli C, 2013, AM J PRIMATOL, V75, P1185, DOI 10.1002/ajp.22180; Bartlett TQ., 2007, PRIMATES PERSPECTIVE, P274; Bergman TJ, 2008, AM J PRIMATOL, V70, P136, DOI 10.1002/ajp.20467; Bergman TJ., 2003, SEXUAL SELECTION REP, P503; Brockelman W.Y., 1978, P315; Brockelman W.Y., 1984, P498; Brockelman W.Y., 1987, Monographs in Primatology, V9, P23; BROCKELMAN WY, 1984, NATURE, V312, P634, DOI 10.1038/312634a0; Carbone L, 2014, NATURE, V513, P195, DOI 10.1038/nature13679; Chan Y-C., 2013, PLOS ONE, V8, DOI [10.1371/annotation/9ca325c6-7a42-4cfd-9085-125571708b5c, DOI 10.1371/ANNOTATION/9CA325C6-7A42-4CFD-9085-125571708B5C]; Chan YC, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-82; Chan YC, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-150; Cortes-Ortiz L, 2019, INT J PRIMATOL, V40, P1, DOI 10.1007/s10764-019-00076-z; de Manuel M, 2016, SCIENCE, V354, P477, DOI 10.1126/science.aag2602; Fan ZX, 2018, MOL PHYLOGENET EVOL, V127, P376, DOI 10.1016/j.ympev.2018.03.038; Fontsere C, 2021, MOL ECOL RESOUR, V21, P745, DOI 10.1111/1755-0998.13300; GEISSMANN T, 1991, PRIMATES, V32, P357, DOI 10.1007/BF02382676; GEISSMANN T, 1984, FOLIA PRIMATOL, V42, P216, DOI 10.1159/000156165; Geissmann Thomas, 1995, IZN (International Zoo News), V42, P467; GROVES CP, 1967, FOLIA PRIMATOL, V7, P276, DOI 10.1159/000155125; HAIMOFF EH, 1987, PRIMATES, V28, P319, DOI 10.1007/BF02381015; Hayaishi S, 2006, PRIMATES, V47, P158, DOI 10.1007/s10329-005-0169-1; HEWITT GM, 1988, TRENDS ECOL EVOL, V3, P158, DOI 10.1016/0169-5347(88)90033-X; HEWITT GM, 1987, BIOL J LINN SOC, V31, P25, DOI 10.1111/j.1095-8312.1987.tb01978.x; Kenyon M, 2011, FOLIA PRIMATOL, V82, P154, DOI 10.1159/000333143; Lappan S, 2007, INT J PRIMATOL, V28, P369, DOI 10.1007/s10764-007-9122-z; Leigh JW, 2015, METHODS ECOL EVOL, V6, P1110, DOI 10.1111/2041-210X.12410; MACKINNON J, 1977, Primates, V18, P747, DOI 10.1007/BF02382929; Marshall J., 1986, P137; MARSHALL J T, 1986, Natural History Bulletin of the Siam Society, V34, P145; Matsudaira K, 2021, HEREDITY, DOI 10.1038/s41437-021-00452-7; Matsudaira Kazunari, 2015, Japanese Journal of Zoo and Wildlife Medicine, V20, P15, DOI 10.5686/jjzwm.20.15; Matsudaira K, 2013, PRIMATES, V54, P33, DOI 10.1007/s10329-012-0323-5; Matsudaira K, 2010, MOL PHYLOGENET EVOL, V55, P454, DOI 10.1016/j.ympev.2010.01.032; Misceo D, 2008, GENOME RES, V18, P1530, DOI 10.1101/gr.078295.108; Morin PA, 2001, MOL ECOL, V10, P1835, DOI 10.1046/j.0962-1083.2001.01308.x; Nater A, 2017, CURR BIOL, V27, P3487, DOI 10.1016/j.cub.2017.09.047; Nsubuga AM, 2004, MOL ECOL, V13, P2089, DOI 10.1111/j.1365-294X.2004.02207.x; Oka T, 2001, PRIMATES, V42, P67, DOI 10.1007/BF02640690; Orkin JD, 2021, P NATL ACAD SCI USA, V118, DOI 10.1073/pnas.2010632118; PALOMBIT RA, 1994, ANIM BEHAV, V47, P721, DOI 10.1006/anbe.1994.1097; Perelman P, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001342; Pritchard JK, 2000, GENETICS, V155, P945; REICHARD U, 1995, ETHOLOGY, V100, P99; Reichard UH, 2008, INT J PRIMATOL, V29, P823, DOI 10.1007/s10764-008-9285-2; Reichard Ulrich H., 2003, P190; Rogers J, 2019, SCI ADV, V5, DOI 10.1126/sciadv.aau6947; Schwenk K, 2008, PHILOS T R SOC B, V363, P2805, DOI 10.1098/rstb.2008.0055; Smith S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf110; Sommer V, 2000, PRIMATE MALES, P159; Suwanvecho U, 2012, PRIMATES, V53, P97, DOI 10.1007/s10329-011-0284-0; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tung J, 2008, MOL ECOL, V17, P1998, DOI 10.1111/j.1365-294X.2008.03723.x; Zinner D, 2011, EVOL ANTHROPOL, V20, P96, DOI 10.1002/evan.20301	58	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0264519	10.1371/journal.pone.0264519	http://dx.doi.org/10.1371/journal.pone.0264519			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358199	gold, Green Published			2022-12-26	WOS:000799828800019
J	Wang, L; Wang, JY; Yin, XL; Guan, X; Li, Y; Xin, CQ; Liu, J				Wang, Liang; Wang, Jiayi; Yin, Xiaolin; Guan, Xin; Li, Ying; Xin, Chenqi; Liu, Jing			GIPC2 interacts with Fzd7 to promote prostate cancer metastasis by activating WNT signaling	ONCOGENE			English	Article							INHIBITION; STATISTICS; EXOSOMES; PROTEIN; CELLS	Prostate cancer (PCa) causes significant mortality and morbidity, with advanced metastasis. WNT signaling is a promising therapeutic target for metastatic PCa. GIPC2 is a GIPC1 paralog involved in WNT signaling pathways associated with tumor progression, but its role in PCa metastasis remains unclear. Herein, we demonstrated that high GIPC2 expression in PCa tissues was significantly associated with distant metastasis and poor prognosis. Functional studies demonstrated that high GIPC2 expression due to CpG-island demethylation promoted increased metastatic capabilities of PCa cells. Conversely, silencing GIPC2 expression significantly inhibited PCa metastasis in vitro and in vivo. Furthermore, GIPC2 directly bound the WNT co-receptor Fzd7 through its PDZ domain, which enabled activation of WNT-beta-catenin cascades, thereby stimulating PCa metastasis. Interestingly, GIPC2 protein was also identified as a component of exosomes and that it robustly stimulated PCa adhesion, invasion, and migration. The presence of GIPC2 in tumor-derived exosomes and ability to impact the behavior of tumor cells suggest that GIPC2 is a novel epigenetic oncogene involved in PCa metastasis. Our findings identified GIPC2 as a novel exosomal molecule associated with WNT signaling and may represent a potential therapeutic target and biomarker for metastatic PCa.	[Wang, Liang; Wang, Jiayi; Yin, Xiaolin; Guan, Xin; Li, Ying; Xin, Chenqi; Liu, Jing] Dalian Med Univ, Affiliated Hosp 1, Regenerat Med Ctr, Stem Cell Clin Res Ctr,Natl Joint Engn Lab, 193 Lianhe Rd, Dalian 116011, Liaoning, Peoples R China; [Wang, Liang; Wang, Jiayi; Yin, Xiaolin; Guan, Xin; Li, Ying; Xin, Chenqi; Liu, Jing] Dalian Innovat Inst Stem Cell & Precis Med, 57 Xinda St,Dalian High Tech Pk, Dalian 116023, Liaoning, Peoples R China	Dalian Medical University	Liu, J (corresponding author), Dalian Med Univ, Affiliated Hosp 1, Regenerat Med Ctr, Stem Cell Clin Res Ctr,Natl Joint Engn Lab, 193 Lianhe Rd, Dalian 116011, Liaoning, Peoples R China.; Liu, J (corresponding author), Dalian Innovat Inst Stem Cell & Precis Med, 57 Xinda St,Dalian High Tech Pk, Dalian 116023, Liaoning, Peoples R China.	liujing@dmu.edu.cn		Wang, Liang/0000-0003-2244-7535	National Nature Science Foundation of China [31600614, 82072953]; Innovative leading talents of Liaoning Province [XLYC1902031]; Young top talents of Liaoning Province [XLYC1907009]; Dalian outstanding young scientific and technological talents [2021RJ12]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Innovative leading talents of Liaoning Province; Young top talents of Liaoning Province; Dalian outstanding young scientific and technological talents	We would like to acknowledge the patients for the tissue samples. This work was supported by the National Nature Science Foundation of China (Grant Nos. 31600614, 82072953), the Innovative leading talents of Liaoning Province (Grant No. XLYC1902031), Young top talents of Liaoning Province (Grant No. XLYC1907009), and Dalian outstanding young scientific and technological talents (Grant No. 2021RJ12).	Anastas JN, 2013, NAT REV CANCER, V13, P11, DOI 10.1038/nrc3419; Atala Anthony, 2017, J Urol, V197, P701, DOI 10.1016/j.juro.2016.12.032; Bersini S, 2014, BIOMATERIALS, V35, P2454, DOI 10.1016/j.biomaterials.2013.11.050; Bovolenta P, 2008, J CELL SCI, V121, P737, DOI 10.1242/jcs.026096; Cooperberg MR, 2015, EUR UROL, V67, P326, DOI 10.1016/j.eururo.2014.05.039; Culp MB, 2020, EUR UROL, V77, P38, DOI 10.1016/j.eururo.2019.08.005; Dong Y., CELL DEATH DIS, V2021; Francis JC, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003180; Fraser M, 2017, NATURE, V541, P359, DOI 10.1038/nature20788; Gurney A, 2012, P NATL ACAD SCI USA, V109, P11717, DOI 10.1073/pnas.1120068109; Heinzelmann-Schwarz VA, 2004, CLIN CANCER RES, V10, P4427, DOI 10.1158/1078-0432.CCR-04-0073; Ito K, 2014, NAT REV UROL, V11, P197, DOI 10.1038/nrurol.2014.42; Katoh M, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.49; Kirikoshi H, 2002, INT J ONCOL, V20, P571; Kong J, 2016, ONCOTARGET, V7, P78421, DOI 10.18632/oncotarget.9382; Kuang SQ, 2008, LEUKEMIA, V22, P1529, DOI 10.1038/leu.2008.130; Kumar A, 2016, NAT MED, V22, P369, DOI 10.1038/nm.4053; Kypta RM, 2012, NAT REV UROL, V9, P418, DOI 10.1038/nrurol.2012.116; Li J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150247; Li Y, 2017, ONCOGENE, V36, P6293, DOI 10.1038/onc.2017.223; Liu TJ, 2009, ELECTROPHORESIS, V30, P4285, DOI 10.1002/elps.200900289; Ma F, 2016, J CLIN INVEST, V126, P1745, DOI 10.1172/JCI78815; Mao XY, 2010, CANCER RES, V70, P5207, DOI 10.1158/0008-5472.CAN-09-4074; Mateo J, 2015, NEW ENGL J MED, V373, P1697, DOI 10.1056/NEJMoa1506859; McMahon HT, 2011, NAT REV MOL CELL BIO, V12, P517, DOI 10.1038/nrm3151; Muders MH, 2009, CLIN CANCER RES, V15, P4095, DOI 10.1158/1078-0432.CCR-08-2837; Murillo-Garzon V, 2017, NAT REV UROL, V14, P683, DOI 10.1038/nrurol.2017.144; Niehrs C, 2012, NAT REV MOL CELL BIO, V13, P767, DOI 10.1038/nrm3470; Nilsson J, 2009, BRIT J CANCER, V100, P1603, DOI 10.1038/sj.bjc.6605058; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Pernar CH, 2018, CSH PERSPECT MED, V8, DOI 10.1101/cshperspect.a030361; Phesse T, 2016, CANCERS, V8, DOI 10.3390/cancers8050050; Shang GJ, 2017, ELIFE, V6, P1, DOI 10.7554/eLife.27322; Siegel RL, 2018, CA-CANCER J CLIN, V68, P7, DOI 10.3322/caac.21442; Song JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005756; Tan C, 2001, DEVELOPMENT, V128, P3665; Taylor BS, 2010, CANCER CELL, V18, P11, DOI 10.1016/j.ccr.2010.05.026; Thiele S, 2011, J CELL BIOCHEM, V112, P1593, DOI 10.1002/jcb.23070; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; van Amerongen R, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007914; Yang YH, 2013, MOL BIOL REP, V40, P4241, DOI 10.1007/s11033-013-2506-6; Yavelsky V, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-247; You SY, 2016, CANCER RES, V76, P4948, DOI 10.1158/0008-5472.CAN-16-0902; Zong Y, 2012, P NATL ACAD SCI USA, V109, pE3395, DOI 10.1073/pnas.1217982109	45	2	2	2	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2609	2623		10.1038/s41388-022-02255-4	http://dx.doi.org/10.1038/s41388-022-02255-4		MAR 2022	15	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35347223	hybrid, Green Published			2022-12-26	WOS:000773837500001
J	Harfouche, MN; Madurska, MJ; Elansary, N; Abdou, H; Lang, E; DuBose, JJ; Kundi, R; Feliciano, DV; Scalea, TM; Morrison, JJ				Harfouche, Melike N.; Madurska, Marta J.; Elansary, Noha; Abdou, Hossam; Lang, Eric; DuBose, Joseph J.; Kundi, Rishi; Feliciano, David, V; Scalea, Thomas M.; Morrison, Jonathan J.			Resuscitative endovascular balloon occlusion of the aorta associated with improved survival in hemorrhagic shock	PLOS ONE			English	Article							TRAUMA; OUTCOMES	Background Resuscitative Endovascular Balloon Occlusion of the Aorta (REBOA) is controversial as a hemorrhage control adjunct due to lack of data with a suitable control group. We aimed to determine outcomes of trauma patients in shock undergoing REBOA versus no-REBOA. Methods This single-center, retrospective, matched cohort study analyzed patients.16 years in hemorrhagic shock without cardiac arrest (2000-2019). REBOA (R; 2015-2019) patients were propensity matched 2:1 to historic (H; 2000-2012) and contemporary (C; 2013-2019) groups. In-hospital mortality and 30-day survival were analyzed using chi-squared and log rank testing, respectively. Results A total of 102,481 patients were included (R = 57, C = 88,545, H = 13,879). Propensity scores were assigned using age, race, mechanism, lowest systolic blood pressure, lowest Glasgow Coma Score (GCS), and body region Abbreviated Injury Scale scores to generate matched groups (R = 57, C = 114, H = 114). In-hospital mortality was significantly lower in the REBOA group (19.3%) compared to the contemporary (35.1%; p = 0.024) and historic (44.7%; p = 0.001) groups. 30-day survival was significantly higher in the REBOA versus no-REBOA groups. Conclusion In a high-volume center where its use is part of a coordinated hemorrhage control strategy, REBOA is associated with improved survival in patients with noncompressible torso hemorrhage.	[Harfouche, Melike N.; Elansary, Noha; Abdou, Hossam; Lang, Eric; Kundi, Rishi; Feliciano, David, V; Scalea, Thomas M.; Morrison, Jonathan J.] Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA; [Madurska, Marta J.] Freeman Rd Hosp, Newcastle Upon Tyne, Tyne & Wear, England; [DuBose, Joseph J.] Univ Texas Austin, Dell Med Sch, Austin, TX 78712 USA	University System of Maryland; University of Maryland Baltimore; Newcastle Freeman Hospital; Newcastle University - UK; University of Texas System; University of Texas Austin	Harfouche, MN (corresponding author), Univ Maryland Med Syst, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA.	mharfouche@som.umaryland.edu		Morrison, Jonathan/0000-0001-7462-8456				Abe T, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1577-x; Brenner M, 2018, J AM COLL SURGEONS, V226, P730, DOI 10.1016/j.jamcollsurg.2018.01.044; Brenner M, 2018, JAMA SURG, V153, P130, DOI 10.1001/jamasurg.2017.3549; Brenner M, 2014, J TRAUMA ACUTE CARE, V77, P286, DOI 10.1097/TA.0000000000000310; Brenner ML, 2013, J TRAUMA ACUTE CARE, V75, P506, DOI 10.1097/TA.0b013e31829e5416; DuBose JJ, 2016, J TRAUMA ACUTE CARE, V81, P409, DOI 10.1097/TA.0000000000001079; Harfouche M, 2021, J SURG RES, V267, P82, DOI 10.1016/j.jss.2021.04.007; HUGHES CW, 1954, SURGERY, V36, P65; Joseph B, 2019, JAMA SURG, V154, P500, DOI 10.1001/jamasurg.2019.0096; Matsuoka S, 2001, CARDIOVASC INTER RAD, V24, P274, DOI 10.1007/s00270-001-0003-0; Moore LJ, 2015, J TRAUMA ACUTE CARE, V79, P523, DOI 10.1097/TA.0000000000000809; Morrison JJ, 2019, ANN SURG, V270, P612, DOI 10.1097/SLA.0000000000003486; Norii T, 2015, J TRAUMA ACUTE CARE, V78, P721, DOI 10.1097/TA.0000000000000578; Osborn LA, 2019, OPEN ACCESS EMERG M, V11, P29, DOI 10.2147/OAEM.S166087; Romagnoli A, 2017, J TRAUMA ACUTE CARE, V83, P1161, DOI 10.1097/TA.0000000000001665; Stannard A, 2011, J TRAUMA, V71, P1869, DOI 10.1097/TA.0b013e31823fe90c; Theodorou CM, 2020, J SURG RES, V253, P18, DOI 10.1016/j.jss.2020.03.027; Yamamoto R, 2019, AM J SURG, V218, P1162, DOI 10.1016/j.amjsurg.2019.09.007	18	1	1	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265778	10.1371/journal.pone.0265778	http://dx.doi.org/10.1371/journal.pone.0265778			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324991	gold, Green Published			2022-12-26	WOS:000780951300073
J	Kalo, D; Reches, D; Netta, N; Komsky-Elbaz, A; Zeron, Y; Moallem, U; Roth, Z				Kalo, Dorit; Reches, Dan; Netta, Noam; Komsky-Elbaz, Alisa; Zeron, Yoel; Moallem, Uzi; Roth, Zvi			Carryover effects of feeding bulls with an omega-3-enriched-diet-From spermatozoa to developed embryos	PLOS ONE			English	Article							POLYUNSATURATED FATTY-ACIDS; IN-VITRO FERTILIZATION; POSTTHAW SEMEN QUALITY; DE-NOVO METHYLATION; DIETARY SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; LIPID-COMPOSITION; OXIDATIVE STRESS; PLASMA-MEMBRANE; BOVINE SPERM	The impact of omega-3 nutritional manipulation on semen cryosurvival and quality post thawing is controversial. Our aim was to examine how feeding bulls with omega-3 supplementation from different sources affects the spermatozoa quality parameters. Fifteen Israeli Holstein bulls were fed for 13 weeks with a standard ration top-dressed with encapsulated-fat supplementation: fish or flaxseed oil or saturated fatty acids (control). Ejaculates were collected before, during, and after the feeding trial. Frozen-thawed samples were evaluated by a flow cytometer for spermatozoa viability, mitochondrial membrane potential, the level of reactive oxygen species (ROS), acrosome membrane integrity, DNA fragmentation, phosphatidylserine translocation, and membrane fluidity. Both fish and flaxseed oil treatment resulted in lower ROS levels vs. control groups, during and after the feeding trial. Fewer spermatozoa with damaged acrosomes were observed in the fish oil group after the feeding trial. The spermatozoa membrane fluidity was altered in both the fish and flaxseed oil groups throughout the feeding trial, but only in the flaxseed oil group after the feeding trial. The proportion of spermatozoa with fragmented DNA was lower in the flaxseed oil group after the feeding trial. The spermatozoa fertilization competence did not differ between groups however, blastocyst formation rate was higher in the fish and flaxseed oil groups relative to the control. This was associated with differential gene expression in the blastocysts. Overall, the omega-3-enriched food improved the spermatozoa characteristics; this was further expressed in the developing blastocysts, suggesting a carryover effect from the spermatozoa to the embryos.	[Kalo, Dorit; Reches, Dan; Netta, Noam; Komsky-Elbaz, Alisa; Roth, Zvi] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel; [Kalo, Dorit; Komsky-Elbaz, Alisa; Zeron, Yoel; Roth, Zvi] Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Anim Sperm Res Ctr, Dept Anim Sci, Rehovot, Israel; [Netta, Noam; Moallem, Uzi] Volcani Ctr, Inst Anim Sci, Dept Ruminant Sci, Bet Dagan, Israel; [Zeron, Yoel] SION Artificial Inseminat & Breeding Ctr, Hafetz Haim, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; VOLCANI INSTITUTE OF AGRICULTURAL RESEARCH	Roth, Z (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Dept Anim Sci, Rehovot, Israel.; Roth, Z (corresponding author), Hebrew Univ Jerusalem, Robert H Smith Fac Agr Food & Environm, Anim Sperm Res Ctr, Dept Anim Sci, Rehovot, Israel.	z.roth@mail.huji.ac.il			Israeli Dairy Board, Yahud, Israel [362-277-12]	Israeli Dairy Board, Yahud, Israel	This research was financially supported by the Israeli Dairy Board, Yahud, Israel, grant number 362-277-12. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu El-Hamd MA, 2019, SLOV VET RES, V56, P765, DOI 10.26873/SVR-817-2019; Adibmoradi M., 2012, Egyptian Journal of Sheep and Goat Sciences, V7, P19; Agarwal A, 2014, WORLD J MENS HEALTH, V32, P1, DOI 10.5534/wjmh.2014.32.1.1; Ahmad S, 2019, LIVEST SCI, V224, P57, DOI 10.1016/j.livsci.2019.04.007; Aitken RJ, 2014, ASIAN J ANDROL, V16, P31, DOI 10.4103/1008-682X.122203; Alizadeh A, 2014, CELL J, V16, P289; Ambrose DJ, 2006, J DAIRY SCI, V89, P3066, DOI 10.3168/jds.S0022-0302(06)72581-4; Andriola YT, 2018, ANDROLOGIA, V50, DOI 10.1111/and.12825; Bailey JL, 2000, J ANDROL, V21, P1; Barbas JP, 2009, CELL TISSUE BANK, V10, P49, DOI 10.1007/s10561-008-9081-4; Barratt CLR, 2010, HUM REPROD, V25, P824, DOI 10.1093/humrep/dep465; Barroso G, 2000, HUM REPROD, V15, P1338, DOI 10.1093/humrep/15.6.1338; Bastos NM, 2021, THERIOGENOLOGY, V175, P23, DOI 10.1016/j.theriogenology.2021.08.031; Behzad AM, 2014, REPROD DOMEST ANIM, V49, P599, DOI 10.1111/rda.12328; Bermejo-Alvarez P, 2008, PHYSIOL GENOMICS, V32, P264, DOI 10.1152/physiolgenomics.00234.2007; Bollwein H, 2018, IMPACTS OXIDATIVE ST, DOI [10.21451/1984-3143-AR2018-0041, DOI 10.21451/1984-3143-AR2018-0041]; Brinsko SP, 2005, THERIOGENOLOGY, V63, P1519, DOI 10.1016/j.theriogenology.2004.07.010; Byrne CJ, 2017, THERIOGENOLOGY, V90, P289, DOI 10.1016/j.theriogenology.2016.12.014; Martinez-Soto JC, 2016, SYST BIOL REPROD MED, V62, P387, DOI 10.1080/19396368.2016.1246623; Castellano CA, 2010, THERIOGENOLOGY, V74, P1482, DOI 10.1016/j.theriogenology.2010.06.020; Comhaire FH, 2000, PROSTAG LEUKOTR ESS, V63, P159, DOI 10.1054/plef.2000.0174; Covington MB, 2004, AM FAM PHYSICIAN, V70, P133; Diaz R, 2017, ANIM REPROD SCI, V183, P132, DOI 10.1016/j.anireprosci.2017.05.002; Du Plessis SS, 2015, J ASSIST REPROD GEN, V32, P509, DOI 10.1007/s10815-014-0425-7; El-Sayed A, 2006, PHYSIOL GENOMICS, V28, P84, DOI 10.1152/physiolgenomics.00111.2006; Esmaeili V, 2014, ANDROLOGIA, V46, P42, DOI 10.1111/and.12040; Evenson D, 2000, CURR PROTOC CYTOM, V13, DOI [10.1023/a:1009844109023, DOI 10.1023/A:1009844109023]; Falsig AML, 2019, ANDROLOGY-US, V7, P794, DOI 10.1111/andr.12649; FAO, 2011, IMP AN NUTR AN WELF; Fatehi AN, 2006, J ANDROL, V27, P176, DOI 10.2164/jandrol.04152; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Flesch FM, 2000, BBA-REV BIOMEMBRANES, V1469, P197, DOI 10.1016/S0304-4157(00)00018-6; Ghanem N, 2011, REPRODUCTION, V142, P551, DOI 10.1530/REP-10-0476; Ghanem N, 2020, ZYGOTE, V28, P116, DOI 10.1017/S0967199419000765; Gholami H, 2011, INT J FERTIL STERIL, V4, P160; Gonzalez-Ravina C, 2018, REPROD BIOL, V18, P282, DOI 10.1016/j.repbio.2018.06.002; Hashimoto M, 1999, LIPIDS, V34, P1297, DOI 10.1007/s11745-999-0481-6; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Iizuka-Hishikawa Y, 2017, J BIOL CHEM, V292, P12065, DOI [10.1074/jbc.M117.791277, 10.1074/jbc.m117.791277]; Jafaroghli M, 2014, ANIM REPROD SCI, V147, P17, DOI 10.1016/j.anireprosci.2014.03.013; Kalo D, 2019, TOXICOLOGY, V421, P59, DOI 10.1016/j.tox.2019.04.016; Kalo D, 2017, TOXICOLOGY, V377, P38, DOI 10.1016/j.tox.2016.12.005; Kalo D, 2015, REPROD TOXICOL, V53, P141, DOI 10.1016/j.reprotox.2015.04.007; Khoshvaght A, 2016, THERIOGENOLOGY, V85, P807, DOI 10.1016/j.theriogenology.2015.10.023; Kim SH, 2010, THERIOGENOLOGY, V73, P282, DOI 10.1016/j.theriogenology.2009.09.011; Komsky-Elbaz A, 2020, REPRODUCTION, V160, P709, DOI 10.1530/REP-20-0286; Komsky-Elbaz A, 2018, JOVE-J VIS EXP, DOI 10.3791/58622; Tran VT, 2017, ASIAN AUSTRAL J ANIM, V30, P622, DOI 10.5713/ajas.15.1034; Li M, 2016, FERTIL STERIL, V106, P781, DOI 10.1016/j.fertnstert.2016.05.018; Martin G, 2005, HUM REPROD, V20, P3459, DOI 10.1093/humrep/dei245; MARTIN OC, 1987, J BIOL CHEM, V262, P5890; Martinez Paz, 1996, Frontiers in Bioscience (online), V1, pD103; Mason RP, 2016, BBA-BIOMEMBRANES, V1858, P3131, DOI 10.1016/j.bbamem.2016.10.002; Mazza M, 2007, PROG NEURO-PSYCHOPH, V31, P12, DOI 10.1016/j.pnpbp.2006.07.010; Medeiros CMO, 2002, THERIOGENOLOGY, V57, P327, DOI 10.1016/S0093-691X(01)00674-4; Meng F, 2015, BIOL REPROD, V93, DOI 10.1095/biolreprod.115.134254; Moallema U, 2015, THERIOGENOLOGY, V83, P1110, DOI 10.1016/j.theriogenology.2014.12.008; Moustafa MH, 2004, HUM REPROD, V19, P129, DOI 10.1093/humrep/deh024; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-18; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Orgal S, 2012, J REPROD DEVELOP, V58, P212, DOI 10.1262/jrd.10-149N; Orozco-Lucero E, 2014, ANIM REPROD, V11, P183; PAULENZ H, 1995, VET RES COMMUN, V19, P273, DOI 10.1007/BF01839310; Perumal P, 2019, THERIOGENOLOGY, V136, P47, DOI 10.1016/j.theriogenology.2019.06.029; Petrunkina AM, 2013, REPROD DOMEST ANIM, V48, P11, DOI 10.1111/rda.12202; POULOS A, 1973, COMP BIOCHEM PHYSIOL, V46, P541, DOI 10.1016/0305-0491(73)90094-1; Ramalho-Santos J, 2009, HUM REPROD UPDATE, V15, P553, DOI 10.1093/humupd/dmp016; Rodriguez-Alvarez L, 2013, IN VITRO CELL DEV-AN, V49, P657, DOI 10.1007/s11626-013-9650-0; Rooke JA, 2001, REPRODUCTION, V121, P315, DOI 10.1530/rep.0.1210315; Roqueta-Rivera M, 2011, BIOL REPROD, V85, P721, DOI 10.1095/biolreprod.110.089524; Safarinejad MR, 2011, ANDROLOGIA, V43, P38, DOI 10.1111/j.1439-0272.2009.01013.x; Sakai C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0187934; Sakurai N, 2016, CELL REPROGRAM, V18, P309, DOI 10.1089/cell.2015.0081; Samadian F, 2010, ANIMAL, V4, P2017, DOI 10.1017/S1751731110001308; Sellem E, 2015, THERIOGENOLOGY, V84, P1447, DOI 10.1016/j.theriogenology.2015.07.035; Shah Syed Mazhar Hussain, 2016, Journal of Animal Science and Technology, V58, P25, DOI 10.1186/s40781-016-0107-3; Shaikh SR, 2008, CHEM PHYS LIPIDS, V153, P24, DOI 10.1016/j.chemphyslip.2008.02.008; Shen HM, 2002, HUM REPROD, V17, P1266, DOI 10.1093/humrep/17.5.1266; Simoes R, 2013, REPRODUCTION, V146, P433, DOI 10.1530/REP-13-0123; Simon L, 2014, HUM REPROD, V29, P2402, DOI 10.1093/humrep/deu228; St John JC, 2000, J ANDROL, V21, P189; Staub C, 2018, ANIMAL, V12, pS27, DOI [10.1017/S1751731118000435, 10.1017/s1751731118000435]; Stillwell W, 2003, CHEM PHYS LIPIDS, V126, P1, DOI 10.1016/S0009-3084(03)00101-4; Tafuri S., 2015, NEW DISCOVERIES EMBR, P19, DOI DOI 10.5772/60632; TESARIK J, 1989, HUM REPROD, V4, P957, DOI 10.1093/oxfordjournals.humrep.a137020; Thangavelu G, 2007, THERIOGENOLOGY, V68, P949, DOI 10.1016/j.theriogenology.2007.07.002; Tran LV, 2016, ANIM REPROD SCI, V173, P63, DOI 10.1016/j.anireprosci.2016.08.012; Uysal F, 2021, J ASSIST REPROD GEN, V38, P3135, DOI 10.1007/s10815-021-02316-9; Vance JE, 2005, PROG LIPID RES, V44, P207, DOI 10.1016/j.plipres.2005.05.001; Velasquez AE, 2019, ZYGOTE, V27, P398, DOI 10.1017/S0967199419000509; VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I; Virro MR, 2004, FERTIL STERIL, V81, P1289, DOI 10.1016/j.fertnstert.2003.09.063; Volpes A, 2016, J ASSIST REPROD GEN, V33, P765, DOI 10.1007/s10815-016-0696-2; Wang HB, 2002, J CLIN ENDOCR METAB, V87, P2629, DOI 10.1210/jc.87.6.2629; Wathes DC, 2007, BIOL REPROD, V77, P190, DOI 10.1095/biolreprod.107.060558; WHITFIELD CH, 1992, THERIOGENOLOGY, V38, P11, DOI 10.1016/0093-691X(92)90214-C; Yeste M, 2011, THERIOGENOLOGY, V76, P184, DOI 10.1016/j.theriogenology.2011.01.032; Zhao S, 2017, REPROD FERT DEVELOP, V29, P1209, DOI 10.1071/RD15209	98	1	1	3	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265650	10.1371/journal.pone.0265650	http://dx.doi.org/10.1371/journal.pone.0265650			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324945	gold, Green Published			2022-12-26	WOS:000780951300055
J	Ueda, D; Yamamoto, A; Onoda, N; Takashima, T; Noda, S; Kashiwagi, S; Morisaki, T; Fukumoto, S; Shiba, M; Morimura, M; Shimono, T; Kageyama, K; Tatekawa, H; Murai, K; Honjo, T; Shimazaki, A; Kabata, D; Miki, Y				Ueda, Daiju; Yamamoto, Akira; Onoda, Naoyoshi; Takashima, Tsutomu; Noda, Satoru; Kashiwagi, Shinichiro; Morisaki, Tamami; Fukumoto, Shinya; Shiba, Masatsugu; Morimura, Mina; Shimono, Taro; Kageyama, Ken; Tatekawa, Hiroyuki; Murai, Kazuki; Honjo, Takashi; Shimazaki, Akitoshi; Kabata, Daijiro; Miki, Yukio			Development and validation of a deep learning model for detection of breast cancers in mammography from multi-institutional datasets	PLOS ONE			English	Article							COMPUTER-AIDED DETECTION; SCREENING MAMMOGRAPHY; DIAGNOSTIC-ACCURACY; PROGNOSIS; MASSES	Objectives The objective of this study was to develop and validate a state-of-the-art, deep learning (DL)-based model for detecting breast cancers on mammography. Methods Mammograms in a hospital development dataset, a hospital test dataset, and a clinic test dataset were retrospectively collected from January 2006 through December 2017 in Osaka City University Hospital and Medcity21 Clinic. The hospital development dataset and a publicly available digital database for screening mammography (DDSM) dataset were used to train and to validate the RetinaNet, one type of DL-based model, with five-fold cross-validation. The model's sensitivity and mean false positive indications per image (mFPI) and partial area under the curve (AUC) with 1.0 mFPI for both test datasets were externally assessed with the test datasets. Results The hospital development dataset, hospital test dataset, clinic test dataset, and DDSM development dataset included a total of 3179 images (1448 malignant images), 491 images (225 malignant images), 2821 images (37 malignant images), and 1457 malignant images, respectively. The proposed model detected all cancers with a 0.45-0.47 mFPI and had partial AUCs of 0.93 in both test datasets. Conclusions The DL-based model developed for this study was able to detect all breast cancers with a very low mFPI. Our DL-based model achieved the highest performance to date, which might lead to improved diagnosis for breast cancer.	[Ueda, Daiju; Yamamoto, Akira; Shimono, Taro; Kageyama, Ken; Tatekawa, Hiroyuki; Murai, Kazuki; Honjo, Takashi; Shimazaki, Akitoshi; Miki, Yukio] Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan; [Onoda, Naoyoshi; Takashima, Tsutomu; Noda, Satoru; Kashiwagi, Shinichiro; Morisaki, Tamami] Osaka City Univ, Grad Sch Med, Dept Breast & Endocrine Surg, Osaka, Japan; [Morisaki, Tamami; Fukumoto, Shinya] Osaka City Univ, Grad Sch Med, Dept Premier Prevent Med, Osaka, Japan; [Shiba, Masatsugu] Osaka City Univ, Grad Sch Med, Dept Gastroenterol, Osaka, Japan; [Morimura, Mina] Osaka City Univ Hosp, Dept Gen Practice, Osaka, Japan; [Kabata, Daijiro] Osaka City Univ, Grad Sch Med, Dept Med Stat, Osaka, Japan	Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University; Osaka Metropolitan University	Ueda, D (corresponding author), Osaka City Univ, Grad Sch Med, Dept Diagnost & Intervent Radiol, Osaka, Japan.	a.labo.ocu@gmail.com	Ueda, Daiju/AAG-2167-2021	Ueda, Daiju/0000-0002-3878-3616	Wellness Open Living Labs, LLC	Wellness Open Living Labs, LLC	This work was supported by Wellness Open Living Labs, LLC. No grant number was provided. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akselrod-Ballin A, DEEP LEARNING AUTOMA; Akselrod-Ballin A, 2019, RADIOLOGY, V292, P331, DOI 10.1148/radiol.2019182622; Al-masni MA, 2018, COMPUT METH PROG BIO, V157, P85, DOI 10.1016/j.cmpb.2018.01.017; Antonio ALM, 2010, BREAST CANCER RES TR, V120, P539, DOI 10.1007/s10549-010-0770-x; Azavedo E, 2012, BMC MED IMAGING, V12, DOI 10.1186/1471-2342-12-22; Bae MS, 2014, RADIOLOGY, V270, P369, DOI 10.1148/radiol.13130724; Banks E, 2004, BMJ-BRIT MED J, V329, P477, DOI 10.1136/bmj.329.7464.477; Bargallo X, 2014, EUR J RADIOL, V83, P2019, DOI 10.1016/j.ejrad.2014.08.010; Becker AS, 2017, INVEST RADIOL, V52, P434, DOI 10.1097/RLI.0000000000000358; BIRD RE, 1992, RADIOLOGY, V184, P613, DOI 10.1148/radiology.184.3.1509041; Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492; Brhane Hagos Y, 2018, IMPROVING BREAST CAN; Broeders MJM, 2003, EUR J CANCER, V39, P1770, DOI 10.1016/S0959-8049(03)00311-3; BUNCH PC, 1978, AM J ROENTGENOL, V130, P382; Choukroun Y., 2017, MAMMOGRAM CLASSIFICA, P11, DOI DOI 10.2312/VCBM.20171232; Clark K, 2013, J DIGIT IMAGING, V26, P1045, DOI 10.1007/s10278-013-9622-7; Collins GS, 2015, CIRCULATION, V131, P211, DOI [10.1016/j.jclinepi.2014.11.010, 10.1161/CIRCULATIONAHA.114.014508, 10.1002/bjs.9736, 10.7326/M14-0697, 10.1016/j.eururo.2014.11.025, 10.1186/s12916-014-0241-z, 10.1136/bmj.g7594, 10.1038/bjc.2014.639, 10.7326/M14-0698]; Dembrower K, 2020, RADIOLOGY, V294, P265, DOI 10.1148/radiol.2019190872; Dhungel N, 2016, AUTOMATED LEARNING D; Dhungel N, 2017, MED IMAGE ANAL, V37, P114, DOI 10.1016/j.media.2017.01.009; Dhungel N, 2015, 2015 INTERNATIONAL CONFERENCE ON DIGITAL IMAGE COMPUTING: TECHNIQUES AND APPLICATIONS (DICTA), P160; Fenton JJ, 2007, NEW ENGL J MED, V356, P1399, DOI 10.1056/NEJMoa066099; Fenton JJ, 2013, ANN INTERN MED, V158, P580, DOI 10.7326/0003-4819-158-8-201304160-00002; Gilbert FJ, 2008, NEW ENGL J MED, V359, P1675, DOI 10.1056/NEJMoa0803545; Gromet M, 2008, AM J ROENTGENOL, V190, P854, DOI 10.2214/AJR.07.2812; He KM, 2016, PROC CVPR IEEE, P770, DOI 10.1109/CVPR.2016.90; Jung H, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0203355; Kooi T, 2017, MED IMAGE ANAL, V35, P303, DOI 10.1016/j.media.2016.07.007; Krizhevsky Alex, 2017, Communications of the ACM, V60, P84, DOI 10.1145/3065386; LeCun Y., 2015, NATURE, V521, P436, DOI [10.1038/nature14539, DOI 10.1038/nmeth.3707, DOI 10.1038/nature14539, DOI 10.1038/NATURE14539]; Lee R. S.., 2016, CURATED BREAST IMAGI; Lee RS, 2017, SCI DATA, V4, DOI 10.1038/sdata.2017.177; Lehman CD, 2015, JAMA INTERN MED, V175, P1828, DOI 10.1001/jamainternmed.2015.5231; Lin TY, 2020, IEEE T PATTERN ANAL, V42, P318, DOI 10.1109/TPAMI.2018.2858826; Lin TY, 2017, PROC CVPR IEEE, P936, DOI 10.1109/CVPR.2017.106; Majid AS, 2003, RADIOGRAPHICS, V23, P881, DOI 10.1148/rg.234025083; McKinney SM, 2020, NATURE, V577, P89, DOI 10.1038/s41586-019-1799-6; Ribli D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-22437-z; Rodriguez-Ruiz A, 2019, RADIOLOGY, V290, P305, DOI 10.1148/radiol.2018181371; Sickles EA., 2013, ACR BIRADS ATLAS BRE, P39; Siu AL, 2016, ANN INTERN MED, V164, P279, DOI 10.7326/M15-2886; Teuwen Jonas, 2018, SOFT TISSUE LESION D; Ueda D, 2021, JCO PRECIS ONCOL, V5, P543, DOI 10.1200/PO.20.00176; Ueda D, 2021, JPN J RADIOL, V39, P333, DOI 10.1007/s11604-020-01070-9; Ueda D, 2019, JPN J RADIOL, V37, P15, DOI 10.1007/s11604-018-0795-3; Weber RJP, 2016, BREAST CANCER RES TR, V158, P471, DOI 10.1007/s10549-016-3882-0; Yala A, 2019, RADIOLOGY, V292, P60, DOI 10.1148/radiol.2019182716	47	1	1	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265751	10.1371/journal.pone.0265751	http://dx.doi.org/10.1371/journal.pone.0265751			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324962	Green Published, gold			2022-12-26	WOS:000780951300066
J	Panagiotoglou, D				Panagiotoglou, Dimitra			Evaluating the population-level effects of overdose prevention sites and supervised consumption sites in British Columbia, Canada: Controlled interrupted time series	PLOS ONE			English	Article							FACILITIES; REDUCTION	Background On 14 April 2016, British Columbia's Provincial Medical Health Officer declared the overdose crisis a public health emergency, sanctioning the implementation of new overdose prevention sites (OPS) and supervised consumption sites (SCS) across the province. Methods We used the BC Centre for Disease Control's Provincial Overdose Cohort of all overdose events between 1 January 2015 and 31 December 2017 to evaluate the population-level effects of OPSs and SCSs on acute health service use and mortality. We matched local health areas (LHA) that implemented any site with propensity score matched controls and conducted controlled interrupted time series analysis. Results During the study period, twenty-five OPSs and SCSs opened across fourteen of British Columbia's 89 LHAs. Results from analysis of LHAs with matched controls (i.e. excluding Vancouver DTES) were mixed. Significant declines in reported overdose events, paramedic attendance, and emergency department visits were observed. However, there were no changes to trends in monthly hospitalization or mortality rates. Extensive sensitivity analyses found these results persisted. Conclusions We found OPSs and SCSs reduce opioid-related paramedic attendance and emergency department visit rates but no evidence that they reduce local hospitalization or mortality rates.	[Panagiotoglou, Dimitra] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada	McGill University	Panagiotoglou, D (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	dimitra.panagiotoglou@mcgill.ca						Abadie A, 2010, J AM STAT ASSOC, V105, P493, DOI 10.1198/jasa.2009.ap08746; [Anonymous], 2018, **DATA OBJECT**; [Anonymous], 2017, BC PROVINCIAL OVERDO; [Anonymous], 2015, TRANSLATION MASTER F; [Anonymous], 2019, OVERDOSE PREVENTION; Austin PC, 2011, MULTIVAR BEHAV RES, V46, P119, DOI 10.1080/00273171.2011.540480; Austin PC, 2011, PHARM STAT, V10, P150, DOI 10.1002/pst.433; B.C. Ministry of Public Safety and Solicitor General, 2020, FENTANYL DETECTED IL; BC Centre for Disease Control, 2017, PUBL HLTH EM BC; BC Centre for Disease Control, 2019, OV RESP IND; BC Centre on Substance Use BMoH, 2017, SUP CONS SERV OP GUI; BC Coroners Service, 2018, ILL DRUG OV DEATHS B; BC Ministry of Health, 2017, NAT AMB CAR REP SYST; BC Ministry of Health, 2017, VIT STAT DEATHS; BC Ministry of Health, 2017, OV PREV; Bernal JL, 2019, INT J EPIDEMIOL, V48, P2062, DOI 10.1093/ije/dyz050; Boyer EW, 2012, NEW ENGL J MED, V367, P146, DOI 10.1056/NEJMra1202561; British Colombia Coroners Service, 2021, ILL DRUG TOX DEATHS; British Columbia Coroners Service, 2020, ILL DRUG TOX DEATHS; British Columbia Ministry of Health [creator], 2017, MED SERV PLAN MSP PA; Canadian Institute for Health Information [creator], 2018, DISCH ABSTR DAT HOSP; Ciccarone D, 2019, INT J DRUG POLICY, V71, P183, DOI 10.1016/j.drugpo.2019.01.010; Collins AB, 2019, INT J DRUG POLICY, V73, P199, DOI 10.1016/j.drugpo.2019.08.002; Dietze P, 2012, INT J DRUG POLICY, V23, P257, DOI 10.1016/j.drugpo.2012.02.006; DURBIN J, 1971, BIOMETRIKA, V58, P1; DURBIN J, 1950, BIOMETRIKA, V37, P409, DOI 10.1093/biomet/37.3-4.409; Elzey MJ, 2016, PAIN PHYSICIAN, V19, P215; European Centre for Disease Prevention and Control, 2018, CONS ANT SYST US COM; Cruz MF, 2007, INT J DRUG POLICY, V18, P54, DOI 10.1016/j.drugpo.2006.12.001; Fox J., 2018, R COMPANION APPL REG, VThird; Fraser Health, 2017, FRAS HLTH WILL OP 1; Fraser Health Vancouver Coastal Health, 2017, OV PREV RESP POL PRO; Government of Canada, SUP CONS SIT STAT AP; Harnett CE, 2016, TIMES COLONIST 1216; Hawkins NG, 2007, AM J PREV MED, V33, P162, DOI 10.1016/j.amepre.2007.03.020; Hooper T, 2016, VICTORIA BUZZ 1209; Irvine MA, 2019, ADDICTION, V114, P1602, DOI 10.1111/add.14664; Irvine MA, 2018, LANCET PUBLIC HEALTH, V3, pE218, DOI 10.1016/S2468-2667(18)30044-6; Island Health, 2017, NAN CAN MENT HLTH AS; Karamouzian M, 2020, INT J DRUG POLICY, V77, DOI 10.1016/j.drugpo.2020.102665; Kennedy MC, 2019, PLOS MED, V16, DOI 10.1371/journal.pmed.1002964; Kurjata A, 2017, CBC NEWS; Legislative Assembly of British Columbia, 2007, COR ACT; Little S, 2019, GLOBAL NEWS 0606; Lupick T., 2016, THE GEORGIA STRAIGHT; Lupick T, 2016, THE GEORGIA STRAIGHT; Lupick T, 2018, THE GEORGIA STRAIGHT; MacNeil J, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-11; Maple Ridge Opioid Overdose Response Task Group, 2018, MAPL RIDG OP OV COMM; Marshall BDL, 2011, LANCET, V377, P1429, DOI 10.1016/S0140-6736(10)62353-7; Mema SC, 2019, HARM REDUCT J, V16, DOI 10.1186/s12954-018-0273-3; Middlemass M., 2016, DUNCANS OVERDOSE PRE; Ministry of Health Uganda, 2020, CONSOLIDATED GUIDELI; Morrow Richard L, 2019, CMAJ Open, V7, pE484, DOI 10.9778/cmajo.20190003; NCHECR, 2007, SYDN MED SUP INJ CTR; Panagiotoglou D, 2018, AIDS BEHAV, V22, P3071, DOI 10.1007/s10461-018-2166-6; Papamihali K, 2020, HARM REDUCT J, V17, DOI 10.1186/s12954-020-00436-6; Pauly B, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0229208; Pinheiro J, 2020, PACKAGENLME; Potier C, 2014, DRUG ALCOHOL DEPEN, V145, P48, DOI 10.1016/j.drugalcdep.2014.10.012; RCore Team, 2020, R LANG ENV STAT COMP; Rhodes T, 2006, ADDICTION, V101, P1384, DOI 10.1111/j.1360-0443.2006.01556.x; SAS Institute Inc, 2013, SAS 9 4 STAT REF; Schuchat A, 2017, JAMA-J AM MED ASSOC, V318, P425, DOI 10.1001/jama.2017.8913; Shaw T., 2017, AB; van der Schier Rutger, 2014, F1000Prime Rep, V6, P79, DOI 10.12703/P6-79; Vancouver Coastal Health, 2018, RESP OP OV CRIS VANC; Vancouver Coastal Health, 2017, OV PREV SIT MAN; Wagar Lori, 2018, EVALUATION OVERDOSE; Wagner AK, 2002, J CLIN PHARM THER, V27, P299, DOI 10.1046/j.1365-2710.2002.00430.x; Wallace B, 2019, INT J DRUG POLICY, V66, P64, DOI 10.1016/j.drugpo.2019.01.017; Walters A, 2019, VERNON MORNING STAR; Wermeling DP, 2015, THER ADV DRUG SAF, V6, P20, DOI 10.1177/2042098614564776; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woo A. B.C, 2017, GLOBE MAIL; Wood E, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-13; Wood E, 2006, CAN MED ASSOC J, V175, P1399, DOI 10.1503/cmaj.060863; Zhang F, 2011, J CLIN EPIDEMIOL, V64, P1252, DOI 10.1016/j.jclinepi.2011.02.007	78	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 22	2022	17	3							e0265665	10.1371/journal.pone.0265665	http://dx.doi.org/10.1371/journal.pone.0265665			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	3K7EP	35316284	gold, Green Published			2022-12-26	WOS:000834238000032
J	Chen, XX; Wang, ZY; Zhao, XG; Zhang, LL; Zhou, L; Li, XX; Ge, C; Zhao, FY; Chen, TY; Xie, HY; Cui, Y; Tian, H; Li, H; Yao, M; Li, JJ				Chen, Xiaoxia; Wang, Zhenyu; Zhao, Xinge; Zhang, Lili; Zhou, Lianer; Li, Xianxian; Ge, Chao; Zhao, Fangyu; Chen, Taoyang; Xie, Haiyang; Cui, Ying; Tian, Hua; Li, Hong; Yao, Ming; Li, Jinjun			STAT5A modulates CDYL2/SLC7A6 pathway to inhibit the proliferation and invasion of hepatocellular carcinoma by targeting to mTORC1	ONCOGENE			English	Article							CDYL; CANCER; TRIMETHYLATION; ACTIVATION; EXPRESSION; PROMOTES	Chromodomain Y-like 2 (CDYL2), as a member of CDY family known to be involved in spermatogenesis, has been reported to participate in breast cancer development recently, but its exact biological role in hepatocellular carcinoma (HCC) remains unclear. Here, we observed that CDYL2 was down-regulated in human primary HCC tissues and the low levels of CDYL2 expression were correlated with poor survival. Gain- and loss-of-function experiments showed that CDYL2 inhibited the proliferation and metastasis of HCC cells in vitro and in vivo. Mechanistically, CDYL2 down-regulates solute carrier family 7 member 6 (SLC7A6) by decreasing the enrichment of H3K4me3 on the promoter region of SLC7A6. Additionally, we also found that signal transducer and activator of transcription 5A (STAT5A) could directly and positively regulate the expression of CDYL2. Thus, CDYL2 was regulated by STAT5A, and suppressed the amino acid transportation through down-regulation of SLC7A6, and then inhibits the mTORC1/S6K pathway, a master regulator of cell growth. Consistently, CDYL2 expression correlated significantly with STAT5A and SLC7A6 expression in HCC. Collectively, we propose a model for a STAT5A/CDYL2/SLC7A6 axis that provides novel insight into CDYL2, which may serve as a potential factor for predicting prognosis and a therapeutic target for HCC patients.	[Chen, Xiaoxia; Li, Jinjun] Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Biomed Engn, Shanghai 200032, Peoples R China; [Chen, Xiaoxia; Wang, Zhenyu; Zhao, Xinge; Zhou, Lianer; Li, Xianxian; Ge, Chao; Zhao, Fangyu; Tian, Hua; Li, Hong; Yao, Ming; Li, Jinjun] Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Sch Med, Shanghai 200032, Peoples R China; [Zhang, Lili] Shanghai Jiao Tong Univ, Shanghai Gen Hosp, Dept Oncol, Sch Med, Shanghai 200080, Peoples R China; [Chen, Taoyang] Qi Dong Liver Canc Inst, Qi Dong 226200, Peoples R China; [Xie, Haiyang] Zhejiang Univ, Dept Gen Surg, Affiliated Hosp 1, Sch Med, Hangzhou 310000, Peoples R China; [Cui, Ying] Canc Inst Guangxi, Nanning 530027, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Zhejiang University	Li, JJ (corresponding author), Shanghai Jiao Tong Univ, State Key Lab Oncogenes & Related Genes, Shanghai Canc Inst, Renji Hosp,Sch Biomed Engn, Shanghai 200032, Peoples R China.; Li, JJ (corresponding author), Shanghai Jiao Tong Univ, Renji Hosp, Shanghai Canc Inst, Sch Med, Shanghai 200032, Peoples R China.	jjli@shsci.org			National Natural Science Foundation of China [82173331, 81972580, 81773152]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors are grateful to Dr. Daqiang Li for donating pLVX-CDYL2 vector. This work was supported by the National Natural Science Foundation of China [Grant number 82173331, 81972580, 81773152].	Abu-Zhayia ER, 2018, J MOL CELL BIOL, V10, P341, DOI 10.1093/jmcb/mjx050; Audia JE, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a019521; Bernaciak TM, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2341; Dorus S, 2003, HUM MOL GENET, V12, P1643, DOI 10.1093/hmg/ddg185; Escamilla-Del-Arenal M, 2013, MOL CELL BIOL, V33, P5005, DOI 10.1128/MCB.00866-13; Gunasekaran G, 2021, HEPATOLOGY, V73, P128, DOI 10.1002/hep.31325; Jewell JL, 2013, NAT REV MOL CELL BIO, V14, P133, DOI 10.1038/nrm3522; Jiang YB, 2021, MOL ONCOL, V15, P710, DOI 10.1002/1878-0261.12846; Kandasamy P, 2018, TRENDS BIOCHEM SCI, V43, P752, DOI 10.1016/j.tibs.2018.05.003; Kollmann S, 2019, LEUKEMIA, V33, P1583, DOI 10.1038/s41375-018-0369-5; Lahn BT, 2002, P NATL ACAD SCI USA, V99, P8707, DOI 10.1073/pnas.082248899; Lee TK, 2006, CANCER RES, V66, P9948, DOI 10.1158/0008-5472.CAN-06-1092; Liu P, 2017, HEPATOLOGY, V66, P167, DOI 10.1002/hep.29183; Liu SM, 2017, MOL CELL, V67, P853, DOI 10.1016/j.molcel.2017.07.011; McGlynn KA, 2021, HEPATOLOGY, V73, P4, DOI 10.1002/hep.31288; Menezes ME, 2016, ADV CANCER RES, V132, P1, DOI 10.1016/bs.acr.2016.07.001; Milewski K, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18112308; Mulligan P, 2008, MOL CELL, V32, P718, DOI 10.1016/j.molcel.2008.10.025; Qiu ZG, 2019, THERANOSTICS, V9, P4717, DOI 10.7150/thno.33680; Rask-Andersen M, 2013, MOL ASPECTS MED, V34, P702, DOI 10.1016/j.mam.2012.07.015; Rotoli BM, 2020, J CELL MOL MED, V24, P921, DOI 10.1111/jcmm.14801; Sharma S, 2010, CARCINOGENESIS, V31, P27, DOI 10.1093/carcin/bgp220; Shen E, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0514; Siouda M, 2020, ISCIENCE, V23, DOI 10.1016/j.isci.2020.101141; Tang JZ, 2010, ENDOCRINOLOGY, V151, P43, DOI 10.1210/en.2009-0651; Vermeulen M, 2010, CELL, V142, P967, DOI 10.1016/j.cell.2010.08.020; Wang A, 2008, ANIM GENET, V39, P207, DOI 10.1111/j.1365-2052.2008.01706.x; Wang Q, 2015, AM J CANCER RES, V5, P1281; Wu H, 2013, GENE CHROMOSOME CANC, V52, P644, DOI 10.1002/gcc.22060; Xia XY, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1455-y; Yang J, 2019, THERANOSTICS, V9, P5810, DOI 10.7150/thno.34973; Yang LF, 2020, THERANOSTICS, V10, P5242, DOI 10.7150/thno.43744; Yu JH, 2012, HEPATOLOGY, V56, P2375, DOI 10.1002/hep.25900; Yu JH, 2010, HEPATOLOGY, V52, P1808, DOI 10.1002/hep.23882; Yue M, 2017, CELL REP, V21, P3819, DOI 10.1016/j.celrep.2017.12.002; Zhang LL, 2020, CANCER RES, V80, P2599, DOI 10.1158/0008-5472.CAN-19-3226; Zhang Y, 2011, J BIOL CHEM, V286, P42414, DOI 10.1074/jbc.M111.271064	37	1	1	3	10	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 22	2022	41	17					2492	2504		10.1038/s41388-022-02273-2	http://dx.doi.org/10.1038/s41388-022-02273-2		MAR 2022	13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0R6YF	35314791				2022-12-26	WOS:000771325000002
J	Brigtsen, AK; Jacobsen, AF; Dedi, L; Melby, KK; Espeland, CN; Fugelseth, D; Whitelaw, A				Brigtsen, Anne Karin; Jacobsen, Anne Flem; Dedi, Lumnije; Melby, Kjetil Klaveness; Espeland, Cathrine Nygaard; Fugelseth, Drude; Whitelaw, Andrew			Group B Streptococcus colonization at delivery is associated with maternal peripartum infection	PLOS ONE			English	Article							SEROTYPE IV; STAPHYLOCOCCUS-AUREUS; PREGNANT-WOMEN; RISK-FACTORS; DISEASE; PREVENTION; TRANSMISSION; MORBIDITY; EMERGENCE; BIRTH	BackgroundGroup B Streptococcus (GBS) is a major cause of serious neonatal infection but its role in maternal morbidity has received little investigation. The aim of this study was to determine whether GBS colonization at delivery is associated with increased risk of maternal peripartum infection. MethodsIn this prospective cohort study, 1746 unselected women had a vaginal-rectal culture taken at the onset of labor. Diagnosis of maternal peripartum infection was based on a combination of two or more signs or symptoms including fever, breast pain, severe wound or pelvic pain, purulent discharge and abnormal laboratory tests including C-reactive protein and white blood cell count occurring from labor until 2 weeks postpartum. The main outcome measure was the proportion of women with maternal peripartum infection according to GBS colonization status. ResultsA total of 25.9% (452/1746) women were colonized with GBS. The rate of peripartum infection was almost twice as high in colonized women (49/452 [10.8%]) vs. non-colonized women (81/1294 [6.3%]); OR 1.82 [1.26-2.64], p = 0.002). This association was confirmed in a multivariable model (OR 1.99 [1.35-2.95], p = 0.001). Women diagnosed with peripartum infection had a significantly longer hospital stay compared to women without peripartum infection (4 days (median) vs. 3 days, p < 0.001). Length of hospital stay did not differ between colonized and non-colonized women. Serotype IV GBS was more frequent in colonized women with peripartum infection than in women without peripartum infection (29.3% vs. 12.5%, p = 0.003). ConclusionsGBS colonization at delivery is associated with increased risk of peripartum infection. Whether this increase is due directly to invasion by GBS or whether GBS colonization is associated with a more general vulnerability to infection remains to be determined.	[Brigtsen, Anne Karin; Jacobsen, Anne Flem; Melby, Kjetil Klaveness; Fugelseth, Drude; Whitelaw, Andrew] Univ Oslo, Inst Clin Med, Oslo, Norway; [Brigtsen, Anne Karin; Espeland, Cathrine Nygaard; Fugelseth, Drude] Univ Oslo, Dept Neonatal Intens Care, Hosp Ulleval, Oslo, Norway; [Jacobsen, Anne Flem] Univ Oslo, Dept Obstet & Gynecol, Hosp Ulleval, Oslo, Norway; [Dedi, Lumnije; Melby, Kjetil Klaveness] Univ Oslo, Dept Microbiol, Hosp Ulleval, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo	Brigtsen, AK (corresponding author), Univ Oslo, Inst Clin Med, Oslo, Norway.; Brigtsen, AK (corresponding author), Univ Oslo, Dept Neonatal Intens Care, Hosp Ulleval, Oslo, Norway.	a.k.brigtsen@medisin.uio.no		Brigtsen, Anne Karin/0000-0002-0904-0426	Norwegian SIDS and Stillbirth Society, The Eckbo Foundation; Renee and Bredo Grimsgaard Foundation	Norwegian SIDS and Stillbirth Society, The Eckbo Foundation; Renee and Bredo Grimsgaard Foundation	Funding: AKB was funded in part by the Norwegian SIDS and Stillbirth Society, The Eckbo Foundation and the Renee and Bredo Grimsgaard Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Cortes JIA, 2013, ENFERM INFEC MICR CL, V31, P159, DOI 10.1016/j.eimc.2012.03.013; Andrews WW, 2008, OBSTET GYNECOL, V111, P113, DOI 10.1097/01.AOG.0000298344.04916.11; [Anonymous], 2019, Obstet Gynecol, V134, P1, DOI 10.1097/AOG.0000000000003334; [Anonymous], 1996, MMWR Recomm Rep, V45, P1; Axelsson D, 2018, J PERINAT MED, V46, P271, DOI 10.1515/jpm-2016-0389; Barnett TC, 2015, CELL MICROBIOL, V17, P1721, DOI 10.1111/cmi.12531; Bekker V, 2014, LANCET INFECT DIS, V14, P1083, DOI 10.1016/S1473-3099(14)70919-3; Branch-Elliman W, 2012, CLIN INFECT DIS, V54, P71, DOI 10.1093/cid/cir751; Brigtsen AK, 2015, J MICROBIOL METH, V108, P31, DOI 10.1016/j.mimet.2014.11.001; Cnattingius S, 2016, LANCET, V387, P558, DOI 10.1016/S0140-6736(15)00990-3; De Luca C, 2016, J MATERN-FETAL NEO M, V29, P911, DOI 10.3109/14767058.2015.1023188; Di Renzo GC, 2015, J MATERN-FETAL NEO M, V28, P766, DOI 10.3109/14767058.2014.934804; Edwards James M, 2019, Infect Dis Obstet Gynecol, V2019, P5430493, DOI 10.1155/2019/5430493; Ferrieri P, 2013, EMERG INFECT DIS, V19, P551, DOI 10.3201/eid1904.121572; Hamilton SM, 2013, CLIN INFECT DIS, V57, P870, DOI 10.1093/cid/cit282; Hebert PR, 1999, OBSTET GYNECOL, V94, P942, DOI 10.1016/S0029-7844(99)00419-6; Henriksen K., 2010, STATISTISK SENTRALBY; Homer CSE, 2014, WOMEN BIRTH, V27, P46, DOI 10.1016/j.wombi.2013.09.006; Hughes RG, 2017, BJOG-INT J OBSTET GY, V124, pE280, DOI 10.1111/1471-0528.14821; Kappeler EM, 2015, PUBLIC HEALTH REP, V130, P196, DOI 10.1177/003335491513000304; Kiely RA, 2011, EPIDEMIOL INFECT, V139, P236, DOI 10.1017/S0950268810001275; Klajnbard A, 2010, CLIN CHEM LAB MED, V48, P237, DOI 10.1515/CCLM.2010.033; Krohn MA, 1999, J INFECT DIS, V179, P1410, DOI 10.1086/314756; Kunze M, 2011, J PERINAT MED, V39, P417, DOI [10.1515/JPM.2011.037, 10.1515/jpm.2011.037]; Landwehr-Kenzel S, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00519; Leftwich HK, 2017, PEDIATR CLIN N AM, V64, P381, DOI 10.1016/j.pcl.2016.11.007; MINKOFF HL, 1982, AM J OBSTET GYNECOL, V142, P992, DOI 10.1016/0002-9378(82)90781-5; Muller AE, 2006, ACTA OBSTET GYN SCAN, V85, P1027, DOI 10.1080/00016340600780508; Pezzicoli A, 2008, J INFECT DIS, V198, P890, DOI 10.1086/591182; Rao GG, 2019, BJOG-INT J OBSTET GY, V126, P1347, DOI 10.1111/1471-0528.15648; REGAN JA, 1991, OBSTET GYNECOL, V77, P604; Remington JS, 2011, INFECT DIS FETUS NEW; Scholl J, 2016, AM J OBSTET GYNECOL, V214, DOI 10.1016/j.ajog.2015.12.053; Sedgh G, 2015, J ADOLESCENT HEALTH, V56, P223, DOI 10.1016/j.jadohealth.2014.09.007; Stapleton RD, 2005, OBSTET GYNECOL, V106, P1246, DOI 10.1097/01.AOG.0000187893.52488.4b; Surgers L, 2013, EUR J CLIN MICROBIOL, V32, P107, DOI 10.1007/s10096-012-1724-5; Svensson E, 2014, EPIDEMIOLOGY, V25, P866, DOI 10.1097/EDE.0000000000000163; Tazi A, 2010, J EXP MED, V207, P2313, DOI 10.1084/jem.20092594; Teatero S, 2015, J CLIN MICROBIOL, V53, P2919, DOI 10.1128/JCM.01128-15; Venkatesh KK, 2021, AM J PERINAT, V38, pE262, DOI 10.1055/s-0040-1709666; Verani Jennifer R., 2010, Morbidity and Mortality Weekly Report, V59, P1; Watkins LKF, 2019, JAMA INTERN MED, V179, P479, DOI 10.1001/jamainternmed.2018.7269; YANCEY MK, 1994, OBSTET GYNECOL, V84, P816	43	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0264309	10.1371/journal.pone.0264309	http://dx.doi.org/10.1371/journal.pone.0264309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363775	Green Published, gold			2022-12-26	WOS:000804748600028
J	Chew, CC; Lim, XJ; Low, LL; Lau, KM; Kari, M; Shamsudin, UK; Rajan, P				Chew, Chii-Chii; Lim, Xin-Jie; Low, Lee-Lan; Lau, Kin-Mun; Kari, Maziana; Shamsudin, Ummi Kalthom; Rajan, Philip			The challenges in managing the growth of indigenous children in Perak State, Malaysia: A qualitative study	PLOS ONE			English	Article							ORANG-ASLI; HEALTH; MALNUTRITION; UNDERNUTRITION	Indigenous peoples in Peninsular Malaysia, known as Orang Asli, have been associated with the problem of malnutrition. Approximately 40% of their children are underweight. Indigenous peoples' distinct social, cultural, and economic traits, which differ from those of the dominant communities in which they live, may pose significant challenges for health care providers (HCPs) in addressing the malnutrition issue. This study explores challenges encountered by HCPs, with at least six months of experience in monitoring the growth parameters of Orang Asli children residing in Perak State in Peninsular Malaysia. A cross-sectional study was conducted between December 2020 and June 2021, involving three focus group discussions and three in-depth interviews. Thematic analysis was used. A total of 19 participants (6 nurses, 5 nursing managers, 4 medical officers, 2 nutritionists, a family medicine specialist, and a paediatrician) took part in this study. The challenges were summarized into four themes: (I) accessibility to nutrition, (II) accessibility to healthcare services, (II) skills of HCPs, and (IV) challenges of implementing nutrition programs. The inability of the Orang Asli children to access nutritious food was due to poverty, different perceptions of life priorities, and the practice of food taboos among the communities. Inadequate infrastructure and transportation discourage parents from bringing their children to healthcare facilities. The belief in and preference for traditional healing, the practice of semi-nomadic lifestyles, and fear of HCPs and their timid nature were factors that prevented Orang Asli children from accessing healthcare services. HCPs need to equip themselves with cross-cultural communication and interaction skills and adapt their skills to environmental challenges to overcome unexpected encounters in mobile clinics. The non-exposed food items, the risk of food basket sharing with other family members, and community feeding programs' coordination were the challenges to be addressed when implementing nutrition programmes for Orang Asli children. The challenges of HCPs are multifactorial and require a multifaceted approach. There is a need for joint efforts of stakeholders, from communities and non-governmental organisations (NGOs) to the health authorities, to address the challenges of HCPs.	[Chew, Chii-Chii; Lim, Xin-Jie; Rajan, Philip] Hosp Raja Permaisuri Bainun, Clin Res Ctr, Minist Hlth, Ipoh, Malaysia; [Low, Lee-Lan] Minist Hlth, Inst Hlth Syst Res, Ipoh, Malaysia; [Lau, Kin-Mun; Kari, Maziana; Shamsudin, Ummi Kalthom] Minist Hlth, Perak State Hlth Dept, Ipoh, Malaysia	Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia; Kementerian Kesihatan Malaysia	Chew, CC (corresponding author), Hosp Raja Permaisuri Bainun, Clin Res Ctr, Minist Hlth, Ipoh, Malaysia.	chiichii.crcperak@gmail.com	CHEW, CHII-CHII/AAD-3715-2020; XIN JIE, LIM/GPP-1893-2022	CHEW, CHII-CHII/0000-0002-9316-3671; XIN JIE, LIM/0000-0003-0676-2113				Aboriginal and Torres Strait Islander Cultural Capability Team, 2014, AB TORR STRAIT ISL P, P283; Allen L.H., 2001, WHAT WORKS REV EFFIC; [Anonymous], 1991, Indian J Pediatr, V58, P13; [Anonymous], 2008, NORD REV, DOI [DOI 10.1515/nor-2017-0181, DOI 10.1177/0022146510383495]; Anticona C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.22888; Anto Cordelia TAD., 2019, MALAYSIAN J PUBLIC H, V19, P84, DOI [10.37268/mjphm/vol.19/no.1/art.40, DOI 10.37268/MJPHM/VOL.19/NO.1/ART.40]; Australian Commission on Safety and Quality in Health Care, NAT SAF QUAL SERV ST; Baharom NA., 2020, IOP C SER EARTH ENV, P596, DOI [10.1088/1755-1315/596/1/012072, DOI 10.1088/1755-1315/596/1/012072]; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; BOLTON JM, 1972, AM J CLIN NUTR, V25, P789; Browne J, 2020, BMJ GLOB HEALTH, V5, DOI 10.1136/bmjgh-2020-002442; Cambridge Dictionary, ACC, P2021; Chew C-C, 2016, MANAGING GROWTH INDI; Chiu CY, 2013, J CROSS CULT PSYCHOL, V44, P843, DOI 10.1177/0022022113493716; Daniels JP, 2017, LANCET, V389, P23, DOI 10.1016/S0140-6736(16)32599-5; Davy C, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0450-5; de Onis M, 2003, INT J EPIDEMIOL, V32, P518, DOI 10.1093/ije/dyg099; de Souza LG, 2011, CAD SAUDE PUBLICA, V27, P1891, DOI 10.1590/S0102-311X2011001000003; Egeland G. M., 2013, Indigenous peoples' food systems and well-being: interventions and policies for healthy communities, P9; Faulkner SandraL., 2017, INT ENCY COMMUNICATI, P1, DOI DOI 10.1002/9781118901731.IECRM0060; Florindo AA, 2013, BMC PUBLIC HEALTH, V13, DOI [10.1186/1471-2458-13-794, 10.1186/1471-2458-13-1066, 10.1186/1471-2458-13-52]; GNR, 2020, GLOB NUTR REP IND EX; Haemamalar K Jr, 2010, Malays J Nutr, V16, P55; Haggerty JL, 2014, HEALTH PLACE, V28, P92, DOI 10.1016/j.healthplace.2014.03.005; Hong PK, 2009, SINGAPORE J TROP GEO, V30, P144, DOI 10.1111/j.1467-9493.2008.00355_4.x; Horta BL., 2013, NUTR STATUS INDIGENO, P1; Institute for Public Health National Institutes of Health (NIH)Ministry of Health Malaysia, 2019, NATL HLTH MORBIDITY; Jongen C, 2019, BMC HEALTH SERV RES, V19, DOI 10.1186/s12913-019-4750-5; Kennelly S, 2010, J HUM NUTR DIET, V23, P567, DOI 10.1111/j.1365-277X.2010.01111.x; Khambalia AZ, 2012, FOOD NUTR BULL, V33, P31, DOI 10.1177/156482651203300103; Khor GL, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-8055-8; Koletzko B, 2009, AM J CLIN NUTR, V89, pS1502, DOI 10.3945/ajcn.2009.27113D; Law LS, 2018, NUTRIENTS, V10, DOI 10.3390/nu10101455; Law LS, 2018, PUBLIC HEALTH NUTR, V21, P2819, DOI [10.1017/S136898001800160X, 10.1017/s136898001800160x]; Lawson DW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110447; Lee A., 2018, AUST INDIG HLTH B, V18; Li J.L., 2017, CLIN NURS RES, V4, P207, DOI DOI 10.1016/J.CNRE.2017.10.009; Liamputtong P., 2013, QUALITATIVE RES METH; Loignon C., 2015, International Journal for Equity in Health, V14; Manjong F. T., 2020, Journal of Public Health and Epidemiology, V12, P340, DOI 10.5897/JPHE2020.1279; Mas-Harithulfadhli-Agus AR, 2021, ETHNIC HEALTH, V26, P264, DOI 10.1080/13557858.2018.1494820; Masron T., 2010, ORANG ASLI PENINSULA, P75; Masroor N., 2014, FACTORS AFFECTING NU, P20; Montenegro RA, 2006, LANCET, V367, P1859, DOI 10.1016/S0140-6736(06)68808-9; Morris SS, 2008, LANCET, V371, P608, DOI 10.1016/S0140-6736(07)61695-X; Muslim A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245377; Napier AD, 2014, LANCET, V384, P1607, DOI 10.1016/S0140-6736(14)61603-2; National Collaborating Centre for Aboriginal Health (NCCIH), 2013, OV AB HLTH CAN; NSW Board of Studies, 2008, WORK AB COMM GUID CO; Nutrition Department Ministry of Health Malaysia, 2015, GAR PAND PROGR PEM K; Nutrition Department Ministry of Health Malaysia, 2021, COMM FEED PROGR; Nutrition Division Ministry of Health Malaysia, COMM FEED PROGR IMPR; Oakland T., 2003, ADAPTIVE BEHAV ASSES, V3rd ed.; Pulver LJ., 2010, WORLD HLTH REPORT FI, P1; Richmond CAM, 2016, PUBLIC HEALTH REV, V37, DOI 10.1186/s40985-016-0016-5; Saibul N, 2009, ASIA PAC J CLIN NUTR, V18, P412; Singh KD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130567; SYEDHUSSAIN TPR, 2017, INT J HUMANITIES SOC, V6, P40; The World Bank, 2021, INDIGENOUS PEOPLES; The World Bank, 2021, INDIGENOUS PEOPLES; Waterworth P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142323; Wilson AM, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05462-5; Wong CY, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2058-x; Wong WK, 2016, CAN J INFECT DIS MED, V2016, DOI 10.1155/2016/1326085; Wong YS, 2019, CRIT PUBLIC HEALTH, V29, P192, DOI 10.1080/09581596.2018.1438588; World Health Organization, 2021, MALN KEY FACTS; Yen WC, 2018, ASIA PAC J CLIN NUTR, V27, P886, DOI 10.6133/apjcn.072017.02	67	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265917	10.1371/journal.pone.0265917	http://dx.doi.org/10.1371/journal.pone.0265917			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320328	gold, Green Published			2022-12-26	WOS:000784240600034
J	Hayashi, M; Nishiya, K; Kaneko, K				Hayashi, Mikio; Nishiya, Katsumi; Kaneko, Kazunari			Transition from undergraduates to residents: A SWOT analysis of the expectations and concerns of Japanese medical graduates during the COVID-19 pandemic	PLOS ONE			English	Article							PERCEPTIONS	IntroductionInterruptions in undergraduate clinical clerkship during the COVID-19 pandemic have reduced the confidence and preparedness of residents beginning their postgraduate training. We explore the thoughts of new residents about this transition and reflect on the support needed. MethodsAn exploratory qualitative case study was conducted with 51 residents. All had experienced interruptions in clinical training due to the pandemic and had just started their postgraduate training. Qualitative data were collected through 6 focus groups and 12 individual follow-up interviews. A thematic analysis was undertaken, and the data were categorised using a Strengths, Weaknesses, Opportunities, and Threats (SWOT) framework. ResultsGraduates beginning their residency were aware of their professionalism and independence during the transition. They also faced the predicament of needing close supervision while their supervisors managed pandemic conditions. Residents emphasised the importance of developing relationships with colleagues and supervisors during the transition to residency and wanted direct observation and detailed feedback from their supervisors during procedures. ConclusionsThe experiences of residents were not uniformly negative. In fact, some had developed a positive mindset when entering the clinical field. Medical faculty members reflecting on interactions with new residents and planning future clinical internships could benefit from placing a high value on building relationships among residents, who may expect direct observation and detailed feedback from their supervisors.	[Hayashi, Mikio; Nishiya, Katsumi] Kansai Med Univ, Ctr Med Educ, Osaka, Japan; [Kaneko, Kazunari] Kansai Med Univ, Dept Pediat, Osaka, Japan	Kansai Medical University; Kansai Medical University	Hayashi, M (corresponding author), Kansai Med Univ, Ctr Med Educ, Osaka, Japan.	h_mikio106@hotmail.com		Hayashi, Mikio/0000-0002-5372-0664				AACOM AAMC ACGME and ECFMG/FAIMER, 2021, TRANS TIM DISR PRACT; Alshdaifat E, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02655-2; Barnes T, 2020, MED TEACH, V42, P79, DOI 10.1080/0142159X.2019.1665632; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Brennan N, 2010, MED EDUC, V44, P449, DOI 10.1111/j.1365-2923.2009.03604.x; Cameron A, 2014, CLIN TEACH, V11, P188, DOI 10.1111/tct.12127; Cleland Jennifer, 2016, Adv Simul (Lond), V1, P14, DOI 10.1186/s41077-016-0015-0; Compton S, 2020, MED EDUC, V54, P943, DOI 10.1111/medu.14268; Consorti F, 2021, MED TEACH, V43, P546, DOI 10.1080/0142159X.2021.1877266; Daniel M, 2021, UNIV TOR MED J, V98, P68, DOI 10.1080/0142159X.2020.1864310; Gordon L, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018583; Gordon M, 2020, MED TEACH, V42, P1202, DOI 10.1080/0142159X.2020.1807484; Hall AK, 2020, MED TEACH, V42, P756, DOI 10.1080/0142159X.2020.1766669; Hollweck T, 2015, CAN J PROGRAM EVAL, V30, P108, DOI 10.3138/cjpe.30.1.108; Kassam A, 2020, TEACH LEARN MED, V33, P10, DOI 10.1080/10401334.2020.1789466; Kiger ME, 2020, MED TEACH, V42, P846, DOI 10.1080/0142159X.2020.1755030; LaDonna KA, 2017, MED EDUC, V51, P498, DOI 10.1111/medu.13232; Longhurst GJ, 2020, ANAT SCI EDUC, V13, P298, DOI 10.1002/ase.1967; Mann K., 2015, RES MED ED, P51; Merriam S.B., 1988, CASE STUDY RES ED; Michaelides A, 2020, BMC MED EDUC, V20, DOI 10.1186/s12909-020-01999-5; Monrouxe LV, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023146; Monrouxe LV, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-013656; Morrow G, 2012, MED TEACH, V34, P123, DOI 10.3109/0142159X.2012.643260; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; Osita IC., 2014, INT J INNOV APPL RES, V2, P23; Ottrey E, 2021, MED EDUC, V55, P1078, DOI 10.1111/medu.14475; Pravder HD, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02577-z; Sitobata M, 2022, MED EDUC ONLINE, V27, DOI 10.1080/10872981.2021.2005458; Stake R. E., 1995, ART CASE STUDY RES; Stalmeijer RE, 2014, MED TEACH, V36, P923, DOI 10.3109/0142159X.2014.917165; Strauss A., 2008, BASICS QUALITATIVE R; Takeda Y., 2020, MED ED JPN, V51, P198; Winn AS, 2021, BMC MED EDUC, V21, DOI 10.1186/s12909-021-02777-7; Yardley S, 2018, PERSPECT MED EDUC, V7, P8, DOI 10.1007/s40037-018-0403-3	35	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266284	10.1371/journal.pone.0266284	http://dx.doi.org/10.1371/journal.pone.0266284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353865	Green Published, gold			2022-12-26	WOS:000786647900037
J	Huang, XP; Liu, X; Ding, WX; Meng, CL; An, P				Huang, Xinpeng; Liu, Xin; Ding, Wenxin; Meng, Chunli; An, Ping			No-reference panoramic image quality assessment based on multi-region adjacent pixels correlation	PLOS ONE			English	Article								The distortion measurement plays an important role in panoramic image processing. Most measurement algorithms judge the panoramic image quality by means of weighting the quality of the local areas. However, such a calculation fails to globally reflect the quality of the panoramic image. Therefore, the multi-region adjacent pixels correlation (MRAPC) is proposed as the efficient feature for no-reference panoramic images quality assessment in this paper. Specifically, from the perspective of the statistical characteristics, the differences of the adjacent pixels in panoramic image are proved to be highly related to the degree of distortion and independent of image content. Besides, the difference map has limited pixel value range, which can improve the efficiency of quality assessment. Based on these advantages, the proposed MRAPC feature collaborates with the support vector regression to globally predict the quality of panoramic images. Extensive experimental results show that the proposed no-reference panoramic image quality assessment algorithm achieves higher evaluation performance than the existing algorithms.	[Huang, Xinpeng; Liu, Xin; Ding, Wenxin; Meng, Chunli; An, Ping] Shanghai Univ, Sch Commun & Informat Engn, Shanghai Inst Adv Commun & Data Sci, Shanghai, Peoples R China	Shanghai University	An, P (corresponding author), Shanghai Univ, Sch Commun & Informat Engn, Shanghai Inst Adv Commun & Data Sci, Shanghai, Peoples R China.	anping@shu.edu.cn			National Natural Science Foundation of China [62001279, 62020106011, 62071287, 61901252]; Science and Technology Commission of Shanghai Municipality [20DZ2290100]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work was supported in part by the National Natural Science Foundation of China [Grants 62001279, 62020106011, 62071287, 61901252], and Science and Technology Commission of Shanghai Municipality [Grant 20DZ2290100]. There was no additional external funding received for this study.	Antkowiak J, 2000, VQEG M; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Dosselmann R, 2011, SIGNAL IMAGE VIDEO P, V5, P81, DOI 10.1007/s11760-009-0144-1; Duan HY, 2018, IEEE INT SYMP CIRC S, DOI 10.1109/ISCAS.2018.8351786; Kim HG, 2020, IEEE T CIRC SYST VID, V30, P917, DOI 10.1109/TCSVT.2019.2898732; Li C, 2019, PROC CVPR IEEE, P10169, DOI 10.1109/CVPR.2019.01042; Li C, 2018, PROCEEDINGS OF THE 2018 ACM MULTIMEDIA CONFERENCE (MM'18), P932, DOI 10.1145/3240508.3240581; Lim HT, 2018, 2018 IEEE INTERNATIONAL CONFERENCE ON ACOUSTICS, SPEECH AND SIGNAL PROCESSING (ICASSP), P6737; Mittal A, 2012, IEEE T IMAGE PROCESS, V21, P4695, DOI 10.1109/TIP.2012.2214050; Singla A, 2017, INT WORK QUAL MULTIM; Sun W, 2017, IEEE IMAGE PROC, P3450; Sun YL, 2017, IEEE SIGNAL PROC LET, V24, P1408, DOI 10.1109/LSP.2017.2720693; Wang Z, 2004, IEEE T IMAGE PROCESS, V13, P600, DOI 10.1109/TIP.2003.819861; Wang Z, 2009, IEEE SIGNAL PROC MAG, V26, P98, DOI 10.1109/MSP.2008.930649; Xu M, 2020, IEEE J-STSP, V14, P5, DOI 10.1109/JSTSP.2020.2966864; Yang SY, 2017, PROC INT CONF EDU IN, P1, DOI 10.1109/EITT.2017.9; Yu M, 2015, 2015 IEEE International Symposium on Mixed and Augmented Reality, P31, DOI 10.1109/ISMAR.2015.12; Zakharchenko V, 2017, IEEE DATA COMPR CONF, P472, DOI 10.1109/DCC.2017.90; Zhou YF, 2018, INT CONF SIGN PROCES, P54, DOI 10.1109/ICSP.2018.8652269	19	0	0	9	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266021	10.1371/journal.pone.0266021	http://dx.doi.org/10.1371/journal.pone.0266021			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344545	Green Published, gold			2022-12-26	WOS:000788055200006
J	Morhason-Bello, IO; Baisley, K; Pavon, MA; Adewole, IF; Bakare, RA; de Sanjose, S; Francis, SC; Watson-Jones, D				Morhason-Bello, Imran O.; Baisley, Kathy; Pavon, Miquel A.; Adewole, Isaac F.; Bakare, Rasheed A.; de Sanjose, Silvia; Francis, Suzanna C.; Watson-Jones, Deborah			Oral, genital and anal human papillomavirus infections among female sex workers in Ibadan, Nigeria	PLOS ONE			English	Article							INVASIVE CERVICAL-CANCER; RISK-FACTORS; PREVALENCE; HIV; CONCORDANCE	BackgroundThere are limited data on the epidemiology of HPV in different anatomical sites of female sex workers (FSW). We investigated the prevalence and concordance of cervical, vulval, oral and anal HPV among FSW in Ibadan, Nigeria. MethodsFSWs aged 18-45 years were enrolled in a cross-sectional survey. After interview and clinical examination, samples were collected from mouth, cervix, vulva and anus. HPV genotyping was done with Anyplex II 28HPV assay. Multivariable analyses were performed to explore associated risk factors and concordance of HPV infections across sites. ResultsIn total, 315 FSWs participated in the study with a mean age of 30-6.5 years. The prevalence of any HPV infection was 88% in the vulva, 84% in the cervix, 75% in the anus and 24% in the oral cavity. HPV 35 was the most prevalent and concordant high-risk type in the four sites. The risk factors for HPV infection by anatomic site varied. ConclusionThis large study showed a high prevalence and concordance of HPV infections of cervical, vulval, oral and anal HPV among FSWs in Nigeria. The potential to acquire and transmit HPV is high in this population, and we highlighted the urgency to protect young women through HPV vaccination.	[Morhason-Bello, Imran O.; Adewole, Isaac F.] Univ Ibadan, Coll Med, Fac Clin Sci, Obstet & Gynaecol Dept, Ibadan, Nigeria; [Morhason-Bello, Imran O.] Univ Ibadan, Coll Med, Inst Adv Med Res & Training, Ibadan, Nigeria; [Morhason-Bello, Imran O.; Watson-Jones, Deborah] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England; [Baisley, Kathy] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Infect Dis Epidemiol, London, England; [Pavon, Miquel A.] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Bellvitge Biomed Res Inst IDIBELL, Infect & Canc Lab, ICO,Canc Epidemiol Res Program, Barcelona, Spain; [Pavon, Miquel A.] Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Madrid, Spain; [Bakare, Rasheed A.] Univ Ibadan, Coll Med, Fac Basic Med Sci, Dept Microbiol, Ibadan, Nigeria; [de Sanjose, Silvia] NCI, Div Canc Epidemiol & Genet DCEG, NIH, Bethesda, MD 20892 USA; [de Sanjose, Silvia] ISGlobal, Barcelona, Spain; [Francis, Suzanna C.] London Sch Hyg & Trop Med, Int Stat & Epidemiol Grp, London, England; [Watson-Jones, Deborah] Natl Inst Med Res, Mwanza Intervent Trials Unit, Mwanza, Tanzania	University of Ibadan; University of Ibadan; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; University of Ibadan; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); ISGlobal; University of London; London School of Hygiene & Tropical Medicine; National Institute of Medical Research	Morhason-Bello, IO (corresponding author), Univ Ibadan, Coll Med, Fac Clin Sci, Obstet & Gynaecol Dept, Ibadan, Nigeria.; Morhason-Bello, IO (corresponding author), Univ Ibadan, Coll Med, Inst Adv Med Res & Training, Ibadan, Nigeria.; Morhason-Bello, IO (corresponding author), London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Clin Res Dept, London, England.	imranmorhasonbello@gmail.com		Morhason-Bello, Imran/0000-0002-7448-4824	University of Ibadan, Ibadan, Nigeria	University of Ibadan, Ibadan, Nigeria	IMB received grant support from the University of Ibadan, Ibadan, Nigeria for his PhD programme at the London School of Hygiene and Tropical Medicine, London. The SHINI Study was supported by the Management of University of Ibadan, Ibadan, Nigeria, under a Staff Development Program Grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AR, 2019, J ONCOL, V2019, DOI 10.1155/2019/8062176; Adesina A, 2021, INT Q COMMUNITY HEAL, DOI 10.1177/0272684X211006616; Anyplex II HPV28 Detection, SIMULTANEOUS DETECTI; Arbyn M, 2020, LANCET GLOB HEALTH, V8, pE191, DOI 10.1016/S2214-109X(19)30482-6; Baral S, 2012, LANCET INFECT DIS, V12, P538, DOI 10.1016/S1473-3099(12)70066-X; Bayo S, 2002, INT J EPIDEMIOL, V31, P202, DOI 10.1093/ije/31.1.202; Beyrer C, 2015, LANCET, V385, P287, DOI 10.1016/S0140-6736(14)60933-8; Biglu MH, 2016, SEX REPROD HEALTHC, V10, P3, DOI 10.1016/j.srhc.2016.07.002; Brown B, 2011, INT J STD AIDS, V22, P655, DOI 10.1258/ijsa.2011.010541; Canadas MP, 2004, J CLIN MICROBIOL, V42, P1330, DOI 10.1128/JCM.42.3.1330-1332.2004; Denny L, 2014, INT J CANCER, V134, P1389, DOI 10.1002/ijc.28425; Diop-Ndiaye H, 2019, PAPILLOMAVIRUS RES, V7, P97, DOI 10.1016/j.pvr.2019.02.003; Farahmand M, 2020, BMC PUBLIC HEALTH, V20, DOI 10.1186/s12889-020-09570-z; Federal Ministry of Health, 2016, NAT GUID SYNDR MAN S; Ferre VM, 2019, CLIN MICROBIOL INFEC, V25, DOI 10.1016/j.cmi.2019.04.015; George G, 2019, AIDS CARE, V31, P1168, DOI 10.1080/09540121.2018.1563284; Goodman MT, 2010, J INFECT DIS, V201, P1331, DOI 10.1086/651620; Hernandez Brenda Y, 2008, Infect Agent Cancer, V3, P7, DOI 10.1186/1750-9378-3-7; Jia HQ, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2066-x; Laurson J, 2010, CARCINOGENESIS, V31, P918, DOI 10.1093/carcin/bgq027; Li YY, 2017, ADV EXP MED BIOL, V1018, P23, DOI 10.1007/978-981-10-5765-6_3; Looker KJ, 2018, J INT AIDS SOC, V21, DOI 10.1002/jia2.25110; Marek E, 2014, EUR J CANCER CARE, V23, P65, DOI 10.1111/ecc.12110; Marra E, 2018, J INFECTION, V76, P393, DOI 10.1016/j.jinf.2017.12.011; Matsushita K, 2011, JPN J INFECT DIS, V64, P34; Menon S, 2017, INFECT AGENTS CANCER, V12, DOI 10.1186/s13027-016-0114-5; Morhason Bello I O, 2015, Afr J Med Med Sci, V44, P61; Morhason-Bello IO, 2021, INFECT AGENTS CANCER, V16, DOI 10.1186/s13027-021-00398-9; Morhason-Bello IO, 2019, REPROD HEALTH, V16, DOI 10.1186/s12978-019-0722-9; Morhason-Bello IO., 2021, ARCH SEX BEHAV; Osterman AL, 2019, INT J CANCER, V144, P1302, DOI 10.1002/ijc.31829; Patel SJ, 2013, INT J STD AIDS, V24, P221, DOI 10.1177/0956462412472446; Rouzi AA, 2017, AM J OBSTET GYNECOL, V217, DOI 10.1016/j.ajog.2017.02.044; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Sendagorta-Cudos E, 2019, ENFERM INFEC MICR CL, V37, P324, DOI 10.1016/j.eimc.2019.01.010; Shannon K, 2015, LANCET, V385, P55, DOI 10.1016/S0140-6736(14)60931-4; Shikova E, 2011, INT J STD AIDS, V22, P278, DOI 10.1258/ijsa.2009.009362; Soohoo Melissa, 2013, Open AIDS J, V7, P58, DOI 10.2174/1874613601307010058; Bui TC, 2018, J MED VIROL, V90, P1765, DOI 10.1002/jmv.25268; Valles X, 2009, INT J CANCER, V125, P1161, DOI 10.1002/ijc.24444; Vorsters A, 2016, BMC PUBLIC HEALTH, V16, DOI 10.1186/s12889-016-3099-5	41	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265269	10.1371/journal.pone.0265269	http://dx.doi.org/10.1371/journal.pone.0265269			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0T0FS	35353833	Green Published, gold, Green Accepted			2022-12-26	WOS:000786647900055
J	Opoku-Addai, K; Korsah, KA; Mensah, GP				Opoku-Addai, Kwabena; Korsah, Kwadwo Ameyaw; Mensah, Gwendolyn Patience			Nutritional self-care practices and skills of patients with diabetes mellitus: A study at a tertiary hospital in Ghana	PLOS ONE			English	Article							CARDIOMETABOLIC RISK PROFILES; ADULTS; CONSUMPTION; RECOMMENDATIONS; MANAGEMENT; KNOWLEDGE; EDUCATION; ALCOHOL; MEALS; FRUIT	IntroductionNutritional management decreases and/or prevents the complications and deaths associated with diabetes mellitus. However, the majority of patients living with diabetes do not engage in optimal nutritional management of diabetes because they see it as the most difficult aspect of managing the condition. This study aimed to explore and describe the practices and skills on nutritional management of diabetes mellitus among patients living with diabetes attending a Ghanaian hospital. Materials and methodsThis study employed an exploratory, descriptive qualitative research design. Fifteen participants were recruited using purposive sampling, and interviewed with a semi-structured interview guide. Content analysis was performed on the data gathered, following which three main themes emerged. ResultsMore than two-thirds of the participants of this study had adequate meal planning skills, ate the right quantity of foods, engaged in healthy eating habits, and consumed healthy sources of carbohydrates, fats and protein when eating. However, more than half of the participants had insufficient knowledge and skills in the reading and usage of food labels. ConclusionsThe participants of this study largely engaged in optimal nutritional management of diabetes due to their healthy dietary practices and preferences. It is recommended that health care professionals in Ghana find practical and robust ways to factor the reading and usage of food labels into the care and management of patients with diabetes.	[Opoku-Addai, Kwabena; Korsah, Kwadwo Ameyaw; Mensah, Gwendolyn Patience] Univ Ghana, Coll Hlth Sci, Sch Nursing & Midwifery, Legon, Accra, Ghana; [Opoku-Addai, Kwabena] Presbyterian Univ Coll, Fac Hlth & Med Sci, Dept Nursing & Midwifery, Asante Akyem, Agogo, Ghana	University of Ghana	Mensah, GP (corresponding author), Univ Ghana, Coll Hlth Sci, Sch Nursing & Midwifery, Legon, Accra, Ghana.	gpmensah@ug.edu.gh		Mensah, Gwendolyn Patience/0000-0002-9943-1622				Amer Diabet Assoc, 2018, DIABETES CARE, V41, pS38, DOI 10.2337/dc18-S004; Andaya AA, 2011, J NUTR EDUC BEHAV, V43, P308, DOI 10.1016/j.jneb.2009.11.005; [Anonymous], 2017, 2016 ANN REP; Atlas D., 2015, IDF DIABETES ATLAS, V7th; Baliunas DO, 2009, DIABETES CARE, V32, P2123, DOI 10.2337/dc09-0227; Beck J, 2017, DIABETES EDUCATOR, V43, P449, DOI 10.1177/0145721717722968; Beck JK, 2015, FAM SYST HEALTH, V33, P28, DOI 10.1037/fsh0000101; Boucher Jackie L, 2017, Diabetes Spectr, V30, P72, DOI 10.2337/ds16-0074; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Burke SD, 2014, DIABET METAB SYND OB, V7, P45, DOI 10.2147/DMSO.S40036; Chen Wei, 2011, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V33, P253, DOI 10.3881/j.issn.1000-503X.2011.03.009; Cotton B, 2018, CALLS HALTELECTRONIC; Doherty ML, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1069; Ducrot P, 2017, INT J BEHAV NUTR PHY, V14, DOI 10.1186/s12966-017-0461-7; Dyson PA, 2011, DIABETIC MED, V28, P1282, DOI [10.1111/j.1464-5491.2011.03371.x, 10.1111/dme.13603]; Ekong G, 2016, PATIENT EDUC COUNS, V99, P944, DOI 10.1016/j.pec.2015.11.022; Evert AB, 2014, DIABETES CARE, V37, pS120, DOI 10.2337/dc14-S120; Ewers B, 2019, NUTRITION, V61, P49, DOI 10.1016/j.nut.2018.10.021; Gibney MJ, 2018, NUTRIENTS, V10, DOI 10.3390/nu10050559; Gray A., 2015, ENDOTEXT; Griffith DM, 2013, HEALTH PROMOT PRACT, V14, P181, DOI 10.1177/1524839912437789; IDF International Diabetes Federation, 2017, DIABETES ATLAS, V8th; Iqbal K, 2017, EUR J CLIN NUTR, V71, P1312, DOI 10.1038/ejcn.2017.116; Jaffar S, 2017, LANCET DIABETES ENDO, V5, P574, DOI 10.1016/S2213-8587(17)30219-X; Jakobsen ML, 2016, SCAND J PUBLIC HEALT, V44, P517, DOI 10.1177/1403494816645223; Kahleova H, 2014, DIABETOLOGIA, V57, P1552, DOI 10.1007/s00125-014-3253-5; Kamuhabwa AR, 2014, DRUG HEALTHC PATIENT, V6, P155, DOI 10.2147/DHPS.S68786; Levesque C, 2017, NURS CLIN N AM, V52, P679, DOI 10.1016/j.cnur.2017.07.012; Li YC, 2017, BIOMED ENVIRON SCI, V30, P863, DOI 10.3967/bes2017.117; Li ZJ, 2017, J DIABETES RES, V2017, DOI 10.1155/2017/8948452; Manne-Goehler J, 2016, LANCET DIABETES ENDO, V4, P903, DOI 10.1016/S2213-8587(16)30181-4; Mason M., 2010, FORUM QUAL SOC RES, V11; Miller ST, 2014, J OBES, V2014, DOI 10.1155/2014/345941; Peek ME, 2014, HEALTH PROMOT PRACT, V15, p40S, DOI 10.1177/1524839914532292; Raimi TH, 2014, AFR J DIABETES MED, V22, P9; Ruhee D, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0187-5; Sakai R, 2018, ENDOCR J, V65, P395, DOI 10.1507/endocrj.EJ17-0414; Sandhu SK, 2017, DIABETIC MED, V34, P539, DOI 10.1111/dme.13081; Sato-Mito N, 2011, SLEEP MED, V12, P289, DOI 10.1016/j.sleep.2010.09.012; Sorato MM, 2016, J DIABETES METAB, V7, DOI 10.4172/2155-6156.1000684; Spronk I, 2014, BRIT J NUTR, V111, P1713, DOI 10.1017/S0007114514000087; Uchenna O., 2010, INT J PSYCHOL BEHAV, V4, P2004; Ulrich PA, 2010, AM J NURS, V110, P62, DOI 10.1097/01.NAJ.0000383938.76085.00; Washi S, 2012, INT J MARKETING STUD, V4, P38, DOI DOI 10.5539/IJMS.V4N1P38; Yoshimura Y, 2012, GERIATR GERONTOL INT, V12, P29, DOI 10.1111/j.1447-0594.2011.00810.x; Zanchim MC, 2018, CIENC SAUDE COLETIVA, V23, P4199, DOI 10.1590/1413-812320182312.01412017	46	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265608	10.1371/journal.pone.0265608	http://dx.doi.org/10.1371/journal.pone.0265608			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320308	gold, Green Published			2022-12-26	WOS:000784240600018
J	Schonenberg, A; Prell, T				Schoenenberg, Aline; Prell, Tino			Measuring quality of life with the Parkinson's Disease Questionnaire-39 in people with cognitive impairment	PLOS ONE			English	Article							DEPRESSION; VALIDATION; MOCA	IntroductionQuality of life (QoL) is a key outcome in healthcare. However, whether cognitively impaired people with Parkinson's disease (PD) can reliably self-report QoL is unclear, and patients are often excluded from studies based on cognition test scores. The aim of this analysis was to assess the validity of the Parkinson's Disease Questionnaire-39 (PDQ-39) in PD patients with and without cognitive impairment. MethodsIn this study, 221 individuals with PD completed the PDQ-39, Montreal Cognitive Assessment (MOCA), and Beck's Depression Inventory (BDI-II). The PDQ-39's internal consistency, convergent validity with BDI-II, and floor and ceiling effects were analyzed for patients with and without cognitive impairment. ResultsNinety-four patients showed cognitive impairment (MOCA <21), whereas 127 patients had mild/no impairment. Both MOCA groups differed significantly with regards to PD severity. The PDQ-39's internal consistency was adequate for most subdomains in both MOCA groups, but floor effects were present for the subdomains Stigmatization, Social Support and Communication, regardless of impairment. For some subdomains, the PDQ-39's convergent validity with the BDI receded in the low MOCA group but remained significant for most PDQ-39 domains, especially for the PDQ total score (r = .386, p < .001) and for the subdomain emotional well-being (r = .446, p < .001). ConclusionThe PDQ-39 can be used to measure QoL in cognitively impaired PD patients, thus test scores indicating cognitive impairment alone should not lead to exclusion of PD patients from clinical studies. Although the correlation between BDI-II and PDQ-39 shrinks for some subdomains in cognitively impairment patients, this finding may be explained by the difference in PD severity, as factors influencing QoL may shift with increasing age and PD symptoms.	[Schoenenberg, Aline; Prell, Tino] Halle Univ Hosp, Dept Geriatr, Halle, Germany; [Prell, Tino] Jena Univ Hosp, Dept Neurol, Jena, Germany; [Prell, Tino] Jena Univ Hosp, Ctr Hlth Ageing, Jena, Germany	Martin Luther University Halle Wittenberg; Friedrich Schiller University of Jena; Friedrich Schiller University of Jena	Schonenberg, A (corresponding author), Halle Univ Hosp, Dept Geriatr, Halle, Germany.	aline.schoenenberg@uk-halle.de		Schonenberg, Aline/0000-0003-2913-9535	Bundesministerium fur Bildung und Forschung (BMBF) [01GY1804]	Bundesministerium fur Bildung und Forschung (BMBF)(Federal Ministry of Education & Research (BMBF))	We thank Eric Winter and Caroline Kamprath for their assistance in data acquisition.	Aarsland D, 2010, J NEUROL SCI, V289, P18, DOI 10.1016/j.jns.2009.08.034; Anthoine Emmanuelle, 2014, Health Qual Life Outcomes, V12, P176, DOI 10.1186/s12955-014-0176-2; Cui SS, 2017, BMC GERIATR, V17, DOI 10.1186/s12877-017-0666-2; Dalrymple-Alford JC, 2010, NEUROLOGY, V75, P1717, DOI 10.1212/WNL.0b013e3181fc29c9; Ettema TP, 2005, QUAL LIFE RES, V14, P675, DOI 10.1007/s11136-004-1258-0; Goetz CG, 2007, MOVEMENT DISORD, V22, P41, DOI 10.1002/mds.21198; Hagell Peter, 2009, Ther Adv Neurol Disord, V2, P205, DOI 10.1177/1756285609103726; Hughes LJ, 2021, INT PSYCHOGERIATR, V33, P917, DOI 10.1017/S1041610218002259; Jones JD, 2014, PARKINSONISM RELAT D, V20, P1236, DOI 10.1016/j.parkreldis.2014.09.014; Kassambara A, 2019, PIPE FRIENDLY FRAMEW; Landeiro F, 2020, ALZHEIMERS RES THER, V12, DOI 10.1186/s13195-020-00723-1; Lawson RA, 2014, PARKINSONISM RELAT D, V20, P1071, DOI 10.1016/j.parkreldis.2014.07.004; Leroi I, 2012, J GERIATR PSYCH NEUR, V25, P208, DOI 10.1177/0891988712464823; Martinez-Martin P, 2011, MOVEMENT DISORD, V26, P2371, DOI 10.1002/mds.23834; Nasreddine ZS, 2005, J AM GERIATR SOC, V53, P695, DOI 10.1111/j.1532-5415.2005.53221.x; Nicoletti A., 2019, FRONT AGING NEUROSCI, P11, DOI [10.3389/fnagi.2019.00011, DOI 10.3389/FNAGI.2019.00011]; Peto V, 1998, J NEUROL, V245, pS10, DOI 10.1007/PL00007730; Prinsen CAC, 2018, QUAL LIFE RES, V27, P1147, DOI 10.1007/s11136-018-1798-3; Romenets SR, 2012, PARKINSONISM RELAT D, V18, P54, DOI 10.1016/j.parkreldis.2011.08.013; Scholzel-Dorenbos CJM, 2007, INT J GERIATR PSYCH, V22, P511, DOI 10.1002/gps.1719; Schonenberg A, 2021, HEALTH QUAL LIFE OUT, V19, DOI 10.1186/s12955-021-01753-5; Slawek J, 2005, PARKINSONISM RELAT D, V11, P465, DOI 10.1016/j.parkreldis.2005.04.006; Visser M, 2006, MOVEMENT DISORD, V21, P668, DOI 10.1002/mds.20792; Zhao N, 2021, CNS NEUROSCI THER, V27, P270, DOI 10.1111/cns.13549	24	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0266140	10.1371/journal.pone.0266140	http://dx.doi.org/10.1371/journal.pone.0266140			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363801	Green Published, gold			2022-12-26	WOS:000804748600003
J	Takase, R; Boasen, J; Kuriki, S; Toyomura, A; Yokosawa, K				Takase, Ryoken; Boasen, Jared; Kuriki, Shinya; Toyomura, Akira; Yokosawa, Koichi			Processing time affects sequential memory performance beginning at the level of visual encoding	PLOS ONE			English	Article							SHORT-TERM-MEMORY; FRONTAL-MIDLINE THETA; WORKING-MEMORY; OSCILLATIONS; DYNAMICS; CORTEX; ALPHA; LOAD	Electrophysiological studies have demonstrated that theta-band activity is useful for investigating neural mechanisms of memory. However, mechanisms specifically driving memory performance remain poorly understood. In sequential memory, performance can be artificially attenuated by shortening the inter-stimulus interval (ISI) between memory item presentations. Therefore, we sought to clarify the mechanisms of sequential memory performance by analyzing theta-band (4-8 Hz) activity recorded via magnetoencephalogram in 33 participants during performance of a sequential memory task where memory items were presented at either slow or fast rates in accordance with longer or shorter ISIs, respectively. Particularly in the slow task, theta activity clearly modulated in accordance with the presentation of memory items. Common cortical target regions in the occipital and frontal cortex were identified in both tasks and related to visual encoding and memory maintenance, respectively. Compared to the slow task, occipital-theta activity was significantly lower in the fast task from the midterm until the ending of encoding, in correspondence with significantly lower recall for memory items in this same period. Meanwhile, despite a loss of clarity in responsiveness to individual memory items in the fast task, frontal-theta activity was not different between tasks and exhibited particularly strong responses in both tasks during the holding period prior to recall. Our results indicate that shorter processing time erodes sequential memory performance beginning at the level of visual encoding.	[Takase, Ryoken] Hokkaido Univ, Grad Sch Hlth Sci, Sapporo, Hokkaido, Japan; [Boasen, Jared; Kuriki, Shinya; Yokosawa, Koichi] Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan; [Boasen, Jared] HEC Montreal, Tech3Lab, Montreal, PQ, Canada; [Toyomura, Akira] Gunma Univ, Grad Sch Hlth Sci, Maebashi, Gunma, Japan	Hokkaido University; Hokkaido University; Universite de Montreal; HEC Montreal; Gunma University	Yokosawa, K (corresponding author), Hokkaido Univ, Fac Hlth Sci, Sapporo, Hokkaido, Japan.	yokosawa@med.hokudai.ac.jp			Japan Society for the Promotion of Science (JSPS) [JP16K01345, JP20H04496]; JSPS KAKENHI [19H04195]	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funding: KY was supported by Japan Society for the Promotion of Science (JSPS): https://www. jsps.go.jp/ under KAKENHI JP16K01345 and JP20H04496. AT was supported by JSPS KAKENHI 19H04195. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albers AM, 2013, CURR BIOL, V23, P1427, DOI 10.1016/j.cub.2013.05.065; Anna-Katharine B., 2013, LEARN MEMORY, V116, P693, DOI [10.1016/B978-0-444-53497-2.00055-3, DOI 10.1016/B978-0-444-53497-2.00055]; Bastiaansen M, 2003, CORTEX, V39, P967, DOI 10.1016/S0010-9452(08)70873-6; Boasen J, 2018, FRONT HUM NEUROSCI, V12, DOI 10.3389/fnhum.2018.00156; Calderone DJ, 2014, TRENDS COGN SCI, V18, P300, DOI 10.1016/j.tics.2014.02.005; Chou WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129019; Davelaar EJ, 2005, PSYCHOL REV, V112, P3, DOI 10.1037/0033-295X.112.1.3; Dugue L, 2015, J COGNITIVE NEUROSCI, V27, P945, DOI 10.1162/jocn_a_00755; Gevins A, 1997, CEREB CORTEX, V7, P374, DOI 10.1093/cercor/7.4.374; Giraud AL, 2012, NAT NEUROSCI, V15, P511, DOI 10.1038/nn.3063; Glanzer M., 1972, PSYCHOL LEARNING MOT, V5, P129, DOI [10.1016/S0079-7421(08)60441-7, DOI 10.1016/S0079-7421(08)60441-7]; Hasegawa R, 1998, J NEUROPHYSIOL, V79, P322, DOI 10.1152/jn.1998.79.1.322; Itthipuripat S, 2013, EXP BRAIN RES, V224, P255, DOI 10.1007/s00221-012-3305-3; Jensen O, 2002, EUR J NEUROSCI, V15, P1395, DOI 10.1046/j.1460-9568.2002.01975.x; Jiang YH, 2004, PSYCHON B REV, V11, P495, DOI 10.3758/BF03196601; Kaplan R, 2017, J COGNITIVE NEUROSCI, V29, P507, DOI 10.1162/jocn_a_01064; Kawasaki M, 2012, NEUROIMAGE, V59, P808, DOI 10.1016/j.neuroimage.2011.07.042; Kimura K, 2016, ADV BIOMED ENG, V5, P43, DOI 10.14326/abe.5.43; Klimesch W, 1999, BRAIN RES REV, V29, P169, DOI 10.1016/S0165-0173(98)00056-3; Klimesch W, 2008, BRAIN RES, V1235, P31, DOI 10.1016/j.brainres.2008.06.049; Kumar A, 2005, MEM COGNITION, V33, P488, DOI 10.3758/BF03193066; Lee TG, 2012, J NEUROSCI, V32, P15458, DOI 10.1523/JNEUROSCI.0627-12.2012; Maurer U, 2015, BRAIN TOPOGR, V28, P127, DOI 10.1007/s10548-014-0361-y; Missonnier P, 2007, NEUROSCIENCE, V150, P346, DOI 10.1016/j.neuroscience.2007.09.009; Mitchell DJ, 2008, PROG NEUROBIOL, V86, P156, DOI 10.1016/j.pneurobio.2008.09.005; Moran RJ, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00200; Muthukrishnan SP, 2020, BRAIN TOPOGR, V33, P75, DOI 10.1007/s10548-019-00739-3; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onton J, 2005, NEUROIMAGE, V27, P341, DOI 10.1016/j.neuroimage.2005.04.014; Parkkonen L., 2010, MEG INTRO METHODS, P65, DOI [10.1093/acprof:oso/9780195307238.001.0001, DOI 10.1093/ACPROF:OSO/9780195307238.001.0001]; Pavlov YG, 2022, PSYCHOPHYSIOLOGY, V59, DOI 10.1111/psyp.13735; Proskovec AL, 2019, NEUROIMAGE, V184, P256, DOI 10.1016/j.neuroimage.2018.09.022; Proskoyec AL, 2019, HUM BRAIN MAPP, V40, P3682, DOI 10.1002/hbm.24625; Raghavachari S, 2001, J NEUROSCI, V21, P3175, DOI 10.1523/JNEUROSCI.21-09-03175.2001; Riley MR, 2016, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00181; Roelfsema PR, 2016, ANNU REV VIS SCI, V2, P131, DOI 10.1146/annurev-vision-111815-114443; Sauseng P, 2004, NEUROSCI LETT, V354, P123, DOI 10.1016/j.neulet.2003.10.002; Schwartze M, 2020, INT J PSYCHOL, V55, P342, DOI 10.1002/ijop.12588; Siebenhuhner F, 2016, ELIFE, V5, DOI 10.7554/eLife.13451; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Takase R, 2019, IEEE ENG MED BIO, P1713, DOI 10.1109/EMBC.2019.8856816; Tseng PT, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-19096-x; von Lautz AH, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00576; Wianda E, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1263; Yokosawa K, 2016, IEEE ENG MED BIO, P4539, DOI 10.1109/EMBC.2016.7591737; Zakrzewska MZ, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00399	46	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265719	10.1371/journal.pone.0265719	http://dx.doi.org/10.1371/journal.pone.0265719			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320312	Green Published, gold			2022-12-26	WOS:000784240600035
J	van Helvoort, EM; Hodgins, D; Mastbergen, SC; Marijnissen, ACA; Kloppenburg, M; Blanco, FJ; Haugen, IK; Berenbaum, F; Lafeber, FPJG; Welsing, PMJ				van Helvoort, Eefje M.; Hodgins, D.; Mastbergen, Simon C.; Marijnissen, Anne C. A.; Kloppenburg, M.; Blanco, Fransisco J.; Haugen, Ida K.; Berenbaum, F.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.			GaitSmart motion analysis compared to commonly used function outcome measures in the IMI-APPROACH knee osteoarthritis cohort	PLOS ONE			English	Article							ASSESS PHYSICAL FUNCTION; PERFORMANCE-BASED TESTS; SCORE KOOS; HIP; INJURY; PEOPLE	BackgroundThere are multiple measures for assessment of physical function in knee osteoarthritis (OA), but each has its strengths and limitations. The GaitSmart (R) system, which uses inertial measurement units (IMUs), might be a user-friendly and objective method to assess function. This study evaluates the validity and responsiveness of GaitSmart (R) motion analysis as a function measurement in knee OA and compares this to Knee Injury and Osteoarthritis Outcome Score (KOOS), Short Form 36 Health Survey (SF-36), 30s chair stand test, and 40m self-paced walk test. MethodsThe 2-year Innovative Medicines Initiative-Applied Public-Private Research enabling OsteoArthritis Clinical Headway (IMI-APPROACH) knee OA cohort was conducted between January 2018 and April 2021. For this study, available baseline and 6 months follow-up data (n = 262) was used. Principal component analysis was used to investigate whether above mentioned function instruments could represent one or more function domains. Subsequently, linear regression was used to explore the association between GaitSmart (R) parameters and those function domains. In addition, standardized response means, effect sizes and t-tests were calculated to evaluate the ability of GaitSmart (R) to differentiate between good and poor general health (based on SF-36). Lastly, the responsiveness of GaitSmart (R) to detect changes in function was determined. ResultsKOOS, SF-36, 30s chair test and 40m self-paced walk test were first combined into one function domain (total function). Thereafter, two function domains were substracted related to either performance based (objective function) or self-reported (subjective function) function. Linear regression resulted in the highest R-2 for the total function domain: 0.314 (R-2 for objective and subjective function were 0.252 and 0.142, respectively.). Furthermore, GaitSmart (R) was able to distinguish a difference in general health status, and is responsive to changes in the different aspects of objective function (Standardized response mean (SRMs) up to 0.74). ConclusionGaitSmart (R) analysis can reflect performance based and self-reported function and may be of value in the evaluation of function in knee OA. Future studies are warranted to validate whether GaitSmart (R) can be used as clinical outcome measure in OA research and clinical practice.	[van Helvoort, Eefje M.; Mastbergen, Simon C.; Marijnissen, Anne C. A.; Lafeber, Floris P. J. G.; Welsing, Paco M. J.] Univ Utrecht, Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands; [Hodgins, D.] Dynam Metr Ltd, Codicote, England; [Kloppenburg, M.] Leiden Univ, Dept Rheumatol, Med Ctr, Leiden, Netherlands; [Kloppenburg, M.] Leiden Univ, Dept Clin Epidemiol, Med Ctr, Leiden, Netherlands; [Blanco, Fransisco J.] Univ A Coruna, Hosp Univ A Coruna, Dept Fisioterapia Med & Ciencias Biomed,INIBIC, Serv Reumatol,Grp Invest Reumatol,Agrupac CICA IN, La Coruna, Spain; [Haugen, Ida K.] Diakonhjemmet Hosp, Dept Rheumatol, Oslo, Norway; [Berenbaum, F.] Sorbonne Univ, Hop St Antoine, APHP, INSERM, Paris, France	Utrecht University; Utrecht University Medical Center; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Complejo Hospitalario Universitario A Coruna; Universidade da Coruna; Instituto de Investigacion Biomedica de A Coruna (INIBIC); Diakonhjemmet Hospital; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	van Helvoort, EM (corresponding author), Univ Utrecht, Univ Med Ctr Utrecht, Dept Rheumatol & Clin Immunol, Utrecht, Netherlands.	E.M.vanHelvoort-3@umcutrecht.nl	Blanco, Francisco J./C-3192-2014	Blanco, Francisco J./0000-0001-9821-7635	Innovative Medicines Initiative Joint Undertaking from the European Union [115770]; Dutch Arthritis Society; EFPIA companies	Innovative Medicines Initiative Joint Undertaking from the European Union; Dutch Arthritis Society; EFPIA companies	The research leading to these results have received support from the Innovative Medicines Initiative Joint Undertaking under Grant Agreement n degrees 115770, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies' in kind contribution. See www.imi.europa.eu and www.approachproject.eu.SM and FL are supported by the Dutch Arthritis Society This communication reflects the views of the authors and neither IMI nor the European Union and EFPIA are liable for any use that may be made of the information contained herein. See www.approachproject.	ALTMAN R, 1986, ARTHRITIS RHEUM, V29, P1039, DOI 10.1002/art.1780290816; Angst F, 2018, RMD OPEN, V4, DOI 10.1136/rmdopen-2018-000685; Baczkowicz D, 2018, KNEE, V25, P888, DOI 10.1016/j.knee.2018.06.004; Biggs PR, 2019, GAIT POSTURE, V70, P65, DOI 10.1016/j.gaitpost.2019.02.028; Bolink SAAN, 2016, CLIN BIOMECH, V32, P171, DOI 10.1016/j.clinbiomech.2015.11.014; Collins NJ, 2016, OSTEOARTHR CARTILAGE, V24, P1317, DOI 10.1016/j.joca.2016.03.010; Dobson F, 2017, OSTEOARTHR CARTILAGE, V25, P1792, DOI 10.1016/j.joca.2017.06.006; Dobson F, 2013, OSTEOARTHR CARTILAGE, V21, P1042, DOI 10.1016/j.joca.2013.05.002; Dobson F, 2012, OSTEOARTHR CARTILAGE, V20, P1548, DOI 10.1016/j.joca.2012.08.015; Hodgins D., 2020, RHEUMATOLOGY; Jordan KP, 2009, CURR OPIN RHEUMATOL, V21, P525, DOI 10.1097/BOR.0b013e32832e45fc; McCarthy I., 2015, PHYS MED REHABIL INT, V2, P1073; Mizner RL, 2011, J ARTHROPLASTY, V26, P728, DOI 10.1016/j.arth.2010.06.004; Monde M, 2015, J AGING PHYS ACTIV, V23, P18, DOI [10.1123/JAPA.2012-0328, 10.1123/japa.2012-0328]; Reiman MP, 2011, J MAN MANIP THER, V19, P91, DOI 10.1179/106698111X12973307659546; Roos EM, 1998, J ORTHOP SPORT PHYS, V28, P88, DOI 10.2519/jospt.1998.28.2.88; Stevens-Lapsley JE, 2011, PM&R, V3, P541, DOI 10.1016/j.pmrj.2011.03.002; Stratford PW, 2006, J CLIN EPIDEMIOL, V59, P160, DOI 10.1016/j.jclinepi.2005.07.012; Terwee CB, 2006, J CLIN EPIDEMIOL, V59, P724, DOI 10.1016/j.jclinepi.2005.11.019; Tolk JJ, 2019, KNEE SURG SPORT TR A, V27, P2898, DOI 10.1007/s00167-017-4789-y; van Helvoort EM, 2020, BMJ OPEN, V10, DOI 10.1136/bmjopen-2019-035101; Ware J., 1993, SF 36 HLTH SURVEY MA; Ware JE, 2000, SPINE, V25, P3130, DOI 10.1097/00007632-200012150-00008; Widera P, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64643-8; Wright Alexis A., 2011, Physiotherapy Theory and Practice, V27, P253, DOI 10.3109/09593985.2010.491150; Zugner R, 2019, BMC MUSCULOSKEL DIS, V20, DOI 10.1186/s12891-019-2416-4	26	0	0	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265883	10.1371/journal.pone.0265883	http://dx.doi.org/10.1371/journal.pone.0265883			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320321	Green Published, gold			2022-12-26	WOS:000784240600026
J	Yang, MK; Sa, HS; Kim, N; Kim, JH; Choung, H; Khwarg, SI				Yang, Min Kyu; Sa, Ho-Seok; Kim, Namju; Kim, Jeong Hun; Choung, Hokyung; Khwarg, Sang In			Bony nasolacrimal duct size and outcomes of nasolacrimal silicone intubation for incomplete primary acquired nasolacrimal duct obstruction	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; REPRODUCIBILITY; DILATION; AGE; CT	PurposeTo investigate the association between the bony nasolacrimal duct (NLD) size and outcomes of nasolacrimal silicone intubation for incomplete primary acquired nasolacrimal duct obstruction (PANDO). MethodsPatients who underwent silicone intubation for incomplete PANDO and had undergone facial computed tomography (CT) were included. Surgical success was judged by both epiphora improvement and normalized tear meniscus height (TMH; < 300 mu m) on anterior segment optical coherence tomography at 3 months after tube removal. The area, major axis diameter, and minor axis diameter of the elliptic bony NLD sections were measured in 1.0 mm-thick axial CT images. These bony NLD sizes were analyzed for associations with surgical success and TMH normalization. ResultsEighty-one eyes of 48 patients were investigated. The smallest area and the smallest minor axis diameter were significantly larger in the success group (49 eyes), compared with those in the failure group (median smallest minor axis diameter: 4.7 mm vs. 3.8 mm, P = 0.008, Mann-Whitney U test). There was also a tendency for the TMH normalization rate to significantly increase as the smallest area and the smallest minor axis diameter increased (P = 0.028 and 0.037, respectively, Fisher's 2 x 4 tests). Under multivariable logistic regression analysis using generalized estimating equation, a larger smallest minor axis diameter was associated with success of the nasolacrimal silicone intubation (odds ratio: 2.481, 95% confidence interval: 1.143-5.384). ConclusionSurgical success of the nasolacrimal silicone intubation in incomplete PANDO is associated with a larger smallest minor axis diameter of the bony NLD. This finding will help understand the pathophysiology of surgical failure after nasolacrimal silicone intubation.	[Yang, Min Kyu; Sa, Ho-Seok] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Ophthalmol, Seoul, South Korea; [Kim, Namju] Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Seongnam, South Korea; [Kim, Jeong Hun; Khwarg, Sang In] Seoul Natl Univ, Seoul Natl Univ Hosp, Coll Med, Dept Ophthalmol, Seoul, South Korea; [Choung, Hokyung] Seoul Natl Univ, Seoul Metropolitan Govt, Boramae Med Ctr, Dept Ophthalmol, Seoul, South Korea	University of Ulsan; Asan Medical Center; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University Hospital	Kim, N (corresponding author), Seoul Natl Univ, Coll Med, Bundang Hosp, Dept Ophthalmol, Seongnam, South Korea.	resourceful@hanmail.net		Kim, Jeong Hun/0000-0003-2957-1766				Ali MJ, 2019, OPHTHAL PLAST RECONS, V35, P426, DOI 10.1097/IOP.0000000000001310; Baek Ji Sun, 2016, Korean J Ophthalmol, V30, P157, DOI 10.3341/kjo.2016.30.3.157; Bitton E, 2007, OPTOMETRY VISION SCI, V84, P903, DOI 10.1097/OPX.0b013e3181560ba8; Canan H, 2014, CURR EYE RES, V39, P1145, DOI 10.3109/02713683.2014.898311; Clark RA, 2002, J AAPOS, V6, P364, DOI 10.1067/mpa.2002.128210; Connell PP, 2006, BRIT J OPHTHALMOL, V90, P435, DOI 10.1136/bjo.2005.084590; Couch SM, 2004, OPHTHALMOLOGY, V111, P585, DOI 10.1016/j.ophtha.2003.06.013; DRESNER SC, 1984, AM J OPHTHALMOL, V98, P609, DOI 10.1016/0002-9394(84)90247-2; Fayet B., 1997, ORBIT-ABINGDON, V16, P99, DOI [10.3109/01676839709019124, DOI 10.3109/01676839709019124]; Groell R, 1997, SURG RADIOL ANAT, V19, P189, DOI 10.1007/BF01627974; Janssen AG, 2001, AM J NEURORADIOL, V22, P845; Kim CY, 2019, BMC CANCER, V19, DOI 10.1186/s12885-019-5986-5; Lee H, 2012, OPHTHALMOLOGICA, V227, P153, DOI 10.1159/000331986; 박종서, 2011, [Journal of The Korean Ophthalmological Society, 대한안과학회지], V52, P129; LINBERG JV, 1986, OPHTHALMOLOGY, V93, P1055; Mimura M, 2016, JPN J OPHTHALMOL, V60, P280, DOI 10.1007/s10384-016-0446-0; MUNK PL, 1990, RADIOLOGY, V177, P687, DOI 10.1148/radiology.177.3.2243969; Papathanassiou S, 2019, LARYNGOSCOPE INVEST, V4, P393, DOI 10.1002/lio2.293; Park DI, 2012, ACTA OPHTHALMOL, V90, P783, DOI 10.1111/j.1755-3768.2011.02183.x; Ramey NA, 2013, OPHTHAL PLAST RECONS, V29, P475, DOI 10.1097/IOP.0b013e3182a230b0; Shen MX, 2008, AM J OPHTHALMOL, V145, P801, DOI 10.1016/j.ajo.2007.12.024; Shigeta K, 2007, ARCH OPHTHALMOL-CHIC, V125, P1677, DOI 10.1001/archopht.125.12.1677; Takahashi Y, 2014, OPHTHAL PLAST RECONS, V30, P434, DOI 10.1097/IOP.0000000000000238; Takahashi Y, 2013, OPHTHAL PLAST RECONS, V29, P318, DOI 10.1097/IOP.0b013e31828de0b0; Yang MK, 2019, GRAEF ARCH CLIN EXP, V257, P2315, DOI 10.1007/s00417-019-04392-1; Ye L, 2015, GENET MOL RES, V14, P7929, DOI 10.4238/2015.July.14.19; Zhou S, 2009, OPHTHAL SURG LAS IM, V40, P442, DOI 10.3928/15428877-20090901-01	27	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266040	10.1371/journal.pone.0266040	http://dx.doi.org/10.1371/journal.pone.0266040			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0V0SA	35344555	gold, Green Published			2022-12-26	WOS:000788055200005
J	Zhang, YH; Tanner, NA				Zhang, Yinhua; Tanner, Nathan A.			Improving RT-LAMP detection of SARS-CoV-2 RNA through primer set selection and combination	PLOS ONE			English	Article							MEDIATED ISOTHERMAL AMPLIFICATION	Reverse transcription loop-mediated isothermal amplification (RT-LAMP) has emerged as a viable molecular diagnostic method to expand the breadth and reach of nucleic acid testing, particularly for SARS-CoV-2 detection and surveillance. While rapidly growing in prominence, RT-LAMP remains a relatively new method compared to the standard RT-qPCR, and contribution to our body of knowledge on designing LAMP primer sets and assays can have significant impact on its utility and adoption. Here we select and evaluate 18 LAMP primer sets for SARS-CoV-2 previously identified as sensitive ones under various conditions, comparing their speed and sensitivity with two LAMP formulations each with 2 reaction temperatures. We find that both LAMP formulations have some effects on the speed and detection sensitivity and identify several primer sets with similar high sensitivity for different SARS-CoV-2 gene targets. Significantly we observe a consistent sensitivity enhancement by combining primer sets for different targets, confirming and building on earlier work to create a simple, general approach to building better and more sensitive RT-LAMP assays.	[Zhang, Yinhua; Tanner, Nathan A.] New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA	New England Biolabs	Tanner, NA (corresponding author), New England Biolabs Inc, Res Dept, Ipswich, MA 01938 USA.	tanner@neb.com		Tanner, Nathan/0000-0001-7601-7077				Baek YH, 2020, EMERG MICROBES INFEC, V9, P998, DOI 10.1080/22221751.2020.1756698; Broughton JP, 2020, NAT BIOTECHNOL, V38, P870, DOI 10.1038/s41587-020-0513-4; Dong YJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-020-80314-0; F.Pei, 2020, medRxiv, DOI 10.1101/2020.03.02.20030130; Heithoff DM, 2022, JAMA NETW OPEN, V5, DOI 10.1001/jamanetworkopen.2021.45669; Huang WE, 2020, MICROB BIOTECHNOL, V13, P950, DOI 10.1111/1751-7915.13586; Huang X, 2022, EBIOMEDICINE, V75, DOI 10.1016/j.ebiom.2021.103736; Janikova M, 2021, MICROB BIOTECHNOL, V14, P307, DOI 10.1111/1751-7915.13737; Jiang MH, 2020, FRONT CELL INFECT MI, V10, DOI 10.3389/fcimb.2020.00331; Joung J, 2020, NEW ENGL J MED, V383, P1492, DOI 10.1056/NEJMc2026172; Kundrod KA, 2022, PLOS ONE, V17, DOI 10.1371/journal.pone.0264130; Lamb LE, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0234682; Lau YL, 2020, AM J TROP MED HYG, V103, P2350, DOI 10.4269/ajtmh.20-1079; Local Government Association, 2020, COUNC WORKB HLTH ALL; Lu RF, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21082826; Meagher RJ, 2018, ANALYST, V143, P1924, DOI 10.1039/c7an01897e; Park GS, 2020, J MOL DIAGN, V22, P729, DOI 10.1016/j.jmoldx.2020.03.006; Quino W, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-03623-y; Rabe BA, 2020, P NATL ACAD SCI USA, V117, P24450, DOI 10.1073/pnas.2011221117; Thompson D, 2020, SENSOR ACTUATOR REP, V2, DOI 10.1016/j.snr.2020.100017; U.S. Food & Drug Association, 2020, COVID 19 DEV DRUGS B; Yan C, 2020, CLIN MICROBIOL INFEC, V26, P773, DOI 10.1016/j.cmi.2020.04.001; Zhang Y., 2020, RAPID MOL DETECTION, V2, P1, DOI [10.1101/2020.02.26.20028373, DOI 10.1101/2020.02.26.20028373]; Zhang Yinhua, 2020, Biotechniques, V69, P178, DOI 10.2144/btn-2020-0078	24	0	0	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0254324	10.1371/journal.pone.0254324	http://dx.doi.org/10.1371/journal.pone.0254324			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363770	Green Published, gold, Green Submitted			2022-12-26	WOS:000804748600014
J	Dasgupta, S; Saha, A; Ganguly, N; Bhuniya, A; Dhar, S; Guha, I; Ghosh, T; Sarkar, A; Ghosh, S; Roy, K; Das, T; Banerjee, S; Pal, C; Baral, R; Bose, A				Dasgupta, Shayani; Saha, Akata; Ganguly, Nilanjan; Bhuniya, Avishek; Dhar, Sukanya; Guha, Ipsita; Ghosh, Tithi; Sarkar, Anirban; Ghosh, Sarbari; Roy, Kamalika; Das, Tapasi; Banerjee, Saptak; Pal, Chiranjib; Baral, Rathindranath; Bose, Anamika			NLGP regulates RGS5-TGF beta axis to promote pericyte-dependent vascular normalization during restricted tumor growth	FASEB JOURNAL			English	Article						apoptosis; endothelial cells; pericytes; RGS5; TGF beta; tumor-microenvironment	T-CELLS; SUPPRESSION; EXPRESSION	Altered RGS5-associated intracellular pericyte signaling and its abnormal crosstalk with endothelial cells (ECs) result chaotic tumor-vasculature, prevent effective drug delivery, promote immune-evasion and many more to ensure ultimate tumor progression. Moreover, the frequency of lethal-RGS5(high) pericytes within tumor was found to increase with disease progression, which signifies the presence of altered cell death pathway within tumor microenvironment (TME). In this study, we checked whether and how neem leaf glycoprotein (NLGP)-immunotherapy-mediated tumor growth restriction is associated with modification of pericytes' signaling, functions and its interaction with ECs. Analysis of pericytes isolated from tumors of NLGP treated mice suggested that NLGP treatment promotes apoptosis of NG2(+)RGS5(high) -fuctionally altered pericytes by downregulating intra-tumoral TGF beta along with maintenance of more matured RGS5(neg) pericytes. NLGP-mediated inhibition of TGE beta within THE rescues binding of RGS5 with Gal and thereby termination of PI3K-AKT mediated survival signaling by downregulating Bcl2 and initiating pJNK mediated apoptosis. Limited availability of TGFP also prevents complex-formation between RGS5 and Smad2 and rapid RGS5 nuclear translocation to mitigate alternate immunoregulatory functions of RGS5(high) tumor-pericytes. We also observed binding of Ang1 from pericytes with Tie2 on ECs in NLGP-treated tumor, which support re-association of pericytes with endothelium and subsequent vessel stabilization. Furthermore, NLGP-therapy- associated RGS5 deficiency relieved CD4(+) and CD8(+) T cells from anergy by regulating 'alternate-APC-like' immunomodulatory characters of tumor-pericytes. Taken together, present study described the mechanisms of NLGP's effectiveness in normalizing tumor-vasculature by chiefly modulating pericyte-biology and EC-pericyte interactions in tumor-host to further strengthen its translational potential as single modality treatment.	[Dasgupta, Shayani; Saha, Akata; Ganguly, Nilanjan; Bhuniya, Avishek; Dhar, Sukanya; Guha, Ipsita; Ghosh, Tithi; Sarkar, Anirban; Ghosh, Sarbari; Das, Tapasi; Banerjee, Saptak; Baral, Rathindranath; Bose, Anamika] Chittaranjan Natl Canc Inst, Dept Immunoregulat & Immunodiagnost, Kolkata, India; [Roy, Kamalika; Pal, Chiranjib] West Bengal State Univ, Dept Zool, Cellular Immunol & Expt Therapeut Lab, Barasat, India	West Bengal State University	Bose, A (corresponding author), Chittaranjan Natl Canc Inst CNCI, Dept Immunoregulat & Immunodiagnost, 37 SP Mukherjee Rd, Kolkata 700026, India.	anamikabose2@gmail.com	Banerjee, Dr Saptak/HDO-6987-2022	Banerjee, Dr Saptak/0000-0001-9211-2074; Bhuniya, Avishek/0000-0001-6253-0400; Pal, Chiranjib/0000-0002-0724-5292; Ganguly, Nilanjan/0000-0002-7260-1601	Department of Science and Technology, Government of India, New Delhi [SB/YS/LS-289/2013, SR/WOS-A/LS-152/2017]; Indian Council of Medical Research, New Delhi, India [2019-6410/CMB-BMS]; ICMR [61/1/2018-BMS]; DHR [R-12013/05/2018/HR]	Department of Science and Technology, Government of India, New Delhi(Department of Science & Technology (India)); Indian Council of Medical Research, New Delhi, India(Indian Council of Medical Research (ICMR)); ICMR(Indian Council of Medical Research (ICMR)); DHR	In addition to institutional support, this study was supported by Department of Science and Technology, Government of India, New Delhi; Awards to AB, Grant number: SB/YS/LS-289/2013 and SR/WOS-A/LS-152/2017, Indian Council of Medical Research, New Delhi, India (F. No-2019-6410/CMB-BMS), ICMR grant no. 61/1/2018-BMS and DHR (File no. R-12013/05/2018/HR). These funding agencies had no role in study design, data collection and analysis, decision to publish, or the preparation of this manuscript. Funding includes fellowship to scholars and cost of reagents only	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Augustin HG, 2009, NAT REV MOL CELL BIO, V10, P165, DOI 10.1038/nrm2639; Banerjee S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110040; Barik S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066501; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bhuniya A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00201; Bose A, 2013, J IMMUNOL, V191, P971, DOI 10.4049/jimmunol.1300280; Bose A, 2009, J IMMUNOTHER, V32, P42, DOI 10.1097/CJI.0b013e31818e997d; Chakraborty T, 2012, INT IMMUNOPHARMACOL, V12, P326, DOI 10.1016/j.intimp.2011.12.002; Coffelt SB, 2010, CANCER RES, V70, P5270, DOI 10.1158/0008-5472.CAN-10-0012; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Das A, 2014, J IMMUNOTHER, V37, P394, DOI 10.1097/CJI.0000000000000050; Dasgupta S, 2021, CELL DEATH DIFFER, V28, P3052, DOI 10.1038/s41418-021-00801-3; Ghosh S, 2016, IMMUNOL LETT, V175, P31, DOI 10.1016/j.imlet.2016.05.004; Ghosh T, 2019, STEM CELL RES THER, V10, DOI 10.1186/s13287-019-1349-z; Goswami KK, 2014, MOL IMMUNOL, V59, P119, DOI 10.1016/j.molimm.2014.01.015; Goswami KK, 2016, MOL IMMUNOL, V80, P1, DOI [10.1016/j.molimm.2016.10.008, 10.1016/j,molimm.2016.10.008]; Goswami S, 2010, VACCINE, V28, P1241, DOI 10.1016/j.vaccine.2009.11.018; Hamzah J, 2008, NATURE, V453, P410, DOI 10.1038/nature06868; Hao F, 2014, BBA-REV CANCER, V1846, P247, DOI 10.1016/j.bbcan.2014.07.002; Huang YH, 2013, CANCER RES, V73, P2943, DOI 10.1158/0008-5472.CAN-12-4354; Jain RK, 2001, NAT MED, V7, P987, DOI 10.1038/nm0901-987; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Mallick A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0047434; Manzur M, 2008, CELL CYCLE, V7, P2452, DOI 10.4161/cc.7.16.6451; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Neves KB, 2020, CLIN SCI, V134, P2503, DOI 10.1042/CS20200308; Pichiule P, 2004, J BIOL CHEM, V279, P12171, DOI 10.1074/jbc.M305146200; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Roy S, 2013, HUM IMMUNOL, V74, P1015, DOI 10.1016/j.humimm.2013.04.022; Roy S, 2011, CLIN VACCINE IMMUNOL, V18, P571, DOI 10.1128/CVI.00499-10; Saha A, 2020, FRONT ONCOL, V10, DOI 10.3389/fonc.2020.00260; Sarkar K, 2008, VACCINE, V26, P4352, DOI 10.1016/j.vaccine.2008.06.048; Sarkar M, 2021, MELANOMA RES, V31, P130, DOI 10.1097/CMR.0000000000000721; Sarkar M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175540; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silini A, 2012, CELL MOL LIFE SCI, V69, P1167, DOI 10.1007/s00018-011-0862-8; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Thijssen VLJL, 2018, J PATHOL, V246, P447, DOI 10.1002/path.5152; Tian L, 2017, NATURE, V544, P250, DOI 10.1038/nature21724; Tsioumpekou M, 2020, THERANOSTICS, V10, P1122, DOI 10.7150/thno.37851; Zhao X, 2011, MOL THER, V19, P805, DOI 10.1038/mt.2010.295; Zonneville J, 2018, BMC CANCER, V18, DOI 10.1186/s12885-018-4587-z	45	0	0	2	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22268	10.1096/fj.202101093R	http://dx.doi.org/10.1096/fj.202101093R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0E5BA	35363396				2022-12-26	WOS:000776695700001
J	Jurkowitz, MS; Azad, A; Monsma, PC; Keiser, TL; Kanyo, J; Lam, TT; Bell, CE; Schlesinger, LS				Jurkowitz, Marianne S.; Azad, Abul K.; Monsma, Paula C.; Keiser, Tracy L.; Kanyo, Jean; Lam, TuKiet T.; Bell, Charles E.; Schlesinger, Larry S.			Mycobacterium tuberculosis encodes a YhhN family membrane protein with lysoplasmalogenase activity that protects against toxic host lysolipids	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ARACHIDONIC-ACID; PHOSPHOLIPASE A(2); LEGIONELLA-PNEUMOPHILA; L-FORMS; PLASMALOGEN; MACROPHAGES; BACTERIA; BIOSYNTHESIS; PURIFICATION; METABOLISM	The pathogen Mycobacterium tuberculosis (M.tb) resides in human macrophages, wherein it exploits host lipids for sur-vival. However, little is known about the interaction between M.tb and macrophage plasmalogens, a subclass of glycer-ophospholipids with a vinyl ether bond at the sn-1 position of the glycerol backbone. Lysoplasmalogens, produced from plasmalogens by hydrolysis at the sn-2 carbon by phospholi-pase A(2), are potentially toxic but can be broken down by host lysoplasmalogenase, an integral membrane protein of the YhhN family that hydrolyzes the vinyl ether bond to release a fatty aldehyde and glycerophospho-ethanolamine or glycerophospho-choline. Curiously, M.tb encodes its own YhhN protein (MtbYhhN), despite having no endogenous plasmalogens. To understand the purpose of this protein, the gene for MtbYhhN (Rv1401) was cloned and expressed in Mycobacterium smegmatis (M.smeg). We found the partially purified protein exhibited abundant lysoplasmalogenase activ-ity specific for lysoplasmenylethanolamine or lysoplasme- nylcholine (pLPC) (V-max similar to 15.5 mu mol/min/mg; km similar to 83 mu M). Based on cell density, we determined that lysoplasmenyletha-nolamine, pLPC, lysophosphatidylcholine, and lysophosphati-dylethanolamine were not toxic to M.smeg cells, but pLPC and LPC were highly toxic to M.smeg spheroplasts, which are cell wall-deficient mycobacterial forms. Importantly, spheroplasts prepared from M.smeg cells overexpressing MtbYhhN were protected from membrane disruption/lysis by pLPC, which was rapidly depleted from the media. Finally, we found that over-expression of full-length MtbYhhN in M.smeg increased its survival within human macrophages by 2.6-fold compared to vector controls. These data support the hypothesis that MtbYhhN protein confers a growth advantage for mycobacteria in macrophages by cleaving toxic host pLPC into potentially energy-producing products.	[Jurkowitz, Marianne S.; Bell, Charles E.] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA; [Azad, Abul K.; Schlesinger, Larry S.] Texas Biomed Res Inst, Host Pathogen Interact Program, San Antonio, TX 78227 USA; [Monsma, Paula C.] Ohio State Univ, Dept Neurosci, Columbus, OH 43210 USA; [Keiser, Tracy L.] Vrije Univ, Dept Mol Microbiol, Amsterdam, Netherlands; [Kanyo, Jean; Lam, TuKiet T.] Yale Univ, Keck MS & Prote Resource, New Haven, CT USA; [Lam, TuKiet T.] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT USA; [Bell, Charles E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Texas Biomedical Research Institute; University System of Ohio; Ohio State University; Vrije Universiteit Amsterdam; Yale University; Yale University; University System of Ohio; Ohio State University	Jurkowitz, MS (corresponding author), Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA.; Schlesinger, LS (corresponding author), Texas Biomed Res Inst, Host Pathogen Interact Program, San Antonio, TX 78227 USA.	jurkowitz.1@osu.edu; lschlesinger@txbiomed.org			Ohio State University Development fund Grant [306500]; NIH [SIG RR031795];  [AI059639];  [P30NS104177];  [S10 OD010383]	Ohio State University Development fund Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ; ; 	This work was supported in part by AI059639 (L. S. S.) and by the Ohio State University Development fund Grant 306500 (from Daniel S. and Amy E. F. Jurkowitz) (to M. S. J.) and grants P30NS104177 (Anthony Brown, PI) and S10 OD010383 (Anthony Brown, PI) that supported the confocal microscopy. The LTQ-Orbitrap Elite located at the Keck Mass Spectrometry (MS) & Proteomics Resource at Yale University School of Medicine was funded by NIH SIG RR031795. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Astudillo AM, 2012, BBA-MOL CELL BIOL L, V1821, P249, DOI 10.1016/j.bbalip.2011.11.006; Barisch C, 2017, BIOCHIMIE, V141, P54, DOI 10.1016/j.biochi.2017.06.001; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333; Brites P, 2004, BBA-MOL CELL BIOL L, V1636, P219, DOI 10.1016/j.bbalip.2003.12.010; CLEMENS DL, 1995, J EXP MED, V181, P257, DOI 10.1084/jem.181.1.257; Cook Gregory M, 2014, Microbiol Spectr, V2, DOI 10.1128/microbiolspec.MGM2-0015-2013; CORR PB, 1984, CIRC RES, V55, P135, DOI 10.1161/01.RES.55.2.135; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Domingue GJ, 2010, DISCOV MED, V10, P234; Duan L, 2001, J IMMUNOL, V166, P7469, DOI 10.4049/jimmunol.166.12.7469; Flieger A, 2002, INFECT IMMUN, V70, P6094, DOI 10.1128/IAI.70.11.6094-6106.2002; FORD DA, 1989, P NATL ACAD SCI USA, V86, P3479, DOI 10.1073/pnas.86.10.3479; Fozo EM, 2016, ADV MICROB PHYSIOL, V69, P51, DOI [10.4161/GMIC.25721, 10.1016/bs.ampbs.2016.07.001]; FREEMAN BA, 1980, BIOCHIM BIOPHYS ACTA, V620, P528, DOI 10.1016/0005-2760(80)90145-9; Gaposchkin DP, 2008, BBA-MOL CELL BIOL L, V1781, P213, DOI 10.1016/j.bbalip.2008.01.007; GARBE TR, 1994, MICROBIOL-SGM, V140, P133, DOI 10.1099/13500872-140-1-133; Gil-de-Gomez L, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01251; Goldfine H, 2010, PROG LIPID RES, V49, P493, DOI 10.1016/j.plipres.2010.07.003; GOTTFRIED EL, 1963, J LIPID RES, V4, P57; GROSS RW, 1984, BIOCHEMISTRY-US, V23, P158, DOI 10.1021/bi00296a026; Guirado E, 2013, SEMIN IMMUNOPATHOL, V35, P563, DOI 10.1007/s00281-013-0388-2; Guirado E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00098; GUNAWAN J, 1981, H-S Z PHYSIOL CHEM, V362, P445, DOI 10.1515/bchm2.1981.362.1.445; HARWICK HJ, 1972, INFECT IMMUN, V5, P976, DOI 10.1128/IAI.5.6.976-981.1972; HARWICK HJ, 1977, AUST J EXP BIOL MED, V55, P431, DOI 10.1038/icb.1977.41; Jenkins CM, 2018, J BIOL CHEM, V293, P8693, DOI 10.1074/jbc.RA117.001629; Jurkowitz MS, 2015, BBA-BIOMEMBRANES, V1848, P742, DOI 10.1016/j.bbamem.2014.11.011; Jurkowitz MS, 1999, BBA-MOL CELL BIOL L, V1437, P142, DOI 10.1016/S1388-1981(99)00013-X; JURKOWITZALEXANDER M, 1989, BIOCHIM BIOPHYS ACTA, V1002, P203, DOI 10.1016/0005-2760(89)90288-9; JURKOWITZALEXANDER MS, 1991, METHOD ENZYMOL, V197, P79; KANETSUNA F, 1985, MICROBIOL IMMUNOL, V29, P127, DOI 10.1111/j.1348-0421.1985.tb00811.x; Keiser TL, 2011, INFECT IMMUN, V79, P4668, DOI 10.1128/IAI.05635-11; KONDO E, 1982, JPN J MED SCI BIOL, V35, P197, DOI 10.7883/yoken1952.35.197; KRAMER RM, 1983, J BIOL CHEM, V258, P3806; Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin YB, 2018, J BIOL CHEM, V293, P3386, DOI 10.1074/jbc.RA117.001231; Lovewell RR, 2016, CURR OPIN MICROBIOL, V29, P30, DOI 10.1016/j.mib.2015.10.002; Maitra A, 2019, FEMS MICROBIOL REV, V43, P548, DOI 10.1093/femsre/fuz016; MARDH PA, 1974, ACTA PATH MICRO IM B, VB 82, P748; Markova N, 2015, HUM VACC IMMUNOTHER, V11, P1192, DOI 10.1080/21645515.2015.1016682; Mattman L., 2001, CELL WALL DEFICIENT; Michailova L, 2005, INT J TUBERC LUNG D, V9, P907; Onwuamaegbu M, 2005, J INT MED RES, V33, P1, DOI 10.1177/147323000503300101; Ovchinnikov S, 2017, SCIENCE, V355, P294, DOI 10.1126/science.aah4043; Ovchinnikov S, 2015, ELIFE, V4, DOI 10.7554/eLife.09248; Parsons JF, 2003, BIOCHEMISTRY-US, V42, P5684, DOI 10.1021/bi027385d; Penuelas-Urquides K, 2013, BRAZ J MICROBIOL, V44, P287, DOI 10.1590/S1517-83822013000100042; Perez-Riverol Y, 2019, NUCLEIC ACIDS RES, V47, pD442, DOI 10.1093/nar/gky1106; Queval CJ, 2017, FRONT MICROBIOL, V8, DOI 10.3389/fmicb.2017.02284; Rajaram MVS, 2010, J IMMUNOL, V185, P929, DOI 10.4049/jimmunol.1000866; Rajararna MVS, 2014, SEMIN IMMUNOL, V26, P471, DOI 10.1016/j.smim.2014.09.010; RAPPORT MM, 1957, J BIOL CHEM, V225, P859; RASTOGI N, 1981, J GEN MICROBIOL, V124, P71; Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x; Rosu V, 2013, MICROBIOL RES, V168, P153, DOI 10.1016/j.micres.2012.10.002; ROUSER G, 1970, LIPIDS, V5, P494, DOI 10.1007/BF02531316; Rubio JM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01723; Russell DG, 2009, NAT IMMUNOL, V10, P943, DOI 10.1038/ni.1781; SCHLESINGER LS, 1993, J IMMUNOL, V150, P2920; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563; Slavchev G, 2016, INT J MYCOBACT, V5, P454, DOI 10.1016/j.ijmyco.2016.06.011; STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277; UDOU T, 1982, J BACTERIOL, V151, P1035, DOI 10.1128/JB.151.2.1035-1039.1982; UDOU T, 1983, CAN J MICROBIOL, V29, P60, DOI 10.1139/m83-010; Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307; Wallner S, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205706; WARNER HR, 1961, J BIOL CHEM, V236, P2404; Weiss G, 2015, IMMUNOL REV, V264, P182, DOI 10.1111/imr.12266; WELTZIEN HU, 1979, BIOCHIM BIOPHYS ACTA, V559, P259, DOI 10.1016/0304-4157(79)90004-2; Wu LC, 2011, J BIOL CHEM, V286, P24916, DOI 10.1074/jbc.M111.247163; ZHANG Y, 1988, J BIOL CHEM, V263, P9965; Zhang YJJ, 2013, CELL, V155, P1296, DOI 10.1016/j.cell.2013.10.045; ZOELLER RA, 1988, J BIOL CHEM, V263, P11590	78	1	1	5	5	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101849	10.1016/j.jbc.2022.101849	http://dx.doi.org/10.1016/j.jbc.2022.101849			22	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	4W8EX	35314194	gold, Green Published			2022-12-26	WOS:000860390500005
J	Behzadifar, M; Aalipour, A; Kehsvari, M; Teli, BD; Ghanbari, MK; Gorji, HA; Sheikhi, A; Azari, S; Heydarian, M; Ehsanzadeh, SJ; Kong, JD; Ahadi, M; Bragazzi, NL				Behzadifar, Masoud; Aalipour, Afshin; Kehsvari, Mohammad; Teli, Banafsheh Darvishi; Ghanbari, Mahboubeh Khaton; Gorji, Hasan Abolghasem; Sheikhi, Alaeddin; Azari, Samad; Heydarian, Mohammad; Ehsanzadeh, Seyed Jafar; Kong, Jude Dzevela; Ahadi, Maryam; Bragazzi, Nicola Luigi			The effect of COVID-19 on public hospital revenues in Iran: An interrupted time-series analysis	PLOS ONE			English	Article							INTERVENTIONS; POLICY; MODEL	Background The "Coronavirus Disease 2019" (COVID-19) pandemic has become a major challenge for all healthcare systems worldwide, and besides generating a high toll of deaths, it has caused economic losses. Hospitals have played a key role in providing services to patients and the volume of hospital activities has been refocused on COVID-19 patients. Other activities have been limited/repurposed or even suspended and hospitals have been operating with reduced capacity. With the decrease in non-COVID-19 activities, their financial system and sustainability have been threatened, with hospitals facing shortage of financial resources. The aim of this study was to investigate the effects of COVID-19 on the revenues of public hospitals in Lorestan province in western Iran, as a case study. Method In this quasi-experimental study, we conducted the interrupted time series analysis to evaluate COVID-19 induced changes in monthly revenues of 18 public hospitals, from April 2018 to August 2021, in Lorestan, Iran. In doing so, public hospitals report their earnings to the University of Medical Sciences monthly; then, we collected this data through the finance office. Results Due to COVID-19, the revenues of public hospitals experienced an average monthly decrease of $172,636 thousand (P-value = 0.01232). For about 13 months, the trend of declining hospital revenues continued. However, after February 2021, a relatively stable increase could be observed, with patient admission and elective surgeries restrictions being lifted. The average monthly income of hospitals increased by $83,574 thousand. Conclusion COVID-19 has reduced the revenues of public hospitals, which have faced many problems due to the high costs they have incurred. During the crisis, lack of adequate fundings can damage healthcare service delivery, and policymakers should allocate resources to prevent potential shocks.	[Behzadifar, Masoud; Aalipour, Afshin] Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran; [Kehsvari, Mohammad; Teli, Banafsheh Darvishi; Sheikhi, Alaeddin] Lorestan Univ Med Sci, Vice Chancellor Treatment, Khorramabad, Iran; [Ghanbari, Mahboubeh Khaton; Gorji, Hasan Abolghasem] Iran Univ Med Sci, Hlth Management Res Inst, Tehran, Iran; [Azari, Samad] Iran Univ Med Sci, Hosp Management Res Ctr, Tehran, Iran; [Heydarian, Mohammad] Lorestan Univ Med Sci, Fac Med, Dept Radiol, Khorramabad, Iran; [Ehsanzadeh, Seyed Jafar] Iran Univ Med Sci, Sch Hlth Management & Informat Sci, English Language Dept, Tehran, Iran; [Kong, Jude Dzevela; Bragazzi, Nicola Luigi] York Univ, Dept Math & Stat, Lab Ind & Appl Math LIAM, Toronto, ON, Canada; [Ahadi, Maryam] Lorestan Univ Med Sci, Fac Med, Dept Emergency Med, Khorramabad, Iran	Lorestan University of Medical Sciences; Lorestan University of Medical Sciences; Iran University of Medical Sciences; Iran University of Medical Sciences; Lorestan University of Medical Sciences; Iran University of Medical Sciences; York University - Canada; Lorestan University of Medical Sciences	Behzadifar, M (corresponding author), Lorestan Univ Med Sci, Social Determinants Hlth Res Ctr, Khorramabad, Iran.	masoudbehzadifar@gmail.com		Ehsanzadeh, S.J./0000-0002-2620-7814				Abebe W, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06730-8; Abolghasem Gorji, 2021, J PREV MED HYG, V61, pE508, DOI DOI 10.15167/2421-4248/JPMH2020.61.4.1613; Azari S, 2020, ADV J EMERG MED, V4, DOI 10.22114/ajem.v4i2s.414; Bai G, 2020, J GEN INTERN MED, V35, P2807, DOI 10.1007/s11606-020-05996-8; Barasa E, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06726-4; Behzadifar M, 2020, INT J EQUITY HEALTH, V19, DOI 10.1186/s12939-020-01181-9; Behzadifar M, 2020, INT J HEALTH PLAN M, V35, P339, DOI 10.1002/hpm.2916; Beiranvand S, 2020, BMC HEALTH SERV RES, V20, DOI 10.1186/s12913-020-05186-6; Bernal JL, 2017, INT J EPIDEMIOL, V46, P348, DOI 10.1093/ije/dyw098; Czypionka T, 2014, HEALTH CARE MANAG SC, V17, P331, DOI 10.1007/s10729-013-9256-9; Darab MG, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06126-8; Dennis J, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f2674; Dopfer C, 2020, BMC PEDIATR, V20, DOI 10.1186/s12887-020-02303-6; Essien UR, 2020, J GEN INTERN MED, V35, P2760, DOI 10.1007/s11606-020-05976-y; Gaffney A, 2020, INT J HEALTH SERV, V50, P396, DOI 10.1177/0020731420931431; Goudarzi R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0247155; Jamaati H, 2020, IRAN J PHARM RES, V19, P1, DOI 10.22037/ijpr.2020.113365.14255; Kazempour-Dizaji M, 2021, HEALTH SCOPE, V10, DOI 10.5812/jhealthscope.111620; Khan JR, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00347; Khullar D, 2020, JAMA-J AM MED ASSOC, V323, P2127, DOI 10.1001/jama.2020.6269; Komen J, 2017, BRIT J CLIN PHARMACO, V83, P642, DOI 10.1111/bcp.13150; Kontopantelis E, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2750; Korean Soc Infect Dis, 2020, J KOREAN MED SCI, V35, DOI 10.3346/jkms.2020.35.e112; Linden A, 2011, J EVAL CLIN PRACT, V17, P1231, DOI 10.1111/j.1365-2753.2010.01504.x; Lu HZ, 2020, J MED VIROL, V92, P401, DOI [10.1002/jmv.25678, 10.1002/jmv.2567]; Ministry of Health and Medical Education, COVID 19 2022; Morlock R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0245586; Nasiri T, 2021, ANN IG MED PREV COMU, V33, P103, DOI 10.7416/ai.2021.2412; Olyaeemanesh Alireza, 2018, Med J Islam Repub Iran, V32, P39, DOI 10.14196/mjiri.32.39; Piroozi B, 2017, INT J HEALTH POLICY, V6, P573, DOI 10.15171/ijhpm.2017.16; Sajadi HS, 2020, COST EFFECT RESOUR A, V18, DOI 10.1186/s12962-020-00215-x; Saki M, 2021, YALE J BIOL MED, V94, P13; Singh DR, 2021, BMC HEALTH SERV RES, V21, DOI 10.1186/s12913-021-06176-y; White DB, 2020, JAMA-J AM MED ASSOC, V323, P1773, DOI 10.1001/jama.2020.5046	34	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266343	10.1371/journal.pone.0266343	http://dx.doi.org/10.1371/journal.pone.0266343			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358279	Green Published, gold			2022-12-26	WOS:000799828800094
J	Murata, T; Kyozuka, H; Yasuda, S; Fukuda, T; Tanaka, T; Fujimori, K				Murata, Tsuyoshi; Kyozuka, Hyo; Yasuda, Shun; Fukuda, Toma; Tanaka, Teruyoshi; Fujimori, Keiya			Effects of maternal ritodrine hydrochloride administration on the heart rate of preterm fetal sheep with intraamniotic inflammation	PLOS ONE			English	Article							RATE-VARIABILITY; NERVOUS-SYSTEM; BLOOD-PRESSURE; RESPONSES; ENDOTOXIN; LABOR; EXPOSURE; ASPHYXIA; UTERINE; BIRTH	Ritodrine hydrochloride is used for pregnancy prolongation and intrauterine fetal resuscitation. However, its clinical significance in intraamniotic inflammation during preterm labor and intrauterine fetal distress is unclear. We investigated the effects of maternal ritodrine hydrochloride administration (MRA; 200 mu g/min for 2 h, followed by 800 mu g/min for 2 h after 24 h) on fetal physiological parameters. For this purpose, we used chronically instrumented pregnant sheep at 113-119 d (term = 145 d) of gestation without (Group 1, n = 5) and with (Group 2, n = 5) intraamniotic inflammation induced by lipopolysaccharide injection into the amniotic cavity. The changes in fetal heart rate (FHR) and short-term variability (STV) and long-term variability (LTV) in FHR, fetal blood pressure, and fetal arterial blood gas (FABG) values were measured before and at 1 and 2 h after initiating MRA. Before MRA, all parameters were similar between Groups 1 and 2; however, there was significantly higher STV in Group 2 than in Group 1 before MRA at 800 mu g/min, significantly higher partial arterial pressure of carbon dioxide in FABG in Group 2 than in Group 1 before MRA at 200 mu g/min, and significantly lower blood glucose (BG) in Group 2 than in Group 1 before MRA at 800 mu g/min. One hour after MRA, the FHR, STV, and LTV were significantly higher at 800 mu g/min than those at the baseline in Group 1, as determined by the Friedman test; however, no significant difference was observed in Group 2. Additionally, the FABG pH significantly decreased 1 h after MRA at 800 mu g/min in Group 2, whereas FABG lactate and BG significantly increased 2 h after MRA at 800 mu g/min in Groups 1 and 2. Thus, short-term MRA at 800 mu g/min increased the FHR, STV, and LTV significantly; these values were further modified under intraamniotic inflammation.	[Murata, Tsuyoshi; Kyozuka, Hyo; Yasuda, Shun; Fukuda, Toma; Fujimori, Keiya] Fukushima Med Univ, Dept Obstet & Gynecol, Sch Med, Fukushima, Japan; [Tanaka, Teruyoshi] Fukushima Med Univ, Dept Biomol Sci, Sch Med, Fukushima, Japan	Fukushima Medical University; Fukushima Medical University	Murata, T (corresponding author), Fukushima Med Univ, Dept Obstet & Gynecol, Sch Med, Fukushima, Japan.	tuyoshim@fmu.ac.jp	Murata, Tsuyoshi/GMW-4256-2022	Murata, Tsuyoshi/0000-0001-9506-117X	JSPS KAKENHI [16K11099]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by JSPS KAKENHI (Grant Number 16K11099). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American College of Obstetricians and Gynecologists, 2010, Obstet Gynecol, V116, P1232, DOI 10.1097/AOG.0b013e3182004fa9; American College of Obstetricians and Gynecologists Committee on Practice BulletinsObstetrics, 2016, Obstet Gynecol, V128, pe155, DOI 10.1097/AOG.0000000000001711; Ananth CV, 2006, J MATERN-FETAL NEO M, V19, P773, DOI 10.1080/14767050600965882; BARDEN TP, 1980, OBSTET GYNECOL, V56, P1; Barley J., 2005, SCH SCI REV, V87, P105; BARLOW RM, 1969, J COMP NEUROL, V135, P249, DOI 10.1002/cne.901350302; BASSETT JM, 1990, PEDIATR RES, V28, P388, DOI 10.1203/00006450-199010000-00017; Bennet L, 2007, AM J PHYSIOL-REG I, V293, pR1280, DOI 10.1152/ajpregu.00342.2007; Besinger RE., 1997, PRETERM LABOR, P243; BIENIARZ J, 1972, OBSTET GYNECOL, V40, P65; Buhimschi CS, 2008, AM J PERINAT, V25, P359, DOI 10.1055/s-2008-1078761; Bullens LM, 2015, OBSTET GYNECOL SURV, V70, P524, DOI 10.1097/OGX.0000000000000215; CALDEYRO-BARCIA R, 1969, Pan American Health Organization Scientific Publication, V185, P248; DALTON KJ, 1983, AM J OBSTET GYNECOL, V146, P456, DOI 10.1016/0002-9378(83)90828-1; Daniel SS, 1996, AM J PHYSIOL-REG I, V271, pR1415, DOI 10.1152/ajpregu.1996.271.5.R1415; DAWES GS, 1992, OBSTET GYNECOL, V80, P673; Di Renzo GC, 2017, J MATERN-FETAL NEO M, V30, P2011, DOI 10.1080/14767058.2017.1323860; Duncan JR, 2002, PEDIATR RES, V52, P941, DOI 10.1203/01.PDR.0000034224.13885.BE; Durosier LD, 2015, PHYSIOL MEAS, V36, DOI 10.1088/0967-3334/36/10/2089; European Medicines Agency, 2013, RESTR US SHORT ACT B; Frasch MG, 2007, J PHYSIOL-LONDON, V579, P893, DOI 10.1113/jphysiol.2006.124800; Frasch MG, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0567-x; Fujimori K, 2005, OBSTET GYNECOL, V106, P818, DOI 10.1097/01.AOG.0000178764.35532.18; Fujimori K, 2004, J Matern Fetal Neonatal Med, V16, P119; Fukuda S, 2020, SHOCK, V53, P307, DOI 10.1097/SHK.0000000000001364; Galazios G, 2010, ARCH GYNECOL OBSTET, V281, P229, DOI 10.1007/s00404-009-1119-8; Galinsky R, 2018, AM J PHYSIOL-REG I, V315, pR205, DOI 10.1152/ajpregu.00390.2017; Galinsky R, 2011, AM J PHYSIOL-RENAL, V301, pF280, DOI 10.1152/ajprenal.00066.2011; Gokay Z, 2001, ULTRASOUND OBST GYN, V18, P44, DOI 10.1046/j.1469-0705.2001.00453.x; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Goldenberg RL, 2010, LANCET, V375, P1482, DOI 10.1016/S0140-6736(09)61712-8; GROSS TL, 1985, OBSTET GYNECOL, V65, P793; Haas DM, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e6226; Hamed HO, 2013, ARCH GYNECOL OBSTET, V287, P1067, DOI 10.1007/s00404-012-2694-7; HUEY JR, 1979, AM J OBSTET GYNECOL, V134, P691, DOI 10.1016/0002-9378(79)90652-5; IKENOUE T, 1981, AM J OBSTET GYNECOL, V141, P797, DOI 10.1016/0002-9378(81)90707-9; Japan Society of Obstetrics and Gynecology (JSOG) Japan Association of Obstetricians and Gynecologists (JAOG), 2020, GUID OBST PRACT JAP; Kallapur SG, 2014, SEMIN REPROD MED, V32, P56, DOI 10.1055/s-0033-1361823; Kendall G, 2005, EARLY HUM DEV, V81, P27, DOI 10.1016/j.earlhumdev.2004.10.012; Kim CJ, 2015, AM J OBSTET GYNECOL, V213, pS29, DOI 10.1016/j.ajog.2015.08.040; Kramer BW, 2007, AM J PHYSIOL-LUNG C, V293, pL345, DOI 10.1152/ajplung.00003.2007; Kruger K, 1999, AM J OBSTET GYNECOL, V181, P1072, DOI 10.1016/S0002-9378(99)70083-9; Kyozuka H, 2018, EUR J OBSTET GYN R B, V228, P32, DOI 10.1016/j.ejogrb.2018.06.015; Lamont CD, 2016, EXPERT OPIN DRUG SAF, V15, P1163, DOI 10.1080/14740338.2016.1187128; Lear CA, 2014, AM J PHYSIOL-REG I, V307, pR387, DOI 10.1152/ajpregu.00110.2014; Leathersich SJ, 2018, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009770.pub2; Liu AX, 2008, J CHROMATOGR B, V867, P144, DOI 10.1016/j.jchromb.2008.03.007; Mathai S, 2013, AM J PHYSIOL-REG I, V304, pR189, DOI 10.1152/ajpregu.00388.2012; Matsuda Y, 2002, JPN J PHARMACOL, V90, P107, DOI 10.1254/jjp.90.107; MENDEZBAUER C, 1987, AM J OBSTET GYNECOL, V156, P638, DOI 10.1016/0002-9378(87)90067-6; Minakami H, 2014, J OBSTET GYNAECOL RE, V40, P1469, DOI 10.1111/jog.12419; Murata T, 2021, J OBSTET GYNAECOL RE, V47, P3758, DOI 10.1111/jog.14951; Murata T, 2021, PEDIAT ALLERG IMM-UK, V32, P1455, DOI 10.1111/pai.13545; Murata T, 2022, J OBSTET GYNAECOL, V42, P563, DOI 10.1080/01443615.2021.1929111; Murata Tsuyoshi, 2020, Case Rep Womens Health, V25, pe00173, DOI 10.1016/j.crwh.2020.e00173; Neilson JP, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004352.pub3; Neri I, 2009, AM J PERINAT, V26, P259, DOI 10.1055/s-0028-1103153; Ogawa K, 2017, PEDIAT ALLERG IMM-UK, V28, P746, DOI 10.1111/pai.12805; Palomaki O, 2004, AM J PERINAT, V21, P347, DOI 10.1055/s-2004-831879; Parer JT., 2017, ELECT FETAL HEART RA, V3rd ed; PAUL RH, 1975, AM J OBSTET GYNECOL, V123, P206, DOI 10.1016/0002-9378(75)90528-1; Prout AP, 2010, AM J OBSTET GYNECOL, V202, DOI 10.1016/j.ajog.2009.08.020; Schifrin B S, 1994, J Perinatol, V14, P174; SHEYBANY S, 1982, BRIT J OBSTET GYNAEC, V89, P723, DOI 10.1111/j.1471-0528.1982.tb05098.x; Shigemi D, 2019, BMC PREGNANCY CHILDB, V19, DOI 10.1186/s12884-019-2352-1; SIIMES ASI, 1979, AM J OBSTET GYNECOL, V133, P20; STREET P, 1991, AM J OBSTET GYNECOL, V165, P515, DOI 10.1016/0002-9378(91)90277-X; Tjen-A-Looi SC, 2011, AM J PHYSIOL-HEART C, V300, pH1003, DOI 10.1152/ajpheart.01131.2010; Uemura K, 2012, INT J OBSTET ANESTH, V21, P339, DOI 10.1016/j.ijoa.2012.06.010; Unno N, 1999, AM J PHYSIOL-HEART C, V276, pH248, DOI 10.1152/ajpheart.1999.276.1.H248; US Food and Drug Administration, 2011, FDA DRUG SAFETY COMM; Vandenbroucke L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184924; Verdurmen KMJ, 2017, J MATERN-FETAL NEO M, V30, P2387, DOI 10.1080/14767058.2016.1249844; Watanabe T, 2007, PEDIATR RES, V62, P670, DOI 10.1203/PDR.0b013e31815991bf; Wretler S, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-0845-8; Yada Y, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-64687-w; Yasuda S, 2020, J OBSTET GYNAECOL RE, V46, P1035, DOI 10.1111/jog.14274	77	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0265872	10.1371/journal.pone.0265872	http://dx.doi.org/10.1371/journal.pone.0265872			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358222	gold, Green Published, Green Submitted			2022-12-26	WOS:000799828800050
J	Brellier, F; Pujades-Rodriguez, M; Powell, E; Mudie, K; Lacerda, EM; Nacul, L; Wing, K				Brellier, Florence; Pujades-Rodriguez, Mar; Powell, Emma; Mudie, Kathleen; Mattos Lacerda, Eliana; Nacul, Luis; Wing, Kevin			Incidence of Lyme disease in the United Kingdom and association with fatigue: A population-based, historical cohort study	PLOS ONE			English	Article							MYALGIC ENCEPHALOMYELITIS	BackgroundEstimations of Lyme disease incidence rates in the United Kingdom vary. There is evidence that this disease is associated with fatigue in its early stage but reports are contradictory as far as long-term fatigue is concerned. Methods and findingsA population-based historical cohort study was conducted on patients treated in general practices contributing to IQVIA Medical Research Data: 2,130 patients with a first diagnosis of Lyme disease between 2000 and 2018 and 8,510 randomly-sampled patients matched by age, sex, and general practice, followed-up for a median time of 3 years and 8 months. Main outcome measure was time to consultation for (1) any fatigue-related symptoms or diagnosis; or (2) myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). Adjusted hazard ratios (HRs) were estimated from Cox models. Average incidence rate for Lyme disease across the UK was 5.18 per 100,000 person-years, increasing from 2.55 in 2000 to 9.33 in 2018. In total, 929 events of any types of fatigue were observed, leading to an incidence rate of 307.90 per 10,000 person-years in the Lyme cohort (282 events) and 165.60 in the comparator cohort (647 events). Effect of Lyme disease on any subsequent fatigue varied by index season: adjusted HRs were the highest in autumn and winter with 3.14 (95%CI: 1.92-5.13) and 2.23 (1.21-4.11), respectively. For ME/CFS, 17 events were observed in total. Incidence rates were 11.76 per 10,000 person-years in Lyme patients (12 events) and 1.20 in comparators (5 events), corresponding to an adjusted HR of 16.95 (5.17-55.60). Effects were attenuated 6 months after diagnosis but still clearly visible. ConclusionsUK primary care records provided strong evidence that Lyme disease was associated with subsequent fatigue and ME/CFS. Albeit weaker on the long-term, these effects persisted beyond 6 months, suggesting patients and healthcare providers should remain alert to fatigue symptoms months to years following Lyme disease diagnosis.	[Brellier, Florence; Pujades-Rodriguez, Mar] IQVIA, London, England; [Powell, Emma; Wing, Kevin] London Sch Hyg & Trop Med, Fac Epidemiol & Populat Hlth, Dept Noncommunicable Dis Epidemiol, London, England; [Mudie, Kathleen; Mattos Lacerda, Eliana; Nacul, Luis] London Sch Hyg & Trop Med, Fac Infect & Trop Dis, Dept Clin Res, London, England; [Nacul, Luis] British Columbia Womens Hosp & Hlth Ctr, Complex Chron Dis Program, Vancouver, BC, Canada; [Nacul, Luis] Univ British Columbia, Dept Family Practice, Vancouver, BC, Canada	IQVIA; University of London; London School of Hygiene & Tropical Medicine; University of London; London School of Hygiene & Tropical Medicine; University of British Columbia	Brellier, F (corresponding author), IQVIA, London, England.	florence_brellier@hotmail.com	; Pujades Rodriguez, Mar/N-7695-2016; Wing, Kevin/I-7807-2015	Lacerda, Eliana/0000-0002-5077-7868; Pujades Rodriguez, Mar/0000-0002-1375-1028; Nacul, Luis/0000-0003-1411-8088; Mudie, Kathleen/0000-0001-7950-8680; Wing, Kevin/0000-0003-2335-9641; Brellier, Florence/0000-0002-0143-472X				[Anonymous], 2019, DIAGNOSIS, V6, pA1; Bourke Alison, 2004, Inform Prim Care, V12, P171; Cairns V, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2018-025916; Carruthers BM, 2007, J CLIN PATHOL, V60, P117, DOI 10.1136/jcp.2006.042754; Carruthers BM, 2011, J INTERN MED, V270, P327, DOI 10.1111/j.1365-2796.2011.02428.x; Committee on the Diagnostic Criteria for Myalgic Encephalomyelitis/Chronic Fatigue S Board on the Health of Select P Institute of M. The National Academies Collection: Reports funded by National Institutes of Health, 2015, MYALGIC ENCEPHALOMYE; Cottle LE, 2012, QJM-INT J MED, V105, P537, DOI 10.1093/qjmed/hcs003; Dersch R, 2016, J NEUROL, V263, P17, DOI 10.1007/s00415-015-7923-0; Eikeland R, 2011, ACTA NEUROL SCAND, V124, P349, DOI 10.1111/j.1600-0404.2010.01482.x; Estevez-Lopez F, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051557; Gaudino EA, 1997, ARCH NEUROL-CHICAGO, V54, P1372, DOI 10.1001/archneur.1997.00550230045015; Hook SA, 2015, TICKS TICK-BORNE DIS, V6, P483, DOI 10.1016/j.ttbdis.2015.03.017; Kalish RA, 2001, J INFECT DIS, V183, P453, DOI 10.1086/318082; Lacerda EM, 2019, BMC NEUROL, V19, DOI 10.1186/s12883-019-1468-2; Lacerda EM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.01026; Lewis JD, 2007, PHARMACOEPIDEM DR S, V16, P393, DOI 10.1002/pds.1335; Maguire A, 2009, PHARMACOEPIDEM DR S, V18, P76, DOI 10.1002/pds.1688; Matthews A, 2016, PLOS MED, V13, DOI 10.1371/journal.pmed.1002037; Nacul L, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00826; Nadelman RB, 2007, CLIN INFECT DIS, V45, P1032, DOI 10.1086/521256; Nemeth J, 2016, SWISS MED WKLY, V146, DOI 10.4414/smw.2016.14353; NICE, 2018, LYM DIS NICE GUID; Pheby DFH, 2020, HEALTHCARE-BASEL, V8, DOI 10.3390/healthcare8020088; Public Health England, 2018, DEFRA ZOON REP UK 20; Schutzer SE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017287; Sjolander A, 2013, STAT MED, V32, P4696, DOI 10.1002/sim.5879; Sykes RA, 2017, J PUBLIC HEALTH-UK, V39, P74, DOI 10.1093/pubmed/fdw017; Thortveit ET, 2019, TICKS TICK-BORNE DIS, V10, P156, DOI 10.1016/j.ttbdis.2018.09.012; Tulloch JSP, 2019, BMC PUBLIC HEALTH, V19, DOI 10.1186/s12889-019-7245-8; Turner GM, 2016, EUR J NEUROL, V23, P1642, DOI 10.1111/ene.13088; Wormser GP, 2016, DIAGN MICR INFEC DIS, V86, P322, DOI 10.1016/j.diagmicrobio.2016.07.026; Wormser GP, 2015, AM J MED, V128, P181, DOI 10.1016/j.amjmed.2014.09.022	32	0	0	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265765	10.1371/journal.pone.0265765	http://dx.doi.org/10.1371/journal.pone.0265765			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P5DL	35320297	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000784240600029
J	Eason, T; Garmestani, A; Angeler, DG				Eason, Tarsha; Garmestani, Ahjond; Angeler, David G.			Spatiotemporal variability in Swedish lake ecosystems	PLOS ONE			English	Article							FISHER INFORMATION; SPATIAL REGIMES; URBAN SYSTEMS; INDICATORS; RESILIENCE; SUSTAINABILITY; SHIFTS; INVERTEBRATE; REDUNDANCIES; ASSEMBLAGES	Studying ecosystem dynamics is critical to monitoring and managing linked systems of humans and nature. Due to the growth of tools and techniques for collecting data, information on the condition of these systems is more widely available. While there are a variety of approaches for mining and assessing data, there is a need for methods to detect latent characteristics in ecosystems linked to temporal and spatial patterns of change. Resilience-based approaches have been effective at not only identifying environmental change but also providing warning in advance of critical transitions in social-ecological systems (SES). In this study, we examine the usefulness of one such method, Fisher Information (FI) for spatiotemporal analysis. FI is used to assess patterns in data and has been established as an effective tool for capturing complex system dynamics to include regimes and regime shifts. We employed FI to assess the biophysical condition of eighty-five Swedish lakes from 1996-2018. Results showed that FI captured spatiotemporal changes in the Swedish lakes and identified distinct spatial patterns above and below the Limes Norrlandicus, a hard ecotone boundary which separates northern and southern ecoregions in Sweden. Further, it revealed that spatial variance changed approaching this boundary. Our results demonstrate the utility of this resilience-based approach for spatiotemporal and spatial regimes analyses linked to monitoring and managing critical watersheds and waterbodies impacted by accelerating environmental change.	[Eason, Tarsha] US EPA, Off Res & Dev, Athens, GA 30605 USA; [Eason, Tarsha; Garmestani, Ahjond; Angeler, David G.] Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA; [Garmestani, Ahjond] US EPA, Off Res & Dev, Gulf Breeze, FL USA; [Garmestani, Ahjond] Univ Nebraska, Sch Nat Resources, Lincoln, NE USA; [Garmestani, Ahjond] Univ Utrecht, Utrecht Ctr Water Oceans & Sustainabil Law, Utrecht, Netherlands; [Angeler, David G.] Swedish Univ Agr Sci, Dept Aquat Sci & Assessment, Uppsala, Sweden; [Angeler, David G.] PRODEO Inst, San Francisco, CA USA; [Angeler, David G.] Deakin Univ, Inst Mental & Phys Hlth & Clin Translat, IMPACT, Geelong, Vic, Australia	United States Environmental Protection Agency; Emory University; United States Environmental Protection Agency; University of Nebraska System; University of Nebraska Lincoln; Utrecht University; Swedish University of Agricultural Sciences; Deakin University	Eason, T (corresponding author), US EPA, Off Res & Dev, Athens, GA 30605 USA.; Eason, T (corresponding author), Emory Univ, Dept Environm Sci, Atlanta, GA 30322 USA.	eason.tarsha@epa.gov		Garmestani, Ahjond/0000-0001-5678-7293; Eason, Tarsha/0000-0001-9881-3293				Ahmad N, 2016, ROY SOC OPEN SCI, V3, DOI 10.1098/rsos.160582; Allen CR, 2019, NAT SUSTAIN, V2, P898, DOI 10.1038/s41893-019-0401-4; Allen CR, 2016, J APPL ECOL, V53, P625, DOI 10.1111/1365-2664.12634; Allen CR, 2014, ECOSYSTEMS, V17, P578, DOI 10.1007/s10021-013-9744-2; Allen CR, 2010, ECOL SOC, V15; Angeler DG, 2016, J APPL ECOL, V53, P617, DOI 10.1111/1365-2664.12649; Angeler DG, 2016, J APPL ECOL, V53, P688, DOI 10.1111/1365-2664.12494; Angeler DG, 2015, ECOSYSTEMS, V18, P889, DOI 10.1007/s10021-015-9871-z; Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; Angeler DG, 2013, J APPL ECOL, V50, P572, DOI 10.1111/1365-2664.12092; Angeler DG, 2012, ECOL SOC, V17, DOI 10.5751/ES-04928-170232; BATTY M, 1974, GEOGR ANAL, V6, P1; Blomqvist P, 1998, METHODS QUANTITATIVE; Buelo CD, 2018, LIMNOL OCEANOGR LETT, V3, P384, DOI 10.1002/lol2.10091; Bury TM, 2021, P NATL ACAD SCI USA, V118, DOI [10.1073/pnas.2106140118|1of9, 10.1073/pnas.2106140118]; Cabezas H, 2012, EPA600R10182; Clements CF, 2018, ECOL LETT, V21, P905, DOI 10.1111/ele.12948; Dai L, 2012, SCIENCE, V336, P1175, DOI 10.1126/science.1219805; Dakos V, 2010, THEOR ECOL-NETH, V3, P163, DOI 10.1007/s12080-009-0060-6; Donangelo R, 2010, INT J BIFURCAT CHAOS, V20, P315, DOI 10.1142/S0218127410025764; Eason T, 2019, ENTROPY-SWITZ, V21, DOI 10.3390/e21020182; Eason T, 2012, REV DEV, P55; Eason T, 2016, J APPL ECOL, V53, P656, DOI 10.1111/1365-2664.12597; Eason T, 2014, CLEAN TECHNOL ENVIR, V16, P773, DOI 10.1007/s10098-013-0687-2; Eason T, 2012, J ENVIRON MANAGE, V94, P41, DOI 10.1016/j.jenvman.2011.08.003; Eby S, 2017, GLOBAL ECOL BIOGEOGR, V26, P638, DOI 10.1111/geb.12570; Eklof JS, 2020, COMMUN BIOL, V3, DOI 10.1038/s42003-020-01180-0; Fath BD, 2003, J THEOR BIOL, V222, P517, DOI 10.1016/S0022-5193(03)00067-5; Folster J, 2014, AMBIO, V43, P3, DOI 10.1007/s13280-014-0558-z; Fried-Petersen HB, 2020, GLOBAL CHANGE BIOL, V26, P1259, DOI 10.1111/gcb.14952; Garmestani A, 2020, FRONT ECOL ENVIRON, V18, P576, DOI 10.1002/fee.2264; Garmestani AS, 2009, ECOL SOC, V14; Genin A., 2018, ECOL INDIC; Gonzalez Mejia AM., 2011, FISHER INFORM SUSTAI; Gonzalez-Mejia A., 2015, ASSESSING MEASURING, P25; Gonzalez-Mejia AM, 2014, SUSTAIN SCI, V9, P217, DOI 10.1007/s11625-013-0227-3; Gonzalez-Mejia AM, 2012, CLEAN TECHNOL ENVIR, V14, P775, DOI 10.1007/s10098-011-0445-2; Gonzalez-Mejia AM, 2012, ENVIRON SCI TECHNOL, V46, P9620, DOI 10.1021/es3007904; Guttal V, 2008, ECOL LETT, V11, P450, DOI 10.1111/j.1461-0248.2008.01160.x; Heino J, 2021, BIOL REV, V96, P89, DOI 10.1111/brv.12647; Heino J, 2010, ECOL INDIC, V10, P112, DOI 10.1016/j.ecolind.2009.04.013; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Huser BJ, 2018, SCI TOTAL ENVIRON, V613, P240, DOI 10.1016/j.scitotenv.2017.09.067; Johnson RK, 2010, J N AM BENTHOL SOC, V29, P1472, DOI 10.1899/09-171.1; Johnson RK, 2010, ECOL APPL, V20, P978, DOI 10.1890/08-1153.1; Johnson RK, 2004, FRESHWATER BIOL, V49, P1179, DOI 10.1111/j.1365-2427.2004.01262.x; Karunanithi AT, 2011, GLOBAL ENVIRON CHANG, V21, P77, DOI 10.1016/j.gloenvcha.2010.11.002; Karunanithi AT, 2008, ECOL SOC, V13; Kefi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092097; Lindegren M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038410; Lopes PM, 2011, ECOL INDIC, V11, P1171, DOI 10.1016/j.ecolind.2010.12.017; Mayer A. L., 2007, EXPLORATORY DATA ANA, DOI [10.1007/978-1-84628-777-0_7, DOI 10.1007/978-1-84628-777-0{_}]; Mayer AL, 2006, ECOL MODEL, V195, P72, DOI 10.1016/j.ecolmodel.2005.11.011; Mayfield RJ, 2020, QUATERNARY SCI REV, V249, DOI 10.1016/j.quascirev.2020.106594; Olrik K., 1998, METHODS QUANTITATI 1; Ostrom E, 2004, ECOL ECON, V49, P488, DOI 10.1016/j.ecolecon.2004.01.010; Pawlowski CW, 2008, ECOL COMPLEX, V5, P30, DOI 10.1016/j.ecocom.2007.07.005; Prestes ACL, 2017, MAR ECOL PROG SER, V567, P249, DOI 10.3354/meps12039; Ratajczak Z, 2017, J ECOL, V105, P750, DOI 10.1111/1365-2745.12696; Rindi L, 2017, NAT ECOL EVOL, V1, DOI 10.1038/s41559-017-0153; Roberts CP, 2022, ECOL INDIC, V136, DOI 10.1016/j.ecolind.2022.108567; Roberts CP, 2021, RANGELAND ECOL MANAG, V74, P114, DOI 10.1016/j.rama.2020.09.002; Roberts CP, 2019, NAT CLIM CHANGE, V9, P562, DOI 10.1038/s41558-019-0517-6; Scheffer M, 2009, NATURE, V461, P53, DOI 10.1038/nature08227; Schneider FD, 2016, THEOR ECOL-NETH, V9, P207, DOI 10.1007/s12080-015-0289-1; Spanbauer TL, 2016, P ROY SOC B-BIOL SCI, V283, DOI 10.1098/rspb.2016.0249; Spanbauer TL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108936; Sundstrom SM, 2018, ECOLOGY, V99, P2421, DOI 10.1002/ecy.2508; Sundstrom SM, 2017, ECOL LETT, V20, P19, DOI 10.1111/ele.12709; Tolonen KT, 2020, AQUAT ECOL, V54, P839, DOI 10.1007/s10452-020-09781-x; Vance L, 2017, HELIYON, V3, DOI 10.1016/j.heliyon.2017.e00465; Veness C, 2017, CALCULATE DISTANCE B; Weissmann H, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189058; Weissmann H, 2016, J THEOR BIOL, V397, P128, DOI 10.1016/j.jtbi.2016.02.033; Yin Z, 2016, ECOL COMPLEX, V26, P68, DOI 10.1016/j.ecocom.2016.02.004	76	1	1	6	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265571	10.1371/journal.pone.0265571	http://dx.doi.org/10.1371/journal.pone.0265571			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312714	Green Published, gold			2022-12-26	WOS:000803647900001
J	Hu, HQ; Zhao, RX; He, Q; Cui, C; Song, J; Guo, XH; Zang, N; Yang, MM; Zou, Y; Yang, JW; Li, JQ; Wang, LM; Xia, LQ; Wang, LS; He, FL; Hou, XG; Yan, F; Chen, L				Hu, Huiqing; Zhao, Ruxing; He, Qin; Cui, Chen; Song, Jia; Guo, Xinghong; Zang, Nan; Yang, Mengmeng; Zou, Ying; Yang, Jingwen; Li, Jinquan; Wang, Liming; Xia, Longqing; Wang, Lingshu; He, Falian; Hou, Xinguo; Yan, Fei; Chen, Li			cGAS-STING mediates cytoplasmic mitochondrial-DNA-induced inflammatory signal transduction during accelerated senescence of pancreatic beta-cells induced by metabolic stress	FASEB JOURNAL			English	Article						cGAS-STING pathway; pancreatic beta cell function; SASP; senescence; type 2 diabetes mellitus	SECRETORY PHENOTYPE; DAMAGE	Type 2 diabetes mellitus (T2DM) is an age-related disease characterized by impaired pancreatic beta cell function and insulin resistance. Recent studies have shown that the accumulation of senescent beta cells under metabolic stress conditions leads to the progression of T2DM, while senolysis can improve the prognosis. However, the specific mechanism of beta cell senescence is still unclear. In this study, we found that the increased load of senescence pancreatic beta cells in both older mice and obese mice induced by high-fat diet (HFD) (DIO mice) was accompanied by activation of the Cyclic GMP-AMP synthase (cGAS) - stimulator of interferon genes (STING) pathway and using cGAS or STING small interfering RNA or STING inhibitor C176 to downregulate this pathway reduced the senescence-associated secretion profile (SASP) and senescence of Min6 cells treated with palmitic acid or hydrogen peroxide. C176 intervention in DIO mice also significantly reduced the inflammation and senescence of the islets, thereby protecting the function of pancreatic beta cell and glucose metabolism. Our study further revealed that mitochondrial DNA (mtDNA) leakage under metabolic stress conditions was critical for the activation of the cGAS-STING pathway, which can be reversed by the mtDNA depleting agent ethidium bromide. Consistently, mtDNA leakage was more severe in older mice and was accelerated by a chronic HFD. In conclusion, we demonstrate that cytoplasmic mtDNA activates the cGAS-STING pathway to mediate SASP during the accelerated senescence of pancreatic beta-cells induced by metabolic stress, and this process can be downregulated by the STING inhibitor C176.	[Hu, Huiqing; Zhao, Ruxing; He, Qin; Cui, Chen; Song, Jia; Guo, Xinghong; Zang, Nan; Yang, Mengmeng; Zou, Ying; Yang, Jingwen; Li, Jinquan; Wang, Liming; Xia, Longqing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Univ, Qilu Hosp, Cheeloo Coll Med, Dept Endocrinol, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Univ, Inst Endocrine & Metab Dis, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Shandong Prov Med & Hlth, Key Lab Endocrine & Metab Dis, Jinan, Peoples R China; [Zhao, Ruxing; Wang, Lingshu; Hou, Xinguo; Yan, Fei; Chen, Li] Jinan Clin Res Ctr Endocrine & Metab Dis, Jinan, Peoples R China; [He, Falian; Chen, Li] Nuolai Biomed Technol Co Ltd, Tai An, Shandong, Peoples R China	Shandong University; Shandong University	Yan, F; Chen, L (corresponding author), Shandong Univ, Qilu Hosp, Dept Endocrinol, 107 Wenhua Xi Rd, Jinan 250012, Peoples R China.	yfddbest@163.com; chenli3@email.sdu.edu.cn			National Natural Science Foundation of China [81670706, 81873632, 81770818, 81800727, 81500591]; Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program [2014ZZCX02201]; National Key R&D Program of China [2016YFC0901204, 2018YFC1311800]; Shandong Provincial Natural Science Foundation [ZR2019BH018]; Taishan Industry Leading Talent Project of Shandong Province	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program; National Key R&D Program of China; Shandong Provincial Natural Science Foundation(Natural Science Foundation of Shandong Province); Taishan Industry Leading Talent Project of Shandong Province	We thank LetPub (www.letpub.com) for its linguistic assistance during the preparation of this manuscript. This work was supported by the National Natural Science Foundation of China (grant nos. 81670706, 81873632, 81770818, 81800727, and 81500591). This work also received support from the Science and Technology Department of the Shandong Province--Independent Innovation and Achievement Transformation Program (grant no. 2014ZZCX02201) and the National Key R&D Program of China (grant nos. 2016YFC0901204 and 2018YFC1311800) and the Shandong Provincial Natural Science Foundation (grant no. ZR2019BH018) and the Taishan Industry Leading Talent Project of Shandong Province.	Acosta JC, 2008, CELL, V133, P1006, DOI 10.1016/j.cell.2008.03.038; Aguayo-Mazzucato C, 2019, CELL METAB, V30, P129, DOI 10.1016/j.cmet.2019.05.006; Aguayo-Mazzucato C, 2017, CELL METAB, V25, P898, DOI 10.1016/j.cmet.2017.03.015; Bharath LP, 2020, CELL METAB, V32, P44, DOI 10.1016/j.cmet.2020.04.015; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Correia-Melo C, 2016, EMBO J, V35, P724, DOI 10.15252/embj.201592862; De Cecco M, 2019, NATURE, V572, pE5, DOI [10.1038/s41586-019-1350-9, 10.1038/s41586-018-0784-9]; Dou ZX, 2017, NATURE, V550, P402, DOI 10.1038/nature24050; Guevara APH, 2021, METABOLISM, V117, DOI 10.1016/j.metabol.2021.154711; Guo XH, 2021, MOL CELL ENDOCRINOL, V537, DOI 10.1016/j.mce.2021.111425; Haag SM, 2018, NATURE, V559, P269, DOI 10.1038/s41586-018-0287-8; Helman A, 2016, DIABETES OBES METAB, V18, P58, DOI 10.1111/dom.12719; Hu HQ, 2020, MOL CELL ENDOCRINOL, V518, DOI 10.1016/j.mce.2020.110890; Jauhari A, 2020, J CLIN INVEST, V130, P3124, DOI 10.1172/JCI135026; Jimenez V, 2018, EMBO MOL MED, V10, DOI 10.15252/emmm.201708791; Kaplon J, 2013, NATURE, V498, P109, DOI 10.1038/nature12154; Korolchuk VI, 2017, EBIOMEDICINE, V21, P7, DOI 10.1016/j.ebiom.2017.03.020; Kuilman T, 2009, NAT REV CANCER, V9, P81, DOI 10.1038/nrc2560; Kumar V, 2019, J LEUKOCYTE BIOL, V106, P171, DOI 10.1002/JLB.4MIR1018-397RR; Li T, 2018, J EXP MED, V215, P1287, DOI 10.1084/jem.20180139; Loo TM, 2020, CANCER SCI, V111, P304, DOI 10.1111/cas.14266; Machate DJ, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21114093; Mantovani A, 2001, TRENDS IMMUNOL, V22, P328, DOI 10.1016/S1471-4906(01)01941-X; Mao Y, 2017, ARTERIOSCL THROM VAS, V37, P920, DOI [10.1161/atvbaha.117.309017, 10.1161/ATVBAHA.117.309017]; Moiseeva O, 2009, MOL CELL BIOL, V29, P4495, DOI 10.1128/MCB.01868-08; Riley JS, 2020, EMBO REP, V21, DOI 10.15252/embr.201949799; Santos AL, 2017, OXID MED CELL LONGEV, V2017, DOI 10.1155/2017/5716409; Saul D, 2021, INT J MOL SCI, V22, DOI 10.3390/ijms22010401; Schwingshackl L, 2014, BRIT J NUTR, V111, P2047, DOI 10.1017/S0007114514000464; Tamayo T, 2016, DTSCH ARZTEBL INT, V113, P177, DOI 10.3238/arztebl.2016.0177; Tchkonia T, 2013, J CLIN INVEST, V123, P966, DOI 10.1172/JCI64098; Thompson PJ, 2019, CELL METAB, V29, P1045, DOI 10.1016/j.cmet.2019.01.021; Vizioli MG, 2020, GENE DEV, V34, P428, DOI 10.1101/gad.331272.119; Wajapeyee N, 2008, CELL, V132, P363, DOI 10.1016/j.cell.2007.12.032; Wang LS, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0640-0; Yan CJ, 2019, CELLS-BASEL, V8, DOI 10.3390/cells8040379; Young ARJ, 2009, EMBO REP, V10, P228, DOI 10.1038/embor.2009.22; Yu GW, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20246268; Zhang H, 2019, J CELL PHYSIOL, V234, P619, DOI 10.1002/jcp.26816	39	3	3	5	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2022	36	5							e22266	10.1096/fj.202101988R	http://dx.doi.org/10.1096/fj.202101988R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	0D6DE	35357035				2022-12-26	WOS:000776083000001
J	Mattice, JR; Shisler, KA; DuBois, JL; Peters, JW; Bothner, B				Mattice, Jenna R.; Shisler, Krista A.; DuBois, Jennifer L.; Peters, John W.; Bothner, Brian			A catalytic dyad modulates conformational change in the CO2-fixing flavoenzyme 2-ketopropyl coenzyme M oxidoreductase/carboxylase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GLUTATHIONE-REDUCTASE; DISULFIDE OXIDOREDUCTASE; STABILITY; MECHANISM; BINDING	2-Ketopropyl-coenzyme M oxidoreductase/carboxylase (2-KPCC) is a member of the flavin and cysteine disulfide containing oxidoreductase family (DSOR) that catalyzes the unique reaction between atmospheric CO2 and a ketone/eno-late nucleophile to generate acetoacetate. However, the mechanism of this reaction is not well understood. Here, we present evidence that 2-KPCC, in contrast to the well -characterized DSOR enzyme glutathione reductase, un-dergoes conformational changes during catalysis. Using a suite of biophysical techniques including limited proteolysis, differ-ential scanning fluorimetry, and native mass spectrometry in the presence of substrates and inhibitors, we observed conformational differences between different ligand-bound 2-KPCC species within the catalytic cycle. Analysis of site -specific amino acid variants indicated that 2-KPCC-defining residues, Phe501-His506, within the active site are important for transducing these ligand induced conformational changes. We propose that these conformational changes promote sub-strate discrimination between H+ and CO2 to favor the meta-bolically preferred carboxylation product, acetoacetate.	[Mattice, Jenna R.; DuBois, Jennifer L.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Shisler, Krista A.; Peters, John W.] Washington State Univ, Inst Biol Chem, Pullman, WA 99164 USA	Montana State University System; Montana State University Bozeman; Washington State University	Bothner, B (corresponding author), Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA.	bbothner@montana.edu			U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-FG02x04ER15563]; USDA National Institute of Food and Agriculture [1015621]; MJ Murdock Charitable Trust; National Institute of General Medical Sciences of the National Institutes of Health [P20GM103474, S10OD28650]; MSU Office of Research, Economic Development and Graduate Education	U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); USDA National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); MJ Murdock Charitable Trust; National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MSU Office of Research, Economic Development and Graduate Education	This work was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences under Award DE-FG02x04ER15563 to J. L. D., J. W. P., and B. B. Partial salary support for J. W. P. was supported by the USDA National Institute of Food and Agriculture, Hatch umbrella project #1015621. Funding for the Mass Spectrometry Facility used in this publication was made possible in part by the MJ Murdock Charitable Trust, the National Institute of General Medical Sciences of the National Institutes of Health under Award Numbers P20GM103474 and S10OD28650, and the MSU Office of Research, Economic Development and Graduate Education. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bothner B, 2005, VIROLOGY, V334, P17, DOI 10.1016/j.virol.2005.01.017; Clark DD, 2000, BIOCHEMISTRY-US, V39, P1294, DOI 10.1021/bi992282p; DEONARAIN MP, 1989, BIOCHEMISTRY-US, V28, P9602, DOI 10.1021/bi00451a008; Erb TJ, 2011, APPL ENVIRON MICROB, V77, P8466, DOI 10.1128/AEM.05702-11; Fontana A, 1997, J MOL BIOL, V266, P223, DOI 10.1006/jmbi.1996.0787; Frey P., 2007, ENZYMATIC REACTION M, P418; Guarnera E, 2017, BIOINFORMATICS, V33, P3996, DOI 10.1093/bioinformatics/btx430; Guarnera E, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004678; JANES W, 1990, J BIOL CHEM, V265, P10443; Kofoed MA, 2011, J BACTERIOL, V193, P4904, DOI 10.1128/JB.05231-11; Kopec J, 2011, J STRUCT BIOL, V175, P216, DOI 10.1016/j.jsb.2011.04.006; Kurochkin IV, 2017, BIOCHEMISTRY-US, V56, P228, DOI 10.1021/acs.biochem.6b00783; Matulis D, 2005, BIOCHEMISTRY-US, V44, P5258, DOI 10.1021/bi048135v; Motlagh HN, 2014, NATURE, V508, P331, DOI 10.1038/nature13001; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Nocek B, 2002, BIOCHEMISTRY-US, V41, P12907, DOI 10.1021/bi026580p; PAI EF, 1983, J BIOL CHEM, V258, P1752; Pandey AS, 2011, FEBS LETT, V585, P459, DOI 10.1016/j.febslet.2010.12.035; Pandey AS, 2006, BIOCHEMISTRY-US, V45, P113, DOI 10.1021/bi051518o; Prussia GA, 2021, J BIOL CHEM, V297, DOI 10.1016/j.jbc.2021.100961; Prussia GA, 2016, FEBS LETT, V590, P2991, DOI 10.1002/1873-3468.12325; Rayaprolu V., 2014, BIOPROTOC, V4, P1199; Rayaprolu V, 2013, J VIROL, V87, P13150, DOI 10.1128/JVI.01415-13; RIETVELD P, 1994, BIOCHEMISTRY-US, V33, P13888, DOI 10.1021/bi00250a043; Streit BR, 2019, J BIOL CHEM, V294, P5137, DOI 10.1074/jbc.RA118.005554; Swain JF, 2006, CURR OPIN STRUC BIOL, V16, P102, DOI 10.1016/j.sbi.2006.01.003; Tan ZW, 2020, NUCLEIC ACIDS RES, V48, pW116, DOI 10.1093/nar/gkaa338; Tee WV, 2018, PLOS COMPUT BIOL, V14, DOI 10.1371/journal.pcbi.1006228; Tokmina-Lukaszewska M., 2018, FRONT MICROBIOL, V9, P1; Uetrecht C, 2010, CHEM SOC REV, V39, P1633, DOI 10.1039/b914002f; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; Wright TA, 2017, J PHYS CHEM LETT, V8, P553, DOI 10.1021/acs.jpclett.6b02894; Yang ZY, 2016, BIOCHEMISTRY-US, V55, P3625, DOI 10.1021/acs.biochem.6b00421	34	0	0	3	4	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101884	10.1016/j.jbc.2022.101884	http://dx.doi.org/10.1016/j.jbc.2022.101884			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	1J8CQ	35367206	gold, Green Published			2022-12-26	WOS:000798142000006
J	Sanders, MJ; Ratinaud, Y; Neopane, K; Bonhoure, N; Day, EA; Ciclet, O; Lassueur, S; Pinta, MN; Deak, M; Brinon, B; Christen, S; Steinberg, GR; Barron, D; Sakamoto, K				Sanders, Matthew J.; Ratinaud, Yann; Neopane, Katyayanee; Bonhoure, Nicolas; Day, Emily A.; Ciclet, Olivier; Lassueur, Steve; Pinta, Martine Naranjo; Deak, Maria; Brinon, Benjamin; Christen, Stefan; Steinberg, Gregory R.; Barron, Denis; Sakamoto, Kei			Natural (dihydro)phenanthrene plant compounds are direct activators of AMPK through its allosteric drug and metabolite-binding site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMPROVES GLUCOSE-HOMEOSTASIS; PROTEIN-KINASE; HETEROTRIMERIC COMPLEXES; LIVER; IDENTIFICATION; METFORMIN; SALSALATE; MECHANISM; A-769662; UPSTREAM	AMP-activated protein kinase (AMPK) is a central energy sensor that coordinates the response to energy challenges to maintain cellular ATP levels. AMPK is a potential therapeutic target for treating metabolic disorders, and several direct synthetic activators of AMPK have been developed that show promise in preclinical models of type 2 diabetes. These compounds have been shown to regulate AMPK through binding to a novel allosteric drug and metabolite (ADaM)-binding site on AMPK, and it is possible that other molecules might similarly bind this site. Here, we performed a high-throughput screen with natural plant compounds to identify such direct allosteric activators of AMPK. We identified a natural plant dihydrophenathrene, Lusianthridin, which allosterically activates and protects AMPK from dephos-phorylation by binding to the ADaM site. Similar to other ADaM site activators, Lusianthridin showed preferential activation of AMPK beta 1-containing complexes in intact cells and was unable to activate an AMPK beta 1 S108A mutant. Lusianthridin dose-dependently increased phosphorylation of acetyl-CoA carboxylase in mouse primary hepatocytes, which led to a corresponding decrease in de novo lipogenesis. This ability of Lusianthridin to inhibit lipogenesis was impaired in hepatocytes from beta 1 S108A knock-in mice and mice bearing a mutation at the AMPK phosphorylation site of acetyl-CoA carboxylase 1/2. Finally, we show that activation of AMPK by natural compounds extends to several analogs of Lusian-thridin and the related chemical series, phenanthrenes. The emergence of natural plant compounds that regulate AMPK through the ADaM site raises the distinct possibility that other natural compounds share a common mechanism of regulation.	[Sanders, Matthew J.; Ratinaud, Yann; Neopane, Katyayanee; Bonhoure, Nicolas; Ciclet, Olivier; Lassueur, Steve; Pinta, Martine Naranjo; Deak, Maria; Brinon, Benjamin; Barron, Denis; Sakamoto, Kei] Soc Prod Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland; [Neopane, Katyayanee] Ecole Polytech Fed Lausanne EPFL, Sch Life Sci, Lausanne, Switzerland; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Ctr Metab Obes & Diabet Res, Hamilton, ON, Canada; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Day, Emily A.; Steinberg, Gregory R.] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada; [Christen, Stefan] Soc Prod Nestle SA, Nestle Inst Food Safety & Analyt Sci, Nestle Res, Lausanne, Switzerland; [Sakamoto, Kei] Univ Copenhagen, Novo Nord Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Nestle SA; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; McMaster University; McMaster University; McMaster University; Nestle SA; University of Copenhagen	Sanders, MJ; Sakamoto, K (corresponding author), Soc Prod Nestle SA, Nestle Inst Hlth Sci, Nestle Res, Lausanne, Switzerland.; Sakamoto, K (corresponding author), Univ Copenhagen, Novo Nord Fdn, Ctr Basic Metab Res, Copenhagen, Denmark.	matthew.sanders@rd.nestle.com; kei.sakamoto@sund.ku.dk	; Sakamoto, Kei/C-8806-2019	Ciclet, Olivier/0000-0002-0463-8189; Sakamoto, Kei/0000-0001-8839-5980; Sanders, Matthew James/0000-0001-6185-6337; Neopane, Katyayanee/0000-0002-6281-6588	Diabetes Canada Investigator Award [DI-5-17-5302-GS]; Canadian Institutes of Health Research Foundation [201709FDN-CEBA-116200]; Tier 1 Canada Research Chair; J. Bruce Duncan Endowed Chair in Metabolic Diseases; Novo Nordisk Foundation [NNF21OC0070257]	Diabetes Canada Investigator Award; Canadian Institutes of Health Research Foundation(Canadian Institutes of Health Research (CIHR)); Tier 1 Canada Research Chair(Canada Research Chairs); J. Bruce Duncan Endowed Chair in Metabolic Diseases; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited)	-G. R. S. is supported by a Diabetes Canada Investigator Award (grant no.: DI-5-17-5302-GS) , a Canadian Institutes of Health Research Foundation Grant (grant no.: 201709FDN-CEBA-116200) , a Tier 1 Canada Research Chair and a J. Bruce Duncan Endowed Chair in Metabolic Diseases. K. S. is supported by a project grant from the Novo Nordisk Foundation (grant no.: NNF21OC0070257) . The authors acknowledge the provision of ACC DKI mice to G.R.S. from Prof. Bruce Kemp, St. Vincents Institute of Medical Research, Australia.	Bailey CJ, 2017, DIABETOLOGIA, V60, P1566, DOI 10.1007/s00125-017-4318-z; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bhummaphan N, 2019, PHYTOMEDICINE, V62, DOI 10.1016/j.phymed.2019.152932; Boudaba N, 2018, EBIOMEDICINE, V28, P194, DOI 10.1016/j.ebiom.2018.01.008; Bultot L, 2016, AM J PHYSIOL-ENDOC M, V311, pE706, DOI 10.1152/ajpendo.00237.2016; Cakova V, 2017, AGING DIS, V8, P827, DOI 10.14336/AD.2017.0214; Calabrese MF, 2014, STRUCTURE, V22, P1161, DOI 10.1016/j.str.2014.06.009; Cameron KO, 2016, BIOORG MED CHEM LETT, V26, P5139, DOI 10.1016/j.bmcl.2016.09.065; Cokorinos EC, 2017, CELL METAB, V25, P1147, DOI 10.1016/j.cmet.2017.04.010; Cool B, 2006, CELL METAB, V3, P403, DOI 10.1016/j.cmet.2006.05.005; Coulerie P, 2016, J NAT PROD, V79, P2856, DOI 10.1021/acs.jnatprod.6b00628; Din FVN, 2012, GASTROENTEROLOGY, V142, P1504, DOI 10.1053/j.gastro.2012.02.050; Esquejo RM, 2018, EBIOMEDICINE, V31, P122, DOI 10.1016/j.ebiom.2018.04.009; Ford RJ, 2015, BIOCHEM J, V468, P125, DOI 10.1042/BJ20150125; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; FRITZEMEIER KH, 1983, EUR J BIOCHEM, V133, P545, DOI 10.1111/j.1432-1033.1983.tb07498.x; Fullerton MD, 2013, NAT MED, V19, P1649, DOI 10.1038/nm.3372; Gluais-Dagorn P, 2022, HEPATOL COMMUN, V6, P101, DOI 10.1002/hep4.1799; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Goldfine AB, 2013, ANN INTERN MED, V159, P1, DOI 10.7326/0003-4819-159-1-201307020-00003; Gowans GJ, 2013, CELL METAB, V18, P556, DOI 10.1016/j.cmet.2013.08.019; Hardie DG, 2011, GENE DEV, V25, P1895, DOI 10.1101/gad.17420111; Hardie DG, 2016, ACTA PHARM SIN B, V6, P1, DOI 10.1016/j.apsb.2015.06.002; Hawley SA, 2005, CELL METAB, V2, P9, DOI 10.1016/j.cmet.2005.05.009; Hawley SA, 1996, J BIOL CHEM, V271, P27879, DOI 10.1074/jbc.271.44.27879; Hawley SA, 2016, DIABETES, V65, P2784, DOI 10.2337/db16-0058; Hawley SA, 2012, SCIENCE, V336, P918, DOI 10.1126/science.1215327; Hawley SA, 2010, CELL METAB, V11, P554, DOI 10.1016/j.cmet.2010.04.001; Herzig S, 2018, NAT REV MOL CELL BIO, V19, P121, DOI 10.1038/nrm.2017.95; Hunter RW, 2018, NAT MED, V24, P1395, DOI 10.1038/s41591-018-0159-7; Hunter RW, 2014, CHEM BIOL, V21, P866, DOI 10.1016/j.chembiol.2014.05.014; Jenkins Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081870; Katsyuba E, 2020, NAT METAB, V2, P9, DOI 10.1038/s42255-019-0161-5; Klongkumnuankarn P, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/350410; Kopietz F, 2021, BIOCHEM J, V478, P633, DOI 10.1042/BCJ20200659; LaMoia TE, 2021, ENDOCR REV, V42, P77, DOI 10.1210/endrev/bnaa023; Leri M, 2020, INT J MOL SCI, V21, DOI 10.3390/ijms21041250; Marcinko K, 2015, MOL METAB, V4, P643, DOI 10.1016/j.molmet.2015.06.002; Myers RW, 2017, SCIENCE, V357, P507, DOI 10.1126/science.aah5582; Neumann D, 2003, PROTEIN EXPRES PURIF, V30, P230, DOI 10.1016/S1046-5928(03)00126-8; Ngoei KRW, 2018, CELL CHEM BIOL, V25, P728, DOI 10.1016/j.chembiol.2018.03.008; Oakhill JS, 2011, SCIENCE, V332, P1433, DOI 10.1126/science.1200094; Ou-yang SH, 2018, CHEM CENT J, V12, DOI 10.1186/s13065-018-0423-4; Patel K, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5535; Pinkosky SL, 2020, NAT METAB, V2, P873, DOI 10.1038/s42255-020-0245-2; Pollastro F, 2018, CURR MED CHEM, V25, P1160, DOI 10.2174/0929867324666170810164636; Rajamohan F, 2016, BIOCHEM J, V473, P581, DOI 10.1042/BJ20151051; Rena G, 2014, DIABETOL INT, V5, P212, DOI 10.1007/s13340-014-0177-8; Rhein P, 2021, MOL METAB, V51, DOI 10.1016/j.molmet.2021.101228; Salastekar N, 2017, DIABETES OBES METAB, V19, P1458, DOI 10.1111/dom.12940; Sanders MJ, 2007, J BIOL CHEM, V282, P32539, DOI 10.1074/jbc.M706543200; Scott JW, 2008, CHEM BIOL, V15, P1220, DOI 10.1016/j.chembiol.2008.10.005; Smith BK, 2016, DIABETES, V65, P3352, DOI 10.2337/db16-0564; Smith BK, 2016, AM J PHYSIOL-ENDOC M, V311, pE730, DOI 10.1152/ajpendo.00225.2016; Steinberg GR, 2019, NAT REV DRUG DISCOV, V18, P527, DOI 10.1038/s41573-019-0019-2; Steinberg GR, 2013, TRENDS ENDOCRIN MET, V24, P481, DOI 10.1016/j.tem.2013.06.002; Toth B, 2018, J NAT PROD, V81, P661, DOI [10.1021/acs.jnatprod.7b00619, 10.10]; Willows R, 2017, BIOCHEM J, V474, P1741, DOI 10.1042/BCJ20170046; Woods A, 2005, CELL METAB, V2, P21, DOI 10.1016/j.cmet.2005.06.005; Xiao B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms4017; Xiao B, 2011, NATURE, V472, P230, DOI 10.1038/nature09932	61	1	1	3	3	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		1083-351X		J BIOL CHEM	J. Biol. Chem.	MAY	2022	298	5							101852	10.1016/j.jbc.2022.101852	http://dx.doi.org/10.1016/j.jbc.2022.101852			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	2L7CP	35331736	gold, Green Published			2022-12-26	WOS:000817175700012
J	Nakladal, D; Lambooy, SPH; Misuth, S; Jepcova, D; Joschko, CP; van Buiten, A; Goris, M; Hoogstra-Berends, F; Kloosterhuis, NJ; Huijkman, N; van de Sluis, B; Diercks, GF; Buikema, JH; Henning, RH; Deelman, LE				Nakladal, D.; Lambooy, S. P. H.; Misuth, S.; Jepcova, D.; Joschko, C. P.; van Buiten, A.; Goris, M.; Hoogstra-Berends, F.; Kloosterhuis, N. J.; Huijkman, N.; van de Sluis, B.; Diercks, G. F.; Buikema, J. H.; Henning, R. H.; Deelman, L. E.			Homozygous whole body Cbs knockout in adult mice features minimal pathology during ageing despite severe homocysteinemia	FASEB JOURNAL			English	Article						cystathionine beta synthase deficiency; hydrogen sulfide; hyperhomocysteinemia; inducible mouse model; vascular dysfunction	CYSTATHIONINE-BETA-SYNTHASE; DEFICIENT MICE; RISK-FACTOR; HYDROGEN-SULFIDE; ANIMAL-MODEL; MOUSE MODEL; STEATOSIS; PHENOTYPE; FIBROSIS; DISEASE	Deficiencies in Cystathionine-beta-synthase (CBS) lead to hyperhomocysteinemia (HHCy), which is considered a risk factor for cardiovascular, bone and neurological disease. Moreover, CBS is important for the production of cysteine, hydrogen sulfide (H2S) and glutathione. Studying the biological role of CBS in adult mice has been severely hampered by embryological disturbances and perinatal mortality. To overcome these issues and assess the effects of whole-body CBS deficiency in adult mice, we engineered and characterized a Cre-inducible Cbs knockout model during ageing. No perinatal mortality occurred before Cbs(-/-) induction at 10 weeks of age. Mice were followed until 90 weeks of age and ablation of Cbs was confirmed in liver and kidney but not in brain. Severe HHCy was observed in Cbs(-/-) (289 +/- 58 mu M) but not in Cbs(+/-) or control mice (<10 mu M). Cbs(-/-) showed impaired growth, facial alopecia, endothelial dysfunction in absence of increased mortality, and signs of liver or kidney damage. CBS expression in skin localized to sebaceous glands and epidermis, suggesting local effects of Cbs(-/-) on alopecia. Cbs(-/-) showed increased markers of oxidative stress and senescence but expression of other H2S producing enzymes (CSE and 3-MST) was not affected. CBS deficiency severely impaired H2S production capacity in liver, but not in brain or kidney. In summary, Cbs(-/-) mice presented a mild phenotype without mortality despite severe HHCy. The findings demonstrate that HHCy is not directly linked to development of end organ damage.	[Nakladal, D.; Lambooy, S. P. H.; Misuth, S.; Jepcova, D.; Joschko, C. P.; van Buiten, A.; Goris, M.; Hoogstra-Berends, F.; Buikema, J. H.; Henning, R. H.; Deelman, L. E.] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Pharm & Pharmacol, Groningen, Netherlands; [Misuth, S.; Jepcova, D.] Comenius Univ, Fac Pharm, Dept Pharmacol & Toxicol, Bratislava, Slovakia; [Kloosterhuis, N. J.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, Dept Pediat, Groningen, Netherlands; [Huijkman, N.; van de Sluis, B.] Univ Groningen, Univ Med Ctr Groningen, iPSC CRISPR Ctr Groningen, Groningen, Netherlands; [Diercks, G. F.] Univ Groningen, Univ Med Ctr Groningen, Ctr Blistering Dis, Dept Dermatol, Groningen, Netherlands	University of Groningen; Comenius University Bratislava; University of Groningen; University of Groningen; University of Groningen	Nakladal, D; Deelman, LE (corresponding author), Univ Med Ctr Groningen UMCG, Dept Clin Pharm & Pharmacol, AP50,Hanzepl 1,POB 30001, NL-9700 RB Groningen, Netherlands.	d.nakladal@umcg.nl; l.e.deelman@umcg.nl		Joschko, Christian Paul/0000-0003-2267-5108; Nakladal, Dalibor/0000-0003-0900-0130; Diercks, Gilles/0000-0001-8053-216X; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365	Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen; Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI) [2019-017]	Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen; Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI)	DN was financially supported by an Abel Tasman PhD scholarship by the Graduate School of Medical Sciences, University of Groningen, University Medical Center Groningen and by Life Sciences and Health-Topconsortium voor Kennis en Innovatie (Stichting LSH-TKI): PPP project-2019-017	Akahoshi N, 2008, HUM MOL GENET, V17, P1994, DOI 10.1093/hmg/ddn097; Arndt S, 2017, J BIOL CHEM, V292, P7761, DOI 10.1074/jbc.M117.784678; Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243; BOUSHEY CJ, 1995, JAMA-J AM MED ASSOC, V274, P1049, DOI 10.1001/jama.274.13.1049; BRENTON D P, 1972, Journal of Bone and Joint Surgery British Volume, V54, P277; Chen XB, 2017, REDOX BIOL, V12, P987, DOI 10.1016/j.redox.2017.04.031; Cheng ZJ, 2011, BLOOD, V118, P1998, DOI 10.1182/blood-2011-01-333310; Dai YN, 2016, J CLIN BIOCHEM NUTR, V58, P76, DOI 10.3164/jcbn.15-54; Dayal S, 2012, BLOOD, V119, P3176, DOI 10.1182/blood-2011-09-380568; FOSMIRE GJ, 1990, AM J CLIN NUTR, V51, P225, DOI 10.1093/ajcn/51.2.225; Freund A, 2012, MOL BIOL CELL, V23, P2066, DOI 10.1091/mbc.E11-10-0884; Fukai T, 2011, ANTIOXID REDOX SIGN, V15, P1583, DOI 10.1089/ars.2011.3999; Ganguly P, 2015, NUTR J, V14, DOI 10.1186/1475-2891-14-6; Gupta S, 2021, FASEB J, V35, DOI 10.1096/fj.202100302R; Gupta S, 2014, FASEB J, V28, P781, DOI 10.1096/fj.13-240770; Gupta S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027598; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hameyer D, 2007, PHYSIOL GENOMICS, V31, P32, DOI 10.1152/physiolgenomics.00019.2007; Hanada K, 1998, J INVEST DERMATOL, V110, P259, DOI 10.1046/j.1523-1747.1998.00125.x; Hine C, 2018, ANTIOXID REDOX SIGN, V28, P1483, DOI 10.1089/ars.2017.7434; Jiang JY, 2016, CLIN EXP HYPERTENS, V38, P393, DOI 10.3109/10641963.2016.1148155; Jiang XH, 2005, ARTERIOSCL THROM VAS, V25, P2515, DOI 10.1161/01.ATV.0000189559.87328.e4; Kanagy NL, 2017, AM J PHYSIOL-CELL PH, V312, pC537, DOI 10.1152/ajpcell.00329.2016; KANG SS, 1992, ANNU REV NUTR, V12, P279, DOI 10.1146/annurev.nu.12.070192.001431; Karmin O, 2018, CURR MED CHEM, V25, P367, DOI 10.2174/0929867324666170509145240; Kim CS, 2011, CARDIOVASC RES, V92, P466, DOI 10.1093/cvr/cvr250; Lee HO, 2021, J INHERIT METAB DIS, V44, P1382, DOI 10.1002/jimd.12437; Leustek Thomas, 2002, Arabidopsis Book, V1, pe0017, DOI 10.1199/tab.0017; Li N, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6492469; Maclean KN, 2010, MOL GENET METAB, V101, P153, DOI 10.1016/j.ymgme.2010.06.010; Majtan T, 2018, MOL THER, V26, P834, DOI 10.1016/j.ymthe.2017.12.014; Park I, 2020, HUM MUTAT, V41, P1662, DOI 10.1002/humu.24072; Polhemus DJ, 2015, CARDIOVASC THER, V33, P216, DOI 10.1111/1755-5922.12128; QUENTIN R, 1990, EUR J CLIN MICROBIOL, V9, P138, DOI 10.1007/BF01963641; Rittie L, 2016, J INVEST DERMATOL, V136, P1792, DOI 10.1016/j.jid.2016.05.113; Robert K, 2005, GASTROENTEROLOGY, V128, P1405, DOI 10.1053/j.gastro.2005.02.034; Robert K, 2004, ANAT REC PART A, V280A, P1072, DOI 10.1002/ar.a.20082; Son P., 2021, HYPERHOMOCYSTEINEMIA; Speir RW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126622; Sundberg JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0205775; Ventura A, 2007, NATURE, V445, P661, DOI 10.1038/nature05541; Wang LQ, 2004, CIRC RES, V94, P1318, DOI 10.1161/01.RES.0000129182.46440.4a; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Hoss GRW, 2020, MOL GENET GENOM MED, V8, DOI 10.1002/mgg3.1214; Whiting DA, 2001, CLIN DERMATOL, V19, P211, DOI 10.1016/S0738-081X(00)00132-2; Wu DD, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/2715718; Yan WJ, 2021, CLIN EXP PHARMACOL P, V48, P524, DOI 10.1111/1440-1681.13442; Zaric BL, 2019, CURR MED CHEM, V26, P2948, DOI 10.2174/0929867325666180313105949; Zou CG, 2005, ANTIOXID REDOX SIGN, V7, P547, DOI 10.1089/ars.2005.7.547	49	0	0	1	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2022	36	4							e22260	10.1096/fj.202101550R	http://dx.doi.org/10.1096/fj.202101550R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ZZ0HD	35315960	Green Published, hybrid			2022-12-26	WOS:000772957100006
J	Jang, SH				Jang, Sou Hyun			Social-ecological factors related to preventive behaviors during the COVID-19 pandemic in South Korea	PLOS ONE			English	Article								Most studies on COVID-19 preventive behaviors have focused on single-level factors such as national policy, community social capital, or individuals' sociodemographic characteristics. Through a social-ecological model, this study attempts to comprehensively examine the multilevel factors associated with COVID-19 preventive practices in South Korea. Accordingly, a web survey involving 1,500 participants was conducted in December 2020. An ordinary least squares (OLS) regression was used to examine the multilevel factors (individual, interpersonal, community, and policy levels) related to COVID-19 preventive measures, which are based on wearing a mask, washing hands, covering the mouth when coughing or sneezing, and social distancing. When factors at each level were investigated, higher scores of COVID-19 fear and correct knowledge at the individual level, COVID-19 information share at the interpersonal level, and better evaluation of the national government policies in regard to COVID-19 at the policy level were positively associated with COVID-19 preventive behaviors. Community-level factors-neighborhood perception and community participation-were negatively significantly related to COVID-19 preventive behaviors. Additionally, older age, being female, and having a graduate-level education were positively related to better preventive behaviors. The findings of the current study suggest that multilevel efforts are needed to promote preventive behaviors. Specifically, more effort to alleviate COVID-19-related fear and disseminate correct knowledge among Korean citizens is needed as the individual-level characteristics explained the preventive behaviors more than the factors at upper levels.	[Jang, Sou Hyun] Korea Univ, Dept Sociol, Seoul, South Korea	Korea University	Jang, SH (corresponding author), Korea Univ, Dept Sociol, Seoul, South Korea.	soujang@korea.ac.kr			Presidential Commission on Policy Planning of South Korea [2020090A72B - 00]	Presidential Commission on Policy Planning of South Korea	This work is supported by the Presidential Commission on Policy Planning of South Korea (#2020090A72B - 00).	Ahorsu DK, 2022, INT J MENT HEALTH AD, V20, P1537, DOI 10.1007/s11469-020-00270-8; Al-Hanawi MK, 2020, FRONT PUBLIC HEALTH, V8, DOI 10.3389/fpubh.2020.00217; Anderson RM, 2020, LANCET, V395, P931, DOI 10.1016/S0140-6736(20)30567-5; [Anonymous], 1997, STERN BUSINESS MAGAZ; Azlan AA, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0233668; Bai John(Jianqiu)., 2020, SSRN ELECT J, DOI [https://doi.org/10.2139/ssrn.3609001, DOI 10.2139/SSRN.3609001]; Bartscher AK, 2021, J HEALTH ECON, V80, DOI 10.1016/j.jhealeco.2021.102531; Borgonovi F, 2020, SOC SCI MED, V265, DOI 10.1016/j.socscimed.2020.113501; Boulton ER, 2018, HEALTH EXPECT, V21, P239, DOI 10.1111/hex.12608; Capraro V, 2020, J BEHAV EC POLICY, V4, P45, DOI [DOI 10.31234/OSF.IO/TG7VZ, 10.31234/osf.io/tg7vz]; Cartaud A, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0243023; CDC, PROT YOURS OTH; CDC. Centers for Disease Control and Prevention, SOC EC MOD FRAM PREV; Chen CC, 2020, NAT REV CHEM, V4, P114, DOI [10.1038/s41562-020-0909-7, 10.1038/s41570-020-0163-6]; COLEMAN JS, 1988, AM J SOCIOL, V94, pS95, DOI 10.1086/228943; Dror AA, 2020, EUR J EPIDEMIOL, V35, P775, DOI 10.1007/s10654-020-00671-y; Dryhurst S, 2020, J RISK RES, V23, P994, DOI 10.1080/13669877.2020.1758193; Durante R., CIVIC CAPITAL SOCIAL; Elgar FJ, 2020, SOC SCI MED, V263, DOI 10.1016/j.socscimed.2020.113365; Ferdous MZ, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0239254; Fisher Max, NEW YORK TIMES; Gilchrist K, MALDIVES OFFER HOLID; Guiso L., 2011, HDB SOCIAL EC, V1, P417, DOI [DOI 10.1016/B978-0-444-53187-2.00010-3, 10.1016/B978-0-444-53187-2.00010-3]; Hennein R, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0246602; Iorfa SK, 2020, FRONT PSYCHOL, V11, DOI 10.3389/fpsyg.2020.566773; Islam N, 2021, J EPIDEMIOL COMMUN H, V75, P496, DOI 10.1136/jech-2020-215626; Jordan J., 2020, DONT GET IT DONT SPR, DOI DOI 10.31234/OSF.IO/YUQ7X; Latkin CA, 2021, SOC SCI MED, V270, DOI 10.1016/j.socscimed.2021.113684; Lee David, 2020, Transp Res Interdiscip Perspect, V5, P100111, DOI 10.1016/j.trip.2020.100111; MCLEROY KR, 1988, HEALTH EDUC QUART, V15, P351, DOI 10.1177/109019818801500401; Morales C., NEW YORK TIMES; Murakami M, 2020, ENVIRON SCI TECHNOL, V54, P5311, DOI 10.1021/acs.est.0c02172; Murphy J, 2021, NAT COMMUN, V12, DOI 10.1038/s41467-020-20226-9; Niepel C., CORONAVIRUS SARS COV, DOI [10.31234/osf.io/w52e9, DOI 10.31234/OSF.IO/W52E9]; Oh J, 2020, HEALTH SYST REFORM, V6, DOI 10.1080/23288604.2020.1753464; Razzaghi Hilda, 2020, MMWR Morb Mortal Wkly Rep, V69, P945, DOI 10.15585/mmwr.mm6929a1; Reznik A, 2021, INT J MENT HEALTH AD, V19, P1903, DOI 10.1007/s11469-020-00283-3; Song YE, 2021, ASIA-PAC J PUBLIC HE, V33, P620, DOI 10.1177/10105395211014705; Spadaro G, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0237934; STOKOLS D, 1992, AM PSYCHOL, V47, P6, DOI 10.1037/0003-066X.47.1.6; Tuncgenc B, 2021, BRIT J PSYCHOL, V112, P763, DOI 10.1111/bjop.12491; Wold B, 2018, SCAND J PUBLIC HEALT, V46, P20, DOI 10.1177/1403494817743893; World Health Organization, COR DIS COVID 19 HER; World Health Organization, ECOLOGICAL FRAMEWORK; World Health Organization (WHO), COVID 19 ADV PUBL GE; Wu C, 2021, CHINESE SOCIOL REV, V53, P27, DOI 10.1080/21620555.2020.1814139; Wu C, 2020, SOC SCI RES, V91, DOI 10.1016/j.ssresearch.2020.102449; Yildirim M, 2021, PSYCHOL HEALTH MED, V26, P35, DOI 10.1080/13548506.2020.1776891; Zhong BL, 2020, INT J BIOL SCI, V16, P1745, DOI 10.7150/ijbs.45221	49	2	2	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 31	2022	17	3							e0266264	10.1371/journal.pone.0266264	http://dx.doi.org/10.1371/journal.pone.0266264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1M2UI	35358264	gold, Green Published			2022-12-26	WOS:000799828800087
J	Tu, YM; Xu, L; Xu, J; Bao, ZY; Tian, W; Ye, YF; Sun, GC; Miao, Z; Chao, HL; You, YP; Liu, N; Ji, J				Tu, Yiming; Xu, Lei; Xu, Jia; Bao, Zhongyuan; Tian, Wei; Ye, Yangfan; Sun, Guangchi; Miao, Zong; Chao, Honglu; You, Yongping; Liu, Ning; Ji, Jing			Loss of deubiquitylase USP2 triggers development of glioblastoma via TGF-beta signaling	ONCOGENE			English	Article							CELL-PROLIFERATION; SMAD7; UBIQUITINATION; DEGRADATION; METHYLATION; SIGNATURE; PROTEIN	Glioblastoma (GBM) is the most aggressive primary brain tumor as one of the deadliest cancers. The TGF-beta signaling acts as an oncogenic factor in GBM, and plays vital roles in development of GBM. SMAD7 is a major inhibitor of TGF-beta signaling, while the deubiquitination of SMAD7 has been poorly studied in GBM. Here, we found USP2 as a new prominent candidate that could regulate SMAD7 stability. USP2 was lost in GBM, leading to the poor prognosis in patients. Moreover, aberrant DNA methylation mediated by DNMT3A induced the low expression of USP2 in GBM. USP2 depletion induced TGF-beta signaling and progression of GBM. In contrast, overexpressed USP2 suppressed TGF-beta signaling and GBM development. Specifically, USP2 interacted with SMAD7 and prevented SMAD7 ubiquitination. USP2 directly cleaved Lys27- and Lys48-linked poly-ubiquitin chains of SMAD7, and Lys27-linked poly-ubiquitin chains of SMAD7 K185 mediated the recruitment of SMAD7 to HERC3, which regulated Lys63-linked poly-ubiquitination of SMAD7. Moreover, we demonstrated that the DNMT3A inhibitor SGI-1027 induced USP2, suppressed TGF-beta signaling and GBM development. Thus, USP2 repressed development of GBM by inhibition TGF-beta signaling pathway via the deubiquitination of SMAD7.	[Tu, Yiming; Xu, Lei; Xu, Jia; Bao, Zhongyuan; Tian, Wei; Ye, Yangfan; Sun, Guangchi; Miao, Zong; Chao, Honglu; You, Yongping; Liu, Ning; Ji, Jing] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China; [You, Yongping; Ji, Jing] Nanjing Med Univ, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Inst Brain Tumors, Nanjing, Jiangsu, Peoples R China; [Ji, Jing] Nanjing Med Univ, Gusu Sch, Suzhou, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Ji, J (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China.; Ji, J (corresponding author), Nanjing Med Univ, Jiangsu Collaborat Innovat Ctr Canc Personalized, Jiangsu Key Lab Canc Biomarkers Prevent & Treatme, Inst Brain Tumors, Nanjing, Jiangsu, Peoples R China.; Ji, J (corresponding author), Nanjing Med Univ, Gusu Sch, Suzhou, Peoples R China.	jijing@njmu.edu.cn			National Natural Science Foundation of China [82120108018, 81972153]; China Postdoctoral Science Foundation [2021M701495]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) [JX10231803]; Gusu School, Nanjing Medical University [GSKY202201010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Gusu School, Nanjing Medical University	This study was supported by grants from the National Natural Science Foundation of China (82120108018 and 81972153), China Postdoctoral Science Foundation (2021M701495), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD, Grant No. JX10231803), and Gusu School, Nanjing Medical University (GSKY202201010).	Anido J, 2010, CANCER CELL, V18, P655, DOI 10.1016/j.ccr.2010.10.023; Behnan J, 2019, BRAIN, V142, P847, DOI 10.1093/brain/awz044; Bhat KPL, 2013, CANCER CELL, V24, P331, DOI 10.1016/j.ccr.2013.08.001; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chai RC, 2021, J HEMATOL ONCOL, V14, DOI 10.1186/s13045-021-01124-z; De Boeck M, 2012, UPSALA J MED SCI, V117, P153, DOI 10.3109/03009734.2012.654858; Dixit D, 2021, CANCER DISCOV, V11, P480, DOI 10.1158/2159-8290.CD-20-0331; Feinberg AP, 2004, NAT REV CANCER, V4, P143, DOI 10.1038/nrc1279; Gu XH, 2018, AM J TRANSL RES, V10, P2834; He JB, 2019, CELL DEATH DIS, V10, DOI 10.1038/s41419-019-1512-6; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Imamura T, 2013, J BIOCHEM, V154, P481, DOI 10.1093/jb/mvt097; Izzi L, 2004, ONCOGENE, V23, P2071, DOI 10.1038/sj.onc.1207412; Jiang T, 2021, CANCER LETT, V499, P60, DOI 10.1016/j.canlet.2020.10.050; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Koinuma D, 2003, EMBO J, V22, P6458, DOI 10.1093/emboj/cdg632; Li H, 2019, CLIN CANCER RES, V25, P3602, DOI 10.1158/1078-0432.CCR-18-3791; Lui SKL, 2017, EMBO REP, V18, P797, DOI 10.15252/embr.201643270; Nakao A, 1997, NATURE, V389, P631, DOI 10.1038/39369; Niederlander C, 2001, NATURE, V410, P830, DOI 10.1038/35071103; Park SH, 2015, MOL CELLS, V38, P20, DOI 10.14348/molcells.2015.2120; Qu Q, 2015, TUMOR BIOL, V36, P5415, DOI 10.1007/s13277-015-3207-7; Sanai N, 2018, CLIN CANCER RES, V24, P3820, DOI 10.1158/1078-0432.CCR-17-3348; Song B, 2019, J CLIN INVEST, V129, P569, DOI 10.1172/JCI122367; Song YF, 2020, NEURO-ONCOLOGY, V22, P46, DOI 10.1093/neuonc/noz136; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Tang YL, 2019, GASTROENTEROLOGY, V156, P692, DOI 10.1053/j.gastro.2018.10.023; Tong L, 2020, CELL DEATH DIFFER, V27, P1795, DOI 10.1038/s41418-019-0459-6; Tu YM, 2020, CLIN CANCER RES, V26, P1749, DOI 10.1158/1078-0432.CCR-19-1515; Wang QH, 2018, CANCER CELL, V33, P152, DOI 10.1016/j.ccell.2017.12.012; Wang QX, 2018, THERANOSTICS, V8, P4733, DOI 10.7150/thno.26550; Wiesner S, 2007, CELL, V130, P651, DOI 10.1016/j.cell.2007.06.050; Wu X, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-12145-1; Xu TH, 2020, NATURE, V586, P151, DOI 10.1038/s41586-020-2747-1; Yan XH, 2009, ACTA BIOCH BIOPH SIN, V41, P263, DOI 10.1093/abbs/gmp018; Yin Q, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-09844-0; Zhang JR, 2020, CELL DEATH DIFFER, V27, P2710, DOI 10.1038/s41418-020-0538-8; Zhang QT, 2019, NAT CELL BIOL, V21, P179, DOI 10.1038/s41556-018-0264-3; Zhang SP, 2007, MOL CELL BIOL, V27, P4488, DOI 10.1128/MCB.01636-06; Zhang ZK, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02029-7; Zhao YG, 2011, J BIOL CHEM, V286, P40520, DOI 10.1074/jbc.M111.292961	41	1	1	4	6	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	APR 29	2022	41	18					2597	2608		10.1038/s41388-022-02275-0	http://dx.doi.org/10.1038/s41388-022-02275-0		MAR 2022	12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	0W4LA	35332268				2022-12-26	WOS:000772732900001
J	Akhtar, N; Kamran, S; Al-Jerdi, S; Imam, Y; Joseph, S; Morgan, D; Abokersh, M; Uy, RT; Shuaib, A				Akhtar, Naveed; Kamran, Saadat; Al-Jerdi, Salman; Imam, Yahia; Joseph, Sujatha; Morgan, Deborah; Abokersh, Mohamed; Uy, R. T.; Shuaib, Ashfaq			Trends in stroke admissions before, during and post-peak of the COVID-19 pandemic: A one-year experience from the Qatar stroke database	PLOS ONE			English	Article							EVENTS; RISK	Background Several reports document a decrease in the rates of stroke hospital admissions during the covid-19 pandemic. There is very little information whether the admission rates will change as the infection is controlled. We report on our rates of admissions before, during and following the peak of covid-19 infections in a prospective database from Qatar. Methods and results The stroke admissions in the six months prior to COVID-19 pandemic averaged 229/month. There was a decrease to 157/month in March-June during the peak of the pandemic. In the 6 months following the peak, as covid-19 numbers began to decrease, the average numbers increased back to 192/month. There was an increase in severe ischemic strokes and decreased in functional recovery. The decreased admissions were mainly driven by fewer stroke mimics. Patients presenting with ischemic stroke or cerebral hemorrhage remained unchanged. Conclusions Fewer stroke mimics presenting to the hospital can explain the fewer admissions and poor outcome at the height of the covid-19 pandemic. The continued decrease in the number of ischemic stroke and stroke mimic admissions following the pandemic peak requires more study.	[Akhtar, Naveed; Kamran, Saadat; Imam, Yahia; Joseph, Sujatha; Morgan, Deborah; Abokersh, Mohamed; Uy, R. T.] Hamad Med Corp, Neurosci Inst, Doha, Qatar; [Al-Jerdi, Salman] Weill Cornell Med Coll, Qatar Fdn, Doha, Qatar; [Shuaib, Ashfaq] Univ Alberta, Dept Med, Neurol Div, Edmonton, AB, Canada	Hamad Medical Corporation; Qatar Foundation (QF); Weill Cornell Medical College Qatar; University of Alberta	Shuaib, A (corresponding author), Univ Alberta, Dept Med, Neurol Div, Edmonton, AB, Canada.	ashfaq.shuaib@ualberta.ca		Shuaib, Ashfaq/0000-0002-3380-7068	Hamad Medical Corporation [16016/16]	Hamad Medical Corporation	Dr.Naveed Akhtar received funding for the grant 16016/16 from Hamad Medical Corporation. No role of the sponsor in the study.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; de Sousa DA, 2020, STROKE, V51, P1921, DOI 10.1161/STROKEAHA.120.030792; Akhtar N, 2021, BMJ NEUROL OPEN, V3, DOI 10.1136/bmjno-2020-000084; Akhtar N, 2016, EUR STROKE J, V1, P231, DOI 10.1177/2396987316663776; Akhtar N, 2015, STROKE, V46, P3494, DOI 10.1161/STROKEAHA.115.010552; Bullrich MB, 2020, CAN J NEUROL SCI, V47, P693, DOI 10.1017/cjn.2020.101; Butt AA, 2020, PUBLIC HEALTH, V189, P6, DOI 10.1016/j.puhe.2020.09.010; Clerkin KJ, 2020, CIRCULATION, V141, P1648, DOI 10.1161/CIRCULATIONAHA.120.046941; Diegoli H, 2020, STROKE, V51, P2315, DOI 10.1161/STROKEAHA.120.030481; Dowlatshahi D, 2021, CAN J NEUROL SCI, V48, P118, DOI 10.1017/cjn.2020.193; Grau AJ, 2010, NAT REV NEUROL, V6, P681, DOI 10.1038/nrneurol.2010.163; Hall ME, 2020, J CARD FAIL, V26, P462, DOI 10.1016/j.cardfail.2020.05.005; Holt A, 2020, EUR HEART J, V41, P3072, DOI 10.1093/eurheartj/ehaa494; Hoyer C, 2020, STROKE, V51, P2224, DOI 10.1161/STROKEAHA.120.030395; Imam YZ, 2020, INT J STROKE, V15, P85, DOI 10.1177/1747493019830577; Kato A, 2020, J THROMB THROMBOLYS, V49, P377, DOI 10.1007/s11239-020-02074-y; Katsouras C, 2021, EUR J NEUROL, V28, P3452, DOI 10.1111/ene.14666; Kristoffersen ES, 2021, NEUROL SCI, V42, P791, DOI 10.1007/s10072-021-05039-y; Kristoffersen ES, 2020, ACTA NEUROL SCAND, V142, P632, DOI 10.1111/ane.13307; Kuitunen I, 2020, SCAND J TRAUMA RESUS, V28, DOI 10.1186/s13049-020-00810-0; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Mafham MM, 2020, LANCET, V396, P381, DOI 10.1016/S0140-6736(20)31356-8; Mariet AS, 2021, STROKE, V52, P1362, DOI 10.1161/STROKEAHA.120.032312; Matschke J, 2020, LANCET NEUROL, V19, P919, DOI 10.1016/S1474-4422(20)30308-2; Mehrpour M, 2021, INT J STROKE, V16, P1047, DOI 10.1177/1747493020937397; Meza HT, 2020, INT J STROKE, V15, P755, DOI 10.1177/1747493020938301; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Padmanabhan N, 2021, NEUROL SCI, V42, P15, DOI 10.1007/s10072-020-04775-x; Pasarikovski CR, 2020, CAN J NEUROL SCI, V47, P847, DOI 10.1017/cjn.2020.116; Perry R, 2020, J NEUROL, V267, P3457, DOI 10.1007/s00415-020-10030-2; Powers, 2019, STROKE, V50, pE440, DOI 10.1161/STR.0000000000000215; Qian ZH, 2016, J STROKE CEREBROVASC, V25, P1746, DOI 10.1016/j.jstrokecerebrovasdis.2016.03.027; Rudilosso S, 2020, STROKE, V51, P1991, DOI 10.1161/STROKEAHA.120.030329; Sacco S, 2020, STROKE, V51, P3746, DOI 10.1161/STROKEAHA.120.031293; Schlachetzki F, 2021, CEREBROVASC DIS, V50, P317, DOI 10.1159/000514154; Schwarz V, 2020, CLIN RES CARDIOL, V109, P1500, DOI 10.1007/s00392-020-01688-9; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Uchino K, 2020, STROKE, V51, P2544, DOI 10.1161/STROKEAHA.120.030331; Wichmann D, 2020, ANN INTERN MED, V173, P268, DOI 10.7326/M20-2003; Wu YQ, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.584734	40	0	0	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0255185	10.1371/journal.pone.0255185	http://dx.doi.org/10.1371/journal.pone.0255185			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324905	Green Published, gold			2022-12-26	WOS:000780951300003
J	Bragato, JP; Rebech, GT; de Freitas, JH; dos Santos, MO; Costa, SF; Eugenio, FD; dos Santos, PSP; de Lima, VMF				Bragato, Jaqueline Poleto; Rebech, Gabriela Torres; de Freitas, Jessica Henrique; dos Santos, Marilene Oliveira; Costa, Sidnei Ferro; Eugenio, Flavia de Rezende; Patto dos Santos, Paulo Sergio; Felix de Lima, Valeria Marcal			miRNA-21 regulates CD69 and IL-10 expression in canine leishmaniasis	PLOS ONE			English	Article							VISCERAL LEISHMANIASIS; INTERFERON-GAMMA; PERIPHERAL-BLOOD; IMMUNE-RESPONSE; DOGS; CELLS; RECEPTOR; SPLEEN; APOPTOSIS; CYTOKINE	Visceral leishmaniasis in humans is a chronic and fatal disease if left untreated. Canine leishmaniasis (CanL) is a severe public health problem because infected animals are powerful transmitters of the parasite to humans via phlebotomine vectors. Therefore, dogs are an essential target for control measures. Progression of canine infection is accompanied by failure of cellular immunity with reduction of circulating lymphocytes and increased cytokines that suppress macrophage function. Studies showed that the regulation of the effector function of macrophages and T cells appears to depend on miRNAs; miRNA-21 (miR-21) shows increased expression in splenic leukocytes of dogs with CanL and targets genes related to the immune response. Mimics and inhibitors of miR-21 were used in vitro to transfect splenic leukocytes from dogs with CanL. After transfection, expression levels of the proteins FAS, FASL, CD69, CCR7, TNF-alpha, IL-17, IFN-gamma, and IL-10 were measured. FAS, FASL, CD69, and CCR7 expression levels decreased in splenic leukocytes from dogs with CanL. The miR-21 mimic decreased CD69 expression in splenic leukocytes from CanL and healthy groups. The miR-21 inhibitor decreased IL-10 levels in culture supernatants from splenic leukocytes in the CanL group. These findings suggest that miR-21 alters the immune response in CanL; therefore, miR-21 could be used as a possible therapeutic target for CanL.	[Bragato, Jaqueline Poleto; Rebech, Gabriela Torres; de Freitas, Jessica Henrique; dos Santos, Marilene Oliveira; Costa, Sidnei Ferro; Eugenio, Flavia de Rezende; Patto dos Santos, Paulo Sergio; Felix de Lima, Valeria Marcal] Sao Paulo State Univ, Sch Vet Med, Dept Anim Clin Surg & Reprod, Aracatuba, SP, Brazil	Universidade Estadual Paulista	de Lima, VMF (corresponding author), Sao Paulo State Univ, Sch Vet Med, Dept Anim Clin Surg & Reprod, Aracatuba, SP, Brazil.	valeria.lima@unesp.br			Sao Paulo Research Foundation (FAPESP) [2018/17261-5, 2018/16239-6]; National Council for Scientific and Technological Development (CNPq) [302165/2018-5, 140460/2018-7]; Coordination for the Improvement of Higher Education Personnel (CAPES) [001]; FAPESP [2018/17261-5, 2018/16239-6]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for the Improvement of Higher Education Personnel (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Sao Paulo Research Foundation (FAPESP) (www.fapesp.br), grant 2018/17261-5 and 2018/16239-6; National Council for Scientific and Technological Development (CNPq), process 302165/2018-5 and 140460/2018-7. This study was also partially financed by the Coordination for the Improvement of Higher Education Personnel (CAPES) - Finance Code 001 (student supported: (GTR, JHF, MOS, SFC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. VMFL GRANT FAPESP 2018/17261-5 JPB SCHOLARSHIP FAPESP 2018/16239-6.	Alexander J, 1999, J CELL SCI, V112, P2993; Ato M, 2002, NAT IMMUNOL, V3, P1185, DOI 10.1038/ni861; Bacellar O, 2000, CYTOKINE, V12, P1228, DOI 10.1006/cyto.2000.0694; BADARO R, 1986, J INFECT DIS, V154, P639, DOI 10.1093/infdis/154.4.639; Barbieri CL, 2006, PARASITE IMMUNOL, V28, P329, DOI 10.1111/j.1365-3024.2006.00840.x; BARRAL A, 1993, P NATL ACAD SCI USA, V90, P3442, DOI 10.1073/pnas.90.8.3442; Boggiatto PM, 2010, CLIN VACCINE IMMUNOL, V17, P267, DOI 10.1128/CVI.00456-09; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Bragato JP, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206876; Christodoulou V, 2011, EXP PARASITOL, V128, P279, DOI 10.1016/j.exppara.2011.02.022; Cibrian D, 2017, EUR J IMMUNOL, V47, P946, DOI 10.1002/eji.201646837; de Lima VMF, 2005, PESQUISA VET BRASIL, V25, P215, DOI 10.1590/S0100-736X2005000400005; de Lima VMF, 2012, VET PARASITOL, V184, P147, DOI 10.1016/j.vetpar.2011.08.024; Forster R, 1999, CELL, V99, P23, DOI 10.1016/S0092-8674(00)80059-8; Lage RS, 2007, VET IMMUNOL IMMUNOP, V115, P135, DOI 10.1016/j.vetimm.2006.10.001; Lee K, 2009, GLOB INST, P1; Nascimento MSL, 2015, J INFECT DIS, V211, P1015, DOI 10.1093/infdis/jiu531; Lima VMF, 2003, BRAZ J MED BIOL RES, V36, P485, DOI 10.1590/S0100-879X2003000400010; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Correa APFL, 2007, VET PARASITOL, V143, P267, DOI 10.1016/j.vetpar.2006.08.023; MANCIANTI F, 1988, T ROY SOC TROP MED H, V82, P566, DOI 10.1016/0035-9203(88)90510-X; Martin P, 2010, MOL CELL BIOL, V30, P4877, DOI 10.1128/MCB.00456-10; de Almeida BFM, 2017, IMMUNOBIOLOGY, V222, P693, DOI 10.1016/j.imbio.2016.12.006; Melo LM, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226192; Moreno J, 2002, TRENDS PARASITOL, V18, P399, DOI 10.1016/S1471-4922(02)02347-4; Namdari H, 2017, IRAN J ALLERGY ASTHM, V16, P235; Nascimento MSL, 2015, J COMP PATHOL, V153, P197, DOI 10.1016/j.jcpa.2015.10.174; Silva KLO, 2013, VET PARASITOL, V197, P470, DOI 10.1016/j.vetpar.2013.07.012; Papadogiannakis EI, 2015, VET IMMUNOL IMMUNOP, V163, P94, DOI 10.1016/j.vetimm.2014.11.011; PINELLI E, 1994, INFECT IMMUN, V62, P229, DOI 10.1128/IAI.62.1.229-235.1994; Sanches LD, 2016, REV BRAS PARASITOL V, V25, P465, DOI [10.1590/S1984-29612016071, 10.1590/s1984-29612016071]; Shi L, 2019, INT IMMUNOPHARMACOL, V74, DOI 10.1016/j.intimp.2019.105698; Smigielska-Czepiel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076217; Solano-Gallego L, 2009, VET PARASITOL, V165, P1, DOI 10.1016/j.vetpar.2009.05.022; Solano-Gallego L, 2016, PARASITE VECTOR, V9, DOI [10.1186/s13071-015-1240-4, DOI 10.1186/S13071-015-1240-4]; Strasser A, 2009, IMMUNITY, V30, P180, DOI 10.1016/j.immuni.2009.01.001; TESTI R, 1994, IMMUNOL TODAY, V15, P479, DOI 10.1016/0167-5699(94)90193-7; Tsagozis P, 2003, PARASITE IMMUNOL, V25, P569, DOI 10.1111/j.0141-9838.2004.00672.x; Wang H, 2017, ONCOTARGET, V8, P94069, DOI 10.18632/oncotarget.21578	39	0	0	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265192	10.1371/journal.pone.0265192	http://dx.doi.org/10.1371/journal.pone.0265192			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324917	gold, Green Published			2022-12-26	WOS:000780951300032
J	Conan, N; Simons, E; Chihana, ML; Ohler, L; FordKamara, E; Mbatha, M; VanCutsem, G; Huerga, H				Conan, Nolwenn; Simons, Erica; Chihana, Menard L.; Ohler, Liesbet; FordKamara, Ellie; Mbatha, Mduduzi; VanCutsem, Gilles; Huerga, Helena			Increase in HIV viral suppression in KwaZulu-Natal, South Africa: Community-based cross sectional surveys 2018 and 2013. What remains to be done?	PLOS ONE			English	Article							ANTIRETROVIRAL THERAPY; ACCESS	Introduction High coverage of antiretroviral therapy (ART) in people living with HIV (PLHIV) increases viral suppression at population level and may reduce incidence. Medecins sans Frontieres, in collaboration with the South African Department of Health, has been working in Eshowe/ Mbongolwane (KwaZulu Natal) since 2011 to increase access to quality HIV services. Five years after an initial survey, we conducted a second survey to measure progress in HIV diagnosis and viral suppression and to identify remaining gaps. Methods A cross-sectional, population-based, stratified two-stage cluster survey was implemented in 2018, using the same design as in 2013. Consenting participants aged 15-59 years were interviewed and tested for HIV at home. Those HIV-positive were tested for HIV viral load (viral suppression defined as <1000 copies/mL). Results Overall, 3,278 individuals were included. The proportion of HIV-positive participants virally suppressed was 83.8% in 2018 compared to 57.1% in 2013 (p< 0.001), with increases in all subpopulations. The largest gap remained in men aged 15-29 years, among whom viral suppression was 51.5%. Nevertheless, of the total unsuppressed participants, 60.3% were women, and 57.4% were individuals aged 30-59 years. Between 2013 and 2018, HIV-positive status awareness progressed from 75.2% to 89.9% and ART coverage among those aware from 70.4% to 93.8%, respectively. Among those on ART, 94.5% were virally suppressed in 2018. Conclusions Viral suppression improved significantly from 2013 to 2018, in all age and gender groups of PLHIV. However, almost half of HIV-positive young men remained unsuppressed, while the majority of virally unsuppressed PLHIV were women and older adults. To continue lowering HIV transmission, specific strategies are needed to increase viral suppression in those groups.	[Conan, Nolwenn; Simons, Erica; Chihana, Menard L.; Huerga, Helena] Epicentre, Paris, France; [Ohler, Liesbet; FordKamara, Ellie] Med Sans Frontieres, Eshowe, South Africa; [Mbatha, Mduduzi] Dept Hlth South Africa, Cape Town, South Africa; [VanCutsem, Gilles] Med Sans Frontieres, Southern Africa Med Unit, Cape Town, South Africa; [VanCutsem, Gilles] Univ Cape Town, Ctr Infect Dis Epidemiol & Res, Cape Town, South Africa	University of Cape Town	Conan, N (corresponding author), Epicentre, Paris, France.	nolwenn.conan@epicentre.msf.org	Conan, Nolwenn/GXV-2604-2022	Conan, Nolwenn/0000-0002-7182-4934	Medecins Sans Frontieres -Operational Centre Brussels	Medecins Sans Frontieres -Operational Centre Brussels	This survey was funded by Medecins Sans Frontieres -Operational Centre Brussels. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2017, 5 S AFR NAT HIV PREV; [Anonymous], 2015, NAT HIV COUNS TEST P; [Anonymous], 2017, S AFRICAS NATL STRAT; Bacaer N, 2010, B MATH BIOL, V72, P2180, DOI 10.1007/s11538-010-9535-2; Bemelmans M, 2010, TROP MED INT HEALTH, V15, P1413, DOI 10.1111/j.1365-3156.2010.02649.x; Bilinski A, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185699; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Eisinger RW, 2018, JAMA-J AM MED ASSOC, V190; Furtado J, 2014, SAO PAULO MED J, V132, P383, DOI 10.1590/1516-3180.20141326T2; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Grobler A, 2017, LANCET HIV, V4, pE505, DOI 10.1016/S2352-3018(17)30122-4; Huerga H, 2018, BMC PUBLIC HEALTH, V18, DOI 10.1186/s12889-018-5208-0; Huerga H, 2017, BMC INFECT DIS, V17, DOI 10.1186/s12879-017-2740-y; Huerga H, 2016, JAIDS-J ACQ IMM DEF, V73, P411, DOI 10.1097/QAI.0000000000001081; Joint United Nations Programme on HIV/AIDS, 2017, 90 90 90 AMB TREATM; LeMessurier J, 2018, CAN MED ASSOC J, V190, pE1350, DOI 10.1503/cmaj.180311; Lyamuya EF, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-19; Piwowar-manning E, 2011, J INT ASS PHYS AIDS, V9, P170; Rodger AJ, 2019, LANCET, V393, P2428, DOI 10.1016/S0140-6736(19)30418-0; Statistics South Africa, 2011, CENS 2011 MUN REP GA; Takuva S, 2017, AIDS, V31, P545, DOI 10.1097/QAD.0000000000001340; WHO, 2017, WHO PREQ DIAGN PROGR; World Health Organization, 2015, GLOB ACT PLAN ANT RE	23	1	1	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0265488	10.1371/journal.pone.0265488	http://dx.doi.org/10.1371/journal.pone.0265488			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324923	gold, Green Published			2022-12-26	WOS:000780951300046
J	Jegal, KH; Ko, MM; Kim, BY; Son, MJ; Kim, S				Jegal, Kyung Hwan; Ko, Mi Mi; Kim, Bo-Young; Son, Mi Ju; Kim, Sungha			A national survey on current clinical practice pattern of Korean Medicine doctors for treating obesity	PLOS ONE			English	Article							ORIENTAL HERBAL MEDICINE; BOFU-TSUSHO-SAN; EFFICACY; EPHEDRA; ACUPUNCTURE; MULTICENTER; MANAGEMENT; SAFETY	Background and aims Given the multifactorial nature of obesity, there is current interest on Korean medicine (KM) for weight loss. This survey aimed to investigate current practice patterns of KM treatment for obesity among doctors. Methods A questionnaire on clinical practice patterns of KM treatment for obesity was constructed and distributed to 21,788 KM doctors (KMDs). The questionnaire was consisted of respondent characteristics, state of treated patient, diagnosis, treatment, and usage pattern of herbal medicine for obesity. Results A total of 4.9% of KMDs (n = 1,084/21,788) validly completed the survey. Patients with Obesity Class I (25 <= Body mass index (BMI) <= 29.9) are the most common in KM clinics. Bioelectric impedance and KM Obesity Pattern Identification Questionnaire were routinely used for diagnosis. The average treatment duration was 4.16 weeks, and patients visited on an average 4.25 times per month for treatment. Herbal medicine is the most commonly used for obesity treatment by KMDs, and Taeeumjowui-tang was the most frequently prescribed. Ephedrae Herba, which is identified as the most used herbs for weight loss, was prescribed 5.18 +/- 2.7 g/day at minimum and 10.06 +/- 4.23 g/day at maximum. A total of 62.9% of responded KMDs had ever a patient with uncomfortable symptoms due to Ephedrae Herba use, neuropsychiatric events were the most common symptoms, followed by gastrointestinal events. Conclusion Taken together, this study provides information on real clinical practice patterns of KM including patients, diagnosis, treatments, and herbal medicine for obesity.	[Jegal, Kyung Hwan] Korea Inst Oriental Med, Digital Hlth Res Div, Daejeon, South Korea; [Jegal, Kyung Hwan] Daegu Haany Univ, Coll Korean Med, Gyongsan, South Korea; [Ko, Mi Mi; Kim, Bo-Young; Son, Mi Ju; Kim, Sungha] Korea Inst Oriental Med, KM Sci Res Div, Daejeon, South Korea	Korea Institute of Oriental Medicine (KIOM); Daegu Haany University; Korea Institute of Oriental Medicine (KIOM)	Kim, S (corresponding author), Korea Inst Oriental Med, KM Sci Res Div, Daejeon, South Korea.	bozzol@kiom.re.kr		Kim, Sungha/0000-0001-5542-3850	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HF20C0208]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (Grant No.: HF20C0208). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abourashed EA, 2003, PHYTOTHER RES, V17, P703, DOI 10.1002/ptr.1337; Azushima K, 2015, ATHEROSCLEROSIS, V240, P297, DOI 10.1016/j.atherosclerosis.2015.01.025; Bae HW., 2020, KOREAN J FAM PRACT, V10, P424; Baik I, 2018, NUTR RES PRACT, V12, P251, DOI 10.4162/nrp.2018.12.3.251; Cheon C, 2021, EXPLORE-NY, V17, P320, DOI 10.1016/j.explore.2020.03.010; Cheon C, 2020, COMPLEMENT THER MED, V51, DOI 10.1016/j.ctim.2020.102423; Fang SJ, 2017, AM J CHINESE MED, V45, P239, DOI 10.1142/S0192415X1750015X; Feng X, 2021, SURG CLIN N AM, V101, P731, DOI 10.1016/j.suc.2021.05.017; Geoffroy M, 2019, OBES SURG, V29, P1765, DOI 10.1007/s11695-019-03719-5; Gimigliano F, 2018, AGING CLIN EXP RES, V30, P625, DOI 10.1007/s40520-018-0921-1; Greenway F L, 2001, Obes Rev, V2, P199, DOI 10.1046/j.1467-789x.2001.00038.x; Haase CL, 2021, INT J OBESITY, V45, P1249, DOI 10.1038/s41366-021-00788-4; Haller CA, 2000, NEW ENGL J MED, V343, P1833, DOI 10.1056/NEJM200012213432502; Hasani-Ranjbar S, 2009, WORLD J GASTROENTERO, V15, P3073, DOI 10.3748/wjg.15.3073; Hioki C, 2004, CLIN EXP PHARMACOL P, V31, P614, DOI 10.1111/j.1440-1681.2004.04056.x; Jang IS, 2007, J SOC KOREAN MED OBE, V7, P23; 임경은, 2017, Korean Journal of Health Promotion, V17, P31, DOI 10.15384/kjhp.2017.17.1.31; Jo Ga-Won, 2017, [Journal of Korean Medicine, 대한한의학회지], V38, P170, DOI 10.13048/jkm.17034; Kang B-K, 2007, KOREAN J ORIENTAL ME, V13, P109; Kim BY, 2021, J OBES METAB SYNDR, V30, P81, DOI 10.7570/jomes21022; Kim Kyoung Kon, 2015, Journal of Obesity & Metabolic Syndrome, V24, P17; Kim SY, 2018, OBES REV, V19, P1585, DOI 10.1111/obr.12747; 윤나라, 2018, [Journal of Korean Medicine for Obesity Research, 한방비만학회지], V18, P1, DOI 10.15429/jkomor.2018.18.1.1; Kim Sungha, 2021, [Journal of Korean Medicine for Obesity Research, 한방비만학회지], V21, P22, DOI 10.15429/jkomor.2021.21.1.22; 이수정, 2012, [The Journal of Korean Medicine Ophthalmology&Otorhinolaryngology&Dermatology, 한방안이비인후피부과학회지], V25, P97; Korea Institute of Oriental Medicine, 2016, KOR MED CLIN PRACT G; Korean National Health Insurance Service, 2018 OB WHIT BOOK 20; Lee HA, 2021, EPIDEMIOL HEALTH, V43, DOI 10.4178/epih.e2021018; Liu YF, 2017, EVID-BASED COMPL ALT, V2017, DOI 10.1155/2017/8943059; Losco L, 2020, AESTHET PLAST SURG, V44, P421, DOI 10.1007/s00266-019-01543-x; Maglione M, 2005, AM J PSYCHIAT, V162, P189, DOI 10.1176/appi.ajp.162.1.189; Maunder A, 2020, DIABETES OBES METAB, V22, P891, DOI 10.1111/dom.13973; Mills S, 2004, ESSENTIAL GUIDE HERB, V1; Nam GE, 2020, J OBES METAB SYNDR, V29, P124, DOI 10.7570/jomes20058; National Institute of Korean Medicine Development. Development, 2018, SURV US TRAD KOR MED; Park JY, 2019, ANN SURG TREAT RES, V96, P283, DOI 10.4174/astr.2019.96.6.283; Park JH, 2012, J MED FOOD, V15, P589, DOI 10.1089/jmf.2011.1982; Park J, 2014, J MED FOOD, V17, P558, DOI 10.1089/jmf.2013.2836; Ryan DH, 2017, CURR OBES REP, V6, P187, DOI 10.1007/s13679-017-0262-y; Saad B, 2021, EVID-BASED COMPL ALT, V2021, DOI 10.1155/2021/9995903; Sarlio-Luhteenkorva S., 2000, HLTH INTERDISCIPLINA, V4, P73, DOI DOI 10.1177/136345930000400104; Seo MH, 2019, J OBES METAB SYNDR, V28, P40, DOI 10.7570/jomes.2019.28.1.40; Shekelle P, 2003, Evid Rep Technol Assess (Summ), P1; 정호근, 2017, [Journal of Health Informatics and Statistics, 보건정보통계학회지], V42, P355, DOI 10.21032/jhis.2017.42.4.355; Stohs SJ, 2016, PHYTOTHER RES, V30, P732, DOI 10.1002/ptr.5583; Sui Y, 2012, OBES REV, V13, P409, DOI 10.1111/j.1467-789X.2011.00979.x; 이지은, 2010, [Journal of Korean Medicine Rehabilitation, 한방재활의학과학회지], V20, P197; 한경선, 2016, [Journal of Korean Medicine Rehabilitation, 한방재활의학과학회지], V26, P23; 이용호, 2015, [Journal of Korean Medicine for Obesity Research, 한방비만학회지], V15, P33	49	1	1	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0266034	10.1371/journal.pone.0266034	http://dx.doi.org/10.1371/journal.pone.0266034			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324995	Green Published, gold			2022-12-26	WOS:000780951300099
J	Schreiber, K; Decouture, B; Lafragette, A; Chollet, S; Bruneau, M; Nicollet, M; Wittmann, C; Gadrat, F; Mansour, A; Forest-Villegas, P; Gauthier, O; Touzot-Jourde, G				Schreiber, Kevin; Decouture, Benoit; Lafragette, Audrey; Chollet, Stephane; Bruneau, Marine; Nicollet, Maxence; Wittmann, Catherine; Gadrat, Francis; Mansour, Alexandre; Forest-Villegas, Patricia; Gauthier, Olivier; Touzot-Jourde, Gwenola			A novel autotransfusion device saving erythrocytes and platelets used in a 72 h survival swine model of surgically induced controlled blood loss	PLOS ONE			English	Article							CELL TRANSFUSION; CARDIOPULMONARY BYPASS; COAGULATION; SALVAGE; PORCINE; COST; COAGULOPATHY; HEMORRHAGE; PRODUCTS; PROGRAM	Background The purpose of this study was to develop a swine model of surgically induced blood loss to evaluate the performances of a new autotransfusion system allowing red blood cells and platelets preservation while collecting, washing and concentrating hemorrhagic blood intraoperatively. Methods Two types of surgically induced blood loss were used in 12 minipigs to assess system performance and potential animal complications following autotransfusion: a cardiac model (cardiopulmonary bypass) and a visceral model (induced splenic bleeding). Animal clinical and hematological parameters were evaluated at different time-points from before bleeding to the end of a 72-hour post-transfusion period and followed by a post-mortem examination. System performances were evaluated by qualitative and quantitative parameters. Results All animals that received the autotransfusion survived. Minimal variations were seen on the red blood cell count, hemoglobin, hematocrit at the different sampling times. Coagulation tests failed to show any hypo or hypercoagulable state. Gross and histologic examination didn't reveal any thrombotic lesions. Performance parameters exceeded set objectives in both models: heparin clearance (>= 90%), final heparin concentration (<= 0.5 IU/mL), free hemoglobin washout (>= 90%) and hematocrit (between 45% and 65%). The device treatment rate of diluted blood was over 80 mL/min. Conclusions In the present study, both animal models succeeded in reproducing clinical conditions of perioperative cardiac and non-cardiac blood loss. Sufficient blood was collected to allow evaluation of autotransfusion effects on animals and to demonstrate the system performance by evaluating its capacity to collect, wash and concentrate red blood cells and platelets. Reinfusion of the treated blood, containing not only concentrated red blood cells but also platelets, did not lead to any postoperative adverse nor thrombogenic events. Clinical and comparative studies need to be conducted to confirm the clinical benefit of platelet reinfusion.	[Schreiber, Kevin; Lafragette, Audrey; Gauthier, Olivier; Touzot-Jourde, Gwenola] Oniris Nantes Atlantic Coll Vet Med Food Sci & En, Ctr Res & Preclin Invest, CRIP, Nantes, France; [Decouture, Benoit; Chollet, Stephane; Bruneau, Marine; Nicollet, Maxence; Wittmann, Catherine; Gadrat, Francis; Forest-Villegas, Patricia] I SEP, Nantes, France; [Mansour, Alexandre] Univ Rennes, Inserm CIC Ctr Invest Clin Rennes 1414, Dept Anesthesiol Crit Care Med & Perioperat Med, CHU Rennes, Rennes, France; [Gauthier, Olivier; Touzot-Jourde, Gwenola] Univ Nantes, ONIRIS, UMRS RMeS Regenerat Med & Skeleton 1229, INSERM, Nantes, France	Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; CHU Rennes; Universite de Rennes; Ecole Nationale Veterinaire, Agroalimentaire et de l'Alimentation Nantes-Atlantique; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite	Touzot-Jourde, G (corresponding author), Oniris Nantes Atlantic Coll Vet Med Food Sci & En, Ctr Res & Preclin Invest, CRIP, Nantes, France.; Touzot-Jourde, G (corresponding author), Univ Nantes, ONIRIS, UMRS RMeS Regenerat Med & Skeleton 1229, INSERM, Nantes, France.	gwenola.touzot-jourde@oniris-nantes.fr		Touzot-Jourde, Gwenola/0000-0001-9176-0715	BPi France (French Public Bank for investments) [PSPC-402492]	BPi France (French Public Bank for investments)	The study was funded by BPi France (French Public Bank for investments) by the grant PSPC-402492 (BPI grants for structuring competitive research and development). The grant was awarded to the consortium Isep/Oniris/Universite ' de Rennes. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Association of Blood Banks (AABB), 2021, STAND PER AUT BLOOD, V9th; Amin M, 2004, TRANSFUSION, V44, P1479, DOI 10.1111/j.1537-2995.2004.04065.x; [Anonymous], 2020, 109931 ISO; [Anonymous], 2017, 1099342017 ISO; Beckett Andrew, 2015, Can J Surg, V58, pS153; Biagini Silvana, 2014, Rev. bras. ter. intensiva, V26, P287, DOI 10.5935/0103-507X.20140040; Bode G, 2010, J PHARMACOL TOX MET, V62, P196, DOI 10.1016/j.vascn.2010.05.009; Boer C, 2018, J CARDIOTHOR VASC AN, V32, P88, DOI 10.1053/j.jvca.2017.06.026; Callum JL, 2014, TRANSFUSION, V54, P2344, DOI 10.1111/trf.12802; Carless PA, 2010, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001888.pub3; Clemetson KJ, 2012, THROMB RES, V129, P220, DOI 10.1016/j.thromres.2011.11.036; Davidson AJ, 2017, J SURG RES, V218, P306, DOI 10.1016/j.jss.2017.06.045; De Somer F, 2019, PERFUSION-UK, V34, P318, DOI 10.1177/0267659118819927; Di Dedda U, 2018, CLIN HEMORHEOL MICRO, V70, P327, DOI 10.3233/CH-180391; EDQM, 2020, GUIDE PREPARATION US, V20th ed.; Filos KS, 1996, CRIT CARE MED, V24, P855, DOI 10.1097/00003246-199605000-00021; Freedman J, 2014, TRANSFUS APHER SCI, V50, P32, DOI 10.1016/j.transci.2013.12.010; GAYDOS LA, 1962, NEW ENGL J MED, V266, P905, DOI 10.1056/NEJM196205032661802; Gourlay T, 2018, J ROY ARMY MED CORPS, V164, P96, DOI 10.1136/jramc-2017-000789; Gregoretti S, 1996, TRANSFUSION, V36, P57, DOI 10.1046/j.1537-2995.1996.36196190516.x; HANNON JP, 1992, SWINE AS MODELS IN BIOMEDICAL RESEARCH, P197; Hofer J, 2016, CLIN APPL THROMB-HEM, V22, P505, DOI 10.1177/1076029616651146; Hofbauer N, 2016, J VET EMERG CRIT CAR, V26, P373, DOI 10.1111/vec.12472; Jain NC, 1993, ESSENTIALS VET HEMAT, P417; Kellett-Gregory LM, 2013, J VET EMERG CRIT CAR, V23, P82, DOI 10.1111/vec.12017; Kessler U, 2011, THROMB RES, V128, P477, DOI 10.1016/j.thromres.2011.03.013; KESTIN AS, 1993, BLOOD, V82, P107, DOI 10.1182/blood.V82.1.107.bloodjournal821107; Klein AA, 2018, ANAESTHESIA, V73, P1141, DOI 10.1111/anae.14331; Ledgerwood AM, 2012, J TRAUMA ACUTE CARE, V72, P1714, DOI 10.1097/TA.0b013e318245225c; Lelovas PP, 2014, J AM ASSOC LAB ANIM, V53, P432; Lemke M, 2016, HPB, V18, P428, DOI 10.1016/j.hpb.2016.02.002; Lu M, 2019, J BLOOD MED, V10, P37, DOI 10.2147/JBM.S166316; Mansour A, 2021, ANESTHESIOLOGY, V135, P246, DOI 10.1097/ALN.0000000000003820; Martin RCG, 2005, ANN SURG ONCOL, V12, P1017, DOI 10.1245/ASO.2005.12.018; McCrackin MA, 2016, SWINE IN THE LABORATORY: SURGERY, ANESTHESIA, IMAGING, AND EXPERIMENTAL TECHNIQUES, 3RD EDITION, P1; McQuilten ZK, 2018, TRANSFUS MED REV, V32, P6, DOI 10.1016/j.tmrv.2017.06.003; Meybohm P, 2020, VOX SANG, V115, P182, DOI 10.1111/vox.12873; Meybohm P, 2016, ANN SURG, V264, P203, DOI 10.1097/SLA.0000000000001747; Myers DD, 2016, SWINE IN THE LABORATORY: SURGERY, ANESTHESIA, IMAGING, AND EXPERIMENTAL TECHNIQUES, 3RD EDITION, P213; NAITO K, 1994, ARTIF ORGANS, V18, P7, DOI 10.1111/j.1525-1594.1994.tb03292.x; Naumenko Konstantin S, 2008, Interact Cardiovasc Thorac Surg, V7, P759, DOI 10.1510/icvts.2008.183582; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; O'Brien SF, 2012, VOX SANG, V103, P83, DOI 10.1111/j.1423-0410.2012.01584.x; Olsen AK, 1999, SCAND J LAB ANIM SCI, V26, P214; Paparella D, 2016, SEMIN THROMB HEMOST, V42, P166, DOI 10.1055/s-0035-1569067; Patel NN, 2011, AM J PHYSIOL-RENAL, V301, pF605, DOI 10.1152/ajprenal.00145.2011; Pelagalli A, 2003, J COMP PATHOL, V128, P127, DOI 10.1053/jcpa.2002.0615; Rohde JM, 2014, JAMA-J AM MED ASSOC, V311, P1317, DOI 10.1001/jama.2014.2726; Samolyk KA, 2005, PERFUSION-UK, V20, P343, DOI 10.1191/0267659105pf831oa; Scott BH, 2008, ANN CARD ANAESTH, V11, P15, DOI 10.4103/0971-9784.38444; Shander A, 2010, TRANSFUSION, V50, P753, DOI 10.1111/j.1537-2995.2009.02518.x; Sharma S, 2011, AM FAM PHYSICIAN, V83, P719; Shen SL, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0986-6; Sondeen JL, 2014, J AM ASSOC LAB ANIM, V53, P307; Spinella PC, 2016, CURR OPIN HEMATOL, V23, P536, DOI 10.1097/MOH.0000000000000284; Tretiak R, 1996, CAN MED ASSOC J, V154, P1501; VAGIANOS C, 1990, ACTA CHIR SCAND, V156, P121; Varghese S J, 2005, Med J Armed Forces India, V61, P316, DOI 10.1016/S0377-1237(05)80053-X; Velik-Salchner C, 2006, THROMB RES, V117, P597, DOI 10.1016/j.thromres.2005.05.015; Yarham G, 2011, PERFUSION-UK, V26, P263, DOI 10.1177/0267659111399951; Yoon C, 2014, J ARTIF ORGANS, V17, P118, DOI 10.1007/s10047-013-0745-x; Zhou J, 2016, BRAZ J MED BIOL RES, V49, DOI [10.1590/1414-431X20165493, 10.1590/1414-431x20165493]	62	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0260855	10.1371/journal.pone.0260855	http://dx.doi.org/10.1371/journal.pone.0260855			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0K7DW	35324911	Green Published, gold			2022-12-26	WOS:000780951300007
J	Zhang, Y; Yu, Z; Zhang, J				Zhang, Yuan; Yu, Zhen; Zhang, Juan			Spatiotemporal evolution characteristics and dynamic efficiency decomposition of carbon emission efficiency in the Yellow River Basin	PLOS ONE			English	Article							KERNEL DENSITY-ESTIMATION; CO2 EMISSIONS; DECOUPLING INDICATOR; DIOXIDE EMISSIONS; ECONOMIC-GROWTH; CHINA; DETERMINANTS; ALLOCATION; SYSTEM; PATH	The Yellow River Basin (YRB) is China's substantial energy consumption base. The issue of carbon emission efficiency directly affects the ecological protection and high-quality development of the YRB. It is the key to achieving carbon peak in 2030 and carbon neutralization in 2060 ("30.60") double carbon emission reduction targets. Therefore, taking YRB as the research object, this paper first calculates the carbon emission and the decoupling state in the YRB. Secondly, the super-efficiency slacks-based measurement (SE-SBM) model is combined with the Malmquist index to analyze the temporal and spatial evolution characteristics of YRB's carbon emission efficiency from static and dynamic perspectives. Thirdly, the dynamic evolution characteristics of carbon emission efficiency are analyzed with the help of the Kernel density function. Finally, the Tobit model analyzes the influencing factors of YRB's and China's carbon emission efficiency. The results show that: (1) Among the nine provinces of YRB, the decoupling state between carbon emissions and economic growth in most provinces changes from weak decoupling to strong decoupling, and the decoupling elasticity index shows a fluctuating downward trend. (2) There are significant differences in carbon emission efficiency among provinces, but on the whole, it shows a stable growth trend. The high-value area of carbon emission efficiency is increasing, and the phenomenon of two-level differentiation is improving. The decline of the technological progress index causes the Malmquist index in Qinghai and Ningxia. On the contrary, the rise of the Malmquist index in the other seven provinces is caused by improving the technical efficiency index. (3) Industrial structure, economic development, and industrialization are the main positive factors affecting YRB's carbon emission efficiency. Urbanization level, green development level, and energy consumption level are the leading negative indicators hindering YRB's improvement of carbon emission efficiency. Therefore, targeted emission reduction suggestions should be formulated according to YRB's resource endowment and development stage characteristics.	[Zhang, Yuan] China Univ Min & Technol Beijing, Sch Management, Beijing, Peoples R China; [Yu, Zhen] Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China; [Zhang, Juan] Binzhou Univ, Airport Coll, Binzhou, Peoples R China	China University of Mining & Technology; Tianjin University; Binzhou University	Yu, Z (corresponding author), Tianjin Univ, State Key Lab Precis Measuring Technol & Instrume, Tianjin, Peoples R China.	solseagull@163.com		Yu, Zhen/0000-0002-7994-8851				Ali KSS, 2020, COMPUT J; Amarasinghe PAGM, 2020, IEEE ACCESS, V8, P138661, DOI 10.1109/ACCESS.2020.3012406; Chang YT, 2013, ENERG POLICY, V58, P277, DOI 10.1016/j.enpol.2013.03.011; Chen XT, 2021, ENERGY, V232; Cheng ZH, 2018, RENEW SUST ENERG REV, V94, P330, DOI 10.1016/j.rser.2018.06.015; Dong F, 2022, RESOUR CONSERV RECY, V177, DOI 10.1016/j.resconrec.2021.106002; Dong F, 2021, J ENVIRON MANAGE, V300, DOI 10.1016/j.jenvman.2021.113738; Dong F, 2021, J CLEAN PROD, V316, DOI 10.1016/j.jclepro.2021.128316; Dong F, 2021, J CLEAN PROD, V306, DOI 10.1016/j.jclepro.2021.127099; Fang DB, 2021, ENERG POLICY, V149, DOI 10.1016/j.enpol.2020.112017; Feng C, 2017, ECON MODEL, V64, P334, DOI 10.1016/j.econmod.2017.04.007; Grassi G, 2021, NAT CLIM CHANGE, V11, P425, DOI 10.1038/s41558-021-01033-6; Guo MD, 2021, SCI PROGRESS-UK, V104, DOI 10.1177/00368504211018054; Huang JB, 2022, ENERGY, V238, DOI 10.1016/j.energy.2021.121965; Huang YJ, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-89293-2; Intergovernmental Panel on Climate Change (IPCC), 2013, CLIM CHANG 2013 PHYS; Jin F., 2019, REFORM, V309, P33; Langrene N, 2019, J COMPUT GRAPH STAT, V28, P596, DOI 10.1080/10618600.2018.1549052; Li JB, 2018, J CLEAN PROD, V188, P38, DOI 10.1016/j.jclepro.2018.03.198; Li JX, 2020, J CLEAN PROD, V260, DOI 10.1016/j.jclepro.2020.121021; Li Y, 2019, SOFT SCI, V33, P21, DOI DOI 10.13956/J.SS.1001-8409.2019.07.04; Liu S, 2018, ENRGY PROCED, V152, P762, DOI 10.1016/j.egypro.2018.09.242; Liu WB, 2010, ANN OPER RES, V173, P177, DOI 10.1007/s10479-009-0587-3; Long LJ, 2021, ENVIRON DEV SUSTAIN, V23, P14982, DOI 10.1007/s10668-021-01282-7; Miao Z, 2016, J CLEAN PROD, V112, P4144, DOI 10.1016/j.jclepro.2015.07.035; Mielnik O, 1999, ENERG POLICY, V27, P307, DOI 10.1016/S0301-4215(99)00018-X; Pan YL, 2022, ENERG POLICY, V160, DOI 10.1016/j.enpol.2021.112668; Ramanathan R., 2002, International Journal of Global Energy Issues, V17, P214; Shuai S, 2020, J ENVIRON MANAGE, V261, DOI 10.1016/j.jenvman.2020.110227; Siying Li, 2020, Journal of Physics: Conference Series, V1646, DOI 10.1088/1742-6596/1646/1/012018; Song Y, 2019, J ENVIRON MANAGE, V245, P302, DOI 10.1016/j.jenvman.2019.05.094; Stretesky PB, 2009, SOC SCI RES, V38, P239, DOI 10.1016/j.ssresearch.2008.08.004; Sun JW, 2005, ENERG POLICY, V33, P975, DOI 10.1016/j.enpol.2003.10.023; Tang K, 2021, ENVIRON SCI POLLUT R, V28, P1533, DOI 10.1007/s11356-020-10518-4; Tian N, 2020, J CLEAN PROD, V242, DOI 10.1016/j.jclepro.2019.118474; Tone K, 2020, EUR J OPER RES, V287, P560, DOI 10.1016/j.ejor.2020.04.019; Wang B., 2013, J FINANC RES, V10, P128; Wang CN, 2017, APPL ECON, V49, P1; Wang JY, 2019, SCI TOTAL ENVIRON, V663, P878, DOI 10.1016/j.scitotenv.2019.01.413; Wang K, 2013, ENERG POLICY, V54, P214, DOI 10.1016/j.enpol.2012.11.030; Wang R, 2021, INT J ENVIRON SCI TE, V18, P1453, DOI 10.1007/s13762-020-02903-w; Wang WL, 2020, SUSTAINABILITY-BASEL, V12, DOI 10.3390/su12083146; Wang WW, 2017, ENERGY, V128, P11, DOI 10.1016/j.energy.2017.04.004; Wu SJ, 2021, SUSTAINABILITY-BASEL, V13, DOI 10.3390/su13052722; YAMAJI K, 1993, ENERG POLICY, V21, P123, DOI 10.1016/0301-4215(93)90134-2; Yu BL, 2021, RENEW ENERG, V180, P438, DOI 10.1016/j.renene.2021.08.079; Yu BL, 2021, ENERGY, V234, DOI 10.1016/j.energy.2021.121295; Yu YT, 2021, ENERG ECON, V96, DOI 10.1016/j.eneco.2021.105125; Zhang CQ, 2021, ENVIRON SCI POLLUT R, V28, P66914, DOI 10.1007/s11356-021-15309-z; Zhang H, 2021, NAT ENVIRON POLLUT T, V20, P625, DOI DOI 10.46488/NEPT.2021.v20i02.020; Zhang H, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0228223; Zhang Jun, 2004, EC RES J, P35, DOI [DOI 10.1080/14765280802028302, 10.1080/14765280802028302]; [张可云 Zhang Keyun], 2020, [经济地理, Economic Geography], V40, P1; Zhang M, 2015, ENERG EFFIC, V8, P1231, DOI 10.1007/s12053-015-9348-0; Zhang SR, 2020, PLOS ONE, V15, DOI 10.1371/journal.pone.0242029; Zhang WH, 1991, J ARID LAND RESOURCE, V5, P1; Zhou P, 2014, ENERG ECON, V45, P99, DOI 10.1016/j.eneco.2014.06.019; Zhou P, 2010, ENERG ECON, V32, P194, DOI 10.1016/j.eneco.2009.10.003	58	2	2	23	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 24	2022	17	3							e0264274	10.1371/journal.pone.0264274	http://dx.doi.org/10.1371/journal.pone.0264274			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	0K7DW	35324928	Green Published, gold			2022-12-26	WOS:000780951300016
J	Chen, XJ; He, JX; Zhang, MY; Bai, ZY; Li, JL				Chen, Xiajun; He, Jixiang; Zhang, Mengying; Bai, Zhiyi; Li, Jiale			Identification of a coproporphyrinogen-III oxidase gene and its correlation with nacre color in Hyriopsis cumingii	PLOS ONE			English	Article							PEARL MUSSEL; SHELL COLOR; EXPRESSION; QUALITY; CLONING	Pearl color is an important factor influencing pearl value, and is affected by the nacre color of the shell in Hyriopsis cumingii. Coproporphyrinogen-III oxidase (CPOX) is a key enzyme in porphyrin synthesis, and porphyrins are involved in color formation in different organisms, including in the nacre color of mussels. In this study, a CPOX gene (HcCPOX) was identified from H. cumingii, and its amino acid sequence was found to contain a coprogen-oxidase domain. HcCPOX mRNA was expressed widely in the tissues of white and purple mussels, and the highest expression was found in the gill, followed by the fringe mantle. The expression of HcCPOX in all tissues of purple mussels (except in the middle mantle) was higher than that of white mussels. Strong hybridization signals for HcCPOX were observed in the dorsal epithelial cells of the outer fold of the mantle. The activity of CPOX in the gill, fringe mantle, and foot of purple mussels was significantly higher than that in white mussels. Moreover, the expression of HcCPOX and CPOX activity were decreased in RNA interference experiments. The findings indicate that HcCPOX might contributes to nacre color formation in H. cumingii by being involved in porphyrin synthesis.	[Chen, Xiajun; He, Jixiang] Anhui Acad Agr Sci, Fishery Inst, Anhui Prov Key Lab Aquaculture & Stock Enhancemen, Hefei, Peoples R China; [Chen, Xiajun; Zhang, Mengying; Bai, Zhiyi; Li, Jiale] Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China; [Chen, Xiajun; Zhang, Mengying; Bai, Zhiyi; Li, Jiale] Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China; [Bai, Zhiyi; Li, Jiale] Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China	Anhui Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Shanghai Ocean University; Shanghai Ocean University	Li, JL (corresponding author), Minist Agr, Key Lab Freshwater Aquat Genet Resources, Shanghai, Peoples R China.; Li, JL (corresponding author), Shanghai Ocean Univ, Natl Demonstrat Ctr Expt Fisheries Sci Educ, Shanghai, Peoples R China.; Li, JL (corresponding author), Shanghai Ocean Univ, Shanghai Engn Res Ctr Aquaculture, Shanghai, Peoples R China.	jlli2009@126.com			Doctoral Research Initiation Fund of the Anhui Academy of Agricultural Sciences [2021YL028]; National Key R&D Program of China [2018YFD0901406]; National Natural Science Foundation of China [31872565]	Doctoral Research Initiation Fund of the Anhui Academy of Agricultural Sciences; National Key R&D Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	We thank International Science Editing (http://www.international scienceediting.com) for editing this manuscript.	Addadi L, 2006, CHEM-EUR J, V12, P981, DOI 10.1002/chem.200500980; Armanini D, 2005, STEROIDS, V70, P538, DOI 10.1016/j.steroids.2005.01.007; Bai ZY, 2014, MOL GENET GENOMICS, V289, P717, DOI 10.1007/s00438-014-0837-1; Bai ZY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053617; BARRY PH, 1971, J MEMBRANE BIOL, V4, P295, DOI 10.1007/BF02431977; Bonnard M, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-69133-5; BURNHAM BF, 1970, J AM CHEM SOC, V92, P1547, DOI 10.1021/ja00709a019; Cassey P, 2012, METHODS ECOL EVOL, V3, P450, DOI 10.1111/j.2041-210X.2011.00152.x; Chen XJ, 2019, BIOCHEM BIOPH RES CO, V517, P210, DOI 10.1016/j.bbrc.2019.07.054; Chen XJ, 2019, MAR BIOTECHNOL, V21, P634, DOI 10.1007/s10126-019-09908-8; Chen XJ, 2017, COMP BIOCHEM PHYS B, V204, P1, DOI 10.1016/j.cbpb.2016.11.005; COMFORT A, 1949, BIOCHEM J, V44, P111, DOI 10.1042/bj0440111; COMFORT A, 1951, BIOL REV, V26, P285, DOI 10.1111/j.1469-185X.1951.tb01358.x; Cooper S, 2010, AQUAT TOXICOL, V100, P303, DOI 10.1016/j.aquatox.2010.07.027; Gardner LD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-455; Gorchein A, 2009, BIOMED CHROMATOGR, V23, P602, DOI 10.1002/bmc.1158; Hao Xiao-ling, 2009, Journal of Hebei Normal University (Natural Science Edition), V33, P85; Igic B, 2010, CHEMOECOLOGY, V20, P43, DOI 10.1007/s00049-009-0038-2; Jerry DR, 2012, AQUACULTURE, V338, P66, DOI 10.1016/j.aquaculture.2012.02.001; KENNEDY GY, 1976, COMP BIOCHEM PHYS B, V55, P117, DOI 10.1016/0305-0491(76)90183-8; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Li JiaLe, 2011, Journal of Fisheries of China, V35, P1753; Li QQ, 2017, AQUAC RES, V48, P4656, DOI 10.1111/are.13288; Li XL, 2014, GENE, V538, P258, DOI 10.1016/j.gene.2014.01.046; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; NEFF JM, 1972, TISSUE CELL, V4, P311, DOI 10.1016/S0040-8166(72)80050-8; Paoli M, 2002, DNA CELL BIOL, V21, P271, DOI 10.1089/104454902753759690; REDDI E, 1981, INT J PEPT PROT RES, V18, P402; Rong OU., 2006, RES MED ED, V05, P474; Shen Jiexuan, 2022, Aquaculture and Fisheries, V7, P18, DOI 10.1016/j.aaf.2020.07.004; Shen Jiexuan, 2018, Aquaculture and Fisheries, V3, P217, DOI 10.1016/j.aaf.2018.09.004; Shi L, 2014, J APPL SPECTROSC+, V81, P97, DOI 10.1007/s10812-014-9893-x; Stenger PL, 2021, GENES-BASEL, V12, DOI 10.3390/genes12030421; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; VANBRUGGEN EFJ, 1980, TRENDS BIOCHEM SCI, V5, P185, DOI 10.1016/0968-0004(80)90235-2; Wang G.L., 2007, J FISH CHINA, V12, P12; Williams ST, 2017, ECOL EVOL, V7, P10379, DOI 10.1002/ece3.3552; Zhan YanLing, 2017, Journal of Fisheries of China, V41, P1054; Zhang S., 2015, CREATION ANAL ZEBRAF	39	0	0	8	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265318	10.1371/journal.pone.0265318	http://dx.doi.org/10.1371/journal.pone.0265318			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1R8XY	35312719	Green Published, gold			2022-12-26	WOS:000803647900034
J	Ellis, BJ; Whitley, CA; Triantafyllou, A; Gunning, PJ; Smith, CI; Barrett, SD; Gardner, P; Shaw, RJ; Weightman, P; Risk, JM				Ellis, Barnaby J.; Whitley, Conor A.; Triantafyllou, Asterios; Gunning, Philip J.; Smith, Caroline, I; Barrett, Steve D.; Gardner, Peter; Shaw, Richard J.; Weightman, Peter; Risk, Janet M.			Prediction of malignant transformation in oral epithelial dysplasia using infrared absorbance spectra	PLOS ONE			English	Article							HISTOPATHOLOGY; SPECTROSCOPY; DIFFERENTIATION; LEUKOPLAKIA; LESIONS; CAVITY	Oral epithelial dysplasia (OED) is a histopathologically-defined, potentially premalignant condition of the oral cavity. The rate of transformation to frank carcinoma is relatively low (12% within 2 years) and prediction based on histopathological grade is unreliable, leading to both over- and under-treatment. Alternative approaches include infrared (IR) spectroscopy, which is able to classify cancerous and non-cancerous tissue in a number of cancers, including oral. The aim of this study was to explore the capability of FTIR (Fourier-transform IR) microscopy and machine learning as a means of predicting malignant transformation of OED. Supervised, retrospective analysis of longitudinally-collected OED biopsy samples from 17 patients with high risk OED lesions: 10 lesions transformed and 7 did not over a follow-up period of more than 3 years. FTIR spectra were collected from routine, unstained histopathological sections and machine learning used to predict malignant transformation, irrespective of OED classification. PCA-LDA (principal component analysis followed by linear discriminant analysis) provided evidence that the subsequent transforming status of these 17 lesions could be predicted from FTIR data with a sensitivity of 79 +/- 5% and a specificity of 76 +/- 5%. Six key wavenumbers were identified as most important in this classification. Although this pilot study used a small cohort, the strict inclusion criteria and classification based on known outcome, rather than OED grade, make this a novel study in the field of FTIR in oral cancer and support the clinical potential of this technology in the surveillance of OED.	[Ellis, Barnaby J.; Whitley, Conor A.; Smith, Caroline, I; Barrett, Steve D.; Weightman, Peter] Univ Liverpool, Dept Phys, Liverpool, England; [Triantafyllou, Asterios] Univ Liverpool, Dept Pathol, Liverpool Clin Labs, Liverpool, England; [Gunning, Philip J.; Shaw, Richard J.; Risk, Janet M.] Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol & Clin Canc Med, Liverpool, England; [Gardner, Peter] Univ Manchester, Manchester Inst Biotechnol, Manchester, England; [Shaw, Richard J.] Univ Liverpool, Hosp NHS Fdn Trust Reg Maxillofacial Unit, Liverpool, England	University of Liverpool; University of Liverpool; University of Liverpool; University of Manchester; University of Liverpool	Shaw, RJ (corresponding author), Univ Liverpool, Inst Syst Mol & Integrat Biol, Dept Mol & Clin Canc Med, Liverpool, England.; Shaw, RJ (corresponding author), Univ Liverpool, Hosp NHS Fdn Trust Reg Maxillofacial Unit, Liverpool, England.	rjshaw@liverpool.ac.uk		Smith, Caroline/0000-0001-6878-0697	Cancer Research UK [C7738/A26196]; Engineering and Physical Sciences Research Council (EPSRC) PhD studentships	Cancer Research UK(Cancer Research UK); Engineering and Physical Sciences Research Council (EPSRC) PhD studentships(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	JMR, RJS, PW & SDB: Cancer Research UK grant number C7738/A26196. https://www.cancerresearchuk.org/ BGE & CAW were supported by Engineering and Physical Sciences Research Council (EPSRC) PhD studentships. https://epsrc.ukri.org/ The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa H, 2017, ARCH ORAL BIOL, V83, P340, DOI 10.1016/j.archoralbio.2017.08.014; Alaizari NA, 2018, J ORAL PATHOL MED, V47, P97, DOI 10.1111/jop.12603; Arduino PG, 2009, J ORAL PATHOL MED, V38, P540, DOI 10.1111/j.1600-0714.2009.00782.x; Baker MJ, 2008, BRIT J CANCER, V99, P1859, DOI 10.1038/sj.bjc.6604753; Baker MJ, 2018, ANALYST, V143, P1735, DOI 10.1039/c7an01871a; Banerjee S, 2015, ANAL BIOANAL CHEM, V407, P7935, DOI 10.1007/s00216-015-8960-3; Barnes L, 2005, PATHOLOGY GENETICS H; Barth A, 2002, Q REV BIOPHYS, V35, P369, DOI 10.1017/S0033583502003815; Chicco D, 2020, BMC GENOMICS, V21, DOI 10.1186/s12864-019-6413-7; Silva BSD, 2021, CLIN ORAL INVEST, V25, P4329, DOI 10.1007/s00784-021-04008-1; Donadini A, 2010, CELL ONCOL, V32, P373, DOI 10.3233/CLO-2010-0525; Ellis BG, 2021, ANALYST, V146, P4895, DOI 10.1039/d1an00922b; Ferlay J, 2020, GLOBAL CANC OBSERVAT; Henderson A, CHITOOLBOX MATLAB TO; Ho MW, 2012, ORAL ONCOL, V48, P969, DOI 10.1016/j.oraloncology.2012.04.002; Johnson NW, 2011, PERIODONTOL 2000, V57, P19, DOI 10.1111/j.1600-0757.2011.00401.x; Jolliffe IT, 2016, PHILOS T R SOC A, V374, DOI 10.1098/rsta.2015.0202; Kujan O, 2007, ORAL ONCOL, V43, P224, DOI 10.1016/j.oraloncology.2006.03.009; Lasch P, 2012, CHEMOMETR INTELL LAB, V117, P100, DOI 10.1016/j.chemolab.2012.03.011; Li B, 2017, ONCOTARGET, V8, P76257, DOI 10.18632/oncotarget.19343; LUMERMAN H, 1995, ORAL SURG ORAL MED O, V79, P321, DOI 10.1016/S1079-2104(05)80226-4; MATTHEWS BW, 1975, BIOCHIM BIOPHYS ACTA, V405, P442, DOI 10.1016/0005-2795(75)90109-9; McCaul JA, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-310; Mehanna HM, 2009, HEAD NECK-J SCI SPEC, V31, P1600, DOI 10.1002/hed.21131; Monteiro L, 2021, ORAL DIS, V27, P1977, DOI 10.1111/odi.13747; Morais CLM, 2019, NAT PROTOC, V14, P1546, DOI 10.1038/s41596-019-0150-x; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Muller S, 2017, HEAD NECK PATHOL, V11, P33, DOI 10.1007/s12105-017-0792-3; Panwar A, 2014, EXPERT REV ANTICANC, V14, P349, DOI 10.1586/14737140.2013.842898; Paraskevaidi M, 2021, APPL SPECTROSC REV, V56, P804, DOI 10.1080/05704928.2021.1946076; Pilling M, 2016, CHEM SOC REV, V45, P1935, DOI 10.1039/c5cs00846h; Pilling MJ, 2017, ANAL CHEM, V89, P7348, DOI 10.1021/acs.analchem.7b00426; Pilling MJ, 2016, FARADAY DISCUSS, V187, P135, DOI 10.1039/c5fd00176e; Pitiyage G, 2009, J ORAL PATHOL MED, V38, P737, DOI 10.1111/j.1600-0714.2009.00804.x; Reddi Sanjay P, 2006, Oral Maxillofac Surg Clin North Am, V18, P425, DOI 10.1016/j.coms.2006.08.002; Sattlecker M, 2014, TRAC-TREND ANAL CHEM, V59, P17, DOI 10.1016/j.trac.2014.02.016; SAVITZKY A, 1964, ANAL CHEM, V36, P1627, DOI 10.1021/ac60214a047; Schepman KP, 1995, ORAL ONCOL, V31B, P396, DOI 10.1016/0964-1955(95)00032-1; Trevisan J, 2012, ANALYST, V137, P3202, DOI 10.1039/c2an16300d; Warnakulasuriya S, 2011, J ORAL PATHOL MED, V40, P677, DOI 10.1111/j.1600-0714.2011.01054.x; Warnakulasuriya S, 2021, ORAL DIS, V27, P1862, DOI 10.1111/odi.13704	41	0	0	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0266043	10.1371/journal.pone.0266043	http://dx.doi.org/10.1371/journal.pone.0266043			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333891	gold, Green Published			2022-12-26	WOS:000784335700009
J	Wendie, TF; Mengistu, G				Fentie Wendie, Teklehaimanot; Mengistu, Getnet			Prevalence and predictors of anemia among adults on highly active antiretroviral therapy in Northeast Ethiopia: A retrospective cohort study	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HIV-INFECTED PATIENTS; ZIDOVUDINE; INDIVIDUALS; SURVIVAL; DISEASE	BackgroundAlthough antiretroviral therapy has significantly altered the natural history of human immunodeficiency virus infection and improved the quality of life of patients, there are conflicting reports regarding its impact on hematological outcomes. Thus, this study aimed at investigating the prevalence and predictors of anemia among adults on antiretroviral therapy in Northeast Ethiopia. Materials and methodsA retrospective cohort study was carried out among adults who began antiretroviral treatment between September 2005 and January 2019 at two governmental hospitals in Dessie town. Data were collected from patients' medical records using a pretested data extraction instrument. Anemia was the primary outcome variable of the study. It was defined based on WHO criteria after adjustment for altitude and smoking status of measured values. Data were entered and validated using EpiData Version 3.1 and then exported to SPSS Version 20.0 for analysis. Descriptive analysis was done for prevalence and binary logistic regression was carried out to assess whether covariates were associated with experiencing anemia. Statistical significance has been considered at p-value ResultsMedical records of 392 patients (mean age: 35.58 +/- 9.46 years) were reviewed. Of the total 392 patients, 218 (55.6%) were females, 261 (66.6%) were categorized under WHO clinical stage III/IV and 134 (34.2%) had a baseline CD4 cell count of <100 cells/mm(3). The mean baseline CD4 cell count was 179 cells/mm(3) (range: 2 to 853 cells) and 230 (58.7%) of the participants were on zidovudine-based regimen. Anemia was diagnosed among 162 (41.3%) patients. After adjustment for other confounding factors, risk of anemia was significantly associated with low baseline CD4 cell count (AOR 1.80, 95% CI 1.05-3.06) and tenofovir based regimen (AOR 2.05, 95% CI 1.31-3.21). On the other hand, being educated was found to be protective (AOR 0.40, 95% CI 0.21-0.78). ConclusionIn this research, the prevalence of anemia was relatively high. Low baseline CD4 cell count and tenofovir based regimen were independent predictors of anemia; while being educated was protective. Treatment programs should focus on early diagnosis and treatment of HIV as well as routine screening and proper treatment of anemia.	[Fentie Wendie, Teklehaimanot] Wollo Univ, Dept Pharm, Dessie, Ethiopia		Wendie, TF (corresponding author), Wollo Univ, Dept Pharm, Dessie, Ethiopia.	tklhmntfnt5@gmail.com		Fentie, Teklehaimanot/0000-0001-9111-3753				Abdissa Senbeta Guteta, 2012, Ethiop Med J, V50, P107; Adane Asfaw, 2012, Ethiop Med J, V50, P13; Ageru TA, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0221853; Akilimali PZ, 2014, REV EPIDEMIOL SANTE, V62, P201, DOI 10.1016/j.respe.2014.03.004; Assefa Muluken, 2015, BMC Hematol, V15, P6, DOI 10.1186/s12878-015-0024-6; Bain B J, 1999, Curr Opin Hematol, V6, P89, DOI 10.1097/00062752-199903000-00006; Belperio PS, 2004, AM J MED, V116, P27, DOI 10.1016/j.amjmed.2003.12.010; Berhane Y., 2020, ETHIOPIA CASE CONTRO, V11, P379; Curkendall SM, 2007, HIV MED, V8, P483, DOI 10.1111/j.1468-1293.2007.00500.x; Denue Ballah Akawu, 2013, Infect Dis (Auckl), V6, P25, DOI 10.4137/IDRT.S10477; Deressa Tekalign, 2018, EJIFCC, V29, P36; Egata G., 2016, J MED PHYSL BIOPHYSI, V22; Ferede Getachew, 2013, BMC Hematol, V13, P8, DOI 10.1186/2052-1839-13-8; FISCHL MA, 1990, NEW ENGL J MED, V323, P1009, DOI 10.1056/NEJM199010113231501; Gebremedhin Ketema Bizuwork, 2019, Adv Hematol, V2019, P9614205, DOI 10.1155/2019/9614205; Gedefaw L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072202; Harris RJ, 2008, ANTIVIR THER, V13, P959; Jin YT, 2017, INT J STD AIDS, V28, P63, DOI 10.1177/0956462415622866; Johannessen A, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-190; Katemba C, 2018, J BLOOD MED, V9, P105, DOI 10.2147/JBM.S157148; Kyeyune R, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-496; Lartey M, 2014, PAN AFR MED J, V18, DOI 10.11604/pamj.2014.18.25.3886; Lau B, 2005, JAIDS-J ACQ IMM DEF, V39, P620; Lundgren JD, 2003, CLIN INFECT DIS, V37, pS297, DOI 10.1086/376909; Marconi VC, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-14; Meidani M, 2012, J RES MED SCI, V17, P138; Melese H, 2017, HIV AIDS-RES PALLIAT, V9, P25, DOI 10.2147/HIV.S121021; Mocroft A, 1999, AIDS, V13, P943, DOI 10.1097/00002030-199905280-00010; Moh R, 2005, ANTIVIR THER, V10, P615; Moore RD, 2000, SEMIN HEMATOL, V37, P18, DOI 10.1053/shem.2000.18120; MOORE RD, 1991, ARCH INTERN MED, V151, P981, DOI 10.1001/archinte.151.5.981; Moyle Graeme, 2002, AIDS Reviews, V4, P13; Negesse Ayenew, 2018, BMC Hematol, V18, P32, DOI 10.1186/s12878-018-0127-y; Obirikorang C, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-102; Odunukwe Nkiru, 2005, Turk J Haematol, V22, P125; Owiredu WKBA, 2011, AFR HEALTH SCI, V11, P2; Sah SK, 2020, HIV AIDS-RES PALLIAT, V12, DOI 10.2147/HIV.S244618; Sullivan PS, 1998, BLOOD, V91, P301, DOI 10.1182/blood.V91.1.301.301_301_308; Tamir Z, 2018, ETHIOP J HEALTH SCI, V28, P73, DOI 10.4314/ejhs.v28i1.9; Volberding P, 2002, J INFECT DIS, V185, pS110, DOI 10.1086/340198; Volberding Paul A, 2004, Clin Infect Dis, V38, P1454, DOI 10.1086/383031; WHO, 2011, WHONMHNHDMNM111; Woldeamanuel Gashaw Garedew, 2018, BMC Hematol, V18, P7, DOI 10.1186/s12878-018-0099-y; Yesuf T, 2019, HIV AIDS-RES PALLIAT, V11, P211, DOI 10.2147/HIV.S209446; Zenebe WA, 2019, ETHIOPIA, V11, P351, DOI [10.2147/HIV.S220461, DOI 10.2147/HIV.S220461]; Zerihun KW, 2019, BMC RES NOTES, V12, DOI 10.1186/s13104-019-4214-3	46	0	0	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	3							e0265337	10.1371/journal.pone.0265337	http://dx.doi.org/10.1371/journal.pone.0265337			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	0P6KD	35333889	Green Published, gold			2022-12-26	WOS:000784335700010
J	Saeed, A; Algehyne, EA; Aldhabani, MS; Dawar, A; Kumam, P; Kumam, W				Saeed, Anwar; Algehyne, Ebrahem A.; Aldhabani, Musaad S.; Dawar, Abdullah; Kumam, Poom; Kumam, Wiyada			Mixed convective flow of a magnetohydrodynamic Casson fluid through a permeable stretching sheet with first-order chemical reaction	PLOS ONE			English	Article							STAGNATION POINT FLOW; BOUNDARY-LAYER-FLOW; MASS-TRANSFER; POROUS-MEDIUM; HEAT-TRANSFER; NATURAL-CONVECTION; NANOFLUID; RADIATION; PLATE	This research article presents the magnetohydrodynamic Casson fluid flow through an extending surface embedded in a porous medium. Furthermore, the Casson fluid flow is investigated under the effects of thermal radiation, Joule heating, viscous dissipation, and chemical reaction. The analytical solution of the modeled problem is utilized with the help of homotopy analysis method (HAM). The convergence region of the applied technique is portrayed graphically. The impacts of the embedded factors on the flow profiles are exhibited with the help of figures. Furthermore, numerical values of the surface drag force, heat, and mass transfer rates are highlighted via table. The results show that the augmented Darcy number, Casson and magnetic parameters have declined the velocity profile of the Casson fluid flow. Growth in Brownian motion augments the chaotic motion amongst the particles due to which the kinetic energy of the particles transforms to heat energy which consequently augmented the thermal profile, while reduced the concentration profile. The mass and energy profiles are positively effects with the increment of thermophoresis term. And the growing values of chemical reaction and Lewis number cause a reduction in the diffusivity of mass of fluid due to which less transfer of mass takes place that weakens the concentration layer thickness and declines the concentration profiles.	[Saeed, Anwar; Kumam, Poom] King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Ctr Excellence Theoret & Computat Sci TaCS CoE, Bangkok, Thailand; [Algehyne, Ebrahem A.; Aldhabani, Musaad S.] Univ Tabuk, Fac Sci, Dept Math, Tabuk, Saudi Arabia; [Algehyne, Ebrahem A.] Univ Tabuk, Nanotechnol Res Unit NRU, Tabuk, Saudi Arabia; [Dawar, Abdullah] Abdul Wali Khan Univ, Dept Math, Mardan, Khyber Pakhtunk, Pakistan; [Kumam, Poom] China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan; [Kumam, Wiyada] Rajamangala Univ Technol Thanyaburi, Fac Sci & Technol, Appl Math Sci & Engn Res Unit AMSERU, Dept Math & Comp Sci,Program Appl Stat, Thanyaburi, Pathumthani, Thailand	King Mongkuts University of Technology Thonburi; University of Tabuk; University of Tabuk; Abdul Wali Khan University; China Medical University Taiwan; China Medical University Hospital - Taiwan; Rajamangala University of Technology Thanyaburi	Kumam, P (corresponding author), King Mongkuts Univ Technol Thonburi KMUTT, Fac Sci, Ctr Excellence Theoret & Computat Sci TaCS CoE, Bangkok, Thailand.; Kumam, P (corresponding author), China Med Univ, China Med Univ Hosp, Dept Med Res, Taichung, Taiwan.	poom.kum@kmutt.ac.th	Kumam, Poom/E-7122-2011; Dawar, Abdullah/W-1870-2018	Kumam, Poom/0000-0002-5463-4581; Dawar, Abdullah/0000-0001-9073-7556; Saeed, Anwar/0000-0003-1566-6457	Center of Excellence in Theoretical and Computational Science; KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund [2022 (FF65)]	Center of Excellence in Theoretical and Computational Science; KMUTT; Thailand Science Research and Innovation (TSRI) Basic Research Fund	The authors acknowledge the financial support provided by the Center of Excellence in Theoretical and Computational Science (TaCS-CoE), KMUTT. Moreover, this research project is supported by Thailand Science Research and Innovation (TSRI) Basic Research Fund: Fiscal year 2022 (FF65). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelmalek Z, 2020, J MATER RES TECHNOL, V9, P11948, DOI 10.1016/j.jmrt.2020.08.014; Ahmad S, 2021, CASE STUD THERM ENG, V25, DOI 10.1016/j.csite.2021.100932; Ashraf K, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/ab72c1; Bandaru M, 2017, THERM SCI, V21, P2781, DOI 10.2298/TSCI150619004B; BEJAN A, 1985, INT J HEAT MASS TRAN, V28, P909, DOI 10.1016/0017-9310(85)90272-8; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Carbonell R.G., 1984, FUNDAMENTALS TRANSPO, P121, DOI 10.1007/978-94-009-6175-33; Chaudhary RC, 2007, ROM J PHYS, V52, P505; Dagana J., 2020, MHD FREE CONVECTION; Das S, 1999, INT COMMUN HEAT MASS, V26, P569, DOI 10.1016/S0735-1933(99)00043-3; Gangadhar K., 2013, CHEM REACTING MHD BO; Gowda RJP, 2021, PROCESSES, V9, DOI 10.3390/pr9040702; Hussain SM, 2017, J MAGN MAGN MATER, V422, P112, DOI 10.1016/j.jmmm.2016.08.081; Jiang XY, 2020, PHYS FLUIDS, V32, DOI 10.1063/5.0032821; Khan A, 2021, CASE STUD THERM ENG, V25, DOI 10.1016/j.csite.2021.100989; Khan A, 2021, PLOS ONE, V16, DOI 10.1371/journal.pone.0249264; Khan A, 2021, SCI REP-UK, V11, DOI 10.1038/s41598-021-86968-8; Khan A, 2021, PHYS SCRIPTA, V96, DOI 10.1088/1402-4896/abdf83; Krishna MV, 2020, J POROUS MEDIA, V23, P751, DOI 10.1615/JPorMedia.2020023817; Kumar MA., 2021, INT J THERMOFLUIDS, V9, P100061; Mabood F, 2016, ADV POWDER TECHNOL, V27, P742, DOI 10.1016/j.apt.2016.02.033; Makinde OD, 2013, INT J HEAT MASS TRAN, V62, P526, DOI 10.1016/j.ijheatmasstransfer.2013.03.049; Mittal AS, 2020, PHYSICA A, V537, DOI 10.1016/j.physa.2019.122710; Noor NAM, 2020, PHYS SCRIPTA, V95, DOI 10.1088/1402-4896/abb695; Raju RS, 2018, J NANOFLUIDS, V7, P694, DOI 10.1166/jon.2018.1500; Ramezanizadeh M, 2019, INT J LOW-CARBON TEC, V14, P468, DOI 10.1093/ijlct/ctz030; Rashidi MM, 2021, NANOMATERIALS-BASEL, V11, DOI 10.3390/nano11113084; Reddy PS, 2017, POWDER TECHNOL, V307, P46, DOI 10.1016/j.powtec.2016.11.017; Sankad GC., 2021, ADV MATH SCI J, V10, P155, DOI [10.37418/amsj.10.1.16, DOI 10.37418/AMSJ.10.1.16]; Seth G., 2015, J EGYPT MATH SOC, V23, P197, DOI [10.1016/j.joems.2014.03.006, DOI 10.1016/J.JOEMS.2014.03.006]; Shah Z, 2020, SCI REP-UK, V10, DOI 10.1038/s41598-020-61125-9; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Ul Haq R, 2020, INT COMMUN HEAT MASS, V114, DOI 10.1016/j.icheatmasstransfer.2020.104583; YAGLOM AM, 1974, J FLUID MECH, V62, P601, DOI 10.1017/S0022112074000838	34	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One		2022	17	4							e0265238	10.1371/journal.pone.0265238	http://dx.doi.org/10.1371/journal.pone.0265238			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	1T5DI	35363789	Green Published, gold			2022-12-26	WOS:000804748600036
